,Unnamed: 0,label,word_pos,text
0,564,mainstream,"Ousted_VBN Health_NNP and_CC Human_NNP Services_NNPS scientist_NN Rick_NNP Bright_NNP is_VBZ accusing_VBG HHS_NNP Secretary_NNP Alex_NNP Azar_NNP of_IN continuing_VBG to_TO retaliate_VB against_IN him_PRP in_IN his_PRP$ new_JJ position_NN at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. In_IN early_JJ May_NNP ,_, Bright_NNP filed_VBD a_DT whistleblower_NN complaint_NN alleging_VBG he_PRP was_VBD removed_VBN from_IN his_PRP$ original_JJ role_NN after_IN he_PRP pushed_VBD to_TO vet_VB and_CC to_TO limit_VB drug_NN treatments_NNS often_RB touted_VBN by_IN President_NNP Trump_NNP ._. In_IN an_DT amended_VBN whistleblower_NN complaint_NN ,_, Bright_NNP claimed_VBD that_IN Dr._NNP Gary_NNP Disbrow_NNP ,_, who_WP replaced_VBD Bright_NNP in_IN an_DT acting_NN capacity_NN as_IN head_NN of_IN the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP (_-LRB- BARDA_NNP )_-RRB- ,_, told_VBD an_DT HHS_NNP employee_NN that_IN Azar_NNP said_VBD ""_`` if_IN anyone_NN were_VBD to_TO help_VB Dr._NNP Bright_NNP be_VB successful_JJ ,_, '_`` there_EX would_MD be_VB hell_NN to_TO pay_VB ._. '_'' ""_'' Disbrow_NNP ,_, with_IN whom_WP Bright_NNP said_VBD he_PRP had_VBD a_DT ""_`` positive_JJ relationship_NN for_IN nearly_RB ten_CD years_NNS ,_, ""_'' reportedly_RB told_VBD the_DT employee_NN that_IN ""_`` Azar_NNP 's_POS staff_NN was_VBD '_`` watching_VBG them_PRP closely_RB ._. '_'' ""_'' Disbrow_NNP denied_VBD Bright_NNP 's_POS claims_NNS on_IN Thursday_NNP night_NN ._. ""_`` I_PRP did_VBD not_RB make_VB any_DT of_IN these_DT statements_NNS and_CC Secretary_NNP Azar_NNP has_VBZ never_RB spoken_VBN to_IN me_PRP in_IN the_DT manner_NN alleged_VBN ,_, ""_'' he_PRP said_VBD in_IN a_DT statement_NN ._. ""_`` I_PRP have_VBP also_RB never_RB instructed_VBN any_DT BARDA_NNP employee_NN not_RB to_TO talk_VB to_IN Rick_NNP ._. In_IN fact_NN ,_, I_PRP had_VBD a_DT conversation_NN with_IN him_PRP yesterday_NN about_IN how_WRB to_TO collaborate_VB between_IN RADx_NNP and_CC BARDA_NNP ._. I_PRP am_VBP confused_VBN by_IN these_DT untrue_JJ statements_NNS and_CC allegations_NNS ,_, which_WDT distract_VBP from_IN the_DT important_JJ work_NN we_PRP are_VBP doing_VBG in_IN response_NN to_IN the_DT coronavirus_NN ._. ""_'' HHS_NNP spokesman_NN Michael_NNP Caputo_NNP also_RB denied_VBD the_DT allegations_NNS on_IN Twitter_NNP ,_, writing_VBG ,_, ""_`` Once_RB again_RB ,_, more_RBR misleading_JJ claims_NNS from_IN Rick_NNP Bright_NNP ._. His_PRP$ whistleblower_NN complaint_NN is_VBZ filled_VBN with_IN one_CD -_HYPH sided_VBN arguments_NNS and_CC misinformation_NN that_WDT have_VBP been_VBN completely_RB debunked_VBN ._. ""_'' Bright_NNP has_VBZ repeatedly_RB linked_VBN his_PRP$ removal_NN from_IN BARDA_NNP to_IN his_PRP$ stance_NN on_IN chloroquine_NN and_CC hydroxychloroquine_NN ._. Bright_NNP said_VBD the_DT drugs_NNS were_VBD ""_`` promoted_VBN by_IN the_DT Administration_NNP as_IN a_DT panacea_NN ,_, but_CC ..._, clearly_RB lack_VBP scientific_JJ merit_NN ._. ""_'' The_DT drugs_NNS were_VBD granted_VBN an_DT emergency_NN use_NN authorization_NN by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP for_IN treatment_NN of_IN COVID_NNP -_HYPH 19_CD ,_, and_CC President_NNP Trump_NNP even_RB took_VBD a_DT course_NN of_IN hydroxychloroquine_NN ._. Earlier_RBR this_DT month_NN ,_, the_DT FDA_NNP withdrew_VBD the_DT authorization_NN because_IN the_DT drugs_NNS are_VBP ""_`` unlikely_JJ to_TO be_VB effective_JJ in_IN treating_VBG COVID_NN -_HYPH 19_CD for_IN the_DT authorized_VBN uses_NNS ,_, ""_'' and_CC could_MD have_VB ""_`` serious_JJ side_NN effects_NNS ,_, ""_'' according_VBG to_IN the_DT administration_NN ._. Bright_NNP told_VBD Congress_NNP in_IN testimony_NN in_IN May_NNP that_IN ""_`` time_NN is_VBZ running_VBG out_RP ""_'' to_TO develop_VB a_DT nationwide_JJ strategy_NN for_IN combating_VBG the_DT coronavirus_NN pandemic_NN and_CC distributing_VBG a_DT vaccine_NN ._. Without_IN such_PDT a_DT strategy_NN ,_, he_PRP said_VBD he_PRP feared_VBD the_DT pandemic_NN would_MD ""_`` get_VB far_RB worse_JJR and_CC be_VB prolonged_VBN ,_, causing_VBG unprecedented_JJ illness_NN and_CC fatalities_NNS ._. ""_'' In_IN his_PRP$ tenure_NN at_IN BARDA_NNP ,_, Bright_NNP ,_, who_WP is_VBZ one_CD of_IN the_DT nation_NN 's_POS leading_VBG vaccine_NN experts_NNS ,_, worked_VBD on_IN the_DT development_NN of_IN vaccines_NNS for_IN the_DT flu_NN ,_, Zika_NNP and_CC Ebola_NNP ._. Now_RB ,_, in_IN his_PRP$ NIH_NNP role_NN ,_, Bright_NNP said_VBD he_PRP 's_VBZ excluded_VBN from_IN that_DT work_NN ,_, and_CC has_VBZ what_WP he_PRP characterized_VBD as_IN an_DT ""_`` extremely_RB narrow_JJ role_NN ""_'' in_IN making_VBG contracts_NNS with_IN diagnostics_NN companies_NNS to_TO increase_VB their_PRP$ production_NN ._. In_IN his_PRP$ amended_VBN complaint_NN ,_, Bright_NNP requested_VBD that_IN he_PRP be_VB reinstated_VBN as_IN director_NN of_IN BARDA_NNP ,_, that_IN Azar_NNP recuse_VB himself_PRP from_IN the_DT case_NN and_CC that_IN HHS_NNP leadership_NN stop_VB retaliating_VBG against_IN him_PRP ._. Adam_NNP Verdugo_NNP ,_, Weijia_NNP Jiang_NNP and_CC Grace_NNP Segers_NNP contributed_VBD to_IN this_DT report_NN ._.","VBN NNP and NNP NNPS NN NNP NNP VBZ VBG NNP NNP NNP NNP of VBG to VB against him in his JJ NN at the NNP NNPS of NNP . In JJ NNP , NNP VBD a NN NN VBG he VBD VBN from his JJ NN after he VBD to VB and to VB NN NNS RB VBN by NNP NNP . In an VBN NN NN , NNP VBD that NNP NNP NNP , who VBD NNP in an NN NN as NN of the NNP NNP NNP and NNP NNP ( NNP ) , VBD an NNP NN that NNP VBD "" if NN VBD to VB NNP NNP VB JJ , ' there would VB NN to VB . ' "" NNP , with whom NNP VBD he VBD a "" JJ NN for RB ten NNS , "" RB VBD the NN that "" NNP 's NN VBD ' VBG them RB . ' "" NNP VBD NNP 's NNS on NNP NN . "" I VBD RB VB any of these NNS and NNP NNP VBZ RB VBN to me in the NN VBN , "" he VBD in a NN . "" I VBP RB RB VBN any NNP NN RB to VB to NNP . In NN , I VBD a NN with him NN about how to VB between NNP and NNP . I VBP VBN by these JJ NNS and NNS , which VBP from the JJ NN we VBP VBG in NN to the NN . "" NNP NN NNP NNP RB VBD the NNS on NNP , VBG , "" RB RB , RBR JJ NNS from NNP NNP . His NN NN VBZ VBN with one - VBN NNS and NN that VBP VBN RB VBN . "" NNP VBZ RB VBN his NN from NNP to his NN on NN and NN . NNP VBD the NNS VBD "" VBN by the NNP as a NN , but ... RB VBP JJ NN . "" The NNS VBD VBN an NN NN NN by the NNP and NNP NNP for NN of NNP - 19 , and NNP NNP RB VBD a NN of NN . RBR this NN , the NNP VBD the NN because the NNS VBP "" JJ to VB JJ in VBG NN - 19 for the VBN NNS , "" and could VB "" JJ NN NNS , "" VBG to the NN . NNP VBD NNP in NN in NNP that "" NN VBZ VBG out "" to VB a JJ NN for VBG the NN NN and VBG a NN . Without such a NN , he VBD he VBD the NN would "" VB RB JJR and VB VBN , VBG JJ NN and NNS . "" In his NN at NNP , NNP , who VBZ one of the NN 's VBG NN NNS , VBD on the NN of NNS for the NN , NNP and NNP . RB , in his NNP NN , NNP VBD he VBZ VBN from that NN , and VBZ what he VBD as an "" RB JJ NN "" in VBG NNS with NN NNS to VB their NN . In his VBN NN , NNP VBD that he VB VBN as NN of NNP , that NNP VB himself from the NN and that NNP NN VB VBG against him . NNP NNP , NNP NNP and NNP NNP VBD to this NN ."
1,292,mainstream,"Humans_NNS are_VBP hard_RB -_HYPH wired_VBN to_TO avoid_VB uncertainty_NN ._. But_CC when_WRB it_PRP comes_VBZ to_IN the_DT coronavirus_NN crisis_NN ,_, uncertainty_NN is_VBZ unavoidable_JJ ._. Every_DT day_NN ,_, we_PRP ’re_VBP bombarded_VBN with_IN ambiguous_JJ ,_, complex_JJ ,_, and_CC often_RB conflicting_VBG information_NN ._. To_TO make_VB sense_NN out_IN of_IN all_PDT this_DT noise_NN ,_, the_DT authors_NNS describe_VBP a_DT framework_NN for_IN understanding_VBG different_JJ types_NNS of_IN informational_JJ uncertainty_NN ._. They_PRP then_RB suggest_VBP several_JJ strategies_NNS for_IN coping_VBG with_IN that_DT uncertainty_NN ,_, both_CC cognitively_RB (_-LRB- to_TO more_RBR effectively_RB process_VB and_CC make_VB sense_NN of_IN information_NN )_-RRB- and_CC emotionally_RB (_-LRB- to_TO mitigate_VB the_DT stress_NN and_CC anxiety_NN that_WDT result_VBP from_IN uncertainty_NN )_-RRB- ._. Will_MD colleges_NNS and_CC universities_NNS restart_VB in_IN -_HYPH person_NN classes_NNS this_DT fall_NN ?_. Will_MD there_EX be_VB a_DT vaccine_NN for_IN the_DT novel_JJ coronavirus_NN soon_RB ?_. Will_MD there_EX be_VB second_JJ wave_NN of_IN the_DT virus_NN ?_. Do_VBP I_PRP wear_VB a_DT mask_NN outside_RB even_RB if_IN I_PRP plan_VBP to_TO socially_RB distance_NN ?_. How_WRB can_MD I_PRP figure_VB out_RP which_WDT news_NN sources_NNS and_CC leaders_NNS to_TO trust_VB ?_. Every_DT day_NN we_PRP are_VBP faced_VBN with_IN a_DT torrent_NN of_IN information_NN from_IN news_NN articles_NNS ,_, cable_NN networks_NNS ,_, social_JJ media_NN ,_, the_DT White_NNP House_NNP ,_, the_DT Center_NNP for_IN Disease_NNP Control_NNP –_: and_CC yet_RB ,_, there_EX are_VBP no_DT clear_JJ answers_NNS ._. As_IN humans_NNS ,_, we_PRP innately_RB find_VBP uncertainty_NN to_TO be_VB an_DT aversive_JJ state_NN and_CC are_VBP motivated_VBN to_TO reduce_VB it_PRP ,_, even_RB at_IN a_DT cost_NN ._. Research_NN has_VBZ shown_VBN that_IN people_NNS are_VBP calmer_JJR and_CC less_RBR agitated_JJ when_WRB they_PRP know_VBP they_PRP are_VBP going_VBG to_TO receive_VB an_DT electric_JJ shock_NN than_IN when_WRB they_PRP know_VBP there_EX is_VBZ a_DT 50_CD %_NN chance_NN they_PRP might_MD receive_VB an_DT electric_JJ shock_NN ._. Similarly_RB ,_, the_DT threat_NN of_IN perceived_VBN job_NN insecurity_NN has_VBZ more_RBR detrimental_JJ health_NN effects_NNS than_IN actually_RB losing_VBG a_DT job_NN ._. Feeling_VBG uncertain_JJ is_VBZ not_RB a_DT natural_JJ state_NN of_IN being_VBG for_IN us_PRP —_: it_PRP signals_VBZ to_IN the_DT brain_NN that_IN things_NNS are_VBP not_RB right_JJ ._. The_DT brain_NN then_RB seeks_VBZ out_RP information_NN to_TO resolve_VB the_DT uncertainty_NN ._. This_DT desire_NN for_IN resolution_NN is_VBZ why_WRB feelings_NNS of_IN uncertainty_NN lead_VBP us_PRP to_TO process_VB information_NN more_RBR systematically_RB and_CC deeply_RB in_IN the_DT hope_NN of_IN finding_VBG answers_NNS ._. But_CC the_DT coronavirus_NN pandemic_NN leaves_VBZ us_PRP in_IN a_DT quandary_NN :_: Our_PRP$ natural_JJ instinct_NN is_VBZ to_TO try_VB to_TO resolve_VB our_PRP$ intense_JJ feelings_NNS of_IN uncertainty_NN ,_, but_CC there_EX is_VBZ so_RB much_JJ uncertainty_NN around_IN the_DT virus_NN and_CC its_PRP$ effects_NNS that_IN a_DT quest_NN for_IN complete_JJ resolution_NN is_VBZ futile_JJ ._. So_RB what_WP can_MD we_PRP do_VB ?_. First_RB ,_, it_PRP is_VBZ important_JJ to_TO understand_VB that_IN uncertainty_NN is_VBZ multi-dimensional_JJ ._. There_EX are_VBP at_IN least_JJS three_CD types_NNS of_IN uncertainty_NN :_: probability_NN ,_, ambiguity_NN ,_, and_CC complexity_NN ._. To_TO cope_VB with_IN each_DT ,_, we_PRP have_VBP identified_VBN several_JJ strategies_NNS ,_, both_CC cognitive_JJ (_-LRB- to_TO more_RBR effectively_RB process_VB and_CC make_VB sense_NN of_IN information_NN )_-RRB- and_CC emotional_JJ (_-LRB- to_TO mitigate_VB the_DT stress_NN and_CC anxiety_NN that_WDT result_VBP from_IN uncertainty_NN )_-RRB- ._. Probability_NN uncertainty_NN refers_VBZ to_IN situations_NNS in_IN which_WDT it_PRP is_VBZ difficult_JJ to_TO ascertain_VB risk_NN levels_NNS :_: Not_RB only_RB do_VBP you_PRP not_RB know_VB what_WP will_MD happen_VB ,_, you_PRP also_RB do_VBP n’t_RB know_VB how_WRB likely_JJ each_DT outcome_NN is_VBZ ._. For_IN example_NN ,_, how_WRB much_JJ am_VBP I_PRP really_RB at_IN risk_NN compared_VBN to_IN others_NNS in_IN my_PRP$ group_NN ?_. People_NNS of_IN my_PRP$ age_NN ?_. People_NNS where_WRB I_PRP live_VBP ?_. People_NNS who_WP behave_VBP like_IN me_PRP ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, the_DT first_JJ thing_NN to_TO do_VB is_VBZ to_TO understand_VB that_IN you_PRP are_VBP at_IN risk_NN as_RB much_RB as_IN any_DT other_JJ member_NN of_IN your_PRP$ group_NN ._. Research_NN shows_VBZ that_IN people_NNS tend_VBP to_TO underestimate_VB their_PRP$ own_JJ risk_NN of_IN contracting_VBG a_DT disease_NN or_CC encountering_VBG a_DT negative_JJ event_NN ._. This_DT is_VBZ a_DT self_NN -_HYPH positivity_NN bias_NN ,_, that_DT needs_VBZ to_TO be_VB overcome_VBN ._. Recognize_VB that_IN you_PRP are_VBP as_RB much_RB at_IN risk_NN as_IN everyone_NN else_JJ ,_, and_CC focus_VB on_IN what_WP you_PRP know_VBP you_PRP can_MD do_VB to_TO reduce_VB risk_NN by_IN complying_VBG with_IN expert_NN recommendations_NNS (_-LRB- e.g._FW ,_, wash_VB hands_NNS often_RB ,_, wear_VB facial_JJ coverings_NNS in_IN public_NN ,_, maintain_VB social_JJ distancing_NN )_-RRB- ._. Do_VB n’t_RB be_VB that_DT person_NN who_WP gets_VBZ yelled_VBN at_IN in_IN a_DT grocery_NN store_NN for_IN not_RB wearing_VBG a_DT mask_NN !_. Emotionally_RB ,_, it_PRP is_VBZ important_JJ to_TO embrace_VB that_IN you_PRP are_VBP at_IN as_RB much_JJ risk_NN as_IN the_DT people_NNS around_IN you_PRP and_CC empathize_VBP with_IN them_PRP on_IN this_DT common_JJ ground_NN ._. Connect_VB virtually_RB (_-LRB- or_CC in_IN person_NN with_IN appropriate_JJ social_JJ distance_NN ,_, if_IN allowed_VBN )_-RRB- with_IN people_NNS you_PRP care_VBP about_IN ,_, whether_IN they_PRP are_VBP friends_NNS ,_, family_NN or_CC neighbors_NNS ._. Accept_VB that_IN we_PRP ’re_VBP all_RB in_IN the_DT same_JJ boat_NN and_CC we_PRP ’re_VBP all_RB doing_VBG our_PRP$ best_JJS to_TO get_VB through_IN this_DT together_RB ._. Ambiguity_NN uncertainty_NN refers_VBZ to_IN situations_NNS in_IN which_WDT we_PRP are_VBP faced_VBN with_IN imprecise_JJ ,_, insufficient_JJ ,_, or_CC conflicting_JJ information_NN ._. For_IN example_NN ,_, we_PRP were_VBD told_VBN that_IN the_DT virus_NN could_MD be_VB transmitted_VBN through_IN hard_JJ surfaces_NNS such_JJ as_IN cardboard_NN ,_, plastic_NN ,_, metal_NN ,_, etc_FW ._. Now_RB the_DT CDC_NNP believes_VBZ that_IN the_DT virus_NN is_VBZ mostly_RB airborne_JJ and_CC that_IN the_DT chances_NNS of_IN contracting_VBG the_DT virus_NN through_IN surfaces_NNS is_VBZ very_RB small_JJ ._. What_WP does_VBZ that_DT mean_VB for_IN my_PRP$ behavior_NN ?_. Can_MD I_PRP get_VB the_DT virus_NN from_IN not_RB just_RB someone_NN ’s_POS cough_NN ,_, but_CC if_IN they_PRP speak_VBP to_IN me_PRP ?_. Is_VBZ six_CD feet_NNS of_IN social_JJ distancing_NN enough_RB to_TO protect_VB myself_PRP ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, consolidate_VB the_DT different_JJ sources_NNS of_IN information_NN and_CC try_VB to_TO get_VB clarity_NN through_IN what_WP social_JJ scientists_NNS call_VBP triangulation_NN (_-LRB- i.e._FW ,_, using_VBG multiple_JJ measures_NNS or_CC methods_NNS to_TO ensure_VB that_IN they_PRP all_DT converge_VBP on_IN the_DT same_JJ result_NN )_-RRB- ._. Rely_VB most_JJS on_IN information_NN that_WDT is_VBZ reported_VBN consistently_RB through_IN multiple_JJ reliable_JJ sources_NNS ._. But_CC also_RB understand_VB that_IN the_DT coronavirus_NN is_VBZ novel_JJ ,_, and_CC that_IN the_DT science_NN around_IN it_PRP keeps_VBZ evolving_VBG ._. So_RB sometimes_RB we_PRP need_VBP to_TO find_VB a_DT non-cognitive_JJ approach_NN that_WDT does_VBZ not_RB involve_VB trying_VBG to_TO resolve_VB uncertainty_NN ._. Cope_VB emotionally_RB by_IN knowing_VBG when_WRB it_PRP ’s_VBZ time_NN to_TO end_VB the_DT search_NN for_IN more_JJR information_NN ._. Sources_NNS such_JJ as_IN the_DT CDC_NNP warn_VBP against_IN information_NN overload_NN :_: “_`` Take_VB breaks_NNS from_IN watching_VBG ,_, reading_NN ,_, or_CC listening_VBG to_IN news_NN stories_NNS ,_, including_VBG social_JJ media_NN ._. Hearing_VBG about_IN the_DT pandemic_NN repeatedly_RB can_MD be_VB upsetting_JJ ._. ”_'' Recognize_VB that_IN the_DT endless_JJ search_NN for_IN clarity_NN can_MD create_VB more_JJR stress_NN than_IN it_PRP alleviates_VBZ ,_, and_CC sometimes_RB enough_RB is_VBZ enough_JJ ._. This_DT occurs_VBZ when_WRB an_DT issue_NN is_VBZ technically_RB complex_JJ and_CC difficult_JJ to_TO understand_VB :_: For_IN example_NN ,_, for_IN non-statisticians_NNS ,_, it_PRP can_MD be_VB hard_JJ to_TO understand_VB what_WP “_`` flattening_VBG the_DT curve_NN ”_'' really_RB means_VBZ ,_, why_WRB it_PRP ’s_VBZ important_JJ ,_, and_CC how_WRB to_TO balance_VB different_JJ factors_NNS such_JJ as_IN resource_NN constraints_NNS ,_, geographical_JJ variances_NNS ,_, and_CC economic_JJ considerations_NNS ._. Is_VBZ it_PRP true_JJ that_IN a_DT week_NN ’s_POS delay_NN in_IN lockdown_NN in_IN March_NNP led_VBD to_IN a_DT loss_NN of_IN 36,000_CD lives_NNS ?_. And_CC now_RB ,_, how_WRB is_VBZ each_DT state_NN or_CC county_NN making_VBG the_DT decision_NN to_TO reopen_VB ,_, and_CC how_WRB are_VBP they_PRP balancing_VBG economic_JJ loss_NN against_IN the_DT loss_NN of_IN human_JJ life_NN ?_. As_IN a_DT cognitive_JJ coping_NN mechanism_NN ,_, consult_VB an_DT expert_NN source_NN well_RB versed_VBN in_IN the_DT field_NN to_TO break_VB down_RP complex_JJ information_NN into_IN understandable_JJ nuggets_NNS ._. Make_VB sure_JJ to_TO find_VB sources_NNS grounded_VBN in_IN science_NN ,_, not_RB partisanship_NN ._. And_CC again_RB ,_, recognize_VB when_WRB the_DT quest_NN for_IN information_NN is_VBZ helpful_JJ ,_, and_CC when_WRB it_PRP is_VBZ n’t_RB ._. Maybe_RB what_WP ’s_VBZ needed_VBN right_RB now_RB is_VBZ not_RB to_TO understand_VB the_DT details_NNS of_IN each_DT epidemiological_JJ model_NN ,_, but_CC instead_RB to_TO just_RB understand_VB what_WDT actions_NNS we_PRP need_VBP to_TO take_VB to_TO be_VB safe_JJ ._. Simplify_VB the_DT complexity_NN into_IN an_DT actionable_JJ piece_NN of_IN information_NN (_-LRB- e.g._FW ,_, wear_VB a_DT mask_NN when_WRB going_VBG outside_RB )_-RRB- ._. If_IN this_DT gets_VBZ too_RB overwhelming_JJ ,_, cope_VB emotionally_RB by_IN finding_VBG ways_NNS to_TO escape_VB the_DT complexity_NN :_: Re-watch_VB a_DT favorite_JJ TV_NN show_NN ,_, knit_VB a_DT blanket_NN ,_, or_CC organize_VB your_PRP$ closet_NN by_IN color_NN ._. Or_CC if_IN you_PRP can_MD ,_, escape_VB your_PRP$ own_JJ stresses_NNS by_IN making_VBG this_DT world_NN a_DT little_JJ less_RBR stressful_JJ for_IN others_NNS :_: Donate_VB to_IN your_PRP$ local_JJ food_NN bank_NN ,_, support_VB your_PRP$ local_JJ businesses_NNS ,_, or_CC even_RB bail_VB someone_NN out_IN of_IN jail_NN ._. Taking_VBG these_DT steps_NNS to_TO mitigate_VB informational_JJ uncertainty_NN will_MD leave_VB you_PRP with_IN the_DT mental_JJ bandwidth_NN to_TO cope_VB with_IN the_DT many_JJ other_JJ important_JJ issues_NNS we_PRP all_DT face_VBP ._. And_CC in_IN these_DT trying_VBG times_NNS ,_, it_PRP ’s_VBZ best_JJS to_TO take_VB every_DT chance_NN you_PRP get_VBP to_TO unwind_VB and_CC find_VB some_DT moments_NNS of_IN zen_NN ._.","NNS VBP RB - VBN to VB NN . But when it VBZ to the NN NN , NN VBZ JJ . Every NN , we VBP VBN with JJ , JJ , and RB VBG NN . To VB NN out of all this NN , the NNS VBP a NN for VBG JJ NNS of JJ NN . They RB VBP JJ NNS for VBG with that NN , both RB ( to RBR RB VB and VB NN of NN ) and RB ( to VB the NN and NN that VBP from NN ) . Will NNS and NNS VB in - NN NNS this NN ? Will there VB a NN for the JJ NN RB ? Will there VB JJ NN of the NN ? VBP I VB a NN RB RB if I VBP to RB NN ? How can I VB out which NN NNS and NNS to VB ? Every NN we VBP VBN with a NN of NN from NN NNS , NN NNS , JJ NN , the NNP NNP , the NNP for NNP NNP – and RB , there VBP no JJ NNS . As NNS , we RB VBP NN to VB an JJ NN and VBP VBN to VB it , RB at a NN . NN VBZ VBN that NNS VBP JJR and RBR JJ when they VBP they VBP VBG to VB an JJ NN than when they VBP there VBZ a 50 NN NN they might VB an JJ NN . RB , the NN of VBN NN NN VBZ RBR JJ NN NNS than RB VBG a NN . VBG JJ VBZ RB a JJ NN of VBG for us — it VBZ to the NN that NNS VBP RB JJ . The NN RB VBZ out NN to VB the NN . This NN for NN VBZ why NNS of NN VBP us to VB NN RBR RB and RB in the NN of VBG NNS . But the NN NN VBZ us in a NN : Our JJ NN VBZ to VB to VB our JJ NNS of NN , but there VBZ RB JJ NN around the NN and its NNS that a NN for JJ NN VBZ JJ . RB what can we VB ? RB , it VBZ JJ to VB that NN VBZ JJ . There VBP at JJS three NNS of NN : NN , NN , and NN . To VB with each , we VBP VBN JJ NNS , both JJ ( to RBR RB VB and VB NN of NN ) and JJ ( to VB the NN and NN that VBP from NN ) . NN NN VBZ to NNS in which it VBZ JJ to VB NN NNS : RB RB VBP you RB VB what will VB , you RB VBP RB VB how JJ each NN VBZ . For NN , how JJ VBP I RB at NN VBN to NNS in my NN ? NNS of my NN ? NNS where I VBP ? NNS who VBP like me ? As a JJ NN NN , the JJ NN to VB VBZ to VB that you VBP at NN RB RB as any JJ NN of your NN . NN VBZ that NNS VBP to VB their JJ NN of VBG a NN or VBG a JJ NN . This VBZ a NN - NN NN , that VBZ to VB VBN . VB that you VBP RB RB at NN as NN JJ , and VB on what you VBP you can VB to VB NN by VBG with NN NNS ( FW , VB NNS RB , VB JJ NNS in NN , VB JJ NN ) . VB RB VB that NN who VBZ VBN at in a NN NN for RB VBG a NN ! RB , it VBZ JJ to VB that you VBP at RB JJ NN as the NNS around you and VBP with them on this JJ NN . VB RB ( or in NN with JJ JJ NN , if VBN ) with NNS you VBP about , whether they VBP NNS , NN or NNS . VB that we VBP RB in the JJ NN and we VBP RB VBG our JJS to VB through this RB . NN NN VBZ to NNS in which we VBP VBN with JJ , JJ , or JJ NN . For NN , we VBD VBN that the NN could VB VBN through JJ NNS JJ as NN , NN , NN , FW . RB the NNP VBZ that the NN VBZ RB JJ and that the NNS of VBG the NN through NNS VBZ RB JJ . What VBZ that VB for my NN ? Can I VB the NN from RB RB NN ’s NN , but if they VBP to me ? VBZ six NNS of JJ NN RB to VB myself ? As a JJ NN NN , VB the JJ NNS of NN and VB to VB NN through what JJ NNS VBP NN ( FW , VBG JJ NNS or NNS to VB that they all VBP on the JJ NN ) . VB JJS on NN that VBZ VBN RB through JJ JJ NNS . But RB VB that the NN VBZ JJ , and that the NN around it VBZ VBG . RB RB we VBP to VB a JJ NN that VBZ RB VB VBG to VB NN . VB RB by VBG when it VBZ NN to VB the NN for JJR NN . NNS JJ as the NNP VBP against NN NN : “ VB NNS from VBG , NN , or VBG to NN NNS , VBG JJ NN . VBG about the NN RB can VB JJ . ” VB that the JJ NN for NN can VB JJR NN than it VBZ , and RB RB VBZ JJ . This VBZ when an NN VBZ RB JJ and JJ to VB : For NN , for NNS , it can VB JJ to VB what “ VBG the NN ” RB VBZ , why it VBZ JJ , and how to VB JJ NNS JJ as NN NNS , JJ NNS , and JJ NNS . VBZ it JJ that a NN ’s NN in NN in NNP VBD to a NN of 36,000 NNS ? And RB , how VBZ each NN or NN VBG the NN to VB , and how VBP they VBG JJ NN against the NN of JJ NN ? As a JJ NN NN , VB an NN NN RB VBN in the NN to VB down JJ NN into JJ NNS . VB JJ to VB NNS VBN in NN , RB NN . And RB , VB when the NN for NN VBZ JJ , and when it VBZ RB . RB what VBZ VBN RB RB VBZ RB to VB the NNS of each JJ NN , but RB to RB VB what NNS we VBP to VB to VB JJ . VB the NN into an JJ NN of NN ( FW , VB a NN when VBG RB ) . If this VBZ RB JJ , VB RB by VBG NNS to VB the NN : VB a JJ NN NN , VB a NN , or VB your NN by NN . Or if you can , VB your JJ NNS by VBG this NN a JJ RBR JJ for NNS : VB to your JJ NN NN , VB your JJ NNS , or RB VB NN out of NN . VBG these NNS to VB JJ NN will VB you with the JJ NN to VB with the JJ JJ JJ NNS we all VBP . And in these VBG NNS , it VBZ JJS to VB every NN you VBP to VB and VB some NNS of NN ."
2,270,mainstream,"NEW_NNP YORK_NNP (_-LRB- Reuters_NNP Health_NNP )_-RRB- -_, A_DT new_JJ government_NN study_NN adds_VBZ to_IN the_DT evidence_NN that_IN thimerosal_NN ,_, a_DT mercury_NN -_HYPH based_VBN preservative_NN until_IN recently_RB found_VBN in_IN many_JJ vaccines_NNS ,_, does_VBZ not_RB increase_VB children_NNS ’s_POS risk_NN of_IN autism_NN ._. It_PRP shows_VBZ kids_NNS who_WP had_VBD been_VBN exposed_VBN as_IN babies_NNS to_IN high_JJ levels_NNS of_IN the_DT preservative_NN —_: through_IN vaccines_NNS they_PRP received_VBD or_CC their_PRP$ mothers_NNS received_VBD while_IN pregnant_JJ —_: were_VBD no_RB more_RBR likely_JJ to_TO develop_VB autism_NN ,_, including_VBG two_CD distinct_JJ subtypes_NNS of_IN the_DT condition_NN ._. “_`` This_DT study_NN should_MD reassure_VB parents_NNS about_IN following_VBG the_DT recommended_VBN immunization_NN schedule_NN ,_, ”_'' said_VBD Dr._NNP Frank_NNP Destefano_NNP ,_, director_NN of_IN the_DT Immunization_NNP Safety_NNP Office_NNP at_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- in_IN Atlanta_NNP ,_, and_CC the_DT study_NN ’s_POS senior_JJ author_NN ._. Concerns_NNS about_IN a_DT link_NN between_IN vaccines_NNS and_CC autism_NN were_VBD first_RB raised_VBN more_JJR than_IN a_DT decade_NN ago_RB by_IN British_JJ physician_NN Andrew_NNP Wakefield_NNP ._. His_PRP$ report_NN ,_, based_VBN on_IN 12_CD children_NNS ,_, has_VBZ since_RB been_VBN discredited_VBN and_CC was_VBD retracted_VBN earlier_RBR this_DT year_NN by_IN the_DT journal_NN that_WDT published_VBD it_PRP ._. In_IN the_DT meantime_NN ,_, it_PRP sparked_VBD a_DT fierce_JJ worldwide_JJ debate_NN among_IN scientists_NNS and_CC a_DT health_NN scare_NN that_WDT caused_VBD many_JJ parents_NNS to_TO shy_VB away_RB from_IN recommended_VBN vaccines_NNS like_IN the_DT one_NN against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN ._. Outbreaks_NNS of_IN all_DT three_CD diseases_NNS followed_VBD ._. One_CD widespread_JJ worry_NN has_VBZ been_VBN that_IN thimerosal_NN might_MD play_VB a_DT role_NN in_IN the_DT development_NN of_IN autism_NN ,_, a_DT condition_NN that_WDT affects_VBZ as_RB many_JJ as_IN one_CD in_IN 110_CD U.S._NNP children_NNS ,_, according_VBG to_IN the_DT CDC_NNP ._. Most_JJS scientists_NNS consider_VBP autism_NN a_DT developmental_JJ disorder_NN ,_, likely_RB influenced_VBN by_IN genes_NNS ._. Autism_NN spectrum_NN disorders_NNS range_VBP from_IN mild_JJ Asperger_NN ’s_POS Syndrome_NN to_IN severe_JJ mental_JJ retardation_NN and_CC social_JJ disability_NN ,_, and_CC there_EX is_VBZ no_DT cure_NN or_CC good_JJ treatment_NN ._. The_DT CDC_NNP researchers_NNS used_VBD data_NNS for_IN U.S._NNP children_NNS born_VBN between_IN 1994_CD and_CC 1999_CD ,_, who_WP were_VBD enrolled_VBN in_IN one_CD of_IN three_CD managed_VBN care_NN organizations_NNS ._. They_PRP found_VBD 256_CD children_NNS with_IN an_DT autism_NN spectrum_NN disorder_NN and_CC compared_VBD them_PRP with_IN 752_CD children_NNS who_WP did_VBD not_RB have_VB the_DT condition_NN ,_, but_CC were_VBD matched_VBN for_IN age_NN and_CC sex_NN ._. No_RB matter_RB when_WRB a_DT child_NN had_VBD been_VBN exposed_VBN to_IN thimerosal_NN —_: before_IN birth_NN when_WRB the_DT mother_NN had_VBD a_DT shot_NN ,_, or_CC when_WRB the_DT child_NN itself_PRP was_VBD vaccinated_VBN as_IN a_DT baby_NN or_CC toddler_NN —_: there_EX was_VBD no_DT increase_NN in_IN the_DT risk_NN of_IN any_DT type_NN of_IN autism_NN spectrum_NN disorder_NN ._. In_IN fact_NN ,_, those_DT kids_NNS who_WP were_VBD exposed_VBN to_IN the_DT preservative_NN between_IN birth_NN and_CC 20_CD months_NNS of_IN age_NN had_VBD slightly_RB lower_JJR odds_NNS of_IN developing_VBG the_DT condition_NN ,_, although_IN the_DT researchers_NNS could_MD not_RB explain_VB that_DT result_NN ._. “_`` This_DT is_VBZ a_DT very_RB reassuring_JJ study_NN ,_, ”_'' said_VBD Dr._NNP Michael_NNP J._NNP Smith_NNP ,_, a_DT pediatrician_NN at_IN the_DT University_NNP of_IN Louisville_NNP School_NNP of_IN Medicine_NNP in_IN Kentucky_NNP who_WP was_VBD not_RB involved_VBN in_IN the_DT research_NN ._. “_`` These_DT data_NNS show_VBP that_IN you_PRP could_MD receive_VB a_DT thimerosal_NN vaccine_NN and_CC not_RB be_VB concerned_VBN about_IN it_PRP ._. ”_'' Smith_NNP ,_, who_WP said_VBD he_PRP has_VBZ a_DT fully_RB vaccinated_VBN two_CD -_HYPH month_NN -_HYPH old_JJ at_IN home_NN ,_, noted_VBD that_IN autism_NN rates_NNS have_VBP continued_VBN to_TO rise_VB ,_, although_IN thimerosal_NN has_VBZ been_VBN removed_VBN from_IN all_DT routine_JJ childhood_NN vaccines_NNS ,_, except_IN flu_NN shots_NNS ._. For_IN parents_NNS who_WP remain_VBP concerned_JJ about_IN thimerosal_NN in_IN the_DT flu_NN shots_NNS ,_, he_PRP said_VBD there_EX are_VBP alternatives_NNS without_IN the_DT preservative_NN ,_, such_JJ as_IN FluMist_NNP ,_, a_DT nasal_JJ spray_NN that_WDT can_MD be_VB used_VBN in_IN children_NNS aged_JJ two_CD and_CC older_JJR ._. Some_DT parents_NNS have_VBP also_RB worried_VBN that_IN giving_VBG too_RB many_JJ shots_NNS at_IN once_RB ,_, or_CC in_IN children_NNS who_WP are_VBP too_RB young_JJ ,_, could_MD cause_VB mental_JJ problems_NNS ._. Smith_NNP said_VBD studies_NNS had_VBD dispelled_VBN those_DT concerns_NNS one_CD by_IN one_CD ._. “_`` There_EX is_VBZ no_DT credible_JJ evidence_NN ”_'' for_IN a_DT link_NN between_IN vaccines_NNS and_CC autism_NN ,_, he_PRP told_VBD Reuters_NNP Health_NNP ._.","NNP NNP ( NNP NNP ) - A JJ NN NN VBZ to the NN that NN , a NN - VBN NN until RB VBN in JJ NNS , VBZ RB VB NNS ’s NN of NN . It VBZ NNS who VBD VBN VBN as NNS to JJ NNS of the NN — through NNS they VBD or their NNS VBD while JJ — VBD RB RBR JJ to VB NN , VBG two JJ NNS of the NN . “ This NN should VB NNS about VBG the VBN NN NN , ” VBD NNP NNP NNP , NN of the NNP NNP NNP at the NNPS for NNP NNP and NNP ( NNP ) in NNP , and the NN ’s JJ NN . NNS about a NN between NNS and NN VBD RB VBN JJR than a NN RB by JJ NN NNP NNP . His NN , VBN on 12 NNS , VBZ RB VBN VBN and VBD VBN RBR this NN by the NN that VBD it . In the NN , it VBD a JJ JJ NN among NNS and a NN NN that VBD JJ NNS to VB RB from VBN NNS like the NN against NNS , NNS and NN . NNS of all three NNS VBD . One JJ NN VBZ VBN that NN might VB a NN in the NN of NN , a NN that VBZ RB JJ as one in 110 NNP NNS , VBG to the NNP . JJS NNS VBP NN a JJ NN , RB VBN by NNS . NN NN NNS VBP from JJ NN ’s NN to JJ JJ NN and JJ NN , and there VBZ no NN or JJ NN . The NNP NNS VBD NNS for NNP NNS VBN between 1994 and 1999 , who VBD VBN in one of three VBN NN NNS . They VBD 256 NNS with an NN NN NN and VBD them with 752 NNS who VBD RB VB the NN , but VBD VBN for NN and NN . RB RB when a NN VBD VBN VBN to NN — before NN when the NN VBD a NN , or when the NN itself VBD VBN as a NN or NN — there VBD no NN in the NN of any NN of NN NN NN . In NN , those NNS who VBD VBN to the NN between NN and 20 NNS of NN VBD RB JJR NNS of VBG the NN , although the NNS could RB VB that NN . “ This VBZ a RB JJ NN , ” VBD NNP NNP NNP NNP , a NN at the NNP of NNP NNP of NNP in NNP who VBD RB VBN in the NN . “ These NNS VBP that you could VB a NN NN and RB VB VBN about it . ” NNP , who VBD he VBZ a RB VBN two - NN - JJ at NN , VBD that NN NNS VBP VBN to VB , although NN VBZ VBN VBN from all JJ NN NNS , except NN NNS . For NNS who VBP JJ about NN in the NN NNS , he VBD there VBP NNS without the NN , JJ as NNP , a JJ NN that can VB VBN in NNS JJ two and JJR . Some NNS VBP RB VBN that VBG RB JJ NNS at RB , or in NNS who VBP RB JJ , could VB JJ NNS . NNP VBD NNS VBD VBN those NNS one by one . “ There VBZ no JJ NN ” for a NN between NNS and NN , he VBD NNP NNP ."
3,120,conspiracy,"In_IN an_DT explosive_JJ new_JJ report_NN ,_, famed_JJ investigative_JJ reporter_NN Bill_NNP Gertz_NNP details_VBZ how_WRB an_DT unsecured_JJ ,_, low_JJ -_HYPH level_NN Chinese_JJ laboratory_NN near_IN Wuhan_NNP ,_, China_NNP ,_, had_VBD isolated_VBN and_CC was_VBD studying_VBG viruses_NNS in_IN bats_NNS just_RB before_IN the_DT Covid_NNP -_HYPH 19_CD virus_NN began_VBD to_TO spread_VB among_IN residents_NNS in_IN the_DT bustling_VBG Chinese_JJ city_NN ._. If_IN true_JJ ,_, the_DT claim_NN could_MD provide_VB scientists_NNS with_IN clues_NNS as_IN to_IN how_WRB a_DT common_JJ respiratory_JJ illness_NN in_IN bats_NNS jumped_VBD from_IN animals_NNS to_IN humans_NNS before_IN spreading_VBG like_IN wildfire_NN across_IN the_DT world_NN ._. According_VBG to_IN the_DT latest_JJS reports_NNS ,_, Covid_NNP -_HYPH 19_CD ,_, which_WDT it_PRP is_VBZ believed_VBN originated_VBN in_IN or_CC around_IN Wuhan_NNP ,_, China_NNP ,_, population_NN 11_CD million_CD ,_, is_VBZ now_RB present_JJ in_IN 151_CD countries_NNS around_IN the_DT world_NN ._. As_IN testing_NN ramps_VBZ up_RP in_IN more_JJR countries_NNS ,_, the_DT United_NNP States_NNPS now_RB leads_VBZ the_DT world_NN in_IN confirmed_VBN cases_NNS ,_, with_IN over_RB 164,000_CD confirmed_VBN cases_NNS ._. Writes_VBZ Gertz_NNP ,_, “_`` Several_JJ Chinese_JJ state_NN media_NN outlets_NNS in_IN recent_JJ months_NNS touted_VBD the_DT virus_NN research_NN and_CC lionized_VBD in_IN particular_JJ a_DT key_JJ researcher_NN in_IN Wuhan_NNP ,_, Tian_NNP Junhua_NNP ,_, as_IN a_DT leader_NN in_IN bat_NN virus_NN work_NN ._. ”_'' Gertz_NNP quoted_VBD Rep._NNP Michael_NNP T._NNP McCaul_NNP ,_, Texas_NNP Republican_NNP and_CC ranking_VBG member_NN of_IN the_DT House_NNP Foreign_NNP Affairs_NNPS Committee_NNP ._. McCaul_NNP said_VBD China_NNP should_MD be_VB held_VBN accountable_JJ for_IN the_DT pandemic_NN ._. “_`` This_DT is_VBZ one_CD of_IN the_DT worst_JJS cover_NN -ups_NNS in_IN human_JJ history_NN ,_, and_CC now_RB the_DT world_NN is_VBZ facing_VBG a_DT global_JJ pandemic_NN ,_, ”_'' McCaul_NNP added_VBD ._. According_VBG to_IN Gertz_NNP ,_, a_DT video_NN has_VBZ been_VBN posted_VBN online_RB that_WDT was_VBD funded_VBN by_IN the_DT Chinese_JJ government_NN ._. In_IN it_PRP ,_, Tian_NNP can_MD be_VB seen_VBN inside_IN caves_NNS in_IN Hubei_NNP province_NN near_IN Wuhan_NNP taking_VBG samples_NNS from_IN captured_VBN bats_NNS and_CC storing_VBG them_PRP in_IN vials_NNS ._. “_`` I_PRP am_VBP not_RB a_DT doctor_NN ,_, but_CC I_PRP work_VBP to_TO cure_VB and_CC save_VB people_NNS ,_, ”_'' Tian_NNP reportedly_RB says_VBZ in_IN the_DT video_NN ._. “_`` I_PRP am_VBP not_RB a_DT soldier_NN ,_, but_CC I_PRP work_VBP to_TO safeguard_VB an_DT invisible_JJ national_JJ defense_NN line_NN ._. ”_'' An_DT article_NN by_IN “_`` JQKNews_NNP ._. Com_NN ”_'' published_VBN online_RB in_IN February_NNP 2020_CD discussed_VBD a_DT Chinese_JJ documentary_NN on_IN Tian_NNP ’s_POS work_NN collecting_VBG specimens_NNS from_IN bats_NNS in_IN 2019_CD ._. Here_RB is_VBZ an_DT excerpt_NN from_IN that_DT article_NN :_: In_IN a_DT documentary_NN released_VBN in_IN December_NNP last_JJ year_NN ,_, Tian_NNP Junhua_NNP has_VBZ been_VBN out_RB in_IN the_DT daytime_NN and_CC at_IN night_NN in_IN the_DT past_JJ decade_NN ._. He_PRP has_VBZ visited_VBN dozens_NNS of_IN bat_NN caves_NNS in_IN Hubei_NNP Province_NNP and_CC collected_VBN precious_JJ bat_NN virus_NN samples_NNS ._. “_`` In_IN the_DT past_JJ ten_CD years_NNS ,_, we_PRP have_VBP visited_VBN every_DT corner_NN of_IN Hubei_NNP Province_NNP ,_, explored_VBD dozens_NNS of_IN undeveloped_JJ caves_NNS and_CC studied_VBN more_JJR than_IN 300_CD kinds_NNS of_IN virus_NN vectors_NNS ,_, ”_'' Tian_NNP said_VBD ._. “_`` If_IN our_PRP$ skin_NN is_VBZ bare_JJ ,_, it_PRP ’s_VBZ easy_JJ to_TO get_VB in_IN touch_NN with_IN bat_NN feces_NNS ,_, pollutants_NNS ,_, ”_'' he_PRP said_VBD ._. The_DT researchers_NNS wore_VBD protective_JJ clothing_NN ,_, goggles_NNS ,_, masks_NNS ,_, headlights_NNS ,_, [_-LRB- and_CC had_VBD ]_-RRB- flashlights_NNS ._. “_`` We_PRP are_VBP well_RB prepared_VBN for_IN this_DT unknown_JJ adventure_NN ._. ”_'' This_DT is_VBZ a_DT war_NN without_IN gunpowder_NN ._. In_IN the_DT film_NN ,_, two_CD researchers_NNS armed_JJ [_-LRB- sic_NN ]_-RRB- ,_, climbed_VBD the_DT rugged_JJ cave_NN wall_NN to_TO remove_VB the_DT captured_VBN bats_NNS ._. A_DT staff_NN member_NN wearing_VBG gloves_NNS grabbed_VBD the_DT bat_NN ._. Tian_NNP Junhua_NNP put_VBD the_DT collected_VBN samples_NNS of_IN the_DT bat_NN into_IN the_DT specimen_NN box_NN and_CC then_RB put_VB the_DT bat_NN back_RB into_IN the_DT cave_NN ._. In_IN May_NNP 2017_CD ,_, a_DT report_NN by_IN Xinhua_NNP News_NNP Agency_NNP described_VBD Tian_NNP ’s_POS work_NN :_: “_`` The_DT environment_NN for_IN collecting_VBG bat_NN samples_NNS is_VBZ extremely_RB bad_JJ ._. There_EX is_VBZ a_DT stench_NN in_IN the_DT bat_NN cave_NN ._. Bats_NNS carry_VBP a_DT large_JJ number_NN of_IN viruses_NNS in_IN their_PRP$ bodies_NNS ._. If_IN they_PRP are_VBP not_RB careful_JJ ,_, they_PRP are_VBP at_IN risk_NN of_IN infection_NN ._. But_CC Tian_NNP Junhua_NNP is_VBZ not_RB afraid_JJ to_TO go_VB to_IN the_DT mountain_NN with_IN his_PRP$ wife_NN to_TO catch_VB Batman_NNP ._. ”_'' Tian_NNP Junhua_NNP summed_VBD up_RP the_DT experience_NN that_WDT the_DT most_JJS bats_NNS can_MD be_VB caught_VBN by_IN using_VBG the_DT sky_NN cannon_NN and_CC pulling_VBG the_DT net_NN ._. But_CC in_IN the_DT process_NN of_IN operation_NN ,_, Tian_NNP Junhua_NNP forgot_VBD to_TO take_VB protective_JJ measures_NNS ._. Bat_NN urine_NN dripped_VBD on_IN him_PRP like_IN raindrops_NNS from_IN the_DT top_NN ._. If_IN he_PRP was_VBD infected_VBN ,_, he_PRP could_MD not_RB find_VB any_DT medicine_NN ._. It_PRP was_VBD written_VBN in_IN the_DT report_NN ._. The_DT wings_NNS of_IN bats_NNS carry_VBP sharp_JJ claws_NNS ._. When_WRB the_DT big_JJ bats_NNS are_VBP caught_VBN by_IN bat_NN tools_NNS ,_, they_PRP can_MD easily_RB spray_VB blood_NN ._. Several_JJ times_NNS bat_NN blood_NN was_VBD sprayed_VBN directly_RB on_IN Tian_NNP ’s_POS skin_NN ,_, but_CC he_PRP did_VBD n’t_RB flinch_VB at_IN all_DT ._. After_IN returning_VBG home_RB ,_, Tian_NNP Junhua_NNP took_VBD the_DT initiative_NN to_TO isolate_VB for_IN half_PDT a_DT month_NN ._. As_RB long_RB as_IN the_DT incubation_NN period_NN of_IN 14_CD days_NNS does_VBZ not_RB occur_VB ,_, he_PRP will_MD be_VB lucky_JJ to_TO escape_VB ,_, the_DT report_NN said_VBD We_PRP do_VBP n’t_RB know_VB if_IN Tian_NNP Junhua_NNP has_VBZ been_VBN so_RB lucky_JJ on_IN bat_NN -_HYPH catching_VBG ._. But_CC scientists_NNS have_VBP shown_VBN that_IN bat_NN viruses_NNS can_MD infect_VB people_NNS directly_RB ,_, without_IN the_DT need_NN for_IN so_RB -_HYPH called_VBN intermediate_JJ hosts_NNS ._. Most_JJS microbiologists_NNS dismiss_VBP the_DT belief_NN that_IN the_DT virus_NN was_VBD manufactured_VBN in_IN a_DT lab_NN ,_, arguing_VBG that_IN viruses_NNS do_VBP on_IN occasion_NN jump_VB from_IN animals_NNS to_IN humans_NNS on_IN their_PRP$ own_JJ such_JJ as_IN in_IN the_DT case_NN of_IN the_DT Middle_NNP East_NNP Respiratory_NNP Syndrome_NNP ,_, which_WDT is_VBZ passed_VBN from_IN camels_NNS to_IN humans_NNS ,_, or_CC the_DT swine_NN and_CC the_DT avian_NN flu—especially_RB when_WRB humans_NNS and_CC animals_NNS live_VBP in_IN close_JJ proximity_NN to_IN each_DT other_JJ ,_, as_IN is_VBZ the_DT case_NN in_IN Asia_NNP ._. Gertz_NNP ’s_POS report_NN ,_, however_RB ,_, could_MD shed_VB light_NN on_IN how_WRB this_DT particular_JJ virus_NN jumped_VBD from_IN bats_NNS to_IN humans_NNS before_IN morphing_VBG into_IN a_DT global_JJ pandemic_NN ._. At_IN this_DT time_NN ,_, scientists_NNS believe_VBP they_PRP have_VBP identified_VBN as_RB many_JJ as_IN eight_CD different_JJ subtypes_NNS of_IN Covid_NNP -_HYPH 19_CD ._. A_DT report_NN in_IN USA_NNP Today_NN published_VBN March_NNP 27_CD documents_VBZ these_DT different_JJ strains_NNS ,_, noting_VBG that_IN there_EX is_VBZ good_JJ news_NN to_TO be_VB found_VBN in_IN this_DT ._. “_`` The_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD virus_NN first_RB began_VBD causing_VBG illness_NN in_IN China_NNP sometime_RB between_IN mid-November_NNP and_CC mid-December_NNP ,_, ”_'' reported_VBD USA_NNP Today_NN ._. “_`` Its_PRP$ genome_NN is_VBZ made_VBN up_RP of_IN about_RB 30,000_CD base_NN pairs_NNS ._. Humans_NNS ,_, by_IN comparison_NN ,_, have_VBP more_JJR than_IN 3_CD billion_CD ._. So_RB far_RB even_RB in_IN the_DT virus_NN ’s_POS most_RBS divergent_JJ strains_NNS scientists_NNS have_VBP found_VBN only_RB 11_CD base_NN pair_NN changes_NNS ._. ”_'' That_DT is_VBZ good_JJ news_NN for_IN scientists_NNS and_CC healthcare_NN workers_NNS ._. Finding_VBG a_DT cure_NN for_IN one_CD virus_NN is_VBZ a_DT lot_NN easier_JJR than_IN finding_VBG cures_NNS for_IN eight_CD —_: or_CC even_RB more_JJR —_: different_JJ ones_NNS ._. According_VBG to_IN this_DT report_NN ,_, scientists_NNS believe_VBP they_PRP have_VBP located_VBN patient_NN X_NN for_IN the_DT United_NNP States_NNPS ._. “_`` Most_JJS cases_NNS on_IN the_DT U.S._NNP West_NNP Coast_NNP are_VBP linked_VBN to_IN a_DT strain_NN first_RB identified_VBN in_IN Washington_NNP state_NN ,_, ”_'' reports_VBZ USA_NNP Today_NN ._. “_`` It_PRP may_MD have_VB come_VBN from_IN a_DT man_NN who_WP had_VBD been_VBN in_IN Wuhan_NNP ,_, China_NNP ,_, the_DT virus_NN ’s_POS epicenter_NN ,_, and_CC returned_VBD home_RB on_IN Jan._NNP 15_CD ._. It_PRP is_VBZ only_RB three_CD mutations_NNS away_RB from_IN the_DT original_JJ Wuhan_NNP strain_NN ,_, according_VBG to_IN work_NN done_VBN early_RB in_IN the_DT outbreak_NN by_IN Trevor_NNP Bedford_NNP ,_, a_DT computational_JJ biologist_NN at_IN Fred_NNP Hutch_NNP ,_, a_DT medical_JJ research_NN center_NN in_IN Seattle_NNP ._. ”_''","In an JJ JJ NN , JJ JJ NN NNP NNP VBZ how an JJ , JJ - NN JJ NN near NNP , NNP , VBD VBN and VBD VBG NNS in NNS RB before the NNP - 19 NN VBD to VB among NNS in the VBG JJ NN . If JJ , the NN could VB NNS with NNS as to how a JJ JJ NN in NNS VBD from NNS to NNS before VBG like NN across the NN . VBG to the JJS NNS , NNP - 19 , which it VBZ VBN VBN in or around NNP , NNP , NN 11 million , VBZ RB JJ in 151 NNS around the NN . As NN VBZ up in JJR NNS , the NNP NNPS RB VBZ the NN in VBN NNS , with RB 164,000 VBN NNS . VBZ NNP , “ JJ JJ NN NN NNS in JJ NNS VBD the NN NN and VBD in JJ a JJ NN in NNP , NNP NNP , as a NN in NN NN NN . ” NNP VBD NNP NNP NNP NNP , NNP NNP and VBG NN of the NNP NNP NNPS NNP . NNP VBD NNP should VB VBN JJ for the NN . “ This VBZ one of the JJS NN NNS in JJ NN , and RB the NN VBZ VBG a JJ NN , ” NNP VBD . VBG to NNP , a NN VBZ VBN VBN RB that VBD VBN by the JJ NN . In it , NNP can VB VBN inside NNS in NNP NN near NNP VBG NNS from VBN NNS and VBG them in NNS . “ I VBP RB a NN , but I VBP to VB and VB NNS , ” NNP RB VBZ in the NN . “ I VBP RB a NN , but I VBP to VB an JJ JJ NN NN . ” An NN by “ NNP . NN ” VBN RB in NNP 2020 VBD a JJ NN on NNP ’s NN VBG NNS from NNS in 2019 . RB VBZ an NN from that NN : In a NN VBN in NNP JJ NN , NNP NNP VBZ VBN RB in the NN and at NN in the JJ NN . He VBZ VBN NNS of NN NNS in NNP NNP and VBN JJ NN NN NNS . “ In the JJ ten NNS , we VBP VBN every NN of NNP NNP , VBD NNS of JJ NNS and VBN JJR than 300 NNS of NN NNS , ” NNP VBD . “ If our NN VBZ JJ , it VBZ JJ to VB in NN with NN NNS , NNS , ” he VBD . The NNS VBD JJ NN , NNS , NNS , NNS , [ and VBD ] NNS . “ We VBP RB VBN for this JJ NN . ” This VBZ a NN without NN . In the NN , two NNS JJ [ NN ] , VBD the JJ NN NN to VB the VBN NNS . A NN NN VBG NNS VBD the NN . NNP NNP VBD the VBN NNS of the NN into the NN NN and RB VB the NN RB into the NN . In NNP 2017 , a NN by NNP NNP NNP VBD NNP ’s NN : “ The NN for VBG NN NNS VBZ RB JJ . There VBZ a NN in the NN NN . NNS VBP a JJ NN of NNS in their NNS . If they VBP RB JJ , they VBP at NN of NN . But NNP NNP VBZ RB JJ to VB to the NN with his NN to VB NNP . ” NNP NNP VBD up the NN that the JJS NNS can VB VBN by VBG the NN NN and VBG the NN . But in the NN of NN , NNP NNP VBD to VB JJ NNS . NN NN VBD on him like NNS from the NN . If he VBD VBN , he could RB VB any NN . It VBD VBN in the NN . The NNS of NNS VBP JJ NNS . When the JJ NNS VBP VBN by NN NNS , they can RB VB NN . JJ NNS NN NN VBD VBN RB on NNP ’s NN , but he VBD RB VB at all . After VBG RB , NNP NNP VBD the NN to VB for half a NN . RB RB as the NN NN of 14 NNS VBZ RB VB , he will VB JJ to VB , the NN VBD We VBP RB VB if NNP NNP VBZ VBN RB JJ on NN - VBG . But NNS VBP VBN that NN NNS can VB NNS RB , without the NN for RB - VBN JJ NNS . JJS NNS VBP the NN that the NN VBD VBN in a NN , VBG that NNS VBP on NN VB from NNS to NNS on their JJ JJ as in the NN of the NNP NNP NNP NNP , which VBZ VBN from NNS to NNS , or the NN and the NN RB when NNS and NNS VBP in JJ NN to each JJ , as VBZ the NN in NNP . NNP ’s NN , RB , could VB NN on how this JJ NN VBD from NNS to NNS before VBG into a JJ NN . At this NN , NNS VBP they VBP VBN RB JJ as eight JJ NNS of NNP - 19 . A NN in NNP NN VBN NNP 27 VBZ these JJ NNS , VBG that there VBZ JJ NN to VB VBN in this . “ The NNP - NNP - 2 NN RB VBD VBG NN in NNP RB between NNP and NNP , ” VBD NNP NN . “ Its NN VBZ VBN up of RB 30,000 NN NNS . NNS , by NN , VBP JJR than 3 billion . RB RB RB in the NN ’s RBS JJ NNS NNS VBP VBN RB 11 NN NN NNS . ” That VBZ JJ NN for NNS and NN NNS . VBG a NN for one NN VBZ a NN JJR than VBG NNS for eight — or RB JJR — JJ NNS . VBG to this NN , NNS VBP they VBP VBN NN NN for the NNP NNPS . “ JJS NNS on the NNP NNP NNP VBP VBN to a NN RB VBN in NNP NN , ” VBZ NNP NN . “ It may VB VBN from a NN who VBD VBN in NNP , NNP , the NN ’s NN , and VBD RB on NNP 15 . It VBZ RB three NNS RB from the JJ NNP NN , VBG to NN VBN RB in the NN by NNP NNP , a JJ NN at NNP NNP , a JJ NN NN in NNP . ”"
4,595,mainstream,"Pharma_NNP is_VBZ looking_VBG to_TO reset_VB its_PRP$ image_NN with_IN COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS ,_, but_CC landmines_NNS loom_VBP —_: with_IN pricing_NN likely_RB the_DT biggest_JJS ._. The_DT halo_NN from_IN pharma_NN ’s_POS rapid_JJ response_NN in_IN research_NN and_CC discovery_NN —_: and_CC the_DT hope_NN that_IN a_DT vaccine_NN or_CC effective_JJ treatments_NNS will_MD allow_VB the_DT world_NN to_TO return_VB to_IN some_DT sort_NN of_IN normal_JJ —_: has_VBZ propelled_VBN the_DT industry_NN ’s_POS reputation_NN at_IN an_DT all_DT -_HYPH time_NN high_NN ._. Forty_CD percent_NN of_IN Americans_NNPS say_VBP their_PRP$ opinion_NN of_IN the_DT pharma_NN industry_NN has_VBZ turned_VBN positive_JJ during_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, according_VBG to_IN The_DT Harris_NNP Poll_NNP ._. However_RB ,_, pricing_NN lurks_VBZ just_RB beyond_IN the_DT lab_NN ._. Just_RB this_DT week_NN in_IN media_NN ,_, one_CD well_RB -_HYPH known_VBN pundit_NN posited_VBN in_IN a_DT Forbes_NNP column_NN that_WDT the_DT industry_NN ’s_POS reputation_NN hinges_VBZ on_IN the_DT pricing_NN of_IN Gilead_NNP Sciences_NNPS '_POS treatment_NN remdesivir_NN ,_, while_IN another_DT touted_VBD Pfizer_NNP CEO_NN Albert_NNP Bourla_NNP ’s_POS promise_NN to_TO not_RB price_VB its_PRP$ vaccine_NN too_RB high_JJ in_IN part_NN because_IN “_`` people_NNS will_MD not_RB forget_VB if_IN you_PRP do_VBP that_DT ._. ”_'' Yet_CC in_IN the_DT same_JJ Axios_NNP article_NN ,_, Bourla_NNP is_VBZ quoted_VBN as_IN saying_VBG the_DT vaccine_NN represents_VBZ a_DT “_`` huge_JJ commercial_JJ opportunity_NN ”_'' for_IN Pfizer_NNP ._. Industry_NN experts_NNS say_VBP it_PRP ’s_VBZ a_DT safe_JJ bet_NN that_IN other_JJ pharma_NN companies_NNS are_VBP wrangling_VBG with_IN the_DT same_JJ contradictory_JJ issues_NNS ._. RELATED_JJ :_: Can_MD the_DT price_NN be_VB right_JJ ?_. With_IN the_DT world_NN watching_VBG ,_, Gilead_NNP faces_VBZ a_DT no-win_JJ decision_NN on_IN remdesivir_NN Stewart_NNP Lyman_NNP ,_, a_DT biotech_NN and_CC pharma_NN consultant_NN ,_, said_VBD while_IN scientists_NNS and_CC researchers_NNS will_MD be_VB satisfied_JJ with_IN just_RB the_DT discovery_NN of_IN a_DT vaccine_NN ,_, executives_NNS at_IN the_DT top_NN of_IN pharma_NN companies_NNS will_MD likely_RB want_VB more_JJR ._. “_`` I_PRP suspect_VBP they_PRP will_MD be_VB very_RB sensitive_JJ to_IN not_RB gouging_VBG because_IN there_EX will_MD be_VB both_CC political_JJ pressure_NN and_CC pressure_NN from_IN the_DT other_JJ companies_NNS to_TO not_RB do_VB that_DT this_DT one_CD time_NN ,_, ”_'' said_VBD Lyman_NNP ,_, who_WP is_VBZ also_RB a_DT former_JJ scientist_NN at_IN Immunex_NNP ,_, now_RB owned_VBN by_IN Amgen_NNP ._. “_`` (_-LRB- But_CC )_-RRB- they_PRP ’re_VBP going_VBG to_TO be_VB looking_VBG for_IN something_NN in_IN return_NN ,_, ""_'' he_PRP added_VBD ._. ""_`` Exactly_RB how_WRB that_DT gets_VBZ sorted_VBN out_RP ,_, I_PRP do_VBP n’t_RB know_VB ,_, but_CC one_PRP can_MD easily_RB imagine_VB a_DT quid_FW pro_FW quo_FW of_IN some_DT type_NN where_WRB they_PRP say_VBP ‘_`` yes_UH ,_, we_PRP ’re_VBP giving_VBG this_DT to_IN you_PRP for_IN cheap_JJ but_CC let_VB ’s_PRP not_RB have_VB any_DT price_NN controls_NNS ’_'' ”_'' on_IN other_JJ drugs_NNS in_IN the_DT future_NN ._. The_DT Harris_NNP Poll_NN Managing_NN Director_NN Rob_NNP Jekielek_NNP said_VBD pricing_NN alone_RB ,_, whether_IN Gilead_NNP 's_POS remdesivir_NN or_CC vaccines_NNS ,_, has_VBZ n't_RB been_VBN the_DT key_NN to_IN pharma_NN 's_POS improved_VBN reputation_NN during_IN the_DT pandemic_NN ._. Pricing_NN has_VBZ been_VBN a_DT top_JJ three_CD issue_NN in_IN Harris_NNP Poll_NNP surveys_NNS since_IN March_NNP ,_, but_CC vaccines_NNS and_CC treatments_NNS —_: especially_RB vaccines_NNS —_: are_VBP what_WP 's_VBZ driving_VBG the_DT hockey_NN -_HYPH stick_NN spike_NN in_IN the_DT industry_NN 's_POS reputation_NN ._. The_DT bigger_JJR pricing_NN issue_NN will_MD be_VB affordability_NN once_IN vaccines_NNS and_CC treatments_NNS are_VBP released_VBN ,_, he_PRP said_VBD ,_, although_IN as_IN he_PRP pointed_VBD out_RP ,_, that_DT will_MD be_VB a_DT more_RBR integrated_VBN issue_NN across_IN industries_NNS including_VBG pharma_NN ,_, insurance_NN ,_, pharmacy_NN benefit_NN managers_NNS and_CC others_NNS ._. ""_`` If_IN a_DT vaccine_NN or_CC treatment_NN exists_VBZ ,_, but_CC Americans_NNPS ca_MD n’t_RB afford_VB to_TO get_VB it_PRP ,_, especially_RB the_DT most_RBS vulnerable_JJ or_CC at_IN risk_NN populations_NNS —_: for_IN example_NN ,_, lower_JJR income_NN ,_, minority_NN ,_, or_CC living_VBG in_IN more_RBR densely_RB populated_VBN areas_NNS —_: it_PRP will_MD likely_RB be_VB a_DT major_JJ issue_NN ,_, ""_'' Jekielek_NNP said_VBD ._. Of_IN course_NN ,_, pricing_NN is_VBZ n’t_RB the_DT only_JJ hurdle_NN pharma_NN companies_NNS face_VBP in_IN navigating_VBG their_PRP$ reputations_NNS through_IN developing_VBG and_CC delivering_VBG COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS ._. Managing_VBG expectations_NNS —_: for_IN instance_NN ,_, avoiding_VBG overpromising_VBG and_CC underdelivering_VBG on_IN a_DT vaccine_NN 's_POS timeline_NN —_: is_VBZ another_DT important_JJ consideration_NN ,_, said_VBD N._NNP Craig_NNP Smith_NNP ,_, the_DT chaired_VBN professor_NN of_IN ethics_NN and_CC social_JJ responsibility_NN at_IN INSEAD_NNP graduate_NN business_NN school_NN in_IN France_NNP ._. Smith_NNP pointed_VBD to_IN global_JJ access_NN to_IN vaccines_NNS and_CC treatments_NNS ,_, along_IN with_IN manufacturing_NN and_CC distribution_NN issues_NNS ,_, as_IN other_JJ challenges_NNS ._. He_PRP co-authored_VBD an_DT MIT_NNP Sloan_NNP Management_NN Review_NN article_NN about_IN the_DT liability_NN of_IN the_DT pharma_NN industry_NN 's_POS competition_NN -_HYPH based_VBN model_NN in_IN COVID_NN -_HYPH 19_CD drug_NN development_NN ._. “_`` There_EX are_VBP still_RB questions_NNS around_IN how_WRB drugs_NNS and_CC vaccine_NN get_VBP made_VBN available_JJ ,_, who_WP gets_VBZ them_PRP first_RB and_CC what_WDT prices_NNS are_VBP charged_VBN ,_, but_CC I_PRP do_VBP think_VB there_EX ’s_VBZ a_DT great_JJ opportunity_NN here_RB for_IN the_DT industry_NN to_TO come_VB out_RP looking_VBG a_DT whole_JJ lot_NN better_JJR than_IN it_PRP has_VBZ in_IN recent_JJ years_NNS ,_, ”_'' Smith_NNP said_VBD ._. Safety_NN and_CC efficacy_NN of_IN the_DT medicines_NNS is_VBZ yet_RB another_DT consideration_NN ._. While_IN Operation_NNP Warp_NNP Speed_NNP in_IN both_CC name_NN and_CC effort_NN seems_VBZ to_TO be_VB focused_VBN on_IN speed_NN ,_, Lyman_NNP said_VBD ,_, safety_NN and_CC efficacy_NN are_VBP both_CC more_RBR important_JJ ._. “_`` Coming_VBG up_RP with_IN and_CC launching_VBG a_DT vaccine_NN fast_RB —_: but_CC one_CD that_WDT is_VBZ neither_CC safe_JJ or_CC efficacious_JJ or_CC is_VBZ just_RB one_CD of_IN those_DT —_: would_MD be_VB an_DT unmitigated_JJ disaster_NN ,_, ”_'' he_PRP said_VBD ._. “_`` Not_RB just_RB for_IN the_DT COVID_NN -_HYPH 19_CD programs_NNS ,_, but_CC for_IN every_DT other_JJ vaccine_NN made_VBN these_DT days_NNS ._. Because_IN then_RB you_PRP ’re_VBP going_VBG to_TO get_VB people_NNS afraid_JJ ,_, pushed_VBN by_IN these_DT anti-vaccine_JJ groups_NNS ,_, and_CC starting_VBG to_TO question_VB the_DT safety_NN and_CC efficacy_NN of_IN other_JJ vaccines_NNS ._. ”_'' RELATED_JJ :_: One_CD COVID_NN -_HYPH 19_CD opportunity_NN for_IN pharma_NN ?_. A_DT chance_NN to_TO bolster_VB its_PRP$ reputation_NN ,_, Lilly_NNP CEO_NN says_VBZ Jane_NNP Sarasohn_NNP -_HYPH Kahn_NNP ,_, a_DT health_NN economist_NN with_IN THINK_NNP -_HYPH Health_NNP and_CC blogger_NN at_IN Health_NNP Populi_NNP ,_, agreed_VBD about_IN the_DT vaccine_NN concerns_NNS ._. She_PRP has_VBZ already_RB begun_VBN to_TO see_VB shifts_NNS in_IN opinions_NNS in_IN the_DT past_JJ few_JJ weeks_NNS as_IN the_DT pandemic_NN wears_VBZ on_RP ._. “_`` There_EX ’s_VBZ been_VBN an_DT erosion_NN in_IN public_JJ support_NN in_IN the_DT U.S._NNP for_IN vaccines_NNS —_: we_PRP ’ve_VBP seen_VBN challenges_NNS in_IN getting_VBG people_NNS signed_VBN up_RP into_IN trials_NNS ,_, and_CC a_DT growing_VBG chasm_NN between_IN folks_NNS who_WP would_MD plan_VB to_TO take_VB advantage_NN of_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN versus_IN those_DT who_WP would_MD not_RB ,_, ”_'' she_PRP said_VBD in_IN an_DT email_NN ._. Still_RB ,_, pricing_NN is_VBZ top_NN of_IN mind_NN not_RB just_RB for_IN pharma_NN companies_NNS but_CC for_IN government_NN officials_NNS ._. Consumer_NN pricing_NN bills_NNS in_IN both_CC the_DT U.S._NNP House_NNP and_CC Senate_NNP seek_VBP to_TO limit_VB companies_NNS from_IN profiting_VBG during_IN national_JJ emergencies_NNS ._. That_DT includes_VBZ drug_NN companies_NNS and_CC would_MD impose_VB a_DT 10_CD %_NN profit_NN margin_NN for_IN treatments_NNS or_CC vaccines_NNS ._. However_RB ,_, Anthony_NNP Fauci_NNP ,_, M.D._NNP ,_, head_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, cautioned_VBD at_IN BIO_NNP this_DT week_NN that_IN “_`` the_DT federal_JJ government_NN should_MD n’t_RB force_VB drug_NN companies_NNS to_TO lower_VB the_DT costs_NNS of_IN COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS but_CC should_MD encourage_VB fair_JJ pricing_NN ,_, ”_'' according_VBG to_IN a_DT Bloomberg_NNP report_NN ._. Where_WRB does_VBZ that_DT leave_VB the_DT industry_NN ?_. In_IN a_DT delicate_JJ spot_NN ._. As_IN Forbes_NNP contributor_NN John_NNP LaMattina_NNP summed_VBD up_RP in_IN his_PRP$ column_NN about_IN the_DT importance_NN of_IN Gilead_NNP 's_POS pricing_NN decision_NN ,_, saying_VBG that_IN it_PRP “_'' will_MD set_VB the_DT tone_NN for_IN the_DT Covid_NNP -_HYPH 19_CD vaccines_NNS and_CC drugs_NNS that_WDT will_MD follow_VB ._. It_PRP will_MD also_RB impact_VB the_DT reputation_NN of_IN the_DT whole_JJ industry_NN ._. It_PRP ’s_VBZ not_RB an_DT easy_JJ decision_NN ._. Let_VB ’s_PRP hope_VB they_PRP get_VBP it_PRP right_JJ ._. ”_''","NNP VBZ VBG to VB its NN with NN - 19 NNS and NNS , but NNS VBP — with NN RB the JJS . The NN from NN ’s JJ NN in NN and NN — and the NN that a NN or JJ NNS will VB the NN to VB to some NN of JJ — VBZ VBN the NN ’s NN at an all - NN NN . Forty NN of NNPS VBP their NN of the NN NN VBZ VBN JJ during the NN - 19 NN , VBG to The NNP NNP . RB , NN VBZ RB beyond the NN . RB this NN in NN , one RB - VBN NN VBN in a NNP NN that the NN ’s NN VBZ on the NN of NNP NNPS ' NN NN , while another VBD NNP NN NNP NNP ’s NN to RB VB its NN RB JJ in NN because “ NNS will RB VB if you VBP that . ” Yet in the JJ NNP NN , NNP VBZ VBN as VBG the NN VBZ a “ JJ JJ NN ” for NNP . NN NNS VBP it VBZ a JJ NN that JJ NN NNS VBP VBG with the JJ JJ NNS . JJ : Can the NN VB JJ ? With the NN VBG , NNP VBZ a JJ NN on NN NNP NNP , a NN and NN NN , VBD while NNS and NNS will VB JJ with RB the NN of a NN , NNS at the NN of NN NNS will RB VB JJR . “ I VBP they will VB RB JJ to RB VBG because there will VB both JJ NN and NN from the JJ NNS to RB VB that this one NN , ” VBD NNP , who VBZ RB a JJ NN at NNP , RB VBN by NNP . “ ( But ) they VBP VBG to VB VBG for NN in NN , "" he VBD . "" RB how that VBZ VBN out , I VBP RB VB , but one can RB VB a FW FW FW of some NN where they VBP ‘ yes , we VBP VBG this to you for JJ but VB ’s RB VB any NN NNS ’ ” on JJ NNS in the NN . The NNP NN NN NN NNP NNP VBD NN RB , whether NNP 's NN or NNS , VBZ RB VBN the NN to NN 's VBN NN during the NN . NN VBZ VBN a JJ three NN in NNP NNP NNS since NNP , but NNS and NNS — RB NNS — VBP what VBZ VBG the NN - NN NN in the NN 's NN . The JJR NN NN will VB NN once NNS and NNS VBP VBN , he VBD , although as he VBD out , that will VB a RBR VBN NN across NNS VBG NN , NN , NN NN NNS and NNS . "" If a NN or NN VBZ , but NNPS ca RB VB to VB it , RB the RBS JJ or at NN NNS — for NN , JJR NN , NN , or VBG in RBR RB VBN NNS — it will RB VB a JJ NN , "" NNP VBD . Of NN , NN VBZ RB the JJ NN NN NNS VBP in VBG their NNS through VBG and VBG NN - 19 NNS and NNS . VBG NNS — for NN , VBG VBG and VBG on a NN 's NN — VBZ another JJ NN , VBD NNP NNP NNP , the VBN NN of NN and JJ NN at NNP NN NN NN in NNP . NNP VBD to JJ NN to NNS and NNS , along with NN and NN NNS , as JJ NNS . He VBD an NNP NNP NN NN NN about the NN of the NN NN 's NN - VBN NN in NN - 19 NN NN . “ There VBP RB NNS around how NNS and NN VBP VBN JJ , who VBZ them RB and what NNS VBP VBN , but I VBP VB there VBZ a JJ NN RB for the NN to VB out VBG a JJ NN JJR than it VBZ in JJ NNS , ” NNP VBD . NN and NN of the NNS VBZ RB another NN . While NNP NNP NNP in both NN and NN VBZ to VB VBN on NN , NNP VBD , NN and NN VBP both RBR JJ . “ VBG up with and VBG a NN RB — but one that VBZ neither JJ or JJ or VBZ RB one of those — would VB an JJ NN , ” he VBD . “ RB RB for the NN - 19 NNS , but for every JJ NN VBN these NNS . Because RB you VBP VBG to VB NNS JJ , VBN by these JJ NNS , and VBG to VB the NN and NN of JJ NNS . ” JJ : One NN - 19 NN for NN ? A NN to VB its NN , NNP NN VBZ NNP NNP - NNP , a NN NN with NNP - NNP and NN at NNP NNP , VBD about the NN NNS . She VBZ RB VBN to VB NNS in NNS in the JJ JJ NNS as the NN VBZ on . “ There VBZ VBN an NN in JJ NN in the NNP for NNS — we VBP VBN NNS in VBG NNS VBN up into NNS , and a VBG NN between NNS who would VB to VB NN of a NN - 19 NN versus those who would RB , ” she VBD in an NN . RB , NN VBZ NN of NN RB RB for NN NNS but for NN NNS . NN NN NNS in both the NNP NNP and NNP VBP to VB NNS from VBG during JJ NNS . That VBZ NN NNS and would VB a 10 NN NN NN for NNS or NNS . RB , NNP NNP , NNP , NN of the NNP NNP of NNP and NNP NNPS , VBD at NNP this NN that “ the JJ NN should RB VB NN NNS to VB the NNS of NN - 19 NNS and NNS but should VB JJ NN , ” VBG to a NNP NN . Where VBZ that VB the NN ? In a JJ NN . As NNP NN NNP NNP VBD up in his NN about the NN of NNP 's NN NN , VBG that it “ will VB the NN for the NNP - 19 NNS and NNS that will VB . It will RB VB the NN of the JJ NN . It VBZ RB an JJ NN . VB ’s VB they VBP it JJ . ”"
5,905,mainstream,"Our_PRP$ general_JJ interest_NN e-newsletter_NN keeps_VBZ you_PRP up_RP to_IN date_NN on_IN a_DT wide_JJ variety_NN of_IN health_NN topics_NNS ._. Childhood_NN vaccines_NNS protect_VBP children_NNS from_IN a_DT variety_NN of_IN serious_JJ or_CC potentially_RB fatal_JJ diseases_NNS ,_, including_VBG diphtheria_NN ,_, measles_NNS ,_, mumps_NNS ,_, rubella_NN ,_, polio_NN ,_, tetanus_NN ,_, whooping_NN cough_NN (_-LRB- pertussis_NN )_-RRB- and_CC others_NNS ._. If_IN these_DT diseases_NNS seem_VBP uncommon_JJ —_: or_CC even_RB unheard_JJ of_IN —_: it_PRP 's_VBZ usually_RB because_IN these_DT vaccines_NNS are_VBP doing_VBG their_PRP$ job_NN ._. Still_RB ,_, you_PRP might_MD wonder_VB about_IN the_DT benefits_NNS and_CC risks_NNS of_IN childhood_NN vaccines_NNS ._. Here_RB are_VBP straight_JJ answers_NNS to_IN common_JJ questions_NNS about_IN childhood_NN vaccines_NNS ._. Is_VBZ natural_JJ immunity_NN better_JJR than_IN vaccination_NN ?_. A_DT natural_JJ infection_NN might_MD provide_VB better_JJR immunity_NN than_IN vaccination_NN —_: but_CC there_EX are_VBP serious_JJ risks_NNS ._. For_IN example_NN ,_, a_DT natural_JJ chickenpox_NN (_-LRB- varicella_NN )_-RRB- infection_NN could_MD lead_VB to_IN pneumonia_NN ._. A_DT natural_JJ polio_NN infection_NN could_MD cause_VB permanent_JJ paralysis_NN ._. A_DT natural_JJ mumps_NNS infection_NN could_MD lead_VB to_IN deafness_NN ._. A_DT natural_JJ Haemophilus_NN influenzae_NN type_NN b_NN (_-LRB- Hib_NN )_-RRB- infection_NN could_MD result_VB in_IN permanent_JJ brain_NN damage_NN or_CC even_RB death_NN ._. Vaccination_NN can_MD help_VB prevent_VB these_DT diseases_NNS and_CC their_PRP$ potentially_RB serious_JJ complications_NNS ._. Vaccines_NNS do_VBP not_RB cause_VB autism_NN ._. Despite_IN much_JJ controversy_NN on_IN the_DT topic_NN ,_, researchers_NNS have_VBP n't_RB found_VBN a_DT connection_NN between_IN autism_NN and_CC childhood_NN vaccines_NNS ._. In_IN fact_NN ,_, the_DT original_JJ study_NN that_WDT ignited_VBD the_DT debate_NN years_NNS ago_RB has_VBZ been_VBN retracted_VBN ._. Any_DT vaccine_NN can_MD cause_VB side_NN effects_NNS ._. Usually_RB ,_, these_DT side_NN effects_NNS are_VBP minor_JJ —_: a_DT low_JJ -_HYPH grade_NN fever_NN ,_, fussiness_NN and_CC soreness_NN at_IN the_DT injection_NN site_NN ._. Some_DT vaccines_NNS cause_VBP a_DT temporary_JJ headache_NN ,_, fatigue_NN or_CC loss_NN of_IN appetite_NN ._. Rarely_RB ,_, a_DT child_NN might_MD experience_VB a_DT severe_JJ allergic_JJ reaction_NN or_CC a_DT neurological_JJ side_NN effect_NN ,_, such_JJ as_IN a_DT seizure_NN ._. Although_IN these_DT rare_JJ side_NN effects_NNS are_VBP a_DT concern_NN ,_, the_DT risk_NN of_IN a_DT vaccine_NN causing_VBG serious_JJ harm_NN or_CC death_NN is_VBZ extremely_RB small_JJ ._. The_DT benefits_NNS of_IN getting_VBG a_DT vaccine_NN are_VBP much_RB greater_JJR than_IN the_DT possible_JJ side_NN effects_NNS for_IN almost_RB all_DT children_NNS ._. Of_IN course_NN ,_, vaccines_NNS are_VBP n't_RB given_VBN to_IN children_NNS who_WP have_VBP known_VBN allergies_NNS to_IN specific_JJ vaccine_NN components_NNS ._. Likewise_RB ,_, if_IN your_PRP$ child_NN develops_VBZ a_DT life_NN -_HYPH threatening_VBG reaction_NN to_IN a_DT particular_JJ vaccine_NN ,_, further_JJ doses_NNS of_IN that_DT vaccine_NN wo_MD n't_RB be_VB given_VBN ._. Why_WRB are_VBP vaccines_NNS given_VBN so_RB early_RB ?_. The_DT diseases_NNS that_WDT childhood_NN vaccines_NNS are_VBP meant_VBN to_TO prevent_VB are_VBP most_RBS likely_JJ to_TO occur_VB when_WRB a_DT child_NN is_VBZ very_RB young_JJ and_CC the_DT risk_NN of_IN complications_NNS is_VBZ greatest_JJS ._. That_DT makes_VBZ early_JJ vaccination_NN —_: sometimes_RB beginning_VBG shortly_RB after_IN birth_NN —_: essential_JJ ._. If_IN you_PRP postpone_VBP vaccines_NNS until_IN a_DT child_NN is_VBZ older_JJR ,_, it_PRP might_MD be_VB too_RB late_JJ ._. Is_VBZ it_PRP OK_JJ to_TO pick_VB and_CC choose_VB vaccines_NNS ?_. In_IN general_JJ ,_, skipping_VBG vaccines_NNS is_VBZ n't_RB a_DT good_JJ idea_NN ._. This_DT can_MD leave_VB your_PRP$ child_NN vulnerable_JJ to_IN potentially_RB serious_JJ diseases_NNS that_WDT could_MD otherwise_RB be_VB avoided_VBN ._. And_CC consider_VB this_DT :_: For_IN some_DT children_NNS —_: including_VBG those_DT who_WP can't_VBP receive_VB certain_JJ vaccines_NNS for_IN medical_JJ reasons_NNS (_-LRB- such_JJ as_IN cancer_NN therapy_NN )_-RRB- —_: the_DT only_JJ protection_NN from_IN vaccine_NN -_HYPH preventable_JJ diseases_NNS is_VBZ the_DT immunity_NN of_IN the_DT people_NNS around_IN them_PRP ._. If_IN immunization_NN rates_NNS drop_VBP ,_, vaccine_NN -_HYPH preventable_JJ diseases_NNS might_MD once_RB again_RB become_VB common_JJ threats_NNS ._. If_IN you_PRP have_VBP reservations_NNS about_IN particular_JJ vaccines_NNS ,_, discuss_VB your_PRP$ concerns_NNS with_IN your_PRP$ child_NN 's_POS doctor_NN ._. If_IN your_PRP$ child_NN falls_VBZ behind_IN the_DT standard_JJ vaccines_NNS schedule_NN ,_, ask_VB the_DT doctor_NN about_IN catch_NN -_HYPH up_RP immunizations_NNS ._. Mayo_NNP Clinic_NNP Minute_NN :_: Why_WRB and_CC when_WRB children_NNS should_MD be_VB vaccinated_VBN for_IN video_NN Mayo_NNP Clinic_NN Minute_NN :_: Why_WRB and_CC when_WRB children_NNS should_MD be_VB vaccinated_VBN Elizabeth_NNP Cozine_NNP ,_, M.D._NNP :_: Vaccination_NN prevents_VBZ a_DT child_NN from_IN getting_VBG an_DT illness_NN ._. It_PRP also_RB prevents_VBZ them_PRP from_IN spreading_VBG an_DT illness_NN ._. Jason_NNP Howland_NNP :_: Dr._NNP Elizabeth_NNP Cozine_NNP ,_, a_DT Mayo_NNP Clinic_NNP family_NN physician_NN ,_, says_VBZ the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP has_VBZ a_DT standard_JJ immunization_NN schedule_NN for_IN school_NN -_HYPH age_NN children_NNS that_WDT begins_VBZ with_IN ages_NNS 4_CD to_IN 6_CD ._. Dr._NNP Cozine_NNP :_: …_: which_WDT we_PRP think_VBP of_IN as_IN kindergarten_NN shots_NNS ._. So_RB that_DT 's_VBZ measles_NN ,_, mumps_NNS ,_, rubella_NN and_CC varicella_NN ._. Jason_NNP Howland_NNP :_: She_PRP says_VBZ the_DT next_JJ set_NN of_IN routine_JJ immunizations_NNS is_VBZ at_IN age_NN 11_CD …_, Dr._NNP Cozine_NNP :_: …_: which_WDT is_VBZ tetanus_NN ,_, diphtheria_NN and_CC pertussis_NN ,_, and_CC the_DT meningococcal_JJ immunization_NN ._. Jason_NNP Howland_NNP :_: It_PRP 's_VBZ also_RB recommended_VBN every_DT child_NN get_VB an_DT annual_JJ flu_NN shot_NN ._. And_CC HPV_NN vaccination_NN ,_, which_WDT prevents_VBZ cancer_NN ,_, can_MD start_VB as_RB early_RB as_IN age_NN 9_CD ._. Dr._NNP Cozine_NNP says_VBZ it_PRP 's_VBZ important_JJ to_TO educate_VB families_NNS on_IN the_DT importance_NN of_IN childhood_NN vaccinations_NNS ._. She_PRP likens_VBZ it_PRP to_IN seat_NN belt_NN safety_NN ._. Dr._NNP Cozine_NNP :_: Immunizations_NNS are_VBP no_RB different_JJ ._. If_IN we_PRP have_VBP opportunities_NNS to_TO protect_VB our_PRP$ children_NNS against_IN serious_JJ illness_NN and_CC potentially_RB even_RB death_NN ,_, even_RB if_IN the_DT risk_NN of_IN that_DT illness_NN or_CC the_DT risk_NN of_IN death_NN from_IN that_DT illness_NN is_VBZ really_RB quite_RB low_JJ ,_, I_PRP 'm_VBP all_RB for_IN it_PRP ._.","Our JJ NN NN VBZ you up to NN on a JJ NN of NN NNS . NN NNS VBP NNS from a NN of JJ or RB JJ NNS , VBG NN , NNS , NNS , NN , NN , NN , NN NN ( NN ) and NNS . If these NNS VBP JJ — or RB JJ of — it VBZ RB because these NNS VBP VBG their NN . RB , you might VB about the NNS and NNS of NN NNS . RB VBP JJ NNS to JJ NNS about NN NNS . VBZ JJ NN JJR than NN ? A JJ NN might VB JJR NN than NN — but there VBP JJ NNS . For NN , a JJ NN ( NN ) NN could VB to NN . A JJ NN NN could VB JJ NN . A JJ NNS NN could VB to NN . A JJ NN NN NN NN ( NN ) NN could VB in JJ NN NN or RB NN . NN can VB VB these NNS and their RB JJ NNS . NNS VBP RB VB NN . Despite JJ NN on the NN , NNS VBP RB VBN a NN between NN and NN NNS . In NN , the JJ NN that VBD the NN NNS RB VBZ VBN VBN . Any NN can VB NN NNS . RB , these NN NNS VBP JJ — a JJ - NN NN , NN and NN at the NN NN . Some NNS VBP a JJ NN , NN or NN of NN . RB , a NN might VB a JJ JJ NN or a JJ NN NN , JJ as a NN . Although these JJ NN NNS VBP a NN , the NN of a NN VBG JJ NN or NN VBZ RB JJ . The NNS of VBG a NN VBP RB JJR than the JJ NN NNS for RB all NNS . Of NN , NNS VBP RB VBN to NNS who VBP VBN NNS to JJ NN NNS . RB , if your NN VBZ a NN - VBG NN to a JJ NN , JJ NNS of that NN wo RB VB VBN . Why VBP NNS VBN RB RB ? The NNS that NN NNS VBP VBN to VB VBP RBS JJ to VB when a NN VBZ RB JJ and the NN of NNS VBZ JJS . That VBZ JJ NN — RB VBG RB after NN — JJ . If you VBP NNS until a NN VBZ JJR , it might VB RB JJ . VBZ it JJ to VB and VB NNS ? In JJ , VBG NNS VBZ RB a JJ NN . This can VB your NN JJ to RB JJ NNS that could RB VB VBN . And VB this : For some NNS — VBG those who VBP VB JJ NNS for JJ NNS ( JJ as NN NN ) — the JJ NN from NN - JJ NNS VBZ the NN of the NNS around them . If NN NNS VBP , NN - JJ NNS might RB RB VB JJ NNS . If you VBP NNS about JJ NNS , VB your NNS with your NN 's NN . If your NN VBZ behind the JJ NNS NN , VB the NN about NN - up NNS . NNP NNP NN : Why and when NNS should VB VBN for NN NNP NN NN : Why and when NNS should VB VBN NNP NNP , NNP : NN VBZ a NN from VBG an NN . It RB VBZ them from VBG an NN . NNP NNP : NNP NNP NNP , a NNP NNP NN NN , VBZ the NNPS for NNP NNP and NNP VBZ a JJ NN NN for NN - NN NNS that VBZ with NNS 4 to 6 . NNP NNP : … which we VBP of as NN NNS . RB that VBZ NN , NNS , NN and NN . NNP NNP : She VBZ the JJ NN of JJ NNS VBZ at NN 11 … NNP NNP : … which VBZ NN , NN and NN , and the JJ NN . NNP NNP : It VBZ RB VBN every NN VB an JJ NN NN . And NN NN , which VBZ NN , can VB RB RB as NN 9 . NNP NNP VBZ it VBZ JJ to VB NNS on the NN of NN NNS . She VBZ it to NN NN NN . NNP NNP : NNS VBP RB JJ . If we VBP NNS to VB our NNS against JJ NN and RB RB NN , RB if the NN of that NN or the NN of NN from that NN VBZ RB RB JJ , I VBP RB for it ."
6,436,conspiracy,"Legendary_JJ gold_NN and_CC market_NN expert_NN Jim_NNP Sinclair_NNP says_VBZ the_DT virus_NN that_WDT originated_VBD in_IN China_NNP may_MD have_VB ,_, oddly_RB enough_RB ,_, done_VBN some_DT good_NN ._. Sinclair_NNP explains_VBZ ,_, “_`` The_DT effect_NN of_IN the_DT coronavirus_NN was_VBD literally_RB to_TO shut_VB down_RP business_NN globally_RB ,_, therefore_RB ,_, shut_VBD off_RP the_DT demand_NN for_IN loans_NNS ,_, which_WDT also_RB shut_VBD off_RP demand_NN for_IN short_JJ term_NN money_NN ._. So_RB ,_, what_WP the_DT public_NN has_VBZ not_RB seen_VBN ,_, is_VBZ not_RB considering_VBG and_CC does_VBZ not_RB understand_VB is_VBZ we_PRP were_VBD stepping_VBG into_IN the_DT door_NN of_IN a_DT major_JJ financial_JJ crisis_NN magnitudes_NNS larger_JJR than_IN what_WP happened_VBD in_IN 2008_CD and_CC 2009_CD ._. It_PRP ’s_VBZ a_DT horrible_JJ thing_NN that_WDT this_DT virus_NN occurred_VBD ,_, but_CC if_IN it_PRP had_VBD not_RB occurred_VBN ,_, we_PRP would_MD have_VB been_VBN in_IN a_DT crisis_NN much_RB more_RBR serious_JJ than_IN 2008_CD and_CC 2009_CD ._. ._. ._. ._. It_PRP was_VBD blowing_VBG sky_NN high_JJ ._. ._. ._. ._. Shutting_VBG down_RP demand_NN is_VBZ all_DT we_PRP could_MD do_VB ._. It_PRP stopped_VBD the_DT explosion_NN of_IN interest_NN rates_NNS ._. ”_'' Where_WRB do_VBP we_PRP go_VB from_IN here_RB ?_. Sinclair_NNP says_VBZ ,_, “_`` We_PRP are_VBP going_VBG to_TO make_VB a_DT recovery_NN ._. It_PRP ’s_VBZ not_RB going_VBG to_TO be_VB a_DT ‘_`` V_NN ’_'' by_IN any_DT means_NNS ._. The_DT stock_NN market_NN could_MD be_VB a_DT ‘_`` V_NN ’_'' because_IN the_DT stock_NN market_NN has_VBZ very_RB little_JJ to_TO do_VB with_IN reality_NN ._. ._. ._. ._. As_RB far_RB as_IN business_NN is_VBZ concerned_VBN ,_, very_RB serious_JJ damage_NN has_VBZ been_VBN done_VBN to_IN the_DT infrastructure_NN to_IN the_DT business_NN equation_NN ._. Many_JJ employers_NNS are_VBP gone_VBN ._. Many_JJ corporations_NNS have_VBP significant_JJ readjustments_NNS to_TO be_VB able_JJ to_TO build_VB up_RP again_RB ._. The_DT supply_NN lines_NNS and_CC logistics_NNS ,_, where_WRB did_VBD everything_NN come_VB from_IN ?_. China_NNP ._. ._. ._. ._. This_DT is_VBZ a_DT major_JJ worldwide_JJ adjustment_NN ,_, both_CC economically_RB and_CC politically_RB ._. ._. ._. ._. We_PRP had_VBD everything_NN made_VBN in_IN the_DT cheapest_JJS place_NN possible_JJ ._. ._. ._. ._. This_DT is_VBZ not_RB a_DT passing_VBG phenomenon_NN ._. ._. ._. ._. The_DT only_JJ thing_NN that_WDT has_VBZ been_VBN steady_JJ is_VBZ gold_NN ._. ._. ._. ._. The_DT change_NN that_WDT this_DT brings_VBZ about_IN is_VBZ a_DT reconstruction_NN of_IN the_DT basic_JJ business_NN foundations_NNS ._. It_PRP ’s_VBZ a_DT start_NN over_RP ,_, it_PRP ’s_VBZ not_RB just_RB a_DT slowdown_NN ._. How_WRB many_JJ restaurants_NNS make_VBP money_NN on_IN 50_CD %_NN of_IN the_DT clients_NNS ?_. You_PRP can_MD ’t_RB ._. How_WRB many_JJ automobiles_NNS have_VBP built_VBN up_RP on_IN the_DT lots_NNS ?_. Enormous_JJ amounts_NNS ._. How_WRB many_JJ clothing_NN stores_NNS shut_VBP down_RP full_JJ of_IN winter_NN clothes_NNS and_CC ca_MD n’t_RB make_VB the_DT shift_NN to_IN summer_NN wear_NN ?_. You_PRP can_MD go_VB down_IN the_DT entire_JJ line_NN ._. So_RB ,_, this_DT recovery_NN will_MD be_VB more_RBR like_IN an_DT ‘_`` L_NNP ’_'' ._. We_PRP ’ve_VBP come_VBN straight_RB down_RP ,_, and_CC we_PRP are_VBP going_VBG to_TO go_VB sideways_RB now_RB ._. ._. ._. ._. Many_JJ businesses_NNS are_VBP not_RB going_VBG to_TO open_VB up_RP again_RB ._. ._. ._. ._. The_DT idea_NN of_IN the_DT coming_VBG inflation_NN as_IN a_DT result_NN of_IN this_DT is_VBZ simple_JJ ._. Everything_NN that_WDT you_PRP need_VBP will_MD go_VB up_RP in_IN price_NN ._. Everything_NN you_PRP do_VBP n’t_RB need_VB is_VBZ not_RB going_VBG to_TO hold_VB value_NN ._. You_PRP are_VBP better_JJR off_RP with_IN a_DT freezer_NN full_JJ of_IN fine_JJ cuts_NNS of_IN beef_NN than_IN you_PRP are_VBP with_IN a_DT brand_NN new_JJ Tesla_NNP ._. The_DT beef_NN will_MD go_VB up_RP in_IN price_NN ,_, the_DT Tesla_NNP will_MD go_VB down_RP ._. ”_'' On_IN gold_NN ,_, Sinclair_NNP says_VBZ the_DT ultimate_JJ price_NN is_VBZ an_DT easy_JJ -_HYPH to_IN -_HYPH calculate_NN math_NN problem_NN ._. How_WRB much_JJ gold_NN does_VBZ America_NNP have_VB compared_VBN to_IN how_WRB much_JJ debt_NN it_PRP has_VBZ ?_. So_RB ,_, how_WRB high_JJ could_MD gold_NN ultimately_RB go_VB ?_. Sinclair_NNP says_VBZ ,_, “_`` It_PRP ’s_VBZ simple_JJ math_NN ._. You_PRP take_VBP the_DT amount_NN of_IN gold_NN the_DT U.S._NNP says_VBZ it_PRP has_VBZ ,_, and_CC then_RB you_PRP take_VBP the_DT debt_NN it_PRP has_VBZ ,_, and_CC what_WDT price_NN would_MD you_PRP need_VB for_IN the_DT debt_NN to_TO balance_VB to_IN zero_CD ?_. The_DT price_NN on_IN the_DT low_JJ end_NN is_VBZ $_$ 50,000_CD per_IN ounce_NN ._. The_DT true_JJ price_NN is_VBZ $_$ 87,500_CD per_IN ounce_NN ._. ”_'' Is_VBZ a_DT biblical_JJ debt_NN jubilee_NN coming_VBG to_IN America_NNP ?_. Sinclair_NNP says_VBZ ,_, “_`` We_PRP already_RB have_VBP jubilees_NNS ._. If_IN you_PRP do_VBP n’t_RB pay_VB your_PRP$ rent_NN ,_, you_PRP have_VBP a_DT jubilee_NN ._. If_IN you_PRP do_VBP n’t_RB pay_VB your_PRP$ student_NN loan_NN ,_, you_PRP have_VBP a_DT jubilee_NN ._. If_IN the_DT payment_NN of_IN your_PRP$ auto_NN insurance_NN is_VBZ postponed_VBN ,_, you_PRP have_VBP a_DT jubilee_NN ._. We_PRP ’ve_VBP got_VBN jubilee_NN after_IN jubilee_NN after_IN jubilee_NN ._. Keep_VB in_IN mind_NN ,_, one_CD man_NN ’s_POS jubilee_NN is_VBZ another_DT man_NN ’s_POS disaster_NN ._. It_PRP ’s_VBZ almost_RB as_IN if_IN the_DT Bible_NNP is_VBZ correct_JJ in_IN terms_NNS of_IN economics_NNS ._. Also_RB ,_, keep_VB in_IN mind_NN ,_, the_DT people_NNS who_WP are_VBP n’t_RB being_VBG paid_VBN are_VBP being_VBG hurt_VBN very_RB badly_RB ._. ”_'' Sinclair_NNP thinks_VBZ the_DT recovery_NN will_MD take_VB a_DT decade_NN or_CC longer_RBR ,_, and_CC Sinclair_NNP says_VBZ ,_, “_`` It_PRP will_MD be_VB just_RB like_IN the_DT period_NN between_IN 1929_CD up_IN to_IN WWII_NNP (_-LRB- 1941_CD )_-RRB- ._. ”_'' Join_VB Greg_NNP Hunter_NNP as_IN he_PRP goes_VBZ One_CD -_HYPH on_IN -_HYPH One_CD with_IN renowned_VBN gold_NN expert_NN Jim_NNP Sinclair_NNP ._. Sinclair_NNP did_VBD call_VB back_RB in_RP and_CC said_VBD his_PRP$ power_NN was_VBD knocked_VBN out_RP for_IN a_DT short_JJ while_NN ._. He_PRP also_RB added_VBD ,_, “_`` I_PRP will_MD give_VB the_DT re-election_NN of_IN President_NNP Trump_NNP a_DT 50/50_CD chance_NN ._. Trump_NNP knows_VBZ what_WP he_PRP has_VBZ to_TO do_VB ,_, and_CC that_DT is_VBZ bring_VB the_DT economy_NN back_RB ._. If_IN he_PRP does_VBZ that_DT ,_, Trumps_NNP re-election_NN will_MD be_VB a_DT slam_NN dunk_NN ._. If_IN Trump_NNP is_VBZ not_RB re-elected_VBN ,_, the_DT game_NN board_NN breaks_VBZ ._. ”_'' If_IN you_PRP want_VBP to_TO know_VB about_IN Sinclair_NNP ’s_POS company_NN that_WDT he_PRP talked_VBD about_IN and_CC news_NN that_IN gold_NN is_VBZ finally_RB being_VBG brought_VBN up_RP out_IN of_IN the_DT ground_NN ,_, go_VB to_IN TanGoldCorp.com_NNP ._. There_EX is_VBZ much_JJ free_JJ information_NN ,_, articles_NNS and_CC analysis_NN on_IN the_DT homepage_NN of_IN JSMineset.com_NNP ._. To_TO get_VB even_RB more_RBR original_JJ information_NN ,_, articles_NNS and_CC analysis_NN ,_, you_PRP can_MD become_VB a_DT subscriber_NN for_IN $_$ 129_CD per_IN year_NN ._. Click_VB here_RB to_TO be_VB a_DT subscriber_NN to_IN JSMineset.com_ADD ._. This_DT segment_NN is_VBZ sponsored_VBN by_IN Discount_NNP Gold_NNP and_CC Silver_NNP Trading_NNP ._. Ask_VB for_IN Melody_NNP Cedarstrom_NNP ,_, the_DT owner_NN ,_, at_IN 1-800-375-4188_CD ._.","JJ NN and NN NN NNP NNP VBZ the NN that VBD in NNP may VB , RB RB , VBN some NN . NNP VBZ , “ The NN of the NN VBD RB to VB down NN RB , RB , VBD off the NN for NNS , which RB VBD off NN for JJ NN NN . RB , what the NN VBZ RB VBN , VBZ RB VBG and VBZ RB VB VBZ we VBD VBG into the NN of a JJ JJ NN NNS JJR than what VBD in 2008 and 2009 . It VBZ a JJ NN that this NN VBD , but if it VBD RB VBN , we would VB VBN in a NN RB RBR JJ than 2008 and 2009 . . . . It VBD VBG NN JJ . . . . VBG down NN VBZ all we could VB . It VBD the NN of NN NNS . ” Where VBP we VB from RB ? NNP VBZ , “ We VBP VBG to VB a NN . It VBZ RB VBG to VB a ‘ NN ’ by any NNS . The NN NN could VB a ‘ NN ’ because the NN NN VBZ RB JJ to VB with NN . . . . RB RB as NN VBZ VBN , RB JJ NN VBZ VBN VBN to the NN to the NN NN . JJ NNS VBP VBN . JJ NNS VBP JJ NNS to VB JJ to VB up RB . The NN NNS and NNS , where VBD NN VB from ? NNP . . . . This VBZ a JJ JJ NN , both RB and RB . . . . We VBD NN VBN in the JJS NN JJ . . . . This VBZ RB a VBG NN . . . . The JJ NN that VBZ VBN JJ VBZ NN . . . . The NN that this VBZ about VBZ a NN of the JJ NN NNS . It VBZ a NN over , it VBZ RB RB a NN . How JJ NNS VBP NN on 50 NN of the NNS ? You can RB . How JJ NNS VBP VBN up on the NNS ? JJ NNS . How JJ NN NNS VBP down JJ of NN NNS and ca RB VB the NN to NN NN ? You can VB down the JJ NN . RB , this NN will VB RBR like an ‘ NNP ’ . We VBP VBN RB down , and we VBP VBG to VB RB RB . . . . JJ NNS VBP RB VBG to VB up RB . . . . The NN of the VBG NN as a NN of this VBZ JJ . NN that you VBP will VB up in NN . NN you VBP RB VB VBZ RB VBG to VB NN . You VBP JJR off with a NN JJ of JJ NNS of NN than you VBP with a NN JJ NNP . The NN will VB up in NN , the NNP will VB down . ” On NN , NNP VBZ the JJ NN VBZ an JJ - to - NN NN NN . How JJ NN VBZ NNP VB VBN to how JJ NN it VBZ ? RB , how JJ could NN RB VB ? NNP VBZ , “ It VBZ JJ NN . You VBP the NN of NN the NNP VBZ it VBZ , and RB you VBP the NN it VBZ , and what NN would you VB for the NN to VB to zero ? The NN on the JJ NN VBZ $ 50,000 per NN . The JJ NN VBZ $ 87,500 per NN . ” VBZ a JJ NN NN VBG to NNP ? NNP VBZ , “ We RB VBP NNS . If you VBP RB VB your NN , you VBP a NN . If you VBP RB VB your NN NN , you VBP a NN . If the NN of your NN NN VBZ VBN , you VBP a NN . We VBP VBN NN after NN after NN . VB in NN , one NN ’s NN VBZ another NN ’s NN . It VBZ RB as if the NNP VBZ JJ in NNS of NNS . RB , VB in NN , the NNS who VBP RB VBG VBN VBP VBG VBN RB RB . ” NNP VBZ the NN will VB a NN or RBR , and NNP VBZ , “ It will VB RB like the NN between 1929 up to NNP ( 1941 ) . ” VB NNP NNP as he VBZ One - on - One with VBN NN NN NNP NNP . NNP VBD VB RB in and VBD his NN VBD VBN out for a JJ NN . He RB VBD , “ I will VB the NN of NNP NNP a 50/50 NN . NNP VBZ what he VBZ to VB , and that VBZ VB the NN RB . If he VBZ that , NNP NN will VB a NN NN . If NNP VBZ RB VBN , the NN NN VBZ . ” If you VBP to VB about NNP ’s NN that he VBD about and NN that NN VBZ RB VBG VBN up out of the NN , VB to NNP . There VBZ JJ JJ NN , NNS and NN on the NN of NNP . To VB RB RBR JJ NN , NNS and NN , you can VB a NN for $ 129 per NN . VB RB to VB a NN to JSMineset.com . This NN VBZ VBN by NNP NNP and NNP NNP . VB for NNP NNP , the NN , at 1-800-375-4188 ."
7,417,mainstream,"Gold_NN prices_NNS ended_VBD lower_JJR on_IN Monday_NNP ,_, giving_VBG up_RP earlier_JJR gains_NNS that_WDT had_VBD lifted_VBN prices_NNS toward_IN their_PRP$ highest_JJS levels_NNS since_IN 2012_CD ,_, as_IN early_JJ positive_JJ results_NNS from_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN prompted_VBD a_DT rally_NN in_IN the_DT U.S._NNP stock_NN market_NN ,_, dulling_VBG haven_NN demand_NN for_IN the_DT precious_JJ metal_NN ._. “_`` Gold_NN sold_VBD off_RP on_IN upbeat_JJ trader_NN attitudes_NNS after_IN the_DT Moderna_NNP news_NN of_IN a_DT positive_JJ initial_JJ result_NN from_IN a_DT Covid_NNP -_HYPH 19_CD vaccine_NN test_NN ,_, ”_'' Jim_NNP Wyckoff_NNP ,_, senior_JJ analyst_NN at_IN Kitco.com_NNP ,_, told_VBD MarketWatch_NNP ._. Biotechnology_NN company_NN Moderna_NNP Inc._NNP MRNA_NNP ,_, announced_VBN positive_JJ results_NNS from_IN a_DT Phase_NN 1_CD clinical_JJ trial_NN for_IN its_PRP$ experimental_JJ mRNA_NN coronavirus_NN vaccine_NN ._. The_DT U.S._NNP stock_NN market_NN jumped_VBD right_RB away_RB on_IN the_DT news_NN ,_, “_`` suggesting_VBG keener_JJ risk_NN appetite_NN in_IN the_DT marketplace_NN ._. That_DT is_VBZ usually_RB bearish_JJ for_IN safe_JJ -_HYPH haven_NN gold_NN ,_, Wyckoff_NNP said_VBD ._. Gold_NN for_IN June_NNP delivery_NN on_IN Comex_NNP GC00_NNP ,_, US_NNP :_: GCM20_NNP fell_VBD by_IN $_$ 21.90_CD ,_, or_CC nearly_RB 1.3_CD %_NN ,_, to_TO settle_VB $_$ 1,734.40_CD an_DT ounce_NN ,_, marking_VBG its_PRP$ first_JJ loss_NN in_IN five_CD sessions_NNS ._. It_PRP had_VBD touched_VBN an_DT intraday_JJ high_NN of_IN $_$ 1,775.80_CD ,_, which_WDT put_VBD the_DT metal_NN near_IN its_PRP$ highest_JJS settlement_NN since_IN 2012_CD ._. Last_JJ week_NN ,_, gold_NN gained_VBD 2.5_CD %_NN based_VBN on_IN the_DT most_RBS -_HYPH active_JJ contract_NN at_IN Friday_NNP ’s_POS close_JJ ._. “_`` After_IN a_DT torrid_JJ run_NN higher_JJR in_IN the_DT first_JJ half_NN of_IN April_NNP ,_, gold_NN spent_VBD the_DT next_JJ few_JJ weeks_NNS digesting_VBG those_DT gains_NNS by_IN trading_VBG sideways_RB in_IN an_DT ever_RB -_HYPH tightening_NN pattern_NN ,_, ”_'' said_VBD Brien_NNP Lundin_NNP ,_, editor_NN of_IN Gold_NNP Newsletter_NNP ._. “_`` This_DT pattern_NN indicated_VBD a_DT looming_VBG breakout_NN ,_, and_CC that_DT ’s_VBZ just_RB what_WP we_PRP got_VBD late_RB last_JJ week_NN as_IN gold_NN powered_VBD through_IN upside_NN resistance_NN on_IN Thursday_NNP and_CC Friday_NNP ._. ”_'' “_`` After_IN gold_NN ’s_POS breakout_NN last_JJ week_NN and_CC the_DT seeming_JJ likelihood_NN of_IN another_DT big_JJ run_NN higher_JJR ,_, those_DT holding_VBG big_JJ gold_NN short_JJ positions_NNS were_VBD increasingly_RB desperate_JJ to_TO defend_VB them_PRP ,_, and_CC the_DT good_JJ news_NN on_IN a_DT potential_JJ vaccine_NN provided_VBD a_DT great_JJ entry_NN point_NN ,_, ”_'' he_PRP told_VBD MarketWatch_NNP ._. Meanwhile_RB ,_, July_NNP silver_NN SIN20_NNP ,_, surged_VBD 39.8_CD cents_NNS ,_, or_CC 2.3_CD %_NN ,_, at_IN $_$ 17.468_CD an_DT ounce_NN ,_, after_IN rallying_VBG by_IN 8.2_CD %_NN last_JJ week_NN ._. Gold_NN bullion_NN has_VBZ marked_VBN mostly_RB rangebound_NN moves_NNS from_IN a_DT high_NN of_IN $_$ 1,788_CD to_IN a_DT low_NN of_IN $_$ 1,676_CD an_DT ounce_NN in_IN recent_JJ weeks_NNS but_CC has_VBZ been_VBN underpinned_VBN by_IN worries_NNS about_IN the_DT harm_NN to_IN the_DT global_JJ economy_NN from_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN and_CC the_DT monetary_JJ -_HYPH policy_NN response_NN by_IN central_JJ banks_NNS to_TO limit_VB the_DT impact_NN of_IN business_NN closures_NNS ,_, which_WDT were_VBD only_RB recently_RB being_VBG undone_VBN ._. Federal_NNP Reserve_NNP Chairman_NNP Jerome_NNP Powell_NNP said_VBD during_IN a_DT CBS_NNP ’s_POS “_`` 60_CD Minutes_NNS ”_'' on_IN Sunday_NNP that_IN the_DT central_JJ bank_NN was_VBD still_RB able_JJ to_TO deliver_VB more_JJR stimulus_NN as_IN needed_VBN to_TO help_VB alleviate_VB problems_NNS for_IN the_DT economy_NN ._. “_`` We_PRP ’re_VBP not_RB out_IN of_IN ammunition_NN by_IN a_DT long_JJ shot_NN ,_, ”_'' Powell_NNP said_VBD ._. Other_JJ metals_NNS traded_VBN on_IN Comex_NNP settled_VBD higher_JJR ,_, with_IN July_NNP copper_NN HGN20_CD ,_, up_RB almost_RB 3.2_CD %_NN at_IN $_$ 2.404_CD a_DT pound_NN ._. July_NNP platinum_NN PLN20_NNP ,_, rose_VBD 6.4_CD %_NN to_IN $_$ 869.30_CD an_DT ounce_NN and_CC June_NNP palladium_NN US_NNP :_: PAM20_NNP ended_VBD at_IN $_$ 2,027.10_CD an_DT ounce_NN ,_, up_RB 9.1_CD %_NN ._. In_IN a_DT note_NN Monday_NNP ,_, analysts_NNS at_IN Zaner_NNP Metals_NNPS said_VBD palladium_NN has_VBZ found_VBN support_NN “_'' from_IN analyst_NN predictions_NNS that_IN very_RB slow_JJ and_CC gradual_JJ returns_NNS to_IN production_NN will_MD balance_VB the_DT market_NN ”_'' from_IN the_DT demand_NN lost_VBN due_IN to_IN the_DT pandemic_NN ._.","NN NNS VBD JJR on NNP , VBG up JJR NNS that VBD VBN NNS toward their JJS NNS since 2012 , as JJ JJ NNS from a NN - 19 NN VBD a NN in the NNP NN NN , VBG NN NN for the JJ NN . “ NN VBD off on JJ NN NNS after the NNP NN of a JJ JJ NN from a NNP - 19 NN NN , ” NNP NNP , JJ NN at NNP , VBD NNP . NN NN NNP NNP NNP , VBN JJ NNS from a NN 1 JJ NN for its JJ NN NN NN . The NNP NN NN VBD RB RB on the NN , “ VBG JJ NN NN in the NN . That VBZ RB JJ for JJ - NN NN , NNP VBD . NN for NNP NN on NNP NNP , NNP : NNP VBD by $ 21.90 , or RB 1.3 NN , to VB $ 1,734.40 an NN , VBG its JJ NN in five NNS . It VBD VBN an JJ NN of $ 1,775.80 , which VBD the NN near its JJS NN since 2012 . JJ NN , NN VBD 2.5 NN VBN on the RBS - JJ NN at NNP ’s JJ . “ After a JJ NN JJR in the JJ NN of NNP , NN VBD the JJ JJ NNS VBG those NNS by VBG RB in an RB - NN NN , ” VBD NNP NNP , NN of NNP NNP . “ This NN VBD a VBG NN , and that VBZ RB what we VBD RB JJ NN as NN VBD through NN NN on NNP and NNP . ” “ After NN ’s NN JJ NN and the JJ NN of another JJ NN JJR , those VBG JJ NN JJ NNS VBD RB JJ to VB them , and the JJ NN on a JJ NN VBD a JJ NN NN , ” he VBD NNP . RB , NNP NN NNP , VBD 39.8 NNS , or 2.3 NN , at $ 17.468 an NN , after VBG by 8.2 NN JJ NN . NN NN VBZ VBN RB NN NNS from a NN of $ 1,788 to a NN of $ 1,676 an NN in JJ NNS but VBZ VBN VBN by NNS about the NN to the JJ NN from the NN - 19 NN and the JJ - NN NN by JJ NNS to VB the NN of NN NNS , which VBD RB RB VBG VBN . NNP NNP NNP NNP NNP VBD during a NNP ’s “ 60 NNS ” on NNP that the JJ NN VBD RB JJ to VB JJR NN as VBN to VB VB NNS for the NN . “ We VBP RB out of NN by a JJ NN , ” NNP VBD . JJ NNS VBN on NNP VBD JJR , with NNP NN HGN20 , RB RB 3.2 NN at $ 2.404 a NN . NNP NN NNP , VBD 6.4 NN to $ 869.30 an NN and NNP NN NNP : NNP VBD at $ 2,027.10 an NN , RB 9.1 NN . In a NN NNP , NNS at NNP NNPS VBD NN VBZ VBN NN “ from NN NNS that RB JJ and JJ NNS to NN will VB the NN ” from the NN VBN due to the NN ."
8,639,mainstream,"The_DT docking_NN complex_NN of_IN the_DT construct_NN vaccine_NN and_CC TLR5_NNP is_VBZ described_VBN ._. Recently_RB ,_, a_DT novel_NN coronavirus_NN (_-LRB- SARS_NNP ‐COV‐2_NNP )_-RRB- emerged_VBD which_WDT is_VBZ responsible_JJ for_IN the_DT recent_JJ outbreak_NN in_IN Wuhan_NNP ,_, China_NNP ._. Genetically_RB ,_, it_PRP is_VBZ closely_RB related_JJ to_IN SARS_NNP ‐CoV_NNP and_CC MERS_NNP ‐CoV_NNP ._. The_DT situation_NN is_VBZ getting_VBG worse_JJR and_CC worse_JJR ,_, therefore_RB ,_, there_EX is_VBZ an_DT urgent_JJ need_NN for_IN designing_VBG a_DT suitable_JJ peptide_NN vaccine_NN component_NN against_IN the_DT SARS_NNP ‐COV_NN ‐2_CD ._. Here_RB ,_, we_PRP characterized_VBD spike_NN glycoprotein_NN to_TO obtain_VB immunogenic_JJ epitopes_NNS ._. Next_RB ,_, we_PRP chose_VBD 13_CD Major_NNP Histocompatibility_NNP Complex_NNP ‐(_-LRB- MHC_NNP )_-RRB- I_PRP and_CC 3_CD MHC‐II_NNP epitopes_NNS ,_, having_VBG antigenic_JJ properties_NNS ._. These_DT epitopes_NNS are_VBP usually_RB linked_VBN to_IN specific_JJ linkers_NNS to_TO build_VB vaccine_NN components_NNS and_CC molecularly_RB dock_VB on_IN toll_NN ‐like_NN receptor_NN ‐5_CD to_TO get_VB binding_VBG affinity_NN ._. Therefore_RB ,_, to_TO provide_VB a_DT fast_JJ immunogenic_JJ profile_NN of_IN these_DT epitopes_NNS ,_, we_PRP performed_VBD immunoinformatics_NN analysis_NN so_IN that_IN the_DT rapid_JJ development_NN of_IN the_DT vaccine_NN might_MD bring_VB this_DT disastrous_JJ situation_NN to_IN the_DT end_NN earlier_RBR ._. At_IN the_DT end_NN of_IN 2019_CD ,_, a_DT novel_JJ coronavirus_NN (_-LRB- SARS_NNP ‐COV‐2_NNP )_-RRB- was_VBD identified_VBN as_IN the_DT cause_NN of_IN a_DT cluster_NN of_IN pneumonia_NN cases_NNS in_IN Wuhan_NNP ,_, a_DT city_NN in_IN the_DT Hubei_NNP province_NN of_IN China_NNP ._. 1_LS It_PRP has_VBZ a_DT positive_JJ ‐sense_NN single_JJ ‐stranded_VBN RNA_NN as_IN their_PRP$ genetic_JJ component_NN and_CC shares_VBZ genome_NN similarity_NN with_IN SARS_NN ‐CoV_NN and_CC bat_NN coronavirus_NN ,_, 2_CD ,_, 3_CD 79.5_CD %_NN and_CC 96_CD %_NN respectively_RB ._. Phylogenetically_RB ,_, it_PRP belongs_VBZ to_IN the_DT family_NN Coronaviridae_NNP ,_, order_VB Nidovirales_NNP and_CC is_VBZ a_DT β‐coronavirus_NN of_IN 2B_CD group_NN ._. 4_LS Regarding_VBG epidemiology_NN ,_, human‐to‐human_JJ transmission_NN of_IN the_DT virus_NN through_IN the_DT sneezes_NNS ,_, cough_NN ,_, and_CC respiratory_JJ droplets_NNS has_VBZ been_VBN confirmed_VBN ,_, yet_CC the_DT zoonotic_JJ nature_NN has_VBZ not_RB been_VBN confirmed_VBN ._. 5_CD -_: 7_CD Epidemiologic_JJ investigation_NN in_IN Wuhan_NNP ,_, China_NNP identified_VBD an_DT initial_JJ association_NN with_IN a_DT seafood_NN market_NN where_WRB most_JJS patients_NNS had_VBD worked_VBN or_CC visited_VBN ._. 4_LS However_RB ,_, as_IN the_DT outbreak_NN progressed_VBD ,_, several_JJ confirmed_VBN cases_NNS were_VBD reported_VBN sporadically_RB all_RB over_IN the_DT world_NN ,_, showing_VBG the_DT pandemic_NN nature_NN of_IN the_DT disease_NN named_VBN as_IN COVID_NNP ‐19_CD ._. At_IN last_JJ ,_, on_IN 30_CD January_NNP 2020_CD ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- declared_VBD this_DT outbreak_NN a_DT public_JJ health_NN emergency_NN of_IN international_JJ concern_NN ._. 8_LS According_VBG to_IN the_DT situation_NN report_NN 35_CD (_-LRB- reported_VBN by_IN 24_CD February_NNP 2020_CD )_-RRB- of_IN WHO_NNP ,_, in_IN China_NNP ,_, 77_CD 262_CD confirmed_VBN cases_NNS were_VBD reported_VBN ,_, of_IN which_WDT 2595_CD cases_NNS were_VBD with_IN deaths_NNS ._. Moreover_RB ,_, outside_RB of_IN China_NNP ,_, 2069_CD confirmed_VBN cases_NNS were_VBD reported_VBN in_IN 29_CD other_JJ countries_NNS (_-LRB- https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/20200224‐sitrep‐35‐covid‐19.pdf?sfvrsn=1ac4218d_2)._ADD Therefore_RB ,_, as_IN the_DT situation_NN was_VBD getting_VBG worse_JJR and_CC worse_JJR ,_, the_DT need_NN for_IN designing_VBG a_DT suitable_JJ peptide_NN vaccine_NN component_NN against_IN the_DT SARS_NNP ‐COV_NNP ‐2_CD was_VBD growing_VBG ._. Our_PRP$ work_NN was_VBD to_TO find_VB suitable_JJ epitopes_NNS ,_, which_WDT can_MD generate_VB enough_JJ immune_JJ response_NN against_IN the_DT SARS_NN ‐COV_NN ‐2_NN infection_NN ._. Using_VBG immunoinformatics_NNS ,_, we_PRP could_MD recognize_VB and_CC characterize_VB potential_JJ B_NN and_CC T‐cell_NN epitopes_NNS for_IN the_DT generation_NN of_IN the_DT epitopic_JJ vaccine_NN against_IN SARS_NN ‐COV_NN ‐_SYM 2.9_CD Specifically_RB ,_, the_DT spike_NN glycoprotein_NN of_IN SARS_NN ‐COV_NN ‐2_CD is_VBZ considered_VBN as_IN the_DT target_NN because_IN it_PRP forms_VBZ a_DT characteristic_JJ crown_NN of_IN the_DT virus_NN and_CC protrudes_VBZ from_IN the_DT viral_JJ envelope_NN .10_CD So_RB ,_, the_DT protein_NN sequence_NN of_IN spike_NN glycoprotein_NN was_VBD explored_VBN thoroughly_RB using_VBG multiple_JJ immunoinformatic_JJ ‐based_NN servers_NNS and_CC software_NN ,_, to_TO identify_VB various_JJ epitopes_NNS for_IN an_DT effective_JJ vaccine_NN ._. The_DT amino_NN acid_NN sequence_NN of_IN the_DT targeted_VBN protein_NN on_IN SARS_NNP ‐COV‐2_NN was_VBD collected_VBN from_IN the_DT National_NNP Centre_NNP for_IN Biotechnological_NNP Information_NNP (_-LRB- NCBI_NNP )_-RRB- database_NN .11_CD The_DT protein_NN sequence_NN is_VBZ very_RB crucial_JJ for_IN identifying_VBG the_DT potential_JJ epitopes_NNS of_IN the_DT targeted_VBN protein_NN ._. In_IN this_DT subsection_NN ,_, we_PRP used_VBD the_DT Immune_NNP Epitope_NN Database_NN (_-LRB- IEDB_NNP )_-RRB- to_TO identify_VB linear_JJ B‐cell_NNP epitopes_NNS using_VBG the_DT incorporated_VBN BepiPred_NNP 2.0_CD prediction_NN module_NN ._. 12_CD ,_, 13_CD We_PRP provided_VBD the_DT FASTA_NNP sequence_NN of_IN the_DT targeted_VBN protein_NN as_IN an_DT input_NN considering_VBG all_DT default_NN parameters_NNS ._. T‐cell_NNP epitopes_NNS having_VBG the_DT binding_VBG affinity_NN towards_IN MHC‐I_NNP and_CC MHC‐II_NNP alleles_NNS were_VBD selected_VBN to_TO boost_VB up_RP both_CC cytotoxic_JJ T‐cell_NN and_CC helper_NN T‐cell_NNP mediated_VBN immune_NN response_NN ._. We_PRP adopted_VBD two_CD servers_NNS which_WDT are_VBP ProPred_NNP ‐I_NN and_CC ProPred_NNP server_NN to_IN the_DT selection_NN of_IN MHC‐I_NNP and_CC MHC‐II_NNP binding_NN epitopes_NNS respectively_RB within_IN preidentified_JJ B‐cell_NNP epitopic_JJ region_NN ._. 14_CD ,_, 15_CD The_DT selected_VBN epitopes_NNS were_VBD submitted_VBN to_IN the_DT VaxiJen_NNP v.2.0_NN server_NN applying_VBG a_DT virus_NN as_IN a_DT target_NN field_NN with_IN the_DT given_VBN threshold_NN value_NN of_IN 0.4_CD for_IN analyzing_VBG the_DT antigenic_JJ propensity_NN ._. 16_LS With_IN the_DT help_NN of_IN a_DT specific_JJ peptide_NN linker_NN ,_, we_PRP fused_VBD the_DT antigenic_JJ epitopes_NNS to_TO construct_VB an_DT effectual_JJ vaccine_NN component_NN ._. Later_RBR ,_, the_DT vaccine_NN component_NN was_VBD modeled_VBN in_IN the_DT SPARKS_NNP ‐X_NN server_NN ._. 17_CD An_DT adjuvant_NN was_VBD also_RB added_VBN with_IN the_DT vaccine_NN component_NN to_TO accelerate_VB the_DT adaptive_JJ immune_JJ responses_NNS ._. The_DT vaccine_NN model_NN passed_VBD through_IN two_CD different_JJ servers_NNS ProSA‐web_NNP and_CC PROCHECK_NNP —_: in_IN a_DT subsequent_JJ manner_NN for_IN evaluating_VBG the_DT structural_JJ accuracy_NN of_IN the_DT model_NN ._. 18_CD ,_, 19_CD Molecular_NN docking_NN is_VBZ the_DT most_RBS promising_JJ part_NN of_IN the_DT modern_JJ drug‐discovery_NN method_NN ._. Here_RB ,_, in_IN this_DT study_NN ,_, we_PRP adopted_VBD PatchDock_NNP (_-LRB- Beta_NNP 1.3_CD Version_NNP )_-RRB- docking_NN server_NN to_IN receptor‐ligand_NN docking_NN ._. 20_CD PatchDock_NNP server_NN analyzes_VBZ the_DT molecular_JJ docking_NN between_IN the_DT vaccine_NN component_NN and_CC the_DT toll_NN ‐like_NN receptor_NN (_-LRB- TLR_NNP )_-RRB- ‐5_CD ._. The_DT generated_VBN Protein_NN Data_NN Bank_NN (_-LRB- PDB_NNP )_-RRB- file_NN of_IN the_DT protein‐peptide_NN docking_NN complex_NN was_VBD visualized_VBN in_IN PyMOL_NN software_NN v.2.3.21_CD Spike_NN glycoprotein_NN of_IN SARS_NNP ‐COV‐2_NN ,_, retrieved_VBN from_IN the_DT NCBI_NNP has_VBZ the_DT GenBank_NN accession_NN ID_NN :_: QHR63290.1_CD ._. This_DT spike_NN glycoprotein_NN has_VBZ 1282_CD ‐long_NN amino_NN acid_NN sequences_NNS and_CC this_DT sequence_NN was_VBD downloaded_VBN in_IN a_DT FASTA_NNP format_NN to_TO carry_VB out_RP the_DT further_JJ process_NN ._. We_PRP obtained_VBD a_DT total_NN of_IN 34_CD sequential_JJ linear_JJ B‐cell_NN epitopes_NNS of_IN varying_VBG lengths_NNS from_IN the_DT IEDB_NN server_NN within_IN spike_NN glycoprotein_NN of_IN SARS_NN ‐COV‐2_NN ._. Those_DT B‐cell_NNP epitopes_NNS were_VBD placed_VBN into_IN Table_NNP 1_CD based_VBN on_IN their_PRP$ positional_JJ value_NN ,_, sequence_NN ,_, and_CC length_NN ._. In_IN Figure_NNP 1_CD the_DT yellow_JJ ‐colored_NN peaks_NNS represent_VBP the_DT epitopic_JJ region_NN ,_, while_IN the_DT green_JJ ‐colored_JJ slopes_NNS ,_, represent_VBP the_DT nonepitopic_JJ region_NN ._. List_VB of_IN linear_JJ B‐cell_NNP epitopes_NNS along_IN with_IN their_PRP$ sequence_NN ,_, position_NN ,_, and_CC length_NN Graphical_JJ representation_NN of_IN linear_JJ B‐cell_NNP epitopes_NNS within_IN the_DT spike_NN glycoprotein_NN of_IN SARS_NNP ‐COV‐2_NN We_PRP identified_VBD 29_CD MHC‐I_NNP epitopes_NNS and_CC 8_CD MHC‐II_NNP epitopes_NNS ,_, which_WDT fall_VBP within_IN the_DT preidentified_JJ B‐cell_NNP epitopic_NN region_NN ._. Among_IN them_PRP ,_, 13_CD MHC‐I_NNP epitopes_NNS and_CC 3_CD MHC‐II_NNP epitopes_NNS had_VBD the_DT antigenic_JJ propensity_NN ,_, according_VBG to_IN the_DT VaxiJen_NNP v.2.0_NN server_NN analysis_NN ._. The_DT MHC‐I_NNP and_CC MHC‐II_NNP epitopes_NNS are_VBP listed_VBN in_IN Tables_NNPS 2_CD and_CC 3_CD with_IN encountering_VBG MHC_NN alleles_NNS and_CC antigenic_JJ scores_NNS ._. List_NN of_IN epitopes_NNS with_IN encountering_VBG MHC‐I_NN alleles_NNS ,_, positional_JJ value_NN ,_, and_CC VaxiJen_NNP antigenic_JJ score_NN List_NN showing_VBG the_DT epitopes_NNS with_IN encountering_VBG MHC‐II_NN alleles_NNS ,_, positional_JJ value_NN and_CC VaxiJen_NNP antigenic_JJ score_NN In_IN this_DT study_NN ,_, we_PRP linked_VBD the_DT 13_CD MHC‐I_NNP and_CC 3_CD MHC‐II_NNP antigenic_JJ epitopes_NNS with_IN (_-LRB- EAAAK_NN )_-RRB- linker_NN peptide_NN to_TO construct_VB a_DT vaccine_NN component_NN ._. This_DT linker_NN peptide_NN was_VBD easily_RB fused_VBN with_IN the_DT virus_NN coat_NN protein_NN and_CC increased_VBN stability_NN as_RB well_RB as_IN folding_NN of_IN the_DT vaccine_NN component_NN ._. 22_CD The_DT predicted_VBN structure_NN of_IN the_DT vaccine_NN component_NN is_VBZ shown_VBN in_IN Figure_NNP 2_CD ._. It_PRP has_VBZ 90.0_CD %_NN ,_, 7.1_CD %_NN ,_, 1.6_CD %_NN ,_, and_CC 1.3_CD %_NN residues_NNS in_IN most_RBS favored_VBN ,_, additionally_RB allowed_VBN ,_, generously_RB allowed_VBN and_CC disallowed_VBN regions_NNS respectively_RB within_IN PROCHECK_NNP as_IN the_DT validation_NN server_NN to_TO generate_VB Ramachandran_NNP plot_NN ._. Using_VBG the_DT ProSA_NNP server_NN ,_, the_DT “_`` Z_NN ”_'' score_NN was_VBD −_SYM 3.82_CD and_CC most_JJS of_IN the_DT residues_NNS had_VBD negative_JJ energy_NN value_NN as_IN shown_VBN in_IN Figure_NNP 3_CD ._. Results_NNS from_IN both_DT servers_NNS indicate_VBP the_DT model_NN is_VBZ in_IN a_DT good_JJ quality_NN ._. 23_CD ,_, 24_CD Different_JJ molecular_JJ characterization_NN of_IN vaccine_NN model_NN ._. (_-LRB- a_LS )_-RRB- All_DT atoms_NNS at_IN Ramachandran_NNP plot_NN ,_, (_-LRB- b_LS )_-RRB- “_`` Z_NN ”_'' score_NN plot_NN of_IN vaccine_NN model_NN in_IN ProSA_FW server_NN ,_, and_CC (_-LRB- c_LS )_-RRB- all_DT residue_NN energy_NN plot_NN The_DT PatchDock_NNP server_NN provided_VBD 20_CD docking_NN complexes_NNS ,_, and_CC among_IN them_PRP ,_, we_PRP selected_VBD only_RB the_DT docking_NN complex_NN with_IN the_DT highest_JJS negative_JJ atomic_JJ contact_NN energy_NN (_-LRB- ACE_NN )_-RRB- value_NN for_IN analysis_NN ._. The_DT ACE_NNP value_NN of_IN the_DT docking_NN complex_NN was_VBD −_SYM 259.62_CD ,_, which_WDT indicates_VBZ spontaneous_JJ reactivity_NN between_IN the_DT vaccine_NN component_NN and_CC TLR_NN ‐_SYM 5.25_CD As_IN proper_JJ protein_NN ‐protein_NN docking_NN regulates_VBZ the_DT cellular_JJ functions_NNS ,_, the_DT docking_NN between_IN the_DT vaccine_NN component_NN and_CC TLR‐5_NN will_MD activate_VB immune_NN cascades_NNS for_IN destroying_VBG the_DT viral_JJ antigens_NNS ._. 26_CD The_DT selected_VBN docking_NN complex_NN is_VBZ shown_VBN in_IN Figures_NNPS 4_CD and_CC 5_CD ,_, along_IN with_IN molecular_JJ surface_NN interaction_NN as_RB well_RB as_IN some_DT bonding_NN interactions_NNS ._. Docking_NN complex_NN exhibiting_VBG the_DT surface_NN interaction_NN between_IN vaccine_NN component_NN (_-LRB- cyan_NN color_NN )_-RRB- and_CC toll_NN ‐like_NN receptor_NN ‐5_CD (_-LRB- green_JJ color_NN )_-RRB- Docking_NN complex_NN exhibiting_VBG the_DT bonding_NN interaction_NN between_IN vaccine_NN component_NN and_CC toll_NN ‐like_NN receptor‐5_NN The_DT SARS_NNP ‐COV‐2_NNP ,_, the_DT causative_JJ pathogen_NN for_IN respiratory_JJ distress_NN syndrome_NN ,_, led_VBD more_JJR than_IN 10_CD 000_CD people_NNS to_IN infection_NN all_RB over_IN the_DT world_NN ,_, even_RB several_JJ to_IN death_NN ._. After_IN first_RB identified_VBN in_IN Wuhan_NNP ,_, Hubei_NNP province_NN of_IN China_NNP ,_, the_DT COVID_NNP ‐19_CD disease_NN spread_VBD unchecked_JJ which_WDT finally_RB became_VBD a_DT global_JJ threat_NN ._. Scientists_NNS from_IN all_RB over_IN the_DT world_NN are_VBP struggling_VBG to_TO find_VB a_DT solution_NN to_IN this_DT evil_JJ outbreak_NN ._. In_IN our_PRP$ present_JJ study_NN ,_, we_PRP attempted_VBD to_TO find_VB out_RP various_JJ B‐cell_NNP and_CC T‐cell_NNP epitopes_NNS against_IN SARS_NNP ‐COV‐2_NN ,_, using_VBG the_DT immunoinformatics_NNS ,_, as_IN quick_JJ identification_NN of_IN B‐cell_NNP and_CC T‐cell_NN epitopes_NNS is_VBZ crucial_JJ for_IN designing_NN of_IN vaccine_NN component_NN against_IN this_DT disease_NN ._. The_DT spike_NN glycoprotein_NN was_VBD analyzed_VBN for_IN B‐cell_NNP epitope_NN identification_NN in_IN the_DT IEDB_NN server_NN ,_, and_CC 34_CD linear_JJ B‐cell_NNP epitopes_NNS were_VBD identified_VBN as_IN a_DT result_NN ._. Subsequently_RB ,_, the_DT sequence_NN was_VBD also_RB analyzed_VBN in_IN ProPred_NNP ‐I_NNP and_CC ProPred_NNP servers_NNS for_IN the_DT identification_NN of_IN the_DT T‐cell_NN epitope_NN that_WDT can_MD combine_VB with_IN MHC‐I_NNP and_CC MHC_NN ‐II_NN molecules_NNS ._. Fortunately_RB ,_, we_PRP found_VBD 29_CD epitopes_NNS against_IN MHC‐I_NNP and_CC 8_CD epitopes_NNS against_IN MHC‐II_NNP that_WDT can_MD be_VB possibly_RB used_VBN for_IN vaccine_NN ._. Unfortunately_RB ,_, antigenic_JJ characterization_NN in_IN VaxiJen_NNP v.2.0_CD discarded_VBD 16_CD MHC‐I_NNP epitopes_NNS out_IN of_IN 29_CD and_CC 5_CD out_IN of_IN 8_CD MHC_NNP ‐II_NN epitopes_NNS as_IN these_DT seemed_VBD to_TO be_VB nonantigenic_JJ in_IN nature_NN ._. Nevertheless_RB ,_, we_PRP converted_VBD the_DT antigenic_JJ epitopes_NNS into_IN a_DT single_JJ vaccine_NN component_NN ,_, using_VBG (_-LRB- EAAAK_NN )_-RRB- peptide_NN linker_NN ._. Later_RBR ,_, the_DT vaccine_NN component_NN was_VBD modeled_VBN in_IN the_DT SPARK‐X_NNP server_NN and_CC validated_VBN in_IN PROCHECK_NNP and_CC ProSA_NNP ._. A_DT total_NN of_IN 90_CD %_NN of_IN nonglycine_JJ and_CC nonproline_JJ residues_NNS presented_VBN within_IN the_DT most_RBS favored_VBN region_NN ,_, while_IN the_DT “_`` Z_NN ”_'' score_NN of_IN the_DT model_NN was_VBD −_SYM 3.82_CD ._. These_DT results_NNS from_IN both_DT servers_NNS indicate_VBP the_DT model_NN is_VBZ in_IN good_JJ quality_NN ._. Molecular_JJ docking_NN between_IN vaccine_NN component_NN and_CC TLR_NNP ‐5_CD showed_VBD significant_JJ ACE_NN value_NN ,_, which_WDT indicates_VBZ spontaneous_JJ reactivity_NN within_IN the_DT receptor‐ligand_NN complex_NN ._. All_PDT the_DT observations_NNS of_IN our_PRP$ present_JJ work_NN depict_VBP the_DT effectiveness_NN of_IN selected_VBN epitopes_NNS within_IN the_DT spike_NN glycoprotein_NN of_IN SARS_NN ‐COV_NN ‐2_CD ._. These_DT epitopes_NNS can_MD be_VB used_VBN to_TO make_VB an_DT immunogenic_JJ multi‐epitopic_JJ peptide_NN vaccine_NN against_IN SARS_NN ‐COV‐2_NN ._. Present_JJ immunoinformatic_JJ analysis_NN pointed_VBD out_RP 13_CD MHC‐I_NNP and_CC 3_CD MHC‐II_NNP epitopes_NNS within_IN the_DT spike_NN glycoprotein_NN of_IN SARS_NN ‐COV_NN ‐2_CD ._. These_DT epitopes_NNS are_VBP the_DT ideal_JJ candidate_NN to_TO formulate_VB a_DT multi‐epitopic_JJ peptide_NN vaccine_NN ,_, not_RB only_RB because_IN of_IN being_VBG selected_VBN from_IN the_DT linear_JJ B‐cell_NNP epitopic_JJ region_NN but_CC also_RB because_IN of_IN their_PRP$ antigenic_JJ property_NN was_VBD confirmed_VBN ._. Moreover_RB ,_, the_DT molecular_JJ docking_NN of_IN vaccine_NN components_NNS with_IN the_DT TLR‐5_NN proves_VBZ the_DT significance_NN and_CC effectiveness_NN of_IN these_DT epitopes_NNS as_IN an_DT ideal_JJ vaccine_NN candidate_NN against_IN SARS_NNP ‐COV‐2_NNP ._. However_RB ,_, these_DT immunoinformatic_JJ analyses_NNS require_VBP several_JJ in_IN vitro_NN and_CC in_IN vivo_NN validations_NNS before_IN formulating_VBG the_DT vaccine_NN to_TO resist_VB COVID_NN ‐19_CD ._.","The NN NN of the NN NN and NNP VBZ VBN . RB , a NN NN ( NNP NNP ) VBD which VBZ JJ for the JJ NN in NNP , NNP . RB , it VBZ RB JJ to NNP NNP and NNP NNP . The NN VBZ VBG JJR and JJR , RB , there VBZ an JJ NN for VBG a JJ NN NN NN against the NNP NN ‐2 . RB , we VBD NN NN to VB JJ NNS . RB , we VBD 13 NNP NNP NNP ‐( NNP ) I and 3 NNP NNS , VBG JJ NNS . These NNS VBP RB VBN to JJ NNS to VB NN NNS and RB VB on NN NN NN ‐5 to VB VBG NN . RB , to VB a JJ JJ NN of these NNS , we VBD NN NN so that the JJ NN of the NN might VB this JJ NN to the NN RBR . At the NN of 2019 , a JJ NN ( NNP NNP ) VBD VBN as the NN of a NN of NN NNS in NNP , a NN in the NNP NN of NNP . 1 It VBZ a JJ NN JJ VBN NN as their JJ NN and VBZ NN NN with NN NN and NN NN , 2 , 3 79.5 NN and 96 NN RB . RB , it VBZ to the NN NNP , VB NNP and VBZ a NN of 2B NN . 4 VBG NN , JJ NN of the NN through the NNS , NN , and JJ NNS VBZ VBN VBN , yet the JJ NN VBZ RB VBN VBN . 5 - 7 JJ NN in NNP , NNP VBD an JJ NN with a NN NN where JJS NNS VBD VBN or VBN . 4 RB , as the NN VBD , JJ VBN NNS VBD VBN RB RB over the NN , VBG the NN NN of the NN VBN as NNP ‐19 . At JJ , on 30 NNP 2020 , the NNP NNP NNP ( NNP ) VBD this NN a JJ NN NN of JJ NN . 8 VBG to the NN NN 35 ( VBN by 24 NNP 2020 ) of NNP , in NNP , 77 262 VBN NNS VBD VBN , of which 2595 NNS VBD with NNS . RB , RB of NNP , 2069 VBN NNS VBD VBN in 29 JJ NNS ( https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/20200224‐sitrep‐35‐covid‐19.pdf?sfvrsn=1ac4218d RB , as the NN VBD VBG JJR and JJR , the NN for VBG a JJ NN NN NN against the NNP NNP ‐2 VBD VBG . Our NN VBD to VB JJ NNS , which can VB JJ JJ NN against the NN NN NN NN . VBG NNS , we could VB and VB JJ NN and NN NNS for the NN of the JJ NN against NN NN ‐ 2.9 RB , the NN NN of NN NN ‐2 VBZ VBN as the NN because it VBZ a JJ NN of the NN and VBZ from the JJ NN .10 RB , the NN NN of NN NN VBD VBN RB VBG JJ JJ NN NNS and NN , to VB JJ NNS for an JJ NN . The NN NN NN of the VBN NN on NNP NN VBD VBN from the NNP NNP for NNP NNP ( NNP ) NN .11 The NN NN VBZ RB JJ for VBG the JJ NNS of the VBN NN . In this NN , we VBD the NNP NN NN ( NNP ) to VB JJ NNP NNS VBG the VBN NNP 2.0 NN NN . 12 , 13 We VBD the NNP NN of the VBN NN as an NN VBG all NN NNS . NNP NNS VBG the VBG NN towards NNP and NNP NNS VBD VBN to VB up both JJ NN and NN NNP VBN NN NN . We VBD two NNS which VBP NNP NN and NNP NN to the NN of NNP and NNP NN NNS RB within JJ NNP JJ NN . 14 , 15 The VBN NNS VBD VBN to the NNP NN NN VBG a NN as a NN NN with the VBN NN NN of 0.4 for VBG the JJ NN . 16 With the NN of a JJ NN NN , we VBD the JJ NNS to VB an JJ NN NN . RBR , the NN NN VBD VBN in the NNP NN NN . 17 An NN VBD RB VBN with the NN NN to VB the JJ JJ NNS . The NN NN VBD through two JJ NNS NNP and NNP — in a JJ NN for VBG the JJ NN of the NN . 18 , 19 NN NN VBZ the RBS JJ NN of the JJ NN NN . RB , in this NN , we VBD NNP ( NNP 1.3 NNP ) NN NN to NN NN . 20 NNP NN VBZ the JJ NN between the NN NN and the NN NN NN ( NNP ) ‐5 . The VBN NN NN NN ( NNP ) NN of the NN NN NN VBD VBN in NN NN v.2.3.21 NN NN of NNP NN , VBN from the NNP VBZ the NN NN NN : QHR63290.1 . This NN NN VBZ 1282 NN NN NN NNS and this NN VBD VBN in a NNP NN to VB out the JJ NN . We VBD a NN of 34 JJ JJ NN NNS of VBG NNS from the NN NN within NN NN of NN NN . Those NNP NNS VBD VBN into NNP 1 VBN on their JJ NN , NN , and NN . In NNP 1 the JJ NN NNS VBP the JJ NN , while the JJ JJ NNS , VBP the JJ NN . VB of JJ NNP NNS along with their NN , NN , and NN JJ NN of JJ NNP NNS within the NN NN of NNP NN We VBD 29 NNP NNS and 8 NNP NNS , which VBP within the JJ NNP NN NN . Among them , 13 NNP NNS and 3 NNP NNS VBD the JJ NN , VBG to the NNP NN NN NN . The NNP and NNP NNS VBP VBN in NNPS 2 and 3 with VBG NN NNS and JJ NNS . NN of NNS with VBG NN NNS , JJ NN , and NNP JJ NN NN VBG the NNS with VBG NN NNS , JJ NN and NNP JJ NN In this NN , we VBD the 13 NNP and 3 NNP JJ NNS with ( NN ) NN NN to VB a NN NN . This NN NN VBD RB VBN with the NN NN NN and VBN NN RB RB as NN of the NN NN . 22 The VBN NN of the NN NN VBZ VBN in NNP 2 . It VBZ 90.0 NN , 7.1 NN , 1.6 NN , and 1.3 NN NNS in RBS VBN , RB VBN , RB VBN and VBN NNS RB within NNP as the NN NN to VB NNP NN . VBG the NNP NN , the “ NN ” NN VBD − 3.82 and JJS of the NNS VBD JJ NN NN as VBN in NNP 3 . NNS from both NNS VBP the NN VBZ in a JJ NN . 23 , 24 JJ JJ NN of NN NN . ( a ) All NNS at NNP NN , ( b ) “ NN ” NN NN of NN NN in FW NN , and ( c ) all NN NN NN The NNP NN VBD 20 NN NNS , and among them , we VBD RB the NN NN with the JJS JJ JJ NN NN ( NN ) NN for NN . The NNP NN of the NN NN VBD − 259.62 , which VBZ JJ NN between the NN NN and NN ‐ 5.25 As JJ NN NN NN VBZ the JJ NNS , the NN between the NN NN and NN will VB NN NNS for VBG the JJ NNS . 26 The VBN NN NN VBZ VBN in NNPS 4 and 5 , along with JJ NN NN RB RB as some NN NNS . NN NN VBG the NN NN between NN NN ( NN NN ) and NN NN NN ‐5 ( JJ NN ) NN NN VBG the NN NN between NN NN and NN NN NN The NNP NNP , the JJ NN for JJ NN NN , VBD JJR than 10 000 NNS to NN RB over the NN , RB JJ to NN . After RB VBN in NNP , NNP NN of NNP , the NNP ‐19 NN VBD JJ which RB VBD a JJ NN . NNS from RB over the NN VBP VBG to VB a NN to this JJ NN . In our JJ NN , we VBD to VB out JJ NNP and NNP NNS against NNP NN , VBG the NNS , as JJ NN of NNP and NN NNS VBZ JJ for NN of NN NN against this NN . The NN NN VBD VBN for NNP NN NN in the NN NN , and 34 JJ NNP NNS VBD VBN as a NN . RB , the NN VBD RB VBN in NNP NNP and NNP NNS for the NN of the NN NN that can VB with NNP and NN NN NNS . RB , we VBD 29 NNS against NNP and 8 NNS against NNP that can VB RB VBN for NN . RB , JJ NN in NNP v.2.0 VBD 16 NNP NNS out of 29 and 5 out of 8 NNP NN NNS as these VBD to VB JJ in NN . RB , we VBD the JJ NNS into a JJ NN NN , VBG ( NN ) NN NN . RBR , the NN NN VBD VBN in the NNP NN and VBN in NNP and NNP . A NN of 90 NN of JJ and JJ NNS VBN within the RBS VBN NN , while the “ NN ” NN of the NN VBD − 3.82 . These NNS from both NNS VBP the NN VBZ in JJ NN . JJ NN between NN NN and NNP ‐5 VBD JJ NN NN , which VBZ JJ NN within the NN NN . All the NNS of our JJ NN VBP the NN of VBN NNS within the NN NN of NN NN ‐2 . These NNS can VB VBN to VB an JJ JJ NN NN against NN NN . JJ JJ NN VBD out 13 NNP and 3 NNP NNS within the NN NN of NN NN ‐2 . These NNS VBP the JJ NN to VB a JJ NN NN , RB RB because of VBG VBN from the JJ NNP JJ NN but RB because of their JJ NN VBD VBN . RB , the JJ NN of NN NNS with the NN VBZ the NN and NN of these NNS as an JJ NN NN against NNP NNP . RB , these JJ NNS VBP JJ in NN and in NN NNS before VBG the NN to VB NN ‐19 ."
9,259,mainstream,"The_DT day_NN after_IN data_NNS appeared_VBN from_IN the_DT vaccine_NN maker_NN Sinovac_NNP showed_VBD complete_JJ protection_NN of_IN rhesus_NN monkeys_NNS by_IN their_PRP$ vaccine_NN candidate_NN (_-LRB- whole_RB inactivated_VBN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN particles_NNS )_-RRB- ,_, scientists_NNS from_IN the_DT Jenner_NNP Institute_NNP in_IN Oxford_NNP issued_VBD a_DT press_NN release_NN announcing_VBG that_IN their_PRP$ vaccine_NN (_-LRB- an_DT adenovirus_NN vector_NN based_VBN vaccine_NN that_WDT carried_VBD the_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD spike_NN protein_NN )_-RRB- worked_VBD to_TO protect_VB rhesus_NN monkeys_NNS and_CC that_IN they_PRP were_VBD moving_VBG forward_RB with_IN large_JJ scale_NN human_JJ safety_NN trials_NNS ._. At_IN the_DT time_NN ,_, the_DT substantiating_VBG data_NNS was_VBD not_RB available_JJ ._. Now_RB it_PRP is_VBZ ,_, in_IN the_DT form_NN of_IN a_DT May_NNP 13_CD BioRxiv_NN preprint_NN ._. Does_VBZ the_DT data_NNS support_VB the_DT claim_NN ?_. Not_RB really_RB ._. All_DT of_IN the_DT vaccinated_VBN monkeys_NNS treated_VBN with_IN the_DT Oxford_JJ vaccine_NN became_VBD infected_VBN when_WRB challenged_VBN ,_, as_IN judged_VBN by_IN recovery_NN of_IN virus_NN genomic_JJ RNA_NN from_IN nasal_JJ secretions_NNS ._. There_EX was_VBD no_DT difference_NN in_IN the_DT amount_NN of_IN viral_JJ RNA_NN detected_VBN from_IN this_DT site_NN in_IN the_DT vaccinated_VBN monkeys_NNS as_IN compared_VBN to_IN the_DT unvaccinated_JJ animals_NNS ._. Which_WDT is_VBZ to_TO say_VB ,_, all_DT vaccinated_VBN animals_NNS were_VBD infected_VBN ._. This_DT observation_NN is_VBZ in_IN marked_VBN contrast_NN to_IN the_DT results_NNS reported_VBD from_IN Sinovac_NNP trial_NN ._. At_IN the_DT highest_JJS dose_NN studied_VBN ,_, no_DT virus_NN was_VBD recovered_VBN from_IN vaccinated_VBN monkeys_NNS from_IN the_DT throat_NN ,_, lung_NN ,_, or_CC rectum_NN of_IN the_DT vaccinated_VBN animals_NNS ._. There_EX is_VBZ a_DT second_JJ troubling_JJ result_NN of_IN the_DT Oxford_NNP paper_NN ._. The_DT titer_NN of_IN neutralizing_VBG antibody_NN ,_, as_IN judged_VBN by_IN inhibition_NN of_IN virus_NN replication_NN by_IN successive_JJ serum_NN dilutions_NNS as_IN reported_VBN is_VBZ extremely_RB low_JJ ._. Typically_RB ,_, neutralizing_VBG antibodies_NNS in_IN effective_JJ vaccines_NNS can_MD be_VB diluted_VBN by_IN more_JJR than_IN a_DT thousand_CD fold_NN and_CC retain_VB activity_NN ._. In_IN these_DT experiments_NNS the_DT serum_NN could_MD be_VB diluted_VBN only_RB by_IN 4_CD to_IN 40_CD fold_NN before_IN neutralizing_VBG activity_NN was_VBD lost_VBN ._. Again_RB ,_, by_IN contrast_NN the_DT titer_NN of_IN neutralizing_VBG antibodies_NNS in_IN the_DT serum_NN of_IN those_DT vaccinated_VBN with_IN whole_JJ inactivated_VBN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD was_VBD high_JJ ._. What_WP then_RB is_VBZ the_DT argument_NN for_IN pressing_VBG forward_RB with_IN the_DT adenovirus_NN vector_NN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD spike_NN protein_NN vaccine_NN ?_. The_DT authors_NNS present_VBP evidence_NN to_IN the_DT effect_NN that_IN ,_, although_IN the_DT vaccine_NN did_VBD not_RB protect_VB the_DT animals_NNS from_IN infection_NN ,_, it_PRP did_VBD moderate_VB the_DT disease_NN ._. The_DT vaccinated_VBN and_CC control_NN animals_NNS were_VBD followed_VBN for_IN clinical_JJ signs_NNS of_IN infection_NN for_IN seven_CD days_NNS post_JJ infection_NN ._. One_CD clinical_JJ sign_NN of_IN infection_NN in_IN rhesus_NN monkeys_NNS is_VBZ breathing_VBG rate_NN ._. Monkeys_NNS ill_JJ from_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD infection_NN breathe_VBP more_RBR rapidly_RB than_IN normal_JJ ._. By_IN this_DT measure_NN 3_CD of_IN the_DT 6_CD vaccinated_VBN monkeys_NNS were_VBD clinically_RB ill_JJ ,_, the_DT remaining_VBG three_CD were_VBD not_RB clinically_RB distinguishable_JJ from_IN the_DT unvaccinated_JJ animals_NNS ._. A_DT second_JJ test_NN is_VBZ measurement_NN of_IN the_DT amount_NN of_IN virus_NN in_IN the_DT lungs_NNS (_-LRB- bronchial_JJ lavage_NN )_-RRB- ._. Viral_JJ RNA_NN was_VBD detected_VBN in_IN the_DT bronchial_JJ lavage_NN of_IN 2_CD of_IN the_DT 6_CD vaccinated_VBN animals_NNS and_CC in_IN all_DT three_CD unvaccinated_JJ animals_NNS ,_, again_RB suggesting_VBG only_RB partial_JJ protection_NN ._. At_IN day_NN seven_CD post_NN challenge_NN the_DT animals_NNS were_VBD euthanized_VBN and_CC examined_VBN for_IN lung_NN damage_NN ._. Two_CD of_IN the_DT three_CD unvaccinated_JJ animals_NNS “_'' developed_VBD some_DT degree_NN of_IN interstitial_JJ pneumonia_NN ”_'' as_IN judged_VBN by_IN pathological_JJ examination_NN of_IN the_DT lungs_NNS ._. No_DT such_JJ damage_NN was_VBD observed_VBN in_IN any_DT of_IN the_DT vaccinated_VBN animals_NNS ._. It_PRP is_VBZ encouraging_VBG that_IN no_DT evidence_NN of_IN vaccine_NN induced_VBN disease_NN enhancement_NN was_VBD observed_VBN in_IN either_CC the_DT Sinovac_NNP vaccine_NN nor_CC the_DT Oxford_NNP trials_NNS ._. However_RB ,_, experience_NN with_IN other_JJ vaccines_NNS tells_VBZ us_PRP that_DT is_VBZ not_RB a_DT firm_JJ guarantee_NN that_IN such_JJ will_MD be_VB the_DT case_NN for_IN humans_NNS ._. What_WP to_TO make_VB of_IN this_DT data_NNS ?_. It_PRP is_VBZ crystal_RB clear_JJ that_IN the_DT vaccine_NN did_VBD not_RB provide_VB sterilizing_VBG immunity_NN to_IN the_DT virus_NN challenge_NN ,_, the_DT gold_NN standard_NN for_IN any_DT vaccine_NN ._. It_PRP may_MD provide_VB partial_JJ protection_NN ._. The_DT question_NN then_RB becomes_VBZ :_: Will_MD partial_JJ protection_NN be_VB enough_JJ to_TO control_VB the_DT COVID_NN -_HYPH 19_CD pandemic_NN ?_. That_DT is_VBZ an_DT open_JJ question_NN ._. For_IN an_DT answer_NN we_PRP can_MD look_VB to_IN other_JJ diseases_NNS for_IN which_WDT only_RB partially_RB effective_JJ vaccines_NNS exist_VBP —_: HIV_NN ,_, tuberculosis_NN ,_, and_CC malaria_NN ._. The_DT answers_NNS are_VBP not_RB encouraging_VBG ,_, except_IN perhaps_RB for_IN the_DT protection_NN of_IN childhood_NN malaria_NN ._. What_WP are_VBP the_DT potential_JJ implications_NNS for_IN other_JJ vaccine_NN trials_NNS ?_. We_PRP know_VBP adenovirus_NN is_VBZ a_DT good_JJ vector_NN for_IN eliciting_VBG protective_JJ responses_NNS for_IN protein_NN coding_NN genes_NNS of_IN other_JJ viruses_NNS ,_, in_IN fact_NN better_JJR than_IN many_JJ others_NNS ._. This_DT then_RB raises_VBZ the_DT question_NN of_IN whether_IN vaccine_NN strategies_NNS based_VBN on_IN the_DT delivery_NN of_IN viral_JJ antigens_NNS by_IN nucleic_JJ acids_NNS ,_, be_VB it_PRP DNA_NN or_CC RNA_NN ,_, will_MD suffice_VB ._. From_IN the_DT published_VBN data_NNS the_DT nucleic_JJ acid_NN of_IN select_JJ viral_JJ genes_NNS and_CC proteins_NNS delivery_NN technology_NN seems_VBZ inferior_JJ to_IN a_DT whole_JJ killed_VBN virus_NN vaccine_NN approach_NN ._. What_WP then_RB are_VBP the_DT choices_NNS for_IN the_DT Oxford_NNP group_NN ?_. Steam_VB ahead_RB with_IN a_DT vaccine_NN known_VBN to_TO be_VB partially_RB effective_JJ at_IN best_JJS ,_, one_CD which_WDT we_PRP already_RB know_VBP elicits_VBZ poor_JJ neutralizing_NN responses_NNS ?_. Work_VB to_TO improve_VB the_DT immunogenicity_NN of_IN the_DT current_JJ vaccine_NN ?_. Attempt_NN trials_NNS with_IN combinations_NNS of_IN two_CD or_CC more_JJR vaccines_NNS ,_, a_DT prime_JJ boost_NN strategy_NN ?_. These_DT questions_NNS are_VBP all_RB the_DT more_RBR fraught_JJ by_IN what_WP we_PRP already_RB know_VBP about_IN the_DT complexities_NNS of_IN antibody_NN reposes_NNS to_IN natural_JJ infections_NNS ._. For_IN example_NN ,_, we_PRP know_VBP in_IN the_DT case_NN of_IN SARS_NN and_CC other_JJ coronavirus_NN infections_NNS that_WDT even_RB high_JJ titers_NNS of_IN neutralizing_VBG antibodies_NNS fade_VBP quickly_RB over_IN time_NN ._. How_WRB long_RB can_MD we_PRP expect_VB weakly_RB neutralizing_VBG antibodies_NNS to_TO protect_VB ?_. We_PRP know_VBP what_WP the_DT public_JJ response_NN is_VBZ of_IN the_DT Oxford_NNP group_NN and_CC their_PRP$ collaborators_NNS ._. Proceed_VB with_IN full_JJ speed_NN to_IN human_JJ safety_NN then_RB efficacy_NN trials_NNS ._. Time_NN will_MD tell_VB if_IN this_DT is_VBZ the_DT best_JJS approach_NN ._. I_PRP would_MD n’t_RB bet_VB on_IN it_PRP ._.","The NN after NNS VBN from the NN NN NNP VBD JJ NN of NN NNS by their NN NN ( RB VBN NN - NN - 2 NN NNS ) , NNS from the NNP NNP in NNP VBD a NN NN VBG that their NN ( an NN NN VBN NN that VBD the NN - NN - 2 NN NN ) VBD to VB NN NNS and that they VBD VBG RB with JJ NN JJ NN NNS . At the NN , the VBG NNS VBD RB JJ . RB it VBZ , in the NN of a NNP 13 NN NN . VBZ the NNS VB the NN ? RB RB . All of the VBN NNS VBN with the JJ NN VBD VBN when VBN , as VBN by NN of NN JJ NN from JJ NNS . There VBD no NN in the NN of JJ NN VBN from this NN in the VBN NNS as VBN to the JJ NNS . Which VBZ to VB , all VBN NNS VBD VBN . This NN VBZ in VBN NN to the NNS VBD from NNP NN . At the JJS NN VBN , no NN VBD VBN from VBN NNS from the NN , NN , or NN of the VBN NNS . There VBZ a JJ JJ NN of the NNP NN . The NN of VBG NN , as VBN by NN of NN NN by JJ NN NNS as VBN VBZ RB JJ . RB , VBG NNS in JJ NNS can VB VBN by JJR than a thousand NN and VB NN . In these NNS the NN could VB VBN RB by 4 to 40 NN before VBG NN VBD VBN . RB , by NN the NN of VBG NNS in the NN of those VBN with JJ VBN NNP - NNP - 2 VBD JJ . What RB VBZ the NN for VBG RB with the NN NN NN - NN - 2 NN NN NN ? The NNS VBP NN to the NN that , although the NN VBD RB VB the NNS from NN , it VBD VB the NN . The VBN and NN NNS VBD VBN for JJ NNS of NN for seven NNS JJ NN . One JJ NN of NN in NN NNS VBZ VBG NN . NNS JJ from NNP - NN - 2 NN VBP RBR RB than JJ . By this NN 3 of the 6 VBN NNS VBD RB JJ , the VBG three VBD RB RB JJ from the JJ NNS . A JJ NN VBZ NN of the NN of NN in the NNS ( JJ NN ) . JJ NN VBD VBN in the JJ NN of 2 of the 6 VBN NNS and in all three JJ NNS , RB VBG RB JJ NN . At NN seven NN NN the NNS VBD VBN and VBN for NN NN . Two of the three JJ NNS “ VBD some NN of JJ NN ” as VBN by JJ NN of the NNS . No JJ NN VBD VBN in any of the VBN NNS . It VBZ VBG that no NN of NN VBN NN NN VBD VBN in either the NNP NN nor the NNP NNS . RB , NN with JJ NNS VBZ us that VBZ RB a JJ NN that JJ will VB the NN for NNS . What to VB of this NNS ? It VBZ RB JJ that the NN VBD RB VB VBG NN to the NN NN , the NN NN for any NN . It may VB JJ NN . The NN RB VBZ : Will JJ NN VB JJ to VB the NN - 19 NN ? That VBZ an JJ NN . For an NN we can VB to JJ NNS for which RB RB JJ NNS VBP — NN , NN , and NN . The NNS VBP RB VBG , except RB for the NN of NN NN . What VBP the JJ NNS for JJ NN NNS ? We VBP NN VBZ a JJ NN for VBG JJ NNS for NN NN NNS of JJ NNS , in NN JJR than JJ NNS . This RB VBZ the NN of whether NN NNS VBN on the NN of JJ NNS by JJ NNS , VB it NN or NN , will VB . From the VBN NNS the JJ NN of JJ JJ NNS and NNS NN NN VBZ JJ to a JJ VBN NN NN NN . What RB VBP the NNS for the NNP NN ? VB RB with a NN VBN to VB RB JJ at JJS , one which we RB VBP VBZ JJ NN NNS ? VB to VB the NN of the JJ NN ? NN NNS with NNS of two or JJR NNS , a JJ NN NN ? These NNS VBP RB the RBR JJ by what we RB VBP about the NNS of NN NNS to JJ NNS . For NN , we VBP in the NN of NN and JJ NN NNS that RB JJ NNS of VBG NNS VBP RB over NN . How RB can we VB RB VBG NNS to VB ? We VBP what the JJ NN VBZ of the NNP NN and their NNS . VB with JJ NN to JJ NN RB NN NNS . NN will VB if this VBZ the JJS NN . I would RB VB on it ."
10,625,mainstream,"On_IN the_DT backdrop_NN of_IN novel_JJ coronavirus_NN (_-LRB- COVID_NNP ‐19_CD ‐_SYM SARS_NNP ‐CoV2_NN )_-RRB- creating_VBG a_DT pandemic_NN situation_NN and_CC creating_VBG some_DT desertion_NN of_IN the_DT city_NN of_IN Wuhan_NNP ,_, China_NNP ,_, the_DT epicenter_NN ,_, it_PRP is_VBZ an_DT emergent_JJ need_NN that_WDT the_DT medical_JJ and_CC scientific_JJ community_NN undertake_VBP quick_JJ measures_NNS ._. This_DT virus_NN has_VBZ made_VBN social_JJ ,_, political_JJ ,_, economic_JJ ,_, financial_JJ ,_, medical_JJ ,_, and_CC scientific_JJ fraternity_NN to_TO go_VB in_IN a_DT state_NN of_IN emergency_NN ._. The_DT spread_NN of_IN the_DT virus_NN has_VBZ been_VBN as_RB fast_JJ as_IN the_DT dissemination_NN of_IN fear_NN and_CC false_JJ news_NN ._. Rapid_JJ isolation_NN measures_NNS taken_VBN have_VBP restricted_VBN the_DT spread_NN ,_, yet_CC it_PRP may_MD be_VB premature_JJ to_TO say_VB if_IN they_PRP were_VBD delayed_VBN ._. WHO_WP declared_VBD coronavirus_NN disease_NN (_-LRB- COVID_NNP ‐19_CD )_-RRB- outbreak_NN as_IN pandemic_NN on_IN March_NNP 12_CD ,_, 2020_CD ._. The_DT virus_NN responsible_JJ for_IN COVID_NN ‐19_NN disease_NN is_VBZ SARS_NNP ‐CoV2_NN ._. It_PRP was_VBD on_IN February_NNP 11_CD ,_, 2020_CD ,_, that_IN the_DT international_JJ committee_NN on_IN taxonomy_NN of_IN viruses_NNS announced_VBD severe_JJ acute_JJ respiratory_JJ syndrome_NN coronavirus_NN 2_CD as_IN the_DT name_NN of_IN this_DT new_JJ virus_NN earlier_RBR called_VBN novel_NN coronavirus_NN (_-LRB- nCov_NNP )_-RRB- ._. Coronavirus_NN belongs_VBZ to_IN the_DT family_NN of_IN coronaviridae_NN in_IN the_DT order_NN Nidovirales_NNPS ._. There_EX are_VBP four_CD groups_NNS of_IN coronaviruses_NNS (_-LRB- Zhu_NNP &_CC Zhang_NNP ,_, 2020_CD )_-RRB- :_: alphacoronaviruses_NNS infect_VBP mammals_NNS (_-LRB- human_JJ coronavirus_NN NL63_NN )_-RRB- ,_, Betacoronaviruses_NNS infect_VBP mammals_NNS (_-LRB- SARS_NN CoV_NN ,_, MERS_NN CoV_NN ,_, Bat_NN CoV_NN )_-RRB- ,_, gammacoronaviruses_NNS infect_VBP birds_NNS (_-LRB- avian_JJ infectious_JJ bronchitis_NN coronavirus_NN )_-RRB- ,_, deltacoronaviruses_NNS infect_VBP both_CC birds_NNS and_CC mammals_NNS (_-LRB- porcein_NN delta_NN CoV_NN )_-RRB- ._. Four_CD viruses_NNS 229_CD E_NN (_-LRB- alpha_NN )_-RRB- ,_, UC_NNP 43_CD (_-LRB- beta_NN )_-RRB- ,_, NL_NNP 63_CD (_-LRB- alpha_NN )_-RRB- ,_, and_CC HKU1_NN (_-LRB- beta_NN )_-RRB- cause_VBP common_JJ cold_JJ symptoms_NNS ._. COVID‐19_NNP is_VBZ a_DT betacoronavirus_NN (_-LRB- Zhu_NNP &_CC Zhang_NNP ,_, 2020_CD )_-RRB- ._. Bat_NN coronavirus_NN HKU4_NNP is_VBZ also_RB a_DT betacoronavirus_NN ._. It_PRP is_VBZ a_DT large_JJ (_-LRB- 27–32_CD kb_NN )_-RRB- ,_, enveloped_VBN ,_, positive_JJ ‐stranded_JJ RNA_NN virus_NN ._. Its_PRP$ viral_JJ genome_NN is_VBZ packed_VBN inside_IN a_DT helical_JJ capsid_NN formed_VBN by_IN nucleocapsid_JJ protein_NN and_CC is_VBZ surrounded_VBN by_IN an_DT envelope_NN ._. The_DT virus_NN has_VBZ four_CD proteins_NNS :_: membrane_NN protein_NN (_-LRB- M_NN )_-RRB- ,_, envelope_NN protein_NN (_-LRB- E_NN )_-RRB- ,_, spike_NN protein_NN (_-LRB- S_NN )_-RRB- ,_, and_CC nucleocapsid_JJ protein_NN (_-LRB- N_NN )_-RRB- ._. Spike_NN forms_VBZ large_JJ protrusions_NNS on_IN viral_JJ surface_NN ,_, giving_VBG it_PRP a_DT crownlike_JJ appearance_NN ,_, and_CC hence_RB the_DT name_NN corona_NN ._. Spike_NN protein_NN mediates_VBZ the_DT entry_NN of_IN the_DT virus_NN into_IN host_NN cells_NNS (_-LRB- Lellan_NNP &_CC Wrapp_NNP ,_, 2020_CD )_-RRB- ._. It_PRP is_VBZ also_RB the_DT critical_JJ determinant_NN of_IN viral_JJ host_NN range_NN and_CC tissue_NN tropism_NN and_CC is_VBZ a_DT major_JJ inducer_NN of_IN host_NN immune_JJ response_NN (_-LRB- Li_NNP ,_, 2016_CD )_-RRB- ._. Spike_NN protein_NN is_VBZ in_IN charge_NN of_IN receptor_NN binding_NN and_CC subsequent_JJ viral_JJ entry_NN into_IN the_DT host_NN cells_NNS ._. Therefore_RB ,_, it_PRP can_MD be_VB the_DT major_JJ therapeutic_JJ target_NN ._. It_PRP binds_VBZ to_IN the_DT cellular_JJ receptor_NN angiotensin_NN converting_VBG enzyme_NN 2_CD (_-LRB- ACE2_NN )_-RRB- and_CC cellular_JJ receptor_NN dipeptidyl_NN peptidase_NN 4_CD (_-LRB- DPP_NN 4_CD )_-RRB- or_CC CD_NN 26_CD ._. The_DT former_NN is_VBZ more_JJR for_IN SARS_NNP and_CC the_DT latter_NN is_VBZ for_IN MERS_NNP ._. CD_NNP 209_CD L_NNP is_VBZ the_DT alternative_JJ receptor_NN with_IN lower_JJR affinity_NN to_IN respiratory_JJ tract_NN (_-LRB- Song_NNP et_FW al._FW ,_, 2019_CD )_-RRB- ._. Scientists_NNS (_-LRB- Wan_NNP ,_, Shang_NNP ,_, Graham_NNP ,_, Baric_NNP ,_, &_CC Li_NNP ,_, 2020_CD )_-RRB- have_VBP analyzed_VBN the_DT potential_JJ receptor_NN usage_NN by_IN 2019_CD ‐nCoV_NN based_VBN on_IN the_DT knowledge_NN on_IN sequencing_NN of_IN SARS_NNP ‐CoV_NN ._. They_PRP have_VBP found_VBN that_IN the_DT sequence_NN of_IN 2019_CD nCoV_NN receptor_NN binding_NN motif_NN (_-LRB- RBM_NNP )_-RRB- that_WDT directly_RB contacts_VBZ ACE2_NN receptor_NN is_VBZ similar_JJ to_IN that_DT of_IN SARS_NNP ‐CoV_NNP and_CC suggest_VBP that_IN 2019_CD ‐nCoV_NNP (_-LRB- Wuhan_NNP )_-RRB- uses_VBZ ACE2_NNP as_IN its_PRP$ receptor_NN ._. Their_PRP$ structural_JJ analysis_NN predicted_VBD that_IN the_DT Wuhan_NNP coronavirus_NN uses_VBZ ACE2_NNP as_IN its_PRP$ host_NN receptor_NN ._. They_PRP have_VBP further_RB stated_VBN that_IN a_DT single_JJ mutation_NN significantly_RB enhances_VBZ the_DT ability_NN of_IN nCoV_NNP (_-LRB- Wuhan_NNP )_-RRB- to_TO bind_VB with_IN human_JJ ACE2_NN (_-LRB- Zhu_NNP &_CC Zhang_NNP ,_, 2020_CD )_-RRB- ._. Spike_NN protein_NN has_VBZ S1_NNP and_CC S2_NNP subunits_NNS ._. A_DT minimal_JJ receptor‐binding_NN domain_NN (_-LRB- RBD_NNP )_-RRB- is_VBZ located_VBN in_IN the_DT S1_NNP subunit_NN and_CC can_MD combine_VB with_IN host_NN cell_NN receptor_NN ACE2_NN ._. On_IN the_DT RBD_NNP ,_, RBM_NNP is_VBZ located_VBN ,_, which_WDT is_VBZ responsible_JJ for_IN complete_JJ contact_NN with_IN ACE2_NNP ._. There_EX is_VBZ no_DT definite_JJ treatment_NN for_IN COVID_NNP ‐19_CD ._. The_DT most_RBS important_JJ method_NN is_VBZ to_TO prevent_VB viral_JJ transmission_NN by_IN rapid_JJ isolation_NN and_CC disease_NN containment_NN measures_NNS ._. As_IN the_DT spread_NN of_IN COVID_NN ‐19_CD is_VBZ mainly_RB respiratory_JJ in_IN origin_NN by_IN droplet_NN infection_NN ,_, utmost_JJ care_NN is_VBZ required_VBN with_IN the_DT use_NN of_IN personal_JJ protective_JJ gadgets_NNS ,_, masks_NNS ,_, assessment_NN ,_, and_CC notification_NN of_IN true_JJ picture_NN and_CC prevention_NN of_IN spread_NN by_IN controlling_VBG travel_NN and_CC isolation_NN ,_, screening_NN of_IN individuals_NNS ,_, and_CC so_RB forth_RB ._. Treatment_NN of_IN pneumonia_NN and_CC acute_JJ lung_NN injury_NN is_VBZ largely_RB empiric_JJ ._. There_EX is_VBZ an_DT urgent_JJ need_NN to_TO device_VB and_CC develop_VB various_JJ treatment_NN modalities_NNS in_IN the_DT form_NN of_IN vaccine_NN ,_, newer_JJR drug_NN molecules_NNS ,_, or_CC repurpose_VB some_DT of_IN the_DT existing_VBG drugs_NNS ._. The_DT health_NN care_NN community_NN and_CC biotech_NN industry_NN need_VBP to_TO take_VB an_DT urgent_JJ call_NN and_CC undertake_VB quick_JJ clinical_JJ trials_NNS on_IN humanitarian_JJ grounds_NNS ._. Various_JJ modalities_NNS of_IN treatment_NN can_MD be_VB tried_VBN ._. •_NFP Antiviral_JJ drugs_NNS —viral_JJ polymerases_NNS and_CC protease_NN inhibitors_NNS ,_, which_WDT are_VBP components_NNS of_IN the_DT HIV_NN and_CC HCV_NN antiviral_JJ regimen_NN ,_, find_VBP an_DT immediate_JJ place_NN ._. Lopinavir_NNP and_CC ritonavir_NN ,_, which_WDT are_VBP protease_NN inhibitors_NNS ,_, and_CC oseltamivir_NN neuraminidase_NN are_VBP under_IN study_NN ._. Remdesivir_NN ,_, which_WDT interferes_VBZ with_IN viral_JJ polymerase_NN ,_, can_MD be_VB tried_VBN (_-LRB- it_PRP has_VBZ shown_VBN efficacy_NN against_IN MERS_NN )_-RRB- (_-LRB- Wan_NNP et_FW al._FW ,_, )_-RRB- ._. •_NFP Vaccine_NN trials_NNS need_VBP to_TO be_VB started_VBN ._. Antibodies_NNS raised_VBN against_IN the_DT S1_NNP subunit_NN can_MD be_VB protective_JJ ,_, so_RB can_MD antibodies_NNS against_IN the_DT RBD_NN fragment_NN ._. Spike_NN protein‐based_VBN vaccine_NN will_MD also_RB produce_VB antibodies_NNS and_CC will_MD offer_VB protection_NN ._. Passive_JJ antibody_NN transfer_NN from_IN convalescent_JJ sera_NN of_IN recovered_VBN patients_NNS will_MD have_VB polyclonal_JJ antibodies_NNS ,_, and_CC their_PRP$ plasma_NN can_MD be_VB transfused_VBN ._. A_DT new_JJ idea_NN of_IN target_NN viral_NN receptor_NN protein_NN on_IN cell_NN surface_NN ACE2_NN and_CC RBD_NN protein_NN can_MD be_VB attached_VBN to_IN an_DT Fc_NN fragment_NN and_CC can_MD be_VB used_VBN to_TO attack_VB the_DT virus_NN ._. Extracellular_JJ domain_NN of_IN ACE2_NN protein_NN fused_VBN to_IN a_DT human_JJ immunoglobulin_NN G_NN ,_, Fc_NN domain_NN may_MD hold_VB promise_NN (_-LRB- David_NNP Fedson_NNP ,_, )_-RRB- ._. ACE2_NNP Fc_NN fusion_NN protein_NN against_IN COVID_NN may_MD neutralize_VB the_DT virus_NN and_CC prevent_VB lung_NN injury_NN ._. It_PRP can_MD also_RB be_VB used_VBN to_TO give_VB passive_JJ immunity_NN to_IN health_NN care_NN workers_NNS ._. All_PDT these_DT are_VBP still_RB highly_RB experimental_JJ ._. An_DT interesting_JJ paper_NN (_-LRB- Hoffmann_NNP et_FW al._FW ,_, )_-RRB- mentions_VBZ the_DT use_NN of_IN a_DT drug_NN called_VBN CAMOSTAT_NNP acting_VBG on_IN TMPRSS_NNP 2_CD protein_NN ,_, which_WDT could_MD prevent_VB viral_JJ entry_NN as_IN the_DT virus_NN uses_VBZ the_DT protein_NN ._. •_NFP Based_VBN on_IN the_DT structure_NN of_IN the_DT virus_NN ,_, the_DT presence_NN of_IN ACE2_NNP as_IN the_DT receptor_NN ,_, which_WDT facilitates_VBZ entry_NN of_IN the_DT virus_NN ,_, and_CC based_VBN on_IN work_NN done_VBN in_IN SARS_NN ,_, ARDS_NN ,_, and_CC sepsis_NN by_IN Fedson_NNP (_-LRB- )_-RRB- ,_, some_DT treatments_NNS can_MD be_VB hypothesized_VBN ._. A_DT large_JJ body_NN of_IN experimental_JJ and_CC clinical_JJ research_NN done_VBN on_IN treating_VBG patients_NNS with_IN pneumonia_NN ,_, ARDS_NN ,_, sepsis_NN ,_, influenza_NN ,_, and_CC Ebola_NNP (_-LRB- with_IN lung_NN injury_NN )_-RRB- suggest_VBP that_IN statins_NNS and_CC angiotensin_NN receptor_NN blockers_NNS might_MD be_VB effective_JJ in_IN COVID_NN ‐19_CD infection_NN ._. Statins_NNS are_VBP known_VBN to_TO have_VB lipid‐lowering_NN and_CC also_RB anti‐inflammatory_JJ and_CC immunomodulatory_JJ activities_NNS on_IN cytokines_NNS ,_, chemokines_NNS ,_, complement_NN cascade_NN ,_, and_CC coagulation_NN factors_NNS ._. Thus_RB ,_, the_DT host_NN response_NN to_IN COVID_NNP ‐19_CD resulting_VBG in_IN lung_NN injury_NN may_MD be_VB controlled_VBN with_IN the_DT use_NN of_IN statins_NNS ._. Hypercytokinemia_NNP is_VBZ not_RB directly_RB associated_VBN with_IN viral_JJ replication_NN ,_, but_CC it_PRP can_MD be_VB variability_NN in_IN host_NN response_NN ._. Early_JJ use_NN of_IN statins_NNS could_MD prove_VB beneficial_JJ ._. Other_JJ anti‐inflammatory_JJ drugs_NNS can_MD be_VB used_VBN ._. Chloroquine_NNP is_VBZ being_VBG tried_VBN too_RB ._. •_NFP We_PRP also_RB hypothesize_VBP that_IN the_DT use_NN of_IN angiotensin_NN II_CD receptor_NN blockers_NNS (_-LRB- ARB_NN )_-RRB- available_JJ for_IN clinical_JJ use_NN as_IN antihypertensives_NNS can_MD be_VB potential_JJ drugs_NNS to_TO be_VB given_VBN for_IN control_NN of_IN viral_JJ spread_NN of_IN novel_JJ coronavirus_NN (_-LRB- Wuhan_NNP )_-RRB- infection_NN ._. An_DT unpublished_JJ observation_NN by_IN one_CD of_IN us_PRP (_-LRB- M.P._NNP )_-RRB- is_VBZ that_IN people_NNS using_VBG losartan_NN or_CC telmisartan_NN (_-LRB- ARB_NN )_-RRB- as_IN antihypertensives_NNS get_VBP fewer_JJR attacks_NNS of_IN cold_JJ and_CC flu‐like_JJ illnesses_NNS ._. Both_CC these_DT drugs_NNS also_RB do_VBP not_RB produce_VB cough_NN as_IN the_DT side_NN effect_NN so_RB commonly_RB seen_VBN with_IN ACE_NN inhibitors_NNS ._. Losartan_NNP and_CC telmisartan_NNP strongly_RB binds_VBZ to_IN the_DT AT1_NN receptors_NNS more_JJR than_IN valsartan_NN (_-LRB- Phadke_NNP &_CC Saunik_NNP ,_, )_-RRB- ._. Therefore_RB ,_, the_DT use_NN of_IN the_DT former_NN could_MD be_VB suitable_JJ in_IN the_DT treatment_NN of_IN coronavirus_NN disease_NN ._. The_DT mode_NN of_IN administration_NN in_IN addition_NN to_IN being_VBG given_VBN orally_RB could_MD be_VB in_IN the_DT form_NN of_IN a_DT nasal_JJ spray_NN ._. Published_VBN literature_NN is_VBZ scant_JJ on_IN this_DT information_NN ._. Clinicians_NNS and_CC scientists_NNS may_MD consider_VB the_DT use_NN of_IN losartan_NN or_CC telmisartan_NN in_IN therapeutic_JJ doses_NNS for_IN preventing_VBG the_DT virus_NN entering_VBG the_DT host_NN cell_NN and_CC spread_NN of_IN infection_NN ._. Rapid_JJ clinical_JJ trials_NNS are_VBP the_DT need_NN of_IN the_DT hour_NN ._. In_IN mice_NNS ,_, experimentally_RB infected_VBN with_IN H_NN N_NN influenza_NN ,_, treatment_NN with_IN ARB_NN (_-LRB- Losartan_NNP )_-RRB- improved_VBN survival_NN (_-LRB- Kruse_NNP ,_, )_-RRB- ._. The_DT use_NN of_IN zinc_NN supplement_NN can_MD help_VB intracellular_JJ killing_NN and_CC phagocytosis_NN ,_, and_CC can_MD modulate_VB immune_NN function_NN ,_, and_CC may_MD be_VB tried_VBN ._. Thus_RB ,_, the_DT use_NN of_IN ARB_NN (_-LRB- telmisartan_NN and_CC losartan_NN )_-RRB- to_TO be_VB given_VBN in_IN therapeutic_JJ doses_NNS along_IN with_IN zinc_NN to_TO control_VB viral_JJ replication_NN warrants_VBZ attention_NN ._. ACE2_NN receptors_NNS are_VBP widely_RB expressed_VBN on_IN epithelial_JJ cells_NNS of_IN alveoli_NN ,_, trancheobronchial_NN free_JJ and_CC may_MD help_VB virus_NN entry_NN (_-LRB- Song_NNP et_FW al._FW ,_, 2019_CD )_-RRB- ._. Therefore_RB ,_, the_DT use_NN of_IN ARBs_NNS in_IN the_DT form_NN of_IN nebulization_NN can_MD be_VB tried_VBN ._. Developing_VBG scientific_JJ treatment_NN that_WDT will_MD target_VB the_DT viruses_NNS in_IN the_DT form_NN of_IN vaccines_NNS and_CC new_JJ molecules_NNS is_VBZ a_DT “_`` top‐down_NN ”_'' approach_NN ,_, but_CC can_MD be_VB time_NN ‐consuming_VBG ,_, though_IN eventually_RB required_VBN ._. However_RB ,_, one_PRP can_MD think_VB of_IN a_DT “_`` bottom‐up_NN ”_'' approach_NN by_IN repurposing_VBG commonly_RB used_VBN low_JJ ‐cost_NN generic_JJ drugs_NNS such_JJ as_IN ARB_NN ,_, zinc_NN in_IN controlling_VBG viral_JJ multiplication_NN ,_, and_CC statins_NNS to_TO control_VB lung_NN injury_NN ._. This_DT ,_, if_IN found_VBN useful_JJ ,_, can_MD make_VB an_DT immeasurable_JJ contribution_NN to_IN global_JJ health_NN ,_, equity_NN ,_, and_CC global_JJ viral_JJ security_NN ._. The_DT authors_NNS declare_VBP no_DT conflict_NN of_IN interest_NN ._.","On the NN of JJ NN ( NNP ‐19 ‐ NNP NN ) VBG a NN NN and VBG some NN of the NN of NNP , NNP , the NN , it VBZ an JJ NN that the JJ and JJ NN VBP JJ NNS . This NN VBZ VBN JJ , JJ , JJ , JJ , JJ , and JJ NN to VB in a NN of NN . The NN of the NN VBZ VBN RB JJ as the NN of NN and JJ NN . JJ NN NNS VBN VBP VBN the NN , yet it may VB JJ to VB if they VBD VBN . WHO VBD NN NN ( NNP ‐19 ) NN as NN on NNP 12 , 2020 . The NN JJ for NN NN NN VBZ NNP NN . It VBD on NNP 11 , 2020 , that the JJ NN on NN of NNS VBD JJ JJ JJ NN NN 2 as the NN of this JJ NN RBR VBN NN NN ( NNP ) . NN VBZ to the NN of NN in the NN NNPS . There VBP four NNS of NNS ( NNP & NNP , 2020 ) : NNS VBP NNS ( JJ NN NN ) , NNS VBP NNS ( NN NN , NN NN , NN NN ) , NNS VBP NNS ( JJ JJ NN NN ) , NNS VBP both NNS and NNS ( NN NN NN ) . Four NNS 229 NN ( NN ) , NNP 43 ( NN ) , NNP 63 ( NN ) , and NN ( NN ) VBP JJ JJ NNS . NNP VBZ a NN ( NNP & NNP , 2020 ) . NN NN NNP VBZ RB a NN . It VBZ a JJ ( 27–32 NN ) , VBN , JJ JJ NN NN . Its JJ NN VBZ VBN inside a JJ NN VBN by JJ NN and VBZ VBN by an NN . The NN VBZ four NNS : NN NN ( NN ) , NN NN ( NN ) , NN NN ( NN ) , and JJ NN ( NN ) . NN VBZ JJ NNS on JJ NN , VBG it a JJ NN , and RB the NN NN . NN NN VBZ the NN of the NN into NN NNS ( NNP & NNP , 2020 ) . It VBZ RB the JJ NN of JJ NN NN and NN NN and VBZ a JJ NN of NN JJ NN ( NNP , 2016 ) . NN NN VBZ in NN of NN NN and JJ JJ NN into the NN NNS . RB , it can VB the JJ JJ NN . It VBZ to the JJ NN NN VBG NN 2 ( NN ) and JJ NN NN NN 4 ( NN 4 ) or NN 26 . The NN VBZ JJR for NNP and the NN VBZ for NNP . NNP 209 NNP VBZ the JJ NN with JJR NN to JJ NN ( NNP FW FW , 2019 ) . NNS ( NNP , NNP , NNP , NNP , & NNP , 2020 ) VBP VBN the JJ NN NN by 2019 NN VBN on the NN on NN of NNP NN . They VBP VBN that the NN of 2019 NN NN NN NN ( NNP ) that RB VBZ NN NN VBZ JJ to that of NNP NNP and VBP that 2019 NNP ( NNP ) VBZ NNP as its NN . Their JJ NN VBD that the NNP NN VBZ NNP as its NN NN . They VBP RB VBN that a JJ NN RB VBZ the NN of NNP ( NNP ) to VB with JJ NN ( NNP & NNP , 2020 ) . NN NN VBZ NNP and NNP NNS . A JJ NN NN ( NNP ) VBZ VBN in the NNP NN and can VB with NN NN NN NN . On the NNP , NNP VBZ VBN , which VBZ JJ for JJ NN with NNP . There VBZ no JJ NN for NNP ‐19 . The RBS JJ NN VBZ to VB JJ NN by JJ NN and NN NN NNS . As the NN of NN ‐19 VBZ RB JJ in NN by NN NN , JJ NN VBZ VBN with the NN of JJ JJ NNS , NNS , NN , and NN of JJ NN and NN of NN by VBG NN and NN , NN of NNS , and RB RB . NN of NN and JJ NN NN VBZ RB JJ . There VBZ an JJ NN to VB and VB JJ NN NNS in the NN of NN , JJR NN NNS , or VB some of the VBG NNS . The NN NN NN and NN NN VBP to VB an JJ NN and VB JJ JJ NNS on JJ NNS . JJ NNS of NN can VB VBN . • JJ NNS JJ NNS and NN NNS , which VBP NNS of the NN and NN JJ NN , VBP an JJ NN . NNP and NN , which VBP NN NNS , and NN NN VBP under NN . NN , which VBZ with JJ NN , can VB VBN ( it VBZ VBN NN against NN ) ( NNP FW FW , ) . • NN NNS VBP to VB VBN . NNS VBN against the NNP NN can VB JJ , RB can NNS against the NN NN . NN VBN NN will RB VB NNS and will VB NN . JJ NN NN from JJ NN of VBN NNS will VB JJ NNS , and their NN can VB VBN . A JJ NN of NN NN NN NN on NN NN NN and NN NN can VB VBN to an NN NN and can VB VBN to VB the NN . JJ NN of NN NN VBN to a JJ NN NN , NN NN may VB NN ( NNP NNP , ) . NNP NN NN NN against NN may VB the NN and VB NN NN . It can RB VB VBN to VB JJ NN to NN NN NNS . All these VBP RB RB JJ . An JJ NN ( NNP FW FW , ) VBZ the NN of a NN VBN NNP VBG on NNP 2 NN , which could VB JJ NN as the NN VBZ the NN . • VBN on the NN of the NN , the NN of NNP as the NN , which VBZ NN of the NN , and VBN on NN VBN in NN , NN , and NN by NNP ( ) , some NNS can VB VBN . A JJ NN of JJ and JJ NN VBN on VBG NNS with NN , NN , NN , NN , and NNP ( with NN NN ) VBP that NNS and NN NN NNS might VB JJ in NN ‐19 NN . NNS VBP VBN to VB NN and RB JJ and JJ NNS on NNS , NNS , NN NN , and NN NNS . RB , the NN NN to NNP ‐19 VBG in NN NN may VB VBN with the NN of NNS . NNP VBZ RB RB VBN with JJ NN , but it can VB NN in NN NN . JJ NN of NNS could VB JJ . JJ JJ NNS can VB VBN . NNP VBZ VBG VBN RB . • We RB VBP that the NN of NN II NN NNS ( NN ) JJ for JJ NN as NNS can VB JJ NNS to VB VBN for NN of JJ NN of JJ NN ( NNP ) NN . An JJ NN by one of us ( NNP ) VBZ that NNS VBG NN or NN ( NN ) as NNS VBP JJR NNS of JJ and JJ NNS . Both these NNS RB VBP RB VB NN as the NN NN RB RB VBN with NN NNS . NNP and NNP RB VBZ to the NN NNS JJR than NN ( NNP & NNP , ) . RB , the NN of the NN could VB JJ in the NN of NN NN . The NN of NN in NN to VBG VBN RB could VB in the NN of a JJ NN . VBN NN VBZ JJ on this NN . NNS and NNS may VB the NN of NN or NN in JJ NNS for VBG the NN VBG the NN NN and NN of NN . JJ JJ NNS VBP the NN of the NN . In NNS , RB VBN with NN NN NN , NN with NN ( NNP ) VBN NN ( NNP , ) . The NN of NN NN can VB JJ NN and NN , and can VB NN NN , and may VB VBN . RB , the NN of NN ( NN and NN ) to VB VBN in JJ NNS along with NN to VB JJ NN VBZ NN . NN NNS VBP RB VBN on JJ NNS of NN , NN JJ and may VB NN NN ( NNP FW FW , 2019 ) . RB , the NN of NNS in the NN of NN can VB VBN . VBG JJ NN that will VB the NNS in the NN of NNS and JJ NNS VBZ a “ NN ” NN , but can VB NN VBG , though RB VBN . RB , one can VB of a “ NN ” NN by VBG RB VBN JJ NN JJ NNS JJ as NN , NN in VBG JJ NN , and NNS to VB NN NN . This , if VBN JJ , can VB an JJ NN to JJ NN , NN , and JJ JJ NN . The NNS VBP no NN of NN ."
11,986,mainstream,"Sao_NNP Paulo_NNP state_NN authorities_NNS announced_VBD an_DT agreement_NN between_IN the_DT Brazilian_JJ Butantan_NNP Institute_NNP and_CC Chinese_JJ laboratory_NN Sinovac_NNP Biotech_NNP to_TO conduct_VB phase_NN three_CD of_IN a_DT clinical_JJ coronavirus_NN vaccine_NN trial_NN on_IN approximately_RB 9,000_CD volunteers_NNS in_IN Brazil_NNP starting_VBG the_DT first_JJ week_NN of_IN July_NNP ._. ""_`` The_DT vaccine_NN proved_VBD very_RB effective_JJ at_IN phase_NN two_CD ._. It_PRP really_RB protected_VBD against_IN all_DT infections_NNS ._. Now_RB we_PRP are_VBP going_VBG to_TO do_VB a_DT populational_JJ test_NN ._. It_PRP is_VBZ a_DT promising_JJ vaccine_NN ,_, without_IN a_DT doubt_NN ,_, ”_'' Butantan_NNP Institute_NNP President_NN Dimas_NNP Covas_NNP said_VBD while_IN speaking_VBG at_IN a_DT news_NN conference_NN Thursday_NNP ._. Phase_NN three_CD will_MD involve_VB trying_VBG the_DT vaccine_NN on_IN different_JJ types_NNS of_IN people_NNS that_WDT represent_VBP the_DT diversity_NN of_IN the_DT population_NN such_JJ as_IN by_IN age_NN or_CC ethnicity_NN ._. According_VBG to_IN Sao_NNP Paulo´s_NNP health_NN officials_NNS ,_, the_DT vaccine_NN went_VBD through_IN the_DT first_JJ two_CD phases_NNS of_IN testing_NN in_IN China_NNP ,_, where_WRB it_PRP was_VBD tested_VBN on_IN 744_CD volunteers_NNS ._. The_DT Chinese_JJ lab_NN started_VBD human_JJ clinical_JJ trials_NNS with_IN the_DT experimental_JJ vaccine_NN on_IN April_NNP 17_CD ._. The_DT agreement_NN establishes_VBZ that_IN the_DT Butantan_NNP Institute_NNP will_MD own_VB the_DT vaccine_NN technology_NN to_TO potentially_RB mass_VB -_HYPH produce_VB it_PRP inside_IN Brazil_NNP ;_, and_CC if_IN proven_VBN effective_JJ ,_, it_PRP is_VBZ expected_VBN to_TO be_VB available_JJ to_IN the_DT population_NN in_IN the_DT first_JJ half_NN of_IN 2021_CD ,_, according_VBG to_IN Covas_NNP ._. The_DT Butantan_NNP Institute_NNP is_VBZ one_CD of_IN Brazil_NNP 's_POS top_JJ biomedical_JJ research_NN centers_NNS ._. The_DT state_NN of_IN Sao_NNP Paulo_NNP is_VBZ the_DT epicenter_NN of_IN the_DT outbreak_NN in_IN Brazil_NNP with_IN 162,520_CD cases_NNS of_IN coronavirus_NN and_CC 10,145_CD deaths_NNS as_IN of_IN Thursday_NNP afternoon_NN ._. Brazil_NNP has_VBZ the_DT second_JJ highest_JJS cases_NNS in_IN the_DT world_NN ;_: the_DT US_NNP is_VBZ first_RB ,_, according_VBG to_IN Johns_NNP Hopkins_NNP University_NNP ._.","NNP NNP NN NNS VBD an NN between the JJ NNP NNP and JJ NN NNP NNP to VB NN three of a JJ NN NN NN on RB 9,000 NNS in NNP VBG the JJ NN of NNP . "" The NN VBD RB JJ at NN two . It RB VBD against all NNS . RB we VBP VBG to VB a JJ NN . It VBZ a JJ NN , without a NN , ” NNP NNP NN NNP NNP VBD while VBG at a NN NN NNP . NN three will VB VBG the NN on JJ NNS of NNS that VBP the NN of the NN JJ as by NN or NN . VBG to NNP NNP NN NNS , the NN VBD through the JJ two NNS of NN in NNP , where it VBD VBN on 744 NNS . The JJ NN VBD JJ JJ NNS with the JJ NN on NNP 17 . The NN VBZ that the NNP NNP will VB the NN NN to RB VB - VB it inside NNP ; and if VBN JJ , it VBZ VBN to VB JJ to the NN in the JJ NN of 2021 , VBG to NNP . The NNP NNP VBZ one of NNP 's JJ JJ NN NNS . The NN of NNP NNP VBZ the NN of the NN in NNP with 162,520 NNS of NN and 10,145 NNS as of NNP NN . NNP VBZ the JJ JJS NNS in the NN ; the NNP VBZ RB , VBG to NNP NNP NNP ."
12,1122,mainstream,"When_WRB a_DT coronavirus_NN vaccine_NN is_VBZ developed_VBN ,_, who_WP will_MD be_VB first_RB in_IN line_NN to_TO get_VB it_PRP ?_. A_DT CDC_NNP panel_NN usually_RB decides_VBZ No_RB matter_RB how_WRB well_RB -_HYPH prepared_VBN we_PRP are_VBP ,_, there_EX wo_MD n’t_RB immediately_RB be_VB enough_JJ coronavirus_NN vaccine_NN to_TO immunize_VB all_DT Americans_NNPS ._. Choices_NNS will_MD have_VB to_TO be_VB made_VBN about_IN who_WP goes_VBZ to_IN the_DT front_NN of_IN the_DT line_NN ._. “_`` It_PRP ’s_VBZ inevitable_JJ that_IN the_DT vaccine_NN will_MD come_VB out_RB more_RBR slowly_RB than_IN we_PRP like_VBP ._. We_PRP ’re_VBP not_RB going_VBG to_TO have_VB 350_CD million_CD doses_NNS delivered_VBN day_NN one_CD ,_, ”_'' said_VBD Andrew_NNP Pavia_NNP ,_, chief_NN of_IN pediatric_JJ infectious_JJ diseases_NNS at_IN the_DT University_NNP of_IN Utah_NNP in_IN Salt_NNP Lake_NNP City_NNP ._. To_TO be_VB most_RBS protective_JJ ,_, a_DT list_NN of_IN the_DT first_JJ to_TO be_VB immunized_VBN must_MD be_VB carefully_RB crafted_VBN based_VBN on_IN what_WDT type_NN of_IN vaccine_NN may_MD become_VB available_JJ ,_, who_WP it_PRP works_VBZ best_JJS for_IN and_CC whether_IN the_DT disease_NN is_VBZ still_RB raging_VBG ._. Since_IN 1964_CD ,_, the_DT United_NNP States_NNPS has_VBZ relied_VBN on_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ’s_POS Advisory_NNP Committee_NNP on_IN Immunization_NNP Practices_NNPS to_TO make_VB those_DT decisions_NNS ._. As_RB soon_RB as_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP licenses_VBZ a_DT new_JJ vaccine_NN ,_, ACIP_NNP offers_VBZ guidelines_NNS on_IN how_WRB it_PRP should_MD be_VB distributed_VBN ,_, to_IN whom_WP and_CC when_WRB ._. The_DT World_NNP Health_NNP Organization_NNP has_VBZ a_DT similar_JJ group_NN ,_, the_DT Strategic_NNP Advisory_NNP Group_NNP of_IN Experts_NNPS on_IN Immunization_NNP ._. More_JJR :_: Latest_JJS on_IN global_JJ search_NN for_IN coronavirus_NN vaccine_NN :_: Oxford_NNP vaccine_NN may_MD protect_VB monkeys_NNS from_IN COVID_NNP More_RBR :_: '_`` Our_PRP$ moon_NN shot_NN '_'' :_: The_DT world_NN needs_VBZ a_DT coronavirus_NN vaccine_NN ASAP_RB ._. Despite_IN drugmakers_NNS billion_CD -_HYPH dollar_NN bets_NNS ,_, one_CD might_MD not_RB be_VB available_JJ for_IN years_NNS ._. ACIP_NNP already_RB has_VBZ begun_VBN working_VBG on_IN a_DT plan_NN for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. The_DT WHO_NNP group_NN began_VBD its_PRP$ process_NN last_JJ week_NN ._. “_`` We_PRP ’re_VBP starting_VBG as_RB early_RB as_IN we_PRP can_MD to_TO deal_VB with_IN the_DT torrent_NN of_IN data_NNS that_WDT ’s_VBZ coming_VBG out_RP ,_, ""_'' said_VBD Dr._NNP Grace_NNP Lee_NNP ,_, a_DT professor_NN of_IN pediatrics_NN at_IN Stanford_NNP University_NNP School_NNP of_IN Medicine_NNP and_CC a_DT current_JJ ACIP_NNP member_NN ._. ""_`` We_PRP do_VBP n’t_RB want_VB to_TO wait_VB until_IN the_DT vaccine_NN becomes_VBZ available_JJ and_CC begin_VB our_PRP$ deliberations_NNS then_RB ._. ”_'' Typically_RB ,_, ACIP_NNP ’s_POS guidelines_NNS would_MD be_VB used_VBN without_IN question_NN ._. That_DT became_VBD slightly_RB less_RBR clear_JJ Friday_NNP with_IN the_DT announcement_NN of_IN a_DT White_NNP House_NNP initiative_NN called_VBN Operation_NNP Warp_NNP Speed_NNP ._. In_IN a_DT news_NN conference_NN in_IN the_DT Rose_NNP Garden_NNP ,_, President_NNP Donald_NNP Trump_NNP said_VBD the_DT initiative_NN would_MD create_VB a_DT group_NN of_IN experts_NNS and_CC bring_VB together_RP the_DT CDC_NNP ,_, National_NNP Institutes_NNPS of_IN Health_NNP ,_, the_DT FDA_NNP and_CC the_DT U.S._NNP military_NN to_TO work_VB at_IN “_`` record_NN speed_NN ”_'' to_TO find_VB ,_, test_VB ,_, manufacture_VB and_CC distribute_VB a_DT vaccine_NN ._. Moncef_NNP Slaoui_NNP ,_, a_DT former_JJ pharmaceutical_JJ executive_NN who_WP Trump_NNP named_VBN to_TO head_VB Operation_NNP Warp_NNP Speed_NNP ,_, said_VBD early_JJ clinical_JJ trial_NN data_NNS from_IN at_IN least_JJS one_CD vaccine_NN candidate_NN made_VBD him_PRP confident_JJ “_`` we_PRP will_MD be_VB able_JJ to_TO deliver_VB a_DT few_JJ hundred_CD million_CD doses_NNS of_IN vaccine_NN by_IN the_DT end_NN of_IN 2020_CD ._. We_PRP will_MD do_VB the_DT best_JJS we_PRP can_MD to_TO do_VB that_DT ._. ”_'' Vaccine_NN experts_NNS have_VBP consistently_RB urged_VBN caution_NN in_IN presuming_VBG a_DT vaccine_NN will_MD be_VB available_JJ soon_RB ._. The_DT White_NNP House_NNP Coronavirus_NNP Task_NNP Force's_NNP Dr._NNP Anthony_NNP Fauci_NNP has_VBZ said_VBN that_IN while_IN a_DT vaccine_NN is_VBZ likely_JJ within_IN the_DT next_JJ year_NN or_CC two_CD ,_, the_DT process_NN takes_VBZ time_NN ._. Securing_VBG a_DT vaccine_NN quickly_RB would_MD require_VB everything_NN falling_VBG exactly_RB into_IN place_NN ,_, the_DT director_NN of_IN the_DT National_NNP Institute_NNP for_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS has_VBZ said_VBN ._. ""_`` You_PRP can_MD rush_VB vaccine_NN development_NN but_CC only_RB when_WRB you_PRP understand_VBP –_: there_EX ’s_VBZ no_DT way_NN around_IN it_PRP –_: you_PRP are_VBP trading_VBG safety_NN for_IN speed_NN ,_, ""_'' said_VBD Dr._NNP Greg_NNP Poland_NNP ,_, director_NN of_IN the_DT Mayo_NNP Clinic_NNP 's_POS Vaccine_NNP Research_NNP Group_NNP ._. Few_JJ details_NNS of_IN how_WRB coordination_NN within_IN Operation_NNP Warp_NNP Speed_NNP would_MD work_VB were_VBD provided_VBN ,_, and_CC it_PRP is_VBZ unclear_JJ what_WDT role_NN it_PRP will_MD play_VB in_IN vaccine_NN allocation_NN ._. An_DT unnamed_JJ government_NN official_NN involved_VBN with_IN the_DT initiative_NN told_VBD CNN_NNP earlier_RBR this_DT month_NN one_CD of_IN the_DT tasks_NNS of_IN the_DT group_NN is_VBZ to_TO determine_VB who_WP gets_VBZ the_DT first_JJ doses_NNS ._. The_DT CDC_NNP referred_VBD inquiries_NNS about_IN how_WRB the_DT two_CD groups_NNS would_MD work_VB together_RB to_IN the_DT White_NNP House_NNP ._. The_DT White_NNP House_NNP did_VBD not_RB respond_VB to_IN a_DT request_NN for_IN clarification_NN ._. Vaccine_NN experts_NNS have_VBP spent_VBN years_NNS considering_VBG the_DT best_JJS and_CC most_RBS effective_JJ way_NN to_TO dole_VB out_RP immunizations_NNS ._. ACIP_NNP has_VBZ clear_JJ and_CC transparent_JJ guidelines_NNS on_IN how_WRB to_TO conduct_VB the_DT process_NN available_JJ on_IN its_PRP$ website_NN ,_, and_CC all_PDT its_PRP$ meetings_NNS in_IN which_WDT it_PRP votes_NNS on_IN vaccine_NN recommendations_NNS are_VBP public_JJ and_CC webcast_NN ._. The_DT next_JJ is_VBZ on_IN June_NNP 24_CD ._. Discussions_NNS center_VBP on_IN balancing_VBG protection_NN for_IN the_DT largest_JJS number_NN of_IN people_NNS with_IN protecting_VBG the_DT most_RBS vulnerable_JJ ._. “_`` If_IN I_PRP ’ve_VBP only_RB got_VBN 30_CD million_CD doses_NNS for_IN the_DT next_JJ year_NN and_CC I_PRP ’ve_VBP got_VBN a_DT population_NN of_IN 350_CD million_CD ,_, who_WP do_VBP I_PRP assign_VB propriety_NN to_IN ?_. ”_'' said_VBD Dr._NNP Arthur_NNP Reingold_NNP ,_, division_NN head_NN of_IN epidemiology_NN and_CC biostatistics_NN at_IN the_DT University_NNP of_IN California_NNP at_IN Berkeley_NNP and_CC an_DT internationally_RB recognized_VBN expert_NN on_IN infectious_JJ disease_NN ._. Health_NN care_NN providers_NNS ,_, first_JJ responders_NNS ,_, the_DT military_NN ,_, political_JJ leaders_NNS ,_, older_JJR adults_NNS ,_, pregnant_JJ women_NNS and_CC children_NNS are_VBP generally_RB put_VBN at_IN the_DT front_NN of_IN the_DT line_NN ,_, depending_VBG on_IN the_DT disease_NN and_CC the_DT vaccine_NN ,_, said_VBD Reingold_NNP ,_, who_WP served_VBD on_IN ACIP_NNP for_IN many_JJ years_NNS ._. “_`` All_DT kinds_NNS of_IN ethicists_NNS are_VBP brought_VBN to_IN the_DT table_NN ,_, ”_'' he_PRP said_VBD ._. Another_DT approach_NN to_TO control_VB an_DT epidemic_NN is_VBZ to_TO focus_VB on_IN hot_JJ spots_NNS where_WRB a_DT disease_NN is_VBZ spreading_VBG and_CC there_EX are_VBP high_JJ transmission_NN rates_NNS ._. ""_`` You_PRP would_MD rush_VB vaccine_NN to_IN the_DT area_NN ,_, open_VB your_PRP$ clinics_NNS and_CC try_VB to_TO get_VB a_DT large_JJ proportion_NN of_IN the_DT population_NN vaccinated_VBN quickly_RB ,_, ""_'' Pavia_NNP said_VBD ._. For_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT devil_NN is_VBZ in_IN the_DT details_NNS because_IN so_RB much_RB remains_VBZ unknown_JJ about_IN who_WP it_PRP affects_VBZ and_CC how_WRB ._. Vaccines_NNS differ_VBP ._. One_CD may_MD be_VB best_JJS for_IN healthy_JJ adults_NNS ,_, another_DT better_JJR for_IN children_NNS ,_, and_CC a_DT third_NN most_RBS effective_JJ for_IN older_JJR adults_NNS or_CC those_DT with_IN preexisting_JJ medical_JJ conditions_NNS ._. In_IN the_DT case_NN of_IN the_DT new_JJ coronavirus_NN ,_, data_NNS might_MD show_VB although_IN older_JJR people_NNS are_VBP severely_RB affected_VBN by_IN COVID_NN -_HYPH 19_CD ,_, immunizing_VBG their_PRP$ caregivers_NNS could_MD better_RBR protect_VB them_PRP ,_, depending_VBG on_IN how_WRB effective_JJ the_DT vaccine_NN is_VBZ for_IN different_JJ ages_NNS ._. “_`` We_PRP think_VBP about_IN who_WP ’s_VBZ at_IN risk_NN for_IN being_VBG exposed_VBN ,_, who_WP suffers_VBZ the_DT worst_JJS complications_NNS and_CC which_WDT population_NN provides_VBZ the_DT highest_JJS benefit_NN due_IN to_IN herd_NN immunity_NN ,_, ”_'' said_VBD Lee_NNP ._. Herd_NN immunity_NN is_VBZ when_WRB enough_JJ people_NNS in_IN the_DT population_NN have_VBP been_VBN infected_VBN and_CC developed_VBN immunity_NN to_IN the_DT virus_NN that_WDT it_PRP can_MD no_RB longer_RBR spread_VB freely_RB ._. Scientists_NNS '_POS models_NNS estimate_VBP 65_CD %_NN of_IN the_DT population_NN needs_VBZ to_TO be_VB immune_JJ to_TO establish_VB such_JJ immunity_NN and_CC stop_VB the_DT spread_NN of_IN the_DT disease_NN ._. So_RB far_RB ,_, infection_NN rates_NNS alone_RB are_VBP nowhere_RB near_RB high_JJ enough_RB to_TO create_VB herd_NN immunity_NN ._. While_IN a_DT national_JJ infection_NN rate_NN in_IN the_DT United_NNP States_NNPS has_VBZ not_RB yet_RB been_VBN determined_VBN ,_, in_IN France_NNP ,_, an_DT estimated_VBN 4.4_CD %_NN of_IN the_DT population_NN is_VBZ believed_VBN to_TO have_VB been_VBN infected_VBN with_IN the_DT disease_NN as_IN of_IN May_NNP 11_CD ,_, according_VBG to_IN a_DT paper_NN in_IN the_DT journal_NNP Science_NNP ._. Whoever_WP determines_VBZ who_WP gets_VBZ inoculated_VBN first_RB ,_, public_JJ health_NN experts_NNS say_VBP past_JJ experience_NN shows_VBZ the_DT best_JJS medical_JJ conclusion_NN is_VBZ n’t_RB always_RB the_DT best_JJS solution_NN ._. During_IN a_DT shortage_NN of_IN flu_NN vaccine_NN in_IN 2004_CD ,_, it_PRP was_VBD decided_VBN that_IN elderly_JJ people_NNS ,_, who_WP were_VBD at_IN high_JJ risk_NN ,_, should_MD get_VB vaccinated_VBN first_RB ._. It_PRP turned_VBD out_RP they_PRP did_VBD n’t_RB want_VB it_PRP ._. “_`` They_PRP said_VBD ,_, ‘_`` I_PRP ’d_MD rather_RB my_PRP$ grandchildren_NNS receive_VB the_DT vaccine_NN ,_, ’_'' ”_'' said_VBD Dr._NNP William_NNP Schaffner_NNP ,_, a_DT professor_NN in_IN the_DT division_NN of_IN infectious_JJ disease_NN at_IN Vanderbilt_NNP University_NNP in_IN Nashville_NNP ,_, Tennessee_NNP ._. After_IN health_NN care_NN workers_NNS and_CC first_JJ responders_NNS are_VBP immunized_VBN ,_, Schaffner_NNP suggested_VBD simply_RB making_VBG a_DT vaccine_NN available_JJ on_IN a_DT first_JJ -_HYPH come_VB ,_, first_RB -_HYPH served_VBN basis_NN ._. “_`` Vaccine_NN left_VBN in_IN the_DT refrigerator_NN never_RB protected_VBD anyone_NN from_IN anything_NN ,_, ”_'' he_PRP said_VBD ._. Some_DT health_NN care_NN professionals_NNS say_VBP Americans_NNPS need_VBP to_TO be_VB part_NN of_IN the_DT conversation_NN about_IN how_WRB any_DT coming_VBG coronavirus_NN vaccine_NN should_MD be_VB doled_VBN out_RP ._. “_`` We_PRP need_VBP to_TO engage_VB with_IN the_DT public_NN now_RB ._. You_PRP ’ve_VBP got_VBN to_TO consider_VB public_JJ values_NNS ,_, ”_'' said_VBD Daniel_NNP Salmon_NNP ,_, a_DT professor_NN of_IN international_JJ health_NN who_WP directs_VBZ the_DT Institute_NNP for_IN Vaccine_NNP Safety_NNP at_IN the_DT Johns_NNP Hopkins_NNP Bloomberg_NNP School_NNP of_IN Public_NNP Health_NNP ._. “_`` It_PRP ’s_VBZ not_RB all_RB about_IN what_WP the_DT scientists_NNS think_VBP ._. ”_''","When a NN NN VBZ VBN , who will VB RB in NN to VB it ? A NNP NN RB VBZ RB RB how RB - VBN we VBP , there wo RB RB VB JJ NN NN to VB all NNPS . NNS will VB to VB VBN about who VBZ to the NN of the NN . “ It VBZ JJ that the NN will VB RB RBR RB than we VBP . We VBP RB VBG to VB 350 million NNS VBN NN one , ” VBD NNP NNP , NN of JJ JJ NNS at the NNP of NNP in NNP NNP NNP . To VB RBS JJ , a NN of the JJ to VB VBN must VB RB VBN VBN on what NN of NN may VB JJ , who it VBZ JJS for and whether the NN VBZ RB VBG . Since 1964 , the NNP NNPS VBZ VBN on the NNPS for NNP NNP and NNP ’s NNP NNP on NNP NNPS to VB those NNS . RB RB as the NNP and NNP NNP VBZ a JJ NN , NNP VBZ NNS on how it should VB VBN , to whom and when . The NNP NNP NNP VBZ a JJ NN , the NNP NNP NNP of NNPS on NNP . JJR : JJS on JJ NN for NN NN : NNP NN may VB NNS from NNP RBR : ' Our NN NN ' : The NN VBZ a NN NN RB . Despite NNS billion - NN NNS , one might RB VB JJ for NNS . NNP RB VBZ VBN VBG on a NN for NNP - NNP - 2 , the NN that VBZ NN - 19 . The NNP NN VBD its NN JJ NN . “ We VBP VBG RB RB as we can to VB with the NN of NNS that VBZ VBG out , "" VBD NNP NNP NNP , a NN of NN at NNP NNP NNP of NNP and a JJ NNP NN . "" We VBP RB VB to VB until the NN VBZ JJ and VB our NNS RB . ” RB , NNP ’s NNS would VB VBN without NN . That VBD RB RBR JJ NNP with the NN of a NNP NNP NN VBN NNP NNP NNP . In a NN NN in the NNP NNP , NNP NNP NNP VBD the NN would VB a NN of NNS and VB together the NNP , NNP NNPS of NNP , the NNP and the NNP NN to VB at “ NN NN ” to VB , VB , VB and VB a NN . NNP NNP , a JJ JJ NN who NNP VBN to VB NNP NNP NNP , VBD JJ JJ NN NNS from at JJS one NN NN VBD him JJ “ we will VB JJ to VB a JJ hundred million NNS of NN by the NN of 2020 . We will VB the JJS we can to VB that . ” NN NNS VBP RB VBN NN in VBG a NN will VB JJ RB . The NNP NNP NNP NNP NNP NNP NNP NNP VBZ VBN that while a NN VBZ JJ within the JJ NN or two , the NN VBZ NN . VBG a NN RB would VB NN VBG RB into NN , the NN of the NNP NNP for NNP and NNP NNPS VBZ VBN . "" You can VB NN NN but RB when you VBP – there VBZ no NN around it – you VBP VBG NN for NN , "" VBD NNP NNP NNP , NN of the NNP NNP 's NNP NNP NNP . JJ NNS of how NN within NNP NNP NNP would VB VBD VBN , and it VBZ JJ what NN it will VB in NN NN . An JJ NN NN VBN with the NN VBD NNP RBR this NN one of the NNS of the NN VBZ to VB who VBZ the JJ NNS . The NNP VBD NNS about how the two NNS would VB RB to the NNP NNP . The NNP NNP VBD RB VB to a NN for NN . NN NNS VBP VBN NNS VBG the JJS and RBS JJ NN to VB out NNS . NNP VBZ JJ and JJ NNS on how to VB the NN JJ on its NN , and all its NNS in which it NNS on NN NNS VBP JJ and NN . The JJ VBZ on NNP 24 . NNS VBP on VBG NN for the JJS NN of NNS with VBG the RBS JJ . “ If I VBP RB VBN 30 million NNS for the JJ NN and I VBP VBN a NN of 350 million , who VBP I VB NN to ? ” VBD NNP NNP NNP , NN NN of NN and NN at the NNP of NNP at NNP and an RB VBN NN on JJ NN . NN NN NNS , JJ NNS , the NN , JJ NNS , JJR NNS , JJ NNS and NNS VBP RB VBN at the NN of the NN , VBG on the NN and the NN , VBD NNP , who VBD on NNP for JJ NNS . “ All NNS of NNS VBP VBN to the NN , ” he VBD . Another NN to VB an NN VBZ to VB on JJ NNS where a NN VBZ VBG and there VBP JJ NN NNS . "" You would VB NN to the NN , VB your NNS and VB to VB a JJ NN of the NN VBN RB , "" NNP VBD . For NNP - NNP - 2 , the NN VBZ in the NNS because RB RB VBZ JJ about who it VBZ and how . NNS VBP . One may VB JJS for JJ NNS , another JJR for NNS , and a NN RBS JJ for JJR NNS or those with JJ JJ NNS . In the NN of the JJ NN , NNS might VB although JJR NNS VBP RB VBN by NN - 19 , VBG their NNS could RBR VB them , VBG on how JJ the NN VBZ for JJ NNS . “ We VBP about who VBZ at NN for VBG VBN , who VBZ the JJS NNS and which NN VBZ the JJS NN due to NN NN , ” VBD NNP . NN NN VBZ when JJ NNS in the NN VBP VBN VBN and VBN NN to the NN that it can RB RBR VB RB . NNS ' NNS VBP 65 NN of the NN VBZ to VB JJ to VB JJ NN and VB the NN of the NN . RB RB , NN NNS RB VBP RB RB JJ RB to VB NN NN . While a JJ NN NN in the NNP NNPS VBZ RB RB VBN VBN , in NNP , an VBN 4.4 NN of the NN VBZ VBN to VB VBN VBN with the NN as of NNP 11 , VBG to a NN in the NNP NNP . Whoever VBZ who VBZ VBN RB , JJ NN NNS VBP JJ NN VBZ the JJS JJ NN VBZ RB RB the JJS NN . During a NN of NN NN in 2004 , it VBD VBN that JJ NNS , who VBD at JJ NN , should VB VBN RB . It VBD out they VBD RB VB it . “ They VBD , ‘ I ’d RB my NNS VB the NN , ’ ” VBD NNP NNP NNP , a NN in the NN of JJ NN at NNP NNP in NNP , NNP . After NN NN NNS and JJ NNS VBP VBN , NNP VBD RB VBG a NN JJ on a JJ - VB , RB - VBN NN . “ NN VBN in the NN RB VBD NN from NN , ” he VBD . Some NN NN NNS VBP NNPS VBP to VB NN of the NN about how any VBG NN NN should VB VBN out . “ We VBP to VB with the NN RB . You VBP VBN to VB JJ NNS , ” VBD NNP NNP , a NN of JJ NN who VBZ the NNP for NNP NNP at the NNP NNP NNP NNP of NNP NNP . “ It VBZ RB RB about what the NNS VBP . ”"
13,875,mainstream,"‘_`` It_PRP ’s_VBZ going_VBG to_TO be_VB hard_JJ ._. ’_'' We_PRP ’re_VBP also_RB perilously_RB far_RB behind_RB ._. The_DT number_NN of_IN new_JJ cases_NNS appearing_VBG each_DT day_NN is_VBZ swinging_VBG wildly_RB ,_, from_IN 13,000_CD on_IN May_NNP 19_CD to_IN 24,000_CD the_DT next_JJ day_NN ,_, even_RB though_IN much_JJ of_IN the_DT country_NN remains_VBZ locked_VBN down_RP ._. And_CC those_DT are_VBP just_RB the_DT cases_NNS we_PRP know_VBP about_IN ._. Until_IN the_DT U.S._NNP does_VBZ a_DT far_RB better_JJR job_NN of_IN quickly_RB figuring_VBG out_RP who_WP is_VBZ infected_VBN ,_, it_PRP simply_RB wo_MD n’t_RB be_VB possible_JJ to_TO keep_VB up_RP with_IN tracing_NN ._. Marc_NNP Lipsitch_NNP ,_, director_NN of_IN the_DT Center_NNP for_IN Communicable_NNP Disease_NNP Dynamics_NNP at_IN Harvard_NNP University_NNP 's_POS School_NNP of_IN Public_NNP Health_NNP ,_, is_VBZ pessimistic_JJ ._. Even_RB if_IN 80_CD percent_NN of_IN the_DT country_NN managed_VBD to_TO trace_VB cases_NNS effectively_RB —_: “_`` which_WDT would_MD be_VB miraculous_JJ ,_, ”_'' he_PRP said_VBD —_: the_DT remaining_VBG 20_CD percent_NN would_MD be_VB a_DT constant_JJ source_NN of_IN new_JJ infections_NNS ._. New_JJ research_NN ,_, not_RB yet_RB peer_NN reviewed_VBN ,_, suggests_VBZ tracing_NN would_MD have_VB to_TO catch_VB at_IN least_JJS half_NN of_IN all_DT new_JJ cases_NNS to_TO reduce_VB transmission_NN even_RB 10_CD percent_NN ._. “_`` My_PRP$ view_NN is_VBZ it_PRP ’s_VBZ probably_RB not_RB going_VBG to_TO work_VB ,_, ”_'' Lipsitch_NNP said_VBD ._. “_`` But_CC given_VBN the_DT lack_NN of_IN alternatives_NNS ,_, we_PRP have_VBP to_TO try_VB —_: and_CC hopefully_RB demonstrate_VB that_IN I_PRP ’m_VBP wrong_JJ ._. ”_'' Tracing_NN techniques_NNS have_VBP been_VBN honed_VBN over_IN decades_NNS Technology_NN may_MD help_VB some_DT this_DT time_NN around_RB ._. Apple_NNP and_CC Google_NNP and_CC a_DT half_NN dozen_CD other_JJ companies_NNS are_VBP developing_VBG cellphone_NN applications_NNS that_WDT use_VBP GPS_NN or_CC Bluetooth_NN technology_NN ._. These_DT apps_NNS can_MD alert_VB users_NNS that_IN they_PRP were_VBD recently_RB near_IN an_DT infectious_JJ person_NN or_CC allow_VB them_PRP to_TO retrace_VB their_PRP$ steps_NNS to_TO see_VB if_IN they_PRP crossed_VBD paths_NNS with_IN a_DT carrier_NN ._. But_CC most_JJS experts_NNS insist_VBP technology_NN will_MD merely_RB support_VB ,_, not_RB supplant_VB ,_, human_JJ tracing_NN ._. And_CC it_PRP may_MD never_RB be_VB as_RB effective_JJ in_IN the_DT U.S._NNP as_IN it_PRP has_VBZ been_VBN in_IN other_JJ countries_NNS ._. For_IN starters_NNS ,_, tech_NN solutions_NNS are_VBP valuable_JJ only_RB if_IN widely_RB adopted_VBN ,_, and_CC polls_NNS show_VBP Americans_NNPS are_VBP skeptical_JJ and_CC worry_VBP that_IN apps_NNS could_MD infringe_VB on_IN data_NN privacy_NN ._. The_DT U.S._NNP also_RB has_VBZ so_RB many_JJ cases_NNS that_IN it_PRP ca_MD n’t_RB rely_VB on_IN weak_JJ crowdsourcing_NN with_IN limited_JJ penetration_NN to_TO find_VB them_PRP all_DT ._. Meanwhile_RB ,_, in_IN much_JJ of_IN Asia_NNP ,_, previous_JJ viral_JJ outbreaks_NNS bred_VBD enough_JJ comfort_NN and_CC respect_NN for_IN tracing_NN that_IN there_EX is_VBZ less_JJR need_NN for_IN the_DT handholding_NN provided_VBN by_IN human_JJ tracers_NNS ._. In_IN a_DT few_JJ countries_NNS ,_, notably_RB China_NNP ,_, authoritarian_JJ governments_NNS also_RB leave_VBP citizens_NNS little_JJ choice_NN but_IN to_TO participate_VB ._.","‘ It VBZ VBG to VB JJ . ’ We VBP RB RB RB RB . The NN of JJ NNS VBG each NN VBZ VBG RB , from 13,000 on NNP 19 to 24,000 the JJ NN , RB though JJ of the NN VBZ VBN down . And those VBP RB the NNS we VBP about . Until the NNP VBZ a RB JJR NN of RB VBG out who VBZ VBN , it RB wo RB VB JJ to VB up with NN . NNP NNP , NN of the NNP for NNP NNP NNP at NNP NNP 's NNP of NNP NNP , VBZ JJ . RB if 80 NN of the NN VBD to VB NNS RB — “ which would VB JJ , ” he VBD — the VBG 20 NN would VB a JJ NN of JJ NNS . JJ NN , RB RB NN VBN , VBZ NN would VB to VB at JJS NN of all JJ NNS to VB NN RB 10 NN . “ My NN VBZ it VBZ RB RB VBG to VB , ” NNP VBD . “ But VBN the NN of NNS , we VBP to VB — and RB VB that I VBP JJ . ” NN NNS VBP VBN VBN over NNS NN may VB some this NN RB . NNP and NNP and a NN dozen JJ NNS VBP VBG NN NNS that VBP NN or NN NN . These NNS can VB NNS that they VBD RB near an JJ NN or VB them to VB their NNS to VB if they VBD NNS with a NN . But JJS NNS VBP NN will RB VB , RB VB , JJ NN . And it may RB VB RB JJ in the NNP as it VBZ VBN in JJ NNS . For NNS , NN NNS VBP JJ RB if RB VBN , and NNS VBP NNPS VBP JJ and VBP that NNS could VB on NN NN . The NNP RB VBZ RB JJ NNS that it ca RB VB on JJ NN with JJ NN to VB them all . RB , in JJ of NNP , JJ JJ NNS VBD JJ NN and NN for NN that there VBZ JJR NN for the NN VBN by JJ NNS . In a JJ NNS , RB NNP , JJ NNS RB VBP NNS JJ NN but to VB ."
14,828,mainstream,"Smallpox_NNP ranks_VBZ among_IN the_DT most_RBS devastating_JJ illnesses_NNS ever_RB suffered_VBN by_IN humankind_NN ._. It_PRP dramatically_RB altered_VBD the_DT course_NN of_IN human_JJ history_NN ,_, even_RB contributing_VBG to_IN the_DT decline_NN of_IN civilizations_NNS ._. Officially_RB the_DT deadly_JJ virus_NN no_RB longer_RBR exists_VBZ ._. After_IN a_DT final_JJ outbreak_NN in_IN the_DT United_NNP States_NNPS in_IN 1949_CD ,_, the_DT virus_NN was_VBD declared_VBN eradicated_VBN in_IN 1980_CD following_VBG a_DT successful_JJ vaccination_NN program_NN regarded_VBN as_IN one_CD of_IN the_DT greatest_JJS triumphs_NNS of_IN modern_JJ medicine_NN ._. Smallpox_NN is_VBZ an_DT acute_JJ contagious_JJ disease_NN caused_VBN by_IN the_DT variola_NN virus_NN ._. It_PRP gets_VBZ its_PRP$ name_NN from_IN the_DT Latin_JJ word_NN for_IN ""_`` spotted_VBN ,_, ""_'' referring_VBG to_IN the_DT raised_VBN ,_, pustular_JJ bumps_NNS that_WDT break_VBP out_RP over_IN the_DT face_NN and_CC body_NN of_IN those_DT affected_VBN ._. Historically_RB the_DT virus_NN killed_VBD around_RB 30_CD percent_NN of_IN people_NNS who_WP caught_VBD it_PRP ._. Those_DT who_WP survived_VBD were_VBD often_RB left_VBN blind_JJ ,_, sterile_JJ ,_, and_CC with_IN deep_JJ pitted_VBN scars_NNS ,_, or_CC pockmarks_NNS ,_, on_IN the_DT skin_NN ._. Spread_VB through_IN direct_JJ contact_NN with_IN infected_VBN people_NNS ,_, body_NN fluids_NNS ,_, or_CC contaminated_VBN objects_NNS such_JJ as_IN bedding_NN ,_, the_DT disease_NN had_VBD two_CD main_JJ types_NNS ._. Variola_NN major_NN was_VBD the_DT most_RBS common_JJ form–and_NN most_RBS lethal_JJ ._. Variola_NN minor_NN produced_VBD a_DT milder_JJR disease_NN ,_, which_WDT was_VBD fatal_JJ in_IN less_JJR than_IN one_CD percent_NN of_IN cases_NNS ._. Two_CD other_JJ ,_, rarer_JJ forms_NNS also_RB existed_VBD :_: hemorrhagic_JJ and_CC malignant_JJ ._. Both_DT invariably_RB resulted_VBD in_IN death_NN ._. Smallpox_NN is_VBZ thought_VBN to_TO have_VB originated_VBN in_IN India_NNP or_CC Egypt_NNP at_IN least_JJS 3,000_CD years_NNS ago_RB ._. The_DT earliest_JJS evidence_NN for_IN the_DT disease_NN comes_VBZ from_IN the_DT Egyptian_JJ Pharaoh_NNP Ramses_NNP V_NNP ,_, who_WP died_VBD in_IN 1157_CD B.C._NNP His_PRP$ mummified_VBN remains_NNS show_VBP telltale_NN pockmarks_NNS on_IN his_PRP$ skin_NN ._. The_DT disease_NN later_RBR spread_VBD along_IN trade_NN routes_NNS in_IN Asia_NNP ,_, Africa_NNP ,_, and_CC Europe_NNP ,_, eventually_RB reaching_VBG the_DT Americas_NNPS in_IN the_DT 1500s_NNS ._. Indigenous_JJ peoples_NNS there_RB had_VBD no_DT natural_JJ immunity_NN ._. An_DT estimated_VBN 90_CD percent_NN of_IN indigenous_JJ casualties_NNS during_IN European_JJ colonization_NN were_VBD caused_VBN by_IN disease_NN rather_RB than_IN military_JJ conquest_NN ._. Smallpox_NNP contributed_VBD to_IN the_DT decline_NN of_IN the_DT Aztec_NNP Empire_NNP ,_, in_IN what_WP is_VBZ now_RB Mexico_NNP ,_, following_VBG the_DT virus_NN 's_POS arrival_NN with_IN Spanish_JJ conquerors_NNS in_IN 1519_CD ._. More_JJR than_IN three_CD million_CD Aztec_NNP succumbed_VBD to_IN the_DT disease_NN ._. Severely_RB weakened_VBN ,_, the_DT Aztec_NNP were_VBD easily_RB defeated_VBN ._. Likewise_RB ,_, smallpox_NN claimed_VBD the_DT life_NN of_IN an_DT Inca_NNP emperor_NN and_CC wiped_VBD out_RP much_JJ of_IN the_DT Inca_NNP population_NN in_IN western_JJ South_NNP America_NNP ._. In_IN Europe_NNP ,_, smallpox_NN is_VBZ estimated_VBN to_TO have_VB claimed_VBN 60_CD million_CD lives_NNS in_IN the_DT 18th_JJ century_NN alone_RB ._. In_IN the_DT 20th_JJ century_NN ,_, it_PRP killed_VBD some_DT 300_CD million_CD people_NNS globally_RB ._. The_DT human_JJ fight_NN against_IN smallpox_NN dates_VBZ back_RB some_DT 2,000_CD years_NNS ._. In_IN Asia_NNP ,_, a_DT technique_NN known_VBN as_IN variolation_NN involved_VBD deliberately_RB infecting_VBG a_DT person_NN by_IN blowing_VBG dried_VBN smallpox_NN scabs_NNS up_IN their_PRP$ nose_NN ._. Those_DT who_WP received_VBD this_DT treatment_NN contracted_VBD a_DT mild_JJ form_NN of_IN the_DT disease_NN ,_, developing_VBG a_DT lifelong_JJ immunity_NN ._. A_DT key_JJ breakthrough_NN came_VBD in_IN 1796_CD when_WRB an_DT experiment_NN by_IN English_JJ doctor_NN Edward_NNP Jenner_NNP showed_VBD that_IN inoculation_NN using_VBG closely_RB related_JJ cowpox_NN could_MD protect_VB against_IN smallpox_NN ._. Jenner_NNP 's_POS discovery_NN paved_VBD the_DT way_NN for_IN later_JJR vaccination_NN programs_NNS —_: especially_RB crucial_JJ since_IN there_EX is_VBZ no_DT effective_JJ treatment_NN for_IN smallpox_NN ._. In_IN 1967_CD ,_, a_DT year_NN when_WRB some_DT 10_CD million_CD to_IN 15_CD million_CD people_NNS contracted_VBD smallpox_NN ,_, the_DT World_NNP Health_NNP Organization_NNP launched_VBD a_DT worldwide_JJ eradication_NN campaign_NN based_VBN on_IN vaccination_NN ._. Gradually_RB ,_, the_DT disease_NN was_VBD pushed_VBN back_RB to_IN the_DT Horn_NNP of_IN Africa_NNP ,_, and_CC the_DT last_JJ known_VBN natural_JJ case_NN occurred_VBD in_IN Somalia_NNP in_IN 1977_CD ._. Despite_IN being_VBG consigned_VBN to_IN the_DT history_NN books_NNS ,_, there_EX 's_VBZ still_RB a_DT chance_NN of_IN smallpox_NN coming_VBG back_RB to_TO haunt_VB us_PRP —_: as_IN a_DT biological_JJ weapon_NN ._. Such_JJ fears_NNS escalated_VBD dramatically_RB in_IN the_DT United_NNP States_NNPS following_VBG the_DT September_NNP 11_CD ,_, 2001_CD ,_, terrorist_NN attacks_NNS ._. While_IN the_DT risk_NN of_IN such_PDT a_DT bioterror_NN attack_NN is_VBZ considered_VBN very_RB low_JJ ,_, the_DT U.S._NNP has_VBZ since_RB stockpiled_VBN enough_JJ of_IN the_DT vaccine_NN to_TO inoculate_VB every_DT citizen_NN ._.","NNP VBZ among the RBS JJ NNS RB VBN by NN . It RB VBD the NN of JJ NN , RB VBG to the NN of NNS . RB the JJ NN RB RBR VBZ . After a JJ NN in the NNP NNPS in 1949 , the NN VBD VBN VBN in 1980 VBG a JJ NN NN VBN as one of the JJS NNS of JJ NN . NN VBZ an JJ JJ NN VBN by the NN NN . It VBZ its NN from the JJ NN for "" VBN , "" VBG to the VBN , JJ NNS that VBP out over the NN and NN of those VBN . RB the NN VBD RB 30 NN of NNS who VBD it . Those who VBD VBD RB VBN JJ , JJ , and with JJ VBN NNS , or NNS , on the NN . VB through JJ NN with VBN NNS , NN NNS , or VBN NNS JJ as NN , the NN VBD two JJ NNS . NN NN VBD the RBS JJ NN RBS JJ . NN NN VBD a JJR NN , which VBD JJ in JJR than one NN of NNS . Two JJ , JJ NNS RB VBD : JJ and JJ . Both RB VBD in NN . NN VBZ VBN to VB VBN in NNP or NNP at JJS 3,000 NNS RB . The JJS NN for the NN VBZ from the JJ NNP NNP NNP , who VBD in 1157 NNP His VBN NNS VBP NN NNS on his NN . The NN RBR VBD along NN NNS in NNP , NNP , and NNP , RB VBG the NNPS in the NNS . JJ NNS RB VBD no JJ NN . An VBN 90 NN of JJ NNS during JJ NN VBD VBN by NN RB than JJ NN . NNP VBD to the NN of the NNP NNP , in what VBZ RB NNP , VBG the NN 's NN with JJ NNS in 1519 . JJR than three million NNP VBD to the NN . RB VBN , the NNP VBD RB VBN . RB , NN VBD the NN of an NNP NN and VBD out JJ of the NNP NN in JJ NNP NNP . In NNP , NN VBZ VBN to VB VBN 60 million NNS in the JJ NN RB . In the JJ NN , it VBD some 300 million NNS RB . The JJ NN against NN VBZ RB some 2,000 NNS . In NNP , a NN VBN as NN VBD RB VBG a NN by VBG VBN NN NNS up their NN . Those who VBD this NN VBD a JJ NN of the NN , VBG a JJ NN . A JJ NN VBD in 1796 when an NN by JJ NN NNP NNP VBD that NN VBG RB JJ NN could VB against NN . NNP 's NN VBD the NN for JJR NN NNS — RB JJ since there VBZ no JJ NN for NN . In 1967 , a NN when some 10 million to 15 million NNS VBD NN , the NNP NNP NNP VBD a JJ NN NN VBN on NN . RB , the NN VBD VBN RB to the NNP of NNP , and the JJ VBN JJ NN VBD in NNP in 1977 . Despite VBG VBN to the NN NNS , there VBZ RB a NN of NN VBG RB to VB us — as a JJ NN . JJ NNS VBD RB in the NNP NNPS VBG the NNP 11 , 2001 , NN NNS . While the NN of such a NN NN VBZ VBN RB JJ , the NNP VBZ RB VBN JJ of the NN to VB every NN ."
15,823,conspiracy,"EU_NNP Commission_NNP President_NNP Ursula_NNP von_NNP der_NNP Leyen_NNP is_VBZ unveiling_VBG on_IN Wednesday_NNP her_PRP$ road_NN map_NN for_IN lifting_VBG coronavirus_NN restrictions_NNS across_IN the_DT bloc_NN ._. In_IN a_DT 14_CD -_HYPH page_NN document_NN laying_VBG out_RP her_PRP$ ideas_NNS ,_, von_NNP der_NNP Leyen_NNP says_VBZ that_IN ""_`` although_IN it_PRP is_VBZ clear_JJ that_IN the_DT path_NN back_RB to_IN normalcy_NN will_MD take_VB a_DT long_JJ time_NN ,_, it_PRP is_VBZ also_RB obvious_JJ that_IN we_PRP cannot_MD maintain_VB these_DT extraordinary_JJ restrictions_NNS indefinitely_RB ._. ""_'' She_PRP says_VBZ lockdowns_NNS across_IN the_DT continent_NN had_VBD proven_VBN effective_JJ ,_, yet_CC also_RB precipitated_VBD a_DT tremendous_JJ economic_JJ shock_NN and_CC placed_VBD a_DT heavy_JJ burden_NN on_IN public_JJ life_NN ._. EU_NNP officials_NNS estimate_VBP that_IN the_DT eurozone_NNP economy_NN could_MD shrink_VB by_IN 10_CD percent_NN this_DT year_NN —_: a_DT drop_NN in_IN economic_JJ productivity_NN not_RB seen_VBN since_IN the_DT global_JJ economic_JJ crisis_NN of_IN the_DT 1920s_NNS ._. Ursula_NNP von_NNP der_NNP Leyen_NNP urges_VBZ all_DT 27_CD EU_NNP member_NN states_NNS to_TO coordinate_VB their_PRP$ lifting_NN of_IN restrictions_NNS and_CC to_TO continue_VB coordinating_VBG their_PRP$ approach_NN to_IN tackling_VBG the_DT pandemic_NN going_VBG forward_RB ._. She_PRP warns_VBZ that_IN ""_`` insufficient_JJ coordination_NN in_IN the_DT lifting_NN of_IN restrictions_NNS poses_VBZ the_DT risk_NN of_IN creating_VBG negative_JJ effects_NNS for_IN all_DT member_NN states_NNS and_CC most_RBS likely_RB increases_VBZ tensions_NNS between_IN them_PRP ._. ""_'' She_PRP admits_VBZ there_EX is_VBZ no_DT one_CD -_HYPH size_NN -_HYPH fits_NNS -_HYPH all_DT solution_NN ,_, but_CC that_IN member_NN states_NNS should_MD strive_VB to_TO inform_VB each_DT other_JJ of_IN steps_NNS taken_VBN ._. At_IN the_DT onset_NN of_IN the_DT coronavirus_NN outbreak_NN ,_, various_JJ EU_NNP members_NNS states_NNS had_VBD closed_VBN their_PRP$ borders_NNS ,_, or_CC imposed_VBD travel_NN restrictions_NNS ,_, without_IN giving_VBG each_DT other_JJ advance_NN warning_NN ._. Ursula_NNP von_NNP der_NNP Leyen_NNP now_RB hopes_VBZ that_IN the_DT re-opening_NN of_IN borders_NNS over_IN the_DT coming_VBG weeks_NNS and_CC months_NNS will_MD happen_VB in_IN a_DT more_RBR systematic_JJ fashion_NN ._. The_DT EU_NNP Commission_NNP says_VBZ three_CD conditions_NNS must_MD be_VB met_VBN for_IN coronavirus_NN restrictions_NNS to_TO be_VB eased_VBN ._. Brussels_NNP says_VBZ that_IN curfews_NNS could_MD be_VB lifted_VBN once_IN national_JJ health_NN care_NN systems_NNS are_VBP no_RB longer_RBR under_IN such_JJ extreme_JJ strain_NN ,_, once_IN infections_NNS rates_NNS have_VBP dropped_VBN off_RP ,_, and_CC once_IN particularly_RB vulnerable_JJ groups_NNS are_VBP able_JJ to_TO be_VB provided_VBN with_IN extra_JJ protection_NN ._. Brussels_NNP does_VBZ not_RB ,_, however_RB ,_, propose_VB a_DT specific_JJ time_NN plan_NN for_IN this_DT ._. The_DT paper_NN recognizes_VBZ that_IN this_DT is_VBZ fraught_JJ with_IN danger_NN :_: ""_`` It_PRP is_VBZ certain_JJ that_IN such_PDT a_DT gradual_JJ lifting_NN of_IN restrictions_NNS will_MD lead_VB to_IN new_JJ infections_NNS ._. ""_'' This_DT is_VBZ why_WRB ,_, it_PRP states_VBZ ,_, developments_NNS must_MD be_VB closely_RB monitored_VBN and_CC new_JJ ,_, possibly_RB even_RB more_RBR draconian_JJ measures_NNS will_MD have_VB to_TO be_VB imposed_VBN ._. Von_NNP der_NNP Leyen_NNP writes_VBZ that_IN ""_`` we_PRP will_MD have_VB to_TO live_VB with_IN the_DT virus_NN until_IN a_DT vaccine_NN has_VBZ been_VBN developed_VBN ._. ""_'' Some_DT EU_NNP states_NNS ,_, like_IN Austria_NNP and_CC Denmark_NNP ,_, have_VBP already_RB announced_VBN plans_NNS to_TO lift_VB some_DT restrictions_NNS on_IN daily_JJ life_NN ._. Countries_NNS like_IN France_NNP and_CC Spain_NNP ,_, meanwhile_RB ,_, are_VBP keeping_VBG strict_JJ measures_NNS in_IN place_NN ._. And_CC while_IN some_DT states_NNS have_VBP isolated_VBN themselves_PRP ,_, others_NNS are_VBP still_RB permitting_VBG international_JJ flights_NNS to_TO operate_VB ._. Roughly_RB half_NN of_IN all_DT member_NN states_NNS have_VBP declared_VBN a_DT state_NN of_IN emergency_NN ,_, whereas_IN Sweden_NNP ,_, in_IN contrast_NN ,_, has_VBZ kept_VBN restrictions_NNS to_IN a_DT bare_JJ minimum_NN ._. In_IN Germany_NNP ,_, meanwhile_RB ,_, there_EX is_VBZ no_DT universal_JJ approach_NN among_IN its_PRP$ 16_CD federal_JJ states_NNS to_IN fighting_VBG the_DT virus_NN outbreak_NN ._. In_IN the_DT state_NN of_IN Bavaria_NNP ,_, for_IN instance_NN ,_, all_DT DIY_NNP stores_NNS have_VBP been_VBN closed_VBN to_TO help_VB contain_VB the_DT virus_NN ,_, while_IN in_IN neighboring_VBG Baden_NNP -_HYPH Württemberg_NNP they_PRP 're_VBP free_JJ to_TO stay_VB open_JJ ._. The_DT bloc_NN 's_POS heads_NNS of_IN the_DT states_NNS and_CC governments_NNS had_VBD prompted_VBN Ursula_NNP von_NNP der_NNP Leyen_NNP to_TO draw_VB up_RP an_DT exit_NN strategy_NN for_IN the_DT bloc_NN ._. She_PRP had_VBD been_VBN ready_JJ to_TO unveil_VB her_PRP$ road_NN map_NN last_JJ week_NN ,_, yet_CC was_VBD called_VBN back_RB by_IN concerned_JJ governments_NNS demanding_VBG she_PRP revise_VB the_DT paper_NN ._. The_DT amended_VBN paper_NN now_RB has_VBZ a_DT more_RBR cautious_JJ wording_NN ,_, and_CC makes_VBZ suggestions_NNS ,_, instead_RB of_IN demands_NNS ._. It_PRP appeals_VBZ to_IN all_DT states_NNS to_TO gradually_RB reactivate_VB the_DT common_JJ market_NN and_CC ease_VB travel_NN restrictions_NNS ._. EU_NNP members_NNS states_NNS ,_, meanwhile_RB ,_, are_VBP still_RB to_TO reign_VB supreme_JJ with_IN regard_NN to_IN managing_VBG public_JJ health_NN and_CC disease_NN control_NN ._. At_IN the_DT end_NN of_IN the_DT document_NN ,_, Ursula_NNP von_NNP der_NNP Leyen_NNP pledges_VBZ to_TO draw_VB up_RP a_DT plan_NN to_TO kick_VB start_VB the_DT bloc_NN 's_POS economy_NN ,_, which_WDT was_VBD been_VBN hit_VBN hard_RB by_IN the_DT coronavirus_NN ._. She_PRP says_VBZ demand_NN and_CC production_NN must_MD be_VB stimulated_VBN ,_, and_CC taxes_NNS possibly_RB lowered_VBN ._. The_DT paper_NN states_VBZ that_IN ""_`` the_DT Commission_NN will_MD develop_VB a_DT recovery_NN strategy_NN that_WDT builds_VBZ on_IN a_DT new_JJ medium_JJ -_HYPH term_NN budget_NN plan_NN ,_, and_CC a_DT reworked_VBN 2020_CD action_NN plan_NN ._. ""_'' Next_JJ week_NN ,_, the_DT EU_NNP 's_POS heads_NNS of_IN state_NN and_CC government_NN will_MD discuss_VB the_DT possibility_NN of_IN creating_VBG a_DT European_JJ ""_`` Marshall_NNP Plan_NNP ""_'' to_TO stimulate_VB the_DT bloc_NN 's_POS economy_NN recovery_NN ._. Commission_NN President_NNP von_NNP der_NNP Leyen_NNP plans_VBZ to_TO pump_VB hundreds_NNS of_IN billions_NNS of_IN euros_NNS into_IN into_IN the_DT recovery_NN effort_NN ._. You_PRP can_MD read_VB this_DT article_NN as_IN it_PRP originally_RB appears_VBZ at_IN Deutsche_NNP Welle_NNP here_RB ._.","NNP NNP NNP NNP NNP NNP NNP VBZ VBG on NNP her NN NN for VBG NN NNS across the NN . In a 14 - NN NN VBG out her NNS , NNP NNP NNP VBZ that "" although it VBZ JJ that the NN RB to NN will VB a JJ NN , it VBZ RB JJ that we cannot VB these JJ NNS RB . "" She VBZ NNS across the NN VBD VBN JJ , yet RB VBD a JJ JJ NN and VBD a JJ NN on JJ NN . NNP NNS VBP that the NNP NN could VB by 10 NN this NN — a NN in JJ NN RB VBN since the JJ JJ NN of the NNS . NNP NNP NNP NNP VBZ all 27 NNP NN NNS to VB their NN of NNS and to VB VBG their NN to VBG the NN VBG RB . She VBZ that "" JJ NN in the NN of NNS VBZ the NN of VBG JJ NNS for all NN NNS and RBS RB VBZ NNS between them . "" She VBZ there VBZ no one - NN - NNS - all NN , but that NN NNS should VB to VB each JJ of NNS VBN . At the NN of the NN NN , JJ NNP NNS NNS VBD VBN their NNS , or VBD NN NNS , without VBG each JJ NN NN . NNP NNP NNP NNP RB VBZ that the NN of NNS over the VBG NNS and NNS will VB in a RBR JJ NN . The NNP NNP VBZ three NNS must VB VBN for NN NNS to VB VBN . NNP VBZ that NNS could VB VBN once JJ NN NN NNS VBP RB RBR under JJ JJ NN , once NNS NNS VBP VBN off , and once RB JJ NNS VBP JJ to VB VBN with JJ NN . NNP VBZ RB , RB , VB a JJ NN NN for this . The NN VBZ that this VBZ JJ with NN : "" It VBZ JJ that such a JJ NN of NNS will VB to JJ NNS . "" This VBZ why , it VBZ , NNS must VB RB VBN and JJ , RB RB RBR JJ NNS will VB to VB VBN . NNP NNP NNP VBZ that "" we will VB to VB with the NN until a NN VBZ VBN VBN . "" Some NNP NNS , like NNP and NNP , VBP RB VBN NNS to VB some NNS on JJ NN . NNS like NNP and NNP , RB , VBP VBG JJ NNS in NN . And while some NNS VBP VBN themselves , NNS VBP RB VBG JJ NNS to VB . RB NN of all NN NNS VBP VBN a NN of NN , whereas NNP , in NN , VBZ VBN NNS to a JJ NN . In NNP , RB , there VBZ no JJ NN among its 16 JJ NNS to VBG the NN NN . In the NN of NNP , for NN , all NNP NNS VBP VBN VBN to VB VB the NN , while in VBG NNP - NNP they VBP JJ to VB JJ . The NN 's NNS of the NNS and NNS VBD VBN NNP NNP NNP NNP to VB up an NN NN for the NN . She VBD VBN JJ to VB her NN NN JJ NN , yet VBD VBN RB by JJ NNS VBG she VB the NN . The VBN NN RB VBZ a RBR JJ NN , and VBZ NNS , RB of NNS . It VBZ to all NNS to RB VB the JJ NN and VB NN NNS . NNP NNS NNS , RB , VBP RB to VB JJ with NN to VBG JJ NN and NN NN . At the NN of the NN , NNP NNP NNP NNP VBZ to VB up a NN to VB VB the NN 's NN , which VBD VBN VBN RB by the NN . She VBZ NN and NN must VB VBN , and NNS RB VBN . The NN VBZ that "" the NN will VB a NN NN that VBZ on a JJ JJ - NN NN NN , and a VBN 2020 NN NN . "" JJ NN , the NNP 's NNS of NN and NN will VB the NN of VBG a JJ "" NNP NNP "" to VB the NN 's NN NN . NN NNP NNP NNP NNP VBZ to VB NNS of NNS of NNS into into the NN NN . You can VB this NN as it RB VBZ at NNP NNP RB ."
16,1089,mainstream,"There_EX was_VBD not_RB much_JJ in_IN Jenny_NNP McCarthy_NNP 's_POS early_JJ career_NN as_IN a_DT Playboy_NN model_NN and_CC MTV_NNP star_NN to_TO suggest_VB that_IN she_PRP would_MD become_VB a_DT passionate_JJ advocate_NN for_IN family_NN issues_NNS ,_, children_NNS 's_POS health_NN and_CC autism_NN awareness_NN ._. But_CC the_DT birth_NN of_IN her_PRP$ now_RB almost_RB 7_CD -_HYPH year_NN -_HYPH old_JJ son_NN Evan_NNP ,_, who_WP developed_VBD autism_NN early_RB in_IN life_NN ,_, changed_VBD all_DT of_IN that_DT ._. McCarthy_NNP has_VBZ become_VBN a_DT best_RBS -_HYPH selling_VBG author_NN ,_, first_JJ of_IN lighter_JJR stuff_NN like_IN Baby_NNP Laughs_NNP and_CC Life_NNP Laughs_NNP ;_, then_RB of_IN more_RBR serious_JJ fare_NN ,_, like_IN Louder_JJR than_IN Words_NNPS :_: A_DT Mother_NNP 's_POS Journey_NNP in_IN Healing_NNP Autism_NNP ._. (_-LRB- Read_VB ""_`` Fragile_JJ X_NN :_: Unraveling_VBG Autism_NNP 's_POS Secrets_NNPS ._. ""_'' )_-RRB- Now_RB ,_, she_PRP is_VBZ releasing_VBG her_PRP$ fifth_JJ book_NN _, co-authored_VBN with_IN autism_NN specialist_NN Dr._NNP Jerry_NNP Kartzinel_NNP ,_, titled_VBN Healing_NNP and_CC Preventing_VBG Autism_NNP ._. The_DT book_NN is_VBZ awfully_RB smart_JJ when_WRB it_PRP comes_VBZ to_IN hardheaded_JJ advice_NN for_IN families_NNS trying_VBG to_TO heal_VB _NFP or_CC at_IN least_JJS draw_VB out_RP _, an_DT autistic_JJ child_NN ._. But_CC McCarthy_NNP goes_VBZ soft_JJ when_WRB she_PRP starts_VBZ exploring_VBG the_DT causes_NNS of_IN autism_NN ,_, making_VBG the_DT usual_JJ charges_NNS against_IN the_DT usual_JJ suspects_NNS ,_, including_VBG nutrition_NN ,_, environmental_JJ toxins_NNS and_CC ,_, as_IN always_RB ,_, vaccines_NNS ._. McCarthy_NNP and_CC TIME_NNP science_NN editor_NN Jeffrey_NNP Kluger_NNP sparred_VBD over_IN the_DT causes_NNS of_IN autism_NN and_CC the_DT safety_NN of_IN vaccines_NNS ._. (_-LRB- See_VB the_DT year_NN in_IN medicine_NN 2008_CD ._. )_-RRB- Your_PRP$ book_NN points_VBZ out_RP that_IN autism_NN rates_NNS between_IN 1983_CD and_CC 2008_CD have_VBP climbed_VBN in_IN lockstep_NN with_IN vaccination_NN rates_NNS ,_, yet_CC childhood_NN obesity_NN ,_, diabetes_NN and_CC even_RB cell_NN -_HYPH phone_NN use_NN have_VBP soared_VBN since_IN then_RB ,_, too_RB ._. Why_WRB do_VBP you_PRP find_VB causation_NN in_IN one_CD and_CC not_RB the_DT others_NNS ?_. I_PRP 'm_VBP not_RB saying_VBG it_PRP 's_VBZ only_RB the_DT vaccines_NNS ._. But_CC children_NNS are_VBP given_VBN so_RB many_JJ shots_NNS from_IN the_DT moment_NN they_PRP 're_VBP born_VBN ._. They_PRP get_VBP multiple_JJ injections_NNS all_RB at_IN once_RB ,_, and_CC if_IN they_PRP fall_VBP behind_RB ,_, doctors_NNS put_VBP them_PRP on_IN a_DT catch_NN -_HYPH up_RP schedule_NN ._. Babies_NNS get_VBP the_DT hepatitis_NN B_NN vaccine_NN immediately_RB after_IN they_PRP 're_VBP born_VBN and_CC the_DT only_JJ way_NN for_IN a_DT newborn_NN to_TO contract_VB that_DT disease_NN is_VBZ if_IN the_DT mother_NN is_VBZ a_DT carrier_NN ._. Why_WRB not_RB just_RB screen_VB the_DT mother_NN ?_. Evan_NNP was_VBD handed_VBN to_IN me_PRP pre-vaccinated_VBN with_IN a_DT Band_NNP -_HYPH Aid_NNP on_IN his_PRP$ foot_NN ._. Most_JJS people_NNS who_WP blame_VBP autism_NN on_IN vaccines_NNS point_VBP to_IN the_DT mercury_NN in_IN the_DT shots_NNS ,_, yet_CC mercury_NN has_VBZ been_VBN removed_VBN from_IN most_JJS vaccines_NNS and_CC autism_NN rates_NNS continue_VBP to_TO climb_VB ._. We_PRP do_VBP n't_RB believe_VB it_PRP 's_VBZ only_RB the_DT mercury_NN ._. Aluminum_NN and_CC other_JJ toxins_NNS also_RB play_VB a_DT role_NN ._. The_DT viruses_NNS in_IN the_DT vaccines_NNS themselves_PRP can_MD be_VB causing_VBG it_PRP ,_, too_RB ._. Your_PRP$ collaborator_NN recommends_VBZ that_IN parents_NNS accept_VBP only_RB the_DT haemophilus_NN influenzae_NN type_NN B_NN (_-LRB- HIB_NN )_-RRB- and_CC tetanus_NN vaccine_NN for_IN newborns_NNS and_CC then_RB think_VBP about_IN the_DT rest_NN ._. Not_RB polio_NN ?_. What_WP about_IN the_DT polio_NN clusters_NNS in_IN unvaccinated_JJ communities_NNS like_IN the_DT Amish_NNP in_IN the_DT U.S._NNP ?_. What_WP about_IN the_DT 2004_CD outbreak_NN that_WDT swept_VBD across_IN Africa_NNP and_CC Southeast_NNP Asia_NNP after_IN a_DT single_JJ province_NN in_IN northern_JJ Nigeria_NNP banned_VBD vaccines_NNS ?_. I_PRP do_VBP believe_VB sadly_RB it_PRP 's_VBZ going_VBG to_TO take_VB some_DT diseases_NNS coming_VBG back_RB to_TO realize_VB that_IN we_PRP need_VBP to_TO change_VB and_CC develop_VB vaccines_NNS that_WDT are_VBP safe_JJ ._. If_IN the_DT vaccine_NN companies_NNS are_VBP not_RB listening_VBG to_IN us_PRP ,_, it_PRP 's_VBZ their_PRP$ f___ing_NN fault_NN that_IN the_DT diseases_NNS are_VBP coming_VBG back_RB ._. They_PRP 're_VBP making_VBG a_DT product_NN that_WDT 's_VBZ s____UH ._. If_IN you_PRP give_VBP us_PRP a_DT safe_JJ vaccine_NN ,_, we_PRP 'll_MD use_VB it_PRP ._. It_PRP should_MD n't_RB be_VB polio_NN versus_IN autism_NN ._. (_-LRB- Read_VB ""_`` New_JJ Clues_NNPS to_IN Autism_NNP 's_POS Cause_NN ._. ""_'' )_-RRB- And_CC yet_CC in_IN many_JJ cases_NNS ,_, vaccines_NNS have_VBP effectively_RB eliminated_VBN diseases_NNS ._. Measles_NN is_VBZ among_IN the_DT top_JJ five_CD killers_NNS in_IN the_DT world_NN of_IN children_NNS under_IN 5_CD years_NNS old_JJ ,_, yet_CC it_PRP kills_VBZ virtually_RB no_DT one_CD in_IN the_DT U.S._NNP thanks_NN to_IN vaccines_NNS ._. People_NNS have_VBP the_DT misconception_NN that_IN we_PRP want_VBP to_TO eliminate_VB vaccines_NNS ._. Please_UH understand_VB that_IN we_PRP are_VBP not_RB an_DT antivaccine_NN group_NN ._. We_PRP are_VBP demanding_VBG safe_JJ vaccines_NNS ._. We_PRP want_VBP to_TO reduce_VB the_DT schedule_NN and_CC reduce_VB the_DT toxins_NNS ._. If_IN you_PRP ask_VBP a_DT parent_NN of_IN an_DT autistic_JJ child_NN if_IN they_PRP want_VBP the_DT measles_NNS or_CC the_DT autism_NN ,_, we_PRP will_MD stand_VB in_IN line_NN for_IN the_DT f___ing_NN measles_NNS ._. Many_JJ scientists_NNS believe_VBP we_PRP 're_VBP simply_RB diagnosing_VBG autism_NN differently_RB now_RB _, both_CC overdiagnosing_VBG it_PRP in_IN kids_NNS who_WP do_VBP n't_RB have_VB it_PRP and_CC spotting_VBG it_PRP better_RBR in_IN kids_NNS who_WP do_VBP ._. That_DT makes_VBZ it_PRP look_VB like_IN the_DT condition_NN is_VBZ on_IN the_DT rise_NN when_WRB it_PRP 's_VBZ not_RB ._. All_DT you_PRP have_VBP to_TO do_VB is_VBZ find_VB a_DT schoolteacher_NN or_CC principal_NN and_CC ask_VB them_PRP that_DT question_NN ._. They_PRP would_MD say_VB they_PRP 've_VBP never_RB seen_VBN so_RB much_JJ ADHD_NN ,_, autism_NN ,_, OCD_NN as_IN in_IN the_DT past_NN ._. I_PRP think_VBP we_PRP 're_VBP overdiagnosing_VBG it_PRP by_IN maybe_RB 1_CD %_NN ._. Now_RB you_PRP look_VBP around_RB and_CC there_EX are_VBP five_CD shadows_NNS _, kids_NNS with_IN disabilities_NNS _. in_IN every_DT class_NN ._. You_PRP write_VBP in_IN your_PRP$ book_NN that_IN when_WRB your_PRP$ son_NN began_VBD to_TO emerge_VB from_IN the_DT worst_JJS of_IN his_PRP$ autism_NN he_PRP said_VBD that_IN having_VBG the_DT condition_NN felt_VBN like_IN being_VBG buried_VBN alive_JJ ._. What_WP 's_VBZ the_DT most_RBS important_JJ thing_NN a_DT parent_NN can_MD do_VB to_TO help_VB draw_VB a_DT child_NN out_RP ?_. Just_RB remember_VB that_IN there_EX is_VBZ a_DT very_RB alert_NN ,_, bright_JJ ,_, loving_JJ sweet_JJ child_NN in_IN there_RB who_WP simply_RB looks_VBZ like_IN he_PRP does_VBZ n't_RB care_VB and_CC can't_MD hear_VB you_PRP ._. They_PRP very_RB much_RB know_VBP what_WP 's_VBZ going_VBG on_RP ._. Evan_NNP has_VBZ repeated_VBN things_NNS to_IN me_PRP that_IN I_PRP said_VBD to_IN him_PRP when_WRB he_PRP was_VBD three_CD and_CC in_IN his_PRP$ worst_JJS state_NN ._. (_-LRB- See_VB six_CD tips_NNS for_IN traveling_VBG with_IN an_DT autistic_JJ child_NN ._. )_-RRB- How_WRB do_VBP you_PRP manage_VB the_DT frustration_NN or_CC even_RB resentment_NN any_DT parent_NN would_MD feel_VB after_IN pouring_VBG out_RP so_RB much_JJ love_NN to_IN a_DT child_NN who_WP seems_VBZ utterly_RB indifferent_JJ to_IN it_PRP ?_. It_PRP 's_VBZ really_RB ,_, really_RB difficult_JJ ._. I_PRP remember_VBP being_VBG on_IN the_DT floor_NN with_IN Evan_NNP sometimes_RB 10_CD hours_NNS a_DT day_NN trying_VBG to_TO get_VB him_PRP to_TO smile_VB ._. Eventually_RB ,_, my_PRP$ mother_NN said_VBD to_IN me_PRP ,_, ""_`` Jenny_NNP ,_, everything_NN responds_VBZ to_IN love_NN ._. ""_'' It_PRP was_VBD what_WP my_PRP$ mother_NN said_VBD that_WDT allowed_VBD me_PRP to_TO stay_VB on_IN my_PRP$ knees_NNS with_IN my_PRP$ child_NN ._. How_WRB do_VBP you_PRP balance_VB the_DT needs_NNS of_IN the_DT autistic_JJ child_NN with_IN the_DT needs_NNS of_IN the_DT other_JJ children_NNS in_IN the_DT house_NN _, who_WP are_VBP far_RB less_RBR challenging_JJ and_CC are_VBP rewarded_VBN for_IN that_DT with_IN far_RB less_JJR attention_NN ?_. Therapists_NNS deal_VBP with_IN that_DT all_PDT the_DT time_NN ._. They_PRP strongly_RB urge_VBP that_IN you_PRP bring_VB the_DT healthy_JJ kids_NNS _, or_CC what_WP we_PRP call_VBP the_DT typical_JJ kids_NNS _. into_IN the_DT therapy_NN ._. Get_VB them_PRP involved_VBN with_IN the_DT autistic_JJ child_NN ._. Also_RB ,_, it_PRP 's_VBZ absolutely_RB imperative_JJ for_IN the_DT parents_NNS and_CC the_DT typical_JJ kids_NNS to_TO have_VB time_NN by_IN themselves_PRP ,_, to_TO go_VB out_RB to_IN dinner_NN or_CC even_RB go_VB on_IN vacation_NN while_IN someone_NN else_JJ cares_VBZ for_IN the_DT autistic_JJ child_NN ._. When_WRB families_NNS eat_VBP at_IN home_NN ,_, sometimes_RB the_DT autistic_JJ child_NN will_MD have_VB dinner_NN first_RB and_CC then_RB watch_VB a_DT movie_NN ,_, while_IN everyone_NN else_JJ has_VBZ dinner_NN in_IN peace_NN ._. What_WP 's_VBZ the_DT best_JJS prognosis_NN for_IN autistic_JJ kids_NNS ?_. For_IN a_DT seriously_RB autistic_JJ kid_NN ,_, the_DT best_JJS prognosis_NN might_MD be_VB getting_VBG into_IN a_DT mainstream_JJ school_NN without_IN being_VBG too_RB much_JJ of_IN a_DT shadow_NN ._. For_IN a_DT moderately_RB autistic_JJ kid_NN the_DT best_JJS prognosis_NN is_VBZ full_JJ recovery_NN ._. See_VB pictures_NNS of_IN inside_IN a_DT school_NN for_IN autistic_JJ children_NNS ._.","There VBD RB JJ in NNP NNP 's JJ NN as a NN NN and NNP NN to VB that she would VB a JJ NN for NN NNS , NNS 's NN and NN NN . But the NN of her RB RB 7 - NN - JJ NN NNP , who VBD NN RB in NN , VBD all of that . NNP VBZ VBN a RBS - VBG NN , JJ of JJR NN like NNP NNP and NNP NNP ; RB of RBR JJ NN , like JJR than NNPS : A NNP 's NNP in NNP NNP . ( VB "" JJ NN : VBG NNP 's NNPS . "" ) RB , she VBZ VBG her JJ NN  VBN with NN NN NNP NNP NNP , VBN NNP and VBG NNP . The NN VBZ RB JJ when it VBZ to JJ NN for NNS VBG to VB  or at JJS VB out  an JJ NN . But NNP VBZ JJ when she VBZ VBG the NNS of NN , VBG the JJ NNS against the JJ NNS , VBG NN , JJ NNS and , as RB , NNS . NNP and NNP NN NN NNP NNP VBD over the NNS of NN and the NN of NNS . ( VB the NN in NN 2008 . ) Your NN VBZ out that NN NNS between 1983 and 2008 VBP VBN in NN with NN NNS , yet NN NN , NN and RB NN - NN NN VBP VBN since RB , RB . Why VBP you VB NN in one and RB the NNS ? I VBP RB VBG it VBZ RB the NNS . But NNS VBP VBN RB JJ NNS from the NN they VBP VBN . They VBP JJ NNS RB at RB , and if they VBP RB , NNS VBP them on a NN - up NN . NNS VBP the NN NN NN RB after they VBP VBN and the JJ NN for a NN to VB that NN VBZ if the NN VBZ a NN . Why RB RB VB the NN ? NNP VBD VBN to me VBN with a NNP - NNP on his NN . JJS NNS who VBP NN on NNS VBP to the NN in the NNS , yet NN VBZ VBN VBN from JJS NNS and NN NNS VBP to VB . We VBP RB VB it VBZ RB the NN . NN and JJ NNS RB VB a NN . The NNS in the NNS themselves can VB VBG it , RB . Your NN VBZ that NNS VBP RB the NN NN NN NN ( NN ) and NN NN for NNS and RB VBP about the NN . RB NN ? What about the NN NNS in JJ NNS like the NNP in the NNP ? What about the 2004 NN that VBD across NNP and NNP NNP after a JJ NN in JJ NNP VBD NNS ? I VBP VB RB it VBZ VBG to VB some NNS VBG RB to VB that we VBP to VB and VB NNS that VBP JJ . If the NN NNS VBP RB VBG to us , it VBZ their f NN that the NNS VBP VBG RB . They VBP VBG a NN that VBZ s . If you VBP us a JJ NN , we 'll VB it . It should RB VB NN versus NN . ( VB "" JJ NNPS to NNP 's NN . "" ) And yet in JJ NNS , NNS VBP RB VBN NNS . NN VBZ among the JJ five NNS in the NN of NNS under 5 NNS JJ , yet it VBZ RB no one in the NNP NN to NNS . NNS VBP the NN that we VBP to VB NNS . Please VB that we VBP RB an NN NN . We VBP VBG JJ NNS . We VBP to VB the NN and VB the NNS . If you VBP a NN of an JJ NN if they VBP the NNS or the NN , we will VB in NN for the f NNS . JJ NNS VBP we VBP RB VBG NN RB RB  both VBG it in NNS who VBP RB VB it and VBG it RBR in NNS who VBP . That VBZ it VB like the NN VBZ on the NN when it VBZ RB . All you VBP to VB VBZ VB a NN or NN and VB them that NN . They would VB they VBP RB VBN RB JJ NN , NN , NN as in the NN . I VBP we VBP VBG it by RB 1 NN . RB you VBP RB and there VBP five NNS  NNS with NNS  in every NN . You VBP in your NN that when your NN VBD to VB from the JJS of his NN he VBD that VBG the NN VBN like VBG VBN JJ . What VBZ the RBS JJ NN a NN can VB to VB VB a NN out ? RB VB that there VBZ a RB NN , JJ , JJ JJ NN in RB who RB VBZ like he VBZ RB VB and can't VB you . They RB RB VBP what VBZ VBG on . NNP VBZ VBN NNS to me that I VBD to him when he VBD three and in his JJS NN . ( VB six NNS for VBG with an JJ NN . ) How VBP you VB the NN or RB NN any NN would VB after VBG out RB JJ NN to a NN who VBZ RB JJ to it ? It VBZ RB , RB JJ . I VBP VBG on the NN with NNP RB 10 NNS a NN VBG to VB him to VB . RB , my NN VBD to me , "" NNP , NN VBZ to NN . "" It VBD what my NN VBD that VBD me to VB on my NNS with my NN . How VBP you VB the NNS of the JJ NN with the NNS of the JJ NNS in the NN  who VBP RB RBR JJ and VBP VBN for that with RB JJR NN ? NNS VBP with that all the NN . They RB VBP that you VB the JJ NNS  or what we VBP the JJ NNS  into the NN . VB them VBN with the JJ NN . RB , it VBZ RB JJ for the NNS and the JJ NNS to VB NN by themselves , to VB RB to NN or RB VB on NN while NN JJ VBZ for the JJ NN . When NNS VBP at NN , RB the JJ NN will VB NN RB and RB VB a NN , while NN JJ VBZ NN in NN . What VBZ the JJS NN for JJ NNS ? For a RB JJ NN , the JJS NN might VB VBG into a JJ NN without VBG RB JJ of a NN . For a RB JJ NN the JJS NN VBZ JJ NN . VB NNS of inside a NN for JJ NNS ."
17,734,conspiracy,"For_IN a_DT vaccine_NN that_WDT supposedly_RB does_VBZ n’t_RB exist_VB yet_RB and_CC is_VBZ widely_RB thought_VBN to_TO be_VB impossible_JJ ._. Are_VBP you_PRP starting_VBG to_TO get_VB the_DT picture_NN ?_. The_DT Coalition_NNP of_IN United_NNP Political_NNP Parties_NNPS (_-LRB- CUPP_NNP )_-RRB- ,_, on_IN Monday_NNP ,_, alleged_VBD that_IN it_PRP has_VBZ intercepted_VBN a_DT human_JJ intelligence_NN report_NN that_WDT the_DT Nigeria_NNP House_NNP of_IN Representatives_NNPS leadership_NN was_VBD poised_VBN to_TO forcefully_RB pass_VB the_DT compulsory_JJ vaccine_NN bill_NN without_IN subjecting_VBG it_PRP to_IN the_DT traditions_NNS of_IN legislative_JJ proceedings_NNS ._. In_IN a_DT statement_NN issued_VBN and_CC signed_VBN by_IN the_DT spokesperson_NN of_IN the_DT opposition_NN political_JJ parties_NNS ,_, Barrister_NNP Ikenga_NNP Imo_NNP Ugochinyere_NNP and_CC sent_VBN to_IN DAILY_JJ POST_NN in_IN Abuja_NNP on_IN Monday_NNP ,_, the_DT body_NN urged_VBD lawmakers_NNS in_IN the_DT lower_JJR chamber_NN to_TO rise_VB against_IN impunity_NN ._. The_DT body_NN in_IN the_DT statement_NN alleged_VBD that_IN a_DT sum_NN of_IN $_$ 10_CD million_CD was_VBD offered_VBN by_IN the_DT American_NNP Computer_NNP Czar_NNP ,_, Bill_NNP Gates_NNP to_TO influence_VB the_DT speedy_JJ passage_NN of_IN the_DT bill_NN without_IN recourse_NN to_IN legislative_JJ public_JJ hearing_NN ,_, a_DT development_NN they_PRP averted_VBD as_IN anachronistic_JJ ,_, adding_VBG that_IN the_DT Speaker_NNP ,_, Femi_NNP Gbajabiamila_NNP should_MD be_VB impeached_VBN if_IN he_PRP forces_VBZ the_DT bill_NN on_IN members_NNS ._. “_`` Opposition_NNP Coalition_NNP (_-LRB- CUPP_NNP )_-RRB- has_VBZ intercepted_VBN very_RB credible_JJ intelligence_NN and_CC hereby_RB alerts_VBZ Nigerians_NNPS of_IN plans_NNS by_IN the_DT leadership_NN of_IN the_DT House_NNP of_IN Representatives_NNPS led_VBN by_IN Femi_NNP Gbajabiamila_NNP to_IN forcefully_RB and_CC without_IN adherence_NN to_IN the_DT rules_NNS of_IN lawmaking_NN to_TO pass_VB the_DT Control_NNP of_IN Infectious_NNP Diseases_NNPS Bill_NNP 2020_CD otherwise_RB known_VBN as_IN the_DT Compulsory_NNP Vaccination_NNP Bill_NNP which_WDT is_VBZ proposing_VBG a_DT compulsory_JJ vaccination_NN of_IN all_DT Nigerians_NNPS even_RB when_WRB the_DT vaccines_NNS have_VBP not_RB been_VBN discovered_VBN ._. “_`` This_DT intelligence_NN is_VBZ coupled_VBN with_IN the_DT information_NN of_IN the_DT alleged_VBN receipt_NN ,_, from_IN sources_NNS outside_IN the_DT country_NN but_CC very_RB interested_JJ in_IN the_DT Bill_NNP ,_, of_IN the_DT sum_NN of_IN $_$ 10_CD million_CD by_IN the_DT sponsors_NNS and_CC promoters_NNS of_IN the_DT Bill_NNP to_TO distribute_VB among_IN lawmakers_NNS to_TO ensure_VB a_DT smooth_JJ passage_NN of_IN the_DT Bill_NNP ._. “_`` This_DT will_MD manifest_VB in_IN a_DT wishy_JJ -_HYPH washy_JJ public_JJ hearing_NN which_WDT the_DT promoters_NNS still_RB insist_VBP on_IN cancelling_VBG under_IN the_DT pretext_NN of_IN containment_NN of_IN the_DT spread_NN of_IN the_DT coronavirus_NN ._. The_DT intelligence_NN is_VBZ that_IN the_DT House_NNP will_MD under_IN whatever_WDT guise_NN pass_VB the_DT Bill_NNP tomorrow_NN 5th_NN May_NNP ,_, 2020_CD upon_IN resumption_NN ._. “_`` The_DT Nigeria_NNP opposition_NN rejects_VBZ the_DT Bill_NNP and_CC urges_VBZ opposition_NN lawmakers_NNS in_IN the_DT House_NNP of_IN Representatives_NNPS to_TO confront_VB the_DT Speaker_NNP of_IN the_DT House_NNP with_IN these_DT facts_NNS tomorrow_NN at_IN plenary_NN and_CC resist_VB every_DT plan_NN to_TO illegally_RB pass_VB the_DT Bill_NNP ._. “_`` We_PRP have_VBP been_VBN informed_VBN that_IN the_DT alleged_VBN deal_NN on_IN the_DT passage_NN of_IN the_DT Bill_NNP was_VBD struck_VBN during_IN a_DT trip_NN to_IN Austria_NNP a_DT few_JJ months_NNS back_RB while_IN the_DT financial_JJ support_NN for_IN the_DT promotion_NN of_IN the_DT Bill_NNP was_VBD allegedly_RB received_VBN last_JJ week_NN to_TO mobilize_VB for_IN a_DT push_NN leading_VBG to_IN the_DT hurried_VBN attempt_NN to_TO pass_VB the_DT Bill_NNP by_IN any_DT means_NNS necessary_JJ ._. “_`` Nigerians_NNPS are_VBP reminded_VBN that_IN at_IN present_JJ ,_, there_EX is_VBZ no_DT discovered_VBN /_, approved_VBN vaccine_NN anywhere_RB in_IN the_DT world_NN and_CC one_CD now_RB begins_VBZ to_TO wonder_VB why_WRB the_DT hurry_NN to_TO pass_VB a_DT Bill_NNP for_IN a_DT compulsory_JJ vaccine_NN when_WRB there_EX is_VBZ none_NN …_. ._.","For a NN that RB VBZ RB VB RB and VBZ RB VBN to VB JJ . VBP you VBG to VB the NN ? The NNP of NNP NNP NNPS ( NNP ) , on NNP , VBD that it VBZ VBN a JJ NN NN that the NNP NNP of NNPS NN VBD VBN to RB VB the JJ NN NN without VBG it to the NNS of JJ NNS . In a NN VBN and VBN by the NN of the NN JJ NNS , NNP NNP NNP NNP and VBN to JJ NN in NNP on NNP , the NN VBD NNS in the JJR NN to VB against NN . The NN in the NN VBD that a NN of $ 10 million VBD VBN by the NNP NNP NNP , NNP NNP to VB the JJ NN of the NN without NN to JJ JJ NN , a NN they VBD as JJ , VBG that the NNP , NNP NNP should VB VBN if he VBZ the NN on NNS . “ NNP NNP ( NNP ) VBZ VBN RB JJ NN and RB VBZ NNPS of NNS by the NN of the NNP of NNPS VBN by NNP NNP to RB and without NN to the NNS of NN to VB the NNP of NNP NNPS NNP 2020 RB VBN as the NNP NNP NNP which VBZ VBG a JJ NN of all NNPS RB when the NNS VBP RB VBN VBN . “ This NN VBZ VBN with the NN of the VBN NN , from NNS outside the NN but RB JJ in the NNP , of the NN of $ 10 million by the NNS and NNS of the NNP to VB among NNS to VB a JJ NN of the NNP . “ This will VB in a JJ - JJ JJ NN which the NNS RB VBP on VBG under the NN of NN of the NN of the NN . The NN VBZ that the NNP will under whatever NN VB the NNP NN NN NNP , 2020 upon NN . “ The NNP NN VBZ the NNP and VBZ NN NNS in the NNP of NNPS to VB the NNP of the NNP with these NNS NN at NN and VB every NN to RB VB the NNP . “ We VBP VBN VBN that the VBN NN on the NN of the NNP VBD VBN during a NN to NNP a JJ NNS RB while the JJ NN for the NN of the NNP VBD RB VBN JJ NN to VB for a NN VBG to the VBN NN to VB the NNP by any NNS JJ . “ NNPS VBP VBN that at JJ , there VBZ no VBN / VBN NN RB in the NN and one RB VBZ to VB why the NN to VB a NNP for a JJ NN when there VBZ NN … ."
18,814,conspiracy,"Flu_NN vaccine_NN push_NN already_RB underway_JJ ;_, first_JJ batch_NN causes_VBZ seizures_NNS in_IN children_NNS As_RB ridiculous_JJ as_IN it_PRP seems_VBZ ,_, retailers_NNS across_IN the_DT U.S._NNP are_VBP already_RB stocking_VBG their_PRP$ stores_NNS with_IN Christmas_NNP goods_NNS ._. It_PRP ’s_VBZ all_RB about_IN the_DT big_JJ commercial_JJ push_NN ,_, of_IN course_NN ,_, since_IN retailers_NNS make_VBP about_RB 50_CD percent_NN of_IN their_PRP$ profits_NNS during_IN the_DT Christmas_NNP season_NN ._. Similarly_RB ,_, flu_NN vaccine_NN manufacturers_NNS generate_VBP huge_JJ profits_NNS during_IN the_DT Christmas_NNP season_NN ,_, too_RB ,_, and_CC they_PRP ’ve_VBP already_RB begun_VBN shipping_VBG this_DT year_NN ’s_POS winter_NN season_NN flu_NN vaccines_NNS to_IN U.S._NNP pharmacies_NNS and_CC hospitals_NNS ._. Never_RB mind_VB the_DT fact_NN that_IN the_DT actual_JJ flu_NN strain_NN in_IN the_DT vaccine_NN is_VBZ little_RB more_JJR than_IN a_DT hodgepodge_NN collection_NN of_IN last_JJ year_NN ’s_POS flu_NN strains_NNS ._. Each_DT year_NN ’s_POS flu_NN vaccines_NNS are_VBP technically_RB only_RB applicable_JJ to_IN last_JJ year_NN ’s_POS flu_NN season_NN ,_, making_VBG them_PRP perfect_JJ for_IN time_NN travelers_NNS but_CC useless_JJ for_IN everybody_NN else_JJ ._. Along_IN with_IN the_DT big_JJ vaccine_NN push_NN comes_VBZ the_DT inevitable_JJ vaccine_NN propaganda_NN ._. It_PRP ’s_VBZ all_RB so_RB predictable_JJ :_: First_RB there_EX ’s_VBZ the_DT announcement_NN that_IN “_`` everybody_NN should_MD get_VB vaccinated_VBN ._. ”_'' This_DT is_VBZ followed_VBN by_IN some_DT later_JJR announcement_NN in_IN the_DT pre-Christmas_NN season_NN of_IN “_`` how_WRB bad_JJ ”_'' this_DT year_NN ’s_POS flu_NN season_NN is_VBZ getting_VBG ._. This_DT is_VBZ followed_VBN yet_RB again_RB by_IN another_DT urgent_JJ bulletin_NN by_IN health_NN authorities_NNS urging_VBG everyone_NN to_TO get_VB vaccinated_VBN ._. The_DT big_JJ vaccine_NN push_VB only_RB quiets_VBZ down_RP when_WRB vaccine_NN supplies_NNS dwindle_VBP ._. But_CC as_RB long_RB as_IN vaccines_NNS remain_VBP in_IN inventory_NN ,_, the_DT big_JJ vaccine_NN push_NN will_MD stay_VB aggressive_JJ ,_, and_CC during_IN this_DT annual_JJ charade_NN ,_, there_EX wo_MD n’t_RB be_VB a_DT word_NN mentioned_VBN about_IN vitamin_NN D_NN and_CC how_WRB it_PRP is_VBZ far_RB more_RBR effective_JJ than_IN any_DT vaccine_NN at_IN protecting_VBG people_NNS from_IN seasonal_JJ flu_NN ._. This_DT year_NN ’s_POS vaccine_NN push_NN has_VBZ begun_VBN with_IN some_DT curious_JJ admissions_NNS by_IN the_DT vaccine_NN industry_NN ,_, reflected_VBN in_IN a_DT Reuters_NNP story_NN (_-LRB- http://www.reuters.com/article/idUS…)._ADD After_IN the_DT usual_JJ explanatory_JJ text_NN about_IN how_WRB flu_NN vaccine_NN manufacturers_NNS have_VBP started_VBN shipping_VBG their_PRP$ largest_JJS quantity_NN of_IN vaccines_NNS ever_RB produced_VBN for_IN flu_NN season_NN ,_, the_DT story_NN prints_VBZ this_DT curious_JJ text_NN :_: “_`` And_CC U.S._NNP officials_NNS said_VBD they_PRP were_VBD changing_VBG the_DT labeling_NN on_IN a_DT vaccine_NN made_VBN by_IN Australia_NNP ’s_POS CSL_NNP Ltd_NNP (_-LRB- CSL_NNP ._. AX_NNP )_-RRB- because_IN it_PRP appears_VBZ to_TO have_VB caused_VBN a_DT higher_JJR than_IN usual_JJ rate_NN of_IN seizures_NNS in_IN children_NNS ._. ”_'' Now_RB hold_VB on_RP a_DT second_NN ._. If_IN you_PRP read_VBP between_IN the_DT lines_NNS here_RB ,_, this_DT statement_NN implies_VBZ that_IN :_: 1_LS )_-RRB- Vaccines_NNS cause_VBP seizures_NNS in_IN children_NNS ._. And_CC then_RB 2_LS )_-RRB- This_DT particular_JJ vaccines_NNS causes_VBZ a_DT higher_JJR rate_NN of_IN seizures_NNS in_IN children_NNS than_IN the_DT usual_JJ rate_NN of_IN seizures_NNS in_IN children_NNS ._. Why_WRB is_VBZ this_DT curious_JJ ?_. First_RB off_RP ,_, because_IN vaccine_NN pushers_NNS have_VBP always_RB sworn_VBN their_PRP$ vaccines_NNS caused_VBN no_DT seizures_NNS whatsoever_RB ._. No_DT neurological_JJ problems_NNS ._. No_DT spontaneous_JJ abortions_NNS in_IN pregnant_JJ women_NNS ._. No_DT increased_VBN rates_NNS of_IN autism_NN ._. Vaccines_NNS are_VBP all_RB perfectly_RB safe_JJ ,_, they_PRP say_VBP ,_, and_CC no_DT children_NNS are_VBP ever_RB harmed_VBN by_IN them_PRP ._. That_DT ’s_VBZ the_DT mythology_NN ,_, at_IN least_JJS ,_, behind_IN vaccines_NNS ._. But_CC the_DT reality_NN is_VBZ far_RB different_JJ :_: Vaccines_NNS do_VBP cause_VB seizures_NNS in_IN children_NNS ,_, and_CC this_DT year_NN ’s_POS vaccines_NNS look_VBP like_IN they_PRP ’re_VBP going_VBG to_TO cause_VB a_DT significantly_RB higher_JJR rate_NN of_IN seizures_NNS than_IN usual_JJ ._. Note_VB ,_, by_IN the_DT way_NN ,_, that_IN this_DT was_VBD not_RB the_DT headline_NN of_IN the_DT story_NN ._. This_DT admission_NN was_VBD tucked_VBN away_RB in_IN the_DT text_NN of_IN a_DT Reuters_NNP story_NN ,_, without_IN any_DT real_JJ emphasis_NN ._. If_IN Reuters_NNP was_VBD really_RB interested_JJ in_IN reporting_VBG the_DT truth_NN about_IN vaccines_NNS ,_, the_DT story_NN headline_NN would_MD have_VB been_VBN ,_, “_`` Flu_NN vaccines_NNS cause_VBP seizures_NNS in_IN children_NNS ._. ”_'' The_DT story_NN goes_VBZ on_RP to_TO say_VB ,_, “_`` The_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP recommends_VBZ that_IN everyone_NN be_VB vaccinated_VBN against_IN seasonal_JJ flu_NN this_DT year_NN ._. ”_'' Yep_UH ,_, everyone_NN ._. That_DT means_VBZ one_CD -_HYPH month_NN old_JJ infants_NNS ._. Pregnant_JJ women_NNS ._. Children_NNS with_IN seizure_NN disorders_NNS ._. Immune_NN suppressed_VBN seniors_NNS ._. Everyone_NN !_. You_PRP see_VBP ,_, in_IN years_NNS past_NN ,_, vaccines_NNS were_VBD never_RB recommended_VBN for_IN everyone_NN due_IN to_IN well_RB -_HYPH founded_VBN safety_NN concerns_NNS ._. In_IN some_DT people_NNS ,_, you_PRP see_VBP ,_, the_DT nearly_RB -_HYPH dead_JJ viral_JJ strains_NNS used_VBN in_IN vaccines_NNS can_MD actually_RB cause_VB the_DT very_JJ flu_NN they_PRP claim_VBP to_TO prevent_VB ._. So_RB the_DT CDC_NNP has_VBZ ,_, for_IN as_RB long_RB as_IN anyone_NN can_MD remember_VB ,_, always_RB warned_VBD certain_JJ groups_NNS to_TO be_VB excluded_VBN from_IN vaccines_NNS for_IN their_PRP$ own_JJ safety_NN ._. Well_UH not_RB anymore_RB ._. Any_DT safety_NN concerns_NNS have_VBP been_VBN thrown_VBN out_RP the_DT window_NN in_IN the_DT quest_NN to_TO push_VB more_JJR vaccines_NNS onto_IN more_JJR people_NNS ._. Billions_NNS of_IN dollars_NNS in_IN pharmaceutical_JJ profits_NNS are_VBP at_IN stake_NN here_RB ,_, and_CC health_NN officials_NNS can’t_MD afford_VB to_TO let_VB a_DT little_JJ safety_NN get_VB in_IN the_DT way_NN ._. “_`` Most_JJS years_NNS ,_, seasonal_JJ influenza_NN infects_VBZ between_IN 5_CD percent_NN and_CC 20_CD percent_NN of_IN the_DT U.S._NNP population_NN and_CC kills_VBZ 36,000_CD people_NNS ._. It_PRP puts_VBZ about_RB 200,000_CD into_IN the_DT hospital_NN ._. ”_'' Well_UH ,_, not_RB really_RB ._. The_DT 36,000_CD figure_NN often_RB quoted_VBN from_IN the_DT CDC_NNP is_VBZ wildly_RB inaccurate_JJ (_-LRB- http://www.naturalnews.com/026169_m…)._ADD It_PRP ’s_VBZ a_DT statistical_JJ guess_NN based_VBN on_IN such_JJ outdated_JJ data_NNS that_WDT to_TO quote_VB it_PRP as_IN fact_NN is_VBZ laughable_JJ ._. Besides_RB ,_, it_PRP ’s_VBZ technically_RB wrong_JJ to_TO say_VB that_IN influenza_NN kills_VBZ anyone_NN ._. The_DT real_JJ killer_NN here_RB is_VBZ vitamin_NN D_NN deficiency_NN which_WDT causes_VBZ a_DT stalled_VBN out_RP immune_NN system_NN ._. If_IN people_NNS had_VBD sufficient_JJ levels_NNS of_IN vitamin_NN D_NN circulating_VBG in_IN their_PRP$ blood_NN ,_, the_DT flu_NN virus_NN would_MD be_VB powerless_JJ to_TO harm_VB them_PRP ._. And_CC since_IN there_EX are_VBP viruses_NNS everywhere_RB in_IN the_DT world_NN around_IN us_PRP every_DT single_JJ day_NN ,_, is_VBZ n’t_RB it_PRP more_RBR accurate_JJ to_TO say_VB that_IN the_DT “_`` flu_NN season_NN ”_'' is_VBZ actually_RB the_DT “_`` vitamin_NN D_NN deficiency_NN season_NN ?_. ”_'' Think_VB about_IN it_PRP :_: Why_WRB does_VBZ the_DT flu_NN circulate_VB in_IN the_DT winter_NN months_NNS in_IN North_NNP America_NNP ,_, but_CC the_DT summer_NN months_NNS (_-LRB- June_NNP –_SYM August_NNP )_-RRB- in_IN Australia_NNP ?_. It_PRP ’s_VBZ because_IN those_DT are_VBP the_DT times_NNS of_IN weaker_JJR sunlight_NN exposure_NN resulting_VBG in_IN widespread_JJ vitamin_NN D_NN deficiencies_NNS ._. The_DT flu_NN is_VBZ always_RB around_RB ,_, living_VBG amongst_IN us_PRP ,_, just_RB waiting_VBG for_IN weakened_VBN immune_NN systems_NNS so_IN it_PRP can_MD strike_VB ._. To_TO say_VB that_IN “_`` the_DT flu_NN ”_'' kills_VBZ people_NNS in_IN the_DT winter_NN is_VBZ factually_RB wrong_JJ ._. It_PRP ’s_VBZ the_DT vitamin_NN D_NN deficiency_NN that_WDT kills_VBZ people_NNS by_IN giving_VBG the_DT flu_NN an_DT opportunity_NN to_TO attack_VB a_DT weakened_VBN immune_JJ system_NN ._. This_DT is_VBZ a_DT simple_JJ factual_JJ point_NN that_WDT the_DT entire_JJ system_NN of_IN western_JJ medicine_NN ,_, with_IN all_PDT its_PRP$ high_JJ -_HYPH IQ_NN doctors_NNS ,_, has_VBZ so_RB far_RB failed_VBN to_TO realize_VB ._. Sometimes_RB it_PRP feels_VBZ like_IN we_PRP ’re_VBP still_RB living_VBG in_IN the_DT Dark_NNP Ages_NNPS of_IN medicine_NN ,_, I_PRP swear_VBP …_. Where_WRB are_VBP the_DT clinical_JJ trials_NNS ?_. Anyway_UH ,_, this_DT Reuters_NNP story_NN continues_VBZ with_IN one_CD more_JJR whopper_NN of_IN a_DT statement_NN :_: “_`` The_DT labeling_NN for_IN one_CD vaccine_NN ,_, CSL_NNP Limited_NNP ’s_POS Afluria_NNP ,_, has_VBZ undergone_VBN changes_NNS this_DT season_NN to_TO inform_VB health_NN care_NN providers_NNS about_IN an_DT increased_VBN incidence_NN of_IN fever_NN and_CC febrile_JJ seizure_NN …_. The_DT FDA_NNP said_VBD it_PRP was_VBD asking_VBG CSL_NNP to_TO conduct_VB a_DT study_NN of_IN its_PRP$ vaccine_NN in_IN children_NNS ._. ”_'' Read_VB between_IN the_DT lines_NNS on_IN this_DT one_NN :_: This_DT Afluria_NNP vaccine_NN causes_VBZ an_DT increased_VBN risk_NN of_IN seizures_NNS ,_, it_PRP ’s_VBZ being_VBG imported_VBN into_IN the_DT USA_NNP to_TO be_VB injected_VBN in_IN children_NNS this_DT flu_NN season_NN ,_, and_CC the_DT FDA_NNP is_VBZ just_RB now_RB asking_VBG for_IN a_DT study_NN ?_. That_DT means_VBZ ,_, of_IN course_NN ,_, that_IN no_DT study_NN has_VBZ been_VBN conducted_VBN on_IN this_DT vaccine_NN yet_RB ._. In_IN other_JJ words_NNS ,_, this_DT vaccine_NN which_WDT causes_VBZ seizures_NNS in_IN children_NNS has_VBZ never_RB actually_RB been_VBN properly_RB tested_VBN in_IN children_NNS according_VBG to_IN FDA_NNP guidelines_NNS ,_, so_IN the_DT FDA_NNP wants_VBZ a_DT test_NN to_TO be_VB done_VBN but_CC the_DT vaccine_NN will_MD be_VB injected_VBN into_IN children_NNS in_IN the_DT USA_NNP anyway_RB ,_, even_RB before_IN the_DT testing_NN is_VBZ likely_JJ to_TO be_VB completed_VBN ._. And_CC that_DT means_VBZ ,_, of_IN course_NN ,_, that_IN U.S._NNP children_NNS are_VBP being_VBG used_VBN as_IN guinea_NN pigs_NNS to_TO see_VB what_WP happens_VBZ to_IN them_PRP following_VBG this_DT vaccine_NN injection_NN ._. If_IN enough_JJ children_NNS have_VBP seizures_NNS or_CC end_VBP up_RP paralyzed_VBN or_CC dead_JJ ,_, the_DT FDA_NNP will_MD probably_RB pull_VB the_DT vaccine_NN off_IN the_DT market_NN ._. But_CC that_DT only_RB happens_VBZ after_IN the_DT fact_NN and_CC after_IN the_DT damage_NN has_VBZ already_RB been_VBN done_VBN ._. Do_VBP n’t_RB you_PRP get_VB it_PRP ?_. Your_PRP$ children_NNS are_VBP the_DT experiment_NN !_. The_DT American_NNP People_NNPS are_VBP the_DT guinea_NN pigs_NNS for_IN every_DT vaccine_NN these_DT companies_NNS come_VBP up_RP with_IN ,_, and_CC it_PRP does_VBZ n’t_RB matter_VB if_IN the_DT vaccine_NN causes_VBZ seizures_NNS ,_, brain_NN damage_NN or_CC even_RB death_NN …_. American_JJ children_NNS are_VBP going_VBG to_TO be_VB injected_VBN by_IN the_DT millions_NNS in_IN order_NN to_TO find_VB out_RP what_WP happens_VBZ ._. No_DT need_NN for_IN influenza_NN vaccines_NNS in_IN anyone_NN This_DT whole_JJ annual_JJ charade_NN is_VBZ utterly_RB useless_JJ to_TO begin_VB with_IN ._. There_EX is_VBZ simply_RB no_RB medically_RB justifiable_JJ need_NN to_TO inject_VB anyone_NN with_IN a_DT flu_NN vaccine_NN —_: ever_RB !_. What_WDT people_NNS need_VBP is_VBZ vitamin_NN D_NN to_TO activate_VB their_PRP$ immune_JJ response_NN so_IN that_IN natural_JJ exposures_NNS to_IN seasonal_JJ flu_NN are_VBP easily_RB handled_VBN by_IN their_PRP$ existing_VBG immune_JJ system_NN functionality_NN ._. Let_VB ’s_PRP face_VB it_PRP :_: The_DT human_JJ immune_NN system_NN is_VBZ far_RB more_RBR intelligent_JJ and_CC technologically_RB advanced_JJ than_IN any_DT flu_NN vaccine_NN ._. It_PRP already_RB has_VBZ a_DT pattern_NN recognition_NN system_NN that_WDT can_MD identify_VB and_CC destroy_VB foreign_JJ invaders_NNS in_IN the_DT blood_NN ._. But_CC as_IN research_NN has_VBZ shown_VBN ,_, when_WRB vitamin_NN D_NN levels_NNS are_VBP deficient_JJ in_IN the_DT body_NN ,_, the_DT immune_NN system_NN is_VBZ effectively_RB paralyzed_VBN and_CC ca_MD n’t_RB respond_VB ._. (_-LRB- http://www.naturalnews.com/029312_i…)_ADD When_WRB vitamin_NN D_NN levels_NNS are_VBP high_JJ ,_, the_DT immune_NN system_NN responds_VBZ rapidly_RB to_IN any_DT influenza_NN threat_NN ._. That_DT ’s_VBZ why_WRB I_PRP never_RB get_VBP a_DT flu_NN shot_NN and_CC even_RB so_RB ,_, I_PRP have_VBP n’t_RB been_VBN sick_JJ for_IN years_NNS ._. I_PRP do_VBP ,_, however_RB ,_, get_VB sunshine_NN on_IN a_DT regular_JJ basis_NN ,_, and_CC when_WRB I_PRP ca_MD n’t_RB get_VB sunshine_NN ,_, I_PRP take_VBP a_DT quality_JJ vitamin_NN D3_NN supplement_NN ._. And_CC guess_VB what_WP ?_. I_PRP do_VBP n’t_RB need_VB a_DT flu_NN vaccine_NN at_IN all_DT ._. I_PRP can_MD walk_VB into_IN a_DT room_NN full_JJ of_IN sick_JJ people_NNS infected_VBN with_IN influenza_NN and_CC be_VB completely_RB and_CC utterly_RB immune_JJ to_IN their_PRP$ coughing_NN ,_, sneezing_NN ,_, nose_NN wiping_NN and_CC finger_NN -_HYPH licking_VBG handshaking_NN ._. Having_VBG vitamin_NN D_NN in_IN your_PRP$ body_NN is_VBZ like_IN wearing_VBG a_DT bulletproof_JJ vest_NN for_IN influenza_NN ._. The_DT medical_JJ industry_NN wo_MD n’t_RB tell_VB you_PRP this_DT because_IN there_EX ’s_VBZ huge_JJ profit_NN to_TO be_VB made_VBN in_IN scaring_VBG people_NNS into_IN paying_VBG for_IN flu_NN shots_NNS they_PRP do_VBP n’t_RB need_VB ._. If_IN people_NNS were_VBD told_VBN the_DT truth_NN about_IN the_DT dangers_NNS and_CC the_DT ineffectiveness_NN of_IN flu_NN shots_NNS ,_, very_RB few_JJ would_MD buy_VB them_PRP ._. Because_IN the_DT truth_NN is_VBZ that_IN ,_, even_RB in_IN best_JJS -_HYPH case_NN scenarios_NNS ,_, flu_NN shots_NNS are_VBP maybe_RB effective_JJ at_IN preventing_VBG infections_NNS in_IN one_CD percent_NN of_IN those_DT who_WP take_VBP them_PRP ._. And_CC that_DT means_VBZ ninety_CD -_HYPH nine_CD percent_NN of_IN those_DT receiving_VBG flu_NN shots_NNS are_VBP wasting_VBG their_PRP$ time_NN and_CC their_PRP$ money_NN ._. Plus_CC ,_, they_PRP ’re_VBP exposing_VBG themselves_PRP to_IN chemicals_NNS that_WDT are_VBP obviously_RB dangerous_JJ to_IN the_DT human_JJ body_NN or_CC else_RB they_PRP would_MD n’t_RB cause_VB seizures_NNS in_IN children_NNS ,_, get_VB it_PRP ?_. And_CC yet_CC every_DT flu_NN season_NN ,_, people_NNS line_VBP up_RP by_IN the_DT millions_NNS to_TO get_VB injected_VBN with_IN something_NN that_WDT might_MD harm_VB them_PRP ,_, and_CC they_PRP actually_RB pay_VBP for_IN being_VBG potentially_RB harmed_VBN !_. Why_WRB do_VBP people_NNS do_VB this_DT ?_. Because_IN they_PRP foolishly_RB trust_VBP in_IN health_NN authorities_NNS who_WP almost_RB universally_RB have_VBP financial_JJ ties_NNS to_IN the_DT vaccine_NN manufacturing_NN companies_NNS and_CC so_RB are_VBP pushing_VBG a_DT particular_JJ agenda_NN in_IN order_NN to_TO profit_VB from_IN vaccine_NN sales_NNS ._. But_CC scientifically_RB speaking_VBG ,_, the_DT flu_NN season_NN could_MD be_VB stopped_VBN in_IN its_PRP$ tracks_NNS by_IN handing_VBG out_RP vitamin_NN D3_NN supplements_NNS instead_RB of_IN vaccine_NN injections_NNS ._. No_DT needles_NNS ._. No_DT seizures_NNS ._. And_CC no_DT drug_NN company_NN profits_NNS ._. I_PRP do_VBP n’t_RB know_VB about_IN you_PRP ,_, but_CC I_PRP ’d_MD rather_RB swallow_VB a_DT vitamin_NN than_IN get_VB jabbed_VBN with_IN a_DT sharp_JJ needle_NN ._. But_CC that_DT ’s_VBZ just_RB me_PRP ._. Most_JJS other_JJ people_NNS ,_, it_PRP seems_VBZ ,_, would_MD rather_RB spend_VB their_PRP$ winters_NNS wiping_VBG their_PRP$ noses_NNS raw_RB with_IN Kleenex_NNP ,_, drowning_VBG themselves_PRP in_IN over_IN -_HYPH the_DT -_HYPH counter_NN flu_NN medicines_NNS and_CC missing_VBG a_DT week_NN or_CC two_CD of_IN work_NN while_IN they_PRP try_VBP to_TO fight_VB off_RP a_DT flu_NN infection_NN they_PRP could_MD have_VB prevented_VBN with_IN a_DT few_JJ vitamin_NN D_NN supplements_NNS in_IN the_DT first_JJ place_NN ._. Believe_VB me_PRP ,_, it_PRP ’s_VBZ a_DT lot_NN more_JJR fun_NN to_TO laugh_VB off_RP the_DT flu_NN season_NN and_CC spend_VB your_PRP$ winters_NNS healthy_JJ ,_, well_RB rested_VBN and_CC completely_RB immune_JJ to_IN seasonal_JJ flu_NN ._. Wanna_UH join_VB me_PRP in_IN a_DT healthy_JJ winter_NN this_DT year_NN ?_. Just_RB boost_VB your_PRP$ vitamin_NN D_NN levels_NNS and_CC you_PRP too_RB can_MD laugh_VB off_RP seasonal_JJ flu_NN and_CC all_PDT the_DT sheeple_NN lining_VBG up_RP to_TO get_VB injected_VBN like_IN cattle_NNS in_IN a_DT branding_NN line_NN ._. This_DT article_NN was_VBD posted_VBN :_: Sunday_NNP ,_, August_NNP 1_CD ,_, 2010_CD at_IN 3:53_CD am_NN","NN NN NN RB JJ ; JJ NN VBZ NNS in NNS RB JJ as it VBZ , NNS across the NNP VBP RB VBG their NNS with NNP NNS . It VBZ RB about the JJ JJ NN , of NN , since NNS VBP RB 50 NN of their NNS during the NNP NN . RB , NN NN NNS VBP JJ NNS during the NNP NN , RB , and they VBP RB VBN VBG this NN ’s NN NN NN NNS to NNP NNS and NNS . RB VB the NN that the JJ NN NN in the NN VBZ RB JJR than a NN NN of JJ NN ’s NN NNS . Each NN ’s NN NNS VBP RB RB JJ to JJ NN ’s NN NN , VBG them JJ for NN NNS but JJ for NN JJ . Along with the JJ NN NN VBZ the JJ NN NN . It VBZ RB RB JJ : RB there VBZ the NN that “ NN should VB VBN . ” This VBZ VBN by some JJR NN in the NN NN of “ how JJ ” this NN ’s NN NN VBZ VBG . This VBZ VBN RB RB by another JJ NN by NN NNS VBG NN to VB VBN . The JJ NN VB RB VBZ down when NN NNS VBP . But RB RB as NNS VBP in NN , the JJ NN NN will VB JJ , and during this JJ NN , there wo RB VB a NN VBN about NN NN and how it VBZ RB RBR JJ than any NN at VBG NNS from JJ NN . This NN ’s NN NN VBZ VBN with some JJ NNS by the NN NN , VBN in a NNP NN ( http://www.reuters.com/article/idUS…). After the JJ JJ NN about how NN NN NNS VBP VBN VBG their JJS NN of NNS RB VBN for NN NN , the NN VBZ this JJ NN : “ And NNP NNS VBD they VBD VBG the NN on a NN VBN by NNP ’s NNP NNP ( NNP . NNP ) because it VBZ to VB VBN a JJR than JJ NN of NNS in NNS . ” RB VB on a NN . If you VBP between the NNS RB , this NN VBZ that : 1 ) NNS VBP NNS in NNS . And RB 2 ) This JJ NNS VBZ a JJR NN of NNS in NNS than the JJ NN of NNS in NNS . Why VBZ this JJ ? RB off , because NN NNS VBP RB VBN their NNS VBN no NNS RB . No JJ NNS . No JJ NNS in JJ NNS . No VBN NNS of NN . NNS VBP RB RB JJ , they VBP , and no NNS VBP RB VBN by them . That VBZ the NN , at JJS , behind NNS . But the NN VBZ RB JJ : NNS VBP VB NNS in NNS , and this NN ’s NNS VBP like they VBP VBG to VB a RB JJR NN of NNS than JJ . VB , by the NN , that this VBD RB the NN of the NN . This NN VBD VBN RB in the NN of a NNP NN , without any JJ NN . If NNP VBD RB JJ in VBG the NN about NNS , the NN NN would VB VBN , “ NN NNS VBP NNS in NNS . ” The NN VBZ on to VB , “ The NNP NNPS for NNP NNP and NNP VBZ that NN VB VBN against JJ NN this NN . ” Yep , NN . That VBZ one - NN JJ NNS . JJ NNS . NNS with NN NNS . NN VBN NNS . NN ! You VBP , in NNS NN , NNS VBD RB VBN for NN due to RB - VBN NN NNS . In some NNS , you VBP , the RB - JJ JJ NNS VBN in NNS can RB VB the JJ NN they VBP to VB . RB the NNP VBZ , for RB RB as NN can VB , RB VBD JJ NNS to VB VBN from NNS for their JJ NN . Well RB RB . Any NN NNS VBP VBN VBN out the NN in the NN to VB JJR NNS onto JJR NNS . NNS of NNS in JJ NNS VBP at NN RB , and NN NNS can’t VB to VB a JJ NN VB in the NN . “ JJS NNS , JJ NN VBZ between 5 NN and 20 NN of the NNP NN and VBZ 36,000 NNS . It VBZ RB 200,000 into the NN . ” Well , RB RB . The 36,000 NN RB VBN from the NNP VBZ RB JJ ( http://www.naturalnews.com/026169 It VBZ a JJ NN VBN on JJ JJ NNS that to VB it as NN VBZ JJ . RB , it VBZ RB JJ to VB that NN VBZ NN . The JJ NN RB VBZ NN NN NN which VBZ a VBN out NN NN . If NNS VBD JJ NNS of NN NN VBG in their NN , the NN NN would VB JJ to VB them . And since there VBP NNS RB in the NN around us every JJ NN , VBZ RB it RBR JJ to VB that the “ NN NN ” VBZ RB the “ NN NN NN NN ? ” VB about it : Why VBZ the NN VB in the NN NNS in NNP NNP , but the NN NNS ( NNP – NNP ) in NNP ? It VBZ because those VBP the NNS of JJR NN NN VBG in JJ NN NN NNS . The NN VBZ RB RB , VBG amongst us , RB VBG for VBN NN NNS so it can VB . To VB that “ the NN ” VBZ NNS in the NN VBZ RB JJ . It VBZ the NN NN NN that VBZ NNS by VBG the NN an NN to VB a VBN JJ NN . This VBZ a JJ JJ NN that the JJ NN of JJ NN , with all its JJ - NN NNS , VBZ RB RB VBN to VB . RB it VBZ like we VBP RB VBG in the NNP NNPS of NN , I VBP … Where VBP the JJ NNS ? Anyway , this NNP NN VBZ with one JJR NN of a NN : “ The NN for one NN , NNP NNP ’s NNP , VBZ VBN NNS this NN to VB NN NN NNS about an VBN NN of NN and JJ NN … The NNP VBD it VBD VBG NNP to VB a NN of its NN in NNS . ” VB between the NNS on this NN : This NNP NN VBZ an VBN NN of NNS , it VBZ VBG VBN into the NNP to VB VBN in NNS this NN NN , and the NNP VBZ RB RB VBG for a NN ? That VBZ , of NN , that no NN VBZ VBN VBN on this NN RB . In JJ NNS , this NN which VBZ NNS in NNS VBZ RB RB VBN RB VBN in NNS VBG to NNP NNS , so the NNP VBZ a NN to VB VBN but the NN will VB VBN into NNS in the NNP RB , RB before the NN VBZ JJ to VB VBN . And that VBZ , of NN , that NNP NNS VBP VBG VBN as NN NNS to VB what VBZ to them VBG this NN NN . If JJ NNS VBP NNS or VBP up VBN or JJ , the NNP will RB VB the NN off the NN . But that RB VBZ after the NN and after the NN VBZ RB VBN VBN . VBP RB you VB it ? Your NNS VBP the NN ! The NNP NNPS VBP the NN NNS for every NN these NNS VBP up with , and it VBZ RB VB if the NN VBZ NNS , NN NN or RB NN … JJ NNS VBP VBG to VB VBN by the NNS in NN to VB out what VBZ . No NN for NN NNS in NN This JJ JJ NN VBZ RB JJ to VB with . There VBZ RB RB RB JJ NN to VB NN with a NN NN — RB ! What NNS VBP VBZ NN NN to VB their JJ NN so that JJ NNS to JJ NN VBP RB VBN by their VBG JJ NN NN . VB ’s VB it : The JJ NN NN VBZ RB RBR JJ and RB JJ than any NN NN . It RB VBZ a NN NN NN that can VB and VB JJ NNS in the NN . But as NN VBZ VBN , when NN NN NNS VBP JJ in the NN , the NN NN VBZ RB VBN and ca RB VB . ( http://www.naturalnews.com/029312 When NN NN NNS VBP JJ , the NN NN VBZ RB to any NN NN . That VBZ why I RB VBP a NN NN and RB RB , I VBP RB VBN JJ for NNS . I VBP , RB , VB NN on a JJ NN , and when I ca RB VB NN , I VBP a JJ NN NN NN . And VB what ? I VBP RB VB a NN NN at all . I can VB into a NN JJ of JJ NNS VBN with NN and VB RB and RB JJ to their NN , NN , NN NN and NN - VBG NN . VBG NN NN in your NN VBZ like VBG a JJ NN for NN . The JJ NN wo RB VB you this because there VBZ JJ NN to VB VBN in VBG NNS into VBG for NN NNS they VBP RB VB . If NNS VBD VBN the NN about the NNS and the NN of NN NNS , RB JJ would VB them . Because the NN VBZ that , RB in JJS - NN NNS , NN NNS VBP RB JJ at VBG NNS in one NN of those who VBP them . And that VBZ ninety - nine NN of those VBG NN NNS VBP VBG their NN and their NN . Plus , they VBP VBG themselves to NNS that VBP RB JJ to the JJ NN or RB they would RB VB NNS in NNS , VB it ? And yet every NN NN , NNS VBP up by the NNS to VB VBN with NN that might VB them , and they RB VBP for VBG RB VBN ! Why VBP NNS VB this ? Because they RB VBP in NN NNS who RB RB VBP JJ NNS to the NN NN NNS and RB VBP VBG a JJ NN in NN to VB from NN NNS . But RB VBG , the NN NN could VB VBN in its NNS by VBG out NN NN NNS RB of NN NNS . No NNS . No NNS . And no NN NN NNS . I VBP RB VB about you , but I ’d RB VB a NN than VB VBN with a JJ NN . But that VBZ RB me . JJS JJ NNS , it VBZ , would RB VB their NNS VBG their NNS RB with NNP , VBG themselves in over - the - NN NN NNS and VBG a NN or two of NN while they VBP to VB off a NN NN they could VB VBN with a JJ NN NN NNS in the JJ NN . VB me , it VBZ a NN JJR NN to VB off the NN NN and VB your NNS JJ , RB VBN and RB JJ to JJ NN . Wanna VB me in a JJ NN this NN ? RB VB your NN NN NNS and you RB can VB off JJ NN and all the NN VBG up to VB VBN like NNS in a NN NN . This NN VBD VBN : NNP , NNP 1 , 2010 at 3:53 NN"
19,846,mainstream,"At_IN the_DT end_NN of_IN the_DT decades_NNS -_HYPH long_JJ global_JJ battle_NN to_TO eradicate_VB polio_NN from_IN the_DT planet_NN ,_, there_EX is_VBZ what_WP looks_VBZ like_IN a_DT simple_JJ goal_NN :_: Render_VB every_DT person_NN immune_JJ ,_, by_IN vaccination_NN ,_, for_IN long_RB enough_RB that_IN the_DT disease_NN can_MD find_VB no_DT host_NN in_IN which_WDT to_TO breed_VB ,_, and_CC thus_RB dies_VBZ out_RP ._. That_DT was_VBD the_DT strategy_NN behind_IN the_DT eradication_NN of_IN smallpox_NN ,_, and_CC since_IN polio_NN like_IN smallpox_NN affects_VBZ only_RB humans_NNS ,_, it_PRP is_VBZ supposed_VBN to_TO work_VB for_IN that_DT disease_NN too_RB ._. Of_IN course_NN ,_, it_PRP ’s_VBZ a_DT little_JJ more_RBR complicated_JJ ,_, and_CC a_DT paper_NN published_VBN last_JJ week_NN reveals_VBZ one_CD of_IN the_DT most_RBS challenging_JJ complications_NNS ._. It_PRP describes_VBZ a_DT British_JJ man_NN of_IN about_RB 30_CD who_WP ,_, as_IN a_DT toddler_NN ,_, was_VBD given_VBN the_DT full_JJ course_NN of_IN polio_NN vaccines_NNS in_IN use_NN at_IN the_DT time_NN —_: and_CC who_WP ,_, for_IN 28_CD years_NNS ,_, has_VBZ been_VBN harboring_VBG mutated_VBN ,_, virulent_JJ poliovirus_NN in_IN his_PRP$ guts_NNS and_CC shedding_VBG them_PRP in_IN his_PRP$ feces_NNS ._. The_DT researchers_NNS who_WP wrote_VBD about_IN him_PRP call_VB him_PRP ,_, and_CC other_JJ patients_NNS like_IN him_PRP ,_, “_`` an_DT obvious_JJ risk_NN to_IN the_DT eradication_NN program_NN ._. ”_'' Long_JJ -_HYPH term_NN shedders_NNS of_IN poliovirus_NN have_VBP been_VBN identified_VBN before_RB ._. It_PRP ’s_VBZ a_DT rare_JJ phenomenon_NN ,_, and_CC for_IN it_PRP to_TO occur_VB ,_, several_JJ things_NNS have_VBP to_TO happen_VB :_: Someone_NN has_VBZ to_TO be_VB vaccinated_VBN as_IN an_DT infant_NN with_IN the_DT oral_JJ polio_NN vaccine_NN ,_, which_WDT contains_VBZ a_DT weakened_VBN live_JJ virus_NN ;_, has_VBZ to_TO have_VB an_DT immune_JJ -_HYPH system_NN deficiency_NN that_WDT keeps_VBZ the_DT body_NN from_IN eliminating_VBG the_DT vaccine_NN virus_NN after_IN immunity_NN develops_VBZ ;_, and_CC ,_, usually_RB ,_, has_VBZ to_TO live_VB in_IN an_DT industrialized_JJ country_NN where_WRB medical_JJ care_NN is_VBZ good_JJ enough_RB to_TO keep_VB children_NNS with_IN immune_NN -_HYPH system_NN deficiencies_NNS alive_JJ ._. That_DT has_VBZ happened_VBN a_DT number_NN of_IN times_NNS —_: more_JJR than_IN 70_CD —_: since_IN polio_NN vaccination_NN began_VBD in_IN the_DT 1950s_NNS ,_, but_CC only_RB a_DT few_JJ people_NNS shed_VBP virus_NN long_RB enough_RB to_TO make_VB public_JJ health_NN planners_NNS concerned_JJ ._. This_DT man_NN is_VBZ the_DT longest_JJS -_HYPH duration_NN shedder_NN known_VBN ,_, but_CC he_PRP may_MD not_RB be_VB the_DT only_JJ one_NN ._. Sampling_NN programs_NNS that_WDT look_VBP for_IN live_JJ poliovirus_NN in_IN sewage_NN have_VBP identified_VBN mutated_VBN vaccine_NN viruses_NNS in_IN Finland_NNP ,_, Israel_NNP and_CC eastern_JJ Europe_NNP ,_, indicating_VBG other_JJ ,_, unidentified_JJ shedders_NNS may_MD be_VB out_RB there_RB too_RB ._. A_DT little_JJ refresher_NN on_IN polio_NN vaccines_NNS :_: There_EX are_VBP two_CD ,_, the_DT original_JJ injectable_NN that_WDT uses_VBZ killed_VBN virus_NN (_-LRB- Jonas_NNP Salk_NNP ’s_POS original_JJ vaccine_NN )_-RRB- and_CC the_DT oral_JJ drop_NN version_NN that_WDT contains_VBZ a_DT weakened_VBN live_JJ virus_NN (_-LRB- Albert_NNP Sabin_NNP ’s_POS formula_NN )_-RRB- ._. The_DT oral_JJ vaccine_NN was_VBD the_DT first_JJ one_NN used_VBN in_IN the_DT international_JJ eradication_NN campaign_NN ,_, because_IN it_PRP is_VBZ inexpensive_JJ to_TO make_VB and_CC can_MD be_VB administered_VBN by_IN anyone_NN ._. It_PRP is_VBZ still_RB used_VBN in_IN the_DT developing_VBG world_NN ,_, though_IN industrialized_VBN countries_NNS have_VBP gone_VBN back_RB to_IN the_DT original_JJ injectable_JJ ._. For_IN all_PDT its_PRP$ benefits_NNS ,_, the_DT oral_JJ version_NN has_VBZ a_DT known_VBN issue_NN ,_, a_DT combination_NN of_IN bug_NN and_CC feature_NN ._. Once_IN it_PRP is_VBZ given_VBN ,_, the_DT vaccine_NN virus_NN replicates_VBZ in_IN the_DT gut_NN ._. The_DT feature_NN part_NN is_VBZ that_IN ,_, when_WRB the_DT vaccine_NN virus_NN passes_VBZ out_IN of_IN the_DT body_NN ,_, it_PRP can_MD spread_VB through_IN the_DT environment_NN of_IN places_NNS with_IN poor_JJ sanitation_NN ,_, conferring_VBG a_DT kind_NN of_IN passive_JJ secondary_JJ immunization_NN on_IN others_NNS nearby_RB ._. The_DT bug_NN part_NN is_VBZ that_IN ,_, in_IN the_DT few_JJ weeks_NNS it_PRP is_VBZ replicating_VBG ,_, the_DT vaccine_NN virus_NN mutates_VBZ ,_, and_CC sometimes_RB mutates_VBZ back_RB past_IN the_DT artificial_JJ weakening_NN to_IN the_DT original_JJ disease_NN -_HYPH causing_VBG form_NN ._. If_IN that_DT reversion_NN happens_VBZ to_IN someone_NN who_WP lives_VBZ in_IN an_DT area_NN where_WRB vaccination_NN has_VBZ been_VBN patchy_JJ ,_, an_DT outbreak_NN of_IN “_`` vaccine_NN -_HYPH derived_VBN ”_'' polio_NN can_MD spark_VB —_: and_CC has_VBZ ,_, dozens_NNS of_IN times_NNS since_IN the_DT campaign_NN began_VBD ._. It_PRP ’s_VBZ happening_VBG right_RB now_RB in_IN Ukraine_NNP ,_, in_IN fact_NN ,_, and_CC the_DT World_NNP Health_NNP Organization_NNP is_VBZ negotiating_VBG with_IN the_DT country_NN to_TO begin_VB vaccinations_NNS ._. (_-LRB- There_EX ’s_VBZ an_DT update_NN on_IN the_DT index_NN page_NN of_IN the_DT eradication_NN campaign_NN ’s_POS site_NN ,_, but_CC frustratingly_RB it_PRP ’s_VBZ part_NN of_IN a_DT slideshow_NN with_IN no_DT static_JJ link_NN ._. )_-RRB- But_CC those_DT outbreaks_NNS have_VBP always_RB been_VBN easy_JJ to_TO detect_VB ,_, and_CC quenched_VBN by_IN improved_VBN vaccination_NN ._. However_RB ,_, if_IN the_DT reversion_NN happens_VBZ in_IN someone_NN who_WP also_RB has_VBZ an_DT immune_JJ disorder_NN ,_, that_DT person_NN becomes_VBZ a_DT source_NN of_IN infectious_JJ virus_NN that_WDT mutates_VBZ continually_RB not_RB for_IN weeks_NNS ,_, but_CC for_IN years_NNS ._. And_CC because_IN the_DT person_NN is_VBZ probably_RB surrounded_VBN by_IN other_JJ vaccinated_VBN individuals_NNS ,_, there_EX is_VBZ no_DT obvious_JJ outbreak_NN to_TO help_VB pinpoint_VB the_DT problem_NN —_: just_RB a_DT slow_JJ leak_NN of_IN live_JJ virus_NN that_WDT could_MD sicken_VB an_DT unvaccinated_JJ infant_NN ,_, a_DT vaccine_NN refuser_NN ,_, or_CC a_DT vulnerable_JJ immune_JJ -_HYPH compromised_VBN adult_NN somewhere_RB else_RB ._. The_DT British_JJ man_NN ’s_POS problem_NN has_VBZ been_VBN known_VBN since_IN he_PRP was_VBD a_DT child_NN —_: he_PRP was_VBD first_RB tested_VBN in_IN 1995_CD ,_, when_WRB one_CD of_IN this_DT paper_NN ’s_POS authors_NNS was_VBD studying_VBG the_DT immune_JJ condition_NN he_PRP suffers_VBZ from_IN —_: and_CC numerous_JJ attempts_NNS have_VBP been_VBN made_VBN to_TO chase_VB polio_NN from_IN his_PRP$ system_NN ._. None_NN have_VBP worked_VBN ._. Extensive_JJ analysis_NN of_IN the_DT virus_NN he_PRP carries_VBZ shows_VBZ that_IN it_PRP is_VBZ virulent_JJ ,_, paralyzing_VBG lab_NN mice_NNS ;_, but_CC also_RB that_IN the_DT vaccines_NNS currently_RB in_IN use_NN protect_VBP against_IN it_PRP ._. However_RB ._. Poliovirus_NN comes_VBZ in_IN three_CD flavors_NNS ,_, strains_NNS known_VBN for_IN simplicity_NN as_IN type_NN 1_CD ,_, 2_CD and_CC 3_CD ._. The_DT vaccines_NNS used_VBN so_RB far_RB in_IN the_DT campaign_NN have_VBP included_VBN all_DT three_CD strains_NNS ,_, but_CC there_EX are_VBP plans_NNS to_TO reduce_VB the_DT formula_NN to_IN types_NNS 1_CD and_CC 3_CD because_IN type_NN 2_CD has_VBZ disappeared_VBN from_IN the_DT wild_NN ._. The_DT British_JJ man_NN ’s_POS strain_NN ,_, however_RB ,_, is_VBZ type_NN 2_CD ,_, preserved_VBN in_IN his_PRP$ system_NN even_RB as_IN it_PRP was_VBD forced_VBN into_IN extinction_NN elsewhere_RB ._. Could_MD he_PRP ,_, or_CC an_DT unlucky_JJ person_NN like_IN him_PRP ,_, re-ignite_VB an_DT epidemic_NN ?_. If_IN the_DT world_NN switched_VBD from_IN the_DT oral_JJ vaccine_NN to_IN the_DT injectable_JJ ,_, which_WDT the_DT international_JJ eradication_NN campaign_NN is_VBZ planning_VBG for_IN ,_, the_DT risk_NN of_IN random_JJ outbreaks_NNS from_IN mutated_VBN virus_NN would_MD go_VB away_RB ._. The_DT risk_NN of_IN existing_VBG shedders_NNS continuing_VBG to_TO pump_VB out_RP virus_NN would_MD not_RB —_: not_RB unless_IN vaccination_NN continued_VBD indefinitely_RB ._. The_DT entire_JJ goal_NN of_IN the_DT campaign_NN ,_, though_RB ,_, is_VBZ to_TO vaccinate_VB the_DT world_NN until_IN polio_NN is_VBZ eradicated_VBN ,_, and_CC then_RB stop_VB ._. Despite_IN years_NNS of_IN fretting_NN ,_, no_DT one_NN has_VBZ yet_RB proposed_VBN a_DT solution_NN to_IN the_DT problem_NN of_IN shedders_NNS that_WDT accounts_VBZ for_IN all_PDT the_DT complexities_NNS :_: the_DT difficulty_NN of_IN finding_VBG them_PRP ,_, the_DT necessity_NN of_IN respecting_VBG their_PRP$ rights_NNS if_IN found_VBN ,_, the_DT huge_JJ sunk_VBN cost_NN of_IN polio_NN eradication_NN that_WDT makes_VBZ it_PRP hard_JJ to_TO change_VB course_NN ,_, and_CC the_DT difficult_JJ sell_NN of_IN achieving_VBG novel_JJ vaccines_NNS that_WDT could_MD solve_VB the_DT problem_NN but_CC would_MD be_VB useful_JJ only_RB a_DT few_JJ years_NNS afterward_RB ._. The_DT authors_NNS who_WP wrote_VBD up_RP the_DT man_NN ’s_POS plight_NN ,_, though_RB ,_, warn_VBP that_IN it_PRP is_VBZ definitely_RB time_NN to_TO begin_VB strategizing_VBG ._. “_`` [_-LRB- Vaccine_NN -_HYPH derived_VBN polio_NN ]_-RRB- from_IN these_DT patients_NNS ,_, ”_'' they_PRP say_VBP ,_, “_`` represent_VBP a_DT real_JJ risk_NN of_IN polio_NN re-emergence_NN in_IN the_DT post-_JJ eradication_NN era_NN ._. ”_''","At the NN of the NNS - JJ JJ NN to VB NN from the NN , there VBZ what VBZ like a JJ NN : VB every NN JJ , by NN , for RB RB that the NN can VB no NN in which to VB , and RB VBZ out . That VBD the NN behind the NN of NN , and since NN like NN VBZ RB NNS , it VBZ VBN to VB for that NN RB . Of NN , it VBZ a JJ RBR JJ , and a NN VBN JJ NN VBZ one of the RBS JJ NNS . It VBZ a JJ NN of RB 30 who , as a NN , VBD VBN the JJ NN of NN NNS in NN at the NN — and who , for 28 NNS , VBZ VBN VBG VBN , JJ NN in his NNS and VBG them in his NNS . The NNS who VBD about him VB him , and JJ NNS like him , “ an JJ NN to the NN NN . ” JJ - NN NNS of NN VBP VBN VBN RB . It VBZ a JJ NN , and for it to VB , JJ NNS VBP to VB : NN VBZ to VB VBN as an NN with the JJ NN NN , which VBZ a VBN JJ NN ; VBZ to VB an JJ - NN NN that VBZ the NN from VBG the NN NN after NN VBZ ; and , RB , VBZ to VB in an JJ NN where JJ NN VBZ JJ RB to VB NNS with NN - NN NNS JJ . That VBZ VBN a NN of NNS — JJR than 70 — since NN NN VBD in the NNS , but RB a JJ NNS VBP NN RB RB to VB JJ NN NNS JJ . This NN VBZ the JJS - NN NN VBN , but he may RB VB the JJ NN . NN NNS that VBP for JJ NN in NN VBP VBN VBN NN NNS in NNP , NNP and JJ NNP , VBG JJ , JJ NNS may VB RB RB RB . A JJ NN on NN NNS : There VBP two , the JJ NN that VBZ VBN NN ( NNP NNP ’s JJ NN ) and the JJ NN NN that VBZ a VBN JJ NN ( NNP NNP ’s NN ) . The JJ NN VBD the JJ NN VBN in the JJ NN NN , because it VBZ JJ to VB and can VB VBN by NN . It VBZ RB VBN in the VBG NN , though VBN NNS VBP VBN RB to the JJ JJ . For all its NNS , the JJ NN VBZ a VBN NN , a NN of NN and NN . Once it VBZ VBN , the NN NN VBZ in the NN . The NN NN VBZ that , when the NN NN VBZ out of the NN , it can VB through the NN of NNS with JJ NN , VBG a NN of JJ JJ NN on NNS RB . The NN NN VBZ that , in the JJ NNS it VBZ VBG , the NN NN VBZ , and RB VBZ RB past the JJ NN to the JJ NN - VBG NN . If that NN VBZ to NN who VBZ in an NN where NN VBZ VBN JJ , an NN of “ NN - VBN ” NN can VB — and VBZ , NNS of NNS since the NN VBD . It VBZ VBG RB RB in NNP , in NN , and the NNP NNP NNP VBZ VBG with the NN to VB NNS . ( There VBZ an NN on the NN NN of the NN NN ’s NN , but RB it VBZ NN of a NN with no JJ NN . ) But those NNS VBP RB VBN JJ to VB , and VBN by VBN NN . RB , if the NN VBZ in NN who RB VBZ an JJ NN , that NN VBZ a NN of JJ NN that VBZ RB RB for NNS , but for NNS . And because the NN VBZ RB VBN by JJ VBN NNS , there VBZ no JJ NN to VB VB the NN — RB a JJ NN of JJ NN that could VB an JJ NN , a NN NN , or a JJ JJ - VBN NN RB RB . The JJ NN ’s NN VBZ VBN VBN since he VBD a NN — he VBD RB VBN in 1995 , when one of this NN ’s NNS VBD VBG the JJ NN he VBZ from — and JJ NNS VBP VBN VBN to VB NN from his NN . NN VBP VBN . JJ NN of the NN he VBZ VBZ that it VBZ JJ , VBG NN NNS ; but RB that the NNS RB in NN VBP against it . RB . NN VBZ in three NNS , NNS VBN for NN as NN 1 , 2 and 3 . The NNS VBN RB RB in the NN VBP VBN all three NNS , but there VBP NNS to VB the NN to NNS 1 and 3 because NN 2 VBZ VBN from the NN . The JJ NN ’s NN , RB , VBZ NN 2 , VBN in his NN RB as it VBD VBN into NN RB . Could he , or an JJ NN like him , VB an NN ? If the NN VBD from the JJ NN to the JJ , which the JJ NN NN VBZ VBG for , the NN of JJ NNS from VBN NN would VB RB . The NN of VBG NNS VBG to VB out NN would RB — RB unless NN VBD RB . The JJ NN of the NN , RB , VBZ to VB the NN until NN VBZ VBN , and RB VB . Despite NNS of NN , no NN VBZ RB VBN a NN to the NN of NNS that VBZ for all the NNS : the NN of VBG them , the NN of VBG their NNS if VBN , the JJ VBN NN of NN NN that VBZ it JJ to VB NN , and the JJ NN of VBG JJ NNS that could VB the NN but would VB JJ RB a JJ NNS RB . The NNS who VBD up the NN ’s NN , RB , VBP that it VBZ RB NN to VB VBG . “ [ NN - VBN NN ] from these NNS , ” they VBP , “ VBP a JJ NN of NN NN in the JJ NN NN . ”"
20,230,mainstream,"(_-LRB- CNN_NNP )_-RRB- -_, The_DT measles_NNS ,_, mumps_NNS ,_, and_CC rubella_NN vaccine_NN does_VBZ not_RB increase_VB the_DT risk_NN of_IN autism_NN and_CC does_VBZ not_RB trigger_VB autism_NN in_IN children_NNS who_WP are_VBP at_IN risk_NN ,_, according_VBG to_IN a_DT new_JJ study_NN of_IN over_RB 650,000_CD children_NNS ._. Researchers_NNS used_VBD a_DT population_NN registry_NN to_TO evaluate_VB whether_IN the_DT MMR_NNP vaccine_NN increased_VBD the_DT risk_NN of_IN autism_NN in_IN children_NNS born_VBN in_IN Denmark_NNP between_IN 1999_CD and_CC 2010_CD ._. A_DT total_NN of_IN 657,461_CD children_NNS were_VBD followed_VBN through_IN August_NNP 2013_CD ,_, with_IN the_DT researchers_NNS documenting_VBG diagnoses_NNS of_IN autism_NN spectrum_NN disorder_NN as_RB well_RB as_IN known_VBN risk_NN factors_NNS including_VBG age_NN of_IN the_DT parents_NNS ,_, diagnosis_NN of_IN autism_NN in_IN a_DT sibling_NN ,_, preterm_NN birth_NN and_CC low_JJ weight_NN at_IN birth_NN ._. Over_RB 95_CD %_NN of_IN the_DT children_NNS received_VBD the_DT MMR_NN vaccine_NN ,_, and_CC 6,517_CD were_VBD diagnosed_VBN with_IN autism_NN ._. The_DT MMR_NNP vaccine_NN did_VBD not_RB increase_VB the_DT risk_NN of_IN autism_NN in_IN children_NNS who_WP were_VBD not_RB considered_VBN at_IN risk_NN for_IN the_DT disorder_NN and_CC did_VBD not_RB trigger_VB it_PRP in_IN those_DT who_WP were_VBD ,_, according_VBG to_IN the_DT study_NN ,_, published_VBN Monday_NNP in_IN the_DT journal_NNP Annals_NNP of_IN Internal_NNP Medicine_NNP ._. ""_`` This_DT idea_NN that_IN vaccines_NNS cause_VBP autism_NN is_VBZ still_RB around_RB and_CC is_VBZ still_RB getting_VBG a_DT lot_NN of_IN exposure_NN in_IN social_JJ media_NN ,_, ""_'' noted_VBD Anders_NNP Hviid_NNP ,_, lead_JJ study_NN author_NN and_CC senior_JJ investigator_NN at_IN Statens_NNP Serum_NNP Institut_NNP in_IN Denmark_NNP ._. With_IN anti-vaccine_JJ groups_NNS becoming_VBG more_RBR vocal_JJ and_CC even_RB celebrities_NNS and_CC politicians_NNS spreading_VBG fear_NN of_IN vaccines_NNS ,_, Hviid_NNP and_CC his_PRP$ team_NN wanted_VBD to_TO provide_VB solid_JJ scientific_JJ answers_NNS ._. The_DT biggest_JJS contribution_NN of_IN the_DT study_NN was_VBD the_DT inclusion_NN of_IN children_NNS at_IN risk_NN of_IN autism_NN ,_, said_VBD Dr._NNP Paul_NNP Offit_NNP ,_, director_NN of_IN the_DT Vaccine_NNP Education_NNP Center_NNP at_IN Children_NNP 's_POS Hospital_NNP of_IN Philadelphia_NNP ,_, who_WP was_VBD not_RB involved_VBN in_IN the_DT new_JJ research_NN ._. He_PRP hopes_VBZ the_DT latest_JJS piece_NN of_IN evidence_NN will_MD reassure_VB families_NNS with_IN young_JJ children_NNS at_IN risk_NN of_IN developing_VBG autism_NN spectrum_NN disorder_NN that_WDT the_DT vaccine_NN will_MD not_RB increase_VB that_DT risk_NN ._. The_DT myth_NN linking_VBG vaccines_NNS and_CC autism_NN grew_VBD out_IN of_IN a_DT 1998_CD study_NN by_IN Andrew_NNP Wakefield_NNP ,_, published_VBN in_IN the_DT medical_JJ journal_NN The_DT Lancet_NNP ._. Wakefield_NNP had_VBD been_VBN compensated_VBN by_IN a_DT law_NN firm_NN intending_VBG to_TO sue_VB manufacturers_NNS of_IN the_DT MMR_NNP vaccine_NN ,_, and_CC in_IN 2010_CD ,_, he_PRP lost_VBD his_PRP$ medical_JJ license_NN ._. In_IN 2011_CD ,_, The_DT Lancet_NNP retracted_VBD the_DT study_NN after_IN an_DT investigation_NN found_VBD that_IN Wakefield_NNP altered_VBD or_CC misrepresented_VBD information_NN on_IN the_DT 12_CD children_NNS who_WP were_VBD the_DT basis_NN for_IN the_DT conclusion_NN of_IN his_PRP$ study_NN ._. Several_JJ subsequent_JJ studies_NNS trying_VBG to_TO reproduce_VB the_DT results_NNS have_VBP found_VBN no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ._. ""_`` At_IN this_DT point_NN ,_, you_PRP 've_VBP had_VBN 17_CD previous_JJ studies_NNS done_VBN in_IN seven_CD countries_NNS ,_, three_CD different_JJ continents_NNS ,_, involving_VBG hundreds_NNS of_IN thousands_NNS of_IN children_NNS ,_, ""_'' Offit_NNP said_VBD ._. ""_`` I_PRP think_VBP it_PRP 's_VBZ fair_JJ to_TO say_VB a_DT truth_NN has_VBZ emerged_VBN ._. ""_'' Yet_CC the_DT myth_NN of_IN a_DT link_NN between_IN vaccines_NNS and_CC autism_NN continues_VBZ to_TO be_VB used_VBN by_IN anti-vaccine_JJ activists_NNS ,_, who_WP have_VBP been_VBN blamed_VBN for_IN the_DT ongoing_JJ measles_NNS outbreaks_NNS across_IN the_DT United_NNP States_NNPS ._. At_IN least_JJS 206_CD US_NNP cases_NNS of_IN measles_NNS have_VBP been_VBN recorded_VBN in_IN 2019_CD ,_, after_IN 372_CD cases_NNS in_IN 2018_CD ,_, according_VBG to_IN the_DT US_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. Around_IN the_DT world_NN ,_, measles_NNS cases_NNS increased_VBD by_IN 48.4_CD %_NN between_IN 2017_CD and_CC 2018_CD ,_, according_VBG to_IN UNICEF_NNP calculations_NNS from_IN World_NNP Health_NNP Organization_NNP data_NN ._. Ten_CD countries_NNS ,_, including_VBG Brazil_NNP ,_, the_DT Philippines_NNPS and_CC France_NNP ,_, accounted_VBD for_IN nearly_RB three_CD -_HYPH quarters_NNS of_IN the_DT total_JJ increase_NN in_IN measles_NNS cases_NNS in_IN 2018_CD ._. The_DT World_NNP Health_NNP Organization_NNP has_VBZ deemed_VBN vaccine_NN hesitancy_NN --_, the_DT reluctance_NN or_CC refusal_NN to_TO vaccinate_VB despite_IN the_DT availability_NN of_IN vaccines_NNS --_, as_IN a_DT top_JJ 10_CD threat_NN to_IN global_JJ health_NN in_IN 2019_CD ._. ""_`` I_PRP think_VBP we_PRP are_VBP at_IN a_DT tipping_NN point_NN ,_, ""_'' Offit_NNP said_VBD ._. ""_`` I_PRP think_VBP people_NNS need_VBP to_TO realize_VB that_IN a_DT choice_NN not_RB to_TO get_VB a_DT vaccine_NN is_VBZ not_RB a_DT risk_NN -_HYPH free_JJ choice_NN ._. It_PRP 's_VBZ a_DT choice_NN to_TO take_VB a_DT greater_JJR risk_NN ,_, and_CC unfortunately_RB right_RB now_RB ,_, we_PRP are_VBP experiencing_VBG that_DT greater_JJR risk_NN ._. ""_''","( NNP ) - The NNS , NNS , and NN NN VBZ RB VB the NN of NN and VBZ RB VB NN in NNS who VBP at NN , VBG to a JJ NN of RB 650,000 NNS . NNS VBD a NN NN to VB whether the NNP NN VBD the NN of NN in NNS VBN in NNP between 1999 and 2010 . A NN of 657,461 NNS VBD VBN through NNP 2013 , with the NNS VBG NNS of NN NN NN RB RB as VBN NN NNS VBG NN of the NNS , NN of NN in a NN , NN NN and JJ NN at NN . RB 95 NN of the NNS VBD the NN NN , and 6,517 VBD VBN with NN . The NNP NN VBD RB VB the NN of NN in NNS who VBD RB VBN at NN for the NN and VBD RB VB it in those who VBD , VBG to the NN , VBN NNP in the NNP NNP of NNP NNP . "" This NN that NNS VBP NN VBZ RB RB and VBZ RB VBG a NN of NN in JJ NN , "" VBD NNP NNP , JJ NN NN and JJ NN at NNP NNP NNP in NNP . With JJ NNS VBG RBR JJ and RB NNS and NNS VBG NN of NNS , NNP and his NN VBD to VB JJ JJ NNS . The JJS NN of the NN VBD the NN of NNS at NN of NN , VBD NNP NNP NNP , NN of the NNP NNP NNP at NNP 's NNP of NNP , who VBD RB VBN in the JJ NN . He VBZ the JJS NN of NN will VB NNS with JJ NNS at NN of VBG NN NN NN that the NN will RB VB that NN . The NN VBG NNS and NN VBD out of a 1998 NN by NNP NNP , VBN in the JJ NN The NNP . NNP VBD VBN VBN by a NN NN VBG to VB NNS of the NNP NN , and in 2010 , he VBD his JJ NN . In 2011 , The NNP VBD the NN after an NN VBD that NNP VBD or VBD NN on the 12 NNS who VBD the NN for the NN of his NN . JJ JJ NNS VBG to VB the NNS VBP VBN no NN between NNS and NN . "" At this NN , you VBP VBN 17 JJ NNS VBN in seven NNS , three JJ NNS , VBG NNS of NNS of NNS , "" NNP VBD . "" I VBP it VBZ JJ to VB a NN VBZ VBN . "" Yet the NN of a NN between NNS and NN VBZ to VB VBN by JJ NNS , who VBP VBN VBN for the JJ NNS NNS across the NNP NNPS . At JJS 206 NNP NNS of NNS VBP VBN VBN in 2019 , after 372 NNS in 2018 , VBG to the NNP NNPS for NNP NNP and NNP . Around the NN , NNS NNS VBD by 48.4 NN between 2017 and 2018 , VBG to NNP NNS from NNP NNP NNP NN . Ten NNS , VBG NNP , the NNPS and NNP , VBD for RB three - NNS of the JJ NN in NNS NNS in 2018 . The NNP NNP NNP VBZ VBN NN NN -- the NN or NN to VB despite the NN of NNS -- as a JJ 10 NN to JJ NN in 2019 . "" I VBP we VBP at a NN NN , "" NNP VBD . "" I VBP NNS VBP to VB that a NN RB to VB a NN VBZ RB a NN - JJ NN . It VBZ a NN to VB a JJR NN , and RB RB RB , we VBP VBG that JJR NN . """
21,117,mainstream,"Editor_NN 's_POS note_NN :_: Here_RB 's_VBZ a_DT look_NN at_IN all_PDT the_DT drugs_NNS that_WDT are_VBP being_VBG tested_VBN for_IN COVID_NN -_HYPH 19_CD treatment_NN ._. COVID_NNP -_HYPH 19_CD ,_, the_DT respiratory_JJ disease_NN caused_VBN by_IN the_DT new_JJ coronavirus_NN ,_, has_VBZ spread_VBN to_IN every_DT continent_NN except_IN Antarctica_NNP ._. Not_RB too_RB long_RB after_IN the_DT virus_NN was_VBD first_RB discovered_VBN at_IN the_DT end_NN of_IN December_NNP ,_, labs_NNS turned_VBD their_PRP$ sights_NNS toward_IN treatment_NN ._. Currently_RB ,_, however_RB ,_, there_EX is_VBZ no_DT cure_NN for_IN this_DT coronavirus_NN ,_, and_CC treatments_NNS are_VBP based_VBN on_IN the_DT kind_NN of_IN care_NN given_VBN for_IN influenza_NN (_-LRB- seasonal_JJ flu_NN )_-RRB- and_CC other_JJ severe_JJ respiratory_JJ illnesses_NNS ,_, known_VBN as_IN ""_`` supportive_JJ care_NN ,_, ""_'' according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. These_DT treatments_NNS essentially_RB treat_VBP the_DT symptoms_NNS ,_, which_WDT often_RB in_IN the_DT case_NN of_IN COVID_NN -_HYPH 19_CD involve_VBP fever_NN ,_, cough_NN and_CC shortness_NN of_IN breath_NN ._. In_IN mild_JJ cases_NNS ,_, this_DT might_MD simply_RB mean_VB rest_NN and_CC fever_NN -_HYPH reducing_VBG medications_NNS such_JJ as_IN acetaminophen_NN (_-LRB- Tylenol_NNP )_-RRB- for_IN comfort_NN ._. In_IN hospitals_NNS ,_, doctors_NNS and_CC nurses_NNS are_VBP sometimes_RB treating_VBG COVID_NN -_HYPH 19_CD patients_NNS ,_, or_CC Tamiflu_NNP ,_, which_WDT seems_VBZ to_TO suppress_VB the_DT virus_NN '_POS reproduction_NN in_IN at_IN least_JJS some_DT cases_NNS ._. This_DT is_VBZ somewhat_RB surprising_JJ ,_, Michigan_NNP Tech_NN virologist_NN Ebenezer_NNP Tumban_NNP told_VBD Live_NNP Science_NNP ,_, as_IN Tamiflu_NNP was_VBD designed_VBN to_TO target_VB an_DT enzyme_NN on_IN the_DT influenza_NN virus_NN ,_, not_RB on_IN coronaviruses_NNS ._. The_DT National_NNP Institutes_NNPS of_IN Health_NNP has_VBZ begun_VBN a_DT clinical_JJ trial_NN at_IN the_DT University_NNP of_IN Nebraska_NNP Medical_NNP Center_NNP to_TO test_VB the_DT antiviral_JJ remdesivir_NN for_IN COVID_NN -_HYPH 19_CD ,_, ._. In_IN China_NNP ,_, doctors_NNS are_VBP also_RB testing_VBG an_DT array_NN of_IN other_JJ antivirals_NNS originally_RB designed_VBN to_TO treat_VB Ebola_NNP and_CC HIV_NN ,_, ._. In_IN cases_NNS in_IN which_WDT pneumonia_NN inhibits_VBZ breathing_NN ,_, treatment_NN involves_VBZ ventilation_NN with_IN oxygen_NN ._. Ventilators_NNS blow_VBP air_NN into_IN the_DT lungs_NNS through_IN a_DT mask_NN or_CC a_DT tube_NN inserted_VBN directly_RB into_IN the_DT windpipe_NN ._. A_DT of_IN 1,099_CD hospitalized_VBN patients_NNS with_IN the_DT coronavirus_NN in_IN China_NNP found_VBD that_IN 41.3_CD %_NN needed_VBD supplemental_JJ oxygen_NN and_CC 2.3_CD %_NN needed_VBD invasive_JJ mechanical_JJ ventilation_NN ._. Glucocorticoids_NNS were_VBD given_VBN to_IN 18.6_CD %_NN of_IN patients_NNS ,_, a_DT treatment_NN often_RB used_VBN to_TO reduce_VB inflammation_NN and_CC help_VB open_VB airways_NNS during_IN respiratory_JJ disease_NN ._. There_EX is_VBZ no_DT vaccine_NN for_IN the_DT coronavirus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. Scientists_NNS are_VBP working_VBG to_TO develop_VB one_CD ,_, Hilary_NNP Marston_NNP ,_, a_DT medical_JJ officer_NN and_CC policy_NN advisor_NN at_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- ,_, said_VBD in_IN on_IN Monday_NNP (_-LRB- March_NNP 2_CD )_-RRB- ._. As_IN of_IN March_NNP 14_CD ,_, doctors_NNS in_IN Seattle_NNP are_VBP recruiting_VBG volunteers_NNS to_TO participate_VB in_IN a_DT clinical_JJ trial_NN for_IN an_DT experimental_JJ vaccine_NN for_IN COVID_NN -_HYPH 19_CD that_WDT 's_VBZ being_VBG developed_VBN by_IN the_DT biotechnology_NN company_NN Moderna_NNP Therapeutics_NNP ._. However_RB ,_, biomedical_JJ ethicists_NNS are_VBP concerned_VBN that_IN a_DT critical_JJ step_NN in_IN vaccine_NN development_NN was_VBD skipped_VBN ._. In_IN order_NN to_TO fast_JJ -_HYPH track_VB the_DT vaccine_NN ,_, the_DT researchers_NNS did_VBD n’t_RB first_RB show_VB that_IN it_PRP triggered_VBD an_DT immune_JJ response_NN in_IN animals_NNS ,_, a_DT step_NN that_WDT is_VBZ normally_RB required_VBN before_IN human_JJ testing_NN ,_, ._. The_DT researchers_NNS did_VBD begin_VB testing_VBG the_DT experimental_JJ vaccine_NN on_IN lab_NN mice_NNS on_IN the_DT same_JJ day_NN they_PRP started_VBD recruiting_VBG people_NNS for_IN the_DT clinical_JJ trial_NN ,_, ._. The_DT mice_NNS did_VBD show_VB an_DT immune_JJ response_NN that_WDT was_VBD similar_JJ to_IN the_DT one_NN triggered_VBN by_IN an_DT experimental_JJ vaccine_NN for_IN a_DT related_JJ coronavirus_NN MERS_NN -_HYPH CoV_NNP ._. (_-LRB- Vaccines_NNS work_VBP by_IN priming_VBG your_PRP$ immune_JJ system_NN to_TO recognize_VB a_DT virus_NN like_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD as_IN an_DT enemy_NN and_CC put_VB up_RP an_DT attack_NN against_IN it_PRP ._. )_-RRB- Related_JJ :_: How_WRB this_DT experimental_JJ vaccine_NN for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD would_MD work_VB Even_RB so_RB ,_, doctors_NNS are_VBP n't_RB sure_JJ how_WRB much_JJ this_DT ""_`` fast_JJ -_HYPH tracking_NN ""_'' will_MD speed_VB up_RP the_DT time_NN it_PRP takes_VBZ to_TO develop_VB and_CC bring_VB such_PDT a_DT vaccine_NN to_IN market_NN ._. Before_IN this_DT experimental_JJ vaccine_NN was_VBD in_IN the_DT works_NNS ,_, Marston_NNP had_VBD said_VBN not_RB to_TO expect_VB a_DT vaccine_NN in_IN the_DT near_JJ term_NN ._. ""_`` If_IN everything_NN moves_VBZ as_RB quickly_RB as_IN possible_JJ ,_, the_DT soonest_JJS that_IN it_PRP could_MD possibly_RB be_VB is_VBZ about_IN one_CD -_HYPH and_CC -_, a_DT -_HYPH half_NN to_IN two_CD years_NNS ._. That_DT still_RB might_MD be_VB very_RB optimistic_JJ ,_, ""_'' Marston_NNP said_VBD ._. The_DT novel_JJ coronavirus_NN ,_, now_RB called_VBN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, causes_VBZ the_DT disease_NN COVID_NN -_HYPH 19_CD ._. The_DT virus_NN was_VBD first_RB identified_VBN in_IN Wuhan_NNP ,_, China_NNP ,_, on_IN Dec._NNP 31_CD ,_, 2019_CD ,_, though_IN it_PRP seems_VBZ to_TO have_VB been_VBN spreading_VBG well_RB before_IN that_DT date_NN ._. Since_IN then_RB ,_, it_PRP has_VBZ spread_VBN to_IN every_DT continent_NN except_IN Antarctica_NNP ._. The_DT death_NN rate_NN appears_VBZ to_TO be_VB higher_JJR than_IN that_DT of_IN the_DT seasonal_JJ flu_NN ,_, but_CC it_PRP also_RB varies_VBZ by_IN location_NN as_RB well_RB as_IN a_DT person_NN 's_POS age_NN ,_, underlying_JJ health_NN conditions_NNS ,_, among_IN other_JJ factors_NNS ._. For_IN instance_NN ,_, in_IN Hubei_NNP Province_NNP ,_, the_DT epicenter_NN of_IN the_DT outbreak_NN ,_, the_DT death_NN rate_NN reached_VBD 2.9_CD %_NN ,_, whereas_IN it_PRP was_VBD just_RB 0.4_CD %_NN in_IN other_JJ provinces_NNS in_IN China_NNP ,_, according_VBG to_IN a_DT study_NN published_VBN Feb._NNP 18_CD in_IN the_DT China_NNP CDC_NNP Weekly_NNP ._. Scientists_NNS are_VBP n't_RB certain_JJ where_WRB the_DT virus_NN originated_VBD ,_, though_IN they_PRP know_VBP that_IN coronaviruses_NNS (_-LRB- which_WDT also_RB include_VBP SARS_NN and_CC MERS_NN )_-RRB- are_VBP passed_VBN between_IN animals_NNS and_CC humans_NNS ._. Research_NN comparing_VBG the_DT genetic_JJ sequence_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD with_IN a_DT viral_JJ database_NN suggests_VBZ it_PRP originated_VBD in_IN bats_NNS ._. Since_IN no_DT bats_NNS were_VBD sold_VBN at_IN the_DT seafood_NN market_NN in_IN Wuhan_NNP at_IN the_DT disease_NN ’s_POS epicenter_NN ,_, researchers_NNS suggest_VBP an_DT intermediate_JJ animal_NN ,_, possibly_RB the_DT pangolin_NN (_-LRB- an_DT endangered_JJ mammal_NN )_-RRB- is_VBZ responsible_JJ for_IN the_DT transmission_NN to_IN humans_NNS ._. There_EX are_VBP currently_RB no_DT treatments_NNS for_IN the_DT disease_NN ,_, but_CC labs_NNS are_VBP working_VBG on_IN various_JJ types_NNS of_IN treatments_NNS ,_, including_VBG a_DT vaccine_NN ._.","NN 's NN : RB VBZ a NN at all the NNS that VBP VBG VBN for NN - 19 NN . NNP - 19 , the JJ NN VBN by the JJ NN , VBZ VBN to every NN except NNP . RB RB RB after the NN VBD RB VBN at the NN of NNP , NNS VBD their NNS toward NN . RB , RB , there VBZ no NN for this NN , and NNS VBP VBN on the NN of NN VBN for NN ( JJ NN ) and JJ JJ JJ NNS , VBN as "" JJ NN , "" VBG to the NNPS for NNP NNP and NNP ( NNP ) . These NNS RB VBP the NNS , which RB in the NN of NN - 19 VBP NN , NN and NN of NN . In JJ NNS , this might RB VB NN and NN - VBG NNS JJ as NN ( NNP ) for NN . In NNS , NNS and NNS VBP RB VBG NN - 19 NNS , or NNP , which VBZ to VB the NN ' NN in at JJS some NNS . This VBZ RB JJ , NNP NN NN NNP NNP VBD NNP NNP , as NNP VBD VBN to VB an NN on the NN NN , RB on NNS . The NNP NNPS of NNP VBZ VBN a JJ NN at the NNP of NNP NNP NNP to VB the JJ NN for NN - 19 , . In NNP , NNS VBP RB VBG an NN of JJ NNS RB VBN to VB NNP and NN , . In NNS in which NN VBZ NN , NN VBZ NN with NN . NNS VBP NN into the NNS through a NN or a NN VBN RB into the NN . A of 1,099 VBN NNS with the NN in NNP VBD that 41.3 NN VBD JJ NN and 2.3 NN VBD JJ JJ NN . NNS VBD VBN to 18.6 NN of NNS , a NN RB VBN to VB NN and VB VB NNS during JJ NN . There VBZ no NN for the NN that VBZ NN - 19 . NNS VBP VBG to VB one , NNP NNP , a JJ NN and NN NN at the NNP NNP of NNP and NNP NNPS ( NNP ) , VBD in on NNP ( NNP 2 ) . As of NNP 14 , NNS in NNP VBP VBG NNS to VB in a JJ NN for an JJ NN for NN - 19 that VBZ VBG VBN by the NN NN NNP NNP . RB , JJ NNS VBP VBN that a JJ NN in NN NN VBD VBN . In NN to JJ - VB the NN , the NNS VBD RB RB VB that it VBD an JJ NN in NNS , a NN that VBZ RB VBN before JJ NN , . The NNS VBD VB VBG the JJ NN on NN NNS on the JJ NN they VBD VBG NNS for the JJ NN , . The NNS VBD VB an JJ NN that VBD JJ to the NN VBN by an JJ NN for a JJ NN NN - NNP . ( NNS VBP by VBG your JJ NN to VB a NN like NN - NN - 2 as an NN and VB up an NN against it . ) JJ : How this JJ NN for NNP - NNP - 2 would VB RB RB , NNS VBP RB JJ how JJ this "" JJ - NN "" will VB up the NN it VBZ to VB and VB such a NN to NN . Before this JJ NN VBD in the NNS , NNP VBD VBN RB to VB a NN in the JJ NN . "" If NN VBZ RB RB as JJ , the JJS that it could RB VB VBZ about one - and - a - NN to two NNS . That RB might VB RB JJ , "" NNP VBD . The JJ NN , RB VBN NNP - NNP - 2 , VBZ the NN NN - 19 . The NN VBD RB VBN in NNP , NNP , on NNP 31 , 2019 , though it VBZ to VB VBN VBG RB before that NN . Since RB , it VBZ VBN to every NN except NNP . The NN NN VBZ to VB JJR than that of the JJ NN , but it RB VBZ by NN RB RB as a NN 's NN , JJ NN NNS , among JJ NNS . For NN , in NNP NNP , the NN of the NN , the NN NN VBD 2.9 NN , whereas it VBD RB 0.4 NN in JJ NNS in NNP , VBG to a NN VBN NNP 18 in the NNP NNP NNP . NNS VBP RB JJ where the NN VBD , though they VBP that NNS ( which RB VBP NN and NN ) VBP VBN between NNS and NNS . NN VBG the JJ NN of NNP - NNP - 2 with a JJ NN VBZ it VBD in NNS . Since no NNS VBD VBN at the NN NN in NNP at the NN ’s NN , NNS VBP an JJ NN , RB the NN ( an JJ NN ) VBZ JJ for the NN to NNS . There VBP RB no NNS for the NN , but NNS VBP VBG on JJ NNS of NNS , VBG a NN ."
22,1134,mainstream,"A_DT race_NN is_VBZ on_JJ to_TO find_VB the_DT coronavirus_NN vaccine_NN :_: Oxford_NNP University_NNP and_CC Imperial_NNP College_NNP London_NNP have_VBP been_VBN given_VBN a_DT combined_VBN total_NN of_IN £_$ 84_CD million_CD by_IN the_DT UK_NNP government_NN to_TO support_VB their_PRP$ research_NN ._. On_IN 17_CD May_NNP business_NN secretary_NN Alok_NNP Sharma_NNP said_VBD it_PRP is_VBZ hoped_VBN 30_CD million_CD doses_NNS could_MD be_VB available_JJ in_IN the_DT UK_NNP as_RB early_RB as_IN September_NNP ._. But_CC first_RB the_DT vaccine_NN needs_VBZ to_TO undergo_VB rigorous_JJ testing_NN -_, including_VBG on_IN human_JJ volunteers_NNS ._. In_IN May_NNP the_DT first_JJ human_JJ trials_NNS began_VBD in_IN England_NNP with_IN 1,000_CD volunteers_NNS signing_VBG up_RP to_TO take_VB part_NN in_IN the_DT Oxford_NNP trial_NN ._. Then_RB on_IN 16_CD June_NNP ,_, Imperial_NNP College_NNP London_NNP began_VBD its_PRP$ human_JJ testing_NN stage_NN ._. But_CC both_DT groups_NNS are_VBP still_RB looking_VBG for_IN 10,000_CD more_JJR recruits_NNS across_IN England_NNP ,_, Scotland_NNP and_CC Wales_NNP ._. Heres_VBZ what_WP you_PRP need_VBP to_TO know_VB ._. Who_WP is_VBZ running_VBG the_DT human_JJ vaccine_NN trials_NNS ?_. Several_JJ countries_NNS are_VBP racing_VBG to_TO find_VB a_DT vaccine_NN for_IN coronavirus_NN ,_, In_IN the_DT UK_NNP ,_, the_DT first_JJ trials_NNS will_MD be_VB conducted_VBN by_IN two_CD universities_NNS –_: the_DT University_NNP of_IN Oxford_NNP and_CC Imperial_NNP College_NNP London_NNP –_: as_IN separate_JJ research_NN projects_NNS ._. If_IN the_DT trials_NNS are_VBP successful_JJ ,_, the_DT first_JJ vaccines_NNS could_MD come_VB into_IN circulation_NN by_IN autumn_NN this_DT year_NN ._. The_DT Oxford_NNP Vaccine_NNP Centre_NNP ’s_POS COVID_NNP -_HYPH 19_CD vaccine_NN trial_NN is_VBZ run_VBN by_IN the_DT Jenner_NNP Institute_NNP and_CC Oxford_NNP Vaccine_NNP Group_NNP ,_, and_CC is_VBZ a_DT collaborative_JJ project_NN with_IN several_JJ partners_NNS around_IN the_DT world_NN ._. Researches_NNS started_VBD working_VBG on_IN possible_JJ vaccines_NNS on_IN 10_CD January_NNP 2020_CD and_CC now_RB think_VBP they_PRP 've_VBP found_VBN a_DT suitable_JJ candidate_NN ._. The_DT vaccine_NN they_PRP are_VBP testing_VBG is_VBZ a_DT chimpanzee_NN adenovirus_NN vaccine_NN vector_NN (_-LRB- an_DT inactive_JJ virus_NN )_-RRB- currently_RB named_VBN ​_NNP ChAdOx1_NNP ,_, chosen_VBN because_IN ""_`` it_PRP can_MD generate_VB a_DT strong_JJ immune_JJ response_NN from_IN one_CD dose_NN and_CC it_PRP is_VBZ not_RB a_DT replicating_VBG virus_NN ,_, so_IN it_PRP cannot_MD cause_VB an_DT ongoing_JJ infection_NN in_IN the_DT vaccinated_VBN individual_NN ""_'' ._. These_DT characteristics_NNS mean_VBP it_PRP 's_VBZ safe_JJ to_TO be_VB given_VBN to_IN children_NNS ,_, the_DT elderly_NN and_CC those_DT with_IN pre-existing_JJ health_NN conditions_NNS such_JJ as_IN diabetes_NN ._. Researchers_NNS at_IN Imperial_NNP College_NNP London_NNP have_VBP been_VBN working_VBG on_IN a_DT vaccine_NN since_IN early_JJ February_NNP ._. Details_NNS of_IN the_DT vaccine_NN has_VBZ n't_RB been_VBN made_VBN public_NN yet_RB but_CC is_VBZ said_VBN to_TO be_VB a_DT ""_`` self_NN -_HYPH amplifying_VBG RNA_NN vaccine_NN ""_'' ,_, essentially_RB a_DT protein_NN that_WDT can_MD replicate_VB itself_PRP ._. Researchers_NNS said_VBD :_: ""_`` When_WRB immune_NN cells_NNS come_VBP across_IN these_DT proteins_NNS ,_, they_PRP will_MD react_VB by_IN creating_VBG antibodies_NNS to_TO fight_VB off_RP the_DT danger_NN ._. But_CC they_PRP also_RB create_VBP a_DT lasting_VBG memory_NN of_IN the_DT threat_NN for_IN any_DT future_JJ attack_NN ._. ""_'' It_PRP 's_VBZ hoped_VBN that_IN this_DT vaccine_NN will_MD enable_VB the_DT body_NN to_TO learn_VB to_TO fight_VB off_RP the_DT virus_NN quicker_JJR in_IN future_NN ._. Who_WP can_MD take_VB part_NN in_IN the_DT clinical_JJ trials_NNS and_CC how_WRB can_MD I_PRP get_VB involved_VBN ?_. Oxford_NNP University_NNP started_VBD seeking_VBG healthy_JJ volunteers_NNS aged_JJ between_IN 18_CD and_CC 55_CD for_IN their_PRP$ trials_NNS at_IN the_DT end_NN of_IN March_NNP ._. They_PRP are_VBP now_RB looking_VBG for_IN more_JJR volunteers_NNS in_IN the_DT following_VBG areas_NNS :_: West_NNP Midlands_NNP ,_, Thames_NNP Valley_NNP ,_, north_NNP east_NNP of_IN England_NNP ,_, Southampton_NNP ,_, Greater_NNP Glasgow_NNP and_CC Clyde_NNP ,_, London_NNP ,_, Bristol_NNP ,_, Sheffield_NNP ,_, Merseyside_NNP ,_, Hull_NNP ,_, East_NNP Riding_NNP ,_, south_NNP Wales_NNP ,_, Cambridgeshire_NNP ,_, Edinburgh_NNP and_CC Nottinghamshire_NNP ,_, Derbyshire_NNP ,_, Lincolnshire_NNP and_CC Leicestershire_NNP ._. You_PRP can_MD find_VB out_RP more_JJR about_IN the_DT trials_NNS and_CC sign_VB up_RP online_RB ._. Imperial_NNP College_NNP has_VBZ also_RB joined_VBN the_DT Oxford_NNP team_NN and_CC will_MD be_VB running_VBG the_DT trials_NNS in_IN London_NNP ._. Separately_RB ,_, they_PRP are_VBP also_RB looking_VBG to_TO start_VB running_VBG trials_NNS of_IN their_PRP$ version_NN of_IN the_DT vaccine_NN in_IN June_NNP ._. You_PRP can_MD sign_VB up_RP for_IN the_DT Imperial_NNP College_NNP trial_NN online_RB here_RB ._. As_RB well_RB as_IN the_DT human_JJ vaccine_NN trials_NNS ,_, it_PRP 's_VBZ also_RB worth_JJ noting_VBG that_IN the_DT National_NNP Institute_NNP for_IN Health_NNP Research_NNP is_VBZ also_RB recruiting_VBG volunteers_NNS for_IN a_DT number_NN of_IN other_JJ coronavirus_NN -_HYPH related_JJ clinical_JJ trials_NNS ._. You_PRP can_MD find_VB out_RP more_JJR and_CC sign_VB up_RP here_RB ._.","A NN VBZ JJ to VB the NN NN : NNP NNP and NNP NNP NNP VBP VBN VBN a VBN NN of £ 84 million by the NNP NN to VB their NN . On 17 NNP NN NN NNP NNP VBD it VBZ VBN 30 million NNS could VB JJ in the NNP RB RB as NNP . But RB the NN VBZ to VB JJ NN - VBG on JJ NNS . In NNP the JJ JJ NNS VBD in NNP with 1,000 NNS VBG up to VB NN in the NNP NN . RB on 16 NNP , NNP NNP NNP VBD its JJ NN NN . But both NNS VBP RB VBG for 10,000 JJR NNS across NNP , NNP and NNP . VBZ what you VBP to VB . Who VBZ VBG the JJ NN NNS ? JJ NNS VBP VBG to VB a NN for NN , In the NNP , the JJ NNS will VB VBN by two NNS – the NNP of NNP and NNP NNP NNP – as JJ NN NNS . If the NNS VBP JJ , the JJ NNS could VB into NN by NN this NN . The NNP NNP NNP ’s NNP - 19 NN NN VBZ VBN by the NNP NNP and NNP NNP NNP , and VBZ a JJ NN with JJ NNS around the NN . NNS VBD VBG on JJ NNS on 10 NNP 2020 and RB VBP they VBP VBN a JJ NN . The NN they VBP VBG VBZ a NN NN NN NN ( an JJ NN ) RB VBN NNP NNP , VBN because "" it can VB a JJ JJ NN from one NN and it VBZ RB a VBG NN , so it cannot VB an JJ NN in the VBN NN "" . These NNS VBP it VBZ JJ to VB VBN to NNS , the NN and those with JJ NN NNS JJ as NN . NNS at NNP NNP NNP VBP VBN VBG on a NN since JJ NNP . NNS of the NN VBZ RB VBN VBN NN RB but VBZ VBN to VB a "" NN - VBG NN NN "" , RB a NN that can VB itself . NNS VBD : "" When NN NNS VBP across these NNS , they will VB by VBG NNS to VB off the NN . But they RB VBP a VBG NN of the NN for any JJ NN . "" It VBZ VBN that this NN will VB the NN to VB to VB off the NN JJR in NN . Who can VB NN in the JJ NNS and how can I VB VBN ? NNP NNP VBD VBG JJ NNS JJ between 18 and 55 for their NNS at the NN of NNP . They VBP RB VBG for JJR NNS in the VBG NNS : NNP NNP , NNP NNP , NNP NNP of NNP , NNP , NNP NNP and NNP , NNP , NNP , NNP , NNP , NNP , NNP NNP , NNP NNP , NNP , NNP and NNP , NNP , NNP and NNP . You can VB out JJR about the NNS and VB up RB . NNP NNP VBZ RB VBN the NNP NN and will VB VBG the NNS in NNP . RB , they VBP RB VBG to VB VBG NNS of their NN of the NN in NNP . You can VB up for the NNP NNP NN RB RB . RB RB as the JJ NN NNS , it VBZ RB JJ VBG that the NNP NNP for NNP NNP VBZ RB VBG NNS for a NN of JJ NN - JJ JJ NNS . You can VB out JJR and VB up RB ."
23,1056,conspiracy,"Freedom_NN of_IN Information_NN Act_NN in_IN the_DT UK_NNP filed_VBN by_IN a_DT doctor_NN there_RB has_VBZ revealed_VBN 30_CD years_NNS of_IN secret_JJ official_JJ documents_NNS showing_VBG that_IN government_NN experts_NNS have_VBP :_: 1._LS Known_VBN the_DT vaccines_NNS do_VBP n’t_RB work_VB 2_LS ._. Known_VBN they_PRP cause_VBP the_DT diseases_NNS they_PRP are_VBP supposed_VBN to_TO prevent_VB 3_LS ._. Known_VBN they_PRP are_VBP a_DT hazard_NN to_IN children_NNS 4._LS Colluded_VBD to_TO lie_VB to_IN the_DT public_NN 5_LS ._. Worked_VBN to_TO prevent_VB safety_NN studies_NNS Those_DT are_VBP the_DT same_JJ vaccines_NNS that_WDT are_VBP mandated_VBN to_IN children_NNS in_IN the_DT US_NNP Educated_VBN parents_NNS can_MD either_CC get_VB their_PRP$ children_NNS out_IN of_IN harm_NN ’s_POS way_NN or_CC continue_VB living_VBG inside_IN one_CD of_IN the_DT largest_JJS most_RBS evil_JJ lies_NNS in_IN history_NN ,_, that_IN vaccines_NNS –_: full_JJ of_IN heavy_JJ metals_NNS ,_, viral_JJ diseases_NNS ,_, mycoplasma_NN ,_, fecal_JJ material_NN ,_, DNA_NN fragments_NNS from_IN other_JJ species_NNS ,_, formaldehyde_NN ,_, polysorbate_NN 80_CD (_-LRB- a_DT sterilizing_NN agent_NN )_-RRB- –_: are_VBP a_DT miracle_NN of_IN modern_JJ medicine_NN ._. Freedom_NN of_IN Information_NN Act_NN filed_VBN in_IN the_DT US_NNP with_IN the_DT CDC_NNP by_IN a_DT doctor_NN with_IN an_DT autistic_JJ son_NN ,_, seeking_VBG information_NN on_IN what_WP the_DT CDC_NNP knows_VBZ about_IN the_DT dangers_NNS of_IN vaccines_NNS ,_, had_VBD by_IN law_NN to_TO be_VB responded_VBN to_IN in_IN 20_CD days_NNS ._. Nearly_RB 7_CD years_NNS later_RBR ,_, the_DT doctor_NN went_VBD to_IN court_NN and_CC the_DT CDC_NNP argued_VBD it_PRP does_VBZ not_RB have_VB to_TO turn_VB over_RP documents_NNS ._. A_DT judge_NN ordered_VBD the_DT CDC_NNP to_TO turn_VB over_RP the_DT documents_NNS on_IN September_NNP 30th_NN ,_, 2011_CD ._. On_IN October_NNP 26_CD ,_, 2011_CD ,_, a_DT Denver_NNP Post_NNP editorial_NN expressed_VBD shock_NN that_IN the_DT Obama_NNP administration_NN ,_, after_IN promising_VBG to_TO be_VB especially_RB transparent_JJ ,_, was_VBD proposing_VBG changes_NNS to_IN the_DT Freedom_NN of_IN Information_NN Act_NN that_WDT would_MD allow_VB it_PRP to_TO go_VB beyond_IN declaring_VBG some_DT documents_NNS secret_NN and_CC to_TO actually_RB allow_VB government_NN agencies_NNS (_-LRB- such_JJ as_IN the_DT CDC_NNP )_-RRB- to_TO declare_VB some_DT document_NN “_`` non-existent_JJ ._. ”_'' Simultaneous_JJ to_IN this_DT on_IN -_HYPH going_VBG massive_JJ CDC_NNP cover_NN up_RP involving_VBG its_PRP$ primary_JJ “_`` health_NN ”_'' not_RB recommendation_NN but_CC MANDATE_NN for_IN American_JJ children_NNS ,_, the_DT CDC_NNP is_VBZ in_IN deep_JJ trouble_NN over_IN its_PRP$ decades_NNS of_IN covering_VBG up_RP the_DT damaging_JJ effects_NNS of_IN fluoride_NN and_CC affecting_VBG the_DT lives_NNS of_IN all_DT Americans_NNPS ,_, especially_RB children_NNS and_CC the_DT immune_NN compromised_VBN ._. Lawsuits_NNS are_VBP being_VBG prepared_VBN ._. Children_NNS are_VBP ingesting_VBG 3_CD -_SYM 4_CD times_NNS more_JJR fluoride_NN by_IN body_NN weight_NN as_IN adults_NNS and_CC “_`` [t_UH ]_-RRB- he_PRP sheer_JJ number_NN of_IN potentially_RB harmed_VBN citizens_NNS —_: persons_NNS with_IN dental_JJ fluorosis_NN ,_, kidney_NN patients_NNS tipped_VBN into_IN needing_VBG dialysis_NN ,_, diabetics_NNS ,_, thyroid_NN patients_NNS ,_, etc_FW —_: numbers_NNS in_IN the_DT millions_NNS ._. ”_'' The_DT CDC_NNP is_VBZ obviously_RB acting_VBG against_IN the_DT health_NN of_IN the_DT American_JJ people_NNS ._. But_CC the_DT threat_NN to_IN the_DT lives_NNS of_IN the_DT American_JJ people_NNS posed_VBN by_IN the_DT CDC_NNP ’s_POS behavior_NN does_VBZ not_RB stop_VB there_RB ._. It_PRP participated_VBD in_IN designed_VBN pandemic_NN laws_NNS that_WDT are_VBP on_IN the_DT books_NNS in_IN every_DT state_NN in_IN the_DT US_NNP ,_, which_WDT arrange_VBP for_IN the_DT government_NN to_TO use_VB military_NN to_TO force_VB unknown_JJ ,_, untested_JJ vaccines_NNS ,_, drugs_NNS ,_, chemicals_NNS ,_, and_CC “_`` medical_JJ ”_'' treatments_NNS on_IN the_DT entire_JJ country_NN if_IN it_PRP declares_VBZ a_DT pandemic_NN emergency_NN ._. The_DT CDC_NNP ’s_POS credibility_NN in_IN declaring_VBG such_PDT a_DT pandemic_NN emergency_NN is_VBZ non-existent_JJ ,_, again_RB based_VBN on_IN Freedom_NNP of_IN Information_NNP Act_NNP ._. For_IN in_IN 2009_CD ,_, after_IN the_DT CDC_NNP had_VBD declared_VBN the_DT H1N1_NNP “_`` pandemic_NN ,_, ”_'' the_DT CDC_NNP refused_VBD to_TO respond_VB to_IN Freedom_NNP of_IN Information_NNP Act_NNP filed_VBN by_IN CBS_NNP News_NNP and_CC the_DT CDC_NNP also_RB attempted_VBD to_TO block_VB their_PRP$ investigation_NN ._. What_WP the_DT CDC_NNP was_VBD hiding_VBG was_VBD its_PRP$ part_NN in_IN one_CD of_IN the_DT largest_JJS medical_JJ scandals_NNS in_IN history_NN ,_, putting_VBG out_RP wildly_RB exaggerated_VBN data_NNS on_IN what_WP it_PRP claimed_VBD were_VBD H1N1_NNP cases_NNS ,_, and_CC by_IN doing_VBG so_RB ,_, created_VBD the_DT false_JJ impression_NN of_IN a_DT “_`` pandemic_NN ”_'' in_IN the_DT US_NNP ._. The_DT CDC_NNP was_VBD also_RB covering_VBG up_RP e_NN financial_JJ scandal_NN to_TO rival_VB the_DT bailout_NN since_IN the_DT vaccines_NNS for_IN the_DT false_JJ pandemic_NN cost_VBD the_DT US_NNP billions_NNS ._. And_CC worse_JJR ,_, the_DT CDC_NNP put_VBD pregnant_JJ women_NNS first_RB in_IN line_NN for_IN an_DT untested_JJ vaccine_NN with_IN a_DT sterilizing_NN agent_NN ,_, polysorbate_NN 80_CD ,_, in_IN it_PRP ._. Thanks_NN to_IN the_DT CDC_NNP ,_, “_`` the_DT number_NN of_IN vaccine_NN -_HYPH related_JJ “_`` fetal_JJ demise_NN ”_'' reports_NNS increased_VBD by_IN 2,440_CD percent_NN in_IN 2009_CD compared_VBN to_IN previous_JJ years_NNS ,_, which_WDT is_VBZ even_RB more_RBR shocking_JJ than_IN the_DT miscarriage_NN statistic_NN [_-LRB- 700_CD %_NN increase_NN ]_-RRB- ._. The_DT exposure_NN of_IN the_DT vaccine_NN hoax_NN is_VBZ running_VBG neck_NN and_CC neck_NN with_IN the_DT much_RB older_JJR hoax_NN of_IN a_DT deadly_JJ 1918_CD -_HYPH 19_CD flu_NN ._. It_PRP was_VBD aspirin_NN that_WDT killed_VBD people_NNS in_IN 1918_CD -_HYPH 19_CD ,_, not_RB a_DT pandemic_NN flu_NN ._. It_PRP was_VBD the_DT greatest_JJS industrial_JJ catastrophe_NN in_IN human_JJ history_NN with_IN 20_CD -_SYM 50_CD million_CD people_NNS dying_VBG but_CC it_PRP was_VBD blamed_VBN on_IN a_DT flu_NN ._. The_DT beginning_NN of_IN the_DT drug_NN industry_NN began_VBD with_IN that_DT success_NN (_-LRB- and_CC Monsanto_NNP was_VBD part_NN of_IN it_PRP )_-RRB- ._. The_DT flu_NN myth_NN was_VBD used_VBN by_IN George_NNP Bush_NNP to_TO threaten_VB the_DT world_NN with_IN “_`` another_DT pandemic_NN flu_NN that_WDT could_MD kill_VB millions_NNS ”_'' –_: a_DT terror_NN tactic_NN to_TO get_VB pandemic_NN laws_NNS on_IN the_DT books_NNS in_IN every_DT state_NN and_CC worldwide_RB ._. Then_RB the_DT CDC_NNP used_VBD hoax_NN of_IN the_DT pandemic_NN hoax_NN to_TO create_VB terror_NN over_IN H1N1_NN and_CC to_TO push_VB deadly_JJ vaccines_NNS on_IN the_DT public_NN ,_, killing_VBG thousands_NNS of_IN unborn_JJ children_NNS and_CC others_NNS ._. (_-LRB- CDC_NNP will_MD not_RB release_VB the_DT data_NNS and_CC continues_VBZ to_TO push_VB the_DT same_JJ vaccine_NN ._. )_-RRB- The_DT hoax_NN of_IN the_DT vaccine_NN schedule_NN is_VBZ over_RB ,_, exposed_VBN by_IN FOIAs_NNS in_IN the_DT UK_NNP ._. The_DT hoax_NN of_IN the_DT CDC_NNP ’s_POS interest_NN in_IN children_NNS ’s_POS lives_NNS has_VBZ been_VBN exposed_VBN by_IN its_PRP$ refusal_NN to_TO respond_VB to_IN a_DT doctor_NN ’s_POS FOIAs_NNS around_IN its_PRP$ knowledge_NN of_IN vaccine_NN dangers_NNS ._. The_DT 1918_CD -_HYPH 19_CD pandemic_NN hoax_NN has_VBZ been_VBN exposed_VBN by_IN Dr._NNP Karen_NNP Starko_NNP ’s_POS work_NN on_IN aspirin_NN ’s_POS role_NN in_IN killing_VBG people_NNS ._. And_CC despite_IN refusing_VBG to_TO respond_VB to_IN FOIAS_NNP ,_, the_DT CDC_NNP ’s_POS scandalous_JJ hoax_NN of_IN a_DT 2009_CD flu_NN pandemic_NN and_CC its_PRP$ part_NN in_IN creating_VBG it_PRP ,_, was_VBD exposed_VBN by_IN CBS_NNP NEWS_NNP ._. And_CC the_DT Obama_NNP administration_NN ,_, in_IN attempting_VBG to_TO salvage_VB the_DT last_JJ vestige_NN of_IN secrecy_NN around_IN what_WP is_VBZ really_RB happening_VBG with_IN vaccines_NNS ,_, by_IN declaring_VBG agency_NN documents_NNS non-existent_JJ ,_, has_VBZ made_VBN its_PRP$ claim_NN of_IN transparency_NN ,_, non-existent_JJ ._. But_CC pandemic_NN laws_NNS arranging_VBG for_IN unknown_JJ vaccines_NNS to_TO be_VB forced_VBN on_IN the_DT entire_JJ country_NN are_VBP still_RB in_IN place_NN with_IN HHS_NNP creating_VBG a_DT vaccine_NN mixture_NN that_WDT should_MD never_RB be_VB used_VBN on_IN anyone_NN and_CC all_DT liability_NN for_IN vaccines_NNS having_VBG been_VBN removed_VBN ._. Meanwhile_RB ,_, a_DT Canadian_JJ study_NN has_VBZ just_RB proven_VBN that_IN the_DT flu_NN vaccine_NN containing_VBG the_DT H1N1_NN vaccine_NN which_WDT kills_VBZ babies_NNS in_IN utero_NN ,_, actually_RB increases_VBZ the_DT risk_NN of_IN serious_JJ pandemic_NN flu_NN ._. Americans_NNPS who_WP have_VBP been_VBN duped_VBN into_IN submitting_VBG their_PRP$ children_NNS to_IN the_DT CDC_NNP ’s_POS deadly_JJ vaccines_NNS ,_, have_VBP a_DT means_NN to_TO respond_VB now_RB ._. People_NNS from_IN every_DT walk_NN of_IN life_NN and_CC every_DT organization_NN ,_, must_MD :_: 1._LS take_VB the_DT information_NN from_IN the_DT UK_NNP FOIAs_NNPS exposing_VBG 30_CD years_NNS of_IN vaccine_NN lies_NNS ,_, the_DT refusal_NN of_IN the_DT CDC_NNP to_TO provide_VB any_DT information_NN on_IN what_WP it_PRP knows_VBZ about_IN those_DT lies_NNS ,_, and_CC the_DT Obama_NNP Administration_NNP ’s_POS efforts_NNS to_TO hide_VB the_DT CDC_NNP ’s_POS awareness_NN of_IN those_DT lies_NNS ,_, and_CC go_VB to_IN their_PRP$ state_NN legislatures_NNS ,_, demand_VB the_DT immediate_JJ nullification_NN of_IN the_DT CDC_NNP vaccine_NN schedule_NN and_CC the_DT pandemic_NN laws_NNS ._. 2._LS inform_VB every_DT vet_NN ._. active_JJ duty_NN military_JJ person_NN ,_, law_NN enforcement_NN people_NNS ,_, DHS_NNP agents_NNS and_CC medical_JJ personnel_NNS they_PRP know_VBP ,_, of_IN the_DT vaccine_NN hoax_NN ,_, for_IN their_PRP$ families_NNS are_VBP deeply_RB threatened_VBN ,_, too_RB ,_, but_CC they_PRP may_MD not_RB be_VB aware_JJ of_IN it_PRP or_CC that_IN they_PRP have_VBP been_VBN folded_VBN into_IN agency_NN structures_NNS by_IN the_DT pharmaceutical_JJ industry_NN (_-LRB- indistinguishable_JJ from_IN the_DT bankers_NNS and_CC oil_NN companies_NNS )_-RRB- that_WDT would_MD make_VB them_PRP agents_NNS of_IN death_NN for_IN their_PRP$ country_NN with_IN the_DT declaration_NN of_IN a_DT “_`` pandemic_NN ”_'' emergency_NN or_CC “_`` bio-_NN terrorist_NN ”_'' attack_NN ._. It_PRP is_VBZ completely_RB clear_JJ now_RB that_IN the_DT terrorism_NN /_, bioterrorism_NN structures_NNS are_VBP scams_NNS so_IN that_IN any_DT actions_NNS taken_VBN to_TO “_`` protect_VB ”_'' this_DT country_NN using_VBG those_DT laws_NNS would_MD in_IN fact_NN be_VB what_WP threatens_VBZ the_DT existence_NN of_IN Americans_NNPS ._. It_PRP was_VBD aspirin_NN that_WDT killed_VBD millions_NNS in_IN 1918_CD -_SYM 19_CD ._. Now_RB it_PRP is_VBZ mandated_VBN and_CC unknown_JJ ,_, untested_JJ vaccines_NNS with_IN banned_VBN adjuvants_NNS in_IN them_PRP that_WDT threaten_VBP the_DT country_NN with_IN millions_NNS of_IN deaths_NNS ._. At_IN the_DT same_JJ time_NN ,_, the_DT CDC_NNP is_VBZ holding_VBG 500,000_CD mega_NN -_HYPH coffins_NNS ,_, built_VBN to_TO be_VB incinerated_VBN ,_, on_IN its_PRP$ property_NN outside_IN Atlanta_NNP ._. Not_RB to_TO put_VB to_TO fine_VB a_DT point_NN on_IN this_DT ,_, but_CC it_PRP ’s_VBZ clear_JJ now_RB that_IN the_DT CDC_NNP should_MD not_RB be_VB involved_VBN in_IN any_DT way_NN with_IN public_JJ health_NN ._. Thanks_NN to_IN the_DT Freedom_NNP of_IN Information_NNP Act_NNP (_-LRB- FOIA_NNP )_-RRB- ,_, we_PRP know_VBP that_IN vaccines_NNS are_VBP not_RB a_DT miracle_NN of_IN modern_JJ medicine_NN ._. Any_DT medical_JJ or_CC government_NN authority_NN which_WDT insists_VBZ vaccines_NNS prevent_VBP diseases_NNS is_VBZ either_CC ignorant_JJ of_IN government_NN documents_NNS (_-LRB- and_CC endless_JJ studies_NNS )_-RRB- revealing_VBG the_DT exact_JJ opposite_NN or_CC of_IN the_DT CDC_NNP ’s_POS attempts_NNS to_TO hide_VB the_DT truth_NN about_IN vaccines_NNS from_IN the_DT public_NN ,_, or_CC means_VBZ harm_NN to_IN the_DT public_NN ._. Thanks_NN to_IN the_DT Freedom_NNP of_IN Information_NNP Act_NNP (_-LRB- FOIA_NNP )_-RRB- ,_, we_PRP know_VBP the_DT vaccine_NN schedule_NN is_VBZ a_DT hoax_NN ._. The_DT health_NN danger_NN to_IN American_JJ children_NNS and_CC adults_NNS are_VBP vaccines_NNS ._. “_`` The_DT greatest_JJS lie_NN ever_RB told_VBN is_VBZ that_IN vaccines_NNS are_VBP safe_JJ and_CC effective_JJ ._. ”_'' -_NFP Dr._NNP Len_NNP Horowitz_NNP Source_NN :_: End_NN All_DT Disease_NN ._.","NN of NN NN in the NNP VBN by a NN RB VBZ VBN 30 NNS of JJ JJ NNS VBG that NN NNS VBP : 1. VBN the NNS VBP RB VB 2 . VBN they VBP the NNS they VBP VBN to VB 3 . VBN they VBP a NN to NNS 4. VBD to VB to the NN 5 . VBN to VB NN NNS Those VBP the JJ NNS that VBP VBN to NNS in the NNP VBN NNS can either VB their NNS out of NN ’s NN or VB VBG inside one of the JJS RBS JJ NNS in NN , that NNS – JJ of JJ NNS , JJ NNS , NN , JJ NN , NN NNS from JJ NNS , NN , NN 80 ( a NN NN ) – VBP a NN of JJ NN . NN of NN NN VBN in the NNP with the NNP by a NN with an JJ NN , VBG NN on what the NNP VBZ about the NNS of NNS , VBD by NN to VB VBN to in 20 NNS . RB 7 NNS RBR , the NN VBD to NN and the NNP VBD it VBZ RB VB to VB over NNS . A NN VBD the NNP to VB over the NNS on NNP NN , 2011 . On NNP 26 , 2011 , a NNP NNP NN VBD NN that the NNP NN , after VBG to VB RB JJ , VBD VBG NNS to the NN of NN NN that would VB it to VB beyond VBG some NNS NN and to RB VB NN NNS ( JJ as the NNP ) to VB some NN “ JJ . ” JJ to this on - VBG JJ NNP NN up VBG its JJ “ NN ” RB NN but NN for JJ NNS , the NNP VBZ in JJ NN over its NNS of VBG up the JJ NNS of NN and VBG the NNS of all NNPS , RB NNS and the NN VBN . NNS VBP VBG VBN . NNS VBP VBG 3 - 4 NNS JJR NN by NN NN as NNS and “ [t ] he JJ NN of RB VBN NNS — NNS with JJ NN , NN NNS VBN into VBG NN , NNS , NN NNS , FW — NNS in the NNS . ” The NNP VBZ RB VBG against the NN of the JJ NNS . But the NN to the NNS of the JJ NNS VBN by the NNP ’s NN VBZ RB VB RB . It VBD in VBN NN NNS that VBP on the NNS in every NN in the NNP , which VBP for the NN to VB NN to VB JJ , JJ NNS , NNS , NNS , and “ JJ ” NNS on the JJ NN if it VBZ a NN NN . The NNP ’s NN in VBG such a NN NN VBZ JJ , RB VBN on NNP of NNP NNP . For in 2009 , after the NNP VBD VBN the NNP “ NN , ” the NNP VBD to VB to NNP of NNP NNP VBN by NNP NNP and the NNP RB VBD to VB their NN . What the NNP VBD VBG VBD its NN in one of the JJS JJ NNS in NN , VBG out RB VBN NNS on what it VBD VBD NNP NNS , and by VBG RB , VBD the JJ NN of a “ NN ” in the NNP . The NNP VBD RB VBG up NN JJ NN to VB the NN since the NNS for the JJ NN VBD the NNP NNS . And JJR , the NNP VBD JJ NNS RB in NN for an JJ NN with a NN NN , NN 80 , in it . NN to the NNP , “ the NN of NN - JJ “ JJ NN ” NNS VBD by 2,440 NN in 2009 VBN to JJ NNS , which VBZ RB RBR JJ than the NN NN [ 700 NN NN ] . The NN of the NN NN VBZ VBG NN and NN with the RB JJR NN of a JJ 1918 - 19 NN . It VBD NN that VBD NNS in 1918 - 19 , RB a NN NN . It VBD the JJS JJ NN in JJ NN with 20 - 50 million NNS VBG but it VBD VBN on a NN . The NN of the NN NN VBD with that NN ( and NNP VBD NN of it ) . The NN NN VBD VBN by NNP NNP to VB the NN with “ another NN NN that could VB NNS ” – a NN NN to VB NN NNS on the NNS in every NN and RB . RB the NNP VBD NN of the NN NN to VB NN over NN and to VB JJ NNS on the NN , VBG NNS of JJ NNS and NNS . ( NNP will RB VB the NNS and VBZ to VB the JJ NN . ) The NN of the NN NN VBZ RB , VBN by NNS in the NNP . The NN of the NNP ’s NN in NNS ’s NNS VBZ VBN VBN by its NN to VB to a NN ’s NNS around its NN of NN NNS . The 1918 - 19 NN NN VBZ VBN VBN by NNP NNP NNP ’s NN on NN ’s NN in VBG NNS . And despite VBG to VB to NNP , the NNP ’s JJ NN of a 2009 NN NN and its NN in VBG it , VBD VBN by NNP NNP . And the NNP NN , in VBG to VB the JJ NN of NN around what VBZ RB VBG with NNS , by VBG NN NNS JJ , VBZ VBN its NN of NN , JJ . But NN NNS VBG for JJ NNS to VB VBN on the JJ NN VBP RB in NN with NNP VBG a NN NN that should RB VB VBN on NN and all NN for NNS VBG VBN VBN . RB , a JJ NN VBZ RB VBN that the NN NN VBG the NN NN which VBZ NNS in NN , RB VBZ the NN of JJ NN NN . NNPS who VBP VBN VBN into VBG their NNS to the NNP ’s JJ NNS , VBP a NN to VB RB . NNS from every NN of NN and every NN , must : 1. VB the NN from the NNP NNPS VBG 30 NNS of NN NNS , the NN of the NNP to VB any NN on what it VBZ about those NNS , and the NNP NNP ’s NNS to VB the NNP ’s NN of those NNS , and VB to their NN NNS , VB the JJ NN of the NNP NN NN and the NN NNS . 2. VB every NN . JJ NN JJ NN , NN NN NNS , NNP NNS and JJ NNS they VBP , of the NN NN , for their NNS VBP RB VBN , RB , but they may RB VB JJ of it or that they VBP VBN VBN into NN NNS by the JJ NN ( JJ from the NNS and NN NNS ) that would VB them NNS of NN for their NN with the NN of a “ NN ” NN or “ NN NN ” NN . It VBZ RB JJ RB that the NN / NN NNS VBP NNS so that any NNS VBN to “ VB ” this NN VBG those NNS would in NN VB what VBZ the NN of NNPS . It VBD NN that VBD NNS in 1918 - 19 . RB it VBZ VBN and JJ , JJ NNS with VBN NNS in them that VBP the NN with NNS of NNS . At the JJ NN , the NNP VBZ VBG 500,000 NN - NNS , VBN to VB VBN , on its NN outside NNP . RB to VB to VB a NN on this , but it VBZ JJ RB that the NNP should RB VB VBN in any NN with JJ NN . NN to the NNP of NNP NNP ( NNP ) , we VBP that NNS VBP RB a NN of JJ NN . Any JJ or NN NN which VBZ NNS VBP NNS VBZ either JJ of NN NNS ( and JJ NNS ) VBG the JJ NN or of the NNP ’s NNS to VB the NN about NNS from the NN , or VBZ NN to the NN . NN to the NNP of NNP NNP ( NNP ) , we VBP the NN NN VBZ a NN . The NN NN to JJ NNS and NNS VBP NNS . “ The JJS NN RB VBN VBZ that NNS VBP JJ and JJ . ” - NNP NNP NNP NN : NN All NN ."
24,395,conspiracy,"The_DT British_JJ health_NN secretary_NN Matt_NNP Hancock_NNP said_VBD during_IN a_DT briefing_NN that_IN he_PRP hopes_VBZ ‘_`` everybody_NN would_MD have_VB the_DT vaccine_NN ’_'' ,_, if_IN and_CC when_WRB a_DT coronavirus_NN shot_NN is_VBZ rolled_VBN out_RP ,_, and_CC did_VBD not_RB rule_VB out_RP making_VBG it_PRP mandatory_JJ for_IN every_DT citizen_NN ._. Hancock_NNP was_VBD asked_VBN directly_RB by_IN a_DT reporter_NN if_IN getting_VBG the_DT vaccine_NN could_MD be_VB made_VBN compulsory_JJ ,_, and_CC replied_VBD that_IN the_DT question_NN is_VBZ “_`` not_RB one_CD that_WDT we_PRP have_VBP addressed_VBN yet_RB ”_'' ._. “_`` I_PRP would_MD hope_VB given_VBN the_DT scale_NN of_IN this_DT crisis_NN and_CC given_VBN the_DT overwhelming_JJ need_NN for_IN us_PRP to_TO get_VB through_IN this_DT and_CC to_TO get_VB the_DT country_NN back_RB on_IN its_PRP$ feet_NNS and_CC the_DT very_RB positive_JJ impact_NN that_WDT a_DT vaccine_NN would_MD have_VB that_IN everybody_NN would_MD have_VB the_DT vaccine_NN ._. ”_'' Hancock_NNP said_VBD ._. Professor_NNP John_NNP Newton_NNP ,_, who_WP is_VBZ overseeing_VBG Britain_NNP ’s_POS coronavirus_NN testing_NN ,_, then_RB confirmed_VBD that_IN mandating_VBG vaccinations_NNS is_VBZ on_IN the_DT table_NN ._. “_`` Clearly_RB mandation_NN is_VBZ there_RB ,_, it_PRP can_MD be_VB used_VBN in_IN some_DT instances_NNS ._. ”_'' Newton_NNP said_VBD ,_, admitting_VBG however_RB that_IN “_`` most_RBS successful_JJ vaccine_NN programmes_NNS tend_VBP to_TO be_VB by_IN consent_NN ._. ”_'' “_`` Although_IN some_DT countries_NNS have_VBP adopted_VBN mandatory_JJ programmes_NNS ,_, the_DT most_RBS successful_JJ programmes_NNS tend_VBP to_TO be_VB done_VBN on_IN the_DT basis_NN of_IN consent_NN ,_, good_JJ information_NN and_CC good_JJ delivery_NN mechanisms_NNS ._. ”_'' Newton_NNP said_VBD ._. Hancock_NNP has_VBZ previously_RB strenuously_RB criticised_VBN anti-vaccination_NN campaigners_NNS ._. Last_JJ year_NN he_PRP announced_VBD that_IN the_DT UK_NNP Government_NN was_VBD “_`` looking_VBG very_RB seriously_RB ”_'' at_IN instituting_VBG compulsory_JJ vaccinations_NNS for_IN state_NN school_NN pupils_NNS ._. In_IN the_DT US_NNP ,_, calls_NNS have_VBP been_VBN made_VBN to_TO make_VB any_DT vaccination_NN mandatory_JJ with_IN the_DT likes_NNS of_IN the_DT New_NNP York_NNP Times_NNP expressing_VBG concern_NN that_IN half_NN of_IN Americans_NNPS would_MD refuse_VB to_TO take_VB it_PRP ._. In_IN Canada_NNP ,_, a_DT poll_NN recently_RB revealed_VBD that_IN 60_CD per_NN cent_NN think_VBP that_IN when_WRB a_DT vaccine_NN for_IN coronavirus_NN becomes_VBZ available_JJ it_PRP should_MD be_VB made_VBN mandatory_JJ ._. In_IN addition_NN ,_, Canada_NNP ’s_POS current_JJ Chief_NNP Public_NNP Health_NNP Officer_NNP appeared_VBD in_IN a_DT recently_RB resurfaced_VBN 2010_CD documentary_NN in_IN which_WDT she_PRP advocated_VBD using_VBG mandatory_JJ “_`` tracking_NN bracelets_NNS ”_'' for_IN people_NNS who_WP refuse_VBP to_TO take_VB a_DT vaccine_NN after_IN a_DT virus_NN outbreak_NN ._. Many_JJ experts_NNS have_VBP suggested_VBN that_IN a_DT vaccine_NN may_MD not_RB even_RB be_VB successful_JJ due_IN to_IN the_DT nature_NN of_IN the_DT coronavirus_NN family_NN and_CC the_DT fact_NN that_IN it_PRP can_MD mutate_VB ._. In_IN the_DT UK_NNP ,_, Scientists_NNPS have_VBP expressed_VBN doubts_NNS over_IN the_DT effectiveness_NN of_IN a_DT vaccine_NN that_WDT has_VBZ been_VBN rushed_VBN to_IN human_JJ trials_NNS ,_, after_IN all_DT of_IN the_DT monkeys_NNS used_VBN in_IN initial_JJ testing_NN later_RBR contracted_VBD coronavirus_NN ._. Meanwhile_RB ,_, greater_JJR breakthroughs_NNS have_VBP been_VBN made_VBN in_IN anti-body_JJ studies_NNS ,_, with_IN researchers_NNS from_IN Seattle_NNP successfully_RB neutralizing_VBG the_DT spike_NN proteins_NNS of_IN the_DT virus_NN ,_, and_CC researchers_NNS in_IN California_NNP claiming_VBG to_TO have_VB discovered_VBN anti-bodies_NNS that_WDT can_MD completely_RB block_VB COVID_NN -_HYPH 19_CD ._. The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","The JJ NN NN NNP NNP VBD during a NN that he VBZ ‘ NN would VB the NN ’ , if and when a NN NN VBZ VBN out , and VBD RB VB out VBG it JJ for every NN . NNP VBD VBN RB by a NN if VBG the NN could VB VBN JJ , and VBD that the NN VBZ “ RB one that we VBP VBN RB ” . “ I would VB VBN the NN of this NN and VBN the JJ NN for us to VB through this and to VB the NN RB on its NNS and the RB JJ NN that a NN would VB that NN would VB the NN . ” NNP VBD . NNP NNP NNP , who VBZ VBG NNP ’s NN NN , RB VBD that VBG NNS VBZ on the NN . “ RB NN VBZ RB , it can VB VBN in some NNS . ” NNP VBD , VBG RB that “ RBS JJ NN NNS VBP to VB by NN . ” “ Although some NNS VBP VBN JJ NNS , the RBS JJ NNS VBP to VB VBN on the NN of NN , JJ NN and JJ NN NNS . ” NNP VBD . NNP VBZ RB RB VBN NN NNS . JJ NN he VBD that the NNP NN VBD “ VBG RB RB ” at VBG JJ NNS for NN NN NNS . In the NNP , NNS VBP VBN VBN to VB any NN JJ with the NNS of the NNP NNP NNP VBG NN that NN of NNPS would VB to VB it . In NNP , a NN RB VBD that 60 NN NN VBP that when a NN for NN VBZ JJ it should VB VBN JJ . In NN , NNP ’s JJ NNP NNP NNP NNP VBD in a RB VBN 2010 NN in which she VBD VBG JJ “ NN NNS ” for NNS who VBP to VB a NN after a NN NN . JJ NNS VBP VBN that a NN may RB RB VB JJ due to the NN of the NN NN and the NN that it can VB . In the NNP , NNPS VBP VBN NNS over the NN of a NN that VBZ VBN VBN to JJ NNS , after all of the NNS VBN in JJ NN RBR VBD NN . RB , JJR NNS VBP VBN VBN in JJ NNS , with NNS from NNP RB VBG the NN NNS of the NN , and NNS in NNP VBG to VB VBN NNS that can RB VB NN - 19 . The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
25,972,mainstream,"New_NNP Jersey_NNP preschoolers_NNS have_VBP highest_JJS autism_NN rates_NNS in_IN the_DT nation_NN ,_, researchers_NNS say_VBP WOODLAND_NNP PARK_NNP ,_, N.J._NNP –_: New_NNP Jersey_NNP preschoolers_NNS have_VBP the_DT highest_JJS rates_NNS of_IN autism_NN ever_RB measured_VBN in_IN the_DT United_NNP States_NNPS ,_, a_DT rate_NN that_WDT has_VBZ increased_VBN faster_JJR than_IN in_IN other_JJ states_NNS studied_VBN ,_, researchers_NNS at_IN Rutgers_NNP University_NNP reported_VBD Thursday_NNP ._. The_DT rate_NN of_IN autism_NN among_IN children_NNS in_IN the_DT state_NN has_VBZ tripled_VBN in_IN a_DT generation_NN ._. One_CD in_IN 35_CD children_NNS in_IN New_NNP Jersey_NNP was_VBD diagnosed_VBN with_IN autism_NN by_IN their_PRP$ fourth_JJ birthday_NN ,_, according_VBG to_IN the_DT study_NN published_VBN Thursday_NNP by_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. Those_DT children_NNS were_VBD more_RBR likely_JJ to_TO have_VB attracted_VBN the_DT attention_NN of_IN pediatricians_NNS and_CC early_JJ -_HYPH childhood_NN educators_NNS because_IN of_IN moderate_JJ to_IN severe_JJ symptoms_NNS of_IN autism_NN ._. Still_RB ,_, more_JJR children_NNS are_VBP diagnosed_VBN with_IN autism_NN when_WRB they_PRP enter_VBP public_JJ schools_NNS ._. The_DT relentless_JJ climb_NN in_IN autism_NN rates_NNS –_: from_IN 1_CD %_NN of_IN children_NNS born_VBN in_IN 1992_CD to_IN 3_CD %_NN of_IN children_NNS born_VBN in_IN 2010_CD –_: has_VBZ shown_VBN no_DT signs_NNS of_IN reaching_VBG a_DT plateau_NN ,_, said_VBD Walter_NNP Zahorodny_NNP ,_, an_DT associate_NN professor_NN at_IN Rutgers_NNP New_NNP Jersey_NNP Medical_NNP School_NNP who_WP directed_VBD the_DT New_NNP Jersey_NNP portion_NN of_IN the_DT study_NN ._. ""_`` The_DT explosive_JJ rate_NN of_IN autism_NN is_VBZ impossible_JJ to_TO ignore_VB ,_, ""_'' he_PRP said_VBD ._. School_NN districts_NNS face_VBP increasing_VBG demand_NN for_IN educational_JJ resources_NNS for_IN children_NNS with_IN autism_NN ._. Clinicians_NNS face_VBP long_JJ waiting_NN lists_NNS for_IN their_PRP$ services_NNS ._. ""_`` There_EX 's_VBZ no_DT letup_NN ,_, ""_'' he_PRP said_VBD ._. ""_`` I_PRP really_RB do_VBP n't_RB understand_VB why_WRB the_DT rate_NN is_VBZ going_VBG up_RP in_IN this_DT way_NN ._. ""_'' Researchers_NNS can’t_MD explain_VB why_WRB autism_NN rates_NNS have_VBP increased_VBN in_IN New_NNP Jersey_NNP and_CC elsewhere_RB ._. Contributing_VBG factors_NNS include_VBP genetic_JJ mutations_NNS and_CC birth_NN -_HYPH related_JJ risks_NNS ,_, such_JJ as_IN being_VBG born_VBN prematurely_RB ,_, as_IN one_CD of_IN a_DT multiple_JJ birth_NN ,_, to_IN a_DT mother_NN who_WP was_VBD ill_JJ during_IN pregnancy_NN or_CC to_IN parents_NNS who_WP are_VBP older_JJR than_IN 30_CD ._. But_CC the_DT greatest_JJS influences_NNS appear_VBP to_TO be_VB unknown_JJ environmental_JJ factors_NNS ,_, Zahorodny_NNP said_VBD ._. Among_IN 4_CD -_HYPH year_NN -_HYPH olds_NNS ,_, the_DT rate_NN climbed_VBD 43_CD %_NN in_IN just_RB four_CD years_NNS ,_, from_IN 2010_CD to_IN 2014_CD ,_, he_PRP said_VBD ._. One_CD in_IN 23_CD 4_CD -_HYPH year_NN -_HYPH old_JJ boys_NNS in_IN New_NNP Jersey_NNP is_VBZ now_RB diagnosed_VBN with_IN autism_NN ._. ""_`` We_PRP must_MD take_VB swift_JJ and_CC systematic_JJ action_NN to_TO increase_VB access_NN to_IN and_CC fund_VB medically_RB necessary_JJ treatment_NN for_IN every_DT child_NN with_IN autism_NN ,_, ""_'' said_VBD Suzanne_NNP Buchanan_NNP ,_, executive_JJ director_NN of_IN Autism_NNP New_NNP Jersey_NNP ._. ""_`` Early_JJ identification_NN is_VBZ crucial_JJ to_IN helping_VBG families_NNS access_VB services_NNS for_IN these_DT preschoolers_NNS ,_, who_WP need_VBP intensive_JJ treatment_NN to_TO learn_VB developmentally_RB appropriate_JJ skills_NNS and_CC maximize_VB their_PRP$ potential_NN ._. ""_'' More_JJR :_: Large_JJ study_NN adds_VBZ to_IN proof_NN that_IN measles_NNS vaccine_NN does_VBZ n’t_RB cause_VB autism_NN More_JJR :_: I_PRP 'm_VBP married_JJ ._. I_PRP 'm_VBP also_RB autistic_JJ ._. But_CC being_VBG on_IN the_DT spectrum_NN has_VBZ made_VBN me_PRP a_DT better_JJR husband_NN ._. The_DT New_NNP Jersey_NNP data_NNS is_VBZ included_VBN in_IN a_DT seven_CD -_HYPH state_NN study_NN by_IN the_DT Early_NNP Autism_NNP and_CC Developmental_NNP Disabilities_NNPS Monitoring_NNP Network_NNP ,_, which_WDT has_VBZ monitored_VBN rates_NNS of_IN autism_NN diagnoses_NNS for_IN 19_CD years_NNS ._. Researchers_NNS in_IN Arizona_NNP ,_, Colorado_NNP ,_, Missouri_NNP ,_, North_NNP Carolina_NNP ,_, Utah_NNP and_CC Wisconsin_NNP ,_, as_RB well_RB as_IN New_NNP Jersey_NNP ,_, screened_VBD the_DT health_NN records_NNS of_IN nearly_RB 71,000_CD children_NNS ._. Three_CD states_NNS used_VBD education_NN records_NNS in_IN addition_NN to_IN health_NN records_NNS ._. In_IN all_DT ,_, they_PRP identified_VBD more_JJR than_IN 1,200_CD children_NNS with_IN autism_NN ._. The_DT New_NNP Jersey_NNP study_NN included_VBD every_DT 4_CD -_HYPH year_NN -_HYPH old_JJ in_IN Essex_NNP and_CC Union_NNP counties_NNS –_: 18,112_CD children_NNS in_IN 2014_CD –_: and_CC identified_VBD 514_CD with_IN autism_NN ._. Boys_NNS in_IN New_NNP Jersey_NNP were_VBD 3_CD ½_CD times_NNS more_RBR likely_JJ than_IN girls_NNS to_TO be_VB diagnosed_VBN with_IN the_DT disorder_NN ,_, the_DT data_NNS showed_VBD ._. Autism_NN diagnoses_NNS among_IN whites_NNS ,_, blacks_NNS and_CC Hispanic_JJ children_NNS increased_VBD at_IN the_DT same_JJ rate_NN ,_, although_IN white_JJ children_NNS were_VBD slightly_RB more_RBR likely_JJ to_TO be_VB diagnosed_VBN ._. Perhaps_RB most_RBS disturbing_JJ :_: The_DT age_NN at_IN first_JJ diagnosis_NN did_VBD n't_RB budge_VB in_IN 15_CD years_NNS ._. In_IN New_NNP Jersey_NNP ,_, it_PRP even_RB increased_VBD by_IN a_DT few_JJ months_NNS –_: perhaps_RB because_IN the_DT growing_VBG demand_NN for_IN services_NNS and_CC the_DT limited_JJ number_NN of_IN providers_NNS meant_VBD delays_NNS in_IN care_NN ,_, Zahorodny_NNP said_VBD ._. “_`` Despite_IN our_PRP$ greater_JJR awareness_NN ,_, we_PRP are_VBP not_RB effective_JJ yet_RB in_IN early_JJ detection_NN ,_, ”_'' he_PRP said_VBD ._. “_`` Our_PRP$ goal_NN should_MD be_VB systematic_JJ ,_, universal_JJ screening_NN ""_'' by_IN pediatricians_NNS and_CC other_JJ health_NN providers_NNS at_IN regular_JJ visits_NNS from_IN 18_CD months_NNS of_IN age_NN onward_RB ._. Autism_NN is_VBZ a_DT complex_JJ disorder_NN that_WDT interferes_VBZ with_IN social_JJ interaction_NN and_CC communication_NN ._. People_NNS with_IN autism_NN display_VBP a_DT range_NN ,_, or_CC spectrum_NN ,_, of_IN behaviors_NNS from_IN obsessive_JJ interest_NN in_IN certain_JJ subjects_NNS and_CC repetitive_JJ speech_NN patterns_NNS to_IN self_NN -_HYPH injurious_JJ behavior_NN with_IN little_JJ or_CC no_DT ability_NN to_TO communicate_VB ._. The_DT development_NN of_IN a_DT child_NN 's_POS brain_NN is_VBZ affected_VBN early_RB in_IN life_NN ,_, and_CC while_IN there_EX is_VBZ no_DT cure_NN ,_, early_JJ intervention_NN can_MD maximize_VB a_DT child_NN 's_POS ability_NN to_TO function_VB and_CC participate_VB in_IN the_DT community_NN ._. More_JJR :_: Pregnant_JJ women_NNS who_WP take_VBP prenatal_JJ vitamins_NNS may_MD lower_VB child_NN 's_POS risk_NN of_IN autism_NN ,_, study_NN suggests_VBZ More_JJR :_: Autism_NN community_NN lauds_VBZ Amy_NNP Schumer_NNP for_IN comments_NNS on_IN her_PRP$ husband_NN 's_POS autism_NN spectrum_NN disorder_NN diagnosis_NN Across_IN the_DT country_NN ,_, rates_NNS of_IN autism_NN ranged_VBD from_IN a_DT low_NN of_IN eight_CD per_IN 1,000_CD children_NNS in_IN Missouri_NNP to_IN New_NNP Jersey_NNP 's_POS high_JJ of_IN 28_CD per_IN 1,000_CD children_NNS ._. The_DT national_JJ average_NN was_VBD 13_CD per_IN 1,000_CD children_NNS ,_, according_VBG to_IN the_DT study_NN ._. ""_`` The_DT experience_NN of_IN our_PRP$ special_JJ education_NN system_NN and_CC the_DT number_NN of_IN developmental_JJ specialists_NNS in_IN our_PRP$ region_NN ""_'' meant_VBD New_NNP Jersey_NNP 's_POS data_NNS was_VBD probably_RB more_RBR complete_JJ than_IN that_DT of_IN other_JJ states_NNS ,_, Zahorodny_NNP said_VBD ._. States_NNPS with_IN lower_JJR rates_NNS probably_RB had_VBD not_RB identified_VBN all_PDT those_DT affected_VBN ,_, he_PRP said_VBD ._.","NNP NNP NNS VBP JJS NN NNS in the NN , NNS VBP NNP NNP , NNP – NNP NNP NNS VBP the JJS NNS of NN RB VBN in the NNP NNPS , a NN that VBZ VBN JJR than in JJ NNS VBN , NNS at NNP NNP VBD NNP . The NN of NN among NNS in the NN VBZ VBN in a NN . One in 35 NNS in NNP NNP VBD VBN with NN by their JJ NN , VBG to the NN VBN NNP by the NNPS for NNP NNP and NNP . Those NNS VBD RBR JJ to VB VBN the NN of NNS and JJ - NN NNS because of JJ to JJ NNS of NN . RB , JJR NNS VBP VBN with NN when they VBP JJ NNS . The JJ NN in NN NNS – from 1 NN of NNS VBN in 1992 to 3 NN of NNS VBN in 2010 – VBZ VBN no NNS of VBG a NN , VBD NNP NNP , an NN NN at NNP NNP NNP NNP NNP who VBD the NNP NNP NN of the NN . "" The JJ NN of NN VBZ JJ to VB , "" he VBD . NN NNS VBP VBG NN for JJ NNS for NNS with NN . NNS VBP JJ NN NNS for their NNS . "" There VBZ no NN , "" he VBD . "" I RB VBP RB VB why the NN VBZ VBG up in this NN . "" NNS can’t VB why NN NNS VBP VBN in NNP NNP and RB . VBG NNS VBP JJ NNS and NN - JJ NNS , JJ as VBG VBN RB , as one of a JJ NN , to a NN who VBD JJ during NN or to NNS who VBP JJR than 30 . But the JJS NNS VBP to VB JJ JJ NNS , NNP VBD . Among 4 - NN - NNS , the NN VBD 43 NN in RB four NNS , from 2010 to 2014 , he VBD . One in 23 4 - NN - JJ NNS in NNP NNP VBZ RB VBN with NN . "" We must VB JJ and JJ NN to VB NN to and VB RB JJ NN for every NN with NN , "" VBD NNP NNP , JJ NN of NNP NNP NNP . "" JJ NN VBZ JJ to VBG NNS VB NNS for these NNS , who VBP JJ NN to VB RB JJ NNS and VB their NN . "" JJR : JJ NN VBZ to NN that NNS NN VBZ RB VB NN JJR : I VBP JJ . I VBP RB JJ . But VBG on the NN VBZ VBN me a JJR NN . The NNP NNP NNS VBZ VBN in a seven - NN NN by the NNP NNP and NNP NNPS NNP NNP , which VBZ VBN NNS of NN NNS for 19 NNS . NNS in NNP , NNP , NNP , NNP NNP , NNP and NNP , RB RB as NNP NNP , VBD the NN NNS of RB 71,000 NNS . Three NNS VBD NN NNS in NN to NN NNS . In all , they VBD JJR than 1,200 NNS with NN . The NNP NNP NN VBD every 4 - NN - JJ in NNP and NNP NNS – 18,112 NNS in 2014 – and VBD 514 with NN . NNS in NNP NNP VBD 3 ½ NNS RBR JJ than NNS to VB VBN with the NN , the NNS VBD . NN NNS among NNS , NNS and JJ NNS VBD at the JJ NN , although JJ NNS VBD RB RBR JJ to VB VBN . RB RBS JJ : The NN at JJ NN VBD RB VB in 15 NNS . In NNP NNP , it RB VBD by a JJ NNS – RB because the VBG NN for NNS and the JJ NN of NNS VBD NNS in NN , NNP VBD . “ Despite our JJR NN , we VBP RB JJ RB in JJ NN , ” he VBD . “ Our NN should VB JJ , JJ NN "" by NNS and JJ NN NNS at JJ NNS from 18 NNS of NN RB . NN VBZ a JJ NN that VBZ with JJ NN and NN . NNS with NN VBP a NN , or NN , of NNS from JJ NN in JJ NNS and JJ NN NNS to NN - JJ NN with JJ or no NN to VB . The NN of a NN 's NN VBZ VBN RB in NN , and while there VBZ no NN , JJ NN can VB a NN 's NN to VB and VB in the NN . JJR : JJ NNS who VBP JJ NNS may VB NN 's NN of NN , NN VBZ JJR : NN NN VBZ NNP NNP for NNS on her NN 's NN NN NN NN Across the NN , NNS of NN VBD from a NN of eight per 1,000 NNS in NNP to NNP NNP 's JJ of 28 per 1,000 NNS . The JJ NN VBD 13 per 1,000 NNS , VBG to the NN . "" The NN of our JJ NN NN and the NN of JJ NNS in our NN "" VBD NNP NNP 's NNS VBD RB RBR JJ than that of JJ NNS , NNP VBD . NNPS with JJR NNS RB VBD RB VBN all those VBN , he VBD ."
26,643,conspiracy,"Just_RB as_IN COVID_NNP -_HYPH 19_CD (_-LRB- reportedly_RB caused_VBN by_IN the_DT new_JJ coronavirus_NN ,_, SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD )_-RRB- has_VBZ dominated_VBN the_DT news_NN cycle_NN in_IN 2020_CD ,_, so_RB ,_, too_RB ,_, the_DT focus_NN on_IN an_DT eventual_JJ coronavirus_NN vaccine_NN has_VBZ crowded_VBN out_RP needed_VBN attention_NN to_IN a_DT wider_JJR range_NN of_IN prevention_NN and_CC treatment_NN strategies_NNS ._. Self_NN -_HYPH appointed_VBN pandemic_NN guru_NN Bill_NNP Gates_NNP —_: through_IN a_DT complex_JJ tangle_NN of_IN direct_JJ and_CC indirect_JJ funding_NN mechanisms_NNS that_WDT includes_VBZ being_VBG the_DT World_NNP Health_NNP Organization_NNP ’s_POS (_-LRB- WHO_NNP ’s_POS )_-RRB- second_RB largest_JJS donor_NN —_: is_VBZ gleefully_RB leading_VBG the_DT contingent_NN promoting_VBG planet_NN -_HYPH wide_JJ coronavirus_NN vaccination_NN ,_, unashamedly_RB asserting_VBG that_IN a_DT vaccine_NN “_'' is_VBZ the_DT only_JJ thing_NN that_WDT will_MD allow_VB us_PRP to_TO return_VB to_IN normal_JJ ._. ”_'' Gates_NNP has_VBZ the_DT effrontery_NN to_TO make_VB such_JJ claims_NNS despite_IN financial_JJ conflicts_NNS of_IN interest_NN blatant_JJ enough_RB to_TO be_VB noticed_VBN even_RB by_IN the_DT credulous_JJ ,_, and_CC a_DT lengthy_JJ trail_NN of_IN vaccine_NN -_HYPH related_JJ destruction_NN left_VBN in_IN the_DT wake_NN of_IN Gates_NNP -_HYPH funded_VBN vaccine_NN programs_NNS around_IN the_DT world_NN ._. Globally_RB ,_, roughly_RB 70_CD COVID_NN -_HYPH 19_CD vaccines_NNS are_VBP in_IN various_JJ stages_NNS of_IN development_NN —_: a_DT veritable_JJ gold_NN rush_NN that_WDT will_MD be_VB all_RB the_DT more_RBR lucrative_JJ since_IN Gates_NNPS has_VBZ made_VBN sure_JJ that_IN the_DT vaccines_NNS will_MD be_VB indemnified_VBN against_IN lawsuits_NNS ._. Gates_NNS funding_NN ,_, through_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP and_CC the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS (_-LRB- CEPI_NNP )_-RRB- ,_, is_VBZ helping_VBG to_TO spur_VB the_DT accelerated_VBN development_NN of_IN some_DT of_IN the_DT leading_VBG contenders_NNS ,_, including_VBG two_CD of_IN the_DT three_CD experimental_JJ vaccines_NNS rushed_VBN into_IN Phase_NN I_CD trials_NNS in_IN humans_NNS without_IN any_DT preliminary_JJ testing_NN in_IN animal_NN models_NNS ._. (_-LRB- A_DT third_JJ experimental_JJ vaccine_NN will_MD soon_RB proceed_VB to_IN Phase_NN II_CD trials_NNS in_IN China_NNP ._. )_-RRB- The_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- is_VBZ running_VBG the_DT trial_NN of_IN one_CD of_IN these_DT vaccines_NNS (_-LRB- mRNA_NNP -_SYM 1273_CD )_-RRB- ,_, co-developed_VBN under_IN CEPI_NNP sponsorship_NN with_IN Cambridge_NNP -_HYPH based_VBN biotech_NN firm_NN Moderna_NNP ._. Meanwhile_RB ,_, Pennsylvania_NNP -_HYPH based_VBN Inovio_NNP Pharmaceuticals_NNP is_VBZ conducting_VBG a_DT Phase_NN I_CD trial_NN of_IN INO_NNP -_HYPH 4800_CD ,_, a_DT vaccine_NN being_VBG developed_VBN with_IN massive_JJ infusions_NNS of_IN funding_NN from_IN both_CC the_DT Gates_NNP Foundation_NNP and_CC CEPI_NNP ._. In_IN early_JJ April_NNP ,_, Dr._NNP Jerome_NNP H._NNP Kim_NNP (_-LRB- Director_NNP General_NNP of_IN the_DT United_NNP -_HYPH Nations_NNPS -_HYPH affiliated_VBN International_NNP Vaccine_NNP Institute_NNP )_-RRB- called_VBD attention_NN to_IN the_DT “_`` unprecedented_JJ speed_NN ”_'' with_IN which_WDT the_DT Phase_NNP I_NNP trials_NNS launched_VBD ,_, stating_VBG that_IN it_PRP will_MD be_VB difficult_JJ to_TO know_VB whether_IN a_DT vaccine_NN developed_VBD in_IN a_DT scant_JJ four_CD ,_, 12_CD or_CC even_RB 18_CD months_NNS “_'' is_VBZ really_RB safe_JJ ”_'' and_CC noting_VBG that_IN the_DT vaccine_NN development_NN process_NN ordinarily_RB takes_VBZ anywhere_RB from_IN five_CD to_IN ten_CD years_NNS ._. Although_IN striving_VBG for_IN enthusiasm_NN about_IN the_DT “_`` remarkable_JJ ”_'' speed_NN -_HYPH up_NN ,_, Kim_NNP warned_VBD that_IN even_RB when_WRB vaccine_NN makers_NNS appropriately_RB begin_VBP the_DT process_NN with_IN animal_NN studies_NNS ,_, “_`` vaccine_NN development_NN is_VBZ characterized_VBN by_IN a_DT high_JJ failure_NN rate_NN of_IN ‘_`` often_RB 93_CD %_NN ._. ’_'' ”_'' Dr._NNP Kim_NNP ’s_POS words_NNS of_IN warning_NN are_VBP far_RB from_IN theoretical_JJ ._. In_IN the_DT mid_JJ -to_IN -_HYPH late_JJ 2000s_NNS ,_, scientists_NNS engaged_VBD in_IN an_DT ultimately_RB futile_JJ effort_NN to_TO develop_VB a_DT vaccine_NN to_TO address_VB the_DT first_JJ SARS_NN -_HYPH related_JJ coronavirus_NN (_-LRB- SARS_NNP -_HYPH CoV_NNP )_-RRB- ._. Researchers_NNS of_IN the_DT day_NN developed_VBD four_CD SARS_NN -_HYPH CoV_NN vaccines_NNS that_WDT underwent_VBD testing_NN in_IN animal_NN models_NNS and_CC two_CD (_-LRB- described_VBN in_IN 2007_CD and_CC 2008_CD )_-RRB- that_WDT proceeded_VBD to_IN Phase_NN I_CD trials_NNS in_IN humans_NNS ._. The_DT less_JJR -_HYPH than_IN -_HYPH reassuring_JJ results_NNS of_IN the_DT animal_NN studies_NNS ,_, in_IN particular_JJ ,_, prompted_VBD one_CD set_NN of_IN researchers_NNS to_TO conclude_VB that_IN “_`` Caution_NN in_IN proceeding_NN to_IN application_NN of_IN a_DT SARS_NN -_HYPH CoV_NN vaccine_NN in_IN humans_NNS is_VBZ indicated_VBN ”_'' [_-LRB- emphasis_NN added_VBN ]_-RRB- ._. In_IN 2012_CD ,_, Texas_NNP researchers_NNS with_IN combined_VBN expertise_NN in_IN molecular_JJ virology_NN ,_, microbiology_NN ,_, immunology_NN ,_, biodefense_NN and_CC emerging_VBG diseases_NNS reported_VBN in_IN the_DT journal_NN PLoS_NNP ONE_CD on_IN their_PRP$ evaluation_NN —_: in_IN mice_NNS —_: of_IN four_CD candidate_NN vaccines_NNS designed_VBN to_TO prevent_VB SARS_NN -_HYPH CoV_NN ._. All_DT four_CD vaccines_NNS had_VBD run_VBN into_IN trouble_NN in_IN earlier_JJR experimental_JJ studies_NNS ,_, which_WDT showed_VBD that_IN the_DT vaccines_NNS had_VBD a_DT tendency_NN to_TO induce_VB pathologic_JJ lung_NN reactions_NNS in_IN the_DT unfortunate_JJ recipients_NNS —_: whether_IN mice_NNS ,_, ferrets_NNS or_CC nonhuman_JJ primates_NNS ._. The_DT Texas_NNP scientists_NNS reevaluated_VBD the_DT safety_NN ,_, immunogenicity_NN and_CC efficacy_NN of_IN two_CD whole_JJ -_HYPH virus_NN vaccines_NNS prepared_VBN in_IN Vero_NNP tissue_NN or_CC Vero_NNP cell_NN cultures_NNS (_-LRB- from_IN African_JJ green_JJ monkey_NN kidney_NN )_-RRB- ;_, one_CD recombinant_NN (_-LRB- genetically_RB engineered_VBN )_-RRB- DNA_NN spike_NN protein_NN vaccine_NN produced_VBN in_IN insect_NN cells_NNS ;_: and_CC their_PRP$ own_JJ virus_NN -_HYPH like_IN particle_NN (_-LRB- VLP_NN )_-RRB- vaccine_NN containing_VBG SARS_NN -_HYPH CoV_NN proteins_NNS as_RB well_RB as_IN mouse_NN hepatitis_NN coronavirus_NN ._. They_PRP also_RB compared_VBD versions_NNS of_IN the_DT vaccines_NNS containing_VBG an_DT aluminum_NN adjuvant_NN with_IN adjuvant_NN -_HYPH free_JJ formulations_NNS ._. The_DT research_NN team_NN injected_VBD the_DT experimental_JJ groups_NNS of_IN mice_NNS with_IN vaccine_NN on_IN days_NNS zero_CD and_CC 28_CD ,_, exposed_VBD them_PRP to_IN live_JJ SARS_NNP -_HYPH CoV_NNP on_IN day_NN 56_CD and_CC sacrificed_VBD them_PRP two_CD days_NNS later_RBR (_-LRB- day_NN 58_CD )_-RRB- to_TO examine_VB the_DT lungs_NNS for_IN virus_NN and_CC histopathology_NN ,_, comparing_VBG the_DT experimental_JJ mice_NNS to_IN control_NN groups_NNS ._. All_DT four_CD vaccines_NNS appeared_VBD to_TO induce_VB antibodies_NNS against_IN SARS_NNP -_HYPH CoV_NNP two_CD days_NNS after_IN exposure_NN to_IN live_JJ virus_NN ._. However_RB ,_, the_DT second_JJ set_NN of_IN results_NNS —_: the_DT findings_NNS that_WDT persuaded_VBD the_DT researchers_NNS to_TO urge_VB the_DT utmost_JJS caution_NN in_IN proceeding_NN to_IN human_JJ testing_NN —_: showed_VBD that_IN all_DT of_IN the_DT vaccinated_VBN mice_NNS ,_, irrespective_JJ of_IN the_DT type_NN of_IN vaccine_NN or_CC the_DT presence_NN or_CC absence_NN of_IN aluminum_NN adjuvant_NN ,_, displayed_VBD unique_JJ lung_NN damage_NN not_RB seen_VBN in_IN the_DT control_NN mice_NNS ,_, and_CC the_DT pathology_NN occurred_VBD in_IN the_DT absence_NN of_IN any_DT detectable_JJ SARS_NN coronavirus_NN in_IN the_DT lungs_NNS ._. The_DT researchers_NNS described_VBD this_DT “_`` Th2_NN -_HYPH type_NN immunopathology_NN ”_'' —_: indicated_VBN in_IN part_NN by_IN abnormal_JJ levels_NNS of_IN white_JJ blood_NN cells_NNS called_VBN eosinophils_NNS —_: as_IN suggestive_JJ of_IN vaccine_NN -_HYPH induced_VBN “_`` hypersensitivity_NN to_IN SARS_NN -_HYPH CoV_NN components_NNS ._. ”_'' To_TO explain_VB their_PRP$ findings_NNS ,_, the_DT Texas_NNP researchers_NNS pointed_VBD to_IN studies_NNS showing_VBG similar_JJ immunopathologic_JJ reactions_NNS in_IN human_JJ infants_NNS who_WP ,_, in_IN the_DT 1960s_NNS ,_, received_VBD vaccines_NNS for_IN respiratory_JJ syncytial_JJ virus_NN (_-LRB- RSV_NNP )_-RRB- ._. That_DT body_NN of_IN research_NN found_VBD that_IN the_DT RSV_NNP vaccine_NN “_'' stimulated_VBD an_DT unbalanced_JJ immune_JJ response_NN ”_'' that_WDT “_`` potentiated_VBD ”_'' disease_NN in_IN the_DT vaccine_NN recipients_NNS upon_IN subsequent_JJ exposure_NN to_IN RSV_NNP ,_, often_RB leading_VBG to_IN hospitalization_NN and_CC sometimes_RB leading_VBG to_IN death_NN ._. Given_VBN that_IN the_DT very_JJ basis_NN for_IN developing_VBG a_DT SARS_NNP vaccine_NN was_VBD to_TO protect_VB vaccine_NN recipients_NNS from_IN infectious_JJ SARS_NN -_HYPH CoV_NNP ,_, the_DT Texas_NNP researchers_NNS concluded_VBD that_IN a_DT vaccine_NN that_WDT instead_RB elicited_VBD an_DT immunopathologic_JJ reaction_NN (_-LRB- as_IN had_VBD occurred_VBN in_IN the_DT 1960s_NNS with_IN the_DT RSV_NNP vaccine_NN )_-RRB- was_VBD cause_NN for_IN concern_NN ._. More_RBR recently_RB ,_, in_IN 2016_CD ,_, scientists_NNS expressed_VBD similar_JJ worries_NNS when_WRB children_NNS in_IN the_DT Philippines_NNPS developed_VBD serious_JJ complications_NNS or_CC died_VBD after_IN receiving_VBG a_DT vaccine_NN to_TO protect_VB against_IN dengue_NN disease_NN ._. Far_RB from_IN protecting_VBG the_DT children_NNS ,_, the_DT vaccine_NN dramatically_RB worsened_VBD risks_NNS of_IN severe_JJ complications_NNS in_IN children_NNS exposed_VBN to_IN dengue_NN after_IN vaccination_NN ._. The_DT deaths_NNS of_IN roughly_RB 600_CD children_NNS are_VBP now_RB under_IN criminal_JJ investigation_NN ._. Two_CD other_JJ worries_NNS highlighted_VBN by_IN the_DT Texas_NNP researchers_NNS in_IN 2012_CD are_VBP worth_JJ mentioning_VBG in_IN light_NN of_IN today_NN ’s_POS COVID_NNP -_HYPH 19_CD context_NN ._. First_RB ,_, given_VBN that_IN there_EX are_VBP a_DT number_NN of_IN human_JJ coronaviruses_NNS ,_, the_DT researchers_NNS suggested_VBD that_IN their_PRP$ results_NNS raised_VBD important_JJ questions_NNS about_IN the_DT “_`` safety_NN of_IN vaccinated_VBN persons_NNS exposed_VBN to_IN other_JJ coronaviruses_NNS ._. ”_'' Second_RB ,_, they_PRP noted_VBD that_IN although_IN the_DT two_CD Phase_NN I_CD clinical_JJ trials_NNS of_IN SARS_NN -_HYPH CoV_NN vaccines_NNS in_IN humans_NNS had_VBD reported_VBN the_DT vaccines_NNS to_TO “_`` induce_VB antibody_NN responses_NNS and_CC to_TO be_VB ‘_`` safe_JJ ,_, ’_'' ._. ._. ._. the_DT evidence_NN for_IN safety_NN [_-LRB- was_VBD ]_-RRB- for_IN a_DT short_JJ period_NN of_IN observation_NN ._. ”_'' Today_NN ,_, knowing_VBG that_IN even_RB the_DT WHO_NNP ’s_POS top_JJ experts_NNS are_VBP questioning_VBG how_WRB vaccine_NN safety_NN gets_VBZ evaluated_VBN ,_, one_PRP wonders_VBZ how_WRB the_DT rushed_VBN COVID_NN -_HYPH 19_CD vaccine_NN trials_NNS will_MD be_VB able_JJ to_TO address_VB SARS_NN -_HYPH CoV_NN safety_NN concerns_NNS to_IN any_DT meaningful_JJ degree_NN ._. Bill_NNP Gates_NNP and_CC his_PRP$ foundation_NN have_VBP longstanding_JJ ties_NNS with_IN the_DT good_JJ -_HYPH cop_NN /_, bad_JJ -_HYPH cop_NN duo_NN that_WDT has_VBZ been_VBN headlining_VBG the_DT official_JJ COVID_NN -_HYPH 19_CD narrative_NN :_: Dr._NNP Anthony_NNP Fauci_NNP ,_, long_JJ -_HYPH time_NN NIAID_NNP director_NN ,_, and_CC physician_NN and_CC retired_VBN Army_NNP colonel_NN Dr._NNP Deborah_NNP Birx_NNP ,_, U.S._NNP Global_NNP AIDS_NNP Coordinator_NNP and_CC Special_NNP Representative_NNP for_IN Global_NNP Health_NNP Diplomacy_NNP ._. It_PRP is_VBZ noteworthy_JJ that_IN the_DT two_CD government_NN doctors_NNS are_VBP long_JJ -_HYPH time_NN allies_NNS ,_, having_VBG cut_VBN their_PRP$ professional_JJ teeth_NNS working_VBG “_`` side_NN by_IN side_NN ”_'' on_IN the_DT AIDS_NNP epidemic_NN in_IN the_DT 1980s_NNS and_CC sharing_VBG overlapping_VBG career_NN paths_NNS ever_RB since_RB ._. With_IN HIV_NN vaccine_NN patents_NNS to_IN both_CC their_PRP$ names_NNS ,_, neither_CC Birx_NNP nor_CC Fauci_NNP is_VBZ a_DT stranger_NN to_IN the_DT lure_NN and_CC potential_JJ profits_NNS involved_VBN in_IN vaccine_NN development_NN —_: regardless_RB of_IN whether_IN the_DT vaccine_NN ever_RB pans_VBZ out_RP ._. In_IN the_DT early_JJ 2000s_NN ,_, Birx_NNP was_VBD one_CD of_IN the_DT lead_JJ investigators_NNS of_IN an_DT HIV_NNP vaccine_NN clinical_JJ trial_NN in_IN Thailand_NNP ._. Although_IN the_DT trial_NN ’s_POS methodology_NN and_CC results_NNS drew_VBD severe_JJ criticism_NN ,_, Birx_NNP and_CC others_NNS —_: including_VBG Fauci_NNP —_: spun_VBD the_DT study_NN as_IN a_DT success_NN ._. As_IN her_PRP$ reward_NN ,_, Birx_NNP then_RB spent_VBD the_DT next_JJ ten_CD years_NNS directing_VBG the_DT CDC_NNP ’s_POS Division_NN of_IN Global_JJ HIV_NN /_, AIDS_NN ._. In_IN 2016_CD ,_, Fauci_NNP and_CC NIAID_NNP dished_VBD out_RP more_JJR taxpayer_NN money_NN to_TO test_VB the_DT same_JJ HIV_NN vaccine_NN all_RB over_RB again_RB in_IN South_NNP Africa_NNP ,_, but_CC NIAID_NNP had_VBD to_TO call_VB a_DT halt_NN to_IN the_DT study_NN in_IN February_NNP 2020_CD ,_, when_WRB an_DT interim_JJ review_NN found_VBD that_IN the_DT vaccine_NN was_VBD worthless_JJ ._. Around_IN the_DT same_JJ time_NN as_IN the_DT Thai_JJ vaccine_NN trial_NN ,_, Fauci_NNP was_VBD active_JJ as_IN one_CD of_IN the_DT “_`` principal_JJ architects_NNS ”_'' of_IN the_DT 2003_CD President_NNP ’s_POS Emergency_NN Plan_NN for_IN AIDS_NNP Relief_NNP (_-LRB- PEPFAR_NNP )_-RRB- ,_, a_DT still_RB -_HYPH ongoing_JJ program_NN that_WDT has_VBZ since_RB ballooned_VBN into_IN over_RB 50_CD countries_NNS ,_, where_WRB it_PRP coordinates_VBZ (_-LRB- across_IN seven_CD different_JJ U.S._NNP departments_NNS and_CC agencies_NNS )_-RRB- promotion_NN of_IN HIV_NN drugs_NNS and_CC other_JJ measures_NNS ._. Since_IN 2014_CD ,_, PEPFAR_NNP has_VBZ been_VBN led_VBN by_IN none_NN other_JJ than_IN Birx_NNP ,_, who_WP has_VBZ been_VBN only_RB too_RB happy_JJ to_TO accept_VB generous_JJ Gates_NNP Foundation_NNP support_NN ._. The_DT foundation_NN is_VBZ the_DT top_JJ source_NN of_IN philanthropic_JJ funding_NN for_IN all_DT international_JJ HIV_NN efforts_NNS ,_, and_CC development_NN of_IN an_DT HIV_NN vaccine_NN remains_VBZ one_CD of_IN its_PRP$ core_NN “_`` areas_NNS of_IN focus_NN ._. ”_'' In_IN the_DT face_NN of_IN recent_JJ Trump_NNP administration_NN threats_NNS to_TO slash_VB PEPFAR_NNP ’s_POS budget_NN ,_, Birx_NNP has_VBZ declared_VBN her_PRP$ willingness_NN to_TO seek_VB out_RP “_`` other_JJ sources_NNS of_IN funding_NN wherever_WRB she_PRP can_MD find_VB them_PRP ._. ”_'' The_DT National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- ,_, of_IN which_WDT NIAID_NNP is_VBZ a_DT part_NN ,_, have_VBP been_VBN joined_VBN at_IN the_DT hip_NN with_IN the_DT Gates_NNP Foundation_NNP for_IN many_JJ years_NNS ,_, together_RB funding_VBG 57_CD %_NN of_IN “_`` global_JJ -_HYPH health_NN research_NN and_CC development_NN on_IN diseases_NNS that_WDT disproportionately_RB affect_VBP populations_NNS in_IN low_JJ -_HYPH and_CC middle_JJ -_HYPH income_NN countries_NNS ._. ”_'' The_DT close_JJ partnership_NN has_VBZ involved_VBN working_VBG to_TO develop_VB new_JJ vaccines_NNS (_-LRB- such_JJ as_IN a_DT malaria_NN vaccine_NN and_CC a_DT universal_JJ influenza_NN vaccine_NN )_-RRB- as_RB well_RB as_IN mobilizing_VBG Gates_NNS funding_NN streams_NNS to_TO roll_VB out_RP NIH_NNP -_HYPH developed_VBN vaccines_NNS across_IN the_DT developing_VBG world_NN ._. In_IN 2013_CD ,_, Gates_NNPS declared_VBD himself_PRP “_`` thrilled_VBN ”_'' with_IN NIH_NNP for_IN “_`` pushing_VBG [_-LRB- vaccine_NN research_NN ]_-RRB- forward_RB ”_'' and_CC stated_VBD ,_, “_`` We_PRP are_VBP just_RB at_IN the_DT beginning_NN of_IN what_WP we_PRP can_MD do_VB together_RB ._. ”_'' Despite_IN writing_VBG on_IN March_NNP 26_CD in_IN The_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP that_IN the_DT COVID_NN -_HYPH 19_CD case_NN fatality_NN rate_NN is_VBZ likely_JJ to_TO be_VB no_RB worse_JJR than_IN the_DT rate_NN observed_VBN for_IN a_DT severe_JJ seasonal_JJ flu_NN ,_, Dr._NNP Fauci_NNP continues_VBZ to_TO pledge_VB allegiance_NN to_IN extreme_JJ measures_NNS ,_, parroting_VBG Mr._NNP Gates_NNP ’_POS statements_NNS that_IN more_RBR prolonged_JJ lockdowns_NNS are_VBP necessary_JJ and_CC advising_VBG Americans_NNPS to_TO become_VB a_DT nation_NN of_IN obsessive_JJ -_HYPH compulsive_JJ hand_NN -_HYPH washers_NNS who_WP never_RB share_VBP a_DT handshake_NN again_RB ._. On_IN these_DT topics_NNS ,_, Birx_NNP has_VBZ been_VBN evasive_JJ and_CC non-committal_JJ ._. Recently_RB ,_, Dr._NNP Zeke_NNP Emanuel_NNP —_: coronavirus_NN advisor_NN to_IN both_CC Joe_NNP Biden_NNP and_CC the_DT WHO_NNP ,_, and_CC one_CD of_IN the_DT former_JJ ringleaders_NNS behind_IN Obamacare_NNP —_: joined_VBD the_DT fray_NN ,_, urging_VBG the_DT banning_NN of_IN conferences_NNS ,_, concerts_NNS ,_, sporting_NN events_NNS ,_, religious_JJ services_NNS and_CC restaurant_NN meals_NNS for_IN another_DT 18_CD months_NNS ,_, or_CC “_'' until_IN we_PRP have_VBP a_DT vaccine_NN that_WDT protects_VBZ everyone_NN ._. ”_'' The_DT Guardian_NNP obligingly_RB echoed_VBD this_DT vaccine_NN -_HYPH centric_JJ propaganda_NN on_IN April_NNP 8_CD when_WRB ,_, reporting_VBG on_IN a_DT Chinese_JJ study_NN just_RB published_VBN in_IN The_DT Lancet_NNP ,_, the_DT British_JJ rag_NN stated_VBD that_IN “_`` Lockdowns_NNS ca_MD n’t_RB end_VB until_IN Covid_NNP -_HYPH 19_CD vaccine_NN found_VBD ._. ”_'' Listening_VBG to_IN these_DT individuals_NNS ’_POS carefully_RB crafted_VBN public_JJ briefings_NNS on_IN COVID_NNP -_HYPH 19_CD exit_NN strategies_NNS ,_, one_PRP could_MD easily_RB get_VB the_DT impression_NN that_IN a_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD vaccine_NN is_VBZ ,_, indeed_RB ,_, the_DT only_JJ way_NN out_RP ._. For_IN a_DT population_NN amped_VBN up_RP on_IN hysteria_NN and_CC fear_NN ,_, it_PRP may_MD be_VB challenging_JJ to_TO accept_VB other_JJ solutions_NNS —_: including_VBG the_DT historically_RB documented_VBN benefits_NNS of_IN natural_JJ herd_NN immunity_NN —_: but_CC the_DT studies_NNS on_IN unsafe_JJ vaccines_NNS for_IN SARS_NN -_HYPH CoV_NN ,_, RSV_NNP and_CC dengue_NN suggest_VBP that_IN Americans_NNPS would_MD be_VB wise_JJ to_TO ask_VB the_DT age_NN -_HYPH old_JJ question_NN of_IN “_`` who_WP benefits_VBZ ”_'' and_CC push_VB back_RB against_IN the_DT billionaires_NNS and_CC scientists_NNS looking_VBG to_TO limit_VB choices_NNS ,_, control_VB populations_NNS and_CC make_VB a_DT financial_JJ killing_NN ._. *_NFP Article_NN originally_RB appeared_VBN at_IN the_DT Children_NNPS ’s_POS Health_NNP Defense_NNP ._. Republished_VBN with_IN permission_NN ._. Copyright_NN 2020_CD –_: permission_NN to_TO reprint_VB fully_RB granted_VBN ,_, WITH_IN links_NNS to_IN original_JJ story_NN","RB as NNP - 19 ( RB VBN by the JJ NN , NNP - NNP - 2 ) VBZ VBN the NN NN in 2020 , RB , RB , the NN on an JJ NN NN VBZ VBN out VBN NN to a JJR NN of NN and NN NNS . NN - VBN NN NN NNP NNP — through a JJ NN of JJ and JJ NN NNS that VBZ VBG the NNP NNP NNP ’s ( NNP ’s ) RB JJS NN — VBZ RB VBG the NN VBG NN - JJ NN NN , RB VBG that a NN “ VBZ the JJ NN that will VB us to VB to JJ . ” NNP VBZ the NN to VB JJ NNS despite JJ NNS of NN JJ RB to VB VBN RB by the JJ , and a JJ NN of NN - JJ NN VBN in the NN of NNP - VBN NN NNS around the NN . RB , RB 70 NN - 19 NNS VBP in JJ NNS of NN — a JJ NN NN that will VB RB the RBR JJ since NNPS VBZ VBN JJ that the NNS will VB VBN against NNS . NNS NN , through the NNP & NNP NNP NNP and the NNP for NNP NNP NNPS ( NNP ) , VBZ VBG to VB the VBN NN of some of the VBG NNS , VBG two of the three JJ NNS VBN into NN I NNS in NNS without any JJ NN in NN NNS . ( A JJ JJ NN will RB VB to NN II NNS in NNP . ) The NNP NNP of NNP and NNP NNPS ( NNP ) VBZ VBG the NN of one of these NNS ( NNP - 1273 ) , VBN under NNP NN with NNP - VBN NN NN NNP . RB , NNP - VBN NNP NNP VBZ VBG a NN I NN of NNP - 4800 , a NN VBG VBN with JJ NNS of NN from both the NNP NNP and NNP . In JJ NNP , NNP NNP NNP NNP ( NNP NNP of the NNP - NNPS - VBN NNP NNP NNP ) VBD NN to the “ JJ NN ” with which the NNP NNP NNS VBD , VBG that it will VB JJ to VB whether a NN VBD in a JJ four , 12 or RB 18 NNS “ VBZ RB JJ ” and VBG that the NN NN NN RB VBZ RB from five to ten NNS . Although VBG for NN about the “ JJ ” NN - NN , NNP VBD that RB when NN NNS RB VBP the NN with NN NNS , “ NN NN VBZ VBN by a JJ NN NN of ‘ RB 93 NN . ’ ” NNP NNP ’s NNS of NN VBP RB from JJ . In the JJ -to - JJ NNS , NNS VBD in an RB JJ NN to VB a NN to VB the JJ NN - JJ NN ( NNP - NNP ) . NNS of the NN VBD four NN - NN NNS that VBD NN in NN NNS and two ( VBN in 2007 and 2008 ) that VBD to NN I NNS in NNS . The JJR - than - JJ NNS of the NN NNS , in JJ , VBD one NN of NNS to VB that “ NN in NN to NN of a NN - NN NN in NNS VBZ VBN ” [ NN VBN ] . In 2012 , NNP NNS with VBN NN in JJ NN , NN , NN , NN and VBG NNS VBN in the NN NNP ONE on their NN — in NNS — of four NN NNS VBN to VB NN - NN . All four NNS VBD VBN into NN in JJR JJ NNS , which VBD that the NNS VBD a NN to VB JJ NN NNS in the JJ NNS — whether NNS , NNS or JJ NNS . The NNP NNS VBD the NN , NN and NN of two JJ - NN NNS VBN in NNP NN or NNP NN NNS ( from JJ JJ NN NN ) ; one NN ( RB VBN ) NN NN NN NN VBN in NN NNS ; and their JJ NN - like NN ( NN ) NN VBG NN - NN NNS RB RB as NN NN NN . They RB VBD NNS of the NNS VBG an NN NN with NN - JJ NNS . The NN NN VBD the JJ NNS of NNS with NN on NNS zero and 28 , VBD them to JJ NNP - NNP on NN 56 and VBD them two NNS RBR ( NN 58 ) to VB the NNS for NN and NN , VBG the JJ NNS to NN NNS . All four NNS VBD to VB NNS against NNP - NNP two NNS after NN to JJ NN . RB , the JJ NN of NNS — the NNS that VBD the NNS to VB the JJS NN in NN to JJ NN — VBD that all of the VBN NNS , JJ of the NN of NN or the NN or NN of NN NN , VBD JJ NN NN RB VBN in the NN NNS , and the NN VBD in the NN of any JJ NN NN in the NNS . The NNS VBD this “ NN - NN NN ” — VBN in NN by JJ NNS of JJ NN NNS VBN NNS — as JJ of NN - VBN “ NN to NN - NN NNS . ” To VB their NNS , the NNP NNS VBD to NNS VBG JJ JJ NNS in JJ NNS who , in the NNS , VBD NNS for JJ JJ NN ( NNP ) . That NN of NN VBD that the NNP NN “ VBD an JJ JJ NN ” that “ VBD ” NN in the NN NNS upon JJ NN to NNP , RB VBG to NN and RB VBG to NN . VBN that the JJ NN for VBG a NNP NN VBD to VB NN NNS from JJ NN - NNP , the NNP NNS VBD that a NN that RB VBD an JJ NN ( as VBD VBN in the NNS with the NNP NN ) VBD NN for NN . RBR RB , in 2016 , NNS VBD JJ NNS when NNS in the NNPS VBD JJ NNS or VBD after VBG a NN to VB against NN NN . RB from VBG the NNS , the NN RB VBD NNS of JJ NNS in NNS VBN to NN after NN . The NNS of RB 600 NNS VBP RB under JJ NN . Two JJ NNS VBN by the NNP NNS in 2012 VBP JJ VBG in NN of NN ’s NNP - 19 NN . RB , VBN that there VBP a NN of JJ NNS , the NNS VBD that their NNS VBD JJ NNS about the “ NN of VBN NNS VBN to JJ NNS . ” RB , they VBD that although the two NN I JJ NNS of NN - NN NNS in NNS VBD VBN the NNS to “ VB NN NNS and to VB ‘ JJ , ’ . . . the NN for NN [ VBD ] for a JJ NN of NN . ” NN , VBG that RB the NNP ’s JJ NNS VBP VBG how NN NN VBZ VBN , one VBZ how the VBN NN - 19 NN NNS will VB JJ to VB NN - NN NN NNS to any JJ NN . NNP NNP and his NN VBP JJ NNS with the JJ - NN / JJ - NN NN that VBZ VBN VBG the JJ NN - 19 NN : NNP NNP NNP , JJ - NN NNP NN , and NN and VBN NNP NN NNP NNP NNP , NNP NNP NNP NNP and NNP NNP for NNP NNP NNP . It VBZ JJ that the two NN NNS VBP JJ - NN NNS , VBG VBN their JJ NNS VBG “ NN by NN ” on the NNP NN in the NNS and VBG VBG NN NNS RB RB . With NN NN NNS to both their NNS , neither NNP nor NNP VBZ a NN to the NN and JJ NNS VBN in NN NN — RB of whether the NN RB VBZ out . In the JJ NN , NNP VBD one of the JJ NNS of an NNP NN JJ NN in NNP . Although the NN ’s NN and NNS VBD JJ NN , NNP and NNS — VBG NNP — VBD the NN as a NN . As her NN , NNP RB VBD the JJ ten NNS VBG the NNP ’s NN of JJ NN / NN . In 2016 , NNP and NNP VBD out JJR NN NN to VB the JJ NN NN RB RB RB in NNP NNP , but NNP VBD to VB a NN to the NN in NNP 2020 , when an JJ NN VBD that the NN VBD JJ . Around the JJ NN as the JJ NN NN , NNP VBD JJ as one of the “ JJ NNS ” of the 2003 NNP ’s NN NN for NNP NNP ( NNP ) , a RB - JJ NN that VBZ RB VBN into RB 50 NNS , where it VBZ ( across seven JJ NNP NNS and NNS ) NN of NN NNS and JJ NNS . Since 2014 , NNP VBZ VBN VBN by NN JJ than NNP , who VBZ VBN RB RB JJ to VB JJ NNP NNP NN . The NN VBZ the JJ NN of JJ NN for all JJ NN NNS , and NN of an NN NN VBZ one of its NN “ NNS of NN . ” In the NN of JJ NNP NN NNS to VB NNP ’s NN , NNP VBZ VBN her NN to VB out “ JJ NNS of NN wherever she can VB them . ” The NNP NNPS of NNP ( NNP ) , of which NNP VBZ a NN , VBP VBN VBN at the NN with the NNP NNP for JJ NNS , RB VBG 57 NN of “ JJ - NN NN and NN on NNS that RB VBP NNS in JJ - and JJ - NN NNS . ” The JJ NN VBZ VBN VBG to VB JJ NNS ( JJ as a NN NN and a JJ NN NN ) RB RB as VBG NNS NN NNS to VB out NNP - VBN NNS across the VBG NN . In 2013 , NNPS VBD himself “ VBN ” with NNP for “ VBG [ NN NN ] RB ” and VBD , “ We VBP RB at the NN of what we can VB RB . ” Despite VBG on NNP 26 in The NNP NNP NNP of NNP that the NN - 19 NN NN NN VBZ JJ to VB RB JJR than the NN VBN for a JJ JJ NN , NNP NNP VBZ to VB NN to JJ NNS , VBG NNP NNP ’ NNS that RBR JJ NNS VBP JJ and VBG NNPS to VB a NN of JJ - JJ NN - NNS who RB VBP a NN RB . On these NNS , NNP VBZ VBN JJ and JJ . RB , NNP NNP NNP — NN NN to both NNP NNP and the NNP , and one of the JJ NNS behind NNP — VBD the NN , VBG the NN of NNS , NNS , NN NNS , JJ NNS and NN NNS for another 18 NNS , or “ until we VBP a NN that VBZ NN . ” The NNP RB VBD this NN - JJ NN on NNP 8 when , VBG on a JJ NN RB VBN in The NNP , the JJ NN VBD that “ NNS ca RB VB until NNP - 19 NN VBD . ” VBG to these NNS ’ RB VBN JJ NNS on NNP - 19 NN NNS , one could RB VB the NN that a NN - NN - 2 NN VBZ , RB , the JJ NN out . For a NN VBN up on NN and NN , it may VB JJ to VB JJ NNS — VBG the RB VBN NNS of JJ NN NN — but the NNS on JJ NNS for NN - NN , NNP and NN VBP that NNPS would VB JJ to VB the NN - JJ NN of “ who VBZ ” and VB RB against the NNS and NNS VBG to VB NNS , VB NNS and VB a JJ NN . * NN RB VBN at the NNPS ’s NNP NNP . VBN with NN . NN 2020 – NN to VB RB VBN , WITH NNS to JJ NN"
27,256,mainstream,"The_DT idea_NN that_IN vaccines_NNS cause_VBP autism_NN received_VBD yet_RB another_DT blow_NN this_DT week_NN ,_, with_IN a_DT new_JJ article_NN in_IN the_DT British_NNP Journal_NNP of_IN Medicine_NNP declaring_VBG the_DT 1998_CD study_NN by_IN Andrew_NNP Wakefield_NNP ,_, which_WDT originally_RB found_VBD an_DT autism_NN -_HYPH vaccine_NN link_NN ,_, an_DT ""_`` elaborate_JJ fraud_NN ._. ""_'' The_DT article_NN is_VBZ the_DT latest_JJS criticism_NN of_IN a_DT theory_NN that_WDT has_VBZ been_VBN widely_RB discredited_VBN ._. But_CC if_IN vaccines_NNS are_VBP off_IN the_DT table_NN ,_, what_WP does_VBZ cause_VB autism_NN ?_. While_IN scientists_NNS are_VBP still_RB investigating_VBG the_DT issue_NN ,_, they_PRP say_VBP the_DT disorder_NN likely_RB has_VBZ a_DT number_NN of_IN causes_NNS involving_VBG both_CC our_PRP$ genes_NNS and_CC our_PRP$ environment_NN ,_, or_CC some_DT combination_NN of_IN the_DT two_CD ._. For_IN instance_NN ,_, people_NNS may_MD have_VB underlying_JJ genetic_JJ susceptibilities_NNS to_IN autism_NN that_WDT are_VBP triggered_VBN by_IN something_NN they_PRP encounter_VBP in_IN the_DT environment_NN ._. Making_VBG things_NNS even_RB more_RBR complicated_JJ is_VBZ the_DT fact_NN that_IN autism_NN ,_, which_WDT is_VBZ characterized_VBN by_IN problems_NNS interacting_VBG and_CC communicating_VBG with_IN others_NNS ,_, is_VBZ not_RB a_DT single_JJ disorder_NN ,_, but_CC a_DT range_NN of_IN disorders_NNS that_WDT may_MD have_VB various_JJ causes_NNS ._. [_-LRB- See_VB a_DT timeline_NN of_IN events_NNS :_: Vaccines_NNS and_CC Autism_NNP :_: How_WRB the_DT Truth_NNP Unfolded_VBD ]_-RRB- ""_`` People_NNS are_VBP going_VBG to_TO manifest_VB the_DT disorder_NN in_IN different_JJ ways_NNS ,_, and_CC that_DT could_MD be_VB because_IN there_EX are_VBP different_JJ sets_NNS of_IN genes_NNS ,_, [_-LRB- or_CC ]_-RRB- different_JJ sets_NNS of_IN environmental_JJ factors_NNS ,_, ""_'' that_WDT contribute_VBP to_IN how_WRB the_DT disorder_NN presents_VBZ itself_PRP ,_, said_VBD Alycia_NNP Halladay_NNP ,_, director_NN of_IN research_NN for_IN environmental_JJ sciences_NNS for_IN Autism_NNP Speaks_NNP ,_, an_DT autism_NN advocacy_NN organization_NN that_WDT funds_VBZ autism_NN research_NN ._. Here_RB are_VBP the_DT latest_JJS findings_NNS and_CC ideas_NNS from_IN scientists_NNS about_IN what_WP might_MD really_RB cause_VB this_DT mysterious_JJ condition_NN ._. There_EX is_VBZ strong_JJ evidence_NN that_IN changes_NNS in_IN our_PRP$ genes_NNS contribute_VBP to_IN autism_NN ._. For_IN one_CD thing_NN ,_, the_DT disorder_NN is_VBZ highly_RB heritable_JJ ._. Families_NNS that_WDT have_VBP one_CD child_NN with_IN autism_NN have_VBP a_DT 1_CD in_IN 20_CD chance_NN of_IN having_VBG a_DT second_JJ child_NN with_IN autism_NN ,_, according_VBG to_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. This_DT is_VBZ a_DT higher_JJR risk_NN than_IN in_IN the_DT general_JJ population_NN ._. And_CC twin_JJ studies_NNS have_VBP found_VBN that_IN if_IN one_CD twin_NN has_VBZ autism_NN ,_, the_DT other_JJ twin_NN as_IN a_DT 90_CD percent_NN chance_NN of_IN having_VBG the_DT disorder_NN ._. Research_NN has_VBZ also_RB shown_VBN that_IN the_DT genetic_JJ changes_NNS that_WDT contribute_VBP to_IN autism_NN do_VBP n't_RB have_VB to_TO be_VB inherited_VBN —_: they_PRP may_MD also_RB arise_VB spontaneously_RB ._. In_IN total_NN ,_, scientists_NNS have_VBP identified_VBN about_RB 20_CD genes_NNS that_WDT may_MD be_VB involved_VBN in_IN autism_NN spectrum_NN disorder_NN ,_, Halladay_NNP said_VBD ._. While_IN these_DT genes_NNS are_VBP located_VBN all_RB over_IN the_DT human_JJ genome_NN ,_, they_PRP share_VBP a_DT common_JJ theme_NN ,_, she_PRP said_VBD ._. Many_JJ have_VBP a_DT role_NN in_IN brain_NN development_NN ,_, brain_NN growth_NN and_CC the_DT way_NN brain_NN cells_NNS communicate_VBP ._. For_IN example_NN ,_, a_DT recent_JJ study_NN found_VBD that_IN children_NNS with_IN a_DT genetic_JJ mutation_NN on_IN chromosome_NN 17_CD were_VBD 14_CD times_NNS more_RBR likely_JJ to_TO develop_VB autism_NN than_IN those_DT without_IN the_DT mutation_NN ._. Exposure_NN to_IN pesticides_NNS has_VBZ also_RB been_VBN linked_VBN to_IN autism_NN ._. Some_DT studies_NNS have_VBP found_VBN that_IN pesticides_NNS may_MD interfere_VB with_IN genes_NNS involved_VBN in_IN the_DT central_JJ nervous_JJ system_NN ,_, said_VBD Dr._NNP Alice_NNP Mao_NNP ,_, a_DT professor_NN of_IN psychiatry_NN at_IN Baylor_NNP College_NNP of_IN Medicine_NNP in_IN Houston_NNP ._. Scientists_NNS think_VBP that_IN chemicals_NNS in_IN pesticides_NNS may_MD adversely_RB affect_VB those_DT who_WP are_VBP genetically_RB predisposed_VBN to_IN autism_NN ,_, leading_VBG them_PRP to_TO develop_VB the_DT full_JJ -_HYPH blown_VBN disorder_NN ,_, Mao_NNP said_VBD ._. ""_`` Maybe_RB they_PRP were_VBD born_VBN with_IN a_DT vulnerability_NN to_IN autism_NN ,_, but_CC then_RB exposure_NN to_IN the_DT pesticides_NNS might_MD have_VB cause_VB the_DT presentation_NN of_IN autism_NN ,_, ""_'' Mao_NNP told_VBD MyHealthNewsDaily_NNP ._. Babies_NNS that_WDT have_VBP been_VBN exposed_VBN to_IN certain_JJ pharmaceuticals_NNS in_IN the_DT womb_NN ,_, including_VBG valproic_NN acid_NN and_CC thalidomide_NN ,_, have_VBP been_VBN found_VBN to_TO have_VB a_DT higher_JJR risk_NN of_IN autism_NN ._. Thalidomide_NNP is_VBZ a_DT drug_NN that_WDT was_VBD first_RB used_VBN in_IN the_DT 1950s_NNS to_TO treat_VB morning_NN sickness_NN ,_, anxiety_NN and_CC insomnia_NN ._. The_DT drug_NN was_VBD withdrawn_VBN from_IN the_DT market_NN after_IN it_PRP was_VBD linked_VBN with_IN birth_NN defects_NNS ,_, but_CC is_VBZ currently_RB prescribed_VBN for_IN a_DT severe_JJ skin_NN disorder_NN and_CC as_IN a_DT treatment_NN for_IN cancer_NN ._. Valproic_NN acid_NN is_VBZ a_DT medication_NN prescribed_VBN for_IN seizures_NNS ,_, mood_NN disorders_NNS and_CC bipolar_JJ disorder_NN ,_, according_VBG to_IN the_DT NIH_NNP ._. As_IN parents_NNS grow_VBP older_JJR ,_, they_PRP have_VBP a_DT higher_JJR risk_NN of_IN having_VBG children_NNS with_IN autism_NN ,_, Halladay_NNP said_VBD ._. A_DT study_NN published_VBN last_JJ February_NNP found_VBD that_IN women_NNS who_WP are_VBP 40_CD years_NNS old_JJ have_VBP a_DT 50_CD percent_NN greater_JJR risk_NN of_IN having_VBG a_DT child_NN with_IN autism_NN than_IN women_NNS who_WP are_VBP between_IN 20_CD and_CC 29_CD years_NNS old_JJ ._. Researchers_NNS are_VBP n't_RB sure_JJ why_WRB parental_JJ age_NN may_MD influence_VB autism_NN risk_NN ,_, but_CC it_PRP might_MD be_VB related_JJ to_IN genetic_JJ mutations_NNS that_WDT occur_VBP in_IN the_DT sperm_NN or_CC the_DT egg_NN as_IN parents_NNS grow_VBP older_JJR ,_, Halladay_NNP said_VBD ._. The_DT development_NN of_IN the_DT brain_NN Particular_JJ areas_NNS of_IN the_DT brain_NN ,_, including_VBG the_DT cerebral_JJ cortex_NN and_CC the_DT cerebellum_NN ,_, have_VBP been_VBN implicated_VBN in_IN autism_NN ,_, Mao_NNP said_VBD ._. These_DT brain_NN areas_NNS are_VBP thought_VBN to_TO be_VB responsible_JJ for_IN concentration_NN ,_, movement_NN and_CC mood_NN regulation_NN ._. Irregularities_NNS in_IN the_DT levels_NNS of_IN neurotransmitters_NNS ,_, such_JJ as_IN dopamine_NN and_CC serotonin_NN ,_, have_VBP also_RB been_VBN tied_VBN to_IN autism_NN ,_, Mao_NNP said_VBD ._. Problems_NNS regulating_VBG dopamine_NN can_MD lead_VB to_IN problems_NNS with_IN concentration_NN and_CC movement_NN disabilities_NNS ,_, while_IN troubles_NNS controlling_VBG serotonin_NN levels_NNS can_MD result_VB in_IN mood_NN problems_NNS ._. While_IN scientists_NNS cannot_MD say_VB definitively_RB what_WP causes_VBZ autism_NN ,_, they_PRP have_VBP come_VBN a_DT long_JJ way_NN in_IN the_DT last_JJ decade_NN ,_, Halladay_NNP said_VBD ._. For_IN example_NN ,_, researchers_NNS originally_RB thought_VBD there_EX might_MD be_VB just_RB a_DT single_JJ gene_NN or_CC a_DT few_JJ environmental_JJ factors_NNS that_WDT are_VBP linked_VBN to_IN autism_NN ,_, but_CC now_RB evidence_NN has_VBZ shown_VBN there_EX are_VBP likely_JJ to_TO be_VB more_JJR ._. ""_`` I_PRP think_VBP our_PRP$ knowledge_NN has_VBZ increased_VBN ,_, and_CC the_DT way_NN that_WDT we_PRP go_VBP about_IN looking_VBG for_IN potential_JJ genes_NNS and_CC environmental_JJ candidates_NNS has_VBZ improved_VBN ,_, ""_'' Halladay_NNP said_VBD ._. ""_`` We_PRP 're_VBP thinking_VBG about_IN a_DT new_JJ model_NN —_: it_PRP 's_VBZ not_RB just_RB going_VBG to_TO be_VB just_RB one_CD gene_NN or_CC one_CD environmental_JJ factor_NN ,_, it_PRP 's_VBZ more_RBR complex_JJ than_IN that_DT ,_, ""_'' she_PRP said_VBD ._. Pass_VB it_PRP on_IN :_: Autism_NN likely_RB has_VBZ a_DT number_NN of_IN causes_NNS ,_, both_CC genetic_JJ and_CC environmental_JJ ._. •_SYM Vaccines_NNS and_CC Autism_NN Timeline_NN :_: How_WRB the_DT Truth_NNP Unfolded_VBN •_SYM 1998_CD Study_NN Linking_VBG Autism_NNP to_IN Vaccines_NNPS Was_VBD an_DT '_`` Elaborate_JJ Fraud_NN '_''","The NN that NNS VBP NN VBD RB another NN this NN , with a JJ NN in the NNP NNP of NNP VBG the 1998 NN by NNP NNP , which RB VBD an NN - NN NN , an "" JJ NN . "" The NN VBZ the JJS NN of a NN that VBZ VBN RB VBN . But if NNS VBP off the NN , what VBZ VB NN ? While NNS VBP RB VBG the NN , they VBP the NN RB VBZ a NN of NNS VBG both our NNS and our NN , or some NN of the two . For NN , NNS may VB JJ JJ NNS to NN that VBP VBN by NN they VBP in the NN . VBG NNS RB RBR JJ VBZ the NN that NN , which VBZ VBN by NNS VBG and VBG with NNS , VBZ RB a JJ NN , but a NN of NNS that may VB JJ NNS . [ VB a NN of NNS : NNS and NNP : How the NNP VBD ] "" NNS VBP VBG to VB the NN in JJ NNS , and that could VB because there VBP JJ NNS of NNS , [ or ] JJ NNS of JJ NNS , "" that VBP to how the NN VBZ itself , VBD NNP NNP , NN of NN for JJ NNS for NNP NNP , an NN NN NN that VBZ NN NN . RB VBP the JJS NNS and NNS from NNS about what might RB VB this JJ NN . There VBZ JJ NN that NNS in our NNS VBP to NN . For one NN , the NN VBZ RB JJ . NNS that VBP one NN with NN VBP a 1 in 20 NN of VBG a JJ NN with NN , VBG to the NNP NNPS of NNP . This VBZ a JJR NN than in the JJ NN . And JJ NNS VBP VBN that if one NN VBZ NN , the JJ NN as a 90 NN NN of VBG the NN . NN VBZ RB VBN that the JJ NNS that VBP to NN VBP RB VB to VB VBN — they may RB VB RB . In NN , NNS VBP VBN RB 20 NNS that may VB VBN in NN NN NN , NNP VBD . While these NNS VBP VBN RB over the JJ NN , they VBP a JJ NN , she VBD . JJ VBP a NN in NN NN , NN NN and the NN NN NNS VBP . For NN , a JJ NN VBD that NNS with a JJ NN on NN 17 VBD 14 NNS RBR JJ to VB NN than those without the NN . NN to NNS VBZ RB VBN VBN to NN . Some NNS VBP VBN that NNS may VB with NNS VBN in the JJ JJ NN , VBD NNP NNP NNP , a NN of NN at NNP NNP of NNP in NNP . NNS VBP that NNS in NNS may RB VB those who VBP RB VBN to NN , VBG them to VB the JJ - VBN NN , NNP VBD . "" RB they VBD VBN with a NN to NN , but RB NN to the NNS might VB VB the NN of NN , "" NNP VBD NNP . NNS that VBP VBN VBN to JJ NNS in the NN , VBG NN NN and NN , VBP VBN VBN to VB a JJR NN of NN . NNP VBZ a NN that VBD RB VBN in the NNS to VB NN NN , NN and NN . The NN VBD VBN from the NN after it VBD VBN with NN NNS , but VBZ RB VBN for a JJ NN NN and as a NN for NN . NN NN VBZ a NN VBN for NNS , NN NNS and JJ NN , VBG to the NNP . As NNS VBP JJR , they VBP a JJR NN of VBG NNS with NN , NNP VBD . A NN VBN JJ NNP VBD that NNS who VBP 40 NNS JJ VBP a 50 NN JJR NN of VBG a NN with NN than NNS who VBP between 20 and 29 NNS JJ . NNS VBP RB JJ why JJ NN may VB NN NN , but it might VB JJ to JJ NNS that VBP in the NN or the NN as NNS VBP JJR , NNP VBD . The NN of the NN JJ NNS of the NN , VBG the JJ NN and the NN , VBP VBN VBN in NN , NNP VBD . These NN NNS VBP VBN to VB JJ for NN , NN and NN NN . NNS in the NNS of NNS , JJ as NN and NN , VBP RB VBN VBN to NN , NNP VBD . NNS VBG NN can VB to NNS with NN and NN NNS , while NNS VBG NN NNS can VB in NN NNS . While NNS cannot VB RB what VBZ NN , they VBP VBN a JJ NN in the JJ NN , NNP VBD . For NN , NNS RB VBD there might VB RB a JJ NN or a JJ JJ NNS that VBP VBN to NN , but RB NN VBZ VBN there VBP JJ to VB JJR . "" I VBP our NN VBZ VBN , and the NN that we VBP about VBG for JJ NNS and JJ NNS VBZ VBN , "" NNP VBD . "" We VBP VBG about a JJ NN — it VBZ RB RB VBG to VB RB one NN or one JJ NN , it VBZ RBR JJ than that , "" she VBD . VB it on : NN RB VBZ a NN of NNS , both JJ and JJ . • NNS and NN NN : How the NNP VBN • 1998 NN VBG NNP to NNPS VBD an ' JJ NN '"
28,945,conspiracy,"In_IN a_DT recent_JJ lecture_NN debating_VBG the_DT increase_NN of_IN CO2_NN volume_NN caused_VBN by_IN a_DT high_JJ number_NN of_IN humans_NNS being_VBG alive_JJ and_CC breathing_NN ,_, this_DT is_VBZ what_WP Bill_NNP Gates_NNP had_VBD to_TO say_VB :_: “_`` The_DT world_NN today_NN has_VBZ 6.8_CD billion_CD people_NNS …_: now_RB if_IN we_PRP do_VBP a_DT really_RB great_JJ job_NN on_IN new_JJ vaccines_NNS ,_, healthcare_NN ,_, reproductive_JJ health_NN services_NNS ,_, we_PRP could_MD lower_VB that_DT (_-LRB- number_NN )_-RRB- by_IN perhaps_RB 10_CD or_CC 15_CD %_NN ._. ”_'' “_`` Vaccines_NNS are_VBP something_NN I_PRP love_VBP ._. “_'' Now_RB ,_, please_UH correlate_VB this_DT information_NN with_IN the_DT last_JJ year_NN ’s_POS ‘_`` shocking_JJ ’_'' report_NN stating_VBG that_IN Bill_NNP Gates_NNP and_CC Warren_NNP Buffet_NNP convinced_VBD 30_CD billionaires_NNS to_TO donate_VB half_PDT their_PRP$ wealth_NN to_IN ‘_`` Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ’_'' that_WDT is_VBZ currently_RB (_-LRB- among_IN others_NNS )_-RRB- developing_VBG new_JJ vaccines_NNS ._.","In a JJ NN VBG the NN of NN NN VBN by a JJ NN of NNS VBG JJ and NN , this VBZ what NNP NNP VBD to VB : “ The NN NN VBZ 6.8 billion NNS … RB if we VBP a RB JJ NN on JJ NNS , NN , JJ NN NNS , we could VB that ( NN ) by RB 10 or 15 NN . ” “ NNS VBP NN I VBP . “ RB , please VB this NN with the JJ NN ’s ‘ JJ ’ NN VBG that NNP NNP and NNP NNP VBD 30 NNS to VB half their NN to ‘ NNP and NNP NNP NNP ’ that VBZ RB ( among NNS ) VBG JJ NNS ."
29,1313,mainstream,"(_-LRB- Reuters_NNP )_-RRB- -_: The_DT United_NNP States_NNPS recorded_VBD 41_CD new_JJ measles_NNS cases_NNS last_JJ week_NN ,_, bringing_VBG the_DT year_NN ’s_POS total_JJ number_NN of_IN cases_NNS to_IN 981_CD in_IN the_DT worst_JJS outbreak_NN of_IN the_DT disease_NN since_IN 1992_CD ,_, federal_JJ health_NN officials_NNS said_VBD on_IN Monday_NNP ._. The_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP said_VBD the_DT number_NN of_IN cases_NNS of_IN the_DT highly_RB contagious_JJ and_CC sometimes_RB deadly_JJ disease_NN rose_VBD 4_CD %_NN in_IN the_DT week_NN ended_VBN May_NNP 31_CD from_IN the_DT prior_JJ week_NN ._. The_DT 2019_CD outbreak_NN ,_, which_WDT has_VBZ spread_VBN to_IN 26_CD states_NNS ,_, is_VBZ the_DT worst_JJS since_IN 1992_CD ,_, when_WRB 2,126_CD cases_NNS were_VBD recorded_VBN ._. Federal_JJ health_NN officials_NNS attribute_VBP this_DT year_NN ’s_POS outbreak_NN to_IN U.S._NNP parents_NNS who_WP refuse_VBP to_TO vaccinate_VB their_PRP$ children_NNS ._. These_DT parents_NNS believe_VBP ,_, contrary_JJ to_IN scientific_JJ evidence_NN ,_, that_IN ingredients_NNS in_IN the_DT vaccine_NN can_MD cause_VB autism_NN ._. The_DT disease_NN has_VBZ mostly_RB affected_VBN children_NNS who_WP have_VBP not_RB received_VBN the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN vaccine_NN ,_, which_WDT confers_VBZ immunity_NN to_IN the_DT disease_NN ._. On_IN Thursday_NNP ,_, CDC_NNP officials_NNS said_VBD the_DT outbreak_NN had_VBD surpassed_VBN the_DT total_JJ number_NN of_IN cases_NNS per_IN year_NN for_IN the_DT past_JJ 25_CD years_NNS ,_, topping_VBG the_DT 963_CD cases_NNS that_WDT were_VBD confirmed_VBN in_IN 1994_CD ._. Measles_NN was_VBD declared_VBN eliminated_VBN in_IN the_DT United_NNP States_NNPS in_IN 2000_CD ,_, meaning_VBG there_EX was_VBD no_DT continuous_JJ transmission_NN of_IN the_DT disease_NN for_IN a_DT year_NN ._. Still_RB ,_, cases_NNS of_IN the_DT virus_NN occur_VBP and_CC spread_VBP via_IN travelers_NNS coming_VBG from_IN countries_NNS where_WRB measles_NNS is_VBZ common_JJ ._. CDC_NNP officials_NNS have_VBP warned_VBN that_IN the_DT country_NN risks_VBZ losing_VBG its_PRP$ measles_NNS elimination_NN status_NN if_IN the_DT ongoing_JJ outbreak_NN ,_, which_WDT began_VBD in_IN October_NNP 2018_CD in_IN New_NNP York_NNP ,_, continues_VBZ until_IN October_NNP 2019_CD ._. “_`` Measles_NN is_VBZ preventable_JJ and_CC the_DT way_NN to_TO end_VB this_DT outbreak_NN is_VBZ to_TO ensure_VB that_IN all_DT children_NNS and_CC adults_NNS who_WP can_MD get_VB vaccinated_VBN ,_, do_VBP get_VB vaccinated_VBN ,_, ”_'' CDC_NNP Director_NN Robert_NNP Redfield_NNP said_VBD in_IN a_DT statement_NN on_IN Thursday_NNP ._. “_`` I_PRP want_VBP to_TO reassure_VB parents_NNS that_IN vaccines_NNS are_VBP safe_JJ ,_, they_PRP do_VBP not_RB cause_VB autism_NN ._. ”_'' The_DT outbreak_NN has_VBZ escalated_VBN since_IN 82_CD people_NNS in_IN 2018_CD and_CC more_JJR than_IN 40_CD people_NNS in_IN 2019_CD brought_VBD measles_NNS to_IN the_DT United_NNP States_NNPS from_IN other_JJ countries_NNS ,_, most_RBS frequently_RB Ukraine_NNP ,_, Israel_NNP and_CC the_DT Philippines_NNPS ,_, federal_JJ officials_NNS said_VBD ._.","( NNP ) - The NNP NNPS VBD 41 JJ NNS NNS JJ NN , VBG the NN ’s JJ NN of NNS to 981 in the JJS NN of the NN since 1992 , JJ NN NNS VBD on NNP . The NNP NNPS for NNP NNP and NNP VBD the NN of NNS of the RB JJ and RB JJ NN VBD 4 NN in the NN VBN NNP 31 from the JJ NN . The 2019 NN , which VBZ VBN to 26 NNS , VBZ the JJS since 1992 , when 2,126 NNS VBD VBN . JJ NN NNS VBP this NN ’s NN to NNP NNS who VBP to VB their NNS . These NNS VBP , JJ to JJ NN , that NNS in the NN can VB NN . The NN VBZ RB VBN NNS who VBP RB VBN the NNS - NNS - NN NN , which VBZ NN to the NN . On NNP , NNP NNS VBD the NN VBD VBN the JJ NN of NNS per NN for the JJ 25 NNS , VBG the 963 NNS that VBD VBN in 1994 . NN VBD VBN VBN in the NNP NNPS in 2000 , VBG there VBD no JJ NN of the NN for a NN . RB , NNS of the NN VBP and VBP via NNS VBG from NNS where NNS VBZ JJ . NNP NNS VBP VBN that the NN VBZ VBG its NNS NN NN if the JJ NN , which VBD in NNP 2018 in NNP NNP , VBZ until NNP 2019 . “ NN VBZ JJ and the NN to VB this NN VBZ to VB that all NNS and NNS who can VB VBN , VBP VB VBN , ” NNP NN NNP NNP VBD in a NN on NNP . “ I VBP to VB NNS that NNS VBP JJ , they VBP RB VB NN . ” The NN VBZ VBN since 82 NNS in 2018 and JJR than 40 NNS in 2019 VBD NNS to the NNP NNPS from JJ NNS , RBS RB NNP , NNP and the NNPS , JJ NNS VBD ."
30,833,mainstream,"WASHINGTON_NNP —_: The_DT Trump_NNP administration_NN on_IN Friday_NNP rolled_VBD out_RP a_DT hyper-ambitious_JJ plan_NN to_TO develop_VB and_CC manufacture_VB hundreds_NNS of_IN millions_NNS of_IN Covid_NNP -_HYPH 19_CD vaccine_NN doses_NNS by_IN the_DT end_NN of_IN 2020_CD ,_, outlining_VBG an_DT aggressive_JJ process_NN that_WDT ,_, if_IN successful_JJ ,_, would_MD shatter_VB conventional_JJ wisdom_NN about_IN the_DT typical_JJ process_NN for_IN developing_VBG vaccines_NNS for_IN emerging_VBG infectious_JJ diseases_NNS ._. At_IN a_DT Rose_NNP Garden_NNP press_NN conference_NN ,_, the_DT president_NN and_CC his_PRP$ deputies_NNS acknowledged_VBD their_PRP$ goal_NN ,_, dubbed_VBN “_`` Operation_NNP Warp_NNP Speed_NNP ,_, ”_'' was_VBD lofty_JJ ._. Trump_NNP said_VBD the_DT project_NN was_VBD “_`` risky_JJ and_CC expensive_JJ ._. ”_'' Gustave_NNP Perna_NNP ,_, a_DT four_CD -_HYPH star_NN general_NN who_WP oversees_VBZ logistics_NNS for_IN the_DT U.S._NNP Army_NNP ,_, called_VBD the_DT task_NN “_`` Herculean_NNP ._. ”_'' Moncef_NNP Slaoui_NNP ,_, the_DT pharmaceutical_JJ executive_NN Trump_NNP has_VBZ appointed_VBN to_TO lead_VB the_DT initiative_NN ,_, said_VBD the_DT goal_NN was_VBD “_`` extremely_RB challenging_JJ ._. ”_'' But_CC they_PRP allowed_VBD themselves_PRP little_JJ ambiguity_NN ._. Mark_NNP Esper_NNP ,_, the_DT defense_NN secretary_NN ,_, pledged_VBD to_TO deliver_VB a_DT vaccine_NN “_'' at_IN scale_NN ”_'' to_IN the_DT U.S._NNP and_CC its_PRP$ foreign_JJ partners_NNS by_IN the_DT end_NN of_IN the_DT year_NN ._. The_DT rollout_NN highlights_VBZ an_DT overt_JJ shift_NN in_IN the_DT White_NNP House_NNP ’s_POS messaging_NN on_IN vaccines_NNS ._. Anthony_NNP Fauci_NNP ,_, the_DT federal_JJ government_NN ’s_POS top_JJ infectious_JJ disease_NN researcher_NN ,_, has_VBZ long_RB warned_VBN Americans_NNPS that_IN ,_, even_RB optimistically_RB ,_, developing_VBG a_DT Covid_NNP -_HYPH 19_CD vaccine_NN would_MD take_VB between_IN 12_CD and_CC 18_CD months_NNS ._. Even_RB that_DT timeline_NN ,_, Fauci_NNP has_VBZ said_VBN ,_, would_MD represent_VB something_NN of_IN a_DT biomedical_JJ miracle_NN ._. The_DT Trump_NNP administration_NN ’s_POS scientific_JJ muscle_NN ,_, however_RB ,_, was_VBD notably_RB silent_JJ ._. During_IN his_PRP$ remarks_NNS ,_, the_DT president_NN was_VBD flanked_VBN by_IN three_CD physician_NN -_HYPH researchers_NNS :_: Fauci_NNP ;_: Deborah_NNP Birx_NNP ,_, the_DT White_NNP House_NNP coronavirus_NN response_NN coordinator_NN ;_: and_CC Francis_NNP Collins_NNP ,_, the_DT director_NN of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. The_DT three_CD doctors_NNS were_VBD the_DT only_JJ federal_JJ officials_NNS who_WP appeared_VBD on_IN stage_NN wearing_VBG masks_NNS ._. None_NN spoke_VBD at_IN any_DT point_NN during_IN the_DT press_NN conference_NN ._. Instead_RB ,_, it_PRP was_VBD Slaoui_NNP ,_, the_DT former_JJ GlaxoSmithKline_NNP executive_NN who_WP Trump_NNP has_VBZ appointed_VBN to_TO lead_VB the_DT vaccine_NN initiative_NN ,_, who_WP delivered_VBD yet_RB another_DT strikingly_RB confident_JJ prediction_NN ._. “_`` Mr._NNP President_NNP ,_, I_PRP have_VBP very_RB recently_RB seen_VBN early_JJ data_NNS from_IN a_DT clinical_JJ trial_NN with_IN a_DT coronavirus_NN vaccine_NN ,_, ”_'' he_PRP said_VBD to_IN applause_NN ._. “_`` These_DT data_NNS make_VBP me_PRP feel_VB even_RB more_RBR confident_JJ that_IN we_PRP will_MD be_VB able_JJ to_TO deliver_VB a_DT few_JJ hundred_CD million_CD doses_NNS of_IN vaccine_NN by_IN the_DT end_NN of_IN 2020_CD ._. ”_'' Slaoui_NNP ,_, who_WP resigned_VBD his_PRP$ position_NN on_IN the_DT board_NN of_IN the_DT drug_NN manufacturer_NN Moderna_NNP to_TO accept_VB the_DT government_NN appointment_NN ,_, was_VBD likely_RB referencing_VBG the_DT company_NN ’s_POS Covid_NNP -_HYPH 19_CD vaccine_NN candidate_NN ,_, which_WDT was_VBD the_DT first_JJ in_IN the_DT U.S._NNP to_TO enter_VB a_DT Phase_NN 1_CD clinical_JJ trial_NN ._. According_VBG to_IN federal_JJ financial_JJ disclosures_NNS ,_, he_PRP still_RB holds_VBZ over_RB 156,000_CD Moderna_NNP stock_NN options_NNS ,_, worth_JJ over_RB $_$ 10_CD million_CD at_IN the_DT company_NN ’s_POS current_JJ stock_NN price_NN ,_, creating_VBG a_DT potential_JJ conflict_NN of_IN interest_NN if_IN the_DT company_NN ’s_POS vaccine_NN is_VBZ the_DT first_JJ to_TO be_VB proven_VBN effective_JJ ._. Numerous_JJ progressive_JJ groups_NNS in_IN Washington_NNP have_VBP already_RB criticized_VBN Trump_NNP over_IN Slaoui_NNP ’s_POS appointment_NN ._. The_DT project_NN will_MD rely_VB in_IN part_NN on_IN allowing_VBG drug_NN manufacturers_NNS to_TO begin_VB scaling_VBG up_RP their_PRP$ manufacturing_NN efforts_NNS prior_JJ to_IN receiving_VBG approvals_NNS regarding_VBG a_DT potential_JJ vaccine_NN ’s_POS effectiveness_NN ,_, officials_NNS said_VBD ._. Trump_NNP ,_, separately_RB ,_, delivered_VBD a_DT markedly_RB optimistic_JJ message_NN in_IN terms_NNS of_IN the_DT vaccine_NN ’s_POS price_NN ._. “_`` The_DT last_JJ thing_NN anybody_NN ’s_VBZ looking_VBG for_IN is_VBZ profit_NN ,_, ”_'' he_PRP said_VBD ._. Nonetheless_RB ,_, the_DT vaccine_NN ’s_POS price_NN has_VBZ been_VBN a_DT consistent_JJ topic_NN of_IN debate_NN among_IN Democratic_JJ lawmakers_NNS in_IN Washington_NNP ,_, some_DT of_IN whom_WP have_VBP attempted_VBN to_TO pass_VB new_JJ laws_NNS that_WDT would_MD include_VB affordability_NN requirements_NNS for_IN any_DT vaccine_NN developed_VBN via_IN taxpayer_NN -_HYPH funded_VBN research_NN ._. Trump_NNP also_RB downplayed_VBD concerns_NNS about_IN whether_IN ,_, as_IN some_DT public_JJ health_NN experts_NNS have_VBP feared_VBN ,_, the_DT race_NN to_TO develop_VB a_DT vaccine_NN could_MD devolve_VB into_IN an_DT international_JJ showdown_NN that_WDT leaves_VBZ foreign_JJ governments_NNS to_TO compete_VB to_TO secure_VB vaccine_NN allotments_NNS for_IN their_PRP$ populations_NNS ._. He_PRP said_VBD that_IN the_DT U.S._NNP would_MD work_VB with_IN foreign_JJ governments_NNS to_TO distribute_VB a_DT Covid_NNP -_HYPH 19_CD vaccine_NN regardless_RB of_IN which_WDT companies_NNS ,_, or_CC which_WDT countries_NNS ,_, are_VBP first_RB across_IN the_DT finish_NN line_NN ._. The_DT federal_JJ government_NN ,_, he_PRP said_VBD ,_, has_VBZ “_`` no_DT ego_NN ”_'' regarding_VBG vaccine_NN development_NN ._. “_`` We_PRP want_VBP to_TO get_VB to_IN the_DT solution_NN ,_, ”_'' Trump_NNP said_VBD ._. “_`` We_PRP know_VBP exactly_RB where_WRB the_DT other_JJ countries_NNS are_VBP ,_, and_CC we_PRP ’ll_MD be_VB very_RB happy_JJ if_IN they_PRP are_VBP able_JJ to_TO do_VB it_PRP ._. We_PRP ’ll_MD help_VB them_PRP with_IN delivery_NN ,_, we_PRP ’ll_MD help_VB them_PRP with_IN it_PRP in_IN every_DT way_NN we_PRP can_MD ._. ”_'' The_DT pledge_NN ,_, he_PRP indicated_VBD ,_, even_RB applies_VBZ to_IN China_NNP ,_, the_DT country_NN where_WRB Covid_NNP -_HYPH 19_CD was_VBD first_RB identified_VBN ._. Trump_NNP has_VBZ repeatedly_RB expressed_VBN anger_NN over_IN China_NNP ’s_POS handling_NN of_IN the_DT outbreak_NN in_IN early_JJ 2020_CD ,_, casting_VBG doubts_NNS on_IN its_PRP$ reported_VBN death_NN toll_NN ,_, blaming_VBG its_PRP$ government_NN for_IN not_RB containing_VBG the_DT virus_NN within_IN its_PRP$ borders_NNS ,_, and_CC even_RB labeling_VBG Covid_NNP -_HYPH 19_CD the_DT “_`` Chinese_JJ virus_NN ._. ”_'' The_DT new_JJ initiative_NN is_VBZ the_DT latest_JJS sign_NN of_IN the_DT federal_JJ government_NN ’s_POS far_RB -_HYPH reaching_VBG efforts_NNS to_TO accelerate_VB research_NN into_IN coronavirus_NN tests_NNS ,_, treatments_NNS ,_, and_CC vaccines_NNS ._. Those_DT initiatives_NNS ,_, in_IN some_DT cases_NNS ,_, have_VBP tested_VBN the_DT practical_JJ boundaries_NNS of_IN biomedical_JJ research_NN ._. To_IN date_NN ,_, the_DT U.S._NNP government_NN has_VBZ announced_VBN a_DT “_`` Shark_NN Tank_NN ”_'' -_HYPH like_JJ competition_NN to_TO develop_VB new_JJ Covid_NNP -_HYPH 19_CD diagnostics_NNS and_CC a_DT series_NN of_IN partnerships_NNS with_IN drug_NN companies_NNS on_IN both_CC therapeutics_NNS and_CC vaccines_NNS ._. Yet_CC Trump_NNP also_RB warned_VBD that_IN his_PRP$ plans_NNS to_TO reopen_VB the_DT U.S._NNP economy_NN are_VBP not_RB contingent_JJ on_IN the_DT development_NN of_IN a_DT vaccine_NN ._. At_IN one_CD point_NN ,_, he_PRP repeated_VBD the_DT unscientific_JJ claim_NN that_IN the_DT virus_NN will_MD “_`` go_VB away_RB ”_'' even_RB without_IN a_DT vaccine_NN ._. Separately_RB ,_, he_PRP attempted_VBD to_TO downplay_VB the_DT severity_NN of_IN the_DT coronavirus_NN ,_, noting_VBG that_IN despite_IN nearly_RB 90,000_CD recorded_VBN U.S._NNP deaths_NNS to_IN date_NN ,_, many_JJ Americans_NNPS who_WP contracted_VBD the_DT virus_NN displayed_VBD few_JJ symptoms_NNS and_CC are_VBP likely_RB now_RB immune_JJ ._. “_`` We_PRP think_VBP we_PRP ’re_VBP going_VBG to_TO have_VB a_DT vaccine_NN in_IN the_DT pretty_RB near_JJ future_NN ,_, ”_'' Trump_NNP said_VBD ._. “_`` If_IN we_PRP do_VBP ,_, we_PRP ’re_VBP going_VBG to_TO really_RB be_VB a_DT big_JJ step_NN ahead_RB ._. If_IN we_PRP do_VBP n’t_RB ,_, we_PRP ’re_VBP going_VBG to_TO be_VB like_IN so_RB many_JJ other_JJ cases_NNS where_WRB you_PRP had_VBD a_DT problem_NN come_VB in_RP ._. It_PRP ’ll_MD go_VB away_RB at_IN some_DT point_NN ._. It_PRP ’ll_MD go_VB away_RB ._. It_PRP may_MD flare_VB up_RP ,_, and_CC it_PRP may_MD not_RB flare_VB up_RP ._. We_PRP ’ll_MD have_VB to_TO see_VB what_WP happens_VBZ ._. ”_''","NNP — The NNP NN on NNP VBD out a JJ NN to VB and VB NNS of NNS of NNP - 19 NN NNS by the NN of 2020 , VBG an JJ NN that , if JJ , would VB JJ NN about the JJ NN for VBG NNS for VBG JJ NNS . At a NNP NNP NN NN , the NN and his NNS VBD their NN , VBN “ NNP NNP NNP , ” VBD JJ . NNP VBD the NN VBD “ JJ and JJ . ” NNP NNP , a four - NN NN who VBZ NNS for the NNP NNP , VBD the NN “ NNP . ” NNP NNP , the JJ NN NNP VBZ VBN to VB the NN , VBD the NN VBD “ RB JJ . ” But they VBD themselves JJ NN . NNP NNP , the NN NN , VBD to VB a NN “ at NN ” to the NNP and its JJ NNS by the NN of the NN . The NN VBZ an JJ NN in the NNP NNP ’s NN on NNS . NNP NNP , the JJ NN ’s JJ JJ NN NN , VBZ RB VBN NNPS that , RB RB , VBG a NNP - 19 NN would VB between 12 and 18 NNS . RB that NN , NNP VBZ VBN , would VB NN of a JJ NN . The NNP NN ’s JJ NN , RB , VBD RB JJ . During his NNS , the NN VBD VBN by three NN - NNS : NNP ; NNP NNP , the NNP NNP NN NN NN ; and NNP NNP , the NN of the NNP NNPS of NNP . The three NNS VBD the JJ JJ NNS who VBD on NN VBG NNS . NN VBD at any NN during the NN NN . RB , it VBD NNP , the JJ NNP NN who NNP VBZ VBN to VB the NN NN , who VBD RB another RB JJ NN . “ NNP NNP , I VBP RB RB VBN JJ NNS from a JJ NN with a NN NN , ” he VBD to NN . “ These NNS VBP me VB RB RBR JJ that we will VB JJ to VB a JJ hundred million NNS of NN by the NN of 2020 . ” NNP , who VBD his NN on the NN of the NN NN NNP to VB the NN NN , VBD RB VBG the NN ’s NNP - 19 NN NN , which VBD the JJ in the NNP to VB a NN 1 JJ NN . VBG to JJ JJ NNS , he RB VBZ RB 156,000 NNP NN NNS , JJ RB $ 10 million at the NN ’s JJ NN NN , VBG a JJ NN of NN if the NN ’s NN VBZ the JJ to VB VBN JJ . JJ JJ NNS in NNP VBP RB VBN NNP over NNP ’s NN . The NN will VB in NN on VBG NN NNS to VB VBG up their NN NNS JJ to VBG NNS VBG a JJ NN ’s NN , NNS VBD . NNP , RB , VBD a RB JJ NN in NNS of the NN ’s NN . “ The JJ NN NN VBZ VBG for VBZ NN , ” he VBD . RB , the NN ’s NN VBZ VBN a JJ NN of NN among JJ NNS in NNP , some of whom VBP VBN to VB JJ NNS that would VB NN NNS for any NN VBN via NN - VBN NN . NNP RB VBD NNS about whether , as some JJ NN NNS VBP VBN , the NN to VB a NN could VB into an JJ NN that VBZ JJ NNS to VB to VB NN NNS for their NNS . He VBD that the NNP would VB with JJ NNS to VB a NNP - 19 NN RB of which NNS , or which NNS , VBP RB across the NN NN . The JJ NN , he VBD , VBZ “ no NN ” VBG NN NN . “ We VBP to VB to the NN , ” NNP VBD . “ We VBP RB where the JJ NNS VBP , and we ’ll VB RB JJ if they VBP JJ to VB it . We ’ll VB them with NN , we ’ll VB them with it in every NN we can . ” The NN , he VBD , RB VBZ to NNP , the NN where NNP - 19 VBD RB VBN . NNP VBZ RB VBN NN over NNP ’s NN of the NN in JJ 2020 , VBG NNS on its VBN NN NN , VBG its NN for RB VBG the NN within its NNS , and RB VBG NNP - 19 the “ JJ NN . ” The JJ NN VBZ the JJS NN of the JJ NN ’s RB - VBG NNS to VB NN into NN NNS , NNS , and NNS . Those NNS , in some NNS , VBP VBN the JJ NNS of JJ NN . To NN , the NNP NN VBZ VBN a “ NN NN ” - JJ NN to VB JJ NNP - 19 NNS and a NN of NNS with NN NNS on both NNS and NNS . Yet NNP RB VBD that his NNS to VB the NNP NN VBP RB JJ on the NN of a NN . At one NN , he VBD the JJ NN that the NN will “ VB RB ” RB without a NN . RB , he VBD to VB the NN of the NN , VBG that despite RB 90,000 VBN NNP NNS to NN , JJ NNPS who VBD the NN VBD JJ NNS and VBP RB RB JJ . “ We VBP we VBP VBG to VB a NN in the RB JJ NN , ” NNP VBD . “ If we VBP , we VBP VBG to RB VB a JJ NN RB . If we VBP RB , we VBP VBG to VB like RB JJ JJ NNS where you VBD a NN VB in . It ’ll VB RB at some NN . It ’ll VB RB . It may VB up , and it may RB VB up . We ’ll VB to VB what VBZ . ”"
31,471,conspiracy,"A_DT great_JJ number_NN of_IN YouTube_NNP videos_NNS aimed_VBN at_IN children_NNS contain_VBP creepy_JJ ,_, disturbing_JJ ,_, violent_JJ and_CC sexual_JJ content_NN ._. Some_DT even_RB border_NN on_IN child_NN abuse_NN ._. It_PRP is_VBZ time_NN to_TO take_VB a_DT closer_JJR look_NN at_IN these_DT videos_NNS that_WDT generate_VBP millions_NNS of_IN views_NNS per_IN day_NN ._. Warning_NN :_: This_DT article_NN contains_VBZ disturbing_JJ images_NNS …_, although_IN they_PRP ’re_VBP all_RB taken_VBN from_IN children_NNS ’s_POS videos_NNS ._. There_EX is_VBZ no_DT easier_JJR way_NN to_TO get_VB small_JJ children_NNS to_TO pipe_VB down_RP than_IN handing_VBG them_PRP a_DT tablet_NN or_CC a_DT smartphone_NN ._. Toddlers_NNS know_VBP how_WRB to_TO launch_VB YouTube_NNP ,_, play_VB videos_NNS and_CC even_RB navigate_VB to_IN other_JJ “_`` recommended_VBN videos_NNS ”_'' ._. This_DT keeps_VBZ children_NNS silent_JJ and_CC entertained_VBN for_IN long_JJ periods_NNS of_IN time_NN –_: a_DT luxury_NN that_WDT busy_JJ parents_NNS greatly_RB appreciate_VBP ._. While_IN most_JJS parents_NNS hear_VBP the_DT children_NNS ’s_POS music_NN playing_VBG in_IN the_DT background_NN ,_, they_PRP rarely_RB watch_VBP the_DT videos_NNS played_VBN by_IN their_PRP$ children_NNS ._. When_WRB they_PRP do_VBP glimpse_NN at_IN the_DT screen_NN ,_, they_PRP see_VBP a_DT character_NN such_JJ as_IN Spiderman_NNP or_CC Princess_NNP Elsa_NNP and_CC assume_VBP that_IN everything_NN is_VBZ cool_JJ ._. But_CC everything_NN is_VBZ not_RB cool_JJ ._. There_EX is_VBZ something_NN terribly_RB wrong_JJ with_IN some_DT children_NNS ’s_POS YouTube_NNP videos_NNS and_CC ,_, often_RB ,_, those_DT who_WP create_VBP them_PRP do_VBP not_RB have_VB the_DT best_JJS of_IN intentions_NNS ._. A_DT great_JJ deal_NN of_IN these_DT videos_NNS contains_VBZ weird_JJ ,_, disturbing_JJ ,_, violent_JJ and_CC even_RB traumatizing_JJ content_NN ._. They_PRP are_VBP insidiously_RB mixed_VBN with_IN other_JJ children_NNS ’s_POS videos_NNS ,_, causing_VBG them_PRP to_TO appear_VB as_IN “_`` recommended_VBN videos_NNS ”_'' by_IN YouTube_NNP and_CC ,_, therefore_RB ,_, easily_RB accessible_JJ to_IN children_NNS ._. I_PRP am_VBP not_RB talking_VBG about_IN rare_JJ ,_, obscure_JJ videos_NNS hiding_VBG in_IN the_DT depths_NNS of_IN YouTube_NNP ,_, I_PRP am_VBP talking_VBG about_IN channels_NNS that_WDT cumulate_VBP billions_NNS of_IN views_NNS ._. Of_IN course_NN ,_, the_DT main_JJ motivation_NN behind_IN these_DT videos_NNS is_VBZ profit_NN ._. All_DT it_PRP takes_VBZ is_VBZ a_DT few_JJ superhero_NN costumes_NNS and_CC a_DT smartphone_NN to_TO create_VB videos_NNS that_WDT can_MD potentially_RB generate_VB lots_NNS of_IN revenue_NN ._. However_RB ,_, some_DT of_IN these_DT videos_NNS are_VBP simply_RB not_RB right_JJ ._. There_EX appears_VBZ to_TO be_VB a_DT motivation_NN that_WDT goes_VBZ beyond_IN profit_NN ._. Some_DT videos_NNS trick_VBP children_NNS into_IN watching_VBG traumatizing_JJ content_NN ,_, others_NNS expose_VBP them_PRP to_IN oddly_RB “_`` adult_NN ”_'' situations_NNS ._. Even_RB worse_JJR ,_, some_DT appear_VBP to_TO cater_VB to_IN adults_NNS …_: who_WP like_VBP to_TO watch_VB children_NNS ._. Here_RB are_VBP some_DT examples_NNS of_IN the_DT video_NN cancer_NN growing_VBG on_IN YouTube_NNP (_-LRB- I_PRP wo_MD n’t_RB be_VB linking_VBG to_IN any_DT of_IN these_DT videos_NNS or_CC channels_NNS because_IN I_PRP do_VBP n’t_RB want_VB to_TO help_VB them_PRP get_VB more_JJR hits_NNS )_-RRB- ._. Some_DT video_NN channels_NNS use_VBP popular_JJ characters_NNS to_TO trick_VB children_NNS into_IN watching_VBG violent_JJ and_CC disturbing_JJ material_NN ._. The_DT BBC_NNP recently_RB reported_VBD on_IN some_DT of_IN these_DT videos_NNS ._. Many_JJ videos_NNS clearly_RB exploit_VBP children_NNS ’s_POS visceral_JJ fear_NN and_CC repulsion_NN of_IN certain_JJ things_NNS such_JJ as_IN blood_NN ,_, syringes_NNS ,_, cutting_NN skin_NN ,_, tarantulas_NNS ,_, evil_JJ clowns_NNS attacking_VBG them_PRP ,_, etc_FW ._. Children_NNS are_VBP horrified_VBN by_IN what_WP they_PRP are_VBP watching_VBG yet_CC they_PRP cannot_MD look_VB away_RB because_IN the_DT content_NN is_VBZ engrossing_JJ ._. Some_DT videos_NNS are_VBP clearly_RB sexual_JJ –_: in_IN a_DT creepy_JJ and_CC perverted_JJ way_NN ._. YouTube_NNP is_VBZ also_RB quick_JJ to_TO recommend_VB a_DT bunch_NN of_IN other_JJ similar_JJ videos_NNS ._. Several_JJ YouTube_NNP channels_NNS star_NN young_JJ children_NNS in_IN all_DT kinds_NNS of_IN bizarre_JJ situations_NNS ._. Other_JJ than_IN the_DT fact_NN that_IN these_DT children_NNS might_MD be_VB forced_VBN to_TO appear_VB in_IN hundreds_NNS of_IN videos_NNS for_IN profit_NN ,_, they_PRP are_VBP also_RB often_RB made_VBN to_TO enact_VB traumatic_JJ situations_NNS ._. Here_RB are_VBP screenshots_NNS from_IN a_DT channel_NN named_VBN MaddaKenz_NNP Vlogs_NNPS where_WRB the_DT girls_NNS often_RB appear_VBP to_TO be_VB genuinely_RB unhappy_JJ and_CC distressed_JJ ._. Things_NNS get_VBP even_RB weirder_JJR –_: to_IN the_DT point_NN that_IN I_PRP feel_VBP uncomfortable_JJ even_RB posting_VBG screenshots_NNS on_IN there_RB ._. But_CC this_DT filth_NN needs_VBZ to_TO be_VB exposed_VBN ._. Unfortunately_RB ,_, there_EX are_VBP other_JJ channels_NNS that_WDT produce_VBP these_DT kinds_NNS of_IN videos_NNS ._. Viewing_VBG these_DT videos_NNS in_IN order_NN to_TO write_VB this_DT article_NN was_VBD a_DT disturbing_JJ experience_NN ._. Most_JJS of_IN them_PRP trigger_VBP that_DT gut_NN feeling_NN that_IN something_NN is_VBZ wrong_JJ and_CC that_IN children_NNS ’s_POS innocence_NN is_VBZ being_VBG preyed_VBN on_RP by_IN twisted_VBN minds_NNS ._. Although_IN there_EX ’s_VBZ an_DT absurd_JJ amount_NN of_IN this_DT type_NN of_IN content_NN on_IN YouTube_NNP (_-LRB- this_DT article_NN could_MD have_VB been_VBN 10_CD times_NNS longer_RBR )_-RRB- ,_, I_PRP attempted_VBD to_TO expose_VB the_DT various_JJ reasons_NNS why_WRB these_DT videos_NNS are_VBP cancerous_JJ ._. Using_VBG underhanded_JJ and_CC manipulative_JJ ways_NNS ,_, these_DT videos_NNS deliver_VBP disturbing_JJ content_NN directly_RB into_IN the_DT brains_NNS of_IN very_RB young_JJ children_NNS ._. One_PRP wonders_VBZ how_WRB these_DT “_`` amateur_JJ ”_'' channels_NNS can_MD even_RB exploit_VB the_DT likeness_NN of_IN these_DT children_NNS ’s_POS characters_NNS without_IN being_VBG hit_VBN with_IN copyright_NN infringement_NN lawsuits_NNS ._. Also_RB ,_, many_JJ channels_NNS are_VBP clearly_RB sponsored_VBN by_IN major_JJ brands_NNS to_TO produce_VB videos_NNS that_WDT brainwash_VBP children_NNS into_IN consuming_VBG their_PRP$ stuff_NN (_-LRB- I_PRP recall_VBP watching_VBG a_DT video_NN where_WRB The_DT Hulk_NNP eats_VBZ Kinder_NNP chocolates_NNS for_IN like_UH 4_CD minutes_NNS non-stop_RB )_-RRB- ._. Obviously_RB ,_, there_EX is_VBZ big_JJ money_NN and_CC big_JJ corporations_NNS behind_IN these_DT cheap_JJ -_HYPH looking_VBG videos_NNS ._. However_RB ,_, the_DT true_JJ aim_NN of_IN this_DT article_NN is_VBZ not_RB about_IN YouTube_NNP moderation_NN ,_, it_PRP is_VBZ about_IN vigilance_NN :_: Keep_VB an_DT eye_NN on_IN the_DT videos_NNS watched_VBN by_IN children_NNS ._. Analyze_VB their_PRP$ contents_NNS ._. It_PRP only_RB takes_VBZ a_DT few_JJ taps_NNS on_IN a_DT touchscreen_NN for_IN children_NNS to_TO end_VB up_RP watching_VBG videos_NNS custom_NN -_HYPH made_VBN to_TO poison_VB their_PRP$ minds_NNS and_CC shock_VB their_PRP$ very_JJ core_NN ._. And_CC do_VB n’t_RB be_VB surprised_VBN if_IN some_DT of_IN these_DT video_NN channels_NNS are_VBP linked_VBN to_IN actual_JJ child_NN abuse_NN systems_NNS ._.","A JJ NN of NNP NNS VBN at NNS VBP JJ , JJ , JJ and JJ NN . Some RB NN on NN NN . It VBZ NN to VB a JJR NN at these NNS that VBP NNS of NNS per NN . NN : This NN VBZ JJ NNS … although they VBP RB VBN from NNS ’s NNS . There VBZ no JJR NN to VB JJ NNS to VB down than VBG them a NN or a NN . NNS VBP how to VB NNP , VB NNS and RB VB to JJ “ VBN NNS ” . This VBZ NNS JJ and VBN for JJ NNS of NN – a NN that JJ NNS RB VBP . While JJS NNS VBP the NNS ’s NN VBG in the NN , they RB VBP the NNS VBN by their NNS . When they VBP NN at the NN , they VBP a NN JJ as NNP or NNP NNP and VBP that NN VBZ JJ . But NN VBZ RB JJ . There VBZ NN RB JJ with some NNS ’s NNP NNS and , RB , those who VBP them VBP RB VB the JJS of NNS . A JJ NN of these NNS VBZ JJ , JJ , JJ and RB JJ NN . They VBP RB VBN with JJ NNS ’s NNS , VBG them to VB as “ VBN NNS ” by NNP and , RB , RB JJ to NNS . I VBP RB VBG about JJ , JJ NNS VBG in the NNS of NNP , I VBP VBG about NNS that VBP NNS of NNS . Of NN , the JJ NN behind these NNS VBZ NN . All it VBZ VBZ a JJ NN NNS and a NN to VB NNS that can RB VB NNS of NN . RB , some of these NNS VBP RB RB JJ . There VBZ to VB a NN that VBZ beyond NN . Some NNS VBP NNS into VBG JJ NN , NNS VBP them to RB “ NN ” NNS . RB JJR , some VBP to VB to NNS … who VBP to VB NNS . RB VBP some NNS of the NN NN VBG on NNP ( I wo RB VB VBG to any of these NNS or NNS because I VBP RB VB to VB them VB JJR NNS ) . Some NN NNS VBP JJ NNS to VB NNS into VBG JJ and JJ NN . The NNP RB VBD on some of these NNS . JJ NNS RB VBP NNS ’s JJ NN and NN of JJ NNS JJ as NN , NNS , NN NN , NNS , JJ NNS VBG them , FW . NNS VBP VBN by what they VBP VBG yet they cannot VB RB because the NN VBZ JJ . Some NNS VBP RB JJ – in a JJ and JJ NN . NNP VBZ RB JJ to VB a NN of JJ JJ NNS . JJ NNP NNS NN JJ NNS in all NNS of JJ NNS . JJ than the NN that these NNS might VB VBN to VB in NNS of NNS for NN , they VBP RB RB VBN to VB JJ NNS . RB VBP NNS from a NN VBN NNP NNPS where the NNS RB VBP to VB RB JJ and JJ . NNS VBP RB JJR – to the NN that I VBP JJ RB VBG NNS on RB . But this NN VBZ to VB VBN . RB , there VBP JJ NNS that VBP these NNS of NNS . VBG these NNS in NN to VB this NN VBD a JJ NN . JJS of them VBP that NN NN that NN VBZ JJ and that NNS ’s NN VBZ VBG VBN on by VBN NNS . Although there VBZ an JJ NN of this NN of NN on NNP ( this NN could VB VBN 10 NNS RBR ) , I VBD to VB the JJ NNS why these NNS VBP JJ . VBG JJ and JJ NNS , these NNS VBP JJ NN RB into the NNS of RB JJ NNS . One VBZ how these “ JJ ” NNS can RB VB the NN of these NNS ’s NNS without VBG VBN with NN NN NNS . RB , JJ NNS VBP RB VBN by JJ NNS to VB NNS that VBP NNS into VBG their NN ( I VBP VBG a NN where The NNP VBZ NNP NNS for like 4 NNS RB ) . RB , there VBZ JJ NN and JJ NNS behind these JJ - VBG NNS . RB , the JJ NN of this NN VBZ RB about NNP NN , it VBZ about NN : VB an NN on the NNS VBN by NNS . VB their NNS . It RB VBZ a JJ NNS on a NN for NNS to VB up VBG NNS NN - VBN to VB their NNS and VB their JJ NN . And VB RB VB VBN if some of these NN NNS VBP VBN to JJ NN NN NNS ."
32,1011,conspiracy,"Dr._NNP Diane_NNP Harper_NNP was_VBD the_DT lead_JJ researcher_NN in_IN the_DT development_NN of_IN the_DT human_JJ papilloma_NN virus_NN vaccines_NNS ,_, Gardasil_NNP and_CC Cervarix_NNP ._. She_PRP is_VBZ the_DT latest_JJS to_TO come_VB forward_RB and_CC question_VB the_DT safety_NN and_CC effectiveness_NN of_IN these_DT vaccines_NNS ._. She_PRP made_VBD the_DT surprising_JJ announcement_NN at_IN the_DT 4th_JJ International_NNP Public_NNP Conference_NNP on_IN Vaccination_NNP ,_, which_WDT took_VBD place_NN in_IN Reston_NNP ,_, Virginia_NNP on_IN Oct._NNP 2nd_NN through_IN 4th_NN ,_, 2009_CD ._. Her_PRP$ speech_NN was_VBD supposed_VBN to_TO promote_VB the_DT Gardasil_NNP and_CC Cervarix_NNP vaccines_NNS ,_, but_CC she_PRP instead_RB turned_VBD on_RP her_PRP$ corporate_JJ bosses_NNS in_IN a_DT very_RB public_JJ way_NN ._. When_WRB questioned_VBN about_IN the_DT presentation_NN ,_, audience_NN members_NNS remarked_VBD that_IN they_PRP came_VBD away_RB feeling_VBG that_IN the_DT vaccines_NNS should_MD not_RB be_VB used_VBN ._. “_`` I_PRP came_VBD away_RB from_IN the_DT talk_NN with_IN the_DT perception_NN that_IN the_DT risk_NN of_IN adverse_JJ side_NN effects_NNS is_VBZ so_RB much_RB greater_JJR than_IN the_DT risk_NN of_IN cervical_JJ cancer_NN ,_, I_PRP could_MD n’t_RB help_VB but_CC question_VB why_WRB we_PRP need_VBP the_DT vaccine_NN at_IN all_DT ._. ”_'' –_: Joan_NNP Robinson_NNP Dr._NNP Harper_NNP explained_VBD in_IN her_PRP$ presentation_NN that_IN the_DT cervical_JJ cancer_NN risk_NN in_IN the_DT U.S._NNP is_VBZ already_RB extremely_RB low_JJ ,_, and_CC that_IN vaccinations_NNS are_VBP unlikely_JJ to_TO have_VB any_DT effect_NN upon_IN the_DT rate_NN of_IN cervical_JJ cancer_NN in_IN the_DT United_NNP States_NNPS ._. In_IN fact_NN ,_, 70_CD %_NN of_IN all_DT H.P.V._NNP infections_NNS resolve_VBP themselves_PRP without_IN treatment_NN in_IN a_DT year_NN ,_, and_CC the_DT number_NN rises_VBZ to_IN well_RB over_RB 90_CD %_NN in_IN two_CD years_NNS ._. Harper_NNP also_RB mentioned_VBD the_DT safety_NN angle_NN ._. All_DT trials_NNS of_IN the_DT vaccines_NNS were_VBD done_VBN on_IN children_NNS aged_JJ 15_CD and_CC above_RB ,_, despite_IN them_PRP currently_RB being_VBG marketed_VBN for_IN 9_CD -_HYPH year_NN -_HYPH olds_NNS ._. So_RB far_RB ,_, 15,037_CD girls_NNS have_VBP reported_VBN adverse_JJ side_NN effects_NNS from_IN Gardasil_NNP alone_RB to_IN the_DT Vaccine_NNP Adverse_JJ Event_NN Reporting_NN System_NNP (_-LRB- V.A.E.R.S._NN )_-RRB- ,_, and_CC this_DT number_NN only_RB reflects_VBZ parents_NNS who_WP underwent_VBD the_DT hurdles_NNS required_VBN for_IN reporting_VBG adverse_JJ reactions_NNS ._. At_IN the_DT time_NN of_IN writing_NN ,_, 44_CD girls_NNS are_VBP officially_RB known_VBN to_TO have_VB died_VBN from_IN these_DT vaccines_NNS ._. The_DT reported_VBN side_NN effects_NNS include_VBP Guillian_NNP Barré_NNP Syndrome_NN (_-LRB- paralysis_NN lasting_VBG for_IN years_NNS ,_, or_CC permanently_RB —_: sometimes_RB eventually_RB causing_VBG suffocation_NN )_-RRB- ,_, lupus_NN ,_, seizures_NNS ,_, blood_NN clots_NNS ,_, and_CC brain_NN inflammation_NN ._. Parents_NNS are_VBP usually_RB not_RB made_VBN aware_JJ of_IN these_DT risks_NNS ._. Dr._NNP Harper_NNP ,_, the_DT vaccine_NN developer_NN ,_, claimed_VBD that_IN she_PRP was_VBD speaking_VBG out_RP ,_, so_IN that_IN she_PRP might_MD finally_RB be_VB able_JJ to_TO sleep_VB at_IN night_NN ._. “_`` About_RB eight_CD in_IN every_DT ten_CD women_NNS who_WP have_VBP been_VBN sexually_RB active_JJ will_MD have_VB H.P.V._NN at_IN some_DT stage_NN of_IN their_PRP$ life_NN ._. Normally_RB there_EX are_VBP no_DT symptoms_NNS ,_, and_CC in_IN 98_CD per_NN cent_NN of_IN cases_NNS it_PRP clears_VBZ itself_PRP ._. But_CC in_IN those_DT cases_NNS where_WRB it_PRP does_VBZ n’t_RB ,_, and_CC is_VBZ n’t_RB treated_VBN ,_, it_PRP can_MD lead_VB to_IN pre-cancerous_JJ cells_NNS which_WDT may_MD develop_VB into_IN cervical_JJ cancer_NN ._. ”_'' –_: Dr._NNP Diane_NNP Harper_NNP One_PRP must_MD understand_VB how_WRB the_DT establishment_NN ’s_POS word_NN games_NNS are_VBP played_VBN to_TO truly_RB understand_VB the_DT meaning_NN of_IN the_DT above_JJ quote_NN ,_, and_CC one_PRP needs_VBZ to_TO understand_VB its_PRP$ unique_JJ version_NN of_IN “_`` science_NN ”_'' ._. When_WRB they_PRP report_VBP that_IN untreated_JJ cases_NNS “_'' can_MD ”_`` lead_VB to_IN something_NN that_WDT “_'' may_MD ”_`` lead_VB to_IN cervical_JJ cancer_NN ,_, it_PRP really_RB means_VBZ that_IN the_DT relationship_NN is_VBZ merely_RB a_DT hypothetical_JJ conjecture_NN that_WDT is_VBZ profitable_JJ if_IN people_NNS actually_RB believe_VBP it_PRP ._. In_IN other_JJ words_NNS ,_, there_EX is_VBZ no_DT demonstrated_VBN relationship_NN between_IN the_DT condition_NN being_VBG vaccinated_VBN for_IN and_CC the_DT rare_JJ cancers_NNS that_WDT the_DT vaccine_NN might_MD prevent_VB ,_, but_CC it_PRP is_VBZ marketed_VBN to_TO do_VB that_DT nonetheless_RB ._. In_IN fact_NN ,_, there_EX is_VBZ no_DT actual_JJ evidence_NN that_IN the_DT vaccine_NN can_MD prevent_VB any_DT cancer_NN ._. From_IN the_DT manufacturers_NNS own_JJ admissions_NNS ,_, the_DT vaccine_NN only_RB works_VBZ on_IN 4_CD strains_NNS out_IN of_IN 40_CD for_IN a_DT specific_JJ venereal_JJ disease_NN that_WDT dies_VBZ on_IN its_PRP$ own_JJ in_IN a_DT relatively_RB short_JJ period_NN ,_, so_RB the_DT chance_NN of_IN it_PRP actually_RB helping_VBG an_DT individual_NN is_VBZ about_RB about_RB the_DT same_JJ as_IN the_DT chance_NN of_IN him_PRP being_VBG struck_VBN by_IN a_DT meteorite_NN ._. Why_WRB do_VBP nine_CD -_HYPH year_NN -_HYPH old_JJ girls_NNS need_VB vaccinations_NNS for_IN extremely_RB rare_JJ and_CC symptom_NN -_HYPH less_RBR venereal_JJ diseases_NNS that_WDT the_DT immune_NN system_NN usually_RB kills_VBZ anyway_RB ?_.","NNP NNP NNP VBD the JJ NN in the NN of the JJ NN NN NNS , NNP and NNP . She VBZ the JJS to VB RB and VB the NN and NN of these NNS . She VBD the JJ NN at the JJ NNP NNP NNP on NNP , which VBD NN in NNP , NNP on NNP NN through NN , 2009 . Her NN VBD VBN to VB the NNP and NNP NNS , but she RB VBD on her JJ NNS in a RB JJ NN . When VBN about the NN , NN NNS VBD that they VBD RB VBG that the NNS should RB VB VBN . “ I VBD RB from the NN with the NN that the NN of JJ NN NNS VBZ RB RB JJR than the NN of JJ NN , I could RB VB but VB why we VBP the NN at all . ” – NNP NNP NNP NNP VBD in her NN that the JJ NN NN in the NNP VBZ RB RB JJ , and that NNS VBP JJ to VB any NN upon the NN of JJ NN in the NNP NNPS . In NN , 70 NN of all NNP NNS VBP themselves without NN in a NN , and the NN VBZ to RB RB 90 NN in two NNS . NNP RB VBD the NN NN . All NNS of the NNS VBD VBN on NNS JJ 15 and RB , despite them RB VBG VBN for 9 - NN - NNS . RB RB , 15,037 NNS VBP VBN JJ NN NNS from NNP RB to the NNP JJ NN NN NNP ( NN ) , and this NN RB VBZ NNS who VBD the NNS VBN for VBG JJ NNS . At the NN of NN , 44 NNS VBP RB VBN to VB VBN from these NNS . The VBN NN NNS VBP NNP NNP NN ( NN VBG for NNS , or RB — RB RB VBG NN ) , NN , NNS , NN NNS , and NN NN . NNS VBP RB RB VBN JJ of these NNS . NNP NNP , the NN NN , VBD that she VBD VBG out , so that she might RB VB JJ to VB at NN . “ RB eight in every ten NNS who VBP VBN RB JJ will VB NN at some NN of their NN . RB there VBP no NNS , and in 98 NN NN of NNS it VBZ itself . But in those NNS where it VBZ RB , and VBZ RB VBN , it can VB to JJ NNS which may VB into JJ NN . ” – NNP NNP NNP One must VB how the NN ’s NN NNS VBP VBN to RB VB the NN of the JJ NN , and one VBZ to VB its JJ NN of “ NN ” . When they VBP that JJ NNS “ can ” VB to NN that “ may ” VB to JJ NN , it RB VBZ that the NN VBZ RB a JJ NN that VBZ JJ if NNS RB VBP it . In JJ NNS , there VBZ no VBN NN between the NN VBG VBN for and the JJ NNS that the NN might VB , but it VBZ VBN to VB that RB . In NN , there VBZ no JJ NN that the NN can VB any NN . From the NNS JJ NNS , the NN RB VBZ on 4 NNS out of 40 for a JJ JJ NN that VBZ on its JJ in a RB JJ NN , RB the NN of it RB VBG an NN VBZ RB RB the JJ as the NN of him VBG VBN by a NN . Why VBP nine - NN - JJ NNS VB NNS for RB JJ and NN - RBR JJ NNS that the NN NN RB VBZ RB ?"
33,90,conspiracy,"Among_IN the_DT myriad_JJ ,_, earth_NN -_HYPH shattering_VBG geopolitical_JJ effects_NNS of_IN coronavirus_NN ,_, one_CD is_VBZ already_RB graphically_RB evident_JJ ._. China_NNP has_VBZ re-positioned_VBN itself_PRP ._. For_IN the_DT first_JJ time_NN since_IN the_DT start_NN of_IN Deng_NNP Xiaoping_NNP ’s_POS reforms_NNS in_IN 1978_CD ,_, Beijing_NNP openly_RB regards_VBZ the_DT US_NNP as_IN a_DT threat_NN ,_, as_IN stated_VBN a_DT month_NN ago_RB by_IN Foreign_NNP Minister_NNP Wang_NNP Yi_NNP at_IN the_DT Munich_NNP Security_NNP Conference_NNP during_IN the_DT peak_NN of_IN the_DT fight_NN against_IN coronavirus_NN ._. Beijing_NNP is_VBZ carefully_RB ,_, incrementally_RB shaping_VBG the_DT narrative_NN that_IN ,_, from_IN the_DT beginning_NN of_IN the_DT coronovirus_NN attack_NN ,_, the_DT leadership_NN knew_VBD it_PRP was_VBD under_IN a_DT hybrid_JJ war_NN attack_NN ._. Xi_NNP ’s_POS terminology_NN is_VBZ a_DT major_JJ clue_NN ._. He_PRP said_VBD ,_, on_IN the_DT record_NN ,_, that_IN this_DT was_VBD war_NN ._. And_CC ,_, as_IN a_DT counter_NN -_HYPH attack_NN ,_, a_DT “_`` people_NNS ’s_POS war_NN ”_'' had_VBD to_TO be_VB launched_VBN ._. Moreover_RB ,_, he_PRP described_VBD the_DT virus_NN as_IN a_DT demon_NN or_CC devil_NN ._. Xi_NNP is_VBZ a_DT Confucianist_NNP ._. Unlike_IN some_DT other_JJ ancient_JJ Chinese_JJ thinkers_NNS ,_, Confucius_NNP was_VBD loath_JJ to_TO discuss_VB supernatural_JJ forces_NNS and_CC judgment_NN in_IN the_DT afterlife_NN ._. However_RB ,_, in_IN a_DT Chinese_JJ cultural_JJ context_NN ,_, devil_NNP means_VBZ “_`` white_JJ devils_NNS ”_'' or_CC “_`` foreign_JJ devils_NNS ”_'' :_: guailo_NNP in_IN Mandarin_NNP ,_, gweilo_NNP in_IN Cantonese_NNP ._. This_DT was_VBD Xi_NNP delivering_VBG a_DT powerful_JJ statement_NN in_IN code_NN ._. When_WRB Zhao_NNP Lijian_NNP ,_, a_DT spokesman_NN for_IN the_DT Chinese_NNP Foreign_NNP Ministry_NNP ,_, voiced_VBD in_IN an_DT incandescent_JJ tweet_NN the_DT possibility_NN that_IN “_`` it_PRP might_MD be_VB US_NNP Army_NNP who_WP brought_VBD the_DT epidemic_NN to_IN Wuhan_NNP ”_'' –_: the_DT first_JJ blast_NN to_IN this_DT effect_NN to_TO come_VB from_IN a_DT top_JJ official_NN –_: Beijing_NNP was_VBD sending_VBG up_RP a_DT trial_NN balloon_NN signaliing_VBG that_IN the_DT gloves_NNS were_VBD finally_RB off_RB ._. Zhao_NNP Lijian_NNP made_VBD a_DT direct_JJ connection_NN with_IN the_DT Military_NNP Games_NNP in_IN Wuhan_NNP in_IN October_NNP 2019_CD ,_, which_WDT included_VBD a_DT delegation_NN of_IN 300_CD US_NNP military_NN ._. He_PRP directly_RB quoted_VBD US_NNP CDC_NNP director_NN Robert_NNP Redfield_NNP who_WP ,_, when_WRB asked_VBN last_JJ week_NN whether_IN some_DT deaths_NNS by_IN coronavirus_NN had_VBD been_VBN discovered_VBN posthumously_RB in_IN the_DT US_NNP ,_, replied_VBD that_IN “_`` some_DT cases_NNS have_VBP actually_RB been_VBN diagnosed_VBN this_DT way_NN in_IN the_DT US_NNP today_NN ._. ”_'' Zhao_NNP ’s_POS explosive_JJ conclusion_NN is_VBZ that_IN Covid_NNP -_HYPH 19_CD was_VBD already_RB in_IN effect_NN in_IN the_DT US_NNP before_IN being_VBG identified_VBN in_IN Wuhan_NNP –_: due_IN to_IN the_DT by_IN now_RB fully_RB documented_VBN inability_NN of_IN US_NNP to_TO test_VB and_CC verify_VB differences_NNS compared_VBN with_IN the_DT flu_NN ._. Adding_VBG all_DT that_DT to_IN the_DT fact_NN that_IN coronavirus_NN genome_NN variations_NNS in_IN Iran_NNP and_CC Italy_NNP were_VBD sequenced_VBN and_CC it_PRP was_VBD revealed_VBN they_PRP do_VBP not_RB belong_VB to_IN the_DT variety_NN that_WDT infected_VBD Wuhan_NNP ,_, Chinese_JJ media_NN are_VBP now_RB openly_RB asking_VBG questions_NNS and_CC drawing_VBG a_DT connection_NN with_IN the_DT shutting_NN down_RP in_IN August_NNP last_JJ year_NN of_IN the_DT “_`` unsafe_JJ ”_'' military_JJ bioweapon_NN lab_NN at_IN Fort_NNP Detrick_NNP ,_, the_DT Military_NNP Games_NNPS ,_, and_CC the_DT Wuhan_NNP epidemic_NN ._. Some_DT of_IN these_DT questions_NNS had_VBD been_VBN asked_VBN –_: with_IN no_DT response_NN –_: inside_IN the_DT US_NNP itself_PRP ._. Extra_JJ questions_NNS linger_VBP about_IN the_DT opaque_JJ Event_NN 201_CD in_IN New_NNP York_NNP on_IN October_NNP 18_CD ,_, 2019_CD :_: a_DT rehearsal_NN for_IN a_DT worldwide_JJ pandemic_NN caused_VBN by_IN a_DT deadly_JJ virus_NN –_: which_WDT happened_VBD to_TO be_VB coronavirus_NN ._. This_DT magnificent_JJ coincidence_NN happened_VBD one_CD month_NN before_IN the_DT outbreak_NN in_IN Wuhan_NNP ._. Event_NN 201_CD was_VBD sponsored_VBN by_IN Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, the_DT World_NNP Economic_NNP Forum_NNP (_-LRB- WEF_NNP )_-RRB- ,_, the_DT CIA_NNP ,_, Bloomberg_NNP ,_, John_NNP Hopkins_NNP Foundation_NNP and_CC the_DT UN_NNP ._. The_DT World_NNP Military_NNP Games_NNPS opened_VBD in_IN Wuhan_NNP on_IN the_DT exact_RB same_JJ day_NN ._. Irrespective_JJ of_IN its_PRP$ origin_NN ,_, which_WDT is_VBZ still_RB not_RB conclusively_RB established_VBN ,_, as_RB much_JJ as_IN Trump_NNP tweets_VBZ about_IN the_DT “_`` Chinese_JJ virus_NN ,_, ”_'' Covid_NNP -_HYPH 19_CD already_RB poses_VBZ immensely_RB serious_JJ questions_NNS about_IN biopolitics_NN (_-LRB- where_WRB ’s_VBZ Foucault_NNP when_WRB we_PRP need_VBP him_PRP ?_. )_-RRB- and_CC bio-terror_NN ._. The_DT working_NN hypothesis_NN of_IN coronavirus_NN as_IN a_DT very_RB powerful_JJ but_CC not_RB Armageddon_NNP -_HYPH provoking_VBG bio_NN -_HYPH weapon_NN unveils_VBZ it_PRP as_IN a_DT perfect_JJ vehicle_NN for_IN widespread_JJ social_JJ control_NN –_: on_IN a_DT global_JJ scale_NN ._. Just_RB as_IN a_DT fully_RB masked_VBN Xi_NNP visiting_VBG the_DT Wuhan_NNP frontline_NN last_JJ week_NN was_VBD a_DT graphic_JJ demonstration_NN to_IN the_DT whole_JJ planet_NN that_WDT China_NNP ,_, with_IN immense_JJ sacrifice_NN ,_, is_VBZ winning_VBG the_DT “_`` people_NNS ‘s_POS war_NN ”_'' against_IN Covid_NNP -_HYPH 19_CD ,_, Russia_NNP ,_, in_IN a_DT Sun_NNP Tzu_NNP move_NN on_IN Riyadh_NNP whose_WP$ end_NN result_NN was_VBD a_DT much_RB cheaper_JJR barrel_NN of_IN oil_NN ,_, helped_VBD for_IN all_DT practical_JJ purposes_NNS to_TO kick_VB -_HYPH start_VB the_DT inevitable_JJ recovery_NN of_IN the_DT Chinese_JJ economy_NN ._. This_DT is_VBZ how_WRB a_DT strategic_JJ partnership_NN works_VBZ ._. The_DT chessboard_NN is_VBZ changing_VBG at_IN breakneck_JJ speed_NN ._. Once_IN Beijing_NNP identified_VBD coronavirus_NN as_IN a_DT bio_NN -weapon_NN attack_NN the_DT “_`` people_NNS ’s_POS war_NN ”_'' was_VBD launched_VBN with_IN the_DT full_JJ force_NN of_IN the_DT state_NN ._. Methodically_RB ._. On_IN a_DT “_`` whatever_WDT it_PRP takes_VBZ ”_'' basis_NN ._. Now_RB we_PRP are_VBP entering_VBG a_DT new_JJ stage_NN ,_, which_WDT will_MD be_VB used_VBN by_IN Beijing_NNP to_TO substantially_RB recalibrate_VB the_DT interaction_NN with_IN the_DT West_NN ,_, and_CC under_IN very_RB different_JJ frameworks_NNS when_WRB it_PRP comes_VBZ to_IN the_DT US_NNP and_CC the_DT EU_NNP ._. Soft_JJ power_NN is_VBZ paramount_JJ ._. Beijing_NNP sent_VBD an_DT Air_NNP China_NNP flight_NN to_IN Italy_NNP carrying_VBG 2,300_CD big_JJ boxes_NNS full_JJ of_IN masks_NNS bearing_VBG the_DT script_NN ,_, “_`` We_PRP are_VBP waves_NNS from_IN the_DT same_JJ sea_NN ,_, leaves_NNS from_IN the_DT same_JJ tree_NN ,_, flowers_NNS from_IN the_DT same_JJ garden_NN ._. ”_'' China_NNP also_RB sent_VBD a_DT hefty_JJ humanitarian_JJ package_NN to_IN Iran_NNP ,_, significantly_RB aboard_IN eight_CD flights_NNS from_IN Mahan_NNP Air_NNP –_: an_DT airline_NN under_IN illegal_JJ ,_, unilateral_JJ Trump_NNP administration_NN sanctions_NNS ._. Serbian_JJ President_NNP Aleksandar_NNP Vucic_NNP could_MD not_RB have_VB been_VBN more_RBR explicit_JJ :_: “_`` The_DT only_JJ country_NN that_WDT can_MD help_VB us_PRP is_VBZ China_NNP ._. By_IN now_RB ,_, you_PRP all_DT understood_VBD that_IN European_JJ solidarity_NN does_VBZ not_RB exist_VB ._. That_DT was_VBD a_DT fairy_NN tale_NN on_IN paper_NN ._. ”_'' Under_IN harsh_JJ sanctions_NNS and_CC demonized_VBN since_IN forever_RB ,_, Cuba_NNP is_VBZ still_RB able_JJ to_TO perform_VB breakthroughs_NNS –_: even_RB on_IN biotechnology_NN ._. The_DT anti-viral_JJ Heberon_NNP –_: or_CC Interferon_NNP Alpha_NNP 2_CD b_NN –_: a_DT therapeutic_NN ,_, not_RB a_DT vaccine_NN ,_, has_VBZ been_VBN used_VBN with_IN great_JJ success_NN in_IN the_DT treatment_NN of_IN coronavirus_NN ._. A_DT joint_JJ venture_NN in_IN China_NNP is_VBZ producing_VBG an_DT inhalable_JJ version_NN ,_, and_CC at_IN least_JJS 15_CD nations_NNS are_VBP already_RB interested_JJ in_IN importing_VBG the_DT therapeutic_JJ ._. Now_RB compare_VB all_DT of_IN the_DT above_JJ with_IN the_DT Trump_NNP administration_NN offering_VBG $_$ 1_CD billion_CD to_TO poach_VB German_JJ scientists_NNS working_VBG at_IN biotech_NN firm_NN Curevac_NNP ,_, based_VBN in_IN Thuringia_NNP ,_, on_IN an_DT experimental_JJ vaccine_NN against_IN Covid_NNP -_HYPH 19_CD ,_, to_TO have_VB it_PRP as_IN a_DT vaccine_NN “_'' only_RB for_IN the_DT United_NNP States_NNPS ._. ”_'' Sandro_NNP Mezzadra_NNP ,_, co-author_NN with_IN Brett_NNP Neilson_NNP of_IN the_DT seminal_JJ The_DT Politics_NNPS of_IN Operations_NNPS :_: Excavating_VBG Contemporary_NNP Capitalism_NNP ,_, is_VBZ already_RB trying_VBG to_TO conceptualize_VB where_WRB we_PRP stand_VBP now_RB in_IN terms_NNS of_IN fighting_VBG Covid_NNP -_HYPH 19_CD ._. We_PRP are_VBP facing_VBG a_DT choice_NN between_IN a_DT Malthusian_JJ strand_NN –_: inspired_VBN by_IN social_JJ Darwinism_NN –_: “_'' led_VBN by_IN the_DT Johnson_NNP -_HYPH Trump_NNP -_HYPH Bolsonaro_NNP axis_NN ”_'' and_CC ,_, on_IN the_DT other_JJ side_NN ,_, a_DT strand_NN pointing_VBG to_IN the_DT “_`` requalification_NN of_IN public_JJ health_NN as_IN a_DT fundamental_JJ tool_NN ,_, ”_'' exemplified_VBN by_IN China_NNP ,_, South_NNP Korea_NNP and_CC Italy_NNP ._. There_EX are_VBP key_JJ lessons_NNS to_TO be_VB learned_VBN from_IN South_NNP Korea_NNP ,_, Taiwan_NNP and_CC Singapore_NNP ._. The_DT stark_JJ option_NN ,_, Mezzadra_NNP notes_VBZ ,_, is_VBZ between_IN a_DT “_`` natural_JJ population_NN selection_NN ,_, ”_'' with_IN thousands_NNS of_IN dead_JJ ,_, and_CC “_`` defending_VBG society_NN ”_'' by_IN employing_VBG “_`` variable_JJ degrees_NNS of_IN authoritarianism_NN and_CC social_JJ control_NN ._. ”_'' It_PRP ’s_VBZ easy_JJ to_TO imagine_VB who_WP stands_VBZ to_TO benefit_VB from_IN this_DT social_JJ re-engineering_NN ,_, a_DT 21st_JJ century_NN remix_NN of_IN Poe_NNP ’s_POS The_DT Masque_NNP of_IN the_DT Red_NNP Death_NNP ._. Amid_IN so_RB much_JJ doom_NN and_CC gloom_NN ,_, count_VB on_IN Italy_NNP to_TO offer_VB us_PRP Tiepolo_NNP -_HYPH style_NN shades_NNS of_IN light_NN ._. Italy_NNP chose_VBD the_DT Wuhan_NNP option_NN ,_, with_IN immensely_RB serious_JJ consequences_NNS for_IN its_PRP$ already_RB fragile_JJ economy_NN ._. Quarantined_VBN Italians_NNPS remarkably_RB reacted_VBD by_IN singing_VBG on_IN their_PRP$ balconies_NNS :_: a_DT true_JJ act_NN of_IN metaphysical_JJ revolt_NN ._. Not_RB to_TO mention_VB the_DT poetic_JJ justice_NN of_IN the_DT actual_JJ St._NNP Corona_NNP (_-LRB- “_`` crown_NN ”_'' in_IN Latin_NNP )_-RRB- being_VBG buried_VBN in_IN the_DT city_NN of_IN Anzu_NNP since_IN the_DT 9th_JJ century_NN ._. St._NNP Corona_NNP was_VBD a_DT Christian_NNP killed_VBN under_IN Marcus_NNP Aurelius_NNP in_IN 165_CD AD_NN ,_, and_CC has_VBZ been_VBN for_IN centuries_NNS one_CD of_IN the_DT patron_NN saints_NNS of_IN pandemics_NNS ._. Not_RB even_RB trillions_NNS of_IN dollars_NNS raining_VBG from_IN the_DT sky_NN by_IN an_DT act_NN of_IN divine_JJ Fed_JJ mercy_NN were_VBD able_JJ to_TO cure_VB Covid_NNP -_HYPH 19_CD ._. G_NNP -_HYPH 7_CD “_'' leaders_NNS ”_'' had_VBD to_TO resort_VB to_IN a_DT videoconference_NN to_TO realize_VB how_WRB clueless_JJ they_PRP are_VBP –_: even_RB as_IN China_NNP ’s_POS fight_NN against_IN coronavirus_NN gave_VBD the_DT West_NNP a_DT head_NN start_NN of_IN several_JJ weeks_NNS ._. Shanghai_NNP -_HYPH based_VBN Dr._NNP Zhang_NNP Wenhong_NNP ,_, one_CD of_IN China_NNP ’s_POS top_JJ infectious_JJ disease_NN experts_NNS ,_, whose_WP$ analyses_NNS have_VBP been_VBN spot_VBN on_IN so_RB far_RB ,_, now_RB says_VBZ China_NNP has_VBZ emerged_VBN from_IN the_DT darkest_JJS days_NNS in_IN the_DT “_`` people_NNS ’s_POS war_NN ”_'' against_IN Covid_NNP -_HYPH 19_CD ._. But_CC he_PRP does_VBZ not_RB think_VB this_DT will_MD be_VB over_RB by_IN summer_NN ._. Now_RB extrapolate_VB what_WP he_PRP ’s_VBZ saying_VBG to_IN the_DT Western_JJ world_NN ._. It_PRP ’s_VBZ not_RB even_RB spring_NN yet_RB ,_, and_CC we_PRP already_RB know_VBP it_PRP takes_VBZ a_DT virus_NN to_TO mercilessly_RB shatter_VB the_DT Goddess_NNP of_IN the_DT Market_NNP ._. Last_JJ Friday_NNP ,_, Goldman_NNP Sachs_NNP told_VBD no_DT fewer_JJR than_IN 1,500_CD corporations_NNS that_IN there_EX was_VBD no_DT systemic_JJ risk_NN ._. That_DT was_VBD false_JJ ._. New_NNP York_NNP banking_NN sources_NNS told_VBD me_PRP the_DT truth_NN :_: systemic_JJ risk_NN became_VBD way_RB more_RBR severe_JJ in_IN 2020_CD than_IN in_IN 1979_CD ,_, 1987_CD or_CC 2008_CD because_IN of_IN the_DT hugely_RB heightened_VBN danger_NN that_IN the_DT $_$ 1.5_CD quadrillion_NN derivative_NN market_NN would_MD collapse_VB ._. As_IN the_DT sources_NNS put_VBD it_PRP ,_, history_NN had_VBD never_RB before_RB seen_VBN anything_NN like_IN the_DT Fed_NNP ’s_POS intervention_NN via_IN its_PRP$ little_JJ understood_VBN elimination_NN of_IN commercial_JJ bank_NN reserve_NN requirements_NNS ,_, unleashing_VBG a_DT potential_JJ unlimited_JJ expansion_NN of_IN credit_NN to_TO prevent_VB a_DT derivative_JJ implosion_NN stemming_VBG from_IN a_DT total_JJ commodity_NN and_CC stock_NN market_NN collapse_NN of_IN all_DT stocks_NNS around_IN the_DT world_NN ._. Those_DT bankers_NNS thought_VBD it_PRP would_MD work_VB ,_, but_CC as_IN we_PRP know_VBP by_IN now_RB all_PDT the_DT sound_NN and_CC fury_NN signified_VBD nothing_NN ._. The_DT ghost_NN of_IN a_DT derivative_JJ implosion_NN –_: in_IN this_DT case_NN not_RB caused_VBN by_IN the_DT previous_JJ possibility_NN ,_, the_DT shutting_NN down_RP of_IN the_DT Strait_NNP of_IN Hormuz_NNP –_: remains_VBZ ._. We_PRP are_VBP still_RB barely_RB starting_VBG to_TO understand_VB the_DT consequences_NNS of_IN Covid_NNP -_HYPH 19_CD for_IN the_DT future_NN of_IN neoliberal_JJ turbo-_JJ capitalism_NN ._. What_WP ’s_VBZ certain_JJ is_VBZ that_IN the_DT whole_JJ global_JJ economy_NN has_VBZ been_VBN hit_VBN by_IN an_DT insidious_JJ ,_, literally_RB invisible_JJ circuit_NN breaker_NN ._. This_DT may_MD be_VB just_RB a_DT “_`` coincidence_NN ._. ”_'' Or_CC this_DT may_MD be_VB ,_, as_IN some_DT are_VBP boldly_RB arguing_VBG ,_, part_NN of_IN a_DT possible_JJ ,_, massive_JJ psy_NN -_HYPH op_NN creating_VBG the_DT perfect_JJ geopolitlcal_JJ and_CC social_JJ engineering_NN environment_NN for_IN full_JJ -_HYPH spectrum_NN dominance_NN ._. Additionally_RB ,_, along_IN the_DT hard_JJ slog_NN down_IN the_DT road_NN ,_, with_IN immense_JJ ,_, inbuilt_JJ human_JJ and_CC economic_JJ sacrifice_NN ,_, with_IN or_CC without_IN a_DT reboot_NN of_IN the_DT world_NN -_HYPH system_NN ,_, a_DT more_RBR pressing_JJ question_NN remains_VBZ :_: will_MD imperial_JJ elites_NNS still_RB choose_VB to_TO keep_VB waging_VBG full_JJ -_HYPH spectrum_NN -_HYPH dominance_NN hybrid_JJ war_NN against_IN China_NNP ?_. *(_NFP Top_JJ image_NN :_: A_DT medical_JJ staff_NN from_IN east_NNP China_NNP 's_POS Anhui_NNP Province_NNP ,_, waits_VBZ for_IN patients_NNS with_IN her_PRP$ colleague_NN at_IN the_DT temporary_JJ hospital_NN converted_VBN from_IN Wuhan_NNP Sports_NNP Center_NNP in_IN Wuhan_NNP ,_, central_JJ China_NNP 's_POS Hubei_NNP Province_NNP ,_, Feb._NNP 12_CD ,_, 2020_CD ._. Credit_NN :_: Xiao_NNP Yijiu_NNP /_, Xinhua_NNP )_-RRB- *_NFP This_DT article_NN was_VBD originally_RB published_VBN on_IN Asia_NNP Times_NNP ._.","Among the JJ , NN - VBG JJ NNS of NN , one VBZ RB RB JJ . NNP VBZ VBN itself . For the JJ NN since the NN of NNP NNP ’s NNS in 1978 , NNP RB VBZ the NNP as a NN , as VBN a NN RB by NNP NNP NNP NNP at the NNP NNP NNP during the NN of the NN against NN . NNP VBZ RB , RB VBG the NN that , from the NN of the NN NN , the NN VBD it VBD under a JJ NN NN . NNP ’s NN VBZ a JJ NN . He VBD , on the NN , that this VBD NN . And , as a NN - NN , a “ NNS ’s NN ” VBD to VB VBN . RB , he VBD the NN as a NN or NN . NNP VBZ a NNP . Unlike some JJ JJ JJ NNS , NNP VBD JJ to VB JJ NNS and NN in the NN . RB , in a JJ JJ NN , NNP VBZ “ JJ NNS ” or “ JJ NNS ” : NNP in NNP , NNP in NNP . This VBD NNP VBG a JJ NN in NN . When NNP NNP , a NN for the NNP NNP NNP , VBD in an JJ NN the NN that “ it might VB NNP NNP who VBD the NN to NNP ” – the JJ NN to this NN to VB from a JJ NN – NNP VBD VBG up a NN NN VBG that the NNS VBD RB RB . NNP NNP VBD a JJ NN with the NNP NNP in NNP in NNP 2019 , which VBD a NN of 300 NNP NN . He RB VBD NNP NNP NN NNP NNP who , when VBN JJ NN whether some NNS by NN VBD VBN VBN RB in the NNP , VBD that “ some NNS VBP RB VBN VBN this NN in the NNP NN . ” NNP ’s JJ NN VBZ that NNP - 19 VBD RB in NN in the NNP before VBG VBN in NNP – due to the by RB RB VBN NN of NNP to VB and VB NNS VBN with the NN . VBG all that to the NN that NN NN NNS in NNP and NNP VBD VBN and it VBD VBN they VBP RB VB to the NN that VBD NNP , JJ NN VBP RB RB VBG NNS and VBG a NN with the NN down in NNP JJ NN of the “ JJ ” JJ NN NN at NNP NNP , the NNP NNPS , and the NNP NN . Some of these NNS VBD VBN VBN – with no NN – inside the NNP itself . JJ NNS VBP about the JJ NN 201 in NNP NNP on NNP 18 , 2019 : a NN for a JJ NN VBN by a JJ NN – which VBD to VB NN . This JJ NN VBD one NN before the NN in NNP . NN 201 VBD VBN by NNP & NNP NNP NNP , the NNP NNP NNP ( NNP ) , the NNP , NNP , NNP NNP NNP and the NNP . The NNP NNP NNPS VBD in NNP on the RB JJ NN . JJ of its NN , which VBZ RB RB RB VBN , RB JJ as NNP VBZ about the “ JJ NN , ” NNP - 19 RB VBZ RB JJ NNS about NN ( where VBZ NNP when we VBP him ? ) and NN . The NN NN of NN as a RB JJ but RB NNP - VBG NN - NN VBZ it as a JJ NN for JJ JJ NN – on a JJ NN . RB as a RB VBN NNP VBG the NNP NN JJ NN VBD a JJ NN to the JJ NN that NNP , with JJ NN , VBZ VBG the “ NNS ‘s NN ” against NNP - 19 , NNP , in a NNP NNP NN on NNP whose NN NN VBD a RB JJR NN of NN , VBD for all JJ NNS to VB - VB the JJ NN of the JJ NN . This VBZ how a JJ NN VBZ . The NN VBZ VBG at JJ NN . Once NNP VBD NN as a NN NN NN the “ NNS ’s NN ” VBD VBN with the JJ NN of the NN . RB . On a “ whatever it VBZ ” NN . RB we VBP VBG a JJ NN , which will VB VBN by NNP to RB VB the NN with the NN , and under RB JJ NNS when it VBZ to the NNP and the NNP . JJ NN VBZ JJ . NNP VBD an NNP NNP NN to NNP VBG 2,300 JJ NNS JJ of NNS VBG the NN , “ We VBP NNS from the JJ NN , NNS from the JJ NN , NNS from the JJ NN . ” NNP RB VBD a JJ JJ NN to NNP , RB aboard eight NNS from NNP NNP – an NN under JJ , JJ NNP NN NNS . JJ NNP NNP NNP could RB VB VBN RBR JJ : “ The JJ NN that can VB us VBZ NNP . By RB , you all VBD that JJ NN VBZ RB VB . That VBD a NN NN on NN . ” Under JJ NNS and VBN since RB , NNP VBZ RB JJ to VB NNS – RB on NN . The JJ NNP – or NNP NNP 2 NN – a NN , RB a NN , VBZ VBN VBN with JJ NN in the NN of NN . A JJ NN in NNP VBZ VBG an JJ NN , and at JJS 15 NNS VBP RB JJ in VBG the JJ . RB VB all of the JJ with the NNP NN VBG $ 1 billion to VB JJ NNS VBG at NN NN NNP , VBN in NNP , on an JJ NN against NNP - 19 , to VB it as a NN “ RB for the NNP NNPS . ” NNP NNP , NN with NNP NNP of the JJ The NNPS of NNPS : VBG NNP NNP , VBZ RB VBG to VB where we VBP RB in NNS of VBG NNP - 19 . We VBP VBG a NN between a JJ NN – VBN by JJ NN – “ VBN by the NNP - NNP - NNP NN ” and , on the JJ NN , a NN VBG to the “ NN of JJ NN as a JJ NN , ” VBN by NNP , NNP NNP and NNP . There VBP JJ NNS to VB VBN from NNP NNP , NNP and NNP . The JJ NN , NNP VBZ , VBZ between a “ JJ NN NN , ” with NNS of JJ , and “ VBG NN ” by VBG “ JJ NNS of NN and JJ NN . ” It VBZ JJ to VB who VBZ to VB from this JJ NN , a JJ NN NN of NNP ’s The NNP of the NNP NNP . Amid RB JJ NN and NN , VB on NNP to VB us NNP - NN NNS of NN . NNP VBD the NNP NN , with RB JJ NNS for its RB JJ NN . VBN NNPS RB VBD by VBG on their NNS : a JJ NN of JJ NN . RB to VB the JJ NN of the JJ NNP NNP ( “ NN ” in NNP ) VBG VBN in the NN of NNP since the JJ NN . NNP NNP VBD a NNP VBN under NNP NNP in 165 NN , and VBZ VBN for NNS one of the NN NNS of NNS . RB RB NNS of NNS VBG from the NN by an NN of JJ JJ NN VBD JJ to VB NNP - 19 . NNP - 7 “ NNS ” VBD to VB to a NN to VB how JJ they VBP – RB as NNP ’s NN against NN VBD the NNP a NN NN of JJ NNS . NNP - VBN NNP NNP NNP , one of NNP ’s JJ JJ NN NNS , whose NNS VBP VBN VBN on RB RB , RB VBZ NNP VBZ VBN from the JJS NNS in the “ NNS ’s NN ” against NNP - 19 . But he VBZ RB VB this will VB RB by NN . RB VB what he VBZ VBG to the JJ NN . It VBZ RB RB NN RB , and we RB VBP it VBZ a NN to RB VB the NNP of the NNP . JJ NNP , NNP NNP VBD no JJR than 1,500 NNS that there VBD no JJ NN . That VBD JJ . NNP NNP NN NNS VBD me the NN : JJ NN VBD RB RBR JJ in 2020 than in 1979 , 1987 or 2008 because of the RB VBN NN that the $ 1.5 NN NN NN would VB . As the NNS VBD it , NN VBD RB RB VBN NN like the NNP ’s NN via its JJ VBN NN of JJ NN NN NNS , VBG a JJ JJ NN of NN to VB a JJ NN VBG from a JJ NN and NN NN NN of all NNS around the NN . Those NNS VBD it would VB , but as we VBP by RB all the NN and NN VBD NN . The NN of a JJ NN – in this NN RB VBN by the JJ NN , the NN down of the NNP of NNP – VBZ . We VBP RB RB VBG to VB the NNS of NNP - 19 for the NN of JJ JJ NN . What VBZ JJ VBZ that the JJ JJ NN VBZ VBN VBN by an JJ , RB JJ NN NN . This may VB RB a “ NN . ” Or this may VB , as some VBP RB VBG , NN of a JJ , JJ NN - NN VBG the JJ JJ and JJ NN NN for JJ - NN NN . RB , along the JJ NN down the NN , with JJ , JJ JJ and JJ NN , with or without a NN of the NN - NN , a RBR JJ NN VBZ : will JJ NNS RB VB to VB VBG JJ - NN - NN JJ NN against NNP ? *( JJ NN : A JJ NN from NNP NNP 's NNP NNP , VBZ for NNS with her NN at the JJ NN VBN from NNP NNP NNP in NNP , JJ NNP 's NNP NNP , NNP 12 , 2020 . NN : NNP NNP / NNP ) * This NN VBD RB VBN on NNP NNP ."
34,442,conspiracy,"Hannah_NNP was_VBD described_VBN as_IN normal_JJ ,_, happy_JJ and_CC precocious_JJ in_IN her_PRP$ first_JJ 18_CD months_NNS ._. Then_RB ,_, in_IN July_NNP 2000_CD ,_, she_PRP was_VBD vaccinated_VBN against_IN nine_CD diseases_NNS in_IN one_CD doctor_NN 's_POS visit_NN :_: measles_NNS ,_, mumps_NNS ,_, rubella_NN ,_, polio_NN ,_, varicella_NN ,_, diphtheria_NN ,_, pertussis_NN ,_, tetanus_NN ,_, and_CC Haemophilus_NN influenzae_NN ._. Afterward_RB ,_, her_PRP$ health_NN declined_VBD rapidly_RB ._. She_PRP developed_VBD high_JJ fevers_NNS ,_, stopped_VBD eating_VBG ,_, did_VBD n't_RB respond_VB when_WRB spoken_VBN to_IN ,_, began_VBD showing_VBG signs_NNS of_IN autism_NN ,_, and_CC began_VBD having_VBG screaming_VBG fits_NNS ._. In_IN 2002_CD ,_, Hannah_NNP 's_POS parents_NNS filed_VBD an_DT autism_JJ claim_NN in_IN federal_JJ vaccine_NN court_NN ._. Five_CD years_NNS later_RBR ,_, the_DT government_NN settled_VBD the_DT case_NN before_IN trial_NN and_CC had_VBD it_PRP sealed_VBN ._. It_PRP 's_VBZ taken_VBN more_JJR than_IN two_CD years_NNS for_IN both_DT sides_NNS to_TO agree_VB on_IN how_WRB much_JJ Hannah_NNP will_MD be_VB compensated_VBN for_IN her_PRP$ injuries_NNS ._.","NNP VBD VBN as JJ , JJ and JJ in her JJ 18 NNS . RB , in NNP 2000 , she VBD VBN against nine NNS in one NN 's NN : NNS , NNS , NN , NN , NN , NN , NN , NN , and NN NN . RB , her NN VBD RB . She VBD JJ NNS , VBD VBG , VBD RB VB when VBN to , VBD VBG NNS of NN , and VBD VBG VBG NNS . In 2002 , NNP 's NNS VBD an JJ NN in JJ NN NN . Five NNS RBR , the NN VBD the NN before NN and VBD it VBN . It VBZ VBN JJR than two NNS for both NNS to VB on how JJ NNP will VB VBN for her NNS ."
35,1169,conspiracy,"Establishment_NN Republican_JJ and_CC neocon_NNP anti-Trumper_NNP Rick_NNP Wilson_NNP calls_VBZ for_IN “_`` anti-vaxxers_NNS ”_'' to_TO be_VB placed_VBN into_IN re-education_NN camps_NNS In_IN response_NN to_IN a_DT vaccine_NN industry_NN propaganda_NN piece_NN recently_RB published_VBN by_IN NBC_NNP News_NNP ,_, Rick_NNP Wilson_NNP ,_, a_DT Trump_NNP -_HYPH hating_VBG member_NN of_IN the_DT establishment_NN Republican_JJ party_NN ,_, tweeted_VBD about_IN how_WRB parents_NNS who_WP oppose_VBP vaccination_NN for_IN their_PRP$ children_NNS should_MD be_VB sent_VBN to_IN re-education_NN camps_NNS ._. A_DT throwback_NN to_IN Nazi_NNP Germany_NNP ,_, Wilson_NNP declared_VBD “_`` anti-vaxxers_NNS ”_'' a_DT “_`` scourge_NN ”_'' on_IN society_NN ,_, and_CC demanded_VBD that_IN all_PDT their_PRP$ property_NN be_VB immediately_RB seized_VBN and_CC their_PRP$ children_NNS taken_VBN into_IN “_`` protective_JJ custody_NN ”_'' –_: all_DT for_IN questioning_VBG the_DT safety_NN and_CC effectiveness_NN of_IN a_DT “_`` medicine_NN ”_'' that_WDT ’s_VBZ never_RB been_VBN tested_VBN against_IN a_DT true_JJ placebo_NN ._. Wilson_NNP was_VBD apparently_RB upset_JJ to_TO read_VB that_IN some_DT New_NNP Yorkers_NNPS and_CC Californians_NNPS have_VBP decided_VBN to_TO picket_VB in_IN front_NN of_IN doctors_NNS ’_POS officers_NNS where_WRB medical_JJ staff_NN insist_VBP upon_IN forcing_VBG all_DT patients_NNS to_TO be_VB vaccinated_VBN ,_, even_RB against_IN their_PRP$ will_NN ._. So_RB ,_, he_PRP chose_VBD to_TO respond_VB by_IN calling_VBG for_IN such_JJ individuals_NNS to_TO be_VB taken_VBN to_IN the_DT gulag_NN like_IN Adolph_NNP Hitler_NNP would_MD have_VB done_VBN ._. “_`` Anti-vaxxers_NNS are_VBP a_DT scourge_NN and_CC a_DT strong_JJ argument_NN for_IN re-education_NN camps_NNS ,_, the_DT immediate_JJ seizure_NN of_IN their_PRP$ property_NN ,_, and_CC putting_VBG their_PRP$ children_NNS into_IN protective_JJ custody_NN ,_, ”_'' were_VBD Wilson_NNP ’s_POS exact_JJ words_NNS on_IN Twitter_NNP ,_, which_WDT earned_VBD him_PRP 7,834_CD likes_NNS as_IN of_IN this_DT writing_NN ._. At_IN least_JJS one_CD Twitter_NNP user_NN responded_VBD to_IN Wilson_NNP ’s_POS rant_NN by_IN pointing_VBG out_RP the_DT vaccine_NN for_IN polio_NN is_VBZ actually_RB spreading_VBG more_JJR polio_NN ,_, while_IN another_DT shared_VBD a_DT link_NN to_IN an_DT article_NN in_IN The_DT Guardian_NNP about_IN how_WRB parents_NNS in_IN Pakistan_NNP are_VBP actually_RB going_VBG to_IN jail_NN for_IN taking_VBG a_DT stand_NN against_IN mandatory_JJ polio_NN vaccination_NN ._. “_`` The_DT parents_NNS in_IN Pakistan_NNP will_MD sacrifice_VB anything_NN to_TO stop_VB it_PRP !_. ”_'' this_DT same_JJ user_NN wrote_VBD in_IN a_DT caption_NN to_IN the_DT linked_VBN article_NN ._. Others_NNS expressed_VBD disgust_NN that_IN Wilson_NNP so_RB glibly_RB ignores_VBZ the_DT plight_NN of_IN vaccine_NN -_HYPH injured_VBN children_NNS ,_, which_WDT number_NN in_IN the_DT thousands_NNS ,_, if_IN not_RB tens_NNS of_IN thousands_NNS ._. Still_RB others_NNS called_VBD out_RP Wilson_NNP ,_, a_DT supposed_VBN journalist_NN ,_, for_IN engaging_VBG in_IN “_`` irresponsible_JJ journalism_NN ._. ”_'' “_`` The_DT start_NN lesson_NN to_TO be_VB learned_VBN is_VBZ that_IN medicine_NN can_MD be_VB weaponized_VBN when_WRB doctors_NNS join_VBP forces_NNS with_IN government_NN &_CC deviate_VBP from_IN their_PRP$ personal_JJ and_CC professional_JJ ethical_JJ commitment_NN under_IN the_DT Hippocratic_JJ Oath_NN –_: ‘_`` First_RB ,_, do_VBP no_DT harm_NN !_. '_'' ”_'' tweeted_VBD yet_CC another_DT ._. For_IN more_JJR related_JJ news_NN about_IN the_DT dangers_NNS and_CC ineffectiveness_NN of_IN vaccines_NNS ,_, be_VB sure_JJ to_TO check_VB out_RP Vaccines.news_NNS ._. Americans_NNPS have_VBP every_DT right_NN to_TO protest_VB forced_VBN “_`` medicine_NN ”_'' that_WDT could_MD harm_VB or_CC kill_VB their_PRP$ children_NNS While_IN the_DT audacity_NN of_IN some_DT parents_NNS standing_VBG up_RP to_IN the_DT medical_JJ police_NN state_NN has_VBZ really_RB thrown_VBN Wilson_NNP into_IN a_DT tizzy_NN ,_, his_PRP$ followers_NNS were_VBD generally_RB opposed_VBN to_IN his_PRP$ gulag_NN sentiment_NN ._. Somehow_RB ,_, they_PRP do_VBP n’t_RB see_VB it_PRP as_IN fitting_JJ to_TO throw_VB people_NNS into_IN concentration_NN camps_NNS simply_RB because_IN they_PRP choose_VBP not_RB to_TO vaccinate_VB ._. When_WRB ,_, exactly_RB ,_, did_VBD vaccination_NN become_VB the_DT type_NN of_IN thing_NN that_WDT has_VBZ to_TO be_VB mandated_VBN at_IN gunpoint_NN ?_. What_WP happened_VBD to_IN freedom_NN of_IN health_NN choice_NN ,_, or_CC the_DT Constitution_NN ,_, for_IN that_DT matter_NN ?_. If_IN vaccines_NNS really_RB work_VBP as_IN claimed_VBN ,_, then_RB it_PRP should_MD n’t_RB matter_VB if_IN some_DT people_NNS choose_VBP not_RB to_TO get_VB them_PRP ._. Those_DT who_WP did_VBD get_VB them_PRP have_VB the_DT protection_NN they_PRP need_VBP ,_, right_JJ ?_. Common_JJ sense_NN further_RB dictates_VBZ that_IN if_IN vaccines_NNS really_RB work_VBP without_IN ever_RB causing_VBG a_DT single_JJ harmful_JJ side_NN effect_NN ,_, then_RB nobody_NN would_MD be_VB opposed_VBN to_IN them_PRP in_IN the_DT first_JJ place_NN ._. But_CC this_DT is_VBZ simply_RB not_RB the_DT case_NN ,_, as_IN thousands_NNS of_IN parents_NNS have_VBP been_VBN left_VBN with_IN injured_JJ or_CC dead_JJ kids_NNS as_IN a_DT result_NN of_IN vaccination_NN ._. While_IN they_PRP may_MD work_VB for_IN some_DT ,_, vaccines_NNS certainly_RB do_VBP n’t_RB work_VB for_IN all_DT –_: which_WDT means_VBZ mandating_VBG them_PRP ,_, as_IN states_NNS like_IN California_NNP and_CC New_NNP York_NNP are_VBP now_RB trying_VBG to_TO do_VB ,_, constitutes_VBZ crimes_NNS against_IN humanity_NN ._. “_`` One_PRP could_MD make_VB the_DT argument_NN that_IN anti-vaxxers_NNS are_VBP pushing_VBG harmful_JJ misinformation_NN ,_, but_CC to_TO suggest_VB they_PRP should_MD have_VB their_PRP$ kids_NNS seized_VBN and_CC put_VBN in_IN gulags_NNS is_VBZ clearly_RB demented_VBN ,_, ”_'' writes_VBZ Paul_NNP Joseph_NNP Watson_NNP for_IN Infowars_NNP ._. “_`` While_IN Wilson_NNP purports_VBZ to_TO be_VB a_DT conservative_NN ,_, he_PRP is_VBZ in_IN reality_NN a_DT deep_JJ state_NN neo-con_NN who_WP has_VBZ trashed_VBN President_NNP Trump_NNP for_IN [_-LRB- three_CD ]_-RRB- years_NNS solid_JJ ._. ”_''","NN JJ and NNP NNP NNP NNP VBZ for “ NNS ” to VB VBN into NN NNS In NN to a NN NN NN NN RB VBN by NNP NNP , NNP NNP , a NNP - VBG NN of the NN JJ NN , VBD about how NNS who VBP NN for their NNS should VB VBN to NN NNS . A NN to NNP NNP , NNP VBD “ NNS ” a “ NN ” on NN , and VBD that all their NN VB RB VBN and their NNS VBN into “ JJ NN ” – all for VBG the NN and NN of a “ NN ” that VBZ RB VBN VBN against a JJ NN . NNP VBD RB JJ to VB that some NNP NNPS and NNPS VBP VBN to VB in NN of NNS ’ NNS where JJ NN VBP upon VBG all NNS to VB VBN , RB against their NN . RB , he VBD to VB by VBG for JJ NNS to VB VBN to the NN like NNP NNP would VB VBN . “ NNS VBP a NN and a JJ NN for NN NNS , the JJ NN of their NN , and VBG their NNS into JJ NN , ” VBD NNP ’s JJ NNS on NNP , which VBD him 7,834 NNS as of this NN . At JJS one NNP NN VBD to NNP ’s NN by VBG out the NN for NN VBZ RB VBG JJR NN , while another VBD a NN to an NN in The NNP about how NNS in NNP VBP RB VBG to NN for VBG a NN against JJ NN NN . “ The NNS in NNP will VB NN to VB it ! ” this JJ NN VBD in a NN to the VBN NN . NNS VBD NN that NNP RB RB VBZ the NN of NN - VBN NNS , which NN in the NNS , if RB NNS of NNS . RB NNS VBD out NNP , a VBN NN , for VBG in “ JJ NN . ” “ The NN NN to VB VBN VBZ that NN can VB VBN when NNS VBP NNS with NN & VBP from their JJ and JJ JJ NN under the JJ NN – ‘ RB , VBP no NN ! ' ” VBD yet another . For JJR JJ NN about the NNS and NN of NNS , VB JJ to VB out NNS . NNPS VBP every NN to VB VBN “ NN ” that could VB or VB their NNS While the NN of some NNS VBG up to the JJ NN NN VBZ RB VBN NNP into a NN , his NNS VBD RB VBN to his NN NN . RB , they VBP RB VB it as JJ to VB NNS into NN NNS RB because they VBP RB to VB . When , RB , VBD NN VB the NN of NN that VBZ to VB VBN at NN ? What VBD to NN of NN NN , or the NN , for that NN ? If NNS RB VBP as VBN , RB it should RB VB if some NNS VBP RB to VB them . Those who VBD VB them VB the NN they VBP , JJ ? JJ NN RB VBZ that if NNS RB VBP without RB VBG a JJ JJ NN NN , RB NN would VB VBN to them in the JJ NN . But this VBZ RB RB the NN , as NNS of NNS VBP VBN VBN with JJ or JJ NNS as a NN of NN . While they may VB for some , NNS RB VBP RB VB for all – which VBZ VBG them , as NNS like NNP and NNP NNP VBP RB VBG to VB , VBZ NNS against NN . “ One could VB the NN that NNS VBP VBG JJ NN , but to VB they should VB their NNS VBN and VBN in NNS VBZ RB VBN , ” VBZ NNP NNP NNP for NNP . “ While NNP VBZ to VB a NN , he VBZ in NN a JJ NN NN who VBZ VBN NNP NNP for [ three ] NNS JJ . ”"
36,114,mainstream,"For_IN how_WRB long_RB is_VBZ the_DT tetanus_NN vaccine_NN effective_JJ ?_. Answered_VBN by_IN :_: Prof_NNP HPS_NN Sachdeva_NNP |_NFP Prof_NNP HPS_NNP Sachdev_NNP ,_, Senior_JJ Consultant_NN Pediatrics_NN ,_, Sitaram_NNP Bhartia_NNP Institute_NNP of_IN Science_NNP and_CC Research_NNP ,_, New_NNP Delhi_NNP Q_NN :_: I_PRP had_VBD a_DT tetanus_NN vaccine_NN in_IN the_DT middle_NN of_IN last_JJ year_NN and_CC then_RB one_CD this_DT year_NN ._. Today_NN I_PRP got_VBD a_DT small_JJ scratch_NN on_IN my_PRP$ leg_NN from_IN an_DT iron_NN channel_NN which_WDT was_VBD rusted_VBN and_CC had_VBD a_DT lot_NN of_IN dust_NN while_IN being_VBG dug_VBN out_RP from_IN our_PRP$ store_NN room_NN ._. The_DT scratch_NN was_VBD small_JJ approx_RB ._. 3_CD inch_NN ._. It_PRP was_VBD not_RB deep_JJ but_CC I_PRP used_VBD my_PRP$ old_JJ spice_NN after_IN shave_NN which_WDT at_IN that_DT time_NN gave_VBD a_DT pinching_NN pain_NN but_CC then_RB pain_NN subsided_VBD immediately_RB ._. Can_MD you_PRP please_UH confirm_VB that_IN should_MD I_PRP get_VB a_DT dose_NN of_IN tetanus_NN put_VBN or_CC the_DT vaccine_NN given_VBN this_DT year_NN is_VBZ good_JJ enough_RB to_TO give_VB me_PRP protection_NN against_IN tetanus_NN ?_. The_DT protection_NN from_IN a_DT tetanus_NN toxoid_NN vaccine_NN remains_VBZ for_IN 5_CD years_NNS ._. Thus_RB there_EX is_VBZ no_DT need_NN to_TO repeat_VB the_DT vaccine_NN for_IN any_DT cuts_NNS or_CC injury_NN ,_, if_IN you_PRP already_RB have_VBP received_VBN the_DT vaccine_NN in_IN the_DT past_JJ five_CD years_NNS ._.","For how RB VBZ the NN NN JJ ? VBN by : NNP NN NNP | NNP NNP NNP , JJ NN NN , NNP NNP NNP of NNP and NNP , NNP NNP NN : I VBD a NN NN in the NN of JJ NN and RB one this NN . NN I VBD a JJ NN on my NN from an NN NN which VBD VBN and VBD a NN of NN while VBG VBN out from our NN NN . The NN VBD JJ RB . 3 NN . It VBD RB JJ but I VBD my JJ NN after NN which at that NN VBD a NN NN but RB NN VBD RB . Can you please VB that should I VB a NN of NN VBN or the NN VBN this NN VBZ JJ RB to VB me NN against NN ? The NN from a NN NN NN VBZ for 5 NNS . RB there VBZ no NN to VB the NN for any NNS or NN , if you RB VBP VBN the NN in the JJ five NNS ."
37,169,mainstream,"As_IN the_DT race_NN intensifies_VBZ for_IN a_DT vaccine_NN against_IN the_DT new_JJ coronavirus_NN ,_, rich_JJ countries_NNS are_VBP rushing_VBG to_TO place_VB advance_JJ orders_NNS for_IN the_DT inevitably_RB limited_VBN supply_NN to_TO guarantee_VB their_PRP$ citizens_NNS get_VB immunized_VBN first_RB —_: leaving_VBG significant_JJ questions_NNS about_IN whether_IN developing_VBG countries_NNS will_MD get_VB any_DT vaccines_NNS in_IN time_NN to_TO save_VB lives_NNS before_IN the_DT pandemic_NN ends_VBZ ._. Earlier_RBR this_DT month_NN ,_, the_DT United_NNP Nations_NNPS ,_, the_DT International_NNP Red_NNP Cross_NNP and_CC Red_NNP Crescent_NNP ,_, and_CC others_NNS said_VBD it_PRP was_VBD a_DT “_`` moral_JJ imperative_NN ”_'' that_IN everyone_NN have_VBP access_NN to_IN a_DT “_`` people_NN ’s_POS vaccine_NN ._. ”_'' But_CC such_JJ grand_JJ declarations_NNS are_VBP unenforceable_JJ ,_, and_CC without_IN a_DT detailed_JJ strategy_NN ,_, the_DT allocation_NN of_IN vaccines_NNS could_MD be_VB inequitable_JJ and_CC extremely_RB messy_JJ ,_, said_VBD health_NN experts_NNS ._. “_`` We_PRP have_VBP this_DT beautiful_JJ picture_NN of_IN everyone_NN getting_VBG the_DT vaccine_NN ,_, but_CC there_EX is_VBZ no_DT road_NN map_NN on_IN how_WRB to_TO do_VB it_PRP ,_, ”_'' said_VBD Yuan_NNP Qiong_NNP Hu_NNP ,_, a_DT senior_JJ legal_JJ and_CC policy_NN advisor_NN at_IN Doctors_NNP Without_IN Borders_NNP in_IN Geneva_NNP ._. Few_JJ measures_NNS have_VBP been_VBN taken_VBN to_TO resolve_VB numerous_JJ problems_NNS for_IN achieving_VBG fair_JJ distribution_NN ,_, she_PRP said_VBD ._. In_IN the_DT past_NN ,_, Hu_NNP said_VBD ,_, companies_NNS have_VBP often_RB applied_VBN for_IN patents_NNS for_IN nearly_RB every_DT step_NN of_IN a_DT vaccine_NN ’s_POS development_NN and_CC production_NN ,_, from_IN the_DT biological_JJ material_NN used_VBN to_IN the_DT preservative_NN needed_VBN to_TO stretch_VB vaccine_NN doses_NNS to_IN even_RB how_WRB the_DT shots_NNS are_VBP administered_VBN ._. “_`` We_PRP ca_MD n’t_RB afford_VB to_TO face_VB these_DT multiple_JJ layers_NNS of_IN private_JJ rights_NNS to_TO create_VB a_DT ‘_`` people_NN ’s_POS vaccine_NN ,_, ’_'' ”_'' she_PRP said_VBD ._. Speaking_VBG at_IN a_DT vaccine_NN summit_NN earlier_RBR this_DT month_NN that_WDT addressed_VBD the_DT thorny_JJ issue_NN of_IN equitable_JJ distribution_NN ,_, Ghanaian_JJ President_NNP Nana_NNP Akufo_NNP -_HYPH Addo_NNP agreed_VBD ._. “_`` Only_RB a_DT people_NN ’s_POS vaccine_NN with_IN equality_NN and_CC solidarity_NN at_IN its_PRP$ core_NN can_MD protect_VB all_DT of_IN humanity_NN from_IN the_DT virus_NN ,_, ”_'' he_PRP said_VBD ._. At_IN a_DT summit_NN with_IN African_JJ leaders_NNS on_IN Wednesday_NNP ,_, Chinese_JJ President_NNP Xi_NNP Jinping_NNP said_VBD countries_NNS in_IN Africa_NNP would_MD be_VB “_`` among_IN the_DT first_JJ to_TO benefit_VB ”_'' once_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN is_VBZ developed_VBN and_CC deployed_VBN in_IN China_NNP ,_, but_CC no_DT deals_NNS were_VBD announced_VBN to_TO back_VB up_RP his_PRP$ promise_NN ._. Worldwide_RB ,_, about_RB a_DT dozen_CD potential_JJ COVID_NN -_HYPH 19_CD vaccines_NNS are_VBP in_IN early_JJ stages_NNS of_IN testing_NN ._. While_IN some_DT could_MD move_VB into_IN late_JJ -_HYPH stage_NN testing_NN later_RBR this_DT year_NN if_IN all_DT goes_VBZ well_RB ,_, it_PRP ’s_VBZ unlikely_JJ any_DT would_MD be_VB licensed_VBN before_IN early_RB next_JJ year_NN at_IN the_DT earliest_JJS ._. Still_RB ,_, numerous_JJ rich_JJ countries_NNS have_VBP already_RB ordered_VBN some_DT of_IN these_DT experimental_JJ shots_NNS and_CC expect_VBP delivery_NN even_RB before_IN they_PRP are_VBP granted_VBN marketing_NN approval_NN ._. Britain_NNP and_CC the_DT U.S._NNP have_VBP spent_VBN millions_NNS of_IN dollars_NNS on_IN various_JJ vaccine_NN candidates_NNS ,_, including_VBG one_CD being_VBG developed_VBN by_IN Oxford_NNP University_NNP and_CC manufactured_VBN by_IN AstraZeneca_NNP ._. In_IN return_NN ,_, both_DT countries_NNS are_VBP expected_VBN to_TO get_VB priority_NN treatment_NN ;_, the_DT British_JJ government_NN declared_VBD that_IN if_IN the_DT vaccine_NN proves_VBZ effective_JJ ,_, the_DT first_JJ 30_CD million_CD doses_NNS would_MD be_VB earmarked_VBN for_IN Britons_NNPS ._. Separately_RB AstraZeneca_NNP signed_VBD an_DT agreement_NN to_TO make_VB at_IN least_JJS 300_CD million_CD doses_NNS available_JJ for_IN the_DT U.S._NNP ,_, with_IN the_DT first_JJ batches_NNS delivered_VBN as_RB early_RB as_IN October_NNP ._. In_IN a_DT briefing_NN Tuesday_NNP ,_, senior_JJ Trump_NNP administration_NN officials_NNS said_VBD there_EX will_MD be_VB a_DT tiered_VBN system_NN to_TO determine_VB who_WP in_IN America_NNP is_VBZ offered_VBN the_DT first_JJ vaccine_NN doses_NNS ._. Tiers_NNS likely_RB would_MD include_VB groups_NNS most_RBS at_IN risk_NN of_IN severe_JJ disease_NN and_CC workers_NNS performing_VBG essential_JJ services_NNS ._. Last_JJ week_NN ,_, the_DT European_NNP Union_NNP moved_VBD to_TO ensure_VB its_PRP$ own_JJ supply_NN ._. On_IN Saturday_NNP ,_, AstraZeneca_NNP struck_VBD a_DT deal_NN with_IN a_DT vaccines_NNS group_NN forged_VBN by_IN Germany_NNP ,_, France_NNP ,_, Italy_NNP and_CC the_DT Netherlands_NNPS to_TO secure_VB 400_CD million_CD doses_NNS by_IN the_DT end_NN of_IN the_DT year_NN ._. Among_IN several_JJ global_JJ efforts_NNS underway_JJ to_TO try_VB to_TO ensure_VB developing_VBG countries_NNS do_VBP n’t_RB get_VB left_VBN behind_RB is_VBZ an_DT “_`` advance_NN market_NN commitment_NN ”_'' from_IN the_DT vaccines_NNS alliance_NN GAVI_NNP ,_, whose_WP$ chief_JJ executive_NN has_VBZ warned_VBN countries_NNS about_IN the_DT dangers_NNS of_IN vaccines_NNS not_RB being_VBG available_JJ globally_RB ._. “_`` Even_RB if_IN a_DT few_JJ countries_NNS go_VBP ahead_RB and_CC have_VBP vaccines_NNS ,_, if_IN there_EX are_VBP raging_VBG outbreaks_NNS in_IN other_JJ places_NNS ..._, that_WDT is_VBZ going_VBG to_TO continue_VB to_TO threaten_VB the_DT world_NN and_CC the_DT return_NN to_IN normality_NN ,_, ”_'' said_VBD Seth_NNP Berkley_NNP ,_, the_DT GAVI_NNP chief_JJ executive_NN ._. GAVI_NNP and_CC partners_NNS have_VBP inked_VBN a_DT $_$ 750_CD -_HYPH million_CD deal_NN with_IN AstraZeneca_NNP to_TO supply_VB 400_CD million_CD doses_NNS by_IN the_DT end_NN of_IN 2020_CD ._. The_DT Anglo_NNP -_HYPH Swedish_JJ pharma_NN giant_NN has_VBZ also_RB agreed_VBN to_TO license_VB its_PRP$ vaccine_NN to_IN India_NNP ’s_POS Serum_NNP Institute_NNP for_IN the_DT production_NN of_IN 1_CD billion_CD doses_NNS ._. Johnson_NNP &_CC Johnson_NNP plans_VBZ to_TO make_VB its_PRP$ coronavirus_NN shot_NN for_IN poor_JJ countries_NNS at_IN a_DT not_RB -_HYPH for_IN -_HYPH profit_NN price_NN ,_, because_IN of_IN the_DT complexity_NN of_IN the_DT technology_NN and_CC expertise_NN needed_VBN ,_, said_VBD the_DT company_NN ’s_POS chief_JJ scientific_JJ officer_NN ,_, Dr._NNP Paul_NNP Stoffels_NNP ._. Likewise_RB ,_, AstraZeneca_NNP has_VBZ pledged_VBN to_TO make_VB the_DT vaccine_NN available_JJ at_IN no_DT profit_NN during_IN the_DT pandemic_NN ._. The_DT World_NNP Health_NNP Organization_NNP and_CC others_NNS have_VBP called_VBN for_IN a_DT COVID_NN -_HYPH 19_CD “_'' patents_NNS pool_NN ,_, ”_'' where_WRB intellectual_JJ property_NN rights_NNS would_MD be_VB surrendered_VBN so_IN pharmaceuticals_NNS could_MD freely_RB share_VB data_NNS and_CC technical_JJ knowledge_NN ._. Numerous_JJ countries_NNS ,_, including_VBG Australia_NNP ,_, Brazil_NNP ,_, Canada_NNP and_CC Germany_NNP ,_, have_VBP already_RB begun_VBN revising_VBG their_PRP$ licensing_NN laws_NNS to_TO allow_VB them_PRP to_TO suspend_VB intellectual_JJ property_NN rights_NNS if_IN authorities_NNS decide_VBP there_EX is_VBZ an_DT overwhelming_JJ need_NN given_VBN the_DT pandemic_NN ._. But_CC the_DT response_NN from_IN the_DT industry_NN has_VBZ been_VBN lukewarm_JJ ._. Executives_NNS at_IN Pfizer_NNP and_CC some_DT other_JJ major_JJ drug_NN makers_NNS say_VBP they_PRP oppose_VBP suspending_VBG patent_NN rights_NNS for_IN potential_JJ COVID_NN -_HYPH 19_CD vaccines_NNS ._. Health_NN officials_NNS worry_VBP what_WP that_DT might_MD mean_VB for_IN divvying_VBG up_RP supplies_NNS of_IN a_DT vaccine_NN arguably_RB needed_VBN by_IN every_DT country_NN on_IN the_DT planet_NN ._. “_`` We_PRP ca_MD n’t_RB just_RB rely_VB on_IN goodwill_NN to_TO ensure_VB access_NN ,_, ”_'' said_VBD Arzoo_NNP Ahmed_NNP ,_, of_IN Britain_NNP ’s_POS Nuffield_NNP Council_NNP on_IN Bioethics_NNP ,_, noting_VBG that_IN precedents_NNS of_IN how_WRB innovative_JJ drugs_NNS have_VBP been_VBN distributed_VBN are_VBP not_RB encouraging_VBG ._. “_`` With_IN HIV_NN /_, AIDS_NN ,_, it_PRP took_VBD 10_CD years_NNS for_IN the_DT drugs_NNS to_TO reach_VB people_NNS in_IN lower_JJR -_HYPH income_NN countries_NNS ._. ”_'' African_JJ nations_NNS have_VBP already_RB been_VBN at_IN the_DT back_NN of_IN the_DT line_NN for_IN medical_JJ supplies_NNS in_IN the_DT pandemic_NN and_CC “_`` it_PRP will_MD be_VB worse_JJR if_IN a_DT vaccine_NN is_VBZ found_VBN ,_, ”_'' UNAIDS_NNP chief_NN Winnie_NNP Byanyima_NNP told_VBD reporters_NNS Thursday_NNP ._. “_`` We_PRP ca_MD n’t_RB afford_VB to_TO be_VB in_IN the_DT back_NN of_IN the_DT queue_NN ._. ”_'' Other_JJ experts_NNS pointed_VBD out_RP that_IN there_EX are_VBP billions_NNS of_IN taxpayer_NN dollars_NNS devoted_VBN to_IN every_DT stage_NN of_IN vaccine_NN development_NN ,_, but_CC little_JJ oversight_NN over_IN how_WRB the_DT funds_NNS are_VBP spent_VBN and_CC few_JJ guarantees_NNS the_DT inoculations_NNS will_MD get_VB to_IN those_DT who_WP need_VBP them_PRP most_JJS ._. “_`` We_PRP do_VBP n’t_RB know_VB what_WP the_DT process_NN will_MD look_VB like_IN or_CC how_WRB transparent_JJ it_PRP will_MD be_VB ,_, ”_'' said_VBD Suerie_NNP Moon_NNP ,_, co-director_NN of_IN the_DT Global_NNP Health_NNP Centre_NNP at_IN the_DT Graduate_NNP Institute_NNP Geneva_NNP ._. The_DT World_NNP Health_NNP Organization_NNP is_VBZ currently_RB working_VBG on_IN developing_VBG an_DT “_`` allocation_NN framework_NN ”_'' for_IN how_WRB coronavirus_NN vaccines_NNS should_MD be_VB given_VBN out_RP ,_, said_VBD Dr._NNP Soumya_NNP Swaminathan_NNP ,_, the_DT U.N._NNP health_NN agency_NN ’s_POS chief_JJ scientist_NN ._. But_CC this_DT guidance_NN would_MD not_RB be_VB binding_VBG ._. Swaminathan_NNP said_VBD she_PRP hoped_VBD there_EX might_MD be_VB 2_CD billion_CD doses_NNS available_JJ for_IN vulnerable_JJ and_CC priority_NN health_NN workers_NNS globally_RB by_IN the_DT end_NN of_IN next_JJ year_NN and_CC that_IN WHO_NNP would_MD propose_VB how_WRB they_PRP might_MD be_VB distributed_VBN ._. “_`` Countries_NNS need_VBP to_TO agree_VB and_CC come_VB to_IN a_DT consensus_NN ,_, ”_'' she_PRP said_VBD ._. “_`` That_DT ’s_VBZ the_DT only_JJ way_NN this_DT can_MD work_VB ._. ”_''","As the NN VBZ for a NN against the JJ NN , JJ NNS VBP VBG to VB JJ NNS for the RB VBN NN to VB their NNS VB VBN RB — VBG JJ NNS about whether VBG NNS will VB any NNS in NN to VB NNS before the NN VBZ . RBR this NN , the NNP NNPS , the NNP NNP NNP and NNP NNP , and NNS VBD it VBD a “ JJ NN ” that NN VBP NN to a “ NN ’s NN . ” But JJ JJ NNS VBP JJ , and without a JJ NN , the NN of NNS could VB JJ and RB JJ , VBD NN NNS . “ We VBP this JJ NN of NN VBG the NN , but there VBZ no NN NN on how to VB it , ” VBD NNP NNP NNP , a JJ JJ and NN NN at NNP Without NNP in NNP . JJ NNS VBP VBN VBN to VB JJ NNS for VBG JJ NN , she VBD . In the NN , NNP VBD , NNS VBP RB VBN for NNS for RB every NN of a NN ’s NN and NN , from the JJ NN VBN to the NN VBN to VB NN NNS to RB how the NNS VBP VBN . “ We ca RB VB to VB these JJ NNS of JJ NNS to VB a ‘ NN ’s NN , ’ ” she VBD . VBG at a NN NN RBR this NN that VBD the JJ NN of JJ NN , JJ NNP NNP NNP - NNP VBD . “ RB a NN ’s NN with NN and NN at its NN can VB all of NN from the NN , ” he VBD . At a NN with JJ NNS on NNP , JJ NNP NNP NNP VBD NNS in NNP would VB “ among the JJ to VB ” once a NN - 19 NN VBZ VBN and VBN in NNP , but no NNS VBD VBN to VB up his NN . RB , RB a dozen JJ NN - 19 NNS VBP in JJ NNS of NN . While some could VB into JJ - NN NN RBR this NN if all VBZ RB , it VBZ JJ any would VB VBN before RB JJ NN at the JJS . RB , JJ JJ NNS VBP RB VBN some of these JJ NNS and VBP NN RB before they VBP VBN NN NN . NNP and the NNP VBP VBN NNS of NNS on JJ NN NNS , VBG one VBG VBN by NNP NNP and VBN by NNP . In NN , both NNS VBP VBN to VB NN NN ; the JJ NN VBD that if the NN VBZ JJ , the JJ 30 million NNS would VB VBN for NNPS . RB NNP VBD an NN to VB at JJS 300 million NNS JJ for the NNP , with the JJ NNS VBN RB RB as NNP . In a NN NNP , JJ NNP NN NNS VBD there will VB a VBN NN to VB who in NNP VBZ VBN the JJ NN NNS . NNS RB would VB NNS RBS at NN of JJ NN and NNS VBG JJ NNS . JJ NN , the NNP NNP VBD to VB its JJ NN . On NNP , NNP VBD a NN with a NNS NN VBN by NNP , NNP , NNP and the NNPS to VB 400 million NNS by the NN of the NN . Among JJ JJ NNS JJ to VB to VB VBG NNS VBP RB VB VBN RB VBZ an “ NN NN NN ” from the NNS NN NNP , whose JJ NN VBZ VBN NNS about the NNS of NNS RB VBG JJ RB . “ RB if a JJ NNS VBP RB and VBP NNS , if there VBP VBG NNS in JJ NNS ... that VBZ VBG to VB to VB the NN and the NN to NN , ” VBD NNP NNP , the NNP JJ NN . NNP and NNS VBP VBN a $ 750 - million NN with NNP to VB 400 million NNS by the NN of 2020 . The NNP - JJ NN NN VBZ RB VBN to VB its NN to NNP ’s NNP NNP for the NN of 1 billion NNS . NNP & NNP VBZ to VB its NN NN for JJ NNS at a RB - for - NN NN , because of the NN of the NN and NN VBN , VBD the NN ’s JJ JJ NN , NNP NNP NNP . RB , NNP VBZ VBN to VB the NN JJ at no NN during the NN . The NNP NNP NNP and NNS VBP VBN for a NN - 19 “ NNS NN , ” where JJ NN NNS would VB VBN so NNS could RB VB NNS and JJ NN . JJ NNS , VBG NNP , NNP , NNP and NNP , VBP RB VBN VBG their NN NNS to VB them to VB JJ NN NNS if NNS VBP there VBZ an JJ NN VBN the NN . But the NN from the NN VBZ VBN JJ . NNS at NNP and some JJ JJ NN NNS VBP they VBP VBG NN NNS for JJ NN - 19 NNS . NN NNS VBP what that might VB for VBG up NNS of a NN RB VBN by every NN on the NN . “ We ca RB RB VB on NN to VB NN , ” VBD NNP NNP , of NNP ’s NNP NNP on NNP , VBG that NNS of how JJ NNS VBP VBN VBN VBP RB VBG . “ With NN / NN , it VBD 10 NNS for the NNS to VB NNS in JJR - NN NNS . ” JJ NNS VBP RB VBN at the NN of the NN for JJ NNS in the NN and “ it will VB JJR if a NN VBZ VBN , ” NNP NN NNP NNP VBD NNS NNP . “ We ca RB VB to VB in the NN of the NN . ” JJ NNS VBD out that there VBP NNS of NN NNS VBN to every NN of NN NN , but JJ NN over how the NNS VBP VBN and JJ NNS the NNS will VB to those who VBP them JJS . “ We VBP RB VB what the NN will VB like or how JJ it will VB , ” VBD NNP NNP , NN of the NNP NNP NNP at the NNP NNP NNP . The NNP NNP NNP VBZ RB VBG on VBG an “ NN NN ” for how NN NNS should VB VBN out , VBD NNP NNP NNP , the NNP NN NN ’s JJ NN . But this NN would RB VB VBG . NNP VBD she VBD there might VB 2 billion NNS JJ for JJ and NN NN NNS RB by the NN of JJ NN and that NNP would VB how they might VB VBN . “ NNS VBP to VB and VB to a NN , ” she VBD . “ That VBZ the JJ NN this can VB . ”"
38,214,mainstream,"Last_JJ week_NN ,_, the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP announced_VBD that_IN it_PRP would_MD donate_VB USD_$ 10_CD million_CD to_TO help_VB fund_VB an_DT Australian_JJ trial_NN testing_NN whether_IN an_DT old_JJ vaccine_NN –_: BCG_NN –_: could_MD be_VB used_VBN against_IN a_DT new_JJ threat_NN ,_, COVID_NNP -_HYPH 19_CD ._. The_DT BCG_NNP vaccine_NN has_VBZ been_VBN used_VBN for_IN nearly_RB a_DT century_NN to_TO protect_VB against_IN tuberculosis_NN ._. According_VBG to_IN some_DT recent_JJ studies_NNS ,_, there_EX is_VBZ a_DT clear_JJ correlation_NN between_IN the_DT use_NN of_IN the_DT BCG_NN vaccine_NN and_CC COVID_NN -_HYPH 19_CD infections_NNS and_CC the_DT course_NN of_IN the_DT disease_NN ._. Many_JJ believe_VBP that_IN mandatory_JJ BCG_NN vaccination_NN has_VBZ enabled_VBN some_DT countries_NNS to_TO stop_VB the_DT epidemic_NN from_IN breaking_VBG loose_RB on_IN a_DT considerable_JJ scale_NN ._. In_IN countries_NNS where_WRB compulsory_JJ BCG_NN vaccination_NN has_VBZ been_VBN suspended_VBN (_-LRB- e.g._FW Spain_NNP and_CC France_NNP )_-RRB- ,_, or_CC where_WRB it_PRP has_VBZ never_RB been_VBN introduced_VBN at_IN all_DT (_-LRB- e.g._FW Italy_NNP )_-RRB- ,_, the_DT mortality_NN rate_NN from_IN viral_JJ infection_NN seems_VBZ to_TO be_VB much_RB higher_JJR ._. If_IN the_DT BCG_NNP vaccine_NN can_MD provide_VB non-specific_JJ protection_NN to_TO bridge_VB the_DT gap_NN before_IN a_DT disease_NN -_HYPH specific_JJ vaccine_NN is_VBZ developed_VBN ,_, it_PRP could_MD serve_VB as_IN an_DT important_JJ tool_NN in_IN the_DT response_NN to_IN COVID_NN -_HYPH 19_CD and_CC future_JJ pandemics_NNS ._. Is_VBZ the_DT Commission_NN financing_VBG this_DT research_NN ?_. Are_VBP there_EX any_DT studies_NNS researching_VBG the_DT BCG_NN vaccine_NN that_WDT are_VBP financed_VBN through_IN the_DT EU_NNP budget_NN ?_.","JJ NN , the NNP and NNP NNP NNP VBD that it would VB USD 10 million to VB VB an JJ NN NN whether an JJ NN – NN – could VB VBN against a JJ NN , NNP - 19 . The NNP NN VBZ VBN VBN for RB a NN to VB against NN . VBG to some JJ NNS , there VBZ a JJ NN between the NN of the NN NN and NN - 19 NNS and the NN of the NN . JJ VBP that JJ NN NN VBZ VBN some NNS to VB the NN from VBG RB on a JJ NN . In NNS where JJ NN NN VBZ VBN VBN ( FW NNP and NNP ) , or where it VBZ RB VBN VBN at all ( FW NNP ) , the NN NN from JJ NN VBZ to VB RB JJR . If the NNP NN can VB JJ NN to VB the NN before a NN - JJ NN VBZ VBN , it could VB as an JJ NN in the NN to NN - 19 and JJ NNS . VBZ the NN VBG this NN ? VBP there any NNS VBG the NN NN that VBP VBN through the NNP NN ?"
39,919,conspiracy,"When_WRB you_PRP buy_VBP Microsoft_NNP products_NNS ,_, you_PRP are_VBP now_RB promoting_VBG the_DT pharmaceutical_NN industry_NN and_CC its_PRP$ global_JJ vaccine_NN agenda_NN ._. That_DT ’s_VBZ the_DT new_JJ reality_NN in_IN which_WDT we_PRP live_VBP ,_, where_WRB the_DT world_NN ’s_POS largest_JJS software_NN company_NN is_VBZ “_`` in_IN bed_NN ”_'' with_IN the_DT world_NN ’s_POS largest_JJS vaccine_NN pusher_NN ._. How_WRB so_RB ?_. In_IN 2009_CD ,_, Microsoft_NNP purchased_VBD a_DT key_JJ piece_NN of_IN technology_NN from_IN the_DT drug_NN company_NN Merck_NNP ,_, the_DT world_NN ’s_POS largest_JJS maker_NN of_IN vaccines_NNS (_-LRB- which_WDT Bill_NNP Gates_NNP says_VBZ can_MD help_VB “_`` reduce_VB the_DT global_JJ population_NN ”_'' by_IN 10_CD to_IN 15_CD percent_NN )_-RRB- ._. That_DT technology_NN ,_, as_IN you_PRP ’ll_MD see_VB below_RB ,_, can_MD conceivably_RB be_VB used_VBN to_TO develop_VB eugenics_NN vaccines_NNS that_WDT target_VBP specific_JJ races_NNS and_CC nationalities_NNS with_IN infertility_NN -_HYPH inducing_VBG pharmaceuticals_NNS —_: something_NN that_WDT is_VBZ entirely_RB consistent_JJ with_IN Bill_NNP Gates_NNP ’_POS openly_RB -_HYPH admitted_VBN goal_NN of_IN reducing_VBG world_NN population_NN through_IN the_DT use_NN of_IN vaccines_NNS (_-LRB- see_VB link_NN to_IN video_NN below_RB )_-RRB- ._. This_DT gene_NN -_HYPH targeting_VBG vaccine_NN research_NN technology_NN purchased_VBN by_IN Microsoft_NNP was_VBD developed_VBN by_IN the_DT company_NN known_VBN as_IN Rosetta_NNP Biosciences_NNP ,_, formerly_RB owned_VBN by_IN Merck_NNP ._. Their_PRP$ software_NN is_VBZ described_VBN as_IN a_DT way_NN to_TO “_`` figure_VB out_RP how_WRB genes_NNS interact_VBP with_IN each_DT other_JJ ,_, analyze_VB peptides_NNS and_CC metabolites_NNS ,_, and_CC determine_VB how_WRB they_PRP relate_VBP to_IN gene_NN expression_NN ._. ”_'' (_-LRB- seattletimes.nwsource.com_ADD )_-RRB- An_DT announcement_NN on_IN the_DT Rosetta_NNP Biosoftware_NNP web_NN site_NN explains_VBZ ,_, “_`` The_DT deal_NN allows_VBZ Microsoft_NNP to_TO incorporate_VB genetic_JJ ,_, genomic_JJ ,_, metabolomic_JJ and_CC proteomics_NN data_NN management_NN software_NN into_IN the_DT Microsoft_NNP Amalga_NNP Life_NNP Sciences_NNPS platform_NN for_IN enhanced_VBN translational_JJ research_NN capabilities_NNS ._. ”_'' This_DT same_JJ announcement_NN goes_VBZ on_RP to_TO say_VB that_IN vaccine_NN maker_NN Merck_NNP will_MD “_`` provide_VB strategic_JJ input_NN to_IN Microsoft_NNP ”_'' as_IN a_DT part_NN of_IN the_DT deal_NN ._. Merck_NNP ’s_POS strategy_NN ,_, of_IN course_NN ,_, is_VBZ to_TO make_VB money_NN by_IN pimping_VBG vaccines_NNS and_CC pharmaceuticals_NNS ,_, including_VBG the_DT now_RB -_HYPH infamous_JJ Gardasil_NN vaccine_NN ._. Rupert_NNP Vessey_NNP ,_, the_DT vice_JJ president_NN of_IN Merck_NNP Research_NNP Laboratories_NNP ,_, openly_RB admits_VBZ this_DT deal_NN puts_VBZ Microsoft_NNP in_IN the_DT role_NN of_IN being_VBG a_DT drug_NN developer_NN ._. He_PRP says_VBZ ,_, “_`` We_PRP look_VBP forward_RB to_IN collaborating_VBG with_IN Microsoft_NNP to_TO develop_VB new_JJ bioinformatic_JJ solutions_NNS to_TO enable_VB and_CC expedite_VB drug_NN discovery_NN and_CC development_NN …_. ”_'' This_DT is_VBZ a_DT key_JJ statement_NN to_TO understand_VB ,_, because_IN the_DT term_NN “_`` bioinformatic_JJ ”_'' can_MD only_RB mean_VB one_CD thing_NN ._. What_WP stores_VBZ information_NN in_IN biology_NN ?_. These_DT is_VBZ only_RB one_CD digital_JJ storage_NN system_NN in_IN human_JJ biology_NN ,_, and_CC that_DT system_NN is_VBZ ,_, of_IN course_NN ,_, DNA_NN ._. Therefore_RB ,_, the_DT idea_NN of_IN developing_VBG “_`` bioinformatic_JJ solutions_NNS ”_'' really_RB means_VBZ to_TO develop_VB “_`` gene_NN -_HYPH targeting_VBG drugs_NNS and_CC vaccines_NNS ._. ”_'' This_DT is_VBZ fully_RB consistent_JJ with_IN Bill_NNP Gates_NNP ’_POS admitted_VBD agenda_NN of_IN reducing_VBG world_NN population_NN with_IN the_DT help_NN of_IN drug_NN company_NN technologies_NNS ._. At_IN a_DT TED_NNP conference_NN ,_, he_PRP announced_VBD in_IN front_NN of_IN a_DT live_JJ audience_NN :_: “_`` …_: if_IN we_PRP do_VBP a_DT really_RB great_JJ job_NN on_IN new_JJ vaccines_NNS ,_, health_NN care_NN ,_, reproductive_JJ health_NN services_NNS ,_, we_PRP could_MD lower_VB [_-LRB- global_JJ population_NN ]_-RRB- by_IN perhaps_RB 10_CD or_CC 15_CD percent_NN ._. ”_'' All_PDT this_DT comes_VBZ on_IN the_DT heels_NNS of_IN other_JJ recent_JJ news_NN that_IN Bill_NNP Gates_NNP is_VBZ funding_VBG sperm_NN -_HYPH destroying_VBG technology_NN to_TO cause_VB widespread_JJ male_JJ infertility_NN ._. His_PRP$ foundation_NN has_VBZ also_RB funded_VBN genetically_RB modified_VBN mosquitoes_NNS and_CC other_JJ mad_JJ science_NN experiments_NNS ._. Microsoft_NNP the_DT new_JJ leader_NN in_IN eugenics_NN technology_NN ?_. What_WP ’s_VBZ clear_JJ from_IN all_PDT this_DT is_VBZ that_IN Bill_NNP Gates_NNP is_VBZ pursuing_VBG an_DT agenda_NN of_IN human_JJ depopulation_NN ._. This_DT is_VBZ a_DT similar_JJ agenda_NN of_IN those_DT who_WP pursue_VBP eugenics_NN efforts_NNS around_IN the_DT globe_NN ,_, including_VBG Adolf_NNP Hitler_NNP and_CC a_DT long_JJ list_NN of_IN former_JJ FDA_NNP Commissioners_NNS in_IN the_DT United_NNP States_NNPS ._. One_CD of_IN the_DT most_RBS common_JJ ambitions_NNS of_IN those_DT in_IN the_DT highest_JJS positions_NNS of_IN power_NN ,_, it_PRP seems_VBZ ,_, is_VBZ to_TO cull_VB the_DT human_JJ population_NN and_CC eliminate_VB “_`` the_DT little_JJ people_NNS ,_, ”_'' leaving_VBG only_RB a_DT “_`` master_NN race_NN ”_'' of_IN supreme_JJ beings_NNS ._. Even_RB major_JJ universities_NNS around_IN the_DT globe_NN are_VBP now_RB teaching_VBG students_NNS that_IN human_JJ beings_NNS are_VBP evil_JJ for_IN merely_RB being_VBG alive_JJ and_CC exhaling_VBG carbon_NN dioxide_NN ,_, and_CC that_IN killing_VBG off_RP humans_NNS is_VBZ “_`` green_JJ ”_'' for_IN the_DT planet_NN ._. In_IN order_NN to_TO kill_VB off_RP large_JJ swaths_NNS of_IN human_JJ beings_NNS ,_, the_DT most_RBS efficient_JJ mechanism_NN to_TO use_VB is_VBZ a_DT self_NN -_HYPH replicating_VBG ,_, gene_NN -_HYPH targeted_VBN bio_NN -weapon_NN ._. Microsoft_NNP ’s_POS Amalga_NNP Life_NNP Sciences_NNP technology_NN ,_, purchased_VBN from_IN vaccine_NN developer_NN March_NNP ,_, theoretically_RB provides_VBZ a_DT viable_JJ platform_NN to_TO develop_VB precisely_RB such_JJ bio_NN -weapons_NNS ._. It_PRP is_VBZ interesting_JJ that_IN no_DT announcements_NNS from_IN the_DT company_NN appear_VBP to_TO have_VB been_VBN made_VBN since_IN being_VBG acquired_VBN by_IN Microsoft_NNP in_IN 2009_CD ,_, indicating_VBG that_IN their_PRP$ work_NN is_VBZ now_RB being_VBG conducted_VBN in_IN total_JJ secrecy_NN ,_, behind_IN closed_VBN doors_NNS ._. Recent_JJ headlines_NNS reveal_VBP that_IN the_DT United_NNP States_NNPS government_NN has_VBZ also_RB secretly_RB funded_VBN bioweapons_NNS research_NN that_WDT resulted_VBD in_IN the_DT development_NN of_IN super_RB -_HYPH deadly_JJ flu_NN strains_NNS that_WDT could_MD wipe_VB out_RP far_RB more_JJR than_IN just_RB 15_CD percent_NN of_IN the_DT human_JJ population_NN ._. As_IN revealed_VBN in_IN recent_JJ news_NN headlines_NNS :_: “_`` Scientists_NNS agreed_VBD Friday_NNP to_IN a_DT 60_CD -_HYPH day_NN moratorium_NN on_IN research_NN into_IN a_DT modified_VBN avian_JJ flu_NN virus_NN that_WDT has_VBZ been_VBN demonstrated_VBN to_TO be_VB more_RBR transmissible_JJ among_IN mammals_NNS ._. Although_IN the_DT investigators_NNS believe_VBP their_PRP$ research_NN has_VBZ a_DT public_JJ health_NN benefit_NN ,_, they_PRP acknowledge_VBP the_DT fear_NN of_IN some_DT governments_NNS and_CC others_NNS that_IN the_DT genetically_RB altered_VBN virus_NN could_MD escape_VB from_IN labs_NNS and_CC infect_VB people_NNS ._. ”_'' That_DT may_MD be_VB precisely_RB the_DT point_NN ,_, it_PRP turns_VBZ out_RP ._. There_EX is_VBZ no_DT better_JJR way_NN to_TO promote_VB the_DT vaccine_NN profits_NNS of_IN the_DT pharmaceutical_JJ industry_NN than_IN to_TO actually_RB release_VB an_DT engineered_VBN bioweapon_NN virus_NN into_IN the_DT wild_NN ._. And_CC there_EX is_VBZ no_DT faster_JJR way_NN to_TO reduce_VB the_DT world_NN population_NN than_IN to_TO engineer_VB either_CC a_DT vaccine_NN or_CC a_DT weaponized_VBN flu_NN virus_NN that_WDT burns_VBZ through_IN the_DT human_JJ population_NN ,_, targeting_VBG those_DT of_IN an_DT “_`` undesirable_JJ ”_'' genetic_JJ profile_NN who_WP need_VBP to_TO be_VB “_`` cleansed_VBN ”_'' from_IN the_DT human_JJ gene_NN pool_NN ._. This_DT about_IN this_DT the_DT next_JJ time_NN you_PRP think_VBP about_IN purchasing_VBG Microsoft_NNP Office_NNP ,_, Windows_NNPS or_CC some_DT other_JJ Microsoft_NNP product_NN ._. By_IN doing_VBG so_RB ,_, you_PRP are_VBP funding_VBG what_WP could_MD very_RB well_RB be_VB a_DT global_JJ eugenics_NN agenda_NN with_IN the_DT ultimate_JJ goal_NN of_IN wiping_VBG out_RP a_DT significant_JJ proportion_NN of_IN the_DT human_JJ race_NN ._.","When you VBP NNP NNS , you VBP RB VBG the NN NN and its JJ NN NN . That VBZ the JJ NN in which we VBP , where the NN ’s JJS NN NN VBZ “ in NN ” with the NN ’s JJS NN NN . How RB ? In 2009 , NNP VBD a JJ NN of NN from the NN NN NNP , the NN ’s JJS NN of NNS ( which NNP NNP VBZ can VB “ VB the JJ NN ” by 10 to 15 NN ) . That NN , as you ’ll VB RB , can RB VB VBN to VB NN NNS that VBP JJ NNS and NNS with NN - VBG NNS — NN that VBZ RB JJ with NNP NNP ’ RB - VBN NN of VBG NN NN through the NN of NNS ( VB NN to NN RB ) . This NN - VBG NN NN NN VBN by NNP VBD VBN by the NN VBN as NNP NNP , RB VBN by NNP . Their NN VBZ VBN as a NN to “ VB out how NNS VBP with each JJ , VB NNS and NNS , and VB how they VBP to NN NN . ” ( seattletimes.nwsource.com ) An NN on the NNP NNP NN NN VBZ , “ The NN VBZ NNP to VB JJ , JJ , JJ and NN NN NN NN into the NNP NNP NNP NNPS NN for VBN JJ NN NNS . ” This JJ NN VBZ on to VB that NN NN NNP will “ VB JJ NN to NNP ” as a NN of the NN . NNP ’s NN , of NN , VBZ to VB NN by VBG NNS and NNS , VBG the RB - JJ NN NN . NNP NNP , the JJ NN of NNP NNP NNP , RB VBZ this NN VBZ NNP in the NN of VBG a NN NN . He VBZ , “ We VBP RB to VBG with NNP to VB JJ JJ NNS to VB and VB NN NN and NN … ” This VBZ a JJ NN to VB , because the NN “ JJ ” can RB VB one NN . What VBZ NN in NN ? These VBZ RB one JJ NN NN in JJ NN , and that NN VBZ , of NN , NN . RB , the NN of VBG “ JJ NNS ” RB VBZ to VB “ NN - VBG NNS and NNS . ” This VBZ RB JJ with NNP NNP ’ VBD NN of VBG NN NN with the NN of NN NN NNS . At a NNP NN , he VBD in NN of a JJ NN : “ … if we VBP a RB JJ NN on JJ NNS , NN NN , JJ NN NNS , we could VB [ JJ NN ] by RB 10 or 15 NN . ” All this VBZ on the NNS of JJ JJ NN that NNP NNP VBZ VBG NN - VBG NN to VB JJ JJ NN . His NN VBZ RB VBN RB VBN NNS and JJ JJ NN NNS . NNP the JJ NN in NN NN ? What VBZ JJ from all this VBZ that NNP NNP VBZ VBG an NN of JJ NN . This VBZ a JJ NN of those who VBP NN NNS around the NN , VBG NNP NNP and a JJ NN of JJ NNP NNS in the NNP NNPS . One of the RBS JJ NNS of those in the JJS NNS of NN , it VBZ , VBZ to VB the JJ NN and VB “ the JJ NNS , ” VBG RB a “ NN NN ” of JJ NNS . RB JJ NNS around the NN VBP RB VBG NNS that JJ NNS VBP JJ for RB VBG JJ and VBG NN NN , and that VBG off NNS VBZ “ JJ ” for the NN . In NN to VB off JJ NNS of JJ NNS , the RBS JJ NN to VB VBZ a NN - VBG , NN - VBN NN NN . NNP ’s NNP NNP NNP NN , VBN from NN NN NNP , RB VBZ a JJ NN to VB RB JJ NN NNS . It VBZ JJ that no NNS from the NN VBP to VB VBN VBN since VBG VBN by NNP in 2009 , VBG that their NN VBZ RB VBG VBN in JJ NN , behind VBN NNS . JJ NNS VBP that the NNP NNPS NN VBZ RB RB VBN NNS NN that VBD in the NN of RB - JJ NN NNS that could VB out RB JJR than RB 15 NN of the JJ NN . As VBN in JJ NN NNS : “ NNS VBD NNP to a 60 - NN NN on NN into a VBN JJ NN NN that VBZ VBN VBN to VB RBR JJ among NNS . Although the NNS VBP their NN VBZ a JJ NN NN , they VBP the NN of some NNS and NNS that the RB VBN NN could VB from NNS and VB NNS . ” That may VB RB the NN , it VBZ out . There VBZ no JJR NN to VB the NN NNS of the JJ NN than to RB VB an VBN NN NN into the NN . And there VBZ no JJR NN to VB the NN NN than to VB either a NN or a VBN NN NN that VBZ through the JJ NN , VBG those of an “ JJ ” JJ NN who VBP to VB “ VBN ” from the JJ NN NN . This about this the JJ NN you VBP about VBG NNP NNP , NNPS or some JJ NNP NN . By VBG RB , you VBP VBG what could RB RB VB a JJ NN NN with the JJ NN of VBG out a JJ NN of the JJ NN ."
40,987,mainstream,"Donald_NNP Trump_NNP ,_, who_WP hawks_VBZ wondrous_JJ COVID_NN -_HYPH 19_CD elixirs_NNS from_IN the_DT White_NNP House_NNP lectern_NN as_IN if_IN he_PRP were_VBD a_DT nineteenth_JJ -_HYPH century_NN patent_NN -_HYPH medicine_NN salesman_NN ,_, knows_VBZ nothing_NN about_IN pandemic_NN planning_NN ,_, vaccine_NN development_NN ,_, antiviral_JJ drugs_NNS ,_, or_CC how_WRB to_TO design_VB the_DT diagnostic_JJ tools_NNS required_VBN to_TO track_VB an_DT epidemic_NN such_JJ as_IN the_DT one_NN that_WDT has_VBZ devastated_VBN the_DT nation_NN he_PRP leads_VBZ ._. Rick_NNP A._NNP Bright_NNP ,_, perhaps_RB more_JJR than_IN any_DT other_JJ federal_JJ health_NN official_NN in_IN the_DT United_NNP States_NNPS ,_, has_VBZ devoted_VBN his_PRP$ career_NN to_IN studying_VBG those_DT very_JJ issues_NNS :_: first_RB ,_, at_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP ,_, where_WRB for_IN a_DT decade_NN he_PRP evaluated_VBD the_DT comparative_JJ merits_NNS of_IN antiviral_JJ drugs_NNS ,_, and_CC then_RB as_IN the_DT scientific_JJ director_NN of_IN the_DT Influenza_NNP Vaccine_NNP Project_NNP at_IN PATH_NNP ,_, an_DT international_JJ ,_, nonprofit_JJ global_JJ health_NN organization_NN based_VBN in_IN Seattle_NNP ._. Since_IN 2010_CD ,_, Bright_NNP has_VBZ worked_VBN for_IN the_DT federal_JJ government_NN at_IN BARDA_NNP ,_, the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP ._. He_PRP began_VBD as_IN the_DT director_NN of_IN the_DT agency_NN ’s_POS Influenza_NNP and_CC Emerging_NNP Infectious_NNP Diseases_NNPS Division_NNP ,_, and_CC ,_, since_IN 2016_CD ,_, he_PRP has_VBZ been_VBN the_DT head_NN of_IN the_DT agency_NN itself_PRP ._. This_DT week_NN ,_, Bright_NNP was_VBD abruptly_RB fired_VBN from_IN his_PRP$ job_NN because_IN he_PRP insisted_VBD that_IN the_DT federal_JJ government_NN rely_VB on_IN science_NN when_WRB making_VBG scientific_JJ decisions_NNS ._. Bright_NNP said_VBD in_IN a_DT statement_NN yesterday_NN that_IN he_PRP was_VBD fired_VBN ,_, in_IN particular_JJ ,_, because_IN he_PRP insisted_VBD that_IN hydroxychloroquine_NN ,_, the_DT anti-malaria_JJ drug_NN Trump_NNP has_VBZ repeatedly_RB touted_VBN as_IN a_DT “_`` miracle_NN cure_NN ”_'' for_IN COVID_NN -_HYPH 19_CD ,_, be_VB tested_VBN rigorously_RB ._. In_IN an_DT era_NN when_WRB the_DT President_NNP of_IN the_DT United_NNP States_NNPS withdrew_VBD all_DT American_JJ funding_NN for_IN the_DT World_NNP Health_NNP Organization_NNP in_IN the_DT middle_NN of_IN a_DT global_JJ pandemic_NN ,_, Bright_NNP ’s_POS adherence_NN to_IN the_DT primacy_NN of_IN data_NNS doomed_VBD him_PRP ._. Anthony_NNP S._NNP Fauci_NNP ,_, the_DT director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Disease_NNP ,_, has_VBZ also_RB consistently_RB failed_VBN to_TO echo_VB Trump_NNP ’s_POS enthusiasm_NN for_IN hydroxychloroquine_NN ._. At_IN a_DT daily_JJ White_NNP House_NNP briefing_NN ,_, on_IN April_NNP 5th_NN ,_, as_IN Trump_NNP continued_VBD to_TO put_VB forth_RP the_DT notion_NN ,_, without_IN any_DT basis_NN in_IN fact_NN ,_, that_IN this_DT drug_NN could_MD conquer_VB the_DT virus_NN ,_, a_DT reporter_NN asked_VBD Fauci_NNP ,_, who_WP is_VBZ the_DT nation_NN ’s_POS leading_VBG infectious_JJ -_HYPH disease_NN expert_NN ,_, to_TO comment_VB ._. Trump_NNP refused_VBD to_TO let_VB him_PRP speak_VB ._. Fauci_NNP ,_, though_RB ,_, is_VBZ the_DT public_JJ face_NN of_IN the_DT epidemic_NN -_HYPH response_NN team_NN and_CC immensely_RB popular_JJ ._. To_TO fire_VB him_PRP ,_, simply_RB because_IN he_PRP tells_VBZ the_DT truth_NN ,_, carries_VBZ a_DT political_JJ risk_NN that_IN Trump_NNP is_VBZ apparently_RB unwilling_JJ to_TO take_VB —_: for_IN now_RB ._. Bright_NNP ,_, a_DT deeply_RB reserved_VBN man_NN who_WP is_VBZ not_RB known_VBN to_IN the_DT public_NN ,_, was_VBD easier_JJR to_TO toss_VB aside_RP ._. At_IN Wednesday_NNP night_NN ’s_POS briefing_NN ,_, Trump_NNP ridiculed_VBD a_DT reporter_NN who_WP suggested_VBD that_IN Bright_NNP was_VBD gifted_VBN and_CC highly_RB qualified_JJ ._. “_`` Why_WRB did_VBD you_PRP say_VB that_IN he_PRP has_VBZ great_JJ gifts_NNS or_CC gifts_NNS ?_. ”_'' Trump_NNP asked_VBD ._. “_`` What_WP ,_, do_VBP you_PRP know_VB him_PRP ?_. ”_'' Bright_NNP ,_, for_IN his_PRP$ part_NN ,_, has_VBZ made_VBN it_PRP clear_JJ that_IN he_PRP has_VBZ no_DT intention_NN of_IN shuffling_VBG off_RP to_IN some_DT lesser_JJR job_NN at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP without_IN a_DT fight_NN ._. In_IN his_PRP$ statement_NN yesterday_NN ,_, he_PRP accused_VBD the_DT Trump_NNP Administration_NNP of_IN putting_VBG “_`` politics_NNS and_CC cronyism_NN ahead_RB of_IN science_NN ._. ”_'' He_PRP elaborated_VBD that_IN ,_, “_`` specifically_RB ,_, and_CC contrary_JJ to_IN misguided_JJ directives_NNS ,_, I_PRP limited_VBD the_DT broad_JJ use_NN of_IN chloroquine_NN and_CC hydroxychloroquine_NN ,_, promoted_VBN by_IN the_DT Administration_NNP as_IN a_DT panacea_NN ,_, which_WDT clearly_RB lack_VBP scientific_JJ merit_NN ._. ”_'' Bright_NNP also_RB said_VBD that_IN he_PRP has_VBZ engaged_VBN two_CD attorneys_NNS to_TO represent_VB him_PRP in_IN a_DT whistle_NN -_HYPH blower_NN case_NN against_IN the_DT government_NN ._. He_PRP said_VBD that_IN he_PRP resisted_VBD “_`` efforts_NNS to_TO provide_VB an_DT unproven_JJ drug_NN on_IN demand_NN to_IN the_DT American_JJ public_NN ._. ’’_'' Bright_NNP ’s_POS colleagues_NNS in_IN the_DT field_NN were_VBD astonished_VBN at_IN his_PRP$ sudden_JJ removal_NN ._. Bruce_NNP Gellin_NNP ,_, who_WP runs_VBZ the_DT global_JJ immunization_NN program_NN for_IN the_DT Sabin_NNP Vaccine_NNP Institute_NNP ,_, spent_VBD fifteen_CD years_NNS as_IN the_DT director_NN of_IN the_DT National_NNP Vaccine_NNP Program_NNP Office_NNP ,_, a_DT position_NN in_IN which_WDT he_PRP worked_VBD often_RB with_IN Bright_NNP ._. Gellin_NNP told_VBD me_PRP ,_, “_`` Rick_NNP was_VBD able_JJ to_TO advance_VB our_PRP$ national_JJ pandemic_NN preparedness_NN for_IN drugs_NNS ,_, diagnostics_NN ,_, and_CC vaccines_NNS ,_, ”_'' adding_VBG ,_, “_'' He_PRP knows_VBZ the_DT science_NN and_CC embraces_VBZ cutting_NN -_HYPH edge_NN technology_NN like_IN few_JJ others_NNS ._. ’’_'' Margaret_NNP A._NNP Hamburg_NNP ,_, who_WP was_VBD the_DT commissioner_NN of_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP under_IN President_NNP Barack_NNP Obama_NNP ,_, also_RB worked_VBD closely_RB with_IN Bright_NNP ._. “_`` This_DT is_VBZ hard_JJ to_TO understand_VB ,_, ’’_'' she_PRP said_VBD ._. “_`` Rick_NNP is_VBZ exactly_RB the_DT person_NN you_PRP want_VBP to_TO have_VB at_IN the_DT table_NN when_WRB planning_VBG new_JJ programs_NNS ,_, especially_RB in_IN the_DT midst_NN of_IN a_DT pandemic_NN ._. ’’_'' I_PRP have_VBP known_VBN Bright_NNP for_IN years_NNS ._. He_PRP is_VBZ measured_VBN ,_, technical_JJ ,_, and_CC scientific_JJ in_IN his_PRP$ approach_NN to_IN problems_NNS ._. For_IN that_DT reason_NN ,_, I_PRP found_VBD his_PRP$ statement_NN startling_JJ ._. It_PRP is_VBZ a_DT good_JJ thing_NN that_WDT Bright_NNP spoke_VBD out_RP ._. This_DT week_NN ,_, preliminary_JJ data_NNS from_IN a_DT large_JJ study_NN showed_VBD that_IN coronavirus_NN patients_NNS given_VBN hydroxychloroquine_NN were_VBD no_RB less_RBR likely_JJ to_TO need_VB mechanical_JJ ventilation_NN and_CC had_VBD higher_JJR death_NN rates_NNS than_IN those_DT who_WP were_VBD not_RB ._. The_DT study_NN ,_, which_WDT reviewed_VBD veterans_NNPS ’_POS medical_JJ charts_NNS ,_, was_VBD posted_VBN Tuesday_NNP on_IN MedRxiv_NNP ,_, a_DT preprint_NN server_NN ,_, meaning_VBG that_IN it_PRP was_VBD not_RB peer_NN reviewed_VBN or_CC published_VBN in_IN a_DT medical_JJ journal_NN ._. The_DT research_NN was_VBD funded_VBN by_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP and_CC the_DT University_NNP of_IN Virginia_NNP ._. (_-LRB- Such_PDT a_DT study_NN is_VBZ not_RB conclusive_JJ ;_, it_PRP is_VBZ too_RB soon_RB to_TO know_VB the_DT ultimate_JJ results_NNS ._. But_CC no_DT responsible_JJ physician_NN would_MD read_VB it_PRP and_CC say_VB ,_, Hey_UH ,_, let_VB ’s_PRP get_VB this_DT drug_NN out_RP to_IN millions_NNS of_IN people_NNS right_RB away_RB ._. )_-RRB- Late_RB last_JJ year_NN ,_, at_IN a_DT panel_NN discussion_NN on_IN the_DT future_NN of_IN influenza_NN pandemics_NNS ,_, Bright_NNP explained_VBD his_PRP$ fundamental_JJ concerns_NNS :_: the_DT country_NN was_VBD not_RB investing_VBG enough_RB in_IN creating_VBG vaccines_NNS that_WDT could_MD potentially_RB limit_VB the_DT impact_NN of_IN the_DT annual_JJ flu_NN season_NN as_RB well_RB as_IN potential_JJ pandemics_NNS ._. “_`` We_PRP can_MD make_VB better_JJR vaccines_NNS and_CC make_VB them_PRP faster_JJR ,_, ”_'' he_PRP said_VBD ._. “_`` But_CC three_CD hundred_CD and_CC fifty_CD -_HYPH one_CD billion_CD dollars_NNS every_DT year_NN is_VBZ our_PRP$ economic_JJ cost_NN for_IN seasonal_JJ influenza_NN ,_, and_CC a_DT pandemic_NN goes_VBZ into_IN the_DT trillions_NNS of_IN dollars_NNS ._. We_PRP have_VBP to_TO take_VB that_DT sense_NN of_IN urgency_NN and_CC economic_JJ assets_NNS to_TO explain_VB this_DT disruption_NN and_CC the_DT lives_NNS lost_VBN ._. ”_'' It_PRP had_VBD been_VBN a_DT continual_JJ frustration_NN to_IN Bright_NNP —_: as_RB well_RB as_IN to_IN Fauci_NNP and_CC many_JJ others_NNS —_: that_IN political_JJ leaders_NNS do_VBP n’t_RB seem_VB to_TO learn_VB this_DT lesson_NN ._. We_PRP are_VBP entering_VBG a_DT dangerous_JJ new_JJ phase_NN of_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._. Rick_NNP Bright_NNP ’s_POS vision_NN has_VBZ never_RB been_VBN needed_VBN more_JJR ._. Even_RB now_RB ,_, the_DT President_NNP refuses_VBZ to_TO acknowledge_VB the_DT severity_NN of_IN the_DT pandemic_NN or_CC how_WRB far_RB we_PRP are_VBP from_IN being_VBG able_JJ to_TO safely_RB “_`` open_VB ”_'' the_DT country_NN ._. That_DT is_VBZ a_DT depressing_JJ reality_NN ,_, and_CC we_PRP will_MD need_VB leaders_NNS to_TO help_VB explain_VB and_CC guide_VB us_PRP to_IN a_DT safer_JJR and_CC healthier_JJR future_NN ._. Rick_NNP Bright_NNP has_VBZ always_RB been_VBN one_CD of_IN those_DT leaders_NNS ._. Bright_NNP said_VBD in_IN his_PRP$ statement_NN ,_, “_`` Sidelining_VBG me_PRP in_IN the_DT middle_NN of_IN this_DT pandemic_NN and_CC placing_VBG politics_NNS and_CC cronyism_NN ahead_RB of_IN science_NN puts_VBZ lives_NNS at_IN risk_NN and_CC stunts_VBZ national_JJ efforts_NNS to_TO safely_RB and_CC effectively_RB address_VB this_DT urgent_JJ public_JJ -_HYPH health_NN crisis_NN ._. ”_'' Every_DT one_CD of_IN those_DT words_NNS is_VBZ true_JJ ._. Unfortunately_RB ,_, it_PRP is_VBZ no_RB longer_RBR clear_JJ that_IN we_PRP live_VBP in_IN a_DT country_NN where_WRB expertise_NN matters_VBZ ._. •_NFP How_WRB to_TO practice_VB social_JJ distancing_NN ,_, from_IN responding_VBG to_IN a_DT sick_JJ housemate_NN to_IN the_DT pros_NNS and_CC cons_NNS of_IN ordering_VBG food_NN ._. •_NFP Can_MD survivors_NNS help_VB cure_VB the_DT disease_NN and_CC rescue_VB the_DT economy_NN ?_. •_NFP The_DT long_JJ crusade_NN of_IN Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT infectious_JJ -_HYPH disease_NN expert_NN pinned_VBN between_IN Donald_NNP Trump_NNP and_CC the_DT American_JJ people_NNS ._. •_NFP The_DT success_NN of_IN Hong_NNP Kong_NNP and_CC Singapore_NNP in_IN stemming_VBG the_DT spread_NN holds_VBZ lessons_NNS for_IN how_WRB to_TO contain_VB it_PRP in_IN the_DT United_NNP States_NNPS ._. •_NFP The_DT coronavirus_NN is_VBZ likely_JJ to_TO spread_VB for_IN more_JJR than_IN a_DT year_NN before_IN a_DT vaccine_NN is_VBZ widely_RB available_JJ ._. •_NFP With_IN each_DT new_JJ virus_NN ,_, we_PRP have_VBP scrambled_VBN for_IN a_DT new_JJ treatment_NN ._. Can_MD we_PRP prepare_VB antivirals_NNS to_TO combat_VB the_DT next_JJ global_JJ crisis_NN ?_. •_NFP How_WRB pandemics_NNS have_VBP propelled_VBN public_JJ -_HYPH health_NN innovations_NNS ,_, prefigured_VBN revolutions_NNS ,_, and_CC redrawn_VBN maps_NNS ._. •_NFP What_WP to_TO read_VB ,_, watch_VB ,_, cook_VB ,_, and_CC listen_VB to_IN under_IN coronavirus_NN quarantine_NN ._.","NNP NNP , who VBZ JJ NN - 19 NNS from the NNP NNP NN as if he VBD a JJ - NN NN - NN NN , VBZ NN about NN NN , NN NN , JJ NNS , or how to VB the JJ NNS VBN to VB an NN JJ as the NN that VBZ VBN the NN he VBZ . NNP NNP NNP , RB JJR than any JJ JJ NN NN in the NNP NNPS , VBZ VBN his NN to VBG those JJ NNS : RB , at the NNPS for NNP NNP , where for a NN he VBD the JJ NNS of JJ NNS , and RB as the JJ NN of the NNP NNP NNP at NNP , an JJ , JJ JJ NN NN VBN in NNP . Since 2010 , NNP VBZ VBN for the JJ NN at NNP , the NNP NNP NNP and NNP NNP . He VBD as the NN of the NN ’s NNP and NNP NNP NNPS NNP , and , since 2016 , he VBZ VBN the NN of the NN itself . This NN , NNP VBD RB VBN from his NN because he VBD that the JJ NN VB on NN when VBG JJ NNS . NNP VBD in a NN NN that he VBD VBN , in JJ , because he VBD that NN , the JJ NN NNP VBZ RB VBN as a “ NN NN ” for NN - 19 , VB VBN RB . In an NN when the NNP of the NNP NNPS VBD all JJ NN for the NNP NNP NNP in the NN of a JJ NN , NNP ’s NN to the NN of NNS VBD him . NNP NNP NNP , the NN of the NNP NNP of NNP and NNP NNP , VBZ RB RB VBN to VB NNP ’s NN for NN . At a JJ NNP NNP NN , on NNP NN , as NNP VBD to VB forth the NN , without any NN in NN , that this NN could VB the NN , a NN VBD NNP , who VBZ the NN ’s VBG JJ - NN NN , to VB . NNP VBD to VB him VB . NNP , RB , VBZ the JJ NN of the NN - NN NN and RB JJ . To VB him , RB because he VBZ the NN , VBZ a JJ NN that NNP VBZ RB JJ to VB — for RB . NNP , a RB VBN NN who VBZ RB VBN to the NN , VBD JJR to VB aside . At NNP NN ’s NN , NNP VBD a NN who VBD that NNP VBD VBN and RB JJ . “ Why VBD you VB that he VBZ JJ NNS or NNS ? ” NNP VBD . “ What , VBP you VB him ? ” NNP , for his NN , VBZ VBN it JJ that he VBZ no NN of VBG off to some JJR NN at the NNP NNPS of NNP without a NN . In his NN NN , he VBD the NNP NNP of VBG “ NNS and NN RB of NN . ” He VBD that , “ RB , and JJ to JJ NNS , I VBD the JJ NN of NN and NN , VBN by the NNP as a NN , which RB VBP JJ NN . ” NNP RB VBD that he VBZ VBN two NNS to VB him in a NN - NN NN against the NN . He VBD that he VBD “ NNS to VB an JJ NN on NN to the JJ NN . ’’ NNP ’s NNS in the NN VBD VBN at his JJ NN . NNP NNP , who VBZ the JJ NN NN for the NNP NNP NNP , VBD fifteen NNS as the NN of the NNP NNP NNP NNP , a NN in which he VBD RB with NNP . NNP VBD me , “ NNP VBD JJ to VB our JJ NN NN for NNS , NN , and NNS , ” VBG , “ He VBZ the NN and VBZ NN - NN NN like JJ NNS . ’’ NNP NNP NNP , who VBD the NN of the NNP and NNP NNP under NNP NNP NNP , RB VBD RB with NNP . “ This VBZ JJ to VB , ’’ she VBD . “ NNP VBZ RB the NN you VBP to VB at the NN when VBG JJ NNS , RB in the NN of a NN . ’’ I VBP VBN NNP for NNS . He VBZ VBN , JJ , and JJ in his NN to NNS . For that NN , I VBD his NN JJ . It VBZ a JJ NN that NNP VBD out . This NN , JJ NNS from a JJ NN VBD that NN NNS VBN NN VBD RB RBR JJ to VB JJ NN and VBD JJR NN NNS than those who VBD RB . The NN , which VBD NNPS ’ JJ NNS , VBD VBN NNP on NNP , a NN NN , VBG that it VBD RB NN VBN or VBN in a JJ NN . The NN VBD VBN by the NNP NNPS of NNP and the NNP of NNP . ( Such a NN VBZ RB JJ ; it VBZ RB RB to VB the JJ NNS . But no JJ NN would VB it and VB , Hey , VB ’s VB this NN out to NNS of NNS RB RB . ) RB JJ NN , at a NN NN on the NN of NN NNS , NNP VBD his JJ NNS : the NN VBD RB VBG RB in VBG NNS that could RB VB the NN of the JJ NN NN RB RB as JJ NNS . “ We can VB JJR NNS and VB them JJR , ” he VBD . “ But three hundred and fifty - one billion NNS every NN VBZ our JJ NN for JJ NN , and a NN VBZ into the NNS of NNS . We VBP to VB that NN of NN and JJ NNS to VB this NN and the NNS VBN . ” It VBD VBN a JJ NN to NNP — RB RB as to NNP and JJ NNS — that JJ NNS VBP RB VB to VB this NN . We VBP VBG a JJ JJ NN of the NN - 19 NN . NNP NNP ’s NN VBZ RB VBN VBN JJR . RB RB , the NNP VBZ to VB the NN of the NN or how RB we VBP from VBG JJ to RB “ VB ” the NN . That VBZ a JJ NN , and we will VB NNS to VB VB and VB us to a JJR and JJR NN . NNP NNP VBZ RB VBN one of those NNS . NNP VBD in his NN , “ VBG me in the NN of this NN and VBG NNS and NN RB of NN VBZ NNS at NN and VBZ JJ NNS to RB and RB VB this JJ JJ - NN NN . ” Every one of those NNS VBZ JJ . RB , it VBZ RB RBR JJ that we VBP in a NN where NN VBZ . • How to VB JJ NN , from VBG to a JJ NN to the NNS and NNS of VBG NN . • Can NNS VB VB the NN and VB the NN ? • The JJ NN of NNP NNP NNP , the JJ - NN NN VBN between NNP NNP and the JJ NNS . • The NN of NNP NNP and NNP in VBG the NN VBZ NNS for how to VB it in the NNP NNPS . • The NN VBZ JJ to VB for JJR than a NN before a NN VBZ RB JJ . • With each JJ NN , we VBP VBN for a JJ NN . Can we VB NNS to VB the JJ JJ NN ? • How NNS VBP VBN JJ - NN NNS , VBN NNS , and VBN NNS . • What to VB , VB , VB , and VB to under NN NN ."
41,652,mainstream,"Mercury_NN from_IN vaccines_NNS seems_VBZ to_TO disappear_VB rapidly_RB from_IN the_DT blood_NN ,_, returning_VBG to_IN pre-vaccination_NN levels_NNS in_IN one_CD month_NN ,_, according_VBG to_IN a_DT small_JJ study_NN of_IN children_NNS in_IN Argentina_NNP ._. The_DT findings_NNS bolster_VBP the_DT argument_NN that_IN a_DT mercury_NN -_HYPH based_VBN vaccine_NN preservative_NN does_VBZ n't_RB cause_VB autism_NN in_IN children_NNS ,_, although_IN it_PRP 's_VBZ unclear_JJ from_IN the_DT study_NN whether_IN some_DT mercury_NN may_MD linger_VB elsewhere_RB in_IN the_DT body_NN ._. The_DT research_NN addresses_VBZ an_DT unanswered_JJ question_NN about_IN the_DT safety_NN of_IN thimerosal_NN ,_, a_DT preservative_NN that_WDT has_VBZ been_VBN eliminated_VBN from_IN routine_JJ U.S._NNP vaccines_NNS ,_, and_CC breaks_VBZ down_RP as_IN ethyl_JJ mercury_NN in_IN the_DT body_NN ._. It_PRP is_VBZ still_RB used_VBN in_IN other_JJ countries_NNS ,_, including_VBG Argentina_NNP ._. Scientists_NNS assumed_VBD the_DT health_NN risks_NNS from_IN ethyl_JJ mercury_NN were_VBD similar_JJ to_IN methyl_JJ mercury_NN from_IN eating_VBG fish_NN ._. And_CC in_IN 1999_CD ,_, the_DT federal_JJ government_NN and_CC vaccine_NN manufacturers_NNS agreed_VBD that_IN thimerosal_NN should_MD be_VB reduced_VBN or_CC eliminated_VBN in_IN vaccines_NNS to_TO lower_JJR exposure_NN to_IN mercury_NN from_IN all_DT sources_NNS ._. The_DT decision_NN was_VBD based_VBN on_IN what_WP was_VBD known_VBN about_IN methyl_JJ mercury_NN exposure_NN ._. The_DT new_JJ findings_NNS suggest_VBP that_IN methyl_NN mercury_NN and_CC ethyl_JJ mercury_NN are_VBP very_RB different_JJ and_CC that_IN the_DT removal_NN of_IN thimerosal_NN from_IN vaccines_NNS may_MD have_VB been_VBN over_RB -_HYPH cautious_JJ ._. ""_`` The_DT study_NN supports_VBZ the_DT decision_NN by_IN the_DT World_NNP Health_NNP Organization_NNP to_TO continue_VB to_TO permit_VB thimerosal_NN to_TO remain_VB in_IN vaccines_NNS for_IN the_DT world_NN 's_POS children_NNS ,_, ""_'' said_VBD study_NN co-author_NN Dr._NNP Michael_NNP Pichichero_NNP of_IN the_DT University_NNP of_IN Rochester_NNP in_IN Rochester_NNP ,_, N.Y_NNP ._. He_PRP said_VBD thimerosal_NN vaccines_NNS are_VBP cheaper_JJR to_TO produce_VB and_CC therefore_RB more_RBR accessible_JJ to_IN much_JJ of_IN the_DT world_NN ._. In_IN the_DT U.S._NNP -_HYPH funded_VBN study_NN ,_, blood_NN samples_NNS were_VBD taken_VBN from_IN 216_CD healthy_JJ babies_NNS before_RB and_CC after_IN they_PRP got_VBD vaccines_NNS containing_VBG the_DT preservative_JJ thimerosal_NN ._. Blood_NN levels_NNS of_IN mercury_NN were_VBD highest_JJS shortly_RB after_IN the_DT babies_NNS were_VBD vaccinated_VBN and_CC fell_VBD to_IN pre-vaccination_NN levels_NNS within_IN a_DT few_JJ weeks_NNS ._. ""_`` The_DT amount_NN found_VBN in_IN the_DT blood_NN was_VBD about_RB one_CD -_HYPH tenth_NN of_IN that_DT predicted_VBD in_IN that_DT the_DT late_JJ 1990s_NNS and_CC the_DT length_NN of_IN time_NN it_PRP stays_VBZ in_IN the_DT blood_NN is_VBZ one_CD -_HYPH tenth_NN of_IN that_DT predicted_VBN ,_, ""_'' Pichichero_NNP said_VBD ._. Mercury_NN levels_NNS also_RB were_VBD measured_VBN in_IN the_DT babies_NNS '_POS stools_NNS and_CC urine_NN ._. In_IN the_DT stool_NN samples_NNS ,_, the_DT levels_NNS were_VBD highest_JJS after_IN vaccination_NN and_CC also_RB fell_VBD ,_, but_CC more_RBR slowly_RB than_IN blood_NN levels_NNS ._. There_EX was_VBD no_DT significant_JJ amount_NN of_IN mercury_NN in_IN the_DT urine_NN ._. The_DT authors_NNS could_MD not_RB determine_VB what_WP happened_VBD to_IN all_PDT the_DT mercury_NN after_IN it_PRP left_VBD the_DT blood_NN ._. All_PDT the_DT infants_NNS gave_VBD samples_NNS twice_RB :_: before_IN vaccination_NN and_CC at_IN one_CD other_JJ time_NN ,_, ranging_VBG from_IN 12_CD hours_NNS later_RBR to_IN 30_CD days_NNS ._. The_DT study_NN will_MD be_VB published_VBN in_IN the_DT February_NNP issue_NN of_IN the_DT journal_NNP Pediatrics_NNP ._. The_DT medical_JJ journal_NN released_VBD the_DT findings_NNS early_RB because_IN of_IN a_DT controversy_NN surrounding_VBG a_DT new_JJ TV_NN series_NN premiering_VBG Thursday_NNP ,_, which_WDT features_VBZ a_DT lawyer_NN who_WP argues_VBZ in_IN court_NN that_IN a_DT flu_NN vaccine_NN made_VBD a_DT child_NN autistic_JJ ._. The_DT journal_NN is_VBZ published_VBN by_IN the_DT American_NNP Academy_NNP of_IN Pediatrics_NNP ,_, which_WDT on_IN Monday_NNP called_VBD on_IN ABC_NNP to_TO cancel_VB the_DT first_JJ episode_NN of_IN the_DT series_NN ,_, ""_`` Eli_NNP Stone_NNP ,_, ""_'' saying_VBG that_IN it_PRP perpetuates_VBZ the_DT myth_NN that_IN vaccines_NNS can_MD cause_VB autism_NN ._. Autism_NN is_VBZ a_DT complex_JJ disorder_NN featuring_VBG repetitive_JJ behaviors_NNS and_CC poor_JJ social_JJ interaction_NN and_CC communication_NN skills_NNS ._. Scientists_NNS generally_RB believe_VBP that_IN genetics_NN plays_VBZ a_DT role_NN in_IN causing_VBG the_DT disorder_NN ;_: a_DT theory_NN that_IN thimerosal_NN is_VBZ to_TO blame_VB has_VBZ been_VBN repeatedly_RB discounted_VBN in_IN scientific_JJ studies_NNS ._. Pichichero_NNP said_VBD he_PRP has_VBZ received_VBN research_NN grants_NNS and_CC served_VBN as_IN a_DT consultant_NN to_IN several_JJ vaccine_NN makers_NNS ,_, but_CC said_VBD there_EX was_VBD no_DT industry_NN involvement_NN in_IN the_DT new_JJ study_NN ._. He_PRP is_VBZ an_DT unpaid_JJ consultant_NN to_IN the_DT WHO_NN on_IN vaccines_NNS ._.","NN from NNS VBZ to VB RB from the NN , VBG to NN NNS in one NN , VBG to a JJ NN of NNS in NNP . The NNS VBP the NN that a NN - VBN NN NN VBZ RB VB NN in NNS , although it VBZ JJ from the NN whether some NN may VB RB in the NN . The NN VBZ an JJ NN about the NN of NN , a NN that VBZ VBN VBN from JJ NNP NNS , and VBZ down as JJ NN in the NN . It VBZ RB VBN in JJ NNS , VBG NNP . NNS VBD the NN NNS from JJ NN VBD JJ to JJ NN from VBG NN . And in 1999 , the JJ NN and NN NNS VBD that NN should VB VBN or VBN in NNS to JJR NN to NN from all NNS . The NN VBD VBN on what VBD VBN about JJ NN NN . The JJ NNS VBP that NN NN and JJ NN VBP RB JJ and that the NN of NN from NNS may VB VBN RB - JJ . "" The NN VBZ the NN by the NNP NNP NNP to VB to VB NN to VB in NNS for the NN 's NNS , "" VBD NN NN NNP NNP NNP of the NNP of NNP in NNP , NNP . He VBD NN NNS VBP JJR to VB and RB RBR JJ to JJ of the NN . In the NNP - VBN NN , NN NNS VBD VBN from 216 JJ NNS RB and after they VBD NNS VBG the JJ NN . NN NNS of NN VBD JJS RB after the NNS VBD VBN and VBD to NN NNS within a JJ NNS . "" The NN VBN in the NN VBD RB one - NN of that VBD in that the JJ NNS and the NN of NN it VBZ in the NN VBZ one - NN of that VBN , "" NNP VBD . NN NNS RB VBD VBN in the NNS ' NNS and NN . In the NN NNS , the NNS VBD JJS after NN and RB VBD , but RBR RB than NN NNS . There VBD no JJ NN of NN in the NN . The NNS could RB VB what VBD to all the NN after it VBD the NN . All the NNS VBD NNS RB : before NN and at one JJ NN , VBG from 12 NNS RBR to 30 NNS . The NN will VB VBN in the NNP NN of the NNP NNP . The JJ NN VBD the NNS RB because of a NN VBG a JJ NN NN VBG NNP , which VBZ a NN who VBZ in NN that a NN NN VBD a NN JJ . The NN VBZ VBN by the NNP NNP of NNP , which on NNP VBD on NNP to VB the JJ NN of the NN , "" NNP NNP , "" VBG that it VBZ the NN that NNS can VB NN . NN VBZ a JJ NN VBG JJ NNS and JJ JJ NN and NN NNS . NNS RB VBP that NN VBZ a NN in VBG the NN ; a NN that NN VBZ to VB VBZ VBN RB VBN in JJ NNS . NNP VBD he VBZ VBN NN NNS and VBN as a NN to JJ NN NNS , but VBD there VBD no NN NN in the JJ NN . He VBZ an JJ NN to the NN on NNS ."
42,1290,mainstream,"Sean_NNP Penn_NNP ’s_POS CORE_NN praises_VBZ Los_NNP Angeles_NNP ’_POS guardian_NN angels_NNS —_: those_DT on_IN the_DT ground_NN administering_VBG COVID_NN -_HYPH 19_CD tests_NNS —_: in_IN a_DT new_JJ PSA_NN that_WDT reiterates_VBZ that_IN “_`` testing_NN saves_VBZ lives_NNS ._. ”_'' On_IN March_NNP 30th_NN ,_, CORE_NNP (_-LRB- Community_NNP Organized_NNP Relief_NNP Effort_NNP )_-RRB- opened_VBD its_PRP$ first_JJ coronavirus_NN testing_NN site_NN in_IN Los_NNP Angeles_NNP ;_: since_IN that_DT time_NN ,_, CORE_NNP now_RB oversees_VBZ 15_CD sites_NNS ,_, including_VBG 12_CD in_IN California_NNP ,_, two_CD in_IN Atlanta_NNP and_CC a_DT mobile_JJ site_NN in_IN Detroit_NNP ._. Their_PRP$ team_NN of_IN 120_CD staff_NN members_NNS and_CC 300_CD volunteers_NNS have_VBP thus_RB far_RB administered_VBN 70,000_CD tests_NNS as_IN of_IN May_NNP 6th_NN ._. The_DT “_`` Guardians_NNPS ”_'' PSA_NN —_: narrated_VBN by_IN actor_NN Edward_NNP James_NNP Olmos_NNP —_: features_VBZ a_DT visual_JJ tapestry_NN of_IN near_RB -_HYPH desolate_JJ Los_NNP Angeles_NNP ,_, “_`` the_DT City_NNP of_IN Angels_NNPS ,_, ”_'' where_WRB only_RB essential_JJ workers_NNS and_CC CORE_NN volunteers_NNS remain_VBP on_IN the_DT streets_NNS ._. “_`` Angels_NNS come_VBP in_IN many_JJ ways_NNS ._. You_PRP might_MD not_RB recognize_VB their_PRP$ faces_NNS ,_, do_VBP n’t_RB know_VB who_WP they_PRP are_VBP ,_, ”_'' Olmos_NNP says_VBZ in_IN the_DT PSA_NNP over_IN footage_NN of_IN the_DT testers_NNS at_IN work_NN ._. “_`` From_IN downtown_NN to_IN LAX_NNP ,_, from_IN South_NNP Central_NNP to_IN PCH_NNP ,_, watching_VBG over_IN us_PRP ._. Protecting_VBG us_PRP ._. Let_VB them_PRP know_VB that_IN we_PRP see_VBP them_PRP ._. ”_'' “_`` CORE_NN ’s_POS role_NN is_VBZ twofold_JJ ”_'' First_RB ,_, to_TO have_VB direct_JJ impact_NN on_IN the_DT health_NN of_IN each_DT and_CC every_DT individual_NN we_PRP can_MD reach_VB ._. But_CC secondly_RB ,_, it_PRP is_VBZ our_PRP$ singular_JJ role_NN in_IN modeling_VBG government_NN /_, civilian_JJ NGO_NN partnerships_NNS that_WDT ,_, in_IN replication_NN can_MD test_VB all_DT Americans_NNPS and_CC re-test_VB all_DT Americans_NNPS as_RB long_RB as_IN science_NN and_CC medicine_NN demands_VBZ to_TO develop_VB a_DT vaccine_NN ,_, ”_'' Penn_NNP tells_VBZ Rolling_NNP Stone_NNP ._. “_`` The_DT importance_NN of_IN testing_NN begins_VBZ with_IN identifying_VBG those_DT who_WP may_MD transmit_VB the_DT virus_NN ._. Hospitalization_NN is_VBZ not_RB necessarily_RB required_VBN for_IN those_DT who_WP test_VBP positive_JJ ._. Until_IN ,_, or_CC unless_IN those_DT positive_JJ begin_VBP to_TO experience_VB respiratory_JJ issues_NNS ,_, they_PRP may_MD convalesce_VB at_IN home_NN ,_, but_CC they_PRP must_MD immediately_RB isolate_VB ._. The_DT other_JJ contribution_NN we_PRP make_VBP when_WRB we_PRP submit_VBP to_IN being_VBG tested_VBN is_VBZ a_DT contribution_NN to_IN the_DT national_JJ surveillance_NN piece_NN ,_, ”_'' Penn_NNP added_VBD ._. “_`` We_PRP are_VBP ALL_RB responsible_JJ to_TO fight_VB this_DT virus_NN ._. Give_VB us_PRP robust_JJ defense_NN production_NN ,_, then_RB ,_, our_PRP$ great_JJ country_NN of_IN Republicans_NNPS ,_, Democrats_NNPS ,_, Asians_NNPS ,_, blacks_NNS ,_, whites_NNS ,_, browns_NNS ,_, men_NNS ,_, women_NNS WILL_MD do_VB our_PRP$ part_NN ._. This_DT is_VBZ a_DT moment_NN where_WRB our_PRP$ president_NN can_MD establish_VB a_DT glorious_JJ legacy_NN ._. It_PRP ’s_VBZ got_VBN to_TO be_VB NOW_RB ._. ”_'' The_DT “_`` Guardians_NNPS ”_'' PSA_NNP was_VBD directed_VBN by_IN Samuel_NNP Bayer_NNP ,_, who_WP helmed_VBD Nirvana_NNP ’s_POS iconic_JJ “_`` Smells_NNPS Like_IN Teen_NNP Spirit_NNP ”_'' video_NN ._. “_`` I_PRP ’ve_VBP known_VBN Sean_NNP for_IN a_DT number_NN of_IN years_NNS ._. When_WRB the_DT pandemic_NN hit_VBD ,_, I_PRP knew_VBD his_PRP$ organization_NN CORE_NN would_MD be_VB fighting_VBG the_DT good_JJ fight_NN ,_, ”_'' Bayer_NNP tells_VBZ Rolling_NNP Stone_NNP ._. “_`` I_PRP called_VBD him_PRP up_RP and_CC asked_VBD if_IN I_PRP could_MD contribute_VB something_NN ._. ”_'' “_`` I_PRP saw_VBD firsthand_RB all_PDT the_DT brave_JJ ,_, selfless_JJ and_CC vital_JJ work_NN the_DT CORE_NN volunteers_NNS were_VBD doing_VBG during_IN a_DT very_RB difficult_JJ time_NN ,_, ”_'' he_PRP added_VBD ._. “_`` I_PRP thought_VBD maybe_RB if_IN I_PRP could_MD document_VB the_DT anguish_NN that_IN Los_NNP Angeles_NNP is_VBZ feeling_VBG right_RB now_RB and_CC the_DT hope_NN that_WDT I_PRP saw_VBD at_IN those_DT testing_NN facilities_NNS ,_, maybe_RB a_DT film_NN could_MD touch_VB people_NNS and_CC make_VB a_DT difference_NN ._. ”_'' Asked_VBD what_WP his_PRP$ vision_NN was_VBD for_IN the_DT PSA_NNP ,_, Bayer_NNP replies_VBZ ,_, “_`` I_PRP wanted_VBD to_TO create_VB something_NN real_JJ and_CC honest_JJ ._. A_DT snapshot_NN ,_, a_DT small_JJ piece_NN of_IN the_DT story_NN ._. It_PRP sure_RB is_VBZ n’t_RB about_IN me_PRP ,_, there_EX ’s_VBZ nothing_NN heroic_JJ in_IN making_VBG a_DT film_NN about_IN this_DT pandemic_NN ._. I_PRP saw_VBD real_JJ heroes_NNS ._. That_DT ’s_VBZ the_DT story_NN I_PRP tried_VBD to_TO tell_VB ._. ”_'' “_`` Sam_NNP Bayer_NNP so_RB beautifully_RB captures_VBZ our_PRP$ most_RBS essential_JJ message_NN ,_, ”_'' Penn_NNP says_VBZ ._. “_`` The_DT hope_NN to_TO disarm_VB this_DT beast_NN is_VBZ volunteerism_NN ._. I_PRP am_VBP a_DT full_JJ tilt_NN believer_NN in_IN a_DT policy_NN of_IN mandatory_JJ service_NN ,_, but_CC when_WRB I_PRP see_VBP CORE_NN ’s_POS volunteers_NNS serving_VBG …_: that_IN one_CD makes_VBZ me_PRP weep_VB ._. ”_'' CORE_NN plans_VBZ on_IN additional_JJ sites_NNS opening_VBG around_IN the_DT country_NN ,_, including_VBG Navajo_NNP Nation_NNP ,_, New_NNP Orleans_NNP ,_, Georgia_NNP and_CC North_NNP Carolina_NNP ._.","NNP NNP ’s NN VBZ NNP NNP ’ NN NNS — those on the NN VBG NN - 19 NNS — in a JJ NN that VBZ that “ NN VBZ NNS . ” On NNP NN , NNP ( NNP NNP NNP NNP ) VBD its JJ NN NN NN in NNP NNP ; since that NN , NNP RB VBZ 15 NNS , VBG 12 in NNP , two in NNP and a JJ NN in NNP . Their NN of 120 NN NNS and 300 NNS VBP RB RB VBN 70,000 NNS as of NNP NN . The “ NNPS ” NN — VBN by NN NNP NNP NNP — VBZ a JJ NN of RB - JJ NNP NNP , “ the NNP of NNPS , ” where RB JJ NNS and NN NNS VBP on the NNS . “ NNS VBP in JJ NNS . You might RB VB their NNS , VBP RB VB who they VBP , ” NNP VBZ in the NNP over NN of the NNS at NN . “ From NN to NNP , from NNP NNP to NNP , VBG over us . VBG us . VB them VB that we VBP them . ” “ NN ’s NN VBZ JJ ” RB , to VB JJ NN on the NN of each and every NN we can VB . But RB , it VBZ our JJ NN in VBG NN / JJ NN NNS that , in NN can VB all NNPS and VB all NNPS RB RB as NN and NN VBZ to VB a NN , ” NNP VBZ NNP NNP . “ The NN of NN VBZ with VBG those who may VB the NN . NN VBZ RB RB VBN for those who VBP JJ . Until , or unless those JJ VBP to VB JJ NNS , they may VB at NN , but they must RB VB . The JJ NN we VBP when we VBP to VBG VBN VBZ a NN to the JJ NN NN , ” NNP VBD . “ We VBP RB JJ to VB this NN . VB us JJ NN NN , RB , our JJ NN of NNPS , NNPS , NNPS , NNS , NNS , NNS , NNS , NNS WILL VB our NN . This VBZ a NN where our NN can VB a JJ NN . It VBZ VBN to VB RB . ” The “ NNPS ” NNP VBD VBN by NNP NNP , who VBD NNP ’s JJ “ NNPS Like NNP NNP ” NN . “ I VBP VBN NNP for a NN of NNS . When the NN VBD , I VBD his NN NN would VB VBG the JJ NN , ” NNP VBZ NNP NNP . “ I VBD him up and VBD if I could VB NN . ” “ I VBD RB all the JJ , JJ and JJ NN the NN NNS VBD VBG during a RB JJ NN , ” he VBD . “ I VBD RB if I could VB the NN that NNP NNP VBZ VBG RB RB and the NN that I VBD at those NN NNS , RB a NN could VB NNS and VB a NN . ” VBD what his NN VBD for the NNP , NNP VBZ , “ I VBD to VB NN JJ and JJ . A NN , a JJ NN of the NN . It RB VBZ RB about me , there VBZ NN JJ in VBG a NN about this NN . I VBD JJ NNS . That VBZ the NN I VBD to VB . ” “ NNP NNP RB RB VBZ our RBS JJ NN , ” NNP VBZ . “ The NN to VB this NN VBZ NN . I VBP a JJ NN NN in a NN of JJ NN , but when I VBP NN ’s NNS VBG … that one VBZ me VB . ” NN VBZ on JJ NNS VBG around the NN , VBG NNP NNP , NNP NNP , NNP and NNP NNP ."
43,533,mainstream,"At_IN age_NN 65_CD ,_, immunisation_NN against_IN influenza_NN ,_, shingles_NN ,_, tetanus_NN and_CC diphtheria_NN is_VBZ recommended_VBN by_IN the_DT Ministry_NNP of_IN Health_NNP ._. These_DT vaccines_NNS are_VBP free_JJ (_-LRB- practices_NNS may_MD charge_VB a_DT small_JJ fee_NN to_TO administer_VB tetanus_NN and_CC diphtheria_NN vaccine_NN )_-RRB- ._. Talk_VB to_IN your_PRP$ doctor_NN or_CC practice_VB nurse_NN to_TO find_VB out_RP how_WRB to_TO protect_VB yourself_PRP ._. As_IN you_PRP get_VBP older_JJR ,_, the_DT protection_NN you_PRP received_VBD from_IN some_DT of_IN your_PRP$ earlier_JJR immunisations_NNS begins_VBZ to_TO wear_VB off_RP ._. Your_PRP$ immune_JJ system_NN may_MD no_RB longer_RBR work_VB as_RB well_RB and_CC you_PRP are_VBP at_IN increased_VBN risk_NN from_IN some_DT infectious_JJ diseases_NNS ._. Free_JJ immunisation_NN is_VBZ offered_VBN at_IN age_NN 65_CD onwards_RB to_TO protect_VB you_PRP against_IN some_DT serious_JJ diseases_NNS ._. Shingles_NN is_VBZ a_DT painful_JJ rash_NN affecting_VBG a_DT particular_JJ nerve_NN ._. It_PRP is_VBZ a_DT long_JJ term_NN effect_NN of_IN chickenpox_NN many_JJ years_NNS after_IN people_NNS recover_VBP from_IN the_DT disease_NN ._. Shingles_NNS usually_RB occurs_VBZ in_IN older_JJR people_NNS and_CC lasts_VBZ from_IN 10_CD to_IN 15_CD days_NNS ._. The_DT nerve_NN pain_NN can_MD last_VB long_RB after_IN the_DT rash_NN disappears_VBZ ._. Shingles_NN vaccine_NN is_VBZ free_JJ at_IN age_NN 65_CD ._. Until_IN 31_CD December_NNP 2020_CD ,_, anyone_NN aged_JJ 66_CD to_IN 80_CD inclusive_JJ is_VBZ also_RB eligible_JJ for_IN a_DT free_JJ shingles_NN vaccine_NN ._. Influenza_NN (_-LRB- or_CC the_DT flu_NN )_-RRB- is_VBZ a_DT serious_JJ illness_NN that_WDT can_MD be_VB fatal_JJ ._. Influenza_NN may_MD lead_VB to_IN a_DT stay_NN in_IN hospital_NN at_IN any_DT age_NN but_CC particularly_RB if_IN you_PRP are_VBP older_JJR or_CC have_VBP an_DT underlying_JJ medical_JJ condition_NN ._. Influenza_NN kills_VBZ around_RB 400_CD New_NNP Zealanders_NNPS every_DT year_NN ._. Influenza_NN vaccine_NN is_VBZ free_JJ and_CC recommended_VBN every_DT year_NN from_IN age_NN 65_CD onwards_RB ._. The_DT vaccine_NN is_VBZ changed_VBN each_DT year_NN to_TO make_VB sure_JJ it_PRP protects_VBZ against_IN the_DT most_RBS common_JJ strains_NNS of_IN the_DT virus_NN ._. You_PRP can_MD get_VB the_DT vaccine_NN free_JJ at_IN your_PRP$ doctors_NNS and_CC some_DT pharmacies_NNS from_IN late_JJ autumn_NN each_DT year_NN ._. Diphtheria_NN is_VBZ a_DT serious_JJ bacterial_JJ infection_NN of_IN the_DT throat_NN ,_, which_WDT can_MD close_VB off_IN the_DT airway_NN ._. It_PRP can_MD also_RB affect_VB the_DT heart_NN and_CC nervous_JJ system_NN and_CC cause_VB death_NN ._. Because_IN of_IN immunisation_NN ,_, diphtheria_NN is_VBZ now_RB extremely_RB rare_JJ in_IN New_NNP Zealand_NNP ,_, however_RB it_PRP can_MD still_RB be_VB brought_VBN back_RB into_IN the_DT country_NN through_IN travel_NN ._. Tetanus_NN (_-LRB- or_CC lockjaw_NN )_-RRB- is_VBZ a_DT serious_JJ infection_NN caused_VBN by_IN bacteria_NN that_WDT live_VBP in_IN dirt_NN and_CC dust_NN ,_, and_CC enter_VBP the_DT body_NN through_IN a_DT cut_NN or_CC wound_NN ._. Tetanus_NN causes_VBZ muscle_NN stiffness_NN ,_, painful_JJ spasms_NNS and_CC sometimes_RB death_NN ._. Combined_VBN tetanus_NN and_CC diphtheria_NN (_-LRB- TD_NN )_-RRB- vaccine_NN is_VBZ recommended_VBN at_IN ages_NNS 45_CD and_CC 65_CD to_TO boost_VB the_DT immunity_NN you_PRP received_VBD as_IN a_DT child_NN ._. The_DT vaccine_NN is_VBZ free_JJ ,_, but_CC your_PRP$ general_JJ practice_NN will_MD charge_VB a_DT small_JJ fee_NN to_TO give_VB the_DT injection_NN ._. For_IN more_JJR information_NN about_IN immunisation_NN ,_, talk_VB to_IN your_PRP$ family_NN doctor_NN or_CC practice_NN nurse_NN ._.","At NN 65 , NN against NN , NN , NN and NN VBZ VBN by the NNP of NNP . These NNS VBP JJ ( NNS may VB a JJ NN to VB NN and NN NN ) . VB to your NN or VB NN to VB out how to VB yourself . As you VBP JJR , the NN you VBD from some of your JJR NNS VBZ to VB off . Your JJ NN may RB RBR VB RB RB and you VBP at VBN NN from some JJ NNS . JJ NN VBZ VBN at NN 65 RB to VB you against some JJ NNS . NN VBZ a JJ NN VBG a JJ NN . It VBZ a JJ NN NN of NN JJ NNS after NNS VBP from the NN . NNS RB VBZ in JJR NNS and VBZ from 10 to 15 NNS . The NN NN can VB RB after the NN VBZ . NN NN VBZ JJ at NN 65 . Until 31 NNP 2020 , NN JJ 66 to 80 JJ VBZ RB JJ for a JJ NN NN . NN ( or the NN ) VBZ a JJ NN that can VB JJ . NN may VB to a NN in NN at any NN but RB if you VBP JJR or VBP an JJ JJ NN . NN VBZ RB 400 NNP NNPS every NN . NN NN VBZ JJ and VBN every NN from NN 65 RB . The NN VBZ VBN each NN to VB JJ it VBZ against the RBS JJ NNS of the NN . You can VB the NN JJ at your NNS and some NNS from JJ NN each NN . NN VBZ a JJ JJ NN of the NN , which can VB off the NN . It can RB VB the NN and JJ NN and VB NN . Because of NN , NN VBZ RB RB JJ in NNP NNP , RB it can RB VB VBN RB into the NN through NN . NN ( or NN ) VBZ a JJ NN VBN by NN that VBP in NN and NN , and VBP the NN through a NN or NN . NN VBZ NN NN , JJ NNS and RB NN . VBN NN and NN ( NN ) NN VBZ VBN at NNS 45 and 65 to VB the NN you VBD as a NN . The NN VBZ JJ , but your JJ NN will VB a JJ NN to VB the NN . For JJR NN about NN , VB to your NN NN or NN NN ."
44,485,mainstream,"About_RB 120,000_CD Americans_NNPS have_VBP died_VBN of_IN COVID_NN -_HYPH 19_CD ,_, and_CC daily_JJ counts_NNS of_IN new_JJ cases_NNS in_IN the_DT U.S._NNP are_VBP the_DT highest_JJS they_PRP ’ve_VBP been_VBN in_IN more_JJR than_IN a_DT month_NN ,_, driven_VBN by_IN recent_JJ increases_NNS in_IN the_DT South_NNP and_CC Southwest_NNP ._. The_DT alarming_JJ trend_NN has_VBZ spurred_VBN talk_NN of_IN a_DT “_`` second_JJ wave_NN ”_'' of_IN coronavirus_NN infections_NNS in_IN the_DT U.S._NNP But_CC health_NN experts_NNS agree_VBP that_IN “_`` second_JJ wave_NN ”_'' is_VBZ probably_RB the_DT wrong_JJ term_NN to_TO describe_VB what_WP ’s_VBZ happening_VBG ._. “_`` When_WRB you_PRP have_VBP 20,000_CD -_HYPH plus_CC infections_NNS per_IN day_NN ,_, how_WRB can_MD you_PRP talk_VB about_IN a_DT second_JJ wave_NN ?_. ”_'' said_VBD Dr._NNP Anthony_NNP Fauci_NNP ,_, director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ._. “_`` We_PRP ’re_VBP in_IN the_DT first_JJ wave_NN ._. Let_VB ’s_PRP get_VB out_IN of_IN the_DT first_JJ wave_NN before_IN you_PRP have_VBP a_DT second_JJ wave_NN ._. ”_'' Clearly_RB there_EX was_VBD an_DT initial_JJ infection_NN peak_NN in_IN April_NNP as_IN cases_NNS exploded_VBD in_IN New_NNP York_NNP City_NNP ._. After_IN schools_NNS and_CC businesses_NNS were_VBD closed_VBN across_IN the_DT country_NN ,_, the_DT rate_NN of_IN new_JJ cases_NNS dropped_VBD somewhat_RB ._. But_CC “_`` it_PRP ’s_VBZ more_JJR of_IN a_DT plateau_NN ,_, or_CC a_DT mesa_NN ,_, ”_'' not_RB the_DT trough_NN after_IN a_DT wave_NN ,_, said_VBD Caitlin_NNP Rivers_NNP ,_, a_DT disease_NN researcher_NN at_IN Johns_NNP Hopkins_NNP University_NNP ’s_POS Center_NNP for_IN Health_NNP Security_NNP ._. Scientists_NNS generally_RB agree_VBP the_DT nation_NN is_VBZ still_RB in_IN its_PRP$ first_JJ wave_NN of_IN coronavirus_NN infections_NNS ,_, albeit_IN one_CD that_WDT ’s_VBZ dipping_VBG in_IN some_DT parts_NNS of_IN the_DT country_NN while_IN rising_VBG in_IN others_NNS ._. “_`` This_DT virus_NN is_VBZ spreading_VBG around_IN the_DT United_NNP States_NNPS and_CC hitting_VBG different_JJ places_NNS with_IN different_JJ intensity_NN at_IN different_JJ times_NNS ,_, ”_'' said_VBD Dr._NNP Richard_NNP Besser_NNP ,_, chief_JJ executive_NN of_IN the_DT Robert_NNP Wood_NNP Johnson_NNP Foundation_NNP who_WP was_VBD acting_VBG director_NN of_IN the_DT federal_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP when_WRB the_DT H1N1_NNP flu_NN pandemic_NN hit_VBD the_DT U.S._NNP in_IN 2009_CD ._. Dr._NNP Arnold_NNP Monto_NNP ,_, a_DT flu_NN expert_NN at_IN the_DT University_NNP of_IN Michigan_NNP ,_, echoed_VBD that_DT sentiment_NN ._. “_`` What_WP I_PRP would_MD call_VB this_DT is_VBZ continued_VBN transmission_NN with_IN flare_NN -_HYPH ups_NNS ,_, ”_'' he_PRP said_VBD ._. Flu_NN seasons_NNS sometimes_RB feature_VBP a_DT second_JJ wave_NN of_IN infections_NNS ._. But_CC in_IN those_DT cases_NNS ,_, the_DT second_JJ wave_NN is_VBZ a_DT distinct_JJ new_JJ surge_NN in_IN cases_NNS from_IN a_DT strain_NN of_IN flu_NN that_WDT is_VBZ different_JJ than_IN the_DT strain_NN that_WDT caused_VBD earlier_JJR illnesses_NNS ._. That_DT ’s_VBZ not_RB the_DT case_NN in_IN the_DT coronavirus_NN epidemic_NN ._. Monto_NNP does_VBZ n’t_RB think_VB “_`` second_JJ wave_NN ”_'' really_RB describes_VBZ what_WP ’s_VBZ happening_VBG now_RB ,_, calling_VBG it_PRP “_`` totally_RB semantics_NN ._. ”_'' “_`` Second_JJ waves_NNS are_VBP basically_RB in_IN the_DT eye_NN of_IN the_DT beholder_NN ,_, ”_'' he_PRP said_VBD ._. But_CC Besser_NNP said_VBD semantics_NN matter_NN ,_, because_IN implying_VBG that_IN a_DT first_JJ wave_NN has_VBZ passed_VBN may_MD give_VB people_NNS a_DT false_JJ sense_NN that_IN the_DT worst_JJS is_VBZ over_RB ._. Some_DT worry_VBP a_DT large_JJ wave_NN of_IN coronavirus_NN might_MD occur_VB this_DT fall_NN or_CC winter_NN —_: after_IN schools_NNS reopen_VBP ,_, the_DT weather_NN turns_VBZ colder_JJR and_CC less_RBR humid_JJ ,_, and_CC people_NNS huddle_VBP inside_RB more_JJR ._. That_DT would_MD follow_VB seasonal_JJ patterns_NNS seen_VBN with_IN flu_NN and_CC other_JJ respiratory_JJ viruses_NNS ._. And_CC such_PDT a_DT fall_NN wave_NN could_MD be_VB very_RB bad_JJ ,_, given_VBN that_IN there_EX ’s_VBZ no_DT vaccine_NN and_CC most_JJS Americans_NNPS still_RB wo_MD n’t_RB have_VB any_DT immunity_NN to_IN the_DT virus_NN ._. But_CC the_DT new_JJ coronavirus_NN so_RB far_RB has_VBZ been_VBN spreading_VBG more_RBR episodically_RB and_CC sporadically_RB than_IN flu_NN ,_, and_CC it_PRP may_MD not_RB follow_VB the_DT same_JJ playbook_NN ._. “_`` It_PRP ’s_VBZ very_RB difficult_JJ to_TO make_VB a_DT prediction_NN ,_, ”_'' Rivers_NNP said_VBD ._. “_`` We_PRP do_VBP n’t_RB know_VB the_DT degree_NN to_IN which_WDT this_DT virus_NN is_VBZ seasonal_JJ ,_, if_IN at_IN all_DT ._. ”_''","RB 120,000 NNPS VBP VBN of NN - 19 , and JJ NNS of JJ NNS in the NNP VBP the JJS they VBP VBN in JJR than a NN , VBN by JJ NNS in the NNP and NNP . The JJ NN VBZ VBN NN of a “ JJ NN ” of NN NNS in the NNP But NN NNS VBP that “ JJ NN ” VBZ RB the JJ NN to VB what VBZ VBG . “ When you VBP 20,000 - plus NNS per NN , how can you VB about a JJ NN ? ” VBD NNP NNP NNP , NN of the NNP NNP of NNP and NNP NNPS . “ We VBP in the JJ NN . VB ’s VB out of the JJ NN before you VBP a JJ NN . ” RB there VBD an JJ NN NN in NNP as NNS VBD in NNP NNP NNP . After NNS and NNS VBD VBN across the NN , the NN of JJ NNS VBD RB . But “ it VBZ JJR of a NN , or a NN , ” RB the NN after a NN , VBD NNP NNP , a NN NN at NNP NNP NNP ’s NNP for NNP NNP . NNS RB VBP the NN VBZ RB in its JJ NN of NN NNS , albeit one that VBZ VBG in some NNS of the NN while VBG in NNS . “ This NN VBZ VBG around the NNP NNPS and VBG JJ NNS with JJ NN at JJ NNS , ” VBD NNP NNP NNP , JJ NN of the NNP NNP NNP NNP who VBD VBG NN of the NNP NNPS for NNP NNP and NNP when the NNP NN NN VBD the NNP in 2009 . NNP NNP NNP , a NN NN at the NNP of NNP , VBD that NN . “ What I would VB this VBZ VBN NN with NN - NNS , ” he VBD . NN NNS RB VBP a JJ NN of NNS . But in those NNS , the JJ NN VBZ a JJ JJ NN in NNS from a NN of NN that VBZ JJ than the NN that VBD JJR NNS . That VBZ RB the NN in the NN NN . NNP VBZ RB VB “ JJ NN ” RB VBZ what VBZ VBG RB , VBG it “ RB NN . ” “ JJ NNS VBP RB in the NN of the NN , ” he VBD . But NNP VBD NN NN , because VBG that a JJ NN VBZ VBN may VB NNS a JJ NN that the JJS VBZ RB . Some VBP a JJ NN of NN might VB this NN or NN — after NNS VBP , the NN VBZ JJR and RBR JJ , and NNS VBP RB JJR . That would VB JJ NNS VBN with NN and JJ JJ NNS . And such a NN NN could VB RB JJ , VBN that there VBZ no NN and JJS NNPS RB wo RB VB any NN to the NN . But the JJ NN RB RB VBZ VBN VBG RBR RB and RB than NN , and it may RB VB the JJ NN . “ It VBZ RB JJ to VB a NN , ” NNP VBD . “ We VBP RB VB the NN to which this NN VBZ JJ , if at all . ”"
45,82,conspiracy,"Some_DT are_VBP suggesting_VBG that_IN the_DT current_JJ crisis_NN is_VBZ the_DT end_NN of_IN globalization_NN ,_, or_CC that_IN it_PRP will_MD wipe_VB out_RP the_DT New_NNP World_NNP Order_NNP altogether_RB ._. ._. ._. but_CC they_PRP are_VBP wrong_JJ ._. In_IN fact_NN ,_, this_DT crisis_NN is_VBZ the_DT globalists_NNS ’_POS dream_NN ,_, and_CC what_WP we_PRP are_VBP witnessing_VBG is_VBZ the_DT birth_NN of_IN a_DT totalitarian_JJ control_NN grid_NN the_DT likes_NNS of_IN which_WDT could_MD scarcely_RB have_VB been_VBN imagined_VBN before_IN this_DT pandemic_NN panic_NN kicked_VBD off_RP ._. Welcome_UH to_IN the_DT Corona_NNP World_NNP Order_NNP ._. For_IN those_DT with_IN limited_JJ bandwidth_NN ,_, CLICK_VB HERE_RB to_TO download_VB a_DT smaller_JJR ,_, lower_JJR file_NN size_NN version_NN of_IN this_DT episode_NN ._. For_IN those_DT interested_JJ in_IN audio_NN quality_NN ,_, CLICK_VB HERE_RB for_IN the_DT highest_JJS -_HYPH quality_NN version_NN of_IN this_DT episode_NN (_-LRB- WARNING_NN :_: very_RB large_JJ download_NN )_-RRB- ._. Watch_VB this_DT video_NN on_IN BitChute_NNP /_, LBRY_NNP /_, Minds.com_NNP /_, YouTube_NNP or_CC Download_VB the_DT mp4_NN Will_MD The_DT Coronavirus_NNP Wipe_VB Out_RP The_DT New_NNP World_NNP Order_NNP ?_. GLOBALISATION_NN :_: Is_VBZ it_PRP in_IN Reverse_NNP ?_. The_DT Coronavirus_NNP Pandemic_NNP Will_MD Forever_NNP Alter_VB the_DT World_NNP Order_NN Kissinger_NNP Still_RB Pushing_VBG The_DT Myth_NN Of_IN A_DT Happy_JJ New_JJ World_NN Order_NN The_DT US_NNP is_VBZ tracking_VBG people_NNS ’s_POS movements_NNS with_IN phone_NN data_NNS ,_, and_CC it_PRP ’s_VBZ part_NN of_IN a_DT massive_JJ increase_NN in_IN global_JJ surveillance_NN ‘_`` Immunity_NN passports_NNS ’_'' could_MD speed_VB up_RP return_NN to_IN work_NN after_IN Covid_NNP -_HYPH 19_CD","Some VBP VBG that the JJ NN VBZ the NN of NN , or that it will VB out the NNP NNP NNP RB . . . but they VBP JJ . In NN , this NN VBZ the NNS ’ NN , and what we VBP VBG VBZ the NN of a JJ NN NN the NNS of which could RB VB VBN VBN before this NN NN VBD off . Welcome to the NNP NNP NNP . For those with JJ NN , VB RB to VB a JJR , JJR NN NN NN of this NN . For those JJ in NN NN , VB RB for the JJS - NN NN of this NN ( NN : RB JJ NN ) . VB this NN on NNP / NNP / NNP / NNP or VB the NN Will The NNP VB Out The NNP NNP NNP ? NN : VBZ it in NNP ? The NNP NNP Will NNP VB the NNP NN NNP RB VBG The NN Of A JJ JJ NN NN The NNP VBZ VBG NNS ’s NNS with NN NNS , and it VBZ NN of a JJ NN in JJ NN ‘ NN NNS ’ could VB up NN to NN after NNP - 19"
46,629,mainstream,"The_DT BCG_NNP (_-LRB- Bacillus_NNP Calmette_NNP -_HYPH Guérin_NNP )_-RRB- tuberculosis_NN vaccine_NN boosts_VBZ the_DT production_NN of_IN immune_NN cells_NNS ,_, which_WDT may_MD explain_VB why_WRB it_PRP can_MD protect_VB newborn_NN babies_NNS from_IN dying_VBG of_IN sepsis_NN ._. Previous_JJ studies_NNS have_VBP shown_VBN that_IN BCG_NNP vaccination_NN can_MD protect_VB newborns_NNS against_IN a_DT broad_JJ range_NN of_IN infections_NNS beyond_IN tuberculosis_NN ,_, reducing_VBG overall_JJ deaths_NNS from_IN sepsis_NN ._. But_CC exactly_RB how_WRB this_DT works_VBZ was_VBD unclear_JJ ._. “_`` Knowing_VBG the_DT mechanism_NN behind_IN this_DT effect_NN will_MD support_VB the_DT use_NN of_IN the_DT BCG_NN vaccine_NN to_TO prevent_VB newborn_JJ sepsis_NN ,_, ”_'' says_VBZ Nelly_NNP Amenyogbe_NNP at_IN the_DT Telethon_NNP Kids_NNPS Institute_NNP in_IN Perth_NNP ,_, Australia_NNP ._. Amenyogbe_NNP and_CC her_PRP$ colleagues_NNS analysed_VBD blood_NN samples_NNS from_IN 85_CD newborn_NN babies_NNS in_IN Gambia_NNP ,_, Guinea_NNP -_HYPH Bissau_NNP and_CC Papua_NNP New_NNP Guinea_NNP ,_, half_NN of_IN whom_WP had_VBD been_VBN vaccinated_VBN ._. They_PRP found_VBD that_IN ,_, three_CD days_NNS later_RBR ,_, the_DT newborns_NNS who_WP had_VBD been_VBN vaccinated_VBN had_VBD about_RB twice_RB as_RB many_JJ immune_JJ cells_NNS ,_, called_VBN neutrophils_NNS ,_, in_IN their_PRP$ blood_NN ._. In_IN another_DT experiment_NN ,_, the_DT researchers_NNS vaccinated_VBD newborn_NN mice_NNS with_IN BCG_NNP and_CC then_RB infected_VBD them_PRP with_IN bacteria_NN to_TO induce_VB sepsis_NN ._. They_PRP also_RB infected_VBD non-vaccinated_JJ mice_NNS ._. Just_RB like_IN the_DT human_JJ babies_NNS ,_, the_DT mice_NNS that_WDT had_VBD been_VBN vaccinated_VBN produced_VBD about_RB double_JJ the_DT number_NN of_IN neutrophils_NNS ,_, which_WDT then_RB protected_VBD them_PRP from_IN dying_VBG by_IN gobbling_VBG up_RP the_DT bacteria_NN that_WDT cause_VBP sepsis_NN ._. “_`` There_EX is_VBZ increasingly_RB strong_JJ evidence_NN that_IN BCG_NNP ,_, a_DT vaccine_NN designed_VBN to_TO work_VB against_IN tuberculosis_NN ,_, has_VBZ advantageous_JJ non-specific_JJ effects_NNS against_IN a_DT range_NN of_IN pathogens_NNS in_IN humans_NNS ,_, ”_'' says_VBZ Danika_NNP Hill_NNP at_IN the_DT Babraham_NNP Institute_NNP in_IN Cambridge_NNP ,_, UK_NNP ._. With_IN this_DT in_IN mind_NN ,_, the_DT BCG_NNP vaccine_NN is_VBZ currently_RB being_VBG trialled_VBN in_IN people_NNS as_IN potential_JJ protection_NN against_IN covid_NN -_HYPH 19_CD ._. But_CC “_`` whether_IN BCG_NNP ,_, and_CC any_DT potential_JJ effect_NN on_IN neutrophils_NNS ,_, could_MD be_VB beneficial_JJ against_IN [_-LRB- the_DT coronavirus_NN ]_-RRB- is_VBZ unclear_JJ and_CC warrants_VBZ careful_JJ consideration_NN ”_'' ,_, says_VBZ Hill_NNP ._. Amenyogbe_NNP says_VBZ BCG_NNP also_RB has_VBZ effects_NNS on_IN other_JJ parts_NNS of_IN the_DT immune_NN system_NN ,_, beyond_IN neutrophils_NNS ,_, and_CC it_PRP is_VBZ possible_JJ that_IN these_DT other_JJ effects_NNS may_MD provide_VB some_DT benefit_NN against_IN covid_NN -_HYPH 19_CD ._. “_`` If_IN vaccines_NNS such_JJ as_IN BCG_NNP are_VBP able_JJ to_TO provide_VB non-specific_JJ protection_NN against_IN newly_RB emerging_VBG pathogens_NNS ,_, this_DT could_MD be_VB a_DT game_NN changer_NN for_IN managing_VBG covid_NN -_HYPH 19_CD and_CC any_DT future_JJ pandemics_NNS ,_, ”_'' says_VBZ Hill_NNP ._. Sign_VB up_RP to_IN our_PRP$ free_JJ Health_NN Check_NN newsletter_NN for_IN a_DT monthly_JJ round_NN -_HYPH up_NN of_IN all_PDT the_DT health_NN and_CC fitness_NN news_NN you_PRP need_VBP to_TO know_VB","The NNP ( NNP NNP - NNP ) NN NN VBZ the NN of NN NNS , which may VB why it can VB NN NNS from VBG of NN . JJ NNS VBP VBN that NNP NN can VB NNS against a JJ NN of NNS beyond NN , VBG JJ NNS from NN . But RB how this VBZ VBD JJ . “ VBG the NN behind this NN will VB the NN of the NN NN to VB JJ NN , ” VBZ NNP NNP at the NNP NNPS NNP in NNP , NNP . NNP and her NNS VBD NN NNS from 85 NN NNS in NNP , NNP - NNP and NNP NNP NNP , NN of whom VBD VBN VBN . They VBD that , three NNS RBR , the NNS who VBD VBN VBN VBD RB RB RB JJ JJ NNS , VBN NNS , in their NN . In another NN , the NNS VBD NN NNS with NNP and RB VBD them with NN to VB NN . They RB VBD JJ NNS . RB like the JJ NNS , the NNS that VBD VBN VBN VBD RB JJ the NN of NNS , which RB VBD them from VBG by VBG up the NN that VBP NN . “ There VBZ RB JJ NN that NNP , a NN VBN to VB against NN , VBZ JJ JJ NNS against a NN of NNS in NNS , ” VBZ NNP NNP at the NNP NNP in NNP , NNP . With this in NN , the NNP NN VBZ RB VBG VBN in NNS as JJ NN against NN - 19 . But “ whether NNP , and any JJ NN on NNS , could VB JJ against [ the NN ] VBZ JJ and VBZ JJ NN ” , VBZ NNP . NNP VBZ NNP RB VBZ NNS on JJ NNS of the NN NN , beyond NNS , and it VBZ JJ that these JJ NNS may VB some NN against NN - 19 . “ If NNS JJ as NNP VBP JJ to VB JJ NN against RB VBG NNS , this could VB a NN NN for VBG NN - 19 and any JJ NNS , ” VBZ NNP . VB up to our JJ NN NN NN for a JJ NN - NN of all the NN and NN NN you VBP to VB"
47,541,conspiracy,"[_-LRB- Kris_NNP Gaublomme_NNP is_VBZ a_DT Belgian_JJ medical_JJ doctor_NN and_CC homeopath_NN ._. Orthodox_NNP trained_VBN ,_, Dr_NNP Gaublomme_NNP began_VBD researching_VBG vaccination_NN after_IN qualifying_VBG as_IN a_DT homeopath_NN in_IN 1985_CD and_CC has_VBZ continued_VBN to_TO study_VB the_DT subject_NN with_IN growing_VBG concern_NN ._. Editor_NN of_IN the_DT International_NNP Vaccination_NNP Newsletter_NNP from_IN 1993_CD to_IN 1998_CD ,_, editor_NN of_IN a_DT Dutch_JJ vaccination_NN newsletter_NN since_IN 1990_CD ,_, and_CC also_RB an_DT invited_VBN speaker_NN at_IN many_JJ international_JJ vaccination_NN lectures_NNS ,_, his_PRP$ knowledge_NN on_IN this_DT subject_NN is_VBZ broad_JJ and_CC thought_VBN -_HYPH provoking_VBG ._. In_IN April_NNP last_JJ year_NN ,_, Dr_NNP Gaublomme_NNP was_VBD invited_VBN to_TO make_VB a_DT presentation_NN at_IN a_DT one_CD -_HYPH day_NN European_JJ Parliament_NN conference_NN in_IN which_WDT he_PRP focused_VBD on_IN autoimimune_NN diseases_NNS linked_VBN to_IN vaccination_NN ._. (_-LRB- Source_NN http://www.internationalsymposium.co.uk_ADD )_-RRB- ]_-RRB- ""_`` I_PRP always_RB said_VBD that_IN private_JJ interests_NNS were_VBD hidden_VBN behind_IN official_JJ vaccination_NN policy_NN making_NN ._. I_PRP was_VBD wrong_JJ ._. It_PRP is_VBZ not_RB hidden_VBN ,_, it_PRP happens_VBZ in_IN the_DT open_JJ ._. The_DT powers_NNS concerned_VBN do_VBP not_RB even_RB feel_VB the_DT need_NN to_TO be_VB secret_JJ about_IN it_PRP ._. They_PRP feel_VBP so_RB almighty_JJ they_PRP can_MD publicise_VB their_PRP$ malicious_JJ intentions_NNS in_IN official_NN reports_NNS without_IN any_DT significant_JJ opposition_NN to_IN it_PRP ._. The_DT vaccination_NN lobby_NN shamelessly_RB takes_VBZ all_PDT the_DT children_NNS of_IN this_DT world_NN as_IN hostages_NNS to_TO still_RB their_PRP$ greed_NN for_IN money_NN and_CC power_NN ._. They_PRP relentlessly_RB abuse_VBP our_PRP$ compassion_NN for_IN the_DT weaker_JJR and_CC our_PRP$ concern_NN about_IN health_NN to_TO promote_VB their_PRP$ giga_NN -_HYPH business_NN ._. No_RB matter_RB what_WP ._. No_RB matter_RB how_WRB many_JJ more_JJR vaccine_NN victims_NNS will_MD suffer_VB death_NN or_CC side_NN -_HYPH effects_NNS ._. No_RB matter_RB how_WRB many_JJ financial_JJ resources_NNS this_DT strategy_NN devours_VBZ at_IN the_DT expense_NN of_IN essential_JJ social_JJ investments_NNS like_IN housing_NN and_CC employment_NN ._. No_RB matter_RB what_WP ._. Shocking_JJ !""---_, Kris_NNP Gaublomme_NNP MD_NNP ""_`` It_PRP is_VBZ a_DT pretty_RB bad_JJ habit_NN of_IN vaccine_NN researchers_NNS to_TO give_VB several_JJ vaccines_NNS simultaneously_RB where_WRB the_DT effect_NN of_IN only_RB one_CD of_IN them_PRP has_VBZ to_TO be_VB studied_VBN and_CC evaluated_VBN ._. Obviously_RB this_DT leads_VBZ to_IN confounding_VBG results_NNS .........._, for_IN evaluation_NN of_IN side_NN -_HYPH effects_NNS in_IN most_JJS studies_NNS was_VBD restricted_VBN to_IN 48_CD to_IN 72_CD hours_NNS ._. Needless_JJ to_TO say_VB that_IN many_JJ serious_JJ adverse_JJ effects_NNS show_VBP up_RP long_RB after_IN that_DT time_NN span_NN ;_: by_IN definition_NN they_PRP could_MD never_RB be_VB mentioned_VBN in_IN those_DT studies_NNS ._. Nevertheless_RB most_JJS of_IN these_DT studies_NNS pretend_VBP to_TO prove_VB the_DT safety_NN of_IN the_DT vaccine_NN ._. ""_'' --_NFP Kris_NNP Gaublomme_NNP MD_NNP The_DT Childrens_NNP Vaccine_NNP Initiative_NNP :_: An_DT open_JJ window_NN upon_IN global_JJ vaccination_NN strategies_NNS ----_, Kris_NNP Gaublomme_NNP ,_, MD_NNP Polio_NN :_: the_DT roots_NNS of_IN the_DT story_NN ---_, Kris_NNP Gaublomme_NNP ,_, MD_NNP","[ NNP NNP VBZ a JJ JJ NN and NN . NNP VBN , NNP NNP VBD VBG NN after VBG as a NN in 1985 and VBZ VBN to VB the NN with VBG NN . NN of the NNP NNP NNP from 1993 to 1998 , NN of a JJ NN NN since 1990 , and RB an VBN NN at JJ JJ NN NNS , his NN on this NN VBZ JJ and VBN - VBG . In NNP JJ NN , NNP NNP VBD VBN to VB a NN at a one - NN JJ NN NN in which he VBD on NN NNS VBN to NN . ( NN http://www.internationalsymposium.co.uk ) ] "" I RB VBD that JJ NNS VBD VBN behind JJ NN NN NN . I VBD JJ . It VBZ RB VBN , it VBZ in the JJ . The NNS VBN VBP RB RB VB the NN to VB JJ about it . They VBP RB JJ they can VB their JJ NNS in NN NNS without any JJ NN to it . The NN NN RB VBZ all the NNS of this NN as NNS to RB their NN for NN and NN . They RB VBP our NN for the JJR and our NN about NN to VB their NN - NN . RB RB what . RB RB how JJ JJR NN NNS will VB NN or NN - NNS . RB RB how JJ JJ NNS this NN VBZ at the NN of JJ JJ NNS like NN and NN . RB RB what . JJ !""--- NNP NNP NNP "" It VBZ a RB JJ NN of NN NNS to VB JJ NNS RB where the NN of RB one of them VBZ to VB VBN and VBN . RB this VBZ to VBG NNS .......... for NN of NN - NNS in JJS NNS VBD VBN to 48 to 72 NNS . JJ to VB that JJ JJ JJ NNS VBP up RB after that NN NN ; by NN they could RB VB VBN in those NNS . RB JJS of these NNS VBP to VB the NN of the NN . "" -- NNP NNP NNP The NNP NNP NNP : An JJ NN upon JJ NN NNS ---- NNP NNP , NNP NN : the NNS of the NN --- NNP NNP , NNP"
48,621,conspiracy,"An_DT AIM_NNP patriot_NN sent_VBD us_PRP a_DT note_NN with_IN a_DT video_NN ._. We_PRP are_VBP posting_VBG a_DT public_JJ reply_NN as_IN many_JJ of_IN you_PRP have_VBP asked_VBN about_IN this_DT video_NN which_WDT has_VBZ been_VBN shown_VBN in_IN full_JJ ,_, and_CC in_IN part_NN ,_, around_IN the_DT internet_NN ._. Our_PRP$ community_NN member_NN writes_VBZ :_: Below_RB is_VBZ a_DT FYI_RB of_IN a_DT video_NN ,_, reportedly_RB from_IN June_NNP 17_CD ,_, 2010_CD ,_, which_WDT might_MD be_VB of_IN interest_NN if_IN you_PRP have_VBP not_RB come_VBN across_IN it_PRP in_IN the_DT past_NN ._. The_DT minutes_NNS below_RB are_VBP drawn_VBN from_IN minutes_NNS 4:00_CD to_IN 16:30_CD …_, some_DT of_IN the_DT Pilgrim_NNP Society_NNP plans_NNS exposed_VBN from_IN a_DT 56_CD minute_NN video_NN created_VBN almost_RB ten_CD years_NNS ago_RB ._. 05:00_CD In_IN 2010_CD ,_, a_DT retired_VBN military_JJ whistle_NN blower_NN ,_, outlines_VBZ a_DT June_NNP ,_, 2005_CD City_NNP of_IN London_NNP banksters_NNS ’_POS meeting_NN he_PRP attended_VBD ._. There_EX with_IN some_DT Masons_NNPS ,_, he_PRP served_VBD no_DT more_JJR purpose_NN than_IN a_DT fly_NN -_HYPH on_IN -_HYPH the_DT -_HYPH wall_NN ._. At_IN this_DT unusual_JJ meeting_NN alarm_NN bells_NNS began_VBD to_TO fire_VB off_RP in_IN his_PRP$ head_NN upon_IN realizing_VBG what_WP the_DT group_NN was_VBD talking_VBG about_IN ._. 06:00_CD This_DT whistle_NN -_HYPH blower_NN (_-LRB- statement_NN is_VBZ supported_VBN by_IN video_NN and_CC transcript_NN )_-RRB- that_IN there_EX were_VBD about_RB thirty_CD senior_JJ masons_NNS in_IN the_DT meeting_NN room_NN including_VBG senior_JJ politicians_NNS ,_, the_DT chief_NN of_IN police_NN was_VBD there_RB ;_, representatives_NNS of_IN the_DT church_NN and_CC military_NN were_VBD there_RB ;_, 25_CD or_CC 30_CD people_NNS in_IN the_DT room_NN ._. 05:56_CD What_WP they_PRP were_VBD talking_VBG about_IN was_VBD a_DT plan_NN created_VBN years_NNS earlier_RBR ._. This_DT meeting_NN was_VBD to_TO update_VB attendees_NNS on_IN it_PRP status_NN ._. A_DT report_NN was_VBD being_VBG given_VBN where_WRB first_RB they_PRP expressed_VBD concern_NN the_DT Israeli_JJ -_HYPH Iran_NNP war_NN was_VBD not_RB following_VBG the_DT schedule_NN they_PRP had_VBD set_VBN ._. 08:00_CD In_IN this_DT Pilgrim_NNP Society_NNP meeting_NN they_PRP expressed_VBD their_PRP$ concerns_NNS with_IN China_NNP growing_VBG as_IN a_DT treat_NN ,_, both_CC military_NN and_CC financially_RB and_CC that_IN Japan_NNP was_VBD a_DT disappointment_NN in_IN not_RB ,_, as_IN planned_VBN ,_, impeding_VBG their_PRP$ China_NNP ’s_POS progress_NN on_IN the_DT global_JJ stage_NN ._. 08:40_CD Other_JJ things_NNS discussed_VBN were_VBD the_DT coming_VBG financial_JJ crash_NN and_CC the_DT initiation_NN of_IN global_JJ centralization_NN of_IN all_DT resources_NNS in_IN 2008_CD was_VBD examined_VBN in_IN this_DT 2010_CD session_NN ._. 10:20_CD Though_IN the_DT timeline_NN is_VBZ falling_VBG behind_RB ,_, this_DT group_NN is_VBZ committed_VBN to_IN initiating_VBG the_DT following_VBG :_: Israeli_NNP launched_VBD a_DT war_NN against_IN Iran_NNP ._. Iran_NNP will_MD be_VB set_VBN up_RP as_IN the_DT bad_JJ guys_NNS ._. That_DT is_VBZ the_DT opening_VBG move_NN in_IN a_DT big_JJ chess_NN game_NN ._. Iran_NNP has_VBZ secretly_RB been_VBN already_RB provide_VB nuclear_JJ weapons_NNS by_IN China_NNP ._. 11:25_CD This_DT cabal_NN actually_RB want_VBP this_DT weapons_NNS to_TO be_VB used_VBN in_IN the_DT Middle_NNP East_NNP ._. They_PRP want_VBP Iran_NNP or_CC China_NNP to_TO retaliate_VB with_IN a_DT nuclear_JJ weapon_NN ._. 11:45_CD At_IN the_DT point_NN there_EX will_MD be_VB a_DT “_`` limited_VBN ”_'' nuclear_JJ exchange_NN followed_VBN by_IN a_DT cease_NN -_HYPH fire_NN ._. This_DT ex-military_JJ whistle_NN -_HYPH blower_NN heard_VBD this_DT all_DT being_VBG laid_VBN out_RP in_IN this_DT meeting_NN like_IN a_DT script_NN to_IN a_DT movie_NN ._. 12:05_CD The_DT other_JJ thing_NN being_VBG set_VBN up_RP in_IN many_JJ of_IN the_DT western_JJ countries_NNS for_IN marshal_NN law_NN and_CC people_NNS control…ability_NN to_TO arrest_VB ,_, detain…etc_VB ._. The_DT group_NN wants_VBZ humanity_NN to_TO demand_VB heavy_JJ control_NN on_IN travel_NN and_CC communication_NN due_IN to_IN fears_NNS arising_VBG from_IN limited_JJ nuclear_JJ war_NN ._. This_DT is_VBZ only_RB the_DT beginning_NN ._. 15:00_CD The_DT next_JJ thing_NN that_WDT happens_VBZ in_IN this_DT chess_NN game_NN of_IN manipulation_NN of_IN the_DT public_NN is_VBZ that_IN bio-weapons_NNS are_VBP released_VBN on_IN China_NNP ._. He_PRP heard_VBD this_DT openly_RB discussed_VBN in_IN this_DT meeting_NN ._. They_PRP will_MD release_VB a_DT flu_NN like_IN virus_NN which_WDT will_MD be_VB modified_VBN genetically_RB to_TO specifically_RB attack_VB the_DT Chinese_JJ people_NNS ._. It_PRP is_VBZ designed_VBN to_TO spread_VB like_IN wildfire_NN to_TO knock_VB out_RP a_DT large_JJ portion_NN of_IN the_DT Chinese_JJ people_NNS ._. And_CC these_DT people_NNS in_IN this_DT meeting_NN were_VBD laughing_VBG about_IN this_DT ._. They_PRP said_VBD “_`` China_NNP will_MD catch_VB a_DT cold_NN ”_'' ._. They_PRP laughed_VBD again_RB about_IN these_DT bio-weapons_NNS wreaking_VBG havoc_NN across_IN China_NNP ._. 15:50_CD After_IN that_DT then_RB a_DT plague_NN will_MD sweep_VB across_IN the_DT Western_JJ nations_NNS …_, though_IN the_DT whistle_NN blower_NN was_VBD not_RB certain_JJ if_IN this_DT was_VBD due_IN to_IN Chinese_JJ retaliation_NN or_CC a_DT mutation_NN of_IN the_DT virus_NN ._. So_RB after_IN limited_JJ nuclear_JJ war_NN ,_, and_CC a_DT bio_NN -_HYPH weapon_NN release_NN ,_, a_DT pandemic_NN arises_VBZ around_IN the_DT globe_NN and_CC you_PRP have_VBP a_DT totalitarian_JJ lockdown_NN all_RB around_IN the_DT world_NN because_IN everyone_NN is_VBZ going_VBG to_TO be_VB in_IN a_DT panic_NN about_IN all_PDT this_DT ._. 16:30_CD …_, and_CC then_RB the_DT real_JJ war_NN starts_VBZ …._, the_DT Third_NNP World_NNP War_NNP …_. I_PRP will_MD be_VB listening_VBG to_IN the_DT rest_NN to_TO see_VB where_WRB it_PRP goes_VBZ from_IN here_RB ._. Betsy_NNP replies_VBZ :_: I_PRP listened_VBD to_IN this_DT the_DT other_JJ day_NN ._. Did_VBD n’t_RB bother_VB to_TO post_VB ,_, as_IN in_IN my_PRP$ opinion_NN ,_, it_PRP is_VBZ propaganda_NN b.s.._. It_PRP ’s_VBZ a_DT video_NN distraction_NN to_TO keep_VB the_DT heat_NN off_IN the_DT research_NN AIM_NNP and_CC AFI_NNP are_VBP posting_VBG –_: which_WDT are_VBP naming_VBG names_NNS ,_, showing_VBG locations_NNS on_IN maps_NNS ,_, revealing_VBG patents_NNS and_CC showing_VBG you_PRP the_DT Queen_NNP ’s_POS controlling_VBG share_NN of_IN QinetiQ_NNP ._. Folks_NNS around_IN the_DT world_NN are_VBP waking_VBG up_RP to_TO see_VB the_DT evil_JJ intentions_NNS of_IN the_DT Pilgrims_NNPS Society_NNP ,_, Privy_NNP Council_NNP ,_, and_CC the_DT British_NNP Imperial_NNP Empire_NNP ._. In_IN this_DT piece_NN of_IN British_JJ propaganda_NN ,_, the_DT speaker_NN says_VBZ things_NNS that_WDT are_VBP generally_RB true_JJ …_, but_CC offers_VBZ no_DT concrete_JJ evidence_NN or_CC documentation_NN ._. He_PRP ’s_VBZ just_RB telling_VBG you_PRP a_DT nice_JJ story_NN ,_, and_CC ,_, frankly_RB ,_, he_PRP takes_VBZ forever_RB to_TO tell_VB you_PRP ._. It_PRP ’s_VBZ called_VBN WORD_NNP SALAD_NN when_WRB they_PRP talk_VBP and_CC talk_VBP …_: filling_VBG space_NN up_RP with_IN words_NNS ,_, but_CC never_RB getting_VBG to_IN the_DT point_NN ._. If_IN you_PRP listen_VBP ,_, you_PRP will_MD hear_VB lots_NNS of_IN speculation_NN and_CC conjecture_NN with_IN the_DT mystery_NN man_NN at_IN the_DT mystery_NN meeting_NN ._. The_DT speaker_NN drops_VBZ buzz_NN words_NNS like_IN “_`` Pilgrims_NNPS Society_NNP ”_'' “_`` martial_JJ law_NN ”_'' “_`` CityofLondon_NNP ”_'' so_RB you_PRP think_VBP he_PRP is_VBZ really_RB giving_VBG you_PRP “_`` the_DT scoop_NN ._. ”_'' In_IN order_NN to_TO buy_VB his_PRP$ story_NN you_PRP first_RB have_VBP to_TO believe_VB in_IN the_DT mystery_NN man_NN –_: which_WDT I_PRP do_VBP n’t_RB …_: so_RB the_DT rest_NN is_VBZ hearsay_JJ ,_, at_IN best_JJS .._. One_CD of_IN our_PRP$ AIM_NNP patriots_NNS asked_VBD that_IN we_PRP offer_VBP a_DT prayer_NN to_TO help_VB us_PRP get_VB through_IN the_DT storm_NN ._. Without_IN hesitation_NN ,_, we_PRP offer_VBP one_CD of_IN our_PRP$ Steiner_NNP favorites_NNS :_: We_PRP must_MD eradicate_VB from_IN the_DT soul_NN All_DT fear_NN and_CC terror_NN of_IN what_WP comes_VBZ towards_IN man_NN out_IN of_IN the_DT future_NN ._. In_IN all_DT feelings_NNS and_CC sensations_NNS about_IN the_DT future_NN ._. We_PRP must_MD look_VB forward_RB with_IN absolute_JJ equanimity_NN To_IN everything_NN that_WDT may_MD come_VB ._. And_CC we_PRP must_MD think_VB only_RB that_IN whatever_WDT comes_VBZ Is_VBZ given_VBN to_IN us_PRP by_IN a_DT world_NN -_HYPH directive_NN full_JJ of_IN wisdom_NN ._. It_PRP is_VBZ part_NN of_IN what_WP we_PRP must_MD learn_VB in_IN this_DT age_NN ,_, namely_RB ,_, to_TO live_VB out_IN of_IN pure_JJ trust_NN ,_, Without_IN any_DT security_NN in_IN existence_NN ._. Trust_VB in_IN the_DT ever_RB present_JJ help_NN Truly_RB ,_, nothing_NN else_JJ will_MD do_VB If_IN our_PRP$ courage_NN is_VBZ not_RB to_TO fail_VB us_PRP ._. And_CC let_VB us_PRP seek_VB the_DT awakening_NN from_IN within_IN ourselves_PRP Every_DT morning_NN and_CC every_DT evening_NN ._.","An NNP NN VBD us a NN with a NN . We VBP VBG a JJ NN as JJ of you VBP VBN about this NN which VBZ VBN VBN in JJ , and in NN , around the NN . Our NN NN VBZ : RB VBZ a RB of a NN , RB from NNP 17 , 2010 , which might VB of NN if you VBP RB VBN across it in the NN . The NNS RB VBP VBN from NNS 4:00 to 16:30 … some of the NNP NNP NNS VBN from a 56 NN NN VBN RB ten NNS RB . 05:00 In 2010 , a VBN JJ NN NN , VBZ a NNP , 2005 NNP of NNP NNS ’ NN he VBD . There with some NNPS , he VBD no JJR NN than a NN - on - the - NN . At this JJ NN NN NNS VBD to VB off in his NN upon VBG what the NN VBD VBG about . 06:00 This NN - NN ( NN VBZ VBN by NN and NN ) that there VBD RB thirty JJ NNS in the NN NN VBG JJ NNS , the NN of NN VBD RB ; NNS of the NN and NN VBD RB ; 25 or 30 NNS in the NN . 05:56 What they VBD VBG about VBD a NN VBN NNS RBR . This NN VBD to VB NNS on it NN . A NN VBD VBG VBN where RB they VBD NN the JJ - NNP NN VBD RB VBG the NN they VBD VBN . 08:00 In this NNP NNP NN they VBD their NNS with NNP VBG as a NN , both NN and RB and that NNP VBD a NN in RB , as VBN , VBG their NNP ’s NN on the JJ NN . 08:40 JJ NNS VBN VBD the VBG JJ NN and the NN of JJ NN of all NNS in 2008 VBD VBN in this 2010 NN . 10:20 Though the NN VBZ VBG RB , this NN VBZ VBN to VBG the VBG : NNP VBD a NN against NNP . NNP will VB VBN up as the JJ NNS . That VBZ the VBG NN in a JJ NN NN . NNP VBZ RB VBN RB VB JJ NNS by NNP . 11:25 This NN RB VBP this NNS to VB VBN in the NNP NNP . They VBP NNP or NNP to VB with a JJ NN . 11:45 At the NN there will VB a “ VBN ” JJ NN VBN by a NN - NN . This JJ NN - NN VBD this all VBG VBN out in this NN like a NN to a NN . 12:05 The JJ NN VBG VBN up in JJ of the JJ NNS for NN NN and NNS NN to VB , VB . The NN VBZ NN to VB JJ NN on NN and NN due to NNS VBG from JJ JJ NN . This VBZ RB the NN . 15:00 The JJ NN that VBZ in this NN NN of NN of the NN VBZ that NNS VBP VBN on NNP . He VBD this RB VBN in this NN . They will VB a NN like NN which will VB VBN RB to RB VB the JJ NNS . It VBZ VBN to VB like NN to VB out a JJ NN of the JJ NNS . And these NNS in this NN VBD VBG about this . They VBD “ NNP will VB a NN ” . They VBD RB about these NNS VBG NN across NNP . 15:50 After that RB a NN will VB across the JJ NNS … though the NN NN VBD RB JJ if this VBD due to JJ NN or a NN of the NN . RB after JJ JJ NN , and a NN - NN NN , a NN VBZ around the NN and you VBP a JJ NN RB around the NN because NN VBZ VBG to VB in a NN about all this . 16:30 … and RB the JJ NN VBZ …. the NNP NNP NNP … I will VB VBG to the NN to VB where it VBZ from RB . NNP VBZ : I VBD to this the JJ NN . VBD RB VB to VB , as in my NN , it VBZ NN b.s.. It VBZ a NN NN to VB the NN off the NN NNP and NNP VBP VBG – which VBP VBG NNS , VBG NNS on NNS , VBG NNS and VBG you the NNP ’s VBG NN of NNP . NNS around the NN VBP VBG up to VB the JJ NNS of the NNPS NNP , NNP NNP , and the NNP NNP NNP . In this NN of JJ NN , the NN VBZ NNS that VBP RB JJ … but VBZ no JJ NN or NN . He VBZ RB VBG you a JJ NN , and , RB , he VBZ RB to VB you . It VBZ VBN NNP NN when they VBP and VBP … VBG NN up with NNS , but RB VBG to the NN . If you VBP , you will VB NNS of NN and NN with the NN NN at the NN NN . The NN VBZ NN NNS like “ NNPS NNP ” “ JJ NN ” “ NNP ” RB you VBP he VBZ RB VBG you “ the NN . ” In NN to VB his NN you RB VBP to VB in the NN NN – which I VBP RB … RB the NN VBZ JJ , at JJS .. One of our NNP NNS VBD that we VBP a NN to VB us VB through the NN . Without NN , we VBP one of our NNP NNS : We must VB from the NN All NN and NN of what VBZ towards NN out of the NN . In all NNS and NNS about the NN . We must VB RB with JJ NN To NN that may VB . And we must VB RB that whatever VBZ VBZ VBN to us by a NN - NN JJ of NN . It VBZ NN of what we must VB in this NN , RB , to VB out of JJ NN , Without any NN in NN . VB in the RB JJ NN RB , NN JJ will VB If our NN VBZ RB to VB us . And VB us VB the NN from within ourselves Every NN and every NN ."
49,83,mainstream,"In_IN this_DT episode_NN of_IN Futuris_NNP the_DT team_NN examine_VBP what_WP Europe_NNP is_VBZ doing_VBG to_TO boost_VB funding_NN for_IN research_NN and_CC innovation_NN in_IN the_DT fight_NN against_IN COVID_NNP -_HYPH 19_CD ._. At_IN the_DT University_NNP of_IN Copenhagen_NNP researchers_NNS are_VBP working_VBG on_IN a_DT candidate_NN vaccine_NN with_IN what_WP is_VBZ known_VBN as_IN ""_`` recombinant_JJ technology_NN ""_'' ._. It_PRP involves_VBZ cloning_VBG Coronavirus_NN genes_NNS to_TO identify_VB and_CC isolate_VB proteins_NNS in_IN order_NN to_TO understand_VB how_WRB they_PRP bind_VBP to_IN human_JJ cell_NN receptors_NNS ._. ""_`` The_DT idea_NN is_VBZ to_TO generate_VB antibodies_NNS that_WDT hinder_VBP the_DT virus_NN penetrating_VBG into_IN human_JJ cells_NNS ._. Right_RB now_RB we_PRP are_VBP testing_VBG prototype_NN vaccines_NNS in_IN mice_NNS ._. Those_DT serums_NNS will_MD be_VB sent_VBN to_IN Holland_NNP ,_, where_WRB we_PRP will_MD test_VB the_DT antibodies_NNS ._. The_DT timelines_NNS are_VBP very_RB aggressive_JJ in_IN this_DT project_NN ,_, ""_'' says_VBZ Morten_NNP Acertoug_NNP Nielsen_NNP ,_, Associate_NN Professor_NNP of_IN Immunology_NNP and_CC Microbiology_NNP ,_, at_IN the_DT University_NNP of_IN Copenhagen_NNP ._. The_DT European_JJ funded_VBN project_NN is_VBZ just_RB one_CD of_IN many_JJ currently_RB underway_JJ in_IN Europe_NNP in_IN the_DT fight_NN against_IN the_DT coronavirus_NN ._. Working_VBG closely_RB with_IN the_DT World_NNP Health_NNP Organization_NNP ,_, the_DT European_NNP Union_NNP has_VBZ been_VBN coordinating_VBG a_DT so_RB -_HYPH called_VBN pledging_NN conference_NN to_TO tackle_VB the_DT pandemic_NN ._. Focused_VBN on_IN improving_VBG diagnosis_NN ,_, treatment_NN and_CC prevention_NN ,_, the_DT conference_NN aims_VBZ to_TO make_VB sure_JJ that_IN any_DT new_JJ medical_JJ technology_NN ,_, developed_VBN both_CC during_IN and_CC after_IN the_DT pandemic_NN ,_, is_VBZ made_VBN available_JJ to_IN all_DT ._. During_IN the_DT pledging_NN Conference_NNP ,_, the_DT European_NNP Commission_NNP announced_VBD one_CD billion_CD euros_NNS for_IN research_NN into_IN COVID_NNP -_HYPH 19_CD through_IN its_PRP$ flagship_JJ Horizon_NNP 2020_CD programme_NN ._. The_DT extra_JJ funding_NN includes_VBZ 450_CD million_CD euros_NNS for_IN treatment_NN ,_, diagnostics_NNS and_CC prevention_NN ;_, 400_CD million_CD euros_NNS for_IN R&D_NN and_CC production_NN facilities_NNS and_CC an_DT additional_JJ 150_CD million_CD euros_NNS for_IN further_JJR innovation_NN ._. In_IN addition_NN to_IN enabling_VBG a_DT greater_JJR understanding_NN of_IN the_DT virus_NN ,_, so_IN as_IN to_TO prepare_VB and_CC respond_VB better_RBR to_IN outbreaks_NNS ,_, the_DT money_NN will_MD also_RB go_VB towards_IN treatment_NN and_CC vaccines_NNS ._. ""_`` We_PRP have_VBP 48_CD projects_NNS which_WDT are_VBP up_RB and_CC running_VBG ,_, on_IN testing_NN ,_, preventing_VBG ,_, treating_VBG ,_, which_WDT allow_VBP 159_CD teams_NNS in_IN Europe_NNP ,_, in_IN fact_NN ,_, to_TO come_VB together_RB ._. Part_NN of_IN the_DT effort_NN is_VBZ also_RB investment_NN into_IN clinical_JJ trials_NNS ._. We_PRP are_VBP funding_VBG clinical_JJ trials_NNS for_IN therapies_NNS ._. At_IN the_DT same_JJ time_NN ,_, we_PRP are_VBP also_RB working_VBG quite_RB closely_RB with_IN industry_NN ._. We_PRP have_VBP an_DT existing_VBG partnership_NN called_VBN ""_`` Innovative_NNP Medicines_NNPS Initiative_NNP ""_'' ._. This_DT partnership_NN with_IN the_DT pharmaceutical_JJ industry_NN is_VBZ now_RB of_IN course_NN looking_VBG into_IN COVID_NN ,_, ""_'' explains_VBZ Jean_NNP -_HYPH Eric_NNP Paquet_NNP ,_, Director_NN -_HYPH General_NNP of_IN DG_NNP Research_NNP &_CC Innovation_NNP at_IN the_DT European_NNP Commission_NNP ._. ""_`` What_WP we_PRP are_VBP also_RB providing_VBG is_VBZ a_DT platform_NN around_IN the_DT European_NNP Open_NNP Science_NNP Cloud_NNP to_TO allow_VB researchers_NNS to_TO share_VB their_PRP$ research_NN results_NNS ,_, but_CC also_RB to_TO share_VB the_DT data_NNS of_IN those_DT results_NNS ._. And_CC this_DT is_VBZ increasingly_RB taking_VBG up_RP ,_, and_CC this_DT I_PRP think_VBP will_MD also_RB very_RB much_RB help_VB to_TO bring_VB together_RP the_DT more_RBR global_JJ efforts_NNS around_IN the_DT Science_NNP against_IN COVID_NNP -_HYPH 19_CD ,_, ""_'' he_PRP adds_VBZ ._. In_IN Rotterdam_NNP researchers_NNS taking_VBG part_NN in_IN another_DT European_JJ funded_VBN project_NN are_VBP studying_VBG to_TO see_VB if_IN antibodies_NNS offer_VBP sufficient_JJ protection_NN against_IN the_DT virus_NN ._. They_PRP say_VBP they_PRP are_VBP confident_JJ their_PRP$ research_NN will_MD eventually_RB result_VB in_IN multiple_JJ strategies_NNS to_TO fight_VB COVID_NN -_HYPH 19_CD ._. ""_`` We_PRP can_MD use_VB the_DT antibodies_NNS for_IN diagnostics_NNS ._. That_DT 's_VBZ number_NN one_CD ._. Number_NN two_CD would_MD be_VB to_TO use_VB the_DT antibodies_NNS as_IN a_DT prophylactic_NN ,_, so_RB give_VB them_PRP to_IN people_NNS who_WP are_VBP at_IN risk_NN of_IN infection_NN ,_, so_IN that_IN they_PRP do_VBP n't_RB get_VB infected_VBN ._. And_CC number_NN three_CD would_MD be_VB to_TO use_VB it_PRP as_IN a_DT therapeutic_NN to_TO treat_VB patients_NNS who_WP have_VBP been_VBN infected_VBN ,_, ""_'' says_VBZ Franck_NNP Grosveld_NNP ,_, a_DT cell_NN biologist_NN at_IN the_DT Erasmus_NNP University_NNP Medical_NNP Center_NNP ._.","In this NN of NNP the NN VBP what NNP VBZ VBG to VB NN for NN and NN in the NN against NNP - 19 . At the NNP of NNP NNS VBP VBG on a NN NN with what VBZ VBN as "" JJ NN "" . It VBZ VBG NN NNS to VB and VB NNS in NN to VB how they VBP to JJ NN NNS . "" The NN VBZ to VB NNS that VBP the NN VBG into JJ NNS . RB RB we VBP VBG NN NNS in NNS . Those NNS will VB VBN to NNP , where we will VB the NNS . The NNS VBP RB JJ in this NN , "" VBZ NNP NNP NNP , NN NNP of NNP and NNP , at the NNP of NNP . The JJ VBN NN VBZ RB one of JJ RB JJ in NNP in the NN against the NN . VBG RB with the NNP NNP NNP , the NNP NNP VBZ VBN VBG a RB - VBN NN NN to VB the NN . VBN on VBG NN , NN and NN , the NN VBZ to VB JJ that any JJ JJ NN , VBN both during and after the NN , VBZ VBN JJ to all . During the NN NNP , the NNP NNP VBD one billion NNS for NN into NNP - 19 through its JJ NNP 2020 NN . The JJ NN VBZ 450 million NNS for NN , NNS and NN ; 400 million NNS for NN and NN NNS and an JJ 150 million NNS for JJR NN . In NN to VBG a JJR NN of the NN , so as to VB and VB RBR to NNS , the NN will RB VB towards NN and NNS . "" We VBP 48 NNS which VBP RB and VBG , on NN , VBG , VBG , which VBP 159 NNS in NNP , in NN , to VB RB . NN of the NN VBZ RB NN into JJ NNS . We VBP VBG JJ NNS for NNS . At the JJ NN , we VBP RB VBG RB RB with NN . We VBP an VBG NN VBN "" NNP NNPS NNP "" . This NN with the JJ NN VBZ RB of NN VBG into NN , "" VBZ NNP - NNP NNP , NN - NNP of NNP NNP & NNP at the NNP NNP . "" What we VBP RB VBG VBZ a NN around the NNP NNP NNP NNP to VB NNS to VB their NN NNS , but RB to VB the NNS of those NNS . And this VBZ RB VBG up , and this I VBP will RB RB RB VB to VB together the RBR JJ NNS around the NNP against NNP - 19 , "" he VBZ . In NNP NNS VBG NN in another JJ VBN NN VBP VBG to VB if NNS VBP JJ NN against the NN . They VBP they VBP JJ their NN will RB VB in JJ NNS to VB NN - 19 . "" We can VB the NNS for NNS . That VBZ NN one . NN two would VB to VB the NNS as a NN , RB VB them to NNS who VBP at NN of NN , so that they VBP RB VB VBN . And NN three would VB to VB it as a NN to VB NNS who VBP VBN VBN , "" VBZ NNP NNP , a NN NN at the NNP NNP NNP NNP ."
50,1244,mainstream,"The_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP recently_RB granted_VBD an_DT “_`` emergency_NN use_NN authorization_NN ”_'' of_IN a_DT blood_NN test_NN for_IN antibodies_NNS against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT novel_JJ coronavirus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. It_PRP is_VBZ the_DT first_JJ such_JJ test_NN to_TO receive_VB approval_NN for_IN the_DT U.S._NNP market_NN ._. And_CC it_PRP comes_VBZ at_IN a_DT time_NN when_WRB health_NN experts_NNS and_CC leaders_NNS are_VBP embracing_VBG immunity_NN as_IN a_DT potential_JJ end_NN point_NN to_IN the_DT pandemic_NN ._. In_IN Colorado_NNP ,_, a_DT company_NN that_WDT makes_VBZ a_DT coronavirus_NN antibody_NN test_NN has_VBZ donated_VBN kits_NNS to_IN the_DT state_NN ’s_POS San_NNP Miguel_NNP County_NNP so_IN that_IN everyone_NN there_RB can_MD be_VB tested_VBN if_IN they_PRP want_VBP to_TO ._. And_CC in_IN Italy_NNP ,_, politicians_NNS want_VBP to_TO use_VB antibody_NN status_NN to_TO determine_VB which_WDT people_NNS will_MD get_VB “_`` back_RB to_IN work_NN ”_'' passes_NNS ._. Several_JJ ambitious_JJ surveys_NNS to_TO test_VB for_IN these_DT antibodies_NNS have_VBP now_RB been_VBN launched_VBN around_IN the_DT globe_NN ._. The_DT World_NNP Health_NNP Organization_NNP ’s_POS Solidarity_NNP II_CD study_NN will_MD pool_VB antibody_NN data_NNS from_IN more_JJR than_IN half_PDT a_DT dozen_CD countries_NNS ._. In_IN the_DT U.S._NNP ,_, a_DT collaborative_JJ multiyear_JJ project_NN aims_VBZ to_TO provide_VB a_DT picture_NN of_IN nationwide_JJ antibody_NN prevalence_NN ._. Its_PRP$ first_JJ phase_NN is_VBZ already_RB collecting_VBG samples_NNS from_IN blood_NN donors_NNS in_IN six_CD major_JJ urban_JJ areas_NNS ,_, including_VBG New_NNP York_NNP City_NNP ,_, Seattle_NNP and_CC Minneapolis_NNP ._. And_CC the_DT effort_NN will_MD evolve_VB into_IN three_CD national_JJ surveys_NNS of_IN donors_NNS ,_, supported_VBN by_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP and_CC conducted_VBN this_DT fall_NN and_CC in_IN the_DT fall_NN of_IN 2021_CD ._. Unlike_IN diagnostic_JJ tests_NNS ,_, which_WDT are_VBP used_VBN to_TO confirm_VB the_DT presence_NN and_CC sometimes_RB load_NN ,_, or_CC amount_NN ,_, of_IN the_DT virus_NN ,_, antibody_NN tests_NNS help_VBP determine_VB whether_IN or_CC not_RB someone_NN was_VBD previously_RB infected_VBN —_: even_RB if_IN that_DT person_NN never_RB showed_VBD symptoms_NNS ._. Widespread_JJ use_NN of_IN such_JJ assays_NNS could_MD give_VB scientists_NNS greater_JJR insight_NN into_IN how_WRB deadly_JJ the_DT virus_NN is_VBZ and_CC how_WRB widely_RB it_PRP has_VBZ spread_VBN throughout_IN the_DT population_NN ._. It_PRP is_VBZ less_RBR clear_JJ what_WP those_DT antibody_NN tests_NNS mean_VBP for_IN real_JJ life_NN ,_, however_RB ,_, because_IN immunity_NN functions_VBZ on_IN a_DT continuum_NN ._. With_IN some_DT pathogens_NNS ,_, such_JJ as_IN the_DT varicella_NN -_HYPH zoster_NN virus_NN (_-LRB- which_WDT causes_VBZ chicken_NN pox_NN )_-RRB- ,_, infection_NN confers_VBZ near_RB -_HYPH universal_JJ ,_, long_JJ -_HYPH lasting_VBG resistance_NN ._. Natural_JJ infection_NN with_IN Clostridium_NN tetani_NN ,_, the_DT bacterium_NN that_WDT causes_VBZ tetanus_NN ,_, on_IN the_DT other_JJ hand_NN ,_, offers_VBZ no_DT protection_NN —_: and_CC even_RB people_NNS getting_VBG vaccinated_VBN for_IN it_PRP require_VBP regular_JJ booster_NN shots_NNS ._. On_IN the_DT extreme_JJ end_NN of_IN this_DT spectrum_NN ,_, individuals_NNS infected_VBN with_IN HIV_NNP often_RB have_VBP large_JJ amounts_NNS of_IN antibodies_NNS that_WDT do_VBP nothing_NN to_TO prevent_VB or_CC clear_VB the_DT disease_NN ._. At_IN this_DT early_JJ stage_NN of_IN understanding_VBG the_DT new_JJ coronavirus_NN ,_, it_PRP is_VBZ unclear_JJ where_WRB COVID_NNP -_HYPH 19_CD falls_NNS on_IN the_DT immunity_NN spectrum_NN ._. Although_IN most_JJS people_NNS with_IN SARS_NN -_HYPH CoV_NNP -_HYPH 2_CD seem_VBP to_TO produce_VB antibodies_NNS ,_, “_`` we_PRP simply_RB do_VBP n’t_RB know_VB yet_RB what_WP it_PRP takes_VBZ to_TO be_VB effectively_RB protected_VBN from_IN this_DT infection_NN ,_, ”_'' says_VBZ Dawn_NNP Bowdish_NNP ,_, a_DT professor_NN of_IN pathology_NN and_CC molecular_JJ medicine_NN and_CC Canada_NNP Research_NNP Chair_NNP in_IN Aging_NNP and_CC Immunity_NNP at_IN McMaster_NNP University_NNP in_IN Ontario_NNP ._. Researchers_NNS are_VBP scrambling_VBG to_TO answer_VB two_CD questions_NNS :_: How_WRB long_RB do_VBP SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD antibodies_NNS stick_VB around_RB ?_. And_CC do_VBP they_PRP protect_VB against_IN reinfection_NN ?_. Early_RB on_RB ,_, some_DT people_NNS —_: most_RBS notably_RB U.K._NNP Prime_NNP Minister_NNP Boris_NNP Johnson_NNP (_-LRB- who_WP has_VBZ the_DT virus_NN and_CC is_VBZ currently_RB in_IN intensive_JJ care_NN )_-RRB- and_CC his_PRP$ government_NN ’s_POS scientific_JJ adviser_NN Patrick_NNP Vallance_NNP —_: touted_VBD hopes_NNS that_IN herd_NN immunity_NN could_MD be_VB an_DT eventual_JJ means_NN for_IN ending_VBG the_DT pandemic_NN ._. And_CC although_IN it_PRP appears_VBZ that_IN recovered_VBN COVID_NN -_HYPH 19_CD patients_NNS have_VBP antibodies_NNS for_IN at_IN least_JJS two_CD weeks_NNS ,_, long_JJ -_HYPH term_NN data_NNS are_VBP still_RB lacking_VBG ._. So_RB many_JJ scientists_NNS are_VBP looking_VBG to_IN other_JJ coronaviruses_NNS for_IN answers_NNS ._. Immunity_NN to_IN seasonal_JJ coronaviruses_NNS (_-LRB- such_JJ as_IN those_DT that_WDT cause_VBP common_JJ colds_NNS )_-RRB- ,_, for_IN example_NN ,_, starts_VBZ declining_VBG a_DT couple_NN of_IN weeks_NNS after_IN infection_NN ._. And_CC within_IN a_DT year_NN ,_, some_DT people_NNS are_VBP vulnerable_JJ to_IN reinfection_NN ._. That_DT observation_NN is_VBZ disconcerting_JJ when_WRB experts_NNS say_VBP it_PRP is_VBZ unlikely_JJ we_PRP will_MD have_VB a_DT vaccine_NN for_IN COVID_NN -_HYPH 19_CD within_IN 18_CD months_NNS ._. But_CC studies_NNS of_IN SARS_NN -_HYPH CoV_NN —_: the_DT virus_NN that_WDT causes_VBZ severe_JJ acute_JJ respiratory_JJ syndrome_NN ,_, or_CC SARS_NN ,_, which_WDT shares_VBZ a_DT considerable_JJ amount_NN of_IN its_PRP$ genetic_JJ material_NN with_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD —_: are_VBP more_RBR promising_JJ ._. Antibody_NN testing_NN shows_VBZ SARS_NNP -_HYPH CoV_NNP immunity_NN peaks_NNS at_IN around_RB four_CD months_NNS and_CC offers_VBZ protection_NN for_IN roughly_RB two_CD to_IN three_CD years_NNS ._. As_IN Preeti_NNP Malani_NNP ,_, chief_JJ health_NN officer_NN and_CC a_DT professor_NN of_IN medicine_NN at_IN the_DT University_NNP of_IN Michigan_NNP ,_, said_VBD in_IN a_DT video_NN interview_NN with_IN JAMA_NNP Editor_NNP in_IN Chief_NNP Howard_NNP Bauchner_NNP ,_, this_DT period_NN presents_VBZ “_`` a_DT pretty_RB good_JJ time_NN line_NN for_IN thinking_VBG about_IN vaccines_NNS and_CC therapeutics_NNS ”_'' for_IN COVID_NNP -_HYPH 19_CD ._. Even_RB if_IN the_DT antibodies_NNS stick_VBP around_RB in_IN the_DT body_NN ,_, however_RB ,_, it_PRP is_VBZ not_RB yet_RB certain_JJ that_IN they_PRP will_MD prevent_VB future_JJ infection_NN ._. What_WP we_PRP want_VBP ,_, Bowdish_NNP says_VBZ ,_, are_VBP neutralizing_VBG antibodies_NNS ._. These_DT are_VBP the_DT proteins_NNS that_WDT reduce_VBP and_CC prevent_VBP infection_NN by_IN binding_NN to_IN the_DT part_NN of_IN a_DT virus_NN that_WDT connects_VBZ to_IN and_CC “_`` unlocks_VBZ ”_'' host_NN cells_NNS ._. They_PRP are_VBP relatively_RB easy_JJ to_TO detect_VB ,_, and_CC they_PRP are_VBP far_RB easier_JJR for_IN vaccine_NN developers_NNS to_TO generate_VB than_IN the_DT alternative_NN :_: the_DT immune_NN system_NN ’s_POS T_NN cells_NNS ._. In_IN contrast_NN ,_, nonneutralizing_VBG antibodies_NNS still_RB recognize_VBP parts_NNS of_IN the_DT pathogen_NN ,_, but_CC they_PRP do_VBP not_RB bind_VB effectively_RB and_CC so_RB do_VBP not_RB prevent_VB it_PRP from_IN invading_VBG cells_NNS ._. “_`` If_IN humans_NNS naturally_RB make_VBP neutralizing_VBG antibodies_NNS [_-LRB- against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ]_-RRB- ,_, then_RB all_DT we_PRP have_VBP to_TO do_VB is_VBZ figure_VB out_RP what_WP [_-LRB- sites_NNS they_PRP are_VBP ]_-RRB- binding_VBG on_IN the_DT virus_NN and_CC really_RB target_VBP that_DT one_CD little_JJ piece_NN of_IN protein_NN ,_, and_CC that_DT ’s_VBZ our_PRP$ magic_NN bullet_NN ,_, ”_'' Bowdish_NNP says_VBZ ._. For_IN SARS_NNP -_, CoV_NNP -_HYPH 2_CD ,_, that_DT target_NN site_NN is_VBZ most_RBS likely_JJ on_IN the_DT so_RB -_HYPH called_VBN receptor_NN -_HYPH binding_VBG domain_NN of_IN its_PRP$ spike_NN glycoprotein_NN —_: a_DT protein_NN attached_VBN to_IN a_DT sugar_NN that_WDT the_DT virus_NN uses_VBZ to_TO enter_VB cells_NNS ._. But_CC ,_, Bowdish_NNP says_VBZ ,_, this_DT spot_NN may_MD present_VB a_DT challenge_NN because_IN human_JJ immune_NN systems_NNS are_VBP not_RB very_RB good_JJ at_IN making_VBG antibodies_NNS against_IN sugar_NN -_HYPH coated_VBN substances_NNS ._. Nevertheless_RB ,_, a_DT few_JJ small_JJ studies_NNS of_IN cells_NNS in_IN laboratory_NN dishes_NNS suggest_VBP that_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD infection_NN triggers_VBZ the_DT production_NN of_IN neutralizing_VBG antibodies_NNS ._. And_CC animal_NN studies_NNS indicate_VBP such_JJ antibodies_NNS do_VBP prevent_VB reinfection_NN ,_, at_IN least_JJS for_IN a_DT couple_NN of_IN weeks_NNS ._. Furthermore_RB ,_, because_IN some_DT antibodies_NNS seem_VBP to_TO recognize_VB and_CC react_VB to_IN the_DT spike_NN proteins_NNS on_IN multiple_JJ coronaviruses_NNS ,_, including_VBG SARS_NN -_HYPH CoV_NNP and_CC MERS_NNP -_HYPH CoV_NNP (_-LRB- the_DT virus_NN that_WDT causes_VBZ Middle_JJ East_NNP respiratory_JJ syndrome_NN ,_, or_CC MERS_NN )_-RRB- ,_, researchers_NNS can_MD build_VB on_IN knowledge_NN learned_VBN from_IN previous_JJ outbreaks_NNS ._. Research_NN on_IN real_JJ -_HYPH life_NN immunity_NN to_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ in_IN its_PRP$ preliminary_JJ stages_NNS ,_, and_CC uncertainties_NNS remain_VBP ._. One_CD study_NN found_VBD no_DT correlation_NN between_IN viral_JJ load_NN and_CC antibody_NN presence_NN ,_, leading_VBG the_DT authors_NNS to_TO question_VB the_DT antibodies_NNS ’_POS actual_JJ role_NN in_IN clearing_VBG the_DT virus_NN in_IN humans_NNS ._. In_IN addition_NN ,_, peer_NN -_HYPH reviewed_VBN research_NN on_IN SARS_NN -_HYPH CoV_NN and_CC preprint_JJ studies_NNS on_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD report_NN that_IN some_DT nonneutralizing_VBG coronavirus_NN antibodies_NNS might_MD trigger_VB a_DT harmful_JJ immune_JJ response_NN upon_IN reinfection_NN with_IN those_DT pathogens_NNS or_CC cross_NN infection_NN with_IN other_JJ coronaviruses_NNS ._. Thus_RB ,_, while_IN much_JJ of_IN the_DT emerging_VBG research_NN is_VBZ promising_JJ ,_, Bowdish_NNP cautions_VBZ against_IN using_VBG antibody_NN testing_NN to_TO drive_VB policy_NN until_IN researchers_NNS know_VBP the_DT proportion_NN of_IN COVID_NN -_HYPH 19_CD survivors_NNS who_WP are_VBP producing_VBG neutralizing_VBG antibodies_NNS ._. In_IN an_DT ideal_JJ world_NN ,_, SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD immunity_NN would_MD resemble_VB that_DT acquired_VBN by_IN children_NNS who_WP get_VBP chicken_NN pox_NN ._. Early_JJ research_NN suggests_VBZ we_PRP are_VBP in_IN for_IN a_DT much_RB more_RBR complex_JJ scenario_NN but_CC one_CD that_DT time_NN and_CC unprecedented_JJ global_JJ cooperation_NN might_MD be_VB able_JJ to_TO untangle_VB ._. Eventually_RB antibody_NN tests_NNS could_MD be_VB the_DT key_NN to_IN getting_VBG our_PRP$ lives_NNS and_CC economies_NNS back_RB on_IN track_NN ._. For_IN now_RB ,_, they_PRP promise_VBP to_TO give_VB experts_NNS ,_, officials_NNS and_CC citizens_NNS a_DT clearer_JJR picture_NN of_IN the_DT pandemic_NN ._. Read_VB more_JJR about_IN the_DT coronavirus_NN outbreak_NN here_RB ._.","The NNP NNP and NNP NNP RB VBD an “ NN NN NN ” of a NN NN for NNS against NNP - NNP - 2 , the JJ NN that VBZ NN - 19 . It VBZ the JJ JJ NN to VB NN for the NNP NN . And it VBZ at a NN when NN NNS and NNS VBP VBG NN as a JJ NN NN to the NN . In NNP , a NN that VBZ a NN NN NN VBZ VBN NNS to the NN ’s NNP NNP NNP so that NN RB can VB VBN if they VBP to . And in NNP , NNS VBP to VB NN NN to VB which NNS will VB “ RB to NN ” NNS . JJ JJ NNS to VB for these NNS VBP RB VBN VBN around the NN . The NNP NNP NNP ’s NNP II NN will VB NN NNS from JJR than half a dozen NNS . In the NNP , a JJ JJ NN VBZ to VB a NN of JJ NN NN . Its JJ NN VBZ RB VBG NNS from NN NNS in six JJ JJ NNS , VBG NNP NNP NNP , NNP and NNP . And the NN will VB into three JJ NNS of NNS , VBN by the NNPS for NNP NNP and NNP and VBN this NN and in the NN of 2021 . Unlike JJ NNS , which VBP VBN to VB the NN and RB NN , or NN , of the NN , NN NNS VBP VB whether or RB NN VBD RB VBN — RB if that NN RB VBD NNS . JJ NN of JJ NNS could VB NNS JJR NN into how JJ the NN VBZ and how RB it VBZ VBN throughout the NN . It VBZ RBR JJ what those NN NNS VBP for JJ NN , RB , because NN VBZ on a NN . With some NNS , JJ as the NN - NN NN ( which VBZ NN NN ) , NN VBZ RB - JJ , JJ - VBG NN . JJ NN with NN NN , the NN that VBZ NN , on the JJ NN , VBZ no NN — and RB NNS VBG VBN for it VBP JJ NN NNS . On the JJ NN of this NN , NNS VBN with NNP RB VBP JJ NNS of NNS that VBP NN to VB or VB the NN . At this JJ NN of VBG the JJ NN , it VBZ JJ where NNP - 19 NNS on the NN NN . Although JJS NNS with NN - NNP - 2 VBP to VB NNS , “ we RB VBP RB VB RB what it VBZ to VB RB VBN from this NN , ” VBZ NNP NNP , a NN of NN and JJ NN and NNP NNP NNP in NNP and NNP at NNP NNP in NNP . NNS VBP VBG to VB two NNS : How RB VBP NNP - NNP - 2 NNS VB RB ? And VBP they VB against NN ? RB RB , some NNS — RBS RB NNP NNP NNP NNP NNP ( who VBZ the NN and VBZ RB in JJ NN ) and his NN ’s JJ NN NNP NNP — VBD NNS that NN NN could VB an JJ NN for VBG the NN . And although it VBZ that VBN NN - 19 NNS VBP NNS for at JJS two NNS , JJ - NN NNS VBP RB VBG . RB JJ NNS VBP VBG to JJ NNS for NNS . NN to JJ NNS ( JJ as those that VBP JJ NNS ) , for NN , VBZ VBG a NN of NNS after NN . And within a NN , some NNS VBP JJ to NN . That NN VBZ JJ when NNS VBP it VBZ JJ we will VB a NN for NN - 19 within 18 NNS . But NNS of NN - NN — the NN that VBZ JJ JJ JJ NN , or NN , which VBZ a JJ NN of its JJ NN with NN - NN - 2 — VBP RBR JJ . NN NN VBZ NNP - NNP NN NNS at RB four NNS and VBZ NN for RB two to three NNS . As NNP NNP , JJ NN NN and a NN of NN at the NNP of NNP , VBD in a NN NN with NNP NNP in NNP NNP NNP , this NN VBZ “ a RB JJ NN NN for VBG about NNS and NNS ” for NNP - 19 . RB if the NNS VBP RB in the NN , RB , it VBZ RB RB JJ that they will VB JJ NN . What we VBP , NNP VBZ , VBP VBG NNS . These VBP the NNS that VBP and VBP NN by NN to the NN of a NN that VBZ to and “ VBZ ” NN NNS . They VBP RB JJ to VB , and they VBP RB JJR for NN NNS to VB than the NN : the NN NN ’s NN NNS . In NN , VBG NNS RB VBP NNS of the NN , but they VBP RB VB RB and RB VBP RB VB it from VBG NNS . “ If NNS RB VBP VBG NNS [ against NNP - NNP - 2 ] , RB all we VBP to VB VBZ VB out what [ NNS they VBP ] VBG on the NN and RB VBP that one JJ NN of NN , and that VBZ our NN NN , ” NNP VBZ . For NNP - NNP - 2 , that NN NN VBZ RBS JJ on the RB - VBN NN - VBG NN of its NN NN — a NN VBN to a NN that the NN VBZ to VB NNS . But , NNP VBZ , this NN may VB a NN because JJ NN NNS VBP RB RB JJ at VBG NNS against NN - VBN NNS . RB , a JJ JJ NNS of NNS in NN NNS VBP that NN - NN - 2 NN VBZ the NN of VBG NNS . And NN NNS VBP JJ NNS VBP VB NN , at JJS for a NN of NNS . RB , because some NNS VBP to VB and VB to the NN NNS on JJ NNS , VBG NN - NNP and NNP - NNP ( the NN that VBZ JJ NNP JJ NN , or NN ) , NNS can VB on NN VBN from JJ NNS . NN on JJ - NN NN to NNP - NNP - 2 VBZ in its JJ NNS , and NNS VBP . One NN VBD no NN between JJ NN and NN NN , VBG the NNS to VB the NNS ’ JJ NN in VBG the NN in NNS . In NN , NN - VBN NN on NN - NN and JJ NNS on NN - NN - 2 NN that some VBG NN NNS might VB a JJ JJ NN upon NN with those NNS or NN NN with JJ NNS . RB , while JJ of the VBG NN VBZ JJ , NNP VBZ against VBG NN NN to VB NN until NNS VBP the NN of NN - 19 NNS who VBP VBG VBG NNS . In an JJ NN , NNP - NNP - 2 NN would VB that VBN by NNS who VBP NN NN . JJ NN VBZ we VBP in for a RB RBR JJ NN but one that NN and JJ JJ NN might VB JJ to VB . RB NN NNS could VB the NN to VBG our NNS and NNS RB on NN . For RB , they VBP to VB NNS , NNS and NNS a JJR NN of the NN . VB JJR about the NN NN RB ."
51,1108,mainstream,"Pfizer_NNP says_VBZ it_PRP will_MD begin_VB testing_VBG the_DT experimental_JJ vaccine_NN in_IN the_DT United_NNP States_NNPS as_RB early_RB as_IN next_JJ week_NN ,_, and_CC says_VBZ a_DT vaccine_NN could_MD be_VB ready_JJ for_IN emergency_NN use_NN in_IN the_DT fall_NN ,_, the_DT Wall_NNP Street_NNP Journal_NNP reported_VBD on_IN Tuesday_NNP ._. Mainz_NNP -_HYPH based_VBN BioNTech_NNP reported_VBD that_IN the_DT first_JJ cohort_NN of_IN participants_NNS had_VBD been_VBN given_VBN doses_NNS of_IN the_DT potential_JJ vaccine_NN ,_, BNT162_NNP ,_, in_IN a_DT Phase_NN 1/2_CD clinical_JJ study_NN in_IN Germany_NNP ._. ""_`` Twelve_CD study_NN participants_NNS have_VBP been_VBN vaccinated_VBN with_IN the_DT vaccine_NN candidate_NN BNT162_NNP in_IN Germany_NNP since_IN the_DT start_NN of_IN the_DT study_NN on_IN April_NNP 23_CD ,_, 2020_CD ,_, ""_'' the_DT company_NN said_VBD in_IN a_DT statement_NN ._. No_DT information_NN on_IN the_DT results_NNS is_VBZ currently_RB available_JJ ._. BioNTech_NNP said_VBD around_RB 200_CD healthy_JJ volunteers_NNS aged_JJ 18_CD to_IN 55_CD years_NNS old_JJ would_MD be_VB given_VBN doses_NNS ranging_VBG from_IN 1µg_NN (_-LRB- microgram_NN )_-RRB- to_IN 100µg_CD to_TO find_VB the_DT optimal_JJ dose_NN for_IN further_JJR studies_NNS ._. ""_`` In_IN addition_NN ,_, the_DT safety_NN and_CC immunogenicity_NN of_IN the_DT vaccine_NN will_MD be_VB investigated_VBN ,_, ""_'' added_VBD the_DT biotech_NN company_NN ._. Pfizer_NNP and_CC BioNTech_NNP plan_VBP to_TO initiate_VB trials_NNS for_IN BNT162_NNP in_IN the_DT US_NNP on_IN regulatory_JJ approval_NN ,_, expected_VBN shortly_RB ,_, the_DT statement_NN said_VBD ._. Some_DT anti-vaxxers_NNS are_VBP changing_VBG their_PRP$ minds_NNS because_IN of_IN the_DT coronavirus_NN pandemic_NN The_DT German_JJ Federal_NNP Institute_NNP for_IN Vaccines_NNPS and_CC Biomedical_NNP Drugs_NNPS approved_VBD the_DT trial_NN --_, the_DT country_NN 's_POS first_JJ clinical_JJ trial_NN for_IN a_DT vaccine_NN against_IN Covid_NNP 19_CD --_, on_IN April_NNP 22_CD ._. ""_`` The_DT two_CD companies_NNS plan_VBP to_TO jointly_RB conduct_VB clinical_JJ trials_NNS for_IN the_DT COVID_NNP -_HYPH 19_CD vaccine_NN candidates_NNS initially_RB in_IN Europe_NNP and_CC the_DT U.S._NNP ,_, across_IN multiple_JJ research_NN sites_NNS ,_, ""_'' Pfizer_NNP announced_VBD in_IN its_PRP$ first_JJ quarter_NN report_NN ,_, published_VBN online_RB Tuesday_NNP ._. ""_`` The_DT companies_NNS estimate_VBP that_IN there_EX is_VBZ potential_NN to_TO supply_VB millions_NNS of_IN vaccine_NN doses_NNS by_IN the_DT end_NN of_IN 2020_CD ,_, subject_JJ to_IN technical_JJ success_NN of_IN the_DT development_NN program_NN and_CC approval_NN by_IN regulatory_JJ authorities_NNS ,_, and_CC the_DT potential_NN to_TO rapidly_RB scale_VB up_RP the_DT capacity_NN to_TO produce_VB hundreds_NNS of_IN millions_NNS of_IN doses_NNS in_IN 2021_CD ._. ""_'' Pfizer_NNP is_VBZ n't_RB the_DT only_JJ group_NN with_IN a_DT potential_JJ Covid_NNP -_HYPH 19_CD vaccine_NN in_IN the_DT works_NNS ._. Last_JJ week_NN ,_, scientists_NNS at_IN Oxford_NNP University_NNP 's_POS Jenner_NNP Institute_NNP in_IN the_DT United_NNP Kingdom_NNP began_VBD testing_VBG its_PRP$ vaccine_NN on_IN humans_NNS Thursday_NNP and_CC ,_, depending_VBG on_IN the_DT trial_NN results_NNS ,_, could_MD be_VB ready_JJ as_RB early_RB as_IN September_NNP ._. Officials_NNS say_VBP that_IN more_JJR than_IN a_DT half_NN -_HYPH dozen_CD vaccine_NN programs_NNS are_VBP in_IN the_DT clinical_JJ trial_NN phase_NN and_CC more_JJR than_IN 80_CD are_VBP in_IN preliminary_JJ phases_NNS ._.","NNP VBZ it will VB VBG the JJ NN in the NNP NNPS RB RB as JJ NN , and VBZ a NN could VB JJ for NN NN in the NN , the NNP NNP NNP VBD on NNP . NNP - VBN NNP VBD that the JJ NN of NNS VBD VBN VBN NNS of the JJ NN , NNP , in a NN 1/2 JJ NN in NNP . "" Twelve NN NNS VBP VBN VBN with the NN NN NNP in NNP since the NN of the NN on NNP 23 , 2020 , "" the NN VBD in a NN . No NN on the NNS VBZ RB JJ . NNP VBD RB 200 JJ NNS JJ 18 to 55 NNS JJ would VB VBN NNS VBG from NN ( NN ) to 100µg to VB the JJ NN for JJR NNS . "" In NN , the NN and NN of the NN will VB VBN , "" VBD the NN NN . NNP and NNP VBP to VB NNS for NNP in the NNP on JJ NN , VBN RB , the NN VBD . Some NNS VBP VBG their NNS because of the NN NN The JJ NNP NNP for NNPS and NNP NNPS VBD the NN -- the NN 's JJ JJ NN for a NN against NNP 19 -- on NNP 22 . "" The two NNS VBP to RB VB JJ NNS for the NNP - 19 NN NNS RB in NNP and the NNP , across JJ NN NNS , "" NNP VBD in its JJ NN NN , VBN RB NNP . "" The NNS VBP that there VBZ NN to VB NNS of NN NNS by the NN of 2020 , JJ to JJ NN of the NN NN and NN by JJ NNS , and the NN to RB VB up the NN to VB NNS of NNS of NNS in 2021 . "" NNP VBZ RB the JJ NN with a JJ NNP - 19 NN in the NNS . JJ NN , NNS at NNP NNP 's NNP NNP in the NNP NNP VBD VBG its NN on NNS NNP and , VBG on the NN NNS , could VB JJ RB RB as NNP . NNS VBP that JJR than a NN - dozen NN NNS VBP in the JJ NN NN and JJR than 80 VBP in JJ NNS ."
52,896,mainstream,"Twenty_CD years_NNS ago_RB one_CD of_IN the_DT most_RBS serious_JJ public_JJ health_NN scandals_NNS of_IN the_DT 20th_JJ century_NN emerged_VBD –_: when_WRB the_DT British_JJ doctor_NN Andrew_NNP Wakefield_NNP published_VBD a_DT paper_NN in_IN the_DT medical_JJ journal_NN ,_, The_DT Lancet_NNP ._. It_PRP suggested_VBD there_EX was_VBD a_DT link_NN between_IN MMR_NNP -_, the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN -_, and_CC autism_NN ._. His_PRP$ work_NN would_MD be_VB later_RBR completely_RB discredited_VBN as_IN “_`` an_DT elaborate_JJ fraud_NN ”_'' and_CC retracted_VBN ._. Wakefield_NNP himself_PRP was_VBD struck_VBN off_IN the_DT medical_JJ register_NN in_IN the_DT UK_NNP ._. But_CC the_DT ripples_NNS surrounding_VBG his_PRP$ claims_NNS are_VBP still_RB being_VBG felt_VBN all_RB over_IN the_DT world_NN –_: as_IN anti-vaccine_NN movements_NNS continue_VBP to_TO drive_VB down_RP inoculation_NN rates_NNS ,_, particularly_RB in_IN developed_JJ countries_NNS ._. The_DT result_NN has_VBZ been_VBN outbreaks_NNS of_IN measles_NNS in_IN Europe_NNP and_CC the_DT United_NNP states_NNPS –_: where_WRB it_PRP was_VBD once_RB almost_RB eradicated_VBN ._. The_DT scandal_NN also_RB played_VBD a_DT key_JJ role_NN in_IN undermining_VBG trust_NN in_IN science_NN ._. Polio_NNP is_VBZ on_IN the_DT brink_NN of_IN extinction_NN –_: but_CC a_DT fake_JJ vaccination_NN campaign_NN set_VBN up_RP to_TO enable_VB the_DT assassination_NN of_IN Osama_NNP bin_NNP Laden_NNP undermined_VBD these_DT efforts_NNS and_CC trust_NN in_IN key_JJ communities_NNS ,_, as_IN Adam_NNP Rutherford_NNP explains_VBZ in_IN this_DT special_JJ edition_NN of_IN Health_NNP Check_NNP ._.","Twenty NNS RB one of the RBS JJ JJ NN NNS of the JJ NN VBD – when the JJ NN NNP NNP VBD a NN in the JJ NN , The NNP . It VBD there VBD a NN between NNP - the NNS , NNS and NN NN - and NN . His NN would VB RBR RB VBN as “ an JJ NN ” and VBN . NNP himself VBD VBN off the JJ NN in the NNP . But the NNS VBG his NNS VBP RB VBG VBN RB over the NN – as NN NNS VBP to VB down NN NNS , RB in JJ NNS . The NN VBZ VBN NNS of NNS in NNP and the NNP NNPS – where it VBD RB RB VBN . The NN RB VBD a JJ NN in VBG NN in NN . NNP VBZ on the NN of NN – but a JJ NN NN VBN up to VB the NN of NNP NNP NNP VBD these NNS and NN in JJ NNS , as NNP NNP VBZ in this JJ NN of NNP NNP ."
53,480,mainstream,"Elena_NNP Conis’_NNP Vaccine_NNP Nation_NNP examines_VBZ the_DT changing_VBG perceptions_NNS of_IN vaccines_NNS in_IN the_DT United_NNP States_NNPS ._. In_IN the_DT early_JJ 1960s_NNS ,_, vaccines_NNS were_VBD held_VBN in_IN great_JJ confidence_NN by_IN the_DT public_NN ,_, and_CC scientists_NNS hoped_VBD that_IN vaccines_NNS could_MD be_VB used_VBN to_TO eradicate_VB common_JJ childhood_NN diseases_NNS such_JJ as_IN mumps_NNS and_CC rubella_NN ._. Yet_CC this_DT optimism_NN soon_RB gave_VBD way_NN as_IN critiques_NNS of_IN vaccination_NN became_VBD increasingly_RB popular_JJ ._. Conis_NNP traces_VBZ the_DT disparate_JJ influences_NNS of_IN environmentalism_NN ,_, feminism_NN ,_, and_CC cultural_JJ politics_NNS in_IN creating_VBG an_DT anti-vaccination_JJ movement_NN Conis_NNP begins_VBZ the_DT book_NN in_IN the_DT Kennedy_NNP Administration_NNP after_IN briefly_RB reviewing_VBG the_DT successful_JJ vaccination_NN campaigns_NNS aimed_VBN at_IN polio_NN and_CC smallpox_NN ._. Kennedy_NNP and_CC other_JJ lawmakers_NNS saw_VBD federal_JJ involvement_NN with_IN the_DT 1962_CD Vaccination_NNP Assistance_NNP Act_NNP as_IN a_DT cost_NN -_HYPH effective_JJ way_NN to_TO improve_VB public_JJ health_NN (_-LRB- 20_CD )_-RRB- ._. Vaccination_NN also_RB played_VBD into_IN concerns_NNS about_IN national_JJ security_NN :_: improving_VBG the_DT health_NN of_IN American_JJ children_NNS was_VBD critical_JJ at_IN a_DT time_NN when_WRB a_DT fifth_NN of_IN applicants_NNS to_IN the_DT U.S._NNP military_NN were_VBD being_VBG rejected_VBN (_-LRB- 27_CD )_-RRB- ._. More_RBR serious_JJ diseases_NNS such_JJ as_IN polio_NN and_CC smallpox_NN were_VBD disappearing_VBG or_CC had_VBD already_RB been_VBN eradicated_VBN in_IN the_DT United_NNP States_NNPS ,_, and_CC now_RB federal_JJ attention_NN was_VBD turned_VBN to_IN so_RB -_HYPH called_VBN dirty_JJ diseases_NNS such_JJ as_IN measles_NNS ._. Modern_JJ confidence_NN in_IN science_NN was_VBD such_JJ that_IN many_JJ believed_VBD these_DT older_JJR diseases_NNS could_MD and_CC should_MD be_VB eradicated_VBN ._. Conis_NNP writes_VBZ ,_, “_`` Nature_NNP was_VBD something_NN to_TO be_VB overcome_VBN with_IN technological_JJ breakthroughs_NNS and_CC scientific_JJ expertise_NN ”_'' (_-LRB- 54_CD )_-RRB- ._. Yet_CC doctors_NNS were_VBD n’t_RB in_IN lockstep_NN regarding_VBG the_DT benefits_NNS of_IN vaccines_NNS ,_, especially_RB regarding_VBG mumps_NNS ,_, which_WDT was_VBD regarded_VBN as_IN a_DT harmless_JJ and_CC comical_JJ disease_NN of_IN childhood_NN ._. These_DT diseases_NNS ,_, once_RB understood_VBN as_IN an_DT inescapable_JJ fact_NN of_IN childhood_NN ,_, were_VBD now_RB targeted_VBN because_IN of_IN the_DT damage_NN they_PRP could_MD to_TO do_VB a_DT young_JJ child_NN ’s_POS development_NN (_-LRB- 52_CD )_-RRB- ._. Vaccine_NN manufacturers_NNS such_JJ as_IN Merck_NNP expounded_VBD on_IN the_DT threat_NN that_IN these_DT diseases_NNS could_MD pose_VB ,_, such_JJ as_IN the_DT risk_NN of_IN sterility_NN from_IN mumps_NNS ._. Vaccine_NN manufacturers_NNS and_CC public_JJ health_NN officials_NNS pushed_VBD the_DT vaccine_NN as_IN part_NN of_IN responsible_JJ parenthood_NN ,_, especially_RB after_IN a_DT combined_VBN measles_NNS ,_, mumps_NNS ,_, and_CC rubella_NN vaccine_NN became_VBD available_JJ ._. While_IN mumps_NNS was_VBD never_RB fully_RB eradicated_VBN ,_, by_IN 1985_CD there_EX were_VBD just_RB 3,000_CD cases_NNS in_IN the_DT U.S._NNP ,_, down_RB by_IN 98_CD %_NN from_IN 1968_CD ._. The_DT next_JJ major_JJ federal_JJ push_NN for_IN immunization_NN came_VBD during_IN the_DT Carter_NNP Administration_NNP as_IN the_DT Childhood_NNP Immunization_NNP Initiative_NNP ._. Rather_RB than_IN relying_VBG on_IN the_DT federal_JJ government_NN to_TO immunize_VB children_NNS ,_, Carter_NNP used_VBD celebrities_NNS ,_, PTAs_NNS ,_, corporate_JJ leaders_NNS ,_, and_CC governors_NNS to_TO force_VB states_NNS to_TO tighten_VB their_PRP$ vaccination_NN laws_NNS combined_VBN with_IN parental_JJ education_NN campaigns_NNS to_TO push_VB vaccination_NN rates_NNS up_RP ._. It_PRP was_VBD a_DT cost_NN -_HYPH saving_VBG measure_NN that_IN Conis_NNP asserts_VBZ reflected_VBD the_DT general_JJ philosophy_NN of_IN Carter_NNP and_CC his_PRP$ administration_NN ,_, which_WDT favored_VBD decentralized_VBN control_NN over_IN medicine_NN and_CC a_DT reduced_VBN federal_JJ presence_NN (_-LRB- 88_CD )_-RRB- ._. Carter_NNP ’s_POS initiative_NN also_RB reflected_VBD changing_VBG American_JJ concerns_NNS with_IN healthcare_NN ._. Health_NN care_NN costs_NNS were_VBD rising_VBG precipitously_RB ._. In_IN Carter_NNP ’s_POS view_NN ,_, a_DT major_JJ part_NN of_IN the_DT problem_NN was_VBD that_IN few_JJ Americans_NNPS seriously_RB tried_VBD to_TO prevent_VB serious_JJ diseases_NNS before_IN they_PRP happened_VBD ._. Responsible_JJ parents_NNS needed_VBD to_TO be_VB active_JJ in_IN protecting_VBG their_PRP$ children_NNS with_IN immunization_NN ._. Pushing_VBG vaccination_NN as_IN a_DT way_NN to_TO keep_VB health_NN care_NN costs_NNS low_JJ was_VBD a_DT less_RBR -_HYPH expensive_JJ way_NN to_TO tackle_VB the_DT larger_JJR problem_NN ._. Carter_NNP ’s_POS initiative_NN was_VBD the_DT high_JJ -_HYPH water_NN mark_NN of_IN public_JJ confidence_NN in_IN vaccination_NN ,_, and_CC by_IN 1980_CD 96_CD %_NN of_IN children_NNS were_VBD being_VBG immunized_VBN against_IN measles_NNS ,_, mumps_NNS ,_, rubella_NN ,_, pertussis_NN ,_, and_CC other_JJ diseases_NNS ._. At_IN the_DT same_JJ time_NN ,_, several_JJ disparate_JJ cultural_JJ movements_NNS posed_VBD new_JJ challenges_NNS to_IN public_JJ confidence_NN in_IN vaccination_NN ._. Second_JJ -_HYPH wave_NN feminism_NN was_VBD one_CD such_JJ movement_NN ._. As_IN caregivers_NNS ,_, women_NNS traditionally_RB bore_VBP the_DT burden_NN of_IN overseeing_VBG vaccinations_NNS ._. Yet_CC second_JJ -_HYPH wave_NN feminism_NN challenged_VBD the_DT patriarchal_JJ nature_NN of_IN medicine_NN by_IN trying_VBG to_TO give_VB women_NNS agency_NN over_IN women_NNS ’s_POS health_NN issues_NNS (_-LRB- 114_CD )_-RRB- ._. Magazines_NNS such_JJ as_IN Mothering_NNP urged_VBD women_NNS to_TO be_VB cautious_JJ with_IN the_DT measles_NN vaccine_NN ,_, for_IN example_NN ,_, because_IN the_DT vaccine_NN could_MD sicken_VB those_DT allergic_JJ to_IN eggs_NNS ._. When_WRB women_NNS expressed_VBD concerns_NNS about_IN complications_NNS from_IN the_DT pertussis_NN vaccine_NN ,_, doctors_NNS brushed_VBD them_PRP aside_RP ._. The_DT effect_NN was_VBD that_IN women_NNS increasingly_RB questioned_VBD the_DT utility_NN of_IN vaccinations_NNS ,_, especially_RB in_IN their_PRP$ role_NN as_IN a_DT responsible_JJ parent_NN ._. The_DT burgeoning_JJ environmental_JJ movement_NN also_RB posed_VBD a_DT challenge_NN ,_, as_IN environmental_JJ concerns_NNS clashed_VBD with_IN the_DT scientific_JJ triumphalism_NN of_IN the_DT 1960s_NNS ._. Even_RB in_IN the_DT nineteenth_JJ century_NN ,_, some_DT people_NNS had_VBD feared_VBN that_IN vaccines_NNS transmitted_VBN poisons_NNS or_CC animal_NN matter_NN into_IN the_DT human_JJ body_NN (_-LRB- 133_CD )_-RRB- ._. Rachel_NNP Carson_NNP ’s_POS Silent_NNP Spring_NNP ushered_VBD in_IN new_JJ fears_NNS of_IN radiation_NN and_CC heavy_JJ metals_NNS in_IN the_DT environment_NN ,_, and_CC critics_NNS of_IN vaccination_NN would_MD frequently_RB compare_VB vaccines_NNS with_IN environmental_JJ pollutants_NNS ._. By_IN the_DT early_JJ 1990s_NNS ,_, authors_NNS such_JJ as_IN Harris_NNP Coulter_NNP were_VBD proposing_VBG that_IN vaccinations_NNS were_VBD responsible_JJ for_IN psychiatric_JJ disturbances_NNS ,_, including_VBG the_DT behavior_NN of_IN serial_JJ killer_NN Ted_NNP Bundy_NNP (_-LRB- 148_CD )_-RRB- ._. In_IN the_DT view_NN of_IN environmentalists_NNS ,_, nature_NN had_VBD an_DT intrinsic_JJ value_NN ,_, and_CC it_PRP was_VBD better_JJR to_TO let_VB nature_NN run_VB its_PRP$ course_NN with_IN diseases_NNS like_IN the_DT chicken_NN pox_NN ._. The_DT hepatitis_NN B_NN vaccine_NN was_VBD developed_VBN in_IN 1982_CD ,_, largely_RB to_TO immunize_VB health_NN care_NN workers_NNS ._. At_IN that_DT time_NN ,_, the_DT disease_NN barely_RB existed_VBD in_IN the_DT public_JJ imagination_NN (_-LRB- 182_CD )_-RRB- ._. Yet_CC concern_NN about_IN the_DT disease_NN grew_VBD throughout_IN the_DT ‘_`` 90s_NNS ,_, and_CC officials_NNS hoped_VBD to_TO vaccinate_VB schoolchildren_NNS to_TO eradicate_VB the_DT disease_NN ._. The_DT vaccinations_NNS proved_VBD to_TO be_VB deeply_RB divisive_JJ and_CC set_VBD off_RP fears_NNS over_IN the_DT vaccines_NNS ’_POS safety_NN and_CC the_DT moral_JJ imperative_NN to_TO vaccinate_VB children_NNS for_IN a_DT disease_NN spread_VBN by_IN “_`` adult_NN ”_'' behavior_NN ._. In_IN the_DT early_JJ 2000s_NN ,_, vaccine_NN -_HYPH safety_NN advocates_NNS stoked_VBD fears_NNS that_IN vaccines_NNS were_VBD causing_VBG autism_NN ._. While_IN the_DT evidence_NN was_VBD widely_RB debunked_VBN by_IN scientists_NNS ,_, news_NN media_NN seized_VBD on_IN one_CD aspect_NN of_IN the_DT story_NN :_: the_DT misinformed_VBN ,_, irrational_JJ parent_NN who_WP refused_VBD to_TO get_VB their_PRP$ kids_NNS vaccinated_VBN (_-LRB- 223_CD )_-RRB- ._. This_DT perspective_NN greatly_RB oversimplified_VBD the_DT debate_NN ,_, Conis_NNP argues_VBZ ,_, by_IN eliminating_VBG any_DT discussion_NN around_IN side_NN -_HYPH effects_NNS from_IN vaccination_NN or_CC dealing_VBG with_IN barriers_NNS created_VBN by_IN poverty_NN and_CC the_DT health_NN care_NN system_NN ._. The_DT author_NN ends_VBZ the_DT book_NN with_IN a_DT discussion_NN of_IN the_DT human_JJ papillomavirus_NN (_-LRB- HPV_NN )_-RRB- vaccine_NN ._. HPV_NNP went_VBD from_IN being_VBG a_DT disease_NN that_IN only_RB a_DT few_JJ people_NNS had_VBD heard_VBN of_IN to_IN a_DT leading_VBG cause_NN of_IN cervical_JJ cancer_NN ._. The_DT vaccine_NN sparked_VBD a_DT large_JJ debate_NN over_IN the_DT vaccination_NN of_IN school_NN -_HYPH age_NN girls_NNS ,_, ranging_VBG from_IN concerns_NNS over_IN teenage_JJ sexuality_NN to_IN safety_NN concerns_NNS as_RB well_RB as_IN intrusion_NN by_IN public_JJ health_NN officials_NNS ._. Teenaged_JJ girls_NNS also_RB had_VBD a_DT voice_NN in_IN this_DT discussion_NN ,_, as_IN emerging_VBG social_JJ media_NN meant_VBD that_IN adolescents_NNS could_MD offer_VB their_PRP$ own_JJ insights_NNS ._. The_DT book_NN is_VBZ about_IN two_CD separate_JJ but_CC connected_VBN narratives_NNS :_: the_DT development_NN of_IN various_JJ vaccines_NNS and_CC the_DT creation_NN of_IN a_DT public_JJ forum_NN in_IN which_WDT they_PRP can_MD be_VB debated_VBN ._. At_IN the_DT start_NN of_IN the_DT book_NN ,_, scientists_NNS and_CC politicians_NNS effectively_RB own_VBP and_CC control_VBP the_DT debate_NN ._. Some_DT figures_NNS on_IN the_DT political_JJ fringe_NN question_VBP the_DT efficacy_NN or_CC use_NN of_IN vaccines_NNS ,_, but_CC their_PRP$ voices_NNS are_VBP largely_RB discounted_VBN ._. By_IN the_DT end_NN of_IN the_DT book_NN ,_, public_JJ opinion_NN is_VBZ an_DT essential_JJ part_NN of_IN policy_NN ,_, and_CC policy_NN is_VBZ consistently_RB framed_VBN around_IN what_WP is_VBZ “_`` responsible_JJ parenthood_NN ._. ”_'' As_IN more_JJR voices_NNS entered_VBD the_DT debate_NN ,_, what_WP exactly_RB made_VBD a_DT responsible_JJ parent_NN became_VBD a_DT heavily_RB debated_VBN and_CC divisive_JJ topic_NN ._. AIDS_NN and_CC the_DT failure_NN to_TO create_VB an_DT AIDS_NNP vaccine_NN is_VBZ strangely_RB absent_JJ from_IN this_DT narrative_NN and_CC would_MD have_VB been_VBN interesting_JJ to_TO use_VB in_IN examining_VBG the_DT public_JJ attitudes_NNS toward_IN vaccination_NN ._. Much_JJ of_IN the_DT book_NN is_VBZ about_IN the_DT public_NN ’s_POS increasing_VBG distrust_NN of_IN expert_NN advice_NN ._. The_DT AIDS_NNP epidemic_NN in_IN the_DT 1980s_NNS was_VBD made_VBN worse_JJR by_IN a_DT delayed_VBN federal_JJ response_NN as_RB well_RB as_IN the_DT failure_NN to_TO develop_VB a_DT vaccine_NN ,_, which_WDT has_VBZ fed_VBN into_IN popular_JJ distrust_NN of_IN public_JJ health_NN officials_NNS ._. Nevertheless_RB ,_, this_DT is_VBZ an_DT interesting_JJ and_CC engaging_JJ book_NN ,_, one_CD which_WDT presents_VBZ a_DT balanced_VBN portrait_NN of_IN debates_NNS about_IN vaccines_NNS without_IN leaving_VBG behind_IN the_DT perspective_NN of_IN scientists_NNS and_CC doctors_NNS ._.","NNP NNP NNP NNP VBZ the VBG NNS of NNS in the NNP NNPS . In the JJ NNS , NNS VBD VBN in JJ NN by the NN , and NNS VBD that NNS could VB VBN to VB JJ NN NNS JJ as NNS and NN . Yet this NN RB VBD NN as NNS of NN VBD RB JJ . NNP VBZ the JJ NNS of NN , NN , and JJ NNS in VBG an JJ NN NNP VBZ the NN in the NNP NNP after RB VBG the JJ NN NNS VBN at NN and NN . NNP and JJ NNS VBD JJ NN with the 1962 NNP NNP NNP as a NN - JJ NN to VB JJ NN ( 20 ) . NN RB VBD into NNS about JJ NN : VBG the NN of JJ NNS VBD JJ at a NN when a NN of NNS to the NNP NN VBD VBG VBN ( 27 ) . RBR JJ NNS JJ as NN and NN VBD VBG or VBD RB VBN VBN in the NNP NNPS , and RB JJ NN VBD VBN to RB - VBN JJ NNS JJ as NNS . JJ NN in NN VBD JJ that JJ VBD these JJR NNS could and should VB VBN . NNP VBZ , “ NNP VBD NN to VB VBN with JJ NNS and JJ NN ” ( 54 ) . Yet NNS VBD RB in NN VBG the NNS of NNS , RB VBG NNS , which VBD VBN as a JJ and JJ NN of NN . These NNS , RB VBN as an JJ NN of NN , VBD RB VBN because of the NN they could to VB a JJ NN ’s NN ( 52 ) . NN NNS JJ as NNP VBD on the NN that these NNS could VB , JJ as the NN of NN from NNS . NN NNS and JJ NN NNS VBD the NN as NN of JJ NN , RB after a VBN NNS , NNS , and NN NN VBD JJ . While NNS VBD RB RB VBN , by 1985 there VBD RB 3,000 NNS in the NNP , RB by 98 NN from 1968 . The JJ JJ JJ NN for NN VBD during the NNP NNP as the NNP NNP NNP . RB than VBG on the JJ NN to VB NNS , NNP VBD NNS , NNS , JJ NNS , and NNS to VB NNS to VB their NN NNS VBN with JJ NN NNS to VB NN NNS up . It VBD a NN - VBG NN that NNP VBZ VBD the JJ NN of NNP and his NN , which VBD VBN NN over NN and a VBN JJ NN ( 88 ) . NNP ’s NN RB VBD VBG JJ NNS with NN . NN NN NNS VBD VBG RB . In NNP ’s NN , a JJ NN of the NN VBD that JJ NNPS RB VBD to VB JJ NNS before they VBD . JJ NNS VBD to VB JJ in VBG their NNS with NN . VBG NN as a NN to VB NN NN NNS JJ VBD a RBR - JJ NN to VB the JJR NN . NNP ’s NN VBD the JJ - NN NN of JJ NN in NN , and by 1980 96 NN of NNS VBD VBG VBN against NNS , NNS , NN , NN , and JJ NNS . At the JJ NN , JJ JJ JJ NNS VBD JJ NNS to JJ NN in NN . JJ - NN NN VBD one JJ NN . As NNS , NNS RB VBP the NN of VBG NNS . Yet JJ - NN NN VBD the JJ NN of NN by VBG to VB NNS NN over NNS ’s NN NNS ( 114 ) . NNS JJ as NNP VBD NNS to VB JJ with the NN NN , for NN , because the NN could VB those JJ to NNS . When NNS VBD NNS about NNS from the NN NN , NNS VBD them aside . The NN VBD that NNS RB VBD the NN of NNS , RB in their NN as a JJ NN . The JJ JJ NN RB VBD a NN , as JJ NNS VBD with the JJ NN of the NNS . RB in the JJ NN , some NNS VBD VBN that NNS VBN NNS or NN NN into the JJ NN ( 133 ) . NNP NNP ’s NNP NNP VBD in JJ NNS of NN and JJ NNS in the NN , and NNS of NN would RB VB NNS with JJ NNS . By the JJ NNS , NNS JJ as NNP NNP VBD VBG that NNS VBD JJ for JJ NNS , VBG the NN of JJ NN NNP NNP ( 148 ) . In the NN of NNS , NN VBD an JJ NN , and it VBD JJR to VB NN VB its NN with NNS like the NN NN . The NN NN NN VBD VBN in 1982 , RB to VB NN NN NNS . At that NN , the NN RB VBD in the JJ NN ( 182 ) . Yet NN about the NN VBD throughout the ‘ NNS , and NNS VBD to VB NNS to VB the NN . The NNS VBD to VB RB JJ and VBD off NNS over the NNS ’ NN and the JJ NN to VB NNS for a NN VBN by “ NN ” NN . In the JJ NN , NN - NN NNS VBD NNS that NNS VBD VBG NN . While the NN VBD RB VBN by NNS , NN NN VBD on one NN of the NN : the VBN , JJ NN who VBD to VB their NNS VBN ( 223 ) . This NN RB VBD the NN , NNP VBZ , by VBG any NN around NN - NNS from NN or VBG with NNS VBN by NN and the NN NN NN . The NN VBZ the NN with a NN of the JJ NN ( NN ) NN . NNP VBD from VBG a NN that RB a JJ NNS VBD VBN of to a VBG NN of JJ NN . The NN VBD a JJ NN over the NN of NN - NN NNS , VBG from NNS over JJ NN to NN NNS RB RB as NN by JJ NN NNS . JJ NNS RB VBD a NN in this NN , as VBG JJ NN VBD that NNS could VB their JJ NNS . The NN VBZ about two JJ but VBN NNS : the NN of JJ NNS and the NN of a JJ NN in which they can VB VBN . At the NN of the NN , NNS and NNS RB VBP and VBP the NN . Some NNS on the JJ NN VBP the NN or NN of NNS , but their NNS VBP RB VBN . By the NN of the NN , JJ NN VBZ an JJ NN of NN , and NN VBZ RB VBN around what VBZ “ JJ NN . ” As JJR NNS VBD the NN , what RB VBD a JJ NN VBD a RB VBN and JJ NN . NN and the NN to VB an NNP NN VBZ RB JJ from this NN and would VB VBN JJ to VB in VBG the JJ NNS toward NN . JJ of the NN VBZ about the NN ’s VBG NN of NN NN . The NNP NN in the NNS VBD VBN JJR by a VBN JJ NN RB RB as the NN to VB a NN , which VBZ VBN into JJ NN of JJ NN NNS . RB , this VBZ an JJ and JJ NN , one which VBZ a VBN NN of NNS about NNS without VBG behind the NN of NNS and NNS ."
54,883,mainstream,"Top_NN of_IN the_DT morning_NN to_IN you_PRP ,_, and_CC a_DT fine_JJ one_NN it_PRP is_VBZ ._. Once_RB again_RB ,_, clear_JJ blue_JJ skies_NNS and_CC cool_JJ breezes_NNS are_VBP enveloping_VBG the_DT Pharmalot_NNP campus_NN ,_, where_WRB the_DT short_JJ person_NN is_VBZ hovering_VBG over_IN a_DT laptop_NN and_CC the_DT fast_RB -_HYPH growing_VBG official_JJ mascot_NN is_VBZ unsuccessfully_RB chasing_VBG squirrels_NNS ._. As_IN for_IN us_PRP ,_, we_PRP are_VBP engaged_VBN in_IN our_PRP$ usual_JJ ritual_NN of_IN heating_VBG the_DT coffee_NN kettle_NN to_TO concoct_VB cups_NNS of_IN stimulation_NN ._. Once_RB again_RB ,_, we_PRP are_VBP enjoying_VBG glazed_VBN doughnut_NN ._. One_PRP can_MD never_RB be_VB too_RB sweet_JJ ,_, yes_UH ?_. Meanwhile_RB ,_, here_RB are_VBP some_DT items_NNS of_IN interest_NN for_IN you_PRP ._. Have_VB a_DT smashing_NN day_NN and_CC do_VB keep_VB in_IN touch_NN ._. …_. Moncef_NNP Slaoui_NNP ,_, a_DT venture_NN capitalist_NN and_CC a_DT former_JJ GlaxoSmithKline_NNP (_-LRB- GSK_NNP )_-RRB- executive_NN who_WP was_VBD tapped_VBN to_TO lead_VB the_DT Trump_NNP administration_NN Covid_NNP -_HYPH 19_CD vaccine_NN effort_NN ,_, has_VBZ spent_VBN the_DT last_JJ several_JJ days_NNS trying_VBG to_TO disentangle_VB his_PRP$ stock_NN portfolio_NN and_CC his_PRP$ intricate_JJ ties_NNS to_IN pharmaceutical_JJ interests_NNS ,_, The_DT New_NNP York_NNP Times_NNP reports_VBZ ._. But_CC some_DT ethics_NN and_CC financial_JJ securities_NNS experts_NNS voiced_VBD concerns_NNS about_IN the_DT arrangement_NN he_PRP struck_VBD with_IN the_DT administration_NN ._. In_IN agreeing_VBG to_TO accept_VB the_DT position_NN ,_, Slaoui_NNP did_VBD not_RB come_VB on_IN board_NN as_IN a_DT government_NN employee_NN ,_, but_CC on_IN a_DT contract_NN ,_, receiving_VBG $_$ 1_CD for_IN his_PRP$ service_NN ._.","NN of the NN to you , and a JJ NN it VBZ . RB RB , JJ JJ NNS and JJ NNS VBP VBG the NNP NN , where the JJ NN VBZ VBG over a NN and the RB - VBG JJ NN VBZ RB VBG NNS . As for us , we VBP VBN in our JJ NN of VBG the NN NN to VB NNS of NN . RB RB , we VBP VBG VBN NN . One can RB VB RB JJ , yes ? RB , RB VBP some NNS of NN for you . VB a NN NN and VB VB in NN . … NNP NNP , a NN NN and a JJ NNP ( NNP ) NN who VBD VBN to VB the NNP NN NNP - 19 NN NN , VBZ VBN the JJ JJ NNS VBG to VB his NN NN and his JJ NNS to JJ NNS , The NNP NNP NNP VBZ . But some NN and JJ NNS NNS VBD NNS about the NN he VBD with the NN . In VBG to VB the NN , NNP VBD RB VB on NN as a NN NN , but on a NN , VBG $ 1 for his NN ."
55,651,conspiracy,"Trump_NNP 's_POS executive_JJ order_NN rejecting_VBG the_DT US_NNP 's_POS refugee_NN programme_NN to_TO be_VB reversed_VBN Almost_RB 100_CD Democratic_JJ lawmakers_NNS have_VBP introduced_VBN legislation_NN on_IN Wednesday_NNP to_TO stop_VB Donald_NNP Trump_NNP 's_POS ban_NN on_IN travel_NN to_IN the_DT United_NNP States_NNPS by_IN people_NNS from_IN countries_NNS connected_VBN to_IN terrorism_NN ._. ""_`` Thousands_NNS of_IN American_JJ citizens_NNS have_VBP been_VBN forced_VBN to_TO live_VB apart_RB from_IN their_PRP$ spouses_NNS ;_, their_PRP$ lives_NNS put_VBD on_IN hold_NN ._. Thousands_NNS of_IN children_NNS will_MD not_RB get_VB to_TO spend_VB time_NN with_IN their_PRP$ grandparents_NNS ,_, ""_'' Senator_NNP Chris_NNP Coons_NNP said_VBD ._. ""_`` Thousands_NNS of_IN people_NNS have_VBP been_VBN denied_VBN the_DT opportunity_NN to_TO either_CC grieve_VB the_DT passing_NN of_IN a_DT loved_VBN one_NN or_CC to_TO celebrate_VB a_DT marriage_NN or_CC a_DT birth_NN ._. ""_'' Trump_NNP promised_VBD to_TO place_VB a_DT temporary_JJ ban_NN on_IN immigrants_NNS and_CC refugees_NNS from_IN specific_JJ Middle_NNP Eastern_JJ countries_NNS from_IN entering_VBG the_DT country_NN ._. In_IN 2017_CD ,_, Trump_NNP signed_VBD an_DT executive_JJ order_NN rejecting_VBG the_DT US_NNP 's_POS refugee_NN programme_NN and_CC blocking_VBG travelers_NNS from_IN several_JJ Muslim_JJ -_HYPH majority_NN countries_NNS ._. During_IN the_DT ban_NN ,_, many_JJ travelers_NNS were_VBD detained_VBN at_IN US_NNP airports_NNS ,_, and_CC travel_NN disrupted_VBN ._. Ilhan_NNP Omar_NNP promised_VBD to_TO end_VB ,_, what_WP she_PRP described_VBD as_IN Trump_NNP 's_POS '_`` hateful_JJ Muslim_JJ ban_NN ._. '_'' According_VBG to_IN The_DT Hill_NNP :_: Trump_NNP and_CC the_DT White_NNP House_NNP argue_VBP the_DT travel_NN ban_NN is_VBZ not_RB a_DT Muslim_JJ ban_NN ._. The_DT policy_NN prevents_VBZ travelers_NNS from_IN Iran_NNP ,_, Libya_NNP ,_, Syria_NNP ,_, Somalia_NNP ,_, and_CC Yemen_NNP from_IN entering_VBG the_DT U.S._NNP ,_, and_CC the_DT administration_NN argues_VBZ it_PRP is_VBZ necessary_JJ to_TO protect_VB national_JJ security_NN ._. Trump_NNP 's_POS third_JJ executive_JJ order_NN issuing_VBG the_DT ban_NN was_VBD upheld_VBN in_IN a_DT 5_CD -_HYPH 4_CD ruling_NN by_IN the_DT Supreme_NNP Court_NNP last_JJ year_NN ._. The_DT majority_NN opinion_NN ,_, authored_VBN by_IN Chief_NNP Justice_NNP John_NNP Roberts_NNP ,_, said_VBD Trump_NNP was_VBD well_RB within_IN his_PRP$ authority_NN to_TO impose_VB the_DT ban_NN based_VBN on_IN the_DT president_NN 's_POS judgments_NNS about_IN national_JJ security_NN ._. Roberts_NNP wrote_VBD that_IN it_PRP was_VBD not_RB the_DT court_NN 's_POS place_NN to_TO criticize_VB or_CC pass_VB judgment_NN on_IN comments_NNS Trump_NNP made_VBD on_IN the_DT campaign_NN trail_NN about_IN a_DT ""_`` total_JJ and_CC complete_JJ shutdown_NN of_IN Muslims_NNPS entering_VBG the_DT United_NNP States_NNPS ""_'' and_CC that_IN the_DT executive_JJ order_NN was_VBD neutral_JJ in_IN not_RB targeting_VBG travelers_NNS of_IN a_DT specific_JJ religion_NN ._. In_IN a_DT dissenting_VBG opinion_NN ,_, Justice_NNP Sonia_NNP Sotomayor_NNP lashed_VBD out_RP at_IN the_DT court_NN 's_POS majority_NN ,_, arguing_VBG Trump_NNP 's_POS comments_NNS targeting_VBG Muslims_NNPS should_MD have_VB led_VBN the_DT justices_NNS to_TO strike_VB down_RP the_DT ban_NN ._. Legislation_NN introduced_VBN to_TO overturn_VB the_DT ban_NN is_VBZ unlikely_JJ to_TO become_VB law_NN with_IN Trump_NNP in_IN the_DT White_NNP House_NNP and_CC Republicans_NNPS holding_VBG a_DT majority_NN in_IN the_DT Senate_NNP ._. “_`` This_DT is_VBZ not_RB a_DT bill_NN that_WDT I_PRP expect_VBP to_TO become_VB law_NN in_IN this_DT administration_NN ,_, ”_'' Coons_NNP acknowledged_VBD on_IN MSNBC_NNP ._. [_-LRB- RELATED_JJ ]_-RRB- Democrats_NNPS to_TO Remove_VB ‘_`` So_RB Help_VB Me_PRP God_NNP ’_'' From_IN House_NN Committee_NN Oath_NN ,_, Draft_NN Shows_NNS","NNP 's JJ NN VBG the NNP 's NN NN to VB VBN RB 100 JJ NNS VBP VBN NN on NNP to VB NNP NNP 's NN on NN to the NNP NNPS by NNS from NNS VBN to NN . "" NNS of JJ NNS VBP VBN VBN to VB RB from their NNS ; their NNS VBD on NN . NNS of NNS will RB VB to VB NN with their NNS , "" NNP NNP NNP VBD . "" NNS of NNS VBP VBN VBN the NN to either VB the NN of a VBN NN or to VB a NN or a NN . "" NNP VBD to VB a JJ NN on NNS and NNS from JJ NNP JJ NNS from VBG the NN . In 2017 , NNP VBD an JJ NN VBG the NNP 's NN NN and VBG NNS from JJ JJ - NN NNS . During the NN , JJ NNS VBD VBN at NNP NNS , and NN VBN . NNP NNP VBD to VB , what she VBD as NNP 's ' JJ JJ NN . ' VBG to The NNP : NNP and the NNP NNP VBP the NN NN VBZ RB a JJ NN . The NN VBZ NNS from NNP , NNP , NNP , NNP , and NNP from VBG the NNP , and the NN VBZ it VBZ JJ to VB JJ NN . NNP 's JJ JJ NN VBG the NN VBD VBN in a 5 - 4 NN by the NNP NNP JJ NN . The NN NN , VBN by NNP NNP NNP NNP , VBD NNP VBD RB within his NN to VB the NN VBN on the NN 's NNS about JJ NN . NNP VBD that it VBD RB the NN 's NN to VB or VB NN on NNS NNP VBD on the NN NN about a "" JJ and JJ NN of NNPS VBG the NNP NNPS "" and that the JJ NN VBD JJ in RB VBG NNS of a JJ NN . In a VBG NN , NNP NNP NNP VBD out at the NN 's NN , VBG NNP 's NNS VBG NNPS should VB VBN the NNS to VB down the NN . NN VBN to VB the NN VBZ JJ to VB NN with NNP in the NNP NNP and NNPS VBG a NN in the NNP . “ This VBZ RB a NN that I VBP to VB NN in this NN , ” NNP VBD on NNP . [ JJ ] NNPS to VB ‘ RB VB Me NNP ’ From NN NN NN , NN NNS"
56,882,mainstream,"Here_RB are_VBP some_DT of_IN the_DT most_RBS well_RB -_HYPH known_VBN myths_NNS about_IN vaccines_NNS as_RB well_RB as_IN the_DT reality_NN ._. TRUTH_NN :_: This_DT myth_NN gained_VBD popularity_NN when_WRB children_NNS were_VBD diagnosed_VBN with_IN autism_NN around_IN the_DT time_NN that_IN they_PRP received_VBD the_DT MMR_NN vaccine_NN (_-LRB- around_RB 18_CD months_NNS of_IN age_NN )_-RRB- ,_, according_VBG to_IN Joyce_NNP Allers_NNP ,_, RN_NNP ,_, with_IN Children_NNP 's_POS Healthcare_NNP of_IN Atlanta_NNP ._. (_-LRB- There_EX was_VBD also_RB a_DT now_RB -_HYPH discredited_VBN study_NN published_VBN in_IN Lancet_NNP in_IN 1998_CD alleging_VBG a_DT connection_NN ._. )_-RRB- At_IN the_DT time_NN ,_, the_DT mercury_NN -_HYPH containing_VBG preservative_NN Thimerosal_NNP was_VBD being_VBG put_VBN in_IN some_DT vaccines_NNS –_: although_IN not_RB the_DT MMR_NNP vaccine_NN –_: to_TO keep_VB bacteria_NN from_IN growing_VBG ,_, so_RB many_JJ people_NNS connected_VBD that_DT to_IN autism_NN ._. However_RB ,_, there_EX appears_VBZ to_TO be_VB no_DT link_NN between_IN previous_JJ use_NN of_IN Thimerosal_NNP and_CC autism_NN ._. Thimerosal_NNP was_VBD completely_RB removed_VBN from_IN all_DT infant_NN vaccines_NNS in_IN the_DT United_NNP States_NNPS in_IN 2001_CD ,_, yet_CC autism_NN rates_NNS continue_VBP to_TO increase_VB ._. ""_`` Study_NN after_IN study_NN has_VBZ shown_VBN that_IN there_EX is_VBZ no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ,_, ""_'' says_VBZ Angie_NNP Matthiessen_NNP with_IN Children_NNP 's_POS Healthcare_NNP of_IN Atlanta_NNP ._. Thimerosal_NNP is_VBZ currently_RB present_JJ only_RB in_IN minute_NN amounts_NNS in_IN the_DT influenza_NN vaccine_NN ._. There_EX are_VBP also_RB Thimerosal_NNP -_HYPH free_JJ influenza_NN vaccines_NNS ._. MYTH_NN :_: Vaccines_NNS are_VBP n't_RB necessary_JJ anymore_RB because_IN all_PDT the_DT diseases_NNS are_VBP gone_VBN anyway_RB ._. TRUTH_NN :_: According_VBG to_IN the_DT CDC_NNP ,_, if_IN we_PRP stopped_VBD vaccinating_VBG ,_, many_JJ diseases_NNS that_WDT are_VBP largely_RB unknown_JJ would_MD come_VB back_RB with_IN a_DT vengeance_NN ._. The_DT only_JJ vaccine_NN -_HYPH preventable_JJ disease_NN that_WDT 's_VBZ been_VBN completely_RB wiped_VBN out_RP is_VBZ smallpox_NN ._. ""_`` These_DT diseases_NNS are_VBP coming_VBG into_IN our_PRP$ country_NN ,_, into_IN our_PRP$ schools_NNS and_CC into_IN our_PRP$ workplace_NN ,_, ""_'' says_VBZ Matthiessen_NNP ._. ""_`` Do_VB n't_RB believe_VB that_IN your_PRP$ child_NN is_VBZ 100_CD percent_NN protected_VBN because_IN the_DT disease_NN is_VBZ n't_RB currently_RB in_IN the_DT United_NNP States_NNPS ._. International_JJ travel_NN and_CC adoption_NN are_VBP two_CD of_IN the_DT ways_NNS that_WDT dangerous_JJ diseases_NNS make_VBP their_PRP$ way_NN into_IN the_DT country_NN ._. ""_'' Measles_NN ,_, which_WDT the_DT U.S._NNP considered_VBD wiped_VBN out_RP in_IN 2000_CD has_VBZ returned_VBN ._. There_EX were_VBD 1,282_CD cases_NNS of_IN measles_NNS in_IN the_DT U.S._NNP in_IN 2019_CD ._. The_DT CDC_NNP attributed_VBD the_DT outbreak_NN to_IN ""_`` an_DT increase_NN in_IN the_DT number_NN of_IN travelers_NNS who_WP get_VBP measles_NNS abroad_RB and_CC bring_VBP it_PRP into_IN the_DT U.S._NNP ,_, and_CC a_DT spread_NN of_IN measles_NNS in_IN U.S._NNP communities_NNS with_IN pockets_NNS of_IN unvaccinated_JJ people_NNS ._. ""_'' Some_DT Americans_NNPS have_VBP become_VBN resistant_JJ to_IN immunizing_VBG their_PRP$ children_NNS ,_, which_WDT has_VBZ contributed_VBN to_IN the_DT spread_NN of_IN some_DT childhood_NN diseases_NNS that_WDT were_VBD once_RB seldom_RB seen_VBN ._. MYTH_NN :_: Babies_NNS are_VBP too_RB fragile_JJ to_TO get_VB so_RB many_JJ shots_NNS ._. TRUTH_NN :_: ""_`` A_DT lot_NN of_IN young_JJ parents_NNS are_VBP worried_VBN about_IN giving_VBG their_PRP$ babies_NNS so_RB many_JJ shots_NNS ,_, thinking_VBG that_IN they_PRP will_MD overwhelm_VB their_PRP$ immune_JJ system_NN ,_, ""_'' says_VBZ Allers_NNP ._. ""_`` I_PRP tell_VBP them_PRP that_IN as_IN human_JJ beings_NNS we_PRP are_VBP exposed_VBN to_IN disease_NN all_PDT the_DT time_NN ,_, like_UH at_IN the_DT mall_NN and_CC church_NN ,_, so_RB we_PRP can't_MD overwhelm_VB their_PRP$ systems_NNS ._. ""_'' According_VBG to_IN the_DT Children_NNP 's_POS Hospital_NNP of_IN Philadelphia_NNP 's_POS Vaccine_NNP Education_NNP Center_NNP ,_, diseases_NNS often_RB occur_VBP in_IN very_RB young_JJ infants_NNS ,_, so_RB the_DT best_JJS way_NN to_TO prevent_VB them_PRP is_VBZ to_TO give_VB vaccines_NNS as_RB soon_RB as_IN possible_JJ after_IN birth_NN ._. ""_`` We_PRP have_VBP a_DT wonderful_JJ history_NN of_IN eliminating_VBG disease_NN ,_, but_CC what_WP worries_VBZ us_PRP is_VBZ all_PDT the_DT good_JJ progress_NN we_PRP 've_VBP made_VBN is_VBZ going_VBG to_TO be_VB diminished_VBN by_IN families_NNS choosing_VBG their_PRP$ own_JJ vaccination_NN schedule_NN or_CC choosing_VBG not_RB to_TO vaccinate_VB at_IN all_DT ,_, ""_'' Allers_NNP says_VBZ ._. MYTH_NN :_: A_DT live_JJ vaccine_NN can_MD give_VB me_PRP the_DT disease_NN it_PRP 's_VBZ supposed_VBN to_TO prevent_VB ._. TRUTH_NN :_: As_IN we_PRP 've_VBP discussed_VBN ,_, live_JJ vaccines_NNS can_MD cause_VB extremely_RB mild_JJ symptoms_NNS ._. However_RB ,_, experts_NNS agree_VBP that_IN they_PRP are_VBP very_RB minor_JJ and_CC much_RB better_JJR than_IN coming_VBG down_RP with_IN the_DT full_JJ -_HYPH blown_VBN disease_NN ._. For_IN more_JJR information_NN on_IN vaccines_NNS and_CC related_JJ topics_NNS ,_, check_VB out_RP the_DT links_NNS below_RB ._. Last_JJ editorial_JJ update_NN on_IN May_NNP 6_CD ,_, 2020_CD 07:53:13_CD pm_NN ._.","RB VBP some of the RBS RB - VBN NNS about NNS RB RB as the NN . NN : This NN VBD NN when NNS VBD VBN with NN around the NN that they VBD the NN NN ( RB 18 NNS of NN ) , VBG to NNP NNP , NNP , with NNP 's NNP of NNP . ( There VBD RB a RB - VBN NN VBN in NNP in 1998 VBG a NN . ) At the NN , the NN - VBG NN NNP VBD VBG VBN in some NNS – although RB the NNP NN – to VB NN from VBG , RB JJ NNS VBD that to NN . RB , there VBZ to VB no NN between JJ NN of NNP and NN . NNP VBD RB VBN from all NN NNS in the NNP NNPS in 2001 , yet NN NNS VBP to VB . "" NN after NN VBZ VBN that there VBZ no NN between NNS and NN , "" VBZ NNP NNP with NNP 's NNP of NNP . NNP VBZ RB JJ RB in NN NNS in the NN NN . There VBP RB NNP - JJ NN NNS . NN : NNS VBP RB JJ RB because all the NNS VBP VBN RB . NN : VBG to the NNP , if we VBD VBG , JJ NNS that VBP RB JJ would VB RB with a NN . The JJ NN - JJ NN that VBZ VBN RB VBN out VBZ NN . "" These NNS VBP VBG into our NN , into our NNS and into our NN , "" VBZ NNP . "" VB RB VB that your NN VBZ 100 NN VBN because the NN VBZ RB RB in the NNP NNPS . JJ NN and NN VBP two of the NNS that JJ NNS VBP their NN into the NN . "" NN , which the NNP VBD VBN out in 2000 VBZ VBN . There VBD 1,282 NNS of NNS in the NNP in 2019 . The NNP VBD the NN to "" an NN in the NN of NNS who VBP NNS RB and VBP it into the NNP , and a NN of NNS in NNP NNS with NNS of JJ NNS . "" Some NNPS VBP VBN JJ to VBG their NNS , which VBZ VBN to the NN of some NN NNS that VBD RB RB VBN . NN : NNS VBP RB JJ to VB RB JJ NNS . NN : "" A NN of JJ NNS VBP VBN about VBG their NNS RB JJ NNS , VBG that they will VB their JJ NN , "" VBZ NNP . "" I VBP them that as JJ NNS we VBP VBN to NN all the NN , like at the NN and NN , RB we can't VB their NNS . "" VBG to the NNP 's NNP of NNP 's NNP NNP NNP , NNS RB VBP in RB JJ NNS , RB the JJS NN to VB them VBZ to VB NNS RB RB as JJ after NN . "" We VBP a JJ NN of VBG NN , but what VBZ us VBZ all the JJ NN we VBP VBN VBZ VBG to VB VBN by NNS VBG their JJ NN NN or VBG RB to VB at all , "" NNP VBZ . NN : A JJ NN can VB me the NN it VBZ VBN to VB . NN : As we VBP VBN , JJ NNS can VB RB JJ NNS . RB , NNS VBP that they VBP RB JJ and RB JJR than VBG down with the JJ - VBN NN . For JJR NN on NNS and JJ NNS , VB out the NNS RB . JJ JJ NN on NNP 6 , 2020 07:53:13 NN ."
57,768,mainstream,"This_DT two_CD -_HYPH way_NN relationship_NN may_MD be_VB an_DT unlikely_JJ key_NN to_IN solving_VBG one_CD of_IN medicine_NN 's_POS most_RBS pressing_VBG —_: and_CC perplexing_JJ —_: mysteries_NNS :_: autism_NN ._. Nearly_RB 60_CD years_NNS after_IN the_DT disorder_NN was_VBD first_RB identified_VBN ,_, the_DT number_NN of_IN cases_NNS has_VBZ surged_VBN ,_, and_CC the_DT United_NNP Nations_NNPS estimates_VBZ that_IN up_IN to_IN 70_CD million_CD people_NNS worldwide_RB fall_VBP on_IN the_DT autism_NN spectrum_NN ._. Yet_CC there_EX is_VBZ no_DT known_VBN cause_NN or_CC cure_NN ._. But_CC scientists_NNS have_VBP found_VBN promising_JJ clues_NNS in_IN the_DT gut_NN ._. Research_NN has_VBZ revealed_VBN striking_VBG differences_NNS in_IN the_DT trillions_NNS of_IN bacteria_NN -_, collectively_RB known_VBN as_IN the_DT microbiome_NN —_: in_IN the_DT intestines_NNS of_IN autistic_JJ and_CC healthy_JJ children_NNS ._. But_CC the_DT gut_NN bacteria_NN in_IN autistic_JJ individuals_NNS are_VBP n't_RB just_RB different_JJ ._. Researchers_NNS at_IN the_DT California_NNP Institute_NNP of_IN Technology_NNP have_VBP shown_VBN for_IN the_DT first_JJ time_NN that_IN they_PRP may_MD actually_RB contribute_VB to_IN the_DT disorder_NN ._. Last_JJ month_NN ,_, they_PRP reported_VBD in_IN the_DT journal_NN Cell_NNP that_IN an_DT experimental_JJ probiotic_JJ therapy_NN alleviated_VBD autism_NN -_HYPH like_IN behaviors_NNS in_IN mice_NNS and_CC are_VBP already_RB planning_VBG a_DT clinical_JJ trial_NN ._. Today_NN autism_NN is_VBZ treated_VBN primarily_RB through_IN behavioral_JJ therapy_NN ._. But_CC the_DT new_JJ study_NN suggests_VBZ that_IN treatment_NN may_MD one_CD day_NN come_VB in_IN the_DT form_NN of_IN a_DT probiotic_NN —_: live_JJ ,_, ""_`` friendly_JJ ""_'' bacteria_NN like_IN those_DT found_VBN in_IN yogurt_NN ._. ""_`` If_IN you_PRP block_VBP the_DT gastrointestinal_JJ problem_NN ,_, you_PRP can_MD treat_VB the_DT behavioral_JJ symptoms_NNS ,_, ""_'' Paul_NNP Patterson_NNP ,_, a_DT professor_NN of_IN biology_NN at_IN Caltech_NNP who_WP co-authored_VBD the_DT study_NN ,_, told_VBD SFARI.org_NNP ._. University_NNP of_IN Colorado_NNP Boulder_NNP professor_NN Rob_NNP Knight_NNP hailed_VBD the_DT finding_NN as_IN ""_`` groundbreaking_NN ""_'' in_IN a_DT commentary_NN in_IN Cell_NN ._. Autism_NN is_VBZ a_DT complex_JJ spectrum_NN of_IN disorders_NNS that_WDT share_VBP three_CD classic_JJ features_NNS -_HYPH impaired_JJ communication_NN ,_, poor_JJ social_JJ engagement_NN and_CC repetitive_JJ behaviors_NNS ._. On_IN one_CD end_NN of_IN the_DT spectrum_NN are_VBP people_NNS who_WP are_VBP socially_RB awkward_JJ but_CC ,_, in_IN many_JJ cases_NNS ,_, incredibly_RB bright_JJ ._. At_IN the_DT other_JJ extreme_NN are_VBP individuals_NNS with_IN severe_JJ mental_JJ disabilities_NNS and_CC behavioral_JJ problems_NNS ._. Among_IN autistic_JJ children_NNS 's_POS most_RBS common_JJ health_NN complaints_NNS ?_. Gastrointestinal_JJ problems_NNS ._. Although_IN estimates_NNS vary_VBP widely_RB ,_, some_DT studies_NNS have_VBP concluded_VBN that_IN up_IN to_IN 90_CD percent_NN of_IN autistic_JJ children_NNS suffer_VBP from_IN tummy_NN troubles_NNS ._. According_VBG to_IN the_DT CDC_NNP ,_, they_PRP 're_VBP more_JJR than_IN 3.5_CD times_NNS more_RBR likely_JJ to_TO experience_VB chronic_JJ diarrhea_NN and_CC constipation_NN than_IN their_PRP$ normally_RB developing_VBG peers_NNS ._. Following_VBG these_DT hints_NNS ,_, Arizona_NNP State_NNP University_NNP researchers_NNS analyzed_VBD the_DT gut_NN bacteria_NN in_IN fecal_JJ samples_NNS obtained_VBN from_IN autistic_JJ and_CC normally_RB developing_VBG children_NNS ._. They_PRP found_VBD that_IN autistic_JJ participants_NNS had_VBD many_JJ fewer_JJR types_NNS of_IN bacteria_NN ,_, probably_RB making_VBG the_DT gut_NN more_RBR susceptible_JJ to_IN attack_NN from_IN disease_NN -_HYPH causing_VBG pathogens_NNS ._. Other_JJ studies_NNS have_VBP also_RB found_VBN striking_VBG differences_NNS in_IN the_DT types_NNS and_CC abundance_NN of_IN gut_NN bacteria_NN in_IN autistic_JJ versus_IN healthy_JJ patients_NNS ._. But_CC is_VBZ the_DT gut_NN microbiome_NN in_IN autistic_JJ individuals_NNS responsible_JJ for_IN the_DT disorder_NN ?_. To_TO find_VB out_RP ,_, Caltech_NNP postdoctoral_JJ researcher_NN Elaine_NNP Hsiao_NNP engineered_VBD mice_NNS based_VBN on_IN earlier_JJR studies_NNS showing_VBG that_IN women_NNS who_WP get_VBP the_DT flu_NN during_IN pregnancy_NN double_VBP their_PRP$ risk_NN of_IN giving_VBG birth_NN to_IN an_DT autistic_JJ child_NN ._. In_IN the_DT mouse_NN model_NN ,_, pregnant_JJ females_NNS injected_VBN with_IN a_DT mock_NN virus_NN gave_VBD birth_NN to_IN pups_NNS with_IN autism_NN -_HYPH like_JJ symptoms_NNS ,_, such_JJ as_IN obsessive_JJ grooming_NN ,_, anxiety_NN and_CC aloofness_NN ._. But_CC how_WRB did_VBD these_DT bacteria_NNS influence_VB behavior_NN ?_. To_TO find_VB out_RP ,_, Hsiao_NNP analyzed_VBD the_DT mice_NNS 's_POS blood_NN ._. The_DT blood_NN of_IN ""_`` autistic_JJ ""_'' mice_NNS contained_VBD a_DT whopping_VBG 46_CD times_NNS more_JJR 4EPS_NN ,_, a_DT molecule_NN produced_VBN by_IN gut_NN bacteria_NN ,_, thought_VBN to_TO have_VB seeped_VBN from_IN their_PRP$ intestines_NNS ._. What_WP 's_VBZ more_JJR ,_, injecting_VBG healthy_JJ mice_NNS with_IN 4EPS_NN made_VBD them_PRP more_RBR anxious_JJ ._. A_DT similar_JJ molecule_NN has_VBZ been_VBN detected_VBN at_IN elevated_VBN levels_NNS in_IN autistic_JJ patients_NNS ._. Five_CD weeks_NNS later_RBR ,_, the_DT leaky_JJ gut_NN in_IN ""_`` autistic_JJ ""_'' mice_NNS had_VBD sealed_VBN up_RP ,_, and_CC the_DT levels_NNS of_IN 4EPS_NN in_IN their_PRP$ blood_NN had_VBD plummeted_VBN ._. Their_PRP$ gut_NN microbiomes_NNS had_VBD come_VBN to_TO more_RBR closely_RB resemble_VB those_DT of_IN healthy_JJ mice_NNS —_: and_CC so_RB did_VBD their_PRP$ behavior_NN ._. They_PRP were_VBD less_RBR anxious_JJ and_CC more_RBR vocal_JJ ,_, and_CC stopped_VBD obsessively_RB burying_VBG marbles_NNS in_IN their_PRP$ cages_NNS ._. But_CC the_DT treated_VBN mice_NNS remained_VBD aloof_JJ when_WRB a_DT new_JJ mouse_NN was_VBD placed_VBN in_IN their_PRP$ cage_NN ._. ""_`` This_DT is_VBZ a_DT real_JJ limitation_NN in_IN the_DT conclusions_NNS from_IN this_DT study_NN as_IN ,_, in_IN many_JJ ways_NNS ,_, social_JJ interaction_NN deficits_NNS are_VBP at_IN the_DT core_NN ..._, of_IN autism_NN ,_, ""_'' Ted_NNP Abel_NNP ,_, a_DT professor_NN of_IN biology_NN at_IN the_DT University_NNP of_IN Pennsylvania_NNP ,_, told_VBD SFARI.org_NNP ._. Still_RB ,_, autism_NN researchers_NNS should_MD n't_RB underestimate_VB the_DT importance_NN of_IN gut_NN bacteria_NN ,_, said_VBD John_NNP Cryan_NNP ,_, a_DT professor_NN of_IN anatomy_NN and_CC neuroscience_NN at_IN University_NNP Cork_NNP College_NNP ._. In_IN 2011_CD ,_, his_PRP$ group_NN reported_VBD in_IN the_DT Proceedings_NNPS of_IN the_DT National_NNP Academy_NNP of_IN Sciences_NNPS that_IN probiotic_JJ -_HYPH fed_VBN mice_NNS were_VBD less_RBR anxious_JJ and_CC produced_VBD fewer_JJR stress_NN hormones_NNS ._. ""_'' You_PRP have_VBP this_DT kilo_NN of_IN microbes_NNS in_IN your_PRP$ gut_NN that_WDT 's_VBZ as_RB important_JJ as_IN the_DT kilo_NN of_IN nerve_NN cells_NNS in_IN your_PRP$ brain_NN ,_, ""_'' he_PRP said_VBD ._. ""_`` We_PRP need_VBP to_TO do_VB much_RB more_JJR studies_NNS on_IN autistic_JJ biota_NN ._. ""_'' For_IN autistic_JJ patients_NNS and_CC their_PRP$ families_NNS ,_, however_RB ,_, even_RB a_DT supplemental_JJ therapy_NN for_IN a_DT subset_NN of_IN sufferers_NNS is_VBZ a_DT huge_JJ step_NN forward_RB ._. ""_`` It_PRP 's_VBZ really_RB impactful_JJ ,_, this_DT notion_NN that_IN by_IN changing_VBG the_DT bacteria_NN ,_, you_PRP could_MD ameliorate_VB what_WP 's_VBZ often_RB considered_VBN an_DT intractable_JJ disorder_NN ,_, ""_'' Hsiao_NNP said_VBD ._. ""_`` It_PRP 's_VBZ a_DT really_RB crazy_JJ notion_NN and_CC a_DT big_JJ advance_NN ._. ""_''","This two - NN NN may VB an JJ NN to VBG one of NN 's RBS VBG — and JJ — NNS : NN . RB 60 NNS after the NN VBD RB VBN , the NN of NNS VBZ VBN , and the NNP NNPS VBZ that up to 70 million NNS RB VBP on the NN NN . Yet there VBZ no VBN NN or NN . But NNS VBP VBN JJ NNS in the NN . NN VBZ VBN VBG NNS in the NNS of NN - RB VBN as the NN — in the NNS of JJ and JJ NNS . But the NN NN in JJ NNS VBP RB RB JJ . NNS at the NNP NNP of NNP VBP VBN for the JJ NN that they may RB VB to the NN . JJ NN , they VBD in the NN NNP that an JJ JJ NN VBD NN - like NNS in NNS and VBP RB VBG a JJ NN . NN NN VBZ VBN RB through JJ NN . But the JJ NN VBZ that NN may one NN VB in the NN of a NN — JJ , "" JJ "" NN like those VBN in NN . "" If you VBP the JJ NN , you can VB the JJ NNS , "" NNP NNP , a NN of NN at NNP who VBD the NN , VBD NNP . NNP of NNP NNP NN NNP NNP VBD the NN as "" NN "" in a NN in NN . NN VBZ a JJ NN of NNS that VBP three JJ NNS - JJ NN , JJ JJ NN and JJ NNS . On one NN of the NN VBP NNS who VBP RB JJ but , in JJ NNS , RB JJ . At the JJ NN VBP NNS with JJ JJ NNS and JJ NNS . Among JJ NNS 's RBS JJ NN NNS ? JJ NNS . Although NNS VBP RB , some NNS VBP VBN that up to 90 NN of JJ NNS VBP from NN NNS . VBG to the NNP , they VBP JJR than 3.5 NNS RBR JJ to VB JJ NN and NN than their RB VBG NNS . VBG these NNS , NNP NNP NNP NNS VBD the NN NN in JJ NNS VBN from JJ and RB VBG NNS . They VBD that JJ NNS VBD JJ JJR NNS of NN , RB VBG the NN RBR JJ to NN from NN - VBG NNS . JJ NNS VBP RB VBN VBG NNS in the NNS and NN of NN NN in JJ versus JJ NNS . But VBZ the NN NN in JJ NNS JJ for the NN ? To VB out , NNP JJ NN NNP NNP VBD NNS VBN on JJR NNS VBG that NNS who VBP the NN during NN VBP their NN of VBG NN to an JJ NN . In the NN NN , JJ NNS VBN with a NN NN VBD NN to NNS with NN - JJ NNS , JJ as JJ NN , NN and NN . But how VBD these NNS VB NN ? To VB out , NNP VBD the NNS 's NN . The NN of "" JJ "" NNS VBD a VBG 46 NNS JJR NN , a NN VBN by NN NN , VBN to VB VBN from their NNS . What VBZ JJR , VBG JJ NNS with NN VBD them RBR JJ . A JJ NN VBZ VBN VBN at VBN NNS in JJ NNS . Five NNS RBR , the JJ NN in "" JJ "" NNS VBD VBN up , and the NNS of NN in their NN VBD VBN . Their NN NNS VBD VBN to RBR RB VB those of JJ NNS — and RB VBD their NN . They VBD RBR JJ and RBR JJ , and VBD RB VBG NNS in their NNS . But the VBN NNS VBD JJ when a JJ NN VBD VBN in their NN . "" This VBZ a JJ NN in the NNS from this NN as , in JJ NNS , JJ NN NNS VBP at the NN ... of NN , "" NNP NNP , a NN of NN at the NNP of NNP , VBD NNP . RB , NN NNS should RB VB the NN of NN NN , VBD NNP NNP , a NN of NN and NN at NNP NNP NNP . In 2011 , his NN VBD in the NNPS of the NNP NNP of NNPS that JJ - VBN NNS VBD RBR JJ and VBD JJR NN NNS . "" You VBP this NN of NNS in your NN that VBZ RB JJ as the NN of NN NNS in your NN , "" he VBD . "" We VBP to VB RB JJR NNS on JJ NN . "" For JJ NNS and their NNS , RB , RB a JJ NN for a NN of NNS VBZ a JJ NN RB . "" It VBZ RB JJ , this NN that by VBG the NN , you could VB what VBZ RB VBN an JJ NN , "" NNP VBD . "" It VBZ a RB JJ NN and a JJ NN . """
58,147,mainstream,"As_IN the_DT world_NN races_VBZ to_TO combat_VB the_DT coronavirus_NN ,_, one_CD nation_NN is_VBZ notably_RB absent_JJ from_IN multinational_JJ efforts_NNS :_: the_DT United_NNP States_NNPS ._. But_CC scientists_NNS say_VBP that_IN for_IN now_RB ,_, the_DT international_JJ research_NN community_NN is_VBZ working_VBG together_RB to_TO do_VB all_DT it_PRP can_MD ._. Global_JJ actors_NNS are_VBP joining_VBG forces_NNS on_IN multiple_JJ fronts_NNS to_TO bring_VB the_DT coronavirus_NN pandemic_NN under_IN control_NN ._. On_IN April_NNP 24_CD ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- held_VBD a_DT virtual_JJ conference_NN to_TO launch_VB an_DT international_JJ collaboration_NN to_TO accelerate_VB the_DT development_NN and_CC production_NN of_IN the_DT health_NN technologies_NNS necessary_JJ to_TO do_VB so_RB ._. The_DT United_NNP States_NNPS did_VBD not_RB participate_VB in_IN the_DT conference_NN ,_, which_WDT culminated_VBD in_IN a_DT joint_JJ call_NN for_IN action_NN ._. Next_JJ Monday_NNP ,_, May_NNP 4_CD ,_, the_DT European_NNP Commission_NNP will_MD respond_VB to_IN that_DT call_NN by_IN hosting_VBG a_DT global_JJ virtual_JJ conference_NN to_TO raise_VB money_NN from_IN countries_NNS and_CC business_NN foundations_NNS to_TO fund_VB the_DT development_NN of_IN tests_NNS ,_, treatments_NNS and_CC a_DT vaccine_NN for_IN the_DT coronavirus_NN ._. It_PRP has_VBZ invited_VBN “_`` governments_NNS ,_, business_NN leaders_NNS ,_, public_JJ figures_NNS ,_, philanthropists_NNS ,_, artists_NNS and_CC citizens_NNS ”_'' to_TO help_VB with_IN its_PRP$ efforts_NNS to_TO raise_VB the_DT €_$ 7.5_CD billion_CD it_PRP has_VBZ set_VBN as_IN its_PRP$ initial_JJ target_NN ._. Announced_VBN partners_NNS include_VBP France_NNP ,_, Germany_NNP ,_, the_DT United_NNP Kingdom_NNP ,_, Norway_NNP and_CC Saudi_NNP Arabia_NNP ._. It_PRP remains_VBZ unclear_JJ if_IN the_DT US_NNP will_MD take_VB part_NN ._. Under_IN President_NNP Donald_NNP Trump_NNP ’s_POS “_`` America_NNP First_JJ ”_'' doctrine_NN ,_, the_DT US_NNP has_VBZ tended_VBN to_TO favour_VB unilateral_JJ action_NN and_CC eschew_VB cooperation_NN with_IN international_JJ organisations_NNS ._. Case_NN in_IN point_NN :_: On_IN March_NNP 14_CD ,_, Trump_NNP announced_VBD that_IN he_PRP was_VBD suspending_VBG funding_NN to_IN the_DT WHO_NNP ,_, which_WDT has_VBZ spearheaded_VBN the_DT global_JJ response_NN to_IN the_DT pandemic_NN ._. With_IN an_DT annual_JJ input_NN of_IN about_RB $_$ 400_CD million_CD ,_, the_DT US_NNP is_VBZ the_DT biggest_JJS contributor_NN to_IN the_DT organisation_NN ;_, the_DT reduction_NN in_IN funds_NNS comes_VBZ at_IN a_DT vital_JJ moment_NN ._. What_WP all_DT that_DT will_MD mean_VB in_IN the_DT battle_NN against_IN a_DT virus_NN that_WDT –_: as_IN global_JJ health_NN experts_NNS have_VBP repeatedly_RB reminded_VBN us_PRP –_: knows_VBZ no_DT borders_NNS and_CC requires_VBZ coordinated_VBN action_NN remains_VBZ to_TO be_VB seen_VBN ._. On_IN the_DT scientific_JJ front_NN ,_, the_DT impact_NN may_MD be_VB minimal_JJ ._. While_IN global_JJ cooperation_NN and_CC the_DT sharing_NN of_IN expertise_NN and_CC information_NN is_VBZ critical_JJ ,_, it_PRP also_RB happens_VBZ largely_RB without_IN government_NN involvement_NN and_CC ,_, as_IN of_IN now_RB ,_, continues_VBZ unimpeded_JJ ,_, said_VBD Laurent_NNP Humeau_NNP ,_, chief_JJ scientific_JJ officer_NN at_IN Inovio_NNP Pharmaceuticals_NNPS ._. Humeau_NNP ’s_POS team_NN has_VBZ relied_VBN on_IN the_DT sequencing_NN of_IN the_DT genome_NN provided_VBN by_IN China_NNP ,_, genetic_JJ material_NN from_IN Australia_NNP and_CC has_VBZ cooperated_VBN with_IN researchers_NNS in_IN South_NNP Korea_NNP and_CC the_DT UK_NNP ._. “_`` It_PRP ’s_VBZ a_DT community_NN that_WDT is_VBZ moving_VBG very_RB fast_RB and_CC we_PRP need_VBP everyone_NN else_JJ ’s_POS help_NN to_TO get_VB a_DT vaccine_NN ,_, ”_'' he_PRP said_VBD ._. “_`` It_PRP ’s_VBZ absolutely_RB critical_JJ for_IN us_PRP to_TO have_VB this_DT network_NN of_IN scientists_NNS ._. ”_'' The_DT Inovio_NNP team_NN is_VBZ part_NN of_IN the_DT WHO_NNP ’s_POS R_NNP &_CC D_NNP Blueprint_NNP ,_, which_WDT pulls_VBZ together_RP a_DT coalition_NN of_IN experts_NNS and_CC allows_VBZ for_IN “_`` the_DT rapid_JJ activation_NN of_IN research_NN and_CC development_NN activities_NNS during_IN epidemics_NNS ”_'' ._. And_CC despite_IN the_DT public_JJ distance_NN between_IN the_DT US_NNP and_CC the_DT WHO_NNP ,_, key_JJ health_NN personnel_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- and_CC the_DT National_NNP Institutes_NNPS of_IN Health_NNP continue_VBP to_TO be_VB part_NN of_IN the_DT global_JJ scientific_JJ dialogue_NN ._. For_IN now_RB ,_, the_DT international_JJ research_NN community_NN is_VBZ working_VBG together_RB to_TO do_VB all_DT it_PRP can_MD ._. “_`` We_PRP keep_VBP pushing_VBG as_RB fast_RB –_: it_PRP ’s_VBZ not_RB as_RB fast_RB as_IN we_PRP can_MD run_VB ,_, but_CC as_RB fast_RB as_IN we_PRP can_MD fly_VB ,_, ”_'' Humeau_NNP said_VBD ._. Unless_IN governments_NNS issue_VBP restrictions_NNS –_: such_JJ as_IN those_DT the_DT US_NNP imposed_VBN on_IN stem_NN -_HYPH cell_NN research_NN –_: politics_NNS tends_VBZ to_TO exist_VB in_IN a_DT sphere_NN separate_JJ from_IN science_NN ,_, said_VBD Gregory_NNP Poland_NNP ,_, director_NN of_IN the_DT Mayo_NNP Clinic_NNP ’s_POS Vaccine_NNP Research_NNP Group_NNP and_CC who_WP also_RB edits_VBZ the_DT international_JJ journal_NN Vaccine_NNP ._. “_`` You_PRP ’re_VBP not_RB working_VBG in_IN a_DT political_JJ framework_NN –_: at_IN least_JJS in_IN the_DT US_NNP –_: you_PRP ’re_VBP working_VBG in_IN a_DT scientific_JJ framework_NN ,_, ”_'' Poland_NNP said_VBD ._. Researchers_NNS end_VBP up_RP primarily_RB communicating_VBG through_IN journals_NNS and_CC meetings_NNS and_CC ,_, perhaps_RB most_RBS importantly_RB in_IN the_DT current_JJ crisis_NN ,_, on_IN ""_`` preprint_NN servers_NNS ""_'' ,_, where_WRB researchers_NNS place_VBP articles_NNS before_IN they_PRP have_VBP gone_VBN through_IN peer_NN review_NN and_CC been_VBN published_VBN ._. “_`` That_DT has_VBZ been_VBN the_DT primary_JJ way_NN that_WDT scientists_NNS have_VBP been_VBN communicating_VBG with_IN one_CD another_DT ,_, ”_'' Poland_NNP said_VBD ._. There_EX may_MD even_RB be_VB a_DT silver_JJ lining_NN to_IN a_DT little_JJ bit_NN of_IN distance_NN between_IN researchers_NNS ,_, said_VBD Peter_NNP Hotez_NNP ,_, dean_NN for_IN the_DT National_NNP School_NNP of_IN Medicine_NNP at_IN the_DT Baylor_NNP College_NNP of_IN Medicine_NNP ._. “_`` The_DT US_NNP and_CC Europe_NNP sometimes_RB have_VBP different_JJ approaches_NNS to_IN vaccine_NN development_NN and_CC how_WRB to_TO support_VB vaccine_NN science_NN ,_, and_CC that_DT may_MD not_RB be_VB so_RB bad_JJ because_IN it_PRP creates_VBZ additional_JJ opportunities_NNS for_IN innovation_NN ,_, ”_'' he_PRP said_VBD ._. Poland_NNP hopes_VBZ that_IN this_DT pandemic_NN ,_, unlike_IN the_DT ones_NNS that_WDT preceded_VBD it_PRP ,_, will_MD finally_RB have_VB helped_VBN people_NNS understand_VB how_WRB interrelated_JJ their_PRP$ nations_NNS are_VBP ._. “_`` We_PRP ’ve_VBP had_VBN multiple_JJ examples_NNS now_RB ,_, that_IN anything_NN that_WDT happens_VBZ anywhere_RB on_IN this_DT globe_NN is_VBZ maybe_RB ,_, at_IN most_JJS ,_, 36_CD hours_NNS away_RB from_IN Europe_NNP or_CC North_NNP America_NNP ,_, ”_'' he_PRP said_VBD ._. “_`` There_EX ’s_VBZ where_WRB you_PRP need_VBP a_DT lot_NN of_IN cooperation_NN ,_, for_IN example_NN ,_, on_IN surveillance_NN ,_, on_IN what_WP is_VBZ happening_VBG where_WRB ,_, because_IN –_: literally_RB –_: days_NNS are_VBP lives_NNS ._. ”_'' Finding_VBG a_DT vaccine_NN is_VBZ only_RB a_DT first_JJ step_NN ,_, warned_VBD David_NNP Salisbury_NNP ,_, associate_NN fellow_NN in_IN the_DT Global_NNP Health_NNP Programme_NNP at_IN Chatham_NNP House_NNP ._. “_`` The_DT fact_NN that_IN scientists_NNS are_VBP talking_VBG to_IN each_DT other_JJ is_VBZ admirable_JJ ,_, because_IN sharing_VBG what_WP we_PRP are_VBP learning_VBG about_IN vaccine_NN development_NN is_VBZ ,_, of_IN course_NN ,_, hugely_RB important_JJ ,_, ""_'' Salisbury_NNP said_VBD ._. “_`` But_CC that_DT is_VBZ the_DT beginning_NN of_IN the_DT story_NN …_: Ultimately_RB ,_, we_PRP ’ve_VBP got_VBN to_TO get_VB from_IN developing_VBG a_DT vaccine_NN to_IN manufacturing_NN and_CC buying_VBG it_PRP country_NN by_IN country_NN ,_, and_CC then_RB we_PRP ’re_VBP into_IN a_DT political_JJ world_NN that_WDT has_VBZ left_VBN the_DT scientists_NNS behind_IN …_. The_DT critical_JJ thing_NN is_VBZ not_RB when_WRB do_VBP we_PRP get_VB the_DT first_JJ dose_NN ,_, it_PRP ’s_VBZ when_WRB do_VBP we_PRP get_VB enough_JJ ._. ”_'' Manufacturing_NN and_CC distributing_VBG a_DT vaccine_NN will_MD be_VB herculean_JJ tasks_NNS for_IN a_DT disease_NN that_WDT potentially_RB affects_VBZ everyone_NN on_IN the_DT planet_NN ,_, and_CC that_DT ’s_VBZ where_WRB a_DT new_JJ set_NN of_IN potential_JJ problems_NNS arises_VBZ ._. “_`` You_PRP could_MD imagine_VB a_DT philosophy_NN of_IN America_NNP First_RB that_WDT might_MD actually_RB prevent_VB vaccines_NNS manufactured_VBN in_IN the_DT US_NNP from_IN leaving_VBG the_DT US_NNP until_IN everyone_NN [_-LRB- there_RB ]_-RRB- had_VBD been_VBN vaccinated_VBN ,_, ”_'' Salisbury_NNP said_VBD ._. “_`` Or_CC what_WP if_IN the_DT EU_NNP says_VBZ we_PRP will_MD prioritise_VB European_JJ customers_NNS first_RB ?_. Geopolitics_NNS becomes_VBZ really_RB important_JJ in_IN what_WP becomes_VBZ available_JJ when_WRB and_CC for_IN whom_WP ._. ”_'' Salisbury_NNP said_VBD that_IN countries_NNS that_WDT ca_MD n’t_RB afford_VB to_TO pay_VB market_NN rate_NN also_RB risk_VBP getting_VBG pushed_VBN to_IN the_DT bottom_NN of_IN “_`` this_DT great_JJ long_JJ list_NN of_IN customers_NNS ”_'' ._. The_DT international_JJ community_NN needs_VBZ to_TO consider_VB carefully_RB how_WRB what_WP are_VBP certain_JJ to_TO be_VB scarce_JJ supplies_NNS to_TO begin_VB with_IN get_VB distributed_VBN ._. “_`` How_WRB do_VBP we_PRP share_VB a_DT hugely_RB valuable_JJ resource_NN equitably_RB ?_. ”_'' he_PRP asked_VBD ._. “_`` I_PRP do_VBP n’t_RB know_VB that_IN we_PRP have_VBP a_DT solution_NN yet_RB ._. ”_''","As the NN VBZ to VB the NN , one NN VBZ RB JJ from JJ NNS : the NNP NNPS . But NNS VBP that for RB , the JJ NN NN VBZ VBG RB to VB all it can . JJ NNS VBP VBG NNS on JJ NNS to VB the NN NN under NN . On NNP 24 , the NNP NNP NNP ( NNP ) VBD a JJ NN to VB an JJ NN to VB the NN and NN of the NN NNS JJ to VB RB . The NNP NNPS VBD RB VB in the NN , which VBD in a JJ NN for NN . JJ NNP , NNP 4 , the NNP NNP will VB to that NN by VBG a JJ JJ NN to VB NN from NNS and NN NNS to VB the NN of NNS , NNS and a NN for the NN . It VBZ VBN “ NNS , NN NNS , JJ NNS , NNS , NNS and NNS ” to VB with its NNS to VB the € 7.5 billion it VBZ VBN as its JJ NN . VBN NNS VBP NNP , NNP , the NNP NNP , NNP and NNP NNP . It VBZ JJ if the NNP will VB NN . Under NNP NNP NNP ’s “ NNP JJ ” NN , the NNP VBZ VBN to VB JJ NN and VB NN with JJ NNS . NN in NN : On NNP 14 , NNP VBD that he VBD VBG NN to the NNP , which VBZ VBN the JJ NN to the NN . With an JJ NN of RB $ 400 million , the NNP VBZ the JJS NN to the NN ; the NN in NNS VBZ at a JJ NN . What all that will VB in the NN against a NN that – as JJ NN NNS VBP RB VBN us – VBZ no NNS and VBZ VBN NN VBZ to VB VBN . On the JJ NN , the NN may VB JJ . While JJ NN and the NN of NN and NN VBZ JJ , it RB VBZ RB without NN NN and , as of RB , VBZ JJ , VBD NNP NNP , JJ JJ NN at NNP NNPS . NNP ’s NN VBZ VBN on the NN of the NN VBN by NNP , JJ NN from NNP and VBZ VBN with NNS in NNP NNP and the NNP . “ It VBZ a NN that VBZ VBG RB RB and we VBP NN JJ ’s NN to VB a NN , ” he VBD . “ It VBZ RB JJ for us to VB this NN of NNS . ” The NNP NN VBZ NN of the NNP ’s NNP & NNP NNP , which VBZ together a NN of NNS and VBZ for “ the JJ NN of NN and NN NNS during NNS ” . And despite the JJ NN between the NNP and the NNP , JJ NN NNS from the NNPS for NNP NNP and NNP ( NNP ) and the NNP NNPS of NNP VBP to VB NN of the JJ JJ NN . For RB , the JJ NN NN VBZ VBG RB to VB all it can . “ We VBP VBG RB RB – it VBZ RB RB RB as we can VB , but RB RB as we can VB , ” NNP VBD . Unless NNS VBP NNS – JJ as those the NNP VBN on NN - NN NN – NNS VBZ to VB in a NN JJ from NN , VBD NNP NNP , NN of the NNP NNP ’s NNP NNP NNP and who RB VBZ the JJ NN NNP . “ You VBP RB VBG in a JJ NN – at JJS in the NNP – you VBP VBG in a JJ NN , ” NNP VBD . NNS VBP up RB VBG through NNS and NNS and , RB RBS RB in the JJ NN , on "" NN NNS "" , where NNS VBP NNS before they VBP VBN through NN NN and VBN VBN . “ That VBZ VBN the JJ NN that NNS VBP VBN VBG with one another , ” NNP VBD . There may RB VB a JJ NN to a JJ NN of NN between NNS , VBD NNP NNP , NN for the NNP NNP of NNP at the NNP NNP of NNP . “ The NNP and NNP RB VBP JJ NNS to NN NN and how to VB NN NN , and that may RB VB RB JJ because it VBZ JJ NNS for NN , ” he VBD . NNP VBZ that this NN , unlike the NNS that VBD it , will RB VB VBN NNS VB how JJ their NNS VBP . “ We VBP VBN JJ NNS RB , that NN that VBZ RB on this NN VBZ RB , at JJS , 36 NNS RB from NNP or NNP NNP , ” he VBD . “ There VBZ where you VBP a NN of NN , for NN , on NN , on what VBZ VBG where , because – RB – NNS VBP NNS . ” VBG a NN VBZ RB a JJ NN , VBD NNP NNP , NN NN in the NNP NNP NNP at NNP NNP . “ The NN that NNS VBP VBG to each JJ VBZ JJ , because VBG what we VBP VBG about NN NN VBZ , of NN , RB JJ , "" NNP VBD . “ But that VBZ the NN of the NN … RB , we VBP VBN to VB from VBG a NN to NN and VBG it NN by NN , and RB we VBP into a JJ NN that VBZ VBN the NNS behind … The JJ NN VBZ RB when VBP we VB the JJ NN , it VBZ when VBP we VB JJ . ” NN and VBG a NN will VB JJ NNS for a NN that RB VBZ NN on the NN , and that VBZ where a JJ NN of JJ NNS VBZ . “ You could VB a NN of NNP RB that might RB VB NNS VBN in the NNP from VBG the NNP until NN [ RB ] VBD VBN VBN , ” NNP VBD . “ Or what if the NNP VBZ we will VB JJ NNS RB ? NNS VBZ RB JJ in what VBZ JJ when and for whom . ” NNP VBD that NNS that ca RB VB to VB NN NN RB VBP VBG VBN to the NN of “ this JJ JJ NN of NNS ” . The JJ NN VBZ to VB RB how what VBP JJ to VB JJ NNS to VB with VB VBN . “ How VBP we VB a RB JJ NN RB ? ” he VBD . “ I VBP RB VB that we VBP a NN RB . ”"
59,450,mainstream,"Kentucky_NNP Derby_NNP fans_NNS may_MD need_VB to_TO take_VB some_DT extra_JJ precautions_NNS before_IN heading_VBG off_RP to_IN the_DT races_NNS ._. The_DT Indiana_NNP State_NNP Department_NNP of_IN Health_NNP is_VBZ recommending_VBG that_IN its_PRP$ residents_NNS get_VBP vaccinated_VBN against_IN hepatitis_NN A_NN and_CC take_VBP other_JJ steps_NNS to_TO protect_VB themselves_PRP from_IN the_DT illness_NN before_IN traveling_VBG to_IN Kentucky_NNP or_CC Michigan_NNP ,_, both_DT of_IN which_WDT are_VBP experiencing_VBG large_JJ outbreaks_NNS of_IN the_DT viral_JJ infection_NN ._. Kentucky_NNP has_VBZ reported_VBN more_JJR than_IN 300_CD cases_NNS of_IN hepatitis_NN A_NN since_IN November_NNP 2017_CD ,_, with_IN 39_CD new_JJ cases_NNS reported_VBN in_IN the_DT first_JJ week_NN of_IN April_NNP ,_, according_VBG to_IN the_DT Kentucky_NNP Department_NNP for_IN Public_NNP Health_NNP ._. Most_JJS cases_NNS in_IN the_DT state_NN have_VBP occurred_VBN around_IN Louisville_NNP —_: the_DT city_NN where_WRB the_DT Kentucky_NNP Derby_NNP is_VBZ held_VBN ._. The_DT famous_JJ horse_NN race_NN ,_, which_WDT draws_VBZ more_JJR than_IN 150,000_CD people_NNS each_DT year_NN ,_, takes_VBZ place_NN on_IN the_DT first_JJ Saturday_NNP in_IN May_NNP ._. ""_`` With_IN popular_JJ tourist_NN events_NNS coming_VBG up_RP in_IN other_JJ states_NNS ,_, we_PRP know_VBP many_JJ Hoosiers_NNPS will_MD be_VB traveling_VBG to_IN areas_NNS impacted_VBN by_IN hepatitis_NN A_NN ,_, and_CC we_PRP want_VBP them_PRP to_TO be_VB safe_JJ ,_, ""_'' Pam_NNP Pontones_NNP ,_, the_DT Indiana_NNP deputy_NN state_NN health_NN commissioner_NN ,_, said_VBD in_IN a_DT statement_NN ._. ""_`` Getting_VBG vaccinated_VBN and_CC thoroughly_RB washing_VBG your_PRP$ hands_NNS before_IN and_CC after_IN preparing_VBG food_NN and_CC eating_VBG and_CC after_IN using_VBG the_DT restroom_NN are_VBP simple_JJ ,_, safe_JJ and_CC effective_JJ ways_NNS to_TO prevent_VB the_DT spread_NN of_IN hepatitis_NN A_NN ._. ""_'' But_CC do_VBP you_PRP really_RB need_VB to_TO get_VB a_DT hepatitis_NN A_NN vaccine_NN if_IN you_PRP 're_VBP going_VBG to_IN the_DT Kentucky_NNP Derby_NNP ?_. Dr._NNP Amesh_NNP Adalja_NNP ,_, a_DT senior_JJ scholar_NN at_IN the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP ,_, said_VBD the_DT Indiana_NNP recommendation_NN is_VBZ an_DT interesting_JJ step_NN to_TO take_VB ,_, and_CC it_PRP 's_VBZ not_RB a_DT bad_JJ idea_NN ._. ""_`` I_PRP can_MD see_VB why_WRB they_PRP would_MD advise_VB it_PRP ,_, ""_'' Adalja_NNP said_VBD ._. ""_`` It_PRP 's_VBZ something_NN that_WDT 's_VBZ an_DT easy_JJ measure_NN that_WDT can_MD minimize_VB risk_NN ._. ""_'' [_-LRB- 27_CD Devastating_VBG Infectious_JJ Diseases_NNS ]_-RRB- At_IN the_DT same_JJ time_NN ,_, Adalja_NNP told_VBD Live_NNP Science_NNP that_IN the_DT risk_NN of_IN hepatitis_NN A_NN probably_RB is_VBZ n't_RB very_RB high_JJ for_IN the_DT average_JJ visitor_NN to_IN the_DT Derby_NNP ._. A_DT number_NN of_IN recent_JJ U.S._NNP hepatitis_NN A_NN outbreaks_NNS ,_, including_VBG the_DT one_NN in_IN Kentucky_NNP ,_, have_VBP occurred_VBN primarily_RB among_IN the_DT homeless_JJ population_NN and_CC illicit_JJ -_HYPH drug_NN users_NNS —_: a_DT group_NN that_WDT may_MD have_VB limited_VBN access_NN to_IN clean_JJ toilets_NNS and_CC handwashing_NN facilities_NNS ,_, which_WDT are_VBP important_JJ in_IN preventing_VBG the_DT spread_NN of_IN hepatitis_NN A_NN ._. But_CC hepatitis_NN A_NN outbreaks_NNS can_MD also_RB occur_VB through_IN contaminated_VBN food_NN ,_, Adalja_NNP noted_VBD —_: for_IN instance_NN ,_, if_IN food_NN workers_NNS contract_VBP the_DT illness_NN and_CC handle_VBP food_NN without_IN properly_RB washing_VBG their_PRP$ hands_NNS ._. (_-LRB- The_DT Kentucky_NNP hepatitis_NN A_NNP outbreak_NN has_VBZ not_RB been_VBN linked_VBN with_IN contaminated_VBN food_NN ,_, although_IN it_PRP was_VBD recently_RB reported_VBN that_IN a_DT McDonald_NNP 's_POS employee_NN in_IN Berea_NNP ,_, Kentucky_NNP ,_, south_RB of_IN Lexington_NNP ,_, had_VBD the_DT infection_NN and_CC could_MD have_VB potentially_RB spread_VBN it_PRP to_IN customers_NNS ._. )_-RRB- If_IN Kentucky_NNP Derby_NNP -_HYPH goers_NNS want_VBP to_TO minimize_VB their_PRP$ risk_NN of_IN getting_VBG the_DT illness_NN ,_, ""_'' the_DT vaccine_NN is_VBZ one_CD way_NN to_TO do_VB that_DT ,_, ""_'' Adalja_NNP said_VBD ._. Hepatitis_NN A_NN is_VBZ a_DT contagious_JJ liver_NN infection_NN caused_VBN by_IN the_DT hepatitis_NN A_NN virus_NN ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. The_DT virus_NN is_VBZ spread_VBN through_IN the_DT ""_`` fecal_JJ -_HYPH oral_JJ ""_'' route_NN —_: that_DT is_VBZ ,_, when_WRB small_JJ amounts_NNS of_IN stool_NN from_IN an_DT ill_JJ person_NN contaminate_VB objects_NNS ,_, food_NN or_CC drinks_NNS that_WDT are_VBP then_RB touched_VBN and_CC ingested_VBN by_IN another_DT person_NN ,_, the_DT CDC_NNP says_VBZ ._. For_IN this_DT reason_NN ,_, thorough_JJ handwashing_NN —_: particularly_RB after_IN using_VBG the_DT bathroom_NN or_CC changing_VBG a_DT child_NN 's_POS diaper_NN ,_, or_CC before_IN eating_VBG —_: can_MD help_VB reduce_VB a_DT person_NN 's_POS risk_NN of_IN getting_VBG hepatitis_NN A_NN ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. It_PRP 's_VBZ important_JJ to_TO note_VB that_IN the_DT Indiana_NNP announcement_NN is_VBZ not_RB a_DT nationwide_JJ recommendation_NN ._. In_IN general_JJ ,_, the_DT CDC_NNP recommends_VBZ the_DT hepatitis_JJ vaccine_NN for_IN children_NNS at_IN age_NN 1_CD ,_, as_RB well_RB as_IN adults_NNS who_WP may_MD be_VB at_IN higher_JJR risk_NN for_IN hepatitis_NN A_NN or_CC for_IN complications_NNS from_IN the_DT illness_NN ._. These_DT include_VBP travelers_NNS to_IN countries_NNS where_WRB hepatitis_NN A_NN is_VBZ common_JJ ,_, people_NNS who_WP use_VBP recreational_JJ drugs_NNS ,_, people_NNS with_IN chronic_JJ liver_NN disease_NN ,_, men_NNS who_WP have_VBP sexual_JJ contact_NN with_IN other_JJ men_NNS ,_, and_CC people_NNS who_WP have_VBP direct_JJ contact_NN with_IN others_NNS who_WP have_VBP hepatitis_NN A_NN ._. The_DT CDC_NNP says_VBZ that_IN ideally_RB ,_, a_DT person_NN should_MD get_VB the_DT hepatitis_NN vaccine_NN two_CD weeks_NNS or_CC more_JJR before_IN departing_VBG for_IN their_PRP$ trip_NN ,_, but_CC getting_VBG the_DT vaccine_NN any_DT time_NN before_IN travel_NN will_MD provide_VB some_DT protection_NN ._. Adalja_NNP noted_VBD that_IN a_DT number_NN of_IN Americans_NNPS are_VBP already_RB vaccinated_VBN against_IN hepatitis_NN A_NN ._. The_DT vaccine_NN was_VBD first_RB licensed_VBN in_IN 1995_CD and_CC was_VBD recommended_VBN for_IN all_DT U.S._NNP children_NNS starting_VBG in_IN 2006_CD ._. But_CC that_DT would_MD still_RB leave_VB many_JJ adults_NNS today_NN unvaccinated_VBN ,_, unless_IN they_PRP already_RB got_VBD the_DT vaccine_NN for_IN travel_NN or_CC because_IN they_PRP fall_VBP into_IN a_DT group_NN that_WDT 's_VBZ at_IN higher_JJR risk_NN for_IN contracting_VBG the_DT illness_NN ._. Symptoms_NNS of_IN hepatitis_NN A_NN infection_NN usually_RB do_VBP n't_RB appear_VB until_IN two_CD to_IN six_CD weeks_NNS after_IN a_DT person_NN has_VBZ been_VBN infected_VBN ,_, and_CC include_VBP fever_NN ,_, fatigue_NN ,_, nausea_NN ,_, vomiting_NN ,_, dark_JJ -_HYPH yellow_JJ urine_NN ,_, joint_JJ pain_NN and_CC jaundice_NN (_-LRB- a_DT yellowing_NN of_IN the_DT skin_NN and_CC eyes_NNS )_-RRB- ,_, according_VBG to_IN the_DT CDC_NNP ._. People_NNS with_IN the_DT infection_NN usually_RB get_VBP better_JJR on_IN their_PRP$ own_JJ without_IN a_DT specific_JJ treatment_NN ,_, but_CC in_IN some_DT cases_NNS ,_, the_DT infection_NN can_MD lead_VB to_IN liver_NN failure_NN ,_, particularly_RB in_IN older_JJR adults_NNS or_CC people_NNS who_WP have_VBP other_JJ liver_NN diseases_NNS ,_, according_VBG to_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._.","NNP NNP NNS may VB to VB some JJ NNS before VBG off to the NNS . The NNP NNP NNP of NNP VBZ VBG that its NNS VBP VBN against NN NN and VBP JJ NNS to VB themselves from the NN before VBG to NNP or NNP , both of which VBP VBG JJ NNS of the JJ NN . NNP VBZ VBN JJR than 300 NNS of NN NN since NNP 2017 , with 39 JJ NNS VBN in the JJ NN of NNP , VBG to the NNP NNP for NNP NNP . JJS NNS in the NN VBP VBN around NNP — the NN where the NNP NNP VBZ VBN . The JJ NN NN , which VBZ JJR than 150,000 NNS each NN , VBZ NN on the JJ NNP in NNP . "" With JJ NN NNS VBG up in JJ NNS , we VBP JJ NNPS will VB VBG to NNS VBN by NN NN , and we VBP them to VB JJ , "" NNP NNP , the NNP NN NN NN NN , VBD in a NN . "" VBG VBN and RB VBG your NNS before and after VBG NN and VBG and after VBG the NN VBP JJ , JJ and JJ NNS to VB the NN of NN NN . "" But VBP you RB VB to VB a NN NN NN if you VBP VBG to the NNP NNP ? NNP NNP NNP , a JJ NN at the NNP NNP NNP for NNP NNP , VBD the NNP NN VBZ an JJ NN to VB , and it VBZ RB a JJ NN . "" I can VB why they would VB it , "" NNP VBD . "" It VBZ NN that VBZ an JJ NN that can VB NN . "" [ 27 VBG JJ NNS ] At the JJ NN , NNP VBD NNP NNP that the NN of NN NN RB VBZ RB RB JJ for the JJ NN to the NNP . A NN of JJ NNP NN NN NNS , VBG the NN in NNP , VBP VBN RB among the JJ NN and JJ - NN NNS — a NN that may VB VBN NN to JJ NNS and NN NNS , which VBP JJ in VBG the NN of NN NN . But NN NN NNS can RB VB through VBN NN , NNP VBD — for NN , if NN NNS VBP the NN and VBP NN without RB VBG their NNS . ( The NNP NN NNP NN VBZ RB VBN VBN with VBN NN , although it VBD RB VBN that a NNP 's NN in NNP , NNP , RB of NNP , VBD the NN and could VB RB VBN it to NNS . ) If NNP NNP - NNS VBP to VB their NN of VBG the NN , "" the NN VBZ one NN to VB that , "" NNP VBD . NN NN VBZ a JJ NN NN VBN by the NN NN NN , VBG to the NNPS for NNP NNP and NNP . The NN VBZ VBN through the "" JJ - JJ "" NN — that VBZ , when JJ NNS of NN from an JJ NN VB NNS , NN or NNS that VBP RB VBN and VBN by another NN , the NNP VBZ . For this NN , JJ NN — RB after VBG the NN or VBG a NN 's NN , or before VBG — can VB VB a NN 's NN of VBG NN NN , VBG to the NNP NNP . It VBZ JJ to VB that the NNP NN VBZ RB a JJ NN . In JJ , the NNP VBZ the JJ NN for NNS at NN 1 , RB RB as NNS who may VB at JJR NN for NN NN or for NNS from the NN . These VBP NNS to NNS where NN NN VBZ JJ , NNS who VBP JJ NNS , NNS with JJ NN NN , NNS who VBP JJ NN with JJ NNS , and NNS who VBP JJ NN with NNS who VBP NN NN . The NNP VBZ that RB , a NN should VB the NN NN two NNS or JJR before VBG for their NN , but VBG the NN any NN before NN will VB some NN . NNP VBD that a NN of NNPS VBP RB VBN against NN NN . The NN VBD RB VBN in 1995 and VBD VBN for all NNP NNS VBG in 2006 . But that would RB VB JJ NNS NN VBN , unless they RB VBD the NN for NN or because they VBP into a NN that VBZ at JJR NN for VBG the NN . NNS of NN NN NN RB VBP RB VB until two to six NNS after a NN VBZ VBN VBN , and VBP NN , NN , NN , NN , JJ - JJ NN , JJ NN and NN ( a NN of the NN and NNS ) , VBG to the NNP . NNS with the NN RB VBP JJR on their JJ without a JJ NN , but in some NNS , the NN can VB to NN NN , RB in JJR NNS or NNS who VBP JJ NN NNS , VBG to the NNP NNPS of NNP ."
60,513,conspiracy,"Here_RB are_VBP just_RB a_DT handful_NN of_IN the_DT high_JJ crimes_NNS and_CC misdemeanors_NNS committed_VBN by_IN Barack_NNP Hussein_NNP Obama_NNP ._. He_PRP lied_VBD to_IN the_DT American_JJ people_NNS when_WRB he_PRP said_VBD we_PRP could_MD keep_VB our_PRP$ private_JJ insurance_NN ,_, knowing_VBG full_JJ well_RB that_IN his_PRP$ legislation_NN would_MD inevitably_RB drive_VB private_JJ insurers_NNS out_IN of_IN business_NN ._. Gerald_NNP Walpin_NNP ,_, Inspector_NNP General_NNP of_IN the_DT Corporation_NNP For_IN National_NNP and_CC Community_NNP Service_NNP investigated_VBD Kevin_NNP Johnson_NNP ,_, a_DT big_JJ buddy_NN of_IN the_DT president_NN ,_, for_IN misuse_NN of_IN funds_NNS from_IN an_DT AmeriCorps_NNP grant_NN ._. Whereupon_IN Obama_NNP vindictively_RB fired_VBD Walpin_NNP to_TO cover_VB for_IN Johnson_NNP ._. A_DT subsequent_JJ investigation_NN vindicated_VBD Walpin_NNP 's_POS judgment_NN in_IN the_DT matter_NN ._. Barack_NNP Hussein_NNP Obama_NNP has_VBZ overseen_VBN the_DT effective_JJ takeover_NN by_IN government_NN of_IN banks_NNS ,_, the_DT largest_JJS insurance_NN company_NN (_-LRB- AIG_NNP )_-RRB- ,_, and_CC General_NNP Motors_NNPS (_-LRB- GM_NNP )_-RRB- and_CC Chrysler_NNP ..._, the_DT bulk_NN of_IN the_DT U.S._NNP auto_NN industry_NN ,_, thus_RB depriving_VBG bondholders_NNS ,_, shareholders_NNS ,_, and_CC others_NNS of_IN their_PRP$ property_NN ._. Barack_NNP Hussein_NNP Obama_NNP is_VBZ actively_RB pursuing_VBG cap_NN -_HYPH and_CC -_HYPH trade_NN legislation_NN ._. Instead_RB of_IN taxing_VBG the_DT very_JJ air_NN we_PRP breathe_VBP ,_, it_PRP would_MD instead_RB ,_, in_IN a_DT manner_NN of_IN speaking_VBG ,_, tax_VB the_DT air_NN we_PRP exhale_VBP and_CC give_VBP the_DT government_NN unprecedented_JJ control_NN over_IN the_DT economy_NN and_CC American_JJ businesses_NNS ._. Barack_NNP Hussein_NNP Obama_NNP is_VBZ running_VBG up_RP our_PRP$ debt_NN at_IN an_DT alarming_JJ rate_NN ._. In_IN just_RB 9_CD months_NNS since_IN Obama_NNP assumed_VBD office_NN ,_, our_PRP$ National_NNP Debt_NNP has_VBZ gone_VBN up_RP by_IN over_RB a_DT trillion_CD dollars_NNS ._. To_TO put_VB that_DT figure_NN in_IN perspective_NN ,_, it_PRP took_VBD George_NNP W._NNP Bush_NNP 8_CD years_NNS to_TO add_VB 4.8_CD trillion_CD to_IN the_DT National_NNP Debt_NNP ._. And_CC ,_, to_TO add_VB insult_NN to_IN injury_NN ,_, we_PRP 're_VBP printing_VBG money_NN like_IN it_PRP 's_VBZ going_VBG out_IN of_IN style_NN ._. The_DT effect_NN will_MD be_VB hyper-_JJ inflation_NN ,_, a_DT crippling_NN of_IN our_PRP$ economy_NN and_CC ,_, quite_RB possibly_RB ,_, personal_JJ hardship_NN on_IN a_DT scale_NN that_WDT has_VBZ not_RB been_VBN experienced_VBN since_IN the_DT Great_NNP Depression_NNP ._. Barack_NNP Hussein_NNP Obama_NNP has_VBZ appointed_VBN countless_JJ ""_`` Czars_NNPS ""_'' to_TO oversee_VB everything_NN from_IN the_DT closing_NN of_IN Guantanamo_NNP to_IN the_DT food_NN we_PRP eat_VBP ._. These_DT Czars_NNS do_VBP n't_RB have_VB to_TO be_VB approved_VBN by_IN the_DT Senate_NNP ._. The_DT Czars_NNPS have_VBP unprecedented_JJ power_NN and_CC report_VBP only_RB to_IN Obama_NNP ._. Members_NNS of_IN both_DT parties_NNS are_VBP disturbed_VBN by_IN these_DT extra-Constitutional_JJ excrescences_NNS ._. Senator_NNP Robert_NNP Byrd_NNP said_VBD :_: ""_`` The_DT accumulation_NN of_IN power_NN by_IN White_NNP House_NNP staff_NN can_MD threaten_VB the_DT Constitutional_JJ system_NN of_IN checks_NNS and_CC balances_NNS ._. ""_'' Congressman_NNP Jack_NNP Kingston_NNP called_VBD the_DT Czars_NNPS a_DT ""_`` parallel_JJ government_NN ._. ""_'' And_CC finally_RB ,_, Obama_NNP has_VBZ consistently_RB refused_VBN to_TO approve_VB the_DT release_NN of_IN his_PRP$ actual_JJ birth_NN certificate_NN ,_, college_NN transcripts_NNS and_CC his_PRP$ medical_JJ records_NNS ._. And_CC these_DT matters_NNS only_RB scratch_VBP the_DT surface_NN ._. It_PRP 's_VBZ almost_RB as_IN if_IN Obama_NNP is_VBZ intentionally_RB trying_VBG to_TO destroy_VB the_DT country_NN ._. Barack_NNP Hussein_NNP Obama_NNP has_VBZ said_VBN that_IN America_NNP is_VBZ not_RB a_DT Christian_JJ nation_NN ,_, on_IN countless_JJ occasions_NNS ,_, despite_IN surveys_NNS that_WDT find_VBP a_DT whopping_VBG majority_NN say_VBP the_DT contrary_NN ._. In_IN his_PRP$ book_NN ,_, The_DT Audacity_NNP of_IN Hope_NNP ,_, he_PRP wrote_VBD of_IN Muslims_NNPS and_CC Arabic_JJ immigrants_NNS :_: ""_`` ..._, I_PRP will_MD stand_VB with_IN them_PRP should_MD the_DT political_JJ winds_NNS shift_VB in_IN an_DT ugly_JJ direction_NN ._. ""_'' When_WRB he_PRP spoke_VBD at_IN Georgetown_NNP University_NNP ,_, a_DT Catholic_JJ institution_NN ,_, the_DT White_NNP House_NNP insisted_VBD that_IN the_DT name_NN of_IN Jesus_NNP ,_, be_VB covered_VBN ._. Georgetown_NNP complied_VBD ._. In_IN 2006_CD ,_, he_PRP said_VBD ;_, ""_`` Whatever_WP we_PRP once_RB were_VBD ,_, we_PRP are_VBP no_RB longer_RBR a_DT Christian_JJ nation_NN ._. ""_'' He_PRP went_VBD to_IN Egypt_NNP and_CC said_VBD ,_, ""_`` You_PRP might_MD say_VB that_IN America_NNP is_VBZ a_DT Muslim_JJ nation_NN ._. ""_'' Why_WRB go_VB to_IN such_JJ lengths_NNS to_TO deny_VB the_DT Christian_JJ heritage_NN of_IN the_DT United_NNP States_NNPS ?_. Surely_RB Barack_NNP Hussein_NNP Obama_NNP knows_VBZ that_IN our_PRP$ personal_JJ liberties_NNS flow_VBP directly_RB from_IN our_PRP$ Christian_JJ heritage_NN ..._, that_IN there_EX is_VBZ no_DT surer_JJ way_NN to_TO destroy_VB our_PRP$ republic_NN than_IN to_TO deny_VB that_DT heritage_NN ._. President_NNP Thomas_NNP Jefferson_NNP :_: ""_`` God_NNP who_WP gave_VBD us_PRP life_NN gave_VBD us_PRP liberty_NN ._. Can_MD the_DT liberties_NNS of_IN a_DT nation_NN be_VB secure_JJ when_WRB we_PRP have_VBP removed_VBN a_DT conviction_NN that_IN these_DT liberties_NNS are_VBP the_DT gift_NN of_IN God_NNP ?_. ""_'' President_NNP Andrew_NNP Jackson_NNP called_VBD the_DT Bible_NNP ;_: ""_`` the_DT Rock_NN upon_IN which_WDT our_PRP$ republic_NN rests_VBZ ._. ""_'' President_NNP John_NNP Adams_NNP said_VBD ;_: ""_`` We_PRP have_VBP no_DT government_NN armed_JJ with_IN power_NN capable_JJ of_IN contending_VBG with_IN human_JJ passions_NNS unbridled_VBN by_IN morality_NN and_CC religion_NN ._. ""_'' Patrick_NNP Henry_NNP said_VBD ,_, ""_`` It_PRP is_VBZ when_WRB a_DT people_NNS forget_VBP God_NNP ,_, that_IN tyrants_NNS forge_VBP their_PRP$ chains_NNS ._. ""_'' George_NNP Washington_NNP ,_, in_IN his_PRP$ Farewell_NNP Address_NN said_VBD ;_, ""_`` Of_IN all_PDT the_DT dispositions_NNS and_CC habits_NNS which_WDT lead_VBP to_IN political_JJ prosperity_NN ,_, religion_NN and_CC morality_NN are_VBP indispensable_JJ supports_VBZ ._. ""_'' Alexis_NNP de_NNP Tocqueville_NNP ,_, in_IN Democracy_NNP in_IN America_NNP ,_, wrote_VBD extensively_RB on_IN the_DT relationship_NN between_IN the_DT Christian_JJ religion_NN and_CC liberty_NN in_IN American_NNP :_: ""_`` America_NNP is_VBZ great_JJ because_IN she_PRP is_VBZ good_JJ ._. If_IN America_NNP ceases_VBZ to_TO be_VB good_JJ ,_, America_NNP will_MD cease_VB to_TO be_VB great_JJ ._. ""_'' It_PRP 's_VBZ enough_JJ to_TO make_VB one_CD wonder_VB ..._, does_VBZ Barack_NNP Hussein_NNP Obama_NNP realize_VB that_IN every_DT stab_NN he_PRP takes_VBZ at_IN the_DT Christian_JJ heritage_NN of_IN this_DT great_JJ nation_NN is_VBZ a_DT blow_NN to_IN the_DT very_JJ foundation_NN of_IN our_PRP$ nation_NN ..._, a_DT blow_NN to_IN freedom_NN our_PRP$ personal_JJ liberty_NN ?_. Does_VBZ he_PRP simply_RB hate_VB Christianity_NNP ..._, does_VBZ he_PRP hate_VB the_DT United_NNP States_NNPS ..._, or_CC both_DT ?_. Barack_NNP Hussein_NNP Obama_NNP simply_RB has_VBZ n't_RB denied_VBN the_DT Christian_JJ heritage_NN of_IN this_DT nation_NN ._. He_PRP has_VBZ used_VBN his_PRP$ presidency_NN to_IN bad_JJ -_HYPH mouth_NN America_NNP itself_PRP at_IN every_DT turn_NN ._. He_PRP said_VBD ,_, ""_`` America_NNP has_VBZ been_VBN arrogant_JJ ._. ""_'' thus_RB giving_VBG our_PRP$ enemies_NNS and_CC our_PRP$ allies_NNS every_DT reason_NN to_TO believe_VB that_IN we_PRP are_VBP less_RBR resolved_VBN to_TO defend_VB ourselves_PRP and_CC hence_RB more_RBR vulnerable_JJ to_TO attack_VB ._. Following_VBG his_PRP$ inauguration_NN ,_, he_PRP ordered_VBD Gitmo_NNP closed_VBD ,_, within_IN a_DT year_NN ,_, despite_IN the_DT fact_NN that_IN it_PRP was_VBD (_-LRB- and_CC is_VBZ )_-RRB- the_DT best_JJS possible_JJ facility_NN for_IN detaining_VBG terrorists_NNS ._. His_PRP$ first_JJ presidential_JJ phone_NN call_NN was_VBD to_IN Mahmoud_NNP Abbas_NNP ,_, leader_NN of_IN the_DT Fatah_NNP Party_NNP in_IN the_DT Palestine_NNP territory_NN ._. According_VBG to_IN press_NN reports_NNS he_PRP told_VBD Abbas_NNP ;_, ""_`` This_DT is_VBZ my_PRP$ first_JJ phone_NN call_NN to_IN a_DT foreign_JJ leader_NN and_CC I_PRP 'm_VBP making_VBG it_PRP only_RB hours_NNS after_IN I_PRP took_VBD office_NN ._. ""_'' His_PRP$ first_JJ one_CD -_HYPH on_IN -_HYPH one_CD TV_NN interview_NN was_VBD not_RB with_IN NBC_NNP or_CC ABC_NNP ,_, but_CC with_IN Al_NNP Arabiya_NNP ,_, where_WRB he_PRP said_VBD :_: ""_`` My_PRP$ job_NN to_IN the_DT Muslim_JJ world_NN is_VBZ to_TO communicate_VB that_IN the_DT Americans_NNPS are_VBP not_RB your_PRP$ enemy_NN ._. We_PRP sometimes_RB make_VBP mistakes_NNS ._. We_PRP have_VBP not_RB been_VBN perfect_JJ ._. ""_'' He_PRP immediately_RB issued_VBD an_DT Executive_JJ Order_NN halting_VBG military_JJ commissions_NNS which_WDT resulted_VBD in_IN charges_NNS being_VBG dropped_VBN against_IN Abd_NNP al_NNP -_HYPH Rahim_NNP al_NNP -_HYPH Nashiri_NNP ,_, the_DT animal_NN accused_VBN of_IN planning_VBG numerous_JJ terrorist_JJ attacks_NNS against_IN Americans_NNPS ,_, including_VBG the_DT USS_NNP Cole_NNP bombing_NN in_IN which_WDT 17_CD U.S._NNP sailors_NNS died_VBD ._. While_IN treating_VBG the_DT Queen_NNP of_IN England_NNP with_IN casual_JJ familiarity_NN ,_, he_PRP obsequiously_RB bowed_VBD from_IN the_DT waist_NN to_IN King_NNP Abdullah_NNP of_IN Saudi_NNP Arabia_NNP ,_, leader_NN of_IN a_DT Muslim_JJ nation_NN that_WDT wo_MD n't_RB permit_VB Christian_JJ worship_NN within_IN its_PRP$ borders_NNS ..._, under_IN penalty_NN of_IN death_NN ._. Are_VBP Obama_NNP 's_POS denunciations_NNS of_IN America_NNP ,_, in_IN words_NNS and_CC deeds_NNS ,_, simply_RB faux_NN -_HYPH pas_NN or_CC do_VBP they_PRP show_VB ,_, as_IN Tammy_NNP Bruce_NNP said_VBD ,_, ""_`` malevolence_NN toward_IN this_DT country_NN ,_, which_WDT is_VBZ unabated_JJ ._. ""_'' Does_VBZ it_PRP really_RB matter_VB ?_. Barack_NNP Hussein_NNP Obama_NNP 's_POS words_NNS and_CC actions_NNS clearly_RB rise_VBP well_RB beyond_IN the_DT level_NN of_IN ""_`` bad_JJ behavior_NN ""_'' and_CC our_PRP$ Founding_NNP Fathers_NNPS left_VBD us_PRP a_DT remedy_NN for_IN presidents_NNS guilty_JJ of_IN bad_JJ behavior_NN ._. The_DT Obama_NNP presidency_NN is_VBZ the_DT disease_NN ;_, Article_NN II_CD ,_, Section_NN 4_CD of_IN the_DT Constitution_NN ,_, is_VBZ the_DT cure_NN ._. You_PRP can_MD join_VB us_PRP by_IN using_VBG the_DT sign_NN -_HYPH up_RP button_NN below_RB to_TO read_VB and_CC then_RB add_VB your_PRP$ name_NN to_IN the_DT Articles_NNS of_IN Impeachment_NN we_PRP 've_VBP drawn_VBN -_HYPH up_RP against_IN Barack_NNP Hussein_NNP Obama_NNP ._. If_IN ,_, after_IN reading_VBG the_DT Articles_NNS of_IN Impeachment_NNP against_IN Barack_NNP Hussein_NNP Obama_NNP ,_, you_PRP agree_VBP that_IN action_NN must_MD be_VB taken_VBN now_RB ,_, all_DT you_PRP have_VBP to_TO do_VB to_TO join_VB our_PRP$ growing_VBG network_NN of_IN patriotic_JJ Americans_NNPS is_VBZ add_VB your_PRP$ name_NN (_-LRB- which_WDT will_MD remain_VB on_IN our_PRP$ secure_JJ form_NN and_CC be_VB kept_VBN in_IN the_DT strictest_JJS confidence_NN until_IN the_DT time_NN is_VBZ right_JJ )_-RRB- to_IN the_DT Articles_NNS of_IN Impeachment_NNP against_IN Barack_NNP Hussein_NNP Obama_NNP ._. That_DT 's_VBZ all_DT there_EX is_VBZ to_IN it_PRP ._. Be_VB among_IN the_DT first_JJ to_TO join_VB this_DT growing_VBG nationwide_JJ movement_NN and_CC help_VB us_PRP spread_VB the_DT word_NN far_RB -_HYPH and_CC -_HYPH wide_JJ ._. Together_RB ,_, we_PRP can_MD take_VB back_RP our_PRP$ country_NN before_IN it_PRP is_VBZ too_RB late_JJ ._.","RB VBP RB a NN of the JJ NNS and NNS VBN by NNP NNP NNP . He VBD to the JJ NNS when he VBD we could VB our JJ NN , VBG JJ RB that his NN would RB VB JJ NNS out of NN . NNP NNP , NNP NNP of the NNP For NNP and NNP NNP VBD NNP NNP , a JJ NN of the NN , for NN of NNS from an NNP NN . Whereupon NNP RB VBD NNP to VB for NNP . A JJ NN VBD NNP 's NN in the NN . NNP NNP NNP VBZ VBN the JJ NN by NN of NNS , the JJS NN NN ( NNP ) , and NNP NNPS ( NNP ) and NNP ... the NN of the NNP NN NN , RB VBG NNS , NNS , and NNS of their NN . NNP NNP NNP VBZ RB VBG NN - and - NN NN . RB of VBG the JJ NN we VBP , it would RB , in a NN of VBG , VB the NN we VBP and VBP the NN JJ NN over the NN and JJ NNS . NNP NNP NNP VBZ VBG up our NN at an JJ NN . In RB 9 NNS since NNP VBD NN , our NNP NNP VBZ VBN up by RB a trillion NNS . To VB that NN in NN , it VBD NNP NNP NNP 8 NNS to VB 4.8 trillion to the NNP NNP . And , to VB NN to NN , we VBP VBG NN like it VBZ VBG out of NN . The NN will VB JJ NN , a NN of our NN and , RB RB , JJ NN on a NN that VBZ RB VBN VBN since the NNP NNP . NNP NNP NNP VBZ VBN JJ "" NNPS "" to VB NN from the NN of NNP to the NN we VBP . These NNS VBP RB VB to VB VBN by the NNP . The NNPS VBP JJ NN and VBP RB to NNP . NNS of both NNS VBP VBN by these JJ NNS . NNP NNP NNP VBD : "" The NN of NN by NNP NNP NN can VB the JJ NN of NNS and NNS . "" NNP NNP NNP VBD the NNPS a "" JJ NN . "" And RB , NNP VBZ RB VBN to VB the NN of his JJ NN NN , NN NNS and his JJ NNS . And these NNS RB VBP the NN . It VBZ RB as if NNP VBZ RB VBG to VB the NN . NNP NNP NNP VBZ VBN that NNP VBZ RB a JJ NN , on JJ NNS , despite NNS that VBP a VBG NN VBP the NN . In his NN , The NNP of NNP , he VBD of NNPS and JJ NNS : "" ... I will VB with them should the JJ NNS VB in an JJ NN . "" When he VBD at NNP NNP , a JJ NN , the NNP NNP VBD that the NN of NNP , VB VBN . NNP VBD . In 2006 , he VBD ; "" Whatever we RB VBD , we VBP RB RBR a JJ NN . "" He VBD to NNP and VBD , "" You might VB that NNP VBZ a JJ NN . "" Why VB to JJ NNS to VB the JJ NN of the NNP NNPS ? RB NNP NNP NNP VBZ that our JJ NNS VBP RB from our JJ NN ... that there VBZ no JJ NN to VB our NN than to VB that NN . NNP NNP NNP : "" NNP who VBD us NN VBD us NN . Can the NNS of a NN VB JJ when we VBP VBN a NN that these NNS VBP the NN of NNP ? "" NNP NNP NNP VBD the NNP ; "" the NN upon which our NN VBZ . "" NNP NNP NNP VBD ; "" We VBP no NN JJ with NN JJ of VBG with JJ NNS VBN by NN and NN . "" NNP NNP VBD , "" It VBZ when a NNS VBP NNP , that NNS VBP their NNS . "" NNP NNP , in his NNP NN VBD ; "" Of all the NNS and NNS which VBP to JJ NN , NN and NN VBP JJ VBZ . "" NNP NNP NNP , in NNP in NNP , VBD RB on the NN between the JJ NN and NN in NNP : "" NNP VBZ JJ because she VBZ JJ . If NNP VBZ to VB JJ , NNP will VB to VB JJ . "" It VBZ JJ to VB one VB ... VBZ NNP NNP NNP VB that every NN he VBZ at the JJ NN of this JJ NN VBZ a NN to the JJ NN of our NN ... a NN to NN our JJ NN ? VBZ he RB VB NNP ... VBZ he VB the NNP NNPS ... or both ? NNP NNP NNP RB VBZ RB VBN the JJ NN of this NN . He VBZ VBN his NN to JJ - NN NNP itself at every NN . He VBD , "" NNP VBZ VBN JJ . "" RB VBG our NNS and our NNS every NN to VB that we VBP RBR VBN to VB ourselves and RB RBR JJ to VB . VBG his NN , he VBD NNP VBD , within a NN , despite the NN that it VBD ( and VBZ ) the JJS JJ NN for VBG NNS . His JJ JJ NN NN VBD to NNP NNP , NN of the NNP NNP in the NNP NN . VBG to NN NNS he VBD NNP ; "" This VBZ my JJ NN NN to a JJ NN and I VBP VBG it RB NNS after I VBD NN . "" His JJ one - on - one NN NN VBD RB with NNP or NNP , but with NNP NNP , where he VBD : "" My NN to the JJ NN VBZ to VB that the NNPS VBP RB your NN . We RB VBP NNS . We VBP RB VBN JJ . "" He RB VBD an JJ NN VBG JJ NNS which VBD in NNS VBG VBN against NNP NNP - NNP NNP - NNP , the NN VBN of VBG JJ JJ NNS against NNPS , VBG the NNP NNP NN in which 17 NNP NNS VBD . While VBG the NNP of NNP with JJ NN , he RB VBD from the NN to NNP NNP of NNP NNP , NN of a JJ NN that wo RB VB JJ NN within its NNS ... under NN of NN . VBP NNP 's NNS of NNP , in NNS and NNS , RB NN - NN or VBP they VB , as NNP NNP VBD , "" NN toward this NN , which VBZ JJ . "" VBZ it RB VB ? NNP NNP NNP 's NNS and NNS RB VBP RB beyond the NN of "" JJ NN "" and our NNP NNPS VBD us a NN for NNS JJ of JJ NN . The NNP NN VBZ the NN ; NN II , NN 4 of the NN , VBZ the NN . You can VB us by VBG the NN - up NN RB to VB and RB VB your NN to the NNS of NN we VBP VBN - up against NNP NNP NNP . If , after VBG the NNS of NNP against NNP NNP NNP , you VBP that NN must VB VBN RB , all you VBP to VB to VB our VBG NN of JJ NNPS VBZ VB your NN ( which will VB on our JJ NN and VB VBN in the JJS NN until the NN VBZ JJ ) to the NNS of NNP against NNP NNP NNP . That VBZ all there VBZ to it . VB among the JJ to VB this VBG JJ NN and VB us VB the NN RB - and - JJ . RB , we can VB back our NN before it VBZ RB JJ ."
61,1329,conspiracy,"I_PRP have_VBP already_RB written_VBN about_IN the_DT currency_NN reset_NN and_CC other_JJ features_NNS of_IN a_DT technocratic_JJ future_NN waiting_VBG in_IN the_DT wings_NNS ._. —_: New_JJ levels_NNS of_IN visible_JJ surveillance_NN ,_, social_JJ credit_NN scores_NNS ,_, universal_JJ guaranteed_VBN income_NN ,_, Internet_NN of_IN Things_NNS ,_, energy_NN -_HYPH use_NN quotas_NNS ,_, smart_JJ cities_NNS ._. —_: Events_NNS can_MD move_VB in_IN several_JJ directions_NNS ,_, going_VBG forward_RB ._. In_IN this_DT article_NN ,_, I_PRP explore_VBP one_CD of_IN those_DT directions_NNS ._. The_DT occasion_NN is_VBZ this_DT fake_JJ pandemic_NN ;_, the_DT big_JJ hammer_NN is_VBZ the_DT vaccine_NN against_IN the_DT phony_JJ COVID_NN ._. As_IN Fauci_NNP mentioned_VBD a_DT couple_NN of_IN months_NNS ago_RB ,_, it_PRP could_MD be_VB a_DT DNA_NN vaccine_NN —_: new_JJ technology_NN —_: which_WDT means_VBZ it_PRP is_VBZ really_RB gene_NN therapy_NN ._. Synthesized_VBN genes_NNS are_VBP injected_VBN into_IN the_DT body_NN ._. They_PRP purportedly_RB set_VBD up_RP immunity_NN ._. Actually_RB ,_, they_PRP PERMANENTLY_RB alter_VBP the_DT genetic_JJ makeup_NN of_IN the_DT recipient_NN ._. As_IN you_PRP can_MD imagine_VB ,_, this_DT creates_VBZ the_DT opportunity_NN to_TO put_VB many_JJ different_JJ genes_NNS into_IN humans_NNS ._. To_TO try_VB to_TO invent_VB “_`` new_JJ humans_NNS ._. ”_'' The_DT so_RB -_HYPH called_VBN immunity_NN certificates_NNS Fauci_NNP is_VBZ now_RB talking_VBG about_IN ?_. They_PRP would_MD be_VB issued_VBN to_IN people_NNS who_WP test_VBP positive_JJ on_IN the_DT new_JJ antibody_NN tests_NNS for_IN COVID_NN -_HYPH 19_CD —_: which_WDT is_VBZ an_DT interesting_JJ turnaround_NN ,_, because_IN ,_, since_IN 1984_CD ,_, positive_JJ tests_NNS results_NNS have_VBP generally_RB been_VBN taken_VBN to_TO mean_VB “_`` infected_VBN ._. ”_'' Why_WRB the_DT shift_NN ?_. Because_IN there_EX is_VBZ a_DT need_NN for_IN these_DT immunity_NN certificates_NNS —_: as_IN an_DT INTRO_NN to_TO condition_VB the_DT population_NN to_IN an_DT IDEA_NN ._. If_IN and_CC when_WRB the_DT COVID_NNP vaccine_NN arrives_VBZ ,_, the_DT certificates_NNS would_MD be_VB used_VBN to_TO signify_VB immunity_NN for_IN all_PDT those_DT who_WP take_VBP the_DT shot_NN ._. It_PRP would_MD function_VB as_IN a_DT license_NN ._. Your_PRP$ passport_NN into_IN the_DT Brave_NNP New_NNP World_NNP ._. You_PRP ’re_VBP “_`` immune_JJ ,_, ”_'' so_RB you_PRP ’re_VBP allowed_VBN to_TO move_VB out_IN of_IN fear_NN mode_NN ._. And_CC circulate_VB and_CC travel_VB and_CC enter_VB schools_NNS …_. For_IN DNA_NN vaccines_NNS ,_, the_DT reference_NN is_VBZ the_DT New_NNP York_NNP Times_NNP ,_, 3/15_CD /_, 15_CD ,_, “_`` Protection_NN Without_IN a_DT Vaccine_NN ._. ”_'' It_PRP describes_VBZ the_DT frontier_NN of_IN research_NN ._. Here_RB are_VBP key_JJ quotes_NNS that_WDT illustrate_VBP the_DT use_NN of_IN synthetic_JJ genes_NNS to_TO “_`` protect_VB against_IN disease_NN ,_, ”_'' while_IN changing_VBG the_DT genetic_JJ makeup_NN of_IN humans_NNS ._. This_DT is_VBZ not_RB science_NN fiction_NN :_: “_`` By_IN delivering_VBG synthetic_JJ genes_NNS into_IN the_DT muscles_NNS of_IN the_DT [_-LRB- experimental_JJ ]_-RRB- monkeys_NNS ,_, the_DT scientists_NNS are_VBP essentially_RB re-engineering_VBG the_DT animals_NNS to_TO resist_VB disease_NN ._. ”_'' “_`` ’_'' The_DT sky_NN ’s_VBZ the_DT limit_NN ,_, ’_'' said_VBD Michael_NNP Farzan_NNP ,_, an_DT immunologist_NN at_IN Scripps_NNP and_CC lead_JJ author_NN of_IN the_DT new_JJ study_NN ._. ”_'' “_`` The_DT first_JJ human_JJ trial_NN based_VBN on_IN this_DT strategy_NN —_: called_VBN immunoprophylaxis_NN by_IN gene_NN transfer_NN ,_, or_CC I.G.T._NN —_: is_VBZ underway_JJ ,_, and_CC several_JJ new_JJ ones_NNS are_VBP planned_VBN ._. ”_'' [_-LRB- That_DT was_VBD five_CD years_NNS ago_RB ._. ]_-RRB- “_`` I.G.T._NN is_VBZ altogether_RB different_JJ from_IN traditional_JJ vaccination_NN ._. It_PRP is_VBZ instead_RB a_DT form_NN of_IN gene_NN therapy_NN ._. Scientists_NNS isolate_VBP the_DT genes_NNS that_WDT produce_VBP powerful_JJ antibodies_NNS against_IN certain_JJ diseases_NNS and_CC then_RB synthesize_VBP artificial_JJ versions_NNS ._. The_DT genes_NNS are_VBP placed_VBN into_IN viruses_NNS and_CC injected_VBN into_IN human_JJ tissue_NN ,_, usually_RB muscle_NN ._. ”_'' Here_RB is_VBZ the_DT punchline_NN :_: “_`` The_DT viruses_NNS invade_VBP human_JJ cells_NNS with_IN their_PRP$ DNA_NN payloads_NNS ,_, and_CC the_DT synthetic_JJ gene_NN is_VBZ incorporated_VBN into_IN the_DT recipient_NN ’s_POS own_JJ DNA_NN ._. If_IN all_DT goes_VBZ well_RB ,_, the_DT new_JJ genes_NNS instruct_VBP the_DT cells_NNS to_TO begin_VB manufacturing_VBG powerful_JJ antibodies_NNS ._. ”_'' Read_VB that_DT again_RB :_: “_`` the_DT synthetic_JJ gene_NN is_VBZ incorporated_VBN into_IN the_DT recipient_NN ’s_POS own_JJ DNA_NN ._. ”_'' The_DT Times_NNP article_NN taps_VBZ Dr._NNP David_NNP Baltimore_NNP for_IN an_DT opinion_NN :_: “_`` Still_RB ,_, Dr._NNP Baltimore_NNP says_VBZ that_IN he_PRP envisions_VBZ that_IN some_DT people_NNS might_MD be_VB leery_JJ of_IN a_DT vaccination_NN strategy_NN that_WDT means_VBZ altering_VBG their_PRP$ own_JJ DNA_NN ,_, even_RB if_IN it_PRP prevents_VBZ a_DT potentially_RB fatal_JJ disease_NN ._. ”_'' Yes_UH ,_, some_DT people_NNS might_MD be_VB leery_JJ ._. If_IN they_PRP have_VBP two_CD or_CC three_CD working_VBG brain_NN cells_NNS ._. This_DT is_VBZ genetic_JJ roulette_NN with_IN a_DT loaded_VBN gun_NN ._. And_CC the_DT further_JJR implications_NNS are_VBP clear_JJ ._. Vaccines_NNS can_MD be_VB used_VBN as_IN a_DT cover_NN for_IN the_DT injections_NNS of_IN any_DT and_CC all_DT genes_NNS ,_, whose_WP$ actual_JJ purpose_NN is_VBZ unannounced_JJ ._.","I VBP RB VBN about the NN NN and JJ NNS of a JJ NN VBG in the NNS . — JJ NNS of JJ NN , JJ NN NNS , JJ VBN NN , NN of NNS , NN - NN NNS , JJ NNS . — NNS can VB in JJ NNS , VBG RB . In this NN , I VBP one of those NNS . The NN VBZ this JJ NN ; the JJ NN VBZ the NN against the JJ NN . As NNP VBD a NN of NNS RB , it could VB a NN NN — JJ NN — which VBZ it VBZ RB NN NN . VBN NNS VBP VBN into the NN . They RB VBD up NN . RB , they RB VBP the JJ NN of the NN . As you can VB , this VBZ the NN to VB JJ JJ NNS into NNS . To VB to VB “ JJ NNS . ” The RB - VBN NN NNS NNP VBZ RB VBG about ? They would VB VBN to NNS who VBP JJ on the JJ NN NNS for NN - 19 — which VBZ an JJ NN , because , since 1984 , JJ NNS NNS VBP RB VBN VBN to VB “ VBN . ” Why the NN ? Because there VBZ a NN for these NN NNS — as an NN to VB the NN to an NN . If and when the NNP NN VBZ , the NNS would VB VBN to VB NN for all those who VBP the NN . It would VB as a NN . Your NN into the NNP NNP NNP . You VBP “ JJ , ” RB you VBP VBN to VB out of NN NN . And VB and VB and VB NNS … For NN NNS , the NN VBZ the NNP NNP NNP , 3/15 / 15 , “ NN Without a NN . ” It VBZ the NN of NN . RB VBP JJ NNS that VBP the NN of JJ NNS to “ VB against NN , ” while VBG the JJ NN of NNS . This VBZ RB NN NN : “ By VBG JJ NNS into the NNS of the [ JJ ] NNS , the NNS VBP RB VBG the NNS to VB NN . ” “ ’ The NN VBZ the NN , ’ VBD NNP NNP , an NN at NNP and JJ NN of the JJ NN . ” “ The JJ JJ NN VBN on this NN — VBN NN by NN NN , or NN — VBZ JJ , and JJ JJ NNS VBP VBN . ” [ That VBD five NNS RB . ] “ NN VBZ RB JJ from JJ NN . It VBZ RB a NN of NN NN . NNS VBP the NNS that VBP JJ NNS against JJ NNS and RB VBP JJ NNS . The NNS VBP VBN into NNS and VBN into JJ NN , RB NN . ” RB VBZ the NN : “ The NNS VBP JJ NNS with their NN NNS , and the JJ NN VBZ VBN into the NN ’s JJ NN . If all VBZ RB , the JJ NNS VBP the NNS to VB VBG JJ NNS . ” VB that RB : “ the JJ NN VBZ VBN into the NN ’s JJ NN . ” The NNP NN VBZ NNP NNP NNP for an NN : “ RB , NNP NNP VBZ that he VBZ that some NNS might VB JJ of a NN NN that VBZ VBG their JJ NN , RB if it VBZ a RB JJ NN . ” Yes , some NNS might VB JJ . If they VBP two or three VBG NN NNS . This VBZ JJ NN with a VBN NN . And the JJR NNS VBP JJ . NNS can VB VBN as a NN for the NNS of any and all NNS , whose JJ NN VBZ JJ ."
62,754,conspiracy,"Why_WRB Do_VBP We_PRP Still_RB Vaccinate_VB ?_. –_NFP 25_CD Questions_NNS From_IN A_DT Former_JJ Vaccine_NN Advocate_NN I_PRP used_VBD to_TO be_VB pro_JJ vaccine_NN ._. I_PRP know_VBP the_DT feeling_NN of_IN thinking_VBG others_NNS were_VBD just_RB plain_JJ crazy_JJ and_CC wrong_JJ for_IN not_RB vaccinating_VBG their_PRP$ children_NNS and_CC themselves_PRP ._. ‘_`` Irresponsible_JJ !_. ’_'' I_PRP said_VBD when_WRB pointing_VBG my_PRP$ finger_NN ._. I_PRP ’d_MD use_VB the_DT same_JJ old_JJ arguments_NNS about_IN polio_NN and_CC small_JJ pox_NN and_CC how_WRB vaccines_NNS saved_VBD us_PRP from_IN all_PDT those_DT horrible_JJ diseases_NNS and_CC just_RB swallowing_VBG and_CC regurgitating_VBG the_DT propaganda_NN I_PRP was_VBD brought_VBN up_RP with_IN ._. It_PRP was_VBD only_RB recently_RB ,_, in_IN 2009_CD that_IN I_PRP started_VBD questioning_VBG my_PRP$ long_JJ held_VBN beliefs_NNS and_CC began_VBD digging_VBG in_RP to_IN the_DT history_NN ,_, efficacy_NN and_CC safety_NN of_IN vaccines_NNS ._. I_PRP was_VBD appalled_VBN at_IN what_WP I_PRP found_VBD and_CC the_DT recklessness_NN of_IN those_DT government_NN health_NN agencies_NNS entrusted_VBN with_IN our_PRP$ health_NN and_CC our_PRP$ children_NNS ’s_POS safety_NN ,_, and_CC angry_JJ with_IN myself_PRP that_IN I_PRP had_VBD put_VBN my_PRP$ family_NN ’s_POS health_NN at_IN risk_NN by_IN blind_JJ faith_NN in_IN others_NNS when_WRB I_PRP was_VBD ultimately_RB responsible_JJ for_IN the_DT medical_JJ decisions_NNS of_IN my_PRP$ family_NN ._. When_WRB I_PRP began_VBD to_TO put_VB this_DT article_NN together_RB I_PRP specifically_RB chose_VBD not_RB to_TO include_VB research_NN from_IN or_CC links_NNS to_IN websites_NNS that_WDT are_VBP considered_VBN untrustworthy_JJ by_IN most_JJS pro-vaxxers_NNS ,_, sites_NNS such_JJ as_IN Natural_NNP News_NNP ,_, Mercola_NNP ,_, etc._FW even_RB though_IN I_PRP personally_RB trust_VBP those_DT sites_NNS and_CC much_RB more_JJR than_IN I_PRP would_MD WebMd_NNP and_CC for_IN good_JJ reason_NN [_-LRB- a_NN ]_-RRB- ._. Instead_RB I_PRP chose_VBD to_TO employ_VB basic_JJ logic_NN and_CC also_RB incorporate_VB independent_JJ and_CC .gov_NN scientific_JJ studies_NNS -_, mostly_RB peer_NN review_NN ,_, journals_NNS ,_, news_NN from_IN mainstream_JJ sources_NNS (_-LRB- that_IN pro-vaxxers_NNS love_VBP and_CC totally_RB trust_VBP )_-RRB- and_CC articles_NNS that_WDT link_VBP to_IN other_JJ .gov_NN scientific_JJ studies_NNS ,_, as_RB well_RB as_IN government_NN statistical_JJ resources_NNS ._. So_RB ,_, I_PRP started_VBD writing_VBG down_RP questions_NNS and_CC then_RB looking_VBG for_IN answers_NNS ._. I_PRP ’ll_MD admit_VB ,_, some_DT of_IN these_DT questions_NNS have_VBP already_RB been_VBN asked_VBN by_IN others_NNS ,_, but_CC I_PRP just_RB expanded_VBD upon_IN it_PRP to_TO form_VB a_DT helpful_JJ list_NN ._. I_PRP hope_VBP the_DT following_VBG information_NN helps_VBZ you_PRP in_IN your_PRP$ lifelong_JJ journey_NN in_IN search_NN of_IN health_NN ,_, vitality_NN and_CC truth_NN in_IN your_PRP$ own_JJ lives_NNS and_CC your_PRP$ children_NNS ’s_POS lives_NNS ._. 1_LS ._. Why_WRB are_VBP newborn_JJ babies_NNS vaccinated_VBN on_IN their_PRP$ first_JJ day_NN of_IN life_NN against_IN a_DT disease_NN that_WDT is_VBZ primarily_RB transmitted_VBN sexually_RB and_CC by_IN needles_NNS in_IN drug_NN users_NNS ?_. (_-LRB- Pregnant_JJ women_NNS are_VBP already_RB tested_VBN for_IN STD_NN ’s_POS prior_JJ to_IN birth_NN so_IN there_EX ’s_VBZ no_DT reason_NN to_TO give_VB it_PRP to_IN an_DT infant_NN )_-RRB- ._. Interesting_JJ to_TO note_VB ,_, of_IN the_DT few_JJ vaccines_NNS that_WDT still_RB are_VBP given_VBN to_IN infants_NNS and_CC STILL_RB has_VBZ thimerasol_NN in_IN it_PRP is_VBZ Hep_NNP B_NN and_CC DipTet_NN (_-LRB- and_CC Flu_NN shot_NN recommended_VBN to_IN pregnant_JJ women_NNS )_-RRB- ._. So_RB ,_, the_DT claim_NN that_IN it_PRP has_VBZ been_VBN removed_VBN from_IN all_DT vaccines_NNS is_VBZ a_DT lie_NN and_CC misdirection_NN ._. If_IN they_PRP give_VBP it_PRP to_IN all_DT newborns_NNS then_RB ALL_PDT the_DT newborns_NNS are_VBP getting_VBG that_DT thimerasol_NN (_-LRB- mercury_NN derivative_NN )_-RRB- ._. “_`` It_PRP was_VBD removed_VBN from_IN many_JJ child_NN vaccines_NNS in_IN 2002_CD but_CC remains_VBZ in_IN some_DT vaccines_NNS (_-LRB- e.g._FW ,_, hepatitis_NN B_NN virus_NN and_CC )_-RRB- ”_'' Page_NN 21_CD ._. 2_LS ._. Why_WRB are_VBP babies_NNS given_VBN vaccines_NNS to_TO produce_VB antibodies_NNS when_WRB they_PRP do_VBP not_RB produce_VB antibodies_NNS until_IN after_IN the_DT age_NN of_IN 3_CD to_IN 6_CD months_NNS ?_. They_PRP get_VBP the_DT required_VBN antibodies_NNS from_IN breastfeeding_NN ._. 3_LS ._. Why_WRB does_VBZ the_DT government_NN tell_VB parents_NNS to_TO delay_VB breast_NN feeding_NN and_CC get_VB more_JJR vaccines_NNS when_WRB breast_NN feeding_NN babies_NNS produce_VBP higher_JJR levels_NNS of_IN antibodies_NNS ?_. http://www.ncbi.nlm.nih.gov…_ADD http://naturalsociety.com…_ADD 4_LS ._. Why_WRB are_VBP n’t_RB vaccine_NN manufacturers_NNS held_VBN responsible_JJ when_WRB their_PRP$ product_NN injures_VBZ your_PRP$ child_NN ?_. Why_WRB would_MD these_DT companies_NNS need_VB to_TO be_VB protected_VBN from_IN the_DT effects_NNS of_IN such_JJ wonderful_JJ products_NNS ?_. (_-LRB- Look_VB into_IN Vaccine_NN Injury_NN Compensation_NN Program_NN .gov_NN and_CC VAERS_NNP )_-RRB- The_DT Supreme_NNP Court_NNP ruling_NN exempting_VBG the_DT vaccine_NN manufacturers_NNS from_IN all_DT liability_NN is_VBZ done_VBN under_IN the_DT explicit_JJ understanding_NN that_IN they_PRP fall_VBP under_IN the_DT category_NN “_`` unavoidably_RB unsafe_JJ products_NNS ._. ”_'' http://www.supremecourt.gov/opinions/10pdf/09-152.pdf_ADD http://www.hrsa.gov/vaccinecompensation/index.html_ADD https://vaers.hhs.gov/index_ADD 5_LS ._. Why_WRB have_VBP no_DT double_JJ blind_JJ ,_, placebo_NN ,_, randomized_VBN controlled_VBN trials_NNS been_VBN done_VBN on_IN any_DT vaccines_NNS ?_. This_DT is_VBZ standard_NN with_IN any_DT other_JJ drug_NN ._. 6_LS ._. Why_WRB are_VBP we_PRP following_VBG the_DT US_NNP vaccination_NN schedule_NN ?_. We_PRP are_VBP the_DT most_RBS vaccinated_VBN population_NN on_IN the_DT planet_NN with_IN the_DT highest_JJS rates_NNS of_IN infant_NN deaths_NNS /_, SIDS_NNS in_IN the_DT western_JJ world_NN ?_. http://www.washingtonpost.com…_ADD http://sm.stanford.edu/archive/stanmed/2013fall/article2.html_ADD 7_LS ._. Why_WRB are_VBP disease_NN outbreaks_NNS occurring_VBG in_IN populations_NNS with_IN 90_CD %_NN +_SYM vaccination_NN rates_NNS ?_. What_WP about_IN that_DT ‘_`` Herd_NN Immunity_NN ’_'' guys_NNS ?_. http://aje.oxfordjournals.org/content/139/1/77.short_ADD http://www.ncbi.nlm.nih.gov/pubmed/8483623_ADD http://wwwnc.cdc.gov/eid/article/6/5/00-0512_article_ADD 8_LS ._. Why_WRB are_VBP children_NNS vaccinated_VBN against_IN these_DT diseases_NNS still_RB catching_VBG and_CC spreading_VBG them_PRP ?_. http://www.ncbi.nlm.nih.gov/pubmed/24076325_ADD http://www.thehealthyhomeeconomist.com…(see_ADD Johns_NNP Hopkins_NNP paper_NN )_-RRB- http://www.ncbi.nlm.nih.gov/pubmed/15954490_ADD http://www.ncbi.nlm.nih.gov/pubmed/8483623_ADD 9_LS ._. Why_WRB are_VBP we_PRP frightened_VBN of_IN non-fatal_JJ illnesses_NNS that_WDT train_VBP a_DT child_NN ’s_POS immune_NN system_NN how_WRB to_TO behave_VB ?_. 10_LS ._. Why_WRB are_VBP vaccine_NN manufacturers_NNS allowed_VBN to_TO reduce_VB antigens_NNS and_CC insert_VB cheap_JJ and_CC toxic_JJ additives_NNS that_WDT aggravate_VBP the_DT injection_NN site_NN ?_. 11_LS ._. Why_WRB do_VBP we_PRP need_VB multi-_JJ dose_NN vaccines_NNS if_IN the_DT number_NN ONE_CD priority_NN of_IN vaccine_NN manufacturers_NNS is_VBZ your_PRP$ child_NN ’s_POS safety_NN ?_. 12_LS ._. Why_WRB will_MD no_DT physician_NN sign_VB a_DT written_VBN guarantee_NN for_IN a_DT child_NN ’s_POS safety_NN prior_JJ to_IN vaccinating_VBG them_PRP with_IN products_NNS they_PRP insist_VBP you_PRP take_VBP and_CC that_WDT they_PRP say_VBP are_VBP completely_RB safe_JJ ?_. 13_LS ._. Why_WRB is_VBZ there_EX no_DT outrage_NN about_IN the_DT 3.1_CD billion_CD dollars_NNS paid_VBN out_RP in_IN vaccine_NN injury_NN /_, death_NN claims_NNS and_CC yet_CC they_PRP claim_VBP there_EX is_VBZ no_DT correlation_NN and_CC they_PRP are_VBP perfectly_RB safe_JJ ?_. http://www.hrsa.gov/vaccinecompensation/statisticsreport.pdf_ADD 14_LS ._. Why_WRB do_VBP n’t_RB people_NNS recognize_VB from_IN history_NN that_IN the_DT most_RBS widespread_JJ and_CC lethal_JJ diseases_NNS in_IN the_DT last_JJ 200_CD years_NNS were_VBD reduced_VBN due_IN to_IN cleaner_JJR drinking_NN water_NN ,_, improved_VBN sanitation_NN ,_, nutrition_NN ,_, less_RBR overcrowded_JJ areas_NNS and_CC better_JJR living_NN conditions_NNS ?_. Vaccines_NNS were_VBD introduced_VBN at_IN points_NNS in_IN time_NN where_WRB every_DT single_JJ disease_NN was_VBD already_RB declining_VBG ,_, most_RBS almost_RB completely_RB gone_VBN ._. To_TO give_VB vaccines_NNS credit_NN for_IN global_JJ reductions_NNS in_IN disease_NN is_VBZ like_IN giving_VBG a_DT band_NN -_HYPH aid_NN credit_NN for_IN healing_VBG a_DT wound_NN that_WDT was_VBD already_RB closing_VBG ._. Dr._NNP Hans_NNP Rosling_NNP shows_VBZ exactly_RB how_WRB the_DT health_NN condition_NN of_IN nearly_RB all_DT countries_NNS of_IN the_DT world_NN have_VBP improved_VBN with_IN wealth_NN ,_, even_RB 200_CD years_NNS ago_RB ,_, at_IN the_DT times_NNS where_WRB there_EX no_DT vaccines_NNS ._. http://youtu.be/jbkSRLYSojo_ADD https://childhealthsafety.wordpress.com/graphs/_ADD (_-LRB- blog_NN yes_UH ,_, but_CC the_DT links_NNS are_VBP amazing_JJ and_CC historical_JJ data_NNS ._. )_-RRB- http://www.columbia.edu…_ADD By_IN the_DT late_JJ 1950s_NNS ,_, even_RB before_IN the_DT introduction_NN of_IN measles_NNS vaccine_NN ,_, measles_NNS -_HYPH related_JJ deaths_NNS and_CC case_NN fatality_NN rates_NNS in_IN the_DT United_NNP States_NNPS had_VBD decreased_VBN markedly_RB ,_, presumably_RB as_IN a_DT result_NN of_IN improvement_NN in_IN health_NN care_NN and_CC nutrition_NN (_-LRB- Oxford_NNP Journal_NNP of_IN Infectious_NNP Diseases_NNPS )_-RRB- ._. 15_CD ._. Why_WRB do_VBP people_NNS keep_VB parroting_VBG what_WP they_PRP hear_VBP about_IN ‘_`` Herd_NN Immunity_NN ?_. ’_'' Herd_NN immunity_NN is_VBZ a_DT hilarious_JJ concept_NN that_WDT assumes_VBZ that_IN 1_LS )_-RRB- Vaccinated_VBN people_NNS are_VBP immune_JJ to_IN the_DT diseases_NNS for_IN which_WDT they_PRP ’ve_VBP been_VBN vaccinated_VBN ,_, 2_LS )_-RRB- Can_MD not_RB carry_VB the_DT diseases_NNS for_IN which_WDT they_PRP are_VBP vaccinated_VBN /_, immune_NN ,_, 3_LS )_-RRB- Because_IN most_JJS of_IN the_DT people_NNS are_VBP vaccinated_VBN ,_, other_JJ people_NNS around_IN them_PRP ca_MD n’t_RB catch_VB the_DT disease_NN ._. My_PRP$ favourite_JJ analogy_NN for_IN herd_NN immunity_NN is_VBZ that_IN if_IN 95_CD %_NN of_IN people_NNS in_IN a_DT building_NN are_VBP wearing_VBG hard_JJ hats_NNS when_WRB the_DT ceiling_NN falls_VBZ in_RP ,_, the_DT 5_CD %_NN are_VBP protected_VBN ._. (_-LRB- credit_NN Dr._NNP Robert_NNP Murdoch_NNP )_-RRB- 16_CD ._. Why_WRB are_VBP almost_RB all_DT pro-vaxxer_JJ adults_NNS we_PRP talk_VBP to_IN not_RB up_IN to_IN date_NN on_IN their_PRP$ adult_JJ vaccinations_NNS /_, boosters_NNS ?_. 18_LS ._. Why_WRB did_VBD n’t_RB our_PRP$ government_NN health_NN agencies_NNS ever_RB safety_NN test_VB thimerasol_NN (_-LRB- a_DT mercury_NN derivative_NN and_CC adjuvant_NN )_-RRB- since_IN Lilly_NNP developed_VBD it_PRP in_IN the_DT 1920’s_NNS ?_. They_PRP used_VBD it_PRP in_IN vaccines_NNS from_IN 1930_CD to_IN 2004_CD !_. It_PRP still_RB is_VBZ in_IN some_DT vaccines_NNS such_JJ as_IN the_DT flu_NN vaccine_NN and_CC others_NNS ._. Here_RB is_VBZ a_DT 2_CD minute_NN clip_NN ,_, from_IN Congressional_NNP Hearings_NNPS ._. The_DT EPA_NNP themselves_PRP acknowledge_VBP the_DT toxic_JJ effects_NNS of_IN mercury_NN :_: http://www.epa.gov/hg/effects.htm_ADD http://www.nytimes.com…_ADD http://www.ncbi.nlm.nih.gov/pubmed/21350943_ADD http://www.ncbi.nlm.nih.gov/pubmed/20803069_ADD http://www.ncbi.nlm.nih.gov/pubmed/21549155_ADD 19_CD ._. Why_WRB is_VBZ it_PRP that_IN only_RB 40_CD %_NN of_IN health_NN professionals_NNS receive_VBP the_DT flu_NN shot_NN each_DT year_NN ?_. They_PRP must_MD not_RB believe_VB in_IN it_PRP ._. http://abcnews.go.com…_ADD 20_LS ._. Why_WRB ?_. Instead_RB of_IN a_DT mandatory_JJ vaccine_NN law_NN ,_, why_WRB do_VBP n’t_RB they_PRP have_VB a_DT mandatory_JJ law_NN passed_VBN to_TO protect_VB us_PRP from_IN Iatrogenic_JJ Death_NN ?_. (_-LRB- Death_NN by_IN Doctor_NNP ,_, 3rd_JJ leading_VBG cause_NN of_IN death_NN !_. )_-RRB- http://articles.mercola.com…_ADD http://www.worldlawdirect.com…_ADD 21_LS ._. Why_WRB does_VBZ n’t_RB the_DT pro_NN vaccination_NN public_NN admit_VB that_IN the_DT vaccinated_VBN spread_NN disease_NN and_CC stop_VB blaming_VBG us_PRP ?_. http://www.cnbc.com/id/102473744_ADD http://www.nc.cdc.gov/eid/article/6/5/00-0512_article_ADD 22_CD ._. Why_WRB do_VBP people_NNS still_RB trust_VB their_PRP$ government_NN health_NN agencies_NNS when_WRB they_PRP say_VBP vaccines_NNS are_VBP perfectly_RB safe_JJ ?_. With_IN all_PDT the_DT big_JJ pharma_NN fraud_NN cases_NNS ,_, Merck_NNP ,_, Glaxo_NNP Smith_NNP Kline_NNP ,_, etc._FW and_CC all_PDT the_DT class_NN action_NN suits_NNS that_WDT come_VBP out_RP several_JJ times_NNS a_DT year_NN for_IN death_NN /_, injury_NN you_PRP see_VBP on_IN tv_NN commercials_NNS every_DT week_NN ,_, combine_VB that_DT with_IN the_DT VICP_NN and_CC VAERS_NN .gov_NN statistics_NNS ,_, and_CC Iatrogenic_JJ Death_NN statistics_NNS ,_, why_WRB do_VBP people_NNS still_RB trust_VB their_PRP$ government_NN health_NN agencies_NNS when_WRB they_PRP say_VBP vaccines_NNS are_VBP perfectly_RB safe_JJ ?_. Having_VBG said_VBN that_DT ,_, why_WRB is_VBZ government_NN trusted_VBN at_IN all_DT since_IN Democide_NN statistics_NNS (_-LRB- death_NN by_IN government_NN )_-RRB- show_VBP that_IN nearly_RB 300_CD million_CD in_IN this_DT last_JJ century_NN were_VBD killed_VBN by_IN the_DT state_NN ._. Those_DT are_VBP non-combatants_NNS ._. Here_RB are_VBP a_DT few_JJ more_JJR studies_NNS :_: –_: Abnormal_JJ measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN antibodies_NNS and_CC CNS_NN autoimmunity_NN in_IN children_NNS with_IN autism_NN ._. http://www.ncbi.nlm.nih.gov/pubmed/12145534_ADD –_: Serological_JJ association_NN of_IN measles_NNS virus_NN and_CC human_JJ herpes_NN virus_NN -_HYPH 6_CD with_IN brain_NN auto_NN -_HYPH antibodies_NNS in_IN autism_NN ._. http://www.ncbi.nlm.nih.gov/pubmed/9756729_ADD This_DT study_NN is_VBZ the_DT first_JJ to_TO report_VB an_DT association_NN between_IN virus_NN serology_NN and_CC brain_NN auto_NN antibody_NN in_IN autism_NN ;_, it_PRP supports_VBZ the_DT hypothesis_NN that_IN a_DT virus_NN -_HYPH induced_VBN autoimmune_JJ response_NN may_MD play_VB a_DT causal_JJ role_NN in_IN autism_NN ._. –_: Effects_NNS of_IN diphtheria_NN -_HYPH tetanus_NN -_HYPH pertussis_NN or_CC tetanus_NN vaccination_NN on_IN allergies_NNS and_CC allergy_NN -_HYPH related_JJ respiratory_JJ symptoms_NNS among_IN children_NNS and_CC adolescents_NNS in_IN the_DT United_NNP States_NNPS ._. http://www.ncbi.nlm.nih.gov/pubmed/10714532_ADD Review_NN is_VBZ made_VBN of_IN 107_CD cases_NNS of_IN neurological_JJ complications_NNS of_IN pertussis_NN inoculation_NN reported_VBN in_IN the_DT literature_NN ._. The_DT early_JJ onset_NN of_IN neurological_JJ symptoms_NNS was_VBD characteristic_JJ ,_, with_IN changes_NNS of_IN consciousness_NN and_CC convulsions_NNS as_IN the_DT most_RBS striking_JJ features_NNS ._. The_DT question_NN of_IN aetiology_NN is_VBZ considered_VBN and_CC contraindications_NNS are_VBP discussed_VBN …as_RB is_VBZ the_DT grave_JJ danger_NN of_IN further_JJR inoculations_NNS when_WRB a_DT previous_JJ one_NN has_VBZ produced_VBN any_DT suggestion_NN of_IN a_DT neurological_JJ reaction_NN ._. Aluminum_NN Studies_NNS :_: –_: Do_VBP aluminum_NN vaccine_NN adjuvants_NNS contribute_VB to_IN the_DT rising_VBG prevalence_NN ofautism_NN ?_. http://www.ncbi.nlm.nih.gov/pubmed/22099159_ADD “_`` …_: A_DT second_JJ series_NN of_IN experiments_NNS was_VBD conducted_VBN on_IN mice_NNS injected_VBN with_IN six_CD doses_NNS of_IN aluminum_NN hydroxide_NN ._. Behavioural_JJ analyses_NNS in_IN these_DT mice_NNS revealed_VBD significant_JJ impairments_NNS in_IN a_DT number_NN of_IN motor_NN functions_NNS as_RB well_RB as_IN diminished_VBN spatial_JJ memory_NN capacity_NN ._. ”_'' Experimental_JJ research_NN ,_, clearly_RB shows_VBZ that_IN aluminum_NN adjuvants_NNS have_VBP a_DT potential_NN to_TO induce_VB serious_JJ immunological_JJ disorders_NNS in_IN humans_NNS ._. In_IN particular_JJ ,_, aluminum_NN in_IN adjuvant_NN form_NN carries_VBZ a_DT risk_NN for_IN autoimmunity_NN ,_, long_JJ -_HYPH term_NN brain_NN inflammation_NN and_CC associated_VBN neurological_JJ complications_NNS and_CC may_MD thus_RB have_VB profound_JJ and_CC widespread_JJ adverse_JJ health_NN consequences_NNS ._. click_VB for_IN entire_JJ study_NN –_: Mechanisms_NNS of_IN aluminum_NN adjuvant_NN toxicity_NN and_CC autoimmunity_NN in_IN pediatric_JJ populations_NNS ._. http://www.ncbi.nlm.nih.gov/pubmed/22235057_ADD The_DT findings_NNS suggest_VBP a_DT possible_JJ role_NN for_IN the_DT aluminum_NN adjuvant_NN in_IN some_DT neurological_JJ features_NNS associated_VBN with_IN GWI_NNP and_CC possibly_RB an_DT additional_JJ role_NN for_IN the_DT combination_NN of_IN adjuvants_NNS (_-LRB- Synergistic_JJ Toxicity_NN )_-RRB- ._. –_: Aluminum_NN in_IN the_DT central_JJ nervous_JJ system_NN (_-LRB- CNS_NNP )_-RRB- :_: toxicity_NN in_IN humans_NNS and_CC animals_NNS ,_, vaccine_NN adjuvants_NNS ,_, and_CC autoimmunity_NN ._. http://www.ncbi.nlm.nih.gov/pubmed/23609067_ADD –_: Biopersistence_NN and_CC brain_NN translocation_NN of_IN aluminum_NN adjuvants_NNS of_IN vaccines_NNS ._. http://www.ncbi.nlm.nih.gov/pubmed/25699008_ADD –_: Long_JJ -term_JJ Persistence_NN of_IN Vaccine_NN -_HYPH Derived_VBN Aluminum_NN Hydroxide_NN is_VBZ Associated_VBN with_IN Chronic_JJ Cognitive_JJ Dysfunction_NN ._. http://www.sciencedirect.com/science/article/pii/S0162013409001895_ADD –_: Long_JJ -_HYPH term_NN follow_NN -_HYPH up_RP of_IN cognitive_JJ dysfunction_NN in_IN patients_NNS with_IN aluminum_NN hydroxideinduced_JJ macrophagic_JJ myofasciitis_NN (_-LRB- MMF_NN )_-RRB- ._. http://www.sciencedirect.com/science/article/pii/S0162013411002194_ADD –_: Integrating_VBG experimental_JJ (_-LRB- in_IN vitro_NN and_CC in_IN vivo_FW )_-RRB- neurotoxicity_NN studies_NNS of_IN low_JJ -_HYPH dose_NN thimerosal_NN relevant_JJ to_IN vaccines_NNS ._. http://www.ncbi.nlm.nih.gov/pubmed/21350943_ADD There_EX is_VBZ a_DT need_NN to_TO interpret_VB neurotoxic_JJ studies_NNS to_TO help_VB deal_VB with_IN uncertainties_NNS surrounding_VBG pregnant_JJ mothers_NNS ,_, newborns_NNS and_CC young_JJ children_NNS who_WP must_MD receive_VB repeated_VBN doses_NNS of_IN Thimerosal_NNP -_HYPH containing_VBG vaccines_NNS (_-LRB- TCVs_NNS )_-RRB- ._. Information_NN extracted_VBN from_IN studies_NNS indicates_VBZ that_IN :_: (_-LRB- a_LS )_-RRB- activity_NN of_IN low_JJ doses_NNS of_IN Thimerosal_NN against_IN isolated_VBN human_JJ and_CC animal_NN brain_NN cells_NNS was_VBD found_VBN in_IN all_DT studies_NNS and_CC is_VBZ consistent_JJ with_IN Hg_NN neurotoxicity_NN ;_, (_-LRB- b_LS )_-RRB- the_DT neurotoxic_JJ effect_NN of_IN ethylmercury_NN has_VBZ not_RB been_VBN studied_VBN with_IN co-occurring_VBG adjuvant_NN -_HYPH Al_NNP in_IN TCVs_NNS ;_, (_-LRB- c_LS )_-RRB- animal_NN studies_NNS have_VBP shown_VBN that_IN exposure_NN to_IN Thimerosal_NNP -_HYPH Hg_NNP can_MD lead_VB to_IN accumulation_NN of_IN inorganic_NN Hg_NN in_IN brain_NN ,_, and_CC that_IN (_-LRB- d_NN )_-RRB- doses_NNS relevant_JJ to_IN TCV_NN exposure_NN possess_VBP the_DT potential_NN to_TO affect_VB human_JJ neuro_NN -_HYPH development_NN ._. –_: Neonatal_JJ administration_NN of_IN thimerosal_NN causes_VBZ persistent_JJ changes_NNS in_IN mu_NN opioid_JJ receptors_NNS in_IN the_DT rat_NN brain_NN ._. http://www.ncbi.nlm.nih.gov/pubmed/20803069_ADD –_: Persistent_JJ behavioural_JJ impairments_NNS and_CC alterations_NNS of_IN brain_NN dopaminesystem_NN after_IN early_JJ postnatal_JJ administration_NN of_IN thimerosal_NN in_IN rats_NNS ._. http://www.ncbi.nlm.nih.gov/pubmed/21549155_ADD –_NFP Maternal_JJ Thimerosal_NN Exposure_NN Results_NNS in_IN Aberrant_JJ Cerebellar_NN Oxidative_NN Stress_NN ,_, Thyroid_NN Hormone_NN Metabolism_NN ,_, and_CC Motor_NN Behaviour_NN in_IN Rat_NN Pups_NNS ;_, Sex_NN -_HYPH and_CC Strain_NN -_HYPH Dependent_JJ Effects_NNS ._. http://www.ncbi.nlm.nih.gov/pubmed/22015705_ADD –_: Administration_NN of_IN thimerosal_NN to_IN infant_NN rats_NNS increases_VBZ overflow_NN of_IN glutamate_NN and_CC aspartate_NN in_IN the_DT prefrontal_JJ cortex_NN :_: protective_JJ role_NN ofdehydroepiandrosterone_NN sulfate_NN ._. http://www.ncbi.nlm.nih.gov/pubmed/22015977_ADD Thimerosal_NNP ,_, a_DT mercury_NN -_HYPH containing_VBG vaccine_NN preservative_NN ,_, is_VBZ a_DT suspected_VBN factor_NN in_IN the_DT etiology_NN of_IN neurodevelopmental_JJ disorders_NNS ._. We_PRP previously_RB showed_VBD that_IN its_PRP$ administration_NN to_IN infant_NN rats_NNS causes_VBZ behavioral_JJ ,_, neurochemical_JJ and_CC neuropathological_JJ abnormalities_NNS similar_JJ to_IN those_DT present_JJ in_IN autism_NN ._. The_DT ACIP_NNP ’s_POS recommendation_NN of_IN influenza_NN vaccination_NN during_IN pregnancy_NN is_VBZ not_RB supported_VBN by_IN citations_NNS in_IN its_PRP$ own_JJ policy_NN paper_NN or_CC in_IN current_JJ medical_JJ literature_NN ._. Considering_VBG the_DT potential_JJ risks_NNS of_IN maternal_JJ and_CC fetal_JJ mercury_NN exposure_NN ,_, the_DT administration_NN of_IN thimerosal_NN during_IN pregnancy_NN is_VBZ both_CC unjustified_JJ and_CC unwise_JJ ._. Also_RB ,_, take_VB note_NN of_IN the_DT 71_CD references_NNS at_IN the_DT end_NN of_IN this_DT study_NN ._. 91_CD Peer_NNP Review_NNP Studies_NNPS on_IN The_DT Dangers_NNPS of_IN Vaccines_NNPS :_: http://adventuresinautism.blogspot.com/2007/06/no-evidence-of-any-link.html_ADD –_: Methodological_JJ Issues_NNS and_CC Evidence_NN of_IN Malfeasance_NN in_IN Research_NN Purporting_VBG to_TO Show_VB Thimerosal_NNP in_IN Vaccines_NNS Is_VBZ Safe_JJ ._. http://www.hindawi.com/journals/bmri/2014/247218/_ADD –_: Research_NN below_RB represents_VBZ under-reported_JJ ,_, minimized_VBN and_CC otherwise_RB overlooked_VBN peer_NN -_HYPH reviewed_VBN data_NNS on_IN adverse_JJ effects_NNS associated_VBN with_IN vaccination_NN ._. http://www.greenmedinfo.com/guide/health-guide-vaccine-research_ADD –_: Neurologic_JJ adverse_JJ events_NNS following_VBG vaccination_NN ._. http://www.rescuepost.com…_ADD Source_NN :_: livelovefruit.com_ADD Brian_NNP Rogers_NNP is_VBZ a_DT freelance_JJ writer_NN and_CC researcher_NN in_IN the_DT area_NN of_IN holistic_JJ health_NN ._. He_PRP administers_VBZ several_JJ health_NN pages_NNS and_CC has_VBZ been_VBN published_VBN in_IN various_JJ publications_NNS such_JJ as_IN PreventDisease.com_NNP and_CC has_VBZ a_DT keen_JJ interest_NN in_IN naturopathic_JJ healing_NN through_IN alternative_JJ medicine_NN ,_, such_JJ as_IN essential_JJ oils_NNS as_RB well_RB as_IN nutritional_JJ healing_NN ._. ~~_NFP Help_NN Waking_NN Times_NNS to_TO raise_VB the_DT vibration_NN by_IN sharing_VBG this_DT article_NN with_IN friends_NNS and_CC family_NN …_.","Why VBP We RB VB ? – 25 NNS From A JJ NN NN I VBD to VB JJ NN . I VBP the NN of VBG NNS VBD RB JJ JJ and JJ for RB VBG their NNS and themselves . ‘ JJ ! ’ I VBD when VBG my NN . I ’d VB the JJ JJ NNS about NN and JJ NN and how NNS VBD us from all those JJ NNS and RB VBG and VBG the NN I VBD VBN up with . It VBD RB RB , in 2009 that I VBD VBG my JJ VBN NNS and VBD VBG in to the NN , NN and NN of NNS . I VBD VBN at what I VBD and the NN of those NN NN NNS VBN with our NN and our NNS ’s NN , and JJ with myself that I VBD VBN my NN ’s NN at NN by JJ NN in NNS when I VBD RB JJ for the JJ NNS of my NN . When I VBD to VB this NN RB I RB VBD RB to VB NN from or NNS to NNS that VBP VBN JJ by JJS NNS , NNS JJ as NNP NNP , NNP , FW RB though I RB VBP those NNS and RB JJR than I would NNP and for JJ NN [ NN ] . RB I VBD to VB JJ NN and RB VB JJ and NN JJ NNS - RB NN NN , NNS , NN from JJ NNS ( that NNS VBP and RB VBP ) and NNS that VBP to JJ NN JJ NNS , RB RB as NN JJ NNS . RB , I VBD VBG down NNS and RB VBG for NNS . I ’ll VB , some of these NNS VBP RB VBN VBN by NNS , but I RB VBD upon it to VB a JJ NN . I VBP the VBG NN VBZ you in your JJ NN in NN of NN , NN and NN in your JJ NNS and your NNS ’s NNS . 1 . Why VBP JJ NNS VBN on their JJ NN of NN against a NN that VBZ RB VBN RB and by NNS in NN NNS ? ( JJ NNS VBP RB VBN for NN ’s JJ to NN so there VBZ no NN to VB it to an NN ) . JJ to VB , of the JJ NNS that RB VBP VBN to NNS and RB VBZ NN in it VBZ NNP NN and NN ( and NN NN VBN to JJ NNS ) . RB , the NN that it VBZ VBN VBN from all NNS VBZ a NN and NN . If they VBP it to all NNS RB ALL the NNS VBP VBG that NN ( NN NN ) . “ It VBD VBN from JJ NN NNS in 2002 but VBZ in some NNS ( FW , NN NN NN and ) ” NN 21 . 2 . Why VBP NNS VBN NNS to VB NNS when they VBP RB VB NNS until after the NN of 3 to 6 NNS ? They VBP the VBN NNS from NN . 3 . Why VBZ the NN VB NNS to VB NN NN and VB JJR NNS when NN NN NNS VBP JJR NNS of NNS ? http://www.ncbi.nlm.nih.gov… http://naturalsociety.com… 4 . Why VBP RB NN NNS VBN JJ when their NN VBZ your NN ? Why would these NNS VB to VB VBN from the NNS of JJ JJ NNS ? ( VB into NN NN NN NN NN and NNP ) The NNP NNP NN VBG the NN NNS from all NN VBZ VBN under the JJ NN that they VBP under the NN “ RB JJ NNS . ” http://www.supremecourt.gov/opinions/10pdf/09-152.pdf http://www.hrsa.gov/vaccinecompensation/index.html https://vaers.hhs.gov/index 5 . Why VBP no JJ JJ , NN , VBN VBN NNS VBN VBN on any NNS ? This VBZ NN with any JJ NN . 6 . Why VBP we VBG the NNP NN NN ? We VBP the RBS VBN NN on the NN with the JJS NNS of NN NNS / NNS in the JJ NN ? http://www.washingtonpost.com… http://sm.stanford.edu/archive/stanmed/2013fall/article2.html 7 . Why VBP NN NNS VBG in NNS with 90 NN + NN NNS ? What about that ‘ NN NN ’ NNS ? http://aje.oxfordjournals.org/content/139/1/77.short http://www.ncbi.nlm.nih.gov/pubmed/8483623 http://wwwnc.cdc.gov/eid/article/6/5/00-0512 8 . Why VBP NNS VBN against these NNS RB VBG and VBG them ? http://www.ncbi.nlm.nih.gov/pubmed/24076325 http://www.thehealthyhomeeconomist.com…(see NNP NNP NN ) http://www.ncbi.nlm.nih.gov/pubmed/15954490 http://www.ncbi.nlm.nih.gov/pubmed/8483623 9 . Why VBP we VBN of JJ NNS that VBP a NN ’s NN NN how to VB ? 10 . Why VBP NN NNS VBN to VB NNS and VB JJ and JJ NNS that VBP the NN NN ? 11 . Why VBP we VB JJ NN NNS if the NN ONE NN of NN NNS VBZ your NN ’s NN ? 12 . Why will no NN VB a VBN NN for a NN ’s NN JJ to VBG them with NNS they VBP you VBP and that they VBP VBP RB JJ ? 13 . Why VBZ there no NN about the 3.1 billion NNS VBN out in NN NN / NN NNS and yet they VBP there VBZ no NN and they VBP RB JJ ? http://www.hrsa.gov/vaccinecompensation/statisticsreport.pdf 14 . Why VBP RB NNS VB from NN that the RBS JJ and JJ NNS in the JJ 200 NNS VBD VBN due to JJR NN NN , VBN NN , NN , RBR JJ NNS and JJR NN NNS ? NNS VBD VBN at NNS in NN where every JJ NN VBD RB VBG , RBS RB RB VBN . To VB NNS NN for JJ NNS in NN VBZ like VBG a NN - NN NN for VBG a NN that VBD RB VBG . NNP NNP NNP VBZ RB how the NN NN of RB all NNS of the NN VBP VBN with NN , RB 200 NNS RB , at the NNS where there no NNS . http://youtu.be/jbkSRLYSojo https://childhealthsafety.wordpress.com/graphs/ ( NN yes , but the NNS VBP JJ and JJ NNS . ) http://www.columbia.edu… By the JJ NNS , RB before the NN of NNS NN , NNS - JJ NNS and NN NN NNS in the NNP NNPS VBD VBN RB , RB as a NN of NN in NN NN and NN ( NNP NNP of NNP NNPS ) . 15 . Why VBP NNS VB VBG what they VBP about ‘ NN NN ? ’ NN NN VBZ a JJ NN that VBZ that 1 ) VBN NNS VBP JJ to the NNS for which they VBP VBN VBN , 2 ) Can RB VB the NNS for which they VBP VBN / NN , 3 ) Because JJS of the NNS VBP VBN , JJ NNS around them ca RB VB the NN . My JJ NN for NN NN VBZ that if 95 NN of NNS in a NN VBP VBG JJ NNS when the NN VBZ in , the 5 NN VBP VBN . ( NN NNP NNP NNP ) 16 . Why VBP RB all JJ NNS we VBP to RB up to NN on their JJ NNS / NNS ? 18 . Why VBD RB our NN NN NNS RB NN VB NN ( a NN NN and NN ) since NNP VBD it in the NNS ? They VBD it in NNS from 1930 to 2004 ! It RB VBZ in some NNS JJ as the NN NN and NNS . RB VBZ a 2 NN NN , from NNP NNPS . The NNP themselves VBP the JJ NNS of NN : http://www.epa.gov/hg/effects.htm http://www.nytimes.com… http://www.ncbi.nlm.nih.gov/pubmed/21350943 http://www.ncbi.nlm.nih.gov/pubmed/20803069 http://www.ncbi.nlm.nih.gov/pubmed/21549155 19 . Why VBZ it that RB 40 NN of NN NNS VBP the NN NN each NN ? They must RB VB in it . http://abcnews.go.com… 20 . Why ? RB of a JJ NN NN , why VBP RB they VB a JJ NN VBN to VB us from JJ NN ? ( NN by NNP , JJ VBG NN of NN ! ) http://articles.mercola.com… http://www.worldlawdirect.com… 21 . Why VBZ RB the NN NN NN VB that the VBN NN NN and VB VBG us ? http://www.cnbc.com/id/102473744 http://www.nc.cdc.gov/eid/article/6/5/00-0512 22 . Why VBP NNS RB VB their NN NN NNS when they VBP NNS VBP RB JJ ? With all the JJ NN NN NNS , NNP , NNP NNP NNP , FW and all the NN NN NNS that VBP out JJ NNS a NN for NN / NN you VBP on NN NNS every NN , VB that with the NN and NN NN NNS , and JJ NN NNS , why VBP NNS RB VB their NN NN NNS when they VBP NNS VBP RB JJ ? VBG VBN that , why VBZ NN VBN at all since NN NNS ( NN by NN ) VBP that RB 300 million in this JJ NN VBD VBN by the NN . Those VBP NNS . RB VBP a JJ JJR NNS : – JJ NNS - NNS - NN NNS and NN NN in NNS with NN . http://www.ncbi.nlm.nih.gov/pubmed/12145534 – JJ NN of NNS NN and JJ NN NN - 6 with NN NN - NNS in NN . http://www.ncbi.nlm.nih.gov/pubmed/9756729 This NN VBZ the JJ to VB an NN between NN NN and NN NN NN in NN ; it VBZ the NN that a NN - VBN JJ NN may VB a JJ NN in NN . – NNS of NN - NN - NN or NN NN on NNS and NN - JJ JJ NNS among NNS and NNS in the NNP NNPS . http://www.ncbi.nlm.nih.gov/pubmed/10714532 NN VBZ VBN of 107 NNS of JJ NNS of NN NN VBN in the NN . The JJ NN of JJ NNS VBD JJ , with NNS of NN and NNS as the RBS JJ NNS . The NN of NN VBZ VBN and NNS VBP VBN RB VBZ the JJ NN of JJR NNS when a JJ NN VBZ VBN any NN of a JJ NN . NN NNS : – VBP NN NN NNS VB to the VBG NN NN ? http://www.ncbi.nlm.nih.gov/pubmed/22099159 “ … A JJ NN of NNS VBD VBN on NNS VBN with six NNS of NN NN . JJ NNS in these NNS VBD JJ NNS in a NN of NN NNS RB RB as VBN JJ NN NN . ” JJ NN , RB VBZ that NN NNS VBP a NN to VB JJ JJ NNS in NNS . In JJ , NN in NN NN VBZ a NN for NN , JJ - NN NN NN and VBN JJ NNS and may RB VB JJ and JJ JJ NN NNS . VB for JJ NN – NNS of NN NN NN and NN in JJ NNS . http://www.ncbi.nlm.nih.gov/pubmed/22235057 The NNS VBP a JJ NN for the NN NN in some JJ NNS VBN with NNP and RB an JJ NN for the NN of NNS ( JJ NN ) . – NN in the JJ JJ NN ( NNP ) : NN in NNS and NNS , NN NNS , and NN . http://www.ncbi.nlm.nih.gov/pubmed/23609067 – NN and NN NN of NN NNS of NNS . http://www.ncbi.nlm.nih.gov/pubmed/25699008 – JJ JJ NN of NN - VBN NN NN VBZ VBN with JJ JJ NN . http://www.sciencedirect.com/science/article/pii/S0162013409001895 – JJ - NN NN - up of JJ NN in NNS with NN JJ JJ NN ( NN ) . http://www.sciencedirect.com/science/article/pii/S0162013411002194 – VBG JJ ( in NN and in FW ) NN NNS of JJ - NN NN JJ to NNS . http://www.ncbi.nlm.nih.gov/pubmed/21350943 There VBZ a NN to VB JJ NNS to VB VB with NNS VBG JJ NNS , NNS and JJ NNS who must VB VBN NNS of NNP - VBG NNS ( NNS ) . NN VBN from NNS VBZ that : ( a ) NN of JJ NNS of NN against VBN JJ and NN NN NNS VBD VBN in all NNS and VBZ JJ with NN NN ; ( b ) the JJ NN of NN VBZ RB VBN VBN with VBG NN - NNP in NNS ; ( c ) NN NNS VBP VBN that NN to NNP - NNP can VB to NN of NN NN in NN , and that ( NN ) NNS JJ to NN NN VBP the NN to VB JJ NN - NN . – JJ NN of NN VBZ JJ NNS in NN JJ NNS in the NN NN . http://www.ncbi.nlm.nih.gov/pubmed/20803069 – JJ JJ NNS and NNS of NN NN after JJ JJ NN of NN in NNS . http://www.ncbi.nlm.nih.gov/pubmed/21549155 – JJ NN NN NNS in JJ NN NN NN , NN NN NN , and NN NN in NN NNS ; NN - and NN - JJ NNS . http://www.ncbi.nlm.nih.gov/pubmed/22015705 – NN of NN to NN NNS VBZ NN of NN and NN in the JJ NN : JJ NN NN NN . http://www.ncbi.nlm.nih.gov/pubmed/22015977 NNP , a NN - VBG NN NN , VBZ a VBN NN in the NN of JJ NNS . We RB VBD that its NN to NN NNS VBZ JJ , JJ and JJ NNS JJ to those JJ in NN . The NNP ’s NN of NN NN during NN VBZ RB VBN by NNS in its JJ NN NN or in JJ JJ NN . VBG the JJ NNS of JJ and JJ NN NN , the NN of NN during NN VBZ both JJ and JJ . RB , VB NN of the 71 NNS at the NN of this NN . 91 NNP NNP NNPS on The NNPS of NNPS : http://adventuresinautism.blogspot.com/2007/06/no-evidence-of-any-link.html – JJ NNS and NN of NN in NN VBG to VB NNP in NNS VBZ JJ . http://www.hindawi.com/journals/bmri/2014/247218/ – NN RB VBZ JJ , VBN and RB VBN NN - VBN NNS on JJ NNS VBN with NN . http://www.greenmedinfo.com/guide/health-guide-vaccine-research – JJ JJ NNS VBG NN . http://www.rescuepost.com… NN : livelovefruit.com NNP NNP VBZ a JJ NN and NN in the NN of JJ NN . He VBZ JJ NN NNS and VBZ VBN VBN in JJ NNS JJ as NNP and VBZ a JJ NN in JJ NN through JJ NN , JJ as JJ NNS RB RB as JJ NN . ~~ NN NN NNS to VB the NN by VBG this NN with NNS and NN …"
63,633,mainstream,"This_DT material_NN has_VBZ been_VBN summarised_VBN from_IN information_NN provided_VBN by_IN ProMED-_NNP mail_NN (_-LRB- http://www.promedmail.org)._ADD A_DT link_NN to_IN this_DT site_NN can_MD be_VB found_VBN under_IN '_`` Other_JJ Australian_JJ and_CC international_JJ communicable_JJ diseases_NNS sites_NNS '_'' on_IN the_DT Communicable_NNP Diseases_NNPS Australia_NNP homepage_NN ._. Confirmation_NN of_IN first_JJ BSE_NN case_NN in_IN the_DT United_NNP States_NNPS The_DT World_NNP Animal_NNP Health_NNP Organisation_NNP (_-LRB- OIE_NNP )_-RRB- Reference_NNP Laboratory_NNP for_IN bovine_NN spongiform_NN encephalopathy_NN (_-LRB- BSE_NNP )_-RRB- in_IN Weybridge_NNP ,_, United_NNP Kingdom_NNP ,_, confirmed_VBD the_DT diagnostic_JJ results_NNS obtained_VBN at_IN the_DT National_NNP Veterinary_NNP Services_NNPS Laboratories_NNP ,_, Ames_NNP ,_, Iowa_NNP ,_, USA_NNP ,_, of_IN finding_VBG a_DT positive_JJ case_NN of_IN BSE_NNP in_IN the_DT State_NNP of_IN Washington_NNP ._. The_DT positive_JJ Holstein_NNP cow_NN was_VBD traced_VBN back_RB from_IN the_DT slaughter_NN plant_NN ,_, where_WRB the_DT positive_JJ brain_NN tissue_NN was_VBD collected_VBN ,_, to_IN a_DT 4,000_CD -_HYPH animal_NN dairy_NN farm_NN ._. The_DT United_NNP States_NNPS Department_NNP of_IN Agriculture_NNP (_-LRB- USDA_NNP )_-RRB- continues_VBZ to_TO work_VB with_IN the_DT Canadian_JJ officials_NNS to_TO verify_VB the_DT origin_NN of_IN the_DT index_NN animal_NN ._. Records_NNS indicate_VBP that_IN this_DT animal_NN was_VBD approximately_RB six_CD and_CC a_DT half_NN years_NNS old_JJ at_IN the_DT time_NN of_IN slaughter_NN ._. The_DT age_NN of_IN the_DT animal_NN is_VBZ significant_JJ ._. She_PRP would_MD have_VB been_VBN born_VBN before_IN feed_NN bans_NNS were_VBD implemented_VBN in_IN North_NNP America_NNP in_IN August_NNP 1997_CD ._. The_DT feed_NN bans_NNS prohibit_VBP the_DT inclusion_NN of_IN ruminant_NN protein_NN in_IN feed_NN intended_VBN for_IN other_JJ ruminants_NNS ._. That_DT practice_NN has_VBZ been_VBN identified_VBN as_IN the_DT primary_JJ means_NNS by_IN which_WDT BSE_NNP is_VBZ spread_VBN ._. The_DT herd_NN the_DT affected_VBN animal_NN came_VBD from_IN is_VBZ under_IN a_DT State_NN quarantine_NN in_IN Washington_NNP ._. While_IN USDA_NNP has_VBZ not_RB made_VBN any_DT decisions_NNS on_IN the_DT dispositions_NNS of_IN this_DT herd_NN ,_, any_DT cattle_NN that_WDT die_VBP on_IN the_DT farm_NN will_MD be_VB tested_VBN for_IN BSE_NNP ._. On_IN 26_CD December_NNP 2003_CD ,_, the_DT Chinese_NNP Ministry_NNP of_IN Health_NNP informed_VBD the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- office_NN in_IN Beijing_NNP of_IN a_DT suspected_VBN case_NN of_IN severe_JJ acute_JJ respiratory_JJ syndrome_NN (_-LRB- SARS_NNP )_-RRB- in_IN a_DT hospital_NN in_IN Guangzhou_NNP ,_, Guangdong_NNP Province_NNP ._. The_DT patient_NN ,_, described_VBN as_IN a_DT 32_CD -_HYPH year_NN -_HYPH old_JJ television_NN producer_NN from_IN Guangzhou_NNP ,_, is_VBZ in_IN isolation_NN in_IN hospital_NN ._. According_VBG to_IN information_NN supplied_VBN to_IN WHO_NNP by_IN the_DT Chinese_NNP Ministry_NNP of_IN Health_NNP ,_, the_DT patient_NN developed_VBD a_DT fever_NN and_CC headache_NN on_IN 16_CD December_NNP 2003_CD ._. On_IN 20_CD December_NNP ,_, he_PRP sought_VBD medical_JJ assistance_NN and_CC was_VBD diagnosed_VBN as_IN having_VBG pneumonia_NN ._. Chest_NN x-rays_NNS showed_VBD changes_NNS in_IN the_DT lower_JJR right_JJ lung_NN ._. He_PRP was_VBD placed_VBN in_IN isolation_NN that_DT day_NN for_IN observation_NN ._. The_DT Ministry_NNP of_IN Health_NNP also_RB reported_VBD that_IN all_DT relevant_JJ human_JJ contacts_NNS of_IN the_DT patient_NN have_VBP been_VBN identified_VBN ,_, tested_VBN ,_, and_CC are_VBP deemed_VBN to_TO be_VB doing_VBG well_RB ,_, although_IN some_DT remain_VBP in_IN isolation_NN ,_, under_IN observation_NN ._. The_DT Chinese_NNP Ministry_NNP of_IN Health_NNP said_VBD epidemiological_JJ investigations_NNS show_VBP that_IN in_IN the_DT two_CD weeks_NNS prior_JJ to_IN the_DT onset_NN of_IN symptoms_NNS ,_, the_DT patient_NN had_VBD no_DT known_VBN contact_NN with_IN high_JJ -_HYPH risk_NN groups_NNS such_JJ as_IN health_NN workers_NNS or_CC animal_NN handlers_NNS ._. The_DT source_NN of_IN the_DT suspected_VBN SARS_NN infection_NN is_VBZ therefore_RB unclear_JJ at_IN this_DT stage_NN ._. This_DT is_VBZ the_DT first_JJ suspected_VBN SARS_NNP case_NN found_VBN since_IN 23_CD May_NNP 2003_CD when_WRB WHO_NNP lifted_VBD the_DT SARS_NNP -_HYPH related_JJ travel_NN advisory_NN against_IN Guangdong_NNP Province_NNP ._. Nearly_RB a_DT million_CD chickens_NNS and_CC ducks_NNS were_VBD slaughtered_VBN across_IN South_NNP Korea_NNP to_TO combat_VB a_DT highly_RB contagious_JJ strain_NN of_IN avian_JJ influenza_NN virus_NN that_WDT has_VBZ spread_VBN across_IN the_DT country_NN and_CC could_MD also_RB infect_VB humans_NNS ._. So_RB far_RB there_EX has_VBZ been_VBN no_DT evidence_NN of_IN transmission_NN of_IN avian_JJ influenza_NN virus_NN from_IN chickens_NNS or_CC ducks_NNS to_IN humans_NNS during_IN the_DT course_NN of_IN this_DT outbreak_NN of_IN avian_JJ influenza_NN A_NN (_-LRB- H5N1_NNP )_-RRB- virus_NN in_IN South_NNP Korea_NNP ._. Avian_JJ influenza_NN ,_, which_WDT in_IN rare_JJ cases_NNS can_MD be_VB deadly_JJ to_IN humans_NNS ,_, has_VBZ caused_VBN poultry_NN sales_NNS to_TO tumble_VB as_IN authorities_NNS confirm_VBP outbreaks_NNS at_IN farm_NN after_IN farm_NN across_IN the_DT country_NN ._. UK_NNP :_: variant_NN CJD_NN suspected_VBN to_TO have_VB been_VBN contracted_VBN by_IN blood_NN donation_NN A_DT man_NN who_WP received_VBD blood_NN during_IN an_DT operation_NN in_IN 1997_CD has_VBZ developed_VBN variant_NN Creutzfeldt_NNP -_HYPH Jakob_NNP disease_NN (_-LRB- vCJD_NNP )_-RRB- and_CC died_VBD ._. The_DT blood_NN was_VBD taken_VBN long_RB before_IN the_DT donor_NN was_VBD diagnosed_VBN with_IN the_DT vCJD_NN ._. Fifteen_CD other_JJ persons_NNS have_VBP received_VBN blood_NN from_IN donors_NNS who_WP went_VBD on_RP to_TO develop_VB vCJD_NN ._. All_DT have_VBP been_VBN contacted_VBN and_CC offered_VBN counselling_NN ._. However_RB ,_, none_NN of_IN these_DT has_VBZ so_RB far_RB gone_VBN on_RP to_TO develop_VB the_DT disease_NN ,_, although_IN it_PRP may_MD have_VB a_DT long_JJ incubation_NN period_NN ._. The_DT risks_NNS of_IN receiving_VBG blood_NN carrying_VBG the_DT '_`` rogue_NN '_'' prions_NNS that_WDT cause_VBP vCJD_NN are_VBP largely_RB unknown_JJ ,_, although_IN previously_RB thought_VBN to_TO be_VB tiny_JJ ,_, as_IN no_DT confirmed_VBN cases_NNS could_MD be_VB identified_VBN ._. In_IN this_DT case_NN ,_, the_DT donor_NN involved_VBD gave_VBD blood_NN in_IN 1997_CD ,_, and_CC fell_VBD ill_JJ with_IN [_-LRB- variant_NN ]_-RRB- CJD_NNP in_IN 1999_CD ,_, dying_VBG shortly_RB afterwards_RB ._. The_DT disease_NN did_VBD not_RB develop_VB in_IN the_DT recipient_NN until_IN this_DT year_NN ,_, and_CC the_DT patient_NN died_VBD earlier_RBR this_DT month_NN ._. Postmortem_NN results_NNS appear_VBP to_TO confirm_VB vCJD_NN ._. Measures_NNS already_RB exist_VBP which_WDT attempt_VBP to_TO cut_VB the_DT risk_NN of_IN CJD_NN transmission_NN during_IN blood_NN transfusions_NNS ._. So_RB far_RB ,_, 143_CD cases_NNS of_IN vCJD_NN have_VBP been_VBN diagnosed_VBN in_IN the_DT United_NNP Kingdom_NNP ,_, although_IN the_DT number_NN of_IN new_JJ cases_NNS is_VBZ falling_VBG ._. There_EX is_VBZ no_DT established_VBN treatment_NN for_IN the_DT illness_NN ,_, which_WDT causes_VBZ massive_JJ brain_NN damage_NN and_CC normally_RB kills_VBZ within_IN months_NNS of_IN being_VBG detected_VBN ._. Cluster_NN of_IN cases_NNS of_IN tetanus_NN in_IN injecting_VBG drug_NN users_NNS in_IN England_NNP Eight_CD cases_NNS of_IN clinical_JJ tetanus_NN ,_, including_VBG one_CD death_NN ,_, have_VBP been_VBN reported_VBN in_IN injecting_VBG drug_NN users_NNS (_-LRB- IDUs_NNS )_-RRB- in_IN England_NNP since_IN July_NNP 2003_CD ,_, six_CD of_IN which_WDT occurred_VBD since_IN October_NNP ._. The_DT cases_NNS are_VBP in_IN five_CD women_NNS and_CC three_CD men_NNS aged_JJ between_RB 20_CD and_CC 47_CD years_NNS ,_, and_CC the_DT latest_JJS reported_VBN onset_NN date_NN was_VBD 17_CD November_NNP 2003_CD ._. Two_CD of_IN the_DT cases_NNS are_VBP known_VBN to_TO be_VB unimmunised_VBN ,_, and_CC one_CD case_NN is_VBZ known_VBN to_TO have_VB received_VBN a_DT dose_NN of_IN tetanus_NN toxoid_NN nine_CD years_NNS ago_RB ._. The_DT presentation_NN of_IN these_DT cases_NNS so_RB far_RB has_VBZ ranged_VBN from_IN mild_JJ trismus_NN to_IN full_JJ -_HYPH blown_VBN tetanus_NN and_CC respiratory_JJ arrest_NN in_IN the_DT emergency_NN department_NN ._. Potential_JJ sources_NNS for_IN tetanus_NN infection_NN in_IN IDUs_NNS are_VBP contaminated_VBN drugs_NNS ,_, paraphernalia_NN ,_, and_CC contaminated_VBN skin_NN ._. The_DT source_NN of_IN infection_NN in_IN this_DT incident_NN is_VBZ not_RB known_VBN ._. The_DT close_JJ clustering_NN of_IN recent_JJ cases_NNS suggests_VBZ contamination_NN of_IN drugs_NNS ,_, either_CC the_DT drug_NN itself_PRP or_CC an_DT adulterant_NN ._. Rabies_NN cases_NNS leapt_VBD nearly_RB 63_CD per_NN cent_NN in_IN China_NNP in_IN the_DT first_JJ nine_CD months_NNS of_IN 2003_CD as_IN the_DT people_NNS 's_POS affair_NN with_IN pet_NN dogs_NNS deepened_VBD ,_, the_DT China_NNP Daily_NNP reported_VBD on_IN 25_CD November_NNP 2003_CD ._. Rabies_NN ,_, '_`` mad_JJ dog_NN disease_NN '_'' in_IN Chinese_NNP ,_, killed_VBD 1,297_CD people_NNS up_IN to_IN the_DT end_NN of_IN September_NNP 2003_CD ,_, far_RB exceeding_VBG the_DT 1,003_CD deaths_NNS the_DT Health_NNP Ministry_NNP reported_VBD for_IN all_DT of_IN 2002_CD ._. This_DT is_VBZ the_DT fifth_JJ straight_JJ year_NN that_WDT China_NNP has_VBZ seen_VBN a_DT big_JJ jump_NN in_IN rabies_NN infections_NNS ._. Experts_NNS from_IN the_DT China_NNP Center_NNP for_IN Disease_NNP Control_NNP and_CC Prevention_NNP are_VBP blaming_VBG the_DT trend_NN on_IN pet_NN ownership_NN ,_, the_DT poor_JJ quality_NN of_IN rabies_NN vaccines_NNS ,_, low_JJ public_JJ awareness_NN and_CC low_JJ vaccination_NN rates_NNS among_IN dogs_NNS as_IN the_DT major_JJ causes_NNS of_IN the_DT rapid_JJ rise_NN in_IN cases_NNS ._. Another_DT factor_NN was_VBD stray_JJ dogs_NNS running_VBG wild_JJ on_IN the_DT outskirts_NNS of_IN cities_NNS and_CC in_IN rural_JJ areas_NNS ._. The_DT Ministry_NNP said_VBD earlier_RBR this_DT year_NN that_IN rabies_NN was_VBD the_DT most_RBS deadly_JJ infectious_JJ killer_NN in_IN China_NNP ,_, well_RB surpassing_VBG SARS_NN and_CC AIDS_NN ._. Cases_NNS of_IN mumps_NNS are_VBP at_IN the_DT highest_JJS levels_NNS for_IN almost_RB a_DT decade_NN ._. So_RB far_RB this_DT year_NN ,_, there_EX have_VBP been_VBN more_JJR than_IN 2,000_CD formal_JJ notifications_NNS of_IN the_DT disease_NN in_IN England_NNP ,_, at_IN least_JJS half_NN of_IN them_PRP thought_VBN to_TO be_VB positive_JJ ._. In_IN Wales_NNP there_EX have_VBP been_VBN 323_CD confirmed_VBN cases_NNS ,_, compared_VBN with_IN just_RB two_CD in_IN 1999_CD ._. Public_JJ health_NN doctors_NNS have_VBP warned_VBN that_IN in_IN some_DT areas_NNS ,_, one_CD child_NN in_IN five_CD starting_VBG primary_JJ school_NN this_DT year_NN was_VBD not_RB protected_VBN against_IN the_DT disease_NN ._. The_DT massive_JJ rise_NN in_IN mumps_NNS cases_NNS is_VBZ a_DT cause_NN of_IN huge_JJ concern_NN for_IN health_NN officials_NNS ,_, who_WP have_VBP seen_VBN the_DT take_NN -_HYPH up_NN of_IN the_DT triple_JJ measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NN )_-RRB- vaccination_NN drop_VBP alarmingly_RB because_IN of_IN health_NN scares_NNS ._. Mumps_NNS can_MD cause_VB fever_NN ,_, headache_NN and_CC inflammation_NN of_IN the_DT salivary_NN glands_NNS ,_, and_CC occasionally_RB infection_NN of_IN the_DT membrane_NN covering_VBG the_DT brain_NN ._. The_DT disease_NN can_MD also_RB cause_VB permanent_JJ deafness_NN ._. About_RB one_CD in_IN five_CD adolescent_JJ or_CC adult_NN males_NNS who_WP contracts_VBZ mumps_NNS develops_VBZ a_DT painful_JJ inflammation_NN and_CC swelling_NN of_IN the_DT testicles_NNS ,_, which_WDT can_MD in_IN a_DT small_JJ number_NN of_IN cases_NNS result_VBP in_IN infertility_NN ._. Central_JJ nervous_JJ system_NN complications_NNS are_VBP not_RB uncommon_JJ ._. Teenagers_NNS are_VBP the_DT group_NN most_RBS at_IN risk_NN because_IN they_PRP may_MD have_VB missed_VBN out_RP on_IN the_DT MMR_NNP ,_, which_WDT was_VBD introduced_VBN in_IN 1988_CD ._. Some_DT universities_NNS are_VBP now_RB offering_VBG MMR_NNP vaccinations_NNS to_IN students_NNS ._. There_EX have_VBP been_VBN warnings_NNS that_IN the_DT fall_NN in_IN the_DT take_NN -_HYPH up_NN of_IN the_DT MMR_NNP ,_, blamed_VBN on_IN controversial_JJ and_CC hotly_RB disputed_VBN links_NNS that_WDT have_VBP been_VBN made_VBN between_IN the_DT vaccine_NN and_CC autism_NN ,_, will_MD result_VB in_IN more_JJR outbreaks_NNS of_IN measles_NNS and_CC rubella_NN ._. Less_JJR attention_NN has_VBZ been_VBN paid_VBN to_IN mumps_NNS ,_, which_WDT is_VBZ often_RB considered_VBN a_DT benign_JJ illness_NN with_IN low_JJ mortality_NN rates_NNS ._. However_RB ,_, doctors_NNS warn_VBP that_IN it_PRP should_MD not_RB be_VB underestimated_VBN ._. A_DT new_JJ '_`` super_JJ '_'' strain_NN of_IN tuberculosis_NN (_-LRB- TB_NN )_-RRB- that_WDT is_VBZ costly_JJ and_CC time_NN -_HYPH consuming_VBG to_TO treat_NN has_VBZ been_VBN identified_VBN in_IN South_NNP Africa_NNP 's_POS Western_NNP Cape_NNP Province_NNP ._. The_DT team_NN found_VBD that_IN the_DT strain_NN (_-LRB- DRF150_NN )_-RRB- was_VBD resistant_JJ to_IN almost_RB all_DT antimicrobial_JJ agents_NNS ,_, used_VBN to_TO treat_VB tuberculosis_NN ._. Usually_RB five_CD drugs_NNS are_VBP used_VBN to_TO combat_VB TB_NN ._. The_DT DRF150_NN strain_NN is_VBZ resistant_JJ to_IN four_CD of_IN these_DT ._. The_DT new_JJ strain_NN had_VBD its_PRP$ epicenter_NN in_IN the_DT town_NN of_IN George_NNP ,_, about_RB 400_CD kilometres_NNS (_-LRB- 250_CD miles_NNS )_-RRB- east_RB of_IN Cape_NNP Town_NNP ,_, where_WRB about_RB 60_CD cases_NNS had_VBD been_VBN identified_VBN ._. About_RB 20_CD other_JJ cases_NNS have_VBP been_VBN identified_VBN in_IN other_JJ parts_NNS of_IN the_DT Western_NNP Cape_NNP ,_, but_CC isolates_NNS of_IN the_DT new_JJ strain_NN have_VBP also_RB been_VBN found_VBN in_IN the_DT South_NNP Africa_NNP 's_POS Northern_NNP Province_NNP ,_, the_DT Pumalanga_NNP Province_NNP and_CC in_IN Nairobi_NNP ,_, Kenya_NNP ._. Last_JJ year_NN 224,420_CD cases_NNS of_IN tuberculosis_NN were_VBD reported_VBN in_IN South_NNP Africa_NNP ._. Health_NN officials_NNS ,_, on_IN 14_CD November_NNP 2003_CD ,_, confirmed_VBD Ebola_NNP haemorrhagic_JJ fever_NN as_IN the_DT cause_NN of_IN 11_CD deaths_NNS in_IN the_DT northern_JJ forests_NNS ,_, signalling_VBG the_DT Republic_NNP of_IN Congo_NNP 's_POS second_JJ outbreak_NN of_IN Ebola_NNP haemorrhagic_JJ fever_NN this_DT year_NN ._. Blood_NN specimens_NNS from_IN corpses_NNS suspected_VBN to_TO be_VB infected_VBN with_IN Ebola_NNP virus_NN have_VBP tested_VBN positive_JJ ._. First_JJ reports_NNS from_IN the_DT remote_JJ northern_JJ region_NN emerged_VBD on_IN 31_CD October_NNP 2003_CD ._. Ebola_NNP haemorrhagic_JJ fever_NN ,_, one_CD of_IN the_DT world_NN 's_POS deadliest_JJS viral_JJ diseases_NNS ,_, causes_VBZ rapid_JJ death_NN through_IN massive_JJ blood_NN loss_NN in_IN up_IN to_IN 90_CD per_NN cent_NN of_IN those_DT infected_VBN ._. In_IN June_NNP 2003_CD ,_, Republic_NNP of_IN Congo_NNP health_NN authorities_NNS announced_VBD the_DT end_NN of_IN an_DT Ebola_NNP epidemic_NN that_WDT killed_VBD over_RB 120_CD people_NNS in_IN the_DT same_JJ region_NN ._. That_DT epidemic_NN was_VBD believed_VBN to_TO have_VB been_VBN started_VBN by_IN contact_NN with_IN infected_VBN gorilla_NN flesh_NN ,_, which_WDT is_VBZ eaten_VBN in_IN parts_NNS of_IN sub-Saharan_JJ Africa_NNP ._. The_DT WHO_NNP says_VBZ Ebola_NNP haemorrhagic_JJ fever_NN has_VBZ killed_VBN more_JJR than_IN 1,000_CD people_NNS since_IN the_DT virus_NN was_VBD first_RB identified_VBN in_IN 1976_CD in_IN western_JJ Sudan_NNP and_CC in_IN the_DT Democratic_NNP Republic_NNP of_IN the_DT Congo_NNP ._. This_DT article_NN was_VBD published_VBN in_IN Communicable_NNP Diseases_NNPS Intelligence_NNP ,_, Volume_NNP 28_CD No_NNP 1_CD ,_, March_NNP 2004_CD ._.","This NN VBZ VBN VBN from NN VBN by NNP NN ( http://www.promedmail.org). A NN to this NN can VB VBN under ' JJ JJ and JJ JJ NNS NNS ' on the NNP NNPS NNP NN . NN of JJ NN NN in the NNP NNPS The NNP NNP NNP NNP ( NNP ) NNP NNP for NN NN NN ( NNP ) in NNP , NNP NNP , VBD the JJ NNS VBN at the NNP NNP NNPS NNP , NNP , NNP , NNP , of VBG a JJ NN of NNP in the NNP of NNP . The JJ NNP NN VBD VBN RB from the NN NN , where the JJ NN NN VBD VBN , to a 4,000 - NN NN NN . The NNP NNPS NNP of NNP ( NNP ) VBZ to VB with the JJ NNS to VB the NN of the NN NN . NNS VBP that this NN VBD RB six and a NN NNS JJ at the NN of NN . The NN of the NN VBZ JJ . She would VB VBN VBN before NN NNS VBD VBN in NNP NNP in NNP 1997 . The NN NNS VBP the NN of NN NN in NN VBN for JJ NNS . That NN VBZ VBN VBN as the JJ NNS by which NNP VBZ VBN . The NN the VBN NN VBD from VBZ under a NN NN in NNP . While NNP VBZ RB VBN any NNS on the NNS of this NN , any NN that VBP on the NN will VB VBN for NNP . On 26 NNP 2003 , the NNP NNP of NNP VBD the NNP NNP NNP ( NNP ) NN in NNP of a VBN NN of JJ JJ JJ NN ( NNP ) in a NN in NNP , NNP NNP . The NN , VBN as a 32 - NN - JJ NN NN from NNP , VBZ in NN in NN . VBG to NN VBN to NNP by the NNP NNP of NNP , the NN VBD a NN and NN on 16 NNP 2003 . On 20 NNP , he VBD JJ NN and VBD VBN as VBG NN . NN NNS VBD NNS in the JJR JJ NN . He VBD VBN in NN that NN for NN . The NNP of NNP RB VBD that all JJ JJ NNS of the NN VBP VBN VBN , VBN , and VBP VBN to VB VBG RB , although some VBP in NN , under NN . The NNP NNP of NNP VBD JJ NNS VBP that in the two NNS JJ to the NN of NNS , the NN VBD no VBN NN with JJ - NN NNS JJ as NN NNS or NN NNS . The NN of the VBN NN NN VBZ RB JJ at this NN . This VBZ the JJ VBN NNP NN VBN since 23 NNP 2003 when NNP VBD the NNP - JJ NN NN against NNP NNP . RB a million NNS and NNS VBD VBN across NNP NNP to VB a RB JJ NN of JJ NN NN that VBZ VBN across the NN and could RB VB NNS . RB RB there VBZ VBN no NN of NN of JJ NN NN from NNS or NNS to NNS during the NN of this NN of JJ NN NN ( NNP ) NN in NNP NNP . JJ NN , which in JJ NNS can VB JJ to NNS , VBZ VBN NN NNS to VB as NNS VBP NNS at NN after NN across the NN . NNP : NN NN VBN to VB VBN VBN by NN NN A NN who VBD NN during an NN in 1997 VBZ VBN NN NNP - NNP NN ( NNP ) and VBD . The NN VBD VBN RB before the NN VBD VBN with the NN . Fifteen JJ NNS VBP VBN NN from NNS who VBD on to VB NN . All VBP VBN VBN and VBN NN . RB , NN of these VBZ RB RB VBN on to VB the NN , although it may VB a JJ NN NN . The NNS of VBG NN VBG the ' NN ' NNS that VBP NN VBP RB JJ , although RB VBN to VB JJ , as no VBN NNS could VB VBN . In this NN , the NN VBD VBD NN in 1997 , and VBD JJ with [ NN ] NNP in 1999 , VBG RB RB . The NN VBD RB VB in the NN until this NN , and the NN VBD RBR this NN . NN NNS VBP to VB NN . NNS RB VBP which VBP to VB the NN of NN NN during NN NNS . RB RB , 143 NNS of NN VBP VBN VBN in the NNP NNP , although the NN of JJ NNS VBZ VBG . There VBZ no VBN NN for the NN , which VBZ JJ NN NN and RB VBZ within NNS of VBG VBN . NN of NNS of NN in VBG NN NNS in NNP Eight NNS of JJ NN , VBG one NN , VBP VBN VBN in VBG NN NNS ( NNS ) in NNP since NNP 2003 , six of which VBD since NNP . The NNS VBP in five NNS and three NNS JJ RB 20 and 47 NNS , and the JJS VBN NN NN VBD 17 NNP 2003 . Two of the NNS VBP VBN to VB VBN , and one NN VBZ VBN to VB VBN a NN of NN NN nine NNS RB . The NN of these NNS RB RB VBZ VBN from JJ NN to JJ - VBN NN and JJ NN in the NN NN . JJ NNS for NN NN in NNS VBP VBN NNS , NN , and VBN NN . The NN of NN in this NN VBZ RB VBN . The JJ NN of JJ NNS VBZ NN of NNS , either the NN itself or an NN . NN NNS VBD RB 63 NN NN in NNP in the JJ nine NNS of 2003 as the NNS 's NN with NN NNS VBD , the NNP NNP VBD on 25 NNP 2003 . NN , ' JJ NN NN ' in NNP , VBD 1,297 NNS up to the NN of NNP 2003 , RB VBG the 1,003 NNS the NNP NNP VBD for all of 2002 . This VBZ the JJ JJ NN that NNP VBZ VBN a JJ NN in NN NNS . NNS from the NNP NNP for NNP NNP and NNP VBP VBG the NN on NN NN , the JJ NN of NN NNS , JJ JJ NN and JJ NN NNS among NNS as the JJ NNS of the JJ NN in NNS . Another NN VBD JJ NNS VBG JJ on the NNS of NNS and in JJ NNS . The NNP VBD RBR this NN that NN VBD the RBS JJ JJ NN in NNP , RB VBG NN and NN . NNS of NNS VBP at the JJS NNS for RB a NN . RB RB this NN , there VBP VBN JJR than 2,000 JJ NNS of the NN in NNP , at JJS NN of them VBN to VB JJ . In NNP there VBP VBN 323 VBN NNS , VBN with RB two in 1999 . JJ NN NNS VBP VBN that in some NNS , one NN in five VBG JJ NN this NN VBD RB VBN against the NN . The JJ NN in NNS NNS VBZ a NN of JJ NN for NN NNS , who VBP VBN the NN - NN of the JJ NNS , NNS and NN ( NN ) NN VBP RB because of NN NNS . NNS can VB NN , NN and NN of the NN NNS , and RB NN of the NN VBG the NN . The NN can RB VB JJ NN . RB one in five JJ or NN NNS who VBZ NNS VBZ a JJ NN and NN of the NNS , which can in a JJ NN of NNS VBP in NN . JJ JJ NN NNS VBP RB JJ . NNS VBP the NN RBS at NN because they may VB VBN out on the NNP , which VBD VBN in 1988 . Some NNS VBP RB VBG NNP NNS to NNS . There VBP VBN NNS that the NN in the NN - NN of the NNP , VBN on JJ and RB VBN NNS that VBP VBN VBN between the NN and NN , will VB in JJR NNS of NNS and NN . JJR NN VBZ VBN VBN to NNS , which VBZ RB VBN a JJ NN with JJ NN NNS . RB , NNS VBP that it should RB VB VBN . A JJ ' JJ ' NN of NN ( NN ) that VBZ JJ and NN - VBG to NN VBZ VBN VBN in NNP NNP 's NNP NNP NNP . The NN VBD that the NN ( NN ) VBD JJ to RB all JJ NNS , VBN to VB NN . RB five NNS VBP VBN to VB NN . The NN NN VBZ JJ to four of these . The JJ NN VBD its NN in the NN of NNP , RB 400 NNS ( 250 NNS ) RB of NNP NNP , where RB 60 NNS VBD VBN VBN . RB 20 JJ NNS VBP VBN VBN in JJ NNS of the NNP NNP , but NNS of the JJ NN VBP RB VBN VBN in the NNP NNP 's NNP NNP , the NNP NNP and in NNP , NNP . JJ NN 224,420 NNS of NN VBD VBN in NNP NNP . NN NNS , on 14 NNP 2003 , VBD NNP JJ NN as the NN of 11 NNS in the JJ NNS , VBG the NNP of NNP 's JJ NN of NNP JJ NN this NN . NN NNS from NNS VBN to VB VBN with NNP NN VBP VBN JJ . JJ NNS from the JJ JJ NN VBD on 31 NNP 2003 . NNP JJ NN , one of the NN 's JJS JJ NNS , VBZ JJ NN through JJ NN NN in up to 90 NN NN of those VBN . In NNP 2003 , NNP of NNP NN NNS VBD the NN of an NNP NN that VBD RB 120 NNS in the JJ NN . That NN VBD VBN to VB VBN VBN by NN with VBN NN NN , which VBZ VBN in NNS of JJ NNP . The NNP VBZ NNP JJ NN VBZ VBN JJR than 1,000 NNS since the NN VBD RB VBN in 1976 in JJ NNP and in the NNP NNP of the NNP . This NN VBD VBN in NNP NNPS NNP , NNP 28 NNP 1 , NNP 2004 ."
64,1270,mainstream,"The_DT use_NN of_IN serology_NN in_IN trials_NNS of_IN antiviral_JJ drugs_NNS or_CC physical_JJ prophylaxis_NN (_-LRB- masks_NNS or_CC condoms_NNS )_-RRB- varies_VBZ by_IN the_DT pathogen_NN under_IN study_NN ._. For_IN trials_NNS to_TO prevent_VB infection_NN with_IN human_JJ immunodeficiency_NN virus_NN ,_, in_IN which_WDT seroconversion_NN (_-LRB- evidence_NN of_IN a_DT new_JJ antibody_NN response_NN to_IN infection_NN )_-RRB- is_VBZ the_DT gold_NN standard_NN for_IN evidence_NN of_IN new_JJ infection_NN ,_, serological_JJ measurements_NNS at_IN baseline_NN and_CC during_IN and_CC after_IN the_DT trial_NN are_VBP routine9_NN ._. On_IN the_DT other_JJ hand_NN ,_, trials_NNS of_IN prophylactic_JJ drugs_NNS or_CC physical_JJ prophylaxis_NN are_VBP often_RB performed_VBN for_IN infections_NNS ,_, such_JJ as_IN infection_NN with_IN the_DT malaria_NN pathogen_NN Plasmodium_NN falciparum10_NN or_CC with_IN influenza_NN virus11_NN ,_, respectively_RB ,_, for_IN which_WDT immunity_NN is_VBZ partial_JJ and_CC short_JJ -_HYPH lived_VBN and_CC is_VBZ therefore_RB hard_JJ to_TO measure_VB at_IN baseline_NN and_CC perhaps_RB difficult_JJ to_TO interpret_VB ._. For_IN this_DT reason_NN ,_, baseline_NN testing_NN has_VBZ been_VBN variable_JJ ._. Nonetheless_RB ,_, in_IN trials_NNS of_IN antiviral_JJ drugs_NNS for_IN prophylaxis_NN of_IN influenza_NN ,_, serology_NN has_VBZ sometimes_RB been_VBN used_VBN to_TO assess_VB the_DT proportion_NN of_IN infections_NNS that_WDT are_VBP symptomatic8_JJ ._. For_IN vaccines_NNS with_IN very_RB high_JJ efficacy_NN ,_, the_DT bias_NN in_IN efficacy_NN estimates_NNS due_IN to_IN unobserved_JJ infections_NNS is_VBZ small_JJ ,_, so_RB it_PRP may_MD not_RB affect_VB estimates_NNS much7_RB ._. That_DT is_VBZ why_WRB vaccine_NN trials_NNS rarely_RB (_-LRB- never_RB ,_, to_IN our_PRP$ knowledge_NN )_-RRB- attempt_VB to_TO correct_VB efficacy_NN estimates_NNS for_IN undetected_JJ or_CC subclinical_JJ infections_NNS through_IN the_DT use_NN of_IN post_NN -_HYPH trial_NN serology_NN ._. They_PRP also_RB ,_, to_IN our_PRP$ knowledge_NN ,_, rarely_RB use_VBP serostatus_NN at_IN the_DT time_NN of_IN enrollment_NN to_TO stratify_VB analyses_NNS ,_, despite_IN recommendations_NNS for_IN such_JJ analyses_NNS in_IN clinical_JJ trial_NN guidelines_NNS 12_CD ._. For_IN COVID_NNP -_HYPH 19_CD ,_, there_EX is_VBZ little_JJ basis_NN on_IN which_WDT to_TO predict_VB vaccine_NN efficacy_NN ,_, as_IN no_DT vaccine_NN against_IN coronavirus_NN has_VBZ been_VBN tested_VBN for_IN efficacy_NN ._. Vaccines_NNS are_VBP also_RB typically_RB tested_VBN for_IN efficacy_NN either_CC in_IN populations_NNS with_IN low_JJ baseline_NN immunity_NN (_-LRB- e.g._FW ,_, vaccines_NNS against_IN measles_NNS ,_, for_IN infants_NNS )_-RRB- and_CC /_, or_CC for_IN diseases_NNS for_IN which_WDT natural_JJ immunity_NN is_VBZ partial_JJ and_CC /_, or_CC short_JJ -_HYPH lived_VBN ,_, so_IN it_PRP would_MD be_VB difficult_JJ to_TO measure_VB (_-LRB- e.g._FW ,_, pneumococcal_JJ vaccines_NNS )_-RRB- 13_CD ._. Nonetheless_RB ,_, simulations_NNS have_VBP shown_VBN that_IN such_JJ trials_NNS can_MD be_VB complicated_VBN by_IN the_DT interplay_NN between_IN naturally_RB induced_VBN immunity_NN and_CC vaccine_NN -_HYPH induced_VBN immunity_NN 14_CD ._. For_IN the_DT Dengvaxia_NNP vaccine_NN against_IN dengue_NN fever_NN ,_, researchers_NNS gathered_VBD but_CC did_VBD not_RB immediately_RB analyze_VB serological_JJ samples_NNS from_IN trial_NN participants_NNS ._. After_IN publication_NN of_IN the_DT original_JJ trial_NN results_NNS ,_, a_DT secondary_JJ analysis_NN of_IN the_DT data_NNS showed_VBD that_IN the_DT vaccine_NN was_VBD most_RBS beneficial_JJ for_IN people_NNS with_IN a_DT prior_JJ seropositivity_NN to_IN infection_NN with_IN dengue_NN virus_NN ,_, but_CC that_IN if_IN a_DT person_NN received_VBD Dengvaxia_NNP while_IN seronegative_JJ to_IN infection_NN with_IN dengue_NN virus_NN ,_, the_DT vaccine_NN could_MD prime_VB an_DT ‘_`` enhancement_NN ’_'' of_IN infection_NN that_WDT made_VBD the_DT symptoms_NNS more_RBR severe15_NN ._. This_DT critical_JJ aspect_NN of_IN vaccine_NN safety_NN and_CC efficacy_NN could_MD not_RB have_VB been_VBN fully_RB understood_VBN if_IN serum_NN samples_NNS had_VBD not_RB been_VBN available_JJ ._. Serological_JJ measurement_NN of_IN infection_NN at_IN the_DT end_NN of_IN a_DT vaccine_NN trial_NN is_VBZ especially_RB important_JJ for_IN infections_NNS for_IN which_WDT asymptomatic_JJ infections_NNS are_VBP very_RB important_JJ ._. This_DT includes_VBZ infections_NNS such_JJ as_IN infection_NN with_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD ,_, in_IN which_WDT asymptomatic_JJ transmission_NN contributes_VBZ to_IN spread_NN ,_, or_CC infections_NNS such_JJ as_IN infection_NN with_IN Zika_NNP virus_NN ,_, in_IN which_WDT asymptomatic_JJ infection_NN can_MD produce_VB sequelae_NN with_IN potentially_RB severe_JJ consequences_NNS ,_, such_JJ as_IN congenital_JJ Zika_NN syndrome_NN ._. Serological_JJ measurement_NN also_RB matters_VBZ when_WRB failing_VBG to_TO do_VB so_RB biases_NNS efficacy_NN measurement_NN downward_RB ._. In_IN sum_NN ,_, serology_NN at_IN the_DT start_NN and_CC end_NN of_IN trials_NNS should_MD be_VB more_RBR common_JJ than_IN it_PRP is_VBZ ._.","The NN of NN in NNS of JJ NNS or JJ NN ( NNS or NNS ) VBZ by the NN under NN . For NNS to VB NN with JJ NN NN , in which NN ( NN of a JJ NN NN to NN ) VBZ the NN NN for NN of JJ NN , JJ NNS at NN and during and after the NN VBP NN . On the JJ NN , NNS of JJ NNS or JJ NN VBP RB VBN for NNS , JJ as NN with the NN NN NN NN or with NN NN , RB , for which NN VBZ JJ and JJ - VBN and VBZ RB JJ to VB at NN and RB JJ to VB . For this NN , NN NN VBZ VBN JJ . RB , in NNS of JJ NNS for NN of NN , NN VBZ RB VBN VBN to VB the NN of NNS that VBP JJ . For NNS with RB JJ NN , the NN in NN NNS due to JJ NNS VBZ JJ , RB it may RB VB NNS RB . That VBZ why NN NNS RB ( RB , to our NN ) VB to VB NN NNS for JJ or JJ NNS through the NN of NN - NN NN . They RB , to our NN , RB VBP NN at the NN of NN to VB NNS , despite NNS for JJ NNS in JJ NN NNS 12 . For NNP - 19 , there VBZ JJ NN on which to VB NN NN , as no NN against NN VBZ VBN VBN for NN . NNS VBP RB RB VBN for NN either in NNS with JJ NN NN ( FW , NNS against NNS , for NNS ) and / or for NNS for which JJ NN VBZ JJ and / or JJ - VBN , so it would VB JJ to VB ( FW , JJ NNS ) 13 . RB , NNS VBP VBN that JJ NNS can VB VBN by the NN between RB VBN NN and NN - VBN NN 14 . For the NNP NN against NN NN , NNS VBD but VBD RB RB VB JJ NNS from NN NNS . After NN of the JJ NN NNS , a JJ NN of the NNS VBD that the NN VBD RBS JJ for NNS with a JJ NN to NN with NN NN , but that if a NN VBD NNP while JJ to NN with NN NN , the NN could VB an ‘ NN ’ of NN that VBD the NNS RBR NN . This JJ NN of NN NN and NN could RB VB VBN RB VBN if NN NNS VBD RB VBN JJ . JJ NN of NN at the NN of a NN NN VBZ RB JJ for NNS for which JJ NNS VBP RB JJ . This VBZ NNS JJ as NN with NN - NN - 2 , in which JJ NN VBZ to NN , or NNS JJ as NN with NNP NN , in which JJ NN can VB NN with RB JJ NNS , JJ as JJ NN NN . JJ NN RB VBZ when VBG to VB RB NNS NN NN RB . In NN , NN at the NN and NN of NNS should VB RBR JJ than it VBZ ."
65,842,mainstream,"A_DT LITTLE_JJ boy_NN with_IN autism_NN was_VBD allegedly_RB forced_VBN out_IN of_IN the_DT cinema_NN after_IN a_DT ""_`` heartless_JJ ""_'' woman_NN told_VBD his_PRP$ mum_NN that_IN she_PRP should_MD have_VB kept_VBN him_PRP at_IN home_NN ._. Vicky_NNP Page_NNP ,_, 36_CD ,_, took_VBD her_PRP$ son_NN Noah_NNP ,_, 5_CD ,_, and_CC his_PRP$ two_CD siblings_NNS ,_, aged_JJ nine_CD and_CC ten_CD to_TO watch_VB Dumbo_NNP as_IN a_DT family_NN day_NN out_RP ._. But_CC she_PRP claims_VBZ the_DT family_NN were_VBD forced_VBN to_TO leave_VB after_IN a_DT fellow_JJ cinema_NN goer_NN kept_VBD giving_VBG them_PRP dirty_JJ looks_NNS and_CC said_VBD that_IN she_PRP ""_`` did_VBD n't_RB care_VB ""_'' that_IN Noah_NNP had_VBD autism_NN and_CC that_IN she_PRP should_MD have_VB left_VBN him_PRP at_IN home_NN ._. She_PRP said_VBD :_: ""_`` Noah_NNP was_VBD n't_RB being_VBG naughty_JJ ,_, he_PRP just_RB got_VBD extremely_RB excited_JJ ._. ""_`` He_PRP finds_VBZ it_PRP quite_RB hard_JJ to_TO stand_VB still_RB when_WRB he_PRP gets_VBZ excited_JJ ._. ""_`` He_PRP could_MD n't_RB believe_VB Dumbo_NNP could_MD fly_VB but_CC instead_RB of_IN saying_VBG things_NNS quietly_RB ,_, he_PRP shouts_VBZ things_NNS out_RP pretty_RB loud_RB ,_, and_CC he_PRP just_RB said_VBD '_`` elephant_NN fly_NN superhero_NN '_'' and_CC then_RB started_VBD really_RB jumping_VBG ._. ""_`` A_DT woman_NN and_CC her_PRP$ son_NN kept_VBD turning_VBG and_CC giving_VBG us_PRP quite_PDT filthy_JJ looks_NNS ._. ""_`` I_PRP ended_VBD up_RP apologising_VBG and_CC I_PRP said_VBD '_`` I_PRP 'm_VBP really_RB sorry_JJ ,_, he_PRP has_VBZ autism_NN '_'' ._. ""_`` But_CC the_DT woman_NN said_VBD '_`` I_PRP do_VBP n't_RB particularly_RB care_VB '_'' and_CC that_IN I_PRP should_MD keep_VB him_PRP at_IN home_NN if_IN he_PRP can't_MD sit_VB still_RB ._. ""_`` It_PRP made_VBD me_PRP see_VB red_JJ and_CC I_PRP think_VBP in_IN the_DT end_NN Noah_NNP saw_VBD me_PRP tensing_VBG up_RP and_CC I_PRP had_VBD to_TO leave_VB with_IN my_PRP$ children_NNS ._. ""_`` We_PRP went_VBD through_IN to_IN the_DT foyer_NN ,_, where_WRB he_PRP ended_VBD up_RP having_VBG a_DT full_JJ blown_VBN meltdown_NN and_CC started_VBD headbutting_VBG the_DT floor_NN ._. ""_`` It_PRP was_VBD very_RB upsetting_JJ and_CC I_PRP ended_VBD up_RP getting_VBG quite_RB emotional_JJ ._. ""_'' Vicky_NNP added_VBD the_DT trip_NN to_IN Faversham_NNP 's_POS Royal_NNP Cinema_NNP was_VBD a_DT treat_NN for_IN all_DT three_CD children_NNS and_CC the_DT family_NN worked_VBD hard_RB to_TO prepare_VB Noah_NNP for_IN the_DT special_JJ outing_NN ._. She_PRP said_VBD :_: ""_`` We_PRP only_RB got_VBD half_NN -_HYPH an_DT -_HYPH hour_NN into_IN the_DT film_NN ,_, and_CC it_PRP is_VBZ hard_JJ for_IN my_PRP$ other_JJ two_CD children_NNS ,_, as_IN it_PRP was_VBD a_DT treat_NN for_IN them_PRP too_RB ._. ""_`` They_PRP need_VBP that_DT treat_NN because_IN it_PRP is_VBZ quite_RB difficult_JJ for_IN them_PRP as_RB well_RB as_IN we_PRP are_VBP very_RB limited_JJ ._. ""_`` Our_PRP$ routines_NNS have_VBP to_TO be_VB quite_RB structured_VBN ,_, so_IN they_PRP can't_MD have_VB people_NNS round_RB to_TO play_VB ._. ""_`` It_PRP is_VBZ all_RB about_IN countdowns_NNS with_IN Noah_NNP ,_, so_RB we_PRP had_VBD been_VBN preparing_VBG him_PRP for_IN the_DT cinema_NN for_IN a_DT week_NN ;_, we_PRP can't_MD just_RB think_VB let_VB 's_PRP go_VB here_RB ,_, there_EX 's_VBZ lots_NNS of_IN preparation_NN with_IN him_PRP ._. ""_'' But_CC Vicky_NNP ,_, who_WP works_VBZ with_IN special_JJ needs_NNS adults_NNS ,_, said_VBD she_PRP is_VBZ often_RB forced_VBN to_TO deal_VB with_IN unwanted_JJ comments_NNS from_IN passers_NNS -_HYPH by_IN and_CC even_RB avoids_VBZ supermarkets_NNS following_VBG similar_JJ incidents_NNS ._. She_PRP said_VBD :_: ""_`` I_PRP get_VBP this_DT sort_NN of_IN thing_NN a_DT lot_NN ._. ""_`` I_PRP try_VBP to_TO avoid_VB supermarkets_NNS -_, people_NNS tut_VB ,_, or_CC come_VBP over_RB to_IN me_PRP and_CC say_VBP '_`` if_IN you_PRP walk_VBP away_RB from_IN him_PRP he_PRP 'll_MD follow_VB you_PRP '_'' when_WRB he_PRP 's_VBZ laying_VBG on_IN the_DT floor_NN ._. ""_`` Or_CC 'if_IN you_PRP give_VBP him_PRP a_DT really_RB hard_JJ smack_NN he_PRP 'll_MD actually_RB start_VB to_TO have_VB some_DT boundaries_NNS '_'' ._. ""_`` This_DT sort_NN of_IN thing_NN happens_VBZ everywhere_RB with_IN everybody_NN ,_, but_CC it_PRP just_RB makes_VBZ you_PRP so_RB cross_NN ._. ""_`` He_PRP does_VBZ look_VB so_RB normal_JJ when_WRB he's_PRP not_RB having_VBG a_DT meltdown_NN ,_, but_CC if_IN you_PRP spoke_VBD to_IN him_PRP you_PRP could_MD tell_VB he_PRP 's_VBZ got_VBN needs_NNS ._. ""_`` He_PRP goes_VBZ to_IN a_DT special_JJ needs_NNS school_NN ,_, so_RB he_PRP is_VBZ behind_IN for_IN his_PRP$ age_NN ._. ""_`` So_RB for_IN him_PRP to_TO even_RB shout_VB out_RP I_PRP was_VBD so_RB proud_JJ of_IN him_PRP as_IN he_PRP has_VBZ only_RB been_VBN able_JJ to_TO string_VB a_DT sentence_NN together_RB for_IN the_DT last_JJ the_DT year_NN -_, it_PRP shows_VBZ he_PRP 's_VBZ really_RB coming_VBG on_RP ._. ""_'' Vicky_NNP said_VBD the_DT cinema_NN should_MD hold_VB screenings_NNS especially_RB for_IN those_DT with_IN additional_JJ needs_NNS to_TO avoid_VB similar_JJ confrontations_NNS from_IN happening_VBG ._. She_PRP said_VBD :_: ""_`` People_NNS have_VBP been_VBN so_RB supportive_JJ on_IN social_JJ media_NN ._. ""_`` There_EX have_VBP been_VBN special_JJ needs_NNS mums_NNS coming_VBG forward_RB and_CC they_PRP want_VBP to_TO do_VB this_DT trip_NN to_IN the_DT cinema_NN ,_, getting_VBG all_PDT the_DT special_JJ -_HYPH needs_NNS mums_NNS together_RB ._. ""_`` It_PRP would_MD be_VB lovely_JJ ,_, the_DT children_NNS could_MD run_VB around_IN the_DT cinema_NN and_CC make_VB noises_NNS ._. ""_`` I_PRP know_VBP people_NNS say_VBP you_PRP should_MD go_VB to_IN autism_NN -_HYPH friendly_JJ screenings_NNS but_CC they_PRP 're_VBP miles_NNS away_RB ._. ""_`` I_PRP wanted_VBD to_TO get_VB my_PRP$ point_NN across_RB and_CC raise_VB awareness_NN because_IN I_PRP found_VBD the_DT situation_NN really_RB sad_JJ and_CC quite_RB heartless_JJ ._. ""_'' Plenty_NN of_IN parents_NNS have_VBP voiced_VBN support_NN for_IN Vicky_NNP on_IN social_JJ media_NN and_CC agreed_VBD that_IN other_JJ members_NNS of_IN the_DT public_NN should_MD be_VB more_RBR understanding_NN of_IN Noah_NNP 's_POS autism_NN ._. Danielle_NNP Chapman_NNP commented_VBD :_: ""_`` This_DT is_VBZ so_RB sad_JJ and_CC something_NN I_PRP really_RB fear_VBP with_IN my_PRP$ son_NN ,_, he_PRP 's_VBZ not_RB diagnosed_VBN yet_RB but_CC is_VBZ showing_VBG potential_JJ early_JJ signs_NNS of_IN autism_NN ._. ""_`` Why_WRB can't_MD people_NNS be_VB understanding_VBG ._. ""_`` Poor_JJ little_JJ boy_NN my_PRP$ heart_NN really_RB goes_VBZ out_RP to_IN him_PRP and_CC his_PRP$ mum_NN ._. ""_`` Just_RB because_IN someone_NN is_VBZ '_`` different_JJ '_'' they_PRP still_RB deserve_VBP to_TO be_VB apart_RB of_IN society_NN and_CC not_RB be_VB judged_VBN ._. ""_'' Emma_NNP Harman_NNP added_VBD :_: ""_`` I_PRP just_RB find_VBP it_PRP so_RB hard_RB in_IN today_NN 's_POS world_NN we_PRP just_RB can't_MD all_DT have_VB some_DT empathy_NN ._. ""_`` I_PRP hope_VBP the_DT other_JJ mother_NN feels_VBZ ashamed_JJ of_IN herself_PRP ,_, she_PRP has_VBZ no_DT right_NN to_TO say_VB keep_VB him_PRP at_IN home_NN ._. ""_'' We_PRP pay_VBP for_IN your_PRP$ stories_NNS !_. Do_VBP you_PRP have_VB a_DT story_NN for_IN The_DT Sun_NNP Online_NNP news_NN team_NN ?_. Email_VB us_PRP at_IN tips@the-sun.co.uk_NNP or_CC call_VB 0207_CD 782_CD 4368_CD ._. You_PRP can_MD WhatsApp_VB us_PRP on_IN 07810_CD 791_CD 502_CD ._. We_PRP pay_VBP for_IN videos_NNS too_RB ._. Click_VB here_RB to_TO upload_VB yours_PRP ._.","A JJ NN with NN VBD RB VBN out of the NN after a "" JJ "" NN VBD his NN that she should VB VBN him at NN . NNP NNP , 36 , VBD her NN NNP , 5 , and his two NNS , JJ nine and ten to VB NNP as a NN NN out . But she VBZ the NN VBD VBN to VB after a JJ NN NN VBD VBG them JJ NNS and VBD that she "" VBD RB VB "" that NNP VBD NN and that she should VB VBN him at NN . She VBD : "" NNP VBD RB VBG JJ , he RB VBD RB JJ . "" He VBZ it RB JJ to VB RB when he VBZ JJ . "" He could RB VB NNP could VB but RB of VBG NNS RB , he VBZ NNS out RB RB , and he RB VBD ' NN NN NN ' and RB VBD RB VBG . "" A NN and her NN VBD VBG and VBG us quite JJ NNS . "" I VBD up VBG and I VBD ' I VBP RB JJ , he VBZ NN ' . "" But the NN VBD ' I VBP RB RB VB ' and that I should VB him at NN if he can't VB RB . "" It VBD me VB JJ and I VBP in the NN NNP VBD me VBG up and I VBD to VB with my NNS . "" We VBD through to the NN , where he VBD up VBG a JJ VBN NN and VBD VBG the NN . "" It VBD RB JJ and I VBD up VBG RB JJ . "" NNP VBD the NN to NNP 's NNP NNP VBD a NN for all three NNS and the NN VBD RB to VB NNP for the JJ NN . She VBD : "" We RB VBD NN - an - NN into the NN , and it VBZ JJ for my JJ two NNS , as it VBD a NN for them RB . "" They VBP that NN because it VBZ RB JJ for them RB RB as we VBP RB JJ . "" Our NNS VBP to VB RB VBN , so they can't VB NNS RB to VB . "" It VBZ RB about NNS with NNP , RB we VBD VBN VBG him for the NN for a NN ; we can't RB VB VB 's VB RB , there VBZ NNS of NN with him . "" But NNP , who VBZ with JJ NNS NNS , VBD she VBZ RB VBN to VB with JJ NNS from NNS - by and RB VBZ NNS VBG JJ NNS . She VBD : "" I VBP this NN of NN a NN . "" I VBP to VB NNS - NNS VB , or VBP RB to me and VBP ' if you VBP RB from him he 'll VB you ' when he VBZ VBG on the NN . "" Or 'if you VBP him a RB JJ NN he 'll RB VB to VB some NNS ' . "" This NN of NN VBZ RB with NN , but it RB VBZ you RB NN . "" He VBZ VB RB JJ when he's RB VBG a NN , but if you VBD to him you could VB he VBZ VBN NNS . "" He VBZ to a JJ NNS NN , RB he VBZ behind for his NN . "" RB for him to RB VB out I VBD RB JJ of him as he VBZ RB VBN JJ to VB a NN RB for the JJ the NN - it VBZ he VBZ RB VBG on . "" NNP VBD the NN should VB NNS RB for those with JJ NNS to VB JJ NNS from VBG . She VBD : "" NNS VBP VBN RB JJ on JJ NN . "" There VBP VBN JJ NNS NNS VBG RB and they VBP to VB this NN to the NN , VBG all the JJ - NNS NNS RB . "" It would VB JJ , the NNS could VB around the NN and VB NNS . "" I VBP NNS VBP you should VB to NN - JJ NNS but they VBP NNS RB . "" I VBD to VB my NN RB and VB NN because I VBD the NN RB JJ and RB JJ . "" NN of NNS VBP VBN NN for NNP on JJ NN and VBD that JJ NNS of the NN should VB RBR NN of NNP 's NN . NNP NNP VBD : "" This VBZ RB JJ and NN I RB VBP with my NN , he VBZ RB VBN RB but VBZ VBG JJ JJ NNS of NN . "" Why can't NNS VB VBG . "" JJ JJ NN my NN RB VBZ out to him and his NN . "" RB because NN VBZ ' JJ ' they RB VBP to VB RB of NN and RB VB VBN . "" NNP NNP VBD : "" I RB VBP it RB RB in NN 's NN we RB can't all VB some NN . "" I VBP the JJ NN VBZ JJ of herself , she VBZ no NN to VB VB him at NN . "" We VBP for your NNS ! VBP you VB a NN for The NNP NNP NN NN ? VB us at NNP or VB 0207 782 4368 . You can VB us on 07810 791 502 . We VBP for NNS RB . VB RB to VB yours ."
66,690,mainstream,"ROME_NNP -_, Brandenburg_NNP has_VBZ become_VBN the_DT first_JJ state_NN in_IN Germany_NNP to_TO require_VB all_DT children_NNS attending_VBG kindergarten_NN to_TO be_VB vaccinated_VBN for_IN measles_NNS and_CC other_JJ infectious_JJ diseases_NNS as_IN fears_NNS spread_VBP across_IN Europe_NNP about_IN the_DT influence_NN of_IN the_DT anti-vaccination_NN movement_NN and_CC lower_JJR immunization_NN rates_NNS ._. A_DT decrease_NN in_IN immunization_NN has_VBZ led_VBN to_IN an_DT increase_NN in_IN measles_NNS in_IN Germany_NNP ,_, France_NNP ,_, Italy_NNP and_CC elsewhere_RB ._. The_DT German_JJ government_NN is_VBZ considering_VBG whether_IN to_TO mandate_VB vaccinations_NNS across_IN the_DT country_NN ._. Authorities_NNS there_RB say_VBP 2019_CD is_VBZ likely_JJ to_TO be_VB a_DT record_NN year_NN for_IN measles_NNS with_IN cases_NNS tripling_VBG in_IN three_CD states_NNS ._. Other_JJ European_JJ countries_NNS have_VBP already_RB introduced_VBN laws_NNS making_VBG vaccinations_NNS compulsory_JJ ,_, including_VBG Italy_NNP which_WDT two_CD years_NNS ago_RB passed_VBD a_DT law_NN making_VBG 10_CD vaccines_NNS obligatory_JJ for_IN children_NNS who_WP enrolled_VBD in_IN Italian_JJ schools_NNS ,_, including_VBG chickenpox_NN and_CC measles_NNS ._. Last_JJ week_NN ,_, New_NNP York_NNP City_NNP Mayor_NNP Bill_NNP de_NNP Blasio_NNP declared_VBD a_DT public_JJ health_NN emergency_NN with_IN 285_CD cases_NNS of_IN measles_NNS confirmed_VBN since_IN October_NNP ._. City_NN health_NN officials_NNS have_VBP ordered_VBN mandatory_JJ vaccinations_NNS for_IN anybody_NN who_WP ’s_VBZ been_VBN in_IN contact_NN with_IN infected_VBN people_NNS and_CC violators_NNS can_MD face_VB fines_NNS of_IN up_IN to_IN $_$ 1,000_CD ._. Health_NN officials_NNS say_VBP a_DT booklet_NN produced_VBN by_IN an_DT anti-vaccine_JJ group_NN has_VBZ been_VBN widely_RB disseminated_VBN through_IN Orthodox_JJ Jewish_JJ communities_NNS ,_, not_RB the_DT first_JJ time_NN in_IN the_DT United_NNP States_NNPS an_DT insular_JJ community_NN has_VBZ seen_VBN a_DT jump_NN in_IN infection_NN rates_NNS as_IN a_DT result_NN of_IN a_DT fall_NN in_IN immunization_NN rates_NNS prompted_VBN by_IN anti-vaccine_JJ campaigners_NNS ._. Under_IN the_DT Brandenburg_NNP law_NN children_NNS who_WP have_VBP not_RB been_VBN vaccinated_VBN against_IN measles_NNS will_MD be_VB excluded_VBN from_IN attending_VBG kindergartens_NNS ._. Brandenburg_NNP lawmakers_NNS say_VBP they_PRP will_MD examine_VB whether_IN to_TO add_VB other_JJ vaccinations_NNS ._. “_`` In_IN the_DT public_JJ interest_NN ,_, individual_JJ concerns_NNS towards_IN vaccination_NN ,_, which_WDT cannot_MD be_VB proven_VBN scientifically_RB ,_, must_MD take_VB second_JJ place_NN ,_, ”_'' said_VBD Sylvia_NNP Lehmann_NNP of_IN the_DT Social_NNP Democratic_NNP Party_NNP ._. State_NN lawmakers_NNS from_IN Germany_NNP 's_POS right_JJ -_HYPH wing_NN populist_NN Alternative_NNP fuer_NNP Deutschland_NNP (_-LRB- AfD_NNP )_-RRB- voted_VBD against_IN the_DT legislation_NN ,_, noting_VBG a_DT vaccine_NN obligation_NN last_RB existed_VBD in_IN east_NNP Germany_NNP when_WRB the_DT communists_NNS were_VBD in_IN power_NN ._. The_DT Green_NNP Party_NNP abstained_VBD from_IN the_DT vaccine_NN vote_NN ._. Brandenburg_NNP ’s_POS health_NN minister_NN Andreas_NNP Buttner_NNP says_VBZ “_`` the_DT protection_NN of_IN babies_NNS and_CC pregnant_JJ women_NNS ”_'' should_MD take_VB “_`` precedence_NN over_IN the_DT rights_NNS of_IN those_DT who_WP refuse_VBP to_TO have_VB their_PRP$ children_NNS vaccinated_VBN ._. ”_'' In_IN Brandenburg_NNP 73.5_CD %_NN of_IN young_JJ children_NNS are_VBP being_VBG vaccinated_VBN within_IN the_DT recommended_VBN time_NN frame_NN of_IN 23_CD months_NNS ._. In_IN some_DT Germany_NNP ’s_POS other_JJ states_NNS ,_, including_VBG Lower_NNP Saxony_NNP and_CC Schleswig_NNP -_HYPH Holstein_NNP ,_, school_NN principals_NNS have_VBP been_VBN taking_VBG action_NN by_IN ordering_VBG children_NNS who_WP have_VBP not_RB been_VBN vaccinated_VBN to_TO go_VB home_RB ._. The_DT World_NNP Health_NNP Organization_NNP said_VBD more_JJR Europeans_NNPS contracted_VBD measles_NNS last_JJ year_NN –_: 82,600_CD –_: than_IN at_IN any_DT time_NN in_IN the_DT past_JJ decade_NN ._. German_JJ Health_NNP Minister_NNP Hermann_NNP Groehe_NNP is_VBZ proposing_VBG a_DT federal_JJ law_NN obligating_VBG nursery_NN schools_NNS in_IN all_DT of_IN the_DT country_NN ’s_POS 16_CD states_NNS to_TO report_VB parents_NNS to_IN health_NN officials_NNS if_IN they_PRP cannot_MD prove_VB that_IN they_PRP sought_VBD vaccination_NN advice_NN for_IN their_PRP$ children_NNS ._. If_IN the_DT law_NN is_VBZ passed_VBN ,_, parents_NNS who_WP do_VBP not_RB show_VB proof_NN of_IN such_JJ medical_JJ consultation_NN could_MD be_VB fined_VBN up_IN to_IN $_$ 2,800_CD ._. “_`` No_DT one_NN can_MD be_VB blasé_JJ about_IN the_DT fact_NN that_IN people_NNS are_VBP still_RB dying_VBG of_IN measles_NNS ,_, ”_'' Groehe_NNP told_VBD Germany_NNP ’s_POS Bild_NNP newspaper_NN ._. “_`` Therefore_RB we_PRP are_VBP now_RB toughening_VBG the_DT regulations_NNS for_IN vaccination_NN protection_NN ._. ”_'' But_CC Groehe_NNP has_VBZ so_RB far_RB ruled_VBN out_RP making_VBG vaccinations_NNS compulsory_JJ for_IN school_NN children_NNS ,_, as_IN Italy_NNP recently_RB did_VBD ._. Italy_NNP ’s_POS approach_NN has_VBZ been_VBN characterized_VBN by_IN U_NNP -_HYPH turns_NNS ,_, thanks_NN to_IN the_DT vaccine_NN -_HYPH sceptic_JJ anti-establishment_JJ Five_NNP Star_NNP Movement_NNP (_-LRB- M5S_NNP )_-RRB- ,_, which_WDT is_VBZ in_IN a_DT coalition_NN government_NN with_IN the_DT populist_JJ Lega_NNP party_NN ._. M5S_NNP had_VBD helped_VBN to_TO fuel_VB the_DT anti-vaccination_NN campaign_NN and_CC poured_VBN scorn_NN on_IN expert_NN opinion_NN that_WDT insists_VBZ vaccines_NNS are_VBP safe_JJ and_CC the_DT combined_VBN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN is_VBZ n’t_RB linked_VBN to_IN autism_NN ._. The_DT party_NN argued_VBD requiring_VBG schoolchildren_NNS to_TO be_VB vaccinated_VBN was_VBD “_`` coercive_JJ ._. ”_'' Last_JJ year_NN ,_, the_DT health_NN minister_NN ,_, a_DT member_NN of_IN the_DT Five_NNP Star_NNP Movement_NNP ,_, introduced_VBD a_DT temporary_JJ measure_NN to_TO allow_VB children_NNS to_TO stay_VB in_IN school_NN as_RB long_RB as_IN their_PRP$ parents_NNS declared_VBD they_PRP had_VBD been_VBN vaccinated_VBN without_IN having_VBG to_TO provide_VB any_DT documentation_NN ._. Italian_JJ measles_NNS rates_NNS then_RB skyrocketed_VBD and_CC last_JJ year_NN the_DT country_NN accounted_VBD for_IN nearly_RB a_DT quarter_NN of_IN all_DT new_JJ cases_NNS in_IN Europe_NNP ,_, according_VBG to_IN WHO_NNP ._. The_DT organization_NN says_VBZ 95_CD %_NN of_IN a_DT population_NN needs_VBZ to_TO be_VB inoculated_VBN for_IN the_DT spread_NN of_IN the_DT disease_NN to_TO become_VB unlikely_JJ ,_, protecting_VBG those_DT who_WP cannot_MD be_VB vaccinated_VBN for_IN serious_JJ health_NN reasons_NNS ,_, including_VBG lowered_VBN immunity_NN ._. In_IN March_NNP ,_, the_DT Italian_JJ government_NN allowed_VBD the_DT M5S_NNP 's_POS temporary_JJ measure_NN relaxing_VBG vaccination_NN rules_NNS to_TO expire_VB ,_, bringing_VBG back_RB into_IN play_VB a_DT two_CD -_HYPH year_NN -_HYPH old_JJ law_NN requiring_VBG children_NNS to_TO receive_VB mandatory_JJ immunizations_NNS before_IN attending_VBG school_NN ._. Analysts_NNS say_VBP there_EX has_VBZ been_VBN a_DT noticeable_JJ shift_NN in_IN public_JJ opinion_NN favoring_VBG vaccinations_NNS since_IN an_DT Italian_JJ populist_JJ politician_NN who_WP has_VBZ campaigned_VBN against_IN compulsory_JJ vaccinations_NNS was_VBD hospitalized_VBN last_JJ month_NN after_IN contracting_VBG chickenpox_NN and_CC was_VBD widely_RB mocked_VBN on_IN social_JJ media_NN ._.","NNP - NNP VBZ VBN the JJ NN in NNP to VB all NNS VBG NN to VB VBN for NNS and JJ JJ NNS as NNS VBP across NNP about the NN of the NN NN and JJR NN NNS . A NN in NN VBZ VBN to an NN in NNS in NNP , NNP , NNP and RB . The JJ NN VBZ VBG whether to VB NNS across the NN . NNS RB VBP 2019 VBZ JJ to VB a NN NN for NNS with NNS VBG in three NNS . JJ JJ NNS VBP RB VBN NNS VBG NNS JJ , VBG NNP which two NNS RB VBD a NN VBG 10 NNS JJ for NNS who VBD in JJ NNS , VBG NN and NNS . JJ NN , NNP NNP NNP NNP NNP NNP NNP VBD a JJ NN NN with 285 NNS of NNS VBN since NNP . NN NN NNS VBP VBN JJ NNS for NN who VBZ VBN in NN with VBN NNS and NNS can VB NNS of up to $ 1,000 . NN NNS VBP a NN VBN by an JJ NN VBZ VBN RB VBN through JJ JJ NNS , RB the JJ NN in the NNP NNPS an JJ NN VBZ VBN a NN in NN NNS as a NN of a NN in NN NNS VBN by JJ NNS . Under the NNP NN NNS who VBP RB VBN VBN against NNS will VB VBN from VBG NNS . NNP NNS VBP they will VB whether to VB JJ NNS . “ In the JJ NN , JJ NNS towards NN , which cannot VB VBN RB , must VB JJ NN , ” VBD NNP NNP of the NNP NNP NNP . NN NNS from NNP 's JJ - NN NN NNP NNP NNP ( NNP ) VBD against the NN , VBG a NN NN RB VBD in NNP NNP when the NNS VBD in NN . The NNP NNP VBD from the NN NN . NNP ’s NN NN NNP NNP VBZ “ the NN of NNS and JJ NNS ” should VB “ NN over the NNS of those who VBP to VB their NNS VBN . ” In NNP 73.5 NN of JJ NNS VBP VBG VBN within the VBN NN NN of 23 NNS . In some NNP ’s JJ NNS , VBG NNP NNP and NNP - NNP , NN NNS VBP VBN VBG NN by VBG NNS who VBP RB VBN VBN to VB RB . The NNP NNP NNP VBD JJR NNPS VBD NNS JJ NN – 82,600 – than at any NN in the JJ NN . JJ NNP NNP NNP NNP VBZ VBG a JJ NN VBG NN NNS in all of the NN ’s 16 NNS to VB NNS to NN NNS if they cannot VB that they VBD NN NN for their NNS . If the NN VBZ VBN , NNS who VBP RB VB NN of JJ JJ NN could VB VBN up to $ 2,800 . “ No NN can VB JJ about the NN that NNS VBP RB VBG of NNS , ” NNP VBD NNP ’s NNP NN . “ RB we VBP RB VBG the NNS for NN NN . ” But NNP VBZ RB RB VBN out VBG NNS JJ for NN NNS , as NNP RB VBD . NNP ’s NN VBZ VBN VBN by NNP - NNS , NN to the NN - JJ JJ NNP NNP NNP ( NNP ) , which VBZ in a NN NN with the JJ NNP NN . NNP VBD VBN to VB the NN NN and VBN NN on NN NN that VBZ NNS VBP JJ and the VBN NNS , NNS and NN ( NN ) NN VBZ RB VBN to NN . The NN VBD VBG NNS to VB VBN VBD “ JJ . ” JJ NN , the NN NN , a NN of the NNP NNP NNP , VBD a JJ NN to VB NNS to VB in NN RB RB as their NNS VBD they VBD VBN VBN without VBG to VB any NN . JJ NNS NNS RB VBD and JJ NN the NN VBD for RB a NN of all JJ NNS in NNP , VBG to NNP . The NN VBZ 95 NN of a NN VBZ to VB VBN for the NN of the NN to VB JJ , VBG those who cannot VB VBN for JJ NN NNS , VBG VBN NN . In NNP , the JJ NN VBD the NNP 's JJ NN VBG NN NNS to VB , VBG RB into VB a two - NN - JJ NN VBG NNS to VB JJ NNS before VBG NN . NNS VBP there VBZ VBN a JJ NN in JJ NN VBG NNS since an JJ JJ NN who VBZ VBN against JJ NNS VBD VBN JJ NN after VBG NN and VBD RB VBN on JJ NN ."
67,733,mainstream,"In_IN December_NNP ,_, 1962_CD ,_, Esquire_NNP magazine_NN established_VBD what_WP it_PRP called_VBD its_PRP$ Dubious_NNP Achievement_NNP Awards_NNP ._. These_DT were_VBD a_DT series_NN of_IN fictional_JJ prizes_NNS given_VBN to_IN celebrities_NNS ,_, politicians_NNS ,_, and_CC business_NN leaders_NNS who_WP committed_VBD some_DT egregious_JJ blunder_NN that_DT year_NN ,_, a_DT gaffe_NN worthy_JJ of_IN a_DT kind_NN of_IN Hall_NNP of_IN Shame_NNP ._. The_DT annual_JJ event_NN became_VBD so_RB popular_JJ that_IN readers_NNS and_CC media_NNS hungered_VBD for_IN it_PRP year_NN after_IN year_NN ._. Now_RB there_EX are_VBP dubious_JJ awards_NNS everywhere_RB ,_, across_IN all_DT genres_NNS —_: movies_NNS ,_, television_NN ,_, commercials_NNS ._. Every_DT news_NN organization_NN hungers_VBZ to_TO win_VB awards_NNS ._. They_PRP display_VBP them_PRP in_IN glass_NN cases_NNS in_IN the_DT lobby_NN ._. They_PRP write_VBP stories_NNS about_IN the_DT individual_JJ winners_NNS ._. Your_PRP$ public_JJ broadcaster_NN is_VBZ no_RB different_JJ ._. We_PRP love_VBP getting_VBG awards_NNS ._. The_DT award_NN season_NN is_VBZ about_JJ to_TO begin_VB ,_, with_IN various_JJ programs_NNS submitting_VBG entries_NNS to_IN award_NN -_HYPH conferring_VBG bodies_NNS ._. Over_IN the_DT years_NNS ,_, the_DT CBC_NNP —_: radio_NN and_CC television_NN —_: has_VBZ received_VBN hundreds_NNS of_IN plaques_NNS ,_, statuettes_NNS ,_, proclamations_NNS recognizing_VBG significant_JJ achievements_NNS in_IN reporting_VBG and_CC broadcasting_NN ._. At_IN the_DT tail_NN end_NN of_IN 2016_CD ,_, we_PRP received_VBD an_DT official_JJ looking_VBG envelope_NN containing_VBG an_DT official_JJ ,_, suitable_JJ -_HYPH for_IN -_HYPH framing_NN ,_, award_NN certificate_NN ._. Because_IN of_IN its_PRP$ importance_NN ,_, I_PRP want_VBP to_TO read_VB the_DT official_JJ proclamation_NN word_NN for_IN word_NN :_: To_TO wit_VB -_, ""_`` The_DT 2016_CD Adding_NNP Insult_NNP to_IN Injury_NNP Award_NNP ,_, recognizing_VBG deception_NN ,_, distortion_NN and_CC dishonesty_NN in_IN Media_NN ,_, awarded_VBN to_IN CBC_NNP Radio_NNP —_: The_DT Sunday_NNP Edition_NNP ._. ""_'' The_DT award_NN was_VBD presented_VBN by_IN the_DT Board_NN of_IN Directors_NNS of_IN Vaccine_NNP Choice_NNP Canada_NNP ._. For_IN those_DT unaware_JJ of_IN Vaccine_NNP Choice_NNP Canada_NNP ,_, it_PRP is_VBZ an_DT organization_NN opposed_VBN to_IN the_DT compulsory_JJ vaccination_NN of_IN children_NNS ._. Its_PRP$ argument_NN is_VBZ that_IN ordinary_JJ vaccinations_NNS can_MD neurologically_RB wound_VB children_NNS or_CC kill_VB them_PRP outright_RB ._. It_PRP blames_VBZ vaccination_NN for_IN seeming_VBG increases_NNS in_IN autism_NN spectrum_NN disorder_NN ._. It_PRP assiduously_RB ignores_VBZ the_DT burden_NN of_IN evidence_NN from_IN the_DT World_NNP Health_NNP Organization_NNP at_IN the_DT top_NN of_IN the_DT health_NN chain_NN ,_, down_RB to_IN your_PRP$ local_JJ family_NN physician_NN and_CC pharmacist_NN ,_, that_IN this_DT is_VBZ not_RB the_DT case_NN ._. Measles_NN is_VBZ one_CD of_IN the_DT most_RBS contagious_JJ and_CC deadly_JJ diseases_NNS on_IN the_DT planet_NN ._. It_PRP kills_VBZ about_RB 100,000_CD children_NNS every_DT year_NN ._. What_WDT Vaccine_NN Choice_NNP Canada_NNP objects_VBZ to_IN is_VBZ a_DT story_NN we_PRP broadcast_VBD on_IN last_JJ June_NNP on_IN the_DT backfire_NN effect_NN ._. I_PRP interviewed_VBD an_DT American_JJ professor_NN named_VBN Brendan_NNP Nyhan_NNP ._. He_PRP explained_VBD the_DT backfire_NN effect_NN as_IN the_DT inability_NN of_IN many_JJ people_NNS to_TO change_VB their_PRP$ opinions_NNS ,_, even_RB after_IN presented_VBN with_IN irrefutable_JJ facts_NNS to_IN the_DT contrary_NN ._. It_PRP matters_VBZ not_RB how_WRB many_JJ facts_NNS are_VBP marshalled_VBN to_TO contradict_VB them_PRP ._. They_PRP are_VBP resolute_JJ ,_, even_RB reinforced_VBN ,_, in_IN their_PRP$ views_NNS ._. During_IN the_DT interview_NN ,_, Professor_NNP Nyhan_NNP used_VBD the_DT anti-vaccine_JJ movement_NN as_IN another_DT example_NN of_IN the_DT intransigence_NN of_IN people_NNS holding_VBG views_NNS which_WDT are_VBP contradicted_VBN by_IN evidence_NN ._. With_IN the_DT anti-vaccine_NN movement_NN ,_, it_PRP is_VBZ especially_RB difficult_JJ ._. As_IN the_DT New_NNP York_NNP Times_NNP pointed_VBD out_RP in_IN early_JJ January_NNP ,_, the_DT anti-vaccine_JJ group_NN ""_`` is_VBZ not_RB a_DT bastion_NN of_IN rationality_NN ._. ""_'' Although_IN study_NN after_IN study_NN has_VBZ demonstrated_VBN there_EX is_VBZ no_DT link_NN between_IN vaccination_NN and_CC such_JJ diseases_NNS as_IN autism_NN ,_, the_DT anti-vaxxers_NNS continue_VBP their_PRP$ crusade_NN ._. You_PRP have_VBP to_TO be_VB an_DT automaton_NN not_RB to_TO feel_VB sorry_JJ for_IN parents_NNS dealing_VBG with_IN autism_NN ,_, who_WP search_VBP for_IN some_DT explanation_NN for_IN their_PRP$ child_NN 's_POS disorder_NN ._. In_IN desperation_NN they_PRP turn_VBP to_IN garbage_NN science_NN and_CC conspiracy_NN theories_NNS ._. The_DT American_NNP Academy_NNP of_IN Pediatrics_NNP has_VBZ issued_VBN a_DT 21_CD page_NN document_NN listing_VBG all_PDT the_DT studies_NNS showing_VBG that_IN there_EX is_VBZ no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ._. Nevertheless_RB ,_, the_DT arguments_NNS put_VBN out_RP by_IN the_DT anti-vaxxers_NNS seems_VBZ to_TO be_VB gaining_VBG ground_NN in_IN the_DT United_NNP State_NNP ,_, especially_RB in_IN the_DT south_NN and_CC especially_RB in_IN Texas_NNP ._. Peter_NNP Hotez_NNP is_VBZ a_DT pediatrician_NN with_IN the_DT Baylor_NNP College_NNP of_IN Medicine_NNP in_IN Texas_NNP ._. Dr._NNP Hotez_NNP ,_, writing_VBG in_IN the_DT New_NNP York_NNP Times_NNP ,_, said_VBD that_IN because_IN the_DT number_NN of_IN unvaccinated_JJ children_NNS is_VBZ rising_VBG ,_, there_EX could_MD be_VB serious_JJ outbreaks_NNS of_IN measles_NNS in_IN his_PRP$ state_NN ._. It_PRP does_VBZ n't_RB help_VB things_NNS when_WRB the_DT sitting_NN president_NN believes_VBZ that_IN vaccines_NNS cause_VBP autism_NN ._. Dr._NNP Hotez_NNP said_VBD :_: ""_`` I_PRP 'm_VBP worried_JJ that_IN our_PRP$ nation_NN 's_POS health_NN will_MD soon_RB be_VB threatened_VBN because_IN we_PRP have_VBP not_RB stood_VBN up_RP to_IN the_DT pseudoscience_NN and_CC fake_JJ conspiracy_NN claims_NNS of_IN this_DT movement_NN ._. ""_'' In_IN 2000_CD ,_, the_DT US_NNP Centres_NNPS for_IN Disease_NNP Control_NNP announced_VBD that_IN measles_NNS had_VBD been_VBN eliminated_VBN in_IN the_DT United_NNP States_NNPS ,_, meaning_VBG it_PRP was_VBD no_RB longer_RBR endemic_JJ to_IN the_DT US_NNP ._. Now_RB it_PRP appears_VBZ to_TO be_VB coming_VBG back_RB ._. Which_WDT means_VBZ a_DT renewed_VBN attention_NN on_IN the_DT importance_NN of_IN vaccination_NN and_CC the_DT skeptics_NNS who_WP oppose_VBP it_PRP ._. So_RB on_IN behalf_NN of_IN The_DT Sunday_NNP Edition_NNP ,_, I_PRP humbly_RB accept_VBP the_DT 2016_CD Adding_NNP Insult_NNP to_IN Injury_NNP Award_NNP ,_, and_CC give_VBP it_PRP pride_NN of_IN place_NN in_IN our_PRP$ office_NN ._. Click_VB the_DT button_NN above_RB to_TO hear_VB Michael_NNP 's_POS essay_NN ._.","In NNP , 1962 , NNP NN VBD what it VBD its NNP NNP NNP . These VBD a NN of JJ NNS VBN to NNS , NNS , and NN NNS who VBD some JJ NN that NN , a NN JJ of a NN of NNP of NNP . The JJ NN VBD RB JJ that NNS and NNS VBD for it NN after NN . RB there VBP JJ NNS RB , across all NNS — NNS , NN , NNS . Every NN NN VBZ to VB NNS . They VBP them in NN NNS in the NN . They VBP NNS about the JJ NNS . Your JJ NN VBZ RB JJ . We VBP VBG NNS . The NN NN VBZ JJ to VB , with JJ NNS VBG NNS to NN - VBG NNS . Over the NNS , the NNP — NN and NN — VBZ VBN NNS of NNS , NNS , NNS VBG JJ NNS in VBG and NN . At the NN NN of 2016 , we VBD an JJ VBG NN VBG an JJ , JJ - for - NN , NN NN . Because of its NN , I VBP to VB the JJ NN NN for NN : To VB - "" The 2016 NNP NNP to NNP NNP , VBG NN , NN and NN in NN , VBN to NNP NNP — The NNP NNP . "" The NN VBD VBN by the NN of NNS of NNP NNP NNP . For those JJ of NNP NNP NNP , it VBZ an NN VBN to the JJ NN of NNS . Its NN VBZ that JJ NNS can RB VB NNS or VB them RB . It VBZ NN for VBG NNS in NN NN NN . It RB VBZ the NN of NN from the NNP NNP NNP at the NN of the NN NN , RB to your JJ NN NN and NN , that this VBZ RB the NN . NN VBZ one of the RBS JJ and JJ NNS on the NN . It VBZ RB 100,000 NNS every NN . What NN NNP NNP VBZ to VBZ a NN we VBD on JJ NNP on the NN NN . I VBD an JJ NN VBN NNP NNP . He VBD the NN NN as the NN of JJ NNS to VB their NNS , RB after VBN with JJ NNS to the NN . It VBZ RB how JJ NNS VBP VBN to VB them . They VBP JJ , RB VBN , in their NNS . During the NN , NNP NNP VBD the JJ NN as another NN of the NN of NNS VBG NNS which VBP VBN by NN . With the NN NN , it VBZ RB JJ . As the NNP NNP NNP VBD out in JJ NNP , the JJ NN "" VBZ RB a NN of NN . "" Although NN after NN VBZ VBN there VBZ no NN between NN and JJ NNS as NN , the NNS VBP their NN . You VBP to VB an NN RB to VB JJ for NNS VBG with NN , who VBP for some NN for their NN 's NN . In NN they VBP to NN NN and NN NNS . The NNP NNP of NNP VBZ VBN a 21 NN NN VBG all the NNS VBG that there VBZ no NN between NNS and NN . RB , the NNS VBN out by the NNS VBZ to VB VBG NN in the NNP NNP , RB in the NN and RB in NNP . NNP NNP VBZ a NN with the NNP NNP of NNP in NNP . NNP NNP , VBG in the NNP NNP NNP , VBD that because the NN of JJ NNS VBZ VBG , there could VB JJ NNS of NNS in his NN . It VBZ RB VB NNS when the NN NN VBZ that NNS VBP NN . NNP NNP VBD : "" I VBP JJ that our NN 's NN will RB VB VBN because we VBP RB VBN up to the NN and JJ NN NNS of this NN . "" In 2000 , the NNP NNPS for NNP NNP VBD that NNS VBD VBN VBN in the NNP NNPS , VBG it VBD RB RBR JJ to the NNP . RB it VBZ to VB VBG RB . Which VBZ a VBN NN on the NN of NN and the NNS who VBP it . RB on NN of The NNP NNP , I RB VBP the 2016 NNP NNP to NNP NNP , and VBP it NN of NN in our NN . VB the NN RB to VB NNP 's NN ."
68,791,conspiracy,"The_DT Health_NNP Secretary_NNP has_VBZ said_VBN he_PRP hopes_VBZ everyone_NN in_IN the_DT country_NN would_MD be_VB immunised_VBN against_IN coronavirus_NN if_IN the_DT UK_NNP develops_VBZ a_DT vaccine_NN ._. Matt_NNP Hancock_NNP stopped_VBD short_JJ of_IN confirming_VBG jab_NN would_MD be_VB mandatory_JJ when_WRB asked_VBN at_IN today_NN ’s_POS Downing_NNP Street_NNP press_NN conference_NN ,_, but_CC he_PRP did_VBD n’t_RB rule_VB it_PRP out_RP either_RB ._. A_DT working_NN vaccination_NN is_VBZ yet_RB to_TO be_VB developed_VBN anywhere_RB in_IN the_DT world_NN ,_, but_CC scientists_NNS at_IN Oxford_NNP University_NNP and_CC Imperial_NNP College_NNP London_NNP are_VBP locked_VBN in_IN a_DT race_NN to_TO make_VB one_CD ._. Speaking_VBG to_IN reporters_NNS the_DT Health_NNP Secretary_NNP said_VBD :_: ‘_`` The_DT question_NN of_IN whether_IN it_PRP ’s_VBZ mandatory_JJ is_VBZ not_RB one_CD that_WDT we_PRP ’ve_VBP addressed_VBN yet_RB ._. We_PRP are_VBP still_RB some_DT time_NN off_IN a_DT vaccine_NN being_VBG available_JJ ._. But_CC I_PRP would_MD hope_VB ,_, given_VBN the_DT scale_NN of_IN this_DT crisis_NN ,_, and_CC given_VBN the_DT overwhelming_JJ need_NN for_IN us_PRP to_TO get_VB through_IN this_DT and_CC to_TO get_VB the_DT country_NN back_RB on_IN its_PRP$ feet_NNS ,_, and_CC the_DT very_RB positive_JJ impact_NN that_WDT a_DT vaccine_NN would_MD have_VB ,_, that_IN everybody_NN would_MD have_VB the_DT vaccine_NN ._. ’_'' National_JJ coordinator_NN of_IN the_DT UK_NNP ’s_POS testing_NN effort_NN Professor_NNP John_NNP Newton_NNP said_VBD mandatory_JJ vaccinations_NNS are_VBP an_DT option_NN ,_, but_CC that_IN hopefully_RB it_PRP wo_MD n’t_RB come_VB to_IN that_DT ._. He_PRP added_VBD :_: ‘_`` The_DT most_RBS successful_JJ vaccine_NN programmes_NNS tend_VBP to_TO be_VB via_IN consent_NN ,_, so_RB what_WP really_RB matters_VBZ is_VBZ clear_JJ explanation_NN of_IN the_DT benefits_NNS and_CC any_DT risks_NNS associated_VBN with_IN the_DT vaccine_NN ,_, and_CC a_DT really_RB good_JJ system_NN to_TO make_VB the_DT vaccine_NN available_JJ to_IN anybody_NN who_WP needs_VBZ it_PRP ._. ‘_`` Although_IN some_DT countries_NNS have_VBP adopted_VBN mandatory_JJ programmes_NNS the_DT most_RBS successful_JJ programmes_NNS tend_VBP to_TO be_VB on_IN the_DT basis_NN of_IN consent_NN ,_, good_JJ information_NN and_CC good_JJ delivery_NN mechanisms_NNS ._. But_CC clearly_RB mandation_NN is_VBZ there_RB and_CC can_MD be_VB used_VBN in_IN some_DT instances_NNS ._. ’_'' Read_VB more_JJR :_: Matt_NNP Hancock_NNP hints_VBZ coronavirus_NN vaccine_NN could_MD be_VB compulsory_JJ","The NNP NNP VBZ VBN he VBZ NN in the NN would VB VBN against NN if the NNP VBZ a NN . NNP NNP VBD JJ of VBG NN would VB JJ when VBN at NN ’s NNP NNP NN NN , but he VBD RB VB it out RB . A NN NN VBZ RB to VB VBN RB in the NN , but NNS at NNP NNP and NNP NNP NNP VBP VBN in a NN to VB one . VBG to NNS the NNP NNP VBD : ‘ The NN of whether it VBZ JJ VBZ RB one that we VBP VBN RB . We VBP RB some NN off a NN VBG JJ . But I would VB , VBN the NN of this NN , and VBN the JJ NN for us to VB through this and to VB the NN RB on its NNS , and the RB JJ NN that a NN would VB , that NN would VB the NN . ’ JJ NN of the NNP ’s NN NN NNP NNP NNP VBD JJ NNS VBP an NN , but that RB it wo RB VB to that . He VBD : ‘ The RBS JJ NN NNS VBP to VB via NN , RB what RB VBZ VBZ JJ NN of the NNS and any NNS VBN with the NN , and a RB JJ NN to VB the NN JJ to NN who VBZ it . ‘ Although some NNS VBP VBN JJ NNS the RBS JJ NNS VBP to VB on the NN of NN , JJ NN and JJ NN NNS . But RB NN VBZ RB and can VB VBN in some NNS . ’ VB JJR : NNP NNP VBZ NN NN could VB JJ"
69,961,mainstream,"The_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP at_IN H.H.S._NNP is_VBZ distributing_VBG billions_NNS of_IN dollars_NNS to_IN companies_NNS to_TO develop_VB vaccines_NNS ,_, including_VBG the_DT latest_JJS funding_NN to_IN AstraZeneca_NNP ._. The_DT authority_NN ,_, known_VBN as_IN Barda_NNP ,_, has_VBZ already_RB agreed_VBN to_TO provide_VB up_IN to_IN $_$ 483_CD million_CD to_IN the_DT biotech_NN company_NN Moderna_NNP and_CC $_$ 500_CD million_CD to_IN Johnson_NNP &_CC Johnson_NNP for_IN their_PRP$ separate_JJ vaccine_NN efforts_NNS ._. It_PRP has_VBZ also_RB agreed_VBN to_TO provide_VB $_$ 30_CD million_CD to_IN a_DT coronavirus_NN vaccine_NN effort_NN by_IN the_DT French_JJ company_NN Sanofi_NNP ,_, building_VBG on_IN a_DT larger_JJR contract_NN announced_VBN last_JJ December_NNP for_IN making_VBG flu_NN inoculations_NNS ._. Scores_NNS of_IN vaccine_NN efforts_NNS are_VBP underway_JJ around_IN the_DT world_NN ,_, and_CC several_JJ potential_JJ vaccines_NNS are_VBP now_RB in_IN at_IN least_JJS small_JJ -_HYPH scale_NN clinical_JJ trials_NNS ._. But_CC the_DT Oxford_NNP vaccine_NN candidate_NN ,_, now_RB licensed_VBN by_IN AstraZeneca_NNP ,_, has_VBZ moved_VBN quickly_RB into_IN the_DT kind_NN of_IN large_JJ -_HYPH scale_NN testing_NN necessary_JJ to_TO prove_VB safety_NN and_CC effectiveness_NN ._. Building_VBG on_IN efforts_NNS to_TO develop_VB a_DT vaccine_NN against_IN a_DT similar_JJ disease_NN ,_, the_DT Middle_NNP East_NNP Respiratory_NNP Syndrome_NNP ,_, the_DT Oxford_NNP scientists_NNS last_JJ month_NN began_VBD a_DT Phase_NN I_CD trial_NN of_IN their_PRP$ potential_JJ vaccine_NN against_IN Covid_NNP -_HYPH 19_CD in_IN Britain_NNP involving_VBG 1,100_CD participants_NNS ._. A_DT combined_VBN Phase_NNP II_CD and_CC Phase_NNP III_CD trial_NN involving_VBG 5,000_CD participants_NNS is_VBZ set_VBN to_TO begin_VB in_IN Britain_NNP by_IN the_DT end_NN of_IN this_DT month_NN ._. The_DT researchers_NNS have_VBP said_VBN that_IN if_IN the_DT vaccine_NN is_VBZ proven_VBN effective_JJ ,_, they_PRP hope_VBP to_TO have_VB an_DT approval_NN for_IN emergency_NN use_NN ,_, worldwide_RB ,_, by_IN September_NNP ._. But_CC a_DT steep_JJ decline_NN in_IN the_DT rate_NN of_IN new_JJ infections_NNS in_IN Britain_NNP may_MD make_VB it_PRP difficult_JJ to_TO prove_VB effectiveness_NN ._. Ethics_NN rules_NNS generally_RB preclude_VBP deliberately_RB infecting_VBG test_NN participants_NNS ._. That_DT means_VBZ unless_IN enough_JJ test_NN participants_NNS who_WP are_VBP given_VBN a_DT placebo_NN become_VB infected_VBN with_IN the_DT virus_NN in_IN the_DT community_NN ,_, the_DT researchers_NNS cannot_MD show_VB that_IN the_DT potential_JJ vaccine_NN does_VBZ its_PRP$ job_NN ._. The_DT large_JJ -_HYPH scale_NN tests_NNS in_IN the_DT United_NNP States_NNPS this_DT summer_NN may_MD provide_VB another_DT opportunity_NN ._. On_IN Monday_NNP ,_, Moderna_NNP announced_VBD partial_JJ data_NNS of_IN its_PRP$ first_JJ -_HYPH phase_NN trial_NN ,_, saying_VBG its_PRP$ vaccine_NN candidate_NN had_VBD proven_VBN safe_JJ and_CC that_IN it_PRP had_VBD provoked_VBN an_DT immune_JJ response_NN in_IN 45_CD people_NNS ,_, including_VBG eight_CD who_WP had_VBD extensive_JJ tests_NNS that_WDT found_VBD they_PRP had_VBD produced_VBN antibodies_NNS that_WDT could_MD prevent_VB the_DT virus_NN from_IN infecting_VBG cells_NNS ._. It_PRP is_VBZ also_RB working_VBG on_IN an_DT accelerated_VBN timetable_NN with_IN partners_NNS at_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS and_CC the_DT Swiss_JJ company_NN Lonza_NNP ._. Moderna_NNP received_VBD approval_NN to_TO move_VB to_IN a_DT second_JJ phase_NN involving_VBG 600_CD people_NNS and_CC said_VBD it_PRP would_MD also_RB begin_VB a_DT third_JJ stage_NN in_IN July_NNP with_IN thousands_NNS of_IN healthy_JJ people_NNS ._. The_DT Trump_NNP administration_NN ’s_POS efforts_NNS to_TO stanch_VB the_DT pandemic_NN have_VBP been_VBN troubled_VBN by_IN a_DT series_NN of_IN agency_NN fumbles_NNS ,_, starting_VBG with_IN defective_JJ C.D.C._NN tests_NNS that_WDT stalled_VBD detection_NN of_IN the_DT virus_NN ’s_POS spread_VBN for_IN weeks_NNS and_CC limited_VBN diagnoses_NNS for_IN patients_NNS at_IN hospitals_NNS and_CC clinics_NNS ._. Recently_RB ,_, President_NNP Trump_NNP reorganized_VBD vaccine_NN and_CC treatment_NN efforts_NNS after_IN he_PRP dismissed_VBD last_JJ month_NN the_DT head_NN of_IN Barda_NNP ,_, Rick_NNP Bright_NNP ,_, who_WP then_RB filed_VBD a_DT whistle_NN -_HYPH blower_NN complaint_NN contending_VBG he_PRP had_VBD been_VBN pressured_VBN to_TO seek_VB approval_NN for_IN certain_JJ treatments_NNS for_IN Covid_NNP -_HYPH 19_CD ._. Just_RB last_JJ week_NN ,_, Mr._NNP Trump_NNP named_VBD Moncef_NNP Slaoui_NNP ,_, a_DT venture_NN capitalist_NN who_WP was_VBD a_DT longtime_JJ vaccine_NN executive_NN at_IN GlaxoSmithKline_NNP and_CC most_RBS recently_RB a_DT board_NN member_NN for_IN Moderna_NNP ,_, to_TO help_VB oversee_VB “_`` Operation_NNP Warp_NNP Speed_NNP ,_, ”_'' the_DT federal_JJ drive_NN to_TO accelerate_VB ways_NNS to_TO combat_VB the_DT virus_NN ._.","The NNP NNP NNP and NNP NNP at NNP VBZ VBG NNS of NNS to NNS to VB NNS , VBG the JJS NN to NNP . The NN , VBN as NNP , VBZ RB VBN to VB up to $ 483 million to the NN NN NNP and $ 500 million to NNP & NNP for their JJ NN NNS . It VBZ RB VBN to VB $ 30 million to a NN NN NN by the JJ NN NNP , VBG on a JJR NN VBN JJ NNP for VBG NN NNS . NNS of NN NNS VBP JJ around the NN , and JJ JJ NNS VBP RB in at JJS JJ - NN JJ NNS . But the NNP NN NN , RB VBN by NNP , VBZ VBN RB into the NN of JJ - NN NN JJ to VB NN and NN . VBG on NNS to VB a NN against a JJ NN , the NNP NNP NNP NNP , the NNP NNS JJ NN VBD a NN I NN of their JJ NN against NNP - 19 in NNP VBG 1,100 NNS . A VBN NNP II and NNP III NN VBG 5,000 NNS VBZ VBN to VB in NNP by the NN of this NN . The NNS VBP VBN that if the NN VBZ VBN JJ , they VBP to VB an NN for NN NN , RB , by NNP . But a JJ NN in the NN of JJ NNS in NNP may VB it JJ to VB NN . NN NNS RB VBP RB VBG NN NNS . That VBZ unless JJ NN NNS who VBP VBN a NN VB VBN with the NN in the NN , the NNS cannot VB that the JJ NN VBZ its NN . The JJ - NN NNS in the NNP NNPS this NN may VB another NN . On NNP , NNP VBD JJ NNS of its JJ - NN NN , VBG its NN NN VBD VBN JJ and that it VBD VBN an JJ NN in 45 NNS , VBG eight who VBD JJ NNS that VBD they VBD VBN NNS that could VB the NN from VBG NNS . It VBZ RB VBG on an VBN NN with NNS at the NNP NNP of NNP and NNP NNPS and the JJ NN NNP . NNP VBD NN to VB to a JJ NN VBG 600 NNS and VBD it would RB VB a JJ NN in NNP with NNS of JJ NNS . The NNP NN ’s NNS to VB the NN VBP VBN VBN by a NN of NN NNS , VBG with JJ NN NNS that VBD NN of the NN ’s VBN for NNS and VBN NNS for NNS at NNS and NNS . RB , NNP NNP VBD NN and NN NNS after he VBD JJ NN the NN of NNP , NNP NNP , who RB VBD a NN - NN NN VBG he VBD VBN VBN to VB NN for JJ NNS for NNP - 19 . RB JJ NN , NNP NNP VBD NNP NNP , a NN NN who VBD a JJ NN NN at NNP and RBS RB a NN NN for NNP , to VB VB “ NNP NNP NNP , ” the JJ NN to VB NNS to VB the NN ."
70,1225,mainstream,"•_NFP A_DT licensed_VBN New_NNP York_NNP pediatrician_NN named_VBN Lawrence_NNP Palevsky_NNP has_VBZ spread_VBN misinformation_NN about_IN the_DT safety_NN of_IN vaccines_NNS for_IN years_NNS ._. •_NFP Palevsky_NNP has_VBZ ramped_VBN up_RP his_PRP$ efforts_NNS amid_IN outbreaks_NNS of_IN measles_NNS largely_RB driven_VBN by_IN misleading_JJ anti-vaccine_JJ rhetoric_NN ._. •_NFP Doctors_NNS like_IN Palevsky_NNP are_VBP prompting_VBG some_DT in_IN the_DT medical_JJ community_NN to_TO question_VB whether_IN physicians_NNS should_MD lose_VB their_PRP$ license_NN for_IN expressing_VBG anti-vaccine_NN views_NNS ._. •_NFP Legal_JJ experts_NNS say_VBP revoking_VBG a_DT doctor_NN 's_POS license_NN for_IN expressing_VBG an_DT opinion_NN would_MD be_VB unprecedented_JJ ._. On_IN May_NNP 13_CD ,_, hundreds_NNS of_IN parents_NNS packed_VBD into_IN a_DT catering_NN hall_NN in_IN Monsey_NNP ,_, New_NNP York_NNP ,_, for_IN an_DT event_NN billed_VBN as_IN a_DT ""_`` Vaccine_NNP Symposium_NN ._. ""_'' Monsey_NNP is_VBZ a_DT hamlet_NN in_IN Rockland_NNP County_NNP ,_, which_WDT is_VBZ struggling_VBG to_TO contain_VB an_DT unprecedented_JJ outbreak_NN of_IN measles_NNS ._. But_CC the_DT event_NN 's_POS organizers_NNS were_VBD n't_RB there_RB to_TO educate_VB the_DT crowd_NN on_IN how_WRB vaccines_NNS can_MD halt_VB the_DT spread_NN of_IN the_DT illness_NN ,_, which_WDT can_MD be_VB fatal_JJ ._. They_PRP were_VBD there_RB to_TO promote_VB a_DT pernicious_JJ and_CC discredited_VBN message_NN that_IN health_NN officials_NNS have_VBP blamed_VBN for_IN the_DT outbreak_NN :_: that_IN vaccines_NNS endanger_VBP young_JJ children_NNS ._. Hardly_RB any_DT of_IN the_DT symposium_NN 's_POS speakers_NNS ,_, which_WDT included_VBD a_DT YouTube_NNP host_NN and_CC a_DT Washington_NNP lobbyist_NN ,_, practice_VB medicine_NN ._. The_DT exception_NN was_VBD a_DT 57_CD -_HYPH year_NN -_HYPH old_JJ pediatrician_NN named_VBN Lawrence_NNP Palevsky_NNP ,_, who_WP sees_VBZ patients_NNS in_IN Manhattan_NNP and_CC the_DT nearby_JJ Suffolk_NNP County_NNP on_IN Long_NNP Island_NNP ._. His_PRP$ clinic_NN 's_POS website_NN promises_VBZ ""_`` personalized_JJ ,_, comprehensive_JJ consultations_NNS ""_'' to_TO address_VB ""_`` children_NNS 's_POS wellness_NN ,_, and_CC acute_JJ and_CC chronic_JJ illnesses_NNS ._. ""_'' ""_`` Hundreds_NNS of_IN thousands_NNS ,_, if_IN not_RB millions_NNS ,_, of_IN mothers_NNS …_, have_VBP witnessed_VBN children_NNS regressing_VBG after_IN they_PRP get_VBP the_DT MMR_NNP ,_, ""_'' Palevsky_NNP told_VBD the_DT crowd_NN ,_, largely_RB composed_VBN of_IN members_NNS of_IN Rockland_NNP 's_POS Orthodox_JJ Jewish_JJ community_NN ,_, according_VBG to_IN a_DT Gothamist_NNP reporter_NN who_WP attended_VBD the_DT event_NN ._. (_-LRB- ""_`` MMR_NNP ""_'' refers_VBZ to_IN the_DT combined_VBN vaccine_NN for_IN measles_NNS ,_, mumps_NNS ,_, and_CC rubella_NN ._. )_-RRB- He_PRP reportedly_RB added_VBD :_: ""_`` Children_NNS stop_VBP talking_VBG ,_, they_PRP do_VBP n't_RB look_VB at_IN you_PRP ,_, they_PRP start_VBP flapping_VBG their_PRP$ arms_NNS ,_, they_PRP start_VBP banging_VBG their_PRP$ head_NN ._. ""_'' As_IN a_DT doctor_NN ,_, Palevsky_NNP pledged_VBD his_PRP$ loyalty_NN to_IN the_DT medical_JJ profession_NN and_CC promised_VBD not_RB to_TO harm_VB patients_NNS ._. Yet_CC for_IN at_IN least_JJS a_DT decade_NN ,_, he_PRP has_VBZ delivered_VBN lectures_NNS ,_, attended_VBN local_JJ meetups_NNS ,_, and_CC given_VBN interviews_NNS in_IN which_WDT he_PRP has_VBZ publicly_RB opposed_VBN the_DT mandatory_JJ vaccination_NN of_IN minors_NNS and_CC linked_VBN certain_JJ vaccines_NNS to_IN disorders_NNS like_IN regressive_JJ autism_NN ._. In_IN April_NNP ,_, The_DT New_NNP York_NNP Times_NNP described_VBD Palevsky_NNP as_IN an_DT ""_`` anti-vaccine_JJ proponent_NN ,_, ""_'' while_IN NBC_NNP News_NNP called_VBD him_PRP ""_`` a_DT star_NN in_IN the_DT anti-vaccine_JJ world_NN ._. ""_'' Figures_NNS like_IN Palevsky_NNP are_VBP drawing_VBG audiences_NNS ,_, and_CC provoking_VBG alarm_NN ,_, in_IN the_DT midst_NN of_IN a_DT public_JJ health_NN crisis_NN fueled_VBN almost_RB exclusively_RB by_IN the_DT failure_NN of_IN some_DT parents_NNS to_TO vaccinate_VB their_PRP$ children_NNS ._. Their_PRP$ efforts_NNS have_VBP revived_VBN a_DT long_JJ -_HYPH standing_NN debate_NN in_IN the_DT medical_JJ and_CC legal_JJ establishments_NNS over_IN whether_IN doctors_NNS who_WP spread_VBP falsehoods_NNS about_IN vaccines_NNS should_MD be_VB seen_VBN as_IN violating_VBG standards_NNS of_IN professional_JJ conduct_NN ._. Palevsky_NNP 's_POS anti-vaccine_JJ views_NNS have_VBP drawn_VBN the_DT ire_NN of_IN the_DT medical_JJ establishment_NN Arthur_NNP Caplan_NNP ,_, a_DT professor_NN of_IN bioethics_NN at_IN New_NNP York_NNP University_NNP 's_POS School_NNP of_IN Medicine_NNP ,_, said_VBD Palevsky_NNP 's_POS conduct_NN was_VBD incompatible_JJ with_IN his_PRP$ role_NN as_IN a_DT healthcare_NN provider_NN ._. ""_`` I_PRP absolutely_RB believe_VBP New_NNP York_NNP state_NN should_MD revoke_VB Palevsky_NNP 's_POS license_NN ,_, because_IN he_PRP 's_VBZ advocating_VBG breaking_VBG the_DT standard_NN of_IN care_NN and_CC spreading_VBG misinformation_NN ,_, putting_VBG children_NNS and_CC the_DT public_NN at_IN risk_NN ,_, ""_'' he_PRP told_VBD INSIDER_NNP ._. ""_`` It_PRP 's_VBZ especially_RB important_JJ in_IN an_DT outbreak_NN ,_, which_WDT could_MD turn_VB into_IN a_DT full_JJ -_HYPH bore_NN epidemic_NN ._. ""_'' ""_`` There_EX are_VBP standards_NNS of_IN care_NN created_VBN by_IN medicine_NN ,_, created_VBN by_IN pediatricians_NNS ,_, by_IN experts_NNS ,_, ""_'' he_PRP added_VBD ._. ""_`` If_IN you_PRP violate_VBP those_DT ,_, you_PRP should_MD lose_VB your_PRP$ license_NN ._. ""_'' Palevsky_NNP is_VBZ neither_CC the_DT first_JJ nor_CC the_DT most_RBS famous_JJ doctor_NN to_TO criticize_VB vaccines_NNS ._. Elements_NNS of_IN the_DT modern_JJ anti-vaccine_JJ movement_NN can_MD be_VB traced_VBN to_IN a_DT British_JJ doctor_NN named_VBN Andrew_NNP Wakefield_NNP ,_, who_WP lost_VBD his_PRP$ medical_JJ license_NN over_IN a_DT discredited_VBN study_NN that_WDT linked_VBD the_DT MMR_NNP vaccine_NN to_IN autism_NN ._. (_-LRB- He_PRP appeared_VBD at_IN the_DT symposium_NN in_IN Monsey_NNP via_IN video_NN conference_NN ._. )_-RRB- And_CC Rand_NNP Paul_NNP ,_, the_DT ophthalmologist_NN serving_VBG as_IN the_DT junior_JJ US_NNP senator_NNP from_IN Kentucky_NNP ,_, denounced_VBD mandatory_JJ vaccination_NN as_RB recently_RB as_IN this_DT March_NNP ,_, citing_VBG personal_JJ -_HYPH liberty_NN concerns_NNS ._. But_CC few_JJ licensed_VBN ,_, practicing_VBG physicians_NNS have_VBP aligned_VBN themselves_PRP with_IN the_DT anti-vaccination_NN movement_NN in_IN the_DT way_NN Palevsky_NNP has_VBZ ._. The_DT Vaccine_NNP Safety_NNP Handbook_NN ,_, an_DT infamous_JJ and_CC error_NN -_HYPH laden_JJ anti-vaccine_NN brochure_NN anonymously_RB distributed_VBN throughout_IN New_NNP York_NNP City_NNP —_: and_CC seemingly_RB targeted_VBN at_IN Orthodox_JJ Jewish_JJ parents_NNS —_: instructs_VBZ readers_NNS to_TO call_VB a_DT Manhattan_NNP phone_NN number_NN to_TO listen_VB to_IN an_DT ""_`` interview_NN with_IN pediatrician_NN Lawrence_NNP Palevsky_NNP ,_, M.D._NNP ,_, including_VBG what_WP he_PRP learned_VBD in_IN medical_JJ school_NN about_IN vaccines_NNS ._. ""_'' Palevsky_NNP 's_POS résumé_NN makes_VBZ him_PRP particularly_RB valuable_JJ to_IN the_DT anti-vaccine_JJ movement_NN ,_, which_WDT has_VBZ long_RB sought_VBN mainstream_JJ legitimacy_NN ._. After_IN graduating_VBG from_IN New_NNP York_NNP University_NNP 's_POS School_NNP of_IN Medicine_NNP in_IN 1987_CD ,_, he_PRP worked_VBD and_CC taught_VBD at_IN Mount_NNP Sinai_NNP Medical_NNP Center_NNP ,_, Lenox_NNP Hill_NNP Hospital_NNP ,_, and_CC New_NNP York_NNP Medical_NNP College_NNP ._. If_IN you_PRP did_VBD n't_RB know_VB about_IN his_PRP$ anti-vaccine_JJ beliefs_NNS ,_, you_PRP would_MD be_VB forgiven_VBN for_IN thinking_VBG Palevsky_NNP was_VBD merely_RB an_DT accomplished_VBN pediatrician_NN ._. There_EX are_VBP ,_, however_RB ,_, certain_JJ discrepancies_NNS in_IN his_PRP$ professional_JJ history_NN ._. The_DT website_NN of_IN Palevsky_NNP 's_POS clinic_NN repeatedly_RB describes_VBZ him_PRP as_IN a_DT ""_`` board_NN certified_VBN pediatrician_NN ._. ""_'' That_DT status_NN is_VBZ conferred_VBN by_IN the_DT American_NNP Board_NNP of_IN Pediatrics_NNP ,_, which_WDT continually_RB tests_VBZ pediatricians_NNS to_TO ensure_VB they_PRP have_VBP up_IN -_HYPH to_IN -_HYPH date_NN training_NN and_CC expertise_NN in_IN the_DT field_NN ._. But_CC a_DT representative_NN for_IN the_DT board_NN told_VBD INSIDER_NNP that_IN Palevsky_NNP 's_POS most_RBS recent_JJ certification_NN expired_VBD at_IN the_DT end_NN of_IN 2014_CD ._. A_DT physician_NN database_NN maintained_VBN by_IN New_NNP York_NNP state_NN indicates_VBZ Palevsky_NNP has_VBZ admission_NN privileges_NNS at_IN two_CD hospitals_NNS affiliated_VBN with_IN the_DT well_RB -_HYPH regarded_VBN Mount_NNP Sinai_NNP Health_NNP System_NNP ,_, Beth_NNP Israel_NNP ,_, and_CC St._NNP Luke's_NNP ._. While_IN the_DT database_NN shows_VBZ Palevsky_NNP 's_POS entry_NN was_VBD last_RB updated_VBN in_IN March_NNP 2018_CD and_CC is_VBZ ""_`` based_VBN on_IN the_DT information_NN supplied_VBN by_IN the_DT physician_NN who_WP is_VBZ the_DT subject_NN of_IN the_DT data_NNS ,_, ""_'' the_DT hospital_NN said_VBD it_PRP was_VBD inaccurate_JJ ._. ""_`` Dr._NNP Palevsky_NNP had_VBD not_RB been_VBN affiliated_VBN with_IN Mount_NNP Sinai_NNP since_IN the_DT late_JJ '_`` 90s_NNS ,_, ""_'' a_DT spokeswoman_NN ,_, Lucia_NNP L._NNP Lee_NNP ,_, said_VBD ._. ""_`` The_DT site_NN that_WDT you_PRP referenced_VBD is_VBZ clearly_RB out_IN of_IN date_NN ._. ""_'' It_PRP would_MD be_VB difficult_JJ ,_, and_CC probably_RB unprecedented_JJ ,_, to_TO strip_VB a_DT doctor_NN of_IN a_DT medical_JJ license_NN solely_RB for_IN expressing_VBG anti-vaccine_JJ views_NNS It_PRP may_MD seem_VB like_IN a_DT no_DT -_HYPH brainer_NN to_TO revoke_VB the_DT license_NN of_IN a_DT physician_NN who_WP regularly_RB spreads_VBZ false_JJ ,_, discredited_VBN information_NN that_WDT ,_, if_IN relied_VBN on_RP ,_, could_MD result_VB in_IN preventable_JJ injury_NN or_CC death_NN ._. But_CC state_NN health_NN departments_NNS ,_, which_WDT license_VBP doctors_NNS and_CC regulate_VBP the_DT medical_JJ industry_NN ,_, have_VBP traditionally_RB drawn_VBN a_DT bright_JJ line_NN between_IN what_WP doctors_NNS say_VBP in_IN public_NN and_CC how_WRB they_PRP treat_VBP their_PRP$ patients_NNS ._. Regulators_NNS monitor_VBP what_WP happens_VBZ in_IN the_DT exam_NN room_NN or_CC surgical_JJ theater_NN ,_, but_CC they_PRP leave_VBP doctors_NNS free_JJ to_TO speak_VB their_PRP$ minds_NNS everywhere_RB else_RB ._. This_DT explains_VBZ why_WRB ,_, in_IN 2015_CD ,_, the_DT Arizona_NNP Board_NNP of_IN Osteopathic_NNP Examiners_NNPS declined_VBD to_TO take_VB action_NN against_IN the_DT cardiologist_NN Jack_NNP Wolfson_NNP over_IN a_DT series_NN of_IN interviews_NNS in_IN which_WDT he_PRP argued_VBD that_IN children_NNS had_VBD a_DT ""_`` right_NN ""_'' to_TO contract_VB the_DT measles_NNS ,_, mumps_NNS ,_, rubella_NN ,_, and_CC chicken_NN pox_NN without_IN the_DT interference_NN of_IN vaccines_NNS ._. Nearly_RB 40_CD people_NNS filed_VBD complaints_NNS against_IN Wolfson_NNP in_IN 2015_CD ,_, but_CC in_IN a_DT 4_CD -_HYPH 1_CD vote_NN ,_, the_DT board_NN held_VBD that_IN he_PRP had_VBD a_DT First_JJ Amendment_NN right_NN to_TO speak_VB his_PRP$ mind_NN about_IN vaccines_NNS and_CC that_IN ""_`` no_DT complaints_NNS have_VBP been_VBN filed_VBN by_IN patients_NNS ""_'' regarding_VBG Wolfson_NNP 's_POS ""_`` actual_JJ medical_JJ care_NN ._. ""_'' In_IN 2013_CD ,_, the_DT Ninth_NNP Circuit_NNP Court_NNP of_IN Appeals_NNPS expressed_VBD a_DT comparable_JJ distinction_NN in_IN its_PRP$ decision_NN to_TO uphold_VB a_DT California_NNP law_NN barring_VBG licensed_VBN therapists_NNS from_IN practicing_VBG conversion_NN therapy_NN on_IN LGBTQ_NNP minors_NNS :_: ""_`` Outside_IN the_DT doctor_NN -_HYPH patient_JJ relationship_NN ,_, doctors_NNS are_VBP constitutionally_RB equivalent_JJ to_IN soapbox_NN orators_NNS and_CC pamphleteers_NNS ,_, and_CC their_PRP$ speech_NN receives_VBZ robust_JJ protection_NN under_IN the_DT First_JJ Amendment_NN ._. ""_'' The_DT most_RBS prominent_JJ example_NN of_IN a_DT health_NN board_NN sanctioning_VBG a_DT vaccine_NN critic_NN was_VBD ultimately_RB about_IN record_NN -_HYPH keeping_NN ,_, not_RB the_DT content_NN of_IN the_DT critic_NN 's_POS views_NNS ._. In_IN 2018_CD ,_, the_DT Medical_NNP Board_NNP of_IN California_NNP sought_VBD to_TO revoke_VB the_DT license_NN of_IN Bob_NNP Sears_NNP ,_, who_WP advises_VBZ parents_NNS that_IN ""_`` you_PRP can_MD safely_RB raise_VB an_DT unvaccinated_JJ child_NN in_IN today_NN 's_POS society_NN ,_, ""_'' for_IN failing_VBG to_TO take_VB a_DT detailed_JJ medical_JJ history_NN and_CC maintain_VB proper_JJ records_NNS when_WRB he_PRP wrote_VBD a_DT letter_NN exempting_VBG a_DT 2_CD -_HYPH year_NN -_HYPH old_JJ patient_NN from_IN vaccinations_NNS ._. (_-LRB- California_NNP requires_VBZ a_DT doctor_NN 's_POS note_NN to_TO avoid_VB vaccines_NNS ;_, the_DT board_NN stayed_VBD its_PRP$ decision_NN pending_VBG the_DT completion_NN of_IN probation_NN and_CC continuing_VBG education_NN classes_NNS ._. )_-RRB- In_IN a_DT statement_NN to_IN INSIDER_NNP ,_, the_DT New_NNP York_NNP State_NNP Department_NNP of_IN Health_NNP was_VBD careful_JJ to_TO distinguish_VB between_IN Palevsky_NNP 's_POS public_JJ statements_NNS ,_, which_WDT it_PRP regards_VBZ as_IN beyond_IN its_PRP$ purview_NN ,_, and_CC his_PRP$ patient_NN care_NN ._. While_IN ""_`` the_DT New_NNP York_NNP State_NNP Department_NNP of_IN Health_NNP will_MD continue_VB our_PRP$ extensive_JJ public_JJ outreach_NN campaign_NN to_TO educate_VB people_NNS on_IN the_DT facts_NNS about_IN vaccinations_NNS and_CC to_TO counter_VB misinformation_NN that_WDT has_VBZ fueled_VBN this_DT outbreak_NN ,_, ""_'' the_DT department_NN spokeswoman_NN Jill_NNP Montag_NNP said_VBD ,_, ""_`` the_DT First_JJ Amendment_NNP protects_VBZ an_DT individual_NN 's_POS right_NN to_TO speak_VB and_CC express_VB opinions_NNS about_IN controversial_JJ topics_NNS without_IN fear_NN of_IN government_NN retaliation_NN ._. Matters_NNS involving_VBG specific_JJ patients_NNS in_IN the_DT practice_NN of_IN medicine_NN may_MD ,_, however_RB ,_, become_VB the_DT subject_NN of_IN an_DT investigation_NN ._. ""_'' Asked_VBD whether_IN Palevsky_NNP was_VBD the_DT subject_NN of_IN such_PDT an_DT investigation_NN ,_, Montag_NNP responded_VBD :_: ""_`` The_DT Department_NNP cannot_MD confirm_VB or_CC deny_VB the_DT existence_NN of_IN a_DT [_-LRB- misconduct_NN ]_-RRB- investigation_NN of_IN a_DT physician_NN ,_, unless_IN charges_NNS are_VBP served_VBN upon_IN the_DT physician_NN ,_, or_CC a_DT public_JJ action_NN is_VBZ taken_VBN by_IN the_DT Board_NN ._. ""_'' Eugene_NNP Volokh_NNP ,_, a_DT constitutional_JJ -_HYPH law_NN professor_NN at_IN the_DT University_NNP of_IN California_NNP at_IN Los_NNP Angeles_NNP ,_, who_WP has_VBZ studied_VBN how_WRB states_NNS wield_VBP occupational_JJ licenses_NNS to_TO punish_VB certain_JJ forms_NNS of_IN speech_NN ,_, argues_VBZ that_IN ,_, in_IN the_DT absence_NN of_IN evidence_NN that_IN any_DT specific_JJ patients_NNS are_VBP being_VBG harmed_VBN ,_, Palevsky_NNP should_MD be_VB free_JJ to_TO spout_VB unscientific_JJ nonsense_NN ._. That_DT freedom_NN ,_, he_PRP says_VBZ ,_, is_VBZ an_DT integral_JJ part_NN of_IN the_DT scientific_JJ process_NN ._. ""_`` This_DT is_VBZ an_DT important_JJ First_JJ Amendment_NN protection_NN ,_, ""_'' Volokh_NNP told_VBD INSIDER_NNP ._. ""_`` How_WRB do_VBP we_PRP know_VB that_IN a_DT consensus_NN on_IN scientific_JJ questions_NNS such_JJ as_IN this_DT is_VBZ right_JJ ?_. Precisely_RB because_IN we_PRP know_VBP that_IN scientists_NNS ,_, doctors_NNS ,_, and_CC others_NNS are_VBP free_JJ to_TO challenge_VB that_DT consensus_NN ,_, and_CC that_IN other_JJ scientists_NNS and_CC doctors_NNS have_VBP heard_VBN those_DT challenges_NNS and_CC continue_VB to_TO reject_VB them_PRP ._. Whenever_WRB the_DT government_NN coerces_VBZ people_NNS to_TO stop_VB critiquing_VBG this_DT sort_NN of_IN established_VBN opinion_NN ,_, that_DT undermines_VBZ the_DT very_JJ foundation_NN for_IN that_DT opinion_NN ._. ""_'' Caplan_NNP ,_, the_DT NYU_NNP professor_NN ,_, disagreed_VBD ._. ""_`` The_DT science_NN is_VBZ rock_NN solid_JJ ,_, ""_'' he_PRP said_VBD ._. ""_`` It_PRP 's_VBZ not_RB something_NN that_WDT 's_VBZ being_VBG bolstered_VBN because_IN there_EX is_VBZ a_DT constant_JJ challenge_NN ._. The_DT only_JJ people_NNS who_WP are_VBP challenging_VBG it_PRP are_VBP fringe_JJ individuals_NNS who_WP are_VBP nonscientists_NNS ._. ""_''","• A VBN NNP NNP NN VBN NNP NNP VBZ VBN NN about the NN of NNS for NNS . • NNP VBZ VBN up his NNS amid NNS of NNS RB VBN by JJ JJ NN . • NNS like NNP VBP VBG some in the JJ NN to VB whether NNS should VB their NN for VBG NN NNS . • JJ NNS VBP VBG a NN 's NN for VBG an NN would VB JJ . On NNP 13 , NNS of NNS VBD into a NN NN in NNP , NNP NNP , for an NN VBN as a "" NNP NN . "" NNP VBZ a NN in NNP NNP , which VBZ VBG to VB an JJ NN of NNS . But the NN 's NNS VBD RB RB to VB the NN on how NNS can VB the NN of the NN , which can VB JJ . They VBD RB to VB a JJ and VBN NN that NN NNS VBP VBN for the NN : that NNS VBP JJ NNS . RB any of the NN 's NNS , which VBD a NNP NN and a NNP NN , VB NN . The NN VBD a 57 - NN - JJ NN VBN NNP NNP , who VBZ NNS in NNP and the JJ NNP NNP on NNP NNP . His NN 's NN VBZ "" JJ , JJ NNS "" to VB "" NNS 's NN , and JJ and JJ NNS . "" "" NNS of NNS , if RB NNS , of NNS … VBP VBN NNS VBG after they VBP the NNP , "" NNP VBD the NN , RB VBN of NNS of NNP 's JJ JJ NN , VBG to a NNP NN who VBD the NN . ( "" NNP "" VBZ to the VBN NN for NNS , NNS , and NN . ) He RB VBD : "" NNS VBP VBG , they VBP RB VB at you , they VBP VBG their NNS , they VBP VBG their NN . "" As a NN , NNP VBD his NN to the JJ NN and VBD RB to VB NNS . Yet for at JJS a NN , he VBZ VBN NNS , VBN JJ NNS , and VBN NNS in which he VBZ RB VBN the JJ NN of NNS and VBN JJ NNS to NNS like JJ NN . In NNP , The NNP NNP NNP VBD NNP as an "" JJ NN , "" while NNP NNP VBD him "" a NN in the JJ NN . "" NNS like NNP VBP VBG NNS , and VBG NN , in the NN of a JJ NN NN VBN RB RB by the NN of some NNS to VB their NNS . Their NNS VBP VBN a JJ - NN NN in the JJ and JJ NNS over whether NNS who VBP NNS about NNS should VB VBN as VBG NNS of JJ NN . NNP 's JJ NNS VBP VBN the NN of the JJ NN NNP NNP , a NN of NN at NNP NNP NNP 's NNP of NNP , VBD NNP 's NN VBD JJ with his NN as a NN NN . "" I RB VBP NNP NNP NN should VB NNP 's NN , because he VBZ VBG VBG the NN of NN and VBG NN , VBG NNS and the NN at NN , "" he VBD NNP . "" It VBZ RB JJ in an NN , which could VB into a JJ - NN NN . "" "" There VBP NNS of NN VBN by NN , VBN by NNS , by NNS , "" he VBD . "" If you VBP those , you should VB your NN . "" NNP VBZ neither the JJ nor the RBS JJ NN to VB NNS . NNS of the JJ JJ NN can VB VBN to a JJ NN VBN NNP NNP , who VBD his JJ NN over a VBN NN that VBD the NNP NN to NN . ( He VBD at the NN in NNP via NN NN . ) And NNP NNP , the NN VBG as the JJ NNP NNP from NNP , VBD JJ NN RB RB as this NNP , VBG JJ - NN NNS . But JJ VBN , VBG NNS VBP VBN themselves with the NN NN in the NN NNP VBZ . The NNP NNP NN , an JJ and NN - JJ NN NN RB VBN throughout NNP NNP NNP — and RB VBN at JJ JJ NNS — VBZ NNS to VB a NNP NN NN to VB to an "" NN with NN NNP NNP , NNP , VBG what he VBD in JJ NN about NNS . "" NNP 's NN VBZ him RB JJ to the JJ NN , which VBZ RB VBN JJ NN . After VBG from NNP NNP NNP 's NNP of NNP in 1987 , he VBD and VBD at NNP NNP NNP NNP , NNP NNP NNP , and NNP NNP NNP NNP . If you VBD RB VB about his JJ NNS , you would VB VBN for VBG NNP VBD RB an VBN NN . There VBP , RB , JJ NNS in his JJ NN . The NN of NNP 's NN RB VBZ him as a "" NN VBN NN . "" That NN VBZ VBN by the NNP NNP of NNP , which RB VBZ NNS to VB they VBP up - to - NN NN and NN in the NN . But a NN for the NN VBD NNP that NNP 's RBS JJ NN VBD at the NN of 2014 . A NN NN VBN by NNP NNP NN VBZ NNP VBZ NN NNS at two NNS VBN with the RB - VBN NNP NNP NNP NNP , NNP NNP , and NNP NNP . While the NN VBZ NNP 's NN VBD RB VBN in NNP 2018 and VBZ "" VBN on the NN VBN by the NN who VBZ the NN of the NNS , "" the NN VBD it VBD JJ . "" NNP NNP VBD RB VBN VBN with NNP NNP since the JJ ' NNS , "" a NN , NNP NNP NNP , VBD . "" The NN that you VBD VBZ RB out of NN . "" It would VB JJ , and RB JJ , to VB a NN of a JJ NN RB for VBG JJ NNS It may VB like a no - NN to VB the NN of a NN who RB VBZ JJ , VBN NN that , if VBN on , could VB in JJ NN or NN . But NN NN NNS , which VBP NNS and VBP the JJ NN , VBP RB VBN a JJ NN between what NNS VBP in NN and how they VBP their NNS . NNS VBP what VBZ in the NN NN or JJ NN , but they VBP NNS JJ to VB their NNS RB RB . This VBZ why , in 2015 , the NNP NNP of NNP NNPS VBD to VB NN against the NN NNP NNP over a NN of NNS in which he VBD that NNS VBD a "" NN "" to VB the NNS , NNS , NN , and NN NN without the NN of NNS . RB 40 NNS VBD NNS against NNP in 2015 , but in a 4 - 1 NN , the NN VBD that he VBD a JJ NN NN to VB his NN about NNS and that "" no NNS VBP VBN VBN by NNS "" VBG NNP 's "" JJ JJ NN . "" In 2013 , the NNP NNP NNP of NNPS VBD a JJ NN in its NN to VB a NNP NN VBG VBN NNS from VBG NN NN on NNP NNS : "" Outside the NN - JJ NN , NNS VBP RB JJ to NN NNS and NNS , and their NN VBZ JJ NN under the JJ NN . "" The RBS JJ NN of a NN NN VBG a NN NN VBD RB about NN - NN , RB the NN of the NN 's NNS . In 2018 , the NNP NNP of NNP VBD to VB the NN of NNP NNP , who VBZ NNS that "" you can RB VB an JJ NN in NN 's NN , "" for VBG to VB a JJ JJ NN and VB JJ NNS when he VBD a NN VBG a 2 - NN - JJ NN from NNS . ( NNP VBZ a NN 's NN to VB NNS ; the NN VBD its NN VBG the NN of NN and VBG NN NNS . ) In a NN to NNP , the NNP NNP NNP NNP of NNP VBD JJ to VB between NNP 's JJ NNS , which it VBZ as beyond its NN , and his NN NN . While "" the NNP NNP NNP NNP of NNP will VB our JJ JJ NN NN to VB NNS on the NNS about NNS and to VB NN that VBZ VBN this NN , "" the NN NN NNP NNP VBD , "" the JJ NNP VBZ an NN 's NN to VB and VB NNS about JJ NNS without NN of NN NN . NNS VBG JJ NNS in the NN of NN may , RB , VB the NN of an NN . "" VBD whether NNP VBD the NN of such an NN , NNP VBD : "" The NNP cannot VB or VB the NN of a [ NN ] NN of a NN , unless NNS VBP VBN upon the NN , or a JJ NN VBZ VBN by the NN . "" NNP NNP , a JJ - NN NN at the NNP of NNP at NNP NNP , who VBZ VBN how NNS VBP JJ NNS to VB JJ NNS of NN , VBZ that , in the NN of NN that any JJ NNS VBP VBG VBN , NNP should VB JJ to VB JJ NN . That NN , he VBZ , VBZ an JJ NN of the JJ NN . "" This VBZ an JJ JJ NN NN , "" NNP VBD NNP . "" How VBP we VB that a NN on JJ NNS JJ as this VBZ JJ ? RB because we VBP that NNS , NNS , and NNS VBP JJ to VB that NN , and that JJ NNS and NNS VBP VBN those NNS and VB to VB them . Whenever the NN VBZ NNS to VB VBG this NN of VBN NN , that VBZ the JJ NN for that NN . "" NNP , the NNP NN , VBD . "" The NN VBZ NN JJ , "" he VBD . "" It VBZ RB NN that VBZ VBG VBN because there VBZ a JJ NN . The JJ NNS who VBP VBG it VBP JJ NNS who VBP NNS . """
71,392,mainstream,"Willcocks_NNP LC_NNP et_FW al._FW (_-LRB- 2007_CD )_-RRB- The_DT effect_NN of_IN sirolimus_NN therapy_NN on_IN vaccine_NN responses_NNS in_IN transplant_NN recipients_NNS ._. Am_VBP J_NNP Transplant_NN 7_CD :_: 2006_CD –2011_CD Immunosuppressants_NNS such_JJ as_IN ciclosporin_NN and_CC mycophenolate_NN mofetil_NN can_MD reduce_VB the_DT protective_JJ antibody_NN response_NN to_IN vaccination_NN in_IN transplant_NN recipients_NNS ,_, putting_VBG these_DT patients_NNS at_IN high_JJ risk_NN of_IN infections_NNS and_CC complications_NNS ._. Few_JJ data_NNS are_VBP available_JJ regarding_VBG the_DT effect_NN of_IN sirolimus_NN on_IN vaccination_NN response_NN ._. Willcocks_NNP et_FW al._FW investigated_VBD immune_NN responses_NNS to_IN influenza_NN and_CC pneumococcal_JJ vaccinations_NNS in_IN 9_CD hepatic_JJ and_CC 23_CD renal_JJ transplant_NN recipients_NNS who_WP had_VBD been_VBN randomized_VBN to_TO either_CC continue_VB on_IN a_DT calcineurin_NN inhibitor_NN (_-LRB- CNI_NN ;_: tacrolimus_NN or_CC ciclosporin_NN ;_: n_NN =_SYM 17_CD )_-RRB- or_CC switch_NN to_IN sirolimus_NN (_-LRB- n_NN =_SYM 15_CD )_-RRB- at_IN least_JJS 3_CD months_NNS after_IN transplantation_NN ._. All_DT patients_NNS received_VBD —_: from_IN the_DT same_JJ batches_NNS —_: an_DT influenza_NN vaccine_NN and_CC ,_, 4_CD weeks_NNS later_RBR ,_, a_DT pneumococcal_JJ vaccine_NN ._. Four_CD weeks_NNS after_IN influenza_NN vaccination_NN ,_, mean_JJ titers_NNS of_IN antibodies_NNS against_IN all_DT three_CD influenza_NN antigens_NNS tested_VBN had_VBD increased_VBN significantly_RB in_IN both_CC patient_NN groups_NNS (_-LRB- P_NN <_-LRB- 0.0005_CD )_-RRB- and_CC there_EX were_VBD no_DT significant_JJ differences_NNS in_IN increases_NNS between_IN groups_NNS ._. Nevertheless_RB ,_, all_DT sirolimus_NN -_HYPH treated_VBN patients_NNS mounted_VBD an_DT antibody_NN response_NN against_IN at_IN least_JJS one_CD influenza_NN antigen_NN that_WDT was_VBD deemed_VBN to_TO be_VB protective_JJ ,_, compared_VBN with_IN only_RB 75_CD %_NN of_IN CNI_NNP -_HYPH treated_VBN patients_NNS (_-LRB- P_NN =_SYM 0.038_CD )_-RRB- ._. Eight_CD weeks_NNS after_IN pneumococcal_JJ vaccination_NN ,_, the_DT mean_JJ antibody_NN levels_NNS for_IN 6_CD of_IN the_DT 7_CD pneumococcus_NN serotypes_NNS measured_VBN had_VBD increased_VBN significantly_RB in_IN patients_NNS in_IN both_DT groups_NNS (_-LRB- P_NN <_-LRB- 0.05_CD )_-RRB- ;_: no_DT significant_JJ differences_NNS in_IN pneumococcus_NN antibody_NN levels_NNS or_CC changes_NNS in_IN antibody_NN levels_NNS were_VBD observed_VBN between_IN groups_NNS ._. Transplant_NN type_NN ,_, serum_NN creatinine_NN level_NN and_CC number_NN of_IN immunosuppressant_NN agents_NNS had_VBD no_DT effect_NN on_IN response_NN to_IN either_CC vaccine_NN ._. Vaccination_NN guidelines_NNS for_IN transplant_NN recipients_NNS on_IN CNIs_NNP are_VBP ,_, therefore_RB ,_, likely_JJ to_TO also_RB be_VB suitable_JJ for_IN those_DT on_IN sirolimus_NN ._.","NNP NNP FW FW ( 2007 ) The NN of NN NN on NN NNS in NN NNS . VBP NNP NN 7 : 2006 –2011 NNS JJ as NN and NN NN can VB the JJ NN NN to NN in NN NNS , VBG these NNS at JJ NN of NNS and NNS . JJ NNS VBP JJ VBG the NN of NN on NN NN . NNP FW FW VBD NN NNS to NN and JJ NNS in 9 JJ and 23 JJ NN NNS who VBD VBN VBN to either VB on a NN NN ( NN ; NN or NN ; NN = 17 ) or NN to NN ( NN = 15 ) at JJS 3 NNS after NN . All NNS VBD — from the JJ NNS — an NN NN and , 4 NNS RBR , a JJ NN . Four NNS after NN NN , JJ NNS of NNS against all three NN NNS VBN VBD VBN RB in both NN NNS ( NN < 0.0005 ) and there VBD no JJ NNS in NNS between NNS . RB , all NN - VBN NNS VBD an NN NN against at JJS one NN NN that VBD VBN to VB JJ , VBN with RB 75 NN of NNP - VBN NNS ( NN = 0.038 ) . Eight NNS after JJ NN , the JJ NN NNS for 6 of the 7 NN NNS VBN VBD VBN RB in NNS in both NNS ( NN < 0.05 ) ; no JJ NNS in NN NN NNS or NNS in NN NNS VBD VBN between NNS . NN NN , NN NN NN and NN of NN NNS VBD no NN on NN to either NN . NN NNS for NN NNS on NNP VBP , RB , JJ to RB VB JJ for those on NN ."
72,890,mainstream,"Who_WP should_MD get_VB a_DT ventilator_NN if_IN there_EX are_VBP n’t_RB enough_JJ to_TO go_VB around_RB ?_. Research_NN on_IN decision_NN making_NN leads_VBZ to_IN three_CD concrete_JJ guidelines_NNS that_WDT policy_NN -_HYPH makers_NNS and_CC physicians_NNS can_MD use_VB to_TO make_VB fair_JJ choices_NNS when_WRB allocating_VBG scarce_JJ ,_, life_NN -_HYPH saving_VBG resources_NNS ._. They_PRP key_VBP to_IN making_VBG fair_JJ and_CC ethical_JJ choices_NNS is_VBZ to_TO assure_VB that_IN decisions_NNS are_VBP made_VBN through_IN an_DT impartial_JJ process_NN ._. Physicians_NNS around_IN the_DT world_NN must_MD make_VB daunting_JJ decisions_NNS in_IN the_DT face_NN of_IN the_DT Covid_NNP -_HYPH 19_CD crisis_NN ._. Chief_JJ among_IN their_PRP$ concerns_NNS is_VBZ that_IN there_EX might_MD not_RB be_VB enough_JJ of_IN a_DT scarce_JJ resource_NN ,_, such_JJ as_IN ventilators_NNS ,_, ICU_NN beds_NNS ,_, or_CC vaccines_NNS ,_, for_IN all_DT of_IN the_DT patients_NNS who_WP need_VBP them_PRP ._. This_DT is_VBZ n’t_RB a_DT theoretical_JJ dilemma_NN ._. Doctors_NNS in_IN Italy_NNP faced_VBD horrifying_JJ choices_NNS about_IN which_WDT patients_NNS should_MD get_VB a_DT ventilator_NN and_CC which_WDT they_PRP should_MD let_VB die_VB ._. Fortunately_RB ,_, major_JJ U.S._NNP cities_NNS have_VBP thus_RB far_RB escaped_VBN that_DT calamity_NN ,_, but_CC this_DT remains_VBZ an_DT important_JJ concern_NN for_IN the_DT months_NNS ahead_RB as_IN we_PRP wait_VBP to_TO see_VB whether_IN the_DT virus_NN slows_VBZ down_RP or_CC resurges_NNS ._. Globally_RB ,_, the_DT situation_NN remains_VBZ challenging_JJ as_IN the_DT virus_NN spreads_VBZ to_IN regions_NNS with_IN fewer_JJR resources_NNS ._. Confronted_VBN with_IN impossible_JJ choices_NNS ,_, hospitals_NNS need_VBP workable_JJ guidelines_NNS that_WDT reflect_VBP society_NN ’s_POS deepest_JJS understanding_NN of_IN fairness_NN ._. Research_NN on_IN moral_JJ decision_NN making_NN ,_, and_CC our_PRP$ own_JJ experiments_NNS asking_VBG ordinary_JJ people_NNS what_WDT choices_NNS they_PRP would_MD make_VB ,_, offers_VBZ some_DT guidance_NN ._. Who_WP should_MD get_VB a_DT ventilator_NN if_IN there_EX are_VBP n’t_RB enough_JJ to_TO go_VB around_RB ?_. Many_JJ medical_JJ ethicists_NNS adopt_VBP a_DT philosophical_JJ perspective_NN called_VBN utilitarianism_NN ._. The_DT idea_NN is_VBZ simple_JJ –_: you_PRP should_MD seek_VB to_TO minimize_VB overall_JJ harm_NN and_CC maximize_VB well_RB -_HYPH being_VBG across_IN society_NN ._. Writing_VBG in_IN the_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP ,_, for_IN instance_NN ,_, bioethicist_NN Ezekiel_NNP Emanuel_NNP and_CC colleagues_NNS argue_VBP for_IN prioritizing_VBG the_DT lives_NNS of_IN health_NN care_NN providers_NNS –_: providing_VBG them_PRP first_RB with_IN testing_NN ,_, ventilators_NNS ,_, treatments_NNS and_CC vaccines_NNS –_: to_TO assure_VB that_IN they_PRP can_MD remain_VB on_IN the_DT job_NN or_CC return_VB quickly_RB to_IN it_PRP if_IN they_PRP become_VBP sick_JJ ._. “_`` These_DT workers_NNS should_MD be_VB given_VBN priority_NN not_RB because_IN they_PRP are_VBP somehow_RB more_RBR worthy_JJ ,_, ”_'' they_PRP write_VBP ,_, “_'' but_CC because_IN of_IN their_PRP$ instrumental_JJ value_NN :_: they_PRP are_VBP essential_JJ to_IN pandemic_NN response_NN ._. ”_'' Utilitarianism_NN likewise_RB endorses_VBZ the_DT traditional_JJ “_`` triage_NN ”_'' of_IN battlefield_NN medicine_NN ,_, where_WRB resources_NNS are_VBP directed_VBN toward_IN those_DT whose_WP$ lives_NNS hang_VBP in_IN the_DT balance_NN and_CC away_RB from_IN those_DT who_WP will_MD surely_RB live_VB or_CC surely_RB die_VB ._. Yet_CC ,_, utilitarianism_NN ’s_POS willingness_NN to_TO confront_VB seemingly_RB impossible_JJ choices_NNS head_NN on_RP makes_VBZ many_JJ people_NNS uncomfortable_JJ ._. Roger_NNP Severino_NNP ,_, the_DT director_NN of_IN the_DT Office_NNP for_IN Civil_NNP Rights_NNP at_IN the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ,_, for_IN example_NN ,_, announced_VBD that_IN there_EX would_MD be_VB investigations_NNS of_IN those_DT who_WP institute_VBP utilitarian_JJ policies_NNS during_IN the_DT crisis_NN ._. But_CC ,_, Severino_NNP failed_VBD to_TO provide_VB any_DT alternative_JJ guidance_NN for_IN making_VBG such_JJ tragic_JJ choices_NNS ._. One_CD especially_RB controversial_JJ feature_NN of_IN utilitarianism_NN is_VBZ that_IN in_IN life_NN -_HYPH or_CC -_HYPH death_NN decisions_NNS it_PRP favors_VBZ the_DT young_JJ over_IN the_DT old_JJ ,_, because_IN doing_VBG so_RB can_MD be_VB expected_VBN to_TO save_VB more_JJR years_NNS of_IN life_NN ._. But_CC when_WRB ventilators_NNS are_VBP scarce_JJ ,_, is_VBZ n’t_RB it_PRP immoral_JJ to_TO explicitly_RB favor_VB the_DT young_JJ ?_. To_TO shed_VB light_NN on_IN the_DT question_NN of_IN whether_IN hospitals_NNS should_MD take_VB a_DT utilitarian_JJ perspective_NN in_IN these_DT challenging_JJ times_NNS we_PRP set_VBP out_RP to_TO understand_VB the_DT perspectives_NNS of_IN American_JJ citizens_NNS about_IN how_WRB they_PRP would_MD want_VB physicians_NNS to_TO prioritize_VB care_NN ._. In_IN a_DT recent_JJ experiment_NN ,_, we_PRP instructed_VBD one_CD group_NN of_IN participants_NNS to_TO imagine_VB a_DT doctor_NN deciding_VBG whether_IN to_TO give_VB the_DT last_JJ available_JJ ventilator_NN to_IN the_DT 65_CD -_HYPH year_NN -_HYPH old_JJ patient_NN who_WP arrived_VBD first_RB or_CC to_IN the_DT 25_CD -_HYPH year_NN -_HYPH old_JJ patient_NN who_WP arrived_VBD moments_NNS later_RBR ._. Participants_NNS were_VBD told_VBN to_TO assume_VB that_IN whichever_WDT patient_NN is_VBZ saved_VBN will_MD live_VB to_IN age_NN 80_CD ,_, and_CC that_IN the_DT ventilator_NN is_VBZ equally_RB capable_JJ of_IN saving_VBG either_CC patient_NN ._. About_RB half_NN of_IN these_DT participants_NNS thought_VBD that_IN it_PRP would_MD be_VB moral_JJ to_TO give_VB the_DT ventilator_NN to_IN the_DT younger_JJR person_NN ._. Perhaps_RB not_RB surprisingly_RB ,_, their_PRP$ answers_NNS were_VBD strongly_RB associated_VBN with_IN their_PRP$ age_NN ;_, 66_CD %_NN of_IN people_NNS between_IN 18_CD and_CC 30_CD considered_VBD it_PRP moral_JJ to_TO give_VB the_DT ventilator_NN to_IN the_DT younger_JJR person_NN ,_, but_CC only_RB 33_CD %_NN of_IN people_NNS 60_CD or_CC older_JJR agreed_VBD ._. But_CC we_PRP saw_VBD an_DT interesting_JJ shift_NN when_WRB we_PRP asked_VBD participants_NNS to_TO look_VB at_IN this_DT dilemma_NN from_IN an_DT impartial_JJ stance_NN ._. Applying_VBG philosopher_NN John_NNP Rawls_NNP ’_POS veil_NN of_IN ignorance_NN perspective_NN ,_, which_WDT argues_VBZ that_IN a_DT fair_JJ decision_NN is_VBZ equivalent_JJ to_IN a_DT selfish_JJ decision_NN ,_, provided_VBN that_IN you_PRP do_VBP n’t_RB know_VB who_WP you_PRP will_MD be_VB among_IN those_DT affected_VBN ,_, we_PRP presented_VBD another_DT group_NN of_IN participants_NNS with_IN the_DT same_JJ situation_NN ._. However_RB ,_, we_PRP first_RB asked_VBD them_PRP to_TO put_VB themselves_PRP into_IN the_DT equation_NN ,_, imagining_VBG that_IN they_PRP had_VBD a_DT 50_CD %_NN chance_NN of_IN being_VBG the_DT older_JJR patient_NN ,_, with_IN 15_CD years_NNS left_VBN to_TO live_VB if_IN saved_VBN ,_, and_CC a_DT 50_CD %_NN chance_NN of_IN being_VBG the_DT younger_JJR patient_NN ,_, who_WP will_MD live_VB 55_CD years_NNS if_IN saved_VBN ._. About_RB three_CD quarters_NNS said_VBD they_PRP would_MD want_VB the_DT doctor_NN to_TO follow_VB the_DT utilitarian_JJ principle_NN ,_, favoring_VBG the_DT younger_JJR patient_NN ._. More_RBR interestingly_RB ,_, after_IN thinking_VBG through_IN what_WP they_PRP would_MD want_VB under_IN the_DT veil_NN of_IN not_RB knowing_VBG whether_IN they_PRP were_VBD the_DT younger_JJR or_CC older_JJR patient_NN ,_, when_WRB we_PRP then_RB asked_VBD whether_IN they_PRP thought_VBD that_IN it_PRP would_MD be_VB moral_JJ to_TO give_VB the_DT ventilator_NN to_IN the_DT younger_JJR person_NN ,_, a_DT much_RB higher_JJR percentage_NN (_-LRB- 62_CD %_NN )_-RRB- now_RB found_VBD the_DT utilitarian_JJ course_NN of_IN action_NN more_RBR ethical_JJ ._. This_DT increase_NN in_IN the_DT proportion_NN of_IN people_NNS favoring_VBG the_DT younger_JJR patient_NN occurred_VBD principally_RB because_IN most_JJS of_IN the_DT older_JJR respondents_NNS ,_, imagining_VBG themselves_PRP with_IN an_DT equal_JJ chance_NN of_IN being_VBG young_JJ or_CC old_JJ ,_, now_RB chose_VBD to_TO save_VB the_DT younger_JJR patient_NN ._. The_DT change_NN in_IN moral_JJ assessment_NN when_WRB the_DT veil_NN of_IN ignorance_NN obscured_VBD which_WDT patient_NN they_PRP were_VBD —_: young_JJ or_CC old_JJ —_: was_VBD strongest_JJS for_IN those_DT over_IN 60_CD ._. Their_PRP$ preferences_NNS tell_VBP us_PRP something_NN about_IN fairness_NN principles_NNS ._. “_`` First_RB come_VB ,_, first_RB served_VBN ”_'' is_VBZ a_DT morally_RB plausible_JJ principle_NN ._. So_RB is_VBZ “_`` Save_VB the_DT most_JJS years_NNS of_IN life_NN ._. ”_'' Which_WDT rule_NN is_VBZ fairer_JJR in_IN the_DT current_JJ moment_NN ?_. When_WRB participants_NNS put_VBD themselves_PRP in_IN the_DT shoes_NNS of_IN both_DT patients_NNS ,_, the_DT majority_NN indicated_VBD that_IN saving_VBG more_JJR life_NN -_HYPH years_NNS is_VBZ fairer_JJR :_: It_PRP ’s_VBZ what_WP they_PRP would_MD want_VB for_IN themselves_PRP if_IN they_PRP did_VBD not_RB know_VB whom_WP they_PRP were_VBD going_VBG to_TO be_VB ._. Our_PRP$ most_RBS important_JJ conclusion_NN is_VBZ not_RB that_IN the_DT young_NN should_MD be_VB favored_VBN over_IN the_DT old_JJ ,_, or_CC that_IN any_DT group_NN should_MD be_VB favored_VBN over_IN any_DT other_JJ ,_, but_CC rather_RB that_IN decisions_NNS should_MD be_VB made_VBN through_IN an_DT impartial_JJ process_NN ._. Research_NN on_IN decision_NN making_NN provides_VBZ three_CD concrete_JJ guidelines_NNS that_WDT policymakers_NNS and_CC physicians_NNS can_MD use_VB to_TO make_VB fair_JJ choices_NNS when_WRB allocating_VBG scarce_JJ ,_, life_NN -_HYPH saving_VBG resources_NNS :_: First_RB ,_, it_PRP can_MD be_VB helpful_JJ to_TO try_VB to_TO use_VB Rawls_NNP ’_POS veil_NN of_IN ignorance_NN ._. Our_PRP$ current_JJ work_NN applied_VBD Rawls_NNP ’_POS idea_NN and_CC found_VBD that_IN assuming_VBG a_DT veil_NN of_IN ignorance_NN shifts_VBZ judgment_NN toward_IN saving_VBG more_JJR life_NN years_NNS ._. We_PRP ’ve_VBP seen_VBN this_DT same_JJ effect_NN in_IN previous_JJ research_NN that_WDT looked_VBD at_IN people_NNS ’s_POS instinct_NN to_TO save_VB the_DT most_JJS lives_NNS in_IN scenarios_NNS involving_VBG self_NN -_HYPH driving_NN cars_NNS ,_, charitable_JJ giving_NN ,_, and_CC health_NN care_NN decisions_NNS ._. Second_RB ,_, decisions_NNS can_MD be_VB improved_VBN when_WRB making_VBG comparative_JJ rather_RB than_IN one_CD -_HYPH off_RP choices_NNS ._. Our_PRP$ research_NN (_-LRB- with_IN Iris_NNP Bohnet_NNP and_CC Alexandra_NNP van_NNP Geen_NNP )_-RRB- shows_VBZ that_IN when_WRB people_NNS evaluate_VBP job_NN candidates_NNS one_CD at_IN a_DT time_NN ,_, they_PRP make_VBP stereotype_NN -_HYPH based_VBN decisions_NNS ,_, such_JJ as_IN hiring_VBG men_NNS for_IN mathematical_JJ tasks_NNS and_CC women_NNS for_IN verbal_JJ tasks_NNS ._. By_IN contrast_NN ,_, when_WRB people_NNS compare_VBP two_CD applicants_NNS at_IN the_DT same_JJ time_NN ,_, they_PRP focus_VBP more_JJR on_IN job_NN -_HYPH relevant_JJ criteria_NNS and_CC make_VBP more_RBR ethical_JJ ,_, less_RBR sexist_JJ hiring_NN choices_NNS ._. In_IN other_JJ research_NN (_-LRB- with_IN Chia_NNP -_HYPH Jung_NNP Tsay_NNP and_CC Fiery_NNP Cushman_NNP )_-RRB- ,_, we_PRP found_VBD that_IN considering_VBG two_CD moral_JJ dilemmas_NNS at_IN the_DT same_JJ time_NN promotes_VBZ consistency_NN in_IN moral_JJ decision_NN -_HYPH making_NN ._. Similarly_RB ,_, comparing_VBG multiple_JJ options_NNS for_IN saving_VBG lives_NNS when_WRB resources_NNS are_VBP limited_VBN should_MD lead_VB to_IN better_JJR ,_, more_RBR ethical_JJ decisions_NNS than_IN evaluating_VBG options_NNS one_CD at_IN a_DT time_NN ._. Thus_RB ,_, rather_RB than_IN make_VB case_NN -_HYPH by_IN -_HYPH case_NN decisions_NNS when_WRB patients_NNS in_IN critical_JJ need_NN arrive_VBP at_IN a_DT hospital_NN ,_, doctors_NNS should_MD consider_VB multiple_JJ options_NNS or_CC policies_NNS for_IN how_WRB they_PRP would_MD allocate_VB limited_JJ resources_NNS ._. Third_RB ,_, it_PRP ’s_VBZ important_JJ to_TO pre-commit_VB to_IN evaluative_JJ standards_NNS ._. Our_PRP$ ongoing_JJ research_NN (_-LRB- with_IN Linda_NNP Chang_NNP ,_, Mina_NNP Cikara_NNP ,_, and_CC Iris_NNP Bohnet_NNP )_-RRB- shows_VBZ that_IN that_IN when_WRB employers_NNS first_RB think_VBP through_IN the_DT criteria_NNS that_WDT define_VBP a_DT good_JJ employee_NN before_IN considering_VBG a_DT specific_JJ candidate_NN ,_, they_PRP make_VBP less_RBR discriminatory_JJ decisions_NNS and_CC hire_VBP better_JJR -_HYPH quality_NN employees_NNS ._. Likewise_RB ,_, when_WRB physicians_NNS and_CC administrators_NNS think_VBP through_IN their_PRP$ goals_NNS when_WRB planning_VBG how_WRB to_TO allocate_VB limited_JJ medical_JJ resources_NNS ,_, they_PRP will_MD reach_VB decisions_NNS that_WDT are_VBP more_RBR aligned_VBN with_IN their_PRP$ values_NNS ._. Just_RB as_IN surgeons_NNS aim_VBP to_TO use_VB the_DT best_JJS available_JJ tools_NNS when_WRB operating_VBG ,_, those_DT at_IN the_DT front_JJ lines_NNS of_IN the_DT pandemic_NN need_VBP the_DT best_JJS decision_NN -_HYPH making_VBG tools_NNS available_JJ to_TO allocate_VB scarce_JJ resources_NNS fairly_RB ._. That_DT means_VBZ moving_VBG beyond_IN intuitive_JJ thinking_NN ,_, harnessing_VBG their_PRP$ deliberative_JJ cognitive_JJ capacities_NNS —_: and_CC empowering_VBG them_PRP to_TO make_VB these_DT tragic_JJ decisions_NNS as_RB ethically_RB as_IN possible_JJ ._.","Who should VB a NN if there VBP RB JJ to VB RB ? NN on NN NN VBZ to three JJ NNS that NN - NNS and NNS can VB to VB JJ NNS when VBG JJ , NN - VBG NNS . They VBP to VBG JJ and JJ NNS VBZ to VB that NNS VBP VBN through an JJ NN . NNS around the NN must VB JJ NNS in the NN of the NNP - 19 NN . JJ among their NNS VBZ that there might RB VB JJ of a JJ NN , JJ as NNS , NN NNS , or NNS , for all of the NNS who VBP them . This VBZ RB a JJ NN . NNS in NNP VBD JJ NNS about which NNS should VB a NN and which they should VB VB . RB , JJ NNP NNS VBP RB RB VBN that NN , but this VBZ an JJ NN for the NNS RB as we VBP to VB whether the NN VBZ down or NNS . RB , the NN VBZ JJ as the NN VBZ to NNS with JJR NNS . VBN with JJ NNS , NNS VBP JJ NNS that VBP NN ’s JJS NN of NN . NN on JJ NN NN , and our JJ NNS VBG JJ NNS what NNS they would VB , VBZ some NN . Who should VB a NN if there VBP RB JJ to VB RB ? JJ JJ NNS VBP a JJ NN VBN NN . The NN VBZ JJ – you should VB to VB JJ NN and VB RB - VBG across NN . VBG in the NNP NNP NNP of NNP , for NN , NN NNP NNP and NNS VBP for VBG the NNS of NN NN NNS – VBG them RB with NN , NNS , NNS and NNS – to VB that they can VB on the NN or VB RB to it if they VBP JJ . “ These NNS should VB VBN NN RB because they VBP RB RBR JJ , ” they VBP , “ but because of their JJ NN : they VBP JJ to NN NN . ” NN RB VBZ the JJ “ NN ” of NN NN , where NNS VBP VBN toward those whose NNS VBP in the NN and RB from those who will RB VB or RB VB . Yet , NN ’s NN to VB RB JJ NNS NN on VBZ JJ NNS JJ . NNP NNP , the NN of the NNP for NNP NNP at the NNP NNP of NNP and NNP NNPS , for NN , VBD that there would VB NNS of those who VBP JJ NNS during the NN . But , NNP VBD to VB any JJ NN for VBG JJ JJ NNS . One RB JJ NN of NN VBZ that in NN - or - NN NNS it VBZ the JJ over the JJ , because VBG RB can VB VBN to VB JJR NNS of NN . But when NNS VBP JJ , VBZ RB it JJ to RB VB the JJ ? To VB NN on the NN of whether NNS should VB a JJ NN in these JJ NNS we VBP out to VB the NNS of JJ NNS about how they would VB NNS to VB NN . In a JJ NN , we VBD one NN of NNS to VB a NN VBG whether to VB the JJ JJ NN to the 65 - NN - JJ NN who VBD RB or to the 25 - NN - JJ NN who VBD NNS RBR . NNS VBD VBN to VB that whichever NN VBZ VBN will VB to NN 80 , and that the NN VBZ RB JJ of VBG either NN . RB NN of these NNS VBD that it would VB JJ to VB the NN to the JJR NN . RB RB RB , their NNS VBD RB VBN with their NN ; 66 NN of NNS between 18 and 30 VBD it JJ to VB the NN to the JJR NN , but RB 33 NN of NNS 60 or JJR VBD . But we VBD an JJ NN when we VBD NNS to VB at this NN from an JJ NN . VBG NN NNP NNP ’ NN of NN NN , which VBZ that a JJ NN VBZ JJ to a JJ NN , VBN that you VBP RB VB who you will VB among those VBN , we VBD another NN of NNS with the JJ NN . RB , we RB VBD them to VB themselves into the NN , VBG that they VBD a 50 NN NN of VBG the JJR NN , with 15 NNS VBN to VB if VBN , and a 50 NN NN of VBG the JJR NN , who will VB 55 NNS if VBN . RB three NNS VBD they would VB the NN to VB the JJ NN , VBG the JJR NN . RBR RB , after VBG through what they would VB under the NN of RB VBG whether they VBD the JJR or JJR NN , when we RB VBD whether they VBD that it would VB JJ to VB the NN to the JJR NN , a RB JJR NN ( 62 NN ) RB VBD the JJ NN of NN RBR JJ . This NN in the NN of NNS VBG the JJR NN VBD RB because JJS of the JJR NNS , VBG themselves with an JJ NN of VBG JJ or JJ , RB VBD to VB the JJR NN . The NN in JJ NN when the NN of NN VBD which NN they VBD — JJ or JJ — VBD JJS for those over 60 . Their NNS VBP us NN about NN NNS . “ RB VB , RB VBN ” VBZ a RB JJ NN . RB VBZ “ VB the JJS NNS of NN . ” Which NN VBZ JJR in the JJ NN ? When NNS VBD themselves in the NNS of both NNS , the NN VBD that VBG JJR NN - NNS VBZ JJR : It VBZ what they would VB for themselves if they VBD RB VB whom they VBD VBG to VB . Our RBS JJ NN VBZ RB that the NN should VB VBN over the JJ , or that any NN should VB VBN over any JJ , but RB that NNS should VB VBN through an JJ NN . NN on NN NN VBZ three JJ NNS that NNS and NNS can VB to VB JJ NNS when VBG JJ , NN - VBG NNS : RB , it can VB JJ to VB to VB NNP ’ NN of NN . Our JJ NN VBD NNP ’ NN and VBD that VBG a NN of NN VBZ NN toward VBG JJR NN NNS . We VBP VBN this JJ NN in JJ NN that VBD at NNS ’s NN to VB the JJS NNS in NNS VBG NN - NN NNS , JJ NN , and NN NN NNS . RB , NNS can VB VBN when VBG JJ RB than one - off NNS . Our NN ( with NNP NNP and NNP NNP NNP ) VBZ that when NNS VBP NN NNS one at a NN , they VBP NN - VBN NNS , JJ as VBG NNS for JJ NNS and NNS for JJ NNS . By NN , when NNS VBP two NNS at the JJ NN , they VBP JJR on NN - JJ NNS and VBP RBR JJ , RBR JJ NN NNS . In JJ NN ( with NNP - NNP NNP and NNP NNP ) , we VBD that VBG two JJ NNS at the JJ NN VBZ NN in JJ NN - NN . RB , VBG JJ NNS for VBG NNS when NNS VBP VBN should VB to JJR , RBR JJ NNS than VBG NNS one at a NN . RB , RB than VB NN - by - NN NNS when NNS in JJ NN VBP at a NN , NNS should VB JJ NNS or NNS for how they would VB JJ NNS . RB , it VBZ JJ to VB to JJ NNS . Our JJ NN ( with NNP NNP , NNP NNP , and NNP NNP ) VBZ that that when NNS RB VBP through the NNS that VBP a JJ NN before VBG a JJ NN , they VBP RBR JJ NNS and VBP JJR - NN NNS . RB , when NNS and NNS VBP through their NNS when VBG how to VB JJ JJ NNS , they will VB NNS that VBP RBR VBN with their NNS . RB as NNS VBP to VB the JJS JJ NNS when VBG , those at the JJ NNS of the NN VBP the JJS NN - VBG NNS JJ to VB JJ NNS RB . That VBZ VBG beyond JJ NN , VBG their JJ JJ NNS — and VBG them to VB these JJ NNS RB RB as JJ ."
73,1193,mainstream,"CHOLERA_NNP is_VBZ the_DT potentially_RB deadly_JJ condition_NN caused_VBN by_IN drinking_VBG dirty_JJ water_NN or_CC eating_VBG contaminated_VBN food_NN ._. Here_RB 's_VBZ all_DT you_PRP need_VBP to_TO know_VB about_IN the_DT bacterial_JJ infection_NN caused_VBN by_IN poor_JJ sanitation_NN ._. Cholera_NNP is_VBZ a_DT bacterial_JJ infection_NN of_IN the_DT small_JJ intestine_NN that_WDT is_VBZ spread_VBN through_IN dirty_JJ water_NN and_CC food_NN that_WDT has_VBZ been_VBN contaminated_VBN with_IN an_DT infected_VBN person_NN 's_POS faeces_NNS ._. Once_IN infected_VBN ,_, people_NNS start_VBP to_TO experience_VB symptoms_NNS of_IN the_DT disease_NN within_IN a_DT few_JJ days_NNS and_CC if_IN left_VBN untreated_JJ -_, it_PRP can_MD prove_VB fatal_JJ ._. Cholera_NNP is_VBZ most_RBS widespread_JJ in_IN places_NNS across_IN the_DT globe_NN where_WRB there_EX is_VBZ poor_JJ sanitation_NN such_JJ as_IN sub-Saharan_JJ Africa_NNP ,_, South_NNP East_NNP Asia_NNP ,_, the_DT Middle_NNP East_NNP and_CC the_DT Caribbean_NNP and_CC Central_NNP America_NNP ._. There_EX also_RB tends_VBZ to_TO be_VB outbreaks_NNS after_IN natural_JJ disasters_NNS or_CC during_IN a_DT humanitarian_JJ crisis_NN ,_, where_WRB people_NNS are_VBP forced_VBN to_TO live_VB in_IN cramped_VBN conditions_NNS with_IN little_JJ access_NN to_IN clean_JJ drinking_NN water_NN ._. The_DT World_NNP Health_NNP Organisation_NNP (_-LRB- WHO_NNP )_-RRB- estimates_VBZ that_IN up_IN to_IN four_CD million_CD people_NNS are_VBP infected_VBN every_DT year_NN ,_, with_IN it_PRP killing_VBG up_IN to_IN 143,000_CD ._. However_RB ,_, there_EX have_VBP not_RB been_VBN any_DT cases_NNS of_IN cholera_NN that_WDT have_VBP originated_VBN in_IN England_NNP and_CC Wales_NNP for_IN over_RB 100_CD years_NNS ._. A_DT public_JJ health_NN emergency_NN was_VBD declared_VBN in_IN Zimbabwe_NNP in_IN September_NNP 2018_CD after_IN a_DT cholera_NN outbreak_NN killed_VBD at_IN least_JJS 20_CD people_NNS and_CC 2,000_CD others_NNS have_VBP been_VBN infected_VBN ._. Health_NN minister_NN Obadiah_NNP Moyo_NNP blamed_VBD the_DT outbreak_NN on_IN burst_VB sewers_NNS which_WDT contaminated_VBD drinking_NN wells_NNS and_CC boreholes_NNS ._. What_WP are_VBP the_DT symptoms_NNS of_IN cholera_NN ?_. As_IN the_DT cholera_NN infection_NN attacks_VBZ the_DT small_JJ intestine_NN ,_, one_CD of_IN the_DT most_RBS common_JJ symptoms_NNS of_IN the_DT condition_NN is_VBZ severe_JJ ,_, watery_JJ ,_, diarrhoea_NN ._. It_PRP can_MD also_RB cause_VB nausea_NN and_CC vomiting_NN and_CC people_NNS also_RB complain_VBP of_IN experiencing_VBG stomach_NN cramps_NNS ._. It_PRP can_MD take_VB between_RB 12_CD hours_NNS and_CC 5_CD days_NNS for_IN a_DT person_NN to_TO show_VB symptoms_NNS after_IN ingesting_VBG contaminated_VBN food_NN or_CC water_NN ._. If_IN at_IN this_DT point_NN the_DT disease_NN is_VBZ n't_RB treated_VBN ,_, the_DT symptoms_NNS will_MD get_VB worse_JJR and_CC a_DT person_NN can_MD become_VB severely_RB dehydrated_VBN very_RB quickly_RB ._. Once_IN this_DT happens_VBZ ,_, there_EX can_MD also_RB be_VB a_DT sudden_JJ drop_NN in_IN blood_NN pressure_NN ,_, which_WDT can_MD prove_VB fatal_JJ if_IN the_DT major_JJ organs_NNS begin_VBP to_TO shut_VB down_RP ._. What_WP is_VBZ the_DT treatment_NN for_IN cholera_NN ?_. Despite_IN the_DT condition_NN being_VBG potentially_RB fatal_JJ ,_, cholera_NN is_VBZ easily_RB treatable_JJ ._. The_DT most_RBS common_JJ treatment_NN for_IN cholera_NN patients_NNS is_VBZ an_DT oral_JJ rehydration_NN solution_NN ,_, which_WDT can_MD prevent_VB a_DT person_NN becoming_VBG too_RB dehydrated_JJ ._. The_DT solution_NN comes_VBZ in_IN the_DT form_NN of_IN a_DT sachet_NN of_IN a_DT mixture_NN of_IN salt_NN and_CC glucose_NN ,_, which_WDT is_VBZ mixed_VBN with_IN clean_JJ water_NN ._. The_DT patient_NN then_RB drinks_VBZ the_DT solution_NN and_CC it_PRP replaces_VBZ any_DT fluids_NNS a_DT person_NN has_VBZ lost_VBN through_IN sickness_NN and_CC diarrhoea_NN ._. Sachets_NNS are_VBP easily_RB available_JJ from_IN shops_NNS and_CC if_IN travelling_VBG to_IN affected_VBN areas_NNS ,_, experts_NNS advise_VBP taking_VBG them_PRP with_IN you_PRP ._. If_IN a_DT person_NN is_VBZ severely_RB dehydrated_VBN ,_, intravenous_JJ saline_NN drips_NNS and_CC antibiotics_NNS may_MD be_VB prescribed_VBN to_TO speed_VB up_RP recovery_NN ._. Is_VBZ there_EX a_DT vaccine_NN against_IN cholera_NN ?_. There_EX is_VBZ a_DT vaccine_NN against_IN cholera_NN ,_, although_IN it_PRP is_VBZ not_RB usually_RB given_VBN as_IN hygiene_NN precautions_NNS are_VBP usually_RB enough_JJ to_TO prevent_VB the_DT infection_NN ._. However_RB ,_, the_DT vaccine_NN is_VBZ given_VBN to_IN people_NNS such_JJ as_IN aid_NN workers_NNS and_CC armed_JJ forces_NNS ,_, who_WP may_MD have_VB to_TO travel_VB to_IN areas_NNS where_WRB there_EX is_VBZ a_DT cholera_NN outbreak_NN ._. The_DT vaccine_NN is_VBZ given_VBN in_IN the_DT form_NN of_IN a_DT liquid_NN ,_, where_WRB it_PRP is_VBZ mixed_VBN with_IN water_NN and_CC then_RB taken_VBN orally_RB ._. For_IN everyone_NN over_IN the_DT age_NN of_IN six_CD ,_, two_CD doses_NNS of_IN the_DT vaccine_NN should_MD be_VB given_VBN six_CD weeks_NNS apart_RB and_CC at_IN least_JJS one_CD week_NN before_IN travelling_VBG to_IN an_DT infected_VBN area_NN ._. The_DT vaccine_NN cannot_MD be_VB given_VBN to_IN those_DT under_IN the_DT age_NN of_IN two_CD ,_, pregnant_JJ or_CC breastfeeding_VBG women_NNS or_CC people_NNS with_IN an_DT immune_JJ system_NN condition_NN ._. It_PRP is_VBZ thought_VBN to_TO be_VB about_RB 85_CD per_NN cent_NN effective_JJ and_CC the_DT level_NN of_IN protection_NN reduces_VBZ over_IN time_NN ,_, meaning_VBG boosters_NNS are_VBP sometimes_RB required_VBN ._. Are_VBP there_EX any_DT other_JJ ways_NNS to_TO prevent_VB cholera_NN ?_. The_DT WHO_NNP is_VBZ working_VBG to_TO reduce_VB the_DT number_NN of_IN cholera_NN cases_NNS by_IN closely_RB monitoring_VBG water_NN sources_NNS for_IN signs_NNS of_IN the_DT infection_NN ._. They_PRP are_VBP also_RB putting_VBG in_RP place_NN the_DT development_NN of_IN piped_VBN water_NN supplies_NNS and_CC safe_JJ sewage_NN disposal_NN in_IN countries_NNS where_WRB there_EX is_VBZ poor_JJ sanitation_NN ._. For_IN travellers_NNS ,_, the_DT NHS_NNP has_VBZ issued_VBN advice_NN on_IN what_WP they_PRP can_MD do_VB to_TO prevent_VB cholera_NN as_RB well_RB as_IN travellers_NNS '_POS diarrhoea_NN ._. •_NFP Only_RB drinking_NN water_NN that_WDT is_VBZ from_IN a_DT bottle_NN that_WDT has_VBZ been_VBN sealed_VBN or_CC recently_RB boiled_VBN •_NFP Avoiding_VBG ice_NN cream_NN and_CC having_VBG ice_NN in_IN drinks_NNS","NNP VBZ the RB JJ NN VBN by VBG JJ NN or VBG VBN NN . RB VBZ all you VBP to VB about the JJ NN VBN by JJ NN . NNP VBZ a JJ NN of the JJ NN that VBZ VBN through JJ NN and NN that VBZ VBN VBN with an VBN NN 's NNS . Once VBN , NNS VBP to VB NNS of the NN within a JJ NNS and if VBN JJ - it can VB JJ . NNP VBZ RBS JJ in NNS across the NN where there VBZ JJ NN JJ as JJ NNP , NNP NNP NNP , the NNP NNP and the NNP and NNP NNP . There RB VBZ to VB NNS after JJ NNS or during a JJ NN , where NNS VBP VBN to VB in VBN NNS with JJ NN to JJ NN NN . The NNP NNP NNP ( NNP ) VBZ that up to four million NNS VBP VBN every NN , with it VBG up to 143,000 . RB , there VBP RB VBN any NNS of NN that VBP VBN in NNP and NNP for RB 100 NNS . A JJ NN NN VBD VBN in NNP in NNP 2018 after a NN NN VBD at JJS 20 NNS and 2,000 NNS VBP VBN VBN . NN NN NNP NNP VBD the NN on VB NNS which VBD NN NNS and NNS . What VBP the NNS of NN ? As the NN NN VBZ the JJ NN , one of the RBS JJ NNS of the NN VBZ JJ , JJ , NN . It can RB VB NN and NN and NNS RB VBP of VBG NN NNS . It can VB RB 12 NNS and 5 NNS for a NN to VB NNS after VBG VBN NN or NN . If at this NN the NN VBZ RB VBN , the NNS will VB JJR and a NN can VB RB VBN RB RB . Once this VBZ , there can RB VB a JJ NN in NN NN , which can VB JJ if the JJ NNS VBP to VB down . What VBZ the NN for NN ? Despite the NN VBG RB JJ , NN VBZ RB JJ . The RBS JJ NN for NN NNS VBZ an JJ NN NN , which can VB a NN VBG RB JJ . The NN VBZ in the NN of a NN of a NN of NN and NN , which VBZ VBN with JJ NN . The NN RB VBZ the NN and it VBZ any NNS a NN VBZ VBN through NN and NN . NNS VBP RB JJ from NNS and if VBG to VBN NNS , NNS VBP VBG them with you . If a NN VBZ RB VBN , JJ NN NNS and NNS may VB VBN to VB up NN . VBZ there a NN against NN ? There VBZ a NN against NN , although it VBZ RB RB VBN as NN NNS VBP RB JJ to VB the NN . RB , the NN VBZ VBN to NNS JJ as NN NNS and JJ NNS , who may VB to VB to NNS where there VBZ a NN NN . The NN VBZ VBN in the NN of a NN , where it VBZ VBN with NN and RB VBN RB . For NN over the NN of six , two NNS of the NN should VB VBN six NNS RB and at JJS one NN before VBG to an VBN NN . The NN cannot VB VBN to those under the NN of two , JJ or VBG NNS or NNS with an JJ NN NN . It VBZ VBN to VB RB 85 NN NN JJ and the NN of NN VBZ over NN , VBG NNS VBP RB VBN . VBP there any JJ NNS to VB NN ? The NNP VBZ VBG to VB the NN of NN NNS by RB VBG NN NNS for NNS of the NN . They VBP RB VBG in NN the NN of VBN NN NNS and JJ NN NN in NNS where there VBZ JJ NN . For NNS , the NNP VBZ VBN NN on what they can VB to VB NN RB RB as NNS ' NN . • RB NN NN that VBZ from a NN that VBZ VBN VBN or RB VBN • VBG NN NN and VBG NN in NNS"
74,51,mainstream,"More_JJR than_IN 100_CD genes_NNS tied_VBN to_IN autism_NN identified_VBN in_IN large_JJ study_NN More_JJR than_IN 100_CD genes_NNS associated_VBN with_IN autism_NN were_VBD identified_VBN in_IN a_DT ""_`` landmark_JJ study_NN ""_'' that_WDT could_MD help_VB better_RBR understand_VB what_WP causes_VBZ the_DT disability_NN ,_, researchers_NNS say_VBP ._. In_IN the_DT large_JJ genetic_JJ -_HYPH sequencing_NN study_NN ,_, a_DT team_NN of_IN researchers_NNS led_VBN by_IN scientists_NNS at_IN Mount_NNP Sinai_NNP and_CC relying_VBG on_IN international_JJ collaboration_NN identified_VBD the_DT 102_CD genes_NNS associated_VBN with_IN autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ._. The_DT team_NN relied_VBD on_IN samples_NNS from_IN more_JJR than_IN 35,000_CD participants_NNS ,_, of_IN which_WDT almost_RB 12,000_CD had_VBD autism_NN ,_, and_CC they_PRP were_VBD able_JJ to_TO study_VB both_CC genes_NNS that_WDT were_VBD inherited_VBN and_CC those_DT that_WDT occurred_VBD when_WRB egg_NN or_CC sperm_NN are_VBP formed_VBN ._. Of_IN the_DT 102_CD genes_NNS ,_, 49_CD were_VBD also_RB tied_VBN with_IN other_JJ development_NN delays_NNS ,_, the_DT researchers_NNS say_VBP ._. ""_`` With_IN these_DT identified_VBN genes_NNS we_PRP can_MD begin_VB to_TO understand_VB what_WDT brain_NN changes_NNS underlie_VBP ASD_NN and_CC begin_VB to_TO consider_VB novel_JJ treatment_NN approaches_NNS ,_, ""_'' Joseph_NNP Buxbaum_NNP ,_, the_DT director_NN of_IN the_DT Seaver_NNP Autism_NNP Center_NNP for_IN Research_NNP and_CC Treatment_NNP at_IN Mount_NNP Sinai_NNP ,_, said_VBD in_IN a_DT statement_NN ._. The_DT study_NN was_VBD published_VBN Thursday_NNP in_IN the_DT peer_NN -_HYPH reviewed_VBN journal_NN Cell_NN ._. In_IN 2015_CD ,_, only_RB 65_CD genes_NNS associated_VBN with_IN ASD_NNP were_VBD known_VBN ,_, the_DT researchers_NNS say_VBP ._. Dr._NNP Andrew_NNP Adesman_NNP ,_, the_DT chief_NN of_IN developmental_JJ and_CC behavioral_JJ pediatrics_NN at_IN Cohen_NNP Children_NNP ’s_POS Medical_NNP Center_NNP of_IN New_NNP York_NNP ,_, said_VBD the_DT study_NN is_VBZ the_DT latest_JJS in_IN a_DT string_NN of_IN advances_NNS to_TO help_VB understand_VB the_DT genetic_JJ factors_NNS associated_VBN with_IN autism_NN in_IN some_DT children_NNS ._. ""_`` Identification_NN of_IN these_DT new_JJ genes_NNS associated_VBN with_IN autism_NN may_MD not_RB only_RB help_VB pinpoint_VB a_DT likely_JJ cause_NN for_IN ASD_NN in_IN some_DT children_NNS ,_, but_CC it_PRP will_MD also_RB help_VB researchers_NNS better_RBR determine_VB the_DT biological_JJ mechanisms_NNS that_WDT underlie_VBP autism_NN ,_, ""_'' he_PRP wrote_VBD in_IN an_DT email_NN to_IN USA_NNP TODAY_NN ._. Adesman_NNP was_VBD not_RB involved_VBN in_IN the_DT study_NN ._. Autism_NN and_CC vaccines_NNS :_: Vaccines_NNS are_VBP definitely_RB not_RB linked_VBN to_IN autism_NN ,_, and_CC other_JJ facts_NNS you_PRP can_MD throw_VB at_IN anti-vaxers_NNS Autism_NN spectrum_NN disorder_NN affects_VBZ communication_NN and_CC behavior_NN ,_, and_CC its_PRP$ effects_NNS usually_RB appear_VBP early_RB in_IN life_NN ,_, according_VBG to_IN the_DT National_NNP Institute_NNP of_IN Mental_NNP Health_NNP ._. The_DT condition_NN is_VBZ known_VBN as_IN a_DT spectrum_NN disorder_NN because_IN an_DT array_NN of_IN behaviors_NNS and_CC their_PRP$ severity_NN may_MD vary_VB depending_VBG on_IN the_DT individual_NN ,_, the_DT institute_NN says_VBZ ._. Reduced_VBN eye_NN contact_NN ,_, lack_NN of_IN response_NN to_IN their_PRP$ name_NN or_CC indifference_NN to_IN caregivers_NNS are_VBP among_IN some_DT of_IN the_DT traits_NNS seen_VBN in_IN early_JJ infancy_NN ,_, according_VBG to_IN the_DT Mayo_NNP Clinic_NNP ._. Some_DT children_NNS later_RBR become_VBP withdrawn_VBN or_CC aggressive_JJ or_CC lose_VB language_NN skills_NNS ,_, the_DT hospital_NN says_VBZ ._. About_RB 1_CD in_IN 59_CD children_NNS has_VBZ been_VBN identified_VBN with_IN ASD_NN ,_, according_VBG to_IN data_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. Adesman_NNP said_VBD the_DT research_NN is_VBZ encouraging_VBG because_IN with_IN genetic_JJ testing_NN ,_, the_DT findings_NNS increase_VBP the_DT likelihood_NN of_IN determining_VBG a_DT probable_JJ genetic_JJ cause_NN for_IN some_DT children_NNS 's_POS autism_NN ._. Still_RB ,_, Adesman_NNP tempered_VBD some_DT exceptions_NNS :_: ""_`` Unfortunately_RB ,_, even_RB though_IN this_DT latest_JJS research_NN has_VBZ newly_RB identified_VBN many_JJ genes_NNS associated_VBN with_IN ASD_NN ,_, the_DT reality_NN is_VBZ that_IN for_IN many_JJ affected_VBN children_NNS ,_, a_DT specific_JJ cause_NN may_MD not_RB be_VB identified_VBN ._. ""_'' Among_IN the_DT other_JJ findings_NNS in_IN the_DT study_NN :_: No_DT one_NN major_JJ class_NN of_IN cells_NNS alone_RB are_VBP tied_VBN to_IN autism_NN ,_, instead_RB ,_, a_DT host_NN of_IN disruptions_NNS in_IN brain_NN development_NN and_CC in_IN neuronal_JJ function_NN can_MD lead_VB to_IN the_DT condition_NN ,_, Buxbaum_NNP said_VBD ._.","JJR than 100 NNS VBN to NN VBN in JJ NN JJR than 100 NNS VBN with NN VBD VBN in a "" JJ NN "" that could VB RBR VB what VBZ the NN , NNS VBP . In the JJ JJ - NN NN , a NN of NNS VBN by NNS at NNP NNP and VBG on JJ NN VBD the 102 NNS VBN with NN NN NN ( NNP ) . The NN VBD on NNS from JJR than 35,000 NNS , of which RB 12,000 VBD NN , and they VBD JJ to VB both NNS that VBD VBN and those that VBD when NN or NN VBP VBN . Of the 102 NNS , 49 VBD RB VBN with JJ NN NNS , the NNS VBP . "" With these VBN NNS we can VB to VB what NN NNS VBP NN and VB to VB JJ NN NNS , "" NNP NNP , the NN of the NNP NNP NNP for NNP and NNP at NNP NNP , VBD in a NN . The NN VBD VBN NNP in the NN - VBN NN NN . In 2015 , RB 65 NNS VBN with NNP VBD VBN , the NNS VBP . NNP NNP NNP , the NN of JJ and JJ NN at NNP NNP ’s NNP NNP of NNP NNP , VBD the NN VBZ the JJS in a NN of NNS to VB VB the JJ NNS VBN with NN in some NNS . "" NN of these JJ NNS VBN with NN may RB RB VB VB a JJ NN for NN in some NNS , but it will RB VB NNS RBR VB the JJ NNS that VBP NN , "" he VBD in an NN to NNP NN . NNP VBD RB VBN in the NN . NN and NNS : NNS VBP RB RB VBN to NN , and JJ NNS you can VB at NNS NN NN NN VBZ NN and NN , and its NNS RB VBP RB in NN , VBG to the NNP NNP of NNP NNP . The NN VBZ VBN as a NN NN because an NN of NNS and their NN may VB VBG on the NN , the NN VBZ . VBN NN NN , NN of NN to their NN or NN to NNS VBP among some of the NNS VBN in JJ NN , VBG to the NNP NNP . Some NNS RBR VBP VBN or JJ or VB NN NNS , the NN VBZ . RB 1 in 59 NNS VBZ VBN VBN with NN , VBG to NNS from the NNPS for NNP NNP and NNP . NNP VBD the NN VBZ VBG because with JJ NN , the NNS VBP the NN of VBG a JJ JJ NN for some NNS 's NN . RB , NNP VBD some NNS : "" RB , RB though this JJS NN VBZ RB VBN JJ NNS VBN with NN , the NN VBZ that for JJ VBN NNS , a JJ NN may RB VB VBN . "" Among the JJ NNS in the NN : No NN JJ NN of NNS RB VBP VBN to NN , RB , a NN of NNS in NN NN and in JJ NN can VB to the NN , NNP VBD ."
75,252,mainstream,"The_DT preliminary_JJ results_NNS of_IN a_DT survey_NN being_VBG run_VBN by_IN the_DT Vaccine_NNP Confidence_NNP Project_NNP —_: which_WDT monitors_VBZ public_JJ trust_NN in_IN vaccination_NN programs_NNS worldwide_RB —_: and_CC ORB_NNP International_NNP show_VBP that_IN between_IN mid-March_NNP and_CC mid-April_NNP of_IN this_DT year_NN ,_, one_CD fifth_NN of_IN Swiss_JJ respondents_NNS and_CC 18_CD percent_NN of_IN those_DT in_IN France_NNP would_MD refuse_VB a_DT coronavirus_NN vaccine_NN ._. Among_IN Austrians_NNPS ,_, the_DT number_NN is_VBZ 16_CD percent_NN ,_, and_CC 9_CD percent_NN in_IN Germany_NNP ._. While_IN this_DT may_MD not_RB be_VB enough_JJ to_TO block_VB efforts_NNS to_TO reach_VB so_RB -_HYPH called_VBN herd_NN immunity_NN —_: estimated_VBN at_IN 60_CD to_IN 70_CD percent_NN —_: European_JJ governments_NNS know_VBP only_RB too_RB well_RB how_WRB vaccine_NN skepticism_NN can_MD derail_VB national_JJ vaccination_NN plans_NNS ,_, as_IN recent_JJ controversies_NNS have_VBP shown_VBN ._. On_IN one_CD hand_NN ,_, a_DT vaccine_NN has_VBZ to_TO come_VB when_WRB the_DT risk_NN of_IN infection_NN is_VBZ still_RB high_JJ ,_, but_CC if_IN it_PRP comes_VBZ too_RB soon_RB ,_, people_NNS may_MD not_RB trust_VB that_IN it_PRP 's_VBZ safe_JJ ._. German_JJ Health_NNP Minister_NNP Jens_NNP Spahn_NNP earlier_RBR this_DT month_NN rejected_VBD the_DT idea_NN that_IN a_DT future_JJ vaccine_NN may_MD be_VB made_VBN mandatory_JJ in_IN the_DT country_NN ,_, saying_VBG a_DT majority_NN of_IN people_NNS would_MD want_VB to_TO get_VB vaccinated_VBN as_RB soon_RB as_IN it_PRP became_VBD available_JJ ._. That_DT does_VBZ not_RB include_VB the_DT world_NN 's_POS top_JJ -_HYPH ranked_VBN tennis_NN player_NN Novak_NNP Djokovic_NNP ,_, who_WP opposes_VBZ vaccination_NN and_CC said_VBD he_PRP would_MD have_VB to_TO make_VB a_DT decision_NN if_IN traveling_VBG to_IN tournaments_NNS becomes_VBZ contingent_JJ on_IN getting_VBG vaccinated_VBN ,_, according_VBG to_IN the_DT Guardian_NNP ._. When_WRB it_PRP comes_VBZ to_IN other_JJ people_NNS 's_POS readiness_NN for_IN it_PRP ,_, timing_NN is_VBZ of_IN the_DT essence_NN ,_, said_VBD Heidi_NNP Larson_NNP ,_, director_NN of_IN the_DT Vaccine_NNP Confidence_NNP Project_NNP ._. “_`` If_IN they_PRP see_VBP there_EX is_VBZ still_RB a_DT threat_NN —_: the_DT second_JJ wave_NN perhaps_RB —_: they_PRP ’re_VBP going_VBG to_TO be_VB more_RBR open_JJ to_IN it_PRP ,_, ”_'' she_PRP said_VBD ._. But_CC if_IN that_DT appears_VBZ to_TO be_VB waning_VBG ,_, they_PRP may_MD not_RB want_VB to_TO take_VB the_DT risk_NN of_IN a_DT new_JJ vaccine_NN that_WDT we_PRP do_VBP n’t_RB know_VB enough_RB about_IN ,_, she_PRP noted_VBD ._. In_IN the_DT U.K._NNP ,_, 7_CD percent_NN of_IN those_DT surveyed_VBN —_: representative_JJ of_IN the_DT country_NN 's_POS population_NN ,_, according_VBG to_IN Larson_NNP —_: said_VBD in_IN mid-March_NNP they_PRP would_MD refuse_VB to_TO be_VB vaccinated_VBN against_IN coronavirus_NN ._. When_WRB the_DT number_NN of_IN deaths_NNS rose_VBD two_CD weeks_NNS later_RBR ,_, that_DT figure_NN dropped_VBD to_IN 5_CD percent_NN ._. ""_`` Now_RB that_IN they_PRP see_VBP the_DT numbers_NNS are_VBP coming_VBG down_RP ,_, it_PRP goes_VBZ up_RP to_IN 9_CD percent_NN saying_VBG they_PRP would_MD refuse_VB ,_, ""_'' Larson_NNP said_VBD ._. Marco_NNP Cavaleri_NNP ,_, head_NN of_IN Biological_NNP Health_NNP Threats_NNPS and_CC Vaccines_NNPS Strategy_NNP at_IN the_DT European_NNP Medicines_NNPS Agency_NNP ,_, is_VBZ well_RB aware_JJ of_IN the_DT dilemma_NN facing_VBG decision_NN -_HYPH makers_NNS in_IN rushing_VBG out_RP a_DT vaccine_NN and_CC making_VBG sure_JJ it_PRP 's_VBZ safe_JJ ._. “_`` We_PRP have_VBP to_TO be_VB sure_JJ that_IN this_DT trade_NN -_HYPH off_NN is_VBZ not_RB compromising_VBG the_DT certainty_NN that_WDT we_PRP need_VBP to_TO have_VB around_IN the_DT safety_NN of_IN the_DT vaccine_NN ,_, ”_'' he_PRP told_VBD reporters_NNS Thursday_NNP ._. For_IN that_DT ,_, the_DT EU_NNP ’s_POS drug_NN regulator_NN has_VBZ to_TO work_VB with_IN vaccine_NN developers_NNS to_TO understand_VB what_WDT kind_NN of_IN evidence_NN they_PRP can_MD provide_VB in_IN the_DT shortest_JJS possible_JJ time_NN ,_, while_IN giving_VBG sufficient_JJ reassurance_NN that_IN these_DT vaccines_NNS are_VBP safe_JJ and_CC effective_JJ ,_, he_PRP said_VBD ._. But_CC that_DT will_MD not_RB be_VB enough_JJ to_TO convince_VB Marie_NNP Werbrègue_NNP ,_, president_NN of_IN the_DT anti-vax_NN group_NN Info_NNP Vaccins_NNP France_NNP ._. She_PRP would_MD refuse_VB and_CC advise_VB against_IN any_DT vaccine_NN that_WDT is_VBZ developed_VBN because_IN “_`` I_PRP know_VBP it_PRP would_MD not_RB work_VB ,_, that_IN it_PRP would_MD be_VB dangerous_JJ and_CC not_RB tested_VBN at_IN all_DT ,_, ”_'' she_PRP said_VBD ,_, claiming_VBG that_IN some_DT vaccine_NN trials_NNS skipped_VBD completing_VBG animal_NN tests_NNS before_IN being_VBG given_VBN to_IN people_NNS ._. Werbrègue_NNP does_VBZ n’t_RB believe_VB the_DT world_NN is_VBZ going_VBG through_IN a_DT pandemic_NN ._. “_`` It_PRP ’s_VBZ a_DT type_NN of_IN flu_NN ,_, like_IN the_DT others_NNS ,_, ”_'' she_PRP said_VBD ,_, adding_VBG that_IN numbers_NNS are_VBP manipulated_VBN to_TO scare_VB people_NNS for_IN political_JJ and_CC financial_JJ purposes_NNS ._. Social_JJ media_NN is_VBZ rife_JJ with_IN theories_NNS that_IN international_JJ groups_NNS created_VBD the_DT virus_NN to_TO get_VB people_NNS vaccinated_VBN ,_, implicating_VBG the_DT World_NNP Health_NNP Organization_NNP and_CC Bill_NNP Gates_NNP as_IN the_DT main_JJ suspects_NNS ,_, given_VBN the_DT substantial_JJ funding_NN the_DT latter_NN ’s_POS foundation_NN provides_VBZ to_IN the_DT former_JJ ._. ""_`` It_PRP 's_VBZ confounding_VBG when_WRB you_PRP see_VBP that_DT out_RB there_RB ,_, ""_'' Melinda_NNP Gates_NNP told_VBD POLITICO_NNP ._. ""_`` When_WRB there_EX 's_VBZ more_JJR anxiety_NN ,_, and_CC people_NNS have_VBP more_JJR time_NN on_IN their_PRP$ hands_NNS ,_, they_PRP want_VBP to_TO ,_, you_PRP know_VBP ,_, attack_VB someone_NN ._. ”_'' People_NNS are_VBP more_RBR likely_JJ to_TO latch_VB onto_IN conspiracy_NN theories_NNS when_WRB times_NNS are_VBP uncertain_JJ “_'' because_IN they_PRP feed_VBP into_IN a_DT need_NN of_IN control_NN and_CC psychological_JJ certainty_NN ,_, and_CC provide_VBP simple_JJ answers_NNS to_IN complex_JJ questions_NNS ,_, ”_'' said_VBD Sander_NNP van_NNP der_NNP Linden_NNP ,_, a_DT social_JJ psychologist_NN at_IN the_DT University_NNP of_IN Cambridge_NNP ._. But_CC David_NNP Salisbury_NNP ,_, an_DT associate_NN fellow_NN at_IN Chatham_NNP House_NNP ’s_POS global_JJ health_NN program_NN ,_, is_VBZ not_RB convinced_VBN these_DT would_MD deter_VB people_NNS from_IN getting_VBG vaccinated_VBN ,_, because_IN they_PRP understand_VBP the_DT severity_NN of_IN the_DT virus_NN ._. “_`` If_IN their_PRP$ perception_NN of_IN this_DT virus_NN is_VBZ that_IN it_PRP can_MD kill_VB them_PRP or_CC make_VB them_PRP extraordinarily_RB ill_JJ ,_, and_CC the_DT studies_NNS to_TO date_NN show_VBP the_DT vaccine_NN is_VBZ safe_JJ ,_, I_PRP think_VBP it_PRP would_MD be_VB a_DT foolhardy_JJ choice_NN to_TO put_VB yourself_PRP and_CC your_PRP$ family_NN at_IN unnecessary_JJ risk_NN ,_, ”_'' he_PRP said_VBD ._. But_CC conspiracy_NN theory_NN experts_NNS are_VBP not_RB so_RB sure_JJ ._. Stephan_NNP Lewandowsky_NNP ,_, a_DT cognitive_JJ psychology_NN professor_NN at_IN the_DT University_NNP of_IN Bristol_NNP ,_, said_VBD there_EX is_VBZ a_DT clear_JJ link_NN between_IN conspiracy_NN theorists_NNS and_CC anti-vaxxers_NNS ._. “_`` My_PRP$ best_JJS guess_NN is_VBZ that_IN in_IN Europe_NNP ,_, most_JJS people_NNS will_MD be_VB delighted_VBN by_IN the_DT availability_NN of_IN the_DT vaccine_NN and_CC will_MD line_VB up_RP to_TO get_VB it_PRP so_RB life_NN can_MD return_VB to_IN normal_JJ ,_, ”_'' Lewandowsky_NNP said_VBD ,_, but_CC “_`` we_PRP can_MD not_RB be_VB sure_JJ until_IN the_DT vaccination_NN arrives_VBZ on_IN the_DT scene_NN ._. ”_'' “_`` You_PRP 're_VBP always_RB going_VBG to_TO have_VB this_DT kind_NN of_IN alternative_JJ thinkers_NNS at_IN the_DT edges_NNS ,_, and_CC we_PRP have_VBP them_PRP in_IN general_JJ ,_, with_IN vaccines_NNS ,_, ”_'' said_VBD Larson_NNP at_IN the_DT Vaccine_NNP Confidence_NNP Project_NNP ._. But_CC there_EX are_VBP also_RB many_JJ who_WP do_VBP n’t_RB believe_VB in_IN conspiracy_NN theories_NNS ,_, but_CC have_VBP safety_NN concerns_NNS and_CC think_VBP the_DT decisions_NNS about_IN vaccination_NN are_VBP top_JJ -_HYPH down_RB ,_, without_IN giving_VBG them_PRP a_DT say_NN in_IN the_DT matter_NN ._. “_`` Parents_NNS feel_VBP like_IN they_PRP just_RB want_VBP to_TO ask_VB some_DT basic_JJ legitimate_JJ questions_NNS and_CC ,_, you_PRP know_VBP ,_, they_PRP 're_VBP being_VBG either_CC judged_VBN or_CC shunned_VBN ,_, ”_'' she_PRP said_VBD ._. Larson_NNP has_VBZ written_VBN a_DT book_NN –_: called_VBN ""_`` Stuck_JJ ""_'' —_: about_IN the_DT issue_NN ,_, expected_VBN to_TO be_VB published_VBN this_DT summer_NN ._. “_`` One_CD of_IN my_PRP$ points_NNS is_VBZ that_IN we_PRP do_VBP n’t_RB have_VB a_DT misinformation_NN problem_NN ,_, we_PRP have_VBP a_DT relationship_NN problem_NN ,_, ”_'' she_PRP said_VBD ._. Misinformation_NN can_MD be_VB deleted_VBN ,_, but_CC the_DT underlying_JJ distrust_NN that_WDT has_VBZ caused_VBN it_PRP remains_VBZ ,_, she_PRP said_VBD ._. Italy_NNP is_VBZ one_CD of_IN the_DT countries_NNS that_WDT has_VBZ struggled_VBN with_IN that_DT and_CC in_IN 2017_CD introduced_VBD a_DT law_NN that_WDT increased_VBD the_DT number_NN of_IN mandatory_JJ vaccines_NNS to_IN 10_CD ,_, mainly_RB in_IN response_NN to_IN a_DT measles_NN outbreak_NN ._. The_DT issue_NN has_VBZ become_VBN highly_RB political_JJ ,_, playing_VBG out_RP in_IN the_DT last_JJ round_NN of_IN elections_NNS ._. As_IN the_DT country_NN cautiously_RB emerges_VBZ from_IN the_DT first_JJ wave_NN of_IN the_DT pandemic_NN ,_, the_DT debate_NN on_IN mandatory_JJ vaccination_NN is_VBZ certain_JJ to_TO be_VB a_DT heated_VBN one_NN ._. The_DT government_NN is_VBZ made_VBN up_RP of_IN a_DT coalition_NN between_IN the_DT 5Star_NNP Movement_NNP ,_, which_WDT has_VBZ long_RB led_VBN a_DT battle_NN against_IN the_DT obligation_NN to_TO vaccinate_VB ,_, and_CC the_DT center_NN -_HYPH left_VBN Democratic_NNP Party_NNP ,_, which_WDT increased_VBD the_DT number_NN of_IN mandatory_JJ vaccinations_NNS when_WRB in_IN power_NN in_IN 2017_CD ._. Health_NN ministry_NN officials_NNS said_VBD Health_NNP Minister_NNP Roberto_NNP Speranza_NNP ,_, from_IN the_DT minority_NN left_JJ -_HYPH wing_NN LeU_NNP party_NN ,_, is_VBZ favorable_JJ to_IN a_DT legal_JJ obligation_NN to_TO vaccinate_VB for_IN the_DT elderly_NN and_CC those_DT with_IN pre-existing_VBG conditions_NNS ,_, when_WRB a_DT vaccine_NN comes_VBZ to_IN the_DT market_NN ._. Pierpaolo_NNP Sileri_NNP of_IN the_DT 5Stars_NNPS ,_, deputy_NN health_NN minister_NN and_CC recovering_VBG coronavirus_NN patient_NN ,_, said_VBD that_IN he_PRP had_VBD “_`` no_DT doubt_NN that_IN such_PDT a_DT vaccine_NN should_MD be_VB mandatory_JJ ,_, ”_'' according_VBG to_IN La_NNP Repubblica_NNP ._. But_CC not_RB everyone_NN agrees_VBZ ._. Davide_NNP Barillari_NNP ,_, a_DT regional_JJ councilor_NN in_IN Lazio_NNP ,_, thinks_VBZ a_DT vaccine_NN is_VBZ not_RB the_DT right_JJ way_NN to_TO go_VB in_IN this_DT epidemic_NN ._. “_`` There_EX is_VBZ no_DT guarantee_NN that_IN the_DT vaccine_NN is_VBZ safe_JJ and_CC reliable_JJ ,_, and_CC the_DT obligation_NN is_VBZ not_RB the_DT correct_JJ solution_NN ,_, ”_'' he_PRP told_VBD POLITICO_NNP ._. “_`` The_DT obligation_NN seems_VBZ an_DT authoritarian_JJ response_NN to_IN a_DT need_NN for_IN security_NN that_WDT can_MD be_VB guaranteed_VBN in_IN other_JJ ways_NNS ._. ”_'' Elected_VBN for_IN the_DT 5Stars_NNPS ,_, Barillari_NNP was_VBD expelled_VBN from_IN the_DT movement_NN in_IN April_NNP for_IN launching_VBG a_DT website_NN giving_VBG information_NN on_IN the_DT coronavirus_NN not_RB endorsed_VBN by_IN the_DT party_NN ._. Larson_NNP warned_VBD that_IN how_WRB public_JJ health_NN authorities_NNS act_VBP in_IN this_DT pandemic_NN is_VBZ crucial_JJ ,_, not_RB just_RB in_IN stopping_VBG it_PRP ,_, but_CC in_IN gaining_VBG —_: or_CC further_RB losing_VBG —_: people_NNS ’s_POS trust_NN ._. Since_IN “_`` we_PRP ’re_VBP not_RB going_VBG to_TO have_VB the_DT vaccine_NN for_IN a_DT while_NN ,_, ”_'' it_PRP ’s_VBZ a_DT good_JJ time_NN to_TO start_VB consulting_VBG with_IN the_DT people_NNS on_IN how_WRB to_TO go_VB about_IN it_PRP ,_, she_PRP said_VBD ._. “_`` Either_CC it_PRP could_MD be_VB used_VBN as_IN a_DT trust_NN -_HYPH building_NN [_-LRB- time_NN ]_-RRB- ,_, or_CC it_PRP can_MD add_VB to_IN the_DT litany_NN of_IN historical_JJ events_NNS where_WRB they_PRP felt_VBD betrayed_VBN or_CC left_VBN out_RP or_CC excluded_VBN ,_, which_WDT adds_VBZ up_RP to_IN some_DT of_IN the_DT contemporary_JJ distrust_NN ,_, ”_'' she_PRP said_VBD ._. This_DT article_NN is_VBZ part_NN of_IN POLITICO_NNP ’s_POS premium_JJ policy_NN service_NN :_: Pro_NNP Health_NNP Care_NNP ._. From_IN drug_NN pricing_NN ,_, EMA_NN ,_, vaccines_NNS ,_, pharma_NN and_CC more_JJR ,_, our_PRP$ specialized_JJ journalists_NNS keep_VBP you_PRP on_IN top_NN of_IN the_DT topics_NNS driving_VBG the_DT health_NN care_NN policy_NN agenda_NN ._. Email_NN [_-LRB- email_NN protected_VBN ]_-RRB- for_IN a_DT complimentary_JJ trial_NN ._.","The JJ NNS of a NN VBG VBN by the NNP NNP NNP — which VBZ JJ NN in NN NNS RB — and NNP NNP VBP that between NNP and NNP of this NN , one NN of JJ NNS and 18 NN of those in NNP would VB a NN NN . Among NNPS , the NN VBZ 16 NN , and 9 NN in NNP . While this may RB VB JJ to VB NNS to VB RB - VBN NN NN — VBN at 60 to 70 NN — JJ NNS VBP RB RB RB how NN NN can VB JJ NN NNS , as JJ NNS VBP VBN . On one NN , a NN VBZ to VB when the NN of NN VBZ RB JJ , but if it VBZ RB RB , NNS may RB VB that it VBZ JJ . JJ NNP NNP NNP NNP RBR this NN VBD the NN that a JJ NN may VB VBN JJ in the NN , VBG a NN of NNS would VB to VB VBN RB RB as it VBD JJ . That VBZ RB VB the NN 's JJ - VBN NN NN NNP NNP , who VBZ NN and VBD he would VB to VB a NN if VBG to NNS VBZ JJ on VBG VBN , VBG to the NNP . When it VBZ to JJ NNS 's NN for it , NN VBZ of the NN , VBD NNP NNP , NN of the NNP NNP NNP . “ If they VBP there VBZ RB a NN — the JJ NN RB — they VBP VBG to VB RBR JJ to it , ” she VBD . But if that VBZ to VB VBG , they may RB VB to VB the NN of a JJ NN that we VBP RB VB RB about , she VBD . In the NNP , 7 NN of those VBN — JJ of the NN 's NN , VBG to NNP — VBD in NNP they would VB to VB VBN against NN . When the NN of NNS VBD two NNS RBR , that NN VBD to 5 NN . "" RB that they VBP the NNS VBP VBG down , it VBZ up to 9 NN VBG they would VB , "" NNP VBD . NNP NNP , NN of NNP NNP NNPS and NNPS NNP at the NNP NNPS NNP , VBZ RB JJ of the NN VBG NN - NNS in VBG out a NN and VBG JJ it VBZ JJ . “ We VBP to VB JJ that this NN - NN VBZ RB VBG the NN that we VBP to VB around the NN of the NN , ” he VBD NNS NNP . For that , the NNP ’s NN NN VBZ to VB with NN NNS to VB what NN of NN they can VB in the JJS JJ NN , while VBG JJ NN that these NNS VBP JJ and JJ , he VBD . But that will RB VB JJ to VB NNP NNP , NN of the NN NN NNP NNP NNP . She would VB and VB against any NN that VBZ VBN because “ I VBP it would RB VB , that it would VB JJ and RB VBN at all , ” she VBD , VBG that some NN NNS VBD VBG NN NNS before VBG VBN to NNS . NNP VBZ RB VB the NN VBZ VBG through a NN . “ It VBZ a NN of NN , like the NNS , ” she VBD , VBG that NNS VBP VBN to VB NNS for JJ and JJ NNS . JJ NN VBZ JJ with NNS that JJ NNS VBD the NN to VB NNS VBN , VBG the NNP NNP NNP and NNP NNP as the JJ NNS , VBN the JJ NN the NN ’s NN VBZ to the JJ . "" It VBZ VBG when you VBP that RB RB , "" NNP NNP VBD NNP . "" When there VBZ JJR NN , and NNS VBP JJR NN on their NNS , they VBP to , you VBP , VB NN . ” NNS VBP RBR JJ to VB onto NN NNS when NNS VBP JJ “ because they VBP into a NN of NN and JJ NN , and VBP JJ NNS to JJ NNS , ” VBD NNP NNP NNP NNP , a JJ NN at the NNP of NNP . But NNP NNP , an NN NN at NNP NNP ’s JJ NN NN , VBZ RB VBN these would VB NNS from VBG VBN , because they VBP the NN of the NN . “ If their NN of this NN VBZ that it can VB them or VB them RB JJ , and the NNS to NN VBP the NN VBZ JJ , I VBP it would VB a JJ NN to VB yourself and your NN at JJ NN , ” he VBD . But NN NN NNS VBP RB RB JJ . NNP NNP , a JJ NN NN at the NNP of NNP , VBD there VBZ a JJ NN between NN NNS and NNS . “ My JJS NN VBZ that in NNP , JJS NNS will VB VBN by the NN of the NN and will VB up to VB it RB NN can VB to JJ , ” NNP VBD , but “ we can RB VB JJ until the NN VBZ on the NN . ” “ You VBP RB VBG to VB this NN of JJ NNS at the NNS , and we VBP them in JJ , with NNS , ” VBD NNP at the NNP NNP NNP . But there VBP RB JJ who VBP RB VB in NN NNS , but VBP NN NNS and VBP the NNS about NN VBP JJ - RB , without VBG them a NN in the NN . “ NNS VBP like they RB VBP to VB some JJ JJ NNS and , you VBP , they VBP VBG either VBN or VBN , ” she VBD . NNP VBZ VBN a NN – VBN "" JJ "" — about the NN , VBN to VB VBN this NN . “ One of my NNS VBZ that we VBP RB VB a NN NN , we VBP a NN NN , ” she VBD . NN can VB VBN , but the JJ NN that VBZ VBN it VBZ , she VBD . NNP VBZ one of the NNS that VBZ VBN with that and in 2017 VBD a NN that VBD the NN of JJ NNS to 10 , RB in NN to a NN NN . The NN VBZ VBN RB JJ , VBG out in the JJ NN of NNS . As the NN RB VBZ from the JJ NN of the NN , the NN on JJ NN VBZ JJ to VB a VBN NN . The NN VBZ VBN up of a NN between the NNP NNP , which VBZ RB VBN a NN against the NN to VB , and the NN - VBN NNP NNP , which VBD the NN of JJ NNS when in NN in 2017 . NN NN NNS VBD NNP NNP NNP NNP , from the NN JJ - NN NNP NN , VBZ JJ to a JJ NN to VB for the NN and those with VBG NNS , when a NN VBZ to the NN . NNP NNP of the NNPS , NN NN NN and VBG NN NN , VBD that he VBD “ no NN that such a NN should VB JJ , ” VBG to NNP NNP . But RB NN VBZ . NNP NNP , a JJ NN in NNP , VBZ a NN VBZ RB the JJ NN to VB in this NN . “ There VBZ no NN that the NN VBZ JJ and JJ , and the NN VBZ RB the JJ NN , ” he VBD NNP . “ The NN VBZ an JJ NN to a NN for NN that can VB VBN in JJ NNS . ” VBN for the NNPS , NNP VBD VBN from the NN in NNP for VBG a NN VBG NN on the NN RB VBN by the NN . NNP VBD that how JJ NN NNS VBP in this NN VBZ JJ , RB RB in VBG it , but in VBG — or RB VBG — NNS ’s NN . Since “ we VBP RB VBG to VB the NN for a NN , ” it VBZ a JJ NN to VB VBG with the NNS on how to VB about it , she VBD . “ Either it could VB VBN as a NN - NN [ NN ] , or it can VB to the NN of JJ NNS where they VBD VBN or VBN out or VBN , which VBZ up to some of the JJ NN , ” she VBD . This NN VBZ NN of NNP ’s JJ NN NN : NNP NNP NNP . From NN NN , NN , NNS , NN and JJR , our JJ NNS VBP you on NN of the NNS VBG the NN NN NN NN . NN [ NN VBN ] for a JJ NN ."
76,447,mainstream,"Some_DT of_IN the_DT questions_NNS about_IN who_WP gets_VBZ vaccinated_VBN first_RB will_MD be_VB answered_VBN by_IN whichever_WDT vaccine_NN succeeds_VBZ first_RB ._. The_DT Moderna_NNP candidate_NN that_WDT is_VBZ racing_VBG into_IN Phase_NNP II_CD and_CC III_CD trials_NNS after_IN promising_VBG early_JJ data_NNS has_VBZ so_RB far_RB only_RB been_VBN studied_VBN in_IN people_NNS over_RB 18_CD years_NNS old_JJ ._. Without_IN trials_NNS in_IN children_NNS at_IN some_DT point_NN ,_, it_PRP would_MD not_RB be_VB authorized_VBN for_IN pediatric_JJ use_NN ._. Vaccines_NNS can_MD sometimes_RB be_VB risky_JJ to_TO administer_VB to_IN the_DT elderly_JJ and_CC others_NNS with_IN weakened_VBN immune_NN systems_NNS because_IN they_PRP might_MD not_RB mount_VB an_DT effective_JJ immune_JJ response_NN —_: and_CC some_DT might_MD become_VB sicker_JJR if_IN they_PRP then_RB got_VBD the_DT virus_NN than_IN they_PRP would_MD have_VB without_IN the_DT shot_NN ._. These_DT potential_JJ dangers_NNS are_VBP usually_RB identified_VBN during_IN late_JJ -_HYPH stage_NN clinical_JJ studies_NNS that_WDT have_VBP not_RB been_VBN completed_VBN for_IN any_DT experimental_JJ coronavirus_NN vaccine_NN ._. Even_RB if_IN an_DT eventual_JJ vaccine_NN does_VBZ not_RB pose_VB special_JJ risk_NN to_IN older_JJR people_NNS ,_, it_PRP may_MD make_VB more_JJR sense_NN to_TO prioritize_VB vaccinating_VBG people_NNS who_WP interact_VBP with_IN the_DT elderly_NN ,_, said_VBD Paul_NNP Offit_NNP ,_, director_NN of_IN the_DT Vaccine_NNP Education_NNP Center_NNP at_IN Children_NNP ’s_POS Hospital_NNP of_IN Philadelphia_NNP ._. In_IN pandemic_NN fiction_NN like_IN the_DT popular_JJ movie_NN ""_`` Contagion_NNP ,_, ""_'' the_DT vaccine_NN is_VBZ the_DT hero_NN ,_, says_VBZ Offit_NNP ._. But_CC in_IN reality_NN ,_, “_`` it_PRP ’s_VBZ never_RB that_RB clean_JJ ”_'' —_: especially_RB when_WRB candidates_NNS are_VBP hurtling_VBG through_IN trials_NNS at_IN a_DT record_NN -_HYPH breaking_NN speed_NN ._. “_`` Because_IN you_PRP ’re_VBP making_VBG this_DT in_IN a_DT ‘_`` break_VB the_DT glass_NN ’_POS mentality_NN ,_, you_PRP are_VBP making_VBG it_PRP very_RB quickly_RB ,_, you_PRP ’re_VBP going_VBG to_TO find_VB things_NNS out_RP later_RBR that_IN you_PRP did_VBD n’t_RB know_VB ,_, ”_'' Offit_NNP said_VBD ._. These_DT include_VBP possible_JJ safety_NN concerns_NNS or_CC how_WRB long_RB a_DT vaccine_NN lasts_VBZ or_CC which_WDT groups_NNS have_VBP the_DT best_JJS immune_JJ response_NN ._. “_`` And_CC vaccine_NN confidence_NN in_IN this_DT country_NN ,_, and_CC the_DT world_NN ,_, is_VBZ already_RB fragile_JJ ._. ”_'' There_EX will_MD most_RBS certainly_RB be_VB a_DT need_NN for_IN multiple_JJ vaccines_NNS ,_, even_RB if_IN Moderna_NNP can_MD bring_VB its_PRP$ candidate_NN to_IN market_NN quickly_RB ._. Dozens_NNS of_IN potential_JJ vaccines_NNS are_VBP in_IN the_DT pipeline_NN —_: many_JJ of_IN which_WDT are_VBP being_VBG developed_VBN by_IN scientists_NNS in_IN China_NNP and_CC European_JJ countries_NNS ._. Trump_NNP and_CC his_PRP$ officials_NNS —_: including_VBG the_DT newly_RB tapped_VBN vaccine_NN czar_NN Slaoui_NNP ,_, GlaxoSmithKline_NNP ’s_POS former_JJ vaccine_NN chief_NN —_: have_VBP said_VBN the_DT government_NN is_VBZ evaluating_VBG 14_CD candidates_NNS ._. While_IN the_DT president_NN has_VBZ said_VBN a_DT vaccine_NN could_MD be_VB ready_JJ before_IN the_DT end_NN of_IN the_DT year_NN ,_, others_NNS ,_, such_JJ as_IN HHS_NNP Secretary_NNP Alex_NNP Azar_NNP ,_, have_VBP suggested_VBN that_DT would_MD not_RB happen_VB before_IN January_NNP 2021_CD ._. Anthony_NNP Fauci_NNP ,_, director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, has_VBZ stressed_VBN that_IN the_DT government_NN ’s_POS timeline_NN assumes_VBZ everything_NN goes_VBZ perfectly_RB as_IN manufacturers_NNS forge_VBP on_RP into_IN increasingly_RB large_JJ and_CC complex_JJ trials_NNS ._. Unlike_IN the_DT handful_NN of_IN swine_NN flu_NN vaccines_NNS in_IN 2009_CD —_: built_VBN using_VBG the_DT foundations_NNS developed_VBN for_IN annual_JJ flu_NN shots_NNS —_: there_EX has_VBZ never_RB before_RB been_VBN a_DT vaccine_NN for_IN any_DT coronavirus_NN ._. “_`` It_PRP was_VBD n’t_RB easy_JJ in_IN 2009_CD and_CC they_PRP had_VBD an_DT easier_JJR task_NN ._. You_PRP knew_VBD all_PDT these_DT things_NNS that_WDT you_PRP do_VBP not_RB know_VB right_RB now_RB about_IN coronavirus_NN ,_, ”_'' said_VBD Ostroff_NNP ._. There_EX have_VBP also_RB been_VBN notable_JJ shifts_NNS in_IN vaccine_NN manufacturing_NN since_IN the_DT swine_NN flu_NN epidemic_NN ._. A_DT central_JJ allegation_NN of_IN the_DT anti-vaccination_NN movement_NN is_VBZ that_IN the_DT preservatives_NNS used_VBN to_TO make_VB multidose_JJ vials_NNS work_VB —_: so_IN that_IN several_JJ people_NNS can_MD receive_VB a_DT vaccine_NN from_IN the_DT same_JJ vial_NN —_: are_VBP dangerous_JJ ._. There_EX is_VBZ not_RB evidence_NN that_IN that_DT is_VBZ the_DT case_NN ,_, but_CC manufacturers_NNS have_VBP drifted_VBN away_RB from_IN multidose_JJ vials_NNS all_PDT the_DT same_JJ ._. Ostroff_NNP recalls_VBZ some_DT days_NNS during_IN the_DT swine_NN flu_NN outbreak_NN where_WRB the_DT multidose_JJ options_NNS were_VBD all_DT that_WDT was_VBD available_JJ —_: and_CC people_NNS against_IN vaccinations_NNS refused_VBD to_TO get_VB them_PRP ._.","Some of the NNS about who VBZ VBN RB will VB VBN by whichever NN VBZ RB . The NNP NN that VBZ VBG into NNP II and III NNS after VBG JJ NNS VBZ RB RB RB VBN VBN in NNS RB 18 NNS JJ . Without NNS in NNS at some NN , it would RB VB VBN for JJ NN . NNS can RB VB JJ to VB to the JJ and NNS with VBN NN NNS because they might RB VB an JJ JJ NN — and some might VB JJR if they RB VBD the NN than they would VB without the NN . These JJ NNS VBP RB VBN during JJ - NN JJ NNS that VBP RB VBN VBN for any JJ NN NN . RB if an JJ NN VBZ RB VB JJ NN to JJR NNS , it may VB JJR NN to VB VBG NNS who VBP with the NN , VBD NNP NNP , NN of the NNP NNP NNP at NNP ’s NNP of NNP . In NN NN like the JJ NN "" NNP , "" the NN VBZ the NN , VBZ NNP . But in NN , “ it VBZ RB RB JJ ” — RB when NNS VBP VBG through NNS at a NN - NN NN . “ Because you VBP VBG this in a ‘ VB the NN ’ NN , you VBP VBG it RB RB , you VBP VBG to VB NNS out RBR that you VBD RB VB , ” NNP VBD . These VBP JJ NN NNS or how RB a NN VBZ or which NNS VBP the JJS JJ NN . “ And NN NN in this NN , and the NN , VBZ RB JJ . ” There will RBS RB VB a NN for JJ NNS , RB if NNP can VB its NN to NN RB . NNS of JJ NNS VBP in the NN — JJ of which VBP VBG VBN by NNS in NNP and JJ NNS . NNP and his NNS — VBG the RB VBN NN NN NNP , NNP ’s JJ NN NN — VBP VBN the NN VBZ VBG 14 NNS . While the NN VBZ VBN a NN could VB JJ before the NN of the NN , NNS , JJ as NNP NNP NNP NNP , VBP VBN that would RB VB before NNP 2021 . NNP NNP , NN of the NNP NNP of NNP and NNP NNPS , VBZ VBN that the NN ’s NN VBZ NN VBZ RB as NNS VBP on into RB JJ and JJ NNS . Unlike the NN of NN NN NNS in 2009 — VBN VBG the NNS VBN for JJ NN NNS — there VBZ RB RB VBN a NN for any NN . “ It VBD RB JJ in 2009 and they VBD an JJR NN . You VBD all these NNS that you VBP RB VB RB RB about NN , ” VBD NNP . There VBP RB VBN JJ NNS in NN NN since the NN NN NN . A JJ NN of the NN NN VBZ that the NNS VBN to VB JJ NNS VB — so that JJ NNS can VB a NN from the JJ NN — VBP JJ . There VBZ RB NN that that VBZ the NN , but NNS VBP VBN RB from JJ NNS all the JJ . NNP VBZ some NNS during the NN NN NN where the JJ NNS VBD all that VBD JJ — and NNS against NNS VBD to VB them ."
77,1010,mainstream,"Research_NN that_IN further_JJ debunks_VBZ any_DT link_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN has_VBZ been_VBN published_VBN ._. The_DT new_JJ reassurrance_NN comes_VBZ as_IN countries_NNS such_JJ as_IN Britain_NNP and_CC the_DT United_NNP States_NNPS are_VBP experiencing_VBG a_DT surge_NN in_IN measles_NNS cases_NNS as_IN parents_NNS leave_VBP their_PRP$ children_NNS unvaccinated_JJ ._. Years_NNS of_IN research_NN with_IN the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN ,_, better_RBR known_VBN as_IN MMR_NNP ,_, have_VBP concluded_VBN that_IN it_PRP does_VBZ not_RB cause_VB autism_NN ._. Still_RB ,_, some_DT parents_NNS '_POS fears_NNS persist_VBP ,_, in_IN part_NN because_IN of_IN one_CD 1998_CD study_NN that_WDT linked_VBD the_DT vaccine_NN with_IN a_DT subgroup_NN of_IN autistic_JJ children_NNS who_WP also_RB have_VBP serious_JJ gastrointestinal_JJ problems_NNS ._. Now_RB researchers_NNS have_VBP at_IN last_RB rigorously_RB replicated_VBN the_DT study_NN by_IN Dr_NNP Andrew_NNP Wakefield_NNP ,_, then_RB of_IN the_DT Royal_NNP Free_NNP Hospital_NNP ,_, that_WDT caused_VBD the_DT furore_NN ,_, by_IN taking_VBG samples_NNS of_IN youngsters_NNS '_POS intestines_NNS to_TO hunt_VB for_IN signs_NNS of_IN virus_NN with_IN the_DT latest_JJS genetic_JJ technology_NN ._. There_EX is_VBZ no_DT evidence_NN that_IN MMR_NNP plays_VBZ any_DT role_NN ,_, concludes_VBZ the_DT international_JJ team_NN -_, which_WDT included_VBD some_DT of_IN the_DT researchers_NNS who_WP first_RB raised_VBD the_DT issue_NN in_IN The_DT Lancet_NNP ._. ""_`` We_PRP are_VBP confident_JJ there_EX is_VBZ no_DT link_NN between_IN MMR_NN and_CC autism_NN ,_, ""_'' said_VBD Prof_NNP Ian_NNP Lipkin_NNP of_IN Columbia_NNP University_NNP New_NNP York_NNP ,_, who_WP led_VBD the_DT work_NN ,_, published_VBN in_IN PLoS_NNP One_CD ._. No_DT one_NN knows_VBZ just_RB how_WRB many_JJ autism_NN patients_NNS also_RB suffer_VBP gastrointestinal_JJ disorders_NNS but_CC by_IN some_DT estimates_NNS ,_, up_IN to_IN a_DT quarter_NN may_MD be_VB affected_VBN ._. The_DT fear_NN about_IN MMR_NNP was_VBD that_IN the_DT vaccine_NN 's_POS weakened_VBN measles_NN virus_NN somehow_RB inflamed_VBD intestines_NNS ,_, allowing_VBG waste_NN products_NNS to_TO escape_VB and_CC reach_VB the_DT central_JJ nervous_JJ system_NN ,_, Prof_NNP Lipkin_NNP said_VBD ._. So_RB his_PRP$ team_NN had_VBD two_CD questions_NNS :_: Does_VBZ measles_NNS virus_NN really_RB persist_VB in_IN children_NNS with_IN both_CC disorders_NNS and_CC not_RB other_JJ youngsters_NNS ?_. And_CC did_VBD vaccination_NN precede_VB the_DT gastro_NN intestinal_NN complaints_NNS which_WDT in_IN turn_NN preceded_VBD autism_NN ?_. The_DT team_NN studied_VBD 25_CD children_NNS with_IN both_CC autism_NN and_CC gut_NN disorders_NNS ,_, and_CC another_DT 13_CD children_NNS with_IN the_DT same_JJ disorders_NNS but_CC no_DT neurological_JJ problems_NNS ._. The_DT children_NNS -_, the_DT average_JJ age_NN was_VBD five_CD -_HYPH all_DT were_VBD undergoing_VBG colonoscopies_NNS for_IN their_PRP$ conditions_NNS anyway_RB ,_, allowing_VBG tissue_NN samples_NNS to_TO be_VB tested_VBN for_IN genetic_JJ traces_NNS of_IN measles_NN virus_NN ._. All_DT had_VBD been_VBN vaccinated_VBN at_IN younger_JJR ages_NNS ._. The_DT samples_NNS were_VBD analysed_VBN in_IN three_CD laboratories_NNS that_WDT were_VBD not_RB told_VBN which_WDT came_VBD from_IN the_DT children_NNS with_IN autism_NN ._. One_CD of_IN the_DT labs_NNS had_VBD been_VBN involved_VBN in_IN the_DT original_JJ study_NN suggesting_VBG a_DT link_NN between_IN measles_NN virus_NN and_CC autism_NN ._. ""_`` We_PRP found_VBD no_DT difference_NN in_IN children_NNS who_WP had_VBD GI_NN complaints_NNS and_CC no_DT autism_NN and_CC children_NNS who_WP had_VBD autism_NN but_CC no_DT GI_NN complaints_NNS ,_, ""_'' said_VBD Prof_NNP Lipkin_NNP ._. ""_`` We_PRP found_VBD no_DT relationship_NN between_IN the_DT timing_NN of_IN MMR_NN vaccine_NN and_CC the_DT onset_NN of_IN either_CC GI_NN complaints_NNS or_CC autism_NN ,_, ""_'' added_VBD first_JJ author_NN Dr_NNP Mady_NNP Hornig_NNP ,_, also_RB of_IN Columbia_NNP ._. Dr_NNP Larry_NNP Pickering_NNP of_IN the_DT US_NNP Centres_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP in_IN Atlanta_NNP added_VBD :_: ""_`` I_PRP feel_VBP very_RB certain_JJ that_IN it_PRP is_VBZ a_DT safe_JJ vaccine_NN ._. ""_'' Growing_VBG fears_NNS of_IN an_DT epidemic_NN of_IN measles_NNS ,_, which_WDT can_MD be_VB fatal_JJ ,_, prompted_VBD the_DT UK_NNP government_NN to_TO launch_VB a_DT campaign_NN a_DT few_JJ weeks_NNS ago_RB to_TO try_VB to_TO make_VB sure_JJ that_IN every_DT child_NN in_IN England_NNP is_VBZ given_VBN the_DT MMR_NN vaccine_NN ,_, since_IN around_RB three_CD million_CD children_NNS aged_JJ 18_CD months_NNS to_IN 18_CD years_NNS have_VBP missed_VBN either_CC their_PRP$ first_JJ or_CC second_JJ MMR_NN vaccination_NN ._. ._.","NN that JJ VBZ any NN between the NN NN and NN VBZ VBN VBN . The JJ NN VBZ as NNS JJ as NNP and the NNP NNPS VBP VBG a NN in NNS NNS as NNS VBP their NNS JJ . NNS of NN with the NNS , NNS and NN NN , RBR VBN as NNP , VBP VBN that it VBZ RB VB NN . RB , some NNS ' NNS VBP , in NN because of one 1998 NN that VBD the NN with a NN of JJ NNS who RB VBP JJ JJ NNS . RB NNS VBP at RB RB VBN the NN by NNP NNP NNP , RB of the NNP NNP NNP , that VBD the NN , by VBG NNS of NNS ' NNS to VB for NNS of NN with the JJS JJ NN . There VBZ no NN that NNP VBZ any NN , VBZ the JJ NN - which VBD some of the NNS who RB VBD the NN in The NNP . "" We VBP JJ there VBZ no NN between NN and NN , "" VBD NNP NNP NNP of NNP NNP NNP NNP , who VBD the NN , VBN in NNP One . No NN VBZ RB how JJ NN NNS RB VBP JJ NNS but by some NNS , up to a NN may VB VBN . The NN about NNP VBD that the NN 's VBN NN NN RB VBD NNS , VBG NN NNS to VB and VB the JJ JJ NN , NNP NNP VBD . RB his NN VBD two NNS : VBZ NNS NN RB VB in NNS with both NNS and RB JJ NNS ? And VBD NN VB the NN NN NNS which in NN VBD NN ? The NN VBD 25 NNS with both NN and NN NNS , and another 13 NNS with the JJ NNS but no JJ NNS . The NNS - the JJ NN VBD five - all VBD VBG NNS for their NNS RB , VBG NN NNS to VB VBN for JJ NNS of NN NN . All VBD VBN VBN at JJR NNS . The NNS VBD VBN in three NNS that VBD RB VBN which VBD from the NNS with NN . One of the NNS VBD VBN VBN in the JJ NN VBG a NN between NN NN and NN . "" We VBD no NN in NNS who VBD NN NNS and no NN and NNS who VBD NN but no NN NNS , "" VBD NNP NNP . "" We VBD no NN between the NN of NN NN and the NN of either NN NNS or NN , "" VBD JJ NN NNP NNP NNP , RB of NNP . NNP NNP NNP of the NNP NNPS for NNP NNP and NNP in NNP VBD : "" I VBP RB JJ that it VBZ a JJ NN . "" VBG NNS of an NN of NNS , which can VB JJ , VBD the NNP NN to VB a NN a JJ NNS RB to VB to VB JJ that every NN in NNP VBZ VBN the NN NN , since RB three million NNS JJ 18 NNS to 18 NNS VBP VBN either their JJ or JJ NN NN . ."
78,1127,conspiracy,"Roman_JJ Catholic_NNP Melinda_NNP Gates_NNP in_IN an_DT interview_NN on_IN TODAY_NN Show_VB pushing_VBG hard_RB for_IN a_DT global_JJ COVID_NN -_HYPH 19_CD vaccine_NN was_VBD wearing_VBG a_DT bright_JJ and_CC shiny_JJ upside_NN -_HYPH down_IN cross_NN around_IN her_PRP$ neck_NN ._. Symbolism_NN is_VBZ very_RB important_JJ to_IN groups_NNS like_IN the_DT Illuminati_NNP ,_, the_DT New_NNP World_NNP Order_NNP and_CC others_NNS ,_, as_IN they_PRP love_VBP to_TO flash_VB you_PRP signs_NNS of_IN how_WRB much_JJ smarter_JJR they_PRP are_VBP than_IN you_PRP and_CC I_PRP are_VBP ._. They_PRP like_VBP to_TO put_VB their_PRP$ true_JJ agenda_NN right_RB in_IN our_PRP$ faces_NNS ,_, and_CC dare_VB us_PRP to_TO figure_VB it_PRP out_RP ._. All_PDT this_DT brings_VBZ us_PRP to_IN an_DT interview_NN the_DT TODAY_NN Show_NN did_VBD with_IN Melinda_NNP Gates_NNP back_RB on_IN November_NNP 8th_NN ,_, where_WRB we_PRP see_VBP Melinda_NNP wearing_VBG an_DT upside_NN -_HYPH down_RB ,_, or_CC inverted_VBN ,_, cross_NN around_IN her_PRP$ neck_NN ._. Who_WP likes_VBZ to_TO wear_VB inverted_VBN crosses_NNS ?_. Satanists_NNS ,_, pagans_NNS ,_, witches_NNS ,_, warlocks_NNS ,_, New_JJ Agers_NNPS ,_, most_JJS people_NNS in_IN Hollywood_NNP …_: you_PRP get_VBP the_DT idea_NN ._. “_`` Christ_NNP hath_NN redeemed_VBD us_PRP from_IN the_DT curse_NN of_IN the_DT law_NN ,_, being_VBG made_VBN a_DT curse_NN for_IN us_PRP :_: for_IN it_PRP is_VBZ written_VBN ,_, Cursed_VBN is_VBZ every_DT one_CD that_WDT hangeth_VBP on_IN a_DT tree_NN :_: ”_`` Galatians_NNP 3:13_CD (_-LRB- KJB_NNP )_-RRB- The_DT early_JJ First_JJ Century_NN Christians_NNPS never_RB used_VBD the_DT cross_NN as_IN a_DT sign_NN or_CC symbol_NN for_IN anything_NN ,_, why_WRB ?_. Because_IN it_PRP was_VBD the_DT instrument_NN of_IN the_DT torturous_JJ death_NN of_IN Jesus_NNP of_IN Nazareth_NNP ._. The_DT cross_NN as_IN iconic_JJ symbolism_NN would_MD not_RB appear_VB until_IN biblical_JJ Christianity_NNP was_VBD hijacked_VBN by_IN the_DT Romans_NNPS around_IN 325_CD A.D._NNP From_IN that_DT point_NN on_IN you_PRP see_VBP crosses_NNS on_IN everything_NN as_IN Rome_NNP infused_VBD paganism_NN with_IN Christianity_NNP ._. The_DT bible_NN tells_VBZ us_PRP that_IN the_DT cross_NN is_VBZ the_DT sign_NN of_IN a_DT curse_NN ,_, and_CC cursed_VBN people_NNS hang_VB on_IN them_PRP ._. No_DT one_NN in_IN their_PRP$ right_JJ minds_NNS who_WP believed_VBD the_DT bible_NN would_MD want_VB the_DT sign_NN of_IN a_DT curse_NN hanging_VBG around_IN their_PRP$ own_JJ necks_NNS ,_, much_RB less_RBR wearing_VBG an_DT upside_NN -_HYPH down_RP cross_NN like_IN the_DT pagans_NNS do_VBP ._. I_PRP will_MD let_VB you_PRP make_VB up_RP your_PRP$ own_JJ mind_NN as_IN to_IN why_WRB Melinda_NNP Gates_NNP chose_VBD to_TO wear_VB an_DT upside_NN -_HYPH down_RP cross_NN on_IN national_JJ television_NN ._. I_PRP know_VBP she_PRP went_VBD to_IN Catholic_JJ school_NN ,_, and_CC that_IN she_PRP and_CC Bill_NNP have_VBP raised_VBN their_PRP$ children_NNS as_IN Catholics_NNPS ._. But_CC when_WRB you_PRP look_VBP at_IN the_DT millions_NNS of_IN dollars_NNS they_PRP give_VBP to_IN Planned_VBN Parenthood_NNP an_DT organization_NN that_WDT exists_VBZ to_TO slaughter_VB children_NNS in_IN the_DT womb_NN ,_, exactly_RB what_WDT kind_NN of_IN Catholic_NNP she_PRP is_VBZ gets_VBZ a_DT little_JJ murky_JJ ,_, to_TO say_VB the_DT least_JJS ._. The_DT Roman_NNP Catholic_NNP Church_NNP ,_, what_WP I_PRP like_VBP to_TO call_VB counterfeit_JJ Christianity_NNP ,_, loves_VBZ weird_JJ occult_NN and_CC pagan_JJ symbolism_NN ._. Over_IN the_DT years_NNS we_PRP ’ve_VBP shown_VBN you_PRP the_DT Vatican_NNP Audience_NNP Hall_NNP that_WDT is_VBZ shaped_VBN exactly_RB like_IN a_DT giant_JJ snake_NN and_CC has_VBZ the_DT freakiest_JJS ,_, most_RBS nastiest_JJS statue_NN right_RB behind_IN here_RB the_DT pope_NN sits_VBZ ._. Occult_JJ symbolism_NN pervades_VBZ the_DT Vatican_NNP to_IN a_DT very_RB high_JJ degree_NN ._. Melinda_NNP Gates_NNP is_VBZ a_DT Catholic_NNP ,_, you_PRP do_VBP the_DT math_NN ._. Melinda_NNP Gates_NNP on_IN pandemic_NN :_: ‘_`` We_PRP have_VBP n’t_RB had_VBN leadership_NN at_IN the_DT national_JJ level_NN …_: it_PRP ’s_VBZ chaos_NN ’_'' FROM_IN TODAY_NN :_: As_IN part_NN of_IN our_PRP$ coronavirus_NN series_NN The_DT Search_NN for_IN Solutions_NNS ,_, TODAY_NN ’s_POS Savannah_NNP Guthrie_NNP spoke_VBD exclusively_RB to_IN Melinda_NNP Gates_NNP ,_, who_WP is_VBZ working_VBG to_TO address_VB the_DT pandemic_NN through_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ._. She_PRP says_VBZ there_EX are_VBP “_`` a_DT few_JJ good_JJ candidates_NNS ”_'' for_IN a_DT vaccine_NN and_CC that_IN the_DT U.S._NNP needs_VBZ “_`` to_TO start_VB looking_VBG at_IN a_DT paid_VBN medical_JJ leave_NN policy_NN ”_'' to_TO help_VB workers_NNS on_IN the_DT front_JJ lines_NNS ._. She_PRP also_RB criticizes_VBZ the_DT Trump_NNP administration_NN for_IN its_PRP$ response_NN to_IN the_DT crisis_NN :_: “_`` We_PRP have_VBP n’t_RB had_VBN leadership_NN at_IN the_DT national_JJ level_NN …_: it_PRP ’s_VBZ chaos_NN ._. ”_'' READ_VB MORE_JJR","JJ NNP NNP NNP in an NN on NN VB VBG RB for a JJ NN - 19 NN VBD VBG a JJ and JJ NN - down NN around her NN . NN VBZ RB JJ to NNS like the NNP , the NNP NNP NNP and NNS , as they VBP to VB you NNS of how JJ JJR they VBP than you and I VBP . They VBP to VB their JJ NN RB in our NNS , and VB us to VB it out . All this VBZ us to an NN the NN NN VBD with NNP NNP RB on NNP NN , where we VBP NNP VBG an NN - RB , or VBN , NN around her NN . Who VBZ to VB VBN NNS ? NNS , NNS , NNS , NNS , JJ NNPS , JJS NNS in NNP … you VBP the NN . “ NNP NN VBD us from the NN of the NN , VBG VBN a NN for us : for it VBZ VBN , VBN VBZ every one that VBP on a NN : ” NNP 3:13 ( NNP ) The JJ JJ NN NNPS RB VBD the NN as a NN or NN for NN , why ? Because it VBD the NN of the JJ NN of NNP of NNP . The NN as JJ NN would RB VB until JJ NNP VBD VBN by the NNPS around 325 NNP From that NN on you VBP NNS on NN as NNP VBD NN with NNP . The NN VBZ us that the NN VBZ the NN of a NN , and VBN NNS VB on them . No NN in their JJ NNS who VBD the NN would VB the NN of a NN VBG around their JJ NNS , RB RBR VBG an NN - down NN like the NNS VBP . I will VB you VB up your JJ NN as to why NNP NNP VBD to VB an NN - down NN on JJ NN . I VBP she VBD to JJ NN , and that she and NNP VBP VBN their NNS as NNPS . But when you VBP at the NNS of NNS they VBP to VBN NNP an NN that VBZ to VB NNS in the NN , RB what NN of NNP she VBZ VBZ a JJ JJ , to VB the JJS . The NNP NNP NNP , what I VBP to VB JJ NNP , VBZ JJ NN and JJ NN . Over the NNS we VBP VBN you the NNP NNP NNP that VBZ VBN RB like a JJ NN and VBZ the JJS , RBS JJS NN RB behind RB the NN VBZ . JJ NN VBZ the NNP to a RB JJ NN . NNP NNP VBZ a NNP , you VBP the NN . NNP NNP on NN : ‘ We VBP RB VBN NN at the JJ NN … it VBZ NN ’ FROM NN : As NN of our NN NN The NN for NNS , NN ’s NNP NNP VBD RB to NNP NNP , who VBZ VBG to VB the NN through the NNP and NNP NNP NNP . She VBZ there VBP “ a JJ JJ NNS ” for a NN and that the NNP VBZ “ to VB VBG at a VBN JJ NN NN ” to VB NNS on the JJ NNS . She RB VBZ the NNP NN for its NN to the NN : “ We VBP RB VBN NN at the JJ NN … it VBZ NN . ” VB JJR"
79,881,conspiracy,"This_DT week_NN ,_, Maine_NNP ’s_POS Senate_NNP voted_VBD 18_CD -_SYM 17_CD to_TO remove_VB religious_JJ exemptions_NNS from_IN the_DT state_NN ’s_POS school_NN vaccination_NN law_NN ._. Supporters_NNS of_IN the_DT bill_NN argued_VBD it_PRP was_VBD necessary_JJ because_IN religious_JJ exemptions_NNS put_VBD others_NNS at_IN risk_NN ._. If_IN Gov._NNP Janet_NNP Mills_NNP (_-LRB- D_NNP )_-RRB- signs_VBZ it_PRP into_IN law_NN ,_, Maine_NNP will_MD become_VB the_DT fourth_JJ state_NN (_-LRB- following_VBG California_NNP ,_, Mississippi_NNP and_CC West_NNP Virginia_NNP )_-RRB- to_TO ban_VB all_DT non-medical_JJ exemptions_NNS ._. “_`` Tuesday_NNP ’s_POS vote_NN followed_VBD an_DT impassioned_JJ debate_NN by_IN opponents_NNS ,_, who_WP said_VBD ending_VBG the_DT religious_JJ exemption_NN ,_, as_RB well_RB as_IN a_DT philosophical_JJ exemption_NN ,_, would_MD send_VB thousands_NNS of_IN families_NNS packing_VBG while_IN doing_VBG little_JJ to_TO improve_VB public_JJ health_NN or_CC protect_VB children_NNS from_IN preventable_JJ diseases_NNS ._. The_DT mostly_RB party_NN -_HYPH line_NN vote_NN ,_, with_IN Republicans_NNPS in_IN opposition_NN and_CC Democrats_NNPS favoring_VBG the_DT change_NN ,_, saw_VBD three_CD Democrats_NNPS join_VB Republicans_NNPS in_IN a_DT failed_VBN effort_NN to_TO preserve_VB the_DT religious_JJ exemption_NN ._. But_CC one_CD Democrat_NNP who_WP supported_VBD the_DT exemption_NN in_IN a_DT vote_NN last_JJ week_NN changed_VBD his_PRP$ position_NN Tuesday_NNP ,_, altering_VBG the_DT results_NNS ._. ”_'' 1_LS Maine_NNP has_VBZ one_CD of_IN the_DT lowest_JJS vaccination_NN rates_NNS among_IN children_NNS entering_VBG kindergarten_NN in_IN the_DT nation_NN ;_: for_IN the_DT 2018_CD -_SYM 19_CD school_NN year_NN ,_, 5.6_CD percent_NN of_IN Maine_NNP children_NNS entering_VBG kindergarten_NN had_VBD non-medical_JJ exemptions_NNS ._. Sen_NNP ._. James_NNP Dill_NNP ,_, D_NNP -_HYPH Old_NNP Town_NNP ,_, a_DT scientist_NN who_WP works_VBZ for_IN the_DT University_NNP of_IN Maine_NNP Cooperative_NNP Extension_NNP ,_, said_VBD he_PRP was_VBD willing_JJ to_TO change_VB his_PRP$ position_NN on_IN the_DT bill_NN because_IN he_PRP believed_VBD expanding_VBG categories_NNS of_IN medical_JJ exemptions_NNS would_MD satisfy_VB most_JJS of_IN the_DT concerns_NNS he_PRP and_CC many_JJ others_NNS had_VBD with_IN the_DT immunization_NN requirements_NNS and_CC schedule_NN ._. However_RB ,_, that_DT did_VBD n’t_RB work_VB out_RP too_RB well_RB in_IN California_NNP ._. He_PRP did_VBD say_VB however_RB that_IN “_`` There_EX needs_VBZ to_TO be_VB more_JJR testing_NN of_IN newborns_NNS for_IN known_VBN genetic_JJ or_CC other_JJ disorders_NNS ,_, which_WDT may_MD cause_VB problems_NNS ,_, which_WDT people_NNS then_RB may_MD link_VB to_IN vaccination_NN ._. The_DT tests_NNS all_DT need_VBP to_TO be_VB covered_VBN by_IN insurance_NN ._. ”_'' 1_CD (_-LRB- Also_RB that_IN spacing_NN of_IN vaccines_NNS ,_, per_IN child_NN ,_, was_VBD appropriate_JJ ._. )_-RRB- “_`` Opponents_NNS of_IN the_DT bill_NN said_VBD the_DT relatively_RB small_JJ number_NN of_IN people_NNS taking_VBG a_DT religious_JJ exemption_NN in_IN Maine_NNP has_VBZ had_VBN no_DT statistical_JJ impact_NN on_IN increased_VBN exposure_NN to_IN preventable_JJ diseases_NNS ._. Sen_NNP ._. David_NNP Miramant_NNP ,_, D_NNP -_HYPH Camden_NNP said_VBD many_JJ parents_NNS have_VBP obtained_VBN only_RB partial_JJ exemptions_NNS and_CC do_VBP vaccinate_VB their_PRP$ children_NNS ,_, although_IN they_PRP may_MD opt_VB out_IN of_IN some_DT of_IN the_DT vaccines_NNS or_CC place_VB their_PRP$ children_NNS on_IN a_DT schedule_NN that_WDT is_VBZ not_RB compliant_JJ with_IN the_DT state_NN ’s_POS regulation_NN ._. Miramant_NNP contended_VBD that_IN 97_CD to_IN 98_CD percent_NN of_IN students_NNS in_IN Maine_NNP were_VBD receiving_VBG all_DT or_CC some_DT of_IN their_PRP$ vaccines_NNS ._. ‘_`` We_PRP are_VBP in_IN a_DT range_NN that_WDT should_MD satisfy_VB you_PRP and_CC should_MD not_RB have_VB you_PRP wanting_VBG to_TO take_VB away_RP the_DT choice_NN of_IN the_DT people_NNS ,_, ’_'' he_PRP said_VBD ._. ”_'' 1_LS But_CC in_IN an_DT erosion_NN of_IN religious_JJ freedom_NN and_CC a_DT direct_JJ attack_NN on_IN parental_JJ rights_NNS ,_, the_DT religious_JJ right_NN to_TO choose_VB is_VBZ now_RB gone_VBN ._. Sen_NNP ._. Brad_NNP Farrin_NNP ,_, R_NNP -_HYPH Skowhegan_NNP ,_, said_VBD ,_, “_`` Fundamentally_RB ,_, this_DT vote_NN is_VBZ n’t_RB about_IN public_JJ health_NN –_: it_PRP ’s_VBZ about_IN how_WRB far_RB is_VBZ too_RB far_RB for_IN the_DT government_NN to_TO reach_VB into_IN our_PRP$ personal_JJ lives_NNS ._. A_DT vote_NN against_IN this_DT bill_NN is_VBZ n’t_RB a_DT vote_NN against_IN vaccinations_NNS –_: it_PRP ’s_VBZ a_DT vote_NN in_IN support_NN of_IN parental_JJ choice_NN and_CC religious_JJ freedoms_NNS ._. ”_'' 1_LS Our_PRP$ hearts_NNS go_VBP out_RP to_IN all_PDT the_DT parents_NNS in_IN Maine_NNP forced_VBN with_IN making_VBG next_JJ steps_NNS about_IN what_WP ’s_VBZ best_JJS for_IN their_PRP$ children_NNS ._. We_PRP stand_VBP with_IN you_PRP ._. Copyright_NN 2020_CD –_: permission_NN to_TO reprint_VB fully_RB granted_VBN ,_, WITH_IN links_NNS to_IN original_JJ story_NN","This NN , NNP ’s NNP VBD 18 - 17 to VB JJ NNS from the NN ’s NN NN NN . NNS of the NN VBD it VBD JJ because JJ NNS VBD NNS at NN . If NNP NNP NNP ( NNP ) VBZ it into NN , NNP will VB the JJ NN ( VBG NNP , NNP and NNP NNP ) to VB all JJ NNS . “ NNP ’s NN VBD an JJ NN by NNS , who VBD VBG the JJ NN , RB RB as a JJ NN , would VB NNS of NNS VBG while VBG JJ to VB JJ NN or VB NNS from JJ NNS . The RB NN - NN NN , with NNPS in NN and NNPS VBG the NN , VBD three NNPS VB NNPS in a VBN NN to VB the JJ NN . But one NNP who VBD the NN in a NN JJ NN VBD his NN NNP , VBG the NNS . ” 1 NNP VBZ one of the JJS NN NNS among NNS VBG NN in the NN ; for the 2018 - 19 NN NN , 5.6 NN of NNP NNS VBG NN VBD JJ NNS . NNP . NNP NNP , NNP - NNP NNP , a NN who VBZ for the NNP of NNP NNP NNP , VBD he VBD JJ to VB his NN on the NN because he VBD VBG NNS of JJ NNS would VB JJS of the NNS he and JJ NNS VBD with the NN NNS and NN . RB , that VBD RB VB out RB RB in NNP . He VBD VB RB that “ There VBZ to VB JJR NN of NNS for VBN JJ or JJ NNS , which may VB NNS , which NNS RB may VB to NN . The NNS all VBP to VB VBN by NN . ” 1 ( RB that NN of NNS , per NN , VBD JJ . ) “ NNS of the NN VBD the RB JJ NN of NNS VBG a JJ NN in NNP VBZ VBN no JJ NN on VBN NN to JJ NNS . NNP . NNP NNP , NNP - NNP VBD JJ NNS VBP VBN RB JJ NNS and VBP VB their NNS , although they may VB out of some of the NNS or VB their NNS on a NN that VBZ RB JJ with the NN ’s NN . NNP VBD that 97 to 98 NN of NNS in NNP VBD VBG all or some of their NNS . ‘ We VBP in a NN that should VB you and should RB VB you VBG to VB away the NN of the NNS , ’ he VBD . ” 1 But in an NN of JJ NN and a JJ NN on JJ NNS , the JJ NN to VB VBZ RB VBN . NNP . NNP NNP , NNP - NNP , VBD , “ RB , this NN VBZ RB about JJ NN – it VBZ about how RB VBZ RB RB for the NN to VB into our JJ NNS . A NN against this NN VBZ RB a NN against NNS – it VBZ a NN in NN of JJ NN and JJ NNS . ” 1 Our NNS VBP out to all the NNS in NNP VBN with VBG JJ NNS about what VBZ JJS for their NNS . We VBP with you . NN 2020 – NN to VB RB VBN , WITH NNS to JJ NN"
80,418,mainstream,"As_IN the_DT world_NN grapples_VBZ with_IN how_WRB to_TO safely_RB reopen_VB society_NN in_IN the_DT midst_NN of_IN the_DT coronavirus_NN pandemic_NN ,_, scientists_NNS have_VBP been_VBN racing_VBG to_TO understand_VB whether_IN COVID_NN -_HYPH 19_CD infection_NN confers_VBZ immunity_NN —_: and_CC how_WRB long_RB such_JJ immunity_NN might_MD last_VB ._. A_DT lot_NN hangs_VBZ in_IN the_DT balance_NN :_: A_DT strong_JJ immune_JJ response_NN could_MD mean_VB people_NNS who_WP have_VBP already_RB been_VBN infected_VBN would_MD be_VB able_JJ to_TO safely_RB return_VB to_IN work_NN ._. And_CC it_PRP would_MD also_RB bode_VB well_RB for_IN vaccine_NN development_NN efforts_NNS ._. A_DT small_JJ but_CC suggestive_JJ new_JJ study_NN finds_VBZ that_IN individuals_NNS who_WP have_VBP had_VBN COVID_NN -_HYPH 19_CD produce_VBP a_DT robust_JJ response_NN in_IN immune_JJ cells_NNS called_VBN T_NN cells_NNS ._. The_DT adaptive_JJ immune_NN system_NN contains_VBZ several_JJ main_JJ components_NNS :_: antibody_NN -_HYPH creating_VBG B_NN cells_NNS ,_, helper_NN T_NN cells_NNS and_CC killer_NN T_NN cells_NNS ._. The_DT latter_JJ two_CD are_VBP important_JJ for_IN recognizing_VBG and_CC destroying_VBG a_DT particular_JJ virus_NN ,_, respectively_RB ._. Alessandro_NNP Sette_NNP and_CC Shane_NNP Crotty_NNP ,_, both_DT professors_NNS at_IN the_DT La_NNP Jolla_NNP Institute_NNP for_IN Immunology_NNP ,_, and_CC their_PRP$ colleagues_NNS found_VBD that_IN of_IN a_DT group_NN of_IN 20_CD people_NNS who_WP had_VBD recovered_VBN from_IN COVID_NN -_HYPH 19_CD ,_, 70_CD percent_NN had_VBD killer_NN T_NN cells_NNS and_CC 100_CD percent_NN had_VBD helper_NN T_NN cells_NNS that_WDT were_VBD specific_JJ to_IN the_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN ,_, which_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. Importantly_RB ,_, the_DT researchers_NNS observed_VBD a_DT strong_JJ T_NN cell_NN response_NN to_IN the_DT “_`` spike_NN ”_'' protein_NN the_DT virus_NN uses_VBZ to_TO bind_VB to_IN and_CC infect_VB cells_NNS (_-LRB- and_CC which_WDT most_JJS vaccine_NN candidates_NNS target_VBP )_-RRB- ._. They_PRP additionally_RB detected_VBD a_DT helper_NN T_NN cell_NN response_NN to_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD in_IN about_RB half_NN of_IN blood_NN samples_NNS they_PRP examined_VBD that_WDT had_VBD been_VBN drawn_VBN before_IN the_DT virus_NN began_VBD circulating_VBG ._. This_DT observation_NN ,_, they_PRP say_VBP ,_, hints_VBZ that_IN exposure_NN to_IN seasonal_JJ common_JJ cold_JJ coronaviruses_NNS may_MD confer_VB some_DT protection_NN against_IN the_DT new_JJ pathogen_NN ._. The_DT findings_NNS build_VBP on_IN earlier_JJR studies_NNS showing_VBG that_IN infection_NN with_IN the_DT novel_JJ coronavirus_NN produces_VBZ protective_JJ ,_, or_CC “_`` neutralizing_VBG ,_, ”_'' antibodies_NNS ._. Taken_VBN together_RB ,_, these_DT results_NNS suggest_VBP that_IN people_NNS who_WP have_VBP had_VBN COVID_NN -_HYPH 19_CD possess_VBP at_IN least_JJS some_DT immunity_NN —_: an_DT encouraging_JJ sign_NN for_IN the_DT dozens_NNS of_IN vaccines_NNS under_IN development_NN ._. Separately_RB ,_, this_DT week_NN the_DT company_NN Moderna_NNP announced_VBD early_JJ results_NNS from_IN a_DT trial_NN of_IN its_PRP$ coronavirus_NN vaccine_NN candidate_NN :_: eight_CD individuals_NNS who_WP have_VBP received_VBN the_DT vaccine_NN produced_VBD antibodies_NNS to_IN the_DT virus_NN at_IN levels_NNS similar_JJ to_IN those_DT of_IN people_NNS who_WP had_VBD the_DT disease_NN ._. Scientific_JJ American_NNP spoke_VBD with_IN Sette_NNP and_CC Crotty_NNP about_IN what_WP their_PRP$ study_NN means_VBZ for_IN immunity_NN to_IN COVID_NN -_HYPH 19_CD ,_, possible_JJ protection_NN from_IN seasonal_JJ cold_JJ infections_NNS and_CC the_DT prospects_NNS for_IN a_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD vaccine_NN ._. [_-LRB- An_DT edited_VBN transcript_NN of_IN the_DT interview_NN follows_VBZ ._. ]_-RRB- What_WP do_VBP we_PRP know_VB so_RB far_RB about_IN immunity_NN to_IN COVID_NNP -_HYPH 19_CD ?_. And_CC why_WRB is_VBZ it_PRP so_RB important_JJ ?_. CROTTY_NNP :_: There_EX ’s_VBZ just_RB been_VBN a_DT huge_JJ amount_NN of_IN uncertainty_NN about_IN immunity_NN to_IN COVID_NNP -_HYPH 19_CD ._. And_CC that_DT question_NN about_IN immunity_NN has_VBZ two_CD major_JJ implications_NNS :_: one_CD ,_, for_IN just_RB understanding_VBG the_DT disease_NN itself_PRP ,_, and_CC two_CD ,_, for_IN vaccine_NN development_NN ._. It_PRP ’s_VBZ clearly_RB been_VBN a_DT world_NN -_HYPH on_IN -_HYPH fire_NN type_NN of_IN situation_NN ._. And_CC so_RB it_PRP has_VBZ made_VBN sense_NN for_IN these_DT 100_CD -_HYPH odd_JJ different_JJ vaccine_NN programs_NNS to_TO get_VB going_VBG and_CC just_RB try_VB moving_VBG things_NNS forward_RB ._. The_DT normal_JJ way_NN you_PRP would_MD try_VB and_CC make_VB a_DT successful_JJ vaccine_NN would_MD be_VB to_TO look_VB at_IN what_WP gets_VBZ you_PRP good_JJ protective_JJ immunity_NN to_IN that_DT disease_NN and_CC copy_VB that_DT ._. A_DT disease_NN such_JJ as_IN COVID_NN -_HYPH 19_CD is_VBZ normally_RB an_DT acute_JJ infection_NN ,_, and_CC most_JJS people_NNS control_VBP and_CC clear_VBP it_PRP without_IN a_DT lot_NN of_IN problems_NNS ._. That_DT ’s_VBZ a_DT good_JJ sign_NN that_WDT indicates_VBZ that_IN the_DT human_JJ immune_JJ system_NN normally_RB makes_VBZ a_DT good_JJ response_NN to_IN that_DT virus_NN and_CC controls_VBZ it_PRP ._. But_CC the_DT immune_NN system_NN is_VBZ a_DT big_JJ ,_, complicated_JJ place_NN ,_, with_IN lots_NNS of_IN different_JJ cell_NN types_NNS with_IN lots_NNS of_IN different_JJ functions_NNS ._. And_CC some_DT are_VBP useful_JJ or_CC important_JJ in_IN one_CD context_NN versus_IN another_DT ._. For_IN a_DT vaccine_NN ,_, you_PRP ’d_MD want_VB to_TO know_VB which_WDT components_NNS of_IN the_DT immune_JJ response_NN are_VBP the_DT important_JJ ones_NNS for_IN protection_NN against_IN this_DT disease_NN ._. And_CC without_IN that_DT information_NN ,_, you_PRP can_MD very_RB much_RB go_VB totally_RB in_IN the_DT wrong_JJ direction_NN with_IN a_DT vaccine_NN program_NN ,_, either_CC in_IN terms_NNS of_IN the_DT type_NN of_IN immune_JJ response_NN you_PRP ’re_VBP trying_VBG to_TO get_VB or_CC the_DT [_-LRB- vaccine_NN ’s_POS molecular_JJ ]_-RRB- target_NN ._. And_CC both_DT of_IN those_DT have_VBP been_VBN things_NNS that_WDT worried_VBD [_-LRB- Sette_NNP ]_-RRB- and_CC me_PRP and_CC other_JJ people_NNS about_IN these_DT ongoing_JJ vaccine_NN efforts_NNS ._. We_PRP really_RB wanted_VBD to_TO generate_VB information_NN that_WDT would_MD help_VB [_-LRB- us_PRP ]_-RRB- understand_VB the_DT disease_NN itself_PRP —_: and_CC also_RB generate_VB information_NN about_IN which_WDT vaccine_NN strategies_NNS are_VBP likely_JJ to_TO be_VB better_JJR or_CC worse_JJR ones_NNS and_CC whether_IN people_NNS are_VBP getting_VBG the_DT right_JJ [_-LRB- molecular_JJ target_NN ]_-RRB- or_CC not_RB ._. Our_PRP$ goal_NN was_VBD to_TO look_VB at_IN essentially_RB average_JJ cases_NNS of_IN COVID_NN -_HYPH 19_CD —_: ones_NNS where_WRB people_NNS definitely_RB are_VBP making_VBG successful_JJ immune_JJ responses_NNS —_: and_CC ask_VBP ,_, “_`` Okay_UH ,_, what_WP does_VBZ that_DT immune_JJ response_NN look_VB like_IN ?_. ”_'' Can_MD you_PRP describe_VB the_DT different_JJ parts_NNS of_IN the_DT immune_JJ response_NN and_CC how_WRB they_PRP work_VBP ?_. CROTTY_NNP :_: Quite_PDT a_DT few_JJ labs_NNS around_IN the_DT world_NN have_VBP looked_VBN at_IN antibody_NN responses_NNS ._. Those_DT are_VBP generally_RB easier_JJR to_TO measure_VB and_CC look_VB at_IN ._. But_CC really_RB ,_, there_EX are_VBP three_CD parts_NNS of_IN the_DT adaptive_JJ immune_NN system_NN :_: you_PRP ’ve_VBP basically_RB got_VBN antibodies_NNS ,_, you_PRP ’ve_VBP got_VBN helper_NN T_NN cells_NNS ,_, and_CC you_PRP ’ve_VBP got_VBN killer_NN T_NN cells_NNS ._. The_DT T_NN cells_NNS are_VBP tougher_JJR to_TO measure_VB ,_, but_CC they_PRP do_VBP really_RB important_JJ things_NNS ._. You_PRP ’ve_VBP got_VBN to_TO have_VB the_DT helper_NN T_NN cells_NNS to_TO get_VB an_DT antibody_NN response_NN ._. For_IN example_NN ,_, in_IN animal_NN models_NNS ,_, [_-LRB- helper_NN T_NN cells_NNS ]_-RRB- are_VBP important_JJ for_IN protecting_VBG against_IN [_-LRB- severe_JJ acute_JJ respiratory_JJ syndrome_NN (_-LRB- SARS_NNP )_-RRB- ]_-RRB- ._. And_CC the_DT killer_NN T_NN cells_NNS are_VBP important_JJ for_IN most_JJS viral_JJ infections_NNS ._. You_PRP do_VBP n’t_RB want_VB to_TO go_VB forward_RB without_IN understanding_VBG anything_NN about_IN the_DT T_NN cell_NN response_NN ._. And_CC [_-LRB- Sette_NNP ]_-RRB- is_VBZ the_DT world_NN ’s_POS expert_NN in_IN predicting_VBG and_CC identifying_VBG T_NN cell_NN [_-LRB- targets_NNS ]_-RRB- ,_, particularly_RB in_IN humans_NNS ._. So_RB we_PRP collaborated_VBD to_TO get_VB COVID_NNP -_HYPH 19_CD patient_NN blood_NN samples_NNS as_RB quickly_RB as_IN possible_JJ and_CC to_TO try_VB and_CC get_VB information_NN about_IN those_DT questions_NNS ._. We_PRP mostly_RB have_VBP concluded_VBN it_PRP ’s_VBZ good_JJ news_NN :_: things_NNS have_VBP largely_RB looked_VBN the_DT ways_NNS we_PRP would_MD expect_VB ._. Do_VBP we_PRP know_VB how_WRB long_RB the_DT immune_JJ response_NN to_IN the_DT new_JJ virus_NN lasts_VBZ ?_. SETTE_NNP :_: What_WP we_PRP certainly_RB can_MD say_VB is_VBZ that_IN the_DT infection_NN induces_VBZ a_DT robust_JJ immune_JJ response_NN ,_, and_CC this_DT is_VBZ in_IN people_NNS that_WDT successfully_RB deal_VBP with_IN the_DT virus_NN and_CC do_VBP n’t_RB get_VB very_RB sick_JJ ._. The_DT question_NN [_-LRB- of_IN ]_-RRB- how_WRB long_RB this_DT response_NN lasts_VBZ obviously_RB takes_VBZ time_NN ,_, because_IN we_PRP have_VBP been_VBN dealing_VBG with_IN this_DT virus_NN for_IN only_RB a_DT few_JJ months_NNS ,_, and_CC we_PRP cannot_MD possibly_RB know_VB what_WP is_VBZ going_VBG to_TO happen_VB a_DT year_NN down_IN the_DT line_NN ._. But_CC what_WP we_PRP ’ve_VBP seen_VBN thus_RB far_RB is_VBZ encouraging_VBG ,_, because_IN these_DT T_NN cells_NNS look_VBP healthy_JJ ,_, look_VBP happy_JJ ._. They_PRP are_VBP not_RB exhausted_VBN ,_, and_CC they_PRP do_VBP n’t_RB express_VB some_DT of_IN the_DT molecular_JJ features_NNS that_WDT are_VBP associated_VBN with_IN cells_NNS that_WDT are_VBP about_JJ to_TO die_VB ._. In_IN general_JJ ,_, immunologic_JJ memory_NN is_VBZ like_IN any_DT other_JJ memory_NN in_IN the_DT sense_NN that_IN the_DT intensity_NN of_IN the_DT event_NN dictates_VBZ how_WRB strong_JJ the_DT memory_NN is_VBZ ._. Pretty_RB much_RB like_IN any_DT event_NN in_IN your_PRP$ life_NN :_: if_IN it_PRP was_VBD a_DT life_NN -_HYPH threatening_VBG situation_NN —_: for_IN example_NN ,_, you_PRP almost_RB got_VBD run_VBN over_RP by_IN a_DT truck_NN —_: you_PRP remember_VBP ._. If_IN it_PRP was_VBD instead_RB what_WDT kind_NN of_IN socks_NNS you_PRP wore_VBD ,_, you_PRP might_MD not_RB remember_VB ._. It_PRP ’s_VBZ the_DT same_JJ for_IN the_DT immune_NN system_NN ,_, in_IN the_DT sense_NN that_IN a_DT very_RB strong_JJ infection_NN with_IN a_DT microbe_NN that_WDT reproduces_VBZ to_IN high_JJ levels_NNS generates_VBZ a_DT strong_JJ level_NN of_IN immune_JJ response_NN ,_, which_WDT then_RB creates_VBZ a_DT long_JJ -_HYPH lasting_JJ impression_NN ._. I_PRP would_MD speculate_VB that_IN the_DT memory_NN generated_VBN by_IN SARS_NNP or_CC [_-LRB- Middle_NNP East_NNP respiratory_JJ syndrome_NN (_-LRB- MERS_NNP )_-RRB- ]_-RRB- could_MD be_VB somewhat_RB different_JJ from_IN one_CD generated_VBN from_IN a_DT common_JJ cold_NN ,_, which_WDT is_VBZ fairly_RB adapted_VBN to_TO not_RB cause_VB much_JJ trouble_NN in_IN the_DT human_JJ host_NN ._. You_PRP also_RB saw_VBD some_DT T_NN cell_NN responses_NNS ,_, or_CC “_`` cross-_JJ reactivity_NN ,_, ”_'' to_IN the_DT new_JJ coronavirus_NN in_IN blood_NN from_IN people_NNS who_WP were_VBD never_RB exposed_VBN to_IN it_PRP ,_, correct_JJ ?_. SETTE_NNP :_: We_PRP looked_VBD at_IN the_DT COVID_NN -_HYPH 19_CD patients_NNS ,_, and_CC then_RB we_PRP looked_VBD at_IN a_DT control_NN group_NN ._. We_PRP purposely_RB went_VBD after_IN blood_NN donations_NNS that_WDT were_VBD obtained_VBN in_IN 2015_CD to_IN 2018_CD —_: before_IN any_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD was_VBD around_RB ._. Surprisingly_RB ,_, in_IN about_RB half_NN of_IN these_DT people_NNS ,_, we_PRP could_MD see_VB some_DT T_NN cell_NN reactivity_NN ._. And_CC we_PRP looked_VBD at_IN the_DT data_NNS hard_RB from_IN the_DT left_NN and_CC from_IN the_DT right_NN and_CC convinced_VBD ourselves_PRP that_IN this_DT was_VBD real_JJ ._. We_PRP do_VBP not_RB know_VB ,_, at_IN this_DT point_NN ,_, exactly_RB what_WP this_DT cross-reactivity_NN means_VBZ ,_, but_CC it_PRP ’s_VBZ reasonable_JJ to_TO assume_VB that_IN it_PRP is_VBZ the_DT result_NN of_IN people_NNS having_VBG been_VBN exposed_VBN to_IN common_JJ cold_JJ coronaviruses_NNS that_WDT are_VBP different_JJ from_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD but_CC have_VBP some_DT similarity_NN [_-LRB- to_IN it_PRP ]_-RRB- ._. This_DT potentially_RB has_VBZ very_RB strong_JJ implications_NNS ,_, because_IN one_CD of_IN the_DT things_NNS that_WDT is_VBZ unknown_JJ and_CC everybody_NN wants_VBZ to_TO gain_VB more_JJR information_NN about_IN is_VBZ why_WRB there_EX is_VBZ such_PDT a_DT spectrum_NN of_IN different_JJ COVID_NN -_HYPH 19_CD outcomes_NNS :_: some_DT people_NNS are_VBP totally_RB asymptomatic_JJ ,_, whereas_IN other_JJ people_NNS die_VBP ._. Of_IN course_NN ,_, age_NN and_CC other_JJ health_NN issues_NNS are_VBP factors_NNS ,_, but_CC one_CD element_NN could_MD be_VB immunological_JJ :_: If_IN someone_NN has_VBZ some_DT T_NN cells_NNS that_WDT can_MD cross-react_VB to_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD ,_, their_PRP$ immune_JJ system_NN has_VBZ an_DT advantage_NN ._. They_PRP can_MD get_VB going_VBG to_TO generate_VB antibody_NN responses_NNS faster_RBR ,_, maybe_RB ,_, and_CC that_DT could_MD give_VB a_DT better_JJR outcome_NN ._. In_IN the_DT context_NN of_IN vaccination_NN ,_, this_DT is_VBZ also_RB very_RB important_JJ ,_, because_IN imagine_VB that_IN you_PRP have_VBP a_DT group_NN of_IN people_NNS ,_, and_CC half_NN of_IN them_PRP have_VBP this_DT coronavirus_NN cross–reactivity_NN ,_, and_CC half_NN of_IN them_PRP do_VBP n’t_RB ._. Now_RB you_PRP give_VBP these_DT people_NNS a_DT vaccine_NN ._. It_PRP could_MD be_VB that_IN the_DT people_NNS that_WDT have_VBP the_DT common_JJ cold_JJ cross-reactivity_NN will_MD respond_VB a_DT lot_NN faster_JJR and_CC a_DT lot_NN better_JJR to_IN the_DT vaccine_NN ,_, compared_VBN with_IN the_DT other_JJ ones_NNS ._. One_CD piece_NN of_IN data_NNS that_WDT is_VBZ encouraging_VBG ,_, in_IN speculating_VBG that_IN some_DT preexisting_JJ immunity_NN may_MD be_VB beneficial_JJ ,_, is_VBZ data_NNS from_IN the_DT 2009_CD H1N1_NNP “_`` swine_NN flu_NN ”_'' pandemic_NN ._. You_PRP might_MD recall_VB that_IN in_IN that_DT case_NN ,_, older_JJR people_NNS did_VBD better_JJR than_IN younger_JJR people_NNS ._. And_CC in_IN fact_NN ,_, it_PRP turned_VBD out_RP that_IN the_DT age_NN of_IN the_DT people_NNS that_WDT did_VBD better_RBR correlated_VBN with_IN when_WRB another_DT H1N1_NN strain_NN ,_, a_DT cousin_NN of_IN the_DT swine_NN flu_NN pandemic_NN strain_NN ,_, had_VBD circulated_VBN —_: so_IN that_IN the_DT people_NNS that_WDT had_VBD been_VBN exposed_VBN in_IN the_DT 1950s_NNS to_IN this_DT other_JJ strain_NN ,_, their_PRP$ immune_JJ system_NN still_RB remembered_VBD a_DT bit_NN ._. Not_RB that_IN the_DT people_NNS did_VBD n’t_RB get_VB sick_JJ ,_, of_IN course_NN ,_, but_CC they_PRP got_VBD less_RBR sick_JJ ._. And_CC they_PRP fared_VBD better_JJR than_IN people_NNS who_WP were_VBD totally_RB naive_JJ and_CC had_VBD never_RB seen_VBN this_DT particular_JJ subtype_NN of_IN influenza_NN ._. Do_VBP we_PRP know_VB whether_IN people_NNS that_WDT had_VBD asymptomatic_JJ COVID_NN -_HYPH 19_CD infections_NNS might_MD be_VB less_RBR protected_VBN against_IN reinfection_NN than_IN people_NNS who_WP had_VBD a_DT very_RB severe_JJ case_NN ?_. CROTTY_NNP :_: We_PRP did_VBD this_DT study_NN with_IN people_NNS who_WP did_VBD n’t_RB have_VB bad_JJ diseases_NNS —_: sort_NN of_IN average_JJ cases_NNS who_WP definitely_RB got_VBD well_RB ._. Asymptomatic_JJ cases_NNS are_VBP definitely_RB a_DT big_JJ unknown_JJ ._. We_PRP have_VBP no_DT idea_NN [_-LRB- if_IN they_PRP will_MD be_VB protected_VBN against_IN reinfection_NN ]_-RRB- ._. Can_MD you_PRP comment_VB on_IN the_DT Moderna_NNP results_NNS from_IN the_DT phase_NN I_PRP trial_NN of_IN its_PRP$ coronavirus_NN vaccine_NN candidate_NN and_CC the_DT prospects_NNS for_IN a_DT vaccine_NN in_IN general_JJ ?_. CROTTY_NNP :_: There_EX are_VBP actually_RB three_CD human_JJ vaccine_NN candidates_NNS that_WDT have_VBP been_VBN tested_VBN in_IN monkeys_NNS that_WDT gave_VBD what_WP seems_VBZ to_TO be_VB pretty_RB good_JJ protection_NN :_: one_PRP ’s_VBZ an_DT inactivated_VBN -_HYPH virus_NN vaccine_NN ;_, another_DT is_VBZ a_DT chimpanzee_NN adenovirus_NN vector_NN [_-LRB- a_DT type_NN of_IN double_JJ -_HYPH stranded_VBN DNA_NN virus_NN used_VBN to_TO harmlessly_RB deliver_VB genetic_JJ material_NN to_IN a_DT host_NN ]_-RRB- ;_, and_CC a_DT third_JJ one_NN is_VBZ a_DT DNA_NN vaccine_NN [_-LRB- a_DT DNA_NN sequence_NN that_WDT stimulates_VBZ the_DT host_NN to_TO produce_VB part_NN of_IN the_DT virus_NN and_CC mount_VB an_DT immune_JJ response_NN against_IN it_PRP ]_-RRB- ._. And_CC then_RB there_EX 's_VBZ the_DT Moderna_NNP vaccine_NN ,_, which_WDT has_VBZ n't_RB been_VBN tested_VBN in_IN monkeys_NNS but_CC has_VBZ been_VBN tested_VBN in_IN a_DT mouse_NN model_NN and_CC in_IN humans_NNS to_TO measure_VB their_PRP$ immune_JJ response_NN ._. So_RB those_DT are_VBP the_DT three_CD examples_NNS of_IN interesting_JJ vaccine_NN candidate_NN data_NNS that_WDT are_VBP available_JJ as_IN of_IN today_NN ._. And_CC I_PRP think_VBP if_IN we_PRP combine_VBP those_DT with_IN the_DT data_NNS from_IN our_PRP$ paper_NN showing_VBG that_IN the_DT T_NN cell_NN responses_NNS generally_RB look_VBP good_JJ and_CC data_NNS from_IN a_DT number_NN of_IN papers_NNS about_IN people_NNS making_VBG neutralizing_VBG antibody_NN responses_NNS overall_RB ,_, I_PRP would_MD say_VB those_DT vaccine_NN studies_NNS —_: particularly_RB the_DT two_CD that_WDT were_VBD done_VBN in_IN monkeys_NNS —_: suggest_VBP ,_, so_RB far_RB ,_, that_IN it_PRP ’s_VBZ not_RB that_RB hard_JJ to_TO protect_VB against_IN this_DT virus_NN ._. I_PRP 'm_VBP certainly_RB encouraged_VBN ,_, based_VBN on_IN the_DT magnitude_NN of_IN the_DT immune_JJ responses_NNS to_IN the_DT vaccines_NNS —_: and_CC the_DT magnitude_NN of_IN immune_NN responses_NNS we_PRP ’re_VBP measuring_VBG in_IN people_NNS who_WP actually_RB have_VBP disease_NN and_CC what_WP happens_VBZ in_IN protection_NN models_NNS ._. So_RB far_RB the_DT available_JJ data_NNS are_VBP positive_JJ here_RB ._. SETTE_NNP :_: One_CD encouraging_JJ thing_NN is_VBZ that_IN there_EX are_VBP so_RB many_JJ different_JJ vaccines_NNS that_WDT are_VBP being_VBG developed_VBN ._. So_RB our_PRP$ hope_NN is_VBZ that_IN there_EX is_VBZ not_RB going_VBG to_TO be_VB a_DT winner_NN ,_, but_CC there_EX are_VBP going_VBG to_TO be_VB many_JJ different_JJ winners_NNS ._. The_DT one_CD thing_NN that_WDT is_VBZ important_JJ from_IN our_PRP$ study_NN is_VBZ that_IN the_DT vast_JJ majority_NN of_IN these_DT different_JJ vaccine_NN concepts_NNS rely_VBP on_IN one_CD particular_JJ protein_NN ,_, which_WDT is_VBZ the_DT spike_NN protein_NN ._. And_CC we_PRP saw_VBD very_RB good_JJ responses_NNS ,_, both_CC in_IN terms_NNS of_IN killer_NN and_CC helper_NN cells_NNS against_IN the_DT spike_NN ,_, which_WDT is_VBZ really_RB good_JJ news_NN ,_, because_IN this_DT was_VBD not_RB a_DT given_VBN ._. In_IN this_DT particular_JJ case_NN ,_, it_PRP so_RB happens_VBZ that_IN it_PRP ’s_VBZ a_DT good_JJ target_NN for_IN all_DT three_CD different_JJ types_NNS of_IN immune_JJ response_NN —_: which_WDT bodes_VBZ well_RB for_IN people_NNS that_WDT are_VBP developing_VBG the_DT spike_NN -_HYPH based_VBN vaccines_NNS ._. At_IN the_DT same_JJ time_NN ,_, our_PRP$ data_NNS found_VBD that_IN there_EX were_VBD responses_NNS also_RB against_IN other_JJ pieces_NNS of_IN the_DT virus_NN ,_, which_WDT opens_VBZ the_DT way_NN to_IN thinking_VBG that_IN maybe_RB these_DT other_JJ pieces_NNS could_MD also_RB be_VB included_VBN to_TO further_RB fortify_VB a_DT vaccine_NN concept_NN ._. Read_VB more_JJR about_IN the_DT coronavirus_NN outbreak_NN from_IN Scientific_JJ American_NNP here_RB ._. And_CC read_VB coverage_NN from_IN our_PRP$ international_JJ network_NN of_IN magazines_NNS here_RB ._.","As the NN VBZ with how to RB VB NN in the NN of the NN NN , NNS VBP VBN VBG to VB whether NN - 19 NN VBZ NN — and how RB JJ NN might VB . A NN VBZ in the NN : A JJ JJ NN could VB NNS who VBP RB VBN VBN would VB JJ to RB VB to NN . And it would RB VB RB for NN NN NNS . A JJ but JJ JJ NN VBZ that NNS who VBP VBN NN - 19 VBP a JJ NN in JJ NNS VBN NN NNS . The JJ NN NN VBZ JJ JJ NNS : NN - VBG NN NNS , NN NN NNS and NN NN NNS . The JJ two VBP JJ for VBG and VBG a JJ NN , RB . NNP NNP and NNP NNP , both NNS at the NNP NNP NNP for NNP , and their NNS VBD that of a NN of 20 NNS who VBD VBN from NN - 19 , 70 NN VBD NN NN NNS and 100 NN VBD NN NN NNS that VBD JJ to the NN - NN - 2 NN , which VBZ NN - 19 . RB , the NNS VBD a JJ NN NN NN to the “ NN ” NN the NN VBZ to VB to and VB NNS ( and which JJS NN NNS VBP ) . They RB VBD a NN NN NN NN to NNP - NN - 2 in RB NN of NN NNS they VBD that VBD VBN VBN before the NN VBD VBG . This NN , they VBP , VBZ that NN to JJ JJ JJ NNS may VB some NN against the JJ NN . The NNS VBP on JJR NNS VBG that NN with the JJ NN VBZ JJ , or “ VBG , ” NNS . VBN RB , these NNS VBP that NNS who VBP VBN NN - 19 VBP at JJS some NN — an JJ NN for the NNS of NNS under NN . RB , this NN the NN NNP VBD JJ NNS from a NN of its NN NN NN : eight NNS who VBP VBN the NN VBD NNS to the NN at NNS JJ to those of NNS who VBD the NN . JJ NNP VBD with NNP and NNP about what their NN VBZ for NN to NN - 19 , JJ NN from JJ JJ NNS and the NNS for a NN - NN - 2 NN . [ An VBN NN of the NN VBZ . ] What VBP we VB RB RB about NN to NNP - 19 ? And why VBZ it RB JJ ? NNP : There VBZ RB VBN a JJ NN of NN about NN to NNP - 19 . And that NN about NN VBZ two JJ NNS : one , for RB VBG the NN itself , and two , for NN NN . It VBZ RB VBN a NN - on - NN NN of NN . And RB it VBZ VBN NN for these 100 - JJ JJ NN NNS to VB VBG and RB VB VBG NNS RB . The JJ NN you would VB and VB a JJ NN would VB to VB at what VBZ you JJ JJ NN to that NN and VB that . A NN JJ as NN - 19 VBZ RB an JJ NN , and JJS NNS VBP and VBP it without a NN of NNS . That VBZ a JJ NN that VBZ that the JJ JJ NN RB VBZ a JJ NN to that NN and VBZ it . But the NN NN VBZ a JJ , JJ NN , with NNS of JJ NN NNS with NNS of JJ NNS . And some VBP JJ or JJ in one NN versus another . For a NN , you ’d VB to VB which NNS of the JJ NN VBP the JJ NNS for NN against this NN . And without that NN , you can RB RB VB RB in the JJ NN with a NN NN , either in NNS of the NN of JJ NN you VBP VBG to VB or the [ NN ’s JJ ] NN . And both of those VBP VBN NNS that VBD [ NNP ] and me and JJ NNS about these JJ NN NNS . We RB VBD to VB NN that would VB [ us ] VB the NN itself — and RB VB NN about which NN NNS VBP JJ to VB JJR or JJR NNS and whether NNS VBP VBG the JJ [ JJ NN ] or RB . Our NN VBD to VB at RB JJ NNS of NN - 19 — NNS where NNS RB VBP VBG JJ JJ NNS — and VBP , “ Okay , what VBZ that JJ NN VB like ? ” Can you VB the JJ NNS of the JJ NN and how they VBP ? NNP : Quite a JJ NNS around the NN VBP VBN at NN NNS . Those VBP RB JJR to VB and VB at . But RB , there VBP three NNS of the JJ NN NN : you VBP RB VBN NNS , you VBP VBN NN NN NNS , and you VBP VBN NN NN NNS . The NN NNS VBP JJR to VB , but they VBP RB JJ NNS . You VBP VBN to VB the NN NN NNS to VB an NN NN . For NN , in NN NNS , [ NN NN NNS ] VBP JJ for VBG against [ JJ JJ JJ NN ( NNP ) ] . And the NN NN NNS VBP JJ for JJS JJ NNS . You VBP RB VB to VB RB without VBG NN about the NN NN NN . And [ NNP ] VBZ the NN ’s NN in VBG and VBG NN NN [ NNS ] , RB in NNS . RB we VBD to VB NNP - 19 NN NN NNS RB RB as JJ and to VB and VB NN about those NNS . We RB VBP VBN it VBZ JJ NN : NNS VBP RB VBN the NNS we would VB . VBP we VB how RB the JJ NN to the JJ NN VBZ ? NNP : What we RB can VB VBZ that the NN VBZ a JJ JJ NN , and this VBZ in NNS that RB VBP with the NN and VBP RB VB RB JJ . The NN [ of ] how RB this NN VBZ RB VBZ NN , because we VBP VBN VBG with this NN for RB a JJ NNS , and we cannot RB VB what VBZ VBG to VB a NN down the NN . But what we VBP VBN RB RB VBZ VBG , because these NN NNS VBP JJ , VBP JJ . They VBP RB VBN , and they VBP RB VB some of the JJ NNS that VBP VBN with NNS that VBP JJ to VB . In JJ , JJ NN VBZ like any JJ NN in the NN that the NN of the NN VBZ how JJ the NN VBZ . RB RB like any NN in your NN : if it VBD a NN - VBG NN — for NN , you RB VBD VBN over by a NN — you VBP . If it VBD RB what NN of NNS you VBD , you might RB VB . It VBZ the JJ for the NN NN , in the NN that a RB JJ NN with a NN that VBZ to JJ NNS VBZ a JJ NN of JJ NN , which RB VBZ a JJ - JJ NN . I would VB that the NN VBN by NNP or [ NNP NNP JJ NN ( NNP ) ] could VB RB JJ from one VBN from a JJ NN , which VBZ RB VBN to RB VB JJ NN in the JJ NN . You RB VBD some NN NN NNS , or “ JJ NN , ” to the JJ NN in NN from NNS who VBD RB VBN to it , JJ ? NNP : We VBD at the NN - 19 NNS , and RB we VBD at a NN NN . We RB VBD after NN NNS that VBD VBN in 2015 to 2018 — before any NNP - NNP - 2 VBD RB . RB , in RB NN of these NNS , we could VB some NN NN NN . And we VBD at the NNS RB from the NN and from the NN and VBD ourselves that this VBD JJ . We VBP RB VB , at this NN , RB what this NN VBZ , but it VBZ JJ to VB that it VBZ the NN of NNS VBG VBN VBN to JJ JJ NNS that VBP JJ from NN - NN - 2 but VBP some NN [ to it ] . This RB VBZ RB JJ NNS , because one of the NNS that VBZ JJ and NN VBZ to VB JJR NN about VBZ why there VBZ such a NN of JJ NN - 19 NNS : some NNS VBP RB JJ , whereas JJ NNS VBP . Of NN , NN and JJ NN NNS VBP NNS , but one NN could VB JJ : If NN VBZ some NN NNS that can VB to NN - NN - 2 , their JJ NN VBZ an NN . They can VB VBG to VB NN NNS RBR , RB , and that could VB a JJR NN . In the NN of NN , this VBZ RB RB JJ , because VB that you VBP a NN of NNS , and NN of them VBP this NN NN , and NN of them VBP RB . RB you VBP these NNS a NN . It could VB that the NNS that VBP the JJ JJ NN will VB a NN JJR and a NN JJR to the NN , VBN with the JJ NNS . One NN of NNS that VBZ VBG , in VBG that some JJ NN may VB JJ , VBZ NNS from the 2009 NNP “ NN NN ” NN . You might VB that in that NN , JJR NNS VBD JJR than JJR NNS . And in NN , it VBD out that the NN of the NNS that VBD RBR VBN with when another NN NN , a NN of the NN NN NN NN , VBD VBN — so that the NNS that VBD VBN VBN in the NNS to this JJ NN , their JJ NN RB VBD a NN . RB that the NNS VBD RB VB JJ , of NN , but they VBD RBR JJ . And they VBD JJR than NNS who VBD RB JJ and VBD RB VBN this JJ NN of NN . VBP we VB whether NNS that VBD JJ NN - 19 NNS might VB RBR VBN against NN than NNS who VBD a RB JJ NN ? NNP : We VBD this NN with NNS who VBD RB VB JJ NNS — NN of JJ NNS who RB VBD RB . JJ NNS VBP RB a JJ JJ . We VBP no NN [ if they will VB VBN against NN ] . Can you VB on the NNP NNS from the NN I NN of its NN NN NN and the NNS for a NN in JJ ? NNP : There VBP RB three JJ NN NNS that VBP VBN VBN in NNS that VBD what VBZ to VB RB JJ NN : one VBZ an VBN - NN NN ; another VBZ a NN NN NN [ a NN of JJ - VBN NN NN VBN to RB VB JJ NN to a NN ] ; and a JJ NN VBZ a NN NN [ a NN NN that VBZ the NN to VB NN of the NN and VB an JJ NN against it ] . And RB there VBZ the NNP NN , which VBZ RB VBN VBN in NNS but VBZ VBN VBN in a NN NN and in NNS to VB their JJ NN . RB those VBP the three NNS of JJ NN NN NNS that VBP JJ as of NN . And I VBP if we VBP those with the NNS from our NN VBG that the NN NN NNS RB VBP JJ and NNS from a NN of NNS about NNS VBG VBG NN NNS RB , I would VB those NN NNS — RB the two that VBD VBN in NNS — VBP , RB RB , that it VBZ RB RB JJ to VB against this NN . I VBP RB VBN , VBN on the NN of the JJ NNS to the NNS — and the NN of NN NNS we VBP VBG in NNS who RB VBP NN and what VBZ in NN NNS . RB RB the JJ NNS VBP JJ RB . NNP : One JJ NN VBZ that there VBP RB JJ JJ NNS that VBP VBG VBN . RB our NN VBZ that there VBZ RB VBG to VB a NN , but there VBP VBG to VB JJ JJ NNS . The one NN that VBZ JJ from our NN VBZ that the JJ NN of these JJ NN NNS VBP on one JJ NN , which VBZ the NN NN . And we VBD RB JJ NNS , both in NNS of NN and NN NNS against the NN , which VBZ RB JJ NN , because this VBD RB a VBN . In this JJ NN , it RB VBZ that it VBZ a JJ NN for all three JJ NNS of JJ NN — which VBZ RB for NNS that VBP VBG the NN - VBN NNS . At the JJ NN , our NNS VBD that there VBD NNS RB against JJ NNS of the NN , which VBZ the NN to VBG that RB these JJ NNS could RB VB VBN to RB VB a NN NN . VB JJR about the NN NN from JJ NNP RB . And VB NN from our JJ NN of NNS RB ."
81,302,mainstream,"Scientists_NNS around_IN the_DT world_NN are_VBP racing_VBG to_TO find_VB ways_NNS out_IN of_IN the_DT new_JJ coronavirus_NN pandemic_NN ._. Some_DT are_VBP working_VBG to_TO develop_VB new_JJ drugs_NNS and_CC vaccines_NNS ,_, while_IN others_NNS are_VBP looking_VBG to_TO see_VB whether_IN therapies_NNS we_PRP already_RB have_VBP may_MD help_VB against_IN COVID_NN -_HYPH 19_CD ._. In_IN the_DT latter_JJ category_NN ,_, researchers_NNS have_VBP dusted_VBN off_RP one_CD intriguing_JJ compound_NN in_IN our_PRP$ collective_JJ medicine_NN cabinet_NN —_: a_DT century_NN -_HYPH old_JJ vaccine_NN to_TO fight_VB tuberculosis_NN ,_, a_DT bacterial_JJ disease_NN that_WDT affects_VBZ the_DT lungs_NNS ._. A_DT couple_NN of_IN early_JJ analyses_NNS ,_, which_WDT have_VBP yet_RB to_TO be_VB peer_NN -_HYPH reviewed_VBN ,_, have_VBP found_VBN that_IN countries_NNS that_WDT require_VBP this_DT vaccine_NN ,_, called_VBN Bacillus_NNP Calmette–Guérin_NNP (_-LRB- BCG_NNP )_-RRB- ,_, seemed_VBD to_TO have_VB been_VBN hit_VBN less_RBR severely_RB ,_, in_IN terms_NNS of_IN both_CC number_NN and_CC severity_NN ,_, by_IN the_DT coronavirus_NN that_WDT causes_VBZ the_DT disease_NN COVID_NN -_HYPH 19_CD ._. Could_MD this_DT vaccine_NN be_VB protecting_VBG people_NNS from_IN COVID_NNP -_HYPH 19_CD ?_. The_DT short_JJ answer_NN is_VBZ :_: We_PRP do_VBP n't_RB know_VB ._. But_CC several_JJ clinical_JJ trials_NNS around_IN the_DT world_NN are_VBP now_RB examining_VBG whether_IN this_DT vaccine_NN could_MD protect_VB against_IN this_DT new_JJ foe_NN ._. ""_`` I_PRP was_VBD originally_RB quite_RB skeptical_JJ ""_'' that_IN the_DT studies_NNS could_MD tease_VB apart_RB all_DT of_IN the_DT other_JJ factors_NNS that_WDT could_MD be_VB causing_VBG some_DT countries_NNS to_TO be_VB hit_VBN harder_RBR with_IN COVID_NN -_HYPH 19_CD than_IN others_NNS ,_, ”_'' said_VBD Paula_NNP Cannon_NNP ,_, a_DT distinguished_JJ professor_NN of_IN molecular_JJ microbiology_NN and_CC immunology_NN at_IN the_DT University_NNP of_IN Southern_NNP California_NNP 's_POS Keck_NNP School_NNP of_IN Medicine_NNP ,_, who_WP is_VBZ not_RB a_DT part_NN of_IN any_DT of_IN these_DT studies_NNS ._. Among_IN those_DT factors_NNS are_VBP the_DT quality_NN of_IN the_DT healthcare_NN system_NN ,_, measures_NNS put_VBN in_IN place_NN to_TO fight_VB the_DT disease_NN and_CC testing_NN capacity_NN ._. Still_RB ,_, it_PRP is_VBZ a_DT ""_`` provocative_JJ idea_NN ""_'' and_CC the_DT ""_`` data_NNS is_VBZ tantalizing_VBG ,_, ""_'' Cannon_NNP said_VBD ._. Dozens_NNS of_IN countries_NNS ,_, including_VBG Japan_NNP and_CC China_NNP ,_, require_VBP children_NNS —_: typically_RB newborns_NNS —_: to_TO receive_VB the_DT BCG_NNP vaccine_NN as_IN protection_NN against_IN tuberculosis_NN ,_, an_DT infection_NN that_WDT is_VBZ typically_RB more_RBR common_JJ in_IN lower_JJR -_HYPH income_NN countries_NNS ._. Other_JJ countries_NNS ,_, such_JJ as_IN Spain_NNP ,_, France_NNP and_CC Switzerland_NNP ,_, used_VBD to_TO require_VB the_DT vaccine_NN but_CC stopped_VBD because_IN the_DT risk_NN of_IN catching_VBG the_DT disease_NN in_IN those_DT countries_NNS lessened_VBD ,_, according_VBG to_IN one_CD of_IN the_DT preprint_JJ studies_NNS published_VBN in_IN medRxiv_NNP on_IN March_NNP 28_CD ._. Other_JJ countries_NNS ,_, such_JJ as_IN the_DT U.S._NNP ,_, Italy_NNP and_CC the_DT Netherlands_NNPS never_RB had_VBD such_PDT a_DT universal_JJ vaccine_NN policy_NN for_IN the_DT BCG_NN vaccine_NN ._. But_CC scientists_NNS have_VBP long_RB known_VBN that_IN ""_`` almost_RB by_IN lucky_JJ accident_NN ,_, ""_'' the_DT BCG_NNP vaccine_NN does_VBZ n't_RB just_RB protect_VB against_IN tuberculosis_NN ,_, it_PRP also_RB helps_VBZ fight_VB other_JJ viruses_NNS ,_, respiratory_JJ infections_NNS in_IN particular_JJ ,_, Cannon_NNP said_VBD ._. The_DT vaccine_NN ,_, ""_`` in_IN some_DT sort_NN of_IN unexpected_JJ and_CC magical_JJ way_NN ,_, is_VBZ like_IN a_DT broad_JJ immune_JJ booster_NN ,_, ""_'' she_PRP said_VBD ._. For_IN example_NN ,_, one_CD study_NN conducted_VBN in_IN Guinea_NNP -_HYPH Bissau_NNP in_IN West_NNP Africa_NNP found_VBD that_IN children_NNS who_WP were_VBD vaccinated_VBN with_IN BCG_NNP had_VBD about_RB a_DT 50_CD %_NN reduction_NN in_IN overall_JJ mortality_NN ,_, largely_RB because_IN the_DT vaccine_NN reduced_VBD respiratory_JJ infections_NNS and_CC sepsis_NN ,_, or_CC blood_NN poisoning_NN ,_, according_VBG to_IN the_DT medRxiv_NNP study_NN ._. Other_JJ studies_NNS ,_, mostly_RB conducted_VBN in_IN animals_NNS ,_, have_VBP found_VBN similar_JJ broad_JJ -_HYPH spectrum_NN protections_NNS from_IN the_DT BCG_NN vaccine_NN ._. The_DT BCG_NNP vaccine_NN is_VBZ made_VBN up_RP of_IN weakened_VBN forms_NNS of_IN live_JJ Mycobacterium_NN bovis_NN ,_, closely_RB related_JJ to_IN the_DT bacteria_NN that_WDT causes_VBZ tuberculosis_NN ._. It_PRP was_VBD first_RB developed_VBN in_IN the_DT 1920s_NNS in_IN Paris_NNP and_CC later_RBR shipped_VBD all_RB over_IN the_DT world_NN ._. Now_RB ,_, countries_NNS from_IN Japan_NNP to_IN Denmark_NNP have_VBP their_PRP$ own_JJ BCG_NN vaccines_NNS ,_, made_VBN using_VBG different_JJ formulations_NNS of_IN live_JJ bacteria_NN —_: and_CC each_DT one_NN has_VBZ varying_JJ degrees_NNS of_IN immune_NN -_HYPH boosting_VBG ability_NN ,_, said_VBD Dr._NNP Ofer_NNP Levy_NNP ,_, the_DT director_NN of_IN the_DT precision_JJ vaccines_NNS program_NN at_IN Boston_NNP Children_NNP 's_POS Hospital_NNP and_CC a_DT professor_NN at_IN Harvard_NNP Medical_NNP School_NNP ._. Typically_RB ,_, live_JJ vaccines_NNS provide_VBP a_DT ""_`` strong_JJ and_CC long_JJ -_HYPH lasting_VBG immune_JJ response_NN ""_'' and_CC sometimes_RB even_RB ""_`` lifelong_JJ protection_NN ""_'' against_IN the_DT germ_NN ,_, whereas_IN inactivated_VBN forms_NNS of_IN vaccines_NNS ,_, such_JJ as_IN those_DT in_IN flu_NN shots_NNS do_VBP n't_RB provide_VB immunity_NN that_WDT 's_VBZ ""_`` as_RB strong_JJ ,_, ""_'' according_VBG to_IN the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ._. While_IN most_JJS vaccines_NNS prompt_VBP one_CD arm_NN of_IN the_DT immune_JJ system_NN —_: the_DT adaptive_JJ immune_NN system_NN —_: to_TO create_VB antibodies_NNS that_WDT target_VBP very_RB specific_JJ pathogens_NNS ,_, the_DT BCG_NNP vaccine_NN taps_VBZ into_IN the_DT other_JJ arm_NN ,_, the_DT innate_JJ immune_NN system_NN ._. This_DT system_NN does_VBZ n't_RB discriminate_VB against_IN pathogens_NNS and_CC releases_VBZ immune_NN cells_NNS rather_RB quickly_RB to_TO fight_VB any_DT foreign_JJ substance_NN ._. The_DT BCG_NNP vaccine_NN thus_RB boosts_VBZ the_DT body_NN 's_POS production_NN of_IN non-specific_JJ immune_NN cells_NNS ._. The_DT medRxiv_NNP study_NN and_CC another_DT preliminary_JJ study_NN recently_RB published_VBN in_IN Research_NNP Gate_NNP came_VBD to_IN similar_JJ conclusions_NNS :_: there_EX seemed_VBD to_TO be_VB a_DT correlation_NN between_IN countries_NNS that_WDT require_VBP BCG_NN vaccines_NNS and_CC a_DT reduced_VBN spread_NN and_CC severity_NN of_IN COVID_NN -_HYPH 19_CD cases_NNS ._. For_IN example_NN ,_, Portugal_NNP —_: which_WDT has_VBZ required_VBN BCG_NNP vaccines_NNS for_IN infants_NNS —_: has_VBZ over_RB 16,000_CD cases_NNS of_IN COVID_NN -_HYPH 19_CD but_CC only_RB 535_CD deaths_NNS whereas_IN neighboring_VBG Spain_NNP has_VBZ over_RB 169,000_CD cases_NNS and_CC over_RB 17,000_CD deaths_NNS ._. Similarly_RB ,_, Ireland_NNP ,_, with_IN 9,655_CD cases_NNS and_CC only_RB 334_CD deaths_NNS ,_, requires_VBZ the_DT BCG_NN vaccination_NN ,_, whereas_IN the_DT U.K._NNP with_IN 89,554_CD cases_NNS and_CC 11,346_CD deaths_NNS no_RB longer_RBR does_VBZ ._. Based_VBN on_IN these_DT numbers_NNS ,_, Ireland_NNP has_VBZ a_DT fatality_NN rate_NN 3.5_CD %_NN whereas_IN the_DT U.K._NNP has_VBZ a_DT fatality_NN rate_NN of_IN 12.7_CD %_NN ._. Of_IN course_NN ,_, there_EX are_VBP big_JJ population_NN number_NN differences_NNS across_IN these_DT countries_NNS ,_, along_IN with_IN other_JJ variables_NNS that_WDT could_MD affect_VB death_NN and_CC infection_NN rates_NNS ._. These_DT preliminary_JJ studies_NNS are_VBP ""_`` very_RB flawed_JJ ,_, ""_'' because_IN many_JJ factors_NNS such_JJ as_IN differences_NNS in_IN wealth_NN and_CC testing_NN ability_NN ,_, can_MD affect_VB the_DT outcomes_NNS Levy_NNP told_VBD Live_NNP Science_NNP ._. But_CC the_DT authors_NNS are_VBP ""_`` doing_VBG the_DT best_JJS they_PRP can_MD in_IN a_DT very_RB difficult_JJ situation_NN ._. ""_'' While_IN there_EX 's_VBZ no_DT direct_JJ evidence_NN that_IN BCG_NNP vaccines_NNS will_MD reduce_VB people_NNS 's_POS risk_NN of_IN developing_VBG COVID_NN -_HYPH 19_CD ,_, ""_`` I_PRP 'm_VBP enthusiastic_JJ about_IN the_DT hypotheses_NNS ,_, ""_'' Levy_NNP said_VBD ._. It_PRP 's_VBZ difficult_JJ to_TO draw_VB firm_JJ conclusions_NNS ,_, but_CC there_EX 's_VBZ enough_JJ scientific_JJ evidence_NN to_TO prompt_VB clinical_JJ trials_NNS ,_, and_CC his_PRP$ team_NN is_VBZ looking_VBG into_IN starting_VBG one_CD in_IN the_DT U.S_NNP ,_, he_PRP said_VBD ._. Clinical_JJ trials_NNS analyzing_VBG the_DT protective_JJ effects_NNS of_IN the_DT vaccine_NN against_IN COVID_NN -_HYPH 19_CD are_VBP already_RB underway_JJ in_IN other_JJ countries_NNS ,_, including_VBG Australia_NNP and_CC the_DT Netherlands_NNPS ._. ""_`` I_PRP 'm_VBP kind_NN of_IN puzzled_JJ ,_, ""_'' by_IN the_DT implication_NN that_IN the_DT BCG_NNP vaccine_NN might_MD be_VB able_JJ to_TO protect_VB for_IN such_PDT a_DT long_JJ period_NN of_IN time_NN once_IN someone_NN has_VBZ received_VBN it_PRP as_IN a_DT baby_NN ,_, Cannon_NNP said_VBD ._. Indeed_RB ,_, it_PRP 's_VBZ not_RB clear_JJ how_WRB long_RB the_DT BCG_NNP vaccine_NN effects_NNS can_MD last_VB ._. The_DT second_JJ study_NN ,_, which_WDT also_RB has_VBZ not_RB been_VBN peer_NN -_HYPH reviewed_VBN ,_, analyzed_VBN how_WRB countries_NNS with_IN re-vaccination_NN policies_NNS —_: or_CC booster_NN shots_NNS —_: fared_VBN in_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._. That_DT study_NN found_VBD that_IN countries_NNS without_IN re-vaccination_NN policies_NNS had_VBD a_DT 5.2_CD %_NN case_NN fatality_NN rate_NN ,_, versus_IN a_DT 0.6_CD %_NN case_NN fatality_NN rate_NN in_IN countries_NNS that_WDT required_VBD re-vaccination_NN ._. ""_`` The_DT big_JJ kind_NN of_IN asterisk_NN ,_, if_IN you_PRP like_VBP ,_, against_IN all_DT of_IN these_DT studies_NNS ,_, is_VBZ that_IN they_PRP are_VBP really_RB dealing_VBG with_IN massively_RB incomplete_JJ information_NN ,_, ""_'' Cannon_NNP said_VBD ._. ""_`` We_PRP 're_VBP all_RB guessing_VBG what_WP the_DT true_JJ infection_NN rates_NNS and_CC the_DT case_NN fatality_NN rates_NNS are_VBP because_IN there_EX is_VBZ n't_RB widespread_JJ uniform_NN testing_NN in_IN every_DT country_NN ._. ""_'' Still_RB ,_, ""_`` I_PRP applaud_VBP the_DT authors_NNS for_IN at_IN least_JJS ,_, you_PRP know_VBP ,_, doing_VBG what_WP they_PRP could_MD with_IN the_DT available_JJ data_NNS and_CC providing_VBG some_DT very_RB provocative_JJ hypotheses_NNS ,_, ""_'' she_PRP said_VBD ._. ""_`` The_DT good_JJ news_NN is_VBZ they_PRP 're_VBP very_RB testable_JJ ._. ""_'' In_IN another_DT world_NN ,_, we_PRP would_MD be_VB doing_VBG animal_NN experiments_NNS to_TO test_VB this_DT hypothesis_NN ._. In_IN this_DT world_NN ,_, amid_IN the_DT coronavirus_NN pandemic_NN ,_, we_PRP do_VBP n't_RB have_VB time_NN for_IN that_DT ,_, she_PRP said_VBD ._. But_CC the_DT BCG_NNP vaccine_NN has_VBZ a_DT ""_`` very_RB safe_JJ track_NN record_NN ,_, ""_'' and_CC likely_RB can_MD be_VB tried_VBN in_IN those_DT who_WP are_VBP n't_RB old_JJ and_CC who_WP do_VBP n't_RB have_VB weakened_VBN immune_NN systems_NNS (_-LRB- since_IN this_DT is_VBZ a_DT live_JJ vaccine_NN ,_, it_PRP can_MD potentially_RB cause_VB more_JJR side_NN effects_NNS for_IN older_JJR people_NNS or_CC those_DT with_IN weakened_VBN immune_NN systems_NNS )_-RRB- ,_, she_PRP added_VBD ._. The_DT human_JJ immune_NN system_NN is_VBZ like_IN an_DT orchestra_NN ,_, ""_`` it_PRP 's_VBZ massively_RB interconnected_VBN and_CC what_WP the_DT BCG_NNP vaccine_NN seems_VBZ to_TO do_VB is_VBZ maybe_RB it_PRP gives_VBZ like_UH a_DT little_JJ bit_NN of_IN extra_JJ control_NN to_IN the_DT conductor_NN ,_, ""_'' Cannon_NNP said_VBD ._. ""_`` So_RB in_IN the_DT symphony_NN of_IN immune_JJ attack_NN against_IN respiratory_JJ viruses_NNS ,_, the_DT orchestra_NN is_VBZ able_JJ to_TO go_VB full_JJ blast_NN ,_, straightaway_NN ,_, all_RB together_RB ,_, in_IN sync_NN ,_, rather_RB than_IN kind_NN of_IN playing_VBG catch_NN up_RP ._. ""_'' •_SYM 11_CD (_-LRB- sometimes_RB )_-RRB- deadly_JJ diseases_NNS that_WDT hopped_VBD across_IN species_NNS","NNS around the NN VBP VBG to VB NNS out of the JJ NN NN . Some VBP VBG to VB JJ NNS and NNS , while NNS VBP VBG to VB whether NNS we RB VBP may VB against NN - 19 . In the JJ NN , NNS VBP VBN off one JJ NN in our JJ NN NN — a NN - JJ NN to VB NN , a JJ NN that VBZ the NNS . A NN of JJ NNS , which VBP RB to VB NN - VBN , VBP VBN that NNS that VBP this NN , VBN NNP NNP ( NNP ) , VBD to VB VBN VBN RBR RB , in NNS of both NN and NN , by the NN that VBZ the NN NN - 19 . Could this NN VB VBG NNS from NNP - 19 ? The JJ NN VBZ : We VBP RB VB . But JJ JJ NNS around the NN VBP RB VBG whether this NN could VB against this JJ NN . "" I VBD RB RB JJ "" that the NNS could VB RB all of the JJ NNS that could VB VBG some NNS to VB VBN RBR with NN - 19 than NNS , ” VBD NNP NNP , a JJ NN of JJ NN and NN at the NNP of NNP NNP 's NNP NNP of NNP , who VBZ RB a NN of any of these NNS . Among those NNS VBP the NN of the NN NN , NNS VBN in NN to VB the NN and NN NN . RB , it VBZ a "" JJ NN "" and the "" NNS VBZ VBG , "" NNP VBD . NNS of NNS , VBG NNP and NNP , VBP NNS — RB NNS — to VB the NNP NN as NN against NN , an NN that VBZ RB RBR JJ in JJR - NN NNS . JJ NNS , JJ as NNP , NNP and NNP , VBD to VB the NN but VBD because the NN of VBG the NN in those NNS VBD , VBG to one of the JJ NNS VBN in NNP on NNP 28 . JJ NNS , JJ as the NNP , NNP and the NNPS RB VBD such a JJ NN NN for the NN NN . But NNS VBP RB VBN that "" RB by JJ NN , "" the NNP NN VBZ RB RB VB against NN , it RB VBZ VB JJ NNS , JJ NNS in JJ , NNP VBD . The NN , "" in some NN of JJ and JJ NN , VBZ like a JJ JJ NN , "" she VBD . For NN , one NN VBN in NNP - NNP in NNP NNP VBD that NNS who VBD VBN with NNP VBD RB a 50 NN NN in JJ NN , RB because the NN VBD JJ NNS and NN , or NN NN , VBG to the NNP NN . JJ NNS , RB VBN in NNS , VBP VBN JJ JJ - NN NNS from the NN NN . The NNP NN VBZ VBN up of VBN NNS of JJ NN NN , RB JJ to the NN that VBZ NN . It VBD RB VBN in the NNS in NNP and RBR VBD RB over the NN . RB , NNS from NNP to NNP VBP their JJ NN NNS , VBN VBG JJ NNS of JJ NN — and each NN VBZ JJ NNS of NN - VBG NN , VBD NNP NNP NNP , the NN of the JJ NNS NN at NNP NNP 's NNP and a NN at NNP NNP NNP . RB , JJ NNS VBP a "" JJ and JJ - VBG JJ NN "" and RB RB "" JJ NN "" against the NN , whereas VBN NNS of NNS , JJ as those in NN NNS VBP RB VB NN that VBZ "" RB JJ , "" VBG to the NNP NNP of NNP and NNP NNPS . While JJS NNS VBP one NN of the JJ NN — the JJ NN NN — to VB NNS that VBP RB JJ NNS , the NNP NN VBZ into the JJ NN , the JJ NN NN . This NN VBZ RB VB against NNS and VBZ NN NNS RB RB to VB any JJ NN . The NNP NN RB VBZ the NN 's NN of JJ NN NNS . The NNP NN and another JJ NN RB VBN in NNP NNP VBD to JJ NNS : there VBD to VB a NN between NNS that VBP NN NNS and a VBN NN and NN of NN - 19 NNS . For NN , NNP — which VBZ VBN NNP NNS for NNS — VBZ RB 16,000 NNS of NN - 19 but RB 535 NNS whereas VBG NNP VBZ RB 169,000 NNS and RB 17,000 NNS . RB , NNP , with 9,655 NNS and RB 334 NNS , VBZ the NN NN , whereas the NNP with 89,554 NNS and 11,346 NNS RB RBR VBZ . VBN on these NNS , NNP VBZ a NN NN 3.5 NN whereas the NNP VBZ a NN NN of 12.7 NN . Of NN , there VBP JJ NN NN NNS across these NNS , along with JJ NNS that could VB NN and NN NNS . These JJ NNS VBP "" RB JJ , "" because JJ NNS JJ as NNS in NN and NN NN , can VB the NNS NNP VBD NNP NNP . But the NNS VBP "" VBG the JJS they can in a RB JJ NN . "" While there VBZ no JJ NN that NNP NNS will VB NNS 's NN of VBG NN - 19 , "" I VBP JJ about the NNS , "" NNP VBD . It VBZ JJ to VB JJ NNS , but there VBZ JJ JJ NN to VB JJ NNS , and his NN VBZ VBG into VBG one in the NNP , he VBD . JJ NNS VBG the JJ NNS of the NN against NN - 19 VBP RB JJ in JJ NNS , VBG NNP and the NNPS . "" I VBP NN of JJ , "" by the NN that the NNP NN might VB JJ to VB for such a JJ NN of NN once NN VBZ VBN it as a NN , NNP VBD . RB , it VBZ RB JJ how RB the NNP NN NNS can VB . The JJ NN , which RB VBZ RB VBN NN - VBN , VBN how NNS with NN NNS — or NN NNS — VBN in the NN - 19 NN . That NN VBD that NNS without NN NNS VBD a 5.2 NN NN NN NN , versus a 0.6 NN NN NN NN in NNS that VBD NN . "" The JJ NN of NN , if you VBP , against all of these NNS , VBZ that they VBP RB VBG with RB JJ NN , "" NNP VBD . "" We VBP RB VBG what the JJ NN NNS and the NN NN NNS VBP because there VBZ RB JJ NN NN in every NN . "" RB , "" I VBP the NNS for at JJS , you VBP , VBG what they could with the JJ NNS and VBG some RB JJ NNS , "" she VBD . "" The JJ NN VBZ they VBP RB JJ . "" In another NN , we would VB VBG NN NNS to VB this NN . In this NN , amid the NN NN , we VBP RB VB NN for that , she VBD . But the NNP NN VBZ a "" RB JJ NN NN , "" and RB can VB VBN in those who VBP RB JJ and who VBP RB VB VBN NN NNS ( since this VBZ a JJ NN , it can RB VB JJR NN NNS for JJR NNS or those with VBN NN NNS ) , she VBD . The JJ NN NN VBZ like an NN , "" it VBZ RB VBN and what the NNP NN VBZ to VB VBZ RB it VBZ like a JJ NN of JJ NN to the NN , "" NNP VBD . "" RB in the NN of JJ NN against JJ NNS , the NN VBZ JJ to VB JJ NN , NN , RB RB , in NN , RB than NN of VBG NN up . "" • 11 ( RB ) JJ NNS that VBD across NNS"
82,448,conspiracy,"26_CD year_NN old_JJ Woman_NN and_CC family_NN say_VBP the_DT CDC_NNP and_CC Health_NN officials_NNS want_VBP her_PRP under_IN quarantine_NN and_CC to_TO get_VB a_DT vaccine_NN or_CC “_`` Go_VB to_IN Jail_NN ”_'' OR_CC be_VB charged_VBN criminally_RB ._. Family_NN says_VBZ they_PRP feel_VBP threatened_VBN ._. The_DT CDC_NNP and_CC local_JJ Health_NNP Officials_NNS have_VBP called_VBN and_CC showed_VBN up_RP uninvited_JJ to_IN their_PRP$ home_NN ._. The_DT frightened_VBN family_NN was_VBD served_VBN a_DT home_NN intervention_NN notice_NN too_RB ._. Just_RB moments_NNS after_IN we_PRP published_VBD our_PRP$ friends_NNS in_IN Washington_NNP DC_NNP ’s_POS piece_NN (_-LRB- Alliance_NNP for_IN Natural_NNP Health_NNP )_-RRB- about_IN how_WRB a_DT new_JJ federal_JJ order_NN could_MD allow_VB you_PRP to_TO be_VB locked_VBN up_RP and_CC given_VBN drugs_NNS against_IN your_PRP$ will_NN -_, we_PRP saw_VBD the_DT following_VBG about_IN a_DT young_JJ girl_NN in_IN South_NNP Pasadena_NNP :_: Twenty_CD six_CD year_NN old_JJ graduate_NN student_NN Ylsa_NNP Tellez_NNP and_CC her_PRP$ family_NN received_VBD an_DT official_JJ home_NN intervention_NN notice_NN from_IN the_DT county_NN in_IN Los_NNP Angeles_NNP (_-LRB- Ylsa_NNP and_CC her_PRP$ family_NN live_VBP in_IN the_DT suburb_NN of_IN Pasadena_NNP )_-RRB- The_DT CDC_NNP and_CC county_NN officials_NNS have_VBP threatened_VBN this_DT intervention_NN (_-LRB- with_IN possible_JJ jail_NN time_NN and_CC charges_NNS )_-RRB- if_IN she_PRP does_VBZ n’t_RB quarantine_VB herself_PRP and_CC or_CC do_VB a_DT forced_VBN vaccination_NN ._. Ylsa_NNP ’s_POS younger_JJR sister_NN has_VBZ the_DT measles_NNS but_CC had_VBD a_DT full_JJ recovery_NN (_-LRB- like_IN many_JJ healthy_JJ kids_NNS have_VBP for_IN centuries_NNS )_-RRB- and_CC she_PRP is_VBZ asymptomatic_JJ ._. Also_RB the_DT family_NN got_VBD a_DT call_NN from_IN the_DT CDC_NNP and_CC wants_VBZ her_PRP to_TO get_VB vaccinated_VBN and_CC quarantine_VB herself_PRP ._. She_PRP is_VBZ resisting_VBG and_CC insists_VBZ she_PRP ’s_VBZ not_RB sick_JJ and_CC that_IN they_PRP cannot_MD force_VB her_PRP to_TO get_VB a_DT vaccine_NN (_-LRB- or_CC intervene_VB as_IN she_PRP is_VBZ 26_CD years_NNS old_JJ )_-RRB- but_CC she_PRP is_VBZ weighing_VBG her_PRP$ options_NNS right_RB now_RB and_CC will_MD see_VB if_IN she_PRP gets_VBZ the_DT shot_NN or_CC not_RB ._. From_IN the_DT article_NN on_IN Ylsa_NNP who_WP could_MD be_VB forced_VBN into_IN quarantine_NN and_CC vaccinated_VBN ._. Ylsa_NNP has_VBZ no_DT symptoms_NNS and_CC feels_VBZ perfectly_RB healthy_JJ ,_, but_CC she_PRP said_VBD she_PRP received_VBD a_DT call_NN on_IN Tuesday_NNP from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP and_CC got_VBD a_DT visit_NN by_IN the_DT local_JJ health_NN department_NN ,_, both_DT of_IN whom_WP wanted_VBD her_PRP to_TO quarantine_VB herself_PRP inside_RB ._. “_`` (_-LRB- They_PRP were_VBD )_-RRB- saying_VBG I_PRP need_VBP to_TO get_VB vaccinated_VBN and_CC I_PRP need_VBP to_TO be_VB quarantined_VBN ,_, otherwise_RB I_PRP ’m_VBP going_VBG to_TO go_VB to_IN jail_NN or_CC something_NN ,_, or_CC I_PRP ’m_VBP going_VBG to_TO get_VB a_DT misdemeanor_NN ,_, ”_'' said_VBD Ylsa_NNP ._. Ylsa_NNP says_VBZ she_PRP refuses_VBZ to_TO be_VB a_DT prisoner_NN in_IN her_PRP$ own_JJ home_NN despite_IN the_DT possible_JJ quarantine_NN order_NN ._. Ylsa_NNP ’s_POS mother_NN is_VBZ also_RB defending_VBG her_PRP$ daughter_NN ._. “_`` It_PRP ’s_VBZ not_RB nice_JJ when_WRB my_PRP$ daughter_NN is_VBZ threatened_VBN like_IN this_DT because_IN she_PRP ’s_VBZ not_RB even_RB sick_JJ ,_, ”_'' said_VBD Myrna_NNP Tellez_NNP ._. Her_PRP$ mother_NN said_VBD on_IN video_NN above_RB she_PRP does_VBZ not_RB like_VB the_DT fact_NN her_PRP$ daughter_NN was_VBD threatened_VBN like_IN this_DT by_IN the_DT health_NN officials_NNS and_CC the_DT CDC_NNP ._. Yisa_NNP goes_VBZ on_RP to_TO say_VB We_PRP feel_VBP for_IN Ylsa_NNP and_CC hope_VBP that_IN she_PRP and_CC her_PRP$ family_NN are_VBP n’t_RB forced_VBN to_TO vaccinate_VB against_IN a_DT 26_CD year_NN old_JJ WOMAN_NN ’s_POS wishes_NNS ._. Her_PRP$ sister_NN fully_RB recovered_VBD and_CC she_PRP ’s_VBZ not_RB symptomatic_JJ and_CC is_VBZ taking_VBG immune_NN boosting_VBG supplements_NNS ._. She_PRP said_VBD she_PRP ’ll_MD meet_VB with_IN her_PRP$ doctor_NN tomorrow_NN to_TO make_VB a_DT decision_NN ._. ABOUT_IN THE_DT FOUNDER_NN AND_CC AUTHOR_NN OF_IN HEALTH_NN NUT_NN NEWS_NN Erin_NNP is_VBZ an_DT animal_NN lover_NN ,_, rescuer_NN ,_, writer_NN and_CC long_JJ time_NN green_JJ eco_NN health_NN nut_NN ._. She_PRP ’s_VBZ survived_VBN Lyme_NNP ,_, being_VBG aborted_VBN (_-LRB- legally_RB )_-RRB- a_DT severe_JJ vaccine_NN injury_NN ,_, 22_CD hurricanes_NNS ,_, a_DT tornado_NN that_WDT took_VBD their_PRP$ house_NN and_CC pets_NNS and_CC a_DT six_CD hour_NN surgery_NN that_WDT might_MD have_VB saved_VBN her_PRP$ life_NN ._. She_PRP ’s_VBZ worked_VBN in_IN the_DT natural_JJ health_NN world_NN and_CC done_VBN volunteer_NN work_NN in_IN the_DT same_JJ arena_NN for_IN nearly_RB 25_CD years_NNS ._. You_PRP can_MD follow_VB her_PRP here_RB on_IN Facebook_NNP ps_NN and_CC sign_VB up_RP for_IN her_PRP$ free_JJ eBook_NN here_RB which_WDT has_VBZ now_RB been_VBN downloaded_VBN thousands_NNS of_IN times_NNS Copyright_NN 2020_CD –_: permission_NN to_TO reprint_VB fully_RB granted_VBN ,_, WITH_IN links_NNS to_IN original_JJ story_NN","26 NN JJ NN and NN VBP the NNP and NN NNS VBP her under NN and to VB a NN or “ VB to NN ” OR VB VBN RB . NN VBZ they VBP VBN . The NNP and JJ NNP NNS VBP VBN and VBN up JJ to their NN . The VBN NN VBD VBN a NN NN NN RB . RB NNS after we VBD our NNS in NNP NNP ’s NN ( NNP for NNP NNP ) about how a JJ JJ NN could VB you to VB VBN up and VBN NNS against your NN - we VBD the VBG about a JJ NN in NNP NNP : Twenty six NN JJ NN NN NNP NNP and her NN VBD an JJ NN NN NN from the NN in NNP NNP ( NNP and her NN VBP in the NN of NNP ) The NNP and NN NNS VBP VBN this NN ( with JJ NN NN and NNS ) if she VBZ RB VB herself and or VB a VBN NN . NNP ’s JJR NN VBZ the NNS but VBD a JJ NN ( like JJ JJ NNS VBP for NNS ) and she VBZ JJ . RB the NN VBD a NN from the NNP and VBZ her to VB VBN and VB herself . She VBZ VBG and VBZ she VBZ RB JJ and that they cannot VB her to VB a NN ( or VB as she VBZ 26 NNS JJ ) but she VBZ VBG her NNS RB RB and will VB if she VBZ the NN or RB . From the NN on NNP who could VB VBN into NN and VBN . NNP VBZ no NNS and VBZ RB JJ , but she VBD she VBD a NN on NNP from the NNPS for NNP NNP and NNP and VBD a NN by the JJ NN NN , both of whom VBD her to VB herself RB . “ ( They VBD ) VBG I VBP to VB VBN and I VBP to VB VBN , RB I VBP VBG to VB to NN or NN , or I VBP VBG to VB a NN , ” VBD NNP . NNP VBZ she VBZ to VB a NN in her JJ NN despite the JJ NN NN . NNP ’s NN VBZ RB VBG her NN . “ It VBZ RB JJ when my NN VBZ VBN like this because she VBZ RB RB JJ , ” VBD NNP NNP . Her NN VBD on NN RB she VBZ RB VB the NN her NN VBD VBN like this by the NN NNS and the NNP . NNP VBZ on to VB We VBP for NNP and VBP that she and her NN VBP RB VBN to VB against a 26 NN JJ NN ’s NNS . Her NN RB VBD and she VBZ RB JJ and VBZ VBG NN VBG NNS . She VBD she ’ll VB with her NN NN to VB a NN . ABOUT THE NN AND NN OF NN NN NN NNP VBZ an NN NN , NN , NN and JJ NN JJ NN NN NN . She VBZ VBN NNP , VBG VBN ( RB ) a JJ NN NN , 22 NNS , a NN that VBD their NN and NNS and a six NN NN that might VB VBN her NN . She VBZ VBN in the JJ NN NN and VBN NN NN in the JJ NN for RB 25 NNS . You can VB her RB on NNP NN and VB up for her JJ NN RB which VBZ RB VBN VBN NNS of NNS NN 2020 – NN to VB RB VBN , WITH NNS to JJ NN"
83,925,conspiracy,"ALERT_NN :_: Vaccine_NN advocate_NN threatens_VBZ mass_JJ murder_NN “_`` suicide_NN mission_NN ”_'' shooting_NN at_IN public_JJ autism_NN event_NN …_. “_`` I_PRP ’m_VBP gonna_TO kill_VB every_DT single_JJ one_CD of_IN you_PRP f##kers_NNS …_: see_VB you_PRP in_IN Hell_NNP ”_'' (_-LRB- VIDEO_NN )_-RRB- Thanks_NN to_IN the_DT extreme_JJ hatred_NN being_VBG whipped_VBN up_RP against_IN autism_NN truth_NN advocates_NNS by_IN vaccine_NN propagandists_NNS such_JJ as_IN Jimmy_NNP Kimmel_NNP ,_, deranged_VBN science_NN troll_VB Dr._NNP David_NNP Gorski_NNP and_CC the_DT “_`` fake_JJ news_NN ”_'' media_NN that_WDT ’s_VBZ beholden_VBN to_IN vaccine_NN industry_NN propaganda_NN ,_, vaccine_NN pushers_NNS are_VBP now_RB resorting_VBG to_IN extreme_JJ threats_NNS of_IN violence_NN and_CC mass_JJ shootings_NNS to_TO try_VB to_TO silence_VB vaccine_NN truth_NN researchers_NNS ,_, authors_NNS and_CC lecturers_NNS ._. In_IN the_DT last_JJ 48_CD hours_NNS ,_, Dr._NNP Suzanne_NNP Humphries_NNP ,_, creator_NN of_IN the_DT Honesty_NNP vs._IN Policy_NNP presentation_NN and_CC author_NN of_IN Dissolving_NNP Illusions_NNPS —_: which_WDT expertly_RB dismantles_VBZ the_DT most_RBS persistent_JJ myths_NNS of_IN the_DT pseudoscience_NN vaccine_NN industry_NN —_: received_VBD a_DT shockingly_RB detailed_JJ death_NN threat_NN that_WDT promises_VBZ a_DT “_`` suicide_NN mission_NN ”_'' mass_NN shooting_NN at_IN a_DT public_JJ autism_NN event_NN ._. (_-LRB- Full_JJ email_NN reprinted_VBN below_RB ,_, WARNING_NN :_: GRAPHIC_NN ._. )_-RRB- “_`` I_PRP ’m_VBP gonna_TO make_VB you_PRP f#cking_VBG squeal_VB and_CC shake_VB on_IN the_DT ground_NN …_: bleeding_VBG out_RP ”_'' According_VBG to_IN the_DT graphic_JJ ,_, vulgar_JJ death_NN threat_NN received_VBN by_IN Dr._NNP Humphries_NNP ,_, the_DT would_MD -_HYPH be_VB killer_NN had_VBD plotted_VBN out_RP a_DT detailed_JJ kidnap_NN -_HYPH and_CC -_HYPH torture_NN scenario_NN that_WDT was_VBD engineered_VBN to_TO make_VB Dr._NNP Humphries_NNP “_`` bleed_VB out_RP ”_'' and_CC suffer_VB while_IN dying_VBG ,_, but_CC they_PRP ultimately_RB decided_VBD the_DT kidnapping_NN would_MD be_VB too_RB risky_JJ to_TO carry_VB out_RP ._. (_-LRB- See_VB details_NNS from_IN the_DT email_NN ,_, below_RB ._. )_-RRB- Instead_RB ,_, they_PRP are_VBP planning_VBG on_IN blending_VBG in_RP with_IN the_DT crowd_NN at_IN a_DT public_JJ autism_NN speaking_NN event_NN ,_, then_RB opening_VBG fire_NN on_IN the_DT speakers_NNS to_TO “_`` kill_VB every_DT single_JJ one_CD of_IN you_PRP f##kers_NNS ._. ”_'' “_`` I_PRP ’m_VBP gonna_TO step_VB right_RB out_RP from_IN the_DT pedestrians_NNS on_IN the_DT street_NN and_CC blast_VB you_PRP right_RB in_IN the_DT f#cking_NN chest_NN ,_, ”_'' the_DT threatening_JJ email_NN promises_VBZ ._. “_`` I_PRP ’m_VBP gonna_TO make_VB you_PRP f#cking_VBG squeal_VB and_CC shake_VB on_IN the_DT ground_NN ,_, flailing_VBG ,_, bleeding_VBG out_RP ._. I_PRP ’m_VBP gonna_TO kill_VB as_RB many_JJ of_IN you_PRP f#cks_NNS as_IN I_PRP can_MD before_IN I_PRP go_VBP down_RP ._. You_PRP ’re_VBP done_VBN bitch_NN ,_, do_VBP you_PRP understand_VB me_PRP ?_. ”_'' “_`` I_PRP ’ve_VBP finally_RB decided_VBN I_PRP have_VBP to_TO do_VB it_PRP ,_, no_RB more_RBR f#cking_VBG around_RB ,_, ”_'' the_DT vaccine_NN advocate_NN promises_VBZ ._. “_`` I_PRP want_VBP to_TO make_VB you_PRP scream_VB so_RB bad_JJ ,_, to_TO taste_VB your_PRP$ blood_NN and_CC watch_VB you_PRP scream_VB ,_, bitch_VB ._. ”_'' Here_RB ’s_VBZ a_DT full_JJ transcript_NN of_IN the_DT threat_NN letter_NN sent_VBN to_IN Dr._NNP Suzanne_NNP Humphries_NNP ,_, who_WP has_VBZ already_RB filed_VBN a_DT police_NN report_NN (_-LRB- and_CC FBI_NNP report_NN )_-RRB- over_IN the_DT threat_NN ._. WARNING_NN :_: Extreme_JJ profanity_NN and_CC vulgarity_NN :_: I_PRP ’m_VBP gonna_TO f#cking_VBG murder_VB you_PRP ,_, you_PRP stupid_JJ f#cking_VBG c#nt_NN ._. I_PRP ’m_VBP just_RB letting_VBG you_PRP know_VB ,_, just_RB to_TO let_VB you_PRP know_VB that_IN when_WRB it_PRP happens_VBZ ,_, you_PRP were_VBD f#cking_VBG warned_VBN bitch_NN ._. You_PRP ’re_VBP always_RB puttin_VBG your_PRP$ location_NN out_RB there_RB ,_, so_RB it_PRP ’s_VBZ real_JJ f#cking_NN easy_JJ to_TO get_VB to_IN you_PRP ._. I_PRP have_VBP a_DT nice_JJ beautiful_JJ Desert_NNP Eagle_NNP that_WDT ’s_VBZ gonna_TO be_VB used_VBN on_IN you_PRP ._. So_RB keep_VB thinkin_JJ all_PDT your_PRP$ health_NN sh#t_NN is_VBZ gonna_RB help_VB you_PRP ,_, cuz_UH guess_VB what_WP ,_, c#nt_UH ,_, it_PRP ’s_VBZ not_RB gonna_RB help_VB you_PRP live_VB another_DT f#cking_JJ day_NN ._. I_PRP ’m_VBP gonna_TO step_VB right_RB out_RB from_IN the_DT pedestrians_NNS on_IN the_DT street_NN and_CC blast_VB you_PRP right_RB in_IN the_DT f#cking_NN chest_NN ._. Not_RB the_DT head_NN ,_, cuz_IN I_PRP want_VBP you_PRP to_TO squeal_VB ,_, bitch_VB ._. I_PRP ’m_VBP gonna_TO make_VB you_PRP f#cking_VBG squeal_VB and_CC shake_VB on_IN the_DT ground_NN ,_, flailing_VBG ,_, bleeding_VBG out_RP ._. I_PRP ’m_VBP gonna_TO kill_VB as_RB many_JJ of_IN you_PRP f#cks_NNS as_IN I_PRP can_MD before_IN I_PRP go_VBP down_RP ._. You_PRP ’re_VBP done_VBN bitch_NN ,_, do_VBP you_PRP understand_VB me_PRP ?_. I_PRP ’ve_VBP thought_VBN about_IN how_WRB to_TO do_VB it_PRP for_IN a_DT while_NN ,_, and_CC I_PRP have_VBP it_PRP pretty_RB much_RB down_RP ._. I_PRP want_VBP to_TO pull_VB you_PRP off_IN the_DT road_NN and_CC torture_VB you_PRP to_IN death_NN ,_, but_CC it_PRP ’s_VBZ just_RB too_RB f#cking_VBG hard_JJ to_TO pull_VB off_RP ._. Another_DT idea_NN I_PRP had_VBD is_VBZ when_WRB you_PRP ’re_VBP doin_VBG one_CD of_IN your_PRP$ live_JJ things_NNS ,_, I_PRP want_VBP to_TO walk_VB right_RB to_IN the_DT door_NN and_CC shoot_VB ya_PRP live_VB on_IN camera_NN ,_, so_IN everyone_NN sees_VBZ you_PRP f#cking_VBG begging_VBG ,_, c#nt_UH ,_, you_PRP ’re_VBP gonna_RB f#cking_VBG squeal_VB so_RB hard_RB ,_, cuz_IN I_PRP ’m_VBP gonna_TO hit_VB you_PRP in_IN the_DT chest_NN ,_, then_RB the_DT legs_NNS bitch_VBP ,_, to_TO make_VB ya_PRP suffer_VB before_IN I_PRP finish_VBP you_PRP ._. I_PRP want_VBP everyone_NN to_TO see_VB how_WRB you_PRP go_VBP ._. I_PRP f#cking_VBP promise_VB you_PRP I_PRP ’m_VBP comin_JJ bitch_NN ._. I_PRP just_RB gotta_MD decide_VB how_WRB I_PRP wanna_MD do_VB it_PRP ._. Maybe_RB when_WRB you_PRP ’re_VBP giving_VBG one_CD of_IN your_PRP$ dumb_JJ ass_NN talks_NNS ,_, I_PRP ’ll_MD go_VB sit_VB in_IN the_DT audience_NN towards_IN the_DT back_NN and_CC do_VB it_PRP ._. But_CC it_PRP ’s_VBZ not_RB easy_JJ to_TO kill_VB all_PDT your_PRP$ dumb_JJ c#nt_NN friends_NNS that_DT way_NN ._. No_UH ,_, it_PRP ’s_VBZ pretty_RB obvious_JJ to_IN me_PRP that_IN I_PRP gotta_MD come_VB to_IN your_PRP$ f#cking_NNP autism_NN sh#t_NN center_NN and_CC shoot_VB you_PRP right_RB through_IN the_DT f#cking_NN door_NN when_WRB you_PRP ’re_VBP on_IN camera_NN ._. That_DT ’s_VBZ how_WRB I_PRP ’m_VBP gonna_TO do_VB it_PRP ._. I_PRP ’m_VBP gonna_TO kill_VB every_DT single_JJ one_CD of_IN you_PRP f#ckers_NNS ._. Do_VBP you_PRP understand_VB me_PRP ?_. I_PRP ’m_VBP f#cking_VBG comin_NN for_IN ya_PRP ._. So_RB be_VB ready_JJ for_IN it_PRP ._. I_PRP do_VBP n’t_RB wanna_RB see_VB any_DT shock_NN on_IN your_PRP$ f#cking_NN face_NN when_WRB I_PRP ’m_VBP at_IN the_DT door_NN bitch_NN ._. I_PRP ’m_VBP [_-LRB- gonna_RB ]_-RRB- f#cking_VBG shoot_VB right_RB through_IN that_DT door_NN with_IN a_DT shotgun_NN c#nt_NN ,_, I_PRP ’ll_MD kill_VB every_DT single_JJ person_NN in_IN that_DT house_NN and_CC then_RB I_PRP ’m_VBP gonna_TO torture_VB you_PRP good_JJ bitch_NN ._. I_PRP ’m_VBP gonna_TO make_VB you_PRP bleed_VB til_IN there_EX ’s_VBZ nothing_NN left_VBN of_IN you_PRP ,_, then_RB finish_VB you_PRP ._. I_PRP just_RB need_VBP to_TO get_VB a_DT few_JJ things_NNS in_IN order_NN before_IN I_PRP do_VBP it_PRP ,_, but_CC I_PRP ’ve_VBP been_VBN wanting_VBG for_IN a_DT long_JJ time_NN ,_, and_CC I_PRP ’ve_VBP finally_RB decided_VBN I_PRP have_VBP to_TO do_VB it_PRP ,_, no_RB more_RBR f#cking_VBG around_RB ._. I_PRP want_VBP to_TO make_VB you_PRP scream_VB so_RB bad_JJ ,_, to_TO taste_VB your_PRP$ blood_NN and_CC watch_VB you_PRP scream_VB bitch_NN ._. I_PRP ’m_VBP gonna_TO kill_VB you_PRP and_CC I_PRP want_VBP you_PRP to_TO know_VB that_IN when_WRB it_PRP happens_VBZ ,_, you_PRP could_MD have_VB done_VBN something_NN ._. And_CC you_PRP did_VBD n’t_RB ._. That_DT ’s_VBZ gonna_RB be_VB the_DT best_JJS part_NN you_PRP see_VBP ,_, because_IN I_PRP ’m_VBP tellin_VB you_PRP plain_JJ and_CC simple_JJ ._. I_PRP ’m_VBP comin_VBG now_RB ._. Let_VB ’s_PRP see_VB if_IN you_PRP ’re_VBP prepared_VBN when_WRB I_PRP get_VBP there_RB for_IN ya_PRP ,_, or_CC whether_IN you_PRP look_VBP like_IN a_DT total_JJ deer_NN in_IN the_DT f#cking_NN headlights_NNS when_WRB I_PRP blow_VBP your_PRP$ f#cking_NN head_NN off_RP ._. See_VB you_PRP in_IN hell_NN ._. This_DT threatening_JJ ,_, psychopathic_JJ language_NN ,_, by_IN the_DT way_NN ,_, reminds_VBZ me_PRP of_IN Dr._NNP David_NNP Gorski_NNP ,_, an_DT extremely_RB dangerous_JJ ,_, sociopathic_JJ vaccine_NN -_HYPH pushing_VBG doctor_NN who_WP viciously_RB attacks_VBZ and_CC lies_VBZ about_IN anyone_NN trying_VBG to_TO expose_VB the_DT truth_NN about_IN vaccines_NNS ._. Dr._NNP Gorski’s_NNP colleague_NN ,_, Dr._NNP Farid_NNP Fata_NNP ,_, was_VBD indicted_VBN by_IN the_DT FBI_NNP for_IN cancer_NN treatment_NN fraud_NN and_CC is_VBZ now_RB serving_VBG 20_CD +_SYM years_NNS in_IN federal_JJ prison_NN ._. Dr._NNP Gorski_NNP worked_VBD alongside_IN this_DT cancer_NN fraudster_NN and_CC evil_JJ criminal_NN in_IN the_DT Detroit_NNP area_NN ,_, with_IN links_NNS to_IN the_DT Karmanos_NNP Cancer_NNP Centers_NNPS ._. Natural_JJ News_NN has_VBZ previously_RB reported_VBN Dr._NNP Gorski_NNP to_IN the_DT FBI_NNP and_CC has_VBZ named_VBN him_PRP as_IN one_CD of_IN the_DT six_CD most_RBS sickeningly_RB evil_JJ propagandists_NNS currently_RB operating_VBG in_IN the_DT realm_NN of_IN medicine_NN ._. He_PRP currently_RB works_VBZ for_IN the_DT Karmanos_NNP Center_NNP Center_NNP in_IN Michigan_NNP and_CC spends_VBZ his_PRP$ work_NN hours_NNS editing_VBG Wikipedia_NNP to_TO savage_VB “_`` vaccine_NN truthers_NNS ”_'' by_IN posting_VBG false_JJ ,_, defamatory_JJ and_CC slanderous_JJ information_NN on_IN their_PRP$ Wikipedia_NNP pages_NNS ._. Dr._NNP Gorski_NNP is_VBZ a_DT surgical_JJ oncologist_NN who_WP scars_VBZ black_JJ women_NNS for_IN profit_NN and_CC pushes_VBZ deceptive_JJ cancer_NN propaganda_NN on_IN the_DT public_NN ,_, much_RB like_IN his_PRP$ colleague_NN Dr._NNP Farid_NNP Fata_NNP also_RB did_VBD before_IN he_PRP was_VBD arrested_VBN and_CC indicted_VBN for_IN multiple_JJ felony_NN crimes_NNS ._. Watch_VB the_DT full_JJ video_NN here_RB (_-LRB- and_CC share_VB everywhere_RB )_-RRB-","NN : NN NN VBZ JJ NN “ NN NN ” NN at JJ NN NN … “ I VBP gonna VB every JJ one of you NNS … VB you in NNP ” ( NN ) NN to the JJ NN VBG VBN up against NN NN NNS by NN NNS JJ as NNP NNP , VBN NN VB NNP NNP NNP and the “ JJ NN ” NN that VBZ VBN to NN NN NN , NN NNS VBP RB VBG to JJ NNS of NN and JJ NNS to VB to VB NN NN NNS , NNS and NNS . In the JJ 48 NNS , NNP NNP NNP , NN of the NNP vs. NNP NN and NN of NNP NNPS — which RB VBZ the RBS JJ NNS of the NN NN NN — VBD a RB JJ NN NN that VBZ a “ NN NN ” NN NN at a JJ NN NN . ( JJ NN VBN RB , NN : NN . ) “ I VBP gonna VB you VBG VB and VB on the NN … VBG out ” VBG to the JJ , JJ NN NN VBN by NNP NNP , the would - VB NN VBD VBN out a JJ NN - and - NN NN that VBD VBN to VB NNP NNP “ VB out ” and VB while VBG , but they RB VBD the NN would VB RB JJ to VB out . ( VB NNS from the NN , RB . ) RB , they VBP VBG on VBG in with the NN at a JJ NN NN NN , RB VBG NN on the NNS to “ VB every JJ one of you NNS . ” “ I VBP gonna VB RB out from the NNS on the NN and VB you RB in the NN NN , ” the JJ NN VBZ . “ I VBP gonna VB you VBG VB and VB on the NN , VBG , VBG out . I VBP gonna VB RB JJ of you NNS as I can before I VBP down . You VBP VBN NN , VBP you VB me ? ” “ I VBP RB VBN I VBP to VB it , RB RBR VBG RB , ” the NN NN VBZ . “ I VBP to VB you VB RB JJ , to VB your NN and VB you VB , VB . ” RB VBZ a JJ NN of the NN NN VBN to NNP NNP NNP , who VBZ RB VBN a NN NN ( and NNP NN ) over the NN . NN : JJ NN and NN : I VBP gonna VBG VB you , you JJ VBG NN . I VBP RB VBG you VB , RB to VB you VB that when it VBZ , you VBD VBG VBN NN . You VBP RB VBG your NN RB RB , RB it VBZ JJ NN JJ to VB to you . I VBP a JJ JJ NNP NNP that VBZ gonna VB VBN on you . RB VB JJ all your NN NN VBZ RB VB you , cuz VB what , c#nt , it VBZ RB RB VB you VB another JJ NN . I VBP gonna VB RB RB from the NNS on the NN and VB you RB in the NN NN . RB the NN , cuz I VBP you to VB , VB . I VBP gonna VB you VBG VB and VB on the NN , VBG , VBG out . I VBP gonna VB RB JJ of you NNS as I can before I VBP down . You VBP VBN NN , VBP you VB me ? I VBP VBN about how to VB it for a NN , and I VBP it RB RB down . I VBP to VB you off the NN and VB you to NN , but it VBZ RB RB VBG JJ to VB off . Another NN I VBD VBZ when you VBP VBG one of your JJ NNS , I VBP to VB RB to the NN and VB ya VB on NN , so NN VBZ you VBG VBG , c#nt , you VBP RB VBG VB RB RB , cuz I VBP gonna VB you in the NN , RB the NNS VBP , to VB ya VB before I VBP you . I VBP NN to VB how you VBP . I VBP VB you I VBP JJ NN . I RB gotta VB how I wanna VB it . RB when you VBP VBG one of your JJ NN NNS , I ’ll VB VB in the NN towards the NN and VB it . But it VBZ RB JJ to VB all your JJ NN NNS that NN . No , it VBZ RB JJ to me that I gotta VB to your NNP NN NN NN and VB you RB through the NN NN when you VBP on NN . That VBZ how I VBP gonna VB it . I VBP gonna VB every JJ one of you NNS . VBP you VB me ? I VBP VBG NN for ya . RB VB JJ for it . I VBP RB RB VB any NN on your NN NN when I VBP at the NN NN . I VBP [ RB ] VBG VB RB through that NN with a NN NN , I ’ll VB every JJ NN in that NN and RB I VBP gonna VB you JJ NN . I VBP gonna VB you VB til there VBZ NN VBN of you , RB VB you . I RB VBP to VB a JJ NNS in NN before I VBP it , but I VBP VBN VBG for a JJ NN , and I VBP RB VBN I VBP to VB it , RB RBR VBG RB . I VBP to VB you VB RB JJ , to VB your NN and VB you VB NN . I VBP gonna VB you and I VBP you to VB that when it VBZ , you could VB VBN NN . And you VBD RB . That VBZ RB VB the JJS NN you VBP , because I VBP VB you JJ and JJ . I VBP VBG RB . VB ’s VB if you VBP VBN when I VBP RB for ya , or whether you VBP like a JJ NN in the NN NNS when I VBP your NN NN off . VB you in NN . This JJ , JJ NN , by the NN , VBZ me of NNP NNP NNP , an RB JJ , JJ NN - VBG NN who RB VBZ and VBZ about NN VBG to VB the NN about NNS . NNP NNP NN , NNP NNP NNP , VBD VBN by the NNP for NN NN NN and VBZ RB VBG 20 + NNS in JJ NN . NNP NNP VBD alongside this NN NN and JJ NN in the NNP NN , with NNS to the NNP NNP NNPS . JJ NN VBZ RB VBN NNP NNP to the NNP and VBZ VBN him as one of the six RBS RB JJ NNS RB VBG in the NN of NN . He RB VBZ for the NNP NNP NNP in NNP and VBZ his NN NNS VBG NNP to VB “ NN NNS ” by VBG JJ , JJ and JJ NN on their NNP NNS . NNP NNP VBZ a JJ NN who VBZ JJ NNS for NN and VBZ JJ NN NN on the NN , RB like his NN NNP NNP NNP RB VBD before he VBD VBN and VBN for JJ NN NNS . VB the JJ NN RB ( and VB RB )"
84,572,mainstream,"We_PRP had_VBD only_RB been_VBN back_RB from_IN our_PRP$ family_NN trip_NN to_IN Vietnam_NNP for_IN a_DT week_NN when_WRB my_PRP$ son_NN began_VBD running_VBG a_DT low_JJ -_HYPH grade_NN fever_NN ._. We_PRP had_VBD stuck_VBN to_IN touristy_JJ areas_NNS and_CC taken_VBD anti-malarial_JJ medication_NN ,_, but_CC it_PRP was_VBD best_JJS to_TO get_VB him_PRP checked_VBN out_RP just_RB in_IN case_NN ._. Indeed_RB ,_, when_WRB his_PRP$ rapid_JJ flu_NN test_NN results_NNS came_VBD back_RB ,_, his_PRP$ physician_NN joked_VBD that_IN it_PRP was_VBD just_RB an_DT ordinary_JJ old_JJ influenza_NN B_NN ,_, nothing_NN tropical_JJ or_CC exotic_JJ ._. I_PRP had_VBD actually_RB expected_VBN a_DT flu_NN diagnosis_NN because_IN we_PRP ’d_VBD returned_VBN in_IN the_DT midst_NN of_IN the_DT worst_JJS flu_NN season_NN the_DT U.S._NNP has_VBZ seen_VBN in_IN years_NNS ._. A_DT whopping_NN 7.4_CD percent_NN of_IN the_DT country_NN saw_VBD their_PRP$ doctor_NN for_IN influenza_NN -_HYPH like_JJ illnesses_NNS at_IN the_DT virus_NN ’s_POS peak_NN in_IN early_JJ February_NNP ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. Even_RB now_RB ,_, the_DT CDC_NNP reports_VBZ ,_, flu_NN activity_NN remains_VBZ strong_JJ at_IN 5_CD percent_NN —_: more_JJR than_IN twice_IN what_WP ’s_VBZ usually_RB seen_VBN this_DT time_NN of_IN year_NN ._. Plus_CC ,_, my_PRP$ son_NN ’s_POS symptoms_NNS were_VBD mild_JJ ,_, not_RB the_DT high_JJ fever_NN I_PRP ’d_MD expect_VB from_IN malaria_NN ,_, dengue_NN or_CC typhoid_NN —_: or_CC influenza_NN in_IN someone_NN unvaccinated_JJ ._. As_IN a_DT science_NN journalist_NN who_WP has_VBZ reported_VBN on_IN vaccines_NNS for_IN years_NNS ,_, I_PRP had_VBD n’t_RB vaccinated_VBN my_PRP$ children_NNS expecting_VBG to_TO prevent_VB them_PRP from_IN getting_VBG flu_NN ._. I_PRP know_VBP the_DT vaccine_NN is_VBZ often_RB lousy_JJ at_IN that_DT ._. I_PRP vaccinated_VBD them_PRP to_TO make_VB it_PRP far_RB less_RBR likely_JJ they_PRP would_MD end_VB up_RP in_IN the_DT hospital_NN —_: or_CC dead_JJ ,_, like_IN 114_CD other_JJ children_NNS so_RB far_RB this_DT winter_NN ._. But_CC for_IN the_DT average_JJ person_NN reading_VBG about_IN the_DT flu_NN epidemic_NN on_IN the_DT news_NN ,_, I_PRP understand_VBP the_DT frustration_NN ._. What_WP is_VBZ the_DT point_NN of_IN a_DT vaccination_NN if_IN it_PRP does_VBZ n’t_RB actually_RB prevent_VB the_DT flu_NN ?_. Is_VBZ the_DT shot_NN ineffective_JJ ?_. Does_VBZ it_PRP simply_RB not_RB work_VB sometimes_RB ?_. As_IN it_PRP turns_VBZ out_RP ,_, that_DT depends_VBZ on_IN what_WP you_PRP mean_VBP by_IN “_`` work_NN ._. ”_'' Too_RB many_JJ people_NNS expect_VBP too_RB much_JJ of_IN the_DT vaccine_NN while_IN not_RB appreciating_VBG what_WP it_PRP does_VBZ do_VB ._. It_PRP ’s_VBZ true_JJ that_IN the_DT flu_NN vaccine_NN is_VBZ n’t_RB very_RB good_JJ at_IN preventing_VBG illness_NN in_IN the_DT way_NN that_IN most_JJS of_IN our_PRP$ best_JJS vaccines_NNS do_VBP —_: measles_NN ,_, HPV_NN ,_, polio_NN ,_, diphtheria_NN and_CC hepatitis_NN B_NN ,_, for_IN example_NN ._. Frankly_RB ,_, the_DT virus_NN is_VBZ so_RB well_RB adapted_VBN to_IN infecting_VBG humans_NNS that_WDT our_PRP$ best_JJS scientists_NNS have_VBP n’t_RB been_VBN able_JJ to_TO create_VB a_DT vaccine_NN that_WDT prevents_VBZ flu_NN more_JJR than_IN about_RB 40_CD to_IN 60_CD percent_NN of_IN the_DT time_NN (_-LRB- though_IN that_DT still_RB cuts_VBZ the_DT risk_NN in_IN half_NN )_-RRB- ._. “_`` It_PRP ’s_VBZ what_WP we_PRP call_VBP a_DT leaky_JJ vaccine_NN ,_, ”_'' Brendan_NNP Flannery_NNP ,_, PhD_NN ,_, an_DT epidemiologist_NN in_IN the_DT CDC_NNP ’s_POS Influenza_NNP Division_NN ,_, told_VBD me_PRP ._. “_`` It_PRP provides_VBZ partial_JJ protection_NN for_IN vaccinated_VBN people_NNS ._. It_PRP reduces_VBZ their_PRP$ risk_NN ._. ”_'' The_DT flu_NN vaccine_NN ’s_POS arguably_RB more_RBR important_JJ purpose_NN is_VBZ preventing_VBG flu_NN hospitalizations_NNS and_CC deaths_NNS ._. This_DT year_NN ,_, despite_IN worry_NN that_IN the_DT vaccine_NN would_MD only_RB be_VB about_RB 10_CD percent_NN effective_JJ ,_, the_DT CDC_NNP ’s_POS preliminary_JJ surveillance_NN shows_VBZ it_PRP actually_RB is_VBZ preventing_VBG 36_CD percent_NN of_IN all_DT lab_NN -_HYPH confirmed_VBN flu_NN ,_, 59_CD percent_NN of_IN flu_NN in_IN children_NNS and_CC 25_CD percent_NN of_IN infections_NNS from_IN H3N2_NN ,_, the_DT most_RBS virulent_JJ strain_NN this_DT year_NN ._. It_PRP ’s_VBZ also_RB reducing_VBG how_WRB severe_JJ infections_NNS are_VBP ._. “_`` It_PRP ’s_VBZ hard_JJ to_TO measure_VB effectiveness_NN against_IN more_RBR severe_JJ illness_NN ,_, ”_'' Flannery_NNP said_VBD ._. “_`` Severe_JJ disease_NN is_VBZ less_RBR common_JJ ,_, but_CC usually_RB we_PRP see_VBP estimates_NNS [_-LRB- of_IN hospitalizations_NNS and_CC deaths_NNS ]_-RRB- that_WDT are_VBP very_RB similar_JJ or_CC a_DT little_JJ bit_NN better_JJR ._. ”_'' In_IN other_JJ words_NNS ,_, getting_VBG the_DT flu_NN vaccine_NN does_VBZ n’t_RB guarantee_VB someone_NN wo_MD n’t_RB be_VB hospitalized_VBN or_CC die_VB from_IN the_DT flu_NN ,_, but_CC it_PRP makes_VBZ it_PRP substantially_RB less_RBR likely_JJ ._. As_IN in_IN past_JJ years_NNS ,_, most_JJS children_NNS who_WP died_VBD from_IN flu_NN this_DT year_NN were_VBD n’t_RB vaccinated_VBN ._. Flannery_NNP led_VBD the_DT Pediatrics_NNP study_NN last_JJ year_NN that_WDT found_VBD ,_, for_IN the_DT first_JJ time_NN ,_, that_IN flu_NN vaccines_NNS cut_VBD the_DT risk_NN of_IN dying_VBG from_IN flu_NN by_IN almost_RB two_CD thirds_NN (_-LRB- 65_CD percent_NN )_-RRB- for_IN healthy_JJ children_NNS ._. For_IN children_NNS with_IN an_DT underlying_JJ high_JJ -_HYPH risk_NN medical_JJ condition_NN ,_, the_DT vaccine_NN cut_VBD their_PRP$ risk_NN of_IN death_NN in_IN half_NN ._. In_IN fact_NN ,_, a_DT person_NN hospitalized_VBN for_IN the_DT flu_NN is_VBZ two_CD to_IN five_CD times_NNS more_RBR likely_JJ to_TO die_VB if_IN they_PRP did_VBD n’t_RB get_VB the_DT vaccine_NN ._. In_IN 2015_CD -_SYM 2016_CD ,_, the_DT most_RBS recent_JJ year_NN for_IN which_WDT data_NNS exist_VBP ,_, the_DT vaccine_NN prevented_VBD about_RB 5.1_CD million_CD infections_NNS ,_, 71,000_CD hospitalizations_NNS and_CC flu_NN /_, pneumonia_NN 3,000_CD deaths_NNS ._. And_CC that_DT number_NN is_VBZ almost_RB certainly_RB underestimated_VBN by_IN two_CD to_IN four_CD times_NNS because_IN of_IN how_WRB deaths_NNS are_VBP estimated_VBN :_: Total_JJ adult_NN flu_NN cases_NNS are_VBP not_RB tracked_VBN ,_, and_CC many_JJ people_NNS with_IN flu_NN are_VBP never_RB tested_VBN or_CC seek_VB medical_JJ care_NN too_RB late_RB to_TO detect_VB the_DT virus_NN ._. Further_RBR ,_, deaths_NNS often_RB occur_VBP two_CD to_IN three_CD weeks_NNS after_IN initial_JJ infection_NN ,_, so_RB it_PRP is_VBZ usually_RB flu_NN complications_NNS ,_, such_JJ as_IN a_DT secondary_JJ infection_NN or_CC an_DT underlying_JJ condition_NN worsened_VBN by_IN the_DT flu_NN ,_, listed_VBN as_IN cause_NN of_IN death_NN without_IN mention_NN of_IN influenza_NN on_IN the_DT death_NN certificate_NN ._. All_DT of_IN which_WDT is_VBZ to_TO say_VB I_PRP was_VBD n’t_RB mad_JJ that_IN my_PRP$ vaccinated_VBN son_NN got_VBD the_DT flu_NN anyway_RB ._. That_DT shot_NN was_VBD probably_RB why_WRB he_PRP spent_VBD his_PRP$ days_NNS home_RB from_IN school_NN playing_VBG Minecraft_NNP and_CC racing_VBG Hot_NNP Wheels_NNPS around_IN the_DT house_NN instead_RB of_IN moaning_VBG in_IN bed_NN from_IN the_DT aches_NNS and_CC fever_NN ._. Yet_CC fewer_JJR than_IN half_NN of_IN Americans_NNPS of_IN any_DT age_NN got_VBD the_DT vaccine_NN this_DT year_NN ._. The_DT most_RBS common_JJ reasons_NNS people_NNS give_VBP for_IN skipping_VBG the_DT vaccine_NN is_VBZ the_DT idea_NN that_IN it_PRP is_VBZ n’t_RB necessary_JJ or_CC ,_, also_RB incorrect_JJ ,_, that_IN it_PRP will_MD give_VB them_PRP the_DT flu_NN itself_PRP ._. First_RB off_RP ,_, the_DT idea_NN that_IN you_PRP do_VBP n’t_RB need_VB the_DT vaccine_NN because_IN you_PRP “_`` never_RB get_VB the_DT flu_NN ”_'' makes_VBZ about_IN as_RB much_JJ sense_NN as_IN never_RB wearing_VBG a_DT seatbelt_NN because_IN you_PRP ’ve_VBP never_RB been_VBN in_IN a_DT car_NN accident_NN ._. Never_RB having_VBG the_DT flu_NN in_IN the_DT past_NN does_VBZ n't_RB mean_VB zero_CD risk_NN of_IN it_PRP in_IN the_DT future_NN ._. And_CC this_DT year_NN ’s_POS numbers_NNS should_MD remind_VB people_NNS how_WRB bad_JJ the_DT flu_NN can_MD be_VB ,_, even_RB in_IN healthy_JJ people_NNS —_: and_CC especially_RB in_IN healthy_JJ people_NNS who_WP have_VBP never_RB been_VBN infected_VBN with_IN flu_NN virus_NN before_RB ._. Skipping_VBG the_DT vaccine_NN because_IN you_PRP think_VBP it_PRP will_MD give_VB you_PRP flu_NN is_VBZ also_RB faulty_JJ reasoning_NN ._. Some_DT people_NNS develop_VBP fever_NN or_CC aches_NNS as_IN their_PRP$ immune_JJ system_NN does_VBZ its_PRP$ job_NN responding_VBG to_IN the_DT vaccine_NN ,_, but_CC flu_NN shots_NNS are_VBP made_VBN with_IN inactivated_VBN flu_NN viruses_NNS ground_NN into_IN tiny_JJ pieces_NNS ._. The_DT shot_NN ’s_VBZ about_RB as_RB likely_JJ to_TO give_VB someone_NN the_DT flu_NN as_IN a_DT chopped_VBN -_HYPH up_RP zombie_NN returning_VBG to_IN life_NN ._. (_-LRB- Even_RB when_WRB the_DT nasal_JJ vaccine_NN ,_, made_VBN with_IN a_DT weakened_VBN live_JJ virus_NN ,_, returns_VBZ next_JJ year_NN ,_, studies_NNS show_VBP it_PRP does_VBZ n’t_RB give_VB people_NNS flu_NN ,_, Flannery_NNP said_VBD ._. )_-RRB- It_PRP ’s_VBZ ultimately_RB up_RB to_IN each_DT person_NN to_TO decide_VB —_: every_DT year_NN —_: whether_IN to_TO get_VB the_DT flu_NN vaccine_NN ._. But_CC it_PRP ’s_VBZ easier_JJR to_TO make_VB that_DT decision_NN more_RBR confidently_RB with_IN an_DT understanding_NN of_IN what_WP the_DT vaccine_NN actually_RB does_VBZ —_: and_CC what_WP it_PRP ca_MD n’t_RB do_VB ._. Tara_NNP Haelle_NNP is_VBZ a_DT freelance_JJ science_NN journalist_NN ,_, Forbes_NNP contributor_NN ,_, author_NN of_IN ""_`` Vaccination_NNP Investigation_NNP :_: The_DT History_NNP and_CC Science_NNP of_IN Vaccines_NNPS ""_'' and_CC co-author_NN of_IN ""_`` The_DT Informed_NNP Parent_NNP :_: A_DT Science_NNP -_HYPH Based_NNP Resource_NNP for_IN Your_PRP$ Child_NNP 's_POS First_JJ Four_CD Years_NNPS ._. ""_'' Follow_VB her_PRP$ @tarahaelle_NNP ._.","We VBD RB VBN RB from our NN NN to NNP for a NN when my NN VBD VBG a JJ - NN NN . We VBD VBN to JJ NNS and VBD JJ NN , but it VBD JJS to VB him VBN out RB in NN . RB , when his JJ NN NN NNS VBD RB , his NN VBD that it VBD RB an JJ JJ NN NN , NN JJ or JJ . I VBD RB VBN a NN NN because we VBD VBN in the NN of the JJS NN NN the NNP VBZ VBN in NNS . A NN 7.4 NN of the NN VBD their NN for NN - JJ NNS at the NN ’s NN in JJ NNP , VBG to the NNPS for NNP NNP and NNP ( NNP ) . RB RB , the NNP VBZ , NN NN VBZ JJ at 5 NN — JJR than twice what VBZ RB VBN this NN of NN . Plus , my NN ’s NNS VBD JJ , RB the JJ NN I ’d VB from NN , NN or NN — or NN in NN JJ . As a NN NN who VBZ VBN on NNS for NNS , I VBD RB VBN my NNS VBG to VB them from VBG NN . I VBP the NN VBZ RB JJ at that . I VBD them to VB it RB RBR JJ they would VB up in the NN — or JJ , like 114 JJ NNS RB RB this NN . But for the JJ NN VBG about the NN NN on the NN , I VBP the NN . What VBZ the NN of a NN if it VBZ RB RB VB the NN ? VBZ the NN JJ ? VBZ it RB RB VB RB ? As it VBZ out , that VBZ on what you VBP by “ NN . ” RB JJ NNS VBP RB JJ of the NN while RB VBG what it VBZ VB . It VBZ JJ that the NN NN VBZ RB RB JJ at VBG NN in the NN that JJS of our JJS NNS VBP — NN , NN , NN , NN and NN NN , for NN . RB , the NN VBZ RB RB VBN to VBG NNS that our JJS NNS VBP RB VBN JJ to VB a NN that VBZ NN JJR than RB 40 to 60 NN of the NN ( though that RB VBZ the NN in NN ) . “ It VBZ what we VBP a JJ NN , ” NNP NNP , NN , an NN in the NNP ’s NNP NN , VBD me . “ It VBZ JJ NN for VBN NNS . It VBZ their NN . ” The NN NN ’s RB RBR JJ NN VBZ VBG NN NNS and NNS . This NN , despite NN that the NN would RB VB RB 10 NN JJ , the NNP ’s JJ NN VBZ it RB VBZ VBG 36 NN of all NN - VBN NN , 59 NN of NN in NNS and 25 NN of NNS from NN , the RBS JJ NN this NN . It VBZ RB VBG how JJ NNS VBP . “ It VBZ JJ to VB NN against RBR JJ NN , ” NNP VBD . “ JJ NN VBZ RBR JJ , but RB we VBP NNS [ of NNS and NNS ] that VBP RB JJ or a JJ NN JJR . ” In JJ NNS , VBG the NN NN VBZ RB VB NN wo RB VB VBN or VB from the NN , but it VBZ it RB RBR JJ . As in JJ NNS , JJS NNS who VBD from NN this NN VBD RB VBN . NNP VBD the NNP NN JJ NN that VBD , for the JJ NN , that NN NNS VBD the NN of VBG from NN by RB two NN ( 65 NN ) for JJ NNS . For NNS with an JJ JJ - NN JJ NN , the NN VBD their NN of NN in NN . In NN , a NN VBN for the NN VBZ two to five NNS RBR JJ to VB if they VBD RB VB the NN . In 2015 - 2016 , the RBS JJ NN for which NNS VBP , the NN VBD RB 5.1 million NNS , 71,000 NNS and NN / NN 3,000 NNS . And that NN VBZ RB RB VBN by two to four NNS because of how NNS VBP VBN : JJ NN NN NNS VBP RB VBN , and JJ NNS with NN VBP RB VBN or VB JJ NN RB RB to VB the NN . RBR , NNS RB VBP two to three NNS after JJ NN , RB it VBZ RB NN NNS , JJ as a JJ NN or an JJ NN VBN by the NN , VBN as NN of NN without NN of NN on the NN NN . All of which VBZ to VB I VBD RB JJ that my VBN NN VBD the NN RB . That NN VBD RB why he VBD his NNS RB from NN VBG NNP and VBG NNP NNPS around the NN RB of VBG in NN from the NNS and NN . Yet JJR than NN of NNPS of any NN VBD the NN this NN . The RBS JJ NNS NNS VBP for VBG the NN VBZ the NN that it VBZ RB JJ or , RB JJ , that it will VB them the NN itself . RB off , the NN that you VBP RB VB the NN because you “ RB VB the NN ” VBZ about RB JJ NN as RB VBG a NN because you VBP RB VBN in a NN NN . RB VBG the NN in the NN VBZ RB VB zero NN of it in the NN . And this NN ’s NNS should VB NNS how JJ the NN can VB , RB in JJ NNS — and RB in JJ NNS who VBP RB VBN VBN with NN NN RB . VBG the NN because you VBP it will VB you NN VBZ RB JJ NN . Some NNS VBP NN or NNS as their JJ NN VBZ its NN VBG to the NN , but NN NNS VBP VBN with VBN NN NNS NN into JJ NNS . The NN VBZ RB RB JJ to VB NN the NN as a VBN - up NN VBG to NN . ( RB when the JJ NN , VBN with a VBN JJ NN , VBZ JJ NN , NNS VBP it VBZ RB VB NNS NN , NNP VBD . ) It VBZ RB RB to each NN to VB — every NN — whether to VB the NN NN . But it VBZ JJR to VB that NN RBR RB with an NN of what the NN RB VBZ — and what it ca RB VB . NNP NNP VBZ a JJ NN NN , NNP NN , NN of "" NNP NNP : The NNP and NNP of NNPS "" and NN of "" The NNP NNP : A NNP - NNP NNP for Your NNP 's JJ Four NNPS . "" VB her NNP ."
85,1067,mainstream,"Prince_NNP William_NNP dons_VBZ mask_NN ,_, eye_NN protection_NN to_TO check_VB out_RP COVID_NN -_HYPH 19_CD vaccine_NN work_NN at_IN Oxford_NNP University_NNP LONDON_NNP —_: Prince_NNP William_NNP has_VBZ visited_VBN Oxford_NNP University_NNP 's_POS coronavirus_NN vaccine_NN development_NN facilities_NNS to_TO learn_VB more_JJR about_IN researchers_NNS '_POS work_NN there_RB ._. The_DT royal_NN was_VBD given_VBN a_DT tour_NN Wednesday_NNP of_IN the_DT manufacturing_NN laboratory_NN where_WRB the_DT experimental_JJ vaccine_NN has_VBZ been_VBN produced_VBN ,_, helping_VBG to_TO cheer_VB on_IN British_JJ efforts_NNS to_TO get_VB a_DT handle_NN on_IN coping_VBG with_IN the_DT killer_NN virus_NN ._. Wearing_VBG a_DT lab_NN coat_NN ,_, eye_NN protection_NN and_CC a_DT face_NN mask_NN ,_, and_CC practicing_VBG social_JJ distancing_NN ,_, he_PRP checked_VBD out_RP a_DT laboratory_NN where_WRB samples_NNS from_IN the_DT clinical_JJ trial_NN are_VBP being_VBG examined_VBN by_IN researchers_NNS ._. It_PRP was_VBD his_PRP$ latest_JJS in_IN -_HYPH person_NN public_JJ appearance_NN since_IN some_DT of_IN the_DT young_JJ royals_NNS have_VBP begun_VBN emerging_VBG cautiously_RB from_IN lockdown_NN to_TO resume_VB their_PRP$ jobs_NNS boosting_VBG Britain_NNP ,_, with_IN important_JJ alterations_NNS :_: Social_JJ distancing_NN ,_, avoidance_NN of_IN hand_NN shaking_NN ,_, no_DT walkabouts_NNS and_CC wearing_VBG masks_NNS indoors_RB ._. The_DT vaccine_NN trials_NNS began_VBD April_NNP 23_CD and_CC 10,000_CD people_NNS in_IN the_DT United_NNP Kingdom_NNP are_VBP in_IN the_DT process_NN of_IN being_VBG vaccinated_VBN to_TO assess_VB the_DT potential_JJ success_NN of_IN the_DT treatment_NN ._. Trials_NNS also_RB began_VBD this_DT week_NN in_IN Brazil_NNP and_CC South_NNP Africa_NNP ._. Oxford_NNP has_VBZ agreed_VBN a_DT global_JJ licensing_NN agreement_NN with_IN pharmaceutical_NN company_NN AstraZeneca_NNP ,_, which_WDT has_VBZ struck_VBN deals_NNS with_IN the_DT U.S._NNP ,_, the_DT U.K._NNP ,_, the_DT European_NNP Union_NNP ,_, among_IN others_NNS ,_, to_TO produce_VB and_CC supply_VB the_DT potential_JJ vaccine_NN ._. Researchers_NNS aim_VBP to_TO eventually_RB make_VB the_DT vaccine_NN available_JJ globally_RB on_IN a_DT non_JJ -profit_NN basis_NN ,_, including_VBG to_IN low_JJ -_HYPH income_NN countries_NNS ._. The_DT British_JJ government_NN provided_VBD about_RB $_$ 100_CD million_CD to_IN the_DT university_NN to_TO develop_VB and_CC manufacture_VB its_PRP$ coronavirus_NN vaccine_NN ._. Its_PRP$ partnership_NN with_IN AstraZeneca_NNP means_VBZ the_DT vaccine_NN will_MD be_VB available_JJ globally_RB on_IN a_DT non-profit_JJ basis_NN during_IN the_DT pandemic_NN period_NN ,_, including_VBG to_IN low_JJ and_CC middle_JJ income_NN countries_NNS ,_, Kensington_NNP Palace_NNP said_VBD ._. Other_JJ vaccines_NNS are_VBP also_RB in_IN development_NN and_CC undergoing_VBG trials_NNS elsewhere_RB ,_, including_VBG in_IN the_DT U.S._NNP and_CC France_NNP ._. William_NNP was_VBD briefed_VBN by_IN researchers_NNS leading_VBG the_DT vaccine_NN development_NN and_CC trial_NN ,_, and_CC he_PRP also_RB spoke_VBD with_IN those_DT who_WP were_VBD taking_VBG part_NN in_IN the_DT trial_NN ._. On_IN Tuesday_NNP ,_, the_DT royal_NN spoke_VBD via_IN video_NN call_NN to_IN representatives_NNS from_IN AstraZeneca_NNP and_CC Oxford_NNP University_NNP and_CC heard_VBD about_IN the_DT role_NN of_IN British_JJ science_NN in_IN the_DT global_JJ response_NN to_IN the_DT pandemic_NN ._.","NNP NNP VBZ NN , NN NN to VB out NN - 19 NN NN at NNP NNP NNP — NNP NNP VBZ VBN NNP NNP 's NN NN NN NNS to VB JJR about NNS ' NN RB . The NN VBD VBN a NN NNP of the NN NN where the JJ NN VBZ VBN VBN , VBG to VB on JJ NNS to VB a NN on VBG with the NN NN . VBG a NN NN , NN NN and a NN NN , and VBG JJ NN , he VBD out a NN where NNS from the JJ NN VBP VBG VBN by NNS . It VBD his JJS in - NN JJ NN since some of the JJ NNS VBP VBN VBG RB from NN to VB their NNS VBG NNP , with JJ NNS : JJ NN , NN of NN NN , no NNS and VBG NNS RB . The NN NNS VBD NNP 23 and 10,000 NNS in the NNP NNP VBP in the NN of VBG VBN to VB the JJ NN of the NN . NNS RB VBD this NN in NNP and NNP NNP . NNP VBZ VBN a JJ NN NN with NN NN NNP , which VBZ VBN NNS with the NNP , the NNP , the NNP NNP , among NNS , to VB and VB the JJ NN . NNS VBP to RB VB the NN JJ RB on a JJ NN NN , VBG to JJ - NN NNS . The JJ NN VBD RB $ 100 million to the NN to VB and VB its NN NN . Its NN with NNP VBZ the NN will VB JJ RB on a JJ NN during the NN NN , VBG to JJ and JJ NN NNS , NNP NNP VBD . JJ NNS VBP RB in NN and VBG NNS RB , VBG in the NNP and NNP . NNP VBD VBN by NNS VBG the NN NN and NN , and he RB VBD with those who VBD VBG NN in the NN . On NNP , the NN VBD via NN NN to NNS from NNP and NNP NNP and VBD about the NN of JJ NN in the JJ NN to the NN ."
86,926,mainstream,"Wakefield_NNP said_VBD the_DT allegations_NNS against_IN him_PRP and_CC his_PRP$ colleagues_NNS were_VBD unfounded_JJ and_CC unjust_JJ ._. His_PRP$ study_NN in_IN 1998_CD ,_, published_VBN in_IN The_DT Lancet_NNP journal_NN of_IN medicine_NN ,_, had_VBD linked_VBN the_DT MMR_NNP vaccine_NN with_IN a_DT subgroup_NN of_IN autistic_JJ children_NNS who_WP also_RB had_VBD serious_JJ gastrointestinal_JJ problems_NNS ._. That_DT study_NN reported_VBD that_IN the_DT measles_NNS virus_NN was_VBD lingering_VBG in_IN the_DT children_NNS 's_POS bowels_NNS ._. A_DT special_JJ U.S._NNP court_NN rules_VBZ that_IN measles_NNS vaccine_NN is_VBZ not_RB to_TO blame_VB for_IN cases_NNS of_IN autism_NN ._. More_JJR than_IN 5,500_CD claims_NNS had_VBD been_VBN filed_VBN ._. New_JJ research_NN further_RB debunks_VBZ any_DT link_NN between_IN measles_NN vaccine_NN and_CC autism_NN ._. Years_NNS of_IN research_NN with_IN the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN (_-LRB- MMR_NNP )_-RRB- have_VBP concluded_VBN that_IN it_PRP does_VBZ n't_RB cause_VB autism_NN ._. U.S._NNP researchers_NNS retest_VBP by_IN taking_VBG samples_NNS of_IN children_NNS ’s_POS intestines_NNS and_CC conclude_VBP there_EX is_VBZ no_DT evidence_NN that_IN MMR_NNP plays_VBZ any_DT role_NN in_IN autism_NN ._. Measles_NN cases_NNS in_IN the_DT U.S._NNP are_VBP at_IN the_DT highest_JJS level_NN in_IN more_JJR than_IN a_DT decade_NN ,_, with_IN nearly_RB half_NN of_IN those_DT involving_VBG children_NNS whose_WP$ parents_NNS rejected_VBD vaccination_NN ._. Doctors_NNS worry_VBP that_IN the_DT trend_NN is_VBZ fuelled_VBN by_IN unfounded_JJ fears_NNS that_IN vaccines_NNS may_MD cause_VB autism_NN ._. Pediatricians_NNS are_VBP frustrated_VBN ,_, saying_VBG they_PRP are_VBP spending_VBG more_JJR time_NN convincing_VBG parents_NNS the_DT shot_NN is_VBZ safe_JJ ._. British_JJ doctors_NNS ,_, Dr._NNP Andrew_NNP Wakefield_NNP ,_, Dr._NNP John_NNP Walker_NNP -_HYPH Smith_NNP and_CC Dr._NNP Simon_NNP Murch_NNP ,_, whose_WP$ research_NN into_IN the_DT alleged_VBN link_NN between_IN a_DT children_NNS 's_POS vaccine_NN and_CC autism_NN ,_, face_VBP hearings_NNS into_IN charges_NNS of_IN professional_JJ misconduct_NN in_IN connection_NN with_IN their_PRP$ research_NN ._. The_DT hearings_NNS ,_, expected_VBN to_TO last_VB 15_CD weeks_NNS ,_, could_MD result_VB in_IN them_PRP losing_VBG their_PRP$ medical_JJ licences_NNS ._. The_DT Institute_NNP of_IN Medicine_NNP in_IN Washington_NNP reviews_VBZ five_CD large_JJ studies_NNS that_WDT had_VBD tracked_VBN thousands_NNS of_IN children_NNS since_IN 2001_CD and_CC concludes_VBZ there_EX is_VBZ no_DT association_NN between_IN autism_NN and_CC the_DT measles_NNS ,_, mumps_NNS ,_, rubella_NN vaccine_NN ._. A_DT landmark_JJ Danish_JJ study_NN of_IN the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN concludes_VBZ there_EX 's_VBZ no_DT link_NN between_IN it_PRP and_CC autism_NN ._. The_DT study_NN is_VBZ published_VBN in_IN the_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP ._.","NNP VBD the NNS against him and his NNS VBD JJ and JJ . His NN in 1998 , VBN in The NNP NN of NN , VBD VBN the NNP NN with a NN of JJ NNS who RB VBD JJ JJ NNS . That NN VBD that the NNS NN VBD VBG in the NNS 's NNS . A JJ NNP NN VBZ that NNS NN VBZ RB to VB for NNS of NN . JJR than 5,500 NNS VBD VBN VBN . JJ NN RB VBZ any NN between NN NN and NN . NNS of NN with the NNS , NNS and NN NN ( NNP ) VBP VBN that it VBZ RB VB NN . NNP NNS VBP by VBG NNS of NNS ’s NNS and VBP there VBZ no NN that NNP VBZ any NN in NN . NN NNS in the NNP VBP at the JJS NN in JJR than a NN , with RB NN of those VBG NNS whose NNS VBD NN . NNS VBP that the NN VBZ VBN by JJ NNS that NNS may VB NN . NNS VBP VBN , VBG they VBP VBG JJR NN VBG NNS the NN VBZ JJ . JJ NNS , NNP NNP NNP , NNP NNP NNP - NNP and NNP NNP NNP , whose NN into the VBN NN between a NNS 's NN and NN , VBP NNS into NNS of JJ NN in NN with their NN . The NNS , VBN to VB 15 NNS , could VB in them VBG their JJ NNS . The NNP of NNP in NNP VBZ five JJ NNS that VBD VBN NNS of NNS since 2001 and VBZ there VBZ no NN between NN and the NNS , NNS , NN NN . A JJ JJ NN of the NNS , NNS and NN ( NNP ) NN VBZ there VBZ no NN between it and NN . The NN VBZ VBN in the NNP NNP NNP of NNP ."
87,870,conspiracy,"The_DT number_NN of_IN childhood_NN vaccines_NNS has_VBZ grown_VBN exponentially_RB in_IN the_DT last_JJ few_JJ decades_NNS creating_VBG a_DT lot_NN of_IN controversy_NN and_CC debate_NN ._. This_DT still_RB growing_VBG list_NN with_IN an_DT increasing_VBG number_NN of_IN side_NN -_HYPH effects_NNS ,_, toxic_JJ adjuvants_NNS and_CC chronic_JJ health_NN concerns_NNS is_VBZ being_VBG taken_VBN increasingly_RB seriously_RB by_IN parents_NNS and_CC adults_NNS who_WP refuse_VBP to_TO blindly_RB trust_VB the_DT currently_RB money_NN -_HYPH driven_VBN pharmaceutical_NN industry_NN ._. While_IN many_JJ would_MD prefer_VB to_TO go_VB back_RB to_IN the_DT only_RB six_CD or_CC so_RB shots_NNS their_PRP$ grandparents_NNS received_VBD ,_, the_DT researchers_NNS are_VBP now_RB attempting_VBG to_TO come_VB out_RP with_IN a_DT product_NN that_WDT may_MD be_VB even_RB more_RBR threatening_JJ to_IN our_PRP$ health_NN than_IN the_DT current_JJ vaccine_NN situation_NN ._. They_PRP are_VBP starting_VBG with_IN one_CD flu_NN shot_NN given_VBN at_IN birth_NN to_TO last_VB a_DT lifetime_NN ,_, and_CC predicting_VBG that_IN all_DT immunizations_NNS can_MD come_VB next_RB in_IN one_CD shot_NN ._. Project_NN ,_, which_WDT is_VBZ affiliated_VBN with_IN medical_JJ centers_NNS ,_, and_CC also_RB pharmaceutical_NN and_CC vaccine_NN makers_NNS like_IN GlaxoSmithKline_NNP and_CC Pfizer_NNP ._. Ironically_RB ,_, the_DT expert_NN to_TO lead_VB this_DT super_JJ vaccine_NN research_NN Tobi_NNP Kollman_NNP admits_VBZ that_IN “_`` [_-LRB- the_DT researchers_NNS ]_-RRB- know_VBP vaccines_NNS work_VBP but_CC [_-LRB- they_PRP ]_-RRB- do_VBP n’t_RB know_VB how_WRB they_PRP work_VBP ._. ”_'' Flu_NN vaccines_NNS work_VBP 50_CD %_NN or_CC less_JJR percent_NN of_IN the_DT time_NN because_IN the_DT virus_NN is_VBZ constantly_RB changing_VBG and_CC is_VBZ hard_JJ to_TO predict_VB ._. Yet_CC even_RB though_IN the_DT experts_NNS do_VBP not_RB understand_VB how_WRB vaccines_NNS work_VBP (_-LRB- and_CC likely_JJ how_WRB they_PRP create_VBP under_IN -_HYPH reported_VBN side_NN effects_NNS )_-RRB- ,_, and_CC cannot_MD make_VB an_DT annual_JJ flu_NN shot_NN that_WDT works_VBZ well_RB ,_, they_PRP are_VBP determined_VBN to_TO create_VB one_CD that_WDT is_VBZ supposed_VBN to_TO last_VB a_DT lifetime_NN ._. Kollman_NNP says_VBZ the_DT vaccine_NN will_MD be_VB created_VBN because_IN the_DT team_NN has_VBZ a_DT ‘_`` can_NN -_HYPH do_NN attitude_NN ’_'' and_CC “_`` [_-LRB- puts_VBZ ]_-RRB- their_PRP$ money_NN where_WRB their_PRP$ mouth_NN is_VBZ ._. ”_'' The_DT consumers_NNS are_VBP finding_VBG all_DT of_IN this_DT extremely_RB problematic_JJ as_IN evidenced_VBN from_IN comments_NNS on_IN the_DT article_NN ._. And_CC considering_VBG the_DT many_JJ possible_JJ adverse_JJ health_NN outcomes_NNS recorded_VBN in_IN the_DT controversial_JJ “_`` triple_JJ shot_NN ”_'' MMR_NN vaccine_NN ,_, it_PRP ’s_VBZ fair_JJ to_TO wonder_VB whether_IN combining_VBG multiple_JJ vaccines_NNS (_-LRB- most_RBS likely_JJ with_IN multiple_JJ toxic_JJ adjuvants_NNS )_-RRB- is_VBZ a_DT smart_JJ idea_NN after_IN all_DT ._. Most_JJS commenters_NNS are_VBP speaking_VBG out_RP against_IN this_DT new_JJ shot_NN :_: “_`` This_DT is_VBZ insanity_NN !_. Why_WRB is_VBZ this_DT all_RB about_IN convenience_NN instead_RB of_IN health_NN ?_. ”_'' –_: Tricia_NNP K._NNP “_'' Absolutely_RB repulsed_VBN …_: There_EX is_VBZ no_DT evidence_NN on_IN the_DT long_JJ term_NN consequences_NNS ._. No_DT one_NN knows_VBZ the_DT effects_NNS it_PRP will_MD have_VB on_IN our_PRP$ children_NNS ’s_POS health_NN in_IN the_DT long_JJ run_NN ._. I_PRP will_MD not_RB allow_VB my_PRP$ children_NNS to_TO be_VB test_NN subjects_NNS ._. ”_'' –_: Eugenia_NNP H._NNP “_`` One_CD super_JJ vaccine_NN to_TO rule_VB them_PRP all_DT …_. And_CC plenty_NN of_IN super_RB adverse_JJ events_NNS to_TO go_VB with_IN it_PRP !_. ”_'' –_: Ashley_NNP E._NNP “_'' How_WRB in_IN humanity_NN can_MD this_DT be_VB ethical_JJ ?_. Or_CC scientifically_RB sound_JJ ?_. That_DT ’s_VBZ absolute_JJ violence_NN on_IN our_PRP$ immune_JJ system_NN ._. ”_'' –_: Selina_NNP W._NNP “_'' This_DT is_VBZ scary_JJ ._. All_DT vaccines_NNS into_IN one_CD shot_NN ?_. They_PRP ca_MD n’t_RB even_RB get_VB the_DT ones_NNS they_PRP do_VBP have_VB right_JJ ._. ”_'' –_: Trina_NNP L_NNP ._. Disclaimer_NN :_: We_PRP at_IN Prepare_NN for_IN Change_NN (_-LRB- PFC_NNP )_-RRB- bring_VBP you_PRP information_NN that_WDT is_VBZ not_RB offered_VBN by_IN the_DT mainstream_JJ news_NN ,_, and_CC therefore_RB may_MD seem_VB controversial_JJ ._. The_DT opinions_NNS ,_, views_NNS ,_, statements_NNS ,_, and_CC /_, or_CC information_NN we_PRP present_VBP are_VBP not_RB necessarily_RB promoted_VBN ,_, endorsed_VBN ,_, espoused_VBN ,_, or_CC agreed_VBN to_TO by_IN Prepare_VB for_IN Change_NNP ,_, its_PRP$ leadership_NN Council_NN ,_, members_NNS ,_, those_DT who_WP work_VBP with_IN PFC_NNP ,_, or_CC those_DT who_WP read_VBP its_PRP$ content_NN ._. However_RB ,_, they_PRP are_VBP hopefully_RB provocative_JJ ._. Please_UH use_VB discernment_NN !_. Use_VB logical_JJ thinking_NN ,_, your_PRP$ own_JJ intuition_NN and_CC your_PRP$ own_JJ connection_NN with_IN Source_NNP ,_, Spirit_NNP and_CC Natural_JJ Laws_NNPS to_TO help_VB you_PRP determine_VB what_WP is_VBZ true_JJ and_CC what_WP is_VBZ not_RB ._. By_IN sharing_VBG information_NN and_CC seeding_VBG dialogue_NN ,_, it_PRP is_VBZ our_PRP$ goal_NN to_TO raise_VB consciousness_NN and_CC awareness_NN of_IN higher_JJR truths_NNS to_TO free_VB us_PRP from_IN enslavement_NN of_IN the_DT matrix_NN in_IN this_DT material_NN realm_NN ._.","The NN of NN NNS VBZ VBN RB in the JJ JJ NNS VBG a NN of NN and NN . This RB VBG NN with an VBG NN of NN - NNS , JJ NNS and JJ NN NNS VBZ VBG VBN RB RB by NNS and NNS who VBP to RB VB the RB NN - VBN NN NN . While JJ would VB to VB RB to the RB six or RB NNS their NNS VBD , the NNS VBP RB VBG to VB out with a NN that may VB RB RBR JJ to our NN than the JJ NN NN . They VBP VBG with one NN NN VBN at NN to VB a NN , and VBG that all NNS can VB RB in one NN . NN , which VBZ VBN with JJ NNS , and RB NN and NN NNS like NNP and NNP . RB , the NN to VB this JJ NN NN NNP NNP VBZ that “ [ the NNS ] VBP NNS VBP but [ they ] VBP RB VB how they VBP . ” NN NNS VBP 50 NN or JJR NN of the NN because the NN VBZ RB VBG and VBZ JJ to VB . Yet RB though the NNS VBP RB VB how NNS VBP ( and JJ how they VBP under - VBN NN NNS ) , and cannot VB an JJ NN NN that VBZ RB , they VBP VBN to VB one that VBZ VBN to VB a NN . NNP VBZ the NN will VB VBN because the NN VBZ a ‘ NN - NN NN ’ and “ [ VBZ ] their NN where their NN VBZ . ” The NNS VBP VBG all of this RB JJ as VBN from NNS on the NN . And VBG the JJ JJ JJ NN NNS VBN in the JJ “ JJ NN ” NN NN , it VBZ JJ to VB whether VBG JJ NNS ( RBS JJ with JJ JJ NNS ) VBZ a JJ NN after all . JJS NNS VBP VBG out against this JJ NN : “ This VBZ NN ! Why VBZ this RB about NN RB of NN ? ” – NNP NNP “ RB VBN … There VBZ no NN on the JJ NN NNS . No NN VBZ the NNS it will VB on our NNS ’s NN in the JJ NN . I will RB VB my NNS to VB NN NNS . ” – NNP NNP “ One JJ NN to VB them all … And NN of RB JJ NNS to VB with it ! ” – NNP NNP “ How in NN can this VB JJ ? Or RB JJ ? That VBZ JJ NN on our JJ NN . ” – NNP NNP “ This VBZ JJ . All NNS into one NN ? They ca RB RB VB the NNS they VBP VB JJ . ” – NNP NNP . NN : We at NN for NN ( NNP ) VBP you NN that VBZ RB VBN by the JJ NN , and RB may VB JJ . The NNS , NNS , NNS , and / or NN we VBP VBP RB RB VBN , VBN , VBN , or VBN to by VB for NNP , its NN NN , NNS , those who VBP with NNP , or those who VBP its NN . RB , they VBP RB JJ . Please VB NN ! VB JJ NN , your JJ NN and your JJ NN with NNP , NNP and JJ NNPS to VB you VB what VBZ JJ and what VBZ RB . By VBG NN and VBG NN , it VBZ our NN to VB NN and NN of JJR NNS to VB us from NN of the NN in this NN NN ."
88,1223,mainstream,"In_IN 1980_CD the_DT World_NNP Health_NNP Organization_NNP declared_VBD that_IN the_DT deadly_JJ disease_NN smallpox_NN had_VBD been_VBN eradicated_VBN ,_, an_DT accomplishment_NN attributed_VBN to_IN the_DT success_NN of_IN the_DT smallpox_NN vaccine_NN ._. The_DT vaccine_NN had_VBD been_VBN developed_VBN almost_RB 200_CD years_NNS earlier_RBR by_IN the_DT British_JJ physician_NN Edward_NNP Jenner_NNP ,_, who_WP had_VBD based_VBN his_PRP$ work_NN on_IN a_DT piece_NN of_IN folk_NN wisdom_NN from_IN the_DT countryside_NN that_WDT few_JJ doctors_NNS had_VBD taken_VBN seriously_RB :_: people_NNS who_WP caught_VBD cowpox_NN ,_, a_DT mild_JJ viral_JJ infection_NN of_IN cattle_NN ,_, never_RB got_VBD smallpox_NN ._. In_IN 1796_CD Jenner_NNP proved_VBD the_DT truth_NN of_IN this_DT scientifically_RB in_IN a_DT famous_JJ experiment_NN he_PRP conducted_VBD on_IN an_DT eight_CD -_HYPH year_NN -_HYPH old_JJ boy_NN named_VBN James_NNP Phipps_NNP ._. Jenner_NNP exposed_VBD Phipps_NNP to_IN a_DT person_NN with_IN cowpox_NN ,_, then_RB two_CD months_NNS later_RBR exposed_VBD him_PRP to_IN smallpox_NN (_-LRB- this_DT would_MD be_VB considered_VBN unethical_JJ by_IN today_NN 's_POS standards_NNS )_-RRB- ._. As_IN Jenner_NNP expected_VBD ,_, the_DT boy_NN warded_VBD off_RP the_DT smallpox_NN without_IN any_DT complications_NNS ._. Prior_JJ to_IN this_DT ,_, there_EX existed_VBD a_DT form_NN of_IN vaccination_NN against_IN smallpox_NN that_WDT consisted_VBD of_IN exposing_VBG people_NNS to_IN a_DT mild_JJ form_NN of_IN the_DT disease_NN ._. Although_IN this_DT method_NN often_RB worked_VBD ,_, it_PRP was_VBD risky_JJ ,_, and_CC the_DT exposed_VBN person_NN sometimes_RB died_VBD ._. Jenner_NNP ,_, who_WP devised_VBD the_DT word_NN from_IN the_DT Latin_NNP for_IN cow_NNP ,_, _NNP is_VBZ considered_VBN to_TO be_VB the_DT father_NN of_IN immunology_NN ._. He_PRP also_RB did_VBD significant_JJ research_NN on_IN heart_NN disease_NN ._.","In 1980 the NNP NNP NNP VBD that the JJ NN NN VBD VBN VBN , an NN VBN to the NN of the NN NN . The NN VBD VBN VBN RB 200 NNS RBR by the JJ NN NNP NNP , who VBD VBN his NN on a NN of NN NN from the NN that JJ NNS VBD VBN RB : NNS who VBD NN , a JJ JJ NN of NN , RB VBD NN . In 1796 NNP VBD the NN of this RB in a JJ NN he VBD on an eight - NN - JJ NN VBN NNP NNP . NNP VBD NNP to a NN with NN , RB two NNS RBR VBD him to NN ( this would VB VBN JJ by NN 's NNS ) . As NNP VBD , the NN VBD off the NN without any NNS . JJ to this , there VBD a NN of NN against NN that VBD of VBG NNS to a JJ NN of the NN . Although this NN RB VBD , it VBD JJ , and the VBN NN RB VBD . NNP , who VBD the NN from the NNP for NNP , NNP VBZ VBN to VB the NN of NN . He RB VBD JJ NN on NN NN ."
89,397,mainstream,"The_DT video_NN shows_VBZ Green_NNP ,_, a_DT Republican_NNP from_IN Tennessee_NNP ,_, saying_VBG he_PRP 'll_MD confront_VB the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP about_IN autism_NN and_CC vaccines_NNS ._. ""_`` Let_VB me_PRP say_VB this_DT about_IN autism_NN ,_, ""_'' Green_NNP said_VBD ._. ""_`` I_PRP have_VBP committed_VBN to_IN people_NNS in_IN my_PRP$ community_NN ,_, up_RB in_IN Montgomery_NNP County_NNP ,_, to_TO stand_VB on_IN the_DT CDC_NNP 's_POS desk_NN and_CC get_VB the_DT real_JJ data_NNS on_IN vaccines_NNS ._. Because_IN there_EX is_VBZ some_DT concern_NN that_IN the_DT rise_NN in_IN autism_NN is_VBZ the_DT result_NN of_IN the_DT preservatives_NNS that_WDT are_VBP in_IN our_PRP$ vaccines_NNS ._. ""_'' However_RB ,_, Green_NNP said_VBD after_IN the_DT video_NN was_VBD published_VBN Wednesday_NNP that_IN his_PRP$ comments_NNS are_VBP being_VBG ""_`` misconstrued_VBN ._. ""_'' ""_`` Recent_JJ comments_NNS I_PRP made_VBD at_IN a_DT town_NN hall_NN regarding_VBG vaccines_NNS has_VBZ been_VBN misconstrued_VBN ._. I_PRP want_VBP to_TO reiterate_VB my_PRP$ wife_NN and_CC I_PRP vaccinated_VBD our_PRP$ children_NNS ,_, and_CC we_PRP believe_VBP ,_, and_CC advise_VBP others_NNS they_PRP should_MD have_VB their_PRP$ children_NNS vaccinated_VBN ,_, ""_'' Green_NNP said_VBD in_IN a_DT statement_NN to_IN CNN_NNP on_IN Wednesday_NNP ._. But_CC ,_, in_IN separate_JJ comments_NNS Wednesday_NNP to_IN The_DT Tennessean_NNP ,_, Green_NNP appeared_VBD to_TO reiterate_VB his_PRP$ previous_JJ comments_NNS ,_, but_CC adding_VBG that_IN vaccines_NNS are_VBP ""_`` essential_JJ to_IN good_JJ population_NN health_NN ._. ""_'' ""_`` There_EX appears_VBZ to_TO be_VB some_DT evidence_NN that_IN as_IN vaccine_NN numbers_NNS increase_VBP ,_, rates_NNS of_IN autism_NN increase_NN ,_, ""_'' Green_NNP told_VBD The_DT Tennessean_NNP ._. ""_`` We_PRP need_VBP better_JJR research_NN ,_, and_CC we_PRP need_VBP it_PRP fast_RB ._. We_PRP also_RB need_VBP complete_JJ transparency_NN of_IN any_DT data_NNS ._. Vaccines_NNS are_VBP essential_JJ to_IN good_JJ population_NN health_NN ._. But_CC that_DT does_VBZ not_RB mean_VB we_PRP should_MD not_RB look_VB closely_RB at_IN the_DT correlation_NN for_IN any_DT causation_NN ._. ""_'' The_DT alleged_VBN correlation_NN between_IN vaccines_NNS and_CC autism_NN has_VBZ been_VBN widely_RB debunked_VBN ,_, and_CC has_VBZ been_VBN called_VBN out_RP by_IN the_DT advocacy_NN group_NN Autism_NNP Speaks_NNP ,_, which_WDT previously_RB said_VBD ,_, ""_`` Over_IN the_DT last_JJ two_CD decades_NNS ,_, extensive_JJ research_NN has_VBZ asked_VBN whether_IN there_EX is_VBZ any_DT link_NN between_IN childhood_NN vaccinations_NNS and_CC autism_NN ._. The_DT results_NNS of_IN this_DT research_NN are_VBP clear_JJ :_: Vaccines_NNS do_VBP not_RB cause_VB autism_NN ._. We_PRP urge_VBP that_IN all_DT children_NNS be_VBP fully_RB vaccinated_VBN ._. ""_'' CNN_NNP has_VBZ reached_VBN out_RP to_IN the_DT CDC_NNP for_IN comment_NN about_IN Green_NNP 's_POS remarks_NNS ._. ,_, including_VBG Studies_NNS ,_, including_VBG one_CD analysis_NN of_IN more_JJR than_IN a_DT million_CD children_NNS ,_, show_VB no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ,_, ""_'' said_VBD CNN_NNP Chief_NNP Medical_NNP Correspondent_NNP Dr._NNP Sanjay_NNP Gupta_NNP ._. ""_`` We_PRP do_VBP n't_RB know_VB what_WP causes_VBZ autism_NN ,_, but_CC we_PRP know_VBP with_IN certainty_NN that_IN vaccines_NNS do_VBP not_RB ._. ""_'' This_DT is_VBZ n't_RB the_DT first_JJ time_NN Green_NNP has_VBZ found_VBN himself_PRP in_IN the_DT middle_NN of_IN controversy_NN --_, he_PRP also_RB had_VBD been_VBN tapped_VBN by_IN President_NNP Donald_NNP Trump_NNP to_TO be_VB considered_VBN for_IN secretary_NN of_IN the_DT Army_NNP ._. He_PRP ultimately_RB withdrew_VBD from_IN the_DT process_NN after_IN his_PRP$ nomination_NN ran_VBD into_IN trouble_NN following_VBG a_DT backlash_NN for_IN past_JJ controversial_JJ statements_NNS he_PRP had_VBD made_VBN on_IN LGBT_NNP issues_NNS ,_, Islam_NNP and_CC evolution_NN ._. In_IN 2016_CD ,_, Green_NNP told_VBD a_DT tea_NN party_NN group_NN that_IN ""_`` if_IN you_PRP poll_VBP the_DT psychiatrists_NNS ,_, they_PRP 're_VBP going_VBG to_TO tell_VB you_PRP that_IN transgender_NN is_VBZ a_DT disease_NN ._. ""_'' In_IN 2013_CD ,_, Green_NNP blasted_VBD President_NNP Barack_NNP Obama_NNP for_IN supporting_VBG what_WP he_PRP said_VBD were_VBD ""_`` '_`` transvestites_NNS in_IN uniform_NN ._. ""_'' Green_NNP ,_, who_WP is_VBZ a_DT former_JJ Army_NNP doctor_NN ,_, is_VBZ also_RB a_DT self_NN -_HYPH identified_VBN ""_`` creationist_NN ""_'' who_WP has_VBZ delivered_VBN a_DT lecture_NN arguing_VBG against_IN the_DT theory_NN of_IN evolution_NN ._.","The NN VBZ NNP , a NNP from NNP , VBG he 'll VB the NNPS for NNP NNP and NNP about NN and NNS . "" VB me VB this about NN , "" NNP VBD . "" I VBP VBN to NNS in my NN , RB in NNP NNP , to VB on the NNP 's NN and VB the JJ NNS on NNS . Because there VBZ some NN that the NN in NN VBZ the NN of the NNS that VBP in our NNS . "" RB , NNP VBD after the NN VBD VBN NNP that his NNS VBP VBG "" VBN . "" "" JJ NNS I VBD at a NN NN VBG NNS VBZ VBN VBN . I VBP to VB my NN and I VBD our NNS , and we VBP , and VBP NNS they should VB their NNS VBN , "" NNP VBD in a NN to NNP on NNP . But , in JJ NNS NNP to The NNP , NNP VBD to VB his JJ NNS , but VBG that NNS VBP "" JJ to JJ NN NN . "" "" There VBZ to VB some NN that as NN NNS VBP , NNS of NN NN , "" NNP VBD The NNP . "" We VBP JJR NN , and we VBP it RB . We RB VBP JJ NN of any NNS . NNS VBP JJ to JJ NN NN . But that VBZ RB VB we should RB VB RB at the NN for any NN . "" The VBN NN between NNS and NN VBZ VBN RB VBN , and VBZ VBN VBN out by the NN NN NNP NNP , which RB VBD , "" Over the JJ two NNS , JJ NN VBZ VBN whether there VBZ any NN between NN NNS and NN . The NNS of this NN VBP JJ : NNS VBP RB VB NN . We VBP that all NNS VBP RB VBN . "" NNP VBZ VBN out to the NNP for NN about NNP 's NNS . , VBG NNS , VBG one NN of JJR than a million NNS , VB no NN between NNS and NN , "" VBD NNP NNP NNP NNP NNP NNP NNP . "" We VBP RB VB what VBZ NN , but we VBP with NN that NNS VBP RB . "" This VBZ RB the JJ NN NNP VBZ VBN himself in the NN of NN -- he RB VBD VBN VBN by NNP NNP NNP to VB VBN for NN of the NNP . He RB VBD from the NN after his NN VBD into NN VBG a NN for JJ JJ NNS he VBD VBN on NNP NNS , NNP and NN . In 2016 , NNP VBD a NN NN NN that "" if you VBP the NNS , they VBP VBG to VB you that NN VBZ a NN . "" In 2013 , NNP VBD NNP NNP NNP for VBG what he VBD VBD "" ' NNS in NN . "" NNP , who VBZ a JJ NNP NN , VBZ RB a NN - VBN "" NN "" who VBZ VBN a NN VBG against the NN of NN ."
90,493,conspiracy,"The_DT takeover_NN of_IN public_JJ health_NN that_WDT we_PRP have_VBP documented_VBN in_IN How_WRB Bill_NNP Gates_NNP Monopolized_VBD Global_NNP Health_NNP and_CC the_DT remarkably_RB brazen_JJ push_NN to_TO vaccinate_VB everyone_NN on_IN the_DT planet_NN that_WDT we_PRP have_VBP documented_VBN in_IN Bill_NNP Gates_NNP ’_POS Plan_NN to_TO Vaccinate_VB the_DT World_NNP was_VBD not_RB ,_, at_IN base_NN ,_, about_IN money_NN ._. The_DT unimaginable_JJ wealth_NN that_WDT Gates_NNPS has_VBZ accrued_VBN is_VBZ now_RB being_VBG used_VBN to_TO purchase_VB something_NN much_RB more_RBR useful_JJ :_: control_NN ._. Control_NN not_RB just_RB of_IN the_DT global_JJ health_NN bodies_NNS that_WDT can_MD coordinate_VB a_DT worldwide_JJ vaccination_NN program_NN or_CC of_IN the_DT governments_NNS that_WDT will_MD mandate_VB such_PDT an_DT unprecedented_JJ campaign_NN ,_, but_CC control_NN over_IN the_DT global_JJ population_NN itself_PRP ._. CLICK_VB HERE_RB for_IN transcript_NN and_CC sources_NNS","The NN of JJ NN that we VBP VBN in How NNP NNP VBD NNP NNP and the RB JJ NN to VB NN on the NN that we VBP VBN in NNP NNP ’ NN to VB the NNP VBD RB , at NN , about NN . The JJ NN that NNPS VBZ VBN VBZ RB VBG VBN to VB NN RB RBR JJ : NN . NN RB RB of the JJ NN NNS that can VB a JJ NN NN or of the NNS that will VB such an JJ NN , but NN over the JJ NN itself . VB RB for NN and NNS"
91,469,mainstream,"Two_CD California_NNP lawmakers_NNS announced_VBD a_DT bill_NN Wednesday_NNP that_WDT would_MD end_VB exemptions_NNS to_IN mandated_VBN school_NN vaccines_NNS due_IN to_IN “_`` personal_JJ beliefs_NNS ._. ”_'' Democratic_NNP State_NNP Sen._NNP Richard_NNP Pan_NNP ,_, who_WP is_VBZ also_RB a_DT pediatrician_NN ,_, will_MD co-author_VB a_DT bill_NN ending_VBG personal_JJ exemptions_NNS ,_, though_IN the_DT legislation_NN will_MD most_RBS likely_RB retain_VB exemptions_NNS for_IN religious_JJ beliefs_NNS ,_, the_DT Los_NNP Angeles_NNP Times_NNP reported_VBD ._. The_DT state_NN ’s_POS two_CD U.S._NNP senators_NNS ,_, Democrats_NNPS Dianne_NNP Feinstein_NNP and_CC Barbara_NNP Boxer_NNP ,_, both_DT support_VBP ending_VBG the_DT opt_NN -_HYPH out_RP policy_NN and_CC asked_VBD the_DT state_NN ’s_POS health_NN authorities_NNS to_TO reexamine_VB the_DT religious_JJ exemption_NN as_RB well_RB ._. Schools_NNS would_MD also_RB be_VB required_VBN to_TO publish_VB the_DT percentage_NN of_IN their_PRP$ students_NNS that_WDT are_VBP vaccinated_VBN under_IN the_DT law_NN ._. Pan_NN announced_VBD the_DT bill_NN at_IN a_DT news_NN conference_NN flanked_VBN by_IN parents_NNS whose_WP$ children_NNS are_VBP not_RB eligible_JJ to_TO receive_VB the_DT vaccines_NNS for_IN medical_JJ reasons_NNS ._. These_DT parents_NNS expressed_VBD concern_NN that_IN parents_NNS of_IN children_NNS who_WP can_MD receive_VB the_DT vaccines_NNS but_CC choose_VBP not_RB to_TO are_VB threatening_VBG their_PRP$ communities_NNS ’_POS “_`` herd_NN immunity_NN ”_'' to_IN certain_JJ diseases_NNS ._. California_NNP is_VBZ one_CD of_IN only_RB 19_CD states_NNS that_WDT currently_RB allow_VBP parents_NNS to_TO opt_VB out_RP for_IN personal_JJ beliefs_NNS ._. In_IN 2012_CD ,_, Pan_NNP authored_VBD a_DT measure_NN that_WDT would_MD require_VB parents_NNS pursuing_VBG exemptions_NNS to_TO consult_VB medical_JJ professionals_NNS ._. He_PRP claims_VBZ that_IN the_DT number_NN of_IN parents_NNS opting_VBG out_IN of_IN vaccinating_VBG their_PRP$ children_NNS has_VBZ fallen_VBN by_IN one_CD -_HYPH fifth_NN since_IN that_DT bill_NN went_VBD into_IN effect_NN ._. California_NNP is_VBZ currently_RB weathering_VBG a_DT measles_NN outbreak_NN that_WDT began_VBD at_IN Disneyland_NNP in_IN December_NNP ._. Almost_RB 100_CD cases_NNS have_VBP been_VBN reported_VBN ._. The_DT state_NN ’s_POS Democratic_JJ governor_NN ,_, Jerry_NNP Brown_NNP —_: who_WP advocated_VBD personal_JJ exemptions_NNS to_IN vaccines_NNS two_CD years_NNS ago_RB —_: indicated_VBD that_IN he_PRP is_VBZ willing_JJ to_TO reconsider_VB ._. “_`` Any_DT bill_NN that_WDT reaches_VBZ his_PRP$ desk_NN will_MD be_VB closely_RB considered_VBN ,_, ”_'' a_DT Brown_NNP spokesperson_NN told_VBD the_DT San_NNP Jose_NNP Mercury_NNP News_NNP ._. The_DT Mercury_NNP News_NNP also_RB reported_VBD that_IN personal_JJ exemption_NN rates_NNS in_IN California_NNP are_VBP up_RB from_IN less_JJR than_IN 1_CD percent_NN 15_CD years_NNS ago_RB to_IN around_RB 2.5_CD percent_NN now_RB ._. “_`` Parents_NNS are_VBP letting_VBG us_PRP know_VB our_PRP$ current_JJ laws_NNS are_VBP insufficient_JJ ,_, ”_'' Pan_NNP told_VBD reporters_NNS Wednesday_NNP ._. “_`` We_PRP should_MD n’t_RB wait_VB for_IN more_JJR children_NNS to_TO sicken_VB or_CC die_VB before_IN we_PRP act_VBP ._. ”_'' The_DT other_JJ presumed_VBN sponsor_NN of_IN the_DT bill_NN to_TO end_VB personal_JJ exemptions_NNS is_VBZ Sen._NNP Ben_NNP Allen_NNP ,_, a_DT Democrat_NNP ._.","Two NNP NNS VBD a NN NNP that would VB NNS to VBN NN NNS due to “ JJ NNS . ” NNP NNP NNP NNP NNP , who VBZ RB a NN , will VB a NN VBG JJ NNS , though the NN will RBS RB VB NNS for JJ NNS , the NNP NNP NNP VBD . The NN ’s two NNP NNS , NNPS NNP NNP and NNP NNP , both VBP VBG the NN - out NN and VBD the NN ’s NN NNS to VB the JJ NN RB RB . NNS would RB VB VBN to VB the NN of their NNS that VBP VBN under the NN . NN VBD the NN at a NN NN VBN by NNS whose NNS VBP RB JJ to VB the NNS for JJ NNS . These NNS VBD NN that NNS of NNS who can VB the NNS but VBP RB to VB VBG their NNS ’ “ NN NN ” to JJ NNS . NNP VBZ one of RB 19 NNS that RB VBP NNS to VB out for JJ NNS . In 2012 , NNP VBD a NN that would VB NNS VBG NNS to VB JJ NNS . He VBZ that the NN of NNS VBG out of VBG their NNS VBZ VBN by one - NN since that NN VBD into NN . NNP VBZ RB VBG a NN NN that VBD at NNP in NNP . RB 100 NNS VBP VBN VBN . The NN ’s JJ NN , NNP NNP — who VBD JJ NNS to NNS two NNS RB — VBD that he VBZ JJ to VB . “ Any NN that VBZ his NN will VB RB VBN , ” a NNP NN VBD the NNP NNP NNP NNP . The NNP NNP RB VBD that JJ NN NNS in NNP VBP RB from JJR than 1 NN 15 NNS RB to RB 2.5 NN RB . “ NNS VBP VBG us VB our JJ NNS VBP JJ , ” NNP VBD NNS NNP . “ We should RB VB for JJR NNS to VB or VB before we VBP . ” The JJ VBN NN of the NN to VB JJ NNS VBZ NNP NNP NNP , a NNP ."
92,782,mainstream,"See_VB also_RB a_DT list_NN of_IN vaccines_NNS by_IN disease_NN ._. Vaccines_NNS are_VBP available_JJ for_IN these_DT 18_CD dangerous_JJ or_CC deadly_JJ diseases_NNS ._. Over_IN the_DT years_NNS ,_, these_DT vaccines_NNS have_VBP prevented_VBN countless_JJ cases_NNS of_IN disease_NN and_CC saved_VBD millions_NNS of_IN lives_NNS ._. Infants_NNS ,_, children_NNS ,_, adolescents_NNS ,_, teens_NNS and_CC adults_NNS need_VBP different_JJ vaccinations_NNS ,_, depending_VBG on_IN their_PRP$ age_NN ,_, location_NN ,_, job_NN ,_, lifestyle_NN ,_, travel_NN schedule_NN ,_, health_NN conditions_NNS or_CC previous_JJ vaccinations_NNS ._. Click_VB on_IN a_DT disease_NN name_NN to_TO learn_VB more_JJR about_IN the_DT diseases_NNS and_CC the_DT vaccines_NNS that_WDT prevent_VBP them_PRP ._. Vaccines_NNS Recommended_VBN for_IN Travel_NN and_CC Some_DT Specific_JJ Groups_NNS People_NNS in_IN certain_JJ research_NN jobs_NNS and_CC travel_NN situations_NNS may_MD be_VB exposed_VBN to_IN dangerous_JJ or_CC deadly_JJ diseases_NNS that_WDT are_VBP no_RB longer_RBR common_JJ in_IN the_DT U.S._NNP Because_IN of_IN the_DT increased_VBN risk_NN of_IN disease_NN exposure_NN in_IN these_DT instances_NNS ,_, these_DT 9_CD non-routine_JJ vaccines_NNS are_VBP available_JJ ,_, listed_VBN below_RB by_IN disease_NN ._. These_DT are_VBP considered_VBN non-routine_JJ vaccines_NNS because_IN they_PRP are_VBP not_RB part_NN of_IN the_DT recommended_VBN immunization_NN schedules_NNS for_IN children_NNS ,_, adolescents_NNS and_CC adults_NNS ._.","VB RB a NN of NNS by NN . NNS VBP JJ for these 18 JJ or JJ NNS . Over the NNS , these NNS VBP VBN JJ NNS of NN and VBD NNS of NNS . NNS , NNS , NNS , NNS and NNS VBP JJ NNS , VBG on their NN , NN , NN , NN , NN NN , NN NNS or JJ NNS . VB on a NN NN to VB JJR about the NNS and the NNS that VBP them . NNS VBN for NN and Some JJ NNS NNS in JJ NN NNS and NN NNS may VB VBN to JJ or JJ NNS that VBP RB RBR JJ in the NNP Because of the VBN NN of NN NN in these NNS , these 9 JJ NNS VBP JJ , VBN RB by NN . These VBP VBN JJ NNS because they VBP RB NN of the VBN NN NNS for NNS , NNS and NNS ."
93,155,conspiracy,"A_DT new_JJ needle_NN -_HYPH free_JJ flu_NN vaccine_NN patch_NN revved_VBD up_RP the_DT immune_NN system_NN much_RB like_IN a_DT traditional_JJ flu_NN shot_NN without_IN any_DT negative_JJ side_NN effects_NNS ,_, according_VBG to_IN a_DT study_NN published_VBN in_IN the_DT Journal_NNP of_IN Investigative_NNP Dermatology_NNP ._. Though_IN the_DT research_NN is_VBZ in_IN the_DT early_JJ stages_NNS (_-LRB- the_DT patch_NN has_VBZ n’t_RB been_VBN tested_VBN in_IN humans_NNS )_-RRB- ,_, it_PRP ’s_VBZ an_DT important_JJ step_NN toward_IN a_DT technology_NN that_WDT could_MD replace_VB needle_NN -_HYPH based_VBN vaccination_NN methods_NNS that_WDT require_VBP administration_NN by_IN health_NN care_NN workers_NNS and_CC biohazard_NN waste_NN removal_NN ._. “_`` Scientists_NNS have_VBP been_VBN studying_VBG needle_NN -_HYPH free_JJ vaccine_NN approaches_NNS for_IN nearly_RB two_CD decades_NNS ,_, but_CC none_NN of_IN the_DT technologies_NNS have_VBP lived_VBN up_RP to_IN the_DT hype_NN ,_, ”_'' said_VBD Benjamin_NNP L._NNP Miller_NNP ,_, Ph.D._NNP ,_, corresponding_VBG author_NN and_CC Dean_NNP ’s_POS Professor_NNP of_IN Dermatology_NNP at_IN the_DT University_NNP of_IN Rochester_NNP Medical_NNP Center_NNP ._. “_`` Our_PRP$ patch_NN overcomes_VBZ a_DT lot_NN of_IN the_DT challenges_NNS faced_VBN by_IN microneedle_NN patches_NNS for_IN vaccine_NN delivery_NN ,_, the_DT main_JJ method_NN that_WDT ’s_VBZ been_VBN tested_VBN over_IN the_DT years_NNS ,_, and_CC our_PRP$ efficacy_NN and_CC lack_NN of_IN toxicity_NN make_VBP me_PRP excited_JJ about_IN the_DT prospect_NN of_IN a_DT product_NN that_WDT could_MD have_VB huge_JJ implications_NNS for_IN global_JJ health_NN ._. ”_'' Common_JJ skin_NN disease_NN paves_VBZ the_DT way_NN for_IN needleless_JJ flu_NN shot_NN Transporting_VBG big_JJ molecules_NNS like_IN flu_NN vaccine_NN proteins_NNS across_IN the_DT skin_NN is_VBZ difficult_JJ to_TO do_VB ,_, as_IN the_DT skin_NN is_VBZ intended_VBN to_TO keep_VB things_NNS out_IN of_IN the_DT body_NN ,_, not_RB to_TO let_VB them_PRP in_RP ._. The_DT study_NN team_NN took_VBD lessons_NNS learned_VBN from_IN the_DT research_NN and_CC treatment_NN of_IN a_DT common_JJ inflammatory_JJ skin_NN disease_NN to_TO overcome_VB this_DT hurdle_NN and_CC inform_VB their_PRP$ flu_NN vaccine_NN patch_NN strategy_NN ._. In_IN patients_NNS with_IN eczema_NN ,_, or_CC atopic_JJ dermatitis_NN ,_, the_DT skin_NN barrier_NN is_VBZ leaky_JJ ,_, allowing_VBG pollens_NNS ,_, molds_NNS and_CC a_DT host_NN of_IN other_JJ allergens_NNS to_TO enter_VB through_IN the_DT skin_NN and_CC be_VB sensed_VBN by_IN the_DT immune_NN system_NN ._. Lisa_NNP A._NNP Beck_NNP ,_, M.D._NNP ,_, corresponding_VBG author_NN and_CC Dean_NNP ’s_POS Professor_NNP of_IN Dermatology_NNP at_IN the_DT University_NNP of_IN Rochester_NNP Medical_NNP Center_NNP discovered_VBD that_IN the_DT expression_NN of_IN a_DT protein_NN called_VBN claudin_NN -_HYPH 1_CD helps_VBZ maintain_VB barrier_NN strength_NN and_CC lessen_VB the_DT permeability_NN of_IN the_DT skin_NN ._. Claudin_NNP -_HYPH 1_CD is_VBZ significantly_RB reduced_VBN in_IN eczema_NN patients_NNS (_-LRB- hence_RB the_DT leaky_JJ skin_NN barrier_NN )_-RRB- compared_VBN to_IN individuals_NNS without_IN the_DT disease_NN ._. In_IN past_JJ research_NN ,_, Beck_NNP found_VBD that_IN decreasing_VBG claudin_NN -_HYPH 1_CD expression_NN in_IN skin_NN cells_NNS from_IN healthy_JJ donors_NNS made_VBD the_DT skin_NN more_RBR permeable_JJ ._. Beck_NNP ,_, Miller_NNP ,_, and_CC first_JJ author_NN Matthew_NNP Brewer_NNP ,_, Ph.D._NNP ,_, wondered_VBD if_IN they_PRP could_MD use_VB this_DT induced_VBN permeability_NN to_TO get_VB a_DT flu_NN vaccine_NN virus_NN through_IN the_DT skin_NN ._. The_DT key_NN would_MD be_VB to_TO disrupt_VB the_DT skin_NN barrier_NN long_RB enough_RB to_TO deliver_VB the_DT virus_NN ,_, but_CC not_RB so_RB long_RB to_TO let_VB unwanted_JJ things_NNS in_IN ._. How_WRB it_PRP works_VBZ :_: Dermatology_NN ,_, chemistry_NN and_CC vaccine_NN biology_NN collide_VBP Miller_NNP ,_, a_DT chemist_NN ,_, worked_VBD with_IN Brewer_NNP ,_, who_WP was_VBD trained_VBN in_IN vaccine_NN biology_NN and_CC immunology_NN ,_, to_TO develop_VB synthetic_JJ peptides_NNS that_WDT bind_VBP to_IN and_CC inhibit_VBP claudin_NN -_HYPH 1_CD in_IN an_DT effort_NN to_TO open_VB up_RP the_DT skin_NN barrier_NN ._. They_PRP tested_VBD their_PRP$ formulations_NNS in_IN human_JJ skin_NN cells_NNS and_CC identified_VBD a_DT peptide_NN that_WDT disrupted_VBD the_DT barrier_NN without_IN any_DT toxic_JJ effects_NNS ._. Next_RB ,_, they_PRP designed_VBD a_DT patch_NN containing_VBG the_DT synthetic_JJ peptide_NN and_CC a_DT recombinant_JJ flu_NN vaccine_NN and_CC tested_VBD two_CD scenarios_NNS ._. In_IN the_DT first_JJ ,_, they_PRP placed_VBD the_DT patch_NN on_IN mice_NNS to_TO prime_VB the_DT immune_NN system_NN and_CC subsequently_RB administrated_VBD an_DT intramuscular_JJ flu_NN shot_NN to_TO boost_VB immunity_NN ._. In_IN the_DT second_JJ they_PRP did_VBD the_DT opposite_NN ,_, delivering_VBG an_DT intramuscular_JJ flu_NN shot_NN first_RB to_TO prime_VB the_DT immune_NN system_NN followed_VBN by_IN the_DT patch_NN to_TO boost_VB immunity_NN ._. In_IN both_DT scenarios_NNS they_PRP placed_VBD the_DT flu_NN vaccine_NN patch_NN ,_, which_WDT looks_VBZ like_IN a_DT tiny_JJ piece_NN of_IN tape_NN ,_, on_IN the_DT backs_NNS of_IN mice_NNS and_CC left_VBD if_IN there_RB for_IN as_RB little_JJ as_IN 18_CD and_CC as_RB long_RB as_IN 36_CD hours_NNS ._. The_DT patch_NN effectively_RB opened_VBD up_RP the_DT skin_NN barrier_NN ,_, as_IN measured_VBN by_IN water_NN loss_NN through_IN the_DT skin_NN ._.","A JJ NN - JJ NN NN NN VBD up the NN NN RB like a JJ NN NN without any JJ NN NNS , VBG to a NN VBN in the NNP of NNP NNP . Though the NN VBZ in the JJ NNS ( the NN VBZ RB VBN VBN in NNS ) , it VBZ an JJ NN toward a NN that could VB NN - VBN NN NNS that VBP NN by NN NN NNS and NN NN NN . “ NNS VBP VBN VBG NN - JJ NN NNS for RB two NNS , but NN of the NNS VBP VBN up to the NN , ” VBD NNP NNP NNP , NNP , VBG NN and NNP ’s NNP of NNP at the NNP of NNP NNP NNP . “ Our NN VBZ a NN of the NNS VBN by NN NNS for NN NN , the JJ NN that VBZ VBN VBN over the NNS , and our NN and NN of NN VBP me JJ about the NN of a NN that could VB JJ NNS for JJ NN . ” JJ NN NN VBZ the NN for JJ NN NN VBG JJ NNS like NN NN NNS across the NN VBZ JJ to VB , as the NN VBZ VBN to VB NNS out of the NN , RB to VB them in . The NN NN VBD NNS VBN from the NN and NN of a JJ JJ NN NN to VB this NN and VB their NN NN NN NN . In NNS with NN , or JJ NN , the NN NN VBZ JJ , VBG NNS , NNS and a NN of JJ NNS to VB through the NN and VB VBN by the NN NN . NNP NNP NNP , NNP , VBG NN and NNP ’s NNP of NNP at the NNP of NNP NNP NNP VBD that the NN of a NN VBN NN - 1 VBZ VB NN NN and VB the NN of the NN . NNP - 1 VBZ RB VBN in NN NNS ( RB the JJ NN NN ) VBN to NNS without the NN . In JJ NN , NNP VBD that VBG NN - 1 NN in NN NNS from JJ NNS VBD the NN RBR JJ . NNP , NNP , and JJ NN NNP NNP , NNP , VBD if they could VB this VBN NN to VB a NN NN NN through the NN . The NN would VB to VB the NN NN RB RB to VB the NN , but RB RB RB to VB JJ NNS in . How it VBZ : NN , NN and NN NN VBP NNP , a NN , VBD with NNP , who VBD VBN in NN NN and NN , to VB JJ NNS that VBP to and VBP NN - 1 in an NN to VB up the NN NN . They VBD their NNS in JJ NN NNS and VBD a NN that VBD the NN without any JJ NNS . RB , they VBD a NN VBG the JJ NN and a JJ NN NN and VBD two NNS . In the JJ , they VBD the NN on NNS to VB the NN NN and RB VBD an JJ NN NN to VB NN . In the JJ they VBD the NN , VBG an JJ NN NN RB to VB the NN NN VBN by the NN to VB NN . In both NNS they VBD the NN NN NN , which VBZ like a JJ NN of NN , on the NNS of NNS and VBD if RB for RB JJ as 18 and RB RB as 36 NNS . The NN RB VBD up the NN NN , as VBN by NN NN through the NN ."
94,366,mainstream,"A_DT Cambridge_NNP -_HYPH based_VBN pharmaceutical_JJ company_NN claims_VBZ it_PRP can_MD now_RB supply_VB two_CD billion_CD doses_NNS of_IN a_DT potential_JJ coronavirus_NN vaccine_NN ,_, which_WDT is_VBZ double_JJ the_DT number_NN it_PRP announced_VBD last_JJ month_NN ._. AstraZeneca_NNP has_VBZ signed_VBN two_CD new_JJ deals_NNS ,_, including_VBG one_CD backed_VBN by_IN Microsoft_NNP computer_NN system_NN founder_NN Bill_NNP Gates_NNP ,_, allowing_VBG it_PRP to_TO double_VB production_NN of_IN the_DT vaccine_NN being_VBG developed_VBN by_IN Oxford_NNP University_NNP ._. Pascal_NNP Soriot_NNP ,_, from_IN AstraZeneca_NNP ,_, said_VBD the_DT firm_NN should_MD know_VB by_IN September_NNP if_IN it_PRP works_VBZ ._. ""_`` It_PRP is_VBZ still_RB on_IN track_NN but_CC of_IN course_NN what_WP we_PRP cannot_MD predict_VB is_VBZ the_DT speed_NN the_DT disease_NN will_MD [_-LRB- spread_VB ]_-RRB- in_IN the_DT UK_NNP ,_, ""_'' he_PRP said_VBD ._. ""_`` On_IN the_DT one_CD hand_NN we_PRP want_VBP to_TO see_VB the_DT disease_NN decline_NN ,_, but_CC on_IN the_DT other_JJ it_PRP will_MD create_VB an_DT issue_NN because_IN we_PRP may_MD not_RB be_VB able_JJ to_TO show_VB the_DT efficacy_NN of_IN the_DT vaccine_NN ._. ""_''","A NNP - VBN JJ NN VBZ it can RB VB two billion NNS of a JJ NN NN , which VBZ JJ the NN it VBD JJ NN . NNP VBZ VBN two JJ NNS , VBG one VBN by NNP NN NN NN NNP NNP , VBG it to VB NN of the NN VBG VBN by NNP NNP . NNP NNP , from NNP , VBD the NN should VB by NNP if it VBZ . "" It VBZ RB on NN but of NN what we cannot VB VBZ the NN the NN will [ VB ] in the NNP , "" he VBD . "" On the one NN we VBP to VB the NN NN , but on the JJ it will VB an NN because we may RB VB JJ to VB the NN of the NN . """
95,1143,mainstream,"“_`` Leaky_JJ gut_NN autism_NN theory_NN doubted_VBN ”_'' ,_, was_VBD the_DT headline_NN from_IN BBC_NNP News_NNP on_IN March_NNP 17_CD 2008_CD ._. The_DT Daily_NNP Telegraph_NNP and_CC the_DT Daily_NNP Mail_NNP also_RB reported_VBD that_IN researchers_NNS have_VBP found_VBN no_DT evidence_NN to_TO support_VB the_DT ’_`` leaky_JJ gut_NN theory_NN ’_'' ._. They_PRP say_VBP that_IN this_DT theory_NN proposes_VBZ that_IN vaccines_NNS such_JJ as_IN MMR_NNP damage_VBP the_DT intestine_NN causing_VBG digestive_JJ problems_NNS ,_, leading_VBG to_IN the_DT production_NN of_IN peptides_NNS “_'' which_WDT can_MD damage_VB the_DT brain_NN and_CC possibly_RB cause_VB autism_NN ”_'' ._. This_DT well_RB conducted_VBN study_NN used_VBD reliable_JJ analysis_NN techniques_NNS to_TO compare_VB autistic_JJ children_NNS across_IN a_DT broad_JJ range_NN of_IN intelligences_NNS to_IN age_NN -_HYPH matched_VBN control_NN children_NNS ._. Despite_IN the_DT newspaper_NN headlines_NNS and_CC coverage_NN ,_, the_DT study_NN did_VBD not_RB look_VB at_IN the_DT effects_NNS of_IN the_DT MMR_NN jab_NN and_CC autism_NN ._. Instead_RB ,_, it_PRP tested_VBD and_CC compared_VBD the_DT urine_NN of_IN autistic_JJ boys_NNS with_IN the_DT urine_NN of_IN boys_NNS without_IN autism_NN ._. The_DT researchers_NNS conclude_VBP that_IN there_EX were_VBD no_DT differences_NNS between_IN the_DT levels_NNS of_IN peptides_NNS in_IN the_DT groups_NNS and_CC say_VBP they_PRP have_VBP effectively_RB disproved_VBN the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' ._. However_RB ,_, further_JJ research_NN is_VBZ needed_VBN to_TO establish_VB whether_IN a_DT casein_NN and_CC gluten_NN -_HYPH free_JJ diet_NN has_VBZ other_JJ effects_NNS on_IN autism_NN ._. The_DT researchers_NNS call_VBP for_IN more_JJR studies_NNS into_IN special_JJ diet_NN as_IN a_DT treatment_NN for_IN autism_NN ,_, but_CC they_PRP do_VBP not_RB suggest_VB that_IN their_PRP$ research_NN has_VBZ any_DT implication_NN for_IN the_DT discredited_VBN MMR_NN vaccine_NN /_, autism_NN theory_NN ._. Where_WRB did_VBD the_DT story_NN come_VB from_IN ?_. Dr_NNP Hilary_NNP Cass_NNP from_IN the_DT Great_NNP Ormond_NNP Street_NNP Hospital_NNP for_IN Children_NNPS and_CC colleagues_NNS from_IN around_IN England_NNP and_CC Scotland_NNP carried_VBD out_RP the_DT research_NN ._. The_DT authors_NNS acknowledge_VBP the_DT support_NN of_IN the_DT research_NN and_CC development_NN fund_NN of_IN the_DT Royal_NNP Hospital_NNP for_IN Sick_NNP Children_NNPS in_IN Edinburgh_NNP and_CC the_DT Chief_NNP Scientist_NNP Office_NNP in_IN Scotland_NNP ._. Competing_VBG interests_NNS were_VBD declared_VBN ._. The_DT study_NN was_VBD published_VBN in_IN Archives_NNPS of_IN Disease_NNP in_IN Childhood_NNP ,_, a_DT peer_NN -_HYPH reviewed_VBN medical_JJ journal_NN ._. What_WDT kind_NN of_IN scientific_JJ study_NN was_VBD this_DT ?_. This_DT was_VBD a_DT case_NN control_NN study_NN that_WDT compared_VBD 65_CD boys_NNS with_IN autism_NN ,_, aged_JJ between_IN five_CD and_CC 11_CD years_NNS ,_, with_IN 158_CD control_NN boys_NNS of_IN a_DT similar_JJ age_NN ._. The_DT researchers_NNS say_VBP that_IN ,_, for_IN a_DT number_NN of_IN years_NNS ,_, it_PRP has_VBZ been_VBN thought_VBN that_IN the_DT urine_NN of_IN children_NNS with_IN autism_NN contains_VBZ opioid_JJ peptides_NNS that_WDT originate_VBP from_IN outside_IN the_DT body_NN ._. Opioid_NN peptides_NNS are_VBP chemical_JJ compounds_NNS that_WDT are_VBP so_RB called_VBN because_IN they_PRP resemble_VBP morphine_NN ._. They_PRP can_MD be_VB produced_VBN by_IN the_DT body_NN and_CC through_IN the_DT digestion_NN of_IN foods_NNS such_JJ as_IN grain_NN and_CC milk_NN ._. Grains_NNS such_JJ as_IN wheat_NN ,_, rye_NN ,_, barley_NN and_CC oats_NNS contain_VBP the_DT protein_NN gluten_NN ,_, that_WDT produces_VBZ opioid_JJ peptides_NNS in_IN the_DT gut_NN ,_, while_IN milk_NN produces_VBZ another_DT variety_NN ,_, casein_NN ._. One_CD theory_NN for_IN the_DT development_NN of_IN autism_NN is_VBZ the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' :_: the_DT idea_NN that_IN children_NNS with_IN autism_NN become_VBP sensitive_JJ to_IN gluten_NN ._. The_DT gluten_NN is_VBZ thought_VBN to_TO inflame_VB the_DT small_JJ bowel_NN ._. The_DT resulting_VBG damage_NN allows_VBZ opioid_JJ peptides_NNS from_IN food_NN to_TO be_VB absorbed_VBN into_IN the_DT blood_NN and_CC then_RB enter_VB the_DT urine_NN ._. Before_IN the_DT opioid_JJ peptides_NNS in_IN the_DT blood_NN are_VBP excreted_VBN they_PRP are_VBP assumed_VBN to_TO cross_VB into_IN the_DT brain_NN and_CC result_VB in_IN the_DT symptoms_NNS of_IN autism_NN ._. Previous_JJ research_NN has_VBZ proposed_VBN that_IN excluding_VBG casein_NN and_CC gluten_NN (_-LRB- milk_NN and_CC grains_NNS )_-RRB- from_IN the_DT diet_NN might_MD help_VB children_NNS with_IN autism_NN by_IN reducing_VBG the_DT amount_NN of_IN circulating_VBG opioid_JJ peptides_NNS ._. The_DT theory_NN proposes_VBZ that_IN opioid_JJ peptides_NNS found_VBN in_IN urine_NN reflect_VBP a_DT disturbance_NN in_IN the_DT integrity_NN of_IN the_DT gut_NN epithelium_NN (_-LRB- i.e._FW a_DT leaky_JJ gut_NN )_-RRB- ._. Proponents_NNS of_IN the_DT theory_NN hope_VBP that_IN the_DT peptides_NNS can_MD act_VB as_IN a_DT diagnostic_JJ marker_NN for_IN autism_NN and_CC predict_VBP that_IN a_DT diet_NN excluding_VBG gluten_NN and_CC casein_NN could_MD help_VB to_TO treat_VB children_NNS with_IN autistic_JJ symptoms_NNS ._. This_DT study_NN aimed_VBD to_TO determine_VB the_DT occurrence_NN of_IN the_DT peptides_NNS in_IN the_DT urine_NN of_IN children_NNS who_WP have_VBP autism_NN and_CC those_DT who_WP do_VBP not_RB ._. The_DT researchers_NNS recruited_VBD 65_CD boys_NNS from_IN two_CD hospitals_NNS specialising_VBG in_IN autistic_JJ spectrum_NN disorders_NNS in_IN London_NNP ._. For_IN the_DT control_NN group_NN ,_, 202_CD non-autistic_JJ boys_NNS of_IN similar_JJ age_NN were_VBD recruited_VBN from_IN mainstream_JJ infant_NN and_CC primary_JJ schools_NNS in_IN the_DT same_JJ area_NN ._. A_DT questionnaire_NN was_VBD given_VBN to_IN the_DT parents_NNS of_IN the_DT controls_NNS to_TO ‘_`` screen_VB out_RP ’_POS children_NNS with_IN possible_JJ neurological_JJ or_CC psychiatric_JJ difficulties_NNS ._. Forty_CD of_IN the_DT controls_NNS were_VBD excluded_VBN from_IN the_DT study_NN as_IN their_PRP$ parents_NNS did_VBD not_RB complete_VB the_DT questionnaire_NN ,_, or_CC the_DT boys_NNS ’_POS results_NNS were_VBD abnormal_JJ or_CC borderline_JJ ._. Urine_NN samples_NNS were_VBD collected_VBN from_IN all_PDT the_DT children_NNS and_CC analysed_VBN using_VBG equipment_NN that_WDT separates_VBZ the_DT chemical_NN in_IN a_DT liquid_NN (_-LRB- HPLC_NN )_-RRB- ._. Other_JJ equipment_NN was_VBD used_VBN to_TO identify_VB small_JJ and_CC fragile_JJ biological_JJ molecules_NNS ,_, such_JJ as_IN the_DT opioid_JJ peptides_NNS (_-LRB- MALDI_NNP -_HYPH TOF_NNP MS_NNP )_-RRB- ._. What_WP were_VBD the_DT results_NNS of_IN the_DT study_NN ?_. The_DT researchers_NNS say_VBP that_IN their_PRP$ study_NN finds_VBZ no_DT evidence_NN of_IN opioid_JJ peptides_NNS in_IN the_DT urine_NN of_IN boys_NNS with_IN autism_NN or_CC similar_JJ disorders_NNS ._. After_IN adjusting_VBG for_IN the_DT amount_NN of_IN creatinine_NN in_IN the_DT urine_NN ,_, which_WDT is_VBZ a_DT measure_NN of_IN kidney_NN function_NN ,_, the_DT researchers_NNS found_VBD no_DT significant_JJ differences_NNS in_IN the_DT urinary_JJ profiles_NNS (_-LRB- shown_VBN by_IN HPLC_NN )_-RRB- between_IN groups_NNS of_IN boys_NNS with_IN or_CC without_IN autism_NN ._. In_IN those_DT cases_NNS where_WRB HPLC_NNP showed_VBD peaks_NNS in_IN the_DT locations_NNS at_IN which_WDT opioid_JJ peptides_NNS might_MD be_VB expected_VBN to_TO be_VB found_VBN ,_, further_JJ testing_NN by_IN mass_JJ spectrometry_NN (_-LRB- MALDI_NNP -_HYPH TOF_NNP )_-RRB- showed_VBD that_IN these_DT peaks_NNS did_VBD not_RB represent_VB opioid_JJ peptides_NNS ._. What_WDT interpretations_NNS did_VBD the_DT researchers_NNS draw_VB from_IN these_DT results_NNS ?_. The_DT researchers_NNS say_VBP that_IN “_`` given_VBN the_DT lack_NN of_IN evidence_NN for_IN any_DT opioid_JJ peptiduria_NN in_IN children_NNS with_IN autism_NN it_PRP can_MD neither_CC serve_VB as_IN a_DT biomedical_JJ marker_NN for_IN autism_NN ,_, nor_CC be_VB employed_VBN to_TO predict_VB or_CC monitor_VB response_NN to_IN a_DT casein_NN and_CC gluten_NN exclusion_NN diet_NN ”_'' ._. The_DT researchers_NNS say_VBP that_IN these_DT findings_NNS effectively_RB disprove_VBP the_DT ’_`` leaky_JJ gut_NN theory_NN ‘_'' ,_, which_WDT predicts_VBZ that_IN these_DT proteins_NNS should_MD be_VB found_VBN in_IN the_DT urine_NN of_IN autistic_JJ children_NNS ._. They_PRP suggest_VBP that_IN healthcare_NN professionals_NNS and_CC parents_NNS should_MD stop_VB testing_VBG children_NNS with_IN autism_NN for_IN urinary_JJ opioid_JJ peptides_NNS ,_, and_CC note_VB that_IN commercial_JJ laboratories_NNS around_IN the_DT world_NN still_RB widely_RB advertise_VBP these_DT tests_NNS on_IN the_DT internet_NN ._. What_WP does_VBZ the_DT NHS_NNP Knowledge_NN Service_NN make_VB of_IN this_DT study_NN ?_. This_DT study_NN has_VBZ a_DT number_NN of_IN strengths_NNS ._. The_DT researchers_NNS used_VBD accepted_VBD and_CC applied_VBD definitions_NNS of_IN autism_NN and_CC selected_VBN children_NNS across_IN a_DT broad_JJ range_NN of_IN intelligence_NN ._. The_DT urine_NN testing_NN appears_VBZ to_TO have_VB been_VBN conducted_VBN reliably_RB and_CC the_DT researchers_NNS further_RB analysed_VBD the_DT peptide_NN peaks_NNS found_VBN by_IN chromatography_NN (_-LRB- HPLC_NNP )_-RRB- with_IN advanced_JJ mass_NN spectroscopy_NN techniques_NNS (_-LRB- MALDI_NNP -_HYPH TOF_NNP )_-RRB- ._. They_PRP acknowledge_VBP some_DT limitations_NNS ,_, however_RB ,_, including_VBG :_: •_NFP The_DT autistic_JJ children_NNS were_VBD selected_VBN from_IN tertiary_JJ or_CC specialist_NN centres_NNS ._. This_DT may_MD mean_VB that_IN they_PRP had_VBD more_RBR severe_JJ autism_NN than_IN that_DT commonly_RB found_VBN in_IN the_DT community_NN ._. •_NFP It_PRP was_VBD not_RB possible_JJ to_TO match_VB the_DT autistic_JJ children_NNS with_IN low_JJ IQ_NN to_TO control_VB children_NNS with_IN the_DT same_JJ level_NN of_IN IQ_NN ._. Strictly_RB speaking_VBG ,_, this_DT means_VBZ that_IN the_DT groups_NNS were_VBD not_RB balanced_VBN at_IN the_DT start_NN of_IN the_DT study_NN ._. However_RB ,_, as_IN no_DT significant_JJ differences_NNS were_VBD found_VBN in_IN the_DT peptide_NN levels_NNS between_IN any_DT of_IN the_DT groups_NNS that_WDT were_VBD examined_VBN ,_, it_PRP is_VBZ unlikely_JJ that_IN a_DT link_NN would_MD have_VB been_VBN found_VBN between_IN peptide_NN levels_NNS and_CC IQ_NN either_RB ._. The_DT researchers_NNS say_VBP that_IN there_EX is_VBZ no_DT evidence_NN that_IN opioid_JJ peptides_NNS can_MD leak_VB through_IN the_DT gut_NN and_CC cause_VB autism_NN in_IN children_NNS ._. However_RB ,_, further_JJ research_NN is_VBZ needed_VBN to_TO establish_VB whether_IN a_DT casein_NN and_CC gluten_NN -_HYPH free_JJ diet_NN has_VBZ other_JJ effects_NNS on_IN autism_NN ._. The_DT researchers_NNS do_VBP not_RB comment_VB on_IN any_DT implications_NNS of_IN their_PRP$ study_NN with_IN regard_NN to_IN the_DT MMR_NN vaccine_NN ._. Immunisation_NN is_VBZ topical_JJ and_CC attracts_VBZ the_DT reader_NN ’s_POS attention_NN ,_, but_CC well_RB -_HYPH designed_VBN research_NN into_IN other_JJ theories_NNS of_IN how_WRB autism_NN is_VBZ caused_VBN is_VBZ needed_VBN ._.","“ JJ NN NN NN VBN ” , VBD the NN from NNP NNP on NNP 17 2008 . The NNP NNP and the NNP NNP RB VBD that NNS VBP VBN no NN to VB the ’ JJ NN NN ’ . They VBP that this NN VBZ that NNS JJ as NNP VBP the NN VBG JJ NNS , VBG to the NN of NNS “ which can VB the NN and RB VB NN ” . This RB VBN NN VBD JJ NN NNS to VB JJ NNS across a JJ NN of NNS to NN - VBN NN NNS . Despite the NN NNS and NN , the NN VBD RB VB at the NNS of the NN NN and NN . RB , it VBD and VBD the NN of JJ NNS with the NN of NNS without NN . The NNS VBP that there VBD no NNS between the NNS of NNS in the NNS and VBP they VBP RB VBN the ’ JJ NN NN ‘ . RB , JJ NN VBZ VBN to VB whether a NN and NN - JJ NN VBZ JJ NNS on NN . The NNS VBP for JJR NNS into JJ NN as a NN for NN , but they VBP RB VB that their NN VBZ any NN for the VBN NN NN / NN NN . Where VBD the NN VB from ? NNP NNP NNP from the NNP NNP NNP NNP for NNPS and NNS from around NNP and NNP VBD out the NN . The NNS VBP the NN of the NN and NN NN of the NNP NNP for NNP NNPS in NNP and the NNP NNP NNP in NNP . VBG NNS VBD VBN . The NN VBD VBN in NNPS of NNP in NNP , a NN - VBN JJ NN . What NN of JJ NN VBD this ? This VBD a NN NN NN that VBD 65 NNS with NN , JJ between five and 11 NNS , with 158 NN NNS of a JJ NN . The NNS VBP that , for a NN of NNS , it VBZ VBN VBN that the NN of NNS with NN VBZ JJ NNS that VBP from outside the NN . NN NNS VBP JJ NNS that VBP RB VBN because they VBP NN . They can VB VBN by the NN and through the NN of NNS JJ as NN and NN . NNS JJ as NN , NN , NN and NNS VBP the NN NN , that VBZ JJ NNS in the NN , while NN VBZ another NN , NN . One NN for the NN of NN VBZ the ’ JJ NN NN ‘ : the NN that NNS with NN VBP JJ to NN . The NN VBZ VBN to VB the JJ NN . The VBG NN VBZ JJ NNS from NN to VB VBN into the NN and RB VB the NN . Before the JJ NNS in the NN VBP VBN they VBP VBN to VB into the NN and VB in the NNS of NN . JJ NN VBZ VBN that VBG NN and NN ( NN and NNS ) from the NN might VB NNS with NN by VBG the NN of VBG JJ NNS . The NN VBZ that JJ NNS VBN in NN VBP a NN in the NN of the NN NN ( FW a JJ NN ) . NNS of the NN VBP that the NNS can VB as a JJ NN for NN and VBP that a NN VBG NN and NN could VB to VB NNS with JJ NNS . This NN VBD to VB the NN of the NNS in the NN of NNS who VBP NN and those who VBP RB . The NNS VBD 65 NNS from two NNS VBG in JJ NN NNS in NNP . For the NN NN , 202 JJ NNS of JJ NN VBD VBN from JJ NN and JJ NNS in the JJ NN . A NN VBD VBN to the NNS of the NNS to ‘ VB out ’ NNS with JJ JJ or JJ NNS . Forty of the NNS VBD VBN from the NN as their NNS VBD RB VB the NN , or the NNS ’ NNS VBD JJ or JJ . NN NNS VBD VBN from all the NNS and VBN VBG NN that VBZ the NN in a NN ( NN ) . JJ NN VBD VBN to VB JJ and JJ JJ NNS , JJ as the JJ NNS ( NNP - NNP NNP ) . What VBD the NNS of the NN ? The NNS VBP that their NN VBZ no NN of JJ NNS in the NN of NNS with NN or JJ NNS . After VBG for the NN of NN in the NN , which VBZ a NN of NN NN , the NNS VBD no JJ NNS in the JJ NNS ( VBN by NN ) between NNS of NNS with or without NN . In those NNS where NNP VBD NNS in the NNS at which JJ NNS might VB VBN to VB VBN , JJ NN by JJ NN ( NNP - NNP ) VBD that these NNS VBD RB VB JJ NNS . What NNS VBD the NNS VB from these NNS ? The NNS VBP that “ VBN the NN of NN for any JJ NN in NNS with NN it can neither VB as a JJ NN for NN , nor VB VBN to VB or VB NN to a NN and NN NN NN ” . The NNS VBP that these NNS RB VBP the ’ JJ NN NN ‘ , which VBZ that these NNS should VB VBN in the NN of JJ NNS . They VBP that NN NNS and NNS should VB VBG NNS with NN for JJ JJ NNS , and VB that JJ NNS around the NN RB RB VBP these NNS on the NN . What VBZ the NNP NN NN VB of this NN ? This NN VBZ a NN of NNS . The NNS VBD VBD and VBD NNS of NN and VBN NNS across a JJ NN of NN . The NN NN VBZ to VB VBN VBN RB and the NNS RB VBD the NN NNS VBN by NN ( NNP ) with JJ NN NN NNS ( NNP - NNP ) . They VBP some NNS , RB , VBG : • The JJ NNS VBD VBN from JJ or NN NNS . This may VB that they VBD RBR JJ NN than that RB VBN in the NN . • It VBD RB JJ to VB the JJ NNS with JJ NN to VB NNS with the JJ NN of NN . RB VBG , this VBZ that the NNS VBD RB VBN at the NN of the NN . RB , as no JJ NNS VBD VBN in the NN NNS between any of the NNS that VBD VBN , it VBZ JJ that a NN would VB VBN VBN between NN NNS and NN RB . The NNS VBP that there VBZ no NN that JJ NNS can VB through the NN and VB NN in NNS . RB , JJ NN VBZ VBN to VB whether a NN and NN - JJ NN VBZ JJ NNS on NN . The NNS VBP RB VB on any NNS of their NN with NN to the NN NN . NN VBZ JJ and VBZ the NN ’s NN , but RB - VBN NN into JJ NNS of how NN VBZ VBN VBZ VBN ."
96,699,conspiracy,"Gardasil_NNP vaccine_NN manufacturer_NN ,_, Merck_NNP ,_, announced_VBD earlier_RBR this_DT month_NN (_-LRB- June_NNP ,_, 2018_CD )_-RRB- that_IN the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- has_VBZ granted_VBN them_PRP a_DT “_`` Priority_NN Review_NN ”_'' to_TO approve_VB the_DT dangerous_JJ and_CC controversial_JJ Gardasil_NNP 9_CD vaccine_NN to_IN women_NNS and_CC men_NNS ,_, ages_NNS 27_CD to_IN 45_CD ._. The_DT Gardasil_NNP vaccine_NN is_VBZ currently_RB approved_VBN for_IN girls_NNS and_CC boys_NNS ,_, ages_NNS 9_CD through_IN 26_CD ._. The_DT request_NN by_IN Merck_NNP to_TO expand_VB its_PRP$ market_NN to_IN women_NNS and_CC men_NNS ,_, ages_NNS 27_CD to_IN 45_CD ,_, and_CC the_DT FDA_NNP ’s_POS approval_NN to_TO grant_VB it_PRP a_DT Priority_NN Review_NN by_IN October_NNP 6_CD ,_, 2018_CD ,_, follows_VBZ 10_CD years_NNS after_IN the_DT FDA_NNP struck_VBD down_RP a_DT similar_JJ request_NN to_TO expand_VB the_DT older_JJR version_NN of_IN Gardasil_NNP to_IN the_DT same_JJ age_NN group_NN ._. Back_RB in_IN 2008_CD ,_, after_IN agreeing_VBG to_IN a_DT faster_JJR review_NN in_IN the_DT age_NN group_NN ,_, the_DT FDA_NNP decided_VBD against_IN Merck_NNP ’s_POS case_NN for_IN an_DT additional_JJ Gardasil_NNP approval_NN in_IN females_NNS 27_CD to_IN 45_CD ._. The_DT agency_NN in_IN 2009_CD issued_VBD a_DT second_JJ complete_JJ response_NN letter_NN for_IN that_DT application_NN ,_, demanding_VBG Merck_NNP to_TO provide_VB longer_JJR -_HYPH term_NN efficacy_NN data_NNS in_IN the_DT age_NN group_NN ._. That_DT set_NN of_IN data_NNS apparently_RB did_VBD n’t_RB turn_VB things_NNS around_RB for_IN Merck_NNP ._. In_IN both_CC Gardasil_NNP ’s_POS and_CC Gardasil_NNP 9_CD ’s_POS current_JJ labels_NNS ,_, information_NN about_IN a_DT study_NN on_IN 3,253_CD women_NNS 27_CD through_IN 45_CD years_NNS of_IN age_NN states_VBZ that_IN there_EX was_VBD “_`` no_DT statistically_RB significant_JJ efficacy_NN ”_'' demonstrated_VBN by_IN the_DT vaccine_NN in_IN preventing_VBG high_JJ -_HYPH grade_NN cervical_JJ lesions_NNS or_CC cervical_JJ cancer_NN ._. So_RB what_WP has_VBZ changed_VBN that_IN Merck_NNP now_RB wants_VBZ the_DT FDA_NNP to_TO act_VB on_IN their_PRP$ request_NN again_RB ?_. According_VBG to_IN FiercePharma_NNP :_: Observational_JJ and_CC clinical_JJ data_NNS over_IN the_DT past_JJ decade_NN demonstrate_VBP that_IN women_NNS 27_CD to_IN 45_CD are_VBP also_RB at_IN risk_NN of_IN acquiring_VBG new_JJ HPV_NN infections_NNS ,_, Merck_NNP spokeswoman_NN Pamela_NNP Eisele_NNP told_VBD FiercePharma_NNP ._. Even_RB though_IN many_JJ people_NNS have_VBP already_RB been_VBN exposed_VBN to_IN HPV_NN at_IN an_DT younger_JJR age_NN ,_, they_PRP have_VBP not_RB been_VBN exposed_VBN to_IN all_DT nine_CD HPV_NN types_NNS targeted_VBN by_IN Gardasil_NNP 9_CD ._. Besides_RB ,_, a_DT follow_NN -_HYPH up_NN of_IN the_DT long_JJ -_HYPH term_NN study_NN with_IN Gardasil_NNP in_IN women_NNS ages_NNS 27_CD -_SYM 45_CD showed_VBD no_DT additional_JJ cases_NNS of_IN HPV_NN disease_NN for_IN at_IN least_JJS 10_CD years_NNS following_VBG vaccination_NN ,_, a_DT result_NN that_WDT can_MD be_VB extended_VBN to_IN Gardasil_NNP 9_CD ,_, she_PRP said_VBD ._. Will_MD the_DT FDA_NNP Look_VB at_IN Published_VBN Data_NNS on_IN Gardasil_NNP Side-effects_NNS ?_. Besides_IN the_DT hundreds_NNS of_IN stories_NNS of_IN young_JJ women_NNS being_VBG injured_VBN or_CC even_RB killed_VBN by_IN the_DT Gardasil_NNP vaccine_NN ,_, as_RB well_RB as_IN the_DT lawsuits_NNS mounting_VBG in_IN countries_NNS outside_IN the_DT U.S._NNP ,_, the_DT published_VBN data_NNS regarding_VBG Gardasil_NNP just_RB keeps_VBZ getting_VBG worse_JJR ._. Will_MD the_DT FDA_NNP consider_VB these_DT studies_NNS in_IN determining_VBG if_IN Gardasil_NNP should_MD be_VB expanded_VBN to_IN a_DT larger_JJR population_NN ?_. Should_MD n’t_RB the_DT FDA_NNP instead_RB be_VB determining_VBG if_IN Gardasil_NNP should_MD even_RB stay_VB in_IN the_DT market_NN ,_, as_IN other_JJ countries_NNS are_VBP beginning_VBG to_TO ask_VB ?_. Two_CD recent_JJ studies_NNS published_VBN this_DT year_NN (_-LRB- 2018_CD )_-RRB- on_IN the_DT Gardasil_NNP vaccine_NN should_MD put_VB an_DT immediate_JJ halt_NN on_IN increasing_VBG the_DT vaccine_NN ’s_POS market_NN ,_, and_CC should_MD ,_, instead_RB ,_, prompt_VB investigations_NNS into_IN the_DT safety_NN of_IN this_DT dangerous_JJ vaccine_NN and_CC whether_IN or_CC not_RB it_PRP should_MD remain_VB on_IN the_DT market_NN ._. A_DT study_NN published_VBN earlier_RBR this_DT month_NN (_-LRB- June_NNP ,_, 2018_CD )_-RRB- in_IN the_DT Journal_NNP of_IN Toxicology_NNP and_CC Environmental_NNP Health_NNP looked_VBD at_IN declining_VBG fertility_NN rates_NNS among_IN eight_CD million_CD U.S._NNP women_NNS ,_, aged_JJ 25_CD to_IN 29_CD ,_, during_IN a_DT 7_CD -_HYPH year_NN period_NN ._. The_DT title_NN of_IN study_NN ,_, published_VBN by_IN Gayle_NNP DeLong_NNP ,_, Ph.D._NNP ,_, from_IN the_DT Department_NNP of_IN Economics_NNP and_CC Finance_NNP ,_, Baruch_NNP College_NNP /_, City_NNP University_NNP of_IN New_NNP York_NNP ,_, is_VBZ “_`` A_DT lowered_VBN probability_NN of_IN pregnancy_NN in_IN females_NNS in_IN the_DT USA_NNP aged_JJ 25_CD –_SYM 29_CD who_WP received_VBD a_DT human_JJ papillomavirus_NN vaccine_NN injection_NN ._. ”_'' This_DT study_NN analyzed_VBD information_NN gathered_VBN in_IN National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP ,_, which_WDT represented_VBD 8_CD million_CD 25_CD -_HYPH to_IN -_HYPH 29_CD -_HYPH year_NN -_HYPH old_JJ women_NNS residing_VBG in_IN the_DT United_NNP States_NNPS between_IN 2007_CD and_CC 2014_CD ._. Approximately_RB 60_CD %_NN of_IN women_NNS who_WP did_VBD not_RB receive_VB the_DT HPV_NN vaccine_NN had_VBD been_VBN pregnant_JJ at_IN least_JJS once_RB ,_, whereas_IN only_RB 35_CD %_NN of_IN women_NNS who_WP were_VBD exposed_VBN to_IN the_DT vaccine_NN had_VBD conceived_VBN ._. Using_VBG logistic_JJ regression_NN to_TO analyze_VB the_DT data_NNS ,_, the_DT probability_NN of_IN having_VBG been_VBN pregnant_JJ was_VBD estimated_VBN for_IN females_NNS who_WP received_VBD an_DT HPV_NN vaccine_NN compared_VBN with_IN females_NNS who_WP did_VBD not_RB receive_VB the_DT shot_NN ._. Results_NNS suggest_VBP that_IN females_NNS who_WP received_VBD the_DT HPV_NNP shot_NN were_VBD less_RBR likely_JJ to_TO have_VB ever_RB been_VBN pregnant_JJ than_IN women_NNS in_IN the_DT same_JJ age_NN group_NN who_WP did_VBD not_RB receive_VB the_DT shot_NN ._. If_IN 100_CD %_NN of_IN females_NNS in_IN this_DT study_NN had_VBD received_VBN the_DT HPV_NN vaccine_NN ,_, data_NNS suggest_VBP the_DT number_NN of_IN women_NNS having_VBG ever_RB conceived_VBN would_MD have_VB fallen_VBN by_IN 2_CD million_CD ._. (_-LRB- emphasis_NN added_VBD )_-RRB- We_PRP did_VBD not_RB find_VB a_DT single_JJ corporate_JJ -_HYPH sponsored_VBN “_`` mainstream_JJ ”_'' media_NN report_NN on_IN this_DT study_NN ,_, and_CC based_VBN on_IN previous_JJ studies_NNS shedding_VBG a_DT negative_JJ light_NN on_IN Gardasil_NNP ,_, one_CD wonders_VBZ if_IN this_DT study_NN will_MD remain_VB published_VBN or_CC eventually_RB be_VB retracted_VBN due_IN to_IN pressure_NN from_IN outside_JJ influences_NNS ._. Given_VBN the_DT fact_NN that_IN many_JJ women_NNS in_IN the_DT U.S._NNP are_VBP waiting_VBG longer_RBR to_TO begin_VB a_DT family_NN and_CC conceive_VB children_NNS ,_, the_DT expansion_NN of_IN Gardasil_NNP to_IN this_DT older_JJR age_NN group_NN could_MD have_VB even_RB more_RBR devastating_JJ consequences_NNS to_IN fertility_NN rates_NNS ._. Learn_VB more_JJR about_IN this_DT study_NN :_: Another_DT study_NN published_VBN earlier_RBR this_DT year_NN in_IN the_DT Indian_NNP Journal_NNP of_IN Medical_NNP Ethics_NNP examined_VBD cervical_JJ cancer_NN rates_NNS among_IN women_NNS in_IN Sweden_NNP and_CC discovered_VBD a_DT link_NN between_IN increased_VBN cervical_JJ cancer_NN rates_NNS among_IN women_NNS ,_, aged_JJ 20_CD -_SYM 49_CD ,_, during_IN a_DT two_CD -_HYPH year_NN period_NN between_IN 2014_CD and_CC 2015_CD ,_, corresponding_VBG to_IN increased_VBN HPV_NN vaccination_NN rates_NNS in_IN this_DT population_NN group_NN ,_, years_NNS earlier_RBR ,_, when_WRB mass_JJ HPV_NN vaccinations_NNS started_VBD in_IN Sweden_NNP ._. The_DT study_NN has_VBZ been_VBN retracted_VBN subsequent_JJ to_IN being_VBG published_VBN ,_, due_IN to_IN the_DT fact_NN that_IN the_DT study_NN author_NN claimed_VBD his_PRP$ life_NN was_VBD in_IN danger_NN for_IN publishing_VBG such_PDT a_DT study_NN and_CC had_VBD to_TO use_VB a_DT pseudonym_NN ,_, but_CC in_IN publishing_VBG the_DT retraction_NN ,_, the_DT Journal_NNP affirmed_VBD the_DT validity_NN of_IN the_DT data_NNS and_CC study_NN conclusion_NN :_: The_DT data_NNS that_WDT this_DT study_NN examines_VBZ is_VBZ obviously_RB very_RB important_JJ when_WRB considering_VBG whether_IN or_CC not_RB to_TO expand_VB the_DT Gardasil_NNP vaccine_NN to_IN ages_NNS 27_CD –_SYM 45_CD ,_, as_IN that_DT is_VBZ the_DT same_JJ age_NN group_NN of_IN the_DT study_NN subjects_NNS in_IN Sweden_NNP ,_, and_CC it_PRP suggests_VBZ that_IN Gardasil_NNP not_RB only_RB does_VBZ not_RB prevent_VB cervical_JJ cancer_NN in_IN that_DT age_NN group_NN ,_, but_CC might_MD ,_, in_IN fact_NN ,_, increase_VB their_PRP$ risk_NN of_IN cervical_JJ cancer_NN ._. See_VB :_: The_DT U.S._NNP FDA_NNP Should_MD Follow_VB Japan_NNP ’s_POS Example_NN of_IN Questioning_VBG the_DT Risk_NN of_IN the_DT Gardasil_NN Vaccine_NN Versus_IN Perceived_VBN Benefits_NNS We_PRP recently_RB published_VBD an_DT investigative_JJ report_NN written_VBN by_IN Vera_NNP Sharav_NNP of_IN the_DT Alliance_NNP for_IN Human_NNP Research_NNP Protection_NNP ,_, titled_VBN :_: Japan_NNP Leading_VBG the_DT World_NNP in_IN Exposing_VBG Fraud_NN with_IN Gardasil_NN HPV_NN Vaccine_NN Injuries_NNS and_CC Deaths_NNS Sharav_NNP showed_VBD how_WRB the_DT Japanese_JJ Government_NN does_VBZ not_RB have_VB strong_JJ ties_NNS with_IN pharmaceutical_JJ companies_NNS producing_VBG HPV_NN vaccines_NNS and_CC is_VBZ ,_, therefore_RB ,_, more_RBR prone_JJ to_TO conduct_VB honest_JJ investigations_NNS into_IN the_DT dangers_NNS of_IN the_DT HPV_NN vaccines_NNS ._. Japan_NNP has_VBZ not_RB only_RB rescinded_VBN its_PRP$ recommendation_NN for_IN the_DT Gardasil_NNP vaccine_NN ,_, it_PRP has_VBZ actually_RB helped_VBN facilitate_VB clinics_NNS to_TO deal_VB with_IN Garsasil_NN vaccine_NN injuries_NNS :_: Featured_VBN image_NN is_VBZ from_IN the_DT author_NN ._.","NNP NN NN , NNP , VBD RBR this NN ( NNP , 2018 ) that the NNP NNP and NNP NNP ( NNP ) VBZ VBN them a “ NN NN ” to VB the JJ and JJ NNP 9 NN to NNS and NNS , NNS 27 to 45 . The NNP NN VBZ RB VBN for NNS and NNS , NNS 9 through 26 . The NN by NNP to VB its NN to NNS and NNS , NNS 27 to 45 , and the NNP ’s NN to VB it a NN NN by NNP 6 , 2018 , VBZ 10 NNS after the NNP VBD down a JJ NN to VB the JJR NN of NNP to the JJ NN NN . RB in 2008 , after VBG to a JJR NN in the NN NN , the NNP VBD against NNP ’s NN for an JJ NNP NN in NNS 27 to 45 . The NN in 2009 VBD a JJ JJ NN NN for that NN , VBG NNP to VB JJR - NN NN NNS in the NN NN . That NN of NNS RB VBD RB VB NNS RB for NNP . In both NNP ’s and NNP 9 ’s JJ NNS , NN about a NN on 3,253 NNS 27 through 45 NNS of NN VBZ that there VBD “ no RB JJ NN ” VBN by the NN in VBG JJ - NN JJ NNS or JJ NN . RB what VBZ VBN that NNP RB VBZ the NNP to VB on their NN RB ? VBG to NNP : JJ and JJ NNS over the JJ NN VBP that NNS 27 to 45 VBP RB at NN of VBG JJ NN NNS , NNP NN NNP NNP VBD NNP . RB though JJ NNS VBP RB VBN VBN to NN at an JJR NN , they VBP RB VBN VBN to all nine NN NNS VBN by NNP 9 . RB , a NN - NN of the JJ - NN NN with NNP in NNS NNS 27 - 45 VBD no JJ NNS of NN NN for at JJS 10 NNS VBG NN , a NN that can VB VBN to NNP 9 , she VBD . Will the NNP VB at VBN NNS on NNP NNS ? Besides the NNS of NNS of JJ NNS VBG VBN or RB VBN by the NNP NN , RB RB as the NNS VBG in NNS outside the NNP , the VBN NNS VBG NNP RB VBZ VBG JJR . Will the NNP VB these NNS in VBG if NNP should VB VBN to a JJR NN ? Should RB the NNP RB VB VBG if NNP should RB VB in the NN , as JJ NNS VBP VBG to VB ? Two JJ NNS VBN this NN ( 2018 ) on the NNP NN should VB an JJ NN on VBG the NN ’s NN , and should , RB , VB NNS into the NN of this JJ NN and whether or RB it should VB on the NN . A NN VBN RBR this NN ( NNP , 2018 ) in the NNP of NNP and NNP NNP VBD at VBG NN NNS among eight million NNP NNS , JJ 25 to 29 , during a 7 - NN NN . The NN of NN , VBN by NNP NNP , NNP , from the NNP of NNP and NNP , NNP NNP / NNP NNP of NNP NNP , VBZ “ A VBN NN of NN in NNS in the NNP JJ 25 – 29 who VBD a JJ NN NN NN . ” This NN VBD NN VBN in NNP NNP and NNP NNP NNP , which VBD 8 million 25 - to - 29 - NN - JJ NNS VBG in the NNP NNPS between 2007 and 2014 . RB 60 NN of NNS who VBD RB VB the NN NN VBD VBN JJ at JJS RB , whereas RB 35 NN of NNS who VBD VBN to the NN VBD VBN . VBG JJ NN to VB the NNS , the NN of VBG VBN JJ VBD VBN for NNS who VBD an NN NN VBN with NNS who VBD RB VB the NN . NNS VBP that NNS who VBD the NNP NN VBD RBR JJ to VB RB VBN JJ than NNS in the JJ NN NN who VBD RB VB the NN . If 100 NN of NNS in this NN VBD VBN the NN NN , NNS VBP the NN of NNS VBG RB VBN would VB VBN by 2 million . ( NN VBD ) We VBD RB VB a JJ JJ - VBN “ JJ ” NN NN on this NN , and VBN on JJ NNS VBG a JJ NN on NNP , one VBZ if this NN will VB VBN or RB VB VBN due to NN from JJ NNS . VBN the NN that JJ NNS in the NNP VBP VBG RBR to VB a NN and VB NNS , the NN of NNP to this JJR NN NN could VB RB RBR JJ NNS to NN NNS . VB JJR about this NN : Another NN VBN RBR this NN in the NNP NNP of NNP NNP VBD JJ NN NNS among NNS in NNP and VBD a NN between VBN JJ NN NNS among NNS , JJ 20 - 49 , during a two - NN NN between 2014 and 2015 , VBG to VBN NN NN NNS in this NN NN , NNS RBR , when JJ NN NNS VBD in NNP . The NN VBZ VBN VBN JJ to VBG VBN , due to the NN that the NN NN VBD his NN VBD in NN for VBG such a NN and VBD to VB a NN , but in VBG the NN , the NNP VBD the NN of the NNS and NN NN : The NNS that this NN VBZ VBZ RB RB JJ when VBG whether or RB to VB the NNP NN to NNS 27 – 45 , as that VBZ the JJ NN NN of the NN NNS in NNP , and it VBZ that NNP RB RB VBZ RB VB JJ NN in that NN NN , but might , in NN , VB their NN of JJ NN . VB : The NNP NNP Should VB NNP ’s NN of VBG the NN of the NN NN Versus VBN NNS We RB VBD an JJ NN VBN by NNP NNP of the NNP for NNP NNP NNP , VBN : NNP VBG the NNP in VBG NN with NN NN NN NNS and NNS NNP VBD how the JJ NN VBZ RB VB JJ NNS with JJ NNS VBG NN NNS and VBZ , RB , RBR JJ to VB JJ NNS into the NNS of the NN NNS . NNP VBZ RB RB VBN its NN for the NNP NN , it VBZ RB VBN VB NNS to VB with NN NN NNS : VBN NN VBZ from the NN ."
97,974,mainstream,"Get_VB breaking_VBG news_NN alerts_NNS and_CC special_JJ reports_NNS ._. The_DT news_NN and_CC stories_NNS that_WDT matter_VBP ,_, delivered_VBD weekday_NN mornings_NNS ._. A_DT study_NN released_VBN Wednesday_NNP supports_VBZ the_DT argument_NN that_IN infections_NNS during_IN pregnancy_NN may_MD cause_VB some_DT cases_NNS of_IN autism_NN ._. Women_NNS who_WP had_VBD active_JJ infections_NNS with_IN genital_JJ herpes_NN early_RB in_IN pregnancy_NN were_VBD twice_RB as_RB likely_JJ to_TO have_VB a_DT child_NN with_IN autism_NN than_IN women_NNS who_WP did_VBD not_RB ,_, a_DT team_NN of_IN researchers_NNS found_VBD ._. The_DT findings_NNS ,_, published_VBN in_IN the_DT journal_NN mSphere_NNP ,_, add_VBP to_IN evidence_NN that_IN inflammation_NN during_IN pregnancy_NN may_MD affect_VB the_DT brain_NN of_IN a_DT developing_VBG fetus_NN ._. ""_`` We_PRP believe_VBP the_DT mother_NN 's_POS immune_JJ response_NN to_IN HSV_NNP -_HYPH 2_CD (_-LRB- herpes_NN simplex_NN type_NN 2_CD )_-RRB- could_MD be_VB disrupting_VBG fetal_JJ central_JJ nervous_JJ system_NN development_NN ,_, raising_VBG risk_NN for_IN autism_NN ,_, ""_'' said_VBD Milada_NNP Mahic_NNP ,_, a_DT researcher_NN at_IN Columbia_NNP University_NNP who_WP led_VBD the_DT research_NN team_NN ._. Viruses_NNS can_MD infect_VB a_DT developing_VBG baby_NN 's_POS brain_NN —_: Zika_NNP is_VBZ the_DT most_RBS notorious_JJ now_RB ,_, but_CC cytomegalovirus_NN and_CC rubella_NN also_RB cause_VBP severe_JJ birth_NN defects_NNS ,_, including_VBG brain_NN damage_NN ._. But_CC that_DT 's_VBZ not_RB what_WP 's_VBZ going_VBG on_RP with_IN autism_NN ,_, said_VBD Dr._NNP Ian_NNP Lipkin_NNP ,_, an_DT epidemiologist_NN and_CC infectious_JJ disease_NN expert_NN at_IN Columbia_NNP who_WP oversaw_VBD the_DT research_NN ._. ""_`` Most_JJS people_NNS ,_, when_WRB they_PRP think_VBP about_IN viral_JJ infections_NNS ,_, think_VBP in_IN terms_NNS of_IN viruses_NNS going_VBG into_IN tissue_NN ,_, killing_VBG cells_NNS ,_, damaging_VBG cells_NNS ,_, ""_'' Lipkin_NNP told_VBD NBC_NNP News_NNP ._. But_CC Lipkin_NNP believes_VBZ that_IN ,_, in_IN fact_NN ,_, it_PRP 's_VBZ the_DT mother_NN 's_POS immune_JJ response_NN —_: the_DT inflammation_NN —_: that_WDT 's_VBZ causing_VBG the_DT damage_NN ._. It_PRP may_MD be_VB that_IN inflammatory_JJ chemicals_NNS such_JJ as_IN cytokines_NNS are_VBP crossing_VBG the_DT placenta_NN and_CC affecting_VBG the_DT developing_VBG brain_NN of_IN the_DT fetus_NN ,_, he_PRP said_VBD ._. For_IN the_DT study_NN ,_, Lipkin_NNP 's_POS team_NN started_VBD looking_VBG at_IN women_NNS who_WP were_VBD pregnant_JJ in_IN Norway_NNP in_IN the_DT 1990s_NNS ._. They_PRP found_VBD 442_CD mothers_NNS of_IN children_NNS with_IN autism_NN and_CC compared_VBD them_PRP to_IN 464_CD women_NNS who_WP had_VBD babies_NNS without_IN autism_NN in_IN the_DT same_JJ months_NNS ._. Related_JJ :_: More_JJR Studies_NNS Show_VB Vaccines_NNS Do_VB Not_RB Cause_VB Autism_NN The_DT women_NNS were_VBD tested_VBN for_IN immune_NN responses_NNS to_IN four_CD viruses_NNS known_VBN to_TO cause_VB birth_NN defects_NNS :_: cytomegalovirus_NN ,_, rubella_NN ,_, herpes_NN simplex_NN 1_CD (_-LRB- HSV_NN -_HYPH 1_CD ,_, which_WDT causes_VBZ cold_JJ sores_NNS )_-RRB- and_CC HSV_NN -_HYPH 2_CD ,_, also_RB known_VBN as_IN genital_JJ herpes_NN ._. The_DT women_NNS were_VBD also_RB tested_VBN for_IN the_DT toxoplasmosis_NN parasite_NN ._. The_DT women_NNS with_IN high_JJ levels_NNS of_IN antibodies_NNS to_IN HSV_NNP -_HYPH 2_CD midway_RB through_IN their_PRP$ pregnancies_NNS were_VBD twice_RB as_RB likely_JJ to_TO have_VB a_DT baby_NN later_RBR diagnosed_VBN with_IN autism_NN ._. None_NN of_IN the_DT other_JJ viruses_NNS seemed_VBD to_TO affect_VB autism_NN risk_NN ._. ""_`` The_DT elevated_VBN antibody_NN levels_NNS to_IN HSV_NNP -_HYPH 2_CD may_MD indicate_VB either_CC recent_JJ primary_JJ infection_NN or_CC reactivation_NN of_IN latent_JJ infection_NN ,_, ""_'' the_DT researchers_NNS wrote_VBD ._. Herpes_NN infections_NNS are_VBP incurable_JJ and_CC can_MD flare_VB up_RP throughout_IN a_DT person_NN 's_POS life_NN ._. They_PRP are_VBP also_RB very_RB common_JJ ,_, so_RB having_VBG been_VBN infected_VBN with_IN herpes_NN does_VBZ not_RB mean_VB a_DT woman_NN is_VBZ going_VBG to_TO have_VB children_NNS with_IN autism_NN ._. However_RB ,_, autism_NN is_VBZ becoming_VBG diagnosed_VBN more_RBR commonly_RB ._. Surveys_NNS by_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP find_VBP that_IN as_IN many_JJ as_RB than_IN 2_CD percent_NN of_IN U.S._NNP kids_NNS have_VBP been_VBN diagnosed_VBN with_IN autism_NN —_: anywhere_RB between_IN 1_CD in_IN 68_CD and_CC 1_CD in_IN 45_CD children_NNS ._. The_DT autism_NN spectrum_NN refers_VBZ to_IN a_DT broad_JJ range_NN of_IN symptoms_NNS ,_, from_IN the_DT relatively_RB mild_JJ social_JJ awkwardness_NN of_IN Asperger_NNP 's_POS syndrome_NN to_IN profound_JJ mental_JJ retardation_NN ,_, debilitating_VBG repetitive_JJ behaviors_NNS and_CC an_DT inability_NN to_TO communicate_VB ._. There_EX 's_VBZ no_DT cure_NN and_CC no_DT good_JJ treatment_NN ._. There_EX are_VBP genetic_JJ links_NNS ._. If_IN one_CD twin_NN has_VBZ autism_NN ,_, the_DT other_JJ twin_NN is_VBZ very_RB likely_JJ to_TO ._. There_EX 's_VBZ also_RB growing_VBG evidence_NN that_IN infections_NNS in_IN pregnancy_NN might_MD play_VB a_DT role_NN ._. A_DT 2013_CD study_NN found_VBD that_IN women_NNS who_WP had_VBD flu_NN while_IN they_PRP were_VBD pregnant_JJ were_VBD twice_RB as_RB likely_JJ to_TO have_VB a_DT child_NN later_RBR diagnosed_VBN with_IN autism_NN ._. Those_DT who_WP had_VBD a_DT fever_NN lasting_VBG a_DT week_NN or_CC longer_RBR —_: perhaps_RB caused_VBN by_IN flu_NN or_CC maybe_RB by_IN something_NN else_JJ —_: were_VBD three_CD times_NNS as_RB likely_JJ to_TO have_VB an_DT autistic_JJ child_NN ._. ""_`` A_DT wide_JJ range_NN of_IN infectious_JJ agents_NNS has_VBZ been_VBN linked_VBN to_IN autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ,_, suggesting_VBG the_DT possibility_NN that_IN general_JJ immune_JJ activation_NN in_IN susceptible_JJ subjects_NNS ,_, rather_RB than_IN a_DT specific_JJ pathogen_NN per_IN se_FW ,_, is_VBZ associated_VBN with_IN risk_NN of_IN ASD_NN ,_, ""_'' the_DT Columbia_NNP team_NN wrote_VBD ._. ""_`` We_PRP speculate_VBP that_IN ASD_NN risk_NN associated_VBN with_IN high_JJ levels_NNS of_IN antibodies_NNS to_IN HSV_NNP -_HYPH 2_CD is_VBZ not_RB specific_JJ to_IN HSV_NNP -_HYPH 2_CD but_CC instead_RB reflects_VBZ the_DT impact_NN of_IN immune_JJ activation_NN and_CC inflammation_NN on_IN a_DT vulnerable_JJ developing_VBG nervous_JJ system_NN ._. ""_'' The_DT team_NN found_VBD the_DT risk_NN if_IN a_DT woman_NN had_VBD signs_NNS of_IN herpes_NN infection_NN only_RB during_IN the_DT first_JJ trimester_NN of_IN pregnancy_NN ,_, when_WRB the_DT brain_NN of_IN the_DT fetus_NN is_VBZ developing_VBG quickly_RB ._. It_PRP also_RB did_VBD not_RB have_VB enough_JJ girls_NNS with_IN autism_NN in_IN the_DT study_NN to_TO be_VB able_JJ to_TO tell_VB whether_IN the_DT risk_NN is_VBZ also_RB higher_JJR for_IN girls_NNS ._. Boys_NNS are_VBP far_RB more_RBR likely_JJ to_TO be_VB diagnosed_VBN with_IN autism_NN ._. ""_`` We_PRP are_VBP now_RB looking_VBG at_IN other_JJ triggers_NNS ._. We_PRP think_VBP that_IN a_DT wide_JJ range_NN of_IN different_JJ types_NNS of_IN infections_NNS can_MD cause_VB this_DT ,_, ""_'' Lipkin_NNP said_VBD ._. ""_`` I_PRP think_VBP that_IN this_DT makes_VBZ a_DT very_RB strong_JJ case_NN for_IN continuing_VBG to_TO try_VB to_TO develop_VB herpes_NN simplex_JJ vaccines_NNS ._. ""_''","VB VBG NN NNS and JJ NNS . The NN and NNS that VBP , VBD NN NNS . A NN VBN NNP VBZ the NN that NNS during NN may VB some NNS of NN . NNS who VBD JJ NNS with JJ NN RB in NN VBD RB RB JJ to VB a NN with NN than NNS who VBD RB , a NN of NNS VBD . The NNS , VBN in the NN NNP , VBP to NN that NN during NN may VB the NN of a VBG NN . "" We VBP the NN 's JJ NN to NNP - 2 ( NN NN NN 2 ) could VB VBG JJ JJ JJ NN NN , VBG NN for NN , "" VBD NNP NNP , a NN at NNP NNP who VBD the NN NN . NNS can VB a VBG NN 's NN — NNP VBZ the RBS JJ RB , but NN and NN RB VBP JJ NN NNS , VBG NN NN . But that VBZ RB what VBZ VBG on with NN , VBD NNP NNP NNP , an NN and JJ NN NN at NNP who VBD the NN . "" JJS NNS , when they VBP about JJ NNS , VBP in NNS of NNS VBG into NN , VBG NNS , VBG NNS , "" NNP VBD NNP NNP . But NNP VBZ that , in NN , it VBZ the NN 's JJ NN — the NN — that VBZ VBG the NN . It may VB that JJ NNS JJ as NNS VBP VBG the NN and VBG the VBG NN of the NN , he VBD . For the NN , NNP 's NN VBD VBG at NNS who VBD JJ in NNP in the NNS . They VBD 442 NNS of NNS with NN and VBD them to 464 NNS who VBD NNS without NN in the JJ NNS . JJ : JJR NNS VB NNS VB RB VB NN The NNS VBD VBN for NN NNS to four NNS VBN to VB NN NNS : NN , NN , NN NN 1 ( NN - 1 , which VBZ JJ NNS ) and NN - 2 , RB VBN as JJ NN . The NNS VBD RB VBN for the NN NN . The NNS with JJ NNS of NNS to NNP - 2 RB through their NNS VBD RB RB JJ to VB a NN RBR VBN with NN . NN of the JJ NNS VBD to VB NN NN . "" The VBN NN NNS to NNP - 2 may VB either JJ JJ NN or NN of JJ NN , "" the NNS VBD . NN NNS VBP JJ and can VB up throughout a NN 's NN . They VBP RB RB JJ , RB VBG VBN VBN with NN VBZ RB VB a NN VBZ VBG to VB NNS with NN . RB , NN VBZ VBG VBN RBR RB . NNS by the NNPS for NNP NNP and NNP VBP that as JJ RB than 2 NN of NNP NNS VBP VBN VBN with NN — RB between 1 in 68 and 1 in 45 NNS . The NN NN VBZ to a JJ NN of NNS , from the RB JJ JJ NN of NNP 's NN to JJ JJ NN , VBG JJ NNS and an NN to VB . There VBZ no NN and no JJ NN . There VBP JJ NNS . If one NN VBZ NN , the JJ NN VBZ RB JJ to . There VBZ RB VBG NN that NNS in NN might VB a NN . A 2013 NN VBD that NNS who VBD NN while they VBD JJ VBD RB RB JJ to VB a NN RBR VBN with NN . Those who VBD a NN VBG a NN or RBR — RB VBN by NN or RB by NN JJ — VBD three NNS RB JJ to VB an JJ NN . "" A JJ NN of JJ NNS VBZ VBN VBN to NN NN NN ( NNP ) , VBG the NN that JJ JJ NN in JJ NNS , RB than a JJ NN per FW , VBZ VBN with NN of NN , "" the NNP NN VBD . "" We VBP that NN NN VBN with JJ NNS of NNS to NNP - 2 VBZ RB JJ to NNP - 2 but RB VBZ the NN of JJ NN and NN on a JJ VBG JJ NN . "" The NN VBD the NN if a NN VBD NNS of NN NN RB during the JJ NN of NN , when the NN of the NN VBZ VBG RB . It RB VBD RB VB JJ NNS with NN in the NN to VB JJ to VB whether the NN VBZ RB JJR for NNS . NNS VBP RB RBR JJ to VB VBN with NN . "" We VBP RB VBG at JJ NNS . We VBP that a JJ NN of JJ NNS of NNS can VB this , "" NNP VBD . "" I VBP that this VBZ a RB JJ NN for VBG to VB to VB NN JJ NNS . """
98,915,mainstream,"A_DT year_NN after_IN the_DT emergence_NN of_IN swine_NN flu_NN ,_, US_NNP health_NN authorities_NNS and_CC laboratories_NNS say_VBP the_DT pandemic_NN illustrated_VBD the_DT need_NN for_IN new_JJ vaccine_NN production_NN techniques_NNS that_WDT are_VBP faster_JJR and_CC more_RBR reliable_JJ ._. At_IN present_NN ,_, vaccines_NNS like_IN the_DT one_NN used_VBN against_IN the_DT swine_NN flu_NN are_VBP developed_VBN inside_IN eggs_NNS ,_, into_IN which_WDT scientists_NNS implant_VBP a_DT weakened_VBN version_NN of_IN the_DT virus_NN that_WDT will_MD grow_VB into_IN a_DT form_NN suitable_JJ for_IN inoculation_NN ._. But_CC that_DT process_NN is_VBZ relatively_RB slow_JJ and_CC unpredictable_JJ ,_, and_CC experts_NNS say_VBP the_DT future_NN lies_VBZ in_IN developing_VBG vaccines_NNS at_IN the_DT cell_NN and_CC DNA_NN -_HYPH level_NN ._. ""_`` We_PRP have_VBP never_RB been_VBN in_IN a_DT stronger_JJR position_NN to_TO create_VB new_JJ and_CC better_JJR vaccines_NNS ,_, ""_'' US_NNP Health_NNP and_CC Human_NNP Services_NNPS Secretary_NNP Kathleen_NNP Sebelius_NNP said_VBD this_DT week_NN on_IN the_DT anniversary_NN of_IN the_DT discovery_NN of_IN the_DT A(_`` H1N1_NNP )_-RRB- virus_NN ._. The_DT swine_NN flu_NN pandemic_NN illustrated_VBD the_DT need_NN ""_`` to_TO bring_VB the_DT technology_NN of_IN influenza_NN vaccine_NN development_NN and_CC manufacture_NN into_IN the_DT 21st_JJ century_NN ,_, ""_'' said_VBD Anthony_NNP Fauci_NNP ,_, director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, part_NN of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. The_DT US_NNP government_NN is_VBZ now_RB partnering_VBG with_IN the_DT private_JJ sector_NN and_CC investing_VBG billions_NNS of_IN dollars_NNS into_IN research_NN to_TO foster_VB new_JJ vaccine_NN development_NN methods_NNS in_IN time_NN for_IN future_JJ pandemics_NNS ,_, Fauci_NNP told_VBD AFP_NNP in_IN an_DT interview_NN ._. He_PRP said_VBD US_NNP laboratories_NNS were_VBD able_JJ to_TO quickly_RB identify_VB the_DT A(_`` H1N1_NN )_-RRB- virus_NN ,_, isolate_VB a_DT ""_`` seed_NN ""_'' for_IN implantation_NN in_IN eggs_NNS and_CC carry_VB out_RP clinical_JJ trials_NNS ._. But_CC despite_IN their_PRP$ speed_NN ,_, they_PRP failed_VBD to_TO produce_VB the_DT number_NN of_IN vaccine_NN doses_NNS expected_VBN because_IN growing_VBG the_DT vaccine_NN remained_VBD so_RB slow_JJ ._. ""_`` It_PRP 's_VBZ still_RB a_DT fragile_JJ technology_NN ,_, it_PRP 's_VBZ subject_JJ to_IN vicissitudes_NNS that_WDT are_VBP beyond_IN the_DT control_NN of_IN the_DT people_NNS that_WDT are_VBP making_VBG the_DT vaccine_NN ,_, ""_'' said_VBD Fauci_NNP ._. ""_`` Unfortunately_RB that_DT 's_VBZ what_WP happened_VBD ,_, ""_'' he_PRP added_VBD ._. ""_`` We_PRP were_VBD fortunate_JJ that_IN a_DT single_JJ dose_NN worked_VBD ._. ""_'' He_PRP said_VBD bringing_VBG vaccine_NN development_NN ""_`` into_IN the_DT 21st_JJ century_NN ""_'' would_MD occur_VB in_IN two_CD phases_NNS ._. ""_`` The_DT first_JJ phase_NN is_VBZ to_TO make_VB a_DT conversion_NN from_IN growing_VBG viruses_NNS in_IN eggs_NNS to_IN growing_VBG viruses_NNS in_IN cells_NNS ,_, which_WDT is_VBZ much_RB more_RBR reliable_JJ ,_, and_CC being_VBG able_JJ to_TO scale_VB up_RP ,_, ""_'' he_PRP said_VBD ._. Cell_NN -_HYPH based_VBN development_NN of_IN vaccines_NNS is_VBZ still_RB not_RB a_DT speedy_JJ process_NN ,_, Fauci_NNP said_VBD ._. But_CC the_DT development_NN of_IN vaccines_NNS in_IN eggs_NNS can_MD take_VB between_IN six_CD and_CC nine_CD months_NNS ,_, and_CC cell_NN -_HYPH based_VBN vaccine_NN development_NN is_VBZ much_RB more_RBR reliable_JJ ._. Eventually_RB ,_, the_DT second_JJ phase_NN of_IN perfecting_VBG production_NN techniques_NNS will_MD be_VB a_DT move_NN to_IN so_RB -_HYPH called_VBN recombinant_JJ DNA_NN technology_NN ,_, where_WRB pieces_NNS of_IN different_JJ DNA_NN strands_NNS are_VBP combined_VBN ._. The_DT technology_NN would_MD eliminate_VB the_DT need_NN for_IN scientists_NNS to_TO grow_VB the_DT target_NN virus_NN in_IN order_NN to_TO extract_VB a_DT vaccine_NN ,_, speeding_VBG up_RP the_DT process_NN to_IN as_RB little_JJ as_IN two_CD months_NNS ,_, Fauci_NNP said_VBD ._. Informed_VBN by_IN its_PRP$ experience_NN with_IN the_DT swine_NN flu_NN pandemic_NN ,_, the_DT US_NNP government_NN is_VBZ now_RB partnering_VBG with_IN the_DT private_JJ sector_NN to_TO speed_VB the_DT emergence_NN of_IN quicker_JJR and_CC more_RBR reliable_JJ vaccine_NN development_NN methods_NNS ._. Fauci_NNP cited_VBD a_DT partnership_NN with_IN Novartis_NNP ,_, which_WDT has_VBZ built_VBN a_DT plant_NN for_IN the_DT production_NN of_IN cell_NN -_HYPH based_VBN flu_NN vaccines_NNS in_IN North_NNP Carolina_NNP ._. ""_`` It_PRP will_MD be_VB a_DT gradual_JJ process_NN ,_, ""_'' he_PRP said_VBD ._. ""_`` In_IN the_DT next_JJ year_NN or_CC so_RB ,_, you_PRP will_MD be_VB seeing_VBG some_DT of_IN these_DT recombinant_JJ products_NNS ready_JJ to_TO be_VB used_VBN in_IN humans_NNS ._. ""_'' Another_DT field_NN of_IN continued_VBN research_NN is_VBZ a_DT so_RB -_HYPH called_VBN ""_`` universal_JJ vaccine_NN ""_'' for_IN influenza_NN ._. ""_`` That_DT 's_VBZ the_DT Holy_NNP Grail_NNP ,_, ""_'' Fauci_NNP ,_, adding_VBG that_IN it_PRP was_VBD n't_RB likely_JJ to_TO emerge_VB for_IN another_DT five_CD to_IN 10_CD years_NNS ,_, though_IN he_PRP remained_VBD hopeful_JJ ._. ""_`` I_PRP think_VBP it_PRP 's_VBZ possible_JJ ,_, ""_'' he_PRP said_VBD ._.","A NN after the NN of NN NN , NNP NN NNS and NNS VBP the NN VBD the NN for JJ NN NN NNS that VBP JJR and RBR JJ . At NN , NNS like the NN VBN against the NN NN VBP VBN inside NNS , into which NNS VBP a VBN NN of the NN that will VB into a NN JJ for NN . But that NN VBZ RB JJ and JJ , and NNS VBP the NN VBZ in VBG NNS at the NN and NN - NN . "" We VBP RB VBN in a JJR NN to VB JJ and JJR NNS , "" NNP NNP and NNP NNPS NNP NNP NNP VBD this NN on the NN of the NN of the A( NNP ) NN . The NN NN NN VBD the NN "" to VB the NN of NN NN NN and NN into the JJ NN , "" VBD NNP NNP , NN of the NNP NNP of NNP and NNP NNPS , NN of the NNP NNPS of NNP . The NNP NN VBZ RB VBG with the JJ NN and VBG NNS of NNS into NN to VB JJ NN NN NNS in NN for JJ NNS , NNP VBD NNP in an NN . He VBD NNP NNS VBD JJ to RB VB the A( NN ) NN , VB a "" NN "" for NN in NNS and VB out JJ NNS . But despite their NN , they VBD to VB the NN of NN NNS VBN because VBG the NN VBD RB JJ . "" It VBZ RB a JJ NN , it VBZ JJ to NNS that VBP beyond the NN of the NNS that VBP VBG the NN , "" VBD NNP . "" RB that VBZ what VBD , "" he VBD . "" We VBD JJ that a JJ NN VBD . "" He VBD VBG NN NN "" into the JJ NN "" would VB in two NNS . "" The JJ NN VBZ to VB a NN from VBG NNS in NNS to VBG NNS in NNS , which VBZ RB RBR JJ , and VBG JJ to VB up , "" he VBD . NN - VBN NN of NNS VBZ RB RB a JJ NN , NNP VBD . But the NN of NNS in NNS can VB between six and nine NNS , and NN - VBN NN NN VBZ RB RBR JJ . RB , the JJ NN of VBG NN NNS will VB a NN to RB - VBN JJ NN NN , where NNS of JJ NN NNS VBP VBN . The NN would VB the NN for NNS to VB the NN NN in NN to VB a NN , VBG up the NN to RB JJ as two NNS , NNP VBD . VBN by its NN with the NN NN NN , the NNP NN VBZ RB VBG with the JJ NN to VB the NN of JJR and RBR JJ NN NN NNS . NNP VBD a NN with NNP , which VBZ VBN a NN for the NN of NN - VBN NN NNS in NNP NNP . "" It will VB a JJ NN , "" he VBD . "" In the JJ NN or RB , you will VB VBG some of these JJ NNS JJ to VB VBN in NNS . "" Another NN of VBN NN VBZ a RB - VBN "" JJ NN "" for NN . "" That VBZ the NNP NNP , "" NNP , VBG that it VBD RB JJ to VB for another five to 10 NNS , though he VBD JJ . "" I VBP it VBZ JJ , "" he VBD ."
99,144,conspiracy,"According_VBG to_IN two_CD Merck_NNP scientists_NNS who_WP filed_VBD a_DT False_NNP Claims_NNPS Act_NNP complaint_NN in_IN 2010_CD —_: a_DT complaint_NN which_WDT has_VBZ just_RB now_RB been_VBN unsealed_VBN —_: vaccine_NN manufacturer_NN Merck_NNP knowingly_RB falsified_VBD its_PRP$ mumps_NNS vaccine_NN test_NN data_NNS ,_, spiked_VBN blood_NN samples_NNS with_IN animal_NN antibodies_NNS ,_, sold_VBD a_DT vaccine_NN that_WDT actually_RB promoted_VBD mumps_NNS and_CC measles_NNS outbreaks_NNS ,_, and_CC ripped_VBD off_RP governments_NNS and_CC consumers_NNS who_WP bought_VBD the_DT vaccine_NN thinking_VBG it_PRP was_VBD “_`` 95_CD %_NN effective_JJ ._. ”_'' According_VBG to_IN Stephen_NNP Krahling_NNP and_CC Joan_NNP Wlochowski_NNP ,_, both_CC former_JJ Merck_NNP virologists_NNS ,_, the_DT Merck_NNP company_NN engaged_VBD in_IN all_PDT the_DT following_VBG behavior_NN :_: •_NFP In_IN order_NN to_TO do_VB this_DT ,_, Merck_NNP spiked_VBD the_DT blood_NN test_NN with_IN animal_NN antibodies_NNS in_IN order_NN to_TO artificially_RB inflate_VB the_DT appearance_NN of_IN immune_NN system_NN antibodies_NNS ._. As_IN reported_VBN in_IN CourthouseNews.com_NNP :_: Merck_NNP also_RB added_VBD animal_NN antibodies_NNS to_IN blood_NN samples_NNS to_TO achieve_VB more_RBR favorable_JJ test_NN results_NNS ,_, though_IN it_PRP knew_VBD that_IN the_DT human_JJ immune_JJ system_NN would_MD never_RB produce_VB such_JJ antibodies_NNS ,_, and_CC that_IN the_DT antibodies_NNS created_VBD a_DT laboratory_NN testing_NN scenario_NN that_WDT “_'' did_VBD not_RB in_IN any_DT way_NN correspond_VB to_IN ,_, correlate_VB with_IN ,_, or_CC represent_VB real_JJ life_NN …_HYPH virus_NN neutralization_NN in_IN vaccinated_VBN people_NNS ,_, ”_'' according_VBG to_IN the_DT complaint_NN ._. (_-LRB- www.courthousenews.com)_ADD •_-RRB- Merck_NNP then_RB used_VBD the_DT falsified_VBN trial_NN results_NNS to_TO swindle_VB the_DT U.S._NNP government_NN out_IN of_IN “_`` hundreds_NNS of_IN millions_NNS of_IN dollars_NNS for_IN a_DT vaccine_NN that_WDT does_VBZ not_RB provide_VB adequate_JJ immunization_NN ._. ”_'' •_NFP Merck_NNP ’s_POS vaccine_NN fraud_NN has_VBZ actually_RB contributed_VBN to_IN the_DT continuation_NN of_IN mumps_NNS across_IN America_NNP ,_, causing_VBG more_JJR children_NNS to_TO become_VB infected_VBN with_IN mumps_NNS ._. (_-LRB- Gee_UH ,_, really_RB ?_. This_DT is_VBZ what_WP NaturalNews_NNP has_VBZ been_VBN reporting_VBG for_IN years_NNS …_, vaccines_NNS are_VBP actually_RB formulated_VBN to_TO keep_VB the_DT outbreaks_NNS going_VBG because_IN it_PRP ’s_VBZ great_JJ for_IN repeat_JJ business_NN !_. )_-RRB- •_NFP Merck_NNP used_VBD its_PRP$ false_JJ claims_NNS of_IN “_`` 95_CD percent_NN effectiveness_NN ”_'' to_TO monopolize_VB the_DT vaccine_NN market_NN and_CC eliminate_VB possible_JJ competitors_NNS ._. •_NFP The_DT Merck_NNP vaccine_NN fraud_NN has_VBZ been_VBN going_VBG on_RP since_IN the_DT late_JJ 1990_CD ’s_POS ,_, say_VB the_DT Merck_NNP virologists_NNS ._. •_NFP Testing_NN of_IN Merck_NNP ’s_POS vaccine_NN was_VBD never_RB done_VBN against_IN “_`` real_JJ -_HYPH world_NN ”_'' mumps_VBZ viruses_NNS in_IN the_DT wild_NN ._. Instead_RB ,_, test_NN results_NNS were_VBD simply_RB falsified_VBN to_TO achieve_VB the_DT desired_VBN outcome_NN ._. •_NFP This_DT entire_JJ fraud_NN took_VBD place_NN “_'' with_IN the_DT knowledge_NN ,_, authority_NN and_CC approval_NN of_IN Merck_NNP ’s_POS senior_JJ management_NN ._. ”_'' •_NFP Merck_NNP scientists_NNS “_'' witnessed_VBD firsthand_RB the_DT improper_JJ testing_NN and_CC data_NN falsification_NN in_IN which_WDT Merck_NNP engaged_VBD to_TO artificially_RB inflate_VB the_DT vaccine_NN ’s_POS efficacy_NN findings_NNS ,_, ”_'' according_VBG to_IN court_NN documents_NNS (_-LRB- see_VB below_RB )_-RRB- ._. US_NNP government_NN chose_VBD to_TO ignore_VB the_DT 2010_CD False_NNP Claims_NNPS Act_NNP !_. Rather_RB than_IN taking_VBG action_NN on_IN this_DT false_JJ claims_NNS act_NN ,_, the_DT U.S._NNP government_NN simply_RB ignored_VBD it_PRP ,_, thereby_RB protecting_VBG Merck_NNP ’s_POS market_NN monopoly_NN instead_RB of_IN properly_RB serving_VBG justice_NN ._. This_DT demonstrates_VBZ the_DT conspiracy_NN of_IN fraud_NN between_IN the_DT U.S._NNP government_NN ,_, FDA_NNP regulators_NNS and_CC the_DT vaccine_NN industry_NN ._. Chatom_NNP Primary_NNP Care_NNP sues_VBZ Merck_NNP for_IN Sherman_NNP Act_NN monopolization_NN ,_, breach_NN of_IN warranty_NN ,_, violation_NN of_IN consumer_NN protection_NN laws_NNS Following_VBG the_DT unsealing_NN of_IN this_DT 2010_CD False_NNP Claims_NNPS Act_NNP ,_, Chatom_NNP Primary_NNP Care_NNP ,_, based_VBN in_IN Alabama_NNP ,_, smelled_VBD something_NN rotten_JJ ._. Three_CD days_NNS ago_RB ,_, Chatom_NNP filed_VBD a_DT lawsuit_NN against_IN Merck_NNP ._. That_DT lawsuit_NN record_NN is_VBZ available_JJ here_RB :_: www.naturalnews.com_ADD It_PRP alleges_VBZ ,_, among_IN other_JJ shocking_JJ things_NNS :_: [_-LRB- Merck_NNP engaged_VBD in_IN ]_-RRB- …_: a_DT decade_NN -_HYPH long_JJ scheme_NN to_TO falsify_VB and_CC misrepresent_VB the_DT true_JJ efficacy_NN of_IN its_PRP$ vaccine_NN ._. Merck_NNP fraudulently_RB represented_VBD and_CC continues_VBZ to_TO falsely_RB represent_VB in_IN its_PRP$ labeling_NN and_CC elsewhere_RB that_IN its_PRP$ Mumps_NNP Vaccine_NNP has_VBZ an_DT efficacy_NN rate_NN of_IN 95_CD percent_NN of_IN higher_JJR ._. In_IN reality_NN ,_, Merck_NNP knows_VBZ and_CC has_VBZ taken_VBN affirmative_JJ steps_NNS to_TO conceal_VB —_: by_IN using_VBG improper_JJ testing_NN techniques_NNS and_CC falsifying_VBG test_NN data_NNS —_: that_WDT its_PRP$ Mumps_NNP Vaccine_NNP is_VBZ ,_, and_CC has_VBZ been_VBN since_IN at_IN least_JJS 1999_CD ,_, far_RB less_JJR than_IN 95_CD percent_NN effective_JJ ._. Merck_NNP designed_VBD a_DT testing_NN methodology_NN that_WDT evaluated_VBD its_PRP$ vaccine_NN against_IN a_DT less_RBR virulent_JJ strain_NN of_IN the_DT mumps_NNS virus_NN ._. After_IN the_DT results_NNS failed_VBD to_TO yield_VB Merck_NNP ’s_POS desired_VBN efficacy_NN ,_, Merck_NNP abandoned_VBD the_DT methodology_NN and_CC concealed_VBD the_DT study_NN ’s_POS findings_NNS ._. …_: incorporating_VBG the_DT use_NN of_IN animal_NN antibodies_NNS to_TO artificially_RB inflate_VB the_DT results_NNS …_. …_NFP destroying_VBG evidence_NN of_IN the_DT falsified_VBN data_NNS and_CC then_RB lying_VBG to_IN an_DT FDA_NNP investigator_NN …_. …_: threatened_VBD a_DT virologist_NN in_IN Merck_NNP ’s_POS vaccine_NN division_NN with_IN jail_NN if_IN he_PRP reported_VBD the_DT fraud_NN to_IN the_DT FDA_NNP …_. …_: the_DT ultimate_JJ victims_NNS here_RB are_VBP the_DT millions_NNS of_IN children_NNS who_WP every_DT year_NN are_VBP being_VBG injected_VBN with_IN a_DT mumps_NNS vaccine_NN that_WDT is_VBZ not_RB providing_VBG them_PRP with_IN an_DT adequate_JJ level_NN of_IN protection_NN ._. And_CC while_IN this_DT is_VBZ a_DT disease_NN that_WDT ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP (_-LRB- ‘_`` CDC_NNP ’_'' )_-RRB- ,_, was_VBD supposed_VBN to_TO be_VB eradicated_VBN by_IN now_RB ,_, the_DT failure_NN in_IN Merck_NNP ’s_POS vaccine_NN has_VBZ allowed_VBN this_DT disease_NN to_TO linger_VB ,_, with_IN significant_JJ outbreaks_NNS continuing_VBG to_TO occur_VB ._. Chatom_NNP Primary_NNP Care_NNP also_RB alleges_VBZ that_IN the_DT fraudulent_JJ Merck_NNP vaccine_NN contributed_VBD to_IN the_DT 2006_CD mumps_NNS outbreak_NN in_IN the_DT Midwest_NNP ,_, and_CC a_DT 2009_CD outbreak_NN elsewhere_RB ._. It_PRP says_VBZ ,_, “_`` there_EX has_VBZ remained_VBN a_DT significant_JJ risk_NN of_IN a_DT resurgence_NN of_IN mumps_NNS outbreaks_NNS …_: ”_'' This_DT investigation_NN is_VBZ only_RB beginning_VBG NaturalNews_NNP has_VBZ only_RB begun_VBN to_TO investigate_VB this_DT incredible_JJ breaking_NN news_NN about_IN Merck_NNP and_CC the_DT vaccine_NN industry_NN ._. We_PRP are_VBP pouring_VBG through_IN the_DT court_NN documents_NNS to_TO identify_VB additional_JJ information_NN that_WDT may_MD be_VB relevant_JJ to_IN this_DT case_NN ,_, and_CC we_PRP plan_VBP to_TO bring_VB you_PRP that_DT information_NN soon_RB ._. For_IN the_DT record_NN ,_, Merck_NNP denies_VBZ all_DT allegations_NNS ._. Is_VBZ anyone_NN surprised_VBN ?_. 2010_CD False_JJ Claims_NNS Act_VB against_IN Merck_NNP ,_, by_IN two_CD Merck_NNP virologists_NNS www.naturalnews.com_ADD","VBG to two NNP NNS who VBD a NNP NNPS NNP NN in 2010 — a NN which VBZ RB RB VBN VBN — NN NN NNP RB VBD its NNS NN NN NNS , VBN NN NNS with NN NNS , VBD a NN that RB VBD NNS and NNS NNS , and VBD off NNS and NNS who VBD the NN VBG it VBD “ 95 NN JJ . ” VBG to NNP NNP and NNP NNP , both JJ NNP NNS , the NNP NN VBD in all the VBG NN : • In NN to VB this , NNP VBD the NN NN with NN NNS in NN to RB VB the NN of NN NN NNS . As VBN in NNP : NNP RB VBD NN NNS to NN NNS to VB RBR JJ NN NNS , though it VBD that the JJ JJ NN would RB VB JJ NNS , and that the NNS VBD a NN NN NN that “ VBD RB in any NN VB to , VB with , or VB JJ NN … NN NN in VBN NNS , ” VBG to the NN . ( www.courthousenews.com) • NNP RB VBD the VBN NN NNS to VB the NNP NN out of “ NNS of NNS of NNS for a NN that VBZ RB VB JJ NN . ” • NNP ’s NN NN VBZ RB VBN to the NN of NNS across NNP , VBG JJR NNS to VB VBN with NNS . ( Gee , RB ? This VBZ what NNP VBZ VBN VBG for NNS … NNS VBP RB VBN to VB the NNS VBG because it VBZ JJ for JJ NN ! ) • NNP VBD its JJ NNS of “ 95 NN NN ” to VB the NN NN and VB JJ NNS . • The NNP NN NN VBZ VBN VBG on since the JJ 1990 ’s , VB the NNP NNS . • NN of NNP ’s NN VBD RB VBN against “ JJ - NN ” VBZ NNS in the NN . RB , NN NNS VBD RB VBN to VB the VBN NN . • This JJ NN VBD NN “ with the NN , NN and NN of NNP ’s JJ NN . ” • NNP NNS “ VBD RB the JJ NN and NN NN in which NNP VBD to RB VB the NN ’s NN NNS , ” VBG to NN NNS ( VB RB ) . NNP NN VBD to VB the 2010 NNP NNPS NNP ! RB than VBG NN on this JJ NNS NN , the NNP NN RB VBD it , RB VBG NNP ’s NN NN RB of RB VBG NN . This VBZ the NN of NN between the NNP NN , NNP NNS and the NN NN . NNP NNP NNP VBZ NNP for NNP NN NN , NN of NN , NN of NN NN NNS VBG the NN of this 2010 NNP NNPS NNP , NNP NNP NNP , VBN in NNP , VBD NN JJ . Three NNS RB , NNP VBD a NN against NNP . That NN NN VBZ JJ RB : www.naturalnews.com It VBZ , among JJ JJ NNS : [ NNP VBD in ] … a NN - JJ NN to VB and VB the JJ NN of its NN . NNP RB VBD and VBZ to RB VB in its NN and RB that its NNP NNP VBZ an NN NN of 95 NN of JJR . In NN , NNP VBZ and VBZ VBN JJ NNS to VB — by VBG JJ NN NNS and VBG NN NNS — that its NNP NNP VBZ , and VBZ VBN since at JJS 1999 , RB JJR than 95 NN JJ . NNP VBD a NN NN that VBD its NN against a RBR JJ NN of the NNS NN . After the NNS VBD to VB NNP ’s VBN NN , NNP VBD the NN and VBD the NN ’s NNS . … VBG the NN of NN NNS to RB VB the NNS … … VBG NN of the VBN NNS and RB VBG to an NNP NN … … VBD a NN in NNP ’s NN NN with NN if he VBD the NN to the NNP … … the JJ NNS RB VBP the NNS of NNS who every NN VBP VBG VBN with a NNS NN that VBZ RB VBG them with an JJ NN of NN . And while this VBZ a NN that , VBG to the NNPS for NNP NNP ( ‘ NNP ’ ) , VBD VBN to VB VBN by RB , the NN in NNP ’s NN VBZ VBN this NN to VB , with JJ NNS VBG to VB . NNP NNP NNP RB VBZ that the JJ NNP NN VBD to the 2006 NNS NN in the NNP , and a 2009 NN RB . It VBZ , “ there VBZ VBN a JJ NN of a NN of NNS NNS … ” This NN VBZ RB VBG NNP VBZ RB VBN to VB this JJ NN NN about NNP and the NN NN . We VBP VBG through the NN NNS to VB JJ NN that may VB JJ to this NN , and we VBP to VB you that NN RB . For the NN , NNP VBZ all NNS . VBZ NN VBN ? 2010 JJ NNS VB against NNP , by two NNP NNS www.naturalnews.com"
100,211,mainstream,"And_CC the_DT government_NN trusts_VBZ the_DT public_NN to_TO act_VB as_IN a_DT responsible_JJ co-partner_NN in_IN public_JJ health_NN ._. Rather_RB than_IN announcing_VBG an_DT official_JJ lockdown_NN that_WDT would_MD fully_RB close_VB restaurants_NNS and_CC businesses_NNS and_CC force_VB citizens_NNS to_TO stay_VB home_RB ,_, the_DT Korean_JJ government_NN has_VBZ opted_VBN to_TO keep_VB more_JJR of_IN its_PRP$ economy_NN open_JJ ._. “_`` We_PRP were_VBD never_RB on_IN lockdown_NN ,_, and_CC we_PRP ’re_VBP still_RB not_RB on_IN lockdown_NN ,_, ”_'' Paul_NNP Choi_NNP ,_, a_DT consultant_NN who_WP lives_VBZ in_IN Seoul_NNP ,_, told_VBD me_PRP ._. “_`` But_CC citizens_NNS have_VBP taken_VBN it_PRP upon_IN ourselves_PRP to_TO stay_VB inside_RB ._. We_PRP ’re_VBP very_RB careful_JJ to_TO wash_VB our_PRP$ hands_NNS and_CC keep_VB our_PRP$ distance_NN ._. Almost_RB everybody_NN is_VBZ wearing_VBG masks_NNS ._. If_IN you_PRP do_VBP n’t_RB wear_VB masks_NNS ,_, you_PRP get_VBP looks_VBZ on_IN the_DT street_NN ._. ”_'' -_, Before_IN the_DT crisis_NN ,_, Choi_NNP said_VBD ,_, he_PRP would_MD leave_VB his_PRP$ apartment_NN early_RB ,_, ride_VB a_DT crowded_JJ subway_NN ,_, elbow_VB his_PRP$ way_NN through_IN a_DT packed_VBN gym_NN to_IN the_DT treadmills_NNS ,_, and_CC then_RB go_VB to_IN the_DT office_NN ._. “_`` Today_NN ,_, the_DT subway_NN is_VBZ much_RB less_RBR crowded_JJ ,_, because_IN more_JJR people_NNS work_VBP from_IN home_NN ,_, ”_'' he_PRP said_VBD ._. “_`` When_WRB I_PRP arrive_VBP at_IN my_PRP$ office_NN building_NN ,_, there_EX are_VBP temperature_NN cameras_NNS in_IN the_DT lobby_NN ._. There_EX ’s_VBZ a_DT regular_JJ diner_NN that_WDT I_PRP go_VBP to_IN for_IN lunch_NN ,_, and_CC the_DT staff_NN there_RB tell_VB me_PRP that_IN their_PRP$ work_NN schedules_NNS have_VBP been_VBN reduced_VBN to_TO avoid_VB layoffs_NNS ._. Larger_JJR social_JJ gatherings_NNS ,_, at_IN bars_NNS and_CC restaurants_NNS ,_, have_VBP been_VBN paused_VBN ._. ”_'' I_PRP asked_VBD Choi_NNP how_WRB the_DT country_NN had_VBD come_VBN together_RB so_RB quickly_RB to_TO stem_VB the_DT spread_NN of_IN the_DT disease_NN ._. “_`` It_PRP ’s_VBZ about_IN civic_JJ memory_NN ,_, not_RB Confucius_NNP ,_, ”_'' he_PRP said_VBD ._. “_`` We_PRP remember_VBP MERS_NN ._. We_PRP remember_VBP other_JJ epidemics_NNS ._. We_PRP know_VBP this_DT is_VBZ a_DT marathon_NN ._. But_CC we_PRP ’re_VBP in_IN a_DT better_JJR place_NN because_IN the_DT entire_JJ society_NN has_VBZ been_VBN in_IN this_DT game_NN ,_, fighting_VBG together_RB ._. ”_'' As_IN he_PRP spoke_VBD ,_, my_PRP$ mind_NN turned_VBD to_IN vaccination_NN ._. A_DT live_JJ vaccine_NN uses_VBZ a_DT weakened_VBN version_NN of_IN a_DT virus_NN to_TO teach_VB the_DT immune_JJ system_NN how_WRB to_TO respond_VB to_IN the_DT real_JJ thing_NN ._. Long_RB after_IN the_DT vaccine_NN is_VBZ gone_VBN ,_, the_DT body_NN remembers_VBZ its_PRP$ immuno_NN -_HYPH playbook_NN and_CC stands_VBZ prepared_VBN to_TO fight_VB a_DT stronger_JJR pathogen_NN in_IN the_DT future_NN ._. South_NNP Korea_NNP ’s_POS national_JJ immune_NN system_NN was_VBD instructed_VBN and_CC strengthened_VBN by_IN previous_JJ crises_NNS ._. Other_JJ epidemics_NNS came_VBD and_CC went_VBD ,_, but_CC they_PRP left_VBD behind_IN guidance_NN that_WDT Koreans_NNPS recalled_VBD and_CC executed_VBD when_WRB they_PRP were_VBD suddenly_RB confronted_VBN with_IN the_DT plague_NN of_IN the_DT century_NN ._. South_NNP Korea_NNP ’s_POS world_NN -_HYPH class_NN response_NN to_IN COVID_NNP -_HYPH 19_CD is_VBZ not_RB the_DT product_NN of_IN religion_NN ,_, or_CC cultural_JJ destiny_NN ,_, but_CC rather_RB the_DT result_NN of_IN diseases_NNS bested_VBN and_CC crises_NNS weathered_VBD ._. Unlike_IN the_DT biological_JJ response_NN to_IN a_DT pathogen_NN ,_, public_JJ policy_NN is_VBZ not_RB an_DT automatic_JJ response_NN ,_, but_CC a_DT deliberate_JJ one_NN ._. South_NNP Korea_NNP chose_VBD to_TO learn_VB ._. The_DT United_NNP States_NNPS entered_VBD this_DT pandemic_NN discombobulated_VBN ,_, blundering_VBG ,_, and_CC hamstrung_VBN by_IN our_PRP$ lack_NN of_IN readiness_NN ._. Neither_DT history_NN nor_CC contagion_NN will_MD wait_VB for_IN us_PRP to_TO catch_VB up_RP ._. That_DT is_VBZ the_DT bad_JJ news_NN ._. The_DT good_JJ news_NN is_VBZ that_IN history_NN will_MD go_VB on_RP ._. And_CC we_PRP still_RB have_VBP time_NN to_TO learn_VB from_IN it_PRP ._.","And the NN VBZ the NN to VB as a JJ NN in JJ NN . RB than VBG an JJ NN that would RB VB NNS and NNS and VB NNS to VB RB , the JJ NN VBZ VBN to VB JJR of its NN JJ . “ We VBD RB on NN , and we VBP RB RB on NN , ” NNP NNP , a NN who VBZ in NNP , VBD me . “ But NNS VBP VBN it upon ourselves to VB RB . We VBP RB JJ to VB our NNS and VB our NN . RB NN VBZ VBG NNS . If you VBP RB VB NNS , you VBP VBZ on the NN . ” - Before the NN , NNP VBD , he would VB his NN RB , VB a JJ NN , VB his NN through a VBN NN to the NNS , and RB VB to the NN . “ NN , the NN VBZ RB RBR JJ , because JJR NNS VBP from NN , ” he VBD . “ When I VBP at my NN NN , there VBP NN NNS in the NN . There VBZ a JJ NN that I VBP to for NN , and the NN RB VB me that their NN NNS VBP VBN VBN to VB NNS . JJR JJ NNS , at NNS and NNS , VBP VBN VBN . ” I VBD NNP how the NN VBD VBN RB RB RB to VB the NN of the NN . “ It VBZ about JJ NN , RB NNP , ” he VBD . “ We VBP NN . We VBP JJ NNS . We VBP this VBZ a NN . But we VBP in a JJR NN because the JJ NN VBZ VBN in this NN , VBG RB . ” As he VBD , my NN VBD to NN . A JJ NN VBZ a VBN NN of a NN to VB the JJ NN how to VB to the JJ NN . RB after the NN VBZ VBN , the NN VBZ its NN - NN and VBZ VBN to VB a JJR NN in the NN . NNP NNP ’s JJ NN NN VBD VBN and VBN by JJ NNS . JJ NNS VBD and VBD , but they VBD behind NN that NNPS VBD and VBD when they VBD RB VBN with the NN of the NN . NNP NNP ’s NN - NN NN to NNP - 19 VBZ RB the NN of NN , or JJ NN , but RB the NN of NNS VBN and NNS VBD . Unlike the JJ NN to a NN , JJ NN VBZ RB an JJ NN , but a JJ NN . NNP NNP VBD to VB . The NNP NNPS VBD this NN VBN , VBG , and VBN by our NN of NN . Neither NN nor NN will VB for us to VB up . That VBZ the JJ NN . The JJ NN VBZ that NN will VB on . And we RB VBP NN to VB from it ."
101,405,mainstream,"Most_JJS pediatricians_NNS say_VBP parents_NNS have_VBP refused_VBN vaccines_NNS for_IN their_PRP$ kids_NNS More_JJR doctors_NNS are_VBP reporting_VBG encounters_NNS with_IN parents_NNS refusing_VBG to_TO vaccinate_VB their_PRP$ kids_NNS than_IN a_DT decade_NN ago_RB ,_, but_CC parents_NNS ’_POS reasons_NNS for_IN skipping_VBG immunizations_NNS have_VBP shifted_VBN in_IN the_DT past_JJ decade_NN ._. A_DT new_JJ survey_NN published_VBN in_IN Pediatrics_NNP on_IN Monday_NNP reports_VBZ that_IN 87_CD percent_NN of_IN pediatricians_NNS in_IN the_DT United_NNP States_NNPS say_VBP they_PRP encountered_VBD parents_NNS refusing_VBG to_TO vaccinate_VB their_PRP$ children_NNS in_IN 2013_CD ._. A_DT decade_NN earlier_RBR ,_, 75_CD percent_NN of_IN doctors_NNS reported_VBD they_PRP had_VBD experienced_VBN vaccine_NN refusals_NNS ._. The_DT most_RBS common_JJ reason_NN parents_NNS gave_VBD ,_, according_VBG to_IN doctors_NNS ?_. The_DT vaccines_NNS were_VBD n’t_RB necessary_JJ ._. “_`` Vaccines_NNS have_VBP been_VBN so_RB good_JJ at_IN taking_VBG diseases_NNS away_RB that_IN when_WRB we_PRP do_VBP n’t_RB see_VB diseases_NNS ,_, we_PRP do_VBP n’t_RB think_VB they_PRP ’re_VBP important_JJ ,_, ”_'' said_VBD Dr._NNP Kathryn_NNP Edwards_NNP ,_, a_DT pediatrician_NN and_CC director_NN of_IN the_DT Vanderbilt_NNP Vaccine_NNP Research_NNP Program_NNP ._. It_PRP ’s_VBZ the_DT paradox_NN of_IN vaccines_NNS —_: they_PRP do_VBP away_RB with_IN infectious_JJ diseases_NNS to_IN the_DT point_NN that_IN they_PRP no_RB longer_RBR seem_VBP necessary_JJ ._. The_DT uptick_NN in_IN parents_NNS feeling_VBG that_IN vaccines_NNS are_VBP n’t_RB needed_VBN is_VBZ concerning_JJ ,_, Edwards_NNP said_VBD ._. Recent_JJ outbreaks_NNS of_IN diseases_NNS such_JJ as_IN measles_NNS have_VBP been_VBN blamed_VBN on_IN a_DT decline_NN in_IN vaccination_NN rates_NNS ._. “_`` If_IN you_PRP have_VBP a_DT four_CD -_HYPH way_NN stop_NN and_CC everybody_NN stops_VBZ at_IN the_DT stop_NN sign_NN ,_, we_PRP ’re_VBP fine_JJ ._. If_IN one_CD person_NN does_VBZ n’t_RB stop_VB ,_, we_PRP ’re_VBP fine_JJ ,_, ”_'' Edwards_NNP explained_VBD ._. “_`` But_CC if_IN more_JJR people_NNS are_VBP n’t_RB stopping_VBG ,_, we_PRP ’re_VBP going_VBG to_TO have_VB an_DT accident_NN ._. ”_'' The_DT survey_NN also_RB showed_VBD a_DT shift_NN in_IN the_DT number_NN of_IN parents_NNS who_WP cite_VBP worries_NNS about_IN the_DT unfounded_JJ claim_NN that_IN vaccines_NNS or_CC thimerosal_NN —_: a_DT preservative_NN formerly_RB used_VBN in_IN childhood_NN vaccines_NNS —_: can_MD cause_VB autism_NN as_IN the_DT reason_NN why_WRB they_PRP did_VBD n’t_RB want_VB their_PRP$ children_NNS to_TO be_VB vaccinated_VBN ._. The_DT proportion_NN of_IN doctors_NNS who_WP had_VBD encountered_VBN autism_NN concerns_NNS fell_VBD from_IN 74_CD percent_NN in_IN 2006_CD to_IN 64_CD percent_NN in_IN 2013_CD ._. It_PRP ’s_VBZ the_DT first_JJ documented_VBN drop_NN in_IN that_DT concern_NN ,_, the_DT authors_NNS said_VBD ._. “_`` I_PRP ’m_VBP not_RB surprised_VBN by_IN that_DT ,_, ”_'' said_VBD Dr._NNP Paul_NNP Offit_NNP ,_, the_DT director_NN of_IN the_DT Vaccine_NNP Education_NNP Center_NNP at_IN Children_NNP ’s_POS Hospital_NNP of_IN Philadelphia_NNP ._. “_`` I_PRP hear_VBP from_IN pediatricians_NNS that_WDT ’s_VBZ been_VBN happening_VBG less_RBR ._. ”_'' Offit_NNP ,_, who_WP was_VBD not_RB involved_VBN in_IN the_DT Pediatrics_NNP study_NN ,_, said_VBD that_IN scientific_JJ research_NN and_CC subsequent_JJ media_NN coverage_NN have_VBP helped_VBN to_TO dispel_VB the_DT myth_NN ._. The_DT 2014_CD measles_NNS outbreak_NN in_IN California_NNP also_RB served_VBD as_IN “_`` an_DT education_NN ”_'' about_IN the_DT importance_NN of_IN immunization_NN ,_, he_PRP said_VBD ._. Many_JJ parents_NNS are_VBP concerned_JJ about_IN giving_VBG their_PRP$ children_NNS too_RB many_JJ vaccines_NNS in_IN a_DT short_JJ period_NN of_IN time_NN ,_, a_DT nod_NN to_IN the_DT idea_NN of_IN an_DT alternate_JJ vaccine_NN schedule_NN that_WDT ’s_VBZ gained_VBN steam_NN in_IN recent_JJ years_NNS ._. Nearly_RB 73_CD percent_NN of_IN pediatricians_NNS say_VBP that_IN parents_NNS delayed_VBD vaccines_NNS because_IN of_IN scheduling_NN concerns_NNS —_: something_NN public_JJ health_NN officials_NNS discourage_VBP because_IN delays_NNS increase_VBP the_DT time_NN unvaccinated_JJ children_NNS are_VBP at_IN risk_NN of_IN becoming_VBG sick_JJ ._. It_PRP ’s_VBZ not_RB clear_JJ whether_IN this_DT concern_NN increased_VBD or_CC decreased_VBD —_: the_DT 2006_CD survey_NN did_VBD n’t_RB ask_VB doctors_NNS about_IN vaccine_NN schedules_NNS ._. The_DT retrospective_NN survey_NN asked_VBD pediatricians_NNS to_TO recall_VB encounters_NNS with_IN parents_NNS ._. Doctors_NNS were_VBD n’t_RB asked_VBN to_TO keep_VB hard_JJ numbers_NNS on_IN those_DT encounters_NNS ,_, so_RB the_DT study_NN could_MD have_VB introduced_VBN recollection_NN bias_NN ._. More_RBR and_CC more_JJR ,_, doctors_NNS do_VBP n’t_RB want_VB to_TO put_VB up_RP with_IN vaccine_NN refusal_NN ._. The_DT rate_NN of_IN doctors_NNS who_WP reported_VBD always_RB dismissing_VBG families_NNS who_WP refuse_VBP vaccinations_NNS from_IN their_PRP$ practices_NNS nearly_RB doubled_VBD between_IN surveys_NNS ._. Their_PRP$ efforts_NNS to_TO convince_VB parents_NNS to_TO vaccinate_VB their_PRP$ kids_NNS are_VBP sometimes_RB fruitless_JJ —_: pediatricians_NNS reported_VBD that_IN they_PRP were_VBD able_JJ to_TO persuade_VB only_RB about_RB one_CD -_HYPH third_NN of_IN parents_NNS who_WP had_VBD refused_VBN vaccines_NNS to_TO change_VB their_PRP$ minds_NNS ._. The_DT American_NNP Academy_NNP of_IN Pediatrics_NNP is_VBZ trying_VBG to_TO give_VB doctors_NNS some_DT added_VBN ammunition_NN in_IN those_DT conversations_NNS with_IN parents_NNS ._. The_DT organization_NN released_VBD a_DT new_JJ guide_NN called_VBN “_`` Countering_NNP Vaccine_NNP Hesitancy_NNP ”_'' to_TO accompany_VB the_DT survey_NN ._. “_`` Generally_RB ,_, doctors_NNS are_VBP n’t_RB prepared_VBN ._. It_PRP ’s_VBZ hard_JJ to_TO counter_VB ,_, ”_'' Offit_NNP said_VBD ._. “_`` We_PRP need_VBP to_TO arm_VB physicians_NNS with_IN info_NN to_TO answer_VB those_DT questions_NNS ._. ”_'' Correction_NN :_: An_DT earlier_JJR version_NN of_IN this_DT story_NN incorrectly_RB identified_VBD Dr._NNP Paul_NNP Offit_NNP as_IN head_NN of_IN infectious_JJ diseases_NNS at_IN Children_NNP ’s_POS Hospital_NNP of_IN Philadelphia_NNP ._.","JJS NNS VBP NNS VBP VBN NNS for their NNS JJR NNS VBP VBG NNS with NNS VBG to VB their NNS than a NN RB , but NNS ’ NNS for VBG NNS VBP VBN in the JJ NN . A JJ NN VBN in NNP on NNP VBZ that 87 NN of NNS in the NNP NNPS VBP they VBD NNS VBG to VB their NNS in 2013 . A NN RBR , 75 NN of NNS VBD they VBD VBN NN NNS . The RBS JJ NN NNS VBD , VBG to NNS ? The NNS VBD RB JJ . “ NNS VBP VBN RB JJ at VBG NNS RB that when we VBP RB VB NNS , we VBP RB VB they VBP JJ , ” VBD NNP NNP NNP , a NN and NN of the NNP NNP NNP NNP . It VBZ the NN of NNS — they VBP RB with JJ NNS to the NN that they RB RBR VBP JJ . The NN in NNS VBG that NNS VBP RB VBN VBZ JJ , NNP VBD . JJ NNS of NNS JJ as NNS VBP VBN VBN on a NN in NN NNS . “ If you VBP a four - NN NN and NN VBZ at the NN NN , we VBP JJ . If one NN VBZ RB VB , we VBP JJ , ” NNP VBD . “ But if JJR NNS VBP RB VBG , we VBP VBG to VB an NN . ” The NN RB VBD a NN in the NN of NNS who VBP NNS about the JJ NN that NNS or NN — a NN RB VBN in NN NNS — can VB NN as the NN why they VBD RB VB their NNS to VB VBN . The NN of NNS who VBD VBN NN NNS VBD from 74 NN in 2006 to 64 NN in 2013 . It VBZ the JJ VBN NN in that NN , the NNS VBD . “ I VBP RB VBN by that , ” VBD NNP NNP NNP , the NN of the NNP NNP NNP at NNP ’s NNP of NNP . “ I VBP from NNS that VBZ VBN VBG RBR . ” NNP , who VBD RB VBN in the NNP NN , VBD that JJ NN and JJ NN NN VBP VBN to VB the NN . The 2014 NNS NN in NNP RB VBD as “ an NN ” about the NN of NN , he VBD . JJ NNS VBP JJ about VBG their NNS RB JJ NNS in a JJ NN of NN , a NN to the NN of an JJ NN NN that VBZ VBN NN in JJ NNS . RB 73 NN of NNS VBP that NNS VBD NNS because of NN NNS — NN JJ NN NNS VBP because NNS VBP the NN JJ NNS VBP at NN of VBG JJ . It VBZ RB JJ whether this NN VBD or VBD — the 2006 NN VBD RB VB NNS about NN NNS . The NN NN VBD NNS to VB NNS with NNS . NNS VBD RB VBN to VB JJ NNS on those NNS , RB the NN could VB VBN NN NN . RBR and JJR , NNS VBP RB VB to VB up with NN NN . The NN of NNS who VBD RB VBG NNS who VBP NNS from their NNS RB VBD between NNS . Their NNS to VB NNS to VB their NNS VBP RB JJ — NNS VBD that they VBD JJ to VB RB RB one - NN of NNS who VBD VBN NNS to VB their NNS . The NNP NNP of NNP VBZ VBG to VB NNS some VBN NN in those NNS with NNS . The NN VBD a JJ NN VBN “ NNP NNP NNP ” to VB the NN . “ RB , NNS VBP RB VBN . It VBZ JJ to VB , ” NNP VBD . “ We VBP to VB NNS with NN to VB those NNS . ” NN : An JJR NN of this NN RB VBD NNP NNP NNP as NN of JJ NNS at NNP ’s NNP of NNP ."
102,218,conspiracy,"Bill_NNP Gates_NNP —_: who_WP invests_VBZ in_IN the_DT same_JJ industries_NNS he_PRP gives_VBZ charitable_JJ donations_NNS to_IN ,_, and_CC who_WP promotes_VBZ a_DT global_JJ public_JJ health_NN agenda_NN that_WDT benefits_VBZ the_DT companies_NNS he_PRP ’s_VBZ invested_VBN in_IN —_: has_VBZ gone_VBN on_IN record_NN saying_VBG life_NN will_MD not_RB go_VB back_RB to_IN normal_JJ until_IN we_PRP have_VBP the_DT ability_NN to_TO vaccinate_VB the_DT entire_JJ global_JJ population_NN against_IN COVID_NN -_HYPH 19.1_CD To_IN that_DT end_NN ,_, he_PRP is_VBZ pushing_VBG for_IN disease_NN surveillance_NN and_CC a_DT vaccine_NN tracking_NN system2_NN that_WDT might_MD involve_VB embedding_VBG vaccination_NN records_NNS on_IN our_PRP$ bodies_NNS ._. One_CD example_NN of_IN how_WRB this_DT might_MD be_VB done_VBN is_VBZ using_VBG an_DT invisible_JJ ink_NN quantum_NN dot_NN tattoo_NN ,_, described_VBN in_IN a_DT December_NNP 18_CD ,_, 2019_CD ,_, Science_NNP Translational_NNP Medicine_NNP paper_NN ._. 3,_CD 4_LS According_VBG to_IN statements_NNS made_VBN by_IN Gates_NNPS ,_, societal_JJ and_CC financial_JJ normalcy_NN may_MD never_RB return_VB to_IN those_DT who_WP refuse_VBP vaccination_NN ,_, as_IN the_DT digital_JJ vaccination_NN certificate_NN Gates_NNPS is_VBZ pushing_VBG for_IN might_MD ultimately_RB be_VB required_VBN to_TO go_VB about_IN your_PRP$ day_NN -_HYPH to_IN -_HYPH day_NN life_NN and_CC business_NN ._. Without_IN this_DT “_`` digital_JJ immunity_NN proof_NN ,_, ”_'' you_PRP may_MD not_RB even_RB be_VB allowed_VBN to_TO travel_VB locally_RB or_CC visit_VB certain_JJ public_JJ buildings_NNS ._. Gates_NNPS has_VBZ a_DT history_NN of_IN “_`` predicting_VBG ”_'' global_JJ pandemics_NNS with_IN vast_JJ numbers_NNS of_IN deaths_NNS ,_, 5_CD and_CC with_IN his_PRP$ call_NN for_IN a_DT tracking_NN system_NN to_TO keep_VB tabs_NNS on_IN infected_JJ /_, noninfected_JJ and_CC vaccinated_VBN /_, unvaccinated_JJ individuals_NNS ,_, he_PRP ’s_VBZ ensuring_VBG an_DT unimaginably_RB profitable_JJ future_NN for_IN the_DT vaccine_NN makers_NNS he_PRP supports_VBZ and_CC makes_VBZ money_NN from_IN via_IN his_PRP$ Foundation_NNP investments_NNS ._. Along_IN with_IN Gates_NNPS ,_, The_DT Rockefeller_NNP Foundation_NNP is_VBZ also_RB coordinating_VBG efforts_NNS in_IN the_DT direction_NN of_IN social_JJ control_NN through_IN the_DT implementation_NN of_IN draconian_JJ COVID_NN -_HYPH 19_CD tracking_NN and_CC tracing_NN measures_NNS that_WDT are_VBP clearly_RB meant_VBN to_TO become_VB permanent_JJ ._. April_NNP 21_CD ,_, 2020_CD ,_, The_DT Rockefeller_NNP Foundation_NNP released_VBD a_DT white_JJ paper6_NN titled_VBN ,_, “_`` National_JJ COVID_NNP -_HYPH 19_CD Testing_NN Action_NN Plan_NN —_: Strategic_JJ Steps_NNS to_TO Reopen_VB Our_PRP$ Workplaces_NNS and_CC Our_PRP$ Communities_NNS ._. ”_'' In_IN the_DT foreword_NN ,_, Rockefeller_NNP Foundation_NNP president_NN Dr._NNP Rajiv_NNP J._NNP Shah_NNP writes_VBZ :_: The_DT plan_NN calls_VBZ for_IN testing_NN and_CC tracing_VBG 1_CD million_CD Americans_NNPS per_IN week_NN to_TO start_VB ,_, incrementally_RB ramping_VBG it_PRP up_RP to_IN 3_CD million_CD and_CC then_RB 30_CD million_CD per_IN week_NN (_-LRB- the_DT “_`` 1_CD -_SYM 3_CD -_SYM 30_CD plan_NN ”_'' )_-RRB- over_IN the_DT next_JJ six_CD months_NNS until_IN the_DT entire_JJ population_NN has_VBZ been_VBN covered_VBN ._. Test_NN results_NNS would_MD then_RB be_VB collected_VBN on_IN a_DT digital_JJ platform_NN capable_JJ of_IN tracking_VBG all_DT tested_VBN individuals_NNS so_IN that_IN contact_NN -_HYPH tracing_NN can_MD be_VB performed_VBN when_WRB someone_NN tests_VBZ positive_JJ ._. According_VBG to_IN the_DT “_`` National_JJ COVID_NNP -_HYPH 19_CD Testing_NN Action_NN Plan_NN ”_'' :_: To_IN this_DT end_NN ,_, they_PRP suggest_VBP using_VBG incentives_NNS “_'' to_TO nudge_VB the_DT voluntary_JJ use_NN ”_'' of_IN tracking_NN and_CC contact_NN tracing_NN apps_NNS rather_RB than_IN making_VBG them_PRP mandatory_JJ ._. They_PRP also_RB call_VBP for_IN the_DT use_NN of_IN “_`` innovative_JJ digital_JJ technologies_NNS ”_'' aimed_VBN at_IN improving_VBG “_`` workforce_NN monitoring_NN and_CC early_JJ detection_NN of_IN recurrent_JJ outbreaks_NNS ._. ”_'' According_VBG to_IN the_DT “_`` National_JJ COVID_NNP -_HYPH 19_CD Testing_NN Action_NN Plan_NN ”_'' :_: 8_LS Call_VB me_PRP jaded_JJ ,_, but_CC this_DT sounds_VBZ like_IN a_DT plan_NN to_TO surveil_VB Americans_NNPS so_IN that_IN they_PRP can_MD easily_RB be_VB tracked_VBN down_RP for_IN mandatory_JJ vaccination_NN once_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN becomes_VBZ available_JJ ._. It_PRP also_RB creates_VBZ the_DT necessary_JJ infrastructure_NN for_IN vaccination_NN tracking_NN across_IN the_DT board_NN ,_, for_IN all_DT vaccines_NNS ._. While_IN they_PRP give_VBP lip_NN -_HYPH service_NN to_IN privacy_NN and_CC anonymization_NN of_IN data_NNS ,_, privacy_NN promises_NNS have_VBP been_VBN repeatedly_RB broken_VBN in_IN the_DT past_NN ._. Besides_RB ,_, the_DT document_NN clearly_RB states_VBZ that_IN :_: 9_LS Are_VBP You_PRP Ready_JJ to_TO Give_VB Up_RP EVERYTHING_NN Over_IN a_DT Virus_NN ?_. “_`` Privacy_NN concerns_NNS must_MD be_VB set_VBN aside_RP ._. ”_'' Infection_NN status_NN must_MD be_VB “_`` accessed_VBN and_CC validated_VBN in_IN a_DT few_JJ required_VBN settings_NNS ._. ”_'' Infection_NN status_NN will_MD be_VB linked_VBN to_IN schools_NNS ,_, office_NN buildings_NNS ,_, places_NNS of_IN work_NN ,_, airports_NNS ,_, concert_NN and_CC sport_NN venues_NNS —_: in_IN other_JJ words_NNS ,_, most_JJS areas_NNS people_NNS need_VBP or_CC want_VBP to_TO frequent_VB ,_, if_IN not_RB daily_RB ,_, then_RB at_IN least_JJS occasionally_RB ._. Infection_NN status_NN must_MD be_VB known_VBN “_`` for_IN people_NNS to_TO participate_VB in_IN societal_JJ functions_NNS ._. ”_'' Legislation_NN must_MD be_VB passed_VBN to_TO protect_VB people_NNS from_IN being_VBG fired_VBN from_IN their_PRP$ jobs_NNS based_VBN on_IN their_PRP$ infection_NN status_NN ._. Are_VBP you_PRP concerned_JJ yet_RB ?_. Anyone_NN who_WP remembers_VBZ the_DT tactics_NNS employed_VBN in_IN Nazi_NNP Germany_NNP ,_, or_CC anyone_NN familiar_JJ with_IN the_DT current_JJ surveillance_NN of_IN the_DT Chinese_JJ population_NN ,_, will_MD realize_VB where_WRB this_DT is_VBZ headed_VBN ._. Reading_VBG through_IN the_DT plan_NN ,_, it_PRP should_MD also_RB be_VB crystal_RB clear_JJ that_IN this_DT tracking_NN and_CC surveillance_NN program_NN is_VBZ not_RB designed_VBN to_TO be_VB temporary_JJ ._. You_PRP can_MD be_VB strongly_RB assured_VBN this_DT will_MD be_VB permanent_JJ ._. It_PRP calls_VBZ for_IN hundreds_NNS of_IN thousands_NNS of_IN new_JJ employees_NNS ,_, updating_VBG computer_NN systems_NNS and_CC new_JJ laws_NNS that_WDT in_IN many_JJ ways_NNS resemble_VBP the_DT implementation_NN of_IN TSA_NN post_NN -_HYPH 9/11_CD ._. Not_RB addressed_VBN in_IN this_DT report_NN is_VBZ the_DT question_NN of_IN just_RB how_WRB often_RB would_MD you_PRP have_VB to_TO undergo_VB testing_NN ._. A_DT negative_JJ test_NN today_NN may_MD not_RB be_VB valid_JJ tomorrow_NN ,_, if_IN you_PRP happen_VBP to_TO come_VB across_IN someone_NN who_WP is_VBZ infected_VBN between_IN now_RB and_CC then_RB ._. Would_MD you_PRP have_VB to_TO undergo_VB testing_NN every_DT single_JJ day_NN ?_. Once_RB a_DT week_NN ?_. If_IN regular_JJ retesting_NN is_VBZ not_RB part_NN of_IN the_DT plan_NN ,_, then_RB the_DT whole_JJ system_NN is_VBZ worthless_JJ as_IN your_PRP$ infection_NN status_NN could_MD change_VB at_IN any_DT time_NN ._. Other_JJ questions_NNS not_RB addressed_VBN :_: If_IN you_PRP happen_VBP to_TO be_VB in_IN the_DT vicinity_NN of_IN someone_NN who_WP tests_VBZ positive_JJ in_IN the_DT near_JJ future_NN ,_, would_MD you_PRP have_VB to_TO quarantine_VB for_IN two_CD weeks_NNS ?_. Will_MD your_PRP$ employer_NN pay_VB for_IN that_DT time_NN off_RP ?_. Will_MD you_PRP have_VB a_DT job_NN when_WRB you_PRP come_VBP out_IN of_IN quarantine_NN ?_. What_WP if_IN you_PRP quarantine_VBP for_IN two_CD weeks_NNS but_CC do_VB n’t_RB get_VB sick_JJ and_CC test_VB negative_JJ for_IN antibodies_NNS ,_, then_RB go_VB out_RB and_CC happen_VB across_IN yet_RB another_DT person_NN who_WP ends_VBZ up_RP testing_VBG positive_JJ shortly_RB thereafter_RB ._. Will_MD you_PRP be_VB forced_VBN into_IN quarantine_NN again_RB ?_. Where_WRB does_VBZ it_PRP end_VB ?_. The_DT tracking_NN system_NN The_DT Rockefeller_NNP Foundation_NNP is_VBZ calling_VBG for_IN is_VBZ eerily_RB similar_JJ to_IN that_DT already_RB being_VBG used_VBN in_IN China_NNP ,_, where_WRB residents_NNS are_VBP required_VBN to_TO enroll_VB in_IN a_DT health_NN condition_NN registry_NN ._. Once_IN enrolled_VBN ,_, they_PRP get_VBP a_DT personal_JJ QR_NN code_NN ,_, which_WDT they_PRP must_MD then_RB enter_VB in_IN order_NN to_TO gain_VB access_NN to_IN grocery_NN stores_NNS and_CC other_JJ facilities_NNS ._. 10_CD The_DT plan_NN also_RB demands_VBZ access_NN to_IN other_JJ medical_JJ data_NNS ._. According_VBG to_IN the_DT “_`` National_JJ COVID_NNP -_HYPH 19_CD Testing_NN Action_NN Plan_NN ”_'' :11_CD In_IN other_JJ words_NNS ,_, this_DT plan_NN is_VBZ far_RB more_RBR comprehensive_JJ than_IN merely_RB tracking_VBG COVID_NN -_HYPH 19_CD cases_NNS ._. It_PRP ’s_VBZ designed_VBN to_TO replace_VB the_DT current_JJ system_NN of_IN “_`` disparate_JJ and_CC sometimes_RB deliberately_RB isolated_VBN electronic_JJ medical_JJ records_NNS systems_NNS across_IN the_DT country_NN ._. ”_'' While_IN The_DT Rockefeller_NNP Foundation_NNP ’s_POS white_JJ paper_NN simply_RB calls_VBZ for_IN the_DT use_NN of_IN a_DT digital_JJ “_`` patient_NN identification_NN number_NN ”_'' without_IN indicating_VBG exactly_RB how_WRB you_PRP would_MD carry_VB this_DT ID_NN number_NN on_IN your_PRP$ person_NN ,_, Gates_NNPS has_VBZ repeatedly_RB talked_VBN about_IN the_DT “_`` need_NN ”_'' for_IN some_DT sort_NN of_IN implantable_JJ vaccine_NN certificate_NN ._. In_IN 1999_CD ,_, The_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP donated_VBD $_$ 750_CD million_CD to_TO set_VB up_RP Gavi_NNP ,_, The_DT Vaccine_NNP Alliance_NNP ._. 12_CD Gavi_NNP ,_, in_IN turn_NN ,_, has_VBZ partnered_VBN with_IN the_DT ID2020_NNP Alliance_NNP ,_, along_IN with_IN the_DT Bangladeshi_JJ government_NN ,_, to_TO launch_VB a_DT digital_JJ identity_NN program_NN called_VBN ID2020.13_NN The_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP also_RB funded_VBD the_DT GSMA_NNP Inclusive_NNP Tech_NNP Lab_NNP ,_, launched_VBN in_IN 2019_CD ,_, the_DT aim_NN of_IN which_WDT is_VBZ to_TO promote_VB access_NN to_IN digital_JJ and_CC biometric_JJ identity_NN services_NNS and_CC systems_NNS ._. 14,15_CD ID2020_NN ,_, which_WDT also_RB launched_VBN in_IN 2019_CD ,_, is_VBZ designed_VBN to_TO “_`` leverage_VB immunization_NN as_IN an_DT opportunity_NN to_TO establish_VB digital_JJ identity_NN ._. ”_'' This_DT digital_JJ identity_NN system_NN is_VBZ said_VBN to_TO carry_VB “_`` far_RB -_HYPH reaching_VBG implications_NNS for_IN individuals_NNS ’_POS access_NN to_IN services_NNS and_CC livelihoods_NNS ,_, ”_'' so_RB to_TO think_VB that_IN Gates_NNPS ’_POS call_VB for_IN implantable_JJ COVID_NN -_HYPH 19_CD vaccine_NN certificates_NNS would_MD be_VB limited_VBN to_IN that_DT alone_RB would_MD again_RB be_VB a_DT grave_JJ mistake_NN ._. Like_IN The_DT Rockefeller_NNP Foundation_NNP ,_, Gates_NNP is_VBZ not_RB presenting_VBG short_JJ -_HYPH term_NN ,_, temporary_JJ measures_NNS ._. They_PRP ’re_VBP both_CC aiming_VBG to_TO implement_VB a_DT Worldwide_JJ control_NN system_NN ._. It_PRP ’s_VBZ not_RB so_RB far_RB -_HYPH fetched_VBN to_TO imagine_VB a_DT future_NN in_IN which_WDT your_PRP$ vaccine_NN certificate_NN or_CC “_`` unique_JJ patient_NN ID_NN number_NN ”_'' replaces_VBZ personal_JJ identifications_NNS such_JJ as_IN your_PRP$ driver_NN ’s_POS license_NN ,_, state_NN ID_NN card_NN ,_, Social_JJ Security_NN card_NN and_CC passport_NN ,_, and_CC is_VBZ tied_VBN not_RB only_RB to_IN your_PRP$ medical_JJ records_NNS in_IN total_NN ,_, but_CC also_RB your_PRP$ finances_NNS ._. I_PRP remain_VBP confident_JJ that_IN it_PRP would_MD be_VB a_DT tragic_JJ mistake_NN to_TO trust_VB Gates_NNPS ,_, Rockefeller_NNP ,_, Google_NNP or_CC any_DT of_IN the_DT other_JJ players_NNS that_WDT are_VBP being_VBG brought_VBN before_IN us_PRP as_IN the_DT saviors_NNS of_IN the_DT day_NN ._. While_IN most_JJS people_NNS are_VBP well_RB -_HYPH acquainted_VBN with_IN the_DT Rockefeller_NNP name_NN ,_, few_JJ probably_RB know_VBP the_DT true_JJ history_NN of_IN the_DT Rockefellers_NNPS ’_POS rise_NN to_IN power_NN ._. If_IN you_PRP fall_VBP in_IN this_DT category_NN ,_, be_VB sure_JJ to_TO read_VB “_`` How_WRB the_DT Oil_NN Industry_NN Conquered_VBN Medicine_NN ,_, Finance_NN and_CC Agriculture_NN ,_, ”_'' which_WDT features_VBZ an_DT excellent_JJ video_NN report_NN by_IN James_NNP Corbett_NNP ._. Those_DT who_WP are_VBP ignorant_JJ of_IN history_NN are_VBP bound_VBN to_TO repeat_VB it_PRP ,_, and_CC if_IN the_DT Rockefeller_NNP story_NN tells_VBZ us_PRP anything_NN ,_, it_PRP is_VBZ that_IN unless_IN we_PRP realize_VBP what_WP has_VBZ been_VBN done_VBN ,_, we_PRP ’ll_MD be_VB deceived_VBN again_RB and_CC again_RB ,_, because_IN the_DT oil_NN oligarchy_NN ’s_POS end_NN game_NN is_VBZ yet_RB to_TO be_VB realized_VBN —_: if_IN we_PRP let_VBP them_PRP ._. Note_VB to_IN readers_NNS :_: please_UH click_VB the_DT share_NN buttons_NNS above_RB or_CC below_RB ._. Forward_VB this_DT article_NN to_IN your_PRP$ email_NN lists_NNS ._. Crosspost_NNP on_IN your_PRP$ blog_NN site_NN ,_, internet_NN forums_NNS ._. etc_FW ._. 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 11_CD The_DT Rockefeller_NNP Foundation_NNP ,_, National_NNP COVID_NNP -_HYPH 19_CD Testing_NN Action_NN Plan_NN —_: Strategic_JJ Steps_NNS to_TO Reopen_VB Our_PRP$ Workplaces_NNS and_CC Our_PRP$ Communities_NNPS ,_, April_NNP 21_CD ,_, 2020_CD (_-LRB- PDF_NNP )_-RRB-","NNP NNP — who VBZ in the JJ NNS he VBZ JJ NNS to , and who VBZ a JJ JJ NN NN that VBZ the NNS he VBZ VBN in — VBZ VBN on NN VBG NN will RB VB RB to JJ until we VBP the NN to VB the JJ JJ NN against NN - 19.1 To that NN , he VBZ VBG for NN NN and a NN NN NN that might VB VBG NN NNS on our NNS . One NN of how this might VB VBN VBZ VBG an JJ NN NN NN NN , VBN in a NNP 18 , 2019 , NNP NNP NNP NN . 3, 4 VBG to NNS VBN by NNPS , JJ and JJ NN may RB VB to those who VBP NN , as the JJ NN NN NNPS VBZ VBG for might RB VB VBN to VB about your NN - to - NN NN and NN . Without this “ JJ NN NN , ” you may RB RB VB VBN to VB RB or VB JJ JJ NNS . NNPS VBZ a NN of “ VBG ” JJ NNS with JJ NNS of NNS , 5 and with his NN for a NN NN to VB NNS on JJ / JJ and VBN / JJ NNS , he VBZ VBG an RB JJ NN for the NN NNS he VBZ and VBZ NN from via his NNP NNS . Along with NNPS , The NNP NNP VBZ RB VBG NNS in the NN of JJ NN through the NN of JJ NN - 19 NN and NN NNS that VBP RB VBN to VB JJ . NNP 21 , 2020 , The NNP NNP VBD a JJ NN VBN , “ JJ NNP - 19 NN NN NN — JJ NNS to VB Our NNS and Our NNS . ” In the NN , NNP NNP NN NNP NNP NNP NNP VBZ : The NN VBZ for NN and VBG 1 million NNPS per NN to VB , RB VBG it up to 3 million and RB 30 million per NN ( the “ 1 - 3 - 30 NN ” ) over the JJ six NNS until the JJ NN VBZ VBN VBN . NN NNS would RB VB VBN on a JJ NN JJ of VBG all VBN NNS so that NN - NN can VB VBN when NN VBZ JJ . VBG to the “ JJ NNP - 19 NN NN NN ” : To this NN , they VBP VBG NNS “ to VB the JJ NN ” of NN and NN NN NNS RB than VBG them JJ . They RB VBP for the NN of “ JJ JJ NNS ” VBN at VBG “ NN NN and JJ NN of JJ NNS . ” VBG to the “ JJ NNP - 19 NN NN NN ” : 8 VB me JJ , but this VBZ like a NN to VB NNPS so that they can RB VB VBN down for JJ NN once a NN - 19 NN VBZ JJ . It RB VBZ the JJ NN for NN NN across the NN , for all NNS . While they VBP NN - NN to NN and NN of NNS , NN NNS VBP VBN RB VBN in the NN . RB , the NN RB VBZ that : 9 VBP You JJ to VB Up NN Over a NN ? “ NN NNS must VB VBN aside . ” NN NN must VB “ VBN and VBN in a JJ VBN NNS . ” NN NN will VB VBN to NNS , NN NNS , NNS of NN , NNS , NN and NN NNS — in JJ NNS , JJS NNS NNS VBP or VBP to VB , if RB RB , RB at JJS RB . NN NN must VB VBN “ for NNS to VB in JJ NNS . ” NN must VB VBN to VB NNS from VBG VBN from their NNS VBN on their NN NN . VBP you JJ RB ? NN who VBZ the NNS VBN in NNP NNP , or NN JJ with the JJ NN of the JJ NN , will VB where this VBZ VBN . VBG through the NN , it should RB VB RB JJ that this NN and NN NN VBZ RB VBN to VB JJ . You can VB RB VBN this will VB JJ . It VBZ for NNS of NNS of JJ NNS , VBG NN NNS and JJ NNS that in JJ NNS VBP the NN of NN NN - 9/11 . RB VBN in this NN VBZ the NN of RB how RB would you VB to VB NN . A JJ NN NN may RB VB JJ NN , if you VBP to VB across NN who VBZ VBN between RB and RB . Would you VB to VB NN every JJ NN ? RB a NN ? If JJ NN VBZ RB NN of the NN , RB the JJ NN VBZ JJ as your NN NN could VB at any NN . JJ NNS RB VBN : If you VBP to VB in the NN of NN who VBZ JJ in the JJ NN , would you VB to VB for two NNS ? Will your NN VB for that NN off ? Will you VB a NN when you VBP out of NN ? What if you VBP for two NNS but VB RB VB JJ and VB JJ for NNS , RB VB RB and VB across RB another NN who VBZ up VBG JJ RB RB . Will you VB VBN into NN RB ? Where VBZ it VB ? The NN NN The NNP NNP VBZ VBG for VBZ RB JJ to that RB VBG VBN in NNP , where NNS VBP VBN to VB in a NN NN NN . Once VBN , they VBP a JJ NN NN , which they must RB VB in NN to VB NN to NN NNS and JJ NNS . 10 The NN RB VBZ NN to JJ JJ NNS . VBG to the “ JJ NNP - 19 NN NN NN ” :11 In JJ NNS , this NN VBZ RB RBR JJ than RB VBG NN - 19 NNS . It VBZ VBN to VB the JJ NN of “ JJ and RB RB VBN JJ JJ NNS NNS across the NN . ” While The NNP NNP ’s JJ NN RB VBZ for the NN of a JJ “ NN NN NN ” without VBG RB how you would VB this NN NN on your NN , NNPS VBZ RB VBN about the “ NN ” for some NN of JJ NN NN . In 1999 , The NNP & NNP NNP NNP VBD $ 750 million to VB up NNP , The NNP NNP . 12 NNP , in NN , VBZ VBN with the NNP NNP , along with the JJ NN , to VB a JJ NN NN VBN NN The NNP & NNP NNP NNP RB VBD the NNP NNP NNP NNP , VBN in 2019 , the NN of which VBZ to VB NN to JJ and JJ NN NNS and NNS . 14,15 NN , which RB VBN in 2019 , VBZ VBN to “ VB NN as an NN to VB JJ NN . ” This JJ NN NN VBZ VBN to VB “ RB - VBG NNS for NNS ’ NN to NNS and NNS , ” RB to VB that NNPS ’ VB for JJ NN - 19 NN NNS would VB VBN to that RB would RB VB a JJ NN . Like The NNP NNP , NNP VBZ RB VBG JJ - NN , JJ NNS . They VBP both VBG to VB a JJ NN NN . It VBZ RB RB RB - VBN to VB a NN in which your NN NN or “ JJ NN NN NN ” VBZ JJ NNS JJ as your NN ’s NN , NN NN NN , JJ NN NN and NN , and VBZ VBN RB RB to your JJ NNS in NN , but RB your NNS . I VBP JJ that it would VB a JJ NN to VB NNPS , NNP , NNP or any of the JJ NNS that VBP VBG VBN before us as the NNS of the NN . While JJS NNS VBP RB - VBN with the NNP NN , JJ RB VBP the JJ NN of the NNPS ’ NN to NN . If you VBP in this NN , VB JJ to VB “ How the NN NN VBN NN , NN and NN , ” which VBZ an JJ NN NN by NNP NNP . Those who VBP JJ of NN VBP VBN to VB it , and if the NNP NN VBZ us NN , it VBZ that unless we VBP what VBZ VBN VBN , we ’ll VB VBN RB and RB , because the NN NN ’s NN NN VBZ RB to VB VBN — if we VBP them . VB to NNS : please VB the NN NNS RB or RB . VB this NN to your NN NNS . NNP on your NN NN , NN NNS . FW . 6 , 7 , 8 , 9 , 11 The NNP NNP , NNP NNP - 19 NN NN NN — JJ NNS to VB Our NNS and Our NNPS , NNP 21 , 2020 ( NNP )"
103,558,conspiracy,"Financial_JJ writer_NN and_CC precious_JJ metals_NNS expert_NN Bill_NNP Holter_NNP says_VBZ forget_VB about_IN the_DT relatively_RB small_JJ sell_NN -_HYPH off_RP in_IN the_DT gold_NN and_CC silver_NN markets_NNS ._. The_DT big_JJ worry_NN shaking_VBG the_DT markets_NNS is_VBZ an_DT enormous_JJ global_JJ credit_NN problem_NN ._. Holter_NNP explains_VBZ ,_, “_`` Your_PRP$ protection_NN about_IN the_DT credit_NN market_NN coming_VBG down_RP is_VBZ asset_NN money_NN ,_, if_IN you_PRP want_VBP to_TO call_VB it_PRP that_DT ._. Gold_NN and_CC silver_NN have_VBP no_DT liability_NN ._. They_PRP are_VBP not_RB issued_VBN by_IN a_DT central_JJ bank_NN ,_, and_CC there_EX is_VBZ no_DT promise_NN that_WDT has_VBZ to_TO be_VB kept_VBN for_IN it_PRP to_TO perform_VB ._. ._. ._. ._. Dollars_NNS ,_, euros_NNS ,_, bonds_NNS or_CC what_WP have_VBP you_PRP ,_, those_DT are_VBP all_DT liabilities_NNS of_IN a_DT central_JJ bank_NN or_CC sovereign_JJ treasury_NN ._. They_PRP all_DT carry_VBP liability_NN ,_, and_CC that_DT ’s_VBZ what_WP the_DT problem_NN is_VBZ in_IN today_NN ’s_POS world_NN ._. It_PRP ’s_VBZ a_DT world_NN completely_RB awash_JJ in_IN liability_NN ._. ._. ._. ._. I_PRP think_VBP ,_, ultimately_RB ,_, you_PRP are_VBP going_VBG to_TO see_VB a_DT credit_NN meltdown_NN ._. ”_'' Holter_NNP points_VBZ out_RP the_DT U.S._NNP government_NN “_`` Plunge_NNP Protection_NNP Team_NNP ”_'' is_VBZ not_RB only_RB trying_VBG to_TO prop_VB up_RP the_DT stock_NN market_NN ,_, but_CC also_RB is_VBZ suppressing_VBG gold_NN and_CC silver_NN prices_NNS ._. Holter_NNP says_VBZ ,_, “_`` Friday_NNP ’s_POS hit_VBN in_IN the_DT gold_NN market_NN (_-LRB- down_IN $_$ 60_CD per_IN ounce_NN )_-RRB- is_VBZ obviously_RB an_DT ‘_`` official_JJ ’_'' movement_NN because_IN they_PRP do_VBP n’t_RB want_VB people_NNS getting_VBG the_DT idea_NN that_IN your_PRP$ safe_JJ haven_NN is_VBZ physical_JJ gold_NN and_CC silver_NN ._. In_IN other_JJ words_NNS ,_, they_PRP tried_VBD to_TO steer_VB investment_NN away_RB from_IN gold_NN and_CC silver_NN by_IN smashing_VBG it_PRP with_IN paper_NN contracts_NNS ._. ”_'' Holter_NNP ,_, who_WP has_VBZ two_CD decades_NNS of_IN brokerage_NN and_CC equity_NN experience_NN ,_, also_RB points_VBZ out_RP ,_, “_`` This_DT coming_VBG week_NN and_CC the_DT weeks_NNS going_VBG forward_RB ,_, I_PRP am_VBP sure_JJ there_EX are_VBP all_DT kinds_NNS of_IN margin_NN calls_NNS that_WDT will_MD be_VB forced_VBN selling_VBG ._. ._. ._. ._. So_RB ,_, this_DT thing_NN could_MD become_VB a_DT self_NN -_HYPH perpetuating_VBG spiral_NN (_-LRB- down_RB )_-RRB- ._. ”_'' What_WP about_IN the_DT Fed_NN riding_VBG to_IN the_DT rescue_NN again_RB like_IN in_IN 2008_CD -_SYM 2009_CD ?_. Holter_NNP says_VBZ ,_, “_`` Zero_CD percent_NN is_VBZ very_RB close_JJ to_IN where_WRB we_PRP are_VBP right_RB now_RB ._. The_DT Fed_NNP does_VBZ not_RB have_VB the_DT leeway_NN they_PRP had_VBD back_RB in_IN 2008_CD -_SYM 2009_CD ._. They_PRP were_VBD lucky_JJ then_RB to_TO get_VB away_RB with_IN it_PRP ._. The_DT markets_NNS are_VBP going_VBG to_TO call_VB their_PRP$ bluff_NN ._. That_DT ’s_VBZ pretty_RB much_RB what_WP has_VBZ happened_VBN already_RB ._. ”_'' Is_VBZ there_EX no_DT bottom_NN in_IN the_DT stock_NN market_NN here_RB ?_. Holter_NNP says_VBZ ,_, “_`` Basically_RB ,_, that_DT ’s_VBZ correct_JJ ._. ._. ._. ._. A_DT cliff_NN dive_NN into_IN a_DT pool_NN with_IN two_CD inches_NNS of_IN water_NN is_VBZ a_DT good_JJ analogy_NN ._. ._. ._. ._. The_DT global_JJ yield_NN curve_NN is_VBZ fully_RB inverted_VBN ._. ._. ._. ._. We_PRP have_VBP never_RB had_VBN an_DT inverted_VBN yield_NN curve_NN (_-LRB- short_JJ interest_NN rates_NNS higher_JJR than_IN long_JJ interest_NN rates_NNS )_-RRB- that_WDT has_VBZ not_RB been_VBN followed_VBN by_IN a_DT recession_NN ._. It_PRP ’s_VBZ going_VBG to_TO be_VB inflate_VBN or_CC die_VB ._. If_IN they_PRP do_VBP n’t_RB inflate_VB ,_, the_DT system_NN will_MD implode_VB upon_IN itself_PRP ._. ”_'' Holter_NNP predicts_VBZ ,_, “_`` I_PRP think_VBP in_IN a_DT short_JJ period_NN of_IN time_NN you_PRP are_VBP going_VBG to_TO see_VB swings_NNS of_IN $_$ 200_CD to_IN $_$ 300_CD per_IN ounce_NN in_IN gold_NN and_CC $_$ 5_CD to_IN $_$ 10_CD per_IN ounce_NN swings_NNS in_IN silver_NN ._. From_IN the_DT standpoint_NN of_IN so_RB much_JJ paper_NN being_VBG sold_VBN compared_VBN to_IN real_JJ physical_JJ metal_NN ,_, there_EX is_VBZ going_VBG to_TO be_VB a_DT cash_NN call_NN ._. This_DT will_MD expose_VB the_DT fact_NN that_IN there_EX are_VBP 300_CD or_CC 400_CD paper_NN ounces_NNS for_IN every_DT one_CD real_JJ ounce_NN that_WDT exists_VBZ ._. ”_'' On_IN top_NN of_IN that_DT ,_, with_IN China_NNP bailing_VBG out_RP everything_NN in_IN China_NNP ,_, it_PRP may_MD have_VB to_TO back_VB its_PRP$ currency_NN to_TO keep_VB the_DT yuan_NNP from_IN hyper_NN -_HYPH inflating_VBG away_RB ._. If_IN that_DT happens_VBZ ,_, Holter_NNP says_VBZ ,_, “_`` Gold_NN will_MD have_VB to_TO be_VB substantially_RB higher_JJR to_TO do_VB that_DT ._. ”_'' In_IN closing_NN ,_, Holter_NNP says_VBZ ,_, “_`` Cash_NN generation_NN is_VBZ slowing_VBG ,_, and_CC that_DT is_VBZ going_VBG to_TO be_VB a_DT problem_NN with_IN servicing_VBG the_DT existing_VBG debt_NN ._. There_EX is_VBZ so_RB much_JJ debt_NN that_IN it_PRP ca_MD n’t_RB be_VB paid_VBN off_RP ._. That_DT is_VBZ the_DT problem_NN ._. ._. ._. ._. I_PRP have_VBP said_VBN this_DT many_JJ times_NNS ,_, once_IN the_DT credit_NN markets_NNS break_VBP ,_, distribution_NN will_MD not_RB happen_VB and_CC then_RB it_PRP is_VBZ credit_NN game_NN over_RB ._. ”_'' Join_VB Greg_NNP Hunter_NNP of_IN USAWatchdog.com_NNP as_IN he_PRP goes_VBZ One_CD -_HYPH on_IN -_HYPH One_CD with_IN Bill_NNP Holter_NNP of_IN JSMineset.com_NNP ._. There_EX is_VBZ much_JJ free_JJ information_NN and_CC analysis_NN on_IN JSMineset.com_NNP ._. If_IN you_PRP want_VBP to_TO become_VB a_DT subscriber_NN to_IN cutting_VBG edge_NN original_JJ analysis_NN and_CC articles_NNS click_VB here_RB ._. This_DT segment_NN is_VBZ sponsored_VBN by_IN Discount_NNP Gold_NNP and_CC Silver_NNP Trading_NNP ._. Ask_VB for_IN Melody_NNP Cedarstrom_NNP ,_, the_DT owner_NN ,_, at_IN 1-800-375-4188_CD ._.","JJ NN and JJ NNS NN NNP NNP VBZ VB about the RB JJ NN - off in the NN and NN NNS . The JJ NN VBG the NNS VBZ an JJ JJ NN NN . NNP VBZ , “ Your NN about the NN NN VBG down VBZ NN NN , if you VBP to VB it that . NN and NN VBP no NN . They VBP RB VBN by a JJ NN , and there VBZ no NN that VBZ to VB VBN for it to VB . . . . NNS , NNS , NNS or what VBP you , those VBP all NNS of a JJ NN or JJ NN . They all VBP NN , and that VBZ what the NN VBZ in NN ’s NN . It VBZ a NN RB JJ in NN . . . . I VBP , RB , you VBP VBG to VB a NN NN . ” NNP VBZ out the NNP NN “ NNP NNP NNP ” VBZ RB RB VBG to VB up the NN NN , but RB VBZ VBG NN and NN NNS . NNP VBZ , “ NNP ’s VBN in the NN NN ( down $ 60 per NN ) VBZ RB an ‘ JJ ’ NN because they VBP RB VB NNS VBG the NN that your JJ NN VBZ JJ NN and NN . In JJ NNS , they VBD to VB NN RB from NN and NN by VBG it with NN NNS . ” NNP , who VBZ two NNS of NN and NN NN , RB VBZ out , “ This VBG NN and the NNS VBG RB , I VBP JJ there VBP all NNS of NN NNS that will VB VBN VBG . . . . RB , this NN could VB a NN - VBG NN ( RB ) . ” What about the NN VBG to the NN RB like in 2008 - 2009 ? NNP VBZ , “ Zero NN VBZ RB JJ to where we VBP RB RB . The NNP VBZ RB VB the NN they VBD RB in 2008 - 2009 . They VBD JJ RB to VB RB with it . The NNS VBP VBG to VB their NN . That VBZ RB RB what VBZ VBN RB . ” VBZ there no NN in the NN NN RB ? NNP VBZ , “ RB , that VBZ JJ . . . . A NN NN into a NN with two NNS of NN VBZ a JJ NN . . . . The JJ NN NN VBZ RB VBN . . . . We VBP RB VBN an VBN NN NN ( JJ NN NNS JJR than JJ NN NNS ) that VBZ RB VBN VBN by a NN . It VBZ VBG to VB VBN or VB . If they VBP RB VB , the NN will VB upon itself . ” NNP VBZ , “ I VBP in a JJ NN of NN you VBP VBG to VB NNS of $ 200 to $ 300 per NN in NN and $ 5 to $ 10 per NN NNS in NN . From the NN of RB JJ NN VBG VBN VBN to JJ JJ NN , there VBZ VBG to VB a NN NN . This will VB the NN that there VBP 300 or 400 NN NNS for every one JJ NN that VBZ . ” On NN of that , with NNP VBG out NN in NNP , it may VB to VB its NN to VB the NNP from NN - VBG RB . If that VBZ , NNP VBZ , “ NN will VB to VB RB JJR to VB that . ” In NN , NNP VBZ , “ NN NN VBZ VBG , and that VBZ VBG to VB a NN with VBG the VBG NN . There VBZ RB JJ NN that it ca RB VB VBN off . That VBZ the NN . . . . I VBP VBN this JJ NNS , once the NN NNS VBP , NN will RB VB and RB it VBZ NN NN RB . ” VB NNP NNP of NNP as he VBZ One - on - One with NNP NNP of NNP . There VBZ JJ JJ NN and NN on NNP . If you VBP to VB a NN to VBG NN JJ NN and NNS VB RB . This NN VBZ VBN by NNP NNP and NNP NNP . VB for NNP NNP , the NN , at 1-800-375-4188 ."
104,238,mainstream,"Gavi_NNP ,_, the_DT Vaccine_NNP Alliance_NNP is_VBZ seeking_VBG funds_NNS to_TO extend_VB its_PRP$ early_JJ childhood_NN vaccine_NN program_NN in_IN developing_VBG countries_NNS ._. Gavi's_NNP CEO_NN says_VBZ he_PRP 's_VBZ confident_JJ the_DT organization_NN 's_POS $_$ 7.5_CD billion_CD goal_NN can_MD be_VB reached_VBN ._. Even_RB as_IN the_DT organization_NN works_VBZ to_TO increase_VB vaccinations_NNS around_IN the_DT world_NN ,_, in_IN the_DT U.S._NNP ,_, some_DT parents_NNS are_VBP rejecting_VBG vaccines_NNS for_IN their_PRP$ children_NNS ._. One_CD result_NN is_VBZ a_DT measles_NN outbreak_NN that_WDT started_VBD in_IN southern_JJ California_NNP ._. So_RB far_RB ,_, 68_CD people_NNS ,_, including_VBG young_JJ children_NNS ,_, have_VBP gotten_VBN measles_NNS ._. It_PRP started_VBD in_IN Disneyland_NNP ,_, often_RB portrayed_VBN as_IN the_DT ""_`` happiest_JJS place_NN on_IN earth_NN ._. ""_'' Since_IN January_NNP 1_CD it's_PRP also_RB been_VBN known_VBN as_IN ground_NN zero_CD of_IN a_DT measles_NN outbreak_NN in_IN the_DT U.S._NNP that_WDT may_MD have_VB far_RB -_HYPH reaching_VBG consequences_NNS ._. Measles_NN is_VBZ highly_RB contagious_JJ ._. It_PRP can_MD rob_VB a_DT child_NN of_IN hearing_NN ,_, vision_NN ,_, intellect_NN and_CC even_RB life_NN ._. Yet_CC a_DT significant_JJ number_NN of_IN American_JJ parents_NNS -_, including_VBG many_JJ in_IN California_NNP -_, are_VBP choosing_VBG not_RB to_TO vaccinate_VB their_PRP$ children_NNS ._. They_PRP cite_VBP concerns_NNS about_IN side_NN effects_NNS ,_, including_VBG autism_NN ._. But_CC there_EX is_VBZ no_DT link_NN between_IN autism_NN and_CC the_DT vaccine_NN ,_, say_VB specialists_NNS like_IN Dr._NNP Martha_NNP Rivera_NNP ._. ""_`` There_EX 's_VBZ no_DT risk_NN of_IN autism_NN -_, that_DT was_VBD disproven_VBN .._, .._, all_PDT the_DT fear_NN factors_NNS have_VBP been_VBN taken_VBN away_RB ,_, ""_'' she_PRP said_VBD ._. Some_DT of_IN the_DT world_NN 's_POS top_JJ infectious_JJ disease_NN experts_NNS say_VBP vaccines_NNS are_VBP not_RB only_RB medically_RB effective_JJ ,_, they_PRP are_VBP cost_NN -_HYPH effective_JJ ,_, eliminating_VBG the_DT financial_JJ burden_NN of_IN treating_VBG preventable_JJ diseases_NNS ._. Dr._NNP Anthony_NNP Fauci_NNP addressed_VBD the_DT issue_NN in_IN an_DT earlier_JJR interview_NN with_IN VOA_NNP ._. ""_`` If_IN you_PRP had_VBD to_TO pick_VB out_RP one_CD intervention_NN ,_, if_IN you_PRP balance_VBP the_DT investment_NN that_WDT you_PRP make_VBP in_IN the_DT research_NN and_CC the_DT implementation_NN and_CC the_DT health_NN benefits_NNS ,_, vaccines_NNS have_VBP to_TO be_VB at_IN either_CC the_DT top_NN of_IN the_DT list_NN or_CC very_RB much_RB on_IN the_DT short_JJ list_NN ,_, ""_'' he_PRP said_VBD ._. ""_`` Vaccines_NNS are_VBP among_IN the_DT most_RBS effective_JJ and_CC cost_NN -_HYPH effective_JJ interventions_NNS that_WDT exist_VBP ,_, ""_'' he_PRP said_VBD ._. In_IN Somalia_NNP ,_, vaccination_NN programs_NNS are_VBP a_DT cause_NN for_IN celebration_NN ._. Since_IN it_PRP was_VBD founded_VBN 15_CD years_NNS ago_RB ,_, Gavi_NNP estimates_VBZ it_PRP has_VBZ immunized_VBN more_JJR than_IN 500_CD million_CD children_NNS and_CC ,_, as_IN a_DT result_NN ,_, saved_VBD more_JJR than_IN six_CD million_CD young_JJ lives_NNS around_IN the_DT world_NN ._. Gavi_NNP is_VBZ looking_VBG to_TO immunize_VB more_JJR than_IN 300_CD million_CD children_NNS in_IN the_DT next_JJ few_JJ years_NNS ._. Meanwhile_RB ,_, in_IN the_DT U.S._NNP ,_, experts_NNS say_VBP childhood_NN diseases_NNS have_VBP become_VBN rare_JJ because_IN vaccines_NNS are_VBP so_RB effective_JJ ._. In_IN this_DT sense_NN ,_, vaccines_NNS are_VBP a_DT victim_NN of_IN their_PRP$ own_JJ success_NN ._.","NNP , the NNP NNP VBZ VBG NNS to VB its JJ NN NN NN in VBG NNS . NNP NN VBZ he VBZ JJ the NN 's $ 7.5 billion NN can VB VBN . RB as the NN VBZ to VB NNS around the NN , in the NNP , some NNS VBP VBG NNS for their NNS . One NN VBZ a NN NN that VBD in JJ NNP . RB RB , 68 NNS , VBG JJ NNS , VBP VBN NNS . It VBD in NNP , RB VBN as the "" JJS NN on NN . "" Since NNP 1 it's RB VBN VBN as NN zero of a NN NN in the NNP that may VB RB - VBG NNS . NN VBZ RB JJ . It can VB a NN of NN , NN , NN and RB NN . Yet a JJ NN of JJ NNS - VBG JJ in NNP - VBP VBG RB to VB their NNS . They VBP NNS about NN NNS , VBG NN . But there VBZ no NN between NN and the NN , VB NNS like NNP NNP NNP . "" There VBZ no NN of NN - that VBD VBN .. .. all the NN NNS VBP VBN VBN RB , "" she VBD . Some of the NN 's JJ JJ NN NNS VBP NNS VBP RB RB RB JJ , they VBP NN - JJ , VBG the JJ NN of VBG JJ NNS . NNP NNP NNP VBD the NN in an JJR NN with NNP . "" If you VBD to VB out one NN , if you VBP the NN that you VBP in the NN and the NN and the NN NNS , NNS VBP to VB at either the NN of the NN or RB RB on the JJ NN , "" he VBD . "" NNS VBP among the RBS JJ and NN - JJ NNS that VBP , "" he VBD . In NNP , NN NNS VBP a NN for NN . Since it VBD VBN 15 NNS RB , NNP VBZ it VBZ VBN JJR than 500 million NNS and , as a NN , VBD JJR than six million JJ NNS around the NN . NNP VBZ VBG to VB JJR than 300 million NNS in the JJ JJ NNS . RB , in the NNP , NNS VBP NN NNS VBP VBN JJ because NNS VBP RB JJ . In this NN , NNS VBP a NN of their JJ NN ."
105,1162,mainstream,"Engineers_NNS at_IN Sinovac_NNP Biotech_NNP in_IN Beijing_NNP have_VBP been_VBN working_VBG on_IN an_DT experimental_JJ coronavirus_NN vaccine_NN (_-LRB- enlarged_VBN monkey_NN kidney_NN cells_NNS being_VBG used_VBN in_IN tests_NNS are_VBP seen_VBN here_RB )_-RRB- --_, and_CC that_IN vaccine_NN will_MD be_VB produced_VBN in_IN Brazil_NNP ,_, officials_NNS say_VBP Brazilian_JJ officials_NNS on_IN Thursday_NNP announced_VBD an_DT agreement_NN with_IN China_NNP 's_POS Sinovac_NNP Biotech_NNP to_TO produce_VB its_PRP$ coronavirus_NN vaccine_NN in_IN the_DT state_NN of_IN Sao_NNP Paulo_NNP ,_, where_WRB tests_NNS involving_VBG 9,000_CD volunteers_NNS are_VBP to_TO begin_VB next_JJ month_NN ._. Brazil_NNP has_VBZ the_DT world_NN 's_POS second_RB -_HYPH highest_JJS coronavirus_NN caseload_NN after_IN the_DT United_NNP States_NNPS ,_, with_IN more_JJR than_IN 770,000_CD confirmed_VBN infections_NNS and_CC nearly_RB 40,000_CD deaths_NNS ._. Sao_NNP Paulo_NNP governor_NN Joao_NNP Doria_NNP told_VBD a_DT news_NN conference_NN that_IN the_DT Butantan_NNP Institute_NNP ,_, Brazil_NNP 's_POS leading_VBG research_NN center_NN ,_, had_VBD reached_VBN a_DT technology_NN transfer_NN agreement_NN with_IN Sinovac_NNP Biotech_NNP ._. ""_`` The_DT studies_NNS show_VBP that_IN the_DT vaccine_NN could_MD be_VB distributed_VBN by_IN June_NNP 2021_CD ,_, ""_'' if_IN tests_NNS prove_VBP conclusive_JJ ,_, Doria_NNP said_VBD ._. ""_`` This_DT agreement_NN would_MD allow_VB us_PRP to_TO produce_VB at_IN large_JJ scale_NN and_CC immunize_VB millions_NNS of_IN Brazilians_NNPS ._. ""_'' Sinovac_NNP Biotech_NNP ,_, one_CD of_IN four_CD Chinese_JJ laboratories_NNS authorized_VBN to_TO conduct_VB clinical_JJ vaccine_NN trials_NNS ,_, said_VBD a_DT month_NN ago_RB that_IN it_PRP was_VBD prepared_VBN to_TO produce_VB 100_CD million_CD doses_NNS of_IN the_DT vaccine_NN under_IN the_DT commercial_JJ name_NN Coronavac_NNP ._. In_IN Sao_NNP Paulo_NNP ,_, 9,000_CD volunteers_NNS will_MD be_VB injected_VBN with_IN doses_NNS of_IN that_DT vaccine_NN beginning_VBG in_IN mid-July_NNP ,_, in_IN the_DT third_JJ and_CC final_JJ phase_NN of_IN testing_NN ._. Last_JJ week_NN ,_, Sao_NNP Paulo_NNP State_NNP University_NNP announced_VBD that_IN a_DT vaccine_NN being_VBG developed_VBN by_IN the_DT University_NNP of_IN Oxford_NNP will_MD be_VB tested_VBN among_IN 2,000_CD Brazilian_JJ volunteers_NNS beginning_VBG in_IN mid-June_NNP ._. Doria_NNP used_VBD the_DT unveiling_NN of_IN the_DT Sinovac_NNP Biotech_NNP deal_NN ,_, which_WDT he_PRP described_VBD as_IN ""_`` historic_JJ ,_, ""_'' to_TO criticize_VB President_NNP Jair_NNP Bolsonaro_NNP ._. ""_`` We_PRP have_VBP had_VBN to_TO overcome_VB Brazil_NNP 's_POS disagreements_NNS with_IN China_NNP ,_, with_IN other_JJ countries_NNS and_CC with_IN organizations_NNS like_IN the_DT WHO_NNP ,_, ""_'' he_PRP said_VBD ,_, referring_VBG to_IN criticism_NN of_IN China_NNP by_IN several_JJ of_IN Bolsonaro_NNP 's_POS cabinet_NN ministers_NNS ._. In_IN March_NNP ,_, one_CD of_IN the_DT president_NN 's_POS sons_NNS accused_VBD the_DT Chinese_JJ ""_`` dictatorship_NN ""_'' of_IN hiding_VBG what_WP it_PRP knew_VBD about_IN the_DT coronavirus_NN ,_, prompting_VBG Beijing_NNP to_TO demand_VB an_DT apology_NN ._. Bolsonaro_NNP in_IN recent_JJ days_NNS has_VBZ also_RB threatened_VBN to_TO withdraw_VB Brazil_NNP from_IN the_DT World_NNP Health_NNP Organization_NNP --_, as_IN the_DT United_NNP States_NNPS did_VBD last_JJ month_NN --_, accusing_VBG it_PRP of_IN ""_`` ideological_JJ bias_NN ._. ""_'' Alluding_VBG to_IN the_DT controversy_NN ,_, Doria_NNP said_VBD ,_, ""_`` The_DT politicization_NN of_IN disease_NN has_VBZ never_RB saved_VBN a_DT life_NN ,_, to_IN the_DT contrary_NN ._. ""_'' Since_IN the_DT onset_NN of_IN the_DT pandemic_NN ,_, Bolsonaro_NNP has_VBZ clashed_VBN with_IN state_NN governors_NNS over_IN stay_NN -_HYPH at_IN -_HYPH home_NN measures_NNS that_WDT they_PRP 've_VBP adopted_VBN to_TO prevent_VB the_DT spread_NN of_IN the_DT virus_NN ._. He_PRP has_VBZ continued_VBN to_TO press_VB for_IN a_DT resumption_NN of_IN economic_JJ activities_NNS even_RB though_IN infections_NNS continue_VBP to_TO rise_VB ._.","NNS at NNP NNP in NNP VBP VBN VBG on an JJ NN NN ( VBN NN NN NNS VBG VBN in NNS VBP VBN RB ) -- and that NN will VB VBN in NNP , NNS VBP JJ NNS on NNP VBD an NN with NNP 's NNP NNP to VB its NN NN in the NN of NNP NNP , where NNS VBG 9,000 NNS VBP to VB JJ NN . NNP VBZ the NN 's RB - JJS NN NN after the NNP NNPS , with JJR than 770,000 VBN NNS and RB 40,000 NNS . NNP NNP NN NNP NNP VBD a NN NN that the NNP NNP , NNP 's VBG NN NN , VBD VBN a NN NN NN with NNP NNP . "" The NNS VBP that the NN could VB VBN by NNP 2021 , "" if NNS VBP JJ , NNP VBD . "" This NN would VB us to VB at JJ NN and VB NNS of NNPS . "" NNP NNP , one of four JJ NNS VBN to VB JJ NN NNS , VBD a NN RB that it VBD VBN to VB 100 million NNS of the NN under the JJ NN NNP . In NNP NNP , 9,000 NNS will VB VBN with NNS of that NN VBG in NNP , in the JJ and JJ NN of NN . JJ NN , NNP NNP NNP NNP VBD that a NN VBG VBN by the NNP of NNP will VB VBN among 2,000 JJ NNS VBG in NNP . NNP VBD the NN of the NNP NNP NN , which he VBD as "" JJ , "" to VB NNP NNP NNP . "" We VBP VBN to VB NNP 's NNS with NNP , with JJ NNS and with NNS like the NNP , "" he VBD , VBG to NN of NNP by JJ of NNP 's NN NNS . In NNP , one of the NN 's NNS VBD the JJ "" NN "" of VBG what it VBD about the NN , VBG NNP to VB an NN . NNP in JJ NNS VBZ RB VBN to VB NNP from the NNP NNP NNP -- as the NNP NNPS VBD JJ NN -- VBG it of "" JJ NN . "" VBG to the NN , NNP VBD , "" The NN of NN VBZ RB VBN a NN , to the NN . "" Since the NN of the NN , NNP VBZ VBN with NN NNS over NN - at - NN NNS that they VBP VBN to VB the NN of the NN . He VBZ VBN to VB for a NN of JJ NNS RB though NNS VBP to VB ."
106,154,conspiracy,"The_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS is_VBZ seeking_VBG to_TO create_VB a_DT vaccine_NN that_WDT ,_, theoretically_RB ,_, would_MD protect_VB people_NNS from_IN most_JJS flu_NN strains_NNS with_IN a_DT single_JJ shot_NN of_IN a_DT universal_JJ vaccine_NN ._. Senator_NNP Ed_NNP Markey_NNP introduced_VBD a_DT bill_NN that_WDT would_MD funnel_VB no_RB less_JJR than_IN a_DT billion_CD tax_NN dollars_NNS toward_IN the_DT project_NN ._. The_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS researchers_NNS are_VBP working_VBG on_IN a_DT DNA_NN vaccine_NN that_WDT ,_, instead_RB of_IN injecting_VBG a_DT piece_NN of_IN virus_NN into_IN a_DT person_NN to_TO stimulate_VB an_DT immune_JJ response_NN ,_, would_MD inject_VB synthesized_VBN genes_NNS ._. [_-LRB- No_RB matter_RB what_WP the_DT promoters_NNS (_-LRB- who_WP will_MD be_VB given_VBN the_DT money_NN )_-RRB- say_VB ,_, if_IN genes_NNS are_VBP edited_VBN ,_, deleted_VBN ,_, or_CC added_VBN ,_, there_EX inevitably_RB will_MD be_VB unintended_JJ consequences_NNS ._. These_DT unintended_JJ traits_NNS can_MD never_RB be_VB removed_VBN from_IN the_DT human_JJ gene_NN pool_NN ._. Once_IN monsters_NNS are_VBP created_VBN –_: even_RB accidentally_RB –_: they_PRP will_MD be_VB with_IN us_PRP forever_RB ._. ]_-RRB- -_NFP GEG_NNP Children_NNS ’s_POS Health_NNP Defense_NNP Note_NNP :_: CHD_NNP has_VBZ internal_JJ documents_NNS in_IN which_WDT the_DT FDA_NNP acknowledges_VBZ that_IN technology_NN that_WDT allows_VBZ for_IN the_DT creation_NN of_IN these_DT new_JJ vaccines_NNS has_VBZ outpaced_VBN their_PRP$ ability_NN to_TO predict_VB adverse_JJ events_NNS ._. Should_MD n’t_RB our_PRP$ federal_JJ agencies_NNS be_VB calling_VBG for_IN a_DT moratorium_NN until_IN we_PRP have_VBP that_DT knowledge_NN —_: especially_RB since_IN it_PRP is_VBZ heavily_RB reported_VBN that_IN the_DT CDC_NNP /_, FDA_NNP post_NN -_HYPH marketing_NN surveillance_NN systems_NNS are_VBP inadequate_JJ to_TO pick_VB up_RP problems_NNS after_IN licensure_NN ?_. The_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS (_-LRB- NIAID_NNP )_-RRB- has_VBZ launched_VBN efforts_NNS to_TO create_VB a_DT vaccine_NN that_WDT would_MD protect_VB people_NNS from_IN most_JJS flu_NN strains_NNS ,_, all_RB at_IN once_RB ,_, with_IN a_DT single_JJ shot_NN ._. Over_IN the_DT years_NNS ,_, I_PRP ’ve_VBP written_VBN many_JJ articles_NNS refuting_VBG claims_NNS that_IN vaccines_NNS are_VBP safe_JJ and_CC effective_JJ ,_, but_CC we_PRP ’ll_MD put_VB all_PDT that_DT aside_RB for_IN the_DT moment_NN and_CC follow_VB the_DT bouncing_NN ball_NN ._. Massachusetts_NNP Senator_NNP and_CC big_JJ spender_NN ,_, Ed_NNP Markey_NNP ,_, has_VBZ introduced_VBN a_DT bill_NN that_WDT would_MD shovel_VB no_RB less_JJR than_IN a_DT billion_CD dollars_NNS toward_IN the_DT universal_JJ flu-vaccine_NN project_NN ._. Here_RB is_VBZ a_DT sentence_NN from_IN an_DT NIAID_NNP press_NN release_NN that_WDT mentions_VBZ one_CD of_IN several_JJ research_NN approaches_NNS :_: “_`` NIAID_NNP Vaccine_NNP Research_NNP Center_NNP scientists_NNS have_VBP initiated_VBN Phase_NN 1/2_CD studies_NNS of_IN a_DT universal_JJ flu_NN vaccine_NN strategy_NN that_WDT includes_VBZ an_DT investigational_JJ DNA_NN -_HYPH based_VBN vaccine_NN (_-LRB- called_VBN a_DT DNA_NN ‘_`` prime_JJ ’_'' )_-RRB- …_. ”_'' This_DT is_VBZ quite_RB troubling_JJ ,_, if_IN you_PRP know_VBP what_WP the_DT phrase_NN “_`` DNA_NN vaccine_NN ”_'' means_VBZ ._. It_PRP refers_VBZ to_IN what_WP the_DT experts_NNS are_VBP touting_VBG as_IN the_DT next_JJ generation_NN of_IN immunizations_NNS ._. Instead_RB of_IN injecting_VBG a_DT piece_NN of_IN a_DT virus_NN into_IN a_DT person_NN ,_, in_IN order_NN to_TO stimulate_VB the_DT immune_NN system_NN ,_, synthesized_VBN genes_NNS would_MD be_VB shot_VBN into_IN the_DT body_NN ._. This_DT is_VBZ n’t_RB traditional_JJ vaccination_NN anymore_RB ._. It_PRP ’s_VBZ gene_NN therapy_NN ._. In_IN any_DT such_JJ method_NN ,_, where_WRB genes_NNS are_VBP edited_VBN ,_, deleted_VBN ,_, added_VBD ,_, no_RB matter_RB what_WP the_DT pros_NNS say_VBP ,_, there_EX are_VBP always_RB “_`` unintended_JJ consequences_NNS ,_, ”_'' to_TO use_VB their_PRP$ polite_JJ phrase_NN ._. The_DT ripple_NN effects_NNS scramble_VBP the_DT genetic_JJ structure_NN in_IN numerous_JJ unknown_JJ ways_NNS ._. This_DT is_VBZ genetic_JJ roulette_NN with_IN a_DT loaded_VBN gun_NN ._. Anyone_NN and_CC everyone_NN on_IN Earth_NNP injected_VBN with_IN a_DT DNA_NN vaccine_NN will_MD undergo_VB permanent_JJ and_CC unknown_JJ genetic_JJ changes_NNS …_. Here_RB is_VBZ the_DT inconvenient_JJ truth_NN about_IN DNA_NN vaccines_NNS —_: They_PRP will_MD permanently_RB alter_VB your_PRP$ DNA_NN ._. The_DT reference_NN is_VBZ the_DT New_NNP York_NNP Times_NNP ,_, 3/15_CD /_, 15_CD ,_, “_`` Protection_NN Without_IN a_DT Vaccine_NN ._. ”_'' It_PRP describes_VBZ the_DT frontier_NN of_IN research_NN —_: the_DT use_NN of_IN synthetic_JJ genes_NNS to_TO “_`` protect_VB against_IN disease_NN ,_, ”_'' while_IN changing_VBG the_DT genetic_JJ makeup_NN of_IN humans_NNS ._. This_DT is_VBZ not_RB science_NN fiction_NN :_: “_`` By_IN delivering_VBG synthetic_JJ genes_NNS into_IN the_DT muscles_NNS of_IN the_DT [_-LRB- experimental_JJ ]_-RRB- monkeys_NNS ,_, the_DT scientists_NNS are_VBP essentially_RB re-engineering_VBG the_DT animals_NNS to_TO resist_VB disease_NN ._. ”_'' “_`` ’_'' The_DT sky_NN ’s_VBZ the_DT limit_NN ,_, ’_'' said_VBD Michael_NNP Farzan_NNP ,_, an_DT immunologist_NN at_IN Scripps_NNP and_CC lead_JJ author_NN of_IN the_DT new_JJ study_NN ._. ”_'' “_`` The_DT first_JJ human_JJ trial_NN based_VBN on_IN this_DT strategy_NN —_: called_VBN immunoprophylaxis_NN by_IN gene_NN transfer_NN ,_, or_CC I.G.T._NN —_: is_VBZ underway_JJ ,_, and_CC several_JJ new_JJ ones_NNS are_VBP planned_VBN ._. ”_'' [_-LRB- That_DT was_VBD three_CD years_NNS ago_RB ._. ]_-RRB- “_`` I.G.T._NN is_VBZ altogether_RB different_JJ from_IN traditional_JJ vaccination_NN ._. It_PRP is_VBZ instead_RB a_DT form_NN of_IN gene_NN therapy_NN ._. Scientists_NNS isolate_VBP the_DT genes_NNS that_WDT produce_VBP powerful_JJ antibodies_NNS against_IN certain_JJ diseases_NNS and_CC then_RB synthesize_VBP artificial_JJ versions_NNS ._. The_DT genes_NNS are_VBP placed_VBN into_IN viruses_NNS and_CC injected_VBN into_IN human_JJ tissue_NN ,_, usually_RB muscle_NN ._. ”_'' Here_RB is_VBZ the_DT punchline_NN :_: Read_VB that_DT again_RB :_: “_`` the_DT synthetic_JJ gene_NN is_VBZ incorporated_VBN into_IN the_DT recipient_NN ’s_POS own_JJ DNA_NN ._. ”_''","The NNP NNP of NNP and NNP NNPS VBZ VBG to VB a NN that , RB , would VB NNS from JJS NN NNS with a JJ NN of a JJ NN . NNP NNP NNP VBD a NN that would VB RB JJR than a billion NN NNS toward the NN . The NNP NNP of NNP and NNP NNPS NNS VBP VBG on a NN NN that , RB of VBG a NN of NN into a NN to VB an JJ NN , would VB VBN NNS . [ RB RB what the NNS ( who will VB VBN the NN ) VB , if NNS VBP VBN , VBN , or VBN , there RB will VB JJ NNS . These JJ NNS can RB VB VBN from the JJ NN NN . Once NNS VBP VBN – RB RB – they will VB with us RB . ] - NNP NNS ’s NNP NNP NNP : NNP VBZ JJ NNS in which the NNP VBZ that NN that VBZ for the NN of these JJ NNS VBZ VBN their NN to VB JJ NNS . Should RB our JJ NNS VB VBG for a NN until we VBP that NN — RB since it VBZ RB VBN that the NNP / NNP NN - NN NN NNS VBP JJ to VB up NNS after NN ? The NNP NNP of NNP and NNP NNPS ( NNP ) VBZ VBN NNS to VB a NN that would VB NNS from JJS NN NNS , RB at RB , with a JJ NN . Over the NNS , I VBP VBN JJ NNS VBG NNS that NNS VBP JJ and JJ , but we ’ll VB all that RB for the NN and VB the NN NN . NNP NNP and JJ NN , NNP NNP , VBZ VBN a NN that would VB RB JJR than a billion NNS toward the JJ NN NN . RB VBZ a NN from an NNP NN NN that VBZ one of JJ NN NNS : “ NNP NNP NNP NNP NNS VBP VBN NN 1/2 NNS of a JJ NN NN NN that VBZ an JJ NN - VBN NN ( VBN a NN ‘ JJ ’ ) … ” This VBZ RB JJ , if you VBP what the NN “ NN NN ” VBZ . It VBZ to what the NNS VBP VBG as the JJ NN of NNS . RB of VBG a NN of a NN into a NN , in NN to VB the NN NN , VBN NNS would VB VBN into the NN . This VBZ RB JJ NN RB . It VBZ NN NN . In any JJ NN , where NNS VBP VBN , VBN , VBD , RB RB what the NNS VBP , there VBP RB “ JJ NNS , ” to VB their JJ NN . The NN NNS VBP the JJ NN in JJ JJ NNS . This VBZ JJ NN with a VBN NN . NN and NN on NNP VBN with a NN NN will VB JJ and JJ JJ NNS … RB VBZ the JJ NN about NN NNS — They will RB VB your NN . The NN VBZ the NNP NNP NNP , 3/15 / 15 , “ NN Without a NN . ” It VBZ the NN of NN — the NN of JJ NNS to “ VB against NN , ” while VBG the JJ NN of NNS . This VBZ RB NN NN : “ By VBG JJ NNS into the NNS of the [ JJ ] NNS , the NNS VBP RB VBG the NNS to VB NN . ” “ ’ The NN VBZ the NN , ’ VBD NNP NNP , an NN at NNP and JJ NN of the JJ NN . ” “ The JJ JJ NN VBN on this NN — VBN NN by NN NN , or NN — VBZ JJ , and JJ JJ NNS VBP VBN . ” [ That VBD three NNS RB . ] “ NN VBZ RB JJ from JJ NN . It VBZ RB a NN of NN NN . NNS VBP the NNS that VBP JJ NNS against JJ NNS and RB VBP JJ NNS . The NNS VBP VBN into NNS and VBN into JJ NN , RB NN . ” RB VBZ the NN : VB that RB : “ the JJ NN VBZ VBN into the NN ’s JJ NN . ”"
107,1197,mainstream,"This_DT year_NN thousands_NNS of_IN children_NNS in_IN Afghanistan_NNP will_MD die_VB from_IN measles_NNS ;_: they_PRP 're_VBP among_IN the_DT quarter_NN million_CD of_IN children_NNS worldwide_RB who_WP die_VBP annually_RB from_IN this_DT preventable_JJ disease_NN ,_, a_DT tragic_JJ situation_NN that_WDT is_VBZ at_IN least_JJS improving_VBG ._. Meanwhile_RB ,_, in_IN the_DT United_NNP States_NNPS this_DT year_NN ,_, thousands_NNS of_IN parents_NNS will_MD deny_VB the_DT measles_NNS vaccine_NN for_IN their_PRP$ children_NNS ,_, having_VBG heard_VBN from_IN someone_NN somewhere_RB that_WDT vaccines_NNS cause_VBP autism_NN ._. At_IN the_DT hub_NN between_IN these_DT contrasting_JJ trajectories_NNS —_: measles_NN deaths_NNS dropping_VBG from_IN about_RB a_DT million_CD to_IN 250,000_CD annually_RB since_IN 1999_CD as_IN a_DT result_NN of_IN focused_VBN immunization_NN programs_NNS ,_, and_CC measles_NNS on_IN the_DT rise_NN year_NN by_IN year_NN in_IN the_DT United_NNP States_NNPS and_CC United_NNP Kingdom_NNP since_IN 1999_CD as_IN a_DT result_NN of_IN dramatic_JJ declines_NNS in_IN immunization_NN rates_NNS —_: is_VBZ a_DT 1998_CD study_NN published_VBN in_IN the_DT Lancet_NNP that_WDT invented_VBD the_DT vaccine_NN -_HYPH autism_NN myth_NN ._. The_DT Lancet_NNP ,_, once_RB referred_VBN to_IN as_IN a_DT prestigious_JJ British_JJ medical_JJ journal_NN ,_, retracted_VBD that_DT study_NN last_JJ week_NN ,_, finally_RB understanding_VBG that_IN the_DT work_NN was_VBD flawed_JJ and_CC that_IN the_DT lead_JJ author_NN ,_, Andrew_NNP Wakefield_NNP ,_, hid_VBD data_NNS and_CC lied_VBD about_IN his_PRP$ financial_JJ stake_NN ._. Ooops_NN ,_, sorry_JJ about_IN that_DT outbreak_NN Here_RB 's_VBZ the_DT backdrop_NN :_: An_DT unknown_JJ British_JJ scientist_NN named_VBN Andrew_NNP Wakefield_NNP and_CC 12_CD colleagues_NNS published_VBD a_DT paper_NN claiming_VBG a_DT link_NN between_IN the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN ,_, gastrointestinal_JJ disease_NN and_CC autism_NN ._. The_DT Lancet_NNP promoted_VBD it_PRP ;_, the_DT news_NN media_NN reported_VBD it_PRP ;_, and_CC parents_NNS in_IN wealthy_JJ countries_NNS believed_VBD it_PRP ._. There_EX were_VBD just_RB a_DT few_JJ problems_NNS ,_, though_RB ._. The_DT first_JJ and_CC most_RBS obvious_JJ was_VBD the_DT fact_NN that_IN there_EX were_VBD more_JJR authors_NNS than_IN subjects_NNS ._. The_DT study_NN was_VBD based_VBN on_IN 12_CD children_NNS from_IN the_DT hospital_NN where_WRB Wakefield_NNP was_VBD working_VBG ._. For_IN The_DT Lancet_NNP to_TO publish_VB ,_, let_VB alone_JJ promote_VB ,_, work_NN that_WDT negates_VBZ years_NNS of_IN medical_JJ wisdom_NN based_VBN on_IN a_DT skimpy_JJ analysis_NN of_IN 12_CD kids_NNS was_VBD highly_RB irresponsible_JJ from_IN the_DT get_NN go_VB ._. Next_RB was_VBD the_DT article_NN 's_POS opening_NN line_NN :_: ""_`` We_PRP investigated_VBD a_DT consecutive_JJ series_NN of_IN children_NNS with_IN chronic_JJ enterocolitis_NN and_CC regressive_JJ developmental_JJ disorder_NN ._. ""_'' Nope_UH ,_, unless_IN ""_`` consecutive_JJ ""_'' means_VBZ 1_CD ,_, 5_CD ,_, 8_CD and_CC onward_RB ._. Subsequent_JJ analysis_NN of_IN the_DT methodology_NN ,_, which_WDT should_MD have_VB been_VBN done_VBN during_IN the_DT peer_NN review_NN process_NN ,_, revealed_VBD that_IN Wakefield_NNP cherry_NN picked_VBD the_DT patients_NNS for_IN the_DT study_NN ._. Next_RB came_VBD the_DT lousy_JJ job_NN in_IN cheery_JJ picking_NN ._. Although_IN the_DT paper_NN claimed_VBD that_IN cognitive_JJ problems_NNS developed_VBD a_DT few_JJ days_NNS after_IN the_DT MMR_NNP vaccine_NN ,_, a_DT simple_JJ investigation_NN of_IN hospital_NN records_NNS revealed_VBD this_DT was_VBD n't_RB so_RB ;_, and_CC in_IN several_JJ cases_NNS parents_NNS reported_VBD problems_NNS before_IN the_DT vaccine_NN ._. Next_RB were_VBD the_DT conflicts_NNS of_IN interest_NN ._. Seems_VBZ that_IN Wakefield_NNP was_VBD getting_VBG money_NN from_IN lawyers_NNS planning_VBG on_IN suing_VBG vaccine_NN makers_NNS ,_, and_CC he_PRP owned_VBD a_DT patent_NN on_IN an_DT alternative_NN to_IN the_DT MMR_NN vaccine_NN ._. Next_RB were_VBD the_DT questionable_JJ practices_NNS ._. Seems_VBZ that_IN Wakefield_NNP subjected_VBD the_DT kids_NNS to_IN invasive_JJ tests_NNS ,_, such_JJ as_IN lumbar_NN punctures_NNS ,_, which_WDT they_PRP did_VBD n't_RB need_VB and_CC for_IN which_WDT he_PRP never_RB received_VBD ethical_JJ approval_NN ._. Just_RB about_RB every_DT aspect_NN of_IN the_DT study_NN ,_, such_JJ as_IN the_DT detection_NN of_IN the_DT measles_NN virus_NN in_IN the_DT guts_NNS of_IN these_DT children_NNS ,_, is_VBZ questionable_JJ ._. Ten_CD of_IN the_DT other_JJ 12_CD authors_NNS indeed_RB formally_RB retracted_VBD their_PRP$ interpretation_NN of_IN the_DT results_NNS in_IN 2004_CD ._. The_DT UK_NNP General_NNP Medical_NNP Council_NNP ,_, which_WDT regulates_VBZ doctors_NNS ,_, launched_VBD an_DT investigation_NN of_IN Wakefield_NNP in_IN 2004_CD based_VBN largely_RB on_IN facts_NNS revealed_VBN by_IN British_JJ journalist_NN Brian_NNP Deer_NNP about_IN the_DT aforementioned_JJ lies_NNS and_CC fudged_VBN data_NNS ._. The_DT Council_NNP issued_VBD their_PRP$ report_NN in_IN January_NNP 2010_CD and_CC concluded_VBD that_IN Wakefield_NNP had_VBD ""_`` callous_JJ disregard_NN ""_'' for_IN the_DT children_NNS he_PRP studies_VBZ ._. He_PRP may_MD lose_VB his_PRP$ right_NN to_TO practice_VB medicine_NN ._. But_CC what_WP does_VBZ Jenny_NNP McCarthy_NNP have_VB to_TO say_VB ?_. McCarthy_NNP ,_, the_DT author_NN of_IN the_DT best_JJS book_NN on_IN the_DT vaccine_NN -_HYPH autism_NN connection_NN to_TO be_VB written_VBN by_IN a_DT former_JJ Playboy_NNP bunny_NN ,_, and_CC husband_NN Jim_NNP Carrey_NNP are_VBP convinced_VBN that_IN vaccines_NNS caused_VBD the_DT autism_NN in_IN McCarthy_NNP 's_POS boy_NN ._. ""_`` Dr._NNP Andrew_NNP Wakefield_NNP is_VBZ being_VBG discredited_VBN to_TO prevent_VB a_DT historic_JJ study_NN from_IN being_VBG published_VBN that_IN for_IN the_DT first_JJ time_NN looks_VBZ at_IN vaccinated_VBN versus_IN unvaccinated_JJ primates_NNS and_CC compares_VBZ ..._, ""_`` blah_UH blah_UH blah_UH blah_UH blah_UH ,_, according_VBG to_IN an_DT exhaustive_JJ statement_NN issued_VBN last_JJ week_NN by_IN the_DT couple_NN ._. What_WP this_DT really_RB means_VBZ is_VBZ that_IN Wakefield_NNP is_VBZ still_RB a_DT hero_NN to_IN many_JJ ._. Are_VBP vaccines_NNS without_IN danger_NN ?_. No_UH ._. There_EX 's_VBZ a_DT slight_JJ risk_NN of_IN a_DT serious_JJ adverse_JJ reaction_NN ._. Far_RB more_RBR dangerous_JJ ,_, though_RB ,_, is_VBZ driving_VBG to_IN the_DT doctor_NN 's_POS office_NN to_TO get_VB the_DT vaccine_NN ,_, given_VBN the_DT number_NN of_IN highway_NN fatalities_NNS ._. Staying_VBG home_NN might_MD be_VB best_JJS ,_, particularly_RB if_IN your_PRP$ kid_NN is_VBZ n't_RB vaccinated_VBN ,_, because_IN these_DT kids_NNS are_VBP the_DT source_NN of_IN the_DT vast_JJ majority_NN of_IN measles_NNS ,_, whooping_NN cough_NN and_CC other_JJ outbreaks_NNS ._. •_NFP The_DT Most_JJS Popular_JJ Myths_NNPS in_IN Science_NNP Christopher_NNP Wanjek_NNP is_VBZ the_DT author_NN of_IN the_DT books_NNS ""_`` Bad_JJ Medicine_NNP ""_'' and_CC ""_`` Food_NN At_IN Work_NN ._. ""_'' His_PRP$ column_NN ,_, Bad_NNP Medicine_NNP ,_, appears_VBZ each_DT Tuesday_NNP on_IN LiveScience_NNP ._.","This NN NNS of NNS in NNP will VB from NNS ; they VBP among the NN million of NNS RB who VBP RB from this JJ NN , a JJ NN that VBZ at JJS VBG . RB , in the NNP NNPS this NN , NNS of NNS will VB the NNS NN for their NNS , VBG VBN from NN RB that NNS VBP NN . At the NN between these JJ NNS — NN NNS VBG from RB a million to 250,000 RB since 1999 as a NN of VBN NN NNS , and NNS on the NN NN by NN in the NNP NNPS and NNP NNP since 1999 as a NN of JJ NNS in NN NNS — VBZ a 1998 NN VBN in the NNP that VBD the NN - NN NN . The NNP , RB VBN to as a JJ JJ JJ NN , VBD that NN JJ NN , RB VBG that the NN VBD JJ and that the JJ NN , NNP NNP , VBD NNS and VBD about his JJ NN . NN , JJ about that NN RB VBZ the NN : An JJ JJ NN VBN NNP NNP and 12 NNS VBD a NN VBG a NN between the NNS - NNS - NN ( NN ) NN , JJ NN and NN . The NNP VBD it ; the NN NN VBD it ; and NNS in JJ NNS VBD it . There VBD RB a JJ NNS , RB . The JJ and RBS JJ VBD the NN that there VBD JJR NNS than NNS . The NN VBD VBN on 12 NNS from the NN where NNP VBD VBG . For The NNP to VB , VB JJ VB , NN that VBZ NNS of JJ NN VBN on a JJ NN of 12 NNS VBD RB JJ from the NN VB . RB VBD the NN 's NN NN : "" We VBD a JJ NN of NNS with JJ NN and JJ JJ NN . "" Nope , unless "" JJ "" VBZ 1 , 5 , 8 and RB . JJ NN of the NN , which should VB VBN VBN during the NN NN NN , VBD that NNP NN VBD the NNS for the NN . RB VBD the JJ NN in JJ NN . Although the NN VBD that JJ NNS VBD a JJ NNS after the NNP NN , a JJ NN of NN NNS VBD this VBD RB RB ; and in JJ NNS NNS VBD NNS before the NN . RB VBD the NNS of NN . VBZ that NNP VBD VBG NN from NNS VBG on VBG NN NNS , and he VBD a NN on an NN to the NN NN . RB VBD the JJ NNS . VBZ that NNP VBD the NNS to JJ NNS , JJ as NN NNS , which they VBD RB VB and for which he RB VBD JJ NN . RB RB every NN of the NN , JJ as the NN of the NN NN in the NNS of these NNS , VBZ JJ . Ten of the JJ 12 NNS RB RB VBD their NN of the NNS in 2004 . The NNP NNP NNP NNP , which VBZ NNS , VBD an NN of NNP in 2004 VBN RB on NNS VBN by JJ NN NNP NNP about the JJ NNS and VBN NNS . The NNP VBD their NN in NNP 2010 and VBD that NNP VBD "" JJ NN "" for the NNS he VBZ . He may VB his NN to VB NN . But what VBZ NNP NNP VB to VB ? NNP , the NN of the JJS NN on the NN - NN NN to VB VBN by a JJ NNP NN , and NN NNP NNP VBP VBN that NNS VBD the NN in NNP 's NN . "" NNP NNP NNP VBZ VBG VBN to VB a JJ NN from VBG VBN that for the JJ NN VBZ at VBN versus JJ NNS and VBZ ... "" blah blah blah blah blah , VBG to an JJ NN VBN JJ NN by the NN . What this RB VBZ VBZ that NNP VBZ RB a NN to JJ . VBP NNS without NN ? No . There VBZ a JJ NN of a JJ JJ NN . RB RBR JJ , RB , VBZ VBG to the NN 's NN to VB the NN , VBN the NN of NN NNS . VBG NN might VB JJS , RB if your NN VBZ RB VBN , because these NNS VBP the NN of the JJ NN of NNS , NN NN and JJ NNS . • The JJS JJ NNPS in NNP NNP NNP VBZ the NN of the NNS "" JJ NNP "" and "" NN At NN . "" His NN , NNP NNP , VBZ each NNP on NNP ."
108,622,conspiracy,"“_`` The_DT News_NN You_PRP Need_VBP Today_NN …_: For_IN The_DT World_NN You_PRP ’ll_MD Live_VB In_IN Tomorrow_NN ._. ”_'' You_PRP WERE_VBD Warned_VBN About_IN The_DT Coronavirus_NN “_`` Telephone_NN Disease_NN ”_'' —_: But_CC Lies_NNS Won_VBN Out_RP Over_IN Truth_NN They_PRP Died_VBD For_IN The_DT Crime_NN Of_IN What_WP They_PRP Knew_VBD —_: Where_WRB Is_VBZ Your_PRP$ Name_NN On_IN The_DT Death_NN List_NN ?_. Revenge_NN -_HYPH Fueled_VBN Democrats_NNPS Watch_VBP In_IN Rage_NNP As_IN Trump_NNP Judges_NNS Begin_VB Laying_VBG Waste_NN To_IN Leftist_NNP America_NNP Russia_NNP Cuts_VBZ Trade_NN Ties_NNS With_IN US_NNP As_IN Black_NNP Swan_NNP Rides_NNS Coronavirus_NNP -_HYPH Locust_NNP Apocalypse_NNP Wave_NNP Across_IN World_NNP Russian_JJ Disease_NN Expert_NN Talks_NNS To_IN US_NNP Intel_NNP Expert_NN About_IN Coronavirus_NN In_IN Iran_NNP —_: She_PRP Gets_VBZ Thrown_VBN Into_IN Spanish_NNP Prison_NNP ,_, He_PRP Gets_VBZ Bullet_NN In_IN Head_NN Click_VB Here_RB For_IN More_JJR Sorcha_NNP Faal_NNP Reports_NNPS Sister_NN Maria_NNP Theresa_NNP is_VBZ the_DT 73rd_JJ Sorcha_NNP Faal_NNP of_IN the_DT Sorcha_NNP Faal_NNP Order_NNP ,_, Elected_VBN as_IN Mother_NNP Superior_NNP 3_CD February_NNP 2007_CD “_`` Conspiracy_NN theorists_NNS concentrate_VBP their_PRP$ time_NN on_IN transmuting_VBG the_DT ""_`` base_NN matter_NN ""_'' of_IN current_JJ events_NNS ,_, official_JJ stories_NNS ,_, propaganda_NN and_CC public_JJ relations_NNS into_IN the_DT gleaming_VBG golden_JJ truth_NN buried_VBN within_IN ._. They_PRP do_VBP this_DT through_IN the_DT very_JJ right_JJ -_HYPH brained_VBN activity_NN of_IN uncovering_VBG and_CC inventing_VBG connections_NNS between_IN disparate_JJ elements_NNS ._. They_PRP create_VBP story_NN -_HYPH systems_NNS to_TO understand_VB and_CC explain_VB events_NNS -_, essentially_RB a_DT religious_JJ activity_NN ._. For_IN whatever_WDT reason_NN ,_, it_PRP ’s_VBZ much_RB easier_JJR for_IN us_PRP to_TO deal_VB with_IN our_PRP$ internal_JJ contents_NNS by_IN projecting_VBG them_PRP into_IN the_DT world_NN around_IN us_PRP ._. These_DT outward_JJ signs_NNS inevitably_RB become_VBP carriers_NNS of_IN the_DT archetypal_JJ content_NN and_CC psychodrama_NN latent_NN in_IN the_DT seeker_NN ._. Conspiracy_NN theory_NN also_RB overcomes_VBZ the_DT strictures_NNS of_IN literalism_NN and_CC the_DT problems_NNS of_IN simplistic_JJ thinking_NN by_IN experimenting_VBG with_IN multiplicity_NN of_IN meaning_NN ._. Ordinary_JJ events_NNS ,_, people_NNS and_CC signs_NNS become_VBP symbols_NNS bristling_VBG with_IN complex_JJ ,_, malleable_JJ ,_, even_RB contradictory_JJ meanings_NNS ._. Mystery_NN is_VBZ revived_VBN and_CC idealized_VBN ._. Facts_NNS become_VBP more_JJR than_IN the_DT sum_NN of_IN their_PRP$ parts_NNS ._. Theory_NN becomes_VBZ poetry_NN and_CC even_RB theology_NN ._. ”_'' Conspiracy_NN Theories_NNS Can’t_MD Be_VB Stopped_VBN —_: And_CC Some_DT Scientists_NNS Think_VBP We_PRP Would_MD n’t_RB Want_VB To_TO Even_RB If_IN We_PRP Could_MD Brief_NNP History_NNP of_IN the_DT Order_NNP of_IN Sorcha_NNP Faal_NNP Wikipedia_NNP :_: Sorcha_NNP Faal_NNP Reports_NNS Sorcha_NNP Faal_NNP Belongs_NNP To_IN A_DT Cabal_NN Of_IN Ashkenazim_NNP Jewish_JJ Women_NNS From_IN 1290_CD A.D_NN ._. Sorcha_NNP Faal_NNP Is_VBZ A_DT Misinformation_NN Agent_NN For_IN The_DT Russian_NNP Foreign_NNP Intelligence_NNP Service_NNP SVR_NNP Sorcha_NNP Faal_NNP Works_NNPS Within_IN The_DT Central_NNP Intelligence_NNP Agency_NNP In_IN COINTELPRO_NNP Sorcha_NNP Faal_NNP Used_VBN By_IN DHS_NN To_TO Compile_VB Report_NN On_IN Right_JJ Wing_NN Extremism_NN Sorcha_NNP Faal_NNP Is_VBZ Information_NN Warfare_NNP Site_NN For_IN British_JJ MI6_NNP ,_, Mossad_NNP and_CC CIA_NNP Sorcha_NNP Faal_NNP Link_NNP Says_NNP Proves_VBZ US_NNP Broadcaster_NN Sean_NNP Hannity_NNP Is_VBZ Russian_JJ Spy_NN Sorcha_NNP Faal_NNP Called_VBN Right_JJ Wing_NN By_IN Guardian_NN Newspaper_NN For_IN Aiding_VBG Judge_NNP Kavanaugh_NNP How_WRB Covert_JJ Agents_NNS Infiltrate_VBP the_DT Internet_NNP to_TO Manipulate_VB ,_, Deceive_VB ,_, and_CC Destroy_VB Reputations_NNS American_JJ 2020_CD Death_NN Toll_NN Update_NN :_: 0_CD Americans_NNPS Killed_VBN By_IN Terror_NNP 209_CD Americans_NNPS Killed_VBN By_IN Their_PRP$ Own_NNP Police_NNP American_JJ 2015_CD -_HYPH 2019_CD Death_NN Toll_NN :_: Americans_NNPS Killed_VBN By_IN Their_PRP$ Own_NNP Police_NNP :_: 5,304_CD Americans_NNPS Killed_VBN By_IN Terror_NN :_: 271_CD US_NNP Government_NN Labels_NNS Domestic_JJ Citizens_NNS As_IN The_DT #_NN 1_CD Terrorist_JJ Group_NNP Police_NNP State_NNP USA_NNP In_IN Iraq_NNP ,_, I_PRP raided_VBD insurgents_NNS ._. In_IN Virginia_NNP ,_, the_DT police_NNS raided_VBD me_PRP ._. Drivers_NNS ,_, Beware_NN :_: The_DT Costly_JJ ,_, Deadly_NNP Dangers_NNPS Of_IN Traffic_NNP Stops_NNS In_IN The_DT American_NNP Police_NNP State_NNP American_NNP Sheriffs_NNPS Ask_VBP Pentagon_NNP For_IN More_JJR Tanks_NNPS To_TO Battle_NNP Marijuana_NNP US_NNP Police_NN Now_RB Trained_VBN To_TO Kill_VB First_JJ ,_, Ask_VB Questions_NNS Later_RBR How_WRB Do_VBP You_PRP Prepare_VB A_DT Child_NN For_IN Life_NN In_IN The_DT American_JJ Police_NN State_NN ?_. US_NNP Supreme_NNP Court_NNP Rules_NNS Cops_NNS Can_MD Kill_VB Non-Threatening_JJ People_NNS As_RB Long_JJ As_IN They_PRP Say_VBP They_PRP Were_VBD Scared_JJ Why_WRB Google_NNP when_WRB you_PRP can_MD use_VB non-tracking_JJ sites_NNS like_IN :_: DuckDuckGo_NNP ,_, or_CC Qwant_NNP ,_, or_CC searX_NNP ,_, or_CC Good_NNP Gopher_NNP ?_. Are_VBP ""_`` Conspiracy_NN Theories_NNS ""_'' Tearing_VBG Society_NN Apart_RB Or_CC Saving_VBG Us_PRP From_IN Destruction_NN ?_. Conspiracy_NN :_: Comes_VBZ from_IN Latin_NNP word_NN '_`` conspirare_FW '_'' meaning_NN to_TO breathe_VB together_RB ;_, conspiracy_NN theories_NNS emphasize_VBP the_DT invisible_JJ forces_NNS and_CC actions_NNS (_-LRB- of_IN selfish_JJ harmful_JJ intent_NN by_IN special_JJ interests_NNS )_-RRB- behind_IN the_DT visible_JJ historical_JJ events_NNS ._.","“ The NN You VBP NN … For The NN You ’ll VB In NN . ” You VBD VBN About The NN “ NN NN ” — But NNS VBN Out Over NN They VBD For The NN Of What They VBD — Where VBZ Your NN On The NN NN ? NN - VBN NNPS VBP In NNP As NNP NNS VB VBG NN To NNP NNP NNP VBZ NN NNS With NNP As NNP NNP NNS NNP - NNP NNP NNP Across NNP JJ NN NN NNS To NNP NNP NN About NN In NNP — She VBZ VBN Into NNP NNP , He VBZ NN In NN VB RB For JJR NNP NNP NNPS NN NNP NNP VBZ the JJ NNP NNP of the NNP NNP NNP , VBN as NNP NNP 3 NNP 2007 “ NN NNS VBP their NN on VBG the "" NN NN "" of JJ NNS , JJ NNS , NN and JJ NNS into the VBG JJ NN VBN within . They VBP this through the JJ JJ - VBN NN of VBG and VBG NNS between JJ NNS . They VBP NN - NNS to VB and VB NNS - RB a JJ NN . For whatever NN , it VBZ RB JJR for us to VB with our JJ NNS by VBG them into the NN around us . These JJ NNS RB VBP NNS of the JJ NN and NN NN in the NN . NN NN RB VBZ the NNS of NN and the NNS of JJ NN by VBG with NN of NN . JJ NNS , NNS and NNS VBP NNS VBG with JJ , JJ , RB JJ NNS . NN VBZ VBN and VBN . NNS VBP JJR than the NN of their NNS . NN VBZ NN and RB NN . ” NN NNS Can’t VB VBN — And Some NNS VBP We Would RB VB To RB If We Could NNP NNP of the NNP of NNP NNP NNP : NNP NNP NNS NNP NNP NNP To A NN Of NNP JJ NNS From 1290 NN . NNP NNP VBZ A NN NN For The NNP NNP NNP NNP NNP NNP NNP NNPS Within The NNP NNP NNP In NNP NNP NNP VBN By NN To VB NN On JJ NN NN NNP NNP VBZ NN NNP NN For JJ NNP , NNP and NNP NNP NNP NNP NNP VBZ NNP NN NNP NNP VBZ JJ NN NNP NNP VBN JJ NN By NN NN For VBG NNP NNP How JJ NNS VBP the NNP to VB , VB , and VB NNS JJ 2020 NN NN NN : 0 NNPS VBN By NNP 209 NNPS VBN By Their NNP NNP JJ 2015 - 2019 NN NN : NNPS VBN By Their NNP NNP : 5,304 NNPS VBN By NN : 271 NNP NN NNS JJ NNS As The NN 1 JJ NNP NNP NNP NNP In NNP , I VBD NNS . In NNP , the NNS VBD me . NNS , NN : The JJ , NNP NNPS Of NNP NNS In The NNP NNP NNP NNP NNPS VBP NNP For JJR NNPS To NNP NNP NNP NN RB VBN To VB JJ , VB NNS RBR How VBP You VB A NN For NN In The JJ NN NN ? NNP NNP NNP NNS NNS Can VB JJ NNS RB JJ As They VBP They VBD JJ Why NNP when you can VB JJ NNS like : NNP , or NNP , or NNP , or NNP NNP ? VBP "" NN NNS "" VBG NN RB Or VBG Us From NN ? NN : VBZ from NNP NN ' FW ' NN to VB RB ; NN NNS VBP the JJ NNS and NNS ( of JJ JJ NN by JJ NNS ) behind the JJ JJ NNS ."
109,735,mainstream,"The_DT band_NN ,_, who_WP are_VBP set_VBN to_TO release_VB their_PRP$ fourth_JJ album_NN ‘_`` Strangeland_NNP ’_'' on_IN May_NNP 7_CD and_CC embark_VB on_IN a_DT mini-_NN tour_NN to_TO support_VB it_PRP ,_, said_VBD the_DT sound_NN was_VBD inspired_VBN by_IN ‘_`` What_WP Did_VBD You_PRP Expect_VB From_IN The_DT Vaccines_NNS ?_. ’_'' ,_, the_DT band_NN ’s_POS 2011_CD debut_NN album_NN ._. Speaking_VBG exclusively_RB to_IN NME_NNP ,_, the_DT band_NN ’s_POS pianist_NN Tim_NNP Rice_NNP -_HYPH Oxley_NNP said_VBD :_: “_`` We_PRP loved_VBD what_WP (_-LRB- producer_NN )_-RRB- Dan_NNP Grech_NNP did_VBD on_IN The_DT Vaccines_NNPS album_NN ._. It_PRP had_VBD just_RB come_VBN out_RP ._. He_PRP ’d_VBD also_RB done_VBN stuff_NN with_IN Radiohead_NNP and_CC produced_VBD the_DT second_JJ Howling_NNP Bells_NNPS album_NN ,_, which_WDT I_PRP loved_VBD ._. As_IN luck_NN would_MD have_VB it_PRP ,_, Dan_NNP was_VBD a_DT massive_JJ Keane_NNP fan_NN ,_, so_RB we_PRP ended_VBD working_VBG with_IN him_PRP ._. ”_'' Meanwhile_RB ,_, singer_NN Tom_NNP Chaplin_NNP compared_VBD the_DT process_NN of_IN making_VBG ‘_`` Strangeland_NNP ’_'' to_IN their_PRP$ 2004_CD debut_NN ‘_`` Hopes_NNPS And_CC Fears_NNS ’_'' ._. He_PRP said_VBD :_: “_`` The_DT process_NN began_VBD in_IN 2010_CD ._. We_PRP began_VBD demoing_VBG tracks_NNS then_RB ._. It_PRP ’s_VBZ the_DT longest_JJS we_PRP ’ve_VBP spent_VBN making_VBG a_DT record_NN since_IN ‘_`` Hopes_NNPS and_CC Fears_NNPS ’_'' ._. ”_'' He_PRP added_VBD :_: “_`` The_DT album_NN has_VBZ the_DT vibe_NN of_IN earlier_JJR Keane_NNP ._. 2008_CD ’s_POS ‘_`` Perfect_NNP Symmetry_NNP ’_'' was_VBD a_DT big_JJ self_NN -_HYPH indulgent_JJ and_CC this_DT record_NN felt_VBD a_DT bit_NN more_RBR like_IN we_PRP knew_VBD ourselves_PRP a_DT bit_NN better_JJR and_CC what_WP our_PRP$ strengths_NNS were_VBD ._. ”_'' Rice_NNP -_HYPH Oxley_NNP added_VBD :_: “_`` We_PRP wanted_VBD it_PRP be_VB less_JJR production_NN led_VBN and_CC focus_VB on_IN making_VBG sure_JJ that_IN the_DT songs_NNS were_VBD great_JJ ._. You_PRP write_VBP a_DT lot_NN of_IN shit_NN songs_NNS to_TO get_VB to_IN the_DT good_JJ ones_NNS ._. ”_'' He_PRP said_VBD the_DT album_NN was_VBD more_RBR deeply_RB felt_VBN than_IN before_RB ._. “_`` It_PRP ’s_VBZ a_DT very_RB emotional_JJ album_NN ._. The_DT title_NN track_NN is_VBZ about_IN setting_VBG off_RP in_IN a_DT certain_JJ path_NN in_IN life_NN and_CC thinking_VBG it_PRP ’s_VBZ going_VBG to_TO go_VB one_CD way_NN ,_, but_CC finding_VBG out_RP life_NN ’s_VBZ taken_VBN a_DT detour_NN ._. Pretty_RB much_RB every_DT song_NN on_IN the_DT album_NN is_VBZ about_IN that_DT ._. (_-LRB- But_CC )_-RRB- it_PRP ’s_VBZ a_DT more_RBR hopeful_JJ record_NN than_IN it_PRP might_MD sound_VB !_. ”_'' The_DT band_NN recently_RB revealed_VBD the_DT artwork_NN for_IN the_DT album_NN ._. They_PRP will_MD play_VB a_DT nine_CD date_NN mini_NN -_HYPH tour_NN in_IN May_NNP ._. The_DT run_NN begins_VBZ at_IN Newcastle_NNP ’s_POS O2_NNP Academy_NNP on_IN May_NNP 23_CD and_CC runs_VBZ until_IN June_NNP 8_CD ,_, when_WRB Keane_NNP will_MD headline_VB London_NNP ’s_POS O2_NNP Academy_NNP Brixton_NNP ._. To_TO check_VB the_DT availability_NN of_IN Keane_NNP tickets_NNS and_CC get_VB all_PDT the_DT latest_JJS listings_NNS ,_, go_VB to_IN NME._NNP COM_NN /_, TICKETS_NNPS now_RB ,_, or_CC call_VB 0871_CD 230_CD 1094_CD ._. The_DT tracklisting_NN for_IN ‘_`` Strangeland_NNP ’_'' is_VBZ as_IN follows_VBZ :_: ‘_`` You_PRP Are_VBP Young_JJ ’_'' ‘_`` Silenced_VBN By_IN The_DT Night_NN ’_'' ‘_`` Disconnected_VBN ’_'' ‘_`` Watch_VB How_WRB You_PRP Go_VBP ’_'' ‘_`` Sovereign_NNP Light_NNP Café_NNP ’_'' ‘_`` On_IN The_DT Road_NNP ’_'' ‘_`` The_DT Starting_NNP Line_NNP ’_'' ‘_`` Black_NNP Rain_NNP ’_'' ‘_`` Neon_NNP River_NNP ’_'' ‘_`` Day_NN Will_MD Come_VB ’_'' ‘_`` In_IN Your_PRP$ Own_JJ Time_NN ’_'' ‘_`` Sea_NNP Fog_NNP ’_''","The NN , who VBP VBN to VB their JJ NN ‘ NNP ’ on NNP 7 and VB on a NN NN to VB it , VBD the NN VBD VBN by ‘ What VBD You VB From The NNS ? ’ , the NN ’s 2011 NN NN . VBG RB to NNP , the NN ’s NN NNP NNP - NNP VBD : “ We VBD what ( NN ) NNP NNP VBD on The NNPS NN . It VBD RB VBN out . He VBD RB VBN NN with NNP and VBD the JJ NNP NNPS NN , which I VBD . As NN would VB it , NNP VBD a JJ NNP NN , RB we VBD VBG with him . ” RB , NN NNP NNP VBD the NN of VBG ‘ NNP ’ to their 2004 NN ‘ NNPS And NNS ’ . He VBD : “ The NN VBD in 2010 . We VBD VBG NNS RB . It VBZ the JJS we VBP VBN VBG a NN since ‘ NNPS and NNPS ’ . ” He VBD : “ The NN VBZ the NN of JJR NNP . 2008 ’s ‘ NNP NNP ’ VBD a JJ NN - JJ and this NN VBD a NN RBR like we VBD ourselves a NN JJR and what our NNS VBD . ” NNP - NNP VBD : “ We VBD it VB JJR NN VBN and VB on VBG JJ that the NNS VBD JJ . You VBP a NN of NN NNS to VB to the JJ NNS . ” He VBD the NN VBD RBR RB VBN than RB . “ It VBZ a RB JJ NN . The NN NN VBZ about VBG off in a JJ NN in NN and VBG it VBZ VBG to VB one NN , but VBG out NN VBZ VBN a NN . RB RB every NN on the NN VBZ about that . ( But ) it VBZ a RBR JJ NN than it might VB ! ” The NN RB VBD the NN for the NN . They will VB a nine NN NN - NN in NNP . The NN VBZ at NNP ’s NNP NNP on NNP 23 and VBZ until NNP 8 , when NNP will VB NNP ’s NNP NNP NNP . To VB the NN of NNP NNS and VB all the JJS NNS , VB to NNP NN / NNPS RB , or VB 0871 230 1094 . The NN for ‘ NNP ’ VBZ as VBZ : ‘ You VBP JJ ’ ‘ VBN By The NN ’ ‘ VBN ’ ‘ VB How You VBP ’ ‘ NNP NNP NNP ’ ‘ On The NNP ’ ‘ The NNP NNP ’ ‘ NNP NNP ’ ‘ NNP NNP ’ ‘ NN Will VB ’ ‘ In Your JJ NN ’ ‘ NNP NNP ’"
110,1243,mainstream,"Re_IN “_`` Low_JJ Prices_NNS for_IN Vaccines_NNS Can_MD Come_VB at_IN a_DT Great_JJ Cost_NN ”_'' (_-LRB- The_DT Upshot_NN ,_, nytimes.com_NNP ,_, June_NNP 27_CD )_-RRB- :_: While_IN this_DT article_NN claims_VBZ that_IN a_DT $_$ 2,000_CD vaccination_NN is_VBZ a_DT bargain_NN for_IN a_DT lifetime_NN of_IN coverage_NN ,_, it_PRP does_VBZ n’t_RB recognize_VB that_IN vaccines_NNS are_VBP useless_JJ if_IN they_PRP sit_VBP on_IN shelves_NNS priced_VBN out_IN of_IN the_DT reach_NN of_IN the_DT children_NNS who_WP need_VBP them_PRP most_JJS ._. In_IN a_DT world_NN where_WRB countries_NNS struggle_VBP to_TO afford_VB lifesaving_JJ preventions_NNS like_IN the_DT pneumonia_NN vaccine_NN ,_, high_JJ prices_NNS mean_VBP fewer_JJR children_NNS vaccinated_VBN ,_, threatening_VBG individual_JJ and_CC public_JJ health_NN ._. For_IN example_NN ,_, Pfizer_NNP and_CC GSK_NNP have_VBP made_VBN more_JJR than_IN $_$ 30_CD billion_CD in_IN seven_CD years_NNS from_IN their_PRP$ duopoly_NN on_IN pneumonia_NN vaccines_NNS ,_, while_IN at_IN the_DT lowest_JJS global_JJ prices_NNS ,_, the_DT vaccine_NN package_NN recommended_VBN for_IN every_DT child_NN is_VBZ 68_CD times_NNS more_RBR expensive_JJ than_IN it_PRP was_VBD just_RB over_IN a_DT decade_NN ago_RB ._. This_DT ,_, in_IN part_NN ,_, means_VBZ that_IN 18.7_CD million_CD babies_NNS ,_, most_JJS of_IN whom_WP live_VBP in_IN low_JJ -_HYPH income_NN ,_, high_JJ -_HYPH risk_NN regions_NNS ,_, have_VBP n’t_RB received_VBN basic_JJ vaccines_NNS ._. Additionally_RB ,_, there_EX ’s_VBZ no_DT proof_NN that_IN increasing_VBG prices_NNS would_MD make_VB drug_NN companies_NNS invest_VB in_IN certain_JJ vaccines_NNS to_TO prevent_VB shortages_NNS ._. Earlier_RBR this_DT year_NN ,_, the_DT United_NNP Nations_NNPS World_NNP Health_NNP Assembly_NNP reported_VBD that_IN shortages_NNS are_VBP worsened_VBN by_IN many_JJ factors_NNS ._. High_JJ prices_NNS do_VBP little_JJ except_IN leave_VB the_DT most_RBS vulnerable_JJ children_NNS unprotected_JJ ._.","Re “ JJ NNS for NNS Can VB at a JJ NN ” ( The NN , NNP , NNP 27 ) : While this NN VBZ that a $ 2,000 NN VBZ a NN for a NN of NN , it VBZ RB VB that NNS VBP JJ if they VBP on NNS VBN out of the NN of the NNS who VBP them JJS . In a NN where NNS VBP to VB JJ NNS like the NN NN , JJ NNS VBP JJR NNS VBN , VBG JJ and JJ NN . For NN , NNP and NNP VBP VBN JJR than $ 30 billion in seven NNS from their NN on NN NNS , while at the JJS JJ NNS , the NN NN VBN for every NN VBZ 68 NNS RBR JJ than it VBD RB over a NN RB . This , in NN , VBZ that 18.7 million NNS , JJS of whom VBP in JJ - NN , JJ - NN NNS , VBP RB VBN JJ NNS . RB , there VBZ no NN that VBG NNS would VB NN NNS VB in JJ NNS to VB NNS . RBR this NN , the NNP NNPS NNP NNP NNP VBD that NNS VBP VBN by JJ NNS . JJ NNS VBP JJ except VB the RBS JJ NNS JJ ."
111,1151,mainstream,"Things_NNS you_PRP can_MD do_VB on_IN the_DT day_NN There_EX are_VBP some_DT things_NNS you_PRP could_MD try_VB that_WDT may_MD help_VB your_PRP$ child_NN 's_POS vaccination_NN appointment_NN go_VB smoothly_RB ._. What_WP to_TO expect_VB after_IN the_DT appointment_NN Your_PRP$ baby_NN or_CC child_NN may_MD cry_VB for_IN a_DT little_JJ while_NN after_IN a_DT vaccination_NN ,_, but_CC they_PRP should_MD feel_VB better_JJR after_IN a_DT cuddle_NN ._. Sometimes_RB the_DT area_NN where_WRB the_DT needle_NN goes_VBZ in_RP can_MD be_VB sore_JJ and_CC red_JJ for_IN 2_CD to_IN 3_CD days_NNS ._. This_DT should_MD go_VB away_RB on_IN its_PRP$ own_JJ ._. Some_DT children_NNS may_MD also_RB develop_VB a_DT high_JJ temperature_NN (_-LRB- fever_NN )_-RRB- ._. How_WRB to_TO treat_VB a_DT high_JJ temperature_NN after_IN vaccination_NN •_SYM make_VB sure_JJ they_PRP 're_VBP not_RB wearing_VBG too_RB many_JJ layers_NNS of_IN clothes_NNS or_CC blankets_NNS •_NFP give_VB them_PRP liquid_JJ paracetamol_NN or_CC ibuprofen_NN for_IN children_NNS to_TO bring_VB their_PRP$ temperature_NN down_RB It_PRP 's_VBZ recommended_VBN that_IN you_PRP give_VBP your_PRP$ baby_NN liquid_JJ paracetamol_NN after_IN the_DT MenB_NN vaccine_NN to_TO reduce_VB the_DT risk_NN of_IN a_DT high_JJ temperature_NN ._. This_DT vaccine_NN is_VBZ given_VBN at_IN 8_CD weeks_NNS ,_, 16_CD weeks_NNS and_CC 1_CD year_NN old_JJ ._. Make_VB sure_JJ you_PRP follow_VBP the_DT instructions_NNS that_WDT come_VBP with_IN the_DT medicine_NN ._. If_IN you_PRP 're_VBP unsure_JJ ,_, ask_VB a_DT pharmacist_NN for_IN advice_NN ._. It_PRP 's_VBZ rare_JJ for_IN anyone_NN to_TO have_VB a_DT serious_JJ allergic_JJ reaction_NN to_IN a_DT vaccination_NN ._. If_IN this_DT does_VBZ happen_VB ,_, it_PRP usually_RB happens_VBZ within_IN minutes_NNS ._. The_DT person_NN who_WP vaccinates_VBZ you_PRP or_CC your_PRP$ child_NN will_MD be_VB trained_VBN to_TO deal_VB with_IN allergic_JJ reactions_NNS and_CC treat_VB them_PRP immediately_RB ._. With_IN prompt_JJ treatment_NN ,_, your_PRP$ child_NN will_MD make_VB a_DT good_JJ recovery_NN ._. Read_VB an_DT NHS_NNP leaflet_NN about_IN the_DT common_JJ side_NN effects_NNS of_IN vaccinations_NNS in_IN babies_NNS and_CC children_NNS and_CC how_WRB to_TO treat_VB them_PRP (_-LRB- PDF_NN ,_, 118_CD kb_NN )_-RRB- ._.","NNS you can VB on the NN There VBP some NNS you could VB that may VB your NN 's NN NN VB RB . What to VB after the NN Your NN or NN may VB for a JJ NN after a NN , but they should VB JJR after a NN . RB the NN where the NN VBZ in can VB JJ and JJ for 2 to 3 NNS . This should VB RB on its JJ . Some NNS may RB VB a JJ NN ( NN ) . How to VB a JJ NN after NN • VB JJ they VBP RB VBG RB JJ NNS of NNS or NNS • VB them JJ NN or NN for NNS to VB their NN RB It VBZ VBN that you VBP your NN JJ NN after the NN NN to VB the NN of a JJ NN . This NN VBZ VBN at 8 NNS , 16 NNS and 1 NN JJ . VB JJ you VBP the NNS that VBP with the NN . If you VBP JJ , VB a NN for NN . It VBZ JJ for NN to VB a JJ JJ NN to a NN . If this VBZ VB , it RB VBZ within NNS . The NN who VBZ you or your NN will VB VBN to VB with JJ NNS and VB them RB . With JJ NN , your NN will VB a JJ NN . VB an NNP NN about the JJ NN NNS of NNS in NNS and NNS and how to VB them ( NN , 118 NN ) ."
112,792,mainstream,"When_WRB a_DT virus_NN invades_VBZ your_PRP$ cells_NNS ,_, it_PRP changes_VBZ your_PRP$ body_NN ._. But_CC in_IN the_DT process_NN ,_, the_DT pathogen_NN changes_VBZ its_PRP$ shape_NN ,_, too_RB ._. A_DT new_JJ mathematical_JJ model_NN predicts_VBZ the_DT points_NNS on_IN the_DT virus_NN that_WDT allow_VBP this_DT shape_NN -_HYPH shifting_VBG to_TO occur_VB ,_, revealing_VBG a_DT new_JJ way_NN to_TO find_VB potential_JJ drug_NN and_CC vaccine_NN targets_NNS ._. The_DT unique_JJ math_NN -_HYPH based_VBN approach_NN has_VBZ already_RB identified_VBN potential_JJ targets_NNS in_IN the_DT coronavirus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. Outlined_VBN in_IN April_NNP in_IN the_DT Journal_NNP of_IN Computational_NNP Biology_NNP ,_, the_DT strategy_NN predicts_VBZ protein_NN sites_NNS on_IN viruses_NNS that_WDT stash_VBP energy_NN —_: important_JJ spots_NNS that_WDT drugs_NNS could_MD disable_VB ._. In_IN a_DT rare_JJ feat_NN ,_, the_DT work_NN proceeds_VBZ from_IN pure_JJ mathematics_NN ,_, says_VBZ study_NN author_NN and_CC mathematician_NN Robert_NNP Penner_NNP of_IN the_DT Institute_NNP of_IN Advanced_NNP Scientific_NNP Studies_NNPS in_IN France_NNP ._. “_`` There_EX 's_VBZ precious_JJ little_JJ pure_JJ math_NN in_IN biology_NN ,_, ”_'' he_PRP adds_VBZ ._. The_DT paper_NN ’s_POS predictions_NNS face_VBP a_DT long_JJ road_NN before_IN they_PRP can_MD be_VB verified_VBN experimentally_RB ,_, says_VBZ John_NNP Yin_NNP ,_, who_WP studies_VBZ viruses_NNS at_IN the_DT University_NNP of_IN Wisconsin–Madison_NNP and_CC was_VBD not_RB involved_VBN in_IN the_DT research_NN ._. But_CC he_PRP agrees_VBZ that_IN Penner_NNP ’s_POS approach_NN has_VBZ potential_NN ._. “_`` He_PRP ’s_VBZ coming_VBG at_IN this_DT from_IN a_DT mathematician_NN ’s_POS point_NN of_IN view_NN —_: but_CC a_DT very_RB scientifically_RB informed_VBN mathematician_NN ,_, ”_'' Yin_NNP says_VBZ ._. “_`` So_RB that_DT ’s_VBZ highly_RB rare_JJ ._. ”_'' Penner_NNP ’s_POS method_NN takes_VBZ advantage_NN of_IN the_DT fact_NN that_IN certain_JJ viral_JJ proteins_NNS alter_VBP their_PRP$ shape_NN dramatically_RB when_WRB viruses_NNS breach_VBP cells_NNS ,_, and_CC this_DT transformation_NN depends_VBZ on_IN unstable_JJ features_NNS ._. (_-LRB- A_DT stable_JJ protein_NN site_NN ,_, by_IN definition_NN ,_, resists_VBZ change_NN ._. )_-RRB- By_IN identifying_VBG “_`` high_JJ free_JJ energy_NN sites_NNS ”_'' —_: areas_NNS on_IN a_DT viral_JJ protein_NN that_WDT store_VBP lots_NNS of_IN energy_NN —_: Penner_NNP realized_VBD he_PRP could_MD spot_VB likely_JJ “_`` spring_NN ”_'' points_NNS that_WDT mediate_VBP this_DT change_NN in_IN shape_NN ._. He_PRP calls_VBZ such_JJ high_JJ -_HYPH energy_NN spots_NNS exotic_JJ sites_NNS ._. Finding_VBG them_PRP required_VBD some_DT complex_JJ math_NN ._. Penner_NNP focused_VBD on_IN the_DT backbones_NNS of_IN the_DT proteins_NNS that_WDT undergo_VBP the_DT most_JJS change_NN during_IN cell_NN fusion_NN and_CC entry_NN ._. He_PRP examined_VBD the_DT hydrogen_NN bonds_NNS that_WDT form_VBP between_IN backbone_NN sections_NNS when_WRB proteins_NNS fold_VBP ._. A_DT protein_NN consists_VBZ of_IN a_DT series_NN of_IN individual_JJ units_NNS ,_, or_CC residues_NNS ,_, with_IN two_CD such_JJ units_NNS forming_VBG hydrogen_NN bonds_NNS ._. The_DT bonded_VBN units_NNS rotate_VBP relative_RB to_IN each_DT other_JJ ,_, and_CC those_DT twists_NNS imply_VBP varying_VBG amounts_NNS of_IN free_JJ energy_NN in_IN the_DT residues_NNS involved_VBN ._. To_TO isolate_VB the_DT exotic_JJ rotations_NNS ,_, Penner_NNP cranked_VBD a_DT few_JJ mathematical_JJ levers_NNS on_IN a_DT giant_JJ collection_NN of_IN protein_NN shapes_NNS ._. He_PRP and_CC his_PRP$ colleagues_NNS had_VBD previously_RB gathered_VBN a_DT representative_JJ sample_NN of_IN proteins_NNS from_IN a_DT database_NN and_CC looked_VBD at_IN the_DT roughly_RB 1.17_CD million_CD backbone_NN hydrogen_NN bonds_NNS in_IN the_DT set_NN ._. He_PRP then_RB needed_VBD to_TO establish_VB how_WRB frequently_RB different_JJ rotations_NNS appeared_VBD ._. To_TO find_VB that_DT information_NN ,_, Penner_NNP turned_VBD to_IN geometry_NN ._. In_IN the_DT 19th_JJ century_NN ,_, German_JJ mathematician_NN Carl_NNP Friedrich_NNP Gauss_NNP showed_VBD that_IN you_PRP can_MD describe_VB each_DT unique_JJ rotation_NN of_IN three_CD -_HYPH dimensional_JJ space_NN by_IN specifying_VBG the_DT axis_NN around_IN which_WDT that_DT rotation_NN turns_VBZ and_CC the_DT amount_NN by_IN which_WDT it_PRP does_VBZ so_RB (_-LRB- picture_VB a_DT wheel_NN turning_VBG around_IN car_NN axle_NN by_IN anywhere_RB from_IN zero_CD to_IN 360_CD degrees_NNS ,_, or_CC zero_CD to_IN two_CD pi_NN radians_NNS )_-RRB- ._. You_PRP can_MD represent_VB each_DT rotation_NN with_IN a_DT vector_NN ,_, a_DT measurement_NN that_WDT has_VBZ both_CC a_DT magnitude_NN and_CC a_DT direction_NN and_CC that_WDT is_VBZ usually_RB pictured_VBN as_IN an_DT arrow_NN of_IN a_DT certain_JJ length_NN pointing_VBG in_IN a_DT specific_JJ direction_NN ._. This_DT arrow_NN ’s_POS orientation_NN describes_VBZ the_DT rotation_NN ’s_POS axis_NN ,_, and_CC the_DT vector_NN ’s_POS length_NN gives_VBZ the_DT amount_NN of_IN rotation_NN (_-LRB- imagine_VB an_DT axle_NN that_WDT lengthens_VBZ with_IN further_JJR rotation_NN )_-RRB- ._. Collect_VB all_PDT the_DT vector_NN arrows_NNS pointing_VBG out_RP every_DT which_WDT way_NN from_IN a_DT central_JJ point_NN ,_, and_CC you_PRP have_VBP all_DT possible_JJ axes_NNS for_IN a_DT rotation_NN to_TO spin_VB about_IN ._. Spots_NNS along_IN each_DT axis_NN (_-LRB- the_DT arrow_NN points_NNS of_IN different_JJ vectors_NNS )_-RRB- identify_VBP all_DT unique_JJ rotations_NNS :_: the_DT possible_JJ amounts_NNS of_IN rotation_NN ,_, from_IN zero_CD to_IN two_CD pi_NN radians_NNS ,_, around_IN every_DT axis_NN ._. Altogether_RB these_DT arrows_NNS make_VBP up_RP a_DT 3_CD -_HYPH D_NN ball_NN (_-LRB- imagine_VB a_DT spiny_NN Koosh_NN ball_NN or_CC a_DT rolled_VBN -_HYPH up_RP hedgehog_NN )_-RRB- ._. This_DT structure_NN is_VBZ what_WP Penner_NNP wanted_VBD ,_, because_IN it_PRP allowed_VBD him_PRP to_TO do_VB some_DT math_NN on_IN the_DT points_NNS appearing_VBG in_IN it_PRP ._. Penner_NNP mapped_VBD the_DT rotations_NNS found_VBN in_IN the_DT database_NN onto_IN the_DT ball_NN ._. Then_RB he_PRP calculated_VBD the_DT frequency_NN of_IN each_DT one_NN by_IN looking_VBG at_IN the_DT density_NN of_IN its_PRP$ surrounding_VBG region_NN in_IN the_DT structure_NN :_: rotations_NNS in_IN less_RBR dense_JJ parts_NNS of_IN the_DT ball_NN are_VBP rarer_JJR ._. Scientists_NNS know_VBP that_IN the_DT frequency_NN of_IN a_DT protein_NN feature_NN is_VBZ related_JJ to_IN a_DT function_NN of_IN its_PRP$ free_JJ energy_NN ,_, such_JJ that_IN rarer_JJR features_NNS have_VBP higher_JJR energies_NNS ._. So_RB using_VBG established_VBN equations_NNS and_CC the_DT densities_NNS on_IN the_DT ball_NN ,_, Penner_NNP computed_VBD the_DT free_JJ energy_NN of_IN different_JJ rotations_NNS ,_, revealing_VBG exotic_JJ sites_NNS ._. One_CD indication_NN that_IN the_DT approach_NN works_VBZ is_VBZ that_IN it_PRP predicted_VBD already_RB known_VBN functional_JJ sites_NNS ,_, Penner_NNP says_VBZ ._. But_CC previously_RB unknown_JJ sites_NNS discovered_VBN by_IN this_DT method_NN could_MD prove_VB to_TO be_VB promising_JJ targets_NNS for_IN drugs_NNS to_TO attack_VB ._. If_IN experiments_NNS verify_VBP Penner_NNP 's_POS predicted_VBN sites_NNS —_: a_DT big_JJ if_IN —_: the_DT approach_NN holds_VBZ promise_NN ,_, says_VBZ Arndt_NNP Benecke_NNP ,_, a_DT biological_JJ researcher_NN at_IN the_DT French_NNP National_NNP Center_NNP for_IN Scientific_NNP Research_NNP ,_, who_WP advises_VBZ the_DT mathematician_NN ._. “_`` If_IN that_DT were_VBD the_DT case_NN ,_, then_RB automatically_RB ,_, the_DT free_JJ energy_NN is_VBZ something_NN you_PRP could_MD target_VB that_WDT we_PRP ’re_VBP not_RB currently_RB doing_VBG ,_, ”_'' he_PRP says_VBZ ._. “_`` The_DT whole_JJ thought_NN of_IN what_WP could_MD or_CC should_MD a_DT drug_NN or_CC antibody_NN do_VB might_MD change_VB ._. ”_'' In_IN a_DT follow_NN -_HYPH up_RP study_NN published_VBN in_IN the_DT same_JJ journal_NN on_IN Wednesday_NNP ,_, Penner_NNP pinpointed_VBD three_CD exotic_JJ “_`` sites_NNS of_IN interest_NN ”_'' on_IN the_DT coronavirus_NN behind_IN COVID_NNP -_HYPH 19_CD ._. But_CC now_RB they_PRP must_MD survive_VB the_DT rigors_NNS of_IN the_DT lab_NN ._. Experimenters_NNS need_VBP to_TO show_VB that_IN knocking_VBG out_RP the_DT sites_NNS indeed_RB releases_VBZ free_JJ energy_NN ,_, Benecke_NNP says_VBZ ._. Even_RB then_RB ,_, they_PRP may_MD remain_VB inaccessible_JJ to_IN drugs_NNS ,_, he_PRP adds_VBZ ._. And_CC any_DT treatments_NNS targeting_VBG the_DT sites_NNS must_MD survive_VB the_DT usual_JJ tests_NNS for_IN efficacy_NN and_CC safety_NN in_IN animal_NN models_NNS and_CC then_RB in_IN people_NNS ._. “_`` The_DT literature_NN is_VBZ littered_VBN with_IN failures_NNS ,_, ”_'' Penner_NNP says_VBZ ._. Still_RB ,_, if_IN the_DT method_NN works_VBZ ,_, it_PRP could_MD have_VB applications_NNS for_IN a_DT wider_JJR range_NN of_IN targets_NNS ,_, from_IN the_DT signaling_NN proteins_NNS that_WDT allow_VBP cells_NNS to_TO communicate_VB with_IN their_PRP$ environment_NN to_IN prions_NNS ,_, the_DT misfolded_VBN proteins_NNS behind_IN conditions_NNS such_JJ as_IN mad_JJ cow_NN disease_NN ._. “_`` This_DT could_MD go_VB far_RB beyond_IN the_DT viruses_NNS ,_, ”_'' Benecke_NNP says_VBZ ._. Read_VB more_JJR about_IN the_DT coronavirus_NN outbreak_NN from_IN Scientific_JJ American_NNP here_RB ._. And_CC read_VB coverage_NN from_IN our_PRP$ international_JJ network_NN of_IN magazines_NNS here_RB ._.","When a NN VBZ your NNS , it VBZ your NN . But in the NN , the NN VBZ its NN , RB . A JJ JJ NN VBZ the NNS on the NN that VBP this NN - VBG to VB , VBG a JJ NN to VB JJ NN and NN NNS . The JJ NN - VBN NN VBZ RB VBN JJ NNS in the NN that VBZ NN - 19 . VBN in NNP in the NNP of NNP NNP , the NN VBZ NN NNS on NNS that VBP NN — JJ NNS that NNS could VB . In a JJ NN , the NN VBZ from JJ NN , VBZ NN NN and NN NNP NNP of the NNP of NNP NNP NNPS in NNP . “ There VBZ JJ JJ JJ NN in NN , ” he VBZ . The NN ’s NNS VBP a JJ NN before they can VB VBN RB , VBZ NNP NNP , who VBZ NNS at the NNP of NNP and VBD RB VBN in the NN . But he VBZ that NNP ’s NN VBZ NN . “ He VBZ VBG at this from a NN ’s NN of NN — but a RB RB VBN NN , ” NNP VBZ . “ RB that VBZ RB JJ . ” NNP ’s NN VBZ NN of the NN that JJ JJ NNS VBP their NN RB when NNS VBP NNS , and this NN VBZ on JJ NNS . ( A JJ NN NN , by NN , VBZ NN . ) By VBG “ JJ JJ NN NNS ” — NNS on a JJ NN that VBP NNS of NN — NNP VBD he could VB JJ “ NN ” NNS that VBP this NN in NN . He VBZ JJ JJ - NN NNS JJ NNS . VBG them VBD some JJ NN . NNP VBD on the NNS of the NNS that VBP the JJS NN during NN NN and NN . He VBD the NN NNS that VBP between NN NNS when NNS VBP . A NN VBZ of a NN of JJ NNS , or NNS , with two JJ NNS VBG NN NNS . The VBN NNS VBP RB to each JJ , and those NNS VBP VBG NNS of JJ NN in the NNS VBN . To VB the JJ NNS , NNP VBD a JJ JJ NNS on a JJ NN of NN NNS . He and his NNS VBD RB VBN a JJ NN of NNS from a NN and VBD at the RB 1.17 million NN NN NNS in the NN . He RB VBD to VB how RB JJ NNS VBD . To VB that NN , NNP VBD to NN . In the JJ NN , JJ NN NNP NNP NNP VBD that you can VB each JJ NN of three - JJ NN by VBG the NN around which that NN VBZ and the NN by which it VBZ RB ( VB a NN VBG around NN NN by RB from zero to 360 NNS , or zero to two NN NNS ) . You can VB each NN with a NN , a NN that VBZ both a NN and a NN and that VBZ RB VBN as an NN of a JJ NN VBG in a JJ NN . This NN ’s NN VBZ the NN ’s NN , and the NN ’s NN VBZ the NN of NN ( VB an NN that VBZ with JJR NN ) . VB all the NN NNS VBG out every which NN from a JJ NN , and you VBP all JJ NNS for a NN to VB about . NNS along each NN ( the NN NNS of JJ NNS ) VBP all JJ NNS : the JJ NNS of NN , from zero to two NN NNS , around every NN . RB these NNS VBP up a 3 - NN NN ( VB a NN NN NN or a VBN - up NN ) . This NN VBZ what NNP VBD , because it VBD him to VB some NN on the NNS VBG in it . NNP VBD the NNS VBN in the NN onto the NN . RB he VBD the NN of each NN by VBG at the NN of its VBG NN in the NN : NNS in RBR JJ NNS of the NN VBP JJR . NNS VBP that the NN of a NN NN VBZ JJ to a NN of its JJ NN , JJ that JJR NNS VBP JJR NNS . RB VBG VBN NNS and the NNS on the NN , NNP VBD the JJ NN of JJ NNS , VBG JJ NNS . One NN that the NN VBZ VBZ that it VBD RB VBN JJ NNS , NNP VBZ . But RB JJ NNS VBN by this NN could VB to VB JJ NNS for NNS to VB . If NNS VBP NNP 's VBN NNS — a JJ if — the NN VBZ NN , VBZ NNP NNP , a JJ NN at the NNP NNP NNP for NNP NNP , who VBZ the NN . “ If that VBD the NN , RB RB , the JJ NN VBZ NN you could VB that we VBP RB RB VBG , ” he VBZ . “ The JJ NN of what could or should a NN or NN VB might VB . ” In a NN - up NN VBN in the JJ NN on NNP , NNP VBD three JJ “ NNS of NN ” on the NN behind NNP - 19 . But RB they must VB the NNS of the NN . NNS VBP to VB that VBG out the NNS RB VBZ JJ NN , NNP VBZ . RB RB , they may VB JJ to NNS , he VBZ . And any NNS VBG the NNS must VB the JJ NNS for NN and NN in NN NNS and RB in NNS . “ The NN VBZ VBN with NNS , ” NNP VBZ . RB , if the NN VBZ , it could VB NNS for a JJR NN of NNS , from the NN NNS that VBP NNS to VB with their NN to NNS , the VBN NNS behind NNS JJ as JJ NN NN . “ This could VB RB beyond the NNS , ” NNP VBZ . VB JJR about the NN NN from JJ NNP RB . And VB NN from our JJ NN of NNS RB ."
113,720,mainstream,"THE_DT coronavirus_NN vaccine_NN could_MD be_VB ready_JJ to_TO give_VB in_IN the_DT form_NN of_IN an_DT inhaler_NN by_IN next_JJ month_NN ,_, it_PRP was_VBD reported_VBN ._. Trials_NNS of_IN a_DT vaccine_NN being_VBG developed_VBN by_IN Oxford_NNP University_NNP are_VBP currently_RB ongoing_JJ with_IN the_DT initial_JJ target_NN of_IN September_NNP to_TO be_VB available_JJ to_IN the_DT public_NN ._. ⚠️_NFP Read_VB our_PRP$ coronavirus_NN live_JJ blog_NN for_IN the_DT latest_JJS news_NN &_CC updates_NNS Drug_NN company_NN Astra_NNP Zeneca_NNP has_VBZ said_VBN it_PRP will_MD produce_VB the_DT vaccine_NN light_NN so_IN it_PRP ’s_VBZ ready_JJ when_WRB final_JJ approval_NN is_VBZ given_VBN and_CC intends_VBZ to_TO produce_VB two_CD billion_CD doses_NNS thanks_NNS to_IN funding_NN from_IN Microsoft_NNP billionaire_NN Bill_NNP Gates_NNP ._. The_DT Oxford_NNP University_NNP team_NN are_VBP reportedly_RB “_`` 80_CD per_NN cent_NN confident_JJ ”_'' the_DT Covid_NNP -_HYPH 19_CD vaccine_NN work_NN in_IN younger_JJR people_NNS and_CC say_VBP the_DT vaccine_NN could_MD be_VB given_VBN using_VBG a_DT device_NN like_IN an_DT asthma_NN inhaler_NN next_JJ month_NN ._. The_DT news_NN came_VBD in_IN an_DT online_JJ lecture_NN for_IN Oxford_NNP University_NNP 's_POS Centre_NNP for_IN Personalised_NNP Medicine_NNP given_VBN by_IN team_NN member_NN Professor_NNP Adrian_NNP Hill_NNP ,_, the_DT Daily_NNP Mail_NNP reports_NNS ._. He_PRP said_VBD that_IN clinical_JJ trials_NNS will_MD end_VB when_WRB the_DT vaccine_NN has_VBZ clearly_RB been_VBN found_VBN to_TO protect_VB people_NNS ._. “_`` We_PRP are_VBP guessing_VBG that_DT might_MD be_VB around_RB about_RB August_NNP time_NN -_, it_PRP might_MD be_VB before_RB if_IN cases_NNS do_VBP not_RB decline_VB as_RB quickly_RB as_IN we_PRP expect_VBP ,_, or_CC be_VB later_RBR if_IN we_PRP run_VBP out_IN of_IN cases_NNS ,_, ”_'' he_PRP said_VBD ._. The_DT Oxford_NNP trial_NN began_VBD back_RB in_IN April_NNP and_CC began_VBD recruiting_VBG up_IN to_IN 10,260_CD adults_NNS over_IN 55_CD and_CC children_NNS ._. AstraZeneca_NNP has_VBZ already_RB agreed_VBN to_TO supply_VB 100_CD million_CD doses_NNS of_IN the_DT potential_JJ vaccine_NN to_IN the_DT UK_NNP ._. It_PRP has_VBZ also_RB signed_VBN a_DT massive_JJ $_$ 1_CD billion_CD deal_NN for_IN a_DT coronavirus_NN vaccine_NN with_IN the_DT U.S_NNP government_NN ._. The_DT Anglo_JJ -_HYPH Swedish_JJ firm_NN will_MD supply_VB 400_CD million_CD doses_NNS of_IN the_DT Covid_NNP -_HYPH 19_CD drug_NN currently_RB being_VBG developed_VBN by_IN the_DT University_NNP of_IN Oxford_NNP ._. The_DT drug_NN is_VBZ still_RB undergoing_VBG trials_NNS at_IN the_DT university_NN ’s_POS Jenner_NNP Institute_NNP ,_, which_WDT is_VBZ working_VBG with_IN the_DT Oxford_NNP Vaccine_NNP Group_NNP on_IN the_DT project_NN ._. The_DT order_NN from_IN US_NNP Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP comes_VBZ after_IN demands_NNS for_IN from_IN Donald_NNP Trump_NNP for_IN a_DT coronavirus_NN vaccine_NN by_IN the_DT end_NN of_IN the_DT year_NN ,_, as_IN part_NN of_IN program_NN dubbed_VBN ‘_`` Operation_NNP Warp_NNP Speed_NNP ’_'' ._. Currently_RB ,_, there_EX is_VBZ no_DT vaccine_NN or_CC treatment_NN available_JJ for_IN Covid_NNP -_HYPH 19_CD but_CC doctors_NNS across_IN the_DT globe_NN are_VBP testing_VBG current_JJ anti-viral_JJ drugs_NNS to_TO see_VB if_IN they_PRP can_MD beat_VB coronavirus_NN ._.","THE NN NN could VB JJ to VB in the NN of an NN by JJ NN , it VBD VBN . NNS of a NN VBG VBN by NNP NNP VBP RB JJ with the JJ NN of NNP to VB JJ to the NN . ⚠️ VB our NN JJ NN for the JJS NN & NNS NN NN NNP NNP VBZ VBN it will VB the NN NN so it VBZ JJ when JJ NN VBZ VBN and VBZ to VB two billion NNS NNS to NN from NNP NN NNP NNP . The NNP NNP NN VBP RB “ 80 NN NN JJ ” the NNP - 19 NN NN in JJR NNS and VBP the NN could VB VBN VBG a NN like an NN NN JJ NN . The NN VBD in an JJ NN for NNP NNP 's NNP for NNP NNP VBN by NN NN NNP NNP NNP , the NNP NNP NNS . He VBD that JJ NNS will VB when the NN VBZ RB VBN VBN to VB NNS . “ We VBP VBG that might VB RB RB NNP NN - it might VB RB if NNS VBP RB VB RB RB as we VBP , or VB RBR if we VBP out of NNS , ” he VBD . The NNP NN VBD RB in NNP and VBD VBG up to 10,260 NNS over 55 and NNS . NNP VBZ RB VBN to VB 100 million NNS of the JJ NN to the NNP . It VBZ RB VBN a JJ $ 1 billion NN for a NN NN with the NNP NN . The JJ - JJ NN will VB 400 million NNS of the NNP - 19 NN RB VBG VBN by the NNP of NNP . The NN VBZ RB VBG NNS at the NN ’s NNP NNP , which VBZ VBG with the NNP NNP NNP on the NN . The NN from NNP NNP NNP NNP and NNP NNP VBZ after NNS for from NNP NNP for a NN NN by the NN of the NN , as NN of NN VBN ‘ NNP NNP NNP ’ . RB , there VBZ no NN or NN JJ for NNP - 19 but NNS across the NN VBP VBG JJ JJ NNS to VB if they can VB NN ."
114,125,mainstream,"As_IN the_DT influenza_NN season_NN heads_VBZ in_RP ,_, Carol_NNP Baker_NNP ,_, who_WP chairs_VBZ the_DT National_NNP Foundation_NNP for_IN Infectious_NNP Diseases_NNPS '_POS Childhood_NNP Influenza_NNP Immunization_NNP Coalition_NNP ,_, answers_VBZ some_DT common_JJ questions_NNS about_IN the_DT flu_NN vaccine_NN ._. Baker_NNP is_VBZ a_DT professor_NN of_IN pediatrics_NN ,_, molecular_JJ virology_NN and_CC microbiology_NN at_IN Baylor_NNP College_NNP of_IN Medicine_NNP in_IN Houston_NNP ._. Q_LS ._. What_WP is_VBZ the_DT flu_NN vaccine_NN and_CC who_WP should_MD receive_VB it_PRP ?_. A_LS ._. The_DT influenza_NN vaccine_NN protects_VBZ against_IN three_CD different_JJ strains_NNS of_IN the_DT virus_NN that_WDT are_VBP determined_VBN each_DT year_NN by_IN flu_NN trends_NNS in_IN the_DT Southern_NNP Hemisphere_NNP six_CD months_NNS previously_RB ._. This_DT year_NN 's_POS vaccine_NN is_VBZ identical_JJ to_IN last_JJ year's_NNS ._. But_CC even_RB if_IN you_PRP got_VBD the_DT flu_NN shot_NN last_JJ year_NN ,_, it_PRP 's_VBZ still_RB important_JJ to_TO get_VB one_CD this_DT year_NN because_IN the_DT vaccine_NN does_VBZ n't_RB last_VB more_JJR than_IN a_DT year_NN ,_, at_IN most_JJS ._. In_IN general_JJ ,_, everyone_NN 6_CD months_NNS of_IN age_NN and_CC older_JJR should_MD receive_VB the_DT vaccine_NN ._. It_PRP 's_VBZ especially_RB important_JJ that_IN the_DT very_RB old_JJ ,_, the_DT very_RB young_JJ ,_, people_NNS with_IN compromised_VBN immune_JJ systems_NNS and_CC pregnant_JJ women_NNS be_VBP vaccinated_VBN ,_, because_IN they_PRP are_VBP the_DT populations_NNS more_RBR likely_JJ to_TO develop_VB serious_JJ complications_NNS ._. During_IN the_DT H1N1_NNP flu_NN pandemic_NN in_IN 2009_CD ,_, 5_CD percent_NN of_IN the_DT deaths_NNS from_IN the_DT outbreak_NN were_VBD pregnant_JJ women_NNS ._. Immunity_NN passes_VBZ from_IN the_DT mother_NN to_IN the_DT baby_NN in_IN utero_NN and_CC protects_VBZ them_PRP against_IN the_DT flu_NN until_IN they_PRP are_VBP old_JJ enough_RB to_TO be_VB vaccinated_VBN ._. Because_IN infants_NNS can't_MD be_VB immunized_VBN until_IN they_PRP are_VBP 6_CD months_NNS ,_, they_PRP should_MD be_VB surrounded_VBN by_IN vaccinated_VBN people_NNS ,_, just_RB as_IN cancer_NN patients_NNS and_CC other_JJ especially_RB vulnerable_JJ people_NNS should_MD be_VB surrounded_VBN by_IN people_NNS who_WP are_VBP vaccinated_VBN ._. Q._LS How_WRB effective_JJ is_VBZ the_DT flu_NN vaccine_NN ?_. A_LS ._. Unfortunately_RB ,_, getting_VBG vaccinated_VBN wo_MD n't_RB guarantee_VB you_PRP wo_MD n't_RB get_VB the_DT flu_NN ,_, but_CC it_PRP greatly_RB lessens_VBZ the_DT chance_NN ._. Even_RB if_IN the_DT vaccine_NN is_VBZ a_DT good_JJ match_NN to_IN the_DT flu_NN strains_NNS that_DT year_NN ,_, its_PRP$ effectiveness_NN is_VBZ just_RB 70_CD percent_NN ._. Everyone_NN in_IN the_DT medical_JJ world_NN agrees_VBZ we_PRP need_VBP a_DT better_JJR vaccine_NN that_WDT covers_VBZ all_DT strains_NNS and_CC lasts_VBZ a_DT lot_NN longer_RBR ._. Scientists_NNS around_IN the_DT world_NN are_VBP working_VBG on_IN developing_VBG a_DT universal_JJ vaccine_NN that_WDT potentially_RB would_MD work_VB like_IN the_DT measles_NNS vaccine_NN —_: two_CD doses_NNS and_CC you_PRP 're_VBP protected_VBN for_IN life_NN —_: but_CC this_DT is_VBZ five_CD to_IN seven_CD years_NNS off_RB or_CC longer_RBR ._. Q_LS ._. What_WP is_VBZ new_JJ this_DT year_NN ?_. A_LS ._. The_DT Fluzone_NNP high_JJ -_HYPH dose_NN vaccine_NN ,_, which_WDT is_VBZ four_CD times_NNS stronger_JJR than_IN the_DT standard_JJ dose_NN ,_, is_VBZ being_VBG offered_VBN to_IN adults_NNS 65_CD and_CC older_JJR ._. The_DT standard_JJ vaccine_NN does_VBZ not_RB work_VB as_RB well_RB in_IN older_JJR people_NNS and_CC young_JJ children_NNS ,_, and_CC we_PRP hope_VBP that_IN the_DT higher_JJR dose_NN of_IN antigen_NN in_IN this_DT vaccine_NN will_MD strengthen_VB their_PRP$ immune_JJ response_NN ._. For_IN people_NNS who_WP avoid_VBP the_DT flu_NN vaccine_NN because_IN they_PRP are_VBP afraid_JJ of_IN needles_NNS ,_, the_DT intradermal_JJ vaccine_NN uses_VBZ an_DT ultrafine_JJ needle_NN to_TO inject_VB the_DT flu_NN vaccine_NN directly_RB into_IN the_DT skin_NN ,_, instead_RB of_IN the_DT muscle_NN ._. The_DT needle_NN is_VBZ 90_CD percent_NN smaller_JJR ._. Only_RB healthy_JJ people_NNS ,_, aged_JJ 18_CD to_IN 54_CD ,_, can_MD receive_VB the_DT intradermal_JJ vaccine_NN ._. This_DT year_NN ,_, children_NNS under_IN 9_CD who_WP were_VBD fully_RB vaccinated_VBN last_JJ year_NN only_RB need_VBP one_CD dose_NN of_IN the_DT flu_NN vaccine_NN ,_, because_IN it_PRP is_VBZ the_DT same_JJ as_IN last_JJ year_NN ._. Normally_RB ,_, children_NNS under_IN 9_CD receive_VBP two_CD doses_NNS ._. Children_NNS who_WP were_VBD not_RB vaccinated_VBN last_JJ year_NN should_MD receive_VB two_CD doses_NNS ,_, as_IN usual_JJ ._. Also_RB ,_, the_DT American_NNP Academy_NNP of_IN Pediatrics_NNP recommends_VBZ that_IN children_NNS with_IN minor_JJ allergies_NNS to_IN eggs_NNS receive_VBP the_DT vaccine_NN ._. Previously_RB ,_, children_NNS with_IN egg_NN allergies_NNS were_VBD not_RB vaccinated_VBN ._. Parents_NNS of_IN children_NNS with_IN more_RBR serious_JJ egg_NN allergies_NNS should_MD talk_VB to_IN their_PRP$ health_NN care_NN professionals_NNS ._. Q_LS ._. What_WP are_VBP some_DT of_IN the_DT myths_NNS about_IN the_DT flu_NN vaccine_NN ?_. A_LS ._. The_DT oldest_JJS and_CC worst_JJS myth_NN I_PRP 've_VBP heard_VBN —_: and_CC I_PRP 've_VBP even_RB heard_VBN nurses_NNS say_VBP this_DT —_: is_VBZ ,_, ""_`` I_PRP got_VBD the_DT vaccine_NN and_CC it_PRP caused_VBD the_DT flu_NN ._. ""_'' The_DT shot_NN is_VBZ made_VBN up_RP of_IN dead_JJ virus_NN that_WDT can't_MD give_VB anyone_NN the_DT flu_NN ,_, and_CC even_RB the_DT live_JJ virus_NN present_JJ in_IN the_DT nasal_JJ spray_NN flu_NN vaccine_NN has_VBZ been_VBN weakened_VBN so_RB much_JJ that_IN it_PRP wo_MD n't_RB cause_VB any_DT symptoms_NNS ._. It_PRP takes_VBZ two_CD weeks_NNS for_IN the_DT flu_NN shot_NN to_TO become_VB effective_JJ ._. That_DT 's_VBZ why_WRB I_PRP tell_VBP people_NNS to_TO get_VB flu_NN vaccine_NN early_RB ._. The_DT flu_NN usually_RB starts_VBZ with_IN winter_NN and_CC peaks_NNS in_IN February_NNP ._. If_IN the_DT vaccine_NN is_VBZ available_JJ in_IN September_NNP ,_, get_VB it_PRP in_IN September_NNP ._. I_PRP also_RB hear_VBP a_DT lot_NN of_IN people_NNS say_VBP :_: ""_`` My_PRP$ child_NN is_VBZ healthy_JJ ,_, so_IN he_PRP does_VBZ n't_RB need_VB to_TO be_VB vaccinated_VBN ._. Only_RB children_NNS with_IN weakened_VBN immune_JJ symptoms_NNS really_RB need_VBP the_DT flu_NN shot_NN ._. ""_'' In_IN reality_NN ,_, about_RB 150_CD children_NNS died_VBD last_JJ year_NN from_IN the_DT flu_NN ,_, and_CC about_RB half_NN of_IN them_PRP were_VBD previously_RB healthy_JJ ._. Likewise_RB ,_, about_RB 20,000_CD children_NNS were_VBD hospitalized_VBN due_IN to_IN complications_NNS from_IN the_DT flu_NN and_CC about_RB half_NN of_IN them_PRP were_VBD previously_RB healthy_JJ ._. Q_NN ._. What_WP can_MD you_PRP do_VB if_IN you_PRP get_VBP the_DT flu_NN ?_. A._LS Remember_VB ,_, it_PRP 's_VBZ very_RB contagious_JJ ,_, so_RB use_VB cough_NN and_CC hand_NN hygiene_NN to_TO keep_VB it_PRP from_IN spreading_VBG ._. Prescription_NN drugs_NNS ,_, like_IN Tamiflu_NNP ,_, are_VBP effective_JJ in_IN shortening_VBG the_DT duration_NN of_IN the_DT illness_NN ,_, but_CC you_PRP need_VBP to_TO begin_VB taking_VBG them_PRP within_IN 36_CD hours_NNS of_IN the_DT onset_NN of_IN symptoms_NNS ._. People_NNS really_RB should_MD n't_RB go_VB to_IN work_NN ._. They_PRP 're_VBP not_RB productive_JJ and_CC can_MD make_VB everyone_NN else_JJ sick_JJ ._. The_DT best_JJS thing_NN ,_, though_RB ,_, is_VBZ to_TO try_VB to_TO prevent_VB the_DT flu_NN by_IN making_VBG it_PRP a_DT habit_NN to_TO get_VB vaccinated_VBN every_DT year_NN ._.","As the NN NN VBZ in , NNP NNP , who VBZ the NNP NNP for NNP NNPS ' NNP NNP NNP NNP , VBZ some JJ NNS about the NN NN . NNP VBZ a NN of NN , JJ NN and NN at NNP NNP of NNP in NNP . Q . What VBZ the NN NN and who should VB it ? A . The NN NN VBZ against three JJ NNS of the NN that VBP VBN each NN by NN NNS in the NNP NNP six NNS RB . This NN 's NN VBZ JJ to JJ NNS . But RB if you VBD the NN NN JJ NN , it VBZ RB JJ to VB one this NN because the NN VBZ RB VB JJR than a NN , at JJS . In JJ , NN 6 NNS of NN and JJR should VB the NN . It VBZ RB JJ that the RB JJ , the RB JJ , NNS with VBN JJ NNS and JJ NNS VBP VBN , because they VBP the NNS RBR JJ to VB JJ NNS . During the NNP NN NN in 2009 , 5 NN of the NNS from the NN VBD JJ NNS . NN VBZ from the NN to the NN in NN and VBZ them against the NN until they VBP JJ RB to VB VBN . Because NNS can't VB VBN until they VBP 6 NNS , they should VB VBN by VBN NNS , RB as NN NNS and JJ RB JJ NNS should VB VBN by NNS who VBP VBN . Q. How JJ VBZ the NN NN ? A . RB , VBG VBN wo RB VB you wo RB VB the NN , but it RB VBZ the NN . RB if the NN VBZ a JJ NN to the NN NNS that NN , its NN VBZ RB 70 NN . NN in the JJ NN VBZ we VBP a JJR NN that VBZ all NNS and VBZ a NN RBR . NNS around the NN VBP VBG on VBG a JJ NN that RB would VB like the NNS NN — two NNS and you VBP VBN for NN — but this VBZ five to seven NNS RB or RBR . Q . What VBZ JJ this NN ? A . The NNP JJ - NN NN , which VBZ four NNS JJR than the JJ NN , VBZ VBG VBN to NNS 65 and JJR . The JJ NN VBZ RB VB RB RB in JJR NNS and JJ NNS , and we VBP that the JJR NN of NN in this NN will VB their JJ NN . For NNS who VBP the NN NN because they VBP JJ of NNS , the JJ NN VBZ an JJ NN to VB the NN NN RB into the NN , RB of the NN . The NN VBZ 90 NN JJR . RB JJ NNS , JJ 18 to 54 , can VB the JJ NN . This NN , NNS under 9 who VBD RB VBN JJ NN RB VBP one NN of the NN NN , because it VBZ the JJ as JJ NN . RB , NNS under 9 VBP two NNS . NNS who VBD RB VBN JJ NN should VB two NNS , as JJ . RB , the NNP NNP of NNP VBZ that NNS with JJ NNS to NNS VBP the NN . RB , NNS with NN NNS VBD RB VBN . NNS of NNS with RBR JJ NN NNS should VB to their NN NN NNS . Q . What VBP some of the NNS about the NN NN ? A . The JJS and JJS NN I VBP VBN — and I VBP RB VBN NNS VBP this — VBZ , "" I VBD the NN and it VBD the NN . "" The NN VBZ VBN up of JJ NN that can't VB NN the NN , and RB the JJ NN JJ in the JJ NN NN NN VBZ VBN VBN RB JJ that it wo RB VB any NNS . It VBZ two NNS for the NN NN to VB JJ . That VBZ why I VBP NNS to VB NN NN RB . The NN RB VBZ with NN and NNS in NNP . If the NN VBZ JJ in NNP , VB it in NNP . I RB VBP a NN of NNS VBP : "" My NN VBZ JJ , so he VBZ RB VB to VB VBN . RB NNS with VBN JJ NNS RB VBP the NN NN . "" In NN , RB 150 NNS VBD JJ NN from the NN , and RB NN of them VBD RB JJ . RB , RB 20,000 NNS VBD VBN due to NNS from the NN and RB NN of them VBD RB JJ . NN . What can you VB if you VBP the NN ? A. VB , it VBZ RB JJ , RB VB NN and NN NN to VB it from VBG . NN NNS , like NNP , VBP JJ in VBG the NN of the NN , but you VBP to VB VBG them within 36 NNS of the NN of NNS . NNS RB should RB VB to NN . They VBP RB JJ and can VB NN JJ JJ . The JJS NN , RB , VBZ to VB to VB the NN by VBG it a NN to VB VBN every NN ."
115,688,mainstream,"THE_DT WHITE_JJ HOUSE_NN Office_NN of_IN the_DT Press_NNP Secretary_NNP President_NNP Clinton_NNP Unveils_VBZ Millennium_NNP Initiative_NNP to_TO Promote_NNP Delivery_NNP of_IN Existing_NNP Vaccines_NNPS in_IN Developing_VBG Countries_NNS and_CC Accelerate_VB Development_NN of_IN New_NNP Vaccines_NNPS In_IN his_PRP$ State_NN of_IN the_DT Union_NN address_NN ,_, President_NNP Clinton_NNP will_MD call_VB for_IN concerted_VBN international_JJ action_NN to_TO combat_VB infectious_JJ diseases_NNS in_IN developing_VBG countries_NNS ._. These_DT diseases_NNS cause_VBP almost_RB half_NN of_IN all_DT deaths_NNS worldwide_RB of_IN people_NNS under_IN age_NN 45_CD ,_, killing_VBG over_RB eight_CD million_CD children_NNS each_DT year_NN and_CC orphaning_VBG millions_NNS more_JJR ._. The_DT President_NNP committed_VBD the_DT United_NNP States_NNPS to_IN addressing_VBG this_DT terrible_JJ problem_NN in_IN his_PRP$ September_NNP speech_NN to_IN the_DT United_NNP Nations_NNPS General_NNP Assembly_NNP ._. Now_RB the_DT President_NNP is_VBZ asking_VBG for_IN foundations_NNS ,_, pharmaceutical_NN companies_NNS ,_, international_JJ agencies_NNS ,_, and_CC other_JJ governments_NNS to_TO join_VB us_PRP in_IN this_DT task_NN ,_, and_CC he_PRP is_VBZ announcing_VBG these_DT specific_JJ elements_NNS of_IN his_PRP$ Millennium_NNP Initiative_NNP :_: •_NFP A_DT new_JJ financial_JJ commitment_NN to_TO purchase_VB and_CC deliver_VB existing_VBG vaccines_NNS in_IN poor_JJ countries_NNS ._. As_IN Vice_NNP President_NNP Gore_NNP told_VBD the_DT U._NNP N._NNP Security_NNP Council_NNP earlier_RBR this_DT month_NN ,_, the_DT Administration�s_NNP FY_NNP 2001_CD budget_NN will_MD include_VB a_DT proposed_VBN $_$ 50_CD million_CD contribution_NN to_IN the_DT vaccine_NN purchase_NN fund_NN of_IN the_DT Global_NNP Alliance_NNP for_IN Vaccines_NNPS and_CC Immunization_NNP (_-LRB- GAVI_NNP )_-RRB- ._. •_NFP Increased_VBN investments_NNS in_IN health_NN in_IN developing_VBG countries_NNS ._. The_DT President_NNP is_VBZ calling_VBG on_IN the_DT World_NNP Bank_NNP and_CC other_JJ multilateral_JJ development_NN banks_NNS to_TO dedicate_VB an_DT additional_JJ $_$ 400_CD million_CD to_IN $_$ 900_CD million_CD annually_RB of_IN their_PRP$ low_JJ -_HYPH interest_NN -_HYPH rate_NN loans_NNS to_TO expand_VB immunization_NN ,_, prevent_VB and_CC treat_VB infectious_JJ diseases_NNS ,_, and_CC build_VB effective_JJ delivery_NN systems_NNS for_IN other_JJ basic_JJ health_NN services_NNS ._. These_DT investments_NNS are_VBP as_RB central_JJ to_IN economic_JJ progress_NN as_IN investments_NNS in_IN education_NN and_CC physical_JJ infrastructure_NN ,_, and_CC they_PRP would_MD build_VB on_IN the_DT new_JJ focus_NN on_IN basic_JJ health_NN services_NNS that_WDT we_PRP have_VBP supported_VBN as_IN part_NN of_IN the_DT Highly_RB Indebted_NNP Poor_NNP Countries_NNPS (_-LRB- HIPC_NNP )_-RRB- debt_NN initiative_NN ._. This_DT proposed_VBN shift_NN in_IN existing_VBG resources_NNS does_VBZ not_RB require_VB additional_JJ U.S._NNP budget_NN expenditures_NNS ._. •_NFP A_DT significant_JJ increase_NN in_IN basic_JJ research_NN on_IN diseases_NNS that_WDT affect_VBP developing_VBG nations_NNS ._. The_DT Administration�s_NNP FY_NNP 2001_CD budget_NN for_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP includes_VBZ a_DT sharp_JJ step_NN -_HYPH up_NN in_IN research_NN critical_JJ to_IN the_DT development_NN of_IN vaccines_NNS for_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC HIV_NN /_, AIDS_NN ._. •_NFP A_DT new_JJ tax_NN credit_NN for_IN sales_NNS of_IN vaccines_NNS for_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC HIV_NN /_, AIDS_NN to_TO accelerate_VB the_DT invention_NN and_CC production_NN of_IN these_DT vaccines_NNS ._. Because_IN developing_VBG countries_NNS often_RB cannot_MD afford_VB to_TO buy_VB vaccines_NNS ,_, the_DT market_NN provides_VBZ little_JJ incentive_NN for_IN pharmaceutical_JJ companies_NNS to_TO develop_VB vaccines_NNS for_IN diseases_NNS that_WDT disproportionately_RB affect_VBP those_DT countries_NNS ._. This_DT tax_NN credit_NN would_MD provide_VB such_PDT an_DT incentive_NN ,_, because_IN every_DT dollar_NN paid_VBN by_IN a_DT qualifying_NN organization_NN to_TO buy_VB a_DT qualifying_NN vaccine_NN would_MD be_VB matched_VBN by_IN a_DT dollar_NN of_IN tax_NN credits_NNS �_, representing_VBG up_IN to_IN $_$ 1_CD billion_CD of_IN additional_JJ funding_NN for_IN future_JJ vaccine_NN purchases_NNS ._. The_DT President_NNP is_VBZ calling_VBG on_IN other_JJ governments_NNS to_TO make_VB similar_JJ purchase_NN commitments_NNS ,_, so_IN that_IN we_PRP can_MD ensure_VB a_DT future_JJ market_NN for_IN these_DT critically_RB needed_VBN vaccines_NNS ._. Infectious_JJ Diseases_NNS Pose_VBP a_DT Mounting_VBG Social_JJ and_CC Economic_JJ Burden_NN on_IN Developing_VBG Countries_NNS �_'' And_CC a_DT Threat_NN to_IN Our_PRP$ Health_NN As_IN Well_UH ._. •_NFP More_JJR than_IN eight_CD million_CD children_NNS die_VBP each_DT year_NN of_IN centuries_NNS -_HYPH old_JJ diseases_NNS like_IN malaria_NN ,_, tuberculosis_NN ,_, and_CC respiratory_JJ and_CC diarrheal_NN diseases_NNS ._. Deaths_NNS from_IN the_DT modern_JJ scourge_NN of_IN AIDS_NN are_VBP climbing_VBG rapidly_RB ._. Altogether_RB ,_, as_IN many_JJ children_NNS die_VBP of_IN infectious_JJ diseases_NNS each_DT year_NN as_IN the_DT total_JJ number_NN of_IN combatants_NNS who_WP perished_VBD in_IN World_NNP War_NNP I_CD ._. •_NFP In_IN an_DT interconnected_VBN and_CC highly_RB mobile_JJ world_NN ,_, health_NN crises_NNS in_IN other_JJ countries_NNS are_VBP a_DT threat_NN to_IN everyone_NN ._. We_PRP have_VBP seen_VBN this_DT with_IN HIV_NN /_, AIDS_NN ,_, with_IN the_DT resurfacing_NN of_IN tuberculosis_NN ,_, and_CC with_IN the_DT outbreak_NN last_JJ year_NN of_IN West_NNP Nile_NNP encephalitis_NN in_IN New_NNP York_NNP ._. According_VBG to_IN the_DT Global_NNP Health_NNP Council_NNP ,_, during_IN the_DT past_JJ 50_CD years_NNS ,_, at_IN least_JJS five_CD times_NNS as_IN many_JJ Americans_NNPS have_VBP died_VBN from_IN communicable_JJ diseases_NNS that_WDT have_VBP come_VBN from_IN the_DT developing_VBG world_NN than_IN have_VBP died_VBN in_IN military_JJ conflicts_NNS ._. Vaccines_NNS Are_VBP One_CD of_IN the_DT Most_JJS Cost_NN -_HYPH Effective_JJ Ways_NNS to_TO Improve_VB the_DT Well_NN -_HYPH Being_NN and_CC Productivity_NN of_IN the_DT Poorest_JJS Countries_NNS �_, And_CC Medicines_NNS and_CC Other_JJ Basic_JJ Health_NN Services_NNS Are_VBP a_DT Necessary_JJ Complement_NN ._. •_NFP It_PRP costs_VBZ about_RB $_$ 17_CD to_TO immunize_VB a_DT child_NN ,_, but_CC millions_NNS of_IN children_NNS die_VBP each_DT year_NN of_IN diseases_NNS that_WDT could_MD be_VB prevented_VBN by_IN existing_VBG vaccines_NNS ._. Indeed_RB ,_, children_NNS in_IN developing_VBG nations_NNS are_VBP 10_CD times_NNS more_RBR likely_JJ to_TO die_VB of_IN a_DT vaccine_NN -_HYPH preventable_JJ disease_NN than_IN children_NNS in_IN developed_JJ nations_NNS ._. And_CC these_DT tragedies_NNS occur_VBP in_IN spite_NN of_IN the_DT enormous_JJ efforts_NNS of_IN UNICEF_NNP and_CC others_NNS to_TO vaccinate_VB children_NNS ,_, which_WDT save_VBP 3_CD million_CD lives_NNS each_DT year_NN ._. •_NFP Highly_RB effective_JJ vaccines_NNS do_VBP not_RB yet_RB exist_VB for_IN malaria_NN ,_, TB_NN and_CC AIDS_NN ,_, which_WDT take_VBP over_RB 5_CD million_CD lives_NNS each_DT year_NN ._. But_CC developed_VBN nations_NNS have_VBP the_DT scientific_JJ and_CC technological_JJ capacity_NN to_TO make_VB new_JJ vaccines_NNS possible_JJ ._. For_IN example_NN ,_, recent_JJ work_NN on_IN genetic_JJ sequencing_NN ,_, including_VBG the_DT human_JJ genome_NN ,_, will_MD open_VB vast_JJ possibilities_NNS ._. •_NFP Another_DT health_NN investment_NN with_IN very_RB high_JJ returns_NNS is_VBZ simple_JJ preventive_JJ and_CC curative_JJ services_NNS ._. Providing_VBG this_DT basic_JJ health_NN care_NN together_RB with_IN vaccines_NNS would_MD save_VB millions_NNS of_IN lives_NNS each_DT year_NN ._. A_DT $_$ 50_CD Million_CD Contribution_NN to_IN GAVI_NN to_TO Buy_VB Vaccines_NNS For_IN Children_NNS �_, Which_WDT Will_MD Save_VB Lives_NNS Now_RB and_CC Create_VB Confidence_NN that_WDT a_DT Market_NN for_IN New_JJ Vaccines_NNS Will_MD Exist_VB in_IN the_DT Future_NN ._. •_NFP GAVI_NNP ,_, the_DT Global_NNP Alliance_NNP for_IN Vaccines_NNPS and_CC Immunization_NNP ,_, was_VBD formed_VBN as_IN a_DT collaborative_JJ effort_NN of_IN UNICEF_NNP ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, the_DT World_NNP Bank_NNP ,_, private_JJ foundations_NNS ,_, bilateral_JJ aid_NN agencies_NNS (_-LRB- including_VBG the_DT U.S._NNP Agency_NNP for_IN International_NNP Development_NNP )_-RRB- ,_, industry_NN representatives_NNS ,_, and_CC developing_VBG countries_NNS ._. GAVI_NNP established_VBD the_DT �_`` Global_NNP Fund_NNP for_IN Children�s_NNP Vaccines_NNPS �_, with_IN an_DT initial_JJ grant_NN of_IN $_$ 750_CD million_CD over_RB 5_CD years_NNS from_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ._. The_DT formal_JJ launch_NN of_IN GAVI_NNP ,_, and_CC the_DT official_JJ announcement_NN of_IN the_DT Gates_NNP gift_NN ,_, will_MD occur_VB shortly_RB in_IN Davos_NNP ,_, Switzerland_NNP ._. •_NFP A_DT U.S._NNP contribution_NN will_MD help_VB to_TO purchase_VB vaccines_NNS for_IN Hepatitis_NN B_NN ,_, Haemophilus_NN Influenzae_NN B_NN (_-LRB- Hib_NNP )_-RRB- ,_, and_CC Yellow_NNP Fever_NNP ,_, along_IN with_IN related_JJ safe_JJ delivery_NN equipment_NN such_JJ as_IN auto_NN -_HYPH destruct_NN syringes_NNS ._. To_TO ensure_VB that_IN GAVI�s_NN vaccine_NN purchases_NNS complement_VBP ,_, rather_RB than_IN replace_VB ,_, existing_VBG vaccination_NN efforts_NNS ,_, they_PRP will_MD be_VB conditional_JJ on_IN a_DT country_NN achieving_VBG 50_CD percent_NN coverage_NN of_IN the_DT DTP_NN (_-LRB- diptheria_NN -_HYPH tetanus_NN -_HYPH pertussis_NN )_-RRB- vaccine_NN ,_, which_WDT is_VBZ included_VBN along_IN with_IN measles_NNS and_CC polio_NN in_IN the_DT existing_VBG EPI_NN (_-LRB- Expanded_VBN Program_NN for_IN Immunization_NN )_-RRB- ._. •_NFP A_DT U.S._NNP contribution_NN will_MD hopefully_RB catalyze_VB significant_JJ contributions_NNS from_IN other_JJ countries_NNS and_CC foundations_NNS ._. It_PRP will_MD also_RB add_VB crucial_JJ credibility_NN to_IN the_DT international_JJ community�s_NNS commitment_NN to_TO provide_VB a_DT market_NN for_IN new_JJ vaccines_NNS when_WRB they_PRP are_VBP developed_VBN ._. We_PRP Must_MD Shift_VB Existing_VBG International_NNP Resources_NNPS Toward_IN Building_NNP Health_NNP Infrastructure_NNP in_IN Poor_NNP Countries_NNPS That_WDT Can_MD Deliver_VB Vaccines_NNS and_CC Medicines_NNPS and_CC Provide_VB Essential_NNP Basic_NNP Health_NNP Services_NNPS ._. •_NFP The_DT World_NNP Bank_NNP and_CC other_JJ multilateral_JJ development_NN banks_NNS (_-LRB- MDBs_NNS ,_, such_JJ as_IN the_DT African_NNP Development_NNP Fund_NNP )_-RRB- lend_VBP money_NN on_IN highly_RB favorable_JJ terms_NNS to_IN the_DT world�s_NNS poorest_JJS countries_NNS ._. Today_NN ,_, roughly_RB $_$ 1_CD billion_CD to_IN $_$ 1_CD -_SYM 1/_CD 2_CD billion_CD of_IN this_DT so_RB -_HYPH called_VBN �_HYPH concessional_JJ funding_NN �_, is_VBZ devoted_VBN to_IN health_NN care_NN each_DT year_NN ._. The_DT Administration_NN proposes_VBZ to_TO increase_VB that_DT amount_NN by_IN $_$ 400_CD million_CD to_IN $_$ 900_CD million_CD per_IN year_NN ,_, with_IN a_DT focus_NN on_IN :_: •_NFP prevention_NN of_IN diseases_NNS using_VBG basic_JJ measures_NNS such_JJ as_IN information_NN and_CC condoms_NNS for_IN AIDS_NN ,_, treated_VBN bed_NN nets_NNS for_IN malaria_NN ,_, and_CC stronger_JJR systems_NNS for_IN containing_VBG TB_NN ;_, •_SYM treatment_NN of_IN diseases_NNS ,_, including_VBG common_JJ respiratory_JJ and_CC diarrheal_NN infections_NNS ;_: and_CC •_NFP The_DT Administration_NN is_VBZ exploring_VBG ways_NNS to_TO use_VB the_DT HIPC_NNP debt_NN reform_NN to_TO support_VB this_DT part_NN of_IN the_DT Millennium_NNP Initiative_NNP ._. One_CD possibility_NN is_VBZ to_TO make_VB an_DT increase_NN in_IN vaccination_NN rates_NNS one_CD of_IN the_DT performance_NN targets_NNS monitored_VBN in_IN the_DT HIPC_NNP progress_NN reports_NNS ._. This_DT could_MD be_VB accompanied_VBN by_IN debtor_NN countries_NNS �_SYM agreements_NNS to_TO include_VB specific_JJ improvements_NNS in_IN vaccine_NN delivery_NN systems_NNS as_IN priority_NN uses_NNS of_IN debt_NN relief_NN proceeds_NNS ._. We_PRP also_RB expect_VBP that_IN all_DT Poverty_NN Reduction_NN Strategy_NN Papers_NNS that_WDT are_VBP prepared_VBN for_IN HIPC_NNP candidates_NNS will_MD discuss_VB the_DT adequacy_NN of_IN budget_NN resources_NNS and_CC suggested_VBN policy_NN reforms_NNS devoted_VBN to_IN basic_JJ health_NN care_NN ._. •_NFP This_DT re-direction_NN of_IN resources_NNS supports_VBZ the_DT Administration�s_NNPS overall_JJ strategy_NN for_IN global_JJ development_NN ,_, which_WDT emphasizes_VBZ poverty_NN reduction_NN and_CC gives_VBZ a_DT central_JJ role_NN to_IN �global_JJ public_JJ goods_NNS �_, �_CC like_IN health_NN or_CC the_DT environment_NN �_, in_IN which_WDT positive_JJ actions_NNS taken_VBN in_IN one_CD country_NN benefit_VBP other_JJ countries_NNS as_RB well_RB ._. To_TO meet_VB this_DT objective_NN ,_, these_DT funds_NNS should_MD not_RB come_VB from_IN spending_NN on_IN other_JJ basic_JJ social_JJ programs_NNS ,_, such_JJ as_IN education_NN and_CC health_NN care_NN ._. •_NFP This_DT aspect_NN of_IN the_DT Millennium_NNP Initiative_NNP does_VBZ not_RB require_VB a_DT new_JJ budgetary_JJ commitment_NN by_IN the_DT United_NNP States_NNPS (_-LRB- or_CC other_JJ donor_NN countries_NNS )_-RRB- ._. However_RB ,_, the_DT U.S._NNP ability_NN to_TO influence_VB the_DT direction_NN of_IN MDB_NN lending_NN and_CC the_DT use_NN of_IN HIPC_NNP proceeds_NNS depends_VBZ crucially_RB on_IN meeting_VBG our_PRP$ existing_VBG commitments_NNS to_IN these_DT aid_NN programs_NNS ._. We_PRP will_MD work_VB with_IN other_JJ G_NNP -_HYPH 8_CD finance_NN and_CC development_NN ministries_NNS to_TO refine_VB this_DT proposal_NN ._. •_NFP A_DT conservative_JJ estimate_NN suggests_VBZ that_IN if_IN basic_JJ health_NN care_NN including_VBG immunization_NN were_VBD made_VBN broadly_RB available_JJ ,_, up_IN to_IN 2_CD million_CD children�s_NNS lives_NNS could_MD be_VB saved_VBN each_DT year_NN ._. Higher_JJR Funding_NN for_IN Basic_NNP Scientific_NNP Research_NNP Through_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- and_CC Elsewhere_RB Will_MD Hasten_VB the_DT Development_NN of_IN Vaccines_NNS for_IN Malaria_NN ,_, TB_NN ,_, and_CC AIDS_NN ._. •_NFP The_DT Administration�s_NNP FY_NNP 2001_CD budget_NN for_IN NIH_NNP includes_VBZ a_DT significant_JJ increase_NN in_IN research_NN critical_JJ to_IN creating_VBG vaccines_NNS for_IN these_DT diseases_NNS ._. For_IN malaria_NN and_CC TB_NN ,_, this_DT increase_NN will_MD build_VB on_IN recent_JJ advances_NNS in_IN the_DT genetic_JJ sequencing_NN of_IN these_DT diseases_NNS ,_, which_WDT have_VBP set_VBN the_DT stage_NN for_IN major_JJ breakthroughs_NNS in_IN vaccine_NN development_NN ._. •_NFP Funding_NN for_IN NIH_NNP malaria_NN vaccine_NN research_NN will_MD increase_VB more_JJR than_IN 10_CD percent_NN over_IN the_DT FY_NNP 2000_CD level_NN ._. Future_JJ research_NN will_MD range_VB from_IN pre-clinical_JJ studies_NNS aimed_VBN at_IN improving_VBG our_PRP$ understanding_NN of_IN the_DT malaria_NN parasite_NN ,_, through_IN the_DT development_NN of_IN vaccine_NN candidates_NNS ,_, to_IN clinical_JJ trials_NNS judging_VBG vaccine_NN efficacy_NN and_CC safety_NN ._. NIH_NNP will_MD also_RB expand_VB its_PRP$ collaboration_NN with_IN scientists_NNS in_IN malaria_NN -_HYPH endemic_JJ regions_NNS ,_, especially_RB in_IN Africa_NNP ,_, to_TO strengthen_VB those_DT regions_NNS �_, capacity_NN for_IN conducting_VBG clinical_JJ trials_NNS of_IN malaria_NN vaccines_NNS in_IN the_DT future_NN ._. •_SYM NIH_NNP research_NN on_IN a_DT tuberculosis_NN vaccine_NN will_MD receive_VB over_RB 40_CD percent_NN more_JJR funding_NN than_IN in_IN FY_NNP 2000_CD and_CC more_JJR than_IN double_JJ the_DT FY_NNP 1999_CD level_NN ._. NIH_NNP will_MD focus_VB on_IN studying_VBG the_DT body�s_NNS defense_NN mechanisms_NNS against_IN TB_NN ,_, and_CC developing_VBG and_CC studying_VBG vaccine_NN candidates_NNS ._. Through_IN its_PRP$ Tuberculosis_NNP Research_NNP Unit_NNP ,_, NIH_NNP supports_VBZ an_DT international_JJ multi-disciplinary_JJ team_NN to_TO translate_VB advances_NNS in_IN basic_JJ research_NN into_IN new_JJ tools_NNS for_IN fighting_VBG TB_NN ._. •_NFP NIH_NNP funding_NN for_IN AIDS_NN vaccine_NN research_NN will_MD increase_VB substantially_RB in_IN FY_NNP 2001_CD and_CC will_MD have_VB more_JJR than_IN doubled_VBN since_IN FY_NNP 1997_CD ._. These_DT additional_JJ resources_NNS will_MD allow_VB NIH_NNP to_TO accelerate_VB basic_JJ research_NN on_IN developing_VBG vaccine_NN candidates_NNS and_CC to_TO significantly_RB expand_VB testing_NN of_IN potential_JJ vaccine_NN candidates_NNS in_IN both_CC developing_VBG and_CC developed_VBN countries_NNS ._. The_DT new_JJ Vaccine_NNP Research_NNP Center_NNP on_IN the_DT NIH_NNP campus_NN ,_, which_WDT will_MD be_VB occupied_VBN this_DT summer_NN ,_, will_MD receive_VB a_DT sizeable_JJ increase_NN in_IN funding_NN for_IN the_DT development_NN and_CC pre-clinical_JJ testing_NN of_IN HIV_NNP vaccine_NN candidates_NNS ._. •_NFP The_DT Administration_NN is_VBZ providing_VBG strong_JJ support_NN for_IN the_DT path_NN -_HYPH breaking_VBG research_NN on_IN infectious_JJ diseases_NNS being_VBG conducted_VBN by_IN U.S._NNP military_JJ scientists_NNS ,_, including_VBG the_DT opening_NN (_-LRB- in_IN October_NNP 1999_CD )_-RRB- of_IN the_DT Walter_NNP Reed_NNP Army_NNP Institute_NNP of_IN Research_NNP /_, Naval_NNP Medical_NNP Research_NNP Center_NNP ._. Working_VBG in_IN close_JJ collaboration_NN with_IN scientists_NNS worldwide_RB ,_, military_JJ scientists_NNS have_VBP developed_VBN and_CC tested_VBN successful_JJ vaccines_NNS against_IN Japanese_JJ encephalitis_NN and_CC hepatitis_NN A_NNP �_, and_CC they_PRP are_VBP working_VBG to_TO create_VB vaccines_NNS and_CC medicines_NNS to_TO protect_VB service_NN people_NNS ,_, travelers_NNS ,_, and_CC millions_NNS of_IN others_NNS from_IN malaria_NN ,_, HIV_NN /_, AIDS_NN ,_, and_CC other_JJ infectious_JJ diseases_NNS ._. A_DT New_JJ Tax_NN Credit_NN Would_MD Effectively_RB Provide_VB Up_RP to_IN $_$ 1_CD Billion_CD for_IN Future_NN Vaccine_NN Purchases_NNS ,_, Speeding_VBG the_DT Invention_NN and_CC Production_NN of_IN New_JJ Vaccines_NNS ._. •_NFP Current_JJ tax_NN law_NN provides_VBZ substantial_JJ incentives_NNS for_IN pharmaceutical_JJ research_NN and_CC development_NN ,_, including_VBG the_DT research_NN and_CC experimentation_NN (_-LRB- R&E_NNP )_-RRB- tax_NN credit_NN ,_, the_DT orphan_NN drug_NN tax_NN credit_NN ,_, and_CC an_DT enhanced_VBN deduction_NN for_IN charitable_JJ contributions_NNS of_IN certain_JJ products_NNS ._. Nonetheless_RB ,_, pharmaceutical_JJ companies_NNS may_MD be_VB reluctant_JJ to_TO invest_VB in_IN developing_VBG vaccines_NNS for_IN diseases_NNS that_WDT primarily_RB afflict_VBP people_NNS in_IN poor_JJ countries_NNS ,_, because_IN little_JJ or_CC no_DT paying_VBG market_NN exists_VBZ in_IN those_DT countries_NNS ._. •_NFP Under_IN the_DT proposal_NN ,_, the_DT seller_NN of_IN a_DT qualified_VBN vaccine_NN could_MD claim_VB a_DT tax_NN credit_NN equal_JJ to_IN 100_CD percent_NN of_IN the_DT amount_NN paid_VBN by_IN a_DT qualifying_NN organization_NN that_WDT received_VBD a_DT �credit_NN allocation�_NN by_IN the_DT U.S._NNP Agency_NNP for_IN International_NNP Development_NNP (_-LRB- AID_NNP )_-RRB- ._. The_DT tax_NN credit_NN would_MD match_VB the_DT qualified_VBN organizations_NNS �_HYPH expenditures_NNS dollar_NN -_HYPH for_IN -_HYPH dollar_NN ,_, thereby_RB doubling_VBG their_PRP$ purchasing_NN power_NN ._. A_DT qualifying_NN vaccine_NN would_MD be_VB a_DT new_JJ vaccine_NN that_WDT received_VBD FDA_NNP approval_NN for_IN use_NN against_IN malaria_NN ,_, tuberculosis_NN ,_, HIV_NN /_, AIDS_NN ,_, or_CC any_DT infectious_JJ disease_NN that_WDT causes_VBZ over_RB 1_CD million_CD deaths_NNS annually_RB worldwide_RB ._. •_NFP For_IN 2002_CD through_IN 2010_CD ,_, AID_NNP could_MD designate_VB up_IN to_IN $_$ 1_CD billion_CD of_IN vaccine_NN sales_NNS as_IN eligible_JJ for_IN the_DT credit_NN ._. This_DT tax_NN credit_NN would_MD be_VB limited_VBN to_IN new_JJ vaccines_NNS developed_VBN to_TO fight_VB these_DT terrible_JJ diseases_NNS ._. The_DT credit_NN would_MD provide_VB a_DT specific_JJ and_CC credible_JJ commitment_NN to_TO purchase_VB future_JJ vaccines_NNS at_IN reasonable_JJ prices_NNS ._. Together_RB with_IN similar_JJ commitments_NNS from_IN foundations_NNS and_CC other_JJ governments_NNS ,_, it_PRP would_MD provide_VB a_DT critical_JJ and_CC powerful_JJ incentive_NN to_TO accelerate_VB vaccine_NN research_NN and_CC development_NN ._.","THE JJ NN NN of the NNP NNP NNP NNP VBZ NNP NNP to NNP NNP of NNP NNPS in VBG NNS and VB NN of NNP NNPS In his NN of the NN NN , NNP NNP will VB for VBN JJ NN to VB JJ NNS in VBG NNS . These NNS VBP RB NN of all NNS RB of NNS under NN 45 , VBG RB eight million NNS each NN and VBG NNS JJR . The NNP VBD the NNP NNPS to VBG this JJ NN in his NNP NN to the NNP NNPS NNP NNP . RB the NNP VBZ VBG for NNS , NN NNS , JJ NNS , and JJ NNS to VB us in this NN , and he VBZ VBG these JJ NNS of his NNP NNP : • A JJ JJ NN to VB and VB VBG NNS in JJ NNS . As NNP NNP NNP VBD the NNP NNP NNP NNP RBR this NN , the NNP NNP 2001 NN will VB a VBN $ 50 million NN to the NN NN NN of the NNP NNP for NNPS and NNP ( NNP ) . • VBN NNS in NN in VBG NNS . The NNP VBZ VBG on the NNP NNP and JJ JJ NN NNS to VB an JJ $ 400 million to $ 900 million RB of their JJ - NN - NN NNS to VB NN , VB and VB JJ NNS , and VB JJ NN NNS for JJ JJ NN NNS . These NNS VBP RB JJ to JJ NN as NNS in NN and JJ NN , and they would VB on the JJ NN on JJ NN NNS that we VBP VBN as NN of the RB NNP NNP NNPS ( NNP ) NN NN . This VBN NN in VBG NNS VBZ RB VB JJ NNP NN NNS . • A JJ NN in JJ NN on NNS that VBP VBG NNS . The NNP NNP 2001 NN for the NNP NNPS of NNP VBZ a JJ NN - NN in NN JJ to the NN of NNS for NN , NN , and NN / NN . • A JJ NN NN for NNS of NNS for NN , NN , and NN / NN to VB the NN and NN of these NNS . Because VBG NNS RB cannot VB to VB NNS , the NN VBZ JJ NN for JJ NNS to VB NNS for NNS that RB VBP those NNS . This NN NN would VB such an NN , because every NN VBN by a NN NN to VB a NN NN would VB VBN by a NN of NN NNS � VBG up to $ 1 billion of JJ NN for JJ NN NNS . The NNP VBZ VBG on JJ NNS to VB JJ NN NNS , so that we can VB a JJ NN for these RB VBN NNS . JJ NNS VBP a VBG JJ and JJ NN on VBG NNS � And a NN to Our NN As Well . • JJR than eight million NNS VBP each NN of NNS - JJ NNS like NN , NN , and JJ and NN NNS . NNS from the JJ NN of NN VBP VBG RB . RB , as JJ NNS VBP of JJ NNS each NN as the JJ NN of NNS who VBD in NNP NNP I . • In an VBN and RB JJ NN , NN NNS in JJ NNS VBP a NN to NN . We VBP VBN this with NN / NN , with the NN of NN , and with the NN JJ NN of NNP NNP NN in NNP NNP . VBG to the NNP NNP NNP , during the JJ 50 NNS , at JJS five NNS as JJ NNPS VBP VBN from JJ NNS that VBP VBN from the VBG NN than VBP VBN in JJ NNS . NNS VBP One of the JJS NN - JJ NNS to VB the NN - NN and NN of the JJS NNS � And NNS and JJ JJ NN NNS VBP a JJ NN . • It VBZ RB $ 17 to VB a NN , but NNS of NNS VBP each NN of NNS that could VB VBN by VBG NNS . RB , NNS in VBG NNS VBP 10 NNS RBR JJ to VB of a NN - JJ NN than NNS in JJ NNS . And these NNS VBP in NN of the JJ NNS of NNP and NNS to VB NNS , which VBP 3 million NNS each NN . • RB JJ NNS VBP RB RB VB for NN , NN and NN , which VBP RB 5 million NNS each NN . But VBN NNS VBP the JJ and JJ NN to VB JJ NNS JJ . For NN , JJ NN on JJ NN , VBG the JJ NN , will VB JJ NNS . • Another NN NN with RB JJ NNS VBZ JJ JJ and JJ NNS . VBG this JJ NN NN RB with NNS would VB NNS of NNS each NN . A $ 50 Million NN to NN to VB NNS For NNS � Which Will VB NNS RB and VB NN that a NN for JJ NNS Will VB in the NN . • NNP , the NNP NNP for NNPS and NNP , VBD VBN as a JJ NN of NNP , the NNP NNP NNP ( NNP ) , the NNP NNP , JJ NNS , JJ NN NNS ( VBG the NNP NNP for NNP NNP ) , NN NNS , and VBG NNS . NNP VBD the � NNP NNP for NNP NNPS � with an JJ NN of $ 750 million RB 5 NNS from the NNP and NNP NNP NNP . The JJ NN of NNP , and the JJ NN of the NNP NN , will VB RB in NNP , NNP . • A NNP NN will VB to VB NNS for NN NN , NN NN NN ( NNP ) , and NNP NNP , along with JJ JJ NN NN JJ as NN - NN NNS . To VB that NN NN NNS VBP , RB than VB , VBG NN NNS , they will VB JJ on a NN VBG 50 NN NN of the NN ( NN - NN - NN ) NN , which VBZ VBN along with NNS and NN in the VBG NN ( VBN NN for NN ) . • A NNP NN will RB VB JJ NNS from JJ NNS and NNS . It will RB VB JJ NN to the JJ NNS NN to VB a NN for JJ NNS when they VBP VBN . We Must VB VBG NNP NNPS Toward NNP NNP NNP in NNP NNPS That Can VB NNS and NNPS and VB NNP NNP NNP NNPS . • The NNP NNP and JJ JJ NN NNS ( NNS , JJ as the NNP NNP NNP ) VBP NN on RB JJ NNS to the NNS JJS NNS . NN , RB $ 1 billion to $ 1 - 1/ 2 billion of this RB - VBN � JJ NN � VBZ VBN to NN NN each NN . The NN VBZ to VB that NN by $ 400 million to $ 900 million per NN , with a NN on : • NN of NNS VBG JJ NNS JJ as NN and NNS for NN , VBN NN NNS for NN , and JJR NNS for VBG NN ; • NN of NNS , VBG JJ JJ and NN NNS ; and • The NN VBZ VBG NNS to VB the NNP NN NN to VB this NN of the NNP NNP . One NN VBZ to VB an NN in NN NNS one of the NN NNS VBN in the NNP NN NNS . This could VB VBN by NN NNS � NNS to VB JJ NNS in NN NN NNS as NN NNS of NN NN NNS . We RB VBP that all NN NN NN NNS that VBP VBN for NNP NNS will VB the NN of NN NNS and VBN NN NNS VBN to JJ NN NN . • This NN of NNS VBZ the NNPS JJ NN for JJ NN , which VBZ NN NN and VBZ a JJ NN to JJ JJ NNS � � like NN or the NN � in which JJ NNS VBN in one NN VBP JJ NNS RB RB . To VB this NN , these NNS should RB VB from NN on JJ JJ JJ NNS , JJ as NN and NN NN . • This NN of the NNP NNP VBZ RB VB a JJ JJ NN by the NNP NNPS ( or JJ NN NNS ) . RB , the NNP NN to VB the NN of NN NN and the NN of NNP NNS VBZ RB on VBG our VBG NNS to these NN NNS . We will VB with JJ NNP - 8 NN and NN NNS to VB this NN . • A JJ NN VBZ that if JJ NN NN VBG NN VBD VBN RB JJ , up to 2 million NNS NNS could VB VBN each NN . JJR NN for NNP NNP NNP Through the NNP NNPS of NNP ( NNP ) and RB Will VB the NN of NNS for NN , NN , and NN . • The NNP NNP 2001 NN for NNP VBZ a JJ NN in NN JJ to VBG NNS for these NNS . For NN and NN , this NN will VB on JJ NNS in the JJ NN of these NNS , which VBP VBN the NN for JJ NNS in NN NN . • NN for NNP NN NN NN will VB JJR than 10 NN over the NNP 2000 NN . JJ NN will VB from JJ NNS VBN at VBG our NN of the NN NN , through the NN of NN NNS , to JJ NNS VBG NN NN and NN . NNP will RB VB its NN with NNS in NN - JJ NNS , RB in NNP , to VB those NNS � NN for VBG JJ NNS of NN NNS in the NN . • NNP NN on a NN NN will VB RB 40 NN JJR NN than in NNP 2000 and JJR than JJ the NNP 1999 NN . NNP will VB on VBG the NNS NN NNS against NN , and VBG and VBG NN NNS . Through its NNP NNP NNP , NNP VBZ an JJ JJ NN to VB NNS in JJ NN into JJ NNS for VBG NN . • NNP NN for NN NN NN will VB RB in NNP 2001 and will VB JJR than VBN since NNP 1997 . These JJ NNS will VB NNP to VB JJ NN on VBG NN NNS and to RB VB NN of JJ NN NNS in both VBG and VBN NNS . The JJ NNP NNP NNP on the NNP NN , which will VB VBN this NN , will VB a JJ NN in NN for the NN and JJ NN of NNP NN NNS . • The NN VBZ VBG JJ NN for the NN - VBG NN on JJ NNS VBG VBN by NNP JJ NNS , VBG the NN ( in NNP 1999 ) of the NNP NNP NNP NNP of NNP / NNP NNP NNP NNP . VBG in JJ NN with NNS RB , JJ NNS VBP VBN and VBN JJ NNS against JJ NN and NN NNP � and they VBP VBG to VB NNS and NNS to VB NN NNS , NNS , and NNS of NNS from NN , NN / NN , and JJ JJ NNS . A JJ NN NN Would RB VB Up to $ 1 Billion for NN NN NNS , VBG the NN and NN of JJ NNS . • JJ NN NN VBZ JJ NNS for JJ NN and NN , VBG the NN and NN ( NNP ) NN NN , the NN NN NN NN , and an VBN NN for JJ NNS of JJ NNS . RB , JJ NNS may VB JJ to VB in VBG NNS for NNS that RB VBP NNS in JJ NNS , because JJ or no VBG NN VBZ in those NNS . • Under the NN , the NN of a VBN NN could VB a NN NN JJ to 100 NN of the NN VBN by a NN NN that VBD a NN NN by the NNP NNP for NNP NNP ( NNP ) . The NN NN would VB the VBN NNS � NNS NN - for - NN , RB VBG their NN NN . A NN NN would VB a JJ NN that VBD NNP NN for NN against NN , NN , NN / NN , or any JJ NN that VBZ RB 1 million NNS RB RB . • For 2002 through 2010 , NNP could VB up to $ 1 billion of NN NNS as JJ for the NN . This NN NN would VB VBN to JJ NNS VBN to VB these JJ NNS . The NN would VB a JJ and JJ NN to VB JJ NNS at JJ NNS . RB with JJ NNS from NNS and JJ NNS , it would VB a JJ and JJ NN to VB NN NN and NN ."
116,897,conspiracy,"The_DT Trump_NNP Executive_NNP Order_NNP (_-LRB- EO_NNP )_-RRB- on_IN “_`` human_JJ rights_NNS or_CC corruption_NN ”_'' may_MD get_VB some_DT use_NN in_IN 2018_CD ._. Anonymous_JJ sources_NNS and_CC Washington_NNP insiders_NNS think_VBP this_DT EO_NN will_MD be_VB used_VBN to_TO mount_VB a_DT counter_NN attack_NN against_IN the_DT so_RB -_HYPH called_VBN Washington_NNP Swamp_NNP and_CC the_DT Deep_NNP State_NNP who_WP are_VBP trying_VBG to_TO kick_VB President_NNP Trump_NNP out_IN of_IN office_NN ._. The_DT order_NN allows_VBZ the_DT Treasury_NNP Department_NNP to_TO block_VB and_CC take_VB assets_NNS of_IN anyone_NN involved_VBN in_IN human_JJ trafficking_NN or_CC corruption_NN ,_, and_CC this_DT means_VBZ any_DT corruption_NN ._. In_IN short_JJ ,_, Trump_NNP is_VBZ going_VBG to_TO war_NN against_IN globalists_NNS who_WP have_VBP been_VBN selling_VBG out_RP and_CC ripping_VBG off_RP America_NNP for_IN decades_NNS ._. Some_DT Intel_NNP experts_NNS say_VBP this_DT is_VBZ one_CD of_IN the_DT most_RBS pivotal_JJ times_NNS in_IN American_JJ history_NN ._. President_NNP Trump_NNP has_VBZ disbanded_VBN his_PRP$ voter_NN fraud_NN commission_NN because_IN of_IN heavy_JJ resistance_NN from_IN some_DT very_RB blue_JJ states_NNS such_JJ as_IN New_NNP York_NNP and_CC California_NNP ._. Trump_NNP has_VBZ charged_VBN that_IN he_PRP will_MD not_RB get_VB bogged_VBN down_RP in_IN legal_JJ action_NN and_CC ,_, instead_RB ,_, has_VBZ turned_VBN the_DT investigation_NN over_RP to_IN Homeland_NNP Security_NNP ._. Is_VBZ voter_NN fraud_NN a_DT national_JJ security_NN issue_NN ?_. According_VBG to_IN this_DT move_NN by_IN the_DT White_NNP House_NNP —_: yes_UH ,_, it_PRP is_VBZ ._. On_IN New_NNP Year_NNP ’s_POS Eve_NNP ,_, CNN_NNP promoted_VBD drug_NN use_NN in_IN the_DT form_NN of_IN pot_NN smoking_NN to_TO ring_VB in_IN the_DT New_NNP Year_NNP ._. Pot_NNP became_VBD legal_JJ in_IN the_DT state_NN of_IN Colorado_NNP ,_, and_CC CNN_NNP was_VBD not_RB only_RB covering_VBG the_DT implementation_NN of_IN the_DT new_JJ law_NN ,_, but_CC promoting_VBG it_PRP as_IN a_DT good_JJ thing_NN ._. The_DT Christian_JJ community_NN and_CC people_NNS like_IN Reverend_NNP Franklin_NNP Graham_NNP think_VBP the_DT coverage_NN by_IN CNN_NNP was_VBD “_`` shameless_JJ ._. ”_'' It_PRP shows_VBZ a_DT morally_RB sinking_VBG mainstream_JJ media_NN ._. Join_VB Greg_NNP Hunter_NNP as_IN he_PRP talks_VBZ about_IN these_DT stories_NNS and_CC more_JJR in_IN the_DT Weekly_NNP News_NNP Wrap_NNP -_HYPH Up_NNP ._. Gregory_NNP Mannarino_NNP of_IN TradersChoice.net_NNP will_MD be_VB the_DT guest_NN for_IN the_DT Early_JJ Sunday_NNP Release_NN ._.","The NNP NNP NNP ( NNP ) on “ JJ NNS or NN ” may VB some NN in 2018 . JJ NNS and NNP NNS VBP this NN will VB VBN to VB a NN NN against the RB - VBN NNP NNP and the NNP NNP who VBP VBG to VB NNP NNP out of NN . The NN VBZ the NNP NNP to VB and VB NNS of NN VBN in JJ NN or NN , and this VBZ any NN . In JJ , NNP VBZ VBG to NN against NNS who VBP VBN VBG out and VBG off NNP for NNS . Some NNP NNS VBP this VBZ one of the RBS JJ NNS in JJ NN . NNP NNP VBZ VBN his NN NN NN because of JJ NN from some RB JJ NNS JJ as NNP NNP and NNP . NNP VBZ VBN that he will RB VB VBN down in JJ NN and , RB , VBZ VBN the NN over to NNP NNP . VBZ NN NN a JJ NN NN ? VBG to this NN by the NNP NNP — yes , it VBZ . On NNP NNP ’s NNP , NNP VBD NN NN in the NN of NN NN to VB in the NNP NNP . NNP VBD JJ in the NN of NNP , and NNP VBD RB RB VBG the NN of the JJ NN , but VBG it as a JJ NN . The JJ NN and NNS like NNP NNP NNP VBP the NN by NNP VBD “ JJ . ” It VBZ a RB VBG JJ NN . VB NNP NNP as he VBZ about these NNS and JJR in the NNP NNP NNP - NNP . NNP NNP of NNP will VB the NN for the JJ NNP NN ."
117,607,mainstream,"Our_PRP$ general_JJ interest_NN e-newsletter_NN keeps_VBZ you_PRP up_RP to_IN date_NN on_IN a_DT wide_JJ variety_NN of_IN health_NN topics_NNS ._. Along_IN with_IN its_PRP$ needed_VBN effects_NNS ,_, a_DT medicine_NN may_MD cause_VB some_DT unwanted_JJ effects_NNS ._. Although_IN not_RB all_DT of_IN these_DT side_NN effects_NNS may_MD occur_VB ,_, if_IN they_PRP do_VBP occur_VB they_PRP may_MD need_VB medical_JJ attention_NN ._. Check_VB with_IN your_PRP$ doctor_NN immediately_RB if_IN any_DT of_IN the_DT following_VBG side_NN effects_NNS occur_VBP :_: •_NFP itching_NN ,_, especially_RB of_IN feet_NNS or_CC hands_NNS •_, reddening_NN of_IN skin_NN ,_, especially_RB around_IN ears_NNS •_SYM swelling_NN of_IN eyes_NNS ,_, face_NN ,_, or_CC inside_IN of_IN nose_NN Check_VB with_IN your_PRP$ doctor_NN as_RB soon_RB as_IN possible_JJ if_IN any_DT of_IN the_DT following_VBG side_NN effects_NNS occur_VBP :_: •_NFP swelling_NN ,_, blistering_NN or_CC pain_NN at_IN place_NN of_IN injection_NN Some_DT side_NN effects_NNS may_MD occur_VB that_WDT usually_RB do_VBP not_RB need_VB medical_JJ attention_NN ._. These_DT side_NN effects_NNS may_MD go_VB away_RB during_IN treatment_NN as_IN your_PRP$ body_NN adjusts_VBZ to_IN the_DT medicine_NN ._. Also_RB ,_, your_PRP$ health_NN care_NN professional_NN may_MD be_VB able_JJ to_TO tell_VB you_PRP about_IN ways_NNS to_TO prevent_VB or_CC reduce_VB some_DT of_IN these_DT side_NN effects_NNS ._. Check_VB with_IN your_PRP$ health_NN care_NN professional_NN if_IN any_DT of_IN the_DT following_VBG side_NN effects_NNS continue_VBP or_CC are_VBP bothersome_JJ or_CC if_IN you_PRP have_VBP any_DT questions_NNS about_IN them_PRP :_: •_NFP Burning_VBG or_CC stinging_VBG at_IN place_NN of_IN injection_NN •_SYM fever_NN of_IN 100_CD °F_NN (_-LRB- 37.7_CD °C_NNS )_-RRB- or_CC less_JJR •_SYM Fever_NN between_IN 100_CD and_CC 103_CD °F_NN (_-LRB- 37.7_CD and_CC 39.4_CD °C_NNS )_-RRB- •_NFP itching_NN ,_, swelling_NN ,_, redness_NN ,_, tenderness_NN ,_, or_CC hard_JJ lump_NN at_IN place_NN of_IN injection_NN Fever_NN or_CC skin_NN rash_NN may_MD occur_VB from_IN 5_CD to_IN 12_CD days_NNS after_IN vaccination_NN and_CC usually_RB lasts_VBZ several_JJ days_NNS ._. Other_JJ side_NN effects_NNS not_RB listed_VBN may_MD also_RB occur_VB in_IN some_DT patients_NNS ._. If_IN you_PRP notice_VBP any_DT other_JJ effects_NNS ,_, check_VB with_IN your_PRP$ healthcare_NN professional_NN ._. Call_VB your_PRP$ doctor_NN for_IN medical_JJ advice_NN about_IN side_NN effects_NNS ._. You_PRP may_MD report_VB side_NN effects_NNS to_IN the_DT FDA_NNP at_IN 1_CD -_SYM 800_CD -_HYPH FDA_NNP -_SYM 1088_CD ._.","Our JJ NN NN VBZ you up to NN on a JJ NN of NN NNS . Along with its VBN NNS , a NN may VB some JJ NNS . Although RB all of these NN NNS may VB , if they VBP VB they may VB JJ NN . VB with your NN RB if any of the VBG NN NNS VBP : • NN , RB of NNS or NNS • NN of NN , RB around NNS • NN of NNS , NN , or inside of NN VB with your NN RB RB as JJ if any of the VBG NN NNS VBP : • NN , NN or NN at NN of NN Some NN NNS may VB that RB VBP RB VB JJ NN . These NN NNS may VB RB during NN as your NN VBZ to the NN . RB , your NN NN NN may VB JJ to VB you about NNS to VB or VB some of these NN NNS . VB with your NN NN NN if any of the VBG NN NNS VBP or VBP JJ or if you VBP any NNS about them : • VBG or VBG at NN of NN • NN of 100 NN ( 37.7 NNS ) or JJR • NN between 100 and 103 NN ( 37.7 and 39.4 NNS ) • NN , NN , NN , NN , or JJ NN at NN of NN NN or NN NN may VB from 5 to 12 NNS after NN and RB VBZ JJ NNS . JJ NN NNS RB VBN may RB VB in some NNS . If you VBP any JJ NNS , VB with your NN NN . VB your NN for JJ NN about NN NNS . You may VB NN NNS to the NNP at 1 - 800 - NNP - 1088 ."
118,630,mainstream,"Coronavirus_NN live_JJ updates_NNS :_: President_NNP Trump_NNP does_VBZ n't_RB wear_VB mask_NN on_IN part_NN of_IN trip_NN to_IN Michigan_NNP ;_, Universal_NNP Orlando_NNP wants_VBZ to_TO reopen_VB by_IN June_NNP 1_CD As_IN the_DT world_NN surged_VBD past_IN the_DT 5_CD million_CD -_HYPH mark_NN in_IN confirmed_VBN coronavirus_NN cases_NNS Thursday_NNP ,_, the_DT director_NN of_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP said_VBD he_PRP can't_MD predict_VB whether_IN another_DT round_NN of_IN lockdowns_NNS is_VBZ coming_VBG as_IN a_DT possible_JJ second_JJ wave_NN of_IN the_DT virus_NN looms_VBZ ._. Meanwhile_RB ,_, the_DT U.S._NNP pledged_VBD to_TO spend_VB up_IN to_IN $_$ 1.2_CD billion_CD for_IN an_DT experimental_JJ COVID_NN -_HYPH 19_CD vaccine_NN being_VBG tested_VBN in_IN England_NNP ,_, and_CC researchers_NNS said_VBD tens_NNS of_IN thousands_NNS of_IN American_JJ lives_NNS could_MD have_VB been_VBN saved_VBN if_IN social_JJ distancing_NN measures_NNS had_VBD been_VBN enacted_VBN only_RB a_DT week_NN earlier_RBR ._. On_IN his_PRP$ visit_NN to_IN Ford_NNP in_IN Michigan_NNP on_IN Thursday_NNP ,_, President_NNP Donald_NNP Trump_NNP did_VBD not_RB wear_VB a_DT mask_NN in_IN front_NN of_IN photographers_NNS because_IN he_PRP ""_`` did_VBD n’t_RB want_VB to_TO give_VB the_DT press_NN the_DT pleasure_NN of_IN seeing_VBG it_PRP ""_'' although_IN Ford_NNP officials_NNS encouraged_VBD him_PRP to_TO wear_VB one_CD ._. The_DT United_NNP States_NNPS accounts_VBZ for_IN 31_CD %_NN of_IN the_DT 5_CD million_CD global_JJ coronavirus_NN cases_NNS with_IN more_JJR than_IN 1.5_CD million_CD confirmed_VBN ,_, according_VBG to_IN the_DT Johns_NNP Hopkins_NNP University_NNP data_NN dashboard_NN ._. More_JJR than_IN 329,000_CD people_NNS have_VBP died_VBN globally_RB ;_: the_DT U.S._NNP death_NN toll_NN is_VBZ more_JJR than_IN 94,700_CD ._. Our_PRP$ live_JJ blog_NN is_VBZ being_VBG updated_VBN throughout_IN the_DT day_NN ._. Refresh_VB for_IN the_DT latest_JJS news_NN ,_, and_CC get_VB updates_NNS in_IN your_PRP$ inbox_NN with_IN The_DT Daily_NNP Briefing_NNP ._. Scroll_VB down_RP for_IN more_JJR details_NNS ._. Here_RB are_VBP some_DT highlights_NNS to_TO know_VB Thursday_NNP :_: •_NFP Robert_NNP Redfield_NNP ,_, director_NN of_IN the_DT CDC_NNP ,_, says_VBZ the_DT U.S._NNP must_MD be_VB as_RB ""_`` overprepared_JJ as_IN possible_JJ ""_'' for_IN a_DT second_JJ wave_NN of_IN both_CC lockdowns_NNS and_CC infections_NNS ._. •_NFP New_JJ research_NN shows_VBZ that_IN 36,000_CD lives_NNS could_MD have_VB been_VBN saved_VBN if_IN states_NNS in_IN the_DT U.S._NNP had_VBD issued_VBN stay_NN -_HYPH at_IN -_HYPH home_NN orders_NNS a_DT week_NN before_IN they_PRP did_VBD ._. •_SYM Universal_NNP Orlando_NNP in_IN Florida_NNP wants_VBZ to_TO reopen_VB as_RB soon_RB as_IN June_NNP 1_CD with_IN social_JJ distancing_NN precautions_NNS like_IN face_NN masks_NNS ,_, temperature_NN checks_NNS and_CC additional_JJ space_NN for_IN parking_NN ._. •_NFP At_IN least_JJS 32_CD workers_NNS in_IN an_DT Amazon_NNP campus_NN near_IN Milwaukee_NNP have_VBP contracted_VBN the_DT coronavirus_NN in_IN the_DT last_JJ two_CD months_NNS ._. Public_JJ health_NN officials_NNS are_VBP worried_VBN that_IN the_DT company_NN is_VBZ n't_RB tracking_VBG cases_NNS ,_, offering_VBG tests_NNS or_CC practicing_VBG social_JJ distancing_NN with_IN its_PRP$ workers_NNS ._. As_IN states_NNPS reopen_VBP ,_, we_PRP ’re_VBP answering_VBG your_PRP$ questions_NNS :_: Can_MD your_PRP$ kids_NNS and_CC grandkids_NNS visit_VB ?_. It_PRP 's_VBZ not_RB safe_JJ until_IN community_NN transmission_NN has_VBZ been_VBN eliminated_VBN in_IN both_DT areas_NNS and_CC the_DT groups_NNS getting_VBG together_RB have_VBP no_DT illness_NN and_CC have_VBP had_VBN no_DT outside_JJ exposures_NNS for_IN a_DT week_NN to_IN two_CD weeks_NNS ._. What_WP we_PRP 're_VBP talking_VBG about_IN :_: New_NNP CDC_NNP guidelines_NNS say_VBP the_DT coronavirus_NN ""_'' does_VBZ not_RB spread_VB easily_RB ""_'' via_IN surfaces_NNS ._. ""_`` I_PRP believe_VBP (_-LRB- that_IN the_DT guidelines_NNS )_-RRB- are_VBP trying_VBG to_TO reduce_VB fear_NN and_CC paranoia_NN about_IN methods_NNS of_IN transmission_NN ,_, ""_'' said_VBD Dr._NNP Manisha_NNP Juthani_NNP ,_, an_DT infectious_JJ disease_NN doctor_NN at_IN Yale_NNP ._. Here_RB 's_VBZ what_WP else_RB you_PRP should_MD know_VB about_IN the_DT guidelines_NNS ._. Leaving_VBG your_PRP$ coronavirus_NN isolation_NN ?_. Think_VB about_IN these_DT 3_CD things_NNS first_RB to_TO minimize_VB the_DT risk_NN ._. Staying_VBG Apart_RB ,_, Together_RB :_: USA_NNP TODAY_NN brings_VBZ a_DT newsletter_NN about_IN how_WRB to_TO cope_VB with_IN these_DT trying_VBG times_NNS straight_RB to_IN your_PRP$ inbox_NN ._. 📥_NFP Trump_NNP did_VBD not_RB wear_VB mask_NN in_IN front_NN of_IN photographers_NNS during_IN trip_NN in_IN Michigan_NNP Ford_NNP executives_NNS encouraged_VBD President_NNP Donald_NNP Trump_NNP to_TO don_VB a_DT face_NN mask_NN during_IN his_PRP$ visit_NN to_IN one_CD of_IN its_PRP$ factories_NNS Thursday_NNP ,_, but_CC he_PRP said_VBD he_PRP chose_VBD not_RB to_TO wear_VB it_PRP near_IN photographers_NNS because_IN he_PRP ""_`` did_VBD n’t_RB want_VB to_TO give_VB the_DT press_NN the_DT pleasure_NN of_IN seeing_VBG it_PRP ._. ""_'' Trump_NNP ,_, who_WP was_VBD seen_VBN holding_VBG a_DT navy_NN blue_JJ mask_NN with_IN the_DT presidential_JJ seal_NN but_CC not_RB wearing_VBG it_PRP ,_, said_VBD he_PRP put_VBD it_PRP on_RP earlier_RBR in_IN the_DT tour_NN ._. Ford_NNP officials_NNS accompanying_VBG the_DT president_NN were_VBD seen_VBN wearing_VBG face_NN masks_NNS ,_, according_VBG to_IN reporters_NNS traveling_VBG with_IN the_DT president_NN ._. The_DT president_NN has_VBZ come_VBN under_IN scrutiny_NN in_IN the_DT past_NN for_IN largely_RB ignoring_VBG recommendations_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, which_WDT recommends_VBZ Americans_NNPS wear_VB masks_NNS in_IN public_NN during_IN the_DT coronavirus_NN pandemic_NN ._. Trump_NNP ,_, who_WP notes_VBZ the_DT CDC_NNP advice_NN is_VBZ not_RB mandatory_JJ ,_, has_VBZ described_VBN the_DT decision_NN as_IN a_DT ""_`` personal_JJ choice_NN ._. ""_'' An_DT Amazon_NNP warehouse_NN worker_NN in_IN North_NNP Randall_NNP ,_, Ohio_NNP ,_, died_VBD from_IN COVID_NNP -_HYPH 19_CD ,_, bringing_VBG the_DT total_JJ known_VBN deaths_NNS at_IN the_DT company_NN to_IN eight_CD employees_NNS ,_, officials_NNS confirmed_VBD Thursday_NNP to_IN NBC_NNP News_NNP ._. The_DT female_JJ employee_NN went_VBD to_IN work_NN the_DT same_JJ day_NN she_PRP was_VBD diagnosed_VBN on_IN April_NNP 30_CD but_CC the_DT company_NN was_VBD n't_RB informed_VBN until_IN May_NNP 8_CD ,_, an_DT Amazon_NNP spokesperson_NN told_VBD NBC_NNP News_NNP ._. The_DT employee_NN passed_VBD away_RB on_IN May_NNP 18_CD ._. ""_`` We_PRP are_VBP saddened_VBN by_IN the_DT loss_NN of_IN an_DT associate_NN who_WP had_VBD worked_VBN at_IN our_PRP$ site_NN in_IN Randall_NNP ,_, Ohio_NNP ,_, ""_'' Amazon_NNP spokesperson_NN Lisa_NNP Levandowski_NNP told_VBD the_DT outlet_NN ._. ""_`` Her_PRP$ family_NN and_CC loved_JJ ones_NNS are_VBP in_IN our_PRP$ thoughts_NNS ,_, and_CC we_PRP are_VBP supporting_VBG her_PRP$ fellow_JJ colleagues_NNS ._. ""_'' Federal_JJ regulators_NNS are_VBP investigating_VBG a_DT Texas_NNP laboratory_NN that_WDT a_DT Florida_NNP hospital_NN chain_NN dropped_VBD last_JJ week_NN because_IN of_IN delayed_VBN and_CC unreliable_JJ COVID_NN -_HYPH 19_CD test_NN results_NNS ._. AdventHealth_NNP ,_, which_WDT has_VBZ 45_CD hospitals_NNS in_IN nine_CD states_NNS ,_, terminated_VBD its_PRP$ Florida_NNP contract_NN with_IN MicroGen_NNP DX_NNP due_IN to_IN concerns_NNS about_IN the_DT validity_NN of_IN some_DT of_IN the_DT 60,000_CD tests_NNS MicroGen_NNP had_VBD processed_VBN for_IN the_DT system_NN because_IN the_DT lab_NN left_VBD them_PRP at_IN room_NN temperature_NN for_IN days_NNS ,_, according_VBG to_IN an_DT AdventHealth_NN statement_NN ._. The_DT specimens_NNS should_MD be_VB refrigerated_VBN at_IN 2_CD to_IN 7_CD degrees_NNS Celsius_NNP (_-LRB- about_RB 32_CD degrees_NNS Fahrenheit_NNP )_-RRB- and_CC then_RB put_VBN in_RP freezers_NNS at_IN -_SYM 70_CD degrees_NNS Celsius_NNP after_IN three_CD days_NNS ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. MicroGen_NNP promotes_VBZ shipping_NN COVID_NN -_HYPH 19_CD samples_NNS through_IN FedEx_NNP on_IN its_PRP$ website_NN ._. The_DT company_NN is_VBZ also_RB selling_VBG a_DT saliva_NN -_HYPH only_RB test_NN that_WDT can_MD be_VB administered_VBN in_IN a_DT ""_`` hospital_NN ,_, clinic_NN ,_, drive_NN -_HYPH thru_NN clinic_NN or_CC at_IN -_HYPH home_NN ,_, ""_'' in_IN all_DT 50_CD states_NNS without_IN an_DT Emergency_NN Use_NN Authorization_NN from_IN the_DT Food_NN and_CC Drug_NNP Administration_NNP ,_, said_VBD MicroGen_NNP spokeswoman_NN Ashley_NNP Moore_NNP ._. MicroGen_NNP CEO_NN Rick_NNP Martin_NNP said_VBD he_PRP does_VBZ n't_RB believe_VB the_DT company_NN needs_VBZ one_CD ._. Martin_NNP said_VBD he_PRP was_VBD unaware_JJ of_IN ""_`` any_DT inquiries_NNS into_IN our_PRP$ lab_NN ,_, ""_'' but_CC added_VBD that_IN after_IN the_DT AdventHealth_NNP announcement_NN it_PRP started_VBD working_VBG with_IN the_DT American_NNP College_NNP of_IN Pathologists_NNPS on_IN its_PRP$ testing_NN requirements_NNS ,_, ""_'' which_WDT we_PRP are_VBP confident_JJ we_PRP will_MD continue_VB to_TO meet_VB ._. ""_'' At_IN least_JJS 32_CD workers_NNS at_IN the_DT Amazon_NNP campus_NN in_IN the_DT city_NN of_IN Kenosha_NNP in_IN Wisconsin_NNP have_VBP contracted_VBN coronavirus_NN in_IN the_DT past_JJ two_CD months_NNS ,_, according_VBG to_IN messages_NNS sent_VBN to_IN employees_NNS and_CC shared_VBN with_IN the_DT Milwaukee_NNP Journal_NNP Sentinel_NNP ._. Amazon_NNP officials_NNS have_VBP not_RB fully_RB cooperated_VBN with_IN public_JJ health_NN workers_NNS trying_VBG to_TO track_VB cases_NNS ,_, inform_VB workers_NNS who_WP might_MD be_VB at_IN risk_NN or_CC offer_VB testing_NN and_CC other_JJ safety_NN measures_NNS ,_, said_VBD Jen_NNP Freiheit_NNP ,_, health_NN officer_NN for_IN Kenosha_NNP County_NNP ._. “_`` We_PRP ’re_VBP at_IN the_DT point_NN now_RB that_IN since_IN we_PRP ’re_VBP not_RB getting_VBG that_DT ,_, we_PRP ’re_VBP going_VBG to_TO look_VB into_IN what_WDT other_JJ measures_NNS we_PRP can_MD take_VB for_IN Amazon_NNP ,_, because_IN we_PRP are_VBP not_RB getting_VBG as_RB far_RB with_IN compliance_NN as_IN we_PRP would_MD like_VB ,_, ”_'' Freiheit_NNP said_VBD ._. If_IN Amazon_NNP officials_NNS do_VBP not_RB cooperate_VB with_IN health_NN officials_NNS ,_, Freiheit_NNP said_VBD she_PRP would_MD consider_VB attempting_VBG to_TO shut_VB down_RP the_DT Kenosha_NNP facilities_NNS ,_, located_VBN in_IN Wisconsin_NNP ,_, south_RB of_IN Milwaukee_NNP and_CC north_RB of_IN Chicago_NNP ._. Amazon_NNP has_VBZ not_RB provided_VBN an_DT official_JJ total_JJ number_NN of_IN cases_NNS at_IN its_PRP$ Kenosha_NNP facilities_NNS to_IN county_NN health_NN officials_NNS and_CC declined_VBD to_TO provide_VB the_DT number_NN to_IN the_DT Journal_NNP Sentinel_NNP ._. Universal_NNP Orlando_NNP wants_VBZ to_TO reopen_VB by_IN June_NNP 1_CD with_IN coronavirus_NN precautions_NNS Universal_NNP Orlando_NNP asked_VBD state_NN and_CC local_JJ officials_NNS in_IN Florida_NNP on_IN Thursday_NNP to_TO allow_VB the_DT theme_NN park_NN to_TO reopen_VB as_RB soon_RB as_IN June_NNP 1_CD ,_, with_IN precautions_NNS due_IN to_IN the_DT coronavirus_NN ._. The_DT economic_JJ recovery_NN task_NN force_NN in_IN Orange_NNP County_NNP unanimously_RB approved_VBD Universal_NNP 's_POS plan_NN ._. The_DT plan_NN must_MD also_RB be_VB approved_VBN by_IN Florida_NNP Gov._NNP Ron_NNP DeSantis_NNP ._. If_IN approved_VBN ,_, Universal_NNP Orlando_NNP could_MD be_VB one_CD of_IN the_DT biggest_JJS theme_NN parks_NNS in_IN the_DT country_NN to_TO reopen_VB ._. Universal_NNP ,_, Walt_NNP Disney_NNP World_NNP and_CC SeaWorld_NNP in_IN Florida_NNP have_VBP been_VBN closed_VBN since_IN mid-March_NNP because_IN of_IN the_DT global_JJ pandemic_NN ._. A_DT reopened_VBN Universal_NNP will_MD look_VB very_RB different_JJ for_IN visitors_NNS and_CC employees_NNS ,_, according_VBG to_IN a_DT presentation_NN made_VBN to_IN the_DT local_JJ economic_JJ recovery_NN task_NN force_NN Thursday_NNP by_IN company_NN officials_NNS ._. Upon_IN arrival_NN ,_, valet_NN parking_NN will_MD not_RB be_VB available_JJ ,_, and_CC cars_NNS will_MD park_VB one_CD or_CC two_CD spaces_NNS apart_RB ._. Visitors_NNS and_CC employees_NNS will_MD receive_VB temperature_NN checks_NNS and_CC will_MD be_VB required_VBN to_TO wear_VB face_NN coverings_NNS ._. Universal_NNP will_MD provide_VB disposable_JJ face_NN masks_NNS for_IN visitors_NNS who_WP do_VBP n't_RB bring_VB their_PRP$ own_JJ ._. Up_IN to_IN $_$ 1.2_CD billion_CD for_IN possible_JJ vaccine_NN The_DT U.S._NNP is_VBZ betting_VBG more_JJR than_IN $_$ 1_CD billion_CD on_IN a_DT vaccine_NN that_WDT does_VBZ not_RB exist_VB ._. The_DT American_JJ government_NN has_VBZ pledged_VBN to_TO pay_VB as_RB much_JJ as_IN $_$ 1.2_CD billion_CD to_TO get_VB early_JJ access_NN to_IN 300_CD million_CD doses_NNS of_IN an_DT experimental_JJ COVID_NN -_HYPH 19_CD vaccine_NN being_VBG developed_VBN and_CC tested_VBN in_IN England_NNP ._. The_DT vaccine_NN is_VBZ being_VBG developed_VBN by_IN the_DT University_NNP of_IN Oxford_NNP ’s_POS Jenner_NNP Institute_NNP and_CC licensed_VBN to_IN British_JJ drugmaker_NN AstraZeneca_NNP ._. The_DT vaccine_NN is_VBZ in_IN early_JJ clinical_JJ trials_NNS and_CC being_VBG tested_VBN for_IN safety_NN ,_, whether_IN it_PRP produces_VBZ antibodies_NNS against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ,_, and_CC whether_IN it_PRP protects_VBZ the_DT immunized_VBN from_IN becoming_VBG infected_VBN with_IN the_DT virus_NN ._. The_DT first_JJ tests_NNS began_VBD in_IN England_NNP on_IN April_NNP 23_CD ._. The_DT vaccine_NN could_MD be_VB delivered_VBN as_RB early_RB as_IN October_NNP but_CC would_MD still_RB have_VB to_TO go_VB through_IN the_DT completion_NN of_IN clinical_JJ trials_NNS before_IN it_PRP can_MD be_VB administered_VBN ._. The_DT contract_NN “_'' is_VBZ a_DT major_JJ milestone_NN in_IN Operation_NNP Warp_NNP Speed_NNP ’s_POS work_NN toward_IN a_DT safe_JJ ,_, effective_JJ ,_, widely_RB available_JJ vaccine_NN by_IN 2021_CD ,_, ”_'' Health_NNP and_CC Human_NNP Services_NNPS Secretary_NNP Alex_NNP Azar_NNP said_VBD in_IN a_DT news_NN release_NN ._. One_CD week_NN could_MD have_VB saved_VBN 36,000_CD lives_NNS ,_, researchers_NNS say_VBP Had_VBD states_NNS across_IN the_DT country_NN begun_VBN issuing_VBG stay_NN -_HYPH at_IN -_HYPH home_NN orders_NNS just_RB one_CD week_NN before_IN they_PRP did_VBD ,_, nearly_RB 36,000_CD people_NNS would_MD not_RB have_VB died_VBN and_CC more_JJR than_IN 700,000_CD positive_JJ virus_NN cases_NNS would_MD have_VB been_VBN avoided_VBN ,_, new_JJ research_NN from_IN Columbia_NNP University_NNP shows_VBZ ._. Social_JJ distancing_NN for_IN two_CD weeks_NNS before_RB when_WRB most_JJS people_NNS began_VBD staying_VBG at_IN home_NN could_MD have_VB prevented_VBN 54,000_CD deaths_NNS and_CC 960,000_CD cases_NNS ,_, the_DT researchers_NNS found_VBD ._. Both_DT figures_NNS are_VBP more_JJR than_IN 57_CD %_NN of_IN the_DT current_JJ U.S._NNP numbers_NNS in_IN those_DT categories_NNS ._. Many_JJ states_NNS told_VBD residents_NNS to_TO stay_VB home_RB in_IN mid-March_NNP ,_, but_CC research_NN indicates_VBZ that_IN by_IN then_RB the_DT virus_NN had_VBD already_RB reached_VBN community_NN spread_NN in_IN some_DT places_NNS ,_, like_IN New_NNP York_NNP City_NNP ._. The_DT researchers_NNS found_VBD that_IN at_IN least_JJS 17,500_CD deaths_NNS in_IN the_DT New_NNP York_NNP metropolitan_JJ area_NN alone_RB could_MD have_VB been_VBN prevented_VBN had_VBD social_JJ distancing_NN measures_NNS been_VBN enacted_VBN a_DT week_NN earlier_RBR ._. ""_`` That_DT small_JJ moment_NN in_IN time_NN ,_, catching_VBG it_PRP in_IN that_DT growth_NN phase_NN ,_, is_VBZ incredibly_RB critical_JJ in_IN reducing_VBG the_DT number_NN of_IN deaths_NNS ,_, ""_'' Jeffrey_NNP Shaman_NNP ,_, an_DT epidemiologist_NN who_WP led_VBD the_DT research_NN at_IN Columbia_NNP University_NNP ,_, told_VBD the_DT New_NNP York_NNP Times_NNP ._. Ohio_NNP to_TO allow_VB weddings_NNS with_IN up_IN to_IN 300_CD guests_NNS Starting_VBG in_IN June_NNP ,_, couples_NNS getting_VBG married_VBN in_IN Ohio_NNP will_MD be_VB able_JJ to_TO invite_VB up_IN to_IN 300_CD guests_NNS to_IN the_DT reception_NN without_IN running_VBG afoul_NN of_IN public_JJ health_NN regulations_NNS ._. Lt._NNP Gov._NNP Jon_NNP Husted_NNP said_VBD Thursday_NNP the_DT modification_NN to_IN current_JJ restrictions_NNS ,_, part_NN of_IN Gov._NNP Mike_NNP DeWine_NNP 's_POS loosening_NN of_IN measures_NNS to_TO combat_VB the_DT coronavirus_NN ,_, will_MD be_VB effective_JJ June_NNP 1_CD ._. There_EX was_VBD no_DT word_NN on_IN whether_IN the_DT bride_NN and_CC groom_NN would_MD be_VB allowed_VBN to_TO get_VB close_JJ enough_RB to_TO kiss_VB ,_, but_CC Husted_NNP said_VBD catering_NN and_CC banquet_NN facilities_NNS would_MD have_VB to_TO set_VB tables_NNS at_IN least_JJS six_CD feet_NNS apart_RB ._. Wedding_NN receptions_NNS have_VBP been_VBN limited_VBN to_IN no_RB more_JJR than_IN 10_CD people_NNS as_IN Ohio_NNP banned_VBD large_JJ gatherings_NNS starting_VBG in_IN mid-March_NNP ._. Florida_NNP is_VBZ no_RB longer_RBR suppressing_VBG information_NN in_IN the_DT table_NN of_IN COVID_NN -_HYPH 19_CD deaths_NNS compiled_VBN by_IN the_DT state_NN 's_POS medical_JJ examiners_NNS ,_, according_VBG to_IN Dr._NNP Stephen_NNP J._NNP Nelson_NNP ,_, the_DT chairman_NN of_IN the_DT state_NN 's_POS medical_JJ examiners_NNS commission_NN ._. State_NN medical_JJ examiners_NNS are_VBP tasked_VBN with_IN investigating_VBG and_CC certifying_VBG COVID_NN -_HYPH 19_CD deaths_NNS ,_, including_VBG cause_NN -_HYPH of_IN -_HYPH death_NN determinations_NNS ._. A_DT COVID_NNP -_HYPH 19_CD positive_JJ test_NN result_NN is_VBZ a_DT requirement_NN for_IN reporting_VBG any_DT death_NN as_IN due_IN to_IN the_DT coronavirus_NN ._. FLORIDA_NNP TODAY_NN ,_, part_NN of_IN the_DT USA_NNP TODAY_NNP Network_NNP ,_, first_RB reported_VBD that_IN cause_NN of_IN death_NN and_CC descriptive_JJ entries_NNS of_IN the_DT medical_JJ examiners_NNS database_NN were_VBD suppressed_VBN from_IN public_JJ record_NN in_IN April_NNP ._. The_DT Tampa_NNP Bay_NNP Times_NNP earlier_RBR in_IN April_NNP reported_VBD that_IN the_DT count_NN of_IN the_DT deaths_NNS by_IN medical_JJ examiners_NNS diverged_VBD from_IN the_DT Department_NNP of_IN Health_NNP 's_POS death_NN count_NN ,_, at_IN times_NNS by_IN as_RB much_JJ as_IN 10_CD %_NN ._. The_DT timing_NN of_IN the_DT reversal_NN comes_VBZ as_IN the_DT state_NN faces_VBZ scrutiny_NN over_IN data_NNS as_IN it_PRP reopens_VBZ ._. CDC_NNP director_NN noncommittal_JJ on_IN another_DT round_NN of_IN lockdowns_NNS in_IN winter_NN CDC_NNP director_NN Dr._NNP Robert_NNP Redfield_NNP told_VBD the_DT Financial_NNP Times_NNP that_IN he_PRP ""_`` ca_MD n't_RB guarantee_VB ""_'' whether_IN or_CC not_RB a_DT second_JJ round_NN of_IN stay_NN -_HYPH at_IN -_HYPH home_NN orders_NNS is_VBZ coming_VBG for_IN the_DT United_NNP States_NNPS in_IN the_DT winter_NN as_IN the_DT new_JJ coronavirus_NN may_MD see_VB a_DT second_JJ wave_NN that_WDT coincides_VBZ with_IN cold_JJ weather_NN and_CC a_DT flu_NN season_NN ._. ""_`` I_PRP can't_MD guarantee_VB ;_, that_DT 's_VBZ kind_NN of_IN getting_VBG into_IN the_DT opinion_NN mode_NN ._. We_PRP have_VBP to_TO be_VB data_NNS driven_VBN ,_, ''_'' Redfield_NNP told_VBD the_DT newspaper_NN ._. ""_`` What_WP I_PRP can_MD say_VB is_VBZ that_IN we_PRP are_VBP committed_VBN to_IN using_VBG the_DT time_NN that_WDT we_PRP have_VBP now_RB to_TO get_VB this_DT nation_NN as_RB overprepared_JJ as_IN possible_JJ ._. ""_'' Redfield_NNP said_VBD the_DT spread_NN of_IN the_DT virus_NN in_IN the_DT southern_JJ hemisphere_NN gives_VBZ him_PRP concern_NN about_IN a_DT second_JJ wave_NN at_IN the_DT end_NN of_IN 2020_CD in_IN the_DT northern_JJ hemisphere_NN ._. About_RB 2.4_CD million_CD Americans_NNPS filed_VBD initial_JJ unemployment_NN claims_NNS last_JJ week_NN ,_, the_DT Labor_NNP Department_NNP said_VBD Thursday_NNP ,_, as_IN the_DT health_NN and_CC economic_JJ crisis_NN sparked_VBN by_IN the_DT coronavirus_NN ruptures_VBZ a_DT growing_VBG number_NN of_IN industries_NNS ._. In_IN just_RB nine_CD weeks_NNS ,_, nearly_RB 39_CD million_CD have_VBP sought_VBN jobless_NN benefits_NNS that_WDT represent_VBP the_DT nation_NN ’s_POS most_RBS reliable_JJ gauge_NN of_IN layoffs_NNS ._. The_DT latest_JJS claims_NNS tally_NN was_VBD down_RB from_IN the_DT 3_CD million_CD who_WP filed_VBD claims_NNS the_DT week_NN before_RB ,_, and_CC the_DT record_JJ 6.9_CD million_CD who_WP sought_VBD assistance_NN in_IN late_JJ March_NNP ._. Initial_JJ applications_NNS for_IN unemployment_NN insurance_NN have_VBP now_RB steadily_RB declined_VBN seven_CD weeks_NNS in_IN a_DT row_NN ._. The_DT federal_JJ government_NN expects_VBZ a_DT busy_JJ hurricane_NN season_NN for_IN the_DT Atlantic_NNP Basin_NNP ,_, with_IN six_CD to_IN 10_CD hurricanes_NNS forming_VBG ,_, forecasters_NNS said_VBD Thursday_NNP ._. The_DT announcement_NN comes_VBZ against_IN the_DT backdrop_NN of_IN the_DT coronavirus_NN ,_, which_WDT will_MD almost_RB certainly_RB impact_VB evacuations_NNS and_CC shelter_NN from_IN approaching_VBG storms_NNS ._. Overall_RB ,_, the_DT National_NNP Oceanic_NNP and_CC Atmospheric_NNP Administration_NNP (_-LRB- NOAA_NNP )_-RRB- said_VBD 13_CD to_IN 19_CD named_VBN storms_NNS will_MD develop_VB ._. This_DT number_NN includes_VBZ tropical_JJ storms_NNS ,_, which_WDT contain_VBP wind_NN speeds_NNS of_IN 39_CD mph_NN or_CC higher_JJR ._. Of_IN the_DT predicted_VBN six_CD to_IN 10_CD hurricanes_NNS ,_, three_CD to_IN six_CD could_MD be_VB major_JJ ,_, packing_VBG wind_NN speeds_NNS of_IN 111_CD mph_NNS or_CC higher_JJR ._. One_CD of_IN the_DT longest_RBS -_HYPH serving_VBG White_NNP House_NNP employees_NNS ever_RB died_VBD last_JJ week_NN from_IN COVID_NNP -_HYPH 19_CD ,_, his_PRP$ granddaughter_NN told_VBD WTTG_NNP in_IN Washington_NNP ,_, D.C._NNP Wilson_NNP Roosevelt_NNP Jerman_NNP ,_, 91_CD ,_, started_VBD working_VBG at_IN the_DT White_NNP House_NNP as_IN a_DT cleaner_NN in_IN 1957_CD ,_, during_IN the_DT Eisenhower_NNP administration_NN ,_, granddaughter_NN Jamila_NNP Garrett_NNP told_VBD the_DT TV_NN station_NN ._. First_JJ lady_NN Jackie_NNP Kennedy_NNP promoted_VBD Jerman_NNP to_TO become_VB a_DT butler_NN ,_, said_VBD Garrett_NNP ,_, adding_VBG that_IN he_PRP worked_VBD for_IN 11_CD presidents_NNS and_CC their_PRP$ families_NNS ._. In_IN a_DT statement_NN to_IN NBC_NNP News_NNP ,_, former_JJ President_NNP George_NNP W._NNP Bush_NNP and_CC first_JJ lady_NN Laura_NNP Bush_NNP called_VBD Jerman_NNP ""_`` a_DT lovely_JJ man_NN ._. He_PRP was_VBD the_DT first_JJ person_NN we_PRP saw_VBD in_IN the_DT morning_NN when_WRB we_PRP left_VBD the_DT residence_NN and_CC the_DT last_JJ person_NN we_PRP saw_VBD each_DT night_NN when_WRB we_PRP returned_VBD ._. ""_'' Fauci_NNP to_IN new_JJ doctors_NNS :_: We_PRP need_VBP you_PRP '_`` now_RB more_JJR than_IN ever_RB '_'' Speaking_VBG at_IN a_DT virtual_JJ graduation_NN ceremony_NN for_IN medical_JJ students_NNS ,_, Dr._NNP Anthony_NNP Fauci_NNP ,_, head_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, said_VBD new_JJ doctors_NNS '_POS contributions_NNS will_MD be_VB needed_VBN to_TO combat_VB the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._. ""_`` This_DT challenge_NN is_VBZ exactly_RB what_WP you_PRP trained_VBD for_IN ,_, and_CC a_DT successful_JJ response_NN requires_VBZ the_DT training_NN that_WDT you_PRP have_VBP received_VBN ,_, ""_'' Fauci_NNP said_VBD ._. ""_`` Now_RB more_JJR than_IN ever_RB ,_, we_PRP need_VBP your_PRP$ talent_NN ,_, your_PRP$ energy_NN ,_, your_PRP$ resolve_NN and_CC your_PRP$ character_NN ._. ""_'' Making_VBG a_DT mask_NN ?_. Here_RB 's_VBZ where_WRB you_PRP can_MD buy_VB the_DT material_NN to_IN DIY_NN Michael_NNP Cohen_NNP ,_, President_NNP Donald_NNP Trump_NNP 's_POS former_JJ personal_JJ lawyer_NN who_WP is_VBZ serving_VBG a_DT three_CD -_HYPH year_NN sentence_NN ,_, was_VBD released_VBN from_IN a_DT New_NNP York_NNP federal_JJ prison_NN Thursday_NNP to_TO serve_VB the_DT remainder_NN of_IN his_PRP$ term_NN at_IN home_NN amid_IN coronavirus_NN fears_NNS ._. Cohen_NNP ,_, who_WP had_VBD been_VBN held_VBN at_IN a_DT prison_NN camp_NN in_IN Otisville_NNP ,_, New_NNP York_NNP ,_, was_VBD to_TO be_VB released_VBN on_IN furlough_NN pending_VBG a_DT formal_JJ placement_NN in_IN home_NN confinement_NN ,_, said_VBD a_DT person_NN familiar_JJ with_IN the_DT matter_NN who_WP is_VBZ not_RB authorized_VBN to_TO comment_VB publicly_RB ._. More_JJR than_IN two_CD dozen_CD inmates_NNS and_CC officers_NNS have_VBP been_VBN infected_VBN with_IN the_DT virus_NN at_IN the_DT prison_NN facility_NN ._. It_PRP just_RB got_VBD a_DT little_JJ easier_JJR to_TO unlock_VB your_PRP$ iPhone_NNP while_IN wearing_VBG a_DT face_NN mask_NN 😷_. Having_VBG trouble_NN unlocking_VBG your_PRP$ iPhone_NNP with_IN Face_NN ID_NN while_IN wearing_VBG a_DT face_NN mask_NN ?_. Apple_NNP ’s_POS latest_JJS iPhone_NNP software_NN update_NN ,_, iOS_NNP 13.5_CD ,_, released_VBN Wednesday_NNP ,_, will_MD make_VB it_PRP easier_JJR to_TO unlock_VB the_DT phone_NN ._. After_IN installing_VBG the_DT update_NN ,_, users_NNS will_MD no_RB longer_RBR have_VB to_TO wait_VB for_IN Face_NN ID_NN to_TO fail_VB several_JJ times_NNS before_IN being_VBG prompted_VBN to_TO enter_VB a_DT passcode_NN ._. After_IN Face_NN ID_NN fails_VBZ for_IN the_DT first_JJ time_NN ,_, users_NNS can_MD swipe_VB up_RP from_IN the_DT bottom_NN of_IN the_DT screen_NN and_CC enter_VB a_DT passcode_NN to_TO unlock_VB the_DT phone_NN or_CC approve_VB an_DT Apple_NNP Pay_NN transaction_NN ._. Users_NNS can_MD also_RB swipe_VB up_RP from_IN the_DT bottom_NN of_IN the_DT iPhone_NNP screen_NN right_RB away_RB ._. More_JJR coronavirus_NN news_NN and_CC information_NN from_IN USA_NNP TODAY_NN :_: •_NFP The_DT life_NN -_HYPH saving_VBG lesson_NN suicidal_JJ people_NNS can_MD teach_VB a_DT world_NN in_IN pandemic_NN ._. •_NFP Bootleg_NN barbershops_NNS and_CC hair_NN salons_NNS thrive_VBP as_IN coronavirus_NN stay_VBP -_HYPH at_IN -_HYPH home_NN orders_NNS persist_VBP in_IN some_DT states_NNS ._. •_NFP Youth_NN sports_NNS may_MD have_VB an_DT easier_JJR time_NN returning_VBG to_IN action_NN than_IN the_DT pros_NNS ._. Here_RB 's_VBZ why_WRB ._. Ohio_NNP and_CC West_NNP Virginia_NNP will_MD reopen_VB restaurants_NNS for_IN indoor_JJ seating_NN on_IN Thursday_NNP ,_, one_CD day_NN after_IN Connecticut_NNP took_VBD its_PRP$ initial_JJ reopening_NN steps_NNS and_CC Delaware_NNP reopened_VBD retail_NN businesses_NNS by_IN appointment_NN only_RB ._. More_JJR changes_NNS are_VBP coming_VBG Friday_NNP :_: Alaska_NNP will_MD resume_VB life_NN as_IN it_PRP was_VBD ""_`` prior_JJ to_IN the_DT virus_NN ,_, ""_'' with_IN a_DT full_JJ reopening_NN of_IN the_DT economy_NN without_IN restrictions_NNS ;_: Iowa_NNP will_MD reopen_VB movie_NN theaters_NNS ,_, museums_NNS and_CC zoos_NNS ;_: and_CC Kentucky_NNP will_MD allow_VB restaurants_NNS to_TO operate_VB at_IN 33_CD %_NN capacity_NN indoors_RB with_IN unlimited_JJ outdoor_JJ seating_NN ._. Find_VB the_DT latest_JJS news_NN in_IN your_PRP$ state_NN ._. CDC_NNP :_: Coronavirus_NN '_'' does_VBZ not_RB spread_VB easily_RB '_'' by_IN touching_VBG surfaces_NNS or_CC objects_NNS The_DT CDC_NNP has_VBZ always_RB warned_VBN that_IN ""_`` it_PRP may_MD be_VB possible_JJ ""_'' to_TO become_VB infected_VBN with_IN the_DT coronavirus_NN by_IN touching_VBG contaminated_VBN surfaces_NNS or_CC objects_NNS ._. It_PRP just_RB ""_`` does_VBZ not_RB spread_VB easily_RB ""_'' in_IN that_DT manner_NN ,_, the_DT agency_NN now_RB says_VBZ ,_, nor_CC by_IN animal_NN -_HYPH to_IN -_HYPH human_JJ contact_NN ,_, or_CC vice_RB versa_RB ._. ""_`` COVID_NNP -_HYPH 19_CD is_VBZ a_DT new_JJ disease_NN and_CC we_PRP are_VBP still_RB learning_VBG about_IN how_WRB it_PRP spreads_VBZ ,_, ""_'' the_DT CDC_NNP said_VBD in_IN updating_VBG its_PRP$ guidelines_NNS ._. ""_`` It_PRP may_MD be_VB possible_JJ for_IN COVID_NNP -_HYPH 19_CD to_TO spread_VB in_IN other_JJ ways_NNS ,_, but_CC these_DT are_VBP not_RB thought_VBN to_TO be_VB the_DT main_JJ ways_NNS the_DT virus_NN spreads_VBZ ._. ""_'' The_DT CDC_NNP still_RB warns_VBZ that_IN the_DT main_JJ way_NN the_DT virus_NN is_VBZ spread_VBN is_VBZ through_IN person_NN -_HYPH to_IN -_HYPH person_NN contact_NN ,_, even_RB among_IN those_DT who_WP are_VBP not_RB showing_VBG any_DT symptoms_NNS ._. •_NFP Online_JJ programs_NNS used_VBN for_IN coronavirus_NN -_HYPH era_NN school_NN promise_NN results_NNS ._. The_DT claims_NNS are_VBP misleading_JJ ._. •_NFP For_IN Instacart_NNP shopper_NN ,_, the_DT chance_NN to_TO earn_VB money_NN outweighs_VBZ coronavirus_NN safety_NN risk_NN ._.","NN JJ NNS : NNP NNP VBZ RB VB NN on NN of NN to NNP ; NNP NNP VBZ to VB by NNP 1 As the NN VBD past the 5 million - NN in VBN NN NNS NNP , the NN of the NNP NNPS for NNP NNP and NNP VBD he can't VB whether another NN of NNS VBZ VBG as a JJ JJ NN of the NN VBZ . RB , the NNP VBD to VB up to $ 1.2 billion for an JJ NN - 19 NN VBG VBN in NNP , and NNS VBD NNS of NNS of JJ NNS could VB VBN VBN if JJ NN NNS VBD VBN VBN RB a NN RBR . On his NN to NNP in NNP on NNP , NNP NNP NNP VBD RB VB a NN in NN of NNS because he "" VBD RB VB to VB the NN the NN of VBG it "" although NNP NNS VBD him to VB one . The NNP NNPS VBZ for 31 NN of the 5 million JJ NN NNS with JJR than 1.5 million VBN , VBG to the NNP NNP NNP NN NN . JJR than 329,000 NNS VBP VBN RB ; the NNP NN NN VBZ JJR than 94,700 . Our JJ NN VBZ VBG VBN throughout the NN . VB for the JJS NN , and VB NNS in your NN with The NNP NNP . VB down for JJR NNS . RB VBP some NNS to VB NNP : • NNP NNP , NN of the NNP , VBZ the NNP must VB RB "" JJ as JJ "" for a JJ NN of both NNS and NNS . • JJ NN VBZ that 36,000 NNS could VB VBN VBN if NNS in the NNP VBD VBN NN - at - NN NNS a NN before they VBD . • NNP NNP in NNP VBZ to VB RB RB as NNP 1 with JJ NN NNS like NN NNS , NN NNS and JJ NN for NN . • At JJS 32 NNS in an NNP NN near NNP VBP VBN the NN in the JJ two NNS . JJ NN NNS VBP VBN that the NN VBZ RB VBG NNS , VBG NNS or VBG JJ NN with its NNS . As NNPS VBP , we VBP VBG your NNS : Can your NNS and NNS VB ? It VBZ RB JJ until NN NN VBZ VBN VBN in both NNS and the NNS VBG RB VBP no NN and VBP VBN no JJ NNS for a NN to two NNS . What we VBP VBG about : NNP NNP NNS VBP the NN "" VBZ RB VB RB "" via NNS . "" I VBP ( that the NNS ) VBP VBG to VB NN and NN about NNS of NN , "" VBD NNP NNP NNP , an JJ NN NN at NNP . RB VBZ what RB you should VB about the NNS . VBG your NN NN ? VB about these 3 NNS RB to VB the NN . VBG RB , RB : NNP NN VBZ a NN about how to VB with these VBG NNS RB to your NN . 📥 NNP VBD RB VB NN in NN of NNS during NN in NNP NNP NNS VBD NNP NNP NNP to VB a NN NN during his NN to one of its NNS NNP , but he VBD he VBD RB to VB it near NNS because he "" VBD RB VB to VB the NN the NN of VBG it . "" NNP , who VBD VBN VBG a NN JJ NN with the JJ NN but RB VBG it , VBD he VBD it on RBR in the NN . NNP NNS VBG the NN VBD VBN VBG NN NNS , VBG to NNS VBG with the NN . The NN VBZ VBN under NN in the NN for RB VBG NNS from the NNPS for NNP NNP and NNP , which VBZ NNPS VB NNS in NN during the NN NN . NNP , who VBZ the NNP NN VBZ RB JJ , VBZ VBN the NN as a "" JJ NN . "" An NNP NN NN in NNP NNP , NNP , VBD from NNP - 19 , VBG the JJ VBN NNS at the NN to eight NNS , NNS VBD NNP to NNP NNP . The JJ NN VBD to NN the JJ NN she VBD VBN on NNP 30 but the NN VBD RB VBN until NNP 8 , an NNP NN VBD NNP NNP . The NN VBD RB on NNP 18 . "" We VBP VBN by the NN of an NN who VBD VBN at our NN in NNP , NNP , "" NNP NN NNP NNP VBD the NN . "" Her NN and JJ NNS VBP in our NNS , and we VBP VBG her JJ NNS . "" JJ NNS VBP VBG a NNP NN that a NNP NN NN VBD JJ NN because of VBN and JJ NN - 19 NN NNS . NNP , which VBZ 45 NNS in nine NNS , VBD its NNP NN with NNP NNP due to NNS about the NN of some of the 60,000 NNS NNP VBD VBN for the NN because the NN VBD them at NN NN for NNS , VBG to an NN NN . The NNS should VB VBN at 2 to 7 NNS NNP ( RB 32 NNS NNP ) and RB VBN in NNS at - 70 NNS NNP after three NNS , VBG to the NNPS for NNP NNP and NNP . NNP VBZ NN NN - 19 NNS through NNP on its NN . The NN VBZ RB VBG a NN - RB NN that can VB VBN in a "" NN , NN , NN - NN NN or at - NN , "" in all 50 NNS without an NN NN NN from the NN and NNP NNP , VBD NNP NN NNP NNP . NNP NN NNP NNP VBD he VBZ RB VB the NN VBZ one . NNP VBD he VBD JJ of "" any NNS into our NN , "" but VBD that after the NNP NN it VBD VBG with the NNP NNP of NNPS on its NN NNS , "" which we VBP JJ we will VB to VB . "" At JJS 32 NNS at the NNP NN in the NN of NNP in NNP VBP VBN NN in the JJ two NNS , VBG to NNS VBN to NNS and VBN with the NNP NNP NNP . NNP NNS VBP RB RB VBN with JJ NN NNS VBG to VB NNS , VB NNS who might VB at NN or VB NN and JJ NN NNS , VBD NNP NNP , NN NN for NNP NNP . “ We VBP at the NN RB that since we VBP RB VBG that , we VBP VBG to VB into what JJ NNS we can VB for NNP , because we VBP RB VBG RB RB with NN as we would VB , ” NNP VBD . If NNP NNS VBP RB VB with NN NNS , NNP VBD she would VB VBG to VB down the NNP NNS , VBN in NNP , RB of NNP and RB of NNP . NNP VBZ RB VBN an JJ JJ NN of NNS at its NNP NNS to NN NN NNS and VBD to VB the NN to the NNP NNP . NNP NNP VBZ to VB by NNP 1 with NN NNS NNP NNP VBD NN and JJ NNS in NNP on NNP to VB the NN NN to VB RB RB as NNP 1 , with NNS due to the NN . The JJ NN NN NN in NNP NNP RB VBD NNP 's NN . The NN must RB VB VBN by NNP NNP NNP NNP . If VBN , NNP NNP could VB one of the JJS NN NNS in the NN to VB . NNP , NNP NNP NNP and NNP in NNP VBP VBN VBN since NNP because of the JJ NN . A VBN NNP will VB RB JJ for NNS and NNS , VBG to a NN VBN to the JJ JJ NN NN NN NNP by NN NNS . Upon NN , NN NN will RB VB JJ , and NNS will VB one or two NNS RB . NNS and NNS will VB NN NNS and will VB VBN to VB NN NNS . NNP will VB JJ NN NNS for NNS who VBP RB VB their JJ . Up to $ 1.2 billion for JJ NN The NNP VBZ VBG JJR than $ 1 billion on a NN that VBZ RB VB . The JJ NN VBZ VBN to VB RB JJ as $ 1.2 billion to VB JJ NN to 300 million NNS of an JJ NN - 19 NN VBG VBN and VBN in NNP . The NN VBZ VBG VBN by the NNP of NNP ’s NNP NNP and VBN to JJ NN NNP . The NN VBZ in JJ JJ NNS and VBG VBN for NN , whether it VBZ NNS against NNP - NNP - 2 , the NN that VBZ NN - 19 , and whether it VBZ the VBN from VBG VBN with the NN . The JJ NNS VBD in NNP on NNP 23 . The NN could VB VBN RB RB as NNP but would RB VB to VB through the NN of JJ NNS before it can VB VBN . The NN “ VBZ a JJ NN in NNP NNP NNP ’s NN toward a JJ , JJ , RB JJ NN by 2021 , ” NNP and NNP NNPS NNP NNP NNP VBD in a NN NN . One NN could VB VBN 36,000 NNS , NNS VBP VBD NNS across the NN VBN VBG NN - at - NN NNS RB one NN before they VBD , RB 36,000 NNS would RB VB VBN and JJR than 700,000 JJ NN NNS would VB VBN VBN , JJ NN from NNP NNP VBZ . JJ NN for two NNS RB when JJS NNS VBD VBG at NN could VB VBN 54,000 NNS and 960,000 NNS , the NNS VBD . Both NNS VBP JJR than 57 NN of the JJ NNP NNS in those NNS . JJ NNS VBD NNS to VB RB in NNP , but NN VBZ that by RB the NN VBD RB VBN NN NN in some NNS , like NNP NNP NNP . The NNS VBD that at JJS 17,500 NNS in the NNP NNP JJ NN RB could VB VBN VBN VBD JJ NN NNS VBN VBN a NN RBR . "" That JJ NN in NN , VBG it in that NN NN , VBZ RB JJ in VBG the NN of NNS , "" NNP NNP , an NN who VBD the NN at NNP NNP , VBD the NNP NNP NNP . NNP to VB NNS with up to 300 NNS VBG in NNP , NNS VBG VBN in NNP will VB JJ to VB up to 300 NNS to the NN without VBG NN of JJ NN NNS . NNP NNP NNP NNP VBD NNP the NN to JJ NNS , NN of NNP NNP NNP 's NN of NNS to VB the NN , will VB JJ NNP 1 . There VBD no NN on whether the NN and NN would VB VBN to VB JJ RB to VB , but NNP VBD NN and NN NNS would VB to VB NNS at JJS six NNS RB . NN NNS VBP VBN VBN to RB JJR than 10 NNS as NNP VBD JJ NNS VBG in NNP . NNP VBZ RB RBR VBG NN in the NN of NN - 19 NNS VBN by the NN 's JJ NNS , VBG to NNP NNP NNP NNP , the NN of the NN 's JJ NNS NN . NN JJ NNS VBP VBN with VBG and VBG NN - 19 NNS , VBG NN - of - NN NNS . A NNP - 19 JJ NN NN VBZ a NN for VBG any NN as due to the NN . NNP NN , NN of the NNP NNP NNP , RB VBD that NN of NN and JJ NNS of the JJ NNS NN VBD VBN from JJ NN in NNP . The NNP NNP NNP RBR in NNP VBD that the NN of the NNS by JJ NNS VBD from the NNP of NNP 's NN NN , at NNS by RB JJ as 10 NN . The NN of the NN VBZ as the NN VBZ NN over NNS as it VBZ . NNP NN JJ on another NN of NNS in NN NNP NN NNP NNP NNP VBD the NNP NNP that he "" ca RB VB "" whether or RB a JJ NN of NN - at - NN NNS VBZ VBG for the NNP NNPS in the NN as the JJ NN may VB a JJ NN that VBZ with JJ NN and a NN NN . "" I can't VB ; that VBZ NN of VBG into the NN NN . We VBP to VB NNS VBN , '' NNP VBD the NN . "" What I can VB VBZ that we VBP VBN to VBG the NN that we VBP RB to VB this NN RB JJ as JJ . "" NNP VBD the NN of the NN in the JJ NN VBZ him NN about a JJ NN at the NN of 2020 in the JJ NN . RB 2.4 million NNPS VBD JJ NN NNS JJ NN , the NNP NNP VBD NNP , as the NN and JJ NN VBN by the NN VBZ a VBG NN of NNS . In RB nine NNS , RB 39 million VBP VBN NN NNS that VBP the NN ’s RBS JJ NN of NNS . The JJS NNS NN VBD RB from the 3 million who VBD NNS the NN RB , and the JJ 6.9 million who VBD NN in JJ NNP . JJ NNS for NN NN VBP RB RB VBN seven NNS in a NN . The JJ NN VBZ a JJ NN NN for the NNP NNP , with six to 10 NNS VBG , NNS VBD NNP . The NN VBZ against the NN of the NN , which will RB RB VB NNS and NN from VBG NNS . RB , the NNP NNP and NNP NNP ( NNP ) VBD 13 to 19 VBN NNS will VB . This NN VBZ JJ NNS , which VBP NN NNS of 39 NN or JJR . Of the VBN six to 10 NNS , three to six could VB JJ , VBG NN NNS of 111 NNS or JJR . One of the RBS - VBG NNP NNP NNS RB VBD JJ NN from NNP - 19 , his NN VBD NNP in NNP , NNP NNP NNP NNP , 91 , VBD VBG at the NNP NNP as a NN in 1957 , during the NNP NN , NN NNP NNP VBD the NN NN . JJ NN NNP NNP VBD NNP to VB a NN , VBD NNP , VBG that he VBD for 11 NNS and their NNS . In a NN to NNP NNP , JJ NNP NNP NNP NNP and JJ NN NNP NNP VBD NNP "" a JJ NN . He VBD the JJ NN we VBD in the NN when we VBD the NN and the JJ NN we VBD each NN when we VBD . "" NNP to JJ NNS : We VBP you ' RB JJR than RB ' VBG at a JJ NN NN for JJ NNS , NNP NNP NNP , NN of the NNP NNP of NNP and NNP NNPS , VBD JJ NNS ' NNS will VB VBN to VB the NN - 19 NN . "" This NN VBZ RB what you VBD for , and a JJ NN VBZ the NN that you VBP VBN , "" NNP VBD . "" RB JJR than RB , we VBP your NN , your NN , your NN and your NN . "" VBG a NN ? RB VBZ where you can VB the NN to NN NNP NNP , NNP NNP NNP 's JJ JJ NN who VBZ VBG a three - NN NN , VBD VBN from a NNP NNP JJ NN NNP to VB the NN of his NN at NN amid NN NNS . NNP , who VBD VBN VBN at a NN NN in NNP , NNP NNP , VBD to VB VBN on NN VBG a JJ NN in NN NN , VBD a NN JJ with the NN who VBZ RB VBN to VB RB . JJR than two dozen NNS and NNS VBP VBN VBN with the NN at the NN NN . It RB VBD a JJ JJR to VB your NNP while VBG a NN NN 😷 VBG NN VBG your NNP with NN NN while VBG a NN NN ? NNP ’s JJS NNP NN NN , NNP 13.5 , VBN NNP , will VB it JJR to VB the NN . After VBG the NN , NNS will RB RBR VB to VB for NN NN to VB JJ NNS before VBG VBN to VB a NN . After NN NN VBZ for the JJ NN , NNS can VB up from the NN of the NN and VB a NN to VB the NN or VB an NNP NN NN . NNS can RB VB up from the NN of the NNP NN RB RB . JJR NN NN and NN from NNP NN : • The NN - VBG NN JJ NNS can VB a NN in NN . • NN NNS and NN NNS VBP as NN VBP - at - NN NNS VBP in some NNS . • NN NNS may VB an JJR NN VBG to NN than the NNS . RB VBZ why . NNP and NNP NNP will VB NNS for JJ NN on NNP , one NN after NNP VBD its JJ NN NNS and NNP VBD NN NNS by NN RB . JJR NNS VBP VBG NNP : NNP will VB NN as it VBD "" JJ to the NN , "" with a JJ NN of the NN without NNS ; NNP will VB NN NNS , NNS and NNS ; and NNP will VB NNS to VB at 33 NN NN RB with JJ JJ NN . VB the JJS NN in your NN . NNP : NN ' VBZ RB VB RB ' by VBG NNS or NNS The NNP VBZ RB VBN that "" it may VB JJ "" to VB VBN with the NN by VBG VBN NNS or NNS . It RB "" VBZ RB VB RB "" in that NN , the NN RB VBZ , nor by NN - to - JJ NN , or RB RB . "" NNP - 19 VBZ a JJ NN and we VBP RB VBG about how it VBZ , "" the NNP VBD in VBG its NNS . "" It may VB JJ for NNP - 19 to VB in JJ NNS , but these VBP RB VBN to VB the JJ NNS the NN VBZ . "" The NNP RB VBZ that the JJ NN the NN VBZ VBN VBZ through NN - to - NN NN , RB among those who VBP RB VBG any NNS . • JJ NNS VBN for NN - NN NN NN NNS . The NNS VBP JJ . • For NNP NN , the NN to VB NN VBZ NN NN NN ."
119,780,conspiracy,"""_`` The_DT News_NN You_PRP Need_VBP Today_NN …_: For_IN The_DT World_NN You_PRP ’ll_MD Live_VB In_IN Tomorrow_NN ._. ""_'' What_WP You_PRP Are_VBP n’t_RB Being_VBG Told_VBN About_IN The_DT World_NN You_PRP Live_VBP In_IN How_WRB The_DT “_`` Conspiracy_NN Theory_NN ”_'' Label_NN Was_VBD Conceived_VBN To_TO Derail_VB The_DT Truth_NN Movement_NN How_WRB Covert_JJ American_JJ Agents_NNPS Infiltrate_VBP the_DT Internet_NNP to_TO Manipulate_VB ,_, Deceive_VB ,_, and_CC Destroy_VB Reputations_NNS Hillary_NNP Clinton_NNP “_`` Total_JJ Terror_NN ”_'' Descends_VBZ Upon_IN Disabled_JJ Mother_NN Who_WP Discovered_VBD Her_PRP$ Link_NN To_TO By_IN :_: Sorcha_NNP Faal_NNP ,_, and_CC as_IN reported_VBN to_IN her_PRP$ Western_JJ Subscribers_NNS A_DT heartbreaking_JJ Foreign_NNP Intelligence_NNP Service_NNP (_-LRB- SVR_NNP )_-RRB- report_NN circulating_VBG in_IN the_DT Kremlin_NNP today_NN details_VBZ the_DT “_`` total_JJ terror_NN ”_'' Hillary_NNP Clinton_NNP and_CC her_PRP$ Obama_NNP regime_NN allies_NNS have_VBP unleashed_VBN upon_IN a_DT disabled_JJ American_JJ mother_NN of_IN an_DT autistic_JJ son_NN who_WP had_VBD “_`` inadvertently_RB /_, mistakenly_RB ”_'' discovered_VBN an_DT “_`` electronic_JJ document_NN ”_'' (_-LRB- email_NN ?_. photocopy_NN ?_. )_-RRB- written_VBN by_IN the_DT former_JJ Secretary_NNP of_IN State_NNP authorizing_VBG a_DT massive_JJ weapons_NNS shipment_NN from_IN ,_, ,_, to_IN Islamic_NNP State_NNP (_-LRB- ISIS_NNP /_, ISIL_NNP /_, Daesh_NNP )_-RRB- terrorists_NNS in_IN ._. [_-LRB- Note_NN :_: Some_DT words_NNS and_CC /_, or_CC phrases_NNS appearing_VBG in_IN quotes_NNS are_VBP English_JJ language_NN approximations_NNS of_IN Russian_JJ words_NNS /_, phrases_NNS having_VBG no_DT exact_JJ counterpart_NN ._. ]_-RRB- According_VBG to_IN this_DT report_NN ,_, earlier_RBR this_DT spring_NN the_DT General_NNP Directorate_NNP of_IN the_DT General_NNP Staff_NNP (_-LRB- GRU_NNP )_-RRB- reported_VBD that_IN they_PRP obtained_VBD a_DT “_`` treasure_NN trove_NN ”_'' of_IN secret_JJ Islamic_NNP State_NN documents_NNS from_IN a_DT Syrian_JJ village_NN that_WDT had_VBD been_VBN retaking_VBG by_IN Kurdish_JJ forces_NNS ._. Among_IN these_DT documents_NNS (_-LRB- now_RB classified_VBN at_IN the_DT highest_JJS security_NN level_NN )_-RRB- obtained_VBN by_IN the_DT GRU_NNP ,_, this_DT report_NN continues_VBZ ,_, were_VBD detailed_JJ arrangements_NNS between_IN the_DT Islamic_NNP State_NNP terrorists_NNS and_CC the_DT US_NNP Department_NNP of_IN State_NNP on_IN the_DT transferring_NN of_IN weapons_NNS and_CC other_JJ war_NN materials_NNS to_IN Syria_NNP from_IN Libya_NNP in_IN exchange_NN for_IN payment_NN at_IN the_DT Turkish_JJ -_HYPH Syrian_JJ border_NN of_IN oil_NN stolen_VBN from_IN by_IN these_DT terrorists_NNS from_IN both_CC Syria_NNP and_CC Iraq_NNP ._. Upon_IN the_DT SVR_NNP ’s_POS examination_NN of_IN these_DT Islamic_NNP State_NNP documents_NNS ,_, as_IN was_VBD requested_VBN by_IN the_DT GRU_NNP ,_, this_DT report_NN continues_VBZ ,_, it_PRP was_VBD discovered_VBN that_IN these_DT terrorists_NNS had_VBD “_`` electronically_RB sent_VBN ”_'' (_-LRB- Twitter_NNP )_-RRB- a_DT number_NN of_IN them_PRP to_IN their_PRP$ global_JJ supporters_NNS via_IN online_JJ social_JJ media_NN as_IN proof_NN that_IN they_PRP were_VBD being_VBG supported_VBN by_IN the_DT United_NNP States_NNPS ._. With_IN Wikileaks_NNP having_VBG confirmed_VBN the_DT validity_NN of_IN these_DT documents_NNS proving_VBG Hillary_NNP Clinton_NNP armed_VBD these_DT Islamic_NNP State_NNP terrorists_NNS ,_, and_CC US_NNP Senator_NNP Rand_NNP Paul_NNP ,_, likewise_RB ,_, publically_RB stating_VBG that_IN she_PRP had_VBD shipped_VBN weapons_NNS to_IN ISIS_NNP terror_NN forces_NNS in_IN Syria_NNP from_IN Benghazi_NNP ,_, and_CC then_RB lied_VBD about_IN it_PRP ,_, this_DT report_NN notes_VBZ ,_, none_NN of_IN America_NNP ’s_POS mainstream_JJ propaganda_NN press_NN organs_NNS have_VBP yet_RB to_TO tell_VB the_DT American_JJ people_NNS of_IN these_DT horrific_JJ facts_NNS ._. With_IN the_DT “_`` vacuum_NN of_IN truth_NN ”_'' relating_VBG to_IN Hillary_NNP Clinton_NNP ’s_POS grave_NN crimes_NNS being_VBG created_VBN by_IN America_NNP ’s_POS mainstream_JJ press_NN ,_, this_DT report_NN continues_VBZ ,_, it_PRP has_VBZ been_VBN left_VBN to_IN that_DT nations_NNS independent_JJ journalists_NNS to_TO keep_VB the_DT true_JJ facts_NNS flowing_VBG —_: and_CC whom_WP the_DT Obama_NNP regime_NN ,_, and_CC its_PRP$ propaganda_NN press_NN supporters_NNS ,_, now_RB label_VBP as_IN “_`` conspiracy_NN theorists_NNS ”_'' ._. So_RB terrified_JJ ,_, in_IN fact_NN ,_, has_VBZ Hillary_NNP Clinton_NNP and_CC the_DT Obama_NNP regime_NN become_VB of_IN these_DT independent_JJ journalists_NNS they_PRP now_RB call_VBP “_`` conspiracy_NN theorists_NNS ”_'' ,_, this_DT report_NN documents_NNS ,_, top_JJ Obama_NNP official_NN Cass_NNP Sunstein_NNP co-authored_VBD ,_, in_IN 2008_CD ,_, a_DT report_NN titled_VBN Conspiracy_NN Theories_NNS :_: Causes_NNS and_CC Cures_NNPS telling_VBG both_CC Obama_NNP and_CC Hillary_NNP Clinton_NNP how_WRB to_TO move_VB against_IN them_PRP —_: and_CC that_IN the_DT secret_NN US_NNP intelligence_NN documents_NNS released_VBN by_IN Edward_NNP Snowden_NNP proved_VBD was_VBD being_VBG implemented_VBN by_IN covert_JJ American_JJ agents_NNS who_WP had_VBD infiltrated_VBN the_DT internet_NN to_TO manipulate_VB ,_, deceive_VB and_CC destroy_VB the_DT reputations_NNS of_IN all_DT dissidents_NNS considered_VBN as_IN enemies_NNS ._. To_IN those_DT independent_JJ journalists_NNS who_WP could_MD n’t_RB be_VB stopped_VBN by_IN having_VBG Obama_NNP and_CC Hillary_NNP Clinton_NNP destroy_VB their_PRP$ reputations_NNS ,_, this_DT report_NN continues_VBZ ,_, they_PRP turned_VBD to_IN methods_NNS of_IN “_`` total_JJ terror_NN ”_'' —_: such_JJ as_IN is_VBZ currently_RB being_VBG used_VBN against_IN a_DT disabled_VBN 38_CD -_HYPH year_NN -_HYPH old_JJ mother_NN of_IN two_CD named_VBN Safya_NNP Roe_NNP Yassin_NNP ,_, one_CD of_IN whose_WP$ children_NNS is_VBZ autistic_JJ ._. Ms_NNP Yassin_NNP ,_, this_DT report_NN explains_VBZ is_VBZ an_DT American_JJ citizen_NN born_VBN in_IN the_DT United_NNP States_NNPS ,_, who_WP has_VBZ never_RB left_VBN her_PRP$ country_NN ,_, considers_VBZ herself_PRP as_IN an_DT independent_JJ journalist_NN ,_, has_VBZ never_RB met_VBN a_DT Muslim_JJ person_NN ,_, but_CC was_VBD charged_VBN by_IN the_DT Obama_NNP regime_NN with_IN the_DT grave_JJ crime_NN of_IN supporting_VBG ISIS_NNP —_: she_PRP is_VBZ n’t_RB accused_VBN of_IN plotting_VBG a_DT domestic_JJ attack_NN or_CC trying_VBG to_TO travel_VB overseas_RB to_TO join_VB the_DT terrorist_NN group_NN ._. she_PRP simply_RB reported_VBD the_DT news_NN ._. What_WP made_VBD Ms_NNP Yassin_NNP terrifying_VBG to_IN Hillary_NNP Clinton_NNP ,_, however_RB ,_, this_DT report_NN says_VBZ ,_, was_VBD that_IN she_PRP was_VBD investigating_VBG ISIS_NNP and_CC resending_VBG to_IN her_PRP$ “_`` readers_NNS /_, followers_NNS ”_'' copies_NNS of_IN “_`` electronic_JJ documents_NNS ”_'' (_-LRB- Tweets_NNS )_-RRB- proving_VBG Clinton_NNP ’s_POS US_NNP State_NNP Department_NNP was_VBD funneling_VBG weapons_NNS to_IN these_DT terrorists_NNS from_IN Libya_NNP ._. This_DT report_NN notes_VBZ that_IN from_IN US_NNP news_NN reports_NNS Ms_NNP Yassin_NNP has_VBZ been_VBN a_DT longtime_JJ independent_JJ journalist_NN investigator_NN examining_VBG various_JJ controversial_JJ issues_NNS such_JJ as_IN chemtrials_NNS ,_, genetically_RB modified_VBN foods_NNS ,_, the_DT dangers_NNS of_IN vaccines_NNS as_IN they_PRP pertain_VBP to_IN autism_NN ,_, and_CC was_VBD a_DT frequent_JJ reader_NN of_IN longtime_JJ “_`` conspiracy_NN theory_NN ”_'' reporters_NNS Alex_NNP Jones_NNP and_CC David_NNP Icke_NNP ._. Living_VBG as_IN a_DT shut_NN -_HYPH in_NN with_IN her_PRP$ father_NN and_CC two_CD children_NNS in_IN Buffalo_NNP ,_, Missouri_NNP ,_, this_DT report_NN continues_VBZ ,_, Ms_NNP Yassin_NNP rarely_RB left_VBD home_RB because_IN she_PRP is_VBZ severely_RB disabled_VBN from_IN a_DT spinal_JJ injury_NN and_CC depends_VBZ upon_IN a_DT catheter_NN (_-LRB- inserted_VBN medical_JJ device_NN for_IN releasing_VBG urine_NN from_IN the_DT bladder_NN )_-RRB- in_IN her_PRP$ daily_JJ life_NN —_: but_CC whom_WP when_WRB she_PRP began_VBD re-Tweeting_VBG ISIS_NNP documents_NNS showing_VBG Hillary_NNP Clinton_NNP ’s_POS crimes_NNS in_IN arming_VBG them_PRP ,_, was_VBD put_VBN under_IN daily_JJ surveillance_NN by_IN the_DT FBI_NNP with_IN them_PRP charging_VBG her_PRP ,_, on_IN 11_CD January_NNP ,_, and_CC her_PRP$ trial_NN scheduled_VBN to_TO start_VB on_IN 19_CD September_NNP ._. SVR_NNP analysts_NNS contributing_VBG to_IN this_DT report_NN state_VBP that_IN Mr_NNP Yassin_NNP ’s_POS “_`` motive_NN /_, reason_NN ”_'' for_IN investigating_VBG Hillary_NNP Clinton_NNP ’s_POS links_NNS with_IN ISIS_NNP related_JJ to_IN her_PRP$ Christian_JJ belief_NN that_IN the_DT “_`` end_NN times_NNS ”_'' might_MD be_VB near_RB —_: and_CC that_DT was_VBD explained_VBN by_IN Audrey_NNP Alexander_NNP ,_, a_DT researcher_NN at_IN George_NNP Washington_NNP University_NNP ’s_POS Program_NNP on_IN Extremism_NNP ,_, who_WP noted_VBD that_IN her_PRP$ postings_NNS might_MD be_VB confusing_JJ to_IN other_JJ ISIS_NNP supporters_NNS due_IN to_IN her_PRP$ originality_NN :_: “_`` She_PRP is_VBZ questioning_VBG whether_IN ISIL_NNP is_VBZ the_DT end_NN of_IN times_NNS army_NN ._. That_DT ’s_VBZ something_NN that_WDT a_DT lot_NN of_IN the_DT community_NN does_VBZ n’t_RB necessarily_RB latch_VB onto_IN ,_, which_WDT is_VBZ why_WRB we_PRP believe_VBP her_PRP$ views_NNS are_VBP quite_RB well_RB informed_VBN ._. ”_'' Though_IN Ms_NNP Yassin_NNP ’s_POS aunt_NN ,_, Sandra_NNP Mick_NNP ,_, told_VBD authorities_NNS “_`` The_DT real_JJ story_NN is_VBZ ,_, she_PRP ’s_VBZ not_RB a_DT terrorist_NN ._. She_PRP retweeted_VBD and_CC reposted_VBD what_WP other_JJ people_NNS had_VBD posted_VBN ,_, that_DT ’s_VBZ the_DT story_NN ._. She_PRP ’s_VBZ never_RB been_VBN outside_IN this_DT country_NN ._. I_PRP doubt_VBP she_PRP ’s_VBZ even_RB met_VBN a_DT real_JJ Muslim_NNP ”_'' ,_, her_PRP$ cousin_NN ,_, Janice_NNP Valenti_NNP ,_, asserting_VBG that_IN she_PRP is_VBZ a_DT Christian_NNP who_WP teaches_VBZ her_PRP$ two_CD children_NNS Bible_NNP verses_NNS ,_, and_CC the_DT US_NNP Federal_NNP Judge_NNP at_IN her_PRP$ bail_NN hearing_NN stating_VBG “_'' when_WRB it_PRP comes_VBZ down_RP to_IN it_PRP ,_, she_PRP is_VBZ a_DT disabled_JJ woman_NN who_WP poses_VBZ no_DT physical_JJ threat_NN [_-LRB- to_IN ]_-RRB- herself_PRP and_CC to_IN anyone_NN else_JJ ”_'' ,_, this_DT report_NN sadly_RB notes_VBZ ,_, Obama_NNP -_HYPH Clinton_NNP forces_NNS have_VBP been_VBN able_JJ to_TO keep_VB her_PRP jailed_VBN and_CC separated_VBN from_IN her_PRP$ young_JJ children_NNS ,_, and_CC even_RB worse_JJR ,_, have_VBP still_RB refused_VBN to_TO turn_VB over_RP to_IN her_PRP$ defense_NN attorneys_NNS the_DT evidence_NN they_PRP claim_VBP to_TO have_VB against_IN her_PRP ._. To_IN the_DT fullest_JJS horror_NN ,_, however_RB ,_, of_IN what_WP Hillary_NNP Clinton_NNP has_VBZ planned_VBN for_IN Ms_NNP Yassin_NNP ,_, this_DT report_NN says_VBZ ,_, is_VBZ the_DT Obama_NNP regime_NN planning_VBG to_TO silence_VB her_PRP under_IN what_WP is_VBZ called_VBN Classified_NNP Information_NNP Procedures_NNPS Act_NNP (_-LRB- CIPA_NNP )_-RRB- that_WDT will_MD deny_VB her_PRP the_DT ability_NN to_TO see_VB any_DT evidence_NN against_IN her_PRP ,_, her_PRP$ attorneys_NNS not_RB allowed_VBN to_TO offer_VB any_DT defense_NN of_IN any_DT kind_NN ,_, and_CC is_VBZ an_DT exact_JJ duplicate_NN of_IN the_DT Show_NN Trials_NNS used_VBN to_TO silence_VB dissidents_NNS in_IN the_DT former_JJ Soviet_NNP Union_NNP ._. Statement_NN of_IN Jeffrey_NNP Melhorn_NNP about_IN his_PRP$ neighbor_NN Safya_NNP Roe_NNP Yassin_NNP To_IN how_WRB the_DT American_JJ people_NNS themselves_PRP are_VBP reacting_VBG to_IN this_DT disabled_JJ young_JJ mothers_NNS torture_NN by_IN Hillary_NNP Clinton_NNP ,_, this_DT report_NN continues_VBZ ,_, cannot_MD be_VB known_VBN as_IN the_DT Obama_NNP regime_NN supported_VBN press_NN still_RB remains_VBZ silent_JJ about_IN this_DT case_NN that_WDT puts_VBZ all_DT of_IN these_DT peoples_NNS lives_VBZ in_IN jeopardy_NN —_: as_IN now_RB any_DT of_IN them_PRP who_WP re-Tweets_VBZ ,_, or_CC in_IN other_JJ way_NN ,_, forwards_NNS information_NN the_DT US_NNP considers_VBZ subversive_JJ can_MD now_RB be_VB jailed_VBN for_IN the_DT rest_NN of_IN their_PRP$ lives_NNS ._. As_IN to_IN what_WP Hillary_NNP Clinton_NNP is_VBZ most_RBS fearful_JJ about_IN ,_, this_DT report_NN says_VBZ ,_, is_VBZ the_DT American_JJ people_NNS discovering_VBG the_DT tens_NNS -_HYPH of_IN -_HYPH millions_NNS of_IN dollars_NNS she_PRP has_VBZ been_VBN given_VBN by_IN Saudi_NNP Arabia_NNP and_CC the_DT Gulf_NNP States_NNPS ,_, the_DT over_RB $_$ 165_CD billion_CD in_IN arms_NNS she_PRP gave_VBD them_PRP too_RB while_IN Secretary_NNP of_IN State_NNP ,_, as_IN the_DT Wikileaks_NNP Cablegate_NNP emails_NNS prove_VBP ,_, and_CC all_DT for_IN the_DT single_JJ purpose_NN of_IN destroying_VBG Syria_NNP and_CC Iraq_NNP in_IN order_NN for_IN these_DT Arab_JJ states_NNS to_TO build_VB natural_JJ gas_NN pipelines_NNS across_IN in_IN order_NN to_TO achieve_VB the_DT ultimate_JJ goal_NN of_IN destroying_VBG both_CC Russia_NNP and_CC China_NNP ._. To_IN the_DT only_JJ hope_NN Ms_NNP Yassin_NNP ,_, or_CC for_IN that_DT matter_NN the_DT American_JJ people_NNS ,_, has_VBZ ,_, this_DT report_NN concludes_VBZ ,_, is_VBZ Donald_NNP Trump_NNP —_: who_WP this_DT past_JJ week_NN became_VBD the_DT highest_JJS positioned_VBN figure_NN in_IN the_DT US_NNP to_TO join_VB with_IN the_DT independent_JJ journalists_NNS truthfully_RB telling_VBG these_DT people_NNS that_IN Obama_NNP -_HYPH Clinton_NNP are_VBP ,_, indeed_RB ,_, the_DT founders_NNS of_IN ISIS_NNP ,_, and_CC who_WP ,_, also_RB ,_, by_IN the_DT most_RBS accurate_JJ ,_, and_CC honest_JJ ,_, accounting_NN made_VBN yet_RB of_IN the_DT upcoming_VBG presidential_JJ election_NN ,_, is_VBZ showed_VBN to_TO be_VB winning_VBG by_IN a_DT landslide_NN ._. August_NNP 14_CD ,_, 2016_CD ©_, EU_NNP and_CC US_NNP all_DT rights_NNS reserved_VBN ._. Permission_NN to_TO use_VB this_DT report_NN in_IN its_PRP$ entirety_NN is_VBZ granted_VBN under_IN the_DT condition_NN it_PRP is_VBZ linked_VBN back_RB to_IN its_PRP$ original_JJ source_NN at_IN WhatDoesItMean_NNP ._. Com_NN ._. Freebase_NNP content_NN licensed_VBN under_IN CC_NNP -_HYPH BY_NNP and_CC GFDL_NNP ._. [_-LRB- Note_NN :_: Many_JJ governments_NNS and_CC their_PRP$ intelligence_NN services_NNS actively_RB campaign_VBP against_IN the_DT information_NN found_VBN in_IN these_DT reports_NNS so_IN as_IN not_RB to_TO alarm_VB their_PRP$ citizens_NNS about_IN the_DT many_JJ catastrophic_JJ Earth_NNP changes_NNS and_CC events_NNS to_TO come_VB ,_, a_DT stance_NN that_WDT the_DT Sisters_NNPS of_IN Sorcha_NNP Faal_NNP strongly_RB disagree_VBP with_IN in_IN believing_VBG that_IN it_PRP is_VBZ every_DT human_JJ beings_NNS right_JJ to_TO know_VB the_DT truth_NN ._. Due_IN to_IN our_PRP$ missions_NNS conflicts_VBZ with_IN that_DT of_IN those_DT governments_NNS ,_, the_DT responses_NNS of_IN their_PRP$ ‘_`` agents_NNS ’_'' has_VBZ been_VBN a_DT longstanding_JJ misinformation_NN /_, misdirection_NN campaign_NN designed_VBN to_TO discredit_VB us_PRP ,_, and_CC others_NNS like_IN us_PRP ,_, that_WDT is_VBZ exampled_VBN in_IN numerous_JJ places_NNS ,_, including_VBG HERE_RB ._. ]_-RRB- They_PRP Are_VBP Going_VBG To_TO Come_VB For_IN You_PRP …_: Why_WRB Are_VBP You_PRP Helping_VBG Them_PRP ?_.",""" The NN You VBP NN … For The NN You ’ll VB In NN . "" What You VBP RB VBG VBN About The NN You VBP In How The “ NN NN ” NN VBD VBN To VB The NN NN How JJ JJ NNPS VBP the NNP to VB , VB , and VB NNS NNP NNP “ JJ NN ” VBZ Upon JJ NN Who VBD Her NN To By : NNP NNP , and as VBN to her JJ NNS A JJ NNP NNP NNP ( NNP ) NN VBG in the NNP NN VBZ the “ JJ NN ” NNP NNP and her NNP NN NNS VBP VBN upon a JJ JJ NN of an JJ NN who VBD “ RB / RB ” VBN an “ JJ NN ” ( NN ? NN ? ) VBN by the JJ NNP of NNP VBG a JJ NNS NN from , , to NNP NNP ( NNP / NNP / NNP ) NNS in . [ NN : Some NNS and / or NNS VBG in NNS VBP JJ NN NNS of JJ NNS / NNS VBG no JJ NN . ] VBG to this NN , RBR this NN the NNP NNP of the NNP NNP ( NNP ) VBD that they VBD a “ NN NN ” of JJ NNP NN NNS from a JJ NN that VBD VBN VBG by JJ NNS . Among these NNS ( RB VBN at the JJS NN NN ) VBN by the NNP , this NN VBZ , VBD JJ NNS between the NNP NNP NNS and the NNP NNP of NNP on the NN of NNS and JJ NN NNS to NNP from NNP in NN for NN at the JJ - JJ NN of NN VBN from by these NNS from both NNP and NNP . Upon the NNP ’s NN of these NNP NNP NNS , as VBD VBN by the NNP , this NN VBZ , it VBD VBN that these NNS VBD “ RB VBN ” ( NNP ) a NN of them to their JJ NNS via JJ JJ NN as NN that they VBD VBG VBN by the NNP NNPS . With NNP VBG VBN the NN of these NNS VBG NNP NNP VBD these NNP NNP NNS , and NNP NNP NNP NNP , RB , RB VBG that she VBD VBN NNS to NNP NN NNS in NNP from NNP , and RB VBD about it , this NN VBZ , NN of NNP ’s JJ NN NN NNS VBP RB to VB the JJ NNS of these JJ NNS . With the “ NN of NN ” VBG to NNP NNP ’s NN NNS VBG VBN by NNP ’s JJ NN , this NN VBZ , it VBZ VBN VBN to that NNS JJ NNS to VB the JJ NNS VBG — and whom the NNP NN , and its NN NN NNS , RB VBP as “ NN NNS ” . RB JJ , in NN , VBZ NNP NNP and the NNP NN VB of these JJ NNS they RB VBP “ NN NNS ” , this NN NNS , JJ NNP NN NNP NNP VBD , in 2008 , a NN VBN NN NNS : NNS and NNPS VBG both NNP and NNP NNP how to VB against them — and that the NN NNP NN NNS VBN by NNP NNP VBD VBD VBG VBN by JJ JJ NNS who VBD VBN the NN to VB , VB and VB the NNS of all NNS VBN as NNS . To those JJ NNS who could RB VB VBN by VBG NNP and NNP NNP VB their NNS , this NN VBZ , they VBD to NNS of “ JJ NN ” — JJ as VBZ RB VBG VBN against a VBN 38 - NN - JJ NN of two VBN NNP NNP NNP , one of whose NNS VBZ JJ . NNP NNP , this NN VBZ VBZ an JJ NN VBN in the NNP NNPS , who VBZ RB VBN her NN , VBZ herself as an JJ NN , VBZ RB VBN a JJ NN , but VBD VBN by the NNP NN with the JJ NN of VBG NNP — she VBZ RB VBN of VBG a JJ NN or VBG to VB RB to VB the NN NN . she RB VBD the NN . What VBD NNP NNP VBG to NNP NNP , RB , this NN VBZ , VBD that she VBD VBG NNP and VBG to her “ NNS / NNS ” NNS of “ JJ NNS ” ( NNS ) VBG NNP ’s NNP NNP NNP VBD VBG NNS to these NNS from NNP . This NN VBZ that from NNP NN NNS NNP NNP VBZ VBN a JJ JJ NN NN VBG JJ JJ NNS JJ as NNS , RB VBN NNS , the NNS of NNS as they VBP to NN , and VBD a JJ NN of JJ “ NN NN ” NNS NNP NNP and NNP NNP . VBG as a NN - NN with her NN and two NNS in NNP , NNP , this NN VBZ , NNP NNP RB VBD RB because she VBZ RB VBN from a JJ NN and VBZ upon a NN ( VBN JJ NN for VBG NN from the NN ) in her JJ NN — but whom when she VBD VBG NNP NNS VBG NNP NNP ’s NNS in VBG them , VBD VBN under JJ NN by the NNP with them VBG her , on 11 NNP , and her NN VBN to VB on 19 NNP . NNP NNS VBG to this NN VBP that NNP NNP ’s “ NN / NN ” for VBG NNP NNP ’s NNS with NNP JJ to her JJ NN that the “ NN NNS ” might VB RB — and that VBD VBN by NNP NNP , a NN at NNP NNP NNP ’s NNP on NNP , who VBD that her NNS might VB JJ to JJ NNP NNS due to her NN : “ She VBZ VBG whether NNP VBZ the NN of NNS NN . That VBZ NN that a NN of the NN VBZ RB RB VB onto , which VBZ why we VBP her NNS VBP RB RB VBN . ” Though NNP NNP ’s NN , NNP NNP , VBD NNS “ The JJ NN VBZ , she VBZ RB a NN . She VBD and VBD what JJ NNS VBD VBN , that VBZ the NN . She VBZ RB VBN outside this NN . I VBP she VBZ RB VBN a JJ NNP ” , her NN , NNP NNP , VBG that she VBZ a NNP who VBZ her two NNS NNP NNS , and the NNP NNP NNP at her NN NN VBG “ when it VBZ down to it , she VBZ a JJ NN who VBZ no JJ NN [ to ] herself and to NN JJ ” , this NN RB VBZ , NNP - NNP NNS VBP VBN JJ to VB her VBN and VBN from her JJ NNS , and RB JJR , VBP RB VBN to VB over to her NN NNS the NN they VBP to VB against her . To the JJS NN , RB , of what NNP NNP VBZ VBN for NNP NNP , this NN VBZ , VBZ the NNP NN VBG to VB her under what VBZ VBN NNP NNP NNPS NNP ( NNP ) that will VB her the NN to VB any NN against her , her NNS RB VBN to VB any NN of any NN , and VBZ an JJ NN of the NN NNS VBN to VB NNS in the JJ NNP NNP . NN of NNP NNP about his NN NNP NNP NNP To how the JJ NNS themselves VBP VBG to this JJ JJ NNS NN by NNP NNP , this NN VBZ , cannot VB VBN as the NNP NN VBN NN RB VBZ JJ about this NN that VBZ all of these NNS VBZ in NN — as RB any of them who VBZ , or in JJ NN , NNS NN the NNP VBZ JJ can RB VB VBN for the NN of their NNS . As to what NNP NNP VBZ RBS JJ about , this NN VBZ , VBZ the JJ NNS VBG the NNS - of - NNS of NNS she VBZ VBN VBN by NNP NNP and the NNP NNPS , the RB $ 165 billion in NNS she VBD them RB while NNP of NNP , as the NNP NNP NNS VBP , and all for the JJ NN of VBG NNP and NNP in NN for these JJ NNS to VB JJ NN NNS across in NN to VB the JJ NN of VBG both NNP and NNP . To the JJ NN NNP NNP , or for that NN the JJ NNS , VBZ , this NN VBZ , VBZ NNP NNP — who this JJ NN VBD the JJS VBN NN in the NNP to VB with the JJ NNS RB VBG these NNS that NNP - NNP VBP , RB , the NNS of NNP , and who , RB , by the RBS JJ , and JJ , NN VBN RB of the VBG JJ NN , VBZ VBN to VB VBG by a NN . NNP 14 , 2016 © NNP and NNP all NNS VBN . NN to VB this NN in its NN VBZ VBN under the NN it VBZ VBN RB to its JJ NN at NNP . NN . NNP NN VBN under NNP - NNP and NNP . [ NN : JJ NNS and their NN NNS RB VBP against the NN VBN in these NNS so as RB to VB their NNS about the JJ JJ NNP NNS and NNS to VB , a NN that the NNPS of NNP NNP RB VBP with in VBG that it VBZ every JJ NNS JJ to VB the NN . Due to our NNS VBZ with that of those NNS , the NNS of their ‘ NNS ’ VBZ VBN a JJ NN / NN NN VBN to VB us , and NNS like us , that VBZ VBN in JJ NNS , VBG RB . ] They VBP VBG To VB For You … Why VBP You VBG Them ?"
120,272,mainstream,"Amid_IN fears_NNS that_IN Washington_NNP was_VBD planning_VBG to_TO poach_VB the_DT exclusive_JJ rights_NNS for_IN the_DT medicine_NN to_TO prevent_VB the_DT deadly_JJ disease_NN ,_, Ursula_NNP von_NNP der_NNP Leyen_NNP and_CC Charles_NNP Michel_NNP begged_VBD the_DT US_NNP President_NNP to_TO “_`` work_VB together_RB ”_'' ._. According_VBG to_IN newspaper_NN reporters_NNS ,_, Mr_NNP Trump_NNP offered_VBD $_$ 1_CD billion_CD to_IN German_JJ biopharmaceutical_JJ company_NN CureVac_NNP to_TO secure_VB the_DT vaccine_NN “_'' only_RB for_IN the_DT United_NNP States_NNPS ”_'' ._. The_DT EU_NNP Commission_NNP and_CC Council_NNP leaders_NNS both_DT spoke_VBD with_IN their_PRP$ American_JJ counterpart_NN during_IN a_DT G7_NNP teleconference_NN to_TO discuss_VB the_DT global_JJ reaction_NN to_IN the_DT coronavirus_NN outbreak_NN ._. Mr_NNP Michel_NNP told_VBD reporters_NNS :_: “_`` We_PRP expressed_VBD a_DT very_RB strong_JJ political_JJ will_NN and_CC we_PRP can_MD see_VB that_IN it_PRP is_VBZ very_RB important_JJ to_TO work_VB together_RB in_IN order_NN to_TO develop_VB therapies_NNS ,_, to_TO develop_VB vaccines_NNS ._. “_`` We_PRP mentioned_VBD two_CD very_RB concrete_JJ initiatives_NNS and_CC a_DT very_RB concrete_JJ proposal_NN ,_, and_CC during_IN the_DT video_NN conference_NN we_PRP felt_VBD a_DT very_RB strong_JJ political_JJ will_NN in_IN order_NN to_TO make_VB progress_NN together_RB ._. ”_'' Mrs_NNP von_NNP der_NNP Leyen_NNP held_VBD separate_JJ talks_NNS with_IN CureVac_NNP bosses_NNS in_IN the_DT hope_NN of_IN offering_VBG them_PRP a_DT package_NN to_TO keep_VB production_NN of_IN any_DT coronavirus_NN vaccines_NNS available_JJ throughout_IN Europe_NNP ._. She_PRP vowed_VBD to_TO finance_VB the_DT company_NN in_IN their_PRP$ efforts_NNS to_TO create_VB a_DT new_JJ medicine_NN ._. “_`` It_PRP ’s_VBZ crucial_JJ to_TO find_VB as_RB soon_RB as_IN possible_JJ the_DT vaccine_NN that_WDT will_MD help_VB the_DT whole_JJ world_NN ,_, ”_'' the_DT eurocrat_NN added_VBD ._. A_DT Commission_NN spokesman_NN said_VBD the_DT Brussels_NNP -_HYPH based_VBN executive_NN will_MD “_`` ensure_VB this_DT company_NN can_MD continue_VB to_TO operate_VB in_IN Europe_NNP ”_'' ._. Meanwhile_RB ,_, the_DT EU_NNP has_VBZ announced_VBN plans_NNS to_TO implement_VB a_DT travel_NN ban_NN for_IN foreigners_NNS entering_VBG its_PRP$ Schengen_NNP free_JJ -_HYPH travel_NN zone_NN ._. Brussels_NNP will_MD ask_VB European_JJ leaders_NNS to_TO sign_VB off_RP on_IN the_DT dramatic_JJ measures_NNS during_IN a_DT telephone_NN summit_NN tomorrow_NN ._. All_DT non-essential_JJ travel_NN into_IN the_DT bloc_NN will_MD be_VB prevented_VBN ,_, while_IN plans_NNS allow_VBP for_IN cross_NN -_HYPH border_NN workers_NNS ,_, medical_JJ staff_NN and_CC goods_NNS continue_VBP to_IN travelling_VBG across_IN frontiers_NNS ._. MUST_MD READ_VB :_: Online_JJ shopping_NN warning_NN :_: No_DT food_NN shop_NN delivery_NN slots_NNS before_IN APRIL_NNP The_DT measures_NNS could_MD be_VB implemented_VBN as_RB early_RB as_IN Wednesday_NNP if_IN they_PRP are_VBP agreed_VBN by_IN EU_NNP leaders_NNS ._. Boris_NNP Johnson_NNP has_VBZ been_VBN invited_VBN to_TO join_VB the_DT blanket_NN travel_NN ban_NN ,_, which_WDT would_MD mean_VB Britons_NNPS are_VBP still_RB able_JJ to_TO travel_VB into_IN Europe_NNP for_IN work_NN ._. Mrs_NNP von_NNP der_NNP Leyen_NNP said_VBD :_: ""_`` The_DT UK_NNP citizens_NNS are_VBP European_JJ citizens_NNS ,_, so_RB ,_, of_IN course_NN ,_, there_EX are_VBP no_DT restrictions_NNS for_IN the_DT UK_NNP citizens_NNS to_TO travel_VB to_IN the_DT Continent_NNP ._. ""_'' DON'T_LS MISS_NN Coronavirus_NN :_: Incredible_JJ reason_NN behind_IN couple_NN kissing_VBG in_IN face_NN masks_NNS [_-LRB- INSIGHT_NN ]_-RRB- Coronavirus_NN flights_NNS :_: Norwegian_NNP to_TO cancel_VB 85_CD percent_NN of_IN flights_NNS [_-LRB- FORECAST_NN ]_-RRB- Coronavirus_NN symptoms_NNS :_: COVID_NN -_HYPH 19_CD spreads_VBZ BEFORE_IN symptoms_NNS show_VBP -_HYPH study_NN [_-LRB- INSIGHT_NN ]_-RRB-","Amid NNS that NNP VBD VBG to VB the JJ NNS for the NN to VB the JJ NN , NNP NNP NNP NNP and NNP NNP VBD the NNP NNP to “ VB RB ” . VBG to NN NNS , NNP NNP VBD $ 1 billion to JJ JJ NN NNP to VB the NN “ RB for the NNP NNPS ” . The NNP NNP and NNP NNS both VBD with their JJ NN during a NNP NN to VB the JJ NN to the NN NN . NNP NNP VBD NNS : “ We VBD a RB JJ JJ NN and we can VB that it VBZ RB JJ to VB RB in NN to VB NNS , to VB NNS . “ We VBD two RB JJ NNS and a RB JJ NN , and during the NN NN we VBD a RB JJ JJ NN in NN to VB NN RB . ” NNP NNP NNP NNP VBD JJ NNS with NNP NNS in the NN of VBG them a NN to VB NN of any NN NNS JJ throughout NNP . She VBD to VB the NN in their NNS to VB a JJ NN . “ It VBZ JJ to VB RB RB as JJ the NN that will VB the JJ NN , ” the NN VBD . A NN NN VBD the NNP - VBN NN will “ VB this NN can VB to VB in NNP ” . RB , the NNP VBZ VBN NNS to VB a NN NN for NNS VBG its NNP JJ - NN NN . NNP will VB JJ NNS to VB off on the JJ NNS during a NN NN NN . All JJ NN into the NN will VB VBN , while NNS VBP for NN - NN NNS , JJ NN and NNS VBP to VBG across NNS . MUST VB : JJ NN NN : No NN NN NN NNS before NNP The NNS could VB VBN RB RB as NNP if they VBP VBN by NNP NNS . NNP NNP VBZ VBN VBN to VB the NN NN NN , which would VB NNPS VBP RB JJ to VB into NNP for NN . NNP NNP NNP NNP VBD : "" The NNP NNS VBP JJ NNS , RB , of NN , there VBP no NNS for the NNP NNS to VB to the NNP . "" DON'T NN NN : JJ NN behind NN VBG in NN NNS [ NN ] NN NNS : NNP to VB 85 NN of NNS [ NN ] NN NNS : NN - 19 VBZ BEFORE NNS VBP - NN [ NN ]"
121,107,conspiracy,"An_DT Orthodox_JJ Jewish_JJ daycare_NN has_VBZ been_VBN shut_VBN by_IN New_NNP York_NNP City_NNP ’s_POS Health_NNP Department_NNP after_IN it_PRP violated_VBD a_DT city_NN order_NN about_IN the_DT measles_NNS public_JJ health_NN emergency_NN ,_, while_IN 23_CD other_JJ daycares_NNS and_CC yeshivas_NNPS have_VBP received_VBN violation_NN notices_NNS ._. The_DT United_NNP Talmudical_NNP Academy_NNP in_IN the_DT Haredi_NNP neighborhood_NN of_IN Williamsburg_NNP ,_, Brooklyn_NNP failed_VBD to_TO “_`` provide_VB access_NN to_IN medical_JJ and_CC attendance_NN records_NNS ,_, ”_'' the_DT health_NN department_NN said_VBD ,_, which_WDT made_VBD it_PRP impossible_JJ to_TO check_VB whether_IN the_DT school_NN has_VBZ been_VBN excluding_VBG staff_NNS and_CC students_NNS who_WP are_VBP n’t_RB vaccinated_VBN against_IN measles_NNS ._. A_DT public_JJ health_NN emergency_NN was_VBD declared_VBN in_IN four_CD areas_NNS of_IN Brooklyn_NNP last_JJ week_NN to_TO deal_VB with_IN the_DT measles_NNS outbreak_NN ,_, the_DT worst_JJS the_DT city_NN has_VBZ seen_VBN since_IN 1991_CD ._. The_DT areas_NNS affected_VBN are_VBP largely_RB in_IN Ultra_NNP -_HYPH Orthodox_JJ Jewish_JJ communities_NNS ._. All_DT children_NNS over_IN six_CD months_NNS of_IN age_NN were_VBD required_VBN to_TO get_VB the_DT measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN (_-LRB- MMR_NN )_-RRB- vaccine_NN ,_, and_CC parents_NNS who_WP did_VBD n’t_RB comply_VB could_MD be_VB fined_VBN $_$ 1,000_CD ._. Schools_NNS were_VBD told_VBN to_TO only_RB accept_VB vaccinated_VBN children_NNS and_CC to_TO keep_VB medical_JJ and_CC attendance_NN records_NNS that_WDT authorities_NNS can_MD have_VB access_NN to_IN ._. There_EX have_VBP been_VBN 329_CD confirmed_VBN cases_NNS of_IN the_DT measles_NNS ,_, a_DT highly_RB contagious_JJ disease_NN ,_, in_IN New_NNP York_NNP since_IN October_NNP ,_, and_CC 44_CD new_JJ cases_NNS since_IN the_DT emergency_NN declaration_NN last_JJ week_NN ._. No_DT deaths_NNS have_VBP been_VBN reported_VBN ,_, but_CC 25_CD have_VBP been_VBN hospitalized_VBN ,_, with_IN six_CD sent_VBN to_IN the_DT intensive_JJ care_NN unit_NN ._. The_DT health_NN department_NN is_VBZ concerned_VBN more_JJR cases_NNS may_MD occur_VB as_IN families_NNS gather_VBP for_IN the_DT upcoming_VBG Passover_NNP holiday_NN ._. Ultra-Orthodox_JJ Jewish_JJ communities_NNS are_VBP showing_VBG resistance_NN to_IN the_DT vaccine_NN drive_NN ,_, with_IN information_NN circulating_VBG that_IN the_DT jabs_NNS are_VBP ineffective_JJ or_CC harmful_JJ ._. The_DT Orthodox_JJ Jewish_JJ anti-vaccine_NN group_NN Parents_NNPS Educating_NNP and_CC Advocating_NNP for_IN Children_NNP ’s_POS Health_NNP (_-LRB- PEACH_NNP )_-RRB- claims_VBZ doctors_NNS hide_VBP evidence_NN that_IN vaccines_NNS are_VBP linked_VBN to_IN swelling_NN ,_, paralysis_NN ,_, and_CC death_NN ._. Vaccinations_NNS are_VBP also_RB the_DT subject_NN of_IN a_DT heated_VBN ,_, wider_JJR public_JJ debate_NN ,_, particularly_RB since_IN an_DT erroneous_JJ paper_NN in_IN the_DT Lancet_NNP in_IN 1998_CD claimed_VBD to_TO have_VB found_VBN a_DT link_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ._. The_DT respected_VBN medical_JJ journal_NN later_RBR retracted_VBD the_DT publication_NN ._. Measles_NN was_VBD essentially_RB eradicated_VBN in_IN the_DT US_NNP by_IN 2000_CD ,_, but_CC there_EX has_VBZ been_VBN a_DT spate_NN of_IN outbreaks_NNS as_IN a_DT result_NN of_IN people_NNS not_RB vaccinating_VBG their_PRP$ children_NNS ._. In_IN 2014_CD ,_, the_DT Amish_NNP community_NN in_IN Ohio_NNP suffered_VBD an_DT outbreak_NN ._.","An JJ JJ NN VBZ VBN VBN by NNP NNP NNP ’s NNP NNP after it VBD a NN NN about the NNS JJ NN NN , while 23 JJ NNS and NNPS VBP VBN NN NNS . The NNP NNP NNP in the NNP NN of NNP , NNP VBD to “ VB NN to JJ and NN NNS , ” the NN NN VBD , which VBD it JJ to VB whether the NN VBZ VBN VBG NNS and NNS who VBP RB VBN against NNS . A JJ NN NN VBD VBN in four NNS of NNP JJ NN to VB with the NNS NN , the JJS the NN VBZ VBN since 1991 . The NNS VBN VBP RB in NNP - JJ JJ NNS . All NNS over six NNS of NN VBD VBN to VB the NNS - NNS - NN ( NN ) NN , and NNS who VBD RB VB could VB VBN $ 1,000 . NNS VBD VBN to RB VB VBN NNS and to VB JJ and NN NNS that NNS can VB NN to . There VBP VBN 329 VBN NNS of the NNS , a RB JJ NN , in NNP NNP since NNP , and 44 JJ NNS since the NN NN JJ NN . No NNS VBP VBN VBN , but 25 VBP VBN VBN , with six VBN to the JJ NN NN . The NN NN VBZ VBN JJR NNS may VB as NNS VBP for the VBG NNP NN . JJ JJ NNS VBP VBG NN to the NN NN , with NN VBG that the NNS VBP JJ or JJ . The JJ JJ NN NN NNPS NNP and NNP for NNP ’s NNP ( NNP ) VBZ NNS VBP NN that NNS VBP VBN to NN , NN , and NN . NNS VBP RB the NN of a VBN , JJR JJ NN , RB since an JJ NN in the NNP in 1998 VBD to VB VBN a NN between the NN NN and NN . The VBN JJ NN RBR VBD the NN . NN VBD RB VBN in the NNP by 2000 , but there VBZ VBN a NN of NNS as a NN of NNS RB VBG their NNS . In 2014 , the NNP NN in NNP VBD an NN ."
122,463,mainstream,"All_DT preterm_NN infants_NNS born_VBN at_IN <_-LRB- 28_CD weeks_NNS gestation_NN are_VBP recommended_VBN to_TO receive_VB 4_CD doses_NNS of_IN (_-LRB- 13_CD -_HYPH valent_NN pneumococcal_NN conjugate_NN vaccine_NN )_-RRB- and_CC 2_CD doses_NNS of_IN (_-LRB- 23_CD -_HYPH valent_NN pneumococcal_JJ polysaccharide_NN vaccine_NN )_-RRB- ._. The_DT doses_NNS of_IN should_MD be_VB given_VBN at_IN 2_CD ,_, 4_CD ,_, 6_CD and_CC 12_CD months_NNS of_IN age_NN ._. The_DT 1st_JJ dose_NN of_IN should_MD be_VB given_VBN at_IN 4_CD years_NNS of_IN age_NN ,_, and_CC the_DT 2nd_JJ dose_NN given_VBN at_IN least_JJS 5_CD years_NNS later_RBR ._. Children_NNS who_WP were_VBD born_VBN at_IN <_-LRB- 28_CD weeks_NNS gestation_NN do_VBP not_RB need_VB more_JJR pneumococcal_JJ vaccine_NN doses_NNS after_IN 5_CD years_NNS of_IN age_NN if_IN they_PRP :_: •_SYM do_VBP not_RB have_VB a_DT chronic_JJ medical_JJ condition_NN (s_-LRB- )_-RRB- and_CC are_VBP not_RB Aboriginal_JJ or_CC Torres_NNP Strait_NNP Islander_NNP ,_, and_CC therefore_RB are_VBP not_RB at_IN ongoing_JJ increased_VBN risk_NN of_IN pneumococcal_JJ disease_NN •_, have_VBP received_VBN the_DT extra_JJ pneumococcal_JJ vaccine_NN doses_NNS to_IN 5_CD years_NNS of_IN age_NN as_IN recommended_VBN above_RB However_RB ,_, all_DT children_NNS and_CC adults_NNS who_WP have_VBP chronic_JJ lung_NN disease_NN or_CC certain_JJ other_JJ chronic_JJ medical_JJ conditions_NNS (_-LRB- whether_IN related_JJ to_IN preterm_NN birth_NN or_CC not_RB )_-RRB- should_MD receive_VB extra_JJ pneumococcal_JJ vaccine_NN doses_NNS up_IN to_IN and_CC beyond_IN the_DT age_NN of_IN 5_CD years_NNS ._. For_IN more_JJR details_NNS ,_, see_VB :_: •_NFP Table_NN ._. Catch_NN -_HYPH up_RP schedule_NN for_IN 13vPCV_NNP for_IN Aboriginal_JJ and_CC Torres_NNP Strait_NNP Islander_NNP children_NNS living_VBG in_IN NT_NNP ,_, Qld_NNP ,_, SA_NNP or_CC WA_NNP ONLY_RB ,_, and_CC all_DT children_NNS with_IN risk_NN conditions_NNS for_IN pneumococcal_JJ disease_NN ,_, aged_JJ <_-LRB- 5_CD years_NNS","All NN NNS VBN at < 28 NNS NN VBP VBN to VB 4 NNS of ( 13 - NN NN NN NN ) and 2 NNS of ( 23 - NN JJ NN NN ) . The NNS of should VB VBN at 2 , 4 , 6 and 12 NNS of NN . The JJ NN of should VB VBN at 4 NNS of NN , and the JJ NN VBN at JJS 5 NNS RBR . NNS who VBD VBN at < 28 NNS NN VBP RB VB JJR JJ NN NNS after 5 NNS of NN if they : • VBP RB VB a JJ JJ NN (s ) and VBP RB JJ or NNP NNP NNP , and RB VBP RB at JJ VBN NN of JJ NN • VBP VBN the JJ JJ NN NNS to 5 NNS of NN as VBN RB RB , all NNS and NNS who VBP JJ NN NN or JJ JJ JJ JJ NNS ( whether JJ to NN NN or RB ) should VB JJ JJ NN NNS up to and beyond the NN of 5 NNS . For JJR NNS , VB : • NN . NN - up NN for NNP for JJ and NNP NNP NNP NNS VBG in NNP , NNP , NNP or NNP RB , and all NNS with NN NNS for JJ NN , JJ < 5 NNS"
123,411,conspiracy,"Mandatory_JJ vaccinations_NNS are_VBP a_DT highly_RB controversial_JJ subject_NN ._. For_IN years_NNS ,_, medical_JJ propaganda_NN has_VBZ been_VBN conditioning_VBG us_PRP to_TO believe_VB that_IN vaccines_NNS provide_VBP what_WP is_VBZ known_VBN as_IN “_`` herd_NN immunity_NN ._. ”_'' This_DT propaganda_NN teaches_VBZ that_IN if_IN a_DT significant_JJ proportion_NN of_IN the_DT population_NN is_VBZ vaccinated_VBN against_IN a_DT disease_NN then_RB the_DT whole_JJ community_NN will_MD be_VB protected_VBN ,_, including_VBG those_DT who_WP do_VBP not_RB receive_VB the_DT vaccine_NN ._. Based_VBN on_IN this_DT faulty_JJ premise_NN ,_, many_JJ states_NNS have_VBP passed_VBN laws_NNS making_VBG vaccinations_NNS mandatory_JJ –_: supposedly_RB for_IN the_DT greater_JJR good_NN of_IN all_DT ._. Many_JJ vaccine_NN advocates_NNS go_VBP so_RB far_RB as_IN to_TO accuse_VB those_DT who_WP refuse_VBP to_TO be_VB vaccinated_VBN of_IN compromising_VBG the_DT health_NN of_IN the_DT entire_JJ community_NN ._. However_RB ,_, decades_NNS after_IN the_DT first_JJ vaccines_NNS were_VBD created_VBN ,_, history_NN has_VBZ proven_VBN that_IN these_DT toxic_JJ jabs_NNS do_VBP not_RB confer_VB a_DT lifetime_NN of_IN immunity_NN ,_, which_WDT is_VBZ why_WRB booster_NN shots_NNS are_VBP now_RB recommended_VBN for_IN many_JJ vaccines_NNS ._. And_CC the_DT simple_JJ fact_NN is_VBZ that_IN in_IN addition_NN to_IN being_VBG ineffective_JJ ,_, vaccines_NNS also_RB carry_VBP serious_JJ risks_NNS and_CC contain_VBP dangerous_JJ and_CC ethically_RB questionable_JJ ingredients_NNS ._. Yet_CC ,_, more_JJR and_CC more_JJR states_NNS are_VBP passing_VBG laws_NNS making_VBG it_PRP mandatory_JJ for_IN children_NNS to_TO be_VB vaccinated_VBN ,_, even_RB denying_VBG school_NN entry_NN to_IN those_DT who_WP refuse_VBP to_TO comply_VB ._. It_PRP is_VBZ therefore_RB more_RBR important_JJ than_IN ever_RB to_TO know_VB exactly_RB what_WP vaccines_NNS are_VBP made_VBN of_IN and_CC why_WRB we_PRP need_VBP to_TO be_VB extremely_RB cautious_JJ about_IN allowing_VBG healthcare_NN workers_NNS to_TO administer_VB them_PRP to_IN our_PRP$ children_NNS ._. There_EX is_VBZ a_DT common_JJ misconception_NN that_IN being_VBG vaccinated_VBN simply_RB entails_VBZ being_VBG injected_VBN with_IN a_DT small_JJ amount_NN of_IN a_DT disease_NN so_IN that_IN the_DT immune_NN system_NN can_MD produce_VB antibodies_NNS against_IN it_PRP ,_, thereby_RB conferring_VBG lifelong_JJ immunity_NN to_IN the_DT recipient_NN ._. In_IN reality_NN ,_, however_RB ,_, vaccines_NNS are_VBP manufactured_VBN using_VBG a_DT host_NN of_IN ingredients_NNS that_WDT have_VBP serious_JJ side_NN effects_NNS ._. In_IN addition_NN ,_, many_JJ are_VBP made_VBN with_IN fetal_JJ cells_NNS taken_VBN from_IN aborted_VBN babies_NNS ,_, which_WDT would_MD shock_VB and_CC horrify_VB many_JJ of_IN the_DT people_NNS who_WP willingly_RB allow_VBP their_PRP$ young_JJ children_NNS to_TO be_VB vaccinated_VBN ._. As_IN reported_VBN by_IN Families_NNPS 4_CD Vaccine_NNP Choice_NNP (_-LRB- and_CC confirmed_VBN by_IN the_DT CDC_NNP )_-RRB- ,_, vaccines_NNS also_RB contain_VBP serum_NN derived_VBN from_IN the_DT blood_NN of_IN bovine_NN fetuses_NNS ,_, protein_NN from_IN human_JJ blood_NN plasma_NN ,_, kidney_NN epithelial_JJ cells_NNS extracted_VBN from_IN African_JJ green_JJ monkeys_NNS ,_, yeast_NN DNA_NN ,_, yeast_NN protein_NN ,_, Madin_NNP Darby_NNP canine_NN kidney_NN cells_NNS derived_VBN from_IN an_DT adult_JJ cocker_NN spaniel_NN ,_, chicken_NN fibroblasts_NNS ,_, DNA_NN taken_VBN from_IN porcine_NN circoviruses_NNS and_CC other_JJ disgusting_JJ ingredients_NNS ._. Then_RB ,_, of_IN course_NN ,_, there_EX are_VBP the_DT other_JJ controversial_JJ vaccine_NN ingredients_NNS like_IN mercury_NN (_-LRB- thimerosal_NN )_-RRB- ,_, formaldehyde_NN and_CC monosodium_NN glutamate_NN ,_, which_WDT have_VBP all_RB been_VBN linked_VBN to_IN a_DT host_NN of_IN adverse_JJ health_NN effects_NNS ._. Families_NNS 4_CD Vaccine_NN Choice_NN explains_VBZ how_WRB all_DT of_IN these_DT vile_JJ ingredients_NNS are_VBP used_VBN to_TO create_VB vaccines_NNS :_: Now_RB we_PRP learn_VBP that_IN with_IN RNA_NN …_: “_`` DNA_NN molecules_NNS from_IN two_CD different_JJ species_NNS are_VBP inserted_VBN into_IN a_DT host_NN organism_NN to_TO produce_VB new_JJ genetic_JJ combinations_NNS ._. ”_'' So_RB that_DT means_VBZ they_PRP are_VBP splitting_VBG human_JJ DNA_NN with_IN the_DT DNA_NN of_IN animals_NNS and_CC aborted_VBN fetuses_NNS and_CC then_RB injecting_VBG it_PRP back_RB into_IN our_PRP$ bodies_NNS with_IN the_DT hopes_NNS that_IN it_PRP will_MD cause_VB us_PRP to_TO create_VB the_DT antigen_NN needed_VBN to_TO immunize_VB us_PRP against_IN a_DT virus_NN ._. While_IN the_DT government_NN and_CC the_DT mainstream_JJ media_NNS promote_VBP the_DT idea_NN that_IN all_DT healthcare_NN professionals_NNS support_VBP vaccinations_NNS ,_, nothing_NN could_MD be_VB further_RB from_IN the_DT truth_NN ._. Natural_JJ health_NN practitioners_NNS like_IN naturopathic_JJ physicians_NNS and_CC homeopaths_NNS have_VBP long_RB warned_VBN against_IN the_DT negative_JJ effects_NNS of_IN vaccines_NNS ,_, and_CC even_RB many_JJ mainstream_JJ doctors_NNS are_VBP opposed_VBN to_IN vaccinations_NNS ,_, especially_RB when_WRB they_PRP are_VBP forced_VBN on_IN people_NNS ._. After_IN all_DT ,_, it_PRP is_VBZ a_DT basic_JJ human_JJ right_NN –_: as_IN asserted_VBN by_IN the_DT American_NNP Medical_NNP Association_NNP ’s_POS Code_NNP of_IN Medical_NNP Ethics_NNP –_: to_TO choose_VB whether_IN or_CC not_RB to_TO accept_VB a_DT risky_JJ medical_JJ procedure_NN :_: The_DT patient_NN should_MD make_VB his_PRP$ or_CC her_PRP$ own_JJ determination_NN about_IN treatment_NN …_. Informed_VBN consent_NN is_VBZ a_DT basic_JJ policy_NN in_IN both_CC ethics_NN and_CC law_NN that_WDT physicians_NNS must_MD honor_VB ,_, unless_IN the_DT patient_NN is_VBZ unconscious_JJ or_CC otherwise_RB incapable_JJ of_IN consenting_NN and_CC harm_NN from_IN failure_NN to_TO treat_VB is_VBZ imminent_JJ ._. Disclaimer_NN :_: We_PRP at_IN Prepare_NN for_IN Change_NN (_-LRB- PFC_NNP )_-RRB- bring_VBP you_PRP information_NN that_WDT is_VBZ not_RB offered_VBN by_IN the_DT mainstream_JJ news_NN ,_, and_CC therefore_RB may_MD seem_VB controversial_JJ ._. The_DT opinions_NNS ,_, views_NNS ,_, statements_NNS ,_, and_CC /_, or_CC information_NN we_PRP present_VBP are_VBP not_RB necessarily_RB promoted_VBN ,_, endorsed_VBN ,_, espoused_VBN ,_, or_CC agreed_VBN to_TO by_IN Prepare_VB for_IN Change_NNP ,_, its_PRP$ leadership_NN Council_NN ,_, members_NNS ,_, those_DT who_WP work_VBP with_IN PFC_NNP ,_, or_CC those_DT who_WP read_VBP its_PRP$ content_NN ._. However_RB ,_, they_PRP are_VBP hopefully_RB provocative_JJ ._. Please_UH use_VB discernment_NN !_. Use_VB logical_JJ thinking_NN ,_, your_PRP$ own_JJ intuition_NN and_CC your_PRP$ own_JJ connection_NN with_IN Source_NNP ,_, Spirit_NNP and_CC Natural_JJ Laws_NNPS to_TO help_VB you_PRP determine_VB what_WP is_VBZ true_JJ and_CC what_WP is_VBZ not_RB ._. By_IN sharing_VBG information_NN and_CC seeding_VBG dialogue_NN ,_, it_PRP is_VBZ our_PRP$ goal_NN to_TO raise_VB consciousness_NN and_CC awareness_NN of_IN higher_JJR truths_NNS to_TO free_VB us_PRP from_IN enslavement_NN of_IN the_DT matrix_NN in_IN this_DT material_NN realm_NN ._.","JJ NNS VBP a RB JJ NN . For NNS , JJ NN VBZ VBN VBG us to VB that NNS VBP what VBZ VBN as “ NN NN . ” This NN VBZ that if a JJ NN of the NN VBZ VBN against a NN RB the JJ NN will VB VBN , VBG those who VBP RB VB the NN . VBN on this JJ NN , JJ NNS VBP VBN NNS VBG NNS JJ – RB for the JJR NN of all . JJ NN NNS VBP RB RB as to VB those who VBP to VB VBN of VBG the NN of the JJ NN . RB , NNS after the JJ NNS VBD VBN , NN VBZ VBN that these JJ NNS VBP RB VB a NN of NN , which VBZ why NN NNS VBP RB VBN for JJ NNS . And the JJ NN VBZ that in NN to VBG JJ , NNS RB VBP JJ NNS and VBP JJ and RB JJ NNS . Yet , JJR and JJR NNS VBP VBG NNS VBG it JJ for NNS to VB VBN , RB VBG NN NN to those who VBP to VB . It VBZ RB RBR JJ than RB to VB RB what NNS VBP VBN of and why we VBP to VB RB JJ about VBG NN NNS to VB them to our NNS . There VBZ a JJ NN that VBG VBN RB VBZ VBG VBN with a JJ NN of a NN so that the NN NN can VB NNS against it , RB VBG JJ NN to the NN . In NN , RB , NNS VBP VBN VBG a NN of NNS that VBP JJ NN NNS . In NN , JJ VBP VBN with JJ NNS VBN from VBN NNS , which would VB and VB JJ of the NNS who RB VBP their JJ NNS to VB VBN . As VBN by NNPS 4 NNP NNP ( and VBN by the NNP ) , NNS RB VBP NN VBN from the NN of NN NNS , NN from JJ NN NN , NN JJ NNS VBN from JJ JJ NNS , NN NN , NN NN , NNP NNP NN NN NNS VBN from an JJ NN NN , NN NNS , NN VBN from NN NNS and JJ JJ NNS . RB , of NN , there VBP the JJ JJ NN NNS like NN ( NN ) , NN and NN NN , which VBP RB VBN VBN to a NN of JJ NN NNS . NNS 4 NN NN VBZ how all of these JJ NNS VBP VBN to VB NNS : RB we VBP that with NN … “ NN NNS from two JJ NNS VBP VBN into a NN NN to VB JJ JJ NNS . ” RB that VBZ they VBP VBG JJ NN with the NN of NNS and VBN NNS and RB VBG it RB into our NNS with the NNS that it will VB us to VB the NN VBN to VB us against a NN . While the NN and the JJ NNS VBP the NN that all NN NNS VBP NNS , NN could VB RB from the NN . JJ NN NNS like JJ NNS and NNS VBP RB VBN against the JJ NNS of NNS , and RB JJ JJ NNS VBP VBN to NNS , RB when they VBP VBN on NNS . After all , it VBZ a JJ JJ NN – as VBN by the NNP NNP NNP ’s NNP of NNP NNP – to VB whether or RB to VB a JJ JJ NN : The NN should VB his or her JJ NN about NN … VBN NN VBZ a JJ NN in both NN and NN that NNS must VB , unless the NN VBZ JJ or RB JJ of NN and NN from NN to VB VBZ JJ . NN : We at NN for NN ( NNP ) VBP you NN that VBZ RB VBN by the JJ NN , and RB may VB JJ . The NNS , NNS , NNS , and / or NN we VBP VBP RB RB VBN , VBN , VBN , or VBN to by VB for NNP , its NN NN , NNS , those who VBP with NNP , or those who VBP its NN . RB , they VBP RB JJ . Please VB NN ! VB JJ NN , your JJ NN and your JJ NN with NNP , NNP and JJ NNPS to VB you VB what VBZ JJ and what VBZ RB . By VBG NN and VBG NN , it VBZ our NN to VB NN and NN of JJR NNS to VB us from NN of the NN in this NN NN ."
124,401,mainstream,"It_PRP 's_VBZ rare_JJ in_IN science_NN and_CC science_NN writing_NN to_TO make_VB definitive_JJ statements_NNS ,_, particularly_RB about_IN causation_NN ._. We_PRP like_VBP to_TO add_VB what_WP I_PRP call_VBP ""_`` wishy_JJ washy_JJ ""_'' words_NNS like_IN ""_`` may_MD ""_'' and_CC ""_`` probably_RB ""_'' and_CC ""_`` perhaps_RB ._. ""_'' So_RB when_WRB scientists_NNS or_CC science_NN writers_NNS make_VBP definitive_JJ statements_NNS like_IN ""_`` vaccines_NNS do_VBP n't_RB cause_VB autism_NN ""_'' and_CC ""_`` vaccines_NNS save_VB lives_NNS ,_, ""_'' it_PRP 's_VBZ because_IN we_PRP have_VBP overwhelming_JJ evidence_NN to_TO back_VB it_PRP up_RP ._. But_CC 25_CD percent_NN of_IN parents_NNS in_IN a_DT recent_JJ University_NNP of_IN Michigan_NNP poll_NN agreed_VBD with_IN the_DT statement_NN ""_`` some_DT vaccines_NNS cause_VBP autism_NN in_IN healthy_JJ children_NNS ""_'' and_CC 11.5_CD percent_NN have_VBP refused_VBN at_IN least_JJS one_CD vaccination_NN for_IN their_PRP$ child_NN ._. This_DT is_VBZ worrisome_JJ ._. The_DT now_RB -_HYPH discredited_VBN link_NN between_IN autism_NN and_CC vaccines_NNS was_VBD proposed_VBN by_IN British_JJ scientist_NN Andrew_NNP Wakefield_NNP in_IN a_DT 1998_CD paper_NN in_IN the_DT Lancet_NNP ._. No_DT one_NN was_VBD ever_RB able_JJ to_TO reproduce_VB the_DT results_NNS of_IN that_DT study_NN ,_, and_CC the_DT paper_NN has_VBZ since_RB been_VBN retracted_VBN by_IN the_DT journal_NN ._. A_DT recently_RB concluded_VBN investigation_NN of_IN Wakefield_NNP found_VBD that_IN he_PRP had_VBD conducted_VBN unapproved_JJ and_CC unnecessary_JJ tests_NNS on_IN children_NNS and_CC even_RB paid_VBN children_NNS at_IN his_PRP$ son's_NN birthday_NN party_NN for_IN providing_VBG blood_NN samples_NNS ._. Wakefield_NNP has_VBZ since_RB resigned_VBN from_IN the_DT autism_NN center_NN he_PRP began_VBD in_IN Texas_NNP ._. Other_JJ studies_NNS that_WDT have_VBP examined_VBN childhood_NN vaccines_NNS and_CC autism_NN have_VBP failed_VBN to_TO find_VB any_DT link_NN ._. When_WRB the_DT Institute_NNP of_IN Medicine_NNP reviewed_VBD the_DT issue_NN six_CD years_NNS ago_RB ,_, they_PRP concluded_VBD ""_`` the_DT body_NN of_IN epidemiological_JJ evidence_NN favors_VBZ rejection_NN of_IN a_DT causal_JJ relationship_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ""_'' and_CC recommended_VBD ""_`` a_DT public_JJ health_NN response_NN that_WDT fully_RB supports_VBZ an_DT array_NN of_IN vaccine_NN safety_NN activities_NNS ._. ""_'' No_DT one_NN should_MD die_VB from_IN a_DT preventable_JJ disease_NN like_IN measles_NNS or_CC pertussis_NN ,_, but_CC they_PRP do_VBP ,_, even_RB here_RB in_IN the_DT United_NNP States_NNPS ,_, when_WRB parents_NNS choose_VBP to_TO leave_VB their_PRP$ children_NNS unvaccinated_JJ ._. Vaccines_NNS work_VBP ._. They_PRP do_VBP n't_RB cause_VB autism_NN ._. Now_RB ,_, perhaps_RB ,_, scientists_NNS can_MD spend_VB their_PRP$ resources_NNS on_IN figuring_VBG out_RP what_WP does_VBZ instead_RB of_IN wasting_VBG them_PRP on_IN a_DT debunked_VBN theory_NN ._.","It VBZ JJ in NN and NN NN to VB JJ NNS , RB about NN . We VBP to VB what I VBP "" JJ JJ "" NNS like "" may "" and "" RB "" and "" RB . "" RB when NNS or NN NNS VBP JJ NNS like "" NNS VBP RB VB NN "" and "" NNS VB NNS , "" it VBZ because we VBP JJ NN to VB it up . But 25 NN of NNS in a JJ NNP of NNP NN VBD with the NN "" some NNS VBP NN in JJ NNS "" and 11.5 NN VBP VBN at JJS one NN for their NN . This VBZ JJ . The RB - VBN NN between NN and NNS VBD VBN by JJ NN NNP NNP in a 1998 NN in the NNP . No NN VBD RB JJ to VB the NNS of that NN , and the NN VBZ RB VBN VBN by the NN . A RB VBN NN of NNP VBD that he VBD VBN JJ and JJ NNS on NNS and RB VBN NNS at his NN NN NN for VBG NN NNS . NNP VBZ RB VBN from the NN NN he VBD in NNP . JJ NNS that VBP VBN NN NNS and NN VBP VBN to VB any NN . When the NNP of NNP VBD the NN six NNS RB , they VBD "" the NN of JJ NN VBZ NN of a JJ NN between the NN NN and NN "" and VBD "" a JJ NN NN that RB VBZ an NN of NN NN NNS . "" No NN should VB from a JJ NN like NNS or NN , but they VBP , RB RB in the NNP NNPS , when NNS VBP to VB their NNS JJ . NNS VBP . They VBP RB VB NN . RB , RB , NNS can VB their NNS on VBG out what VBZ RB of VBG them on a VBN NN ."
125,626,mainstream,"WASHINGTON_NNP (_-LRB- CBS.MW_NNP )_-RRB- --_, The_DT Senate_NNP approved_VBD the_DT creation_NN of_IN a_DT massive_JJ ,_, Cabinet_NN -_HYPH level_NN Department_NNP of_IN Homeland_NNP Security_NNP on_IN Tuesday_NNP night_NN in_IN a_DT decisive_JJ 90_CD -_HYPH 9_CD vote_NN ._. Hours_NNS earlier_RBR ,_, Republicans_NNPS beat_VBD back_RB a_DT challenge_NN to_IN provisions_NNS Democrats_NNPS had_VBD described_VBN as_IN special_JJ favors_NNS to_IN drug_NN companies_NNS and_CC other_JJ interests_NNS ._. Republican_JJ leaders_NNS ,_, fearing_VBG the_DT Democratic_JJ amendment_NN could_MD derail_VB or_CC delay_VB final_JJ action_NN on_IN the_DT department_NN ,_, promised_VBD wavering_VBG GOP_NNP and_CC Democratic_JJ moderates_NNS they_PRP would_MD revisit_VB some_DT of_IN the_DT provisions_NNS when_WRB the_DT 108th_JJ Congress_NNP meets_VBZ next_JJ year_NN ._. The_DT creation_NN of_IN the_DT department_NN ,_, identified_VBN by_IN the_DT president_NN as_IN his_PRP$ top_JJ legislative_JJ priority_NN of_IN the_DT post-election_NN ,_, lame_JJ -_HYPH duck_NN session_NN ,_, marks_VBZ the_DT biggest_JJS reorganization_NN of_IN the_DT federal_JJ government_NN in_IN more_JJR than_IN a_DT half_NN -_HYPH century_NN ,_, throwing_VBG together_RP more_JJR than_IN 170,000_CD workers_NNS from_IN nearly_RB two_CD -_HYPH dozen_CD departments_NNS and_CC agencies_NNS ._. ""_`` We_PRP are_VBP making_VBG great_JJ progress_NN on_IN the_DT war_NN on_IN terror_NN ._. Part_NN of_IN that_DT progress_NN will_MD be_VB the_DT ability_NN for_IN us_PRP to_TO protect_VB the_DT American_JJ public_NN at_IN home_NN ._. This_DT is_VBZ a_DT very_RB important_JJ piece_NN of_IN legislation_NN ,_, ""_'' Bush_NNP ,_, who_WP is_VBZ traveling_VBG in_IN Europe_NNP ,_, said_VBD in_IN a_DT phone_NN call_NN with_IN Senate_NNP Republican_JJ leaders_NNS ._. He_PRP added_VBD that_IN ""_`` setting_VBG up_RP this_DT new_JJ department_NN will_MD take_VB time_NN ""_'' but_CC he_PRP looks_VBZ forward_RB to_IN signing_VBG the_DT bill_NN ._. Tom_NNP Ridge_NNP ,_, director_NN of_IN the_DT White_NNP House_NNP Office_NNP of_IN Homeland_NNP Security_NNP ,_, on_IN Wednesday_NNP indicated_VBD he_PRP was_VBD ready_JJ to_TO take_VB the_DT helm_NN of_IN the_DT new_JJ department_NN if_IN asked_VBN to_TO do_VB so_RB by_IN Bush_NNP ._. ""_`` I_PRP 'm_VBP prepared_VBN to_TO serve_VB the_DT president_NN in_IN whatever_WDT capacity_NN he_PRP thinks_VBZ I_PRP can_MD serve_VB the_DT country_NN ,_, ""_'' Ridge_NNP said_VBD on_IN CBS_NNP '_POS ""_`` The_DT Early_JJ Show_NNP ._. ""_'' Sen_NNP ._. James_NNP Jeffords_NNP ,_, a_DT Vermont_NNP independent_NN ,_, joined_VBD eight_CD Democrats_NNPS in_IN opposing_VBG the_DT final_JJ bill_NN ._. The_DT bill_NN overcame_VBD a_DT key_JJ hurdle_NN earlier_RBR in_IN the_DT day_NN when_WRB GOP_NNP leaders_NNS agreed_VBD to_TO revisit_VB controversial_JJ provisions_NNS added_VBN to_IN the_DT legislation_NN just_RB before_IN it_PRP passed_VBD the_DT House_NNP last_JJ week_NN ._. The_DT pledge_NN by_IN Sen._NNP Minority_NNP Leader_NNP Trent_NNP Lott_NNP ,_, R_NNP -_HYPH Miss._NNP ,_, helped_VBD defeat_VB a_DT Democratic_JJ amendment_NN that_WDT would_MD have_VB stripped_VBN or_CC modified_VBN seven_CD separate_JJ provisions_NNS from_IN the_DT final_JJ bill_NN ._. The_DT Democratic_JJ amendment_NN was_VBD defeated_VBN on_IN a_DT 52_CD -_HYPH 47_CD vote_NN ._. Republicans_NNPS said_VBD Democrats_NNPS were_VBD mischaracterizing_VBG the_DT provisions_NNS and_CC warned_VBD that_IN passage_NN of_IN the_DT amendment_NN would_MD have_VB derailed_VBN the_DT creation_NN of_IN the_DT new_JJ department_NN ,_, possibly_RB delaying_VBG action_NN until_IN the_DT Republican_JJ -_HYPH controlled_VBN 108th_NNP Congress_NNP convenes_VBZ in_IN January_NNP ._. Passage_NN would_MD have_VB required_VBN House_NNP and_CC Senate_NNP lawmakers_NNS to_TO meet_VB and_CC iron_VB out_RP differences_NNS in_IN their_PRP$ competing_VBG versions_NNS of_IN the_DT bill_NN ,_, which_WDT both_DT houses_NNS would_MD have_VB had_VBN to_TO approve_VB ._. Democrats_NNPS said_VBD the_DT most_RBS offensive_JJ of_IN the_DT provisions_NNS would_MD shield_VB pharmaceutical_JJ firms_NNS from_IN suits_NNS over_IN vaccines_NNS and_CC their_PRP$ side_NN effects_NNS ,_, as_RB well_RB as_IN wipe_VB out_RP those_DT lawsuits_NNS already_RB in_IN court_NN ._. The_DT bill_NN specifies_VBZ that_IN the_DT vaccine_NN provisions_NNS ""_`` shall_MD apply_VB to_IN all_DT actions_NNS or_CC proceedings_NNS pending_VBG on_IN or_CC after_IN the_DT date_NN of_IN enactment_NN ""_'' of_IN the_DT bill_NN unless_IN a_DT court_NN has_VBZ already_RB entered_VBN judgment_NN ._. Some_DT Republicans_NNPS said_VBD liability_NN protection_NN is_VBZ needed_VBN to_TO ensure_VB that_IN drug_NN companies_NNS will_MD produce_VB vaccines_NNS needed_VBN to_TO fight_VB the_DT war_NN on_IN terrorism_NN ._. The_DT vaccine_NN measure_NN is_VBZ seen_VBN as_IN a_DT boon_NN to_IN drug_NN companies_NNS ,_, including_VBG pharmaceutical_JJ giant_NN Eli_NNP Lilly_NNP LLY_NNP ,_, ,_, the_DT developer_NN of_IN thimerosal_NN ,_, a_DT mercury_NN -_HYPH based_VBN additive_NN used_VBN in_IN vaccines_NNS thought_VBN by_IN some_DT people_NNS to_TO be_VB linked_VBN to_IN an_DT increase_NN in_IN autism_NN ._. Lott_NNP said_VBD that_IN the_DT legislation_NN ""_`` was_VBD not_RB a_DT perfect_JJ bill_NN ,_, ""_'' but_CC that_IN it_PRP was_VBD imperative_JJ lawmakers_NNS act_VBP quickly_RB to_TO get_VB the_DT new_JJ Homeland_NNP Security_NNP Department_NNP in_IN place_NN ,_, he_PRP said_VBD ._. ""_`` If_IN we_PRP do_VBP n't_RB do_VB it_PRP now_RB when_WRB are_VBP we_PRP going_VBG to_TO do_VB it_PRP ?_. ..._. The_DT terrorists_NNS are_VBP not_RB going_VBG to_TO wait_VB for_IN a_DT process_NN that_WDT will_MD go_VB on_RP for_IN days_NNS or_CC weeks_NNS or_CC months_NNS ._. We_PRP have_VBP fought_VBN this_DT fight_NN ._. We_PRP need_VBP to_TO get_VB this_DT done_VBN ,_, ""_'' Lott_NNP said_VBD ._. Maine_NNP 's_POS two_CD moderate_JJ Republican_JJ senators_NNS ,_, Susan_NNP Collins_NNP and_CC Olympia_NNP Snowe_NNP ,_, and_CC Sen._NNP Lincoln_NNP Chafee_NNP ,_, R-_NNP R.I._NNP ,_, said_VBD they_PRP voted_VBD against_IN the_DT amendment_NN only_RB after_IN receiving_VBG assurances_NNS from_IN Lott_NNP that_IN he_PRP would_MD work_VB next_JJ year_NN to_TO remove_VB three_CD of_IN the_DT provisions_NNS ,_, including_VBG one_CD that_WDT gives_VBZ protections_NNS to_IN pharmaceutical_JJ companies_NNS that_WDT have_VBP already_RB been_VBN sued_VBN over_IN certain_JJ ingredients_NNS used_VBN in_IN vaccines_NNS ,_, the_DT Associated_NNP Press_NNP reported_VBD ._. Sen_NNP ._. Ben_NNP Nelson_NNP ,_, D_NNP -_HYPH Neb._NNP ,_, one_CD of_IN three_CD Democrats_NNPS to_TO vote_VB with_IN Republicans_NNPS ,_, said_VBD he_PRP had_VBD received_VBN similar_JJ assurances_NNS ._. Senate_NNP Majority_NNP Leader_NNP Tom_NNP Daschle_NNP ,_, D_NNP -_HYPH S.D._NNP ,_, said_VBD Democrats_NNPS would_MD press_VB to_TO remove_VB the_DT provisions_NNS next_JJ year_NN ,_, but_CC said_VBD he_PRP was_VBD ""_`` dubious_JJ ""_'' of_IN GOP_NNP promises_NNS to_TO revisit_VB the_DT measures_NNS ._. ""_`` I_PRP have_VBP to_TO say_VB ,_, if_IN they_PRP are_VBP so_RB bad_JJ ,_, why_WRB did_VBD n't_RB they_PRP take_VB them_PRP out_RP now_RB ,_, you_PRP know_VBP ?_. Why_WRB wait_VB ?_. I_PRP think_VBP it_PRP 's_VBZ always_RB harder_JJR to_TO take_VB things_NNS out_RP than_IN to_TO put_VB them_PRP in_RP ,_, and_CC it_PRP will_MD get_VB even_RB harder_JJR as_IN we_PRP go_VBP into_IN the_DT next_JJ Congress_NNP ,_, ""_'' he_PRP said_VBD ._. Both_DT sides_NNS had_VBD anticipated_VBN a_DT close_JJ vote_NN ._. The_DT Senate_NNP currently_RB is_VBZ divided_VBN 49_CD -_SYM 49_CD between_IN Republicans_NNPS and_CC Democrats_NNPS ,_, with_IN two_CD independents_NNS ,_, but_CC the_DT GOP_NNP will_MD regain_VB in_IN the_DT next_JJ Congress_NNP a_DT majority_NN in_IN the_DT Senate_NNP and_CC have_VB a_DT slightly_RB wider_JJR edge_NN in_IN the_DT House_NNP ,_, courtesy_NN of_IN the_DT Nov._NNP 5_CD midterm_NN elections_NNS ._. Democratic_NNP Sen._NNP Mary_NNP Landrieu_NNP of_IN Louisiana_NNP ,_, who_WP faces_VBZ a_DT tough_JJ run-off_NN battle_NN with_IN Republican_JJ Suzanne_NNP Terrell_NNP on_IN Dec._NNP 7_CD ,_, also_RB voted_VBD with_IN Republicans_NNPS ,_, along_IN with_IN Zell_NNP Miller_NNP of_IN Georgia_NNP ,_, one_CD of_IN the_DT bill_NN 's_POS co-sponsors_NNS ._. Sen._NNP John_NNP McCain_NNP ,_, R_NNP -_HYPH Ariz._NNP ,_, was_VBD the_DT only_JJ Republican_NNP to_TO vote_VB with_IN Democrats_NNPS ._. The_DT Senate_NNP 's_POS two_CD independents_NNS split_VBD their_PRP$ votes_NNS ,_, with_IN Vermont_NNP 's_POS James_NNP Jeffords_NNP voting_VBG with_IN Democrats_NNPS and_CC Minnesota_NNP 's_POS Dean_NNP Barkley_NNP voting_VBG with_IN Republicans_NNPS ._. Sen._NNP Edward_NNP Kennedy_NNP ,_, D_NNP -_HYPH Mass._NNP ,_, missed_VBD the_DT vote_NN ._. He_PRP was_VBD attending_VBG a_DT Paris_NNP fashion_NN tribute_NN to_IN the_DT late_JJ Jacqueline_NNP Kennedy_NNP ,_, the_DT Associated_NNP Press_NNP reported_VBD ._. See_VB how_WRB your_PRP$ senator_NN voted_VBD ._. The_DT House_NNP initially_RB passed_VBD a_DT homeland_NN security_NN bill_NN in_IN July_NNP ,_, but_CC Senate_NNP action_NN stalled_VBD amid_IN Democratic_JJ objections_NNS over_IN provisions_NNS dealing_VBG with_IN worker_NN protections_NNS ._. Republicans_NNPS used_VBD the_DT issue_NN in_IN the_DT Nov._NNP 5_CD midterm_NN elections_NNS ._. Democrats_NNPS largely_RB yielded_VBD to_IN the_DT administration_NN on_IN the_DT worker_NN provisions_NNS after_IN the_DT election_NN ._. In_IN debating_VBG the_DT Democratic_JJ amendment_NN ,_, Sen._NNP Phil_NNP Gramm_NNP ,_, R_NNP -_HYPH Texas_NNP ,_, told_VBD senators_NNS that_IN most_JJS of_IN the_DT seven_CD provisions_NNS at_IN issue_NN strengthened_VBD the_DT bill_NN ._. Moreover_RB ,_, passage_NN of_IN the_DT amendment_NN would_MD require_VB a_DT conference_NN committee_NN to_TO reconcile_VB differences_NNS with_IN the_DT House_NNP 's_POS version_NN of_IN the_DT homeland_NN bill_NN ,_, something_NN that_WDT could_MD at_IN worst_RBS derail_VB the_DT entire_JJ bill_NN and_CC at_IN best_RBS force_VB lawmakers_NNS to_TO return_VB in_IN December_NNP ._. Daschle_NNP ,_, D_NNP -_HYPH S.D._NNP ,_, on_IN the_DT Senate_NNP floor_NN ,_, accused_VBD House_NNP Republicans_NNPS of_IN inserting_VBG the_DT measures_NNS at_IN the_DT last_JJ minute_NN in_IN ""_`` an_DT atrocious_JJ demeaning_NN of_IN the_DT legislative_JJ process_NN ._. ""_'' The_DT Washington_NNP Post_NNP on_IN Tuesday_NNP said_VBD President_NNP Bush_NNP had_VBD called_VBN at_IN least_JJS two_CD wavering_VBG senators_NNS in_IN an_DT effort_NN to_TO defeat_VB the_DT amendment_NN ._. Other_JJ provisions_NNS targeted_VBN by_IN the_DT Democratic_JJ amendment_NN were_VBD liability_NN shields_NNS for_IN airport_NN security_NN firms_NNS and_CC businesses_NNS that_WDT market_VBP anti-terrorism_NN technologies_NNS ,_, and_CC a_DT measure_NN to_TO narrow_JJ provisions_NNS restricting_VBG government_NN contracts_NNS with_IN companies_NNS that_WDT have_VBP moved_VBN their_PRP$ headquarters_NN overseas_RB to_TO avoid_VB paying_VBG U.S._NNP taxes_NNS ._. The_DT amendment_NN also_RB targeted_VBD a_DT provision_NN that_WDT Democrats_NNPS said_VBD was_VBD intended_VBN to_TO ensure_VB that_IN Texas_NNP A&M_NNP University_NNP gets_VBZ funding_NN for_IN a_DT homeland_NN -_HYPH security_NN research_NN center_NN ._.","NNP ( NNP ) -- The NNP VBD the NN of a JJ , NN - NN NNP of NNP NNP on NNP NN in a JJ 90 - 9 NN . NNS RBR , NNPS VBD RB a NN to NNS NNPS VBD VBN as JJ NNS to NN NNS and JJ NNS . JJ NNS , VBG the JJ NN could VB or VB JJ NN on the NN , VBD VBG NNP and JJ NNS they would VB some of the NNS when the JJ NNP VBZ JJ NN . The NN of the NN , VBN by the NN as his JJ JJ NN of the NN , JJ - NN NN , VBZ the JJS NN of the JJ NN in JJR than a NN - NN , VBG together JJR than 170,000 NNS from RB two - dozen NNS and NNS . "" We VBP VBG JJ NN on the NN on NN . NN of that NN will VB the NN for us to VB the JJ NN at NN . This VBZ a RB JJ NN of NN , "" NNP , who VBZ VBG in NNP , VBD in a NN NN with NNP JJ NNS . He VBD that "" VBG up this JJ NN will VB NN "" but he VBZ RB to VBG the NN . NNP NNP , NN of the NNP NNP NNP of NNP NNP , on NNP VBD he VBD JJ to VB the NN of the JJ NN if VBN to VB RB by NNP . "" I VBP VBN to VB the NN in whatever NN he VBZ I can VB the NN , "" NNP VBD on NNP ' "" The JJ NNP . "" NNP . NNP NNP , a NNP NN , VBD eight NNPS in VBG the JJ NN . The NN VBD a JJ NN RBR in the NN when NNP NNS VBD to VB JJ NNS VBN to the NN RB before it VBD the NNP JJ NN . The NN by NNP NNP NNP NNP NNP , NNP - NNP , VBD VB a JJ NN that would VB VBN or VBN seven JJ NNS from the JJ NN . The JJ NN VBD VBN on a 52 - 47 NN . NNPS VBD NNPS VBD VBG the NNS and VBD that NN of the NN would VB VBN the NN of the JJ NN , RB VBG NN until the JJ - VBN NNP NNP VBZ in NNP . NN would VB VBN NNP and NNP NNS to VB and VB out NNS in their VBG NNS of the NN , which both NNS would VB VBN to VB . NNPS VBD the RBS JJ of the NNS would VB JJ NNS from NNS over NNS and their NN NNS , RB RB as VB out those NNS RB in NN . The NN VBZ that the NN NNS "" shall VB to all NNS or NNS VBG on or after the NN of NN "" of the NN unless a NN VBZ RB VBN NN . Some NNPS VBD NN NN VBZ VBN to VB that NN NNS will VB NNS VBN to VB the NN on NN . The NN NN VBZ VBN as a NN to NN NNS , VBG JJ NN NNP NNP NNP , , the NN of NN , a NN - VBN NN VBN in NNS VBN by some NNS to VB VBN to an NN in NN . NNP VBD that the NN "" VBD RB a JJ NN , "" but that it VBD JJ NNS VBP RB to VB the JJ NNP NNP NNP in NN , he VBD . "" If we VBP RB VB it RB when VBP we VBG to VB it ? ... The NNS VBP RB VBG to VB for a NN that will VB on for NNS or NNS or NNS . We VBP VBN this NN . We VBP to VB this VBN , "" NNP VBD . NNP 's two JJ JJ NNS , NNP NNP and NNP NNP , and NNP NNP NNP , NNP NNP , VBD they VBD against the NN RB after VBG NNS from NNP that he would VB JJ NN to VB three of the NNS , VBG one that VBZ NNS to JJ NNS that VBP RB VBN VBN over JJ NNS VBN in NNS , the NNP NNP VBD . NNP . NNP NNP , NNP - NNP , one of three NNPS to VB with NNPS , VBD he VBD VBN JJ NNS . NNP NNP NNP NNP NNP , NNP - NNP , VBD NNPS would VB to VB the NNS JJ NN , but VBD he VBD "" JJ "" of NNP NNS to VB the NNS . "" I VBP to VB , if they VBP RB JJ , why VBD RB they VB them out RB , you VBP ? Why VB ? I VBP it VBZ RB JJR to VB NNS out than to VB them in , and it will VB RB JJR as we VBP into the JJ NNP , "" he VBD . Both NNS VBD VBN a JJ NN . The NNP RB VBZ VBN 49 - 49 between NNPS and NNPS , with two NNS , but the NNP will VB in the JJ NNP a NN in the NNP and VB a RB JJR NN in the NNP , NN of the NNP 5 NN NNS . NNP NNP NNP NNP of NNP , who VBZ a JJ NN NN with JJ NNP NNP on NNP 7 , RB VBD with NNPS , along with NNP NNP of NNP , one of the NN 's NNS . NNP NNP NNP , NNP - NNP , VBD the JJ NNP to VB with NNPS . The NNP 's two NNS VBD their NNS , with NNP 's NNP NNP VBG with NNPS and NNP 's NNP NNP VBG with NNPS . NNP NNP NNP , NNP - NNP , VBD the NN . He VBD VBG a NNP NN NN to the JJ NNP NNP , the NNP NNP VBD . VB how your NN VBD . The NNP RB VBD a NN NN NN in NNP , but NNP NN VBD amid JJ NNS over NNS VBG with NN NNS . NNPS VBD the NN in the NNP 5 NN NNS . NNPS RB VBD to the NN on the NN NNS after the NN . In VBG the JJ NN , NNP NNP NNP , NNP - NNP , VBD NNS that JJS of the seven NNS at NN VBD the NN . RB , NN of the NN would VB a NN NN to VB NNS with the NNP 's NN of the NN NN , NN that could at RBS VB the JJ NN and at RBS VB NNS to VB in NNP . NNP , NNP - NNP , on the NNP NN , VBD NNP NNPS of VBG the NNS at the JJ NN in "" an JJ NN of the JJ NN . "" The NNP NNP on NNP VBD NNP NNP VBD VBN at JJS two VBG NNS in an NN to VB the NN . JJ NNS VBN by the JJ NN VBD NN NNS for NN NN NNS and NNS that VBP NN NNS , and a NN to JJ NNS VBG NN NNS with NNS that VBP VBN their NN RB to VB VBG NNP NNS . The NN RB VBD a NN that NNPS VBD VBD VBN to VB that NNP NNP NNP VBZ NN for a NN - NN NN NN ."
126,145,conspiracy,"German_JJ Medical_NNP Doctor_NNP Katrin_NNP Korb_NNP discusses_VBZ COVID_NNP -_HYPH 19_CD ,_, the_DT lockdown_NN and_CC the_DT vaccine_NN during_IN a_DT protest_NN held_VBN in_IN Oldeburg_NNP ._. Below_RB is_VBZ the_DT transcript_NN of_IN her_PRP$ speech_NN ._. I_PRP ’m_VBP thankful_JJ for_IN being_VBG able_JJ to_TO stand_VB here_RB today_NN ._. My_PRP$ name_NN is_VBZ Katrin_NNP Korb_NNP ,_, I_PRP have_VBP 3_CD children_NNS and_CC I_PRP ’m_VBP a_DT doctor_NN here_RB in_IN Oldenburg_NNP ._. I_PRP ’m_VBP standing_VBG here_RB because_IN I_PRP feel_VBP the_DT responsibility_NN for_IN the_DT health_NN of_IN my_PRP$ parents_NNS ,_, my_PRP$ children_NNS and_CC myself_PRP ._. I_PRP stand_VBP here_RB because_IN I_PRP am_VBP furious_JJ about_IN the_DT attempts_NNS to_TO get_VB more_JJR control_NN over_IN people_NNS ,_, by_IN attacking_VBG them_PRP with_IN fear_NN ._. I_PRP am_VBP not_RB sure_JJ what_WP happens_VBZ exactly_RB ,_, though_IN I_PRP ’m_VBP sure_JJ it_PRP has_VBZ to_TO do_VB with_IN money_NN and_CC power_NN ._. Firstly_RB ,_, I_PRP recognize_VBP this_DT principle_NN ._. It_PRP ’s_VBZ the_DT principle_NN of_IN our_PRP$ health_NN -_HYPH care_NN system_NN !_. A_DT system_NN which_WDT unfortunately_RB is_VBZ guilty_JJ of_IN spreading_VBG fear_NN in_IN order_NN to_TO earn_VB money_NN ._. This_DT fear_NN is_VBZ on_IN both_CC our_PRP$ sides_NNS ,_, my_PRP$ side_NN as_IN a_DT doctor_NN ,_, but_CC also_RB my_PRP$ patients_NNS ._. There_EX are_VBP guidelines_NNS I_PRP have_VBP to_TO follow_VB ,_, guidelines_NNS for_IN various_JJ health_NN problems_NNS ._. But_CC who_WP is_VBZ writing_VBG these_DT guidelines_NNS ?_. I_PRP will_MD give_VB you_PRP an_DT example_NN :_: There_EX is_VBZ a_DT European_JJ guideline_NN for_IN heart_NN diseases_NNS ._. There_EX are_VBP 25_CD different_JJ authors_NNS who_WP draft_VBP these_DT guidelines_NNS ,_, 19_CD of_IN which_WDT are_VBP funded_VBN by_IN the_DT pharmaceutical_JJ industry_NN ._. They_PRP call_VBP it_PRP an_DT ‘_`` advisory_NN fee_NN ’_'' ._. The_DT guidelines_NNS state_VBP that_IN I_PRP must_MD prescribe_VB medications_NNS that_WDT have_VBP a_DT lot_NN of_IN side_NN effects_NNS but_CC that_DT do_VBP not_RB make_VB people_NNS better_JJR ._. This_DT makes_VBZ a_DT lot_NN of_IN money_NN ._. If_IN I_PRP do_VBP n’t_RB follow_VB these_DT guidelines_NNS and_CC something_NN happens_VBZ to_IN these_DT people_NNS ;_, for_IN example_NN ,_, the_DT situation_NN is_VBZ deteriorating_VBG for_IN whatever_WDT reason_NN ,_, then_RB I_PRP will_MD be_VB held_VBN responsible_JJ for_IN that_DT ._. So_RB ,_, fear_NN is_VBZ cultivated_VBN so_IN that_IN I_PRP have_VBP to_TO act_VB against_IN my_PRP$ professional_JJ beliefs_NNS ._. The_DT sick_JJ people_NNS are_VBP also_RB frightened_VBN ;_, “_`` if_IN you_PRP do_VBP not_RB take_VB these_DT pills_NNS you_PRP will_MD have_VB a_DT heart_NN attack_NN ”_'' ._. “_`` Then_RB you_PRP will_MD become_VB even_RB sicker_JJR ”_'' ._. “_`` Listen_VB to_IN me_PRP ;_, I_PRP can_MD know_VB ,_, I_PRP studied_VBD for_IN it_PRP ._. ”_'' “_`` You_PRP are_VBP not_RB sensible_JJ enough_RB to_TO think_VB for_IN yourself_PRP ”_'' ._. “_`` There_EX is_VBZ therefore_RB no_DT room_NN to_TO discuss_VB this_DT ._. ”_'' As_IN a_DT result_NN ,_, people_NNS fear_VBP taking_VBG this_DT medication_NN day_NN after_IN day_NN ,_, week_NN to_IN week_NN ,_, year_NN to_IN year_NN ,_, which_WDT makes_VBZ a_DT lot_NN of_IN money_NN ._. That_DT ’s_VBZ the_DT way_NN ._. Since_IN the_DT beginning_NN of_IN this_DT corona_NN virus_NN ,_, we_PRP have_VBP been_VBN kept_VBN in_IN a_DT kind_NN of_IN shock_NN from_IN the_DT frightening_JJ messages_NNS ._. Our_PRP$ governments_NNS say_VBP there_EX is_VBZ a_DT new_JJ virus_NN so_RB terribly_RB dangerous_JJ that_IN millions_NNS will_MD die_VB ,_, if_IN we_PRP do_VBP n’t_RB protect_VB you_PRP !_. “_`` We_PRP know_VBP best_JJS what_WP is_VBZ good_JJ for_IN you_PRP because_IN we_PRP have_VBP experts_NNS ._. ”_'' You_PRP can_MD not_RB make_VB a_DT decision_NN for_IN yourself_PRP ._. You_PRP are_VBP too_RB stupid_JJ for_IN that_DT ._. ”_`` We_PRP have_VBP to_TO isolate_VB you_PRP ,_, take_VB away_RP your_PRP$ rights_NNS and_CC silent_VB you_PRP by_IN putting_VBG on_RP a_DT muzzle_NN ._. But_CC we_PRP really_RB do_VBP this_DT for_IN your_PRP$ protection_NN ”_'' ._. “_`` We_PRP frighten_VBP you_PRP so_RB much_RB every_DT day_NN through_IN the_DT most_RBS horrible_JJ reports_NNS that_WDT you_PRP wo_MD n’t_RB even_RB dare_VB to_TO ask_VB yourself_PRP if_IN it_PRP ’s_VBZ all_RB right_JJ ”_'' ._. The_DT mantra_NN of_IN the_DT authorities_NNS is_VBZ :_: Only_RB when_WRB we_PRP have_VBP a_DT vaccination_NN can_MD we_PRP return_VB to_IN “_`` a_DT normal_JJ ”_'' ._. In_IN other_JJ words_NNS ,_, only_RB a_DT vaccination_NN can_MD give_VB us_PRP back_RP our_PRP$ fundamental_JJ rights_NNS ._. This_DT week_NN ,_, Mrs._NNP von_NNP den_NNP Leyen_NNP (_-LRB- EU_NNP )_-RRB- has_VBZ collected_VBN E_$ 7.4_CD billion_CD worldwide_RB for_IN the_DT development_NN and_CC distribution_NN of_IN such_PDT a_DT vaccine_NN ._. Also_RB Germany_NNP has_VBZ paid_VBN E525,000_CD ._. Normally_RB ,_, the_DT development_NN of_IN such_PDT a_DT vaccination_NN takes_VBZ years_NNS ._. That_DT ’s_VBZ because_IN security_NN investigations_NNS need_VBP to_TO be_VB done_VBN ._. This_DT new_JJ virus_NN from_IN the_DT corona_NN family_NN was_VBD discovered_VBN less_JJR than_IN six_CD months_NNS ago_RB but_CC experiments_NNS with_IN “_`` MRNA_NN ”_'' are_VBP already_RB being_VBG tried_VBN on_IN humans_NNS ._. This_DT is_VBZ unknown_JJ genetic_JJ material_NN that_WDT will_MD be_VB injected_VBN into_IN our_PRP$ cells_NNS ._. You_PRP do_VBP n’t_RB have_VB to_TO be_VB a_DT doctor_NN to_TO get_VB an_DT ominous_JJ feeling_NN about_IN this_DT ._. I_PRP will_MD not_RB be_VB vaccinated_VBN ,_, I_PRP will_MD not_RB get_VB my_PRP$ children_NNS vaccinated_VBN ,_, and_CC I_PRP will_MD also_RB advise_VB my_PRP$ patients_NNS not_RB to_TO do_VB this_DT !_. Paragraph_NN Two_CD of_IN the_DT Constitution_NN does_VBZ NOT_RB specify_VB :_: RIGHT_RB TO_IN HEALTH_NN but_CC right_NN to_IN physical_JJ integrity_NN ._. That_DT is_VBZ a_DT very_RB big_JJ difference_NN ._. So_RB there_EX is_VBZ no_DT right_NN to_IN health_NN !_. Being_VBG sick_JJ is_VBZ part_NN of_IN our_PRP$ human_JJ life_NN ,_, but_CC no_DT one_NN should_MD inflict_VB physical_JJ harm_NN on_IN us_PRP even_RB with_IN a_DT dubious_JJ vaccine_NN ._. We_PRP are_VBP the_DT ones_NNS paying_VBG for_IN this_DT ._. We_PRP already_RB pay_VBP for_IN the_DT scientific_JJ and_CC social_JJ impact_NN of_IN the_DT lockdowns_NNS ._. OUR_PRP$ TAX_NN MONEY_NN is_VBZ spent_VBN for_IN this_DT ._. And_CC a_DT vaccine_NN must_MD be_VB financed_VBN with_IN our_PRP$ tax_NN money_NN !_. Already_RB E_NNP 525_CD million_CD German_JJ tax_NN money_NN and_CC this_DT is_VBZ only_RB the_DT beginning_NN ._. Are_VBP we_PRP being_VBG asked_VBN if_IN we_PRP want_VBP to_TO do_VB this_DT ?_. Are_VBP we_PRP asked_VBN if_IN we_PRP want_VBP to_TO pay_VB for_IN Lockdowns_NNS ?_. NO_UH !_. All_PDT this_DT money_NN ,_, the_DT taxes_NNS we_PRP ’ve_VBP paid_VBN ,_, we_PRP want_VBP that_DT to_TO be_VB spent_VBN on_IN other_JJ things_NNS ._. For_IN good_JJ education_NN for_IN our_PRP$ children_NNS ,_, for_IN the_DT development_NN of_IN new_JJ technologies_NNS for_IN the_DT environment_NN ,_, for_IN decent_JJ wages_NNS for_IN employees_NNS in_IN our_PRP$ “_`` vital_JJ ”_'' professionals_NNS ._. For_IN immigration_NN of_IN people_NNS who_WP fled_VBD from_IN the_DT war_NN ._. For_IN sports_NNS ,_, culture_NN ,_, etc._FW ,_, etc_FW …_. This_DT list_NN is_VBZ endless_JJ ._. In_IN short_JJ ,_, for_IN things_NNS that_WDT make_VBP and_CC keep_VBP people_NNS healthy_JJ ._. But_CC with_IN this_DT no_DT money_NN can_MD be_VB made_VBN ._. We_PRP are_VBP in_IN a_DT crisis_NN ._. What_WP is_VBZ the_DT way_NN out_IN of_IN this_DT crisis_NN ?_. The_DT victory_NN over_IN fear_NN is_VBZ the_DT way_NN out_IN of_IN this_DT crisis_NN ._. People_NNS who_WP can_MD think_VB for_IN themselves_PRP ,_, being_VBG creative_JJ ,_, take_VBP responsibility_NN for_IN themselves_PRP working_VBG on_IN their_PRP$ own_JJ health_NN and_CC the_DT health_NN of_IN our_PRP$ world_NN ._. People_NNS who_WP are_VBP positive_JJ ,_, who_WP have_VBP friends_NNS ,_, who_WP enjoy_VBP life_NN ,_, do_VBP not_RB get_VB sick_JJ easily_RB ._. And_CC if_IN they_PRP do_VBP get_VB sick_JJ ,_, they_PRP eventually_RB unite_VBP with_IN death_NN ._. Knowing_VBG that_IN life_NN in_IN this_DT world_NN will_MD ever_RB end_VB and_CC are_VBP at_IN peace_NN with_IN it_PRP ._. You_PRP ca_MD n’t_RB scare_VB these_DT kinds_NNS of_IN people_NNS ._. You_PRP have_VBP no_DT power_NN over_IN these_DT people_NNS ._. This_DT body_NN has_VBZ only_RB been_VBN borrowed_VBN and_CC someday_RB I_PRP will_MD have_VB to_TO give_VB it_PRP back_RP ._. But_CC as_RB long_RB as_IN I_PRP live_VBP in_IN this_DT body_NN ,_, as_RB long_RB as_IN I_PRP feel_VBP ,_, think_VB and_CC act_VB ,_, it_PRP will_MD be_VB MY_PRP$ body_NN !_. I_PRP am_VBP responsible_JJ for_IN that_DT and_CC no_DT one_NN else_JJ ._. MY_PRP$ BODY_NN ,_, which_WDT I_PRP treat_VBP in_IN the_DT way_NN I_PRP think_VBP is_VBZ right_JJ ._. I_PRP do_VBP not_RB wish_VB to_TO return_VB to_IN the_DT old_JJ normal_JJ ._. I_PRP wish_VBP for_IN a_DT new_JJ better_JJR normal_JJ ._. With_IN free_JJ and_CC self_NN -_HYPH determined_VBN people_NNS ,_, who_WP are_VBP responsible_JJ for_IN themselves_PRP ._. I_PRP believe_VBP many_JJ of_IN us_PRP are_VBP here_RB together_RB with_IN the_DT same_JJ wish_NN ._. This_DT gives_VBZ me_PRP hope_NN and_CC I_PRP thank_VBP you_PRP ._. Note_VB to_IN readers_NNS :_: please_UH click_VB the_DT share_NN buttons_NNS above_RB or_CC below_RB ._. Forward_VB this_DT article_NN to_IN your_PRP$ email_NN lists_NNS ._. Crosspost_NNP on_IN your_PRP$ blog_NN site_NN ,_, internet_NN forums_NNS ._. etc_FW ._.","JJ NNP NNP NNP NNP VBZ NNP - 19 , the NN and the NN during a NN VBN in NNP . RB VBZ the NN of her NN . I VBP JJ for VBG JJ to VB RB NN . My NN VBZ NNP NNP , I VBP 3 NNS and I VBP a NN RB in NNP . I VBP VBG RB because I VBP the NN for the NN of my NNS , my NNS and myself . I VBP RB because I VBP JJ about the NNS to VB JJR NN over NNS , by VBG them with NN . I VBP RB JJ what VBZ RB , though I VBP JJ it VBZ to VB with NN and NN . RB , I VBP this NN . It VBZ the NN of our NN - NN NN ! A NN which RB VBZ JJ of VBG NN in NN to VB NN . This NN VBZ on both our NNS , my NN as a NN , but RB my NNS . There VBP NNS I VBP to VB , NNS for JJ NN NNS . But who VBZ VBG these NNS ? I will VB you an NN : There VBZ a JJ NN for NN NNS . There VBP 25 JJ NNS who VBP these NNS , 19 of which VBP VBN by the JJ NN . They VBP it an ‘ NN NN ’ . The NNS VBP that I must VB NNS that VBP a NN of NN NNS but that VBP RB VB NNS JJR . This VBZ a NN of NN . If I VBP RB VB these NNS and NN VBZ to these NNS ; for NN , the NN VBZ VBG for whatever NN , RB I will VB VBN JJ for that . RB , NN VBZ VBN so that I VBP to VB against my JJ NNS . The JJ NNS VBP RB VBN ; “ if you VBP RB VB these NNS you will VB a NN NN ” . “ RB you will VB RB JJR ” . “ VB to me ; I can VB , I VBD for it . ” “ You VBP RB JJ RB to VB for yourself ” . “ There VBZ RB no NN to VB this . ” As a NN , NNS VBP VBG this NN NN after NN , NN to NN , NN to NN , which VBZ a NN of NN . That VBZ the NN . Since the NN of this NN NN , we VBP VBN VBN in a NN of NN from the JJ NNS . Our NNS VBP there VBZ a JJ NN RB RB JJ that NNS will VB , if we VBP RB VB you ! “ We VBP JJS what VBZ JJ for you because we VBP NNS . ” You can RB VB a NN for yourself . You VBP RB JJ for that . ” We VBP to VB you , VB away your NNS and VB you by VBG on a NN . But we RB VBP this for your NN ” . “ We VBP you RB RB every NN through the RBS JJ NNS that you wo RB RB VB to VB yourself if it VBZ RB JJ ” . The NN of the NNS VBZ : RB when we VBP a NN can we VB to “ a JJ ” . In JJ NNS , RB a NN can VB us back our JJ NNS . This NN , NNP NNP NNP NNP ( NNP ) VBZ VBN E 7.4 billion RB for the NN and NN of such a NN . RB NNP VBZ VBN E525,000 . RB , the NN of such a NN VBZ NNS . That VBZ because NN NNS VBP to VB VBN . This JJ NN from the NN NN VBD VBN JJR than six NNS RB but NNS with “ NN ” VBP RB VBG VBN on NNS . This VBZ JJ JJ NN that will VB VBN into our NNS . You VBP RB VB to VB a NN to VB an JJ NN about this . I will RB VB VBN , I will RB VB my NNS VBN , and I will RB VB my NNS RB to VB this ! NN Two of the NN VBZ RB VB : RB TO NN but NN to JJ NN . That VBZ a RB JJ NN . RB there VBZ no NN to NN ! VBG JJ VBZ NN of our JJ NN , but no NN should VB JJ NN on us RB with a JJ NN . We VBP the NNS VBG for this . We RB VBP for the JJ and JJ NN of the NNS . OUR NN NN VBZ VBN for this . And a NN must VB VBN with our NN NN ! RB NNP 525 million JJ NN NN and this VBZ RB the NN . VBP we VBG VBN if we VBP to VB this ? VBP we VBN if we VBP to VB for NNS ? NO ! All this NN , the NNS we VBP VBN , we VBP that to VB VBN on JJ NNS . For JJ NN for our NNS , for the NN of JJ NNS for the NN , for JJ NNS for NNS in our “ JJ ” NNS . For NN of NNS who VBD from the NN . For NNS , NN , FW , FW … This NN VBZ JJ . In JJ , for NNS that VBP and VBP NNS JJ . But with this no NN can VB VBN . We VBP in a NN . What VBZ the NN out of this NN ? The NN over NN VBZ the NN out of this NN . NNS who can VB for themselves , VBG JJ , VBP NN for themselves VBG on their JJ NN and the NN of our NN . NNS who VBP JJ , who VBP NNS , who VBP NN , VBP RB VB JJ RB . And if they VBP VB JJ , they RB VBP with NN . VBG that NN in this NN will RB VB and VBP at NN with it . You ca RB VB these NNS of NNS . You VBP no NN over these NNS . This NN VBZ RB VBN VBN and RB I will VB to VB it back . But RB RB as I VBP in this NN , RB RB as I VBP , VB and VB , it will VB MY NN ! I VBP JJ for that and no NN JJ . MY NN , which I VBP in the NN I VBP VBZ JJ . I VBP RB VB to VB to the JJ JJ . I VBP for a JJ JJR JJ . With JJ and NN - VBN NNS , who VBP JJ for themselves . I VBP JJ of us VBP RB RB with the JJ NN . This VBZ me NN and I VBP you . VB to NNS : please VB the NN NNS RB or RB . VB this NN to your NN NNS . NNP on your NN NN , NN NNS . FW ."
127,818,mainstream,"A_DT single_JJ sperm_NN donor_NN is_VBZ the_DT biological_JJ father_NN of_IN at_IN least_JJS 12_CD children_NNS who_WP all_DT developed_VBD —_: an_DT extraordinary_JJ case_NN that_WDT prompted_VBD one_CD woman_NN to_TO sue_VB her_PRP$ sperm_NN bank_NN ,_, according_VBG to_IN news_NN reports_NNS ._. The_DT case_NN came_VBD to_IN light_NN when_WRB the_DT woman_NN ,_, Danielle_NNP Rizzo_NNP of_IN Illinois_NNP ,_, was_VBD researching_VBG treatments_NNS for_IN her_PRP$ two_CD sons_NNS ,_, who_WP both_DT have_VBP autism_NN ,_, according_VBG to_IN ._. Both_DT sons_NNS were_VBD conceived_VBN with_IN sperm_NN from_IN the_DT same_JJ donor_NN ,_, and_CC Rizzo_NNP was_VBD shocked_JJ to_TO discover_VB that_IN other_JJ mothers_NNS who_WP used_VBD the_DT same_JJ donor_NN also_RB had_VBD sons_NNS with_IN autism_NN ,_, the_DT Post_NNP reported_VBD ._. Rizzo_NNP was_VBD told_VBN that_IN the_DT likelihood_NN of_IN all_PDT these_DT related_JJ children_NNS having_VBG autism_NN by_IN chance_NN was_VBD like_IN all_PDT the_DT mothers_NNS ""_`` opening_VBG up_RP a_DT dictionary_NN and_CC pointing_VBG to_IN the_DT same_JJ letter_NN of_IN the_DT same_JJ word_NN on_IN the_DT same_JJ page_NN at_IN the_DT same_JJ time_NN ,_, ""_'' she_PRP told_VBD the_DT Post_NNP ._. That_DT means_VBZ a_DT mutation_NN in_IN the_DT donor_NN 's_POS sperm_NN was_VBD likely_RB responsible_JJ ._. But_CC is_VBZ there_EX a_DT single_JJ ""_`` autism_NN gene_NN ?_. ""_'' In_IN short_JJ ,_, no_UH :_: There_EX are_VBP hundreds_NNS of_IN genetic_JJ variations_NNS tied_VBN to_IN autism_NN spectrum_NN disorder_NN ,_, according_VBG to_IN the_DT ._. In_IN most_JJS cases_NNS ,_, these_DT mutations_NNS increase_VBP a_DT person_NN 's_POS risk_NN of_IN autism_NN ,_, but_CC they_PRP do_VBP n't_RB destine_VB someone_NN to_TO develop_VB the_DT condition_NN ._. In_IN other_JJ words_NNS ,_, genes_NNS typically_RB play_VBP only_RB a_DT partial_JJ role_NN in_IN the_DT risk_NN of_IN developing_VBG autism_NN ,_, with_IN environmental_JJ factors_NNS ,_, such_JJ as_IN the_DT parents_NNS '_POS ages_NNS and_CC birth_NN complications_NNS ,_, contributing_VBG as_RB well_RB ._. But_CC in_IN rare_JJ cases_NNS ,_, genetic_JJ mutations_NNS are_VBP thought_VBN to_TO be_VB the_DT main_JJ cause_NN of_IN autism_NN ._. Only_RB about_RB 2_CD %_NN to_IN 4_CD %_NN of_IN people_NNS with_IN autism_NN have_VBP these_DT mutations_NNS ,_, according_VBG to_IN the_DT NIH_NNP ._. ""_`` We_PRP call_VBP autism_NN one_CD thing_NN ,_, but_CC it_PRP 's_VBZ different_JJ in_IN every_DT person_NN ._. In_IN some_DT ,_, it_PRP 's_VBZ all_RB about_IN the_DT genes_NNS ._. Some_DT it_PRP 's_VBZ a_DT combination_NN of_IN genes_NNS and_CC the_DT environment_NN ._. Some_DT people_NNS ,_, it_PRP 's_VBZ unknown_JJ ,_, ""_'' Dr._NNP Wendy_NNP Chung_NNP ,_, a_DT professor_NN of_IN pediatric_JJ medicine_NN at_IN Columbia_NNP University_NNP ,_, told_VBD the_DT Post_NNP ._. Studies_NNS of_IN Rizzo's_NNP children_NNS found_VBD that_IN they_PRP had_VBD two_CD mutations_NNS tied_VBN to_IN autism_NN in_IN genes_NNS called_VBN MBD1_NNP and_CC SHANK1_NNP ._. Most_JJS reproductive_JJ clinics_NNS test_VBP for_IN several_JJ hundred_CD genetic_JJ conditions_NNS ,_, but_CC there_EX is_VBZ no_DT test_NN for_IN autism_NN ,_, The_DT Post_NNP reported_VBD ._. In_IN Rizzo_NNP 's_POS lawsuit_NN ,_, she_PRP alleged_VBD that_IN the_DT donor_NN 's_POS profile_NN had_VBD false_JJ information_NN ._. For_IN example_NN ,_, she_PRP said_VBD that_IN the_DT donor_NN did_VBD not_RB have_VB a_DT college_NN degree_NN ,_, as_IN the_DT profile_NN listed_VBN ,_, and_CC that_IN he_PRP had_VBD been_VBN ,_, which_WDT was_VBD omitted_VBN from_IN the_DT profile_NN ,_, the_DT Post_NNP reported_VBD ._. She_PRP settled_VBD the_DT lawsuit_NN in_IN March_NNP for_IN $_$ 250,000_CD ._. Read_VB more_JJR about_IN the_DT case_NN at_IN The_DT Washington_NNP Post_NNP ._. •_NFP Beyond_IN Vaccines_NNPS :_: 5_CD Things_NNS that_WDT Might_MD Really_RB Cause_VB Autism_NN","A JJ NN NN VBZ the JJ NN of at JJS 12 NNS who all VBD — an JJ NN that VBD one NN to VB her NN NN , VBG to NN NNS . The NN VBD to NN when the NN , NNP NNP of NNP , VBD VBG NNS for her two NNS , who both VBP NN , VBG to . Both NNS VBD VBN with NN from the JJ NN , and NNP VBD JJ to VB that JJ NNS who VBD the JJ NN RB VBD NNS with NN , the NNP VBD . NNP VBD VBN that the NN of all these JJ NNS VBG NN by NN VBD like all the NNS "" VBG up a NN and VBG to the JJ NN of the JJ NN on the JJ NN at the JJ NN , "" she VBD the NNP . That VBZ a NN in the NN 's NN VBD RB JJ . But VBZ there a JJ "" NN NN ? "" In JJ , no : There VBP NNS of JJ NNS VBN to NN NN NN , VBG to the . In JJS NNS , these NNS VBP a NN 's NN of NN , but they VBP RB VB NN to VB the NN . In JJ NNS , NNS RB VBP RB a JJ NN in the NN of VBG NN , with JJ NNS , JJ as the NNS ' NNS and NN NNS , VBG RB RB . But in JJ NNS , JJ NNS VBP VBN to VB the JJ NN of NN . RB RB 2 NN to 4 NN of NNS with NN VBP these NNS , VBG to the NNP . "" We VBP NN one NN , but it VBZ JJ in every NN . In some , it VBZ RB about the NNS . Some it VBZ a NN of NNS and the NN . Some NNS , it VBZ JJ , "" NNP NNP NNP , a NN of JJ NN at NNP NNP , VBD the NNP . NNS of NNP NNS VBD that they VBD two NNS VBN to NN in NNS VBN NNP and NNP . JJS JJ NNS VBP for JJ hundred JJ NNS , but there VBZ no NN for NN , The NNP VBD . In NNP 's NN , she VBD that the NN 's NN VBD JJ NN . For NN , she VBD that the NN VBD RB VB a NN NN , as the NN VBN , and that he VBD VBN , which VBD VBN from the NN , the NNP VBD . She VBD the NN in NNP for $ 250,000 . VB JJR about the NN at The NNP NNP . • Beyond NNPS : 5 NNS that Might RB VB NN"
128,949,mainstream,"Re_IN “_`` Stand_VB on_IN Drug_NN Led_VBN to_IN Ouster_NN ,_, Official_JJ Asserts_NNS ”_'' (_-LRB- front_JJ page_NN ,_, April_NNP 23_CD )_-RRB- :_: The_DT firing_NN of_IN Rick_NNP Bright_NNP is_VBZ among_IN the_DT worst_JJS decisions_NNS ever_RB ._. Dr._NNP Bright_NNP is_VBZ a_DT leading_VBG authority_NN on_IN vaccines_NNS who_WP has_VBZ spent_VBN his_PRP$ entire_JJ career_NN studying_VBG and_CC developing_VBG vaccines_NNS ._. He_PRP is_VBZ the_DT perfect_JJ person_NN to_TO run_VB the_DT Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ’_POS Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP ._. His_PRP$ expertise_NN is_VBZ urgently_RB needed_VBN as_IN we_PRP face_VBP the_DT greatest_JJS public_JJ health_NN crisis_NN of_IN our_PRP$ lifetimes_NNS ._. Abruptly_RB reassigning_VBG him_PRP to_IN an_DT unrelated_JJ position_NN should_MD be_VB the_DT last_JJ thing_NN anyone_NN would_MD want_VB to_TO do_VB ._. It_PRP is_VBZ painfully_RB apparent_JJ that_IN this_DT move_NN was_VBD made_VBN in_IN retaliation_NN against_IN Dr._NNP Bright_NNP for_IN his_PRP$ having_VBG properly_RB disputed_VBN President_NNP Trump_NNP ’s_POS unfounded_JJ assertions_NNS that_IN hydroxychloroquine_NN is_VBZ a_DT miracle_NN drug_NN that_WDT can_MD cure_VB coronavirus_NN infections_NNS ._. When_WRB our_PRP$ government_NN chooses_VBZ to_TO put_VB politics_NNS ahead_RB of_IN science_NN ,_, we_PRP all_DT suffer_VBP ._. America_NNP should_MD not_RB be_VB deprived_VBN of_IN Dr._NNP Bright_NNP ’s_POS contributions_NNS to_IN vaccine_NN development_NN as_IN we_PRP endeavor_VBP to_TO develop_VB a_DT vaccine_NN against_IN Covid_NNP -_HYPH 19_CD ._.","Re “ VB on NN VBN to NN , JJ NNS ” ( JJ NN , NNP 23 ) : The NN of NNP NNP VBZ among the JJS NNS RB . NNP NNP VBZ a VBG NN on NNS who VBZ VBN his JJ NN VBG and VBG NNS . He VBZ the JJ NN to VB the NNP of NNP and NNP NNPS ’ NNP NNP NNP and NNP NNP . His NN VBZ RB VBN as we VBP the JJS JJ NN NN of our NNS . RB VBG him to an JJ NN should VB the JJ NN NN would VB to VB . It VBZ RB JJ that this NN VBD VBN in NN against NNP NNP for his VBG RB VBN NNP NNP ’s JJ NNS that NN VBZ a NN NN that can VB NN NNS . When our NN VBZ to VB NNS RB of NN , we all VBP . NNP should RB VB VBN of NNP NNP ’s NNS to NN NN as we VBP to VB a NN against NNP - 19 ."
129,567,mainstream,"Immunisation_NN coverage_NN is_VBZ measured_VBN at_IN ‘_`` milestone_NN ages_NNS ’_'' using_VBG National_NNP Immunisation_NNP Register_NNP (_-LRB- NIR_NNP )_-RRB- data_NNS ._. The_DT milestone_NN ages_NNS are_VBP six_CD months_NNS ,_, eight_CD months_NNS ,_, 12_CD months_NNS (_-LRB- one_CD year_NN )_-RRB- ,_, 18_CD months_NNS ,_, 24_CD months_NNS (_-LRB- two_CD years_NNS )_-RRB- and_CC five_CD years_NNS of_IN age_NN ._. The_DT following_VBG tables_NNS show_VBP the_DT immunisation_NN coverage_NN for_IN children_NNS who_WP turned_VBD the_DT milestone_NN age_NN during_IN a_DT three_CD -_HYPH month_NN or_CC 12_CD -_HYPH month_NN reporting_VBG period_NN ending_VBG 31_CD March_NNP 2020_CD and_CC who_WP have_VBP completed_VBN their_PRP$ age_NN appropriate_JJ immunisations_NNS ._. The_DT table_NN below_RB shows_VBZ the_DT immunisation_NN coverage_NN of_IN children_NNS who_WP turned_VBD one_CD of_IN the_DT milestone_NN ages_NNS during_IN a_DT three_CD -_HYPH month_NN period_NN from_IN 1_CD January_NNP to_IN 31_CD March_NNP 2020_CD and_CC who_WP have_VBP completed_VBN their_PRP$ age_NN -_HYPH appropriate_JJ immunisations_NNS ._. The_DT table_NN below_RB shows_VBZ the_DT immunisation_NN coverage_NN of_IN children_NNS who_WP turned_VBD one_CD of_IN the_DT milestone_NN ages_NNS during_IN the_DT 12_CD -_HYPH month_NN period_NN from_IN 1_CD April_NNP 2019_CD to_IN 31_CD March_NNP 2020_CD ,_, and_CC who_WP have_VBP completed_VBN their_PRP$ age_NN -_HYPH appropriate_JJ immunisations_NNS ._. In_IN the_DT tables_NNS above_RB :_: •_SYM ‘_`` Number_NN eligible_JJ ’_'' –_: the_DT number_NN of_IN children_NNS who_WP turned_VBD one_CD of_IN the_DT milestone_NN ages_NNS in_IN the_DT three_CD -_HYPH month_NN or_CC 12_CD -_HYPH month_NN reporting_VBG period_NN ._. •_NFP ‘_`` Fully_RB immunised_VBN for_IN age_NN ’_'' –_: the_DT number_NN of_IN eligible_JJ children_NNS who_WP have_VBP completed_VBN all_DT of_IN their_PRP$ age_NN -_HYPH appropriate_JJ immunisations_NNS by_IN the_DT time_NN they_PRP turned_VBD the_DT milestone_NN age_NN ._. •_NFP ‘_`` Opt_VB off_RP '_'' is_VBZ a_DT count_NN of_IN individuals_NNS who_WP have_VBP opted_VBN off_RP the_DT NIR_NNP ._. •_NFP '_`` Decline_NN '_'' is_VBZ a_DT count_NN of_IN individuals_NNS who_WP have_VBP declined_VBN any_DT one_CD vaccination_NN ._. Detailed_JJ immunisation_NN coverage_NN data_NNS for_IN New_NNP Zealand_NNP and_CC for_IN each_DT of_IN the_DT 20_CD district_NN health_NN boards_NNS are_VBP in_IN the_DT spreadsheets_NNS below_RB ._. Milestone_NN age_NN data_NNS is_VBZ presented_VBN by_IN ethnicity_NN and_CC level_NN of_IN deprivation_NN for_IN three_CD -_HYPH month_NN and_CC 12_CD -_HYPH month_NN reporting_VBG periods_NNS ._. From_IN 1_CD July_NNP 2012_CD coverage_NN figures_NNS reported_VBN in_IN the_DT following_VBG tables_NNS include_VBP pneumococcal_JJ vaccine_NN ._. •_SYM 1_CD July_NNP 2010_CD to_IN 1_CD October_NNP 2010_CD (_-LRB- Excel_NNP ,_, 435_CD KB_NN )_-RRB- –_, as_IN at_IN 7/10/2010_CD •_SYM 1_CD January_NNP 2010_CD to_IN 1_CD April_NNP 2010_CD (_-LRB- Excel_NNP ,_, 228_CD KB_NN )_-RRB- –_, as_IN at_IN 08/04/2010_CD •_SYM 1_CD October_NNP 2009_CD to_IN 1_CD January_NNP 2010_CD (_-LRB- Excel_NNP ,_, 259_CD KB_NN )_-RRB- –_, as_IN at_IN 11/03/2010_CD •_SYM 1_CD April_NNP 2009_CD to_IN 1_CD July_NNP 2009_CD (_-LRB- Excel_NNP ,_, 447_CD KB_NN )_-RRB- –_, as_IN at_IN 13/10/2009_CD •_SYM 1_CD October_NNP 2009_CD to_IN 1_CD October_NNP 2010_CD (_-LRB- Excel_NNP ,_, 407_CD KB_NN )_-RRB- –_, as_IN at_IN 7/10/2010_CD •_SYM 1_CD April_NNP 2009_CD to_IN 1_CD April_NNP 2010_CD (_-LRB- Excel_NNP ,_, 185_CD KB_NN )_-RRB- –_, as_IN at_IN 08/04/2010_CD •_SYM 1_CD January_NNP 2009_CD to_IN 1_CD January_NNP 2010_CD (_-LRB- Excel_NNP ,_, 216_CD KB_NN )_-RRB- –_, as_IN at_IN 11/03/2010_CD •_SYM 1_CD July_NNP 2008_CD to_IN 1_CD July_NNP 2009_CD (_-LRB- Excel_NNP ,_, 195_CD KB_NN )_-RRB- –_: as_IN at_IN 13/10/2009_CD Immunisation_NN coverage_NN data_NNS is_VBZ reported_VBN quarterly_RB ._. The_DT next_JJ update_NN will_MD be_VB August_NNP 2020_CD ._.","NN NN VBZ VBN at ‘ NN NNS ’ VBG NNP NNP NNP ( NNP ) NNS . The NN NNS VBP six NNS , eight NNS , 12 NNS ( one NN ) , 18 NNS , 24 NNS ( two NNS ) and five NNS of NN . The VBG NNS VBP the NN NN for NNS who VBD the NN NN during a three - NN or 12 - NN VBG NN VBG 31 NNP 2020 and who VBP VBN their NN JJ NNS . The NN RB VBZ the NN NN of NNS who VBD one of the NN NNS during a three - NN NN from 1 NNP to 31 NNP 2020 and who VBP VBN their NN - JJ NNS . The NN RB VBZ the NN NN of NNS who VBD one of the NN NNS during the 12 - NN NN from 1 NNP 2019 to 31 NNP 2020 , and who VBP VBN their NN - JJ NNS . In the NNS RB : • ‘ NN JJ ’ – the NN of NNS who VBD one of the NN NNS in the three - NN or 12 - NN VBG NN . • ‘ RB VBN for NN ’ – the NN of JJ NNS who VBP VBN all of their NN - JJ NNS by the NN they VBD the NN NN . • ‘ VB off ' VBZ a NN of NNS who VBP VBN off the NNP . • ' NN ' VBZ a NN of NNS who VBP VBN any one NN . JJ NN NN NNS for NNP NNP and for each of the 20 NN NN NNS VBP in the NNS RB . NN NN NNS VBZ VBN by NN and NN of NN for three - NN and 12 - NN VBG NNS . From 1 NNP 2012 NN NNS VBN in the VBG NNS VBP JJ NN . • 1 NNP 2010 to 1 NNP 2010 ( NNP , 435 NN ) – as at 7/10/2010 • 1 NNP 2010 to 1 NNP 2010 ( NNP , 228 NN ) – as at 08/04/2010 • 1 NNP 2009 to 1 NNP 2010 ( NNP , 259 NN ) – as at 11/03/2010 • 1 NNP 2009 to 1 NNP 2009 ( NNP , 447 NN ) – as at 13/10/2009 • 1 NNP 2009 to 1 NNP 2010 ( NNP , 407 NN ) – as at 7/10/2010 • 1 NNP 2009 to 1 NNP 2010 ( NNP , 185 NN ) – as at 08/04/2010 • 1 NNP 2009 to 1 NNP 2010 ( NNP , 216 NN ) – as at 11/03/2010 • 1 NNP 2008 to 1 NNP 2009 ( NNP , 195 NN ) – as at 13/10/2009 NN NN NNS VBZ VBN RB . The JJ NN will VB NNP 2020 ."
130,1025,conspiracy,"THERE_EX ARE_VBP TWO_CD OUTSTANDING_JJ QUESTIONS_NNS —_: AMERICA_NNP NEEDS_VBZ OBAMA_NNP AND_CC HIS_PRP$ ADMINISTRATION_NN TO_TO ANSWER_VB :_: (_-LRB- 1_LS )_-RRB- ._. WHY_WRB did_VBD Obama_NNP send_VB $_$ 400_CD Million_CD to_IN Iran_NNP —_: cash_NN currency_NN on_IN a_DT plane_NN in_IN the_DT dead_NN of_IN night_NN ?_. (_-LRB- 2_LS )_-RRB- WHERE_WRB did_VBD the_DT $_$ 400_CD Million_CD come_VB from_IN out_IN of_IN our_PRP$ American_JJ paid_VBN taxes_NNS ?_. Neither_DT question_NN has_VBZ been_VBN answered_VBN ._. WE_PRP STILL_RB HAVE_VBP A_DT RIGHT_JJ TO_TO KNOW_VB ._. And_CC the_DT amount_NN totally_RB paid_VBN to_IN Iran_NNP …_: was_VBD $_$ 1.7_CD BILLION_CD ._. IRAN_NNP VIDEO_NN 1:04_CD —_: VIA_NNP –_: ANGRY_JJ PATRIOT_JJ MOVEMENT_NN —_: Iran_NNP video_NN of_IN plane_NN bringing_VBG $_$ 400,000,000_CD in_IN exchange_NN for_IN 4_CD Americans_NNPS —_: they_PRP show_VBP photos_NNS /_, names_NNS of_IN hostages_NNS in_IN the_DT video_NN …._, plus_CC the_DT OBUMMA_NN RANSOM_NNP PAYMENT_NN (_-LRB- first_RB in_IN $_$ 1.7_CD BILLION_CD DEAL_NN )_-RRB- ._.","THERE VBP TWO JJ NNS — NNP VBZ NNP AND HIS NN TO VB : ( 1 ) . WHY VBD NNP VB $ 400 Million to NNP — NN NN on a NN in the NN of NN ? ( 2 ) WHERE VBD the $ 400 Million VB from out of our JJ VBN NNS ? Neither NN VBZ VBN VBN . WE RB VBP A JJ TO VB . And the NN RB VBN to NNP … VBD $ 1.7 BILLION . NNP NN 1:04 — NNP – JJ JJ NN — NNP NN of NN VBG $ 400,000,000 in NN for 4 NNPS — they VBP NNS / NNS of NNS in the NN …. plus the NN NNP NN ( RB in $ 1.7 BILLION NN ) ."
131,790,mainstream,"The_DT hope_NN is_VBZ that_IN we_PRP will_MD have_VB a_DT coronavirus_NN vaccine_NN in_IN 12_CD -_SYM 18_CD months_NNS ,_, but_CC for_IN that_DT to_TO happen_VB we_PRP may_MD have_VB to_TO rely_VB on_IN untested_JJ techniques_NNS -_, and_CC that_DT comes_VBZ with_IN its_PRP$ own_JJ risks_NNS ._. POTTERING_VBG around_IN her_PRP$ kitchen_NN on_IN the_DT morning_NN of_IN 31_CD December_NNP ,_, Kate_NNP Broderick_NNP scrolled_VBD through_IN the_DT headlines_NNS while_IN she_PRP waited_VBD for_IN her_PRP$ tea_NN to_TO brew_VB ._. One_CD story_NN caught_VBD her_PRP$ eye_NN :_: a_DT mysterious_JJ outbreak_NN of_IN severe_JJ pneumonia_NN in_IN Wuhan_NNP ,_, China_NNP ._. Nearly_RB overnight_RB ,_, the_DT number_NN of_IN cases_NNS seemed_VBD to_TO explode_VB ._. “_`` I_PRP knew_VBD we_PRP did_VBD n’t_RB have_VB time_NN to_TO wait_VB ,_, ”_'' she_PRP says_VBZ ._. A_DT molecular_JJ geneticist_NN at_IN Inovio_NNP Pharmaceuticals_NNPS in_IN California_NNP ,_, Broderick_NNP was_VBD poised_VBN for_IN what_WP came_VBD next_RB ._. When_WRB Chinese_JJ officials_NNS published_VBD the_DT genetic_JJ sequence_NN of_IN the_DT new_JJ SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD coronavirus_NN causing_VBG the_DT illness_NN just_RB two_CD weeks_NNS after_IN the_DT first_JJ cases_NNS were_VBD reported_VBN to_IN the_DT World_NNP Health_NNP Organization_NNP ,_, Broderick_NNP got_VBD to_TO work_VB ._. Within_IN 3_CD hours_NNS ,_, her_PRP$ team_NN had_VBD a_DT prototype_NN vaccine_NN ready_JJ for_IN initial_JJ testing_NN ._. It_PRP was_VBD an_DT unprecedented_JJ turnaround_NN ,_, but_CC a_DT moment_NN Broderick_NNP and_CC many_JJ others_NNS had_VBD long_RB seen_VBN coming_VBG ._. Making_VBG vaccines_NNS usually_RB takes_VBZ a_DT decade_NN or_CC more_JJR between_IN development_NN ,_, safety_NN testing_NN and_CC manufacturing_NN ,_, says_VBZ Seth_NNP Berkley_NNP ,_, head_NN of_IN Gavi_NNP ,_, an_DT international_JJ group_NN that_WDT promotes_VBZ vaccine_NN use_NN around_IN the_DT world_NN ._. With_IN global_JJ confirmed_VBN cases_NNS of_IN the_DT new_JJ disease_NN ,_, covid_NN -_HYPH 19_CD ,_, surging_VBG past_IN 180,000_CD at_IN the_DT time_NN of_IN writing_NN ,_, time_NN is_VBZ of_IN the_DT essence_NN ._. To_TO speed_VB things_NNS up_RP ,_, scientists_NNS are_VBP turning_VBG to_IN untested_JJ classes_NNS of_IN vaccines_NNS ,_, and_CC rethinking_VBG every_DT part_NN of_IN how_WRB they_PRP are_VBP designed_VBN ,_, evaluated_VBN and_CC manufactured_VBN ._. If_IN the_DT approach_NN works_VBZ ,_, we_PRP will_MD ,_, for_IN the_DT first_JJ time_NN ,_, have_VBP identified_VBN a_DT new_JJ disease_NN and_CC developed_VBD a_DT vaccine_NN against_IN it_PRP while_IN the_DT initial_JJ outbreak_NN is_VBZ still_RB ongoing_JJ ._. But_CC speed_NN can_MD come_VB with_IN downsides_NNS ._. “_`` We_PRP could_MD have_VB a_DT vaccine_NN in_IN three_CD weeks_NNS ,_, but_CC we_PRP ca_MD n’t_RB guarantee_VB its_PRP$ safety_NN or_CC efficacy_NN ,_, ”_'' says_VBZ Gary_NNP Kobinger_NNP ,_, a_DT virologist_NN at_IN Laval_NNP University_NNP in_IN Canada_NNP ._. …_.","The NN VBZ that we will VB a NN NN in 12 - 18 NNS , but for that to VB we may VB to VB on JJ NNS - and that VBZ with its JJ NNS . VBG around her NN on the NN of 31 NNP , NNP NNP VBD through the NNS while she VBD for her NN to VB . One NN VBD her NN : a JJ NN of JJ NN in NNP , NNP . RB RB , the NN of NNS VBD to VB . “ I VBD we VBD RB VB NN to VB , ” she VBZ . A JJ NN at NNP NNPS in NNP , NNP VBD VBN for what VBD RB . When JJ NNS VBD the JJ NN of the JJ NNP - NNP - 2 NN VBG the NN RB two NNS after the JJ NNS VBD VBN to the NNP NNP NNP , NNP VBD to VB . Within 3 NNS , her NN VBD a NN NN JJ for JJ NN . It VBD an JJ NN , but a NN NNP and JJ NNS VBD RB VBN VBG . VBG NNS RB VBZ a NN or JJR between NN , NN NN and NN , VBZ NNP NNP , NN of NNP , an JJ NN that VBZ NN NN around the NN . With JJ VBN NNS of the JJ NN , NN - 19 , VBG past 180,000 at the NN of NN , NN VBZ of the NN . To VB NNS up , NNS VBP VBG to JJ NNS of NNS , and VBG every NN of how they VBP VBN , VBN and VBN . If the NN VBZ , we will , for the JJ NN , VBP VBN a JJ NN and VBD a NN against it while the JJ NN VBZ RB JJ . But NN can VB with NNS . “ We could VB a NN in three NNS , but we ca RB VB its NN or NN , ” VBZ NNP NNP , a NN at NNP NNP in NNP . …"
132,206,mainstream,"New_NNP Jersey_NNP -_HYPH based_VBN pharmaceutical_NN Merck_NNP announced_VBD three_CD initiatives_NNS Tuesday_NNP to_TO fight_VB the_DT novel_JJ coronavirus_NN ,_, including_VBG teaming_VBG up_RP with_IN nonprofit_NN scientific_JJ research_NN firm_NN IAVI_NNP to_TO develop_VB a_DT vaccine_NN ,_, as_IN companies_NNS around_IN the_DT world_NN race_VBP to_TO find_VB an_DT effective_JJ treatment_NN against_IN the_DT virus_NN ._. Merck_NNP and_CC IAVI_NNP ’s_POS potential_JJ coronavirus_NN vaccine_NN will_MD use_VB the_DT same_JJ technology_NN that_WDT is_VBZ in_IN Merck_NNP ’s_POS Ebola_NNP Zaire_NNP virus_NN vaccine_NN ,_, known_VBN as_IN recombinant_JJ vesicular_JJ stomatitis_NN virus_NN (_-LRB- rVSV_NN )_-RRB- ._. The_DT rVSV_NN vaccine_NN uses_VBZ a_DT weakened_VBN strain_NN of_IN the_DT virus_NN to_TO generate_VB an_DT immune_JJ response_NN in_IN the_DT recipient_NN ._. Merck_NNP also_RB said_VBD it_PRP is_VBZ acquiring_VBG Themis_NNP ,_, a_DT company_NN that_WDT focuses_VBZ on_IN vaccines_NNS and_CC immune_NN modulation_NN therapies_NNS for_IN infectious_JJ diseases_NNS and_CC cancer_NN and_CC is_VBZ working_VBG on_IN a_DT Covid_NNP -_HYPH 19_CD vaccine_NN that_WDT uses_VBZ a_DT weakened_VBN strain_NN of_IN the_DT measles_NN virus_NN ._. In_IN addition_NN to_IN the_DT two_CD vaccine_NN efforts_NNS ,_, Merck_NNP is_VBZ collaborating_VBG with_IN Ridgeback_NNP Biotherapeutics_NNP to_TO create_VB an_DT oral_JJ antiviral_JJ treatment_NN for_IN the_DT virus_NN ._. Clinical_JJ studies_NNS for_IN the_DT two_CD vaccines_NNS are_VBP expected_VBN to_TO start_VB later_RBR in_IN 2020_CD ,_, according_VBG to_IN press_NN statements_NNS ._. Shares_NNS of_IN Merck_NNP jumped_VBD over_RB 4_CD %_NN before_IN the_DT morning_NN bell_NN ._. “_`` COVID_NNP -_HYPH 19_CD is_VBZ a_DT global_JJ challenge_NN and_CC requires_VBZ global_JJ solutions_NNS ,_, ”_'' said_VBD Merck_NNP chairman_NN and_CC chief_JJ executive_NN Kenneth_NNP C._NNP Frazier_NNP in_IN a_DT statement_NN ._. “_`` Merck_NNP intends_VBZ to_TO make_VB any_DT vaccine_NN or_CC medicine_NN we_PRP develop_VBP for_IN this_DT pandemic_NN broadly_RB accessible_JJ and_CC affordable_JJ globally_RB ,_, and_CC we_PRP are_VBP working_VBG now_RB to_TO accomplish_VB this_DT goal_NN as_RB quickly_RB as_IN possible_JJ ._. ”_'' One_CD ._. That_DT ’s_VBZ the_DT number_NN of_IN doses_NNS Merck_NNP is_VBZ ultimately_RB aiming_VBG for_IN in_IN either_CC Covid_NNP -_HYPH 19_CD vaccine_NN ._. Roger_NNP Perlmutter_NNP ,_, the_DT head_NN of_IN Merck_NNP ’s_POS Research_NNP Laboratories_NNP ,_, told_VBD Stat_NNP News_NNP that_IN having_VBG to_TO give_VB booster_NN shots_NNS would_MD make_VB immunizing_VBG people_NNS more_RBR difficult_JJ ._. According_VBG to_IN Stat_NNP News_NNP ,_, Merck_NNP ’s_POS efforts_NNS against_IN Covid_NNP -_HYPH 19_CD have_VBP been_VBN going_VBG on_RP behind_IN the_DT scenes_NNS for_IN at_IN least_JJS two_CD and_CC a_DT half_NN months_NNS prior_JJ to_IN its_PRP$ announcements_NNS Tuesday_NNP ._. In_IN that_DT space_NN of_IN time_NN ,_, other_JJ companies_NNS —_: including_VBG Pfizer_NNP ,_, Moderna_NNP and_CC Novavax_NNP —_: have_VBP announced_VBN their_PRP$ efforts_NNS to_TO create_VB a_DT vaccine_NN ,_, and_CC are_VBP in_IN varying_JJ stages_NNS of_IN development_NN ._. Although_IN the_DT World_NNP Health_NNP Organization_NNP says_VBZ over_RB 100_CD vaccines_NNS are_VBP in_IN the_DT works_NNS ,_, with_IN some_DT promising_VBG early_JJ trial_NN results_NNS ,_, experts_NNS like_IN National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS director_NN Dr._NNP Anthony_NNP Fauci_NNP have_VBP expressed_VBN caution_NN ._. 12_CD to_IN 18_CD months_NNS is_VBZ the_DT timeline_NN in_IN which_WDT most_JJS health_NN officials_NNS agree_VBP a_DT safe_JJ vaccine_NN could_MD be_VB made_VBN available_JJ ._. The_DT Race_NN Is_VBZ On_IN :_: Why_WRB Pfizer_NNP May_MD Be_VB The_DT Best_JJS Bet_NN To_TO Deliver_VB A_DT Vaccine_NN By_IN The_DT Fall_NN (_-LRB- Forbes_NNP )_-RRB- Novavax_NNP Is_VBZ Beginning_VBG Clinical_JJ Trials_NNS Of_IN Its_PRP$ Coronavirus_NNP Vaccine_NNP (_-LRB- Forbes_NNP )_-RRB- Full_JJ coverage_NN and_CC live_JJ updates_NNS on_IN the_DT Coronavirus_NN","NNP NNP - VBN NN NNP VBD three NNS NNP to VB the JJ NN , VBG VBG up with NN JJ NN NN NNP to VB a NN , as NNS around the NN VBP to VB an JJ NN against the NN . NNP and NNP ’s JJ NN NN will VB the JJ NN that VBZ in NNP ’s NNP NNP NN NN , VBN as JJ JJ NN NN ( NN ) . The NN NN VBZ a VBN NN of the NN to VB an JJ NN in the NN . NNP RB VBD it VBZ VBG NNP , a NN that VBZ on NNS and NN NN NNS for JJ NNS and NN and VBZ VBG on a NNP - 19 NN that VBZ a VBN NN of the NN NN . In NN to the two NN NNS , NNP VBZ VBG with NNP NNP to VB an JJ JJ NN for the NN . JJ NNS for the two NNS VBP VBN to VB RBR in 2020 , VBG to NN NNS . NNS of NNP VBD RB 4 NN before the NN NN . “ NNP - 19 VBZ a JJ NN and VBZ JJ NNS , ” VBD NNP NN and JJ NN NNP NNP NNP in a NN . “ NNP VBZ to VB any NN or NN we VBP for this NN RB JJ and JJ RB , and we VBP VBG RB to VB this NN RB RB as JJ . ” One . That VBZ the NN of NNS NNP VBZ RB VBG for in either NNP - 19 NN . NNP NNP , the NN of NNP ’s NNP NNP , VBD NNP NNP that VBG to VB NN NNS would VB VBG NNS RBR JJ . VBG to NNP NNP , NNP ’s NNS against NNP - 19 VBP VBN VBG on behind the NNS for at JJS two and a NN NNS JJ to its NNS NNP . In that NN of NN , JJ NNS — VBG NNP , NNP and NNP — VBP VBN their NNS to VB a NN , and VBP in JJ NNS of NN . Although the NNP NNP NNP VBZ RB 100 NNS VBP in the NNS , with some VBG JJ NN NNS , NNS like NNP NNP of NNP and NNP NNPS NN NNP NNP NNP VBP VBN NN . 12 to 18 NNS VBZ the NN in which JJS NN NNS VBP a JJ NN could VB VBN JJ . The NN VBZ On : Why NNP May VB The JJS NN To VB A NN By The NN ( NNP ) NNP VBZ VBG JJ NNS Of Its NNP NNP ( NNP ) JJ NN and JJ NNS on the NN"
133,1196,mainstream,"There_EX is_VBZ no_DT link_NN between_IN the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN jab_NN and_CC autism_NN ,_, according_VBG to_IN the_DT latest_JJS research_NN ._. The_DT Danish_JJ study_NN ,_, which_WDT looked_VBD at_IN over_RB 530,000_CD children_NNS ,_, reinforces_VBZ previous_JJ findings_NNS that_IN there_EX is_VBZ no_DT link_NN between_IN the_DT jab_NN and_CC the_DT condition_NN ._. It_PRP found_VBD the_DT risk_NN of_IN autism_NN was_VBD the_DT same_JJ for_IN children_NNS who_WP had_VBD been_VBN vaccinated_VBN as_IN those_DT who_WP had_VBD not_RB ._. There_EX was_VBD also_RB no_DT cluster_NN of_IN autism_NN cases_NNS seen_VBN at_IN any_DT time_NN after_IN immunisation_NN ._. And_CC no_DT kind_NN of_IN autistic_JJ disorder_NN was_VBD linked_VBN to_IN the_DT MMR_NNP jab_NN ._. Four_CD years_NNS ago_RB ,_, Finnish_JJ scientists_NNS carried_VBD out_RP a_DT study_NN based_VBN on_IN 14_CD years_NNS worth_NN of_IN data_NNS ,_, which_WDT ruled_VBD out_RP a_DT link_NN between_IN MMR_NN and_CC autism_NN ,_, or_CC a_DT chronic_JJ bowel_NN inflammation_NN ._. Experts_NNS say_VBP this_DT latest_JJS study_NN reinforces_VBZ those_DT findings_NNS ._. But_CC it_PRP is_VBZ accepted_VBN that_IN some_DT parents_NNS still_RB have_VBP concerns_NNS over_IN the_DT vaccine_NN 's_POS safety_NN ._. The_DT study_NN ,_, published_VBN in_IN the_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP ,_, looked_VBD at_IN all_DT children_NNS born_VBN in_IN January_NNP 1991_CD until_IN December_NNP 1998_CD ._. Over_RB 440,000_CD children_NNS who_WP had_VBD been_VBN given_VBN the_DT MMR_NN vaccine_NN and_CC over_RB 100,000_CD who_WP had_VBD not_RB ._. No_DT increased_VBN risk_NN was_VBD linked_VBN to_IN MMR_NNP ._. The_DT researchers_NNS ,_, led_VBN by_IN Dr_NNP Kreesten_NNP Meldgaard_NNP Madsen_NNP ,_, wrote_VBD :_: ""_`` One_CD of_IN the_DT main_JJ reasons_NNS for_IN public_JJ concern_NN has_VBZ been_VBN that_IN the_DT widespread_JJ use_NN of_IN the_DT MMR_NNP vaccine_NN in_IN some_DT regions_NNS appeared_VBD to_TO coincide_VB with_IN an_DT increase_NN in_IN the_DT incidence_NN of_IN autism_NN ._. ""_`` However_RB ,_, this_DT is_VBZ not_RB a_DT uniform_JJ finding_NN ._. ""_`` The_DT increase_NN in_IN autism_NN both_CC in_IN California_NNP and_CC in_IN Denmark_NNP occurred_VBD well_RB after_IN the_DT introduction_NN of_IN the_DT MMR_NN vaccine_NN ._. ""_'' But_CC in_IN the_DT New_NNP England_NNP Journal_NNP ,_, editor_NN Dr_NNP Edward_NNP Campion_NNP ,_, said_VBD :_: ""_`` Unfortunately_RB ,_, objective_JJ data_NNS are_VBP not_RB likely_JJ to_TO put_VB an_DT end_NN to_IN the_DT controversy_NN ._. But_CC he_PRP added_VBD :_: ""_`` Those_DT arguing_VBG against_IN vaccination_NN forget_VBP how_WRB bad_JJ the_DT illnesses_NNS and_CC their_PRP$ complications_NNS can_MD be_VB ._. ""_`` Children_NNS everywhere_RB deserve_VBP the_DT protection_NN that_WDT carefully_RB developed_VBD ,_, carefully_RB monitored_VBN vaccines_NNS can_MD provide_VB against_IN so_RB much_JJ disease_NN ._. ""_'' A_DT spokesperson_NN for_IN the_DT Public_NNP Health_NNP Laboratory_NNP Service_NNP ,_, which_WDT covers_VBZ England_NNP and_CC Wales_NNP ,_, said_VBD :_: ""_`` It_PRP is_VBZ interesting_JJ research_NN that_WDT adds_VBZ yet_RB further_JJ weight_NN of_IN evidence_NN against_IN the_DT hypothesis_NN that_IN MMR_NNP causes_VBZ autism_NN ""_'' ._. A_DT Department_NNP of_IN Health_NNP spokeswoman_NN said_VBD :_: ""_`` This_DT large_JJ ,_, peer_NN -_HYPH reviewed_VBN study_NN from_IN Denmark_NNP ,_, undertaken_VBN by_IN independent_JJ researchers_NNS and_CC published_VBN in_IN the_DT internationally_RB respected_VBN New_NNP England_NNP Journal_NNP of_IN Medicine_NNP adds_VBZ to_IN the_DT increasing_VBG body_NN of_IN research_NN from_IN around_IN the_DT world_NN which_WDT has_VBZ found_VBN no_DT link_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN ._. ""_''","There VBZ no NN between the NNS , NNS and NN NN and NN , VBG to the JJS NN . The JJ NN , which VBD at RB 530,000 NNS , VBZ JJ NNS that there VBZ no NN between the NN and the NN . It VBD the NN of NN VBD the JJ for NNS who VBD VBN VBN as those who VBD RB . There VBD RB no NN of NN NNS VBN at any NN after NN . And no NN of JJ NN VBD VBN to the NNP NN . Four NNS RB , JJ NNS VBD out a NN VBN on 14 NNS NN of NNS , which VBD out a NN between NN and NN , or a JJ NN NN . NNS VBP this JJS NN VBZ those NNS . But it VBZ VBN that some NNS RB VBP NNS over the NN 's NN . The NN , VBN in the NNP NNP NNP of NNP , VBD at all NNS VBN in NNP 1991 until NNP 1998 . RB 440,000 NNS who VBD VBN VBN the NN NN and RB 100,000 who VBD RB . No VBN NN VBD VBN to NNP . The NNS , VBN by NNP NNP NNP NNP , VBD : "" One of the JJ NNS for JJ NN VBZ VBN that the JJ NN of the NNP NN in some NNS VBD to VB with an NN in the NN of NN . "" RB , this VBZ RB a JJ NN . "" The NN in NN both in NNP and in NNP VBD RB after the NN of the NN NN . "" But in the NNP NNP NNP , NN NNP NNP NNP , VBD : "" RB , JJ NNS VBP RB JJ to VB an NN to the NN . But he VBD : "" Those VBG against NN VBP how JJ the NNS and their NNS can VB . "" NNS RB VBP the NN that RB VBD , RB VBN NNS can VB against RB JJ NN . "" A NN for the NNP NNP NNP NNP , which VBZ NNP and NNP , VBD : "" It VBZ JJ NN that VBZ RB JJ NN of NN against the NN that NNP VBZ NN "" . A NNP of NNP NN VBD : "" This JJ , NN - VBN NN from NNP , VBN by JJ NNS and VBN in the RB VBN NNP NNP NNP of NNP VBZ to the VBG NN of NN from around the NN which VBZ VBN no NN between the NN NN and NN . """
134,484,conspiracy,"In_IN order_NN to_TO renew_VB ,_, you_PRP must_MD login_VB to_IN your_PRP$ account_NN ._. Please_UH use_VB this_DT link_NN :_: Renew_VB The_DT World_NNP Affairs_NNPS Brief_NNP appears_VBZ here_RB every_DT Friday_NNP 52_CD weeks_NNS /_, year_NN :_: One_CD year_NN only_RB $_$ 48_CD Two_CD years_NNS $_$ 88_CD One_CD month_NN trial_NN $_$ 5_CD All_DT subscribers_NNS should_MD include_VB their_PRP$ full_JJ address_NN and_CC phone_NN number_NN so_IN you_PRP can_MD be_VB contacted_VBN if_IN there_EX are_VBP any_DT problems_NNS ._. We_PRP are_VBP thrilled_VBN to_TO have_VB you_PRP on_IN board_NN ._. Your_PRP$ readership_NN and_CC engagement_NN at_IN any_DT level_NN is_VBZ a_DT great_JJ asset_NN to_IN us_PRP ._. We_PRP hope_VBP to_TO return_VB the_DT favor_NN by_IN providing_VBG you_PRP with_IN the_DT best_JJS insight_NN and_CC like_JJ -_HYPH minded_JJ community_NN for_IN information_NN analysis_NN on_IN the_DT internet_NN !_. Make_VB checks_NNS payable_JJ to_IN Joel_NNP Skousen_NNP and_CC mail_VB it_PRP to_IN PO_NN Box_NN 565_CD ,_, Spring_NNP City_NNP ,_, UT_NNP 84662_CD ._. Include_VB your_PRP$ name_NN ,_, email_NN ,_, and_CC phone_NN in_IN your_PRP$ letter_NN and_CC an_DT email_NN so_IN that_IN your_PRP$ subscription_NN can_MD be_VB created_VBN or_CC renewed_VBN ._. Along_IN with_IN your_PRP$ check_NN ,_, send_VB Joel_NNP your_PRP$ email_NN address_NN and_CC pick_VB a_DT username_NN and_CC password_NN so_IN that_IN staff_NN can_MD manually_RB enter_VB it_PRP in_IN the_DT database_NN ._. This_DT is_VBZ necessary_JJ so_IN that_IN you_PRP get_VBP on_IN the_DT mailing_NN list_NN ,_, and_CC so_IN that_IN you_PRP can_MD log_VB into_IN the_DT website_NN to_TO access_VB the_DT archives_NNS PLEASE_UH do_VB NOT_RB make_VB checks_NNS payable_JJ to_IN World_NNP Affairs_NNPS Brief_NNP ._. Feel_VB free_JJ to_TO contact_VB us_PRP if_IN you_PRP have_VBP any_DT questions_NNS ._. We_PRP are_VBP currently_RB implementing_VBG a_DT number_NN of_IN changes_NNS to_IN the_DT site_NN ._. We_PRP hope_VBP you_PRP will_MD find_VB these_DT beneficial_JJ ._. Please_UH contact_VB us_PRP to_TO help_VB us_PRP improve_VB your_PRP$ experience_NN on_IN this_DT site_NN ._.","In NN to VB , you must VB to your NN . Please VB this NN : VB The NNP NNPS NNP VBZ RB every NNP 52 NNS / NN : One NN RB $ 48 Two NNS $ 88 One NN NN $ 5 All NNS should VB their JJ NN and NN NN so you can VB VBN if there VBP any NNS . We VBP VBN to VB you on NN . Your NN and NN at any NN VBZ a JJ NN to us . We VBP to VB the NN by VBG you with the JJS NN and JJ - JJ NN for NN NN on the NN ! VB NNS JJ to NNP NNP and VB it to NN NN 565 , NNP NNP , NNP 84662 . VB your NN , NN , and NN in your NN and an NN so that your NN can VB VBN or VBN . Along with your NN , VB NNP your NN NN and VB a NN and NN so that NN can RB VB it in the NN . This VBZ JJ so that you VBP on the NN NN , and so that you can VB into the NN to VB the NNS PLEASE VB RB VB NNS JJ to NNP NNPS NNP . VB JJ to VB us if you VBP any NNS . We VBP RB VBG a NN of NNS to the NN . We VBP you will VB these JJ . Please VB us to VB us VB your NN on this NN ."
135,1135,mainstream,"Lest_IN Siberian_JJ excavation_NN makes_VBZ you_PRP think_VB of_IN frozen_VBN woolly_JJ mammoths_NNS ,_, make_VB no_DT mistake_NN :_: These_DT giants_NNS are_VBP still_RB decidedly_RB microscopic_JJ ._. But_CC in_IN the_DT diminutive_JJ world_NN of_IN viruses_NNS they_PRP 're_VBP larger_JJR than_IN normal_JJ specimens_NNS ,_, measuring_VBG 1.5_CD microns_NNS in_IN length_NN and_CC 0.5_CD microns_NNS in_IN diameter_NN ._. The_DT pandoraviruses_NNS ,_, the_DT largest_JJS viruses_NNS previously_RB discovered_VBN ,_, also_RB by_IN the_DT team_NN of_IN Claverie_NNP and_CC Abergel_NNP ,_, measure_VB 1_CD micron_NN in_IN length_NN and_CC 0.5_CD in_IN diameter_NN ._. Amazingly_RB ,_, even_RB after_IN more_JJR than_IN 30,000_CD years_NNS embedded_VBN in_IN ancient_JJ permafrost_NN ,_, when_WRB Claverie_NNP and_CC Abergel_NNP exposed_VBD amoebas_NNS in_IN their_PRP$ lab_NN to_IN the_DT virus_NN ,_, they_PRP found_VBD that_IN the_DT virus_NN was_VBD still_RB active_JJ and_CC quickly_RB infected_VBD the_DT host_NN cell_NN ._. ""_`` We_PRP use_VBP amoeba_NN on_IN purpose_NN as_IN a_DT safe_JJ bait_NN for_IN capturing_VBG viruses_NNS ._. We_PRP then_RB immediately_RB verify_VBP that_IN they_PRP are_VBP not_RB able_JJ to_TO infect_VB animal_NN /_, human_JJ cells_NNS ,_, ""_'' stressed_VBD the_DT researchers_NNS ._. Giant_NN viruses_NNS are_VBP not_RB just_RB bigger_JJR but_CC are_VBP hardier_JJR than_IN others_NNS as_RB well_RB ,_, said_VBD the_DT researchers_NNS ._. This_DT hardiness_NN ,_, along_IN with_IN a_DT favorable_JJ environment_NN ,_, likely_RB helped_VBD the_DT newly_RB discovered_VBN specimen_NN stay_VB intact_JJ for_IN the_DT thousands_NNS of_IN years_NNS that_WDT it_PRP did_VBD ._. Viruses_NNS are_VBP often_RB destroyed_VBN or_CC rendered_VBN inactive_JJ by_IN a_DT number_NN of_IN factors_NNS ,_, including_VBG light_NN and_CC biochemical_JJ degradation_NN ._. ""_`` Among_IN known_VBN viruses_NNS ,_, the_DT giant_JJ viruses_NNS tend_VBP to_TO be_VB very_RB tough_JJ ,_, almost_RB impossible_JJ to_TO break_VB open_JJ ,_, ""_'' said_VBD Claverie_NNP and_CC Abergel_NNP ._. ""_`` Special_JJ environments_NNS such_JJ as_IN deep_JJ ocean_NN sediments_NNS and_CC permafrost_NN are_VBP very_RB good_JJ preservers_NNS of_IN microbes_NNS [_-LRB- and_CC viruses_NNS ]_-RRB- because_IN they_PRP are_VBP cold_JJ ,_, anoxic_JJ [_-LRB- lacking_VBG oxygen_NN ]_-RRB- ,_, and_CC in_IN the_DT dark_NN ._. ""_'' The_DT past_JJ decade_NN has_VBZ seen_VBN something_NN of_IN a_DT renaissance_NN in_IN the_DT discovery_NN of_IN large_JJ ,_, genetically_RB complex_JJ viruses_NNS ,_, with_IN the_DT discovery_NN of_IN three_CD distinct_JJ groups_NNS (_-LRB- Mimivirus_NNP ,_, Pandoravirus_NNP ,_, and_CC now_RB Pithovirus_NNP )_-RRB- suggesting_VBG that_IN viruses_NNS can_MD be_VB much_RB more_RBR intricate_JJ and_CC varied_JJ than_IN previously_RB thought_VBN ,_, and_CC that_IN giant_JJ viruses_NNS may_MD not_RB be_VB especially_RB uncommon_JJ ._. If_IN long_RB -_HYPH buried_VBN viruses_NNS can_MD be_VB unearthed_VBN ,_, what_WP else_RB might_MD be_VB capable_JJ of_IN coming_VBG to_IN the_DT surface_NN ?_. Climate_NN change_NN as_RB well_RB as_IN industrial_JJ activities_NNS may_MD shake_VB up_RP the_DT ancient_JJ ice_NN enough_RB to_TO bring_VB potential_JJ pathogens_NNS to_IN the_DT surface_NN ._. ""_`` The_DT idea_NN would_MD make_VB a_DT great_JJ movie_NN but_CC is_VBZ extremely_RB unlikely_JJ unless_IN the_DT virus_NN came_VBD from_IN a_DT frozen_VBN human_JJ being_NN who_WP possibly_RB died_VBD from_IN a_DT virus_NN that_WDT is_VBZ no_RB longer_RBR in_IN circulation_NN ,_, ""_'' said_VBD Mocarski_NNP when_WRB contacted_VBN via_IN email_NN ._. ""_`` The_DT biggest_JJS source_NN of_IN genes_NNS on_IN the_DT planet_NN is_VBZ probably_RB from_IN viruses_NNS ,_, and_CC they_PRP 're_VBP just_RB everywhere_RB ,_, but_CC in_IN general_JJ they_PRP 're_VBP highly_RB specific_JJ for_IN the_DT organisms_NNS that_WDT they_PRP grow_VBP in_IN ,_, ""_'' said_VBD Van_NNP Etten_NNP ._. The_DT researchers_NNS behind_IN the_DT discovery_NN ,_, Claverie_NNP and_CC Abergel_NNP ,_, believe_VBP that_IN whether_IN or_CC not_RB it_PRP 's_VBZ likely_JJ ,_, such_PDT a_DT scenario_NN remains_VBZ feasible_JJ ._. They_PRP counsel_VBP vigilance_NN and_CC continued_VBD testing_NN ._. As_IN their_PRP$ latest_JJS research_NN has_VBZ shown_VBN ,_, large_JJ DNA_NN viruses_NNS may_MD remain_VB infectious_JJ for_IN very_RB long_JJ stretches_NNS of_IN time_NN ._. ""_`` The_DT fact_NN that_IN we_PRP might_MD catch_VB a_DT viral_JJ infection_NN from_IN a_DT long_JJ -_HYPH extinct_JJ Neanderthal_JJ individual_NN is_VBZ a_DT good_JJ demonstration_NN that_IN the_DT notion_NN that_IN a_DT virus_NN could_MD be_VB '_`` eradicated_VBN '_'' from_IN the_DT planet_NN is_VBZ plain_JJ wrong_JJ and_CC gives_VBZ us_PRP a_DT false_JJ sense_NN of_IN security_NN ._. At_IN least_JJS a_DT stock_NN of_IN vaccine_NN should_MD be_VB kept_VBN ,_, just_RB in_IN case_NN ,_, ""_'' said_VBD Claverie_NNP and_CC Abergel_NNP ._. ""_`` We_PRP are_VBP now_RB doing_VBG more_JJR work_NN to_TO analyze_VB the_DT DNA_NN content_NN of_IN these_DT permafrost_NN layers_NNS in_IN a_DT search_NN for_IN the_DT genetic_JJ signature_NN of_IN viruses_NNS resembling_VBG human_JJ pathogens_NNS ,_, ""_'' said_VBD Claverie_NNP and_CC Abergel_NNP ,_, who_WP stressed_VBD that_IN they_PRP are_VBP not_RB attempting_VBG to_TO ""_`` revive_VB ""_'' any_DT such_JJ pathogenic_JJ viruses_NNS ,_, but_CC rather_RB hoping_VBG to_TO determine_VB the_DT potential_JJ danger_NN ._.","Lest JJ NN VBZ you VB of VBN JJ NNS , VB no NN : These NNS VBP RB RB JJ . But in the JJ NN of NNS they VBP JJR than JJ NNS , VBG 1.5 NNS in NN and 0.5 NNS in NN . The NNS , the JJS NNS RB VBN , RB by the NN of NNP and NNP , VB 1 NN in NN and 0.5 in NN . RB , RB after JJR than 30,000 NNS VBN in JJ NN , when NNP and NNP VBD NNS in their NN to the NN , they VBD that the NN VBD RB JJ and RB VBD the NN NN . "" We VBP NN on NN as a JJ NN for VBG NNS . We RB RB VBP that they VBP RB JJ to VB NN / JJ NNS , "" VBD the NNS . NN NNS VBP RB RB JJR but VBP JJR than NNS RB RB , VBD the NNS . This NN , along with a JJ NN , RB VBD the RB VBN NN VB JJ for the NNS of NNS that it VBD . NNS VBP RB VBN or VBN JJ by a NN of NNS , VBG NN and JJ NN . "" Among VBN NNS , the JJ NNS VBP to VB RB JJ , RB JJ to VB JJ , "" VBD NNP and NNP . "" JJ NNS JJ as JJ NN NNS and NN VBP RB JJ NNS of NNS [ and NNS ] because they VBP JJ , JJ [ VBG NN ] , and in the NN . "" The JJ NN VBZ VBN NN of a NN in the NN of JJ , RB JJ NNS , with the NN of three JJ NNS ( NNP , NNP , and RB NNP ) VBG that NNS can VB RB RBR JJ and JJ than RB VBN , and that JJ NNS may RB VB RB JJ . If RB - VBN NNS can VB VBN , what RB might VB JJ of VBG to the NN ? NN NN RB RB as JJ NNS may VB up the JJ NN RB to VB JJ NNS to the NN . "" The NN would VB a JJ NN but VBZ RB JJ unless the NN VBD from a VBN JJ NN who RB VBD from a NN that VBZ RB RBR in NN , "" VBD NNP when VBN via NN . "" The JJS NN of NNS on the NN VBZ RB from NNS , and they VBP RB RB , but in JJ they VBP RB JJ for the NNS that they VBP in , "" VBD NNP NNP . The NNS behind the NN , NNP and NNP , VBP that whether or RB it VBZ JJ , such a NN VBZ JJ . They VBP NN and VBD NN . As their JJS NN VBZ VBN , JJ NN NNS may VB JJ for RB JJ NNS of NN . "" The NN that we might VB a JJ NN from a JJ - JJ JJ NN VBZ a JJ NN that the NN that a NN could VB ' VBN ' from the NN VBZ JJ JJ and VBZ us a JJ NN of NN . At JJS a NN of NN should VB VBN , RB in NN , "" VBD NNP and NNP . "" We VBP RB VBG JJR NN to VB the NN NN of these NN NNS in a NN for the JJ NN of NNS VBG JJ NNS , "" VBD NNP and NNP , who VBD that they VBP RB VBG to "" VB "" any JJ JJ NNS , but RB VBG to VB the JJ NN ."
136,1280,mainstream,"A_DT vaccine_NN adverse_JJ event_NN ,_, sometimes_RB referred_VBN to_IN as_IN a_DT vaccine_NN injury_NN ,_, is_VBZ an_DT adverse_JJ event_NN caused_VBN by_IN vaccination_NN ._. Most_JJS vaccine_NN adverse_JJ events_NNS are_VBP mild_JJ ;_, serious_JJ injuries_NNS and_CC deaths_NNS caused_VBN by_IN vaccines_NNS are_VBP very_RB rare_JJ ,_, and_CC the_DT idea_NN that_IN severe_JJ events_NNS are_VBP common_JJ has_VBZ been_VBN classed_VBN as_IN a_DT ""_`` common_JJ misconception_NN about_IN immunization_NN ""_'' by_IN the_DT World_NNP Health_NNP Organization_NNP ._. [_-LRB- 1_CD ]_-RRB- Some_DT claimed_VBD vaccine_NN injuries_NNS are_VBP not_RB ,_, in_IN fact_NN ,_, caused_VBN by_IN vaccines_NNS ;_, for_IN example_NN ,_, there_EX is_VBZ a_DT subculture_NN of_IN advocates_NNS who_WP attribute_VBP their_PRP$ children_NNS ’s_POS autism_NN to_IN vaccine_NN injury_NN ,_, [_-LRB- 2_CD ]_-RRB- despite_IN the_DT fact_NN that_IN vaccines_NNS do_VBP not_RB cause_VB autism_NN ._. [_-LRB- 3_CD ]_-RRB- [_-LRB- 4_CD ]_-RRB- Claims_NNS of_IN vaccine_NN injuries_NNS appeared_VBD in_IN litigation_NN in_IN the_DT United_NNP States_NNPS in_IN the_DT latter_JJ part_NN of_IN the_DT 20th_JJ Century_NN ._. Some_DT families_NNS have_VBP won_VBN substantial_JJ awards_NNS from_IN sympathetic_JJ juries_NNS ,_, even_RB though_IN many_JJ public_JJ health_NN officials_NNS have_VBP said_VBN that_IN the_DT claims_NNS of_IN injuries_NNS are_VBP unfounded_JJ ._. [_-LRB- 5_CD ]_-RRB- In_IN response_NN ,_, several_JJ vaccine_NN makers_NNS stopped_VBD production_NN ,_, threatening_VBG public_JJ health_NN ,_, and_CC laws_NNS were_VBD passed_VBN to_TO shield_NN makers_NNS from_IN liabilities_NNS stemming_VBG from_IN vaccine_NN injury_NN claims_NNS ._. [_-LRB- 5_CD ]_-RRB- Anti-vaccination_NN websites_NNS greatly_RB exaggerate_VBP the_DT risk_NN of_IN serious_JJ adverse_JJ effects_NNS from_IN vaccines_NNS and_CC falsely_RB describe_VBP conditions_NNS such_JJ as_IN autism_NN and_CC shaken_VBN baby_NN syndrome_NN as_IN vaccine_NN injuries_NNS ,_, [_-LRB- 6_CD ]_-RRB- [_-LRB- 7_CD ]_-RRB- [_-LRB- 8_CD ]_-RRB- leading_VBG to_IN misconceptions_NNS about_IN the_DT safety_NN and_CC effectiveness_NN of_IN vaccines_NNS ._. [_-LRB- 9_CD ]_-RRB- [_-LRB- 10_CD ]_-RRB- This_DT has_VBZ had_VBN the_DT result_NN of_IN stigmatizing_VBG autistic_JJ people_NNS and_CC the_DT parents_NNS who_WP had_VBD them_PRP immunized_VBN ._. [_-LRB- 11_CD ]_-RRB- According_VBG to_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, while_IN ""_`` [_-LRB- a_DT ]_-RRB- ny_NNP vaccine_NN can_MD cause_VB side_NN effects_NNS ""_'' ,_, [_-LRB- 12_CD ]_-RRB- most_JJS side_NN effects_NNS are_VBP minor_JJ ,_, primarily_RB including_VBG sore_JJ arms_NNS or_CC a_DT mild_JJ fever_NN ._. [_-LRB- 12_CD ]_-RRB- Immunization_NN safety_NN is_VBZ taken_VBN very_RB seriously_RB by_IN the_DT scientific_JJ community_NN ,_, with_IN constant_JJ monitoring_NN of_IN a_DT number_NN of_IN data_NN sources_NNS looking_VBG for_IN patterns_NNS of_IN adverse_JJ events_NNS ._. [_-LRB- 13_CD ]_-RRB- As_IN the_DT success_NN of_IN immunization_NN programs_NNS increases_VBZ and_CC the_DT incidence_NN of_IN disease_NN decreases_VBZ ,_, public_JJ attention_NN shifts_VBZ away_RB from_IN the_DT risks_NNS of_IN disease_NN to_IN the_DT risk_NN of_IN vaccination_NN ._. [_-LRB- 14_CD ]_-RRB- Unlike_IN most_JJS medical_JJ interventions_NNS vaccines_NNS are_VBP given_VBN to_IN healthy_JJ people_NNS ._. Concerns_NNS about_IN immunization_NN safety_NN often_RB follow_VBP a_DT pattern_NN ._. [_-LRB- 14_CD ]_-RRB- First_RB ,_, some_DT investigators_NNS suggest_VBP that_IN a_DT medical_JJ condition_NN of_IN increasing_VBG prevalence_NN or_CC unknown_JJ cause_NN is_VBZ due_IN to_IN an_DT adverse_JJ effect_NN of_IN vaccination_NN ._. The_DT initial_JJ study_NN ,_, and_CC subsequent_JJ studies_NNS by_IN the_DT same_JJ investigators_NNS ,_, have_VBP inadequate_JJ methodology_NN ,_, typically_RB a_DT poorly_RB controlled_VBN or_CC uncontrolled_JJ case_NN series_NN ._. [_-LRB- 14_CD ]_-RRB- A_DT premature_JJ announcement_NN is_VBZ made_VBN of_IN the_DT alleged_VBN adverse_JJ effect_NN ,_, which_WDT resonates_VBZ with_IN individuals_NNS suffering_VBG from_IN the_DT condition_NN and_CC which_WDT underestimates_VBZ the_DT potential_JJ harm_NN of_IN not_RB being_VBG vaccinated_VBN ._. The_DT initial_JJ study_NN is_VBZ not_RB reproduced_VBN by_IN other_JJ investigators_NNS ._. [_-LRB- 14_CD ]_-RRB- Finally_RB ,_, it_PRP takes_VBZ several_JJ years_NNS before_IN the_DT public_NN regains_VBZ confidence_NN in_IN the_DT vaccine_NN ._. [_-LRB- 14_CD ]_-RRB- Controversies_NNS in_IN this_DT area_NN revolve_VBP around_IN the_DT question_NN of_IN whether_IN the_DT risks_NNS of_IN adverse_JJ events_NNS following_VBG immunization_NN outweigh_VBP the_DT benefits_NNS of_IN preventing_VBG infectious_JJ disease_NN ._. In_IN rare_JJ cases_NNS immunizations_NNS can_MD cause_VB serious_JJ adverse_JJ effects_NNS ,_, such_JJ as_IN gelatin_NN measles_NNS -_HYPH mumps_NNS -_HYPH rubella_NN vaccine_NN (_-LRB- MMR_NN )_-RRB- causing_VBG anaphylaxis_NN ,_, a_DT severe_JJ allergic_JJ reaction_NN ._. [_-LRB- 14_CD ]_-RRB- Allegations_NNS particularly_RB focus_VBP on_IN disorders_NNS claimed_VBN to_TO be_VB caused_VBN by_IN the_DT MMR_NN vaccine_NN and_CC thiomersal_NN ,_, a_DT preservative_NN used_VBN in_IN vaccines_NNS routinely_RB given_VBN to_IN U.S._NNP infants_NNS prior_JJ to_IN 2001_CD ._. Current_JJ scientific_JJ evidence_NN does_VBZ not_RB support_VB claims_NNS of_IN vaccines_NNS causing_VBG the_DT various_JJ disorders_NNS cited_VBN in_IN the_DT claims_NNS ._. [_-LRB- 15_CD ]_-RRB- [_-LRB- 16_CD ]_-RRB- The_DT debate_NN is_VBZ complicated_VBN by_IN misconceptions_NNS around_IN the_DT recording_NN and_CC reporting_NN of_IN adverse_JJ events_NNS by_IN anti-vaccination_NN activists_NNS ._. [_-LRB- 17_CD ]_-RRB- The_DT oral_JJ polio_NN vaccine_NN (_-LRB- OPV_NN )_-RRB- is_VBZ unusual_JJ in_IN that_IN it_PRP contains_VBZ a_DT live_JJ attenuated_VBN virus_NN that_WDT can_MD be_VB excreted_VBN leading_VBG ,_, under_IN -_HYPH vaccinated_VBN communities_NNS ,_, to_IN secondary_JJ infection_NN ._. [_-LRB- 18_CD ]_-RRB- Since_IN 2000_CD ,_, more_JJR than_IN 10_CD billion_CD doses_NNS of_IN OPV_NN have_VBP been_VBN administered_VBN to_IN nearly_RB 3_CD billion_CD children_NNS worldwide_RB ._. During_IN that_DT time_NN ,_, 24_CD vaccine_NN -_HYPH derived_VBN polio_NN outbreaks_NNS occurred_VBD in_IN 21_CD countries_NNS ,_, resulting_VBG in_IN fewer_JJR than_IN 760_CD cases_NNS ._. [_-LRB- 18_CD ]_-RRB- Polio_NN vaccine_NN was_VBD also_RB involved_VBN in_IN the_DT only_JJ large_JJ -_HYPH scale_NN outbreak_NN of_IN vaccine_NN induced_VBN disease_NN ,_, in_IN the_DT Cutter_NNP incident_NN ._. It_PRP is_VBZ likely_JJ that_IN polio_NN will_MD not_RB be_VB eradicated_VBN until_IN OPV_NN is_VBZ fully_RB replaced_VBN with_IN inactivated_VBN vaccines_NNS ._. [_-LRB- 19_CD ]_-RRB- Many_JJ countries_NNS ,_, including_VBG Canada_NNP ,_, Germany_NNP ,_, Japan_NNP ,_, and_CC the_DT United_NNP States_NNPS have_VBP specific_JJ requirements_NNS for_IN reporting_VBG vaccine_NN -_HYPH related_JJ adverse_JJ effects_NNS ,_, while_IN other_JJ countries_NNS including_VBG Australia_NNP ,_, France_NNP ,_, and_CC the_DT United_NNP Kingdom_NNP include_VBP vaccines_NNS under_IN their_PRP$ general_JJ requirements_NNS for_IN reporting_VBG injuries_NNS associated_VBN with_IN medical_JJ treatments_NNS ._. [_-LRB- 20_CD ]_-RRB- :8–11_CD A_DT number_NN of_IN countries_NNS have_VBP programs_NNS for_IN the_DT compensation_NN of_IN injuries_NNS alleged_VBN to_TO have_VB been_VBN caused_VBN by_IN a_DT vaccination_NN ._. [_-LRB- 20]:9–44_CD In_IN 1988_CD ,_, the_DT National_NNP Vaccine_NNP Injury_NNP Compensation_NNP Program_NNP (_-LRB- VICP_NNP )_-RRB- went_VBD into_IN effect_NN to_TO compensate_VB individuals_NNS and_CC families_NNS of_IN individuals_NNS who_WP have_VBP been_VBN injured_VBN by_IN specified_VBN childhood_NN vaccines_NNS ._. [_-LRB- 21_CD ]_-RRB- The_DT VICP_NNP was_VBD adopted_VBN in_IN response_NN to_IN an_DT earlier_JJR scare_NN over_IN the_DT pertussis_NN portion_NN of_IN the_DT DPT_NN vaccine_NN ._. These_DT claims_NNS were_VBD later_RB generally_RB discredited_VBN ,_, but_CC some_DT U.S._NNP lawsuits_NNS against_IN vaccine_NN makers_NNS won_VBD substantial_JJ awards_NNS ;_, most_JJS makers_NNS ceased_VBD production_NN ,_, and_CC the_DT last_JJ remaining_VBG major_JJ manufacturer_NN threatened_VBD to_TO do_VB so_RB ._. [_-LRB- 22_CD ]_-RRB- As_IN of_IN October_NNP 2019_CD ,_, $_$ 4.2_CD Billion_CD in_IN compensation_NN (_-LRB- not_RB including_VBG attorneys_NNS fees_NNS and_CC costs_NNS )_-RRB- has_VBZ been_VBN awarded_VBN ._. [_-LRB- 23_CD ]_-RRB- VICP_NNP uses_VBZ a_DT streamlined_JJ system_NN for_IN litigating_VBG vaccine_NN injury_NN claims_NNS under_IN which_WDT the_DT claimant_NN must_MD show_VB that_IN the_DT vaccine_NN caused_VBD the_DT injury_NN ,_, but_CC just_RB as_IN in_IN litigation_NN for_IN injury_NN by_IN any_DT other_JJ product_NN ,_, he_PRP is_VBZ not_RB required_VBN to_TO establish_VB it_PRP was_VBD anyone_NN ’s_POS fault_NN (_-LRB- i.e._FW negligence_NN need_VBP not_RB be_VB proven_VBN )_-RRB- [_-LRB- 24_CD ]_-RRB- Claims_NNS that_WDT are_VBP denied_VBN can_MD be_VB pursued_VBN through_IN civil_JJ lawsuits_NNS ,_, though_IN this_DT is_VBZ rare_JJ ,_, and_CC the_DT statute_NN creating_VBG the_DT VICP_NNP also_RB imposes_VBZ substantial_JJ limitations_NNS on_IN the_DT ability_NN to_TO pursue_VB such_JJ lawsuits_NNS ._. The_DT VICP_NNP covers_VBZ all_DT vaccines_NNS listed_VBN on_IN the_DT Vaccine_NNP Injury_NNP Table_NNP [_-LRB- 25_CD ]_-RRB- which_WDT is_VBZ maintained_VBN by_IN the_DT Secretary_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ._. To_TO win_VB an_DT award_NN ,_, a_DT claimant_NN is_VBZ required_VBN to_TO show_VB a_DT causal_JJ connection_NN between_IN an_DT injury_NN and_CC one_CD of_IN the_DT vaccines_NNS listed_VBN in_IN the_DT Vaccine_NNP Injury_NNP Table_NNP ._. Compensation_NN is_VBZ payable_JJ for_IN ""_`` table_NN ""_'' injuries_NNS ,_, those_DT listed_VBN in_IN the_DT Vaccine_NN Injury_NN Table_NN ,_, as_RB well_RB as_IN ,_, ""_`` non-table_JJ ""_'' injuries_NNS ,_, injuries_NNS not_RB listed_VBN in_IN the_DT table_NN ._. [_-LRB- 26_CD ]_-RRB- In_IN addition_NN ,_, an_DT award_NN may_MD only_RB be_VB given_VBN if_IN the_DT claimant_NN ’s_POS injury_NN lasted_VBD for_IN more_JJR than_IN 6_CD months_NNS after_IN the_DT vaccine_NN was_VBD given_VBN ,_, resulted_VBN in_IN a_DT hospital_NN stay_NN and_CC surgery_NN or_CC resulted_VBD in_IN death_NN ._. Awards_NNS are_VBP based_VBN on_IN medical_JJ expenses_NNS ,_, lost_VBN earnings_NNS and_CC pain_NN and_CC suffering_NN (_-LRB- capped_VBN at_IN $_$ 250,000_CD )_-RRB- ._. [_-LRB- 27_CD ]_-RRB- From_IN 1988_CD until_IN March_NNP 3_CD ,_, 2011_CD ,_, 5,636_CD claims_NNS relating_VBG to_IN autism_NN ,_, and_CC 8,119_CD non-autism_JJ claims_NNS ,_, were_VBD made_VBN to_IN the_DT VICP_NN ._. 2,620_CD of_IN these_DT claims_NNS ,_, one_CD autism_NN -_HYPH related_JJ ,_, were_VBD compensated_VBN ,_, with_IN 4,463_CD non-autism_NN and_CC 814_CD autism_NN claims_NNS dismissed_VBN ;_, awards_NNS (_-LRB- including_VBG attorney_NN 's_POS fees_NNS )_-RRB- totaled_VBD over_RB $_$ 2_CD billion_CD ._. The_DT VICP_NNP also_RB applies_VBZ to_IN claims_NNS for_IN injuries_NNS suffered_VBN before_IN 1988_CD ;_, there_EX were_VBD 4,264_CD of_IN these_DT claims_NNS of_IN which_WDT 1,189_CD were_VBD compensated_VBN with_IN awards_NNS totaling_VBG $_$ 903_CD million_CD ._. [_-LRB- 25_CD ]_-RRB- As_IN of_IN October_NNP 2019_CD ,_, $_$ 4.2_CD billion_CD in_IN compensation_NN (_-LRB- not_RB including_VBG attorneys_NNS fees_NNS and_CC costs_NNS )_-RRB- has_VBZ been_VBN awarded_VBN over_IN the_DT life_NN of_IN the_DT program_NN ._. [_-LRB- 28_CD ]_-RRB- As_IN part_NN of_IN NVICP_NNP ,_, a_DT table_NN has_VBZ been_VBN created_VBN which_WDT lists_VBZ various_JJ vaccines_NNS ,_, side_NN effects_NNS that_WDT might_MD plausibly_RB be_VB caused_VBN by_IN them_PRP ,_, and_CC the_DT time_NN within_IN which_WDT the_DT symptoms_NNS must_MD present_VB in_IN order_NN to_TO be_VB eligible_JJ to_TO apply_VB for_IN compensation_NN ._. [_-LRB- 29_CD ]_-RRB- [_-LRB- 30_CD ]_-RRB- For_IN example_NN ,_, for_IN vaccines_NNS containing_VBG tetanus_NN toxoid_NN (_-LRB- e.g._FW ,_, DTaP_NN ,_, DTP_NN ,_, DT_NN ,_, Td_NN ,_, or_CC TT_NN )_-RRB- ,_, anaphylaxis_NN within_IN four_CD hours_NNS or_CC brachial_JJ neuritis_NN between_IN two_CD and_CC twenty_CD -_HYPH eight_CD days_NNS after_IN administration_NN ,_, may_MD be_VB compensated_VBN ._. [_-LRB- 31_CD ]_-RRB- The_DT Vaccine_NNP Adverse_JJ Event_NNP Reporting_NNP System_NNP (_-LRB- VAERS_NNP )_-RRB- is_VBZ a_DT passive_JJ surveillance_NN program_NN administered_VBN jointly_RB by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- and_CC the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- .[_-LRB- citation_NN needed_VBN ]_-RRB- VAERS_NNP is_VBZ intended_VBN to_TO track_VB adverse_JJ events_NNS associated_VBN with_IN vaccines_NNS ._. VAERS_NNP collects_VBZ and_CC analyzes_VBZ information_NN from_IN reports_NNS of_IN adverse_JJ events_NNS (_-LRB- possible_JJ side_NN effects_NNS )_-RRB- that_WDT occur_VBP after_IN the_DT administration_NN of_IN US_NNP licensed_VBN vaccines_NNS ._. The_DT program_NN 's_POS success_NN in_IN tracking_VBG vaccine_NN injuries_NNS has_VBZ been_VBN questioned_VBN by_IN some_DT ,_, who_WP allege_VBP medical_JJ practitioners_NNS frequently_RB fail_VBP to_TO make_VB reports_NNS ._. [_-LRB- 32_CD ]_-RRB- Others_NNS say_VBP that_IN it_PRP may_MD overstate_VB possible_JJ injuries_NNS since_IN many_JJ neurological_JJ problems_NNS in_IN childhood_NN may_MD manifest_VB around_IN the_DT same_JJ ages_NNS when_WRB vaccines_NNS are_VBP routinely_RB administered_VBN .[_-LRB- citation_NN needed_VBN ]_-RRB- Dravet_NN syndrome_NN is_VBZ one_CD example_NN of_IN a_DT genetically_RB based_VBN neurological_JJ disease_NN which_WDT frequently_RB manifests_VBZ at_IN the_DT time_NN of_IN childhood_NN vaccinations_NNS ._. [_-LRB- 33_CD ]_-RRB- The_DT Vaccine_NNP Safety_NNP Datalink_NNP (_-LRB- VSD_NNP )_-RRB- is_VBZ composed_VBN of_IN databases_NNS from_IN several_JJ organizations_NNS containing_VBG information_NN regarding_VBG health_NN outcomes_NNS for_IN millions_NNS of_IN US_NNP citizens_NNS and_CC to_TO enhance_VB assessment_NN of_IN vaccine_NN injuries_NNS ._. It_PRP was_VBD designed_VBN to_TO allow_VB for_IN such_JJ things_NNS as_IN comparisons_NNS between_IN vaccinated_VBN and_CC non-vaccinated_JJ populations_NNS ,_, and_CC for_IN the_DT identification_NN of_IN possible_JJ groups_NNS at_IN risk_NN for_IN adverse_JJ events_NNS .[_-LRB- citation_NN needed_VBN ]_-RRB- In_IN 2003_CD ,_, parents_NNS of_IN over_RB 1,000_CD United_NNP Kingdom_NNP children_NNS diagnosed_VBN with_IN autism_NN spectrum_NN disorders_NNS ,_, alleging_VBG the_DT MMR_NNP vaccine_NN was_VBD the_DT culprit_NN ,_, were_VBD dealt_VBN a_DT major_JJ setback_NN when_WRB the_DT Legal_NNP Services_NNPS Commission_NNP withdrew_VBD legal_JJ aid_NN ._. This_DT followed_VBD advice_NN to_IN the_DT commission_NN by_IN the_DT lawyers_NNS representing_VBG the_DT parents_NNS themselves_PRP that_IN the_DT lawsuit_NN had_VBD no_DT reasonable_JJ prospects_NNS of_IN success_NN ._. [_-LRB- 34_CD ]_-RRB- Under_IN the_DT Vaccine_NNP Damage_NNP Payment_NNP Scheme_NNP (_-LRB- VDPS_NNP )_-RRB- ,_, it_PRP is_VBZ thought_VBN that_IN thousands_NNS of_IN unsuccessful_JJ claims_NNS have_VBP been_VBN made_VBN ._. The_DT maximum_JJ payment_NN per_IN claim_NN is_VBZ currently_RB £_$ 120,000_CD ._. Disabled_JJ vaccine_NN injury_NN patients_NNS are_VBP allowed_VBN to_TO file_VB a_DT claim_NN up_IN to_IN the_DT age_NN of_IN 21_CD ._. The_DT '_`` disability_NN threshold_NN '_'' before_IN payments_NNS are_VBP granted_VBN is_VBZ 60_CD %_NN ._. The_DT scheme_NN covers_VBZ vaccinations_NNS for_IN illnesses_NNS such_JJ as_IN tetanus_NN ,_, measles_NN ,_, tuberculosis_NN ,_, and_CC meningitis_NN C_NNP ._. As_IN of_IN 2005_CD ,_, the_DT British_JJ government_NN had_VBD paid_VBN out_RP £_$ 3.5_CD million_CD to_IN vaccine_NN injury_NN patients_NNS since_IN 1997_CD ._. [_-LRB- 35_CD ]_-RRB- Quebec_NNP has_VBZ a_DT legal_JJ process_NN to_TO compensate_VB certain_JJ forms_NNS of_IN vaccination_NN injuries_NNS ;_: the_DT program_NN 's_POS first_JJ awards_NNS were_VBD made_VBN in_IN 1988_CD ._. [_-LRB- 36_CD ]_-RRB-","A NN JJ NN , RB VBN to as a NN NN , VBZ an JJ NN VBN by NN . JJS NN JJ NNS VBP JJ ; JJ NNS and NNS VBN by NNS VBP RB JJ , and the NN that JJ NNS VBP JJ VBZ VBN VBN as a "" JJ NN about NN "" by the NNP NNP NNP . [ 1 ] Some VBD NN NNS VBP RB , in NN , VBN by NNS ; for NN , there VBZ a NN of NNS who VBP their NNS ’s NN to NN NN , [ 2 ] despite the NN that NNS VBP RB VB NN . [ 3 ] [ 4 ] NNS of NN NNS VBD in NN in the NNP NNPS in the JJ NN of the JJ NN . Some NNS VBP VBN JJ NNS from JJ NNS , RB though JJ JJ NN NNS VBP VBN that the NNS of NNS VBP JJ . [ 5 ] In NN , JJ NN NNS VBD NN , VBG JJ NN , and NNS VBD VBN to NN NNS from NNS VBG from NN NN NNS . [ 5 ] NN NNS RB VBP the NN of JJ JJ NNS from NNS and RB VBP NNS JJ as NN and VBN NN NN as NN NNS , [ 6 ] [ 7 ] [ 8 ] VBG to NNS about the NN and NN of NNS . [ 9 ] [ 10 ] This VBZ VBN the NN of VBG JJ NNS and the NNS who VBD them VBN . [ 11 ] VBG to the NNP NNPS for NNP NNP and NNP , while "" [ a ] NNP NN can VB NN NNS "" , [ 12 ] JJS NN NNS VBP JJ , RB VBG JJ NNS or a JJ NN . [ 12 ] NN NN VBZ VBN RB RB by the JJ NN , with JJ NN of a NN of NN NNS VBG for NNS of JJ NNS . [ 13 ] As the NN of NN NNS VBZ and the NN of NN VBZ , JJ NN VBZ RB from the NNS of NN to the NN of NN . [ 14 ] Unlike JJS JJ NNS NNS VBP VBN to JJ NNS . NNS about NN NN RB VBP a NN . [ 14 ] RB , some NNS VBP that a JJ NN of VBG NN or JJ NN VBZ due to an JJ NN of NN . The JJ NN , and JJ NNS by the JJ NNS , VBP JJ NN , RB a RB VBN or JJ NN NN . [ 14 ] A JJ NN VBZ VBN of the VBN JJ NN , which VBZ with NNS VBG from the NN and which VBZ the JJ NN of RB VBG VBN . The JJ NN VBZ RB VBN by JJ NNS . [ 14 ] RB , it VBZ JJ NNS before the NN VBZ NN in the NN . [ 14 ] NNS in this NN VBP around the NN of whether the NNS of JJ NNS VBG NN VBP the NNS of VBG JJ NN . In JJ NNS NNS can VB JJ JJ NNS , JJ as NN NNS - NNS - NN NN ( NN ) VBG NN , a JJ JJ NN . [ 14 ] NNS RB VBP on NNS VBN to VB VBN by the NN NN and NN , a NN VBN in NNS RB VBN to NNP NNS JJ to 2001 . JJ JJ NN VBZ RB VB NNS of NNS VBG the JJ NNS VBN in the NNS . [ 15 ] [ 16 ] The NN VBZ VBN by NNS around the NN and NN of JJ NNS by NN NNS . [ 17 ] The JJ NN NN ( NN ) VBZ JJ in that it VBZ a JJ VBN NN that can VB VBN VBG , under - VBN NNS , to JJ NN . [ 18 ] Since 2000 , JJR than 10 billion NNS of NN VBP VBN VBN to RB 3 billion NNS RB . During that NN , 24 NN - VBN NN NNS VBD in 21 NNS , VBG in JJR than 760 NNS . [ 18 ] NN NN VBD RB VBN in the JJ JJ - NN NN of NN VBN NN , in the NNP NN . It VBZ JJ that NN will RB VB VBN until NN VBZ RB VBN with VBN NNS . [ 19 ] JJ NNS , VBG NNP , NNP , NNP , and the NNP NNPS VBP JJ NNS for VBG NN - JJ JJ NNS , while JJ NNS VBG NNP , NNP , and the NNP NNP VBP NNS under their JJ NNS for VBG NNS VBN with JJ NNS . [ 20 ] :8–11 A NN of NNS VBP NNS for the NN of NNS VBN to VB VBN VBN by a NN . [ 20]:9–44 In 1988 , the NNP NNP NNP NNP NNP ( NNP ) VBD into NN to VB NNS and NNS of NNS who VBP VBN VBN by VBN NN NNS . [ 21 ] The NNP VBD VBN in NN to an JJR NN over the NN NN of the NN NN . These NNS VBD RB RB VBN , but some NNP NNS against NN NNS VBD JJ NNS ; JJS NNS VBD NN , and the JJ VBG JJ NN VBD to VB RB . [ 22 ] As of NNP 2019 , $ 4.2 Billion in NN ( RB VBG NNS NNS and NNS ) VBZ VBN VBN . [ 23 ] NNP VBZ a JJ NN for VBG NN NN NNS under which the NN must VB that the NN VBD the NN , but RB as in NN for NN by any JJ NN , he VBZ RB VBN to VB it VBD NN ’s NN ( FW NN VBP RB VB VBN ) [ 24 ] NNS that VBP VBN can VB VBN through JJ NNS , though this VBZ JJ , and the NN VBG the NNP RB VBZ JJ NNS on the NN to VB JJ NNS . The NNP VBZ all NNS VBN on the NNP NNP NNP [ 25 ] which VBZ VBN by the NNP of NNP and NNP NNPS . To VB an NN , a NN VBZ VBN to VB a JJ NN between an NN and one of the NNS VBN in the NNP NNP NNP . NN VBZ JJ for "" NN "" NNS , those VBN in the NN NN NN , RB RB as , "" JJ "" NNS , NNS RB VBN in the NN . [ 26 ] In NN , an NN may RB VB VBN if the NN ’s NN VBD for JJR than 6 NNS after the NN VBD VBN , VBN in a NN NN and NN or VBD in NN . NNS VBP VBN on JJ NNS , VBN NNS and NN and NN ( VBN at $ 250,000 ) . [ 27 ] From 1988 until NNP 3 , 2011 , 5,636 NNS VBG to NN , and 8,119 JJ NNS , VBD VBN to the NN . 2,620 of these NNS , one NN - JJ , VBD VBN , with 4,463 NN and 814 NN NNS VBN ; NNS ( VBG NN 's NNS ) VBD RB $ 2 billion . The NNP RB VBZ to NNS for NNS VBN before 1988 ; there VBD 4,264 of these NNS of which 1,189 VBD VBN with NNS VBG $ 903 million . [ 25 ] As of NNP 2019 , $ 4.2 billion in NN ( RB VBG NNS NNS and NNS ) VBZ VBN VBN over the NN of the NN . [ 28 ] As NN of NNP , a NN VBZ VBN VBN which VBZ JJ NNS , NN NNS that might RB VB VBN by them , and the NN within which the NNS must VB in NN to VB JJ to VB for NN . [ 29 ] [ 30 ] For NN , for NNS VBG NN NN ( FW , NN , NN , NN , NN , or NN ) , NN within four NNS or JJ NN between two and twenty - eight NNS after NN , may VB VBN . [ 31 ] The NNP JJ NNP NNP NNP ( NNP ) VBZ a JJ NN NN VBN RB by the NNP and NNP NNP ( NNP ) and the NNPS for NNP NNP and NNP ( NNP ) .[ NN VBN ] NNP VBZ VBN to VB JJ NNS VBN with NNS . NNP VBZ and VBZ NN from NNS of JJ NNS ( JJ NN NNS ) that VBP after the NN of NNP VBN NNS . The NN 's NN in VBG NN NNS VBZ VBN VBN by some , who VBP JJ NNS RB VBP to VB NNS . [ 32 ] NNS VBP that it may VB JJ NNS since JJ JJ NNS in NN may VB around the JJ NNS when NNS VBP RB VBN .[ NN VBN ] NN NN VBZ one NN of a RB VBN JJ NN which RB VBZ at the NN of NN NNS . [ 33 ] The NNP NNP NNP ( NNP ) VBZ VBN of NNS from JJ NNS VBG NN VBG NN NNS for NNS of NNP NNS and to VB NN of NN NNS . It VBD VBN to VB for JJ NNS as NNS between VBN and JJ NNS , and for the NN of JJ NNS at NN for JJ NNS .[ NN VBN ] In 2003 , NNS of RB 1,000 NNP NNP NNS VBN with NN NN NNS , VBG the NNP NN VBD the NN , VBD VBN a JJ NN when the NNP NNPS NNP VBD JJ NN . This VBD NN to the NN by the NNS VBG the NNS themselves that the NN VBD no JJ NNS of NN . [ 34 ] Under the NNP NNP NNP NNP ( NNP ) , it VBZ VBN that NNS of JJ NNS VBP VBN VBN . The JJ NN per NN VBZ RB £ 120,000 . JJ NN NN NNS VBP VBN to VB a NN up to the NN of 21 . The ' NN NN ' before NNS VBP VBN VBZ 60 NN . The NN VBZ NNS for NNS JJ as NN , NN , NN , and NN NNP . As of 2005 , the JJ NN VBD VBN out £ 3.5 million to NN NN NNS since 1997 . [ 35 ] NNP VBZ a JJ NN to VB JJ NNS of NN NNS ; the NN 's JJ NNS VBD VBN in 1988 . [ 36 ]"
137,1068,mainstream,"In_IN the_DT early_JJ 1950s_NNS ,_, two_CD prominent_JJ medical_JJ researchers_NNS each_DT found_VBD a_DT way_NN to_TO protect_VB the_DT world_NN from_IN poliomyelitis_NN ,_, the_DT paralysis_NN -_HYPH causing_VBG disease_NN commonly_RB known_VBN as_IN polio_NN ._. The_DT vaccines_NNS created_VBN by_IN Dr._NNP Jonas_NNP Salk_NNP and_CC Dr._NNP Albert_NNP Sabin_NNP resulted_VBD in_IN the_DT near_JJ -_HYPH global_JJ eradication_NN of_IN polio_NN ._. Here_RB 's_VBZ how_WRB they_PRP did_VBD it_PRP ._. Polio_NNP is_VBZ a_DT disease_NN caused_VBN by_IN three_CD variants_NNS of_IN the_DT poliovirus_NN ,_, according_VBG to_IN a_DT 2012_CD review_NN written_VBN by_IN microbiologist_NN and_CC polio_NN expert_NN Anda_NNP Baicus_NNP and_CC published_VBN in_IN the_DT World_NNP Journal_NNP of_IN Virology_NNP ._. The_DT virus_NN ,_, which_WDT only_RB infects_VBZ humans_NNS ,_, can_MD damage_VB the_DT neurons_NNS that_WDT control_VBP movement_NN ,_, resulting_VBG in_IN partial_JJ or_CC complete_JJ paralysis_NN ._. A_DT person_NN can_MD become_VB infected_VBN with_IN the_DT virus_NN by_IN consuming_VBG contaminated_VBN food_NN or_CC water_NN ,_, or_CC by_IN allowing_VBG contaminated_VBN items_NNS (_-LRB- such_JJ as_IN dirty_JJ hands_NNS )_-RRB- to_TO touch_VB or_CC enter_VB the_DT mouth_NN ,_, according_VBG to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. Studies_NNS of_IN Egyptian_JJ mummies_NNS suggest_VBP that_IN polio_NN affected_VBD children_NNS at_IN least_JJS as_RB early_RB as_IN ancient_JJ times_NNS ,_, but_CC the_DT U.S._NNP did_VBD n't_RB experience_VB its_PRP$ first_JJ polio_NN epidemic_NN until_IN the_DT late_JJ 1800s_NNS ._. In_IN the_DT U.S._NNP in_IN 1916_CD ,_, more_JJR than_IN 27,000_CD people_NNS were_VBD paralyzed_VBN by_IN the_DT disease_NN and_CC at_IN least_JJS 6,000_CD people_NNS died_VBD from_IN it_PRP ,_, according_VBG to_IN History.com_NNP ._. For_IN the_DT next_JJ several_JJ decades_NNS ,_, the_DT epidemic_NN expanded_VBD throughout_IN the_DT U.S._NNP and_CC Europe_NNP ._. In_IN 1952_CD alone_RB ,_, there_EX were_VBD 58,000_CD new_JJ cases_NNS of_IN polio_NN and_CC 3,000_CD deaths_NNS from_IN the_DT disease_NN in_IN the_DT U.S_NNP ._. As_IN medical_JJ experts_NNS worked_VBD to_TO understand_VB the_DT virus_NN ,_, they_PRP discovered_VBD that_IN it_PRP could_MD infect_VB people_NNS without_IN causing_VBG symptoms_NNS ._. In_IN a_DT 1947_CD study_NN published_VBN in_IN the_DT American_NNP Journal_NNP of_IN Hygiene_NNP ,_, researchers_NNS reported_VBD that_IN the_DT prevalence_NN of_IN poliovirus_NN in_IN New_NNP York_NNP City_NNP sewage_NN water_NN meant_VBD that_IN there_EX were_VBD an_DT estimated_VBN 100_CD asymptomatic_JJ cases_NNS of_IN polio_NN for_IN every_DT symptomatic_JJ ,_, or_CC paralytic_NN ,_, case_NN of_IN the_DT disease_NN at_IN the_DT time_NN ._. Today_NN ,_, more_RBR recent_JJ research_NN suggests_VBZ that_IN 72_CD out_IN of_IN 100_CD people_NNS who_WP are_VBP infected_VBN with_IN the_DT virus_NN will_MD never_RB experience_VB symptoms_NNS ,_, and_CC about_RB 1_CD in_IN 4_CD infected_VBN people_NNS will_MD experience_VB only_RB flu_NN -_HYPH like_JJ symptoms_NNS that_WDT last_VBP between_IN 2_CD and_CC 5_CD days_NNS before_IN going_VBG away_RB on_IN their_PRP$ own_JJ ,_, according_VBG to_IN the_DT CDC_NNP ._. In_IN the_DT late_JJ 1930s_NNS ,_, researchers_NNS learned_VBD that_IN infected_VBN individuals_NNS shed_VBD the_DT virus_NN in_IN feces_NNS for_IN several_JJ weeks_NNS ,_, whether_IN or_CC not_RB they_PRP had_VBD symptoms_NNS of_IN the_DT disease_NN ._. Researchers_NNS have_VBP since_RB confirmed_VBN that_IN infected_VBN ,_, but_CC asymptomatic_JJ ,_, people_NNS can_MD still_RB shed_VB the_DT virus_NN and_CC make_VB people_NNS sick_JJ ._. People_NNS who_WP do_VBP become_VBN sick_JJ can_MD shed_VB the_DT virus_NN immediately_RB before_IN they_PRP show_VBP symptoms_NNS and_CC for_IN up_IN to_IN 2_CD weeks_NNS after_IN their_PRP$ symptoms_NNS appear_VBP ,_, according_VBG to_IN the_DT CDC_NNP ._. Researchers_NNS began_VBD working_VBG on_IN a_DT polio_NN vaccine_NN in_IN the_DT 1930s_NNS ,_, but_CC early_JJ attempts_NNS were_VBD unsuccessful_JJ ._. An_DT effective_JJ vaccine_NN did_VBD n't_RB come_VB around_RB until_IN 1953_CD ,_, when_WRB Jonas_NNP Salk_NNP introduced_VBD his_PRP$ inactivated_VBN polio_NN vaccine_NN (_-LRB- IPV_NNP )_-RRB- ._. Salk_NNP had_VBD studied_VBN viruses_NNS as_IN a_DT student_NN at_IN New_NNP York_NNP University_NNP in_IN the_DT 1930s_NNS and_CC helped_VBD develop_VB flu_NN vaccines_NNS during_IN World_NNP War_NNP II_CD ,_, according_VBG to_IN History.com_NNP ._. In_IN 1948_CD ,_, he_PRP was_VBD awarded_VBN a_DT research_NN grant_NN from_IN President_NNP Franklin_NNP D._NNP Roosevelt_NNP 's_POS National_NNP Foundation_NNP for_IN Infantile_NNP Paralysis_NNP ,_, later_RBR named_VBN March_NNP of_IN Dimes_NNP ._. Roosevelt_NNP had_VBD contracted_VBN polio_NN in_IN 1921_CD at_IN age_NN 39_CD ,_, and_CC the_DT disease_NN left_VBD him_PRP with_IN both_DT legs_NNS permanently_RB paralyzed_VBN ._. In_IN 1938_CD ,_, five_CD years_NNS into_IN his_PRP$ presidency_NN ,_, Roosevelt_NNP helped_VBD to_TO create_VB the_DT National_NNP Foundation_NNP for_IN Infantile_NNP Paralysis_NNP to_TO raise_VB money_NN and_CC deliver_VB aid_NN to_IN areas_NNS experiencing_VBG polio_NN epidemics_NNS ._. Thanks_NN to_IN the_DT work_NN of_IN researchers_NNS before_IN him_PRP ,_, Salk_NNP was_VBD able_JJ to_TO grow_VB poliovirus_NN in_IN monkey_NN kidney_NN cells_NNS ._. He_PRP then_RB isolated_VBD the_DT virus_NN and_CC inactivated_VBD it_PRP with_IN formalin_NN ,_, an_DT organic_JJ solution_NN of_IN formaldehyde_NN and_CC water_NN that_WDT is_VBZ commonly_RB used_VBN as_IN a_DT disinfectant_NN and_CC embalming_NN agent_NN ._. A_DT similar_JJ procedure_NN had_VBD been_VBN tested_VBN years_NNS prior_JJ ,_, in_IN 1935_CD ,_, by_IN American_JJ scientist_NN Maurice_NNP Brodie_NNP ,_, in_IN which_WDT he_PRP extracted_VBD poliovirus_NN from_IN live_JJ monkey_NN spinal_JJ cord_NN tissue_NN and_CC then_RB suspended_VBD the_DT virus_NN in_IN a_DT 10_CD %_NN formalin_JJ solution_NN ,_, polio_NN expert_NN Baicus_NNP wrote_VBD ._. Brodie_NNP tested_VBD his_PRP$ vaccine_NN on_IN 20_CD monkeys_NNS and_CC then_RB on_IN 300_CD schoolchildren_NNS ,_, but_CC the_DT results_NNS were_VBD poor_JJ and_CC Brodie_NNP did_VBD n't_RB test_VB any_DT further_RBR ._. Salk_NNP 's_POS vaccine_NN was_VBD unusual_JJ because_IN instead_RB of_IN using_VBG a_DT weakened_VBN version_NN of_IN the_DT live_JJ virus_NN ,_, such_JJ as_IN what_WP is_VBZ used_VBN for_IN mumps_NNS and_CC measles_NNS ,_, Salk_NNP 's_POS vaccine_NN used_VBD a_DT ""_`` killed_VBN ,_, ""_'' or_CC inactivated_VBN ,_, version_NN of_IN the_DT virus_NN ._. When_WRB the_DT ""_`` dead_JJ ""_'' poliovirus_NN is_VBZ injected_VBN into_IN the_DT bloodstream_NN ,_, it_PRP can't_MD cause_VB an_DT infection_NN because_IN the_DT virus_NN is_VBZ inactive_JJ ;_, but_CC the_DT immune_NN system_NN can't_MD distinguish_VB an_DT activated_VBN virus_NN from_IN an_DT inactivated_VBN one_NN ,_, and_CC it_PRP creates_VBZ antibodies_NNS to_TO fight_VB the_DT virus_NN ._. Those_DT antibodies_NNS persist_VBP and_CC protect_VBP the_DT person_NN from_IN future_JJ poliovirus_NN infection_NN ._. In_IN 1953_CD ,_, Salk_NNP began_VBD testing_VBG his_PRP$ inactivated_VBN polio_NN vaccine_NN (_-LRB- IPV_NNP )_-RRB- on_IN a_DT small_JJ number_NN of_IN former_JJ polio_NN patients_NNS in_IN the_DT Pittsburgh_NNP area_NN and_CC on_IN himself_PRP ,_, his_PRP$ wife_NN and_CC their_PRP$ three_CD sons_NNS ._. The_DT initial_JJ results_NNS were_VBD promising_JJ ,_, and_CC he_PRP announced_VBD his_PRP$ success_NN on_IN the_DT CBS_NNP national_JJ radio_NN network_NN on_IN March_NNP 25_CD ,_, 1953_CD ,_, according_VBG to_IN History.com_NNP ._. He_PRP became_VBD an_DT instant_JJ celebrity_NN ._. The_DT first_JJ large_JJ -_HYPH scale_NN clinical_JJ trial_NN of_IN Salk_NNP 's_POS vaccine_NN began_VBD in_IN 1954_CD and_CC enrolled_VBD more_JJR than_IN 1_CD million_CD participants_NNS ._. It_PRP was_VBD the_DT first_JJ vaccine_NN trial_NN to_TO implement_VB a_DT double_JJ -_HYPH blind_JJ ,_, placebo_NN -_HYPH controlled_VBN design_NN —_: now_RB a_DT standard_JJ requirement_NN in_IN the_DT modern_JJ era_NN of_IN vaccine_NN research_NN ,_, according_VBG to_IN Arnold_NNP S._NNP Monto_NNP 's_POS 1999_CD review_NN published_VBN in_IN the_DT journal_NN Epidemiological_NNP Reviews_NNPS ._. The_DT scientist_NN leading_VBG the_DT vaccine_NN trial_NN ,_, Dr._NNP Thomas_NNP Francis_NNP ,_, Jr._NNP from_IN the_DT University_NNP of_IN Michigan_NNP ,_, announced_VBD the_DT positive_JJ results_NNS at_IN a_DT press_NN conference_NN on_IN April_NNP 12_CD ,_, 1955_CD ._. Later_RBR that_DT same_JJ day_NN ,_, the_DT U.S._NNP government_NN declared_VBD Salk_NNP 's_POS vaccine_NN safe_JJ and_CC effective_JJ for_IN use_NN ,_, according_VBG to_IN The_DT College_NNP of_IN Physicians_NNPS of_IN Philadelphia_NNP 's_POS History_NNP of_IN Vaccines_NNPS ._. Related_JJ :_: 20_CD of_IN the_DT worst_JJS epidemics_NNS and_CC pandemics_NNS in_IN history_NN After_IN the_DT press_NN conference_NN ,_, CBS_NNP reporter_NN Edward_NNP R._NNP Murrow_NNP asked_VBD Salk_NNP who_WP owned_VBD the_DT vaccine_NN ._. ""_`` Well_UH the_DT people_NNS ,_, I_PRP would_MD say_VB ,_, ""_'' Salk_NNP famously_RB answered_VBD ._. ""_`` There_EX is_VBZ no_DT patent_NN ._. Can_MD you_PRP patent_VB the_DT sun_NN ?_. ""_'' Salk_NNP never_RB patented_VBD his_PRP$ vaccine_NN ._. Only_RB a_DT few_JJ weeks_NNS later_RBR ,_, reports_NNS began_VBD surfacing_NN of_IN children_NNS experiencing_VBG paralysis_NN after_IN receiving_VBG the_DT vaccine_NN ._. More_JJR than_IN 250_CD new_JJ polio_NN cases_NNS were_VBD traced_VBN back_RB to_IN batches_NNS of_IN the_DT vaccine_NN made_VBN by_IN Cutter_NNP Laboratories_NNP ,_, according_VBG to_IN the_DT CDC_NNP ._. The_DT batches_NNS had_VBD contained_VBN live_JJ ,_, active_JJ strains_NNS of_IN poliovirus_NN ._. The_DT U.S._NNP Surgeon_NNP General_NNP halted_VBD all_DT polio_NN vaccine_NN administration_NN until_IN all_DT manufacturers_NNS could_MD be_VB investigated_VBN and_CC verified_VBN for_IN safety_NN ._. At_IN the_DT time_NN ,_, there_EX had_VBD been_VBN little_JJ government_NN regulation_NN over_IN vaccine_NN manufacturers_NNS ,_, but_CC that_DT quickly_RB changed_VBD after_IN what_WP is_VBZ now_RB known_VBN as_IN the_DT Cutter_NNP Incident_NNP ._. Since_IN then_RB ,_, not_RB a_DT single_JJ case_NN of_IN polio_NN has_VBZ ever_RB been_VBN attributed_VBN to_IN the_DT Salk_NNP vaccine_NN ._. While_IN Salk_NNP was_VBD developing_VBG his_PRP$ inactivated_VBN polio_NN vaccine_NN ,_, his_PRP$ professional_JJ rival_NN ,_, virologist_NN Dr._NNP Albert_NNP Sabin_NNP at_IN the_DT University_NNP of_IN Cincinnati_NNP ,_, was_VBD working_VBG on_IN a_DT vaccine_NN made_VBN with_IN active_JJ ,_, but_CC weakened_VBN ,_, virus_NN ._. Sabin_NNP opposed_VBD Salk_NNP 's_POS vaccine_NN design_NN and_CC considered_VBD an_DT inactivated_VBN virus_NN vaccine_NN to_TO be_VB dangerous_JJ ._. By_IN 1963_CD ,_, Sabin_NNP had_VBD created_VBN an_DT oral_JJ live_JJ -_HYPH virus_NN vaccine_NN for_IN all_DT three_CD types_NNS of_IN poliovirus_NN that_WDT was_VBD approved_VBN for_IN use_NN by_IN the_DT U.S._NNP government_NN ._. Sabin_NNP 's_POS version_NN was_VBD cheaper_JJR and_CC easier_JJR to_TO produce_VB than_IN the_DT Salk_NNP vaccine_NN ,_, and_CC it_PRP quickly_RB supplanted_VBD the_DT Salk_NNP vaccine_NN in_IN the_DT U.S._NNP In_IN 1972_CD ,_, Sabin_NNP donated_VBD his_PRP$ vaccine_NN strains_NNS to_IN the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, which_WDT greatly_RB increased_VBD the_DT vaccine_NN 's_POS availability_NN in_IN low_JJ -_HYPH income_NN countries_NNS ._. Sabin_NNP 's_POS oral_JJ polio_NN vaccine_NN (_-LRB- OPV_NNP )_-RRB- was_VBD critical_JJ for_IN helping_VBG to_TO decrease_VB the_DT number_NN of_IN polio_NN cases_NNS globally_RB ,_, but_CC unlike_IN the_DT Salk_NNP vaccine_NN —_: which_WDT carries_VBZ no_DT risk_NN of_IN paralysis_NN —_: the_DT OPV_NN carries_VBZ an_DT extremely_RB small_JJ risk_NN of_IN causing_VBG paralysis_NN ._. Today_NN ,_, the_DT WHO_NNP estimates_VBZ that_IN about_RB 1_CD in_IN 2.7_CD million_CD doses_NNS of_IN OPV_NN result_NN in_IN paralytic_NN polio_NN ._. Since_IN 2000_CD ,_, Salk_NNP 's_POS inactivated_VBN polio_NN vaccine_NN is_VBZ the_DT only_JJ version_NN administered_VBN in_IN the_DT U.S._NNP ,_, in_IN order_NN to_TO avoid_VB any_DT risk_NN of_IN vaccine_NN -_HYPH induced_VBN polio_NN associated_VBN with_IN OPV_NN ._. The_DT OPV_NN is_VBZ still_RB administered_VBN in_IN many_JJ parts_NNS of_IN the_DT world_NN ,_, but_CC the_DT WHO_NNP 's_POS Global_NNP Polio_NNP Eradication_NNP Initiative_NNP aims_VBZ to_TO cease_VB the_DT administration_NN of_IN OPV_NN altogether_RB once_IN wild_JJ (_-LRB- non_AFX vaccine_NN -_HYPH related_JJ )_-RRB- polio_NN is_VBZ completely_RB eradicated_VBN ._. The_DT CDC_NNP now_RB recommends_VBZ children_NNS receive_VB four_CD doses_NNS of_IN IPV_NN ,_, one_CD each_DT at_IN ages_NNS 2_CD months_NNS ,_, 4_CD months_NNS ,_, between_IN 6_CD and_CC 18_CD months_NNS ,_, and_CC between_IN 4_CD and_CC 6_CD years_NNS ._. Thanks_NN to_IN widespread_JJ use_NN of_IN the_DT polio_NN vaccine_NN ,_, the_DT U.S._NNP has_VBZ been_VBN polio_NN -_HYPH free_JJ since_IN 1979_CD ._. Globally_RB ,_, cases_NNS of_IN polio_NN due_IN to_IN wild_JJ poliovirus_NN have_VBP decreased_VBN by_IN 99_CD %_NN since_IN 1988_CD ,_, according_VBG to_IN the_DT WHO_NNP ,_, from_IN an_DT estimated_VBN 350,000_CD cases_NNS per_IN year_NN to_IN just_RB 33_CD new_JJ cases_NNS in_IN 2018_CD ._. •_NFP Find_VB a_DT timeline_NN of_IN polio_NN vaccine_NN development_NN from_IN The_DT History_NNP of_IN Vaccines_NNPS ,_, created_VBN by_IN The_DT College_NNP of_IN Physicians_NNPS of_IN Philadelphia_NNP ._. •_NFP Listen_VB to_IN Stanley_NNP Plotkin_NNP ,_, a_DT researcher_NN who_WP worked_VBD on_IN the_DT development_NN of_IN the_DT polio_NN vaccine_NN ,_, discuss_VB the_DT merits_NNS of_IN OPV_NN and_CC IPV_NNP ,_, from_IN The_DT History_NNP of_IN Vaccines_NNPS ._. •_SYM Watch_VB a_DT 1991_CD interview_NN with_IN Jonas_NNP Salk_NNP from_IN the_DT American_NNP Academy_NNP of_IN Achievement_NNP ._.","In the JJ NNS , two JJ JJ NNS each VBD a NN to VB the NN from NN , the NN - VBG NN RB VBN as NN . The NNS VBN by NNP NNP NNP and NNP NNP NNP VBD in the JJ - JJ NN of NN . RB VBZ how they VBD it . NNP VBZ a NN VBN by three NNS of the NN , VBG to a 2012 NN VBN by NN and NN NN NNP NNP and VBN in the NNP NNP of NNP . The NN , which RB VBZ NNS , can VB the NNS that VBP NN , VBG in JJ or JJ NN . A NN can VB VBN with the NN by VBG VBN NN or NN , or by VBG VBN NNS ( JJ as JJ NNS ) to VB or VB the NN , VBG to the NNPS for NNP NNP and NNP ( NNP ) . NNS of JJ NNS VBP that NN VBD NNS at JJS RB RB as JJ NNS , but the NNP VBD RB VB its JJ NN NN until the JJ NNS . In the NNP in 1916 , JJR than 27,000 NNS VBD VBN by the NN and at JJS 6,000 NNS VBD from it , VBG to NNP . For the JJ JJ NNS , the NN VBD throughout the NNP and NNP . In 1952 RB , there VBD 58,000 JJ NNS of NN and 3,000 NNS from the NN in the NNP . As JJ NNS VBD to VB the NN , they VBD that it could VB NNS without VBG NNS . In a 1947 NN VBN in the NNP NNP of NNP , NNS VBD that the NN of NN in NNP NNP NNP NN NN VBD that there VBD an VBN 100 JJ NNS of NN for every JJ , or NN , NN of the NN at the NN . NN , RBR JJ NN VBZ that 72 out of 100 NNS who VBP VBN with the NN will RB VB NNS , and RB 1 in 4 VBN NNS will VB RB NN - JJ NNS that VBP between 2 and 5 NNS before VBG RB on their JJ , VBG to the NNP . In the JJ NNS , NNS VBD that VBN NNS VBD the NN in NNS for JJ NNS , whether or RB they VBD NNS of the NN . NNS VBP RB VBN that VBN , but JJ , NNS can RB VB the NN and VB NNS JJ . NNS who VBP VBN JJ can VB the NN RB before they VBP NNS and for up to 2 NNS after their NNS VBP , VBG to the NNP . NNS VBD VBG on a NN NN in the NNS , but JJ NNS VBD JJ . An JJ NN VBD RB VB RB until 1953 , when NNP NNP VBD his VBN NN NN ( NNP ) . NNP VBD VBN NNS as a NN at NNP NNP NNP in the NNS and VBD VB NN NNS during NNP NNP II , VBG to NNP . In 1948 , he VBD VBN a NN NN from NNP NNP NNP NNP 's NNP NNP for NNP NNP , RBR VBN NNP of NNP . NNP VBD VBN NN in 1921 at NN 39 , and the NN VBD him with both NNS RB VBN . In 1938 , five NNS into his NN , NNP VBD to VB the NNP NNP for NNP NNP to VB NN and VB NN to NNS VBG NN NNS . NN to the NN of NNS before him , NNP VBD JJ to VB NN in NN NN NNS . He RB VBD the NN and VBD it with NN , an JJ NN of NN and NN that VBZ RB VBN as a NN and NN NN . A JJ NN VBD VBN VBN NNS JJ , in 1935 , by JJ NN NNP NNP , in which he VBD NN from JJ NN JJ NN NN and RB VBD the NN in a 10 NN JJ NN , NN NN NNP VBD . NNP VBD his NN on 20 NNS and RB on 300 NNS , but the NNS VBD JJ and NNP VBD RB VB any RBR . NNP 's NN VBD JJ because RB of VBG a VBN NN of the JJ NN , JJ as what VBZ VBN for NNS and NNS , NNP 's NN VBD a "" VBN , "" or VBN , NN of the NN . When the "" JJ "" NN VBZ VBN into the NN , it can't VB an NN because the NN VBZ JJ ; but the NN NN can't VB an VBN NN from an VBN NN , and it VBZ NNS to VB the NN . Those NNS VBP and VBP the NN from JJ NN NN . In 1953 , NNP VBD VBG his VBN NN NN ( NNP ) on a JJ NN of JJ NN NNS in the NNP NN and on himself , his NN and their three NNS . The JJ NNS VBD JJ , and he VBD his NN on the NNP JJ NN NN on NNP 25 , 1953 , VBG to NNP . He VBD an JJ NN . The JJ JJ - NN JJ NN of NNP 's NN VBD in 1954 and VBD JJR than 1 million NNS . It VBD the JJ NN NN to VB a JJ - JJ , NN - VBN NN — RB a JJ NN in the JJ NN of NN NN , VBG to NNP NNP NNP 's 1999 NN VBN in the NN NNP NNPS . The NN VBG the NN NN , NNP NNP NNP , NNP from the NNP of NNP , VBD the JJ NNS at a NN NN on NNP 12 , 1955 . RBR that JJ NN , the NNP NN VBD NNP 's NN JJ and JJ for NN , VBG to The NNP of NNPS of NNP 's NNP of NNPS . JJ : 20 of the JJS NNS and NNS in NN After the NN NN , NNP NN NNP NNP NNP VBD NNP who VBD the NN . "" Well the NNS , I would VB , "" NNP RB VBD . "" There VBZ no NN . Can you VB the NN ? "" NNP RB VBD his NN . RB a JJ NNS RBR , NNS VBD NN of NNS VBG NN after VBG the NN . JJR than 250 JJ NN NNS VBD VBN RB to NNS of the NN VBN by NNP NNP , VBG to the NNP . The NNS VBD VBN JJ , JJ NNS of NN . The NNP NNP NNP VBD all NN NN NN until all NNS could VB VBN and VBN for NN . At the NN , there VBD VBN JJ NN NN over NN NNS , but that RB VBD after what VBZ RB VBN as the NNP NNP . Since RB , RB a JJ NN of NN VBZ RB VBN VBN to the NNP NN . While NNP VBD VBG his VBN NN NN , his JJ NN , NN NNP NNP NNP at the NNP of NNP , VBD VBG on a NN VBN with JJ , but VBN , NN . NNP VBD NNP 's NN NN and VBD an VBN NN NN to VB JJ . By 1963 , NNP VBD VBN an JJ JJ - NN NN for all three NNS of NN that VBD VBN for NN by the NNP NN . NNP 's NN VBD JJR and JJR to VB than the NNP NN , and it RB VBD the NNP NN in the NNP In 1972 , NNP VBD his NN NNS to the NNP NNP NNP ( NNP ) , which RB VBD the NN 's NN in JJ - NN NNS . NNP 's JJ NN NN ( NNP ) VBD JJ for VBG to VB the NN of NN NNS RB , but unlike the NNP NN — which VBZ no NN of NN — the NN VBZ an RB JJ NN of VBG NN . NN , the NNP VBZ that RB 1 in 2.7 million NNS of NN NN in NN NN . Since 2000 , NNP 's VBN NN NN VBZ the JJ NN VBN in the NNP , in NN to VB any NN of NN - VBN NN VBN with NN . The NN VBZ RB VBN in JJ NNS of the NN , but the NNP 's NNP NNP NNP NNP VBZ to VB the NN of NN RB once JJ ( non NN - JJ ) NN VBZ RB VBN . The NNP RB VBZ NNS VB four NNS of NN , one each at NNS 2 NNS , 4 NNS , between 6 and 18 NNS , and between 4 and 6 NNS . NN to JJ NN of the NN NN , the NNP VBZ VBN NN - JJ since 1979 . RB , NNS of NN due to JJ NN VBP VBN by 99 NN since 1988 , VBG to the NNP , from an VBN 350,000 NNS per NN to RB 33 JJ NNS in 2018 . • VB a NN of NN NN NN from The NNP of NNPS , VBN by The NNP of NNPS of NNP . • VB to NNP NNP , a NN who VBD on the NN of the NN NN , VB the NNS of NN and NNP , from The NNP of NNPS . • VB a 1991 NN with NNP NNP from the NNP NNP of NNP ."
138,39,mainstream,"What_WP Are_VBP Diphtheria_NNP ,_, Tetanus_NNP ,_, and_CC Pertussis_NNP ?_. The_DT diphtheria_NN ,_, tetanus_NN ,_, and_CC pertussis_NN (_-LRB- DTaP_NN )_-RRB- vaccine_NN protects_VBZ against_IN :_: •_NFP Diphtheria_NN :_: a_DT serious_JJ infection_NN of_IN the_DT throat_NN that_WDT can_MD block_VB the_DT airway_NN and_CC cause_VB severe_JJ breathing_NN problems_NNS •_NFP Tetanus_NN (_-LRB- lockjaw_NN )_-RRB- :_: a_DT nerve_NN disease_NN that_WDT can_MD happen_VB at_IN any_DT age_NN ,_, caused_VBN by_IN toxin_NN -_HYPH producing_VBG bacteria_NN contaminating_VBG a_DT wound_NN •_SYM Pertussis_NN (_-LRB- whooping_NN cough_NN )_-RRB- :_: a_DT respiratory_JJ illness_NN with_IN cold_JJ -_HYPH like_JJ symptoms_NNS that_WDT lead_VBP to_IN severe_JJ coughing_NN (_-LRB- the_DT ""_`` whooping_NN ""_'' sound_NN happens_VBZ when_WRB a_DT child_NN breathes_VBZ in_RP deeply_RB after_IN a_DT severe_JJ coughing_NN fit_NN )_-RRB- ._. Serious_JJ complications_NNS can_MD affect_VB children_NNS under_IN 1_CD year_NN old_JJ ,_, and_CC those_DT younger_JJR than_IN 6_CD months_NNS old_JJ are_VBP especially_RB at_IN risk_NN ._. Teens_NNS and_CC adults_NNS with_IN a_DT lasting_JJ cough_NN might_MD have_VB pertussis_NN and_CC not_RB realize_VB it_PRP ,_, and_CC could_MD pass_VB it_PRP to_IN vulnerable_JJ infants_NNS ._. DTaP_NNP immunizations_NNS are_VBP given_VBN as_IN a_DT series_NN of_IN 5_CD injections_NNS ,_, usually_RB given_VBN at_IN ages_NNS :_: A_DT vaccine_NN called_VBN Tdap_NNP (_-LRB- the_DT booster_NN shot_NN )_-RRB- should_MD be_VB given_VBN at_IN ages_NNS 11_CD to_IN 12_CD ,_, and_CC to_IN older_JJR teens_NNS and_CC adults_NNS who_WP have_VBP n't_RB yet_RB had_VBN a_DT booster_NN with_IN pertussis_NN coverage_NN ._. (_-LRB- This_DT is_VBZ especially_RB important_JJ for_IN adults_NNS who_WP will_MD be_VB around_IN newborn_NN babies_NNS ,_, such_JJ as_IN grandparents_NNS or_CC other_JJ caregivers_NNS ._. )_-RRB- Then_RB ,_, Td_NNP (_-LRB- tetanus_NN and_CC diphtheria_NN )_-RRB- boosters_NNS are_VBP recommended_VBN every_DT 10_CD years_NNS ._. Pregnant_JJ women_NNS should_MD get_VB the_DT Tdap_NN vaccine_NN in_IN the_DT second_JJ half_NN of_IN each_DT pregnancy_NN ,_, even_RB if_IN they_PRP 've_VBP been_VBN vaccinated_VBN in_IN the_DT past_NN ._. Tdap_NN also_RB can_MD be_VB given_VBN after_IN a_DT deep_JJ cut_NN or_CC severe_JJ burn_NN to_TO prevent_VB tetanus_NN infection_NN ._. Why_WRB Is_VBZ the_DT DTaP_NNP Vaccine_NN Recommended_VBN ?_. Use_NN of_IN the_DT DTaP_NN vaccine_NN has_VBZ virtually_RB eliminated_VBN diphtheria_NN and_CC tetanus_NN in_IN childhood_NN and_CC has_VBZ greatly_RB reduced_VBN the_DT number_NN of_IN pertussis_NN cases_NNS ._. The_DT vaccine_NN can_MD cause_VB mild_JJ side_NN effects_NNS :_: fever_NN ;_, mild_JJ crankiness_NN ;_, tiredness_NN ;_: loss_NN of_IN appetite_NN ;_, and_CC tenderness_NN ,_, redness_NN ,_, or_CC swelling_NN in_IN the_DT area_NN where_WRB the_DT shot_NN was_VBD given_VBN ._. Rarely_RB ,_, a_DT child_NN may_MD have_VB a_DT seizure_NN ,_, a_DT high_JJ fever_NN ,_, or_CC uncontrollable_JJ crying_NN after_IN getting_VBG the_DT vaccine_NN ._. But_CC these_DT sorts_NNS of_IN side_NN effects_NNS are_VBP so_RB rare_JJ that_IN researchers_NNS question_VBP whether_IN they_PRP 're_VBP even_RB caused_VBN by_IN the_DT vaccine_NN ._. Most_JJS kids_NNS have_VBP a_DT few_JJ minor_JJ or_CC no_DT side_NN effects_NNS ._. When_WRB to_TO Delay_VB or_CC Avoid_VB DTaP_NNP Immunization_NN Simple_JJ colds_NNS or_CC other_JJ minor_JJ illnesses_NNS should_MD not_RB prevent_VB immunization_NN ,_, but_CC your_PRP$ doctor_NN might_MD choose_VB to_TO reschedule_VB the_DT vaccine_NN if_IN your_PRP$ child_NN has_VBZ a_DT more_RBR serious_JJ illness_NN ._. Talk_VB to_IN your_PRP$ doctor_NN about_IN whether_IN getting_VBG the_DT vaccine_NN is_VBZ a_DT good_JJ idea_NN if_IN your_PRP$ child_NN had_VBD any_DT of_IN the_DT following_VBG after_IN an_DT earlier_JJR DTaP_NNP shot_NN :_: •_NFP a_DT brain_NN or_CC nervous_JJ -_HYPH system_NN problem_NN ,_, like_IN coma_NN or_CC seizures_NNS •_, severe_JJ pain_NN or_CC swelling_NN of_IN a_DT whole_JJ arm_NN or_CC leg_NN Your_PRP$ doctor_NN might_MD give_VB a_DT partial_JJ vaccine_NN or_CC no_DT vaccine_NN ,_, or_CC may_MD decide_VB that_IN the_DT benefits_NNS of_IN vaccinating_VBG your_PRP$ child_NN outweigh_VBP the_DT potential_JJ risks_NNS ._. Caring_VBG for_IN Your_PRP$ Child_NN After_IN DTaP_NN Immunization_NN Your_PRP$ child_NN may_MD have_VB a_DT fever_NN ,_, soreness_NN ,_, and_CC some_DT swelling_NN and_CC redness_NN in_IN the_DT area_NN where_WRB the_DT shot_NN was_VBD given_VBN ._. For_IN pain_NN and_CC fever_NN ,_, check_VB with_IN your_PRP$ doctor_NN to_TO see_VB if_IN you_PRP can_MD give_VB either_CC acetaminophen_NN or_CC ibuprofen_NN ,_, and_CC to_TO find_VB out_RP the_DT right_JJ dose_NN ._. A_DT warm_JJ ,_, damp_JJ cloth_NN or_CC a_DT heating_NN pad_NN on_IN the_DT injection_NN site_NN may_MD help_VB reduce_VB soreness_NN ,_, as_IN can_MD moving_VBG or_CC using_VBG the_DT arm_NN ._. When_WRB Should_MD I_PRP Call_VB the_DT Doctor_NN ?_. •_NFP Call_VB if_IN you_PRP are_VBP n't_RB sure_JJ whether_IN the_DT vaccine_NN should_MD be_VB postponed_VBN or_CC avoided_VBN ._. Children_NNS who_WP have_VBP had_VBN certain_JJ problems_NNS with_IN the_DT DTaP_NN vaccine_NN usually_RB can_MD safely_RB receive_VB the_DT Td_NN (_-LRB- tetanus_NN and_CC diphtheria_NN )_-RRB- vaccine_NN ._. •_NFP Call_VB if_IN anything_NN concerns_VBZ you_PRP after_IN immunization_NN ._.","What VBP NNP , NNP , and NNP ? The NN , NN , and NN ( NN ) NN VBZ against : • NN : a JJ NN of the NN that can VB the NN and VB JJ NN NNS • NN ( NN ) : a NN NN that can VB at any NN , VBN by NN - VBG NN VBG a NN • NN ( NN NN ) : a JJ NN with JJ - JJ NNS that VBP to JJ NN ( the "" NN "" NN VBZ when a NN VBZ in RB after a JJ NN NN ) . JJ NNS can VB NNS under 1 NN JJ , and those JJR than 6 NNS JJ VBP RB at NN . NNS and NNS with a JJ NN might VB NN and RB VB it , and could VB it to JJ NNS . NNP NNS VBP VBN as a NN of 5 NNS , RB VBN at NNS : A NN VBN NNP ( the NN NN ) should VB VBN at NNS 11 to 12 , and to JJR NNS and NNS who VBP RB RB VBN a NN with NN NN . ( This VBZ RB JJ for NNS who will VB around NN NNS , JJ as NNS or JJ NNS . ) RB , NNP ( NN and NN ) NNS VBP VBN every 10 NNS . JJ NNS should VB the NN NN in the JJ NN of each NN , RB if they VBP VBN VBN in the NN . NN RB can VB VBN after a JJ NN or JJ NN to VB NN NN . Why VBZ the NNP NN VBN ? NN of the NN NN VBZ RB VBN NN and NN in NN and VBZ RB VBN the NN of NN NNS . The NN can VB JJ NN NNS : NN ; JJ NN ; NN ; NN of NN ; and NN , NN , or NN in the NN where the NN VBD VBN . RB , a NN may VB a NN , a JJ NN , or JJ NN after VBG the NN . But these NNS of NN NNS VBP RB JJ that NNS VBP whether they VBP RB VBN by the NN . JJS NNS VBP a JJ JJ or no NN NNS . When to VB or VB NNP NN JJ NNS or JJ JJ NNS should RB VB NN , but your NN might VB to VB the NN if your NN VBZ a RBR JJ NN . VB to your NN about whether VBG the NN VBZ a JJ NN if your NN VBD any of the VBG after an JJR NNP NN : • a NN or JJ - NN NN , like NN or NNS • JJ NN or NN of a JJ NN or NN Your NN might VB a JJ NN or no NN , or may VB that the NNS of VBG your NN VBP the JJ NNS . VBG for Your NN After NN NN Your NN may VB a NN , NN , and some NN and NN in the NN where the NN VBD VBN . For NN and NN , VB with your NN to VB if you can VB either NN or NN , and to VB out the JJ NN . A JJ , JJ NN or a NN NN on the NN NN may VB VB NN , as can VBG or VBG the NN . When Should I VB the NN ? • VB if you VBP RB JJ whether the NN should VB VBN or VBN . NNS who VBP VBN JJ NNS with the NN NN RB can RB VB the NN ( NN and NN ) NN . • VB if NN VBZ you after NN ."
139,698,mainstream,"In_IN light_NN of_IN President_NNP Obama_NNP ’s_POS declaration_NN that_IN the_DT outbreak_NN of_IN the_DT H1N1_NNP virus_NN is_VBZ a_DT national_JJ emergency_NN ,_, Surprising_NNP Science_NNP is_VBZ setting_VBG this_DT week_NN aside_RB to_TO discuss_VB the_DT history_NN and_CC science_NN of_IN vaccines_NNS and_CC their_PRP$ importance_NN in_IN battling_VBG diseases_NNS ,_, including_VBG swine_NN flu_NN ._. See_VB Monday_NNP ’s_POS post_NN for_IN part_NN 1_CD ,_, A_DT Brief_JJ History_NN and_CC How_WRB Vaccines_NNS Work_NN ,_, and_CC yesterday_NN for_IN part_NN 2_CD ,_, Success_NN Stories_NNS ._. It_PRP ’s_VBZ kind_NN of_IN startling_JJ that_IN the_DT idea_NN of_IN vaccines_NNS ever_RB caught_VBD on_RP ._. There_EX is_VBZ an_DT amazing_JJ amount_NN of_IN trust_NN needed_VBN :_: A_DT person_NN —_: often_RB a_DT complete_JJ stranger_NN —_: is_VBZ injecting_VBG you_PRP with_IN a_DT foreign_JJ substance_NN ._. You_PRP have_VBP to_TO trust_VB that_IN the_DT substance_NN is_VBZ really_RB what_WP you_PRP ’ve_VBP been_VBN told_VBN it_PRP is_VBZ ,_, that_IN it_PRP has_VBZ been_VBN sufficiently_RB tested_VBN and_CC is_VBZ safe_JJ ,_, and_CC that_IN it_PRP will_MD work_VB as_IN advertised_VBN and_CC not_RB hurt_VB you_PRP ._. Despite_IN this_DT ,_, most_JJS people_NNS trust_VBP the_DT doctors_NNS ,_, science_NN and_CC government_NN and_CC do_VBP get_VB vaccinated_VBN ._. A_DT small_JJ percentage_NN ,_, however_RB ,_, choose_VBP not_RB to_TO be_VB vaccinated_VBN (_-LRB- or_CC not_RB to_TO have_VB their_PRP$ children_NNS vaccinated_VBN )_-RRB- ._. And_CC it_PRP ’s_VBZ been_VBN this_DT way_NN almost_RB since_IN Edward_NNP Jenner_NNP first_RB began_VBD vaccinating_VBG people_NNS against_IN smallpox_NN (_-LRB- see_VB the_DT illustration_NN )_-RRB- ._. Decades_NNS after_IN Jenner_NNP ’s_POS discovery_NN ,_, the_DT British_JJ government_NN got_VBD involved_VBN in_IN vaccination_NN by_IN passing_VBG a_DT law_NN in_IN 1840_CD that_WDT provided_VBD free_JJ smallpox_NN vaccinations_NNS to_IN the_DT poor_NN ._. But_CC later_JJR efforts_NNS did_VBD n’t_RB go_VB over_RB so_RB well_RB ._. A_DT 1853_CD law_NN required_VBD all_DT infants_NNS be_VB vaccinated_VBN in_IN the_DT first_JJ three_CD months_NNS of_IN life_NN and_CC threatened_VBD parents_NNS who_WP did_VBD not_RB vaccinate_VB their_PRP$ children_NNS with_IN a_DT fine_NN or_CC imprisonment_NN ._. Riots_NNS soon_RB broke_VBD out_RP in_IN several_JJ towns_NNS ._. In_IN London_NNP ,_, an_DT Anti-Vaccination_NNP League_NNP was_VBD founded_VBN ._. In_IN 1867_CD ,_, after_IN the_DT law_NN was_VBD extended_VBN to_IN children_NNS up_IN to_IN age_NN 14_CD ,_, the_DT Anti-Compulsory_NNP Vaccination_NNP League_NNP was_VBD founded_VBN ._. Opposition_NN now_RB focused_VBD on_IN the_DT law_NN ’s_POS threat_NN to_IN personal_JJ liberty_NN ._. (_-LRB- “_`` As_IN parliament_NN ,_, instead_RB of_IN guarding_VBG the_DT liberty_NN of_IN the_DT subject_NN ,_, has_VBZ invaded_VBN this_DT liberty_NN by_IN rendering_VBG good_JJ health_NN a_DT crime_NN …_, parliament_NN is_VBZ deserving_VBG of_IN public_JJ condemnation_NN ._. ”_'' )_-RRB- In_IN the_DT late_JJ 19th_JJ century_NN ,_, anti-vaccination_NN movements_NNS spread_VBD across_IN Europe_NNP and_CC into_IN the_DT United_NNP States_NNPS ,_, where_WRB they_PRP succeeded_VBD in_IN repealing_VBG compulsory_JJ vaccination_NN laws_NNS in_IN several_JJ western_JJ and_CC Midwest_NNP states_NNS ._. But_CC despite_IN the_DT controversy_NN ,_, protests_NNS and_CC pamphlets_NNS ,_, the_DT doctors_NNS ,_, science_NN and_CC governments_NNS eradicated_VBD smallpox_NN from_IN the_DT United_NNP States_NNPS by_IN 1950_CD and_CC from_IN the_DT entire_JJ world_NN by_IN 1980_CD ._. Along_IN the_DT way_NN ,_, though_RB ,_, anti-vaccination_NN sentiments_NNS have_VBP resulted_VBN in_IN serious_JJ harm_NN ._. For_IN example_NN ,_, when_WRB the_DT majority_NN of_IN the_DT residents_NNS of_IN Stockholm_NNP ,_, Sweden_NNP refused_VBD vaccination_NN for_IN smallpox_NN in_IN the_DT early_JJ 1870s_NNS ,_, they_PRP were_VBD left_VBN vulnerable_JJ to_IN the_DT disease_NN ._. The_DT city_NN experienced_VBD a_DT major_JJ epidemic_NN in_IN 1874_CD ,_, after_IN which_WDT vaccination_NN was_VBD again_RB popular_JJ ._. Efforts_NNS to_TO eradicate_VB polio_NN —_: a_DT disease_NN now_RB confined_VBN to_IN just_RB a_DT few_JJ countries_NNS —_: came_VBD off_IN track_NN in_IN Nigeria_NNP due_IN to_IN a_DT 2004_CD rumor_NN that_IN the_DT vaccine_NN “_'' contained_VBD birth_NN control_NN drugs_NNS as_IN part_NN of_IN a_DT secret_JJ western_JJ plot_NN to_TO reduce_VB population_NN growth_NN in_IN the_DT Muslim_JJ world_NN ._. ”_'' Polio_NNP is_VBZ on_IN the_DT rise_NN again_RB in_IN Nigeria_NNP ,_, and_CC more_JJR than_IN 100_CD children_NNS have_VBP been_VBN left_VBN paralyzed_VBN by_IN the_DT disease_NN this_DT year_NN ._. And_CC in_IN places_NNS like_IN Europe_NNP ,_, Australia_NNP and_CC the_DT United_NNP States_NNPS ,_, in_IN communities_NNS where_WRB parents_NNS have_VBP stopped_VBN vaccinating_VBG their_PRP$ children_NNS for_IN fear_NN that_IN common_JJ childhood_NN immunization_NN causes_VBZ autism_NN (_-LRB- a_DT fear_NN that_WDT is_VBZ completely_RB unfounded_JJ )_-RRB- ,_, diseases_NNS that_WDT had_VBD become_VBN rare_JJ —_: like_IN measles_NNS and_CC pertussis_NN —_: are_VBP making_VBG a_DT comeback_NN ,_, as_IN Wired_JJ magazine_NN notes_VBZ in_IN their_PRP$ November_NNP issue_NN :_: The_DT anti-vaccination_NN movement_NN ebbs_VBZ and_CC flows_VBZ over_IN time_NN ,_, with_IN fear_NN of_IN disease_NN fighting_VBG mistrust_NN of_IN doctors_NNS ,_, science_NN and_CC government_NN ._. Which_WDT will_MD win_VB ?_. If_IN history_NN is_VBZ any_DT guide_NN :_: neither_CC ._. But_CC doctors_NNS ,_, science_NN and_CC government_NN will_MD all_RB need_VB to_TO work_VB together_RB to_TO find_VB a_DT way_NN to_TO protect_VB public_JJ health_NN ._. And_CC then_RB ,_, perhaps_RB ,_, they_PRP will_MD find_VB more_JJR vaccine_NN success_NN stories_NNS along_IN the_DT way_NN ._.","In NN of NNP NNP ’s NN that the NN of the NNP NN VBZ a JJ NN , NNP NNP VBZ VBG this NN RB to VB the NN and NN of NNS and their NN in VBG NNS , VBG NN NN . VB NNP ’s NN for NN 1 , A JJ NN and How NNS NN , and NN for NN 2 , NN NNS . It VBZ NN of JJ that the NN of NNS RB VBD on . There VBZ an JJ NN of NN VBN : A NN — RB a JJ NN — VBZ VBG you with a JJ NN . You VBP to VB that the NN VBZ RB what you VBP VBN VBN it VBZ , that it VBZ VBN RB VBN and VBZ JJ , and that it will VB as VBN and RB VB you . Despite this , JJS NNS VBP the NNS , NN and NN and VBP VB VBN . A JJ NN , RB , VBP RB to VB VBN ( or RB to VB their NNS VBN ) . And it VBZ VBN this NN RB since NNP NNP RB VBD VBG NNS against NN ( VB the NN ) . NNS after NNP ’s NN , the JJ NN VBD VBN in NN by VBG a NN in 1840 that VBD JJ NN NNS to the NN . But JJR NNS VBD RB VB RB RB RB . A 1853 NN VBD all NNS VB VBN in the JJ three NNS of NN and VBD NNS who VBD RB VB their NNS with a NN or NN . NNS RB VBD out in JJ NNS . In NNP , an NNP NNP VBD VBN . In 1867 , after the NN VBD VBN to NNS up to NN 14 , the NNP NNP NNP VBD VBN . NN RB VBD on the NN ’s NN to JJ NN . ( “ As NN , RB of VBG the NN of the NN , VBZ VBN this NN by VBG JJ NN a NN … NN VBZ VBG of JJ NN . ” ) In the JJ JJ NN , NN NNS VBD across NNP and into the NNP NNPS , where they VBD in VBG JJ NN NNS in JJ JJ and NNP NNS . But despite the NN , NNS and NNS , the NNS , NN and NNS VBD NN from the NNP NNPS by 1950 and from the JJ NN by 1980 . Along the NN , RB , NN NNS VBP VBN in JJ NN . For NN , when the NN of the NNS of NNP , NNP VBD NN for NN in the JJ NNS , they VBD VBN JJ to the NN . The NN VBD a JJ NN in 1874 , after which NN VBD RB JJ . NNS to VB NN — a NN RB VBN to RB a JJ NNS — VBD off NN in NNP due to a 2004 NN that the NN “ VBD NN NN NNS as NN of a JJ JJ NN to VB NN NN in the JJ NN . ” NNP VBZ on the NN RB in NNP , and JJR than 100 NNS VBP VBN VBN VBN by the NN this NN . And in NNS like NNP , NNP and the NNP NNPS , in NNS where NNS VBP VBN VBG their NNS for NN that JJ NN NN VBZ NN ( a NN that VBZ RB JJ ) , NNS that VBD VBN JJ — like NNS and NN — VBP VBG a NN , as JJ NN VBZ in their NNP NN : The NN NN VBZ and VBZ over NN , with NN of NN VBG NN of NNS , NN and NN . Which will VB ? If NN VBZ any NN : neither . But NNS , NN and NN will RB VB to VB RB to VB a NN to VB JJ NN . And RB , RB , they will VB JJR NN NN NNS along the NN ."
140,1087,conspiracy,"It_PRP is_VBZ a_DT common_JJ myth_NN today_NN that_IN the_DT vaccines_NNS administered_VBN to_IN children_NNS no_RB longer_RBR contain_VBP the_DT toxic_JJ additive_NN thimerosal_NN ,_, a_DT mercury_NN -_HYPH based_VBN preservative_NN linked_VBN to_IN causing_VBG permanent_JJ neurological_JJ damage_NN ._. But_CC a_DT recent_JJ federal_JJ case_NN involving_VBG the_DT U.S.Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- has_VBZ revealed_VBN that_IN ,_, contrary_JJ to_IN this_DT widely_RB -_HYPH held_VBN belief_NN ,_, thimerosal_NN is_VBZ actually_RB still_RB present_JJ in_IN many_JJ batch_NN vaccines_NNS ,_, including_VBG in_IN the_DT annual_JJ influenza_NN vaccine_NN that_WDT is_VBZ now_RB administered_VBN to_IN children_NNS as_RB young_JJ as_IN six_CD months_NNS old_JJ ._. Filed_VBN by_IN a_DT citizen_NN -_HYPH backed_VBN coalition_NN advocating_VBG vaccine_NN safety_NN ,_, the_DT lawsuit_NN against_IN the_DT FDA_NNP alleged_VBD that_IN the_DT agency_NN ’s_POS continued_VBN endorsement_NN and_CC approval_NN of_IN thimerosal_NN as_IN a_DT vaccine_NN additive_NN is_VBZ a_DT serious_JJ public_JJ health_NN threat_NN ,_, especially_RB since_IN safer_JJR alternatives_NNS already_RB exist_VBP and_CC are_VBP widely_RB used_VBN voluntarily_RB by_IN many_JJ vaccine_NN manufacturers_NNS ._. But_CC Judge_NNP Brett_NNP Kavanaugh_NNP ,_, siding_VBG with_IN antiquated_JJ pseudoscience_NN ,_, decided_VBD that_IN thimerosal_NN is_VBZ not_RB a_DT health_NN threat_NN ,_, and_CC that_IN those_DT who_WP wish_VBP to_TO avoid_VB it_PRP can_MD simply_RB choose_VB thimerosal_NN -_HYPH free_JJ alternatives_NNS ._. Ignoring_VBG the_DT evidence_NN of_IN thimerosal_NN ’s_POS dangers_NNS brought_VBN before_IN him_PRP on_IN behalf_NN of_IN the_DT millions_NNS of_IN children_NNS across_IN the_DT country_NN who_WP continue_VBP to_TO be_VB injected_VBN with_IN this_DT mercury_NN -_HYPH based_VBN additive_NN ,_, Judge_NNP Kavanaugh_NNP declared_VBD that_IN the_DT plaintiffs_NNS ,_, which_WDT include_VBP groups_NNS like_IN theCoalition_NNP for_IN Mercury_NNP -_HYPH Free_NNP Drugs_NNPS (_-LRB- CMFD_NNP )_-RRB- ,_, did_VBD not_RB have_VB proper_JJ standing_NN to_TO file_VB the_DT lawsuit_NN ._. And_CC in_IN the_DT process_NN ,_, both_CC he_PRP and_CC the_DT FDA_NNP inadvertently_RB admitted_VBD that_IN thimerosal_NN is_VBZ still_RB present_JJ in_IN many_JJ childhood_NN vaccines_NNS ,_, which_WDT counters_VBZ popular_JJ claims_NNS to_IN the_DT contrary_NN ._. FDA_NNP admits_VBZ on_IN its_PRP$ website_NN that_IN thimerosal_NN is_VBZ still_RB in_IN vaccines_NNS The_DT fact_NN that_IN Judge_NNP Kavanaugh_NNP refused_VBD to_TO hear_VB the_DT case_NN is_VBZ tragic_JJ in_IN and_CC of_IN itself_PRP ,_, as_IN thimerosal_NN ,_, which_WDT is_VBZ composed_VBN of_IN 50_CD percent_NN mercury_NN ,_, has_VBZ been_VBN proven_VBN to_TO cause_VB serious_JJ health_NN damage_NN ._. But_CC what_WP may_MD be_VB even_RB worse_JJR is_VBZ the_DT fact_NN that_IN many_JJ people_NNS falsely_RB believe_VBP that_IN thimerosal_NN is_VBZ not_RB even_RB included_VBN in_IN vaccines_NNS anymore_RB ,_, which_WDT is_VBZ leading_VBG them_PRP to_TO blindly_RB allow_VB them_PRP to_TO be_VB administered_VBN to_IN their_PRP$ children_NNS ._. And_CC the_DT U.S.Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- and_CC the_DT FDA_NNP have_VBP continued_VBN to_TO provide_VB dubious_JJ and_CC misleading_JJ information_NN on_IN the_DT subject_NN ,_, which_WDT the_DT mainstream_JJ media_NN has_VBZ been_VBN complicit_JJ in_IN spreading_VBG over_IN the_DT years_NNS ._. But_CC the_DT FDA_NNP explains_VBZ ,_, in_IN no_DT uncertain_JJ terms_NNS ,_, directly_RB on_IN its_PRP$ website_NN that_IN thimerosal_NN is_VBZ still_RB added_VBN to_IN certain_JJ vaccines_NNS ._. For_IN this_DT reason_NN alone_RB ,_, it_PRP is_VBZ crucial_JJ that_IN parents_NNS who_WP choose_VBP to_TO vaccinate_VB their_PRP$ children_NNS ask_VB for_IN an_DT ingredients_NNS list_NN for_IN each_DT and_CC every_DT vaccine_NN before_IN allowing_VBG them_PRP to_TO be_VB administered_VBN to_IN their_PRP$ children_NNS ._. “_`` While_IN the_DT use_NN of_IN mercury_NN -_HYPH containing_VBG preservatives_NNS has_VBZ declined_VBN in_IN recent_JJ years_NNS with_IN the_DT development_NN of_IN new_JJ products_NNS formulated_VBN with_IN alternative_JJ or_CC no_DT preservatives_NNS ,_, thimerosal_NN has_VBZ been_VBN used_VBN in_IN some_DT immune_JJ globulin_NN preparations_NNS ,_, anti-venins_NNS ,_, skin_NN test_NN antigens_NNS ,_, and_CC ophthalmic_JJ and_CC nasal_JJ products_NNS ,_, in_IN addition_NN to_IN certain_JJ vaccines_NNS ,_, ”_'' writes_VBZ the_DT FDA_NNP on_IN its_PRP$ Thimerosal_NNP in_IN Vaccinespage_NNP (_-LRB- http://www.fda.gov)._ADD Do_VB n’t_RB believe_VB the_DT lie_NN :_: Thimerosal_NNP is_VBZ eventually_RB converted_VBN by_IN the_DT body_NN into_IN highly_RB -_HYPH toxic_JJ inorganic_JJ mercury_NN Another_DT myth_NN often_RB spread_VBN by_IN thimerosal_NN advocates_NNS claims_VBZ that_IN the_DT ethylmercury_JJ compounds_NNS that_WDT compose_VBP roughly_RB 50_CD percent_NN of_IN the_DT preservative_NN are_VBP not_RB actually_RB harmful_JJ because_IN they_PRP are_VBP different_JJ from_IN the_DT type_NN found_VBN in_IN a_DT can_NN of_IN tuna_NN ._. But_CC a_DT comprehensive_JJ review_NN conducted_VBN by_IN Dr._NNP Paul_NNP G._NNP King_NNP has_VBZ proven_VBN otherwise_RB ,_, showing_VBG that_IN ethylmercury_NN is_VBZ first_RB metabolized_VBN by_IN the_DT body_NN into_IN toxic_JJ methylmercury_NN ,_, which_WDT is_VBZ then_RB metabolized_VBN into_IN inorganic_JJ mercury_NN ._. Both_CC methylmercury_NN and_CC inorganic_JJ mercury_NN are_VBP listed_VBN by_IN the_DT U.S.Environmental_NNP Protection_NNP Agency_NNP (_-LRB- EPA_NNP )_-RRB- as_IN toxic_JJ substances_NNS responsible_JJ for_IN causing_VBG neurological_JJ problems_NNS ,_, brain_NN disorders_NNS ,_, nervous_JJ system_NN illnesses_NNS ,_, gastrointestinal_JJ problems_NNS ,_, kidney_NN failure_NN ,_, respiratory_JJ illness_NN ,_, and_CC death_NN ._.","It VBZ a JJ NN NN that the NNS VBN to NNS RB RBR VBP the JJ NN NN , a NN - VBN NN VBN to VBG JJ JJ NN . But a JJ JJ NN VBG the NNP and NNP NNP ( NNP ) VBZ VBN that , JJ to this RB - VBN NN , NN VBZ RB RB JJ in JJ NN NNS , VBG in the JJ NN NN that VBZ RB VBN to NNS RB JJ as six NNS JJ . VBN by a NN - VBN NN VBG NN NN , the NN against the NNP VBD that the NN ’s VBN NN and NN of NN as a NN NN VBZ a JJ JJ NN NN , RB since JJR NNS RB VBP and VBP RB VBN RB by JJ NN NNS . But NNP NNP NNP , VBG with JJ NN , VBD that NN VBZ RB a NN NN , and that those who VBP to VB it can RB VB NN - JJ NNS . VBG the NN of NN ’s NNS VBN before him on NN of the NNS of NNS across the NN who VBP to VB VBN with this NN - VBN NN , NNP NNP VBD that the NNS , which VBP NNS like NNP for NNP - NNP NNPS ( NNP ) , VBD RB VB JJ NN to VB the NN . And in the NN , both he and the NNP RB VBD that NN VBZ RB JJ in JJ NN NNS , which VBZ JJ NNS to the NN . NNP VBZ on its NN that NN VBZ RB in NNS The NN that NNP NNP VBD to VB the NN VBZ JJ in and of itself , as NN , which VBZ VBN of 50 NN NN , VBZ VBN VBN to VB JJ NN NN . But what may VB RB JJR VBZ the NN that JJ NNS RB VBP that NN VBZ RB RB VBN in NNS RB , which VBZ VBG them to RB VB them to VB VBN to their NNS . And the NNPS for NNP NNP and NNP ( NNP ) and the NNP VBP VBN to VB JJ and JJ NN on the NN , which the JJ NN VBZ VBN JJ in VBG over the NNS . But the NNP VBZ , in no JJ NNS , RB on its NN that NN VBZ RB VBN to JJ NNS . For this NN RB , it VBZ JJ that NNS who VBP to VB their NNS VB for an NNS NN for each and every NN before VBG them to VB VBN to their NNS . “ While the NN of NN - VBG NNS VBZ VBN in JJ NNS with the NN of JJ NNS VBN with JJ or no NNS , NN VBZ VBN VBN in some JJ NN NNS , NNS , NN NN NNS , and JJ and JJ NNS , in NN to JJ NNS , ” VBZ the NNP on its NNP in NNP ( http://www.fda.gov). VB RB VB the NN : NNP VBZ RB VBN by the NN into RB - JJ JJ NN Another NN RB VBN by NN NNS VBZ that the JJ NNS that VBP RB 50 NN of the NN VBP RB RB JJ because they VBP JJ from the NN VBN in a NN of NN . But a JJ NN VBN by NNP NNP NNP NNP VBZ VBN RB , VBG that NN VBZ RB VBN by the NN into JJ NN , which VBZ RB VBN into JJ NN . Both NN and JJ NN VBP VBN by the NNP NNP NNP ( NNP ) as JJ NNS JJ for VBG JJ NNS , NN NNS , JJ NN NNS , JJ NNS , NN NN , JJ NN , and NN ."
141,226,mainstream,"SCIENTISTS_NNPS racing_VBG to_TO find_VB a_DT coronavirus_NN vaccine_NN will_MD infect_VB volunteers_NNS with_IN a_DT strain_NN of_IN the_DT deadly_JJ bug_NN -_, for_IN £_$ 3,500_CD ._. Up_IN to_IN 24_CD people_NNS at_IN a_DT time_NN will_MD be_VB paid_VBN to_TO be_VB infected_VBN with_IN a_DT less_RBR harmful_JJ form_NN of_IN Covid_NNP -_HYPH 19_CD at_IN a_DT lab_NN in_IN east_NNP London_NNP ,_, as_IN part_NN of_IN a_DT global_JJ experiment_NN ._. ⚠️_NFP Read_VB our_PRP$ coronavirus_NN live_JJ blog_NN for_IN the_DT latest_JJS news_NN &_CC updates_NNS The_DT participants_NNS will_MD be_VB regularly_RB monitored_VBN by_IN doctors_NNS in_IN protective_JJ gear_NN while_IN in_IN quarantine_NN for_IN 14_CD days_NNS ._. Experts_NNS hope_VBP it_PRP will_MD help_VB them_PRP develop_VB a_DT vaccine_NN that_WDT could_MD be_VB used_VBN next_JJ winter_NN to_TO protect_VB the_DT elderly_NN and_CC those_DT with_IN underlying_JJ health_NN conditions_NNS ._. Testing_NN will_MD begin_VB once_IN Hvivo_NNP ,_, the_DT company_NN that_WDT runs_VBZ the_DT quarantine_NN unit_NN at_IN the_DT Queen_NNP Mary_NNP BioEnterprises_NNP Innovation_NNP Centre_NNP in_IN Whitechapel_NNP ,_, has_VBZ secured_VBN permission_NN from_IN the_DT UK's_NNP Medicines_NNPS and_CC Healthcare_NNP products_NNS Regulatory_NNP Agency_NNP (_-LRB- MHRA_NNP )_-RRB- ._. Scientists_NNS will_MD infect_VB participants_NNS with_IN two_CD common_JJ strains_NNS of_IN coronavirus_NN -_HYPH 0C43_CD and_CC 229E_CD -_, which_WDT cause_VBP mild_JJ respiratory_JJ illness_NN ._. Professor_NNP John_NNP Oxford_NNP ,_, an_DT expert_NN in_IN virology_NN at_IN the_DT Queen_NNP Mary_NNP University_NNP of_IN London_NNP ,_, said_VBD volunteers_NNS would_MD feel_VB the_DT symptoms_NNS of_IN a_DT cough_NN or_CC cold_JJ ,_, which_WDT would_MD model_VB those_DT of_IN Covid_NNP -_HYPH 19_CD ._. He_PRP told_VBD The_DT Times_NNP :_: “_`` If_IN it_PRP works_VBZ on_IN our_PRP$ little_JJ virus_NN ,_, it_PRP is_VBZ very_RB likely_JJ to_TO work_VB in_IN the_DT real_JJ world_NN ._. ""_'' Before_IN they_PRP can_MD take_VB part_NN ,_, volunteers_NNS will_MD be_VB questioned_VBN about_IN their_PRP$ medical_JJ history_NN and_CC given_VBN blood_NN ,_, urine_NN ,_, and_CC cardiac_JJ tests_NNS ._. They_PRP will_MD also_RB be_VB screened_VBN to_TO ensure_VB they_PRP do_VBP n't_RB already_RB have_VB antibodies_NNS against_IN coronavirus_NN ._. Andrew_NNP Catchpole_NNP ,_, Hvivo_NNP ’s_POS chief_JJ scientist_NN ,_, told_VBD the_DT paper_NN :_: “_`` We_PRP ’ve_VBP actually_RB all_RB been_VBN exposed_VBN to_IN many_JJ coronaviruses_NNS ,_, which_WDT means_VBZ we_PRP could_MD have_VB some_DT kind_NN of_IN underlying_JJ immunity_NN to_IN it_PRP ._. ""_'' Participants_NNS who_WP are_VBP given_VBN clearance_NN to_TO take_VB part_NN will_MD then_RB attend_VB the_DT lab_NN where_WRB they_PRP will_MD be_VB inoculated_VBN before_IN going_VBG into_IN isolation_NN for_IN 14_CD days_NNS ._. During_IN that_DT time_NN they_PRP will_MD be_VB unable_JJ to_TO have_VB physical_JJ contact_NN with_IN other_JJ people_NNS ._. The_DT only_JJ human_JJ contact_NN they_PRP will_MD have_VB is_VBZ with_IN nurses_NNS and_CC doctors_NNS in_IN protective_JJ gear_NN and_CC ventilators_NNS who_WP will_MD enter_VB the_DT room_NN for_IN regular_JJ nasal_JJ swabs_NNS and_CC blood_NN tests_NNS ._. Medics_NNS will_MD also_RB collect_VB any_DT dirty_JJ tissues_NNS so_IN they_PRP can_MD be_VB weighed_VBN to_TO measure_VB their_PRP$ ""_`` viral_JJ load_NN ""_'' ._. Researchers_NNS say_VBP it_PRP will_MD allow_VB them_PRP to_TO test_VB the_DT efficacy_NN of_IN new_JJ viruses_NNS and_CC antiviral_JJ medications_NNS in_IN a_DT safe_JJ environment_NN ._. The_DT testing_NN is_VBZ part_NN of_IN a_DT $_$ 2bn_CD global_JJ effort_NN to_TO find_VB a_DT vaccine_NN for_IN Covid_NNP -_HYPH 19_CD ,_, which_WDT has_VBZ now_RB infected_VBN more_JJR than_IN 110,00_CD people_NNS worldwide_RB ._. Dr_NNP Edward_NNP Wright_NNP ,_, a_DT senior_JJ lecturer_NN in_IN microbiology_NN at_IN the_DT University_NNP of_IN Sussex_NNP ,_, told_VBD The_DT Sun_NNP Online_NNP :_: ""_`` There_EX are_VBP several_JJ coronaviruses_NNS -_HYPH seven_CD types_NNS can_MD infect_VB humans_NNS ._. ""_`` They_PRP include_VBP OC43_NN and_CC 229E_CD ,_, which_WDT are_VBP being_VBG used_VBN in_IN this_DT study_NN and_CC are_VBP responsible_JJ for_IN a_DT large_JJ proportion_NN of_IN common_JJ colds_NNS ._. ""_`` The_DT other_JJ three_CD are_VBP SARS_NNS ,_, MERS_NNP and_CC this_DT new_JJ coronavirus_NN ,_, known_VBN as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. ""_`` It_PRP is_VBZ not_RB necessarily_RB unusual_JJ for_IN researchers_NNS to_TO infect_VB people_NNS with_IN a_DT milder_JJR cousin_NN of_IN the_DT disease_NN to_TO stimulate_VB an_DT immune_JJ response_NN ._. ""_`` One_CD of_IN the_DT very_RB common_JJ approaches_NNS is_VBZ to_TO use_VB a_DT version_NN of_IN the_DT virus_NN that_WDT has_VBZ been_VBN inactivated_VBN ,_, meaning_VBG it_PRP ’s_VBZ unable_JJ to_TO cause_VB the_DT disease_NN and_CC is_VBZ chemically_RB inactivated_VBN ._. ""_`` This_DT actually_RB is_VBZ very_RB similar_JJ to_IN how_WRB the_DT whole_JJ process_NN of_IN vaccination_NN was_VBD first_RB identified_VBN ._. ""_'' Dr_NNP Wright_NNP ,_, who_WP is_VBZ n't_RB involved_VBN in_IN the_DT new_JJ study_NN ,_, added_VBD that_IN from_IN his_PRP$ understanding_NN those_DT taking_VBG part_NN in_IN the_DT trial_NN will_MD have_VB to_TO undergo_VB regimented_VBN procedures_NNS and_CC only_RB people_NNS who_WP are_VBP considered_VBN healthy_JJ would_MD be_VB infected_VBN ._. He_PRP added_VBD :_: ""_`` There_EX are_VBP guidelines_NNS and_CC regulations_NNS on_IN who_WP would_MD be_VB enrolled_VBN and_CC it_PRP would_MD rule_VB out_RP those_DT people_NNS with_IN underlying_JJ health_NN conditions_NNS ._. ""_`` If_IN they_PRP ’re_VBP healthy_JJ individuals_NNS ,_, it_PRP is_VBZ highly_RB unlikely_JJ they_PRP will_MD develop_VB anything_NN more_RBR serious_JJ than_IN the_DT symptoms_NNS of_IN a_DT common_JJ cold_NN ._. ""_`` For_IN those_DT who_WP are_VBP thinking_VBG about_IN taking_VBG part_NN and_CC are_VBP healthy_JJ ,_, I_PRP would_MD not_RB be_VB concerned_JJ ._. ""_'' Last_JJ week_NN ,_, the_DT UK_NNP Government_NN pledged_VBD £_$ 46_CD million_CD for_IN vaccine_NN research_NN and_CC faster_JJR testing_NN ._. Boris_NNP Johnson_NNP ’s_POS funding_NN boost_NN is_VBZ coming_VBG from_IN the_DT UK_NNP ’s_POS foreign_JJ aid_NN budget_NN and_CC brings_VBZ the_DT Government_NN ’s_POS commitment_NN up_IN to_IN £_$ 91_CD million_CD ._. Mr_NNP Johnson_NNP is_VBZ confident_JJ that_IN the_DT funding_NN will_MD be_VB able_JJ to_TO deliver_VB a_DT vaccine_NN in_IN a_DT year_NN ’s_POS time_NN ._. It_PRP comes_VBZ as_IN a_DT top_JJ medical_JJ expert_NN warned_VBD Brits_NNPS can_MD now_RB catch_VB coronavirus_NN “_'' from_IN anyone_NN ,_, anywhere_RB ,_, anytime_NN ”_'' —_: and_CC admitted_VBD we_PRP have_VBP lost_VBN track_NN of_IN who_WP has_VBZ it_PRP ._. A_DT surge_NN in_IN cases_NNS not_RB linked_VBN to_IN trips_NNS abroad_RB ,_, or_CC contact_NN with_IN known_VBN carriers_NNS ,_, means_VBZ the_DT bug_NN is_VBZ now_RB spreading_VBG from_IN person_NN to_IN person_NN within_IN the_DT UK_NNP ._. Dr_NNP Bharat_NNP Pankhania_NNP ,_, senior_JJ clinical_JJ lecturer_NN at_IN the_DT University_NNP of_IN Exeter_NNP ,_, said_VBD :_: “_`` The_DT implication_NN is_VBZ we_PRP are_VBP now_RB in_IN the_DT phase_NN of_IN ‘_`` community_NN transmission_NN ’_'' ._. “_`` We_PRP no_RB longer_RBR know_VBP where_WRB the_DT virus_NN is_VBZ ._. You_PRP could_MD catch_VB it_PRP from_IN anyone_NN ,_, anywhere_RB ,_, anytime_RB —_: in_IN your_PRP$ supermarket_NN ,_, coffee_NN shop_NN ,_, petrol_NN station_NN or_CC pub_NN ._. ”_'' Dr_NNP Pankhania_NNP added_VBD :_: “_`` Preventative_JJ measures_NNS ,_, such_JJ as_IN handwashing_NN and_CC catching_NN sneezes_NNS ,_, are_VBP more_RBR important_JJ than_IN ever_RB ._. “_`` This_DT is_VBZ serious_JJ and_CC not_RB a_DT joke_NN ._. You_PRP have_VBP no_DT idea_NN how_WRB an_DT individual_NN may_MD react_VB if_IN they_PRP catch_VBP it_PRP ,_, so_RB do_VB not_RB take_VB risks_NNS ._. ”_'' The_DT Government_NN ’s_POS chief_JJ scientific_JJ adviser_NN Sir_NNP Patrick_NNP Vallance_NNP added_VBD :_: “_`` We_PRP can_MD expect_VB more_JJR cases_NNS ._. This_DT is_VBZ now_RB outbreaks_NNS in_IN the_DT community_NN ._. ”_'' To_TO take_VB part_NN in_IN the_DT study_NN and_CC join_VB the_DT global_JJ fight_NN or_CC for_IN more_JJR information_NN visit_VB the_DT Hvivo_NNP website_NN flucamp.com_ADD ._.","NNPS VBG to VB a NN NN will VB NNS with a NN of the JJ NN - for £ 3,500 . Up to 24 NNS at a NN will VB VBN to VB VBN with a RBR JJ NN of NNP - 19 at a NN in NNP NNP , as NN of a JJ NN . ⚠️ VB our NN JJ NN for the JJS NN & NNS The NNS will VB RB VBN by NNS in JJ NN while in NN for 14 NNS . NNS VBP it will VB them VB a NN that could VB VBN JJ NN to VB the NN and those with JJ NN NNS . NN will VB once NNP , the NN that VBZ the NN NN at the NNP NNP NNP NNP NNP in NNP , VBZ VBN NN from the NNP NNPS and NNP NNS NNP NNP ( NNP ) . NNS will VB NNS with two JJ NNS of NN - 0C43 and 229E - which VBP JJ JJ NN . NNP NNP NNP , an NN in NN at the NNP NNP NNP of NNP , VBD NNS would VB the NNS of a NN or JJ , which would VB those of NNP - 19 . He VBD The NNP : “ If it VBZ on our JJ NN , it VBZ RB JJ to VB in the JJ NN . "" Before they can VB NN , NNS will VB VBN about their JJ NN and VBN NN , NN , and JJ NNS . They will RB VB VBN to VB they VBP RB RB VB NNS against NN . NNP NNP , NNP ’s JJ NN , VBD the NN : “ We VBP RB RB VBN VBN to JJ NNS , which VBZ we could VB some NN of JJ NN to it . "" NNS who VBP VBN NN to VB NN will RB VB the NN where they will VB VBN before VBG into NN for 14 NNS . During that NN they will VB JJ to VB JJ NN with JJ NNS . The JJ JJ NN they will VB VBZ with NNS and NNS in JJ NN and NNS who will VB the NN for JJ JJ NNS and NN NNS . NNS will RB VB any JJ NNS so they can VB VBN to VB their "" JJ NN "" . NNS VBP it will VB them to VB the NN of JJ NNS and JJ NNS in a JJ NN . The NN VBZ NN of a $ 2bn JJ NN to VB a NN for NNP - 19 , which VBZ RB VBN JJR than 110,00 NNS RB . NNP NNP NNP , a JJ NN in NN at the NNP of NNP , VBD The NNP NNP : "" There VBP JJ NNS - seven NNS can VB NNS . "" They VBP NN and 229E , which VBP VBG VBN in this NN and VBP JJ for a JJ NN of JJ NNS . "" The JJ three VBP NNS , NNP and this JJ NN , VBN as NNP - NNP - 2 . "" It VBZ RB RB JJ for NNS to VB NNS with a JJR NN of the NN to VB an JJ NN . "" One of the RB JJ NNS VBZ to VB a NN of the NN that VBZ VBN VBN , VBG it VBZ JJ to VB the NN and VBZ RB VBN . "" This RB VBZ RB JJ to how the JJ NN of NN VBD RB VBN . "" NNP NNP , who VBZ RB VBN in the JJ NN , VBD that from his NN those VBG NN in the NN will VB to VB VBN NNS and RB NNS who VBP VBN JJ would VB VBN . He VBD : "" There VBP NNS and NNS on who would VB VBN and it would VB out those NNS with JJ NN NNS . "" If they VBP JJ NNS , it VBZ RB JJ they will VB NN RBR JJ than the NNS of a JJ NN . "" For those who VBP VBG about VBG NN and VBP JJ , I would RB VB JJ . "" JJ NN , the NNP NN VBD £ 46 million for NN NN and JJR NN . NNP NNP ’s NN NN VBZ VBG from the NNP ’s JJ NN NN and VBZ the NN ’s NN up to £ 91 million . NNP NNP VBZ JJ that the NN will VB JJ to VB a NN in a NN ’s NN . It VBZ as a JJ JJ NN VBD NNPS can RB VB NN “ from NN , RB , NN ” — and VBD we VBP VBN NN of who VBZ it . A NN in NNS RB VBN to NNS RB , or NN with VBN NNS , VBZ the NN VBZ RB VBG from NN to NN within the NNP . NNP NNP NNP , JJ JJ NN at the NNP of NNP , VBD : “ The NN VBZ we VBP RB in the NN of ‘ NN NN ’ . “ We RB RBR VBP where the NN VBZ . You could VB it from NN , RB , RB — in your NN , NN NN , NN NN or NN . ” NNP NNP VBD : “ JJ NNS , JJ as NN and NN NNS , VBP RBR JJ than RB . “ This VBZ JJ and RB a NN . You VBP no NN how an NN may VB if they VBP it , RB VB RB VB NNS . ” The NN ’s JJ JJ NN NNP NNP NNP VBD : “ We can VB JJR NNS . This VBZ RB NNS in the NN . ” To VB NN in the NN and VB the JJ NN or for JJR NN VB the NNP NN flucamp.com ."
142,982,mainstream,"A_DT vaccine_NN for_IN the_DT common_JJ and_CC sometimes_RB deadly_JJ RSV_NN (_-LRB- respiratory_JJ syncytial_JJ virus_NN )_-RRB- has_VBZ been_VBN elusive_JJ ,_, but_CC scientists_NNS say_VBP a_DT new_JJ discovery_NN puts_VBZ them_PRP much_RB closer_JJR to_IN success_NN ._. A_DT new_JJ study_NN from_IN The_DT Ohio_NNP State_NNP University_NNP provides_VBZ a_DT potential_JJ blueprint_NN for_IN finding_VBG the_DT immunological_JJ sweet_JJ spot_NN –_: a_DT vaccine_NN weak_JJ enough_RB that_IN it_PRP does_VBZ n’t_RB make_VB people_NNS sick_JJ but_CC strong_JJ enough_RB that_IN it_PRP prompts_VBZ an_DT ample_JJ immune_JJ response_NN ,_, ensuring_VBG that_IN the_DT body_NN will_MD recognize_VB RSV_NNP as_IN an_DT intruder_NN in_IN the_DT future_NN ,_, and_CC quickly_RB mount_VB a_DT protective_JJ defense_NN ._. In_IN a_DT study_NN published_VBN today_NN (_-LRB- Oct._NNP 9_CD ,_, 2019_CD )_-RRB- in_IN the_DT journal_NNP Nature_NNP Communications_NNPS ,_, researchers_NNS report_VBP success_NN in_IN knocking_VBG out_RP an_DT epigenetic_JJ modification_NN known_VBN as_IN N6_NNP -_HYPH methyladenosine_NN in_IN RSV_NNP RNA_NN –_: a_DT technique_NN that_WDT proved_VBD to_TO tamp_VB down_RP the_DT virus_NN and_CC prompt_VB a_DT robust_JJ immune_JJ response_NN in_IN cotton_NN rats_NNS ._. “_`` We_PRP now_RB have_VBP a_DT novel_JJ target_NN to_TO go_VB after_RB ,_, and_CC are_VBP working_VBG with_IN industry_NN toward_IN a_DT vaccine_NN ,_, ”_'' said_VBD the_DT study_NN ’s_POS senior_JJ author_NN ,_, Jianrong_NNP Li_NNP ,_, an_DT Ohio_NNP State_NNP professor_NN of_IN virology_NN in_IN the_DT Department_NNP of_IN Veterinary_NNP Biosciences_NNP ._. Using_VBG a_DT technique_NN called_VBN reverse_JJ genetics_NNS ,_, Ohio_NNP State_NNP researchers_NNS generated_VBD RSV_NNP that_WDT is_VBZ defective_JJ in_IN N6_NNP -_HYPH methyladenosine_NN methylation_NN –_: one_CD of_IN the_DT most_RBS common_JJ modifications_NNS that_WDT our_PRP$ cells_NNS make_VBP to_IN RNA_NN ._. “_`` What_WP makes_VBZ this_DT especially_RB exciting_JJ is_VBZ that_IN using_VBG this_DT modified_VBN virus_NN in_IN a_DT vaccine_NN is_VBZ likely_JJ to_TO enhance_VB a_DT person_NN ’s_POS innate_JJ immune_NN response_NN ,_, a_DT challenge_NN that_WDT has_VBZ stood_VBN in_IN the_DT way_NN of_IN vaccine_NN development_NN in_IN the_DT past_NN ,_, ”_'' said_VBD Miaoge_NNP Xue_NNP ,_, the_DT study_NN ’s_POS lead_JJ author_NN and_CC a_DT graduate_NN student_NN in_IN Li_NNP ’s_POS laboratory_NN ._. “_`` This_DT approach_NN may_MD also_RB work_VB for_IN similar_JJ viruses_NNS ,_, such_JJ human_JJ metapneumovirus_NN and_CC human_JJ parainfluenza_NN virus_NN 3_CD ,_, ”_'' said_VBD Xue_NNP ,_, who_WP recently_RB presented_VBD these_DT findings_NNS at_IN the_DT annual_JJ meeting_NN of_IN the_DT American_NNP Society_NNP for_IN Virology_NNP ._. This_DT discovery_NN could_MD also_RB make_VB vaccine_NN production_NN more_RBR economically_RB feasible_JJ because_IN it_PRP does_VBZ not_RB slow_VB RSV_NNP growth_NN in_IN the_DT lab_NN –_: a_DT critical_JJ step_NN in_IN vaccine_NN production_NN ,_, said_VBD Li_NNP ,_, who_WP is_VBZ also_RB a_DT member_NN of_IN Ohio_NNP State_NNP ’s_POS Infectious_NNP Disease_NNP Institute_NNP ._.","A NN for the JJ and RB JJ NN ( JJ JJ NN ) VBZ VBN JJ , but NNS VBP a JJ NN VBZ them RB JJR to NN . A JJ NN from The NNP NNP NNP VBZ a JJ NN for VBG the JJ JJ NN – a NN JJ RB that it VBZ RB VB NNS JJ but JJ RB that it VBZ an JJ JJ NN , VBG that the NN will VB NNP as an NN in the NN , and RB VB a JJ NN . In a NN VBN NN ( NNP 9 , 2019 ) in the NNP NNP NNPS , NNS VBP NN in VBG out an JJ NN VBN as NNP - NN in NNP NN – a NN that VBD to VB down the NN and VB a JJ JJ NN in NN NNS . “ We RB VBP a JJ NN to VB RB , and VBP VBG with NN toward a NN , ” VBD the NN ’s JJ NN , NNP NNP , an NNP NNP NN of NN in the NNP of NNP NNP . VBG a NN VBN JJ NNS , NNP NNP NNS VBD NNP that VBZ JJ in NNP - NN NN – one of the RBS JJ NNS that our NNS VBP to NN . “ What VBZ this RB JJ VBZ that VBG this VBN NN in a NN VBZ JJ to VB a NN ’s JJ NN NN , a NN that VBZ VBN in the NN of NN NN in the NN , ” VBD NNP NNP , the NN ’s JJ NN and a NN NN in NNP ’s NN . “ This NN may RB VB for JJ NNS , JJ JJ NN and JJ NN NN 3 , ” VBD NNP , who RB VBD these NNS at the JJ NN of the NNP NNP for NNP . This NN could RB VB NN NN RBR RB JJ because it VBZ RB VB NNP NN in the NN – a JJ NN in NN NN , VBD NNP , who VBZ RB a NN of NNP NNP ’s NNP NNP NNP ."
143,414,mainstream,"French_JJ drugmaker_NN Sanofi_NNP SA_NNP said_VBD on_IN Tuesday_NNP it_PRP expects_VBZ to_TO get_VB approval_NN for_IN the_DT potential_JJ COVID_NN -_HYPH 19_CD vaccine_NN it_PRP is_VBZ developing_VBG with_IN Britain_NNP 's_POS GlaxoSmithKline_NNP Plc_NNP by_IN the_DT first_JJ half_NN of_IN next_JJ year_NN ,_, faster_JJR than_IN previously_RB anticipated_VBN ._. Sanofi_NNP ,_, which_WDT is_VBZ hosting_VBG a_DT virtual_JJ research_NN and_CC development_NN event_NN ,_, and_CC GSK_NNP had_VBD said_VBN in_IN April_NNP the_DT vaccine_NN ,_, if_IN successful_JJ ,_, would_MD be_VB available_JJ in_IN the_DT second_JJ half_NN of_IN 2021_CD ._. ""_`` We_PRP are_VBP being_VBG guided_VBN by_IN our_PRP$ dialogue_NN with_IN regulatory_JJ authorities_NNS ,_, ""_'' Sanofi_NNP research_NN chief_NN John_NNP Reed_NNP told_VBD reporters_NNS ,_, when_WRB asked_VBN about_IN the_DT accelerated_VBN time_NN frame_NN ._. There_EX are_VBP currently_RB no_DT vaccines_NNS to_TO prevent_VB the_DT coronavirus_NN that_WDT has_VBZ infected_VBN more_JJR than_IN 9_CD million_CD people_NNS and_CC killed_VBN over_RB 469,000_CD globally_RB ,_, and_CC only_RB a_DT couple_NN of_IN medicines_NNS that_WDT have_VBP demonstrated_VBN benefit_NN in_IN hospitalized_VBN COVID_NN -_HYPH 19_CD patients_NNS in_IN clinical_JJ trials_NNS ._. Many_JJ drugmakers_NNS are_VBP racing_VBG to_TO come_VB up_RP with_IN a_DT safe_JJ and_CC effective_JJ vaccine_NN that_WDT can_MD be_VB produced_VBN at_IN large_JJ scale_NN ._. Moderna_NNP Inc_NNP ,_, the_DT University_NNP of_IN Oxford_NNP in_IN collaboration_NN with_IN AstraZeneca_NNP Plc_NNP ,_, and_CC an_DT alliance_NN of_IN BioNTech_NNP and_CC Pfizer_NNP Inc_NNP grabbed_VBD headlines_NNS by_IN moving_VBG to_IN human_JJ trials_NNS as_RB early_RB as_IN March_NNP ._. Sanofi_NNP Chief_JJ Executive_NN Paul_NNP Hudson_NNP said_VBD the_DT firsts_NNS in_IN the_DT race_NN now_RB were_VBD not_RB assured_VBN of_IN securing_VBG victory_NN ._. ""_`` There_EX are_VBP companies_NNS moving_VBG faster_RBR ,_, but_CC let_VB us_PRP be_VB brutally_RB clear_JJ ,_, speed_NN has_VBZ three_CD downsides_NNS ,_, ""_'' he_PRP said_VBD of_IN competition_NN ._. ""_`` They_PRP are_VBP using_VBG existing_VBG work_NN ,_, in_IN many_JJ cases_NNS done_VBN for_IN SARS_NN ;_, it_PRP is_VBZ likely_JJ not_RB to_TO be_VB as_RB efficacious_JJ ;_, and_CC there_EX is_VBZ no_DT guarantee_NN on_IN supply_NN in_IN large_JJ volumes_NNS ,_, ""_'' Hudson_NNP said_VBD ._. The_DT probability_NN of_IN success_NN for_IN Sanofi_NNP is_VBZ ""_`` higher_JJR than_IN anybody_NN else_JJ ,_, ""_'' the_DT CEO_NN said_VBD ._. The_DT comments_NNS echoed_VBD those_DT of_IN GSK_NNP ,_, whose_WP$ chief_JJ medical_JJ officer_NN for_IN vaccines_NNS told_VBD Reuters_NNP on_IN Friday_NNP the_DT company_NN was_VBD aiming_VBG at_IN quality_NN before_IN speed_NN ._. Sanofi_NNP ,_, whose_WP$ Pasteur_NNP vaccines_NNS division_NN has_VBZ a_DT long_JJ established_VBN reputation_NN ,_, notably_RB in_IN flu_NN ,_, is_VBZ currently_RB working_VBG on_IN two_CD vaccine_NN projects_NNS ._. One_PRP uses_VBZ an_DT adjuvant_NN made_VBN by_IN GSK_NNP to_TO potentially_RB boost_VB its_PRP$ efficacy_NN ._. It_PRP has_VBZ received_VBN financial_JJ support_NN from_IN the_DT US_NNP Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP (_-LRB- BARDA_NNP )_-RRB- ._. The_DT other_JJ ,_, being_VBG developed_VBN with_IN US_NNP company_NN Translate_NNP Bio_NNP Inc_NNP ,_, relies_VBZ on_IN a_DT different_JJ technology_NN known_VBN as_IN mRNA_NN ,_, similar_JJ to_IN the_DT Moderna_NNP approach_NN ._. Clinical_JJ trials_NNS of_IN the_DT vaccine_NN developed_VBN with_IN GSK_NN ,_, described_VBN as_IN a_DT recombinant_JJ vaccine_NN because_IN of_IN the_DT use_NN of_IN GSK_NNP 's_POS boosting_NN adjuvant_NN ,_, are_VBP to_TO start_VB in_IN September_NNP ._. Trials_NNS of_IN the_DT mRNA_NN vaccine_NN candidate_NN should_MD begin_VB around_IN the_DT end_NN of_IN the_DT year_NN ,_, the_DT company_NN said_VBD ._. Sanofi_NNP said_VBD it_PRP had_VBD capacity_NN to_TO produce_VB up_IN to_IN 1_CD billion_CD doses_NNS a_DT year_NN of_IN its_PRP$ recombinant_JJ vaccine_NN ,_, and_CC that_IN it_PRP would_MD be_VB able_JJ to_TO supply_VB up_IN to_IN 360_CD million_CD doses_NNS of_IN its_PRP$ mRNA_NN vaccine_NN annually_RB ._. In_IN April_NNP ,_, Sanofi_NNP said_VBD it_PRP had_VBD manufacturing_NN capacity_NN for_IN 600_CD million_CD doses_NNS for_IN its_PRP$ recombinant_JJ vaccine_NN ,_, with_IN the_DT ambition_NN to_TO double_VB production_NN by_IN mid-2021_NN ._. The_DT company_NN also_RB said_VBD it_PRP would_MD expand_VB its_PRP$ collaboration_NN with_IN Translate_NNP Bio_NNP on_IN developing_VBG vaccines_NNS ,_, in_IN a_DT deal_NN which_WDT will_MD give_VB the_DT US_NNP group_NN $_$ 425_CD million_CD in_IN upfront_NN payments_NNS ._.","JJ NN NNP NNP VBD on NNP it VBZ to VB NN for the JJ NN - 19 NN it VBZ VBG with NNP 's NNP NNP by the JJ NN of JJ NN , JJR than RB VBN . NNP , which VBZ VBG a JJ NN and NN NN , and NNP VBD VBN in NNP the NN , if JJ , would VB JJ in the JJ NN of 2021 . "" We VBP VBG VBN by our NN with JJ NNS , "" NNP NN NN NNP NNP VBD NNS , when VBN about the VBN NN NN . There VBP RB no NNS to VB the NN that VBZ VBN JJR than 9 million NNS and VBN RB 469,000 RB , and RB a NN of NNS that VBP VBN NN in VBN NN - 19 NNS in JJ NNS . JJ NNS VBP VBG to VB up with a JJ and JJ NN that can VB VBN at JJ NN . NNP NNP , the NNP of NNP in NN with NNP NNP , and an NN of NNP and NNP NNP VBD NNS by VBG to JJ NNS RB RB as NNP . NNP JJ NN NNP NNP VBD the NNS in the NN RB VBD RB VBN of VBG NN . "" There VBP NNS VBG RBR , but VB us VB RB JJ , NN VBZ three NNS , "" he VBD of NN . "" They VBP VBG VBG NN , in JJ NNS VBN for NN ; it VBZ JJ RB to VB RB JJ ; and there VBZ no NN on NN in JJ NNS , "" NNP VBD . The NN of NN for NNP VBZ "" JJR than NN JJ , "" the NN VBD . The NNS VBD those of NNP , whose JJ JJ NN for NNS VBD NNP on NNP the NN VBD VBG at NN before NN . NNP , whose NNP NNS NN VBZ a JJ VBN NN , RB in NN , VBZ RB VBG on two NN NNS . One VBZ an NN VBN by NNP to RB VB its NN . It VBZ VBN JJ NN from the NNP NNP NNP NNP and NNP NNP ( NNP ) . The JJ , VBG VBN with NNP NN NNP NNP NNP , VBZ on a JJ NN VBN as NN , JJ to the NNP NN . JJ NNS of the NN VBN with NN , VBN as a JJ NN because of the NN of NNP 's NN NN , VBP to VB in NNP . NNS of the NN NN NN should VB around the NN of the NN , the NN VBD . NNP VBD it VBD NN to VB up to 1 billion NNS a NN of its JJ NN , and that it would VB JJ to VB up to 360 million NNS of its NN NN RB . In NNP , NNP VBD it VBD NN NN for 600 million NNS for its JJ NN , with the NN to VB NN by NN . The NN RB VBD it would VB its NN with NNP NNP on VBG NNS , in a NN which will VB the NNP NN $ 425 million in NN NNS ."
144,924,conspiracy,"Vaccines_NNS ,_, for_IN Bill_NNP Gates_NNP ,_, are_VBP a_DT strategic_JJ philanthropy_NN that_WDT feed_VBP his_PRP$ many_JJ vaccine_NN -_HYPH related_JJ businesses_NNS (_-LRB- including_VBG Microsoft_NNP ’s_POS ambition_NN to_TO control_VB a_DT global_JJ vaccination_NN ID_NN enterprise_NN )_-RRB- and_CC give_VB him_PRP dictatorial_JJ control_NN of_IN global_JJ health_NN policy_NN ._. Gates_NNPS ’_POS obsession_NN with_IN vaccines_NNS seems_VBZ to_TO be_VB fueled_VBN by_IN a_DT conviction_NN to_TO save_VB the_DT world_NN with_IN technology_NN ._. Promising_VBG his_PRP$ share_NN of_IN $_$ 450_CD million_CD of_IN $_$ 1.2_CD billion_CD to_TO eradicate_VB Polio_NNP ,_, Gates_NNPS took_VBD control_NN of_IN India_NNP ’s_POS National_NNP Technical_NNP Advisory_NNP Group_NNP on_IN Immunization_NNP (_-LRB- NTAGI_NNP )_-RRB- which_WDT mandated_VBD up_IN to_IN 50_CD doses_NNS (_-LRB- Table_NN 1_CD )_-RRB- of_IN polio_NN vaccines_NNS through_IN overlapping_VBG immunization_NN programs_NNS to_IN children_NNS before_IN the_DT age_NN of_IN five_CD ._. Indian_JJ doctors_NNS blame_VBP the_DT Gates_NNP campaign_NN for_IN a_DT devastating_JJ non-polio_JJ acute_JJ flaccid_JJ paralysis_NN (_-LRB- NPAFP_NNP )_-RRB- epidemic_NN that_WDT paralyzed_VBD 490,000_CD children_NNS beyond_IN expected_VBN rates_NNS between_IN 2000_CD and_CC 2017_CD ._. In_IN 2017_CD ,_, the_DT Indian_JJ government_NN dialed_VBD back_RP Gates_NNP ’_POS vaccine_NN regimen_NN and_CC asked_VBD Gates_NNPS and_CC his_PRP$ vaccine_NN policies_NNS to_TO leave_VB India_NNP ._. NPAFP_NNP rates_NNS dropped_VBD precipitously_RB ._. In_IN 2017_CD ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- reluctantly_RB admitted_VBD that_IN the_DT global_JJ explosion_NN in_IN polio_NN is_VBZ predominantly_RB vaccine_NN strain_NN ._. The_DT most_RBS frightening_JJ epidemics_NNS in_IN Congo_NNP ,_, Afghanistan_NNP ,_, and_CC the_DT Philippines_NNPS ,_, are_VBP all_RB linked_VBN to_IN vaccines_NNS ._. In_IN fact_NN ,_, by_IN 2018_CD ,_, 70_CD %_NN of_IN global_JJ polio_NN cases_NNS were_VBD vaccine_NN strain_NN ._. In_IN 2014_CD ,_, the_DT Gates_NNP Foundation_NNP funded_VBD tests_NNS of_IN experimental_JJ HPV_NN vaccines_NNS ,_, developed_VBN by_IN Glaxo_NNP Smith_NNP Kline_NNP (_-LRB- GSK_NNP )_-RRB- and_CC Merck_NNP ,_, on_IN 23,000_CD young_JJ girls_NNS in_IN remote_JJ Indian_JJ provinces_NNS ._. Approximately_RB 1,200_CD suffered_VBD severe_JJ side_NN effects_NNS ,_, including_VBG autoimmune_JJ and_CC fertility_NN disorders_NNS ._. Seven_CD died_VBD ._. Indian_JJ government_NN investigations_NNS charged_VBD that_IN Gates_NNPS -_HYPH funded_VBN researchers_NNS committed_VBD pervasive_JJ ethical_JJ violations_NNS :_: pressuring_VBG vulnerable_JJ village_NN girls_NNS into_IN the_DT trial_NN ,_, bullying_VBG parents_NNS ,_, forging_VBG consent_NN forms_NNS ,_, and_CC refusing_VBG medical_JJ care_NN to_IN the_DT injured_VBN girls_NNS ._. The_DT case_NN is_VBZ now_RB in_IN the_DT country_NN ’s_POS Supreme_NNP Court_NNP ._. In_IN 2010_CD ,_, the_DT Gates_NNP Foundation_NNP funded_VBD a_DT phase_NN 3_CD trial_NN of_IN GSK_NNP ’s_POS experimental_JJ malaria_NN vaccine_NN ,_, killing_VBG 151_CD African_JJ infants_NNS and_CC causing_VBG serious_JJ adverse_JJ effects_NNS including_VBG paralysis_NN ,_, seizure_NN ,_, and_CC febrile_JJ convulsions_NNS to_IN 1,048_CD of_IN the_DT 5,949_CD children_NNS ._. During_IN Gates_NNP ’_POS 2002_CD MenAfriVac_NNP campaign_NN in_IN Sub-Saharan_NNP Africa_NNP ,_, Gates_NNPS ’_POS operatives_NNS forcibly_RB vaccinated_VBD thousands_NNS of_IN African_JJ children_NNS against_IN meningitis_NN ._. Approximately_RB 50_CD of_IN the_DT 500_CD children_NNS vaccinated_VBN developed_VBD paralysis_NN ._. South_NNP African_JJ newspapers_NNS complained_VBD ,_, “_`` We_PRP are_VBP guinea_NN pigs_NNS for_IN the_DT drug_NN makers_NNS ._. ”_'' Nelson_NNP Mandela_NNP ’s_POS former_JJ Senior_NNP Economist_NNP ,_, Professor_NNP Patrick_NNP Bond_NNP ,_, describes_VBZ Gates_NNPS ’_POS philanthropic_JJ practices_NNS as_IN “_`` ruthless_JJ and_CC immoral_JJ ._. ”_'' In_IN 2010_CD ,_, Gates_NNPS committed_VBD $_$ 10_CD billion_CD to_IN the_DT WHO_NNP saying_VBG ,_, “_`` We_PRP must_MD make_VB this_DT the_DT decade_NN of_IN vaccines_NNS ._. ”_'' A_DT month_NN later_RBR ,_, Gates_NNPS said_VBD in_IN a_DT Ted_NNP Talk_NN that_IN new_JJ vaccines_NNS “_'' could_MD reduce_VB population_NN ”_'' ._. In_IN 2014_CD ,_, Kenya_NNP ’s_POS Catholic_NNP Doctors_NNPS Association_NNP accused_VBD the_DT WHO_NNP of_IN chemically_RB sterilizing_VBG millions_NNS of_IN unwilling_JJ Kenyan_JJ women_NNS with_IN a_DT “_`` tetanus_NN ”_'' vaccine_NN campaign_NN ._. Independent_JJ labs_NNS found_VBD a_DT sterility_NN formula_NN in_IN every_DT vaccine_NN tested_VBN ._. After_IN denying_VBG the_DT charges_NNS ,_, WHO_NNP finally_RB admitted_VBD it_PRP had_VBD been_VBN developing_VBG the_DT sterility_NN vaccines_NNS for_IN over_IN a_DT decade_NN ._. Similar_JJ accusations_NNS came_VBD from_IN Tanzania_NNP ,_, Nicaragua_NNP ,_, Mexico_NNP ,_, and_CC the_DT Philippines_NNPS ._. A_DT 2017_CD study_NN (_-LRB- Morgenson_NNP et._FW al._FW 2017_CD )_-RRB- showed_VBD that_IN WHO_NNP ’s_POS popular_JJ DTP_NN vaccine_NN is_VBZ killing_VBG more_JJR African_JJ children_NNS than_IN the_DT diseases_NNS it_PRP prevents_VBZ ._. DTP_NNP -_HYPH vaccinated_VBN girls_NNS suffered_VBD 10_CD x_SYM the_DT death_NN rate_NN of_IN children_NNS who_WP had_VBD not_RB yet_RB received_VBN the_DT vaccine_NN ._. WHO_WP has_VBZ refused_VBN to_TO recall_VB the_DT lethal_JJ vaccine_NN which_WDT it_PRP forces_VBZ upon_IN tens_NNS of_IN millions_NNS of_IN African_JJ children_NNS annually_RB ._. Global_JJ public_JJ health_NN advocates_NNS around_IN the_DT world_NN accuse_VBP Gates_NNS of_IN steering_VBG WHO_NNP ’s_POS agenda_NN away_RB from_IN the_DT projects_NNS that_WDT are_VBP proven_VBN to_TO curb_VB infectious_JJ diseases_NNS :_: clean_JJ water_NN ,_, hygiene_NN ,_, nutrition_NN ,_, and_CC economic_JJ development_NN ._. The_DT Gates_NNP Foundation_NNP only_RB spends_VBZ about_RB $_$ 650_CD million_CD of_IN its_PRP$ $_$ 5_CD billion_CD dollar_NN budget_NN on_IN these_DT areas_NNS ._. They_PRP say_VBP he_PRP has_VBZ diverted_VBN agency_NN resources_NNS to_TO serve_VB his_PRP$ personal_JJ philosophy_NN that_IN good_JJ health_NN only_RB comes_VBZ in_IN a_DT syringe_NN ._. In_IN addition_NN to_IN using_VBG his_PRP$ philanthropy_NN to_TO control_VB WHO_NNP ,_, UNICEF_NNP ,_, GAVI_NNP ,_, and_CC PATH_NNP ,_, Gates_NNP funds_VBZ a_DT private_JJ pharmaceutical_JJ company_NN that_WDT manufactures_VBZ vaccines_NNS ,_, and_CC additionally_RB is_VBZ donating_VBG $_$ 50_CD million_CD to_IN 12_CD pharmaceutical_JJ companies_NNS to_TO speed_VB up_RP development_NN of_IN a_DT coronavirus_NN vaccine_NN ._. In_IN his_PRP$ recent_JJ media_NN appearances_NNS ,_, Gates_NNP appears_VBZ confident_JJ that_IN the_DT Covid_NNP -_HYPH 19_CD crisis_NN will_MD now_RB give_VB him_PRP the_DT opportunity_NN to_TO force_VB his_PRP$ dictatorial_JJ vaccine_NN programs_NNS on_IN American_JJ children_NNS ._. David_NNP Knight_NNP is_VBZ joined_VBN by_IN Dr._NNP Sherri_NNP Tenpenny_NNP to_TO discuss_VB the_DT hidden_VBN globalist_JJ agenda_NN of_IN Bill_NNP Gates_NNP and_CC what_WP you_PRP can_MD do_VB to_TO prepare_VB ._. The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","NNS , for NNP NNP , VBP a JJ NN that VBP his JJ NN - JJ NNS ( VBG NNP ’s NN to VB a JJ NN NN NN ) and VB him JJ NN of JJ NN NN . NNPS ’ NN with NNS VBZ to VB VBN by a NN to VB the NN with NN . VBG his NN of $ 450 million of $ 1.2 billion to VB NNP , NNPS VBD NN of NNP ’s NNP NNP NNP NNP on NNP ( NNP ) which VBD up to 50 NNS ( NN 1 ) of NN NNS through VBG NN NNS to NNS before the NN of five . JJ NNS VBP the NNP NN for a JJ JJ JJ JJ NN ( NNP ) NN that VBD 490,000 NNS beyond VBN NNS between 2000 and 2017 . In 2017 , the JJ NN VBD back NNP ’ NN NN and VBD NNPS and his NN NNS to VB NNP . NNP NNS VBD RB . In 2017 , the NNP NNP NNP ( NNP ) RB VBD that the JJ NN in NN VBZ RB NN NN . The RBS JJ NNS in NNP , NNP , and the NNPS , VBP RB VBN to NNS . In NN , by 2018 , 70 NN of JJ NN NNS VBD NN NN . In 2014 , the NNP NNP VBD NNS of JJ NN NNS , VBN by NNP NNP NNP ( NNP ) and NNP , on 23,000 JJ NNS in JJ JJ NNS . RB 1,200 VBD JJ NN NNS , VBG JJ and NN NNS . Seven VBD . JJ NN NNS VBD that NNPS - VBN NNS VBD JJ JJ NNS : VBG JJ NN NNS into the NN , VBG NNS , VBG NN NNS , and VBG JJ NN to the VBN NNS . The NN VBZ RB in the NN ’s NNP NNP . In 2010 , the NNP NNP VBD a NN 3 NN of NNP ’s JJ NN NN , VBG 151 JJ NNS and VBG JJ JJ NNS VBG NN , NN , and JJ NNS to 1,048 of the 5,949 NNS . During NNP ’ 2002 NNP NN in NNP NNP , NNPS ’ NNS RB VBD NNS of JJ NNS against NN . RB 50 of the 500 NNS VBN VBD NN . NNP JJ NNS VBD , “ We VBP NN NNS for the NN NNS . ” NNP NNP ’s JJ NNP NNP , NNP NNP NNP , VBZ NNPS ’ JJ NNS as “ JJ and JJ . ” In 2010 , NNPS VBD $ 10 billion to the NNP VBG , “ We must VB this the NN of NNS . ” A NN RBR , NNPS VBD in a NNP NN that JJ NNS “ could VB NN ” . In 2014 , NNP ’s NNP NNPS NNP VBD the NNP of RB VBG NNS of JJ JJ NNS with a “ NN ” NN NN . JJ NNS VBD a NN NN in every NN VBN . After VBG the NNS , NNP RB VBD it VBD VBN VBG the NN NNS for over a NN . JJ NNS VBD from NNP , NNP , NNP , and the NNPS . A 2017 NN ( NNP FW FW 2017 ) VBD that NNP ’s JJ NN NN VBZ VBG JJR JJ NNS than the NNS it VBZ . NNP - VBN NNS VBD 10 x the NN NN of NNS who VBD RB RB VBN the NN . WHO VBZ VBN to VB the JJ NN which it VBZ upon NNS of NNS of JJ NNS RB . JJ JJ NN NNS around the NN VBP NNS of VBG NNP ’s NN RB from the NNS that VBP VBN to VB JJ NNS : JJ NN , NN , NN , and JJ NN . The NNP NNP RB VBZ RB $ 650 million of its $ 5 billion NN NN on these NNS . They VBP he VBZ VBN NN NNS to VB his JJ NN that JJ NN RB VBZ in a NN . In NN to VBG his NN to VB NNP , NNP , NNP , and NNP , NNP VBZ a JJ JJ NN that VBZ NNS , and RB VBZ VBG $ 50 million to 12 JJ NNS to VB up NN of a NN NN . In his JJ NN NNS , NNP VBZ JJ that the NNP - 19 NN will RB VB him the NN to VB his JJ NN NNS on JJ NNS . NNP NNP VBZ VBN by NNP NNP NNP to VB the VBN JJ NN of NNP NNP and what you can VB to VB . The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
145,467,mainstream,"People_NNS over_IN the_DT age_NN of_IN 50_CD ,_, frontline_NN workers_NNS and_CC people_NNS with_IN heart_NN and_CC kidney_NN conditions_NNS will_MD be_VB prioritised_VBN if_IN and_CC when_WRB a_DT coronavirus_NN vaccine_NN is_VBZ available_JJ ,_, the_DT government_NN has_VBZ said_VBN ._. Health_NNP Secretary_NNP Matt_NNP Hancock_NNP said_VBD work_NN is_VBZ underway_JJ to_TO ""_`` stockpile_VB ""_'' jabs_NNS so_IN they_PRP 're_VBP available_JJ straight_RB away_RB if_IN a_DT vaccine_NN is_VBZ approved_VBN ._. He_PRP told_VBD today_NN 's_POS Downing_NNP Street_NNP briefing_NN that_IN drug_NN company_NN AstraZeneca_NNP has_VBZ already_RB started_VBN manufacturing_VBG a_DT jab_NN being_VBG produced_VBN by_IN scientists_NNS at_IN Oxford_NNP University_NNP ._. Mr_NNP Hancock_NNP said_VBD :_: ""_`` They_PRP 're_VBP starting_VBG manufacture_NN now_RB ,_, even_RB ahead_RB of_IN approval_NN ,_, so_IN we_PRP can_MD build_VB up_RP a_DT stockpile_NN and_CC be_VB ready_JJ should_MD it_PRP be_VB clinically_RB approved_VBN ._. ""_'' A_DT separate_JJ vaccine_NN being_VBG produced_VBN at_IN Imperial_NNP College_NNP in_IN London_NNP is_VBZ also_RB at_IN the_DT first_JJ stage_NN of_IN clinical_JJ trials_NNS ,_, he_PRP said_VBD ._. People_NNS who_WP will_MD be_VB first_RB in_IN the_DT queue_NN for_IN jabs_NNS when_WRB one_PRP becomes_VBZ available_JJ are_VBP :_: •_NFP Social_JJ care_NN workers_NNS ,_, including_VBG those_DT who_WP work_VBP in_IN care_NN homes_NNS and_CC who_WP carry_VBP out_RP home_NN visits_NNS On_IN top_NN of_IN this_DT ,_, he_PRP said_VBD further_JJ research_NN was_VBD being_VBG carried_VBN out_RP to_TO find_VB out_RP whether_IN people_NNS from_IN ethnic_JJ minority_NN groups_NNS are_VBP at_IN higher_JJR risk_NN ._. ""_`` We_PRP can_MD protect_VB the_DT most_JJS at_IN risk_NN first_RB should_MD a_DT vaccine_NN become_VB available_JJ ,_, ""_'' Mr_NNP Hancock_NNP said_VBD ._. At_IN the_DT Downing_NNP Street_NNP press_NN conference_NN he_PRP said_VBD the_DT joint_JJ committee_NN on_IN vaccination_NN and_CC immunisation_NN had_VBD published_VBN interim_JJ advice_NN ._. ""_`` They_PRP recommend_VBP priority_NN vaccination_NN for_IN two_CD groups_NNS :_: frontline_JJ health_NN and_CC social_JJ care_NN workers_NNS and_CC those_DT at_IN increased_VBN risk_NN of_IN serious_JJ disease_NN and_CC death_NN from_IN coronavirus_NN ._. ""_'' That_DT would_MD include_VB the_DT over_RB -_HYPH 50s_NNS and_CC those_DT with_IN heart_NN and_CC kidney_NN disease_NN ._. ""_`` As_IN we_PRP learn_VBP more_JJR about_IN the_DT virus_NN we_PRP will_MD continue_VB to_TO take_VB into_IN account_NN which_WDT groups_NNS may_MD be_VB particularly_RB vulnerable_JJ ,_, including_VBG ,_, for_IN example_NN ,_, those_DT from_IN ethnic_JJ minority_NN backgrounds_NNS so_IN that_IN we_PRP can_MD protect_VB the_DT most_JJS at_IN risk_NN first_RB ,_, should_MD a_DT vaccine_NN become_VB available_JJ ,_, and_CC get_VB this_DT country_NN back_RB on_IN our_PRP$ feet_NNS as_RB soon_RB as_IN we_PRP possibly_RB can_MD ._. ""_'' Earlier_RBR today_NN a_DT World_NNP Health_NNP Organisation_NNP (_-LRB- WHO_NNP )_-RRB- boss_NN warned_VBD a_DT second_JJ wave_NN of_IN coronavirus_NN could_MD hit_VB this_DT autumn_NN ._. Nations_NNPS have_VBP been_VBN urged_VBN today_NN to_TO adopt_VB the_DT track_NN ,_, test_NN and_CC isolate_VB programme_NN or_CC suffer_VB the_DT consequences_NNS of_IN the_DT deadly_JJ new_JJ wave_NN ._. The_DT warning_NN comes_VBZ just_RB as_IN the_DT UK_NNP is_VBZ abandoning_VBG its_PRP$ efforts_NNS to_TO develop_VB its_PRP$ own_JJ contact_NN -_HYPH tracing_NN app_NN ._. Dr_NNP Hans_NNP Kluge_NNP ,_, WHO_NNP 's_POS European_JJ regional_JJ director_NN ,_, said_VBD :_: ""_`` It_PRP 's_VBZ well_RB possible_JJ that_IN when_WRB the_DT autumn_NN starts_VBZ and_CC we_PRP have_VBP also_RB the_DT seasonal_JJ influenza_NN ,_, there_EX is_VBZ the_DT possibility_NN of_IN a_DT seasonal_JJ effect_NN on_IN the_DT virus_NN -_, but_CC we_PRP 're_VBP not_RB sure_JJ yet_RB -_, that_IN then_RB we_PRP will_MD see_VB a_DT second_JJ wave_NN ._. ""_`` So_RB the_DT lesson_NN is_VBZ that_IN we_PRP have_VBP to_TO implement_VB what_WP we_PRP know_VBP works_VBZ -_, at_IN the_DT core_NN of_IN the_DT strategy_NN is_VBZ to_TO find_VB as_RB early_RB as_IN possible_JJ ,_, isolate_VB ,_, test_VB suspected_VBN people_NNS from_IN Covid_NNP ,_, and_CC if_IN needs_NNS be_VBP treat_VBG them_PRP without_IN any_DT stigma_NN or_CC discrimination_NN ._.","NNS over the NN of 50 , NN NNS and NNS with NN and NN NNS will VB VBN if and when a NN NN VBZ JJ , the NN VBZ VBN . NNP NNP NNP NNP VBD NN VBZ JJ to "" VB "" NNS so they VBP JJ RB RB if a NN VBZ VBN . He VBD NN 's NNP NNP NN that NN NN NNP VBZ RB VBN VBG a NN VBG VBN by NNS at NNP NNP . NNP NNP VBD : "" They VBP VBG NN RB , RB RB of NN , so we can VB up a NN and VB JJ should it VB RB VBN . "" A JJ NN VBG VBN at NNP NNP in NNP VBZ RB at the JJ NN of JJ NNS , he VBD . NNS who will VB RB in the NN for NNS when one VBZ JJ VBP : • JJ NN NNS , VBG those who VBP in NN NNS and who VBP out NN NNS On NN of this , he VBD JJ NN VBD VBG VBN out to VB out whether NNS from JJ NN NNS VBP at JJR NN . "" We can VB the JJS at NN RB should a NN VB JJ , "" NNP NNP VBD . At the NNP NNP NN NN he VBD the JJ NN on NN and NN VBD VBN JJ NN . "" They VBP NN NN for two NNS : JJ NN and JJ NN NNS and those at VBN NN of JJ NN and NN from NN . "" That would VB the RB - NNS and those with NN and NN NN . "" As we VBP JJR about the NN we will VB to VB into NN which NNS may VB RB JJ , VBG , for NN , those from JJ NN NNS so that we can VB the JJS at NN RB , should a NN VB JJ , and VB this NN RB on our NNS RB RB as we RB can . "" RBR NN a NNP NNP NNP ( NNP ) NN VBD a JJ NN of NN could VB this NN . NNPS VBP VBN VBN NN to VB the NN , NN and VB NN or VB the NNS of the JJ JJ NN . The NN VBZ RB as the NNP VBZ VBG its NNS to VB its JJ NN - NN NN . NNP NNP NNP , NNP 's JJ JJ NN , VBD : "" It VBZ RB JJ that when the NN VBZ and we VBP RB the JJ NN , there VBZ the NN of a JJ NN on the NN - but we VBP RB JJ RB - that RB we will VB a JJ NN . "" RB the NN VBZ that we VBP to VB what we VBP VBZ - at the NN of the NN VBZ to VB RB RB as JJ , VB , VB VBN NNS from NNP , and if NNS VBP VBG them without any NN or NN ."
146,1318,mainstream,"Mandatory_JJ Vaccination_NN :_: Why_WRB We_PRP Still_RB Got_VBD to_TO Get_VB Folks_NNS to_TO Take_VB Their_PRP$ Shots_NNP (_-LRB- 2006_CD Third_NNP Year_NNP Paper_NN )_-RRB- Vaccination_NN is_VBZ widely_RB considered_VBN one_CD of_IN the_DT greatest_JJS medical_JJ achievements_NNS of_IN modern_JJ civilization_NN ._. Childhood_NN diseases_NNS that_WDT were_VBD commonplace_JJ less_JJR than_IN a_DT generation_NN ago_RB are_VBP now_RB increasingly_RB rare_JJ because_IN of_IN vaccines_NNS ._. In_IN order_NN to_TO be_VB effective_JJ at_IN eliminating_VBG communicable_JJ diseases_NNS ,_, vaccines_NNS must_MD be_VB administered_VBN to_IN sufficient_JJ levels_NNS of_IN persons_NNS in_IN the_DT community_NN ._. Because_IN of_IN this_DT ,_, public_JJ health_NN officials_NNS have_VBP mandated_VBN vaccination_NN for_IN certain_JJ diseases_NNS as_IN a_DT condition_NN to_IN school_NN attendance_NN ._. The_DT overwhelming_JJ effectiveness_NN of_IN vaccination_NN programs_NNS may_MD lead_VB individuals_NNS to_TO ignore_VB the_DT benefits_NNS of_IN vaccination_NN and_CC focus_VB more_JJR on_IN the_DT risk_NN of_IN side_NN effects_NNS ._. Moreover_RB ,_, some_DT have_VBP criticized_VBN the_DT coercive_JJ nature_NN of_IN these_DT programs_NNS ._. These_DT objections_NNS may_MD lead_VB to_IN an_DT unacceptably_RB high_JJ number_NN of_IN exemptions_NNS ,_, which_WDT can_MD compromise_VB vaccination_NN programs_NNS and_CC leave_VB the_DT population_NN susceptible_JJ to_IN outbreaks_NNS ._. This_DT paper_NN explores_VBZ vaccination_NN programs_NNS with_IN an_DT eye_NN toward_IN greater_JJR public_JJ safety_NN without_IN ignoring_VBG the_DT reality_NN of_IN a_DT small_JJ but_CC committed_VBN group_NN of_IN vaccine_NN critics_NNS ._. The_DT paper_NN begins_VBZ with_IN a_DT discussion_NN of_IN the_DT historical_JJ development_NN of_IN mandatory_JJ vaccination_NN policies_NNS and_CC the_DT issues_NNS posed_VBN by_IN exemptions_NNS ._. It_PRP then_RB addresses_VBZ some_DT of_IN these_DT issues_NNS in_IN the_DT context_NN of_IN vaccine_NN safety_NN ._. It_PRP also_RB seeks_VBZ solution_NN by_IN framing_VBG the_DT discussion_NN in_IN economic_JJ terms_NNS ._. It_PRP concludes_VBZ by_IN recommending_VBG stricter_JJR enforcement_NN of_IN mandatory_JJ requirements_NNS for_IN most_JJS vaccines_NNS and_CC greater_JJR dissemination_NN of_IN information_NN on_IN the_DT continued_VBN importance_NN of_IN vaccination_NN ._.","JJ NN : Why We RB VBD to VB NNS to VB Their NNP ( 2006 NNP NNP NN ) NN VBZ RB VBN one of the JJS JJ NNS of JJ NN . NN NNS that VBD JJ JJR than a NN RB VBP RB RB JJ because of NNS . In NN to VB JJ at VBG JJ NNS , NNS must VB VBN to JJ NNS of NNS in the NN . Because of this , JJ NN NNS VBP VBN NN for JJ NNS as a NN to NN NN . The JJ NN of NN NNS may VB NNS to VB the NNS of NN and VB JJR on the NN of NN NNS . RB , some VBP VBN the JJ NN of these NNS . These NNS may VB to an RB JJ NN of NNS , which can VB NN NNS and VB the NN JJ to NNS . This NN VBZ NN NNS with an NN toward JJR JJ NN without VBG the NN of a JJ but VBN NN of NN NNS . The NN VBZ with a NN of the JJ NN of JJ NN NNS and the NNS VBN by NNS . It RB VBZ some of these NNS in the NN of NN NN . It RB VBZ NN by VBG the NN in JJ NNS . It VBZ by VBG JJR NN of JJ NNS for JJS NNS and JJR NN of NN on the VBN NN of NN ."
147,588,mainstream,"I_PRP 'm_VBP traveling_VBG this_DT week_NN and_CC have_VBP not_RB only_RB experienced_VBN ""_`` away_RB from_IN the_DT internet_NN ""_'' for_IN longer_JJR periods_NNS than_IN I_PRP planned_VBD ,_, I_PRP 'm_VBP exhausted_JJ ._. And_CC now_RB ,_, bedtime_NN ,_, I_PRP realize_VBP I_PRP left_VBD my_PRP$ New_NNP Yorker_NNP at_IN home_NN ._. And_CC dumb_JJ www.newyorker.com_ADD is_VBZ n't_RB delivering_VBG me_PRP the_DT article_NN in_IN a_DT search_NN ,_, nor_CC have_VBP I_PRP been_VBN able_JJ to_TO find_VB it_PRP through_IN the_DT browse_NN ._. I_PRP 'm_VBP reading_VBG an_DT article_NN in_IN one_CD of_IN the_DT February_NNP issues_NNS about_IN the_DT politics_NNS surrounding_VBG the_DT HPV_NN –_: er_NN ,_, Human_JJ papillomavirus_NN –_: vaccine_NN ._. IIRC_NNP ,_, two_CD drug_NN companies_NNS have_VBP developed_VBN and_CC tested_VBN vaccines_NNS that_WDT have_VBP been_VBN 100_CD percent_NN effective_JJ in_IN animal_NN and_CC human_JJ tests_NNS in_IN preventing_VBG HPV_NN infections_NNS ._. HPV_NNP ,_, as_IN you_PRP know_VBP ,_, causes_VBZ genital_JJ warts_NNS ,_, is_VBZ highly_RB contagious_JJ (_-LRB- roughly_RB 50_CD %_NN of_IN Americans_NNPS contract_VBP it_PRP ,_, and_CC that_DT 's_VBZ a_DT conservative_JJ figure_NN )_-RRB- ,_, is_VBZ incurable_JJ albeit_RB treatable_JJ ,_, and_CC is_VBZ a_DT prime_JJ culprit_NN in_IN cervical_JJ cancer_NN ._.","I VBP VBG this NN and VBP RB RB VBN "" RB from the NN "" for JJR NNS than I VBD , I VBP JJ . And RB , NN , I VBP I VBD my NNP NNP at NN . And JJ www.newyorker.com VBZ RB VBG me the NN in a NN , nor VBP I VBN JJ to VB it through the NN . I VBP VBG an NN in one of the NNP NNS about the NNS VBG the NN – NN , JJ NN – NN . NNP , two NN NNS VBP VBN and VBN NNS that VBP VBN 100 NN JJ in NN and JJ NNS in VBG NN NNS . NNP , as you VBP , VBZ JJ NNS , VBZ RB JJ ( RB 50 NN of NNPS VBP it , and that VBZ a JJ NN ) , VBZ JJ RB JJ , and VBZ a JJ NN in JJ NN ."
148,1031,mainstream,"Public_JJ health_NN advocates_NNS and_CC doctors_NNS in_IN Alberta_NNP are_VBP voicing_VBG concerns_NNS about_IN the_DT spread_NN of_IN misinformation_NN after_IN an_DT anti-vaccination_NN film_NN was_VBD screened_VBN at_IN public_JJ libraries_NNS and_CC select_JJ movie_NN theatres_NNS in_IN the_DT province_NN ._. Princess_NN Theatre_NN in_IN Edmonton_NNP and_CC Plaza_NNP Theatre_NNP in_IN Calgary_NNP hosted_VBD multiple_JJ screenings_NNS of_IN the_DT controversial_JJ film_NN Vaxxed_NNP II_CD :_: The_DT People_NNP 's_POS Truth_NNP ,_, a_DT sequel_NN to_IN a_DT 2016_CD documentary_NN that_WDT spread_VBD the_DT unfounded_JJ claim_NN that_IN vaccines_NNS are_VBP linked_VBN to_IN autism_NN ._. The_DT anti-vaccine_JJ non-profit_JJ group_NN Canadians_NNPS for_IN Vaccine_NNP Choice_NNP has_VBZ also_RB hosted_VBN screenings_NNS at_IN the_DT Grande_NNP Prairie_NNP and_CC Medicine_NNP Hat_NNP public_JJ libraries_NNS this_DT month_NN ._. ""_`` It_PRP 's_VBZ not_RB scientific_JJ at_IN all_DT ._. It_PRP 's_VBZ total_JJ propaganda_NN based_VBN on_IN people_NNS 's_POS emotions_NNS ,_, ""_'' said_VBD Dr._NNP Joan_NNP Robinson_NNP ,_, a_DT pediatric_JJ infectious_JJ diseases_NNS specialist_NN at_IN the_DT University_NNP of_IN Alberta_NNP ._. ""_`` I_PRP think_VBP it_PRP 's_VBZ very_RB disappointing_JJ that_IN it_PRP would_MD be_VB shown_VBN in_IN a_DT public_JJ forum_NN ,_, especially_RB by_IN the_DT public_JJ library_NN ._. ""_'' The_DT original_JJ 2016_CD Vaxxed_NNP documentary_NN was_VBD directed_VBN and_CC co-written_VBN by_IN Andrew_NNP Wakefield_NNP ,_, who_WP led_VBD a_DT now_RB -_HYPH discredited_VBN 1998_CD study_NN that_WDT fuelled_VBD the_DT claim_NN that_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN is_VBZ linked_VBN to_IN autism_NN ._. The_DT filmmakers_NNS say_VBP they_PRP connected_VBD with_IN thousands_NNS of_IN people_NNS eager_JJ to_TO tell_VB their_PRP$ stories_NNS in_IN the_DT wake_NN of_IN its_PRP$ release_NN ._. Those_DT stories_NNS form_VBP the_DT backbone_NN of_IN the_DT sequel_NN ,_, Vaxxed_NNP II_CD ._. ""_`` There_EX is_VBZ absolutely_RB no_DT question_NN in_IN my_PRP$ mind_NN after_IN making_VBG this_DT film_NN that_IN these_DT doctors_NNS do_VBP n't_RB know_VB what_WP they_PRP 're_VBP talking_VBG about_IN ,_, ""_'' said_VBD director_NN Brian_NNP Burrowes_NNP ._. The_DT film_NN leans_VBZ to_IN anecdotal_JJ evidence_NN more_JJR than_IN data_NN ,_, featuring_VBG parents_NNS emboldened_VBN by_IN the_DT original_JJ film_NN sharing_VBG the_DT belief_NN that_IN immunizations_NNS harmed_VBD their_PRP$ child_NN ._. ""_`` It_PRP 's_VBZ untrue_JJ ._. It_PRP 's_VBZ fearmongering_VBG ,_, ""_'' said_VBD Timothy_NNP Caulfield_NNP ,_, Canada_NNP Research_NNP Chair_NNP in_IN health_NN law_NN and_CC policy_NN at_IN the_DT University_NNP of_IN Alberta_NNP ._. ""_`` This_DT is_VBZ not_RB about_IN an_DT open_JJ debate_NN and_CC freedom_NN of_IN expression_NN ._. This_DT is_VBZ really_RB about_IN the_DT spreading_NN of_IN harmful_JJ information_NN that_WDT can_MD really_RB erode_VB public_JJ confidence_NN in_IN vaccines_NNS ._. ""_'' The_DT owner_NN of_IN Princess_NNP and_CC Plaza_NNP theatres_NNS did_VBD not_RB respond_VB to_IN a_DT request_NN for_IN comment_NN from_IN CBC_NNP News_NNP ._. Canadians_NNPS for_IN Vaccine_NNP Choice_NNP scheduled_VBD another_DT screening_NN of_IN the_DT film_NN in_IN Edmonton_NNP on_IN Feb._NNP 1_CD ,_, but_CC will_MD only_RB disclose_VB the_DT location_NN to_IN ticket_NN holders_NNS a_DT day_NN in_IN advance_NN ._. ""_`` If_IN we_PRP really_RB believe_VBP in_IN science_NN in_IN society_NN ,_, then_RB I_PRP think_VBP we_PRP should_MD not_RB be_VB trying_VBG to_TO promote_VB something_NN that_WDT 's_VBZ completely_RB not_RB scientific_JJ to_IN the_DT general_JJ public_NN ,_, ""_'' Robinson_NNP said_VBD ._. The_DT film_NN was_VBD screened_VBN in_IN a_DT rented_VBN room_NN at_IN the_DT Grande_NNP Prairie_NNP Public_NNP Library_NNP on_IN Monday_NNP afternoon_NN to_IN about_RB eight_CD people_NNS ,_, including_VBG three_CD organizers_NNS of_IN the_DT event_NN ,_, according_VBG to_IN library_NN director_NN Deb_NNP Cryderman_NNP ._. Cryderman_NNP justified_VBD the_DT decision_NN to_TO rent_VB the_DT room_NN based_VBN on_IN the_DT library_NN 's_POS commitment_NN to_IN free_JJ expression_NN ._. The_DT rental_JJ policy_NN simply_RB states_VBZ a_DT library_NN will_MD not_RB knowingly_RB allow_VB the_DT space_NN to_TO be_VB used_VBN for_IN any_DT illegal_JJ activity_NN ._. Otherwise_RB ,_, anyone_NN is_VBZ welcome_JJ ,_, Cryderman_NNP said_VBD ._. ""_`` Even_RB if_IN information_NN is_VBZ controversial_JJ or_CC does_VBZ n't_RB correlate_VB with_IN our_PRP$ beliefs_NNS or_CC we_PRP do_VBP n't_RB agree_VB with_IN it_PRP ,_, we_PRP can_MD still_RB offer_VB a_DT room_NN rental_NN ,_, ""_'' she_PRP said_VBD ._. Chief_JJ librarian_NN Ken_NNP Feser_NNP of_IN the_DT Medicine_NNP Hat_NNP Public_NNP Library_NNP referenced_VBD a_DT similar_JJ policy_NN to_TO justify_VB the_DT decision_NN to_TO rent_VB out_RP a_DT room_NN for_IN the_DT film_NN on_IN Jan._NNP 21_CD ._. But_CC Caulfield_NNP said_VBD he_PRP feared_VBD the_DT public_JJ libraries_NNS were_VBD offering_VBG a_DT veneer_NN of_IN legitimacy_NN to_IN the_DT film_NN 's_POS misinformation_NN ._. ""_`` We_PRP know_VBP that_IN the_DT spread_NN of_IN misinformation_NN is_VBZ connected_VBN to_IN physical_JJ harm_NN ,_, people_NNS getting_VBG infectious_JJ diseases_NNS ,_, and_CC given_VBN that_IN I_PRP think_VBP there_EX 's_VBZ a_DT justification_NN for_IN saying_VBG ,_, no_UH ,_, we_PRP 're_VBP not_RB going_VBG to_TO show_VB this_DT kind_NN of_IN material_NN ,_, ""_'' he_PRP said_VBD ._. About_RB a_DT dozen_CD people_NNS mingled_VBD in_IN the_DT foyer_NN of_IN the_DT Princess_NNP Theatre_NNP after_IN a_DT Sunday_NNP matinee_NN screening_NN of_IN the_DT documentary_NN ._. Luba_NNP Moe_NNP said_VBD that_IN while_IN she_PRP immunized_VBD her_PRP$ own_JJ children_NNS ,_, she_PRP 's_VBZ glad_JJ her_PRP$ grandchildren_NNS are_VBP unvaccinated_VBN after_IN watching_VBG the_DT film_NN ._. ""_`` If_IN I_PRP had_VBD to_TO do_VB it_PRP over_RP again_RB ,_, there_EX is_VBZ no_DT way_NN I_PRP would_MD vaccinate_VB them_PRP ._. No_DT way_NN ,_, ""_'' she_PRP said_VBD ._. Moe_NNP teared_VBD up_RP as_IN she_PRP recalled_VBD the_DT parents_NNS in_IN the_DT film_NN ._. ""_`` These_DT are_VBP n't_RB tears_NNS of_IN sadness_NN ,_, they_PRP 're_VBP tears_NNS of_IN passion_NN ,_, ""_'' Moe_NNP said_VBD ._. ""_`` They_PRP 're_VBP holding_VBG us_PRP in_IN fear_NN ,_, and_CC we_PRP 've_VBP got_VBN to_TO wake_VB up_RP and_CC do_VB our_PRP$ own_JJ research_NN and_CC not_RB follow_VB like_IN a_DT bunch_NN of_IN lambs_NNS to_IN the_DT slaughter_NN ._. ""_'' The_DT rise_NN of_IN the_DT anti-vaccination_NN movement_NN has_VBZ prompted_VBN the_DT World_NNP Health_NNP Organization_NNP to_TO name_VB vaccine_NN hesitancy_NN a_DT last_JJ year_NN ._. About_RB half_NN of_IN Canadians_NNPS have_VBP some_DT level_NN of_IN vaccine_NN hesitancy_NN ,_, according_VBG to_IN by_IN U.K._NNP -_HYPH based_VBN Wellcome_NNP Global_NNP Monitor_NNP that_WDT tracks_VBZ global_JJ confidence_NN in_IN immunization_NN ._. that_IN hesitancy_NN is_VBZ propelling_VBG some_DT measles_NNS outbreaks_NNS in_IN ._. But_CC the_DT filmmakers_NNS are_VBP pleased_JJ to_TO know_VB the_DT movie_NN is_VBZ turning_VBG people_NNS away_RB from_IN immunization_NN ._. ""_`` Anytime_RB someone_NN decides_VBZ not_RB to_TO vaccinate_VB ,_, I_PRP 'm_VBP perfectly_RB happy_JJ with_IN it_PRP ._. I_PRP 'm_VBP not_RB worried_JJ these_DT diseases_NNS are_VBP going_VBG to_TO come_VB back_RB ,_, ""_'' said_VBD film_NN director_NN Burrowes_NNP ._. The_DT largest_JJS and_CC most_RBS recent_JJ study_NN looking_VBG for_IN correlation_NN between_IN the_DT MMR_NN vaccine_NN and_CC autism_NN covered_VBD roughly_RB 650,000_CD children_NNS born_VBN in_IN Denmark_NNP over_RB 14_CD years_NNS and_CC found_VBD no_DT increased_VBN risk_NN for_IN autism_NN among_IN babies_NNS with_IN the_DT MMR_NN vaccine_NN ._. Measles_NN has_VBZ been_VBN virtually_RB eliminated_VBN in_IN Canada_NNP since_IN the_DT vaccine_NN was_VBD introduced_VBN in_IN the_DT 1960s_NNS ._. At_IN the_DT time_NN ,_, there_EX were_VBD upwards_NNS of_IN ._. Last_JJ year_NN ,_, there_EX were_VBD 113_CD cases_NNS reported_VBN by_IN ._. Another_DT chief_JJ claim_NN of_IN the_DT film_NN is_VBZ that_IN the_DT HPV_NN vaccine_NN produced_VBD serious_JJ ,_, life_NN -_HYPH altering_VBG symptoms_NNS ._. But_CC a_DT systematic_JJ review_NN completed_VBN for_IN the_DT found_VBN no_DT relationship_NN between_IN any_DT serious_JJ adverse_JJ event_NN and_CC the_DT vaccine_NN ._. On_IN the_DT contrary_NN ,_, scientists_NNS from_IN Canada_NNP and_CC Britain_NNP found_VBD the_DT vaccine_NN significantly_RB reduced_VBD the_DT likelihood_NN of_IN contracting_VBG the_DT virus_NN that_WDT causes_VBZ a_DT majority_NN of_IN cervical_JJ cancers_NNS ._. ""_`` I_PRP really_RB do_VBP n't_RB see_VB how_WRB anyone_NN could_MD think_VB that_DT 's_VBZ not_RB a_DT good_JJ thing_NN :_: a_DT vaccine_NN for_IN cancer_NN ,_, ""_'' said_VBD Robinson_NNP","JJ NN NNS and NNS in NNP VBP VBG NNS about the NN of NN after an NN NN VBD VBN at JJ NNS and JJ NN NNS in the NN . NN NN in NNP and NNP NNP in NNP VBD JJ NNS of the JJ NN NNP II : The NNP 's NNP , a NN to a 2016 NN that VBD the JJ NN that NNS VBP VBN to NN . The JJ JJ NN NNPS for NNP NNP VBZ RB VBN NNS at the NNP NNP and NNP NNP JJ NNS this NN . "" It VBZ RB JJ at all . It VBZ JJ NN VBN on NNS 's NNS , "" VBD NNP NNP NNP , a JJ JJ NNS NN at the NNP of NNP . "" I VBP it VBZ RB JJ that it would VB VBN in a JJ NN , RB by the JJ NN . "" The JJ 2016 NNP NN VBD VBN and VBN by NNP NNP , who VBD a RB - VBN 1998 NN that VBD the NN that NNS , NNS and NN ( NNP ) NN VBZ VBN to NN . The NNS VBP they VBD with NNS of NNS JJ to VB their NNS in the NN of its NN . Those NNS VBP the NN of the NN , NNP II . "" There VBZ RB no NN in my NN after VBG this NN that these NNS VBP RB VB what they VBP VBG about , "" VBD NN NNP NNP . The NN VBZ to JJ NN JJR than NN , VBG NNS VBN by the JJ NN VBG the NN that NNS VBD their NN . "" It VBZ JJ . It VBZ VBG , "" VBD NNP NNP , NNP NNP NNP in NN NN and NN at the NNP of NNP . "" This VBZ RB about an JJ NN and NN of NN . This VBZ RB about the NN of JJ NN that can RB VB JJ NN in NNS . "" The NN of NNP and NNP NNS VBD RB VB to a NN for NN from NNP NNP . NNPS for NNP NNP VBD another NN of the NN in NNP on NNP 1 , but will RB VB the NN to NN NNS a NN in NN . "" If we RB VBP in NN in NN , RB I VBP we should RB VB VBG to VB NN that VBZ RB RB JJ to the JJ NN , "" NNP VBD . The NN VBD VBN in a VBN NN at the NNP NNP NNP NNP on NNP NN to RB eight NNS , VBG three NNS of the NN , VBG to NN NN NNP NNP . NNP VBD the NN to VB the NN VBN on the NN 's NN to JJ NN . The JJ NN RB VBZ a NN will RB RB VB the NN to VB VBN for any JJ NN . RB , NN VBZ JJ , NNP VBD . "" RB if NN VBZ JJ or VBZ RB VB with our NNS or we VBP RB VB with it , we can RB VB a NN NN , "" she VBD . JJ NN NNP NNP of the NNP NNP NNP NNP VBD a JJ NN to VB the NN to VB out a NN for the NN on NNP 21 . But NNP VBD he VBD the JJ NNS VBD VBG a NN of NN to the NN 's NN . "" We VBP that the NN of NN VBZ VBN to JJ NN , NNS VBG JJ NNS , and VBN that I VBP there VBZ a NN for VBG , no , we VBP RB VBG to VB this NN of NN , "" he VBD . RB a dozen NNS VBD in the NN of the NNP NNP after a NNP NN NN of the NN . NNP NNP VBD that while she VBD her JJ NNS , she VBZ JJ her NNS VBP VBN after VBG the NN . "" If I VBD to VB it over RB , there VBZ no NN I would VB them . No NN , "" she VBD . NNP VBD up as she VBD the NNS in the NN . "" These VBP RB NNS of NN , they VBP NNS of NN , "" NNP VBD . "" They VBP VBG us in NN , and we VBP VBN to VB up and VB our JJ NN and RB VB like a NN of NNS to the NN . "" The NN of the NN NN VBZ VBN the NNP NNP NNP to VB NN NN a JJ NN . RB NN of NNPS VBP some NN of NN NN , VBG to by NNP - VBN NNP NNP NNP that VBZ JJ NN in NN . that NN VBZ VBG some NNS NNS in . But the NNS VBP JJ to VB the NN VBZ VBG NNS RB from NN . "" RB NN VBZ RB to VB , I VBP RB JJ with it . I VBP RB JJ these NNS VBP VBG to VB RB , "" VBD NN NN NNP . The JJS and RBS JJ NN VBG for NN between the NN NN and NN VBD RB 650,000 NNS VBN in NNP RB 14 NNS and VBD no VBN NN for NN among NNS with the NN NN . NN VBZ VBN RB VBN in NNP since the NN VBD VBN in the NNS . At the NN , there VBD NNS of . JJ NN , there VBD 113 NNS VBN by . Another JJ NN of the NN VBZ that the NN NN VBD JJ , NN - VBG NNS . But a JJ NN VBN for the VBN no NN between any JJ JJ NN and the NN . On the NN , NNS from NNP and NNP VBD the NN RB VBD the NN of VBG the NN that VBZ a NN of JJ NNS . "" I RB VBP RB VB how NN could VB that VBZ RB a JJ NN : a NN for NN , "" VBD NNP"
149,1017,mainstream,"Our_PRP$ general_JJ interest_NN e-newsletter_NN keeps_VBZ you_PRP up_RP to_IN date_NN on_IN a_DT wide_JJ variety_NN of_IN health_NN topics_NNS ._. Along_IN with_IN its_PRP$ needed_VBN effects_NNS ,_, a_DT medicine_NN may_MD cause_VB some_DT unwanted_JJ effects_NNS ._. Although_IN not_RB all_DT of_IN these_DT side_NN effects_NNS may_MD occur_VB ,_, if_IN they_PRP do_VBP occur_VB they_PRP may_MD need_VB medical_JJ attention_NN ._. Check_VB with_IN your_PRP$ doctor_NN or_CC nurse_NN immediately_RB if_IN any_DT of_IN the_DT following_VBG side_NN effects_NNS occur_VBP :_: •_NFP Bloating_VBG or_CC swelling_NN of_IN the_DT face_NN ,_, arms_NNS ,_, hands_NNS ,_, lower_JJR legs_NNS ,_, or_CC feet_NNS •_, puffiness_NN or_CC swelling_NN of_IN the_DT eyelids_NNS or_CC around_IN the_DT eyes_NNS ,_, face_NN ,_, lips_NNS ,_, or_CC tongue_NN •_, swelling_NN or_CC puffiness_NN of_IN the_DT face_NN •_, swollen_JJ ,_, painful_JJ ,_, or_CC tender_JJ lymph_NN glands_NNS in_IN the_DT neck_NN ,_, armpit_NN ,_, or_CC groin_NN •_, tingling_NN of_IN the_DT hands_NNS or_CC feet_NNS Some_DT side_NN effects_NNS may_MD occur_VB that_WDT usually_RB do_VBP not_RB need_VB medical_JJ attention_NN ._. These_DT side_NN effects_NNS may_MD go_VB away_RB during_IN treatment_NN as_IN your_PRP$ body_NN adjusts_VBZ to_IN the_DT medicine_NN ._. Also_RB ,_, your_PRP$ health_NN care_NN professional_NN may_MD be_VB able_JJ to_TO tell_VB you_PRP about_IN ways_NNS to_TO prevent_VB or_CC reduce_VB some_DT of_IN these_DT side_NN effects_NNS ._. Check_VB with_IN your_PRP$ health_NN care_NN professional_NN if_IN any_DT of_IN the_DT following_VBG side_NN effects_NNS continue_VBP or_CC are_VBP bothersome_JJ or_CC if_IN you_PRP have_VBP any_DT questions_NNS about_IN them_PRP :_: •_NFP Hard_JJ lumps_NNS ,_, redness_NN ,_, tenderness_NN ,_, or_CC warmth_NN at_IN the_DT injection_NN site_NN •_NFP pain_NN in_IN the_DT arms_NNS or_CC legs_NNS Other_JJ side_NN effects_NNS not_RB listed_VBN may_MD also_RB occur_VB in_IN some_DT patients_NNS ._. If_IN you_PRP notice_VBP any_DT other_JJ effects_NNS ,_, check_VB with_IN your_PRP$ healthcare_NN professional_NN ._. Call_VB your_PRP$ doctor_NN for_IN medical_JJ advice_NN about_IN side_NN effects_NNS ._. You_PRP may_MD report_VB side_NN effects_NNS to_IN the_DT FDA_NNP at_IN 1_CD -_SYM 800_CD -_HYPH FDA_NNP -_SYM 1088_CD ._.","Our JJ NN NN VBZ you up to NN on a JJ NN of NN NNS . Along with its VBN NNS , a NN may VB some JJ NNS . Although RB all of these NN NNS may VB , if they VBP VB they may VB JJ NN . VB with your NN or NN RB if any of the VBG NN NNS VBP : • VBG or NN of the NN , NNS , NNS , JJR NNS , or NNS • NN or NN of the NNS or around the NNS , NN , NNS , or NN • NN or NN of the NN • JJ , JJ , or JJ NN NNS in the NN , NN , or NN • NN of the NNS or NNS Some NN NNS may VB that RB VBP RB VB JJ NN . These NN NNS may VB RB during NN as your NN VBZ to the NN . RB , your NN NN NN may VB JJ to VB you about NNS to VB or VB some of these NN NNS . VB with your NN NN NN if any of the VBG NN NNS VBP or VBP JJ or if you VBP any NNS about them : • JJ NNS , NN , NN , or NN at the NN NN • NN in the NNS or NNS JJ NN NNS RB VBN may RB VB in some NNS . If you VBP any JJ NNS , VB with your NN NN . VB your NN for JJ NN about NN NNS . You may VB NN NNS to the NNP at 1 - 800 - NNP - 1088 ."
150,1144,mainstream,"Our_PRP$ general_JJ interest_NN e-newsletter_NN keeps_VBZ you_PRP up_RP to_IN date_NN on_IN a_DT wide_JJ variety_NN of_IN health_NN topics_NNS ._. Be_VB sure_JJ to_TO notify_VB your_PRP$ doctor_NN of_IN any_DT side_NN effects_NNS that_WDT occur_VBP after_IN you_PRP receive_VBP this_DT vaccine_NN ._. This_DT vaccine_NN may_MD cause_VB a_DT serious_JJ type_NN of_IN allergic_JJ reaction_NN called_VBN anaphylaxis_NN ._. Anaphylaxis_NN can_MD be_VB life_NN -_HYPH threatening_VBG and_CC requires_VBZ immediate_JJ medical_JJ attention_NN ._. Tell_VB your_PRP$ doctor_NN right_RB away_RB if_IN you_PRP have_VBP a_DT rash_NN ,_, itching_NN ,_, swelling_NN of_IN the_DT tongue_NN and_CC throat_NN ,_, or_CC troubled_VBN breathing_NN after_IN you_PRP get_VBP the_DT injection_NN ._. Influenza_NN virus_NN vaccine_NN may_MD not_RB protect_VB everyone_NN who_WP receives_VBZ the_DT vaccine_NN ._. Also_RB ,_, this_DT vaccine_NN will_MD not_RB treat_VB flu_NN symptoms_NNS if_IN you_PRP already_RB have_VBP the_DT virus_NN ._. Make_VB sure_JJ your_PRP$ doctor_NN knows_VBZ if_IN you_PRP are_VBP using_VBG a_DT medicine_NN or_CC treatment_NN that_WDT weakens_VBZ your_PRP$ immune_JJ system_NN ,_, such_JJ as_IN a_DT steroid_NN ,_, radiation_NN ,_, or_CC cancer_NN treatment_NN ._. This_DT vaccine_NN may_MD not_RB work_VB as_RB well_RB if_IN you_PRP are_VBP also_RB using_VBG these_DT medicines_NNS ._. Your_PRP$ doctor_NN may_MD still_RB want_VB you_PRP to_TO get_VB the_DT vaccine_NN because_IN it_PRP can_MD give_VB you_PRP some_DT protection_NN ._.","Our JJ NN NN VBZ you up to NN on a JJ NN of NN NNS . VB JJ to VB your NN of any NN NNS that VBP after you VBP this NN . This NN may VB a JJ NN of JJ NN VBN NN . NN can VB NN - VBG and VBZ JJ JJ NN . VB your NN RB RB if you VBP a NN , NN , NN of the NN and NN , or VBN NN after you VBP the NN . NN NN NN may RB VB NN who VBZ the NN . RB , this NN will RB VB NN NNS if you RB VBP the NN . VB JJ your NN VBZ if you VBP VBG a NN or NN that VBZ your JJ NN , JJ as a NN , NN , or NN NN . This NN may RB VB RB RB if you VBP RB VBG these NNS . Your NN may RB VB you to VB the NN because it can VB you some NN ."
151,736,conspiracy,"As_IN Natural_JJ News_NN readers_NNS are_VBP well_RB aware_JJ ,_, Americans_NNPS who_WP dare_VBP to_TO oppose_VB mandatory_JJ vaccination_NN for_IN any_DT reason_NN ,_, including_VBG that_IN they_PRP do_VBP n’t_RB believe_VB that_IN all_DT vaccines_NNS are_VBP safe_JJ ,_, are_VBP often_RB ridiculed_VBN ,_, marginalized_VBN and_CC minimized_VBN by_IN Big_NNP Pharma_NNP vaccine_NN pushers_NNS and_CC the_DT mainstream_JJ medical_JJ community_NN ._. One_CD of_IN the_DT things_NNS that_WDT they_PRP most_RBS often_RB insist_VBP on_IN is_VBZ that_IN “_`` vaccines_NNS are_VBP safe_JJ ”_'' and_CC that_IN there_EX is_VBZ no_DT reason_NN to_TO fear_VB being_VBG vaccinated_VBN ._. •_SYM ABC_NNP :_: Senator_NNP Dick_NNP Pan_NN seeks_VBZ to_TO do_VB away_RB with_IN “_`` bogus_JJ medical_JJ exemptions_NNS ”_'' in_IN California_NNP (_-LRB- he_PRP ’s_VBZ already_RB gotten_VBN rid_JJ of_IN religious_JJ and_CC personal_JJ belief_NN )_-RRB- And_CC yet_CC ,_, when_WRB vaccine_NN injuries_NNS occur_VBP –_: which_WDT is_VBZ often_RB enough_JJ that_IN the_DT federal_JJ government_NN maintains_VBZ a_DT vaccine_NN injury_NN fund_NN –_: they_PRP are_VBP brushed_VBN under_IN the_DT rug_NN by_IN the_DT mainstream_JJ media_NN as_IN “_`` rare_JJ ”_'' and_CC “_`` unusual_JJ ,_, ”_'' if_IN such_JJ incidents_NNS are_VBP covered_VBN at_IN all_DT ._. But_CC one_CD man_NN who_WP was_VBD recently_RB injured_VBN by_IN vaccines_NNS has_VBZ as_IN compelling_JJ a_DT case_NN to_TO make_VB against_IN mandatory_JJ vaccination_NN as_IN anyone_NN :_: Ironically_RB ,_, he_PRP once_RB worked_VBD for_IN California_NNP Sen_NNP ._. Richard_NNP Pan_NNP –_: the_DT pediatrician_NN /_, lawmaker_NN behind_IN SB277_NNP ,_, the_DT state_NN ’s_POS recently_RB enacted_VBN mandatory_JJ vaccination_NN law_NN ._. He_PRP explains_VBZ in_IN a_DT new_JJ video_NN (_-LRB- which_WDT is_VBZ no_RB longer_RBR available_JJ )_-RRB- what_WP he_PRP believes_VBZ is_VBZ motivating_VBG his_PRP$ former_JJ boss_NN ._. The_DT man_NN ,_, John_NNP Berchielli_NNP ,_, says_VBZ he_PRP “_`` was_VBD a_DT perfectly_RB healthy_JJ person_NN ”_'' before_IN he_PRP received_VBD “_`` a_DT vaccination_NN recommended_VBN by_IN my_PRP$ doctor_NN ._. ”_'' (_-LRB- Although_IN the_DT original_JJ video_NN is_VBZ no_RB longer_RBR available_JJ ,_, you_PRP can_MD check_VB out_RP the_DT one_CD below_RB that_WDT we_PRP found_VBD ._. )_-RRB- The_DT “_`` disease_NN or_CC syndrome_NN ”_'' that_WDT he_PRP has_VBZ since_RB contracted_VBN has_VBZ left_VBN him_PRP bedridden_JJ ,_, wheelchair_NN -_HYPH bound_VBN and_CC partially_RB paralyzed_VBN ,_, he_PRP said_VBD ._. And_CC now_RB that_IN he_PRP is_VBZ stricken_VBN ,_, he_PRP says_VBZ slowly_RB ,_, “_`` it_PRP ’s_VBZ hard_JJ not_RB to_TO think_VB of_IN the_DT decisions_NNS of_IN …_: Gov._NNP [_-LRB- Jerry_NNP ]_-RRB- Brown_NNP [_-LRB- of_IN California_NNP ]_-RRB- and_CC [_-LRB- Democratic_NNP ]_-RRB- Sen_NNP ._. Richard_NNP Pan_NNP on_IN the_DT mandatory_JJ bill_NN they_PRP signed_VBD into_IN law_NN requiring_VBG children_NNS to_TO be_VB vaccinated_VBN in_IN order_NN to_TO get_VB a_DT public_JJ education_NN ._. ”_'' “_`` From_IN looking_VBG on_IN the_DT Internet_NNP and_CC from_IN the_DT Mayo_NNP Clinic_NNP ’s_POS website_NN ,_, ”_'' he_PRP continued_VBD ,_, “_`` 20,000_CD people_NNS a_DT year_NN are_VBP afflicted_VBN by_IN this_DT …_: syndrome_NN that_WDT I_PRP have_VBP ._. Our_PRP$ lawmakers_NNS recently_RB passed_VBD a_DT law_NN that_WDT allows_VBZ vaccines_NNS to_TO be_VB mandated_VBN ,_, yet_CC the_DT manufacturers_NNS have_VBP complete_JJ immunity_NN of_IN the_DT side_NN effects_NNS and_CC damages_NNS caused_VBN by_IN their_PRP$ vaccines_NNS ._. ”_'' You_PRP can_MD learn_VB more_JJR about_IN the_DT destruction_NN caused_VBN by_IN the_DT vaccines_NNS being_VBG forced_VBN on_IN the_DT American_NNP People_NNP by_IN visiting_VBG VaccineDamage.news_NNP ,_, powered_VBN by_IN FETCH._NNP news_NN ._. •_NFP Is_VBZ this_DT the_DT most_RBS savage_JJ witch_NN hunt_NN of_IN the_DT 21st_JJ Century_NN ?_. Berchielli_NNP went_VBD on_RP to_TO question_VB how_WRB Pan_NNP ,_, a_DT physician_NN who_WP runs_VBZ the_DT pediatric_JJ training_NN program_NN at_IN the_DT University_NNP of_IN California_NNP ,_, Davis_NNP ,_, campus_NN ,_, could_MD be_VB such_PDT an_DT advocate_NN for_IN a_DT vaccine_NN capable_JJ of_IN causing_VBG the_DT kind_NN of_IN harm_NN that_WDT he_PRP and_CC thousands_NNS of_IN others_NNS are_VBP suffering_VBG from_IN ,_, something_NN he_PRP called_VBD “_`` incomprehensible_JJ ._. ”_'' “_`` Not_RB only_RB does_VBZ he…_PRP lack_VB any_DT moral_JJ character_NN of_IN any_DT kind_NN ,_, but_CC because_IN this_DT law_NN is_VBZ a_DT primary_JJ fiscal_JJ benefit_NN to_IN the_DT University_NNP of_IN California_NNP [_-LRB- which_WDT ]_-RRB- does_VBZ the_DT research_NN and_CC development_NN of_IN these_DT vaccines_NNS and_CC then_RB gets_VBZ paid_VBN to_TO test_VB these_DT vaccines_NNS ,_, and_CC then_RB gets_VBZ paid_VBN to_TO administrate_VB these_DT vaccines_NNS ,_, it_PRP ’s_VBZ a_DT complete_JJ cash_NN cow_NN for_IN the_DT university_NN ,_, ”_'' he_PRP said_VBD ._. “_`` They_PRP bought_VBD themselves_PRP a_DT senator_NN named_VBN Dr._NNP Richard_NNP Pan_NNP ,_, who_WP used_VBD to_TO be_VB a_DT community_NN pediatrician_NN whose_WP$ philosophy_NN used_VBD to_TO be_VB at_IN the_DT time_NN I_PRP worked_VBD for_IN this_DT man_NN as_IN a_DT volunteer_NN for_IN over_RB seven_CD years_NNS ,_, in_IN the_DT capacity_NN of_IN pediatric_JJ training_NN ,_, ”_'' Berchielli_NNP continued_VBD ._. •_SYM YAHOO_NNP :_: Best_JJS -_HYPH selling_VBG novelist_NN ’s_POS anti-vax_JJ post_NN goes_VBZ viral_JJ :_: ‘_`` I_PRP do_VBP not_RB consent_VB ’_'' “_`` To_TO have_VB him_PRP become_VB a_DT tool_NN and_CC a_DT pawn_NN of_IN the_DT university_NN for_IN the_DT sake_NN of_IN generating_VBG billions_NNS and_CC billions_NNS of_IN dollars_NNS into_IN the_DT university_NN ,_, which_WDT is_VBZ a_DT direct_JJ benefit_NN to_IN the_DT state_NN of_IN California_NNP …_: it_PRP ’s_VBZ all_RB about_IN the_DT money_NN ,_, folks_NNS ,_, ”_'' he_PRP said_VBD ,_, adding_VBG that_IN UC_NNP Davis_NNP was_VBD also_RB one_CD of_IN Pan_NNP ’s_POS major_JJ campaign_NN contributors_NNS ._. What_WP has_VBZ happened_VBN in_IN California_NNP –_: and_CC likely_JJ to_TO happen_VB in_IN other_JJ states_NNS or_CC in_IN all_DT states_NNS –_: is_VBZ that_IN informed_VBN consent_NN and_CC personal_JJ choice_NN have_VBP been_VBN stripped_VBN away_RB from_IN residents_NNS ,_, Berchielli_NNP said_VBD ._. Another_DT man_NN interviewed_VBN in_IN the_DT (_-LRB- unavailable_JJ )_-RRB- video_NN ,_, Scott_NNP Cooper_NNP ,_, a_DT former_JJ Big_NNP Pharma_NNP rep_NN for_IN vaccine_NN giant_NN Merck_NNP ,_, said_VBD he_PRP would_MD never_RB vaccinate_VB his_PRP$ children_NNS ._. He_PRP said_VBD his_PRP$ son_NN ,_, now_RB 24_CD ,_, has_VBZ never_RB received_VBN vaccines_NNS and_CC was_VBD rarely_RB ever_RB sick_JJ ._. In_IN fact_NN ,_, he_PRP said_VBD ,_, his_PRP$ boy_NN seemed_VBD to_TO always_RB be_VB much_RB healthier_JJR than_IN his_PRP$ peers_NNS ._. Copyright_NN 2020_CD –_: permission_NN to_TO reprint_VB fully_RB granted_VBN ,_, WITH_IN links_NNS to_IN original_JJ story_NN","As JJ NN NNS VBP RB JJ , NNPS who VBP to VB JJ NN for any NN , VBG that they VBP RB VB that all NNS VBP JJ , VBP RB VBN , VBN and VBN by NNP NNP NN NNS and the JJ JJ NN . One of the NNS that they RBS RB VBP on VBZ that “ NNS VBP JJ ” and that there VBZ no NN to VB VBG VBN . • NNP : NNP NNP NN VBZ to VB RB with “ JJ JJ NNS ” in NNP ( he VBZ RB VBN JJ of JJ and JJ NN ) And yet , when NN NNS VBP – which VBZ RB JJ that the JJ NN VBZ a NN NN NN – they VBP VBN under the NN by the JJ NN as “ JJ ” and “ JJ , ” if JJ NNS VBP VBN at all . But one NN who VBD RB VBN by NNS VBZ as JJ a NN to VB against JJ NN as NN : RB , he RB VBD for NNP NNP . NNP NNP – the NN / NN behind NNP , the NN ’s RB VBN JJ NN NN . He VBZ in a JJ NN ( which VBZ RB RBR JJ ) what he VBZ VBZ VBG his JJ NN . The NN , NNP NNP , VBZ he “ VBD a RB JJ NN ” before he VBD “ a NN VBN by my NN . ” ( Although the JJ NN VBZ RB RBR JJ , you can VB out the one RB that we VBD . ) The “ NN or NN ” that he VBZ RB VBN VBZ VBN him JJ , NN - VBN and RB VBN , he VBD . And RB that he VBZ VBN , he VBZ RB , “ it VBZ JJ RB to VB of the NNS of … NNP [ NNP ] NNP [ of NNP ] and [ NNP ] NNP . NNP NNP on the JJ NN they VBD into NN VBG NNS to VB VBN in NN to VB a JJ NN . ” “ From VBG on the NNP and from the NNP NNP ’s NN , ” he VBD , “ 20,000 NNS a NN VBP VBN by this … NN that I VBP . Our NNS RB VBD a NN that VBZ NNS to VB VBN , yet the NNS VBP JJ NN of the NN NNS and NNS VBN by their NNS . ” You can VB JJR about the NN VBN by the NNS VBG VBN on the NNP NNP by VBG NNP , VBN by NNP NN . • VBZ this the RBS JJ NN NN of the JJ NN ? NNP VBD on to VB how NNP , a NN who VBZ the JJ NN NN at the NNP of NNP , NNP , NN , could VB such an NN for a NN JJ of VBG the NN of NN that he and NNS of NNS VBP VBG from , NN he VBD “ JJ . ” “ RB RB VBZ he… VB any JJ NN of any NN , but because this NN VBZ a JJ JJ NN to the NNP of NNP [ which ] VBZ the NN and NN of these NNS and RB VBZ VBN to VB these NNS , and RB VBZ VBN to VB these NNS , it VBZ a JJ NN NN for the NN , ” he VBD . “ They VBD themselves a NN VBN NNP NNP NNP , who VBD to VB a NN NN whose NN VBD to VB at the NN I VBD for this NN as a NN for RB seven NNS , in the NN of JJ NN , ” NNP VBD . • NNP : JJS - VBG NN ’s JJ NN VBZ JJ : ‘ I VBP RB VB ’ “ To VB him VB a NN and a NN of the NN for the NN of VBG NNS and NNS of NNS into the NN , which VBZ a JJ NN to the NN of NNP … it VBZ RB about the NN , NNS , ” he VBD , VBG that NNP NNP VBD RB one of NNP ’s JJ NN NNS . What VBZ VBN in NNP – and JJ to VB in JJ NNS or in all NNS – VBZ that VBN NN and JJ NN VBP VBN VBN RB from NNS , NNP VBD . Another NN VBN in the ( JJ ) NN , NNP NNP , a JJ NNP NNP NN for NN NN NNP , VBD he would RB VB his NNS . He VBD his NN , RB 24 , VBZ RB VBN NNS and VBD RB RB JJ . In NN , he VBD , his NN VBD to RB VB RB JJR than his NNS . NN 2020 – NN to VB RB VBN , WITH NNS to JJ NN"
152,934,mainstream,"The_DT responders_NNS carried_VBD 3,500_CD doses_NNS of_IN Ebola_NNP vaccine_NN and_CC 2,000_CD cartridges_NNS for_IN lab_NN testing_NN ,_, WHO_NNP chief_NN Tedros_NNP Adhanom_NNP Ghebreyesus_NNP told_VBD journalists_NNS covering_VBG his_PRP$ regular_JJ virtual_JJ update_NN on_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._. “_`` This_DT is_VBZ an_DT important_JJ reminder_NN that_IN even_RB as_IN WHO_NNP focuses_VBZ on_IN responding_VBG to_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, we_PRP continue_VBP to_TO monitor_VB and_CC respond_VB to_IN many_JJ other_JJ health_NN emergencies_NNS ,_, ”_'' he_PRP said_VBD ._. The_DT Ebola_NNP outbreak_NN in_IN Mbandaka_NNP ,_, located_VBN in_IN Equateur_NNP province_NN in_IN northwest_JJ DRC_NNP –_: on_IN the_DT opposite_JJ side_NN of_IN the_DT country_NN to_IN the_DT worst_JJS epidemic_NN in_IN the_DT country_NN ’s_POS history_NN that_WDT is_VBZ petering_VBG out_RP -_, was_VBD confirmed_VBN earlier_RBR this_DT week_NN ._. So_RB far_RB ,_, eight_CD cases_NNS have_VBP been_VBN detected_VBN ,_, four_CD of_IN whom_WP have_VBP died_VBN ._. “_`` The_DT latest_JJS person_NN confirmed_VBN with_IN Ebola_NNP attended_VBD the_DT burial_NN of_IN one_CD of_IN the_DT first_JJ cases_NNS ,_, but_CC was_VBD detected_VBN in_IN the_DT town_NN of_IN Bikoro_NNP ,_, 150_CD kilometres_NNS away_RB from_IN Mbandaka_NNP ._. This_DT means_VBZ that_IN two_CD health_NN zones_NNS are_VBP now_RB affected_VBN ,_, ”_'' said_VBD Tedros_NNP ._. Mbandaka_NNP had_VBD suffered_VBN a_DT previous_JJ Ebola_NNP outbreak_NN in_IN May_NNP 2018_CD ,_, which_WDT was_VBD halted_VBN in_IN three_CD months_NNS ._. Meanwhile_RB ,_, the_DT DRC_NNP is_VBZ still_RB fighting_VBG an_DT Ebola_NNP outbreak_NN in_IN the_DT east_NN that_WDT emerged_VBD in_IN August_NNP 2018_CD ,_, and_CC now_RB appears_VBZ to_TO be_VB in_IN its_PRP$ final_JJ stages_NNS ._. As_IN of_IN Wednesday_NNP ,_, the_DT global_JJ COVID_NN -_HYPH 19_CD caseload_NN had_VBD reached_VBN nearly_RB 6.3_CD million_CD ,_, with_IN nearly_RB 380,000_CD deaths_NNS ._. Tedros_NNP said_VBD more_JJR than_IN 100,000_CD cases_NNS of_IN the_DT disease_NN have_VBP been_VBN reported_VBN to_IN WHO_NNP for_IN each_DT of_IN the_DT past_JJ five_CD days_NNS ._. The_DT Americas_NNPS continue_VBP to_TO account_VB for_IN most_JJS cases_NNS worldwide_RB ._. For_IN several_JJ weeks_NNS now_RB ,_, the_DT region_NN has_VBZ had_VBN more_JJR cases_NNS than_IN all_DT other_JJ countries_NNS combined_VBN ._. “_`` We_PRP are_VBP especially_RB worried_JJ about_IN Central_JJ and_CC South_NNP America_NNP ,_, where_WRB many_JJ countries_NNS are_VBP witnessing_VBG accelerating_VBG epidemics_NNS ”_'' ,_, said_VBD the_DT WHO_NNP chief_NN ._. “_`` We_PRP also_RB see_VBP increasing_VBG numbers_NNS of_IN cases_NNS in_IN the_DT Eastern_NNP Mediterranean_NNP ,_, South_NNP -_HYPH East_NNP Asia_NNP and_CC Africa_NNP ,_, although_IN the_DT numbers_NNS are_VBP much_RB smaller_JJR ._. ”_'' Meanwhile_RB ,_, COVID_NNP -_HYPH 19_CD continues_VBZ to_TO be_VB on_IN the_DT decline_NN in_IN Europe_NNP ._. Tuesday_NNP saw_VBD the_DT fewest_JJS cases_NNS reported_VBN in_IN the_DT region_NN in_IN more_JJR than_IN two_CD months_NNS ._. Investigations_NNS will_MD continue_VB into_IN the_DT effectiveness_NN of_IN hydroxychloroquine_NN in_IN treating_VBG COVID_NN -_HYPH 19_CD ,_, Tedros_NNP further_RB reported_VBD ._. The_DT drug_NN ,_, which_WDT is_VBZ used_VBN to_TO treat_VB rheumatology_NN conditions_NNS ,_, was_VBD among_IN four_CD medicines_NNS being_VBG tested_VBN in_IN a_DT Solidarity_NNP Clinical_NNP Trial_NNP conducted_VBN by_IN WHO_NNP and_CC partners_NNS ._. The_DT Executive_JJ Group_NNP for_IN the_DT trial_NN ,_, representing_VBG 10_CD participating_VBG countries_NNS ,_, put_VBD hydroxychloroquine_NN on_IN pause_NN due_IN to_IN safety_NN concerns_NNS ._. A_DT monitoring_NN committee_NN has_VBZ been_VBN reviewing_VBG related_JJ data_NNS ._. “_`` On_IN the_DT basis_NN of_IN the_DT available_JJ mortality_NN data_NNS ,_, the_DT members_NNS of_IN the_DT committee_NN recommended_VBD that_IN there_EX are_VBP no_DT reasons_NNS to_TO modify_VB the_DT trial_NN protocol_NN ”_'' ,_, said_VBD Tedros_NNP ._. “_`` The_DT Executive_NNP Group_NNP received_VBD this_DT recommendation_NN and_CC endorsed_VBD the_DT continuation_NN of_IN all_DT arms_NNS of_IN the_DT Solidarity_NNP Trial_NNP ,_, including_VBG hydroxychloroquine_NN ._. ”_'' The_DT Solidarity_NNP Clinical_NNP Trial_NNP was_VBD announced_VBN on_IN 18_CD March_NNP :_: one_CD week_NN after_IN the_DT pandemic_NN was_VBD declared_VBN ,_, and_CC 60_CD days_NNS after_IN China_NNP shared_VBD the_DT genetic_JJ sequence_NN of_IN the_DT new_JJ coronavirus_NN ._. So_RB far_RB ,_, more_JJR than_IN 3,500_CD patients_NNS in_IN 35_CD countries_NNS have_VBP been_VBN recruited_VBN ._. The_DT other_JJ treatments_NNS under_IN study_NN are_VBP remdesivir_NN ,_, previously_RB tested_VBN as_IN an_DT Ebola_NNP treatment_NN ;_, lopinavir_NN /_, ritonavir_NN ,_, which_WDT is_VBZ a_DT licensed_VBN treatment_NN for_IN HIV_NN ;_, and_CC interferon_NN beta_NN -_HYPH 1a_NN ,_, a_DT medicine_NN for_IN multiple_JJ sclerosis_NN ._. Relatedly_RB ,_, the_DT UN_NNP and_CC the_DT International_NNP Red_NNP Cross_NNP and_CC Red_NNP Crescent_NNP Movement_NNP on_IN Wednesday_NNP called_VBD for_IN governments_NNS and_CC the_DT private_JJ sector_NN to_TO unite_VB towards_IN developing_VBG “_`` a_DT people_NN ’s_POS vaccine_NN ”_'' against_IN COVID_NN -_HYPH 19_CD ._. They_PRP stressed_VBD that_IN “_`` no_DT one_NN should_MD be_VB left_VBN behind_IN ”_'' in_IN the_DT race_NN to_TO identify_VB the_DT most_RBS effective_JJ means_NNS to_TO defeat_VB the_DT virus_NN ._. “_`` A_DT people_NNS ’s_POS vaccine_NN should_MD protect_VB the_DT affluent_JJ in_IN cities_NNS and_CC the_DT poor_JJ in_IN rural_JJ communities_NNS ,_, the_DT old_JJ in_IN care_NN homes_NNS and_CC the_DT young_JJ in_IN refugee_NN camps_NNS ”_'' ,_, they_PRP said_VBD ._. “_`` A_DT global_JJ social_JJ contract_NN for_IN a_DT people_NN ’s_POS vaccine_NN against_IN COVID_NNP -_HYPH 19_CD is_VBZ a_DT moral_JJ imperative_NN that_WDT brings_VBZ us_PRP all_RB together_RB in_IN our_PRP$ shared_VBN humanity_NN ._. ”_'' The_DT partners_NNS said_VBD unity_NN and_CC commitment_NN towards_IN this_DT common_JJ goal_NN should_MD also_RB spark_VB global_JJ resolve_NN to_TO sustain_VB immunization_NN against_IN preventable_JJ diseases_NNS ._. As_IN UN_NNP agencies_NNS have_VBP reported_VBN ,_, the_DT COVID_NNP -_HYPH 19_CD pandemic_NN has_VBZ forced_VBN many_JJ countries_NNS to_TO suspend_VB or_CC curtail_VB routine_JJ childhood_NN immunization_NN programmes_NNS ,_, putting_VBG some_DT 80_CD million_CD young_JJ lives_NNS at_IN risk_NN ._.","The NNS VBD 3,500 NNS of NNP NN and 2,000 NNS for NN NN , NNP NN NNP NNP NNP VBD NNS VBG his JJ JJ NN on the NN - 19 NN . “ This VBZ an JJ NN that RB as NNP VBZ on VBG to the NN - 19 NN , we VBP to VB and VB to JJ JJ NN NNS , ” he VBD . The NNP NN in NNP , VBN in NNP NN in JJ NNP – on the JJ NN of the NN to the JJS NN in the NN ’s NN that VBZ VBG out - VBD VBN RBR this NN . RB RB , eight NNS VBP VBN VBN , four of whom VBP VBN . “ The JJS NN VBN with NNP VBD the NN of one of the JJ NNS , but VBD VBN in the NN of NNP , 150 NNS RB from NNP . This VBZ that two NN NNS VBP RB VBN , ” VBD NNP . NNP VBD VBN a JJ NNP NN in NNP 2018 , which VBD VBN in three NNS . RB , the NNP VBZ RB VBG an NNP NN in the NN that VBD in NNP 2018 , and RB VBZ to VB in its JJ NNS . As of NNP , the JJ NN - 19 NN VBD VBN RB 6.3 million , with RB 380,000 NNS . NNP VBD JJR than 100,000 NNS of the NN VBP VBN VBN to NNP for each of the JJ five NNS . The NNPS VBP to VB for JJS NNS RB . For JJ NNS RB , the NN VBZ VBN JJR NNS than all JJ NNS VBN . “ We VBP RB JJ about JJ and NNP NNP , where JJ NNS VBP VBG VBG NNS ” , VBD the NNP NN . “ We RB VBP VBG NNS of NNS in the NNP NNP , NNP - NNP NNP and NNP , although the NNS VBP RB JJR . ” RB , NNP - 19 VBZ to VB on the NN in NNP . NNP VBD the JJS NNS VBN in the NN in JJR than two NNS . NNS will VB into the NN of NN in VBG NN - 19 , NNP RB VBD . The NN , which VBZ VBN to VB NN NNS , VBD among four NNS VBG VBN in a NNP NNP NNP VBN by NNP and NNS . The JJ NNP for the NN , VBG 10 VBG NNS , VBD NN on NN due to NN NNS . A NN NN VBZ VBN VBG JJ NNS . “ On the NN of the JJ NN NNS , the NNS of the NN VBD that there VBP no NNS to VB the NN NN ” , VBD NNP . “ The NNP NNP VBD this NN and VBD the NN of all NNS of the NNP NNP , VBG NN . ” The NNP NNP NNP VBD VBN on 18 NNP : one NN after the NN VBD VBN , and 60 NNS after NNP VBD the JJ NN of the JJ NN . RB RB , JJR than 3,500 NNS in 35 NNS VBP VBN VBN . The JJ NNS under NN VBP NN , RB VBN as an NNP NN ; NN / NN , which VBZ a VBN NN for NN ; and NN NN - NN , a NN for JJ NN . RB , the NNP and the NNP NNP NNP and NNP NNP NNP on NNP VBD for NNS and the JJ NN to VB towards VBG “ a NN ’s NN ” against NN - 19 . They VBD that “ no NN should VB VBN behind ” in the NN to VB the RBS JJ NNS to VB the NN . “ A NNS ’s NN should VB the JJ in NNS and the JJ in JJ NNS , the JJ in NN NNS and the JJ in NN NNS ” , they VBD . “ A JJ JJ NN for a NN ’s NN against NNP - 19 VBZ a JJ NN that VBZ us RB RB in our VBN NN . ” The NNS VBD NN and NN towards this JJ NN should RB VB JJ NN to VB NN against JJ NNS . As NNP NNS VBP VBN , the NNP - 19 NN VBZ VBN JJ NNS to VB or VB JJ NN NN NNS , VBG some 80 million JJ NNS at NN ."
153,178,mainstream,"WASHINGTON_NNP (_-LRB- Reuters_NNP )_-RRB- -_: A_DT special_JJ U.S._NNP court_NN ruled_VBD against_IN three_CD families_NNS on_IN Thursday_NNP who_WP claimed_VBD vaccines_NNS caused_VBD their_PRP$ children_NNS ’s_POS autism_NN ._. The_DT Vaccine_NNP Court_NNP Omnibus_NNP Autism_NNP Proceeding_NNP ruled_VBD against_IN the_DT parents_NNS of_IN Michelle_NNP Cedillo_NNP ,_, Colten_NNP Snyder_NNP and_CC William_NNP Yates_NNP Hazlehurst_NNP ,_, who_WP had_VBD claimed_VBN that_IN a_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN had_VBD combined_VBN with_IN other_JJ vaccine_NN ingredients_NNS to_TO damage_VB the_DT three_CD children_NNS ._. “_`` Unfortunately_RB ,_, the_DT Cedillos_NNPS have_VBP been_VBN misled_VBN by_IN physicians_NNS who_WP are_VBP guilty_JJ ,_, in_IN my_PRP$ view_NN ,_, of_IN gross_JJ medical_JJ misjudgment_NN ,_, ”_'' Special_JJ Master_NN George_NNP Hastings_NNP ,_, a_DT former_JJ tax_NN claims_NNS expert_NN at_IN the_DT Department_NNP of_IN Justice_NNP ,_, wrote_VBD in_IN the_DT 183_CD -_HYPH page_NN Cedillo_NNP ruling_NN ._. The_DT families_NNS sought_VBD payment_NN under_IN the_DT National_NNP Vaccine_NNP Injury_NNP Compensation_NNP Program_NNP ,_, a_DT no_DT -_HYPH fault_NN system_NN that_WDT has_VBZ a_DT $_$ 2.5_CD billion_CD fund_NN built_VBN up_RP from_IN a_DT 75_CD -_HYPH cent_NN -_HYPH per_IN -_HYPH dose_NN tax_NN on_IN vaccines_NNS ._. Instead_RB of_IN judges_NNS ,_, three_CD “_`` special_JJ masters_NNS ”_'' heard_VBD the_DT three_CD test_NN cases_NNS representing_VBG thousands_NNS of_IN other_JJ petitioners_NNS ._. They_PRP asked_VBD whether_IN a_DT combination_NN vaccine_NN for_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN ,_, or_CC MMR_NN ,_, plus_CC a_DT mercury_NN -_HYPH containing_VBG preservative_NN called_VBN thimerosal_NN ,_, caused_VBD the_DT children_NNS ’s_POS symptoms_NNS ._. “_`` The_DT evidence_NN does_VBZ not_RB support_VB the_DT general_JJ proposition_NN that_IN thimerosal_NN -_HYPH containing_VBG vaccines_NNS can_MD damage_VB infants_NNS ’_POS immune_NN systems_NNS ,_, ”_'' Hastings_NNP wrote_VBD ,_, after_IN reviewing_VBG tens_NNS of_IN thousands_NNS of_IN documents_NNS and_CC hours_NNS of_IN oral_JJ arguments_NNS ._. “_`` I_PRP further_RB conclude_VBP that_IN while_IN Michelle_NNP Cedillo_NNP has_VBZ tragically_RB suffered_VBN from_IN autism_NN and_CC other_JJ severe_JJ conditions_NNS ,_, the_DT petitioners_NNS have_VBP also_RB failed_VBN to_TO demonstrate_VB that_IN her_PRP$ vaccinations_NNS played_VBD any_DT role_NN at_IN all_DT in_IN causing_VBG those_DT problems_NNS ._. ”_'' Michelle_NNP ’s_POS parents_NNS argued_VBD that_IN she_PRP was_VBD a_DT normal_JJ baby_NN until_IN she_PRP received_VBD the_DT vaccine_NN ._. Experts_NNS say_VBP parents_NNS often_RB link_VBP vaccines_NNS with_IN their_PRP$ children_NNS ’s_POS symptoms_NNS because_IN they_PRP are_VBP vaccinated_VBN at_IN an_DT age_NN when_WRB autism_NN and_CC related_JJ disorders_NNS are_VBP often_RB first_RB diagnosed_VBN ._. “_`` We_PRP need_VBP ongoing_JJ research_NN into_IN the_DT causes_NNS of_IN autism_NN ,_, but_CC cannot_MD let_VB unfounded_JJ myths_NNS keep_VB us_PRP from_IN giving_VBG our_PRP$ children_NNS the_DT proven_VBN protection_NN they_PRP need_VBP against_IN infectious_JJ diseases_NNS ,_, ”_'' the_DT American_NNP Medical_NNP Association_NNP said_VBD in_IN response_NN to_IN the_DT ruling_NN ._. The_DT Institute_NNP of_IN Medicine_NNP reviewed_VBD the_DT evidence_NN in_IN 2001_CD and_CC 2004_CD ,_, and_CC determined_VBD there_EX was_VBD no_DT link_NN between_IN vaccines_NNS and_CC autism_NN ._. Many_JJ other_JJ studies_NNS have_VBP shown_VBN no_DT link_NN ,_, but_CC a_DT small_JJ and_CC vocal_JJ group_NN of_IN parents_NNS continues_VBZ to_TO press_VB the_DT case_NN ._. The_DT advocacy_NN group_NN Autism_NNP Speaks_NNP said_VBD the_DT ruling_NN did_VBD not_RB necessarily_RB clear_VB vaccines_NNS ,_, or_CC any_DT other_JJ potential_JJ cause_NN ._. “_`` We_PRP will_MD continue_VB to_TO support_VB authoritative_JJ research_NN that_WDT addresses_VBZ unanswered_JJ questions_NNS about_IN whether_IN certain_JJ subgroups_NNS of_IN individuals_NNS with_IN particular_JJ underlying_JJ medical_JJ or_CC genetic_JJ conditions_NNS may_MD be_VB more_RBR vulnerable_JJ to_IN adverse_JJ effects_NNS of_IN vaccines_NNS ,_, ”_'' the_DT group_NN said_VBD in_IN a_DT statement_NN ._. Hastings_NNP rejected_VBD this_DT argument_NN in_IN his_PRP$ ruling_NN ._. More_JJR than_IN 5,300_CD cases_NNS were_VBD filed_VBN by_IN parents_NNS who_WP believed_VBD vaccines_NNS may_MD have_VB caused_VBN autism_NN in_IN their_PRP$ children_NNS and_CC were_VBD seeking_VBG payment_NN under_IN the_DT National_NNP Vaccine_NNP Injury_NNP Compensation_NNP Program_NNP ._. The_DT no_DT -_HYPH fault_NN payout_NN system_NN is_VBZ meant_VBN to_TO protect_VB vaccine_NN makers_NNS from_IN costly_JJ lawsuits_NNS that_WDT drove_VBD many_JJ out_IN of_IN the_DT vaccine_NN -_HYPH making_VBG business_NN ._. Autism_NN is_VBZ a_DT mysterious_JJ condition_NN that_WDT affects_VBZ as_RB many_JJ as_IN one_CD in_IN 150_CD U.S._NNP children_NNS ._. The_DT so_RB -_HYPH called_VBN spectrum_NN ranges_VBZ from_IN mild_JJ Asperger_NN ’s_POS Syndrome_NN to_IN severe_JJ mental_JJ retardation_NN and_CC social_JJ disability_NN ,_, and_CC there_EX is_VBZ no_DT cure_NN or_CC good_JJ treatment_NN ._.","NNP ( NNP ) - A JJ NNP NN VBD against three NNS on NNP who VBD NNS VBD their NNS ’s NN . The NNP NNP NNP NNP NNP VBD against the NNS of NNP NNP , NNP NNP and NNP NNP NNP , who VBD VBN that a NNS , NNS and NN NN VBD VBN with JJ NN NNS to VB the three NNS . “ RB , the NNPS VBP VBN VBN by NNS who VBP JJ , in my NN , of JJ JJ NN , ” JJ NN NNP NNP , a JJ NN NNS NN at the NNP of NNP , VBD in the 183 - NN NNP NN . The NNS VBD NN under the NNP NNP NNP NNP NNP , a no - NN NN that VBZ a $ 2.5 billion NN VBN up from a 75 - NN - per - NN NN on NNS . RB of NNS , three “ JJ NNS ” VBD the three NN NNS VBG NNS of JJ NNS . They VBD whether a NN NN for NNS , NNS and NN , or NN , plus a NN - VBG NN VBN NN , VBD the NNS ’s NNS . “ The NN VBZ RB VB the JJ NN that NN - VBG NNS can VB NNS ’ NN NNS , ” NNP VBD , after VBG NNS of NNS of NNS and NNS of JJ NNS . “ I RB VBP that while NNP NNP VBZ RB VBN from NN and JJ JJ NNS , the NNS VBP RB VBN to VB that her NNS VBD any NN at all in VBG those NNS . ” NNP ’s NNS VBD that she VBD a JJ NN until she VBD the NN . NNS VBP NNS RB VBP NNS with their NNS ’s NNS because they VBP VBN at an NN when NN and JJ NNS VBP RB RB VBN . “ We VBP JJ NN into the NNS of NN , but cannot VB JJ NNS VB us from VBG our NNS the VBN NN they VBP against JJ NNS , ” the NNP NNP NNP VBD in NN to the NN . The NNP of NNP VBD the NN in 2001 and 2004 , and VBD there VBD no NN between NNS and NN . JJ JJ NNS VBP VBN no NN , but a JJ and JJ NN of NNS VBZ to VB the NN . The NN NN NNP NNP VBD the NN VBD RB RB VB NNS , or any JJ JJ NN . “ We will VB to VB JJ NN that VBZ JJ NNS about whether JJ NNS of NNS with JJ JJ JJ or JJ NNS may VB RBR JJ to JJ NNS of NNS , ” the NN VBD in a NN . NNP VBD this NN in his NN . JJR than 5,300 NNS VBD VBN by NNS who VBD NNS may VB VBN NN in their NNS and VBD VBG NN under the NNP NNP NNP NNP NNP . The no - NN NN NN VBZ VBN to VB NN NNS from JJ NNS that VBD JJ out of the NN - VBG NN . NN VBZ a JJ NN that VBZ RB JJ as one in 150 NNP NNS . The RB - VBN NN VBZ from JJ NN ’s NN to JJ JJ NN and JJ NN , and there VBZ no NN or JJ NN ."
154,619,mainstream,"Humans_NNS may_MD be_VB to_TO blame_VB for_IN rising_VBG mercury_NN levels_NNS in_IN a_DT species_NN of_IN fish_NN that_WDT 's_VBZ very_RB popular_JJ as_IN food_NN ,_, according_VBG to_IN a_DT news_NN study_NN published_VBN this_DT week_NN ._. Levels_NNS of_IN a_DT potentially_RB poisonous_JJ form_NN of_IN the_DT element_NN have_VBP been_VBN creeping_VBG up_RP in_IN Pacific_NNP yellowfin_NN tuna_NN 3.8_CD percent_NN every_DT year_NN since_IN 1998_CD ,_, according_VBG to_IN a_DT report_NN discussed_VBD an_DT article_NN by_IN the_DT Los_NNP Angeles_NNP Times_NNP ._. Methyl_NNP Mercury_NN levels_NNS in_IN tuna_NN and_CC other_JJ large_JJ fish_NNS have_VBP been_VBN a_DT public_JJ health_NN concern_NN for_IN some_DT time_NN ._. Health_NN authorities_NNS such_JJ as_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP recommend_VBP that_IN young_JJ children_NNS ,_, as_RB well_RB as_IN women_NNS who_WP are_VBP either_CC pregnant_JJ or_CC nursing_NN limit_VB their_PRP$ intake_NN of_IN tuna_NN ,_, and_CC avoid_VBP other_JJ large_JJ species_NNS entirely_RB ,_, including_VBG swordfish_NN and_CC tilefish_NN ._. The_DT study_NN adds_VBZ to_IN evidence_NN suggesting_VBG that_IN human_JJ activity_NN —_: particularly_RB the_DT burning_NN of_IN coal_NN —_: is_VBZ causing_VBG a_DT buildup_NN of_IN the_DT element_NN in_IN the_DT air_NN and_CC water_NN that_WDT is_VBZ subsequently_RB making_VBG its_PRP$ way_NN into_IN the_DT food_NN chain_NN ,_, according_VBG to_IN an_DT article_NN in_IN the_DT Los_NNP Angeles_NNP Times_NNP discussing_VBG the_DT research_NN ._. Some_DT fishing_NN industry_NN groups_NNS have_VBP long_RB maintained_VBN that_IN mercury_NN levels_NNS in_IN tuna_NN and_CC large_JJ fish_NNS are_VBP stable_JJ and_CC come_VBP from_IN natural_JJ sources_NNS ,_, such_JJ as_IN deep_JJ ocean_NN vents_NNS ._. Yellowfin_NN —_: sometimes_RB called_VBN ahi_FW tuna_NN —_: is_VBZ sold_VBN in_IN steaks_NNS and_CC eaten_VBN in_IN sushi_NN ,_, and_CC can_MD be_VB sometimes_RB found_VBN in_IN small_JJ amounts_NNS in_IN canned_VBN light_NN tuna_NN ._. The_DT fact_NN that_IN the_DT fish_NNS are_VBP not_RB top_JJ -_HYPH level_NN predators_NNS could_MD indicate_VB that_IN a_DT broader_JJR swath_NN of_IN ocean_NN life_NN may_MD be_VB accumulating_VBG mercury_NN levels_NNS that_WDT would_MD make_VB them_PRP hazardous_JJ to_IN human_JJ health_NN ,_, if_IN eaten_VBN ._. ""_`` What_WP this_DT number_NN is_VBZ saying_VBG is_VBZ that_IN the_DT amount_NN of_IN mercury_NN in_IN fish_NN is_VBZ getting_VBG higher_JJR and_CC higher_JJR all_PDT the_DT time_NN ,_, and_CC if_IN it_PRP keeps_VBZ going_VBG like_IN that_DT ,_, at_IN some_DT point_NN ,_, most_JJS every_DT kind_NN of_IN fish_NN is_VBZ going_VBG to_TO be_VB potentially_RB hazardous_JJ ,_, ""_'' study_NN coauthor_NN Carl_NNP Lamborg_NNP told_VBD the_DT Los_NNP Angeles_NNP Times_NNP ._. ""_`` Where_WRB that_DT point_NN is_VBZ ,_, I_PRP do_VBP n't_RB know_VB ._. ""_'' Read_VB the_DT full_JJ article_NN in_IN the_DT Los_NNP Angeles_NNP Times_NNP ._.","NNS may VB to VB for VBG NN NNS in a NN of NN that VBZ RB JJ as NN , VBG to a NN NN VBN this NN . NNS of a RB JJ NN of the NN VBP VBN VBG up in NNP NN NN 3.8 NN every NN since 1998 , VBG to a NN VBD an NN by the NNP NNP NNP . NNP NN NNS in NN and JJ JJ NNS VBP VBN a JJ NN NN for some NN . NN NNS JJ as the NNP and NNP NNP VBP that JJ NNS , RB RB as NNS who VBP either JJ or NN VB their NN of NN , and VBP JJ JJ NNS RB , VBG NN and NN . The NN VBZ to NN VBG that JJ NN — RB the NN of NN — VBZ VBG a NN of the NN in the NN and NN that VBZ RB VBG its NN into the NN NN , VBG to an NN in the NNP NNP NNP VBG the NN . Some NN NN NNS VBP RB VBN that NN NNS in NN and JJ NNS VBP JJ and VBP from JJ NNS , JJ as JJ NN NNS . NN — RB VBN FW NN — VBZ VBN in NNS and VBN in NN , and can VB RB VBN in JJ NNS in VBN NN NN . The NN that the NNS VBP RB JJ - NN NNS could VB that a JJR NN of NN NN may VB VBG NN NNS that would VB them JJ to JJ NN , if VBN . "" What this NN VBZ VBG VBZ that the NN of NN in NN VBZ VBG JJR and JJR all the NN , and if it VBZ VBG like that , at some NN , JJS every NN of NN VBZ VBG to VB RB JJ , "" NN NN NNP NNP VBD the NNP NNP NNP . "" Where that NN VBZ , I VBP RB VB . "" VB the JJ NN in the NNP NNP NNP ."
155,582,mainstream,"COVID_NNP -_HYPH 19_CD vaccine_NN still_RB far_RB off_RB ,_, experts_NNS say_VBP Vaccines_NNS save_VBP lives_NNS and_CC protect_VB our_PRP$ children_NNS from_IN debilitating_JJ and_CC deadly_JJ disease_NN ,_, and_CC they_PRP promote_VBP the_DT overall_JJ health_NN of_IN our_PRP$ communities_NNS ._. Natalia_NNP Cales_NNP is_VBZ executive_JJ officer_NN of_IN the_DT U.S._NNP Department_NNP of_IN Health_NNP &_CC Human_NNP Services_NNPS ,_, Region_NNP IV_NNP ._. Measles_NN is_VBZ not_RB a_DT harmless_JJ childhood_NN illness_NN ._. It_PRP is_VBZ actually_RB a_DT highly_RB contagious_JJ ,_, dangerous_JJ disease_NN that_WDT can_MD even_RB be_VB deadly_JJ ._. But_CC measles_NNS is_VBZ also_RB easily_RB preventable_JJ with_IN a_DT vaccine_NN ._. As_IN the_DT executive_JJ officer_NN for_IN the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS Region_NNP 4_CD ,_, which_WDT includes_VBZ Alabama_NNP ,_, Florida_NNP ,_, Georgia_NNP ,_, Kentucky_NNP ,_, Mississippi_NNP ,_, North_NNP Carolina_NNP ,_, South_NNP Carolina_NNP and_CC Tennessee_NNP ,_, it_PRP ’s_VBZ my_PRP$ job_NN to_TO raise_VB awareness_NN of_IN facts_NNS that_WDT can_MD help_VB protect_VB the_DT health_NN of_IN all_DT Americans_NNPS ._. Make_VB sure_JJ to_TO talk_VB to_IN your_PRP$ doctor_NN about_IN vaccinations_NNS for_IN your_PRP$ children_NNS Vaccines_NNS do_VBP not_RB cause_VB autism_NN and_CC do_VBP not_RB contain_VB toxic_JJ chemicals_NNS ._. Any_DT serious_JJ side_NN effects_NNS from_IN vaccines_NNS are_VBP exceedingly_RB rare_JJ ,_, and_CC the_DT protection_NN from_IN disease_NN that_WDT vaccines_NNS provide_VBP far_RB outweighs_VBZ any_DT potential_JJ risks_NNS ._. If_IN you_PRP ’re_VBP a_DT parent_NN ,_, talk_VB to_IN your_PRP$ child_NN ’s_POS doctor_NN to_TO make_VB sure_JJ your_PRP$ child_NN is_VBZ up_RB to_IN date_NN on_IN all_DT of_IN his_PRP$ or_CC her_PRP$ scheduled_VBN vaccinations_NNS ._. This_DT is_VBZ especially_RB important_JJ if_IN you_PRP have_VBP an_DT infant_NN ,_, because_IN vaccinating_VBG your_PRP$ baby_NN on_IN the_DT recommended_VBN immunization_NN schedule_NN provides_VBZ protection_NN against_IN 14_CD serious_JJ childhood_NN illnesses_NNS ._. For_IN measles_NNS ,_, the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP recommends_VBZ that_IN children_NNS get_VBP two_CD doses_NNS of_IN the_DT MMR_NN vaccine_NN ,_, starting_VBG with_IN the_DT first_JJ dose_NN at_IN 12_CD to_IN 15_CD months_NNS of_IN age_NN ,_, and_CC the_DT second_JJ dose_NN at_IN 4_CD through_IN 6_CD years_NNS of_IN age_NN ._. We_PRP all_DT want_VBP our_PRP$ children_NNS to_TO grow_VB up_RP in_IN a_DT world_NN that_WDT is_VBZ free_JJ from_IN preventable_JJ diseases_NNS ._. The_DT single_JJ most_RBS important_JJ thing_NN each_DT of_IN us_PRP can_MD do_VB to_TO achieve_VB that_DT goal_NN is_VBZ to_TO get_VB fully_RB vaccinated_VBN –_: for_IN ourselves_PRP ,_, our_PRP$ families_NNS ,_, and_CC our_PRP$ communities_NNS ._. May_NNP political_JJ cartoons_NNS from_IN the_DT USA_NNP TODAY_NN network_NN","NNP - 19 NN RB RB RB , NNS VBP NNS VBP NNS and VB our NNS from JJ and JJ NN , and they VBP the JJ NN of our NNS . NNP NNP VBZ JJ NN of the NNP NNP of NNP & NNP NNPS , NNP NNP . NN VBZ RB a JJ NN NN . It VBZ RB a RB JJ , JJ NN that can RB VB JJ . But NNS VBZ RB RB JJ with a NN . As the JJ NN for the NNP NNP of NNP and NNP NNPS NNP 4 , which VBZ NNP , NNP , NNP , NNP , NNP , NNP NNP , NNP NNP and NNP , it VBZ my NN to VB NN of NNS that can VB VB the NN of all NNPS . VB JJ to VB to your NN about NNS for your NNS NNS VBP RB VB NN and VBP RB VB JJ NNS . Any JJ NN NNS from NNS VBP RB JJ , and the NN from NN that NNS VBP RB VBZ any JJ NNS . If you VBP a NN , VB to your NN ’s NN to VB JJ your NN VBZ RB to NN on all of his or her VBN NNS . This VBZ RB JJ if you VBP an NN , because VBG your NN on the VBN NN NN VBZ NN against 14 JJ NN NNS . For NNS , the NNPS for NNP NNP and NNP VBZ that NNS VBP two NNS of the NN NN , VBG with the JJ NN at 12 to 15 NNS of NN , and the JJ NN at 4 through 6 NNS of NN . We all VBP our NNS to VB up in a NN that VBZ JJ from JJ NNS . The JJ RBS JJ NN each of us can VB to VB that NN VBZ to VB RB VBN – for ourselves , our NNS , and our NNS . NNP JJ NNS from the NNP NN NN"
156,207,mainstream,"Whether_IN you_PRP call_VBP it_PRP a_DT fitness_NN trend_NN or_CC a_DT mindfulness_NN practice_NN (_-LRB- or_CC a_DT bit_NN of_IN both_DT )_-RRB- ,_, what_WP exactly_RB is_VBZ forest_NN bathing_NN ?_. The_DT term_NN emerged_VBD in_IN Japan_NNP in_IN the_DT 1980s_NNS as_IN a_DT physiological_JJ and_CC psychological_JJ exercise_NN called_VBN shinrin_NN -_HYPH yoku_NN (_-LRB- “_`` forest_NN bathing_NN ”_'' or_CC “_`` taking_VBG in_IN the_DT forest_NN atmosphere_NN ”_'' )_-RRB- ._. The_DT purpose_NN was_VBD twofold_JJ :_: to_TO offer_VB an_DT eco-antidote_NN to_IN tech_NN -_HYPH boom_NN burnout_NN and_CC to_TO inspire_VB residents_NNS to_TO reconnect_VB with_IN and_CC protect_VB the_DT country_NN ’s_POS forests_NNS ._. The_DT Japanese_NNP quickly_RB embraced_VBD this_DT form_NN of_IN ecotherapy_NN ._. In_IN the_DT 1990s_NNS ,_, researchers_NNS began_VBD studying_VBG the_DT physiological_JJ benefits_NNS of_IN forest_NN bathing_NN ,_, providing_VBG the_DT science_NN to_TO support_VB what_WP we_PRP innately_RB know_VBP :_: time_NN spent_VBN immersed_VBN in_IN nature_NN is_VBZ good_JJ for_IN us_PRP ._. While_IN Japan_NNP is_VBZ credited_VBN with_IN the_DT term_NN shinrin_NN -_HYPH yoku_NN ,_, the_DT concept_NN at_IN the_DT heart_NN of_IN the_DT practice_NN is_VBZ not_RB new_JJ ._. Many_JJ cultures_NNS have_VBP long_RB recognised_VBN the_DT importance_NN of_IN the_DT natural_JJ world_NN to_IN human_JJ health_NN ._. Forest_NN bathing_NN is_VBZ not_RB just_RB for_IN the_DT wilderness_NN -_HYPH lover_NN ;_, the_DT practice_NN can_MD be_VB as_RB simple_JJ as_IN walking_VBG in_IN any_DT natural_JJ environment_NN and_CC consciously_RB connecting_VBG with_IN what_WP ’s_VBZ around_IN you_PRP ._. For_IN a_DT more_RBR structured_VBN experience_NN ,_, you_PRP can_MD join_VB trained_VBN guides_NNS for_IN a_DT meditative_JJ two_CD -_HYPH to_IN three_CD -_HYPH hour_NN ecotherapy_NN excursion_NN ._. Here_RB are_VBP five_CD places_NNS to_TO try_VB forest_NN bathing_NN ._.","Whether you VBP it a NN NN or a NN NN ( or a NN of both ) , what RB VBZ NN NN ? The NN VBD in NNP in the NNS as a JJ and JJ NN VBN NN - NN ( “ NN NN ” or “ VBG in the NN NN ” ) . The NN VBD JJ : to VB an NN to NN - NN NN and to VB NNS to VB with and VB the NN ’s NNS . The NNP RB VBD this NN of NN . In the NNS , NNS VBD VBG the JJ NNS of NN NN , VBG the NN to VB what we RB VBP : NN VBN VBN in NN VBZ JJ for us . While NNP VBZ VBN with the NN NN - NN , the NN at the NN of the NN VBZ RB JJ . JJ NNS VBP RB VBN the NN of the JJ NN to JJ NN . NN NN VBZ RB RB for the NN - NN ; the NN can VB RB JJ as VBG in any JJ NN and RB VBG with what VBZ around you . For a RBR VBN NN , you can VB VBN NNS for a JJ two - to three - NN NN NN . RB VBP five NNS to VB NN NN ."
157,71,mainstream,"Horseshoe_NN crabs_NNS may_MD be_VB the_DT answer_NN to_IN a_DT safe_JJ coronavirus_NN vaccine_NN next_JJ year_NN ._. Here_RB 's_VBZ why_WRB ._. EAST_NNP FALMOUTH_NNP —_: For_IN 450_CD million_CD years_NNS ,_, horseshoe_NN crabs_NNS have_VBP scuttled_VBN along_IN the_DT ocean_NN floor_NN ,_, coming_VBG ashore_RB to_TO lay_VB eggs_NNS ._. You_PRP need_VBP pretty_RB strong_JJ defenses_NNS to_TO survive_VB mass_JJ extinctions_NNS and_CC the_DT oversized_JJ predators_NNS that_WDT evolved_VBD before_IN man_NN came_VBD on_IN the_DT scene_NN ._. While_IN its_PRP$ helmeted_JJ body_NN certainly_RB protected_VBD it_PRP ,_, the_DT horseshoe_NN crab_NN ,_, living_VBG in_IN a_DT bacterial_JJ soup_NN ,_, had_VBD another_DT defense_NN —_: blood_NN that_WDT quickly_RB clotted_VBD to_TO stop_VB infection_NN from_IN cuts_NNS and_CC loss_NN of_IN limbs_NNS ._. Just_RB as_IN it_PRP is_VBZ for_IN this_DT primordial_JJ animal_NN ,_, bacteria_NN is_VBZ all_RB around_IN us_PRP ._. “_`` It_PRP ’s_VBZ not_RB dangerous_JJ until_IN it_PRP crosses_VBZ the_DT blood_NN wall_NN ,_, ”_'' said_VBD Brett_NNP Hoffmeister_NNP ,_, limulous_JJ amebocyte_NN lysate_NN (_-LRB- LAL_NNP )_-RRB- production_NN manager_NN for_IN Associates_NNPS of_IN Cape_NNP Cod_NNP in_IN East_NNP Falmouth_NNP ._. “_`` If_IN it_PRP gets_VBZ into_IN the_DT blood_NN or_CC spinal_JJ fluid_NN ,_, you_PRP have_VBP a_DT problem_NN ._. ”_'' Because_IN of_IN its_PRP$ quick_JJ and_CC detectable_JJ response_NN to_IN bacteria_NN ,_, horseshoe_NN crab_NN blood_NN is_VBZ used_VBN in_IN testing_VBG anything_NN that_WDT can_MD be_VB surgically_RB implanted_VBN ,_, injected_VBN or_CC swallowed_VBN as_IN medication_NN ._. That_DT includes_VBZ hip_NN replacements_NNS ,_, heart_NN stents_NNS ,_, pharmaceuticals_NNS ,_, intravenous_JJ solutions_NNS and_CC vaccines_NNS such_JJ as_IN the_DT annual_JJ flu_NN vaccine_NN ,_, and_CC the_DT coronavirus_NN vaccines_NNS now_RB in_IN development_NN with_IN potentially_RB worldwide_JJ distribution_NN ._. While_IN other_JJ tests_NNS exist_VBP like_IN synthetic_JJ LAL_NNP and_CC a_DT human_JJ blood_NN test_NN ,_, LAL_NNP bacterial_NN endotoxin_NN testing_NN is_VBZ the_DT gold_NN standard_NN ,_, Hoffmeister_NNP said_VBD ._. The_DT LAL_NNP test_NN was_VBD first_RB developed_VBN in_IN Falmouth_NNP by_IN Jack_NNP Levin_NNP and_CC Frederik_NNP Bang_NNP of_IN Massachusetts_NNP Biological_NNP Laboratory_NNP ._. Associates_NNS of_IN Cape_NNP Cod_NNP ,_, the_DT first_JJ company_NN licensed_VBN to_TO manufacture_VB it_PRP ,_, was_VBD founded_VBN in_IN 1974_CD by_IN Stanley_NNP Watson_NNP ,_, a_DT Woods_NNP Hole_NNP Oceanographic_NNP Institution_NNP senior_JJ scientist_NN who_WP investigated_VBD the_DT horseshoe_NN crab_NN extract_NN as_IN a_DT way_NN to_TO measure_VB bacterial_JJ biomass_NN in_IN seawater_NN ._. The_DT company_NN now_RB has_VBZ over_RB 200_CD employees_NNS and_CC offices_NNS worldwide_RB ,_, Hoffmeister_NNP said_VBD ._. There_EX are_VBP only_RB four_CD manufacturers_NNS in_IN the_DT U.S_NNP ._. Hoffmeister_NNP said_VBD his_PRP$ company_NN does_VBZ n’t_RB anticipate_VB a_DT very_RB big_JJ increase_NN in_IN demand_NN for_IN LAL_NNP to_TO test_VB and_CC manufacture_VB new_JJ vaccines_NNS ._. Very_RB little_JJ is_VBZ needed_VBN to_TO test_VB a_DT sample_NN of_IN the_DT vaccine_NN ,_, and_CC it_PRP would_MD take_VB only_RB a_DT day_NN of_IN production_NN to_TO manufacture_VB enough_RB to_TO assure_VB the_DT purity_NN of_IN even_RB an_DT estimated_VBN five_CD billion_CD doses_NNS ,_, he_PRP said_VBD ._. Back_RB in_IN the_DT late_JJ 1990s_NNS and_CC early_JJ 2000s_NNS ,_, there_EX was_VBD concern_NN over_IN the_DT fate_NN of_IN the_DT horseshoe_NN crab_NN ._. The_DT crab_NN ’s_POS numbers_NNS appeared_VBD to_TO drop_VB to_IN the_DT point_NN where_WRB birders_NNS and_CC national_JJ bird_NN conservation_NN organizations_NNS like_IN the_DT National_NNP Audubon_NNP Society_NNP expressed_VBD alarm_NN over_IN a_DT lack_NN of_IN horseshoe_NN crab_NN eggs_NNS ,_, a_DT primary_JJ food_NN for_IN endangered_JJ shorebird_NN species_NNS like_IN red_JJ knot_NN along_IN their_PRP$ migratory_JJ route_NN ._. Coronavirus_NN vaccine_NN :_: When_WRB there_EX is_VBZ one_CD ,_, how_WRB will_MD we_PRP make_VB sure_JJ everybody_NN gets_VBZ it_PRP ?_. That_DT 's_VBZ the_DT job_NN of_IN state_NN immunization_NN registries_NNS ._. More_JJR questions_NNS :_: Fauci_NNP says_VBZ he_PRP 's_VBZ optimistic_JJ about_IN coronavirus_NN vaccine_NN protection_NN but_CC concerned_JJ how_WRB long_RB it_PRP will_MD last_VB Many_JJ were_VBD concerned_VBN about_IN a_DT big_JJ increase_NN in_IN harvests_NNS by_IN a_DT bait_NN fishery_NN in_IN which_WDT the_DT crabs_NNS were_VBD used_VBN to_TO attract_VB conch_NN ,_, eels_NNS and_CC other_JJ species_NNS to_IN traps_NNS ._. Others_NNS worried_VBD about_IN the_DT number_NN of_IN crabs_NNS dying_VBG from_IN handling_NN and_CC bleeding_NN in_IN the_DT biomedical_JJ industry_NN ._. Daily_JJ limits_NNS and_CC bans_NNS on_IN bait_NN fishing_NN in_IN critical_JJ horseshoe_NN crab_NN areas_NNS like_IN Delaware_NNP Bay_NNP and_CC in_IN Massachusetts_NNP and_CC other_JJ spots_NNS along_IN the_DT eastern_JJ shore_NN helped_VBD bring_VB that_DT fishery_NN under_IN control_NN ._. The_DT bait_NN harvest_NN peaked_VBD in_IN 1999_CD at_IN 2.6_CD million_CD crabs_NNS and_CC has_VBZ remained_VBN under_IN 1_CD million_CD crabs_NNS since_IN 2003_CD ,_, according_VBG to_IN a_DT 2019_CD stock_NN assessment_NN by_IN the_DT Atlantic_NNP States_NNPS Marine_NNP Fisheries_NNPS Commission_NNP ._. In_IN that_DT 2019_CD assessment_NN ,_, the_DT commission_NN estimated_VBD a_DT 15_CD %_NN mortality_NN for_IN the_DT biomedical_JJ field_NN ._. Most_JJS of_IN the_DT horseshoe_NN crab_NN blood_NN is_VBZ in_IN the_DT gills_NNS ,_, and_CC LAL_NNP technicians_NNS only_RB use_VBP a_DT small_JJ portion_NN contained_VBN in_IN sinus_NN sack_NN ._. The_DT animal_NN is_VBZ returned_VBN to_IN the_DT water_NN within_IN 24_CD hours_NNS ,_, Hoffmeister_NNP said_VBD ._. Total_JJ estimated_VBN mortality_NN for_IN the_DT nearly_RB 500,000_CD crabs_NNS used_VBN exclusively_RB for_IN the_DT biomedical_JJ industry_NN in_IN 2017_CD was_VBD 72,674_CD animals_NNS ._. Over_RB 990,000_CD were_VBD caught_VBN and_CC killed_VBN in_IN the_DT bait_NN fishery_NN that_DT year_NN ,_, according_VBG to_IN commission_NN data_NN ._. Derek_NNP Perry_NNP ,_, an_DT invertebrate_JJ fisheries_NN biologist_NN at_IN the_DT Massachusetts_NNP Division_NNP of_IN Marine_NNP Fisheries_NNPS ,_, said_VBD that_IN other_JJ fisheries_NNS dwarf_VBP the_DT impact_NN of_IN the_DT biomedical_JJ industry_NN ._. “_`` In_IN the_DT (_-LRB- ASMFC_NNP )_-RRB- stock_NN assessment_NN ,_, they_PRP say_VBP that_IN discard_NN mortality_NN from_IN the_DT mobile_JJ gear_NN fleet_NN (_-LRB- fish_NN trawlers_NNS and_CC shellfish_NN draggers_NNS )_-RRB- could_MD be_VB higher_JJR than_IN the_DT biomedical_JJ and_CC bait_NN fish_NN combined_VBN ,_, ”_'' he_PRP said_VBD ._. Although_IN they_PRP have_VBP n’t_RB been_VBN able_JJ to_TO determine_VB what_WP constitutes_VBZ a_DT healthy_JJ horseshoe_NN crab_NN population_NN ,_, or_CC a_DT sustainable_JJ amount_NN to_TO harvest_VB ,_, commission_NN officials_NNS said_VBD that_IN the_DT majority_NN of_IN indices_NNS indicate_VBP these_DT prehistoric_JJ survivors_NNS appear_VBP headed_VBN in_IN the_DT right_JJ direction_NN ._. Perry_NNP pointed_VBD out_RP that_IN trawl_NN surveys_NNS along_IN the_DT East_NNP Coast_NNP ,_, with_IN the_DT exception_NN of_IN the_DT New_NNP York_NNP area_NN ,_, were_VBD all_RB showing_VBG increased_VBN horseshoe_NN crab_NN abundance_NN ._. “_`` Our_PRP$ trawl_NN survey_NN ,_, with_IN a_DT 40_CD year_NN history_NN ,_, had_VBD the_DT highest_JJS data_NN point_NN in_IN years_NNS this_DT year_NN ,_, so_RB our_PRP$ population_NN seems_VBZ to_TO be_VB increasing_VBG ,_, ”_'' Perry_NNP said_VBD ._. His_PRP$ agency_NN sends_VBZ guidelines_NNS to_IN Associates_NNPS of_IN Cape_NNP Cod_NNP on_IN how_WRB to_TO safely_RB handle_VB crabs_NNS to_TO reduce_VB mortality_NN ,_, and_CC they_PRP are_VBP in_IN the_DT East_NNP Falmouth_NNP facility_NN once_RB a_DT month_NN during_IN the_DT season_NN to_TO assess_VB the_DT health_NN and_CC handling_NN of_IN the_DT crabs_NNS ._.","NN NNS may VB the NN to a JJ NN NN JJ NN . RB VBZ why . NNP NNP — For 450 million NNS , NN NNS VBP VBN along the NN NN , VBG RB to VB NNS . You VBP RB JJ NNS to VB JJ NNS and the JJ NNS that VBD before NN VBD on the NN . While its JJ NN RB VBD it , the NN NN , VBG in a JJ NN , VBD another NN — NN that RB VBD to VB NN from NNS and NN of NNS . RB as it VBZ for this JJ NN , NN VBZ RB around us . “ It VBZ RB JJ until it VBZ the NN NN , ” VBD NNP NNP , JJ NN NN ( NNP ) NN NN for NNPS of NNP NNP in NNP NNP . “ If it VBZ into the NN or JJ NN , you VBP a NN . ” Because of its JJ and JJ NN to NN , NN NN NN VBZ VBN in VBG NN that can VB RB VBN , VBN or VBN as NN . That VBZ NN NNS , NN NNS , NNS , JJ NNS and NNS JJ as the JJ NN NN , and the NN NNS RB in NN with RB JJ NN . While JJ NNS VBP like JJ NNP and a JJ NN NN , NNP NN NN NN VBZ the NN NN , NNP VBD . The NNP NN VBD RB VBN in NNP by NNP NNP and NNP NNP of NNP NNP NNP . NNS of NNP NNP , the JJ NN VBN to VB it , VBD VBN in 1974 by NNP NNP , a NNP NNP NNP NNP JJ NN who VBD the NN NN NN as a NN to VB JJ NN in NN . The NN RB VBZ RB 200 NNS and NNS RB , NNP VBD . There VBP RB four NNS in the NNP . NNP VBD his NN VBZ RB VB a RB JJ NN in NN for NNP to VB and VB JJ NNS . RB JJ VBZ VBN to VB a NN of the NN , and it would VB RB a NN of NN to VB RB to VB the NN of RB an VBN five billion NNS , he VBD . RB in the JJ NNS and JJ NNS , there VBD NN over the NN of the NN NN . The NN ’s NNS VBD to VB to the NN where NNS and JJ NN NN NNS like the NNP NNP NNP VBD NN over a NN of NN NN NNS , a JJ NN for JJ NN NNS like JJ NN along their JJ NN . NN NN : When there VBZ one , how will we VB JJ NN VBZ it ? That VBZ the NN of NN NN NNS . JJR NNS : NNP VBZ he VBZ JJ about NN NN NN but JJ how RB it will VB JJ VBD VBN about a JJ NN in NNS by a NN NN in which the NNS VBD VBN to VB NN , NNS and JJ NNS to NNS . NNS VBD about the NN of NNS VBG from NN and NN in the JJ NN . JJ NNS and NNS on NN NN in JJ NN NN NNS like NNP NNP and in NNP and JJ NNS along the JJ NN VBD VB that NN under NN . The NN NN VBD in 1999 at 2.6 million NNS and VBZ VBN under 1 million NNS since 2003 , VBG to a 2019 NN NN by the NNP NNPS NNP NNPS NNP . In that 2019 NN , the NN VBD a 15 NN NN for the JJ NN . JJS of the NN NN NN VBZ in the NNS , and NNP NNS RB VBP a JJ NN VBN in NN NN . The NN VBZ VBN to the NN within 24 NNS , NNP VBD . JJ VBN NN for the RB 500,000 NNS VBN RB for the JJ NN in 2017 VBD 72,674 NNS . RB 990,000 VBD VBN and VBN in the NN NN that NN , VBG to NN NN . NNP NNP , an JJ NN NN at the NNP NNP of NNP NNPS , VBD that JJ NNS VBP the NN of the JJ NN . “ In the ( NNP ) NN NN , they VBP that NN NN from the JJ NN NN ( NN NNS and NN NNS ) could VB JJR than the JJ and NN NN VBN , ” he VBD . Although they VBP RB VBN JJ to VB what VBZ a JJ NN NN NN , or a JJ NN to VB , NN NNS VBD that the NN of NNS VBP these JJ NNS VBP VBN in the JJ NN . NNP VBD out that NN NNS along the NNP NNP , with the NN of the NNP NNP NN , VBD RB VBG VBN NN NN NN . “ Our NN NN , with a 40 NN NN , VBD the JJS NN NN in NNS this NN , RB our NN VBZ to VB VBG , ” NNP VBD . His NN VBZ NNS to NNPS of NNP NNP on how to RB VB NNS to VB NN , and they VBP in the NNP NNP NN RB a NN during the NN to VB the NN and NN of the NNS ."
158,1115,mainstream,"TOKYO_NNP (_-LRB- Reuters_NNP )_-RRB- -_, The_DT Tokyo_NNP Olympics_NNP next_JJ July_NNP will_MD be_VB a_DT “_`` uniquely_RB risky_JJ ”_'' event_NN ,_, demanding_VBG flexibility_NN from_IN organisers_NNS amid_IN the_DT uncertainty_NN of_IN the_DT coronavirus_NN pandemic_NN ,_, particularly_RB if_IN a_DT vaccine_NN has_VBZ not_RB been_VBN rolled_VBN out_RP by_IN then_RB ,_, medical_JJ experts_NNS say_VBP ._. Japan_NNP and_CC the_DT International_NNP Olympic_NNP Committee_NNP made_VBD the_DT unprecedented_JJ decision_NN last_JJ month_NN to_TO delay_VB the_DT Games_NNPS for_IN a_DT year_NN ,_, as_IN the_DT world_NN battles_VBZ the_DT virus_NN that_WDT has_VBZ infected_VBN 2.3_CD million_CD people_NNS and_CC killed_VBD more_JJR than_IN 150,000_CD globally_RB ._. But_CC questions_NNS persist_VBP whether_IN the_DT Games_NNPS can_MD go_VB ahead_RB 15_CD months_NNS from_IN now_RB ,_, as_IN a_DT vaccine_NN could_MD still_RB be_VB at_IN least_JJS a_DT year_NN away_RB ,_, according_VBG to_IN the_DT most_RBS optimistic_JJ estimates_NNS ._. “_`` When_WRB we_PRP talk_VBP about_IN bringing_VBG sports_NNS back_RB with_IN packed_VBN stadiums_NNS ,_, I_PRP really_RB think_VBP that_DT is_VBZ something_NN we_PRP are_VBP going_VBG to_TO have_VB to_TO wait_VB for_IN a_DT vaccine_NN to_TO be_VB able_JJ to_TO do_VB ,_, ”_'' said_VBD Zach_NNP Binney_NNP ,_, an_DT epidemiologist_NN at_IN Emory_NNP University_NNP in_IN the_DT United_NNP States_NNPS ._. Tokyo_NNP 2020_CD is_VBZ set_VBN to_TO run_VB from_IN July_NNP 23_CD to_IN Aug._NNP 8_CD next_JJ year_NN ,_, but_CC organisers_NNS expect_VBP few_JJ changes_NNS to_IN the_DT original_JJ plan_NN ,_, including_VBG attendance_NN by_IN enthusiastic_JJ supporters_NNS ._. But_CC that_DT might_MD be_VB over_RB optimistic_JJ ,_, Binney_NNP ,_, a_DT specialist_NN in_IN aspects_NNS of_IN athlete_NN health_NN ,_, told_VBD Reuters_NNP ._. “_`` Every_DT person_NN that_WDT you_PRP add_VBP to_IN a_DT gathering_NN adds_VBZ risk_NN ,_, ”_'' said_VBD Binney_NNP ,_, who_WP expects_VBZ vaccine_NN development_NN would_MD take_VB 1_CD -_SYM 1/_CD 2_CD years_NNS from_IN the_DT start_NN of_IN the_DT outbreak_NN ,_, or_CC until_IN late_JJ 2021_CD ,_, at_IN the_DT earliest_JJS ._. “_`` So_RB once_IN you_PRP get_VBP up_IN to_IN 50,000_CD ,_, 70,000_CD ,_, 100,000_CD (_-LRB- fans_NNS )_-RRB- ..._, that_DT is_VBZ an_DT enormous_JJ amount_NN of_IN risk_NN to_TO be_VB taking_VBG on_RP without_IN a_DT vaccine_NN ._. ”_'' The_DT Olympics_NNPS was_VBD “_`` a_DT uniquely_RB risky_JJ event_NN ”_'' ,_, he_PRP added_VBD ,_, because_IN of_IN the_DT threats_NNS represented_VBN by_IN visitors_NNS streaming_VBG in_RP from_IN areas_NNS with_IN a_DT lot_NN of_IN infections_NNS ,_, and_CC the_DT reverse_JJ flow_NN when_WRB they_PRP return_VBP afterwards_RB ,_, perhaps_RB carrying_VBG home_NN infections_NNS ._. Although_IN more_RBR hopeful_JJ for_IN a_DT vaccine_NN to_TO be_VB found_VBN within_IN a_DT year_NN ,_, Jason_NNP Kindrachuk_NNP ,_, an_DT infectious_JJ diseases_NNS expert_NN at_IN the_DT University_NNP of_IN Manitoba_NNP in_IN Canada_NNP ,_, flagged_VBD a_DT risk_NN of_IN further_JJ delay_NN to_IN the_DT Games_NNPS ,_, as_IN vaccinating_VBG people_NNS would_MD take_VB time_NN ._. “_`` It_PRP is_VBZ going_VBG to_TO push_VB the_DT limits_NNS right_RB up_RP to_IN the_DT border_NN of_IN when_WRB the_DT Olympics_NNPS should_MD be_VB starting_VBG ,_, ”_'' said_VBD Kindrachuk_NNP ,_, who_WP has_VBZ worked_VBN on_IN outbreaks_NNS of_IN Ebola_NNP and_CC SARS_NNP ._. “_`` You_PRP want_VBP to_TO get_VB people_NNS vaccinated_VBN not_RB right_RB at_IN the_DT point_NN of_IN the_DT Olympics_NNPS ,_, but_CC a_DT little_JJ bit_NN beforehand_RB ,_, so_RB they_PRP build_VBP up_RP that_DT protective_JJ immunity_NN ._. ”_'' Dr_NNP Kentaro_NNP Iwata_NNP ,_, who_WP drew_VBD international_JJ attention_NN for_IN his_PRP$ criticism_NN of_IN the_DT Japanese_JJ government_NN after_IN a_DT visit_NN in_IN February_NNP to_IN the_DT Diamond_NNP Princess_NNP cruise_NN ship_NN quarantined_VBN with_IN thousands_NNS of_IN passengers_NNS ,_, expressed_VBD pessimism_NN over_IN the_DT new_JJ date_NN ._. “_`` I_PRP do_VBP n’t_RB think_VB the_DT Olympics_NNPS is_VBZ likely_JJ to_TO be_VB held_VBN next_JJ year_NN ,_, if_IN held_VBN at_IN any_DT time_NN ,_, ”_'' the_DT virologist_NN told_VBD the_DT Foreign_NNP Correspondents_NNPS Club_NNP of_IN Japan_NNP in_IN a_DT teleconference_NN ._. “_`` Japan_NNP might_MD be_VB able_JJ to_TO control_VB this_DT disease_NN by_IN next_JJ summer_NN ,_, and_CC I_PRP wish_VBP we_PRP could_MD ,_, but_CC I_PRP do_VBP n’t_RB think_VB that_DT would_MD happen_VB everywhere_RB on_IN earth_NN ,_, ”_'' the_DT Kobe_NNP University_NNP professor_NN added_VBD ._. In_IN response_NN ,_, the_DT Tokyo_NNP 2020_CD Organising_NNP Committee_NNP said_VBD it_PRP was_VBD focusing_VBG purely_RB on_IN delivering_VBG the_DT Games_NNPS next_JJ year_NN ._. “_`` The_DT mission_NN is_VBZ to_TO prepare_VB the_DT stage_NN for_IN next_JJ summer_NN ;_, we_PRP do_VBP not_RB feel_VB it_PRP is_VBZ appropriate_JJ to_TO respond_VB to_IN speculative_JJ questions_NNS ,_, ”_'' spokesman_NN Masa_NNP Takaya_NNP said_VBD in_IN an_DT email_NN to_IN Reuters_NNP on_IN Monday_NNP ._. Even_RB if_IN a_DT vaccine_NN were_VBD not_RB ready_JJ ,_, the_DT organisers_NNS might_MD still_RB be_VB able_JJ to_TO hold_VB the_DT Games_NNPS ,_, as_RB long_RB as_IN they_PRP were_VBD flexible_JJ and_CC well_RB prepared_VBN ,_, Kindrachuk_NNP added_VBD ._. “_`` It_PRP is_VBZ going_VBG to_TO take_VB some_DT creative_JJ thinking_NN ,_, and_CC hopefully_RB some_DT willingness_NN from_IN the_DT public_NN ,_, to_TO at_IN least_JJS still_RB partake_VB in_IN watching_VBG ..._, understanding_NN that_IN it_PRP is_VBZ just_RB simply_RB not_RB going_VBG to_TO look_VB like_IN what_WP we_PRP have_VBP seen_VBN before_RB ._. ”_'' Binney_NNP said_VBD the_DT safest_JJS option_NN would_MD be_VB for_IN athletes_NNS to_TO arrive_VB in_IN Tokyo_NNP four_CD to_IN six_CD weeks_NNS in_IN advance_NN and_CC follow_VB rigorous_JJ isolation_NN measures_NNS for_IN two_CD weeks_NNS before_IN moving_VBG into_IN the_DT Olympic_JJ village_NN to_TO train_VB for_IN the_DT remaining_VBG period_NN ._. “_`` My_PRP$ goal_NN would_MD be_VB to_TO have_VB the_DT Olympic_NNP Village_NNP as_IN a_DT virus_NN -_HYPH free_JJ quarantine_NN zone_NN ,_, ”_'' he_PRP added_VBD ._.","NNP ( NNP ) - The NNP NNP JJ NNP will VB a “ RB JJ ” NN , VBG NN from NNS amid the NN of the NN NN , RB if a NN VBZ RB VBN VBN out by RB , JJ NNS VBP . NNP and the NNP NNP NNP VBD the JJ NN JJ NN to VB the NNPS for a NN , as the NN VBZ the NN that VBZ VBN 2.3 million NNS and VBD JJR than 150,000 RB . But NNS VBP whether the NNPS can VB RB 15 NNS from RB , as a NN could RB VB at JJS a NN RB , VBG to the RBS JJ NNS . “ When we VBP about VBG NNS RB with VBN NNS , I RB VBP that VBZ NN we VBP VBG to VB to VB for a NN to VB JJ to VB , ” VBD NNP NNP , an NN at NNP NNP in the NNP NNPS . NNP 2020 VBZ VBN to VB from NNP 23 to NNP 8 JJ NN , but NNS VBP JJ NNS to the JJ NN , VBG NN by JJ NNS . But that might VB RB JJ , NNP , a NN in NNS of NN NN , VBD NNP . “ Every NN that you VBP to a NN VBZ NN , ” VBD NNP , who VBZ NN NN would VB 1 - 1/ 2 NNS from the NN of the NN , or until JJ 2021 , at the JJS . “ RB once you VBP up to 50,000 , 70,000 , 100,000 ( NNS ) ... that VBZ an JJ NN of NN to VB VBG on without a NN . ” The NNPS VBD “ a RB JJ NN ” , he VBD , because of the NNS VBN by NNS VBG in from NNS with a NN of NNS , and the JJ NN when they VBP RB , RB VBG NN NNS . Although RBR JJ for a NN to VB VBN within a NN , NNP NNP , an JJ NNS NN at the NNP of NNP in NNP , VBD a NN of JJ NN to the NNPS , as VBG NNS would VB NN . “ It VBZ VBG to VB the NNS RB up to the NN of when the NNPS should VB VBG , ” VBD NNP , who VBZ VBN on NNS of NNP and NNP . “ You VBP to VB NNS VBN RB RB at the NN of the NNPS , but a JJ NN RB , RB they VBP up that JJ NN . ” NNP NNP NNP , who VBD JJ NN for his NN of the JJ NN after a NN in NNP to the NNP NNP NN NN VBN with NNS of NNS , VBD NN over the JJ NN . “ I VBP RB VB the NNPS VBZ JJ to VB VBN JJ NN , if VBN at any NN , ” the NN VBD the NNP NNPS NNP of NNP in a NN . “ NNP might VB JJ to VB this NN by JJ NN , and I VBP we could , but I VBP RB VB that would VB RB on NN , ” the NNP NNP NN VBD . In NN , the NNP 2020 NNP NNP VBD it VBD VBG RB on VBG the NNPS JJ NN . “ The NN VBZ to VB the NN for JJ NN ; we VBP RB VB it VBZ JJ to VB to JJ NNS , ” NN NNP NNP VBD in an NN to NNP on NNP . RB if a NN VBD RB JJ , the NNS might RB VB JJ to VB the NNPS , RB RB as they VBD JJ and RB VBN , NNP VBD . “ It VBZ VBG to VB some JJ NN , and RB some NN from the NN , to at JJS RB VB in VBG ... NN that it VBZ RB RB RB VBG to VB like what we VBP VBN RB . ” NNP VBD the JJS NN would VB for NNS to VB in NNP four to six NNS in NN and VB JJ NN NNS for two NNS before VBG into the JJ NN to VB for the VBG NN . “ My NN would VB to VB the NNP NNP as a NN - JJ NN NN , ” he VBD ."
159,22,mainstream,"Although_IN public_JJ health_NN researchers_NNS have_VBP worked_VBN to_TO counter_VB misinformation_NN about_IN vaccines_NNS and_CC raise_VB vaccination_NN rates_NNS ,_, a_DT number_NN of_IN the_DT methods_NNS they_PRP are_VBP using_VBG may_MD be_VB ineffective_JJ ,_, according_VBG to_IN a_DT new_JJ study_NN ._. In_IN the_DT study_NN ,_, researchers_NNS focused_VBD on_IN the_DT now_RB -_HYPH debunked_VBN idea_NN that_IN the_DT vaccine_NN for_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- or_CC MMR_NN )_-RRB- caused_VBD autism_NN ._. Surveying_VBG 1,759_CD parents_NNS ,_, researchers_NNS found_VBD that_IN while_IN they_PRP were_VBD able_JJ to_TO teach_VB parents_NNS that_IN the_DT vaccine_NN and_CC autism_NN were_VBD not_RB linked_VBN ,_, parents_NNS who_WP were_VBD surveyed_VBN who_WP had_VBD initial_JJ reservations_NNS about_IN vaccines_NNS said_VBD they_PRP were_VBD actually_RB less_RBR likely_JJ to_TO vaccinate_VB their_PRP$ children_NNS after_IN hearing_VBG the_DT researchers_NNS messages_NNS ._. ""_`` The_DT first_JJ message_NN of_IN our_PRP$ study_NN is_VBZ that_IN the_DT messaging_NN we_PRP use_VBP to_TO promote_VB childhood_NN vaccines_NNS may_MD not_RB be_VB effective_JJ ,_, and_CC in_IN some_DT cases_NNS may_MD be_VB counterproductive_JJ ,_, ""_'' said_VBD Brendan_NNP Nyhan_NNP ,_, an_DT assistant_JJ professor_NN in_IN the_DT department_NN of_IN government_NN at_IN Dartmouth_NNP College_NNP ,_, who_WP researches_VBZ misconceptions_NNS about_IN health_NN care_NN ._. ""_`` We_PRP need_VBP more_JJR evidence_NN -_HYPH based_VBN messaging_NN about_IN vaccines_NNS ._. We_PRP do_VBP n't_RB know_VB what_WP works_VBZ ,_, and_CC we_PRP need_VBP to_TO learn_VB more_JJR ,_, rather_RB than_IN relying_VBG on_IN hunches_NNS or_CC intuition_NN ._. ""_'' The_DT myth_NN that_IN the_DT MMR_NNP vaccine_NN can_MD cause_VB autism_NN grew_VBD out_IN of_IN a_DT small_JJ ,_, 1998_CD British_JJ study_NN that_WDT has_VBZ since_RB been_VBN retracted_VBN ._. The_DT paper_NN 's_POS author_NN was_VBD later_RBR found_VBN guilty_JJ of_IN misconduct_NN and_CC can_MD no_RB longer_RBR practice_VB medicine_NN in_IN the_DT UK_NNP ._. A_DT number_NN of_IN large_JJ -_HYPH scale_NN studies_NNS conducted_VBN since_IN then_RB have_VBP showed_VBN no_DT connection_NN ._. [_-LRB- 7_CD Medical_NNP Myths_NNPS Even_RB Doctors_NNS Believe_VBP ]_-RRB- In_IN the_DT new_JJ study_NN ,_, researchers_NNS looked_VBD at_IN four_CD methods_NNS designed_VBN to_TO counter_VB the_DT myth_NN that_IN the_DT MMR_NNP vaccine_NN can_MD cause_VB autism_NN ._. They_PRP gave_VBD people_NNS either_CC information_NN from_IN health_NN authorities_NNS about_IN the_DT lack_NN of_IN evidence_NN for_IN a_DT connection_NN ,_, information_NN about_IN the_DT danger_NN of_IN the_DT three_CD diseases_NNS the_DT MMR_NNP vaccine_NN protects_VBZ against_IN ,_, pictures_NNS of_IN children_NNS who_WP had_VBD one_CD of_IN those_DT three_CD diseases_NNS ,_, or_CC a_DT story_NN about_IN an_DT infant_NN who_WP almost_RB died_VBD from_IN measles_NNS ._. At_IN the_DT study_NN 's_POS start_NN ,_, the_DT group_NN of_IN parents_NNS who_WP were_VBD most_RBS opposed_VBN to_IN vaccination_NN said_VBD that_IN on_IN average_NN ,_, the_DT chance_NN they_PRP would_MD vaccinate_VB a_DT future_JJ child_NN against_IN MMR_NNP was_VBD 70_CD percent_NN ._. After_IN these_DT parents_NNS had_VBD been_VBN given_VBN information_NN that_IN the_DT MMR_NNP vaccine_NN does_VBZ not_RB cause_VB autism_NN ,_, they_PRP said_VBD ,_, on_IN average_NN ,_, the_DT chance_NN they_PRP would_MD vaccinate_VB a_DT future_JJ child_NN was_VBD only_RB 45_CD percent_NN —_: even_RB though_IN they_PRP also_RB said_VBD they_PRP were_VBD now_RB less_RBR likely_JJ to_TO believe_VB the_DT vaccine_NN could_MD cause_VB autism_NN ._. In_IN other_JJ words_NNS ,_, giving_VBG the_DT parents_NNS new_JJ information_NN made_VBD them_PRP more_RBR opposed_JJ to_IN vaccinating_VBG a_DT future_JJ child_NN ._. Nyhan_NNP said_VBD the_DT exact_JJ reason_NN for_IN this_DT phenomenon_NN is_VBZ unclear_JJ ,_, but_CC past_JJ research_NN gives_VBZ some_DT hints_NNS ._. ""_`` We_PRP suggest_VBP that_IN people_NNS are_VBP motivated_VBN to_TO defend_VB their_PRP$ more_RBR skeptical_JJ or_CC less_RBR favorable_JJ attitudes_NNS towards_IN vaccines_NNS ,_, ""_'' Nyhan_NNP told_VBD Live_NNP Science_NNP ._. In_IN the_DT face_NN of_IN evidence_NN that_IN one_CD of_IN their_PRP$ notions_NNS about_IN vaccines_NNS is_VBZ incorrect_JJ ,_, he_PRP explained_VBD ,_, people_NNS may_MD recall_VB other_JJ objections_NNS or_CC concerns_NNS they_PRP have_VBP ,_, and_CC as_IN a_DT result_NN they_PRP become_VBP less_RBR likely_JJ to_TO say_VB they_PRP would_MD vaccinate_VB ,_, rather_RB than_IN more_JJR ._. To_TO counter_VB this_DT ,_, he_PRP said_VBD ,_, public_JJ health_NN strategies_NNS will_MD need_VB to_TO target_VB opposition_NN to_IN vaccines_NNS by_IN keeping_VBG in_IN mind_NN that_IN there_EX are_VBP a_DT number_NN of_IN reasons_NNS parents_NNS may_MD be_VB opting_VBG not_RB to_TO vaccinate_VB ._. One_CD limit_NN ,_, Nyhan_NNP said_VBD ,_, is_VBZ that_IN the_DT study_NN merely_RB looked_VBD at_IN parents_NNS '_POS intentions_NNS ._. As_IN the_DT actual_JJ concern_NN is_VBZ vaccination_NN ,_, it_PRP 's_VBZ important_JJ for_IN researchers_NNS to_TO consider_VB vaccination_NN rates_NNS ,_, he_PRP said_VBD ._. Also_RB ,_, as_IN vaccination_NN rates_NNS are_VBP currently_RB high_JJ ,_, it_PRP 's_VBZ important_JJ to_TO keep_VB in_IN mind_NN that_IN any_DT strategies_NNS should_MD focus_VB on_IN retaining_VBG these_DT numbers_NNS and_CC not_RB raise_VB more_JJR concerns_NNS ,_, tipping_VBG parents_NNS who_WP are_VBP willing_JJ to_TO vaccinate_VB away_RB from_IN doing_VBG so_RB ._. The_DT positive_JJ takeaway_NN ,_, Nyhan_NNP said_VBD ,_, is_VBZ that_IN researchers_NNS have_VBP the_DT tools_NNS to_TO learn_VB more_JJR about_IN what_WDT messages_NNS do_VBP work_VB ,_, and_CC can_MD hopefully_RB develop_VB strategies_NNS that_WDT will_MD lift_VB vaccination_NN rates_NNS higher_JJR ._. But_CC given_VBN the_DT range_NN of_IN groups_NNS with_IN some_DT impulse_NN against_IN vaccination_NN ,_, it_PRP likely_RB wo_MD n't_RB be_VB simple_JJ to_TO find_VB a_DT message_NN that_WDT works_VBZ for_IN everyone_NN ._. ""_`` We_PRP should_MD n't_RB put_VB too_RB much_JJ weight_NN on_IN the_DT idea_NN that_IN there_EX 's_VBZ some_DT magic_JJ message_NN out_RB there_RB that_WDT will_MD change_VB people_NNS minds_NNS ,_, ""_'' he_PRP said_VBD ._. The_DT study_NN is_VBZ published_VBN today_NN (_-LRB- March_NNP 3_CD )_-RRB- in_IN the_DT journal_NNP Pediatrics_NNP ._. •_SYM 10_CD Medical_JJ Myths_NNS that_WDT Just_RB Wo_MD n't_RB Go_VB Away_RB Copyright_NN 2014_CD LiveScience_NNP ,_, a_DT TechMediaNetwork_NNP company_NN ._. All_DT rights_NNS reserved_VBN ._. This_DT material_NN may_MD not_RB be_VB published_VBN ,_, broadcast_VBN ,_, rewritten_VBN or_CC redistributed_VBN ._.","Although JJ NN NNS VBP VBN to VB NN about NNS and VB NN NNS , a NN of the NNS they VBP VBG may VB JJ , VBG to a JJ NN . In the NN , NNS VBD on the RB - VBN NN that the NN for NNS , NNS and NN ( or NN ) VBD NN . VBG 1,759 NNS , NNS VBD that while they VBD JJ to VB NNS that the NN and NN VBD RB VBN , NNS who VBD VBN who VBD JJ NNS about NNS VBD they VBD RB RBR JJ to VB their NNS after VBG the NNS NNS . "" The JJ NN of our NN VBZ that the NN we VBP to VB NN NNS may RB VB JJ , and in some NNS may VB JJ , "" VBD NNP NNP , an JJ NN in the NN of NN at NNP NNP , who VBZ NNS about NN NN . "" We VBP JJR NN - VBN NN about NNS . We VBP RB VB what VBZ , and we VBP to VB JJR , RB than VBG on NNS or NN . "" The NN that the NNP NN can VB NN VBD out of a JJ , 1998 JJ NN that VBZ RB VBN VBN . The NN 's NN VBD RBR VBN JJ of NN and can RB RBR VB NN in the NNP . A NN of JJ - NN NNS VBN since RB VBP VBN no NN . [ 7 NNP NNPS RB NNS VBP ] In the JJ NN , NNS VBD at four NNS VBN to VB the NN that the NNP NN can VB NN . They VBD NNS either NN from NN NNS about the NN of NN for a NN , NN about the NN of the three NNS the NNP NN VBZ against , NNS of NNS who VBD one of those three NNS , or a NN about an NN who RB VBD from NNS . At the NN 's NN , the NN of NNS who VBD RBS VBN to NN VBD that on NN , the NN they would VB a JJ NN against NNP VBD 70 NN . After these NNS VBD VBN VBN NN that the NNP NN VBZ RB VB NN , they VBD , on NN , the NN they would VB a JJ NN VBD RB 45 NN — RB though they RB VBD they VBD RB RBR JJ to VB the NN could VB NN . In JJ NNS , VBG the NNS JJ NN VBD them RBR JJ to VBG a JJ NN . NNP VBD the JJ NN for this NN VBZ JJ , but JJ NN VBZ some NNS . "" We VBP that NNS VBP VBN to VB their RBR JJ or RBR JJ NNS towards NNS , "" NNP VBD NNP NNP . In the NN of NN that one of their NNS about NNS VBZ JJ , he VBD , NNS may VB JJ NNS or NNS they VBP , and as a NN they VBP RBR JJ to VB they would VB , RB than JJR . To VB this , he VBD , JJ NN NNS will VB to VB NN to NNS by VBG in NN that there VBP a NN of NNS NNS may VB VBG RB to VB . One NN , NNP VBD , VBZ that the NN RB VBD at NNS ' NNS . As the JJ NN VBZ NN , it VBZ JJ for NNS to VB NN NNS , he VBD . RB , as NN NNS VBP RB JJ , it VBZ JJ to VB in NN that any NNS should VB on VBG these NNS and RB VB JJR NNS , VBG NNS who VBP JJ to VB RB from VBG RB . The JJ NN , NNP VBD , VBZ that NNS VBP the NNS to VB JJR about what NNS VBP VB , and can RB VB NNS that will VB NN NNS JJR . But VBN the NN of NNS with some NN against NN , it RB wo RB VB JJ to VB a NN that VBZ for NN . "" We should RB VB RB JJ NN on the NN that there VBZ some JJ NN RB RB that will VB NNS NNS , "" he VBD . The NN VBZ VBN NN ( NNP 3 ) in the NNP NNP . • 10 JJ NNS that RB Wo RB VB RB NN 2014 NNP , a NNP NN . All NNS VBN . This NN may RB VB VBN , VBN , VBN or VBN ."
160,1109,mainstream,"Shares_NNS of_IN Vaxcyte_NNP Inc._NNP PCVX_NNP ,_, soared_VBD 22_CD %_NN in_IN their_PRP$ trading_NN debut_NN Friday_NNP ,_, after_IN the_DT company_NN 's_POS IPO_NNP priced_VBN at_IN the_DT top_JJ end_NN of_IN its_PRP$ price_NN range_NN ,_, and_CC was_VBD upsized_VBN to_IN 15.6_CD million_CD shares_NNS from_IN earlier_JJR plans_NNS to_TO sell_VB just_RB 14_CD million_CD ._. The_DT company_NN raised_VBD $_$ 249.6_CD million_CD ._. The_DT shares_NNS are_VBP trading_VBG on_IN Nasdaq_NNP later_RBR Friday_NNP under_IN the_DT ticker_NN symbol_NN ""_`` PCVX_NN ._. ""_'' BofA_NNP Securities_NNPS ,_, Jefferies_NNP and_CC Evercore_NNP ISI_NNP were_VBD lead_VBN underwriters_NNS on_IN the_DT deal_NN with_IN Cantor_NNP and_CC Needham_NNP acting_VBG as_IN co-managers_NNS ._. ""_`` We_PRP are_VBP a_DT next_JJ -_HYPH generation_NN vaccine_NN company_NN seeking_VBG to_TO improve_VB global_JJ health_NN by_IN developing_VBG superior_JJ and_CC novel_JJ vaccines_NNS designed_VBN to_TO prevent_VB or_CC treat_VB some_DT of_IN the_DT most_RBS common_JJ and_CC deadly_JJ infectious_JJ diseases_NNS worldwide_RB ,_, ""_'' says_VBZ the_DT prospectus_NN ._. Proceeds_NNS of_IN the_DT deal_NN will_MD be_VB used_VBN top_NN fund_NN clinical_JJ development_NN and_CC for_IN general_JJ corporate_JJ purposes_NNS ._.","NNS of NNP NNP NNP , VBD 22 NN in their NN NN NNP , after the NN 's NNP VBN at the JJ NN of its NN NN , and VBD VBN to 15.6 million NNS from JJR NNS to VB RB 14 million . The NN VBD $ 249.6 million . The NNS VBP VBG on NNP RBR NNP under the NN NN "" NN . "" NNP NNPS , NNP and NNP NNP VBD VBN NNS on the NN with NNP and NNP VBG as NNS . "" We VBP a JJ - NN NN NN VBG to VB JJ NN by VBG JJ and JJ NNS VBN to VB or VB some of the RBS JJ and JJ JJ NNS RB , "" VBZ the NN . NNS of the NN will VB VBN NN NN JJ NN and for JJ JJ NNS ."
161,786,mainstream,"Two_CD years_NNS ago_RB ,_, Facebook_NNP CEO_NN Mark_NNP Zuckerberg_NNP announced_VBD a_DT renewed_VBN focus_NN on_IN communities_NNS and_CC its_PRP$ Groups_NNS feature_NN ,_, boasting_VBG that_IN it_PRP would_MD help_VB create_VB a_DT more_RBR ""_`` meaningful_JJ ""_'' social_JJ infrastructure_NN ._. It_PRP worked_VBD ._. Last_JJ month_NN ,_, Zuckerberg_NNP told_VBD investors_NNS that_IN ""_`` hundreds_NNS of_IN millions_NNS ""_'' of_IN users_NNS reported_VBD belonging_VBG in_IN ""_`` meaningful_JJ groups_NNS ,_, ""_'' up_RB from_IN one_CD million_CD in_IN 2017_CD ,_, when_WRB the_DT company_NN began_VBD focusing_VBG on_IN Groups_NNS ._. ""_`` Connecting_VBG with_IN communities_NNS of_IN people_NNS that_WDT you_PRP 're_VBP interested_JJ in_IN is_VBZ going_VBG to_TO be_VB as_RB central_JJ to_IN the_DT experience_NN as_IN connecting_VBG with_IN friends_NNS and_CC family_NN ,_, ""_'' he_PRP told_VBD investors_NNS last_JJ month_NN ._. But_CC that_DT shift_NN has_VBZ also_RB moved_VBN Facebook_NNP activity_NN out_IN of_IN public_JJ view_NN ,_, leaving_VBG researchers_NNS to_TO warn_VB that_IN they_PRP now_RB know_VBP less_RBR about_IN what_WP is_VBZ happening_VBG on_IN the_DT social_JJ network_NN and_CC how_WRB the_DT company_NN 's_POS algorithm_NN -_HYPH driven_VBN recommendations_NNS are_VBP funneling_VBG people_NNS to_TO fringe_NN communities_NNS and_CC misinformation_NN ._. ""_`` As_IN a_DT researcher_NN ,_, we_PRP can_MD get_VB content_NN but_CC content_NN is_VBZ n't_RB what_WP you_PRP need_VBP to_TO research_VB Facebook_NNP and_CC see_VB how_WRB these_DT groups_NNS work_VBP ,_, ""_'' said_VBD Jonathan_NNP Albright_NNP ,_, director_NN of_IN research_NN at_IN Columbia_NNP University_NNP 's_POS Tow_NNP Center_NNP for_IN Digital_NNP Journalism_NNP ._. ""_`` We_PRP need_VBP to_TO know_VB more_JJR about_IN the_DT networks_NNS and_CC members_NNS of_IN groups_NNS that_WDT spread_VBP false_JJ information_NN and_CC target_VBP individuals_NNS ._. ""_'' ""_`` It_PRP would_MD take_VB a_DT lot_NN of_IN work_NN and_CC more_JJR of_IN a_DT partnership_NN than_IN Facebook_NNP is_VBZ willing_JJ to_TO establish_VB ,_, especially_RB for_IN this_DT kind_NN of_IN work_NN ,_, ""_'' Albright_NNP said_VBD ._. Groups_NNS gained_VBD public_JJ attention_NN this_DT week_NN when_WRB The_DT Guardian_NNP uncovered_VBD a_DT vast_JJ network_NN of_IN groups_NNS spreading_VBG false_JJ information_NN about_IN vaccines_NNS ._. ""_`` STOP_NNP Mandatory_NNP Vaccination_NNP ,_, ""_'' one_CD of_IN the_DT largest_JJS anti-vaccine_JJ private_JJ groups_NNS at_IN more_JJR than_IN 126,000_CD members_NNS ,_, is_VBZ led_VBN by_IN Larry_NNP Cook_NNP ,_, a_DT self_NN -_HYPH described_VBN ""_`` social_JJ media_NN activist_NN ""_'' with_IN no_DT children_NNS or_CC medical_JJ training_NN ._. Cook_NNP and_CC his_PRP$ members_NNS promote_VBP the_DT disproven_VBN theory_NN that_IN vaccines_NNS cause_VBP autism_NN and_CC spread_VBP conspiracies_NNS that_WDT outbreaks_NNS of_IN preventable_JJ diseases_NNS are_VBP ""_`` hoaxes_NNS ""_'' perpetrated_VBN by_IN the_DT government_NN ._. In_IN response_NN to_IN the_DT negative_JJ press_NN ,_, Facebook_NNP told_VBD Bloomberg_NNP News_NNP it_PRP was_VBD considering_VBG ""_`` reducing_VBG or_CC removing_VBG this_DT type_NN of_IN content_NN ""_'' from_IN the_DT recommendations_NNS it_PRP offers_VBZ users_NNS ._. Those_DT recommendations_NNS have_VBP also_RB come_VBN under_IN increased_VBN scrutiny_NN ._. Part_NN of_IN Facebook_NNP 's_POS plan_NN for_IN growth_NN has_VBZ relied_VBN on_IN it's_PRP$ recommendation_NN engine_NN —_: the_DT algorithm_NN the_DT company_NN relies_VBZ on_RP to_TO get_VB users_NNS to_TO join_VB more_JJR groups_NNS ._. Reddit_NNP takes_VBZ aim_NN at_IN Google_NNP and_CC Facebook_NNP with_IN help_NN from_IN China_NNP Germany_NNP to_IN Facebook_NNP :_: Stop_VB pooling_VBG user_NN data_NNS from_IN multiple_JJ apps_NNS and_CC internet_NN use_NN Loophole_NN allows_VBZ pirated_JJ apps_NNS to_TO be_VB installed_VBN on_IN Apple_NNP iPhones_NNS The_DT algorithm_NN that_WDT powers_VBZ the_DT right_JJ rail_NN of_IN ""_`` suggested_VBN groups_NNS ""_'' is_VBZ n't_RB public_JJ ,_, and_CC a_DT Facebook_NNP spokesperson_NN declined_VBD to_TO give_VB details_NNS other_JJ than_IN saying_VBG they_PRP are_VBP tailored_VBN to_IN individual_JJ users_NNS ._. But_CC researchers_NNS like_IN Renée_NNP DiResta_NNP ,_, who_WP studies_VBZ online_JJ disinformation_NN as_IN director_NN of_IN research_NN at_IN cybersecurity_NN company_NN New_NNP Knowledge_NNP ,_, have_VBP found_VBN Facebook_NNP users_NNS down_IN a_DT rabbit_NN hole_NN of_IN increasingly_RB misinformed_VBN ,_, conspiratorial_JJ and_CC radical_JJ communities_NNS ._. Zuckerberg_NNP has_VBZ acknowledged_VBN the_DT significance_NN of_IN the_DT recommendation_NN engine_NN ,_, writing_VBG in_IN 2017_CD ,_, ""_`` Most_JJS do_VBP n't_RB seek_VB out_RP groups_NNS on_IN their_PRP$ own_JJ —_: friends_NNS send_VB invites_NNS or_CC Facebook_NNP suggests_VBZ them_PRP ._. ""_'' Facebook_NNP is_VBZ not_RB the_DT only_JJ tech_NN company_NN to_TO face_VB criticism_NN for_IN developing_VBG automated_JJ recommendations_NNS that_WDT push_VBP users_NNS toward_IN misinformation_NN ._. YouTube_NNP ,_, a_DT subsidiary_NN of_IN Alphabet_NNP 's_POS Google_NNP ,_, recently_RB announced_VBD it_PRP would_MD be_VB changing_VBG its_PRP$ own_JJ recommendation_NN engine_NN to_TO stop_VB suggesting_VBG conspiracy_NN videos_NNS ,_, after_IN years_NNS of_IN similar_JJ outcry_NN from_IN researchers_NNS and_CC former_JJ employees_NNS critical_JJ of_IN what_WP they_PRP claimed_VBD was_VBD the_DT company_NN 's_POS bargain_NN in_IN which_WDT it_PRP suggested_VBD extreme_JJ content_NN to_TO keep_VB people_NNS watching_VBG ._. Facebook_NNP does_VBZ n't_RB appear_VB to_TO have_VB any_DT plans_NNS to_TO follow_VB suit_NN ._. A_DT Facebook_NNP spokesperson_NN pointed_VBD NBC_NNP News_NNP to_IN the_DT option_NN it_PRP provides_VBZ users_NNS to_TO hide_VB or_CC remove_VB the_DT groups_NNS that_WDT Facebook_NNP suggests_VBZ ._. Meanwhile_RB ,_, uneven_JJ enforcement_NN across_IN the_DT platform_NN means_VBZ a_DT person_NN or_CC page_NN may_MD be_VB disciplined_VBN or_CC banned_VBN while_IN a_DT related_JJ group_NN continues_VBZ to_TO operate_VB ._. Facebook_NNP does_VBZ not_RB appear_VB to_TO be_VB enforcing_VBG its_PRP$ 2018_CD ban_NN on_IN the_DT conspiracy_NN news_NN site_NN Infowars_NNP in_IN its_PRP$ Groups_NNS feature_NN ,_, highlighting_VBG how_WRB communities_NNS can_MD skirt_VB Facebook_NNP 's_POS broader_JJR efforts_NNS to_TO clean_VB up_RP its_PRP$ platform_NN ._. Facebook_NNP updated_VBD its_PRP$ enforcement_NN policy_NN last_JJ week_NN ,_, closing_VBG a_DT loophole_NN that_WDT had_VBD allowed_VBN Alex_NNP Jones_NNP ,_, owner_NN of_IN Infowars_NNP ,_, to_TO operate_VB pages_NNS on_IN the_DT platform_NN despite_IN the_DT ban_NN ._. In_IN doing_VBG so_RB ,_, it_PRP shut_VBD down_RP 22_CD separate_JJ InfoWars_NNP pages_NNS ._. But_CC in_IN a_DT private_JJ Facebook_NNP group_NN of_IN more_JJR than_IN 117,000_CD members_NNS ,_, administered_VBN by_IN Jones_NNP and_CC several_JJ of_IN his_PRP$ employees_NNS ,_, Infowars_NNP lives_VBZ on_RP ._. The_DT group_NN describes_VBZ itself_PRP as_IN ""_`` an_DT alternative_JJ media_NN source_NN for_IN those_DT who_WP are_VBP awake_JJ !_. ""_'' and_CC members_NNS share_VBP and_CC comment_VBP on_IN far_RB -_HYPH right_JJ ,_, anti-Muslim_JJ and_CC conspiracy_NN content_NN —_: much_JJ of_IN it_PRP from_IN InfoWars_NNP '_POS website_NN —_: while_IN Jones_NNP and_CC the_DT other_JJ moderators_NNS and_CC administrators_NNS keep_VBP members_NNS informed_VBN of_IN alternate_JJ pages_NNS and_CC groups_NNS set_VBN up_RP to_TO evade_VB the_DT company_NN 's_POS original_JJ ban_NN and_CC promote_VB supplements_NNS and_CC prepper_NN gear_NN sold_VBN in_IN the_DT Infowars_NNP '_POS store_NN ._. When_WRB asked_VBN about_IN the_DT Infowars_NNP group_NN ,_, a_DT Facebook_NNP spokesperson_NN noted_VBD that_IN the_DT updated_VBN policy_NN applies_VBZ across_IN Facebook_NNP features_NNS and_CC products_NNS including_VBG Pages_NNPS ,_, Groups_NNS ,_, Events_NNPS and_CC Instagram_NNP ,_, and_CC said_VBD the_DT company_NN had_VBD only_RB begun_VBN to_TO enforce_VB it_PRP ._. At_IN its_PRP$ rollout_NN of_IN the_DT updated_VBN policy_NN ,_, Facebook_NNP said_VBD it_PRP would_MD be_VB looking_VBG at_IN two_CD criteria_NNS to_TO decide_VB which_WDT groups_NNS to_TO purge_VB :_: whether_IN the_DT groups_NNS have_VBP the_DT same_JJ admins_NNS or_CC similar_JJ group_NN names_NNS to_IN those_DT that_WDT had_VBD been_VBN removed_VBN —_: benchmarks_NNS the_DT InfoWars_NNP group_NN appears_VBZ to_TO meet_VB ._. ""_`` The_DT recent_JJ removals_NNS are_VBP a_DT first_JJ step_NN ,_, and_CC we_PRP will_MD continue_VB to_TO expand_VB in_IN the_DT months_NNS ahead_RB ,_, ""_'' the_DT Facebook_NNP spokesperson_NN said_VBD in_IN a_DT statement_NN ._. Meanwhile_RB ,_, inside_IN its_PRP$ private_JJ community_NN ,_, the_DT InfoWars_NNP description_NN reads_VBZ :_: ""_`` This_DT group_NN is_VBZ doing_VBG great_JJ ._.","Two NNS RB , NNP NN NNP NNP VBD a VBN NN on NNS and its NNS NN , VBG that it would VB VB a RBR "" JJ "" JJ NN . It VBD . JJ NN , NNP VBD NNS that "" NNS of NNS "" of NNS VBD VBG in "" JJ NNS , "" RB from one million in 2017 , when the NN VBD VBG on NNS . "" VBG with NNS of NNS that you VBP JJ in VBZ VBG to VB RB JJ to the NN as VBG with NNS and NN , "" he VBD NNS JJ NN . But that NN VBZ RB VBN NNP NN out of JJ NN , VBG NNS to VB that they RB VBP RBR about what VBZ VBG on the JJ NN and how the NN 's NN - VBN NNS VBP VBG NNS to NN NNS and NN . "" As a NN , we can VB NN but NN VBZ RB what you VBP to VB NNP and VB how these NNS VBP , "" VBD NNP NNP , NN of NN at NNP NNP 's NNP NNP for NNP NNP . "" We VBP to VB JJR about the NNS and NNS of NNS that VBP JJ NN and VBP NNS . "" "" It would VB a NN of NN and JJR of a NN than NNP VBZ JJ to VB , RB for this NN of NN , "" NNP VBD . NNS VBD JJ NN this NN when The NNP VBD a JJ NN of NNS VBG JJ NN about NNS . "" NNP NNP NNP , "" one of the JJS JJ JJ NNS at JJR than 126,000 NNS , VBZ VBN by NNP NNP , a NN - VBN "" JJ NN NN "" with no NNS or JJ NN . NNP and his NNS VBP the VBN NN that NNS VBP NN and VBP NNS that NNS of JJ NNS VBP "" NNS "" VBN by the NN . In NN to the JJ NN , NNP VBD NNP NNP it VBD VBG "" VBG or VBG this NN of NN "" from the NNS it VBZ NNS . Those NNS VBP RB VBN under VBN NN . NN of NNP 's NN for NN VBZ VBN on it's NN NN — the NN the NN VBZ on to VB NNS to VB JJR NNS . NNP VBZ NN at NNP and NNP with NN from NNP NNP to NNP : VB VBG NN NNS from JJ NNS and NN NN NN VBZ JJ NNS to VB VBN on NNP NNS The NN that VBZ the JJ NN of "" VBN NNS "" VBZ RB JJ , and a NNP NN VBD to VB NNS JJ than VBG they VBP VBN to JJ NNS . But NNS like NNP NNP , who VBZ JJ NN as NN of NN at NN NN NNP NNP , VBP VBN NNP NNS down a NN NN of RB VBN , JJ and JJ NNS . NNP VBZ VBN the NN of the NN NN , VBG in 2017 , "" JJS VBP RB VB out NNS on their JJ — NNS VB NNS or NNP VBZ them . "" NNP VBZ RB the JJ NN NN to VB NN for VBG JJ NNS that VBP NNS toward NN . NNP , a NN of NNP 's NNP , RB VBD it would VB VBG its JJ NN NN to VB VBG NN NNS , after NNS of JJ NN from NNS and JJ NNS JJ of what they VBD VBD the NN 's NN in which it VBD JJ NN to VB NNS VBG . NNP VBZ RB VB to VB any NNS to VB NN . A NNP NN VBD NNP NNP to the NN it VBZ NNS to VB or VB the NNS that NNP VBZ . RB , JJ NN across the NN VBZ a NN or NN may VB VBN or VBN while a JJ NN VBZ to VB . NNP VBZ RB VB to VB VBG its 2018 NN on the NN NN NN NNP in its NNS NN , VBG how NNS can VB NNP 's JJR NNS to VB up its NN . NNP VBD its NN NN JJ NN , VBG a NN that VBD VBN NNP NNP , NN of NNP , to VB NNS on the NN despite the NN . In VBG RB , it VBD down 22 JJ NNP NNS . But in a JJ NNP NN of JJR than 117,000 NNS , VBN by NNP and JJ of his NNS , NNP VBZ on . The NN VBZ itself as "" an JJ NN NN for those who VBP JJ ! "" and NNS VBP and VBP on RB - JJ , JJ and NN NN — JJ of it from NNP ' NN — while NNP and the JJ NNS and NNS VBP NNS VBN of JJ NNS and NNS VBN up to VB the NN 's JJ NN and VB NNS and NN NN VBN in the NNP ' NN . When VBN about the NNP NN , a NNP NN VBD that the VBN NN VBZ across NNP NNS and NNS VBG NNPS , NNS , NNPS and NNP , and VBD the NN VBD RB VBN to VB it . At its NN of the VBN NN , NNP VBD it would VB VBG at two NNS to VB which NNS to VB : whether the NNS VBP the JJ NNS or JJ NN NNS to those that VBD VBN VBN — NNS the NNP NN VBZ to VB . "" The JJ NNS VBP a JJ NN , and we will VB to VB in the NNS RB , "" the NNP NN VBD in a NN . RB , inside its JJ NN , the NNP NN VBZ : "" This NN VBZ VBG JJ ."
162,856,mainstream,"The_DT Trump_NNP administration_NN has_VBZ reportedly_RB named_VBN five_CD drugmakers_NNS that_WDT it_PRP expects_VBZ to_TO be_VB the_DT most_RBS likely_JJ to_TO produce_VB a_DT viable_JJ COVID_NN -_HYPH 19_CD vaccine_NN ,_, according_VBG to_IN The_DT New_NNP York_NNP Times_NNP ,_, which_WDT cited_VBD people_NNS familiar_JJ with_IN the_DT matter_NN ._. This_DT includes_VBZ AstraZeneca_NNP AZN_NNP ,_, in_IN combination_NN with_IN Oxford_NNP University_NNP ,_, Johnson_NNP &_CC Johnson_NNP JNJ_NNP ,_, ,_, Moderna_NNP Inc._NNP MRNA_NNP ,_, ,_, Merck_NNP &_CC Co._NNP Inc._NNP MCK_NNP ,_, ,_, and_CC Pfizer_NNP in_IN combination_NN with_IN BioNTech_NNP SE_NNP BNTX_NNP ,_, ._. With_IN the_DT exception_NN of_IN Merck_NNP ,_, Pfizer_NNP ,_, and_CC BioNTech_NNP ,_, shares_NNS of_IN those_DT companies_NNS were_VBD up_RB in_IN afternoon_NN trading_NN on_IN Wednesday_NNP ._. Inovio_NNP Pharmaceuticals_NNP Inc._NNP INO_NNP ,_, ,_, an_DT early_JJ vaccine_NN contender_NN ,_, was_VBD not_RB included_VBN in_IN the_DT Times_NNP '_POS report_NN ._. Its_PRP$ stock_NN was_VBD down_RB 10.8_CD %_NN ._. Much_JJ of_IN the_DT nation_NN 's_POS hopes_NNS for_IN an_DT economic_JJ recovery_NN are_VBP tied_VBN to_IN the_DT development_NN of_IN a_DT vaccine_NN that_WDT can_MD successfully_RB prevent_VB people_NNS from_IN becoming_VBG infected_VBN with_IN COVID_NN -_HYPH 19_CD ._. The_DT administration_NN has_VBZ tirelessly_RB promoted_VBN the_DT idea_NN that_IN a_DT vaccine_NN can_MD be_VB developed_VBN by_IN the_DT end_NN of_IN the_DT year_NN ;_, however_RB ,_, executives_NNS at_IN J&J_NNP and_CC Merck_NNP have_VBP pointed_VBN out_RP that_IN the_DT research_NN and_CC development_NN process_NN can_MD take_VB years_NNS to_TO develop_VB a_DT safe_JJ ,_, efficacious_JJ vaccine_NN ._. Merck_NNP CEO_NN Ken_NNP Frazier_NNP recently_RB told_VBD the_DT Financial_NNP Times_NNP a_DT 12_CD -_HYPH to_IN 18_CD -_HYPH month_NN timeline_NN is_VBZ ""_`` very_RB aggressive_JJ ._. ""_''","The NNP NN VBZ RB VBN five NNS that it VBZ to VB the RBS JJ to VB a JJ NN - 19 NN , VBG to The NNP NNP NNP , which VBD NNS JJ with the NN . This VBZ NNP NNP , in NN with NNP NNP , NNP & NNP NNP , , NNP NNP NNP , , NNP & NNP NNP NNP , , and NNP in NN with NNP NNP NNP , . With the NN of NNP , NNP , and NNP , NNS of those NNS VBD RB in NN NN on NNP . NNP NNP NNP NNP , , an JJ NN NN , VBD RB VBN in the NNP ' NN . Its NN VBD RB 10.8 NN . JJ of the NN 's NNS for an JJ NN VBP VBN to the NN of a NN that can RB VB NNS from VBG VBN with NN - 19 . The NN VBZ RB VBN the NN that a NN can VB VBN by the NN of the NN ; RB , NNS at NNP and NNP VBP VBN out that the NN and NN NN can VB NNS to VB a JJ , JJ NN . NNP NN NNP NNP RB VBD the NNP NNP a 12 - to 18 - NN NN VBZ "" RB JJ . """
163,1321,mainstream,"The_DT world_NN 's_POS largest_JJS vaccine_NN maker_NN has_VBZ said_VBN a_DT Covid_NNP -_HYPH 19_CD immunisation_NN will_MD not_RB be_VB available_JJ on_IN a_DT mass_JJ scale_NN until_IN late_JJ 2021_CD ._. Britain_NNP -_HYPH based_VBN GlaxoSmithKline_NNP 's_POS CEO_NN Emma_NNP Walmsley_NNP said_VBD even_RB getting_VBG ""_`` hundreds_NNS of_IN millions_NNS ""_'' of_IN doses_NNS ready_JJ by_IN the_DT second_JJ half_NN of_IN next_JJ year_NN would_MD require_VB swift_JJ progress_NN to_TO ensure_VB safety_NN ._. It_PRP comes_VBZ as_IN US_NNP pharmaceutical_JJ corporation_NN Pfizer_NNP claimed_VBD it_PRP could_MD have_VB a_DT vaccine_NN ready_JJ by_IN this_DT autumn_NN ,_, having_VBG already_RB started_VBN mass_JJ manufacturing_NN ._. The_DT firm_NN 's_POS CEO_NN Albert_NNP Bourla_NNP told_VBD The_DT Wall_NNP Street_NNP Journal_NNP :_: ""_`` This_DT is_VBZ a_DT crisis_NN right_RB now_RB ,_, and_CC a_DT solution_NN is_VBZ desperately_RB needed_VBN by_IN all_DT ._. ""_'' For_IN updates_NNS on_IN coronavirus_NN ,_, follow_VB our_PRP$ live_JJ blog_NN HERE_RB ._. But_CC while_IN GlaxoSmithKline_NNP has_VBZ confirmed_VBN developing_VBG a_DT Covid_NNP -_HYPH 19_CD vaccine_NN is_VBZ its_PRP$ ""_`` primary_JJ aim_NN ""_'' thanks_NN to_IN recent_JJ soaring_VBG profits_NNS ,_, Ms_NNP Walmsley_NNP stuck_VBD to_IN the_DT 18_CD -_HYPH month_NN timeline_NN ._. ""_`` You_PRP will_MD see_VB a_DT reasonable_JJ amount_NN of_IN consensus_NN from_IN many_JJ global_JJ authorities_NNS ,_, when_WRB this_DT was_VBD all_RB emerging_VBG ,_, an_DT 18_CD -_HYPH month_NN time_NN line_NN was_VBD an_DT ambitious_JJ one_NN to_TO be_VB going_VBG after_IN but_CC one_CD that_WDT everyone_NN is_VBZ [_-LRB- targeting_VBG ]_-RRB- ""_'' ,_, she_PRP told_VBD reporters_NNS yesterday_NN ._. The_DT UK_NNP -_HYPH headquartered_VBN pharmaceutical_NN group_NN has_VBZ joined_VBN forces_NNS with_IN a_DT raft_NN of_IN partners_NNS around_IN the_DT world_NN to_TO develop_VB a_DT number_NN of_IN vaccines_NNS for_IN the_DT disease_NN ._. Its_PRP$ update_NN showed_VBD pre-tax_NN profits_NNS soared_VBD 42_CD %_NN to_IN £_$ 1.84_CD billion_CD in_IN the_DT first_JJ three_CD months_NNS of_IN the_DT year_NN on_IN revenues_NNS 19_CD %_NN higher_JJR ,_, helped_VBN by_IN global_JJ stockbuilding_NN of_IN its_PRP$ drugs_NNS and_CC healthcare_NN products_NNS ._. More_JJR than_IN 70_CD global_JJ vaccine_NN development_NN projects_NNS are_VBP under_IN way_NN as_IN economies_NNS across_IN the_DT globe_NN are_VBP burdened_VBN by_IN restrictions_NNS on_IN movement_NN to_TO slow_VB the_DT spread_NN of_IN the_DT disease_NN ._. Germany_NNP 's_POS vaccine_NN body_NN ,_, the_DT Paul_NNP Ehrlich_NNP Institute_NNP ,_, said_VBD this_DT week_NN that_IN seven_CD of_IN the_DT global_JJ projects_NNS had_VBD started_VBN testing_VBG on_IN humans_NNS ._. GSK_NNP and_CC rival_JJ vaccine_NN maker_NN Sanofi_NNP this_DT month_NN teamed_VBD up_RP for_IN a_DT coronavirus_NN vaccine_NN project_NN ,_, the_DT latest_JJS in_IN a_DT string_NN of_IN alliances_NNS that_WDT have_VBP seen_VBN the_DT British_JJ drug_NN maker_NN contributing_VBG its_PRP$ expertise_NN on_IN adjuvants_NNS ._. Adjuvants_NNS are_VBP efficacy_NN boosters_NNS that_WDT allow_VBP for_IN lower_JJR dosing_NN of_IN the_DT immunising_VBG active_JJ ingredient_NN in_IN a_DT vaccine_NN ._. ""_`` The_DT world_NN needs_VBZ several_JJ vaccines_NNS and_CC there_EX are_VBP several_JJ different_JJ approaches_NNS ,_, ""_'' Walmsley_NNP continued_VBD ._. She_PRP said_VBD the_DT group_NN had_VBD ""_`` taken_VBN action_NN to_TO deploy_VB our_PRP$ science_NN and_CC technologies_NNS ""_'' to_TO fight_VB the_DT coronavirus_NN pandemic_NN ._. ""_`` Our_PRP$ primary_JJ aim_NN is_VBZ to_TO develop_VB multiple_JJ adjuvanted_VBN Covid_NN -_HYPH 19_CD vaccines_NNS ,_, and_CC we_PRP are_VBP working_VBG with_IN companies_NNS and_CC institutions_NNS across_IN the_DT world_NN to_TO do_VB so_RB ._. ""_'' It_PRP is_VBZ also_RB looking_VBG at_IN so_RB -_HYPH called_VBN therapeutic_JJ options_NNS for_IN coronavirus_NN treatment_NN and_CC is_VBZ collaborating_VBG with_IN Vir_NNP Biotechnology_NNP to_TO work_VB on_IN new_JJ antiviral_JJ antibodies_NNS that_WDT could_MD be_VB used_VBN for_IN Covid_NNP -_HYPH 19_CD or_CC future_JJ coronavirus_NN outbreaks_NNS ._. The_DT firm_NN is_VBZ likewise_RB looking_VBG at_IN drugs_NNS in_IN its_PRP$ stable_NN that_WDT could_MD be_VB used_VBN as_IN antivirals_NNS or_CC to_TO prevent_VB or_CC treat_VB Covid_NNP -_HYPH 19_CD symptoms_NNS ._. It_PRP comes_VBZ as_IN the_DT top_JJ U.S._NNP infectious_JJ disease_NN official_NN said_VBD Gilead_NNP Sciences_NNP Inc_NNP 's_POS experimental_JJ antiviral_JJ drug_NN remdesivir_NN will_MD become_VB the_DT standard_NN of_IN care_NN for_IN COVID_NNP -_HYPH 19_CD ._. Dr_NNP Anthony_NNP Fauci_NNP was_VBD speaking_VBG after_IN early_JJ clinical_JJ trial_NN results_NNS on_IN Wednesday_NNP showed_VBD it_PRP helped_VBD patients_NNS recover_VB more_RBR quickly_RB from_IN the_DT illness_NN caused_VBN by_IN the_DT coronavirus_NN ._. Preliminary_JJ results_NNS from_IN a_DT U.S._NNP government_NN trial_NN showing_VBG that_IN patients_NNS given_VBN remdesivir_NN recovered_VBD 31_CD %_NN faster_JJR than_IN those_DT given_VBN a_DT placebo_NN ,_, were_VBD hailed_VBN by_IN Dr_NNP Fauci_NNP as_IN ""_`` highly_RB significant_JJ ._. ""_''","The NN 's JJS NN NN VBZ VBN a NNP - 19 NN will RB VB JJ on a JJ NN until JJ 2021 . NNP - VBN NNP 's NN NNP NNP VBD RB VBG "" NNS of NNS "" of NNS JJ by the JJ NN of JJ NN would VB JJ NN to VB NN . It VBZ as NNP JJ NN NNP VBD it could VB a NN JJ by this NN , VBG RB VBN JJ NN . The NN 's NN NNP NNP VBD The NNP NNP NNP : "" This VBZ a NN RB RB , and a NN VBZ RB VBN by all . "" For NNS on NN , VB our JJ NN RB . But while NNP VBZ VBN VBG a NNP - 19 NN VBZ its "" JJ NN "" NN to JJ VBG NNS , NNP NNP VBD to the 18 - NN NN . "" You will VB a JJ NN of NN from JJ JJ NNS , when this VBD RB VBG , an 18 - NN NN NN VBD an JJ NN to VB VBG after but one that NN VBZ [ VBG ] "" , she VBD NNS NN . The NNP - VBN NN NN VBZ VBN NNS with a NN of NNS around the NN to VB a NN of NNS for the NN . Its NN VBD NN NNS VBD 42 NN to £ 1.84 billion in the JJ three NNS of the NN on NNS 19 NN JJR , VBN by JJ NN of its NNS and NN NNS . JJR than 70 JJ NN NN NNS VBP under NN as NNS across the NN VBP VBN by NNS on NN to VB the NN of the NN . NNP 's NN NN , the NNP NNP NNP , VBD this NN that seven of the JJ NNS VBD VBN VBG on NNS . NNP and JJ NN NN NNP this NN VBD up for a NN NN NN , the JJS in a NN of NNS that VBP VBN the JJ NN NN VBG its NN on NNS . NNS VBP NN NNS that VBP for JJR NN of the VBG JJ NN in a NN . "" The NN VBZ JJ NNS and there VBP JJ JJ NNS , "" NNP VBD . She VBD the NN VBD "" VBN NN to VB our NN and NNS "" to VB the NN NN . "" Our JJ NN VBZ to VB JJ VBN NN - 19 NNS , and we VBP VBG with NNS and NNS across the NN to VB RB . "" It VBZ RB VBG at RB - VBN JJ NNS for NN NN and VBZ VBG with NNP NNP to VB on JJ JJ NNS that could VB VBN for NNP - 19 or JJ NN NNS . The NN VBZ RB VBG at NNS in its NN that could VB VBN as NNS or to VB or VB NNP - 19 NNS . It VBZ as the JJ NNP JJ NN NN VBD NNP NNP NNP 's JJ JJ NN NN will VB the NN of NN for NNP - 19 . NNP NNP NNP VBD VBG after JJ JJ NN NNS on NNP VBD it VBD NNS VB RBR RB from the NN VBN by the NN . JJ NNS from a NNP NN NN VBG that NNS VBN NN VBD 31 NN JJR than those VBN a NN , VBD VBN by NNP NNP as "" RB JJ . """
164,254,mainstream,"Children_NNS with_IN autism_NN and_CC their_PRP$ younger_JJR siblings_NNS are_VBP less_RBR likely_JJ to_TO be_VB fully_RB vaccinated_VBN than_IN neurotypical_JJ children_NNS and_CC their_PRP$ siblings_NNS ,_, new_JJ research_NN from_IN the_DT US_NNP has_VBZ found_VBN ._. Of_IN children_NNS aged_JJ seven_CD years_NNS and_CC older_JJR ,_, 94_CD %_NN of_IN neurotypical_JJ children_NNS had_VBD received_VBN all_PDT the_DT recommended_VBN vaccinations_NNS for_IN children_NNS aged_JJ 4_CD -_SYM 6_CD years_NNS ._. For_IN those_DT with_IN autism_NN ,_, the_DT rate_NN was_VBD 82_CD %_NN ._. It_PRP has_VBZ been_VBN two_CD decades_NNS since_IN Andrew_NNP Wakefield_NNP ’s_POS now_RB retracted_VBN and_CC widely_RB discredited_VBN study_NN in_IN The_DT Lancet_NNP falsely_RB linked_VBD the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN to_IN autism_NN ._. This_DT new_JJ study_NN ,_, published_VBN today_NN in_IN the_DT journal_NN JAMA_NNP Pediatrics_NNP ,_, suggests_VBZ many_JJ parents_NNS still_RB have_VBP concerns_NNS around_IN vaccines_NNS and_CC autism_NN ._. The_DT study_NN included_VBD 3,729_CD children_NNS with_IN autism_NN and_CC 592,907_CD neurotypical_JJ children_NNS who_WP were_VBD born_VBN between_IN 1995_CD and_CC 2010_CD ,_, and_CC their_PRP$ younger_JJR siblings_NNS born_VBN between_IN 1997_CD and_CC 2014_CD ._. Children_NNS with_IN autism_NN were_VBD observed_VBN after_IN diagnosis_NN ;_, matched_VBN with_IN neurotypical_JJ children_NNS based_VBN on_IN age_NN ,_, sex_NN and_CC location_NN ._. Researchers_NNS reviewed_VBD what_WDT proportion_NN of_IN each_DT group_NN had_VBD received_VBN the_DT vaccines_NNS recommended_VBN by_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP at_IN 4_CD -_SYM 6_CD years_NNS and_CC 11_CD -_SYM 12_CD years_NNS ._. “_`` We_PRP found_VBD that_IN after_IN children_NNS received_VBD an_DT autism_NN diagnosis_NN ,_, the_DT rates_NNS of_IN vaccination_NN were_VBD significantly_RB lower_JJR when_WRB compared_VBN with_IN children_NNS of_IN the_DT same_JJ age_NN who_WP did_VBD not_RB have_VB an_DT autism_NN diagnosis_NN ,_, ”_'' said_VBD lead_JJ author_NN Ousseny_NNP Zerbo_NNP ,_, a_DT researcher_NN at_IN Kaiser_NNP Permanente_NNP ._. The_DT vaccine_NN adherence_NN of_IN the_DT younger_JJR siblings_NNS was_VBD studied_VBN at_IN 1_CD -_SYM 11_CD months_NNS ,_, 1_CD -_SYM 2_CD years_NNS ,_, 4_CD -_SYM 6_CD years_NNS ,_, and_CC 11_CD -_SYM 12_CD years_NNS ._. The_DT highest_JJS rates_NNS of_IN under-vaccination_NN in_IN this_DT study_NN were_VBD among_IN siblings_NNS of_IN children_NNS with_IN autism_NN in_IN the_DT 1_CD -_SYM 11_CD months_NNS and_CC 1_CD -_SYM 2_CD years_NNS age_NN groups_NNS ._. In_IN the_DT youngest_JJS age_NN group_NN ,_, 73_CD %_NN of_IN younger_JJR siblings_NNS of_IN children_NNS with_IN autism_NN were_VBD fully_RB vaccinated_VBN ,_, compared_VBN with_IN 85_CD %_NN of_IN younger_JJR siblings_NNS of_IN neurotypical_JJ children_NNS ._. In_IN 1_CD -_SYM 2_CD -_HYPH year_NN -_HYPH olds_NNS ,_, this_DT was_VBD 60_CD %_NN compared_VBN with_IN 71_CD %_NN ._. At_IN 4_CD -_SYM 6_CD years_NNS ,_, 83_CD %_NN of_IN younger_JJR siblings_NNS of_IN children_NNS with_IN autism_NN were_VBD fully_RB vaccinated_VBN ,_, compared_VBN with_IN 95_CD %_NN of_IN younger_JJR siblings_NNS of_IN neurotypical_JJ children_NNS ._. This_DT suggests_VBZ some_DT parents_NNS consider_VBP the_DT potential_JJ risks_NNS of_IN autism_NN associated_VBN with_IN vaccination_NN to_TO be_VB highest_JJS at_IN these_DT younger_JJR ages_NNS at_IN which_WDT more_JJR vaccines_NNS are_VBP recommended_VBN ._. However_RB ,_, as_IN their_PRP$ children_NNS grow_VBP older_JJR ,_, these_DT parents_NNS may_MD be_VB more_RBR willing_JJ to_TO vaccinate_VB ._. Despite_IN the_DT fluctuation_NN between_IN age_NN groups_NNS ,_, the_DT disparities_NNS in_IN vaccination_NN rates_NNS between_IN children_NNS with_IN autism_NN and_CC neurotypical_JJ children_NNS ,_, and_CC their_PRP$ younger_JJR siblings_NNS ,_, are_VBP reasonably_RB consistent_JJ (_-LRB- with_IN the_DT exception_NN of_IN the_DT 11_CD -_SYM 12_CD -_HYPH year_NN -_HYPH old_JJ age_NN group_NN )_-RRB- ._. While_IN this_DT research_NN was_VBD quantitative_JJ in_IN nature_NN and_CC therefore_RB not_RB able_JJ to_TO give_VB insight_NN into_IN why_WRB these_DT disparities_NNS exist_VBP ,_, the_DT authors_NNS said_VBD parental_JJ vaccine_NN refusal_NN would_MD likely_RB play_VB a_DT role_NN ._. Sydney_NNP University_NNP ’s_POS Dr_NNP Nicholas_NNP Wood_NNP ,_, who_WP was_VBD not_RB involved_VBN in_IN the_DT study_NN ,_, said_VBD this_DT could_MD be_VB the_DT case_NN on_IN two_CD fronts_NNS ._. For_IN children_NNS with_IN autism_NN ,_, parents_NNS might_MD resist_VB administering_VBG further_JJR vaccinations_NNS for_IN fear_NN of_IN worsening_VBG the_DT condition_NN ;_: a_DT notion_NN which_WDT is_VBZ not_RB grounded_VBN in_IN evidence_NN ._. For_IN the_DT younger_JJR siblings_NNS ,_, parents_NNS might_MD feel_VB the_DT early_JJ childhood_NN vaccinations_NNS caused_VBD autism_NN in_IN their_PRP$ older_JJR child_NN ,_, and_CC are_VBP therefore_RB unwilling_JJ to_TO have_VB their_PRP$ subsequent_JJ children_NNS vaccinated_VBN ._. “_`` Traditionally_RB there_EX has_VBZ been_VBN a_DT thinking_NN that_IN ASD_NN (_-LRB- autism_NN spectrum_NN disorder_NN )_-RRB- is_VBZ linked_VBN with_IN the_DT MMR_NN vaccine_NN ,_, ”_'' Wood_NNP said_VBD ._. Looking_VBG specifically_RB at_IN the_DT MMR_NNP vaccine_NN ,_, 96_CD %_NN of_IN neurotypical_JJ children_NNS were_VBD vaccinated_VBN at_IN 4_CD -_SYM 6_CD years_NNS ,_, compared_VBN with_IN 84_CD %_NN of_IN those_DT with_IN autism_NN ._. Of_IN the_DT younger_JJR siblings_NNS of_IN neurotypical_JJ children_NNS ,_, 94_CD %_NN received_VBD their_PRP$ MMR_NN vaccination_NN for_IN 1_CD -_SYM 2_CD years_NNS ,_, while_IN for_IN siblings_NNS of_IN children_NNS with_IN autism_NN in_IN the_DT same_JJ age_NN group_NN ,_, the_DT rate_NN was_VBD 77_CD %_NN ._. These_DT figures_NNS suggest_VBP Wakefield_NNP ’s_POS 1998_CD study_NN continues_VBZ to_TO generate_VB fear_NN ._. “_`` Parents_NNS of_IN ASD_NN kids_NNS may_MD be_VB worried_VBN ;_, they_PRP may_MD still_RB feel_VB that_IN the_DT MMR_NNP vaccine_NN led_VBD to_IN autism_NN ._. And_CC that_IN a_DT second_JJ dose_NN may_MD cause_VB a_DT regression_NN ,_, ”_'' Wood_NNP said_VBD ._. While_IN the_DT MMR_NNP vaccine_NN had_VBD the_DT lowest_JJS uptake_NN of_IN all_PDT the_DT vaccines_NNS studied_VBN among_IN children_NNS with_IN an_DT ASD_NN and_CC their_PRP$ younger_JJR siblings_NNS ,_, Wood_NNP noted_VBD parents_NNS ’_POS concerns_NNS surrounding_VBG MMR_NNP appeared_VBD to_TO have_VB translated_VBN across_IN to_IN other_JJ vaccines_NNS ,_, too_RB ._. The_DT Murdoch_NNP Children_NNP ’s_POS Research_NNP Institute_NNP ’s_POS Dr_NNP Margie_NNP Danchin_NNP ,_, who_WP was_VBD n’t_RB involved_VBN with_IN the_DT study_NN ,_, said_VBD this_DT research_NN provides_VBZ important_JJ information_NN on_IN parents_NNS ’_POS behaviour_NN ._. Clinically_RB ,_, she_PRP sees_VBZ concerns_NNS expressed_VBN by_IN parents_NNS about_IN vaccines_NNS and_CC autism_NN every_DT week_NN -_, and_CC this_DT study_NN is_VBZ evidence_NN these_DT concerns_NNS translate_VBP into_IN behaviour_NN on_IN a_DT population_NN level_NN ,_, albeit_RB in_IN the_DT US_NNP ._. “_`` What_WP it_PRP really_RB highlights_VBZ is_VBZ that_IN we_PRP as_IN health_NN care_NN providers_NNS have_VBP a_DT lot_NN of_IN work_NN to_TO do_VB to_TO reassure_VB parents_NNS that_IN there_EX is_VBZ no_DT association_NN ._. The_DT evidence_NN is_VBZ clear_JJ that_IN there_EX is_VBZ no_DT causal_JJ link_NN ,_, ”_'' Danchin_NNP said_VBD ._. In_IN 2017_CD ,_, Danchin_NNP and_CC her_PRP$ colleagues_NNS published_VBD research_NN in_IN an_DT Australian_JJ setting_NN which_WDT found_VBD 16_CD %_NN of_IN mothers_NNS who_WP were_VBD pregnant_JJ for_IN the_DT first_JJ time_NN were_VBD concerned_VBN vaccines_NNS can_MD cause_VB autism_NN ._. “_`` This_DT study_NN needs_VBZ to_TO be_VB followed_VBN up_RP with_IN qualitative_JJ research_NN ._. By_IN speaking_VBG to_IN these_DT parents_NNS ,_, we_PRP can_MD drill_VB down_RP on_IN what_WP their_PRP$ specific_JJ concerns_NNS are_VBP so_IN that_IN we_PRP can_MD develop_VB better_JJR strategies_NNS to_TO reassure_VB them_PRP and_CC increase_VB vaccine_NN uptake_NN ,_, ”_'' she_PRP said_VBD ._.","NNS with NN and their JJR NNS VBP RBR JJ to VB RB VBN than JJ NNS and their NNS , JJ NN from the NNP VBZ VBN . Of NNS JJ seven NNS and JJR , 94 NN of JJ NNS VBD VBN all the VBN NNS for NNS JJ 4 - 6 NNS . For those with NN , the NN VBD 82 NN . It VBZ VBN two NNS since NNP NNP ’s RB VBN and RB VBN NN in The NNP RB VBD the NNS , NNS and NN ( NNP ) NN to NN . This JJ NN , VBN NN in the NN NNP NNP , VBZ JJ NNS RB VBP NNS around NNS and NN . The NN VBD 3,729 NNS with NN and 592,907 JJ NNS who VBD VBN between 1995 and 2010 , and their JJR NNS VBN between 1997 and 2014 . NNS with NN VBD VBN after NN ; VBN with JJ NNS VBN on NN , NN and NN . NNS VBD what NN of each NN VBD VBN the NNS VBN by the NNPS for NNP NNP and NNP at 4 - 6 NNS and 11 - 12 NNS . “ We VBD that after NNS VBD an NN NN , the NNS of NN VBD RB JJR when VBN with NNS of the JJ NN who VBD RB VB an NN NN , ” VBD JJ NN NNP NNP , a NN at NNP NNP . The NN NN of the JJR NNS VBD VBN at 1 - 11 NNS , 1 - 2 NNS , 4 - 6 NNS , and 11 - 12 NNS . The JJS NNS of NN in this NN VBD among NNS of NNS with NN in the 1 - 11 NNS and 1 - 2 NNS NN NNS . In the JJS NN NN , 73 NN of JJR NNS of NNS with NN VBD RB VBN , VBN with 85 NN of JJR NNS of JJ NNS . In 1 - 2 - NN - NNS , this VBD 60 NN VBN with 71 NN . At 4 - 6 NNS , 83 NN of JJR NNS of NNS with NN VBD RB VBN , VBN with 95 NN of JJR NNS of JJ NNS . This VBZ some NNS VBP the JJ NNS of NN VBN with NN to VB JJS at these JJR NNS at which JJR NNS VBP VBN . RB , as their NNS VBP JJR , these NNS may VB RBR JJ to VB . Despite the NN between NN NNS , the NNS in NN NNS between NNS with NN and JJ NNS , and their JJR NNS , VBP RB JJ ( with the NN of the 11 - 12 - NN - JJ NN NN ) . While this NN VBD JJ in NN and RB RB JJ to VB NN into why these NNS VBP , the NNS VBD JJ NN NN would RB VB a NN . NNP NNP ’s NNP NNP NNP , who VBD RB VBN in the NN , VBD this could VB the NN on two NNS . For NNS with NN , NNS might VB VBG JJR NNS for NN of VBG the NN ; a NN which VBZ RB VBN in NN . For the JJR NNS , NNS might VB the JJ NN NNS VBD NN in their JJR NN , and VBP RB JJ to VB their JJ NNS VBN . “ RB there VBZ VBN a NN that NN ( NN NN NN ) VBZ VBN with the NN NN , ” NNP VBD . VBG RB at the NNP NN , 96 NN of JJ NNS VBD VBN at 4 - 6 NNS , VBN with 84 NN of those with NN . Of the JJR NNS of JJ NNS , 94 NN VBD their NN NN for 1 - 2 NNS , while for NNS of NNS with NN in the JJ NN NN , the NN VBD 77 NN . These NNS VBP NNP ’s 1998 NN VBZ to VB NN . “ NNS of NN NNS may VB VBN ; they may RB VB that the NNP NN VBD to NN . And that a JJ NN may VB a NN , ” NNP VBD . While the NNP NN VBD the JJS NN of all the NNS VBN among NNS with an NN and their JJR NNS , NNP VBD NNS ’ NNS VBG NNP VBD to VB VBN across to JJ NNS , RB . The NNP NNP ’s NNP NNP ’s NNP NNP NNP , who VBD RB VBN with the NN , VBD this NN VBZ JJ NN on NNS ’ NN . RB , she VBZ NNS VBN by NNS about NNS and NN every NN - and this NN VBZ NN these NNS VBP into NN on a NN NN , RB in the NNP . “ What it RB VBZ VBZ that we as NN NN NNS VBP a NN of NN to VB to VB NNS that there VBZ no NN . The NN VBZ JJ that there VBZ no JJ NN , ” NNP VBD . In 2017 , NNP and her NNS VBD NN in an JJ NN which VBD 16 NN of NNS who VBD JJ for the JJ NN VBD VBN NNS can VB NN . “ This NN VBZ to VB VBN up with JJ NN . By VBG to these NNS , we can VB down on what their JJ NNS VBP so that we can VB JJR NNS to VB them and VB NN NN , ” she VBD ."
165,712,conspiracy,"The_DT massive_JJ controversy_NN over_IN Texas_NNP Gov._NNP Rick_NNP Perry_NNP ’s_POS appalling_JJ 2007_CD executive_JJ order_NN mandating_VBG that_IN all_DT young_JJ girls_NNS in_IN his_PRP$ state_NN receive_VBP Merck_NNP &_CC Co._NNP ’s_POS Gardasil_NNP vaccine_NN before_IN entering_VBG school_NN has_VBZ brought_VBN the_DT issue_NN of_IN the_DT vaccine_NN ’s_POS safety_NN and_CC effectiveness_NN ,_, or_CC lack_NN thereof_NN ,_, back_RB to_IN the_DT forefront_NN of_IN the_DT national_JJ conversation_NN ._. And_CC a_DT European_JJ physician_NN has_VBZ now_RB openly_RB spoken_VBN out_RP against_IN Gardasil_NNP ,_, claiming_VBG that_IN it_PRP is_VBZ both_CC dangerous_JJ and_CC completely_RB ineffective_JJ at_IN preventing_VBG cervical_JJ cancer_NN ._. Dr._NNP Christian_NNP Fiala_NNP ,_, a_DT general_JJ practitioner_NN from_IN Vienna_NNP ,_, Austria_NNP ,_, told_VBD WorldNetDaily_NNP (_-LRB- WND_NNP )_-RRB- in_IN a_DT recent_JJ report_NN that_IN Merck_NNP ’s_POS Gardasil_NNP does_VBZ not_RB actually_RB work_VB to_TO prevent_VB cervical_JJ cancer_NN ,_, and_CC that_IN it_PRP is_VBZ not_RB safe_JJ ._. According_VBG to_IN Dr._NNP Fiala_NNP ,_, “_`` there_EX is_VBZ no_DT proof_NN of_IN a_DT causal_JJ relationship_NN of_IN HPV_NN (_-LRB- human_JJ papillomavirus_NN )_-RRB- and_CC cervical_JJ cancer_NN ,_, and_CC there_EX is_VBZ no_DT evidence_NN that_IN HPV_NN vaccine_NN reduces_VBZ the_DT overall_JJ number_NN of_IN cervical_JJ cancer_NN (_-LRB- cases_NNS )_-RRB- ._. ”_'' Assuming_VBG for_IN a_DT moment_NN that_IN the_DT Gardasil_NNP vaccine_NN actually_RB does_VBZ help_VB prevent_VB HPV_NN ,_, Dr._NNP Fiala_NNP asserts_VBZ that_IN HPV_NN is_VBZ not_RB even_RB itself_PRP responsible_JJ for_IN causing_VBG cervical_JJ cancer_NN ,_, which_WDT makes_VBZ the_DT vaccine_NN completely_RB useless_JJ at_IN accomplishing_VBG the_DT very_JJ thing_NN for_IN which_WDT it_PRP is_VBZ marketed_VBN ._. And_CC as_IN we_PRP previously_RB reported_VBD ,_, the_DT US_NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- has_VBZ also_RB known_VBN since_IN at_IN least_JJS 2003_CD that_IN HPV_NN is_VBZ not_RB associated_VBN with_IN causing_VBG cervical_JJ cancer_NN as_RB well_RB (_-LRB- http://www.naturalnews.com/022404_vaccines_vaccinations.html)._ADD But_CC none_NN of_IN this_DT has_VBZ stopped_VBN Merck_NNP and_CC its_PRP$ lackeys_NNS in_IN the_DT government_NN and_CC media_NN from_IN continuing_VBG to_TO endorse_VB the_DT “_`` money_NN -_HYPH making_VBG machine_NN without_IN any_DT benefits_NNS for_IN patients_NNS ,_, ”_'' as_IN Dr._NNP Fiala_NNP calls_VBZ it_PRP ._. And_CC this_DT was_VBD made_VBN abundantly_RB clear_JJ when_WRB the_DT mainstream_JJ media_NN went_VBD on_IN its_PRP$ rampage_NN against_IN Rep._NNP Michele_NNP Bachmann_NNP following_VBG her_PRP$ recent_JJ comments_NNS about_IN Gardasil_NNP ’s_POS dangers_NNS at_IN the_DT GOP_NNP presidential_JJ debates_NNS ._. Dr._NNP Fiala_NNP has_VBZ been_VBN fighting_VBG against_IN Gardasil_NNP in_IN Austria_NNP for_IN years_NNS ,_, especially_RB after_IN several_JJ otherwise_RB healthy_JJ and_CC vibrant_JJ young_JJ girls_NNS in_IN his_PRP$ country_NN died_VBD just_RB days_NNS after_IN receiving_VBG their_PRP$ Gardasil_NNP vaccines_NNS ._. And_CC while_IN Gardasil_NNP is_VBZ still_RB legal_JJ in_IN Austria_NNP ,_, Dr._NNP Fiala_NNP says_VBZ it_PRP is_VBZ “_`` used_VBN infrequently_RB ,_, ”_'' thanks_NN to_IN widespread_JJ awareness_NN of_IN its_PRP$ potential_NN to_TO seriously_RB injure_VB and_CC kill_VB those_DT who_WP receive_VBP it_PRP ._. “_`` To_TO say_VB Gardasil_NNP has_VBZ a_DT suspect_JJ safety_NN record_NN is_VBZ a_DT big_JJ understatement_NN ,_, ”_'' said_VBD Tom_NNP Fitton_NNP ,_, president_NN of_IN Washington_NNP watchdog_NN group_NN Judicial_NNP Watch_NNP ,_, to_IN WND_NNP ._. His_PRP$ group_NN uncovered_VBD documents_NNS back_RB in_IN 2008_CD revealing_VBG that_IN the_DT FDA_NNP has_VBZ known_VBN for_IN a_DT while_NN that_IN Gardasil_NNP is_VBZ responsible_JJ for_IN causing_VBG anaphylactic_JJ shock_NN ,_, foaming_VBG at_IN the_DT mouth_NN ,_, grand_JJ mal_NN convulsions_NNS ,_, coma_NN ,_, and_CC paralyzation_NN ,_, among_IN other_JJ things_NNS ._. “_`` These_DT reports_NNS are_VBP troubling_JJ and_CC show_VBP that_IN the_DT FDA_NNP and_CC other_JJ public_JJ health_NN authorities_NNS may_MD be_VB asleep_JJ at_IN the_DT switch_NN ._. ”_'' This_DT article_NN was_VBD originally_RB posted_VBN at_IN Natural_NNP News_NNP ._. The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","The JJ NN over NNP NNP NNP NNP ’s JJ 2007 JJ NN VBG that all JJ NNS in his NN VBP NNP & NNP ’s NNP NN before VBG NN VBZ VBN the NN of the NN ’s NN and NN , or NN NN , RB to the NN of the JJ NN . And a JJ NN VBZ RB RB VBN out against NNP , VBG that it VBZ both JJ and RB JJ at VBG JJ NN . NNP NNP NNP , a JJ NN from NNP , NNP , VBD NNP ( NNP ) in a JJ NN that NNP ’s NNP VBZ RB RB VB to VB JJ NN , and that it VBZ RB JJ . VBG to NNP NNP , “ there VBZ no NN of a JJ NN of NN ( JJ NN ) and JJ NN , and there VBZ no NN that NN NN VBZ the JJ NN of JJ NN ( NNS ) . ” VBG for a NN that the NNP NN RB VBZ VB VB NN , NNP NNP VBZ that NN VBZ RB RB itself JJ for VBG JJ NN , which VBZ the NN RB JJ at VBG the JJ NN for which it VBZ VBN . And as we RB VBD , the NNP NNP and NNP NNP ( NNP ) VBZ RB VBN since at JJS 2003 that NN VBZ RB VBN with VBG JJ NN RB RB ( http://www.naturalnews.com/022404 But NN of this VBZ VBN NNP and its NNS in the NN and NN from VBG to VB the “ NN - VBG NN without any NNS for NNS , ” as NNP NNP VBZ it . And this VBD VBN RB JJ when the JJ NN VBD on its NN against NNP NNP NNP VBG her JJ NNS about NNP ’s NNS at the NNP JJ NNS . NNP NNP VBZ VBN VBG against NNP in NNP for NNS , RB after JJ RB JJ and JJ JJ NNS in his NN VBD RB NNS after VBG their NNP NNS . And while NNP VBZ RB JJ in NNP , NNP NNP VBZ it VBZ “ VBN RB , ” NN to JJ NN of its NN to RB VB and VB those who VBP it . “ To VB NNP VBZ a JJ NN NN VBZ a JJ NN , ” VBD NNP NNP , NN of NNP NN NN NNP NNP , to NNP . His NN VBD NNS RB in 2008 VBG that the NNP VBZ VBN for a NN that NNP VBZ JJ for VBG JJ NN , VBG at the NN , JJ NN NNS , NN , and NN , among JJ NNS . “ These NNS VBP JJ and VBP that the NNP and JJ JJ NN NNS may VB JJ at the NN . ” This NN VBD RB VBN at NNP NNP . The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
166,274,mainstream,"The_DT British_JJ doctor_NN who_WP controversially_RB drew_VBD a_DT link_NN between_IN autism_NN and_CC the_DT triple_JJ vaccine_NN against_IN measles_NNS ,_, mumps_NNS and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- should_MD be_VB banned_VBN from_IN practising_VBG medicine_NN ._. That_DT ’s_VBZ the_DT ruling_NN issued_VBN today_NN (_-LRB- pdf_NN )_-RRB- by_IN a_DT panel_NN of_IN the_DT General_NNP Medical_NNP Council_NNP ,_, which_WDT regulates_VBZ the_DT medical_JJ profession_NN in_IN the_DT UK_NNP ._. Andrew_NNP Wakefield_NNP ,_, who_WP worked_VBD at_IN the_DT Royal_NNP Free_NNP Hospital_NNP ,_, London_NNP ,_, in_IN 1998_CD when_WRB his_PRP$ controversial_JJ paper_NN on_IN MMR_NNP and_CC autism_NN was_VBD published_VBN ,_, has_VBZ said_VBN that_IN he_PRP will_MD appeal_VB against_IN the_DT verdict_NN ._. Wakefield_NNP has_VBZ told_VBN the_DT BBC_NNP in_IN a_DT radio_NN interview_NN that_IN he_PRP “_`` categorically_RB denies_VBZ the_DT charges_NNS ”_'' and_CC will_MD appeal_VB against_IN the_DT verdict_NN ._. If_IN he_PRP does_VBZ n’t_RB ,_, he_PRP will_MD automatically_RB be_VB struck_VBN off_IN the_DT UK_NNP medical_JJ register_NN in_IN 28_CD days_NNS ._. The_DT GMC_NNP panel_NN also_RB ruled_VBD that_IN John_NNP Walker_NNP -_HYPH Smith_NNP (_-LRB- pdf_NN )_-RRB- ,_, a_DT former_JJ colleague_NN of_IN Wakefield_NNP ’s_POS at_IN the_DT Royal_NNP Free_NNP Hospital_NNP ,_, should_MD be_VB struck_VBN off_RP ._. It_PRP cleared_VBD a_DT third_JJ colleague_NN ,_, Simon_NNP Murch_NNP (_-LRB- pdf_NN )_-RRB- ,_, of_IN any_DT wrongdoing_NN ._. The_DT panel_NN found_VBD Wakefield_NNP guilty_JJ of_IN a_DT litany_NN of_IN transgressions_NNS in_IN the_DT late_JJ 1990s_NNS ,_, when_WRB he_PRP and_CC his_PRP$ colleagues_NNS conducted_VBD their_PRP$ research_NN on_IN 12_CD children_NNS ,_, leading_VBG to_IN publication_NN of_IN the_DT controversial_JJ findings_NNS in_IN The_DT Lancet_NNP in_IN 1998_CD ._. The_DT findings_NNS ,_, retracted_VBN by_IN The_DT Lancet_NNP in_IN February_NNP this_DT year_NN (_-LRB- pdf_NN )_-RRB- ,_, linked_VBD the_DT vaccine_NN shots_NNS with_IN the_DT development_NN of_IN autism_NN and_CC bowel_NN disorders_NNS ._. Panicked_JJ parents_NNS failed_VBD to_TO have_VB their_PRP$ children_NNS vaccinated_VBN ,_, and_CC the_DT uptake_NN rate_NN for_IN MMR_NNP ,_, which_WDT had_VBD peaked_VBN at_IN 92_CD per_NN cent_NN ,_, fell_VBD to_IN a_DT low_NN of_IN 81_CD per_NN cent_NN in_IN 2004_CD ._. The_DT transgressions_NNS listed_VBN by_IN the_DT panel_NN include_VBP dishonesty_NN about_IN the_DT paper_NN itself_PRP ,_, undeclared_JJ conflicts_NNS of_IN interest_NN and_CC ethical_JJ irregularities_NNS in_IN how_WRB the_DT children_NNS were_VBD recruited_VBN and_CC managed_VBN during_IN course_NN of_IN the_DT research_NN ._. The_DT panel_NN points_VBZ out_RP that_IN Wakefield_NNP ’s_POS patent_NN on_IN an_DT alternative_NN to_IN MMR_NNP called_VBN Transfer_NN Factor_NN meant_VBD he_PRP stood_VBD to_TO gain_VB financially_RB by_IN discrediting_VBG the_DT triple_JJ vaccine_NN ._. He_PRP was_VBD also_RB appearing_VBG as_IN an_DT expert_NN witness_NN in_IN a_DT court_NN action_NN against_IN the_DT vaccine_NN ._. He_PRP failed_VBD to_TO mention_VB any_DT of_IN this_DT either_CC to_IN the_DT hospital_NN ’s_POS research_NN and_CC ethics_NN committee_NN or_CC to_IN The_DT Lancet_NNP ,_, the_DT panel_NN says_VBZ ._. The_DT panel_NN also_RB concluded_VBD that_IN Wakefield_NNP subjected_VBD the_DT children_NNS to_IN painful_JJ and_CC invasive_JJ procedures_NNS that_WDT were_VBD not_RB clinically_RB necessary_JJ ._. Three_CD children_NNS had_VBD spinal_JJ fluid_NN taken_VBN through_IN lumbar_NN punctures_NNS ,_, for_IN example_NN ,_, and_CC others_NNS underwent_VBD colonoscopies_NNS ._. Not_RB all_PDT the_DT children_NNS had_VBD a_DT history_NN of_IN being_VBG treated_VBN for_IN gastrointestinal_JJ problems_NNS ,_, contrary_JJ to_IN what_WP was_VBD stated_VBN in_IN the_DT paper_NN in_IN The_DT Lancet_NNP ,_, and_CC nine_CD underwent_VBD procedures_NNS for_IN which_WDT Wakefield_NNP had_VBD not_RB sought_VBN ethical_JJ approval_NN ._. The_DT panel_NN also_RB condemned_VBD Wakefield_NNP ’s_POS failure_NN to_TO state_VB in_IN The_DT Lancet_NNP the_DT true_JJ purpose_NN of_IN the_DT research_NN ,_, which_WDT was_VBD to_TO investigate_VB a_DT proposed_VBN new_JJ syndrome_NN following_VBG vaccination_NN ._. On_IN another_DT occasion_NN ,_, in_IN 1999_CD ,_, he_PRP took_VBD blood_NN from_IN children_NNS at_IN a_DT party_NN then_RB paid_VBD them_PRP £_$ 5_CD for_IN agreeing_VBG to_IN it_PRP ._. “_`` Accordingly_RB ,_, the_DT panel_NN has_VBZ determined_VBN that_IN Dr_NNP Wakefield_NNP ’s_POS name_NN should_MD be_VB erased_VBN from_IN the_DT medical_JJ register_NN ,_, ”_'' it_PRP said_VBD in_IN its_PRP$ ruling_NN ,_, citing_VBG the_DT need_NN to_TO protect_VB patients_NNS and_CC to_TO maintain_VB public_JJ trust_NN and_CC confidence_NN in_IN the_DT medical_JJ profession_NN ._. The_DT panel_NN also_RB recommended_VBD striking_VBG off_RP John_NNP Walker_NNP -_HYPH Smith_NNP for_IN subjecting_VBG children_NNS to_IN painful_JJ but_CC unnecessary_JJ procedures_NNS ,_, including_VBG colonoscopies_NNS ,_, barium_NN meals_NNS and_CC lumbar_NN punctures_NNS ._. The_DT panel_NN determined_VBD that_IN ,_, like_IN Wakefield_NNP ,_, Walker_NNP -_HYPH Smith_NNP ,_, an_DT author_NN on_IN The_DT Lancet_NNP paper_NN ,_, ought_MD to_TO have_VB known_VBN of_IN the_DT widespread_JJ implications_NNS of_IN the_DT paper_NN ,_, and_CC failed_VBD in_IN his_PRP$ duty_NN to_TO ensure_VB that_IN the_DT information_NN in_IN it_PRP was_VBD accurate_JJ ._. Simon_NNP Murch_NNP was_VBD cleared_VBN of_IN any_DT wrongdoing_NN and_CC is_VBZ free_JJ to_TO continue_VB practising_VBG as_IN a_DT doctor_NN ._. The_DT panel_NN accepted_VBD that_IN in_IN carrying_VBG out_RP colonoscopies_NNS for_IN Walker_NNP -_HYPH Smith_NNP ,_, Murch_NNP was_VBD quite_RB reasonably_RB deferring_VBG to_IN the_DT clinical_JJ judgements_NNS and_CC authority_NN of_IN his_PRP$ senior_JJ colleague_NN ._. The_DT investigation_NN is_VBZ the_DT longest_JJS in_IN the_DT GMC_NNP ’s_POS history_NN ,_, having_VBG lasted_VBN more_JJR than_IN three_CD years_NNS ._. Earlier_RBR this_DT year_NN ,_, the_DT GMC_NNP issued_VBD its_PRP$ preliminary_JJ findings_NNS on_IN whether_IN the_DT three_CD should_MD face_VB censure_NN ._. Shortly_RB after_IN this_DT ,_, Wakefield_NNP left_VBD the_DT Thoughtful_NNP House_NNP Center_NNP for_IN Children_NNP ,_, which_WDT he_PRP founded_VBD in_IN 2005_CD in_IN Austin_NNP ,_, Texas_NNP ,_, to_TO treat_VB autism_NN and_CC related_JJ disorders_NNS ._. Wakefield_NNP has_VBZ no_DT licence_NN to_TO practise_VB in_IN the_DT US_NNP ,_, and_CC the_DT GMC_NNP says_VBZ it_PRP will_MD circulate_VB its_PRP$ verdict_NN on_IN him_PRP to_IN similar_JJ bodies_NNS throughout_IN the_DT world_NN ._.","The JJ NN who RB VBD a NN between NN and the JJ NN against NNS , NNS and NN ( NNP ) should VB VBN from VBG NN . That VBZ the NN VBN NN ( NN ) by a NN of the NNP NNP NNP , which VBZ the JJ NN in the NNP . NNP NNP , who VBD at the NNP NNP NNP , NNP , in 1998 when his JJ NN on NNP and NN VBD VBN , VBZ VBN that he will VB against the NN . NNP VBZ VBN the NNP in a NN NN that he “ RB VBZ the NNS ” and will VB against the NN . If he VBZ RB , he will RB VB VBN off the NNP JJ NN in 28 NNS . The NNP NN RB VBD that NNP NNP - NNP ( NN ) , a JJ NN of NNP ’s at the NNP NNP NNP , should VB VBN off . It VBD a JJ NN , NNP NNP ( NN ) , of any NN . The NN VBD NNP JJ of a NN of NNS in the JJ NNS , when he and his NNS VBD their NN on 12 NNS , VBG to NN of the JJ NNS in The NNP in 1998 . The NNS , VBN by The NNP in NNP this NN ( NN ) , VBD the NN NNS with the NN of NN and NN NNS . JJ NNS VBD to VB their NNS VBN , and the NN NN for NNP , which VBD VBN at 92 NN NN , VBD to a NN of 81 NN NN in 2004 . The NNS VBN by the NN VBP NN about the NN itself , JJ NNS of NN and JJ NNS in how the NNS VBD VBN and VBN during NN of the NN . The NN VBZ out that NNP ’s NN on an NN to NNP VBN NN NN VBD he VBD to VB RB by VBG the JJ NN . He VBD RB VBG as an NN NN in a NN NN against the NN . He VBD to VB any of this either to the NN ’s NN and NN NN or to The NNP , the NN VBZ . The NN RB VBD that NNP VBD the NNS to JJ and JJ NNS that VBD RB RB JJ . Three NNS VBD JJ NN VBN through NN NNS , for NN , and NNS VBD NNS . RB all the NNS VBD a NN of VBG VBN for JJ NNS , JJ to what VBD VBN in the NN in The NNP , and nine VBD NNS for which NNP VBD RB VBN JJ NN . The NN RB VBD NNP ’s NN to VB in The NNP the JJ NN of the NN , which VBD to VB a VBN JJ NN VBG NN . On another NN , in 1999 , he VBD NN from NNS at a NN RB VBD them £ 5 for VBG to it . “ RB , the NN VBZ VBN that NNP NNP ’s NN should VB VBN from the JJ NN , ” it VBD in its NN , VBG the NN to VB NNS and to VB JJ NN and NN in the JJ NN . The NN RB VBD VBG off NNP NNP - NNP for VBG NNS to JJ but JJ NNS , VBG NNS , NN NNS and NN NNS . The NN VBD that , like NNP , NNP - NNP , an NN on The NNP NN , ought to VB VBN of the JJ NNS of the NN , and VBD in his NN to VB that the NN in it VBD JJ . NNP NNP VBD VBN of any NN and VBZ JJ to VB VBG as a NN . The NN VBD that in VBG out NNS for NNP - NNP , NNP VBD RB RB VBG to the JJ NNS and NN of his JJ NN . The NN VBZ the JJS in the NNP ’s NN , VBG VBN JJR than three NNS . RBR this NN , the NNP VBD its JJ NNS on whether the three should VB NN . RB after this , NNP VBD the NNP NNP NNP for NNP , which he VBD in 2005 in NNP , NNP , to VB NN and JJ NNS . NNP VBZ no NN to VB in the NNP , and the NNP VBZ it will VB its NN on him to JJ NNS throughout the NN ."
167,329,mainstream,"Johnson_NNP &_CC Johnson_NNP JNJ_NNP ,_, announced_VBD Wednesday_NNP that_IN it_PRP has_VBZ initiated_VBN development_NN of_IN a_DT vaccine_NN against_IN the_DT new_JJ coronavirus_NN ,_, 2019nCoV_NNP ,_, as_IN part_NN of_IN its_PRP$ ""_`` multi-_JJ pronged_JJ ""_'' response_NN to_IN the_DT outbreak_NN of_IN the_DT deadly_JJ virus_NN ._. The_DT consumer_NN products_NNS and_CC drug_NN giant_NN said_VBD it_PRP will_MD leverage_VB the_DT AdVac_NN and_CC PER_NN ._. c6_CD technologies_NNS of_IN its_PRP$ Janssen_NNP Pharmaceuticals_NNP Companies_NNS ,_, which_WDT were_VBD used_VBN to_TO develop_VB and_CC manufacture_VB Janssen_NNP 's_POS Ebola_NNP vaccine_NN currently_RB in_IN use_NN ,_, and_CC to_TO develop_VB its_PRP$ Zika_NNP and_CC HIV_NN vaccine_NN candidates_NNS ._. J&J_NNP said_VBD it_PRP will_MD also_RB review_VB known_VBN pathways_NNS in_IN coronavirus_NN pathophysiology_NN to_TO determine_VB whether_IN previously_RB tested_VBN medicines_NNS can_MD be_VB used_VBN to_TO reduce_VB the_DT severity_NN of_IN 2019_CD -_HYPH nCoV_NN ._. ""_`` We_PRP are_VBP collaborating_VBG with_IN regulators_NNS ,_, healthcare_NN organizations_NNS ,_, institutions_NNS and_CC communities_NNS worldwide_RB to_TO help_VB ensure_VB our_PRP$ research_NN platforms_NNS ,_, existing_VBG science_NN and_CC outbreak_NN expertise_NN can_MD be_VB maximized_VBN to_TO stem_VB this_DT public_JJ health_NN threat_NN ,_, ""_'' said_VBD J&J's_NNP Chief_NNP Scientific_NNP Officer_NNP Paul_NNP Stoffels_NNP ._. The_DT stock_NN ,_, which_WDT was_VBD little_RB changed_VBN in_IN premarket_JJ trading_NN ,_, has_VBZ soared_VBN 15.8_CD %_NN over_IN the_DT past_JJ three_CD months_NNS through_IN Tuesday_NNP ,_, while_IN the_DT Dow_NNP Jones_NNP Industrial_NNP Average_NNP DJIA_NNP ,_, has_VBZ gained_VBN 6.1_CD %_NN ._.","NNP & NNP NNP , VBD NNP that it VBZ VBN NN of a NN against the JJ NN , NNP , as NN of its "" JJ JJ "" NN to the NN of the JJ NN . The NN NNS and NN NN VBD it will VB the NN and NN . c6 NNS of its NNP NNP NNS , which VBD VBN to VB and VB NNP 's NNP NN RB in NN , and to VB its NNP and NN NN NNS . NNP VBD it will RB VB VBN NNS in NN NN to VB whether RB VBN NNS can VB VBN to VB the NN of 2019 - NN . "" We VBP VBG with NNS , NN NNS , NNS and NNS RB to VB VB our NN NNS , VBG NN and NN NN can VB VBN to VB this JJ NN NN , "" VBD NNP NNP NNP NNP NNP NNP . The NN , which VBD RB VBN in JJ NN , VBZ VBN 15.8 NN over the JJ three NNS through NNP , while the NNP NNP NNP NNP NNP , VBZ VBN 6.1 NN ."
168,1049,mainstream,"A_DT wide_JJ majority_NN of_IN pediatricians_NNS and_CC family_NN physicians_NNS acquiesce_VBP to_IN parents_NNS who_WP wish_VBP to_TO delay_VB vaccinating_VBG their_PRP$ children_NNS ,_, even_RB though_IN the_DT doctors_NNS feel_VBP these_DT decisions_NNS put_VBP children_NNS at_IN risk_NN for_IN measles_NNS ,_, whooping_NN cough_NN and_CC other_JJ ailments_NNS ,_, a_DT new_JJ survey_NN has_VBZ found_VBN ._. Physicians_NNS who_WP reluctantly_RB agreed_VBD said_VBD they_PRP did_VBD so_RB to_TO build_VB trust_NN with_IN families_NNS and_CC to_TO avoid_VB losing_VBG them_PRP as_IN patients_NNS ._. The_DT survey_NN ,_, published_VBN Monday_NNP in_IN the_DT journal_NNP Pediatrics_NNP ,_, asked_VBD a_DT nationally_RB representative_JJ sample_NN of_IN 534_CD primary_JJ care_NN physicians_NNS in_IN 2012_CD how_WRB often_RB parents_NNS in_IN their_PRP$ practices_NNS postponed_VBD one_CD or_CC more_JJR vaccinations_NNS for_IN children_NNS younger_JJR than_IN age_NN 2_CD ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP advises_VBZ that_IN children_NNS be_VB vaccinated_VBN for_IN 14_CD diseases_NNS before_IN age_NN 6_CD on_IN a_DT schedule_NN ,_, which_WDT entails_VBZ roughly_RB 29_CD shots_NNS ,_, sometimes_RB several_JJ at_IN once_RB ._.","A JJ NN of NNS and NN NNS VBP to NNS who VBP to VB VBG their NNS , RB though the NNS VBP these NNS VBP NNS at NN for NNS , NN NN and JJ NNS , a JJ NN VBZ VBN . NNS who RB VBD VBD they VBD RB to VB NN with NNS and to VB VBG them as NNS . The NN , VBN NNP in the NNP NNP , VBD a RB JJ NN of 534 JJ NN NNS in 2012 how RB NNS in their NNS VBD one or JJR NNS for NNS JJR than NN 2 . The NNPS for NNP NNP and NNP VBZ that NNS VB VBN for 14 NNS before NN 6 on a NN , which VBZ RB 29 NNS , RB JJ at RB ."
169,263,conspiracy,"Doctors_NNS in_IN Kenya_NNP have_VBP accused_VBN UNICEF_NNP ,_, the_DT World_NNP Health_NNP Organization_NNP and_CC the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP of_IN secretly_RB trying_VBG to_TO sterilize_VB millions_NNS of_IN women_NNS in_IN Africa_NNP via_IN a_DT tetanus_NN vaccine_NN program_NN ._. According_VBG to_IN LifeSiteNews_NNP ,_, the_DT Kenya_NNP Catholic_NNP Doctors_NNPS Association_NNP say_VBP that_IN doctors_NNS have_VBP uncovered_VBN evidence_NN of_IN a_DT mass_JJ sterilisation_NN program_NN sponsored_VBN by_IN the_DT Kenyan_JJ government_NN and_CC funded_VBN by_IN Bill_NNP Gates_NNP ._. The_DT Kenyan_JJ government_NN denies_VBZ there_EX is_VBZ anything_NN wrong_JJ with_IN the_DT vaccine_NN ,_, and_CC says_VBZ it_PRP is_VBZ perfectly_RB safe_JJ ._. The_DT Kenya_NNP Catholic_NNP Doctors_NNPS Association_NNP ,_, however_RB ,_, saw_VBD evidence_NN to_IN the_DT contrary_NN ,_, and_CC had_VBD six_CD different_JJ samples_NNS of_IN the_DT tetanus_NN vaccine_NN from_IN various_JJ locations_NNS around_IN Kenya_NNP sent_VBN to_IN an_DT independent_JJ laboratory_NN in_IN South_NNP Africa_NNP for_IN testing_NN ._. The_DT results_NNS confirmed_VBD their_PRP$ worst_JJS fears_NNS :_: all_DT six_CD samples_NNS tested_VBD positive_JJ for_IN the_DT HCG_NN antigen_NN ._. The_DT HCG_NN antigen_NN is_VBZ used_VBN in_IN anti-fertility_JJ vaccines_NNS ,_, but_CC was_VBD found_VBN present_JJ in_IN tetanus_NN vaccines_NNS targeted_VBN to_IN young_JJ girls_NNS and_CC women_NNS of_IN childbearing_NN age_NN ._. Dr._NNP Ngare_NNP ,_, spokesman_NN for_IN the_DT Kenya_NNP Catholic_NNP Doctors_NNPS Association_NNP ,_, stated_VBD in_IN a_DT bulletin_NN released_VBN November_NNP 4_CD :_: “_`` This_DT proved_VBD right_RB our_PRP$ worst_JJS fears_NNS ;_, that_IN this_DT WHO_NN campaign_NN is_VBZ not_RB about_IN eradicating_VBG neonatal_JJ tetanus_NN but_CC a_DT well_RB -_HYPH coordinated_VBN forceful_JJ population_NN control_NN mass_NN sterilization_NN exercise_NN using_VBG a_DT proven_VBN fertility_NN regulating_NN vaccine_NN ._. This_DT evidence_NN was_VBD presented_VBN to_IN the_DT Ministry_NNP of_IN Health_NNP before_IN the_DT third_JJ round_NN of_IN immunization_NN but_CC was_VBD ignored_VBN ._. ”_'' (_-LRB- Source_NN )_-RRB- Dr._NNP Ngare_NNP brought_VBD up_RP several_JJ points_NNS about_IN the_DT mass_JJ tetanus_NN vaccination_NN program_NN in_IN Kenya_NNP that_WDT caused_VBD the_DT Catholic_JJ doctors_NNS to_TO become_VB suspicious_JJ :_: Dr._NNP Ngare_NNP told_VBD LifeSiteNews_NNP that_IN several_JJ things_NNS alerted_VBD doctors_NNS in_IN the_DT Church_NNP ’s_POS far_RB -_HYPH flung_JJ medical_JJ system_NN of_IN 54_CD hospitals_NNS ,_, 83_CD health_NN centers_NNS ,_, and_CC 17_CD medical_JJ and_CC nursing_NN schools_NNS to_IN the_DT possibility_NN the_DT anti-tetanus_NN campaign_NN was_VBD secretly_RB an_DT anti-fertility_JJ campaign_NN ._. Why_WRB ,_, they_PRP ask_VBP does_VBZ it_PRP involve_VB an_DT unprecedented_JJ five_CD shots_NNS (_-LRB- or_CC “_`` jabs_NNS ”_'' as_IN they_PRP are_VBP known_VBN ,_, in_IN Kenya_NNP )_-RRB- over_IN more_JJR than_IN two_CD years_NNS and_CC why_WRB is_VBZ it_PRP applied_VBN only_RB to_IN women_NNS of_IN childbearing_NN years_NNS ,_, and_CC why_WRB is_VBZ it_PRP being_VBG conducted_VBN without_IN the_DT usual_JJ fanfare_NN of_IN government_NN publicity_NN ?_. “_`` Usually_RB we_PRP give_VBP a_DT series_NN three_CD shots_NNS over_IN two_CD to_IN three_CD years_NNS ,_, we_PRP give_VBP it_PRP anyone_NN who_WP comes_VBZ into_IN the_DT clinic_NN with_IN an_DT open_JJ wound_NN ,_, men_NNS ,_, women_NNS or_CC children_NNS ._. ”_'' said_VBD Dr._NNP Ngare_NNP ._. But_CC it_PRP is_VBZ the_DT five_CD vaccination_NN regime_NN that_WDT is_VBZ most_RBS alarming_JJ ._. “_`` The_DT only_JJ time_NN tetanus_NN vaccine_NN has_VBZ been_VBN given_VBN in_IN five_CD doses_NNS is_VBZ when_WRB it_PRP is_VBZ used_VBN as_IN a_DT carrier_NN in_IN fertility_NN regulating_VBG vaccines_NNS laced_VBN with_IN the_DT pregnancy_NN hormone_NN ,_, Human_JJ Chorionic_NNP Gonadotropin_NNP (_-LRB- HCG_NNP )_-RRB- developed_VBN by_IN WHO_NNP in_IN 1992_CD ._. ”_'' UNICEF_NNP :_: A_DT History_NN of_IN Taking_VBG Advantage_NN of_IN Disasters_NNS to_IN Mass_NN Vaccinate_NN It_PRP should_MD be_VB noted_VBN that_IN UNICEF_NNP and_CC WHO_NNP distribute_VBP these_DT vaccines_NNS for_IN free_JJ ,_, and_CC that_IN there_EX are_VBP financial_JJ incentives_NNS for_IN the_DT Kenyan_JJ government_NN to_TO participate_VB in_IN these_DT programs_NNS ._. When_WRB funds_NNS from_IN the_DT UN_NNP are_VBP not_RB enough_JJ to_TO purchase_VB yearly_JJ allotments_NNS of_IN vaccines_NNS ,_, an_DT organization_NN started_VBN and_CC funded_VBN by_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, GAVI_NNP ,_, provides_VBZ extra_JJ funding_NN for_IN many_JJ of_IN these_DT vaccination_NN programs_NNS in_IN poor_JJ countries_NNS ._. Also_RB ,_, there_EX was_VBD no_DT outbreak_NN of_IN tetanus_NN in_IN Kenya_NNP ,_, only_RB the_DT perceived_VBN “_`` threat_NN ”_'' of_IN tetanus_NN due_IN to_IN local_JJ flood_NN conditions_NNS ._. These_DT local_JJ disasters_NNS are_VBP a_DT common_JJ reason_NN UNICEF_NNP goes_VBZ into_IN poorer_JJR countries_NNS with_IN free_JJ vaccines_NNS to_TO begin_VB mass_JJ vaccination_NN programs_NNS ._. Health_NNP Impact_NNP News_NNP reported_VBD last_JJ year_NN that_IN UNICEF_NNP began_VBD a_DT similar_JJ mass_JJ vaccination_NN program_NN with_IN 500,000_CD doses_NNS of_IN live_JJ oral_JJ polio_NN vaccine_NN in_IN the_DT Philippines_NNPS after_IN a_DT Super_NNP Typhoon_NNP devastated_VBD Tacolban_NNP and_CC surrounding_VBG areas_NNS ._. This_DT was_VBD in_IN spite_NN of_IN the_DT fact_NN there_EX were_VBD no_DT reported_VBN cases_NNS of_IN polio_NN in_IN the_DT Philippines_NNPS since_IN 1993_CD ,_, and_CC people_NNS who_WP have_VBP had_VBN the_DT live_JJ polio_NN vaccine_NN can_MD “_`` shed_VB ”_'' the_DT virus_NN into_IN sewage_NN systems_NNS ,_, thereby_RB causing_VBG the_DT actual_JJ disease_NN it_PRP is_VBZ supposed_VBN to_TO be_VB preventing_VBG ._. A_DT very_RB similar_JJ mass_NN vaccination_NN with_IN the_DT live_JJ oral_JJ polio_NN vaccine_NN occurred_VBD among_IN Syrian_JJ refugees_NNS in_IN 2013_CD ,_, when_WRB 1.7_CD million_CD doses_NNS of_IN polio_NN vaccine_NN were_VBD purchased_VBN by_IN UNICEF_NNP ,_, in_IN spite_NN of_IN the_DT fact_NN that_IN no_DT cases_NNS of_IN polio_NN had_VBD been_VBN seen_VBN since_IN 1999_CD ._. After_IN the_DT mass_JJ vaccination_NN program_NN started_VBD ,_, cases_NNS of_IN polio_NN began_VBD to_TO reappear_VB in_IN Syria_NNP ._. It_PRP seems_VBZ quite_RB apparent_JJ that_IN UNICEF_NNP and_CC WHO_NNP use_VBP these_DT local_JJ disasters_NNS to_TO mass_VB vaccinate_VB people_NNS ,_, mainly_RB children_NNS and_CC young_JJ women_NNS ._. Massive_JJ education_NN and_CC propaganda_NN efforts_NNS are_VBP also_RB necessary_JJ to_TO convince_VB the_DT local_JJ populations_NNS that_IN they_PRP need_VBP these_DT vaccines_NNS ._. Here_RB is_VBZ a_DT video_NN UNICEF_NNP produced_VBN for_IN the_DT tetanus_NN vaccine_NN in_IN Kenya_NNP ._. Notice_VB how_WRB they_PRP use_VBP school_NN teachers_NNS and_CC local_JJ doctors_NNS to_TO do_VB the_DT educating_NN ,_, even_RB though_IN the_DT vaccines_NNS are_VBP produced_VBN by_IN western_JJ countries_NNS ._.","NNS in NNP VBP VBN NNP , the NNP NNP NNP and the NNP and NNP NNP NNP of RB VBG to VB NNS of NNS in NNP via a NN NN NN . VBG to NNP , the NNP NNP NNPS NNP VBP that NNS VBP VBN NN of a JJ NN NN VBN by the JJ NN and VBN by NNP NNP . The JJ NN VBZ there VBZ NN JJ with the NN , and VBZ it VBZ RB JJ . The NNP NNP NNPS NNP , RB , VBD NN to the NN , and VBD six JJ NNS of the NN NN from JJ NNS around NNP VBN to an JJ NN in NNP NNP for NN . The NNS VBD their JJS NNS : all six NNS VBD JJ for the NN NN . The NN NN VBZ VBN in JJ NNS , but VBD VBN JJ in NN NNS VBN to JJ NNS and NNS of NN NN . NNP NNP , NN for the NNP NNP NNPS NNP , VBD in a NN VBN NNP 4 : “ This VBD RB our JJS NNS ; that this NN NN VBZ RB about VBG JJ NN but a RB - VBN JJ NN NN NN NN NN VBG a VBN NN NN NN . This NN VBD VBN to the NNP of NNP before the JJ NN of NN but VBD VBN . ” ( NN ) NNP NNP VBD up JJ NNS about the JJ NN NN NN in NNP that VBD the JJ NNS to VB JJ : NNP NNP VBD NNP that JJ NNS VBD NNS in the NNP ’s RB - JJ JJ NN of 54 NNS , 83 NN NNS , and 17 JJ and NN NNS to the NN the NN NN VBD RB an JJ NN . Why , they VBP VBZ it VB an JJ five NNS ( or “ NNS ” as they VBP VBN , in NNP ) over JJR than two NNS and why VBZ it VBN RB to NNS of NN NNS , and why VBZ it VBG VBN without the JJ NN of NN NN ? “ RB we VBP a NN three NNS over two to three NNS , we VBP it NN who VBZ into the NN with an JJ NN , NNS , NNS or NNS . ” VBD NNP NNP . But it VBZ the five NN NN that VBZ RBS JJ . “ The JJ NN NN NN VBZ VBN VBN in five NNS VBZ when it VBZ VBN as a NN in NN VBG NNS VBN with the NN NN , JJ NNP NNP ( NNP ) VBN by NNP in 1992 . ” NNP : A NN of VBG NN of NNS to NN NN It should VB VBN that NNP and NNP VBP these NNS for JJ , and that there VBP JJ NNS for the JJ NN to VB in these NNS . When NNS from the NNP VBP RB JJ to VB JJ NNS of NNS , an NN VBN and VBN by the NNP and NNP NNP NNP , NNP , VBZ JJ NN for JJ of these NN NNS in JJ NNS . RB , there VBD no NN of NN in NNP , RB the VBN “ NN ” of NN due to JJ NN NNS . These JJ NNS VBP a JJ NN NNP VBZ into JJR NNS with JJ NNS to VB JJ NN NNS . NNP NNP NNP VBD JJ NN that NNP VBD a JJ JJ NN NN with 500,000 NNS of JJ JJ NN NN in the NNPS after a NNP NNP VBD NNP and VBG NNS . This VBD in NN of the NN there VBD no VBN NNS of NN in the NNPS since 1993 , and NNS who VBP VBN the JJ NN NN can “ VB ” the NN into NN NNS , RB VBG the JJ NN it VBZ VBN to VB VBG . A RB JJ NN NN with the JJ JJ NN NN VBD among JJ NNS in 2013 , when 1.7 million NNS of NN NN VBD VBN by NNP , in NN of the NN that no NNS of NN VBD VBN VBN since 1999 . After the JJ NN NN VBD , NNS of NN VBD to VB in NNP . It VBZ RB JJ that NNP and NNP VBP these JJ NNS to VB VB NNS , RB NNS and JJ NNS . JJ NN and NN NNS VBP RB JJ to VB the JJ NNS that they VBP these NNS . RB VBZ a NN NNP VBN for the NN NN in NNP . VB how they VBP NN NNS and JJ NNS to VB the NN , RB though the NNS VBP VBN by JJ NNS ."
170,917,mainstream,"With_IN the_DT aim_NN of_IN minimizing_VBG adverse_JJ health_NN outcomes_NNS and_CC reducing_VBG the_DT risk_NN of_IN outbreaks_NNS ,_, we_PRP offered_VBD one_CD dose_NN of_IN MMR_NN vaccine_NN to_IN children_NNS known_VBN to_TO be_VB incompletely_RB immunized_VBN at_IN the_DT time_NN of_IN teenage_JJ booster_NN vaccination_NN in_IN secondary_JJ schools_NNS in_IN Swindon_NNP in_IN 2011_CD ._. The_DT Child_NNP Health_NNP Department_NNP database_NN was_VBD queried_VBN to_TO identify_VB Year_NN 10_CD children_NNS who_WP had_VBD had_VBN zero_CD or_CC one_CD dose_NN of_IN MMR_NN vaccine_NN previously_RB ._. Of_IN the_DT 316_CD children_NNS offered_VBN vaccination_NN ,_, 60_CD received_VBD a_DT first_JJ dose_NN and_CC 87_CD received_VBD a_DT second_JJ dose_NN of_IN MMR_NN vaccine_NN ._. Fourteen_CD children_NNS had_VBD two_CD documented_VBN doses_NNS in_IN the_DT past_NN and_CC two_CD had_VBD contraindications_NNS to_IN the_DT vaccine_NN ._. Overall_JJ uptake_NN of_IN two_CD doses_NNS of_IN MMR_NN vaccine_NN increased_VBD from_IN 86·3_CD %_NN to_IN 90·6_CD %_NN ._. The_DT valuable_JJ uptake_NN achieved_VBN demonstrates_VBZ that_IN an_DT opportunistic_JJ offer_NN of_IN MMR_NN vaccine_NN for_IN unimmunized_JJ children_NNS at_IN schools_NNS is_VBZ feasible_JJ and_CC beneficial_JJ ._. MMR_NNP vaccine_NN should_MD be_VB offered_VBN routinely_RB to_IN unimmunized_JJ children_NNS at_IN the_DT time_NN of_IN school_NN vaccination_NN programmes_NNS ,_, especially_RB in_IN areas_NNS with_IN sub-optimal_JJ coverage_NN ._.","With the NN of VBG JJ NN NNS and VBG the NN of NNS , we VBD one NN of NN NN to NNS VBN to VB RB VBN at the NN of JJ NN NN in JJ NNS in NNP in 2011 . The NNP NNP NNP NN VBD VBN to VB NN 10 NNS who VBD VBN zero or one NN of NN NN RB . Of the 316 NNS VBN NN , 60 VBD a JJ NN and 87 VBD a JJ NN of NN NN . Fourteen NNS VBD two VBN NNS in the NN and two VBD NNS to the NN . JJ NN of two NNS of NN NN VBD from 86·3 NN to 90·6 NN . The JJ NN VBN VBZ that an JJ NN of NN NN for JJ NNS at NNS VBZ JJ and JJ . NNP NN should VB VBN RB to JJ NNS at the NN of NN NN NNS , RB in NNS with JJ NN ."
171,1272,mainstream,"Get_VB breaking_VBG news_NN alerts_NNS and_CC special_JJ reports_NNS ._. The_DT news_NN and_CC stories_NNS that_WDT matter_VBP ,_, delivered_VBD weekday_NN mornings_NNS ._. An_DT experimental_JJ coronavirus_NN vaccine_NN from_IN Oxford_NNP University_NNP appears_VBZ to_TO be_VB effective_JJ at_IN preventing_VBG COVID_NN -_HYPH 19_CD ,_, according_VBG to_IN findings_NNS from_IN a_DT small_JJ study_NN in_IN six_CD monkeys_NNS ._. Oxford_NNP scientists_NNS posted_VBD the_DT preliminary_JJ findings_NNS on_IN the_DT vaccine_NN on_IN the_DT preprint_NN server_NN bioRxiv_NN early_JJ Thursday_NNP ._. Preprints_NNS are_VBP studies_NNS that_WDT have_VBP not_RB undergone_VBN a_DT rigorous_JJ peer_NN -_HYPH review_NN process_NN required_VBN for_IN publication_NN in_IN medical_JJ or_CC scientific_JJ journals_NNS ._. But_CC many_JJ scientists_NNS have_VBP been_VBN releasing_VBG results_NNS to_IN the_DT public_NN in_IN the_DT form_NN of_IN preprints_NNS because_IN of_IN the_DT high_JJ level_NN of_IN interest_NN surrounding_VBG potential_JJ treatments_NNS and_CC vaccines_NNS for_IN COVID_NN -_HYPH 19_CD ,_, the_DT disease_NN caused_VBN by_IN the_DT coronavirus_NN ._. The_DT new_JJ report_NN from_IN Oxford_NNP University_NNP is_VBZ based_VBN on_IN the_DT vaccination_NN of_IN six_CD rhesus_NN macaques_NNS ._. These_DT monkeys_NNS are_VBP considered_VBN to_TO be_VB good_JJ proxies_NNS for_IN how_WRB drugs_NNS could_MD work_VB in_IN people_NNS because_IN they_PRP share_VBP a_DT majority_NN of_IN their_PRP$ genes_NNS with_IN humans_NNS ._. The_DT animals_NNS were_VBD given_VBN half_NN of_IN the_DT dose_NN currently_RB being_VBG tested_VBN in_IN human_JJ ._. Those_DT trials_NNS began_VBD on_IN April_NNP 24_CD and_CC include_VBP about_RB 1,110_CD people_NNS ._. Researchers_NNS reported_VBD at_IN least_JJS some_DT of_IN the_DT monkeys_NNS developed_VBD antibodies_NNS to_IN the_DT virus_NN within_IN 14_CD days_NNS of_IN being_VBG vaccinated_VBN ,_, and_CC all_DT of_IN the_DT vaccinated_VBN animals_NNS had_VBD evidence_NN of_IN antibodies_NNS within_IN 28_CD days_NNS ._. Download_VB the_DT NBC_NNP News_NNP app_NN for_IN full_JJ coverage_NN of_IN the_DT coronavirus_NN outbreak_NN What_WP 's_VBZ more_RBR ,_, researchers_NNS said_VBD the_DT vaccine_NN appears_VBZ to_TO have_VB prevented_VBN pneumonia_NN and_CC other_JJ lung_NN problems_NNS in_IN the_DT animals_NNS after_IN they_PRP were_VBD exposed_VBN to_IN the_DT coronavirus_NN ._. Still_RB ,_, there_EX is_VBZ no_DT guarantee_NN the_DT Oxford_NNP vaccine_NN will_MD ultimately_RB prove_VB to_TO be_VB successful_JJ ._. Studies_NNS in_IN humans_NNS are_VBP ongoing_JJ ,_, and_CC this_DT research_NN team_NN is_VBZ one_CD of_IN several_JJ around_IN the_DT globe_NN working_VBG at_IN an_DT accelerated_VBN pace_NN to_TO find_VB a_DT safe_JJ and_CC effective_JJ vaccine_NN for_IN the_DT coronavirus_NN ._. But_CC so_RB far_RB ,_, the_DT Oxford_NNP vaccine_NN appears_VBZ to_TO hold_VB the_DT most_JJS promise_NN of_IN becoming_VBG the_DT first_JJ vaccine_NN to_TO be_VB widely_RB accessible_JJ ,_, if_IN proven_VBN to_TO work_VB ._. Oxford_NNP scientists_NNS previously_RB said_VBD they_PRP hope_VBP to_TO have_VB enough_JJ data_NNS to_TO show_VB the_DT vaccine_NN is_VBZ effective_JJ by_IN the_DT beginning_NN of_IN June_NNP ,_, and_CC predicted_VBD the_DT vaccine_NN could_MD be_VB produced_VBN by_IN September_NNP ._.","VB VBG NN NNS and JJ NNS . The NN and NNS that VBP , VBD NN NNS . An JJ NN NN from NNP NNP VBZ to VB JJ at VBG NN - 19 , VBG to NNS from a JJ NN in six NNS . NNP NNS VBD the JJ NNS on the NN on the NN NN NN JJ NNP . NNS VBP NNS that VBP RB VBN a JJ NN - NN NN VBN for NN in JJ or JJ NNS . But JJ NNS VBP VBN VBG NNS to the NN in the NN of NNS because of the JJ NN of NN VBG JJ NNS and NNS for NN - 19 , the NN VBN by the NN . The JJ NN from NNP NNP VBZ VBN on the NN of six NN NNS . These NNS VBP VBN to VB JJ NNS for how NNS could VB in NNS because they VBP a NN of their NNS with NNS . The NNS VBD VBN NN of the NN RB VBG VBN in JJ . Those NNS VBD on NNP 24 and VBP RB 1,110 NNS . NNS VBD at JJS some of the NNS VBD NNS to the NN within 14 NNS of VBG VBN , and all of the VBN NNS VBD NN of NNS within 28 NNS . VB the NNP NNP NN for JJ NN of the NN NN What VBZ RBR , NNS VBD the NN VBZ to VB VBN NN and JJ NN NNS in the NNS after they VBD VBN to the NN . RB , there VBZ no NN the NNP NN will RB VB to VB JJ . NNS in NNS VBP JJ , and this NN NN VBZ one of JJ around the NN VBG at an VBN NN to VB a JJ and JJ NN for the NN . But RB RB , the NNP NN VBZ to VB the JJS NN of VBG the JJ NN to VB RB JJ , if VBN to VB . NNP NNS RB VBD they VBP to VB JJ NNS to VB the NN VBZ JJ by the NN of NNP , and VBD the NN could VB VBN by NNP ."
172,66,mainstream,"Fact_NN check_NN :_: Melinda_NNP Gates_NNP did_VBD n't_RB exactly_RB say_VB Black_JJ people_NNS '_`` must_MD '_`` be_VB vaccinated_VBN for_IN COVID_NN -_HYPH 19_CD The_DT claim_NN :_: Melinda_NNP Gates_NNP says_VBZ Black_JJ people_NNS must_MD be_VB vaccinated_VBN first_RB for_IN COVID_NN -_HYPH 19_CD after_IN health_NN care_NN workers_NNS ._. Melinda_NNP Gates_NNP ,_, philanthropist_NN and_CC co-founder_NN of_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, says_VBZ that_IN after_IN health_NN care_NN workers_NNS ,_, Black_JJ people_NNS must_MD be_VB next_RB in_IN line_NN for_IN vaccination_NN for_IN COVID_NNP -_HYPH 19_CD ,_, according_VBG to_IN a_DT story_NN on_IN Live24_NNP ._. Gates_NNPS ,_, in_IN a_DT Time_NNP magazine_NN interview_NN on_IN the_DT eve_NN of_IN global_JJ vaccine_NN summit_NN in_IN early_JJ June_NNP ,_, discussed_VBD how_WRB anti-racism_NN protests_NNS following_VBG the_DT death_NN of_IN George_NNP Floyd_NNP ,_, an_DT African_JJ American_JJ man_NN ,_, while_IN in_IN custody_NN of_IN Minneapolis_NNP police_NN fits_VBZ into_IN health_NN equity_NN ,_, especially_RB with_IN development_NN of_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN ._. ""_`` The_DT first_JJ people_NNS that_WDT need_VBP this_DT vaccine_NN are_VBP the_DT 60_CD million_CD health_NN care_NN workers_NNS around_IN the_DT world_NN ._. They_PRP deserve_VBP to_TO get_VB it_PRP before_IN anybody_NN else_JJ ._. Then_RB you_PRP start_VBP tiering_NN ,_, ""_'' 24_CD Live_NNP quoted_VBD Gates_NNP as_IN saying_VBG in_IN the_DT Time_NNP story_NN ,_, written_VBN by_IN Jamie_NNP Ducharme_NNP ._. That_DT quote_NN matched_VBD the_DT one_NN in_IN Time_NNP (_-LRB- though_IN Live24_NNP incorrectly_RB identified_VBD the_DT magazine_NN as_IN a_DT newspaper_NN )_-RRB- ._. But_CC then_RB ,_, instead_RB of_IN continuing_VBG the_DT direct_JJ quote_NN ,_, the_DT Live24_NNP piece_NN paraphrased_VBD Gates_NNPS '_POS subsequent_JJ statement_NN ,_, writing_VBG ,_, ""_`` Melinda_NNP went_VBD on_RP to_TO say_VB that_IN Black_JJ people_NNS in_IN the_DT U.S._NNP must_MD be_VB vaccinated_VBN after_IN more_JJR than_IN 60_CD million_CD health_NN care_NN workers_NNS around_IN the_DT world_NN ._. ""_'' The_DT same_JJ headline_NN was_VBD repeated_VBN by_IN Health_NNP Nut_NNP News_NNP ,_, but_CC attributed_VBD to_IN Time_NNP ._. The_DT Time_NNP interview_NN did_VBD not_RB quote_VB Gates_NNP as_IN saying_VBG Black_JJ people_NNS ""_`` must_MD be_VB ""_'' vaccinated_VBN after_IN health_NN workers_NNS ._. Asked_VBD who_WP needs_VBZ vaccines_NNS after_IN health_NN care_NN workers_NNS ,_, Gates_NNPS told_VBD the_DT magazine_NN ,_, ""_`` in_IN the_DT U.S._NNP ,_, that_DT would_MD be_VB Black_JJ people_NNS next_RB ,_, quite_RB honestly_RB ,_, and_CC many_JJ other_JJ people_NNS of_IN color_NN ._. ""_'' Related_JJ :_: Historic_JJ layoffs_NNS take_VBP biggest_JJS toll_NN on_IN Blacks_NNPS ,_, Latinos_NNPS ,_, women_NNS and_CC the_DT young_JJ ""_`` They_PRP are_VBP having_VBG disproportionate_JJ effects_NNS from_IN COVID_NN -_HYPH 19_CD ._. From_IN there_RB ,_, people_NNS with_IN underlying_JJ health_NN conditions_NNS ,_, and_CC then_RB people_NNS who_WP are_VBP older_JJR ._. Those_DT are_VBP the_DT ones_NNS who_WP all_DT need_VBP it_PRP first_RB ._. We_PRP also_RB need_VBP to_TO think_VB about_IN essential_JJ workers_NNS who_WP are_VBP keeping_VBG our_PRP$ grocery_NN stores_NNS open_JJ for_IN us_PRP so_IN we_PRP can_MD buy_VB food_NN ,_, or_CC who_WP are_VBP making_VBG sure_JJ that_IN food_NN moves_VBZ through_IN the_DT warehouses_NNS ._. ""_'' Live24_NNP did_VBD n't_RB immediately_RB respond_VB to_IN a_DT request_NN for_IN comment_NN on_IN the_DT way_NN it_PRP characterized_VBD Gates_NNPS '_POS statement_NN ._. Asked_VBN about_IN the_DT Live24_NNP article_NN ,_, the_DT Gates_NNP Foundation_NNP directed_VBD USA_NNP TODAY_NN to_IN the_DT Time_NNP piece_NN ._. The_DT Gates_NNP Foundation_NNP said_VBD at_IN the_DT June_NNP 4_CD summit_NN it_PRP will_MD donate_VB $_$ 1.6_CD billion_CD over_IN five_CD years_NNS to_IN Gavi_NNP ,_, a_DT public_JJ -_HYPH private_JJ partnership_NN that_WDT helps_VBZ vaccinate_VB half_PDT the_DT world_NN 's_POS children_NNS against_IN disease_NN ._. The_DT foundation_NN also_RB said_VBD in_IN an_DT online_JJ new_JJ release_NN that_IN it_PRP will_MD donate_VB $_$ 100_CD million_CD to_IN a_DT new_JJ Gavi_NNP effort_NN to_TO purchase_VB COVID_NN -_HYPH 19_CD vaccinations_NNS for_IN lower_JJR -_HYPH income_NN countries_NNS so_IN that_IN ""_`` everyone_NN who_WP needs_VBZ it_PRP can_MD have_VB access_NN to_IN it_PRP ,_, starting_VBG with_IN health_NN care_NN workers_NNS and_CC other_JJ high_JJ -_HYPH risk_NN populations_NNS ._. ""_'' The_DT headline_NN ,_, ""_`` Melinda_NNP Gates_NNP says_VBZ Black_JJ people_NNS must_MD be_VB vaccinated_VBN first_RB for_IN COVID_NNP -_HYPH 19_CD after_IN health_NN care_NN workers_NNS ""_'' is_VBZ misleading_JJ ._. And_CC it_PRP was_VBD repeated_VBN in_IN the_DT story_NN ._. Gates_NNPS did_VBD say_VB ,_, however_RB ,_, that_IN Black_JJ people_NNS and_CC ""_`` many_JJ other_JJ people_NNS of_IN color_NN ""_'' should_MD be_VB next_RB in_IN line_NN for_IN the_DT vaccine_NN after_IN health_NN care_NN workers_NNS ._. •_NFP Time_NN magazine_NN 's_POS ""_`` Melinda_NNP Gates_NNP Lays_NNPS Out_IN Her_PRP$ Biggest_JJS Concern_NNP for_IN the_DT Next_NNP Phase_NNP of_IN the_DT COVID_NNP -_HYPH 19_CD Pandemic_NNP ""_'' •_SYM Live24's_NNP ""_`` Melinda_NNP Gates_NNP Says_VBZ Black_NNP People_NNPS Must_MD Be_VB Vaccinated_VBN First_JJ For_IN COVID_NNP -_HYPH 19_CD After_IN Health_NNP Care_NNP Workers_NNPS ""_'' •_NFP The_DT Gates_NNP Foundation_NNP :_: ""_`` Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP pledges_VBZ $_$ 1.6_CD billion_CD to_IN Gavi_NNP ,_, the_DT Vaccine_NNP Alliance_NNP ,_, to_TO protect_VB the_DT next_JJ generation_NN with_IN lifesaving_VBG vaccines_NNS ""_'' •_NFP Gavi_NNP ,_, the_DT Vaccine_NNP Alliance_NNP 's_POS ""_`` World_NN leaders_NNS make_VBP historic_JJ commitments_NNS to_TO provide_VB equal_JJ access_NN to_IN vaccines_NNS for_IN all_DT ""_'' Donnelle_NNP Eller_NNP covers_VBZ agriculture_NN ,_, the_DT environment_NN and_CC energy_NN for_IN the_DT Register_NN ._. Reach_VB her_PRP at_IN deller@registermedia.com_ADD or_CC 515-284-8457_CD ._. Thank_VBP you_PRP for_IN supporting_VBG our_PRP$ journalism_NN ._. You_PRP can_MD subscribe_VB to_IN our_PRP$ print_NN edition_NN ,_, ad_NN -_HYPH free_JJ app_NN or_CC electronic_JJ newspaper_NN replica_NN here_RB ._. Our_PRP$ fact_NN check_NN work_NN is_VBZ supported_VBN in_IN part_NN by_IN a_DT grant_NN from_IN Facebook_NNP ._.","NN NN : NNP NNP VBD RB RB VB JJ NNS ' must ' VB VBN for NN - 19 The NN : NNP NNP VBZ JJ NNS must VB VBN RB for NN - 19 after NN NN NNS . NNP NNP , NN and NN of the NNP & NNP NNP NNP , VBZ that after NN NN NNS , JJ NNS must VB RB in NN for NN for NNP - 19 , VBG to a NN on NNP . NNPS , in a NNP NN NN on the NN of JJ NN NN in JJ NNP , VBD how NN NNS VBG the NN of NNP NNP , an JJ JJ NN , while in NN of NNP NN VBZ into NN NN , RB with NN of a NN - 19 NN . "" The JJ NNS that VBP this NN VBP the 60 million NN NN NNS around the NN . They VBP to VB it before NN JJ . RB you VBP NN , "" 24 NNP VBD NNP as VBG in the NNP NN , VBN by NNP NNP . That NN VBD the NN in NNP ( though NNP RB VBD the NN as a NN ) . But RB , RB of VBG the JJ NN , the NNP NN VBD NNPS ' JJ NN , VBG , "" NNP VBD on to VB that JJ NNS in the NNP must VB VBN after JJR than 60 million NN NN NNS around the NN . "" The JJ NN VBD VBN by NNP NNP NNP , but VBD to NNP . The NNP NN VBD RB VB NNP as VBG JJ NNS "" must VB "" VBN after NN NNS . VBD who VBZ NNS after NN NN NNS , NNPS VBD the NN , "" in the NNP , that would VB JJ NNS RB , RB RB , and JJ JJ NNS of NN . "" JJ : JJ NNS VBP JJS NN on NNPS , NNPS , NNS and the JJ "" They VBP VBG JJ NNS from NN - 19 . From RB , NNS with JJ NN NNS , and RB NNS who VBP JJR . Those VBP the NNS who all VBP it RB . We RB VBP to VB about JJ NNS who VBP VBG our NN NNS JJ for us so we can VB NN , or who VBP VBG JJ that NN VBZ through the NNS . "" NNP VBD RB RB VB to a NN for NN on the NN it VBD NNPS ' NN . VBN about the NNP NN , the NNP NNP VBD NNP NN to the NNP NN . The NNP NNP VBD at the NNP 4 NN it will VB $ 1.6 billion over five NNS to NNP , a JJ - JJ NN that VBZ VB half the NN 's NNS against NN . The NN RB VBD in an JJ JJ NN that it will VB $ 100 million to a JJ NNP NN to VB NN - 19 NNS for JJR - NN NNS so that "" NN who VBZ it can VB NN to it , VBG with NN NN NNS and JJ JJ - NN NNS . "" The NN , "" NNP NNP VBZ JJ NNS must VB VBN RB for NNP - 19 after NN NN NNS "" VBZ JJ . And it VBD VBN in the NN . NNPS VBD VB , RB , that JJ NNS and "" JJ JJ NNS of NN "" should VB RB in NN for the NN after NN NN NNS . • NN NN 's "" NNP NNP NNPS Out Her JJS NNP for the NNP NNP of the NNP - 19 NNP "" • NNP "" NNP NNP VBZ NNP NNPS Must VB VBN JJ For NNP - 19 After NNP NNP NNPS "" • The NNP NNP : "" NNP & NNP NNP NNP VBZ $ 1.6 billion to NNP , the NNP NNP , to VB the JJ NN with VBG NNS "" • NNP , the NNP NNP 's "" NN NNS VBP JJ NNS to VB JJ NN to NNS for all "" NNP NNP VBZ NN , the NN and NN for the NN . VB her at deller@registermedia.com or 515-284-8457 . VBP you for VBG our NN . You can VB to our NN NN , NN - JJ NN or JJ NN NN RB . Our NN NN NN VBZ VBN in NN by a NN from NNP ."
173,244,mainstream,"A_DT large_JJ study_NN was_VBD able_JJ to_TO determine_VB more_JJR than_IN 100_CD genes_NNS that_WDT are_VBP linked_VBN to_IN autism_NN ._. Getty_NNP Images_NNS •_NFP A_DT large_JJ genetic_JJ study_NN provided_VBD scientists_NNS with_IN a_DT greater_JJR understanding_NN of_IN how_WRB genes_NNS cause_VBP changes_NNS in_IN the_DT brain_NN that_WDT lead_VBP to_IN autism_NN spectrum_NN disorder_NN ._. •_NFP Researchers_NNS analyzed_VBD more_JJR than_IN 35,000_CD participant_NN samples_NNS ,_, including_VBG almost_RB 12,000_CD from_IN people_NNS with_IN ASD_NN ._. •_NFP Scientists_NNS believe_VBP that_IN both_CC genes_NNS and_CC environment_NN are_VBP involved_VBN in_IN the_DT development_NN of_IN ASD_NN ,_, with_IN genetics_NNS playing_VBG a_DT big_JJ part_NN ._. In_IN the_DT largest_JJS genetics_NNS study_NN of_IN its_PRP$ kind_NN to_IN date_NN ,_, scientists_NNS have_VBP identified_VBN 102_CD genes_NNS associated_VBN with_IN the_DT risk_NN for_IN autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ._. Researchers_NNS also_RB gained_VBD further_JJ insight_NN into_IN which_WDT of_IN these_DT genes_NNS are_VBP associated_VBN with_IN both_CC ASD_NN and_CC other_JJ disorders_NNS that_WDT cause_VBP intellectual_JJ disability_NN and_CC developmental_JJ delay_NN ._. For_IN the_DT study_NN ,_, an_DT international_JJ team_NN of_IN researchers_NNS analyzed_VBD more_JJR than_IN 35,000_CD participant_NN samples_NNS ,_, including_VBG almost_RB 12,000_CD from_IN people_NNS with_IN ASD_NN ._. Researchers_NNS used_VBD a_DT genetic_JJ technique_NN called_VBN “_`` exome_NN sequencing_NN ,_, ”_'' which_WDT looks_VBZ at_IN all_PDT the_DT regions_NNS of_IN a_DT person_NN ’s_POS genetic_JJ information_NN —_: or_CC genome_NN —_: that_WDT are_VBP translated_VBN into_IN proteins_NNS ._. This_DT testing_NN can_MD pick_VB up_RP rare_JJ genetic_JJ mutations_NNS that_WDT might_MD not_RB show_VB up_RP with_IN other_JJ methods_NNS ._. Dr._NNP Lonnie_NNP Zwaigenbaum_NNP ,_, a_DT professor_NN in_IN the_DT Department_NNP of_IN Pediatrics_NNP and_CC the_DT Stollery_NNP Children_NNP ’s_POS Hospital_NNP Foundation_NNP Chair_NNP in_IN Autism_NNP at_IN the_DT University_NNP of_IN Alberta_NNP ,_, called_VBD this_DT an_DT “_`` exciting_JJ ”_'' study_NN ,_, both_CC for_IN the_DT sophisticated_JJ methods_NNS used_VBN and_CC the_DT large_JJ sample_NN size_NN ._. These_DT enabled_VBD researchers_NNS to_TO “_`` identify_VB a_DT larger_JJR number_NN of_IN genes_NNS than_IN ever_RB before_RB ,_, which_WDT gives_VBZ insight_NN into_IN how_WRB those_DT genes_NNS operate_VBP and_CC how_WRB they_PRP might_MD increase_VB the_DT risk_NN of_IN ASD_NN ,_, ”_'' said_VBD Zwaigenbaum_NNP ,_, who_WP was_VBD n’t_RB involved_VBN in_IN the_DT research_NN ._. The_DT study_NN results_NNS were_VBD published_VBN January_NNP 23_CD in_IN the_DT journal_NN Cell_NNP ._. ASD_NNP is_VBZ a_DT group_NN of_IN neurological_JJ and_CC developmental_JJ conditions_NNS that_WDT affect_VBP communication_NN and_CC behavior_NN ._. There_EX ’s_VBZ wide_JJ variation_NN in_IN the_DT type_NN and_CC severity_NN of_IN symptoms_NNS in_IN people_NNS with_IN ASD_NN ._. Scientists_NNS believe_VBP that_IN both_CC genes_NNS and_CC environment_NN are_VBP involved_VBN in_IN the_DT development_NN of_IN ASD_NN ,_, with_IN genetics_NNS playing_VBG a_DT big_JJ part_NN ._. “_`` We_PRP know_VBP that_IN inherited_VBN and_CC unique_JJ mutations_NNS in_IN the_DT genome_NN are_VBP a_DT major_JJ source_NN of_IN risk_NN for_IN developing_VBG ASD_NN ,_, but_CC specific_JJ causes_NNS of_IN ASD_NN are_VBP not_RB yet_RB well_RB understood_VBN ,_, ”_'' said_VBD Lori_NNP J._NNP Warner_NNP ,_, PhD_NN ,_, director_NN of_IN the_DT Center_NNP for_IN Human_NNP Development_NNP and_CC Ted_NNP Lindsay_NNP Foundation_NNP HOPE_NNP Center_NNP at_IN Beaumont_NNP Children_NNP ’s_POS Hospital_NNP in_IN Royal_NNP Oak_NNP ,_, Michigan_NNP ,_, who_WP was_VBD n’t_RB involved_VBN in_IN the_DT study_NN ._. Although_IN environmental_JJ factors_NNS play_VBP some_DT role_NN in_IN ASD_NN ,_, scientific_JJ have_VBP found_VBN that_IN there_EX ’s_VBZ no_DT link_NN between_IN receiving_VBG vaccines_NNS and_CC developing_VBG ASD_NN ._. The_DT new_JJ study_NN marks_VBZ an_DT important_JJ step_NN forward_RB in_IN scientists_NNS ’_POS understanding_NN of_IN the_DT genetic_JJ basis_NN of_IN ASD_NN ._. Researchers_NNS identified_VBD both_CC inherited_VBN genetic_JJ mutations_NNS and_CC de_FW novo_FW mutations_NNS —_: ones_NNS that_WDT occur_VBP spontaneously_RB when_WRB an_DT egg_NN or_CC sperm_NN form_NN ._. They_PRP also_RB found_VBD that_IN the_DT ASD_NN genes_NNS identified_VBN in_IN the_DT study_NN can_MD affect_VB brain_NN development_NN or_CC brain_NN function_NN ._. And_CC they_PRP showed_VBD that_IN two_CD major_JJ types_NNS of_IN nerve_NN cells_NNS can_MD be_VB affected_VBN in_IN ASD_NN ._. Of_IN the_DT 102_CD genes_NNS identified_VBN in_IN the_DT study_NN ,_, 49_CD were_VBD associated_VBN with_IN other_JJ developmental_JJ delays_NNS ._. “_`` Some_DT genes_NNS appear_VBP connected_VBN to_IN the_DT development_NN of_IN ASD_NN ,_, whereas_IN others_NNS may_MD increase_VB risk_NN for_IN ASD_NN plus_CC severe_JJ neurodevelopmental_JJ disorder_NN ,_, ”_'' said_VBD Warner_NNP ._. “_`` We_PRP do_VBP n’t_RB yet_RB understand_VB fully_RB this_DT process_NN ,_, but_CC differentiating_VBG ASD_NN from_IN other_JJ disorders_NNS is_VBZ important_JJ for_IN effective_JJ treatment_NN ._. ”_'' Zwaigenbaum_NNP said_VBD the_DT overlap_NN between_IN ASD_NN and_CC other_JJ neurodevelopmental_JJ disorders_NNS fits_VBZ with_IN previous_JJ research_NN ._. “_`` This_DT study_NN reinforces_VBZ that_IN there_EX are_VBP many_JJ genes_NNS that_WDT may_MD have_VB some_DT role_NN in_IN autism_NN vulnerability_NN ,_, but_CC that_DT also_RB have_VBP a_DT broader_JJR role_NN in_IN early_JJ brain_NN development_NN ,_, ”_'' said_VBD Zwaigenbaum_NNP ._. These_DT genes_NNS have_VBP a_DT “_`` broader_JJR expression_NN in_IN terms_NNS of_IN developmental_JJ abilities_NNS and_CC challenges_NNS of_IN the_DT affected_VBN individual_NN ._. ”_'' While_IN scientists_NNS now_RB understand_VBP ASD_NN better_RBR as_IN a_DT result_NN of_IN this_DT study_NN ,_, this_DT kind_NN of_IN research_NN also_RB points_VBZ toward_IN better_JJR ways_NNS to_TO help_VB children_NNS with_IN ASD_NN ._. “_`` The_DT greatest_JJS benefit_NN of_IN studies_NNS of_IN this_DT type_NN is_VBZ helping_VBG researchers_NNS ,_, families_NNS ,_, and_CC interventionists_NNS better_RBR understand_VB how_WRB genetic_JJ factors_NNS actually_RB function_VBP in_IN the_DT developing_VBG brain_NN and_CC body_NN of_IN the_DT individual_NN ,_, ”_'' said_VBD Warner_NNP ,_, “_'' so_IN that_IN treatments_NNS can_MD be_VB developed_VBN to_TO ameliorate_VB or_CC completely_RB block_VB the_DT disruptive_JJ changes_NNS that_WDT lead_VBP to_IN disorders_NNS such_JJ as_IN ASD_NN ._. ”_'' But_CC Zwaigenbaum_NNP cautions_VBZ that_IN the_DT results_NNS of_IN the_DT study_NN will_MD not_RB lead_VB to_IN clinical_JJ benefits_NNS right_RB away_RB ._. “_`` There_EX ’s_VBZ a_DT lot_NN of_IN translational_JJ work_NN that_WDT would_MD still_RB need_VB to_TO happen_VB in_IN order_NN to_TO assess_VB whether_IN the_DT findings_NNS from_IN this_DT study_NN will_MD directly_RB inform_VB assessment_NN ,_, diagnosis_NN ,_, or_CC treatment_NN ,_, ”_'' he_PRP said_VBD ._. Still_RB ,_, he_PRP said_VBD the_DT results_NNS provide_VBP direction_NN for_IN future_JJ research_NN into_IN potential_JJ biological_JJ treatments_NNS ,_, as_RB well_RB as_IN genetic_JJ tests_NNS that_WDT could_MD allow_VB earlier_JJR diagnosis_NN of_IN ASD_NN ._. Warner_NNP said_VBD there_EX are_VBP medications_NNS currently_RB approved_VBN for_IN use_NN in_IN children_NNS with_IN ASD_NN ,_, but_CC they_PRP address_VBP symptoms_NNS like_IN agitation_NN or_CC anxiety_NN ,_, rather_RB than_IN the_DT core_NN social_JJ or_CC behavioral_JJ deficits_NNS of_IN ASD_NN ._. Early_JJ diagnosis_NN is_VBZ another_DT goal_NN of_IN ASD_NN research_NN ,_, because_IN “_`` the_DT sooner_JJR children_NNS are_VBP identified_VBN and_CC appropriately_RB assessed_VBN ,_, the_DT sooner_JJR families_NNS can_MD receive_VB needed_VBN supports_NNS ,_, ”_'' said_VBD Warner_NNP ._. But_CC ASD_NNP is_VBZ a_DT complex_JJ condition_NN ,_, so_RB genetic_JJ diagnosis_NN is_VBZ n’t_RB always_RB straightforward_JJ ._. “_`` Although_IN studies_NNS like_IN this_DT continue_VBP to_TO expand_VB our_PRP$ appreciation_NN for_IN the_DT increasing_VBG number_NN of_IN genes_NNS associated_VBN with_IN ASD_NN ,_, the_DT reality_NN is_VBZ that_IN a_DT genetic_JJ cause_NN is_VBZ seldom_RB identified_VBN in_IN most_JJS children_NNS with_IN ASD_NN —_: even_RB with_IN the_DT most_RBS sophisticated_JJ genetic_JJ testing_NN ,_, ”_'' said_VBD Andrew_NNP Adesman_NNP ,_, MD_NNP ,_, chief_NN of_IN Developmental_NNP &_CC Behavioral_NNP Pediatrics_NNP at_IN Cohen_NNP Children_NNP ’s_POS Medical_NNP Center_NNP in_IN Queens_NNP ,_, New_NNP York_NNP ,_, who_WP was_VBD n’t_RB involved_VBN in_IN the_DT study_NN ._. But_CC he_PRP said_VBD there_EX ’s_VBZ still_RB value_NN in_IN parents_NNS of_IN a_DT child_NN with_IN ASD_NN seeking_VBG out_RP genetic_JJ testing_NN ,_, especially_RB as_IN genetic_JJ technologies_NNS advance_VBP ._. “_`` There_EX have_VBP been_VBN steady_JJ gains_NNS in_IN terms_NNS of_IN the_DT diagnostic_JJ ‘_`` yield_NN ’_'' of_IN genetic_JJ testing_NN ,_, ”_'' said_VBD Adesman_NNP ._. “_`` For_IN this_DT reason_NN ,_, parents_NNS of_IN children_NNS with_IN ASD_NN may_MD wish_VB to_TO discuss_VB with_IN their_PRP$ pediatrician_NN whether_IN their_PRP$ child_NN should_MD have_VB the_DT newer_JJR genetic_JJ tests_NNS done_VBN ._. ”_'' In_IN the_DT absence_NN of_IN a_DT simple_JJ test_NN for_IN ASD_NN ,_, there_EX are_VBP still_RB things_NNS parents_NNS can_MD do_VB for_IN their_PRP$ children_NNS ._. “_`` The_DT single_JJ most_RBS important_JJ things_NNS families_NNS and_CC healthcare_NN providers_NNS can_MD do_VB is_VBZ to_TO be_VB aware_JJ of_IN the_DT risk_NN factors_NNS and_CC early_JJ ,_, and_CC get_VB connected_VBN with_IN needed_VBN services_NNS as_RB soon_RB as_IN possible_JJ ,_, ”_'' said_VBD Warner_NNP ._.","A JJ NN VBD JJ to VB JJR than 100 NNS that VBP VBN to NN . NNP NNS • A JJ JJ NN VBD NNS with a JJR NN of how NNS VBP NNS in the NN that VBP to NN NN NN . • NNS VBD JJR than 35,000 NN NNS , VBG RB 12,000 from NNS with NN . • NNS VBP that both NNS and NN VBP VBN in the NN of NN , with NNS VBG a JJ NN . In the JJS NNS NN of its NN to NN , NNS VBP VBN 102 NNS VBN with the NN for NN NN NN ( NNP ) . NNS RB VBD JJ NN into which of these NNS VBP VBN with both NN and JJ NNS that VBP JJ NN and JJ NN . For the NN , an JJ NN of NNS VBD JJR than 35,000 NN NNS , VBG RB 12,000 from NNS with NN . NNS VBD a JJ NN VBN “ NN NN , ” which VBZ at all the NNS of a NN ’s JJ NN — or NN — that VBP VBN into NNS . This NN can VB up JJ JJ NNS that might RB VB up with JJ NNS . NNP NNP NNP , a NN in the NNP of NNP and the NNP NNP ’s NNP NNP NNP in NNP at the NNP of NNP , VBD this an “ JJ ” NN , both for the JJ NNS VBN and the JJ NN NN . These VBD NNS to “ VB a JJR NN of NNS than RB RB , which VBZ NN into how those NNS VBP and how they might VB the NN of NN , ” VBD NNP , who VBD RB VBN in the NN . The NN NNS VBD VBN NNP 23 in the NN NNP . NNP VBZ a NN of JJ and JJ NNS that VBP NN and NN . There VBZ JJ NN in the NN and NN of NNS in NNS with NN . NNS VBP that both NNS and NN VBP VBN in the NN of NN , with NNS VBG a JJ NN . “ We VBP that VBN and JJ NNS in the NN VBP a JJ NN of NN for VBG NN , but JJ NNS of NN VBP RB RB RB VBN , ” VBD NNP NNP NNP , NN , NN of the NNP for NNP NNP and NNP NNP NNP NNP NNP at NNP NNP ’s NNP in NNP NNP , NNP , who VBD RB VBN in the NN . Although JJ NNS VBP some NN in NN , JJ VBP VBN that there VBZ no NN between VBG NNS and VBG NN . The JJ NN VBZ an JJ NN RB in NNS ’ NN of the JJ NN of NN . NNS VBD both VBN JJ NNS and FW FW NNS — NNS that VBP RB when an NN or NN NN . They RB VBD that the NN NNS VBN in the NN can VB NN NN or NN NN . And they VBD that two JJ NNS of NN NNS can VB VBN in NN . Of the 102 NNS VBN in the NN , 49 VBD VBN with JJ JJ NNS . “ Some NNS VBP VBN to the NN of NN , whereas NNS may VB NN for NN plus JJ JJ NN , ” VBD NNP . “ We VBP RB RB VB RB this NN , but VBG NN from JJ NNS VBZ JJ for JJ NN . ” NNP VBD the NN between NN and JJ JJ NNS VBZ with JJ NN . “ This NN VBZ that there VBP JJ NNS that may VB some NN in NN NN , but that RB VBP a JJR NN in JJ NN NN , ” VBD NNP . These NNS VBP a “ JJR NN in NNS of JJ NNS and NNS of the VBN NN . ” While NNS RB VBP NN RBR as a NN of this NN , this NN of NN RB VBZ toward JJR NNS to VB NNS with NN . “ The JJS NN of NNS of this NN VBZ VBG NNS , NNS , and NNS RBR VB how JJ NNS RB VBP in the VBG NN and NN of the NN , ” VBD NNP , “ so that NNS can VB VBN to VB or RB VB the JJ NNS that VBP to NNS JJ as NN . ” But NNP VBZ that the NNS of the NN will RB VB to JJ NNS RB RB . “ There VBZ a NN of JJ NN that would RB VB to VB in NN to VB whether the NNS from this NN will RB VB NN , NN , or NN , ” he VBD . RB , he VBD the NNS VBP NN for JJ NN into JJ JJ NNS , RB RB as JJ NNS that could VB JJR NN of NN . NNP VBD there VBP NNS RB VBN for NN in NNS with NN , but they VBP NNS like NN or NN , RB than the NN JJ or JJ NNS of NN . JJ NN VBZ another NN of NN NN , because “ the JJR NNS VBP VBN and RB VBN , the JJR NNS can VB VBN NNS , ” VBD NNP . But NNP VBZ a JJ NN , RB JJ NN VBZ RB RB JJ . “ Although NNS like this VBP to VB our NN for the VBG NN of NNS VBN with NN , the NN VBZ that a JJ NN VBZ RB VBN in JJS NNS with NN — RB with the RBS JJ JJ NN , ” VBD NNP NNP , NNP , NN of NNP & NNP NNP at NNP NNP ’s NNP NNP in NNP , NNP NNP , who VBD RB VBN in the NN . But he VBD there VBZ RB NN in NNS of a NN with NN VBG out JJ NN , RB as JJ NNS VBP . “ There VBP VBN JJ NNS in NNS of the JJ ‘ NN ’ of JJ NN , ” VBD NNP . “ For this NN , NNS of NNS with NN may VB to VB with their NN whether their NN should VB the JJR JJ NNS VBN . ” In the NN of a JJ NN for NN , there VBP RB NNS NNS can VB for their NNS . “ The JJ RBS JJ NNS NNS and NN NNS can VB VBZ to VB JJ of the NN NNS and JJ , and VB VBN with VBN NNS RB RB as JJ , ” VBD NNP ."
174,163,mainstream,"Monika_NNP Fleshner_NNP ,_, a_DT neuroimmunophysiologist_NN at_IN the_DT University_NNP of_IN Colorado_NNP ,_, Boulder_NNP ,_, has_VBZ shown_VBN that_IN short_JJ -_HYPH term_NN stress_NN can_MD even_RB boost_VB immunity_NN ._. It_PRP 's_VBZ one_CD of_IN the_DT body_NN 's_POS natural_JJ defense_NN systems_NNS ._. So_RB ,_, if_IN the_DT immune_NN system_NN is_VBZ indeed_RB critical_JJ to_IN how_WRB the_DT body_NN processes_VBZ chronic_JJ stress_NN ,_, short_JJ -_HYPH term_NN stress_NN might_MD help_VB build_VB the_DT body_NN ’s_POS defenses_NNS against_IN stress_NN itself_PRP ._. Brachman_NNP does_VBZ n’t_RB want_VB to_TO completely_RB cut_VB off_RP a_DT person_NN ’s_POS stress_NN response_NN ,_, as_IN that_DT could_MD prove_VB counterproductive_JJ ._. Instead_RB ,_, she_PRP ’s_VBZ seeking_VBG a_DT way_NN for_IN people_NNS to_TO stop_VB the_DT response_NN before_IN it_PRP turns_VBZ dangerous_JJ —_: before_IN it_PRP triggers_VBZ mental_JJ illness_NN ._. It_PRP ’s_VBZ a_DT mission_NN she_PRP landed_VBD on_RP somewhat_RB accidentally_RB while_IN completing_VBG a_DT fellowship_NN at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, where_WRB she_PRP researched_VBD how_WRB the_DT immune_NN system_NN —_: specifically_RB ,_, a_DT compromised_VBN immune_NN system_NN —_: is_VBZ related_JJ to_IN depression_NN ._. She_PRP was_VBD particularly_RB interested_JJ in_IN whether_IN depression_NN influenced_VBD the_DT immune_NN system_NN ,_, or_CC if_IN the_DT immune_NN system_NN helped_VBD trigger_VB depression_NN ._. Working_VBG with_IN 12_CD mice_NNS ,_, her_PRP$ team_NN transferred_VBD immune_NN cells_NNS from_IN depressive_JJ -_HYPH like_IN mice_NNS into_IN new_JJ mice_NNS that_WDT had_VBD not_RB been_VBN exposed_VBN to_IN stress_NN or_CC displayed_VBN depressive_JJ behaviors_NNS ._. The_DT team_NN expected_VBD the_DT new_JJ mice_NNS either_CC to_TO develop_VB a_DT typical_JJ physiological_JJ response_NN to_IN stress_NN (_-LRB- inflammation_NN ,_, increased_VBN heart_NN rate_NN )_-RRB- or_CC to_TO show_VB no_DT changes_NNS ._. But_CC when_WRB they_PRP actually_RB stressed_VBD the_DT new_JJ mice_NNS —_: by_IN putting_VBG them_PRP in_IN cages_NNS with_IN more_RBR aggressive_JJ animals_NNS ,_, forcing_VBG them_PRP to_TO swim_VB ,_, and_CC other_JJ standard_JJ lab_NN methods_NNS —_: the_DT results_NNS ,_, and_CC those_DT of_IN subsequent_JJ studies_NNS ,_, showed_VBD the_DT opposite_NN :_: The_DT new_JJ mice_NNS were_VBD more_RBR resilient_JJ to_IN stress_NN ._. The_DT immune_NN cells_NNS from_IN the_DT depressed_VBN mice_NNS appeared_VBD to_TO immunize_VB the_DT new_JJ mice_NNS against_IN stress_NN -_HYPH induced_VBN depressive_JJ symptoms_NNS ,_, as_IN if_IN they_PRP were_VBD a_DT vaccine_NN ._. By_IN the_DT time_NN Brachman_NNP ’s_POS results_NNS were_VBD published_VBN ,_, in_IN January_NNP 2015_CD ,_, she_PRP ’d_VBD long_RB since_RB moved_VBN on_RP to_IN and_CC completed_VBN a_DT doctoral_JJ program_NN at_IN Columbia_NNP University_NNP ,_, where_WRB she_PRP had_VBD begun_VBN collaborating_VBG with_IN the_DT neurobiologist_NN Christine_NNP Denny_NNP ._. *_NFP In_IN the_DT course_NN of_IN her_PRP$ career_NN ,_, Denny_NNP had_VBD seen_VBN thousands_NNS of_IN mice_NNS anesthetized_VBN with_IN ketamine_NN ,_, the_DT drug_NN also_RB known_VBN as_IN special_JJ -_HYPH K_NNP ,_, for_IN various_JJ studies_NNS ,_, and_CC recognized_VBD that_IN there_EX were_VBD lasting_VBG effects_NNS ._. Ketamine_NNP was_VBD by_IN then_RB also_RB being_VBG used_VBN to_TO treat_VB depression_NN in_IN adults_NNS ._. Brachman_NNP and_CC Denny_NNP decided_VBD to_TO test_VB whether_IN ketamine_NN had_VBD any_DT effect_NN on_IN how_WRB mice_NNS react_VBP to_IN stress_NN ._. They_PRP gave_VBD the_DT drug_NN to_IN lab_NN mice_NNS ,_, waited_VBD one_CD week_NN ,_, then_RB put_VBD those_DT mice_NNS ,_, as_RB well_RB as_IN untreated_VBN mice_NNS ,_, through_IN stressful_JJ situations_NNS ._. The_DT study_NN results_NNS showed_VBD that_IN for_IN up_IN to_IN four_CD weeks_NNS after_IN the_DT injection_NN ,_, the_DT mice_NNS that_WDT were_VBD given_VBN ketamine_NN were_VBD more_RBR social_JJ and_CC less_RBR afraid_JJ than_IN the_DT control_NN animals_NNS ._. They_PRP also_RB exhibited_VBD fewer_JJR depressive_JJ -_HYPH like_JJ symptoms_NNS after_IN facing_VBG stressful_JJ situations_NNS ._. Brachman_NNP ’s_POS results_NNS consistently_RB showed_VBD that_IN there_EX are_VBP ways_NNS to_TO build_VB resilience_NN to_IN stress_NN ,_, by_IN both_CC injecting_VBG immune_NN cells_NNS from_IN another_DT animal_NN and_CC giving_VBG a_DT dose_NN of_IN ketamine_NN prior_JJ to_IN stress_NN ._. This_DT runs_VBZ counter_NN to_IN the_DT long_JJ -_HYPH accepted_VBN notion_NN that_IN stress_NN leads_VBZ to_IN illness_NN because_IN of_IN risk_NN factors_NNS such_JJ as_IN genetic_JJ mutations_NNS ,_, compromised_VBN immune_NN systems_NNS ,_, and_CC prior_JJ exposures_NNS ._. Perhaps_RB the_DT relationship_NN between_IN stress_NN and_CC illness_NN has_VBZ more_JJR to_TO do_VB with_IN a_DT person_NN ’s_POS level_NN of_IN resilience_NN —_: and_CC perhaps_RB specific_JJ interventions_NNS could_MD boost_VB this_DT ._.","NNP NNP , a NN at the NNP of NNP , NNP , VBZ VBN that JJ - NN NN can RB VB NN . It VBZ one of the NN 's JJ NN NNS . RB , if the NN NN VBZ RB JJ to how the NN VBZ JJ NN , JJ - NN NN might VB VB the NN ’s NNS against NN itself . NNP VBZ RB VB to RB VB off a NN ’s NN NN , as that could VB JJ . RB , she VBZ VBG a NN for NNS to VB the NN before it VBZ JJ — before it VBZ JJ NN . It VBZ a NN she VBD on RB RB while VBG a NN at the NNP NNPS of NNP , where she VBD how the NN NN — RB , a VBN NN NN — VBZ JJ to NN . She VBD RB JJ in whether NN VBD the NN NN , or if the NN NN VBD VB NN . VBG with 12 NNS , her NN VBD NN NNS from JJ - like NNS into JJ NNS that VBD RB VBN VBN to NN or VBN JJ NNS . The NN VBD the JJ NNS either to VB a JJ JJ NN to NN ( NN , VBN NN NN ) or to VB no NNS . But when they RB VBD the JJ NNS — by VBG them in NNS with RBR JJ NNS , VBG them to VB , and JJ JJ NN NNS — the NNS , and those of JJ NNS , VBD the NN : The JJ NNS VBD RBR JJ to NN . The NN NNS from the VBN NNS VBD to VB the JJ NNS against NN - VBN JJ NNS , as if they VBD a NN . By the NN NNP ’s NNS VBD VBN , in NNP 2015 , she VBD RB RB VBN on to and VBN a JJ NN at NNP NNP , where she VBD VBN VBG with the NN NNP NNP . * In the NN of her NN , NNP VBD VBN NNS of NNS VBN with NN , the NN RB VBN as JJ - NNP , for JJ NNS , and VBD that there VBD VBG NNS . NNP VBD by RB RB VBG VBN to VB NN in NNS . NNP and NNP VBD to VB whether NN VBD any NN on how NNS VBP to NN . They VBD the NN to NN NNS , VBD one NN , RB VBD those NNS , RB RB as VBN NNS , through JJ NNS . The NN NNS VBD that for up to four NNS after the NN , the NNS that VBD VBN NN VBD RBR JJ and RBR JJ than the NN NNS . They RB VBD JJR JJ - JJ NNS after VBG JJ NNS . NNP ’s NNS RB VBD that there VBP NNS to VB NN to NN , by both VBG NN NNS from another NN and VBG a NN of NN JJ to NN . This VBZ NN to the JJ - VBN NN that NN VBZ to NN because of NN NNS JJ as JJ NNS , VBN NN NNS , and JJ NNS . RB the NN between NN and NN VBZ JJR to VB with a NN ’s NN of NN — and RB JJ NNS could VB this ."
175,372,mainstream,"Health_NN officials_NNS are_VBP urging_VBG people_NNS to_TO have_VB both_CC parts_NNS of_IN the_DT MMR_NNP vaccine_NN after_IN cases_NNS of_IN mumps_NNS in_IN England_NNP reached_VBD their_PRP$ highest_JJS level_NN in_IN a_DT decade_NN ._. Outbreaks_NNS in_IN universities_NNS and_CC colleges_NNS raised_VBD the_DT number_NN of_IN cases_NNS of_IN the_DT painful_JJ viral_JJ illness_NN to_IN 5,042_CD in_IN 2019_CD -_HYPH four_CD times_NNS the_DT number_NN in_IN 2018_CD ._. Most_JJS were_VBD in_IN young_JJ adults_NNS who_WP missed_VBD out_RP on_IN the_DT MMR_NNP jab_NN ._. Public_NNP Health_NNP England_NNP said_VBD the_DT full_JJ two_CD doses_NNS of_IN the_DT vaccination_NN were_VBD needed_VBN to_TO maximise_VB protection_NN ._. •_SYM Mumps_NNS :_: Why_WRB adults_NNS might_MD still_RB need_VB the_DT MMR_NN jab_NN The_DT vaccine_NN prevents_VBZ most_JJS cases_NNS of_IN mumps_NNS -_, but_CC not_RB all_DT ,_, and_CC so_RB some_DT young_JJ people_NNS are_VBP still_RB getting_VBG the_DT illness_NN ._. There_EX were_VBD also_RB increases_NNS in_IN mumps_NNS cases_NNS in_IN Wales_NNP and_CC Scotland_NNP in_IN 2019_CD ._. It_PRP is_VBZ a_DT viral_JJ infection_NN that_WDT used_VBD to_TO be_VB very_RB common_JJ in_IN children_NNS before_IN the_DT MMR_NN (_-LRB- measles_NNS ,_, mumps_NNS and_CC rubella_NN )_-RRB- vaccine_NN was_VBD introduced_VBN in_IN the_DT UK_NNP in_IN 1988_CD ._. A_DT classic_JJ sign_NN is_VBZ puffy_JJ cheeks_NNS under_IN the_DT ears_NNS ._. Mumps_NNS is_VBZ contagious_JJ and_CC spread_VBN through_IN infected_VBN droplets_NNS of_IN saliva_NN breathed_VBN in_RP through_IN the_DT mouth_NN or_CC nose_NN ._. What_WP are_VBP the_DT symptoms_NNS ?_. •_SYM painful_JJ swelling_NN of_IN the_DT glands_NNS at_IN the_DT side_NN of_IN the_DT face_NN Most_JJS people_NNS usually_RB recover_VBP without_IN treatment_NN ._. But_CC in_IN rare_JJ cases_NNS ,_, there_EX can_MD be_VB serious_JJ complications_NNS ,_, such_JJ as_IN inflammation_NN of_IN the_DT testicles_NNS in_IN males_NNS ,_, meningitis_NN and_CC deafness_NN ._. What_WP does_VBZ it_PRP feel_VB like_IN ?_. ""_`` I_PRP went_VBD to_IN bed_NN normal_JJ ,_, everything_NN fine_JJ ,_, and_CC then_RB I_PRP woke_VBD up_RP ,_, and_CC bang_VBP -_, my_PRP$ face_NN was_VBD so_RB puffed_VBN out_RP ,_, so_RB swollen_JJ ,_, ""_'' says_VBZ Olly_NNP Finch_NNP ,_, a_DT student_NN at_IN Leeds_NNP University_NNP ._. ""_`` I_PRP got_VBD prescribed_VBN morphine_NN -_, it_PRP was_VBD that_RB bad_JJ ._. ""_'' Flora_NNP Cox_NNP ,_, another_DT Leeds_NNP student_NN ,_, said_VBD :_: ""_`` It_PRP started_VBD out_RP with_IN just_RB neck_NN pain_NN in_IN my_PRP$ ear_NN and_CC jaw_NN ,_, and_CC then_RB it_PRP started_VBD swelling_VBG -_, it_PRP was_VBD so_RB painful_JJ ._. David_NNP Buckley_NNP ,_, 32_CD ,_, ended_VBD up_RP with_IN a_DT swollen_JJ testicle_NN ""_`` the_DT size_NN of_IN an_DT avocado_NN ""_'' when_WRB he_PRP had_VBD mumps_NNS ._. That_DT followed_VBD 10_CD days_NNS at_IN home_NN in_IN bed_NN with_IN symptoms_NNS and_CC a_DT trip_NN to_IN hospital_NN with_IN a_DT locked_VBN jaw_NN ._. ""_`` It_PRP was_VBD so_RB painful_JJ ,_, really_RB horrible_JJ ._. I_PRP tried_VBD to_TO ice_VB it_PRP ..._, but_CC it_PRP 's_VBZ just_RB something_NN you_PRP have_VBP to_TO ride_VB out_RP ,_, ""_'' he_PRP told_VBD Radio_NNP 1_CD Newsbeat_NNP ._. David_NNP was_VBD n't_RB sure_JJ if_IN he'd_NNP had_VBD the_DT second_JJ dose_NN of_IN the_DT MMR_NNP vaccine_NN ,_, so_RB he_PRP got_VBD the_DT jab_NN again_RB -_, just_RB in_IN case_NN ._. •_SYM Mumps_NNS -_, is_VBZ it_PRP the_DT forgotten_VBN disease_NN ?_. How_WRB can_MD I_PRP protect_VB myself_PRP ?_. The_DT best_JJS and_CC safest_JJS way_NN is_VBZ to_TO get_VB two_CD doses_NNS of_IN the_DT MMR_NN vaccine_NN -_, the_DT middle_JJ '_`` M_NN '_'' stands_VBZ for_IN mumps_NNS ._. It_PRP 's_VBZ never_RB too_RB late_JJ to_TO catch_VB up_RP ,_, says_VBZ Dr_NNP Vanessa_NNP Saliba_NNP ,_, from_IN Public_NNP Health_NNP England_NNP ._. ""_`` We_PRP encourage_VBP all_DT students_NNS and_CC young_JJ people_NNS who_WP may_MD have_VB missed_VBN out_RP on_IN their_PRP$ MMR_NN vaccine_NN in_IN the_DT past_NN to_TO contact_VB their_PRP$ GP_NN practice_NN and_CC get_VB up_RP to_IN date_NN as_RB soon_RB as_IN possible_JJ ,_, ""_'' she_PRP said_VBD ._. Adults_NNS and_CC children_NNS who_WP missed_VBD out_RP on_IN the_DT vaccine_NN as_IN babies_NNS can_MD also_RB have_VB it_PRP on_IN the_DT NHS_NNP at_IN any_DT age_NN -_, it_PRP is_VBZ given_VBN in_IN two_CD doses_NNS ,_, with_IN the_DT second_JJ at_IN least_JJS a_DT month_NN after_IN the_DT first_JJ ._. Why_WRB do_VBP some_DT people_NNS still_RB get_VB mumps_NNS ?_. The_DT part_NN of_IN the_DT triple_JJ vaccine_NN that_WDT specifically_RB protects_VBZ against_IN mumps_NNS is_VBZ n't_RB quite_RB as_RB effective_JJ as_IN the_DT elements_NNS protecting_VBG against_IN measles_NNS and_CC rubella_NN ._. However_RB ,_, getting_VBG the_DT jab_NN is_VBZ still_RB crucial_JJ -_, because_IN the_DT more_JJR people_NNS who_WP are_VBP protected_VBN ,_, the_DT less_RBR likely_JJ mumps_NNS is_VBZ to_TO be_VB shared_VBN around_RB ._. During_IN outbreaks_NNS among_IN students_NNS ,_, which_WDT are_VBP common_JJ ,_, completely_RB unvaccinated_JJ people_NNS are_VBP at_IN highest_JJS risk_NN ._. Even_RB if_IN you_PRP get_VBP the_DT illness_NN after_IN being_VBG vaccinated_VBN ,_, you_PRP are_VBP likely_JJ to_TO have_VB a_DT less_RBR serious_JJ form_NN of_IN it_PRP and_CC fewer_JJR complications_NNS ._. Cases_NNS of_IN mumps_NNS consistently_RB outnumber_VBP measles_NNS and_CC rubella_NN cases_NNS every_DT year_NN ._. Teenagers_NNS and_CC young_JJ adults_NNS in_IN colleges_NNS and_CC universities_NNS are_VBP now_RB the_DT ones_NNS who_WP tend_VBP to_TO be_VB affected_VBN -_, for_IN several_JJ reasons_NNS ._. Many_JJ of_IN the_DT 2019_CD cases_NNS were_VBD born_VBN in_IN the_DT late_JJ 1990s_NNS and_CC early_JJ 2000s_NNS and_CC missed_VBD out_RP on_IN the_DT MMR_NNP vaccine_NN when_WRB they_PRP were_VBD children_NNS ._. Research_NN by_IN a_DT disgraced_VBN UK_NNP doctor_NN falsely_RB linking_VBG the_DT vaccine_NN to_IN autism_NN undoubtedly_RB had_VBD an_DT impact_NN on_IN uptake_NN ._. Current_JJ students_NNS may_MD also_RB be_VB too_RB old_JJ to_TO have_VB been_VBN immunised_VBN or_CC offered_VBN the_DT MMR_NN ,_, or_CC may_MD only_RB have_VB had_VBN one_CD dose_NN of_IN the_DT vaccine_NN and_CC thus_RB not_RB be_VB fully_RB protected_VBN ._. It_PRP is_VBZ also_RB possible_JJ the_DT vaccine_NN 's_POS protection_NN against_IN mumps_NNS may_MD have_VB worn_VBN off_RP ._. Despite_IN the_DT recent_JJ rise_NN in_IN cases_NNS ,_, mumps_NNS has_VBZ n't_RB just_RB reappeared_VBN ._. Before_IN the_DT MMR_NNP vaccine_NN ,_, eight_CD out_IN of_IN 10_CD people_NNS developed_VBD it_PRP and_CC most_JJS of_IN them_PRP were_VBD children_NNS of_IN school_NN age_NN ._. At_IN that_DT time_NN ,_, there_EX were_VBD five_CD deaths_NNS a_DT year_NN from_IN mumps_NNS ,_, mainly_RB due_IN to_IN encephalitis_NN or_CC swelling_NN of_IN the_DT brain_NN ._. The_DT illness_NN then_RB became_VBD relatively_RB rare_JJ before_IN returning_VBG in_IN the_DT 2000s_NNS ._. There_EX was_VBD a_DT particularly_RB large_JJ outbreak_NN (_-LRB- 43,000_CD cases_NNS )_-RRB- in_IN 2005_CD ._.","NN NNS VBP VBG NNS to VB both NNS of the NNP NN after NNS of NNS in NNP VBD their JJS NN in a NN . NNS in NNS and NNS VBD the NN of NNS of the JJ JJ NN to 5,042 in 2019 - four NNS the NN in 2018 . JJS VBD in JJ NNS who VBD out on the NNP NN . NNP NNP NNP VBD the JJ two NNS of the NN VBD VBN to VB NN . • NNS : Why NNS might RB VB the NN NN The NN VBZ JJS NNS of NNS - but RB all , and RB some JJ NNS VBP RB VBG the NN . There VBD RB NNS in NNS NNS in NNP and NNP in 2019 . It VBZ a JJ NN that VBD to VB RB JJ in NNS before the NN ( NNS , NNS and NN ) NN VBD VBN in the NNP in 1988 . A JJ NN VBZ JJ NNS under the NNS . NNS VBZ JJ and VBN through VBN NNS of NN VBN in through the NN or NN . What VBP the NNS ? • JJ NN of the NNS at the NN of the NN JJS NNS RB VBP without NN . But in JJ NNS , there can VB JJ NNS , JJ as NN of the NNS in NNS , NN and NN . What VBZ it VB like ? "" I VBD to NN JJ , NN JJ , and RB I VBD up , and VBP - my NN VBD RB VBN out , RB JJ , "" VBZ NNP NNP , a NN at NNP NNP . "" I VBD VBN NN - it VBD RB JJ . "" NNP NNP , another NNP NN , VBD : "" It VBD out with RB NN NN in my NN and NN , and RB it VBD VBG - it VBD RB JJ . NNP NNP , 32 , VBD up with a JJ NN "" the NN of an NN "" when he VBD NNS . That VBD 10 NNS at NN in NN with NNS and a NN to NN with a VBN NN . "" It VBD RB JJ , RB JJ . I VBD to VB it ... but it VBZ RB NN you VBP to VB out , "" he VBD NNP 1 NNP . NNP VBD RB JJ if NNP VBD the JJ NN of the NNP NN , RB he VBD the NN RB - RB in NN . • NNS - VBZ it the VBN NN ? How can I VB myself ? The JJS and JJS NN VBZ to VB two NNS of the NN NN - the JJ ' NN ' VBZ for NNS . It VBZ RB RB JJ to VB up , VBZ NNP NNP NNP , from NNP NNP NNP . "" We VBP all NNS and JJ NNS who may VB VBN out on their NN NN in the NN to VB their NN NN and VB up to NN RB RB as JJ , "" she VBD . NNS and NNS who VBD out on the NN as NNS can RB VB it on the NNP at any NN - it VBZ VBN in two NNS , with the JJ at JJS a NN after the JJ . Why VBP some NNS RB VB NNS ? The NN of the JJ NN that RB VBZ against NNS VBZ RB RB RB JJ as the NNS VBG against NNS and NN . RB , VBG the NN VBZ RB JJ - because the JJR NNS who VBP VBN , the RBR JJ NNS VBZ to VB VBN RB . During NNS among NNS , which VBP JJ , RB JJ NNS VBP at JJS NN . RB if you VBP the NN after VBG VBN , you VBP JJ to VB a RBR JJ NN of it and JJR NNS . NNS of NNS RB VBP NNS and NN NNS every NN . NNS and JJ NNS in NNS and NNS VBP RB the NNS who VBP to VB VBN - for JJ NNS . JJ of the 2019 NNS VBD VBN in the JJ NNS and JJ NNS and VBD out on the NNP NN when they VBD NNS . NN by a VBN NNP NN RB VBG the NN to NN RB VBD an NN on NN . JJ NNS may RB VB RB JJ to VB VBN VBN or VBN the NN , or may RB VB VBN one NN of the NN and RB RB VB RB VBN . It VBZ RB JJ the NN 's NN against NNS may VB VBN off . Despite the JJ NN in NNS , NNS VBZ RB RB VBN . Before the NNP NN , eight out of 10 NNS VBD it and JJS of them VBD NNS of NN NN . At that NN , there VBD five NNS a NN from NNS , RB due to NN or NN of the NN . The NN RB VBD RB JJ before VBG in the NNS . There VBD a RB JJ NN ( 43,000 NNS ) in 2005 ."
176,511,mainstream,"(_-LRB- A)_VB Recent_JJ measles_NNS outbreaks_NNS in_IN England_NNP and_CC Wales_NNP ._. Cases_NNS were_VBD assigned_VBN to_IN the_DT same_JJ outbreaks_NNS if_IN they_PRP had_VBD had_VBN epidemiological_JJ contact_NN ._. Isolated_VBN cases_NNS and_CC outbreaks_NNS caused_VBN by_IN deliberately_RB bringing_VBG susceptible_JJ and_CC infected_VBN children_NNS together_RB were_VBD excluded_VBN ._. Dashed_VBN line_NN ,_, the_DT vaccine_NN uptake_NN measured_VBN as_IN the_DT percentage_NN of_IN children_NNS that_WDT had_VBD completed_VBN a_DT primary_JJ course_NN with_IN the_DT MMR_NN vaccine_NN at_IN their_PRP$ second_JJ birthday_NN [_-LRB- from_IN (_-LRB- 2_CD )_-RRB- ]_-RRB- ._. (_-LRB- B_LS )_-RRB- The_DT reproductive_JJ number_NN per_IN year_NN ;_: bars_NNS indicate_VBP 90_CD %_NN bootstrap_NN confidence_NN intervals_NNS ._. (_-LRB- C_LS )_-RRB- The_DT frequency_NN distribution_NN of_IN outbreaks_NNS of_IN a_DT certain_JJ size_NN or_CC larger_JJR (_-LRB- stepped_VBN lines_NNS )_-RRB- for_IN the_DT years_NNS 1995_CD –_SYM 1998_CD and_CC 1999_CD –2002_CD and_CC the_DT theoretically_RB predicted_VBN distributions_NNS (_-LRB- curved_VBN lines_NNS )_-RRB- ._. Dashed_VBN line_NN ,_, distribution_NN for_IN R_NN =_SYM 1_CD ._.","( VB JJ NNS NNS in NNP and NNP . NNS VBD VBN to the JJ NNS if they VBD VBN JJ NN . VBN NNS and NNS VBN by RB VBG JJ and VBN NNS RB VBD VBN . VBN NN , the NN NN VBN as the NN of NNS that VBD VBN a JJ NN with the NN NN at their JJ NN [ from ( 2 ) ] . ( B ) The JJ NN per NN ; NNS VBP 90 NN NN NN NNS . ( C ) The NN NN of NNS of a JJ NN or JJR ( VBN NNS ) for the NNS 1995 – 1998 and 1999 –2002 and the RB VBN NNS ( VBN NNS ) . VBN NN , NN for NN = 1 ."
177,1217,mainstream,"His_PRP$ assertion_NN comes_VBZ amid_IN fears_NNS that_IN the_DT coronavirus_NN will_MD continue_VB to_TO upend_VB the_DT globe_NN —_: and_CC its_PRP$ economies_NNS —_: until_IN a_DT vaccine_NN for_IN the_DT highly_RB infectious_JJ disease_NN can_MD be_VB developed_VBN and_CC delivered_VBN on_IN a_DT massive_JJ scale_NN ._. Vaccines_NNS often_RB take_VBP several_JJ years_NNS to_TO develop_VB ,_, and_CC Trump_NNP ’s_POS top_JJ health_NN advisers_NNS have_VBP frequently_RB warned_VBN that_IN it_PRP may_MD take_VB at_IN least_JJS a_DT year_NN before_IN people_NNS can_MD begin_VB to_TO receive_VB a_DT coronavirus_NN vaccine_NN ._. “_`` I_PRP can_MD say_VB this_DT ,_, we_PRP ’re_VBP doing_VBG really_RB great_JJ ,_, ”_'' Trump_NNP told_VBD Muir_NNP on_IN Tuesday_NNP ,_, name_NN -_HYPH dropping_VBG Oxford_NNP University_NNP and_CC the_DT pharmaceutical_JJ giant_NN Johnson_NNP &_CC Johnson_NNP ,_, which_WDT he_PRP said_VBD on_IN Sunday_NNP was_VBD “_`` close_JJ ”_'' to_IN a_DT vaccine_NN ._. “_`` I_PRP get_VBP reports_NNS every_DT single_JJ day_NN ,_, they_PRP ’re_VBP doing_VBG really_RB great_JJ ._. ”_'' Still_RB ,_, he_PRP added_VBD :_: “_`` Am_VBP I_PRP convinced_JJ ?_. I_PRP ca_MD n’t_RB be_VB convinced_VBN of_IN anything_NN ._. ”_'' All_DT vaccines_NNS currently_RB in_IN development_NN are_VBP still_RB in_IN the_DT early_JJ phases_NNS of_IN clinical_JJ trials_NNS ,_, and_CC Johnson_NNP &_CC Johnson_NNP has_VBZ said_VBN the_DT soonest_JJS its_PRP$ first_JJ batch_NN will_MD be_VB available_JJ is_VBZ in_IN 2021_CD ._. The_DT company_NN has_VBZ not_RB yet_RB begun_VBN human_JJ trials_NNS ,_, and_CC does_VBZ n’t_RB expect_VB to_TO do_VB so_RB until_IN September_NNP of_IN this_DT year_NN ._. Two_CD other_JJ companies_NNS have_VBP said_VBN they_PRP have_VBP the_DT potential_NN to_TO supply_VB millions_NNS of_IN doses_NNS by_IN the_DT end_NN of_IN the_DT year_NN if_IN their_PRP$ vaccine_NN candidate_NN shows_VBZ promising_JJ results_NNS in_IN trials_NNS ._. Trump_NNP is_VBZ shepherding_VBG within_IN his_PRP$ administration_NN aimed_VBN at_IN drastically_RB slashing_VBG the_DT timeline_NN for_IN vaccine_NN development_NN ,_, an_DT undertaking_NN his_PRP$ aides_NNS have_VBP compared_VBN to_IN the_DT sprint_NN to_TO develop_VB the_DT atomic_JJ bomb_NN ._. But_CC last_JJ week_NN ,_, Trump_NNP denied_VBD to_IN reporters_NNS that_IN he_PRP was_VBD over_RB -_HYPH promising_VBG with_IN his_PRP$ goal_NN of_IN securing_VBG 300_CD million_CD doses_NNS of_IN the_DT eventual_JJ vaccine_NN once_IN it_PRP ’s_VBZ ready_JJ to_TO be_VB administered_VBN to_IN the_DT public_NN ._. “_`` We_PRP ’re_VBP building_VBG supply_NN lines_NNS ._. We_PRP even_RB have_VBP the_DT final_JJ vaccine_NN ,_, ”_'' he_PRP said_VBD on_IN Sunday_NNP ._. Trump_NNP ’s_POS top_JJ public_JJ health_NN experts_NNS have_VBP expressed_VBN cautious_JJ optimism_NN that_IN finalizing_VBG a_DT vaccine_NN on_IN the_DT president_NN ’s_POS declared_VBN timeline_NN is_VBZ possible_JJ —_: with_IN caveats_NNS ._.","His NN VBZ amid NNS that the NN will VB to VB the NN — and its NNS — until a NN for the RB JJ NN can VB VBN and VBN on a JJ NN . NNS RB VBP JJ NNS to VB , and NNP ’s JJ NN NNS VBP RB VBN that it may VB at JJS a NN before NNS can VB to VB a NN NN . “ I can VB this , we VBP VBG RB JJ , ” NNP VBD NNP on NNP , NN - VBG NNP NNP and the JJ NN NNP & NNP , which he VBD on NNP VBD “ JJ ” to a NN . “ I VBP NNS every JJ NN , they VBP VBG RB JJ . ” RB , he VBD : “ VBP I JJ ? I ca RB VB VBN of NN . ” All NNS RB in NN VBP RB in the JJ NNS of JJ NNS , and NNP & NNP VBZ VBN the JJS its JJ NN will VB JJ VBZ in 2021 . The NN VBZ RB RB VBN JJ NNS , and VBZ RB VB to VB RB until NNP of this NN . Two JJ NNS VBP VBN they VBP the NN to VB NNS of NNS by the NN of the NN if their NN NN VBZ JJ NNS in NNS . NNP VBZ VBG within his NN VBN at RB VBG the NN for NN NN , an NN his NNS VBP VBN to the NN to VB the JJ NN . But JJ NN , NNP VBD to NNS that he VBD RB - VBG with his NN of VBG 300 million NNS of the JJ NN once it VBZ JJ to VB VBN to the NN . “ We VBP VBG NN NNS . We RB VBP the JJ NN , ” he VBD on NNP . NNP ’s JJ JJ NN NNS VBP VBN JJ NN that VBG a NN on the NN ’s VBN NN VBZ JJ — with NNS ."
178,1323,mainstream,"The_DT most_RBS effective_JJ way_NN of_IN preventing_VBG the_DT flu_NN is_VBZ with_IN an_DT influenza_NN vaccination_NN ._. Every_DT fall_NN you_PRP should_MD be_VB immunized_VBN against_IN strains_NNS that_WDT have_VBP developed_VBN since_IN the_DT previous_JJ outbreak_NN ._. If_IN you_PRP are_VBP vaccinated_VBN against_IN three_CD or_CC more_JJR strains_NNS ,_, you_PRP may_MD still_RB come_VB down_RP with_IN flu_NN ,_, but_CC symptoms_NNS are_VBP likely_JJ to_TO be_VB milder_JJR than_IN they_PRP would_MD have_VB been_VBN had_VBN you_PRP not_RB had_VBD an_DT influenza_NN vaccination_NN ._. Influenza_NN vaccine_NN is_VBZ available_JJ through_IN physicians_NNS and_CC public_JJ -_HYPH health_NN facilities_NNS and_CC many_JJ companies_NNS provide_VBP flu_NN vaccines_NNS on_IN -_HYPH site_NN for_IN their_PRP$ workers_NNS ._. Because_IN influenza_NN is_VBZ a_DT serious_JJ threat_NN ,_, the_DT CDC_NNP recommends_VBZ vaccination_NN for_IN everyone_NN 6_CD months_NNS of_IN age_NN and_CC older_JJR and_CC others_NNS at_IN high_JJ risk_NN of_IN flu_NN complications_NNS :_: •_NFP Those_DT with_IN chronic_JJ medical_JJ conditions_NNS ,_, such_JJ as_IN diabetes_NN and_CC asthma_NN •_, People_NNS with_IN a_DT weakened_VBN immune_JJ system_NN ,_, like_IN those_DT with_IN HIV_NN /_, AIDS_NN The_DT seasonal_JJ flu_NN vaccine_NN is_VBZ available_JJ in_IN three_CD forms_NNS ._. One_CD is_VBZ the_DT injectable_JJ vaccine_NN made_VBN from_IN an_DT inactivated_VBN virus_NN ._. This_DT form_NN is_VBZ usually_RB given_VBN as_IN a_DT single_JJ injection_NN and_CC is_VBZ approved_VBN for_IN people_NNS 6_CD months_NNS of_IN age_NN or_CC older_JJR ._. Another_DT form_NN is_VBZ given_VBN as_IN a_DT nasal_JJ spray_NN called_VBN FluMist_NNP ._. This_DT form_NN of_IN the_DT vaccine_NN is_VBZ a_DT live_JJ and_CC weakened_VBN form_NN of_IN the_DT flu_NN and_CC is_VBZ approved_VBN for_IN all_DT healthy_JJ people_NNS 2_CD -_SYM 49_CD years_NNS of_IN age_NN who_WP are_VBP not_RB pregnant_JJ ._. If_IN you_PRP are_VBP pregnant_JJ you_PRP can_MD only_RB receive_VB the_DT injectable_JJ form_NN ._. The_DT CDC_NNP also_RB has_VBZ recommended_VBN the_DT nasal_JJ spray_NN vaccine_NN for_IN healthy_JJ children_NNS 2_CD years_NNS and_CC older_JJR without_IN preference_NN over_IN the_DT flu_NN shot_NN ._. There_EX is_VBZ also_RB a_DT “_`` needle_NN -_HYPH less_JJR ”_'' option_NN for_IN people_NNS 18_CD -_SYM 64_CD years_NNS old_JJ :_: the_DT jet_NN injector_NN vaccine_NN with_IN Afluria_NNP ,_, which_WDT uses_VBZ a_DT tool_NN with_IN high_JJ pressure_NN to_TO deliver_VB the_DT vaccine_NN ._. All_DT of_IN the_DT vaccines_NNS are_VBP given_VBN as_IN a_DT single_JJ dose_NN ,_, although_IN children_NNS who_WP are_VBP receiving_VBG vaccination_NN for_IN the_DT first_JJ time_NN receive_VB two_CD ._. Some_DT people_NNS develop_VBP low_JJ fever_NN and_CC muscle_NN aches_NNS as_IN side_NN effects_NNS of_IN the_DT vaccine_NN ._. •_NFP Intradermal_JJ shots_NNS use_VBP smaller_JJR needles_NNS that_WDT only_RB go_VBP into_IN the_DT top_JJ layer_NN of_IN the_DT skin_NN instead_RB of_IN the_DT muscle_NN ._. They_PRP 're_VBP available_JJ for_IN those_DT ages_NNS 18_CD to_IN 64_CD ._. If_IN you_PRP have_VBP severe_JJ egg_NN allergies_NNS you_PRP should_MD get_VB the_DT flu_NN shot_NN from_IN a_DT doctor_NN who_WP can_MD treat_VB a_DT severe_JJ allergic_JJ reaction_NN --_, either_CC at_IN your_PRP$ doctor_NN 's_POS office_NN ,_, a_DT hospital_NN ,_, a_DT clinic_NN ,_, or_CC a_DT health_NN department_NN ._. •_NFP Egg_NN -_HYPH free_JJ vaccines_NNS are_VBP now_RB available_JJ for_IN those_DT aged_JJ 18_CD and_CC older_JJR who_WP have_VBP severe_JJ egg_NN allergies_NNS ._. •_NFP High_JJ -_HYPH dose_NN vaccines_NNS are_VBP meant_VBN for_IN those_DT ages_NNS 65_CD and_CC older_JJR ,_, when_WRB available_JJ ,_, and_CC may_MD better_RBR protect_VB this_DT group_NN from_IN the_DT flu_NN ._.","The RBS JJ NN of VBG the NN VBZ with an NN NN . Every NN you should VB VBN against NNS that VBP VBN since the JJ NN . If you VBP VBN against three or JJR NNS , you may RB VB down with NN , but NNS VBP JJ to VB JJR than they would VB VBN VBN you RB VBD an NN NN . NN NN VBZ JJ through NNS and JJ - NN NNS and JJ NNS VBP NN NNS on - NN for their NNS . Because NN VBZ a JJ NN , the NNP VBZ NN for NN 6 NNS of NN and JJR and NNS at JJ NN of NN NNS : • Those with JJ JJ NNS , JJ as NN and NN • NNS with a VBN JJ NN , like those with NN / NN The JJ NN NN VBZ JJ in three NNS . One VBZ the JJ NN VBN from an VBN NN . This NN VBZ RB VBN as a JJ NN and VBZ VBN for NNS 6 NNS of NN or JJR . Another NN VBZ VBN as a JJ NN VBN NNP . This NN of the NN VBZ a JJ and VBN NN of the NN and VBZ VBN for all JJ NNS 2 - 49 NNS of NN who VBP RB JJ . If you VBP JJ you can RB VB the JJ NN . The NNP RB VBZ VBN the JJ NN NN for JJ NNS 2 NNS and JJR without NN over the NN NN . There VBZ RB a “ NN - JJR ” NN for NNS 18 - 64 NNS JJ : the NN NN NN with NNP , which VBZ a NN with JJ NN to VB the NN . All of the NNS VBP VBN as a JJ NN , although NNS who VBP VBG NN for the JJ NN VB two . Some NNS VBP JJ NN and NN NNS as NN NNS of the NN . • JJ NNS VBP JJR NNS that RB VBP into the JJ NN of the NN RB of the NN . They VBP JJ for those NNS 18 to 64 . If you VBP JJ NN NNS you should VB the NN NN from a NN who can VB a JJ JJ NN -- either at your NN 's NN , a NN , a NN , or a NN NN . • NN - JJ NNS VBP RB JJ for those JJ 18 and JJR who VBP JJ NN NNS . • JJ - NN NNS VBP VBN for those NNS 65 and JJR , when JJ , and may RBR VB this NN from the NN ."
179,486,mainstream,"HARTFORD_NNP ,_, Conn_NNP ._. (_-LRB- AP_NNP )_-RRB- —_: A_DT Connecticut_NNP couple_NN is_VBZ seeking_VBG to_TO stop_VB the_DT state_NN Department_NNP of_IN Public_NNP Health_NNP from_IN publicly_RB releasing_VBG additional_JJ information_NN about_IN immunization_NN rates_NNS at_IN private_JJ and_CC public_JJ schools_NNS ._. Brian_NNP and_CC Kristen_NNP Festa_NNP ,_, of_IN Woodstock_NNP ,_, have_VBP filed_VBN a_DT lawsuit_NN requesting_VBG a_DT temporary_JJ injunction_NN ._. The_DT parents_NNS of_IN an_DT unvaccinated_JJ son_NN say_VBP they_PRP ’ve_VBP suffered_VBN “_`` mental_JJ and_CC emotional_JJ distress_NN due_IN to_IN the_DT vitriolic_JJ and_CC hateful_JJ statements_NNS from_IN the_DT public_NN ”_'' since_IN the_DT agency_NN released_VBD immunization_NN data_NNS on_IN May_NNP 3_CD ._. The_DT couple_NN ’s_POS 7_CD -_HYPH year_NN -_HYPH old_JJ son_NN attends_VBZ a_DT private_JJ school_NN in_IN Meriden_NNP for_IN students_NNS with_IN autism_NN spectrum_NN disorders_NNS where_WRB 18.5_CD %_NN of_IN students_NNS claim_VBP a_DT religious_JJ exemption_NN from_IN vaccinations_NNS ,_, one_CD of_IN the_DT highest_JJS exemption_NN rates_NNS in_IN the_DT state_NN ._. They_PRP say_VBP it_PRP ’s_VBZ “_`` reasonable_JJ to_TO presume_VB ”_'' their_PRP$ son_NN and_CC other_JJ students_NNS will_MD be_VB harassed_VBN ._.","NNP , NNP . ( NNP ) — A NNP NN VBZ VBG to VB the NN NNP of NNP NNP from RB VBG JJ NN about NN NNS at JJ and JJ NNS . NNP and NNP NNP , of NNP , VBP VBN a NN VBG a JJ NN . The NNS of an JJ NN VBP they VBP VBN “ JJ and JJ NN due to the JJ and JJ NNS from the NN ” since the NN VBD NN NNS on NNP 3 . The NN ’s 7 - NN - JJ NN VBZ a JJ NN in NNP for NNS with NN NN NNS where 18.5 NN of NNS VBP a JJ NN from NNS , one of the JJS NN NNS in the NN . They VBP it VBZ “ JJ to VB ” their NN and JJ NNS will VB VBN ."
180,860,mainstream,"Photos_NNS :_: Volunteers_NNS in_IN Seattle_NNP get_VBP first_JJ doses_NNS of_IN trial_NN vaccine_NN for_IN COVID_NN -_HYPH 19_CD The_DT first_JJ shots_NNS in_IN the_DT first_JJ vaccine_NN trial_NN for_IN the_DT new_JJ coronavirus_NN were_VBD administered_VBN Monday_NNP as_IN a_DT small_JJ group_NN of_IN volunteers_NNS in_IN Seattle_NNP will_MD receive_VB varying_VBG doses_NNS over_IN the_DT next_JJ several_JJ weeks_NNS to_TO test_VB the_DT safety_NN of_IN the_DT experimental_JJ vaccine_NN ._. Doctors_NNS at_IN Kaiser_NNP Permanente_NNP Washington_NNP Health_NNP Research_NNP Institute_NNP in_IN Seattle_NNP gave_VBD the_DT first_JJ shots_NNS in_IN the_DT trial_NN aimed_VBN at_IN combating_VBG the_DT spread_NN of_IN COVID_NN -_HYPH 19_CD ._. ""_`` Finding_VBG a_DT safe_JJ and_CC effective_JJ vaccine_NN to_TO prevent_VB infection_NN with_IN SARS_NN -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ an_DT urgent_JJ public_JJ health_NN priority_NN ,_, ""_'' National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS Director_NNP Anthony_NNP Fauci_NNP said_VBD in_IN a_DT statement_NN ._. ""_`` This_DT Phase_NN 1_CD study_NN ,_, launched_VBN in_IN record_NN speed_NN ,_, is_VBZ an_DT important_JJ first_JJ step_NN toward_IN achieving_VBG that_DT goal_NN ._. ""_'' SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ the_DT name_NN of_IN the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ,_, which_WDT the_DT World_NNP Health_NNP Organization_NNP declared_VBD a_DT pandemic_NN last_JJ week_NN ._. More_JJR than_IN 183,400_CD cases_NNS globally_RB have_VBP been_VBN reported_VBN ,_, with_IN more_JJR than_IN 7,100_CD confirmed_VBN deaths_NNS ,_, since_IN the_DT virus_NN was_VBD first_RB detected_VBN in_IN late_JJ 2019_CD in_IN China_NNP ._. The_DT trial_NN is_VBZ to_TO include_VB 45_CD healthy_JJ adults_NNS ages_NNS 18_CD -_SYM 55_CD and_CC last_JJ for_IN approximately_RB 6_CD weeks_NNS as_IN volunteers_NNS will_MD receive_VB two_CD shots_NNS about_RB a_DT month_NN apart_RB ._. Developed_VBN by_IN scientists_NNS at_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS and_CC at_IN the_DT biotechnology_NN company_NN Moderna_NNP ,_, Inc._NNP ,_, the_DT experimental_JJ vaccine_NN uses_VBZ messenger_NN RNA_NN and_CC ""_`` directs_VBZ the_DT body_NN ’s_POS cells_NNS to_TO express_VB a_DT virus_NN protein_NN that_WDT it_PRP is_VBZ hoped_VBN will_MD elicit_VB a_DT robust_JJ immune_JJ response_NN ,_, ""_'' the_DT institute_NN said_VBD in_IN a_DT news_NN release_NN ._. Scientists_NNS working_VBG on_IN a_DT vaccine_NN for_IN Middle_JJ East_NNP respiratory_JJ syndrome_NN ,_, caused_VBN by_IN another_DT coronavirus_NN ,_, were_VBD able_JJ to_TO develop_VB the_DT COVID_NN -_HYPH 19_CD experimental_JJ vaccine_NN quickly_RB once_IN the_DT genetic_JJ information_NN for_IN the_DT new_JJ coronavirus_NN became_VBD available_JJ ._. What_WP exactly_RB is_VBZ a_DT virus_NN ?_. Is_VBZ it_PRP alive_JJ ?_. Coronaviruses_NNS are_VBP named_VBN for_IN crown_NN -_HYPH like_IN spikes_NNS on_IN their_PRP$ surfaces_NNS ,_, and_CC the_DT potential_JJ COVID_NN -_HYPH 19_CD vaccine_NN targets_VBZ the_DT spike_NN ,_, which_WDT allow_VBP the_DT viruses_NNS to_TO attack_VB the_DT human_JJ body_NN ._. Dr._NNP Lisa_NNP Jackson_NNP ,_, who_WP is_VBZ leading_VBG the_DT study_NN with_IN Kaiser_NNP Permanente_NNP ,_, told_VBD the_DT Associated_NNP Press_NNP that_IN her_PRP$ team_NN is_VBZ ""_`` subdued_JJ ""_'' as_IN the_DT trial_NN gets_VBZ underway_JJ ._. The_DT potential_JJ vaccine_NN is_VBZ one_CD of_IN many_JJ being_VBG developed_VBN around_IN the_DT globe_NN ,_, and_CC it_PRP could_MD still_RB take_VB more_JJR than_IN a_DT year_NN for_IN it_PRP to_TO be_VB widely_RB available_JJ if_IN it_PRP is_VBZ proven_VBN safe_JJ ._. “_`` We_PRP do_VBP n’t_RB know_VB whether_IN this_DT vaccine_NN will_MD induce_VB an_DT immune_JJ response_NN or_CC whether_IN it_PRP will_MD be_VB safe_JJ ._. That_DT ’s_VBZ why_WRB we_PRP ’re_VBP doing_VBG a_DT trial_NN ,_, ”_'' Jackson_NNP told_VBD the_DT Associated_NNP Press_NNP ._. But_CC ,_, ""_`` going_VBG from_IN not_RB even_RB knowing_VBG that_IN this_DT virus_NN was_VBD out_RB there_RB …_, to_TO have_VB any_DT vaccine_NN ""_'' in_IN testing_NN in_IN about_RB two_CD months_NNS is_VBZ unprecedented_JJ ,_, she_PRP added_VBD ._. Social_JJ distancing_NN :_: It_PRP ’s_VBZ not_RB about_IN you_PRP ,_, it_PRP ’s_VBZ about_IN us_PRP ""_`` We_PRP all_DT feel_VBP so_RB helpless_JJ ._. This_DT is_VBZ an_DT amazing_JJ opportunity_NN for_IN me_PRP to_TO do_VB something_NN ,_, ""_'' Jennifer_NNP Haller_NNP ,_, 43_CD ,_, of_IN Seattle_NNP told_VBD the_DT AP_NNP ._. She_PRP 's_VBZ one_CD of_IN the_DT first_JJ people_NNS who_WP will_MD take_VB part_NN in_IN the_DT trial_NN ._. ""_`` I_PRP 'm_VBP feeling_VBG great_JJ ,_, ""_'' she_PRP added_VBD after_IN getting_VBG the_DT shot_NN ._. Other_JJ recipients_NNS of_IN the_DT first_JJ round_NN of_IN the_DT vaccine_NN were_VBD Neal_NNP Browning_NNP ,_, 46_CD ,_, of_IN Bothell_NNP ,_, Washington_NNP ._. He_PRP told_VBD the_DT AP_NNP his_PRP$ daughters_NNS were_VBD proud_JJ of_IN him_PRP for_IN being_VBG part_NN of_IN the_DT trial_NN ._. ""_`` Every_DT parent_NN wants_VBZ their_PRP$ children_NNS to_TO look_VB up_RP to_IN them_PRP ,_, ""_'' he_PRP said_VBD ._. But_CC he_PRP said_VBD he_PRP told_VBD them_PRP not_RB to_TO brag_VB to_IN friends_NNS ._. ""_`` It_PRP 's_VBZ other_JJ people_NNS ,_, too_RB ._. It_PRP 's_VBZ not_RB just_RB Dad_NN out_RB there_RB ._. ""_'' Rebecca_NNP Sirull_NNP ,_, 25_CD ,_, said_VBD she_PRP joined_VBD the_DT trial_NN as_IN ""_`` a_DT way_NN to_TO contribute_VB to_IN the_DT situation_NN in_IN a_DT positive_JJ way_NN ._. ""_'' ""_`` The_DT main_JJ guidelines_NNS that_WDT we_PRP all_DT have_VBP right_RB now_RB are_VBP to_TO stay_VB home_RB and_CC do_VB nothing_NN ,_, which_WDT is_VBZ sort_NN of_IN a_DT hard_JJ message_NN to_TO hear_VB when_WRB you_PRP want_VBP to_TO help_VB out_RP ,_, ""_'' she_PRP said_VBD ._.","NNS : NNS in NNP VBP JJ NNS of NN NN for NN - 19 The JJ NNS in the JJ NN NN for the JJ NN VBD VBN NNP as a JJ NN of NNS in NNP will VB VBG NNS over the JJ JJ NNS to VB the NN of the JJ NN . NNS at NNP NNP NNP NNP NNP NNP in NNP VBD the JJ NNS in the NN VBN at VBG the NN of NN - 19 . "" VBG a JJ and JJ NN to VB NN with NN - NNP - 2 VBZ an JJ JJ NN NN , "" NNP NNP of NNP and NNP NNPS NNP NNP NNP VBD in a NN . "" This NN 1 NN , VBN in NN NN , VBZ an JJ JJ NN toward VBG that NN . "" NNP - NNP - 2 VBZ the NN of the NN that VBZ NN - 19 , which the NNP NNP NNP VBD a NN JJ NN . JJR than 183,400 NNS RB VBP VBN VBN , with JJR than 7,100 VBN NNS , since the NN VBD RB VBN in JJ 2019 in NNP . The NN VBZ to VB 45 JJ NNS NNS 18 - 55 and JJ for RB 6 NNS as NNS will VB two NNS RB a NN RB . VBN by NNS at the NNP NNP of NNP and NNP NNPS and at the NN NN NNP , NNP , the JJ NN VBZ NN NN and "" VBZ the NN ’s NNS to VB a NN NN that it VBZ VBN will VB a JJ JJ NN , "" the NN VBD in a NN NN . NNS VBG on a NN for JJ NNP JJ NN , VBN by another NN , VBD JJ to VB the NN - 19 JJ NN RB once the JJ NN for the JJ NN VBD JJ . What RB VBZ a NN ? VBZ it JJ ? NNS VBP VBN for NN - like NNS on their NNS , and the JJ NN - 19 NN VBZ the NN , which VBP the NNS to VB the JJ NN . NNP NNP NNP , who VBZ VBG the NN with NNP NNP , VBD the NNP NNP that her NN VBZ "" JJ "" as the NN VBZ JJ . The JJ NN VBZ one of JJ VBG VBN around the NN , and it could RB VB JJR than a NN for it to VB RB JJ if it VBZ VBN JJ . “ We VBP RB VB whether this NN will VB an JJ NN or whether it will VB JJ . That VBZ why we VBP VBG a NN , ” NNP VBD the NNP NNP . But , "" VBG from RB RB VBG that this NN VBD RB RB … to VB any NN "" in NN in RB two NNS VBZ JJ , she VBD . JJ NN : It VBZ RB about you , it VBZ about us "" We all VBP RB JJ . This VBZ an JJ NN for me to VB NN , "" NNP NNP , 43 , of NNP VBD the NNP . She VBZ one of the JJ NNS who will VB NN in the NN . "" I VBP VBG JJ , "" she VBD after VBG the NN . JJ NNS of the JJ NN of the NN VBD NNP NNP , 46 , of NNP , NNP . He VBD the NNP his NNS VBD JJ of him for VBG NN of the NN . "" Every NN VBZ their NNS to VB up to them , "" he VBD . But he VBD he VBD them RB to VB to NNS . "" It VBZ JJ NNS , RB . It VBZ RB RB NN RB RB . "" NNP NNP , 25 , VBD she VBD the NN as "" a NN to VB to the NN in a JJ NN . "" "" The JJ NNS that we all VBP RB RB VBP to VB RB and VB NN , which VBZ NN of a JJ NN to VB when you VBP to VB out , "" she VBD ."
181,1096,mainstream,"FRANKFURT_NNP /_, PARIS_NNP (_-LRB- Reuters_NNP )_-RRB- -_, Drugmakers_NNS are_VBP warning_VBG of_IN a_DT potential_JJ shortage_NN of_IN vials_NNS to_TO bottle_VB future_JJ COVID_NN -_HYPH 19_CD vaccines_NNS ,_, but_CC their_PRP$ rush_NN to_TO secure_VB supplies_NNS risks_VBZ making_VBG matters_NNS worse_JJR ,_, some_DT major_JJ medical_JJ equipment_NN manufacturers_NNS warn_VBP ._. Schott_NNP AG_NNP ,_, the_DT world_NN ’s_POS largest_JJS maker_NN of_IN speciality_JJ glass_NN for_IN vaccine_NN vials_NNS ,_, says_VBZ it_PRP has_VBZ turned_VBN down_RP requests_NNS to_TO reserve_VB output_NN from_IN major_JJ pharmaceutical_JJ firms_NNS because_IN it_PRP does_VBZ not_RB want_VB to_TO commit_VB resources_NNS before_IN it_PRP is_VBZ clear_JJ which_WDT vaccines_NNS will_MD work_VB ._. “_`` We_PRP have_VBP to_TO keep_VB the_DT door_NN open_JJ to_TO give_VB capacity_NN to_IN those_DT who_WP really_RB are_VBP successful_JJ in_IN the_DT end_NN ._. We_PRP do_VBP n’t_RB want_VB to_TO be_VB portrayed_VBN in_IN the_DT press_NN as_IN the_DT ones_NNS who_WP were_VBD unable_JJ to_TO package_VB the_DT best_JJS vaccine_NN ,_, ”_'' Chief_JJ Executive_NN Frank_NNP Heinricht_NNP told_VBD Reuters_NNP ._. With_IN thousands_NNS dying_VBG from_IN COVID_NNP -_HYPH 19_CD every_DT day_NN and_CC attempts_NNS to_TO contain_VB the_DT virus_NN plunging_VBG the_DT world_NN into_IN recession_NN ,_, drugmakers_NNS and_CC healthcare_NN groups_NNS including_VBG Pfizer_NNP ,_, AstraZeneca_NNP and_CC the_DT GAVI_NNP vaccines_NNS alliance_NN are_VBP pushing_VBG to_TO mass_NN produce_VB vaccines_NNS even_RB before_IN they_PRP are_VBP shown_VBN to_TO work_VB in_IN trials_NNS ._. They_PRP want_VBP to_TO be_VB sure_JJ a_DT successful_JJ jab_NN can_MD be_VB rolled_VBN out_RP as_RB quickly_RB as_IN possible_JJ to_IN billions_NNS of_IN people_NNS across_IN the_DT world_NN ._. But_CC that_DT is_VBZ creating_VBG worries_NNS about_IN supplies_NNS ._. AstraZeneca_NNP boss_NN Pascal_NNP Soriot_NNP ;_: the_DT head_NN of_IN the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS (_-LRB- CEPI_NNP )_-RRB- ,_, Richard_NNP Hatchett_NNP ;_: and_CC the_DT director_NN general_NN of_IN global_JJ drugmakers_NNS ’_POS lobby_NN group_NN IFPMA_NNP ,_, Thomas_NNP Cueni_NNP ,_, have_VBP all_RB warned_VBN there_EX may_MD not_RB be_VB enough_JJ glass_NN vials_NNS available_JJ for_IN a_DT global_JJ immunisation_NN campaign_NN ._. Privately_RB -_HYPH held_VBN Schott_NNP ,_, the_DT biggest_JJS supplier_NN of_IN borosilicate_NN glass_NN for_IN medical_JJ bottles_NNS and_CC syringes_NNS ,_, is_VBZ confident_JJ vial_NN makers_NNS can_MD meet_VB the_DT challenge_NN ,_, but_CC says_VBZ it_PRP has_VBZ had_VBN to_TO make_VB some_DT very_RB difficult_JJ business_NN decisions_NNS to_TO try_VB to_TO ensure_VB that_DT is_VBZ the_DT case_NN ._. Heinricht_NNP said_VBD Schott_NNP had_VBD turned_VBN down_RP requests_NNS from_IN major_JJ vaccine_NN developers_NNS for_IN future_JJ delivery_NN of_IN 800_CD million_CD to_IN 1_CD billion_CD glass_NN vials_NNS ,_, which_WDT typically_RB hold_VBP 5_CD -_SYM 10_CD doses_NNS ,_, because_IN the_DT company_NN believed_VBD it_PRP was_VBD too_RB early_JJ to_TO make_VB such_PDT a_DT commitment_NN ._. “_`` That_DT is_VBZ the_DT dilemma_NN we_PRP are_VBP in_IN ,_, ”_'' Heinricht_NNP said_VBD ,_, adding_VBG Schott_NNP ’s_POS cautious_JJ stance_NN may_MD have_VB contributed_VBN to_IN an_DT industry_NN view_NN that_WDT vials_NNS ,_, which_WDT drugmakers_NNS buy_VBP for_IN less_JJR than_IN 10_CD euro_CD cents_NNS apiece_RB ,_, may_MD become_VB in_IN short_JJ supply_NN ._. France_NNP ’s_POS SGD_NNP Pharma_NNP ,_, a_DT maker_NN of_IN vials_NNS and_CC one_CD of_IN the_DT world_NN ’s_POS largest_JJS manufacturers_NNS of_IN moulded_VBN glass_NN for_IN the_DT pharmaceutical_JJ industry_NN ,_, said_VBD it_PRP had_VBD a_DT public_JJ health_NN duty_NN and_CC would_MD do_VB everything_NN to_TO avoid_VB vial_NN shortages_NNS ._. “_`` We_PRP trust_VBP our_PRP$ clients_NNS ,_, with_IN whom_WP we_PRP have_VBP long_JJ standing_NN relationships_NNS ,_, not_RB to_TO make_VB speculative_JJ moves_NNS ._. If_IN this_DT was_VBD to_TO be_VB the_DT case_NN ,_, we_PRP would_MD put_VB the_DT reputation_NN and_CC the_DT mission_NN of_IN SGD_NN above_IN any_DT cash_NN gain_NN ,_, ”_'' Chief_JJ Executive_NN Christophe_NNP Nicoli_NNP said_VBD ._. He_PRP sought_VBD to_TO allay_VB concerns_NNS over_IN shortages_NNS ,_, saying_VBG SGD_NNP expected_VBD an_DT additional_JJ pandemic_NN demand_NN for_IN vials_NNS of_IN no_RB more_JJR than_IN 3_CD %_NN of_IN underlying_JJ annual_JJ volumes_NNS ._. Schott_NNP ,_, whose_WP$ founder_NN Otto_NNP Schott_NNP invented_VBD heavy_JJ -_HYPH duty_NN borosilicate_NN glass_NN in_IN the_DT 1890s_NNS ,_, also_RB said_VBD it_PRP was_VBD pulling_VBG out_RP all_PDT the_DT stops_NNS for_IN its_PRP$ part_NN in_IN supplying_VBG a_DT billion_CD multi-_NN dose_NN vials_NNS which_WDT it_PRP says_VBZ will_MD be_VB needed_VBN for_IN a_DT global_JJ immunisation_NN drive_NN ,_, potentially_RB next_JJ year_NN ._. Schott_NNP ,_, with_IN 2.2_CD billion_CD euros_NNS (_-LRB- $_$ 2.5_CD billion_CD )_-RRB- in_IN annual_JJ sales_NNS ,_, competes_VBZ in_IN the_DT market_NN for_IN borosilicate_NN glass_NN tubes_NNS with_IN Nippon_NNP Electric_NNP Glass_NNP ,_, Nipro_NNP and_CC Corning_NNP Inc_NNP ._. It_PRP also_RB makes_VBZ the_DT finished_VBN bottles_NNS ,_, or_CC vials_NNS ,_, where_WRB it_PRP competes_VBZ in_IN a_DT more_RBR fragmented_VBN market_NN with_IN companies_NNS including_VBG SGD_NNP ,_, Germany_NNP ’s_POS Gerresheimer_NNP and_CC Italy_NNP ’s_POS Stevanato_NNP Group_NNP ._. Corning_NNP this_DT week_NN won_VBD $_$ 204_CD million_CD in_IN U.S._NNP government_NN funding_NN to_TO boost_VB output_NN of_IN its_PRP$ vials_NNS for_IN COVID_NN -_HYPH 19_CD vaccines_NNS and_CC treatments_NNS ._. That_DT came_VBD a_DT day_NN after_IN the_DT U.S._NNP government_NN awarded_VBD $_$ 143_CD million_CD to_IN SiO2_NNP Materials_NNPS Science_NNP to_TO boost_VB production_NN of_IN its_PRP$ vials_NNS and_CC syringes_NNS ._. Schott_NNP ’s_POS Heinricht_NNP said_VBD the_DT industry_NN supplies_VBZ about_RB 50_CD billion_CD medical_JJ borosilicate_NN containers_NNS per_IN year_NN ,_, of_IN which_WDT 15_CD -_SYM 20_CD billion_CD are_VBP medical_JJ vials_NNS ,_, even_RB without_IN a_DT pandemic_NN ._. The_DT glass_NN type_NN is_VBZ favoured_VBN by_IN the_DT pharma_NN industry_NN because_IN it_PRP does_VBZ not_RB react_VB with_IN contents_NNS ._. Schott_NNP and_CC its_PRP$ peers_NNS will_MD manage_VB to_TO add_VB about_RB 1_CD billion_CD vials_NNS likely_RB needed_VBN for_IN a_DT global_JJ immunisation_NN effort_NN ,_, he_PRP said_VBD ._. That_DT would_MD require_VB a_DT vial_NN to_TO be_VB used_VBN for_IN multiple_JJ injections_NNS ._. Schott_NNP has_VBZ invested_VBN in_IN glass_NN and_CC vial_NN production_NN over_IN recent_JJ years_NNS because_IN China_NNP is_VBZ switching_VBG to_IN higher_JJR -_HYPH quality_NN borosilicate_NN containers_NNS ,_, standing_VBG the_DT company_NN in_IN good_JJ stead_NN for_IN the_DT pandemic_NN ,_, and_CC 200_CD million_CD euros_NNS were_VBD earmarked_VBN for_IN new_JJ production_NN lines_NNS this_DT year_NN ._. “_`` The_DT day_NN a_DT vaccine_NN nears_VBZ approval_NN we_PRP will_MD be_VB ready_JJ and_CC I_PRP am_VBP certain_JJ that_IN not_RB only_RB we_PRP but_CC also_RB our_PRP$ competitors_NNS will_MD deliver_VB ,_, ”_'' said_VBD Heinricht_NNP ._.","NNP / NNP ( NNP ) - NNS VBP VBG of a JJ NN of NNS to VB JJ NN - 19 NNS , but their NN to VB NNS VBZ VBG NNS JJR , some JJ JJ NN NNS VBP . NNP NNP , the NN ’s JJS NN of JJ NN for NN NNS , VBZ it VBZ VBN down NNS to VB NN from JJ JJ NNS because it VBZ RB VB to VB NNS before it VBZ JJ which NNS will VB . “ We VBP to VB the NN JJ to VB NN to those who RB VBP JJ in the NN . We VBP RB VB to VB VBN in the NN as the NNS who VBD JJ to VB the JJS NN , ” JJ NN NNP NNP VBD NNP . With NNS VBG from NNP - 19 every NN and NNS to VB the NN VBG the NN into NN , NNS and NN NNS VBG NNP , NNP and the NNP NNS NN VBP VBG to NN VB NNS RB before they VBP VBN to VB in NNS . They VBP to VB JJ a JJ NN can VB VBN out RB RB as JJ to NNS of NNS across the NN . But that VBZ VBG NNS about NNS . NNP NN NNP NNP ; the NN of the NNP for NNP NNP NNPS ( NNP ) , NNP NNP ; and the NN NN of JJ NNS ’ NN NN NNP , NNP NNP , VBP RB VBN there may RB VB JJ NN NNS JJ for a JJ NN NN . RB - VBN NNP , the JJS NN of NN NN for JJ NNS and NNS , VBZ JJ NN NNS can VB the NN , but VBZ it VBZ VBN to VB some RB JJ NN NNS to VB to VB that VBZ the NN . NNP VBD NNP VBD VBN down NNS from JJ NN NNS for JJ NN of 800 million to 1 billion NN NNS , which RB VBP 5 - 10 NNS , because the NN VBD it VBD RB JJ to VB such a NN . “ That VBZ the NN we VBP in , ” NNP VBD , VBG NNP ’s JJ NN may VB VBN to an NN NN that NNS , which NNS VBP for JJR than 10 euro NNS RB , may VB in JJ NN . NNP ’s NNP NNP , a NN of NNS and one of the NN ’s JJS NNS of VBN NN for the JJ NN , VBD it VBD a JJ NN NN and would VB NN to VB NN NNS . “ We VBP our NNS , with whom we VBP JJ NN NNS , RB to VB JJ NNS . If this VBD to VB the NN , we would VB the NN and the NN of NN above any NN NN , ” JJ NN NNP NNP VBD . He VBD to VB NNS over NNS , VBG NNP VBD an JJ NN NN for NNS of RB JJR than 3 NN of JJ JJ NNS . NNP , whose NN NNP NNP VBD JJ - NN NN NN in the NNS , RB VBD it VBD VBG out all the NNS for its NN in VBG a billion NN NN NNS which it VBZ will VB VBN for a JJ NN NN , RB JJ NN . NNP , with 2.2 billion NNS ( $ 2.5 billion ) in JJ NNS , VBZ in the NN for NN NN NNS with NNP NNP NNP , NNP and NNP NNP . It RB VBZ the VBN NNS , or NNS , where it VBZ in a RBR VBN NN with NNS VBG NNP , NNP ’s NNP and NNP ’s NNP NNP . NNP this NN VBD $ 204 million in NNP NN NN to VB NN of its NNS for NN - 19 NNS and NNS . That VBD a NN after the NNP NN VBD $ 143 million to NNP NNPS NNP to VB NN of its NNS and NNS . NNP ’s NNP VBD the NN VBZ RB 50 billion JJ NN NNS per NN , of which 15 - 20 billion VBP JJ NNS , RB without a NN . The NN NN VBZ VBN by the NN NN because it VBZ RB VB with NNS . NNP and its NNS will VB to VB RB 1 billion NNS RB VBN for a JJ NN NN , he VBD . That would VB a NN to VB VBN for JJ NNS . NNP VBZ VBN in NN and NN NN over JJ NNS because NNP VBZ VBG to JJR - NN NN NNS , VBG the NN in JJ NN for the NN , and 200 million NNS VBD VBN for JJ NN NNS this NN . “ The NN a NN VBZ NN we will VB JJ and I VBP JJ that RB RB we but RB our NNS will VB , ” VBD NNP ."
182,1233,mainstream,"After_IN winning_VBG a_DT small_JJ grant_NN for_IN early_JJ vaccine_NN work_NN in_IN March_NNP ,_, Novavax_NNP just_RB won_VBD the_DT largest_JJS -_HYPH ever_RB investment_NN from_IN CEPI_NNP ,_, a_DT global_JJ coalition_NN aiding_VBG COVID_NNP -_HYPH 19_CD vaccine_NN development_NN ._. The_DT grant_NN of_IN up_IN to_IN $_$ 384_CD million_CD from_IN the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS will_MD fund_VB Novavax_NNP ’s_POS COVID_NNP -_HYPH 19_CD vaccine_NN testing_NN through_IN phase_NN 2_CD ,_, plus_CC early_JJ work_NN to_TO scale_VB -_HYPH up_RP manufacturing_NN ._. The_DT funding_NN follows_VBZ a_DT $_$ 4_CD million_CD award_NN back_RB in_IN March_NNP ._. The_DT Maryland_NNP biotech_NN will_MD use_VB the_DT funds_NNS to_TO conduct_VB a_DT phase_NN 1/2_CD trial_NN on_IN its_PRP$ candidate_NN ,_, NVX_NNP -_HYPH COV2373_NNP ,_, starting_VBG with_IN the_DT phase_NN 1_CD portion_NN in_IN Australia_NNP this_DT month_NN ._. After_IN phase_NN 1_CD results_NNS —_: expected_VBN in_IN July_NNP —_: the_DT phase_NN 2_CD portion_NN is_VBZ slated_VBN for_IN multiple_JJ countries_NNS ,_, Novavax_NNP said_VBD ._. Beyond_IN testing_NN ,_, the_DT company_NN intends_VBZ to_TO use_VB part_NN of_IN the_DT funds_NNS to_TO scale_VB up_RP production_NN to_TO make_VB up_IN to_IN 100_CD million_CD doses_NNS by_IN the_DT end_NN of_IN 2020_CD ._. The_DT company_NN aims_VBZ to_TO make_VB more_JJR than_IN 1_CD billion_CD doses_NNS in_IN 2021_CD ._. Novavax_NNP 's_POS COVID_NN -_HYPH 19_CD candidate_NN is_VBZ a_DT recombinant_JJ nanoparticle_NN vaccine_NN combined_VBN with_IN the_DT company_NN 's_POS Matrix_NN -_HYPH M_NN adjuvant_NN ._. The_DT platform_NN recently_RB succeeded_VBD in_IN a_DT phase_NN 3_CD trial_NN for_IN NanoFlu_NNP ,_, a_DT quadrivalent_JJ influenza_NN shot_NN ,_, in_IN adults_NNS 65_CD and_CC older_JJR ._. Aside_RB from_IN Novavax_NNP ,_, CEPI_NNP has_VBZ awarded_VBN COVID_NNP -_HYPH 19_CD vaccine_NN R&D_NN funds_NNS to_IN Moderna_NNP ,_, Inovio_NNP and_CC Curevac_NNP ,_, plus_CC the_DT University_NNP of_IN Hong_NNP Kong_NNP ,_, the_DT University_NNP of_IN Oxford_NNP ,_, the_DT University_NNP of_IN Queensland_NNP and_CC a_DT group_NN led_VBN by_IN Institut_NNP Pasteur_NNP ._. “_`` Our_PRP$ vaccine_NN R&D_NN programs_NNS are_VBP starting_VBG to_TO show_VB progress_NN ,_, so_RB it_PRP is_VBZ vital_JJ that_IN we_PRP invest_VBP now_RB to_TO boost_VB manufacturing_NN capacity_NN ,_, so_IN that_IN our_PRP$ partners_NNS have_VBP the_DT ability_NN to_TO produce_VB vaccines_NNS at_IN a_DT global_JJ scale_NN ,_, ”_'' CEPI_NNP CEO_NN Richard_NNP Hatchett_NNP said_VBD in_IN a_DT statement_NN ._. “_`` We_PRP still_RB have_VBP a_DT long_JJ way_NN to_TO go_VB ,_, but_CC we_PRP ’re_VBP making_VBG important_JJ steps_NNS forward_RB to_TO deliver_VB a_DT safe_JJ ,_, effective_JJ ,_, and_CC globally_RB accessible_JJ vaccine_NN as_RB quickly_RB as_IN possible_JJ ._. ”_'' RELATED_JJ :_: Pfizer_NNP plans_VBZ to_TO farm_VB out_RP manufacturing_NN for_IN some_DT of_IN its_PRP$ drugs_NNS to_TO make_VB way_NN for_IN COVID_NN -_HYPH 19_CD vaccine_NN In_IN recent_JJ days_NNS ,_, some_DT of_IN the_DT leading_VBG companies_NNS involved_VBN in_IN the_DT COVID_NN -_HYPH 19_CD vaccine_NN race_NN have_VBP talked_VBN up_RP their_PRP$ progress_NN and_CC timelines_NNS ._. On_IN Monday_NNP ,_, Pfizer_NNP said_VBD it_PRP 's_VBZ planning_VBG to_TO work_VB with_IN contract_NN manufacturers_NNS to_TO establish_VB U.S._NNP -_, and_CC Europe_NNP -_HYPH based_VBN supply_NN chains_NNS to_TO make_VB some_DT of_IN its_PRP$ existing_VBG meds_NNS ,_, including_VBG sterile_JJ injectables_NNS ._. That_DT effort_NN is_VBZ necessary_JJ as_IN the_DT company_NN dedicates_VBZ considerable_JJ resources_NNS to_IN a_DT potential_JJ COVID_NN -_HYPH 19_CD vaccine_NN rollout_NN ._. Last_JJ week_NN ,_, Moderna_NNP said_VBD it_PRP aims_VBZ to_TO launch_VB a_DT phase_NN 3_CD study_NN for_IN its_PRP$ mRNA_NN vaccine_NN candidate_NN in_IN the_DT “_`` early_JJ summer_NN ._. ”_'' Under_IN that_DT timeline_NN ,_, the_DT company_NN could_MD score_VB a_DT full_JJ FDA_NN nod_NN next_JJ year_NN ._. Aside_RB from_IN those_DT companies_NNS ,_, Johnson_NNP &_CC Johnson_NNP is_VBZ involved_VBN in_IN the_DT COVID_NN -_HYPH 19_CD vaccine_NN R&D_NN effort_NN ,_, as_IN are_VBP partners_NNS Sanofi_NNP and_CC GlaxoSmithKline_NNP ._. AstraZeneca_NNP has_VBZ signed_VBN on_RP to_TO produce_VB vaccines_NNS for_IN the_DT University_NNP of_IN Oxford_NNP project_NN ._. In_IN all_DT ,_, the_DT World_NNP Health_NNP Organization_NNP is_VBZ tracking_VBG eight_CD programs_NNS in_IN human_JJ testing_NN and_CC more_JJR than_IN 100_CD programs_NNS in_IN preclinical_JJ testing_NN ._.","After VBG a JJ NN for JJ NN NN in NNP , NNP RB VBD the JJS - RB NN from NNP , a JJ NN VBG NNP - 19 NN NN . The NN of up to $ 384 million from the NNP for NNP NNP NNPS will VB NNP ’s NNP - 19 NN NN through NN 2 , plus JJ NN to VB - up NN . The NN VBZ a $ 4 million NN RB in NNP . The NNP NN will VB the NNS to VB a NN 1/2 NN on its NN , NNP - NNP , VBG with the NN 1 NN in NNP this NN . After NN 1 NNS — VBN in NNP — the NN 2 NN VBZ VBN for JJ NNS , NNP VBD . Beyond NN , the NN VBZ to VB NN of the NNS to VB up NN to VB up to 100 million NNS by the NN of 2020 . The NN VBZ to VB JJR than 1 billion NNS in 2021 . NNP 's NN - 19 NN VBZ a JJ NN NN VBN with the NN 's NN - NN NN . The NN RB VBD in a NN 3 NN for NNP , a JJ NN NN , in NNS 65 and JJR . RB from NNP , NNP VBZ VBN NNP - 19 NN NN NNS to NNP , NNP and NNP , plus the NNP of NNP NNP , the NNP of NNP , the NNP of NNP and a NN VBN by NNP NNP . “ Our NN NN NNS VBP VBG to VB NN , RB it VBZ JJ that we VBP RB to VB NN NN , so that our NNS VBP the NN to VB NNS at a JJ NN , ” NNP NN NNP NNP VBD in a NN . “ We RB VBP a JJ NN to VB , but we VBP VBG JJ NNS RB to VB a JJ , JJ , and RB JJ NN RB RB as JJ . ” JJ : NNP VBZ to VB out NN for some of its NNS to VB NN for NN - 19 NN In JJ NNS , some of the VBG NNS VBN in the NN - 19 NN NN VBP VBN up their NN and NNS . On NNP , NNP VBD it VBZ VBG to VB with NN NNS to VB NNP - and NNP - VBN NN NNS to VB some of its VBG NNS , VBG JJ NNS . That NN VBZ JJ as the NN VBZ JJ NNS to a JJ NN - 19 NN NN . JJ NN , NNP VBD it VBZ to VB a NN 3 NN for its NN NN NN in the “ JJ NN . ” Under that NN , the NN could VB a JJ NN NN JJ NN . RB from those NNS , NNP & NNP VBZ VBN in the NN - 19 NN NN NN , as VBP NNS NNP and NNP . NNP VBZ VBN on to VB NNS for the NNP of NNP NN . In all , the NNP NNP NNP VBZ VBG eight NNS in JJ NN and JJR than 100 NNS in JJ NN ."
183,560,mainstream,"It_PRP is_VBZ an_DT everyday_JJ miracle_NN ,_, mysterious_JJ and_CC beguiling_JJ ,_, and_CC it_PRP is_VBZ replicated_VBN several_JJ thousand_CD times_NNS over_RB ,_, at_IN all_DT hours_NNS ,_, in_IN churches_NNS that_WDT are_VBP beautiful_JJ and_CC churches_NNS that_WDT are_VBP not_RB ._. The_DT priest_NN consecrates_VBZ the_DT bread_NN ,_, and_CC then_RB he_PRP consecrates_VBZ the_DT wine_NN ,_, and_CC there_RB on_IN the_DT altar_NN the_DT meal_NN becomes_VBZ the_DT body_NN and_CC blood_NN of_IN Christ_NNP ._. Then_RB ,_, just_RB as_IN Jesus_NNP broke_VBD bread_NN and_CC shared_VBD wine_NN with_IN the_DT apostles_NNS at_IN the_DT Last_NNP Supper_NNP ,_, believers_NNS rise_VBP from_IN the_DT pews_NNS ,_, receive_VBP the_DT host_NN ,_, eat_VBP it_PRP ,_, and_CC ,_, one_CD by_IN one_CD ,_, drink_VBP the_DT Precious_NNP Blood_NNP ,_, putting_VBG their_PRP$ lips_NNS to_IN the_DT same_JJ cup_NN ._. That_DT last_JJ part_NN does_VBZ n’t_RB happen_VB these_DT days_NNS ._. Churches_NNS are_VBP closed_VBN and_CC services_NNS have_VBP been_VBN moved_VBN online_RB ,_, for_IN one_CD ,_, but_CC the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP has_VBZ also_RB advised_VBN against_IN it_PRP ._. Before_IN the_DT pandemic_NN ,_, William_NNP Ouweleen_NNP had_VBD drunk_JJ from_IN such_PDT a_DT cup_NN countless_JJ times_NNS ._. A_DT vintner_NN in_IN the_DT Finger_NNP Lakes_NNP region_NN of_IN New_NNP York_NNP ,_, he_PRP used_VBD to_TO attend_VB mass_NN and_CC receive_VB communion_NN at_IN St._NNP Matthew_NNP Church_NNP ,_, in_IN Livonia_NNP ,_, where_WRB the_DT Precious_NNP Blood_NNP in_IN the_DT chalice_NN had_VBD been_VBN a_DT blush_NN -_HYPH colored_VBN wine_NN that_WDT he_PRP ’d_VBD made_VBN ._. Ouweleen_NNP runs_VBZ a_DT winery_NN named_VBN O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP ,_, which_WDT makes_VBZ sacramental_JJ wine_NN that_WDT churches_NNS use_VBP to_TO celebrate_VB the_DT Eucharist_NNP ._. The_DT winery_NN ,_, which_WDT is_VBZ next_RB to_IN Hemlock_NNP Lake_NNP —_: “_`` o_IN -_HYPH neh_NNP -_HYPH da_NNP ”_'' is_VBZ the_DT Seneca_NNP word_NN for_IN “_`` hemlock_NN ”_'' —_: is_VBZ the_DT go_NN -_HYPH to_IN for_IN Catholics_NNPS in_IN the_DT Northeast_NNP ._. When_WRB Pope_NNP Francis_NNP visited_VBD New_NNP York_NNP City_NNP ,_, in_IN 2015_CD ,_, he_PRP used_VBD O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP wine_NN for_IN a_DT mass_NN at_IN Madison_NNP Square_NNP Garden_NNP ._. In_IN contrast_NN to_IN regular_JJ wine_NN ,_, which_WDT might_MD be_VB made_VBN with_IN extra_JJ yeast_NN ,_, tannin_NN powders_NNS ,_, and_CC flavorings_NNS ,_, Communion_NN wine_NN must_MD be_VB “_`` natural_JJ ,_, from_IN the_DT fruit_NN of_IN the_DT grape_NN ,_, pure_JJ and_CC incorrupt_JJ ,_, not_RB mixed_VBN with_IN other_JJ substances_NNS ,_, ”_'' according_VBG to_IN Vatican_NNP instructions_NNS ._. So_RB ,_, last_JJ fall_NN ,_, Ouweleen_NNP ,_, a_DT self_NN -_HYPH described_VBN “_`` hippie_NN ”_'' who_WP is_VBZ fifty_CD -_HYPH eight_CD and_CC wears_VBZ his_PRP$ hair_NN in_IN dreadlocks_NNS ,_, did_VBD what_WP he_PRP does_VBZ every_DT fall_NN :_: he_PRP harvested_VBD forty_CD acres_NNS ’_POS worth_NN of_IN grapes_NNS ,_, trucked_VBD them_PRP to_IN his_PRP$ winery_NN ,_, crushed_VBD them_PRP ,_, and_CC allowed_VBD them_PRP to_TO ferment_VB with_IN no_DT additives_NNS ._. (_-LRB- Except_IN ,_, that_DT is_VBZ ,_, for_IN some_DT added_VBN sulfites_NNS ,_, just_RB before_IN bottling_VBG —_: a_DT preservative_NN sanctioned_VBN by_IN the_DT Vatican_NNP ._. )_-RRB- By_IN springtime_NN ,_, he_PRP had_VBD fifty_CD thousand_CD gallons_NNS of_IN wine_NN in_IN his_PRP$ cellar_NN ._. This_DT time_NN of_IN year_NN ,_, he_PRP would_MD usually_RB be_VB filling_VBG fifteen_CD hundred_CD wine_NN bottles_NNS per_IN day_NN ,_, in_IN order_NN to_TO deliver_VB them_PRP to_IN churches_NNS in_IN New_NNP York_NNP and_CC Pennsylvania_NNP ,_, and_CC to_IN religious_JJ -_HYPH goods_NNS stores_NNS as_RB far_RB away_RB as_IN Florida_NNP and_CC Guam_NNP ._. But_CC he_PRP is_VBZ n’t_RB doing_VBG that_DT this_DT year_NN ,_, because_IN it_PRP would_MD mean_VB purchasing_VBG glass_NN bottles_NNS to_TO fill_VB with_IN wine_NN that_WDT might_MD not_RB sell_VB ._. Ouweleen_NNP does_VBZ n’t_RB know_VB when_WRB the_DT churches_NNS will_MD reopen_VB ._. This_DT past_JJ Friday_NNP ,_, President_NNP Trump_NNP deemed_VBD houses_NNS of_IN worship_NN “_`` essential_JJ ”_'' and_CC asked_VBD all_DT governors_NNS to_TO allow_VB them_PRP “_`` to_TO open_VB right_RB now_RB ,_, for_IN this_DT weekend_NN ,_, ”_'' but_CC ,_, in_IN New_NNP York_NNP ,_, houses_NNS of_IN worship_NN can_MD only_RB fully_RB reopen_VB in_IN the_DT last_JJ phase_NN of_IN the_DT state_NN ’s_POS four_CD -_HYPH part_NN reopening_NN plan_NN ,_, along_IN with_IN stadiums_NNS and_CC amusement_NN parks_NNS ._. Ouweleen_NNP is_VBZ also_RB not_RB sure_JJ that_IN ,_, when_WRB they_PRP do_VBP reopen_VB ,_, they_PRP will_MD continue_VB to_TO serve_VB consecrated_VBN wine_NN ,_, which_WDT ,_, in_IN most_JJS of_IN the_DT country_NN ’s_POS Catholic_JJ churches_NNS ,_, is_VBZ drunk_JJ from_IN a_DT chalice_NN that_WDT is_VBZ shared_VBN by_IN the_DT entire_JJ congregation_NN ._. So_RB he_PRP decided_VBD to_TO ask_VB them_PRP ._. Last_JJ month_NN ,_, Ouweleen_NNP typed_VBD up_RP a_DT letter_NN to_IN the_DT bishop_NN in_IN Albany_NNP ,_, to_TO ask_VB if_IN he_PRP had_VBD any_DT foresight_NN on_IN the_DT future_NN of_IN sacramental_JJ wine_NN ._. A_DT week_NN later_RBR ,_, still_RB awaiting_VBG a_DT reply_NN ,_, Ouweleen_NNP broadened_VBD his_PRP$ query_NN ,_, writing_VBG to_IN more_JJR than_IN a_DT thousand_CD parishes_NNS —_: all_DT customers_NNS of_IN his_PRP$ —_: to_TO ask_VB if_IN they_PRP plan_VBP to_TO distribute_VB the_DT Eucharist_NNP by_IN chalice_NN ,_, once_IN church_NN services_NNS resume_VBP ._. In_IN his_PRP$ letter_NN to_IN the_DT priests_NNS ,_, Ouweleen_NNP explained_VBD that_IN O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP had_VBD survived_VBN —_: by_IN God_NNP ’s_POS grace_NN —_: several_JJ wars_NNS ,_, the_DT Great_NNP Depression_NNP ,_, and_CC Prohibition_NNP ,_, but_CC ,_, “_`` the_DT Good_NNP Lord_NNP helps_VBZ those_DT who_WP help_VBP themselves_PRP ,_, so_RB we_PRP are_VBP taking_VBG an_DT active_JJ role_NN in_IN planning_VBG for_IN the_DT other_JJ side_NN of_IN this_DT pandemic_NN ._. ”_'' Ouweleen_NNP figured_VBD that_IN the_DT wine_NN in_IN his_PRP$ cellar_NN would_MD last_VB for_IN about_RB a_DT year_NN before_IN its_PRP$ taste_NN started_VBD to_TO fade_VB ._. “_`` I_PRP ’ll_MD know_VB what_WP to_TO do_VB with_IN that_DT wine_NN when_WRB I_PRP know_VBP what_WP to_TO do_VB ,_, ”_'' he_PRP said_VBD ._. “_`` This_DT graceful_JJ hand_NN of_IN the_DT unseen_NN has_VBZ been_VBN very_RB present_JJ in_IN my_PRP$ life_NN ,_, and_CC I_PRP respect_VBP that_DT ._. ”_'' In_IN the_DT meantime_NN ,_, he_PRP continued_VBD checking_VBG in_RP on_IN his_PRP$ vineyard_NN ._. By_IN September_NNP ,_, his_PRP$ vines_NNS will_MD have_VB produced_VBN two_CD hundred_CD tons_NNS of_IN grapes_NNS ,_, which_WDT will_MD yield_VB another_DT forty_CD thousand_CD gallons_NNS of_IN wine_NN ._. It_PRP was_VBD getting_VBG warm_JJ ,_, and_CC the_DT vines_NNS were_VBD about_RB to_TO bud_VB ._. There_EX are_VBP three_CD major_JJ sacramental_JJ wineries_NNS in_IN the_DT United_NNP States_NNPS :_: Mont_NNP La_NNP Salle_NNP and_CC Cribari_NNP ,_, both_CC in_IN California_NNP ,_, and_CC O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP ,_, in_IN New_NNP York_NNP ,_, which_WDT is_VBZ the_DT smallest_JJS and_CC the_DT oldest_JJS ._. Established_VBN in_IN 1872_CD by_IN Bishop_NNP Bernard_NNP McQuaid_NNP ,_, the_DT first_JJ bishop_NN of_IN Rochester_NNP ,_, O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP was_VBD originally_RB run_VBN by_IN seminarians_NNS ,_, and_CC ,_, later_RBR ,_, by_IN monks_NNS ._. In_IN 2002_CD ,_, it_PRP was_VBD purchased_VBN by_IN Steven_NNP Goldstone_NNP ,_, who_WP ’d_VBD recently_RB retired_VBN as_IN the_DT C.E.O._NNP of_IN RJR_NNP Nabisco_NNP ,_, the_DT food_NN and_CC tobacco_NN conglomerate_NN ,_, and_CC who_WP ’d_VBD seen_VBN a_DT notice_NN in_IN the_DT Wall_NNP Street_NNP Journal_NNP advertising_VBG a_DT winery_NN for_IN sale_NN in_IN the_DT Finger_NNP Lakes_NNPS ._. (_-LRB- Goldstone_NNP ,_, a_DT private_JJ pilot_NN ,_, liked_VBD to_TO fly_VB over_IN the_DT region_NN in_IN his_PRP$ plane_NN ._. )_-RRB- In_IN 2007_CD ,_, there_EX was_VBD another_DT ad_NN —_: this_DT time_NN ,_, in_IN the_DT PennySaver_NNP ,_, for_IN a_DT rental_JJ house_NN on_IN the_DT O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP Winery_NNP ’s_POS property_NN ,_, which_WDT would_MD cost_VB eight_CD hundred_CD and_CC fifty_CD dollars_NNS a_DT month_NN ._. Ouweleen_NNP responded_VBD to_IN it_PRP ;_, he_PRP and_CC his_PRP$ wife_NN ,_, Lisa_NNP Woodhams_NNP ,_, and_CC his_PRP$ stepson_NN ,_, Jacob_NNP ,_, were_VBD facing_VBG eviction_NN from_IN their_PRP$ home_NN in_IN Conesus_NNP ._. The_DT family_NN was_VBD continuously_RB hard_JJ up_RP —_: Ouweleen_NNP was_VBD the_DT manager_NN of_IN an_DT organic_JJ market_NN that_WDT was_VBD trying_VBG (_-LRB- and_CC failing_VBG )_-RRB- to_TO compete_VB with_IN Wegmans_NNPS —_: and_CC they_PRP were_VBD searching_VBG for_IN a_DT gentler_JJR ,_, more_RBR Christ_NN -_HYPH like_IN life_NN ._. (_-LRB- They_PRP wrote_VBD a_DT prayer_NN :_: “_`` Land_NN with_IN a_DT view_NN /_, a_DT ridge_NN line_NN or_CC two_CD …_: a_DT place_NN to_TO grow_VB /_, with_IN maintenance_NN kept_VBN low_JJ /_, sanctuary_NN where_WRB /_, we_PRP reap_VBP what_WP we_PRP sow_VBP ._. ”_'' “_`` Divinity_NNP ,_, ”_'' it_PRP concluded_VBD ,_, “_`` make_VB it_PRP so_RB ._. ”_'' )_-RRB- The_DT rental_NN ,_, an_DT old_JJ winemaker_NN ’s_POS house_NN built_VBN in_IN the_DT twenties_NNS ,_, with_IN three_CD bedrooms_NNS ,_, and_CC a_DT lot_NN of_IN bats_NNS in_IN the_DT attic_NN ,_, felt_VBD fated_JJ ._. The_DT family_NN moved_VBD in_RB and_CC learned_VBD ,_, upon_IN their_PRP$ arrival_NN ,_, that_IN the_DT winery_NN on_IN the_DT grounds_NNS was_VBD n’t_RB doing_VBG too_RB well_RB ._. (_-LRB- They_PRP had_VBD regular_JJ encounters_NNS with_IN the_DT winemaker_NN ,_, who_WP kept_VBD knocking_VBG on_IN their_PRP$ door_NN ,_, asking_VBG if_IN they_PRP had_VBD any_DT spare_NN trash_NN bags_NNS or_CC light_NN bulbs_NNS ._. )_-RRB- Ouweleen_NNP was_VBD also_RB looking_VBG for_IN a_DT new_JJ job_NN ,_, so_RB he_PRP called_VBD Goldstone_NNP and_CC told_VBD him_PRP ,_, “_`` I_PRP think_VBP I_PRP ’m_VBP supposed_VBN to_TO be_VB here_RB to_TO help_VB you_PRP with_IN this_DT winery_NN ._. ”_'' Goldstone_NNP flew_VBD north_RB to_TO meet_VB with_IN Ouweleen_NNP ,_, who_WP had_VBD prepared_VBN a_DT PowerPoint_NNP presentation_NN on_IN what_WP he_PRP described_VBD as_IN the_DT brand_NN ’s_POS “_`` natural_JJ assets_NNS ,_, ”_'' such_JJ as_IN its_PRP$ long_JJ ,_, almost_RB romantic_JJ history_NN of_IN sequestered_VBN religious_JJ men_NNS ministering_VBG to_IN its_PRP$ grapes_NNS ._. Ouweleen_NNP had_VBD no_DT experience_NN in_IN wine_NN -_HYPH making_VBG ,_, but_CC ,_, Goldstone_NNP said_VBD later_RBR ,_, “_`` It_PRP ’s_VBZ not_RB like_IN I_PRP had_VBD a_DT long_JJ line_NN of_IN prestigious_JJ winemakers_NNS waiting_VBG to_TO be_VB interviewed_VBN for_IN the_DT job_NN ._. ”_'' Goldstone_NNP decided_VBD ,_, of_IN Ouweleen_NNP and_CC his_PRP$ family_NN ,_, that_IN “_`` they_PRP belong_VBP there_RB ._. ”_'' The_DT two_CD men_NNS worked_VBD out_RP an_DT arrangement_NN in_IN which_WDT Ouweleen_NNP would_MD run_VB O_NNP -_HYPH Neh_NNP -_HYPH Dah_NNP ._. A_DT year_NN later_RBR ,_, Woodhams_NNP joined_VBD him_PRP ._. (_-LRB- She_PRP ’d_VBD been_VBN bartending_VBG and_CC waiting_VBG tables_NNS until_IN she_PRP was_VBD sure_JJ that_IN this_DT sacramental_JJ winery_NN gig_NN was_VBD going_VBG to_TO work_VB out_RP ._. )_-RRB- Together_RB with_IN one_CD other_JJ full_JJ -_HYPH time_NN employee_NN and_CC several_JJ part_NN -_HYPH time_NN staff_NN ,_, Ouweleen_NNP and_CC Woodhams_NNP do_VBP the_DT work_NN of_IN a_DT hundred_CD unpaid_JJ monks_NNS ._. Ouweleen_NNP plays_VBZ Reggae_NNP for_IN the_DT fermenting_VBG grapes_NNS —_: “_`` conscious_JJ music_NN ,_, ”_'' he_PRP said_VBD ,_, “_`` to_TO encourage_VB them_PRP ”_'' —_: and_CC tastes_NNS and_CC adjusts_VBZ the_DT wine_NN ._. He_PRP also_RB fixes_VBZ the_DT bottle_NN -_HYPH capper_NN ,_, and_CC the_DT crusher_NN ,_, and_CC the_DT labeller_NN ,_, and_CC the_DT filler_NN ,_, and_CC the_DT air_NN -_HYPH compressor_NN ,_, and_CC the_DT tractor_NN ,_, when_WRB they_PRP break_VBP ._. Woodhams_NNP pays_VBZ the_DT bills_NNS ,_, answers_VBZ the_DT phones_NNS ,_, puts_VBZ together_RP wholesale_JJ orders_NNS ,_, and_CC coördinates_VBZ the_DT family_NN ’s_POS appearances_NNS at_IN wine_NN tastings_NNS ._. Friends_NNS help_VBP them_PRP bottle_VB the_DT wine_NN ._. “_`` It_PRP ’s_VBZ like_UH if_IN a_DT Catholic_JJ school_NN lost_VBD all_PDT their_PRP$ nuns_NNS ,_, ”_'' Ouweleen_NNP said_VBD ._. “_`` It_PRP ’s_VBZ noble_JJ but_CC unprofitable_JJ work_NN ._. ”_'' This_DT is_VBZ true_JJ even_RB when_WRB there_EX ’s_VBZ no_DT pandemic_NN ._. (_-LRB- O_NNP -_HYPH Neh_NNP -_HYPH Da_NNP charges_VBZ about_RB eighty_CD dollars_NNS for_IN a_DT case_NN of_IN twelve_CD bottles_NNS of_IN sacramental_JJ wine_NN ,_, and_CC the_DT average_JJ church_NN customer_NN orders_VBZ twenty_CD cases_NNS of_IN wine_NN a_DT year_NN ._. )_-RRB- But_CC it_PRP has_VBZ been_VBN a_DT reliable_JJ source_NN of_IN income_NN ,_, which_WDT ,_, for_IN Ouweleen_NNP ,_, feels_VBZ nothing_NN short_JJ of_IN miraculous_JJ ._. In_IN the_DT spring_NN ,_, when_WRB the_DT grapevines_NNS begin_VBP to_TO sprout_VB ,_, the_DT robins_NNS are_VBP loudest_JJS in_IN the_DT mornings_NNS and_CC the_DT woodpeckers_NNS are_VBP busiest_JJS in_IN the_DT evenings_NNS ._. In_IN the_DT fall_NN ,_, when_WRB the_DT grapes_NNS are_VBP harvested_VBN —_: first_RB the_DT Rosette_NNP ,_, then_RB the_DT Delaware_NNP —_: the_DT lake_NN reflects_VBZ the_DT orange_NN of_IN the_DT trees_NNS ._. Every_DT year_NN is_VBZ different_JJ but_CC also_RB the_DT same_JJ ._. The_DT family_NN has_VBZ been_VBN able_JJ to_TO count_VB on_IN it_PRP ._.","It VBZ an JJ NN , JJ and JJ , and it VBZ VBN JJ thousand NNS RB , at all NNS , in NNS that VBP JJ and NNS that VBP RB . The NN VBZ the NN , and RB he VBZ the NN , and RB on the NN the NN VBZ the NN and NN of NNP . RB , RB as NNP VBD NN and VBD NN with the NNS at the NNP NNP , NNS VBP from the NNS , VBP the NN , VBP it , and , one by one , VBP the NNP NNP , VBG their NNS to the JJ NN . That JJ NN VBZ RB VB these NNS . NNS VBP VBN and NNS VBP VBN VBN RB , for one , but the NNPS for NNP NNP and NNP VBZ RB VBN against it . Before the NN , NNP NNP VBD JJ from such a NN JJ NNS . A NN in the NNP NNP NN of NNP NNP , he VBD to VB NN and VB NN at NNP NNP NNP , in NNP , where the NNP NNP in the NN VBD VBN a NN - VBN NN that he VBD VBN . NNP VBZ a NN VBN NNP - NNP - NNP , which VBZ JJ NN that NNS VBP to VB the NNP . The NN , which VBZ RB to NNP NNP — “ o - NNP - NNP ” VBZ the NNP NN for “ NN ” — VBZ the NN - to for NNPS in the NNP . When NNP NNP VBD NNP NNP NNP , in 2015 , he VBD NNP - NNP - NNP NN for a NN at NNP NNP NNP . In NN to JJ NN , which might VB VBN with JJ NN , NN NNS , and NNS , NN NN must VB “ JJ , from the NN of the NN , JJ and JJ , RB VBN with JJ NNS , ” VBG to NNP NNS . RB , JJ NN , NNP , a NN - VBN “ NN ” who VBZ fifty - eight and VBZ his NN in NNS , VBD what he VBZ every NN : he VBD forty NNS ’ NN of NNS , VBD them to his NN , VBD them , and VBD them to VB with no NNS . ( Except , that VBZ , for some VBN NNS , RB before VBG — a NN VBN by the NNP . ) By NN , he VBD fifty thousand NNS of NN in his NN . This NN of NN , he would RB VB VBG fifteen hundred NN NNS per NN , in NN to VB them to NNS in NNP NNP and NNP , and to JJ - NNS NNS RB RB RB as NNP and NNP . But he VBZ RB VBG that this NN , because it would VB VBG NN NNS to VB with NN that might RB VB . NNP VBZ RB VB when the NNS will VB . This JJ NNP , NNP NNP VBD NNS of NN “ JJ ” and VBD all NNS to VB them “ to VB RB RB , for this NN , ” but , in NNP NNP , NNS of NN can RB RB VB in the JJ NN of the NN ’s four - NN NN NN , along with NNS and NN NNS . NNP VBZ RB RB JJ that , when they VBP VB , they will VB to VB VBN NN , which , in JJS of the NN ’s JJ NNS , VBZ JJ from a NN that VBZ VBN by the JJ NN . RB he VBD to VB them . JJ NN , NNP VBD up a NN to the NN in NNP , to VB if he VBD any NN on the NN of JJ NN . A NN RBR , RB VBG a NN , NNP VBD his NN , VBG to JJR than a thousand NNS — all NNS of his — to VB if they VBP to VB the NNP by NN , once NN NNS VBP . In his NN to the NNS , NNP VBD that NNP - NNP - NNP VBD VBN — by NNP ’s NN — JJ NNS , the NNP NNP , and NNP , but , “ the NNP NNP VBZ those who VBP themselves , RB we VBP VBG an JJ NN in VBG for the JJ NN of this NN . ” NNP VBD that the NN in his NN would VB for RB a NN before its NN VBD to VB . “ I ’ll VB what to VB with that NN when I VBP what to VB , ” he VBD . “ This JJ NN of the NN VBZ VBN RB JJ in my NN , and I VBP that . ” In the NN , he VBD VBG in on his NN . By NNP , his NNS will VB VBN two hundred NNS of NNS , which will VB another forty thousand NNS of NN . It VBD VBG JJ , and the NNS VBD RB to VB . There VBP three JJ JJ NNS in the NNP NNPS : NNP NNP NNP and NNP , both in NNP , and NNP - NNP - NNP , in NNP NNP , which VBZ the JJS and the JJS . VBN in 1872 by NNP NNP NNP , the JJ NN of NNP , NNP - NNP - NNP VBD RB VBN by NNS , and , RBR , by NNS . In 2002 , it VBD VBN by NNP NNP , who VBD RB VBN as the NNP of NNP NNP , the NN and NN NN , and who VBD VBN a NN in the NNP NNP NNP VBG a NN for NN in the NNP NNPS . ( NNP , a JJ NN , VBD to VB over the NN in his NN . ) In 2007 , there VBD another NN — this NN , in the NNP , for a JJ NN on the NNP - NNP - NNP NNP ’s NN , which would VB eight hundred and fifty NNS a NN . NNP VBD to it ; he and his NN , NNP NNP , and his NN , NNP , VBD VBG NN from their NN in NNP . The NN VBD RB JJ up — NNP VBD the NN of an JJ NN that VBD VBG ( and VBG ) to VB with NNPS — and they VBD VBG for a JJR , RBR NN - like NN . ( They VBD a NN : “ NN with a NN / a NN NN or two … a NN to VB / with NN VBN JJ / NN where / we VBP what we VBP . ” “ NNP , ” it VBD , “ VB it RB . ” ) The NN , an JJ NN ’s NN VBN in the NNS , with three NNS , and a NN of NNS in the NN , VBD JJ . The NN VBD RB and VBD , upon their NN , that the NN on the NNS VBD RB VBG RB RB . ( They VBD JJ NNS with the NN , who VBD VBG on their NN , VBG if they VBD any NN NN NNS or NN NNS . ) NNP VBD RB VBG for a JJ NN , RB he VBD NNP and VBD him , “ I VBP I VBP VBN to VB RB to VB you with this NN . ” NNP VBD RB to VB with NNP , who VBD VBN a NNP NN on what he VBD as the NN ’s “ JJ NNS , ” JJ as its JJ , RB JJ NN of VBN JJ NNS VBG to its NNS . NNP VBD no NN in NN - VBG , but , NNP VBD RBR , “ It VBZ RB like I VBD a JJ NN of JJ NNS VBG to VB VBN for the NN . ” NNP VBD , of NNP and his NN , that “ they VBP RB . ” The two NNS VBD out an NN in which NNP would VB NNP - NNP - NNP . A NN RBR , NNP VBD him . ( She VBD VBN VBG and VBG NNS until she VBD JJ that this JJ NN NN VBD VBG to VB out . ) RB with one JJ JJ - NN NN and JJ NN - NN NN , NNP and NNP VBP the NN of a hundred JJ NNS . NNP VBZ NNP for the VBG NNS — “ JJ NN , ” he VBD , “ to VB them ” — and NNS and VBZ the NN . He RB VBZ the NN - NN , and the NN , and the NN , and the NN , and the NN - NN , and the NN , when they VBP . NNP VBZ the NNS , VBZ the NNS , VBZ together JJ NNS , and VBZ the NN ’s NNS at NN NNS . NNS VBP them VB the NN . “ It VBZ like if a JJ NN VBD all their NNS , ” NNP VBD . “ It VBZ JJ but JJ NN . ” This VBZ JJ RB when there VBZ no NN . ( NNP - NNP - NNP VBZ RB eighty NNS for a NN of twelve NNS of JJ NN , and the JJ NN NN VBZ twenty NNS of NN a NN . ) But it VBZ VBN a JJ NN of NN , which , for NNP , VBZ NN JJ of JJ . In the NN , when the NNS VBP to VB , the NNS VBP JJS in the NNS and the NNS VBP JJS in the NNS . In the NN , when the NNS VBP VBN — RB the NNP , RB the NNP — the NN VBZ the NN of the NNS . Every NN VBZ JJ but RB the JJ . The NN VBZ VBN JJ to VB on it ."
184,74,mainstream,"This_DT week_NN ,_, the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP announced_VBD it_PRP will_MD donate_VB A$_$ 10_CD million_CD to_TO help_VB fund_VB an_DT Australian_JJ trial_NN testing_NN whether_IN a_DT very_RB old_JJ vaccine_NN ,_, BCG_NNP ,_, can_MD be_VB used_VBN against_IN a_DT new_JJ threat_NN ,_, COVID_NNP -_HYPH 19_CD ._. So_RB what_WP is_VBZ the_DT BCG_NN vaccine_NN and_CC what_WP might_MD its_PRP$ place_NN be_VB in_IN the_DT fight_NN against_IN coronavirus_NN ?_. The_DT BCG_NNP vaccine_NN has_VBZ been_VBN used_VBN for_IN nearly_RB a_DT century_NN to_TO protect_VB against_IN tuberculosis_NN ,_, a_DT bacterial_JJ disease_NN that_WDT affects_VBZ the_DT lungs_NNS ._. Tuberculosis_NN is_VBZ caused_VBN by_IN a_DT bacterium_NN called_VBN Mycobacterium_NN tuberculosis_NN ._. BCG_NNP is_VBZ short_JJ for_IN Bacillus_NNP Calmette_NNP -_HYPH Guérin_NNP ,_, as_IN it_PRP was_VBD created_VBN by_IN Léon_NNP Charles_NNP Albert_NNP Calmette_NNP and_CC Jean_NNP -_HYPH Marie_NNP Camille_NNP Guérin_NNP in_IN the_DT early_JJ 1900s_NNS ._. To_TO make_VB the_DT vaccine_NN ,_, they_PRP used_VBD Mycobacterium_NN bovis_NN ,_, a_DT bacterium_NN found_VBN in_IN cows_NNS and_CC closely_RB related_JJ to_IN Mycobacterium_NN tuberculosis_NN ._. They_PRP grew_VBD it_PRP on_IN a_DT nutrient_NN -_HYPH rich_JJ jelly_NN in_IN the_DT lab_NN for_IN nearly_RB 13_CD years_NNS ._. The_DT bacterium_NN adapted_VBD to_IN this_DT comfortable_JJ lifestyle_NN by_IN losing_VBG elements_NNS in_IN its_PRP$ DNA_NN it_PRP no_RB longer_RBR needed_VBN ,_, including_VBG elements_NNS that_WDT cause_VBP disease_NN ._. This_DT process_NN is_VBZ called_VBN attenuation_NN and_CC it_PRP results_VBZ in_IN a_DT live_JJ but_CC weakened_VBN microbe_NN that_WDT can_MD be_VB given_VBN to_IN humans_NNS as_IN a_DT vaccine_NN ._. Read_VB more_JJR :_: Coronavirus_NN :_: could_MD the_DT pandemic_NN be_VB controlled_VBN using_VBG existing_VBG vaccines_NNS like_IN MMR_NNP or_CC BCG_NNP ?_. BCG_NNP is_VBZ offered_VBN to_IN infants_NNS in_IN some_DT parts_NNS of_IN the_DT world_NN where_WRB there_EX are_VBP still_RB high_JJ rates_NNS of_IN tuberculosis_NN ._. It_PRP protects_VBZ 86_CD %_NN of_IN the_DT time_NN against_IN some_DT rarer_JJR forms_NNS of_IN tuberculosis_NN more_RBR common_JJ in_IN children_NNS ._. But_CC it_PRP only_RB protects_VBZ about_RB 50_CD %_NN of_IN the_DT time_NN in_IN adults_NNS ._. Scientists_NNS and_CC clinicians_NNS generally_RB feel_VBP we_PRP need_VBP a_DT better_JJR vaccine_NN for_IN tuberculosis_NN ._. However_RB ,_, epidemiologists_NNS have_VBP noticed_VBN children_NNS who_WP received_VBD BCG_NNP had_VBD significantly_RB better_JJR overall_JJ health_NN ,_, with_IN fewer_JJR respiratory_JJ infections_NNS and_CC fewer_JJR deaths_NNS ._. Immunologists_NNS suspect_VBP this_DT is_VBZ caused_VBN by_IN a_DT type_NN of_IN immune_JJ response_NN called_VBN “_`` trained_VBN immunity_NN ”_'' ._. Trained_VBN immunity_NN is_VBZ distinct_JJ from_IN how_WRB we_PRP traditionally_RB think_VBP of_IN immunity_NN ,_, or_CC “_`` immune_JJ memory_NN ”_'' ,_, because_IN it_PRP engages_VBZ different_JJ types_NNS of_IN immune_NN cells_NNS ._. There_EX are_VBP two_CD main_JJ types_NNS of_IN cells_NNS within_IN our_PRP$ immune_JJ system_NN :_: innate_JJ cells_NNS ,_, which_WDT respond_VBP rapidly_RB to_IN microbes_NNS that_WDT cause_VBP disease_NN ,_, and_CC adaptive_JJ cells_NNS ,_, which_WDT initially_RB respond_VBP quite_RB slowly_RB ._. Adaptive_JJ cells_NNS include_VBP B_NN cells_NNS ,_, which_WDT make_VBP antibodies_NNS to_TO block_VB infection_NN ,_, and_CC T_NN cells_NNS ,_, which_WDT can_MD kill_VB infected_VBN cells_NNS ._. Importantly_RB ,_, adaptive_JJ cells_NNS can_MD remember_VB particular_JJ microbes_NNS for_IN years_NNS ,_, or_CC even_RB decades_NNS ,_, after_IN we_PRP first_RB encounter_VBP them_PRP ._. When_WRB adaptive_JJ immune_NN cells_NNS encounter_VBP the_DT same_JJ microbe_NN a_DT second_JJ or_CC subsequent_JJ time_NN ,_, they_PRP respond_VBP much_RB more_RBR quickly_RB ,_, and_CC the_DT immune_NN system_NN can_MD effectively_RB clear_VB an_DT infection_NN before_IN it_PRP causes_VBZ disease_NN ._. Immune_JJ memory_NN is_VBZ why_WRB often_RB we_PRP do_VBP n’t_RB get_VB infected_VBN with_IN a_DT specific_JJ microbe_NN ,_, like_IN chickenpox_NN ,_, more_JJR than_IN once_RB ._. Most_JJS of_IN our_PRP$ current_JJ vaccines_NNS exploit_VBP immune_JJ memory_NN to_TO protect_VB us_PRP from_IN infection_NN ._. Read_VB more_JJR :_: Where_WRB are_VBP we_PRP at_IN with_IN developing_VBG a_DT vaccine_NN for_IN coronavirus_NN ?_. For_IN decades_NNS ,_, scientists_NNS believed_VBD innate_JJ cells_NNS lacked_VBD the_DT ability_NN to_TO remember_VB previous_JJ encounters_NNS with_IN microbes_NNS ._. However_RB ,_, we_PRP ’ve_VBP recently_RB learnt_VBN some_DT innate_JJ cells_NNS ,_, such_JJ as_IN monocytes_NNS ,_, can_MD be_VB “_`` trained_VBN ”_'' during_IN an_DT encounter_NN with_IN a_DT microbe_NN ._. Training_NN can_MD program_VB innate_JJ cells_NNS to_TO activate_VB more_RBR quickly_RB when_WRB they_PRP next_RB encounter_VBP a_DT microbe_NN –_: any_DT microbe_NN ._. Some_DT live_JJ attenuated_VBN vaccines_NNS ,_, such_JJ as_IN BCG_NNP ,_, can_MD trigger_VB trained_VBN immunity_NN ,_, which_WDT can_MD enhance_VB early_JJ control_NN of_IN other_JJ infections_NNS ._. This_DT raises_VBZ the_DT tantalising_JJ possibility_NN that_IN BCG_NNP could_MD train_VB innate_JJ cells_NNS to_TO improve_VB early_JJ control_NN of_IN the_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN ,_, to_TO reduce_VB COVID_NN -_HYPH 19_CD disease_NN or_CC even_RB prevent_VB infection_NN ._. And_CC as_IN a_DT bonus_NN ,_, BCG_NNP could_MD potentially_RB protect_VB us_PRP against_IN other_JJ pathogens_NNS too_RB ._. We_PRP do_VBP n’t_RB know_VB yet_RB whether_IN BCG_NNP will_MD reduce_VB the_DT severity_NN of_IN COVID_NN -_HYPH 19_CD ,_, but_CC the_DT vaccine_NN has_VBZ some_DT interesting_JJ features_NNS ._. First_RB ,_, BCG_NNP is_VBZ a_DT potent_JJ stimulator_NN of_IN the_DT immune_NN system_NN ._. Currently_RB ,_, it_PRP ’s_VBZ used_VBN alongside_IN other_JJ therapies_NNS to_TO treat_VB bladder_NN cancer_NN and_CC melanoma_NN ,_, because_IN it_PRP can_MD stimulate_VB immune_JJ cells_NNS to_TO attack_VB the_DT tumour_NN ._. BCG_NNP also_RB seems_VBZ to_TO benefit_VB lung_NN immunity_NN ._. As_IN we_PRP mentioned_VBD ,_, children_NNS who_WP have_VBP had_VBN the_DT vaccine_NN appear_VB to_TO get_VB fewer_JJR respiratory_JJ infections_NNS ._. There_EX ’s_VBZ a_DT study_NN underway_JJ in_IN Melbourne_NNP looking_VBG at_IN whether_IN BCG_NNP can_MD reduce_VB symptoms_NNS of_IN asthma_NN in_IN children_NNS ._. And_CC finally_RB ,_, BCG_NNP has_VBZ been_VBN shown_VBN to_TO limit_VB viral_JJ infection_NN ._. In_IN one_CD study_NN ,_, human_JJ volunteers_NNS were_VBD given_VBN BCG_NNP or_CC a_DT placebo_NN one_CD month_NN before_IN being_VBG infected_VBN with_IN a_DT virus_NN ._. Volunteers_NNS who_WP received_VBD BCG_NNP had_VBD a_DT modest_JJ reduction_NN in_IN the_DT amount_NN of_IN virus_NN produced_VBN during_IN infection_NN compared_VBN to_IN those_DT who_WP received_VBD the_DT placebo_NN ._. Read_VB more_JJR :_: Explainer_NN :_: what_WP is_VBZ TB_NNP and_CC am_VBP I_PRP at_IN risk_NN of_IN getting_VBG it_PRP in_IN Australia_NNP ?_. However_RB ,_, BCG_NNP can_MD cause_VB side_NN -_HYPH effects_NNS to_TO be_VB mindful_JJ of_IN ._. It_PRP usually_RB causes_VBZ a_DT small_JJ raised_VBN blister_NN on_IN the_DT skin_NN at_IN the_DT vaccine_NN site_NN and_CC it_PRP can_MD cause_VB painful_JJ swelling_NN in_IN the_DT surrounding_VBG lymph_NN nodes_NNS ._. Importantly_RB ,_, because_IN it_PRP ’s_VBZ a_DT live_JJ bacterium_NN ,_, it_PRP can_MD spread_VB from_IN the_DT vaccine_NN site_NN and_CC cause_VB disease_NN ,_, called_VBN disseminated_VBN BCG_NN ,_, in_IN people_NNS who_WP are_VBP immunodeficient_JJ ,_, like_IN people_NNS with_IN HIV_NN ._. This_DT means_VBZ BCG_NNP ca_MD n’t_RB be_VB given_VBN to_IN everyone_NN ._. The_DT ultimate_JJ test_NN of_IN BCG_NNP as_IN a_DT preventative_JJ measure_NN for_IN COVID_NNP -_HYPH 19_CD is_VBZ to_TO run_VB randomised_VBN clinical_JJ trials_NNS ,_, which_WDT are_VBP now_RB underway_JJ ._. Researchers_NNS across_IN Australia_NNP and_CC the_DT Netherlands_NNPS are_VBP preparing_VBG to_TO give_VB BCG_NNP to_IN the_DT people_NNS who_WP have_VBP arguably_RB the_DT highest_JJS risk_NN of_IN COVID_NN -_HYPH 19_CD :_: frontline_JJ health_NN -_HYPH care_NN workers_NNS ._. These_DT phase_NN III_CD trials_NNS will_MD collect_VB data_NNS on_IN whether_IN workers_NNS vaccinated_VBN with_IN BCG_NNP have_VBP fewer_JJR or_CC less_RBR severe_JJ COVID_NN -_HYPH 19_CD infections_NNS ._. If_IN BCG_NNP is_VBZ shown_VBN to_TO be_VB effective_JJ ,_, we_PRP ’ll_MD face_VB other_JJ challenges_NNS ._. For_IN example_NN ,_, supply_NN of_IN the_DT vaccine_NN is_VBZ currently_RB limited_VBN ._. Further_RBR ,_, there_EX are_VBP many_JJ different_JJ strains_NNS of_IN BCG_NNP and_CC they_PRP might_MD not_RB all_RB provide_VB the_DT same_JJ protection_NN against_IN COVID_NN -_HYPH 19_CD ._. Protection_NN would_MD likely_RB start_VB to_TO wane_VB relatively_RB quickly_RB ._. When_WRB trained_VBN immunity_NN was_VBD tracked_VBN in_IN humans_NNS after_IN BCG_NNP ,_, it_PRP started_VBD waning_VBG from_IN three_CD to_IN 12_CD months_NNS after_IN vaccination_NN ._. Protection_NN would_MD also_RB not_RB be_VB as_RB strong_JJ as_IN what_WP we_PRP see_VBP with_IN many_JJ traditional_JJ vaccines_NNS ,_, such_JJ as_IN the_DT MMR_NNP vaccine_NN which_WDT protects_VBZ against_IN measles_NNS 94.1_CD %_NN of_IN the_DT time_NN ._. Read_VB more_JJR :_: Here_RB 's_VBZ why_WRB the_DT WHO_NNP says_VBZ a_DT coronavirus_NN vaccine_NN is_VBZ 18_CD months_NNS away_RB So_RB BCG_NNP would_MD be_VB most_RBS helpful_JJ for_IN people_NNS at_IN high_JJ risk_NN of_IN exposure_NN ,_, but_CC it_PRP would_MD n’t_RB replace_VB a_DT traditional_JJ vaccine_NN based_VBN on_IN immune_JJ memory_NN ._. These_DT studies_NNS are_VBP important_JJ to_TO give_VB us_PRP options_NNS ._. We_PRP need_VBP a_DT complete_JJ toolkit_NN for_IN control_NN of_IN COVID_NN -_HYPH 19_CD ,_, consisting_VBG of_IN anti-viral_JJ and_CC anti-inflammatory_JJ drugs_NNS and_CC vaccines_NNS ._. But_CC an_DT effective_JJ COVID_NN -_HYPH 19_CD vaccine_NN is_VBZ likely_RB still_RB many_JJ months_NNS ,_, even_RB years_NNS ,_, away_RB ._. By_IN repurposing_VBG an_DT old_JJ ,_, well_RB -_HYPH characterised_VBN vaccine_NN ,_, we_PRP could_MD bridge_VB this_DT gap_NN and_CC provide_VB some_DT protection_NN to_IN our_PRP$ health_NN -_HYPH care_NN workers_NNS as_IN they_PRP confront_VBP COVID_NNP -_HYPH 19_CD ._.","This NN , the NNP and NNP NNP NNP VBD it will VB A$ 10 million to VB VB an JJ NN NN whether a RB JJ NN , NNP , can VB VBN against a JJ NN , NNP - 19 . RB what VBZ the NN NN and what might its NN VB in the NN against NN ? The NNP NN VBZ VBN VBN for RB a NN to VB against NN , a JJ NN that VBZ the NNS . NN VBZ VBN by a NN VBN NN NN . NNP VBZ JJ for NNP NNP - NNP , as it VBD VBN by NNP NNP NNP NNP and NNP - NNP NNP NNP in the JJ NNS . To VB the NN , they VBD NN NN , a NN VBN in NNS and RB JJ to NN NN . They VBD it on a NN - JJ NN in the NN for RB 13 NNS . The NN VBD to this JJ NN by VBG NNS in its NN it RB RBR VBN , VBG NNS that VBP NN . This NN VBZ VBN NN and it VBZ in a JJ but VBN NN that can VB VBN to NNS as a NN . VB JJR : NN : could the NN VB VBN VBG VBG NNS like NNP or NNP ? NNP VBZ VBN to NNS in some NNS of the NN where there VBP RB JJ NNS of NN . It VBZ 86 NN of the NN against some JJR NNS of NN RBR JJ in NNS . But it RB VBZ RB 50 NN of the NN in NNS . NNS and NNS RB VBP we VBP a JJR NN for NN . RB , NNS VBP VBN NNS who VBD NNP VBD RB JJR JJ NN , with JJR JJ NNS and JJR NNS . NNS VBP this VBZ VBN by a NN of JJ NN VBN “ VBN NN ” . VBN NN VBZ JJ from how we RB VBP of NN , or “ JJ NN ” , because it VBZ JJ NNS of NN NNS . There VBP two JJ NNS of NNS within our JJ NN : JJ NNS , which VBP RB to NNS that VBP NN , and JJ NNS , which RB VBP RB RB . JJ NNS VBP NN NNS , which VBP NNS to VB NN , and NN NNS , which can VB VBN NNS . RB , JJ NNS can VB JJ NNS for NNS , or RB NNS , after we RB VBP them . When JJ NN NNS VBP the JJ NN a JJ or JJ NN , they VBP RB RBR RB , and the NN NN can RB VB an NN before it VBZ NN . JJ NN VBZ why RB we VBP RB VB VBN with a JJ NN , like NN , JJR than RB . JJS of our JJ NNS VBP JJ NN to VB us from NN . VB JJR : Where VBP we at with VBG a NN for NN ? For NNS , NNS VBD JJ NNS VBD the NN to VB JJ NNS with NNS . RB , we VBP RB VBN some JJ NNS , JJ as NNS , can VB “ VBN ” during an NN with a NN . NN can VB JJ NNS to VB RBR RB when they RB VBP a NN – any NN . Some JJ VBN NNS , JJ as NNP , can VB VBN NN , which can VB JJ NN of JJ NNS . This VBZ the JJ NN that NNP could VB JJ NNS to VB JJ NN of the NN - NN - 2 NN , to VB NN - 19 NN or RB VB NN . And as a NN , NNP could RB VB us against JJ NNS RB . We VBP RB VB RB whether NNP will VB the NN of NN - 19 , but the NN VBZ some JJ NNS . RB , NNP VBZ a JJ NN of the NN NN . RB , it VBZ VBN alongside JJ NNS to VB NN NN and NN , because it can VB JJ NNS to VB the NN . NNP RB VBZ to VB NN NN . As we VBD , NNS who VBP VBN the NN VB to VB JJR JJ NNS . There VBZ a NN JJ in NNP VBG at whether NNP can VB NNS of NN in NNS . And RB , NNP VBZ VBN VBN to VB JJ NN . In one NN , JJ NNS VBD VBN NNP or a NN one NN before VBG VBN with a NN . NNS who VBD NNP VBD a JJ NN in the NN of NN VBN during NN VBN to those who VBD the NN . VB JJR : NN : what VBZ NNP and VBP I at NN of VBG it in NNP ? RB , NNP can VB NN - NNS to VB JJ of . It RB VBZ a JJ VBN NN on the NN at the NN NN and it can VB JJ NN in the VBG NN NNS . RB , because it VBZ a JJ NN , it can VB from the NN NN and VB NN , VBN VBN NN , in NNS who VBP JJ , like NNS with NN . This VBZ NNP ca RB VB VBN to NN . The JJ NN of NNP as a JJ NN for NNP - 19 VBZ to VB VBN JJ NNS , which VBP RB JJ . NNS across NNP and the NNPS VBP VBG to VB NNP to the NNS who VBP RB the JJS NN of NN - 19 : JJ NN - NN NNS . These NN III NNS will VB NNS on whether NNS VBN with NNP VBP JJR or RBR JJ NN - 19 NNS . If NNP VBZ VBN to VB JJ , we ’ll VB JJ NNS . For NN , NN of the NN VBZ RB VBN . RBR , there VBP JJ JJ NNS of NNP and they might RB RB VB the JJ NN against NN - 19 . NN would RB VB to VB RB RB . When VBN NN VBD VBN in NNS after NNP , it VBD VBG from three to 12 NNS after NN . NN would RB RB VB RB JJ as what we VBP with JJ JJ NNS , JJ as the NNP NN which VBZ against NNS 94.1 NN of the NN . VB JJR : RB VBZ why the NNP VBZ a NN NN VBZ 18 NNS RB RB NNP would VB RBS JJ for NNS at JJ NN of NN , but it would RB VB a JJ NN VBN on JJ NN . These NNS VBP JJ to VB us NNS . We VBP a JJ NN for NN of NN - 19 , VBG of JJ and JJ NNS and NNS . But an JJ NN - 19 NN VBZ RB RB JJ NNS , RB NNS , RB . By VBG an JJ , RB - VBN NN , we could VB this NN and VB some NN to our NN - NN NNS as they VBP NNP - 19 ."
185,30,conspiracy,"China_NNP Caught_VBN Shutting_VBG Down_RP COVID_NN -_HYPH 19_CD Research_NN to_TO ‘_`` Control_VB the_DT Narrative_NN ’_'' China_NNP has_VBZ been_VBN caught_VBN shutting_VBG down_RP research_NN into_IN COVID_NNP -_HYPH 19_CD in_IN an_DT apparent_JJ attempt_NN to_TO ""_`` control_VB the_DT narrative_NN ""_'' of_IN the_DT coronavirus_NN pandemic_NN ,_, leading_VBG analysts_NNS have_VBP revealed_VBN ._. The_DT websites_NNS for_IN two_CD of_IN China_NNP 's_POS leading_VBG universities_NNS recently_RB published_VBD academic_JJ research_NN about_IN the_DT origins_NNS of_IN the_DT coronavirus_NN ._. However_RB ,_, the_DT studies_NNS were_VBD then_RB deleted_VBN from_IN both_CC websites_NNS and_CC scrubbed_VBN from_IN the_DT state_NN -_HYPH controlled_VBN Internet_NNP ,_, according_VBG to_IN a_DT report_NN ._. In_IN a_DT possible_JJ bid_NN to_TO ""_`` control_VB the_DT narrative_NN ""_'' surrounding_VBG the_DT pandemic_NN ,_, the_DT posts_NNS on_IN the_DT websites_NNS of_IN the_DT China_NNP University_NNP of_IN Geosciences_NNP (_-LRB- Wuhan_NNP )_-RRB- and_CC Fudan_NNP University_NNP were_VBD erased_VBN from_IN online_JJ caches_NNS ,_, The_DT Guardian_NNP reported_VBD ._. Wuhan_NNP 's_POS university_NN appears_VBZ to_TO have_VB published_VBN and_CC then_RB deleted_VBN posts_NNS about_IN academic_JJ research_NN that_WDT needed_VBD to_TO be_VB approved_VBN by_IN China_NNP ’s_POS ministry_NN of_IN science_NN and_CC technology_NN before_IN publication_NN ._. Posts_NNS originally_RB published_VBN on_IN April_NNP 9_CD by_IN the_DT school_NN of_IN information_NN science_NN and_CC technology_NN at_IN Fudan_NNP University_NNP in_IN Shanghai_NNP were_VBD also_RB deleted_VBN in_IN a_DT similar_JJ apparent_JJ censorship_NN effort_NN ._. “_`` They_PRP are_VBP seeking_VBG to_TO transform_VB it_PRP from_IN a_DT massive_JJ disaster_NN to_IN one_CD where_WRB the_DT government_NN did_VBD everything_NN right_RB and_CC gave_VBD the_DT rest_NN of_IN the_DT world_NN time_NN to_TO prepare_VB ,_, ”_'' Kevin_NNP Carrico_NNP ,_, a_DT senior_JJ research_NN fellow_NN of_IN Chinese_JJ studies_NNS at_IN Monash_NNP University_NNP ,_, told_VBD The_DT Guardian_NNP ._. “_`` There_EX is_VBZ a_DT desire_NN to_IN a_DT degree_NN to_TO deny_VB realities_NNS that_WDT are_VBP staring_VBG at_IN us_PRP in_IN the_DT face_NN …_, that_IN this_DT is_VBZ a_DT massive_JJ pandemic_NN that_WDT originated_VBD in_IN a_DT place_NN that_WDT the_DT Chinese_JJ government_NN really_RB should_MD have_VB cleaned_VBN up_RP after_IN SARS_NNP ,_, ”_'' he_PRP added_VBD ._. China_NNP ’s_POS science_NN and_CC technology_NN ministry_NN had_VBD announced_VBN on_IN April_NNP 3_CD that_IN academic_JJ researchers_NNS needed_VBD to_TO report_VB their_PRP$ coronavirus_NN findings_NNS to_IN officials_NNS within_IN three_CD days_NNS or_CC be_VB terminated_VBN ._. The_DT news_NN outlet_NN noted_VBD that_IN China_NNP ’s_POS President_NNP Xi_NNP Jinping_NNP published_VBD an_DT essay_NN in_IN March_NNP that_WDT included_VBD “_`` tracing_VBG the_DT origin_NN of_IN the_DT virus_NN ”_'' a_DT national_JJ priority_NN ;_, the_DT science_NN and_CC technology_NN ministry_NN referenced_VBD the_DT essay_NN shortly_RB before_IN the_DT universities_NNS changed_VBD tunes_NNS ._. On_IN New_NNP Year_NNP ’s_POS Eve_NNP ,_, China_NNP informed_VBD the_DT World_NNP Health_NNP Organization_NNP of_IN a_DT “_`` mysterious_JJ pneumonia_NN outbreak_NN ”_'' spreading_VBG through_IN Wuhan_NNP ,_, an_DT industrial_JJ city_NN of_IN 11_CD million_CD ._. The_DT government_NN closed_VBD a_DT seafood_NN market_NN at_IN the_DT center_NN of_IN the_DT outbreak_NN ,_, moved_VBD all_DT patients_NNS with_IN the_DT virus_NN to_IN a_DT specially_RB designated_VBN hospital_NN and_CC collected_VBD test_NN samples_NNS to_TO send_VB to_IN government_NN laboratories_NNS ._. Doctors_NNS were_VBD told_VBN to_TO stay_VB quiet_JJ ;_, one_CD who_WP issued_VBD a_DT warning_NN online_RB was_VBD punished_VBN ._. He_PRP later_RBR died_VBD of_IN the_DT virus_NN ._. The_DT Pentagon_NNP was_VBD said_VBN to_TO have_VB first_RB learned_VBN about_IN the_DT new_JJ coronavirus_NN in_IN December_NNP from_IN open_JJ -_HYPH source_NN reports_NNS emanating_VBG from_IN China_NNP ._. By_IN early_JJ January_NNP ,_, warnings_NNS about_IN the_DT virus_NN had_VBD made_VBN their_PRP$ way_NN into_IN intelligence_NN reports_NNS circulating_VBG around_IN the_DT government_NN ._. On_IN Jan._NNP 3_CD ,_, the_DT head_NN of_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP [_-LRB- CDC_NNP ]_-RRB- ,_, Robert_NNP Redfield_NNP ,_, received_VBD a_DT call_NN from_IN his_PRP$ Chinese_JJ counterpart_NN with_IN an_DT official_JJ warning_NN ._. Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT government_NN ’s_POS top_JJ infectious_JJ disease_NN expert_NN ,_, said_VBD he_PRP was_VBD alerted_VBN to_IN the_DT virus_NN around_IN the_DT same_JJ time_NN —_: and_CC within_IN two_CD weeks_NNS was_VBD fearful_JJ it_PRP could_MD bring_VB about_IN a_DT global_JJ catastrophe_NN ._. Quickly_RB ,_, U.S._NNP intelligence_NN and_CC public_JJ health_NN officials_NNS started_VBD doubting_VBG China_NNP ’s_POS reported_VBN rates_NNS of_IN infection_NN and_CC death_NN toll_NN ._. They_PRP pressed_VBD China_NNP to_TO allow_VB in_IN U.S._NNP epidemiologists_NNS —_: both_CC to_TO assist_VB the_DT country_NN in_IN confronting_VBG the_DT spread_NN and_CC to_TO gain_VB valuable_JJ insights_NNS that_WDT could_MD help_VB buy_VB time_NN for_IN the_DT U.S._NNP response_NN ._. U.S._NNP officials_NNS also_RB pressed_VBD China_NNP to_TO send_VB samples_NNS of_IN the_DT virus_NN to_IN U.S._NNP labs_NNS for_IN study_NN and_CC for_IN vaccine_NN and_CC test_NN development_NN ._. That_DT same_JJ day_NN ,_, the_DT National_NNP Institutes_NNPS of_IN Health_NNP started_VBD working_VBG on_IN a_DT vaccine_NN ._. Ultimately_RB ,_, the_DT U.S._NNP was_VBD able_JJ to_TO get_VB China_NNP ’s_POS consent_NN to_TO send_VB two_CD people_NNS on_IN the_DT WHO_NNP team_NN that_WDT traveled_VBD to_IN China_NNP later_RBR in_IN the_DT month_NN ._. But_CC by_IN then_RB precious_JJ weeks_NNS had_VBD been_VBN lost_VBN and_CC the_DT virus_NN had_VBD raced_VBN across_IN Asia_NNP and_CC had_VBD started_VBN to_TO escape_VB the_DT continent_NN ._.","NNP VBN VBG Down NN - 19 NN to ‘ VB the NN ’ NNP VBZ VBN VBN VBG down NN into NNP - 19 in an JJ NN to "" VB the NN "" of the NN NN , VBG NNS VBP VBN . The NNS for two of NNP 's VBG NNS RB VBD JJ NN about the NNS of the NN . RB , the NNS VBD RB VBN from both NNS and VBN from the NN - VBN NNP , VBG to a NN . In a JJ NN to "" VB the NN "" VBG the NN , the NNS on the NNS of the NNP NNP of NNP ( NNP ) and NNP NNP VBD VBN from JJ NNS , The NNP VBD . NNP 's NN VBZ to VB VBN and RB VBN NNS about JJ NN that VBD to VB VBN by NNP ’s NN of NN and NN before NN . NNS RB VBN on NNP 9 by the NN of NN NN and NN at NNP NNP in NNP VBD RB VBN in a JJ JJ NN NN . “ They VBP VBG to VB it from a JJ NN to one where the NN VBD NN RB and VBD the NN of the NN NN to VB , ” NNP NNP , a JJ NN NN of JJ NNS at NNP NNP , VBD The NNP . “ There VBZ a NN to a NN to VB NNS that VBP VBG at us in the NN … that this VBZ a JJ NN that VBD in a NN that the JJ NN RB should VB VBN up after NNP , ” he VBD . NNP ’s NN and NN NN VBD VBN on NNP 3 that JJ NNS VBD to VB their NN NNS to NNS within three NNS or VB VBN . The NN NN VBD that NNP ’s NNP NNP NNP VBD an NN in NNP that VBD “ VBG the NN of the NN ” a JJ NN ; the NN and NN NN VBD the NN RB before the NNS VBD NNS . On NNP NNP ’s NNP , NNP VBD the NNP NNP NNP of a “ JJ NN NN ” VBG through NNP , an JJ NN of 11 million . The NN VBD a NN NN at the NN of the NN , VBD all NNS with the NN to a RB VBN NN and VBD NN NNS to VB to NN NNS . NNS VBD VBN to VB JJ ; one who VBD a NN RB VBD VBN . He RBR VBD of the NN . The NNP VBD VBN to VB RB VBN about the JJ NN in NNP from JJ - NN NNS VBG from NNP . By JJ NNP , NNS about the NN VBD VBN their NN into NN NNS VBG around the NN . On NNP 3 , the NN of the NNP NNPS for NNP NNP and NNP [ NNP ] , NNP NNP , VBD a NN from his JJ NN with an JJ NN . NNP NNP NNP , the NN ’s JJ JJ NN NN , VBD he VBD VBN to the NN around the JJ NN — and within two NNS VBD JJ it could VB about a JJ NN . RB , NNP NN and JJ NN NNS VBD VBG NNP ’s VBN NNS of NN and NN NN . They VBD NNP to VB in NNP NNS — both to VB the NN in VBG the NN and to VB JJ NNS that could VB VB NN for the NNP NN . NNP NNS RB VBD NNP to VB NNS of the NN to NNP NNS for NN and for NN and NN NN . That JJ NN , the NNP NNPS of NNP VBD VBG on a NN . RB , the NNP VBD JJ to VB NNP ’s NN to VB two NNS on the NNP NN that VBD to NNP RBR in the NN . But by RB JJ NNS VBD VBN VBN and the NN VBD VBN across NNP and VBD VBN to VB the NN ."
186,1133,mainstream,"Nothing_NN can_MD stop_VB a_DT global_JJ outbreak_NN in_IN its_PRP$ tracks_NNS better_JJR than_IN a_DT vaccine_NN ._. Unfortunately_RB ,_, creating_VBG a_DT vaccine_NN capable_JJ of_IN preventing_VBG the_DT coronavirus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD will_MD probably_RB take_VB at_IN least_JJS a_DT year_NN to_IN 18_CD months_NNS ,_, health_NN officials_NNS say_VBP ._. “_`` That_DT is_VBZ the_DT time_NN frame_NN ,_, ”_'' Dr._NNP Anthony_NNP Fauci_NNP ,_, director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, told_VBD the_DT House_NNP Oversight_NNP and_CC Reform_NNP Committee_NNP this_DT week_NN ._. Anyone_NN who_WP says_VBZ they_PRP can_MD do_VB it_PRP faster_RBR “_'' will_MD be_VB cutting_VBG corners_NNS that_WDT would_MD be_VB detrimental_JJ ._. ”_'' While_IN there_EX are_VBP about_RB 10_CD vaccine_NN candidates_NNS in_IN the_DT works_NNS —_: and_CC at_IN least_JJS one_CD of_IN them_PRP could_MD begin_VB clinical_JJ trials_NNS in_IN April_NNP —_: it_PRP would_MD still_RB take_VB about_RB three_CD more_JJR months_NNS to_TO conduct_VB the_DT first_JJ stage_NN of_IN human_JJ testing_NN and_CC another_DT eight_CD months_NNS or_CC so_RB to_TO complete_VB the_DT next_JJ stage_NN of_IN the_DT trial_NN process_NN ,_, he_PRP added_VBD ._. New_JJ vaccines_NNS require_VBP copious_JJ research_NN and_CC time_NN -_HYPH consuming_VBG testing_NN that_WDT can_MD cost_VB hundreds_NNS of_IN millions_NNS of_IN dollars_NNS ._. There_EX ’s_VBZ no_DT guarantee_NN of_IN success_NN ,_, but_CC even_RB if_IN everything_NN goes_VBZ well_RB ,_, the_DT final_JJ product_NN might_MD not_RB hit_VB the_DT market_NN until_IN after_IN an_DT outbreak_NN has_VBZ subsided_VBN ._. Here_RB ’s_VBZ a_DT look_NN at_IN how_WRB vaccines_NNS are_VBP made_VBN and_CC why_WRB the_DT process_NN takes_VBZ so_RB long_RB ._. Your_PRP$ body_NN has_VBZ a_DT multi-_JJ pronged_JJ defense_NN system_NN for_IN recognizing_VBG and_CC combating_VBG dangerous_JJ invaders_NNS :_: your_PRP$ white_JJ blood_NN cells_NNS ._. There_EX are_VBP several_JJ types_NNS ,_, each_DT with_IN a_DT different_JJ purpose_NN :_: •_NFP Macrophages_NNS engulf_VBP and_CC then_RB eat_VB pathogens_NNS or_CC cells_NNS that_WDT are_VBP dead_JJ or_CC damaged_VBN ._. They_PRP leave_VBP behind_IN identifying_VBG fragments_NNS of_IN the_DT invading_VBG microbes_NNS ._. These_DT fragments_NNS are_VBP called_VBN antigens_NNS ._. •_NFP B-lymphocytes_NNS produce_VBP antibodies_NNS that_WDT recognize_VBP and_CC bind_VBP to_IN those_DT antigens_NNS ._. If_IN a_DT pathogen_NN with_IN those_DT antigens_NNS shows_VBZ up_RP in_IN the_DT blood_NN stream_NN again_RB ,_, those_DT antibodies_NNS can_MD mount_VB an_DT attack_NN ._. •_NFP If_IN those_DT pathogens_NNS are_VBP already_RB hiding_VBG out_RP inside_IN your_PRP$ cells_NNS beyond_IN the_DT antibodies_NNS ’_POS reach_NN ,_, T_NN -_HYPH lymphocytes_NNS can_MD attack_VB those_DT infected_VBN cells_NNS ._. Your_PRP$ immune_JJ system_NN has_VBZ to_TO go_VB through_IN this_DT process_NN each_DT time_NN it_PRP encounters_VBZ a_DT threat_NN from_IN a_DT new_JJ virus_NN or_CC bacterium_NN ._. A_DT vaccine_NN provides_VBZ a_DT shortcut_NN ._. Essentially_RB ,_, it_PRP helps_VBZ your_PRP$ immune_JJ system_NN learn_VB to_TO recognize_VB a_DT specific_JJ threat_NN by_IN tricking_VBG it_PRP into_IN thinking_VBG it_PRP ’s_VBZ under_IN attack_NN ._. Then_RB it_PRP can_MD produce_VB the_DT antibodies_NNS it_PRP needs_VBZ without_IN having_VBG to_TO face_VB a_DT real_JJ infection_NN ._. Are_VBP all_DT vaccines_NNS the_DT same_JJ ?_. Nope_UH ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP describes_VBZ several_JJ types_NNS of_IN vaccines_NNS :_: •_NFP Attenuated_VBN vaccines_NNS ,_, like_IN those_DT for_IN chickenpox_NN and_CC measles_NNS ,_, use_VBP a_DT live_JJ virus_NN or_CC bacteria_NN that_WDT has_VBZ been_VBN intentionally_RB weakened_VBN so_IN that_IN it_PRP ca_MD n’t_RB cause_VB serious_JJ disease_NN in_IN a_DT healthy_JJ immune_JJ system_NN ._. •_NFP Inactivated_VBN vaccines_NNS ,_, such_JJ as_IN the_DT one_NN for_IN polio_NN ,_, use_VBP germs_NNS that_WDT have_VBP been_VBN killed_VBN ._. They_PRP typically_RB do_VBP n’t_RB provide_VB as_RB much_JJ immunity_NN as_IN attenuated_VBN vaccines_NNS ,_, so_IN they_PRP may_MD require_VB boosters_NNS over_IN time_NN ._. •_SYM Toxoid_NN vaccines_NNS ,_, including_VBG the_DT DTaP_NN vaccine_NN for_IN diphtheria_NN and_CC tetanus_NN ,_, use_VBP weakened_VBN versions_NNS of_IN the_DT toxins_NNS created_VBN by_IN invading_VBG bacteria_NN to_TO teach_VB the_DT body_NN how_WRB to_TO fight_VB the_DT pathogens_NNS ._. •_NFP Subunit_NN vaccines_NNS ,_, such_JJ as_IN DTaP_NN ’s_POS whooping_NN cough_NN component_NN ,_, only_RB use_VB fragments_NNS of_IN the_DT virus_NN or_CC bacterium_NN they_PRP protect_VBP against_IN ._. •_NFP Conjugate_NN vaccines_NNS teach_VBP the_DT immune_NN system_NN to_TO fight_VB bacteria_NN that_WDT try_VBP to_TO disguise_VB their_PRP$ antigens_NNS in_IN the_DT long_JJ chains_NNS of_IN sugar_NN molecules_NNS that_WDT form_VBP the_DT walls_NNS of_IN bacterial_JJ cells_NNS ._. What_WP do_VBP you_PRP need_VB to_TO know_VB about_IN a_DT virus_NN to_TO create_VB a_DT vaccine_NN ?_. The_DT immune_NN system_NN learns_VBZ how_WRB to_TO fight_VB a_DT virus_NN by_IN studying_VBG its_PRP$ face_NN —_: the_DT outside_NN of_IN the_DT particle_NN ,_, including_VBG those_DT telltale_NN antigens_NNS ._. So_RB a_DT vaccine_NN needs_VBZ to_TO give_VB your_PRP$ body_NN a_DT snapshot_NN of_IN that_DT face_NN ._. One_CD classic_JJ technique_NN involves_VBZ injecting_VBG a_DT person_NN with_IN a_DT killed_VBN virus_NN ._. Another_DT uses_VBZ live_JJ viruses_NNS that_WDT have_VBP been_VBN grown_VBN and_CC deliberately_RB weakened_VBN ,_, typically_RB by_IN removing_VBG specific_JJ genes_NNS in_IN their_PRP$ RNA_NN or_CC DNA_NN ._. Both_DT of_IN these_DT strategies_NNS take_VBP some_DT time_NN ,_, and_CC scientists_NNS worry_VBP that_IN if_IN they_PRP use_VBP them_PRP on_IN novel_JJ viruses_NNS ,_, they_PRP may_MD not_RB behave_VB the_DT way_NN researchers_NNS predict_VBP ,_, said_VBD Dr._NNP Kathryn_NNP Stephenson_NNP ,_, who_WP runs_VBZ the_DT clinical_JJ trial_NN unit_NN at_IN Beth_NNP Israel_NNP Deaconess_NNP Medical_NNP Center_NNP ’s_POS Center_NNP for_IN Virology_NNP and_CC Vaccine_NNP Research_NNP ._. Another_DT option_NN for_IN scientists_NNS is_VBZ to_TO reconstruct_VB that_DT snapshot_NN using_VBG information_NN from_IN a_DT virus_NN ’_POS genetic_JJ code_NN ,_, which_WDT may_MD be_VB made_VBN of_IN either_CC RNA_NN or_CC DNA_NN ._. Nowadays_RB ,_, researchers_NNS can_MD get_VB started_VBN fast_RB ._. Scientists_NNS in_IN China_NNP made_VBD the_DT coronavirus_NN ’_POS RNA_NN sequences_NNS available_JJ on_IN Jan._NNP 10_CD ,_, and_CC many_JJ labs_NNS began_VBD working_VBG toward_IN a_DT vaccine_NN the_DT next_JJ day_NN ,_, Stephenson_NNP said_VBD ._. Once_IN you_PRP know_VBP that_DT ,_, is_VBZ the_DT rest_NN easy_JJ ?_. Hardly_RB ._. Designing_VBG the_DT vaccine_NN is_VBZ just_RB the_DT first_JJ step_NN ._. Then_RB it_PRP has_VBZ to_TO be_VB produced_VBN ._. There_EX are_VBP many_JJ different_JJ vaccine_NN -_HYPH making_VBG platforms_NNS ,_, each_DT with_IN its_PRP$ own_JJ set_NN of_IN advantages_NNS and_CC disadvantages_NNS ._. “_`` What_WP would_MD make_VB a_DT great_JJ vaccine_NN for_IN coronavirus_NN is_VBZ one_CD that_WDT you_PRP can_MD make_VB quickly_RB and_CC one_CD that_WDT would_MD provide_VB long_RB -_HYPH lasting_JJ and_CC effective_JJ immunity_NN ,_, ”_'' Stephenson_NNP said_VBD ._. “_`` Those_DT are_VBP not_RB always_RB the_DT same_JJ thing_NN ._. ”_'' For_IN example_NN ,_, a_DT vaccine_NN based_VBN on_IN the_DT virus_NN ’_POS genome_NN can_MD be_VB made_VBN quickly_RB ,_, in_IN perhaps_RB a_DT month_NN or_CC two_CD ,_, but_CC it_PRP may_MD be_VB harder_JJR to_TO manufacture_VB in_IN giant_JJ quantities_NNS ._. Another_DT option_NN is_VBZ to_TO take_VB the_DT virus_NN ’_POS genetic_JJ snapshot_NN and_CC put_VB it_PRP into_IN a_DT different_JJ virus_NN for_IN transport_NN ._. When_WRB introduced_VBN into_IN the_DT body_NN ,_, the_DT so_RB -_HYPH called_VBN viral_JJ vector_NN vaccine_NN enters_VBZ cells_NNS ,_, prompting_VBG them_PRP to_TO produce_VB huge_JJ numbers_NNS of_IN this_DT snapshot_NN for_IN the_DT immune_JJ system_NN to_TO see_VB ._. These_DT vaccines_NNS take_VBP longer_RBR to_TO make_VB —_: say_VB ,_, six_CD to_IN eight_CD months_NNS —_: but_CC they_PRP can_MD be_VB scaled_VBN up_RP more_RBR readily_RB ._. “_`` A_DT lot_NN of_IN us_PRP are_VBP working_VBG on_IN both_DT of_IN those_DT ,_, ”_'' Stephenson_NNP said_VBD ._. Before_IN a_DT vaccine_NN candidate_NN is_VBZ approved_VBN for_IN use_NN ,_, it_PRP must_MD be_VB proven_VBN safe_JJ and_CC effective_JJ in_IN a_DT series_NN of_IN trials_NNS that_WDT are_VBP monitored_VBN by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP ._. The_DT first_JJ step_NN is_VBZ to_TO show_VB that_IN it_PRP ’s_VBZ safe_JJ in_IN preclinical_JJ studies_NNS ._. These_DT can_MD be_VB conducted_VBN in_IN vitro_NN (_-LRB- using_VBG cells_NNS in_IN a_DT laboratory_NN dish_NN )_-RRB- or_CC in_IN vivo_NN (_-LRB- using_VBG an_DT animal_NN as_IN a_DT stand_NN -_HYPH in_NN for_IN humans_NNS )_-RRB- ._. Finding_VBG the_DT right_JJ animal_NN for_IN testing_NN can_MD be_VB a_DT challenge_NN ,_, said_VBD Robert_NNP Grenfell_NNP ,_, director_NN of_IN health_NN and_CC biosecurity_NN at_IN CSIRO_NNP ,_, Australia_NNP ’s_POS national_JJ science_NN agency_NN ,_, but_CC scientists_NNS working_VBG on_IN a_DT vaccine_NN for_IN the_DT new_JJ coronavirus_NN wo_MD n’t_RB have_VB to_TO start_VB from_IN scratch_NN ._. The_DT new_JJ virus_NN shares_VBZ much_JJ of_IN its_PRP$ genome_NN with_IN the_DT coronavirus_NN that_WDT caused_VBD the_DT 2003_CD outbreak_NN of_IN severe_JJ acute_JJ respiratory_JJ syndrome_NN ,_, and_CC some_DT Australian_JJ researchers_NNS already_RB have_VBP been_VBN studying_VBG the_DT SARS_NN virus_NN in_IN ferrets_NNS ._. Then_RB clinical_JJ trials_NNS in_IN humans_NNS can_MD begin_VB ._. Phase_NN 1_CD trials_NNS are_VBP small_JJ ,_, usually_RB with_IN a_DT few_JJ dozen_CD closely_RB monitored_VBN participants_NNS ._. The_DT main_JJ goal_NN here_RB is_VBZ to_TO make_VB sure_JJ the_DT vaccine_NN is_VBZ safe_JJ ._. Phase_NN 2_CD trials_NNS typically_RB enroll_VBP hundreds_NNS of_IN patients_NNS to_TO expand_VB the_DT safety_NN assessment_NN and_CC allow_VB scientists_NNS to_TO dig_VB into_IN the_DT body_NN ’s_POS immune_NN response_NN ._. Phase_NN 3_CD trials_NNS can_MD enroll_VB thousands_NNS of_IN people_NNS ,_, typically_RB with_IN some_DT of_IN them_PRP randomly_RB assigned_VBN to_TO get_VB the_DT vaccine_NN and_CC some_DT getting_VBG a_DT placebo_NN ._. This_DT process_NN can_MD take_VB years_NNS under_IN normal_JJ circumstances_NNS ._. In_IN an_DT emergency_NN ,_, it_PRP could_MD be_VB sped_VBN up_RP dramatically_RB ._. The_DT big_JJ sticking_NN point_NN is_VBZ often_RB the_DT Phase_NN 3_CD trial_NN ._. In_IN an_DT epidemic_NN ,_, many_JJ study_NN volunteers_NNS may_MD not_RB want_VB to_TO risk_VB getting_VBG a_DT placebo_NN instead_RB of_IN the_DT vaccine_NN ,_, Stephenson_NNP said_VBD ._. Researchers_NNS faced_VBD this_DT dilemma_NN during_IN the_DT Western_JJ African_NNP Ebola_NNP outbreak_NN that_WDT took_VBD off_RP in_IN 2014_CD ._. The_DT virus_NN had_VBD a_DT mortality_NN rate_NN of_IN about_RB 40_CD %_NN ,_, making_VBG people_NNS desperate_JJ for_IN the_DT still_RB -_HYPH unproven_JJ vaccine_NN ._. So_RB researchers_NNS employed_VBD a_DT novel_JJ experimental_JJ design_NN that_WDT involved_VBD vaccinating_VBG people_NNS with_IN varying_VBG degrees_NNS of_IN separation_NN from_IN an_DT Ebola_NNP patient_NN and_CC using_VBG computer_NN models_NNS to_TO help_VB determine_VB if_IN the_DT vaccine_NN had_VBD had_VBN an_DT effect_NN ._. “_`` I_PRP think_VBP people_NNS learned_VBD from_IN that_DT that_IN there_EX are_VBP ways_NNS to_TO be_VB creative_JJ ,_, ”_'' Stephenson_NNP said_VBD ._. A_DT creative_JJ solution_NN may_MD be_VB needed_VBN when_WRB a_DT coronavirus_NN vaccine_NN is_VBZ ready_JJ for_IN Phase_NN 3_CD testing_NN ,_, she_PRP added_VBD ._. How_WRB good_JJ does_VBZ a_DT vaccine_NN need_VB to_TO be_VB in_IN order_NN to_TO gain_VB approval_NN ?_. The_DT FDA_NNP wants_VBZ it_PRP to_TO be_VB both_CC safe_JJ and_CC effective_JJ —_: in_IN other_JJ words_NNS ,_, it_PRP has_VBZ to_TO protect_VB enough_JJ people_NNS with_IN as_RB few_JJ unwanted_JJ side_NN effects_NNS as_IN possible_JJ ._. But_CC exactly_RB what_WP qualifies_VBZ as_IN safe_JJ and_CC effective_JJ may_MD depend_VB on_IN the_DT disease_NN in_IN question_NN ._. For_IN some_DT perspective_NN :_: Stephenson_NNP ,_, who_WP also_RB studies_VBZ HIV_NNP ,_, said_VBD that_IN researchers_NNS would_MD be_VB very_RB happy_JJ if_IN they_PRP could_MD come_VB up_RP with_IN an_DT HIV_NN vaccine_NN that_WDT protected_VBD 50_CD %_NN or_CC so_RB of_IN those_DT who_WP got_VBD it_PRP ._. On_IN the_DT other_JJ hand_NN ,_, for_IN a_DT highly_RB contagious_JJ virus_NN like_IN measles_NNS ,_, a_DT vaccine_NN would_MD need_VB to_TO work_VB in_IN almost_RB everyone_NN to_TO establish_VB herd_NN immunity_NN ,_, she_PRP said_VBD ._. David_NNP Weiner_NNP ,_, a_DT molecular_JJ immunologist_NN who_WP directs_VBZ the_DT Wistar_NNP Institute_NNP ’s_POS Vaccine_NNP and_CC Immunotherapy_NNP Center_NNP ,_, said_VBD a_DT successful_JJ coronavirus_NN vaccine_NN would_MD n’t_RB have_VB to_TO be_VB 100_CD %_NN effective_JJ ._. “_`` I_PRP would_MD like_VB us_PRP to_TO see_VB it_PRP work_VB in_IN the_DT majority_NN of_IN people_NNS ,_, ”_'' he_PRP said_VBD ,_, but_CC “_`` if_IN it_PRP worked_VBD in_IN 50_CD %_NN ,_, 50_CD %_NN is_VBZ a_DT big_JJ improvement_NN over_IN 0_CD %_NN ._. ”_'' Once_IN a_DT vaccine_NN is_VBZ approved_VBN ,_, is_VBZ the_DT hard_JJ part_NN over_RB ?_. Definitely_RB not_RB ._. The_DT labs_NNS that_WDT create_VBP a_DT successful_JJ vaccine_NN probably_RB wo_MD n’t_RB be_VB the_DT ones_NNS that_WDT are_VBP able_JJ to_TO scale_VB up_RP —_: they_PRP ’ll_MD need_VB a_DT dedicated_VBN manufacturer_NN for_IN that_DT part_NN ._. And_CC many_JJ companies_NNS may_MD be_VB wary_JJ of_IN investing_VBG the_DT resources_NNS it_PRP takes_VBZ to_TO manufacture_VB a_DT new_JJ vaccine_NN when_WRB the_DT epidemic_NN could_MD end_VB before_IN there_EX ’s_VBZ a_DT chance_NN to_TO bring_VB it_PRP to_IN market_NN ,_, Weiner_NNP said_VBD ._. “_`` Big_NNP Pharma_NNP is_VBZ afraid_JJ to_TO go_VB in_RB because_IN the_DT outbreaks_NNS end_VBP and_CC they_PRP lose_VBP all_PDT the_DT money_NN they_PRP put_VBP in_RP ,_, ”_'' he_PRP said_VBD ._. That_DT ’s_VBZ why_WRB the_DT Oslo_NNP -_HYPH based_VBN Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS ,_, or_CC CEPI_NNP ,_, has_VBZ stepped_VBN in_RP with_IN funding_NN to_TO help_VB shepherd_VB some_DT of_IN those_DT efforts_NNS ,_, he_PRP added_VBD ._. One_CD of_IN the_DT big_JJ technical_JJ challenges_NNS in_IN large_JJ -_HYPH scale_NN manufacturing_NN is_VBZ quality_JJ control_NN ,_, Stephenson_NNP said_VBD ._. “_`` Every_DT vaccine_NN has_VBZ its_PRP$ own_JJ particular_JJ issue_NN ,_, ”_'' she_PRP said_VBD ,_, but_CC “_`` the_DT manufacturing_NN challenges_NNS mainly_RB have_VBP the_DT most_JJS to_TO do_VB with_IN safety_NN precautions_NNS and_CC making_VBG sure_JJ that_IN when_WRB you_PRP ’re_VBP done_VBN ,_, the_DT vial_NN of_IN vaccine_NN has_VBZ in_IN it_PRP what_WP you_PRP say_VBP it_PRP has_VBZ ._. ”_'' Who_WP would_MD get_VB the_DT vaccine_NN first_RB ?_. This_DT can_MD be_VB a_DT difficult_JJ question_NN when_WRB there_EX ’s_VBZ a_DT limited_JJ amount_NN of_IN vaccine_NN and_CC a_DT whole_JJ lot_NN of_IN demand_NN ._. Since_IN older_JJR adults_NNS appear_VBP to_TO be_VB most_RBS at_IN risk_NN from_IN COVID_NNP -_HYPH 19_CD ,_, it_PRP ’s_VBZ likely_JJ that_IN health_NN officials_NNS would_MD focus_VB on_IN them_PRP first_RB ,_, Stephenson_NNP said_VBD ._. Medical_JJ professionals_NNS —_: who_WP are_VBP both_RB at_IN high_JJ risk_NN of_IN exposure_NN and_CC are_VBP needed_VBN to_TO care_VB for_IN those_DT who_WP are_VBP sick_JJ —_: would_MD likely_RB be_VB a_DT priority_NN as_RB well_RB ._. “_`` Front_NN -_HYPH line_NN healthcare_NN workers_NNS are_VBP usually_RB one_CD of_IN the_DT first_JJ groups_NNS you_PRP vaccinate_VBP because_IN you_PRP need_VBP your_PRP$ workforce_NN in_IN place_NN ,_, ”_'' she_PRP said_VBD ._. Vaccines_NNS are_VBP often_RB less_RBR effective_JJ in_IN older_JJR people_NNS than_IN they_PRP are_VBP in_IN younger_JJR ones_NNS ,_, and_CC this_DT could_MD affect_VB the_DT way_NN that_IN a_DT vaccine_NN is_VBZ administered_VBN ._. A_DT vaccine_NN might_MD be_VB given_VBN in_IN multiple_JJ doses_NNS ,_, or_CC an_DT adjuvant_NN might_MD be_VB added_VBN to_IN it_PRP to_TO boost_VB the_DT immune_JJ system_NN ’s_POS reaction_NN to_IN it_PRP ._. How_WRB can_MD I_PRP protect_VB myself_PRP until_IN a_DT vaccine_NN is_VBZ available_JJ ?_. The_DT CDC_NNP suggests_VBZ some_DT common_JJ -_HYPH sense_NN ways_NNS for_IN people_NNS to_TO protect_VB themselves_PRP :_: •_NFP Avoid_VB close_JJ contact_NN with_IN people_NNS who_WP are_VBP sick_JJ ._. •_NFP Wash_VB your_PRP$ hands_NNS often_RB with_IN soap_NN and_CC water_NN for_IN at_IN least_JJS 20_CD seconds_NNS ._. •_NFP If_IN you_PRP ca_MD n’t_RB find_VB soap_NN and_CC water_NN ,_, use_VB an_DT alcohol_NN -_HYPH based_VBN sanitizer_NN with_IN at_IN least_JJS 60_CD %_NN alcohol_NN ._. •_NFP Use_VB a_DT tissue_NN when_WRB you_PRP cough_VBP or_CC sneeze_VB and_CC then_RB throw_VB it_PRP away_RB immediately_RB ._. •_NFP Use_VB a_DT face_NN mask_NN if_IN you_PRP show_VBP symptoms_NNS of_IN COVID_NN -_HYPH 19_CD so_IN you_PRP do_VBP n’t_RB infect_VB others_NNS ._. (_-LRB- The_DT masks_NNS are_VBP not_RB recommended_VBN for_IN healthy_JJ people_NNS who_WP are_VBP just_RB generally_RB trying_VBG to_TO protect_VB themselves_PRP against_IN infection_NN ._. )_-RRB-","NN can VB a JJ NN in its NNS JJR than a NN . RB , VBG a NN JJ of VBG the NN that VBZ NN - 19 will RB VB at JJS a NN to 18 NNS , NN NNS VBP . “ That VBZ the NN NN , ” NNP NNP NNP , NN of the NNP NNP of NNP and NNP NNPS , VBD the NNP NNP and NNP NNP this NN . NN who VBZ they can VB it RBR “ will VB VBG NNS that would VB JJ . ” While there VBP RB 10 NN NNS in the NNS — and at JJS one of them could VB JJ NNS in NNP — it would RB VB RB three JJR NNS to VB the JJ NN of JJ NN and another eight NNS or RB to VB the JJ NN of the NN NN , he VBD . JJ NNS VBP JJ NN and NN - VBG NN that can VB NNS of NNS of NNS . There VBZ no NN of NN , but RB if NN VBZ RB , the JJ NN might RB VB the NN until after an NN VBZ VBN . RB VBZ a NN at how NNS VBP VBN and why the NN VBZ RB RB . Your NN VBZ a JJ JJ NN NN for VBG and VBG JJ NNS : your JJ NN NNS . There VBP JJ NNS , each with a JJ NN : • NNS VBP and RB VB NNS or NNS that VBP JJ or VBN . They VBP behind VBG NNS of the VBG NNS . These NNS VBP VBN NNS . • NNS VBP NNS that VBP and VBP to those NNS . If a NN with those NNS VBZ up in the NN NN RB , those NNS can VB an NN . • If those NNS VBP RB VBG out inside your NNS beyond the NNS ’ NN , NN - NNS can VB those VBN NNS . Your JJ NN VBZ to VB through this NN each NN it VBZ a NN from a JJ NN or NN . A NN VBZ a NN . RB , it VBZ your JJ NN VB to VB a JJ NN by VBG it into VBG it VBZ under NN . RB it can VB the NNS it VBZ without VBG to VB a JJ NN . VBP all NNS the JJ ? Nope . The NNPS for NNP NNP and NNP VBZ JJ NNS of NNS : • VBN NNS , like those for NN and NNS , VBP a JJ NN or NN that VBZ VBN RB VBN so that it ca RB VB JJ NN in a JJ JJ NN . • VBN NNS , JJ as the NN for NN , VBP NNS that VBP VBN VBN . They RB VBP RB VB RB JJ NN as VBN NNS , so they may VB NNS over NN . • NN NNS , VBG the NN NN for NN and NN , VBP VBN NNS of the NNS VBN by VBG NN to VB the NN how to VB the NNS . • NN NNS , JJ as NN ’s NN NN NN , RB VB NNS of the NN or NN they VBP against . • NN NNS VBP the NN NN to VB NN that VBP to VB their NNS in the JJ NNS of NN NNS that VBP the NNS of JJ NNS . What VBP you VB to VB about a NN to VB a NN ? The NN NN VBZ how to VB a NN by VBG its NN — the NN of the NN , VBG those NN NNS . RB a NN VBZ to VB your NN a NN of that NN . One JJ NN VBZ VBG a NN with a VBN NN . Another VBZ JJ NNS that VBP VBN VBN and RB VBN , RB by VBG JJ NNS in their NN or NN . Both of these NNS VBP some NN , and NNS VBP that if they VBP them on JJ NNS , they may RB VB the NN NNS VBP , VBD NNP NNP NNP , who VBZ the JJ NN NN at NNP NNP NNP NNP NNP ’s NNP for NNP and NNP NNP . Another NN for NNS VBZ to VB that NN VBG NN from a NN ’ JJ NN , which may VB VBN of either NN or NN . RB , NNS can VB VBN RB . NNS in NNP VBD the NN ’ NN NNS JJ on NNP 10 , and JJ NNS VBD VBG toward a NN the JJ NN , NNP VBD . Once you VBP that , VBZ the NN JJ ? RB . VBG the NN VBZ RB the JJ NN . RB it VBZ to VB VBN . There VBP JJ JJ NN - VBG NNS , each with its JJ NN of NNS and NNS . “ What would VB a JJ NN for NN VBZ one that you can VB RB and one that would VB RB - JJ and JJ NN , ” NNP VBD . “ Those VBP RB RB the JJ NN . ” For NN , a NN VBN on the NN ’ NN can VB VBN RB , in RB a NN or two , but it may VB JJR to VB in JJ NNS . Another NN VBZ to VB the NN ’ JJ NN and VB it into a JJ NN for NN . When VBN into the NN , the RB - VBN JJ NN NN VBZ NNS , VBG them to VB JJ NNS of this NN for the JJ NN to VB . These NNS VBP RBR to VB — VB , six to eight NNS — but they can VB VBN up RBR RB . “ A NN of us VBP VBG on both of those , ” NNP VBD . Before a NN NN VBZ VBN for NN , it must VB VBN JJ and JJ in a NN of NNS that VBP VBN by the NNP and NNP NNP . The JJ NN VBZ to VB that it VBZ JJ in JJ NNS . These can VB VBN in NN ( VBG NNS in a NN NN ) or in NN ( VBG an NN as a NN - NN for NNS ) . VBG the JJ NN for NN can VB a NN , VBD NNP NNP , NN of NN and NN at NNP , NNP ’s JJ NN NN , but NNS VBG on a NN for the JJ NN wo RB VB to VB from NN . The JJ NN VBZ JJ of its NN with the NN that VBD the 2003 NN of JJ JJ JJ NN , and some JJ NNS RB VBP VBN VBG the NN NN in NNS . RB JJ NNS in NNS can VB . NN 1 NNS VBP JJ , RB with a JJ dozen RB VBN NNS . The JJ NN RB VBZ to VB JJ the NN VBZ JJ . NN 2 NNS RB VBP NNS of NNS to VB the NN NN and VB NNS to VB into the NN ’s NN NN . NN 3 NNS can VB NNS of NNS , RB with some of them RB VBN to VB the NN and some VBG a NN . This NN can VB NNS under JJ NNS . In an NN , it could VB VBN up RB . The JJ NN NN VBZ RB the NN 3 NN . In an NN , JJ NN NNS may RB VB to VB VBG a NN RB of the NN , NNP VBD . NNS VBD this NN during the JJ NNP NNP NN that VBD off in 2014 . The NN VBD a NN NN of RB 40 NN , VBG NNS JJ for the RB - JJ NN . RB NNS VBD a JJ JJ NN that VBD VBG NNS with VBG NNS of NN from an NNP NN and VBG NN NNS to VB VB if the NN VBD VBN an NN . “ I VBP NNS VBD from that that there VBP NNS to VB JJ , ” NNP VBD . A JJ NN may VB VBN when a NN NN VBZ JJ for NN 3 NN , she VBD . How JJ VBZ a NN VB to VB in NN to VB NN ? The NNP VBZ it to VB both JJ and JJ — in JJ NNS , it VBZ to VB JJ NNS with RB JJ JJ NN NNS as JJ . But RB what VBZ as JJ and JJ may VB on the NN in NN . For some NN : NNP , who RB VBZ NNP , VBD that NNS would VB RB JJ if they could VB up with an NN NN that VBD 50 NN or RB of those who VBD it . On the JJ NN , for a RB JJ NN like NNS , a NN would VB to VB in RB NN to VB NN NN , she VBD . NNP NNP , a JJ NN who VBZ the NNP NNP ’s NNP and NNP NNP , VBD a JJ NN NN would RB VB to VB 100 NN JJ . “ I would VB us to VB it VB in the NN of NNS , ” he VBD , but “ if it VBD in 50 NN , 50 NN VBZ a JJ NN over 0 NN . ” Once a NN VBZ VBN , VBZ the JJ NN RB ? RB RB . The NNS that VBP a JJ NN RB wo RB VB the NNS that VBP JJ to VB up — they ’ll VB a VBN NN for that NN . And JJ NNS may VB JJ of VBG the NNS it VBZ to VB a JJ NN when the NN could VB before there VBZ a NN to VB it to NN , NNP VBD . “ NNP NNP VBZ JJ to VB RB because the NNS VBP and they VBP all the NN they VBP in , ” he VBD . That VBZ why the NNP - VBN NNP for NNP NNP NNPS , or NNP , VBZ VBN in with NN to VB VB some of those NNS , he VBD . One of the JJ JJ NNS in JJ - NN NN VBZ JJ NN , NNP VBD . “ Every NN VBZ its JJ JJ NN , ” she VBD , but “ the NN NNS RB VBP the JJS to VB with NN NNS and VBG JJ that when you VBP VBN , the NN of NN VBZ in it what you VBP it VBZ . ” Who would VB the NN RB ? This can VB a JJ NN when there VBZ a JJ NN of NN and a JJ NN of NN . Since JJR NNS VBP to VB RBS at NN from NNP - 19 , it VBZ JJ that NN NNS would VB on them RB , NNP VBD . JJ NNS — who VBP RB at JJ NN of NN and VBP VBN to VB for those who VBP JJ — would RB VB a NN RB RB . “ NN - NN NN NNS VBP RB one of the JJ NNS you VBP because you VBP your NN in NN , ” she VBD . NNS VBP RB RBR JJ in JJR NNS than they VBP in JJR NNS , and this could VB the NN that a NN VBZ VBN . A NN might VB VBN in JJ NNS , or an NN might VB VBN to it to VB the JJ NN ’s NN to it . How can I VB myself until a NN VBZ JJ ? The NNP VBZ some JJ - NN NNS for NNS to VB themselves : • VB JJ NN with NNS who VBP JJ . • VB your NNS RB with NN and NN for at JJS 20 NNS . • If you ca RB VB NN and NN , VB an NN - VBN NN with at JJS 60 NN NN . • VB a NN when you VBP or VB and RB VB it RB RB . • VB a NN NN if you VBP NNS of NN - 19 so you VBP RB VB NNS . ( The NNS VBP RB VBN for JJ NNS who VBP RB RB VBG to VB themselves against NN . )"
187,517,mainstream,"The_DT mother_NN of_IN a_DT Cheshire_NNP teenager_NN who_WP was_VBD left_VBN severely_RB brain_NN damaged_VBN by_IN the_DT MMR_NNP vaccine_NN has_VBZ won_VBN a_DT compensation_NN award_NN from_IN the_DT government_NN ._. Robert_NNP Fletcher_NNP ,_, 18_CD ,_, from_IN Warrington_NNP ,_, suffered_VBD a_DT fit_NN 10_CD days_NNS after_IN he_PRP had_VBD the_DT vaccination_NN when_WRB he_PRP was_VBD 13_CD months_NNS old_JJ ._. His_PRP$ mother_NN Jackie_NNP received_VBD the_DT £_$ 90,000_CD payout_NN from_IN a_DT medical_JJ assessment_NN panel_NN last_JJ week_NN ._. The_DT family_NN successfully_RB appealed_VBD after_IN their_PRP$ application_NN for_IN compensation_NN was_VBD originally_RB turned_VBN down_RP in_IN 1997_CD ._. They_PRP had_VBD originally_RB applied_VBN through_IN the_DT Government_NNP 's_POS Vaccine_NNP Damage_NNP Payment_NNP Scheme_NNP ._. Robert_NNP has_VBZ frequent_JJ epileptic_JJ fits_NNS ,_, is_VBZ unable_JJ to_TO talk_VB ,_, stand_VB unaided_JJ or_CC feed_VB himself_PRP ,_, but_CC is_VBZ not_RB autistic_JJ ._. Mrs_NNP Fletcher_NNP always_RB believed_VBD that_IN her_PRP$ son's_NNS epilepsy_NN was_VBD triggered_VBN by_IN the_DT combined_VBN measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN ._. The_DT ruling_NN and_CC compensation_NN award_NN was_VBD made_VBN by_IN a_DT jury_NN made_VBN up_RP of_IN a_DT judge_NN and_CC two_CD doctors_NNS ._. It_PRP said_VBD the_DT ruling_NN had_VBD no_DT relevance_NN to_IN the_DT question_NN of_IN a_DT link_NN between_IN the_DT vaccine_NN and_CC autism_NN ._. Dr_NNP Andrew_NNP Wakefield_NNP was_VBD the_DT lead_JJ author_NN of_IN the_DT controversial_JJ study_NN ,_, published_VBN in_IN The_DT Lancet_NNP in_IN 1998_CD ,_, which_WDT suggested_VBD there_EX may_MD be_VB a_DT link_NN between_IN MMR_NN and_CC autism_NN and_CC bowel_NN disease_NN ._. His_PRP$ comments_NNS and_CC the_DT subsequent_JJ media_NN furore_NN led_VBD to_IN a_DT sharp_JJ drop_NN in_IN the_DT number_NN of_IN children_NNS vaccinated_VBN against_IN these_DT diseases_NNS ._. The_DT study_NN has_VBZ since_RB been_VBN discredited_VBN and_CC The_DT Lancet_NNP has_VBZ said_VBN it_PRP should_MD not_RB have_VB run_VBN it_PRP ._. Mrs_NNP Fletcher_NNP has_VBZ campaigned_VBN for_IN justice_NN for_IN her_PRP$ son_NN for_IN the_DT past_JJ 16_CD years_NNS ._. She_PRP said_VBD :_: ""_`` I_PRP feel_VBP vindicated_VBN by_IN it_PRP because_IN over_IN the_DT years_NNS I_PRP 've_VBP been_VBN labelled_VBN anti-vaccine_NN and_CC a_DT scaremonger_NN and_CC all_DT sorts_NNS of_IN things_NNS ,_, when_WRB all_DT I_PRP 've_VBP been_VBN trying_VBG to_TO do_VB is_VBZ highlight_VB what_WP 's_VBZ happened_VBN to_IN my_PRP$ son_NN ,_, to_TO help_VB safeguard_VB other_JJ parents_NNS '_POS children_NNS ._. ""_`` What_WP I_PRP 'm_VBP hoping_VBG now_RB is_VBZ that_IN other_JJ parents_NNS whose_WP$ children_NNS have_VBP suffered_VBN a_DT similar_JJ reaction_NN to_IN Robert_NNP can_MD maybe_RB go_VB down_IN the_DT same_JJ route_NN that_WDT we_PRP 've_VBP gone_VBN down_RP to_TO achieve_VB justice_NN for_IN their_PRP$ children_NNS ._. ""_'' A_DT Department_NNP of_IN Health_NNP spokesperson_NN said_VBD :_: ""_`` This_DT decision_NN reflects_VBZ the_DT opinion_NN of_IN a_DT tribunal_NN on_IN the_DT specific_JJ facts_NNS of_IN the_DT case_NN and_CC they_PRP were_VBD clear_JJ that_IN it_PRP should_MD not_RB be_VB seen_VBN as_IN a_DT precedent_NN for_IN any_DT other_JJ case_NN ._. ""_`` The_DT safety_NN of_IN MMR_NNP has_VBZ been_VBN endorsed_VBN through_IN numerous_JJ studies_NNS in_IN many_JJ countries_NNS ._. Thankfully_RB ,_, more_JJR parents_NNS are_VBP having_VBG their_PRP$ children_NNS vaccinated_VBN with_IN MMR_NNP and_CC consider_VBP it_PRP as_RB safe_JJ as_IN other_JJ childhood_NN vaccines_NNS ._. ""_'' He_PRP added_VBD :_: ""_`` MMR_NNP vaccine_NN has_VBZ been_VBN used_VBN extensively_RB and_CC safely_RB around_IN the_DT world_NN for_IN over_RB 30_CD years_NNS ._. Over_RB 500_CD million_CD doses_NNS have_VBP been_VBN given_VBN in_IN over_RB 100_CD countries_NNS ._. ""_`` The_DT World_NNP Health_NNP Organisation_NNP recognises_VBZ MMR_NNP as_IN being_VBG a_DT '_`` highly_RB effective_JJ vaccine_NN which_WDT has_VBZ (_-LRB- such_JJ )_-RRB- an_DT outstanding_JJ safety_NN record_NN '_'' ._. ""_`` Parents_NNS and_CC carers_NNS should_MD continue_VB to_TO get_VB their_PRP$ children_NNS immunised_VBN when_WRB called_VBN to_TO do_VB so_RB ._. ""_''","The NN of a NNP NN who VBD VBN RB NN VBN by the NNP NN VBZ VBN a NN NN from the NN . NNP NNP , 18 , from NNP , VBD a NN 10 NNS after he VBD the NN when he VBD 13 NNS JJ . His NN NNP VBD the £ 90,000 NN from a JJ NN NN JJ NN . The NN RB VBD after their NN for NN VBD RB VBN down in 1997 . They VBD RB VBN through the NNP 's NNP NNP NNP NNP . NNP VBZ JJ JJ NNS , VBZ JJ to VB , VB JJ or VB himself , but VBZ RB JJ . NNP NNP RB VBD that her NNS NN VBD VBN by the VBN NNS , NNS and NN NN . The NN and NN NN VBD VBN by a NN VBN up of a NN and two NNS . It VBD the NN VBD no NN to the NN of a NN between the NN and NN . NNP NNP NNP VBD the JJ NN of the JJ NN , VBN in The NNP in 1998 , which VBD there may VB a NN between NN and NN and NN NN . His NNS and the JJ NN NN VBD to a JJ NN in the NN of NNS VBN against these NNS . The NN VBZ RB VBN VBN and The NNP VBZ VBN it should RB VB VBN it . NNP NNP VBZ VBN for NN for her NN for the JJ 16 NNS . She VBD : "" I VBP VBN by it because over the NNS I VBP VBN VBN NN and a NN and all NNS of NNS , when all I VBP VBN VBG to VB VBZ VB what VBZ VBN to my NN , to VB VB JJ NNS ' NNS . "" What I VBP VBG RB VBZ that JJ NNS whose NNS VBP VBN a JJ NN to NNP can RB VB down the JJ NN that we VBP VBN down to VB NN for their NNS . "" A NNP of NNP NN VBD : "" This NN VBZ the NN of a NN on the JJ NNS of the NN and they VBD JJ that it should RB VB VBN as a NN for any JJ NN . "" The NN of NNP VBZ VBN VBN through JJ NNS in JJ NNS . RB , JJR NNS VBP VBG their NNS VBN with NNP and VBP it RB JJ as JJ NN NNS . "" He VBD : "" NNP NN VBZ VBN VBN RB and RB around the NN for RB 30 NNS . RB 500 million NNS VBP VBN VBN in RB 100 NNS . "" The NNP NNP NNP VBZ NNP as VBG a ' RB JJ NN which VBZ ( JJ ) an JJ NN NN ' . "" NNS and NNS should VB to VB their NNS VBN when VBN to VB RB . """
188,805,mainstream,"British_JJ drug_NN manufacturer_NN AstraZeneca_NNP AZN_NNP ,_, has_VBZ received_VBN more_JJR than_IN $_$ 1_CD billion_CD in_IN U.S._NNP funding_NN to_TO accelerate_VB the_DT development_NN of_IN Oxford_NNP University_NNP ’s_POS coronavirus_NN vaccine_NN candidate_NN ._. The_DT agreement_NN would_MD make_VB 300_CD million_CD doses_NNS of_IN the_DT vaccine_NN available_JJ in_IN the_DT U.S._NNP ,_, with_IN the_DT first_JJ doses_NNS delivered_VBN in_IN October_NNP ,_, the_DT U.S._NNP Department_NNP of_IN Health_NNP &_CC Human_NNP Services_NNPS said_VBD on_IN Thursday_NNP ._. The_DT agreement_NN between_IN AstraZeneca_NNP and_CC the_DT U.S._NNP Biomedical_NNP Research_NNP and_CC Development_NNP Authority_NNP also_RB includes_VBZ a_DT Phase_NN 3_CD clinical_JJ trial_NN in_IN the_DT U.S._NNP this_DT summer_NN with_IN 30,000_CD volunteers_NNS ._. The_DT U.S._NNP has_VBZ also_RB supported_VBN vaccine_NN efforts_NNS by_IN Moderna_NNP MRNA_NNP ,_, ,_, France_NNP ’s_POS Sanofi_NNP SAN_NNP ,_, and_CC Johnson_NNP &_CC Johnson_NNP JNJ_NNP ,_, ,_, as_IN part_NN of_IN the_DT Trump_NNP administration_NN ’s_POS “_`` Operation_NN Warp_NNP Speed_NN ”_'' initiative_NN ._. AstraZeneca_NNP said_VBD it_PRP has_VBZ now_RB secured_VBN orders_NNS for_IN 400_CD million_CD doses_NNS and_CC has_VBZ the_DT manufacturing_NN capacity_NN for_IN 1_CD billion_CD doses_NNS —_: the_DT first_JJ of_IN which_WDT could_MD be_VB delivered_VBN in_IN September_NNP if_IN the_DT Oxford_NNP vaccine_NN proves_VBZ successful_JJ ._. Read_VB :_: Everything_NN you_PRP need_VBP to_TO know_VB about_IN the_DT Oxford_NNP University_NNP vaccine_NN The_DT project_NN ,_, being_VBG developed_VBN by_IN clinical_JJ research_NN teams_NNS at_IN the_DT University_NNP of_IN Oxford_NNP ’s_POS Jenner_NNP Institute_NNP and_CC Oxford_NNP Vaccine_NNP Group_NNP in_IN the_DT U.K._NNP ,_, is_VBZ currently_RB in_IN the_DT human_JJ -_HYPH trial_NN stage_NN ._. The_DT university_NN ’s_POS best_JJS -_HYPH case_NN scenario_NN sees_VBZ an_DT efficacy_NN result_NN from_IN a_DT Phase_NN 3_CD study_NN by_IN the_DT fall_NN ,_, while_IN initial_JJ signs_NNS of_IN whether_IN it_PRP is_VBZ successful_JJ are_VBP expected_VBN by_IN July_NNP ._. The_DT FTSE_NNP 100_CD company_NN struck_VBD a_DT partnership_NN with_IN Oxford_NNP University_NNP at_IN the_DT end_NN of_IN April_NNP to_TO develop_VB ,_, manufacture_VB and_CC distribute_VB the_DT university_NN ’s_POS experimental_JJ vaccine_NN —_: if_IN it_PRP works_VBZ ._. The_DT U.K._NNP is_VBZ set_VBN to_TO be_VB given_VBN first_JJ access_NN to_IN the_DT potential_JJ vaccine_NN ,_, as_IN the_DT British_JJ government_NN said_VBD 30_CD million_CD doses_NNS could_MD be_VB made_VBN available_JJ as_RB early_RB as_IN September_NNP ,_, as_IN part_NN of_IN an_DT agreement_NN for_IN 100_CD million_CD doses_NNS ._. U.K._NNP business_NN secretary_NN Alok_NNP Sharma_NNP committed_VBD a_DT further_JJ £_$ 84_CD million_CD of_IN funding_NN to_IN the_DT project_NN on_IN Sunday_NNP —_: on_IN top_NN of_IN the_DT £_$ 47_CD million_CD already_RB invested_VBD —_: adding_VBG that_IN the_DT Oxford_NNP efforts_NNS were_VBD “_`` progressing_VBG well_RB ._. ”_'' AstraZeneca_NNP CEO_NN Pascal_NNP Soriot_NNP thanked_VBD the_DT U.S._NNP and_CC U.K._NNP governments_NNS for_IN their_PRP$ support_NN on_IN Thursday_NNP ,_, which_WDT he_PRP said_VBD would_MD accelerate_VB the_DT development_NN and_CC production_NN of_IN the_DT vaccine_NN ._. “_`` We_PRP need_VBP to_TO defeat_VB the_DT virus_NN together_RB or_CC it_PRP will_MD continue_VB to_TO inflict_VB huge_JJ personal_JJ suffering_NN and_CC leave_VB long_RB -_HYPH lasting_VBG economic_JJ and_CC social_JJ scars_NNS in_IN every_DT country_NN around_IN the_DT world_NN ._. We_PRP will_MD do_VB everything_NN in_IN our_PRP$ power_NN to_TO make_VB this_DT vaccine_NN quickly_RB and_CC widely_RB available_JJ ._. ”_'' The_DT British_JJ drug_NN maker_NN also_RB has_VBZ a_DT 7.7_CD %_NN stake_NN in_IN Massachusetts_NNP -_HYPH based_VBN biotech_NN company_NN Moderna_NNP ,_, whose_WP$ own_JJ experimental_JJ vaccine_NN has_VBZ been_VBN said_VBN to_TO have_VB had_VBN encouraging_VBG early_JJ results_NNS ._. Moderna_NNP ’s_POS stock_NN has_VBZ soared_VBN 275_CD %_NN so_RB far_RB this_DT year_NN ,_, taking_VBG the_DT value_NN of_IN AstraZeneca_NNP ’s_POS stake_NN above_IN $_$ 2_CD billion_CD ._.","JJ NN NN NNP NNP , VBZ VBN JJR than $ 1 billion in NNP NN to VB the NN of NNP NNP ’s NN NN NN . The NN would VB 300 million NNS of the NN JJ in the NNP , with the JJ NNS VBN in NNP , the NNP NNP of NNP & NNP NNPS VBD on NNP . The NN between NNP and the NNP NNP NNP and NNP NNP RB VBZ a NN 3 JJ NN in the NNP this NN with 30,000 NNS . The NNP VBZ RB VBN NN NNS by NNP NNP , , NNP ’s NNP NNP , and NNP & NNP NNP , , as NN of the NNP NN ’s “ NN NNP NN ” NN . NNP VBD it VBZ RB VBN NNS for 400 million NNS and VBZ the NN NN for 1 billion NNS — the JJ of which could VB VBN in NNP if the NNP NN VBZ JJ . VB : NN you VBP to VB about the NNP NNP NN The NN , VBG VBN by JJ NN NNS at the NNP of NNP ’s NNP NNP and NNP NNP NNP in the NNP , VBZ RB in the JJ - NN NN . The NN ’s JJS - NN NN VBZ an NN NN from a NN 3 NN by the NN , while JJ NNS of whether it VBZ JJ VBP VBN by NNP . The NNP 100 NN VBD a NN with NNP NNP at the NN of NNP to VB , VB and VB the NN ’s JJ NN — if it VBZ . The NNP VBZ VBN to VB VBN JJ NN to the JJ NN , as the JJ NN VBD 30 million NNS could VB VBN JJ RB RB as NNP , as NN of an NN for 100 million NNS . NNP NN NN NNP NNP VBD a JJ £ 84 million of NN to the NN on NNP — on NN of the £ 47 million RB VBD — VBG that the NNP NNS VBD “ VBG RB . ” NNP NN NNP NNP VBD the NNP and NNP NNS for their NN on NNP , which he VBD would VB the NN and NN of the NN . “ We VBP to VB the NN RB or it will VB to VB JJ JJ NN and VB RB - VBG JJ and JJ NNS in every NN around the NN . We will VB NN in our NN to VB this NN RB and RB JJ . ” The JJ NN NN RB VBZ a 7.7 NN NN in NNP - VBN NN NN NNP , whose JJ JJ NN VBZ VBN VBN to VB VBN VBG JJ NNS . NNP ’s NN VBZ VBN 275 NN RB RB this NN , VBG the NN of NNP ’s NN above $ 2 billion ."
189,534,mainstream,"Just_RB three_CD months_NNS after_IN China_NNP first_RB notified_VBD the_DT World_NNP Health_NNP Organization_NNP about_IN a_DT deadly_JJ new_JJ coronavirus_NN ,_, studies_NNS of_IN numerous_JJ antiviral_JJ treatments_NNS and_CC potential_JJ vaccines_NNS are_VBP already_RB underway_JJ ._. Never_RB has_VBZ science_NN advanced_VBN so_RB much_RB in_IN such_PDT a_DT short_JJ period_NN of_IN time_NN to_TO combat_VB an_DT epidemic_NN ._. Many_JJ of_IN the_DT proposals_NNS now_RB under_IN study_NN come_VBP from_IN research_NN groups_NNS that_WDT have_VBP spent_VBN years_NNS working_VBG to_TO combat_VB similar_JJ coronaviruses_NNS ,_, particularly_RB SARS_NN and_CC MERS_NNP ._. All_PDT that_IN accumulated_VBN knowledge_NN has_VBZ allowed_VBN scientists_NNS to_TO advance_VB at_IN unprecedented_JJ speed_NN ._. We_PRP know_VBP ,_, for_IN example_NN ,_, that_IN the_DT genome_NN of_IN the_DT novel_JJ coronavirus_NN ,_, called_VBN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, is_VBZ 79_CD %_NN like_IN that_DT of_IN SARS_NN ._. We_PRP know_VBP the_DT “_`` key_NN ”_'' used_VBN by_IN the_DT virus_NN to_TO get_VB into_IN human_JJ lung_NN cells_NNS is_VBZ protein_NN S_NN and_CC that_IN the_DT “_`` lock_NN ”_'' in_IN the_DT cell_NN is_VBZ the_DT ACE2_NN receptor_NN ._. We_PRP also_RB know_VBP that_IN the_DT entry_NN of_IN the_DT virus_NN is_VBZ facilitated_VBN by_IN a_DT protease_NN ,_, or_CC an_DT enzyme_NN that_WDT breaks_VBZ down_RP proteins_NNS ,_, from_IN the_DT cell_NN itself_PRP ,_, called_VBN TMPRSS211_NNP ._. Other_JJ SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD genes_NNS get_VBP to_IN work_NN once_IN the_DT virus_NN is_VBZ inside_IN the_DT lung_NN cell_NN :_: the_DT genes_NNS for_IN RNA_NN polymerase_NN (_-LRB- RdRp_NN )_-RRB- ,_, an_DT enzyme_NN that_WDT replicates_VBZ the_DT virus_NN genome_NN ,_, and_CC for_IN C3CLpro_NN and_CC PLpro_NN proteases_NNS ,_, which_WDT are_VBP involved_VBN in_IN the_DT processing_NN of_IN viral_JJ proteins_NNS ._. These_DT genes_NNS are_VBP likewise_RB very_RB similar_JJ to_IN those_DT of_IN SARS_NN ._. These_DT details_NNS are_VBP important_JJ ._. Understanding_VBG the_DT biology_NN of_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD –_: and_CC how_WRB it_PRP resembles_VBZ or_CC differs_VBZ from_IN other_JJ deadly_JJ viruses_NNS –_: facilitates_VBZ the_DT design_NN of_IN antiviral_JJ drugs_NNS to_TO treat_VB the_DT disease_NN and_CC vaccines_NNS to_TO prevent_VB it_PRP ._. Antivirals_NNS are_VBP drugs_NNS that_WDT interfere_VBP with_IN the_DT replication_NN of_IN harmful_JJ viruses_NNS without_IN also_RB harming_VBG the_DT host_NN cells_NNS ._. They_PRP can_MD work_VB by_IN blocking_VBG the_DT entry_NN of_IN the_DT virus_NN into_IN the_DT host_NN cell_NN ,_, or_CC by_IN inhibiting_VBG the_DT replication_NN of_IN the_DT virus_NN ._. Chloroquine_NNP has_VBZ been_VBN used_VBN for_IN years_NNS against_IN malaria_NN ._. This_DT cheap_JJ and_CC widely_RB available_JJ drug_NN is_VBZ also_RB a_DT powerful_JJ antiviral_NN ,_, meaning_VBG it_PRP blocks_VBZ a_DT virus_NN from_IN entering_VBG human_JJ cells_NNS ._. Several_JJ research_NN groups_NNS ,_, including_VBG one_CD at_IN the_DT University_NNP of_IN Minnesota_NNP ,_, are_VBP now_RB studying_VBG whether_IN it_PRP is_VBZ effective_JJ in_IN reducing_VBG the_DT viral_JJ load_NN in_IN patients_NNS with_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD ._. Some_DT enveloped_VBN viruses_NNS ,_, such_JJ as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, enter_VB the_DT cell_NN by_IN endocytosis_NN –_: a_DT cellular_JJ process_NN in_IN which_WDT substances_NNS are_VBP brought_VBN into_IN the_DT cell_NN –_: forming_VBG a_DT small_JJ vesicle_NN ._. Once_IN inside_RB ,_, a_DT drop_NN in_IN pH_NN promotes_VBZ the_DT fusion_NN of_IN the_DT virus_NN envelope_NN with_IN the_DT membrane_NN of_IN the_DT vesicle_NN that_WDT contains_VBZ it_PRP ,_, in_IN order_NN to_TO be_VB released_VBN into_IN the_DT cytoplasm_NN ._. Chloroquine_NNP prevents_VBZ this_DT drop_NN in_IN pH_NN ,_, inhibiting_VBG the_DT fusion_NN of_IN the_DT membranes_NNS and_CC thus_RB prevent_VB the_DT passage_NN of_IN the_DT virus_NN to_IN the_DT cell_NN cytoplasm_NN ._. Hydroxychloroquine_NN ,_, a_DT less_RBR toxic_JJ derivative_NN of_IN chloroquine_NN ,_, has_VBZ already_RB been_VBN found_VBN to_TO inhibit_VB the_DT replication_NN of_IN SARS_NN -_HYPH CoV_NN -_HYPH 2_CD in_IN vitro_NN in_IN cell_NN culture_NN ._. Researchers_NNS are_VBP also_RB testing_VBG Barcitinib_NNP ,_, an_DT anti-inflammatory_JJ drug_NN approved_VBN to_TO treat_VB rheumatoid_NN arthritis_NN ,_, which_WDT may_MD also_RB inhibit_VB endocytosis_NN of_IN the_DT virus_NN ._. Another_DT drug_NN they_PRP are_VBP testing_VBG is_VBZ camostat_NN mesylate_NN ,_, a_DT drug_NN approved_VBN in_IN Japan_NNP for_IN use_NN in_IN treating_VBG inflammation_NN of_IN the_DT pancreas_NN ,_, which_WDT has_VBZ been_VBN shown_VBN to_TO block_VB the_DT entry_NN of_IN the_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN into_IN lung_NN cells_NNS ._. One_CD of_IN the_DT most_RBS promising_JJ antiviral_JJ treatments_NNS for_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ called_VBN remdesivir_NN ,_, which_WDT has_VBZ been_VBN used_VBN successfully_RB against_IN SARS_NNP ,_, MERS_NNP and_CC Ebola_NNP ._. Remdesivir_NNP is_VBZ nucleotide_NN analogue_NN ,_, a_DT major_JJ class_NN of_IN anti-cancer_JJ and_CC antiviral_JJ drugs_NNS that_WDT prevents_VBZ the_DT virus_NN from_IN multiplying_VBG within_IN the_DT cell_NN ._. At_IN least_JJS 13_CD clinical_JJ trials_NNS are_VBP already_RB underway_JJ in_IN China_NNP and_CC the_DT United_NNP States_NNPS to_TO see_VB if_IN remdesivir_NN may_MD stop_VB SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. Another_DT wide_JJ -_HYPH spectrum_NN viral_JJ RNA_NN polymerase_NN inhibitor_NN that_WDT has_VBZ already_RB started_VBN clinical_JJ trials_NNS is_VBZ called_VBN favipiravir_NN ,_, already_RB an_DT approved_VBN flu_NN treatment_NN ._. The_DT first_JJ results_NNS with_IN 340_CD Chinese_JJ patients_NNS have_VBP been_VBN satisfactory_JJ ,_, reducing_VBG the_DT number_NN of_IN days_NNS coronavirus_NN patients_NNS were_VBD sick_JJ ._. Some_DT scientists_NNS have_VBP suggested_VBN that_IN a_DT combination_NN of_IN the_DT drugs_NNS ritonavir_NN and_CC lopinavir_NN –_: compounds_NNS used_VBN to_TO treat_VB HIV_NN –_: may_MD also_RB inhibit_VB SARS_NN -_HYPH CoV_NN -_HYPH 2_CD proteases_NNS ,_, or_CC enzymes_NNS that_WDT break_VBP down_RP proteins_NNS ._. Lopinavir_NNP is_VBZ a_DT virus_NN protease_NN inhibitor_NN that_WDT breaks_VBZ down_RP easily_RB in_IN the_DT patient_NN ’s_POS blood_NN ._. Ritonavir_NNP is_VBZ administered_VBN with_IN lopinavir_NN to_TO protect_VB it_PRP from_IN breaking_VBG down_RP ._. A_DT recently_RB published_VBN article_NN detailing_VBG the_DT results_NNS of_IN a_DT study_NN of_IN 199_CD patients_NNS shows_VBZ that_IN the_DT ritonavir_NN /_, lopinavir_NN treatment_NN is_VBZ not_RB effective_JJ against_IN coronavirus_NN ._. At_IN least_JJS 27_CD other_JJ clinical_JJ trials_NNS with_IN experimental_JJ combinations_NNS of_IN different_JJ antiviral_JJ treatments_NNS –_: such_JJ as_IN interferon_NN alfa_NN -_HYPH 2b_CD ,_, ribavirin_NN ,_, methylprednisolone_NN and_CC azvudine_NN –_: are_VBP now_RB underway_JJ ._. The_DT World_NNP Health_NNP Organization_NNP highlights_VBZ at_IN least_JJS 41_CD proposed_VBN vaccines_NNS for_IN testing_NN against_IN coronavirus_NN ._. Vaccines_NNS are_VBP a_DT prevention_NN strategy_NN ._. If_IN they_PRP are_VBP developed_VBN now_RB ,_, they_PRP can_MD give_VB people_NNS immunity_NN from_IN future_JJ outbreaks_NNS ._. One_CD of_IN the_DT most_RBS advanced_JJ efforts_NNS is_VBZ happening_VBG in_IN China_NNP with_IN a_DT recombinant_JJ adenovirus_NN vector_NN -_HYPH based_VBN vaccine_NN based_VBN on_IN the_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD S_NN gene_NN ._. When_WRB tested_VBN in_IN monkeys_NNS ,_, this_DT vaccine_NN candidate_NN produced_VBD antibodies_NNS ,_, which_WDT help_VBP fight_VB the_DT virus_NN ._. A_DT phase_NN I_PRP clinical_JJ trial_NN will_MD soon_RB begin_VB in_IN Wuhan_NNP with_IN 108_CD healthy_JJ volunteers_NNS between_IN 18_CD and_CC 60_CD years_NNS old_JJ ,_, in_IN which_WDT three_CD different_JJ doses_NNS will_MD be_VB tested_VBN ._. The_DT goal_NN of_IN a_DT phase_NN I_PRP trial_NN is_VBZ to_TO check_VB the_DT safety_NN of_IN the_DT vaccine_NN at_IN different_JJ doses_NNS ,_, evaluating_VBG any_DT side_NN effects_NNS ._. If_IN a_DT drug_NN is_VBZ proven_VBN to_TO be_VB safe_JJ ,_, it_PRP may_MD then_RB be_VB moved_VBN into_IN a_DT phase_NN II_CD trial_NN ,_, in_IN which_WDT the_DT drug_NN is_VBZ administered_VBN to_IN people_NNS to_TO see_VB if_IN it_PRP works_VBZ ._. Other_JJ proposals_NNS are_VBP being_VBG promoted_VBN by_IN CEPI_NNP ,_, an_DT international_JJ association_NN in_IN which_WDT public_JJ ,_, private_JJ ,_, civil_JJ and_CC philanthropic_JJ organizations_NNS collaborate_VBP to_TO develop_VB vaccines_NNS against_IN future_JJ epidemics_NNS ._. It_PRP is_VBZ currently_RB funding_VBG eight_CD coronavirus_NN vaccine_NN projects_NNS that_WDT include_VBP recombinant_NN ,_, protein_NN ,_, and_CC nucleic_JJ acid_NN vaccines_NNS (_-LRB- all_DT are_VBP in_IN the_DT preclinical_JJ phase_NN unless_IN otherwise_RB noted_VBN )_-RRB- :_: Recombinant_JJ measles_NNS virus_NN vaccine_NN (_-LRB- Pasteur_NNP Institute_NNP ,_, Themis_NNP Bioscience_NNP and_CC University_NNP of_IN Pittsburg_NNP )_-RRB- -_, Adds_VBZ a_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD gene_NN to_IN a_DT non-virulent_JJ measles_NN virus_NN to_TO induce_VB a_DT protective_JJ response_NN ._. Recombinant_JJ influenza_NN virus_NN vaccine_NN (_-LRB- University_NNP of_IN Hong_NNP Kong_NNP )_-RRB- -_, Adds_VBZ a_DT SARS_NN -_HYPH CoV_NN -_HYPH 2_CD gene_NN to_IN a_DT non-virulent_JJ strain_NN of_IN the_DT flu_NN ,_, which_WDT could_MD be_VB administered_VBN intranasally_RB and_CC work_VB dually_RB as_IN a_DT flu_NN vaccine_NN ._. Recombinant_JJ vaccine_NN using_VBG the_DT Oxford_NNP chimpanzee_NN adenovirus_NN ,_, ChAdOx1_NNP (_-LRB- Jenner_NNP Institute_NNP ,_, University_NNP of_IN Oxford_NNP )_-RRB- -_, Models_NNS of_IN this_DT vaccine_NN type_NN have_VBP been_VBN tested_VBN against_IN MERS_NN ,_, influenza_NN ,_, chikungunya_NN and_CC other_JJ pathogens_NNS such_JJ as_IN malaria_NN and_CC tuberculosis_NN ,_, and_CC can_MD be_VB manufactured_VBN in_IN large_JJ scale_NN in_IN bird_NN embryo_NN cell_NN lines_NNS ._. Recombinant_JJ protein_NN vaccine_NN (_-LRB- Novavax_NNP )_-RRB- -_, This_DT vaccine_NN relies_VBZ on_IN nanoparticle_NN technology_NN ,_, a_DT proprietary_JJ technology_NN that_WDT Novavax_NNP has_VBZ already_RB employed_VBN to_TO manufacture_VB several_JJ well_RB -_HYPH tolerated_VBN vaccines_NNS that_WDT stimulate_VBP a_DT powerful_JJ and_CC long_JJ -_HYPH lasting_VBG non-specific_JJ immune_JJ response_NN that_WDT prevents_VBZ respiratory_JJ infections_NNS like_IN adult_JJ flu_NN ,_, SARS_NN and_CC MERS_NN ._. Recombinant_JJ protein_NN vaccine_NN (_-LRB- University_NNP of_IN Queensland_NNP )_-RRB- -_, This_DT vaccine_NN relies_VBZ on_IN the_DT creation_NN of_IN chimeric_JJ molecules_NNS capable_JJ of_IN maintaining_VBG the_DT original_JJ three_CD -_HYPH dimensional_JJ structure_NN of_IN the_DT viral_JJ antigen_NN ._. They_PRP use_VBP the_DT technique_NN called_VBN “_`` molecular_JJ clamp_NN ,_, ”_'' which_WDT allows_VBZ vaccines_NNS to_TO be_VB produced_VBN using_VBG the_DT virus_NN genome_NN in_IN record_JJ time_NN ._. It_PRP is_VBZ in_IN the_DT preclinical_JJ phase_NN ._. Vaccine_NN mRNA_NN -1273_CD (_-LRB- Moderna_NNP )_-RRB- made_VBD up_RP of_IN a_DT small_JJ fragment_NN of_IN messenger_NN RNA_NN with_IN the_DT instructions_NNS to_TO synthesize_VB part_NN of_IN the_DT SARS_NN -_HYPH Co_NNP -_HYPH V_NNP protein_NN S_NN ._. The_DT idea_NN is_VBZ that_IN once_IN introduced_VBN into_IN our_PRP$ cells_NNS ,_, they_PRP would_MD make_VB this_DT protein_NN ,_, which_WDT would_MD then_RB act_VB as_IN an_DT antigen_NN and_CC stimulate_VB the_DT production_NN of_IN antibodies_NNS ._. It_PRP is_VBZ already_RB in_IN the_DT clinical_JJ phase_NN and_CC it_PRP has_VBZ begun_VBN to_TO be_VB tested_VBN in_IN healthy_JJ volunteers_NNS ._. Messenger_NN RNA_NN vaccine_NN (_-LRB- CureVac_NNP )_-RRB- -_, This_DT is_VBZ similar_JJ to_IN the_DT Moderna_NNP proposal_NN ,_, with_IN recombinant_JJ messenger_NN RNA_NN molecules_NNS that_WDT are_VBP easily_RB recognized_VBN by_IN the_DT cellular_JJ machinery_NN and_CC produce_VBP large_JJ amounts_NNS of_IN antigen_NN ._. They_PRP are_VBP packaged_VBN in_IN lipid_JJ nanoparticles_NNS or_CC other_JJ vectors_NNS ._. DNA_NNP INO_NNP -_HYPH 4800_CD vaccine_NN (_-LRB- Inovio_NNP Pharmaceuticals_NNP )_-RRB- -_, Inovio_NNP manufactures_VBZ synthetic_JJ vaccines_NNS using_VBG DNA_NN of_IN the_DT S_NN gene_NN that_WDT is_VBZ present_JJ in_IN the_DT surface_NN of_IN the_DT coronavirus_NN ._. Clinical_JJ tests_NNS of_IN a_DT similar_JJ prototype_NN vaccine_NN against_IN MERS_NN ,_, called_VBN the_DT INO_NNP -_HYPH 4700_CD vaccine_NN ,_, found_VBD that_IN the_DT drug_NN was_VBD well_RB tolerated_VBN and_CC produced_VBD a_DT good_JJ immune_JJ response_NN (_-LRB- high_JJ antibody_NN levels_NNS and_CC good_JJ T_NN -_HYPH cell_NN response_NN ,_, maintained_VBN for_IN at_IN least_JJS 60_CD weeks_NNS after_IN vaccination_NN )_-RRB- ._. Finally_RB ,_, two_CD Spanish_JJ researchers_NNS ,_, Luis_NNP Enjuanes_NNP and_CC Isabel_NNP Sola_NNP ,_, have_VBP just_RB received_VBN express_JJ funding_NN from_IN the_DT Spanish_JJ government_NN to_TO develop_VB a_DT live_JJ attenuated_VBN coronavirus_NN vaccine_NN that_WDT would_MD create_VB an_DT altered_VBN copy_NN of_IN the_DT virus_NN that_WDT is_VBZ incapable_JJ of_IN producing_VBG the_DT disease_NN but_CC that_WDT serves_VBZ to_TO activate_VB our_PRP$ defenses_NNS ._. There_EX is_VBZ still_RB no_DT approved_VBN antiviral_JJ or_CC specific_JJ SARS_NN -_HYPH CoV_NN -_HYPH 2_CD vaccine_NN ._. All_DT of_IN these_DT antiviral_JJ and_CC vaccine_NN proposals_NNS are_VBP in_IN the_DT experimental_JJ phase_NN ._. Some_DT will_MD not_RB work_VB ,_, but_CC the_DT chances_NNS of_IN finding_VBG one_CD that_WDT will_MD are_VB high_JJ ._. The_DT WHO_NNP ’s_POS new_JJ international_JJ consortium_NN ,_, called_VBN Solidarity_NNP ,_, seeks_VBZ effective_JJ treatment_NN for_IN COVID_NNP -_HYPH 19_CD ._. At_IN the_DT moment_NN ,_, Argentina_NNP ,_, Bahrain_NNP ,_, Canada_NNP ,_, France_NNP ,_, Iran_NNP ,_, Norway_NNP ,_, South_NNP Africa_NNP ,_, Spain_NNP ,_, Switzerland_NNP and_CC Thailand_NNP are_VBP participating_VBG ,_, and_CC it_PRP is_VBZ expected_VBN that_IN ever_RB more_JJR nations_NNS will_MD join_VB in_IN this_DT great_JJ global_JJ clinical_JJ trial_NN project_NN ._. [_-LRB- You_PRP ’re_VBP smart_JJ and_CC curious_JJ about_IN the_DT world_NN ._. So_RB are_VBP The_DT Conversation_NN ’s_POS authors_NNS and_CC editors_NNS ._. You_PRP can_MD get_VB our_PRP$ highlights_NNS each_DT weekend_NN ._. ]_-RRB-","RB three NNS after NNP RB VBD the NNP NNP NNP about a JJ JJ NN , NNS of JJ JJ NNS and JJ NNS VBP RB JJ . RB VBZ NN VBN RB RB in such a JJ NN of NN to VB an NN . JJ of the NNS RB under NN VBP from NN NNS that VBP VBN NNS VBG to VB JJ NNS , RB NN and NNP . All that VBN NN VBZ VBN NNS to VB at JJ NN . We VBP , for NN , that the NN of the JJ NN , VBN NNP - NNP - 2 , VBZ 79 NN like that of NN . We VBP the “ NN ” VBN by the NN to VB into JJ NN NNS VBZ NN NN and that the “ NN ” in the NN VBZ the NN NN . We RB VBP that the NN of the NN VBZ VBN by a NN , or an NN that VBZ down NNS , from the NN itself , VBN NNP . JJ NNP - NNP - 2 NNS VBP to NN once the NN VBZ inside the NN NN : the NNS for NN NN ( NN ) , an NN that VBZ the NN NN , and for NN and NN NNS , which VBP VBN in the NN of JJ NNS . These NNS VBP RB RB JJ to those of NN . These NNS VBP JJ . VBG the NN of NN - NN - 2 – and how it VBZ or VBZ from JJ JJ NNS – VBZ the NN of JJ NNS to VB the NN and NNS to VB it . NNS VBP NNS that VBP with the NN of JJ NNS without RB VBG the NN NNS . They can VB by VBG the NN of the NN into the NN NN , or by VBG the NN of the NN . NNP VBZ VBN VBN for NNS against NN . This JJ and RB JJ NN VBZ RB a JJ NN , VBG it VBZ a NN from VBG JJ NNS . JJ NN NNS , VBG one at the NNP of NNP , VBP RB VBG whether it VBZ JJ in VBG the JJ NN in NNS with NN - NN - 2 . Some VBN NNS , JJ as NNP - NNP - 2 , VB the NN by NN – a JJ NN in which NNS VBP VBN into the NN – VBG a JJ NN . Once RB , a NN in NN VBZ the NN of the NN NN with the NN of the NN that VBZ it , in NN to VB VBN into the NN . NNP VBZ this NN in NN , VBG the NN of the NNS and RB VB the NN of the NN to the NN NN . NN , a RBR JJ NN of NN , VBZ RB VBN VBN to VB the NN of NN - NN - 2 in NN in NN NN . NNS VBP RB VBG NNP , an JJ NN VBN to VB NN NN , which may RB VB NN of the NN . Another NN they VBP VBG VBZ NN NN , a NN VBN in NNP for NN in VBG NN of the NN , which VBZ VBN VBN to VB the NN of the NN - NN - 2 NN into NN NNS . One of the RBS JJ JJ NNS for NNP - NNP - 2 VBZ VBN NN , which VBZ VBN VBN RB against NNP , NNP and NNP . NNP VBZ NN NN , a JJ NN of JJ and JJ NNS that VBZ the NN from VBG within the NN . At JJS 13 JJ NNS VBP RB JJ in NNP and the NNP NNPS to VB if NN may VB NNP - NNP - 2 . Another JJ - NN JJ NN NN NN that VBZ RB VBN JJ NNS VBZ VBN NN , RB an VBN NN NN . The JJ NNS with 340 JJ NNS VBP VBN JJ , VBG the NN of NNS NN NNS VBD JJ . Some NNS VBP VBN that a NN of the NNS NN and NN – NNS VBN to VB NN – may RB VB NN - NN - 2 NNS , or NNS that VBP down NNS . NNP VBZ a NN NN NN that VBZ down RB in the NN ’s NN . NNP VBZ VBN with NN to VB it from VBG down . A RB VBN NN VBG the NNS of a NN of 199 NNS VBZ that the NN / NN NN VBZ RB JJ against NN . At JJS 27 JJ JJ NNS with JJ NNS of JJ JJ NNS – JJ as NN NN - 2b , NN , NN and NN – VBP RB JJ . The NNP NNP NNP VBZ at JJS 41 VBN NNS for NN against NN . NNS VBP a NN NN . If they VBP VBN RB , they can VB NNS NN from JJ NNS . One of the RBS JJ NNS VBZ VBG in NNP with a JJ NN NN - VBN NN VBN on the NNP - NNP - 2 NN NN . When VBN in NNS , this NN NN VBD NNS , which VBP VB the NN . A NN I JJ NN will RB VB in NNP with 108 JJ NNS between 18 and 60 NNS JJ , in which three JJ NNS will VB VBN . The NN of a NN I NN VBZ to VB the NN of the NN at JJ NNS , VBG any NN NNS . If a NN VBZ VBN to VB JJ , it may RB VB VBN into a NN II NN , in which the NN VBZ VBN to NNS to VB if it VBZ . JJ NNS VBP VBG VBN by NNP , an JJ NN in which JJ , JJ , JJ and JJ NNS VBP to VB NNS against JJ NNS . It VBZ RB VBG eight NN NN NNS that VBP NN , NN , and JJ NN NNS ( all VBP in the JJ NN unless RB VBN ) : JJ NNS NN NN ( NNP NNP , NNP NNP and NNP of NNP ) - VBZ a NN - NN - 2 NN to a JJ NN NN to VB a JJ NN . JJ NN NN NN ( NNP of NNP NNP ) - VBZ a NN - NN - 2 NN to a JJ NN of the NN , which could VB VBN RB and VB RB as a NN NN . JJ NN VBG the NNP NN NN , NNP ( NNP NNP , NNP of NNP ) - NNS of this NN NN VBP VBN VBN against NN , NN , NN and JJ NNS JJ as NN and NN , and can VB VBN in JJ NN in NN NN NN NNS . JJ NN NN ( NNP ) - This NN VBZ on NN NN , a JJ NN that NNP VBZ RB VBN to VB JJ RB - VBN NNS that VBP a JJ and JJ - VBG JJ JJ NN that VBZ JJ NNS like JJ NN , NN and NN . JJ NN NN ( NNP of NNP ) - This NN VBZ on the NN of JJ NNS JJ of VBG the JJ three - JJ NN of the JJ NN . They VBP the NN VBN “ JJ NN , ” which VBZ NNS to VB VBN VBG the NN NN in JJ NN . It VBZ in the JJ NN . NN NN -1273 ( NNP ) VBD up of a JJ NN of NN NN with the NNS to VB NN of the NN - NNP - NNP NN NN . The NN VBZ that once VBN into our NNS , they would VB this NN , which would RB VB as an NN and VB the NN of NNS . It VBZ RB in the JJ NN and it VBZ VBN to VB VBN in JJ NNS . NN NN NN ( NNP ) - This VBZ JJ to the NNP NN , with JJ NN NN NNS that VBP RB VBN by the JJ NN and VBP JJ NNS of NN . They VBP VBN in JJ NNS or JJ NNS . NNP NNP - 4800 NN ( NNP NNP ) - NNP VBZ JJ NNS VBG NN of the NN NN that VBZ JJ in the NN of the NN . JJ NNS of a JJ NN NN against NN , VBN the NNP - 4700 NN , VBD that the NN VBD RB VBN and VBD a JJ JJ NN ( JJ NN NNS and JJ NN - NN NN , VBN for at JJS 60 NNS after NN ) . RB , two JJ NNS , NNP NNP and NNP NNP , VBP RB VBN JJ NN from the JJ NN to VB a JJ VBN NN NN that would VB an VBN NN of the NN that VBZ JJ of VBG the NN but that VBZ to VB our NNS . There VBZ RB no VBN JJ or JJ NN - NN - 2 NN . All of these JJ and NN NNS VBP in the JJ NN . Some will RB VB , but the NNS of VBG one that will VB JJ . The NNP ’s JJ JJ NN , VBN NNP , VBZ JJ NN for NNP - 19 . At the NN , NNP , NNP , NNP , NNP , NNP , NNP , NNP NNP , NNP , NNP and NNP VBP VBG , and it VBZ VBN that RB JJR NNS will VB in this JJ JJ JJ NN NN . [ You VBP JJ and JJ about the NN . RB VBP The NN ’s NNS and NNS . You can VB our NNS each NN . ]"
190,399,mainstream,"The_DT University_NNP of_IN Chicago_NNP (_-LRB- UChicago_NNP ,_, U_NNP of_IN C_NNP ,_, or_CC Chicago_NNP )_-RRB- is_VBZ a_DT private_JJ research_NN university_NN in_IN Chicago_NNP ,_, Illinois_NNP ._. Founded_VBN in_IN 1890_CD ,_, the_DT school_NN is_VBZ located_VBN on_IN a_DT 217_CD -_HYPH acre_NN (_-LRB- 88_CD -_HYPH hectare_NN )_-RRB- campus_NN in_IN Chicago_NNP 's_POS Hyde_NNP Park_NNP neighborhood_NN ._. [_-LRB- 6_CD ]_-RRB- The_DT university_NN is_VBZ composed_VBN of_IN the_DT undergraduate_JJ college_NN as_RB well_RB as_IN various_JJ graduate_NN programs_NNS and_CC interdisciplinary_JJ committees_NNS organized_VBN into_IN five_CD academic_JJ research_NN divisions_NNS ._. Beyond_IN the_DT arts_NNS and_CC sciences_NNS ,_, Chicago_NNP is_VBZ well_RB known_VBN for_IN its_PRP$ professional_JJ schools_NNS ,_, which_WDT include_VBP the_DT Pritzker_NNP School_NNP of_IN Medicine_NNP ,_, the_DT Booth_NNP School_NNP of_IN Business_NNP ,_, the_DT Law_NNP School_NNP ,_, the_DT School_NNP of_IN Social_NNP Service_NNP Administration_NNP ,_, the_DT Harris_NNP School_NNP of_IN Public_NNP Policy_NNP ,_, the_DT Divinity_NNP School_NNP and_CC the_DT Graham_NNP School_NNP of_IN Continuing_NNP Liberal_NNP and_CC Professional_NNP Studies_NNPS ,_, as_RB well_RB as_IN the_DT recently_RB launched_VBN Pritzker_NNP School_NNP of_IN Molecular_NNP Engineering_NNP ._. The_DT university_NN has_VBZ additional_JJ campuses_NNS and_CC centers_NNS in_IN London_NNP ,_, Paris_NNP ,_, Beijing_NNP ,_, Delhi_NNP ,_, and_CC Hong_NNP Kong_NNP ,_, as_RB well_RB as_IN in_IN downtown_NN Chicago_NNP ._. [_-LRB- 7_CD ]_-RRB- [_-LRB- 8_CD ]_-RRB- University_NNP of_IN Chicago_NNP scholars_NNS have_VBP played_VBN a_DT major_JJ role_NN in_IN the_DT development_NN of_IN many_JJ academic_JJ disciplines_NNS ,_, including_VBG economics_NN ,_, law_NN ,_, literary_JJ criticism_NN ,_, mathematics_NN ,_, religion_NN ,_, sociology_NN ,_, and_CC the_DT behavioralism_NN school_NN of_IN political_JJ science_NN ,_, establishing_VBG the_DT Chicago_NNP schools_NNS in_IN various_JJ fields_NNS ._. [_-LRB- 9_CD ]_-RRB- [_-LRB- 10_CD ]_-RRB- [_-LRB- 11_CD ]_-RRB- [_-LRB- 12_CD ]_-RRB- [_-LRB- 13_CD ]_-RRB- Chicago_NNP 's_POS Metallurgical_NNP Laboratory_NNP produced_VBD the_DT world_NN 's_POS first_JJ man-made_JJ ,_, self_NN -_HYPH sustaining_VBG nuclear_JJ reaction_NN in_IN Chicago_NNP Pile_NNP -_HYPH 1_CD beneath_IN the_DT viewing_NN stands_NNS of_IN the_DT university_NN 's_POS Stagg_NNP Field_NNP ._. [_-LRB- 14_CD ]_-RRB- Advances_NNS in_IN chemistry_NN led_VBD to_IN the_DT ""_`` radiocarbon_NN revolution_NN ""_'' in_IN the_DT carbon_NN -_HYPH 14_CD dating_NN of_IN ancient_JJ life_NN and_CC objects_NNS ._. [_-LRB- 15_CD ]_-RRB- The_DT university_NN research_NN efforts_NNS include_VBP administration_NN of_IN Fermi_NNP National_NNP Accelerator_NNP Laboratory_NNP and_CC Argonne_NNP National_NNP Laboratory_NNP ,_, as_RB well_RB as_IN the_DT Marine_NNP Biological_NNP Laboratory_NNP ._. The_DT university_NN is_VBZ also_RB home_NN to_IN the_DT University_NNP of_IN Chicago_NNP Press_NNP ,_, the_DT largest_JJS university_NN press_NN in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 16_CD ]_-RRB- The_DT Barack_NNP Obama_NNP Presidential_NNP Center_NNP is_VBZ expected_VBN to_TO be_VB housed_VBN at_IN the_DT university_NN and_CC will_MD include_VB both_CC the_DT Obama_NNP presidential_JJ library_NN and_CC offices_NNS of_IN the_DT Obama_NNP Foundation_NNP ._. [_-LRB- 17_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP has_VBZ produced_VBN many_JJ prominent_JJ alumni_NNS ,_, faculty_NN members_NNS and_CC researchers_NNS ._. As_IN of_IN October_NNP 2019_CD ,_, 100_CD Nobel_NNP laureates_NNS have_VBP been_VBN affiliated_VBN with_IN the_DT university_NN as_IN students_NNS ,_, faculty_NN ,_, or_CC staff_NN ,_, giving_VBG it_PRP one_CD of_IN the_DT highest_JJS concentrations_NNS of_IN Nobel_NNP laureates_NNS in_IN the_DT world_NN ._. [_-LRB- 18_CD ]_-RRB- As_IN of_IN 2018_CD ,_, UChicago_NNP affiliates_NNS also_RB include_VBP 54_CD Rhodes_NNP Scholars_NNPS ,_, [_-LRB- 19_CD ]_-RRB- 26_CD Marshall_NNP Scholars_NNPS ,_, [_-LRB- 20_CD ]_-RRB- 9_CD Fields_NNPS Medalists_NNPS ,_, [_-LRB- 21_CD ]_-RRB- 4_CD Turing_NNP Award_NNP winners_NNS ,_, 52_CD MacArthur_NNP Fellows_NNPS ,_, [_-LRB- 22_CD ]_-RRB- 25_CD Pulitzer_NNP Prize_NNP winners_NNS ,_, [_-LRB- 23_CD ]_-RRB- 20_CD National_NNP Humanities_NNPS Medalists_NNPS [_-LRB- 24_CD ]_-RRB- and_CC 16_CD billionaire_NN graduates_NNS ._. [_-LRB- 25_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP was_VBD incorporated_VBN as_IN a_DT coeducational_JJ [_-LRB- 26_CD ]_-RRB- institution_NN in_IN 1890_CD by_IN the_DT American_NNP Baptist_NNP Education_NNP Society_NNP ,_, using_VBG $_$ 400,000_CD donated_VBN to_IN the_DT ABES_NNP to_TO match_VB a_DT $_$ 600,000_CD donation_NN from_IN Baptist_NNP oil_NN magnate_NN and_CC philanthropist_NN John_NNP D._NNP Rockefeller_NNP ,_, [_-LRB- 27_CD ]_-RRB- and_CC including_VBG land_NN donated_VBN by_IN Marshall_NNP Field_NNP ._. [_-LRB- 28_CD ]_-RRB- While_IN the_DT Rockefeller_NNP donation_NN provided_VBD money_NN for_IN academic_JJ operations_NNS and_CC long_JJ -_HYPH term_NN endowment_NN ,_, it_PRP was_VBD stipulated_VBN that_IN such_JJ money_NN could_MD not_RB be_VB used_VBN for_IN buildings_NNS ._. The_DT Hyde_NNP Park_NNP campus_NN was_VBD financed_VBN by_IN donations_NNS from_IN wealthy_JJ Chicagoans_NNPS like_IN Silas_NNP B._NNP Cobb_NNP who_WP provided_VBD the_DT funds_NNS for_IN the_DT campus_NN '_POS first_JJ building_NN ,_, Cobb_NNP Lecture_NNP Hall_NNP ,_, and_CC matched_VBD Marshall_NNP Field_NNP 's_POS pledge_NN of_IN $_$ 100,000_CD ._. Other_JJ early_JJ benefactors_NNS included_VBD businessmen_NNS Charles_NNP L._NNP Hutchinson_NNP (_-LRB- trustee_NN ,_, treasurer_NN and_CC donor_NN of_IN Hutchinson_NNP Commons_NNP )_-RRB- ,_, Martin_NNP A._NNP Ryerson_NNP (_-LRB- president_NN of_IN the_DT board_NN of_IN trustees_NNS and_CC donor_NN of_IN the_DT Ryerson_NNP Physical_NNP Laboratory_NNP )_-RRB- Adolphus_NNP Clay_NNP Bartlett_NNP and_CC Leon_NNP Mandel_NNP ,_, who_WP funded_VBD the_DT construction_NN of_IN the_DT gymnasium_NN and_CC assembly_NN hall_NN ,_, and_CC George_NNP C._NNP Walker_NNP of_IN the_DT Walker_NNP Museum_NNP ,_, a_DT relative_NN of_IN Cobb_NNP who_WP encouraged_VBD his_PRP$ inaugural_JJ donation_NN for_IN facilities_NNS ._. [_-LRB- 29_CD ]_-RRB- The_DT Hyde_NNP Park_NNP campus_NN continued_VBD the_DT legacy_NN of_IN the_DT original_JJ university_NN of_IN the_DT same_JJ name_NN ,_, which_WDT had_VBD closed_VBN in_IN the_DT 1880s_NNS after_IN its_PRP$ campus_NN was_VBD foreclosed_VBN on_IN ._. [_-LRB- 30_CD ]_-RRB- What_WP became_VBD known_VBN as_IN the_DT Old_NNP University_NNP of_IN Chicago_NNP had_VBD been_VBN founded_VBN by_IN a_DT small_JJ group_NN of_IN Baptist_NNP educators_NNS in_IN 1856_CD through_IN a_DT land_NN endowment_NN from_IN Senator_NNP Stephen_NNP A._NNP Douglas_NNP ._. After_IN a_DT fire_NN ,_, it_PRP closed_VBD in_IN 1886_CD ._. [_-LRB- 31_CD ]_-RRB- Alumni_NNP from_IN the_DT Old_NNP University_NNP of_IN Chicago_NNP are_VBP recognized_VBN as_IN alumni_NNS of_IN the_DT present_JJ University_NNP of_IN Chicago_NNP ._. [_-LRB- 32_CD ]_-RRB- The_DT university_NN 's_POS depiction_NN on_IN its_PRP$ coat_NN of_IN arms_NNS of_IN a_DT phoenix_NN rising_VBG from_IN the_DT ashes_NNS is_VBZ a_DT reference_NN to_IN the_DT fire_NN ,_, foreclosure_NN ,_, and_CC demolition_NN of_IN the_DT Old_NNP University_NNP of_IN Chicago_NNP campus_NN ._. [_-LRB- 33_CD ]_-RRB- As_IN an_DT homage_NN to_IN this_DT pre-1890_JJ legacy_NN ,_, a_DT single_JJ stone_NN from_IN the_DT rubble_NN of_IN the_DT original_JJ Douglas_NNP Hall_NNP on_IN 34th_NNP Place_NNP was_VBD brought_VBN to_IN the_DT current_JJ Hyde_NNP Park_NNP location_NN and_CC set_VBD into_IN the_DT wall_NN of_IN the_DT Classics_NNP Building_NNP ._. These_DT connections_NNS have_VBP led_VBN the_DT Dean_NNP of_IN the_DT College_NNP and_CC University_NNP of_IN Chicago_NNP and_CC Professor_NNP of_IN History_NNP John_NNP Boyer_NNP to_TO conclude_VB that_IN the_DT University_NNP of_IN Chicago_NNP has_VBZ ,_, ""_`` a_DT plausible_JJ genealogy_NN as_IN a_DT pre–Civil_NNP War_NNP institution_NN ""_'' ._. [_-LRB- 34_CD ]_-RRB- William_NNP Rainey_NNP Harper_NNP became_VBD the_DT university_NN 's_POS president_NN on_IN July_NNP 1_CD ,_, 1891_CD and_CC the_DT Hyde_NNP Park_NNP campus_NN opened_VBD for_IN classes_NNS on_IN October_NNP 1_CD ,_, 1892_CD ._. [_-LRB- 30_CD ]_-RRB- Harper_NNP worked_VBD on_IN building_VBG up_RP the_DT faculty_NN and_CC in_IN two_CD years_NNS he_PRP had_VBD a_DT faculty_NN of_IN 120_CD ,_, including_VBG eight_CD former_JJ university_NN or_CC college_NN presidents_NNS ._. [_-LRB- 35_CD ]_-RRB- Harper_NNP was_VBD an_DT accomplished_VBN scholar_NN (_-LRB- Semiticist_NN )_-RRB- and_CC a_DT member_NN of_IN the_DT Baptist_NNP clergy_NNS who_WP believed_VBD that_IN a_DT great_JJ university_NN should_MD maintain_VB the_DT study_NN of_IN faith_NN as_IN a_DT central_JJ focus_NN ._. [_-LRB- 36_CD ]_-RRB- To_TO fulfill_VB this_DT commitment_NN ,_, he_PRP brought_VBD the_DT Old_NNP University_NNP of_IN Chicago_NNP 's_POS Seminary_NNP to_IN Hyde_NNP Park_NNP ._. This_DT became_VBD the_DT Divinity_NNP School_NNP in_IN 1891_CD ,_, the_DT first_JJ professional_JJ school_NN at_IN the_DT University_NNP of_IN Chicago_NNP ._. [_-LRB- 37_CD ]_-RRB- Harper_NNP recruited_VBD acclaimed_VBN Yale_NNP baseball_NN and_CC football_NN player_NN Amos_NNP Alonzo_NNP Stagg_NNP from_IN the_DT Young_NNP Men_NNP 's_POS Christian_NNP Association_NNP training_NN school_NN at_IN Springfield_NNP to_TO coach_VB the_DT school_NN 's_POS football_NN program_NN ._. Stagg_NNP was_VBD given_VBN a_DT position_NN on_IN the_DT faculty_NN ,_, the_DT first_JJ such_JJ athletic_JJ position_NN in_IN the_DT United_NNP States_NNPS ._. While_IN coaching_VBG at_IN the_DT University_NNP ,_, Stagg_NNP invented_VBD the_DT numbered_VBN football_NN jersey_NN ,_, the_DT huddle_NN ,_, and_CC the_DT lighted_VBN playing_NN field_NN ._. Stagg_NNP is_VBZ the_DT namesake_NN of_IN the_DT university_NN 's_POS Stagg_NNP Field_NNP ._. [_-LRB- 38_CD ]_-RRB- The_DT business_NN school_NN was_VBD founded_VBN in_IN 1898_CD ,_, [_-LRB- 39_CD ]_-RRB- and_CC the_DT law_NN school_NN was_VBD founded_VBN in_IN 1902_CD ._. [_-LRB- 40_CD ]_-RRB- Harper_NNP died_VBD in_IN 1906_CD [_-LRB- 41_CD ]_-RRB- and_CC was_VBD replaced_VBN by_IN a_DT succession_NN of_IN three_CD presidents_NNS whose_WP$ tenures_NNS lasted_VBD until_IN 1929_CD ._. [_-LRB- 42_CD ]_-RRB- During_IN this_DT period_NN ,_, the_DT Oriental_NNP Institute_NNP was_VBD founded_VBN to_TO support_VB and_CC interpret_VB archeological_JJ work_NN in_IN what_WP was_VBD then_RB called_VBN the_DT Near_NNP East_NNP ._. [_-LRB- 43_CD ]_-RRB- In_IN the_DT 1890s_NNS ,_, the_DT university_NN ,_, fearful_JJ that_IN its_PRP$ vast_JJ resources_NNS would_MD injure_VB smaller_JJR schools_NNS by_IN drawing_VBG away_RB good_JJ students_NNS ,_, affiliated_VBN with_IN several_JJ regional_JJ colleges_NNS and_CC universities_NNS :_: Des_NNP Moines_NNP College_NNP ,_, Kalamazoo_NNP College_NNP ,_, Butler_NNP University_NNP ,_, and_CC Stetson_NNP University_NNP ._. In_IN 1896_CD ,_, the_DT university_NN affiliated_VBN with_IN Shimer_NNP College_NNP in_IN Mount_NNP Carroll_NNP ,_, Illinois_NNP ._. Under_IN the_DT terms_NNS of_IN the_DT affiliation_NN ,_, the_DT schools_NNS were_VBD required_VBN to_TO have_VB courses_NNS of_IN study_NN comparable_JJ to_IN those_DT at_IN the_DT university_NN ,_, to_TO notify_VB the_DT university_NN early_RB of_IN any_DT contemplated_VBN faculty_NN appointments_NNS or_CC dismissals_NNS ,_, to_TO make_VB no_DT faculty_NN appointment_NN without_IN the_DT university_NN 's_POS approval_NN ,_, and_CC to_TO send_VB copies_NNS of_IN examinations_NNS for_IN suggestions_NNS ._. The_DT University_NNP of_IN Chicago_NNP agreed_VBD to_TO confer_VB a_DT degree_NN on_IN any_DT graduating_NN senior_NN from_IN an_DT affiliated_VBN school_NN who_WP made_VBD a_DT grade_NN of_IN A_NN for_IN all_DT four_CD years_NNS ,_, and_CC on_IN any_DT other_JJ graduate_NN who_WP took_VBD twelve_CD weeks_NNS additional_JJ study_NN at_IN the_DT University_NNP of_IN Chicago_NNP ._. A_DT student_NN or_CC faculty_NN member_NN of_IN an_DT affiliated_VBN school_NN was_VBD entitled_VBN to_IN free_JJ tuition_NN at_IN the_DT University_NNP of_IN Chicago_NNP ,_, and_CC Chicago_NNP students_NNS were_VBD eligible_JJ to_TO attend_VB an_DT affiliated_VBN school_NN on_IN the_DT same_JJ terms_NNS and_CC receive_VB credit_NN for_IN their_PRP$ work_NN ._. The_DT University_NNP of_IN Chicago_NNP also_RB agreed_VBD to_TO provide_VB affiliated_VBN schools_NNS with_IN books_NNS and_CC scientific_JJ apparatus_NN and_CC supplies_NNS at_IN cost_NN ;_, special_JJ instructors_NNS and_CC lecturers_NNS without_IN cost_NN except_IN for_IN travel_NN expenses_NNS ;_, and_CC a_DT copy_NN of_IN every_DT book_NN and_CC journal_NN published_VBN by_IN the_DT University_NNP of_IN Chicago_NNP Press_NNP at_IN no_DT cost_NN ._. The_DT agreement_NN provided_VBD that_IN either_DT party_NN could_MD terminate_VB the_DT affiliation_NN on_IN proper_JJ notice_NN ._. Several_JJ University_NNP of_IN Chicago_NNP professors_NNS disliked_VBD the_DT program_NN ,_, as_IN it_PRP involved_VBD uncompensated_JJ additional_JJ labor_NN on_IN their_PRP$ part_NN ,_, and_CC they_PRP believed_VBD it_PRP cheapened_VBD the_DT academic_JJ reputation_NN of_IN the_DT university_NN ._. The_DT program_NN passed_VBD into_IN history_NN by_IN 1910_CD ._. [_-LRB- 44_CD ]_-RRB- In_IN 1929_CD ,_, the_DT university_NN 's_POS fifth_JJ president_NN ,_, 30_CD -_HYPH year_NN -_HYPH old_JJ legal_JJ philosophy_NN scholar_NN Robert_NNP Maynard_NNP Hutchins_NNP ,_, took_VBD office_NN ._. The_DT university_NN underwent_VBD many_JJ changes_NNS during_IN his_PRP$ 24_CD -_HYPH year_NN tenure_NN ._. Hutchins_NNP reformed_VBD the_DT undergraduate_JJ college_NN 's_POS liberal_JJ -_HYPH arts_NNS curriculum_NN known_VBN as_IN the_DT Common_NNP Core_NNP ,_, [_-LRB- 45_CD ]_-RRB- organized_VBD the_DT university_NN 's_POS graduate_NN work_NN into_IN four_CD divisions_NNS ,_, [_-LRB- 46_CD ]_-RRB- and_CC eliminated_VBD varsity_JJ football_NN from_IN the_DT university_NN in_IN an_DT attempt_NN to_TO emphasize_VB academics_NNS over_IN athletics_NNS ._. [_-LRB- 46_CD ]_-RRB- During_IN his_PRP$ term_NN ,_, the_DT University_NNP of_IN Chicago_NNP Hospitals_NNPS (_-LRB- now_RB called_VBN the_DT University_NNP of_IN Chicago_NNP Medical_NNP Center_NNP )_-RRB- finished_VBD construction_NN and_CC enrolled_VBD their_PRP$ first_JJ medical_JJ students_NNS ._. [_-LRB- 47_CD ]_-RRB- Also_RB ,_, the_DT philosophy_NN oriented_VBN Committee_NNP on_IN Social_NNP Thought_NNP ,_, an_DT institution_NN distinctive_JJ of_IN the_DT university_NN ,_, was_VBD created_VBN ._. Money_NN that_WDT had_VBD been_VBN raised_VBN during_IN the_DT 1920s_NNS and_CC financial_JJ backing_NN from_IN the_DT Rockefeller_NNP Foundation_NNP helped_VBD the_DT school_NN to_TO survive_VB through_IN the_DT Great_NNP Depression_NNP ._. [_-LRB- 46_CD ]_-RRB- Nonetheless_RB ,_, in_IN 1933_CD ,_, Hutchins_NNP proposed_VBD an_DT unsuccessful_JJ plan_NN to_TO merge_VB the_DT University_NNP of_IN Chicago_NNP and_CC Northwestern_NNP University_NNP into_IN a_DT single_JJ university_NN ._. [_-LRB- 48_CD ]_-RRB- During_IN World_NNP War_NNP II_CD ,_, the_DT university_NN 's_POS Metallurgical_NNP Laboratory_NNP made_VBD ground_NN -_HYPH breaking_VBG contributions_NNS to_IN the_DT Manhattan_NNP Project_NNP ._. [_-LRB- 49_CD ]_-RRB- The_DT university_NN was_VBD the_DT site_NN of_IN the_DT first_JJ isolation_NN of_IN plutonium_NN and_CC of_IN the_DT creation_NN of_IN the_DT first_JJ artificial_JJ ,_, self_NN -_HYPH sustained_VBN nuclear_JJ reaction_NN by_IN Enrico_NNP Fermi_NNP in_IN 1942_CD ._. [_-LRB- 49_CD ]_-RRB- [_-LRB- 50_CD ]_-RRB- It_PRP has_VBZ been_VBN noted_VBN that_IN the_DT university_NN did_VBD not_RB provide_VB standard_JJ oversight_NN regarding_VBG Bruno_NNP Bettelheim_NNP and_CC his_PRP$ tenure_NN as_IN director_NN of_IN the_DT Orthogenic_NNP School_NNP for_IN Disturbed_NNP Children_NNPS from_IN 1944_CD to_IN 1973_CD ._. [_-LRB- 51_CD ]_-RRB- [_-LRB- 52_CD ]_-RRB- [_-LRB- 53_CD ]_-RRB- In_IN the_DT early_JJ 1950s_NNS ,_, student_NN applications_NNS declined_VBD as_IN a_DT result_NN of_IN increasing_VBG crime_NN and_CC poverty_NN in_IN the_DT Hyde_NNP Park_NNP neighborhood_NN ._. In_IN response_NN ,_, the_DT university_NN became_VBD a_DT major_JJ sponsor_NN of_IN a_DT controversial_JJ urban_JJ renewal_NN project_NN for_IN Hyde_NNP Park_NNP ,_, which_WDT profoundly_RB affected_VBD both_CC the_DT neighborhood_NN 's_POS architecture_NN and_CC street_NN plan_NN ._. [_-LRB- 54_CD ]_-RRB- During_IN this_DT period_NN the_DT university_NN ,_, like_IN Shimer_NNP College_NNP and_CC 10_CD others_NNS ,_, adopted_VBD an_DT early_JJ entrant_NN program_NN that_WDT allowed_VBD very_RB young_JJ students_NNS to_TO attend_VB college_NN ;_, also_RB ,_, students_NNS enrolled_VBN at_IN Shimer_NNP were_VBD enabled_VBN to_TO transfer_VB automatically_RB to_IN the_DT University_NNP of_IN Chicago_NNP after_IN their_PRP$ second_JJ year_NN ,_, having_VBG taken_VBN comparable_JJ or_CC identical_JJ examinations_NNS and_CC courses_NNS ._. The_DT university_NN experienced_VBD its_PRP$ share_NN of_IN student_NN unrest_NN during_IN the_DT 1960s_NNS ,_, beginning_VBG in_IN 1962_CD when_WRB then_RB -_HYPH freshman_NN Bernie_NNP Sanders_NNP helped_VBD lead_VB a_DT 15_CD -_HYPH day_NN sit-in_NN at_IN the_DT college_NN 's_POS administration_NN building_NN in_IN a_DT protest_NN over_IN the_DT university_NN 's_POS off_IN -_HYPH campus_NN rental_JJ policies_NNS ._. After_IN continued_VBN turmoil_NN ,_, a_DT university_NN committee_NN in_IN 1967_CD issued_VBD what_WP became_VBD known_VBN as_IN the_DT Kalven_NNP Report_NNP ._. The_DT report_NN ,_, a_DT two_CD -_HYPH page_NN statement_NN of_IN the_DT university_NN 's_POS policy_NN in_IN ""_`` social_JJ and_CC political_JJ action_NN ,_, ""_'' declared_VBD that_IN ""_`` To_TO perform_VB its_PRP$ mission_NN in_IN the_DT society_NN ,_, a_DT university_NN must_MD sustain_VB an_DT extraordinary_JJ environment_NN of_IN freedom_NN of_IN inquiry_NN and_CC maintain_VB an_DT independence_NN from_IN political_JJ fashions_NNS ,_, passions_NNS ,_, and_CC pressures_NNS ._. ""_'' [_-LRB- 55_CD ]_-RRB- The_DT report_NN has_VBZ since_RB been_VBN used_VBN to_TO justify_VB decisions_NNS such_JJ as_IN the_DT university_NN 's_POS refusal_NN to_TO divest_VB from_IN South_NNP Africa_NNP in_IN the_DT 1980s_NNS and_CC Darfur_NNP in_IN the_DT late_JJ 2000s_NNS ._. [_-LRB- 56_CD ]_-RRB- In_IN 1969_CD ,_, more_JJR than_IN 400_CD students_NNS ,_, angry_JJ about_IN the_DT dismissal_NN of_IN a_DT popular_JJ professor_NN ,_, Marlene_NNP Dixon_NNP ,_, occupied_VBD the_DT Administration_NNP Building_NNP for_IN two_CD weeks_NNS ._. After_IN the_DT sit_NN -_HYPH in_IN ended_VBD ,_, when_WRB Dixon_NNP turned_VBD down_RP a_DT one_CD -_HYPH year_NN reappointment_NN ,_, 42_CD students_NNS were_VBD expelled_VBN and_CC 81_CD were_VBD suspended_VBN ,_, [_-LRB- 57_CD ]_-RRB- the_DT most_RBS severe_JJ response_NN to_IN student_NN occupations_NNS of_IN any_DT American_JJ university_NN during_IN the_DT student_NN movement_NN ._. [_-LRB- 58_CD ]_-RRB- In_IN 1978_CD ,_, Hanna_NNP Holborn_NNP Gray_NNP ,_, then_RB the_DT provost_NN and_CC acting_NN president_NN of_IN Yale_NNP University_NNP ,_, became_VBD President_NNP of_IN the_DT University_NNP of_IN Chicago_NNP ,_, a_DT position_NN she_PRP held_VBD for_IN 15_CD years_NNS ._. [_-LRB- 59_CD ]_-RRB- In_IN 1999_CD ,_, then_RB -_HYPH President_NNP Hugo_NNP Sonnenschein_NNP announced_VBD plans_NNS to_TO relax_VB the_DT university_NN 's_POS famed_VBN core_NN curriculum_NN ,_, reducing_VBG the_DT number_NN of_IN required_VBN courses_NNS from_IN 21_CD to_IN 15_CD ._. When_WRB The_DT New_NNP York_NNP Times_NNP ,_, The_DT Economist_NNP ,_, and_CC other_JJ major_JJ news_NN outlets_NNS picked_VBD up_RP this_DT story_NN ,_, the_DT university_NN became_VBD the_DT focal_JJ point_NN of_IN a_DT national_JJ debate_NN on_IN education_NN ._. The_DT changes_NNS were_VBD ultimately_RB implemented_VBN ,_, but_CC the_DT controversy_NN played_VBD a_DT role_NN in_IN Sonnenschein_NNP 's_POS decision_NN to_TO resign_VB in_IN 2000_CD ._. [_-LRB- 60_CD ]_-RRB- From_IN the_DT mid-2000s_NNS ,_, the_DT university_NN began_VBD a_DT number_NN of_IN multimillion_JJ -_HYPH dollar_NN expansion_NN projects_NNS ._. In_IN 2008_CD ,_, the_DT University_NNP of_IN Chicago_NNP announced_VBD plans_NNS to_TO establish_VB the_DT Milton_NNP Friedman_NNP Institute_NNP ,_, which_WDT attracted_VBD both_CC support_NN and_CC controversy_NN from_IN faculty_NN members_NNS and_CC students_NNS ._. [_-LRB- 61_CD ]_-RRB- [_-LRB- 62_CD ]_-RRB- [_-LRB- 63_CD ]_-RRB- [_-LRB- 64_CD ]_-RRB- [_-LRB- 65_CD ]_-RRB- The_DT institute_NN will_MD cost_VB around_RB $_$ 200_CD million_CD and_CC occupy_VB the_DT buildings_NNS of_IN the_DT Chicago_NNP Theological_NNP Seminary_NNP ._. During_IN the_DT same_JJ year_NN ,_, investor_NN David_NNP G._NNP Booth_NNP donated_VBD $_$ 300_CD million_CD to_IN the_DT university_NN 's_POS Booth_NNP School_NNP of_IN Business_NNP ,_, which_WDT is_VBZ the_DT largest_JJS gift_NN in_IN the_DT university_NN 's_POS history_NN and_CC the_DT largest_JJS gift_NN ever_RB to_IN any_DT business_NN school_NN ._. [_-LRB- 66_CD ]_-RRB- In_IN 2009_CD ,_, planning_NN or_CC construction_NN on_IN several_JJ new_JJ buildings_NNS ,_, half_NN of_IN which_WDT cost_VBD $_$ 100_CD million_CD or_CC more_JJR ,_, was_VBD underway_JJ ._. [_-LRB- 67_CD ]_-RRB- Since_IN 2011_CD ,_, major_JJ construction_NN projects_NNS have_VBP included_VBN the_DT Jules_NNP and_CC Gwen_NNP Knapp_NNP Center_NNP for_IN Biomedical_NNP Discovery_NNP ,_, a_DT ten_CD -_HYPH story_NN medical_JJ research_NN center_NN ,_, and_CC further_JJR additions_NNS to_IN the_DT medical_JJ campus_NN of_IN the_DT University_NNP of_IN Chicago_NNP Medical_NNP Center_NNP ._. [_-LRB- 68_CD ]_-RRB- In_IN 2014_CD the_DT University_NNP launched_VBD the_DT public_JJ phase_NN of_IN a_DT $_$ 4.5_CD billion_CD fundraising_NN campaign_NN ._. [_-LRB- 69_CD ]_-RRB- In_IN September_NNP 2015_CD ,_, the_DT University_NNP received_VBD $_$ 100_CD million_CD from_IN The_DT Pearson_NNP Family_NNP Foundation_NNP to_TO establish_VB The_DT Pearson_NNP Institute_NNP for_IN the_DT Study_NNP and_CC Resolution_NNP of_IN Global_NNP Conflicts_NNPS and_CC The_DT Pearson_NNP Global_NNP Forum_NNP at_IN the_DT Harris_NNP School_NNP of_IN Public_NNP Policy_NNP Studies_NNPS ._. [_-LRB- 70_CD ]_-RRB- On_IN May_NNP 1_CD ,_, 2014_CD ,_, the_DT University_NNP of_IN Chicago_NNP was_VBD named_VBN one_CD of_IN fifty_CD -_HYPH five_CD higher_JJR education_NN institutions_NNS under_IN investigation_NN by_IN the_DT Office_NNP of_IN Civil_NNP Rights_NNPS ""_'' for_IN possible_JJ violations_NNS of_IN federal_JJ law_NN over_IN the_DT handling_NN of_IN sexual_JJ violence_NN and_CC harassment_NN complaints_NNS ""_'' by_IN the_DT White_NNP House_NNP Task_NNP Force_NNP to_TO Protect_VB Students_NNPS from_IN Sexual_NNP Assault_NNP ._. [_-LRB- 71_CD ]_-RRB- In_IN 2019_CD ,_, the_DT university_NN created_VBD its_PRP$ first_JJ school_NN in_IN three_CD decades_NNS ,_, the_DT Pritzker_NNP School_NNP of_IN Molecular_NNP Engineering_NNP ._. [_-LRB- 72_CD ]_-RRB- [_-LRB- 73_CD ]_-RRB- The_DT main_JJ campus_NN of_IN the_DT University_NNP of_IN Chicago_NNP consists_VBZ of_IN 217_CD acres_NNS (_-LRB- 87.8_CD ha_NN )_-RRB- in_IN the_DT Chicago_NNP neighborhoods_NNS of_IN Hyde_NNP Park_NNP and_CC Woodlawn_NNP ,_, approximately_RB eight_CD miles_NNS (_-LRB- 12_CD km_NNS )_-RRB- south_RB of_IN downtown_NN Chicago_NNP ._. The_DT northern_JJ and_CC southern_JJ portions_NNS of_IN campus_NN are_VBP separated_VBN by_IN the_DT Midway_NNP Plaisance_NNP ,_, a_DT large_JJ ,_, linear_JJ park_NN created_VBN for_IN the_DT 1893_CD World_NNP 's_POS Columbian_NNP Exposition_NNP ._. In_IN 2011_CD ,_, Travel_NNP +_SYM Leisure_NNP listed_VBD the_DT university_NN as_IN one_CD of_IN the_DT most_RBS beautiful_JJ college_NN campuses_NNS in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 74_CD ]_-RRB- The_DT first_JJ buildings_NNS of_IN the_DT campus_NN ,_, which_WDT make_VBP up_RP what_WP is_VBZ now_RB known_VBN as_IN the_DT Main_NNP Quadrangles_NNPS ,_, were_VBD part_NN of_IN a_DT master_NN plan_NN conceived_VBN by_IN two_CD University_NNP of_IN Chicago_NNP trustees_NNS and_CC plotted_VBN by_IN Chicago_NNP architect_NN Henry_NNP Ives_NNP Cobb_NNP ._. [_-LRB- 76_CD ]_-RRB- The_DT Main_NNP Quadrangles_NNPS consist_VBP of_IN six_CD quadrangles_NNS ,_, each_DT surrounded_VBN by_IN buildings_NNS ,_, bordering_VBG one_CD larger_JJR quadrangle_NN ._. [_-LRB- 77_CD ]_-RRB- The_DT buildings_NNS of_IN the_DT Main_NNP Quadrangles_NNPS were_VBD designed_VBN by_IN Cobb_NNP ,_, Shepley_NNP ,_, Rutan_NNP and_CC Coolidge_NNP ,_, Holabird_NNP &_CC Roche_NNP ,_, and_CC other_JJ architectural_JJ firms_NNS in_IN a_DT mixture_NN of_IN the_DT Victorian_JJ Gothic_NNP and_CC Collegiate_JJ Gothic_JJ styles_NNS ,_, patterned_VBN on_IN the_DT colleges_NNS of_IN the_DT University_NNP of_IN Oxford_NNP ._. [_-LRB- 76_CD ]_-RRB- (_-LRB- Mitchell_NNP Tower_NNP ,_, for_IN example_NN ,_, is_VBZ modeled_VBN after_IN Oxford_NNP 's_POS Magdalen_NNP Tower_NNP ,_, [_-LRB- 78_CD ]_-RRB- and_CC the_DT university_NN Commons_NNP ,_, Hutchinson_NNP Hall_NNP ,_, replicates_VBZ Christ_NNP Church_NNP Hall_NNP ._. [_-LRB- 79_CD ]_-RRB- )_-RRB- In_IN celebration_NN of_IN the_DT 2018_CD Illinois_NNP Bicentennial_NNP ,_, the_DT University_NNP of_IN Chicago_NNP Quadrangles_NNPS were_VBD selected_VBN as_IN one_CD of_IN the_DT Illinois_NNP 200_CD Great_NNP Places_NNPS [_-LRB- 80_CD ]_-RRB- by_IN the_DT American_NNP Institute_NNP of_IN Architects_NNPS Illinois_NNP component_NN (_-LRB- AIA_NNP Illinois_NNP )_-RRB- ._. After_IN the_DT 1940s_NNS ,_, the_DT campus_NN 's_POS Gothic_JJ style_NN began_VBD to_TO give_VB way_NN to_IN modern_JJ styles_NNS ._. [_-LRB- 76_CD ]_-RRB- In_IN 1955_CD ,_, Eero_NNP Saarinen_NNP was_VBD contracted_VBN to_TO develop_VB a_DT second_JJ master_NN plan_NN ,_, which_WDT led_VBD to_IN the_DT construction_NN of_IN buildings_NNS both_CC north_RB and_CC south_RB of_IN the_DT Midway_NNP ,_, including_VBG the_DT Laird_NNP Bell_NNP Law_NNP Quadrangle_NNP (_-LRB- a_DT complex_NN designed_VBN by_IN Saarinen_NNP )_-RRB- ;_: [_-LRB- 76_CD ]_-RRB- a_DT series_NN of_IN arts_NNS buildings_NNS ;_: [_-LRB- 76_CD ]_-RRB- a_DT building_NN designed_VBN by_IN Ludwig_NNP Mies_NNP van_NNP der_NNP Rohe_NNP for_IN the_DT university_NN 's_POS School_NNP of_IN Social_NNP Service_NNP Administration_NNP ,_, [_-LRB- 76_CD ]_-RRB- a_DT building_NN which_WDT is_VBZ to_TO become_VB the_DT home_NN of_IN the_DT Harris_NNP School_NNP of_IN Public_NNP Policy_NNP Studies_NNPS by_IN Edward_NNP Durrell_NNP Stone_NNP ,_, and_CC the_DT Regenstein_NNP Library_NNP ,_, the_DT largest_JJS building_NN on_IN campus_NN ,_, a_DT brutalist_JJ structure_NN designed_VBN by_IN Walter_NNP Netsch_NNP of_IN the_DT Chicago_NNP firm_NN Skidmore_NNP ,_, Owings_NNP &_CC Merrill_NNP ._. [_-LRB- 81_CD ]_-RRB- Another_DT master_NN plan_NN ,_, designed_VBN in_IN 1999_CD and_CC updated_VBN in_IN 2004_CD ,_, [_-LRB- 82_CD ]_-RRB- produced_VBD the_DT Gerald_NNP Ratner_NNP Athletics_NNP Center_NNP (_-LRB- 2003_CD )_-RRB- ,_, [_-LRB- 82_CD ]_-RRB- the_DT Max_NNP Palevsky_NNP Residential_NNP Commons_NNP (_-LRB- 2001_CD )_-RRB- ,_, [_-LRB- 76_CD ]_-RRB- South_NNP Campus_NNP Residence_NNP Hall_NNP and_CC dining_NN commons_NNP (_-LRB- 2009_CD )_-RRB- ,_, a_DT new_JJ children_NNS 's_POS hospital_NN ,_, [_-LRB- 83_CD ]_-RRB- and_CC other_JJ construction_NN ,_, expansions_NNS ,_, and_CC restorations_NNS ._. [_-LRB- 84_CD ]_-RRB- In_IN 2011_CD ,_, the_DT university_NN completed_VBD the_DT glass_NN dome_NN -_HYPH shaped_VBN Joe_NNP and_CC Rika_NNP Mansueto_NNP Library_NNP ,_, which_WDT provides_VBZ a_DT grand_JJ reading_NN room_NN for_IN the_DT university_NN library_NN and_CC prevents_VBZ the_DT need_NN for_IN an_DT off_IN -_HYPH campus_NN book_NN depository_NN ._. The_DT site_NN of_IN Chicago_NNP Pile_NNP -_HYPH 1_CD is_VBZ a_DT National_NNP Historic_NNP Landmark_NNP and_CC is_VBZ marked_VBN by_IN the_DT Henry_NNP Moore_NNP sculpture_NN Nuclear_NNP Energy_NNP ._. [_-LRB- 85_CD ]_-RRB- Robie_NNP House_NNP ,_, a_DT Frank_NNP Lloyd_NNP Wright_NNP building_NN acquired_VBN by_IN the_DT university_NN in_IN 1963_CD ,_, is_VBZ a_DT UNESCO_NNP World_NNP Heritage_NNP Site_NNP [_-LRB- 86_CD ]_-RRB- as_RB well_RB as_IN a_DT National_NNP Historic_NNP Landmark_NNP ,_, [_-LRB- 87_CD ]_-RRB- as_IN is_VBZ room_NN 405_CD of_IN the_DT George_NNP Herbert_NNP Jones_NNP Laboratory_NNP ,_, where_WRB Glenn_NNP T._NNP Seaborg_NNP and_CC his_PRP$ team_NN were_VBD the_DT first_JJ to_TO isolate_VB plutonium_NN ._. [_-LRB- 88_CD ]_-RRB- Hitchcock_NNP Hall_NNP ,_, an_DT undergraduate_JJ dormitory_NN ,_, is_VBZ on_IN the_DT National_NNP Register_NNP of_IN Historic_NNP Places_NNPS ._. [_-LRB- 89_CD ]_-RRB- •_, Campus_NNP of_IN the_DT University_NNP of_IN Chicago_NNP •_, None_NNP Snell_NNP -_HYPH Hitchcock_NNP ,_, an_DT undergraduate_JJ dormitory_NN constructed_VBN in_IN the_DT early_JJ 20th_JJ century_NN ,_, is_VBZ part_NN of_IN the_DT Main_NNP Quadrangles_NNPS ._. •_NFP None_NN Rockefeller_NNP Chapel_NNP ,_, constructed_VBN in_IN 1928_CD ,_, was_VBD designed_VBN by_IN Bertram_NNP Goodhue_NNP in_IN the_DT neo-Gothic_JJ style_NN ._. •_NFP None_NN The_DT Henry_NNP Hinds_NNP Laboratory_NNP for_IN Geophysical_NNP Sciences_NNPS was_VBD built_VBN in_IN 1969_CD .[_-LRB- 90_CD ]_-RRB- •_NFP None_NN The_DT Gerald_NNP Ratner_NNP Athletics_NNP Center_NNP ,_, opened_VBN in_IN 2003_CD and_CC designed_VBN by_IN Cesar_NNP Pelli_NNP ,_, houses_VBZ the_DT volleyball_NN ,_, wrestling_NN ,_, swimming_NN ,_, and_CC basketball_NN teams_NNS ._. [_-LRB- 91_CD ]_-RRB- The_DT university_NN also_RB maintains_VBZ facilities_NNS apart_RB from_IN its_PRP$ main_JJ campus_NN ._. The_DT university_NN 's_POS Booth_NNP School_NNP of_IN Business_NNP maintains_VBZ campuses_NNS in_IN Hong_NNP Kong_NNP ,_, London_NNP ,_, and_CC the_DT downtown_NN Streeterville_NNP neighborhood_NN of_IN Chicago_NNP ._. The_DT Center_NNP in_IN Paris_NNP ,_, a_DT campus_NN located_VBN on_IN the_DT left_JJ bank_NN of_IN the_DT Seine_NNP in_IN Paris_NNP ,_, hosts_VBZ various_JJ undergraduate_JJ and_CC graduate_NN study_NN programs_NNS ._. [_-LRB- 92_CD ]_-RRB- In_IN fall_NN 2010_CD ,_, the_DT university_NN opened_VBD a_DT center_NN in_IN Beijing_NNP ,_, near_IN Renmin_NNP University_NNP 's_POS campus_NN in_IN Haidian_NNP District_NNP ._. The_DT most_RBS recent_JJ additions_NNS are_VBP a_DT center_NN in_IN New_NNP Delhi_NNP ,_, India_NNP ,_, which_WDT opened_VBD in_IN 2014_CD ,_, and_CC a_DT center_NN in_IN Hong_NNP Kong_NNP which_WDT opened_VBD in_IN 2015_CD ._. The_DT university_NN is_VBZ governed_VBN by_IN a_DT board_NN of_IN trustees_NNS ._. The_DT Board_NNP of_IN Trustees_NNPS oversees_VBZ the_DT long_JJ -_HYPH term_NN development_NN and_CC plans_NNS of_IN the_DT university_NN and_CC manages_VBZ fundraising_NN efforts_NNS ,_, and_CC is_VBZ composed_VBN of_IN 55_CD members_NNS including_VBG the_DT university_NN President_NNP ._. [_-LRB- 93_CD ]_-RRB- Directly_RB beneath_IN the_DT President_NNP are_VBP the_DT Provost_NNP ,_, fourteen_CD Vice_NNP Presidents_NNPS (_-LRB- including_VBG the_DT Chief_NNP Financial_NNP Officer_NNP ,_, Chief_NNP Investment_NNP Officer_NNP ,_, and_CC Vice_NNP President_NNP for_IN Campus_NNP Life_NNP and_CC Student_NNP Services_NNPS )_-RRB- ,_, the_DT Directors_NNPS of_IN Argonne_NNP National_NNP Laboratory_NNP and_CC Fermilab_NNP ,_, the_DT Secretary_NNP of_IN the_DT university_NN ,_, and_CC the_DT Student_NNP Ombudsperson_NNP ._. [_-LRB- 94_CD ]_-RRB- As_IN of_IN May_NNP 2016_CD ,_, the_DT Chairman_NNP of_IN the_DT Board_NNP of_IN Trustees_NNPS is_VBZ Joseph_NNP Neubauer_NNP ,_, [_-LRB- 95_CD ]_-RRB- and_CC the_DT President_NNP of_IN the_DT university_NN is_VBZ Robert_NNP Zimmer_NNP ._. In_IN December_NNP 2013_CD it_PRP was_VBD announced_VBN that_IN the_DT Director_NNP of_IN Argonne_NNP National_NNP Laboratory_NNP ,_, Eric_NNP Isaacs_NNP ,_, would_MD become_VB Provost_NNP ._. Isaacs_NNP was_VBD replaced_VBN as_IN Provost_NNP in_IN March_NNP 2016_CD by_IN Daniel_NNP Diermeier_NNP ._. [_-LRB- 96_CD ]_-RRB- The_DT university_NN 's_POS endowment_NN was_VBD the_DT 12th_JJ largest_JJS among_IN American_JJ educational_JJ institutions_NNS and_CC state_NN university_NN systems_NNS in_IN 2013_CD [_-LRB- 97_CD ]_-RRB- and_CC as_IN of_IN 2018_CD was_VBD valued_VBN at_IN $_$ 8.2_CD billion_CD ._. [_-LRB- 98_CD ]_-RRB- Part_NN of_IN President_NNP Zimmer_NNP 's_POS financial_JJ plan_NN for_IN the_DT university_NN has_VBZ been_VBN an_DT increase_NN in_IN accumulation_NN of_IN debt_NN to_TO finance_VB large_JJ building_NN projects_NNS ._. [_-LRB- 99_CD ]_-RRB- This_DT has_VBZ drawn_VBN both_CC support_NN and_CC criticism_NN from_IN many_JJ in_IN the_DT university_NN community_NN ._. The_DT academic_JJ bodies_NNS of_IN the_DT University_NNP of_IN Chicago_NNP consist_VBP of_IN the_DT College_NNP ,_, five_CD divisions_NNS of_IN graduate_NN research_NN ,_, six_CD professional_JJ schools_NNS ,_, and_CC the_DT Graham_NNP School_NNP of_IN Continuing_NNP Liberal_NNP and_CC Professional_NNP Studies_NNPS ._. The_DT university_NN also_RB contains_VBZ a_DT library_NN system_NN ,_, the_DT University_NNP of_IN Chicago_NNP Press_NNP ,_, and_CC the_DT University_NNP of_IN Chicago_NNP Medical_NNP Center_NNP ,_, and_CC oversees_VBZ several_JJ laboratories_NNS ,_, including_VBG Fermi_NNP National_NNP Accelerator_NNP Laboratory_NNP (_-LRB- Fermilab_NNP )_-RRB- ,_, Argonne_NNP National_NNP Laboratory_NNP ,_, and_CC the_DT Marine_NNP Biological_NNP Laboratory_NNP ._. The_DT university_NN is_VBZ accredited_VBN by_IN The_DT Higher_NNP Learning_NNP Commission_NNP ._. [_-LRB- 100_CD ]_-RRB- The_DT university_NN runs_VBZ on_IN a_DT quarter_NN system_NN in_IN which_WDT the_DT academic_JJ year_NN is_VBZ divided_VBN into_IN four_CD terms_NNS :_: Summer_NN (_-LRB- June–August_NNP )_-RRB- ,_, Autumn_NNP (_-LRB- September–December_NNP )_-RRB- ,_, Winter_NNP (_-LRB- January_NNP –March_NNP )_-RRB- ,_, and_CC Spring_NNP (_-LRB- April–June_NNP )_-RRB- ._. [_-LRB- 101_CD ]_-RRB- Full_JJ -_HYPH time_NN undergraduate_NN students_NNS take_VBP three_CD to_IN four_CD courses_NNS every_DT quarter_NN [_-LRB- 102_CD ]_-RRB- for_IN approximately_RB eleven_CD weeks_NNS before_IN their_PRP$ quarterly_JJ academic_JJ breaks_NNS ._. The_DT school_NN year_NN typically_RB begins_VBZ in_IN late_JJ September_NNP and_CC ends_VBZ in_IN mid-June_NNP ._. [_-LRB- 101_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP has_VBZ an_DT extensive_JJ record_NN of_IN producing_VBG successful_JJ business_NN leaders_NNS and_CC billionaires_NNS ._. [_-LRB- 25_CD ]_-RRB- [_-LRB- 112_CD ]_-RRB- [_-LRB- 113_CD ]_-RRB- [_-LRB- 114_CD ]_-RRB- ARWU_NNP has_VBZ consistently_RB placed_VBN the_DT University_NNP of_IN Chicago_NNP among_IN the_DT top_JJ 10_CD universities_NNS in_IN the_DT world_NN ,_, [_-LRB- 115_CD ]_-RRB- and_CC the_DT 2020_CD QS_NNP World_NNP University_NNP Rankings_NNPS placed_VBD the_DT university_NN in_IN 10th_JJ place_NN worldwide_RB ._. [_-LRB- 116_CD ]_-RRB- The_DT university_NN 's_POS law_NN and_CC business_NN schools_NNS rank_VBP among_IN the_DT top_JJ five_CD professional_JJ schools_NNS in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 117_CD ]_-RRB- The_DT business_NN school_NN is_VBZ currently_RB ranked_VBN first_RB in_IN the_DT US_NNP by_IN US_NNP News_NNP &_CC World_NNP Report_NNP [_-LRB- 118_CD ]_-RRB- and_CC first_RB in_IN the_DT world_NN by_IN The_DT Economist_NNP ,_, [_-LRB- 119_CD ]_-RRB- while_IN the_DT law_NN school_NN is_VBZ ranked_VBN fourth_JJ by_IN US_NNP News_NNP &_CC World_NNP Report_NNP [_-LRB- 120_CD ]_-RRB- and_CC first_RB by_IN Above_IN the_DT Law_NNP ._. [_-LRB- 121_CD ]_-RRB- Chicago_NNP has_VBZ also_RB been_VBN consistently_RB recognized_VBN to_TO be_VB one_CD of_IN the_DT top_JJ 15_CD university_NN brands_NNS in_IN the_DT world_NN ,_, [_-LRB- 122_CD ]_-RRB- retaining_VBG the_DT number_NN three_CD spot_NN in_IN the_DT 2019_CD U.S._NNP News_NNP Best_JJS Colleges_NNPS Rankings_NNS ._. [_-LRB- 123_CD ]_-RRB- In_IN a_DT corporate_JJ study_NN carried_VBN out_RP by_IN The_DT New_NNP York_NNP Times_NNP ,_, the_DT university_NN 's_POS graduates_NNS were_VBD shown_VBN to_TO be_VB among_IN the_DT most_RBS valued_VBN in_IN the_DT world_NN ._. [_-LRB- 124_CD ]_-RRB- The_DT College_NNP of_IN the_DT University_NNP of_IN Chicago_NNP grants_VBZ Bachelor_NNP of_IN Arts_NNPS and_CC Bachelor_NNP of_IN Science_NNP degrees_NNS in_IN 51_CD academic_JJ majors_NNS [_-LRB- 125_CD ]_-RRB- and_CC 33_CD minors_NNS ._. [_-LRB- 126_CD ]_-RRB- The_DT college_NN 's_POS academics_NNS are_VBP divided_VBN into_IN five_CD divisions_NNS :_: the_DT Biological_NNP Sciences_NNPS Collegiate_NNP Division_NNP ,_, the_DT Physical_NNP Sciences_NNPS Collegiate_NNP Division_NNP ,_, the_DT Social_NNP Sciences_NNPS Collegiate_NNP Division_NNP ,_, the_DT Humanities_NNPS Collegiate_NNP Division_NNP ,_, and_CC the_DT New_NNP Collegiate_NNP Division_NNP ._. [_-LRB- 127_CD ]_-RRB- The_DT first_JJ four_CD are_VBP sections_NNS within_IN their_PRP$ corresponding_JJ graduate_NN divisions_NNS ,_, while_IN the_DT New_NNP Collegiate_NNP Division_NNP administers_VBZ interdisciplinary_JJ majors_NNS and_CC studies_NNS which_WDT do_VBP not_RB fit_VB in_IN one_CD of_IN the_DT other_JJ four_CD divisions_NNS ._. [_-LRB- 128_CD ]_-RRB- Undergraduate_JJ students_NNS are_VBP required_VBN to_TO take_VB a_DT distribution_NN of_IN courses_NNS to_TO satisfy_VB the_DT university_NN 's_POS general_JJ education_NN requirements_NNS ,_, commonly_RB known_VBN as_IN the_DT Common_NNP Core_NNP ._. In_IN 2012_CD –2013_CD ,_, the_DT Core_NN classes_NNS at_IN Chicago_NNP were_VBD limited_VBN to_IN 17_CD courses_NNS ,_, and_CC are_VBP generally_RB led_VBN by_IN a_DT full_JJ -_HYPH time_NN professor_NN (_-LRB- as_IN opposed_VBN to_IN a_DT teaching_NN assistant_NN )_-RRB- ._. [_-LRB- 129_CD ]_-RRB- As_IN of_IN the_DT 2013_CD –2014_CD school_NN year_NN ,_, 15_CD courses_NNS and_CC demonstrated_VBN proficiency_NN in_IN a_DT foreign_JJ language_NN are_VBP required_VBN under_IN the_DT Core_NN ._. [_-LRB- 130_CD ]_-RRB- Undergraduate_JJ courses_NNS at_IN the_DT University_NNP of_IN Chicago_NNP are_VBP known_VBN for_IN their_PRP$ demanding_VBG standards_NNS ,_, heavy_JJ workload_NN and_CC academic_JJ difficulty_NN ;_, according_VBG to_IN Uni_NNP in_IN the_DT USA_NNP ,_, ""_`` Among_IN the_DT academic_JJ cream_NN of_IN American_JJ universities_NNS –_: Harvard_NNP ,_, Yale_NNP ,_, Princeton_NNP ,_, MIT_NNP ,_, and_CC the_DT University_NNP of_IN Chicago_NNP –_: it_PRP is_VBZ UChicago_NNP that_WDT can_MD most_RBS convincingly_RB claim_VB to_TO provide_VB the_DT most_RBS rigorous_JJ ,_, intense_JJ learning_NN experience_NN ._. ""_'' [_-LRB- 131_CD ]_-RRB- The_DT university_NN graduate_NN schools_NNS and_CC committees_NNS are_VBP divided_VBN into_IN five_CD divisions_NNS :_: Biological_NNP Sciences_NNPS ,_, Humanities_NNPS ,_, Physical_NNP Sciences_NNPS ,_, Social_NNP Sciences_NNPS ,_, and_CC the_DT Institute_NNP for_IN Molecular_NNP Engineering_NNP ._. [_-LRB- 132_CD ]_-RRB- In_IN the_DT autumn_NN quarter_NN of_IN 2015_CD ,_, the_DT university_NN enrolled_VBD 3,588_CD graduate_NN students_NNS :_: 438_CD in_IN the_DT Biological_NNP Sciences_NNPS Division_NN ,_, 801_CD in_IN the_DT Humanities_NNPS Division_NN ,_, 1,102_CD in_IN the_DT Physical_NNP Sciences_NNPS Division_NNP ,_, 1,165_CD in_IN the_DT Social_NNP Sciences_NNPS Division_NNP ,_, and_CC 52_CD in_IN the_DT Institute_NNP for_IN Molecular_NNP Engineering_NNP ._. [_-LRB- 133_CD ]_-RRB- The_DT university_NN is_VBZ home_NN to_IN several_JJ committees_NNS for_IN interdisciplinary_JJ scholarship_NN ,_, including_VBG the_DT John_NNP U._NNP Nef_NNP Committee_NNP on_IN Social_NNP Thought_NNP ._. The_DT university_NN contains_VBZ seven_CD professional_JJ schools_NNS :_: the_DT Pritzker_NNP School_NNP of_IN Medicine_NNP ,_, the_DT Booth_NNP School_NNP of_IN Business_NNP ,_, the_DT University_NNP of_IN Chicago_NNP Law_NNP School_NNP ,_, the_DT University_NNP of_IN Chicago_NNP Divinity_NNP School_NNP ,_, the_DT University_NNP of_IN Chicago_NNP Harris_NNP School_NNP of_IN Public_NNP Policy_NNP Studies_NNPS ,_, and_CC the_DT University_NNP of_IN Chicago_NNP School_NNP of_IN Social_NNP Service_NNP Administration_NNP ._. The_DT Graham_NNP School_NNP of_IN Continuing_NNP Liberal_NNP and_CC Professional_NNP Studies_NNPS offers_VBZ non-degree_NN courses_NNS and_CC certificates_NNS as_RB well_RB as_IN degree_NN programs_NNS ._. [_-LRB- 134_CD ]_-RRB- The_DT Law_NNP School_NNP is_VBZ accredited_VBN by_IN the_DT American_NNP Bar_NNP Association_NNP ,_, the_DT Divinity_NNP School_NNP is_VBZ accredited_VBN by_IN the_DT Commission_NNP on_IN Accrediting_NNP of_IN the_DT Association_NNP of_IN Theological_NNP Schools_NNPS in_IN the_DT United_NNP States_NNPS and_CC Canada_NNP ,_, Pritzker_NNP is_VBZ accredited_VBN by_IN the_DT Liaison_NNP Committee_NNP on_IN Medical_NNP Education_NNP ._. [_-LRB- 100_CD ]_-RRB- The_DT university_NN runs_VBZ a_DT number_NN of_IN academic_JJ institutions_NNS and_CC programs_NNS apart_RB from_IN its_PRP$ undergraduate_JJ and_CC postgraduate_JJ schools_NNS ._. It_PRP operates_VBZ the_DT University_NNP of_IN Chicago_NNP Laboratory_NNP Schools_NNPS (_-LRB- a_DT private_JJ day_NN school_NN for_IN K_CD -_HYPH 12_CD students_NNS and_CC day_NN care_NN )_-RRB- ,_, [_-LRB- 135_CD ]_-RRB- and_CC a_DT public_JJ charter_NN school_NN with_IN four_CD campuses_NNS on_IN the_DT South_NNP Side_NNP of_IN Chicago_NNP administered_VBN by_IN the_DT university_NN 's_POS Urban_NNP Education_NNP Institute_NNP ._. [_-LRB- 136_CD ]_-RRB- In_IN addition_NN ,_, the_DT Hyde_NNP Park_NNP Day_NNP School_NNP ,_, a_DT school_NN for_IN students_NNS with_IN learning_NN disabilities_NNS ,_, [_-LRB- 137_CD ]_-RRB- and_CC the_DT Sonia_NNP Shankman_NNP Orthogenic_NNP School_NNP ,_, a_DT residential_JJ treatment_NN program_NN for_IN those_DT with_IN behavioral_JJ and_CC emotional_JJ problems_NNS ,_, [_-LRB- 138_CD ]_-RRB- maintains_VBZ a_DT location_NN on_IN the_DT University_NNP of_IN Chicago_NNP campus_NN ._. Since_IN 1983_CD ,_, the_DT University_NNP of_IN Chicago_NNP has_VBZ maintained_VBN the_DT University_NNP of_IN Chicago_NNP School_NNP Mathematics_NNP Project_NNP ,_, a_DT mathematics_NN program_NN used_VBN in_IN urban_JJ primary_JJ and_CC secondary_JJ schools_NNS ._. [_-LRB- 139_CD ]_-RRB- The_DT university_NN runs_VBZ a_DT program_NN called_VBN the_DT Council_NNP on_IN Advanced_NNP Studies_NNPS in_IN the_DT Humanities_NNPS and_CC Social_NNP Sciences_NNPS ,_, which_WDT administers_VBZ interdisciplinary_JJ workshops_NNS to_TO provide_VB a_DT forum_NN for_IN graduate_NN students_NNS ,_, faculty_NN ,_, and_CC visiting_VBG scholars_NNS to_TO present_VB scholarly_JJ work_NN in_IN progress_NN ._. [_-LRB- 140_CD ]_-RRB- The_DT university_NN also_RB operates_VBZ the_DT University_NNP of_IN Chicago_NNP Press_NNP ,_, the_DT largest_JJS university_NN press_NN in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 141_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP Library_NNP system_NN encompasses_VBZ six_CD libraries_NNS that_WDT contain_VBP a_DT total_NN of_IN 11_CD million_CD volumes_NNS ,_, the_DT 9th_JJ most_JJS among_IN library_NN systems_NNS in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 142_CD ]_-RRB- The_DT university_NN 's_POS main_JJ library_NN is_VBZ the_DT Regenstein_NNP Library_NNP ,_, which_WDT contains_VBZ one_CD of_IN the_DT largest_JJS collections_NNS of_IN print_NN volumes_NNS in_IN the_DT United_NNP States_NNPS ._. The_DT Joe_NNP and_CC Rika_NNP Mansueto_NNP Library_NNP ,_, built_VBN in_IN 2011_CD ,_, houses_VBZ a_DT large_JJ study_NN space_NN and_CC an_DT automated_JJ book_NN storage_NN and_CC retrieval_NN system_NN ._. The_DT John_NNP Crerar_NNP Library_NNP contains_VBZ more_JJR than_IN 1.4_CD million_CD volumes_NNS in_IN the_DT biological_JJ ,_, medical_JJ and_CC physical_JJ sciences_NNS and_CC collections_NNS in_IN general_JJ science_NN and_CC the_DT philosophy_NN and_CC history_NN of_IN science_NN ,_, medicine_NN ,_, and_CC technology_NN ._. [_-LRB- 143_CD ]_-RRB- The_DT university_NN also_RB operates_VBZ a_DT number_NN of_IN special_JJ libraries_NNS ,_, including_VBG the_DT D'Angelo_NNP Law_NNP Library_NNP ,_, the_DT Social_NNP Service_NNP Administration_NNP Library_NNP ,_, and_CC the_DT Eckhart_NNP Library_NNP for_IN mathematics_NN and_CC computer_NN science_NN ._. [_-LRB- 144_CD ]_-RRB- [_-LRB- 145_CD ]_-RRB- Harper_NNP Memorial_NNP Library_NNP is_VBZ now_RB a_DT reading_NN and_CC study_NN room_NN ._. In_IN fiscal_JJ year_NN 2015_CD ,_, the_DT University_NNP of_IN Chicago_NNP spent_VBD $_$ 421.1_CD million_CD on_IN research_NN ._. [_-LRB- 146_CD ]_-RRB- It_PRP is_VBZ classified_VBN by_IN the_DT Carnegie_NNP Foundation_NNP for_IN the_DT Advancement_NNP of_IN Teaching_NNP as_IN an_DT institution_NN with_IN ""_`` highest_JJS research_NN activity_NN ""_'' [_-LRB- 147_CD ]_-RRB- and_CC is_VBZ a_DT founding_VBG member_NN of_IN the_DT Association_NNP of_IN American_NNP Universities_NNPS and_CC was_VBD a_DT member_NN of_IN the_DT Committee_NNP on_IN Institutional_NNP Cooperation_NNP from_IN 1946_CD through_IN June_NNP 29_CD ,_, 2016_CD ,_, when_WRB the_DT group_NN 's_POS name_NN was_VBD changed_VBN to_IN the_DT Big_NNP Ten_NNP Academic_NNP Alliance_NNP ._. The_DT University_NNP of_IN Chicago_NNP is_VBZ not_RB a_DT member_NN of_IN the_DT rebranded_VBN consortium_NN ,_, but_CC will_MD continue_VB to_TO be_VB a_DT collaborator_NN ._. [_-LRB- 148_CD ]_-RRB- [_-LRB- 149_CD ]_-RRB- The_DT university_NN operates_VBZ more_JJR than_IN 140_CD research_NN centers_NNS and_CC institutes_NNS on_IN campus_NN ._. [_-LRB- 150_CD ]_-RRB- Among_IN these_DT are_VBP the_DT Oriental_NNP Institute_NNP —_: a_DT museum_NN and_CC research_NN center_NN for_IN Near_NNP Eastern_NNP studies_NNS owned_VBN and_CC operated_VBN by_IN the_DT university_NN —_: and_CC a_DT number_NN of_IN National_NNP Resource_NNP Centers_NNPS ,_, including_VBG the_DT Center_NNP for_IN Middle_NNP Eastern_NNP Studies_NNPS ._. Chicago_NNP also_RB operates_VBZ or_CC is_VBZ affiliated_VBN with_IN several_JJ research_NN institutions_NNS apart_RB from_IN the_DT university_NN proper_JJ ._. The_DT university_NN manages_VBZ Argonne_NNP National_NNP Laboratory_NNP ,_, part_NN of_IN the_DT United_NNP States_NNPS Department_NNP of_IN Energy_NNP 's_POS national_JJ laboratory_NN system_NN ,_, and_CC co-manages_VBZ Fermi_NNP National_NNP Accelerator_NNP Laboratory_NNP (_-LRB- Fermilab_NNP )_-RRB- ,_, a_DT nearby_JJ particle_NN physics_NN laboratory_NN ,_, as_RB well_RB as_IN a_DT stake_NN in_IN the_DT Apache_NNP Point_NNP Observatory_NNP in_IN Sunspot_NNP ,_, New_NNP Mexico_NNP ._. Faculty_NN and_CC students_NNS at_IN the_DT adjacent_JJ Toyota_NNP Technological_NNP Institute_NNP at_IN Chicago_NNP collaborate_VBP with_IN the_DT university_NN ._. [_-LRB- 151_CD ]_-RRB- In_IN 2013_CD ,_, the_DT university_NN formed_VBD an_DT affiliation_NN with_IN the_DT formerly_RB independent_NNP Marine_NNP Biological_NNP Laboratory_NNP in_IN Woods_NNP Hole_NNP ,_, Mass_NNP ._. [_-LRB- 152_CD ]_-RRB- Although_IN formally_RB unrelated_JJ ,_, the_DT National_NNP Opinion_NNP Research_NNP Center_NNP is_VBZ located_VBN on_IN Chicago_NNP 's_POS campus_NN ._. The_DT University_NNP of_IN Chicago_NNP has_VBZ been_VBN the_DT site_NN of_IN some_DT important_JJ experiments_NNS and_CC academic_JJ movements_NNS ._. In_IN economics_NNS ,_, the_DT university_NN has_VBZ played_VBN an_DT important_JJ role_NN in_IN shaping_VBG ideas_NNS about_IN the_DT free_JJ market_NN [_-LRB- 153_CD ]_-RRB- and_CC is_VBZ the_DT namesake_NN of_IN the_DT Chicago_NNP school_NN of_IN economics_NN ,_, the_DT school_NN of_IN economic_JJ thought_NN supported_VBN by_IN Milton_NNP Friedman_NNP and_CC other_JJ economists_NNS ._. The_DT university_NN 's_POS sociology_NN department_NN was_VBD the_DT first_JJ independent_JJ sociology_NN department_NN in_IN the_DT United_NNP States_NNPS and_CC gave_VBD birth_NN to_IN the_DT Chicago_NNP school_NN of_IN sociology_NN ._. [_-LRB- 154_CD ]_-RRB- In_IN physics_NN ,_, the_DT university_NN was_VBD the_DT site_NN of_IN the_DT Chicago_NNP Pile_NNP -_HYPH 1_CD (_-LRB- the_DT first_JJ controlled_VBN ,_, self_NN -_HYPH sustaining_VBG man-made_JJ nuclear_JJ chain_NN reaction_NN ,_, part_NN of_IN the_DT Manhattan_NNP Project_NNP )_-RRB- ,_, of_IN Robert_NNP Millikan_NNP 's_POS oil_NN -_HYPH drop_NN experiment_NN that_WDT calculated_VBD the_DT charge_NN of_IN the_DT electron_NN ,_, [_-LRB- 155_CD ]_-RRB- and_CC of_IN the_DT development_NN of_IN radiocarbon_NN dating_NN by_IN Willard_NNP F._NNP Libby_NNP in_IN 1947_CD ._. The_DT chemical_JJ experiment_NN that_WDT tested_VBD how_WRB life_NN originated_VBD on_IN early_JJ Earth_NNP ,_, the_DT Miller–Urey_NNP experiment_NN ,_, was_VBD conducted_VBN at_IN the_DT university_NN ._. REM_NNP sleep_NN was_VBD discovered_VBN at_IN the_DT university_NN in_IN 1953_CD by_IN Nathaniel_NNP Kleitman_NNP and_CC Eugene_NNP Aserinsky_NNP ._. [_-LRB- 156_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP (_-LRB- Department_NNP of_IN Astronomy_NNP and_CC Astrophysics_NNP )_-RRB- operated_VBD the_DT Yerkes_NNP Observatory_NNP in_IN Williams_NNP Bay_NNP ,_, Wisconsin_NNP from_IN 1897_CD until_IN 2018_CD ,_, [_-LRB- 157_CD ]_-RRB- where_WRB the_DT largest_JJS operating_NN refracting_VBG telescope_NN in_IN the_DT world_NN and_CC other_JJ telescopes_NNS are_VBP located_VBN ._. The_DT UChicago_NNP Arts_NNP program_NN joins_VBZ academic_JJ departments_NNS and_CC programs_NNS in_IN the_DT Division_NNP of_IN the_DT Humanities_NNPS and_CC the_DT college_NN ,_, as_RB well_RB as_IN professional_JJ organizations_NNS including_VBG the_DT Court_NNP Theatre_NNP ,_, the_DT Oriental_NNP Institute_NNP ,_, the_DT Smart_NNP Museum_NNP of_IN Art_NNP ,_, the_DT Renaissance_NNP Society_NNP ,_, University_NNP of_IN Chicago_NNP Presents_NNPS ,_, and_CC student_NN arts_NNS organizations_NNS ._. The_DT university_NN has_VBZ an_DT artist_NN -_HYPH in_IN -_HYPH residence_NN program_NN and_CC scholars_NNS in_IN performance_NN studies_NNS ,_, contemporary_JJ art_NN criticism_NN ,_, and_CC film_NN history_NN ._. It_PRP has_VBZ offered_VBN a_DT doctorate_NN in_IN music_NN composition_NN since_IN 1933_CD and_CC cinema_NN and_CC media_NN studies_NNS since_IN 2000_CD ,_, a_DT master_NN of_IN fine_JJ arts_NNS in_IN visual_JJ arts_NNS (_-LRB- early_JJ 1970s_NNS )_-RRB- ,_, and_CC a_DT master_NN of_IN arts_NNS in_IN the_DT humanities_NNS with_IN a_DT creative_JJ writing_NN track_NN (_-LRB- 2000_CD )_-RRB- ._. It_PRP has_VBZ bachelor_NN 's_POS degree_NN programs_NNS in_IN visual_JJ arts_NNS ,_, music_NN ,_, and_CC art_NN history_NN ,_, and_CC ,_, more_RBR recently_RB ,_, cinema_NN and_CC media_NN studies_NNS (_-LRB- 1996_CD )_-RRB- and_CC theater_NN and_CC performance_NN studies_NNS (_-LRB- 2002_CD )_-RRB- ._. The_DT college_NN 's_POS general_JJ education_NN core_NN includes_VBZ a_DT ""_`` dramatic_JJ ,_, musical_JJ ,_, and_CC visual_JJ arts_NNS ""_'' requirement_NN ,_, inviting_VBG students_NNS to_TO study_VB the_DT history_NN of_IN the_DT arts_NNS ,_, stage_NN desire_NN ,_, or_CC begin_VB working_VBG with_IN sculpture_NN ._. Several_JJ thousand_CD major_JJ and_CC non-major_JJ undergraduates_NNS enroll_VBP annually_RB in_IN creative_JJ and_CC performing_NN arts_NNS classes_NNS ._. [_-LRB- 158_CD ]_-RRB- UChicago_NNP is_VBZ often_RB considered_VBN the_DT birthplace_NN of_IN improvisational_JJ comedy_NN as_IN the_DT Compass_NNP Players_NNPS student_NN comedy_NN troupe_NN evolved_VBD into_IN The_DT Second_NNP City_NNP improv_NN theater_NN troupe_NN in_IN 1959_CD ._. The_DT Reva_NNP and_CC David_NNP Logan_NNP Center_NNP for_IN the_DT Arts_NNPS opened_VBD in_IN October_NNP 2012_CD ,_, five_CD years_NNS after_IN a_DT $_$ 35_CD million_CD gift_NN from_IN alumnus_NN David_NNP Logan_NNP and_CC his_PRP$ wife_NN Reva_NNP ._. The_DT center_NN includes_VBZ spaces_NNS for_IN exhibitions_NNS ,_, performances_NNS ,_, classes_NNS ,_, and_CC media_NN production_NN ._. The_DT Logan_NNP Center_NNP was_VBD designed_VBN by_IN Tod_NNP Williams_NNP and_CC Billie_NNP Tsien_NNP ._. This_DT building_NN is_VBZ entirely_RB glass_NN ._. The_DT brick_NN is_VBZ a_DT facade_NN designed_VBN to_TO keep_VB the_DT glass_NN safe_JJ from_IN the_DT wind_NN ._. The_DT architects_NNS later_RBR removed_VBD sections_NNS of_IN the_DT bricks_NNS when_WRB pressure_NN arose_VBD in_IN the_DT form_NN of_IN complaints_NNS that_IN the_DT views_NNS of_IN the_DT city_NN were_VBD blocked_VBN ._. In_IN Fall_NN 2018_CD ,_, the_DT university_NN enrolled_VBD 6,595_CD undergraduate_NN students_NNS ,_, 9,899_CD graduate_NN students_NNS ,_, and_CC 616_CD non_JJ -degree_NN students_NNS ._. [_-LRB- 160_CD ]_-RRB- The_DT college_NN class_NN of_IN 2022_CD is_VBZ composed_VBN of_IN 51_CD %_NN male_JJ students_NNS and_CC 49_CD %_NN female_JJ students_NNS ._. 23_CD %_NN of_IN the_DT class_NN identify_VB as_IN Asian_JJ ,_, 15_CD %_NN as_IN Hispanic_JJ ,_, and_CC 9_CD %_NN as_IN Black_NNP ._. 15_CD %_NN of_IN the_DT class_NN is_VBZ international_JJ ._. [_-LRB- 161_CD ]_-RRB- Admissions_NNS to_IN the_DT University_NNP of_IN Chicago_NNP is_VBZ highly_RB selective_JJ ._. The_DT middle_JJ 50_CD %_NN band_NN of_IN SAT_NN scores_NNS for_IN the_DT undergraduate_NN class_NN of_IN 2022_CD was_VBD 1490_CD –_SYM 1560_CD (_-LRB- 98th_NN -_SYM 99th_NN percentiles_NNS )_-RRB- ,_, [_-LRB- 161_CD ]_-RRB- the_DT average_JJ MCAT_NN score_NN for_IN students_NNS entering_VBG the_DT Pritzker_NNP School_NNP of_IN Medicine_NNP class_NN of_IN 2022_CD was_VBD 518_CD (_-LRB- 96th_NNP percentile_NN )_-RRB- ,_, [_-LRB- 162_CD ]_-RRB- the_DT median_JJ GMAT_NN score_NN for_IN students_NNS entering_VBG the_DT full_JJ -_HYPH time_NN Booth_NN MBA_NN program_NN class_NN of_IN 2021_CD was_VBD 730_CD (_-LRB- 96th_NNP percentile_NN )_-RRB- ,_, [_-LRB- 163_CD ]_-RRB- and_CC the_DT median_JJ LSAT_NN score_NN for_IN entering_VBG students_NNS the_DT Law_NNP School_NNP class_NN of_IN 2021_CD was_VBD 171_CD (_-LRB- 98th_JJ percentile_NN )_-RRB- ._. [_-LRB- 164_CD ]_-RRB- For_IN the_DT class_NN of_IN 2024_CD ,_, the_DT College_NNP of_IN the_DT University_NNP of_IN Chicago_NNP had_VBD an_DT acceptance_NN rate_NN of_IN 6.2_CD %_NN ._. [_-LRB- 165_CD ]_-RRB- In_IN 2018_CD ,_, the_DT University_NNP of_IN Chicago_NNP attracted_VBD national_JJ headlines_NNS by_IN becoming_VBG the_DT first_JJ major_JJ research_NN university_NN to_TO no_RB longer_RBR require_VB SAT_NN /_, ACT_NN scores_NNS from_IN college_NN applicants_NNS ._. [_-LRB- 166_CD ]_-RRB- The_DT University_NNP of_IN Chicago_NNP hosts_VBZ 19_CD varsity_JJ sports_NNS teams_NNS :_: 10_CD men_NNS 's_POS teams_NNS and_CC 9_CD women_NNS 's_POS teams_NNS ,_, [_-LRB- 167_CD ]_-RRB- all_RB called_VBN the_DT Maroons_NNPS ,_, with_IN 502_CD students_NNS participating_VBG in_IN the_DT 2012_CD –_SYM 2013_CD school_NN year_NN ._. [_-LRB- 167_CD ]_-RRB- The_DT Maroons_NNPS compete_VBP in_IN the_DT NCAA_NNP 's_POS Division_NNP III_CD as_IN members_NNS of_IN the_DT University_NNP Athletic_NNP Association_NNP (_-LRB- UAA_NNP )_-RRB- ._. The_DT university_NN was_VBD a_DT founding_VBG member_NN of_IN the_DT Big_NNP Ten_NNP Conference_NNP and_CC participated_VBD in_IN the_DT NCAA_NNP Division_NNP I_NNP men's_NNS basketball_NN and_CC football_NN and_CC was_VBD a_DT regular_JJ participant_NN in_IN the_DT men's_NN basketball_NN tournament_NN ._. In_IN 1935_CD ,_, the_DT University_NNP of_IN Chicago_NNP reached_VBD the_DT Sweet_NNP Sixteen_CD ._. [_-LRB- 167_CD ]_-RRB- In_IN 1935_CD ,_, Chicago_NNP Maroons_NNP football_NN player_NN Jay_NNP Berwanger_NNP became_VBD the_DT first_JJ winner_NN of_IN the_DT Heisman_NNP Trophy_NNP ._. However_RB ,_, the_DT university_NN chose_VBD to_TO withdraw_VB from_IN the_DT Big_NNP Ten_NNP Conference_NNP in_IN 1946_CD after_IN University_NNP President_NN Robert_NNP Maynard_NNP Hutchins_NNP de-emphasized_VBD varsity_NN athletics_NNS in_IN 1939_CD and_CC dropped_VBD football_NN ._. [_-LRB- 168_CD ]_-RRB- In_IN 1969_CD ,_, Chicago_NNP reinstated_VBD football_NN as_IN a_DT Division_NN III_CD team_NN ,_, resuming_VBG playing_VBG its_PRP$ home_NN games_NNS at_IN the_DT new_JJ Stagg_NNP Field_NNP ._. UChicago_NNP is_VBZ also_RB the_DT home_NN of_IN the_DT ultimate_JJ frisbee_NN team_NN Chicago_NNP Junk_NNP ._. [_-LRB- 169_CD ]_-RRB- Students_NNS at_IN the_DT University_NNP of_IN Chicago_NNP operate_VBP more_JJR than_IN 400_CD clubs_NNS and_CC organizations_NNS known_VBN as_IN Recognized_NNP Student_NNP Organizations_NNPS (_-LRB- RSOs_NNP )_-RRB- ._. [_-LRB- 170_CD ]_-RRB- [_-LRB- 171_CD ]_-RRB- These_DT include_VBP cultural_JJ and_CC religious_JJ groups_NNS ,_, academic_JJ clubs_NNS and_CC teams_NNS ,_, and_CC common_JJ -_HYPH interest_NN organizations_NNS ._. [_-LRB- 171_CD ]_-RRB- Notable_JJ extracurricular_JJ groups_NNS include_VBP the_DT University_NNP of_IN Chicago_NNP College_NNP Bowl_NNP Team_NNP ,_, which_WDT has_VBZ won_VBN 118_CD tournaments_NNS and_CC 15_CD national_JJ championships_NNS ,_, leading_VBG both_DT categories_NNS internationally_RB ._. The_DT university_NN 's_POS competitive_JJ Model_NNP United_NNP Nations_NNPS team_NN was_VBD the_DT top_JJ -_HYPH ranked_VBN team_NN in_IN North_NNP America_NNP in_IN 2013_CD –_SYM 14_CD ,_, 2014–2015_CD ,_, 2015_CD –2016_CD ,_, and_CC again_RB for_IN the_DT 2017_CD –_SYM 2018_CD season_NN ._. The_DT University_NNP 's_POS Model_NNP UN_NNP team_NN is_VBZ also_RB the_DT first_JJ to_TO be_VB in_IN the_DT top_JJ 5_CD for_IN almost_RB a_DT decade_NN ,_, according_VBG to_IN Best_JJS Delegate_NN ._. Among_IN notable_JJ student_NN organizations_NNS are_VBP the_DT nation_NN 's_POS longest_RBS continuously_RB running_VBG student_NN film_NN society_NN Doc_NNP Films_NNP ,_, the_DT organizing_NN committee_NN for_IN the_DT University_NNP of_IN Chicago_NNP Scavenger_NNP Hunt_NNP ,_, the_DT weekly_JJ student_NN newspaper_NN The_DT Chicago_NNP Maroon_NNP ,_, the_DT satirical_JJ Chicago_NNP Shady_NNP Dealer_NNP ,_, [_-LRB- 172_CD ]_-RRB- the_DT nation_NN 's_POS second_RB -_HYPH oldest_JJS continuously_RB running_VBG student_NN improvisational_JJ theater_NN troupe_NN Off_IN -_HYPH Off_IN Campus_NNP ,_, and_CC the_DT investment_NN club_NN The_DT Blue_NNP Chips_NNPS ._. All_DT Recognized_NNP Student_NNP Organizations_NNPS ,_, from_IN the_DT University_NNP of_IN Chicago_NNP Scavenger_NNP Hunt_NNP to_IN Model_NNP UN_NNP ,_, in_IN addition_NN to_IN academic_JJ teams_NNS ,_, sports_NNS clubs_NNS ,_, arts_NNS groups_NNS ,_, and_CC more_JJR are_VBP funded_VBN by_IN The_DT University_NNP of_IN Chicago_NNP Student_NNP Government_NNP ._. Student_NN Government_NN consists_VBZ of_IN graduate_NN and_CC undergraduate_NN students_NNS elected_VBN to_TO represent_VB members_NNS from_IN their_PRP$ respective_JJ academic_JJ units_NNS ._. It_PRP is_VBZ led_VBN by_IN an_DT Executive_JJ Committee_NN ,_, chaired_VBN by_IN a_DT President_NNP with_IN the_DT assistance_NN of_IN two_CD Vice_NN Presidents_NNS ,_, one_CD for_IN Administration_NNP and_CC the_DT other_JJ for_IN Student_NNP Life_NNP ,_, elected_VBN together_RB as_IN a_DT slate_NN by_IN the_DT student_NN body_NN each_DT spring_NN ._. Its_PRP$ annual_JJ budget_NN is_VBZ greater_JJR than_IN $_$ 2_CD million_CD ._. [_-LRB- 173_CD ]_-RRB- There_EX are_VBP 16_CD Fraternities_NNS at_IN the_DT university_NN :_: Alpha_NNP Delta_NNP Phi_NNP (_-LRB- Chicago_NNP Chapter_NNP )_-RRB- ,_, Alpha_NNP Epsilon_NNP Pi_NNP (_-LRB- Lambda_NNP Chapter_NNP )_-RRB- ,_, Alpha_NNP Phi_NNP Alpha_NNP (_-LRB- Theta_NNP Chapter_NNP )_-RRB- ,_, Delta_NNP Epsilon_NNP Psi_NNP (_-LRB- Alpha_NNP Kappa_NNP )_-RRB- ,_, Delta_NNP Kappa_NNP Epsilon_NNP (_-LRB- Delta_NNP Delta_NNP )_-RRB- ,_, Delta_NNP Tau_NNP Delta_NNP (_-LRB- Gamma_NNP Alpha_NNP )_-RRB- ,_, Delta_NNP Upsilon_NNP (_-LRB- Chicago_NNP Chapter_NNP )_-RRB- ,_, Kappa_NNP Alpha_NNP Psi_NNP (_-LRB- Iota_NNP Chapter_NNP )_-RRB- ,_, Lambda_NNP Phi_NNP Epsilon_NNP (_-LRB- Psi_NNP Chapter_NNP )_-RRB- ,_, Phi_NNP Delta_NNP Theta_NNP (_-LRB- Beta_NNP Chapter_NNP )_-RRB- ,_, Phi_NNP Gamma_NNP Delta_NNP (_-LRB- Chi_NNP Upsilon_NNP Chapter_NNP )_-RRB- ,_, Phi_NNP Iota_NNP Alpha_NNP (_-LRB- Chicago_NNP Colony_NNP Chapter_NNP )_-RRB- ,_, Psi_NNP Upsilon_NNP (_-LRB- Omega_NNP Chapter_NNP )_-RRB- ,_, Sigma_NNP Chi_NNP (_-LRB- Omicron_NNP Omicron_NNP Chapter_NNP )_-RRB- ,_, Sigma_NNP Phi_NNP Epsilon_NNP (_-LRB- Omicron_NNP Omicron_NNP Chapter_NNP )_-RRB- and_CC Zeta_NNP Psi_NNP (_-LRB- Omega_NNP Alpha_NNP Chapter_NNP )_-RRB- ._. There_EX are_VBP Six_CD Sororities_NNS are_VBP Alpha_NNP Kappa_NNP Alpha_NNP (_-LRB- Beta_NNP Chapter_NNP )_-RRB- ,_, Alpha_NNP Omicron_NNP Pi_NNP (_-LRB- Phi_NNP Chi_NNP Chapter_NNP )_-RRB- ,_, Delta_NNP Gamma_NNP (_-LRB- Eta_NNP Zeta_NNP Chapter_NNP )_-RRB- ,_, Delta_NNP Sigma_NNP Theta_NNP (_-LRB- Lambda_NNP Chapter_NNP )_-RRB- ,_, Kappa_NNP Alpha_NNP Theta_NNP (_-LRB- Epsilon_NNP Phi_NNP Chapter_NNP )_-RRB- and_CC Pi_NNP Beta_NNP Phi_NNP (_-LRB- Kappa_NNP Chapter_NNP )_-RRB- at_IN the_DT University_NNP of_IN Chicago_NNP ,_, [_-LRB- 174_CD ]_-RRB- as_RB well_RB as_IN one_CD co-ed_JJ community_NN service_NN fraternity_NN are_VBP Alpha_NNP Phi_NNP Omega(_NNP Gamma_NNP Sigma_NNP Chapter_NNP )_-RRB- ._. [_-LRB- 175_CD ]_-RRB- Social_JJ fraternities_NNS and_CC sororities_NNS are_VBP not_RB recognized_VBN by_IN the_DT university_NN as_IN registered_VBN student_NN organizations_NNS ._. Four_CD of_IN the_DT sororities_NNS are_VBP members_NNS of_IN the_DT National_NNP Panhellenic_NNP Conference_NNP [_-LRB- 176_CD ]_-RRB- There_EX is_VBZ no_DT Interfraternity_NN Council_NN on_IN campus_NN ._. As_IN of_IN 2017_CD ,_, approximately_RB 20_CD to_IN 25_CD percent_NN of_IN students_NNS are_VBP members_NNS of_IN fraternities_NNS or_CC sororities_NNS ._. [_-LRB- 176_CD ]_-RRB- This_DT is_VBZ an_DT increase_NN from_IN the_DT numbers_NNS published_VBN in_IN the_DT year_NN 2007_CD by_IN the_DT student_NN activities_NNS office_NN stating_VBG that_IN one_CD in_IN ten_CD undergraduates_NNS participated_VBD in_IN Greek_JJ life_NN ._. [_-LRB- 174_CD ]_-RRB- On_IN -_HYPH campus_NN undergraduate_NN students_NNS at_IN the_DT University_NNP of_IN Chicago_NNP participate_VBP in_IN a_DT house_NN system_NN in_IN which_WDT each_DT student_NN is_VBZ assigned_VBN to_IN one_CD of_IN the_DT university_NN 's_POS 7_CD residence_NN hall_NN buildings_NNS and_CC to_IN a_DT smaller_JJR community_NN within_IN their_PRP$ residence_NN hall_NN called_VBN a_DT ""_`` House_NNP ""_'' ._. There_EX are_VBP 39_CD houses_NNS ,_, with_IN an_DT average_NN of_IN 70_CD students_NNS in_IN each_DT House_NNP ._. [_-LRB- 177_CD ]_-RRB- Traditionally_RB only_RB first_JJ years_NNS were_VBD required_VBN to_TO live_VB in_IN housing_NN ,_, starting_VBG with_IN the_DT Class_NNP of_IN 2023_CD ,_, students_NNS are_VBP required_VBN to_TO live_VB in_IN housing_NN for_IN the_DT first_JJ 2_CD years_NNS of_IN enrollment_NN ._. [_-LRB- 178_CD ]_-RRB- About_RB 60_CD %_NN of_IN undergraduate_NN students_NNS live_VBP on_IN campus_NN ._. [_-LRB- 178_CD ]_-RRB- For_IN graduate_NN students_NNS ,_, the_DT university_NN owns_VBZ and_CC operates_VBZ 28_CD apartment_NN buildings_NNS near_IN campus_NN ._. [_-LRB- 179_CD ]_-RRB- Every_DT May_NNP since_IN 1987_CD ,_, the_DT University_NNP of_IN Chicago_NNP has_VBZ held_VBN the_DT University_NNP of_IN Chicago_NNP Scavenger_NNP Hunt_NNP ,_, in_IN which_WDT large_JJ teams_NNS of_IN students_NNS compete_VBP to_TO obtain_VB notoriously_RB esoteric_JJ items_NNS from_IN a_DT list_NN ._. [_-LRB- 180_CD ]_-RRB- Since_IN 1963_CD ,_, the_DT Festival_NNP of_IN the_DT Arts_NNPS (_-LRB- FOTA_NNP )_-RRB- takes_VBZ over_RP campus_NN for_IN 7_CD –10_CD days_NNS of_IN exhibitions_NNS and_CC interactive_JJ artistic_JJ endeavors_NNS ._. [_-LRB- 181_CD ]_-RRB- Every_DT January_NNP ,_, the_DT university_NN holds_VBZ a_DT week_NN -_HYPH long_JJ winter_NN festival_NN ,_, Kuviasungnerk_NNP /_, Kangeiko_NNP ,_, which_WDT includes_VBZ early_JJ morning_NN exercise_NN routines_NNS and_CC fitness_NN workshops_NNS ._. The_DT university_NN also_RB annually_RB holds_VBZ a_DT summer_NN carnival_NN and_CC concert_NN called_VBN Summer_NNP Breeze_NNP that_WDT hosts_VBZ outside_JJ musicians_NNS and_CC is_VBZ home_NN to_IN Doc_NNP Films_NNP ,_, a_DT student_NN film_NN society_NN founded_VBN in_IN 1932_CD that_WDT screens_VBZ films_NNS nightly_RB at_IN the_DT university_NN ._. Since_IN 1946_CD ,_, the_DT university_NN has_VBZ organized_VBN the_DT Latke_NNP -_HYPH Hamantash_NNP Debate_NNP ,_, which_WDT involves_VBZ humorous_JJ discussions_NNS about_IN the_DT relative_JJ merits_NNS and_CC meanings_NNS of_IN latkes_NNS and_CC hamantashen_NN ._. As_IN of_IN October_NNP 2019_CD ,_, there_EX have_VBP been_VBN 100_CD Nobel_NNP laureates_NNS affiliated_VBN with_IN the_DT University_NNP of_IN Chicago_NNP ,_, [_-LRB- 182_CD ]_-RRB- 20_CD of_IN whom_WP were_VBD pursuing_VBG research_NN or_CC on_IN faculty_NN at_IN the_DT university_NN at_IN the_DT time_NN of_IN the_DT award_NN announcement_NN ._. [_-LRB- 183_CD ]_-RRB- Notable_JJ alumni_NNS and_CC faculty_NN affiliated_VBN with_IN the_DT university_NN include_VBP 33_CD Nobel_NNP laureates_NNS in_IN Economics_NNP ._. [_-LRB- 184_CD ]_-RRB- No_DT university_NN has_VBZ had_VBN more_RBR affiliated_VBN Nobel_NNP laureates_NNS in_IN Economics_NNP ._. [_-LRB- 185_CD ]_-RRB- In_IN addition_NN ,_, many_JJ Chicago_NNP alumni_NNS and_CC scholars_NNS have_VBP won_VBN the_DT Fulbright_NNP awards_NNS [_-LRB- 186_CD ]_-RRB- and_CC 53_CD have_VBP matriculated_VBN as_IN Rhodes_NNP Scholars_NNPS ._. [_-LRB- 19_CD ]_-RRB- In_IN 2019_CD ,_, the_DT University_NNP of_IN Chicago_NNP claimed_VBD 188,000_CD alumni_NNS ._. [_-LRB- 1_CD ]_-RRB- While_IN the_DT university_NN 's_POS first_JJ president_NN ,_, William_NNP Rainey_NNP Harper_NNP stressed_VBD the_DT importance_NN of_IN perennial_JJ theory_NN over_IN practicality_NN in_IN his_PRP$ institution_NN 's_POS curriculum_NN ,_, this_DT has_VBZ not_RB stopped_VBN the_DT alumni_NN of_IN Chicago_NNP from_IN being_VBG among_IN the_DT wealthiest_JJS in_IN the_DT world_NN ._. [_-LRB- 112_CD ]_-RRB- [_-LRB- 113_CD ]_-RRB- [_-LRB- 114_CD ]_-RRB- In_IN business_NN ,_, notable_JJ alumni_NNS include_VBP Microsoft_NNP CEO_NN Satya_NNP Nadella_NNP ,_, Oracle_NNP Corporation_NNP founder_NN and_CC the_DT third_RB richest_JJS man_NN in_IN America_NNP Larry_NNP Ellison_NNP ,_, Goldman_NNP Sachs_NNP and_CC MF_NNP Global_JJ CEO_NN as_RB well_RB as_IN former_JJ Governor_NNP of_IN New_NNP Jersey_NNP Jon_NNP Corzine_NNP ,_, McKinsey_NNP &_CC Company_NNP founder_NN and_CC author_NN of_IN the_DT first_JJ management_NN accounting_NN textbook_NN James_NNP O._NNP McKinsey_NNP ,_, co-founder_NN of_IN the_DT Blackstone_NNP Group_NNP Peter_NNP G._NNP Peterson_NNP ,_, co-founder_NN of_IN AQR_NNP Capital_NNP Management_NNP Cliff_NNP Asness_NNP ,_, founder_NN of_IN Dimensional_NNP Fund_NNP Advisors_NNPS David_NNP Booth_NNP ,_, founder_NN of_IN The_DT Carlyle_NNP Group_NNP David_NNP Rubenstein_NNP ,_, former_JJ COO_NN of_IN Goldman_NNP Sachs_NNP Andrew_NNP Alper_NNP ,_, billionaire_NN investor_NN and_CC founder_NN of_IN Oaktree_NNP Capital_NNP Management_NNP Howard_NNP Marks_NNP (_-LRB- investor_NN )_-RRB- ,_, Bloomberg_NNP L.P._NNP CEO_NN Daniel_NNP Doctoroff_NNP ,_, Credit_NN Suisse_NNP CEO_NN Brady_NNP Dougan_NNP ,_, Morningstar_NNP ,_, Inc._NNP founder_NN and_CC CEO_NN Joe_NNP Mansueto_NNP ,_, Chicago_NNP Cubs_NNP owner_NN and_CC chairman_NN Thomas_NNP S._NNP Ricketts_NNP ,_, and_CC NBA_NNP commissioner_NN Adam_NNP Silver_NNP ._. Notable_JJ alumni_NNS in_IN the_DT field_NN of_IN law_NN ,_, government_NN and_CC politics_NNS include_VBP Supreme_NNP Court_NNP Justice_NNP John_NNP Paul_NNP Stevens_NNP ,_, the_DT Lord_NNP Chief_NNP Justice_NNP of_IN England_NNP and_CC Wales_NNP Lord_NNP Thomas_NNP of_IN Cwmgiedd_NNP ,_, President_NNP of_IN the_DT Supreme_NNP Court_NNP of_IN Israel_NNP Shimon_NNP Agranat_NNP ,_, Attorney_NNP General_NNP and_CC federal_JJ judge_NN Robert_NNP Bork_NNP ,_, Attorneys_NNP General_NNP Ramsey_NNP Clark_NNP ,_, John_NNP Ashcroft_NNP and_CC Edward_NNP Levi_NNP ,_, Prime_NNP Minister_NNP of_IN Canada_NNP William_NNP Lyon_NNP Mackenzie_NNP King_NNP ,_, 33rd_JJ Prime_NNP Minister_NNP of_IN New_NNP Zealand_NNP Geoffrey_NNP Palmer_NNP (_-LRB- politician_NN )_-RRB- ,_, 11th_NNP Prime_NNP Minister_NNP of_IN Poland_NNP Marek_NNP Belka_NNP ,_, Governor_NNP of_IN the_DT Bank_NNP of_IN Japan_NNP Masaaki_NNP Shirakawa_NNP ,_, Obama_NNP campaign_NN advisor_NN and_CC top_JJ political_JJ advisor_NN to_IN President_NNP Bill_NNP Clinton_NNP David_NNP Axelrod_NNP ,_, the_DT founder_NN of_IN modern_JJ community_NN organizing_NN Saul_NNP Alinsky_NNP ,_, Prohibition_NN agent_NN Eliot_NNP Ness_NNP ,_, current_JJ Chicago_NNP mayor_NN Lori_NNP Lightfoot_NNP ,_, the_DT first_JJ female_JJ African_JJ -_HYPH American_JJ Senator_NNP Carol_NNP Moseley_NNP Braun_NNP ,_, United_NNP States_NNPS Senator_NNP from_IN Vermont_NNP and_CC 2016_CD Democratic_JJ Presidential_JJ Candidate_NN Bernie_NNP Sanders_NNP ,_, former_JJ World_NNP Bank_NNP President_NNP Paul_NNP Wolfowitz_NNP ,_, and_CC Amien_NNP Rais_NNP (_-LRB- Ph.D._NNP 1984_CD )_-RRB- –_: professor_NN ;_: former_JJ chairman_NN of_IN the_DT People_NNP 's_POS Consultative_NNP Assembly_NNP of_IN the_DT Republic_NNP of_IN Indonesia_NNP ._. Notable_JJ alumni_NNS ,_, who_WP are_VBP leaders_NNS in_IN higher_JJR education_NN ,_, have_VBP emerged_VBN from_IN almost_RB all_DT parts_NNS of_IN the_DT university_NN :_: college_NN president_NN and_CC chancellor_NN Rebecca_NNP Chopp_NNP ;_: current_JJ president_NN of_IN Middlebury_NNP College_NNP Laurie_NNP L._NNP Patton_NNP ;_: Master_NNP of_IN Clare_NNP College_NNP ,_, Cambridge_NNP and_CC Vice_NNP -_HYPH Chancellor_NNP of_IN University_NNP of_IN Cambridge_NNP Eric_NNP Ashby_NNP ,_, Baron_NNP Ashby_NNP ;_: president_NN of_IN Princeton_NNP University_NNP Christopher_NNP L._NNP Eisgruber_NNP ;_: former_JJ president_NN of_IN Morehouse_NNP College_NNP Robert_NNP M._NNP Franklin_NNP ,_, Jr._NNP ;_: President_NNP of_IN the_DT Open_NNP University_NNP of_IN Israel_NNP Jacob_NNP Metzer_NNP ;_: and_CC president_NN of_IN Shimer_NNP College_NNP Susan_NNP Henking_NNP ._. In_IN journalism_NN ,_, notable_JJ alumni_NNS include_VBP New_NNP York_NNP Times_NNP columnist_NN and_CC commentator_NN on_IN PBS_NNP News_NNP Hour_NNP David_NNP Brooks_NNP ,_, Washington_NNP Post_NNP columnist_NN David_NNP Broder_NNP ,_, Washington_NNP Post_NNP publisher_NN Katharine_NNP Graham_NNP ,_, reporter_NN and_CC commentator_NN Virginia_NNP Graham_NNP ,_, investigative_JJ journalist_NN and_CC political_JJ writer_NN Seymour_NNP Hersh_NNP ,_, The_DT Progressive_JJ columnist_NN Milton_NNP Mayer_NNP ,_, four_CD -_HYPH time_NN Pulitzer_NNP Prize_NNP winning_VBG journalist_NN Rick_NNP Atkinson_NNP ,_, statistical_JJ analyst_NN and_CC FiveThirty_NNP Eight_CD founder_NN and_CC creator_NN Nate_NNP Silver_NNP ,_, and_CC CBS_NNP News_NNP correspondent_NN Rebecca_NNP Jarvis_NNP ._. In_IN literature_NN ,_, author_NN of_IN the_DT New_NNP York_NNP Times_NNP bestseller_NN Before_IN I_PRP Fall_VBP Lauren_NNP Oliver_NNP ,_, Pulitzer_NNP Prize_NNP -_HYPH winning_VBG novelist_NN Philip_NNP Roth_NNP ;_: Canadian_JJ -_HYPH born_VBN Pulitzer_NNP Prize_NNP and_CC Nobel_NNP Prize_NNP for_IN Literature_NNP winning_VBG writer_NN Saul_NNP Bellow_NNP ;_: political_JJ philosopher_NN ,_, literary_JJ critic_NN and_CC author_NN of_IN the_DT New_NNP York_NNP Times_NNP bestseller_NN The_DT Closing_NNP of_IN the_DT American_NNP Mind_NNP Allan_NNP Bloom_NNP ;_: author_NN of_IN The_DT Big_NNP Country_NNP and_CC Matt_NNP Helm_NNP spy_NN novels_NNS Donald_NNP Hamilton_NNP ;_: The_DT Good_NNP War_NNP author_NN Studs_NNP Terkel_NNP ;_: writer_NN ,_, essayist_NN ,_, filmmaker_NN ,_, teacher_NN ,_, and_CC political_JJ activist_NN Susan_NNP Sontag_NNP ;_: analytic_JJ philosopher_NN and_CC Stanford_NNP University_NNP Professor_NNP of_IN Comparative_JJ literature_NN Richard_NNP Rorty_NNP ;_: cultural_JJ commentator_NN ,_, author_NN ,_, and_CC president_NN of_IN St._NNP Stephen_NNP 's_POS College_NNP (_-LRB- now_RB Bard_NNP College_NNP )_-RRB- Bernard_NNP Iddings_NNP Bell_NNP ;_: and_CC novelist_NN and_CC satirist_NN Kurt_NNP Vonnegut_NNP are_VBP notable_JJ alumni_NNS ._. In_IN the_DT arts_NNS and_CC entertainment_NN ,_, minimalist_JJ composer_NN Philip_NNP Glass_NNP ,_, dancer_NN ,_, choreographer_NN and_CC leader_NN in_IN the_DT field_NN of_IN dance_NN anthropology_NN Katherine_NNP Dunham_NNP ,_, Bungie_NNP founder_NN and_CC developer_NN of_IN the_DT Halo_NNP video_NN game_NN series_NN Alex_NNP Seropian_NNP ,_, Serial_JJ host_NN Sarah_NNP Koenig_NNP ,_, actor_NN Ed_NNP Asner_NNP ,_, actress_NN Anna_NNP Chlumsky_NNP ,_, Pulitzer_NNP Prize_NNP for_IN Criticism_NNP winning_VBG film_NN critic_NN and_CC the_DT subject_NN of_IN the_DT 2014_CD documentary_NN film_NN Life_NNP Itself_PRP Roger_NNP Ebert_NNP ,_, director_NN ,_, writer_NN ,_, and_CC comedian_NN Mike_NNP Nichols_NNP ,_, film_NN director_NN and_CC screenwriter_NN Philip_NNP Kaufman_NNP ,_, and_CC photographer_NN and_CC writer_NN Carl_NNP Van_NNP Vechten_NNP ,_, photographer_NN and_CC writer_NN ,_, are_VBP graduates_NNS ._. In_IN science_NN ,_, alumni_NNS include_VBP astronomers_NNS Carl_NNP Sagan_NNP ,_, a_DT prominent_JJ contributor_NN to_IN the_DT scientific_JJ research_NN of_IN extraterrestrial_JJ life_NN ,_, and_CC Edwin_NNP Hubble_NNP ,_, known_VBN for_IN ""_`` Hubble_NNP 's_POS Law_NNP ""_'' ,_, NASA_NNP astronaut_NN John_NNP M._NNP Grunsfeld_NNP ,_, geneticist_NN James_NNP Watson_NNP ,_, best_RBS known_VBN as_IN one_CD of_IN the_DT co-discoverers_NNS of_IN the_DT structure_NN of_IN DNA_NN ,_, experimental_JJ physicist_NN Luis_NNP Alvarez_NNP ,_, popular_JJ environmentalist_NN David_NNP Suzuki_NNP ,_, balloonist_NN Jeannette_NNP Piccard_NNP ,_, biologists_NNS Ernest_NNP Everett_NNP Just_NNP and_CC Lynn_NNP Margulis_NNP ,_, computer_NN scientist_NN Richard_NNP Hamming_NNP ,_, the_DT creator_NN of_IN the_DT Hamming_NNP Code_NNP ,_, lithium_NN -_HYPH ion_NN battery_NN developer_NN John_NNP B._NNP Goodenough_NNP ,_, mathematician_NN and_CC Fields_NNP Medal_NNP recipient_NN Paul_NNP Joseph_NNP Cohen_NNP ,_, geochemist_NN Clair_NNP Cameron_NNP Patterson_NNP ,_, who_WP developed_VBD the_DT uranium_NN -_HYPH lead_NN dating_NN method_NN into_IN lead_NN -_HYPH lead_NN dating_NN ,_, geologist_NN and_CC geophysicist_NN M._NNP King_NNP Hubbert_NNP ,_, known_VBN for_IN the_DT Hubbert_NNP curve_NN and_CC Hubbert_NNP peak_NN theory_NN ,_, the_DT main_JJ components_NNS of_IN peak_NN oil_NN ,_, and_CC ""_`` Queen_NNP of_IN Carbon_NNP ""_'' Mildred_NNP Dresselhaus_NNP ._. Nuclear_JJ physicist_NN and_CC researcher_NN Stanton_NNP Friedman_NNP ,_, who_WP worked_VBD on_IN some_DT early_JJ projects_NNS involving_VBG nuclear_JJ -_HYPH powered_VBN spacecraft_NN propulsion_NN systems_NNS ,_, is_VBZ also_RB a_DT graduate_NN (_-LRB- M.Sc_NN )_-RRB- ._. Ray_NNP Solomonoff_NNP ,_, one_CD of_IN the_DT founders_NNS of_IN the_DT field_NN of_IN machine_NN learning_NN as_RB well_RB as_IN Kolmogorov_NNP complexity_NN ,_, got_VBD a_DT BS_NN and_CC MS_NNP in_IN Physics_NNP in_IN 1951_CD ,_, studying_VBG under_IN Rudolf_NNP Carnap_NNP ._. In_IN economics_NN ,_, notable_JJ Nobel_NNP Memorial_NNP Prize_NNP in_IN Economic_NNP Sciences_NNP winners_NNS Milton_NNP Friedman_NNP ,_, a_DT major_JJ advisor_NN to_IN Republican_JJ U.S._NNP President_NNP Ronald_NNP Reagan_NNP ,_, Conservative_JJ British_JJ Prime_NNP Minister_NNP Margaret_NNP Thatcher_NNP and_CC Chilean_JJ military_JJ dictator_NN Augusto_NNP Pinochet_NNP ,_, George_NNP Stigler_NNP ,_, Nobel_NNP laureate_NN and_CC proponent_NN of_IN regulatory_JJ capture_NN theory_NN ,_, Herbert_NNP A._NNP Simon_NNP ,_, responsible_JJ for_IN the_DT modern_JJ interpretation_NN of_IN the_DT concept_NN of_IN organizational_JJ decision_NN -_HYPH making_NN ,_, Paul_NNP Samuelson_NNP ,_, the_DT first_JJ American_NNP to_TO win_VB the_DT Nobel_NNP Memorial_NNP Prize_NNP in_IN Economic_NNP Sciences_NNPS ,_, and_CC Eugene_NNP Fama_NNP ,_, known_VBN for_IN his_PRP$ work_NN on_IN portfolio_NN theory_NN ,_, asset_NN pricing_NN and_CC stock_NN market_NN behavior_NN ,_, are_VBP all_RB graduates_NNS ._. American_JJ economist_NN ,_, social_JJ theorist_NN ,_, political_JJ philosopher_NN ,_, and_CC author_NN Thomas_NNP Sowell_NNP is_VBZ also_RB an_DT alumnus_NN ._. Brazil_NNP 's_POS Minister_NNP of_IN the_DT Economy_NNP Paulo_NNP Guedes_NNP received_VBD his_PRP$ Ph.D._NN from_IN UChicago_NNP in_IN 1978_CD ._. Other_JJ prominent_JJ alumni_NNS include_VBP anthropologists_NNS David_NNP Graeber_NNP and_CC Donald_NNP Johanson_NNP ,_, who_WP is_VBZ best_RBS known_VBN for_IN discovering_VBG the_DT fossil_NN of_IN a_DT female_JJ hominid_NN australopithecine_NN known_VBN as_IN ""_`` Lucy_NNP ""_'' in_IN the_DT Afar_NNP Triangle_NNP region_NN ,_, psychologist_NN John_NNP B._NNP Watson_NNP ,_, American_JJ psychologist_NN who_WP established_VBD the_DT psychological_JJ school_NN of_IN behaviorism_NN ,_, communication_NN theorist_NN Harold_NNP Innis_NNP ,_, chess_NN grandmaster_NN Samuel_NNP Reshevsky_NNP ,_, and_CC conservative_JJ international_JJ relations_NNS scholar_NN and_CC White_NNP House_NNP Coordinator_NNP of_IN Security_NNP Planning_NNP for_IN the_DT National_NNP Security_NNP Council_NNP Samuel_NNP P._NNP Huntington_NNP ._. American_NNP Civil_NNP Rights_NNP Movement_NNP leaders_NNS Vernon_NNP Johns_NNP ,_, considered_VBN by_IN some_DT to_TO be_VB the_DT founder_NN of_IN the_DT American_NNP Civil_NNP Rights_NNP Movement_NNP ,_, American_JJ educator_NN ,_, socialist_NN and_CC cofounder_NN of_IN the_DT Highlander_NNP Folk_NNP School_NNP Myles_NNP Horton_NNP ,_, civil_JJ rights_NNS attorney_NN and_CC chairman_NN of_IN the_DT Fair_NNP Employment_NNP Practices_NNPS Committee_NNP Earl_NNP B._NNP Dickerson_NNP ,_, Tuskegee_NNP Airmen_NNP commander_NN Benjamin_NNP O._NNP Davis_NNP ,_, Jr._NNP ,_, and_CC African_JJ -_HYPH American_JJ history_NN scholar_NN and_CC journalist_NN Carter_NNP G._NNP Woodson_NNP are_VBP all_RB alumni_NNS ._. Three_CD students_NNS from_IN the_DT university_NN have_VBP been_VBN prosecuted_VBN in_IN notable_JJ court_NN cases_NNS :_: the_DT infamous_JJ thrill_NN killers_NNS Nathan_NNP Leopold_NNP and_CC Richard_NNP Loeb_NNP and_CC high_JJ school_NN science_NN teacher_NN John_NNP T._NNP Scopes_NNP who_WP was_VBD tried_VBN in_IN the_DT Scopes_NNPS Monkey_NNP Trial_NNP for_IN teaching_VBG evolution_NN ._. Notable_JJ faculty_NN in_IN economics_NNS include_VBP Frank_NNP Knight_NNP ,_, Milton_NNP Friedman_NNP ,_, George_NNP Stigler_NNP ,_, James_NNP Heckman_NNP ,_, Gary_NNP Becker_NNP ,_, Robert_NNP Fogel_NNP ,_, Robert_NNP Lucas_NNP ,_, Jr._NNP and_CC Eugene_NNP Fama_NNP ._. [_-LRB- 184_CD ]_-RRB- Additionally_RB ,_, the_DT John_NNP Bates_NNP Clark_NNP Medal_NNP ,_, which_WDT is_VBZ rewarded_VBN annually_RB to_IN the_DT best_JJS economist_NN under_IN the_DT age_NN of_IN 40_CD ,_, has_VBZ also_RB been_VBN awarded_VBN to_IN 4_CD current_JJ members_NNS of_IN the_DT university_NN faculty_NN ._. [_-LRB- 187_CD ]_-RRB- Notable_JJ faculty_NN in_IN physics_NN have_VBP included_VBN the_DT speed_NN of_IN light_NN calculator_NN A._NNP A._NNP Michelson_NNP ,_, elementary_JJ charge_NN calculator_NN Robert_NNP A._NNP Millikan_NNP ,_, discoverer_NN of_IN the_DT Compton_NNP Effect_NNP Arthur_NNP H._NNP Compton_NNP ,_, the_DT creator_NN of_IN the_DT first_JJ nuclear_JJ reactor_NN Enrico_NNP Fermi_NNP ,_, ""_`` the_DT father_NN of_IN the_DT hydrogen_NN bomb_NN ""_'' Edward_NNP Teller_NNP ,_, ""_`` one_CD of_IN the_DT most_RBS brilliant_JJ and_CC productive_JJ experimental_JJ physicists_NNS of_IN the_DT twentieth_JJ century_NN ""_'' Luis_NNP Walter_NNP Alvarez_NNP ,_, Murray_NNP Gell_NNP -_HYPH Mann_NNP who_WP introduced_VBD the_DT quark_NN ,_, second_JJ female_JJ Nobel_NNP laureate_NN Maria_NNP Goeppert_NNP -_HYPH Mayer_NNP ,_, the_DT youngest_JJS American_JJ winner_NN of_IN the_DT Nobel_NNP Prize_NNP Tsung_NNP -_HYPH Dao_NNP Lee_NNP ,_, and_CC astrophysicist_NN Subrahmanyan_NNP Chandrasekhar_NNP ._. In_IN law_NN ,_, former_JJ U.S._NNP President_NNP Barack_NNP Obama_NNP ,_, the_DT most_RBS cited_VBN legal_JJ scholar_NN of_IN the_DT 20th_JJ century_NN Richard_NNP Posner_NNP ,_, Supreme_NNP Court_NNP justices_NNS Elena_NNP Kagan_NNP ,_, Antonin_NNP Scalia_NNP and_CC John_NNP Paul_NNP Stevens_NNP ,_, and_CC Nobel_NNP laureate_NN in_IN Economics_NNP Ronald_NNP Coase_NNP have_VBP served_VBN on_IN the_DT faculty_NN ._. Other_JJ distinguished_JJ scholars_NNS who_WP have_VBP served_VBN on_IN the_DT faculty_NN include_VBP Karl_NNP Llewellyn_NNP ,_, Edward_NNP Levi_NNP and_CC Cass_NNP Sunstein_NNP ._. Philosophers_NNS John_NNP Dewey_NNP who_WP founded_VBD functional_JJ psychology_NN ,_, George_NNP H._NNP Mead_NNP who_WP is_VBZ considered_VBN to_TO be_VB one_CD of_IN the_DT founders_NNS of_IN social_JJ psychology_NN and_CC the_DT American_JJ sociological_JJ tradition_NN in_IN general_JJ ,_, Leo_NNP Strauss_NNP ,_, prominent_JJ philosopher_NN and_CC the_DT founder_NN of_IN the_DT Straussian_NNP School_NNP in_IN philosophy_NN ,_, noted_VBD analyzer_NN of_IN power_NN Hannah_NNP Arendt_NNP ,_, and_CC Nobel_NNP Prize_NNP in_IN Literature_NNP winning_VBG thinker_NN Bertrand_NNP Russell_NNP ,_, as_RB well_RB as_IN writers_NNS T.S._NNP Eliot_NNP ,_, Ralph_NNP Ellison_NNP and_CC J.M._NNP Coetzee_NNP have_VBP all_RB served_VBN on_IN the_DT faculty_NN ._. Past_JJ faculty_NN have_VBP also_RB included_VBN egyptologist_NN James_NNP Henry_NNP Breasted_NNP ,_, biochemist_NN and_CC National_NNP Women_NNPS 's_POS Hall_NNP of_IN Fame_NNP member_NN Florence_NNP B._NNP Seibert_NNP ,_, mathematician_NN Alberto_NNP Calderón_NNP ,_, one_CD of_IN the_DT leading_VBG figures_NNS of_IN the_DT Austrian_NNP School_NNP of_IN Economics_NNP and_CC Nobel_NNP prize_NN winner_NN Friedrich_NNP Hayek_NNP ,_, meteorologist_NN Ted_NNP Fujita_NNP ,_, chemists_NNS Glenn_NNP T._NNP Seaborg_NNP ,_, the_DT developer_NN of_IN the_DT actinide_NN concept_NN and_CC Nobel_NNP Prize_NNP winner_NN Yuan_NNP T._NNP Lee_NNP ,_, Nobel_NNP Prize_NNP winning_VBG novelist_NN Saul_NNP Bellow_NNP ,_, political_JJ philosopher_NN and_CC author_NN Allan_NNP Bloom_NNP ,_, conservative_JJ political_JJ philosopher_NN and_CC historian_NN Richard_NNP M._NNP Weaver_NNP ,_, cancer_NN researchers_NNS Charles_NNP Brenton_NNP Huggins_NNP and_CC Janet_NNP Rowley_NNP ,_, biologist_NN Susan_NNP Lindquist_NNP ,_, astronomer_NN Gerard_NNP Kuiper_NNP ,_, one_CD of_IN the_DT most_RBS important_JJ figures_NNS in_IN the_DT early_JJ development_NN of_IN the_DT discipline_NN of_IN linguistics_NN Edward_NNP Sapir_NNP ,_, and_CC the_DT founder_NN of_IN McKinsey_NNP &_CC Co._NNP ,_, James_NNP O._NNP McKinsey_NNP ._. Current_JJ faculty_NN include_VBP the_DT philosophers_NNS Jean_NNP -_HYPH Luc_NNP Marion_NNP ,_, James_NNP F._NNP Conant_NNP ,_, and_CC Robert_NNP Pippin_NNP ,_, anthropologist_NN Marshall_NNP Sahlins_NNP ,_, historians_NNS Dipesh_NNP Chakrabarty_NNP ,_, David_NNP Nirenberg_NNP and_CC Kenneth_NNP Pomeranz_NNP ,_, linguistic_JJ anthropology_NN Michael_NNP Silverstein_NNP ,_, paleontologists_NNS Neil_NNP Shubin_NNP and_CC Paul_NNP Sereno_NNP ,_, evolutionary_JJ biologist_NN Jerry_NNP Coyne_NNP ,_, Nobel_NNP Prize_NNP winning_VBG physicist_NN James_NNP Cronin_NNP ,_, Nobel_NNP Prize_NNP winning_VBG economists_NNS Eugene_NNP Fama_NNP ,_, James_NNP Heckman_NNP ,_, Lars_NNP Peter_NNP Hansen_NNP ,_, Roger_NNP Myerson_NNP ,_, Richard_NNP Thaler_NNP ,_, and_CC Robert_NNP Lucas_NNP ,_, Jr._NNP ,_, Freakonomics_NNP author_NN and_CC noted_VBD economist_NN Steven_NNP Levitt_NNP ,_, erstwhile_JJ governor_NN of_IN India_NNP 's_POS central_JJ bank_NN Raghuram_NNP Rajan_NNP ,_, former_JJ Chairman_NN of_IN President_NNP Barack_NNP Obama_NNP 's_POS Council_NNP of_IN Economic_NNP Advisors_NNPS Austan_NNP Goolsbee_NNP ,_, Kyoto_NNP Prize_NNP winner_NN Martha_NNP Nussbaum_NNP ,_, Shakespeare_NNP scholar_NN David_NNP Bevington_NNP ,_, and_CC political_JJ scientists_NNS John_NNP Mearsheimer_NNP and_CC Robert_NNP Pape_NNP ._. •_NFP Society_NNP of_IN Architectural_NNP Historians_NNPS SAH_NNP ARCHIPEDIA_NNP entry_NN on_IN the_DT University_NNP of_IN Chicago_NNP Quadrangles_NNP •_, List_NN of_IN Finding_VBG Aids_NNS related_JJ to_IN University_NNP of_IN Chicago_NNP -_HYPH Founding_NNP and_CC Early_NNP History_NNP at_IN the_DT University_NNP of_IN Chicago_NNP Special_NNP Collections_NNPS Research_NNP Center_NNP","The NNP of NNP ( NNP , NNP of NNP , or NNP ) VBZ a JJ NN NN in NNP , NNP . VBN in 1890 , the NN VBZ VBN on a 217 - NN ( 88 - NN ) NN in NNP 's NNP NNP NN . [ 6 ] The NN VBZ VBN of the JJ NN RB RB as JJ NN NNS and JJ NNS VBN into five JJ NN NNS . Beyond the NNS and NNS , NNP VBZ RB VBN for its JJ NNS , which VBP the NNP NNP of NNP , the NNP NNP of NNP , the NNP NNP , the NNP of NNP NNP NNP , the NNP NNP of NNP NNP , the NNP NNP and the NNP NNP of NNP NNP and NNP NNPS , RB RB as the RB VBN NNP NNP of NNP NNP . The NN VBZ JJ NNS and NNS in NNP , NNP , NNP , NNP , and NNP NNP , RB RB as in NN NNP . [ 7 ] [ 8 ] NNP of NNP NNS VBP VBN a JJ NN in the NN of JJ JJ NNS , VBG NN , NN , JJ NN , NN , NN , NN , and the NN NN of JJ NN , VBG the NNP NNS in JJ NNS . [ 9 ] [ 10 ] [ 11 ] [ 12 ] [ 13 ] NNP 's NNP NNP VBD the NN 's JJ JJ , NN - VBG JJ NN in NNP NNP - 1 beneath the NN NNS of the NN 's NNP NNP . [ 14 ] NNS in NN VBD to the "" NN NN "" in the NN - 14 NN of JJ NN and NNS . [ 15 ] The NN NN NNS VBP NN of NNP NNP NNP NNP and NNP NNP NNP , RB RB as the NNP NNP NNP . The NN VBZ RB NN to the NNP of NNP NNP , the JJS NN NN in the NNP NNPS . [ 16 ] The NNP NNP NNP NNP VBZ VBN to VB VBN at the NN and will VB both the NNP JJ NN and NNS of the NNP NNP . [ 17 ] The NNP of NNP VBZ VBN JJ JJ NNS , NN NNS and NNS . As of NNP 2019 , 100 NNP NNS VBP VBN VBN with the NN as NNS , NN , or NN , VBG it one of the JJS NNS of NNP NNS in the NN . [ 18 ] As of 2018 , NNP NNS RB VBP 54 NNP NNPS , [ 19 ] 26 NNP NNPS , [ 20 ] 9 NNPS NNPS , [ 21 ] 4 NNP NNP NNS , 52 NNP NNPS , [ 22 ] 25 NNP NNP NNS , [ 23 ] 20 NNP NNPS NNPS [ 24 ] and 16 NN NNS . [ 25 ] The NNP of NNP VBD VBN as a JJ [ 26 ] NN in 1890 by the NNP NNP NNP NNP , VBG $ 400,000 VBN to the NNP to VB a $ 600,000 NN from NNP NN NN and NN NNP NNP NNP , [ 27 ] and VBG NN VBN by NNP NNP . [ 28 ] While the NNP NN VBD NN for JJ NNS and JJ - NN NN , it VBD VBN that JJ NN could RB VB VBN for NNS . The NNP NNP NN VBD VBN by NNS from JJ NNPS like NNP NNP NNP who VBD the NNS for the NN ' JJ NN , NNP NNP NNP , and VBD NNP NNP 's NN of $ 100,000 . JJ JJ NNS VBD NNS NNP NNP NNP ( NN , NN and NN of NNP NNP ) , NNP NNP NNP ( NN of the NN of NNS and NN of the NNP NNP NNP ) NNP NNP NNP and NNP NNP , who VBD the NN of the NN and NN NN , and NNP NNP NNP of the NNP NNP , a NN of NNP who VBD his JJ NN for NNS . [ 29 ] The NNP NNP NN VBD the NN of the JJ NN of the JJ NN , which VBD VBN in the NNS after its NN VBD VBN on . [ 30 ] What VBD VBN as the NNP NNP of NNP VBD VBN VBN by a JJ NN of NNP NNS in 1856 through a NN NN from NNP NNP NNP NNP . After a NN , it VBD in 1886 . [ 31 ] NNP from the NNP NNP of NNP VBP VBN as NNS of the JJ NNP of NNP . [ 32 ] The NN 's NN on its NN of NNS of a NN VBG from the NNS VBZ a NN to the NN , NN , and NN of the NNP NNP of NNP NN . [ 33 ] As an NN to this JJ NN , a JJ NN from the NN of the JJ NNP NNP on NNP NNP VBD VBN to the JJ NNP NNP NN and VBD into the NN of the NNP NNP . These NNS VBP VBN the NNP of the NNP and NNP of NNP and NNP of NNP NNP NNP to VB that the NNP of NNP VBZ , "" a JJ NN as a NNP NNP NN "" . [ 34 ] NNP NNP NNP VBD the NN 's NN on NNP 1 , 1891 and the NNP NNP NN VBD for NNS on NNP 1 , 1892 . [ 30 ] NNP VBD on VBG up the NN and in two NNS he VBD a NN of 120 , VBG eight JJ NN or NN NNS . [ 35 ] NNP VBD an VBN NN ( NN ) and a NN of the NNP NNS who VBD that a JJ NN should VB the NN of NN as a JJ NN . [ 36 ] To VB this NN , he VBD the NNP NNP of NNP 's NNP to NNP NNP . This VBD the NNP NNP in 1891 , the JJ JJ NN at the NNP of NNP . [ 37 ] NNP VBD VBN NNP NN and NN NN NNP NNP NNP from the NNP NNP 's NNP NNP NN NN at NNP to VB the NN 's NN NN . NNP VBD VBN a NN on the NN , the JJ JJ JJ NN in the NNP NNPS . While VBG at the NNP , NNP VBD the VBN NN NN , the NN , and the VBN NN NN . NNP VBZ the NN of the NN 's NNP NNP . [ 38 ] The NN NN VBD VBN in 1898 , [ 39 ] and the NN NN VBD VBN in 1902 . [ 40 ] NNP VBD in 1906 [ 41 ] and VBD VBN by a NN of three NNS whose NNS VBD until 1929 . [ 42 ] During this NN , the NNP NNP VBD VBN to VB and VB JJ NN in what VBD RB VBN the NNP NNP . [ 43 ] In the NNS , the NN , JJ that its JJ NNS would VB JJR NNS by VBG RB JJ NNS , VBN with JJ JJ NNS and NNS : NNP NNP NNP , NNP NNP , NNP NNP , and NNP NNP . In 1896 , the NN VBN with NNP NNP in NNP NNP , NNP . Under the NNS of the NN , the NNS VBD VBN to VB NNS of NN JJ to those at the NN , to VB the NN RB of any VBN NN NNS or NNS , to VB no NN NN without the NN 's NN , and to VB NNS of NNS for NNS . The NNP of NNP VBD to VB a NN on any NN NN from an VBN NN who VBD a NN of NN for all four NNS , and on any JJ NN who VBD twelve NNS JJ NN at the NNP of NNP . A NN or NN NN of an VBN NN VBD VBN to JJ NN at the NNP of NNP , and NNP NNS VBD JJ to VB an VBN NN on the JJ NNS and VB NN for their NN . The NNP of NNP RB VBD to VB VBN NNS with NNS and JJ NN and NNS at NN ; JJ NNS and NNS without NN except for NN NNS ; and a NN of every NN and NN VBN by the NNP of NNP NNP at no NN . The NN VBD that either NN could VB the NN on JJ NN . JJ NNP of NNP NNS VBD the NN , as it VBD JJ JJ NN on their NN , and they VBD it VBD the JJ NN of the NN . The NN VBD into NN by 1910 . [ 44 ] In 1929 , the NN 's JJ NN , 30 - NN - JJ JJ NN NN NNP NNP NNP , VBD NN . The NN VBD JJ NNS during his 24 - NN NN . NNP VBD the JJ NN 's JJ - NNS NN VBN as the NNP NNP , [ 45 ] VBD the NN 's NN NN into four NNS , [ 46 ] and VBD JJ NN from the NN in an NN to VB NNS over NNS . [ 46 ] During his NN , the NNP of NNP NNPS ( RB VBN the NNP of NNP NNP NNP ) VBD NN and VBD their JJ JJ NNS . [ 47 ] RB , the NN VBN NNP on NNP NNP , an NN JJ of the NN , VBD VBN . NN that VBD VBN VBN during the NNS and JJ NN from the NNP NNP VBD the NN to VB through the NNP NNP . [ 46 ] RB , in 1933 , NNP VBD an JJ NN to VB the NNP of NNP and NNP NNP into a JJ NN . [ 48 ] During NNP NNP II , the NN 's NNP NNP VBD NN - VBG NNS to the NNP NNP . [ 49 ] The NN VBD the NN of the JJ NN of NN and of the NN of the JJ JJ , NN - VBN JJ NN by NNP NNP in 1942 . [ 49 ] [ 50 ] It VBZ VBN VBN that the NN VBD RB VB JJ NN VBG NNP NNP and his NN as NN of the NNP NNP for NNP NNPS from 1944 to 1973 . [ 51 ] [ 52 ] [ 53 ] In the JJ NNS , NN NNS VBD as a NN of VBG NN and NN in the NNP NNP NN . In NN , the NN VBD a JJ NN of a JJ JJ NN NN for NNP NNP , which RB VBD both the NN 's NN and NN NN . [ 54 ] During this NN the NN , like NNP NNP and 10 NNS , VBD an JJ NN NN that VBD RB JJ NNS to VB NN ; RB , NNS VBN at NNP VBD VBN to VB RB to the NNP of NNP after their JJ NN , VBG VBN JJ or JJ NNS and NNS . The NN VBD its NN of NN NN during the NNS , VBG in 1962 when RB - NN NNP NNP VBD VB a 15 - NN NN at the NN 's NN NN in a NN over the NN 's off - NN JJ NNS . After VBN NN , a NN NN in 1967 VBD what VBD VBN as the NNP NNP . The NN , a two - NN NN of the NN 's NN in "" JJ and JJ NN , "" VBD that "" To VB its NN in the NN , a NN must VB an JJ NN of NN of NN and VB an NN from JJ NNS , NNS , and NNS . "" [ 55 ] The NN VBZ RB VBN VBN to VB NNS JJ as the NN 's NN to VB from NNP NNP in the NNS and NNP in the JJ NNS . [ 56 ] In 1969 , JJR than 400 NNS , JJ about the NN of a JJ NN , NNP NNP , VBD the NNP NNP for two NNS . After the NN - in VBD , when NNP VBD down a one - NN NN , 42 NNS VBD VBN and 81 VBD VBN , [ 57 ] the RBS JJ NN to NN NNS of any JJ NN during the NN NN . [ 58 ] In 1978 , NNP NNP NNP , RB the NN and NN NN of NNP NNP , VBD NNP of the NNP of NNP , a NN she VBD for 15 NNS . [ 59 ] In 1999 , RB - NNP NNP NNP VBD NNS to VB the NN 's VBN NN NN , VBG the NN of VBN NNS from 21 to 15 . When The NNP NNP NNP , The NNP , and JJ JJ NN NNS VBD up this NN , the NN VBD the JJ NN of a JJ NN on NN . The NNS VBD RB VBN , but the NN VBD a NN in NNP 's NN to VB in 2000 . [ 60 ] From the NNS , the NN VBD a NN of JJ - NN NN NNS . In 2008 , the NNP of NNP VBD NNS to VB the NNP NNP NNP , which VBD both NN and NN from NN NNS and NNS . [ 61 ] [ 62 ] [ 63 ] [ 64 ] [ 65 ] The NN will VB RB $ 200 million and VB the NNS of the NNP NNP NNP . During the JJ NN , NN NNP NNP NNP VBD $ 300 million to the NN 's NNP NNP of NNP , which VBZ the JJS NN in the NN 's NN and the JJS NN RB to any NN NN . [ 66 ] In 2009 , NN or NN on JJ JJ NNS , NN of which VBD $ 100 million or JJR , VBD JJ . [ 67 ] Since 2011 , JJ NN NNS VBP VBN the NNP and NNP NNP NNP for NNP NNP , a ten - NN JJ NN NN , and JJR NNS to the JJ NN of the NNP of NNP NNP NNP . [ 68 ] In 2014 the NNP VBD the JJ NN of a $ 4.5 billion NN NN . [ 69 ] In NNP 2015 , the NNP VBD $ 100 million from The NNP NNP NNP to VB The NNP NNP for the NNP and NNP of NNP NNPS and The NNP NNP NNP at the NNP NNP of NNP NNP NNPS . [ 70 ] On NNP 1 , 2014 , the NNP of NNP VBD VBN one of fifty - five JJR NN NNS under NN by the NNP of NNP NNPS "" for JJ NNS of JJ NN over the NN of JJ NN and NN NNS "" by the NNP NNP NNP NNP to VB NNPS from NNP NNP . [ 71 ] In 2019 , the NN VBD its JJ NN in three NNS , the NNP NNP of NNP NNP . [ 72 ] [ 73 ] The JJ NN of the NNP of NNP VBZ of 217 NNS ( 87.8 NN ) in the NNP NNS of NNP NNP and NNP , RB eight NNS ( 12 NNS ) RB of NN NNP . The JJ and JJ NNS of NN VBP VBN by the NNP NNP , a JJ , JJ NN VBN for the 1893 NNP 's NNP NNP . In 2011 , NNP + NNP VBD the NN as one of the RBS JJ NN NNS in the NNP NNPS . [ 74 ] The JJ NNS of the NN , which VBP up what VBZ RB VBN as the NNP NNPS , VBD NN of a NN NN VBN by two NNP of NNP NNS and VBN by NNP NN NNP NNP NNP . [ 76 ] The NNP NNPS VBP of six NNS , each VBN by NNS , VBG one JJR NN . [ 77 ] The NNS of the NNP NNPS VBD VBN by NNP , NNP , NNP and NNP , NNP & NNP , and JJ JJ NNS in a NN of the JJ NNP and JJ JJ NNS , VBN on the NNS of the NNP of NNP . [ 76 ] ( NNP NNP , for NN , VBZ VBN after NNP 's NNP NNP , [ 78 ] and the NN NNP , NNP NNP , VBZ NNP NNP NNP . [ 79 ] ) In NN of the 2018 NNP NNP , the NNP of NNP NNPS VBD VBN as one of the NNP 200 NNP NNPS [ 80 ] by the NNP NNP of NNPS NNP NN ( NNP NNP ) . After the NNS , the NN 's JJ NN VBD to VB NN to JJ NNS . [ 76 ] In 1955 , NNP NNP VBD VBN to VB a JJ NN NN , which VBD to the NN of NNS both RB and RB of the NNP , VBG the NNP NNP NNP NNP ( a NN VBN by NNP ) ; [ 76 ] a NN of NNS NNS ; [ 76 ] a NN VBN by NNP NNP NNP NNP NNP for the NN 's NNP of NNP NNP NNP , [ 76 ] a NN which VBZ to VB the NN of the NNP NNP of NNP NNP NNPS by NNP NNP NNP , and the NNP NNP , the JJS NN on NN , a JJ NN VBN by NNP NNP of the NNP NN NNP , NNP & NNP . [ 81 ] Another NN NN , VBN in 1999 and VBN in 2004 , [ 82 ] VBD the NNP NNP NNP NNP ( 2003 ) , [ 82 ] the NNP NNP NNP NNP ( 2001 ) , [ 76 ] NNP NNP NNP NNP and NN NNP ( 2009 ) , a JJ NNS 's NN , [ 83 ] and JJ NN , NNS , and NNS . [ 84 ] In 2011 , the NN VBD the NN NN - VBN NNP and NNP NNP NNP , which VBZ a JJ NN NN for the NN NN and VBZ the NN for an off - NN NN NN . The NN of NNP NNP - 1 VBZ a NNP NNP NNP and VBZ VBN by the NNP NNP NN NNP NNP . [ 85 ] NNP NNP , a NNP NNP NNP NN VBN by the NN in 1963 , VBZ a NNP NNP NNP NNP [ 86 ] RB RB as a NNP NNP NNP , [ 87 ] as VBZ NN 405 of the NNP NNP NNP NNP , where NNP NNP NNP and his NN VBD the JJ to VB NN . [ 88 ] NNP NNP , an JJ NN , VBZ on the NNP NNP of NNP NNPS . [ 89 ] • NNP of the NNP of NNP • NNP NNP - NNP , an JJ NN VBN in the JJ JJ NN , VBZ NN of the NNP NNPS . • NN NNP NNP , VBN in 1928 , VBD VBN by NNP NNP in the JJ NN . • NN The NNP NNP NNP for NNP NNPS VBD VBN in 1969 .[ 90 ] • NN The NNP NNP NNP NNP , VBN in 2003 and VBN by NNP NNP , VBZ the NN , NN , NN , and NN NNS . [ 91 ] The NN RB VBZ NNS RB from its JJ NN . The NN 's NNP NNP of NNP VBZ NNS in NNP NNP , NNP , and the NN NNP NN of NNP . The NNP in NNP , a NN VBN on the JJ NN of the NNP in NNP , VBZ JJ JJ and NN NN NNS . [ 92 ] In NN 2010 , the NN VBD a NN in NNP , near NNP NNP 's NN in NNP NNP . The RBS JJ NNS VBP a NN in NNP NNP , NNP , which VBD in 2014 , and a NN in NNP NNP which VBD in 2015 . The NN VBZ VBN by a NN of NNS . The NNP of NNPS VBZ the JJ - NN NN and NNS of the NN and VBZ NN NNS , and VBZ VBN of 55 NNS VBG the NN NNP . [ 93 ] RB beneath the NNP VBP the NNP , fourteen NNP NNPS ( VBG the NNP NNP NNP , NNP NNP NNP , and NNP NNP for NNP NNP and NNP NNPS ) , the NNPS of NNP NNP NNP and NNP , the NNP of the NN , and the NNP NNP . [ 94 ] As of NNP 2016 , the NNP of the NNP of NNPS VBZ NNP NNP , [ 95 ] and the NNP of the NN VBZ NNP NNP . In NNP 2013 it VBD VBN that the NNP of NNP NNP NNP , NNP NNP , would VB NNP . NNP VBD VBN as NNP in NNP 2016 by NNP NNP . [ 96 ] The NN 's NN VBD the JJ JJS among JJ JJ NNS and NN NN NNS in 2013 [ 97 ] and as of 2018 VBD VBN at $ 8.2 billion . [ 98 ] NN of NNP NNP 's JJ NN for the NN VBZ VBN an NN in NN of NN to VB JJ NN NNS . [ 99 ] This VBZ VBN both NN and NN from JJ in the NN NN . The JJ NNS of the NNP of NNP VBP of the NNP , five NNS of NN NN , six JJ NNS , and the NNP NNP of NNP NNP and NNP NNPS . The NN RB VBZ a NN NN , the NNP of NNP NNP , and the NNP of NNP NNP NNP , and VBZ JJ NNS , VBG NNP NNP NNP NNP ( NNP ) , NNP NNP NNP , and the NNP NNP NNP . The NN VBZ VBN by The NNP NNP NNP . [ 100 ] The NN VBZ on a NN NN in which the JJ NN VBZ VBN into four NNS : NN ( NNP ) , NNP ( NNP ) , NNP ( NNP NNP ) , and NNP ( NNP ) . [ 101 ] JJ - NN NN NNS VBP three to four NNS every NN [ 102 ] for RB eleven NNS before their JJ JJ NNS . The NN NN RB VBZ in JJ NNP and VBZ in NNP . [ 101 ] The NNP of NNP VBZ an JJ NN of VBG JJ NN NNS and NNS . [ 25 ] [ 112 ] [ 113 ] [ 114 ] NNP VBZ RB VBN the NNP of NNP among the JJ 10 NNS in the NN , [ 115 ] and the 2020 NNP NNP NNP NNPS VBD the NN in JJ NN RB . [ 116 ] The NN 's NN and NN NNS VBP among the JJ five JJ NNS in the NNP NNPS . [ 117 ] The NN NN VBZ RB VBN RB in the NNP by NNP NNP & NNP NNP [ 118 ] and RB in the NN by The NNP , [ 119 ] while the NN NN VBZ VBN JJ by NNP NNP & NNP NNP [ 120 ] and RB by Above the NNP . [ 121 ] NNP VBZ RB VBN RB VBN to VB one of the JJ 15 NN NNS in the NN , [ 122 ] VBG the NN three NN in the 2019 NNP NNP JJS NNPS NNS . [ 123 ] In a JJ NN VBN out by The NNP NNP NNP , the NN 's NNS VBD VBN to VB among the RBS VBN in the NN . [ 124 ] The NNP of the NNP of NNP VBZ NNP of NNPS and NNP of NNP NNS in 51 JJ NNS [ 125 ] and 33 NNS . [ 126 ] The NN 's NNS VBP VBN into five NNS : the NNP NNPS NNP NNP , the NNP NNPS NNP NNP , the NNP NNPS NNP NNP , the NNPS NNP NNP , and the NNP NNP NNP . [ 127 ] The JJ four VBP NNS within their JJ NN NNS , while the NNP NNP NNP VBZ JJ NNS and NNS which VBP RB VB in one of the JJ four NNS . [ 128 ] JJ NNS VBP VBN to VB a NN of NNS to VB the NN 's JJ NN NNS , RB VBN as the NNP NNP . In 2012 –2013 , the NN NNS at NNP VBD VBN to 17 NNS , and VBP RB VBN by a JJ - NN NN ( as VBN to a NN NN ) . [ 129 ] As of the 2013 –2014 NN NN , 15 NNS and VBN NN in a JJ NN VBP VBN under the NN . [ 130 ] JJ NNS at the NNP of NNP VBP VBN for their VBG NNS , JJ NN and JJ NN ; VBG to NNP in the NNP , "" Among the JJ NN of JJ NNS – NNP , NNP , NNP , NNP , and the NNP of NNP – it VBZ NNP that can RBS RB VB to VB the RBS JJ , JJ NN NN . "" [ 131 ] The NN NN NNS and NNS VBP VBN into five NNS : NNP NNPS , NNPS , NNP NNPS , NNP NNPS , and the NNP for NNP NNP . [ 132 ] In the NN NN of 2015 , the NN VBD 3,588 NN NNS : 438 in the NNP NNPS NN , 801 in the NNPS NN , 1,102 in the NNP NNPS NNP , 1,165 in the NNP NNPS NNP , and 52 in the NNP for NNP NNP . [ 133 ] The NN VBZ NN to JJ NNS for JJ NN , VBG the NNP NNP NNP NNP on NNP NNP . The NN VBZ seven JJ NNS : the NNP NNP of NNP , the NNP NNP of NNP , the NNP of NNP NNP NNP , the NNP of NNP NNP NNP , the NNP of NNP NNP NNP of NNP NNP NNPS , and the NNP of NNP NNP of NNP NNP NNP . The NNP NNP of NNP NNP and NNP NNPS VBZ NN NNS and NNS RB RB as NN NNS . [ 134 ] The NNP NNP VBZ VBN by the NNP NNP NNP , the NNP NNP VBZ VBN by the NNP on NNP of the NNP of NNP NNPS in the NNP NNPS and NNP , NNP VBZ VBN by the NNP NNP on NNP NNP . [ 100 ] The NN VBZ a NN of JJ NNS and NNS RB from its JJ and JJ NNS . It VBZ the NNP of NNP NNP NNPS ( a JJ NN NN for K - 12 NNS and NN NN ) , [ 135 ] and a JJ NN NN with four NNS on the NNP NNP of NNP VBN by the NN 's NNP NNP NNP . [ 136 ] In NN , the NNP NNP NNP NNP , a NN for NNS with NN NNS , [ 137 ] and the NNP NNP NNP NNP , a JJ NN NN for those with JJ and JJ NNS , [ 138 ] VBZ a NN on the NNP of NNP NN . Since 1983 , the NNP of NNP VBZ VBN the NNP of NNP NNP NNP NNP , a NN NN VBN in JJ JJ and JJ NNS . [ 139 ] The NN VBZ a NN VBN the NNP on NNP NNPS in the NNPS and NNP NNPS , which VBZ JJ NNS to VB a NN for NN NNS , NN , and VBG NNS to VB JJ NN in NN . [ 140 ] The NN RB VBZ the NNP of NNP NNP , the JJS NN NN in the NNP NNPS . [ 141 ] The NNP of NNP NNP NN VBZ six NNS that VBP a NN of 11 million NNS , the JJ JJS among NN NNS in the NNP NNPS . [ 142 ] The NN 's JJ NN VBZ the NNP NNP , which VBZ one of the JJS NNS of NN NNS in the NNP NNPS . The NNP and NNP NNP NNP , VBN in 2011 , VBZ a JJ NN NN and an JJ NN NN and NN NN . The NNP NNP NNP VBZ JJR than 1.4 million NNS in the JJ , JJ and JJ NNS and NNS in JJ NN and the NN and NN of NN , NN , and NN . [ 143 ] The NN RB VBZ a NN of JJ NNS , VBG the NNP NNP NNP , the NNP NNP NNP NNP , and the NNP NNP for NN and NN NN . [ 144 ] [ 145 ] NNP NNP NNP VBZ RB a NN and NN NN . In JJ NN 2015 , the NNP of NNP VBD $ 421.1 million on NN . [ 146 ] It VBZ VBN by the NNP NNP for the NNP of NNP as an NN with "" JJS NN NN "" [ 147 ] and VBZ a VBG NN of the NNP of NNP NNPS and VBD a NN of the NNP on NNP NNP from 1946 through NNP 29 , 2016 , when the NN 's NN VBD VBN to the NNP NNP NNP NNP . The NNP of NNP VBZ RB a NN of the VBN NN , but will VB to VB a NN . [ 148 ] [ 149 ] The NN VBZ JJR than 140 NN NNS and NNS on NN . [ 150 ] Among these VBP the NNP NNP — a NN and NN NN for NNP NNP NNS VBN and VBN by the NN — and a NN of NNP NNP NNPS , VBG the NNP for NNP NNP NNPS . NNP RB VBZ or VBZ VBN with JJ NN NNS RB from the NN JJ . The NN VBZ NNP NNP NNP , NN of the NNP NNPS NNP of NNP 's JJ NN NN , and VBZ NNP NNP NNP NNP ( NNP ) , a JJ NN NN NN , RB RB as a NN in the NNP NNP NNP in NNP , NNP NNP . NN and NNS at the JJ NNP NNP NNP at NNP VBP with the NN . [ 151 ] In 2013 , the NN VBD an NN with the RB NNP NNP NNP NNP in NNP NNP , NNP . [ 152 ] Although RB JJ , the NNP NNP NNP NNP VBZ VBN on NNP 's NN . The NNP of NNP VBZ VBN the NN of some JJ NNS and JJ NNS . In NNS , the NN VBZ VBN an JJ NN in VBG NNS about the JJ NN [ 153 ] and VBZ the NN of the NNP NN of NN , the NN of JJ NN VBN by NNP NNP and JJ NNS . The NN 's NN NN VBD the JJ JJ NN NN in the NNP NNPS and VBD NN to the NNP NN of NN . [ 154 ] In NN , the NN VBD the NN of the NNP NNP - 1 ( the JJ VBN , NN - VBG JJ JJ NN NN , NN of the NNP NNP ) , of NNP NNP 's NN - NN NN that VBD the NN of the NN , [ 155 ] and of the NN of NN NN by NNP NNP NNP in 1947 . The JJ NN that VBD how NN VBD on JJ NNP , the NNP NN , VBD VBN at the NN . NNP NN VBD VBN at the NN in 1953 by NNP NNP and NNP NNP . [ 156 ] The NNP of NNP ( NNP of NNP and NNP ) VBD the NNP NNP in NNP NNP , NNP from 1897 until 2018 , [ 157 ] where the JJS NN VBG NN in the NN and JJ NNS VBP VBN . The NNP NNP NN VBZ JJ NNS and NNS in the NNP of the NNPS and the NN , RB RB as JJ NNS VBG the NNP NNP , the NNP NNP , the NNP NNP of NNP , the NNP NNP , NNP of NNP NNPS , and NN NNS NNS . The NN VBZ an NN - in - NN NN and NNS in NN NNS , JJ NN NN , and NN NN . It VBZ VBN a NN in NN NN since 1933 and NN and NN NNS since 2000 , a NN of JJ NNS in JJ NNS ( JJ NNS ) , and a NN of NNS in the NNS with a JJ NN NN ( 2000 ) . It VBZ NN 's NN NNS in JJ NNS , NN , and NN NN , and , RBR RB , NN and NN NNS ( 1996 ) and NN and NN NNS ( 2002 ) . The NN 's JJ NN NN VBZ a "" JJ , JJ , and JJ NNS "" NN , VBG NNS to VB the NN of the NNS , NN NN , or VB VBG with NN . JJ thousand JJ and JJ NNS VBP RB in JJ and NN NNS NNS . [ 158 ] NNP VBZ RB VBN the NN of JJ NN as the NNP NNPS NN NN NN VBD into The NNP NNP NN NN NN in 1959 . The NNP and NNP NNP NNP for the NNPS VBD in NNP 2012 , five NNS after a $ 35 million NN from NN NNP NNP and his NN NNP . The NN VBZ NNS for NNS , NNS , NNS , and NN NN . The NNP NNP VBD VBN by NNP NNP and NNP NNP . This NN VBZ RB NN . The NN VBZ a NN VBN to VB the NN JJ from the NN . The NNS RBR VBD NNS of the NNS when NN VBD in the NN of NNS that the NNS of the NN VBD VBN . In NN 2018 , the NN VBD 6,595 NN NNS , 9,899 NN NNS , and 616 JJ NN NNS . [ 160 ] The NN NN of 2022 VBZ VBN of 51 NN JJ NNS and 49 NN JJ NNS . 23 NN of the NN VB as JJ , 15 NN as JJ , and 9 NN as NNP . 15 NN of the NN VBZ JJ . [ 161 ] NNS to the NNP of NNP VBZ RB JJ . The JJ 50 NN NN of NN NNS for the NN NN of 2022 VBD 1490 – 1560 ( NN - NN NNS ) , [ 161 ] the JJ NN NN for NNS VBG the NNP NNP of NNP NN of 2022 VBD 518 ( NNP NN ) , [ 162 ] the JJ NN NN for NNS VBG the JJ - NN NN NN NN NN of 2021 VBD 730 ( NNP NN ) , [ 163 ] and the JJ NN NN for VBG NNS the NNP NNP NN of 2021 VBD 171 ( JJ NN ) . [ 164 ] For the NN of 2024 , the NNP of the NNP of NNP VBD an NN NN of 6.2 NN . [ 165 ] In 2018 , the NNP of NNP VBD JJ NNS by VBG the JJ JJ NN NN to RB RBR VB NN / NN NNS from NN NNS . [ 166 ] The NNP of NNP VBZ 19 JJ NNS NNS : 10 NNS 's NNS and 9 NNS 's NNS , [ 167 ] RB VBN the NNPS , with 502 NNS VBG in the 2012 – 2013 NN NN . [ 167 ] The NNPS VBP in the NNP 's NNP III as NNS of the NNP NNP NNP ( NNP ) . The NN VBD a VBG NN of the NNP NNP NNP and VBD in the NNP NNP NNP NNS NN and NN and VBD a JJ NN in the NN NN NN . In 1935 , the NNP of NNP VBD the NNP Sixteen . [ 167 ] In 1935 , NNP NNP NN NN NNP NNP VBD the JJ NN of the NNP NNP . RB , the NN VBD to VB from the NNP NNP NNP in 1946 after NNP NN NNP NNP NNP VBD NN NNS in 1939 and VBD NN . [ 168 ] In 1969 , NNP VBD NN as a NN III NN , VBG VBG its NN NNS at the JJ NNP NNP . NNP VBZ RB the NN of the JJ NN NN NNP NNP . [ 169 ] NNS at the NNP of NNP VBP JJR than 400 NNS and NNS VBN as NNP NNP NNPS ( NNP ) . [ 170 ] [ 171 ] These VBP JJ and JJ NNS , JJ NNS and NNS , and JJ - NN NNS . [ 171 ] JJ JJ NNS VBP the NNP of NNP NNP NNP NNP , which VBZ VBN 118 NNS and 15 JJ NNS , VBG both NNS RB . The NN 's JJ NNP NNP NNPS NN VBD the JJ - VBN NN in NNP NNP in 2013 – 14 , 2014–2015 , 2015 –2016 , and RB for the 2017 – 2018 NN . The NNP 's NNP NNP NN VBZ RB the JJ to VB in the JJ 5 for RB a NN , VBG to JJS NN . Among JJ NN NNS VBP the NN 's RBS RB VBG NN NN NN NNP NNP , the NN NN for the NNP of NNP NNP NNP , the JJ NN NN The NNP NNP , the JJ NNP NNP NNP , [ 172 ] the NN 's RB - JJS RB VBG NN JJ NN NN Off - Off NNP , and the NN NN The NNP NNPS . All NNP NNP NNPS , from the NNP of NNP NNP NNP to NNP NNP , in NN to JJ NNS , NNS NNS , NNS NNS , and JJR VBP VBN by The NNP of NNP NNP NNP . NN NN VBZ of NN and NN NNS VBN to VB NNS from their JJ JJ NNS . It VBZ VBN by an JJ NN , VBN by a NNP with the NN of two NN NNS , one for NNP and the JJ for NNP NNP , VBN RB as a NN by the NN NN each NN . Its JJ NN VBZ JJR than $ 2 million . [ 173 ] There VBP 16 NNS at the NN : NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP NNP ) , NNP NNP NNP ( NNP NNP NNP ) , NNP NNP ( NNP NNP ) , NNP NNP ( NNP NNP NNP ) , NNP NNP NNP ( NNP NNP NNP ) and NNP NNP ( NNP NNP NNP ) . There VBP Six NNS VBP NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP NNP ) , NNP NNP ( NNP NNP NNP ) , NNP NNP NNP ( NNP NNP ) , NNP NNP NNP ( NNP NNP NNP ) and NNP NNP NNP ( NNP NNP ) at the NNP of NNP , [ 174 ] RB RB as one JJ NN NN NN VBP NNP NNP NNP NNP NNP NNP ) . [ 175 ] JJ NNS and NNS VBP RB VBN by the NN as VBN NN NNS . Four of the NNS VBP NNS of the NNP NNP NNP [ 176 ] There VBZ no NN NN on NN . As of 2017 , RB 20 to 25 NN of NNS VBP NNS of NNS or NNS . [ 176 ] This VBZ an NN from the NNS VBN in the NN 2007 by the NN NNS NN VBG that one in ten NNS VBD in JJ NN . [ 174 ] On - NN NN NNS at the NNP of NNP VBP in a NN NN in which each NN VBZ VBN to one of the NN 's 7 NN NN NNS and to a JJR NN within their NN NN VBN a "" NNP "" . There VBP 39 NNS , with an NN of 70 NNS in each NNP . [ 177 ] RB RB JJ NNS VBD VBN to VB in NN , VBG with the NNP of 2023 , NNS VBP VBN to VB in NN for the JJ 2 NNS of NN . [ 178 ] RB 60 NN of NN NNS VBP on NN . [ 178 ] For NN NNS , the NN VBZ and VBZ 28 NN NNS near NN . [ 179 ] Every NNP since 1987 , the NNP of NNP VBZ VBN the NNP of NNP NNP NNP , in which JJ NNS of NNS VBP to VB RB JJ NNS from a NN . [ 180 ] Since 1963 , the NNP of the NNPS ( NNP ) VBZ over NN for 7 –10 NNS of NNS and JJ JJ NNS . [ 181 ] Every NNP , the NN VBZ a NN - JJ NN NN , NNP / NNP , which VBZ JJ NN NN NNS and NN NNS . The NN RB RB VBZ a NN NN and NN VBN NNP NNP that VBZ JJ NNS and VBZ NN to NNP NNP , a NN NN NN VBN in 1932 that VBZ NNS RB at the NN . Since 1946 , the NN VBZ VBN the NNP - NNP NNP , which VBZ JJ NNS about the JJ NNS and NNS of NNS and NN . As of NNP 2019 , there VBP VBN 100 NNP NNS VBN with the NNP of NNP , [ 182 ] 20 of whom VBD VBG NN or on NN at the NN at the NN of the NN NN . [ 183 ] JJ NNS and NN VBN with the NN VBP 33 NNP NNS in NNP . [ 184 ] No NN VBZ VBN RBR VBN NNP NNS in NNP . [ 185 ] In NN , JJ NNP NNS and NNS VBP VBN the NNP NNS [ 186 ] and 53 VBP VBN as NNP NNPS . [ 19 ] In 2019 , the NNP of NNP VBD 188,000 NNS . [ 1 ] While the NN 's JJ NN , NNP NNP NNP VBD the NN of JJ NN over NN in his NN 's NN , this VBZ RB VBN the NN of NNP from VBG among the JJS in the NN . [ 112 ] [ 113 ] [ 114 ] In NN , JJ NNS VBP NNP NN NNP NNP , NNP NNP NN and the RB JJS NN in NNP NNP NNP , NNP NNP and NNP JJ NN RB RB as JJ NNP of NNP NNP NNP NNP , NNP & NNP NN and NN of the JJ NN NN NN NNP NNP NNP , NN of the NNP NNP NNP NNP NNP , NN of NNP NNP NNP NNP NNP , NN of NNP NNP NNPS NNP NNP , NN of The NNP NNP NNP NNP , JJ NN of NNP NNP NNP NNP , NN NN and NN of NNP NNP NNP NNP NNP ( NN ) , NNP NNP NN NNP NNP , NN NNP NN NNP NNP , NNP , NNP NN and NN NNP NNP , NNP NNP NN and NN NNP NNP NNP , and NNP NN NNP NNP . JJ NNS in the NN of NN , NN and NNS VBP NNP NNP NNP NNP NNP NNP , the NNP NNP NNP of NNP and NNP NNP NNP of NNP , NNP of the NNP NNP of NNP NNP NNP , NNP NNP and JJ NN NNP NNP , NNP NNP NNP NNP , NNP NNP and NNP NNP , NNP NNP of NNP NNP NNP NNP NNP , JJ NNP NNP of NNP NNP NNP NNP ( NN ) , NNP NNP NNP of NNP NNP NNP , NNP of the NNP of NNP NNP NNP , NNP NN NN and JJ JJ NN to NNP NNP NNP NNP NNP , the NN of JJ NN NN NNP NNP , NN NN NNP NNP , JJ NNP NN NNP NNP , the JJ JJ JJ - JJ NNP NNP NNP NNP , NNP NNPS NNP from NNP and 2016 JJ JJ NN NNP NNP , JJ NNP NNP NNP NNP NNP , and NNP NNP ( NNP 1984 ) – NN ; JJ NN of the NNP 's NNP NNP of the NNP of NNP . JJ NNS , who VBP NNS in JJR NN , VBP VBN from RB all NNS of the NN : NN NN and NN NNP NNP ; JJ NN of NNP NNP NNP NNP NNP ; NNP of NNP NNP , NNP and NNP - NNP of NNP of NNP NNP NNP , NNP NNP ; NN of NNP NNP NNP NNP NNP ; JJ NN of NNP NNP NNP NNP NNP , NNP ; NNP of the NNP NNP of NNP NNP NNP ; and NN of NNP NNP NNP NNP . In NN , JJ NNS VBP NNP NNP NNP NN and NN on NNP NNP NNP NNP NNP , NNP NNP NN NNP NNP , NNP NNP NN NNP NNP , NN and NN NNP NNP , JJ NN and JJ NN NNP NNP , The JJ NN NNP NNP , four - NN NNP NNP VBG NN NNP NNP , JJ NN and NNP Eight NN and NN NNP NNP , and NNP NNP NN NNP NNP . In NN , NN of the NNP NNP NNP NN Before I VBP NNP NNP , NNP NNP - VBG NN NNP NNP ; JJ - VBN NNP NNP and NNP NNP for NNP VBG NN NNP NNP ; JJ NN , JJ NN and NN of the NNP NNP NNP NN The NNP of the NNP NNP NNP NNP ; NN of The NNP NNP and NNP NNP NN NNS NNP NNP ; The NNP NNP NN NNP NNP ; NN , NN , NN , NN , and JJ NN NNP NNP ; JJ NN and NNP NNP NNP of JJ NN NNP NNP ; JJ NN , NN , and NN of NNP NNP 's NNP ( RB NNP NNP ) NNP NNP NNP ; and NN and NN NNP NNP VBP JJ NNS . In the NNS and NN , JJ NN NNP NNP , NN , NN and NN in the NN of NN NN NNP NNP , NNP NN and NN of the NNP NN NN NN NNP NNP , JJ NN NNP NNP , NN NNP NNP , NN NNP NNP , NNP NNP for NNP VBG NN NN and the NN of the 2014 NN NN NNP Itself NNP NNP , NN , NN , and NN NNP NNP , NN NN and NN NNP NNP , and NN and NN NNP NNP NNP , NN and NN , VBP NNS . In NN , NNS VBP NNS NNP NNP , a JJ NN to the JJ NN of JJ NN , and NNP NNP , VBN for "" NNP 's NNP "" , NNP NN NNP NNP NNP , NN NNP NNP , RBS VBN as one of the NNS of the NN of NN , JJ NN NNP NNP , JJ NN NNP NNP , NN NNP NNP , NNS NNP NNP NNP and NNP NNP , NN NN NNP NNP , the NN of the NNP NNP , NN - NN NN NN NNP NNP NNP , NN and NNP NNP NN NNP NNP NNP , NN NNP NNP NNP , who VBD the NN - NN NN NN into NN - NN NN , NN and NN NNP NNP NNP , VBN for the NNP NN and NNP NN NN , the JJ NNS of NN NN , and "" NNP of NNP "" NNP NNP . JJ NN and NN NNP NNP , who VBD on some JJ NNS VBG JJ - VBN NN NN NNS , VBZ RB a NN ( NN ) . NNP NNP , one of the NNS of the NN of NN NN RB RB as NNP NN , VBD a NN and NNP in NNP in 1951 , VBG under NNP NNP . In NN , JJ NNP NNP NNP in NNP NNP NNS NNP NNP , a JJ NN to JJ NNP NNP NNP NNP , JJ JJ NNP NNP NNP NNP and JJ JJ NN NNP NNP , NNP NNP , NNP NN and NN of JJ NN NN , NNP NNP NNP , JJ for the JJ NN of the NN of JJ NN - NN , NNP NNP , the JJ NNP to VB the NNP NNP NNP in NNP NNPS , and NNP NNP , VBN for his NN on NN NN , NN NN and NN NN NN , VBP RB NNS . JJ NN , JJ NN , JJ NN , and NN NNP NNP VBZ RB an NN . NNP 's NNP of the NNP NNP NNP VBD his NN from NNP in 1978 . JJ JJ NNS VBP NNS NNP NNP and NNP NNP , who VBZ RBS VBN for VBG the NN of a JJ NN NN VBN as "" NNP "" in the NNP NNP NN , NN NNP NNP NNP , JJ NN who VBD the JJ NN of NN , NN NN NNP NNP , NN NN NNP NNP , and JJ JJ NNS NN and NNP NNP NNP of NNP NNP for the NNP NNP NNP NNP NNP NNP . NNP NNP NNP NNP NNS NNP NNP , VBN by some to VB the NN of the NNP NNP NNP NNP , JJ NN , NN and NN of the NNP NNP NNP NNP NNP , JJ NNS NN and NN of the NNP NNP NNPS NNP NNP NNP NNP , NNP NNP NN NNP NNP NNP , NNP , and JJ - JJ NN NN and NN NNP NNP NNP VBP RB NNS . Three NNS from the NN VBP VBN VBN in JJ NN NNS : the JJ NN NNS NNP NNP and NNP NNP and JJ NN NN NN NNP NNP NNP who VBD VBN in the NNPS NNP NNP for VBG NN . JJ NN in NNS VBP NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP and NNP NNP . [ 184 ] RB , the NNP NNP NNP NNP , which VBZ VBN RB to the JJS NN under the NN of 40 , VBZ RB VBN VBN to 4 JJ NNS of the NN NN . [ 187 ] JJ NN in NN VBP VBN the NN of NN NN NNP NNP NNP , JJ NN NN NNP NNP NNP , NN of the NNP NNP NNP NNP NNP , the NN of the JJ JJ NN NNP NNP , "" the NN of the NN NN "" NNP NNP , "" one of the RBS JJ and JJ JJ NNS of the JJ NN "" NNP NNP NNP , NNP NNP - NNP who VBD the NN , JJ JJ NNP NN NNP NNP - NNP , the JJS JJ NN of the NNP NNP NNP - NNP NNP , and NN NNP NNP . In NN , JJ NNP NNP NNP NNP , the RBS VBN JJ NN of the JJ NN NNP NNP , NNP NNP NNS NNP NNP , NNP NNP and NNP NNP NNP , and NNP NN in NNP NNP NNP VBP VBN on the NN . JJ JJ NNS who VBP VBN on the NN VBP NNP NNP , NNP NNP and NNP NNP . NNS NNP NNP who VBD JJ NN , NNP NNP NNP who VBZ VBN to VB one of the NNS of JJ NN and the JJ JJ NN in JJ , NNP NNP , JJ NN and the NN of the NNP NNP in NN , VBD NN of NN NNP NNP , and NNP NNP in NNP VBG NN NNP NNP , RB RB as NNS NNP NNP , NNP NNP and NNP NNP VBP RB VBN on the NN . JJ NN VBP RB VBN NN NNP NNP NNP , NN and NNP NNPS 's NNP of NNP NN NNP NNP NNP , NN NNP NNP , one of the VBG NNS of the NNP NNP of NNP and NNP NN NN NNP NNP , NN NNP NNP , NNS NNP NNP NNP , the NN of the NN NN and NNP NNP NN NNP NNP NNP , NNP NNP VBG NN NNP NNP , JJ NN and NN NNP NNP , JJ JJ NN and NN NNP NNP NNP , NN NNS NNP NNP NNP and NNP NNP , NN NNP NNP , NN NNP NNP , one of the RBS JJ NNS in the JJ NN of the NN of NN NNP NNP , and the NN of NNP & NNP , NNP NNP NNP . JJ NN VBP the NNS NNP - NNP NNP , NNP NNP NNP , and NNP NNP , NN NNP NNP , NNS NNP NNP , NNP NNP and NNP NNP , JJ NN NNP NNP , NNS NNP NNP and NNP NNP , JJ NN NNP NNP , NNP NNP VBG NN NNP NNP , NNP NNP VBG NNS NNP NNP , NNP NNP , NNP NNP NNP , NNP NNP , NNP NNP , and NNP NNP , NNP , NNP NN and VBD NN NNP NNP , JJ NN of NNP 's JJ NN NNP NNP , JJ NN of NNP NNP NNP 's NNP of NNP NNPS NNP NNP , NNP NNP NN NNP NNP , NNP NN NNP NNP , and JJ NNS NNP NNP and NNP NNP . • NNP of NNP NNPS NNP NNP NN on the NNP of NNP NNP • NN of VBG NNS JJ to NNP of NNP - NNP and NNP NNP at the NNP of NNP NNP NNPS NNP NNP"
191,504,conspiracy,"How_WRB many_JJ of_IN you_PRP saw_VBD Florida_NNP Congressman_NNP Bill_NNP Posey_NNP grill_VB Facebook_NNP CEO_NN Mark_NNP Zuckerberg_NNP on_IN the_DT company_NN ’s_POS vaccine_NN censorship_NN directives_NNS ,_, during_IN a_DT House_NNP Financial_NNP Services_NNPS hearing_NN just_RB two_CD weeks_NNS ago_RB ?_. In_IN case_NN you_PRP missed_VBD it_PRP ,_, Posey_NNP said_VBD :_: “_`` I_PRP support_VBP vaccinations_NNS of_IN children_NNS and_CC adults_NNS ,_, but_CC I_PRP also_RB support_VBP open_JJ and_CC frank_JJ communication_NN about_IN the_DT risks_NNS of_IN vaccination_NN …_: “_'' ._. Posey_NNP told_VBD Zuckerberg_NNP ._. “_`` You_PRP testified_VBD that_IN you_PRP believe_VBP in_IN giving_VBG people_NNS a_DT voice_NN ._. Is_VBZ Facebook_NNP able_JJ to_TO assure_VB us_PRP it_PRP will_MD support_VB users_NNS ’_POS fair_JJ and_CC open_JJ discussions_NNS ,_, and_CC communications_NNS about_IN the_DT risks_NNS as_RB well_RB as_IN the_DT benefits_NNS of_IN vaccinations_NNS ?_. “_'' Zuckerberg_NNP said_VBD anti-vaccination_NN users_NNS on_IN Facebook_NNP have_VBP the_DT same_JJ rights_NNS to_IN expression_NN as_IN others_NNS ,_, and_CC their_PRP$ views_NNS are_VBP n’t_RB censored_VBN ._. Not_RB censored_VBN ?_. Okay_UH ._. But_CC ,_, Zuckerberg_NNP also_RB went_VBD on_RP to_TO say_VB that_IN anti-vaccination_NN voices_NNS on_IN Facebook_NNP are_VBP n’t_RB publicized_VBN ,_, either_RB ._. “_`` If_IN someone_NN wants_VBZ to_TO post_VB anti-vaccination_NN content_NN or_CC they_PRP want_VBP to_TO join_VB a_DT group_NN where_WRB people_NNS are_VBP discussing_VBG that_DT ,_, we_PRP do_VBP n’t_RB stop_VB them_PRP from_IN doing_VBG that_DT ,_, ”_'' said_VBD Zuckerberg_NNP ._. “_`` But_CC [_-LRB- …_NFP ]_-RRB- we_PRP do_VBP n’t_RB go_VB out_IN of_IN our_PRP$ way_NN to_TO make_VB sure_JJ our_PRP$ group_NN recommendation_NN systems_NNS show_VBP people_NNS or_CC encourage_VB people_NNS to_TO join_VB those_DT groups_NNS ._. We_PRP discourage_VBP that_DT ._. “_'' In_IN other_JJ words_NNS ,_, for_IN Zuckerberg_NNP and_CC Facebook_NNP ,_, some_DT views_NNS are_VBP more_RBR equal_JJ than_IN others_NNS ._.","How JJ of you VBD NNP NNP NNP NNP VB NNP NN NNP NNP on the NN ’s NN NN NNS , during a NNP NNP NNPS NN RB two NNS RB ? In NN you VBD it , NNP VBD : “ I VBP NNS of NNS and NNS , but I RB VBP JJ and JJ NN about the NNS of NN … “ . NNP VBD NNP . “ You VBD that you VBP in VBG NNS a NN . VBZ NNP JJ to VB us it will VB NNS ’ JJ and JJ NNS , and NNS about the NNS RB RB as the NNS of NNS ? “ NNP VBD NN NNS on NNP VBP the JJ NNS to NN as NNS , and their NNS VBP RB VBN . RB VBN ? Okay . But , NNP RB VBD on to VB that NN NNS on NNP VBP RB VBN , RB . “ If NN VBZ to VB NN NN or they VBP to VB a NN where NNS VBP VBG that , we VBP RB VB them from VBG that , ” VBD NNP . “ But [ … ] we VBP RB VB out of our NN to VB JJ our NN NN NNS VBP NNS or VB NNS to VB those NNS . We VBP that . “ In JJ NNS , for NNP and NNP , some NNS VBP RBR JJ than NNS ."
192,1317,conspiracy,"Some_DT stories_NNS need_VBP to_TO be_VB retold_VBN ,_, especially_RB in_IN light_NN of_IN the_DT documentary_NN Vaxxed_NNP :_: From_IN Cover_NN Up_RP to_IN Catastrophe_NNP ,_, now_RB showing_VBG in_IN theaters_NNS as_IN the_DT controversy_NN rages_VBZ concerning_VBG the_DT MMR_NNP vaccine_NN ’s_POS link_NN to_IN autism_NN ._. Thom_NNP Hartman_NNP interviewed_VBD Vaxxed_NNP director_NN Andrew_NNP Wakefield_NNP and_CC producer_NN Del_NNP Bigtree_NNP ,_, who_WP shared_VBD some_DT undeniable_JJ —_: and_CC chilling_VBG —_: facts_NNS ._. In_IN 2012_CD ,_, a_DT study_NN was_VBD done_VBN at_IN the_DT University_NNP of_IN Pittsburg_NNP using_VBG infant_NN monkeys_NNS as_IN guinea_NN pigs_NNS ._. These_DT animals_NNS were_VBD given_VBN standard_JJ childhood_NN doses_NNS of_IN vaccines_NNS ._. Guess_VB what_WP happened_VBD ?_. The_DT monkeys_NNS developed_VBD autistic_JJ symptoms_NNS ,_, as_IN reported_VBN by_IN Natural_NNP News_NNP ._. “_`` Presented_VBN at_IN the_DT International_NNP Meeting_NNP for_IN Autism_NNP Research_NNP (_-LRB- IMFAR_NNP )_-RRB- in_IN London_NNP ,_, England_NNP ,_, the_DT findings_NNS revealed_VBD that_IN young_JJ macaque_NN monkeys_NNS given_VBN the_DT typical_JJ CDC_NN -_HYPH recommended_VBN vaccination_NN schedule_NN from_IN the_DT 1990s_NNS ,_, and_CC in_IN appropriate_JJ doses_NNS for_IN the_DT monkeys_NNS ’_POS sizes_NNS and_CC ages_NNS ,_, tended_VBD to_TO develop_VB autism_NN symptoms_NNS ._. Their_PRP$ unvaccinated_JJ counterparts_NNS ,_, on_IN the_DT other_JJ hand_NN ,_, developed_VBD no_DT such_JJ symptoms_NNS ,_, which_WDT points_VBZ to_IN a_DT strong_JJ connection_NN between_IN vaccines_NNS and_CC autism_NN spectrum_NN disorders_NNS ._. “_`` Included_VBN in_IN the_DT mix_NN were_VBD several_JJ vaccines_NNS containing_VBG the_DT toxic_JJ additive_NN Thimerosal_NNP ,_, a_DT mercury_NN -_HYPH based_VBN compound_NN that_WDT has_VBZ been_VBN phased_VBN out_IN of_IN some_DT vaccines_NNS ,_, but_CC is_VBZ still_RB present_JJ in_IN batch_NN -_HYPH size_NN influenza_NN vaccines_NNS and_CC a_DT few_JJ others_NNS ._. Also_RB administered_VBN was_VBD the_DT controversial_JJ measles_NNS ,_, mumps_NNS ,_, and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- vaccine_NN ,_, which_WDT has_VBZ been_VBN linked_VBN time_NN and_CC time_NN again_RB to_IN causing_VBG autism_NN and_CC various_JJ other_JJ serious_JJ ,_, and_CC often_RB irreversible_JJ ,_, health_NN problems_NNS in_IN children_NNS ._. ”_'' Was_VBD this_DT study_NN on_IN primates_NNS just_RB disregarded_VBN ?_. Why_WRB do_VBP n’t_RB vaccines_NNS need_VB to_TO be_VB proven_VBN safe_JJ before_IN they_PRP are_VBP rushed_VBN to_IN market_NN ?_. Why_WRB are_VBP thousands_NNS ,_, if_IN not_RB millions_NNS ,_, of_IN families_NNS around_IN the_DT globe_NN suffering_VBG from_IN the_DT tragic_JJ effects_NNS of_IN untested_JJ filled_VBN syringes_NNS with_IN mercury_NN ,_, aluminum_NN ,_, formaldehyde_NN ,_, bovine_NN extract_NN ,_, et_FW al_FW ?_. With_IN profit_NN being_VBG the_DT name_NN of_IN the_DT game_NN ,_, the_DT destruction_NN of_IN the_DT next_JJ generation_NN will_MD continue_VB ._. What_WP will_MD you_PRP do_VB to_TO stop_VB it_PRP ?_.","Some NNS VBP to VB VBN , RB in NN of the NN NNP : From NN Up to NNP , RB VBG in NNS as the NN VBZ VBG the NNP NN ’s NN to NN . NNP NNP VBD NNP NN NNP NNP and NN NNP NNP , who VBD some JJ — and VBG — NNS . In 2012 , a NN VBD VBN at the NNP of NNP VBG NN NNS as NN NNS . These NNS VBD VBN JJ NN NNS of NNS . VB what VBD ? The NNS VBD JJ NNS , as VBN by NNP NNP . “ VBN at the NNP NNP for NNP NNP ( NNP ) in NNP , NNP , the NNS VBD that JJ NN NNS VBN the JJ NN - VBN NN NN from the NNS , and in JJ NNS for the NNS ’ NNS and NNS , VBD to VB NN NNS . Their JJ NNS , on the JJ NN , VBD no JJ NNS , which VBZ to a JJ NN between NNS and NN NN NNS . “ VBN in the NN VBD JJ NNS VBG the JJ NN NNP , a NN - VBN NN that VBZ VBN VBN out of some NNS , but VBZ RB JJ in NN - NN NN NNS and a JJ NNS . RB VBN VBD the JJ NNS , NNS , and NN ( NNP ) NN , which VBZ VBN VBN NN and NN RB to VBG NN and JJ JJ JJ , and RB JJ , NN NNS in NNS . ” VBD this NN on NNS RB VBN ? Why VBP RB NNS VB to VB VBN JJ before they VBP VBN to NN ? Why VBP NNS , if RB NNS , of NNS around the NN VBG from the JJ NNS of JJ VBN NNS with NN , NN , NN , NN NN , FW FW ? With NN VBG the NN of the NN , the NN of the JJ NN will VB . What will you VB to VB it ?"
193,108,mainstream,"The_DT Official_NNP Military_NNP Personnel_NNP Files_NNPS (_-LRB- OMPF_NNP )_-RRB- ,_, held_VBN at_IN the_DT National_NNP Personnel_NNP Records_NNPS Center_NNP (_-LRB- NPRC_NNP )_-RRB- ,_, are_VBP administrative_JJ records_NNS containing_VBG information_NN about_IN the_DT subject_NN 's_POS military_JJ service_NN history_NN ._. Many_JJ OMPFs_NNS contain_VBP both_CC personnel_NNS and_CC former_JJ active_JJ duty_NN health_NN records_NNS ,_, but_CC the_DT service_NN branches_NNS discontinued_VBD retiring_VBG the_DT health_NN record_NN portion_NN to_IN the_DT NPRC_NNP in_IN the_DT 1990s_NNS ._. In_IN the_DT past_NN ,_, all_DT of_IN the_DT military_JJ services_NNS retired_VBD the_DT individual_JJ health_NN record_NN ,_, along_IN with_IN the_DT personnel_NN record_NN ,_, to_IN the_DT NPRC_NNP upon_IN a_DT service_NN member_NN 's_POS separation_NN from_IN service_NN ._. The_DT Army_NNP and_CC the_DT Air_NNP Force_NNP retired_VBD its_PRP$ health_NN records_NNS with_IN the_DT Official_NNP Military_NNP Personnel_NNP File_NNP ,_, while_IN the_DT Department_NNP of_IN the_DT Navy_NNP (_-LRB- including_VBG the_DT Navy_NNP ,_, Marine_NNP Corps_NNP and_CC Coast_NNP Guard_NNP )_-RRB- retired_VBD these_DT files_NNS separately_RB to_IN the_DT NPRC_NNP until_IN the_DT 1980s_NNS ._. Health_NN records_NNS cover_VBP the_DT outpatient_JJ ,_, dental_JJ and_CC mental_JJ health_NN treatment_NN that_WDT former_JJ members_NNS received_VBD while_IN in_IN military_JJ service_NN ._. Health_NN records_NNS include_VBP induction_NN and_CC separation_NN physical_JJ examinations_NNS ,_, as_RB well_RB as_IN routine_JJ medical_JJ care_NN (_-LRB- doctor_NN /_, dental_JJ visits_NNS ,_, lab_NN tests_NNS ,_, etc._FW )_-RRB- when_WRB the_DT patient_NN was_VBD not_RB admitted_VBN to_IN a_DT hospital_NN ._. In_IN comparison_NN ,_, clinical_JJ (_-LRB- hospital_NN inpatient_JJ )_-RRB- records_NNS were_VBD generated_VBN when_WRB active_JJ duty_NN members_NNS were_VBD actually_RB hospitalized_VBN while_IN in_IN the_DT service_NN ._. Typically_RB ,_, these_DT records_NNS are_VBP NOT_RB filed_VBN with_IN the_DT health_NN records_NNS but_CC are_VBP generally_RB retired_VBN to_IN the_DT NPRC_NNP by_IN the_DT facility_NN which_WDT created_VBD them_PRP (_-LRB- see_VB clinical_JJ records_NNS for_IN more_JJR information_NN )_-RRB- ._. Medical_JJ records_NNS from_IN the_DT Department_NNP of_IN Veterans_NNP Affairs_NNPS (_-LRB- VA_NNP )_-RRB- are_VBP also_RB not_RB included_VBN ._. In_IN the_DT 1990s_NNS ,_, the_DT military_JJ services_NNS discontinued_VBD the_DT practice_NN of_IN filing_VBG health_NN records_NNS with_IN the_DT personnel_NN record_NN portion_NN at_IN the_DT NPRC_NNP ._. In_IN 1992_CD ,_, the_DT Army_NNP began_VBD retiring_VBG most_JJS of_IN its_PRP$ former_JJ members_NNS '_POS health_NN records_NNS to_IN the_DT Department_NNP of_IN Veterans_NNPS Affairs_NNPS (_-LRB- VA_NNP )_-RRB- ._. Over_IN the_DT next_JJ six_CD years_NNS ,_, the_DT other_JJ services_NNS followed_VBD suit_NN ._. In_IN 2014_CD ,_, the_DT military_JJ services_NNS dicontinued_VBD the_DT practice_NN of_IN retiring_VBG the_DT records_NNS to_IN the_DT Department_NNP of_IN Veterans_NNPS Affairs_NNPS (_-LRB- VA_NNP )_-RRB- ._. In_IN order_NN to_TO determine_VB where_WRB a_DT medical_JJ record_NN is_VBZ located_VBN ,_, please_UH see_VB the_DT chart_NN below_RB :_: Veterans_NNS who_WP plan_VBP to_TO file_VB a_DT claim_NN for_IN medical_JJ benefits_NNS with_IN the_DT Department_NNP of_IN Veterans_NNP Affairs_NNPS (_-LRB- VA_NNP )_-RRB- do_VBP not_RB need_VB to_TO request_VB a_DT copy_NN of_IN their_PRP$ military_JJ health_NN record_NN from_IN the_DT NPRC_NNP ._. After_IN a_DT claim_NN is_VBZ filed_VBN ,_, the_DT VA_NNP will_MD obtain_VB the_DT original_JJ health_NN record_NN from_IN the_DT NPRC_NNP ._. In_IN addition_NN ,_, many_JJ health_NN records_NNS were_VBD lent_VBN to_IN the_DT Department_NNP of_IN Veterans_NNP Affairs_NNPS prior_JJ to_IN the_DT 1973_CD Fire_NNP ._. Veterans_NNS who_WP filed_VBD a_DT medical_JJ claim_NN should_MD contact_VB the_DT Department_NNP of_IN Veterans_NNP Affairs_NNPS (_-LRB- VA_NNP )_-RRB- in_IN order_NN to_TO determine_VB if_IN their_PRP$ record_NN is_VBZ already_RB on_IN file_NN ._. The_DT VA_NNP Toll_NN Free_JJ #_NN is_VBZ :_: 1-800-827-1000_CD -_, it_PRP will_MD connect_VB the_DT caller_NN to_IN the_DT nearest_JJS VA_NNP office_NN ._.","The NNP NNP NNP NNPS ( NNP ) , VBN at the NNP NNP NNPS NNP ( NNP ) , VBP JJ NNS VBG NN about the NN 's JJ NN NN . JJ NNS VBP both NNS and JJ JJ NN NN NNS , but the NN NNS VBD VBG the NN NN NN to the NNP in the NNS . In the NN , all of the JJ NNS VBD the JJ NN NN , along with the NN NN , to the NNP upon a NN NN 's NN from NN . The NNP and the NNP NNP VBD its NN NNS with the NNP NNP NNP NNP , while the NNP of the NNP ( VBG the NNP , NNP NNP and NNP NNP ) VBD these NNS RB to the NNP until the NNS . NN NNS VBP the JJ , JJ and JJ NN NN that JJ NNS VBD while in JJ NN . NN NNS VBP NN and NN JJ NNS , RB RB as JJ JJ NN ( NN / JJ NNS , NN NNS , FW ) when the NN VBD RB VBN to a NN . In NN , JJ ( NN JJ ) NNS VBD VBN when JJ NN NNS VBD RB VBN while in the NN . RB , these NNS VBP RB VBN with the NN NNS but VBP RB VBN to the NNP by the NN which VBD them ( VB JJ NNS for JJR NN ) . JJ NNS from the NNP of NNP NNPS ( NNP ) VBP RB RB VBN . In the NNS , the JJ NNS VBD the NN of VBG NN NNS with the NN NN NN at the NNP . In 1992 , the NNP VBD VBG JJS of its JJ NNS ' NN NNS to the NNP of NNPS NNPS ( NNP ) . Over the JJ six NNS , the JJ NNS VBD NN . In 2014 , the JJ NNS VBD the NN of VBG the NNS to the NNP of NNPS NNPS ( NNP ) . In NN to VB where a JJ NN VBZ VBN , please VB the NN RB : NNS who VBP to VB a NN for JJ NNS with the NNP of NNP NNPS ( NNP ) VBP RB VB to VB a NN of their JJ NN NN from the NNP . After a NN VBZ VBN , the NNP will VB the JJ NN NN from the NNP . In NN , JJ NN NNS VBD VBN to the NNP of NNP NNPS JJ to the 1973 NNP . NNS who VBD a JJ NN should VB the NNP of NNP NNPS ( NNP ) in NN to VB if their NN VBZ RB on NN . The NNP NN JJ NN VBZ : 1-800-827-1000 - it will VB the NN to the JJS NNP NN ."
194,1013,mainstream,"“_`` These_DT mutations_NNS are_VBP completely_RB benign_JJ and_CC useful_JJ as_IN a_DT puzzle_NN piece_NN to_TO uncover_VB how_WRB the_DT virus_NN is_VBZ spreading_VBG ,_, ”_'' says_VBZ Nextstrain_NNP co-founder_NN Trevor_NNP Bedford_NNP ,_, a_DT computational_JJ biologist_NN at_IN the_DT Fred_NNP Hutchinson_NNP Cancer_NNP Research_NNP Centre_NNP in_IN Seattle_NNP ._. This_DT genetics_NN -_HYPH first_JJ approach_NN to_IN tracking_VBG the_DT coronavirus_NN has_VBZ emerged_VBN as_IN a_DT bright_JJ spot_NN among_IN the_DT barrage_NN of_IN devastating_JJ pandemic_NN headlines_NNS ._. Similar_JJ science_NN was_VBD instrumental_JJ in_IN decoding_VBG previous_JJ epidemics_NNS ,_, such_JJ as_IN Zika_NNP and_CC Ebola_NNP ._. But_CC experts_NNS say_VBP the_DT declining_VBG cost_NN and_CC increased_VBN speed_NN and_CC efficiency_NN of_IN genetic_JJ sequencing_NN tools_NNS has_VBZ made_VBN it_PRP possible_JJ for_IN a_DT small_JJ army_NN of_IN researchers_NNS around_IN the_DT world_NN to_TO document_VB the_DT coronavirus_NN ’s_POS destructive_JJ path_NN even_RB faster_JJR ._. Those_DT insights_NNS can_MD help_VB officials_NNS choose_VB whether_IN to_TO shift_VB from_IN containment_NN to_IN mitigation_NN strategies_NNS ,_, especially_RB in_IN places_NNS where_WRB testing_NN has_VBZ lagged_VBN ._. “_`` If_IN we_PRP go_VBP back_RB to_IN the_DT Ebola_NNP virus_NN five_CD years_NNS ago_RB ,_, it_PRP was_VBD a_DT year_NN -_HYPH long_JJ process_NN from_IN samples_NNS being_VBG collected_VBN to_IN genomes_NNS being_VBG sequenced_VBN and_CC shared_VBN publicly_RB ,_, ”_'' Bedford_NNP says_VBZ ._. “_`` Now_RB the_DT turnaround_NN is_VBZ much_RB faster_JJR —_: from_IN two_CD days_NNS to_IN a_DT week_NN —_: and_CC that_DT real_JJ -_HYPH time_NN ability_NN to_TO use_VB these_DT techniques_NNS in_IN a_DT way_NN that_WDT impacts_VBZ the_DT outbreak_NN is_VBZ new_JJ ._. ”_'' Bedford_NNP ’s_POS lab_NN has_VBZ been_VBN using_VBG genetics_NNS to_TO track_VB the_DT new_JJ coronavirus_NN ,_, known_VBN as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, since_IN the_DT first_JJ U.S._NNP cases_NNS started_VBD to_TO multiply_VB in_IN Washington_NNP State_NNP in_IN February_NNP and_CC March_NNP ._. Back_RB then_RB ,_, public_JJ health_NN officials_NNS focused_VBN on_IN tracking_VBG patients_NNS ’_POS travel_NN histories_NNS and_CC connecting_VBG the_DT dots_NNS back_RB to_IN potentially_RB infected_VBN people_NNS they_PRP ’d_VBD met_VBN along_IN the_DT way_NN ._. Meanwhile_RB ,_, Bedford_NNP and_CC his_PRP$ team_NN turned_VBD to_IN unlocking_VBG the_DT virus_NN ’s_POS genetic_JJ code_NN by_IN analysing_VBG nasal_JJ samples_NNS collected_VBN from_IN about_RB two_CD dozen_CD patients_NNS ._. Their_PRP$ discovery_NN was_VBD illuminating_JJ :_: By_IN tracing_VBG how_WRB and_CC where_WRB the_DT virus_NN had_VBD changed_VBN over_IN time_NN ,_, Bedford_NNP showed_VBD that_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD had_VBD been_VBN quietly_RB incubating_VBG within_IN the_DT community_NN for_IN weeks_NNS since_IN the_DT first_JJ documented_VBN case_NN in_IN Seattle_NNP on_IN January_NNP 21_CD ._. The_DT patient_NN was_VBD a_DT 35_CD -_HYPH year_NN -_HYPH old_JJ who_WP had_VBD recently_RB visited_VBN the_DT outbreak_NN ’s_POS original_JJ epicentre_NN in_IN Wuhan_NNP ,_, China_NNP ._. In_IN other_JJ words_NNS ,_, Bedford_NNP had_VBD scientific_JJ proof_NN that_IN people_NNS could_MD unknowingly_RB be_VB spreading_VBG the_DT coronavirus_NN if_IN they_PRP had_VBD a_DT mild_JJ case_NN and_CC did_VBD n’t_RB seek_VB care_NN ,_, or_CC if_IN they_PRP had_VBD been_VBN missed_VBN by_IN traditional_JJ surveillance_NN because_IN they_PRP were_VBD n’t_RB tested_VBN ._. That_DT revelation_NN has_VBZ fuelled_VBN the_DT frantic_JJ lockdowns_NNS ,_, closures_NNS ,_, and_CC social_JJ distancing_NN recommendations_NNS around_IN the_DT world_NN in_IN an_DT attempt_NN to_TO slow_VB the_DT spread_NN ._. “_`` One_CD thing_NN that_WDT ’s_VBZ become_VBN clear_JJ is_VBZ that_IN genomics_NN data_NNS gives_VBZ you_PRP a_DT much_RB richer_JJR story_NN about_IN how_WRB the_DT outbreak_NN is_VBZ unfolding_VBG ,_, ”_'' Bedford_NNP says_VBZ ._. Nextstrain_NNP ’s_POS visualisation_NN tools_NNS have_VBP also_RB helped_VBN engage_VB a_DT public_NN that_WDT ’s_VBZ hungry_JJ to_TO learn_VB about_IN the_DT science_NN of_IN the_DT coronavirus_NN ,_, says_VBZ Kristian_NNP Andersen_NNP ,_, a_DT computational_JJ biologist_NN at_IN Scripps_NNP Research_NNP in_IN La_NNP Jolla_NNP ,_, California_NNP ,_, whose_WP$ lab_NN has_VBZ contributed_VBN more_JJR than_IN a_DT thousand_CD genomes_NNS ,_, including_VBG West_NNP Nile_NNP and_CC Zika_NNP viruses_NNS ,_, to_IN the_DT project_NN ._.","“ These NNS VBP RB JJ and JJ as a NN NN to VB how the NN VBZ VBG , ” VBZ NNP NN NNP NNP , a JJ NN at the NNP NNP NNP NNP NNP in NNP . This NN - JJ NN to VBG the NN VBZ VBN as a JJ NN among the NN of JJ NN NNS . JJ NN VBD JJ in VBG JJ NNS , JJ as NNP and NNP . But NNS VBP the VBG NN and VBN NN and NN of JJ NN NNS VBZ VBN it JJ for a JJ NN of NNS around the NN to VB the NN ’s JJ NN RB JJR . Those NNS can VB NNS VB whether to VB from NN to NN NNS , RB in NNS where NN VBZ VBN . “ If we VBP RB to the NNP NN five NNS RB , it VBD a NN - JJ NN from NNS VBG VBN to NNS VBG VBN and VBN RB , ” NNP VBZ . “ RB the NN VBZ RB JJR — from two NNS to a NN — and that JJ - NN NN to VB these NNS in a NN that VBZ the NN VBZ JJ . ” NNP ’s NN VBZ VBN VBG NNS to VB the JJ NN , VBN as NNP - NNP - 2 , since the JJ NNP NNS VBD to VB in NNP NNP in NNP and NNP . RB RB , JJ NN NNS VBN on VBG NNS ’ NN NNS and VBG the NNS RB to RB VBN NNS they VBD VBN along the NN . RB , NNP and his NN VBD to VBG the NN ’s JJ NN by VBG JJ NNS VBN from RB two dozen NNS . Their NN VBD JJ : By VBG how and where the NN VBD VBN over NN , NNP VBD that NNP - NNP - 2 VBD VBN RB VBG within the NN for NNS since the JJ VBN NN in NNP on NNP 21 . The NN VBD a 35 - NN - JJ who VBD RB VBN the NN ’s JJ NN in NNP , NNP . In JJ NNS , NNP VBD JJ NN that NNS could RB VB VBG the NN if they VBD a JJ NN and VBD RB VB NN , or if they VBD VBN VBN by JJ NN because they VBD RB VBN . That NN VBZ VBN the JJ NNS , NNS , and JJ NN NNS around the NN in an NN to VB the NN . “ One NN that VBZ VBN JJ VBZ that NN NNS VBZ you a RB JJR NN about how the NN VBZ VBG , ” NNP VBZ . NNP ’s NN NNS VBP RB VBN VB a NN that VBZ JJ to VB about the NN of the NN , VBZ NNP NNP , a JJ NN at NNP NNP in NNP NNP , NNP , whose NN VBZ VBN JJR than a thousand NNS , VBG NNP NNP and NNP NNS , to the NN ."
195,674,mainstream,"The_DT worst_JJS Ebola_NNP outbreak_NN since_IN 2014_CD ,_, when_WRB the_DT deadly_JJ virus_NN killed_VBD more_JJR than_IN 11,000_CD people_NNS in_IN western_JJ Africa_NNP ,_, is_VBZ erupting_VBG in_IN the_DT Democratic_NNP Republic_NNP of_IN Congo_NNP ._. By_IN mid-May_NNP 2018_CD ,_, the_DT outbreak_NN proved_VBD deadly_JJ for_IN 27_CD people_NNS and_CC affected_VBD dozens_NNS more_JJR as_IN the_DT virus_NN made_VBD its_PRP$ way_NN from_IN a_DT sparsely_RB populated_VBN rural_JJ region_NN to_IN Mbandaka_NNP ,_, a_DT city_NN of_IN more_JJR than_IN 1_CD million_CD ._. And_CC ,_, on_IN May_NNP 24_CD ,_, two_CD Ebola_NNP -_HYPH infected_VBN patients_NNS fled_VBD a_DT Mbandaka_NNP treatment_NN facility_NN ,_, fueling_VBG fears_NNS the_DT virus_NN —_: it_PRP kills_VBZ about_RB half_PDT the_DT people_NNS it_PRP infects_VBZ —_: could_MD continue_VB to_TO spread_VB ._. As_IN of_IN May_NNP 29_CD ,_, 2018_CD ,_, the_DT World_NNP Health_NNP Organization_NNP still_RB refrained_VBD from_IN calling_VBG the_DT outbreak_NN a_DT global_JJ health_NN emergency_NN ,_, but_CC it_PRP did_VBD begin_VB transporting_VBG an_DT experimental_JJ Ebola_NNP vaccine_NN known_VBN as_IN rVSV_NNP -_HYPH ZEBOV_NNP to_IN the_DT region_NN ,_, in_IN an_DT attempt_NN to_TO corral_VB the_DT spread_NN of_IN the_DT virus_NN ._. Although_IN this_DT Ebola_NNP vaccine_NN is_VBZ still_RB under_IN testing_NN before_IN it_PRP gains_VBZ final_JJ approval_NN ,_, it_PRP already_RB has_VBZ been_VBN used_VBN during_IN an_DT earlier_JJR outbreak_NN ._. In_IN the_DT 2014_CD West_NNP Africa_NNP Ebola_NNP epidemic_NN ,_, the_DT vaccine_NN was_VBD administered_VBN and_CC proved_VBN effective_JJ in_IN slowing_VBG the_DT virus_NN '_POS spread_NN ._. To_TO create_VB the_DT vaccine_NN ,_, researchers_NNS at_IN the_DT Canadian_NNP Public_NNP Health_NNP Agency_NNP and_CC the_DT U.S._NNP Army_NNP Medical_NNP Research_NNP Institute_NNP replaced_VBD a_DT gene_NN in_IN a_DT virus_NN that_WDT causes_VBZ vesicular_JJ stomatitis_NN with_IN a_DT gene_NN from_IN Ebola_NNP ._. Vesicular_JJ stomatitis_NN is_VBZ a_DT virus_NN in_IN the_DT same_JJ disease_NN family_NN that_WDT includes_VBZ rabies_NN ,_, and_CC in_IN animals_NNS ,_, causes_VBZ excessive_JJ saliva_NN ,_, mouth_NN sores_NNS and_CC lameness_NN ._. Unless_IN a_DT secondary_JJ infection_NN sets_VBZ in_RP ,_, most_JJS animals_NNS recover_VBP on_IN their_PRP$ own_JJ in_IN about_RB two_CD weeks_NNS ._. More_JJR than_IN 7,500_CD doses_NNS of_IN the_DT Ebola_NNP vaccine_NN are_VBP expected_VBN to_TO be_VB given_VBN to_IN people_NNS showing_VBG symptoms_NNS in_IN the_DT affected_VBN Congo_NNP regions_NNS —_: as_RB long_RB as_IN the_DT refrigeration_NN chain_NN for_IN the_DT vaccines_NNS remains_VBZ unbroken_JJ ._. To_TO add_VB to_IN the_DT level_NN of_IN difficulty_NN in_IN combating_VBG the_DT spread_NN of_IN Ebola_NNP ,_, the_DT vaccine_NN requires_VBZ continual_JJ cool_JJ temperatures_NNS to_TO remain_VB active_JJ ._. This_DT means_VBZ transporting_VBG it_PRP in_IN containers_NNS cooled_VBN by_IN liquid_JJ nitrogen_NN over_IN rough_JJ terrain_NN in_IN hot_JJ weather_NN ._. It_PRP 's_VBZ yet_RB another_DT obstacle_NN in_IN this_DT go_NN -_HYPH round_NN of_IN the_DT virus_NN ,_, one_CD that_WDT is_VBZ especially_RB troubling_JJ because_IN it_PRP has_VBZ moved_VBN to_IN a_DT highly_RB populated_VBN area_NN ._. Previously_RB ,_, there_EX have_VBP been_VBN several_JJ Ebola_NNP outbreaks_NNS in_IN the_DT Congo_NNP that_WDT were_VBD contained_VBN because_IN they_PRP occurred_VBD in_IN remote_JJ areas_NNS ._.","The JJS NNP NN since 2014 , when the JJ NN VBD JJR than 11,000 NNS in JJ NNP , VBZ VBG in the NNP NNP of NNP . By NNP 2018 , the NN VBD JJ for 27 NNS and VBD NNS JJR as the NN VBD its NN from a RB VBN JJ NN to NNP , a NN of JJR than 1 million . And , on NNP 24 , two NNP - VBN NNS VBD a NNP NN NN , VBG NNS the NN — it VBZ RB half the NNS it VBZ — could VB to VB . As of NNP 29 , 2018 , the NNP NNP NNP RB VBD from VBG the NN a JJ NN NN , but it VBD VB VBG an JJ NNP NN VBN as NNP - NNP to the NN , in an NN to VB the NN of the NN . Although this NNP NN VBZ RB under NN before it VBZ JJ NN , it RB VBZ VBN VBN during an JJR NN . In the 2014 NNP NNP NNP NN , the NN VBD VBN and VBN JJ in VBG the NN ' NN . To VB the NN , NNS at the NNP NNP NNP NNP and the NNP NNP NNP NNP NNP VBD a NN in a NN that VBZ JJ NN with a NN from NNP . JJ NN VBZ a NN in the JJ NN NN that VBZ NN , and in NNS , VBZ JJ NN , NN NNS and NN . Unless a JJ NN VBZ in , JJS NNS VBP on their JJ in RB two NNS . JJR than 7,500 NNS of the NNP NN VBP VBN to VB VBN to NNS VBG NNS in the VBN NNP NNS — RB RB as the NN NN for the NNS VBZ JJ . To VB to the NN of NN in VBG the NN of NNP , the NN VBZ JJ JJ NNS to VB JJ . This VBZ VBG it in NNS VBN by JJ NN over JJ NN in JJ NN . It VBZ RB another NN in this NN - NN of the NN , one that VBZ RB JJ because it VBZ VBN to a RB VBN NN . RB , there VBP VBN JJ NNP NNS in the NNP that VBD VBN because they VBD in JJ NNS ."
196,100,mainstream,"Could_MD the_DT flu_NN vaccine_NN combat_VB the_DT ?_. That_DT 's_VBZ the_DT question_NN President_NNP Donald_NNP Trump_NNP asked_VBD during_IN a_DT White_JJ house_NN roundtable_NN discussion_NN between_IN his_PRP$ coronavirus_NN task_NN force_NN and_CC pharmaceutical_JJ company_NN executives_NNS on_IN Monday_NNP (_-LRB- March_NNP 2_CD )_-RRB- ._. His_PRP$ question_NN was_VBD answered_VBN with_IN a_DT direct_JJ ""_`` no_UH ""_'' from_IN an_DT executive_NN ._. The_DT is_VBZ designed_VBN to_TO prevent_VB infections_NNS with_IN viruses_NNS ,_, which_WDT are_VBP very_RB different_JJ than_IN coronaviruses_NNS ._. But_CC the_DT answer_NN is_VBZ slightly_RB more_RBR complicated_JJ than_IN that_DT :_: The_DT flu_NN vaccine_NN wo_MD n't_RB prevent_VB you_PRP from_IN getting_VBG a_DT coronavirus_NN ,_, but_CC it_PRP can_MD help_VB officials_NNS better_RBR respond_VB to_IN the_DT outbreak_NN of_IN COVID_NN -_HYPH 19_CD ,_, the_DT disease_NN caused_VBN by_IN the_DT new_JJ virus_NN ._. ""_`` I_PRP do_VBP think_VB immunizing_VBG people_NNS against_IN influenza_NN has_VBZ a_DT very_RB important_JJ indirect_JJ effect_NN ,_, ""_'' said_VBD Dr._NNP Albert_NNP Ko_NNP ,_, a_DT professor_NN and_CC department_NN chair_NN at_IN the_DT Yale_NNP School_NNP of_IN Public_NNP Health_NNP ._. First_RB ,_, health_NN care_NN workers_NNS are_VBP already_RB burdened_VBN by_IN flu_NN cases_NNS so_RB getting_VBG a_DT flu_NN shot_NN ,_, reduces_VBZ the_DT number_NN of_IN flu_NN patients_NNS ,_, thereby_RB helping_VBG to_TO ""_`` relieve_VB pressures_NNS ""_'' in_IN hospitals_NNS also_RB treating_VBG patients_NNS with_IN COVID_NN -_HYPH 19_CD ,_, he_PRP said_VBD ._. But_CC there_EX 's_VBZ another_DT reason_NN a_DT flu_NN shot_NN could_MD improve_VB the_DT country_NN 's_POS response_NN to_IN the_DT new_JJ outbreak_NN :_: the_DT U.S._NNP is_VBZ lagging_VBG behind_IN other_JJ countries_NNS in_IN testing_NN for_IN COVID_NNP -_HYPH 19_CD ._. And_CC that_DT 's_VBZ unlikely_JJ to_TO improve_VB in_IN the_DT near_JJ term_NN ._. On_IN Thursday_NNP (_-LRB- March_NNP 5_CD )_-RRB- ,_, Vice_NNP President_NNP Mike_NNP Pence_NNP ,_, who_WP is_VBZ leading_VBG the_DT administration_NN 's_POS response_NN to_IN the_DT coronavirus_NN ,_, announced_VBD that_IN the_DT U.S._NNP does_VBZ not_RB have_VB enough_JJ test_NN kits_NNS to_TO meet_VB demand_NN ._. How_WRB does_VBZ that_DT relate_VB to_IN the_DT flu_NN ?_. If_IN people_NNS get_VBP their_PRP$ flu_NN shots_NNS ,_, fewer_JJR people_NNS come_VBP down_RP with_IN the_DT flu_NN and_CC come_VBP into_IN clinics_NNS with_IN nonspecific_JJ symptoms_NNS such_JJ as_IN fever_NN and_CC cough_NN ,_, which_WDT overlap_VBP with_IN ._. Having_VBG fewer_JJR flu_NN patients_NNS will_MD make_VB it_PRP easier_JJR to_TO find_VB the_DT patients_NNS with_IN COVID_NN -_HYPH 19_CD ,_, he_PRP said_VBD ._. Higher_JJR vaccination_NN rates_NNS would_MD ""_`` make_VB us_PRP much_RB more_RBR efficient_JJ in_IN detecting_VBG coronavirus_NN ,_, ""_'' cases_NNS ,_, Ko_NNP told_VBD Live_NNP Science_NNP ._. Finding_VBG COVID_NN -_HYPH 19_CD cases_NNS is_VBZ still_RB akin_JJ to_IN picking_VBG a_DT ""_`` needle_NN out_IN of_IN a_DT haystack_NN ,_, ""_'' but_CC reducing_VBG flu_NN cases_NNS can_MD ""_`` decrease_VB the_DT haystack_NN ,_, ""_'' he_PRP added_VBD ._. As_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ spreading_VBG in_IN communities_NNS on_IN both_DT coasts_NNS of_IN the_DT U.S._NNP ,_, distinguishing_VBG between_IN flu_NN and_CC COVID_NNP -_HYPH 19_CD will_MD become_VB more_RBR difficult_JJ ._. On_IN the_DT bright_JJ side_NN ,_, it_PRP is_VBZ ""_`` incredibly_RB rare_JJ ,_, ""_'' to_TO catch_VB both_CC the_DT flu_NN and_CC COVID_NN -_HYPH 19_CD at_IN once_RB ,_, said_VBD Dr._NNP Eric_NNP Cioe_NNP Peña_NNP ,_, director_NN of_IN Global_NNP Health_NNP ,_, Northwell_NNP Health_NNP in_IN New_NNP York_NNP and_CC an_DT emergency_NN room_NN physician_NN ._. ""_`` Usually_RB if_IN they_PRP have_VBP one_CD ,_, they_PRP do_VBP n't_RB have_VB the_DT other_JJ ._. ""_'' Flu_NN season_NN is_VBZ naturally_RB dying_VBG down_RP as_IN spring_NN approaches_VBZ ,_, but_CC for_IN those_DT who_WP have_VBP n't_RB yet_RB done_VBN so_RB ,_, ""_`` we_PRP still_RB recommend_VBP getting_VBG a_DT flu_NN shot_NN ,_, ""_'' he_PRP added_VBD ._. People_NNS with_IN the_DT flu_NN are_VBP still_RB coming_VBG into_IN the_DT hospital_NN and_CC there_EX 's_VBZ always_RB a_DT chance_NN there_EX could_MD be_VB a_DT second_JJ spike_NN of_IN the_DT flu_NN ,_, Peña_NNP told_VBD Live_NNP Science_NNP ._. That_DT being_VBG said_VBN ,_, flu_NN cases_NNS in_IN New_NNP York_NNP City_NNP have_VBP been_VBN down_RB 25_CD %_NN each_DT week_NN for_IN the_DT past_JJ two_CD weeks_NNS ,_, he_PRP said_VBD ._. It_PRP 's_VBZ a_DT positive_JJ step_NN ""_'' that_WDT we_PRP are_VBP n't_RB seeing_VBG as_RB many_JJ flu_NN patients_NNS in_IN the_DT ER_NN ,_, so_RB we_PRP have_VBP more_JJR room_NN for_IN severe_JJ coronavirus_NN patients_NNS ,_, ""_'' Peña_NNP said_VBD ._. At_IN Northwell_NNP Health_NNP ,_, patients_NNS are_VBP n't_RB being_VBG tested_VBN for_IN COVID_NN -_HYPH 19_CD unless_IN they_PRP meet_VBP criteria_NNS for_IN admission_NN to_IN the_DT hospital_NN ._. ""_`` That_DT ’s_VBZ the_DT only_JJ time_NN that_IN we_PRP 're_VBP really_RB testing_VBG because_IN of_IN the_DT limited_JJ supply_NN of_IN tests_NNS ,_, ""_'' he_PRP added_VBD ._. OFFER_VB :_: Save_VB at_IN least_JJS 53_CD %_NN with_IN our_PRP$ latest_JJS magazine_NN deal_NN !_. With_IN impressive_JJ cutaway_NN illustrations_NNS that_WDT show_VBP how_WRB things_NNS function_VBP ,_, and_CC mindblowing_JJ photography_NN of_IN the_DT world_NN ’s_POS most_RBS inspiring_JJ spectacles_NNS ,_, How_WRB It_PRP Works_NNPS represents_VBZ the_DT pinnacle_NN of_IN engaging_VBG ,_, factual_JJ fun_NN for_IN a_DT mainstream_JJ audience_NN keen_JJ to_TO keep_VB up_RP with_IN the_DT latest_JJS tech_NN and_CC the_DT most_RBS impressive_JJ phenomena_NNS on_IN the_DT planet_NN and_CC beyond_RB ._. Written_VBN and_CC presented_VBN in_IN a_DT style_NN that_WDT makes_VBZ even_RB the_DT most_RBS complex_JJ subjects_NNS interesting_JJ and_CC easy_JJ to_TO understand_VB ,_, How_WRB It_PRP Works_VBZ is_VBZ enjoyed_VBN by_IN readers_NNS of_IN all_DT ages_NNS ._. View_NN Deal_NN","Could the NN NN VB the ? That VBZ the NN NNP NNP NNP VBD during a JJ NN NN NN between his NN NN NN and JJ NN NNS on NNP ( NNP 2 ) . His NN VBD VBN with a JJ "" no "" from an NN . The VBZ VBN to VB NNS with NNS , which VBP RB JJ than NNS . But the NN VBZ RB RBR JJ than that : The NN NN wo RB VB you from VBG a NN , but it can VB NNS RBR VB to the NN of NN - 19 , the NN VBN by the JJ NN . "" I VBP VB VBG NNS against NN VBZ a RB JJ JJ NN , "" VBD NNP NNP NNP , a NN and NN NN at the NNP NNP of NNP NNP . RB , NN NN NNS VBP RB VBN by NN NNS RB VBG a NN NN , VBZ the NN of NN NNS , RB VBG to "" VB NNS "" in NNS RB VBG NNS with NN - 19 , he VBD . But there VBZ another NN a NN NN could VB the NN 's NN to the JJ NN : the NNP VBZ VBG behind JJ NNS in NN for NNP - 19 . And that VBZ JJ to VB in the JJ NN . On NNP ( NNP 5 ) , NNP NNP NNP NNP , who VBZ VBG the NN 's NN to the NN , VBD that the NNP VBZ RB VB JJ NN NNS to VB NN . How VBZ that VB to the NN ? If NNS VBP their NN NNS , JJR NNS VBP down with the NN and VBP into NNS with JJ NNS JJ as NN and NN , which VBP with . VBG JJR NN NNS will VB it JJR to VB the NNS with NN - 19 , he VBD . JJR NN NNS would "" VB us RB RBR JJ in VBG NN , "" NNS , NNP VBD NNP NNP . VBG NN - 19 NNS VBZ RB JJ to VBG a "" NN out of a NN , "" but VBG NN NNS can "" VB the NN , "" he VBD . As NNP - NNP - 2 VBZ VBG in NNS on both NNS of the NNP , VBG between NN and NNP - 19 will VB RBR JJ . On the JJ NN , it VBZ "" RB JJ , "" to VB both the NN and NN - 19 at RB , VBD NNP NNP NNP NNP , NN of NNP NNP , NNP NNP in NNP NNP and an NN NN NN . "" RB if they VBP one , they VBP RB VB the JJ . "" NN NN VBZ RB VBG down as NN VBZ , but for those who VBP RB RB VBN RB , "" we RB VBP VBG a NN NN , "" he VBD . NNS with the NN VBP RB VBG into the NN and there VBZ RB a NN there could VB a JJ NN of the NN , NNP VBD NNP NNP . That VBG VBN , NN NNS in NNP NNP NNP VBP VBN RB 25 NN each NN for the JJ two NNS , he VBD . It VBZ a JJ NN "" that we VBP RB VBG RB JJ NN NNS in the NN , RB we VBP JJR NN for JJ NN NNS , "" NNP VBD . At NNP NNP , NNS VBP RB VBG VBN for NN - 19 unless they VBP NNS for NN to the NN . "" That VBZ the JJ NN that we VBP RB VBG because of the JJ NN of NNS , "" he VBD . VB : VB at JJS 53 NN with our JJS NN NN ! With JJ NN NNS that VBP how NNS VBP , and JJ NN of the NN ’s RBS JJ NNS , How It NNPS VBZ the NN of VBG , JJ NN for a JJ NN JJ to VB up with the JJS NN and the RBS JJ NNS on the NN and RB . VBN and VBN in a NN that VBZ RB the RBS JJ NNS JJ and JJ to VB , How It VBZ VBZ VBN by NNS of all NNS . NN NN"
197,476,mainstream,"During_IN decades_NNS ,_, mathematical_JJ models_NNS have_VBP been_VBN used_VBN to_TO predict_VB the_DT behavior_NN of_IN physical_JJ and_CC biologic_JJ systems_NNS ,_, and_CC to_TO define_VB strategies_NNS aiming_VBG the_DT minimization_NN of_IN the_DT effects_NNS regarding_VBG different_JJ types_NNS of_IN diseases_NNS ._. In_IN the_DT present_JJ days_NNS ,_, the_DT development_NN of_IN mathematical_JJ models_NNS to_TO simulate_VB the_DT dynamic_JJ behavior_NN of_IN novel_JJ coronavirus_NN disease_NN (_-LRB- COVID_NNP -_SYM 19_CD )_-RRB- is_VBZ considered_VBN an_DT important_JJ theme_NN due_IN to_IN the_DT quantity_NN of_IN infected_VBN people_NNS worldwide_RB ._. In_IN this_DT work_NN ,_, the_DT aim_NN is_VBZ to_TO determine_VB an_DT optimal_JJ control_NN strategy_NN for_IN vaccine_NN administration_NN in_IN COVID_NN -_HYPH 19_CD pandemic_NN treatment_NN considering_VBG real_JJ data_NNS from_IN China_NNP ._. For_IN this_DT purpose_NN ,_, an_DT inverse_JJ problem_NN is_VBZ formulated_VBN and_CC solved_VBN in_IN order_NN to_TO determine_VB the_DT parameters_NNS of_IN the_DT compartmental_JJ SIR_NN (_-LRB- Susceptible_JJ -_HYPH Infectious_JJ -_HYPH Recovered_VBN )_-RRB- model_NN ._. To_TO solve_VB such_JJ inverse_JJ problem_NN ,_, the_DT Differential_NNP Evolution_NNP (_-LRB- DE_NNP )_-RRB- algorithm_NN is_VBZ employed_VBN ._. After_IN this_DT step_NN ,_, two_CD optimal_JJ control_NN problems_NNS (_-LRB- mono_NN -_HYPH and_CC multi-_JJ objective_NN )_-RRB- to_TO determine_VB the_DT optimal_JJ strategy_NN for_IN vaccine_NN administration_NN in_IN COVID_NN -_HYPH 19_CD pandemic_NN treatment_NN are_VBP proposed_VBN ._. The_DT first_JJ consists_VBZ of_IN minimizing_VBG the_DT quantity_NN of_IN infected_VBN individuals_NNS during_IN the_DT treatment_NN ._. The_DT second_JJ considers_VBZ minimizing_VBG together_RP the_DT quantity_NN of_IN infected_VBN individuals_NNS and_CC the_DT prescribed_VBN vaccine_NN concentration_NN during_IN the_DT treatment_NN ,_, i.e._FW ,_, a_DT multi-objective_JJ optimal_JJ control_NN problem_NN ._. The_DT solution_NN of_IN each_DT optimal_JJ control_NN problems_NNS is_VBZ obtained_VBN using_VBG DE_NNP and_CC Multi-Objective_NNP Differential_NNP Evolution_NNP (_-LRB- MODE_NNP )_-RRB- algorithms_NNS ,_, respectively_RB ._. The_DT results_NNS regarding_VBG the_DT proposed_VBN multi-objective_JJ optimal_JJ control_NN problem_NN provides_VBZ a_DT set_NN of_IN evidences_NNS from_IN which_WDT an_DT optimal_JJ strategy_NN for_IN vaccine_NN administration_NN can_MD be_VB chosen_VBN ,_, according_VBG to_IN a_DT given_VBN criterion_NN ._.","During NNS , JJ NNS VBP VBN VBN to VB the NN of JJ and JJ NNS , and to VB NNS VBG the NN of the NNS VBG JJ NNS of NNS . In the JJ NNS , the NN of JJ NNS to VB the JJ NN of JJ NN NN ( NNP - 19 ) VBZ VBN an JJ NN due to the NN of VBN NNS RB . In this NN , the NN VBZ to VB an JJ NN NN for NN NN in NN - 19 NN NN VBG JJ NNS from NNP . For this NN , an JJ NN VBZ VBN and VBN in NN to VB the NNS of the JJ NN ( JJ - JJ - VBN ) NN . To VB JJ JJ NN , the NNP NNP ( NNP ) NN VBZ VBN . After this NN , two JJ NN NNS ( NN - and JJ NN ) to VB the JJ NN for NN NN in NN - 19 NN NN VBP VBN . The JJ VBZ of VBG the NN of VBN NNS during the NN . The JJ VBZ VBG together the NN of VBN NNS and the VBN NN NN during the NN , FW , a JJ JJ NN NN . The NN of each JJ NN NNS VBZ VBN VBG NNP and NNP NNP NNP ( NNP ) NNS , RB . The NNS VBG the VBN JJ JJ NN NN VBZ a NN of NNS from which an JJ NN for NN NN can VB VBN , VBG to a VBN NN ."
198,584,mainstream,"(_-LRB- CNN_NNP )_-RRB- Abie_NNP Rohrig_NNP had_VBD just_RB turned_VBN 18_CD when_WRB he_PRP told_VBD his_PRP$ mom_NN he_PRP would_MD be_VB donating_VBG a_DT kidney_NN to_TO save_VB a_DT stranger_NN 's_POS life_NN ._. Her_PRP$ answer_NN :_: No_UH you_PRP 're_VBP not_RB ._. He_PRP did_VBD it_PRP anyway_RB --_, the_DT organ_NN went_VBD to_IN a_DT man_NN about_IN his_PRP$ age_NN --_, and_CC his_PRP$ mom_NN was_VBD so_RB inspired_VBN she_PRP went_VBD and_CC donated_VBD a_DT kidney_NN herself_PRP ._. So_RB Rohrig_NNP expected_VBD her_PRP to_TO understand_VB when_WRB he_PRP told_VBD her_PRP that_IN ,_, for_IN the_DT benefit_NN of_IN humanity_NN ,_, he_PRP may_MD volunteer_VB to_TO become_VB infected_VBN with_IN Covid_NNP -_HYPH 19_CD It_PRP turns_VBZ out_RP ""_`` she_PRP 's_VBZ more_RBR worried_JJ than_IN she_PRP was_VBD about_IN the_DT kidney_NN thing_NN ,_, ""_'' said_VBD Rohrig_NNP ,_, now_RB a_DT 20_CD -_HYPH year_NN -_HYPH old_JJ college_NN student_NN who_WP lives_VBZ with_IN his_PRP$ parents_NNS in_IN a_DT New_NNP York_NNP City_NNP apartment_NN ._. ""_`` She_PRP was_VBD like_RP ,_, '_`` What_WP ?_. What_WP ?_. I_PRP do_VBP n't_RB know_VB ,_, '_'' ""_'' he_PRP said_VBD ._. ""_`` She_PRP 's_VBZ skeptical_JJ ._. ""_'' Rohrig_NNP is_VBZ one_CD of_IN more_JJR than_IN 16,000_CD people_NNS --_, most_JJS of_IN them_PRP young_JJ adults_NNS --_, who_WP have_VBP signaled_VBN their_PRP$ support_NN for_IN a_DT controversial_JJ method_NN of_IN speeding_VBG up_RP the_DT development_NN of_IN a_DT vaccine_NN by_IN intentionally_RB infecting_VBG dozens_NNS of_IN volunteers_NNS ._. The_DT signees_NNS of_IN the_DT online_JJ registry_NN --_, a_DT new_JJ website_NN called_VBN 1_CD Day_NN Sooner_RB --_, have_VBP all_RB checked_VBN a_DT box_NN next_RB to_IN the_DT statement_NN :_: ""_`` I_PRP am_VBP interested_JJ in_IN being_VBG exposed_VBN to_IN the_DT coronavirus_NN to_TO speed_VB up_RP vaccine_NN development_NN ._. ""_'' The_DT practice_NN is_VBZ called_VBN a_DT human_JJ -_HYPH challenge_NN study_NN --_, or_CC controlled_VBN human_JJ infection_NN study_NN --_, and_CC it_PRP can_MD truncate_VB a_DT conventional_JJ vaccine_NN study_NN by_IN several_JJ months_NNS ._. The_DT reason_NN :_: Rather_RB than_IN waiting_VBG for_IN months_NNS to_TO assess_VB what_WDT percentage_NN thousands_NNS of_IN vaccine_NN -_HYPH trial_NN volunteers_NNS get_VBP infected_VBN with_IN the_DT disease_NN in_IN question_NN while_IN leading_VBG their_PRP$ day_NN -_HYPH to_IN -_HYPH day_NN lives_NNS ,_, a_DT challenge_NN trial_NN is_VBZ much_RB simpler_JJR ,_, in_IN that_IN it_PRP exposes_VBZ about_RB 100_CD volunteers_NNS directly_RB to_IN the_DT pathogen_NN --_, via_IN syringe_NN ,_, cocktail_NN ,_, mosquito_NN bite_NN or_CC nasal_JJ spray_NN after_IN an_DT experimental_JJ vaccine_NN or_CC placebo_NN is_VBZ administered_VBN ._. (_-LRB- If_IN the_DT Covid_NNP -_HYPH 19_CD study_NN comes_VBZ to_IN fruition_NN ,_, experts_NNS say_VBP it_PRP would_MD likely_RB be_VB administered_VBN by_IN nose_NN drop_NN ._. )_-RRB- But_CC if_IN it_PRP 's_VBZ high_JJ reward_NN ,_, it_PRP 's_VBZ also_RB high_JJ risk_NN :_: Although_IN Covid_NNP -_HYPH 19_CD is_VBZ a_DT much_RB more_RBR deadly_JJ disease_NN for_IN the_DT elderly_NN and_CC the_DT compromised_VBN than_IN healthy_JJ young_JJ adults_NNS ,_, it_PRP is_VBZ an_DT unpredictable_JJ pathogen_NN that_WDT has_VBZ put_VBN star_NN athletes_NNS in_IN the_DT hospital_NN ._. What_WP 's_VBZ more_JJR ,_, should_MD something_NN go_VB wrong_JJ ,_, treatment_NN options_NNS are_VBP limited_VBN ._. However_RB ,_, with_IN the_DT disease_NN still_RB raging_VBG after_IN having_VBG killed_VBN more_JJR than_IN 82,000_CD Americans_NNPS and_CC 291,000_CD people_NNS worldwide_RB since_IN it_PRP first_RB appeared_VBD in_IN China_NNP late_RB last_JJ year_NN ,_, some_DT say_VBP a_DT riskier_JJR -_HYPH than_IN -_HYPH normal_JJ study_NN is_VBZ justified_VBN ._. Co-authored_VBN by_IN Nir_NNP Eyal_NNP of_IN Rutgers_NNP ,_, Marc_NNP Lipsitch_NNP of_IN Harvard_NNP ,_, and_CC Peter_NNP Smith_NNP of_IN the_DT London_NNP School_NNP of_IN Hygiene_NNP &_CC Tropical_NNP Medicine_NNP ,_, the_DT piece_NN concluded_VBD that_IN while_IN a_DT human_JJ challenge_NN study_NN would_MD not_RB be_VB without_IN risks_NNS ,_, ""_`` every_DT week_NN that_IN vaccine_NN rollout_NN is_VBZ delayed_VBN will_MD be_VB accompanied_VBN by_IN many_JJ thousands_NNS of_IN deaths_NNS globally_RB ._. ""_'' ""_`` It_PRP 's_VBZ an_DT idea_NN that_WDT is_VBZ controversial_JJ when_WRB people_NNS hear_VBP about_IN it_PRP for_IN the_DT first_JJ time_NN ,_, ""_'' Eyal_NNP ,_, a_DT bioethicist_NN ,_, told_VBD CNN_NNP ._. ""_`` However_RB ,_, we_PRP show_VBP that_IN if_IN you_PRP select_VBP people_NNS in_IN the_DT right_JJ way_NN and_CC conduct_VBP the_DT trial_NN in_IN the_DT right_JJ way_NN ,_, it_PRP 's_VBZ surprisingly_RB low_JJ risk_NN and_CC certainly_RB within_IN the_DT bounds_NNS of_IN what_WP we_PRP already_RB approve_VBP ._. ""_'' Such_PDT a_DT study_NN would_MD ultimately_RB need_VB the_DT blessing_NN of_IN the_DT US_NNP Food_NNP and_CC Drug_NNP Administration_NNP ._. But_CC the_DT researchers_NNS '_POS call_NN for_IN a_DT challenge_NN study_NN has_VBZ since_RB been_VBN propelled_VBN by_IN the_DT popular_JJ support_NN of_IN those_DT who_WP have_VBP indicated_VBN on_IN 1_CD Day_NN Sooner_RB --_, which_WDT is_VBZ incorporating_VBG as_IN a_DT nonprofit_JJ organization_NN --_, that_WDT they'd_MD be_VB willing_JJ guinea_NN pigs_NNS ._. (_-LRB- This_DT is_VBZ just_RB an_DT informal_JJ expression_NN of_IN interest_NN ,_, not_RB a_DT binding_VBG contract_NN ._. )_-RRB- The_DT site_NN ,_, which_WDT was_VBD inspired_VBN by_IN the_DT scholarly_JJ article_NN ,_, launched_VBD in_IN mid-April_NNP and_CC is_VBZ premised_VBN on_IN the_DT claim_NN that_IN shaving_VBG even_RB one_CD day_NN from_IN the_DT long_JJ -_HYPH distance_NN race_NN for_IN a_DT Covid_NNP -_HYPH 19_CD vaccine_NN could_MD save_VB up_IN to_IN 7,120_CD lives_NNS ._. What_WP a_DT human_JJ challenge_NN study_NN for_IN coronavirus_NN could_MD look_VB like_IN At_IN some_DT point_NN ,_, should_MD a_DT group_NN of_IN researchers_NNS decide_VB to_TO seriously_RB explore_VB the_DT matter_NN ,_, the_DT site_NN would_MD ask_VB prospective_JJ volunteers_NNS to_TO fill_VB out_RP pre-qualification_NN questionnaires_NNS that_WDT would_MD divulge_VB more_JJR of_IN their_PRP$ medical_JJ history_NN ,_, region_NN of_IN residence_NN and_CC other_JJ information_NN that_WDT would_MD help_VB determine_VB eligibility_NN ,_, said_VBD 1_CD Day_NNP Sooner_NNP 's_POS co-founder_NN Josh_NNP Morrison_NNP ._. The_DT researchers_NNS would_MD then_RB screen_VB those_DT forms_NNS for_IN the_DT most_RBS eligible_JJ applicants_NNS and_CC would_MD eventually_RB seek_VB approval_NN from_IN a_DT research_NN or_CC medical_JJ center_NN to_TO host_VB the_DT study_NN ,_, he_PRP said_VBD ._. Morrison_NNP is_VBZ a_DT former_JJ corporate_JJ lawyer_NN who_WP gave_VBD up_RP life_NN in_IN the_DT fast_JJ lane_NN to_TO start_VB a_DT nonprofit_JJ organization_NN called_VBN Waitlist_NNP Zero_NNP ,_, which_WDT matches_VBZ prospective_JJ kidney_NN donors_NNS with_IN recipients_NNS ._. Because_IN business_NN is_VBZ at_IN a_DT near_JJ -_HYPH standstill_NN in_IN the_DT kidney_NN -_HYPH transplant_NN world_NN ,_, Morrison_NNP found_VBD himself_PRP with_IN a_DT lot_NN of_IN spare_NN time_NN ._. ""_`` I_PRP was_VBD like_IN sitting_VBG at_IN home_NN in_IN my_PRP$ apartment_NN in_IN New_NNP York_NNP City_NNP ,_, just_RB kind_NN of_IN depressed_JJ ,_, ""_'' he_PRP said_VBD ._. Morrison_NNP came_VBD across_IN the_DT Journal_NNP article_NN while_IN noodling_VBG around_RB on_IN the_DT internet_NN ._. ""_`` And_CC I_PRP thought_VBD ,_, '_`` Well_UH ,_, would_MD I_PRP want_VB to_TO do_VB this_DT ?_. '_'' ""_'' he_PRP said_VBD ._. ""_`` I_PRP 'm_VBP pretty_RB young_JJ ,_, 34_CD ,_, and_CC in_IN good_JJ health_NN ._. And_CC so_RB I_PRP thought_VBD ,_, '_`` Yeah_UH ,_, I_PRP think_VBP I_PRP would_MD ._. '_'' ""_'' An_DT FDA_NNP spokesperson_NN told_VBD CNN_NNP that_IN the_DT agency_NN would_MD work_VB with_IN those_DT who_WP are_VBP interested_JJ in_IN conducting_VBG human_JJ challenge_NN trials_NNS to_TO help_VB them_PRP evaluate_VB ethical_JJ and_CC other_JJ issues_NNS ._. ""_`` A_DT formal_JJ determination_NN about_IN any_DT specific_JJ human_JJ challenge_NN trial_NN proposal_NN would_MD be_VB made_VBN by_IN the_DT FDA_NNP in_IN the_DT context_NN of_IN all_PDT the_DT information_NN that_WDT is_VBZ available_JJ at_IN that_DT time_NN ,_, ""_'' Michael_NNP Felberbaum_NNP wrote_VBD in_IN an_DT email_NN ._. Conventional_JJ vaccine_NN trials_NNS typically_RB consist_VBP of_IN three_CD phases_NNS --_, the_DT first_JJ ,_, in_IN which_WDT fewer_JJR than_IN 100_CD participants_NNS are_VBP dosed_VBN to_TO determine_VB the_DT safety_NN ;_, the_DT second_JJ ,_, in_IN which_WDT the_DT number_NN of_IN participants_NNS ramps_VBZ up_RP into_IN the_DT hundreds_NNS ;_, and_CC the_DT third_JJ ,_, in_IN which_WDT the_DT study_NN is_VBZ broadened_VBN to_TO include_VB thousands_NNS of_IN people_NNS ._. Typically_RB ,_, in_IN that_DT third_JJ phase_NN ,_, the_DT participants_NNS return_VBP to_IN their_PRP$ daily_JJ lives_NNS ,_, and_CC researchers_NNS --_, over_IN a_DT period_NN of_IN months_NNS --_, compare_VBP rates_NNS of_IN infection_NN between_IN the_DT placebo_NN and_CC test_NN groups_NNS ._. A_DT human_JJ -_HYPH challenge_NN trial_NN can_MD replace_VB a_DT third_JJ phase_NN ,_, the_DT Journal_NNP article_NN says_VBZ ,_, short_JJ -_HYPH circuiting_VBG the_DT timeline_NN by_IN several_JJ months_NNS because_IN researchers_NNS do_VBP n't_RB have_VB to_TO wait_VB for_IN participants_NNS to_TO get_VB infected_VBN the_DT organic_JJ way_NN --_, by_IN interacting_VBG with_IN people_NNS at_IN work_NN ,_, at_IN school_NN ,_, in_IN houses_NNS of_IN worship_NN or_CC in_IN homes_NNS ._. Instead_RB ,_, they_PRP expose_VBP the_DT volunteers_NNS to_IN the_DT pathogen_NN right_RB then_RB and_CC there_RB ,_, in_IN the_DT lab_NN ._. A_DT challenge_NN trial_NN can_MD also_RB serve_VB as_IN a_DT bridge_NN to_IN a_DT Phase_NN 3_CD study_NN ,_, helping_VBG researchers_NNS determine_VB which_WDT vaccine_NN candidates_NNS are_VBP most_RBS promising_JJ ;_, or_CC it_PRP can_MD pave_VB the_DT way_NN for_IN provisional_JJ licensure_NN in_IN emergency_NN situations_NNS ._. For_IN a_DT Covid_NNP -_HYPH 19_CD trial_NN of_IN the_DT sort_NN that_WDT 1_CD Day_NN Sooner_RB is_VBZ advocating_VBG ,_, the_DT setup_NN would_MD likely_RB entail_VB first_RB injecting_VBG an_DT experimental_JJ vaccine_NN into_IN the_DT arms_NNS of_IN about_RB 50_CD volunteers_NNS and_CC a_DT placebo_NN into_IN 50_CD others_NNS ,_, challenge_NN -_HYPH trial_NN experts_NNS told_VBD CNN_NNP ._. Two_CD to_IN four_CD weeks_NNS later_RBR ,_, all_DT 100_CD would_MD be_VB exposed_VBN to_IN the_DT virus_NN --_, perhaps_RB via_IN nose_NN -_HYPH drop_NN ._. Human_JJ -_HYPH challenge_NN studies_NNS are_VBP n't_RB new_JJ ._. They_PRP have_VBP played_VBN a_DT key_JJ role_NN in_IN the_DT development_NN of_IN several_JJ vaccines_NNS ,_, including_VBG ones_NNS for_IN malaria_NN ,_, flu_NN and_CC dengue_NN ._. Without_IN human_JJ -_HYPH challenge_NN studies_NNS ,_, a_DT new_JJ vaccine_NN for_IN typhoid_NN could_MD n't_RB have_VB been_VBN brought_VBN to_IN Zimbabwe_NNP on_IN a_DT provisional_JJ basis_NN last_JJ year_NN ,_, human_JJ -_HYPH challenge_NN experts_NNS told_VBD CNN_NNP ._. The_DT ""_`` FDA_NNP approved_VBD a_DT cholera_NN vaccine_NN simply_RB on_IN the_DT basis_NN of_IN a_DT human_JJ challenge_NN ,_, ""_'' said_VBD Dr._NNP Robert_NNP Read_NNP ,_, an_DT infectious_JJ -_HYPH disease_NN expert_NN in_IN the_DT UK_NNP ._. The_DT difference_NN is_VBZ that_IN those_DT diseases_NNS came_VBD with_IN fewer_JJR unknowns_NNS than_IN Covid_NNP -_HYPH 19_CD ,_, and_CC clinicians_NNS running_VBG the_DT trials_NNS were_VBD able_JJ to_TO offer_VB medical_JJ treatments_NNS --_, such_JJ as_IN antibiotics_NNS or_CC antivirals_NNS --_, to_IN infected_VBN patients_NNS exhibiting_VBG symptoms_NNS ._. And_CC although_IN the_DT idea_NN of_IN conducting_VBG a_DT human_JJ -_HYPH challenge_NN trial_NN for_IN Covid_NNP -_HYPH 19_CD is_VBZ catching_VBG on_RP in_IN the_DT science_NN community_NN ,_, some_DT experts_NNS have_VBP raised_VBN serious_JJ concerns_NNS about_IN safety_NN ._. Read_VB ,_, head_NN of_IN clinical_JJ and_CC experimental_JJ sciences_NNS at_IN University_NNP of_IN Southampton_NNP ,_, points_VBZ out_RP that_IN Covid_NNP -_HYPH 19_CD remains_VBZ a_DT mysterious_JJ pathogen_NN ,_, and_CC researchers_NNS can't_MD give_VB volunteers_NNS an_DT accurate_JJ sense_NN of_IN the_DT risk_NN associated_VBN with_IN getting_VBG intentionally_RB infected_VBN ._. ""_`` You_PRP do_VBP have_VB to_TO be_VB able_JJ to_TO describe_VB what_WP you_PRP know_VBP of_IN what_WP could_MD happen_VB to_IN them_PRP if_IN they_PRP undertake_VBP a_DT controlled_VBN infection_NN ,_, with_IN complete_JJ clarity_NN and_CC honesty_NN ,_, ""_'' said_VBD Read_NNP ,_, who_WP has_VBZ himself_PRP conducted_VBN challenge_NN trials_NNS --_, he_PRP recently_RB infected_VBD dozens_NNS of_IN volunteers_NNS with_IN whooping_NN cough_NN in_IN search_NN of_IN a_DT more_RBR effective_JJ vaccine_NN ._. ""_`` And_CC I_PRP think_VBP lots_NNS of_IN volunteers_NNS ,_, when_WRB faced_VBN with_IN the_DT information_NN ,_, would_MD probably_RB not_RB consent_VB to_IN it_PRP ._. ""_'' Dr._NNP Anna_NNP Durbin_NNP ,_, a_DT professor_NN of_IN international_JJ health_NN at_IN the_DT Johns_NNP Hopkins_NNP Bloomberg_NNP School_NNP of_IN Public_NNP Health_NNP --_, who_WP has_VBZ led_VBN a_DT human_JJ -_HYPH challenge_NN trial_NN for_IN dengue_NN and_CC worked_VBN on_IN another_DT for_IN malaria_NN --_, said_VBD she_PRP would_MD be_VB interested_JJ to_TO hear_VB how_WRB some_DT prospective_JJ volunteers_NNS would_MD respond_VB to_IN these_DT reports_NNS of_IN ""_`` cerebral_JJ vascular_JJ accidents_NNS ._. ""_'' ""_`` Millennials_NNPS do_VBP n't_RB think_VB they_PRP are_VBP going_VBG to_TO get_VB sick_JJ from_IN this_DT ,_, ""_'' said_VBD Durbin_NNP ,_, who_WP ,_, like_IN Read_NNP ,_, is_VBZ open_JJ to_IN the_DT idea_NN of_IN human_JJ challenge_NN trials_NNS for_IN Covid_NNP -_HYPH 19_CD ,_, but_CC stresses_VBZ that_IN it_PRP is_VBZ incumbent_JJ upon_IN researchers_NNS to_TO fully_RB evaluate_VB the_DT risks_NNS of_IN such_PDT a_DT model_NN and_CC to_TO share_VB them_PRP to_IN the_DT fullest_JJS extent_NN possible_JJ with_IN prospective_JJ participants_NNS ._. ""_`` We_PRP see_VBP lots_NNS of_IN young_JJ people_NNS in_IN the_DT hospital_NN on_IN ventilators_NNS ._. ""_'' Volunteers_NNS have_VBP different_JJ reasons_NNS for_IN signing_VBG up_RP --_, some_DT altruistic_JJ ,_, some_DT pragmatic_JJ Rohrig_NNP said_VBD the_DT frightening_JJ spate_NN of_IN young_JJ Covid_NNP -_HYPH 19_CD patients_NNS having_VBG strokes_NNS was_VBD news_NN to_IN him_PRP ._. ""_`` That_DT 's_VBZ jarring_JJ ,_, ""_'' he_PRP said_VBD ._. ""_`` I_PRP know_VBP there_EX is_VBZ a_DT non-trivial_JJ risk_NN ._. ""_'' And_CC yet_RB ,_, Rohrig_NNP said_VBD he_PRP 's_VBZ almost_RB certainly_RB up_RB for_IN it_PRP ._. ""_`` I_PRP know_VBP that_IN there_EX are_VBP risks_NNS ,_, and_CC if_IN I_PRP were_VBD to_TO do_VB this_DT ,_, and_CC it_PRP were_VBD to_TO go_VB poorly_RB ,_, then_RB that_DT would_MD be_VB terrible_JJ ,_, my_PRP$ family_NN would_MD be_VB really_RB sad_JJ ,_, ""_'' Rohrig_NNP said_VBD ._. But_CC ""_`` someone_NN has_VBZ to_TO step_VB up_RP ._. It_PRP seems_VBZ like_IN this_DT just_RB needs_VBZ to_TO happen_VB ._. ""_'' Not_RB all_DT of_IN the_DT prospective_JJ volunteers_NNS are_VBP in_IN their_PRP$ 20s_NNS ._. John_NNP Gentle_NNP ,_, an_DT entrepreneur_NN in_IN Alabama_NNP ,_, turns_VBZ 41_CD on_IN Thursday_NNP ._. He_PRP has_VBZ a_DT wife_NN and_CC four_CD kids_NNS ._. Like_IN Rohrig_NNP ,_, Gentle_NNP believes_VBZ a_DT challenge_NN study_NN would_MD afford_VB him_PRP a_DT chance_NN to_TO make_VB a_DT societal_JJ contribution_NN to_IN the_DT vaccine_NN effort_NN ._. But_CC as_IN the_DT owner_NN of_IN a_DT business_NN that_WDT has_VBZ him_PRP visiting_VBG warehouses_NNS and_CC flying_VBG regularly_RB ,_, he_PRP figures_VBZ he_PRP 'll_MD inevitably_RB get_VB infected_VBN --_, so_IN he_PRP might_MD as_RB well_RB get_VB it_PRP over_RP with_IN ._. ""_`` I_PRP feel_VBP if_IN I_PRP did_VBD it_PRP under_IN a_DT controlled_VBN environment_NN ,_, and_CC I_PRP had_VBD an_DT adverse_JJ reaction_NN ,_, my_PRP$ chances_NNS are_VBP much_RB better_JJR in_IN a_DT controlled_VBN environment_NN than_IN I_PRP did_VBD n't_RB know_VB I_PRP had_VBD it_PRP for_IN a_DT week_NN until_IN something_NN had_VBD deteriorated_VBN to_IN the_DT point_NN I_PRP realized_VBD ,_, ""_'' Gentle_NNP said_VBD ._. Indeed_RB ,_, human_JJ challenge_NN studies_NNS occur_VBP in_IN tightly_RB controlled_VBN settings_NNS ._. The_DT report_NN in_IN the_DT Journal_NNP of_IN Infectious_NNP Diseases_NNPS advises_VBZ keeping_VBG the_DT subjects_NNS in_IN isolation_NN for_IN several_JJ weeks_NNS and_CC guaranteeing_VBG them_PRP access_NN to_IN the_DT state_NN -_HYPH of_IN -_HYPH the_DT -_HYPH art_NN facilities_NNS of_IN the_DT health_NN system_NN ,_, should_MD the_DT need_NN arise_VB ._. ""_`` As_IN a_DT part_NN of_IN being_VBG in_IN the_DT trial_NN they_PRP would_MD be_VB guaranteed_VBN excellent_JJ care_NN if_IN they_PRP needed_VBD it_PRP ,_, ""_'' Lipsitch_NNP ,_, a_DT Harvard_NNP epidemiologist_NN ,_, told_VBD CNN_NNP ._. ""_`` Of_IN course_NN ,_, you_PRP would_MD expect_VB nobody_NN in_IN the_DT trial_NN on_IN average_NN would_MD need_VB it_PRP ,_, but_CC averages_NNS do_VBP n't_RB always_RB play_VB out_RP ._. ""_'' Over_IN the_DT years_NNS ,_, he_PRP said_VBD ,_, he_PRP has_VBZ infected_VBN some_DT 600_CD students_NNS with_IN the_DT disease_NN ._. They_PRP typically_RB ingest_VBP the_DT disease_NN via_IN a_DT sodium_NN -_HYPH bicarbonate_NN drink_NN resembling_VBG Alka_NNP -_HYPH Seltzer_NNP and_CC go_VBP home_RB ._. There_RB ,_, they_PRP await_VBP the_DT symptoms_NNS of_IN typhoid_NN --_, for_IN the_DT study_NN participants_NNS they_PRP include_VBP headache_NN ,_, fever_NN and_CC constipation_NN --_, which_WDT generally_RB kick_VBP in_RP within_IN four_CD or_CC five_CD days_NNS ._. At_IN this_DT point_NN ,_, he_PRP said_VBD ,_, the_DT volunteers_NNS with_IN symptoms_NNS are_VBP given_VBN a_DT regimen_NN of_IN antibiotics_NNS ,_, which_WDT clear_VBP up_RP the_DT symptoms_NNS in_IN a_DT couple_NN of_IN days_NNS ._. ""_`` We_PRP have_VBP extensive_JJ follow_NN -_HYPH up_RP data_NN and_CC have_VBP not_RB had_VBN any_DT long_JJ -_HYPH term_NN problems_NNS identified_VBN ,_, ""_'' Darton_NNP said_VBD in_IN an_DT email_NN ._. ""_`` The_DT model_NN is_VBZ safe_JJ and_CC reproducible_JJ and_CC is_VBZ a_DT model_NN of_IN mild_JJ symptomatic_JJ illness_NN only_RB ._. ""_'' Today_NN 's_POS standards_NNS for_IN human_JJ -_HYPH challenge_NN trials_NNS are_VBP rigorous_JJ ._. Durbin_NNP of_IN Johns_NNP Hopkins_NNP points_VBZ out_RP that_IN it_PRP takes_VBZ a_DT minimum_NN of_IN six_CD months_NNS of_IN prep_NN work_NN to_TO responsibly_RB carry_VB out_RP a_DT human_JJ -_HYPH challenge_NN trial_NN ._. This_DT is_VBZ in_IN part_NN because_IN a_DT suitable_JJ strain_NN of_IN the_DT virus_NN --_, and_CC the_DT proper_JJ dosage_NN --_, must_MD be_VB developed_VBN in_IN a_DT lab_NN outfitted_VBN with_IN high_JJ biosafety_NN standards_NNS ._. Also_RB ,_, researchers_NNS must_MD find_VB medical_JJ centers_NNS that_WDT are_VBP willing_JJ to_TO house_VB the_DT participants_NNS in_IN isolation_NN for_IN the_DT duration_NN of_IN the_DT study_NN and_CC provide_VB first_JJ -_HYPH rate_NN care_NN to_IN anyone_NN who_WP falls_VBZ seriously_RB ill_JJ ._. ""_`` I_PRP think_VBP it_PRP 's_VBZ very_RB important_JJ that_IN you_PRP plan_VBP for_IN these_DT studies_NNS now_RB ..._, and_CC you_PRP get_VBP it_PRP right_JJ ,_, ""_'' Durbin_NNP said_VBD ._. ""_`` Yes_UH ,_, it_PRP may_MD take_VB time_NN for_IN a_DT good_JJ human_JJ challenge_NN model_NN to_TO be_VB developed_VBN ,_, but_CC if_IN we_PRP wait_VBP too_RB long_RB to_TO develop_VB it_PRP ,_, then_RB I_PRP think_VBP the_DT moment_NN has_VBZ passed_VBN ._. ""_'' Caring_VBG for_IN volunteers_NNS can_MD get_VB tricky_JJ One_CD of_IN the_DT trickier_JJR aspects_NNS of_IN a_DT challenge_NN study_NN is_VBZ compensation_NN ._. Pay_VB too_RB little_JJ ,_, and_CC the_DT study_NN may_MD fail_VB to_TO attract_VB candidates_NNS ;_, pay_VB too_RB much_RB ,_, and_CC people_NNS could_MD be_VB enticed_VBN by_IN the_DT money_NN without_IN thinking_VBG of_IN their_PRP$ safety_NN ._. The_DT latter_JJ scenario_NN played_VBD out_RP with_IN the_DT yellow_JJ -_HYPH fever_NN trials_NNS ,_, in_IN which_WDT a_DT participant_NN who_WP was_VBD hoping_VBG to_TO start_VB a_DT farm_NN in_IN Cuba_NNP said_VBD it_PRP was_VBD a_DT ""_`` cold_JJ -_HYPH blooded_VBN business_NN decision_NN ._. ""_'' The_DT May_NNP 7_CD article_NN in_IN Science_NNP --_, which_WDT concludes_VBZ that_IN the_DT extraordinary_JJ nature_NN of_IN the_DT Covid_NNP -_HYPH 19_CD pandemic_NN warrants_NNS laying_VBG the_DT groundwork_NN for_IN controlled_VBN human_JJ -_HYPH infection_NN trials_NNS --_, recommends_VBZ ""_`` several_JJ thousand_CD dollars_NNS ._. ""_'' Seema_NNP Shah_NNP ,_, a_DT bioethicist_NN and_CC associate_NN professor_NN at_IN Northwestern_NNP University_NNP 's_POS Feinberg_NNP School_NNP of_IN Medicine_NNP --_, and_CC an_DT author_NN of_IN the_DT Science_NNP article_NN --_, said_VBD participants_NNS of_IN a_DT recent_JJ 40_CD -_HYPH day_NN human_JJ -_HYPH challenge_NN study_NN for_IN malaria_NN were_VBD paid_VBN about_RB $_$ 2,300_CD ._. ""_`` Some_DT were_VBD very_RB motivated_VBN by_IN the_DT money_NN ,_, but_CC others_NNS were_VBD also_RB interested_JJ in_IN the_DT experience_NN ,_, and_CC still_RB others_NNS have_VBP strong_JJ motivations_NNS to_TO help_VB others_NNS ,_, ""_'' she_PRP said_VBD ,_, adding_VBG that_IN some_DT participants_NNS personally_RB knew_VBD sufferers_NNS of_IN malaria_NN and_CC some_DT even_RB donated_VBD some_DT of_IN their_PRP$ earnings_NNS to_IN charities_NNS ._. The_DT article_NN in_IN the_DT Journal_NNP of_IN Infectious_NNP Diseases_NNPS likens_VBZ the_DT act_NN of_IN volunteering_VBG for_IN a_DT human_JJ -_HYPH challenge_NN trial_NN to_IN other_JJ public_JJ -_HYPH service_NN endeavors_NNS --_, such_JJ as_IN volunteer_NN firefighting_NN or_CC organ_NN donation_NN ._. ""_`` People_NNS are_VBP willing_JJ to_TO take_VB on_RP life_NN -_HYPH threatening_VBG risk_NN for_IN other_JJ people_NNS 's_POS benefit_NN and_CC often_RB not_RB just_RB as_IN a_DT job_NN but_CC as_IN a_DT form_NN of_IN altruistic_JJ behavior_NN ,_, ""_'' Lipsitch_NNP said_VBD ._. ""_`` We_PRP not_RB only_RB encourage_VBP that_DT ,_, but_CC we_PRP completely_RB depend_VBP on_IN that_DT in_IN many_JJ sectors_NNS of_IN our_PRP$ lives_NNS ._. ""_'' Still_RB ,_, the_DT onus_NN is_VBZ on_IN the_DT researchers_NNS to_TO ensure_VB that_IN the_DT participants_NNS stay_VBP safe_JJ ._. ""_`` What_WP keeps_VBZ me_PRP up_RP at_IN night_NN ,_, ""_'' said_VBD Durbin_NNP ,_, ""_`` is_VBZ if_IN I_PRP administer_VBP a_DT challenge_NN agent_NN to_IN somebody_NN ,_, and_CC that_DT person_NN gets_VBZ seriously_RB ill_JJ or_CC dies_VBZ --_, that_DT 's_VBZ on_IN me_PRP ._. ""_''","( NNP ) NNP NNP VBD RB VBN 18 when he VBD his NN he would VB VBG a NN to VB a NN 's NN . Her NN : No you VBP RB . He VBD it RB -- the NN VBD to a NN about his NN -- and his NN VBD RB VBN she VBD and VBD a NN herself . RB NNP VBD her to VB when he VBD her that , for the NN of NN , he may VB to VB VBN with NNP - 19 It VBZ out "" she VBZ RBR JJ than she VBD about the NN NN , "" VBD NNP , RB a 20 - NN - JJ NN NN who VBZ with his NNS in a NNP NNP NNP NN . "" She VBD like , ' What ? What ? I VBP RB VB , ' "" he VBD . "" She VBZ JJ . "" NNP VBZ one of JJR than 16,000 NNS -- JJS of them JJ NNS -- who VBP VBN their NN for a JJ NN of VBG up the NN of a NN by RB VBG NNS of NNS . The NNS of the JJ NN -- a JJ NN VBN 1 NN RB -- VBP RB VBN a NN RB to the NN : "" I VBP JJ in VBG VBN to the NN to VB up NN NN . "" The NN VBZ VBN a JJ - NN NN -- or VBN JJ NN NN -- and it can VB a JJ NN NN by JJ NNS . The NN : RB than VBG for NNS to VB what NN NNS of NN - NN NNS VBP VBN with the NN in NN while VBG their NN - to - NN NNS , a NN NN VBZ RB JJR , in that it VBZ RB 100 NNS RB to the NN -- via NN , NN , NN NN or JJ NN after an JJ NN or NN VBZ VBN . ( If the NNP - 19 NN VBZ to NN , NNS VBP it would RB VB VBN by NN NN . ) But if it VBZ JJ NN , it VBZ RB JJ NN : Although NNP - 19 VBZ a RB RBR JJ NN for the NN and the VBN than JJ JJ NNS , it VBZ an JJ NN that VBZ VBN NN NNS in the NN . What VBZ JJR , should NN VB JJ , NN NNS VBP VBN . RB , with the NN RB VBG after VBG VBN JJR than 82,000 NNPS and 291,000 NNS RB since it RB VBD in NNP RB JJ NN , some VBP a JJR - than - JJ NN VBZ VBN . VBN by NNP NNP of NNP , NNP NNP of NNP , and NNP NNP of the NNP NNP of NNP & NNP NNP , the NN VBD that while a JJ NN NN would RB VB without NNS , "" every NN that NN NN VBZ VBN will VB VBN by JJ NNS of NNS RB . "" "" It VBZ an NN that VBZ JJ when NNS VBP about it for the JJ NN , "" NNP , a NN , VBD NNP . "" RB , we VBP that if you VBP NNS in the JJ NN and VBP the NN in the JJ NN , it VBZ RB JJ NN and RB within the NNS of what we RB VBP . "" Such a NN would RB VB the NN of the NNP NNP and NNP NNP . But the NNS ' NN for a NN NN VBZ RB VBN VBN by the JJ NN of those who VBP VBN on 1 NN RB -- which VBZ VBG as a JJ NN -- that they'd VB JJ NN NNS . ( This VBZ RB an JJ NN of NN , RB a VBG NN . ) The NN , which VBD VBN by the JJ NN , VBD in NNP and VBZ VBN on the NN that VBG RB one NN from the JJ - NN NN for a NNP - 19 NN could VB up to 7,120 NNS . What a JJ NN NN for NN could VB like At some NN , should a NN of NNS VB to RB VB the NN , the NN would VB JJ NNS to VB out NN NNS that would VB JJR of their JJ NN , NN of NN and JJ NN that would VB VB NN , VBD 1 NNP NNP 's NN NNP NNP . The NNS would RB VB those NNS for the RBS JJ NNS and would RB VB NN from a NN or JJ NN to VB the NN , he VBD . NNP VBZ a JJ JJ NN who VBD up NN in the JJ NN to VB a JJ NN VBN NNP NNP , which VBZ JJ NN NNS with NNS . Because NN VBZ at a JJ - NN in the NN - NN NN , NNP VBD himself with a NN of NN NN . "" I VBD like VBG at NN in my NN in NNP NNP NNP , RB NN of JJ , "" he VBD . NNP VBD across the NNP NN while VBG RB on the NN . "" And I VBD , ' Well , would I VB to VB this ? ' "" he VBD . "" I VBP RB JJ , 34 , and in JJ NN . And RB I VBD , ' Yeah , I VBP I would . ' "" An NNP NN VBD NNP that the NN would VB with those who VBP JJ in VBG JJ NN NNS to VB them VB JJ and JJ NNS . "" A JJ NN about any JJ JJ NN NN NN would VB VBN by the NNP in the NN of all the NN that VBZ JJ at that NN , "" NNP NNP VBD in an NN . JJ NN NNS RB VBP of three NNS -- the JJ , in which JJR than 100 NNS VBP VBN to VB the NN ; the JJ , in which the NN of NNS VBZ up into the NNS ; and the JJ , in which the NN VBZ VBN to VB NNS of NNS . RB , in that JJ NN , the NNS VBP to their JJ NNS , and NNS -- over a NN of NNS -- VBP NNS of NN between the NN and NN NNS . A JJ - NN NN can VB a JJ NN , the NNP NN VBZ , JJ - VBG the NN by JJ NNS because NNS VBP RB VB to VB for NNS to VB VBN the JJ NN -- by VBG with NNS at NN , at NN , in NNS of NN or in NNS . RB , they VBP the NNS to the NN RB RB and RB , in the NN . A NN NN can RB VB as a NN to a NN 3 NN , VBG NNS VB which NN NNS VBP RBS JJ ; or it can VB the NN for JJ NN in NN NNS . For a NNP - 19 NN of the NN that 1 NN RB VBZ VBG , the NN would RB VB RB VBG an JJ NN into the NNS of RB 50 NNS and a NN into 50 NNS , NN - NN NNS VBD NNP . Two to four NNS RBR , all 100 would VB VBN to the NN -- RB via NN - NN . JJ - NN NNS VBP RB JJ . They VBP VBN a JJ NN in the NN of JJ NNS , VBG NNS for NN , NN and NN . Without JJ - NN NNS , a JJ NN for NN could RB VB VBN VBN to NNP on a JJ NN JJ NN , JJ - NN NNS VBD NNP . The "" NNP VBD a NN NN RB on the NN of a JJ NN , "" VBD NNP NNP NNP , an JJ - NN NN in the NNP . The NN VBZ that those NNS VBD with JJR NNS than NNP - 19 , and NNS VBG the NNS VBD JJ to VB JJ NNS -- JJ as NNS or NNS -- to VBN NNS VBG NNS . And although the NN of VBG a JJ - NN NN for NNP - 19 VBZ VBG on in the NN NN , some NNS VBP VBN JJ NNS about NN . VB , NN of JJ and JJ NNS at NNP of NNP , VBZ out that NNP - 19 VBZ a JJ NN , and NNS can't VB NNS an JJ NN of the NN VBN with VBG RB VBN . "" You VBP VB to VB JJ to VB what you VBP of what could VB to them if they VBP a VBN NN , with JJ NN and NN , "" VBD NNP , who VBZ himself VBN NN NNS -- he RB VBD NNS of NNS with NN NN in NN of a RBR JJ NN . "" And I VBP NNS of NNS , when VBN with the NN , would RB RB VB to it . "" NNP NNP NNP , a NN of JJ NN at the NNP NNP NNP NNP of NNP NNP -- who VBZ VBN a JJ - NN NN for NN and VBN on another for NN -- VBD she would VB JJ to VB how some JJ NNS would VB to these NNS of "" JJ JJ NNS . "" "" NNPS VBP RB VB they VBP VBG to VB JJ from this , "" VBD NNP , who , like NNP , VBZ JJ to the NN of JJ NN NNS for NNP - 19 , but VBZ that it VBZ JJ upon NNS to RB VB the NNS of such a NN and to VB them to the JJS NN JJ with JJ NNS . "" We VBP NNS of JJ NNS in the NN on NNS . "" NNS VBP JJ NNS for VBG up -- some JJ , some JJ NNP VBD the JJ NN of JJ NNP - 19 NNS VBG NNS VBD NN to him . "" That VBZ JJ , "" he VBD . "" I VBP there VBZ a JJ NN . "" And RB , NNP VBD he VBZ RB RB RB for it . "" I VBP that there VBP NNS , and if I VBD to VB this , and it VBD to VB RB , RB that would VB JJ , my NN would VB RB JJ , "" NNP VBD . But "" NN VBZ to VB up . It VBZ like this RB VBZ to VB . "" RB all of the JJ NNS VBP in their NNS . NNP NNP , an NN in NNP , VBZ 41 on NNP . He VBZ a NN and four NNS . Like NNP , NNP VBZ a NN NN would VB him a NN to VB a JJ NN to the NN NN . But as the NN of a NN that VBZ him VBG NNS and VBG RB , he VBZ he 'll RB VB VBN -- so he might RB RB VB it over with . "" I VBP if I VBD it under a VBN NN , and I VBD an JJ NN , my NNS VBP RB JJR in a VBN NN than I VBD RB VB I VBD it for a NN until NN VBD VBN to the NN I VBD , "" NNP VBD . RB , JJ NN NNS VBP in RB VBN NNS . The NN in the NNP of NNP NNPS VBZ VBG the NNS in NN for JJ NNS and VBG them NN to the NN - of - the - NN NNS of the NN NN , should the NN VB . "" As a NN of VBG in the NN they would VB VBN JJ NN if they VBD it , "" NNP , a NNP NN , VBD NNP . "" Of NN , you would VB NN in the NN on NN would VB it , but NNS VBP RB RB VB out . "" Over the NNS , he VBD , he VBZ VBN some 600 NNS with the NN . They RB VBP the NN via a NN - NN NN VBG NNP - NNP and VBP RB . RB , they VBP the NNS of NN -- for the NN NNS they VBP NN , NN and NN -- which RB VBP in within four or five NNS . At this NN , he VBD , the NNS with NNS VBP VBN a NN of NNS , which VBP up the NNS in a NN of NNS . "" We VBP JJ NN - up NN and VBP RB VBN any JJ - NN NNS VBN , "" NNP VBD in an NN . "" The NN VBZ JJ and JJ and VBZ a NN of JJ JJ NN RB . "" NN 's NNS for JJ - NN NNS VBP JJ . NNP of NNP NNP VBZ out that it VBZ a NN of six NNS of NN NN to RB VB out a JJ - NN NN . This VBZ in NN because a JJ NN of the NN -- and the JJ NN -- must VB VBN in a NN VBN with JJ NN NNS . RB , NNS must VB JJ NNS that VBP JJ to VB the NNS in NN for the NN of the NN and VB JJ - NN NN to NN who VBZ RB JJ . "" I VBP it VBZ RB JJ that you VBP for these NNS RB ... and you VBP it JJ , "" NNP VBD . "" Yes , it may VB NN for a JJ JJ NN NN to VB VBN , but if we VBP RB RB to VB it , RB I VBP the NN VBZ VBN . "" VBG for NNS can VB JJ One of the JJR NNS of a NN NN VBZ NN . VB RB JJ , and the NN may VB to VB NNS ; VB RB RB , and NNS could VB VBN by the NN without VBG of their NN . The JJ NN VBD out with the JJ - NN NNS , in which a NN who VBD VBG to VB a NN in NNP VBD it VBD a "" JJ - VBN NN NN . "" The NNP 7 NN in NNP -- which VBZ that the JJ NN of the NNP - 19 NN NNS VBG the NN for VBN JJ - NN NNS -- VBZ "" JJ thousand NNS . "" NNP NNP , a NN and NN NN at NNP NNP 's NNP NNP of NNP -- and an NN of the NNP NN -- VBD NNS of a JJ 40 - NN JJ - NN NN for NN VBD VBN RB $ 2,300 . "" Some VBD RB VBN by the NN , but NNS VBD RB JJ in the NN , and RB NNS VBP JJ NNS to VB NNS , "" she VBD , VBG that some NNS RB VBD NNS of NN and some RB VBD some of their NNS to NNS . The NN in the NNP of NNP NNPS VBZ the NN of VBG for a JJ - NN NN to JJ JJ - NN NNS -- JJ as NN NN or NN NN . "" NNS VBP JJ to VB on NN - VBG NN for JJ NNS 's NN and RB RB RB as a NN but as a NN of JJ NN , "" NNP VBD . "" We RB RB VBP that , but we RB VBP on that in JJ NNS of our NNS . "" RB , the NN VBZ on the NNS to VB that the NNS VBP JJ . "" What VBZ me up at NN , "" VBD NNP , "" VBZ if I VBP a NN NN to NN , and that NN VBZ RB JJ or VBZ -- that VBZ on me . """
199,806,conspiracy,"Every_DT sinister_JJ operation_NN that_WDT the_DT biggest_JJS Organized_NNP Crime_NNP Syndicate_NNP on_IN the_DT planet_NN is_VBZ unleashing_VBG upon_IN the_DT unsuspecting_JJ public_NN is_VBZ laced_VBN with_IN multiple_JJ objectives_NNS ,_, i.e._FW geopolitical_JJ ,_, economics_NN ,_, psychological_JJ ,_, medical_JJ objectives_NNS ,_, etc_FW ._. The_DT Zika_NNP virus_NN “_`` epidemic_NN ”_'' is_VBZ just_RB another_DT one_CD of_IN them_PRP and_CC it_PRP is_VBZ time_NN to_TO see_VB the_DT bigger_JJR picture_NN ._. The_DT Khazarian_NNP Mafia_NNP who_WP owns_VBZ the_DT mainstream_JJ media_NN ,_, banks_NNS ,_, politicians_NNS and_CC corporate_JJ governments_NNS are_VBP now_RB experiencing_VBG a_DT “_`` glitch_NN ”_'' in_IN the_DT system_NN caused_VBN by_IN massive_JJ defections_NNS to_IN the_DT other_JJ side_NN ,_, i.e._FW when_WRB the_DT covert_JJ operatives_NNS became_VBD aware_JJ of_IN the_DT plot_NN to_TO eliminate_VB them_PRP ,_, too_RB ,_, in_IN the_DT end_NN ._. In_IN particular_JJ ,_, the_DT breaking_NN point_NN for_IN Asia_NNP is_VBZ the_DT SARS_NNP virus_NN which_WDT was_VBD intended_VBN to_TO eliminate_VB Asian_JJ genome_NN from_IN the_DT face_NN of_IN the_DT Earth_NNP ,_, while_IN the_DT breaking_NN point_NN for_IN Western_JJ intel_NN cowboys_NNS was_VBD the_DT H1N1_NNP virus_NN aimed_VBN at_IN reducing_VBG primarily_RB the_DT US_NNP population_NN ,_, as_IN fully_RB documented_VBN by_IN Nature_NNP &_CC Science_NNP Journalist_NNP ,_, Jane_NNP Burgermeister_NNP ._. You_PRP need_VBP to_TO view_VB this_DT video_NN update_NN in_IN full_JJ in_IN order_NN to_TO understand_VB the_DT deadly_JJ game_NN being_VBG played_VBN against_IN everyone_NN ,_, and_CC who_WP exactly_RB are_VBP behind_IN the_DT genocide_NN ._. The_DT multiple_JJ exposès_NNS about_IN the_DT baseless_JJ “_`` war_NN on_IN terror_NN ,_, ”_'' bioweapons_NNS ,_, vaccines_NNS ,_, chemtrails_NNS and_CC HAARP_NNP made_VBD them_PRP realize_VB they_PRP and_CC their_PRP$ families_NNS are_VBP also_RB victims_NNS of_IN the_DT plot_NN to_TO depopulate_VB the_DT entire_JJ planet_NN through_IN thermonuclear_NN war_NN with_IN Iran_NNP while_IN the_DT Khazarians_NNPS escape_VBP to_IN their_PRP$ cities_NNS underground_RB ._. When_WRB this_DT plot_NN was_VBD uncovered_VBN ,_, the_DT first_JJ thing_NN the_DT Reformist_NNP Collective_NNP did_VBD is_VBZ to_TO blow_VB up_RP those_DT Deep_NNP Underground_NNP Military_NNP Bases_NNPS [_-LRB- DUMBs_NNP ]_-RRB- ,_, more_JJR than_IN a_DT thousand_CD of_IN them_PRP ,_, so_IN that_IN the_DT whole_JJ geopolitical_JJ game_NN would_MD at_IN least_JJS be_VB on_IN the_DT same_JJ footing_NN ._. This_DT explains_VBZ some_DT of_IN the_DT unexpected_JJ tremors_NNS around_IN the_DT world_NN ._. Here_RB ’s_VBZ a_DT documentary_NN video_NN as_IN shown_VBN primetime_NN on_IN Russian_JJ mainstream_JJ REN_NN -_HYPH TV_NN :_: Now_RB ,_, they_PRP could_MD not_RB start_VB a_DT thermonuclear_JJ war_NN with_IN anybody_NN ._. This_DT significant_JJ step_NN ,_, out_IN of_IN many_JJ over_IN the_DT last_JJ four_CD years_NNS ,_, made_VBD the_DT Iran_NNP -_HYPH US_NNP Nuclear_JJ Deal_NN possible_JJ ._. Here_RB ’s_VBZ the_DT proof_NN that_IN they_PRP are_VBP just_RB trying_VBG to_TO arrest_VB your_PRP$ attention_NN from_IN more_RBR pressing_VBG issues_NNS of_IN the_DT day_NN ,_, e.g._FW :_: •_NFP TPP_NNP signing_VBG in_IN New_NNP Zealand_NNP ,_, a_DT trade_NN agreement_NN that_WDT effectively_RB usurped_VBD the_DT power_NN and_CC authority_NN of_IN any_DT State_NNP ,_, the_DT most_RBS significant_JJ of_IN which_WDT is_VBZ the_DT clause_NN which_WDT allows_VBZ any_DT multinational_JJ corporation_NN to_TO sue_VB your_PRP$ government_NN ,_, and_CC you_PRP as_IN taxpayer_NN ,_, for_IN lost_VBN future_JJ profits_NNS ;_: •_NFP The_DT ongoing_JJ move_NN towards_IN Cashless_NNP Society_NNP to_TO completely_RB anchor_VB your_PRP$ capacity_NN to_TO survive_VB to_IN the_DT machines_NNS ,_, on_IN top_NN of_IN the_DT ongoing_JJ bank_NN bail_NN -_, ins_NNS where_WRB your_PRP$ bank_NN deposit_NN is_VBZ now_RB earning_VBG negative_JJ interest_NN [_-LRB- remember_VB Cyprus_NNP skimming_NN bank_NN accounts_NNS ?_. ]_-RRB- and_CC you_PRP cannot_MD withdraw_VB any_DT significant_JJ amount_NN from_IN your_PRP$ own_JJ bank_NN account_NN any_DT given_VBN day_NN ;_, •_NFP The_DT ongoing_JJ Khazarian_NNP Empire_NNP ’s_POS defeat_NN in_IN Syria_NNP and_CC the_DT rest_NN of_IN the_DT Middle_NNP East_NNP ,_, and_CC Eurasia_NNP ;_: •_NFP The_DT fiat_NNP financial_JJ crash_NN that_WDT is_VBZ resulting_VBG from_IN the_DT systematic_JJ move_NN by_IN the_DT BRICS_NNP to_TO do_VB away_RB with_IN the_DT petrodollar_NN ._. The_DT BRICS_NNP is_VBZ now_RB having_VBG their_PRP$ own_JJ global_JJ development_NN bank_NN ,_, SWIFT_NNP alternative_NN ,_, GPS_NN alternative_NN ,_, and_CC is_VBZ implementing_VBG a_DT gradual_JJ shift_NN from_IN oil_NN through_IN hybrid_JJ fusion_NN -_HYPH fission_NN nuclear_JJ reactors_NNS ._. One_PRP cannot_MD possibly_RB fathom_VB the_DT depth_NN of_IN desperation_NN on_IN the_DT part_NN of_IN the_DT Rothschild_NNP dynasty_NN losing_VBG their_PRP$ carefully_RB crafted_VBN Khazarian_NNP Empire_NNP ._. This_DT is_VBZ the_DT reason_NN why_WRB ,_, in_IN order_NN to_TO keep_VB them_PRP still_RB in_IN power_NN ,_, they_PRP have_VBP to_TO keep_VB on_IN using_VBG the_DT only_JJ weapons_NNS they_PRP have_VBP left_VBN against_IN their_PRP$ own_JJ people_NNS in_IN the_DT West_NN ,_, i.e._FW HAARP_NNP ,_, bioweapons_NNS ,_, mass_JJ media_NN and_CC fiat_NN financial_JJ system_NN ._. •_SYM EU_NNP Abolishing_VBG Cash_NN to_TO Facilitate_VB Technocratic_NNP Dictatorship_NNP ;_, BRICS_NNP Using_VBG Asset_NNP -_HYPH backed_VBN Currencies_NNS Only_RB •_NFP Who_WP would_MD actually_RB benefit_VB from_IN a_DT Cashless_NNP Society_NNP ?_. Unless_IN the_DT people_NNS in_IN the_DT West_NNP rises_VBZ to_IN the_DT occasion_NN and_CC grab_VBP this_DT rare_JJ opportunity_NN to_TO end_VB the_DT rule_NN of_IN the_DT Oligarchy_NNP and_CC the_DT Khazarian_NNP Mafia_NNP ,_, there_EX will_MD be_VB a_DT polarized_VBN society_NN divided_VBN by_IN two_CD financial_JJ systems_NNS ,_, i.e_RB ._. West_NNP fiat_NN financial_JJ system_NN and_CC the_DT BRICS_NNP asset_NN -_HYPH backed_VBN basket_NN of_IN currencies_NNS ._. The_DT consequence_NN of_IN this_DT fact_NN is_VBZ the_DT free_JJ falling_VBG London_NNP -_HYPH based_VBN Baltic_NNP Dry_NNP Index_NNP ,_, a_DT prominent_JJ indicator_NN of_IN the_DT actual_JJ movement_NN of_IN physical_JJ goods_NNS around_IN the_DT world_NN ,_, caused_VBN by_IN the_DT non-acceptance_NN of_IN the_DT fiat_NN dollar_NN as_IN payment_NN ._. •_NFP The_DT Unfolding_VBG Global_JJ Reset_NN that_WDT Only_JJ Few_JJ Understand_VBP You_PRP can_MD follow_VB this_DT developing_VBG story_NN from_IN our_PRP$ Covert_NNP Geopolitics_NNP website_NN ._. The_DT BRICS_NNP led_VBD drive_NN to_TO end_VB all_DT hybrid_NN wars_NNS of_IN aggression_NN will_MD continue_VB ._. Brazil_NNP is_VBZ the_DT B_NN in_IN BRICS_NNP and_CC it_PRP is_VBZ no_DT coincidence_NN that_IN it_PRP ’s_VBZ a_DT prime_JJ candidate_NN for_IN another_DT false_JJ flag_NN viral_JJ attack_NN ,_, to_TO disrupt_VB its_PRP$ hosting_NN of_IN the_DT Olympics_NNPS ,_, as_IN they_PRP have_VBP done_VBN in_IN Sochi_NNP Winter_NNP Olympics_NNPS before_RB ,_, and_CC to_TO achieve_VB other_JJ sinister_JJ objectives_NNS stipulated_VBN above_RB ._. by_IN Jon_NNP Rappoport_NNP February_NNP 5_CD ,_, 2016_CD https://www.corbettreport.com/?powerpress_embed=17765-podcast&powerpress_player=mediaelement-video_ADD (_-LRB- Note_NN :_: all_DT source_NN links_NNS for_IN this_DT article_NN can_MD be_VB found_VBN at_IN the_DT blog_NN post_NN ,_, here_RB ._. )_-RRB- I_PRP can_MD now_RB provide_VB the_DT latest_JJS update_NN on_IN what_WP researchers_NNS in_IN Brazil_NNP are_VBP discovering_VBG ,_, as_IN they_PRP dig_VBP into_IN their_PRP$ original_JJ findings_NNS about_IN the_DT Zika_NNP virus_NN and_CC cases_NNS of_IN microcephaly_NN (_-LRB- babies_NNS born_VBN with_IN small_JJ heads_NNS and_CC brain_NN impairment_NN )_-RRB- ._. A_DT correspondent_NN has_VBZ offered_VBN a_DT translation_NN of_IN an_DT article_NN that_WDT appeared_VBD in_IN one_CD of_IN the_DT major_JJ Sao_NNP Paulo_NNP newspapers_NNS ,_, O_NNP Estado_NNP de_NNP São_NNP Paulo_NNP ,_, on_IN February_NNP 2nd_NN ,_, :_: It_PRP is_VBZ obvious_JJ that_IN no_DT significant_JJ connection_NN between_IN microcephaly_NN and_CC the_DT Zika_NNP virus_NN has_VBZ been_VBN found_VBN ._. It_PRP ’s_VBZ not_RB even_RB close_JJ ._. So_RB far_RB ,_, therefore_RB ,_, there_EX is_VBZ absolutely_RB no_DT reason_NN to_TO trumpet_VB an_DT epidemic_NN of_IN Zika_NNP ._. Doing_VBG so_RB is_VBZ quite_RB insane_JJ ,_, by_IN any_DT reasonable_JJ standard_NN ._. Here_RB are_VBP the_DT principal_JJ facts_NNS in_IN the_DT article_NN (_-LRB- after_IN which_WDT I_PRP ’ll_MD comment_VB )_-RRB- :_: •_NFP As_IN of_IN January_NNP 30_CD ,_, 2015_CD ,_, 4,783_CD suspected_VBN cases_NNS of_IN microcephaly_NN were_VBD reported_VBN in_IN Brazil_NNP ._. •_NFP Of_IN those_DT ,_, 3,670_CD suspected_VBN cases_NNS of_IN microcephaly_NN ,_, covering_VBG the_DT entire_JJ country_NN of_IN Brazil_NNP ,_, are_VBP being_VBG investigated_VBN ._. •_NFP Of_IN those_DT 3,670_CD ,_, 404_CD cases_NNS have_VBP been_VBN confirmed_VBN as_IN microcephaly_NN or_CC “_`` other_JJ alterations_NNS in_IN the_DT central_JJ nervous_JJ system_NN ”_'' of_IN babies_NNS ._. •_NFP Of_IN those_DT 404_CD cases_NNS ,_, 17_CD “_'' had_VBD a_DT relationship_NN with_IN zika_NN virus_NN ._. ”_'' •_SYM 98_CD %_NN of_IN the_DT 404_CD microcephaly_JJ cases_NNS come_VBP from_IN the_DT Northeast_NNP area_NN of_IN Brazil_NNP ,_, and_CC in_IN that_DT area_NN ,_, Pernambuco_NNP has_VBZ the_DT highest_JJS number_NN of_IN cases_NNS :_: 56_CD ._. Now_RB ,_, let_VB ’s_PRP take_VB each_DT one_CD of_IN these_DT reported_VBN facts_NNS and_CC examine_VB it_PRP ._. First_RB :_: 4,783_CD suspected_VBN cases_NNS of_IN microcephaly_NN in_IN Brazil_NNP ._. “_`` Suspected_VBN ”_'' is_VBZ the_DT operative_JJ word_NN ._. This_DT number_NN means_VBZ nothing_NN ,_, because_IN it_PRP says_VBZ nothing_NN about_IN confirmation_NN ._. It_PRP ’s_VBZ just_RB a_DT raw_JJ figure_NN ._. 3,670_CD of_IN these_DT cases_NNS are_VBP being_VBG researched_VBN ._. Of_IN these_DT 3,670_CD ,_, 404_CD have_VBP been_VBN confirmed_VBN as_IN microcephaly_JJ or_CC other_JJ alterations_NNS in_IN the_DT central_JJ nervous_JJ system_NN of_IN the_DT babies_NNS ._. The_DT key_JJ word_NN here_RB is_VBZ “_`` or_CC ._. ”_'' The_DT researchers_NNS do_VBP n’t_RB know_VB how_WRB many_JJ of_IN the_DT 404_CD babies_NNS have_VBP microcephaly_NN ._. At_IN the_DT very_JJ most_JJS ,_, it_PRP would_MD be_VB 404_CD ._. 404_CD cases_NNS of_IN microcephaly_NN in_IN the_DT whole_JJ country_NN of_IN Brazil_NNP ,_, so_RB far_RB ._. That_DT is_VBZ not_RB an_DT epidemic_NN ._. For_IN example_NN ,_, every_DT year_NN in_IN the_DT US_NNP ,_, there_EX are_VBP 25,000_CD cases_NNS of_IN microcephaly_NN ._. And_CC the_DT literature_NN is_VBZ very_RB clear_JJ about_IN causes_NNS :_: any_DT insult_NN to_IN the_DT fetal_JJ brain_NN during_IN pregnancy_NN can_MD result_VB in_IN microcephaly_NN ._. Severe_JJ malnutrition_NN ,_, falling_VBG down_RP stairs_NNS ,_, a_DT blow_NN to_IN the_DT stomach_NN ,_, a_DT toxic_JJ street_NN drug_NN or_CC medical_JJ drug_NN or_CC vaccine_NN or_CC pesticide_NN ,_, and_CC so_RB on_RB ._. Of_IN these_DT 404_CD cases_NNS of_IN (_-LRB- possible_JJ )_-RRB- microcephaly_NN in_IN Brazil_NNP ,_, 17_CD babies_NNS have_VBP been_VBN found_VBN who_WP “_`` have_VBP a_DT relationship_NN with_IN the_DT Zika_NNP virus_NN ._. ”_'' It_PRP ’s_VBZ hard_JJ to_TO be_VB more_RBR vague_JJ ._. But_CC for_IN the_DT sake_NN of_IN argument_NN ,_, let_VB ’s_PRP say_VB that_IN in_IN each_DT of_IN the_DT 17_CD ,_, with_IN a_DT correct_JJ test_NN done_VBN properly_RB ,_, the_DT Zika_NNP virus_NN was_VBD isolated_VBN ._. This_DT finding_NN does_VBZ not_RB even_RB remotely_RB approach_VB proof_NN that_IN Zika_NNP is_VBZ causing_VBG microcephaly_NN ._. It_PRP ’s_VBZ miles_NNS away_RB from_IN proof_NN ._. Any_DT honest_JJ researcher_NN will_MD tell_VB you_PRP that_DT ._. If_IN Zika_NNP were_VBD the_DT cause_NN ,_, researchers_NNS should_MD have_VB been_VBN able_JJ to_TO find_VB it_PRP in_IN the_DT overwhelming_JJ majority_NN of_IN the_DT 404_CD babies_NNS ._. 17_CD out_IN of_IN 404_CD is_VBZ ,_, in_IN fact_NN ,_, major_JJ evidence_NN that_IN Zika_NNP is_VBZ not_RB the_DT cause_NN ._. 98_CD %_NN of_IN the_DT 404_CD (_-LRB- possible_JJ )_-RRB- microcephaly_JJ cases_NNS come_VBP from_IN the_DT Northeast_NNP region_NN of_IN Brazil_NNP ._. Before_IN jumping_VBG to_IN any_DT conclusions_NNS ,_, realize_VB that_IN standards_NNS on_IN reporting_VBG such_JJ cases_NNS differ_VBP from_IN region_NN to_IN region_NN ._. Up_IN until_IN now_RB ,_, there_EX was_VBD no_DT national_JJ focus_NN on_IN microcephaly_NN ._. So_RB there_EX may_MD be_VB other_JJ cases_NNS from_IN other_JJ regions_NNS ._. As_IN for_IN the_DT 56_CD cases_NNS in_IN Pernambuco_NNP ,_, understand_VB that_IN the_DT population_NN of_IN this_DT area_NN is_VBZ 9.27_CD million_CD people_NNS ._. It_PRP is_VBZ significant_JJ to_TO note_VB that_IN commercial_JJ agriculture_NN is_VBZ widespread_JJ in_IN Pernambuco_NNP ,_, and_CC agriculture_NN means_VBZ toxic_JJ pesticides_NNS —_: an_DT important_JJ causal_JJ factor_NN in_IN microcephaly_NN ,_, as_IN I_PRP ’ve_VBP detailed_VBN in_IN other_JJ articles_NNS ._. To_TO sum_VB up_RP ,_, researchers_NNS so_RB far_RB have_VBP found_VBN 404_CD cases_NNS of_IN microcephaly_NN in_IN Brazil_NNP ,_, and_CC who_WP knows_VBZ how_WRB many_JJ of_IN those_DT are_VBP actually_RB some_DT other_JJ kind_NN of_IN nervous_JJ -_HYPH system_NN impairment_NN ._. And_CC of_IN those_DT 404_CD babies_NNS ,_, they_PRP have_VBP found_VBN ,_, at_IN best_JJS ,_, 17_CD cases_NNS where_WRB the_DT Zika_NNP virus_NN was_VBD present_JJ ._. And_CC this_DT is_VBZ the_DT epidemic_NN that_WDT is_VBZ shaking_VBG the_DT world_NN ._. The_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- is_VBZ spearheading_VBG the_DT baseless_JJ propaganda_NN and_CC the_DT hysteria_NN ._. At_IN the_DT very_JJ least_JJS ,_, hundreds_NNS of_IN employees_NNS from_IN WHO_NNP should_MD be_VB immediately_RB fired_VBN from_IN their_PRP$ jobs_NNS ,_, if_IN not_RB jailed_VBN ._. You_PRP can_MD find_VB this_DT article_NN and_CC more_JJR at_IN NoMoreFakeNews.com_NNP ._. Here_RB ’s_VBZ the_DT kicker_NN :_: If_IN the_DT Ebola_NNP virus_NN is_VBZ owned_VBN by_IN the_DT Center_NNP for_IN Disease_NNP Control_NNP ,_, the_DT Zika_NNP virus_NN patent_NN is_VBZ owned_VBN by_IN …_. http://www.atcc.org/products/all/VR-84.aspx#history_ADD …_: the_DT Rockefeller_NNP Foundation_NNP !_. You_PRP can_MD actually_RB participate_VB in_IN the_DT global_JJ efforts_NNS to_TO cripple_VB the_DT Deep_NNP State_NNP organized_VBN criminal_JJ cabal_NN 's_POS ability_NN for_IN genocide_NN ,_, while_IN enjoying_VBG healthcare_NN freedom_NN at_IN the_DT same_JJ time_NN ,_, by_IN boycotting_VBG Big_NNP Pharma_NNP for_IN good_NN ._.","Every JJ NN that the JJS NNP NNP NNP on the NN VBZ VBG upon the JJ NN VBZ VBN with JJ NNS , FW JJ , NN , JJ , JJ NNS , FW . The NNP NN “ NN ” VBZ RB another one of them and it VBZ NN to VB the JJR NN . The NNP NNP who VBZ the JJ NN , NNS , NNS and JJ NNS VBP RB VBG a “ NN ” in the NN VBN by JJ NNS to the JJ NN , FW when the JJ NNS VBD JJ of the NN to VB them , RB , in the NN . In JJ , the NN NN for NNP VBZ the NNP NN which VBD VBN to VB JJ NN from the NN of the NNP , while the NN NN for JJ NN NNS VBD the NNP NN VBN at VBG RB the NNP NN , as RB VBN by NNP & NNP NNP , NNP NNP . You VBP to VB this NN NN in JJ in NN to VB the JJ NN VBG VBN against NN , and who RB VBP behind the NN . The JJ NNS about the JJ “ NN on NN , ” NNS , NNS , NNS and NNP VBD them VB they and their NNS VBP RB NNS of the NN to VB the JJ NN through NN NN with NNP while the NNPS VBP to their NNS RB . When this NN VBD VBN , the JJ NN the NNP NNP VBD VBZ to VB up those NNP NNP NNP NNPS [ NNP ] , JJR than a thousand of them , so that the JJ JJ NN would at JJS VB on the JJ NN . This VBZ some of the JJ NNS around the NN . RB VBZ a NN NN as VBN NN on JJ JJ NN - NN : RB , they could RB VB a JJ NN with NN . This JJ NN , out of JJ over the JJ four NNS , VBD the NNP - NNP JJ NN JJ . RB VBZ the NN that they VBP RB VBG to VB your NN from RBR VBG NNS of the NN , FW : • NNP VBG in NNP NNP , a NN NN that RB VBD the NN and NN of any NNP , the RBS JJ of which VBZ the NN which VBZ any JJ NN to VB your NN , and you as NN , for VBN JJ NNS ; • The JJ NN towards NNP NNP to RB VB your NN to VB to the NNS , on NN of the JJ NN NN - NNS where your NN NN VBZ RB VBG JJ NN [ VB NNP NN NN NNS ? ] and you cannot VB any JJ NN from your JJ NN NN any VBN NN ; • The JJ NNP NNP ’s NN in NNP and the NN of the NNP NNP , and NNP ; • The NNP JJ NN that VBZ VBG from the JJ NN by the NNP to VB RB with the NN . The NNP VBZ RB VBG their JJ JJ NN NN , NNP NN , NN NN , and VBZ VBG a JJ NN from NN through JJ NN - NN JJ NNS . One cannot RB VB the NN of NN on the NN of the NNP NN VBG their RB VBN NNP NNP . This VBZ the NN why , in NN to VB them RB in NN , they VBP to VB on VBG the JJ NNS they VBP VBN against their JJ NNS in the NN , FW NNP , NNS , JJ NN and NN JJ NN . • NNP VBG NN to VB NNP NNP ; NNP VBG NNP - VBN NNS RB • Who would RB VB from a NNP NNP ? Unless the NNS in the NNP VBZ to the NN and VBP this JJ NN to VB the NN of the NNP and the NNP NNP , there will VB a VBN NN VBN by two JJ NNS , RB . NNP NN JJ NN and the NNP NN - VBN NN of NNS . The NN of this NN VBZ the JJ VBG NNP - VBN NNP NNP NNP , a JJ NN of the JJ NN of JJ NNS around the NN , VBN by the NN of the NN NN as NN . • The VBG JJ NN that JJ JJ VBP You can VB this VBG NN from our NNP NNP NN . The NNP VBD NN to VB all NN NNS of NN will VB . NNP VBZ the NN in NNP and it VBZ no NN that it VBZ a JJ NN for another JJ NN JJ NN , to VB its NN of the NNPS , as they VBP VBN in NNP NNP NNPS RB , and to VB JJ JJ NNS VBN RB . by NNP NNP NNP 5 , 2016 https://www.corbettreport.com/?powerpress ( NN : all NN NNS for this NN can VB VBN at the NN NN , RB . ) I can RB VB the JJS NN on what NNS in NNP VBP VBG , as they VBP into their JJ NNS about the NNP NN and NNS of NN ( NNS VBN with JJ NNS and NN NN ) . A NN VBZ VBN a NN of an NN that VBD in one of the JJ NNP NNP NNS , NNP NNP NNP NNP NNP , on NNP NN , : It VBZ JJ that no JJ NN between NN and the NNP NN VBZ VBN VBN . It VBZ RB RB JJ . RB RB , RB , there VBZ RB no NN to VB an NN of NNP . VBG RB VBZ RB JJ , by any JJ NN . RB VBP the JJ NNS in the NN ( after which I ’ll VB ) : • As of NNP 30 , 2015 , 4,783 VBN NNS of NN VBD VBN in NNP . • Of those , 3,670 VBN NNS of NN , VBG the JJ NN of NNP , VBP VBG VBN . • Of those 3,670 , 404 NNS VBP VBN VBN as NN or “ JJ NNS in the JJ JJ NN ” of NNS . • Of those 404 NNS , 17 “ VBD a NN with NN NN . ” • 98 NN of the 404 JJ NNS VBP from the NNP NN of NNP , and in that NN , NNP VBZ the JJS NN of NNS : 56 . RB , VB ’s VB each one of these VBN NNS and VB it . RB : 4,783 VBN NNS of NN in NNP . “ VBN ” VBZ the JJ NN . This NN VBZ NN , because it VBZ NN about NN . It VBZ RB a JJ NN . 3,670 of these NNS VBP VBG VBN . Of these 3,670 , 404 VBP VBN VBN as JJ or JJ NNS in the JJ JJ NN of the NNS . The JJ NN RB VBZ “ or . ” The NNS VBP RB VB how JJ of the 404 NNS VBP NN . At the JJ JJS , it would VB 404 . 404 NNS of NN in the JJ NN of NNP , RB RB . That VBZ RB an NN . For NN , every NN in the NNP , there VBP 25,000 NNS of NN . And the NN VBZ RB JJ about NNS : any NN to the JJ NN during NN can VB in NN . JJ NN , VBG down NNS , a NN to the NN , a JJ NN NN or JJ NN or NN or NN , and RB RB . Of these 404 NNS of ( JJ ) NN in NNP , 17 NNS VBP VBN VBN who “ VBP a NN with the NNP NN . ” It VBZ JJ to VB RBR JJ . But for the NN of NN , VB ’s VB that in each of the 17 , with a JJ NN VBN RB , the NNP NN VBD VBN . This NN VBZ RB RB RB VB NN that NNP VBZ VBG NN . It VBZ NNS RB from NN . Any JJ NN will VB you that . If NNP VBD the NN , NNS should VB VBN JJ to VB it in the JJ NN of the 404 NNS . 17 out of 404 VBZ , in NN , JJ NN that NNP VBZ RB the NN . 98 NN of the 404 ( JJ ) JJ NNS VBP from the NNP NN of NNP . Before VBG to any NNS , VB that NNS on VBG JJ NNS VBP from NN to NN . Up until RB , there VBD no JJ NN on NN . RB there may VB JJ NNS from JJ NNS . As for the 56 NNS in NNP , VB that the NN of this NN VBZ 9.27 million NNS . It VBZ JJ to VB that JJ NN VBZ JJ in NNP , and NN VBZ JJ NNS — an JJ JJ NN in NN , as I VBP VBN in JJ NNS . To VB up , NNS RB RB VBP VBN 404 NNS of NN in NNP , and who VBZ how JJ of those VBP RB some JJ NN of JJ - NN NN . And of those 404 NNS , they VBP VBN , at JJS , 17 NNS where the NNP NN VBD JJ . And this VBZ the NN that VBZ VBG the NN . The NNP NNP NNP ( NNP ) VBZ VBG the JJ NN and the NN . At the JJ JJS , NNS of NNS from NNP should VB RB VBN from their NNS , if RB VBN . You can VB this NN and JJR at NNP . RB VBZ the NN : If the NNP NN VBZ VBN by the NNP for NNP NNP , the NNP NN NN VBZ VBN by … http://www.atcc.org/products/all/VR-84.aspx#history … the NNP NNP ! You can RB VB in the JJ NNS to VB the NNP NNP VBN JJ NN 's NN for NN , while VBG NN NN at the JJ NN , by VBG NNP NNP for NN ."
200,380,mainstream,"Latest_JJS on_IN global_JJ search_NN for_IN coronavirus_NN vaccine_NN :_: Three_CD candidates_NNS show_VBP early_JJ promise_NN An_DT all_DT -_HYPH out_NN global_JJ race_NN to_TO develop_VB a_DT safe_JJ vaccine_NN against_IN coronavirus_NN is_VBZ underway_JJ ._. The_DT stakes_NNS could_MD n't_RB be_VB higher_JJR :_: an_DT effective_JJ vaccine_NN or_CC treatment_NN against_IN the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD is_VBZ necessary_JJ to_TO fully_RB restart_VB economies_NNS and_CC resume_VB civic_JJ life_NN ._. As_IN the_DT pace_NN accelerates_VBZ ,_, USA_NNP TODAY_NN is_VBZ rounding_VBG up_RP some_DT of_IN the_DT week_NN 's_POS most_RBS notable_JJ vaccine_NN developments_NNS ._. They_PRP include_VBP a_DT massive_JJ contract_NN by_IN the_DT U.S._NNP government_NN to_TO get_VB dibs_NNS on_IN a_DT possible_JJ vaccine_NN that_WDT may_MD or_CC may_MD not_RB work_VB ,_, very_RB early_RB but_CC promising_JJ news_NN on_IN two_CD different_JJ vaccine_NN candidates_NNS ,_, one_CD from_IN China_NNP and_CC one_CD from_IN the_DT United_NNP States_NNPS ,_, and_CC a_DT caution_NN that_WDT sometimes_RB biology_NN can't_MD be_VB sped_VBN up_RP as_RB much_RB as_IN we_PRP might_MD want_VB ._. A_DT vaccine_NN could_MD work_VB ,_, which_WDT we_PRP did_VBD n't_RB know_VB before_RB Given_VBN all_PDT the_DT discussion_NN of_IN a_DT coronavirus_NN vaccine_NN in_IN the_DT news_NN ,_, it_PRP can_MD be_VB difficult_JJ to_TO remember_VB a_DT crucial_JJ fact_NN was_VBD missing_VBG —_: whether_IN people_NNS who_WP have_VBP recovered_VBN from_IN COVID_NNP -_HYPH 19_CD were_VBD immune_JJ to_IN getting_VBG it_PRP again_RB ._. If_IN protective_JJ immunity_NN was_VBD possible_JJ ,_, a_DT vaccine_NN was_VBD also_RB likely_RB possible_JJ ._. Until_IN this_DT week_NN that_DT had_VBD n’t_RB been_VBN established_VBN ,_, even_RB in_IN animals_NNS ._. Now_RB it_PRP has_VBZ been_VBN ._. A_DT study_NN at_IN Beth_NNP Israel_NNP Deaconess_NNP Medical_NNP Center_NNP in_IN Boston_NNP published_VBN in_IN the_DT journal_NNP Science_NNP on_IN Wednesday_NNP found_VBD that_IN nine_CD rhesus_NN macaque_NN monkeys_NNS which_WDT had_VBD recovered_VBN from_IN COVID_NNP -_HYPH 19_CD developed_VBD natural_JJ protective_JJ immunity_NN against_IN re-infection_NN with_IN the_DT virus_NN ._. Not_RB all_DT viruses_NNS generate_VBP natural_JJ protective_JJ immunity_NN ,_, so_RB scientists_NNS had_VBD worried_JJ people_NNS could_MD potentially_RB be_VB infected_VBN over_RB and_CC over_RB again_RB ._. The_DT monkey_NN data_NNS makes_VBZ that_DT seem_VBP less_RBR likely_JJ ._. “_`` Our_PRP$ findings_NNS increase_VBP optimism_NN that_IN the_DT development_NN of_IN COVID_NN -_HYPH 19_CD vaccines_NNS will_MD be_VB possible_JJ ,_, ”_'' said_VBD the_DT study_NN ’s_POS leader_NN ,_, Dr._NNP Dan_NNP Barouch_NNP ,_, a_DT virologist_NN who_WP is_VBZ also_RB a_DT professor_NN of_IN medicine_NN at_IN Harvard_NNP Medical_NNP School_NNP ._. Chinese_JJ researchers_NNS on_IN Friday_NNP published_VBD a_DT study_NN in_IN the_DT British_JJ medical_JJ journal_NN The_DT Lancet_NNP on_IN an_DT early_JJ candidate_NN vaccine_NN tested_VBN on_IN 108_CD healthy_JJ adults_NNS in_IN Wuhan_NNP ,_, China_NNP ._. Within_IN two_CD weeks_NNS of_IN getting_VBG the_DT vaccine_NN ,_, the_DT immune_NN systems_NNS of_IN people_NNS receiving_VBG all_DT three_CD doses_NNS showed_VBD some_DT level_NN of_IN response_NN ,_, with_IN most_RBS developing_VBG a_DT type_NN of_IN antibody_NN that_WDT can_MD attach_VB to_IN the_DT virus_NN ,_, though_IN not_RB necessarily_RB destroy_VB it_PRP ._. Some_DT also_RB developed_VBD so_RB -_HYPH called_VBN neutralizing_VBG antibodies_NNS ,_, which_WDT can_MD kill_VB the_DT virus_NN ._. The_DT vaccine_NN is_VBZ from_IN CanSino_NNP Biologics_NNP in_IN Tianjin_NNP ,_, China_NNP ._. The_DT trial_NN is_VBZ in_IN the_DT early_JJ stages_NNS and_CC it_PRP is_VBZ not_RB yet_RB known_VBN if_IN the_DT possible_JJ vaccine_NN can_MD generate_VB enough_JJ of_IN these_DT neutralizing_VBG antibodies_NNS to_TO protect_VB people_NNS against_IN the_DT virus_NN ._. The_DT candidate_NN vaccine_NN is_VBZ scheduled_VBN to_TO be_VB tested_VBN in_IN Canada_NNP soon_RB ._. The_DT Canadian_NNP Center_NNP for_IN Vaccinology_NNP is_VBZ working_VBG with_IN CanSino_NNP and_CC Canada_NNP ’s_POS National_NNP Research_NNP Council_NNP to_TO coordinate_VB the_DT trial_NN ._. Canadian_NNP Prime_NNP Minister_NNP Justin_NNP Trudeau_NNP made_VBD the_DT announcement_NN during_IN a_DT press_NN briefing_NN ._. CanSino_NNP chairman_NN Xuefeng_NNP Yu_NNP worked_VBD in_IN Canada_NNP from_IN 1996_CD to_IN 2009_CD ._. $_$ 1.2_CD billion_CD for_IN first_JJ dibs_NNS on_IN untried_JJ vaccine_NN On_IN Thursday_NNP the_DT United_NNP States_NNPS has_VBZ pledged_VBN to_TO pay_VB as_RB much_JJ as_IN $_$ 1.2_CD billion_CD to_TO get_VB early_JJ access_NN to_IN 300_CD million_CD doses_NNS of_IN an_DT experimental_JJ COVID_NN -_HYPH 19_CD vaccine_NN being_VBG developed_VBN and_CC tested_VBN in_IN England_NNP by_IN the_DT University_NNP of_IN Oxford_NNP ’s_POS Jenner_NNP Institute_NNP and_CC licensed_VBN to_IN British_JJ drugmaker_NN AstraZeneca_NNP ._. It_PRP is_VBZ expected_VBN to_TO be_VB delivered_VBN as_RB early_RB as_IN October_NNP ,_, though_IN that_DT means_VBZ only_RB that_IN the_DT doses_NNS will_MD be_VB stored_VBN until_IN the_DT vaccine_NN completes_VBZ clinical_JJ trials_NNS ensuring_VBG it_PRP is_VBZ safe_JJ and_CC effective_JJ in_IN protecting_VBG against_IN COVID_NN -_HYPH 19_CD infection_NN ._. If_IN it_PRP is_VBZ n't_RB ,_, they_PRP 'll_MD be_VB destroyed_VBN ._. The_DT vaccine_NN is_VBZ still_RB in_IN very_RB early_JJ clinical_JJ trials_NNS in_IN humans_NNS and_CC is_VBZ being_VBG tested_VBN for_IN safety_NN ,_, whether_IN it_PRP produces_VBZ antibodies_NNS against_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ,_, and_CC whether_IN it_PRP protects_VBZ the_DT immunized_VBN from_IN becoming_VBG infected_VBN with_IN the_DT virus_NN ._. The_DT first_JJ tests_NNS began_VBD in_IN England_NNP on_IN April_NNP 23_CD ._. Last_JJ week_NN Oxford_NNP reported_VBD that_IN a_DT single_JJ dose_NN of_IN the_DT vaccine_NN caused_VBD six_CD rhesus_NN macaque_NN monkeys_NNS to_TO develop_VB antibodies_NNS to_IN coronavirus_NN within_IN 28_CD days_NNS but_CC did_VBD not_RB protect_VB them_PRP from_IN becoming_VBG infected_VBN with_IN COVID_NN -_HYPH 19_CD ._. The_DT vaccine_NN ,_, called_VBN ChAdOx1_NNP ,_, did_VBD prevent_VB them_PRP from_IN developing_VBG pneumonia_NN and_CC lung_NN inflammatory_JJ disease_NN when_WRB the_DT animals_NNS were_VBD exposed_VBN to_IN the_DT virus_NN ._. On_IN Monday_NNP ,_, Moderna_NNP announced_VBD its_PRP$ candidate_NN vaccine_NN appeared_VBD to_TO be_VB safe_JJ when_WRB given_VBN to_IN eight_CD humans_NNS and_CC that_IN it_PRP stimulated_VBD an_DT immune_JJ response_NN to_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD ,_, the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. Experts_NNS called_VBD it_PRP a_DT ""_`` so_RB far_RB ,_, so_RB good_JJ ""_'' finding_NN ._. Participants_NNS in_IN the_DT Phase_NN 1_CD clinical_JJ trial_NN tests_NNS made_VBN neutralizing_VBG antibodies_NNS to_IN the_DT virus_NN ._. When_WRB tested_VBN on_IN human_JJ cells_NNS in_IN the_DT laboratory_NN the_DT antibodies_NNS stopped_VBD the_DT virus_NN from_IN reproducing_VBG ._. After_IN two_CD doses_NNS of_IN the_DT candidate_NN vaccine_NN ,_, participants_NNS '_POS antibody_NN levels_NNS were_VBD about_RB the_DT same_JJ as_IN in_IN people_NNS who_WP have_VBP recovered_VBN from_IN a_DT COVID_NN -_HYPH 19_CD infection_NN ._. There_EX is_VBZ no_DT data_NNS yet_RB on_IN whether_IN the_DT candidate_NN vaccine_NN protects_VBZ against_IN becoming_VBG infected_VBN with_IN SARS_NNP -_HYPH CoV_NN -_HYPH 2_CD ._. Slow_JJ is_VBZ fast_JJ when_WRB it_PRP comes_VBZ to_IN vaccines_NNS An_DT editorial_NN in_IN the_DT respected_VBN journal_NN Science_NNP cautioned_VBD against_IN effort_NN to_TO speed_VB up_RP testing_NN of_IN potential_JJ SARS_NN -_HYPH CoV_NN -_HYPH 2_CD vaccines_NNS ._. SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD is_VBZ the_DT virus_NN that_WDT causes_VBZ COVID_NN -_HYPH 19_CD ._. While_IN many_JJ advocates_NNS have_VBP suggested_VBN fast_RB -_HYPH tracking_NN vaccine_NN trials_NNS in_IN humans_NNS ,_, deputy_NN editor_NN Douglas_NNP Green_NNP says_VBZ while_IN clinical_JJ trials_NNS ,_, especially_RB the_DT large_JJ -_HYPH scale_NN Phase_NN III_CD portion_NN ,_, are_VBP time_NN consuming_VBG ,_, they_PRP are_VBP vital_JJ to_IN ensuring_VBG a_DT vaccine_NN is_VBZ safe_JJ and_CC effective_JJ ._. All_PDT the_DT vaccine_NN candidates_NNS that_WDT have_VBP been_VBN in_IN the_DT news_NN so_RB far_RB are_VBP in_IN Phase_NN 1_CD and_CC Phase_NN 2_CD ,_, meant_VBN to_TO test_VB that_IN the_DT vaccine_NN itself_PRP does_VBZ n't_RB cause_VB reactions_NNS and_CC that_IN it_PRP causes_VBZ the_DT body_NN to_TO mount_VB an_DT immune_JJ response_NN ._. Moving_VBG too_RB fast_RB on_IN Phase_NNP 3_CD could_MD be_VB ""_`` catastrophic_JJ ,_, ""_'' Green_NNP wrote_VBD ._. There_EX are_VBP examples_NNS of_IN preliminary_JJ vaccines_NNS that_WDT produced_VBD neutralizing_VBG antibodies_NNS but_CC when_WRB large_JJ trials_NNS were_VBD conducted_VBN they_PRP made_VBD infections_NNS worse_JJR ._. That_DT happened_VBD in_IN a_DT 1966_CD trial_NN of_IN a_DT vaccine_NN against_IN Respiratory_NNP Syncytial_NNP Virus_NNP ,_, RVS_NNP ._. Subjects_NNS who_WP got_VBD the_DT vaccine_NN actually_RB did_VBD worse_JJR when_WRB infected_VBN with_IN the_DT virus_NN ._. Green_NN cautions_VBZ that_IN many_JJ scientists_NNS believe_VBP proper_JJ testing_NN will_MD mean_VB an_DT effective_JJ vaccine_NN wo_MD n't_RB be_VB widely_RB available_JJ for_IN 12_CD to_IN 18_CD months_NNS ._. He_PRP quoted_VBD cancer_NN biologist_NN Charles_NNP Sherr_NNP ,_, who_WP told_VBD him_PRP ,_, “_`` Fast_JJ is_VBZ slow_JJ ,_, and_CC slow_JJ is_VBZ fast_JJ ._. ”_''","JJS on JJ NN for NN NN : Three NNS VBP JJ NN An all - NN JJ NN to VB a JJ NN against NN VBZ JJ . The NNS could RB VB JJR : an JJ NN or NN against the NN that VBZ NN - 19 VBZ JJ to RB VB NNS and VB JJ NN . As the NN VBZ , NNP NN VBZ VBG up some of the NN 's RBS JJ NN NNS . They VBP a JJ NN by the NNP NN to VB NNS on a JJ NN that may or may RB VB , RB RB but JJ NN on two JJ NN NNS , one from NNP and one from the NNP NNPS , and a NN that RB NN can't VB VBN up RB RB as we might VB . A NN could VB , which we VBD RB VB RB VBN all the NN of a NN NN in the NN , it can VB JJ to VB a JJ NN VBD VBG — whether NNS who VBP VBN from NNP - 19 VBD JJ to VBG it RB . If JJ NN VBD JJ , a NN VBD RB RB JJ . Until this NN that VBD RB VBN VBN , RB in NNS . RB it VBZ VBN . A NN at NNP NNP NNP NNP NNP in NNP VBN in the NNP NNP on NNP VBD that nine NN NN NNS which VBD VBN from NNP - 19 VBD JJ JJ NN against NN with the NN . RB all NNS VBP JJ JJ NN , RB NNS VBD JJ NNS could RB VB VBN RB and RB RB . The NN NNS VBZ that VBP RBR JJ . “ Our NNS VBP NN that the NN of NN - 19 NNS will VB JJ , ” VBD the NN ’s NN , NNP NNP NNP , a NN who VBZ RB a NN of NN at NNP NNP NNP . JJ NNS on NNP VBD a NN in the JJ JJ NN The NNP on an JJ NN NN VBN on 108 JJ NNS in NNP , NNP . Within two NNS of VBG the NN , the NN NNS of NNS VBG all three NNS VBD some NN of NN , with RBS VBG a NN of NN that can VB to the NN , though RB RB VB it . Some RB VBD RB - VBN VBG NNS , which can VB the NN . The NN VBZ from NNP NNP in NNP , NNP . The NN VBZ in the JJ NNS and it VBZ RB RB VBN if the JJ NN can VB JJ of these VBG NNS to VB NNS against the NN . The NN NN VBZ VBN to VB VBN in NNP RB . The NNP NNP for NNP VBZ VBG with NNP and NNP ’s NNP NNP NNP to VB the NN . NNP NNP NNP NNP NNP VBD the NN during a NN NN . NNP NN NNP NNP VBD in NNP from 1996 to 2009 . $ 1.2 billion for JJ NNS on JJ NN On NNP the NNP NNPS VBZ VBN to VB RB JJ as $ 1.2 billion to VB JJ NN to 300 million NNS of an JJ NN - 19 NN VBG VBN and VBN in NNP by the NNP of NNP ’s NNP NNP and VBN to JJ NN NNP . It VBZ VBN to VB VBN RB RB as NNP , though that VBZ RB that the NNS will VB VBN until the NN VBZ JJ NNS VBG it VBZ JJ and JJ in VBG against NN - 19 NN . If it VBZ RB , they 'll VB VBN . The NN VBZ RB in RB JJ JJ NNS in NNS and VBZ VBG VBN for NN , whether it VBZ NNS against NNP - NNP - 2 , the NN that VBZ NN - 19 , and whether it VBZ the VBN from VBG VBN with the NN . The JJ NNS VBD in NNP on NNP 23 . JJ NN NNP VBD that a JJ NN of the NN VBD six NN NN NNS to VB NNS to NN within 28 NNS but VBD RB VB them from VBG VBN with NN - 19 . The NN , VBN NNP , VBD VB them from VBG NN and NN JJ NN when the NNS VBD VBN to the NN . On NNP , NNP VBD its NN NN VBD to VB JJ when VBN to eight NNS and that it VBD an JJ NN to NNP - NN - 2 , the NN that VBZ NN - 19 . NNS VBD it a "" RB RB , RB JJ "" NN . NNS in the NN 1 JJ NN NNS VBN VBG NNS to the NN . When VBN on JJ NNS in the NN the NNS VBD the NN from VBG . After two NNS of the NN NN , NNS ' NN NNS VBD RB the JJ as in NNS who VBP VBN from a NN - 19 NN . There VBZ no NNS RB on whether the NN NN VBZ against VBG VBN with NNP - NN - 2 . JJ VBZ JJ when it VBZ to NNS An NN in the VBN NN NNP VBD against NN to VB up NN of JJ NN - NN - 2 NNS . NNP - NNP - 2 VBZ the NN that VBZ NN - 19 . While JJ NNS VBP VBN RB - NN NN NNS in NNS , NN NN NNP NNP VBZ while JJ NNS , RB the JJ - NN NN III NN , VBP NN VBG , they VBP JJ to VBG a NN VBZ JJ and JJ . All the NN NNS that VBP VBN in the NN RB RB VBP in NN 1 and NN 2 , VBN to VB that the NN itself VBZ RB VB NNS and that it VBZ the NN to VB an JJ NN . VBG RB RB on NNP 3 could VB "" JJ , "" NNP VBD . There VBP NNS of JJ NNS that VBD VBG NNS but when JJ NNS VBD VBN they VBD NNS JJR . That VBD in a 1966 NN of a NN against NNP NNP NNP , NNP . NNS who VBD the NN RB VBD JJR when VBN with the NN . NN VBZ that JJ NNS VBP JJ NN will VB an JJ NN wo RB VB RB JJ for 12 to 18 NNS . He VBD NN NN NNP NNP , who VBD him , “ JJ VBZ JJ , and JJ VBZ JJ . ”"
201,1293,mainstream,"TOKYO_NNP (_-LRB- Reuters_NNP )_-RRB- -_: A_DT decision_NN by_IN Japan_NNP to_TO stop_VB recommending_VBG adolescent_JJ girls_NNS receive_VBP a_DT HPV_NN vaccination_NN will_MD likely_RB result_VB in_IN almost_RB 11,000_CD deaths_NNS from_IN cervical_JJ cancer_NN if_IN it_PRP is_VBZ not_RB reversed_VBN ,_, according_VBG to_IN a_DT study_NN in_IN a_DT prestigious_JJ medical_JJ journal_NN ._. The_DT HPV_NN vaccine_NN has_VBZ been_VBN a_DT political_JJ lightening_NN rod_NN in_IN Japan_NNP ,_, where_WRB claims_NNS of_IN side_NN effects_NNS prompted_VBD the_DT government_NN to_TO halt_VB active_JJ recommendation_NN of_IN the_DT shots_NNS in_IN June_NNP 2013_CD ._. A_DT study_NN published_VBN in_IN The_DT Lancet_NNP Public_NNP Health_NNP on_IN Monday_NNP said_VBD that_IN policy_NN would_MD lead_VB to_IN more_JJR than_IN 24,600_CD cervical_JJ cancer_NN cases_NNS that_WDT could_MD have_VB been_VBN prevented_VBN ._. Using_VBG Japanese_JJ population_NN and_CC medical_JJ data_NNS and_CC forecasted_VBN cervical_JJ cancer_NN incidence_NN ,_, the_DT study_NN found_VBD that_IN ,_, if_IN nothing_NN changes_VBZ ,_, there_EX would_MD be_VB 10,800_CD preventable_JJ deaths_NNS from_IN cervical_JJ cancer_NN over_IN the_DT next_JJ 50_CD years_NNS ._. “_`` If_IN the_DT government_NN were_VBD to_TO resume_VB promoting_VBG the_DT HPV_NN vaccine_NN in_IN Japan_NNP ,_, our_PRP$ study_NN shows_VBZ that_IN we_PRP could_MD avoid_VB most_JJS of_IN this_DT loss_NN of_IN life_NN ,_, ”_'' said_VBD study_NN co-author_NN Sharon_NNP Hanley_NNP ,_, a_DT professor_NN at_IN Hokkaido_NNP University_NNP in_IN northern_JJ Japan_NNP ._. The_DT Japanese_JJ government_NN could_MD not_RB immediately_RB be_VB reached_VBN for_IN comment_NN on_IN the_DT Lancet_NNP report_NN ._. Kei_NNP Tamura_NNP ,_, deputy_NN director_NN of_IN the_DT Health_NNP Ministry_NNP ’s_POS immunization_NN office_NN ,_, said_VBD in_IN an_DT interview_NN in_IN December_NNP that_IN “_`` there_EX is_VBZ a_DT sort_NN of_IN inner_JJ conflict_NN in_IN that_IN we_PRP are_VBP not_RB aggressively_RB ,_, proactively_RB recommending_VBG it_PRP ,_, but_CC I_PRP do_VBP think_VB it_PRP ’s_VBZ better_JJR to_TO take_VB it_PRP ._. ”_'' HPV_NNP ,_, which_WDT stands_VBZ for_IN the_DT human_JJ papilloma_NN virus_NN ,_, causes_VBZ genital_JJ warts_NNS in_IN both_CC sexes_NNS and_CC cervical_JJ cancer_NN in_IN women_NNS ._. Each_DT year_NN ,_, about_RB 10,000_CD Japanese_JJ women_NNS are_VBP newly_RB diagnosed_VBN with_IN the_DT cancer_NN while_IN 3,000_CD die_VBP from_IN it_PRP ._. Uptake_NN was_VBD swift_JJ when_WRB the_DT vaccine_NN was_VBD introduced_VBN in_IN Japan_NNP in_IN 2009_CD ,_, with_IN immunization_NN reaching_VBG about_RB 70_CD %_NN in_IN adolescent_JJ girls_NNS ._. However_RB ,_, the_DT vaccination_NN rate_NN has_VBZ since_RB slid_VBN to_IN below_IN 1_CD %_NN after_IN the_DT health_NN ministry_NN suspended_VBD its_PRP$ active_JJ recommendation_NN after_IN reports_NNS of_IN side_NN effects_NNS including_VBG muscle_NN pain_NN ,_, sleep_NN disorders_NNS ,_, and_CC light_NN and_CC sound_NN sensitivity_NN ._. Females_NNS aged_JJ 12_CD -_SYM 16_CD can_MD still_RB get_VB free_JJ HPV_NN vaccines_NNS under_IN Japan_NNP ’s_POS national_JJ healthcare_NN system_NN if_IN they_PRP ask_VBP for_IN it_PRP ._. Everyone_NN else_JJ must_MD pay_VB out_IN of_IN pocket_NN ._. In_IN November_NNP ,_, ruling_NN party_NN legislator_NN Junko_NNP Mihara_NNP ,_, a_DT cervical_JJ cancer_NN survivor_NN ,_, said_VBD lawmakers_NNS would_MD hold_VB talks_NNS on_IN the_DT vaccine_NN this_DT summer_NN ._. Tokyo_NNP Governor_NNP Yuriko_NNP Koike_NNP and_CC eight_CD other_JJ regional_JJ leaders_NNS signed_VBD a_DT letter_NN supporting_VBG HPV_NN vaccination_NN ._. The_DT Health_NNP Ministry_NNP said_VBD in_IN December_NNP it_PRP was_VBD working_VBG on_IN improving_VBG leaflets_NNS on_IN the_DT vaccine_NN ,_, but_CC had_VBD no_DT time_NN table_NN for_IN a_DT return_NN to_IN regular_JJ immunization_NN ._.","NNP ( NNP ) - A NN by NNP to VB VBG JJ NNS VBP a NN NN will RB VB in RB 11,000 NNS from JJ NN if it VBZ RB VBN , VBG to a NN in a JJ JJ NN . The NN NN VBZ VBN a JJ NN NN in NNP , where NNS of NN NNS VBD the NN to VB JJ NN of the NNS in NNP 2013 . A NN VBN in The NNP NNP NNP on NNP VBD that NN would VB to JJR than 24,600 JJ NN NNS that could VB VBN VBN . VBG JJ NN and JJ NNS and VBN JJ NN NN , the NN VBD that , if NN VBZ , there would VB 10,800 JJ NNS from JJ NN over the JJ 50 NNS . “ If the NN VBD to VB VBG the NN NN in NNP , our NN VBZ that we could VB JJS of this NN of NN , ” VBD NN NN NNP NNP , a NN at NNP NNP in JJ NNP . The JJ NN could RB RB VB VBN for NN on the NNP NN . NNP NNP , NN NN of the NNP NNP ’s NN NN , VBD in an NN in NNP that “ there VBZ a NN of JJ NN in that we VBP RB RB , RB VBG it , but I VBP VB it VBZ JJR to VB it . ” NNP , which VBZ for the JJ NN NN , VBZ JJ NNS in both NNS and JJ NN in NNS . Each NN , RB 10,000 JJ NNS VBP RB VBN with the NN while 3,000 VBP from it . NN VBD JJ when the NN VBD VBN in NNP in 2009 , with NN VBG RB 70 NN in JJ NNS . RB , the NN NN VBZ RB VBN to below 1 NN after the NN NN VBD its JJ NN after NNS of NN NNS VBG NN NN , NN NNS , and NN and NN NN . NNS JJ 12 - 16 can RB VB JJ NN NNS under NNP ’s JJ NN NN if they VBP for it . NN JJ must VB out of NN . In NNP , NN NN NN NNP NNP , a JJ NN NN , VBD NNS would VB NNS on the NN this NN . NNP NNP NNP NNP and eight JJ JJ NNS VBD a NN VBG NN NN . The NNP NNP VBD in NNP it VBD VBG on VBG NNS on the NN , but VBD no NN NN for a NN to JJ NN ."
202,192,mainstream,"The_DT measure_NN ,_, which_WDT defines_VBZ a_DT public_JJ place_NN as_IN anywhere_RB ""_`` more_JJR than_IN 10_CD persons_NNS are_VBP intended_VBN to_TO congregate_VB ""_'' —_: including_VBG public_JJ transport_NN —_: was_VBD announced_VBN by_IN officials_NNS in_IN Rockland_NNP County_NNP ,_, 25_CD miles_NNS (_-LRB- 40_CD kilometers_NNS )_-RRB- north_RB of_IN New_NNP York_NNP City_NNP ._. Due_IN to_TO come_VB into_IN effect_NN at_IN midnight_NN on_IN Wednesday_NNP and_CC last_JJ for_IN 30_CD days_NNS ,_, it_PRP appears_VBZ to_TO be_VB the_DT most_RBS radical_JJ step_NN by_IN US_NNP officials_NNS following_VBG outbreaks_NNS in_IN several_JJ regions_NNS blamed_VBN on_IN the_DT anti-vaccination_NN movement_NN ._. ""_`` We_PRP must_MD do_VB everything_NN in_IN our_PRP$ power_NN to_TO end_VB this_DT outbreak_NN and_CC protect_VB the_DT health_NN of_IN those_DT who_WP cannot_MD be_VB vaccinated_VBN for_IN medical_JJ reasons_NNS and_CC that_DT of_IN children_NNS too_RB young_JJ to_TO be_VB vaccinated_VBN ,_, ""_'' said_VBD county_NN executive_NN Ed_NNP Day_NNP ._. He_PRP also_RB criticized_VBD the_DT ""_`` resistance_NN ""_'' to_IN health_NN inspectors_NNS by_IN some_DT locals_NNS ._. Rockland_NNP County_NNP ,_, with_IN a_DT population_NN of_IN over_RB 300,000_CD ,_, has_VBZ registered_VBN 153_CD cases_NNS of_IN measles_NNS ,_, which_WDT had_VBD been_VBN declared_VBN officially_RB eliminated_VBN in_IN 2000_CD ._. Despite_IN major_JJ vaccination_NN campaigns_NNS since_IN the_DT outbreak_NN began_VBD in_IN October_NNP ,_, around_RB 27_CD percent_NN of_IN minors_NNS aged_VBN one_CD to_IN 18_CD remain_VBP unvaccinated_JJ ,_, Day_NNP said_VBD ._. The_DT worst_RBS affected_VBN neighborhoods_NNS are_VBP those_DT with_IN a_DT high_JJ ultra-Orthodox_JJ Jewish_JJ population_NN ,_, where_WRB many_JJ oppose_VBP vaccines_NNS on_IN religious_JJ grounds_NNS ._. Vaccinations_NNS are_VBP in_IN theory_NN required_VBN to_TO go_VB to_IN school_NN in_IN the_DT United_NNP States_NNPS ,_, but_CC 47_CD of_IN the_DT 50_CD states_NNS —_: including_VBG New_NNP York_NNP —_: allow_VB exemptions_NNS ,_, notably_RB for_IN religious_JJ reasons_NNS ._. At_IN the_DT beginning_NN of_IN March_NNP ,_, the_DT UN_NNP Children_NNP 's_POS Fund_NNP UNICEF_NNP sounded_VBD the_DT alarm_NN because_IN of_IN the_DT rapidly_RB increasing_VBG number_NN of_IN measles_NNS cases_NNS in_IN some_DT regions_NNS of_IN the_DT world_NN ._. Worldwide_RB ,_, 98_CD countries_NNS recorded_VBD more_JJR cases_NNS in_IN 2018_CD than_IN in_IN the_DT previous_JJ year_NN ._. Reports_NNS also_RB came_VBD from_IN countries_NNS that_WDT had_VBD previously_RB been_VBN measles_NNS -_HYPH free_JJ ,_, including_VBG Brazil_NNP ,_, where_WRB more_JJR than_IN 10,000_CD people_NNS were_VBD infected_VBN with_IN measles_NNS last_JJ year_NN ._. In_IN the_DT Philippines_NNPS ,_, around_RB 13,000_CD people_NNS have_VBP contracted_VBN measles_NNS and_CC more_JJR than_IN 76,000_CD have_VBP in_IN Madagascar_NNP since_IN last_JJ September_NNP ._. The_DT situation_NN is_VBZ also_RB particularly_RB dramatic_JJ in_IN Ukraine_NNP ,_, where_WRB 24,000_CD people_NNS have_VBP been_VBN infected_VBN with_IN the_DT dangerous_JJ virus_NN in_IN the_DT first_JJ weeks_NNS of_IN this_DT year_NN alone_RB ._. Will_MD vaccination_NN become_VB compulsory_JJ …_: in_IN Germany_NNP ?_. According_VBG to_IN the_DT Robert_NNP Koch_NNP Institute_NNP (_-LRB- RKI_NNP )_-RRB- ,_, the_DT number_NN of_IN reported_VBN cases_NNS in_IN Germany_NNP fell_VBD from_IN 929_CD in_IN 2017_CD to_IN 543_CD last_JJ year_NN ._. Nevertheless_RB ,_, Germany_NNP is_VBZ still_RB debating_VBG controversially_RB requiring_VBG measles_NNS vaccinations_NNS ,_, originally_RB demanded_VBN in_IN March_NNP by_IN the_DT SPD_NNP health_NN expert_NN Karl_NNP Lauterbach_NNP ._. Most_RBS recently_RB ,_, Health_NNP Minister_NNP Jens_NNP Spahn_NNP (_-LRB- CDU_NNP )_-RRB- advocated_VBD for_IN compulsory_JJ measles_NNS vaccinations_NNS for_IN school_NN -_HYPH aged_JJ children_NNS ._. But_CC even_RB their_PRP$ own_JJ parties_NNS had_VBD reservations_NNS about_IN the_DT proposals_NNS ._. Karin_NNP Maag_NNP (_-LRB- CDU_NNP )_-RRB- ,_, spokeswoman_NN for_IN health_NN policy_NN for_IN the_DT CDU_NNP /_, CSU_NNP parliamentary_JJ group_NN in_IN the_DT Bundestag_NNP ,_, rejected_VBD compulsory_JJ vaccination_NN ,_, partly_RB because_IN there_EX is_VBZ a_DT lack_NN of_IN knowledge_NN about_IN the_DT advantages_NNS of_IN compulsory_JJ vaccinations_NNS as_IN introduced_VBN in_IN Italy_NNP and_CC France_NNP ._. The_DT Robert_NNP Koch_NNP Institute_NNP has_VBZ also_RB been_VBN cautious_JJ ._. In_IN Germany_NNP ,_, for_IN example_NN ,_, there_EX was_VBD no_DT noticeable_JJ increase_NN in_IN infections_NNS ._. Nevertheless_RB ,_, the_DT vaccination_NN rate_NN could_MD always_RB be_VB improved_VBN ,_, especially_RB among_IN young_JJ adults_NNS ._. Until_IN the_DT beginning_NN of_IN the_DT 1990s_NNS ,_, each_DT person_NN only_RB received_VBD one_CD vaccination_NN against_IN measles_NNS ._. It_PRP was_VBD difficult_JJ adopt_VB the_DT practice_NN of_IN getting_VBG a_DT second_JJ vaccination_NN ,_, especially_RB for_IN those_DT vaccinated_VBN prior_JJ to_IN the_DT 1990s_NNS ._. In_IN contrast_NN ,_, 97_CD %_NN of_IN school_NN children_NNS in_IN Germany_NNP have_VBP the_DT first_JJ measles_NNS vaccination_NN and_CC 93_CD %_NN have_VBP the_DT second_JJ vaccination_NN ._. The_DT second_JJ measles_NNS vaccination_NN ,_, which_WDT should_MD be_VB carried_VBN out_RP by_IN the_DT end_NN of_IN the_DT second_JJ year_NN of_IN life_NN ,_, is_VBZ often_RB carried_VBN out_RP later_RBR ._. According_VBG to_IN the_DT RKI_NNP ,_, only_RB 74_CD %_NN of_IN two_CD -_HYPH year_NN -_HYPH olds_NNS in_IN Germany_NNP have_VBP full_JJ protection_NN ._. The_DT first_JJ telltale_NN sign_NN someone_NN has_VBZ measles_NNS is_VBZ a_DT widespread_JJ itchy_JJ red_JJ rash_NN ._. The_DT spots_NNS are_VBP initially_RB visible_JJ behind_IN the_DT ears_NNS ,_, or_CC on_IN the_DT neck_NN or_CC head_NN ._. Three_CD days_NNS before_IN visible_JJ signs_NNS appear_VBP ,_, the_DT virus_NN has_VBZ peaked_VBN in_IN the_DT body_NN ._. The_DT infected_VBN person_NN is_VBZ contagious_JJ ,_, usually_RB without_IN even_RB knowing_VBG it_PRP ._. For_IN a_DT reliable_JJ diagnosis_NN ,_, patients_NNS suspected_VBN of_IN having_VBG the_DT virus_NN need_VBP to_TO have_VB the_DT antibodies_NNS in_IN their_PRP$ blood_NN tested_VBN ._. The_DT measles_NNS virus_NN is_VBZ transmitted_VBN directly_RB through_IN the_DT air_NN in_IN the_DT form_NN of_IN very_RB fine_JJ droplets_NNS of_IN saliva_NN or_CC mucus_NN —_: usually_RB from_IN coughing_NN or_CC sneezing_NN ._. But_CC they_PRP can_MD also_RB be_VB passed_VBN on_RP simply_RB when_WRB speaking_VBG to_IN someone_NN in_IN close_JJ proximity_NN ._. Measles_NN is_VBZ highly_RB contagious_JJ ._. Each_DT contagious_JJ person_NN infects_VBZ around_RB 15_CD healthy_JJ people_NNS ._. Humans_NNS are_VBP the_DT only_JJ natural_JJ hosts_NNS of_IN the_DT measles_NNS virus_NN ._. Read_VB more_JJR :_: French_JJ boy_NN suspected_VBN of_IN reintroducing_VBG measles_NNS to_IN Costa_NNP Rica_NNP About_RB 14_CD days_NNS after_IN the_DT initial_JJ infection_NN ,_, patients_NNS get_VBP a_DT fever_NN and_CC start_VBP coughing_VBG ._. At_IN that_DT point_NN ,_, the_DT red_JJ rash_NN starts_VBZ to_TO itch_VB ._. To_TO alleviate_VB these_DT symptoms_NNS ,_, doctors_NNS usually_RB administer_VBP medication_NN ._. Patients_NNS may_MD also_RB get_VB a_DT middle_JJ ear_NN infection_NN ,_, pneumonia_NN or_CC have_VB severe_JJ diarrhea_NN ._. In_IN the_DT worst_JJS case_NN ,_, diarrhea_NN can_MD lead_VB to_IN dehydration_NN and_CC ultimately_RB death_NN ._. There_EX is_VBZ no_DT specialized_JJ treatment_NN for_IN measles_NNS ._. The_DT body_NN has_VBZ to_TO fight_VB the_DT infection_NN itself_PRP ._. Measles_NN can_MD cause_VB meningitis_NN ,_, which_WDT can_MD lead_VB to_IN severe_JJ brain_NN damage_NN and_CC mental_JJ disability_NN ._. According_VBG to_IN Germany_NNP 's_POS main_JJ public_JJ health_NN body_NN ,_, the_DT Robert_NNP Koch_NNP Institute_NNP ,_, measles_NNS encephalitis_NN occurs_VBZ in_IN one_CD in_IN every_DT 1,000_CD infections_NNS ._. One_CD in_IN five_CD of_IN these_DT cases_NNS is_VBZ fatal_JJ ._. Such_JJ complications_NNS do_VBP not_RB necessarily_RB occur_VB during_IN the_DT original_JJ bout_NN of_IN the_DT disease_NN ;_, they_PRP can_MD occur_VB years_NNS later_RBR ._. Read_VB more_JJR :_: Top_JJ ten_CD most_RBS dangerous_JJ viruses_NNS in_IN the_DT world_NN Vaccination_NN is_VBZ the_DT best_JJS protection_NN Many_JJ parents_NNS refuse_VBP to_TO vaccinate_VB their_PRP$ children_NNS because_IN they_PRP fear_VBP serious_JJ side_NN effects_NNS ._. Some_DT assume_VBP it_PRP is_VBZ better_JJR for_IN their_PRP$ children_NNS to_TO be_VB infected_VBN with_IN the_DT virus_NN so_IN their_PRP$ bodies_NNS can_MD build_VB up_RP anti-bodies_NNS ._. For_IN a_DT while_NN ,_, measles_NNS parties_NNS were_VBD popular_JJ ._. Parents_NNS would_MD send_VB healthy_JJ children_NNS to_TO play_VB with_IN other_JJ children_NNS who_WP had_VBD the_DT virus_NN in_IN the_DT hope_NN they_PRP too_RB might_MD become_VB infected_VBN ._. Parents_NNS who_WP did_VBD this_DT were_VBD often_RB convinced_VBN that_IN exposure_NN to_IN the_DT virus_NN strengthened_VBD their_PRP$ child_NN 's_POS defenses_NNS if_IN and_CC when_WRB they_PRP got_VBD measles_NNS ._. Read_VB more_JJR :_: Death_NN toll_NN from_IN measles_NNS climbs_VBZ in_IN Philippines_NNPS Experts_NNS ,_, however_RB ,_, are_VBP convinced_VBN this_DT is_VBZ not_RB the_DT case_NN ._. False_JJ claims_NNS and_CC beliefs_NNS contribute_VBP to_IN vaccination_NN fatigue_NN ._. The_DT myth_NN that_IN there_EX is_VBZ a_DT connection_NN between_IN the_DT measles_NN vaccination_NN and_CC autism_NN is_VBZ just_RB that_DT —_: a_DT myth_NN —_: and_CC one_CD doctors_NNS have_VBP debunked_VBN many_JJ times_NNS over_RB ._. The_DT measles_NNS vaccine_NN includes_VBZ two_CD shots_NNS of_IN attenuated_VBN measles_NNS viruses_NNS ._. The_DT Permanent_NNP Vaccination_NNP Commission_NNP (_-LRB- STIKO_NNP )_-RRB- of_IN the_DT Robert_NNP Koch_NNP Institute_NNP recommends_VBZ measles_NNS vaccinations_NNS in_IN combination_NN with_IN inoculations_NNS for_IN mumps_NNS and_CC rubella_NN ._. The_DT vaccinations_NNS should_MD take_VB place_NN just_RB after_IN a_DT child_NN turns_VBZ one_CD ._. Only_RB then_RB can_MD parents_NNS ensure_VB their_PRP$ child_NN is_VBZ protected_VBN from_IN the_DT dangerous_JJ virus_NN ._. The_DT WHO_NNP was_VBD committed_VBN to_IN eradicating_VBG measles_NNS worldwide_RB by_IN 2020_CD ._. The_DT Czech_NNP Republic_NNP ,_, Estonia_NNP ,_, Finland_NNP ,_, Portugal_NNP ,_, Slovakia_NNP and_CC Slovenia_NNP are_VBP the_DT only_JJ countries_NNS to_TO have_VB achieved_VBN this_DT goal_NN so_RB far_RB ._. Read_VB more_JJR :_: WHO_WP :_: Measles_NN infections_NNS surge_VBP in_IN Europe_NNP in_IN 2018_CD","The NN , which VBZ a JJ NN as RB "" JJR than 10 NNS VBP VBN to VB "" — VBG JJ NN — VBD VBN by NNS in NNP NNP , 25 NNS ( 40 NNS ) RB of NNP NNP NNP . Due to VB into NN at NN on NNP and JJ for 30 NNS , it VBZ to VB the RBS JJ NN by NNP NNS VBG NNS in JJ NNS VBN on the NN NN . "" We must VB NN in our NN to VB this NN and VB the NN of those who cannot VB VBN for JJ NNS and that of NNS RB JJ to VB VBN , "" VBD NN NN NNP NNP . He RB VBD the "" NN "" to NN NNS by some NNS . NNP NNP , with a NN of RB 300,000 , VBZ VBN 153 NNS of NNS , which VBD VBN VBN RB VBN in 2000 . Despite JJ NN NNS since the NN VBD in NNP , RB 27 NN of NNS VBN one to 18 VBP JJ , NNP VBD . The RBS VBN NNS VBP those with a JJ JJ JJ NN , where JJ VBP NNS on JJ NNS . NNS VBP in NN VBN to VB to NN in the NNP NNPS , but 47 of the 50 NNS — VBG NNP NNP — VB NNS , RB for JJ NNS . At the NN of NNP , the NNP NNP 's NNP NNP VBD the NN because of the RB VBG NN of NNS NNS in some NNS of the NN . RB , 98 NNS VBD JJR NNS in 2018 than in the JJ NN . NNS RB VBD from NNS that VBD RB VBN NNS - JJ , VBG NNP , where JJR than 10,000 NNS VBD VBN with NNS JJ NN . In the NNPS , RB 13,000 NNS VBP VBN NNS and JJR than 76,000 VBP in NNP since JJ NNP . The NN VBZ RB RB JJ in NNP , where 24,000 NNS VBP VBN VBN with the JJ NN in the JJ NNS of this NN RB . Will NN VB JJ … in NNP ? VBG to the NNP NNP NNP ( NNP ) , the NN of VBN NNS in NNP VBD from 929 in 2017 to 543 JJ NN . RB , NNP VBZ RB VBG RB VBG NNS NNS , RB VBN in NNP by the NNP NN NN NNP NNP . RBS RB , NNP NNP NNP NNP ( NNP ) VBD for JJ NNS NNS for NN - JJ NNS . But RB their JJ NNS VBD NNS about the NNS . NNP NNP ( NNP ) , NN for NN NN for the NNP / NNP JJ NN in the NNP , VBD JJ NN , RB because there VBZ a NN of NN about the NNS of JJ NNS as VBN in NNP and NNP . The NNP NNP NNP VBZ RB VBN JJ . In NNP , for NN , there VBD no JJ NN in NNS . RB , the NN NN could RB VB VBN , RB among JJ NNS . Until the NN of the NNS , each NN RB VBD one NN against NNS . It VBD JJ VB the NN of VBG a JJ NN , RB for those VBN JJ to the NNS . In NN , 97 NN of NN NNS in NNP VBP the JJ NNS NN and 93 NN VBP the JJ NN . The JJ NNS NN , which should VB VBN out by the NN of the JJ NN of NN , VBZ RB VBN out RBR . VBG to the NNP , RB 74 NN of two - NN - NNS in NNP VBP JJ NN . The JJ NN NN NN VBZ NNS VBZ a JJ JJ JJ NN . The NNS VBP RB JJ behind the NNS , or on the NN or NN . Three NNS before JJ NNS VBP , the NN VBZ VBN in the NN . The VBN NN VBZ JJ , RB without RB VBG it . For a JJ NN , NNS VBN of VBG the NN VBP to VB the NNS in their NN VBN . The NNS NN VBZ VBN RB through the NN in the NN of RB JJ NNS of NN or NN — RB from NN or NN . But they can RB VB VBN on RB when VBG to NN in JJ NN . NN VBZ RB JJ . Each JJ NN VBZ RB 15 JJ NNS . NNS VBP the JJ JJ NNS of the NNS NN . VB JJR : JJ NN VBN of VBG NNS to NNP NNP RB 14 NNS after the JJ NN , NNS VBP a NN and VBP VBG . At that NN , the JJ NN VBZ to VB . To VB these NNS , NNS RB VBP NN . NNS may RB VB a JJ NN NN , NN or VB JJ NN . In the JJS NN , NN can VB to NN and RB NN . There VBZ no JJ NN for NNS . The NN VBZ to VB the NN itself . NN can VB NN , which can VB to JJ NN NN and JJ NN . VBG to NNP 's JJ JJ NN NN , the NNP NNP NNP , NNS NN VBZ in one in every 1,000 NNS . One in five of these NNS VBZ JJ . JJ NNS VBP RB RB VB during the JJ NN of the NN ; they can VB NNS RBR . VB JJR : JJ ten RBS JJ NNS in the NN NN VBZ the JJS NN JJ NNS VBP to VB their NNS because they VBP JJ NN NNS . Some VBP it VBZ JJR for their NNS to VB VBN with the NN so their NNS can VB up NNS . For a NN , NNS NNS VBD JJ . NNS would VB JJ NNS to VB with JJ NNS who VBD the NN in the NN they RB might VB VBN . NNS who VBD this VBD RB VBN that NN to the NN VBD their NN 's NNS if and when they VBD NNS . VB JJR : NN NN from NNS VBZ in NNPS NNS , RB , VBP VBN this VBZ RB the NN . JJ NNS and NNS VBP to NN NN . The NN that there VBZ a NN between the NN NN and NN VBZ RB that — a NN — and one NNS VBP VBN JJ NNS RB . The NNS NN VBZ two NNS of VBN NNS NNS . The NNP NNP NNP ( NNP ) of the NNP NNP NNP VBZ NNS NNS in NN with NNS for NNS and NN . The NNS should VB NN RB after a NN VBZ one . RB RB can NNS VB their NN VBZ VBN from the JJ NN . The NNP VBD VBN to VBG NNS RB by 2020 . The NNP NNP , NNP , NNP , NNP , NNP and NNP VBP the JJ NNS to VB VBN this NN RB RB . VB JJR : WHO : NN NNS VBP in NNP in 2018"
203,757,conspiracy,"In_IN four_CD days_NNS this_DT past_JJ week_NN ,_, the_DT market_NN sold_VBD off_RP nearly_RB 4,000_CD points_NNS and_CC wiped_VBD out_RP four_CD months_NNS of_IN gains_NNS ._. Bo_NNP Polny_NNP warned_VBD of_IN a_DT coming_VBG market_NN crash_NN on_IN February_NNP 8_CD on_IN USAWatchdog.com_NNP ._. Polny_NNP was_VBD ridiculed_VBN after_IN the_DT market_NN went_VBD to_IN new_JJ record_NN highs_NNS ,_, but_CC that_DT was_VBD short_JJ lived_VBN ,_, and_CC now_RB Polny_NNP says_VBZ it_PRP ’s_VBZ going_VBG to_TO get_VB worse_JJR ._. The_DT Democrats_NNPS are_VBP facing_VBG a_DT lose_NN /_, lose_NN situation_NN with_IN Bernie_NNP Sanders_NNP ._. If_IN he_PRP wins_VBZ the_DT nomination_NN to_TO represent_VB Democrats_NNPS in_IN November_NNP ,_, many_JJ will_MD turn_VB their_PRP$ backs_NNS on_IN the_DT socialist_NN that_WDT praises_VBZ communism_NN ._. If_IN the_DT Democrats_NNPS stop_VBP him_PRP and_CC cheat_VBP him_PRP again_RB ,_, Bernie_NNP supporters_NNS will_MD flee_VB the_DT party_NN ._. We_PRP are_VBP living_VBG in_IN an_DT age_NN when_WRB lots_NNS of_IN things_NNS are_VBP being_VBG revealed_VBN ._. We_PRP are_VBP finding_VBG out_RP our_PRP$ heroes_NNS are_VBP fake_JJ (_-LRB- Clint_NNP Eastwood_NNP )_-RRB- ,_, right_RB along_IN with_IN our_PRP$ markets_NNS and_CC politicians_NNS ._. Join_VB Greg_NNP Hunter_NNP from_IN USAWatchdog.com_NNP as_IN he_PRP talks_VBZ about_IN these_DT stories_NNS and_CC more_JJR in_IN the_DT Weekly_NNP News_NNP Wrap_NNP -_HYPH Up_NNP ._. Bill_NNP Holter_NNP from_IN JSMineset.com_NNP will_MD be_VB the_DT guest_NN for_IN the_DT Early_JJ Sunday_NNP Release_NNP ._. Do_VB n’t_RB even_RB think_VB that_IN the_DT downturn_NN is_VBZ over_RB —_: it_PRP ’s_VBZ not_RB ._.","In four NNS this JJ NN , the NN VBD off RB 4,000 NNS and VBD out four NNS of NNS . NNP NNP VBD of a VBG NN NN on NNP 8 on NNP . NNP VBD VBN after the NN VBD to JJ NN NNS , but that VBD JJ VBN , and RB NNP VBZ it VBZ VBG to VB JJR . The NNPS VBP VBG a NN / NN NN with NNP NNP . If he VBZ the NN to VB NNPS in NNP , JJ will VB their NNS on the NN that VBZ NN . If the NNPS VBP him and VBP him RB , NNP NNS will VB the NN . We VBP VBG in an NN when NNS of NNS VBP VBG VBN . We VBP VBG out our NNS VBP JJ ( NNP NNP ) , RB along with our NNS and NNS . VB NNP NNP from NNP as he VBZ about these NNS and JJR in the NNP NNP NNP - NNP . NNP NNP from NNP will VB the NN for the JJ NNP NNP . VB RB RB VB that the NN VBZ RB — it VBZ RB ."
204,1229,mainstream,"Imperial_NNP College_NNP has_VBZ promised_VBN that_IN VacEquity_NNP Global_NNP Health_NNP will_MD make_VB its_PRP$ vaccine_NN available_JJ at_IN the_DT lowest_JJS possible_JJ cost_NN in_IN Britain_NNP ,_, as_RB well_RB as_IN in_IN low_JJ -_HYPH and_CC middle_JJ -_HYPH income_NN countries_NNS ._. VacEquity_NNP would_MD work_VB with_IN specialized_VBN drug_NN manufacturers_NNS ,_, in_IN a_DT process_NN similar_JJ to_IN the_DT production_NN and_CC sale_NN of_IN generic_JJ drugs_NNS ._. The_DT new_JJ company_NN may_MD charge_VB higher_JJR prices_NNS in_IN wealthier_JJR countries_NNS such_JJ as_IN the_DT United_NNP States_NNPS ,_, Singapore_NNP ,_, or_CC the_DT Persian_NNP Gulf_NNP monarchies_NNS ._. A_DT clinical_JJ trial_NN involving_VBG 300_CD participants_NNS in_IN Britain_NNP —_: an_DT unusual_JJ combined_VBN phase_NN one_CD and_CC two_CD —_: is_VBZ set_VBN to_TO begin_VB on_IN June_NNP 15_CD ._. If_IN that_DT shows_VBZ the_DT drug_NN to_TO be_VB safe_JJ ,_, Imperial_NNP College_NNP will_MD conduct_VB a_DT 6,000_CD -_HYPH participant_NN phase_NN in_IN October_NNP to_TO test_VB the_DT vaccine_NN ’s_POS effectiveness_NN ._. The_DT location_NN of_IN the_DT later_JJR phase_NN will_MD depend_VB on_IN where_WRB the_DT virus_NN is_VBZ spreading_VBG rapidly_RB at_IN the_DT time_NN ._. The_DT Imperial_NNP College_NNP is_VBZ using_VBG a_DT novel_JJ technology_NN that_WDT has_VBZ never_RB before_RB produced_VBN a_DT licensed_VBN vaccine_NN ._. It_PRP is_VBZ described_VBN as_IN self_NN -_HYPH amplifying_VBG RNA_NNP and_CC was_VBD pioneered_VBN by_IN Professor_NNP Shattock_NNP over_IN decades_NNS of_IN research_NN ._. The_DT vaccine_NN consists_VBZ of_IN specially_RB engineered_VBN genetic_JJ material_NN —_: RNA_NN —_: that_WDT instructs_VBZ muscle_NN cells_NNS in_IN the_DT body_NN to_TO produce_VB a_DT distinctive_JJ “_`` spike_NN ”_'' protein_NN found_VBN on_IN the_DT surface_NN of_IN the_DT coronavirus_NN ._. If_IN the_DT vaccine_NN is_VBZ successful_JJ ,_, those_DT proteins_NNS will_MD trigger_VB an_DT immune_JJ response_NN that_WDT will_MD kill_VB the_DT virus_NN ._. Moderna_NNP ,_, a_DT biotechnology_NN company_NN based_VBN in_IN Cambridge_NNP ,_, Mass._NNP ,_, has_VBZ started_VBN clinical_JJ trials_NNS for_IN a_DT vaccine_NN using_VBG similar_JJ technology_NN ,_, known_VBN as_IN messenger_NN RNA_NN ._. The_DT U.S._NNP government_NN has_VBZ agreed_VBN to_TO provide_VB as_RB much_JJ as_IN $_$ 483_CD million_CD to_IN Moderna_NNP to_TO advance_VB its_PRP$ research_NN ,_, and_CC reports_NNS of_IN positive_JJ results_NNS in_IN the_DT trial_NN ’s_POS early_JJ stages_NNS have_VBP sent_VBN the_DT company_NN ’s_POS stock_NN soaring_VBG ._. Imperial_NNP College_NNP ’s_POS self_NN -_HYPH amplifying_VBG RNA_NN vaccine_NN ,_, Professor_NNP Shattock_NNP said_VBD ,_, would_MD require_VB a_DT much_RB smaller_JJR dose_NN than_IN the_DT Moderna_NNP vaccine_NN —_: 50_CD to_IN 100_CD times_NNS smaller_JJR —_: which_WDT would_MD greatly_RB lower_VB the_DT cost_NN per_IN dose_NN ._. The_DT Imperial_NNP College_NNP vaccine_NN would_MD also_RB require_VB smaller_JJR and_CC less_RBR costly_JJ manufacturing_NN facilities_NNS than_IN vaccines_NNS using_VBG other_JJ technologies_NNS ,_, such_JJ as_IN those_DT involving_VBG the_DT neutralized_VBN or_CC modified_VBN versions_NNS of_IN existing_VBG viruses_NNS ,_, he_PRP said_VBD ._.","NNP NNP VBZ VBN that NNP NNP NNP will VB its NN JJ at the JJS JJ NN in NNP , RB RB as in JJ - and JJ - NN NNS . NNP would VB with VBN NN NNS , in a NN JJ to the NN and NN of JJ NNS . The JJ NN may VB JJR NNS in JJR NNS JJ as the NNP NNPS , NNP , or the NNP NNP NNS . A JJ NN VBG 300 NNS in NNP — an JJ VBN NN one and two — VBZ VBN to VB on NNP 15 . If that VBZ the NN to VB JJ , NNP NNP will VB a 6,000 - NN NN in NNP to VB the NN ’s NN . The NN of the JJR NN will VB on where the NN VBZ VBG RB at the NN . The NNP NNP VBZ VBG a JJ NN that VBZ RB RB VBN a VBN NN . It VBZ VBN as NN - VBG NNP and VBD VBN by NNP NNP over NNS of NN . The NN VBZ of RB VBN JJ NN — NN — that VBZ NN NNS in the NN to VB a JJ “ NN ” NN VBN on the NN of the NN . If the NN VBZ JJ , those NNS will VB an JJ NN that will VB the NN . NNP , a NN NN VBN in NNP , NNP , VBZ VBN JJ NNS for a NN VBG JJ NN , VBN as NN NN . The NNP NN VBZ VBN to VB RB JJ as $ 483 million to NNP to VB its NN , and NNS of JJ NNS in the NN ’s JJ NNS VBP VBN the NN ’s NN VBG . NNP NNP ’s NN - VBG NN NN , NNP NNP VBD , would VB a RB JJR NN than the NNP NN — 50 to 100 NNS JJR — which would RB VB the NN per NN . The NNP NNP NN would RB VB JJR and RBR JJ NN NNS than NNS VBG JJ NNS , JJ as those VBG the VBN or VBN NNS of VBG NNS , he VBD ."
205,453,mainstream,"American_JJ drug_NN maker_NN Moderna_NNP said_VBD Monday_NNP that_IN its_PRP$ experimental_JJ COVID_NN -_HYPH 19_CD vaccine_NN produced_VBD antibodies_NNS in_IN a_DT small_JJ group_NN of_IN healthy_JJ people_NNS in_IN an_DT early_JJ trial_NN ._. The_DT company_NN said_VBD eight_CD people_NNS who_WP received_VBD two_CD small_JJ amounts_NNS of_IN its_PRP$ vaccine_NN developed_VBD antibodies_NNS similar_JJ to_IN those_DT developed_VBN by_IN people_NNS who_WP have_VBP recovered_VBN from_IN the_DT disease_NN ._. The_DT U.S._NNP National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS led_VBD the_DT experiment_NN ,_, also_RB called_VBD a_DT trial_NN ._. It_PRP involved_VBD 45_CD volunteers_NNS who_WP received_VBD one_CD or_CC two_CD shots_NNS of_IN differing_VBG amounts_NNS of_IN the_DT vaccine_NN ._. Tal_NNP Zaks_NNP is_VBZ the_DT chief_JJ medical_JJ officer_NN at_IN Moderna_NNP ._. Based_VBN on_IN early_JJ results_NNS of_IN the_DT trial_NN ,_, he_PRP said_VBD the_DT vaccine_NN “_'' has_VBZ the_DT potential_NN to_TO prevent_VB COVID_NN -_HYPH 19_CD disease_NN …_. ._. ”_'' He_PRP also_RB said_VBD the_DT company_NN now_RB can_MD better_RBR choose_VB the_DT vaccine_NN amount_NN needed_VBN for_IN further_JJR experiments_NNS ._. The_DT testing_NN involved_VBD three_CD different_JJ amounts_NNS ._. Zaks_NNP said_VBD the_DT two_CD smaller_JJR amounts_NNS of_IN vaccine_NN seem_VBP safe_JJ and_CC the_DT larger_JJR amount_NN caused_VBD some_DT short_JJ -_HYPH term_NN side_NN effects_NNS ._. Three_CD study_NN subjects_NNS developed_VBD “_`` flu_NN -_HYPH like_IN ”_'' conditions_NNS following_VBG a_DT second_JJ shot_NN of_IN the_DT large_JJ dose_NN ._. Moderna_NNP said_VBD it_PRP plans_VBZ to_TO drop_VB that_DT amount_NN for_IN the_DT next_JJ part_NN of_IN the_DT trial_NN ._. Amesh_NNP Adalja_NNP is_VBZ an_DT infectious_JJ disease_NN expert_NN at_IN the_DT Johns_NNP Hopkins_NNP Center_NNP for_IN Health_NNP Security_NNP who_WP was_VBD not_RB involved_VBN in_IN the_DT study_NN ._. He_PRP told_VBD Reuters_NNP that_IN the_DT findings_NNS are_VBP meaningful_JJ ,_, but_CC noted_VBD that_IN they_PRP come_VBP from_IN only_RB eight_CD people_NNS ._. “_`` It_PRP was_VBD designed_VBN for_IN safety_NN ._. Not_RB for_IN efficacy_NN ,_, ”_'' he_PRP said_VBD ._. Moderna_NNP has_VBZ been_VBN permitted_VBN to_TO start_VB a_DT second_JJ part_NN of_IN human_JJ testing_NN that_WDT will_MD involve_VB several_JJ hundreds_NNS of_IN people_NNS ._. In_IN April_NNP ,_, the_DT U.S._NNP government_NN gave_VBD the_DT company_NN $_$ 483_CD million_CD for_IN vaccine_NN development_NN ._. Last_JJ week_NN ,_, U.S._NNP officials_NNS gave_VBD the_DT vaccine_NN special_JJ recognition_NN to_TO help_VB speed_VB the_DT process_NN for_IN approval_NN ._. Stéphane_NNP Bancel_NNP ,_, Chief_JJ Executive_JJ Officer_NN of_IN Moderna_NNP ,_, said_VBD the_DT company_NN is_VBZ hoping_VBG to_TO start_VB part_NN three_CD of_IN the_DT study_NN in_IN July_NNP ._. The_DT company_NN will_MD try_VB to_TO find_VB the_DT lowest_JJS amount_NN of_IN vaccine_NN necessary_JJ to_TO protect_VB people_NNS ._. In_IN May_NNP ,_, Moderna_NNP and_CC the_DT biotechnology_NN company_NN Lonza_NNP agreed_VBD to_TO work_VB together_RB over_IN the_DT next_JJ ten_CD years_NNS to_TO make_VB a_DT vaccine_NN ._. The_DT partnership_NN could_MD lead_VB to_IN the_DT manufacture_NN of_IN 1_CD billion_CD COVID_NN -_HYPH 19_CD vaccine_NN treatments_NNS a_DT year_NN ._. There_EX are_VBP currently_RB no_DT approved_VBN treatments_NNS or_CC vaccines_NNS for_IN COVID_NN -_HYPH 19_CD ._. Almost_RB 4.8_CD million_CD people_NNS are_VBP confirmed_VBN to_TO have_VB had_VBN the_DT virus_NN ._. It_PRP is_VBZ known_VBN to_TO have_VB killed_VBN about_RB 320,000_CD ._. However_RB ,_, experts_NNS think_VBP the_DT numbers_NNS may_MD be_VB underreported_VBN ._. The_DT World_NNP Health_NNP Organization_NNP has_VBZ listed_VBN more_JJR than_IN 100_CD efforts_NNS to_TO develop_VB effective_JJ treatments_NNS and_CC vaccines_NNS for_IN the_DT coronavirus_NN ._. The_DT list_NN includes_VBZ clinical_JJ trials_NNS in_IN China_NNP ,_, at_IN the_DT University_NNP of_IN Oxford_NNP ,_, and_CC with_IN American_JJ drug_NN makers_NNS Pfizer_NNP ,_, Inovio_NNP and_CC Moderna_NNP ._. Experts_NNS predict_VBP a_DT safe_JJ and_CC effective_JJ vaccine_NN could_MD take_VB 12_CD to_IN 18_CD months_NNS to_TO develop_VB ._. The_DT results_NNS of_IN Moderna_NNP ’s_POS early_JJ trial_NN have_VBP not_RB been_VBN published_VBN ._. But_CC the_DT news_NN lifted_VBD the_DT company_NN ’s_POS stock_NN prices_NNS and_CC spread_VBD hope_NN that_IN a_DT solution_NN against_IN the_DT infectious_JJ disease_NN might_MD be_VB close_JJ ._. Hai_NNP Do_NNP adapted_VBD this_DT story_NN for_IN Learning_NNP English_NNP based_VBN on_IN Associated_NNP Press_NNP and_CC Reuters_NNP news_NN reports_NNS ._. Caty_NNP Weaver_NNP was_VBD the_DT editor_NN ._. potential_JJ -_HYPH n._LS a_DT chance_NN or_CC possibility_NN that_IN something_NN will_MD happen_VB in_IN the_DT future_NN efficacy_NN -_HYPH n._LS the_DT power_NN to_TO produce_VB a_DT desired_VBN result_NN or_CC effect_NN clinical_JJ -_HYPH adj_NN ._. relating_VBG or_CC based_VBN on_IN work_NN done_VBN with_IN real_JJ patients_NNS","JJ NN NN NNP VBD NNP that its JJ NN - 19 NN VBD NNS in a JJ NN of JJ NNS in an JJ NN . The NN VBD eight NNS who VBD two JJ NNS of its NN VBD NNS JJ to those VBN by NNS who VBP VBN from the NN . The NNP NNP NNP of NNP and NNP NNPS VBD the NN , RB VBD a NN . It VBD 45 NNS who VBD one or two NNS of VBG NNS of the NN . NNP NNP VBZ the JJ JJ NN at NNP . VBN on JJ NNS of the NN , he VBD the NN “ VBZ the NN to VB NN - 19 NN … . ” He RB VBD the NN RB can RBR VB the NN NN VBN for JJR NNS . The NN VBD three JJ NNS . NNP VBD the two JJR NNS of NN VBP JJ and the JJR NN VBD some JJ - NN NN NNS . Three NN NNS VBD “ NN - like ” NNS VBG a JJ NN of the JJ NN . NNP VBD it VBZ to VB that NN for the JJ NN of the NN . NNP NNP VBZ an JJ NN NN at the NNP NNP NNP for NNP NNP who VBD RB VBN in the NN . He VBD NNP that the NNS VBP JJ , but VBD that they VBP from RB eight NNS . “ It VBD VBN for NN . RB for NN , ” he VBD . NNP VBZ VBN VBN to VB a JJ NN of JJ NN that will VB JJ NNS of NNS . In NNP , the NNP NN VBD the NN $ 483 million for NN NN . JJ NN , NNP NNS VBD the NN JJ NN to VB VB the NN for NN . NNP NNP , JJ JJ NN of NNP , VBD the NN VBZ VBG to VB NN three of the NN in NNP . The NN will VB to VB the JJS NN of NN JJ to VB NNS . In NNP , NNP and the NN NN NNP VBD to VB RB over the JJ ten NNS to VB a NN . The NN could VB to the NN of 1 billion NN - 19 NN NNS a NN . There VBP RB no VBN NNS or NNS for NN - 19 . RB 4.8 million NNS VBP VBN to VB VBN the NN . It VBZ VBN to VB VBN RB 320,000 . RB , NNS VBP the NNS may VB VBN . The NNP NNP NNP VBZ VBN JJR than 100 NNS to VB JJ NNS and NNS for the NN . The NN VBZ JJ NNS in NNP , at the NNP of NNP , and with JJ NN NNS NNP , NNP and NNP . NNS VBP a JJ and JJ NN could VB 12 to 18 NNS to VB . The NNS of NNP ’s JJ NN VBP RB VBN VBN . But the NN VBD the NN ’s NN NNS and VBD NN that a NN against the JJ NN might VB JJ . NNP NNP VBD this NN for NNP NNP VBN on NNP NNP and NNP NN NNS . NNP NNP VBD the NN . JJ - n. a NN or NN that NN will VB in the NN NN - n. the NN to VB a VBN NN or NN JJ - NN . VBG or VBN on NN VBN with JJ NNS"
206,422,conspiracy,"Scientists_NNS claim_VBP that_IN autism_NN has_VBZ been_VBN around_RB for_IN over_RB 1,000_CD years_NNS and_CC has_VBZ remained_VBN consistently_RB as_RB prevalent_JJ as_IN it_PRP is_VBZ in_IN today_NN ’s_POS work_NN —_: with_IN 1_CD in_IN every_DT 166_CD in_IN the_DT U.S._NNP being_VBG born_VBN with_IN autism_NN ._. However_RB ,_, within_IN the_DT Amish_JJ community_NN autism_NN does_VBZ not_RB exist_VB ._. Why_WRB is_VBZ this_DT ?_. It_PRP looks_VBZ like_IN the_DT answer_NN to_IN this_DT question_NN leads_VBZ to_IN a_DT much_RB bigger_JJR revelation_NN about_IN the_DT cause_NN of_IN autism_NN itself_PRP ._. Since_IN they_PRP have_VBP been_VBN cut_VBN off_RP for_IN hundreds_NNS of_IN years_NNS from_IN American_JJ culture_NN and_CC scientific_JJ progress_NN ,_, the_DT Amish_NNP may_MD have_VB had_VBN less_JJR exposure_NN to_IN some_DT new_JJ factor_NN triggering_VBG autism_NN in_IN the_DT rest_NN of_IN population_NN ._. The_DT likely_JJ culprit_NN :_: vaccines_NNS ._. Traveling_VBG to_IN the_DT heart_NN of_IN Pennsylvania_NNP Dutch_JJ country_NN in_IN search_NN of_IN autistic_JJ Amish_NNP children_NNS ,_, the_DT reporter_NN ,_, based_VBN on_IN national_JJ statistics_NNS ,_, should_MD have_VB found_VBN as_RB many_JJ as_IN 200_CD children_NNS with_IN autism_NN in_IN the_DT community_NN —_: instead_RB ,_, he_PRP found_VBD only_RB three_CD ,_, the_DT oldest_JJS age_NN 9_CD or_CC 10_CD :_: The_DT first_JJ autistic_JJ Amish_NNP child_NN was_VBD a_DT girl_NN who_WP had_VBD been_VBN brought_VBN over_RP from_IN China_NNP ,_, adopted_VBN by_IN one_CD family_NN only_RB to_TO be_VB given_VBN up_RP after_IN becoming_VBG overwhelmed_VBN by_IN her_PRP$ autism_NN ,_, and_CC then_RB re-adopted_VBN by_IN an_DT Amish_NNP Mennonite_NNP family_NN ._. The_DT second_JJ autistic_JJ Amish_NNP child_NN definitely_RB had_VBD received_VBN a_DT vaccination_NN and_CC developed_VBD autism_NN shortly_RB thereafter_RB ._. The_DT reporter_NN was_VBD unable_JJ to_TO determine_VB the_DT vaccination_NN status_NN of_IN the_DT third_JJ child_NN ._. In_IN some_DT vaccines_NNS ,_, they_PRP use_VBP a_DT mercury_NN -_HYPH based_VBN preservative_NN called_VBN thimerosal_NN that_WDT keeps_VBZ multiple_JJ -_HYPH dose_NN vials_NNS from_IN becoming_VBG contaminated_VBN by_IN repeated_VBN needle_NN sticks_NNS ._. After_IN health_NN officials_NNS became_VBD concerned_JJ about_IN the_DT amount_NN of_IN mercury_NN infants_NNS and_CC children_NNS were_VBD receiving_VBG through_IN thimerosal_NN -_HYPH tainted_VBN vaccines_NNS ,_, the_DT toxin_NN was_VBD phased_VBN out_IN of_IN U.S._NNP vaccines_NNS starting_VBG in_IN 1999_CD ._. However_RB ,_, due_IN to_IN mislabeling_NN and_CC other_JJ problems_NNS ,_, its_PRP$ presence_NN is_VBZ still_RB being_VBG felt_VBN ,_, and_CC more_JJR and_CC more_JJR children_NNS are_VBP suffering_VBG because_IN of_IN it_PRP ._. Does_VBZ anyone_NN out_RB there_RB really_RB need_VB more_JJR evidence_NN than_IN this_DT ?_. Admittedly_RB ,_, this_DT was_VBD not_RB a_DT placebo_NN -_HYPH controlled_VBN scientific_JJ trial_NN but_CC an_DT evidence_NN -_HYPH based_VBN fact_NN analysis_NN that_WDT ,_, in_IN my_PRP$ mind_NN ,_, provides_VBZ an_DT irrefutable_JJ link_NN to_IN a_DT lifestyle_NN and_CC ,_, most_RBS likely_JJ ,_, mercury_NN -_HYPH containing_VBG vaccine_NN connection_NN to_IN autism_NN ._. Folks_NNS ,_, you_PRP do_VBP n’t_RB have_VB to_TO be_VB a_DT medical_JJ doctor_NN ,_, hold_VB advanced_JJ epidemiology_NN degrees_NNS or_CC teach_VB molecular_JJ genetics_NN to_TO figure_VB this_DT one_CD out_RP ._. You_PRP do_VBP n’t_RB even_RB need_VB a_DT degree_NN in_IN rocket_NN science_NN ._. How_WRB much_RB more_RBR obvious_JJ could_MD it_PRP be_VB ?_. The_DT link_NN between_IN autism_NN and_CC vaccines_NNS is_VBZ certainly_RB not_RB a_DT new_JJ idea_NN ._. In_IN fact_NN ,_, suggestions_NNS of_IN this_DT link_NN have_VBP been_VBN in_IN the_DT national_JJ news_NN for_IN at_IN least_JJS six_CD years_NNS now_RB ._. Just_RB last_JJ year_NN a_DT study_NN ,_, that_WDT reviewed_VBD data_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ’s_POS (_-LRB- CDC_NNP )_-RRB- Vaccine_NN Data_NN Link_NNP ,_, concluded_VBD that_IN children_NNS who_WP receive_VBP thimerosal_NN -_HYPH containing_VBG vaccinations_NNS are_VBP 27_CD times_NNS more_RBR likely_JJ to_TO develop_VB autism_NN than_IN children_NNS who_WP do_VBP not_RB ._. This_DT most_RBS recent_JJ investigation_NN simply_RB provides_VBZ the_DT proverbial_JJ icing_NN on_IN the_DT cake_NN ._. There_EX are_VBP n’t_RB too_RB many_JJ other_JJ places_NNS ,_, if_IN any_DT ,_, in_IN America_NNP where_WRB you_PRP can_MD find_VB large_JJ groups_NNS of_IN children_NNS who_WP have_VBP n’t_RB been_VBN vaccinated_VBN ._. The_DT reporter_NN found_VBD three_CD children_NNS with_IN autism_NN ._. One_CD child_NN was_VBD adopted_VBN and_CC previously_RB vaccinated_VBN ,_, another_DT was_VBD one_CD of_IN the_DT few_JJ Amish_JJ children_NNS who_WP were_VBD vaccinated_VBN ,_, and_CC the_DT third_NN had_VBD an_DT unclear_JJ vaccine_NN history_NN ._. That_DT leaves_VBZ ,_, at_IN most_JJS ,_, potentially_RB one_CD child_NN out_IN of_IN an_DT expected_VBN 200_CD (_-LRB- from_IN national_JJ statistics_NNS )_-RRB- with_IN autism_NN ._. The_DT odds_NNS of_IN this_DT being_VBG mere_JJ coincidence_NN are_VBP slim_JJ to_IN none_NN ._. At_IN Least_JJS Change_NN the_DT Rules_NNS Concerning_VBG the_DT Hepatitis_NN B_NN Vaccine_NN Because_IN of_IN their_PRP$ religious_JJ beliefs_NNS ,_, the_DT Amish_JJ community_NN chooses_VBZ not_RB to_TO give_VB their_PRP$ children_NNS any_DT vaccines_NNS ._. Understandably_RB ,_, many_JJ of_IN you_PRP may_MD not_RB choose_VB such_PDT a_DT radical_JJ approach_NN ._. However_RB ,_, if_IN you_PRP were_VBD to_TO focus_VB on_IN just_RB one_CD vaccine_NN ,_, I_PRP would_MD encourage_VB you_PRP to_TO look_VB at_IN the_DT issues_NNS surrounding_VBG the_DT hepatitis_NN B_NN vaccine_NN ._. The_DT multi-dose_JJ version_NN of_IN this_DT vaccine_NN ,_, which_WDT is_VBZ typically_RB administered_VBN to_IN newborns_NNS before_IN they_PRP leave_VBP the_DT hospital_NN ,_, still_RB contains_VBZ thimerosal_NN ._. This_DT is_VBZ reprehensible_JJ ,_, irresponsible_JJ negligence_NN of_IN the_DT highest_JJS magnitude_NN ._. The_DT immature_JJ central_JJ nervous_JJ systems_NNS of_IN these_DT helpless_JJ newborns_NNS are_VBP particularly_RB susceptible_JJ to_IN toxic_JJ insults_NNS ,_, and_CC thimerosal_NN ,_, the_DT mercury_NN -_HYPH containing_VBG preservative_NN used_VBN in_IN these_DT vaccines_NNS ,_, is_VBZ one_CD of_IN the_DT worst_JJS ._. It_PRP would_MD be_VB much_RB easier_JJR to_TO understand_VB if_IN the_DT hepatitis_NN B_NN vaccine_NN had_VBD some_DT value_NN ,_, but_CC most_JJS natural_JJ health_NN experts_NNS who_WP study_VBP this_DT are_VBP convinced_VBN that_IN this_DT is_VBZ nearly_RB always_RB an_DT absolutely_RB unnecessary_JJ vaccine_NN ._. There_EX are_VBP only_RB about_RB 5,000_CD people_NNS a_DT year_NN who_WP develop_VBP the_DT most_RBS serious_JJ consequence_NN of_IN hepatitis_NN B_NN infection_NN ,_, liver_NN cancer_NN ._. That_DT means_VBZ we_PRP are_VBP immunizing_VBG tens_NNS of_IN millions_NNS of_IN infants_NNS and_CC causing_VBG brain_NN injury_NN that_WDT has_VBZ caused_VBN an_DT epidemic_NN of_IN autism_NN to_TO protect_VB liver_NN cancer_NN in_IN 5,000_CD adults_NNS ._. And_CC ,_, many_JJ of_IN these_DT adults_NNS have_VBP serious_JJ social_JJ problems_NNS like_IN IV_NN drug_NN abuse_NN ,_, alcoholism_NN and_CC poor_JJ nutrition_NN that_WDT seriously_RB increases_VBZ their_PRP$ risk_NN for_IN this_DT disease_NN ._. If_IN you_PRP ’re_VBP a_DT young_JJ parent_NN weighing_VBG the_DT pros_NNS and_CC cons_NNS of_IN vaccines_NNS ,_, I_PRP strongly_RB urge_VBP you_PRP to_TO learn_VB more_JJR about_IN the_DT toxicity_NN of_IN thimerosal_NN ,_, which_WDT ,_, again_RB ,_, is_VBZ still_RB present_JJ in_IN multi-_JJ dose_NN hepatitis_NN B_NN vaccines_NNS ,_, and_CC nearly_RB all_PDT the_DT mandated_VBN flu_NN vaccine_NN for_IN infants_NNS ._.","NNS VBP that NN VBZ VBN RB for RB 1,000 NNS and VBZ VBN RB RB JJ as it VBZ in NN ’s NN — with 1 in every 166 in the NNP VBG VBN with NN . RB , within the JJ NN NN VBZ RB VB . Why VBZ this ? It VBZ like the NN to this NN VBZ to a RB JJR NN about the NN of NN itself . Since they VBP VBN VBN off for NNS of NNS from JJ NN and JJ NN , the NNP may VB VBN JJR NN to some JJ NN VBG NN in the NN of NN . The JJ NN : NNS . VBG to the NN of NNP JJ NN in NN of JJ NNP NNS , the NN , VBN on JJ NNS , should VB VBN RB JJ as 200 NNS with NN in the NN — RB , he VBD RB three , the JJS NN 9 or 10 : The JJ JJ NNP NN VBD a NN who VBD VBN VBN over from NNP , VBN by one NN RB to VB VBN up after VBG VBN by her NN , and RB VBN by an NNP NNP NN . The JJ JJ NNP NN RB VBD VBN a NN and VBD NN RB RB . The NN VBD JJ to VB the NN NN of the JJ NN . In some NNS , they VBP a NN - VBN NN VBN NN that VBZ JJ - NN NNS from VBG VBN by VBN NN NNS . After NN NNS VBD JJ about the NN of NN NNS and NNS VBD VBG through NN - VBN NNS , the NN VBD VBN out of NNP NNS VBG in 1999 . RB , due to NN and JJ NNS , its NN VBZ RB VBG VBN , and JJR and JJR NNS VBP VBG because of it . VBZ NN RB RB RB VB JJR NN than this ? RB , this VBD RB a NN - VBN JJ NN but an NN - VBN NN NN that , in my NN , VBZ an JJ NN to a NN and , RBS JJ , NN - VBG NN NN to NN . NNS , you VBP RB VB to VB a JJ NN , VB JJ NN NNS or VB JJ NN to VB this one out . You VBP RB RB VB a NN in NN NN . How RB RBR JJ could it VB ? The NN between NN and NNS VBZ RB RB a JJ NN . In NN , NNS of this NN VBP VBN in the JJ NN for at JJS six NNS RB . RB JJ NN a NN , that VBD NNS from the NNPS for NNP NNP and NNP ’s ( NNP ) NN NN NNP , VBD that NNS who VBP NN - VBG NNS VBP 27 NNS RBR JJ to VB NN than NNS who VBP RB . This RBS JJ NN RB VBZ the JJ NN on the NN . There VBP RB RB JJ JJ NNS , if any , in NNP where you can VB JJ NNS of NNS who VBP RB VBN VBN . The NN VBD three NNS with NN . One NN VBD VBN and RB VBN , another VBD one of the JJ JJ NNS who VBD VBN , and the NN VBD an JJ NN NN . That VBZ , at JJS , RB one NN out of an VBN 200 ( from JJ NNS ) with NN . The NNS of this VBG JJ NN VBP JJ to NN . At JJS NN the NNS VBG the NN NN NN Because of their JJ NNS , the JJ NN VBZ RB to VB their NNS any NNS . RB , JJ of you may RB VB such a JJ NN . RB , if you VBD to VB on RB one NN , I would VB you to VB at the NNS VBG the NN NN NN . The JJ NN of this NN , which VBZ RB VBN to NNS before they VBP the NN , RB VBZ NN . This VBZ JJ , JJ NN of the JJS NN . The JJ JJ JJ NNS of these JJ NNS VBP RB JJ to JJ NNS , and NN , the NN - VBG NN VBN in these NNS , VBZ one of the JJS . It would VB RB JJR to VB if the NN NN NN VBD some NN , but JJS JJ NN NNS who VBP this VBP VBN that this VBZ RB RB an RB JJ NN . There VBP RB RB 5,000 NNS a NN who VBP the RBS JJ NN of NN NN NN , NN NN . That VBZ we VBP VBG NNS of NNS of NNS and VBG NN NN that VBZ VBN an NN of NN to VB NN NN in 5,000 NNS . And , JJ of these NNS VBP JJ JJ NNS like NN NN NN , NN and JJ NN that RB VBZ their NN for this NN . If you VBP a JJ NN VBG the NNS and NNS of NNS , I RB VBP you to VB JJR about the NN of NN , which , RB , VBZ RB JJ in JJ NN NN NN NNS , and RB all the VBN NN NN for NNS ."
207,1209,mainstream,"As_IN a_DT public_JJ health_NN emergency_NN of_IN international_JJ concern_NN ,_, the_DT COVID_NNP -_HYPH 19_CD pandemic_NN (_-LRB- caused_VBN by_IN the_DT novel_JJ SARS_NN -_HYPH CoV_NN -_HYPH 2_CD virus_NN )_-RRB- has_VBZ drawn_VBN global_JJ attention_NN and_CC response_NN ._. As_IN of_IN 19_CD March_NNP 2020_CD ,_, 51_CD of_IN 53_CD countries_NNS in_IN the_DT WHO_NNP European_NNP Region_NNP have_VBP reported_VBN confirmed_VBN COVID_NN -_HYPH 19_CD cases_NNS ._. Each_DT of_IN these_DT countries_NNS has_VBZ initiated_VBN a_DT range_NN of_IN measures_NNS to_TO mitigate_VB the_DT transmission_NN of_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD and_CC reduce_VB the_DT impact_NN of_IN the_DT outbreak_NN on_IN healthcare_NN systems_NNS ,_, including_VBG shifting_NN of_IN healthcare_NN resources_NNS to_IN the_DT COVID_NN -_HYPH 19_CD response_NN ._. In_IN planning_VBG these_DT measures_NNS ,_, due_JJ consideration_NN should_MD be_VB given_VBN to_IN minimizing_VBG the_DT excess_JJ risk_NN of_IN morbidity_NN and_CC mortality_NN from_IN vaccine_NN -_HYPH preventable_JJ diseases_NNS (_-LRB- VPDs_NNS )_-RRB- that_WDT would_MD result_VB if_IN immunization_NN services_NNS are_VBP disrupted_VBN ._. Any_DT disruption_NN of_IN immunization_NN services_NNS ,_, even_RB for_IN short_JJ periods_NNS ,_, will_MD result_VB in_IN an_DT accumulation_NN of_IN susceptible_JJ individuals_NNS ,_, and_CC a_DT higher_JJR likelihood_NN of_IN VPD_NN outbreaks_NNS ._. Such_JJ outbreaks_NNS may_MD result_VB in_IN VPD_NN -_HYPH related_JJ deaths_NNS and_CC an_DT increased_VBN burden_NN on_IN health_NN systems_NNS already_RB strained_VBN by_IN the_DT response_NN to_IN the_DT COVID_NN -_HYPH 19_CD outbreak_NN ._.","As a JJ NN NN of JJ NN , the NNP - 19 NN ( VBN by the JJ NN - NN - 2 NN ) VBZ VBN JJ NN and NN . As of 19 NNP 2020 , 51 of 53 NNS in the NNP NNP NNP VBP VBN VBN NN - 19 NNS . Each of these NNS VBZ VBN a NN of NNS to VB the NN of NNP - NNP - 2 and VB the NN of the NN on NN NNS , VBG NN of NN NNS to the NN - 19 NN . In VBG these NNS , JJ NN should VB VBN to VBG the JJ NN of NN and NN from NN - JJ NNS ( NNS ) that would VB if NN NNS VBP VBN . Any NN of NN NNS , RB for JJ NNS , will VB in an NN of JJ NNS , and a JJR NN of NN NNS . JJ NNS may VB in NN - JJ NNS and an VBN NN on NN NNS RB VBN by the NN to the NN - 19 NN ."
208,3,mainstream,"The_DT flu_NN vaccine_NN stimulates_VBZ your_PRP$ body_NN 's_POS immune_JJ system_NN to_TO make_VB antibodies_NNS to_TO attack_VB the_DT flu_NN virus_NN ._. Antibodies_NNS are_VBP proteins_NNS that_WDT recognise_VBP and_CC fight_VBP off_RP germs_NNS ,_, such_JJ as_IN viruses_NNS ,_, that_WDT have_VBP invaded_VBN your_PRP$ blood_NN ._. If_IN you_PRP 're_VBP exposed_VBN to_IN the_DT flu_NN virus_NN after_IN you_PRP have_VBP had_VBN the_DT flu_NN vaccine_NN ,_, your_PRP$ immune_JJ system_NN will_MD recognise_VB the_DT virus_NN and_CC immediately_RB produce_VB antibodies_NNS to_TO fight_VB it_PRP ._. It_PRP may_MD take_VB 10_CD to_IN 14_CD days_NNS for_IN your_PRP$ immunity_NN to_TO build_VB up_RP fully_RB after_IN you_PRP have_VBP had_VBN the_DT flu_NN vaccine_NN ._. You_PRP need_VBP to_TO have_VB a_DT flu_NN vaccination_NN every_DT year_NN as_IN the_DT antibodies_NNS that_WDT protect_VBP you_PRP from_IN flu_NN decline_NN over_IN time_NN ,_, and_CC flu_NN strains_NNS can_MD also_RB change_VB from_IN year_NN to_IN year_NN ._. Find_VB out_RP more_JJR about_IN how_WRB vaccines_NNS work_VBP There_EX are_VBP 3_CD types_NNS of_IN flu_NN viruses_NNS :_: •_NFP Type_NN A_NN flu_NN virus_NN –_: this_DT is_VBZ usually_RB the_DT more_RBR serious_JJ type_NN ._. The_DT virus_NN is_VBZ most_RBS likely_JJ to_TO mutate_VB into_IN a_DT new_JJ version_NN that_WDT people_NNS are_VBP not_RB resistant_JJ to_IN ._. The_DT H1N1_NNP (_-LRB- swine_NN flu_NN )_-RRB- strain_NN is_VBZ a_DT type_NN A_NN virus_NN ,_, and_CC flu_NN pandemics_NNS in_IN the_DT past_NN were_VBD type_NN A_NN viruses_NNS ._. •_NFP Type_NN B_NN flu_NN virus_NN –_: this_DT generally_RB causes_VBZ a_DT less_RBR severe_JJ illness_NN and_CC is_VBZ responsible_JJ for_IN smaller_JJR outbreaks_NNS ._. It_PRP mainly_RB affects_VBZ young_JJ children_NNS ._. •_NFP Type_NN C_NN flu_NN virus_NN –_: this_DT usually_RB causes_VBZ a_DT mild_JJ illness_NN similar_JJ to_IN the_DT common_JJ cold_NN ._. Most_JJS years_NNS ,_, 1_CD or_CC 2_CD strains_NNS of_IN type_NN A_NN flu_NN circulate_VBP ,_, as_RB well_RB as_IN type_NN B_NN ._. How_WRB the_DT annual_JJ flu_NN vaccine_NN changes_VBZ In_IN February_NNP each_DT year_NN ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- assesses_VBZ the_DT strains_NNS of_IN flu_NN virus_NN that_WDT are_VBP most_RBS likely_JJ to_TO be_VB circulating_VBG in_IN the_DT northern_JJ hemisphere_NN over_IN the_DT following_VBG winter_NN ._. Based_VBN on_IN this_DT assessment_NN ,_, WHO_NNP recommends_VBZ which_WDT flu_NN strains_NNS the_DT vaccines_NNS should_MD contain_VB for_IN the_DT forthcoming_VBG winter_NN ._. Flu_NN vaccines_NNS protect_VBP against_IN 3_CD or_CC 4_CD types_NNS of_IN flu_NN virus_NN (_-LRB- usually_RB 2_CD A_NN types_NNS and_CC 1_CD or_CC 2_CD B_NN types_NNS )_-RRB- ._. Vaccine_NN manufacturers_NNS produce_VBP flu_NN vaccines_NNS based_VBN on_IN WHO_NNP 's_POS recommendations_NNS ._. For_IN most_JJS flu_NN vaccines_NNS ,_, the_DT strains_NNS of_IN the_DT viruses_NNS are_VBP grown_VBN either_CC in_IN hens_NNS '_POS eggs_NNS or_CC mammalian_NN cells_NNS ._. These_DT flu_NN vaccines_NNS are_VBP used_VBN in_IN all_PDT the_DT countries_NNS in_IN the_DT northern_JJ hemisphere_NN ,_, not_RB just_RB the_DT UK_NNP ._. Production_NN of_IN the_DT vaccine_NN starts_VBZ in_IN March_NNP each_DT year_NN after_IN WHO_NNP 's_POS announcement_NN ._. The_DT vaccine_NN is_VBZ usually_RB available_JJ in_IN the_DT UK_NNP from_IN September_NNP ._. The_DT flu_NN vaccine_NN cannot_MD give_VB you_PRP flu_NN The_DT injected_VBN flu_NN vaccine_NN given_VBN to_IN adults_NNS contains_VBZ inactivated_VBN flu_NN viruses_NNS ,_, so_IN it_PRP can_MD not_RB give_VB you_PRP flu_NN ._. The_DT children_NNS 's_POS nasal_JJ spray_NN flu_NN vaccine_NN contains_VBZ live_JJ but_CC weakened_VBN flu_NN viruses_NNS that_WDT will_MD not_RB give_VB your_PRP$ child_NN flu_NN ._. Read_VB facts_NNS about_IN flu_NN and_CC the_DT flu_NN vaccine_NN As_IN there_EX are_VBP lots_NNS of_IN different_JJ flu_NN vaccines_NNS produced_VBN each_DT year_NN ,_, for_IN more_RBR detailed_JJ information_NN on_IN ingredients_NNS ask_VB your_PRP$ doctor_NN or_CC nurse_NN for_IN the_DT patient_NN information_NN leaflet_NN for_IN the_DT specific_JJ vaccine_NN being_VBG offered_VBN ._. Find_VB out_RP more_JJR about_IN vaccine_NN ingredients_NNS","The NN NN VBZ your NN 's JJ NN to VB NNS to VB the NN NN . NNS VBP NNS that VBP and VBP off NNS , JJ as NNS , that VBP VBN your NN . If you VBP VBN to the NN NN after you VBP VBN the NN NN , your JJ NN will VB the NN and RB VB NNS to VB it . It may VB 10 to 14 NNS for your NN to VB up RB after you VBP VBN the NN NN . You VBP to VB a NN NN every NN as the NNS that VBP you from NN NN over NN , and NN NNS can RB VB from NN to NN . VB out JJR about how NNS VBP There VBP 3 NNS of NN NNS : • NN NN NN NN – this VBZ RB the RBR JJ NN . The NN VBZ RBS JJ to VB into a JJ NN that NNS VBP RB JJ to . The NNP ( NN NN ) NN VBZ a NN NN NN , and NN NNS in the NN VBD NN NN NNS . • NN NN NN NN – this RB VBZ a RBR JJ NN and VBZ JJ for JJR NNS . It RB VBZ JJ NNS . • NN NN NN NN – this RB VBZ a JJ NN JJ to the JJ NN . JJS NNS , 1 or 2 NNS of NN NN NN VBP , RB RB as NN NN . How the JJ NN NN VBZ In NNP each NN , the NNP NNP NNP ( NNP ) VBZ the NNS of NN NN that VBP RBS JJ to VB VBG in the JJ NN over the VBG NN . VBN on this NN , NNP VBZ which NN NNS the NNS should VB for the VBG NN . NN NNS VBP against 3 or 4 NNS of NN NN ( RB 2 NN NNS and 1 or 2 NN NNS ) . NN NNS VBP NN NNS VBN on NNP 's NNS . For JJS NN NNS , the NNS of the NNS VBP VBN either in NNS ' NNS or NN NNS . These NN NNS VBP VBN in all the NNS in the JJ NN , RB RB the NNP . NN of the NN VBZ in NNP each NN after NNP 's NN . The NN VBZ RB JJ in the NNP from NNP . The NN NN cannot VB you NN The VBN NN NN VBN to NNS VBZ VBN NN NNS , so it can RB VB you NN . The NNS 's JJ NN NN NN VBZ JJ but VBN NN NNS that will RB VB your NN NN . VB NNS about NN and the NN NN As there VBP NNS of JJ NN NNS VBN each NN , for RBR JJ NN on NNS VB your NN or NN for the NN NN NN for the JJ NN VBG VBN . VB out JJR about NN NNS"
209,55,mainstream,"UPDATE_NN 6/24/2020_CD :_: Lin-Manuel_NNP Miranda_NNP and_CC the_DT cast_NN of_IN Hamilton_NNP have_VBP been_VBN added_VBN to_IN the_DT lineup_NN for_IN Global_NNP Citizen_NNP ’s_POS virtual_JJ concert_NN ._. The_DT Broadway_NNP cast_NN will_MD perform_VB remotely_RB with_IN Jimmy_NNP Fallon_NNP and_CC The_DT Roots_NNPS ._. Global_NNP Citizen_NNP and_CC the_DT European_NNP Commission_NNP are_VBP airing_VBG a_DT special_JJ titled_VBN Global_NNP Goal_NN :_: Unite_NNP for_IN Our_PRP$ Future_NN —_: The_DT Concert_NNP on_IN Saturday_NNP centering_VBG around_IN the_DT impact_NN COVID_NNP -_HYPH 19_CD has_VBZ on_IN marginalized_VBN communities_NNS ._. The_DT global_JJ event_NN will_MD be_VB available_JJ to_IN all_DT online_RB ._. A_DT two_CD -_HYPH part_NN production_NN ,_, Global_NNP Goal_NNP will_MD feature_VB a_DT summit_NN boasting_VBG discussions_NNS and_CC interviews_NNS with_IN experts_NNS and_CC moderators_NNS —_: like_IN Katie_NNP Couric_NNP ,_, Mallika_NNP Kapur_NNP ,_, Morgan_NNP Radford_NNP ,_, Isha_NNP Sesay_NNP and_CC Keir_NNP Simmons_NNP —_: about_IN the_DT progress_NN being_VBG made_VBN to_TO develop_VB a_DT vaccine_NN for_IN COVID_NN -_HYPH 19_CD ._. Guests_NNS will_MD also_RB include_VB Nikolaj_NNP Coster_NNP -_HYPH Waldau_NNP ,_, Miley_NNP Cyrus_NNP ,_, Angelique_NNP Kidjo_NNP ,_, Ken_NNP Jeong_NNP ,_, Brittany_NNP Packnett_NNP Cunningham_NNP ,_, Melinda_NNP Gates_NNP ,_, Dr._NNP Vin_NNP Gupta_NNP ,_, NAACP_NNP President_NNP Derrick_NNP Johnson_NNP ,_, Executive_JJ Director_NN of_IN UN_NNP Women_NNPS ,_, Phumzile_NNP Mlambo_NNP -_HYPH Ngcuka_NNP ,_, Eddie_NNP Ndopu_NNP ,_, Kate_NNP Upton_NNP and_CC Justin_NNP Verlander_NNP ._. A_DT concert_NN hosted_VBN by_IN Dwayne_NNP Johnson_NNP will_MD follow_VB ,_, including_VBG performances_NNS by_IN Chloe_NNP x_NNP Halle_NNP ,_, Christine_NNP and_CC the_DT Queens_NNP ,_, Coldplay_NNP ,_, J_NNP Balvin_NNP ,_, Jennifer_NNP Hudson_NNP ,_, Justin_NNP Bieber_NNP and_CC Quavo_NNP ,_, Miley_NNP Cyrus_NNP ,_, Shakira_NNP ,_, Usher_NNP and_CC Yemi_NNP Alade_NNP ._. Other_JJ guests_NNS will_MD include_VB Antoni_NNP Porowski_NNP ,_, Billy_NNP Porter_NNP ,_, Charlize_NNP Theron_NNP ,_, Chris_NNP Rock_NNP ,_, David_NNP Beckham_NNP ,_, Derrick_NNP Johnson_NNP ,_, Diane_NNP Kruger_NNP ,_, Forest_NNP Whitaker_NNP ,_, Hugh_NNP Jackman_NNP ,_, Ken_NNP Jeong_NNP ,_, Kerry_NNP Washington_NNP ,_, Nikolaj_NNP Coster_NNP -_HYPH Waldau_NNP ,_, Olivia_NNP Colman_NNP ,_, Opal_NNP Tometi_NNP and_CC Salma_NNP Hayek_NNP Pinault_NNP ._. “_`` Global_JJ Citizens_NNS around_IN the_DT world_NN are_VBP calling_VBG on_IN world_NN leaders_NNS to_TO help_VB bring_VB an_DT end_NN to_IN COVID_NNP -_HYPH 19_CD by_IN urging_VBG them_PRP to_TO commit_VB the_DT billions_NNS of_IN dollars_NNS needed_VBN to_TO deliver_VB testing_NN ,_, treatments_NNS and_CC vaccines_NNS to_IN everyone_NN ,_, everywhere_RB ,_, ”_'' Shakira_NNP said_VBD in_IN a_DT release_NN ._. “_`` We_PRP need_VBP health_NN equity_NN and_CC global_JJ justice_NN ,_, and_CC we_PRP know_VBP that_IN only_RB by_IN uniting_VBG to_TO fight_VB for_IN the_DT world_NN we_PRP want_VBP can_MD we_PRP build_VB back_RB toward_IN a_DT healthier_JJR future_NN for_IN all_DT ._. ”_'' Musicians_NNS and_CC entertainers_NNS from_IN all_DT corners_NNS of_IN the_DT business_NN have_VBP been_VBN rallying_VBG to_TO find_VB a_DT cure_NN for_IN COVID_NN -_HYPH 19_CD in_IN the_DT months_NNS since_IN the_DT virus_NN began_VBD to_TO spread_VB across_IN the_DT world_NN ._. Madonna_NNP partnered_VBD with_IN the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP to_TO donate_VB $_$ 1_CD million_CD to_IN the_DT foundation_NN ’s_POS Therapeutics_NNP Accelerator_NN program_NN ,_, and_CC everyone_NN from_IN James_NNP Taylor_NNP to_IN Beyoncé_NNP has_VBZ opened_VBN their_PRP$ pockets_NNS to_IN the_DT cause_NN ._.","NN 6/24/2020 : NNP NNP and the NN of NNP VBP VBN VBN to the NN for NNP NNP ’s JJ NN . The NNP NN will VB RB with NNP NNP and The NNPS . NNP NNP and the NNP NNP VBP VBG a JJ VBN NNP NN : NNP for Our NN — The NNP on NNP VBG around the NN NNP - 19 VBZ on VBN NNS . The JJ NN will VB JJ to all RB . A two - NN NN , NNP NNP will VB a NN VBG NNS and NNS with NNS and NNS — like NNP NNP , NNP NNP , NNP NNP , NNP NNP and NNP NNP — about the NN VBG VBN to VB a NN for NN - 19 . NNS will RB VB NNP NNP - NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP NNP , NNP NNP , NNP NNP NNP , NNP NNP NNP NNP , JJ NN of NNP NNPS , NNP NNP - NNP , NNP NNP , NNP NNP and NNP NNP . A NN VBN by NNP NNP will VB , VBG NNS by NNP NNP NNP , NNP and the NNP , NNP , NNP NNP , NNP NNP , NNP NNP and NNP , NNP NNP , NNP , NNP and NNP NNP . JJ NNS will VB NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP - NNP , NNP NNP , NNP NNP and NNP NNP NNP . “ JJ NNS around the NN VBP VBG on NN NNS to VB VB an NN to NNP - 19 by VBG them to VB the NNS of NNS VBN to VB NN , NNS and NNS to NN , RB , ” NNP VBD in a NN . “ We VBP NN NN and JJ NN , and we VBP that RB by VBG to VB for the NN we VBP can we VB RB toward a JJR NN for all . ” NNS and NNS from all NNS of the NN VBP VBN VBG to VB a NN for NN - 19 in the NNS since the NN VBD to VB across the NN . NNP VBD with the NNP and NNP NNP NNP to VB $ 1 million to the NN ’s NNP NN NN , and NN from NNP NNP to NNP VBZ VBN their NNS to the NN ."
210,923,mainstream,"America_NNP 's_POS nurses_NNS strongly_RB encourage_VBP health_NN care_NN workers_NNS and_CC patients_NNS to_TO get_VB vaccinated_VBN ._. But_CC nurses_NNS ,_, joined_VBN by_IN many_JJ physician_NN organizations_NNS and_CC researchers_NNS ,_, reject_VBP the_DT notion_NN that_IN vaccination_NN is_VBZ a_DT fail_NN -_HYPH safe_JJ solution_NN to_TO prevent_VB the_DT spread_NN of_IN the_DT flu_NN virus_NN ._. We_PRP oppose_VBP forced_VBN vaccinations_NNS or_CC the_DT related_JJ mandate_NN that_IN those_DT who_WP decline_VBP the_DT shots_NNS must_MD wear_VB masks_NNS or_CC risk_VBP losing_VBG their_PRP$ jobs_NNS ._. Vaccinations_NNS are_VBP not_RB foolproof_JJ protection_NN ._. Los_NNP Angeles_NNP County_NNP 's_POS public_JJ health_NN director_NN Jonathan_NNP Fielding_NNP recently_RB told_VBD the_DT Los_NNP Angeles_NNP Times_NNP that_IN the_DT vaccine_NN is_VBZ only_RB 62_CD %_NN effective_JJ ,_, and_CC he_PRP did_VBD not_RB want_VB to_TO give_VB the_DT false_JJ impression_NN it_PRP was_VBD the_DT perfect_JJ antidote_NN ._. It_PRP 's_VBZ not_RB ._. A_DT 2005_CD National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS study_NN over_RB 20_CD years_NNS found_VBD no_DT correlation_NN between_IN increased_VBN vaccine_NN use_NN and_CC a_DT decrease_NN in_IN deaths_NNS ._. Second_RB ,_, there_EX are_VBP health_NN reasons_NNS why_WRB some_DT elect_VBP not_RB to_TO be_VB vaccinated_VBN ._. Some_DT vaccine_NN products_NNS have_VBP been_VBN withdrawn_VBN ,_, as_IN when_WRB Bell_NNP 's_POS palsy_NN developed_VBD for_IN many_JJ recipients_NNS ._. It_PRP has_VBZ just_RB been_VBN reported_VBN that_IN 800_CD European_JJ children_NNS contracted_VBN narcolepsy_NN ,_, an_DT incurable_JJ sleep_NN disorder_NN ,_, after_IN receiving_VBG the_DT swine_NN flu_NN vaccine_NN ._. Mandating_VBG masks_NNS is_VBZ even_RB less_RBR effective_JJ ,_, with_IN no_DT scientific_JJ evidence_NN in_IN support_NN ._. Surgical_JJ masks_NNS are_VBP designed_VBN to_TO prevent_VB dispersion_NN ,_, not_RB inhalation_NN of_IN airborne_JJ particles_NNS ,_, creating_VBG a_DT misleading_JJ sense_NN of_IN protection_NN ._. The_DT masks_NNS make_VBP sense_NN only_RB when_WRB put_VBN on_IN patients_NNS or_CC workers_NNS who_WP are_VBP actively_RB coughing_VBG or_CC sneezing_VBG ._. Nurses_NNS understand_VBP that_IN voluntary_JJ vaccinations_NNS are_VBP just_RB part_NN of_IN a_DT successful_JJ program_NN of_IN protections_NNS for_IN patients_NNS ._. Such_PDT a_DT program_NN includes_VBZ rigorous_JJ cleaning_NN of_IN hospital_NN surfaces_NNS and_CC disinfecting_VBG patient_NN rooms_NNS ;_, promoting_VBG frequent_JJ hand_NN washing_NN with_IN soap_NN ;_: screening_NN and_CC isolating_VBG contagious_JJ patients_NNS when_WRB they_PRP arrive_VBP in_IN the_DT ER_NN or_CC are_VBP admitted_VBN to_IN the_DT hospital_NN ;_, and_CC promoting_VBG education_NN on_IN infectious_JJ control_NN measures_NNS ,_, including_VBG vaccination_NN ._. Too_RB many_JJ hospitals_NNS ,_, whose_WP$ mantra_NN is_VBZ profits_NNS ,_, not_RB patient_JJ safety_NN ,_, favor_VBP forced_VBN vaccinations_NNS while_IN cutting_VBG nursing_NN or_CC housekeeping_NN staff_NN ,_, and_CC denying_VBG paid_VBN sick_JJ leave_NN ,_, as_IN most_JJS industrialized_VBN nations_NNS ensure_VBP ._. Lack_NN of_IN sick_JJ time_NN helped_VBD spread_VB 5_CD million_CD cases_NNS of_IN flu_NN -_HYPH like_JJ illnesses_NNS during_IN the_DT swine_NN flu_NN outbreak_NN ,_, the_DT American_NNP Journal_NNP of_IN Public_NNP Health_NNP reported_VBD ._. Threatening_VBG caregivers_NNS only_RB creates_VBZ a_DT more_RBR hostile_JJ ,_, less_RBR therapeutic_JJ environment_NN ,_, and_CC is_VBZ counter_JJ to_IN the_DT mission_NN of_IN healing_NN ,_, recovery_NN and_CC public_JJ safety_NN ._. Karen_NNP Higgins_NNP is_VBZ a_DT registered_VBN nurse_NN and_CC co-president_NN of_IN National_NNP Nurses_NNPS United_NNP ,_, the_DT largest_JJS U.S._NNP organization_NN of_IN nurses_NNS ._.","NNP 's NNS RB VBP NN NN NNS and NNS to VB VBN . But NNS , VBN by JJ NN NNS and NNS , VBP the NN that NN VBZ a NN - JJ NN to VB the NN of the NN NN . We VBP VBN NNS or the JJ NN that those who VBP the NNS must VB NNS or VBP VBG their NNS . NNS VBP RB JJ NN . NNP NNP NNP 's JJ NN NN NNP NNP RB VBD the NNP NNP NNP that the NN VBZ RB 62 NN JJ , and he VBD RB VB to VB the JJ NN it VBD the JJ NN . It VBZ RB . A 2005 NNP NNP of NNP and NNP NNPS NN RB 20 NNS VBD no NN between VBN NN NN and a NN in NNS . RB , there VBP NN NNS why some VBP RB to VB VBN . Some NN NNS VBP VBN VBN , as when NNP 's NN VBD for JJ NNS . It VBZ RB VBN VBN that 800 JJ NNS VBN NN , an JJ NN NN , after VBG the NN NN NN . VBG NNS VBZ RB RBR JJ , with no JJ NN in NN . JJ NNS VBP VBN to VB NN , RB NN of JJ NNS , VBG a JJ NN of NN . The NNS VBP NN RB when VBN on NNS or NNS who VBP RB VBG or VBG . NNS VBP that JJ NNS VBP RB NN of a JJ NN of NNS for NNS . Such a NN VBZ JJ NN of NN NNS and VBG NN NNS ; VBG JJ NN NN with NN ; NN and VBG JJ NNS when they VBP in the NN or VBP VBN to the NN ; and VBG NN on JJ NN NNS , VBG NN . RB JJ NNS , whose NN VBZ NNS , RB JJ NN , VBP VBN NNS while VBG NN or NN NN , and VBG VBN JJ NN , as JJS VBN NNS VBP . NN of JJ NN VBD VB 5 million NNS of NN - JJ NNS during the NN NN NN , the NNP NNP of NNP NNP VBD . VBG NNS RB VBZ a RBR JJ , RBR JJ NN , and VBZ JJ to the NN of NN , NN and JJ NN . NNP NNP VBZ a VBN NN and NN of NNP NNPS NNP , the JJS NNP NN of NNS ."
211,156,conspiracy,"In_IN June_NNP of_IN 2012_CD ,_, Donald_NNP Trump_NNP told_VBD Fox_NNP News_NNP on_IN the_DT anniversary_NN of_IN the_DT fifth_JJ annual_JJ World_NNP Autism_NNP Awareness_NNP Day_NNP he_PRP is_VBZ concerned_VBN about_IN vaccines_NNS ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- have_VBP for_IN many_JJ years_NNS denied_VBN a_DT possible_JJ link_NN between_IN mercury_NN in_IN vaccines_NNS and_CC autism_NN spectrum_NN disorder_NN (_-LRB- ASD_NNP )_-RRB- ._. However_RB ,_, in_IN October_NNP 2011_CD ,_, the_DT CDC_NNP has_VBZ been_VBN caught_VBN deliberately_RB fudging_VBG data_NNS to_TO try_VB to_TO cover_VB up_RP evidence_NN linking_VBG mercury_NN in_IN vaccines_NNS with_IN ASD_NN ._. [_-LRB- 1_CD ]_-RRB- To_TO conceal_VB any_DT incriminating_JJ vaccine_NN data_NNS ,_, the_DT CDC_NNP had_VBD handed_VBN its_PRP$ massive_JJ database_NN of_IN vaccine_NN records_NNS over_RP to_IN a_DT private_JJ company_NN ,_, effectively_RB pronouncing_VBG it_PRP off_RP -_HYPH limits_NNS to_IN researchers_NNS and_CC preventing_VBG dissemination_NN of_IN the_DT data_NNS through_IN the_DT Freedom_NNP of_IN Information_NNP Act_NNP (_-LRB- FOIA_NNP )_-RRB- ._. However_RB ,_, this_DT did_VBD n’t_RB stop_VB the_DT Coalition_NNP for_IN Mercury_NNP -_HYPH Free_NNP Drugs_NNPS (_-LRB- CoMeD_NNP )_-RRB- ._. During_IN an_DT enquiry_NN through_IN FOIA_NNP it_PRP was_VBD discovered_VBN ,_, as_IN suspected_VBN ,_, that_IN the_DT same_JJ original_JJ Danish_JJ study_NN which_WDT the_DT CDC_NNP referred_VBD to_IN as_IN “_`` definitive_JJ evidence_NN ”_'' that_IN Thimerosal_NNP does_VBZ not_RB increase_VB a_DT child_NN ’s_POS chances_NNS of_IN developing_VBG ASD_NN ,_, actually_RB revealed_VBD the_DT exact_JJ opposite_NN to_TO be_VB true_JJ ._. The_DT Danish_JJ research_NN is_VBZ irrefutably_RB clear_JJ about_IN the_DT findings_NNS :_: *_NFP Thimerosal_NN in_IN vaccines_NNS increases_VBZ a_DT person_NN ’s_POS chances_NNS of_IN developing_VBG autism_NN and_CC other_JJ neurological_JJ diseases_NNS ._. *_NFP In_IN the_DT United_NNP States_NNPS ,_, at_IN least_JJS one_CD in_IN every_DT 100_CD vaccinated_VBN children_NNS is_VBZ afflicted_VBN with_IN ASD_NN ,_, while_IN only_RB 1_CD in_IN every_DT 2,000_CD non-vaccinated_JJ children_NNS has_VBZ the_DT disease_NN ._. In_IN European_JJ countries_NNS like_IN Iceland_NNP ,_, where_WRB children_NNS receive_VBP just_RB one_CD -_HYPH third_JJ the_DT number_NN of_IN vaccines_NNS shots_NNS ,_, only_RB 1_CD in_IN 30,000_CD children_NNS has_VBZ ASD_NN ._. In_IN the_DT US_NNP ,_, now_RB 1_CD in_IN every_DT 88_CD children_NNS has_VBZ ASD_NN ,_, according_VBG to_IN a_DT statement_NN made_VBN by_IN the_DT CDC_NNP in_IN March_NNP 2012_CD ,_, citing_VBG statistics_NNS from_IN the_DT year_NN 2008_CD ._. In_IN those_DT US_NNP states_NNS where_WRB children_NNS receive_VBP the_DT most_JJS vaccines_NNS ,_, or_CC where_WRB relatively_RB more_JJR children_NNS become_VBP vaccinated_VBN ,_, as_IN for_IN example_NN in_IN Utah_NNP and_CC New_NNP Jersey_NNP ,_, as_RB many_JJ as_IN 1_CD in_IN 47_CD children_NNS develop_VBP ASD_NN ._. By_IN comparison_NN ,_, in_IN the_DT mostly_RB rural_JJ state_NN of_IN Iowa_NNP where_WRB fewer_JJR children_NNS become_VBP vaccinated_VBN ,_, 1_CD in_IN 718_CD children_NNS have_VBP autism_NN ._. [_-LRB- 2_CD ]_-RRB- If_IN the_DT overall_JJ trend_NN increase_NN has_VBZ been_VBN consistent_JJ since_IN 2008_CD ,_, which_WDT appears_VBZ to_TO be_VB the_DT case_NN ,_, then_RB 1_CD in_IN every_DT 63_CD children_NNS in_IN the_DT US_NNP now_RB has_VBZ ASD_NN (_-LRB- year_NN 2012_CD )_-RRB- ._. One_PRP does_VBZ n’t_RB need_VB to_TO be_VB a_DT scientist_NN to_TO make_VB sense_NN of_IN this_DT man-made_JJ tragedy_NN ._. The_DT FDA_NNP is_VBZ not_RB an_DT innocent_JJ bystander_NN in_IN this_DT conspiracy_NN against_IN the_DT health_NN of_IN the_DT American_JJ people_NNS ._. Both_CC the_DT CDC_NNP and_CC FDA_NNP have_VBP tried_VBN to_TO conceal_VB from_IN concerned_JJ parents_NNS that_IN the_DT vaccines_NNS still_RB contain_VBP mercury_NN ._. In_IN a_DT recent_JJ court_NN hearing_NN the_DT FDA_NNP unintentionally_RB admitted_VBD that_IN flu_NN vaccines_NNS now_RB routinely_RB given_VBN to_IN babies_NNS as_RB young_JJ as_IN six_CD months_NNS of_IN age_NN contain_VBP it_PRP ,_, according_VBG to_IN *_NFP Courthouse_NNP News_NN Service_NN *_NFP on_IN Friday_NNP ,_, March_NNP 23_CD ,_, 2012_CD ._. [_-LRB- 3_CD ]_-RRB- “_`` The_DT Food_NNP and_CC Drug_NNP Administration_NNP is_VBZ not_RB liable_JJ for_IN approving_VBG a_DT mercury_NN -_HYPH based_VBN vaccine_NN preservative_NN because_IN more_RBR expensive_JJ ,_, mercury_NN -_HYPH free_JJ vaccines_NNS are_VBP available_JJ upon_IN request_NN ,_, ”_'' a_DT federal_JJ judge_NN ruled_VBD ._. “_`` Thimerosal_NNP -_HYPH preserved_VBN flu_NN vaccines_NNS are_VBP necessary_JJ to_TO ensure_VB sufficient_JJ supply_NN at_IN a_DT reasonable_JJ price_NN ,_, ”_'' according_VBG to_IN the_DT judgment_NN ._. The_DT problem_NN with_IN this_DT questionable_JJ ‘_`` solution_NN ’_'' to_TO allegedly_RB avoid_VB mercury_NN poisoning_NN of_IN American_JJ babies_NNS is_VBZ that_IN most_JJS doctors_NNS neither_CC inform_VBP parents_NNS about_IN what_WP flu_NN vaccines_NNS really_RB contain_VBP ,_, nor_CC recommend_VBP the_DT other_JJ ,_, less_RBR toxic_JJ options_NNS ._. Most_JJS parents_NNS still_RB trust_VBP their_PRP$ child_NN ’s_POS pediatrician_NN and_CC do_VBP what_WP they_PRP are_VBP told_VBN ._. And_CC why_WRB pay_VB for_IN an_DT expensive_JJ vaccine_NN ,_, when_WRB there_EX is_VBZ a_DT cheaper_JJR one_NN available_JJ ,_, especially_RB when_WRB the_DT doctor_NN insists_VBZ that_IN the_DT vaccine_NN (_-LRB- containing_VBG mercury_NN )_-RRB- is_VBZ completely_RB safe_JJ ?_. The_DT FDA_NNP has_VBZ no_DT intention_NN of_IN hanging_VBG a_DT poster_NN on_IN the_DT wall_NN of_IN a_DT pediatrician_NN ’s_POS office_NN that_WDT could_MD says_VBZ something_NN like_IN this_DT :_: “_`` Attention_NN parents_NNS :_: beware_VB that_IN the_DT flu_NN shot_NN your_PRP$ child_NN may_MD be_VB receiving_VBG today_NN contains_VBZ brain_NN -_HYPH damaging_VBG mercury_NN !_. ”_'' “_`` While_IN the_DT use_NN of_IN mercury_NN -_HYPH containing_VBG preservatives_NNS has_VBZ declined_VBN in_IN recent_JJ years_NNS with_IN the_DT development_NN of_IN new_JJ products_NNS formulated_VBN with_IN alternativeor_JJ no_DT preservatives_NNS ,_, thimerosal_NN has_VBZ been_VBN used_VBN in_IN some_DT immune_JJ globulin_NN preparations_NNS ,_, anti-venins_NNS ,_, skin_NN test_NN antigens_NNS ,_, and_CC ophthalmic_JJ and_CC nasal_JJ products_NNS ,_, in_IN addition_NN to_IN certain_JJ vaccines_NNS ,_, ”_'' writes_VBZ the_DT FDA_NN on_IN its_PRP$ Thimerosal_NNP in_IN Vaccines_NNPS web_NN page_NN (_-LRB- www.fda.go)._ADD Thimerosal_NNP is_VBZ a_DT mercury_NN -_HYPH based_VBN compound_NN that_WDT is_VBZ FDA_NN -_HYPH approved_VBN as_IN a_DT vaccine_NN preservative_NN ,_, which_WDT makes_VBZ it_PRP perfectly_RB legal_JJ for_IN doctors_NNS to_TO inject_VB this_DT powerful_JJ neurotoxin_NN into_IN babies_NNS ._. Besides_RB ,_, doctors_NNS and_CC pharmaceutical_JJ companies_NNS are_VBP no_RB longer_RBR liable_JJ for_IN causing_VBG vaccine_NN injuries_NNS ,_, including_VBG death_NN ._. One_CD average_JJ flu_NN vaccine_NN contains_VBZ 25_CD micrograms_NNS of_IN mercury_NN and_CC the_DT Environmental_NNP Protection_NNP Agency_NNP (_-LRB- EPA_NNP )_-RRB- stipulates_VBZ a_DT safety_NN limit_NN of_IN 5_CD micrograms_NNS ._. Case_NN in_IN point_NN ,_, children_NNS who_WP are_VBP vaccinated_VBN against_IN the_DT flu_NN receive_VBP over_RB 500_CD percent_NN more_JJR mercury_NN in_IN one_CD day_NN than_IN is_VBZ considered_VBN safe_JJ by_IN the_DT very_JJ governmental_JJ agency_NN responsible_JJ for_IN keeping_VBG us_PRP safe_JJ from_IN environmental_JJ toxins_NNS ._. The_DT FDA_NNP also_RB avoids_VBZ informing_VBG the_DT public_NN that_IN the_DT aluminum_NN phosphate_NN added_VBN to_IN these_DT vaccines_NNS greatly_RB increases_VBZ toxicity_NN of_IN mercury_NN ,_, thereby_RB turning_VBG the_DT *_NFP minimum_JJ mercury_NN tolerance_NN *_NFP level_NN into_IN a_DT complete_JJ joke_NN —_: a_DT joke_NN that_WDT can_MD cause_VB severe_JJ brain_NN damage_NN to_IN an_DT unsuspecting_JJ child_NN ,_, and_CC untold_JJ suffering_NN and_CC financial_JJ hardship_NN to_IN his_PRP$ parents_NNS ._. After_IN millions_NNS of_IN parents_NNS found_VBD that_IN their_PRP$ children_NNS became_VBD autistic_JJ after_IN receiving_VBG vaccine_NN shots_NNS ,_, there_EX was_VBD a_DT massive_JJ increase_NN in_IN class_NN action_NN lawsuits_NNS against_IN the_DT vaccine_NN -_HYPH producing_VBG pharmaceutical_JJ companies_NNS ,_, Wyeth_NNP ,_, GlaxoSmithKline_NNP Plc_NNP ,_, Merck_NNP &_CC Co._NNP and_CC Sanofi_NNP -_HYPH Aventis_NNP SA_NNP ._. A_LS ._. As_IN a_DT result_NN ,_, the_DT vaccine_NN makers_NNS threatened_VBD the_DT Obama_NNP Administration_NNP that_IN they_PRP would_MD stop_VB producing_VBG vaccines_NNS altogether_RB unless_IN they_PRP received_VBD complete_JJ immunity_NN from_IN prosecution_NN for_IN vaccine_NN injuries_NNS ._. In_IN 2010_CD the_DT Supreme_NNP Court_NNP of_IN Justice_NNP passed_VBD a_DT new_JJ law_NN that_WDT granted_VBD these_DT drug_NN giants_NNS the_DT requested_VBN immunity_NN ._. Since_IN then_RB ,_, they_PRP have_VBP free_JJ reign_NN in_IN packing_VBG any_DT kind_NN of_IN toxic_JJ compounds_NNS into_IN their_PRP$ vaccine_NN products_NNS ,_, and_CC nobody_NN can_MD stop_VB them_PRP ._. By_IN adding_VBG toxic_JJ ,_, carcinogenic_JJ ingredients_NNS to_IN their_PRP$ vaccines_NNS ,_, they_PRP generate_VBP an_DT ever_RB -_HYPH increasing_VBG number_NN of_IN new_JJ patients_NNS that_WDT require_VBP medical_JJ treatments_NNS which_WDT mostly_RB consist_VBP of_IN medical_JJ drugs_NNS that_WDT they_PRP also_RB produce_VB ._. The_DT cover-ups_NNS by_IN the_DT CDC_NNP and_CC FDA_NNP have_VBP let_VBN those_DT responsible_JJ for_IN the_DT huge_JJ autism_NN epidemic_NN ,_, which_WDT began_VBD when_WRB mercury_NN and_CC adjuvants_NNS were_VBD first_RB added_VBN to_IN vaccines_NNS ,_, off_IN the_DT hook_NN ._. Without_IN this_DT elaborate_JJ conspiracy_NN against_IN the_DT people_NNS ,_, libel_NN lawsuits_NNS resulting_VBG from_IN permanent_JJ vaccine_NN injuries_NNS in_IN children_NNS would_MD have_VB bankrupted_VBN numerous_JJ governments_NNS ,_, including_VBG the_DT United_NNP States_NNPS and_CC Great_NNP Britain_NNP ,_, and_CC almost_RB the_DT entire_JJ pharmaceutical_JJ industry_NN ._. Donald_NNP Trump_NNP Speak_VB Out_NNP Thankfully_RB ,_, some_DT very_RB influential_JJ spokespeople_NNS and_CC celebrities_NNS are_VBP now_RB coming_VBG to_IN the_DT aid_NN of_IN the_DT ostracized_VBN vaccine_NN safety_NN awareness_NN movement_NN ,_, including_VBG business_NN mogul_NN Donald_NNP Trump_NNP ._. During_IN an_DT interview_NN with_IN Fox_NNP News_NNP on_IN April_NNP 2_CD ,_, 2012_CD ,_, the_DT anniversary_NN of_IN the_DT fifth_JJ annual_JJ World_NNP Autism_NNP Awareness_NNP Day_NNP ,_, Trump_NNP unexpectedly_RB raised_VBD serious_JJ concern_NN about_IN vaccinations_NNS ._. He_PRP told_VBD viewers_NNS he_PRP “_`` *_NFP strongly_RB *_NFP believes_VBZ that_IN Autism_NNP Spectrum_NNP Disorders_NNPS (_-LRB- ASD_NNP )_-RRB- are_VBP linked_VBN to_IN exposure_NN to_IN vaccines_NNS ._. ”_'' [_-LRB- 4_CD ]_-RRB- Trump_NNP has_VBZ been_VBN actively_RB engaged_VBN in_IN helping_VBG children_NNS with_IN autism_NN for_IN many_JJ years_NNS ._. During_IN the_DT interview_NN ,_, the_DT tycoon_NN explained_VBD that_IN a_DT series_NN of_IN casual_JJ observations_NNS had_VBD led_VBN him_PRP to_IN the_DT conclusion_NN that_IN “_`` monster_NN ”_'' vaccinations_NNS cause_VBP autism_NN ._. Trump_NNP ’s_POS remarks_NNS must_MD have_VB been_VBN a_DT bombshell_NN for_IN the_DT most_RBS aggressive_JJ vaccine_NN -_HYPH pushers_NNS ,_, including_VBG doctors_NNS ,_, pharmaceutical_JJ companies_NNS ,_, the_DT government_NN ’s_POS health_NN agencies_NNS and_CC ,_, of_IN course_NN ,_, the_DT most_RBS powerful_JJ vaccine_NN advocate_NN ,_, Bill_NNP Gates_NNP ._. They_PRP all_DT deny_VBP a_DT vaccine_NN -_HYPH autism_NN link_NN exists_VBZ by_IN referring_VBG to_IN the_DT fraudulently_RB altered_VBN research_NN data_NNS the_DT CDC_NNP released_VBD in_IN 2008_CD ._. They_PRP have_VBP exerted_VBN monumental_JJ efforts_NNS in_IN trying_VBG to_TO suppress_VB and_CC delegitimize_VB the_DT work_NN that_WDT has_VBZ been_VBN done_VBN on_IN vaccine_NN -_HYPH caused_VBN autism_NN by_IN researchers_NNS at_IN several_JJ universities_NNS and_CC ,_, most_RBS notably_RB ,_, by_IN Dr_NNP Andrew_NNP Wakefield_NNP ._. Fortunately_RB ,_, through_IN a_DT ruling_NN by_IN Britain_NNP ’s_POS High_NNP Court_NNP ,_, Dr_NNP Wakefield_NNP ’s_POS key_JJ research_NN colleague_NN ,_, Professor_NNP John_NNP Walker_NNP -_HYPH Smith_NNP ,_, has_VBZ recently_RB been_VBN vindicated_VBN of_IN having_VBG falsified_VBN research_NN proving_VBG the_DT vaccine_NN -_HYPH autism_NN link_NN ._. [_-LRB- 5_CD ]_-RRB- In_IN other_JJ words_NNS ,_, the_DT work_NN by_IN these_DT two_CD scientists_NNS is_VBZ now_RB considered_VBN genuine_JJ and_CC valid_JJ ._. While_IN Trump_NNP acknowledged_VBD that_IN speaking_VBG out_RP against_IN vaccines_NNS and_CC the_DT vaccineschedule_NN is_VBZ controversial_JJ ,_, he_PRP said_VBD “_`` …_: I_PRP could_MD n’t_RB care_VB less_JJR ._. I_PRP ’ve_VBP seenpeople_NNS where_WRB they_PRP have_VBP a_DT perfectly_RB healthy_JJ child_NN ,_, and_CC they_PRP go_VBP for_IN the_DT vaccinations_NNS and_CC a_DT month_NN later_RBR the_DT child_NN is_VBZ no_RB longer_RBR healthy_JJ ._. ”_'' “_`` I_PRP ’ve_VBP gotten_VBN to_TO be_VB pretty_RB familiar_JJ with_IN the_DT subject_NN ,_, ”_'' Trump_NNP went_VBD on_RP to_TO say_VB ._. “_`` You_PRP know_VBP ,_, I_PRP have_VBP a_DT theory_NN —_: and_CC it_PRP ’s_VBZ a_DT theory_NN that_WDT some_DT people_NNS believe_VBP in_IN —_: and_CC that_DT ’s_VBZ the_DT vaccinations_NNS ._. We_PRP never_RB had_VBD anything_NN like_IN this_DT ._. This_DT is_VBZ now_RB an_DT epidemic_NN ._. It_PRP ’s_VBZ way_RB ,_, way_RB up_RB over_IN the_DT past_JJ 10_CD years_NNS ._. It_PRP ’s_VBZ way_RB up_RB over_IN the_DT past_JJ two_CD years_NNS ._. And_CC ,_, you_PRP know_VBP ,_, when_WRB you_PRP take_VBP a_DT little_JJ baby_NN that_WDT weighs_VBZ like_IN 12_CD pounds_NNS into_IN a_DT doctor_NN ’s_POS office_NN and_CC they_PRP pump_VBP them_PRP with_IN many_JJ ,_, many_JJ simultaneous_JJ vaccinations_NNS —_: I_PRP ’m_VBP all_RB for_IN vaccinations_NNS ,_, but_CC I_PRP think_VBP when_WRB you_PRP add_VBP all_DT of_IN these_DT vaccinations_NNS together_RB and_CC then_RB two_CD months_NNS later_RBR the_DT baby_NN is_VBZ so_RB different_JJ then_RB lots_NNS of_IN different_JJ things_NNS have_VBP happened_VBN ._. I_PRP really_RB —_: I_PRP ’ve_VBP known_VBN cases_NNS ._. ”_'' Usually_RB ,_, the_DT media_NN which_WDT are_VBP sponsored_VBN ,_, in_IN large_JJ part_NN ,_, through_IN advertisements_NNS paid_VBN for_IN by_IN pharmaceutical_JJ companies_NNS ,_, have_VBP a_DT financial_JJ interest_NN in_IN keeping_VBG their_PRP$ sponsors_NNS happy_JJ ._. I_PRP personally_RB would_MD like_VB to_TO thank_VB Donald_NNP Trump_NNP for_IN bringing_VBG this_DT important_JJ issue_NN ,_, which_WDT concerns_VBZ so_RB many_JJ millions_NNS of_IN individuals_NNS and_CC their_PRP$ families_NNS ,_, back_RB into_IN the_DT minds_NNS of_IN the_DT people_NNS ._. He_PRP has_VBZ clearly_RB shown_VBN that_IN he_PRP is_VBZ not_RB afraid_JJ of_IN surprising_VBG one_CD of_IN the_DT world_NN ’s_POS leading_VBG news_NN channels_NNS by_IN issuing_VBG such_JJ as_IN stern_JJ warning_NN ._. The_DT platinum_NN standard_NN of_IN advanced_JJ multivitamin_NN formulations_NNS is_VBZ back_RB in_IN stock_NN !_. Order_VB Vitamin_NN Mineral_NN Fusion_NN at_IN 50_CD %_NN off_RP with_IN double_JJ Patriot_NN Points_NNS and_CC free_JJ shipping_NN today_NN !_.","In NNP of 2012 , NNP NNP VBD NNP NNP on the NN of the JJ JJ NNP NNP NNP NNP he VBZ VBN about NNS . The NNPS for NNP NNP and NNP ( NNP ) VBP for JJ NNS VBN a JJ NN between NN in NNS and NN NN NN ( NNP ) . RB , in NNP 2011 , the NNP VBZ VBN VBN RB VBG NNS to VB to VB up NN VBG NN in NNS with NN . [ 1 ] To VB any JJ NN NNS , the NNP VBD VBN its JJ NN of NN NNS over to a JJ NN , RB VBG it off - NNS to NNS and VBG NN of the NNS through the NNP of NNP NNP ( NNP ) . RB , this VBD RB VB the NNP for NNP - NNP NNPS ( NNP ) . During an NN through NNP it VBD VBN , as VBN , that the JJ JJ JJ NN which the NNP VBD to as “ JJ NN ” that NNP VBZ RB VB a NN ’s NNS of VBG NN , RB VBD the JJ NN to VB JJ . The JJ NN VBZ RB JJ about the NNS : * NN in NNS VBZ a NN ’s NNS of VBG NN and JJ JJ NNS . * In the NNP NNPS , at JJS one in every 100 VBN NNS VBZ VBN with NN , while RB 1 in every 2,000 JJ NNS VBZ the NN . In JJ NNS like NNP , where NNS VBP RB one - JJ the NN of NNS NNS , RB 1 in 30,000 NNS VBZ NN . In the NNP , RB 1 in every 88 NNS VBZ NN , VBG to a NN VBN by the NNP in NNP 2012 , VBG NNS from the NN 2008 . In those NNP NNS where NNS VBP the JJS NNS , or where RB JJR NNS VBP VBN , as for NN in NNP and NNP NNP , RB JJ as 1 in 47 NNS VBP NN . By NN , in the RB JJ NN of NNP where JJR NNS VBP VBN , 1 in 718 NNS VBP NN . [ 2 ] If the JJ NN NN VBZ VBN JJ since 2008 , which VBZ to VB the NN , RB 1 in every 63 NNS in the NNP RB VBZ NN ( NN 2012 ) . One VBZ RB VB to VB a NN to VB NN of this JJ NN . The NNP VBZ RB an JJ NN in this NN against the NN of the JJ NNS . Both the NNP and NNP VBP VBN to VB from JJ NNS that the NNS RB VBP NN . In a JJ NN NN the NNP RB VBD that NN NNS RB RB VBN to NNS RB JJ as six NNS of NN VBP it , VBG to * NNP NN NN * on NNP , NNP 23 , 2012 . [ 3 ] “ The NNP and NNP NNP VBZ RB JJ for VBG a NN - VBN NN NN because RBR JJ , NN - JJ NNS VBP JJ upon NN , ” a JJ NN VBD . “ NNP - VBN NN NNS VBP JJ to VB JJ NN at a JJ NN , ” VBG to the NN . The NN with this JJ ‘ NN ’ to RB VB NN NN of JJ NNS VBZ that JJS NNS neither VBP NNS about what NN NNS RB VBP , nor VBP the JJ , RBR JJ NNS . JJS NNS RB VBP their NN ’s NN and VBP what they VBP VBN . And why VB for an JJ NN , when there VBZ a JJR NN JJ , RB when the NN VBZ that the NN ( VBG NN ) VBZ RB JJ ? The NNP VBZ no NN of VBG a NN on the NN of a NN ’s NN that could VBZ NN like this : “ NN NNS : VB that the NN NN your NN may VB VBG NN VBZ NN - VBG NN ! ” “ While the NN of NN - VBG NNS VBZ VBN in JJ NNS with the NN of JJ NNS VBN with JJ no NNS , NN VBZ VBN VBN in some JJ NN NNS , NNS , NN NN NNS , and JJ and JJ NNS , in NN to JJ NNS , ” VBZ the NN on its NNP in NNPS NN NN ( www.fda.go). NNP VBZ a NN - VBN NN that VBZ NN - VBN as a NN NN , which VBZ it RB JJ for NNS to VB this JJ NN into NNS . RB , NNS and JJ NNS VBP RB RBR JJ for VBG NN NNS , VBG NN . One JJ NN NN VBZ 25 NNS of NN and the NNP NNP NNP ( NNP ) VBZ a NN NN of 5 NNS . NN in NN , NNS who VBP VBN against the NN VBP RB 500 NN JJR NN in one NN than VBZ VBN JJ by the JJ JJ NN JJ for VBG us JJ from JJ NNS . The NNP RB VBZ VBG the NN that the NN NN VBN to these NNS RB VBZ NN of NN , RB VBG the * JJ NN NN * NN into a JJ NN — a NN that can VB JJ NN NN to an JJ NN , and JJ NN and JJ NN to his NNS . After NNS of NNS VBD that their NNS VBD JJ after VBG NN NNS , there VBD a JJ NN in NN NN NNS against the NN - VBG JJ NNS , NNP , NNP NNP , NNP & NNP and NNP - NNP NNP . A . As a NN , the NN NNS VBD the NNP NNP that they would VB VBG NNS RB unless they VBD JJ NN from NN for NN NNS . In 2010 the NNP NNP of NNP VBD a JJ NN that VBD these NN NNS the VBN NN . Since RB , they VBP JJ NN in VBG any NN of JJ NNS into their NN NNS , and NN can VB them . By VBG JJ , JJ NNS to their NNS , they VBP an RB - VBG NN of JJ NNS that VBP JJ NNS which RB VBP of JJ NNS that they RB VB . The NNS by the NNP and NNP VBP VBN those JJ for the JJ NN NN , which VBD when NN and NNS VBD RB VBN to NNS , off the NN . Without this JJ NN against the NNS , NN NNS VBG from JJ NN NNS in NNS would VB VBN JJ NNS , VBG the NNP NNPS and NNP NNP , and RB the JJ JJ NN . NNP NNP VB NNP RB , some RB JJ NNS and NNS VBP RB VBG to the NN of the VBN NN NN NN NN , VBG NN NN NNP NNP . During an NN with NNP NNP on NNP 2 , 2012 , the NN of the JJ JJ NNP NNP NNP NNP , NNP RB VBD JJ NN about NNS . He VBD NNS he “ * RB * VBZ that NNP NNP NNPS ( NNP ) VBP VBN to NN to NNS . ” [ 4 ] NNP VBZ VBN RB VBN in VBG NNS with NN for JJ NNS . During the NN , the NN VBD that a NN of JJ NNS VBD VBN him to the NN that “ NN ” NNS VBP NN . NNP ’s NNS must VB VBN a NN for the RBS JJ NN - NNS , VBG NNS , JJ NNS , the NN ’s NN NNS and , of NN , the RBS JJ NN NN , NNP NNP . They all VBP a NN - NN NN VBZ by VBG to the RB VBN NN NNS the NNP VBD in 2008 . They VBP VBN JJ NNS in VBG to VB and VB the NN that VBZ VBN VBN on NN - VBN NN by NNS at JJ NNS and , RBS RB , by NNP NNP NNP . RB , through a NN by NNP ’s NNP NNP , NNP NNP ’s JJ NN NN , NNP NNP NNP - NNP , VBZ RB VBN VBN of VBG VBN NN VBG the NN - NN NN . [ 5 ] In JJ NNS , the NN by these two NNS VBZ RB VBN JJ and JJ . While NNP VBD that VBG out against NNS and the NN VBZ JJ , he VBD “ … I could RB VB JJR . I VBP NNS where they VBP a RB JJ NN , and they VBP for the NNS and a NN RBR the NN VBZ RB RBR JJ . ” “ I VBP VBN to VB RB JJ with the NN , ” NNP VBD on to VB . “ You VBP , I VBP a NN — and it VBZ a NN that some NNS VBP in — and that VBZ the NNS . We RB VBD NN like this . This VBZ RB an NN . It VBZ RB , RB RB over the JJ 10 NNS . It VBZ RB RB over the JJ two NNS . And , you VBP , when you VBP a JJ NN that VBZ like 12 NNS into a NN ’s NN and they VBP them with JJ , JJ JJ NNS — I VBP RB for NNS , but I VBP when you VBP all of these NNS RB and RB two NNS RBR the NN VBZ RB JJ RB NNS of JJ NNS VBP VBN . I RB — I VBP VBN NNS . ” RB , the NN which VBP VBN , in JJ NN , through NNS VBN for by JJ NNS , VBP a JJ NN in VBG their NNS JJ . I RB would VB to VB NNP NNP for VBG this JJ NN , which VBZ RB JJ NNS of NNS and their NNS , RB into the NNS of the NNS . He VBZ RB VBN that he VBZ RB JJ of VBG one of the NN ’s VBG NN NNS by VBG JJ as JJ NN . The NN NN of JJ NN NNS VBZ RB in NN ! VB NN NN NN at 50 NN off with JJ NN NNS and JJ NN NN !"
212,936,mainstream,"Social_JJ restrictions_NNS could_MD be_VB kept_VBN in_IN place_NN in_IN the_DT UK_NNP for_IN the_DT rest_NN of_IN the_DT year_NN ,_, it_PRP has_VBZ been_VBN confirmed_VBN ._. Professor_NNP Chris_NNP Whitty_NNP ,_, Chief_JJ Medical_JJ Adviser_NN to_IN the_DT UK_NNP Government_NNP ,_, told_VBD the_DT public_NN it_PRP was_VBD “_`` wholly_RB unrealistic_JJ ”_'' to_TO expect_VB life_NN to_TO return_VB to_IN normal_NN soon_RB ._. Speaking_VBG as_IN part_NN of_IN the_DT Government_NNP ’s_POS daily_JJ briefing_NN on_IN the_DT coronavirus_NN crisis_NN ,_, Whitty_NNP said_VBD that_IN “_`` in_IN the_DT long_JJ run_NN ”_'' the_DT ideal_JJ way_NN for_IN life_NN to_TO return_VB to_IN normal_NN would_MD be_VB via_IN a_DT “_`` highly_RB effective_JJ vaccine_NN ”_'' for_IN Covid_NNP -_HYPH 19_CD ,_, but_CC said_VBD the_DT chance_NN of_IN this_DT becoming_VBG a_DT reality_NN within_IN the_DT next_JJ year_NN was_VBD “_`` incredibly_RB small_JJ ”_'' ._. “_`` This_DT disease_NN is_VBZ not_RB going_VBG to_TO be_VB eradicated_VBN ,_, it_PRP is_VBZ not_RB going_VBG to_TO disappear_VB ,_, ”_'' he_PRP continued_VBD ._. “_`` So_RB we_PRP have_VBP to_TO accept_VB that_IN we_PRP are_VBP working_VBG with_IN a_DT disease_NN that_WDT we_PRP are_VBP going_VBG to_TO be_VB with_IN globally_RB …_: for_IN the_DT foreseeable_JJ future_NN ._. ”_'' While_IN UK_NNP schools_NNS have_VBP been_VBN given_VBN a_DT prospective_JJ reopening_NN date_NN of_IN June_NNP 1_CD ,_, mass_JJ gatherings_NNS such_JJ as_IN concerts_NNS or_CC festivals_NNS and_CC cramped_VBN commuting_NN appear_VBP to_TO be_VB a_DT more_RBR distant_JJ prospect_NN ._. Whitty_NNP continued_VBD :_: “_`` In_IN the_DT long_JJ run_NN ,_, the_DT exit_NN from_IN this_DT is_VBZ going_VBG to_TO be_VB one_CD of_IN two_CD things_NNS ,_, ideally_RB ._. “_`` A_DT vaccine_NN ,_, and_CC there_EX are_VBP a_DT variety_NN of_IN ways_NNS they_PRP can_MD be_VB deployed_VBN …_, or_CC highly_RB effective_JJ drugs_NNS so_IN that_IN people_NNS stop_VBP dying_VBG of_IN this_DT disease_NN even_RB if_IN they_PRP catch_VBP it_PRP ,_, or_CC which_WDT can_MD prevent_VB this_DT disease_NN in_IN vulnerable_JJ people_NNS ._. ”_'' “_`` So_RB what_WP we_PRP have_VBP to_TO do_VB is_VBZ think_VB very_RB seriously_RB about_IN this_DT :_: what_WP is_VBZ the_DT best_JJS balance_NN of_IN measures_NNS that_WDT gives_VBZ us_PRP the_DT best_JJS public_JJ health_NN outcome_NN ?_. ”_'' Last_JJ week_NN ,_, healthcare_NN experts_NNS made_VBD predictions_NNS that_IN live_JJ concerts_NNS and_CC festivals_NNS will_MD not_RB return_VB until_IN autumn_NN 2021_CD ._. “_`` Larger_JJR gatherings_NNS –_: conferences_NNS ,_, concerts_NNS ,_, sporting_NN events_NNS –_: when_WRB people_NNS say_VBP they_PRP ’re_VBP going_VBG to_TO reschedule_VB this_DT conference_NN or_CC graduation_NN event_NN for_IN October_NNP 2020_CD ,_, I_PRP have_VBP no_DT idea_NN how_WRB they_PRP think_VBP that_DT ’s_VBZ a_DT plausible_JJ possibility_NN ,_, bioethicist_NN and_CC professor_NN of_IN healthcare_NN management_NN Zeke_NNP Emanuel_NNP said_VBD during_IN a_DT conference_NN ._. “_`` I_PRP think_VBP those_DT things_NNS will_MD be_VB the_DT last_JJ to_TO return_VB ,_, ”_'' he_PRP continued_VBD ._. The_DT UK_NNP has_VBZ been_VBN in_IN lockdown_NN since_IN the_DT second_JJ half_NN of_IN March_NNP ,_, with_IN residents_NNS only_RB allowed_VBN to_TO leave_VB their_PRP$ home_NN for_IN medical_JJ supplies_NNS ,_, food_NN shopping_NN and_CC one_CD hour_NN of_IN exercise_NN per_IN day_NN ._.","JJ NNS could VB VBN in NN in the NNP for the NN of the NN , it VBZ VBN VBN . NNP NNP NNP , JJ JJ NN to the NNP NNP , VBD the NN it VBD “ RB JJ ” to VB NN to VB to NN RB . VBG as NN of the NNP ’s JJ NN on the NN NN , NNP VBD that “ in the JJ NN ” the JJ NN for NN to VB to NN would VB via a “ RB JJ NN ” for NNP - 19 , but VBD the NN of this VBG a NN within the JJ NN VBD “ RB JJ ” . “ This NN VBZ RB VBG to VB VBN , it VBZ RB VBG to VB , ” he VBD . “ RB we VBP to VB that we VBP VBG with a NN that we VBP VBG to VB with RB … for the JJ NN . ” While NNP NNS VBP VBN VBN a JJ NN NN of NNP 1 , JJ NNS JJ as NNS or NNS and VBN NN VBP to VB a RBR JJ NN . NNP VBD : “ In the JJ NN , the NN from this VBZ VBG to VB one of two NNS , RB . “ A NN , and there VBP a NN of NNS they can VB VBN … or RB JJ NNS so that NNS VBP VBG of this NN RB if they VBP it , or which can VB this NN in JJ NNS . ” “ RB what we VBP to VB VBZ VB RB RB about this : what VBZ the JJS NN of NNS that VBZ us the JJS JJ NN NN ? ” JJ NN , NN NNS VBD NNS that JJ NNS and NNS will RB VB until NN 2021 . “ JJR NNS – NNS , NNS , NN NNS – when NNS VBP they VBP VBG to VB this NN or NN NN for NNP 2020 , I VBP no NN how they VBP that VBZ a JJ NN , NN and NN of NN NN NNP NNP VBD during a NN . “ I VBP those NNS will VB the JJ to VB , ” he VBD . The NNP VBZ VBN in NN since the JJ NN of NNP , with NNS RB VBN to VB their NN for JJ NNS , NN NN and one NN of NN per NN ."
213,1336,mainstream,"As_IN a_DT public_JJ health_NN emergency_NN of_IN international_JJ concern_NN ,_, the_DT novel_JJ coronavirus_NN disease_NN (_-LRB- ‎COVID_NNP -_HYPH 19_CD )_-RRB- ‎_POS pandemic_NN has_VBZ drawn_VBN worldwide_JJ attention_NN and_CC a_DT global_JJ response_NN ._. All_DT countries_NNS and_CC areas_NNS have_VBP initiated_VBN measures_NNS to_TO contain_VB and_CC mitigate_VB transmission_NN and_CC reduce_VB the_DT impact_NN of_IN the_DT outbreak_NN on_IN health_NN -_HYPH care_NN systems_NNS ,_, including_VBG shifting_VBG health_NN -_HYPH care_NN resources_NNS to_IN the_DT COVID_NN -_HYPH 19_CD response_NN ._. During_IN an_DT epidemic_NN ,_, even_RB a_DT temporary_JJ interruption_NN of_IN basic_JJ health_NN -_HYPH care_NN delivery_NN such_JJ as_IN routine_JJ immunization_NN services_NNS may_MD lead_VB to_IN secondary_JJ health_NN crises_NNS such_JJ as_IN measles_NN outbreaks_NNS during_IN or_CC after_IN the_DT recovery_NN phase_NN ,_, amplifying_VBG the_DT economic_JJ damage_NN of_IN the_DT epidemic_NN and_CC exacerbating_VBG morbidity_NN and_CC mortality_NN ._. Immunization_NN delivery_NN strategies_NNS may_MD need_VB to_TO be_VB adapted_VBN and_CC should_MD be_VB conducted_VBN under_IN safe_JJ conditions_NNS ,_, without_IN undue_JJ harm_NN to_IN health_NN workers_NNS ,_, caregivers_NNS and_CC the_DT community_NN ._. This_DT document_NN provides_VBZ guidance_NN to_IN Member_NNP States_NNPS on_IN how_WRB to_TO prioritize_VB and_CC adapt_VB immunization_NN services_NNS during_IN the_DT Covid_NNP -_HYPH 19_CD pandemic_NN ,_, and_CC steps_NNS to_TO mitigate_VB the_DT impact_NN of_IN the_DT pandemic_NN on_IN vaccine_NN -_HYPH preventable_JJ diseases_NNS ._.","As a JJ NN NN of JJ NN , the JJ NN NN ( NNP - 19 ) ‎ NN VBZ VBN JJ NN and a JJ NN . All NNS and NNS VBP VBN NNS to VB and VB NN and VB the NN of the NN on NN - NN NNS , VBG VBG NN - NN NNS to the NN - 19 NN . During an NN , RB a JJ NN of JJ NN - NN NN JJ as JJ NN NNS may VB to JJ NN NNS JJ as NN NNS during or after the NN NN , VBG the JJ NN of the NN and VBG NN and NN . NN NN NNS may VB to VB VBN and should VB VBN under JJ NNS , without JJ NN to NN NNS , NNS and the NN . This NN VBZ NN to NNP NNPS on how to VB and VB NN NNS during the NNP - 19 NN , and NNS to VB the NN of the NN on NN - JJ NNS ."
214,980,mainstream,"Germany_NNP ,_, France_NNP ,_, the_DT Netherlands_NNPS and_CC Italy_NNP Wednesday_NNP announced_VBD the_DT formation_NN of_IN a_DT vaccine_NN alliance_NN aimed_VBN at_IN ensuring_VBG that_IN a_DT possible_JJ future_JJ coronavirus_NN vaccine_NN is_VBZ available_JJ and_CC affordable_JJ for_IN Europeans_NNPS ._. The_DT four_CD countries_NNS have_VBP come_VBN together_RB under_IN the_DT “_`` Inclusive_NNP Vaccine_NNP Alliance_NNP ,_, ”_'' which_WDT will_MD look_VB to_TO make_VB sure_JJ that_IN Europe_NNP not_RB only_RB gets_VBZ a_DT vaccine_NN at_IN a_DT good_JJ price_NN from_IN pharmaceutical_JJ companies_NNS ,_, but_CC that_IN European_JJ production_NN capabilities_NNS are_VBP prioritized_VBN ._. In_IN a_DT statement_NN ,_, the_DT Dutch_JJ health_NN ministry_NN says_VBZ the_DT alliance_NN intends_VBZ to_TO work_VB with_IN the_DT European_NNP Commission_NNP and_CC is_VBZ already_RB in_IN talks_NNS with_IN various_JJ pharmaceutical_JJ companies_NNS ._. It_PRP is_VBZ also_RB offering_VBG other_JJ EU_NNP member_NN countries_NNS the_DT opportunity_NN to_TO take_VB part_NN in_IN any_DT initiatives_NNS arising_VBG from_IN the_DT collaboration_NN ._. In_IN addition_NN ,_, Deputy_NNP Prime_NNP Minister_NNP and_CC Health_NNP Minister_NNP Hugo_NNP de_NNP Jonge_NNP said_VBD in_IN a_DT letter_NN announcing_VBG the_DT initiative_NN that_IN the_DT alliance_NN is_VBZ focusing_VBG on_IN the_DT “_`` stimulation_NN of_IN vaccine_NN production_NN in_IN European_JJ facilities_NNS ._. ”_'' While_IN the_DT aim_NN is_VBZ to_TO secure_VB access_NN to_IN a_DT vaccine_NN for_IN Europe_NNP ,_, de_NNP Jonge_NNP said_VBD the_DT alliance_NN would_MD seek_VB ways_NNS to_TO use_VB the_DT available_JJ capacity_NN to_TO secure_VB access_NN for_IN more_RBR vulnerable_JJ countries_NNS such_JJ as_IN those_DT in_IN Africa_NNP ._. Today_NN 's_POS announcement_NN comes_VBZ as_IN countries_NNS around_IN the_DT globe_NN seek_VBP to_TO shore_VB up_RP their_PRP$ manufacturing_NN capacity_NN and_CC secure_VB preorders_NNS of_IN potential_JJ future_JJ vaccines_NNS with_IN pharmaceutical_JJ companies_NNS ._. This_DT article_NN is_VBZ part_NN of_IN POLITICO_NNP ’s_POS premium_JJ policy_NN service_NN :_: Pro_NNP Health_NNP Care_NNP ._. From_IN drug_NN pricing_NN ,_, EMA_NN ,_, vaccines_NNS ,_, pharma_NN and_CC more_JJR ,_, our_PRP$ specialized_JJ journalists_NNS keep_VBP you_PRP on_IN top_NN of_IN the_DT topics_NNS driving_VBG the_DT health_NN care_NN policy_NN agenda_NN ._. Email_VB pro@politico.eu_NNP for_IN a_DT complimentary_JJ trial_NN ._.","NNP , NNP , the NNPS and NNP NNP VBD the NN of a NN NN VBN at VBG that a JJ JJ NN NN VBZ JJ and JJ for NNPS . The four NNS VBP VBN RB under the “ NNP NNP NNP , ” which will VB to VB JJ that NNP RB RB VBZ a NN at a JJ NN from JJ NNS , but that JJ NN NNS VBP VBN . In a NN , the JJ NN NN VBZ the NN VBZ to VB with the NNP NNP and VBZ RB in NNS with JJ JJ NNS . It VBZ RB VBG JJ NNP NN NNS the NN to VB NN in any NNS VBG from the NN . In NN , NNP NNP NNP and NNP NNP NNP NNP NNP VBD in a NN VBG the NN that the NN VBZ VBG on the “ NN of NN NN in JJ NNS . ” While the NN VBZ to VB NN to a NN for NNP , NNP NNP VBD the NN would VB NNS to VB the JJ NN to VB NN for RBR JJ NNS JJ as those in NNP . NN 's NN VBZ as NNS around the NN VBP to VB up their NN NN and VB NNS of JJ JJ NNS with JJ NNS . This NN VBZ NN of NNP ’s JJ NN NN : NNP NNP NNP . From NN NN , NN , NNS , NN and JJR , our JJ NNS VBP you on NN of the NNS VBG the NN NN NN NN . VB NNP for a JJ NN ."
215,370,mainstream,"An_DT anti-corruption_NN watchdog_NN group_NN is_VBZ urging_VBG the_DT U.S._NNP Securities_NNPS and_CC Exchange_NNP Commission_NNP to_TO investigate_VB top_JJ executives_NNS at_IN Moderna_NNP ,_, the_DT biotech_NN firm_NN developing_VBG a_DT promising_JJ coronavirus_NN vaccine_NN ,_, for_IN allegedly_RB manipulating_VBG the_DT stock_NN market_NN ._. ""_`` This_DT misconduct_NN was_VBD particularly_RB egregious_JJ because_IN it_PRP involved_VBD not_RB only_RB financial_JJ fraud_NN and_CC manipulation_NN of_IN the_DT financial_JJ markets_NNS ,_, but_CC also_RB because_IN it_PRP exploited_VBD widespread_JJ fears_NNS surrounding_VBG the_DT ongoing_JJ COVID_NN -_HYPH 19_CD pandemic_NN ,_, ""_'' wrote_VBD Kyle_NNP Herrig_NNP ,_, who_WP heads_VBZ Accountable_NNP ._. US_NNP ,_, in_IN a_DT letter_NN to_IN the_DT SEC_NNP ._. ""_`` I_PRP strongly_RB urge_VBP the_DT SEC_NNP to_TO investigate_VB these_DT matters_NNS ._. ""_'' The_DT group_NN 's_POS concerns_NNS center_VBP on_IN insider_NN trading_NN activity_NN at_IN Moderna_NNP after_IN the_DT company_NN last_JJ month_NN announced_VBD positive_JJ results_NNS in_IN Phase_NN 1_CD trials_NNS of_IN its_PRP$ coronavirus_NN vaccine_NN ._. The_DT news_NN pushed_VBD up_RP the_DT company_NN 's_POS stock_NN price_NN 30_CD %_NN to_IN an_DT all_DT -_HYPH time_NN high_NN of_IN $_$ 87_CD ._. In_IN the_DT days_NNS following_VBG the_DT announcement_NN ,_, Moderna_NNP 's_POS CEO_NN ,_, other_JJ executives_NNS and_CC funds_NNS controlled_VBN by_IN the_DT chairman_NN of_IN its_PRP$ board_NN sold_VBD about_RB $_$ 90_CD million_CD worth_NN of_IN company_NN shares_NNS ._. Accountable_JJ .US_NNP sent_VBD its_PRP$ letter_NN ,_, a_DT copy_NN of_IN which_WDT was_VBD provided_VBN to_IN CBS_NNP MoneyWatch_NNP ,_, on_IN Tuesday_NNP to_IN Joseph_NNP Sansone_NNP ,_, who_WP heads_VBZ the_DT SEC_NNP 's_POS market_NN abuse_NN unit_NN ._. The_DT agency_NN declined_VBD to_TO comment_VB on_IN the_DT letter_NN or_CC whether_IN it_PRP is_VBZ looking_VBG into_IN allegations_NNS against_IN Moderna_NNP and_CC its_PRP$ executives_NNS ._. Herrig_NNP said_VBD he_PRP has_VBZ n't_RB received_VBN a_DT response_NN from_IN the_DT SEC_NNP ._. Moderna_NNP on_IN Wednesday_NNP defended_VBD the_DT stock_NN sales_NNS that_WDT aroused_VBD Accountable_NNP ._. US_NNP '_POS suspicion_NN ._. ""_`` Executive_JJ sales_NNS are_VBP made_VBN under_IN pre-planned_VBN 10b5_CD -_SYM 1_CD plans_NNS ,_, which_WDT are_VBP executed_VBN during_IN open_JJ trading_NN windows_NNS in_IN accordance_NN with_IN the_DT company_NN 's_POS insider_NN trading_NN policy_NN ,_, ""_'' the_DT company_NN said_VBD in_IN a_DT statement_NN to_IN CBS_NNP MoneyWatch_NNP ._. ""_`` As_IN a_DT matter_NN of_IN practice_NN ,_, Moderna_NNP does_VBZ not_RB intend_VB to_TO comment_VB on_IN any_DT alleged_VBN or_CC potential_JJ litigation_NN or_CC investigation_NN ;_, nor_CC on_IN purchases_NNS or_CC sales_NNS by_IN individual_JJ investors_NNS or_CC groups_NNS ._. ""_'' Moderna_NNP 's_POS vaccine_NN results_NNS have_VBP yet_RB to_TO be_VB reviewed_VBN by_IN outside_JJ experts_NNS or_CC published_VBN in_IN a_DT medical_JJ journal_NN ,_, and_CC some_DT have_VBP questioned_VBN whether_IN the_DT company_NN was_VBD too_RB quick_JJ in_IN publicizing_VBG the_DT trial_NN data_NNS ._. Shares_NNS of_IN the_DT company_NN sunk_VBD as_RB low_JJ as_IN $_$ 52_CD last_JJ week_NN ,_, but_CC have_VBP since_RB rebounded_VBN to_IN $_$ 59_CD ,_, slightly_RB below_IN its_PRP$ stock_NN price_NN before_IN the_DT preliminary_JJ testing_NN results_NNS were_VBD released_VBN ._. Moderna_NNP 's_POS executives_NNS have_VBP continued_VBN to_TO sell_VB their_PRP$ shares_NNS ._. On_IN Tuesday_NNP ,_, the_DT company_NN disclosed_VBD that_IN CEO_NN Stephane_NNP Bancel_NNP had_VBD cashed_VBN in_RP an_DT additional_JJ $_$ 1.9_CD million_CD in_IN stock_NN ._. Chief_NNP Medical_NNP Officer_NNP Tal_NNP Zaks_NNP also_RB netted_VBD an_DT additional_JJ $_$ 6.7_CD million_CD in_IN stock_NN sales_NNS in_IN which_WDT he_PRP liquidated_VBD his_PRP$ entire_JJ holding_NN of_IN Moderna_NNP shares_NNS ,_, according_VBG to_IN a_DT filing_NN with_IN the_DT SEC_NNP ._. Zaks_NNP still_RB holds_VBZ options_NNS to_TO buy_VB an_DT additional_JJ 118,000_CD Moderna_NNP shares_NNS ._. In_IN the_DT letter_NN to_IN the_DT SEC_NNP ,_, Herrig_NNP called_VBD the_DT timing_NN of_IN the_DT post_NN -_HYPH announcment_NN trades_NNS suspicious_JJ ,_, and_CC questioned_VBD whether_IN the_DT company_NN and_CC the_DT executives_NNS had_VBD coordinated_VBN ahead_RB of_IN releasing_VBG the_DT trial_NN results_NNS ,_, including_VBG when_WRB the_DT shares_NNS would_MD be_VB sold_VBN ._. Accountable_JJ .US_NNP is_VBZ a_DT non-profit_NN supported_VBN by_IN the_DT New_NNP Venture_NNP Fund_NNP ,_, which_WDT funds_VBZ left_JJ -_HYPH leaning_VBG policy_NN groups_NNS ._. ""_`` Evidence_NN suggests_VBZ that_IN Moderna_NNP and_CC at_IN least_JJS two_CD of_IN its_PRP$ officers_NNS ,_, possibly_RB among_IN others_NNS ,_, may_MD have_VB improperly_RB exploited_VBN coronavirus_NN fears_NNS to_TO boost_VB the_DT company_NN 's_POS value_NN ,_, as_RB well_RB as_IN their_PRP$ own_JJ bank_NN accounts_NNS ,_, ""_'' Herrig_NNP wrote_VBD ._. On_IN Wednesday_NNP ,_, medical_JJ news_NN website_NN Stat_NNP reported_VBD that_IN Bancel_NNP recently_RB told_VBD investors_NNS at_IN a_DT conference_NN that_IN Moderna_NNP rushed_VBD out_RP its_PRP$ coronavirus_NN testing_NN results_NNS in_IN order_NN to_TO avoid_VB a_DT possible_JJ leak_NN of_IN the_DT findings_NNS ._. Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT government_NN 's_POS top_JJ infectious_JJ disease_NN official_NN ,_, said_VBD that_IN the_DT Phase_NN 3_CD trial_NN of_IN Moderna_NNP 's_POS vaccine_NN could_MD start_VB as_RB early_RB as_IN July_NNP ._.","An NN NN NN VBZ VBG the NNP NNPS and NNP NNP to VB JJ NNS at NNP , the NN NN VBG a JJ NN NN , for RB VBG the NN NN . "" This NN VBD RB JJ because it VBD RB RB JJ NN and NN of the JJ NNS , but RB because it VBD JJ NNS VBG the JJ NN - 19 NN , "" VBD NNP NNP , who VBZ NNP . NNP , in a NN to the NNP . "" I RB VBP the NNP to VB these NNS . "" The NN 's NNS VBP on NN NN NN at NNP after the NN JJ NN VBD JJ NNS in NN 1 NNS of its NN NN . The NN VBD up the NN 's NN NN 30 NN to an all - NN NN of $ 87 . In the NNS VBG the NN , NNP 's NN , JJ NNS and NNS VBN by the NN of its NN VBD RB $ 90 million NN of NN NNS . JJ NNP VBD its NN , a NN of which VBD VBN to NNP NNP , on NNP to NNP NNP , who VBZ the NNP 's NN NN NN . The NN VBD to VB on the NN or whether it VBZ VBG into NNS against NNP and its NNS . NNP VBD he VBZ RB VBN a NN from the NNP . NNP on NNP VBD the NN NNS that VBD NNP . NNP ' NN . "" JJ NNS VBP VBN under VBN 10b5 - 1 NNS , which VBP VBN during JJ NN NNS in NN with the NN 's NN NN NN , "" the NN VBD in a NN to NNP NNP . "" As a NN of NN , NNP VBZ RB VB to VB on any VBN or JJ NN or NN ; nor on NNS or NNS by JJ NNS or NNS . "" NNP 's NN NNS VBP RB to VB VBN by JJ NNS or VBN in a JJ NN , and some VBP VBN whether the NN VBD RB JJ in VBG the NN NNS . NNS of the NN VBD RB JJ as $ 52 JJ NN , but VBP RB VBN to $ 59 , RB below its NN NN before the JJ NN NNS VBD VBN . NNP 's NNS VBP VBN to VB their NNS . On NNP , the NN VBD that NN NNP NNP VBD VBN in an JJ $ 1.9 million in NN . NNP NNP NNP NNP NNP RB VBD an JJ $ 6.7 million in NN NNS in which he VBD his JJ NN of NNP NNS , VBG to a NN with the NNP . NNP RB VBZ NNS to VB an JJ 118,000 NNP NNS . In the NN to the NNP , NNP VBD the NN of the NN - NN NNS JJ , and VBD whether the NN and the NNS VBD VBN RB of VBG the NN NNS , VBG when the NNS would VB VBN . JJ NNP VBZ a NN VBN by the NNP NNP NNP , which VBZ JJ - VBG NN NNS . "" NN VBZ that NNP and at JJS two of its NNS , RB among NNS , may VB RB VBN NN NNS to VB the NN 's NN , RB RB as their JJ NN NNS , "" NNP VBD . On NNP , JJ NN NN NNP VBD that NNP RB VBD NNS at a NN that NNP VBD out its NN NN NNS in NN to VB a JJ NN of the NNS . NNP NNP NNP , the NN 's JJ JJ NN NN , VBD that the NN 3 NN of NNP 's NN could VB RB RB as NNP ."
216,1299,mainstream,"Laura_NNP Dye_NNP was_VBD all_RB for_IN childhood_NN vaccinations_NNS until_IN she_PRP had_VBD her_PRP$ first_JJ child_NN ._. Then_RB she_PRP got_VBD cold_JJ feet_NNS after_IN reading_VBG what_WP she_PRP now_RB calls_VBZ “_`` scare_NN mongering_NN ”_'' online_RB ._. ""_`` I_PRP was_VBD super_RB scared_JJ about_IN vaccines_NNS ,_, ""_'' says_VBZ Dye_NNP ,_, who_WP lives_VBZ in_IN southern_JJ Delaware_NNP ._. ""_`` It_PRP was_VBD my_PRP$ new_JJ little_JJ baby_NN ._. He_PRP was_VBD so_RB perfect_JJ ._. ""_'' She_PRP wanted_VBD to_TO limit_VB vaccines_NNS out_IN of_IN concern_NN they_PRP might_MD harm_VB her_PRP$ newborn_NN son_NN ._. Her_PRP$ husband_NN ,_, Jared_NNP ,_, wanted_VBD their_PRP$ new_JJ son_NN fully_RB vaccinated_VBN ._. “_`` He_PRP had_VBD a_DT great_JJ aunt_NN who_WP had_VBD polio_NN and_CC said_VBD that_DT is_VBZ never_RB happening_VBG to_IN our_PRP$ kid_NN ,_, ”_'' Dye_NNP says_VBZ ._. It_PRP was_VBD the_DT vaccine_NN debate_NN in_IN a_DT nutshell_NN ,_, with_IN each_DT parent_NN pushing_VBG for_IN what_WP they_PRP thought_VBD was_VBD best_JJS for_IN their_PRP$ baby_NN ._. They_PRP compromised_VBD ._. They_PRP would_MD space_VB apart_RP their_PRP$ baby_NN ’s_POS shots_NNS so_IN he_PRP got_VBD no_RB more_JJR than_IN 2_CD per_IN checkup_NN ._. It_PRP would_MD take_VB much_RB longer_RBR to_TO get_VB him_PRP vaccinated_VBN than_IN the_DT CDC_NNP recommends_VBZ ._. At_IN the_DT time_NN ,_, Dye_NNP was_VBD on_IN board_NN ._. But_CC in_IN less_JJR than_IN 3_CD years_NNS ,_, she_PRP had_VBD completely_RB changed_VBN her_PRP$ mind_NN ._. What_WP happened_VBD ?_.","NNP NNP VBD RB for NN NNS until she VBD her JJ NN . RB she VBD JJ NNS after VBG what she RB VBZ “ NN NN ” RB . "" I VBD RB JJ about NNS , "" VBZ NNP , who VBZ in JJ NNP . "" It VBD my JJ JJ NN . He VBD RB JJ . "" She VBD to VB NNS out of NN they might VB her NN NN . Her NN , NNP , VBD their JJ NN RB VBN . “ He VBD a JJ NN who VBD NN and VBD that VBZ RB VBG to our NN , ” NNP VBZ . It VBD the NN NN in a NN , with each NN VBG for what they VBD VBD JJS for their NN . They VBD . They would VB apart their NN ’s NNS so he VBD RB JJR than 2 per NN . It would VB RB RBR to VB him VBN than the NNP VBZ . At the NN , NNP VBD on NN . But in JJR than 3 NNS , she VBD RB VBN her NN . What VBD ?"
217,89,mainstream,"THE_DT first_JJ coronavirus_NN vaccine_NN has_VBZ reportedly_RB been_VBN completed_VBN by_IN scientists_NNS at_IN a_DT genetic_JJ engineering_NN company_NN in_IN Texas_NNP ._. Scientists_NNS at_IN Greffex_NNP Inc_NNP ,_, which_WDT has_VBZ a_DT corporate_JJ headquarters_NN in_IN Houston_NNP and_CC a_DT laboratory_NN in_IN Aurora_NNP ,_, Colorado_NNP ,_, say_VBP they_PRP finished_VBD developing_VBG the_DT vaccine_NN this_DT week_NN ._. Read_VB our_PRP$ coronavirus_NN live_JJ blog_NN for_IN all_PDT the_DT latest_JJS news_NN and_CC updates_NNS However_RB ,_, it_PRP could_MD still_RB be_VB two_CD years_NNS before_IN the_DT vaccine_NN is_VBZ available_JJ to_TO use_VB ._. It_PRP now_RB needs_VBZ to_TO be_VB tested_VBN in_IN animal_NN experiments_NNS before_IN human_JJ trials_NNS can_MD begin_VB ._. The_DT development_NN comes_VBZ as_IN the_DT death_NN toll_NN hit_VBD 2,247_CD ,_, and_CC cases_NNS of_IN the_DT virus_NN reached_VBD 76,727_CD across_IN the_DT world_NN ._. Greffex_NNP 's_POS company_NN president_NN and_CC CEO_NN John_NNP Price_NNP told_VBD the_DT Houston_NNP Business_NNP Journal_NNP that_IN they_PRP did_VBD not_RB use_VB a_DT living_NN or_CC killed_VBN virus_NN to_TO form_VB the_DT vaccine_NN -_HYPH for_IN safety_NN reasons_NNS ._. The_DT coronavirus_NN is_VBZ so_RB poorly_RB understood_VBN ,_, has_VBZ spread_VBN so_RB quickly_RB and_CC has_VBZ killed_VBN enough_JJ people_NNS that_IN scientists_NNS at_IN Greffex_NNP did_VBD not_RB want_VB to_TO risk_VB exposure_NN that_WDT could_MD trigger_VB the_DT deadly_JJ illness_NN known_VBN as_IN COVID_NNP -_HYPH 19_CD ._. Instead_RB ,_, adenovirus_NN -_HYPH based_VBN vector_NN vaccines_NNS ,_, which_WDT are_VBP widely_RB employed_VBN against_IN various_JJ infectious_JJ diseases_NNS or_CC cancers_NNS ,_, were_VBD used_VBN ._. Adenoviruses_NNS are_VBP among_IN the_DT most_RBS common_JJ causes_NNS of_IN viral_JJ respiratory_JJ infections_NNS ,_, accounting_VBG for_IN between_RB two_CD and_CC five_CD per_NN cent_NN of_IN colds_NNS ._. ""_`` The_DT trick_NN in_IN making_VBG a_DT vaccine_NN is_VBZ can_MD you_PRP scale_VB the_DT vaccine_NN that_WDT you_PRP ’ve_VBP made_VBN to_TO be_VB able_JJ to_TO make_VB a_DT certain_JJ number_NN of_IN doses_NNS ,_, can_MD you_PRP test_VB that_DT vaccine_NN quickly_RB and_CC efficiently_RB and_CC then_RB can_MD you_PRP get_VB it_PRP into_IN patients_NNS ,_, ""_'' Price_NNP told_VBD local_JJ outlet_NN KHOU_NNP 11_CD ._. ""_`` And_CC that_DT ’s_VBZ where_WRB we_PRP have_VBP an_DT edge_NN as_RB well_RB on_IN the_DT other_JJ companies_NNS that_WDT are_VBP out_RB there_RB ._. ”_'' The_DT vaccine_NN is_VBZ the_DT product_NN of_IN an_DT $_$ 18.9_CD million_CD (_-LRB- £_$ 14.64_CD million_CD )_-RRB- contract_NN Greffex_NNP received_VBN in_IN September_NNP 2019_CD from_IN the_DT National_NNP Institute_NNP of_IN Health_NNP ’s_POS National_NNP Institute_NNP for_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS ,_, aimed_VBN at_IN fighting_VBG infectious_JJ threats_NNS ,_, the_DT Business_NNP Journal_NNP reported_VBD ._. Coronavirus_NN is_VBZ an_DT airborne_JJ virus_NN ,_, spread_VBN in_IN a_DT similar_JJ way_NN to_IN colds_NNS and_CC the_DT flu_NN ._. Symptoms_NNS include_VBP a_DT runny_JJ nose_NN ,_, headache_NN ,_, cough_NN and_CC fever_NN ,_, shortness_NN of_IN breath_NN ,_, chills_NNS and_CC body_NN aches_NNS ._. It_PRP is_VBZ incredibly_RB contagious_JJ and_CC is_VBZ spread_VBN through_IN contact_NN with_IN anything_NN the_DT virus_NN is_VBZ on_IN as_RB well_RB as_IN infected_VBN breath_NN ,_, coughs_NNS or_CC sneezes_NNS ._. In_IN most_JJS cases_NNS ,_, you_PRP wo_MD n't_RB know_VB whether_IN you_PRP have_VBP a_DT coronavirus_NN or_CC a_DT different_JJ cold_NN -_HYPH causing_VBG virus_NN ,_, such_JJ as_IN rhinovirus_NN ._. But_CC if_IN a_DT coronavirus_NN infection_NN spreads_VBZ to_IN the_DT lower_JJR respiratory_JJ tract_NN (_-LRB- your_PRP$ windpipe_NN and_CC your_PRP$ lungs_NNS )_-RRB- ,_, it_PRP can_MD cause_VB pneumonia_NN ,_, especially_RB in_IN older_JJR people_NNS ,_, people_NNS with_IN heart_NN disease_NN or_CC people_NNS with_IN weakened_VBN immune_NN systems_NNS ._. There_EX is_VBZ no_DT vaccine_NN currently_RB available_JJ for_IN coronavirus_NN ._. In_IN 2003_CD an_DT outbreak_NN of_IN a_DT similar_JJ virus_NN ,_, SARS_NNP ,_, infected_VBD more_JJR than_IN 8,000_CD people_NNS in_IN 37_CD countries_NNS before_IN it_PRP was_VBD brought_VBN under_IN control_NN ,_, killing_VBG 800_CD of_IN those_DT worldwide_RB ._. If_IN the_DT vaccine_NN wins_VBZ government_NN approval_NN in_IN the_DT US_NNP ,_, Greffex_NNP will_MD give_VB it_PRP away_RB for_IN free_JJ to_IN the_DT hardest_JJS -_HYPH hit_NN countries_NNS ,_, Price_NNP said_VBD ._. More_JJR than_IN 2,100_CD people_NNS have_VBP died_VBN as_IN a_DT result_NN of_IN the_DT COVID_NN -_HYPH 19_CD outbreak_NN ,_, with_IN all_DT but_CC 11_CD of_IN those_DT deaths_NNS in_IN mainland_JJ China_NNP ._. Worldwide_RB ,_, more_JJR than_IN 75,700_CD people_NNS have_VBP been_VBN infected_VBN ._. In_IN England_NNP ,_, a_DT total_NN of_IN nine_CD people_NNS have_VBP tested_VBN positive_JJ for_IN the_DT virus_NN ,_, while_IN more_JJR than_IN 5,000_CD have_VBP tested_VBN negative_JJ ._. The_DT NHS_NNP confirmed_VBD that_IN all_DT but_CC one_CD of_IN them_PRP have_VBP been_VBN discharged_VBN from_IN hospital_NN ._. Yesterday_NN ,_, it_PRP was_VBD revealed_VBN that_IN the_DT UK_NNP high_JJ street_NN could_MD be_VB hit_VBN with_IN shortages_NNS of_IN stock_NN due_IN to_IN the_DT deadly_JJ coronavirus_NN ._. Stores_NNS including_VBG Asos_NNP ,_, B&M_NNP and_CC Primark_NNP rely_VBP heavily_RB on_IN supply_NN from_IN China_NNP ,_, where_WRB large_JJ numbers_NNS of_IN factories_NNS have_VBP been_VBN shut_VBN down_RP amid_IN the_DT Covid_NNP -_HYPH 19_CD outbreak_NN ._.","THE JJ NN NN VBZ RB VBN VBN by NNS at a JJ NN NN in NNP . NNS at NNP NNP , which VBZ a JJ NN in NNP and a NN in NNP , NNP , VBP they VBD VBG the NN this NN . VB our NN JJ NN for all the JJS NN and NNS RB , it could RB VB two NNS before the NN VBZ JJ to VB . It RB VBZ to VB VBN in NN NNS before JJ NNS can VB . The NN VBZ as the NN NN VBD 2,247 , and NNS of the NN VBD 76,727 across the NN . NNP 's NN NN and NN NNP NNP VBD the NNP NNP NNP that they VBD RB VB a NN or VBN NN to VB the NN - for NN NNS . The NN VBZ RB RB VBN , VBZ VBN RB RB and VBZ VBN JJ NNS that NNS at NNP VBD RB VB to VB NN that could VB the JJ NN VBN as NNP - 19 . RB , NN - VBN NN NNS , which VBP RB VBN against JJ JJ NNS or NNS , VBD VBN . NNS VBP among the RBS JJ NNS of JJ JJ NNS , VBG for RB two and five NN NN of NNS . "" The NN in VBG a NN VBZ can you VB the NN that you VBP VBN to VB JJ to VB a JJ NN of NNS , can you VB that NN RB and RB and RB can you VB it into NNS , "" NNP VBD JJ NN NNP 11 . "" And that VBZ where we VBP an NN RB RB on the JJ NNS that VBP RB RB . ” The NN VBZ the NN of an $ 18.9 million ( £ 14.64 million ) NN NNP VBN in NNP 2019 from the NNP NNP of NNP ’s NNP NNP for NNP and NNP NNPS , VBN at VBG JJ NNS , the NNP NNP VBD . NN VBZ an JJ NN , VBN in a JJ NN to NNS and the NN . NNS VBP a JJ NN , NN , NN and NN , NN of NN , NNS and NN NNS . It VBZ RB JJ and VBZ VBN through NN with NN the NN VBZ on RB RB as VBN NN , NNS or NNS . In JJS NNS , you wo RB VB whether you VBP a NN or a JJ NN - VBG NN , JJ as NN . But if a NN NN VBZ to the JJR JJ NN ( your NN and your NNS ) , it can VB NN , RB in JJR NNS , NNS with NN NN or NNS with VBN NN NNS . There VBZ no NN RB JJ for NN . In 2003 an NN of a JJ NN , NNP , VBD JJR than 8,000 NNS in 37 NNS before it VBD VBN under NN , VBG 800 of those RB . If the NN VBZ NN NN in the NNP , NNP will VB it RB for JJ to the JJS - NN NNS , NNP VBD . JJR than 2,100 NNS VBP VBN as a NN of the NN - 19 NN , with all but 11 of those NNS in JJ NNP . RB , JJR than 75,700 NNS VBP VBN VBN . In NNP , a NN of nine NNS VBP VBN JJ for the NN , while JJR than 5,000 VBP VBN JJ . The NNP VBD that all but one of them VBP VBN VBN from NN . NN , it VBD VBN that the NNP JJ NN could VB VBN with NNS of NN due to the JJ NN . NNS VBG NNP , NNP and NNP VBP RB on NN from NNP , where JJ NNS of NNS VBP VBN VBN down amid the NNP - 19 NN ."
218,475,mainstream,"Influenza_NN vaccines_NNS ,_, also_RB known_VBN as_IN flu_NN shots_NNS or_CC flu_NN jabs_NNS ,_, are_VBP vaccines_NNS that_WDT protect_VBP against_IN infection_NN by_IN influenza_NN viruses_NNS ._. [_-LRB- 2_CD ]_-RRB- New_JJ versions_NNS of_IN the_DT vaccines_NNS are_VBP developed_VBN twice_RB a_DT year_NN ,_, as_IN the_DT influenza_NN virus_NN rapidly_RB changes_VBZ ._. [_-LRB- 2_CD ]_-RRB- While_IN their_PRP$ effectiveness_NN varies_VBZ from_IN year_NN to_IN year_NN ,_, most_RBS provide_VBP modest_JJ to_IN high_JJ protection_NN against_IN influenza_NN ._. [_-LRB- 2_CD ]_-RRB- [_-LRB- 3_CD ]_-RRB- The_DT United_NNP States_NNPS Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- estimates_VBZ that_IN vaccination_NN against_IN influenza_NN reduces_VBZ sickness_NN ,_, medical_JJ visits_NNS ,_, hospitalizations_NNS ,_, and_CC deaths_NNS ._. [_-LRB- 4_CD ]_-RRB- [_-LRB- 5_CD ]_-RRB- Immunized_VBN workers_NNS who_WP do_VBP catch_VB the_DT flu_NN ,_, return_VBP to_TO work_VB half_PDT a_DT day_NN sooner_RBR on_IN average_NN ._. [_-LRB- 6_CD ]_-RRB- Vaccine_NN effectiveness_NN in_IN those_DT under_IN two_CD years_NNS old_JJ and_CC those_DT over_RB 65_CD years_NNS old_JJ remains_VBZ uncertain_JJ due_IN to_IN a_DT lack_NN of_IN high_JJ quality_NN research_NN ._. [_-LRB- 7_CD ]_-RRB- [_-LRB- 8_CD ]_-RRB- Vaccinating_VBG children_NNS may_MD protect_VB those_DT around_IN them_PRP ._. [_-LRB- 2_CD ]_-RRB- The_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- and_CC the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- recommend_VBP yearly_JJ vaccination_NN for_IN nearly_RB all_DT people_NNS over_IN the_DT age_NN of_IN six_CD months_NNS ,_, especially_RB those_DT at_IN high_JJ risk_NN ._. [_-LRB- 2]_CD [_-LRB- 9_CD ]_-RRB- [_-LRB- 10_CD ]_-RRB- [_-LRB- 11_CD ]_-RRB- The_DT European_NNP Centre_NNP for_IN Disease_NNP Prevention_NNP and_CC Control_NNP (_-LRB- ECDC_NNP )_-RRB- also_RB recommends_VBZ yearly_JJ vaccination_NN of_IN high_JJ risk_NN groups_NNS ._. [_-LRB- 12_CD ]_-RRB- These_DT groups_NNS include_VBP pregnant_JJ women_NNS ,_, the_DT elderly_NN ,_, children_NNS between_IN six_CD months_NNS and_CC five_CD years_NNS of_IN age_NN ,_, those_DT with_IN certain_JJ health_NN problems_NNS ,_, and_CC those_DT who_WP work_VBP in_IN healthcare_NN ._. [_-LRB- 2]_CD [_-LRB- 11_CD ]_-RRB- The_DT vaccines_NNS are_VBP generally_RB safe_JJ ._. [_-LRB- 2_CD ]_-RRB- Fever_NN occurs_VBZ in_IN five_CD to_IN ten_CD percent_NN of_IN children_NNS vaccinated_VBN ._. [_-LRB- 2_CD ]_-RRB- Temporary_JJ muscle_NN pains_NNS or_CC feelings_NNS of_IN tiredness_NN may_MD occur_VB as_RB well_RB ._. [_-LRB- 2_CD ]_-RRB- In_IN certain_JJ years_NNS ,_, the_DT vaccine_NN has_VBZ been_VBN linked_VBN to_IN an_DT increase_NN in_IN Guillain–_NNP Barré_NNP syndrome_NN among_IN older_JJR people_NNS at_IN a_DT rate_NN of_IN about_RB one_CD case_NN per_IN million_CD doses_NNS ._. [_-LRB- 2_CD ]_-RRB- Although_IN most_JJS influenza_NN vaccines_NNS are_VBP produced_VBN using_VBG eggs_NNS ,_, they_PRP are_VBP still_RB recommended_VBN for_IN people_NNS who_WP have_VBP severe_JJ egg_NN allergies_NNS ._. [_-LRB- 13_CD ]_-RRB- However_RB ,_, influenza_NN vaccines_NNS are_VBP not_RB recommended_VBN in_IN those_DT who_WP have_VBP had_VBN a_DT severe_JJ allergy_NN to_IN previous_JJ versions_NNS of_IN the_DT vaccine_NN itself_PRP ._. [_-LRB- 2_CD ]_-RRB- [_-LRB- 13_CD ]_-RRB- The_DT vaccine_NN comes_VBZ in_IN inactive_JJ and_CC weakened_VBN viral_JJ forms_NNS ._. [_-LRB- 2_CD ]_-RRB- The_DT live_JJ ,_, weakened_VBN vaccine_NN is_VBZ generally_RB not_RB recommended_VBN in_IN pregnant_JJ women_NNS ,_, children_NNS less_JJR than_IN two_CD years_NNS old_JJ ,_, adults_NNS older_JJR than_IN 50_CD ,_, or_CC people_NNS with_IN a_DT weakened_VBN immune_JJ system_NN ._. [_-LRB- 2_CD ]_-RRB- Depending_VBG on_IN the_DT type_NN they_PRP can_MD be_VB injected_VBN into_IN a_DT muscle_NN ,_, sprayed_VBN into_IN the_DT nose_NN ,_, or_CC injected_VBN into_IN the_DT middle_JJ layer_NN of_IN the_DT skin_NN (_-LRB- intradermal_NN )_-RRB- ._. [_-LRB- 2_CD ]_-RRB- The_DT intradermal_JJ vaccine_NN was_VBD not_RB available_JJ during_IN the_DT 2018_CD –2019_CD and_CC 2019_CD –_SYM 2020_CD influenza_NN seasons_NNS ._. [_-LRB- 11_CD ]_-RRB- [_-LRB- 14_CD ]_-RRB- [_-LRB- 15_CD ]_-RRB- [_-LRB- 16_CD ]_-RRB- Vaccination_NN against_IN influenza_NN began_VBD in_IN the_DT 1930s_NNS with_IN large_JJ -_HYPH scale_NN availability_NN in_IN the_DT United_NNP States_NNPS beginning_VBG in_IN 1945_CD ._. [_-LRB- 17_CD ]_-RRB- [_-LRB- 18_CD ]_-RRB- It_PRP is_VBZ on_IN the_DT World_NNP Health_NNP Organization_NNP 's_POS List_NNP of_IN Essential_NNP Medicines_NNPS ,_, the_DT safest_JJS and_CC most_RBS effective_JJ medicines_NNS needed_VBN in_IN a_DT health_NN system_NN ._. [_-LRB- 19_CD ]_-RRB- The_DT U.S_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- recommends_VBZ the_DT flu_NN vaccine_NN as_IN the_DT best_JJS way_NN to_TO protect_VB people_NNS against_IN the_DT flu_NN and_CC prevent_VB its_PRP$ spread_NN ._. [_-LRB- 20_CD ]_-RRB- The_DT flu_NN vaccine_NN can_MD also_RB reduce_VB the_DT severity_NN of_IN the_DT flu_NN if_IN a_DT person_NN contracts_VBZ a_DT strain_NN that_WDT the_DT vaccine_NN did_VBD not_RB contain_VB ._. [_-LRB- 20_CD ]_-RRB- It_PRP takes_VBZ about_RB two_CD weeks_NNS following_VBG vaccination_NN for_IN protective_JJ antibodies_NNS to_TO form_VB ._. [_-LRB- 20_CD ]_-RRB- A_DT 2012_CD meta_NN -analysis_NN found_VBD that_IN flu_NN vaccination_NN was_VBD effective_JJ 67_CD percent_NN of_IN the_DT time_NN ;_: the_DT populations_NNS that_WDT benefited_VBD the_DT most_JJS were_VBD HIV_NN -_HYPH positive_JJ adults_NNS aged_JJ 18_CD to_IN 55_CD (_-LRB- 76_CD percent_NN )_-RRB- ,_, healthy_JJ adults_NNS aged_JJ 18_CD to_IN 46_CD (_-LRB- approximately_RB 70_CD percent_NN )_-RRB- ,_, and_CC healthy_JJ children_NNS aged_JJ six_CD to_IN 24_CD months_NNS (_-LRB- 66_CD percent_NN )_-RRB- ._. [_-LRB- 21_CD ]_-RRB- The_DT influenza_NN vaccine_NN also_RB appear_VBP to_TO protect_VB against_IN myocardial_JJ infarction_NN with_IN a_DT benefit_NN of_IN 15_CD to_IN 45_CD %_NN ._. [_-LRB- 22_CD ]_-RRB- A_DT vaccine_NN is_VBZ assessed_VBN by_IN its_PRP$ efficacy_NN –_: the_DT extent_NN to_IN which_WDT it_PRP reduces_VBZ risk_NN of_IN disease_NN under_IN controlled_VBN conditions_NNS –_: and_CC its_PRP$ effectiveness_NN –_: the_DT observed_VBN reduction_NN in_IN risk_NN after_IN the_DT vaccine_NN is_VBZ put_VBN into_IN use_NN ._. [_-LRB- 26_CD ]_-RRB- In_IN the_DT case_NN of_IN influenza_NN ,_, effectiveness_NN is_VBZ expected_VBN to_TO be_VB lower_JJR than_IN the_DT efficacy_NN because_IN it_PRP is_VBZ measured_VBN using_VBG the_DT rates_NNS of_IN influenza_NN -_HYPH like_JJ illness_NN ,_, which_WDT is_VBZ not_RB always_RB caused_VBN by_IN influenza_NN ._. [_-LRB- 6_CD ]_-RRB- Influenza_NN vaccines_NNS generally_RB show_VBP high_JJ efficacy_NN ,_, as_IN measured_VBN by_IN the_DT antibody_NN production_NN in_IN animal_NN models_NNS or_CC vaccinated_VBN people_NNS ._. [_-LRB- 27_CD ]_-RRB- However_RB ,_, studies_NNS on_IN the_DT effectiveness_NN of_IN flu_NN vaccines_NNS in_IN the_DT real_JJ world_NN are_VBP difficult_JJ ;_, vaccines_NNS may_MD be_VB imperfectly_RB matched_VBN ,_, virus_NN prevalence_NN varies_VBZ widely_RB between_IN years_NNS ,_, and_CC influenza_NN is_VBZ often_RB confused_VBN with_IN other_JJ influenza_NN -_HYPH like_JJ illnesses_NNS ._. [_-LRB- 28_CD ]_-RRB- However_RB ,_, in_IN most_JJS years_NNS (_-LRB- 16_CD of_IN the_DT 19_CD years_NNS before_IN 2007_CD )_-RRB- ,_, the_DT flu_NN vaccine_NN strains_NNS have_VBP been_VBN a_DT good_JJ match_NN for_IN the_DT circulating_VBG strains_NNS ,_, [_-LRB- 29_CD ]_-RRB- and_CC even_RB a_DT mismatched_VBN vaccine_NN can_MD often_RB provide_VB cross-protection_NN ._. [_-LRB- 20_CD ]_-RRB- The_DT virus_NN rapidly_RB changes_VBZ due_IN to_IN antigenic_JJ drift_NN ,_, a_DT slight_JJ mutation_NN in_IN the_DT virus_NN that_WDT causes_VBZ a_DT new_JJ strain_NN to_TO arise_VB ._. [_-LRB- 30_CD ]_-RRB- Repeated_VBN annual_JJ influenza_NN vaccination_NN generally_RB offer_VBP consistent_JJ year_NN -_HYPH on_IN -_HYPH year_NN protection_NN against_IN influenza_NN ._. [_-LRB- 31_CD ]_-RRB- There_EX is_VBZ however_RB suggestive_JJ evidence_NN that_IN repeated_VBN vaccinations_NNS may_MD cause_VB a_DT reduction_NN in_IN vaccine_NN effectiveness_NN for_IN certain_JJ influenza_NN subtypes_NNS ;_, this_DT has_VBZ no_DT relevance_NN to_IN current_JJ recommendations_NNS for_IN yearly_JJ vaccinations_NNS but_CC might_MD influence_VB future_JJ vaccination_NN policy_NN ._. [_-LRB- 32_CD ]_-RRB- [_-LRB- 33_CD ]_-RRB- As_IN of_IN 2019_CD ,_, the_DT CDC_NNP recommends_VBZ a_DT yearly_JJ vaccine_NN as_IN most_JJS studies_NNS demonstrate_VBP overall_JJ effectiveness_NN of_IN annual_JJ influenza_NN vaccination_NN ._. [_-LRB- 31_CD ]_-RRB- Tom_NNP Jefferson_NNP ,_, who_WP has_VBZ led_VBN Cochrane_NNP Collaboration_NNP reviews_NNS of_IN flu_NN vaccines_NNS ,_, has_VBZ called_VBN clinical_JJ evidence_NN concerning_VBG flu_NN vaccines_NNS ""_`` rubbish_NN ""_'' and_CC has_VBZ therefore_RB declared_VBN them_PRP to_TO be_VB ineffective_JJ ;_, he_PRP has_VBZ called_VBN for_IN placebo_NN -_HYPH controlled_VBN randomized_VBN clinical_JJ trials_NNS ,_, which_WDT most_JJS in_IN the_DT field_NN hold_VBP as_IN unethical_JJ ._. His_PRP$ views_NNS on_IN the_DT efficacy_NN of_IN flu_NN vaccines_NNS are_VBP rejected_VBN by_IN medical_JJ institutions_NNS including_VBG the_DT CDC_NNP and_CC the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, and_CC by_IN key_JJ figures_NNS in_IN the_DT field_NN like_IN Anthony_NNP Fauci_NNP ._. [_-LRB- 34_CD ]_-RRB- Michael_NNP Osterholm_NNP ,_, who_WP led_VBD the_DT Center_NNP for_IN Infectious_NNP Disease_NNP Research_NNP and_CC Policy_NNP 2012_CD review_NN on_IN flu_NN vaccines_NNS ,_, recommended_VBD getting_VBG the_DT vaccine_NN but_CC criticized_VBD its_PRP$ promotion_NN ,_, saying_VBG ,_, ""_`` We_PRP have_VBP overpromoted_VBN and_CC overhyped_VBN this_DT vaccine_NN ..._, it_PRP does_VBZ not_RB protect_VB as_IN promoted_VBN ._. It_PRP 's_VBZ all_PDT a_DT sales_NN job_NN :_: it_PRP 's_VBZ all_DT public_JJ relations_NNS ""_'' ._. [_-LRB- 35_CD ]_-RRB- The_DT CDC_NNP recommend_VBP that_IN everyone_NN except_IN infants_NNS under_IN the_DT age_NN of_IN six_CD months_NNS should_MD receive_VB the_DT seasonal_JJ influenza_NN vaccine_NN ._. [_-LRB- 9_CD ]_-RRB- Vaccination_NN campaigns_NNS usually_RB focus_VBP special_JJ attention_NN on_IN people_NNS who_WP are_VBP at_IN high_JJ risk_NN of_IN serious_JJ complications_NNS if_IN they_PRP catch_VBP the_DT flu_NN ,_, such_JJ as_IN pregnant_JJ women_NNS ,_, children_NNS under_IN 59_CD months_NNS ,_, the_DT elderly_JJ ,_, and_CC people_NNS with_IN chronic_JJ illnesses_NNS or_CC weakened_VBN immune_NN systems_NNS ,_, as_RB well_RB as_IN those_DT to_IN whom_WP they_PRP are_VBP exposed_VBN ,_, such_JJ as_IN healthcare_NN workers_NNS ._. [_-LRB- 9_CD ]_-RRB- [_-LRB- 36_CD ]_-RRB- As_IN the_DT death_NN rate_NN is_VBZ also_RB high_JJ among_IN infants_NNS who_WP catch_VBP influenza_NN ,_, the_DT CDC_NNP and_CC the_DT WHO_NNP recommend_VBP that_IN household_NN contacts_NNS and_CC caregivers_NNS of_IN infants_NNS be_VBP vaccinated_VBN to_TO reduce_VB the_DT risk_NN of_IN passing_VBG an_DT influenza_NN infection_NN to_IN the_DT infant_NN ._. [_-LRB- 36_CD ]_-RRB- [_-LRB- 37_CD ]_-RRB- In_IN children_NNS ,_, the_DT vaccine_NN appears_VBZ to_TO decrease_VB the_DT risk_NN of_IN influenza_NN and_CC possibly_RB influenza_NN -_HYPH like_JJ illness_NN ._. [_-LRB- 38_CD ]_-RRB- In_IN children_NNS under_IN the_DT age_NN of_IN two_CD data_NNS is_VBZ limited_VBN ._. [_-LRB- 38_CD ]_-RRB- During_IN the_DT 2017_CD –_SYM 18_CD flu_NN season_NN ,_, the_DT CDC_NNP director_NN indicated_VBD that_IN 85_CD percent_NN of_IN the_DT children_NNS who_WP died_VBD ""_`` likely_RB will_MD not_RB have_VB been_VBN vaccinated_VBN ._. ""_'' [_-LRB- 39_CD ]_-RRB- In_IN the_DT United_NNP States_NNPS ,_, as_IN of_IN January_NNP 2019_CD ,_, the_DT CDC_NNP recommend_VBP that_IN children_NNS aged_JJ six_CD through_IN 35_CD months_NNS may_MD receive_VB either_CC 0.25_CD milliliters_NNS or_CC 0.5_CD milliliters_NNS per_IN dose_NN of_IN Fluzone_NNP Quadrivalent_NN ._. [_-LRB- 40_CD ]_-RRB- [_-LRB- 41_CD ]_-RRB- There_EX is_VBZ no_DT preference_NN for_IN one_CD or_CC the_DT other_JJ dose_NN volume_NN of_IN Fluzone_NNP Quadrivalent_NNP for_IN that_DT age_NN group_NN ._. [_-LRB- 40_CD ]_-RRB- All_DT persons_NNS 36_CD months_NNS of_IN age_NN and_CC older_JJR should_MD receive_VB 0.5_CD milliliters_NNS per_IN dose_NN of_IN Fluzone_NNP Quadrivalent_NNP ._. [_-LRB- 40_CD ]_-RRB- As_IN of_IN October_NNP 2018_CD ,_, Afluria_NNP Quadrivalent_NNP is_VBZ licensed_VBN for_IN children_NNS six_CD months_NNS of_IN age_NN and_CC older_JJR in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 40_CD ]_-RRB- [_-LRB- 42_CD ]_-RRB- Children_NNS six_CD months_NNS through_IN 35_CD months_NNS of_IN age_NN should_MD receive_VB 0.25_CD milliliters_NNS for_IN each_DT dose_NN of_IN Afluria_NNP Quadrivalent_NNP ._. [_-LRB- 40_CD ]_-RRB- All_DT persons_NNS 36_CD months_NNS of_IN age_NN and_CC older_JJR should_MD receive_VB 0.5_CD milliliters_NNS per_IN dose_NN of_IN Afluria_NNP Quadrivalent_NN ._. [_-LRB- 40_CD ]_-RRB- As_IN of_IN February_NNP 2018_CD ,_, Afluria_NNP Tetra_NNP is_VBZ licensed_VBN for_IN adults_NNS and_CC children_NNS five_CD years_NNS of_IN age_NN and_CC older_JJR in_IN Canada_NNP ._. [_-LRB- 43_CD ]_-RRB- In_IN 2014_CD ,_, the_DT Canadian_NNP National_NNP Advisory_NNP Committee_NNP on_IN Immunization_NNP (_-LRB- NACI_NNP )_-RRB- published_VBD a_DT review_NN of_IN influenza_NN vaccination_NN in_IN healthy_JJ 5_CD –_SYM 18_CD -_HYPH year_NN -_HYPH olds_NNS ,_, [_-LRB- 44_CD ]_-RRB- and_CC in_IN 2015_CD ,_, published_VBD a_DT review_NN of_IN the_DT use_NN of_IN pediatric_JJ Fluad_NNP in_IN children_NNS 6_CD –_SYM 72_CD months_NNS of_IN age_NN ._. [_-LRB- 45_CD ]_-RRB- In_IN unvaccinated_JJ adults_NNS ,_, 16_CD %_NN get_VBP symptoms_NNS similar_JJ to_IN the_DT flu_NN ,_, while_IN about_RB 10_CD %_NN of_IN vaccinated_VBN adults_NNS do_VBP ._. [_-LRB- 6_CD ]_-RRB- Vaccination_NN decreased_VBD confirmed_VBN cases_NNS of_IN influenza_NN from_IN about_RB 2.4_CD %_NN to_IN 1.1_CD %_NN ._. [_-LRB- 6_CD ]_-RRB- No_DT effect_NN on_IN hospitalization_NN was_VBD found_VBN ._. [_-LRB- 6_CD ]_-RRB- In_IN working_VBG adults_NNS ,_, a_DT review_NN by_IN the_DT Cochrane_NNP Collaboration_NNP found_VBD that_IN vaccination_NN resulted_VBD in_IN a_DT modest_JJ decrease_NN in_IN both_CC influenza_NN symptoms_NNS and_CC working_NN days_NNS lost_VBN ,_, without_IN affecting_VBG transmission_NN or_CC influenza_NN -_HYPH related_JJ complications_NNS ._. [_-LRB- 6_CD ]_-RRB- In_IN healthy_JJ working_NN adults_NNS ,_, influenza_NN vaccines_NNS can_MD provide_VB moderate_JJ protection_NN against_IN virologically_RB confirmed_VBN influenza_NN ,_, though_IN such_JJ protection_NN is_VBZ greatly_RB reduced_VBN or_CC absent_JJ in_IN some_DT seasons_NNS ._. [_-LRB- 7_CD ]_-RRB- In_IN healthcare_NN workers_NNS ,_, a_DT 2006_CD review_NN found_VBD a_DT net_NN benefit_NN ._. [_-LRB- 46_CD ]_-RRB- Of_IN the_DT eighteen_CD studies_NNS in_IN this_DT review_NN ,_, only_RB two_CD also_RB assessed_VBD the_DT relationship_NN of_IN patient_NN mortality_NN relative_JJ to_IN staff_NN influenza_NN vaccine_NN uptake_NN ;_: both_CC found_VBD that_IN higher_JJR rates_NNS of_IN healthcare_NN worker_NN vaccination_NN correlated_VBN with_IN reduced_VBN patient_NN deaths_NNS ._. [_-LRB- 46_CD ]_-RRB- A_DT 2014_CD review_NN found_VBD benefits_NNS to_IN patients_NNS when_WRB healthcare_NN workers_NNS were_VBD immunized_VBN ,_, as_IN supported_VBN by_IN moderate_JJ evidence_NN [_-LRB- 47_CD ]_-RRB- based_VBN in_IN part_NN on_IN the_DT observed_VBN reduction_NN in_IN all_DT -_HYPH cause_NN deaths_NNS in_IN patients_NNS whose_WP$ healthcare_NN workers_NNS were_VBD given_VBN immunization_NN compared_VBN with_IN comparison_NN patients_NNS where_WRB the_DT workers_NNS were_VBD not_RB offered_VBN vaccine_NN ._. [_-LRB- 48_CD ]_-RRB- Evidence_NN for_IN an_DT effect_NN in_IN adults_NNS over_IN 65_CD years_NNS old_JJ is_VBZ unclear_JJ ._. [_-LRB- 49_CD ]_-RRB- Systematic_JJ reviews_NNS examining_VBG both_CC randomized_VBN controlled_VBN and_CC case_NN –control_NN studies_NNS found_VBD a_DT lack_NN of_IN high_JJ -_HYPH quality_JJ evidence_NN ._. [_-LRB- 7_CD ]_-RRB- [_-LRB- 8_CD ]_-RRB- Reviews_NNS of_IN case_NN –control_NN studies_NNS found_VBD effects_NNS against_IN laboratory_NN -_HYPH confirmed_VBN influenza_NN ,_, pneumonia_NN ,_, and_CC death_NN among_IN the_DT community_NN -_HYPH dwelling_VBG elderly_JJ ._. [_-LRB- 50_CD ]_-RRB- [_-LRB- 51_CD ]_-RRB- The_DT group_NN most_RBS vulnerable_JJ to_IN non-pandemic_JJ flu_NN ,_, the_DT elderly_JJ ,_, benefits_NNS least_JJS from_IN the_DT vaccine_NN ._. There_EX are_VBP multiple_JJ reasons_NNS behind_IN this_DT steep_JJ decline_NN in_IN vaccine_NN efficacy_NN ,_, the_DT most_RBS common_JJ of_IN which_WDT are_VBP the_DT declining_VBG immunological_JJ function_NN and_CC frailty_NN associated_VBN with_IN advanced_JJ age_NN ._. [_-LRB- 52_CD ]_-RRB- In_IN a_DT non-pandemic_JJ year_NN ,_, a_DT person_NN in_IN the_DT United_NNP States_NNPS aged_JJ 50_CD –_SYM 64_CD is_VBZ nearly_RB ten_CD times_NNS more_RBR likely_JJ to_TO die_VB an_DT influenza_NN -_HYPH associated_VBN death_NN than_IN a_DT younger_JJR person_NN ,_, and_CC a_DT person_NN over_IN age_NN 65_CD is_VBZ over_RB ten_CD times_NNS more_RBR likely_JJ to_TO die_VB an_DT influenza_NN -_HYPH associated_VBN death_NN than_IN the_DT 50_CD –_SYM 64_CD age_NN group_NN ._. [_-LRB- 53_CD ]_-RRB- There_EX is_VBZ a_DT high_JJ -_HYPH dose_NN flu_NN vaccine_NN specifically_RB formulated_VBN to_TO provide_VB a_DT stronger_JJR immune_JJ response_NN ._. [_-LRB- 54_CD ]_-RRB- Available_JJ evidence_NN indicates_VBZ that_IN vaccinating_VBG the_DT elderly_NN with_IN the_DT high_JJ -_HYPH dose_NN vaccine_NN leads_VBZ to_IN a_DT stronger_JJR immune_JJ response_NN against_IN influenza_NN than_IN the_DT regular_JJ -_HYPH dose_NN vaccine_NN ._. [_-LRB- 55_CD ]_-RRB- [_-LRB- 56_CD ]_-RRB- [_-LRB- 57_CD ]_-RRB- A_DT flu_NN vaccine_NN containing_VBG an_DT adjuvant_NN was_VBD approved_VBN by_IN the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- in_IN November_NNP 2015_CD ,_, for_IN use_NN by_IN adults_NNS aged_JJ 65_CD years_NNS of_IN age_NN and_CC older_JJR ._. The_DT vaccine_NN is_VBZ marketed_VBN as_IN Fluad_NNP in_IN the_DT U.S._NNP and_CC was_VBD first_RB available_JJ in_IN the_DT 2016_CD –_HYPH 2017_CD flu_NN season_NN ._. The_DT vaccine_NN contains_VBZ the_DT MF59C.1_NN adjuvant_NN [_-LRB- 58_CD ]_-RRB- which_WDT is_VBZ an_DT oil_NN -_HYPH in_IN -_HYPH water_NN emulsion_NN of_IN squalene_NN oil_NN ._. It_PRP is_VBZ the_DT first_JJ adjuvanted_VBN seasonal_JJ flu_NN vaccine_NN marketed_VBN in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 59_CD ]_-RRB- [_-LRB- 60_CD ]_-RRB- [_-LRB- 61_CD ]_-RRB- It_PRP is_VBZ not_RB clear_JJ if_IN there_EX is_VBZ a_DT significant_JJ benefit_NN for_IN the_DT elderly_NN to_TO use_VB a_DT flu_NN vaccine_NN containing_VBG the_DT MF59C.1_NN adjuvant_NN ._. [_-LRB- 62_CD ]_-RRB- [_-LRB- 63_CD ]_-RRB- [_-LRB- 64_CD ]_-RRB- Per_IN Advisory_JJ Committee_NN on_IN Immunization_NN Practices_NNS guidelines_NNS ,_, Fluad_NNP can_MD be_VB used_VBN as_IN an_DT alternative_NN to_IN other_JJ influenza_NN vaccines_NNS approved_VBN for_IN people_NNS 65_CD years_NNS and_CC older_JJR ._. [_-LRB- 60_CD ]_-RRB- Vaccinating_VBG healthcare_NN workers_NNS who_WP work_VBP with_IN elderly_JJ people_NNS is_VBZ recommended_VBN in_IN many_JJ countries_NNS ,_, with_IN the_DT goal_NN of_IN reducing_VBG influenza_NN outbreaks_NNS in_IN this_DT vulnerable_JJ population_NN ._. [_-LRB- 65_CD ]_-RRB- [_-LRB- 66_CD ]_-RRB- [_-LRB- 67_CD ]_-RRB- While_IN there_EX is_VBZ no_DT conclusive_JJ evidence_NN from_IN randomized_VBN clinical_JJ trials_NNS that_IN vaccinating_VBG healthcare_NN workers_NNS helps_VBZ protect_VB elderly_JJ people_NNS from_IN influenza_NN ,_, there_EX is_VBZ tentative_JJ evidence_NN of_IN benefit_NN ._. [_-LRB- 68_CD ]_-RRB- Fluad_NNP Quadrivalent_NNP was_VBD approved_VBN for_IN use_NN in_IN the_DT United_NNP States_NNPS in_IN February_NNP 2020_CD [_-LRB- 69_CD ]_-RRB- and_CC Fluad_NNP Tetra_NNP was_VBD approved_VBN for_IN use_NN in_IN the_DT European_NNP Union_NNP in_IN May_NNP 2020_CD ._. [_-LRB- 70_CD ]_-RRB- As_RB well_RB as_IN protecting_VBG mother_NN and_CC child_NN from_IN the_DT effects_NNS of_IN an_DT influenza_NN infection_NN ,_, the_DT immunization_NN of_IN pregnant_JJ women_NNS tends_VBZ to_TO increase_VB their_PRP$ chances_NNS of_IN experiencing_VBG a_DT successful_JJ full_JJ -_HYPH term_NN pregnancy_NN ._. [_-LRB- 71_CD ]_-RRB- The_DT trivalent_JJ inactivated_VBN influenza_NN vaccine_NN is_VBZ protective_JJ in_IN pregnant_JJ women_NNS infected_VBN with_IN HIV_NN ._. [_-LRB- 72_CD ]_-RRB- While_IN side_NN effects_NNS of_IN the_DT flu_NN vaccine_NN may_MD occur_VB ,_, they_PRP are_VBP usually_RB minor_JJ ._. The_DT flu_NN vaccine_NN can_MD cause_VB serious_JJ side_NN effects_NNS ,_, including_VBG an_DT allergic_JJ reaction_NN ,_, but_CC this_DT is_VBZ rare_JJ ._. Furthermore_RB ,_, the_DT common_JJ side_NN effects_NNS and_CC risks_NNS are_VBP mild_JJ and_CC temporary_JJ when_WRB compared_VBN to_IN the_DT risks_NNS and_CC severe_JJ health_NN effects_NNS of_IN the_DT annual_JJ influenza_NN epidemic_NN ._. [_-LRB- 20_CD ]_-RRB- Flu_NN vaccination_NN may_MD lead_VB to_IN side_NN effects_NNS such_JJ as_IN a_DT runny_JJ nose_NN and_CC a_DT sore_JJ throat_NN ,_, which_WDT can_MD last_VB for_IN up_IN to_IN several_JJ days_NNS ._. Although_IN Guillain–Barré_NNP syndrome_NN had_VBD been_VBN feared_VBN as_IN a_DT complication_NN of_IN vaccination_NN ,_, the_DT CDC_NNP states_VBZ that_IN most_JJS studies_NNS on_IN modern_JJ influenza_NN vaccines_NNS have_VBP seen_VBN no_DT link_NN with_IN Guillain–Barré_NNP ._. [_-LRB- 73_CD ]_-RRB- [_-LRB- 74_CD ]_-RRB- Infection_NN with_IN influenza_NN virus_NN itself_PRP increases_VBZ both_CC the_DT risk_NN of_IN death_NN (_-LRB- up_IN to_IN 1_CD in_IN 10,000_CD )_-RRB- and_CC increases_VBZ the_DT risk_NN of_IN developing_VBG Guillain–_NNP Barré_NNP syndrome_NN to_IN a_DT far_RB higher_JJR level_NN than_IN the_DT highest_JJS level_NN of_IN suspected_VBN vaccine_NN involvement_NN (_-LRB- approximately_RB 10_CD times_NNS higher_JJR by_IN 2009_CD estimates_NNS )_-RRB- ._. [_-LRB- 75_CD ]_-RRB- [_-LRB- 76_CD ]_-RRB- Although_IN one_CD review_NN gives_VBZ an_DT incidence_NN of_IN about_RB one_CD case_NN of_IN Guillain–_NNP Barré_NNP per_IN million_CD vaccinations_NNS ,_, [_-LRB- 77_CD ]_-RRB- a_DT large_JJ study_NN in_IN China_NNP ,_, covering_VBG close_JJ to_IN 100_CD million_CD doses_NNS of_IN vaccine_NN against_IN the_DT 2009_CD H1N1_NNP ""_`` swine_NN ""_'' flu_NN found_VBD only_RB eleven_CD cases_NNS of_IN Guillain–_NNP Barré_NNP syndrome_NN ,_, (_-LRB- 0.1_CD per_IN million_CD doses_NNS )_-RRB- total_JJ incidence_NN in_IN persons_NNS vaccinated_VBN ,_, actually_RB lower_JJR than_IN the_DT normal_JJ rate_NN of_IN the_DT disease_NN in_IN China_NNP ,_, and_CC no_DT other_JJ notable_JJ side_NN effects_NNS ._. [_-LRB- 76_CD ]_-RRB- [_-LRB- 78_CD ]_-RRB- Although_IN most_JJS influenza_NN vaccines_NNS are_VBP produced_VBN using_VBG egg_NN -_HYPH based_VBN techniques_NNS ,_, influenza_NN vaccines_NNS are_VBP nonetheless_RB still_RB recommended_VBN for_IN people_NNS with_IN egg_NN allergies_NNS ,_, even_RB if_IN severe_JJ ._. [_-LRB- 13_CD ]_-RRB- Studies_NNS examining_VBG the_DT safety_NN of_IN influenza_NN vaccines_NNS in_IN people_NNS with_IN severe_JJ egg_NN allergies_NNS found_VBD that_IN anaphylaxis_NN was_VBD very_RB rare_JJ ,_, occurring_VBG in_IN 1.3_CD cases_NNS per_IN million_CD doses_NNS given_VBN ._. [_-LRB- 13_CD ]_-RRB- Monitoring_VBG for_IN symptoms_NNS from_IN vaccination_NN is_VBZ recommended_VBN in_IN those_DT with_IN more_RBR severe_JJ symptoms_NNS ._. [_-LRB- 79_CD ]_-RRB- A_DT study_NN of_IN nearly_RB 800_CD children_NNS with_IN egg_NN allergy_NN ,_, including_VBG over_RB 250_CD with_IN previous_JJ anaphylactic_JJ reactions_NNS ,_, had_VBD zero_CD systemic_JJ allergic_JJ reactions_NNS when_WRB given_VBN the_DT live_JJ attenuated_VBN flu_NN vaccine_NN ._. [_-LRB- 80_CD ]_-RRB- [_-LRB- 81_CD ]_-RRB- Several_JJ studies_NNS have_VBP identified_VBN an_DT increased_VBN incidence_NN of_IN narcolepsy_NN among_IN recipients_NNS of_IN the_DT pandemic_NN H1N1_NN influenza_NN ASO3_NN -_HYPH adjuvanted_VBN vaccine_NN ;_: [_-LRB- 82_CD ]_-RRB- efforts_NNS to_TO identify_VB a_DT mechanism_NN for_IN this_DT suggest_VBP that_IN narcolepsy_NN is_VBZ autoimmune_JJ ,_, and_CC that_IN the_DT ASO3_NN -_HYPH adjuvanted_VBN H1N1_NN vaccine_NN may_MD mimic_VB hypocretin_NN ,_, serving_VBG as_IN a_DT trigger_NN ._. [_-LRB- 83_CD ]_-RRB- Some_DT injection_NN -_HYPH based_VBN flu_NN vaccines_NNS intended_VBN for_IN adults_NNS in_IN the_DT United_NNP States_NNPS contain_VBP thiomersal_NN (_-LRB- also_RB known_VBN as_IN thimerosal_NN )_-RRB- ,_, a_DT mercury_NN -_HYPH based_VBN preservative_NN ._. [_-LRB- 84_CD ]_-RRB- [_-LRB- 85_CD ]_-RRB- Despite_IN some_DT controversy_NN in_IN the_DT media_NN ,_, [_-LRB- 86_CD ]_-RRB- the_DT World_NNP Health_NNP Organization_NNP 's_POS Global_NNP Advisory_NNP Committee_NNP on_IN Vaccine_NNP Safety_NNP has_VBZ concluded_VBN that_IN there_EX is_VBZ no_DT evidence_NN of_IN toxicity_NN from_IN thiomersal_NN in_IN vaccines_NNS and_CC no_DT reason_NN on_IN grounds_NNS of_IN safety_NN to_TO change_VB to_IN more_RBR -_HYPH expensive_JJ single_JJ -_HYPH dose_NN administration_NN ._. [_-LRB- 87_CD ]_-RRB- Flu_NN vaccines_NNS are_VBP available_JJ either_CC as_IN :_: •_SYM a_DT trivalent_JJ or_CC quadrivalent_JJ intramuscular_JJ injection_NN (_-LRB- IIV3_NN ,_, IIV4_NN ,_, or_CC RIV4_NN ,_, that_DT is_VBZ ,_, TIV_NN or_CC QIV_NN )_-RRB- ,_, which_WDT contains_VBZ the_DT inactivated_VBN form_NN of_IN the_DT virus_NN •_, a_DT nasal_JJ spray_NN of_IN live_JJ attenuated_VBN influenza_NN vaccine_NN (_-LRB- LAIV_NN ,_, Q_NN /_, LAIV_NN )_-RRB- ,_, which_WDT contains_VBZ the_DT live_JJ but_CC attenuated_VBN (_-LRB- weakened_VBN )_-RRB- form_NN of_IN the_DT virus_NN ._. TIV_NN or_CC QIV_NN induce_VBP protection_NN after_IN injection_NN (_-LRB- typically_RB intramuscular_JJ ,_, though_IN subcutaneous_JJ and_CC intradermal_JJ routes_NNS can_MD also_RB be_VB protective_JJ )_-RRB- [_-LRB- 88_CD ]_-RRB- based_VBN on_IN an_DT immune_JJ response_NN to_IN the_DT antigens_NNS present_JJ on_IN the_DT inactivated_VBN virus_NN ,_, while_IN cold_JJ -_HYPH adapted_VBN LAIV_NN works_VBZ by_IN establishing_VBG infection_NN in_IN the_DT nasal_JJ passages_NNS ._. [_-LRB- 89_CD ]_-RRB- Various_JJ public_JJ health_NN organizations_NNS ,_, including_VBG the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ,_, recommend_VBP that_IN yearly_JJ influenza_NN vaccination_NN be_VBP routinely_RB offered_VBN ,_, particularly_RB to_IN people_NNS at_IN risk_NN of_IN complications_NNS of_IN influenza_NN and_CC those_DT individuals_NNS who_WP live_VBP with_IN or_CC care_VBP for_IN high_JJ -_HYPH risk_NN individuals_NNS ,_, including_VBG :_: •_NFP the_DT elderly_JJ (_-LRB- UK_NNP recommendation_NN is_VBZ those_DT aged_JJ 65_CD or_CC above_RB )_-RRB- •_, people_NNS with_IN chronic_JJ kidney_NN diseases_NNS (_-LRB- such_JJ as_IN the_DT nephrotic_JJ syndrome_NN )_-RRB- •_, people_NNS who_WP have_VBP had_VBN their_PRP$ spleen_NN removed_VBN or_CC whose_WP$ spleen_NN is_VBZ not_RB working_VBG properly_RB •_NFP people_NNS who_WP are_VBP immunosuppressed_VBN (_-LRB- people_NNS with_IN HIV_NN ,_, those_DT receiving_VBG medications_NNS to_TO suppress_VB the_DT immune_NN system_NN ,_, and_CC people_NNS on_IN chemotherapy_NN )_-RRB- and_CC their_PRP$ household_NN contacts_NNS •_, people_NNS who_WP live_VBP together_RB in_IN large_JJ numbers_NNS in_IN an_DT environment_NN where_WRB influenza_NN can_MD spread_VB rapidly_RB ,_, such_JJ as_IN prisons_NNS ,_, nursing_NN homes_NNS ,_, schools_NNS ,_, and_CC dormitories_NNS ._. [_-LRB- 90_CD ]_-RRB- •_, healthcare_NN workers_NNS (_-LRB- both_CC to_TO prevent_VB sickness_NN and_CC to_TO prevent_VB spread_NN to_IN patients_NNS )_-RRB- [_-LRB- 91_CD ]_-RRB- [_-LRB- 92_CD ]_-RRB- •_SYM women_NNS ._. However_RB ,_, a_DT 2009_CD review_NN concluded_VBD that_IN there_EX was_VBD insufficient_JJ evidence_NN to_TO recommend_VB routine_JJ use_NN of_IN trivalent_JJ influenza_NN vaccine_NN during_IN the_DT first_JJ trimester_NN of_IN pregnancy_NN ._. [_-LRB- 93_CD ]_-RRB- Influenza_NN vaccination_NN during_IN flu_NN season_NN is_VBZ part_NN of_IN recommendations_NNS for_IN influenza_NN vaccination_NN of_IN pregnant_JJ women_NNS in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 94_CD ]_-RRB- The_DT flu_NN vaccine_NN is_VBZ contraindicated_VBN for_IN those_DT under_IN six_CD months_NNS of_IN age_NN and_CC those_DT with_IN severe_JJ ,_, life_NN -_HYPH threatening_VBG allergies_NNS to_IN flu_NN vaccine_NN or_CC any_DT ingredient_NN in_IN the_DT vaccine_NN ._. [_-LRB- 9_CD ]_-RRB- [_-LRB- 95_CD ]_-RRB- [_-LRB- 13_CD ]_-RRB- As_IN of_IN 2016_CD ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- recommends_VBZ seasonal_JJ influenza_NN vaccination_NN for_IN :_: [_-LRB- 96_CD ]_-RRB- [_-LRB- 97_CD ]_-RRB- [_-LRB- 98_CD ]_-RRB- [_-LRB- 99_CD ]_-RRB- [_-LRB- 100_CD ]_-RRB- Second_JJ priority_NN (_-LRB- in_IN no_DT particular_JJ order_NN )_-RRB- :_: The_DT National_NNP Advisory_NNP Committee_NNP on_IN Immunization_NNP (_-LRB- NACI_NNP )_-RRB- ,_, the_DT group_NN that_WDT advises_VBZ the_DT Public_NNP Health_NNP Agency_NNP of_IN Canada_NNP ,_, recommends_VBZ that_IN everyone_NN over_RB six_CD months_NNS of_IN age_NN be_VBP encouraged_VBN to_TO receive_VB annual_JJ influenza_NN vaccination_NN ,_, and_CC that_IN children_NNS between_IN the_DT age_NN of_IN six_CD and_CC 24_CD months_NNS ,_, and_CC their_PRP$ household_NN contacts_NNS ,_, should_MD be_VB considered_VBN a_DT high_JJ priority_NN for_IN the_DT flu_NN vaccine_NN ._. [_-LRB- 101_CD ]_-RRB- Particularly_RB :_: •_NFP People_NNS at_IN high_JJ risk_NN of_IN influenza_NN -_HYPH related_JJ complications_NNS or_CC hospitalization_NN ,_, including_VBG the_DT morbidly_RB obese_JJ ,_, healthy_JJ pregnant_JJ women_NNS ,_, children_NNS six_CD to_IN 59_CD months_NNS ,_, the_DT elderly_JJ ,_, aboriginals_NNS ,_, and_CC people_NNS suffering_VBG from_IN one_CD of_IN an_DT itemized_VBN list_NN of_IN chronic_JJ health_NN conditions_NNS •_. People_NNS capable_JJ of_IN transmitting_VBG influenza_NN to_IN those_DT at_IN high_JJ risk_NN ,_, including_VBG household_NN contacts_NNS and_CC healthcare_NN workers_NNS Live_JJ attenuated_VBN influenza_NN vaccine_NN (_-LRB- LAIV_NNP )_-RRB- was_VBD not_RB available_JJ in_IN Canada_NNP for_IN the_DT 2019_CD –_HYPH 2020_CD season_NN ._. [_-LRB- 101_CD ]_-RRB- The_DT European_NNP Centre_NNP for_IN Disease_NNP Prevention_NNP and_CC Control_NNP (_-LRB- ECDC_NNP )_-RRB- recommends_VBZ vaccinating_VBG the_DT elderly_JJ as_IN a_DT priority_NN ,_, with_IN a_DT secondary_JJ priority_NN people_NNS with_IN chronic_JJ medical_JJ conditions_NNS and_CC healthcare_NN workers_NNS ._. [_-LRB- 102_CD ]_-RRB- The_DT influenza_NN vaccination_NN strategy_NN is_VBZ generally_RB that_DT of_IN protecting_VBG vulnerable_JJ people_NNS ,_, rather_RB than_IN limiting_VBG influenza_NN circulation_NN or_CC totally_RB eliminating_VBG human_JJ influenza_NN sickness_NN ._. This_DT is_VBZ in_IN contrast_NN with_IN the_DT high_JJ herd_NN immunity_NN strategies_NNS for_IN other_JJ infectious_JJ diseases_NNS such_JJ as_IN polio_NN and_CC measles_NNS ._. [_-LRB- 103_CD ]_-RRB- This_DT is_VBZ also_RB due_IN in_IN part_NN to_IN the_DT financial_JJ and_CC logistics_NNS burden_NN associated_VBN with_IN the_DT need_NN of_IN an_DT annual_JJ injection_NN ._. [_-LRB- 104_CD ]_-RRB- In_IN the_DT United_NNP States_NNPS routine_JJ influenza_NN vaccination_NN is_VBZ recommended_VBN for_IN all_DT persons_NNS aged_JJ 6_CD months_NNS and_CC over_RB ._. [_-LRB- 105_CD ]_-RRB- [_-LRB- 106_CD ]_-RRB- [_-LRB- 107_CD ]_-RRB- It_PRP takes_VBZ up_IN to_IN two_CD weeks_NNS after_IN vaccination_NN for_IN sufficient_JJ antibodies_NNS to_TO develop_VB in_IN the_DT body_NN ._. [_-LRB- 107_CD ]_-RRB- The_DT CDC_NNP recommends_VBZ vaccination_NN before_IN the_DT end_NN of_IN October_NNP ,_, although_IN it_PRP considers_VBZ getting_VBG a_DT vaccine_NN in_IN January_NNP or_CC even_RB later_RBR to_TO be_VB still_RB beneficial_JJ ._. [_-LRB- 20_CD ]_-RRB- [_-LRB- 107_CD ]_-RRB- According_VBG to_IN the_DT CDC_NNP ,_, the_DT live_JJ attenuated_VBN virus_NN (_-LRB- LAIV4_NNP )_-RRB- (_-LRB- which_WDT comes_VBZ in_IN the_DT form_NN of_IN the_DT nasal_JJ spray_NN in_IN the_DT U.S._NNP )_-RRB- should_MD be_VB avoided_VBN by_IN :_: [_-LRB- 11_CD ]_-RRB- [_-LRB- 108_CD ]_-RRB- •_SYM Concomitant_JJ aspirin-_NN or_CC salicylate_NN -_HYPH containing_VBG therapy_NN in_IN children_NNS and_CC adolescents_NNS •_, Children_NNS aged_JJ 2_CD through_IN 4_CD years_NNS who_WP have_VBP received_VBN a_DT diagnosis_NN of_IN asthma_NN or_CC whose_WP$ parents_NNS or_CC caregivers_NNS report_VBP that_IN a_DT healthcare_NN provider_NN has_VBZ told_VBN them_PRP during_IN the_DT past_JJ 12_CD months_NNS that_IN their_PRP$ child_NN had_VBD wheezing_NN or_CC asthma_NN or_CC whose_WP$ medical_JJ record_NN indicates_VBZ that_IN a_DT wheezing_NN episode_NN has_VBZ occurred_VBN within_IN the_DT past_JJ 12_CD months_NNS •_. Persons_NNS who_WP are_VBP immunocompromised_JJ due_IN to_IN any_DT cause_NN (_-LRB- including_VBG but_CC not_RB limited_VBN to_IN medications_NNS and_CC HIV_NN infection_NN )_-RRB- •_NFP Close_JJ contacts_NNS and_CC caregivers_NNS of_IN severely_RB immunocompromised_JJ persons_NNS who_WP require_VBP a_DT protected_VBN environment_NN •_, Persons_NNS who_WP have_VBP received_VBN influenza_NN antiviral_JJ medications_NNS within_IN the_DT previous_JJ 48_CD hours_NNS Within_IN its_PRP$ blanket_NN recommendation_NN for_IN general_JJ vaccination_NN in_IN the_DT United_NNP States_NNPS ,_, the_DT CDC_NNP ,_, which_WDT began_VBD recommending_VBG the_DT influenza_NN vaccine_NN to_IN healthcare_NN workers_NNS in_IN 1981_CD ,_, emphasizes_VBZ to_IN clinicians_NNS the_DT special_JJ urgency_NN of_IN vaccination_NN for_IN members_NNS of_IN certain_JJ vulnerable_JJ groups_NNS ,_, and_CC their_PRP$ caregivers_NNS :_: The_DT U.S._NNP government_NN requires_VBZ hospitals_NNS to_TO report_VB worker_NN vaccination_NN rates_NNS ._. Some_DT U.S._NNP states_NNS and_CC hundreds_NNS of_IN U.S._NNP hospitals_NNS require_VBP healthcare_NN workers_NNS to_TO either_CC get_VB vaccinations_NNS or_CC wear_VB masks_NNS during_IN flu_NN season_NN ._. These_DT requirements_NNS occasionally_RB engender_VBP union_NN lawsuits_NNS on_IN narrow_JJ collective_JJ bargaining_NN grounds_NNS ,_, but_CC proponents_NNS note_VBP that_IN courts_NNS have_VBP generally_RB endorsed_VBN forced_VBN vaccination_NN laws_NNS affecting_VBG the_DT general_JJ population_NN during_IN disease_NN outbreaks_NNS ._. [_-LRB- 115_CD ]_-RRB- Vaccination_NN against_IN influenza_NN is_VBZ especially_RB considered_VBN important_JJ for_IN members_NNS of_IN high_JJ -_HYPH risk_NN groups_NNS who_WP would_MD be_VB likely_JJ to_TO have_VB complications_NNS from_IN influenza_NN ,_, for_IN example_NN pregnant_JJ women_NNS [_-LRB- 105_CD ]_-RRB- [_-LRB- 116_CD ]_-RRB- and_CC children_NNS and_CC teenagers_NNS from_IN six_CD months_NNS to_IN 18_CD years_NNS of_IN age_NN who_WP are_VBP receiving_VBG aspirin-_NN or_CC salicylate_NN -_HYPH containing_VBG medications_NNS and_CC who_WP might_MD be_VB at_IN risk_NN for_IN experiencing_VBG Reye_NN syndrome_NN after_IN influenza_NN virus_NN infection_NN ;_: [_-LRB- 11_CD ]_-RRB- [_-LRB- 90_CD ]_-RRB- •_NFP In_IN raising_VBG the_DT upper_JJ age_NN limit_NN to_IN 18_CD years_NNS ,_, the_DT aim_NN is_VBZ to_TO reduce_VB both_CC the_DT time_NN children_NNS and_CC parents_NNS lose_VBP from_IN visits_NNS to_IN pediatricians_NNS and_CC missing_JJ school_NN and_CC the_DT need_NN for_IN antibiotics_NNS for_IN complications_NNS [_-LRB- 117_CD ]_-RRB- •_NFP An_DT added_VBN benefit_NN expected_VBN from_IN the_DT vaccination_NN of_IN children_NNS is_VBZ a_DT reduction_NN in_IN the_DT number_NN of_IN influenza_NN cases_NNS among_IN parents_NNS and_CC other_JJ household_NN members_NNS ,_, and_CC of_IN possible_JJ spread_NN to_IN the_DT general_JJ community_NN ._. [_-LRB- 117_CD ]_-RRB- The_DT CDC_NNP indicated_VBD that_IN live_JJ attenuated_VBN influenza_NN vaccine_NN (_-LRB- LAIV_NNP )_-RRB- ,_, also_RB called_VBN the_DT nasal_JJ spray_NN vaccine_NN ,_, was_VBD not_RB recommended_VBN for_IN the_DT 2016_CD –_SYM 2017_CD flu_NN season_NN in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 118_CD ]_-RRB- Furthermore_RB ,_, the_DT CDC_NNP recommends_VBZ that_IN healthcare_NN personnel_NNS who_WP care_VBP for_IN severely_RB immunocompromised_JJ persons_NNS receive_VBP injections_NNS (_-LRB- TIV_NN or_CC QIV_NN )_-RRB- rather_RB than_IN LAIV_NN ._. [_-LRB- 119_CD ]_-RRB- The_DT Australian_JJ Government_NN recommends_VBZ seasonal_JJ flu_NN vaccination_NN for_IN everyone_NN over_IN the_DT age_NN of_IN six_CD months_NNS ._. [_-LRB- 120_CD ]_-RRB- Australia_NNP uses_VBZ inactivated_VBN vaccines_NNS ._. [_-LRB- 120_CD ]_-RRB- The_DT flu_NN vaccine_NN is_VBZ free_JJ for_IN the_DT following_VBG people_NNS :_: [_-LRB- 121_CD ]_-RRB- •_SYM children_NNS aged_JJ six_CD months_NNS to_IN five_CD years_NNS •_SYM Aboriginal_JJ and_CC Torres_NNP Strait_NNP Islander_NNP people_NNS aged_JJ six_CD months_NNS and_CC over_RB •_SYM anyone_NN over_RB six_CD months_NNS of_IN age_NN with_IN medical_JJ conditions_NNS such_JJ as_IN severe_JJ asthma_NN ,_, lung_NN disease_NN or_CC heart_NN disease_NN ,_, low_JJ immunity_NN or_CC diabetes_NN that_WDT can_MD lead_VB to_IN complications_NNS from_IN influenza_NN ._. Uptake_NN of_IN flu_NN vaccination_NN ,_, both_CC seasonally_RB and_CC during_IN pandemics_NNS ,_, is_VBZ often_RB low_JJ ._. [_-LRB- 123_CD ]_-RRB- Systematic_JJ reviews_NNS of_IN pandemic_NN flu_NN vaccination_NN uptake_NN have_VBP identified_VBN several_JJ personal_JJ factors_NNS that_WDT may_MD influence_VB uptake_NN ,_, including_VBG gender_NN (_-LRB- higher_JJR uptake_NN in_IN men_NNS )_-RRB- ,_, ethnicity_NN (_-LRB- higher_JJR in_IN people_NNS from_IN ethnic_JJ minorities_NNS )_-RRB- and_CC having_VBG a_DT chronic_JJ illness_NN ._. [_-LRB- 124_CD ]_-RRB- [_-LRB- 125_CD ]_-RRB- Beliefs_NNS in_IN the_DT safety_NN and_CC effectiveness_NN of_IN the_DT vaccine_NN are_VBP also_RB important_JJ ._. [_-LRB- 123_CD ]_-RRB- A_DT number_NN of_IN measures_NNS have_VBP found_VBN to_TO be_VB useful_JJ to_TO increase_VB rates_NNS of_IN vaccination_NN in_IN those_DT over_RB 60_CD years_NNS old_JJ including_VBG :_: patient_NN reminders_NNS using_VBG leaflets_NNS and_CC letters_NNS ,_, postcard_NN reminders_NNS ,_, client_NN outreach_NN programs_NNS ,_, vaccine_NN home_NN visits_NNS ,_, group_NN vaccinations_NNS ,_, free_JJ vaccinations_NNS ,_, physician_NN payment_NN ,_, physician_NN reminders_NNS and_CC encouraging_VBG physician_NN competition_NN ._. [_-LRB- 126_CD ]_-RRB- Frontline_NN healthcare_NN workers_NNS are_VBP often_RB recommended_VBN to_TO get_VB seasonal_JJ and_CC any_DT pandemic_NN flu_NN vaccination_NN ._. For_IN example_NN ,_, in_IN the_DT UK_NNP all_DT healthcare_NN workers_NNS involved_VBN in_IN patient_NN care_NN are_VBP recommended_VBN to_TO receive_VB the_DT seasonal_JJ flu_NN vaccine_NN ,_, and_CC were_VBD also_RB recommended_VBN to_TO be_VB vaccinated_VBN against_IN the_DT H1N1/09_NN (_-LRB- later_RBR renamed_VBN A_DT (_-LRB- H1N1_NN )_-RRB- pdm09_NN [_-LRB- note_NN 1_CD ]_-RRB- [_-LRB- 127_CD ]_-RRB- )_-RRB- swine_NN flu_NN virus_NN during_IN the_DT 2009_CD pandemic_NN ._. However_RB ,_, uptake_NN is_VBZ often_RB low_JJ ._. [_-LRB- 92_CD ]_-RRB- During_IN the_DT 2009_CD pandemic_NN ,_, low_JJ uptake_NN by_IN healthcare_NN workers_NNS was_VBD seen_VBN in_IN countries_NNS including_VBG the_DT UK_NNP ,_, [_-LRB- 92_CD ]_-RRB- Italy_NNP ,_, [_-LRB- 128_CD ]_-RRB- Greece_NNP ,_, [_-LRB- 129_CD ]_-RRB- and_CC Hong_NNP Kong_NNP ._. [_-LRB- 130_CD ]_-RRB- In_IN a_DT 2010_CD survey_NN of_IN United_NNP States_NNPS healthcare_NN workers_NNS ,_, 63.5_CD %_NN reported_VBD that_IN they_PRP received_VBD the_DT flu_NN vaccine_NN during_IN the_DT 2010_CD –_SYM 11_CD season_NN ,_, an_DT increase_NN from_IN 61.9_CD %_NN reported_VBD the_DT previous_JJ season_NN ._. US_NNP Health_NN professionals_NNS with_IN direct_JJ patient_NN contact_NN had_VBD higher_JJR vaccination_NN uptake_NN ,_, such_JJ as_IN physicians_NNS and_CC dentists_NNS (_-LRB- 84.2_CD %_NN )_-RRB- and_CC nurse_NN practitioners_NNS (_-LRB- 82.6_CD %_NN )_-RRB- ._. [_-LRB- 131_CD ]_-RRB- [_-LRB- 132_CD ]_-RRB- [_-LRB- 133_CD ]_-RRB- The_DT main_JJ reason_NN to_TO vaccinate_VB healthcare_NN workers_NNS is_VBZ to_TO prevent_VB staff_NN from_IN spreading_VBG flu_NN to_IN their_PRP$ patients_NNS and_CC to_TO reduce_VB staff_NN absence_NN at_IN a_DT time_NN of_IN high_JJ service_NN demand_NN ,_, but_CC the_DT reasons_NNS healthcare_NN workers_NNS state_NN for_IN their_PRP$ decisions_NNS to_TO accept_VB or_CC decline_VB vaccination_NN may_MD more_RBR often_RB be_VB to_TO do_VB with_IN perceived_VBN personal_JJ benefits_NNS ._. [_-LRB- 92_CD ]_-RRB- In_IN Victoria_NNP (_-LRB- Australia_NNP )_-RRB- public_JJ hospitals_NNS ,_, rates_NNS of_IN healthcare_NN worker_NN vaccination_NN in_IN 2005_CD ranged_VBD from_IN 34_CD %_NN for_IN non-clinical_JJ staff_NN to_IN 42_CD %_NN for_IN laboratory_NN staff_NN ._. One_CD of_IN the_DT reasons_NNS for_IN rejecting_VBG vaccines_NNS was_VBD concern_NN over_IN adverse_JJ reactions_NNS ;_: in_IN one_CD study_NN ,_, 31_CD %_NN of_IN resident_NN physicians_NNS at_IN a_DT teaching_NN hospital_NN incorrectly_RB believed_VBD Australian_JJ vaccines_NNS could_MD cause_VB influenza_NN ._. [_-LRB- 134_CD ]_-RRB- Flu_NN vaccine_NN is_VBZ usually_RB grown_VBN by_IN vaccine_NN manufacturers_NNS in_IN fertilized_VBN chicken_NN eggs_NNS ._. [_-LRB- 135_CD ]_-RRB- [_-LRB- 136_CD ]_-RRB- In_IN the_DT Northern_JJ hemisphere_NN ,_, the_DT manufacturing_NN process_NN begins_VBZ following_VBG the_DT announcement_NN (_-LRB- typically_RB in_IN February_NNP )_-RRB- of_IN the_DT WHO_NNP recommended_VBN strains_NNS for_IN the_DT winter_NN flu_NN season_NN ._. [_-LRB- 135_CD ]_-RRB- [_-LRB- 137_CD ]_-RRB- Three_CD strains_NNS (_-LRB- representing_VBG an_DT H1N1_NN ,_, an_DT H3N2_NN ,_, and_CC a_DT B_NN strain_NN )_-RRB- of_IN flu_NN are_VBP selected_VBN and_CC chicken_NN eggs_NNS are_VBP inoculated_VBN separately_RB ._. These_DT monovalent_JJ harvests_NNS are_VBP then_RB combined_VBN to_TO make_VB the_DT trivalent_JJ vaccine_NN ._. [_-LRB- 138_CD ]_-RRB- As_IN of_IN November_NNP 2007_CD ,_, both_CC the_DT conventional_JJ injection_NN and_CC the_DT nasal_JJ spray_NN are_VBP manufactured_VBN using_VBG chicken_NN eggs_NNS ._. [_-LRB- 136_CD ]_-RRB- The_DT European_NNP Union_NNP also_RB approved_VBD Optaflu_NNP ,_, a_DT vaccine_NN produced_VBN by_IN Novartis_NNP using_VBG vats_NNS of_IN animal_NN cells_NNS ._. [_-LRB- 136_CD ]_-RRB- This_DT technique_NN is_VBZ expected_VBN to_TO be_VB more_RBR scalable_JJ and_CC avoid_VB problems_NNS with_IN eggs_NNS ,_, such_JJ as_IN allergic_JJ reactions_NNS and_CC incompatibility_NN with_IN strains_NNS that_WDT affect_VBP avians_NNS like_IN chickens_NNS ._. [_-LRB- 136_CD ]_-RRB- Research_NN continues_VBZ into_IN the_DT idea_NN of_IN a_DT ""_`` universal_JJ ""_'' influenza_NN vaccine_NN that_WDT would_MD not_RB require_VB tailoring_NN to_IN a_DT particular_JJ strain_NN ,_, but_CC would_MD be_VB effective_JJ against_IN a_DT broad_JJ variety_NN of_IN influenza_NN viruses_NNS ._. [_-LRB- 139_CD ]_-RRB- However_RB ,_, no_DT vaccine_NN candidates_NNS had_VBD been_VBN announced_VBN by_IN November_NNP 2007_CD ._. [_-LRB- 136_CD ]_-RRB- A_DT DNA_NN -_HYPH based_VBN vaccination_NN ,_, which_WDT is_VBZ hoped_VBN to_TO be_VB even_RB faster_JJR to_TO manufacture_VB ,_, is_VBZ ,_, as_IN of_IN 2011_CD ,_, [_-LRB- needs_VBZ update_NN ]_-RRB- in_IN clinical_JJ trials_NNS ,_, determining_VBG safety_NN and_CC efficacy_NN ._. [_-LRB- 140_CD ]_-RRB- [_-LRB- 141_CD ]_-RRB- [_-LRB- 142_CD ]_-RRB- On_IN November_NNP 20_CD ,_, 2012_CD ,_, Novartis_NNP received_VBD FDA_NNP approval_NN for_IN the_DT first_JJ cell_NN -_HYPH culture_NN vaccine_NN ._. [_-LRB- 143_CD ]_-RRB- [_-LRB- 144_CD ]_-RRB- [_-LRB- 145_CD ]_-RRB- [_-LRB- 146_CD ]_-RRB- [_-LRB- 144_CD ]_-RRB- In_IN a_DT 2007_CD report_NN ,_, the_DT global_JJ capacity_NN of_IN approximately_RB 826_CD million_CD seasonal_JJ influenza_NN vaccine_NN doses_NNS (_-LRB- inactivated_VBN and_CC live_JJ )_-RRB- was_VBD double_JJ the_DT production_NN of_IN 413_CD million_CD doses_NNS ._. In_IN an_DT aggressive_JJ scenario_NN of_IN producing_VBG pandemic_NN influenza_NN vaccines_NNS by_IN 2013_CD ,_, only_RB 2.8_CD billion_CD courses_NNS could_MD be_VB produced_VBN in_IN a_DT six_CD -_HYPH month_NN time_NN frame_NN ._. If_IN all_DT high_JJ -_HYPH and_CC upper_JJ -_HYPH middle_JJ -_HYPH income_NN countries_NNS sought_VBD vaccines_NNS for_IN their_PRP$ entire_JJ populations_NNS in_IN a_DT pandemic_NN ,_, nearly_RB 2_CD billion_CD courses_NNS would_MD be_VB required_VBN ._. If_IN China_NNP pursued_VBD this_DT goal_NN as_RB well_RB ,_, more_JJR than_IN 3_CD billion_CD courses_NNS would_MD be_VB required_VBN to_TO serve_VB these_DT populations_NNS ._. [_-LRB- 147_CD ]_-RRB- Vaccine_NN research_NN and_CC development_NN is_VBZ ongoing_JJ to_TO identify_VB novel_JJ vaccine_NN approaches_NNS that_WDT could_MD produce_VB much_RB greater_JJR quantities_NNS of_IN vaccine_NN at_IN a_DT price_NN that_WDT is_VBZ affordable_JJ to_IN the_DT global_JJ population_NN .[_-LRB- citation_NN needed_VBN ]_-RRB- Methods_NNS of_IN vaccine_NN generation_NN that_WDT bypass_VBP the_DT need_NN for_IN eggs_NNS include_VBP the_DT construction_NN of_IN influenza_NN virus_NN -_HYPH like_IN particles_NNS (_-LRB- VLP_NN )_-RRB- ._. VLP_NNP resemble_VBP viruses_NNS ,_, but_CC there_EX is_VBZ no_DT need_NN for_IN inactivation_NN ,_, as_IN they_PRP do_VBP not_RB include_VB viral_JJ coding_NN elements_NNS ,_, but_CC merely_RB present_VBP antigens_NNS in_IN a_DT similar_JJ manner_NN to_IN a_DT virion_NN ._. Some_DT methods_NNS of_IN producing_VBG VLP_NN include_VBP cultures_NNS of_IN Spodoptera_FW frugiperda_FW Sf9_NN insect_NN cells_NNS and_CC plant_NN -_HYPH based_VBN vaccine_NN production_NN (_-LRB- e.g._FW ,_, production_NN in_IN Nicotiana_NNP benthamiana_FW )_-RRB- ._. There_EX is_VBZ evidence_NN that_IN some_DT VLPs_NNS elicit_VBP antibodies_NNS that_WDT recognize_VBP a_DT broader_JJR panel_NN of_IN antigenically_RB distinct_JJ viral_JJ isolates_NNS compared_VBN to_IN other_JJ vaccines_NNS in_IN the_DT hemagglutination_NN -_HYPH inhibition_NN assay_NN (_-LRB- HIA_NN )_-RRB- ._. [_-LRB- 148_CD ]_-RRB- Influenza_NN vaccines_NNS are_VBP produced_VBN in_IN pathogen_NN -_HYPH free_JJ eggs_NNS that_WDT are_VBP 11_CD to_IN 12_CD days_NNS old_JJ ._. [_-LRB- 149_CD ]_-RRB- The_DT top_NN of_IN the_DT egg_NN is_VBZ disinfected_VBN by_IN wiping_VBG it_PRP with_IN alcohol_NN and_CC then_RB the_DT egg_NN is_VBZ candled_VBN to_TO identify_VB a_DT non-veinous_JJ area_NN in_IN the_DT allantoic_JJ cavity_NN where_WRB a_DT small_JJ hole_NN is_VBZ poked_VBN to_TO serve_VB as_IN a_DT pressure_NN release_NN ._. [_-LRB- 150_CD ]_-RRB- A_DT second_JJ hole_NN is_VBZ made_VBN at_IN the_DT top_NN of_IN the_DT egg_NN ,_, where_WRB the_DT influenza_NN virus_NN is_VBZ injected_VBN in_IN the_DT allantoic_JJ cavity_NN ,_, past_IN the_DT chorioallantoic_JJ membrane_NN ._. The_DT two_CD holes_NNS are_VBP then_RB sealed_VBN with_IN melted_VBN paraffin_NN and_CC the_DT inoculated_VBN eggs_NNS are_VBP incubated_VBN for_IN 48_CD hours_NNS at_IN 37_CD degrees_NNS Celsius_NNP ._. [_-LRB- 149_CD ]_-RRB- During_IN incubation_NN time_NN ,_, the_DT virus_NN replicates_VBZ and_CC newly_RB replicated_VBN viruses_NNS are_VBP released_VBN into_IN the_DT allantoic_JJ fluid_NN [_-LRB- 151_CD ]_-RRB- After_IN the_DT 48_CD -_HYPH hour_NN incubation_NN period_NN ,_, the_DT top_NN of_IN the_DT egg_NN is_VBZ cracked_VBN and_CC the_DT 10_CD milliliters_NNS of_IN allantoic_JJ fluid_NN is_VBZ removed_VBN ,_, from_IN which_WDT about_RB 15_CD micrograms_NNS of_IN the_DT flu_NN vaccine_NN can_MD be_VB obtained_VBN ._. At_IN this_DT point_NN ,_, the_DT viruses_NNS have_VBP been_VBN weakened_VBN or_CC killed_VBN and_CC the_DT viral_JJ antigen_NN is_VBZ purified_VBN and_CC placed_VBN inside_IN vials_NNS ,_, syringes_NNS ,_, or_CC nasal_JJ sprayers_NNS ._. [_-LRB- 151_CD ]_-RRB- Done_VBN on_IN a_DT large_JJ -_HYPH scale_NN ,_, this_DT method_NN is_VBZ used_VBN to_TO produce_VB the_DT flu_NN vaccine_NN for_IN the_DT human_JJ population_NN ._. In_IN 2013_CD ,_, the_DT recombinant_JJ influenza_NN vaccine_NN ,_, Flublok_NNP ,_, was_VBD approved_VBN for_IN use_NN in_IN the_DT United_NNP States_NNPS ._. [_-LRB- 152_CD ]_-RRB- [_-LRB- 153_CD ]_-RRB- [_-LRB- 154_CD ]_-RRB- [_-LRB- 155_CD ]_-RRB- Each_DT year_NN ,_, three_CD strains_NNS are_VBP chosen_VBN for_IN selection_NN in_IN that_DT year_NN 's_POS flu_NN vaccination_NN by_IN the_DT WHO_NNP Global_NNP Influenza_NNP Surveillance_NNP and_CC Response_NNP System_NNP ._. [_-LRB- 156_CD ]_-RRB- The_DT chosen_VBN strains_NNS are_VBP the_DT H1N1_NN ,_, H3N2_NN ,_, and_CC Type_NN -_HYPH B_NN strains_NNS thought_VBN most_RBS likely_JJ to_TO cause_VB significant_JJ human_JJ suffering_NN in_IN the_DT coming_VBG season_NN ._. Starting_VBG with_IN the_DT 2012_CD –2013_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN (_-LRB- coincident_NN with_IN the_DT approval_NN of_IN quadrivalent_JJ influenza_NN vaccines_NNS )_-RRB- ,_, the_DT WHO_NNP has_VBZ also_RB recommended_VBN a_DT 2nd_JJ B_NN -_HYPH strain_NN for_IN use_NN in_IN quadrivalent_NN vaccines_NNS ._. The_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- coordinates_VBZ the_DT contents_NNS of_IN the_DT vaccine_NN each_DT year_NN to_TO contain_VB the_DT most_RBS likely_JJ strains_NNS of_IN the_DT virus_NN to_TO attack_VB the_DT next_JJ year_NN ._. The_DT Global_NNP Influenza_NNP Surveillance_NNP and_CC Response_NNP System_NNP 's_POS selection_NN of_IN viruses_NNS for_IN the_DT vaccine_NN manufacturing_NN process_NN is_VBZ based_VBN on_IN its_PRP$ best_JJS estimate_NN of_IN which_WDT strains_NNS will_MD predominate_VB the_DT next_JJ year_NN ,_, amounting_VBG in_IN the_DT end_NN to_IN well_RB -_HYPH informed_VBN but_CC fallible_JJ guesswork_NN ._. [_-LRB- 159_CD ]_-RRB- Formal_JJ WHO_NNP recommendations_NNS were_VBD first_RB issued_VBN in_IN 1973_CD ._. Beginning_VBG in_IN 1999_CD there_EX have_VBP been_VBN two_CD recommendations_NNS per_IN year_NN :_: one_CD for_IN the_DT northern_JJ hemisphere_NN and_CC the_DT other_JJ for_IN the_DT southern_JJ hemisphere_NN ._. [_-LRB- 160_CD ]_-RRB- Historical_JJ annual_JJ reformulations_NNS of_IN the_DT influenza_NN vaccine_NN are_VBP listed_VBN in_IN a_DT separate_JJ article_NN ._. Recent_JJ WHO_NNP seasonal_JJ influenza_NN vaccine_NN composition_NN recommendations_NNS :_: The_DT composition_NN of_IN trivalent_JJ virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2017_CD –2018_NNP Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT Advisory_NNP Committee_NNP on_IN Immunization_NNP Practices_NNPS on_IN August_NNP 25_CD ,_, 2017_CD [_-LRB- 161_CD ]_-RRB- was_VBD :_: In_IN addition_NN to_IN these_DT components_NNS ,_, quadrivalent_NN vaccines_NNS will_MD also_RB include_VB a_DT B_NN /_, Phuket_NN /_, 3073/2013_CD –_: like_JJ virus_NN (_-LRB- Yamagata_NNP lineage_NN )_-RRB- ._. In_IN California_NNP ,_, some_DT emergency_NN systems_NNS were_VBD strained_VBN by_IN a_DT spike_NN in_IN H3N2_NNP flu_NN cases_NNS ._. In_IN addition_NN ,_, some_DT areas_NNS experienced_VBD local_JJ shortages_NNS of_IN oseltamivir_NN ._. [_-LRB- 163_CD ]_-RRB- The_DT severity_NN of_IN the_DT flu_NN season_NN seemed_VBD somewhat_RB comparable_JJ to_IN the_DT 2009_CD –_SYM 10_CD swine_NN flu_NN outbreak_NN ._. A_DT February_NNP 2018_CD CDC_NNP interim_JJ report_NN estimated_VBD the_DT vaccine_NN effectiveness_NN to_TO be_VB 25_CD %_NN against_IN H3N2_NN ,_, 67_CD %_NN against_IN H1N1_NN ,_, and_CC 42_CD %_NN against_IN influenza_NN B._NN [_-LRB- 164_CD ]_-RRB- [_-LRB- 165_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2018_CD Southern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP on_IN September_NNP 28_CD ,_, 2017_CD was_VBD :_: [_-LRB- 166_CD ]_-RRB- The_DT WHO_NNP recommended_VBD that_IN quadrivalent_NN vaccines_NNS containing_VBG two_CD influenza_NN B_NN viruses_NNS should_MD contain_VB the_DT above_JJ three_CD viruses_NNS and_CC a_DT B_NN /_, Brisbane_NNP /_, 60/2008_CD -_HYPH like_JJ virus_NN ._. [_-LRB- 167_CD ]_-RRB- [_-LRB- 166_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2018_CD –_HYPH 2019_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP on_IN February_NNP 22_CD ,_, 2018_CD was_VBD :_: [_-LRB- 168_CD ]_-RRB- [_-LRB- 169_CD ]_-RRB- The_DT WHO_NNP recommended_VBD that_IN trivalent_JJ vaccines_NNS use_VBP as_IN their_PRP$ influenza_NN B_NN virus_NN a_DT B_NN /_, Colorado_NNP /_, 06/2017_CD -_HYPH like_IN virus_NN of_IN the_DT B_NN /_, Victoria_NNP /_, 2/87_CD -_HYPH lineage_NN ._. [_-LRB- 170_CD ]_-RRB- [_-LRB- 168_CD ]_-RRB- A_DT February_NNP 2019_CD ,_, CDC_NNP interim_JJ report_NN estimated_VBD the_DT vaccine_NN effectiveness_NN to_TO be_VB approximately_RB 47_CD %_NN against_IN the_DT 2018_CD –_HYPH 2019_CD flu_NN strains_NNS ._. [_-LRB- 24_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT United_NNP States_NNPS for_IN the_DT 2018_CD –_HYPH 2019_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP on_IN March_NNP 1_CD ,_, 2018_CD ,_, was_VBD :_: [_-LRB- 171_CD ]_-RRB- The_DT committee_NN also_RB recommended_VBD that_IN quadrivalent_JJ influenza_NN vaccines_NNS contain_VBP the_DT above_JJ three_CD strains_NNS and_CC the_DT following_VBG additional_JJ B_NN strain_NN :_: [_-LRB- 171_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2019_CD Southern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP in_IN September_NNP 2018_CD was_VBD :_: [_-LRB- 172_CD ]_-RRB- The_DT WHO_NNP recommended_VBD that_IN trivalent_JJ vaccines_NNS use_VBP as_IN their_PRP$ influenza_NN B_NN virus_NN a_DT B_NN /_, Colorado_NNP /_, 06/2017_CD -_HYPH like_IN virus_NN of_IN the_DT B_NN /_, Victoria_NNP /_, 2/87_CD -_HYPH lineage_NN ._. [_-LRB- 173_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2019_CD –_HYPH 2020_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP on_IN March_NNP 21_CD ,_, 2019_CD was_VBD :_: The_DT WHO_NNP recommended_VBD that_IN trivalent_JJ vaccines_NNS use_VBP as_IN their_PRP$ influenza_NN B_NN virus_NN a_DT B_NN /_, Colorado_NNP /_, 06/2017_CD -_HYPH like_IN virus_NN of_IN the_DT B_NN /_, Victoria_NNP /_, 2/87_CD -_HYPH lineage_NN ._. [_-LRB- 175_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT United_NNP States_NNPS for_IN the_DT 2019_CD –_HYPH 2020_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT Food_NNP and_CC Drug_NNP Administration_NNP on_IN March_NNP 22_CD ,_, 2019_CD ,_, was_VBD :_: [_-LRB- 176_CD ]_-RRB- [_-LRB- 177_CD ]_-RRB- [_-LRB- 178_CD ]_-RRB- The_DT committee_NN also_RB recommended_VBD that_IN quadrivalent_JJ influenza_NN vaccines_NNS contain_VBP the_DT above_JJ three_CD strains_NNS and_CC the_DT following_VBG additional_JJ B_NN strain_NN :_: [_-LRB- 176_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT European_NNP Union_NNP for_IN the_DT 2019_CD –_HYPH 2020_CD Northern_NNP Hemisphere_NNP influenza_NN season_NN recommended_VBN by_IN the_DT European_NNP Medicines_NNPS Agency_NNP on_IN May_NNP 15_CD ,_, 2019_CD ,_, was_VBD :_: [_-LRB- 179_CD ]_-RRB- Trivalent_NN vaccines_NNS should_MD contain_VB :_: For_IN vaccine_NN manufacturers_NNS considering_VBG the_DT use_NN of_IN a_DT B_NN /_, Yamagata_NNP /_, 16/88_CD virus_NN lineage_NN vaccine_NN virus_NN in_IN quadrivalent_NN vaccines_NNS containing_VBG two_CD influenza_NN B_NN viruses_NNS ,_, a_DT B_NN /_, Phuket_NN /_, 3073/2013_NN -_HYPH like_JJ virus_NN in_IN addition_NN to_IN the_DT strains_NNS mentioned_VBN above_RB is_VBZ considered_VBN appropriate_JJ ._. [_-LRB- 179_CD ]_-RRB- The_DT composition_NN of_IN virus_NN vaccines_NNS for_IN use_NN in_IN the_DT 2020_CD Southern_NNP Hemisphere_NNP influenza_NN season_NN influenza_NN season_NN recommended_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP in_IN September_NNP 2019_CD was_VBD :_: [_-LRB- 180_CD ]_-RRB- The_DT WHO_NNP recommended_VBD that_IN trivalent_JJ vaccines_NNS use_VBP as_IN their_PRP$ influenza_NN B_NN virus_NN a_DT B_NN /_, Washington_NNP /_, 02/2019_CD -_HYPH like_JJ (_-LRB- B_NN /_, Victoria_NNP lineage_NN )_-RRB- virus_NN ._. [_-LRB- 180_CD ]_-RRB- Vaccines_NNS are_VBP used_VBN in_IN both_CC humans_NNS and_CC nonhumans_NNS ._. Human_JJ vaccine_NN is_VBZ meant_VBN unless_IN specifically_RB identified_VBN as_IN a_DT veterinary_NN ,_, poultry_NN or_CC livestock_NN vaccine_NN ._. In_IN the_DT worldwide_JJ Spanish_JJ flu_NN pandemic_NN of_IN 1918_CD ,_, ""_`` Physicians_NNS tried_VBD everything_NN they_PRP knew_VBD ,_, everything_NN they_PRP had_VBD ever_RB heard_VBN of_IN ,_, from_IN the_DT ancient_JJ art_NN of_IN bleeding_VBG patients_NNS ,_, to_IN administering_VBG oxygen_NN ,_, to_IN developing_VBG new_JJ vaccines_NNS and_CC serums_NNS (_-LRB- chiefly_RB against_IN what_WP we_PRP now_RB call_VBP Hemophilus_NNP influenzae_NN –_: a_DT name_NN derived_VBN from_IN the_DT fact_NN that_IN it_PRP was_VBD originally_RB considered_VBN the_DT etiological_JJ agent_NN –_: and_CC several_JJ types_NNS of_IN pneumococci_NN )_-RRB- ._. Only_RB one_CD therapeutic_JJ measure_NN ,_, transfusing_VBG blood_NN from_IN recovered_VBN patients_NNS to_IN new_JJ victims_NNS ,_, showed_VBD any_DT hint_NN of_IN success_NN ._. ""_'' [_-LRB- 181_CD ]_-RRB- In_IN 1931_CD ,_, viral_JJ growth_NN in_IN embryonated_JJ hens_NNS '_POS eggs_NNS was_VBD reported_VBN by_IN Ernest_NNP William_NNP Goodpasture_NNP and_CC colleagues_NNS at_IN Vanderbilt_NNP University_NNP ._. The_DT work_NN was_VBD extended_VBN to_IN growth_NN of_IN influenza_NN virus_NN by_IN several_JJ workers_NNS ,_, including_VBG Thomas_NNP Francis_NNP ,_, Jonas_NNP Salk_NNP ,_, Wilson_NNP Smith_NNP and_CC Macfarlane_NNP Burnet_NNP ,_, leading_VBG to_IN the_DT first_JJ experimental_JJ influenza_NN vaccines_NNS ._. [_-LRB- 182_CD ]_-RRB- In_IN the_DT 1940s_NNS ,_, the_DT US_NNP military_NN developed_VBD the_DT first_JJ approved_VBN inactivated_VBN vaccines_NNS for_IN influenza_NN ,_, which_WDT were_VBD used_VBN in_IN the_DT Second_NNP World_NNP War_NNP ._. [_-LRB- 183_CD ]_-RRB- Hen_NNP 's_POS eggs_NNS continued_VBD to_TO be_VB used_VBN to_TO produce_VB virus_NN used_VBN in_IN influenza_NN vaccines_NNS ,_, but_CC manufacturers_NNS made_VBD improvements_NNS in_IN the_DT purity_NN of_IN the_DT virus_NN by_IN developing_VBG improved_VBN processes_NNS to_TO remove_VB egg_NN proteins_NNS and_CC to_TO reduce_VB systemic_JJ reactivity_NN of_IN the_DT vaccine_NN ._. [_-LRB- 184_CD ]_-RRB- In_IN 2012_CD ,_, the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- approved_VBD influenza_NN vaccines_NNS made_VBN by_IN growing_VBG virus_NN in_IN cell_NN cultures_NNS [_-LRB- 185_CD ]_-RRB- [_-LRB- 144_CD ]_-RRB- [_-LRB- 186_CD ]_-RRB- and_CC influenza_NN vaccines_NNS made_VBN from_IN recombinant_JJ proteins_NNS [_-LRB- 152_CD ]_-RRB- have_VBP been_VBN approved_VBN ,_, with_IN plant_NN -_HYPH based_VBN influenza_NN vaccines_NNS being_VBG tested_VBN [_-LRB- when_WRB ?_. ]_-RRB- in_IN clinical_JJ trials_NNS ._. [_-LRB- 187_CD ]_-RRB- According_VBG to_IN the_DT CDC_NNP :_: ""_`` Influenza_NN vaccination_NN is_VBZ the_DT primary_JJ method_NN for_IN preventing_VBG influenza_NN and_CC its_PRP$ severe_JJ complications_NNS ._. [...]_'' Vaccination_NN is_VBZ associated_VBN with_IN reductions_NNS in_IN influenza_NN -_HYPH related_JJ respiratory_JJ illness_NN and_CC physician_NN visits_NNS among_IN all_DT age_NN groups_NNS ,_, hospitalization_NN and_CC death_NN among_IN persons_NNS at_IN high_JJ risk_NN ,_, otitis_NN media_NN among_IN children_NNS ,_, and_CC work_NN absenteeism_NN among_IN adults_NNS ._. Although_IN influenza_NN vaccination_NN levels_NNS increased_VBD substantially_RB during_IN the_DT 1990s_NNS ,_, further_JJR improvements_NNS in_IN vaccine_NN coverage_NN levels_NNS are_VBP needed_VBN ""_'' ._. [_-LRB- 188_CD ]_-RRB- The_DT egg_NN -_HYPH based_VBN technology_NN (_-LRB- still_RB in_IN use_NN as_IN of_IN 2019_CD )_-RRB- for_IN producing_VBG influenza_NN vaccine_NN was_VBD created_VBN in_IN the_DT 1950s_NNS ._. [_-LRB- 189_CD ]_-RRB- In_IN the_DT U.S._NNP swine_NN flu_NN scare_NN of_IN 1976_CD ,_, President_NNP Gerald_NNP Ford_NNP was_VBD confronted_VBN with_IN a_DT potential_JJ swine_NN flu_NN pandemic_NN ._. The_DT vaccination_NN program_NN was_VBD rushed_VBN ,_, yet_CC plagued_VBN by_IN delays_NNS and_CC public_JJ relations_NNS problems_NNS ._. Meanwhile_RB ,_, maximum_JJ military_JJ containment_NN efforts_NNS succeeded_VBD unexpectedly_RB in_IN confining_VBG the_DT new_JJ strain_NN to_IN the_DT single_JJ army_NN base_NN where_WRB it_PRP had_VBD originated_VBN ._. On_IN that_DT base_NN ,_, a_DT number_NN of_IN soldiers_NNS fell_VBD severely_RB ill_JJ ,_, but_CC only_RB one_CD died_VBD ._. The_DT program_NN was_VBD canceled_VBN after_IN about_RB 24_CD %_NN of_IN the_DT population_NN had_VBD received_VBN vaccinations_NNS ._. An_DT excess_NN in_IN deaths_NNS of_IN twenty_CD -_HYPH five_CD over_IN normal_JJ annual_JJ levels_NNS as_RB well_RB as_IN 400_CD excess_NN hospitalizations_NNS ,_, both_CC from_IN Guillain–_NNP Barré_NNP syndrome_NN ,_, were_VBD estimated_VBN to_TO have_VB occurred_VBN from_IN the_DT vaccination_NN program_NN itself_PRP ,_, illustrating_VBG that_IN the_DT vaccine_NN itself_PRP is_VBZ not_RB free_JJ of_IN risks_NNS ._. The_DT result_NN has_VBZ been_VBN cited_VBN to_TO stoke_VB lingering_VBG doubts_NNS about_IN vaccination_NN ._. [_-LRB- 190_CD ]_-RRB- In_IN the_DT end_NN ,_, however_RB ,_, even_RB the_DT maligned_VBN 1976_CD vaccine_NN may_MD have_VB saved_VBN lives_NNS ._. A_DT 2010_CD study_NN found_VBD a_DT significantly_RB enhanced_VBN immune_JJ response_NN against_IN the_DT 2009_CD pandemic_NN H1N1_NN in_IN study_NN participants_NNS who_WP had_VBD received_VBN vaccination_NN against_IN the_DT swine_NN flu_NN in_IN 1976_CD ._. [_-LRB- 191_CD ]_-RRB- A_DT quadrivalent_JJ flu_NN vaccine_NN administered_VBN by_IN nasal_JJ mist_NN was_VBD approved_VBN by_IN the_DT FDA_NNP in_IN March_NNP 2012_CD ._. [_-LRB- 192_CD ]_-RRB- [_-LRB- 193_CD ]_-RRB- Fluarix_NNP Quadrivalent_NNP was_VBD approved_VBN by_IN the_DT FDA_NNP in_IN December_NNP 2012_CD ._. [_-LRB- 194_CD ]_-RRB- In_IN 2014_CD ,_, the_DT Canadian_NNP National_NNP Advisory_NNP Committee_NNP on_IN Immunization_NNP (_-LRB- NACI_NNP )_-RRB- published_VBD a_DT review_NN of_IN quadrivalent_JJ influenza_NN vaccines_NNS ._. [_-LRB- 195_CD ]_-RRB- Starting_VBG with_IN the_DT 2018_CD -_HYPH 2019_CD influenza_NN season_NN most_JJS of_IN the_DT regular_JJ -_HYPH dose_NN egg_NN -_HYPH based_VBN flu_NN shots_NNS and_CC all_DT of_IN the_DT recombinant_NN and_CC cell_NN -_HYPH grown_VBN flu_NN vaccines_NNS in_IN the_DT United_NNP States_NNPS are_VBP quadrivalent_NN ._. [_-LRB- 196_CD ]_-RRB- In_IN the_DT 2019_CD –2020_CD influenza_NN season_NN all_DT regular_JJ -_HYPH dose_NN flu_NN shots_NNS and_CC all_DT recombinant_JJ influenza_NN vaccine_NN in_IN the_DT United_NNP States_NNPS are_VBP quadrivalent_NN ._. [_-LRB- 40_CD ]_-RRB- In_IN November_NNP 2019_CD ,_, the_DT FDA_NNP approved_VBD Fluzone_NNP High_NNP -_HYPH Dose_NNP Quadrivalent_NNP for_IN use_NN in_IN the_DT United_NNP States_NNPS starting_VBG with_IN the_DT 2020_CD -_HYPH 2021_CD influenza_NN season_NN ._. [_-LRB- 197_CD ]_-RRB- [_-LRB- 198_CD ]_-RRB- The_DT cost_NN -_HYPH effectiveness_NN of_IN seasonal_JJ influenza_NN vaccination_NN has_VBZ been_VBN widely_RB evaluated_VBN for_IN different_JJ groups_NNS and_CC in_IN different_JJ settings_NNS ._. [_-LRB- 199_CD ]_-RRB- In_IN the_DT elderly_JJ (_-LRB- aged_JJ over_RB 65_CD years_NNS )_-RRB- the_DT majority_NN of_IN published_VBN studies_NNS have_VBP found_VBN that_IN vaccination_NN is_VBZ cost_NN saving_VBG ,_, with_IN the_DT cost_NN savings_NNS associated_VBN with_IN influenza_NN vaccination_NN (_-LRB- e.g._FW prevented_VBN healthcare_NN visits_NNS )_-RRB- outweighing_VBG the_DT cost_NN of_IN vaccination_NN ._. [_-LRB- 200_CD ]_-RRB- In_IN older_JJR adults_NNS (_-LRB- aged_JJ 50_CD –_SYM 64_CD years_NNS )_-RRB- ,_, several_JJ published_VBN studies_NNS have_VBP found_VBN that_IN influenza_NN vaccination_NN is_VBZ likely_JJ to_TO be_VB cost_NN -_HYPH effective_JJ ,_, however_RB the_DT results_NNS of_IN these_DT studies_NNS were_VBD often_RB found_VBN to_TO be_VB dependent_JJ on_IN key_JJ assumptions_NNS used_VBN in_IN the_DT economic_JJ evaluations_NNS ._. [_-LRB- 201_CD ]_-RRB- The_DT uncertainty_NN in_IN influenza_NN cost_NN -_HYPH effectiveness_NN models_NNS can_MD partially_RB be_VB explained_VBN by_IN the_DT complexities_NNS involved_VBN in_IN estimating_VBG the_DT disease_NN burden_NN ,_, [_-LRB- 202_CD ]_-RRB- as_RB well_RB as_IN the_DT seasonal_JJ variability_NN in_IN the_DT circulating_VBG strains_NNS and_CC the_DT match_NN of_IN the_DT vaccine_NN ._. [_-LRB- 203_CD ]_-RRB- [_-LRB- 204_CD ]_-RRB- In_IN healthy_JJ working_NN adults_NNS (_-LRB- aged_JJ 18_CD –_SYM 49_CD years_NNS )_-RRB- ,_, a_DT 2012_CD review_NN found_VBD that_IN vaccination_NN was_VBD generally_RB not_RB cost_NN -_HYPH saving_VBG ,_, with_IN the_DT suitability_NN for_IN funding_NN being_VBG dependent_JJ on_IN the_DT willingness_NN to_TO pay_VB to_TO obtain_VB the_DT associated_VBN health_NN benefits_NNS ._. [_-LRB- 205_CD ]_-RRB- In_IN children_NNS ,_, the_DT majority_NN of_IN studies_NNS have_VBP found_VBN that_IN influenza_NN vaccination_NN was_VBD cost_NN -_HYPH effective_JJ ,_, however_RB many_JJ of_IN the_DT studies_NNS included_VBD (_-LRB- indirect_JJ )_-RRB- productivity_NN gains_NNS ,_, which_WDT may_MD not_RB be_VB given_VBN the_DT same_JJ weight_NN in_IN all_DT settings_NNS ._. [_-LRB- 206_CD ]_-RRB- Several_JJ studies_NNS have_VBP attempted_VBN to_TO predict_VB the_DT cost_NN -_HYPH effectiveness_NN of_IN interventions_NNS (_-LRB- including_VBG prepandemic_JJ vaccination_NN )_-RRB- to_TO help_VB protect_VB against_IN a_DT future_JJ pandemic_NN ,_, however_IN estimating_VBG the_DT cost_NN -_HYPH effectiveness_NN has_VBZ been_VBN complicated_VBN by_IN uncertainty_NN as_IN to_IN the_DT severity_NN of_IN a_DT potential_JJ future_JJ pandemic_NN and_CC the_DT efficacy_NN of_IN measures_NNS against_IN it_PRP ._. [_-LRB- 207_CD ]_-RRB- Influenza_NN research_NN includes_VBZ molecular_JJ virology_NN ,_, molecular_JJ evolution_NN ,_, pathogenesis_NN ,_, host_NN immune_NN responses_NNS ,_, genomics_NN ,_, and_CC epidemiology_NN ._. These_DT help_NN in_IN developing_VBG influenza_NN countermeasures_NNS such_JJ as_IN vaccines_NNS ,_, therapies_NNS and_CC diagnostic_JJ tools_NNS ._. Improved_VBN influenza_NN countermeasures_NNS require_VBP basic_JJ research_NN on_IN how_WRB viruses_NNS enter_VBP cells_NNS ,_, replicate_VBP ,_, mutate_VBP ,_, evolve_VBP into_IN new_JJ strains_NNS and_CC induce_VBP an_DT immune_JJ response_NN ._. The_DT Influenza_NNP Genome_NNP Sequencing_NNP Project_NNP is_VBZ creating_VBG a_DT library_NN of_IN influenza_NN sequences_NNS [_-LRB- 208_CD ]_-RRB- that_WDT will_MD help_VB researchers_NNS '_POS understanding_NN of_IN what_WP makes_VBZ one_CD strain_NN more_RBR lethal_JJ than_IN another_DT ,_, what_WDT genetic_JJ determinants_NNS most_RBS affect_VBP immunogenicity_NN ,_, and_CC how_WRB the_DT virus_NN evolves_VBZ over_IN time_NN ._. Solutions_NNS to_IN limitations_NNS in_IN current_JJ [_-LRB- when_WRB ?_. ]_-RRB- vaccine_NN methods_NNS are_VBP being_VBG [_-LRB- when_WRB ?_. ]_-RRB- researched_VBN ._. A_DT different_JJ approach_NN uses_VBZ Internet_NN content_NN to_TO estimate_VB the_DT impact_NN of_IN an_DT influenza_NN vaccination_NN campaign_NN ._. More_RBR specifically_RB ,_, researchers_NNS have_VBP used_VBN data_NNS from_IN Twitter_NNP and_CC Microsoft_NNP 's_POS Bing_NNP search_NN engine_NN ,_, and_CC proposed_VBD a_DT statistical_JJ framework_NN which_WDT ,_, after_IN a_DT series_NN of_IN operations_NNS ,_, maps_VBZ this_DT information_NN to_IN estimates_NNS of_IN the_DT influenza_NN -_HYPH like_IN illness_NN reduction_NN percentage_NN in_IN areas_NNS where_WRB vaccinations_NNS have_VBP been_VBN performed_VBN ._. The_DT method_NN has_VBZ been_VBN used_VBN to_TO quantify_VB the_DT impact_NN of_IN two_CD flu_NN vaccination_NN programmes_NNS in_IN England_NNP (_-LRB- 2013_CD /_, 14_CD and_CC 2014/15_CD )_-RRB- ,_, where_WRB school_NN -_HYPH age_NN children_NNS were_VBD administered_VBN a_DT live_JJ attenuated_VBN influenza_NN vaccine_NN (_-LRB- LAIV_NNP )_-RRB- ._. Notably_RB ,_, the_DT impact_NN estimates_NNS were_VBD in_IN accordance_NN with_IN estimations_NNS from_IN Public_NNP Health_NNP England_NNP based_VBN on_IN traditional_JJ syndromic_JJ surveillance_NN endpoints_NNS ._. [_-LRB- 209_CD ]_-RRB- [_-LRB- 210_CD ]_-RRB- The_DT rapid_JJ development_NN ,_, production_NN ,_, and_CC distribution_NN of_IN pandemic_NN influenza_NN vaccines_NNS could_MD potentially_RB save_VB millions_NNS of_IN lives_NNS during_IN an_DT influenza_NN pandemic_NN ._. Due_IN to_IN the_DT short_JJ time_NN frame_NN between_IN identification_NN of_IN a_DT pandemic_NN strain_NN and_CC need_NN for_IN vaccination_NN ,_, researchers_NNS are_VBP looking_VBG at_IN novel_JJ technologies_NNS for_IN vaccine_NN production_NN that_WDT could_MD provide_VB better_JJR ""_`` real_JJ -_HYPH time_NN ""_'' access_NN and_CC be_VB produced_VBN more_RBR affordably_RB ,_, thereby_RB increasing_VBG access_NN for_IN people_NNS living_VBG in_IN low_JJ -_HYPH and_CC moderate_JJ -_HYPH income_NN countries_NNS ,_, where_WRB an_DT influenza_NN pandemic_NN may_MD likely_RB originate_VB ,_, such_JJ as_IN live_JJ attenuated_VBN (_-LRB- egg_NN -_HYPH based_VBN or_CC cell_NN -_HYPH based_VBN )_-RRB- technology_NN and_CC recombinant_JJ technologies_NNS (_-LRB- proteins_NNS and_CC virus_NN -_HYPH like_IN particles_NNS )_-RRB- ._. [_-LRB- 211_CD ]_-RRB- As_IN of_IN July_NNP 2009_CD ,_, more_JJR than_IN 70_CD known_VBN clinical_JJ trials_NNS have_VBP been_VBN completed_VBN or_CC are_VBP ongoing_JJ for_IN pandemic_NN influenza_NN vaccines_NNS ._. [_-LRB- 212_CD ]_-RRB- In_IN September_NNP 2009_CD ,_, the_DT FDA_NNP approved_VBD four_CD vaccines_NNS against_IN the_DT 2009_CD H1N1_NNP influenza_NN virus_NN (_-LRB- the_DT 2009_CD pandemic_NN strain_NN )_-RRB- ,_, and_CC expected_VBD the_DT initial_JJ vaccine_NN lots_NNS to_TO be_VB available_JJ within_IN the_DT following_VBG month_NN ._. [_-LRB- 213_CD ]_-RRB- In_IN January_NNP 2020_CD ,_, the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- approved_VBD Audenz_NNP as_IN a_DT vaccine_NN for_IN the_DT H5N1_NN flu_NN virus_NN ._. [_-LRB- 214_CD ]_-RRB- Audenz_NNP is_VBZ a_DT vaccine_NN indicated_VBN for_IN active_JJ immunization_NN for_IN the_DT prevention_NN of_IN disease_NN caused_VBN by_IN the_DT influenza_NN A_NN virus_NN H5N1_NN subtype_NN contained_VBN in_IN the_DT vaccine_NN ._. Audenz_NNP is_VBZ approved_VBN for_IN use_NN in_IN persons_NNS six_CD months_NNS of_IN age_NN and_CC older_JJR at_IN increased_VBN risk_NN of_IN exposure_NN to_IN the_DT influenza_NN A_NN virus_NN H5N1_NN subtype_NN contained_VBN in_IN the_DT vaccine_NN ._. [_-LRB- 215_CD ]_-RRB- A_DT ""_`` universal_JJ vaccine_NN ""_'' that_WDT would_MD not_RB have_VB to_TO be_VB designed_VBN and_CC made_VBN for_IN each_DT flu_NN season_NN in_IN each_DT hemisphere_NN would_MD be_VB useful_JJ ,_, in_IN order_NN to_TO stabilize_VB the_DT supply_NN and_CC to_TO ensure_VB against_IN error_NN in_IN the_DT design_NN or_CC escape_NN of_IN the_DT circulating_VBG strains_NNS by_IN mutation_NN ._. [_-LRB- 139_CD ]_-RRB- Such_PDT a_DT vaccine_NN has_VBZ been_VBN the_DT subject_NN of_IN research_NN for_IN decades_NNS ._. [_-LRB- 216_CD ]_-RRB- One_CD promising_JJ approach_NN is_VBZ using_VBG broadly_RB neutralizing_VBG antibodies_NNS that_WDT unlike_IN the_DT annual_JJ seasonal_JJ vaccines_NNS used_VBN over_IN the_DT last_JJ several_JJ decades_NNS which_WDT provoke_VBP the_DT body_NN to_TO generate_VB an_DT immune_JJ response_NN ,_, instead_RB provide_VB a_DT component_NN of_IN the_DT immune_JJ response_NN itself_PRP ._. The_DT first_JJ neutralizing_VBG antibodies_NNS were_VBD identified_VBN in_IN 1993_CD ,_, via_IN experimentation_NN ;_, [_-LRB- 217_CD ]_-RRB- with_IN time_NN researchers_NNS understood_VBD that_IN the_DT flu_NN neutralizing_VBG antibodies_NNS were_VBD binding_VBG to_IN the_DT stalk_NN of_IN the_DT Hemagglutinin_NN protein_NN ;_, later_JJR researchers_NNS identified_VBD antibodies_NNS that_WDT could_MD bind_VB to_IN the_DT head_NN of_IN those_DT proteins_NNS ._. Later_RBR yet_RB ,_, researchers_NNS identified_VBD the_DT highly_RB conserved_VBN M2_NNP proton_NN channel_NN as_IN a_DT potential_JJ target_NN for_IN broadly_RB neutralizing_VBG antibodies_NNS ._. [_-LRB- 216_CD ]_-RRB- [_-LRB- 218_CD ]_-RRB- The_DT challenges_NNS for_IN researchers_NNS have_VBP been_VBN identifying_VBG single_JJ antibodies_NNS that_WDT could_MD neutralize_VB many_JJ subtypes_NNS of_IN the_DT virus_NN ,_, so_IN that_IN they_PRP could_MD be_VB useful_JJ in_IN any_DT season_NN ,_, and_CC that_WDT target_VB conserved_VBN domains_NNS that_WDT are_VBP resistant_JJ to_IN antigenic_JJ drift_NN ._. [_-LRB- 216_CD ]_-RRB- Another_DT approach_NN has_VBZ been_VBN taking_VBG the_DT conserved_VBN domains_NNS identified_VBN from_IN these_DT projects_NNS ,_, and_CC delivering_VBG groups_NNS of_IN these_DT antigens_NNS to_TO provoke_VB an_DT immune_JJ response_NN ;_, various_JJ approaches_NNS with_IN different_JJ antigens_NNS ,_, presented_VBN different_JJ ways_NNS (_-LRB- as_IN fusion_NN proteins_NNS ,_, mounted_VBN on_IN virus_NN -_HYPH like_IN particles_NNS ,_, on_IN non-pathogenic_JJ viruses_NNS ,_, as_IN DNA_NN ,_, and_CC others_NNS )_-RRB- ,_, are_VBP under_IN development_NN ._. [_-LRB- 218_CD ]_-RRB- [_-LRB- 219_CD ]_-RRB- [_-LRB- 220_CD ]_-RRB- Efforts_NNS have_VBP also_RB been_VBN undertaken_VBN to_TO develop_VB universal_JJ vaccines_NNS that_WDT specifically_RB activate_VBP a_DT T_NN -_HYPH cell_NN response_NN ,_, based_VBN on_IN clinical_JJ data_NNS showing_VBG that_IN people_NNS with_IN a_DT strong_JJ ,_, early_JJ T_NN -_HYPH cell_NN response_NN have_VBP better_JJR outcomes_NNS when_WRB infected_VBN with_IN influenza_NN and_CC because_IN T_NN -_HYPH cells_NNS respond_VBP to_IN conserved_VBN epitopes_NNS ._. The_DT challenge_NN for_IN developers_NNS is_VBZ that_IN these_DT epitopes_NNS are_VBP on_IN internal_JJ protein_NN domains_NNS that_WDT are_VBP only_RB mildly_RB immunogenic_JJ ._. [_-LRB- 218_CD ]_-RRB- Along_IN with_IN the_DT rest_NN of_IN the_DT vaccine_NN field_NN ,_, people_NNS working_VBG on_IN universal_JJ vaccines_NNS have_VBP been_VBN experimenting_VBG with_IN vaccine_NN adjuvants_NNS to_TO improve_VB the_DT ability_NN of_IN their_PRP$ vaccines_NNS to_TO create_VB a_DT sufficiently_RB powerful_JJ and_CC enduring_JJ immune_JJ response_NN ._. [_-LRB- 218_CD ]_-RRB- [_-LRB- 221_CD ]_-RRB- There_EX have_VBP been_VBN some_DT clinical_JJ trials_NNS of_IN the_DT M_NN -_HYPH 001_CD [_-LRB- 222_CD ]_-RRB- [_-LRB- 223_CD ]_-RRB- [_-LRB- 139_CD ]_-RRB- [_-LRB- 224_CD ]_-RRB- [_-LRB- 225_CD ]_-RRB- and_CC H1ssF_3928_NNP universal_JJ influenza_NN vaccine_NN candidates_NNS ._. As_IN of_IN May_NNP of_IN 2020_CD ,_, 6_CD of_IN 7_CD M_NN -001_CD trials_NNS are_VBP completed_VBN ._. One_CD of_IN the_DT 7_CD M_NN -001_CD trials_NNS has_VBZ results_NNS ._. None_NN of_IN the_DT BiondVax_NNP -_HYPH sponsored_VBN M-001_NN trials_NNS have_VBP results_NNS ._. [_-LRB- 139_CD ]_-RRB- [_-LRB- 226_CD ]_-RRB- [_-LRB- 227_CD ]_-RRB- As_IN of_IN 2019_CD ,_, an_DT oral_JJ flu_NN vaccine_NN was_VBD in_IN clinical_JJ research_NN ._. [_-LRB- 228_CD ]_-RRB- The_DT oral_JJ vaccine_NN candidate_NN is_VBZ based_VBN on_IN an_DT adenovirus_NN type_NN 5_CD vector_NN modified_VBN to_TO remove_VB genes_NNS needed_VBN for_IN replication_NN ,_, with_IN an_DT added_VBN gene_NN that_WDT expresses_VBZ a_DT small_JJ double_JJ -_HYPH stranded_VBN RNA_NN hairpin_NN molecule_NN as_IN an_DT adjuvant_NN ._. [_-LRB- 229_CD ]_-RRB- In_IN 2020_CD ,_, a_DT phase_NN II_CD human_JJ trial_NN of_IN the_DT pill_NN form_NN of_IN the_DT vaccine_NN showed_VBD that_IN it_PRP was_VBD well_RB tolerated_VBN and_CC provided_VBD similar_JJ immunity_NN to_IN a_DT licensed_VBN injectable_JJ vaccine_NN ._. [_-LRB- 230_CD ]_-RRB- Veterinary_JJ influenza_NN vaccination_NN aims_VBZ to_TO achieve_VB the_DT following_VBG four_CD objectives_NNS :_: [_-LRB- 231_CD ]_-RRB- Horses_NNS with_IN horse_NN flu_NN can_MD run_VB a_DT fever_NN ,_, have_VBP a_DT dry_JJ hacking_NN cough_NN ,_, have_VBP a_DT runny_JJ nose_NN ,_, and_CC become_VBP depressed_JJ and_CC reluctant_JJ to_TO eat_VB or_CC drink_VB for_IN several_JJ days_NNS but_CC usually_RB recover_VBP in_IN two_CD to_IN three_CD weeks_NNS ._. ""_`` Vaccination_NN schedules_NNS generally_RB require_VBP a_DT primary_JJ course_NN of_IN two_CD doses_NNS ,_, 3_CD –_SYM 6_CD weeks_NNS apart_RB ,_, followed_VBN by_IN boosters_NNS at_IN 6_CD –_SYM 12_CD month_NN intervals_NNS ._. It_PRP is_VBZ generally_RB recognized_VBN that_IN in_IN many_JJ cases_NNS such_JJ schedules_NNS may_MD not_RB maintain_VB protective_JJ levels_NNS of_IN antibody_NN and_CC more_RBR frequent_JJ administration_NN is_VBZ advised_VBN in_IN high_JJ -_HYPH risk_NN situations_NNS ._. ""_'' [_-LRB- 232_CD ]_-RRB- It_PRP is_VBZ a_DT common_JJ requirement_NN at_IN shows_NNS in_IN the_DT United_NNP Kingdom_NNP that_IN horses_NNS be_VBP vaccinated_VBN against_IN equine_JJ flu_NN and_CC a_DT vaccination_NN card_NN must_MD be_VB produced_VBN ;_: the_DT International_NNP Federation_NNP for_IN Equestrian_NNP Sports_NNPS (_-LRB- FEI_NNP )_-RRB- requires_VBZ vaccination_NN every_DT six_CD months_NNS ._. [_-LRB- 233_CD ]_-RRB- [_-LRB- 234_CD ]_-RRB- Poultry_NN vaccines_NNS for_IN bird_NN flu_NN are_VBP made_VBN inexpensively_RB and_CC are_VBP not_RB filtered_VBN and_CC purified_VBN like_IN human_JJ vaccines_NNS to_TO remove_VB bits_NNS of_IN bacteria_NN or_CC other_JJ viruses_NNS ._. They_PRP usually_RB contain_VBP whole_JJ virus_NN ,_, not_RB just_RB hemagglutinin_NN as_IN in_IN most_JJS human_JJ flu_NN vaccines_NNS ._. Another_DT difference_NN between_IN human_JJ and_CC poultry_NN vaccines_NNS is_VBZ that_IN poultry_NN vaccines_NNS are_VBP adjuvated_VBN with_IN mineral_JJ oil_NN ,_, which_WDT induces_VBZ a_DT strong_JJ immune_JJ reaction_NN but_CC can_MD cause_VB inflammation_NN and_CC abscesses_NNS ._. ""_`` Chicken_NN vaccinators_NNS who_WP have_VBP accidentally_RB jabbed_VBN themselves_PRP have_VBP developed_VBN painful_JJ swollen_JJ fingers_NNS or_CC even_RB lost_VBN thumbs_NNS ,_, doctors_NNS said_VBD ._. Effectiveness_NN may_MD also_RB be_VB limited_VBN ._. Chicken_NN vaccines_NNS are_VBP often_RB only_RB vaguely_RB similar_JJ to_IN circulating_VBG flu_NN strains_NNS –_: some_DT contain_VBP an_DT H5N2_NN strain_NN isolated_VBN in_IN Mexico_NNP years_NNS ago_RB ._. '_`` With_IN a_DT chicken_NN ,_, if_IN you_PRP use_VBP a_DT vaccine_NN that_WDT 's_VBZ only_RB 85_CD percent_NN related_JJ ,_, you_PRP 'll_MD get_VB protection_NN ,_, '_'' Dr._NNP Cardona_NNP said_VBD ._. '_`` In_IN humans_NNS ,_, you_PRP can_MD get_VB a_DT single_JJ point_NN mutation_NN ,_, and_CC a_DT vaccine_NN that_WDT 's_VBZ 99.99_CD percent_NN related_JJ wo_MD n't_RB protect_VB you_PRP ._. '_'' And_CC they_PRP are_VBP weaker_JJR [_-LRB- than_IN human_JJ vaccines_NNS ]_-RRB- ._. '_`` Chickens_NNS are_VBP smaller_JJR and_CC you_PRP only_RB need_VBP to_TO protect_VB them_PRP for_IN six_CD weeks_NNS ,_, because_IN that_DT 's_VBZ how_WRB long_RB they_PRP live_VBP till_IN you_PRP eat_VBP them_PRP ,_, '_'' said_VBD Dr._NNP John_NNP J._NNP Treanor_NNP ,_, a_DT vaccine_NN expert_NN at_IN the_DT University_NNP of_IN Rochester_NNP ._. Human_JJ seasonal_JJ flu_NN vaccines_NNS contain_VBP about_RB 45_CD micrograms_NNS of_IN antigen_NN ,_, while_IN an_DT experimental_JJ A(_-LRB- H5N1_NN )_-RRB- vaccine_NN contains_VBZ 180_CD ._. Chicken_NN vaccines_NNS may_MD contain_VB less_JJR than_IN one_CD microgram_NN ._. '_`` You_PRP have_VBP to_TO be_VB careful_JJ about_IN extrapolating_VBG data_NNS from_IN poultry_NN to_IN humans_NNS ,_, '_'' warned_VBD Dr._NNP David_NNP E._NNP Swayne_NNP ,_, director_NN of_IN the_DT agriculture_NN department_NN 's_POS Southeast_NNP Poultry_NNP Research_NNP Laboratory_NNP ._. '_`` Birds_NNS are_VBP more_RBR closely_RB related_JJ to_IN dinosaurs_NNS ._. '_'' ""_'' [_-LRB- 235_CD ]_-RRB- Researchers_NNS ,_, led_VBN by_IN Nicholas_NNP Savill_NNP of_IN the_DT University_NNP of_IN Edinburgh_NNP in_IN Scotland_NNP ,_, used_VBD mathematical_JJ models_NNS to_TO simulate_VB the_DT spread_NN of_IN H5N1_NN and_CC concluded_VBD that_IN ""_`` at_IN least_JJS 95_CD percent_NN of_IN birds_NNS need_VBP to_TO be_VB protected_VBN to_TO prevent_VB the_DT virus_NN spreading_VBG silently_RB ._. In_IN practice_NN ,_, it_PRP is_VBZ difficult_JJ to_TO protect_VB more_JJR than_IN 90_CD percent_NN of_IN a_DT flock_NN ;_, protection_NN levels_NNS achieved_VBN by_IN a_DT vaccine_NN are_VBP usually_RB much_RB lower_JJR than_IN this_DT ._. ""_'' [_-LRB- 236_CD ]_-RRB- The_DT Food_NNP and_CC Agriculture_NNP Organization_NNP of_IN the_DT United_NNP Nations_NNPS has_VBZ issued_VBN recommendations_NNS on_IN the_DT prevention_NN and_CC control_NN of_IN avian_JJ influenza_NN in_IN poultry_NN ,_, including_VBG the_DT use_NN of_IN vaccination_NN ._. [_-LRB- 237_CD ]_-RRB- A_DT filtered_VBN and_CC purified_VBN Influenza_NN A_NN vaccine_NN for_IN humans_NNS is_VBZ being_VBG developed_VBN [_-LRB- when_WRB ?_. ]_-RRB- and_CC many_JJ countries_NNS have_VBP recommended_VBN it_PRP be_VB stockpiled_VBN so_IN if_IN an_DT Avian_NNP influenza_NN pandemic_NN starts_VBZ jumping_VBG to_IN humans_NNS ,_, the_DT vaccine_NN can_MD quickly_RB be_VB administered_VBN to_TO avoid_VB loss_NN of_IN life_NN ._. Avian_JJ influenza_NN is_VBZ sometimes_RB called_VBN avian_JJ flu_NN ,_, and_CC commonly_RB bird_NN flu_NN ._. [_-LRB- 238_CD ]_-RRB- Swine_NN influenza_NN vaccines_NNS are_VBP extensively_RB used_VBN in_IN pig_NN farming_NN in_IN Europe_NNP and_CC North_NNP America_NNP ._. Most_JJS swine_NN flu_NN vaccines_NNS include_VBP an_DT H1N1_NN and_CC an_DT H3N2_NN strain_NN ._. Swine_NN influenza_NN has_VBZ been_VBN recognized_VBN as_IN a_DT major_JJ problem_NN since_IN the_DT outbreak_NN in_IN 1976_CD ._. Evolution_NN of_IN the_DT virus_NN has_VBZ resulted_VBN in_IN inconsistent_JJ responses_NNS to_IN traditional_JJ vaccines_NNS ._. Standard_JJ commercial_JJ swine_NN flu_NN vaccines_NNS are_VBP effective_JJ in_IN controlling_VBG the_DT problem_NN when_WRB the_DT virus_NN strains_NNS match_VBP enough_RB to_TO have_VB significant_JJ cross-protection_NN ._. Customised_VBN (_-LRB- autogenous_JJ )_-RRB- vaccines_NNS made_VBN from_IN the_DT specific_JJ viruses_NNS isolated_VBN ,_, are_VBP made_VBN and_CC used_VBN in_IN the_DT more_RBR difficult_JJ cases_NNS ._. [_-LRB- 239_CD ]_-RRB- The_DT vaccine_NN manufacturer_NN Novartis_NNP claims_VBZ that_IN the_DT H3N2_NNP strain_NN (_-LRB- first_RB identified_VBN in_IN 1998_CD )_-RRB- has_VBZ brought_VBN major_JJ losses_NNS to_IN pig_NN farmers_NNS ._. Abortion_NN storms_NNS are_VBP a_DT common_JJ sign_NN and_CC sows_NNS stop_VBP eating_VBG for_IN a_DT few_JJ days_NNS and_CC run_VBP a_DT high_JJ fever_NN ._. The_DT mortality_NN rate_NN can_MD be_VB as_RB high_JJ as_IN 15_CD percent_NN ._. [_-LRB- 240_CD ]_-RRB- In_IN 2004_CD ,_, influenza_NN A_DT virus_NN subtype_NN H3N8_NNP was_VBD discovered_VBN to_TO cause_VB canine_NN influenza_NN ._. Because_IN of_IN the_DT lack_NN of_IN previous_JJ exposure_NN to_IN this_DT virus_NN ,_, dogs_NNS have_VBP no_DT natural_JJ immunity_NN to_IN this_DT virus_NN ._. However_RB ,_, a_DT vaccine_NN was_VBD found_VBN in_IN 2004_CD ._. [_-LRB- 241_CD ]_-RRB- •_SYM None_NN World_NNP Health_NNP Organization_NNP (_-LRB- October_NNP 2017_CD )_-RRB- ._. The_DT immunological_JJ basis_NN for_IN immunization_NN series_NN :_: module_NN 23_CD :_: influenza_NN vaccines_NNS ._. World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- ._. hdl_NN :_: ._. ISBN_NNP ._. •_NFP None_NN Hamborsky_NNP J_NNP ,_, Kroger_NNP A_NNP ,_, Wolfe_NNP S_NNP ,_, eds._FW (_-LRB- 2015_CD )_-RRB- ._. ""_`` Chapter_NNP 12_CD :_: Influenza_NNP ""_'' ._. Epidemiology_NN and_CC Prevention_NN of_IN Vaccine_NN -_HYPH Preventable_JJ Diseases_NNS (_-LRB- 13th_NNP ed._NN )_-RRB- ._. Washington_NNP D.C._NNP :_: U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. ISBN_NNP ._. •_NFP None_NN Budd_NNP A_NNP ,_, Blanton_NNP L_NNP ,_, Grohskopf_NNP L_NNP ,_, Campbell_NNP A_NNP ,_, Dugan_NNP V_NNP ,_, Wentworth_NNP DE_NNP ,_, et_FW al._FW (_-LRB- March_NNP 29_CD ,_, 2019_CD )_-RRB- ._. ""_`` Chapter_NN 6_CD :_: Influenza_NN ""_'' ._. In_IN Roush_NNP SW_NNP ,_, Baldy_NNP LM_NNP ,_, Hall_NNP MA_NNP (_-LRB- eds_NNP ._. )_-RRB- ._. Manual_NN for_IN the_DT surveillance_NN of_IN vaccine_NN -_HYPH preventable_JJ diseases_NNS ._. Atlanta_NNP GA_NN :_: U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- ._. •_SYM None_NN National_NNP Advisory_NNP Committee_NNP on_IN Immunization_NNP (_-LRB- May_NNP 2020_CD )_-RRB- ._. ""_`` Canadian_NNP Immunization_NNP Guide_NNP Chapter_NNP on_IN Influenza_NNP and_CC Statement_NNP on_IN Seasonal_NNP Influenza_NNP Vaccine_NNP for_IN 2020_CD –_SYM 2021_CD ""_'' ._. Public_NNP Health_NNP Agency_NNP of_IN Canada_NNP ._. Cat._NN :_: HP37-25F-PDF_NN ;_: Pub._NN :_: 200003_CD ._. Lay_VB summary_NN ._. •_SYM None_NN National_NNP Advisory_NNP Committee_NNP on_IN Immunization_NNP (_-LRB- NACI_NNP )_-RRB- (_-LRB- May_NNP 2018_CD )_-RRB- ._. ""_`` NACI_NNP literature_NN review_NN on_IN the_DT comparative_JJ effectiveness_NN and_CC immunogenicity_NN of_IN subunit_NN and_CC split_JJ virus_NN inactivated_VBN influenza_NN vaccines_NNS in_IN adults_NNS 65_CD years_NNS of_IN age_NN and_CC older_JJR ""_'' ._. Government_NN of_IN Canada_NNP ._. ISBN_NNP ._. Cat._NN :_: HP40-213/2018E-PDF_NN ;_: Pub._NN :_: 180039_CD ._. Lay_VB summary_NN ._. •_SYM Inactivated_VBN Influenza_NN Vaccine_NN Information_NN Statement_NN ,_, U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- •_, Live_NNP ,_, Intranasal_NNP Influenza_NNP Vaccine_NNP Information_NNP Statement_NNP ,_, U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- •_, Seasonal_NNP Influenza_NNP (_-LRB- Flu_NNP )_-RRB- Vaccination_NNP and_CC Preventable_NNP Disease_NNP ,_, U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- •_SYM Misconceptions_NNPS about_IN Seasonal_NNP Flu_NNP and_CC Flu_NNP Vaccines_NNPS ,_, U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- •_SYM Influenza_NNP Vaccines_NNPS at_IN the_DT US_NNP National_NNP Library_NNP of_IN Medicine_NNP Medical_NNP Subject_NNP Headings_NNPS (_-LRB- MeSH_NNP )_-RRB-","NN NNS , RB VBN as NN NNS or NN NNS , VBP NNS that VBP against NN by NN NNS . [ 2 ] JJ NNS of the NNS VBP VBN RB a NN , as the NN NN RB VBZ . [ 2 ] While their NN VBZ from NN to NN , RBS VBP JJ to JJ NN against NN . [ 2 ] [ 3 ] The NNP NNPS NNPS for NNP NNP and NNP ( NNP ) VBZ that NN against NN VBZ NN , JJ NNS , NNS , and NNS . [ 4 ] [ 5 ] VBN NNS who VBP VB the NN , VBP to VB half a NN RBR on NN . [ 6 ] NN NN in those under two NNS JJ and those RB 65 NNS JJ VBZ JJ due to a NN of JJ NN NN . [ 7 ] [ 8 ] VBG NNS may VB those around them . [ 2 ] The NNP NNP NNP ( NNP ) and the NNP NNPS for NNP NNP and NNP ( NNP ) VBP JJ NN for RB all NNS over the NN of six NNS , RB those at JJ NN . [ 2] [ 9 ] [ 10 ] [ 11 ] The NNP NNP for NNP NNP and NNP ( NNP ) RB VBZ JJ NN of JJ NN NNS . [ 12 ] These NNS VBP JJ NNS , the NN , NNS between six NNS and five NNS of NN , those with JJ NN NNS , and those who VBP in NN . [ 2] [ 11 ] The NNS VBP RB JJ . [ 2 ] NN VBZ in five to ten NN of NNS VBN . [ 2 ] JJ NN NNS or NNS of NN may VB RB RB . [ 2 ] In JJ NNS , the NN VBZ VBN VBN to an NN in NNP NNP NN among JJR NNS at a NN of RB one NN per million NNS . [ 2 ] Although JJS NN NNS VBP VBN VBG NNS , they VBP RB VBN for NNS who VBP JJ NN NNS . [ 13 ] RB , NN NNS VBP RB VBN in those who VBP VBN a JJ NN to JJ NNS of the NN itself . [ 2 ] [ 13 ] The NN VBZ in JJ and VBN JJ NNS . [ 2 ] The JJ , VBN NN VBZ RB RB VBN in JJ NNS , NNS JJR than two NNS JJ , NNS JJR than 50 , or NNS with a VBN JJ NN . [ 2 ] VBG on the NN they can VB VBN into a NN , VBN into the NN , or VBN into the JJ NN of the NN ( NN ) . [ 2 ] The JJ NN VBD RB JJ during the 2018 –2019 and 2019 – 2020 NN NNS . [ 11 ] [ 14 ] [ 15 ] [ 16 ] NN against NN VBD in the NNS with JJ - NN NN in the NNP NNPS VBG in 1945 . [ 17 ] [ 18 ] It VBZ on the NNP NNP NNP 's NNP of NNP NNPS , the JJS and RBS JJ NNS VBN in a NN NN . [ 19 ] The NNP NNPS for NNP NNP and NNP ( NNP ) VBZ the NN NN as the JJS NN to VB NNS against the NN and VB its NN . [ 20 ] The NN NN can RB VB the NN of the NN if a NN VBZ a NN that the NN VBD RB VB . [ 20 ] It VBZ RB two NNS VBG NN for JJ NNS to VB . [ 20 ] A 2012 NN NN VBD that NN NN VBD JJ 67 NN of the NN ; the NNS that VBD the JJS VBD NN - JJ NNS JJ 18 to 55 ( 76 NN ) , JJ NNS JJ 18 to 46 ( RB 70 NN ) , and JJ NNS JJ six to 24 NNS ( 66 NN ) . [ 21 ] The NN NN RB VBP to VB against JJ NN with a NN of 15 to 45 NN . [ 22 ] A NN VBZ VBN by its NN – the NN to which it VBZ NN of NN under VBN NNS – and its NN – the VBN NN in NN after the NN VBZ VBN into NN . [ 26 ] In the NN of NN , NN VBZ VBN to VB JJR than the NN because it VBZ VBN VBG the NNS of NN - JJ NN , which VBZ RB RB VBN by NN . [ 6 ] NN NNS RB VBP JJ NN , as VBN by the NN NN in NN NNS or VBN NNS . [ 27 ] RB , NNS on the NN of NN NNS in the JJ NN VBP JJ ; NNS may VB RB VBN , NN NN VBZ RB between NNS , and NN VBZ RB VBN with JJ NN - JJ NNS . [ 28 ] RB , in JJS NNS ( 16 of the 19 NNS before 2007 ) , the NN NN NNS VBP VBN a JJ NN for the VBG NNS , [ 29 ] and RB a VBN NN can RB VB NN . [ 20 ] The NN RB VBZ due to JJ NN , a JJ NN in the NN that VBZ a JJ NN to VB . [ 30 ] VBN JJ NN NN RB VBP JJ NN - on - NN NN against NN . [ 31 ] There VBZ RB JJ NN that VBN NNS may VB a NN in NN NN for JJ NN NNS ; this VBZ no NN to JJ NNS for JJ NNS but might VB JJ NN NN . [ 32 ] [ 33 ] As of 2019 , the NNP VBZ a JJ NN as JJS NNS VBP JJ NN of JJ NN NN . [ 31 ] NNP NNP , who VBZ VBN NNP NNP NNS of NN NNS , VBZ VBN JJ NN VBG NN NNS "" NN "" and VBZ RB VBN them to VB JJ ; he VBZ VBN for NN - VBN VBN JJ NNS , which JJS in the NN VBP as JJ . His NNS on the NN of NN NNS VBP VBN by JJ NNS VBG the NNP and the NNP NNPS of NNP , and by JJ NNS in the NN like NNP NNP . [ 34 ] NNP NNP , who VBD the NNP for NNP NNP NNP and NNP 2012 NN on NN NNS , VBD VBG the NN but VBD its NN , VBG , "" We VBP VBN and VBN this NN ... it VBZ RB VB as VBN . It VBZ all a NN NN : it VBZ all JJ NNS "" . [ 35 ] The NNP VBP that NN except NNS under the NN of six NNS should VB the JJ NN NN . [ 9 ] NN NNS RB VBP JJ NN on NNS who VBP at JJ NN of JJ NNS if they VBP the NN , JJ as JJ NNS , NNS under 59 NNS , the JJ , and NNS with JJ NNS or VBN NN NNS , RB RB as those to whom they VBP VBN , JJ as NN NNS . [ 9 ] [ 36 ] As the NN NN VBZ RB JJ among NNS who VBP NN , the NNP and the NNP VBP that NN NNS and NNS of NNS VBP VBN to VB the NN of VBG an NN NN to the NN . [ 36 ] [ 37 ] In NNS , the NN VBZ to VB the NN of NN and RB NN - JJ NN . [ 38 ] In NNS under the NN of two NNS VBZ VBN . [ 38 ] During the 2017 – 18 NN NN , the NNP NN VBD that 85 NN of the NNS who VBD "" RB will RB VB VBN VBN . "" [ 39 ] In the NNP NNPS , as of NNP 2019 , the NNP VBP that NNS JJ six through 35 NNS may VB either 0.25 NNS or 0.5 NNS per NN of NNP NN . [ 40 ] [ 41 ] There VBZ no NN for one or the JJ NN NN of NNP NNP for that NN NN . [ 40 ] All NNS 36 NNS of NN and JJR should VB 0.5 NNS per NN of NNP NNP . [ 40 ] As of NNP 2018 , NNP NNP VBZ VBN for NNS six NNS of NN and JJR in the NNP NNPS . [ 40 ] [ 42 ] NNS six NNS through 35 NNS of NN should VB 0.25 NNS for each NN of NNP NNP . [ 40 ] All NNS 36 NNS of NN and JJR should VB 0.5 NNS per NN of NNP NN . [ 40 ] As of NNP 2018 , NNP NNP VBZ VBN for NNS and NNS five NNS of NN and JJR in NNP . [ 43 ] In 2014 , the NNP NNP NNP NNP on NNP ( NNP ) VBD a NN of NN NN in JJ 5 – 18 - NN - NNS , [ 44 ] and in 2015 , VBD a NN of the NN of JJ NNP in NNS 6 – 72 NNS of NN . [ 45 ] In JJ NNS , 16 NN VBP NNS JJ to the NN , while RB 10 NN of VBN NNS VBP . [ 6 ] NN VBD VBN NNS of NN from RB 2.4 NN to 1.1 NN . [ 6 ] No NN on NN VBD VBN . [ 6 ] In VBG NNS , a NN by the NNP NNP VBD that NN VBD in a JJ NN in both NN NNS and NN NNS VBN , without VBG NN or NN - JJ NNS . [ 6 ] In JJ NN NNS , NN NNS can VB JJ NN against RB VBN NN , though JJ NN VBZ RB VBN or JJ in some NNS . [ 7 ] In NN NNS , a 2006 NN VBD a NN NN . [ 46 ] Of the eighteen NNS in this NN , RB two RB VBD the NN of NN NN JJ to NN NN NN NN ; both VBD that JJR NNS of NN NN NN VBN with VBN NN NNS . [ 46 ] A 2014 NN VBD NNS to NNS when NN NNS VBD VBN , as VBN by JJ NN [ 47 ] VBN in NN on the VBN NN in all - NN NNS in NNS whose NN NNS VBD VBN NN VBN with NN NNS where the NNS VBD RB VBN NN . [ 48 ] NN for an NN in NNS over 65 NNS JJ VBZ JJ . [ 49 ] JJ NNS VBG both VBN VBN and NN NN NNS VBD a NN of JJ - JJ NN . [ 7 ] [ 8 ] NNS of NN NN NNS VBD NNS against NN - VBN NN , NN , and NN among the NN - VBG JJ . [ 50 ] [ 51 ] The NN RBS JJ to JJ NN , the JJ , NNS JJS from the NN . There VBP JJ NNS behind this JJ NN in NN NN , the RBS JJ of which VBP the VBG JJ NN and NN VBN with JJ NN . [ 52 ] In a JJ NN , a NN in the NNP NNPS JJ 50 – 64 VBZ RB ten NNS RBR JJ to VB an NN - VBN NN than a JJR NN , and a NN over NN 65 VBZ RB ten NNS RBR JJ to VB an NN - VBN NN than the 50 – 64 NN NN . [ 53 ] There VBZ a JJ - NN NN NN RB VBN to VB a JJR JJ NN . [ 54 ] JJ NN VBZ that VBG the NN with the JJ - NN NN VBZ to a JJR JJ NN against NN than the JJ - NN NN . [ 55 ] [ 56 ] [ 57 ] A NN NN VBG an NN VBD VBN by the NNP NNP and NNP NNP ( NNP ) in NNP 2015 , for NN by NNS JJ 65 NNS of NN and JJR . The NN VBZ VBN as NNP in the NNP and VBD RB JJ in the 2016 – 2017 NN NN . The NN VBZ the NN NN [ 58 ] which VBZ an NN - in - NN NN of NN NN . It VBZ the JJ VBN JJ NN NN VBN in the NNP NNPS . [ 59 ] [ 60 ] [ 61 ] It VBZ RB JJ if there VBZ a JJ NN for the NN to VB a NN NN VBG the NN NN . [ 62 ] [ 63 ] [ 64 ] Per JJ NN on NN NNS NNS , NNP can VB VBN as an NN to JJ NN NNS VBN for NNS 65 NNS and JJR . [ 60 ] VBG NN NNS who VBP with JJ NNS VBZ VBN in JJ NNS , with the NN of VBG NN NNS in this JJ NN . [ 65 ] [ 66 ] [ 67 ] While there VBZ no JJ NN from VBN JJ NNS that VBG NN NNS VBZ VB JJ NNS from NN , there VBZ JJ NN of NN . [ 68 ] NNP NNP VBD VBN for NN in the NNP NNPS in NNP 2020 [ 69 ] and NNP NNP VBD VBN for NN in the NNP NNP in NNP 2020 . [ 70 ] RB RB as VBG NN and NN from the NNS of an NN NN , the NN of JJ NNS VBZ to VB their NNS of VBG a JJ JJ - NN NN . [ 71 ] The JJ VBN NN NN VBZ JJ in JJ NNS VBN with NN . [ 72 ] While NN NNS of the NN NN may VB , they VBP RB JJ . The NN NN can VB JJ NN NNS , VBG an JJ NN , but this VBZ JJ . RB , the JJ NN NNS and NNS VBP JJ and JJ when VBN to the NNS and JJ NN NNS of the JJ NN NN . [ 20 ] NN NN may VB to NN NNS JJ as a JJ NN and a JJ NN , which can VB for up to JJ NNS . Although NNP NN VBD VBN VBN as a NN of NN , the NNP VBZ that JJS NNS on JJ NN NNS VBP VBN no NN with NNP . [ 73 ] [ 74 ] NN with NN NN itself VBZ both the NN of NN ( up to 1 in 10,000 ) and VBZ the NN of VBG NNP NNP NN to a RB JJR NN than the JJS NN of VBN NN NN ( RB 10 NNS JJR by 2009 NNS ) . [ 75 ] [ 76 ] Although one NN VBZ an NN of RB one NN of NNP NNP per million NNS , [ 77 ] a JJ NN in NNP , VBG JJ to 100 million NNS of NN against the 2009 NNP "" NN "" NN VBD RB eleven NNS of NNP NNP NN , ( 0.1 per million NNS ) JJ NN in NNS VBN , RB JJR than the JJ NN of the NN in NNP , and no JJ JJ NN NNS . [ 76 ] [ 78 ] Although JJS NN NNS VBP VBN VBG NN - VBN NNS , NN NNS VBP RB RB VBN for NNS with NN NNS , RB if JJ . [ 13 ] NNS VBG the NN of NN NNS in NNS with JJ NN NNS VBD that NN VBD RB JJ , VBG in 1.3 NNS per million NNS VBN . [ 13 ] VBG for NNS from NN VBZ VBN in those with RBR JJ NNS . [ 79 ] A NN of RB 800 NNS with NN NN , VBG RB 250 with JJ JJ NNS , VBD zero JJ JJ NNS when VBN the JJ VBN NN NN . [ 80 ] [ 81 ] JJ NNS VBP VBN an VBN NN of NN among NNS of the NN NN NN NN - VBN NN ; [ 82 ] NNS to VB a NN for this VBP that NN VBZ JJ , and that the NN - VBN NN NN may VB NN , VBG as a NN . [ 83 ] Some NN - VBN NN NNS VBN for NNS in the NNP NNPS VBP NN ( RB VBN as NN ) , a NN - VBN NN . [ 84 ] [ 85 ] Despite some NN in the NN , [ 86 ] the NNP NNP NNP 's NNP NNP NNP on NNP NNP VBZ VBN that there VBZ no NN of NN from NN in NNS and no NN on NNS of NN to VB to RBR - JJ JJ - NN NN . [ 87 ] NN NNS VBP JJ either as : • a JJ or JJ JJ NN ( NN , NN , or NN , that VBZ , NN or NN ) , which VBZ the VBN NN of the NN • a JJ NN of JJ VBN NN NN ( NN , NN / NN ) , which VBZ the JJ but VBN ( VBN ) NN of the NN . NN or NN VBP NN after NN ( RB JJ , though JJ and JJ NNS can RB VB JJ ) [ 88 ] VBN on an JJ NN to the NNS JJ on the VBN NN , while JJ - VBN NN VBZ by VBG NN in the JJ NNS . [ 89 ] JJ JJ NN NNS , VBG the NNP NNP NNP ( NNP ) , VBP that JJ NN NN VBP RB VBN , RB to NNS at NN of NNS of NN and those NNS who VBP with or VBP for JJ - NN NNS , VBG : • the JJ ( NNP NN VBZ those JJ 65 or RB ) • NNS with JJ NN NNS ( JJ as the JJ NN ) • NNS who VBP VBN their NN VBN or whose NN VBZ RB VBG RB • NNS who VBP VBN ( NNS with NN , those VBG NNS to VB the NN NN , and NNS on NN ) and their NN NNS • NNS who VBP RB in JJ NNS in an NN where NN can VB RB , JJ as NNS , NN NNS , NNS , and NNS . [ 90 ] • NN NNS ( both to VB NN and to VB NN to NNS ) [ 91 ] [ 92 ] • NNS . RB , a 2009 NN VBD that there VBD JJ NN to VB JJ NN of JJ NN NN during the JJ NN of NN . [ 93 ] NN NN during NN NN VBZ NN of NNS for NN NN of JJ NNS in the NNP NNPS . [ 94 ] The NN NN VBZ VBN for those under six NNS of NN and those with JJ , NN - VBG NNS to NN NN or any NN in the NN . [ 9 ] [ 95 ] [ 13 ] As of 2016 , the NNP NNP NNP ( NNP ) VBZ JJ NN NN for : [ 96 ] [ 97 ] [ 98 ] [ 99 ] [ 100 ] JJ NN ( in no JJ NN ) : The NNP NNP NNP on NNP ( NNP ) , the NN that VBZ the NNP NNP NNP of NNP , VBZ that NN RB six NNS of NN VBP VBN to VB JJ NN NN , and that NNS between the NN of six and 24 NNS , and their NN NNS , should VB VBN a JJ NN for the NN NN . [ 101 ] RB : • NNS at JJ NN of NN - JJ NNS or NN , VBG the RB JJ , JJ JJ NNS , NNS six to 59 NNS , the JJ , NNS , and NNS VBG from one of an VBN NN of JJ NN NNS • NNS JJ of VBG NN to those at JJ NN , VBG NN NNS and NN NNS JJ VBN NN NN ( NNP ) VBD RB JJ in NNP for the 2019 – 2020 NN . [ 101 ] The NNP NNP for NNP NNP and NNP ( NNP ) VBZ VBG the JJ as a NN , with a JJ NN NNS with JJ JJ NNS and NN NNS . [ 102 ] The NN NN NN VBZ RB that of VBG JJ NNS , RB than VBG NN NN or RB VBG JJ NN NN . This VBZ in NN with the JJ NN NN NNS for JJ JJ NNS JJ as NN and NNS . [ 103 ] This VBZ RB due in NN to the JJ and NNS NN VBN with the NN of an JJ NN . [ 104 ] In the NNP NNPS JJ NN NN VBZ VBN for all NNS JJ 6 NNS and RB . [ 105 ] [ 106 ] [ 107 ] It VBZ up to two NNS after NN for JJ NNS to VB in the NN . [ 107 ] The NNP VBZ NN before the NN of NNP , although it VBZ VBG a NN in NNP or RB RBR to VB RB JJ . [ 20 ] [ 107 ] VBG to the NNP , the JJ VBN NN ( NNP ) ( which VBZ in the NN of the JJ NN in the NNP ) should VB VBN by : [ 11 ] [ 108 ] • JJ NN or NN - VBG NN in NNS and NNS • NNS JJ 2 through 4 NNS who VBP VBN a NN of NN or whose NNS or NNS VBP that a NN NN VBZ VBN them during the JJ 12 NNS that their NN VBD NN or NN or whose JJ NN VBZ that a NN NN VBZ VBN within the JJ 12 NNS • NNS who VBP JJ due to any NN ( VBG but RB VBN to NNS and NN NN ) • JJ NNS and NNS of RB JJ NNS who VBP a VBN NN • NNS who VBP VBN NN JJ NNS within the JJ 48 NNS Within its NN NN for JJ NN in the NNP NNPS , the NNP , which VBD VBG the NN NN to NN NNS in 1981 , VBZ to NNS the JJ NN of NN for NNS of JJ JJ NNS , and their NNS : The NNP NN VBZ NNS to VB NN NN NNS . Some NNP NNS and NNS of NNP NNS VBP NN NNS to either VB NNS or VB NNS during NN NN . These NNS RB VBP NN NNS on JJ JJ NN NNS , but NNS VBP that NNS VBP RB VBN VBN NN NNS VBG the JJ NN during NN NNS . [ 115 ] NN against NN VBZ RB VBN JJ for NNS of JJ - NN NNS who would VB JJ to VB NNS from NN , for NN JJ NNS [ 105 ] [ 116 ] and NNS and NNS from six NNS to 18 NNS of NN who VBP VBG NN or NN - VBG NNS and who might VB at NN for VBG NN NN after NN NN NN ; [ 11 ] [ 90 ] • In VBG the JJ NN NN to 18 NNS , the NN VBZ to VB both the NN NNS and NNS VBP from NNS to NNS and JJ NN and the NN for NNS for NNS [ 117 ] • An VBN NN VBN from the NN of NNS VBZ a NN in the NN of NN NNS among NNS and JJ NN NNS , and of JJ NN to the JJ NN . [ 117 ] The NNP VBD that JJ VBN NN NN ( NNP ) , RB VBN the JJ NN NN , VBD RB VBN for the 2016 – 2017 NN NN in the NNP NNPS . [ 118 ] RB , the NNP VBZ that NN NNS who VBP for RB JJ NNS VBP NNS ( NN or NN ) RB than NN . [ 119 ] The JJ NN VBZ JJ NN NN for NN over the NN of six NNS . [ 120 ] NNP VBZ VBN NNS . [ 120 ] The NN NN VBZ JJ for the VBG NNS : [ 121 ] • NNS JJ six NNS to five NNS • JJ and NNP NNP NNP NNS JJ six NNS and RB • NN RB six NNS of NN with JJ NNS JJ as JJ NN , NN NN or NN NN , JJ NN or NN that can VB to NNS from NN . NN of NN NN , both RB and during NNS , VBZ RB JJ . [ 123 ] JJ NNS of NN NN NN NN VBP VBN JJ JJ NNS that may VB NN , VBG NN ( JJR NN in NNS ) , NN ( JJR in NNS from JJ NNS ) and VBG a JJ NN . [ 124 ] [ 125 ] NNS in the NN and NN of the NN VBP RB JJ . [ 123 ] A NN of NNS VBP VBN to VB JJ to VB NNS of NN in those RB 60 NNS JJ VBG : NN NNS VBG NNS and NNS , NN NNS , NN NN NNS , NN NN NNS , NN NNS , JJ NNS , NN NN , NN NNS and VBG NN NN . [ 126 ] NN NN NNS VBP RB VBN to VB JJ and any NN NN NN . For NN , in the NNP all NN NNS VBN in NN NN VBP VBN to VB the JJ NN NN , and VBD RB VBN to VB VBN against the NN ( RBR VBN A ( NN ) NN [ NN 1 ] [ 127 ] ) NN NN NN during the 2009 NN . RB , NN VBZ RB JJ . [ 92 ] During the 2009 NN , JJ NN by NN NNS VBD VBN in NNS VBG the NNP , [ 92 ] NNP , [ 128 ] NNP , [ 129 ] and NNP NNP . [ 130 ] In a 2010 NN of NNP NNPS NN NNS , 63.5 NN VBD that they VBD the NN NN during the 2010 – 11 NN , an NN from 61.9 NN VBD the JJ NN . NNP NN NNS with JJ NN NN VBD JJR NN NN , JJ as NNS and NNS ( 84.2 NN ) and NN NNS ( 82.6 NN ) . [ 131 ] [ 132 ] [ 133 ] The JJ NN to VB NN NNS VBZ to VB NN from VBG NN to their NNS and to VB NN NN at a NN of JJ NN NN , but the NNS NN NNS NN for their NNS to VB or VB NN may RBR RB VB to VB with VBN JJ NNS . [ 92 ] In NNP ( NNP ) JJ NNS , NNS of NN NN NN in 2005 VBD from 34 NN for JJ NN to 42 NN for NN NN . One of the NNS for VBG NNS VBD NN over JJ NNS ; in one NN , 31 NN of NN NNS at a NN NN RB VBD JJ NNS could VB NN . [ 134 ] NN NN VBZ RB VBN by NN NNS in VBN NN NNS . [ 135 ] [ 136 ] In the JJ NN , the NN NN VBZ VBG the NN ( RB in NNP ) of the NNP VBN NNS for the NN NN NN . [ 135 ] [ 137 ] Three NNS ( VBG an NN , an NN , and a NN NN ) of NN VBP VBN and NN NNS VBP VBN RB . These JJ NNS VBP RB VBN to VB the JJ NN . [ 138 ] As of NNP 2007 , both the JJ NN and the JJ NN VBP VBN VBG NN NNS . [ 136 ] The NNP NNP RB VBD NNP , a NN VBN by NNP VBG NNS of NN NNS . [ 136 ] This NN VBZ VBN to VB RBR JJ and VB NNS with NNS , JJ as JJ NNS and NN with NNS that VBP NNS like NNS . [ 136 ] NN VBZ into the NN of a "" JJ "" NN NN that would RB VB NN to a JJ NN , but would VB JJ against a JJ NN of NN NNS . [ 139 ] RB , no NN NNS VBD VBN VBN by NNP 2007 . [ 136 ] A NN - VBN NN , which VBZ VBN to VB RB JJR to VB , VBZ , as of 2011 , [ VBZ NN ] in JJ NNS , VBG NN and NN . [ 140 ] [ 141 ] [ 142 ] On NNP 20 , 2012 , NNP VBD NNP NN for the JJ NN - NN NN . [ 143 ] [ 144 ] [ 145 ] [ 146 ] [ 144 ] In a 2007 NN , the JJ NN of RB 826 million JJ NN NN NNS ( VBN and JJ ) VBD JJ the NN of 413 million NNS . In an JJ NN of VBG NN NN NNS by 2013 , RB 2.8 billion NNS could VB VBN in a six - NN NN NN . If all JJ - and JJ - JJ - NN NNS VBD NNS for their JJ NNS in a NN , RB 2 billion NNS would VB VBN . If NNP VBD this NN RB RB , JJR than 3 billion NNS would VB VBN to VB these NNS . [ 147 ] NN NN and NN VBZ JJ to VB JJ NN NNS that could VB RB JJR NNS of NN at a NN that VBZ JJ to the JJ NN .[ NN VBN ] NNS of NN NN that VBP the NN for NNS VBP the NN of NN NN - like NNS ( NN ) . NNP VBP NNS , but there VBZ no NN for NN , as they VBP RB VB JJ NN NNS , but RB VBP NNS in a JJ NN to a NN . Some NNS of VBG NN VBP NNS of FW FW NN NN NNS and NN - VBN NN NN ( FW , NN in NNP FW ) . There VBZ NN that some NNS VBP NNS that VBP a JJR NN of RB JJ JJ NNS VBN to JJ NNS in the NN - NN NN ( NN ) . [ 148 ] NN NNS VBP VBN in NN - JJ NNS that VBP 11 to 12 NNS JJ . [ 149 ] The NN of the NN VBZ VBN by VBG it with NN and RB the NN VBZ VBN to VB a JJ NN in the JJ NN where a JJ NN VBZ VBN to VB as a NN NN . [ 150 ] A JJ NN VBZ VBN at the NN of the NN , where the NN NN VBZ VBN in the JJ NN , past the JJ NN . The two NNS VBP RB VBN with VBN NN and the VBN NNS VBP VBN for 48 NNS at 37 NNS NNP . [ 149 ] During NN NN , the NN VBZ and RB VBN NNS VBP VBN into the JJ NN [ 151 ] After the 48 - NN NN NN , the NN of the NN VBZ VBN and the 10 NNS of JJ NN VBZ VBN , from which RB 15 NNS of the NN NN can VB VBN . At this NN , the NNS VBP VBN VBN or VBN and the JJ NN VBZ VBN and VBN inside NNS , NNS , or JJ NNS . [ 151 ] VBN on a JJ - NN , this NN VBZ VBN to VB the NN NN for the JJ NN . In 2013 , the JJ NN NN , NNP , VBD VBN for NN in the NNP NNPS . [ 152 ] [ 153 ] [ 154 ] [ 155 ] Each NN , three NNS VBP VBN for NN in that NN 's NN NN by the NNP NNP NNP NNP and NNP NNP . [ 156 ] The VBN NNS VBP the NN , NN , and NN - NN NNS VBN RBS JJ to VB JJ JJ NN in the VBG NN . VBG with the 2012 –2013 NNP NNP NN NN ( NN with the NN of JJ NN NNS ) , the NNP VBZ RB VBN a JJ NN - NN for NN in NN NNS . The NNP NNP NNP ( NNP ) VBZ the NNS of the NN each NN to VB the RBS JJ NNS of the NN to VB the JJ NN . The NNP NNP NNP and NNP NNP 's NN of NNS for the NN NN NN VBZ VBN on its JJS NN of which NNS will VB the JJ NN , VBG in the NN to RB - VBN but JJ NN . [ 159 ] JJ NNP NNS VBD RB VBN in 1973 . VBG in 1999 there VBP VBN two NNS per NN : one for the JJ NN and the JJ for the JJ NN . [ 160 ] JJ JJ NNS of the NN NN VBP VBN in a JJ NN . JJ NNP JJ NN NN NN NNS : The NN of JJ NN NNS for NN in the 2017 NNP NNP NNP NN NN VBN by the NNP NNP on NNP NNPS on NNP 25 , 2017 [ 161 ] VBD : In NN to these NNS , NN NNS will RB VB a NN / NN / 3073/2013 – JJ NN ( NNP NN ) . In NNP , some NN NNS VBD VBN by a NN in NNP NN NNS . In NN , some NNS VBD JJ NNS of NN . [ 163 ] The NN of the NN NN VBD RB JJ to the 2009 – 10 NN NN NN . A NNP 2018 NNP JJ NN VBD the NN NN to VB 25 NN against NN , 67 NN against NN , and 42 NN against NN NN [ 164 ] [ 165 ] The NN of NN NNS for NN in the 2018 NNP NNP NN NN VBN by the NNP NNP NNP on NNP 28 , 2017 VBD : [ 166 ] The NNP VBD that NN NNS VBG two NN NN NNS should VB the JJ three NNS and a NN / NNP / 60/2008 - JJ NN . [ 167 ] [ 166 ] The NN of NN NNS for NN in the 2018 – 2019 NNP NNP NN NN VBN by the NNP NNP NNP on NNP 22 , 2018 VBD : [ 168 ] [ 169 ] The NNP VBD that JJ NNS VBP as their NN NN NN a NN / NNP / 06/2017 - like NN of the NN / NNP / 2/87 - NN . [ 170 ] [ 168 ] A NNP 2019 , NNP JJ NN VBD the NN NN to VB RB 47 NN against the 2018 – 2019 NN NNS . [ 24 ] The NN of NN NNS for NN in the NNP NNPS for the 2018 – 2019 NNP NNP NN NN VBN by the NNP and NNP NNP on NNP 1 , 2018 , VBD : [ 171 ] The NN RB VBD that JJ NN NNS VBP the JJ three NNS and the VBG JJ NN NN : [ 171 ] The NN of NN NNS for NN in the 2019 NNP NNP NN NN VBN by the NNP NNP NNP in NNP 2018 VBD : [ 172 ] The NNP VBD that JJ NNS VBP as their NN NN NN a NN / NNP / 06/2017 - like NN of the NN / NNP / 2/87 - NN . [ 173 ] The NN of NN NNS for NN in the 2019 – 2020 NNP NNP NN NN VBN by the NNP NNP NNP on NNP 21 , 2019 VBD : The NNP VBD that JJ NNS VBP as their NN NN NN a NN / NNP / 06/2017 - like NN of the NN / NNP / 2/87 - NN . [ 175 ] The NN of NN NNS for NN in the NNP NNPS for the 2019 – 2020 NNP NNP NN NN VBN by the NNP and NNP NNP on NNP 22 , 2019 , VBD : [ 176 ] [ 177 ] [ 178 ] The NN RB VBD that JJ NN NNS VBP the JJ three NNS and the VBG JJ NN NN : [ 176 ] The NN of NN NNS for NN in the NNP NNP for the 2019 – 2020 NNP NNP NN NN VBN by the NNP NNPS NNP on NNP 15 , 2019 , VBD : [ 179 ] NN NNS should VB : For NN NNS VBG the NN of a NN / NNP / 16/88 NN NN NN NN in NN NNS VBG two NN NN NNS , a NN / NN / NN - JJ NN in NN to the NNS VBN RB VBZ VBN JJ . [ 179 ] The NN of NN NNS for NN in the 2020 NNP NNP NN NN NN NN VBN by the NNP NNP NNP in NNP 2019 VBD : [ 180 ] The NNP VBD that JJ NNS VBP as their NN NN NN a NN / NNP / 02/2019 - JJ ( NN / NNP NN ) NN . [ 180 ] NNS VBP VBN in both NNS and NNS . JJ NN VBZ VBN unless RB VBN as a NN , NN or NN NN . In the JJ JJ NN NN of 1918 , "" NNS VBD NN they VBD , NN they VBD RB VBN of , from the JJ NN of VBG NNS , to VBG NN , to VBG JJ NNS and NNS ( RB against what we RB VBP NNP NN – a NN VBN from the NN that it VBD RB VBN the JJ NN – and JJ NNS of NN ) . RB one JJ NN , VBG NN from VBN NNS to JJ NNS , VBD any NN of NN . "" [ 181 ] In 1931 , JJ NN in JJ NNS ' NNS VBD VBN by NNP NNP NNP and NNS at NNP NNP . The NN VBD VBN to NN of NN NN by JJ NNS , VBG NNP NNP , NNP NNP , NNP NNP and NNP NNP , VBG to the JJ JJ NN NNS . [ 182 ] In the NNS , the NNP NN VBD the JJ VBN VBN NNS for NN , which VBD VBN in the NNP NNP NNP . [ 183 ] NNP 's NNS VBD to VB VBN to VB NN VBN in NN NNS , but NNS VBD NNS in the NN of the NN by VBG VBN NNS to VB NN NNS and to VB JJ NN of the NN . [ 184 ] In 2012 , the NNP NNP and NNP NNP ( NNP ) VBD NN NNS VBN by VBG NN in NN NNS [ 185 ] [ 144 ] [ 186 ] and NN NNS VBN from JJ NNS [ 152 ] VBP VBN VBN , with NN - VBN NN NNS VBG VBN [ when ? ] in JJ NNS . [ 187 ] VBG to the NNP : "" NN NN VBZ the JJ NN for VBG NN and its JJ NNS . [...] NN VBZ VBN with NNS in NN - JJ JJ NN and NN NNS among all NN NNS , NN and NN among NNS at JJ NN , NN NN among NNS , and NN NN among NNS . Although NN NN NNS VBD RB during the NNS , JJR NNS in NN NN NNS VBP VBN "" . [ 188 ] The NN - VBN NN ( RB in NN as of 2019 ) for VBG NN NN VBD VBN in the NNS . [ 189 ] In the NNP NN NN NN of 1976 , NNP NNP NNP VBD VBN with a JJ NN NN NN . The NN NN VBD VBN , yet VBN by NNS and JJ NNS NNS . RB , JJ JJ NN NNS VBD RB in VBG the JJ NN to the JJ NN NN where it VBD VBN . On that NN , a NN of NNS VBD RB JJ , but RB one VBD . The NN VBD VBN after RB 24 NN of the NN VBD VBN NNS . An NN in NNS of twenty - five over JJ JJ NNS RB RB as 400 NN NNS , both from NNP NNP NN , VBD VBN to VB VBN from the NN NN itself , VBG that the NN itself VBZ RB JJ of NNS . The NN VBZ VBN VBN to VB VBG NNS about NN . [ 190 ] In the NN , RB , RB the VBN 1976 NN may VB VBN NNS . A 2010 NN VBD a RB VBN JJ NN against the 2009 NN NN in NN NNS who VBD VBN NN against the NN NN in 1976 . [ 191 ] A JJ NN NN VBN by JJ NN VBD VBN by the NNP in NNP 2012 . [ 192 ] [ 193 ] NNP NNP VBD VBN by the NNP in NNP 2012 . [ 194 ] In 2014 , the NNP NNP NNP NNP on NNP ( NNP ) VBD a NN of JJ NN NNS . [ 195 ] VBG with the 2018 - 2019 NN NN JJS of the JJ - NN NN - VBN NN NNS and all of the NN and NN - VBN NN NNS in the NNP NNPS VBP NN . [ 196 ] In the 2019 –2020 NN NN all JJ - NN NN NNS and all JJ NN NN in the NNP NNPS VBP NN . [ 40 ] In NNP 2019 , the NNP VBD NNP NNP - NNP NNP for NN in the NNP NNPS VBG with the 2020 - 2021 NN NN . [ 197 ] [ 198 ] The NN - NN of JJ NN NN VBZ VBN RB VBN for JJ NNS and in JJ NNS . [ 199 ] In the JJ ( JJ RB 65 NNS ) the NN of VBN NNS VBP VBN that NN VBZ NN VBG , with the NN NNS VBN with NN NN ( FW VBN NN NNS ) VBG the NN of NN . [ 200 ] In JJR NNS ( JJ 50 – 64 NNS ) , JJ VBN NNS VBP VBN that NN NN VBZ JJ to VB NN - JJ , RB the NNS of these NNS VBD RB VBN to VB JJ on JJ NNS VBN in the JJ NNS . [ 201 ] The NN in NN NN - NN NNS can RB VB VBN by the NNS VBN in VBG the NN NN , [ 202 ] RB RB as the JJ NN in the VBG NNS and the NN of the NN . [ 203 ] [ 204 ] In JJ NN NNS ( JJ 18 – 49 NNS ) , a 2012 NN VBD that NN VBD RB RB NN - VBG , with the NN for NN VBG JJ on the NN to VB to VB the VBN NN NNS . [ 205 ] In NNS , the NN of NNS VBP VBN that NN NN VBD NN - JJ , RB JJ of the NNS VBD ( JJ ) NN NNS , which may RB VB VBN the JJ NN in all NNS . [ 206 ] JJ NNS VBP VBN to VB the NN - NN of NNS ( VBG JJ NN ) to VB VB against a JJ NN , however VBG the NN - NN VBZ VBN VBN by NN as to the NN of a JJ JJ NN and the NN of NNS against it . [ 207 ] NN NN VBZ JJ NN , JJ NN , NN , NN NN NNS , NN , and NN . These NN in VBG NN NNS JJ as NNS , NNS and JJ NNS . VBN NN NNS VBP JJ NN on how NNS VBP NNS , VBP , VBP , VBP into JJ NNS and VBP an JJ NN . The NNP NNP NNP NNP VBZ VBG a NN of NN NNS [ 208 ] that will VB NNS ' NN of what VBZ one NN RBR JJ than another , what JJ NNS RBS VBP NN , and how the NN VBZ over NN . NNS to NNS in JJ [ when ? ] NN NNS VBP VBG [ when ? ] VBN . A JJ NN VBZ NN NN to VB the NN of an NN NN NN . RBR RB , NNS VBP VBN NNS from NNP and NNP 's NNP NN NN , and VBD a JJ NN which , after a NN of NNS , VBZ this NN to NNS of the NN - like NN NN NN in NNS where NNS VBP VBN VBN . The NN VBZ VBN VBN to VB the NN of two NN NN NNS in NNP ( 2013 / 14 and 2014/15 ) , where NN - NN NNS VBD VBN a JJ VBN NN NN ( NNP ) . RB , the NN NNS VBD in NN with NNS from NNP NNP NNP VBN on JJ JJ NN NNS . [ 209 ] [ 210 ] The JJ NN , NN , and NN of NN NN NNS could RB VB NNS of NNS during an NN NN . Due to the JJ NN NN between NN of a NN NN and NN for NN , NNS VBP VBG at JJ NNS for NN NN that could VB JJR "" JJ - NN "" NN and VB VBN RBR RB , RB VBG NN for NNS VBG in JJ - and JJ - NN NNS , where an NN NN may RB VB , JJ as JJ VBN ( NN - VBN or NN - VBN ) NN and JJ NNS ( NNS and NN - like NNS ) . [ 211 ] As of NNP 2009 , JJR than 70 VBN JJ NNS VBP VBN VBN or VBP JJ for NN NN NNS . [ 212 ] In NNP 2009 , the NNP VBD four NNS against the 2009 NNP NN NN ( the 2009 NN NN ) , and VBD the JJ NN NNS to VB JJ within the VBG NN . [ 213 ] In NNP 2020 , the NNP NNP and NNP NNP ( NNP ) VBD NNP as a NN for the NN NN NN . [ 214 ] NNP VBZ a NN VBN for JJ NN for the NN of NN VBN by the NN NN NN NN NN VBN in the NN . NNP VBZ VBN for NN in NNS six NNS of NN and JJR at VBN NN of NN to the NN NN NN NN NN VBN in the NN . [ 215 ] A "" JJ NN "" that would RB VB to VB VBN and VBN for each NN NN in each NN would VB JJ , in NN to VB the NN and to VB against NN in the NN or NN of the VBG NNS by NN . [ 139 ] Such a NN VBZ VBN the NN of NN for NNS . [ 216 ] One JJ NN VBZ VBG RB VBG NNS that unlike the JJ JJ NNS VBN over the JJ JJ NNS which VBP the NN to VB an JJ NN , RB VB a NN of the JJ NN itself . The JJ VBG NNS VBD VBN in 1993 , via NN ; [ 217 ] with NN NNS VBD that the NN VBG NNS VBD VBG to the NN of the NN NN ; JJR NNS VBD NNS that could VB to the NN of those NNS . RBR RB , NNS VBD the RB VBN NNP NN NN as a JJ NN for RB VBG NNS . [ 216 ] [ 218 ] The NNS for NNS VBP VBN VBG JJ NNS that could VB JJ NNS of the NN , so that they could VB JJ in any NN , and that VB VBN NNS that VBP JJ to JJ NN . [ 216 ] Another NN VBZ VBN VBG the VBN NNS VBN from these NNS , and VBG NNS of these NNS to VB an JJ NN ; JJ NNS with JJ NNS , VBN JJ NNS ( as NN NNS , VBN on NN - like NNS , on JJ NNS , as NN , and NNS ) , VBP under NN . [ 218 ] [ 219 ] [ 220 ] NNS VBP RB VBN VBN to VB JJ NNS that RB VBP a NN - NN NN , VBN on JJ NNS VBG that NNS with a JJ , JJ NN - NN NN VBP JJR NNS when VBN with NN and because NN - NNS VBP to VBN NNS . The NN for NNS VBZ that these NNS VBP on JJ NN NNS that VBP RB RB JJ . [ 218 ] Along with the NN of the NN NN , NNS VBG on JJ NNS VBP VBN VBG with NN NNS to VB the NN of their NNS to VB a RB JJ and JJ JJ NN . [ 218 ] [ 221 ] There VBP VBN some JJ NNS of the NN - 001 [ 222 ] [ 223 ] [ 139 ] [ 224 ] [ 225 ] and H1ssF JJ NN NN NNS . As of NNP of 2020 , 6 of 7 NN -001 NNS VBP VBN . One of the 7 NN -001 NNS VBZ NNS . NN of the NNP - VBN NN NNS VBP NNS . [ 139 ] [ 226 ] [ 227 ] As of 2019 , an JJ NN NN VBD in JJ NN . [ 228 ] The JJ NN NN VBZ VBN on an NN NN 5 NN VBN to VB NNS VBN for NN , with an VBN NN that VBZ a JJ JJ - VBN NN NN NN as an NN . [ 229 ] In 2020 , a NN II JJ NN of the NN NN of the NN VBD that it VBD RB VBN and VBD JJ NN to a VBN JJ NN . [ 230 ] JJ NN NN VBZ to VB the VBG four NNS : [ 231 ] NNS with NN NN can VB a NN , VBP a JJ NN NN , VBP a JJ NN , and VBP JJ and JJ to VB or VB for JJ NNS but RB VBP in two to three NNS . "" NN NNS RB VBP a JJ NN of two NNS , 3 – 6 NNS RB , VBN by NNS at 6 – 12 NN NNS . It VBZ RB VBN that in JJ NNS JJ NNS may RB VB JJ NNS of NN and RBR JJ NN VBZ VBN in JJ - NN NNS . "" [ 232 ] It VBZ a JJ NN at NNS in the NNP NNP that NNS VBP VBN against JJ NN and a NN NN must VB VBN ; the NNP NNP for NNP NNPS ( NNP ) VBZ NN every six NNS . [ 233 ] [ 234 ] NN NNS for NN NN VBP VBN RB and VBP RB VBN and VBN like JJ NNS to VB NNS of NN or JJ NNS . They RB VBP JJ NN , RB RB NN as in JJS JJ NN NNS . Another NN between JJ and NN NNS VBZ that NN NNS VBP VBN with JJ NN , which VBZ a JJ JJ NN but can VB NN and NNS . "" NN NNS who VBP RB VBN themselves VBP VBN JJ JJ NNS or RB VBN NNS , NNS VBD . NN may RB VB VBN . NN NNS VBP RB RB RB JJ to VBG NN NNS – some VBP an NN NN VBN in NNP NNS RB . ' With a NN , if you VBP a NN that VBZ RB 85 NN JJ , you 'll VB NN , ' NNP NNP VBD . ' In NNS , you can VB a JJ NN NN , and a NN that VBZ 99.99 NN JJ wo RB VB you . ' And they VBP JJR [ than JJ NNS ] . ' NNS VBP JJR and you RB VBP to VB them for six NNS , because that VBZ how RB they VBP till you VBP them , ' VBD NNP NNP NNP NNP , a NN NN at the NNP of NNP . JJ JJ NN NNS VBP RB 45 NNS of NN , while an JJ A( NN ) NN VBZ 180 . NN NNS may VB JJR than one NN . ' You VBP to VB JJ about VBG NNS from NN to NNS , ' VBD NNP NNP NNP NNP , NN of the NN NN 's NNP NNP NNP NNP . ' NNS VBP RBR RB JJ to NNS . ' "" [ 235 ] NNS , VBN by NNP NNP of the NNP of NNP in NNP , VBD JJ NNS to VB the NN of NN and VBD that "" at JJS 95 NN of NNS VBP to VB VBN to VB the NN VBG RB . In NN , it VBZ JJ to VB JJR than 90 NN of a NN ; NN NNS VBN by a NN VBP RB RB JJR than this . "" [ 236 ] The NNP and NNP NNP of the NNP NNPS VBZ VBN NNS on the NN and NN of JJ NN in NN , VBG the NN of NN . [ 237 ] A VBN and VBN NN NN NN for NNS VBZ VBG VBN [ when ? ] and JJ NNS VBP VBN it VB VBN so if an NNP NN NN VBZ VBG to NNS , the NN can RB VB VBN to VB NN of NN . JJ NN VBZ RB VBN JJ NN , and RB NN NN . [ 238 ] NN NN NNS VBP RB VBN in NN NN in NNP and NNP NNP . JJS NN NN NNS VBP an NN and an NN NN . NN NN VBZ VBN VBN as a JJ NN since the NN in 1976 . NN of the NN VBZ VBN in JJ NNS to JJ NNS . JJ JJ NN NN NNS VBP JJ in VBG the NN when the NN NNS VBP RB to VB JJ NN . VBN ( JJ ) NNS VBN from the JJ NNS VBN , VBP VBN and VBN in the RBR JJ NNS . [ 239 ] The NN NN NNP VBZ that the NNP NN ( RB VBN in 1998 ) VBZ VBN JJ NNS to NN NNS . NN NNS VBP a JJ NN and NNS VBP VBG for a JJ NNS and VBP a JJ NN . The NN NN can VB RB JJ as 15 NN . [ 240 ] In 2004 , NN A NN NN NNP VBD VBN to VB NN NN . Because of the NN of JJ NN to this NN , NNS VBP no JJ NN to this NN . RB , a NN VBD VBN in 2004 . [ 241 ] • NN NNP NNP NNP ( NNP 2017 ) . The JJ NN for NN NN : NN 23 : NN NNS . NNP NNP NNP ( NNP ) . NN : . NNP . • NN NNP NNP , NNP NNP , NNP NNP , FW ( 2015 ) . "" NNP 12 : NNP "" . NN and NN of NN - JJ NNS ( NNP NN ) . NNP NNP : NNP NNPS for NNP NNP and NNP ( NNP ) . NNP . • NN NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP , FW FW ( NNP 29 , 2019 ) . "" NN 6 : NN "" . In NNP NNP , NNP NNP , NNP NNP ( NNP . ) . NN for the NN of NN - JJ NNS . NNP NN : NNP NNPS for NNP NNP and NNP ( NNP ) . • NN NNP NNP NNP on NNP ( NNP 2020 ) . "" NNP NNP NNP NNP on NNP and NNP on NNP NNP NNP for 2020 – 2021 "" . NNP NNP NNP of NNP . NN : NN ; NN : 200003 . VB NN . • NN NNP NNP NNP on NNP ( NNP ) ( NNP 2018 ) . "" NNP NN NN on the JJ NN and NN of NN and JJ NN VBN NN NNS in NNS 65 NNS of NN and JJR "" . NN of NNP . NNP . NN : NN ; NN : 180039 . VB NN . • VBN NN NN NN NN , NNP NNPS for NNP NNP and NNP ( NNP ) • NNP , NNP NNP NNP NNP NNP , NNP NNPS for NNP NNP and NNP ( NNP ) • NNP NNP ( NNP ) NNP and NNP NNP , NNP NNPS for NNP NNP and NNP ( NNP ) • NNPS about NNP NNP and NNP NNPS , NNP NNPS for NNP NNP and NNP ( NNP ) • NNP NNPS at the NNP NNP NNP of NNP NNP NNP NNPS ( NNP )"
219,227,mainstream,"In_IN 1796_CD ,_, English_JJ physician_NN Edward_NNP Jenner_NNP had_VBD a_DT hunch_NN ._. As_IN hundreds_NNS of_IN thousands_NNS around_IN him_PRP succumbed_VBD to_IN the_DT blistering_VBG agony_NN of_IN smallpox_NN ,_, Jenner_NNP ’s_POS eye_NN was_VBD on_IN the_DT rosy_JJ ,_, unblemished_JJ complexion_NN of_IN Sarah_NNP Nelmes_NNP ,_, a_DT local_JJ milkmaid_NN ._. Her_PRP$ skin_NN bore_VBD none_NN of_IN the_DT oozing_VBG lesions_NNS that_WDT signaled_VBD almost_RB certain_JJ death_NN for_IN a_DT third_NN of_IN smallpox_NN sufferers_NNS —_: save_IN for_IN her_PRP$ hands_NNS ,_, busily_RB milking_VBG a_DT cow_NN named_VBN Blossom_NNP ._. The_DT locals_NNS called_VBD the_DT unsightly_JJ affliction_NN “_`` cowpox_NN ._. ”_'' But_CC apart_RB from_IN a_DT smattering_NN of_IN welts_NNS ,_, Sarah_NNP and_CC her_PRP$ fellow_JJ milkmaids_NNS were_VBD remarkably_RB free_JJ of_IN disease_NN ._. To_IN Jenner_NNP ,_, this_DT was_VBD n’t_RB a_DT coincidence_NN ._. Acting_VBG on_IN little_JJ more_JJR than_IN sparse_JJ observations_NNS ,_, Jenner_NNP decided_VBD to_TO extract_VB a_DT small_JJ sample_NN of_IN Sarah_NNP ’s_POS pus_NN and_CC inject_VB it_PRP into_IN the_DT arm_NN of_IN a_DT young_JJ boy_NN named_VBN James_NNP Phipps_NNP ._. To_IN everyone_NN ’s_POS amazement_NN —_: including_VBG Jenner_NNP ’s_POS —_: when_WRB Jenner_NNP stuck_VBD Phipps_NNP with_IN a_DT second_JJ needle_NN ,_, this_DT time_NN sporting_VBG a_DT hefty_JJ dose_NN of_IN smallpox_NN ,_, Phipps_NNP remained_VBD healthy_JJ ._. Against_IN all_DT odds_NNS ,_, the_DT risky_JJ treatment_NN had_VBD granted_VBN the_DT child_NN miraculous_JJ immunity_NN ._. This_DT revolutionary_JJ (_-LRB- and_CC wildly_RB unethical_JJ )_-RRB- experiment_NN catapulted_VBD the_DT world_NN into_IN the_DT era_NN of_IN what_WP would_MD come_VB to_TO be_VB called_VBN “_`` vaccination_NN ,_, ”_'' a_DT word_NN whose_WP$ etymology_NN contains_VBZ a_DT reverent_JJ nod_NN to_IN the_DT Latin_JJ vacca_NN ,_, for_IN “_`` cow_NN ._. ”_'' Smallpox_NN would_MD become_VB the_DT first_JJ disease_NN officially_RB conquered_VBN by_IN human_JJ medicine_NN ._. “_`` [_-LRB- Smallpox_NN eradication_NN ]_-RRB- shows_VBZ what_WP we_PRP can_MD really_RB achieve_VB when_WRB we_PRP have_VBP the_DT proper_JJ tools_NNS to_TO fight_VB a_DT disease_NN ,_, ”_'' says_VBZ Sabrina_NNP Sholts_NNP ,_, a_DT curator_NN of_IN anthropology_NN at_IN the_DT National_NNP Museum_NNP of_IN Natural_NNP History_NNP ,_, where_WRB she_PRP developed_VBD the_DT infectious_JJ -_HYPH disease_NN -_HYPH centric_JJ “_`` Outbreak_NN ”_'' exhibit_NN ._. “_`` But_CC knowing_VBG about_IN the_DT disease_NN also_RB shows_VBZ us_PRP how_WRB many_JJ people_NNS were_VBD killed_VBN …_, and_CC we_PRP realize_VBP there_EX ’s_VBZ no_DT reason_NN it_PRP could_MD n’t_RB happen_VB again_RB ._. ”_'' Not_RB only_RB is_VBZ there_EX the_DT potential_NN for_IN smallpox_NN (_-LRB- or_CC at_IN the_DT very_JJ least_JJS ,_, something_NN very_RB similar_JJ )_-RRB- to_TO resurge_VB ,_, but_CC unbeknownst_JJ to_IN most_JJS ,_, the_DT very_JJ origins_NNS of_IN this_DT revolutionary_JJ vaccine_NN are_VBP in_IN question_NN ._. For_IN decades_NNS ,_, scientists_NNS have_VBP thought_VBN the_DT legend_NN of_IN cowpox_NN as_IN the_DT savior_NN —_: first_RB ,_, of_IN James_NNP Phipps_NNP ,_, then_RB ,_, of_IN the_DT world_NN —_: may_MD very_RB well_RB be_VB wrong_JJ ._. That_DT cryptic_JJ crack_NN in_IN medical_JJ history_NN could_MD leave_VB humanity_NN vulnerable_JJ to_IN a_DT future_JJ outbreak_NN —_: however_RB unlikely_JJ it_PRP may_MD be_VB ._. By_IN the_DT end_NN of_IN the_DT 18th_JJ century_NN ,_, smallpox_NN ,_, caused_VBN by_IN variola_NN virus_NN ,_, was_VBD a_DT worldwide_JJ terror_NN ,_, claiming_VBG hundreds_NNS of_IN thousands_NNS of_IN lives_NNS each_DT year_NN ._. The_DT disease_NN was_VBD an_DT ancient_JJ one_NN ,_, plaguing_VBG populations_NNS at_IN least_JJS as_RB far_RB back_RB as_IN the_DT third_JJ century_NN B.C._NNP ,_, and_CC infected_VBN indiscriminately_RB ,_, sparing_VBG neither_CC rich_JJ nor_CC poor_JJ and_CC felling_VBG men_NNS ,_, women_NNS and_CC children_NNS alike_RB ._. So_RB ,_, when_WRB Jenner_NNP ’s_POS “_`` vaccine_NN ”_'' (_-LRB- really_RB just_RB pus_NN teeming_VBG with_IN virus_NN )_-RRB- hit_VBD the_DT scene_NN ,_, it_PRP literally_RB went_VBD viral_JJ ._. By_IN 1813_CD ,_, it_PRP was_VBD widely_RB accessible_JJ in_IN Europe_NNP ,_, Asia_NNP and_CC the_DT Americas_NNPS ._. Because_IN poxviruses_NNS like_IN smallpox_NN are_VBP most_RBS easily_RB passed_VBN from_IN animal_NN to_IN animal_NN ,_, scientists_NNS first_RB created_VBD new_JJ reserves_NNS of_IN the_DT vaccine_NN by_IN collecting_VBG pus_NN from_IN infected_VBN livestock_NN ._. Each_DT time_NN stocks_NNS ran_VBD low_RB ,_, scientists_NNS rounded_VBD up_RP a_DT fresh_JJ herd_NN of_IN naturally_RB infected_VBN animals_NNS and_CC consolidated_VBD their_PRP$ secretions_NNS ._. “_`` The_DT vaccine_NN evolved_VBD ,_, ”_'' says_VBZ Inger_NNP Damon_NNP ,_, who_WP leads_VBZ the_DT poxvirus_NN and_CC rabies_NN branch_NN at_IN the_DT United_NNP States_NNPS Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. “_`` The_DT way_NN it_PRP was_VBD propagated_VBN —_: either_CC on_IN the_DT sides_NNS of_IN cows_NNS or_CC in_IN rabbits_NNS —_: changed_VBD and_CC introduced_VBD related_JJ viruses_NNS into_IN the_DT pool_NN …_: [_-LRB- so_RB ]_-RRB- a_DT swarm_NN of_IN viruses_NNS was_VBD used_VBN in_IN various_JJ vaccines_NNS ._. ”_'' In_IN 1939_CD ,_, a_DT researcher_NN at_IN the_DT University_NNP of_IN Liverpool_NNP named_VBN Allan_NNP Watt_NNP Downie_NNP became_VBD curious_JJ about_IN how_WRB the_DT smallpox_NN vaccine_NN might_MD have_VB changed_VBN over_IN time_NN ._. Nowadays_RB ,_, vaccines_NNS are_VBP meticulously_RB produced_VBN en_IN masse_NN and_CC most_JJS (_-LRB- including_VBG some_DT modern_JJ versions_NNS of_IN smallpox_NN vaccine_NN )_-RRB- contain_VBP severely_RB weakened_VBN versions_NNS of_IN infectious_JJ microbes_NNS or_CC small_JJ ,_, incomplete_JJ bits_NNS of_IN the_DT pathogens_NNS —_: the_DT bare_JJ minimum_NN required_VBN to_TO jolt_VB the_DT immune_NN system_NN into_IN action_NN ._. This_DT circumvents_VBZ the_DT possibility_NN of_IN causing_VBG a_DT real_JJ infection_NN or_CC spreading_VBG a_DT new_JJ agent_NN of_IN disease_NN within_IN the_DT human_JJ population_NN ._. But_CC the_DT early_JJ smallpox_NN vaccine_NN was_VBD based_VBN on_IN a_DT virus_NN fully_RB capable_JJ of_IN causing_VBG disease_NN —_: one_CD less_RBR severe_JJ than_IN smallpox_NN ,_, but_CC disease_NN all_PDT the_DT same_JJ ._. And_CC active_JJ viruses_NNS are_VBP still_RB subject_JJ to_IN the_DT pressures_NNS of_IN evolution_NN ._. When_WRB Downie_NNP compared_VBD the_DT viral_JJ contents_NNS of_IN a_DT smallpox_NN vaccine_NN ,_, still_RB known_VBN to_IN this_DT day_NN as_IN a_DT lineage_NN called_VBN “_`` vaccinia_NN virus_NN ,_, ”_'' to_IN a_DT sample_NN of_IN cowpox_NN isolated_VBN directly_RB from_IN cattle_NNS ,_, he_PRP was_VBD surprised_VBN to_TO find_VB that_IN they_PRP were_VBD different_JJ ._. Related_JJ ,_, yes_UH —_: but_CC certainly_RB not_RB identical_JJ ._. This_DT ,_, unfortunately_RB ,_, opened_VBD quite_PDT the_DT can_NN of_IN worms_NNS ._. The_DT two_CD samples_NNS were_VBD divergent_JJ enough_RB that_IN it_PRP seemed_VBD highly_RB improbable_JJ that_IN vaccinia_NN ,_, the_DT current_JJ smallpox_NN vaccine_NN ,_, was_VBD descended_VBN from_IN cowpox_NN ._. This_DT left_VBD Downie_NNP and_CC his_PRP$ colleagues_NNS with_IN an_DT unsettling_JJ question_NN :_: What_WP on_IN earth_NN had_VBD they_PRP been_VBN injecting_VBG into_IN the_DT arms_NNS of_IN millions_NNS of_IN people_NNS for_IN the_DT past_JJ 150_CD years_NNS ?_. Sleuthing_NN through_IN historical_JJ records_NNS led_VBD some_DT scientists_NNS to_TO speculate_VB that_IN another_DT virus_NN called_VBN horsepox_NN ,_, known_VBN to_TO infect_VB both_CC horses_NNS and_CC cows_NNS ,_, may_MD have_VB been_VBN vaccinia_JJ virus_NN ’_POS ancestor_NN ._. Even_RB Jenner_NNP himself_PRP mused_VBD about_IN the_DT equine_JJ origins_NNS of_IN his_PRP$ miracle_NN drug_NN in_IN his_PRP$ original_JJ publication_NN ,_, speculating_VBG that_IN the_DT most_RBS protective_JJ route_NN of_IN vaccine_NN transmission_NN might_MD be_VB horse_NN to_TO cow_VB to_IN human_JJ ._. As_RB far_RB as_IN science_NN had_VBD progressed_VBN ,_, the_DT field_NN of_IN virology_NN did_VBD not_RB yet_RB have_VB the_DT right_JJ set_NN of_IN tools_NNS to_TO fully_RB suss_VB out_RP the_DT answers_NNS ._. In_IN the_DT meantime_NN ,_, vaccinia_NN —_: despite_IN its_PRP$ murky_JJ ancestry_NN —_: had_VBD been_VBN working_VBG miracles_NNS ._. And_CC so_RB ,_, with_IN a_DT wary_JJ shrug_NN ,_, scientists_NNS put_VBD an_DT exceptionally_RB large_JJ pin_NN in_IN the_DT mysterious_JJ origins_NNS of_IN the_DT millennium_NN ’s_POS medical_JJ marvel_NN and_CC moved_VBD on_RP ._. Soon_RB ,_, it_PRP seemed_VBD humanity_NN ,_, with_IN the_DT help_NN of_IN vaccinia_NN ,_, had_VBD won_VBN its_PRP$ centuries_NNS -_HYPH long_JJ battle_NN with_IN smallpox_NN ._. In_IN May_NNP of_IN 1980_CD ,_, the_DT World_NNP Health_NNP Organization_NNP triumphantly_RB proclaimed_VBD ,_, “_`` Smallpox_NNP is_VBZ dead_JJ ._. ”_'' The_DT world_NN ’s_POS memory_NN is_VBZ brief_JJ ._. As_IN smallpox_NN disappeared_VBD from_IN hospital_NN wards_NNS ,_, so_RB did_VBD it_PRP from_IN the_DT minds_NNS of_IN the_DT public_NN ._. Eventually_RB ,_, technology_NN advanced_VBD to_IN the_DT point_NN where_WRB it_PRP was_VBD finally_RB feasible_JJ to_TO reopen_VB medicine_NN ’s_POS greatest_JJS cold_JJ case_NN and_CC discover_VB the_DT true_JJ roots_NNS of_IN the_DT smallpox_NN vaccine_NN ._. But_CC why_WRB not_RB let_VB sleeping_NN pox_NN lie_VB ?_. The_DT scourge_NN of_IN smallpox_NN had_VBD been_VBN wiped_VBN from_IN the_DT face_NN of_IN the_DT earth_NN —_: whatever_WP was_VBD in_IN that_DT vaccine_NN ,_, be_VB it_PRP derived_VBN of_IN cow_NN or_CC horse_NN or_CC confetti—_NN did_VBD it_PRP even_RB matter_VB ?_. But_CC the_DT era_NN of_IN smallpox_NN is_VBZ far_RB from_IN over_RB ._. Although_IN smallpox_NN is_VBZ technically_RB eradicated_VBN ,_, at_IN least_JJS two_CD laboratories_NNS —_: one_CD in_IN Russia_NNP and_CC one_CD at_IN CDC_NNP headquarters_NN in_IN Atlanta_NNP ,_, Georgia_NNP —_: still_RB harbor_VBP samples_NNS of_IN variola_NN virus_NN ._. And_CC concerns_NNS of_IN a_DT future_JJ outbreak_NN go_VBP far_RB beyond_IN a_DT hapless_JJ laboratory_NN accident_NN :_: Modern_JJ gene_NN -_HYPH editing_NN techniques_NNS have_VBP made_VBN it_PRP possible_JJ to_TO build_VB a_DT lethal_JJ lookalike_NN from_IN scratch_NN ._. Now_RB more_JJR than_IN ever_RB ,_, the_DT threat_NN of_IN bioterrorism_NN looms_VBZ large_JJ ._. Since_IN routine_JJ vaccination_NN efforts_NNS ceased_VBD nearly_RB four_CD decades_NNS ago_RB ,_, the_DT vast_JJ majority_NN of_IN the_DT modern_JJ global_JJ population_NN would_MD be_VB completely_RB vulnerable_JJ to_IN an_DT unexpected_JJ pandemic_NN ._. Anywhere_RB from_IN 30_CD to_IN 88_CD percent_NN of_IN people_NNS exposed_VBN to_IN the_DT virus_NN can_MD be_VB infected_VBN ,_, and_CC nearly_RB a_DT third_NN of_IN those_DT who_WP contract_VBP the_DT disease_NN will_MD die_VB ._. It_PRP was_VBD only_RB in_IN July_NNP of_IN 2018_CD that_IN the_DT FDA_NNP approved_VBD the_DT first_JJ drug_NN to_TO treat_VB smallpox_NN ._. Vaccination_NN remains_VBZ the_DT only_JJ other_JJ tool_NN at_IN our_PRP$ disposal_NN —_: and_CC if_IN an_DT outbreak_NN were_VBD to_TO occur_VB ,_, millions_NNS of_IN Americans_NNPS ,_, including_VBG pregnant_JJ women_NNS and_CC people_NNS with_IN HIV_NN or_CC eczema_NN ,_, would_MD be_VB precluded_VBN from_IN vaccination_NN ._. Creating_VBG a_DT new_JJ or_CC improved_VBN vaccine_NN could_MD help_VB ,_, but_CC working_VBG with_IN the_DT world_NN ’s_POS limited_VBN stores_NNS of_IN smallpox_NN (_-LRB- like_IN those_DT at_IN the_DT CDC_NNP or_CC in_IN Russia_NNP )_-RRB- is_VBZ both_CC impractical_JJ and_CC extremely_RB dangerous_JJ ._. Tooling_VBG instead_RB with_IN a_DT less_RBR virulent_JJ close_JJ relative_NN could_MD help_VB researchers_NNS safely_RB and_CC effectively_RB hit_VB pay_VB dirt_NN ._. So_RB if_IN horsepox_NNP was_VBD the_DT virus_NN that_WDT kicked_VBD off_RP vaccination_NN in_IN the_DT 18th_JJ century_NN ,_, modern_JJ research_NN should_MD trend_VB equine_JJ —_: but_CC first_RB ,_, the_DT world_NN needs_VBZ proof_NN ._. Some_DT researchers_NNS have_VBP taken_VBN steps_NNS in_IN that_DT direction_NN ._. In_IN the_DT 1970s_NNS ,_, a_DT small_JJ handful_NN of_IN scientists_NNS decided_VBD to_TO once_RB again_RB probe_VB the_DT relationship_NN between_IN the_DT vaccinia_NN vaccine_NN strain_NN and_CC horsepox_NN ._. One_CD group_NN was_VBD able_JJ to_TO show_VB an_DT encouraging_VBG degree_NN of_IN relatedness_NN between_IN horsepox_NN and_CC an_DT old_JJ Brazilian_JJ vaccine_NN strain_NN ,_, supposedly_RB sourced_VBN from_IN France_NNP in_IN the_DT mid-1800s_NNS ._. But_CC this_DT finding_NN was_VBD but_CC a_DT blip_NN on_IN the_DT scientific_JJ radar_NN ,_, and_CC little_JJ progress_NN was_VBD made_VBN in_IN the_DT decades_NNS that_WDT followed_VBD ._. Recent_JJ advances_NNS in_IN technology_NN have_VBP reinvigorated_VBN the_DT investigation_NN ,_, however_RB ._. Scientists_NNS like_IN Damon_NNP at_IN the_DT CDC_NNP ,_, along_IN with_IN an_DT independent_JJ team_NN led_VBN by_IN virologist_NN Jose_NNP Esparza_NNP at_IN the_DT University_NNP of_IN Maryland_NNP ,_, have_VBP begun_VBN collecting_VBG old_JJ smallpox_NN vaccines_NNS from_IN museums_NNS and_CC laboratories_NNS from_IN around_IN the_DT world_NN to_TO analyze_VB the_DT genetic_JJ sequences_NNS contained_VBN within_IN ._. With_IN viral_JJ genomes_NNS ,_, researchers_NNS may_MD be_VB able_JJ to_TO trace_VB vaccine_NN ancestry_NN backwards_RB in_IN time_NN and_CC eventually_RB pinpoint_VB the_DT source_NN —_: or_CC likely_JJ ,_, sources_NNS —_: of_IN these_DT protective_JJ artifacts_NNS ._. The_DT work_NN is_VBZ ongoing_JJ ,_, says_VBZ Esparza_NNP ,_, but_CC he_PRP is_VBZ confident_JJ that_IN horsepox_NN entered_VBD the_DT mix_NN at_IN some_DT point_NN ._. His_PRP$ team_NN has_VBZ compiled_VBN 15_CD vaccine_NN samples_NNS and_CC counting_NN ,_, most_JJS from_IN the_DT early_JJ 1900s_NNS ,_, and_CC recently_RB published_VBD a_DT genetic_JJ analysis_NN of_IN a_DT 1902_CD vaccine_NN that_WDT bears_VBZ a_DT striking_VBG resemblance_NN to_IN horsepox_NN ._. The_DT resemblance_NN is_VBZ imperfect_JJ ,_, says_VBZ Esparza_NNP ,_, but_CC together_RB ,_, these_DT findings_NNS provide_VBP strong_JJ evidence_NN that_IN horsepox_NN played_VBD a_DT role_NN in_IN smallpox_NN vaccine_NN production_NN ._. Esparza_NNP calls_VBZ these_DT new_JJ findings_NNS “_`` a_DT lesson_NN in_IN humility_NN ._. ”_'' Jenner_NNP ,_, for_IN all_PDT his_PRP$ genius_NN ,_, was_VBD likely_RB shooting_VBG in_IN the_DT dark_NN ._. (_-LRB- Although_IN it_PRP 's_VBZ possible_JJ he_PRP had_VBD a_DT few_JJ more_JJR hints_NNS than_IN the_DT oft_NN -_HYPH told_VBN story_NN of_IN his_PRP$ discovery_NN implies_VBZ ._. )_-RRB- He_PRP could_MD n’t_RB possibly_RB have_VB understood_VBN the_DT intricacies_NNS of_IN vaccination_NN as_IN we_PRP do_VBP today_NN —_: but_CC often_RB ,_, Esparza_NNP says_VBZ ,_, we_PRP must_MD develop_VB solutions_NNS without_IN knowing_VBG every_DT scientific_JJ detail_NN ._. Now_RB ,_, it_PRP ’s_VBZ time_NN to_TO play_VB catch_NN -_HYPH up_RP :_: Technology_NN finally_RB has_VBZ the_DT power_NN to_TO find_VB the_DT answers_NNS to_IN a_DT medical_JJ problem_NN that_WDT only_RB claims_VBZ to_TO be_VB solved_VBN ._. “_`` There_EX ’s_VBZ nothing_NN more_RBR interesting_JJ to_IN me_PRP ,_, as_IN a_DT scientist_NN ,_, than_IN solving_VBG a_DT problem_NN ,_, ”_'' Esparza_NNP says_VBZ ._. “_`` I_PRP just_RB want_VBP to_TO find_VB the_DT truth_NN ._. ”_'' Importantly_RB ,_, Esparza_NNP adds_VBZ ,_, even_RB if_IN the_DT world_NN does_VBZ n’t_RB have_VB much_JJ to_TO fear_VB from_IN smallpox_NN itself_PRP ,_, plenty_NN of_IN other_JJ viruses_NNS in_IN the_DT “_`` pox_NN ”_'' family_NN could_MD still_RB be_VB cause_JJ for_IN concern_NN for_IN humans_NNS and_CC wildlife_NN alike_RB ._. Many_JJ animals_NNS have_VBP their_PRP$ own_JJ flavor_NN of_IN poxvirus_NN ,_, including_VBG monkeys_NNS ,_, pigs_NNS and_CC even_RB mollusks_NNS ._. Several_JJ —_: though_IN not_RB all_DT —_: of_IN these_DT diseases_NNS have_VBP been_VBN known_VBN to_TO be_VB zoonotic_JJ ,_, hopping_VBG from_IN wildlife_NN into_IN human_JJ populations_NNS ._. Protecting_VBG both_CC animals_NNS and_CC humans_NNS requires_VBZ an_DT intimate_JJ knowledge_NN of_IN the_DT viruses_NNS in_IN question_NN ._. According_VBG to_IN Esparza_NNP ,_, better_RBR understanding_VBG the_DT smallpox_NN vaccine_NN ,_, down_RB to_IN its_PRP$ murky_JJ four_CD -_HYPH legged_VBN roots_NNS ,_, may_MD be_VB one_CD of_IN our_PRP$ most_RBS powerful_JJ tools_NNS to_TO forestall_VB an_DT entire_JJ family_NN of_IN known_VBN diseases_NNS ._. What_WP ’s_VBZ more_JJR ,_, it_PRP ’s_VBZ unlikely_JJ humans_NNS are_VBP done_VBN encountering_VBG all_PDT the_DT poxviruses_NNS that_WDT may_MD trouble_VB us_PRP in_IN the_DT future_NN ._. “_`` Some_DT people_NNS estimate_VBP we_PRP ’ve_VBP discovered_VBN less_JJR than_IN 1_CD percent_NN of_IN the_DT existing_VBG viruses_NNS in_IN nature_NN ,_, ”_'' says_VBZ Esparza_NNP ._. “_`` Smallpox_NN is_VBZ eradicated_VBN ._. But_CC the_DT world_NN is_VBZ full_JJ of_IN viruses_NNS waiting_VBG to_TO be_VB discovered_VBN ._. ”_'' In_IN the_DT meantime_NN ,_, the_DT jury_NN is_VBZ still_RB out_RB on_IN the_DT relative_JJ contributions_NNS of_IN horses_NNS ,_, cows_NNS and_CC their_PRP$ respective_JJ poxviruses_NNS to_IN the_DT eradication_NN of_IN smallpox_NN —_: but_CC horsepox_NN was_VBD certainly_RB ,_, well_UH ,_, the_DT dark_JJ horse_NN of_IN this_DT race_NN ._. As_IN the_DT debate_NN continues_VBZ ,_, though_RB ,_, should_MD we_PRP start_VB making_VBG the_DT verbal_JJ switch_NN from_IN “_`` vaccines_NNS ”_'' to_IN “_`` equines_NNS ”_'' ?_. Not_RB just_RB yet_RB ,_, says_VBZ Damon_NNP ._. Cows_NNS and_CC milkmaids_NNS ,_, regardless_RB of_IN the_DT exact_JJ strain_NN they_PRP carried_VBD ,_, were_VBD still_RB an_DT integral_JJ piece_NN of_IN Jenner_NNP ’s_POS discovery_NN ._. Blossom_NNP ’s_POS legacy_NN remains_VBZ intact_JJ —_: for_IN now_RB ._.","In 1796 , JJ NN NNP NNP VBD a NN . As NNS of NNS around him VBD to the VBG NN of NN , NNP ’s NN VBD on the JJ , JJ NN of NNP NNP , a JJ NN . Her NN VBD NN of the VBG NNS that VBD RB JJ NN for a NN of NN NNS — save for her NNS , RB VBG a NN VBN NNP . The NNS VBD the JJ NN “ NN . ” But RB from a NN of NNS , NNP and her JJ NNS VBD RB JJ of NN . To NNP , this VBD RB a NN . VBG on JJ JJR than JJ NNS , NNP VBD to VB a JJ NN of NNP ’s NN and VB it into the NN of a JJ NN VBN NNP NNP . To NN ’s NN — VBG NNP ’s — when NNP VBD NNP with a JJ NN , this NN VBG a JJ NN of NN , NNP VBD JJ . Against all NNS , the JJ NN VBD VBN the NN JJ NN . This JJ ( and RB JJ ) NN VBD the NN into the NN of what would VB to VB VBN “ NN , ” a NN whose NN VBZ a JJ NN to the JJ NN , for “ NN . ” NN would VB the JJ NN RB VBN by JJ NN . “ [ NN NN ] VBZ what we can RB VB when we VBP the JJ NNS to VB a NN , ” VBZ NNP NNP , a NN of NN at the NNP NNP of NNP NNP , where she VBD the JJ - NN - JJ “ NN ” NN . “ But VBG about the NN RB VBZ us how JJ NNS VBD VBN … and we VBP there VBZ no NN it could RB VB RB . ” RB RB VBZ there the NN for NN ( or at the JJ JJS , NN RB JJ ) to VB , but JJ to JJS , the JJ NNS of this JJ NN VBP in NN . For NNS , NNS VBP VBN the NN of NN as the NN — RB , of NNP NNP , RB , of the NN — may RB RB VB JJ . That JJ NN in JJ NN could VB NN JJ to a JJ NN — RB JJ it may VB . By the NN of the JJ NN , NN , VBN by NN NN , VBD a JJ NN , VBG NNS of NNS of NNS each NN . The NN VBD an JJ NN , VBG NNS at JJS RB RB RB as the JJ NN NNP , and VBN RB , VBG neither JJ nor JJ and VBG NNS , NNS and NNS RB . RB , when NNP ’s “ NN ” ( RB RB NN VBG with NN ) VBD the NN , it RB VBD JJ . By 1813 , it VBD RB JJ in NNP , NNP and the NNPS . Because NNS like NN VBP RBS RB VBN from NN to NN , NNS RB VBD JJ NNS of the NN by VBG NN from VBN NN . Each NN NNS VBD RB , NNS VBD up a JJ NN of RB VBN NNS and VBD their NNS . “ The NN VBD , ” VBZ NNP NNP , who VBZ the NN and NN NN at the NNP NNPS NNPS for NNP NNP and NNP . “ The NN it VBD VBN — either on the NNS of NNS or in NNS — VBD and VBD JJ NNS into the NN … [ RB ] a NN of NNS VBD VBN in JJ NNS . ” In 1939 , a NN at the NNP of NNP VBN NNP NNP NNP VBD JJ about how the NN NN might VB VBN over NN . RB , NNS VBP RB VBN en NN and JJS ( VBG some JJ NNS of NN NN ) VBP RB VBN NNS of JJ NNS or JJ , JJ NNS of the NNS — the JJ NN VBN to VB the NN NN into NN . This VBZ the NN of VBG a JJ NN or VBG a JJ NN of NN within the JJ NN . But the JJ NN NN VBD VBN on a NN RB JJ of VBG NN — one RBR JJ than NN , but NN all the JJ . And JJ NNS VBP RB JJ to the NNS of NN . When NNP VBD the JJ NNS of a NN NN , RB VBN to this NN as a NN VBN “ NN NN , ” to a NN of NN VBN RB from NNS , he VBD VBN to VB that they VBD JJ . JJ , yes — but RB RB JJ . This , RB , VBD quite the NN of NNS . The two NNS VBD JJ RB that it VBD RB JJ that NN , the JJ NN NN , VBD VBN from NN . This VBD NNP and his NNS with an JJ NN : What on NN VBD they VBN VBG into the NNS of NNS of NNS for the JJ 150 NNS ? NN through JJ NNS VBD some NNS to VB that another NN VBN NN , VBN to VB both NNS and NNS , may VB VBN JJ NN ’ NN . RB NNP himself VBD about the JJ NNS of his NN NN in his JJ NN , VBG that the RBS JJ NN of NN NN might VB NN to VB to JJ . RB RB as NN VBD VBN , the NN of NN VBD RB RB VB the JJ NN of NNS to RB VB out the NNS . In the NN , NN — despite its JJ NN — VBD VBN VBG NNS . And RB , with a JJ NN , NNS VBD an RB JJ NN in the JJ NNS of the NN ’s JJ NN and VBD on . RB , it VBD NN , with the NN of NN , VBD VBN its NNS - JJ NN with NN . In NNP of 1980 , the NNP NNP NNP RB VBD , “ NNP VBZ JJ . ” The NN ’s NN VBZ JJ . As NN VBD from NN NNS , RB VBD it from the NNS of the NN . RB , NN VBD to the NN where it VBD RB JJ to VB NN ’s JJS JJ NN and VB the JJ NNS of the NN NN . But why RB VB NN NN VB ? The NN of NN VBD VBN VBN from the NN of the NN — whatever VBD in that NN , VB it VBN of NN or NN or NN VBD it RB VB ? But the NN of NN VBZ RB from RB . Although NN VBZ RB VBN , at JJS two NNS — one in NNP and one at NNP NN in NNP , NNP — RB VBP NNS of NN NN . And NNS of a JJ NN VBP RB beyond a JJ NN NN : JJ NN - NN NNS VBP VBN it JJ to VB a JJ NN from NN . RB JJR than RB , the NN of NN VBZ JJ . Since JJ NN NNS VBD RB four NNS RB , the JJ NN of the JJ JJ NN would VB RB JJ to an JJ NN . RB from 30 to 88 NN of NNS VBN to the NN can VB VBN , and RB a NN of those who VBP the NN will VB . It VBD RB in NNP of 2018 that the NNP VBD the JJ NN to VB NN . NN VBZ the JJ JJ NN at our NN — and if an NN VBD to VB , NNS of NNPS , VBG JJ NNS and NNS with NN or NN , would VB VBN from NN . VBG a JJ or VBN NN could VB , but VBG with the NN ’s VBN NNS of NN ( like those at the NNP or in NNP ) VBZ both JJ and RB JJ . VBG RB with a RBR JJ JJ NN could VB NNS RB and RB VB VB NN . RB if NNP VBD the NN that VBD off NN in the JJ NN , JJ NN should VB JJ — but RB , the NN VBZ NN . Some NNS VBP VBN NNS in that NN . In the NNS , a JJ NN of NNS VBD to RB RB VB the NN between the NN NN NN and NN . One NN VBD JJ to VB an VBG NN of NN between NN and an JJ JJ NN NN , RB VBN from NNP in the NNS . But this NN VBD but a NN on the JJ NN , and JJ NN VBD VBN in the NNS that VBD . JJ NNS in NN VBP VBN the NN , RB . NNS like NNP at the NNP , along with an JJ NN VBN by NN NNP NNP at the NNP of NNP , VBP VBN VBG JJ NN NNS from NNS and NNS from around the NN to VB the JJ NNS VBN within . With JJ NNS , NNS may VB JJ to VB NN NN RB in NN and RB VB the NN — or JJ , NNS — of these JJ NNS . The NN VBZ JJ , VBZ NNP , but he VBZ JJ that NN VBD the NN at some NN . His NN VBZ VBN 15 NN NNS and NN , JJS from the JJ NNS , and RB VBD a JJ NN of a 1902 NN that VBZ a VBG NN to NN . The NN VBZ JJ , VBZ NNP , but RB , these NNS VBP JJ NN that NN VBD a NN in NN NN NN . NNP VBZ these JJ NNS “ a NN in NN . ” NNP , for all his NN , VBD RB VBG in the NN . ( Although it VBZ JJ he VBD a JJ JJR NNS than the NN - VBN NN of his NN VBZ . ) He could RB RB VB VBN the NNS of NN as we VBP NN — but RB , NNP VBZ , we must VB NNS without VBG every JJ NN . RB , it VBZ NN to VB NN - up : NN RB VBZ the NN to VB the NNS to a JJ NN that RB VBZ to VB VBN . “ There VBZ NN RBR JJ to me , as a NN , than VBG a NN , ” NNP VBZ . “ I RB VBP to VB the NN . ” RB , NNP VBZ , RB if the NN VBZ RB VB JJ to VB from NN itself , NN of JJ NNS in the “ NN ” NN could RB VB JJ for NN for NNS and NN RB . JJ NNS VBP their JJ NN of NN , VBG NNS , NNS and RB NNS . JJ — though RB all — of these NNS VBP VBN VBN to VB JJ , VBG from NN into JJ NNS . VBG both NNS and NNS VBZ an JJ NN of the NNS in NN . VBG to NNP , RBR VBG the NN NN , RB to its JJ four - VBN NNS , may VB one of our RBS JJ NNS to VB an JJ NN of VBN NNS . What VBZ JJR , it VBZ JJ NNS VBP VBN VBG all the NNS that may VB us in the NN . “ Some NNS VBP we VBP VBN JJR than 1 NN of the VBG NNS in NN , ” VBZ NNP . “ NN VBZ VBN . But the NN VBZ JJ of NNS VBG to VB VBN . ” In the NN , the NN VBZ RB RB on the JJ NNS of NNS , NNS and their JJ NNS to the NN of NN — but NN VBD RB , well , the JJ NN of this NN . As the NN VBZ , RB , should we VB VBG the JJ NN from “ NNS ” to “ NNS ” ? RB RB RB , VBZ NNP . NNS and NNS , RB of the JJ NN they VBD , VBD RB an JJ NN of NNP ’s NN . NNP ’s NN VBZ JJ — for RB ."
220,634,mainstream,"Yellow_JJ fever_NN is_VBZ a_DT serious_JJ infection_NN spread_VBN by_IN mosquitoes_NNS ._. It_PRP 's_VBZ found_VBN in_IN parts_NNS of_IN Africa_NNP ,_, South_NNP America_NNP ,_, Central_NNP America_NNP and_CC Trinidad_NNP in_IN the_DT Caribbean_NNP ._. There_EX 's_VBZ a_DT vaccine_NN that_WDT can_MD stop_VB you_PRP getting_VBG yellow_JJ fever_NN if_IN you_PRP 're_VBP travelling_VBG to_IN an_DT area_NN where_WRB the_DT infection_NN is_VBZ found_VBN ._. The_DT yellow_JJ fever_NN vaccine_NN is_VBZ recommended_VBN if_IN you_PRP 're_VBP travelling_VBG to_IN :_: •_NFP an_DT area_NN where_WRB yellow_JJ fever_NN is_VBZ found_VBN •_, a_DT country_NN that_WDT requires_VBZ you_PRP to_TO have_VB a_DT certificate_NN proving_VBG you_PRP 've_VBP been_VBN vaccinated_VBN against_IN yellow_JJ fever_NN You_PRP need_VBP to_TO have_VB the_DT vaccine_NN at_IN least_JJS 10_CD days_NNS before_IN travelling_VBG to_TO give_VB it_PRP enough_JJ time_NN to_TO work_VB ._. Your_PRP$ certificate_NN will_MD only_RB be_VB valid_JJ after_IN this_DT time_NN ._. If_IN you_PRP or_CC your_PRP$ child_NN has_VBZ had_VBN the_DT MMR_NN vaccine_NN ,_, you_PRP or_CC they_PRP ideally_RB need_VBP to_TO wait_VB at_IN least_JJS 4_CD weeks_NNS before_IN having_VBG the_DT yellow_JJ fever_NN vaccine_NN ._. The_DT vaccine_NN and_CC certificate_NN are_VBP only_RB available_JJ from_IN registered_VBN yellow_JJ fever_NN vaccination_NN centres_NNS ._. The_DT jab_NN is_VBZ not_RB available_JJ for_IN free_JJ on_IN the_DT NHS_NNP so_IN you_PRP 'll_MD have_VB to_TO pay_VB for_IN it_PRP ._. It_PRP typically_RB costs_VBZ around_RB £_$ 60_CD to_IN £_$ 85_CD ._. The_DT vaccine_NN provides_VBZ lifelong_JJ protection_NN for_IN most_JJS travellers_NNS ,_, so_IN you_PRP will_MD not_RB normally_RB need_VB a_DT booster_NN dose_NN ._. Read_VB more_JJR about_IN the_DT yellow_JJ fever_NN vaccine_NN ._. •_NFP parts_NNS of_IN sub-Saharan_JJ Africa_NNP (_-LRB- the_DT area_NN below_IN the_DT Sahara_NNP desert_NN )_-RRB- It_PRP is_VBZ not_RB found_VBN in_IN the_DT UK_NNP ,_, Europe_NNP ,_, Asia_NNP ,_, Australia_NNP ,_, New_NNP Zealand_NNP or_CC the_DT Pacific_NNP Islands_NNPS ._. To_TO find_VB out_RP if_IN yellow_JJ fever_NN is_VBZ a_DT risk_NN where_WRB you_PRP 're_VBP travelling_VBG to_IN ,_, or_CC if_IN the_DT country_NN you_PRP 're_VBP visiting_VBG requires_VBZ a_DT vaccination_NN certificate_NN ,_, see_VB :_: •_SYM TravelHealthPro_NN :_: country_NN information_NN –_: click_VB on_IN the_DT vaccine_NN recommendation_NN tab_NN for_IN your_PRP$ destination_NN •_SYM TravelHealthPro_NN :_: maps_NNS of_IN where_WRB yellow_JJ fever_NN vaccine_NN is_VBZ recommended_VBN Yellow_JJ fever_NN is_VBZ a_DT virus_NN spread_VBN by_IN mosquito_NN bites_NNS ._. You_PRP can_MD not_RB get_VB it_PRP from_IN close_JJ contact_NN with_IN someone_NN who_WP has_VBZ it_PRP ._. The_DT mosquitoes_NNS that_WDT spread_VBP the_DT infection_NN are_VBP found_VBN in_IN towns_NNS ,_, cities_NNS and_CC rural_JJ areas_NNS ._. They_PRP mainly_RB bite_VBP during_IN the_DT day_NN ._. Mosquitoes_NNS can_MD also_RB spread_VB other_JJ serious_JJ illnesses_NNS ,_, such_JJ as_IN malaria_NN and_CC dengue_NN ._. If_IN you_PRP 're_VBP travelling_VBG to_IN an_DT area_NN where_WRB yellow_JJ fever_NN is_VBZ found_VBN ,_, try_VB to_TO avoid_VB being_VBG bitten_VBN ,_, even_RB if_IN you_PRP have_VBP been_VBN vaccinated_VBN ._. You_PRP can_MD do_VB this_DT by_IN using_VBG mosquito_NN nets_NNS ,_, wearing_VBG clothes_NNS that_WDT cover_VBP your_PRP$ arms_NNS and_CC legs_NNS ,_, and_CC using_VBG insect_NN repellent_NN containing_VBG 30_CD %_NN to_IN 50_CD %_NN DEET_NN (_-LRB- diethyltoluamide_NN )_-RRB- ._. Read_VB more_JJR about_IN how_WRB to_TO prevent_VB insect_NN bites_NNS ._. The_DT first_JJ symptoms_NNS of_IN yellow_JJ fever_NN usually_RB develop_VBP 3_CD to_IN 6_CD days_NNS after_IN being_VBG infected_VBN ._. •_NFP your_PRP$ eyes_NNS being_VBG sensitive_JJ to_IN light_NN Up_IN to_IN 1_CD in_IN 4_CD people_NNS go_VBP on_RP to_TO get_VB more_RBR serious_JJ symptoms_NNS ,_, such_JJ as_IN :_: •_SYM yellowing_NN of_IN the_DT skin_NN and_CC eyes_NNS (_-LRB- jaundice_NN )_-RRB- •_NFP bleeding_VBG from_IN the_DT mouth_NN ,_, nose_NN ,_, eyes_NNS or_CC ears_NNS When_WRB to_TO get_VB medical_JJ help_NN See_VB a_DT doctor_NN straight_RB away_RB if_IN you_PRP get_VBP symptoms_NNS of_IN yellow_JJ fever_NN while_IN travelling_VBG in_IN an_DT area_NN where_WRB the_DT infection_NN is_VBZ found_VBN ._. If_IN you_PRP get_VBP symptoms_NNS after_IN recently_RB returning_VBG from_IN one_CD of_IN these_DT areas_NNS ,_, contact_VB a_DT GP_NN or_CC NHS_NNP 111_CD for_IN advice_NN as_RB soon_RB as_IN possible_JJ ._. Tell_VB them_PRP exactly_RB where_WRB you_PRP have_VBP been_VBN travelling_VBG ,_, whether_IN you_PRP think_VBP you_PRP have_VBP been_VBN bitten_VBN by_IN a_DT mosquito_NN ,_, and_CC what_WDT symptoms_NNS you_PRP have_VBP ._. You_PRP may_MD need_VB to_TO have_VB a_DT blood_NN test_NN to_TO check_VB for_IN the_DT infection_NN ._.","JJ NN VBZ a JJ NN VBN by NNS . It VBZ VBN in NNS of NNP , NNP NNP , NNP NNP and NNP in the NNP . There VBZ a NN that can VB you VBG JJ NN if you VBP VBG to an NN where the NN VBZ VBN . The JJ NN NN VBZ VBN if you VBP VBG to : • an NN where JJ NN VBZ VBN • a NN that VBZ you to VB a NN VBG you VBP VBN VBN against JJ NN You VBP to VB the NN at JJS 10 NNS before VBG to VB it JJ NN to VB . Your NN will RB VB JJ after this NN . If you or your NN VBZ VBN the NN NN , you or they RB VBP to VB at JJS 4 NNS before VBG the JJ NN NN . The NN and NN VBP RB JJ from VBN JJ NN NN NNS . The NN VBZ RB JJ for JJ on the NNP so you 'll VB to VB for it . It RB VBZ RB £ 60 to £ 85 . The NN VBZ JJ NN for JJS NNS , so you will RB RB VB a NN NN . VB JJR about the JJ NN NN . • NNS of JJ NNP ( the NN below the NNP NN ) It VBZ RB VBN in the NNP , NNP , NNP , NNP , NNP NNP or the NNP NNPS . To VB out if JJ NN VBZ a NN where you VBP VBG to , or if the NN you VBP VBG VBZ a NN NN , VB : • NN : NN NN – VB on the NN NN NN for your NN • NN : NNS of where JJ NN NN VBZ VBN JJ NN VBZ a NN VBN by NN NNS . You can RB VB it from JJ NN with NN who VBZ it . The NNS that VBP the NN VBP VBN in NNS , NNS and JJ NNS . They RB VBP during the NN . NNS can RB VB JJ JJ NNS , JJ as NN and NN . If you VBP VBG to an NN where JJ NN VBZ VBN , VB to VB VBG VBN , RB if you VBP VBN VBN . You can VB this by VBG NN NNS , VBG NNS that VBP your NNS and NNS , and VBG NN NN VBG 30 NN to 50 NN NN ( NN ) . VB JJR about how to VB NN NNS . The JJ NNS of JJ NN RB VBP 3 to 6 NNS after VBG VBN . • your NNS VBG JJ to NN Up to 1 in 4 NNS VBP on to VB RBR JJ NNS , JJ as : • NN of the NN and NNS ( NN ) • VBG from the NN , NN , NNS or NNS When to VB JJ NN VB a NN RB RB if you VBP NNS of JJ NN while VBG in an NN where the NN VBZ VBN . If you VBP NNS after RB VBG from one of these NNS , VB a NN or NNP 111 for NN RB RB as JJ . VB them RB where you VBP VBN VBG , whether you VBP you VBP VBN VBN by a NN , and what NNS you VBP . You may VB to VB a NN NN to VB for the NN ."
221,316,conspiracy,"The_DT UK_NNP Government_NN is_VBZ seriously_RB considering_VBG new_JJ legislation_NN that_WDT would_MD ban_VB all_DT negative_JJ information_NN about_IN vaccines_NNS ,_, or_CC what_WP they_PRP describe_VBP as_IN ‘_`` anti-_JJ vaccine_NN ’_'' posts_NNS ._. Health_NNP Secretary_NNP Matt_NNP Hancock_NNP has_VBZ said_VBN Internet_NN companies_NNS like_IN Facebook_NNP ,_, Instagram_NNP and_CC Twitter_NNP have_VBP a_DT ‘_`` Duty_NN of_IN care_NN ’_'' and_CC if_IN they_PRP wo_MD n’t_RB censor_VB such_JJ material_NN ,_, then_RB legislation_NN would_MD ._. Disinformation_NN campaigns_NNS from_IN the_DT controversial_JJ anti-vax_NN movement_NN have_VBP plagued_VBN social_JJ media_NN firms_NNS in_IN recent_JJ years_NNS ,_, with_IN Facebook_NNP among_IN those_DT blamed_VBN for_IN helping_VBG fuel_VB the_DT misguided_VBN belief_NN in_IN scientifically_RB disproven_VBN claims_NNS that_IN vaccinations_NNS are_VBP harmful_JJ and_CC can_MD cause_VB autism_NN ._. The_DT issue_NN has_VBZ become_VBN so_RB severe_JJ that_IN several_JJ vaccine_NN -_HYPH preventable_JJ diseases_NNS like_IN measles_NNS have_VBP seen_VBN outbreaks_NNS in_IN areas_NNS where_WRB they_PRP were_VBD previously_RB almost_RB eliminated_VBN ._. The_DT Independent_NNP bizarrely_RB goes_VBZ onto_IN use_VB Charlie_NNP Sheen_NNP as_IN an_DT example_NN of_IN high_JJ profile_NN faces_NNS of_IN the_DT anti-vaccine_JJ movement_NN ,_, which_WDT is_VBZ a_DT ridiculous_JJ example_NN to_TO use_VB ,_, but_CC of_IN course_NN they_PRP were_VBD never_RB going_VBG to_TO use_VB someone_NN like_IN Del_NNP Bigtree_NNP who_WP provides_VBZ factual_JJ information_NN on_IN the_DT problems_NNS surrounding_VBG Vaccines_NNS ._. With_IN the_DT current_JJ situation_NN regarding_VBG the_DT Covid19_NNP coronavirus_NN this_DT latest_JJS move_NN is_VBZ particularly_RB worrying_VBG ._. Matt_NNP Hancock_NNP has_VBZ also_RB previously_RB said_VBN that_IN he_PRP ‘_`` Would_MD n’t_RB rule_VB out_RP mandatory_JJ vaccines_NNS ’_'' ._. We_PRP ’ll_MD keep_VB you_PRP posted_VBN as_IN this_DT develops_VBZ ._. •_NFP Social_JJ Distancing_NN Was_VBD Created_VBN by_IN the_DT CIA_NNP as_IN a_DT Torture_NNP Technique_NNP •_, UK_NNP Begins_VBZ to_TO Reopen_VB Its_PRP$ Newly_RB Created_VBN Dystopian_NNP Society_NNP to_IN The_DT Public_NN •_, Say_VB Hello_UH to_IN The_DT Next_JJ Possible_JJ Pandemic_NN •_SYM Biofields_NNS –_: Our_PRP$ Ability_NN to_TO Thrive_VB &_CC Prosper_NN is_VBZ Under_IN Attack_NN","The NNP NN VBZ RB VBG JJ NN that would VB all JJ NN about NNS , or what they VBP as ‘ JJ NN ’ NNS . NNP NNP NNP NNP VBZ VBN NN NNS like NNP , NNP and NNP VBP a ‘ NN of NN ’ and if they wo RB VB JJ NN , RB NN would . NN NNS from the JJ NN NN VBP VBN JJ NN NNS in JJ NNS , with NNP among those VBN for VBG VB the VBN NN in RB VBN NNS that NNS VBP JJ and can VB NN . The NN VBZ VBN RB JJ that JJ NN - JJ NNS like NNS VBP VBN NNS in NNS where they VBD RB RB VBN . The NNP RB VBZ onto VB NNP NNP as an NN of JJ NN NNS of the JJ NN , which VBZ a JJ NN to VB , but of NN they VBD RB VBG to VB NN like NNP NNP who VBZ JJ NN on the NNS VBG NNS . With the JJ NN VBG the NNP NN this JJS NN VBZ RB VBG . NNP NNP VBZ RB RB VBN that he ‘ Would RB VB out JJ NNS ’ . We ’ll VB you VBN as this VBZ . • JJ NN VBD VBN by the NNP as a NNP NNP • NNP VBZ to VB Its RB VBN NNP NNP to The NN • VB Hello to The JJ JJ NN • NNS – Our NN to VB & NN VBZ Under NN"
222,693,mainstream,"The_DT Vaccines_NNPS have_VBP shared_VBN an_DT unreleased_JJ demo_NN of_IN a_DT song_NN called_VBN ‘_`` I_PRP Never_RB Go_VBP Out_RP On_IN Fridays_NNPS ’_'' –_: listen_VB to_IN it_PRP below_RB ._. The_DT band_NN ,_, who_WP have_VBP been_VBN busy_JJ working_VBG on_IN the_DT follow_NN -_HYPH up_RP to_IN 2018_CD ’s_POS ‘_`` Combat_NNP Sports_NNPS ’_'' ,_, decided_VBD to_TO release_VB the_DT song_NN because_IN “_`` it_PRP ’s_VBZ recently_RB taken_VBN on_IN a_DT whole_JJ new_JJ meaning_NN ,_, ”_'' due_IN to_IN the_DT current_JJ coronavirus_NN crisis_NN ._. “_`` Made_VBD this_DT demo_NN a_DT couple_NN of_IN years_NNS ago_RB and_CC did_VBD n’t_RB think_VB it_PRP would_MD ever_RB surface_VB ,_, ”_'' the_DT band_NN shared_VBD in_IN a_DT message_NN ,_, “_'' but_CC it_PRP ’s_VBZ recently_RB taken_VBN on_IN a_DT whole_JJ new_JJ meaning_NN and_CC wanted_VBD to_TO share_VB because_IN we_PRP ’ve_VBP always_RB loved_VBN it_PRP !_. ”_'' They_PRP added_VBD :_: “_`` I_PRP guess_VBP we_PRP ’ll_MD all_DT see_VB the_DT light_NN of_IN day_NN in_IN time_NN ._. ”_'' Listen_VB to_IN ‘_`` I_PRP Never_RB Go_VBP Out_RP On_IN Fridays_NNPS ’_'' below_RB :_: Meanwhile_RB ,_, The_DT Vaccines_NNPS ’_POS Justin_NNP Young_NN has_VBZ discussed_VBN the_DT band_NN ’s_POS upcoming_JJ fifth_JJ album_NN ,_, teasing_VBG it_PRP as_IN “_`` heavier_JJR ”_'' and_CC “_`` face_NN -_HYPH melting_NN ._. ”_'' “_`` The_DT new_JJ Vaccines_NNPS album_NN is_VBZ heavier_JJR than_IN anything_NN we_PRP ’ve_VBP ever_RB done_VBN and_CC it_PRP ’s_VBZ quite_RB brutal_JJ in_IN places_NNS ,_, ”_'' he_PRP told_VBD NME_NNP ._. “_`` I_PRP ’m_VBP sure_JJ that_DT ’s_VBZ a_DT consequence_NN of_IN having_VBG made_VBN a_DT pretty_JJ record_NN ._. ”_'' When_WRB asked_VBN if_IN by_IN heavier_JJR he_PRP meant_VBD the_DT record_NN would_MD be_VB more_JJR punk_NN ,_, Young_NNP replied_VBD :_: “_`` There_EX ’s_VBZ lots_NNS of_IN riffs_NNS ._. Yeah_UH actually_RB ,_, there_EX ’s_VBZ two_CD punky_JJ songs_NNS on_IN there_RB ._. It_PRP ’s_VBZ weird_JJ ,_, it_PRP ’s_VBZ the_DT poppiest_JJS and_CC most_RBS colourful_JJ record_NN ,_, but_CC –_: actually_RB ,_, I_PRP ’m_VBP gonna_TO stop_VB myself_PRP there_RB ._. “_`` It_PRP just_RB feels_VBZ really_RB heavy_JJ ,_, it_PRP ’s_VBZ quite_RB face_NN -_HYPH melting_VBG in_IN places_NNS ._. Lots_NNS more_RBR screaming_VBG ._. It_PRP ’s_VBZ good_JJ ,_, I_PRP think_VBP ._. ”_''","The NNPS VBP VBN an JJ NN of a NN VBN ‘ I RB VBP Out On NNPS ’ – VB to it RB . The NN , who VBP VBN JJ VBG on the NN - up to 2018 ’s ‘ NNP NNPS ’ , VBD to VB the NN because “ it VBZ RB VBN on a JJ JJ NN , ” due to the JJ NN NN . “ VBD this NN a NN of NNS RB and VBD RB VB it would RB VB , ” the NN VBD in a NN , “ but it VBZ RB VBN on a JJ JJ NN and VBD to VB because we VBP RB VBN it ! ” They VBD : “ I VBP we ’ll all VB the NN of NN in NN . ” VB to ‘ I RB VBP Out On NNPS ’ RB : RB , The NNPS ’ NNP NN VBZ VBN the NN ’s JJ JJ NN , VBG it as “ JJR ” and “ NN - NN . ” “ The JJ NNPS NN VBZ JJR than NN we VBP RB VBN and it VBZ RB JJ in NNS , ” he VBD NNP . “ I VBP JJ that VBZ a NN of VBG VBN a JJ NN . ” When VBN if by JJR he VBD the NN would VB JJR NN , NNP VBD : “ There VBZ NNS of NNS . Yeah RB , there VBZ two JJ NNS on RB . It VBZ JJ , it VBZ the JJS and RBS JJ NN , but – RB , I VBP gonna VB myself RB . “ It RB VBZ RB JJ , it VBZ RB NN - VBG in NNS . NNS RBR VBG . It VBZ JJ , I VBP . ”"
223,937,mainstream,"Tokyo_NNP says_VBZ it_PRP expects_VBZ a_DT ""_`` large_JJ number_NN ""_'' of_IN new_JJ cases_NNS as_IN a_DT new_JJ cluster_NN surfaced_VBD at_IN an_DT office_NN in_IN Japan_NNP 's_POS capital_NN city_NN ._. Its_PRP$ governor_NN said_VBD clusters_NNS in_IN the_DT workplace_NN ""_`` have_VBP become_VBN a_DT big_JJ problem_NN lately_RB ._. ""_'' White_NNP House_NNP coronavirus_NN advisor_NN Dr._NNP Anthony_NNP Fauci_NNP told_VBD Congress_NNP Tuesday_NNP that_IN some_DT parts_NNS of_IN the_DT U.S._NNP are_VBP seeing_VBG a_DT ""_`` disturbing_JJ surge_NN ""_'' of_IN infections_NNS and_CC he_PRP 's_VBZ concerned_JJ about_IN the_DT increased_VBN community_NN spread_NN ._. Top_JJ officials_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, the_DT Food_NNP and_CC Drug_NNP Administration_NNP and_CC the_DT Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS are_VBP discussing_VBG what_WP each_DT agency_NN has_VBZ done_VBN in_IN response_NN to_IN the_DT coronavirus_NN outbreak_NN ._. The_DT coverage_NN on_IN this_DT live_JJ blog_NN has_VBZ ended_VBN —_: but_CC for_IN up_IN -_HYPH to_IN -_HYPH the_DT -_HYPH minute_NN coverage_NN on_IN the_DT coronavirus_NN ,_, visit_VB the_DT live_JJ blog_NN from_IN CNBC's_NNP U.S._NNP team_NN ._. •_SYM U.S._NNP cases_NNS :_: More_JJR than_IN 2.34_CD million_CD •_SYM U.S._NNP deaths_NNS :_: At_IN least_JJS 121,225_CD •_SYM The_DT data_NNS above_RB was_VBD compiled_VBN by_IN Johns_NNP Hopkins_NNP University_NNP ._. Germany_NNP faces_VBZ test_NN over_IN whether_IN it_PRP can_MD contain_VB major_JJ outbreaks_NNS 10:00_CD a.m._NN London_NNP time_NN :_: Germany_NNP has_VBZ reported_VBN a_DT further_JJ cluster_NN of_IN coronavirus_NN cases_NNS at_IN a_DT slaughterhouse_NN in_IN Lower_NNP Saxony_NNP on_IN Tuesday_NNP ,_, the_DT latest_JJS in_IN a_DT series_NN of_IN outbreaks_NNS seen_VBN in_IN the_DT country_NN ._. Now_RB ,_, containing_VBG the_DT potential_JJ spread_NN of_IN the_DT virus_NN is_VBZ a_DT top_JJ priority_NN for_IN Germany_NNP 's_POS authorities_NNS ,_, who_WP have_VBP so_RB far_RB attracted_VBN praise_NN for_IN their_PRP$ handling_NN of_IN the_DT epidemic_NN ._. ""_`` The_DT important_JJ thing_NN now_RB is_VBZ to_TO try_VB and_CC contain_VB this_DT outbreak_NN and_CC prevent_VB it_PRP from_IN entering_VBG the_DT general_JJ population_NN and_CC making_VBG it_PRP unstoppable_JJ ,_, ""_'' Thomas_NNP Kamradt_NNP ,_, president_NN of_IN the_DT German_NNP Society_NNP for_IN Immunology_NNP ,_, told_VBD CNBC_NNP Wednesday_NNP ._. Germany_NNP has_VBZ reported_VBN a_DT further_JJR outbreak_NN of_IN coronavirus_NN cases_NNS at_IN a_DT slaughterhouse_NN in_IN Lower_NNP Saxony_NNP ,_, the_DT latest_JJS in_IN a_DT series_NN of_IN infections_NNS that_WDT have_VBP been_VBN seen_VBN in_IN the_DT country_NN 's_POS meat_NN -_HYPH processing_NN industry_NN ._. German_JJ media_NN reported_VBD late_RB Tuesday_NNP that_IN the_DT factory_NN in_IN Wildeshausen_NNP is_VBZ the_DT latest_JJS meat_NN -_HYPH processing_NN plant_NN to_TO see_VB an_DT outbreak_NN of_IN the_DT virus_NN ,_, with_IN 23_CD workers_NNS testing_VBG positive_JJ ._. —_: Holly_NNP Ellyatt_NNP The_DT coronavirus_NN pandemic_NN could_MD drive_VB demand_NN for_IN copper_NN New_NNP York_NNP City_NNP opens_VBZ up_RP beaches_NNS for_IN swimming_VBG ahead_RB of_IN Independence_NNP Day_NNP weekend_NN Tokyo_NNP says_VBZ its_PRP expects_VBZ a_DT '_`` large_JJ number_NN '_'' of_IN new_JJ cases_NNS New_NNP York_NNP City_NNP will_MD hold_VB scattered_VBN July_NNP 4_CD fireworks_NNS shows_NNS this_DT year_NN Dr._NNP Fauci_NNP recommends_VBZ states_NNS seeing_VBG surges_NNS should_MD consider_VB pausing_VBG reopening_NN phases_NNS 2:59_CD p.m._NN ET_NN —_: Top_NN -_HYPH ranked_VBN tennis_NN player_NN Novak_NNP Djokovic_NNP apologized_VBD on_IN Twitter_NNP for_IN organizing_VBG a_DT tennis_NN exhibition_NN series_NN during_IN the_DT outbreak_NN ._. Djokovic_NNP and_CC his_PRP$ wife_NN tested_VBD positive_JJ for_IN the_DT coronavirus_NN after_IN attending_VBG the_DT tournament_NN ._. Djokovic_NNP said_VBD he_PRP and_CC other_JJ organizers_NNS believed_VBD health_NN protocols_NNS were_VBD met_VBN and_CC that_IN the_DT region_NN had_VBD combated_VBN the_DT virus_NN well_RB enough_RB to_TO gather_VB ,_, but_CC ""_`` we_PRP were_VBD wrong_JJ and_CC it_PRP was_VBD too_RB soon_RB ._. ""_'' The_DT Associated_NNP Press_NNP reported_VBD earlier_RBR Tuesday_NNP that_IN social_JJ distancing_NN was_VBD not_RB maintained_VBN ,_, as_IN players_NNS were_VBD seen_VBN hugging_VBG each_DT other_JJ ._. ""_`` I_PRP can't_MD express_VB how_WRB sorry_JJ I_PRP am_VBP for_IN this_DT and_CC for_IN every_DT case_NN on_IN infection_NN ,_, ""_'' Djokovic_NNP said_VBD in_IN an_DT apology_NN on_IN Twitter_NNP ._. The_DT Serbian_JJ player_NN caught_VBD criticism_NN for_IN holding_VBG the_DT series_NN amid_IN the_DT pandemic_NN ._. The_DT third_JJ stage_NN of_IN the_DT series_NN ,_, originally_RB planned_VBN for_IN next_JJ week_NN in_IN Bosnia_NNP ,_, was_VBD canceled_VBN ._. Djokovic_NNP encouraged_VBD anyone_NN who_WP attended_VBD the_DT series_NN to_TO get_VB tested_VBN for_IN the_DT virus_NN and_CC practice_VB social_JJ distancing_NN ._. He_PRP and_CC his_PRP$ wife_NN will_MD quarantine_VB for_IN five_CD days_NNS ._. —_NFP Alex_NNP Harring_NNP Fauci_NNP warns_VBZ of_IN serious_JJ symptoms_NNS in_IN young_JJ people_NNS ,_, disturbing_VBG surge_NN in_IN cases_NNS White_NNP House_NNP considers_VBZ shakeup_NN at_IN CDC_NNP over_IN botched_VBN Covid_NNP -_HYPH 19_CD response_NN ,_, report_NN says_VBZ U.S._NNP 7_CD -_HYPH day_NN average_NN of_IN coronavirus_NN cases_NNS surges_VBZ 30_CD %_NN from_IN week_NN ago_RB 1:40_CD p.m._NN ET_NN —_: The_DT seven_CD -_HYPH day_NN average_NN of_IN daily_JJ new_JJ Covid_NNP -_HYPH 19_CD cases_NNS increased_VBD more_JJR than_IN 30_CD %_NN compared_VBN with_IN a_DT week_NN ago_RB ,_, according_VBG to_IN a_DT CNBC_NNP analysis_NN of_IN Johns_NNP Hopkins_NNP University_NNP data_NNS ._. Cases_NNS are_VBP growing_VBG by_IN 5_CD %_NN or_CC more_JJR in_IN 26_CD states_NNS across_IN the_DT U.S._NNP ,_, including_VBG Arizona_NNP ,_, Texas_NNP ,_, Florida_NNP and_CC Montana_NNP ._. Texas_NNP added_VBD 4,846_CD new_JJ cases_NNS on_IN Monday_NNP bringing_VBG its_PRP$ seven_CD -_HYPH day_NN average_NN of_IN daily_JJ new_JJ cases_NNS to_IN 3,940_CD ,_, according_VBG to_IN Hopkins_NNP '_POS data_NN ._. The_DT state_NN has_VBZ seen_VBN more_JJR than_IN 100_CD %_NN increase_NN in_IN its_PRP$ seven_CD -_HYPH day_NN average_NN compared_VBN with_IN a_DT week_NN ago_RB ._. Arizona_NNP is_VBZ averaging_VBG about_RB 2,500_CD daily_JJ new_JJ cases_NNS as_IN of_IN Monday_NNP ,_, which_WDT is_VBZ about_RB a_DT 94_CD %_NN increase_NN since_IN one_CD week_NN ago_RB ._. California_NNP saw_VBD a_DT massive_JJ jump_NN in_IN its_PRP$ daily_JJ report_NN of_IN positive_JJ cases_NNS ,_, adding_VBG 6,219_CD new_JJ cases_NNS ,_, according_VBG to_IN Hopkins_NNP '_POS data_NN ._. This_DT new_JJ figure_NN broke_VBD its_PRP$ previous_JJ single_JJ -_HYPH day_NN record_NN of_IN 4,084_CD new_JJ confirmed_VBN cases_NNS from_IN last_JJ Thursday_NNP ,_, according_VBG to_IN the_DT California_NNP Department_NNP of_IN Health_NNP ._. Monday_NNP 's_POS number_NN reported_VBN by_IN county_NN health_NN departments_NNS across_IN the_DT state_NN includes_VBZ some_DT caveats_NNS as_IN some_DT counties_NNS report_VBP multiple_JJ -_HYPH day_NN totals_NNS after_IN not_RB updating_VBG their_PRP$ case_NN counts_NNS over_IN the_DT weekend_NN ._. —_: Jasmine_NNP Kim_NNP Sales_NNS of_IN newly_RB built_VBN homes_NNS show_VBP big_JJ increase_NN ,_, but_CC meeting_NN demand_NN is_VBZ a_DT challenge_NN Some_DT colleges_NNS cutting_VBG academic_JJ programs_NNS as_IN schools_NNS take_VBP financial_JJ hit_NN from_IN Covid_NNP -_HYPH 19_CD closures_NNS As_IN Trump_NNP blames_VBZ rising_VBG cases_NNS on_IN testing_NN ,_, data_NNS suggests_VBZ the_DT virus_NN is_VBZ spreading_VBG Better_JJR care_NN and_CC younger_JJR patients_NNS could_MD lower_VB the_DT mortality_NN rate_NN ,_, Dr._NNP Scott_NNP Gottlieb_NNP says_VBZ 11:26_CD a.m._NN ET_NN —_: As_IN the_DT coronavirus_NN appears_VBZ to_TO infect_VB mostly_RB younger_JJR people_NNS in_IN at_IN least_JJS some_DT states_NNS and_CC doctors_NNS learn_VBP to_TO provide_VB better_JJR care_NN for_IN Covid_NNP -_HYPH 19_CD patients_NNS ,_, the_DT mortality_NN rate_NN of_IN the_DT disease_NN will_MD likely_RB drop_VB in_IN the_DT weeks_NNS ahead_RB ,_, former_JJ Food_NNP and_CC Drug_NNP Administration_NNP Commissioner_NNP Dr._NNP Scott_NNP Gottlieb_NNP told_VBD CNBC_NNP ._. Young_JJ and_CC otherwise_RB healthy_JJ people_NNS are_VBP less_RBR likely_JJ to_TO die_VB of_IN Covid_NNP -_HYPH 19_CD ,_, according_VBG to_IN data_NNS compiled_VBN by_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ._. However_RB ,_, young_JJ people_NNS can_MD still_RB develop_VB severe_JJ disease_NN as_RB well_RB as_IN die_VB of_IN the_DT disease_NN and_CC scientists_NNS are_VBP still_RB researching_VBG the_DT long_JJ -_HYPH term_NN health_NN effects_NNS of_IN an_DT infection_NN ._. ""_`` As_IN the_DT hospitals_NNS fill_VBP up_RP with_IN Covid_NN patients_NNS ,_, we_PRP 're_VBP going_VBG to_TO see_VB how_WRB much_JJ the_DT mortality_NN rate_NN declines_VBZ as_IN a_DT function_NN of_IN it's_PRP$ a_DT younger_JJR cohort_NN ,_, younger_JJR age_NN cohort_NN ,_, but_CC also_RB we_PRP have_VBP better_JJR treatment_NN ,_, ""_'' Gottlieb_NNP said_VBD on_IN CNBC's_NNP ""_`` Squawk_NNP Box_NN ._. ""_'' ""_`` There_EX 's_VBZ no_DT question_NN that_IN we_PRP 're_VBP going_VBG to_TO preserve_VB more_JJR life_NN now_RB that_IN we_PRP have_VBP these_DT therapeutic_JJ opportunities_NNS available_JJ to_IN us_PRP ._. ""_'' —_: Will_MD Feuer_NNP 10:01_CD a.m._NN ET_NN —_: Major_JJ U.S._NNP airlines_NNS now_RB require_VBP passengers_NNS to_TO wear_VB masks_NNS on_IN board_NN in_IN an_DT effort_NN to_TO curb_VB the_DT spread_NN of_IN Covid_NNP -_HYPH 19_CD ,_, but_CC enforcing_VBG it_PRP is_VBZ tricky_JJ without_IN a_DT government_NN mandate_NN ,_, Delta_NNP Air_NNP Lines_NNP '_POS CEO_NN Ed_NNP Bastian_NNP said_VBD ._. Right_RB now_RB ,_, the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP recommends_VBZ facial_JJ coverings_NNS like_IN masks_NNS in_IN places_NNS where_WRB it_PRP is_VBZ difficult_JJ to_TO socially_RB distance_NN ,_, such_JJ as_IN on_IN airplanes_NNS ._. ""_`` If_IN you_PRP take_VBP your_PRP$ mask_NN off_RP ,_, no_UH ..._, we_PRP will_MD not_RB forcibly_RB remove_VB you_PRP from_IN the_DT plane_NN ,_, ""_'' Bastian_NNP told_VBD Axios_NNP in_IN an_DT interview_NN that_WDT aired_VBD Monday_NNP night_NN ._. ""_`` If_IN the_DT government_NN were_VBD to_TO mandate_VB it_PRP I_PRP think_VBP that_DT would_MD help_VB ._. If_IN the_DT government_NN mandated_VBD it_PRP then_RB you_PRP can_MD enforce_VB it_PRP ._. ""_'' The_DT government_NN has_VBZ ""_`` left_VBN it_PRP to_IN the_DT airlines_NNS to_TO make_VB those_DT decisions_NNS ._. ""_'' Last_JJ week_NN ,_, American_NNP Airlines_NNPS said_VBD it_PRP is_VBZ temporarily_RB banning_VBG a_DT passenger_NN who_WP refused_VBD to_TO wear_VB a_DT mask_NN ,_, saying_VBG he_PRP can_MD return_VB when_WRB those_DT face_NN coverings_NNS are_VBP no_RB longer_RBR required_VBN on_IN flights_NNS ._. —_: Leslie_NNP Josephs_NNP University_NNP of_IN Michigan_NNP pulls_VBZ out_IN of_IN hosting_VBG presidential_JJ debate_NN ,_, citing_VBG health_NN concerns_NNS Daily_JJ new_JJ cases_NNS in_IN the_DT U.S._NNP trend_NN upward_RB Sanofi_NNP CEO_NN says_VBZ the_DT company_NN could_MD contribute_VB two_CD successful_JJ coronavirus_NN vaccines_NNS 8:56_CD a.m._NN ET_NN —_: Sanofi_NNP CEO_NN Paul_NNP Hudson_NNP told_VBD CNBC_NNP both_DT of_IN the_DT French_JJ drugmaker_NN 's_POS vaccine_NN pursuits_NNS could_MD be_VB successful_JJ in_IN preventing_VBG Covid_NNP -_HYPH 19_CD ._. ""_`` The_DT world_NN needs_VBZ billions_NNS of_IN doses_NNS ._. We_PRP want_VBP to_TO make_VB sure_JJ every_DT country_NN ,_, everybody_NN that_WDT needs_VBZ that_DT protection_NN ,_, can_MD get_VB it_PRP ,_, ""_'' Hudson_NNP said_VBD on_IN ""_`` Squawk_NNP Box_NN ._. ""_'' ""_`` We_PRP think_VBP we_PRP 'll_MD definitely_RB play_VB a_DT part_NN with_IN one_CD ,_, and_CC maybe_RB even_RB both_DT of_IN our_PRP$ vaccines_NNS ._. ""_'' Hudson_NNP 's_POS comments_NNS come_VBP after_IN Sanofi_NNP announced_VBD a_DT potential_JJ $_$ 2_CD billion_CD deal_NN with_IN U.S._NNP biotech_NN firm_NN Translate_NNP Bio_NNP to_TO develop_VB a_DT Covid_NNP -_HYPH 19_CD vaccine_NN ._. Sanofi_NNP has_VBZ already_RB entered_VBN a_DT vaccine_NN partnership_NN with_IN GlaxoSmithKline_NNP ,_, a_DT British_JJ pharmaceutical_JJ company_NN ._. Hudson_NNP touted_VBD Translate_NNP Bio's_NNP experience_NN working_VBG on_IN therapeutics_NNS using_VBG mRNA_NN technology_NN ,_, which_WDT tells_VBZ human_JJ cells_NNS to_TO produce_VB specified_VBN proteins_NNS in_IN order_NN to_TO produce_VB an_DT immune_JJ response_NN to_IN a_DT particular_JJ disease_NN ._. The_DT vaccine_NN candidate_NN from_IN Sanofi_NNP and_CC Translate_NNP Bio_NNP could_MD be_VB ready_JJ ""_`` later_RBR in_IN 2021_CD ,_, ""_'' Hudson_NNP said_VBD ._. ""_`` One_CD of_IN the_DT reasons_NNS why_WRB we_PRP went_VBD deeper_RBR into_IN this_DT collaboration_NN was_VBD because_IN they_PRP 've_VBP been_VBN on_IN mRNA_NN for_IN 10_CD years_NNS ._. They_PRP know_VBP how_WRB it_PRP make_VBP it_PRP scaled_VBN ,_, which_WDT has_VBZ never_RB been_VBN done_VBN before_RB with_IN any_DT other_JJ company_NN ._. Once_IN we_PRP 've_VBP cracked_VBN it_PRP ,_, which_WDT we_PRP think_VBP we_PRP will_MD ,_, we_PRP 'll_MD be_VB able_JJ to_TO get_VB to_IN large_JJ volumes_NNS very_RB quickly_RB ,_, ""_'' he_PRP said_VBD ._. —_NFP Kevin_NNP Stankiewicz_NNP England_NNP pubs_NNS ,_, restaurants_NNS and_CC hotels_NNS to_TO reopen_VB on_IN July_NNP 4_CD German_JJ district_NN goes_VBZ back_RB into_IN lockdown_NN after_IN outbreak_NN at_IN meat_NN processing_NN plant_NN 7:13_CD a.m._NN ET_NN —_: A_DT district_NN in_IN Germany_NNP that_WDT has_VBZ seen_VBN an_DT acute_JJ outbreak_NN of_IN coronavirus_NN cases_NNS at_IN a_DT meat_NN -_HYPH processing_NN plant_NN is_VBZ being_VBG put_VBN back_RB into_IN lockdown_NN ,_, the_DT premier_NN of_IN North_NNP Rhine_NNP -_HYPH Westfalia_NNP said_VBD ._. State_NN premier_NN Armin_NNP Laschet_NNP said_VBD he_PRP was_VBD putting_VBG the_DT district_NN of_IN Guetersloh_NNP ,_, home_NN to_IN around_RB 360,000_CD people_NNS ,_, back_RB under_IN lockdown_NN until_IN June_NNP 30_CD ._. The_DT move_NN comes_VBZ after_IN at_IN least_JJS 1,000_CD workers_NNS at_IN a_DT meat_NN processing_NN plant_NN in_IN the_DT area_NN contracted_VBD Covid_NNP -_HYPH 19_CD ._. Germany_NNP has_VBZ been_VBN lauded_VBN throughout_IN the_DT coronavirus_NN crisis_NN in_IN Europe_NNP as_IN a_DT country_NN that_WDT had_VBD seemingly_RB managed_VBN to_TO control_VB the_DT virus_NN '_POS spread_NN ,_, largely_RB through_IN an_DT organized_VBN and_CC early_JJ contact_NN tracing_NN system_NN ._. Now_RB ,_, however_RB ,_, the_DT country_NN has_VBZ seen_VBN a_DT resurgence_NN of_IN cases_NNS due_IN to_IN several_JJ localized_VBN outbreaks_NNS in_IN different_JJ parts_NNS of_IN the_DT country_NN ._. As_RB well_RB as_IN the_DT outbreak_NN in_IN Guetersloh_NNP ,_, a_DT large_JJ Covid_NNP -_HYPH 19_CD outbreak_NN in_IN the_DT district_NN of_IN Goettingen_NNP in_IN Lower_NNP Saxony_NNP was_VBD traced_VBN to_IN family_NN gatherings_NNS and_CC another_DT ,_, in_IN Magdeburg_NNP in_IN the_DT state_NN of_IN Saxony_NNP -_HYPH Anhalt_NNP ,_, emerged_VBD in_IN several_JJ schools_NNS that_WDT are_VBP now_RB closed_VBN ._. In_IN Berlin_NNP ,_, an_DT outbreak_NN of_IN 85_CD cases_NNS has_VBZ been_VBN linked_VBN to_IN members_NNS of_IN a_DT religious_JJ community_NN ._. —_: Holly_NNP Ellyatt_NNP AstraZeneca_NNP 's_POS potential_JJ vaccine_NN shows_VBZ promise_NN in_IN pigs_NNS with_IN two_CD shots_NNS 7:03_CD a.m._NN ET_NN —_: AstraZeneca_NNP 's_POS potential_JJ coronavirus_NN vaccine_NN showed_VBD some_DT promise_NN in_IN a_DT trial_NN of_IN pigs_NNS ,_, which_WDT found_VBD that_IN two_CD doses_NNS of_IN the_DT shot_NN produced_VBD more_JJR antibodies_NNS than_IN one_CD dose_NN ._. The_DT research_NN ,_, which_WDT was_VBD published_VBN by_IN The_DT Pirbright_NNP Institute_NNP ,_, suggests_VBZ that_IN a_DT two_CD -_HYPH shot_NN approach_NN of_IN the_DT Oxford_NNP University_NNP -_HYPH developed_VBN vaccine_NN candidate_NN might_MD be_VB most_RBS effective_JJ in_IN preventing_VBG Covid_NNP -_HYPH 19_CD infection_NN ._. ""_`` The_DT researchers_NNS saw_VBD a_DT marked_VBN increase_NN in_IN neutralizing_VBG antibodies_NNS ,_, which_WDT bind_VBP to_IN the_DT virus_NN in_IN a_DT way_NN that_WDT blocks_VBZ infection_NN ,_, ""_'' the_DT Pirbright_NNP team_NN said_VBD in_IN a_DT statement_NN ._. However_RB ,_, the_DT potential_JJ vaccine_NN still_RB must_MD prove_VB it_PRP 's_VBZ safe_JJ and_CC effective_JJ in_IN humans_NNS as_RB well_RB ._. The_DT potential_JJ vaccine_NN ,_, also_RB known_VBN as_IN AZD1222_NNP ,_, is_VBZ being_VBG developed_VBN in_IN partnership_NN between_IN researchers_NNS at_IN Oxford_NNP University_NNP and_CC pharmaceutical_JJ company_NN AstraZeneca_NNP ._. The_DT candidate_NN is_VBZ already_RB in_IN human_JJ trials_NNS and_CC the_DT company_NN previously_RB said_VBD it_PRP hopes_VBZ to_TO have_VB data_NNS on_IN whether_IN it_PRP 's_VBZ effective_JJ in_IN preventing_VBG Covid_NNP -_HYPH 19_CD later_RBR this_DT year_NN ._. —_: Will_MD Feuer_NNP Read_VB CNBC_NNP 's_POS previous_JJ coronavirus_NN live_JJ coverage_NN here_RB :_: Chinese_JJ firm_NN gets_VBZ approval_NN for_IN potential_JJ vaccine_NN trials_NNS ;_, euro_NN zone_NN downturn_NN eases_VBZ","NNP VBZ it VBZ a "" JJ NN "" of JJ NNS as a JJ NN VBD at an NN in NNP 's NN NN . Its NN VBD NNS in the NN "" VBP VBN a JJ NN RB . "" NNP NNP NN NN NNP NNP NNP VBD NNP NNP that some NNS of the NNP VBP VBG a "" JJ NN "" of NNS and he VBZ JJ about the VBN NN NN . JJ NNS from the NNPS for NNP NNP and NNP , the NNP and NNP NNP and the NNP of NNP and NNP NNPS VBP VBG what each NN VBZ VBN in NN to the NN NN . The NN on this JJ NN VBZ VBN — but for up - to - the - NN NN on the NN , VB the JJ NN from NNP NNP NN . • NNP NNS : JJR than 2.34 million • NNP NNS : At JJS 121,225 • The NNS RB VBD VBN by NNP NNP NNP . NNP VBZ NN over whether it can VB JJ NNS 10:00 NN NNP NN : NNP VBZ VBN a JJ NN of NN NNS at a NN in NNP NNP on NNP , the JJS in a NN of NNS VBN in the NN . RB , VBG the JJ NN of the NN VBZ a JJ NN for NNP 's NNS , who VBP RB RB VBN NN for their NN of the NN . "" The JJ NN RB VBZ to VB and VB this NN and VB it from VBG the JJ NN and VBG it JJ , "" NNP NNP , NN of the NNP NNP for NNP , VBD NNP NNP . NNP VBZ VBN a JJR NN of NN NNS at a NN in NNP NNP , the JJS in a NN of NNS that VBP VBN VBN in the NN 's NN - NN NN . JJ NN VBD RB NNP that the NN in NNP VBZ the JJS NN - NN NN to VB an NN of the NN , with 23 NNS VBG JJ . — NNP NNP The NN NN could VB NN for NN NNP NNP NNP VBZ up NNS for VBG RB of NNP NNP NN NNP VBZ its VBZ a ' JJ NN ' of JJ NNS NNP NNP NNP will VB VBN NNP 4 NNS NNS this NN NNP NNP VBZ NNS VBG NNS should VB VBG NN NNS 2:59 NN NN — NN - VBN NN NN NNP NNP VBD on NNP for VBG a NN NN NN during the NN . NNP and his NN VBD JJ for the NN after VBG the NN . NNP VBD he and JJ NNS VBD NN NNS VBD VBN and that the NN VBD VBN the NN RB RB to VB , but "" we VBD JJ and it VBD RB RB . "" The NNP NNP VBD RBR NNP that JJ NN VBD RB VBN , as NNS VBD VBN VBG each JJ . "" I can't VB how JJ I VBP for this and for every NN on NN , "" NNP VBD in an NN on NNP . The JJ NN VBD NN for VBG the NN amid the NN . The JJ NN of the NN , RB VBN for JJ NN in NNP , VBD VBN . NNP VBD NN who VBD the NN to VB VBN for the NN and VB JJ NN . He and his NN will VB for five NNS . — NNP NNP NNP VBZ of JJ NNS in JJ NNS , VBG NN in NNS NNP NNP VBZ NN at NNP over VBN NNP - 19 NN , NN VBZ NNP 7 - NN NN of NN NNS VBZ 30 NN from NN RB 1:40 NN NN — The seven - NN NN of JJ JJ NNP - 19 NNS VBD JJR than 30 NN VBN with a NN RB , VBG to a NNP NN of NNP NNP NNP NNS . NNS VBP VBG by 5 NN or JJR in 26 NNS across the NNP , VBG NNP , NNP , NNP and NNP . NNP VBD 4,846 JJ NNS on NNP VBG its seven - NN NN of JJ JJ NNS to 3,940 , VBG to NNP ' NN . The NN VBZ VBN JJR than 100 NN NN in its seven - NN NN VBN with a NN RB . NNP VBZ VBG RB 2,500 JJ JJ NNS as of NNP , which VBZ RB a 94 NN NN since one NN RB . NNP VBD a JJ NN in its JJ NN of JJ NNS , VBG 6,219 JJ NNS , VBG to NNP ' NN . This JJ NN VBD its JJ JJ - NN NN of 4,084 JJ VBN NNS from JJ NNP , VBG to the NNP NNP of NNP . NNP 's NN VBN by NN NN NNS across the NN VBZ some NNS as some NNS VBP JJ - NN NNS after RB VBG their NN NNS over the NN . — NNP NNP NNS of RB VBN NNS VBP JJ NN , but NN NN VBZ a NN Some NNS VBG JJ NNS as NNS VBP JJ NN from NNP - 19 NNS As NNP VBZ VBG NNS on NN , NNS VBZ the NN VBZ VBG JJR NN and JJR NNS could VB the NN NN , NNP NNP NNP VBZ 11:26 NN NN — As the NN VBZ to VB RB JJR NNS in at JJS some NNS and NNS VBP to VB JJR NN for NNP - 19 NNS , the NN NN of the NN will RB VB in the NNS RB , JJ NNP and NNP NNP NNP NNP NNP NNP VBD NNP . JJ and RB JJ NNS VBP RBR JJ to VB of NNP - 19 , VBG to NNS VBN by the NNPS for NNP NNP and NNP . RB , JJ NNS can RB VB JJ NN RB RB as VB of the NN and NNS VBP RB VBG the JJ - NN NN NNS of an NN . "" As the NNS VBP up with NN NNS , we VBP VBG to VB how JJ the NN NN VBZ as a NN of it's a JJR NN , JJR NN NN , but RB we VBP JJR NN , "" NNP VBD on NNP "" NNP NN . "" "" There VBZ no NN that we VBP VBG to VB JJR NN RB that we VBP these JJ NNS JJ to us . "" — Will NNP 10:01 NN NN — JJ NNP NNS RB VBP NNS to VB NNS on NN in an NN to VB the NN of NNP - 19 , but VBG it VBZ JJ without a NN NN , NNP NNP NNP ' NN NNP NNP VBD . RB RB , the NNPS for NNP NNP and NNP VBZ JJ NNS like NNS in NNS where it VBZ JJ to RB NN , JJ as on NNS . "" If you VBP your NN off , no ... we will RB RB VB you from the NN , "" NNP VBD NNP in an NN that VBD NNP NN . "" If the NN VBD to VB it I VBP that would VB . If the NN VBD it RB you can VB it . "" The NN VBZ "" VBN it to the NNS to VB those NNS . "" JJ NN , NNP NNPS VBD it VBZ RB VBG a NN who VBD to VB a NN , VBG he can VB when those NN NNS VBP RB RBR VBN on NNS . — NNP NNP NNP of NNP VBZ out of VBG JJ NN , VBG NN NNS JJ JJ NNS in the NNP NN RB NNP NN VBZ the NN could VB two JJ NN NNS 8:56 NN NN — NNP NN NNP NNP VBD NNP both of the JJ NN 's NN NNS could VB JJ in VBG NNP - 19 . "" The NN VBZ NNS of NNS . We VBP to VB JJ every NN , NN that VBZ that NN , can VB it , "" NNP VBD on "" NNP NN . "" "" We VBP we 'll RB VB a NN with one , and RB RB both of our NNS . "" NNP 's NNS VBP after NNP VBD a JJ $ 2 billion NN with NNP NN NN NNP NNP to VB a NNP - 19 NN . NNP VBZ RB VBN a NN NN with NNP , a JJ JJ NN . NNP VBD NNP NNP NN VBG on NNS VBG NN NN , which VBZ JJ NNS to VB VBN NNS in NN to VB an JJ NN to a JJ NN . The NN NN from NNP and NNP NNP could VB JJ "" RBR in 2021 , "" NNP VBD . "" One of the NNS why we VBD RBR into this NN VBD because they VBP VBN on NN for 10 NNS . They VBP how it VBP it VBN , which VBZ RB VBN VBN RB with any JJ NN . Once we VBP VBN it , which we VBP we will , we 'll VB JJ to VB to JJ NNS RB RB , "" he VBD . — NNP NNP NNP NNS , NNS and NNS to VB on NNP 4 JJ NN VBZ RB into NN after NN at NN NN NN 7:13 NN NN — A NN in NNP that VBZ VBN an JJ NN of NN NNS at a NN - NN NN VBZ VBG VBN RB into NN , the NN of NNP NNP - NNP VBD . NN NN NNP NNP VBD he VBD VBG the NN of NNP , NN to RB 360,000 NNS , RB under NN until NNP 30 . The NN VBZ after at JJS 1,000 NNS at a NN NN NN in the NN VBD NNP - 19 . NNP VBZ VBN VBN throughout the NN NN in NNP as a NN that VBD RB VBN to VB the NN ' NN , RB through an VBN and JJ NN NN NN . RB , RB , the NN VBZ VBN a NN of NNS due to JJ VBN NNS in JJ NNS of the NN . RB RB as the NN in NNP , a JJ NNP - 19 NN in the NN of NNP in NNP NNP VBD VBN to NN NNS and another , in NNP in the NN of NNP - NNP , VBD in JJ NNS that VBP RB VBN . In NNP , an NN of 85 NNS VBZ VBN VBN to NNS of a JJ NN . — NNP NNP NNP 's JJ NN VBZ NN in NNS with two NNS 7:03 NN NN — NNP 's JJ NN NN VBD some NN in a NN of NNS , which VBD that two NNS of the NN VBD JJR NNS than one NN . The NN , which VBD VBN by The NNP NNP , VBZ that a two - NN NN of the NNP NNP - VBN NN NN might VB RBS JJ in VBG NNP - 19 NN . "" The NNS VBD a VBN NN in VBG NNS , which VBP to the NN in a NN that VBZ NN , "" the NNP NN VBD in a NN . RB , the JJ NN RB must VB it VBZ JJ and JJ in NNS RB RB . The JJ NN , RB VBN as NNP , VBZ VBG VBN in NN between NNS at NNP NNP and JJ NN NNP . The NN VBZ RB in JJ NNS and the NN RB VBD it VBZ to VB NNS on whether it VBZ JJ in VBG NNP - 19 RBR this NN . — Will NNP VB NNP 's JJ NN JJ NN RB : JJ NN VBZ NN for JJ NN NNS ; NN NN NN VBZ"
224,1240,conspiracy,"People_NNS of_IN goodwill_NN can_MD disagree_VB about_IN the_DT safety_NN ,_, efficacy_NN and_CC religious_JJ implications_NNS of_IN a_DT new_JJ vaccine_NN for_IN the_DT coronavirus_NN ._. But_CC ,_, everyone_NN should_MD agree_VB on_IN this_DT point_NN :_: No_DT government_NN can_MD force_VB anyone_NN who_WP has_VBZ reached_VBN legal_JJ adulthood_NN to_TO be_VB vaccinated_VBN for_IN the_DT coronavirus_NN [_-LRB- we_PRP are_VBP protected_VBN by_IN the_DT Nuremberg_NNP Code_NNP ]_-RRB- ._. Equally_RB ,_, no_DT government_NN can_MD vaccinate_VB minors_NNS for_IN the_DT coronavirus_NN against_IN the_DT will_NN of_IN their_PRP$ parents_NNS or_CC guardians_NNS ._. Please_UH SIGN_VB this_DT urgent_JJ petition_NN which_WDT urges_VBZ policymakers_NNS at_IN every_DT level_NN of_IN government_NN to_TO reject_VB calls_NNS for_IN mandatory_JJ coronavirus_NN vaccination_NN ._. Fear_NN of_IN a_DT disease_NN –_: which_WDT we_PRP know_VBP very_RB little_RB about_IN ,_, relative_JJ to_IN other_JJ similar_JJ diseases_NNS –_: must_MD not_RB lead_VB to_IN knee_NN -_HYPH jerk_NN reactions_NNS regarding_VBG public_JJ health_NN ,_, nor_CC can_MD it_PRP justify_VB supporting_VBG the_DT hidden_VBN agenda_NN of_IN governmental_JJ as_RB well_RB as_IN non-governmental_JJ bodies_NNS that_WDT have_VBP apparent_JJ conflicts_NNS of_IN interest_NN in_IN plans_NNS to_TO restrict_VB personal_JJ freedoms_NNS ._. The_DT so_RB -_HYPH called_VBN “_`` public_JJ health_NN experts_NNS ”_'' have_VBP gotten_VBN it_PRP wrong_JJ many_JJ times_NNS during_IN the_DT current_JJ crisis_NN ._. We_PRP should_MD not_RB ,_, therefore_RB ,_, allow_VB their_PRP$ opinions_NNS to_TO rush_VB decision_NN -_HYPH makers_NNS into_IN policies_NNS regarding_VBG vaccination_NN ._. And_CC ,_, while_IN some_DT people_NNS ,_, like_IN Bill_NNP Gates_NNP ,_, may_MD have_VB a_DT lot_NN of_IN money_NN ,_, his_PRP$ opinion_NN and_CC that_DT of_IN his_PRP$ NGO_NNP (_-LRB- the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP )_-RRB- –_: namely_RB ,_, that_IN life_NN will_MD not_RB return_VB to_IN normal_JJ till_IN people_NNS are_VBP widely_RB vaccinated_VBN –_: should_MD not_RB be_VB permitted_VBN to_TO influence_VB policy_NN decisions_NNS on_IN a_DT coronavirus_NN vaccination_NN program_NN ._. Finally_RB ,_, we_PRP must_MD also_RB not_RB allow_VB the_DT rush_NN by_IN pharmaceutical_JJ companies_NNS to_TO produce_VB a_DT new_JJ coronavirus_NN vaccine_NN to_TO ,_, itself_PRP ,_, become_VB an_DT imperative_NN for_IN vaccination_NN ._. Unwitting_JJ citizens_NNS must_MD not_RB be_VB used_VBN as_IN guinea_NN pigs_NNS for_IN New_NNP World_NNP Order_NNP ideologues_NNS ,_, or_CC Big_NNP Pharma_NNP ,_, in_IN pursuit_NN of_IN a_DT vaccine_NN (_-LRB- and_CC ,_, profits_NNS )_-RRB- which_WDT may_MD not_RB even_RB protect_VB against_IN future_JJ mutated_VBN strains_NNS of_IN the_DT coronavirus_NN ._. And_CC it_PRP goes_VBZ without_IN saying_VBG that_IN the_DT production_NN of_IN vaccines_NNS using_VBG aborted_VBN babies_NNS for_IN cell_NN replication_NN is_VBZ a_DT total_JJ non-starter_NN ,_, as_IN the_DT technique_NN is_VBZ gravely_RB immoral_JJ ._. However_RB ,_, if_IN after_IN sufficient_JJ study_NN of_IN the_DT issue_NN ,_, a_DT person_NN who_WP has_VBZ reached_VBN the_DT age_NN of_IN majority_NN wishes_VBZ to_TO be_VB vaccinated_VBN with_IN a_DT morally_RB produced_VBN vaccine_NN ,_, along_IN with_IN his_PRP$ children_NNS ,_, that_DT is_VBZ his_PRP$ business_NN ._. But_CC we_PRP cannot_MD and_CC will_MD not_RB permit_VB the_DT government_NN to_TO make_VB that_DT decision_NN for_IN us_PRP ._. Thank_VBP you_PRP for_IN SIGNING_NN and_CC SHARING_VBG this_DT petition_NN ,_, urging_VBG policymakers_NNS at_IN all_DT levels_NNS of_IN government_NN to_TO reject_VB mandatory_JJ coronavirus_NN vaccination_NN ._. Please_UH follow_VB THIS_DT LINK_NN and_CC SIGN_VB the_DT petition_NN ._.","NNS of NN can VB about the NN , NN and JJ NNS of a JJ NN for the NN . But , NN should VB on this NN : No NN can VB NN who VBZ VBN JJ NN to VB VBN for the NN [ we VBP VBN by the NNP NNP ] . RB , no NN can VB NNS for the NN against the NN of their NNS or NNS . Please VB this JJ NN which VBZ NNS at every NN of NN to VB NNS for JJ NN NN . NN of a NN – which we VBP RB RB about , JJ to JJ JJ NNS – must RB VB to NN - NN NNS VBG JJ NN , nor can it VB VBG the VBN NN of JJ RB RB as JJ NNS that VBP JJ NNS of NN in NNS to VB JJ NNS . The RB - VBN “ JJ NN NNS ” VBP VBN it JJ JJ NNS during the JJ NN . We should RB , RB , VB their NNS to VB NN - NNS into NNS VBG NN . And , while some NNS , like NNP NNP , may VB a NN of NN , his NN and that of his NNP ( the NNP & NNP NNP NNP ) – RB , that NN will RB VB to JJ till NNS VBP RB VBN – should RB VB VBN to VB NN NNS on a NN NN NN . RB , we must RB RB VB the NN by JJ NNS to VB a JJ NN NN to , itself , VB an NN for NN . JJ NNS must RB VB VBN as NN NNS for NNP NNP NNP NNS , or NNP NNP , in NN of a NN ( and , NNS ) which may RB RB VB against JJ VBN NNS of the NN . And it VBZ without VBG that the NN of NNS VBG VBN NNS for NN NN VBZ a JJ NN , as the NN VBZ RB JJ . RB , if after JJ NN of the NN , a NN who VBZ VBN the NN of NN VBZ to VB VBN with a RB VBN NN , along with his NNS , that VBZ his NN . But we cannot and will RB VB the NN to VB that NN for us . VBP you for NN and VBG this NN , VBG NNS at all NNS of NN to VB JJ NN NN . Please VB THIS NN and VB the NN ."
225,219,mainstream,"The_DT meningococcal_JJ vaccine_NN protects_VBZ you_PRP from_IN four_CD types_NNS of_IN bacteria_NN that_WDT cause_VBP meningococcal_JJ disease_NN ._. This_DT illness_NN can_MD cause_VB meningitis_NN ,_, an_DT infection_NN of_IN the_DT lining_NN around_IN the_DT brain_NN or_CC spinal_JJ cord_NN ._. It_PRP can_MD also_RB cause_VB a_DT blood_NN infection_NN (_-LRB- meningococcal_JJ bacteremia_NN )_-RRB- ,_, pneumonia_NN ,_, and_CC other_JJ problems_NNS ._. Ten_CD percent_NN to_IN 15_CD %_NN of_IN people_NNS who_WP are_VBP infected_VBN with_IN the_DT disease_NN die_VBP from_IN it_PRP ,_, even_RB if_IN they_PRP were_VBD treated_VBN with_IN antibiotics_NNS ._. As_RB many_JJ as_IN 20_CD %_NN of_IN those_DT who_WP survive_VBP may_MD have_VB lasting_VBG problems_NNS such_JJ as_IN hearing_NN loss_NN ,_, brain_NN damage_NN ,_, seizures_NNS ,_, or_CC loss_NN of_IN limbs_NNS ._. Because_IN teens_NNS and_CC young_JJ adults_NNS are_VBP at_IN increased_VBN risk_NN for_IN meningitis_NN ,_, all_DT adolescents_NNS should_MD be_VB vaccinated_VBN against_IN meningitis_NN ._. For_IN adults_NNS at_IN risk_NN ,_, the_DT vaccine_NN is_VBZ important_JJ ._. You_PRP can_MD catch_VB meningococcal_JJ infection_NN through_IN close_JJ contact_NN with_IN someone_NN who_WP has_VBZ the_DT bacteria_NN in_IN his_PRP$ or_CC her_PRP$ throat_NN or_CC nose_NN ._. Early_JJ symptoms_NNS of_IN both_CC meningitis_NN and_CC blood_NN infection_NN can_MD be_VB confused_VBN with_IN the_DT flu_NN or_CC a_DT cold_NN ,_, but_CC symptoms_NNS can_MD rapidly_RB become_VB more_RBR severe_JJ and_CC may_MD include_VB :_: •_NFP Other_JJ symptoms_NNS such_JJ as_IN nausea_NN ,_, vomiting_NN ,_, and_CC changes_NNS in_IN mental_JJ state_NN","The JJ NN VBZ you from four NNS of NN that VBP JJ NN . This NN can VB NN , an NN of the NN around the NN or JJ NN . It can RB VB a NN NN ( JJ NN ) , NN , and JJ NNS . Ten NN to 15 NN of NNS who VBP VBN with the NN VBP from it , RB if they VBD VBN with NNS . RB JJ as 20 NN of those who VBP may VB VBG NNS JJ as NN NN , NN NN , NNS , or NN of NNS . Because NNS and JJ NNS VBP at VBN NN for NN , all NNS should VB VBN against NN . For NNS at NN , the NN VBZ JJ . You can VB JJ NN through JJ NN with NN who VBZ the NN in his or her NN or NN . JJ NNS of both NN and NN NN can VB VBN with the NN or a NN , but NNS can RB VB RBR JJ and may VB : • JJ NNS JJ as NN , NN , and NNS in JJ NN"
226,795,mainstream,"A_DT vaccine_NN against_IN coronavirus_NN appears_VBZ to_TO have_VB provided_VBN protection_NN against_IN the_DT disease_NN Covid_NNP -_HYPH 19_CD in_IN six_CD rhesus_NN macaque_NN monkeys_NNS ._. It_PRP gives_VBZ early_JJ hope_NN for_IN the_DT vaccine_NN ,_, which_WDT is_VBZ now_RB undergoing_VBG human_JJ clinical_JJ trials_NNS ._. There_EX is_VBZ no_DT guarantee_NN this_DT result_NN will_MD translate_VB to_IN people_NNS ,_, though_RB ._. A_DT group_NN of_IN monkeys_NNS was_VBD exposed_VBN to_IN the_DT SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD virus_NN ._. The_DT six_CD animals_NNS that_WDT were_VBD vaccinated_VBN had_VBD less_JJR of_IN the_DT virus_NN in_IN their_PRP$ lungs_NNS and_CC airways_NNS ._. The_DT trial_NN took_VBD place_NN in_IN the_DT US_NNP ,_, involving_VBG researchers_NNS from_IN the_DT US_NNP government_NN 's_POS National_NNP Institutes_NNPS of_IN Health_NNP (_-LRB- NIH_NNP )_-RRB- and_CC from_IN the_DT University_NNP of_IN Oxford_NNP ._. The_DT vaccine_NN appeared_VBD to_TO protect_VB the_DT animals_NNS against_IN developing_VBG pneumonia_NN ._. Promisingly_RB ,_, the_DT animals_NNS also_RB did_VBD n't_RB develop_VB ""_`` immune_JJ -_HYPH enhanced_VBN disease_NN ""_'' -_, which_WDT BBC_NNP News_NNP medical_JJ correspondent_NN Fergus_NNP Walsh_NNP describes_VBZ as_IN a_DT ""_`` theoretical_JJ risk_NN ""_'' ._. That_DT 's_VBZ when_WRB the_DT vaccine_NN triggers_VBZ a_DT worse_JJR response_NN to_IN a_DT disease_NN ._. •_NFP How_WRB close_RB to_IN developing_VBG a_DT vaccine_NN are_VBP we_PRP ?_. This_DT response_NN was_VBD seen_VBN in_IN some_DT early_JJ animal_NN vaccine_NN trials_NNS against_IN SARS_NN -_, another_DT coronavirus_NN -_, and_CC proved_VBD a_DT stumbling_NN block_NN in_IN developing_VBG a_DT vaccine_NN for_IN that_DT disease_NN ._. The_DT study_NN has_VBZ n't_RB yet_RB been_VBN reviewed_VBN by_IN other_JJ scientists_NNS and_CC formally_RB published_VBN ,_, but_CC Prof_NNP Stephen_NNP Evans_NNP at_IN the_DT London_NNP School_NNP of_IN Hygiene_NNP and_CC Tropical_NNP Medicine_NNP ,_, described_VBD it_PRP as_IN ""_`` high_JJ quality_NN ""_'' and_CC ""_`` very_RB encouraging_JJ ""_'' ._. Meanwhile_RB ,_, trials_NNS in_IN the_DT UK_NNP on_IN more_JJR than_IN 1,000_CD human_JJ volunteers_NNS are_VBP currently_RB taking_VBG place_NN through_IN the_DT University_NNP of_IN Oxford_NNP ._. There_EX are_VBP more_JJR than_IN 100_CD experimental_JJ coronavirus_NN vaccines_NNS currently_RB being_VBG developed_VBN ._. •_NFP A_DT SIMPLE_JJ GUIDE_NN :_: How_WRB do_VBP I_PRP protect_VB myself_PRP ?_. •_NFP AVOIDING_VBG CONTACT_NN :_: The_DT rules_NNS on_IN self_NN -_HYPH isolation_NN and_CC exercise_NN •_, TESTING_NN :_: Can_MD I_PRP get_VB tested_VBN for_IN coronavirus_NN ?_. Dr_NNP Penny_NNP Ward_NNP ,_, a_DT visiting_VBG professor_NN in_IN pharmaceutical_JJ medicine_NN at_IN King_NNP 's_POS College_NNP London_NNP ,_, said_VBD it_PRP was_VBD ""_`` helpful_JJ ""_'' to_TO see_VB that_IN the_DT vaccine_NN did_VBD n't_RB cause_VB a_DT worse_JJR disease_NN response_NN in_IN these_DT monkeys_NNS ,_, and_CC that_IN they_PRP did_VBD n't_RB develop_VB pneumonia_NN after_IN being_VBG vaccinated_VBN ._. The_DT vaccine_NN is_VBZ based_VBN on_IN a_DT small_JJ part_NN of_IN the_DT virus_NN 's_POS distinctive_JJ ""_`` spike_NN ""_'' ._. The_DT idea_NN is_VBZ that_IN by_IN getting_VBG the_DT body_NN to_TO recognise_VB a_DT unique_JJ part_NN of_IN the_DT virus_NN ,_, when_WRB it_PRP is_VBZ exposed_VBN to_IN the_DT whole_JJ thing_NN it_PRP will_MD know_VB how_WRB to_TO react_VB ,_, and_CC produce_VB the_DT right_JJ antibodies_NNS to_TO fight_VB it_PRP off_RP ._. That_DT did_VBD seem_VB to_TO be_VB happening_VBG to_IN the_DT vaccinated_VBN macaques_NNS ,_, which_WDT produced_VBD antibodies_NNS capable_JJ of_IN fighting_VBG the_DT virus_NN ._.","A NN against NN VBZ to VB VBN NN against the NN NNP - 19 in six NN NN NNS . It VBZ JJ NN for the NN , which VBZ RB VBG JJ JJ NNS . There VBZ no NN this NN will VB to NNS , RB . A NN of NNS VBD VBN to the NNP - NNP - 2 NN . The six NNS that VBD VBN VBD JJR of the NN in their NNS and NNS . The NN VBD NN in the NNP , VBG NNS from the NNP NN 's NNP NNPS of NNP ( NNP ) and from the NNP of NNP . The NN VBD to VB the NNS against VBG NN . RB , the NNS RB VBD RB VB "" JJ - VBN NN "" - which NNP NNP JJ NN NNP NNP VBZ as a "" JJ NN "" . That VBZ when the NN VBZ a JJR NN to a NN . • How RB to VBG a NN VBP we ? This NN VBD VBN in some JJ NN NN NNS against NN - another NN - and VBD a NN NN in VBG a NN for that NN . The NN VBZ RB RB VBN VBN by JJ NNS and RB VBN , but NNP NNP NNP at the NNP NNP of NNP and NNP NNP , VBD it as "" JJ NN "" and "" RB JJ "" . RB , NNS in the NNP on JJR than 1,000 JJ NNS VBP RB VBG NN through the NNP of NNP . There VBP JJR than 100 JJ NN NNS RB VBG VBN . • A JJ NN : How VBP I VB myself ? • VBG NN : The NNS on NN - NN and NN • NN : Can I VB VBN for NN ? NNP NNP NNP , a VBG NN in JJ NN at NNP 's NNP NNP , VBD it VBD "" JJ "" to VB that the NN VBD RB VB a JJR NN NN in these NNS , and that they VBD RB VB NN after VBG VBN . The NN VBZ VBN on a JJ NN of the NN 's JJ "" NN "" . The NN VBZ that by VBG the NN to VB a JJ NN of the NN , when it VBZ VBN to the JJ NN it will VB how to VB , and VB the JJ NNS to VB it off . That VBD VB to VB VBG to the VBN NNS , which VBD NNS JJ of VBG the NN ."
227,491,mainstream,"Drugs_NNS are_VBP usually_RB administered_VBN to_IN patients_NNS ,_, i.e._FW ,_, ill_JJ /_, injured_VBN subjects_NNS in_IN need_NN of_IN treatment_NN regardless_RB of_IN the_DT severity_NN of_IN their_PRP$ health_NN problems_NNS ._. Many_JJ drugs_NNS can_MD coexist_VB in_IN the_DT same_JJ therapeutic_JJ class_NN because_IN each_DT of_IN them_PRP may_MD have_VB different_JJ effects_NNS on_IN specific_JJ sub_NN -_HYPH groups_NNS of_IN patients_NNS ._. In_IN contrast_NN ,_, the_DT same_JJ vaccines_NNS are_VBP administered_VBN to_IN otherwise_RB healthy_JJ individuals_NNS ,_, to_TO prevent_VB the_DT same_JJ diseases_NNS ._. Wherever_WRB high_JJ coverage_NN rates_NNS are_VBP achieved_VBN ,_, unvaccinated_JJ subjects_NNS may_MD benefit_VB too_RB ,_, by_IN reducing_VBG the_DT risk_NN of_IN transmission_NN and_CC circulation_NN of_IN pathogens_NNS due_IN to_IN the_DT so_RB called_VBN ‘_`` herd_NN immunity_NN ’_'' [_-LRB- 3_CD ]_-RRB- ._. Therefore_RB ,_, the_DT social_JJ benefits_NNS of_IN vaccines_NNS can_MD exceed_VB the_DT private_JJ ones_NNS [_-LRB- 4_CD ]_-RRB- ._. Conversely_RB ,_, because_IN vaccines_NNS can_MD cause_VB a_DT (_-LRB- small_JJ )_-RRB- risk_NN of_IN serious_JJ adverse_JJ effects_NNS in_IN healthy_JJ individuals_NNS —_: often_RB infants_NNS and_CC children_NNS —_: not_RB suffering_VBG the_DT targeted_VBN diseases_NNS ,_, they_PRP may_MD be_VB more_RBR open_JJ to_IN criticism_NN than_IN drugs_NNS [_-LRB- 4_CD ]_-RRB- ._. This_DT can_MD favor_VB campaigning_VBG against_IN them_PRP by_IN the_DT so_RB -_HYPH called_VBN ‘_`` anti-vax_NN ’_POS movements_NNS ,_, especially_RB in_IN highly_RB developed_VBN countries_NNS which_WDT have_VBP not_RB experienced_VBN pandemics_NNS for_IN decades_NNS before_IN COVID_NNP -_HYPH 19_CD ._. Patents_NNS are_VBP crucial_JJ for_IN maximizing_VBG financial_JJ returns_NNS on_IN drugs_NNS ’_POS research_NN investments_NNS ,_, even_RB after_IN the_DT first_JJ invention_NN ,_, which_WDT is_VBZ part_NN of_IN a_DT harsh_JJ debate_NN in_IN the_DT pharmaceutical_JJ literature_NN [_-LRB- 5_CD ]_-RRB- ._. To_TO limit_VB the_DT turnover_NN of_IN off_IN -_HYPH patent_NN medicines_NNS ,_, pharmaceutical_JJ companies_NNS often_RB recur_VBP to_IN secondary_JJ patenting_NN for_IN dramatically_RB prolonging_VBG protection_NN (_-LRB- the_DT so_RB called_VBN ‘_`` ever_RB greening_NN ’_'' strategies_NNS )_-RRB- ._. Secondary_JJ patents_NNS on_IN drugs_NNS are_VBP usually_RB applied_VBN to_IN new_JJ indications_NNS and_CC ‘_`` me_PRP -_HYPH too_RB ’_POS drugs_NNS ._. Besides_IN patents_NNS on_IN products_NNS ,_, complex_JJ biological_JJ drugs_NNS ,_, such_JJ as_IN the_DT recent_JJ monoclonal_JJ antibodies_NNS (_-LRB- mABs_NNS )_-RRB- can_MD be_VB further_RB protected_VBN on_IN production_NN phases_NNS that_WDT affect_VBP their_PRP$ final_JJ mechanism_NN [_-LRB- 6_CD ]_-RRB- ._. Differently_RB ,_, patents_NNS are_VBP less_RBR relevant_JJ for_IN vaccines_NNS ,_, mainly_RB protecting_VBG manufacturing_NN processes_NNS rather_RB than_IN antigens_NNS [_-LRB- 7_CD ]_-RRB- ._. In_IN fact_NN ,_, patents_NNS on_IN products_NNS cannot_MD prevent_VB other_JJ companies_NNS from_IN using_VBG different_JJ strains_NNS to_TO supply_VB competing_VBG vaccines_NNS [_-LRB- 4_CD ]_-RRB- ._. Because_IN vaccines_NNS are_VBP all_RB biological_JJ agents_NNS to_IN date_NN —_: awaiting_VBG future_JJ RNA_NN /_, DNA_NN synthetic_JJ vaccines_NNS —_: their_PRP$ outcomes_NNS can_MD vary_VB a_DT lot_NN on_IN account_NN of_IN the_DT biological_JJ variability_NN in_IN raw_JJ materials_NNS and_CC the_DT steps_NNS involved_VBN in_IN purification_NN processes_NNS [_-LRB- 8_CD ]_-RRB- ;_, thus_RB ,_, patents_NNS on_IN processes_NNS may_MD help_VB prolong_VB their_PRP$ life_NN cycles_NNS ._. Research_NN and_CC promotion_NN have_VBP always_RB been_VBN the_DT major_JJ cost_NN items_NNS for_IN developing_VBG and_CC marketing_NN drugs_NNS ,_, whereas_IN manufacturing_NN costs_NNS hardly_RB ever_RB account_VBP for_IN a_DT substantial_JJ proportion_NN of_IN total_JJ costs_NNS ,_, with_IN the_DT last_JJ generation_NN of_IN sky_NN -_HYPH high_JJ priced_VBN mABs_NNS no_DT exception_NN [_-LRB- 9_CD ]_-RRB- ._. In_IN general_JJ ,_, it_PRP is_VBZ difficult_JJ to_TO estimate_VB single_JJ cost_NN items_NNS per_IN product_NN in_IN a_DT research_NN -_HYPH oriented_VBN industry_NN -_HYPH like_IN pharmaceuticals_NNS ._. Conversely_RB ,_, manufacturing_NN costs_NNS are_VBP the_DT major_JJ ones_NNS for_IN vaccines_NNS ,_, which_WDT can_MD have_VB batch_NN -_HYPH to_IN -_HYPH batch_NN variability_NN and_CC substantial_JJ changes_NNS in_IN manufacturing_NN processes_NNS requiring_VBG extensive_JJ analyses_NNS to_TO show_VB bioequivalence_NN even_RB after_IN marketing_NN approval_NN [_-LRB- 8_CD ]_-RRB- ._. Vaccines_NNS imply_VBP large_JJ -_HYPH scale_NN productions_NNS ,_, which_WDT have_VBP traditionally_RB discouraged_VBN the_DT launch_NN of_IN off_IN -_HYPH patent_NN and_CC ‘_`` me_PRP too_RB ’_POS vaccines_NNS [_-LRB- 4_CD ]_-RRB- ._. High_JJ fixed_VBN manufacturing_NN costs_NNS are_VBP diluted_VBN over_IN many_JJ doses_NNS and_CC are_VBP quite_RB easy_JJ to_TO post_VB to_IN each_DT vaccine_NN given_VBN their_PRP$ limited_JJ number_NN ._. Recent_JJ trends_NNS have_VBP been_VBN to_TO launch_VB combination_NN vaccines_NNS ,_, including_VBG more_JJR than_IN one_CD antigen_NN for_IN reducing_VBG administration_NN processes_NNS and_CC new_JJ adjuvants_NNS for_IN potentiating_VBG immune_NN responses_NNS and_CC /_, or_CC sparing_VBG doses_NNS [_-LRB- 10_CD ]_-RRB- ._. General_JJ practitioners_NNS (_-LRB- GPs_NNS )_-RRB- are_VBP traditionally_RB the_DT major_JJ prescribers_NNS of_IN drugs_NNS ._. Although_IN the_DT prescription_NN of_IN a_DT growing_VBG number_NN of_IN new_JJ and_CC expensive_JJ agents_NNS (_-LRB- e.g._FW ,_, mABs_NNS )_-RRB- may_MD now_RB be_VB limited_VBN to_IN the_DT hospital_NN settings_NNS in_IN many_JJ European_JJ countries_NNS [_-LRB- 11_CD ]_-RRB- ,_, most_JJS drugs_NNS are_VBP still_RB prescribed_VBN by_IN GPs_NNS and_CC thus_RB dispensed_VBN through_IN community_NN pharmacies_NNS ._. Somewhat_RB differently_RB ,_, the_DT delivery_NN of_IN vaccines_NNS is_VBZ more_RBR uneven_JJ throughout_IN European_JJ countries_NNS ,_, varying_VBG a_DT lot_NN according_VBG to_IN the_DT type_NN of_IN health_NN care_NN systems_NNS —_: e.g._FW ,_, Beveridge_NNP -_HYPH type_NN like_IN in_IN Italy_NNP and_CC the_DT UK_NNP ,_, or_CC Bismarck_NNP -_HYPH type_NN such_JJ as_IN in_IN France_NNP and_CC Germany_NNP —_: and_CC the_DT national_JJ framework_NN within_IN the_DT same_JJ type_NN ._. For_IN instance_NN ,_, in_IN Italy_NNP ,_, the_DT vaccines_NNS recommended_VBN for_IN children_NNS are_VBP administered_VBN in_IN local_JJ health_NN districts_NNS by_IN public_JJ health_NN professionals_NNS and_CC those_DT for_IN adults_NNS by_IN GPs_NNS in_IN their_PRP$ cabinets_NNS [_-LRB- 12_CD ]_-RRB- ,_, whereas_IN in_IN the_DT UK_NNP all_DT vaccines_NNS are_VBP mainly_RB provided_VBN by_IN general_JJ practices_NNS ._. Because_IN most_JJS vaccines_NNS are_VBP still_RB injectable_JJ ,_, a_DT common_JJ issue_NN is_VBZ that_DT of_IN storage_NN and_CC preparation_NN [_-LRB- 10_CD ]_-RRB- ._. Hence_RB ,_, beyond_IN reducing_VBG injection_NN overcrowding_NN in_IN health_NN facilities_NNS ,_, combo_NN vaccines_NNS help_VBP contain_VB storage_NN and_CC shipping_NN costs_NNS [_-LRB- 13_CD ]_-RRB- ._. In_IN a_DT typical_JJ ‘_`` market_NN failure_NN ’_POS situation_NN like_IN pharmaceuticals_NNS ,_, physicians_NNS (_-LRB- working_VBG as_IN the_DT patient_NN ’s_POS agent_NN )_-RRB- fill_VB the_DT information_NN gap_NN of_IN patients_NNS in_IN medicine_NN and_CC take_VBP on_IN their_PRP$ behalf_NN the_DT final_JJ decisions_NNS about_IN how_WRB many_JJ and_CC which_WDT drugs_NNS to_TO prescribe_VB among_IN those_DT available_JJ [_-LRB- 14_CD ]_-RRB- ._. Hence_RB ,_, as_IN prescribers_NNS ,_, physicians_NNS are_VBP conventionally_RB the_DT major_JJ marketing_NN target_NN of_IN pharmaceutical_JJ companies_NNS and_CC aggressive_JJ strategies_NNS may_MD raise_VB financial_JJ conflicts_NNS of_IN interest_NN [_-LRB- 15_CD ]_-RRB- ,_, eventually_RB leading_VBG to_IN drug_NN overconsumption_NN and_CC bribery_NN ._. In_IN contrast_NN ,_, vaccines_NNS do_VBP not_RB normally_RB require_VB intensive_JJ promotion_NN by_IN industry_NN ._. Campaigns_NNS to_TO achieve_VB high_JJ rates_NNS of_IN coverage_NN are_VBP mainly_RB a_DT task_NN of_IN health_NN authorities_NNS ,_, with_IN manufacturers_NNS obviously_RB interested_JJ in_IN backing_VBG them_PRP up_RP ._. Activities_NNS may_MD consist_VB of_IN specific_JJ trainings_NNS for_IN healthcare_NN professionals_NNS and_CC awareness_NN campaigns_NNS for_IN patients_NNS ,_, except_IN where_WRB vaccinations_NNS are_VBP mandatory_JJ ,_, which_WDT is_VBZ hardly_RB ever_RB the_DT case_NN in_IN European_JJ countries_NNS nowadays_RB [_-LRB- 12_CD ]_-RRB- ._. Final_JJ results_NNS are_VBP substantially_RB affected_VBN by_IN public_JJ perception_NN of_IN vaccines_NNS values_NNS [_-LRB- 1_CD ]_-RRB- ,_, with_IN single_JJ physicians_NNS playing_VBG an_DT important_JJ role_NN in_IN influencing_VBG vaccine_NN hesitant_JJ families_NNS [_-LRB- 16_CD ]_-RRB- ._. Prices_NNS of_IN new_JJ drugs_NNS have_VBP dramatically_RB increased_VBN all_RB over_IN Europe_NNP in_IN the_DT last_JJ decade_NN ,_, making_VBG pharmaceutical_JJ expenditure_NN somewhat_RB unsustainable_JJ even_RB in_IN the_DT (_-LRB- wealthier_JJR )_-RRB- Western_JJ countries_NNS ._. The_DT most_RBS recent_JJ and_CC ambitious_JJ price_NN schemes_NNS (_-LRB- e.g._FW ,_, value_NN -_HYPH based_VBN pricing_NN and_CC outcome_NN -_HYPH based_VBN agreements_NNS )_-RRB- have_VBP shown_VBN intrinsic_JJ limits_NNS despite_IN their_PRP$ scientific_JJ attractiveness_NN [_-LRB- 17_CD ]_-RRB- ,_, whereas_IN sound_NN strategies_NNS such_JJ as_IN reference_NN pricing_NN and_CC competitive_JJ tendering_NN do_VBP not_RB seem_VB to_TO be_VB enough_JJ to_TO stop_VB the_DT present_JJ trend_NN of_IN sky_NN -_HYPH rocketing_VBG prices_NNS ._. At_IN present_NN ,_, the_DT leading_VBG strategy_NN for_IN cost_NN containment_NN among_IN European_JJ health_NN authorities_NNS is_VBZ to_TO negotiate_VB confidential_JJ prices_NNS directly_RB with_IN companies_NNS ,_, an_DT approach_NN which_WDT inevitably_RB lacks_VBZ transparency_NN [_-LRB- 18_CD ]_-RRB- ._. Although_IN many_JJ European_JJ health_NN authorities_NNS have_VBP conventionally_RB recurred_VBN to_IN public_JJ procurement_NN for_IN buying_VBG vaccines_NNS ,_, so_IN as_IN to_TO exploit_VB at_IN most_JJS their_PRP$ purchasing_NN power_NN ,_, the_DT recent_JJ tendencies_NNS for_IN pricing_NN vaccines_NNS tend_VBP to_TO follow_VB those_DT for_IN drugs_NNS ._. Since_IN any_DT ‘_`` competitor_NN ’_'' is_VBZ (_-LRB- obviously_RB )_-RRB- expected_VBN to_TO be_VB against_IN price_NN competition_NN [_-LRB- 19_CD ]_-RRB- ,_, nowadays_RB the_DT few_JJ (_-LRB- multinational_JJ )_-RRB- companies_NNS which_WDT market_NN vaccines_NNS strive_VBP for_IN undermining_VBG competitive_JJ tenders_NNS by_IN differentiating_VBG their_PRP$ vaccines_NNS and_CC launching_VBG the_DT new_JJ ones_NNS (_-LRB- e.g._FW ,_, HPV_NN and_CC PCV_NN )_-RRB- at_IN prices_NNS which_WDT were_VBD unthinkable_JJ only_RB a_DT few_JJ years_NNS ago_RB [_-LRB- 20_CD ]_-RRB- ._.","NNS VBP RB VBN to NNS , FW , JJ / VBN NNS in NN of NN RB of the NN of their NN NNS . JJ NNS can VB in the JJ JJ NN because each of them may VB JJ NNS on JJ NN - NNS of NNS . In NN , the JJ NNS VBP VBN to RB JJ NNS , to VB the JJ NNS . Wherever JJ NN NNS VBP VBN , JJ NNS may VB RB , by VBG the NN of NN and NN of NNS due to the RB VBN ‘ NN NN ’ [ 3 ] . RB , the JJ NNS of NNS can VB the JJ NNS [ 4 ] . RB , because NNS can VB a ( JJ ) NN of JJ JJ NNS in JJ NNS — RB NNS and NNS — RB VBG the VBN NNS , they may VB RBR JJ to NN than NNS [ 4 ] . This can VB VBG against them by the RB - VBN ‘ NN ’ NNS , RB in RB VBN NNS which VBP RB VBN NNS for NNS before NNP - 19 . NNS VBP JJ for VBG JJ NNS on NNS ’ NN NNS , RB after the JJ NN , which VBZ NN of a JJ NN in the JJ NN [ 5 ] . To VB the NN of off - NN NNS , JJ NNS RB VBP to JJ NN for RB VBG NN ( the RB VBN ‘ RB NN ’ NNS ) . JJ NNS on NNS VBP RB VBN to JJ NNS and ‘ me - RB ’ NNS . Besides NNS on NNS , JJ JJ NNS , JJ as the JJ JJ NNS ( NNS ) can VB RB VBN on NN NNS that VBP their JJ NN [ 6 ] . RB , NNS VBP RBR JJ for NNS , RB VBG NN NNS RB than NNS [ 7 ] . In NN , NNS on NNS cannot VB JJ NNS from VBG JJ NNS to VB VBG NNS [ 4 ] . Because NNS VBP RB JJ NNS to NN — VBG JJ NN / NN JJ NNS — their NNS can VB a NN on NN of the JJ NN in JJ NNS and the NNS VBN in NN NNS [ 8 ] ; RB , NNS on NNS may VB VB their NN NNS . NN and NN VBP RB VBN the JJ NN NNS for VBG and NN NNS , whereas NN NNS RB RB VBP for a JJ NN of JJ NNS , with the JJ NN of NN - JJ VBN NNS no NN [ 9 ] . In JJ , it VBZ JJ to VB JJ NN NNS per NN in a NN - VBN NN - like NNS . RB , NN NNS VBP the JJ NNS for NNS , which can VB NN - to - NN NN and JJ NNS in NN NNS VBG JJ NNS to VB NN RB after NN NN [ 8 ] . NNS VBP JJ - NN NNS , which VBP RB VBN the NN of off - NN and ‘ me RB ’ NNS [ 4 ] . JJ VBN NN NNS VBP VBN over JJ NNS and VBP RB JJ to VB to each NN VBN their JJ NN . JJ NNS VBP VBN to VB NN NNS , VBG JJR than one NN for VBG NN NNS and JJ NNS for VBG NN NNS and / or VBG NNS [ 10 ] . JJ NNS ( NNS ) VBP RB the JJ NNS of NNS . Although the NN of a VBG NN of JJ and JJ NNS ( FW , NNS ) may RB VB VBN to the NN NNS in JJ JJ NNS [ 11 ] , JJS NNS VBP RB VBN by NNS and RB VBN through NN NNS . RB RB , the NN of NNS VBZ RBR JJ throughout JJ NNS , VBG a NN VBG to the NN of NN NN NNS — FW , NNP - NN like in NNP and the NNP , or NNP - NN JJ as in NNP and NNP — and the JJ NN within the JJ NN . For NN , in NNP , the NNS VBN for NNS VBP VBN in JJ NN NNS by JJ NN NNS and those for NNS by NNS in their NNS [ 12 ] , whereas in the NNP all NNS VBP RB VBN by JJ NNS . Because JJS NNS VBP RB JJ , a JJ NN VBZ that of NN and NN [ 10 ] . RB , beyond VBG NN NN in NN NNS , NN NNS VBP VB NN and NN NNS [ 13 ] . In a JJ ‘ NN NN ’ NN like NNS , NNS ( VBG as the NN ’s NN ) VB the NN NN of NNS in NN and VBP on their NN the JJ NNS about how JJ and which NNS to VB among those JJ [ 14 ] . RB , as NNS , NNS VBP RB the JJ NN NN of JJ NNS and JJ NNS may VB JJ NNS of NN [ 15 ] , RB VBG to NN NN and NN . In NN , NNS VBP RB RB VB JJ NN by NN . NNS to VB JJ NNS of NN VBP RB a NN of NN NNS , with NNS RB JJ in VBG them up . NNS may VB of JJ NNS for NN NNS and NN NNS for NNS , except where NNS VBP JJ , which VBZ RB RB the NN in JJ NNS RB [ 12 ] . JJ NNS VBP RB VBN by JJ NN of NNS NNS [ 1 ] , with JJ NNS VBG an JJ NN in VBG NN JJ NNS [ 16 ] . NNS of JJ NNS VBP RB VBN RB over NNP in the JJ NN , VBG JJ NN RB JJ RB in the ( JJR ) JJ NNS . The RBS JJ and JJ NN NNS ( FW , NN - VBN NN and NN - VBN NNS ) VBP VBN JJ NNS despite their JJ NN [ 17 ] , whereas NN NNS JJ as NN NN and JJ NN VBP RB VB to VB JJ to VB the JJ NN of NN - VBG NNS . At NN , the VBG NN for NN NN among JJ NN NNS VBZ to VB JJ NNS RB with NNS , an NN which RB VBZ NN [ 18 ] . Although JJ JJ NN NNS VBP RB VBN to JJ NN for VBG NNS , so as to VB at JJS their NN NN , the JJ NNS for NN NNS VBP to VB those for NNS . Since any ‘ NN ’ VBZ ( RB ) VBN to VB against NN NN [ 19 ] , RB the JJ ( JJ ) NNS which NN NNS VBP for VBG JJ NNS by VBG their NNS and VBG the JJ NNS ( FW , NN and NN ) at NNS which VBD JJ RB a JJ NNS RB [ 20 ] ."
228,1086,conspiracy,"The_DT global_JJ war_NN on_IN women_NNS has_VBZ for_IN many_JJ years_NNS been_VBN an_DT extremely_RB hard_JJ -_HYPH to_IN -_HYPH recognise_VB war_NN ._. For_IN decades_NNS ,_, it_PRP has_VBZ carried_VBN a_DT nice_JJ face_NN ,_, actually_RB looking_VBG like_IN just_RB the_DT opposite_NN of_IN war_NN ._. But_CC now_RB ,_, it_PRP gets_VBZ another_DT face_NN -_, an_DT ugly_JJ one_NN ._. Just_RB like_IN the_DT face_NN of_IN the_DT other_JJ wars_NNS :_: That_DT of_IN terror_NN and_CC that_DT of_IN man-made_JJ global_JJ warming_NN ._. These_DT have_VBP long_RB been_VBN recognizable_JJ as_IN false_JJ and_CC staged_VBN ._. Now_RB ,_, the_DT global_JJ war_NN on_IN women_NNS is_VBZ becoming_VBG visible_JJ ._. For_IN me_PRP ,_, it_PRP started_VBD as_IN a_DT wondering_VBG :_: How_WRB come_VBP that_IN more_JJR and_CC more_JJR vaccination_NN campaigns_NNS are_VBP targeted_VBN on_IN women_NNS ?_. Recently_RB in_IN Denmark_NNP ,_, the_DT media_NN have_VBP been_VBN strongly_RB marketing_VBG the_DT HPV_NN vaccination_NN against_IN cervical_JJ cancer_NN ,_, not_RB as_IN given_VBN to_IN women_NNS of_IN exactly_RB that_DT age_NN where_WRB cervical_JJ cancer_NN occurs_VBZ ,_, no_UH ,_, they_PRP are_VBP about_JJ to_TO be_VB included_VBN in_IN the_DT normal_JJ children_NNS 's_POS vaccination_NN scheme_NN ,_, targeting_VBG girls_NNS at_IN the_DT age_NN of_IN 12_CD -_, where_WRB it_PRP has_VBZ absolutely_RB no_DT positive_JJ effect_NN ._. How_WRB come_VBP ?_. Just_RB before_IN that_DT ,_, the_DT media_NN announced_VBD that_IN Bill_NNP Gates_NNP Foundation_NNP has_VBZ granted_VBN 10_CD million_CD Danish_JJ Kroners_NNPS to_IN a_DT Copenhagen_NNP university_NN for_IN further_JJ research_NN on_IN a_DT vaccine_NN against_IN Malaria_NNP ,_, targeting_VBG women_NNS in_IN the_DT Third_NNP World_NNP ._. Women_NNS again_RB ..._, why_WRB ?_. Before_IN that_DT ,_, we_PRP saw_VBD so_RB many_JJ campaigns_NNS in_IN the_DT whole_JJ western_JJ world_NN on_IN making_VBG HIV_NN test_NN mandatory_JJ for_IN pregnant_JJ women_NNS ._. Since_IN I_PRP have_VBP made_VBN extensive_JJ research_NN on_IN AIDS_NN ,_, this_DT became_VBD my_PRP$ personal_JJ key_JJ point_NN ._. As_IN I_PRP shall_MD explain_VB ,_, the_DT existance_NN of_IN HIV_NN virus_NN has_VBZ never_RB been_VBN documented_VBN ,_, nor_CC has_VBZ it_PRP 's_POS connection_NN with_IN AIDS_NN ._. ""_`` AIDS_NN ""_'' itself_PRP is_VBZ a_DT misleading_JJ term_NN ._. The_DT HIV_NN test_NN is_VBZ not_RB testing_VBG presence_NN of_IN any_DT virus_NN but_CC is_VBZ only_RB indicating_VBG the_DT presence_NN of_IN certain_JJ antibodies_NNS in_IN blood_NN ._. It_PRP is_VBZ very_RB often_RB responding_VBG positivly_RB on_IN pregnancy_NN ,_, despite_IN no_DT particular_JJ virus_NN is_VBZ present_JJ ._. Then_RB why_WRB this_DT obsession_NN of_IN testing_VBG pregnant_JJ women_NNS ?_. There_EX are_VBP many_JJ other_JJ indications_NNS -_, which_WDT I_PRP shall_MD explain_VB -_, all_RB pointing_VBG to_IN the_DT fact_NN that_IN something_NN strange_JJ is_VBZ going_VBG on_RP in_IN respect_NN to_IN women_NNS ._. I_PRP have_VBP earlier_RBR brought_VBN up_RP the_DT suspicion_NN that_IN it_PRP has_VBZ to_TO do_VB with_IN depopulation_NN ._. We_PRP all_DT know_VBP that_IN the_DT agenda_NN for_IN it_PRP has_VBZ existed_VBN at_IN least_JJS since_IN World_NNP War_NNP II_CD ._. We_PRP definitely_RB know_VBP that_IN it_PRP is_VBZ under_IN implementation_NN in_IN the_DT Third_NNP World_NNP ,_, mostly_RB through_IN economic_JJ means_NNS -_, the_DT looting_NN of_IN money_NN and_CC natural_JJ resources_NNS from_IN Africa_NNP and_CC other_JJ continents_NNS ,_, facilitated_VBN by_IN the_DT Debt_NN Trap_NN ,_, IMF_NNP Structural_JJ Adjustments_NNPS and_CC World_NNP Bank_NNP administrations_NNS ._. We_PRP also_RB know_VBP that_IN minimizing_VBG a_DT population_NN must_MD target_VB women_NNS ,_, not_RB men_NNS ._. Only_RB by_IN reducing_VBG the_DT number_NN of_IN females_NNS can_MD you_PRP reduce_VB the_DT amount_NN of_IN offspring_NN ._. One_CD man_NN can_MD fertilize_VB thousands_NNS of_IN women_NNS ._. One_CD woman_NN can_MD not_RB be_VB fertilized_VBN by_IN thousands_NNS of_IN men_NNS ._. Then_RB I_PRP watched_VBD Dr._NNP David_NNP Ayoubs_NNP video_NN lesson_NN <_-LRB- a_DT href=_FW ""_`` http://video.google.com/videoplay?docid=6890106663412840646_ADD ""_'' target=_FW ""_`` _blank_FW ""_'' >_, Global_JJ Vaccine_NN Agenda_NN </a_SYM >_-RRB- a_DT second_JJ time_NN and_CC suddenly_RB the_DT whole_JJ picture_NN was_VBD clear_JJ ._. In_IN his_PRP$ lesson_NN ,_, Dr._NNP Ayoub_NNP uses_VBZ half_PDT the_DT time_NN explaining_VBG the_DT connection_NN between_IN the_DT increasing_VBG frequency_NN of_IN Autism_NN in_IN the_DT US_NNP and_CC the_DT increased_VBN consumption_NN of_IN Mercury_NNP contained_VBN in_IN vaccines_NNS ._. The_DT rest_NN is_VBZ used_VBN to_TO explain_VB that_IN the_DT strange_JJ culture_NN of_IN vaccination_NN plays_VBZ a_DT complete_JJ different_JJ role_NN than_IN what_WP most_JJS of_IN us_PRP think_VBP ._. The_DT Rockefeller_NNP Shadow_NNP Dr._NNP Ayoub_NNP 's_POS story_NN starts_VBZ in_IN the_DT year_NN of_IN 1952_CD where_WRB John_NNP D._NNP Rockefeller_NNP the_DT Third_JJ established_VBD the_DT Population_NNP Council_NNP and_CC thereby_RB seriously_RB brought_VBD the_DT issue_NN of_IN overpopulation_NN forth_RB to_IN the_DT political_JJ arena_NN ._. In_IN 1972_CD ,_, another_DT commission_NN ,_, <_-LRB- i>_NFP The_DT Rockefeller_NNP Commission_NNP on_IN Population_NNP Growth_NNP <_-LRB- /i_NNP >_-RRB- ,_, completed_VBD a_DT two_CD years_NNS study_NN on_IN population_NN growth_NN ,_, on_IN request_NN of_IN then_RB President_NNP Nixon_NNP ._. The_DT commission_NN concluded_VBD :_: <_-LRB- i>""_NFP After_IN two_CD years_NNS of_IN concentrated_VBN effort_NN ,_, we_PRP have_VBP concluded_VBN that_IN ,_, in_IN the_DT long_JJ run_NN ,_, no_DT substantial_JJ benefits_NNS will_MD result_VB from_IN further_JJ growth_NN of_IN the_DT Nation_NNP 's_POS population_NN ,_, rather_RB that_IN the_DT gradual_JJ stabilization_NN of_IN our_PRP$ population_NN through_IN voluntary_JJ means_NNS would_MD contribute_VB significantly_RB to_IN the_DT Nation_NNP 's_POS ability_NN to_TO solve_VB its_PRP$ problems_NNS ._. We_PRP have_VBP looked_VBN for_IN ,_, and_CC have_VBP not_RB found_VBN ,_, any_DT convincing_JJ economic_JJ argument_NN for_IN continued_VBN population_NN growth_NN ._. The_DT health_NN of_IN our_PRP$ country_NN does_VBZ not_RB depend_VB on_IN it_PRP ,_, nor_CC does_VBZ the_DT vitality_NN of_IN business_NN nor_CC the_DT welfare_NN of_IN the_DT average_JJ person_NN ""_'' ._. </i>_NFP Later_RBR ,_, the_DT report_NN states_VBZ :_: <_-LRB- i>""_NFP By_IN its_PRP$ very_JJ nature_NN ,_, population_NN is_VBZ a_DT continuing_VBG concern_NN and_CC should_MD receive_VB contunuing_JJ attention_NN ._. Later_RBR generations_NNS ,_, and_CC later_JJR commissions_NNS ,_, will_MD be_VB able_JJ to_TO see_VB the_DT right_JJ path_NN into_IN the_DT future_NN ._. In_IN any_DT case_NN ,_, no_DT generation_NN needs_VBZ to_TO know_VB the_DT ultimate_JJ goal_NN or_CC the_DT final_JJ means_NNS ,_, only_RB the_DT direction_NN in_IN which_WDT they_PRP will_MD be_VB found_VBN ""_'' ._. John_NNP D._NNP Rockefeller_NNP 1972_CD </i_NN >._NFP Just_RB two_CD years_NNS later_RBR ,_, in_IN 1974_CD ,_, came_VBD the_DT well_RB known_VBN Henry_NNP Kissinger_NNP <_-LRB- i>_, National_NNP Security_NNP Study_NNP Memorandum_NNP 200_CD <_-LRB- /i_SYM >_-RRB- about_IN ""_`` the_DT consequences_NNS of_IN the_DT global_JJ population_NN growth_NN for_IN the_DT US_NNP security_NN and_CC overseas_JJ interests_NNS ""_'' ._. A_DT document_NN we_PRP have_VBP known_VBN since_IN it_PRP 's_VBZ declassification_NN in_IN 1989_CD ._. What_WP we_PRP also_RB know_VBP is_VBZ that_IN the_DT same_JJ Mr._NNP Kissinger_NNP made_VBD his_PRP$ way_NN into_IN top_JJ US_NNP politics_NNS as_IN a_DT protegé_NN of_IN the_DT Rockefellers_NNPS ._. There_EX is_VBZ no_DT doubt_NN that_IN there_EX is_VBZ a_DT straight_JJ line_NN from_IN the_DT Rockefeller_NNP report_NN to_IN the_DT Kissinger_NNP memo_NN ._. The_DT memo_NN states_VBZ that_DT :_: •_NFP We_PRP have_VBP unprecedented_JJ growth_NN rates_NNS •_, Lesser_JJ Developed_VBN Countries_NNS are_VBP growing_VBG faster_JJR •_, Required_VBN US_NNP imports_NNS could_MD be_VB threatened_VBN •_, Risk_NN of_IN global_JJ destabilization_NN •_, Urgent_JJ immediate_JJ measures_NNS must_MD be_VB taken_VBN to_TO reduce_VB fertility_NN ._. And_CC the_DT memo_NN recommends_VBZ these_DT goals_NNS :_: •_NFP Zero_NN rate_NN growth_NN in_IN the_DT developed_VBN countries_NNS by_IN 1985_CD •_SYM Zero_NNP rate_NN growth_NN in_IN Lesser_NNP Developed_NNP Countries_NNPS by_IN 2000_CD It_PRP is_VBZ worth_JJ noticing_VBG that_IN this_DT agenda_NN shall_MD be_VB first_RB implemented_VBN in_IN our_PRP$ own_JJ western_JJ world_NN and_CC then_RB later_RBR be_VB exported_VBN to_IN the_DT Third_NNP World_NNP ._. Probably_RB because_IN people_NNS in_IN the_DT industrialized_VBN world_NN are_VBP easier_JJR to_TO work_VB with_IN ,_, easier_JJR to_TO reach_VB by_IN controlled_VBN centralized_VBN media_NN ,_, easier_JJR to_TO experiment_VB with_IN and_CC easier_JJR to_TO follow_VB up_RP on_IN when_WRB the_DT efficiency_NN of_IN the_DT campaigns_NNS shall_MD be_VB measured_VBN ._. Which_WDT corresponds_VBZ well_RB with_IN the_DT fact_NN that_IN the_DT birth_NN rates_NNS in_IN fact_NN declined_VBD in_IN the_DT western_JJ world_NN before_IN it_PRP fell_VBD in_IN the_DT Third_NNP World_NNP ._. Concerning_VBG the_DT tools_NNS ,_, the_DT memo_NN lists_VBZ :_: •_NFP Reproductive_JJ health_NN (_-LRB- abortion_NN ,_, condoms_NNS )_-RRB- •_NFP Sex_NN education_NN •_SYM Improved_VBN health_NN •_, Women_NNS '_POS equality_NN •_, Day_NN care_NN •_NFP Government_NN participation_NN •_NFP Improve_VB social_JJ security_NN •_NFP Reduce_VB infant_NN mortality_NN Can_MD we_PRP recognize_VB some_DT of_IN these_DT ?_. Ay_UH ..._, all_DT of_IN it_PRP ,_, actually_RB ._. They_PRP are_VBP exactly_RB the_DT ingredients_NNS characterizing_VBG the_DT adult_JJ lifetime_NN of_IN my_PRP$ generation_NN -_, the_DT period_NN from_IN the_DT 1970´ies_CD and_CC ahead_RB ._. Overall_RB and_CC in_IN every_DT context_NN ,_, they_PRP were_VBD called_VBN ""_`` welfare_NN ""_'' and_CC there_EX was_VBD a_DT strong_JJ consensus_NN that_IN they_PRP were_VBD the_DT result_NN of_IN a_DT superior_JJ society_NN model_NN based_VBN on_IN democracy_NN ._. Now_RB ,_, suddenly_RB we_PRP remain_VBP with_IN the_DT question_NN :_: Were_VBD they_PRP just_RB means_VBZ to_TO make_VB us_PRP stop_VB reproducing_VBG ourselves_PRP ?_. To_TO answer_VB that_DT requires_VBZ a_DT deep_JJ analysis_NN ._. Let_VB us_PRP here_RB just_RB state_VB that_IN the_DT headlines_NNS of_IN our_PRP$ life_NN actually_RB can_MD be_VB regulated_VBN ._. That_DT happens_VBZ through_IN regulation_NN of_IN the_DT amount_NN of_IN money_NN in_IN circulation_NN :_: When_WRB the_DT central_JJ banks_NNS let_VBD out_RP money_NN in_IN the_DT market_NN ,_, we_PRP get_VBP ""_`` welfare_NN ""_'' ._. When_WRB they_PRP withdraw_VBP money_NN from_IN circulation_NN ,_, we_PRP get_VBP recession_NN ._. The_DT centralized_VBN management_NN of_IN the_DT global_JJ media_NN network_NN makes_VBZ it_PRP easy_JJ to_TO control_VB the_DT ideas_NNS accompanying_VBG the_DT money_NN -_, and_CC thereby_RB channelling_VBG both_CC money_NN flow_NN and_CC ideas_NNS in_IN the_DT directions_NNS wanted_VBN ._. What_WP is_VBZ hereafter_RB a_DT fact_NN ,_, is_VBZ that_IN we_PRP got_VBD the_DT elements_NNS from_IN the_DT Kissinger_NNP memo_NN ._. What_WP likewise_RB stands_VBZ ,_, is_VBZ the_DT fact_NN that_IN we_PRP got_VBD the_DT declining_VBG birthrates_NNS ._. Around_IN 1970_CD ,_, the_DT birthrate_NN in_IN Denmark_NNP was_VBD 2.0_CD ._. Today_NN it_PRP is_VBZ 1.7_CD -_, a_DT good_JJ deal_NN less_JJR than_IN required_VBN to_TO maintain_VB the_DT size_NN of_IN the_DT population_NN ._. We_PRP find_VBP a_DT similar_JJ development_NN all_RB over_IN the_DT Western_NNP World_NNP ._. Concerning_VBG the_DT implementation_NN in_IN the_DT Third_NNP World_NNP ,_, the_DT memo_NN recommends_VBZ the_DT following_VBG vehicles_NNS :_: •_NFP The_DT World_NNP Bank_NNP •_, WHO_WP •_, UNICEF_NNP •_, Governments_NNS from_IN ""_`` donor_NN ""_'' countries_NNS •_NFP UNFPA_NNP •_, Private_JJ organizations_NNS and_CC groups_NNS This_DT is_VBZ reveiling_VBG a_DT little_JJ bit_NN more_JJR of_IN how_WRB the_DT world_NN functions_VBZ ._. An_DT American_JJ financial_JJ elite_NN demands_VBZ an_DT American_JJ Foreign_JJ Secretary_NN to_TO incorporate_VB international_JJ organizations_NNS in_IN his_PRP$ toolbox_NN ._. We_PRP are_VBP not_RB talking_VBG about_IN a_DT UN_NNP as_IN ""_`` united_NNP nations_NNS ""_'' but_CC about_IN a_DT UN_NNP as_IN branches_NNS of_IN American_NNP Foreign_NNP Department_NNP ._. We_PRP also_RB notice_VBP that_IN the_DT World_NNP Bank_NNP plays_VBZ a_DT central_JJ role_NN ._. We_PRP are_VBP in_IN the_DT 1970´ies_NNP and_CC the_DT Third_JJ World_NNP is_VBZ about_JJ to_TO jump_VB into_IN the_DT debt_NN trap_NN -_, a_DT mechanism_NN completely_RB reversing_VBG the_DT newly_RB obtained_VBN ""_`` independencies_NNS ""_'' ._. After_IN a_DT short_JJ period_NN of_IN time_NN ,_, it_PRP is_VBZ clear_JJ that_IN also_RB these_DT parts_NNS of_IN the_DT world_NN are_VBP controllable_JJ ,_, economically_RB and_CC politically_RB ._. And_CC the_DT World_NNP Bank_NNP is_VBZ ,_, as_IN we_PRP have_VBP since_RB seen_VBN ,_, the_DT number_NN one_CD tool_NN for_IN control_NN ,_, backed_VBN up_RP by_IN the_DT twin_JJ organization_NN IMF_NNP ._. In_IN their_PRP$ period_NN of_IN governance_NN ,_, the_DT Third_NNP World_NNP has_VBZ been_VBN steadily_RB impoverished_VBN and_CC steadily_RB robbed_VBN for_IN the_DT natural_JJ richness_NN of_IN their_PRP$ continents_NNS ._. Apart_RB from_IN that_DT ,_, the_DT agenda_NN of_IN the_DT memo_NN covered_VBN by_IN the_DT health_NN sector_NN (_-LRB- WHO_NNP )_-RRB- ,_, the_DT education_NN sector_NN (_-LRB- UNICEF_NNP )_-RRB- ,_, support_NN from_IN allied_JJ governments_NNS is_VBZ secured_VBN and_CC through_IN financing_NN of_IN thousands_NNS of_IN NGO´s_NNS it_PRP all_DT gets_VBZ a_DT touch_NN of_IN people_NNS -_HYPH to_IN -_HYPH people_NNS -_HYPH commitment_NN ._. So_RB far_RB on_IN the_DT Kissinger_NNP memo_NN ,_, which_WDT we_PRP find_VBP important_JJ as_IN a_DT background_NN painting_NN making_VBG quite_PDT a_DT lot_NN of_IN practical_JJ events_NNS understandable_JJ ._. Let´s_NNS then_RB go_VB to_IN our_PRP$ main_JJ issue_NN :_: The_DT medical_JJ world_NN and_CC it_PRP 's_VBZ remarkable_JJ joy_NN of_IN vaccinations_NNS ._. (_-LRB- To_TO be_VB Continued_VBN Friday_NNP )_-RRB- ---_NFP Kjeld_NNP Heising_NNP is_VBZ an_DT editor_NN ,_, writer_NN ,_, researcher_NN and_CC political_JJ commentator_NN in_IN Denmark_NNP ._. He_PRP is_VBZ also_RB an_DT Africa_NNP -_HYPH ekspert_NNP by_IN the_DT African_NNP Institute_NNP AfriDAD_NNP ._. Has_VBZ written_VBN several_JJ books_NNS (_-LRB- in_IN Danish_NNP )_-RRB- and_CC hundreds_NNS of_IN articles_NNS on_IN scientific_JJ ,_, sociological_JJ and_CC international_JJ political_JJ issues_NNS ._. www.heising.dk._ADD email_NN ;_: [_-LRB- email_NN protected_VBN ]_-RRB-","The JJ NN on NNS VBZ for JJ NNS VBN an RB JJ - to - VB NN . For NNS , it VBZ VBN a JJ NN , RB VBG like RB the NN of NN . But RB , it VBZ another NN - an JJ NN . RB like the NN of the JJ NNS : That of NN and that of JJ JJ NN . These VBP RB VBN JJ as JJ and VBN . RB , the JJ NN on NNS VBZ VBG JJ . For me , it VBD as a VBG : How VBP that JJR and JJR NN NNS VBP VBN on NNS ? RB in NNP , the NN VBP VBN RB VBG the NN NN against JJ NN , RB as VBN to NNS of RB that NN where JJ NN VBZ , no , they VBP JJ to VB VBN in the JJ NNS 's NN NN , VBG NNS at the NN of 12 - where it VBZ RB no JJ NN . How VBP ? RB before that , the NN VBD that NNP NNP NNP VBZ VBN 10 million JJ NNPS to a NNP NN for JJ NN on a NN against NNP , VBG NNS in the NNP NNP . NNS RB ... why ? Before that , we VBD RB JJ NNS in the JJ JJ NN on VBG NN NN JJ for JJ NNS . Since I VBP VBN JJ NN on NN , this VBD my JJ JJ NN . As I shall VB , the NN of NN NN VBZ RB VBN VBN , nor VBZ it 's NN with NN . "" NN "" itself VBZ a JJ NN . The NN NN VBZ RB VBG NN of any NN but VBZ RB VBG the NN of JJ NNS in NN . It VBZ RB RB VBG RB on NN , despite no JJ NN VBZ JJ . RB why this NN of VBG JJ NNS ? There VBP JJ JJ NNS - which I shall VB - RB VBG to the NN that NN JJ VBZ VBG on in NN to NNS . I VBP RBR VBN up the NN that it VBZ to VB with NN . We all VBP that the NN for it VBZ VBN at JJS since NNP NNP II . We RB VBP that it VBZ under NN in the NNP NNP , RB through JJ NNS - the NN of NN and JJ NNS from NNP and JJ NNS , VBN by the NN NN , NNP JJ NNPS and NNP NNP NNS . We RB VBP that VBG a NN must VB NNS , RB NNS . RB by VBG the NN of NNS can you VB the NN of NN . One NN can VB NNS of NNS . One NN can RB VB VBN by NNS of NNS . RB I VBD NNP NNP NNP NN NN < a FW "" http://video.google.com/videoplay?docid=6890106663412840646 "" FW ""  "" > JJ NN NN </a > a JJ NN and RB the JJ NN VBD JJ . In his NN , NNP NNP VBZ half the NN VBG the NN between the VBG NN of NN in the NNP and the VBN NN of NNP VBN in NNS . The NN VBZ VBN to VB that the JJ NN of NN VBZ a JJ JJ NN than what JJS of us VBP . The NNP NNP NNP NNP 's NN VBZ in the NN of 1952 where NNP NNP NNP the JJ VBD the NNP NNP and RB RB VBD the NN of NN RB to the JJ NN . In 1972 , another NN , < i> The NNP NNP on NNP NNP < NNP > , VBD a two NNS NN on NN NN , on NN of RB NNP NNP . The NN VBD : < i>"" After two NNS of VBN NN , we VBP VBN that , in the JJ NN , no JJ NNS will VB from JJ NN of the NNP 's NN , RB that the JJ NN of our NN through JJ NNS would VB RB to the NNP 's NN to VB its NNS . We VBP VBN for , and VBP RB VBN , any JJ JJ NN for VBN NN NN . The NN of our NN VBZ RB VB on it , nor VBZ the NN of NN nor the NN of the JJ NN "" . </i> RBR , the NN VBZ : < i>"" By its JJ NN , NN VBZ a VBG NN and should VB JJ NN . RBR NNS , and JJR NNS , will VB JJ to VB the JJ NN into the NN . In any NN , no NN VBZ to VB the JJ NN or the JJ NNS , RB the NN in which they will VB VBN "" . NNP NNP NNP 1972 NN >. RB two NNS RBR , in 1974 , VBD the RB VBN NNP NNP < i> NNP NNP NNP NNP 200 < /i > about "" the NNS of the JJ NN NN for the NNP NN and JJ NNS "" . A NN we VBP VBN since it VBZ NN in 1989 . What we RB VBP VBZ that the JJ NNP NNP VBD his NN into JJ NNP NNS as a NN of the NNPS . There VBZ no NN that there VBZ a JJ NN from the NNP NN to the NNP NN . The NN VBZ that : • We VBP JJ NN NNS • JJ VBN NNS VBP VBG JJR • VBN NNP NNS could VB VBN • NN of JJ NN • JJ JJ NNS must VB VBN to VB NN . And the NN VBZ these NNS : • NN NN NN in the VBN NNS by 1985 • NNP NN NN in NNP NNP NNPS by 2000 It VBZ JJ VBG that this NN shall VB RB VBN in our JJ JJ NN and RB RBR VB VBN to the NNP NNP . RB because NNS in the VBN NN VBP JJR to VB with , JJR to VB by VBN VBN NN , JJR to VB with and JJR to VB up on when the NN of the NNS shall VB VBN . Which VBZ RB with the NN that the NN NNS in NN VBD in the JJ NN before it VBD in the NNP NNP . VBG the NNS , the NN VBZ : • JJ NN ( NN , NNS ) • NN NN • VBN NN • NNS ' NN • NN NN • NN NN • VB JJ NN • VB NN NN Can we VB some of these ? Ay ... all of it , RB . They VBP RB the NNS VBG the JJ NN of my NN - the NN from the 1970´ies and RB . RB and in every NN , they VBD VBN "" NN "" and there VBD a JJ NN that they VBD the NN of a JJ NN NN VBN on NN . RB , RB we VBP with the NN : VBD they RB VBZ to VB us VB VBG ourselves ? To VB that VBZ a JJ NN . VB us RB RB VB that the NNS of our NN RB can VB VBN . That VBZ through NN of the NN of NN in NN : When the JJ NNS VBD out NN in the NN , we VBP "" NN "" . When they VBP NN from NN , we VBP NN . The VBN NN of the JJ NN NN VBZ it JJ to VB the NNS VBG the NN - and RB VBG both NN NN and NNS in the NNS VBN . What VBZ RB a NN , VBZ that we VBD the NNS from the NNP NN . What RB VBZ , VBZ the NN that we VBD the VBG NNS . Around 1970 , the NN in NNP VBD 2.0 . NN it VBZ 1.7 - a JJ NN JJR than VBN to VB the NN of the NN . We VBP a JJ NN RB over the NNP NNP . VBG the NN in the NNP NNP , the NN VBZ the VBG NNS : • The NNP NNP • WHO • NNP • NNS from "" NN "" NNS • NNP • JJ NNS and NNS This VBZ VBG a JJ NN JJR of how the NN VBZ . An JJ JJ NN VBZ an JJ JJ NN to VB JJ NNS in his NN . We VBP RB VBG about a NNP as "" NNP NNS "" but about a NNP as NNS of NNP NNP NNP . We RB VBP that the NNP NNP VBZ a JJ NN . We VBP in the NNP and the JJ NNP VBZ JJ to VB into the NN NN - a NN RB VBG the RB VBN "" NNS "" . After a JJ NN of NN , it VBZ JJ that RB these NNS of the NN VBP JJ , RB and RB . And the NNP NNP VBZ , as we VBP RB VBN , the NN one NN for NN , VBN up by the JJ NN NNP . In their NN of NN , the NNP NNP VBZ VBN RB VBN and RB VBN for the JJ NN of their NNS . RB from that , the NN of the NN VBN by the NN NN ( NNP ) , the NN NN ( NNP ) , NN from JJ NNS VBZ VBN and through NN of NNS of NNS it all VBZ a NN of NNS - to - NNS - NN . RB RB on the NNP NN , which we VBP JJ as a NN NN VBG quite a NN of JJ NNS JJ . NNS RB VB to our JJ NN : The JJ NN and it VBZ JJ NN of NNS . ( To VB VBN NNP ) --- NNP NNP VBZ an NN , NN , NN and JJ NN in NNP . He VBZ RB an NNP - NNP by the NNP NNP NNP . VBZ VBN JJ NNS ( in NNP ) and NNS of NNS on JJ , JJ and JJ JJ NNS . www.heising.dk. NN ; [ NN VBN ]"
229,403,mainstream,"A_DT view_NN of_IN Moderna_NNP headquarters_NN on_IN May_NNP 08_CD ,_, 2020_CD in_IN Cambridge_NNP ,_, Massachusetts_NNP ._. Moderna_NNP was_VBD given_VBN FDA_NNP approval_NN to_TO continue_VB to_TO phase_VB 2_CD of_IN Coronavirus_NNP (_-LRB- COVID_NNP -_SYM 19_CD )_-RRB- vaccine_NN trials_NNS with_IN 600_CD participants_NNS ._. Israel_NNP is_VBZ in_IN advanced_JJ talks_NNS with_IN Moderna_NNP to_TO buy_VB its_PRP$ coronavirus_NN vaccine_NN that_WDT is_VBZ entering_VBG the_DT final_JJ stage_NN of_IN testing_NN ,_, leading_VBG Israeli_JJ news_NN website_NN YNET_NNP reported_VBD on_IN Sunday_NNP ._. YNET_NNP ,_, quoting_VBG unnamed_JJ officials_NNS at_IN Israel_NNP 's_POS Health_NNP Ministry_NNP ,_, did_VBD not_RB report_VB further_JJ details_NNS ._. A_DT ministry_NN spokesman_NN declined_VBD to_TO comment_VB on_IN the_DT report_NN ._. CNBC_NNP 's_POS Becky_NNP Quick_NNP reached_VBD out_RP to_IN CEO_NN Stephane_NNP Bancel_NNP ,_, who_WP said_VBD :_: ""_`` We_PRP are_VBP having_VBG discussions_NNS with_IN multiple_JJ governments_NNS around_IN the_DT world_NN and_CC are_VBP not_RB able_JJ to_TO comment_VB on_IN these_DT ._. ""_'' Moderna_NNP confirmed_VBD on_IN Thursday_NNP it_PRP planned_VBD to_TO start_VB a_DT trial_NN of_IN 30,000_CD volunteers_NNS for_IN its_PRP$ vaccine_NN in_IN July_NNP ._.","A NN of NNP NN on NNP 08 , 2020 in NNP , NNP . NNP VBD VBN NNP NN to VB to VB 2 of NNP ( NNP - 19 ) NN NNS with 600 NNS . NNP VBZ in JJ NNS with NNP to VB its NN NN that VBZ VBG the JJ NN of NN , VBG JJ NN NN NNP VBD on NNP . NNP , VBG JJ NNS at NNP 's NNP NNP , VBD RB VB JJ NNS . A NN NN VBD to VB on the NN . NNP 's NNP NNP VBD out to NN NNP NNP , who VBD : "" We VBP VBG NNS with JJ NNS around the NN and VBP RB JJ to VB on these . "" NNP VBD on NNP it VBD to VB a NN of 30,000 NNS for its NN in NNP ."
230,817,mainstream,"The_DT Vaccines_NNPS are_VBP set_VBN to_TO support_VB the_DT Arctic_NNP Monkeys_NNPS on_IN their_PRP$ November_NNP UK_NNP arena_NN tour_NN ,_, it_PRP has_VBZ been_VBN confirmed_VBN today_NN ._. The_DT London_NNP quartet_NN ,_, who_WP also_RB supported_VBD the_DT ‘_`` Suck_VB It_PRP And_CC See_VB ’_POS rockers_NNS on_IN their_PRP$ recent_JJ North_NNP American_JJ tour_NN and_CC huge_JJ outdoor_JJ show_NN at_IN Sheffield_NNP ‘s_POS Don_NNP Valley_NNP Bowl_NNP ,_, will_MD provide_VB support_NN on_IN all_DT nine_CD of_IN the_DT Arctic_NNP Monkeys_NNPS ‘_`` arena_NN dates_NNS ._. The_DT shows_NNS kick_VBP off_RP at_IN Nottingham_NNP ‘s_POS Capital_NNP FM_NNP Arena_NNP on_IN October_NNP 28_CD and_CC end_NN at_IN Liverpool_NNP ‘s_POS Echo_NNP Arena_NNP on_IN November_NNP 9_CD ._. Arctic_NNP Monkeys_NNPS ,_, with_IN support_NN from_IN The_DT Vaccines_NNPS ,_, will_MD play_VB :_: Tickets_NNS go_VBP on_IN sale_NN on_IN Friday_NNP (_-LRB- June_NNP 17_CD )_-RRB- at_IN 9_CD am_NN (_-LRB- BST_NNP )_-RRB- ._. To_TO check_VB the_DT availability_NN of_IN Arctic_NNP Monkeys_NNPS tickets_NNS and_CC get_VB all_PDT the_DT latest_JJS listings_NNS ,_, go_VB to_IN NME._NNP COM_NN /_, TICKETS_NNPS now_RB ,_, or_CC call_VB 0871_CD 230_CD 1094_CD ._.","The NNPS VBP VBN to VB the NNP NNPS on their NNP NNP NN NN , it VBZ VBN VBN NN . The NNP NN , who RB VBD the ‘ VB It And VB ’ NNS on their JJ NNP JJ NN and JJ JJ NN at NNP ‘s NNP NNP NNP , will VB NN on all nine of the NNP NNPS ‘ NN NNS . The NNS VBP off at NNP ‘s NNP NNP NNP on NNP 28 and NN at NNP ‘s NNP NNP on NNP 9 . NNP NNPS , with NN from The NNPS , will VB : NNS VBP on NN on NNP ( NNP 17 ) at 9 NN ( NNP ) . To VB the NN of NNP NNPS NNS and VB all the JJS NNS , VB to NNP NN / NNPS RB , or VB 0871 230 1094 ."
231,1156,conspiracy,"A_DT British_JJ study_NN supports_VBZ the_DT position_NN of_IN the_DT anti-vaccination_NN forces_NNS ._. Parents_NNS who_WP have_VBP had_VBN the_DT traumatic_JJ experience_NN of_IN registering_VBG their_PRP$ children_NNS for_IN school_NN are_VBP familiar_JJ with_IN the_DT demand_NN that_IN the_DT children_NNS have_VBP certain_JJ immunizations_NNS ._. Those_DT who_WP do_VBP n’t_RB want_VB to_TO immunize_VB their_PRP$ children_NNS face_VB a_DT gauntlet_NN of_IN state_NN and_CC federal_JJ problems_NNS and_CC the_DT possibility_NN that_IN their_PRP$ children_NNS will_MD not_RB be_VB allowed_VBN to_TO attend_VB school_NN without_IN a_DT court_NN order_NN ._. The_DT parents_NNS are_VBP assured_VBN that_IN the_DT federal_JJ government_NN says_VBZ the_DT shots_NNS are_VBP safe_JJ and_CC effective_JJ ._. But_CC things_NNS may_MD not_RB be_VB as_RB worry_JJ -_HYPH free_JJ as_IN the_DT government_NN says_VBZ ._. A_DT United_NNP Kingdom_NNP study_NN —_: not_RB widely_RB disbursed_VBN in_IN this_DT country_NN —_: says_VBZ the_DT measles_NNS ,_, mumps_NNS and_CC rubella_NN vaccine_NN (_-LRB- MMR_NNP )_-RRB- has_VBZ been_VBN linked_VBN to_IN a_DT rare_JJ bleeding_NN disorder_NN in_IN children_NNS ._. According_VBG to_IN research_NN published_VBN Feb._NNP 21_CD ,_, two_CD out_IN of_IN every_DT three_CD cases_NNS of_IN idiopathic_JJ thrombocytopenic_NN purpura_NN (_-LRB- ITP_NN )_-RRB- ,_, or_CC bleeding_NN under_IN the_DT skin_NN ,_, in_IN the_DT six_CD weeks_NNS after_IN MMR_NNP immunization_NN are_VBP caused_VBN by_IN the_DT vaccine_NN ._. This_DT accounts_VBZ for_IN one_CD child_NN in_IN every_DT 22,300_CD in_IN the_DT UK_NNP given_VBN the_DT MMR_NNP vaccine_NN who_WP were_VBD admitted_VBN to_IN the_DT hospital_NN ._. The_DT study_NN ,_, published_VBN in_IN the_DT Archives_NNPS of_IN Disease_NNP in_IN Childhood_NNP ,_, was_VBD led_VBN by_IN Dr._NNP Elizabeth_NNP Miller_NNP of_IN the_DT Public_NNP Health_NNP Laboratory_NNP Service_NNP who_WP has_VBZ conducted_VBN extensive_JJ research_NN into_IN any_DT adverse_JJ effects_NNS of_IN the_DT MMR_NN vaccine_NN ._. The_DT vaccine_NN has_VBZ been_VBN linked_VBN to_IN an_DT increase_NN in_IN a_DT form_NN of_IN bowel_NN disease_NN and_CC autism_NN in_IN children_NNS ,_, although_IN Miller_NNP ’s_POS earlier_JJR studies_NNS have_VBP found_VBN no_DT association_NN with_IN autism_NN ._. The_DT study_NN says_VBZ that_IN ITP_NN is_VBZ caused_VBN by_IN a_DT shortage_NN of_IN platelets_NNS ,_, the_DT cells_NNS that_WDT make_VBP blood_NN “_`` sticky_JJ ._. ”_'' In_IN the_DT general_JJ population_NN ,_, with_IN or_CC without_IN MMR_NN vaccinations_NNS ,_, ITP_NNP occurs_VBZ in_IN about_RB one_CD in_IN 10,000_CD people_NNS and_CC in_IN children_NNS and_CC young_JJ people_NNS it_PRP is_VBZ often_RB preceded_VBN by_IN a_DT viral_JJ infection_NN ._.","A JJ NN VBZ the NN of the NN NNS . NNS who VBP VBN the JJ NN of VBG their NNS for NN VBP JJ with the NN that the NNS VBP JJ NNS . Those who VBP RB VB to VB their NNS VB a NN of NN and JJ NNS and the NN that their NNS will RB VB VBN to VB NN without a NN NN . The NNS VBP VBN that the JJ NN VBZ the NNS VBP JJ and JJ . But NNS may RB VB RB JJ - JJ as the NN VBZ . A NNP NNP NN — RB RB VBN in this NN — VBZ the NNS , NNS and NN NN ( NNP ) VBZ VBN VBN to a JJ NN NN in NNS . VBG to NN VBN NNP 21 , two out of every three NNS of JJ NN NN ( NN ) , or NN under the NN , in the six NNS after NNP NN VBP VBN by the NN . This VBZ for one NN in every 22,300 in the NNP VBN the NNP NN who VBD VBN to the NN . The NN , VBN in the NNPS of NNP in NNP , VBD VBN by NNP NNP NNP of the NNP NNP NNP NNP who VBZ VBN JJ NN into any JJ NNS of the NN NN . The NN VBZ VBN VBN to an NN in a NN of NN NN and NN in NNS , although NNP ’s JJR NNS VBP VBN no NN with NN . The NN VBZ that NN VBZ VBN by a NN of NNS , the NNS that VBP NN “ JJ . ” In the JJ NN , with or without NN NNS , NNP VBZ in RB one in 10,000 NNS and in NNS and JJ NNS it VBZ RB VBN by a JJ NN ."
232,1242,mainstream,"‘_`` They_PRP have_VBP to_TO get_VB the_DT shots_NNS ’_'' :_: Trump_NNP ,_, once_RB a_DT vaccine_NN skeptic_NN ,_, changes_VBZ his_PRP$ tune_NN amid_IN measles_NN outbreaks_NNS As_IN measles_NNS outbreaks_NNS rage_VBP in_IN a_DT number_NN of_IN states_NNS across_IN the_DT country_NN ,_, President_NNP Trump_NNP urged_VBD families_NNS to_TO vaccinate_VB their_PRP$ children_NNS on_IN Friday_NNP ._. “_`` They_PRP have_VBP to_TO get_VB the_DT shots_NNS ._. The_DT vaccinations_NNS are_VBP so_RB important_JJ ,_, ”_'' Trump_NNP told_VBD reporters_NNS as_IN he_PRP left_VBD the_DT White_NNP House_NNP ._. “_`` This_DT is_VBZ really_RB going_VBG around_RB now_RB ._. They_PRP have_VBP to_TO get_VB their_PRP$ shots_NNS ._. ”_'' The_DT endorsement_NN of_IN vaccination_NN from_IN a_DT previously_RB vaccine_NN -_HYPH questioning_VBG president_NN comes_VBZ as_IN a_DT bit_NN of_IN a_DT surprise_NN ._. Before_IN winning_VBG the_DT presidency_NN ,_, Trump_NNP several_JJ times_NNS alleged_VBD there_EX was_VBD a_DT link_NN between_IN the_DT number_NN of_IN vaccines_NNS children_NNS get_VB in_IN early_JJ infancy_NN and_CC the_DT development_NN of_IN autism_NN ._. But_CC since_IN his_PRP$ inauguration_NN ,_, Trump_NNP has_VBZ made_VBN no_DT public_JJ comment_NN about_IN vaccines_NNS at_IN all_DT ._. With_IN the_DT measles_NNS count_NN in_IN the_DT United_NNP States_NNPS hitting_VBG its_PRP$ highest_JJS point_NN since_IN 1994_CD this_DT week_NN ,_, public_JJ health_NN observers_NNS have_VBP questioned_VBN why_WRB this_DT president_NN ,_, unlike_IN predecessors_NNS going_VBG back_RB to_IN Franklin_NNP Delano_NNP Roosevelt_NNP ,_, has_VBZ n’t_RB been_VBN urging_VBG parents_NNS to_TO vaccinate_VB their_PRP$ children_NNS ._. Some_DT raised_VBD concerns_NNS that_IN Trump_NNP ’s_POS track_NN record_NN on_IN vaccination_NN would_MD undercut_VB the_DT credibility_NN of_IN any_DT pro-vaccination_JJ message_NN he_PRP delivered_VBD ._. But_CC others_NNS noted_VBD that_IN his_PRP$ base_NN voters_NNS might_MD be_VB swayed_VBN if_IN he_PRP endorsed_VBD vaccines_NNS ._. “_`` To_IN me_PRP ,_, this_DT is_VBZ one_CD of_IN the_DT best_JJS things_NNS President_NNP Trump_NNP has_VBZ done_VBN ,_, ”_'' said_VBD Jonathan_NNP Zimmerman_NNP ,_, a_DT professor_NN of_IN the_DT history_NN of_IN education_NN at_IN the_DT University_NNP of_IN Pennsylvania_NNP ,_, who_WP called_VBD out_RP Trump_NNP publicly_RB on_IN his_PRP$ silence_NN in_IN a_DT recent_JJ op_NN -_HYPH ed_NN published_VBN in_IN the_DT Philadelphia_NNP Inquirer_NNP ._. Zimmerman_NNP called_VBD the_DT move_NN “_`` politically_RB brave_JJ ,_, ”_'' noting_VBG there_EX is_VBZ an_DT anti-vaccine_JJ faction_NN within_IN his_PRP$ base_NN ._. “_`` I_PRP hope_VBP my_PRP$ fellow_JJ liberals_NNS will_MD take_VB a_DT break_NN from_IN lambasting_VBG the_DT President_NNP and_CC congratulate_VB him_PRP ._. Whatever_WDT his_PRP$ other_JJ wrongs_NNS ,_, he_PRP was_VBD dead_JJ right_RB about_IN this_DT ,_, ”_'' Zimmerman_NNP said_VBD ._. On_IN Wednesday_NNP ,_, the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP said_VBD that_IN reported_VBN measles_NNS cases_NNS in_IN the_DT country_NN had_VBD hit_VBN 695_CD ,_, the_DT highest_JJS number_NN since_IN before_IN measles_NNS was_VBD declared_VBN in_IN eliminated_VBN in_IN the_DT U.S._NNP in_IN 2000_CD ._. Cases_NNS have_VBP been_VBN reported_VBN from_IN 22_CD states_NNS ._. The_DT president_NN ’s_POS comments_NNS were_VBD welcomed_VBN by_IN Dr._NNP Matt_NNP Zahn_NNP ,_, the_DT chair_NN of_IN the_DT Infectious_NNP Diseases_NNPS Society_NNP of_IN America_NNP ’s_POS public_JJ health_NN committee_NN ,_, who_WP suggested_VBD they_PRP could_MD be_VB helpful_JJ in_IN winning_VBG over_IN parents_NNS who_WP worry_VBP about_IN the_DT safety_NN of_IN vaccines_NNS ._. “_`` It_PRP ’s_VBZ just_RB so_RB important_JJ that_IN there_EX ’s_VBZ clarity_NN here_RB ,_, ”_'' said_VBD Zahn_NNP ,_, who_WP is_VBZ medical_JJ director_NN for_IN the_DT communicable_JJ diseases_NNS program_NN for_IN Orange_NNP County_NNP Public_NNP Health_NNP in_IN California_NNP ._. “_`` You_PRP are_VBP safer_JJR and_CC the_DT public_NN will_MD be_VB healthier_JJR when_WRB our_PRP$ kids_NNS are_VBP getting_VBG immunized_VBN and_CC when_WRB our_PRP$ community_NN immunization_NN rates_NNS go_VBP up_RP ._. ”_'' Orange_NNP County_NNP is_VBZ home_NN to_IN Disneyland_NNP ,_, the_DT epicenter_NN of_IN a_DT big_JJ measles_NNS outbreak_NN in_IN 2015_CD ._. Working_VBG to_TO contain_VB it_PRP was_VBD an_DT enormous_JJ amount_NN of_IN work_NN ,_, Zahn_NNP said_VBD ._. He_PRP said_VBD there_EX is_VBZ a_DT fear_NN among_IN public_JJ health_NN officials_NNS that_IN the_DT ground_NN is_VBZ now_RB shifting_VBG ._. Where_WRB in_IN recent_JJ years_NNS U.S._NNP measles_NN numbers_NNS have_VBP been_VBN driven_VBN by_IN one_CD or_CC two_CD large_JJ outbreaks_NNS —_: among_IN Amish_NNP communities_NNS in_IN Ohio_NNP in_IN 2014_CD ,_, Disneyland_NNP in_IN 2015_CD —_: this_DT year_NN there_EX are_VBP multiple_JJ large_JJ outbreaks_NNS around_IN the_DT country_NN ._. “_`` It_PRP feels_VBZ different_JJ ,_, ”_'' Zahn_NNP said_VBD ,_, noting_VBG that_IN even_RB counties_NNS like_IN his_PRP that_WDT are_VBP n’t_RB currently_RB battling_VBG a_DT measles_NN outbreak_NN are_VBP finding_VBG themselves_PRP having_VBG to_TO chase_VB down_RP contacts_NNS who_WP were_VBD exposed_VBN elsewhere_RB ._. “_`` There_EX is_VBZ an_DT awful_JJ lot_NN of_IN spillover_NN to_IN other_JJ communities_NNS and_CC to_IN other_JJ counties_NNS ._. ”_'' “_`` I_PRP think_VBP for_IN all_DT of_IN public_JJ health_NN ,_, we_PRP ’re_VBP all_RB a_DT little_JJ apprehensive_JJ that_IN we_PRP ’re_VBP reaching_VBG a_DT new_JJ normal_JJ wherein_WRB every_DT community_NN deals_VBZ with_IN these_DT events_NNS or_CC cases_NNS or_CC outbreaks_NNS on_IN a_DT semi-_JJ regular_JJ basis_NN ,_, ”_'' he_PRP said_VBD ._. And_CC with_IN a_DT growing_VBG number_NN of_IN pockets_NNS across_IN the_DT country_NN where_WRB vaccination_NN rates_NNS are_VBP low_JJ ,_, the_DT U.S._NNP is_VBZ likely_JJ to_TO find_VB itself_PRP having_VBG to_TO fight_VB ever_RB larger_JJR outbreaks_NNS when_WRB unvaccinated_JJ Americans_NNPS get_VBP infected_VBN abroad_RB and_CC return_VBP home_RB sick_JJ ,_, or_CC when_WRB infected_VBN tourists_NNS bring_VBP the_DT virus_NN to_IN the_DT country_NN ._. “_`` We_PRP certainly_RB have_VBP …_: communities_NNS of_IN significant_JJ size_NN in_IN this_DT country_NN where_WRB immunization_NN rates_NNS are_VBP quite_RB low_JJ ,_, ”_'' Zahn_NNP said_VBD ._. “_`` So_RB the_DT ground_NN in_IN the_DT United_NNP States_NNPS is_VBZ more_RBR fertile_JJ for_IN these_DT outbreaks_NNS than_IN it_PRP has_VBZ been_VBN in_IN decades_NNS past_NN ._. ”_''","‘ They VBP to VB the NNS ’ : NNP , RB a NN NN , VBZ his NN amid NN NNS As NNS NNS VBP in a NN of NNS across the NN , NNP NNP VBD NNS to VB their NNS on NNP . “ They VBP to VB the NNS . The NNS VBP RB JJ , ” NNP VBD NNS as he VBD the NNP NNP . “ This VBZ RB VBG RB RB . They VBP to VB their NNS . ” The NN of NN from a RB NN - VBG NN VBZ as a NN of a NN . Before VBG the NN , NNP JJ NNS VBD there VBD a NN between the NN of NNS NNS VB in JJ NN and the NN of NN . But since his NN , NNP VBZ VBN no JJ NN about NNS at all . With the NNS NN in the NNP NNPS VBG its JJS NN since 1994 this NN , JJ NN NNS VBP VBN why this NN , unlike NNS VBG RB to NNP NNP NNP , VBZ RB VBN VBG NNS to VB their NNS . Some VBD NNS that NNP ’s NN NN on NN would VB the NN of any JJ NN he VBD . But NNS VBD that his NN NNS might VB VBN if he VBD NNS . “ To me , this VBZ one of the JJS NNS NNP NNP VBZ VBN , ” VBD NNP NNP , a NN of the NN of NN at the NNP of NNP , who VBD out NNP RB on his NN in a JJ NN - NN VBN in the NNP NNP . NNP VBD the NN “ RB JJ , ” VBG there VBZ an JJ NN within his NN . “ I VBP my JJ NNS will VB a NN from VBG the NNP and VB him . Whatever his JJ NNS , he VBD JJ RB about this , ” NNP VBD . On NNP , the NNPS for NNP NNP and NNP VBD that VBN NNS NNS in the NN VBD VBN 695 , the JJS NN since before NNS VBD VBN in VBN in the NNP in 2000 . NNS VBP VBN VBN from 22 NNS . The NN ’s NNS VBD VBN by NNP NNP NNP , the NN of the NNP NNPS NNP of NNP ’s JJ NN NN , who VBD they could VB JJ in VBG over NNS who VBP about the NN of NNS . “ It VBZ RB RB JJ that there VBZ NN RB , ” VBD NNP , who VBZ JJ NN for the JJ NNS NN for NNP NNP NNP NNP in NNP . “ You VBP JJR and the NN will VB JJR when our NNS VBP VBG VBN and when our NN NN NNS VBP up . ” NNP NNP VBZ NN to NNP , the NN of a JJ NNS NN in 2015 . VBG to VB it VBD an JJ NN of NN , NNP VBD . He VBD there VBZ a NN among JJ NN NNS that the NN VBZ RB VBG . Where in JJ NNS NNP NN NNS VBP VBN VBN by one or two JJ NNS — among NNP NNS in NNP in 2014 , NNP in 2015 — this NN there VBP JJ JJ NNS around the NN . “ It VBZ JJ , ” NNP VBD , VBG that RB NNS like his that VBP RB RB VBG a NN NN VBP VBG themselves VBG to VB down NNS who VBD VBN RB . “ There VBZ an JJ NN of NN to JJ NNS and to JJ NNS . ” “ I VBP for all of JJ NN , we VBP RB a JJ JJ that we VBP VBG a JJ JJ wherein every NN VBZ with these NNS or NNS or NNS on a JJ JJ NN , ” he VBD . And with a VBG NN of NNS across the NN where NN NNS VBP JJ , the NNP VBZ JJ to VB itself VBG to VB RB JJR NNS when JJ NNPS VBP VBN RB and VBP RB JJ , or when VBN NNS VBP the NN to the NN . “ We RB VBP … NNS of JJ NN in this NN where NN NNS VBP RB JJ , ” NNP VBD . “ RB the NN in the NNP NNPS VBZ RBR JJ for these NNS than it VBZ VBN in NNS NN . ”"
233,20,mainstream,"The_DT first_JJ history_NN of_IN any_DT vaccine_NN goes_VBZ back_RB to_IN China_NNP ,_, hundreds_NNS of_IN years_NNS ago_RB ,_, for_IN smallpox_NN ._. The_DT first_JJ experimental_JJ use_NN of_IN vaccines_NNS goes_VBZ back_RB 200_CD years_NNS to_IN Jenner_NNP in_IN England_NNP ,_, where_WRB he_PRP took_VBD a_DT scab_NN of_IN cowpox_NN from_IN a_DT cow_NN and_CC rubbed_VBD it_PRP on_IN a_DT cut_NN on_IN the_DT arm_NN of_IN a_DT boy_NN ,_, and_CC there_EX was_VBD sort_NN of_IN a_DT reaction_NN to_IN it_PRP ._. And_CC then_RB --_, you_PRP never_RB do_VBP this_DT today_NN --_, but_CC he_PRP challenged_VBD the_DT kid_NN with_IN authentic_JJ smallpox_NN ._. And_CC the_DT boy_NN did_VBD not_RB get_VB smallpox_NN ,_, so_RB he_PRP made_VBD the_DT correlation_NN ._. President_NNP emeritus_NNP of_IN the_DT Boyce_NNP Thompson_NNP Institute_NNP for_IN Plant_NNP Research_NNP at_IN Cornell_NNP University_NNP ,_, Arntzen_NNP is_VBZ working_VBG on_IN making_VBG safer_JJR vaccines_NNS for_IN viruses_NNS which_WDT kill_VBP millions_NNS in_IN the_DT developing_VBG world_NN ._. He_PRP discusses_VBZ his_PRP$ work_NN developing_VBG edible_JJ vaccines_NNS (_-LRB- inside_IN GM_NN bananas_NNS ,_, tomatoes_NNS ,_, or_CC potatoes_NNS )_-RRB- ._. He_PRP also_RB talks_VBZ about_IN Europe_NNP 's_POS opposition_NN to_IN GM_NNP foods_NNS and_CC science_NN 's_POS hopes_NNS for_IN applying_VBG GM_NN techniques_NNS to_IN future_JJ foods_NNS ,_, medicines_NNS ,_, and_CC environmental_JJ cleanup_NN ._. (_-LRB- Interview_NN conducted_VBN September_NNP 2000_CD ._. )_-RRB- That_DT was_VBD the_DT first_JJ model_NN of_IN a_DT vaccine_NN where_WRB you_PRP used_VBD ,_, in_IN that_DT case_NN ,_, a_DT related_JJ virus_NN ._. Today_NN we_PRP call_VBP them_PRP attenuated_VBN viruses_NNS ,_, because_IN they_PRP 're_VBP like_IN the_DT real_JJ pathogen_NN -_, -_, a_DT thing_NN that_WDT causes_VBZ disease_NN --_, but_CC they_PRP 're_VBP either_CC weakened_VBN ,_, sometimes_RB killed_VBN ,_, chemically_RB inactivated_VBN --_, or_CC there_EX are_VBP relatives_NNS ._. So_RB it_PRP could_MD be_VB a_DT virus_NN that_WDT attacks_VBZ cattle_NNS but_CC not_RB people_NNS ,_, but_CC it_PRP still_RB triggers_VBZ an_DT immune_JJ response_NN ._. So_RB for_IN 200_CD years_NNS ,_, most_JJS vaccines_NNS have_VBP been_VBN built_VBN around_IN this_DT concept_NN of_IN using_VBG a_DT relative_NN of_IN what_WP causes_VBZ disease_NN in_IN us_PRP ,_, or_CC an_DT inactivated_VBN form_NN ._. Then_RB along_RB came_VBD molecular_JJ biology_NN in_IN the_DT mid-_NN to_IN late_JJ 1970s_NNS ._. The_DT first_JJ vaccine_NN that_WDT came_VBD out_IN of_IN this_DT was_VBD for_IN hepatitis_NN B_NN ._. The_DT scientists_NNS in_IN that_DT case_NN looked_VBD at_IN the_DT entire_JJ genome_NN of_IN the_DT hepatitis_NN B_NN virus_NN ._. That_DT was_VBD a_DT pretty_RB heroic_JJ scientific_JJ feat_NN ,_, with_IN the_DT simple_JJ techniques_NNS they_PRP had_VBD about_IN 25_CD years_NNS ago_RB ._. But_CC they_PRP found_VBD a_DT gene_NN in_IN the_DT virus_NN that_WDT encodes_VBZ ,_, or_CC it_PRP has_VBZ the_DT information_NN for_IN ,_, the_DT surface_NN of_IN the_DT hepatitis_NN B_NN virus_NN ._. You_PRP can_MD picture_VB hepatitis_NN B_NN like_IN a_DT little_JJ tennis_NN ball_NN ._. It_PRP 's_VBZ got_VBN a_DT furry_NN outside_RB and_CC that_IN furry_JJ stuff_NN on_IN the_DT outside_NN is_VBZ protein_NN ._. That_DT 's_VBZ what_WP sticks_VBZ to_IN a_DT human_JJ cell_NN and_CC causes_VBZ the_DT virus_NN to_TO be_VB taken_VBN up_RP ._. So_RB these_DT guys_NNS did_VBD take_VB that_DT gene_NN ,_, moved_VBD it_PRP to_IN yeast_NN ,_, and_CC grew_VBD the_DT yeast_NN in_IN fermentation_NN vats_NNS ._. Now_RB the_DT yeast_NN produces_VBZ a_DT furry_JJ little_JJ tennis_NN ball_NN ,_, or_CC a_DT virus_NN -_HYPH like_JJ particle_NN ,_, but_CC there_EX 's_VBZ nothing_NN inside_IN it_PRP ,_, so_RB there_EX 's_VBZ no_DT capacity_NN for_IN disease_NN ._. They_PRP purified_VBD this_DT furry_JJ little_JJ tennis_NN ball_NN from_IN yeast_NN ,_, and_CC now_RB formulate_VBP it_PRP and_CC put_VBP it_PRP into_IN an_DT injectable_JJ form_NN ._. That_DT was_VBD the_DT first_JJ hepatitis_NN B_NN vaccine_NN ._. That_DT came_VBD out_RP in_IN 1986_CD ._. It_PRP was_VBD licensed_VBN by_IN the_DT federal_JJ government_NN as_IN being_VBG very_RB safe_JJ and_CC very_RB effective_JJ ._. That_DT was_VBD the_DT first_JJ of_IN now_RB what_WP 's_VBZ appearing_VBG to_TO be_VB a_DT flood_NN of_IN subunit_NN vaccines_NNS that_WDT are_VBP coming_VBG in_RP ._. The_DT molecular_JJ vaccines_NNS are_VBP really_RB safe_JJ ._. Are_VBP there_EX disadvantages_NNS ?_. I_PRP do_VBP n't_RB want_VB to_TO emphasize_VB that_IN there_EX are_VBP disadvantages_NNS to_IN modern_JJ vaccines_NNS ._. But_CC there_PRP$ inconveniences_NNS ,_, if_IN you_PRP will_MD ,_, and_CC those_DT relate_VBP to_IN the_DT cost_NN ._. This_DT is_VBZ a_DT pretty_RB high_JJ -_HYPH technology_NN process_NN ._. It_PRP 's_VBZ not_RB been_VBN very_RB easy_JJ to_TO transfer_VB it_PRP to_IN developing_VBG countries_NNS ._. The_DT second_JJ point_NN is_VBZ that_IN these_DT new_JJ vaccines_NNS all_DT require_VBP refrigeration_NN from_IN the_DT point_NN of_IN manufacture_NN to_IN the_DT point_NN of_IN use_NN ._. If_IN you_PRP 're_VBP trying_VBG to_TO take_VB a_DT vaccine_NN to_IN a_DT Third_NNP World_NNP country_NN ,_, that_DT adds_VBZ an_DT enormous_JJ cost_NN ,_, and_CC adds_VBZ a_DT certain_JJ unreliability_NN ._. If_IN this_DT cold_JJ chain_NN breaks_VBZ down_RP someplace_NN ,_, you_PRP could_MD lose_VB the_DT effectiveness_NN of_IN your_PRP$ vaccine_NN ._. So_RB those_DT are_VBP the_DT two_CD biggest_JJS issues_NNS ._. In_IN addition_NN ,_, the_DT World_NNP Health_NNP Organization_NNP says_VBZ ,_, ""_`` We_PRP 'd_MD really_RB like_VB these_DT to_TO be_VB oral_JJ vaccines_NNS ,_, because_IN they_PRP 're_VBP easier_JJR to_TO implement_VB ._. ""_'' Their_PRP$ model_NN for_IN that_DT is_VBZ a_DT polio_NN vaccine_NN --_, a_DT simple_JJ thing_NN that_WDT was_VBD developed_VBN more_RBR than_IN two_CD or_CC three_CD decades_NNS ago_RB ._. You_PRP take_VBP the_DT polio_NN virus_NN in_IN a_DT weakened_VBN form_NN ,_, but_CC put_VBP it_PRP on_IN a_DT sugar_NN cube_NN ,_, and_CC just_RB put_VBP that_DT on_IN the_DT mouth_NN or_CC the_DT tongue_NN of_IN a_DT kid_NN ._. It_PRP 's_VBZ an_DT easy_JJ delivery_NN mechanism_NN ._. So_RB the_DT World_NNP Health_NNP Organization_NNP has_VBZ been_VBN looking_VBG for_IN the_DT equivalent_NN of_IN the_DT sugar_NN cube_NN delivery_NN system_NN ._. What_WP 's_VBZ wrong_JJ with_IN syringes_NNS ?_. Well_UH ,_, syringes_NNS cost_VBP money_NN ._. Because_IN they_PRP cost_VBP money_NN ,_, they_PRP 're_VBP often_RB inappropriately_RB used_VBN in_IN developing_VBG world_NN ._. People_NNS try_VBP to_TO clean_VB them_PRP ,_, and_CC they_PRP should_MD n't_RB ._. They_PRP should_MD be_VB throwing_VBG them_PRP away_RB ,_, but_CC at_IN the_DT cost_NN ,_, they_PRP add_VBP significantly_RB to_IN the_DT delivery_NN system_NN ._. The_DT World_NNP Health_NNP Organization_NNP estimates_VBZ that_IN there_EX are_VBP hundreds_NNS of_IN thousands_NNS of_IN deaths_NNS and_CC disease_NN incidents_NNS caused_VBN by_IN inappropriate_JJ needle_NN use_NN ._. So_RB they_PRP 'd_MD like_VB to_TO get_VB away_RB from_IN that_DT technology_NN ._. Given_VBN those_DT hurdles_NNS ,_, how_WRB can_MD a_DT plant_NN get_VB you_PRP through_IN this_DT ?_. With_IN plant_NN -_HYPH based_VBN vaccines_NNS ,_, we_PRP 're_VBP not_RB trying_VBG to_TO replace_VB the_DT immunology_NN side_NN of_IN it_PRP ._. We_PRP 're_VBP totally_RB dependent_JJ upon_IN our_PRP$ friends_NNS who_WP know_VBP virology_NN and_CC bacteriology_NN to_TO figure_VB out_RP how_WRB to_TO find_VB the_DT genes_NNS and_CC find_VB the_DT right_JJ components_NNS to_TO make_VB the_DT vaccine_NN ._. I_PRP picture_VBP myself_PRP ,_, as_IN a_DT plant_NN biologist_NN ,_, as_IN a_DT manufacturing_NN specialist_NN ._. We_PRP can_MD put_VB the_DT gene_NN now_RB into_IN the_DT chromosome_NN of_IN the_DT plant_NN ,_, so_IN that_IN every_DT cell_NN in_IN the_DT plant_NN that_WDT comes_VBZ back_RB out_IN of_IN this_DT has_VBZ the_DT capacity_NN to_TO manufacture_VB a_DT new_JJ protein_NN ._. Then_RB ,_, even_RB more_RBR ,_, the_DT plant_NN itself_PRP is_VBZ a_DT delivery_NN system_NN ._. So_RB if_IN you_PRP can_MD simply_RB eat_VB it_PRP ,_, now_RB you_PRP do_VBP n't_RB have_VB to_TO do_VB any_DT complex_JJ formulation_NN ;_, you_PRP do_VBP n't_RB have_VB to_TO do_VB purification_NN ;_, and_CC you_PRP do_VBP n't_RB have_VB to_TO deal_VB with_IN some_DT of_IN the_DT other_JJ issues_NNS about_IN toxicants_NNS or_CC other_JJ materials_NNS that_WDT could_MD get_VB into_IN the_DT formulated_VBN vaccine_NN ._. So_RB plants_NNS offer_VBP a_DT less_RBR expensive_JJ production_NN system_NN ,_, and_CC also_RB ,_, we_PRP believe_VBP ,_, a_DT more_RBR efficient_JJ and_CC effective_JJ delivery_NN system_NN ._. Coupled_VBN with_IN growing_VBG a_DT plant_NN and_CC using_VBG food_NN -_HYPH processing_NN technology_NN to_TO prepare_VB the_DT vaccine_NN ,_, we_PRP can_MD now_RB take_VB existing_VBG technology_NN that_WDT 's_VBZ in_IN the_DT developing_VBG world_NN --_, agriculture_NN and_CC food_NN processing_NN that_WDT exists_VBZ around_IN the_DT world_NN --_, and_CC adapt_VBP that_DT to_IN making_VBG a_DT pharmaceutical_NN ._. Is_VBZ it_PRP in_IN a_DT safe_JJ form_NN in_IN the_DT plant_NN ?_. When_WRB we_PRP started_VBD thinking_VBG about_IN delivery_NN systems_NNS ,_, the_DT one_NN that_WDT I_PRP began_VBD focusing_VBG on_IN about_IN eight_CD years_NNS ago_RB was_VBD bananas_NNS ._. When_WRB you_PRP start_VBP peeling_VBG a_DT banana_NN ,_, the_DT minute_NN that_WDT peeling_NN comes_VBZ off_RP ,_, you_PRP are_VBP exposing_VBG a_DT sterile_JJ environment_NN inside_RB ._. There_EX are_VBP no_DT bacteria_NN ._. There_EX are_VBP no_DT fungi_NN in_IN there_RB ._. This_DT is_VBZ a_DT self_NN -_HYPH contained_VBN sterile_JJ container_NN that_WDT also_RB contains_VBZ protein_NN ._. So_RB you_PRP can_MD think_VB of_IN it_PRP as_IN a_DT sterile_JJ protein_NN -_HYPH manufacturing_NN system_NN ._. If_IN we_PRP can_MD put_VB genes_NNS into_IN bananas_NNS and_CC cause_VB them_PRP to_TO produce_VB the_DT protein_NN we_PRP want_VBP --_, in_IN this_DT case_NN ,_, a_DT vaccine_NN --_, in_IN that_DT sterile_JJ compartment_NN ,_, then_RB all_DT we_PRP have_VBP to_TO do_VB is_VBZ pop_VB it_PRP open_JJ and_CC deliver_VB it_PRP ._. What_WP is_VBZ the_DT process_NN ,_, from_IN start_NN to_TO finish_VB ,_, of_IN how_WRB you_PRP transform_VBP a_DT plant_NN ?_. ._. ._. ._. We_PRP 've_VBP spent_VBN the_DT most_JJS time_NN working_VBG on_IN diseases_NNS caused_VBN by_IN viruses_NNS or_CC bacteria_NN that_WDT ._. ._. ._. cause_VB diarrhea_NN ._. ._. ._. ._. Diarrheal_NN disease_NN is_VBZ an_DT enormous_JJ problem_NN in_IN the_DT developing_VBG world_NN ._. It_PRP causes_VBZ deaths_NNS of_IN about_RB 2_CD million_CD children_NNS every_DT year_NN ._. That_DT comes_VBZ from_IN a_DT variety_NN of_IN reasons_NNS :_: inadequate_JJ water_NN purification_NN ,_, public_JJ hygiene_NN systems_NNS ,_, etc_FW ._. That_DT 's_VBZ one_CD part_NN of_IN solving_VBG this_DT problem_NN in_IN the_DT long_JJ term_NN ._. But_CC in_IN the_DT short_JJ term_NN ,_, vaccines_NNS would_MD be_VB the_DT best_JJS route_NN to_TO prevent_VB the_DT disease_NN ._. Because_IN the_DT disease_NN is_VBZ endemic_JJ ?_. It_PRP 's_VBZ an_DT endemic_JJ problem_NN ._. Diarrheal_NN disease_NN re-occurs_VBZ ,_, especially_RB in_IN the_DT developing_VBG world_NN ._. Whenever_WRB they_PRP enter_VBP the_DT monsoon_NN season_NN and_CC other_JJ problems_NNS like_IN that_DT ,_, it_PRP spreads_VBZ more_RBR rapidly_RB ._. Enormous_JJ loss_NN of_IN life_NN occurs_VBZ from_IN diseases_NNS like_IN cholera_NN ,_, enterotoxic_JJ E._NN coli_NN ,_, rotovirus_NN outbreaks_NNS ._. You_PRP 've_VBP identified_VBN a_DT pathogen_NN you_PRP 're_VBP interested_JJ in_IN ?_. ._. ._. ._. Let_VB me_PRP try_VB to_TO describe_VB how_WRB we_PRP make_VBP a_DT vaccine_NN for_IN Norwalk_NNP virus_NN ._. Norwalk_NNP virus_NN causes_VBZ diarrhea_NN ._. You_PRP get_VBP it_PRP in_IN contaminated_VBN food_NN ,_, and_CC we_PRP in_IN the_DT U.S._NNP would_MD think_VB of_IN it_PRP as_IN a_DT case_NN of_IN food_NN poisoning_NN ._. The_DT Norwalk_NNP virus_NN ,_, when_WRB we_PRP take_VBP it_PRP in_RP with_IN contaminated_VBN food_NN ,_, has_VBZ a_DT surface_NN protein_NN that_WDT binds_VBZ to_IN cells_NNS in_IN our_PRP$ gut_NN ,_, primarily_RB in_IN the_DT intestine_NN ._. Once_IN it_PRP binds_VBZ ,_, the_DT viral_JJ material_NN --_, which_WDT is_VBZ genes_NNS from_IN the_DT virus_NN --_, is_VBZ injected_VBN into_IN the_DT epithelial_JJ cells_NNS in_IN our_PRP$ gut_NN ._. So_RB ,_, essentially_RB ,_, the_DT virus_NN takes_VBZ over_RP and_CC does_VBZ genetic_JJ engineering_NN in_IN the_DT cells_NNS in_IN our_PRP$ gut_NN ._. The_DT result_NN is_VBZ massive_JJ diarrhea_NN ,_, with_IN its_PRP$ inconvenience_NN ,_, discomfort_NN ,_, etc_FW ._. We_PRP in_IN the_DT U.S._NNP generally_RB do_VBP survive_VB this_DT ,_, because_IN we_PRP have_VBP rehydration_NN therapy_NN ,_, etc_FW ._. If_IN you_PRP survive_VBP that_DT ,_, your_PRP$ immune_JJ system_NN has_VBZ been_VBN triggered_VBN ,_, and_CC the_DT immune_NN system_NN now_RB starts_VBZ producing_VBG antibodies_NNS that_WDT are_VBP secreted_VBN into_IN the_DT gut_NN ._. If_IN that_DT disease_NN -_HYPH causing_VBG agent_NN comes_VBZ along_RB again_RB ,_, we_PRP 're_VBP prepared_VBN for_IN it_PRP ._. The_DT antibodies_NNS bind_VBP to_IN the_DT virus_NN and_CC prevent_VBP the_DT infection_NN process_NN ._. What_WP we_PRP wanted_VBD to_TO do_VB was_VBD take_VB the_DT gene_NN for_IN that_DT surface_NN protein_NN ,_, put_VB it_PRP into_IN plant_NN cells_NNS ,_, and_CC ask_VB whether_IN the_DT plant_NN would_MD make_VB a_DT virus_NN -_HYPH like_JJ particle_NN ._. It_PRP 's_VBZ a_DT mimic_NN ,_, or_CC a_DT decoy_NN ,_, that_WDT looks_VBZ like_IN the_DT virus_NN ,_, but_CC with_IN none_NN of_IN the_DT genes_NNS inside_RB ,_, so_RB it_PRP can't_MD cause_VB disease_NN ._. First_RB of_IN all_DT ,_, we_PRP found_VBD that_IN we_PRP could_MD do_VB that_DT ._. We_PRP did_VBD that_DT in_IN collaboration_NN with_IN Mary_NNP Estes_NNP at_IN Baylor_NNP College_NNP of_IN Medicine_NNP ,_, who_WP 's_VBZ an_DT expert_NN in_IN this_DT stuff_NN ._. Do_VBP you_PRP use_VB a_DT gene_NN gun_NN technique_NN to_TO get_VB them_PRP in_RP ?_. We_PRP use_VBP one_CD of_IN two_CD routes_NNS to_TO put_VB the_DT gene_NN for_IN Norwalk_NNP virus_NN into_IN plants_NNS ._. We_PRP can_MD use_VB the_DT gene_NN gun_NN ,_, so_IN we_PRP essentially_RB are_VBP shooting_VBG the_DT piece_NN of_IN DNA_NN into_IN a_DT plant_NN cell_NN ,_, where_WRB it_PRP gets_VBZ integrated_VBN into_IN the_DT chromosome_NN ._. Or_CC we_PRP use_VBP another_DT approach_NN ,_, called_VBN agrobacterium_NN -_HYPH mediated_VBN transformation_NN ._. That_DT 's_VBZ where_WRB we_PRP first_RB take_VBP the_DT gene_NN out_IN of_IN the_DT virus_NN and_CC move_VBP it_PRP into_IN a_DT plant_NN pathogen_NN ._. Then_RB the_DT plant_NN pathogen_NN is_VBZ a_DT bacterium_NN ,_, and_CC that_WDT moves_VBZ the_DT gene_NN into_IN a_DT plant_NN cell_NN ._. Each_DT system_NN has_VBZ some_DT advantages_NNS ._. We_PRP can_MD use_VB either_CC one_CD ._. But_CC we_PRP end_VBP up_RP with_IN an_DT individual_JJ cell_NN ,_, which_WDT now_RB has_VBZ this_DT new_JJ gene_NN ._. From_IN that_DT cell_NN ,_, we_PRP regenerate_VBP a_DT plant_NN back_RB ._. So_RB the_DT first_JJ part_NN of_IN this_DT has_VBZ just_RB become_VBN absolutely_RB routine_JJ ._. There_EX 's_VBZ so_RB much_JJ molecular_JJ biology_NN going_VBG on_RP around_IN the_DT world_NN today_NN ._. We_PRP can_MD bring_VB in_RP a_DT high_JJ school_NN student_NN and_CC have_VB them_PRP do_VB the_DT first_JJ part_NN of_IN putting_VBG the_DT genes_NNS into_IN the_DT plants_NNS for_IN us_PRP ._. The_DT more_RBR complicated_JJ side_NN of_IN it_PRP then_RB is_VBZ to_TO regenerate_VB plants_NNS back_RB out_IN of_IN this_DT ,_, look_VB at_IN each_DT one_NN and_CC say_VB ,_, ""_`` Is_VBZ it_PRP producing_VBG the_DT vaccine_NN in_IN the_DT form_NN we_PRP want_VBP it_PRP ?_. Is_VBZ it_PRP producing_VBG it_PRP in_IN the_DT right_JJ place_NN ?_. ""_'' For_IN instance_NN ,_, we_PRP initially_RB focused_VBD on_IN potatoes_NNS ,_, and_CC then_RB tomatoes_NNS ,_, and_CC later_JJR banana_NN fruit_NN ._. We_PRP want_VBP to_TO make_VB sure_JJ that_IN it's_PRP in_IN the_DT proper_JJ cells_NNS ,_, that_IN it_PRP 's_VBZ forming_VBG the_DT right_JJ vaccine_NN ._. So_RB the_DT first_JJ one_NN you_PRP did_VBD was_VBD the_DT potato_NN ?_. That_DT was_VBD the_DT easiest_JJS to_TO transform_VB ?_. ._. ._. ._. For_IN a_DT variety_NN of_IN reasons_NNS ,_, the_DT potato_NN was_VBD simplest_JJS ._. You_PRP can_MD put_VB the_DT genes_NNS in_RP relatively_RB easily_RB ._. More_RBR important_JJ for_IN us_PRP ,_, we_PRP knew_VBD how_WRB to_TO cause_VB the_DT genes_NNS to_TO work_VB in_IN the_DT potato_NN tuber_NN ._. There_EX 'd_VBZ been_VBN a_DT lot_NN of_IN work_NN by_IN collaborators_NNS of_IN ours_PRP ._. So_RB essentially_RB ,_, we_PRP had_VBD a_DT good_JJ toolbox_NN to_TO work_VB with_IN ,_, a_DT molecular_JJ toolbox_NN ,_, so_IN we_PRP could_MD create_VB the_DT gene_NN we_PRP wanted_VBD ._. The_DT other_JJ nice_JJ thing_NN about_IN potatoes_NNS is_VBZ that_IN we_PRP can_MD regenerate_VB a_DT lot_NN of_IN edible_JJ plant_NN material_NN back_RB quickly_RB ._. In_IN about_RB four_CD to_IN five_CD months_NNS ,_, we_PRP can_MD have_VB a_DT pot_NN full_JJ of_IN potatoes_NNS ,_, and_CC each_DT pot_NN will_MD give_VB us_PRP probably_RB about_RB a_DT kilogram_NN of_IN material_NN ._. That_DT 's_VBZ enough_JJ to_TO do_VB a_DT lot_NN of_IN mouse_NN feeding_NN studies_NNS ._. In_IN these_DT potatoes_NNS ,_, everything_NN else_JJ is_VBZ the_DT same_JJ ,_, but_CC there_EX 's_VBZ an_DT additional_JJ molecule_NN being_VBG generated_VBN ?_. Right_UH ._. When_WRB they_PRP put_VBD a_DT gene_NN into_IN a_DT potato_NN ,_, essentially_RB all_DT we_PRP 've_VBP added_VBN is_VBZ one_CD new_JJ protein_NN ._. For_IN all_DT practical_JJ purposes_NNS ,_, that_DT 's_VBZ invisible_JJ ._. You_PRP do_VBP n't_RB see_VB any_DT effect_NN of_IN it_PRP ._. The_DT way_NN we_PRP determine_VBP that_IN it_PRP is_VBZ ,_, in_IN fact_NN ,_, there_RB ,_, is_VBZ to_TO do_VB a_DT bioassay_NN ._. That_DT means_VBZ taking_VBG a_DT piece_NN of_IN the_DT potato_NN and_CC feeding_VBG it_PRP to_IN a_DT mouse_NN ,_, and_CC then_RB taking_VBG blood_NN samples_NNS from_IN the_DT mouse_NN and_CC saying_VBG ,_, ""_`` Does_VBZ it_PRP get_VB new_JJ antibodies_NNS ?_. Does_VBZ it_PRP get_VB an_DT antibody_NN against_IN this_DT protein_NN we_PRP 're_VBP interested_JJ in_IN ?_. ""_'' Once_IN we'd_RB shown_VBN that_IN that_DT works_VBZ with_IN potatoes_NNS and_CC what_WP the_DT advantage_NN of_IN the_DT system_NN was_VBD ,_, we_PRP could_MD save_VB some_DT of_IN the_DT potatoes_NNS and_CC just_RB cut_VB them_PRP up_RP into_IN pieces_NNS ,_, replant_VB them_PRP ._. Now_RB we_PRP get_VBP identical_JJ plants_NNS coming_VBG back_RB out_RP ._. So_RB we_PRP had_VBD uniformity_NN of_IN our_PRP$ experiment_NN ._. The_DT next_JJ step_NN for_IN us_PRP has_VBZ been_VBN to_TO move_VB the_DT same_JJ type_NN of_IN work_NN into_IN tomatoes_NNS ._. That_DT took_VBD a_DT bit_NN more_JJR work_NN to_TO build_VB a_DT toolbox_NN ,_, if_IN you_PRP will_MD ,_, so_RB we_PRP can_MD create_VB the_DT genes_NNS that_WDT will_MD work_VB in_IN the_DT tomato_NN fruit_NN ._. Before_IN that_DT ,_, how_WRB were_VBD you_PRP sure_JJ this_DT is_VBZ working_VBG in_IN the_DT potato_NN ?_. The_DT question_NN is_VBZ ,_, ""_`` How_WRB do_VBP we_PRP know_VB that_IN the_DT vaccine_NN is_VBZ there_RB ?_. ""_'' The_DT answer_NN is_VBZ pretty_RB simple_JJ ._. We_PRP just_RB peel_VBP it_PRP ,_, cut_VBP it_PRP up_RP into_IN cubes_NNS ,_, and_CC feed_VBP the_DT potato_NN to_IN a_DT mouse_NN ._. We_PRP then_RB take_VBP blood_NN samples_NNS from_IN that_DT mouse_NN on_IN a_DT periodic_JJ basis_NN ,_, and_CC we_PRP ask_VBP if_IN the_DT mouse_NN has_VBZ serum_NN antibodies_NNS ,_, or_CC is_VBZ he_PRP now_RB making_VBG antibodies_NNS against_IN that_DT protein_NN ?_. The_DT answer_NN was_VBD yes_UH ,_, we_PRP found_VBD them_PRP ._. ._. ._. ._. In_IN all_DT mammals_NNS ,_, we_PRP 're_VBP producing_VBG secretory_JJ antibodies_NNS all_PDT the_DT time_NN --_, in_IN our_PRP$ lungs_NNS ,_, in_IN our_PRP$ saliva_NN ,_, throughout_IN the_DT gut_NN ._. We_PRP can_MD detect_VB those_DT antibodies_NNS in_IN fecal_JJ pellets_NNS ._. Sure_RB enough_RB ,_, after_IN eating_VBG our_PRP$ genetically_RB designed_VBN potatoes_NNS ,_, the_DT mouse_NN would_MD start_VB making_VBG secretory_JJ antibodies_NNS ._. Is_VBZ the_DT mouse_NN a_DT good_JJ model_NN then_RB for_IN humans_NNS ?_. Mice_NNS are_VBP the_DT traditional_JJ model_NN for_IN human_JJ vaccines_NNS ._. Once_IN we_PRP had_VBD pre-clinical_JJ data_NNS with_IN mice_NNS ,_, we_PRP then_RB went_VBD to_IN the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP and_CC asked_VBD for_IN permission_NN to_TO try_VB the_DT same_JJ experiments_NNS with_IN people_NNS ._. They_PRP went_VBD through_IN all_PDT the_DT regulatory_JJ issues_NNS ,_, and_CC the_DT first_JJ time_NN we_PRP tried_VBD this_DT ,_, it_PRP took_VBD about_RB eight_CD months_NNS for_IN us_PRP to_TO get_VB approval_NN to_TO guarantee_VB safety_NN for_IN the_DT volunteers_NNS ._. But_CC we_PRP then_RB had_VBD human_JJ volunteers_NNS eat_VB some_DT of_IN our_PRP$ potatoes_NNS ,_, and_CC sure_RB enough_RB ,_, got_VBD the_DT same_JJ result_NN ._. They_PRP got_VBD antibodies_NNS in_IN the_DT blood_NN serum_NN and_CC secretory_JJ antibodies_NNS ._. So_RB we_PRP can_MD tell_VB that_IN the_DT human_JJ immune_JJ system_NN can_MD also_RB be_VB triggered_VBN by_IN simply_RB eating_VBG raw_JJ potatoes_NNS that_WDT contain_VBP our_PRP$ vaccine_NN that_WDT we_PRP 've_VBP designed_VBN into_IN them_PRP ._. Do_VBP they_PRP have_VB to_TO eat_VB raw_JJ potatoes_NNS ?_. Well_UH ,_, raw_JJ potatoes_NNS are_VBP n't_RB bad_JJ ._. I_PRP sat_VBD and_CC ate_VBD raw_JJ potatoes_NNS when_WRB my_PRP$ mother_NN was_VBD peeling_VBG them_PRP ._. I_PRP remember_VBP that_DT as_IN a_DT kid_NN ._. Now_RB ,_, we_PRP perhaps_RB did_VBD a_DT bit_NN more_JJR ,_, because_IN some_DT of_IN the_DT volunteers_NNS had_VBD to_TO eat_VB up_RP to_IN 100_CD grams_NNS of_IN raw_JJ potato_NN ,_, which_WDT is_VBZ about_RB the_DT size_NN of_IN a_DT tennis_NN ball_NN or_CC so_RB ._. That_DT 's_VBZ a_DT big_JJ bowl_NN of_IN some_DT starch_NN ._. But_CC they_PRP did_VBD it_PRP ,_, and_CC we_PRP thanked_VBD them_PRP for_IN it_PRP ,_, and_CC sure_RB enough_RB ,_, they_PRP got_VBD the_DT proper_JJ immune_NN response_NN ._. You_PRP were_VBD thinking_VBG that_IN ,_, because_IN it_PRP was_VBD raw_JJ ,_, this_DT might_MD not_RB be_VB the_DT ideal_JJ delivery_NN ?_. Yes_UH ._. The_DT reason_NN we_PRP do_VBP raw_JJ potatoes_NNS is_VBZ because_IN many_JJ of_IN these_DT antigens_NNS or_CC vaccines_NNS that_WDT we_PRP 're_VBP interested_JJ in_IN would_MD be_VB destroyed_VBN by_IN heating_NN ._. So_RB if_IN you_PRP boiled_VBD the_DT potatoes_NNS ,_, if_IN you_PRP made_VBD a_DT mashed_VBN potato_NN or_CC a_DT french_JJ fry_NN ,_, we_PRP anticipate_VBP that_IN all_PDT the_DT activity_NN would_MD be_VB gone_VBN ._. So_RB then_RB you_PRP moved_VBD on_RP to_IN other_JJ plants_NNS ?_. Well_UH ,_, because_IN you_PRP can't_MD process_VB or_CC cook_VB a_DT potato_NN easily_RB ,_, we_PRP decided_VBD that_IN we_PRP 're_VBP going_VBG to_TO try_VB the_DT same_JJ experiments_NNS in_IN other_JJ plants_NNS ._. The_DT next_JJ step_NN was_VBD to_TO go_VB to_IN tomatoes_NNS ._. ._. ._. ._. One_CD of_IN the_DT big_JJ reasons_NNS to_TO try_VB tomatoes_NNS is_VBZ that_IN they_PRP are_VBP easily_RB processed_VBN ._. We_PRP can_MD now_RB start_VB taking_VBG food_NN -_HYPH processing_NN technology_NN ..._, and_CC just_RB make_VB tomato_NN juice_NN ,_, or_CC more_RBR important_JJ for_IN us_PRP ,_, we_PRP 're_VBP trying_VBG to_TO freeze_VB -_, dry_VB the_DT tomato_NN juice_NN and_CC just_RB get_VB a_DT dry_JJ powder_NN ._. I_PRP want_VBP to_TO emphasize_VB ,_, why_WRB should_MD we_PRP go_VB and_CC make_VB a_DT dry_JJ tomato_NN powder_NN ?_. The_DT answer_NN is_VBZ really_RB that_IN this_DT is_VBZ a_DT medicine_NN ._. We_PRP 're_VBP not_RB trying_VBG to_TO make_VB a_DT new_JJ V8_NNP juice_NN ._. We_PRP 're_VBP trying_VBG to_TO make_VB a_DT medicine_NN ._. If_IN we_PRP 're_VBP going_VBG to_TO be_VB successful_JJ ,_, we_PRP have_VBP to_TO deal_VB with_IN things_NNS that_WDT are_VBP part_NN of_IN the_DT pharmaceutical_JJ industry_NN ._. They_PRP talk_VBP about_IN proper_JJ dosage_NN ._. They_PRP talk_VBP about_IN lot_NN -_HYPH to_IN -_HYPH lot_NN variation_NN ,_, meaning_NN ,_, if_IN you_PRP make_VBP up_RP 100,000_CD doses_NNS at_IN one_CD time_NN ,_, the_DT next_JJ lot_NN has_VBZ to_TO be_VB comparable_JJ in_IN activity_NN ._. The_DT only_JJ way_NN I_PRP can_MD deal_VB with_IN that_DT from_IN a_DT plant_NN side_NN of_IN things_NNS is_VBZ to_TO start_VB using_VBG food_NN -_HYPH processing_NN technology_NN to_TO get_VB a_DT dry_JJ powder_NN ,_, or_CC ultimately_RB ,_, when_WRB we_PRP get_VBP to_IN bananas_NNS ,_, I_PRP think_VBP something_NN like_IN a_DT baby_NN food_NN puree_NN ._. You_PRP can_MD make_VB tens_NNS of_IN thousands_NNS of_IN little_JJ containers_NNS of_IN a_DT banana_NN baby_NN food_NN ,_, and_CC you_PRP can_MD sample_VB each_DT one_NN and_CC verify_VB that_IN the_DT dosage_NN is_VBZ uniform_JJ --_, that_IN they_PRP 're_VBP free_JJ of_IN any_DT sort_NN of_IN bacterial_JJ toxins_NNS or_CC anything_NN else_JJ --_, the_DT standard_JJ sort_NN of_IN stuff_NN that_WDT has_VBZ to_TO be_VB done_VBN with_IN any_DT pharmaceutical_JJ product_NN ._. Our_PRP$ switch_NN on_IN this_DT is_VBZ we_PRP can_MD use_VB food_NN -_HYPH processing_NN technology_NN ,_, which_WDT is_VBZ available_JJ in_IN the_DT developing_VBG world_NN ,_, and_CC apply_VB it_PRP to_IN a_DT medicine_NN ._. Assuming_VBG everything_NN goes_VBZ well_RB ,_, what_WP is_VBZ your_PRP$ vision_NN ?_. Let_VB 's_PRP say_VB we_PRP want_VBP to_TO deliver_VB vaccines_NNS against_IN diarrhea_NN in_IN Africa_NNP ,_, where_WRB they_PRP 're_VBP needed_VBN ._. I_PRP 'll_MD tell_VB you_PRP what_WP I_PRP do_VBP not_RB see_VB :_: I_PRP do_VBP n't_RB see_VB a_DT village_NN banana_NN tree_NN with_IN vaccines_NNS in_IN it_PRP ,_, where_WRB everyone_NN goes_VBZ up_RP and_CC takes_VBZ one_CD when_WRB they_PRP want_VBP to_TO ._. That_DT ,_, for_IN a_DT variety_NN of_IN reasons_NNS ,_, would_MD be_VB impractical_JJ ._. You_PRP would_MD n't_RB control_VB dosage_NN ,_, etc_FW ._. What_WP I_PRP do_VBP see_VB would_MD be_VB a_DT company_NN or_CC a_DT government_NN organization_NN established_VBN in_IN a_DT country_NN --_, maybe_RB South_NNP Africa_NNP initially_RB ,_, because_IN they_PRP have_VBP a_DT very_RB good_JJ infrastructure_NN ._. I_PRP see_VBP them_PRP having_VBG their_PRP$ own_JJ vaccine_NN companies_NNS in_IN South_NNP Africa_NNP ,_, where_WRB they_PRP would_MD take_VB some_DT of_IN the_DT plant_NN material_NN that_WDT 's_VBZ generated_VBN ,_, begin_VB to_TO grow_VB it_PRP under_IN confined_VBN ,_, regulated_VBN conditions_NNS ,_, and_CC manufacturing_VBG an_DT herbal_JJ medicine_NN of_IN sorts_NNS ._. It_PRP 's_VBZ very_RB acceptable_JJ and_CC they_PRP 're_VBP accustomed_VBN to_IN it_PRP in_IN Africa_NNP ,_, and_CC they_PRP 're_VBP used_VBN to_IN taking_VBG a_DT dried_VBN plant_NN material_NN ._. Let_VB 's_PRP say_VB it_PRP was_VBD a_DT banana_NN ._. Making_VBG a_DT dried_VBN banana_NN chip_NN and_CC delivering_VBG that_DT in_IN a_DT little_JJ package_NN ,_, saying_VBG ,_, ""_`` This_DT is_VBZ a_DT medicine_NN ""_'' would_MD be_VB normal_JJ ._. They_PRP have_VBP dried_VBN banana_NN chips_NNS around_IN the_DT world_NN ._. If_IN we_PRP could_MD just_RB do_VB that_DT ,_, or_CC grind_VB up_RP this_DT dried_VBN banana_NN chip_NN and_CC spike_VB it_PRP into_IN a_DT little_JJ milk_NN and_CC give_VB it_PRP to_IN an_DT infant_NN --_, that_DT 's_VBZ something_NN that_WDT could_MD be_VB done_VBN at_IN a_DT local_JJ level_NN ,_, without_IN a_DT lot_NN of_IN high_JJ technology_NN ._. It_PRP would_MD take_VB an_DT educational_JJ activity_NN ._. But_CC this_DT is_VBZ something_NN that_WDT would_MD be_VB consistent_JJ with_IN a_DT type_NN of_IN medicine_NN that_WDT they_PRP have_VBP today_NN ._. Would_MD it_PRP be_VB cheap_JJ ?_. The_DT question_NN is_VBZ ,_, what_WP would_MD it_PRP cost_VB to_TO do_VB this_DT in_IN a_DT developing_VBG country_NN ?_. I_PRP think_VBP it_PRP 's_VBZ pretty_RB obvious_JJ that_IN the_DT actual_JJ production_NN of_IN the_DT material_NN could_MD be_VB extremely_RB cheap_JJ ._. The_DT next_JJ step_NN ,_, having_VBG some_DT sort_NN of_IN quality_NN assurance_NN ,_, is_VBZ tougher_JJR for_IN me_PRP to_TO estimate_VB ._. You_PRP would_MD want_VB to_TO make_VB sure_JJ that_IN you_PRP have_VBP the_DT systems_NNS in_IN place_NN ,_, that_IN the_DT dosage_NN is_VBZ accurate_JJ and_CC reliable_JJ ,_, and_CC that_IN the_DT processing_NN ._. ._. ._. is_VBZ reliable_JJ ._. It_PRP 's_VBZ hard_JJ for_IN me_PRP to_TO anticipate_VB the_DT cost_NN to_IN this_DT ._. But_CC clearly_RB it_PRP 's_VBZ something_NN that_WDT 's_VBZ doable_JJ ._. There_EX has_VBZ to_TO be_VB a_DT will_NN to_TO accomplish_VB this_DT ._. First_RB of_IN all_DT ,_, it_PRP does_VBZ n't_RB have_VB to_TO be_VB expensive_JJ ._. It_PRP simply_RB has_VBZ to_TO be_VB something_NN that_WDT 's_VBZ built_VBN into_IN an_DT organization_NN in_IN the_DT developing_VBG world_NN ._. It_PRP 's_VBZ for_IN these_DT sorts_NNS of_IN reasons_NNS that_IN our_PRP$ goal_NN is_VBZ n't_RB necessarily_RB to_TO take_VB this_DT first_JJ to_IN a_DT very_RB poor_JJ country_NN in_IN Africa_NNP ._. In_IN fact_NN ,_, we_PRP 've_VBP built_VBN our_PRP$ first_JJ connections_NNS with_IN extremely_RB good_JJ ,_, sophisticated_JJ scientists_NNS in_IN Mexico_NNP ._. There_EX is_VBZ a_DT demand_NN for_IN diarrheal_NN disease_NN vaccines_NNS in_IN Mexico_NNP ,_, and_CC they_PRP have_VBP very_RB good_JJ in_IN -_HYPH country_NN vaccine_NN companies_NNS ._. Some_DT of_IN these_DT are_VBP already_RB making_VBG and_CC distributing_VBG vaccines_NNS ._. They_PRP have_VBP a_DT very_RB good_JJ public_JJ health_NN system_NN ._. So_RB our_PRP$ goal_NN is_VBZ to_TO try_VB to_TO collaborate_VB with_IN people_NNS in_IN Mexico_NNP ,_, transfer_VB this_DT technology_NN ,_, test_VB it_PRP there_RB ,_, demonstrate_VB that_IN it_PRP works_VBZ ,_, and_CC do_VB that_DT in_IN parallel_NN with_IN what_WP we_PRP 're_VBP doing_VBG in_IN the_DT U.S._NNP I_PRP should_MD emphasize_VB --_, we_PRP 're_VBP trying_VBG to_TO do_VB this_DT first_RB in_IN the_DT U.S._NNP ,_, not_RB because_IN I_PRP 'm_VBP nationalistic_JJ ,_, but_CC because_IN I_PRP do_VBP n't_RB want_VB to_TO be_VB accused_VBN of_IN taking_VBG this_DT technology_NN and_CC testing_VBG it_PRP on_IN poor_JJ people_NNS someplace_RB else_RB in_IN the_DT world_NN ._. We_PRP 've_VBP had_VBN the_DT rise_NN of_IN this_DT controversy_NN over_IN genetically_RB modified_VBN foods_NNS ._. Did_VBD this_DT surprise_VB you_PRP when_WRB it_PRP happened_VBD ?_. Has_VBZ it_PRP affected_VBN your_PRP$ work_NN ?_. The_DT controversy_NN over_IN genetically_RB modified_VBN foods_NNS really_RB has_VBZ n't_RB had_VBN any_DT direct_JJ impact_NN on_IN our_PRP$ research_NN activities_NNS ._. And_CC I_PRP 'm_VBP happy_JJ about_IN that_DT ._. I_PRP keep_VBP emphasizing_VBG ,_, we_PRP 're_VBP producing_VBG medicines_NNS ._. Materials_NNS that_WDT generate_VBP as_IN an_DT edible_JJ vaccine_NN will_MD never_RB be_VB in_IN the_DT grocery_NN store_NN ,_, and_CC we_PRP 're_VBP building_VBG in_IN controls_NNS to_TO ensure_VB that_IN that_DT wo_MD n't_RB happen_VB ._. But_CC in_IN the_DT broader_JJR issue_NN ,_, am_VBP I_PRP surprised_VBN at_IN what_WP has_VBZ happened_VBN ?_. Perhaps_RB not_RB ,_, because_IN I_PRP think_VBP this_DT has_VBZ been_VBN a_DT surprise_NN to_IN the_DT public_NN ._. They_PRP have_VBP n't_RB seen_VBN all_PDT this_DT background_NN science_NN and_CC technology_NN being_VBG developed_VBN ._. It_PRP 's_VBZ been_VBN something_NN that_WDT is_VBZ so_RB common_JJ to_IN us_PRP in_IN the_DT scientific_JJ community_NN ._. I_PRP have_VBP n't_RB seen_VBN anything_NN that_WDT 's_VBZ shocking_JJ or_CC that_DT concerns_VBZ me_PRP about_IN any_DT sort_NN of_IN safety_NN issue_NN ,_, but_CC I_PRP 've_VBP seen_VBN it_PRP coming_VBG for_IN the_DT last_JJ 20_CD -_HYPH plus_CC years_NNS ._. It_PRP seems_VBZ obvious_JJ and_CC routine_NN to_IN me_PRP ._. But_CC I_PRP certainly_RB am_VBP aware_JJ ,_, just_RB from_IN my_PRP$ conversations_NNS with_IN family_NN and_CC relatives_NNS ,_, that_IN they_PRP find_VBP it_PRP shocking_JJ that_IN all_PDT these_DT changes_NNS are_VBP possible_JJ ._. It_PRP 's_VBZ sort_NN of_IN science_NN fiction_NN stuff_NN ,_, and_CC I_PRP guess_VBP whenever_WRB something_NN comes_VBZ along_RB that_WDT you_PRP had_VBD n't_RB thought_VBN about_IN ,_, it_PRP raises_VBZ some_DT concerns_NNS ._. What_WDT potential_NN in_IN this_DT technology_NN people_NNS should_MD be_VB aware_JJ of_IN ?_. Well_UH ,_, clearly_RB the_DT next_JJ generation_NN of_IN plants_NNS that_WDT are_VBP genetically_RB modified_VBN are_VBP going_VBG to_TO be_VB enormously_RB different_JJ from_IN the_DT first_JJ generation_NN that_WDT came_VBD out_RP ._. We_PRP 're_VBP seeing_VBG a_DT lot_NN more_JJR activity_NN that_WDT 's_VBZ focused_VBN around_IN human_JJ health_NN ._. There_EX are_VBP a_DT variety_NN of_IN reasons_NNS for_IN that_DT ,_, but_CC probably_RB the_DT greatest_JJS reason_NN in_IN the_DT U.S._NNP is_VBZ that_IN we_PRP 've_VBP got_VBN excess_JJ food_NN today_NN ._. There_EX 's_VBZ less_JJR return_NN in_IN just_RB increasing_VBG yields_NNS ._. What_WP we_PRP have_VBP to_TO focus_VB on_IN is_VBZ how_WRB we_PRP make_VBP our_PRP$ foods_NNS better_RBR ._. We_PRP can_MD keep_VB reminding_VBG ourselves_PRP that_IN we_PRP can_MD do_VB things_NNS that_WDT will_MD improve_VB the_DT human_JJ health_NN value_NN ,_, that_IN we_PRP 're_VBP going_VBG to_TO add_VB value_NN to_IN society_NN and_CC to_IN the_DT products_NNS that_WDT farmers_NNS are_VBP producing_VBG ,_, and_CC we_PRP 're_VBP going_VBG to_TO have_VB a_DT good_JJ economic_JJ impact_NN all_RB throughout_IN this_DT food_NN chain_NN ._. My_PRP$ own_JJ special_JJ interest_NN is_VBZ this_DT area_NN of_IN producing_VBG actual_JJ pharmaceuticals_NNS in_IN plants_NNS ._. Because_IN of_IN the_DT institute_NN where_WRB I_PRP am_VBP ,_, it_PRP really_RB has_VBZ n't_RB been_VBN a_DT focus_NN on_IN the_DT U.S._NNP in_IN particular_JJ ._. It_PRP 's_VBZ been_VBN more_RBR a_DT focus_NN on_IN the_DT Third_NNP World_NNP ._. How_WRB can_MD we_PRP deliver_VB ._. ._. ._. a_DT very_RB effective_JJ vaccine_NN ,_, but_CC make_VB developing_VBG countries_NNS less_RBR dependent_JJ upon_IN philanthropy_NN and_CC big_JJ industry_NN and_CC things_NNS of_IN that_DT nature_NN ?_. How_WRB can_MD we_PRP provide_VB the_DT technology_NN so_IN that_IN a_DT Third_JJ World_NNP country_NN can_MD make_VB the_DT vaccines_NNS themselves_PRP ?_. Is_VBZ this_DT technology_NN useful_JJ because_IN it_PRP allows_VBZ you_PRP to_TO grow_VB plants_NNS in_IN inhospitable_JJ soils_NNS ?_. What_WP about_IN the_DT ""_`` golden_JJ rice_NN ""_'' argument_NN ?_. Well_UH ,_, if_IN you_PRP start_VBP looking_VBG at_IN specific_JJ examples_NNS of_IN where_WRB genetically_RB modified_VBN foods_NNS have_VBP a_DT value_NN in_IN the_DT developing_VBG world_NN ,_, I_PRP think_VBP number_NN one_CD is_VBZ the_DT issue_NN of_IN food_NN security_NN --_, protecting_VBG plants_NNS against_IN disease_NN ,_, so_IN that_IN they_PRP grow_VBP better_JJR ._. Also_RB ,_, perhaps_RB ,_, virus_NN resistance_NN ,_, sort_NN of_IN immunizing_VBG plants_NNS against_IN viruses_NNS as_IN the_DT number_NN one_CD example_NN ._. It_PRP 's_VBZ going_VBG to_TO have_VB the_DT biggest_JJS effect_NN in_IN the_DT developing_VBG world_NN ._. But_CC secondarily_RB ,_, as_IN we_PRP have_VBP seen_VBN with_IN the_DT golden_JJ rice_NN story_NN ,_, you_PRP can_MD also_RB change_VB the_DT qualities_NNS of_IN the_DT plant_NN itself_PRP ._. We_PRP can_MD put_VB things_NNS like_IN vitamin_NN A_NN into_IN a_DT rice_NN plant_NN ,_, as_IN Dr._NNP Potrykus_NNP and_CC his_PRP$ colleagues_NNS did_VBD ._. That_DT 's_VBZ quite_RB incredible_JJ ,_, and_CC it's_PRP going_VBG to_TO solve_VB major_JJ problems_NNS in_IN the_DT developing_VBG world_NN ,_, as_IN to_IN the_DT availability_NN of_IN food_NN materials_NNS for_IN good_JJ nutrition_NN ._. I_PRP know_VBP that_IN a_DT standard_JJ response_NN is_VBZ ,_, ""_`` Well_UH ,_, they_PRP should_MD just_RB be_VB eating_VBG more_JJR green_JJ leafy_JJ vegetables_NNS ._. ""_'' I_PRP 've_VBP been_VBN to_IN India_NNP ._. I_PRP 've_VBP stayed_VBN in_IN a_DT very_RB nice_JJ hotel_NN in_IN the_DT center_NN of_IN New_NNP Delhi_NNP ._. And_CC you_PRP see_VBP families_NNS living_VBG on_IN the_DT sidewalk_NN on_IN an_DT old_JJ patch_NN of_IN blanket_NN out_RB there_RB ._. This_DT is_VBZ part_NN of_IN this_DT global_JJ migration_NN of_IN families_NNS to_IN the_DT cities_NNS ,_, as_IN populations_NNS grow_VBP ._. They_PRP no_RB longer_RBR have_VBP a_DT little_JJ garden_NN plot_NN to_TO grow_VB their_PRP$ materials_NNS ._. They_PRP 're_VBP stuck_VBN in_IN a_DT concrete_JJ jungle_NN someplace_RB ._. They_PRP do_VBP n't_RB have_VB access_NN to_IN green_JJ leafy_JJ vegetables_NNS and_CC things_NNS that_WDT they_PRP need_VBP ,_, and_CC they_PRP 're_VBP living_VBG on_IN a_DT handful_NN of_IN rice_NN every_DT day_NN ._. I_PRP see_VBP the_DT Rockefeller_NNP Foundation_NNP and_CC others_NNS recognizing_VBG this_DT ,_, and_CC seeing_VBG that_IN we_PRP 've_VBP got_VBN these_DT global_JJ shifts_NNS in_IN people_NNS stuck_VBN in_IN desperate_JJ poverty_NN ,_, and_CC the_DT few_JJ foods_NNS they_PRP can_MD eat_VB ._. They_PRP have_VBP focused_VBN on_IN issues_NNS like_IN ,_, how_WRB can_MD we_PRP change_VB the_DT quality_NN of_IN that_DT food_NN that_WDT they_PRP do_VBP have_VB available_JJ ,_, and_CC improve_VB the_DT nutrition_NN of_IN these_DT people_NNS ?_. Because_IN the_DT people_NNS are_VBP n't_RB getting_VBG a_DT balanced_VBN diet_NN ?_. Because_IN they_PRP get_VBP a_DT balanced_VBN diet_NN ._. They_PRP 're_VBP desperately_RB poor_JJ ._. They_PRP 're_VBP part_NN of_IN this_DT urban_JJ migration_NN that_WDT is_VBZ just_RB dragging_VBG people_NNS into_IN a_DT situation_NN where_WRB they_PRP have_VBP no_DT choice_NN ._. It_PRP would_MD be_VB nice_JJ to_TO solve_VB the_DT poverty_NN issue_NN ._. That_DT would_MD be_VB great_JJ ._. But_CC until_IN we_PRP can_MD do_VB that_DT ,_, one_CD of_IN the_DT accomplishments_NNS of_IN modifying_VBG our_PRP$ food_NN is_VBZ that_IN we_PRP can_MD help_VB give_VB these_DT desperately_RB poor_JJ people_NNS something_NN better_JJR to_TO improve_VB their_PRP$ health_NN as_IN they_PRP try_VBP to_TO dig_VB their_PRP$ way_NN out_IN of_IN the_DT situation_NN that_WDT they_PRP 're_VBP in_IN ._. Greenpeace_NNP says_VBZ that_IN there_EX 's_VBZ enough_JJ food_NN to_TO feed_VB the_DT world_NN already_RB --_, that_IN the_DT problem_NN is_VBZ distribution_NN ._. Yes_UH ._. The_DT argument_NN that_IN there_EX 's_VBZ enough_JJ food_NN in_IN the_DT world_NN ,_, but_CC it's_VBZ in_IN the_DT wrong_JJ place_NN at_IN the_DT wrong_JJ time_NN --_, that_DT 's_VBZ a_DT real_JJ argument_NN ._. But_CC a_DT lot_NN of_IN the_DT food_NN sources_NNS we_PRP have_VBP are_VBP not_RB easily_RB shipped_VBN ._. A_DT fresh_JJ tomato_NN is_VBZ n't_RB going_VBG to_TO be_VB shipped_VBN from_IN Iowa_NNP to_IN Bangladesh_NNP ._. Grains_NNS can_MD be_VB shipped_VBN --_, cereal_NN ,_, grains_NNS ,_, and_CC legumes_NNS and_CC things_NNS like_IN that_DT ._. But_CC we_PRP tried_VBD some_DT experiments_NNS of_IN just_RB shipping_VBG food_NN and_CC giving_VBG it_PRP away_RB ._. For_IN instance_NN ,_, in_IN India_NNP and_CC Bangladesh_NNP in_IN the_DT 1960s_NNS ,_, when_WRB there_EX was_VBD famine_NN ,_, if_IN a_DT country_NN like_IN the_DT U.S._NNP comes_VBZ in_RP and_CC just_RB provides_VBZ food_NN ,_, it_PRP further_RB degrades_VBZ the_DT capacity_NN of_IN the_DT country_NN itself_PRP to_TO stimulate_VB its_PRP$ own_JJ agricultural_JJ economy_NN ._. I_PRP think_VBP we_PRP saw_VBD when_WRB we_PRP made_VBD those_DT mistakes_NNS at_IN one_CD time_NN ,_, and_CC then_RB we_PRP shifted_VBD our_PRP$ emphasis_NN on_IN providing_VBG the_DT technology_NN to_IN people_NNS to_TO produce_VB their_PRP$ own_JJ food_NN ._. That_DT 's_VBZ been_VBN much_RB more_RBR successful_JJ ._. In_IN a_DT sense_NN ,_, we_PRP have_VBP n't_RB even_RB been_VBN involved_VBN in_IN it_PRP so_RB much_RB in_IN China_NNP ,_, but_CC you_PRP can_MD see_VB the_DT enormous_JJ advancements_NNS in_IN China_NNP in_IN feeding_VBG their_PRP$ own_JJ people_NNS ._. It_PRP 's_VBZ been_VBN through_IN an_DT implementation_NN of_IN good_JJ agricultural_JJ policy_NN ,_, using_VBG the_DT best_JJS of_IN the_DT new_JJ technologies_NNS that_WDT are_VBP available_JJ ,_, and_CC moving_VBG very_RB rapidly_RB ._. If_IN you_PRP travel_VBP in_IN China_NNP today_NN ,_, you_PRP do_VBP n't_RB see_VB the_DT starvation_NN that_WDT is_VBZ prevalent_JJ in_IN other_JJ parts_NNS of_IN the_DT world_NN ,_, especially_RB in_IN the_DT poorer_JJR parts_NNS of_IN the_DT world_NN today_NN ._. Is_VBZ it_PRP your_PRP$ sense_NN that_IN India_NNP and_CC China_NNP see_VBP a_DT lot_NN of_IN potential_NN in_IN this_DT technology_NN ?_. It_PRP 's_VBZ very_RB interesting_JJ to_TO compare_VB India_NNP and_CC China_NNP ._. China_NNP has_VBZ moved_VBN very_RB aggressively_RB in_IN all_DT aspects_NNS of_IN food_NN technology_NN ,_, emphasizing_VBG things_NNS like_IN infrastructure_NN for_IN transport_NN of_IN foods_NNS ,_, but_CC also_RB rapidly_RB mobilizing_VBG to_TO use_VB new_JJ genetic_JJ engineering_NN techniques_NNS ._. Essentially_RB ,_, they_PRP do_VBP n't_RB take_VB just_RB one_CD part_NN of_IN it_PRP ._. Biotechnology_NN is_VBZ not_RB a_DT sole_JJ solution_NN ,_, but_CC a_DT whole_JJ structural_JJ analysis_NN is_VBZ a_DT solution_NN ._. I_PRP 've_VBP traveled_VBN a_DT fair_JJ amount_NN in_IN India_NNP ._. India_NNP has_VBZ apparently_RB just_RB taken_VBN more_JJR of_IN a_DT piecemeal_JJ part_NN ._. It_PRP 's_VBZ a_DT highly_RB democratic_JJ country_NN ,_, and_CC some_DT of_IN the_DT disadvantages_NNS of_IN democracy_NN have_VBP come_VBN in_IN not_RB having_VBG China_NNP 's_POS sort_NN of_IN overall_JJ planning_NN system_NN ._. But_CC India_NNP has_VBZ done_VBN a_DT remarkable_JJ job_NN of_IN feeding_VBG a_DT population_NN that_WDT has_VBZ doubled_VBN in_IN the_DT last_JJ several_JJ decades_NNS ._. They_PRP 're_VBP still_RB feeding_VBG their_PRP$ people_NNS ._. They_PRP have_VBP been_VBN slower_JJR to_TO adopt_VB technology_NN for_IN genetic_JJ engineering_NN ,_, and_CC in_IN part_NN ,_, maybe_RB that_DT 's_VBZ because_IN they_PRP have_VBP n't_RB had_VBN the_DT demand_NN yet_RB ._. They_PRP have_VBP n't_RB had_VBN the_DT food_NN demands_NNS that_WDT China_NNP has_VBZ seen_VBN ._. We_PRP have_VBP a_DT projection_NN over_IN the_DT next_JJ 100_CD years_NNS of_IN a_DT doubling_NN of_IN world_NN population_NN ._. Without_IN new_JJ agricultural_JJ technologies_NNS ,_, is_VBZ that_DT going_VBG to_TO be_VB impossible_JJ ?_. Well_UH ,_, it_PRP 's_VBZ hard_JJ for_IN me_PRP to_TO talk_VB about_IN what_WP 's_VBZ going_VBG to_TO happen_VB over_IN the_DT next_JJ 100_CD years_NNS or_CC 50_CD years_NNS ._. It_PRP 's_VBZ easier_JJR to_TO picture_VB what_WP 's_VBZ going_VBG to_TO happen_VB over_IN the_DT next_JJ two_CD decades_NNS ._. Now_RB ,_, we_PRP have_VBP the_DT young_JJ people_NNS born_VBN on_IN the_DT ground_NN today_NN ,_, who_WP are_VBP going_VBG to_TO produce_VB an_DT additional_JJ 1_CD billion_CD people_NNS each_DT decade_NN ._. That_IN many_JJ new_JJ people_NNS every_DT ten_CD years_NNS is_VBZ the_DT size_NN of_IN India_NNP ._. When_WRB you_PRP start_VBP thinking_VBG of_IN this_DT massive_JJ food_NN need_NN that_WDT we_PRP have_VBP --_, and_CC largely_RB the_DT population_NN is_VBZ increasing_VBG where_WRB we_PRP do_VBP n't_RB have_VB an_DT adequate_JJ food_NN supply_NN --_, we_PRP 're_VBP just_RB going_VBG to_TO exacerbate_VB all_PDT the_DT problems_NNS we_PRP have_VBP today_NN ._. Of_IN course_NN we_PRP need_VBP new_JJ technology_NN ._. We_PRP can't_MD just_RB continue_VB to_TO plow_VB up_RP forests_NNS or_CC try_VB to_TO find_VB new_JJ prairies_NNS to_TO convert_VB into_IN farmland_NN ._. That_DT does_VBZ n't_RB exist_VB in_IN the_DT places_NNS we_PRP need_VBP it_PRP ,_, and_CC we_PRP do_VBP n't_RB want_VB to_TO shift_VB the_DT remaining_VBG natural_JJ areas_NNS of_IN the_DT world_NN that_WDT we_PRP have_VBP today_NN and_CC destroy_VB them_PRP to_TO get_VB more_JJR farmland_NN ._. All_DT we_PRP can_MD do_VB is_VBZ increase_VB the_DT productivity_NN of_IN the_DT land_NN that_WDT we_PRP have_VBP today_NN ,_, to_TO meet_VB this_DT enormous_JJ coming_VBG increase_NN in_IN population_NN ._. The_DT other_JJ argument_NN is_VBZ that_IN a_DT more_RBR efficient_JJ type_NN of_IN organic_JJ farming_NN should_MD be_VB instituted_VBN ,_, rather_RB than_IN developing_VBG new_JJ technology_NN ._. It_PRP 's_VBZ really_RB baffling_JJ to_IN me_PRP how_WRB anyone_NN can_MD say_VB that_IN we_PRP just_RB do_VBP n't_RB need_VB new_JJ technology_NN ._. India_NNP is_VBZ largely_RB an_DT organic_JJ farming_NN nation_NN today_NN ._. As_IN they_PRP try_VBP to_TO take_VB on_RP new_JJ technology_NN ,_, the_DT most_RBS successful_JJ has_VBZ been_VBN genetic_JJ technology_NN ._. It_PRP 's_VBZ the_DT improved_VBN rices_NNS that_WDT came_VBD out_IN of_IN international_JJ research_NN activities_NNS ,_, and_CC the_DT improved_VBN wheats_NNS ._. Taking_VBG genetically_RB improved_VBN materials_NNS is_VBZ what_WP 's_VBZ allowed_VBN them_PRP to_TO feed_VB their_PRP$ population_NN ._. Some_DT of_IN that_DT has_VBZ been_VBN coupled_VBN with_IN use_NN of_IN fertilizer_NN ,_, for_IN instance_NN ,_, in_IN India_NNP ,_, which_WDT has_VBZ dramatically_RB increased_VBN the_DT rice_NN yields_NNS ._. What_WP 's_VBZ missing_VBG in_IN places_NNS like_IN India_NNP ,_, for_IN instance_NN ,_, is_VBZ a_DT lot_NN of_IN additional_JJ technology_NN --_, like_IN post_NN -_HYPH harvest_VB storage_NN of_IN the_DT material_NN ,_, drying_NN of_IN the_DT material_NN ,_, packaging_NN of_IN it_PRP ,_, so_IN they_PRP do_VBP n't_RB have_VB losses_NNS to_IN insects_NNS or_CC disease_NN problems_NNS in_IN the_DT stored_VBN material_NN ._. So_RB I_PRP think_VBP people_NNS are_VBP fixated_VBN right_RB now_RB on_IN ,_, ""_`` Oh_UH ,_, my_PRP$ God_NNP ,_, they_PRP 're_VBP doing_VBG something_NN with_IN genetics_NN ,_, and_CC that_DT 's_VBZ the_DT problem_NN ._. ""_'' But_CC we_PRP have_VBP a_DT whole_JJ suite_NN of_IN things_NNS that_WDT need_VBP to_TO be_VB done_VBN in_IN agriculture_NN ,_, and_CC using_VBG the_DT best_JJS of_IN new_JJ genetics_NNS is_VBZ just_RB part_NN of_IN the_DT solution_NN ._. It_PRP 's_VBZ not_RB a_DT silver_JJ bullet_NN that_WDT 's_VBZ going_VBG to_TO work_VB by_IN itself_PRP ._. But_CC it_PRP 's_VBZ just_RB part_NN of_IN the_DT overall_JJ solution_NN ._. We_PRP see_VBP the_DT moratorium_NN in_IN Europe_NNP ,_, and_CC labeling_VBG laws_NNS ._. And_CC you_PRP see_VBP a_DT few_JJ companies_NNS in_IN this_DT country_NN ,_, like_IN Gerber_NNP and_CC Frito_NNP -_HYPH Lay_NNP ,_, deciding_VBG not_RB to_TO produce_VB these_DT ._. Do_VBP you_PRP have_VB any_DT concerns_NNS that_IN this_DT might_MD be_VB delayed_VBN ,_, or_CC stopped_VBN in_IN its_PRP$ tracks_NNS ?_. Clearly_RB ,_, the_DT attitudes_NNS about_IN genetically_RB modified_VBN foods_NNS in_IN Europe_NNP have_VBP delayed_VBN its_PRP$ implementation_NN in_IN Europe_NNP ._. I_PRP think_VBP their_PRP$ perceptions_NNS are_VBP based_VBN upon_IN a_DT series_NN of_IN other_JJ things_NNS that_WDT do_VBP n't_RB have_VB any_DT relevance_NN to_IN genetic_JJ engineering_NN per_IN se_NN ._. Such_JJ as_IN ?_. Such_JJ as_IN ,_, they_PRP have_VBP problems_NNS with_IN BSE_NN ,_, the_DT mad_JJ cow_NN disease_NN ,_, which_WDT has_VBZ caused_VBN in_IN England_NNP in_IN particular_JJ a_DT lack_NN of_IN confidence_NN in_IN their_PRP$ regulatory_JJ system_NN ._. A_DT whole_JJ series_NN of_IN other_JJ events_NNS in_IN Europe_NNP has_VBZ just_RB caused_VBN people_NNS to_TO be_VB concerned_VBN about_IN safety_NN of_IN their_PRP$ food_NN supply_NN ._. None_NN of_IN these_DT have_VBP any_DT relevance_NN directly_RB to_IN genetic_JJ engineering_NN ,_, but_CC it_PRP 's_VBZ caused_VBN the_DT public_NN to_TO question_VB their_PRP$ governments_NNS and_CC what_WP their_PRP$ governments_NNS can_MD do_VB ._. In_IN addition_NN ,_, the_DT Europeans_NNPS are_VBP affluent_JJ ._. They_PRP have_VBP an_DT excess_JJ supply_NN of_IN food_NN ,_, and_CC they_PRP 're_VBP subsidizing_VBG their_PRP$ farmers_NNS to_TO reduce_VB production_NN ._. And_CC I_PRP can_MD understand_VB this_DT ._. The_DT whole_JJ notion_NN of_IN adding_VBG new_JJ technology_NN to_TO add_VB more_JJR food_NN seems_VBZ bizarre_JJ ._. ._. ._. ._. Why_WRB is_VBZ it_PRP different_JJ in_IN the_DT U.S._NNP ?_. Well_UH ,_, in_IN part_NN ,_, I_PRP believe_VBP ,_, even_RB though_IN we_PRP have_VBP more_JJR food_NN than_IN we_PRP need_VBP ,_, most_JJS folks_NNS here_RB recognize_VBP that_IN the_DT food_NN supply_NN from_IN the_DT U.S._NNP is_VBZ part_NN of_IN the_DT global_JJ economy_NN ._. It_PRP 's_VBZ good_JJ for_IN our_PRP$ economics_NNS ,_, but_CC it_PRP 's_VBZ also_RB good_JJ for_IN the_DT rest_NN of_IN the_DT world_NN ._. Because_IN if_IN we_PRP just_RB stopped_VBD exporting_VBG food_NN ,_, it_PRP would_MD have_VB an_DT enormous_JJ impact_NN on_IN other_JJ parts_NNS of_IN the_DT world_NN ._. So_RB I_PRP see_VBP a_DT fundamental_JJ difference_NN there_RB in_IN the_DT acceptance_NN of_IN the_DT technology_NN ._. Let_VB 's_PRP say_VB that_IN the_DT U.S._NNP and_CC Europe_NNP would_MD decide_VB ,_, ""_`` We_PRP 're_VBP never_RB going_VBG to_TO do_VB genetically_RB modified_VBN foods_NNS ._. ""_'' ._. ._. ._. I_PRP do_VBP n't_RB think_VB it_PRP 's_VBZ going_VBG to_TO stop_VB the_DT technology_NN ._. It_PRP 's_VBZ so_RB essential_JJ for_IN China_NNP ,_, for_IN India_NNP ,_, for_IN other_JJ parts_NNS of_IN the_DT developing_VBG world_NN to_TO increase_VB their_PRP$ food_NN supply_NN to_TO meet_VB their_PRP$ burgeoning_VBG populations_NNS ;_, it_PRP 's_VBZ going_VBG to_TO happen_VB ._. We_PRP can't_MD be_VB so_RB arrogant_JJ to_TO think_VB that_IN we_PRP determine_VBP what_WDT sort_NN of_IN science_NN is_VBZ going_VBG to_TO be_VB done_VBN on_IN a_DT global_JJ basis_NN ._. We_PRP can_MD be_VB pleased_JJ with_IN ourselves_PRP that_IN ,_, in_IN the_DT U.S._NNP ,_, we_PRP 've_VBP really_RB been_VBN the_DT leaders_NNS in_IN developing_VBG the_DT new_JJ technology_NN and_CC implementing_VBG it_PRP safely_RB in_IN this_DT country_NN ._. We_PRP have_VBP n't_RB had_VBN so_RB much_JJ as_IN a_DT headache_NN from_IN any_DT genetically_RB modified_VBN food_NN ,_, and_CC I_PRP think_VBP that_DT 's_VBZ because_IN we_PRP thought_VBD about_IN these_DT things_NNS ._. We_PRP go_VBP back_RB to_IN something_NN called_VBN the_DT Asilomar_NNP Conference_NNP ,_, back_RB in_IN the_DT 1970s_NNS ._. Back_RB in_IN the_DT 1980s_NNS ,_, I_PRP was_VBD involved_VBN in_IN government_NN committees_NNS that_WDT dealt_VBD with_IN safety_NN issues_NNS ,_, about_IN what_WDT type_NN of_IN genetic_JJ engineering_NN we_PRP could_MD do_VB ,_, how_WRB we_PRP would_MD move_VB genetically_RB modified_VBN plants_NNS into_IN the_DT field_NN ._. We_PRP 've_VBP been_VBN working_VBG on_IN this_DT stuff_NN since_IN the_DT technology_NN was_VBD developed_VBN ._. In_IN the_DT U.S._NNP it_PRP 's_VBZ been_VBN science_NN -_HYPH driven_VBN ._. We_PRP have_VBP had_VBN great_JJ cooperation_NN between_IN federal_JJ agencies_NNS ._. But_CC we_PRP 've_VBP had_VBN the_DT scientists_NNS who_WP understand_VBP this_DT and_CC who_WP developed_VBD it_PRP ,_, working_VBG on_IN this_DT all_PDT the_DT way_NN through_IN ._. So_RB ,_, people_NNS who_WP say_VBP that_IN regulatory_JJ agencies_NNS are_VBP giving_VBG this_DT a_DT free_JJ ride_NN --_, are_VBP they_PRP wrong_JJ ?_. I_PRP think_VBP we_PRP 've_VBP got_VBN a_DT very_RB efficient_JJ regulatory_JJ system_NN in_IN the_DT U.S._NNP I_PRP believe_VBP it_PRP 's_VBZ because_IN we_PRP 've_VBP focused_VBN on_IN science_NN ,_, and_CC we_PRP 've_VBP had_VBN the_DT scientists_NNS who_WP understand_VBP this_DT ,_, engaged_VBN from_IN the_DT beginning_NN --_, back_RB from_IN the_DT 1970s_NNS ._. The_DT idea_NN that_IN the_DT U.S._NNP government_NN is_VBZ just_RB letting_VBG things_NNS fly_VB through_IN -_, -_, I_PRP can_MD guarantee_VB you_PRP that_IN it_PRP 's_VBZ not_RB the_DT case_NN ._. The_DT amount_NN of_IN time_NN we_PRP 've_VBP spent_VBN in_IN the_DT last_JJ two_CD years_NNS just_RB dealing_VBG with_IN regulatory_JJ issues_NNS to_TO test_VB our_PRP$ plant_NN -_HYPH based_VBN vaccines_NNS ._. ._. ._. at_IN times_NNS ,_, as_IN a_DT scientist_NN ,_, I_PRP 'm_VBP ready_JJ to_TO pull_VB my_PRP$ hair_NN out_RP ,_, saying_VBG ,_, ""_`` Why_WRB do_VBP n't_RB these_DT people_NNS just_RB let_VB us_PRP move_VB ahead_RB ?_. Let_VB 's_PRP get_VB on_RP with_IN it_PRP ._. ""_'' We_PRP 've_VBP got_VBN something_NN that_WDT can_MD solve_VB a_DT world_NN problem_NN ,_, and_CC they_PRP want_VBP us_PRP to_TO write_VB another_DT form_NN to_TO prove_VB that_IN this_DT is_VBZ safe_JJ ,_, etc_FW ._. At_IN the_DT same_JJ time_NN ,_, as_IN a_DT rational_JJ scientist_NN ,_, I_PRP 've_VBP seen_VBN this_DT stuff_NN evolving_VBG ,_, and_CC I_PRP also_RB know_VBP that_IN we_PRP have_VBP to_TO do_VB this_DT ._. While_IN I_PRP 'm_VBP absolutely_RB convinced_JJ that_IN the_DT products_NNS we_PRP 're_VBP testing_VBG for_IN vaccines_NNS are_VBP safe_JJ ,_, I_PRP know_VBP that_IN perception_NN is_VBZ a_DT crucial_JJ issue_NN ._. If_IN we_PRP ever_RB did_VBD something_NN that_WDT would_MD cause_VB the_DT public_NN to_TO lose_VB confidence_NN in_IN what_WP we_PRP 're_VBP doing_VBG ,_, what_WP I_PRP 've_VBP spent_VBN the_DT last_JJ nine_CD years_NNS on_RB could_MD just_RB collapse_VB ._. Then_RB I_PRP 'd_MD really_RB be_VB frustrated_JJ ._. So_RB I_PRP want_VBP to_TO make_VB sure_JJ that_IN we_PRP do_VBP this_DT right_RB ._. In_IN spite_NN of_IN how_WRB frustrated_JJ I_PRP get_VBP with_IN government_NN folks_NNS at_IN some_DT times_NNS ,_, I_PRP 'm_VBP so_RB pleased_JJ they_PRP 're_VBP there_RB ,_, because_IN I_PRP know_VBP that_IN ,_, in_IN the_DT U.S._NNP ,_, we_PRP have_VBP this_DT process_NN in_IN place_NN ._. I_PRP can_MD always_RB refer_VB back_RB to_IN it_PRP and_CC say_VB ,_, ""_`` Yes_UH ,_, we_PRP 've_VBP done_VBN all_PDT these_DT things_NNS ,_, we_PRP 've_VBP considered_VBN all_PDT these_DT things_NNS ,_, and_CC it_PRP works_VBZ ._. ""_'' Are_VBP you_PRP concerned_JJ about_IN safety_NN and_CC ecological_JJ issues_NNS ?_. Well_UH ,_, I_PRP 'm_VBP very_RB concerned_JJ about_IN the_DT perception_NN issues_NNS ._. From_IN a_DT scientific_JJ standpoint_NN ,_, I_PRP do_VBP n't_RB see_VB anything_NN inherently_RB unsafe_JJ about_IN what_WP we_PRP 're_VBP doing_VBG in_IN putting_VBG genes_NNS into_IN ,_, say_VB ,_, a_DT tomato_NN ,_, that_WDT would_MD cause_VB a_DT tomato_NN to_TO produce_VB a_DT vaccine_NN ._. But_CC I_PRP am_VBP extremely_RB concerned_JJ that_IN someone_NN might_MD say_VB ,_, ""_`` Oh_UH ,_, he_PRP 's_VBZ putting_VBG hepatitis_NN B_NN in_IN tomatoes_NNS ._. ""_'' Well_UH ,_, we_PRP 're_VBP not_RB ,_, of_IN course_NN ._. But_CC it_PRP 's_VBZ so_RB easy_JJ to_TO make_VB an_DT incorrect_JJ assumption_NN about_IN this_DT ._. So_RB what_WP we_PRP 're_VBP trying_VBG to_TO do_VB is_VBZ build_VB in_IN safeguards_NNS right_RB now_RB ._. We_PRP have_VBP funding_NN from_IN the_DT U.S._NNP Department_NNP of_IN Agriculture_NNP for_IN a_DT project_NN that_WDT I_PRP think_VBP is_VBZ pretty_RB neat_JJ ._. We_PRP are_VBP taking_VBG our_PRP$ tomatoes_NNS ,_, which_WDT now_RB contain_VBP genes_NNS for_IN a_DT vaccine_NN ._. We_PRP 're_VBP crossing_VBG them_PRP into_IN other_JJ genetic_JJ varieties_NNS that_WDT are_VBP male_JJ -_HYPH sterile_JJ --_, that_DT means_VBZ they_PRP do_VBP n't_RB produce_VB pollen_NN ._. Furthermore_RB ,_, with_IN these_DT plants_NNS now_RB ,_, we_PRP 're_VBP crossing_VBG them_PRP so_IN that_IN we_PRP will_MD produce_VB seedless_JJ tomatoes_NNS ._. ._. ._. ._. So_RB we_PRP can_MD grow_VB tomatoes_NNS now_RB --_, and_CC I_PRP would_MD expect_VB this_DT would_MD be_VB done_VBN in_IN greenhouses_NNS ,_, because_IN that_DT 's_VBZ pretty_RB standard_JJ production_NN system_NN --_, but_CC there_EX would_MD be_VB no_DT pollen_NN ,_, no_DT seeds_NNS ._. There_EX 's_VBZ no_DT way_NN that_IN this_DT stuff_NN can_MD inadvertently_RB escape_VB into_IN the_DT environment_NN ._. It_PRP 's_VBZ going_VBG to_TO add_VB a_DT little_JJ bit_NN of_IN cost_NN to_IN the_DT production_NN ,_, because_IN we_PRP 'll_MD have_VB to_TO make_VB cuttings_NNS of_IN our_PRP$ tomatoes_NNS to_TO get_VB the_DT next_JJ generation_NN ,_, rather_RB than_IN collecting_VBG seeds_NNS ._. But_CC I_PRP believe_VBP that_IN to_TO prevent_VB misperception_NN is_VBZ much_RB more_RBR important_JJ ._. So_RB even_RB though_IN I_PRP do_VBP n't_RB see_VB the_DT safety_NN need_NN for_IN this_DT ,_, I_PRP firmly_RB believe_VBP that_IN we_PRP should_MD move_VB in_IN this_DT direction_NN ,_, to_TO give_VB the_DT public_JJ confidence_NN that_IN our_PRP$ vaccine_NN -_HYPH containing_VBG tomatoes_NNS are_VBP never_RB going_VBG to_TO show_VB up_RP in_IN the_DT marketplace_NN in_IN their_PRP$ grocery_NN store_NN ._. In_IN addition_NN to_IN using_VBG plants_NNS for_IN food_NN ,_, what_WP are_VBP the_DT things_NNS we_PRP might_MD use_VB in_IN the_DT future_NN ?_. We_PRP 're_VBP just_RB at_IN the_DT tip_NN of_IN the_DT iceberg_NN of_IN an_DT enormous_JJ number_NN of_IN things_NNS that_WDT will_MD be_VB technically_RB possible_JJ to_TO do_VB with_IN plants_NNS ._. Some_DT folks_NNS are_VBP talking_VBG about_IN how_WRB they_PRP are_VBP going_VBG to_TO change_VB the_DT qualities_NNS of_IN plants_NNS so_IN that_IN they_PRP 'll_MD be_VB able_JJ to_TO do_VB bio-remediation_NN and_CC clean_VB up_RP toxic_JJ sites_NNS ._. To_IN some_DT extent_NN ,_, that_DT is_VBZ a_DT viable_JJ technology_NN ,_, and_CC it's_PRP a_DT sustainable_JJ way_NN of_IN dealing_VBG with_IN complex_JJ issues_NNS ._. We_PRP 're_VBP clearly_RB going_VBG to_TO use_VB plants_NNS to_TO produce_VB more_JJR nutritious_JJ foods_NNS ,_, or_CC actually_RB medicines_NNS themselves_PRP ,_, as_IN I_PRP 've_VBP talked_VBN about_IN ._. I_PRP see_VBP that_IN we_PRP 're_VBP going_VBG to_TO also_RB very_RB rapidly_RB move_VB into_IN biological_JJ systems_NNS to_TO produce_VB industrial_JJ precursor_NN chemicals_NNS ._. Growing_VBG switchgrass_NN ,_, for_IN instance_NN ,_, a_DT very_RB easy_JJ ,_, high_JJ -_HYPH productive_JJ grass_NN to_TO make_VB chemicals_NNS ,_, which_WDT will_MD substitute_VB for_IN petrochemicals_NNS coming_VBG out_IN of_IN the_DT petrol_NN industry_NN ._. Now_RB that_IN petroleum_NN is_VBZ upwards_RB from_IN $_$ 30_CD a_DT barrel_NN ,_, this_DT sort_NN of_IN interest_NN gets_VBZ more_RBR interesting_JJ ._. All_DT of_IN these_DT things_NNS ._. ._. ._. do_VBP n't_RB have_VB to_TO depend_VB on_IN genetic_JJ modification_NN ._. But_CC what_WP we_PRP 're_VBP going_VBG to_TO find_VB is_VBZ that_IN more_JJR and_CC more_JJR examples_NNS will_MD appear_VB where_WRB ,_, if_IN you_PRP could_MD switch_VB off_RP a_DT gene_NN or_CC an_DT enzyme_NN in_IN a_DT plant_NN ,_, or_CC you_PRP could_MD add_VB some_DT new_JJ component_NN ,_, it_PRP 's_VBZ going_VBG to_TO make_VB it_PRP much_RB easier_JJR to_TO do_VB ._. If_IN we_PRP can_MD just_RB cut_VB down_RP the_DT amount_NN of_IN lignin_NN in_IN the_DT poplar_JJ trees_NNS that_WDT we_PRP 're_VBP growing_VBG for_IN paper_NN pulp_NN to_TO make_VB newspapers_NNS ,_, and_CC get_VB less_JJR lignin_NN contamination_NN in_IN streams_NNS and_CC waterways_NNS ,_, that_DT makes_VBZ a_DT lot_NN of_IN sense_NN ._. As_IN time_NN goes_VBZ on_RP ,_, as_IN we_PRP try_VBP more_JJR and_CC more_JJR systems_NNS over_IN the_DT next_JJ two_CD decades_NNS ,_, we_PRP 're_VBP going_VBG to_TO see_VB a_DT gradual_JJ replacement_NN to_IN using_VBG the_DT power_NN of_IN genetics_NNS ,_, a_DT sustainable_JJ modification_NN of_IN a_DT biological_JJ resource_NN ,_, as_IN the_DT much_RB preferred_VBN avenue_NN over_IN using_VBG cost_NN -_HYPH intensive_JJ industrial_JJ processes_NNS to_TO do_VB the_DT same_JJ things_NNS ._. What_WP 's_VBZ the_DT idea_NN in_IN taking_VBG a_DT quality_NN from_IN one_CD organism_NN into_IN another_DT ?_. ._. ._. ._. An_DT example_NN that_WDT 's_VBZ used_VBN a_DT lot_NN was_VBD the_DT flounder_NN gene_NN into_IN tomatoes_NNS ._. The_DT background_NN of_IN it_PRP ,_, from_IN a_DT scientific_JJ standpoint_NN ,_, is_VBZ that_IN we_PRP have_VBP a_DT good_JJ understanding_NN of_IN why_WRB some_DT fish_NN can_MD tolerate_VB cold_JJ ,_, like_IN the_DT flounder_NN ._. We_PRP 'd_MD like_VB to_TO have_VB some_DT of_IN our_PRP$ fruits_NNS and_CC vegetables_NNS tolerate_VBP cold_JJ ,_, like_IN strawberries_NNS ,_, so_IN they_PRP do_VBP n't_RB get_VB nipped_VBN by_IN an_DT early_JJ frost_NN ,_, or_CC by_IN a_DT late_JJ frost_NN ._. So_RB scientists_NNS have_VBP done_VBN experiments_NNS trying_VBG to_TO mimic_VB the_DT cellular_JJ environment_NN of_IN a_DT flounder_NN in_IN a_DT strawberry_NN ._. These_DT are_VBP really_RB excellent_JJ basic_JJ science_NN studies_NNS ,_, and_CC I_PRP should_MD emphasize_VB ,_, they_PRP 've_VBP never_RB gone_VBN beyond_IN that_DT ._. No_DT one_NN 's_VBZ ever_RB started_VBN a_DT commercial_JJ development_NN of_IN anything_NN from_IN it_PRP ._. But_CC I_PRP think_VBP the_DT public_NN responds_VBZ negatively_RB to_IN that_DT ._. My_PRP$ perception_NN ,_, after_IN talking_VBG just_RB to_IN family_NN members_NNS and_CC others_NNS ,_, is_VBZ that_IN you_PRP can_MD almost_RB see_VB their_PRP$ nose_NN wrinkling_VBG up_RP ,_, because_IN there_EX 's_VBZ something_NN about_IN a_DT fishy_JJ smell_NN to_IN a_DT strawberry_NN ._. It_PRP 's_VBZ a_DT mental_JJ image_NN ._. More_JJR than_IN anything_NN else_JJ ,_, it_PRP 's_VBZ just_RB ,_, ""_`` Ooh_UH ,_, I_PRP would_MD n't_RB like_VB that_DT ._. ""_'' It_PRP has_VBZ nothing_NN to_TO do_VB with_IN the_DT science_NN ,_, I_PRP believe_VBP ._. It_PRP 's_VBZ just_RB the_DT way_NN we_PRP 're_VBP wired_VBN in_IN our_PRP$ brain_NN ._. A_DT fish_NN is_VBZ supposed_VBN to_TO smell_VB like_IN a_DT fish_NN ,_, and_CC a_DT strawberry_NN like_IN a_DT strawberry_NN ._. And_CC just_RB superimposing_VBG words_NNS on_IN each_DT other_JJ --_, we_PRP back_VBP off_RP ._. We_PRP do_VBP n't_RB like_VB that_DT ._. ._. ._. ._. People_NNS do_VBP n't_RB see_VB the_DT connection_NN between_IN humans_NNS and_CC the_DT tomato_NN in_IN terms_NNS of_IN the_DT shared_VBN genetic_JJ heritage_NN ._. Do_VBP you_PRP think_VB we_PRP have_VBP a_DT big_JJ educational_JJ job_NN here_RB ?_. Genetics_NNS is_VBZ a_DT really_RB complex_JJ issue_NN for_IN public_JJ acceptance_NN ,_, because_IN almost_RB all_PDT the_DT things_NNS we_PRP think_VBP about_IN with_IN regard_NN to_IN genetics_NNS have_VBP been_VBN bad_JJ ._. It_PRP somehow_RB goes_VBZ back_RB to_IN Hitlerism_NNP and_CC something_NN that_WDT has_VBZ a_DT negative_JJ connotation_NN ._. When_WRB the_DT positive_JJ stories_NNS about_IN genetics_NNS have_VBP come_VBN out_RP ,_, about_IN increasing_VBG the_DT yields_NNS of_IN our_PRP$ crops_NNS or_CC making_VBG larger_JJR tomatoes_NNS or_CC strawberries_NNS that_WDT taste_VBP good_JJ ,_, that_DT 's_VBZ genetics_NNS ._. But_CC those_DT stories_NNS are_VBP n't_RB linked_VBN to_IN genetics_NNS ._. We_PRP just_RB have_VBP the_DT wrong_JJ connection_NN of_IN negative_JJ images_NNS ,_, and_CC I_PRP think_VBP that_DT persists_VBZ at_IN the_DT present_JJ time_NN ._. How_WRB do_VBP you_PRP educate_VB the_DT public_NN ?_. That_DT 's_VBZ being_VBG a_DT little_JJ bit_NN arrogant_JJ on_IN the_DT scientific_JJ standpoint_NN ._. They_PRP should_MD know_VB as_RB much_RB as_IN we_PRP do_VBP ._. I_PRP 'd_MD say_VB it_PRP 's_VBZ more_RBR like_IN ,_, how_WRB do_VBP you_PRP interest_VB the_DT public_NN in_IN genetics_NN ,_, causing_VBG the_DT public_NN to_TO want_VB to_TO inquire_VB more_JJR and_CC understand_VB more_JJR about_IN it_PRP ?_. And_CC I_PRP think_VBP that_DT 's_VBZ going_VBG to_TO be_VB one_CD of_IN the_DT positive_JJ outcomes_NNS of_IN all_PDT this_DT genetically_RB modified_VBN food_NN ,_, because_IN once_IN the_DT initial_JJ potentially_RB negative_JJ response_NN occurs_VBZ ,_, I_PRP think_VBP we_PRP have_VBP an_DT intelligent_JJ public_NN overall_RB ._. They_PRP want_VBP to_TO know_VB more_JJR about_IN this_DT ._. As_IN they_PRP begin_VBP to_TO understand_VB that_IN it_PRP 's_VBZ just_RB a_DT continuation_NN of_IN what_WP we_PRP 've_VBP been_VBN doing_VBG in_IN crop_NN improvement_NN for_IN the_DT last_JJ 100_CD years_NNS ,_, it_PRP 's_VBZ Burpee_NNP 's_POS tomatoes_NNS ,_, you_PRP know_VBP ,_, the_DT old_JJ seed_NN catalogues_NNS that_WDT our_PRP$ parents_NNS used_VBD to_TO buy_VB ._. It_PRP 's_VBZ just_RB in_IN a_DT new_JJ formulation_NN ._. Once_IN people_NNS realize_VBP this_DT ,_, then_RB I_PRP think_VBP all_DT of_IN this_DT is_VBZ going_VBG to_TO calm_VB down_RP ._. We_PRP had_VBD this_DT controversy_NN in_IN medical_JJ research_NN in_IN the_DT 1970s_NNS ,_, and_CC most_JJS people_NNS now_RB accept_VBP that_IN genetically_RB engineered_VBN insulin_NN is_VBZ a_DT good_JJ thing_NN ._. Do_VBP you_PRP think_VB we_PRP 'll_MD get_VB to_IN that_DT stage_NN with_IN agriculture_NN ?_. It_PRP 's_VBZ not_RB controversial_JJ anymore_RB in_IN medicine_NN ._. I_PRP do_VBP n't_RB think_VB in_IN general_JJ that_IN the_DT public_NN is_VBZ concerned_JJ about_IN the_DT use_NN of_IN biotechnology_NN to_TO make_VB products_NNS for_IN medicine_NN anymore_RB ._. Clearly_RB ,_, there_EX are_VBP still_RB issues_NNS with_IN regard_NN to_IN the_DT origin_NN of_IN stem_NN cells_NNS for_IN treatment_NN ._. There_EX will_MD be_VB more_JJR controversies_NNS that_WDT will_MD come_VB along_RB in_IN human_JJ medicine_NN ,_, but_CC they_PRP 're_VBP not_RB focused_VBN on_IN the_DT process_NN of_IN biotechnology_NN ._. I_PRP believe_VBP that_DT 's_VBZ because_IN of_IN the_DT profound_JJ benefits_NNS that_WDT we_PRP 've_VBP seen_VBN from_IN some_DT of_IN the_DT new_JJ products_NNS ._. I_PRP believe_VBP ,_, as_IN a_DT new_JJ generation_NN of_IN products_NNS appears_VBZ in_IN the_DT agricultural_JJ side_NN ,_, as_IN the_DT public_NN sees_VBZ the_DT immediate_JJ benefit_NN and_CC value_NN from_IN these_DT things_NNS ,_, we_PRP will_MD slide_VB into_IN this_DT same_JJ sort_NN of_IN acceptance_NN ._. Essentially_RB what_WP we_PRP 're_VBP going_VBG to_TO move_VB to_IN ,_, rather_RB than_IN focusing_VBG on_IN how_WRB it_PRP was_VBD done_VBN ,_, we_PRP 're_VBP going_VBG to_TO focus_VB on_IN ,_, ""_'' What_WP 's_VBZ the_DT outcome_NN ?_. What_WP is_VBZ the_DT material_NN that_WDT we_PRP 're_VBP going_VBG to_TO get_VB in_IN the_DT end_NN of_IN the_DT day_NN ?_. Is_VBZ it_PRP better_JJR for_IN my_PRP$ health_NN ?_. Is_VBZ it_PRP better_JJR for_IN the_DT way_NN we_PRP treat_VBP the_DT environment_NN ?_. Is_VBZ it_PRP good_JJ for_IN the_DT developing_VBG world_NN and_CC for_IN solving_VBG problems_NNS of_IN global_JJ importance_NN ?_. ""_'' ._. ._. ._.","The JJ NN of any NN VBZ RB to NNP , NNS of NNS RB , for NN . The JJ JJ NN of NNS VBZ RB 200 NNS to NNP in NNP , where he VBD a NN of NN from a NN and VBD it on a NN on the NN of a NN , and there VBD NN of a NN to it . And RB -- you RB VBP this NN -- but he VBD the NN with JJ NN . And the NN VBD RB VB NN , RB he VBD the NN . NNP NNP of the NNP NNP NNP for NNP NNP at NNP NNP , NNP VBZ VBG on VBG JJR NNS for NNS which VBP NNS in the VBG NN . He VBZ his NN VBG JJ NNS ( inside NN NNS , NNS , or NNS ) . He RB VBZ about NNP 's NN to NNP NNS and NN 's NNS for VBG NN NNS to JJ NNS , NNS , and JJ NN . ( NN VBN NNP 2000 . ) That VBD the JJ NN of a NN where you VBD , in that NN , a JJ NN . NN we VBP them VBN NNS , because they VBP like the JJ NN - - a NN that VBZ NN -- but they VBP either VBN , RB VBN , RB VBN -- or there VBP NNS . RB it could VB a NN that VBZ NNS but RB NNS , but it RB VBZ an JJ NN . RB for 200 NNS , JJS NNS VBP VBN VBN around this NN of VBG a NN of what VBZ NN in us , or an VBN NN . RB RB VBD JJ NN in the NN to JJ NNS . The JJ NN that VBD out of this VBD for NN NN . The NNS in that NN VBD at the JJ NN of the NN NN NN . That VBD a RB JJ JJ NN , with the JJ NNS they VBD about 25 NNS RB . But they VBD a NN in the NN that VBZ , or it VBZ the NN for , the NN of the NN NN NN . You can VB NN NN like a JJ NN NN . It VBZ VBN a NN RB and that JJ NN on the NN VBZ NN . That VBZ what VBZ to a JJ NN and VBZ the NN to VB VBN up . RB these NNS VBD VB that NN , VBD it to NN , and VBD the NN in NN NNS . RB the NN VBZ a JJ JJ NN NN , or a NN - JJ NN , but there VBZ NN inside it , RB there VBZ no NN for NN . They VBD this JJ JJ NN NN from NN , and RB VBP it and VBP it into an JJ NN . That VBD the JJ NN NN NN . That VBD out in 1986 . It VBD VBN by the JJ NN as VBG RB JJ and RB JJ . That VBD the JJ of RB what VBZ VBG to VB a NN of NN NNS that VBP VBG in . The JJ NNS VBP RB JJ . VBP there NNS ? I VBP RB VB to VB that there VBP NNS to JJ NNS . But there NNS , if you will , and those VBP to the NN . This VBZ a RB JJ - NN NN . It VBZ RB VBN RB JJ to VB it to VBG NNS . The JJ NN VBZ that these JJ NNS all VBP NN from the NN of NN to the NN of NN . If you VBP VBG to VB a NN to a NNP NNP NN , that VBZ an JJ NN , and VBZ a JJ NN . If this JJ NN VBZ down NN , you could VB the NN of your NN . RB those VBP the two JJS NNS . In NN , the NNP NNP NNP VBZ , "" We 'd RB VB these to VB JJ NNS , because they VBP JJR to VB . "" Their NN for that VBZ a NN NN -- a JJ NN that VBD VBN RBR than two or three NNS RB . You VBP the NN NN in a VBN NN , but VBP it on a NN NN , and RB VBP that on the NN or the NN of a NN . It VBZ an JJ NN NN . RB the NNP NNP NNP VBZ VBN VBG for the NN of the NN NN NN NN . What VBZ JJ with NNS ? Well , NNS VBP NN . Because they VBP NN , they VBP RB RB VBN in VBG NN . NNS VBP to VB them , and they should RB . They should VB VBG them RB , but at the NN , they VBP RB to the NN NN . The NNP NNP NNP VBZ that there VBP NNS of NNS of NNS and NN NNS VBN by JJ NN NN . RB they 'd VB to VB RB from that NN . VBN those NNS , how can a NN VB you through this ? With NN - VBN NNS , we VBP RB VBG to VB the NN NN of it . We VBP RB JJ upon our NNS who VBP NN and NN to VB out how to VB the NNS and VB the JJ NNS to VB the NN . I VBP myself , as a NN NN , as a NN NN . We can VB the NN RB into the NN of the NN , so that every NN in the NN that VBZ RB out of this VBZ the NN to VB a JJ NN . RB , RB RBR , the NN itself VBZ a NN NN . RB if you can RB VB it , RB you VBP RB VB to VB any JJ NN ; you VBP RB VB to VB NN ; and you VBP RB VB to VB with some of the JJ NNS about NNS or JJ NNS that could VB into the VBN NN . RB NNS VBP a RBR JJ NN NN , and RB , we VBP , a RBR JJ and JJ NN NN . VBN with VBG a NN and VBG NN - NN NN to VB the NN , we can RB VB VBG NN that VBZ in the VBG NN -- NN and NN NN that VBZ around the NN -- and VBP that to VBG a NN . VBZ it in a JJ NN in the NN ? When we VBD VBG about NN NNS , the NN that I VBD VBG on about eight NNS RB VBD NNS . When you VBP VBG a NN , the NN that NN VBZ off , you VBP VBG a JJ NN RB . There VBP no NN . There VBP no NN in RB . This VBZ a NN - VBN JJ NN that RB VBZ NN . RB you can VB of it as a JJ NN - NN NN . If we can VB NNS into NNS and VB them to VB the NN we VBP -- in this NN , a NN -- in that JJ NN , RB all we VBP to VB VBZ VB it JJ and VB it . What VBZ the NN , from NN to VB , of how you VBP a NN ? . . . We VBP VBN the JJS NN VBG on NNS VBN by NNS or NN that . . . VB NN . . . . NN NN VBZ an JJ NN in the VBG NN . It VBZ NNS of RB 2 million NNS every NN . That VBZ from a NN of NNS : JJ NN NN , JJ NN NNS , FW . That VBZ one NN of VBG this NN in the JJ NN . But in the JJ NN , NNS would VB the JJS NN to VB the NN . Because the NN VBZ JJ ? It VBZ an JJ NN . NN NN VBZ , RB in the VBG NN . Whenever they VBP the NN NN and JJ NNS like that , it VBZ RBR RB . JJ NN of NN VBZ from NNS like NN , JJ NN NN , NN NNS . You VBP VBN a NN you VBP JJ in ? . . . VB me VB to VB how we VBP a NN for NNP NN . NNP NN VBZ NN . You VBP it in VBN NN , and we in the NNP would VB of it as a NN of NN NN . The NNP NN , when we VBP it in with VBN NN , VBZ a NN NN that VBZ to NNS in our NN , RB in the NN . Once it VBZ , the JJ NN -- which VBZ NNS from the NN -- VBZ VBN into the JJ NNS in our NN . RB , RB , the NN VBZ over and VBZ JJ NN in the NNS in our NN . The NN VBZ JJ NN , with its NN , NN , FW . We in the NNP RB VBP VB this , because we VBP NN NN , FW . If you VBP that , your JJ NN VBZ VBN VBN , and the NN NN RB VBZ VBG NNS that VBP VBN into the NN . If that NN - VBG NN VBZ RB RB , we VBP VBN for it . The NNS VBP to the NN and VBP the NN NN . What we VBD to VB VBD VB the NN for that NN NN , VB it into NN NNS , and VB whether the NN would VB a NN - JJ NN . It VBZ a NN , or a NN , that VBZ like the NN , but with NN of the NNS RB , RB it can't VB NN . RB of all , we VBD that we could VB that . We VBD that in NN with NNP NNP at NNP NNP of NNP , who VBZ an NN in this NN . VBP you VB a NN NN NN to VB them in ? We VBP one of two NNS to VB the NN for NNP NN into NNS . We can VB the NN NN , so we RB VBP VBG the NN of NN into a NN NN , where it VBZ VBN into the NN . Or we VBP another NN , VBN NN - VBN NN . That VBZ where we RB VBP the NN out of the NN and VBP it into a NN NN . RB the NN NN VBZ a NN , and that VBZ the NN into a NN NN . Each NN VBZ some NNS . We can VB either one . But we VBP up with an JJ NN , which RB VBZ this JJ NN . From that NN , we VBP a NN RB . RB the JJ NN of this VBZ RB VBN RB JJ . There VBZ RB JJ JJ NN VBG on around the NN NN . We can VB in a JJ NN NN and VB them VB the JJ NN of VBG the NNS into the NNS for us . The RBR JJ NN of it RB VBZ to VB NNS RB out of this , VB at each NN and VB , "" VBZ it VBG the NN in the NN we VBP it ? VBZ it VBG it in the JJ NN ? "" For NN , we RB VBD on NNS , and RB NNS , and JJR NN NN . We VBP to VB JJ that it's in the JJ NNS , that it VBZ VBG the JJ NN . RB the JJ NN you VBD VBD the NN ? That VBD the JJS to VB ? . . . For a NN of NNS , the NN VBD JJS . You can VB the NNS in RB RB . RBR JJ for us , we VBD how to VB the NNS to VB in the NN NN . There VBZ VBN a NN of NN by NNS of ours . RB RB , we VBD a JJ NN to VB with , a JJ NN , so we could VB the NN we VBD . The JJ JJ NN about NNS VBZ that we can VB a NN of JJ NN NN RB RB . In RB four to five NNS , we can VB a NN JJ of NNS , and each NN will VB us RB RB a NN of NN . That VBZ JJ to VB a NN of NN NN NNS . In these NNS , NN JJ VBZ the JJ , but there VBZ an JJ NN VBG VBN ? Right . When they VBD a NN into a NN , RB all we VBP VBN VBZ one JJ NN . For all JJ NNS , that VBZ JJ . You VBP RB VB any NN of it . The NN we VBP that it VBZ , in NN , RB , VBZ to VB a NN . That VBZ VBG a NN of the NN and VBG it to a NN , and RB VBG NN NNS from the NN and VBG , "" VBZ it VB JJ NNS ? VBZ it VB an NN against this NN we VBP JJ in ? "" Once RB VBN that that VBZ with NNS and what the NN of the NN VBD , we could VB some of the NNS and RB VB them up into NNS , VB them . RB we VBP JJ NNS VBG RB out . RB we VBD NN of our NN . The JJ NN for us VBZ VBN to VB the JJ NN of NN into NNS . That VBD a NN JJR NN to VB a NN , if you will , RB we can VB the NNS that will VB in the NN NN . Before that , how VBD you JJ this VBZ VBG in the NN ? The NN VBZ , "" How VBP we VB that the NN VBZ RB ? "" The NN VBZ RB JJ . We RB VBP it , VBP it up into NNS , and VBP the NN to a NN . We RB VBP NN NNS from that NN on a JJ NN , and we VBP if the NN VBZ NN NNS , or VBZ he RB VBG NNS against that NN ? The NN VBD yes , we VBD them . . . . In all NNS , we VBP VBG JJ NNS all the NN -- in our NNS , in our NN , throughout the NN . We can VB those NNS in JJ NNS . RB RB , after VBG our RB VBN NNS , the NN would VB VBG JJ NNS . VBZ the NN a JJ NN RB for NNS ? NNS VBP the JJ NN for JJ NNS . Once we VBD JJ NNS with NNS , we RB VBD to the NNP NNP and NNP NNP and VBD for NN to VB the JJ NNS with NNS . They VBD through all the JJ NNS , and the JJ NN we VBD this , it VBD RB eight NNS for us to VB NN to VB NN for the NNS . But we RB VBD JJ NNS VB some of our NNS , and RB RB , VBD the JJ NN . They VBD NNS in the NN NN and JJ NNS . RB we can VB that the JJ JJ NN can RB VB VBN by RB VBG JJ NNS that VBP our NN that we VBP VBN into them . VBP they VB to VB JJ NNS ? Well , JJ NNS VBP RB JJ . I VBD and VBD JJ NNS when my NN VBD VBG them . I VBP that as a NN . RB , we RB VBD a NN JJR , because some of the NNS VBD to VB up to 100 NNS of JJ NN , which VBZ RB the NN of a NN NN or RB . That VBZ a JJ NN of some NN . But they VBD it , and we VBD them for it , and RB RB , they VBD the JJ NN NN . You VBD VBG that , because it VBD JJ , this might RB VB the JJ NN ? Yes . The NN we VBP JJ NNS VBZ because JJ of these NNS or NNS that we VBP JJ in would VB VBN by NN . RB if you VBD the NNS , if you VBD a VBN NN or a JJ NN , we VBP that all the NN would VB VBN . RB RB you VBD on to JJ NNS ? Well , because you can't VB or VB a NN RB , we VBD that we VBP VBG to VB the JJ NNS in JJ NNS . The JJ NN VBD to VB to NNS . . . . One of the JJ NNS to VB NNS VBZ that they VBP RB VBN . We can RB VB VBG NN - NN NN ... and RB VB NN NN , or RBR JJ for us , we VBP VBG to VB - VB the NN NN and RB VB a JJ NN . I VBP to VB , why should we VB and VB a JJ NN NN ? The NN VBZ RB that this VBZ a NN . We VBP RB VBG to VB a JJ NNP NN . We VBP VBG to VB a NN . If we VBP VBG to VB JJ , we VBP to VB with NNS that VBP NN of the JJ NN . They VBP about JJ NN . They VBP about NN - to - NN NN , NN , if you VBP up 100,000 NNS at one NN , the JJ NN VBZ to VB JJ in NN . The JJ NN I can VB with that from a NN NN of NNS VBZ to VB VBG NN - NN NN to VB a JJ NN , or RB , when we VBP to NNS , I VBP NN like a NN NN NN . You can VB NNS of NNS of JJ NNS of a NN NN NN , and you can VB each NN and VB that the NN VBZ JJ -- that they VBP JJ of any NN of JJ NNS or NN JJ -- the JJ NN of NN that VBZ to VB VBN with any JJ NN . Our NN on this VBZ we can VB NN - NN NN , which VBZ JJ in the VBG NN , and VB it to a NN . VBG NN VBZ RB , what VBZ your NN ? VB 's VB we VBP to VB NNS against NN in NNP , where they VBP VBN . I 'll VB you what I VBP RB VB : I VBP RB VB a NN NN NN with NNS in it , where NN VBZ up and VBZ one when they VBP to . That , for a NN of NNS , would VB JJ . You would RB VB NN , FW . What I VBP VB would VB a NN or a NN NN VBN in a NN -- RB NNP NNP RB , because they VBP a RB JJ NN . I VBP them VBG their JJ NN NNS in NNP NNP , where they would VB some of the NN NN that VBZ VBN , VB to VB it under VBN , VBN NNS , and VBG an JJ NN of NNS . It VBZ RB JJ and they VBP VBN to it in NNP , and they VBP VBN to VBG a VBN NN NN . VB 's VB it VBD a NN . VBG a VBN NN NN and VBG that in a JJ NN , VBG , "" This VBZ a NN "" would VB JJ . They VBP VBN NN NNS around the NN . If we could RB VB that , or VB up this VBN NN NN and VB it into a JJ NN and VB it to an NN -- that VBZ NN that could VB VBN at a JJ NN , without a NN of JJ NN . It would VB an JJ NN . But this VBZ NN that would VB JJ with a NN of NN that they VBP NN . Would it VB JJ ? The NN VBZ , what would it VB to VB this in a VBG NN ? I VBP it VBZ RB JJ that the JJ NN of the NN could VB RB JJ . The JJ NN , VBG some NN of NN NN , VBZ JJR for me to VB . You would VB to VB JJ that you VBP the NNS in NN , that the NN VBZ JJ and JJ , and that the NN . . . VBZ JJ . It VBZ JJ for me to VB the NN to this . But RB it VBZ NN that VBZ JJ . There VBZ to VB a NN to VB this . RB of all , it VBZ RB VB to VB JJ . It RB VBZ to VB NN that VBZ VBN into an NN in the VBG NN . It VBZ for these NNS of NNS that our NN VBZ RB RB to VB this JJ to a RB JJ NN in NNP . In NN , we VBP VBN our JJ NNS with RB JJ , JJ NNS in NNP . There VBZ a NN for NN NN NNS in NNP , and they VBP RB JJ in - NN NN NNS . Some of these VBP RB VBG and VBG NNS . They VBP a RB JJ JJ NN NN . RB our NN VBZ to VB to VB with NNS in NNP , VB this NN , VB it RB , VB that it VBZ , and VB that in NN with what we VBP VBG in the NNP I should VB -- we VBP VBG to VB this RB in the NNP , RB because I VBP JJ , but because I VBP RB VB to VB VBN of VBG this NN and VBG it on JJ NNS RB RB in the NN . We VBP VBN the NN of this NN over RB VBN NNS . VBD this VB you when it VBD ? VBZ it VBN your NN ? The NN over RB VBN NNS RB VBZ RB VBN any JJ NN on our NN NNS . And I VBP JJ about that . I VBP VBG , we VBP VBG NNS . NNS that VBP as an JJ NN will RB VB in the NN NN , and we VBP VBG in NNS to VB that that wo RB VB . But in the JJR NN , VBP I VBN at what VBZ VBN ? RB RB , because I VBP this VBZ VBN a NN to the NN . They VBP RB VBN all this NN NN and NN VBG VBN . It VBZ VBN NN that VBZ RB JJ to us in the JJ NN . I VBP RB VBN NN that VBZ JJ or that VBZ me about any NN of NN NN , but I VBP VBN it VBG for the JJ 20 - plus NNS . It VBZ JJ and NN to me . But I RB VBP JJ , RB from my NNS with NN and NNS , that they VBP it JJ that all these NNS VBP JJ . It VBZ NN of NN NN NN , and I VBP whenever NN VBZ RB that you VBD RB VBN about , it VBZ some NNS . What NN in this NN NNS should VB JJ of ? Well , RB the JJ NN of NNS that VBP RB VBN VBP VBG to VB RB JJ from the JJ NN that VBD out . We VBP VBG a NN JJR NN that VBZ VBN around JJ NN . There VBP a NN of NNS for that , but RB the JJS NN in the NNP VBZ that we VBP VBN JJ NN NN . There VBZ JJR NN in RB VBG NNS . What we VBP to VB on VBZ how we VBP our NNS RBR . We can VB VBG ourselves that we can VB NNS that will VB the JJ NN NN , that we VBP VBG to VB NN to NN and to the NNS that NNS VBP VBG , and we VBP VBG to VB a JJ JJ NN RB throughout this NN NN . My JJ JJ NN VBZ this NN of VBG JJ NNS in NNS . Because of the NN where I VBP , it RB VBZ RB VBN a NN on the NNP in JJ . It VBZ VBN RBR a NN on the NNP NNP . How can we VB . . . a RB JJ NN , but VB VBG NNS RBR JJ upon NN and JJ NN and NNS of that NN ? How can we VB the NN so that a JJ NNP NN can VB the NNS themselves ? VBZ this NN JJ because it VBZ you to VB NNS in JJ NNS ? What about the "" JJ NN "" NN ? Well , if you VBP VBG at JJ NNS of where RB VBN NNS VBP a NN in the VBG NN , I VBP NN one VBZ the NN of NN NN -- VBG NNS against NN , so that they VBP JJR . RB , RB , NN NN , NN of VBG NNS against NNS as the NN one NN . It VBZ VBG to VB the JJS NN in the VBG NN . But RB , as we VBP VBN with the JJ NN NN , you can RB VB the NNS of the NN itself . We can VB NNS like NN NN into a NN NN , as NNP NNP and his NNS VBD . That VBZ RB JJ , and it's VBG to VB JJ NNS in the VBG NN , as to the NN of NN NNS for JJ NN . I VBP that a JJ NN VBZ , "" Well , they should RB VB VBG JJR JJ JJ NNS . "" I VBP VBN to NNP . I VBP VBN in a RB JJ NN in the NN of NNP NNP . And you VBP NNS VBG on the NN on an JJ NN of NN RB RB . This VBZ NN of this JJ NN of NNS to the NNS , as NNS VBP . They RB RBR VBP a JJ NN NN to VB their NNS . They VBP VBN in a JJ NN RB . They VBP RB VB NN to JJ JJ NNS and NNS that they VBP , and they VBP VBG on a NN of NN every NN . I VBP the NNP NNP and NNS VBG this , and VBG that we VBP VBN these JJ NNS in NNS VBN in JJ NN , and the JJ NNS they can VB . They VBP VBN on NNS like , how can we VB the NN of that NN that they VBP VB JJ , and VB the NN of these NNS ? Because the NNS VBP RB VBG a VBN NN ? Because they VBP a VBN NN . They VBP RB JJ . They VBP NN of this JJ NN that VBZ RB VBG NNS into a NN where they VBP no NN . It would VB JJ to VB the NN NN . That would VB JJ . But until we can VB that , one of the NNS of VBG our NN VBZ that we can VB VB these RB JJ NNS NN JJR to VB their NN as they VBP to VB their NN out of the NN that they VBP in . NNP VBZ that there VBZ JJ NN to VB the NN RB -- that the NN VBZ NN . Yes . The NN that there VBZ JJ NN in the NN , but VBZ in the JJ NN at the JJ NN -- that VBZ a JJ NN . But a NN of the NN NNS we VBP VBP RB RB VBN . A JJ NN VBZ RB VBG to VB VBN from NNP to NNP . NNS can VB VBN -- NN , NNS , and NNS and NNS like that . But we VBD some NNS of RB VBG NN and VBG it RB . For NN , in NNP and NNP in the NNS , when there VBD NN , if a NN like the NNP VBZ in and RB VBZ NN , it RB VBZ the NN of the NN itself to VB its JJ JJ NN . I VBP we VBD when we VBD those NNS at one NN , and RB we VBD our NN on VBG the NN to NNS to VB their JJ NN . That VBZ VBN RB RBR JJ . In a NN , we VBP RB RB VBN VBN in it RB RB in NNP , but you can VB the JJ NNS in NNP in VBG their JJ NNS . It VBZ VBN through an NN of JJ JJ NN , VBG the JJS of the JJ NNS that VBP JJ , and VBG RB RB . If you VBP in NNP NN , you VBP RB VB the NN that VBZ JJ in JJ NNS of the NN , RB in the JJR NNS of the NN NN . VBZ it your NN that NNP and NNP VBP a NN of NN in this NN ? It VBZ RB JJ to VB NNP and NNP . NNP VBZ VBN RB RB in all NNS of NN NN , VBG NNS like NN for NN of NNS , but RB RB VBG to VB JJ JJ NN NNS . RB , they VBP RB VB RB one NN of it . NN VBZ RB a JJ NN , but a JJ JJ NN VBZ a NN . I VBP VBN a JJ NN in NNP . NNP VBZ RB RB VBN JJR of a JJ NN . It VBZ a RB JJ NN , and some of the NNS of NN VBP VBN in RB VBG NNP 's NN of JJ NN NN . But NNP VBZ VBN a JJ NN of VBG a NN that VBZ VBN in the JJ JJ NNS . They VBP RB VBG their NNS . They VBP VBN JJR to VB NN for JJ NN , and in NN , RB that VBZ because they VBP RB VBN the NN RB . They VBP RB VBN the NN NNS that NNP VBZ VBN . We VBP a NN over the JJ 100 NNS of a NN of NN NN . Without JJ JJ NNS , VBZ that VBG to VB JJ ? Well , it VBZ JJ for me to VB about what VBZ VBG to VB over the JJ 100 NNS or 50 NNS . It VBZ JJR to VB what VBZ VBG to VB over the JJ two NNS . RB , we VBP the JJ NNS VBN on the NN NN , who VBP VBG to VB an JJ 1 billion NNS each NN . That JJ JJ NNS every ten NNS VBZ the NN of NNP . When you VBP VBG of this JJ NN NN that we VBP -- and RB the NN VBZ VBG where we VBP RB VB an JJ NN NN -- we VBP RB VBG to VB all the NNS we VBP NN . Of NN we VBP JJ NN . We can't RB VB to VB up NNS or VB to VB JJ NNS to VB into NN . That VBZ RB VB in the NNS we VBP it , and we VBP RB VB to VB the VBG JJ NNS of the NN that we VBP NN and VB them to VB JJR NN . All we can VB VBZ VB the NN of the NN that we VBP NN , to VB this JJ VBG NN in NN . The JJ NN VBZ that a RBR JJ NN of JJ NN should VB VBN , RB than VBG JJ NN . It VBZ RB JJ to me how NN can VB that we RB VBP RB VB JJ NN . NNP VBZ RB an JJ NN NN NN . As they VBP to VB on JJ NN , the RBS JJ VBZ VBN JJ NN . It VBZ the VBN NNS that VBD out of JJ NN NNS , and the VBN NNS . VBG RB VBN NNS VBZ what VBZ VBN them to VB their NN . Some of that VBZ VBN VBN with NN of NN , for NN , in NNP , which VBZ RB VBN the NN NNS . What VBZ VBG in NNS like NNP , for NN , VBZ a NN of JJ NN -- like NN - VB NN of the NN , NN of the NN , NN of it , so they VBP RB VB NNS to NNS or NN NNS in the VBN NN . RB I VBP NNS VBP VBN RB RB on , "" Oh , my NNP , they VBP VBG NN with NN , and that VBZ the NN . "" But we VBP a JJ NN of NNS that VBP to VB VBN in NN , and VBG the JJS of JJ NNS VBZ RB NN of the NN . It VBZ RB a JJ NN that VBZ VBG to VB by itself . But it VBZ RB NN of the JJ NN . We VBP the NN in NNP , and VBG NNS . And you VBP a JJ NNS in this NN , like NNP and NNP - NNP , VBG RB to VB these . VBP you VB any NNS that this might VB VBN , or VBN in its NNS ? RB , the NNS about RB VBN NNS in NNP VBP VBN its NN in NNP . I VBP their NNS VBP VBN upon a NN of JJ NNS that VBP RB VB any NN to JJ NN per NN . JJ as ? JJ as , they VBP NNS with NN , the JJ NN NN , which VBZ VBN in NNP in JJ a NN of NN in their JJ NN . A JJ NN of JJ NNS in NNP VBZ RB VBN NNS to VB VBN about NN of their NN NN . NN of these VBP any NN RB to JJ NN , but it VBZ VBN the NN to VB their NNS and what their NNS can VB . In NN , the NNPS VBP JJ . They VBP an JJ NN of NN , and they VBP VBG their NNS to VB NN . And I can VB this . The JJ NN of VBG JJ NN to VB JJR NN VBZ JJ . . . . Why VBZ it JJ in the NNP ? Well , in NN , I VBP , RB though we VBP JJR NN than we VBP , JJS NNS RB VBP that the NN NN from the NNP VBZ NN of the JJ NN . It VBZ JJ for our NNS , but it VBZ RB JJ for the NN of the NN . Because if we RB VBD VBG NN , it would VB an JJ NN on JJ NNS of the NN . RB I VBP a JJ NN RB in the NN of the NN . VB 's VB that the NNP and NNP would VB , "" We VBP RB VBG to VB RB VBN NNS . "" . . . I VBP RB VB it VBZ VBG to VB the NN . It VBZ RB JJ for NNP , for NNP , for JJ NNS of the VBG NN to VB their NN NN to VB their VBG NNS ; it VBZ VBG to VB . We can't VB RB JJ to VB that we VBP what NN of NN VBZ VBG to VB VBN on a JJ NN . We can VB JJ with ourselves that , in the NNP , we VBP RB VBN the NNS in VBG the JJ NN and VBG it RB in this NN . We VBP RB VBN RB JJ as a NN from any RB VBN NN , and I VBP that VBZ because we VBD about these NNS . We VBP RB to NN VBN the NNP NNP , RB in the NNS . RB in the NNS , I VBD VBN in NN NNS that VBD with NN NNS , about what NN of JJ NN we could VB , how we would VB RB VBN NNS into the NN . We VBP VBN VBG on this NN since the NN VBD VBN . In the NNP it VBZ VBN NN - VBN . We VBP VBN JJ NN between JJ NNS . But we VBP VBN the NNS who VBP this and who VBD it , VBG on this all the NN through . RB , NNS who VBP that JJ NNS VBP VBG this a JJ NN -- VBP they JJ ? I VBP we VBP VBN a RB JJ JJ NN in the NNP I VBP it VBZ because we VBP VBN on NN , and we VBP VBN the NNS who VBP this , VBN from the NN -- RB from the NNS . The NN that the NNP NN VBZ RB VBG NNS VB through - - I can VB you that it VBZ RB the NN . The NN of NN we VBP VBN in the JJ two NNS RB VBG with JJ NNS to VB our NN - VBN NNS . . . at NNS , as a NN , I VBP JJ to VB my NN out , VBG , "" Why VBP RB these NNS RB VB us VB RB ? VB 's VB on with it . "" We VBP VBN NN that can VB a NN NN , and they VBP us to VB another NN to VB that this VBZ JJ , FW . At the JJ NN , as a JJ NN , I VBP VBN this NN VBG , and I RB VBP that we VBP to VB this . While I VBP RB JJ that the NNS we VBP VBG for NNS VBP JJ , I VBP that NN VBZ a JJ NN . If we RB VBD NN that would VB the NN to VB NN in what we VBP VBG , what I VBP VBN the JJ nine NNS RB could RB VB . RB I 'd RB VB JJ . RB I VBP to VB JJ that we VBP this RB . In NN of how JJ I VBP with NN NNS at some NNS , I VBP RB JJ they VBP RB , because I VBP that , in the NNP , we VBP this NN in NN . I can RB VB RB to it and VB , "" Yes , we VBP VBN all these NNS , we VBP VBN all these NNS , and it VBZ . "" VBP you JJ about NN and JJ NNS ? Well , I VBP RB JJ about the NN NNS . From a JJ NN , I VBP RB VB NN RB JJ about what we VBP VBG in VBG NNS into , VB , a NN , that would VB a NN to VB a NN . But I VBP RB JJ that NN might VB , "" Oh , he VBZ VBG NN NN in NNS . "" Well , we VBP RB , of NN . But it VBZ RB JJ to VB an JJ NN about this . RB what we VBP VBG to VB VBZ VB in NNS RB RB . We VBP NN from the NNP NNP of NNP for a NN that I VBP VBZ RB JJ . We VBP VBG our NNS , which RB VBP NNS for a NN . We VBP VBG them into JJ JJ NNS that VBP JJ - JJ -- that VBZ they VBP RB VB NN . RB , with these NNS RB , we VBP VBG them so that we will VB JJ NNS . . . . RB we can VB NNS RB -- and I would VB this would VB VBN in NNS , because that VBZ RB JJ NN NN -- but there would VB no NN , no NNS . There VBZ no NN that this NN can RB VB into the NN . It VBZ VBG to VB a JJ NN of NN to the NN , because we 'll VB to VB NNS of our NNS to VB the JJ NN , RB than VBG NNS . But I VBP that to VB NN VBZ RB RBR JJ . RB RB though I VBP RB VB the NN NN for this , I RB VBP that we should VB in this NN , to VB the JJ NN that our NN - VBG NNS VBP RB VBG to VB up in the NN in their NN NN . In NN to VBG NNS for NN , what VBP the NNS we might VB in the NN ? We VBP RB at the NN of the NN of an JJ NN of NNS that will VB RB JJ to VB with NNS . Some NNS VBP VBG about how they VBP VBG to VB the NNS of NNS so that they 'll VB JJ to VB NN and VB up JJ NNS . To some NN , that VBZ a JJ NN , and it's a JJ NN of VBG with JJ NNS . We VBP RB VBG to VB NNS to VB JJR JJ NNS , or RB NNS themselves , as I VBP VBN about . I VBP that we VBP VBG to RB RB RB VB into JJ NNS to VB JJ NN NNS . VBG NN , for NN , a RB JJ , JJ - JJ NN to VB NNS , which will VB for NNS VBG out of the NN NN . RB that NN VBZ RB from $ 30 a NN , this NN of NN VBZ RBR JJ . All of these NNS . . . VBP RB VB to VB on JJ NN . But what we VBP VBG to VB VBZ that JJR and JJR NNS will VB where , if you could VB off a NN or an NN in a NN , or you could VB some JJ NN , it VBZ VBG to VB it RB JJR to VB . If we can RB VB down the NN of NN in the JJ NNS that we VBP VBG for NN NN to VB NNS , and VB JJR NN NN in NNS and NNS , that VBZ a NN of NN . As NN VBZ on , as we VBP JJR and JJR NNS over the JJ two NNS , we VBP VBG to VB a JJ NN to VBG the NN of NNS , a JJ NN of a JJ NN , as the RB VBN NN over VBG NN - JJ JJ NNS to VB the JJ NNS . What VBZ the NN in VBG a NN from one NN into another ? . . . An NN that VBZ VBN a NN VBD the NN NN into NNS . The NN of it , from a JJ NN , VBZ that we VBP a JJ NN of why some NN can VB JJ , like the NN . We 'd VB to VB some of our NNS and NNS VBP JJ , like NNS , so they VBP RB VB VBN by an JJ NN , or by a JJ NN . RB NNS VBP VBN NNS VBG to VB the JJ NN of a NN in a NN . These VBP RB JJ JJ NN NNS , and I should VB , they VBP RB VBN beyond that . No NN VBZ RB VBN a JJ NN of NN from it . But I VBP the NN VBZ RB to that . My NN , after VBG RB to NN NNS and NNS , VBZ that you can RB VB their NN VBG up , because there VBZ NN about a JJ NN to a NN . It VBZ a JJ NN . JJR than NN JJ , it VBZ RB , "" Ooh , I would RB VB that . "" It VBZ NN to VB with the NN , I VBP . It VBZ RB the NN we VBP VBN in our NN . A NN VBZ VBN to VB like a NN , and a NN like a NN . And RB VBG NNS on each JJ -- we VBP off . We VBP RB VB that . . . . NNS VBP RB VB the NN between NNS and the NN in NNS of the VBN JJ NN . VBP you VB we VBP a JJ JJ NN RB ? NNS VBZ a RB JJ NN for JJ NN , because RB all the NNS we VBP about with NN to NNS VBP VBN JJ . It RB VBZ RB to NNP and NN that VBZ a JJ NN . When the JJ NNS about NNS VBP VBN out , about VBG the NNS of our NNS or VBG JJR NNS or NNS that VBP JJ , that VBZ NNS . But those NNS VBP RB VBN to NNS . We RB VBP the JJ NN of JJ NNS , and I VBP that VBZ at the JJ NN . How VBP you VB the NN ? That VBZ VBG a JJ NN JJ on the JJ NN . They should VB RB RB as we VBP . I 'd VB it VBZ RBR like , how VBP you VB the NN in NN , VBG the NN to VB to VB JJR and VB JJR about it ? And I VBP that VBZ VBG to VB one of the JJ NNS of all this RB VBN NN , because once the JJ RB JJ NN VBZ , I VBP we VBP an JJ NN RB . They VBP to VB JJR about this . As they VBP to VB that it VBZ RB a NN of what we VBP VBN VBG in NN NN for the JJ 100 NNS , it VBZ NNP 's NNS , you VBP , the JJ NN NNS that our NNS VBD to VB . It VBZ RB in a JJ NN . Once NNS VBP this , RB I VBP all of this VBZ VBG to VB down . We VBD this NN in JJ NN in the NNS , and JJS NNS RB VBP that RB VBN NN VBZ a JJ NN . VBP you VB we 'll VB to that NN with NN ? It VBZ RB JJ RB in NN . I VBP RB VB in JJ that the NN VBZ JJ about the NN of NN to VB NNS for NN RB . RB , there VBP RB NNS with NN to the NN of NN NNS for NN . There will VB JJR NNS that will VB RB in JJ NN , but they VBP RB VBN on the NN of NN . I VBP that VBZ because of the JJ NNS that we VBP VBN from some of the JJ NNS . I VBP , as a JJ NN of NNS VBZ in the JJ NN , as the NN VBZ the JJ NN and NN from these NNS , we will VB into this JJ NN of NN . RB what we VBP VBG to VB to , RB than VBG on how it VBD VBN , we VBP VBG to VB on , "" What VBZ the NN ? What VBZ the NN that we VBP VBG to VB in the NN of the NN ? VBZ it JJR for my NN ? VBZ it JJR for the NN we VBP the NN ? VBZ it JJ for the VBG NN and for VBG NNS of JJ NN ? "" . . ."
234,10,conspiracy,"Genocidal_JJ corporate_JJ media_NN presstitutes_NNS follow_VBP the_DT all_DT -_HYPH too_RB -_HYPH familiar_JJ script_NN of_IN blaming_VBG the_DT victim_NN for_IN the_DT crimes_NNS perpetrated_VBN by_IN aggressor_NN nations_NNS ._. NATO_NNP terrorists_NNS ,_, for_IN example_NN ,_, are_VBP invading_VBG and_CC occupying_VBG Syria_NNP ,_, and_CC the_DT Syria_NNP government_NN is_VBZ blamed_VBN for_IN the_DT ensuing_VBG disasters_NNS ,_, but_CC the_DT presstitutes_NNS omit_VBP this_DT from_IN their_PRP$ narratives_NNS and_CC instead_RB find_VBP creative_JJ ways_NNS to_TO blame_VB the_DT Assad_NNP government_NN whose_WP$ duty_NN it_PRP is_VBZ to_TO protect_VB Syria_NNP ,_, its_PRP$ sovereignty_NN ,_, and_CC its_PRP$ territorial_JJ integrity_NN ._. When_WRB terrorists_NNS are_VBP occupying_VBG cities_NNS ,_, as_IN they_PRP do_VBP in_IN Syria_NNP ,_, innocent_JJ people_NNS will_MD always_RB be_VB victimized_VBN ,_, including_VBG during_IN government_NN operations_NNS to_TO clear_VB out_RP the_DT terrorist_JJ infestations_NNS ,_, but_CC the_DT presstitutes_NNS blame_VBP the_DT Syrian_JJ government_NN ,_, not_RB the_DT NATO_NNP terrorists_NNS ._. President_NNP Assad_NNP is_VBZ fraudulently_RB demonized_VBN for_IN a_DT war_NN perpetrated_VBN by_IN aggressors_NNS who_WP are_VBP tasked_VBN with_IN destroying_VBG Syria_NNP so_IN the_DT West_NNP can_MD further_VB the_DT destruction_NN under_IN a_DT fraudulent_JJ Responsibility_NN To_TO Protect_VB (_-LRB- R2P_NNP )_-RRB- mandate_NN ,_, wherein_WRB criminal_JJ West_NN promises_VBZ to_TO save_VB Syrians_NNPS from_IN the_DT West_NNP ’s_POS own_JJ terrorists_NNS ._. It_PRP ’s_VBZ basically_RB a_DT Mafia_NNP –style_NN protection_NN racket_NN writ_NN large_JJ :_: If_IN Assad_NNP steps_VBZ down_RP ,_, we_PRP ’ll_MD “_`` protect_VB you_PRP ”_'' and_CC replace_VB him_PRP with_IN a_DT Wahhabi_NNP stooge_NN government_NN ,_, and_CC everyone_NN will_MD be_VB happy_JJ ._. The_DT reality_NN of_IN course_NN ,_, is_VBZ that_IN if_IN the_DT Western_JJ terrorists_NNS win_VBP the_DT war_NN ,_, Syria_NNP will_MD be_VB totally_RB destroyed_VBN ,_, much_RB like_IN Libya_NNP ,_, Iraq_NNP ,_, and_CC the_DT Ukraine_NNP ._. The_DT crimes_NNS of_IN the_DT aggressors_NNS have_VBP been_VBN well_RB -_HYPH documented_VBN for_IN years_NNS ,_, and_CC all_DT but_CC ignored_VBN by_IN the_DT presstitutes_NNS ._. A_DT 2012_CD Defence_NNP Intelligence_NNP Agency_NNP (_-LRB- DIA_NNP )_-RRB- memo_NN stated_VBD unequivocally_RB that_IN the_DT U.S_NNP support_NN for_IN ISIS_NNP was_VBD willful_JJ ._. In_IN an_DT interview_NN with_IN Mehdi_NNP Hasan_NNP ,_, Michael_NNP T._NNP Flynn_NNP ,_, former_JJ director_NN of_IN the_DT DIA_NNP ,_, was_VBD blunt_JJ ._. “_`` In_IN 2012_CD the_DT U.S._NNP was_VBD helping_VBG coordinate_VB arms_NNS transfers_NNS to_IN those_DT same_JJ groups_NNS [_-LRB- Salafists_NNPS ,_, Muslim_NNP Brotherhood_NNP ,_, Al_NNP Qaeda_NNP in_IN Iraq_NNP ]_-RRB- ,_, why_WRB did_VBD you_PRP not_RB stop_VB that_IN if_IN you_PRP ’re_VBP worried_JJ about_IN the_DT rise_NN of_IN quote_NN -_HYPH unquote_JJ Islamic_JJ extremists_NNS ?_. ”_'' Flynn_NNP responded_VBD ,_, “_`` I_PRP hate_VBP to_TO say_VB it_PRP ’s_VBZ not_RB my_PRP$ job_NN …_, but_CC that_IN …my_PRP$ job_NN was_VBD to_TO …was_VB to_TO to_TO ensure_VB that_IN the_DT accuracy_NN of_IN our_PRP$ intelligence_NN that_WDT was_VBD being_VBG presented_VBN was_VBD as_RB good_JJ as_IN it_PRP could_MD be_VB ._. The_DT New_NNP York_NNP Times_NNP newspaper_NN ,_, another_DT propaganda_NN outlet_NN ,_, ca_MD n’t_RB help_VB but_CC reveal_VB the_DT truth_NN ,_, even_RB if_IN indirectly_RB ,_, when_WRB ,_, in_IN a_DT recent_JJ article_NN ,_, “_`` C.I.A_NNP ._. Arms_NNS for_IN Syrian_JJ Rebels_NNS Supplied_VBN Black_NNP Market_NNP ,_, Officials_NNPS Say_VB ”_'' it_PRP acknowledged_VBD that_IN “_`` Weapons_NNS shipped_VBN into_IN Jordan_NNP by_IN the_DT Central_NNP Intelligence_NNP Agency_NNP and_CC Saudi_NNP Arabia_NNP (_-LRB- were_VBD )_-RRB- intended_VBN for_IN Syrian_JJ rebels_NNS ._. ”_'' Meanwhile_RB ,_, UN_NNP Security_NNP Council_NNP Resolution_NNP 1373_CD states_VBZ clearly_RB that_IN :_: All_DT of_IN this_DT evidence_NN assigns_VBZ guilt_NN directly_RB to_IN the_DT West_NN for_IN the_DT disaster_NN befalling_VBG Syria_NNP ._. The_DT West_NN ’s_POS actions_NNS contradict_VBP international_JJ law_NN ,_, and_CC they_PRP expose_VBP the_DT lies_NNS of_IN the_DT presstitute_NN media_NN that_WDT typically_RB vilifies_VBZ the_DT Assad_NNP government_NN rather_RB than_IN the_DT real_JJ perpetrators_NNS (_-LRB- including_VBG themselves_PRP )_-RRB- ._. Yet_CC another_DT recent_JJ article_NN ,_, “_`` U.S._NNP Relies_NNPS Heavily_RB on_IN Saudi_NNP Money_NNP to_TO Support_VB Syrian_JJ Rebels_NNPS ”_'' ,_, indicates_VBZ that_IN the_DT West_NNP is_VBZ also_RB behind_IN the_DT financing_NN of_IN the_DT terrorists_NNS ._. The_DT writers_NNS revel_VBP that_IN :_: Financing_NN terrorists_NNS is_VBZ also_RB a_DT violation_NN of_IN UN_NNP Resolutions_NNPS (_-LRB- and_CC international_JJ law_NN )_-RRB- ._. UN_NNP Resolution_NNP 2199_CD “_`` urges_VBZ ”_'' ,_, Add_VB to_IN this_DT the_DT fact_NN that_IN now_RB Israel_NNP is_VBZ publicly_RB admitting_VBG that_IN it_PRP prefers_VBZ ISIS_NNP to_IN the_DT Syrian_JJ government_NN ,_, and_CC we_PRP see_VBP that_IN the_DT presstitute_NN narratives_NNS are_VBP falling_VBG apart_RB yet_RB again_RB ._. Dr._NNP Bouthaina_NNP Shaaban_NNP ,_, Syrian_JJ President_NNP Bashar_NNP Assad_NNP ’s_POS media_NN advisor_NN correctly_RB assesses_VBZ the_DT damage_NN committed_VBN by_IN Western_JJ media_NN outlets_NNS that_WDT propagate_VBP false_JJ narratives_NNS about_IN Syria_NNP :_: What_WP will_MD be_VB the_DT next_JJ story_NN advanced_VBN by_IN the_DT genocidal_JJ media_NN to_TO account_VB for_IN the_DT clear_JJ criminality_NN of_IN the_DT West_NNP and_CC its_PRP$ terrorists_NNS ?_. How_WRB many_JJ more_JJR thousands_NNS of_IN innocent_JJ people_NNS will_MD lose_VB their_PRP$ lives_NNS because_IN of_IN the_DT Western_JJ lies_NNS ,_, and_CC the_DT grovelling_VBG presstitute_NN media_NN echo_NN chambers_NNS covering_VBG for_IN the_DT criminality_NN of_IN the_DT Western_JJ foreign_JJ policies_NNS ?_.","JJ JJ NN NNS VBP the all - RB - JJ NN of VBG the NN for the NNS VBN by NN NNS . NNP NNS , for NN , VBP VBG and VBG NNP , and the NNP NN VBZ VBN for the VBG NNS , but the NNS VBP this from their NNS and RB VBP JJ NNS to VB the NNP NN whose NN it VBZ to VB NNP , its NN , and its JJ NN . When NNS VBP VBG NNS , as they VBP in NNP , JJ NNS will RB VB VBN , VBG during NN NNS to VB out the JJ NNS , but the NNS VBP the JJ NN , RB the NNP NNS . NNP NNP VBZ RB VBN for a NN VBN by NNS who VBP VBN with VBG NNP so the NNP can VB the NN under a JJ NN To VB ( NNP ) NN , wherein JJ NN VBZ to VB NNPS from the NNP ’s JJ NNS . It VBZ RB a NNP NN NN NN NN JJ : If NNP VBZ down , we ’ll “ VB you ” and VB him with a NNP NN NN , and NN will VB JJ . The NN of NN , VBZ that if the JJ NNS VBP the NN , NNP will VB RB VBN , RB like NNP , NNP , and the NNP . The NNS of the NNS VBP VBN RB - VBN for NNS , and all but VBN by the NNS . A 2012 NNP NNP NNP ( NNP ) NN VBD RB that the NNP NN for NNP VBD JJ . In an NN with NNP NNP , NNP NNP NNP , JJ NN of the NNP , VBD JJ . “ In 2012 the NNP VBD VBG VB NNS NNS to those JJ NNS [ NNPS , NNP NNP , NNP NNP in NNP ] , why VBD you RB VB that if you VBP JJ about the NN of NN - JJ JJ NNS ? ” NNP VBD , “ I VBP to VB it VBZ RB my NN … but that …my NN VBD to VB to to VB that the NN of our NN that VBD VBG VBN VBD RB JJ as it could VB . The NNP NNP NNP NN , another NN NN , ca RB VB but VB the NN , RB if RB , when , in a JJ NN , “ NNP . NNS for JJ NNS VBN NNP NNP , NNPS VB ” it VBD that “ NNS VBN into NNP by the NNP NNP NNP and NNP NNP ( VBD ) VBN for JJ NNS . ” RB , NNP NNP NNP NNP 1373 VBZ RB that : All of this NN VBZ NN RB to the NN for the NN VBG NNP . The NN ’s NNS VBP JJ NN , and they VBP the NNS of the NN NN that RB VBZ the NNP NN RB than the JJ NNS ( VBG themselves ) . Yet another JJ NN , “ NNP NNPS RB on NNP NNP to VB JJ NNPS ” , VBZ that the NNP VBZ RB behind the NN of the NNS . The NNS VBP that : NN NNS VBZ RB a NN of NNP NNPS ( and JJ NN ) . NNP NNP 2199 “ VBZ ” , VB to this the NN that RB NNP VBZ RB VBG that it VBZ NNP to the JJ NN , and we VBP that the NN NNS VBP VBG RB RB RB . NNP NNP NNP , JJ NNP NNP NNP ’s NN NN RB VBZ the NN VBN by JJ NN NNS that VBP JJ NNS about NNP : What will VB the JJ NN VBN by the JJ NN to VB for the JJ NN of the NNP and its NNS ? How JJ JJR NNS of JJ NNS will VB their NNS because of the JJ NNS , and the VBG NN NN NN NNS VBG for the NN of the JJ JJ NNS ?"
235,769,mainstream,"In_IN virology_NN ,_, the_DT pandemic_NN H1N1/09_NN virus_NN is_VBZ a_DT swine_NN origin_NN influenza_NN A_DT virus_NN subtype_NN H1N1_NN strain_NN that_WDT was_VBD responsible_JJ for_IN the_DT 2009_CD swine_NN flu_NN pandemic_NN ._. This_DT strain_NN is_VBZ often_RB called_VBN swine_NN flu_NN by_IN the_DT public_JJ media_NN ._. For_IN other_JJ names_NNS ,_, see_VB the_DT Nomenclature_NNP section_NN below_RB ._. The_DT virus_NN is_VBZ a_DT novel_JJ strain_NN of_IN the_DT influenza_NN virus_NN ,_, [_-LRB- 2_CD ]_-RRB- for_IN which_WDT existing_VBG vaccines_NNS against_IN seasonal_JJ flu_NN provided_VBD no_DT protection_NN ._. A_DT study_NN at_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- published_VBN in_IN May_NNP 2009_CD found_VBD that_IN children_NNS had_VBD no_DT preexisting_JJ immunity_NN to_IN the_DT new_JJ strain_NN but_CC that_IN adults_NNS ,_, particularly_RB those_DT over_IN 60_CD ,_, had_VBD some_DT degree_NN of_IN immunity_NN ._. Children_NNS showed_VBD no_DT cross-reactive_JJ antibody_NN reaction_NN to_IN the_DT then_IN -_HYPH new_JJ strain_NN ,_, while_IN adults_NNS aged_JJ 18_CD to_IN 64_CD had_VBD 6–9_CD %_NN ,_, and_CC older_JJR adults_NNS 34_CD %_NN ._. [_-LRB- 3_CD ]_-RRB- [_-LRB- 4_CD ]_-RRB- Much_JJ reporting_NN of_IN early_JJ analysis_NN repeated_VBD that_IN the_DT strain_NN contained_VBD genes_NNS from_IN five_CD different_JJ flu_NN viruses_NNS :_: North_NNP American_JJ swine_NN influenza_NN ,_, North_NNP American_JJ avian_JJ influenza_NN ,_, human_JJ influenza_NN ,_, and_CC two_CD swine_NN influenza_NN viruses_NNS typically_RB found_VBN in_IN Asia_NNP and_CC Europe_NNP ._. [_-LRB- 5_CD ]_-RRB- Further_JJR analysis_NN showed_VBD that_IN several_JJ of_IN the_DT proteins_NNS of_IN the_DT virus_NN are_VBP most_RBS similar_JJ to_IN strains_NNS that_WDT cause_VBP mild_JJ symptoms_NNS in_IN humans_NNS ,_, leading_VBG virologist_NN Wendy_NNP Barclay_NNP to_TO suggest_VB that_IN the_DT virus_NN was_VBD unlikely_JJ to_TO cause_VB severe_JJ symptoms_NNS for_IN most_JJS people_NNS ._. [_-LRB- 6_CD ]_-RRB- Other_JJ leading_VBG researchers_NNS indicated_VBD that_IN all_DT segments_NNS of_IN the_DT virus_NN were_VBD in_IN fact_NN swine_NN in_IN origin_NN ,_, despite_IN it_PRP being_VBG a_DT multiple_JJ reassortment_NN ._. [_-LRB- 7_CD ]_-RRB- [_-LRB- 8_CD ]_-RRB- The_DT first_JJ complete_JJ genome_NN sequence_NN of_IN the_DT pandemic_NN strain_NN was_VBD deposited_VBN in_IN public_JJ databases_NNS on_IN April_NNP 27_CD ,_, 2009_CD ,_, by_IN scientists_NNS from_IN the_DT U.S._NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP in_IN Atlanta_NNP ._. [_-LRB- 9_CD ]_-RRB- Scientists_NNS in_IN Winnipeg_NNP later_RBR completed_VBD the_DT full_JJ genetic_JJ sequencing_NN of_IN viruses_NNS from_IN Mexico_NNP and_CC Canada_NNP on_IN May_NNP 6_CD ,_, 2009_CD ._. [_-LRB- 10_CD ]_-RRB- Analysis_NN of_IN the_DT genetic_JJ divergence_NN of_IN the_DT virus_NN in_IN samples_NNS from_IN different_JJ cases_NNS indicated_VBD that_IN the_DT virus_NN jumped_VBD to_IN humans_NNS in_IN 2008_CD ,_, probably_RB after_IN June_NNP ,_, and_CC not_RB later_RBR than_IN the_DT end_NN of_IN November_NNP ,_, [_-LRB- 11_CD ]_-RRB- likely_RB around_IN September_NNP 2008_CD ._. [_-LRB- 12_CD ]_-RRB- [_-LRB- 13_CD ]_-RRB- A_DT report_NN by_IN researchers_NNS at_IN the_DT Mount_NNP Sinai_NNP School_NNP of_IN Medicine_NNP in_IN 2016_CD found_VBD that_IN the_DT 2009_CD H1N1_NNP virus_NN likely_RB originated_VBD from_IN pigs_NNS in_IN a_DT very_RB small_JJ region_NN of_IN central_JJ Mexico_NNP ._. [_-LRB- 14_CD ]_-RRB- On_IN April_NNP 17_CD ,_, 2009_CD ,_, Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- determined_VBD that_IN two_CD cases_NNS of_IN febrile_JJ respiratory_JJ illness_NN occurring_VBG in_IN children_NNS who_WP resided_VBD in_IN adjacent_JJ counties_NNS in_IN Southern_NNP California_NNP were_VBD caused_VBN by_IN infection_NN with_IN a_DT swine_NN influenza_NN A_NN (_-LRB- H1N1_NN )_-RRB- virus_NN ._. The_DT viruses_NNS from_IN the_DT two_CD cases_NNS were_VBD closely_RB related_VBN genetically_RB ,_, resistant_JJ to_IN amantadine_NN and_CC rimantadine_NN ,_, and_CC contain_VBP a_DT unique_JJ combination_NN of_IN gene_NN segments_NNS that_WDT previously_RB had_VBD not_RB been_VBN reported_VBN among_IN swine_NN or_CC human_JJ influenza_NN viruses_NNS in_IN the_DT United_NNP States_NNPS or_CC elsewhere_RB ._. After_IN the_DT emergence_NN of_IN the_DT novel_JJ virus_NN in_IN the_DT spring_NN of_IN 2009_CD ,_, it_PRP spread_VBD quickly_RB across_IN the_DT United_NNP States_NNPS ,_, Mexico_NNP and_CC the_DT world_NN ._. [_-LRB- 15_CD ]_-RRB- [_-LRB- 16_CD ]_-RRB- In_IN late_JJ April_NNP ,_, the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- declared_VBD its_PRP$ first_JJ ever_RB ""_`` public_JJ health_NN emergency_NN of_IN international_JJ concern_NN ""_'' ,_, or_CC PHEIC_NNP ,_, [_-LRB- 17_CD ]_-RRB- and_CC in_IN June_NNP ,_, the_DT WHO_NNP and_CC the_DT U.S._NNP CDC_NNP stopped_VBD counting_VBG cases_NNS and_CC declared_VBD the_DT outbreak_NN a_DT pandemic_NN ._. [_-LRB- 18_CD ]_-RRB- On_IN June_NNP 23_CD ,_, 2009_CD ,_, The_DT New_NNP York_NNP Times_NNP reported_VBD that_IN U.S._NNP federal_JJ agriculture_NN officials_NNS believed_VBD that_IN ,_, ""_`` contrary_JJ to_IN the_DT popular_JJ assumption_NN that_IN the_DT new_JJ swine_NN flu_NN pandemic_NN arose_VBD on_IN factory_NN farms_NNS in_IN Mexico_NNP ""_'' ,_, now_RB believe_VBP it_PRP ""_`` most_RBS likely_RB emerged_VBN in_IN pigs_NNS in_IN Asia_NNP ,_, but_CC then_RB traveled_VBD to_IN North_NNP America_NNP in_IN a_DT human_NN ""_'' ._. They_PRP emphasized_VBD that_IN there_EX was_VBD no_DT way_NN to_TO prove_VB their_PRP$ hypothesis_NN but_CC said_VBD there_EX is_VBZ no_DT evidence_NN this_DT new_JJ virus_NN ,_, which_WDT combines_VBZ Eurasian_JJ and_CC North_NNP American_JJ genes_NNS ,_, has_VBZ never_RB circulated_VBN in_IN North_NNP American_JJ pigs_NNS ,_, ""_'' while_IN there_EX is_VBZ tantalizing_JJ evidence_NN that_IN a_DT closely_RB related_JJ '_`` sister_NN virus_NN '_'' has_VBZ circulated_VBN in_IN Asia_NNP ""_'' ._. [_-LRB- 19_CD ]_-RRB- However_RB ,_, a_DT subsequent_JJ report_NN by_IN researchers_NNS at_IN the_DT Mount_NNP Sinai_NNP School_NNP of_IN Medicine_NNP in_IN 2016_CD found_VBD that_IN the_DT 2009_CD H1N1_NNP virus_NN likely_RB originated_VBD in_IN central_JJ Mexico_NNP ._. [_-LRB- 14_CD ]_-RRB- In_IN early_JJ June_NNP 2009_CD ,_, using_VBG computational_JJ methods_NNS developed_VBN over_IN the_DT previous_JJ ten_CD years_NNS ,_, an_DT international_JJ team_NN of_IN researchers_NNS attempted_VBD to_TO reconstruct_VB the_DT origins_NNS and_CC timescale_NN of_IN the_DT 2009_CD flu_NN pandemic_NN ._. Oliver_NNP Pybus_NNP of_IN Oxford_NNP University_NNP 's_POS Department_NNP of_IN Zoology_NNP ,_, and_CC part_NN of_IN the_DT research_NN team_NN ,_, claims_VBZ ""_`` Our_PRP$ results_NNS show_VBP that_IN this_DT strain_NN has_VBZ been_VBN circulating_VBG among_IN pigs_NNS ,_, possibly_RB among_IN multiple_JJ continents_NNS ,_, for_IN many_JJ years_NNS prior_JJ to_IN its_PRP$ transmission_NN to_IN humans_NNS ._. ""_'' The_DT research_NN team_NN who_WP worked_VBD on_IN this_DT case_NN also_RB believed_VBD it_PRP was_VBD ""_`` derived_VBN from_IN several_JJ viruses_NNS circulating_VBG in_IN swine_NN ""_'' ,_, and_CC that_IN the_DT initial_JJ transmission_NN to_IN humans_NNS occurred_VBD several_JJ months_NNS before_IN recognition_NN of_IN the_DT outbreak_NN ._. The_DT team_NN concluded_VBD that_IN ""_`` despite_IN widespread_JJ influenza_NN surveillance_NN in_IN humans_NNS ,_, the_DT lack_NN of_IN systematic_JJ swine_NN surveillance_NN allowed_VBD for_IN the_DT undetected_JJ persistence_NN and_CC evolution_NN of_IN this_DT potentially_RB pandemic_NN strain_NN for_IN many_JJ years_NNS ._. ""_'' [_-LRB- 20_CD ]_-RRB- According_VBG to_IN the_DT researchers_NNS ,_, movement_NN of_IN live_JJ pigs_NNS between_IN Eurasia_NNP and_CC North_NNP America_NNP ""_'' seems_VBZ to_TO have_VB facilitated_VBN the_DT mixing_NN of_IN diverse_JJ swine_NN influenza_NN viruses_NNS ,_, leading_VBG to_IN the_DT multiple_JJ reassortment_NN events_NNS associated_VBN with_IN the_DT genesis_NN of_IN the_DT (_-LRB- new_JJ H1N1_NN )_-RRB- strain_NN ""_'' ._. They_PRP also_RB said_VBD this_DT new_JJ pandemic_NN ""_`` provides_VBZ further_JJ evidence_NN of_IN the_DT role_NN of_IN domestic_JJ pigs_NNS in_IN the_DT ecosystem_NN of_IN influenza_NN A_NN ""_'' ._. [_-LRB- 21_CD ]_-RRB- In_IN November_NNP 2009_CD ,_, a_DT study_NN was_VBD published_VBN in_IN Virology_NNP Journal_NNP in_IN which_WDT it_PRP was_VBD suggested_VBN that_IN the_DT virus_NN may_MD be_VB the_DT product_NN of_IN three_CD strains_NNS from_IN three_CD continents_NNS that_WDT swapped_VBD genes_NNS in_IN a_DT lab_NN or_CC a_DT vaccine_NN -_HYPH making_VBG plant_NN ,_, and_CC subsequently_RB ""_`` escaped_VBD ""_'' ._. The_DT study_NN followed_VBD debate_NN among_IN researchers_NNS in_IN May_NNP 2009_CD ,_, when_WRB the_DT authors_NNS asked_VBD the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- to_TO consider_VB the_DT hypothesis_NN ._. After_IN reviewing_VBG the_DT initial_JJ paper_NN ,_, WHO_NNP and_CC other_JJ organizations_NNS concluded_VBD the_DT pandemic_NN strain_NN was_VBD a_DT naturally_RB -_HYPH occurring_VBG virus_NN and_CC not_RB laboratory_NN -_HYPH derived_VBN ._. [_-LRB- 22_CD ]_-RRB- [_-LRB- 23_CD ]_-RRB- The_DT virus_NN is_VBZ contagious_JJ with_IN an_DT R_NN of_IN 1.4_CD to_IN 1.6_CD [_-LRB- 24_CD ]_-RRB- and_CC spreads_VBZ from_IN human_JJ to_IN human_JJ in_IN much_RB the_DT same_JJ way_NN as_IN seasonal_JJ flu_NN ._. The_DT most_RBS common_JJ mechanisms_NNS by_IN which_WDT it_PRP spreads_VBZ are_VBP by_IN droplets_NNS from_IN coughs_NNS and_CC sneezes_NNS of_IN infected_VBN people_NNS ,_, and_CC also_RB potentially_RB touching_VBG a_DT surface_NN or_CC the_DT hand_NN of_IN a_DT person_NN contaminated_VBN with_IN the_DT virus_NN and_CC then_RB touching_VBG one_PRP 's_POS eyes_NNS ,_, nose_NN or_CC mouth_NN ._. [_-LRB- 25_CD ]_-RRB- In_IN 2009_CD ,_, the_DT WHO_NNP reported_VBD that_IN H1N1/09_NNP seemed_VBD to_TO be_VB more_RBR contagious_JJ than_IN seasonal_JJ flu_NN ._. [_-LRB- 26_CD ]_-RRB- However_RB ,_, a_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP report_NN said_VBD the_DT transmissibility_NN of_IN the_DT 2009_CD H1N1_NN influenza_NN virus_NN in_IN households_NNS was_VBD lower_JJR than_IN that_DT seen_VBN in_IN past_JJ pandemics_NNS ._. [_-LRB- 27_CD ]_-RRB- The_DT U.S._NNP CDC_NNP recommended_VBD that_IN people_NNS should_MD wait_VB at_IN least_JJS a_DT day_NN after_IN their_PRP$ fever_NN subsides_VBZ (_-LRB- usually_RB 3_CD –_SYM 4_CD days_NNS after_IN the_DT onset_NN of_IN symptoms_NNS )_-RRB- before_IN resuming_VBG normal_JJ activities_NNS ,_, but_CC it_PRP has_VBZ been_VBN found_VBN that_IN they_PRP can_MD continue_VB to_TO shed_VB virus_NN for_IN several_JJ more_JJR days_NNS ._. [_-LRB- 28_CD ]_-RRB- The_DT virulence_NN of_IN swine_NN flu_NN virus_NN is_VBZ mild_JJ and_CC the_DT mortality_NN rates_NNS are_VBP very_RB low_JJ ._. [_-LRB- 29_CD ]_-RRB- [_-LRB- 30_CD ]_-RRB- In_IN mid-2009_NN ,_, the_DT U.S._NNP CDC_NNP noted_VBD that_IN most_JJS infections_NNS were_VBD mild_JJ ,_, similar_JJ to_IN seasonal_JJ flu_NN ,_, and_CC that_IN recovery_NN tended_VBD to_TO be_VB fairly_RB quick_JJ ._. [_-LRB- 31_CD ]_-RRB- The_DT number_NN of_IN deaths_NNS as_IN of_IN September_NNP 2009_CD was_VBD said_VBN to_TO be_VB a_DT tiny_JJ fraction_NN of_IN the_DT annual_JJ number_NN of_IN deaths_NNS from_IN seasonal_JJ flu_NN ._. [_-LRB- 32_CD ]_-RRB- However_RB ,_, comparisons_NNS of_IN human_JJ fatality_NN figures_NNS with_IN seasonal_JJ influenza_NN are_VBP prone_JJ to_TO underestimate_VB impact_NN of_IN the_DT pandemic_NN ,_, [_-LRB- 33_CD ]_-RRB- and_CC the_DT pandemic_NN H1N1/09_NNP virus_NN was_VBD in_IN fact_NN the_DT dominant_JJ strain_NN of_IN influenza_NN causing_VBG illness_NN in_IN the_DT 2009_CD /_, 10_CD flu_NN season_NN ._. [_-LRB- 34_CD ]_-RRB- Research_NN carried_VBN out_RP at_IN Imperial_NNP College_NNP London_NNP [_-LRB- 35_CD ]_-RRB- has_VBZ shown_VBN that_IN ,_, unlike_IN seasonal_JJ flu_NN ,_, H1N1/09_NN can_MD infect_VB cells_NNS deep_RB in_IN the_DT lungs_NNS ._. Seasonal_JJ flu_NN can_MD infect_VB only_RB cells_NNS with_IN receptor_JJ type_NN a_DT 2_CD -_SYM 6_CD which_WDT are_VBP typically_RB located_VBN in_IN the_DT nose_NN and_CC throat_NN but_CC H1N1_NN /_, 09_CD can_MD also_RB infect_VB cells_NNS with_IN receptor_JJ type_NN a_IN 2_CD -_SYM 3_CD ._. This_DT may_MD explain_VB why_WRB some_DT patients_NNS experience_VBP severe_JJ respiratory_JJ symptoms_NNS ._. (_-LRB- The_DT H5N1_NNP virus_NN is_VBZ also_RB able_JJ to_TO infect_VB cells_NNS deep_RB in_IN the_DT lungs_NNS with_IN receptor_JJ type_NN a_DT 2_CD -_SYM 3_CD but_CC cannot_MD infect_VB cells_NNS with_IN receptor_JJ type_NN a_DT 2_CD -_SYM 6_CD making_VBG it_PRP less_RBR contagious_JJ than_IN H1N1/_NNP 09_CD ._. )_-RRB- As_IN of_IN September_NNP 2009_CD ,_, most_JJS people_NNS infected_VBN by_IN this_DT flu_NN suffered_VBD a_DT mild_JJ illness_NN ,_, but_CC the_DT small_JJ minority_NN hospitalized_VBN were_VBD often_RB severely_RB ill_JJ ._. Arand_NNP Kumar_NNP ,_, an_DT intensive_JJ care_NN expert_NN at_IN the_DT University_NNP of_IN Manitoba_NNP ,_, Winnipeg_NNP ,_, Canada_NNP ,_, said_VBD ""_`` this_DT pandemic_NN is_VBZ like_IN two_CD diseases_NNS ;_, either_CC you_PRP 're_VBP off_IN work_NN for_IN a_DT few_JJ days_NNS or_CC you_PRP go_VBP to_IN hospital_NN ,_, often_RB to_IN the_DT intensive_JJ -_HYPH care_NN unit_NN (_-LRB- ICU_NN )_-RRB- ._. There_EX 's_VBZ no_DT middle_JJ ground_NN ._. ""_'' In_IN the_DT southern_JJ hemisphere_NN 15_CD to_IN 33_CD %_NN of_IN hospitalized_VBN cases_NNS went_VBD to_IN the_DT ICU_NNP in_IN July_NNP and_CC August_NNP 2009_CD ._. Unlike_IN H5N1_NNP avian_NN flu_NN and_CC SARS_NN which_WDT provoke_VBP a_DT runaway_JJ body_NN -_HYPH wide_JJ immune_NN response_NN ,_, H1N1/09_NNP destroys_VBZ the_DT lungs_NNS '_POS alveoli_NN ,_, often_RB causing_VBG acute_JJ respiratory_JJ distress_NN syndrome_NN ,_, which_WDT kills_VBZ in_IN half_NN of_IN all_DT cases_NNS ._. Preliminary_JJ research_NN suggests_VBZ that_IN severity_NN is_VBZ linked_VBN to_IN a_DT genetic_JJ variation_NN in_IN immune_JJ systems_NNS ._. [_-LRB- 36_CD ]_-RRB- From_IN April_NNP 2009_CD to_IN November_NNP 2009_CD ,_, 3,900_CD people_NNS died_VBD of_IN the_DT H1N1_NNP pandemic_NN virus_NN in_IN the_DT U.S._NNP This_DT is_VBZ sometimes_RB compared_VBN to_IN the_DT 36,000_CD people_NNS per_IN year_NN who_WP die_VBP from_IN the_DT ""_`` common_JJ flu_NN ""_'' ,_, mostly_RB in_IN winter_NN ,_, although_IN this_DT number_NN is_VBZ an_DT estimate_NN ._. [_-LRB- 37_CD ]_-RRB- The_DT death_NN rate_NN of_IN H1N1_NN in_IN the_DT U.S._NNP was_VBD calculated_VBN as_IN less_JJR than_IN 0.02_CD %_NN from_IN November_NNP 2009_CD figures_NNS from_IN the_DT CDC_NNP ,_, [_-LRB- 38_CD ]_-RRB- and_CC has_VBZ been_VBN explicitly_RB calculated_VBN as_IN 0.026_CD %_NN in_IN England_NNP ._. [_-LRB- 39_CD ]_-RRB- Existing_VBG vaccines_NNS against_IN seasonal_JJ flu_NN provided_VBD no_DT protection_NN ._. Vaccines_NNS were_VBD released_VBN in_IN North_NNP America_NNP in_IN late_JJ October_NNP ._. Production_NN may_MD be_VB three_CD billion_CD doses_NNS per_IN year_NN rather_RB than_IN the_DT earlier_JJR estimate_NN of_IN five_CD billion_CD ._. [_-LRB- 40_CD ]_-RRB- On_IN May_NNP 22_CD ,_, 2009_CD ,_, World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- Director_NN -_HYPH General_NNP Margaret_NNP Chan_NNP said_VBD the_DT virus_NN must_MD be_VB closely_RB monitored_VBN in_IN the_DT southern_JJ hemisphere_NN ,_, as_IN it_PRP could_MD mix_VB with_IN ordinary_JJ seasonal_JJ influenza_NN and_CC change_NN in_IN unpredictable_JJ ways_NNS .[_-LRB- citation_NN needed_VBN ]_-RRB- Experts_NNS writing_VBG in_IN the_DT July_NNP issue_NN of_IN The_DT New_NNP England_NNP Journal_NNP of_IN Medicine_NNP noted_VBD that_IN historically_RB ,_, pandemic_NN viruses_NNS have_VBP evolved_VBN between_IN seasons_NNS ,_, and_CC the_DT current_JJ strain_NN may_MD become_VB more_RBR severe_JJ or_CC transmissible_JJ in_IN the_DT coming_VBG months_NNS ._. They_PRP therefore_RB stressed_VBD the_DT importance_NN of_IN international_JJ cooperation_NN to_TO engage_VB in_IN proper_JJ surveillance_NN to_TO help_VB monitor_VB changes_NNS in_IN the_DT virus_NN 's_POS behavior_NN ,_, which_WDT will_MD aid_VB in_IN both_CC ""_`` vaccine_NN targeting_NN ""_'' and_CC interpreting_VBG illness_NN patterns_NNS in_IN the_DT fall_NN of_IN 2009_CD ._. [_-LRB- 41_CD ]_-RRB- Other_JJ experts_NNS in_IN 2009_CD were_VBD also_RB concerned_VBN that_IN the_DT new_JJ virus_NN strain_NN could_MD mutate_VB over_IN the_DT coming_VBG months_NNS ._. Guan_NNP Yi_NNP ,_, a_DT leading_VBG virologist_NN from_IN the_DT University_NNP of_IN Hong_NNP Kong_NNP ,_, for_IN instance_NN ,_, described_VBD the_DT new_JJ H1N1_NNP influenza_NN virus_NN as_IN ""_`` very_RB unstable_JJ ""_'' ,_, meaning_VBG it_PRP could_MD mix_VB and_CC swap_VB genetic_JJ material_NN (_-LRB- reassortment_NN )_-RRB- when_WRB exposed_VBN to_IN other_JJ viruses_NNS ._. During_IN an_DT interview_NN he_PRP said_VBD ,_, ""_`` Both_CC H1N1_NN and_CC H5N1_NN are_VBP unstable_JJ so_IN the_DT chances_NNS of_IN them_PRP exchanging_VBG genetic_JJ material_NN are_VBP higher_JJR ,_, whereas_IN a_DT stable_JJ (_-LRB- seasonal_JJ flu_NN )_-RRB- virus_NN is_VBZ less_RBR likely_JJ to_TO take_VB on_IN genetic_JJ material_NN ._. ""_'' The_DT H5N1_NNP virus_NN is_VBZ mostly_RB limited_VBN to_IN birds_NNS ,_, but_CC in_IN rare_JJ cases_NNS when_WRB it_PRP infects_VBZ humans_NNS it_PRP has_VBZ a_DT mortality_NN rate_NN of_IN between_RB 60_CD %_NN to_IN 70_CD %_NN ._. [_-LRB- 42_CD ]_-RRB- Experts_NNS worry_VBP about_IN the_DT emergence_NN of_IN a_DT hybrid_NN of_IN the_DT more_RBR virulent_JJ Asian_JJ -_HYPH lineage_NN HPAI_NN (_-LRB- highly_RB pathogenic_JJ avian_JJ influenza_NN )_-RRB- A_DT /H5N1_NN strain_NN (_-LRB- media_NN labeled_VBN ""_`` bird_NN flu_NN ""_'' )_-RRB- with_IN more_RBR human_JJ -_HYPH transmissible_JJ influenza_NN A_NN strains_NNS such_JJ as_IN this_DT novel_JJ 2009_CD swine_NN -_HYPH origin_NN A_NN /_, H1N1_NN strain_NN (_-LRB- media_NN labeled_VBN ""_`` swine_NN flu_NN ""_'' )_-RRB- ,_, especially_RB since_IN the_DT H5N1_NNP strain_NN is_VBZ endemic_JJ among_IN birds_NNS in_IN countries_NNS like_IN China_NNP ,_, Indonesia_NNP ,_, Vietnam_NNP and_CC Egypt_NNP ._. [_-LRB- 42_CD ]_-RRB- [_-LRB- 43_CD ]_-RRB- (_-LRB- See_VB the_DT suite_NN of_IN H5N1_NN articles_NNS for_IN details_NNS ._. )_-RRB- Other_JJ studies_NNS concluded_VBD that_IN the_DT virus_NN was_VBD likely_RB well_RB adapted_VBN to_IN humans_NNS ,_, had_VBD a_DT clear_JJ biological_JJ advantage_NN over_IN seasonal_JJ flu_NN strains_NNS and_CC that_IN reassortment_NN was_VBD unlikely_JJ at_IN that_DT time_NN due_IN to_IN its_PRP$ ease_NN in_IN replication_NN and_CC transmission_NN ._. [_-LRB- 44_CD ]_-RRB- However_RB ,_, Federal_JJ health_NN officials_NNS in_IN the_DT U.S._NNP noted_VBD that_IN the_DT horrific_JJ 1918_CD flu_NN epidemic_NN ,_, which_WDT killed_VBD hundreds_NNS of_IN thousands_NNS in_IN the_DT United_NNP States_NNPS alone_RB ,_, was_VBD preceded_VBN by_IN a_DT mild_JJ ""_`` herald_NN ""_'' wave_NN of_IN cases_NNS in_IN the_DT spring_NN ,_, followed_VBN by_IN devastating_JJ waves_NNS of_IN illness_NN in_IN the_DT autumn_NN ._. [_-LRB- 45_CD ]_-RRB- As_IN of_IN late_JJ July_NNP 2009_CD ,_, U.S._NNP health_NN officials_NNS said_VBD the_DT swine_NN flu_NN was_VBD n't_RB yet_RB mutating_VBG to_TO become_VB more_RBR dangerous_JJ ,_, but_CC they_PRP were_VBD closely_RB tracking_VBG that_IN as_IN the_DT virus_NN continued_VBD to_TO circle_VB the_DT globe_NN ._. [_-LRB- 46_CD ]_-RRB- As_IN of_IN October_NNP 2009_CD ,_, research_NN done_VBN by_IN Taubenberger_NNP showed_VBD that_IN the_DT evolution_NN of_IN A_NN (_-LRB- H1N1_NN )_-RRB- is_VBZ relatively_RB slow_JJ since_IN the_DT structure_NN of_IN the_DT 2009_CD H1N1_NNP virus_NN is_VBZ similar_JJ to_IN the_DT strain_NN of_IN H1N1_NN implicated_VBN in_IN the_DT 1918_CD flu_NN pandemic_NN ._. [_-LRB- 47_CD ]_-RRB- A_DT study_NN from_IN Hokkaido_NNP University_NNP found_VBD a_DT sequence_NN homology_NN between_IN the_DT Hemagglutinin_NN antigen_NN amino_NN acid_NN residues_NNS found_VBN in_IN the_DT earlier_JJR 1918_CD strain_NN and_CC the_DT 2009_CD H1N1_NN strain_NN ._. This_DT may_MD have_VB played_VBN a_DT role_NN in_IN individuals_NNS who_WP had_VBD been_VBN infected_VBN with_IN the_DT 1918_CD strain_NN and_CC its_PRP$ early_JJ descendants_NNS in_IN showing_VBG stronger_JJR specific_JJ immunity_NN to_IN the_DT 2009_CD H1N1_NNP virus_NN ._. This_DT finding_NN provided_VBD insight_NN into_IN future_JJ monitoring_NN of_IN the_DT H1N1_NN virus_NN and_CC its_PRP$ evolution_NN within_IN the_DT human_JJ population_NN ._. [_-LRB- 48_CD ]_-RRB- On_IN November_NNP 20_CD ,_, 2013_CD ,_, the_DT Norwegian_NNP Institute_NNP of_IN Public_NNP Health_NNP released_VBD a_DT statement_NN saying_VBG they_PRP had_VBD discovered_VBN a_DT potentially_RB significant_JJ mutation_NN in_IN the_DT H1N1_NN influenza_NN strain_NN that_WDT could_MD be_VB responsible_JJ for_IN causing_VBG the_DT severest_JJS symptoms_NNS among_IN those_DT infected_VBN ._. In_IN the_DT statement_NN they_PRP said_VBD ""_`` The_DT mutation_NN could_MD be_VB affecting_VBG the_DT virus_NN '_POS ability_NN to_TO go_VB deeper_RBR into_IN the_DT respiratory_JJ system_NN ,_, thus_RB causing_VBG more_RBR serious_JJ illness_NN ""_'' ._. [_-LRB- 49_CD ]_-RRB- The_DT World_NNP Health_NNP Organization_NNP said_VBD the_DT mutation_NN did_VBD not_RB appear_VB to_TO be_VB widespread_JJ in_IN Norway_NNP and_CC the_DT virus_NN in_IN its_PRP$ mutated_VBN form_NN remained_VBD sensitive_JJ to_IN antivirals_NNS and_CC pandemic_NN vaccines_NNS ._. A_DT similar_JJ mutation_NN had_VBD been_VBN detected_VBN in_IN H1N1_NNP viruses_NNS circulating_VBG in_IN several_JJ other_JJ countries_NNS ,_, including_VBG China_NNP and_CC the_DT United_NNP States_NNPS ,_, in_IN severe_JJ as_RB well_RB as_IN in_IN some_DT mild_JJ cases_NNS ._. ""_`` Although_IN further_JJR investigation_NN is_VBZ under_IN way_NN ,_, no_DT evidence_NN currently_RB suggests_VBZ that_IN these_DT mutations_NNS are_VBP leading_VBG to_IN an_DT unusual_JJ increase_NN in_IN the_DT number_NN of_IN H1N1_NN infections_NNS or_CC a_DT greater_JJR number_NN of_IN severe_JJ or_CC fatal_JJ cases_NNS ._. ""_'' [_-LRB- 49_CD ]_-RRB- On_IN December_NNP 2_CD ,_, 2009_CD ,_, the_DT WHO_NNP announced_VBD that_IN they_PRP had_VBD been_VBN informed_VBN of_IN two_CD recent_JJ clusters_NNS of_IN patients_NNS infected_VBN with_IN oseltamivir_NN -_HYPH resistant_JJ H1N1_NN viruses_NNS ._. Both_DT clusters_NNS ,_, detected_VBN in_IN the_DT UK_NNP (_-LRB- including_VBG Wales_NNP )_-RRB- and_CC in_IN North_NNP Carolina_NNP ,_, occurred_VBD in_IN a_DT single_JJ ward_NN and_CC involved_VBD patients_NNS whose_WP$ immune_JJ systems_NNS were_VBD severely_RB compromised_VBN or_CC suppressed_VBN ._. Transmission_NN of_IN resistant_JJ virus_NN from_IN one_CD patient_NN to_IN another_DT is_VBZ suspected_VBN in_IN both_CC outbreaks_NNS ._. As_IN of_IN December_NNP 2010_CD ,_, the_DT WHO_NNP reported_VBD 314_CD samples_NNS of_IN 2009_CD pandemic_NN H1N1_NN flu_NN tested_VBN worldwide_RB have_VBP shown_VBN resistance_NN to_IN oseltamivir_NN (_-LRB- Tamiflu_NNP )_-RRB- ._. This_DT was_VBD not_RB totally_RB unexpected_JJ as_IN 99.6_CD %_NN of_IN the_DT seasonal_JJ H1N1_NN flu_NN strains_NNS tested_VBN have_VBP developed_VBN resistance_NN to_IN amantadine_NN and_CC rimantadine_NN ._. [_-LRB- 51_CD ]_-RRB- As_IN of_IN August_NNP 2009_CD no_DT circulating_VBG flu_NN had_VBD yet_RB shown_VBN any_DT resistance_NN to_IN zanamivir_NN (_-LRB- Relenza_NNP )_-RRB- ,_, the_DT other_JJ available_JJ anti-viral_NN ._. [_-LRB- 52_CD ]_-RRB- Before_IN being_VBG transmitted_VBN to_IN humans_NNS ,_, an_DT H1N1_NNP type_NN virus_NN is_VBZ known_VBN to_TO have_VB circulated_VBN in_IN swine_NN ._. In_IN August_NNP 2007_CD ,_, about_RB 25_CD people_NNS and_CC 160_CD pigs_NNS developed_VBD flu_NN at_IN a_DT county_NN fair_NN in_IN Ohio_NNP ._. Analysis_NN showed_VBD they_PRP were_VBD infected_VBN with_IN the_DT same_JJ strain_NN —_: an_DT H1N1_NN type_NN containing_VBG genes_NNS of_IN human_JJ ,_, bird_NN and_CC swine_NN origin_NN ._. A_DT 2004_CD study_NN found_VBD that_IN in_IN Iowa_NNP ,_, 20_CD percent_NN of_IN swine_NN veterinarians_NNS and_CC 3_CD percent_NN of_IN meatpackers_NNS ,_, but_CC no_DT university_NN workers_NNS ,_, had_VBD antibodies_NNS in_IN their_PRP$ blood_NN indicating_VBG they_PRP had_VBD been_VBN infected_VBN with_IN swine_NN flu_NN ._. Another_DT study_NN ,_, of_IN 804_CD rural_JJ Iowans_NNPS ,_, found_VBD that_IN pig_NN farmers_NNS were_VBD 50_CD times_NNS more_RBR likely_JJ ,_, and_CC their_PRP$ spouses_NNS about_RB 30_CD times_NNS more_RBR likely_JJ ,_, than_IN university_NN workers_NNS to_TO carry_VB swine_NN flu_NN antibodies_NNS ._. [_-LRB- 53_CD ]_-RRB- Pigs_NNS are_VBP also_RB known_VBN to_TO have_VB been_VBN infected_VBN by_IN humans_NNS ._. [_-LRB- 54_CD ]_-RRB- Humans_NNS have_VBP been_VBN affected_VBN since_IN early_JJ 2009_CD ._. The_DT November_NNP 27_CD ,_, 2009_CD worldwide_JJ update_NN by_IN the_DT U.N._NNP 's_POS World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- states_VBZ that_IN ""_`` more_JJR than_IN 207_CD countries_NNS and_CC overseas_JJ territories_NNS or_CC communities_NNS have_VBP reported_VBN laboratory_NN confirmed_VBN cases_NNS of_IN pandemic_NN influenza_NN H1N1_NN 2009_CD ,_, including_VBG over_RB 7,820_CD deaths_NNS ""_'' ._. The_DT WHO_NNP has_VBZ also_RB tracked_VBN more_JJR than_IN 622,482_CD laboratory_NN -_HYPH confirmed_VBN cases_NNS of_IN H1N1_NN ._. [_-LRB- 55_CD ]_-RRB- The_DT symptoms_NNS of_IN this_DT virus_NN are_VBP identical_JJ to_IN that_DT of_IN seasonal_JJ influenza_NN ._. In_IN late_JJ August_NNP 2009_CD ,_, the_DT government_NN of_IN Chile_NNP discovered_VBD that_IN the_DT human_JJ H1N1/09_NN virus_NN had_VBD jumped_VBN ,_, unmutated_JJ ,_, to_IN birds_NNS ,_, ""_`` opening_VBG a_DT new_JJ chapter_NN in_IN the_DT global_JJ epidemic_NN ""_'' ._. Top_JJ flu_NN and_CC animal_NN -_HYPH health_NN experts_NNS with_IN the_DT WHO_NNP and_CC the_DT CDC_NNP were_VBD monitoring_VBG the_DT situation_NN closely_RB ._. They_PRP said_VBD the_DT infected_VBN turkeys_NNS had_VBD suffered_VBN only_RB mild_JJ effects_NNS ,_, easing_VBG concern_NN about_IN a_DT potentially_RB dangerous_JJ development_NN ._. Chile_NNP 's_POS turkey_NN meat_NN remained_VBD safe_JJ to_TO eat_VB ,_, they_PRP said_VBD ,_, and_CC so_RB far_RB there_EX had_VBD been_VBN no_DT signs_NNS of_IN a_DT potentially_RB dangerous_JJ mutation_NN ._. [_-LRB- 56_CD ]_-RRB- Virus_NN experts_NNS were_VBD concerned_VBN that_IN a_DT more_RBR dangerous_JJ and_CC easily_RB transmitted_VBN strain_NN could_MD emerge_VB if_IN H1N1/09_NNP combines_VBZ again_RB with_IN avian_JJ flu_NN ,_, which_WDT is_VBZ far_RB more_RBR virulent_JJ but_CC much_RB less_RBR contagious_JJ to_IN humans_NNS ._. By_IN October_NNP 2009_CD ,_, another_DT outbreak_NN was_VBD identified_VBN at_IN a_DT turkey_NN breeder_NN in_IN Ontario_NNP ,_, Canada_NNP ._. [_-LRB- 57_CD ]_-RRB- In_IN October_NNP 2009_CD ,_, a_DT ferret_NN exhibiting_VBG flu_NN symptoms_NNS was_VBD confirmed_VBN to_TO have_VB contracted_VBN the_DT H1N1_NNP virus_NN from_IN its_PRP$ owner_NN in_IN Oregon_NNP ._. [_-LRB- 58_CD ]_-RRB- In_IN November_NNP 2009_CD ,_, a_DT case_NN of_IN novel_JJ H1N1_NN was_VBD confirmed_VBN in_IN a_DT household_NN cat_NN ._. [_-LRB- 59_CD ]_-RRB- [_-LRB- 60_CD ]_-RRB- [_-LRB- 61_CD ]_-RRB- Although_IN the_DT earliest_JJS cat_NN fatality_NN from_IN the_DT H1N1_NNP virus_NN in_IN the_DT U.S._NNP occurred_VBD in_IN Pennsylvania_NNP ,_, [_-LRB- 62_CD ]_-RRB- the_DT Oregon_NNP Veterinary_NNP Medical_NNP Association_NNP was_VBD the_DT first_JJ to_TO confirm_VB a_DT cat_NN fatality_NN in_IN the_DT U.S._NNP The_DT association_NN recommended_VBD that_IN cat_NN owners_NNS with_IN flu_NN symptoms_NNS avoid_VBP touching_VBG cat_NN 's_POS eyes_NNS ,_, nose_NN ,_, and_CC mouth_NN while_IN sick_JJ ._. They_PRP recommended_VBD thoroughly_RB washing_VBG hands_NNS after_IN handling_VBG a_DT sick_JJ pet_NN as_IN it_PRP might_MD be_VB possible_JJ for_IN cats_NNS to_TO transmit_VB the_DT virus_NN to_IN humans_NNS ._. This_DT was_VBD the_DT third_JJ confirmed_VBN case_NN of_IN H1N1_NN in_IN a_DT cat_NN in_IN the_DT U.S._NNP ;_, other_JJ cases_NNS have_VBP occurred_VBN in_IN Utah_NNP and_CC Iowa_NNP ._. [_-LRB- 63_CD ]_-RRB- The_DT first_JJ case_NN of_IN a_DT dog_NN with_IN H1N1_NN was_VBD reported_VBN in_IN December_NNP 2009_CD ._. [_-LRB- 64_CD ]_-RRB- On_IN July_NNP 22_CD ,_, 2011_CD the_DT Norwegian_NNP Veterinary_NNP Institute_NNP reported_VBD the_DT first_JJ occurrence_NN of_IN 2009_CD -_HYPH H1N1_NN influenza_NN virus_NN in_IN minks_NNS ._. [_-LRB- 65_CD ]_-RRB- The_DT initial_JJ outbreak_NN of_IN a_DT novel_NN [_-LRB- 2_CD ]_-RRB- swine_NN -_HYPH origin_NN H1N1_NN flu_NN pandemic_NN in_IN 2009_CD and_CC the_DT virus_NN strain_NN that_WDT caused_VBD it_PRP were_VBD called_VBN by_IN many_JJ names_NNS ._. In_IN July_NNP 2009_CD ,_, WHO_NNP experts_NNS named_VBD the_DT virus_NN ""_`` pandemic_NN H1N1/09_NN virus_NN ""_'' to_TO distinguish_VB it_PRP from_IN both_CC various_JJ seasonal_JJ H1N1_NN virus_NN strains_NNS and_CC the_DT 1918_CD flu_NN pandemic_NN H1N1_NN strain_NN ._. Some_DT authorities_NNS objected_VBD to_IN calling_VBG the_DT flu_NN outbreak_NN ""_`` swine_NN flu_NN ""_'' ._. U.S._NNP Agriculture_NNP Secretary_NNP Tom_NNP Vilsack_NNP expressed_VBD concerns_NNS that_IN this_DT would_MD lead_VB to_IN the_DT misconception_NN that_IN pork_NN is_VBZ unsafe_JJ for_IN consumption_NN ._. [_-LRB- 66_CD ]_-RRB- The_DT CDC_NNP began_VBD referring_VBG to_IN it_PRP as_IN ""_`` novel_JJ influenza_NN A_NN (_-LRB- H1N1_NN )_-RRB- ""_'' ;_, ""_`` A_DT /_, H1N1_NN ""_'' is_VBZ sometimes_RB used_VBN ._. [_-LRB- 2_CD ]_-RRB- [_-LRB- 67_CD ]_-RRB- The_DT CDC_NNP stopped_VBD using_VBG the_DT nomenclature_NN ""_`` novel_JJ H1N1_NN ""_'' and_CC updated_VBD various_JJ web_NN pages_NNS to_TO reflect_VB the_DT change_NN to_IN ""_`` 2009_CD H1N1_NNP Flu_NNP ""_'' ._. In_IN the_DT Netherlands_NNPS it_PRP was_VBD originally_RB called_VBN ""_`` pig_NN flu_NN ""_'' but_CC ,_, later_RBR called_VBN ""_`` Mexican_JJ flu_NN ""_'' by_IN the_DT National_NNP Health_NNP Institute_NNP and_CC in_IN the_DT media_NN ._. South_NNP Korea_NNP and_CC Israel_NNP briefly_RB considered_VBD calling_VBG it_PRP the_DT ""_`` Mexican_JJ virus_NN ""_'' ._. [_-LRB- 68_CD ]_-RRB- Later_RBR the_DT South_NNP Korean_JJ press_NN used_VBD ""_`` SI_NN ""_'' ,_, short_JJ for_IN ""_`` swine_NN influenza_NN ""_'' ._. Taiwan_NNP suggested_VBD the_DT names_NNS ""_`` H1N1_NN flu_NN ""_'' or_CC ""_`` new_JJ flu_NN ""_'' ,_, which_WDT most_JJS local_JJ media_NN adopted_VBD ._. [_-LRB- 69_CD ]_-RRB- The_DT World_NNP Organization_NNP for_IN Animal_NNP Health_NNP proposed_VBD the_DT name_NN ""_`` North_NNP American_JJ influenza_NN ""_'' ._. [_-LRB- 70_CD ]_-RRB- The_DT European_NNP Commission_NNP adopted_VBD the_DT term_NN ""_`` novel_JJ flu_NN virus_NN ""_'' ._. [_-LRB- 71_CD ]_-RRB- The_DT name_NN A_NNP (_-LRB- H1N1_NNP )_-RRB- pdm09_NN later_RBR came_VBD into_IN widespread_JJ use_NN ,_, sometimes_RB qualified_VBN as_IN A_NNP /_, California/7/2009_NNP (_-LRB- H1N1_NNP )_-RRB- pdm_NN ,_, etc_FW ._. [_-LRB- 72_CD ]_-RRB- [_-LRB- 73_CD ]_-RRB- The_DT pdm09_NN in_IN the_DT above_JJ nomenclature_NN refers_VBZ to_IN Pandemic_NNP Disease_NNP Mexico_NNP 2009_CD ._. On_IN April_NNP 24_CD ,_, 2009_CD ,_, the_DT U.S._NNP CDC_NNP determined_VBD that_IN seven_CD samples_NNS from_IN suspected_VBN cases_NNS in_IN Mexico_NNP matched_VBD the_DT strain_NN that_WDT had_VBD infected_VBN patients_NNS in_IN Texas_NNP and_CC California_NNP with_IN no_DT known_VBN linkages_NNS to_IN animals_NNS or_CC one_CD another_DT ;_, the_DT strain_NN appeared_VBD to_TO be_VB spreading_VBG from_IN human_JJ to_IN human_JJ ._. [_-LRB- 82_CD ]_-RRB- [_-LRB- 83_CD ]_-RRB- The_DT CDC_NNP determined_VBD that_IN the_DT strain_NN contained_VBN genes_NNS from_IN four_CD different_JJ flu_NN viruses_NNS —_: North_NNP American_JJ swine_NN influenza_NN ,_, North_NNP American_JJ avian_JJ influenza_NN ,_, human_JJ influenza_NN ,_, and_CC swine_NN influenza_NN virus_NN typically_RB found_VBN in_IN Asia_NNP and_CC Europe_NNP —_: ""_`` an_DT unusually_RB mongrelised_JJ mix_NN of_IN genetic_JJ sequences_NNS ""_'' ._. [_-LRB- 5_CD ]_-RRB- A_DT CDC_NNP investigative_JJ team_NN arrived_VBD in_IN Mexico_NNP City_NNP on_IN April_NNP 25_CD ,_, 2009_CD to_TO work_VB with_IN Mexican_JJ counterparts_NNS to_TO study_VB the_DT virus_NN ._. [_-LRB- 84_CD ]_-RRB- Pigs_NNS are_VBP susceptible_JJ to_IN influenza_NN viruses_NNS that_WDT can_MD also_RB infect_VB both_CC humans_NNS and_CC birds_NNS ,_, so_IN they_PRP may_MD act_VB as_IN a_DT ""_`` mixing_NN vessel_NN ""_'' in_IN which_WDT reassortment_NN can_MD occur_VB between_IN flu_NN viruses_NNS of_IN several_JJ species_NNS ._. [_-LRB- 85_CD ]_-RRB- [_-LRB- 86_CD ]_-RRB- Reassortment_NN is_VBZ a_DT process_NN that_WDT happens_VBZ if_IN two_CD different_JJ types_NNS of_IN influenza_NN virus_NN infect_VBP a_DT single_JJ cell_NN and_CC it_PRP can_MD produce_VB a_DT new_JJ strain_NN of_IN influenza_NN ._. This_DT is_VBZ because_IN the_DT virus_NN genome_NN is_VBZ split_VBN between_IN eight_CD independent_JJ pieces_NNS of_IN RNA_NN ,_, which_WDT allows_VBZ pieces_NNS of_IN RNA_NN from_IN different_JJ viruses_NNS to_TO mix_VB and_CC form_VB a_DT novel_JJ type_NN of_IN virus_NN as_IN new_JJ virus_NN particles_NNS are_VBP being_VBG assembled_VBN ._. [_-LRB- 87_CD ]_-RRB- This_DT new_JJ strain_NN appears_VBZ to_TO be_VB a_DT result_NN of_IN the_DT reassortment_NN of_IN two_CD swine_NN influenza_NN viruses_NNS ,_, one_CD from_IN North_NNP America_NNP and_CC one_CD from_IN Europe_NNP ._. [_-LRB- 88_CD ]_-RRB- But_CC the_DT North_NNP American_JJ pig_NN strain_NN was_VBD itself_PRP the_DT product_NN of_IN previous_JJ reassortments_NNS ,_, and_CC has_VBZ carried_VBN an_DT avian_JJ PB2_NN gene_NN for_IN at_IN least_JJS ten_CD years_NNS and_CC a_DT human_JJ PB1_NN gene_NN since_IN 1993_CD ._. [_-LRB- 89_CD ]_-RRB- These_DT genes_NNS were_VBD passed_VBN on_RP to_IN the_DT new_JJ virus_NN ._. [_-LRB- 90_CD ]_-RRB- [_-LRB- 91_CD ]_-RRB- Gene_NN sequences_NNS for_IN every_DT viral_JJ gene_NN were_VBD made_VBN available_JJ through_IN the_DT Global_NNP Initiative_NNP on_IN Sharing_VBG Avian_NNP Influenza_NNP Data_NNP (_-LRB- GISAID_NNP )_-RRB- ._. [_-LRB- 92_CD ]_-RRB- [_-LRB- 93_CD ]_-RRB- A_DT preliminary_JJ analysis_NN found_VBD that_IN the_DT hemagglutinin_NN (_-LRB- HA_NN )_-RRB- gene_NN was_VBD similar_JJ to_IN that_DT of_IN swine_NN flu_NN viruses_NNS present_JJ in_IN U.S._NNP pigs_NNS since_IN 1999_CD ,_, but_CC the_DT neuraminidase_NN (_-LRB- NA_NN )_-RRB- and_CC matrix_NN protein_NN (_-LRB- M_NN )_-RRB- genes_NNS resembled_VBD versions_NNS present_JJ in_IN European_JJ swine_NN flu_NN isolates_NNS ._. While_IN viruses_NNS with_IN this_DT genetic_JJ makeup_NN had_VBD not_RB previously_RB been_VBN found_VBN to_TO be_VB circulating_VBG in_IN humans_NNS or_CC pigs_NNS ,_, there_EX is_VBZ no_DT formal_JJ national_JJ surveillance_NN system_NN to_TO determine_VB what_WP viruses_NNS are_VBP circulating_VBG in_IN pigs_NNS in_IN the_DT U.S._NNP [_-LRB- 94_CD ]_-RRB- So_RB far_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT spread_NN of_IN the_DT virus_NN in_IN any_DT pig_NN population_NN ._. A_DT preliminary_JJ analysis_NN has_VBZ also_RB shown_VBN that_IN several_JJ of_IN the_DT proteins_NNS involved_VBN in_IN the_DT pathophysiology_NN of_IN the_DT virus_NN are_VBP most_RBS similar_JJ to_IN strains_NNS that_WDT cause_VBP mild_JJ symptoms_NNS in_IN humans_NNS ._. This_DT suggests_VBZ the_DT virus_NN is_VBZ unlikely_JJ to_TO cause_VB severe_JJ infections_NNS similar_JJ to_IN those_DT caused_VBN by_IN the_DT 1918_CD pandemic_NN flu_NN virus_NN or_CC the_DT H5N1_NN avian_NN influenza_NN ._. [_-LRB- 95_CD ]_-RRB- Late_RB on_IN May_NNP 6_CD ,_, 2009_CD ,_, Canada_NNP 's_POS National_NNP Microbiology_NNP Laboratory_NNP first_RB completed_VBD the_DT sequencing_NN of_IN Mexican_JJ samples_NNS of_IN the_DT virus_NN ,_, publishing_VBG the_DT result_NN to_IN GenBank_NNP as_IN A_NNP /_, Mexico_NNP /_, InDRE4487/2009_NNP (_-LRB- H1N1_NNP )_-RRB- ._. [_-LRB- 96_CD ]_-RRB- This_DT was_VBD later_RBR shown_VBN to_TO be_VB nearly_RB identical_JJ to_IN A_NNP /_, California_NNP /_, 07/2009_CD (_-LRB- H1N1_NN )_-RRB- ,_, the_DT strain_NN from_IN California_NNP sequenced_VBN and_CC published_VBN by_IN the_DT CDC_NNP on_IN 27_CD April_NNP ._. [_-LRB- 9_CD ]_-RRB- Samples_NNS from_IN Mexico_NNP ,_, Nova_NNP Scotia_NNP and_CC Ontario_NNP had_VBD the_DT same_JJ sequence_NN ,_, ruling_VBG out_RP genetic_JJ explanations_NNS for_IN the_DT greater_JJR severity_NN of_IN the_DT Mexican_JJ cases_NNS ._. [_-LRB- 97_CD ]_-RRB- [_-LRB- 98_CD ]_-RRB- The_DT genetic_JJ divergence_NN of_IN the_DT virus_NN in_IN samples_NNS from_IN different_JJ cases_NNS has_VBZ been_VBN analysed_VBN by_IN an_DT international_JJ collaboration_NN who_WP found_VBD that_IN the_DT virus_NN jumped_VBD to_IN humans_NNS in_IN 2008_CD ,_, probably_RB after_IN June_NNP ,_, and_CC not_RB later_RBR than_IN the_DT end_NN of_IN November_NNP ._. [_-LRB- 11_CD ]_-RRB- The_DT research_NN also_RB indicated_VBD the_DT virus_NN had_VBD been_VBN latent_JJ in_IN pigs_NNS for_IN several_JJ months_NNS prior_JJ to_IN the_DT outbreak_NN ,_, suggesting_VBG a_DT need_NN to_TO increase_VB agricultural_JJ surveillance_NN to_TO prevent_VB future_JJ outbreaks_NNS ._. [_-LRB- 20_CD ]_-RRB- •_NFP Graphical_JJ Image_NN of_IN the_DT viral_JJ makeup_NN of_IN the_DT 2009_CD pandemic_NN h1n1_NN virus_NN —_: NEJM_NNP","In NN , the NN NN NN VBZ a NN NN NN A NN NN NN NN that VBD JJ for the 2009 NN NN NN . This NN VBZ RB VBN NN NN by the JJ NN . For JJ NNS , VB the NNP NN RB . The NN VBZ a JJ NN of the NN NN , [ 2 ] for which VBG NNS against JJ NN VBD no NN . A NN at the NNP NNPS for NNP NNP and NNP ( NNP ) VBN in NNP 2009 VBD that NNS VBD no JJ NN to the JJ NN but that NNS , RB those over 60 , VBD some NN of NN . NNS VBD no JJ NN NN to the then - JJ NN , while NNS JJ 18 to 64 VBD 6–9 NN , and JJR NNS 34 NN . [ 3 ] [ 4 ] JJ NN of JJ NN VBD that the NN VBD NNS from five JJ NN NNS : NNP JJ NN NN , NNP JJ JJ NN , JJ NN , and two NN NN NNS RB VBN in NNP and NNP . [ 5 ] JJR NN VBD that JJ of the NNS of the NN VBP RBS JJ to NNS that VBP JJ NNS in NNS , VBG NN NNP NNP to VB that the NN VBD JJ to VB JJ NNS for JJS NNS . [ 6 ] JJ VBG NNS VBD that all NNS of the NN VBD in NN NN in NN , despite it VBG a JJ NN . [ 7 ] [ 8 ] The JJ JJ NN NN of the NN NN VBD VBN in JJ NNS on NNP 27 , 2009 , by NNS from the NNP NNPS for NNP NNP and NNP in NNP . [ 9 ] NNS in NNP RBR VBD the JJ JJ NN of NNS from NNP and NNP on NNP 6 , 2009 . [ 10 ] NN of the JJ NN of the NN in NNS from JJ NNS VBD that the NN VBD to NNS in 2008 , RB after NNP , and RB RBR than the NN of NNP , [ 11 ] RB around NNP 2008 . [ 12 ] [ 13 ] A NN by NNS at the NNP NNP NNP of NNP in 2016 VBD that the 2009 NNP NN RB VBD from NNS in a RB JJ NN of JJ NNP . [ 14 ] On NNP 17 , 2009 , NNPS for NNP NNP and NNP ( NNP ) VBD that two NNS of JJ JJ NN VBG in NNS who VBD in JJ NNS in NNP NNP VBD VBN by NN with a NN NN NN ( NN ) NN . The NNS from the two NNS VBD RB VBN RB , JJ to NN and NN , and VBP a JJ NN of NN NNS that RB VBD RB VBN VBN among NN or JJ NN NNS in the NNP NNPS or RB . After the NN of the JJ NN in the NN of 2009 , it VBD RB across the NNP NNPS , NNP and the NN . [ 15 ] [ 16 ] In JJ NNP , the NNP NNP NNP ( NNP ) VBD its JJ RB "" JJ NN NN of JJ NN "" , or NNP , [ 17 ] and in NNP , the NNP and the NNP NNP VBD VBG NNS and VBD the NN a NN . [ 18 ] On NNP 23 , 2009 , The NNP NNP NNP VBD that NNP JJ NN NNS VBD that , "" JJ to the JJ NN that the JJ NN NN NN VBD on NN NNS in NNP "" , RB VBP it "" RBS RB VBN in NNS in NNP , but RB VBD to NNP NNP in a NN "" . They VBD that there VBD no NN to VB their NN but VBD there VBZ no NN this JJ NN , which VBZ JJ and NNP JJ NNS , VBZ RB VBN in NNP JJ NNS , "" while there VBZ JJ NN that a RB JJ ' NN NN ' VBZ VBN in NNP "" . [ 19 ] RB , a JJ NN by NNS at the NNP NNP NNP of NNP in 2016 VBD that the 2009 NNP NN RB VBD in JJ NNP . [ 14 ] In JJ NNP 2009 , VBG JJ NNS VBN over the JJ ten NNS , an JJ NN of NNS VBD to VB the NNS and NN of the 2009 NN NN . NNP NNP of NNP NNP 's NNP of NNP , and NN of the NN NN , VBZ "" Our NNS VBP that this NN VBZ VBN VBG among NNS , RB among JJ NNS , for JJ NNS JJ to its NN to NNS . "" The NN NN who VBD on this NN RB VBD it VBD "" VBN from JJ NNS VBG in NN "" , and that the JJ NN to NNS VBD JJ NNS before NN of the NN . The NN VBD that "" despite JJ NN NN in NNS , the NN of JJ NN NN VBD for the JJ NN and NN of this RB NN NN for JJ NNS . "" [ 20 ] VBG to the NNS , NN of JJ NNS between NNP and NNP NNP "" VBZ to VB VBN the NN of JJ NN NN NNS , VBG to the JJ NN NNS VBN with the NN of the ( JJ NN ) NN "" . They RB VBD this JJ NN "" VBZ JJ NN of the NN of JJ NNS in the NN of NN NN "" . [ 21 ] In NNP 2009 , a NN VBD VBN in NNP NNP in which it VBD VBN that the NN may VB the NN of three NNS from three NNS that VBD NNS in a NN or a NN - VBG NN , and RB "" VBD "" . The NN VBD NN among NNS in NNP 2009 , when the NNS VBD the NNP NNP NNP ( NNP ) to VB the NN . After VBG the JJ NN , NNP and JJ NNS VBD the NN NN VBD a RB - VBG NN and RB NN - VBN . [ 22 ] [ 23 ] The NN VBZ JJ with an NN of 1.4 to 1.6 [ 24 ] and VBZ from JJ to JJ in RB the JJ NN as JJ NN . The RBS JJ NNS by which it VBZ VBP by NNS from NNS and NNS of VBN NNS , and RB RB VBG a NN or the NN of a NN VBN with the NN and RB VBG one 's NNS , NN or NN . [ 25 ] In 2009 , the NNP VBD that NNP VBD to VB RBR JJ than JJ NN . [ 26 ] RB , a NNP NNP NNP of NNP NN VBD the NN of the 2009 NN NN NN in NNS VBD JJR than that VBN in JJ NNS . [ 27 ] The NNP NNP VBD that NNS should VB at JJS a NN after their NN VBZ ( RB 3 – 4 NNS after the NN of NNS ) before VBG JJ NNS , but it VBZ VBN VBN that they can VB to VB NN for JJ JJR NNS . [ 28 ] The NN of NN NN NN VBZ JJ and the NN NNS VBP RB JJ . [ 29 ] [ 30 ] In NN , the NNP NNP VBD that JJS NNS VBD JJ , JJ to JJ NN , and that NN VBD to VB RB JJ . [ 31 ] The NN of NNS as of NNP 2009 VBD VBN to VB a JJ NN of the JJ NN of NNS from JJ NN . [ 32 ] RB , NNS of JJ NN NNS with JJ NN VBP JJ to VB NN of the NN , [ 33 ] and the NN NNP NN VBD in NN the JJ NN of NN VBG NN in the 2009 / 10 NN NN . [ 34 ] NN VBN out at NNP NNP NNP [ 35 ] VBZ VBN that , unlike JJ NN , NN can VB NNS RB in the NNS . JJ NN can VB RB NNS with JJ NN a 2 - 6 which VBP RB VBN in the NN and NN but NN / 09 can RB VB NNS with JJ NN a 2 - 3 . This may VB why some NNS VBP JJ JJ NNS . ( The NNP NN VBZ RB JJ to VB NNS RB in the NNS with JJ NN a 2 - 3 but cannot VB NNS with JJ NN a 2 - 6 VBG it RBR JJ than NNP 09 . ) As of NNP 2009 , JJS NNS VBN by this NN VBD a JJ NN , but the JJ NN VBN VBD RB RB JJ . NNP NNP , an JJ NN NN at the NNP of NNP , NNP , NNP , VBD "" this NN VBZ like two NNS ; either you VBP off NN for a JJ NNS or you VBP to NN , RB to the JJ - NN NN ( NN ) . There VBZ no JJ NN . "" In the JJ NN 15 to 33 NN of VBN NNS VBD to the NNP in NNP and NNP 2009 . Unlike NNP NN NN and NN which VBP a JJ NN - JJ NN NN , NNP VBZ the NNS ' NN , RB VBG JJ JJ NN NN , which VBZ in NN of all NNS . JJ NN VBZ that NN VBZ VBN to a JJ NN in JJ NNS . [ 36 ] From NNP 2009 to NNP 2009 , 3,900 NNS VBD of the NNP NN NN in the NNP This VBZ RB VBN to the 36,000 NNS per NN who VBP from the "" JJ NN "" , RB in NN , although this NN VBZ an NN . [ 37 ] The NN NN of NN in the NNP VBD VBN as JJR than 0.02 NN from NNP 2009 NNS from the NNP , [ 38 ] and VBZ VBN RB VBN as 0.026 NN in NNP . [ 39 ] VBG NNS against JJ NN VBD no NN . NNS VBD VBN in NNP NNP in JJ NNP . NN may VB three billion NNS per NN RB than the JJR NN of five billion . [ 40 ] On NNP 22 , 2009 , NNP NNP NNP ( NNP ) NN - NNP NNP NNP VBD the NN must VB RB VBN in the JJ NN , as it could VB with JJ JJ NN and NN in JJ NNS .[ NN VBN ] NNS VBG in the NNP NN of The NNP NNP NNP of NNP VBD that RB , NN NNS VBP VBN between NNS , and the JJ NN may VB RBR JJ or JJ in the VBG NNS . They RB VBD the NN of JJ NN to VB in JJ NN to VB VB NNS in the NN 's NN , which will VB in both "" NN NN "" and VBG NN NNS in the NN of 2009 . [ 41 ] JJ NNS in 2009 VBD RB VBN that the JJ NN NN could VB over the VBG NNS . NNP NNP , a VBG NN from the NNP of NNP NNP , for NN , VBD the JJ NNP NN NN as "" RB JJ "" , VBG it could VB and VB JJ NN ( NN ) when VBN to JJ NNS . During an NN he VBD , "" Both NN and NN VBP JJ so the NNS of them VBG JJ NN VBP JJR , whereas a JJ ( JJ NN ) NN VBZ RBR JJ to VB on JJ NN . "" The NNP NN VBZ RB VBN to NNS , but in JJ NNS when it VBZ NNS it VBZ a NN NN of RB 60 NN to 70 NN . [ 42 ] NNS VBP about the NN of a NN of the RBR JJ JJ - NN NN ( RB JJ JJ NN ) A NN NN ( NN VBN "" NN NN "" ) with RBR JJ - JJ NN NN NNS JJ as this JJ 2009 NN - NN NN / NN NN ( NN VBN "" NN NN "" ) , RB since the NNP NN VBZ JJ among NNS in NNS like NNP , NNP , NNP and NNP . [ 42 ] [ 43 ] ( VB the NN of NN NNS for NNS . ) JJ NNS VBD that the NN VBD RB RB VBN to NNS , VBD a JJ JJ NN over JJ NN NNS and that NN VBD JJ at that NN due to its NN in NN and NN . [ 44 ] RB , JJ NN NNS in the NNP VBD that the JJ 1918 NN NN , which VBD NNS of NNS in the NNP NNPS RB , VBD VBN by a JJ "" NN "" NN of NNS in the NN , VBN by JJ NNS of NN in the NN . [ 45 ] As of JJ NNP 2009 , NNP NN NNS VBD the NN NN VBD RB RB VBG to VB RBR JJ , but they VBD RB VBG that as the NN VBD to VB the NN . [ 46 ] As of NNP 2009 , NN VBN by NNP VBD that the NN of NN ( NN ) VBZ RB JJ since the NN of the 2009 NNP NN VBZ JJ to the NN of NN VBN in the 1918 NN NN . [ 47 ] A NN from NNP NNP VBD a NN NN between the NN NN NN NN NNS VBN in the JJR 1918 NN and the 2009 NN NN . This may VB VBN a NN in NNS who VBD VBN VBN with the 1918 NN and its JJ NNS in VBG JJR JJ NN to the 2009 NNP NN . This NN VBD NN into JJ NN of the NN NN and its NN within the JJ NN . [ 48 ] On NNP 20 , 2013 , the NNP NNP of NNP NNP VBD a NN VBG they VBD VBN a RB JJ NN in the NN NN NN that could VB JJ for VBG the JJS NNS among those VBN . In the NN they VBD "" The NN could VB VBG the NN ' NN to VB RBR into the JJ NN , RB VBG RBR JJ NN "" . [ 49 ] The NNP NNP NNP VBD the NN VBD RB VB to VB JJ in NNP and the NN in its VBN NN VBD JJ to NNS and NN NNS . A JJ NN VBD VBN VBN in NNP NNS VBG in JJ JJ NNS , VBG NNP and the NNP NNPS , in JJ RB RB as in some JJ NNS . "" Although JJR NN VBZ under NN , no NN RB VBZ that these NNS VBP VBG to an JJ NN in the NN of NN NNS or a JJR NN of JJ or JJ NNS . "" [ 49 ] On NNP 2 , 2009 , the NNP VBD that they VBD VBN VBN of two JJ NNS of NNS VBN with NN - JJ NN NNS . Both NNS , VBN in the NNP ( VBG NNP ) and in NNP NNP , VBD in a JJ NN and VBD NNS whose JJ NNS VBD RB VBN or VBN . NN of JJ NN from one NN to another VBZ VBN in both NNS . As of NNP 2010 , the NNP VBD 314 NNS of 2009 NN NN NN VBN RB VBP VBN NN to NN ( NNP ) . This VBD RB RB JJ as 99.6 NN of the JJ NN NN NNS VBN VBP VBN NN to NN and NN . [ 51 ] As of NNP 2009 no VBG NN VBD RB VBN any NN to NN ( NNP ) , the JJ JJ NN . [ 52 ] Before VBG VBN to NNS , an NNP NN NN VBZ VBN to VB VBN in NN . In NNP 2007 , RB 25 NNS and 160 NNS VBD NN at a NN NN in NNP . NN VBD they VBD VBN with the JJ NN — an NN NN VBG NNS of JJ , NN and NN NN . A 2004 NN VBD that in NNP , 20 NN of NN NNS and 3 NN of NNS , but no NN NNS , VBD NNS in their NN VBG they VBD VBN VBN with NN NN . Another NN , of 804 JJ NNPS , VBD that NN NNS VBD 50 NNS RBR JJ , and their NNS RB 30 NNS RBR JJ , than NN NNS to VB NN NN NNS . [ 53 ] NNS VBP RB VBN to VB VBN VBN by NNS . [ 54 ] NNS VBP VBN VBN since JJ 2009 . The NNP 27 , 2009 JJ NN by the NNP 's NNP NNP NNP ( NNP ) VBZ that "" JJR than 207 NNS and JJ NNS or NNS VBP VBN NN VBN NNS of NN NN NN 2009 , VBG RB 7,820 NNS "" . The NNP VBZ RB VBN JJR than 622,482 NN - VBN NNS of NN . [ 55 ] The NNS of this NN VBP JJ to that of JJ NN . In JJ NNP 2009 , the NN of NNP VBD that the JJ NN NN VBD VBN , JJ , to NNS , "" VBG a JJ NN in the JJ NN "" . JJ NN and NN - NN NNS with the NNP and the NNP VBD VBG the NN RB . They VBD the VBN NNS VBD VBN RB JJ NNS , VBG NN about a RB JJ NN . NNP 's NN NN VBD JJ to VB , they VBD , and RB RB there VBD VBN no NNS of a RB JJ NN . [ 56 ] NN NNS VBD VBN that a RBR JJ and RB VBN NN could VB if NNP VBZ RB with JJ NN , which VBZ RB RBR JJ but RB RBR JJ to NNS . By NNP 2009 , another NN VBD VBN at a NN NN in NNP , NNP . [ 57 ] In NNP 2009 , a NN VBG NN NNS VBD VBN to VB VBN the NNP NN from its NN in NNP . [ 58 ] In NNP 2009 , a NN of JJ NN VBD VBN in a NN NN . [ 59 ] [ 60 ] [ 61 ] Although the JJS NN NN from the NNP NN in the NNP VBD in NNP , [ 62 ] the NNP NNP NNP NNP VBD the JJ to VB a NN NN in the NNP The NN VBD that NN NNS with NN NNS VBP VBG NN 's NNS , NN , and NN while JJ . They VBD RB VBG NNS after VBG a JJ NN as it might VB JJ for NNS to VB the NN to NNS . This VBD the JJ VBN NN of NN in a NN in the NNP ; JJ NNS VBP VBN in NNP and NNP . [ 63 ] The JJ NN of a NN with NN VBD VBN in NNP 2009 . [ 64 ] On NNP 22 , 2011 the NNP NNP NNP VBD the JJ NN of 2009 - NN NN NN in NNS . [ 65 ] The JJ NN of a NN [ 2 ] NN - NN NN NN NN in 2009 and the NN NN that VBD it VBD VBN by JJ NNS . In NNP 2009 , NNP NNS VBD the NN "" NN NN NN "" to VB it from both JJ JJ NN NN NNS and the 1918 NN NN NN NN . Some NNS VBD to VBG the NN NN "" NN NN "" . NNP NNP NNP NNP NNP VBD NNS that this would VB to the NN that NN VBZ JJ for NN . [ 66 ] The NNP VBD VBG to it as "" JJ NN NN ( NN ) "" ; "" A / NN "" VBZ RB VBN . [ 2 ] [ 67 ] The NNP VBD VBG the NN "" JJ NN "" and VBD JJ NN NNS to VB the NN to "" 2009 NNP NNP "" . In the NNPS it VBD RB VBN "" NN NN "" but , RBR VBN "" JJ NN "" by the NNP NNP NNP and in the NN . NNP NNP and NNP RB VBD VBG it the "" JJ NN "" . [ 68 ] RBR the NNP JJ NN VBD "" NN "" , JJ for "" NN NN "" . NNP VBD the NNS "" NN NN "" or "" JJ NN "" , which JJS JJ NN VBD . [ 69 ] The NNP NNP for NNP NNP VBD the NN "" NNP JJ NN "" . [ 70 ] The NNP NNP VBD the NN "" JJ NN NN "" . [ 71 ] The NN NNP ( NNP ) NN RBR VBD into JJ NN , RB VBN as NNP / NNP ( NNP ) NN , FW . [ 72 ] [ 73 ] The NN in the JJ NN VBZ to NNP NNP NNP 2009 . On NNP 24 , 2009 , the NNP NNP VBD that seven NNS from VBN NNS in NNP VBD the NN that VBD VBN NNS in NNP and NNP with no VBN NNS to NNS or one another ; the NN VBD to VB VBG from JJ to JJ . [ 82 ] [ 83 ] The NNP VBD that the NN VBN NNS from four JJ NN NNS — NNP JJ NN NN , NNP JJ JJ NN , JJ NN , and NN NN NN RB VBN in NNP and NNP — "" an RB JJ NN of JJ NNS "" . [ 5 ] A NNP JJ NN VBD in NNP NNP on NNP 25 , 2009 to VB with JJ NNS to VB the NN . [ 84 ] NNS VBP JJ to NN NNS that can RB VB both NNS and NNS , so they may VB as a "" NN NN "" in which NN can VB between NN NNS of JJ NNS . [ 85 ] [ 86 ] NN VBZ a NN that VBZ if two JJ NNS of NN NN VBP a JJ NN and it can VB a JJ NN of NN . This VBZ because the NN NN VBZ VBN between eight JJ NNS of NN , which VBZ NNS of NN from JJ NNS to VB and VB a JJ NN of NN as JJ NN NNS VBP VBG VBN . [ 87 ] This JJ NN VBZ to VB a NN of the NN of two NN NN NNS , one from NNP NNP and one from NNP . [ 88 ] But the NNP JJ NN NN VBD itself the NN of JJ NNS , and VBZ VBN an JJ NN NN for at JJS ten NNS and a JJ NN NN since 1993 . [ 89 ] These NNS VBD VBN on to the JJ NN . [ 90 ] [ 91 ] NN NNS for every JJ NN VBD VBN JJ through the NNP NNP on VBG NNP NNP NNP ( NNP ) . [ 92 ] [ 93 ] A JJ NN VBD that the NN ( NN ) NN VBD JJ to that of NN NN NNS JJ in NNP NNS since 1999 , but the NN ( NN ) and NN NN ( NN ) NNS VBD NNS JJ in JJ NN NN NNS . While NNS with this JJ NN VBD RB RB VBN VBN to VB VBG in NNS or NNS , there VBZ no JJ JJ NN NN to VB what NNS VBP VBG in NNS in the NNP [ 94 ] RB RB , JJ VBZ VBN about the NN of the NN in any NN NN . A JJ NN VBZ RB VBN that JJ of the NNS VBN in the NN of the NN VBP RBS JJ to NNS that VBP JJ NNS in NNS . This VBZ the NN VBZ JJ to VB JJ NNS JJ to those VBN by the 1918 NN NN NN or the NN NN NN . [ 95 ] RB on NNP 6 , 2009 , NNP 's NNP NNP NNP RB VBD the NN of JJ NNS of the NN , VBG the NN to NNP as NNP / NNP / NNP ( NNP ) . [ 96 ] This VBD RBR VBN to VB RB JJ to NNP / NNP / 07/2009 ( NN ) , the NN from NNP VBN and VBN by the NNP on 27 NNP . [ 9 ] NNS from NNP , NNP NNP and NNP VBD the JJ NN , VBG out JJ NNS for the JJR NN of the JJ NNS . [ 97 ] [ 98 ] The JJ NN of the NN in NNS from JJ NNS VBZ VBN VBN by an JJ NN who VBD that the NN VBD to NNS in 2008 , RB after NNP , and RB RBR than the NN of NNP . [ 11 ] The NN RB VBD the NN VBD VBN JJ in NNS for JJ NNS JJ to the NN , VBG a NN to VB JJ NN to VB JJ NNS . [ 20 ] • JJ NN of the JJ NN of the 2009 NN NN NN — NNP"
236,123,mainstream,"The_DT pneumococcal_JJ vaccine_NN is_VBZ very_RB safe_JJ ,_, although_IN ,_, like_IN all_DT vaccinations_NNS ,_, it_PRP can_MD cause_VB side_NN effects_NNS ._. It_PRP 's_VBZ not_RB possible_JJ to_TO catch_VB a_DT pneumococcal_JJ infection_NN from_IN the_DT vaccine_NN ,_, as_IN the_DT vaccine_NN does_VBZ not_RB contain_VB any_DT live_JJ bacteria_NN ._. Side_NN effects_NNS of_IN the_DT pneumococcal_JJ vaccine_NN in_IN babies_NNS Mild_JJ side_NN effects_NNS of_IN the_DT pneumococcal_JJ conjugate_NN vaccine_NN (_-LRB- PCV_NNP )_-RRB- ,_, which_WDT is_VBZ the_DT version_NN of_IN the_DT pneumococcal_JJ vaccine_NN given_VBN to_IN babies_NNS under_IN the_DT age_NN of_IN 2_CD ,_, include_VBP :_: •_NFP redness_NN and_CC swelling_NN at_IN the_DT site_NN of_IN the_DT injection_NN •_, feeling_VBG sleepy_JJ or_CC not_RB sleeping_VBG well_RB Serious_JJ side_NN effects_NNS of_IN the_DT PCV_NN vaccine_NN are_VBP rare_JJ ,_, and_CC include_VBP :_: •_SYM allergic_JJ reactions_NNS ,_, such_JJ as_IN an_DT itchy_JJ skin_NN rash_NN Side_NN effects_NNS of_IN the_DT pneumococcal_JJ vaccine_NN in_IN adults_NNS and_CC older_JJR children_NNS Mild_JJ side_NN effects_NNS of_IN the_DT pneumococcal_JJ polysaccharide_NN vaccine_NN (_-LRB- PPV_NN )_-RRB- ,_, the_DT version_NN of_IN the_DT pneumococcal_JJ vaccine_NN given_VBN to_IN adults_NNS and_CC children_NNS over_IN the_DT age_NN of_IN 2_CD ,_, include_VBP :_: •_NFP mild_JJ soreness_NN or_CC hardness_NN at_IN the_DT site_NN of_IN the_DT injection_NN lasting_VBG 1_CD to_IN 3_CD days_NNS More_RBR serious_JJ side_NN effects_NNS of_IN the_DT PPV_NN vaccine_NN ,_, such_JJ as_IN allergic_JJ reactions_NNS ,_, are_VBP rare_JJ ._. What_WP to_TO do_VB if_IN your_PRP$ child_NN is_VBZ unwell_JJ after_IN pneumococcal_JJ vaccination_NN Most_RBS common_JJ side_NN effects_NNS in_IN babies_NNS and_CC young_JJ children_NNS ,_, such_JJ as_IN swelling_NN or_CC redness_NN at_IN the_DT injection_NN site_NN ,_, usually_RB go_VBP away_RB within_IN a_DT couple_NN of_IN days_NNS and_CC you_PRP do_VBP not_RB need_VB to_TO do_VB anything_NN about_IN them_PRP ._. If_IN your_PRP$ child_NN develops_VBZ a_DT fever_NN ,_, keep_VB them_PRP cool_JJ ._. Make_VB sure_JJ they_PRP do_VBP not_RB wear_VB too_RB many_JJ layers_NNS of_IN clothes_NNS or_CC blankets_NNS ,_, and_CC give_VB them_PRP cool_JJ drinks_NNS ._. You_PRP can_MD also_RB give_VB them_PRP a_DT dose_NN of_IN infant_NN paracetamol_NN or_CC ibuprofen_NN liquid_NN according_VBG to_IN the_DT instructions_NNS on_IN the_DT bottle_NN ._. Read_VB an_DT NHS_NNP leaflet_NN about_IN the_DT common_JJ side_NN effects_NNS of_IN vaccination_NN that_WDT may_MD occur_VB in_IN babies_NNS and_CC children_NNS (_-LRB- PDF_NN ,_, 118_CD kb_NN )_-RRB- under_IN the_DT age_NN of_IN 5_CD ,_, and_CC how_WRB to_TO treat_VB them_PRP ._. Very_RB occasionally_RB ,_, a_DT child_NN or_CC adult_NN may_MD have_VB a_DT serious_JJ allergic_JJ reaction_NN after_IN either_CC type_NN of_IN pneumococcal_JJ vaccination_NN ._. Known_VBN as_IN an_DT anaphylactic_JJ reaction_NN ,_, this_DT can_MD cause_VB life_NN -_HYPH threatening_VBG breathing_NN difficulties_NNS ._. Anaphylaxis_NN is_VBZ a_DT rare_JJ ,_, serious_JJ side_NN effect_NN that_WDT can_MD happen_VB within_IN minutes_NNS of_IN the_DT injection_NN ._. It_PRP 's_VBZ very_RB alarming_JJ at_IN the_DT time_NN ,_, but_CC it_PRP can_MD be_VB treated_VBN with_IN adrenaline_NN ._. The_DT doctor_NN or_CC nurse_NN giving_VBG the_DT vaccine_NN will_MD have_VB been_VBN trained_VBN to_TO know_VB how_WRB to_TO treat_VB anaphylactic_JJ reactions_NNS ._. Call_VB your_PRP$ GP_NN if_IN you_PRP notice_VBP any_DT unusual_JJ symptoms_NNS in_IN your_PRP$ baby_NN or_CC yourself_PRP after_IN being_VBG vaccinated_VBN ._. Find_VB out_RP more_JJR about_IN vaccine_NN safety_NN and_CC side_NN effects_NNS The_DT Yellow_NNP Card_NNP Scheme_NNP allows_VBZ you_PRP to_TO report_VB suspected_VBN side_NN effects_NNS from_IN any_DT type_NN of_IN medicine_NN you_PRP 're_VBP taking_VBG or_CC vaccines_NNS you_PRP have_VBP received_VBN ._. It_PRP 's_VBZ run_VBN by_IN a_DT medicines_NNS safety_NN watchdog_NN called_VBN the_DT Medicines_NNPS and_CC Healthcare_NNP products_NNPS Regulatory_NNP Agency_NNP (_-LRB- MHRA_NNP )_-RRB- ._. See_VB the_DT Yellow_NNP Card_NNP Scheme_NNP website_NN for_IN more_JJR information_NN ._. Find_VB out_RP how_WRB to_TO report_VB a_DT vaccine_NN side_NN effect_NN","The JJ NN VBZ RB JJ , although , like all NNS , it can VB NN NNS . It VBZ RB JJ to VB a JJ NN from the NN , as the NN VBZ RB VB any JJ NN . NN NNS of the JJ NN in NNS JJ NN NNS of the JJ NN NN ( NNP ) , which VBZ the NN of the JJ NN VBN to NNS under the NN of 2 , VBP : • NN and NN at the NN of the NN • VBG JJ or RB VBG RB JJ NN NNS of the NN NN VBP JJ , and VBP : • JJ NNS , JJ as an JJ NN NN NN NNS of the JJ NN in NNS and JJR NNS JJ NN NNS of the JJ NN NN ( NN ) , the NN of the JJ NN VBN to NNS and NNS over the NN of 2 , VBP : • JJ NN or NN at the NN of the NN VBG 1 to 3 NNS RBR JJ NN NNS of the NN NN , JJ as JJ NNS , VBP JJ . What to VB if your NN VBZ JJ after JJ NN RBS JJ NN NNS in NNS and JJ NNS , JJ as NN or NN at the NN NN , RB VBP RB within a NN of NNS and you VBP RB VB to VB NN about them . If your NN VBZ a NN , VB them JJ . VB JJ they VBP RB VB RB JJ NNS of NNS or NNS , and VB them JJ NNS . You can RB VB them a NN of NN NN or NN NN VBG to the NNS on the NN . VB an NNP NN about the JJ NN NNS of NN that may VB in NNS and NNS ( NN , 118 NN ) under the NN of 5 , and how to VB them . RB RB , a NN or NN may VB a JJ JJ NN after either NN of JJ NN . VBN as an JJ NN , this can VB NN - VBG NN NNS . NN VBZ a JJ , JJ NN NN that can VB within NNS of the NN . It VBZ RB JJ at the NN , but it can VB VBN with NN . The NN or NN VBG the NN will VB VBN VBN to VB how to VB JJ NNS . VB your NN if you VBP any JJ NNS in your NN or yourself after VBG VBN . VB out JJR about NN NN and NN NNS The NNP NNP NNP VBZ you to VB VBN NN NNS from any NN of NN you VBP VBG or NNS you VBP VBN . It VBZ VBN by a NNS NN NN VBN the NNPS and NNP NNPS NNP NNP ( NNP ) . VB the NNP NNP NNP NN for JJR NN . VB out how to VB a NN NN NN"
237,384,mainstream,"•_NFP One_CD in_IN five_CD Americans_NNPS surveyed_VBN in_IN a_DT new_JJ AP_NNP -_HYPH NORC_NNP poll_NN said_VBD they_PRP 'd_MD refuse_VB a_DT coronavirus_NN vaccine_NN ,_, and_CC only_RB about_RB half_NN said_VBD they_PRP would_MD get_VB such_PDT a_DT vaccination_NN ,_, which_WDT scientists_NNS around_IN the_DT world_NN are_VBP racing_VBG to_TO create_VB ._. •_NFP The_DT results_NNS were_VBD published_VBN Wednesday_NNP ,_, the_DT same_JJ day_NN when_WRB the_DT US_NNP reached_VBD a_DT grim_JJ milestone_NN of_IN 100,000_CD deaths_NNS from_IN the_DT novel_JJ coronavirus_NN ._. •_NFP ""_`` There_EX 's_VBZ still_RB a_DT large_JJ amount_NN of_IN uncertainty_NN around_IN taking_VBG the_DT vaccine_NN ,_, ""_'' Caitlin_NNP Oppenheimer_NNP ,_, the_DT senior_JJ vice_NN president_NN of_IN Public_NNP Health_NNP at_IN NORC_NNP ,_, told_VBD the_DT Associated_NNP Press_NNP ._. ""_`` There_EX is_VBZ a_DT lot_NN of_IN opportunity_NN to_TO communicate_VB with_IN Americans_NNPS about_IN the_DT value_NN and_CC the_DT safety_NN of_IN a_DT vaccine_NN ._. ""_'' •_NFP About_RB seven_CD in_IN 10_CD of_IN those_DT who_WP said_VBD they_PRP would_MD get_VB a_DT coronavirus_NN vaccine_NN said_VBD they_PRP believed_VBD life_NN would_MD not_RB return_VB to_IN normal_JJ without_IN one_CD ._. A_DT new_JJ poll_NN published_VBN Wednesday_NNP found_VBD that_IN about_RB one_CD in_IN five_CD Americans_NNPS said_VBD they_PRP 'd_MD refuse_VB a_DT COVID_NN -_HYPH 19_CD vaccine_NN should_MD one_CD become_VB available_JJ ._. Only_RB about_RB half_NN of_IN respondents_NNS to_IN the_DT poll_NN ,_, conducted_VBN by_IN The_DT Associated_NNP Press_NNP -_HYPH NORC_NNP Center_NNP for_IN Public_NNP Affairs_NNPS Research_NNP ,_, said_VBD they_PRP would_MD get_VB such_PDT a_DT vaccine_NN ,_, while_IN 31_CD %_NN said_VBD they_PRP were_VBD not_RB yet_RB sure_JJ whether_IN they_PRP would_MD get_VB one_CD ._. The_DT poll_NN surveyed_VBD 1,056_CD adults_NNS and_CC was_VBD conducted_VBN May_NNP 14_CD -_SYM 18_CD ._. The_DT results_NNS were_VBD released_VBN on_IN the_DT same_JJ day_NN when_WRB the_DT US_NNP reached_VBD a_DT grim_JJ milestone_NN of_IN 100,000_CD deaths_NNS from_IN the_DT novel_JJ coronavirus_NN ,_, which_WDT causes_VBZ the_DT illness_NN known_VBN as_IN COVID_NNP -_HYPH 19_CD ._. ""_`` There_EX 's_VBZ still_RB a_DT large_JJ amount_NN of_IN uncertainty_NN around_IN taking_VBG the_DT vaccine_NN ,_, ""_'' Caitlin_NNP Oppenheimer_NNP ,_, the_DT senior_JJ vice_NN president_NN of_IN Public_NNP Health_NNP at_IN NORC_NNP ,_, told_VBD the_DT AP_NNP ._. ""_`` There_EX is_VBZ a_DT lot_NN of_IN opportunity_NN to_TO communicate_VB with_IN Americans_NNPS about_IN the_DT value_NN and_CC the_DT safety_NN of_IN a_DT vaccine_NN ._. ""_'' Experts_NNS have_VBP touted_VBN a_DT COVID_NN -_HYPH 19_CD vaccine_NN as_IN the_DT solution_NN to_IN allowing_VBG the_DT world_NN to_TO return_VB to_IN something_NN resembling_VBG normality_NN ._. The_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP describes_VBZ vaccinations_NNS as_IN ""_`` one_CD of_IN the_DT best_JJS ways_NNS to_TO put_VB an_DT end_NN to_IN the_DT serious_JJ effects_NNS of_IN certain_JJ diseases_NNS ._. ""_'' Respondents_NNS '_POS uncertainty_NN in_IN this_DT case_NN ,_, however_RB ,_, could_MD have_VB to_TO do_VB with_IN the_DT unprecedented_JJ circumstances_NNS surrounding_VBG COVID_NNP -_HYPH 19_CD ,_, which_WDT has_VBZ prompted_VBN a_DT worldwide_JJ race_NN to_TO condense_VB a_DT development_NN process_NN that_WDT normally_RB takes_VBZ several_JJ years_NNS into_IN what_WP scientists_NNS hope_VBP could_MD be_VB 12_CD to_IN 18_CD months_NNS ._. Melanie_NNP Dries_NNP ,_, 56_CD ,_, from_IN Colorado_NNP ,_, told_VBD the_DT AP_NNP she_PRP was_VBD not_RB an_DT anti-vaxxer_NN but_CC was_VBD concerned_JJ about_IN getting_VBG a_DT COVID_NN -_HYPH 19_CD vaccine_NN in_IN the_DT near_JJ feature_NN ,_, saying_VBG it_PRP ""_`` causes_VBZ me_PRP to_TO fear_VB that_IN it_PRP wo_MD n't_RB be_VB widely_RB tested_VBN as_IN to_IN side_NN effects_NNS ._. ""_'' Dr._NNP Francis_NNP Collins_NNP ,_, the_DT director_NN of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, told_VBD the_DT AP_NNP in_IN a_DT previous_JJ interview_NN that_IN he_PRP ""_`` would_MD not_RB want_VB people_NNS to_TO think_VB that_IN we_PRP 're_VBP cutting_VBG corners_NNS because_IN that_DT would_MD be_VB a_DT big_JJ mistake_NN ._. ""_'' ""_`` I_PRP think_VBP this_DT is_VBZ an_DT effort_NN to_TO try_VB to_TO achieve_VB efficiencies_NNS ,_, but_CC not_RB to_TO sacrifice_VB rigor_NN ,_, ""_'' he_PRP said_VBD ,_, adding_VBG that_IN ""_`` definitely_RB the_DT worst_JJS thing_NN that_WDT could_MD happen_VB is_VBZ if_IN we_PRP rush_VBP through_IN a_DT vaccine_NN that_WDT turns_VBZ out_RP to_TO have_VB significant_JJ side_NN effects_NNS ._. ""_'' The_DT Trump_NNP administration_NN announced_VBD a_DT vaccine_NN -_HYPH distribution_NN program_NN ,_, dubbed_VBN Operation_NNP Warp_NNP Speed_NNP ,_, meant_VBD to_TO have_VB 300_CD million_CD doses_NNS in_IN stock_NN by_IN January_NNP ._. The_DT Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS also_RB promised_VBD earlier_RBR this_DT week_NN to_TO provide_VB ""_`` up_IN to_IN $_$ 1.2_CD billion_CD ""_'' in_IN funds_NNS to_IN a_DT laboratory_NN at_IN Oxford_NNP University_NNP working_VBG to_TO develop_VB a_DT vaccine_NN ,_, The_DT New_NNP York_NNP Times_NNP reported_VBD ._. ""_`` It_PRP 's_VBZ always_RB better_JJR to_TO underpromise_VB and_CC overdeliver_VB ,_, ""_'' Dr._NNP William_NNP Schaffner_NNP ,_, an_DT infectious_JJ -_HYPH disease_NN expert_NN at_IN Vanderbilt_NNP University_NNP Medical_NNP Center_NNP ,_, told_VBD the_DT AP_NNP ._. ""_`` The_DT unexpected_JJ looms_VBZ large_JJ ,_, and_CC that_DT 's_VBZ why_WRB I_PRP think_VBP for_IN any_DT of_IN these_DT vaccines_NNS ,_, we_PRP 're_VBP going_VBG to_TO need_VB a_DT large_JJ safety_NN database_NN to_TO provide_VB the_DT reassurance_NN ._. ""_'' The_DT AP_NNP -_HYPH NORC_NNP poll_NN found_VBD that_IN 20_CD %_NN of_IN Americans_NNPS believed_VBD a_DT coronavirus_NN vaccine_NN would_MD be_VB available_JJ to_IN the_DT public_NN this_DT year_NN ,_, with_IN a_DT majority_NN saying_VBG it_PRP was_VBD more_RBR likely_JJ that_IN a_DT vaccine_NN would_MD be_VB available_JJ next_JJ year_NN ._. About_RB seven_CD in_IN 10_CD of_IN those_DT who_WP said_VBD they_PRP would_MD get_VB the_DT coronavirus_NN vaccine_NN said_VBD they_PRP believed_VBD life_NN would_MD not_RB return_VB to_IN normal_JJ without_IN one_CD ,_, with_IN other_JJ top_JJ reasons_NNS for_IN getting_VBG vaccinated_VBN including_VBG protecting_VBG themselves_PRP ,_, their_PRP$ families_NNS ,_, and_CC the_DT community_NN ._. ""_`` I_PRP 'm_VBP definitely_RB going_VBG to_TO get_VB it_PRP ,_, ""_'' Brandon_NNP Grimes_NNP ,_, 35_CD ,_, from_IN Austin_NNP ,_, Texas_NNP ,_, told_VBD the_DT AP_NNP ._. ""_`` As_IN a_DT father_NN who_WP takes_VBZ care_NN of_IN his_PRP$ family_NN ,_, I_PRP think_VBP ..._, it_PRP 's_VBZ important_JJ for_IN me_PRP to_TO get_VB vaccinated_VBN as_RB soon_RB as_IN it's_PRP available_JJ to_TO better_RBR protect_VB my_PRP$ family_NN ._. ""_''","• One in five NNPS VBN in a JJ NNP - NNP NN VBD they 'd VB a NN NN , and RB RB NN VBD they would VB such a NN , which NNS around the NN VBP VBG to VB . • The NNS VBD VBN NNP , the JJ NN when the NNP VBD a JJ NN of 100,000 NNS from the JJ NN . • "" There VBZ RB a JJ NN of NN around VBG the NN , "" NNP NNP , the JJ NN NN of NNP NNP at NNP , VBD the NNP NNP . "" There VBZ a NN of NN to VB with NNPS about the NN and the NN of a NN . "" • RB seven in 10 of those who VBD they would VB a NN NN VBD they VBD NN would RB VB to JJ without one . A JJ NN VBN NNP VBD that RB one in five NNPS VBD they 'd VB a NN - 19 NN should one VB JJ . RB RB NN of NNS to the NN , VBN by The NNP NNP - NNP NNP for NNP NNPS NNP , VBD they would VB such a NN , while 31 NN VBD they VBD RB RB JJ whether they would VB one . The NN VBD 1,056 NNS and VBD VBN NNP 14 - 18 . The NNS VBD VBN on the JJ NN when the NNP VBD a JJ NN of 100,000 NNS from the JJ NN , which VBZ the NN VBN as NNP - 19 . "" There VBZ RB a JJ NN of NN around VBG the NN , "" NNP NNP , the JJ NN NN of NNP NNP at NNP , VBD the NNP . "" There VBZ a NN of NN to VB with NNPS about the NN and the NN of a NN . "" NNS VBP VBN a NN - 19 NN as the NN to VBG the NN to VB to NN VBG NN . The NNPS for NNP NNP and NNP VBZ NNS as "" one of the JJS NNS to VB an NN to the JJ NNS of JJ NNS . "" NNS ' NN in this NN , RB , could VB to VB with the JJ NNS VBG NNP - 19 , which VBZ VBN a JJ NN to VB a NN NN that RB VBZ JJ NNS into what NNS VBP could VB 12 to 18 NNS . NNP NNP , 56 , from NNP , VBD the NNP she VBD RB an NN but VBD JJ about VBG a NN - 19 NN in the JJ NN , VBG it "" VBZ me to VB that it wo RB VB RB VBN as to NN NNS . "" NNP NNP NNP , the NN of the NNP NNPS of NNP , VBD the NNP in a JJ NN that he "" would RB VB NNS to VB that we VBP VBG NNS because that would VB a JJ NN . "" "" I VBP this VBZ an NN to VB to VB NNS , but RB to VB NN , "" he VBD , VBG that "" RB the JJS NN that could VB VBZ if we VBP through a NN that VBZ out to VB JJ NN NNS . "" The NNP NN VBD a NN - NN NN , VBN NNP NNP NNP , VBD to VB 300 million NNS in NN by NNP . The NNP of NNP and NNP NNPS RB VBD RBR this NN to VB "" up to $ 1.2 billion "" in NNS to a NN at NNP NNP VBG to VB a NN , The NNP NNP NNP VBD . "" It VBZ RB JJR to VB and VB , "" NNP NNP NNP , an JJ - NN NN at NNP NNP NNP NNP , VBD the NNP . "" The JJ VBZ JJ , and that VBZ why I VBP for any of these NNS , we VBP VBG to VB a JJ NN NN to VB the NN . "" The NNP - NNP NN VBD that 20 NN of NNPS VBD a NN NN would VB JJ to the NN this NN , with a NN VBG it VBD RBR JJ that a NN would VB JJ JJ NN . RB seven in 10 of those who VBD they would VB the NN NN VBD they VBD NN would RB VB to JJ without one , with JJ JJ NNS for VBG VBN VBG VBG themselves , their NNS , and the NN . "" I VBP RB VBG to VB it , "" NNP NNP , 35 , from NNP , NNP , VBD the NNP . "" As a NN who VBZ NN of his NN , I VBP ... it VBZ JJ for me to VB VBN RB RB as it's JJ to RBR VB my NN . """
238,978,mainstream,"Get_VB all_PDT the_DT latest_JJS news_NN on_IN coronavirus_NN and_CC more_RBR delivered_VBN daily_RB to_IN your_PRP$ inbox_NN ._. Sign_VB up_RP here_RB ._. American_JJ universities_NNS ,_, pharmaceutical_JJ and_CC other_JJ healthcare_NN firms_NNS are_VBP being_VBG targeted_VBN by_IN Chinese_JJ and_CC Iranian_JJ hackers_NNS in_IN the_DT midst_NN of_IN the_DT coronavirus_NN crisis_NN ,_, according_VBG to_IN reports_NNS ._. The_DT aggressiveness_NN of_IN the_DT cyberattacks_NNS is_VBZ such_JJ that_IN some_DT U.S._NNP officials_NNS view_VBP them_PRP as_IN tantamount_JJ to_IN war_NN ,_, according_VBG to_IN the_DT Wall_NNP Street_NNP Journal_NNP ,_, because_IN they_PRP may_MD have_VB hurt_VBN research_NN into_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN ._. The_DT FBI_NNP and_CC the_DT Cybersecurity_NNP and_CC Infrastructure_NNP Security_NNP Agency_NNP ,_, the_DT cyber_NN branch_NN of_IN the_DT Department_NNP of_IN Homeland_NNP Security_NNP ,_, are_VBP expected_VBN to_TO issue_VB a_DT “_`` public_JJ service_NN announcement_NN ”_'' regarding_VBG China_NNP today_NN ,_, the_DT Journal_NNP reports_VBZ ._. Iran_NNP ,_, meanwhile_RB ,_, is_VBZ suspected_VBN of_IN targeting_VBG some_DT of_IN the_DT same_JJ facilities_NNS ,_, the_DT report_NN claims_VBZ ._. Hackers_NNS linked_VBN to_IN Iran_NNP reportedly_RB targeted_VBD staff_NN at_IN U.S._NNP drugmaker_NN Gilead_NNP Sciences_NNPS recently_RB ,_, according_VBG to_IN Reuters_NNP ._. “_`` It_PRP is_VBZ difficult_JJ ,_, and_CC sometimes_RB impossible_JJ ,_, to_TO know_VB what_WP motivates_VBZ such_JJ malfeasance_NN ,_, but_CC any_DT such_JJ activity_NN carries_VBZ with_IN it_PRP the_DT risk_NN of_IN triggering_VBG accidental_JJ ,_, disruptive_JJ effects_NNS ,_, ”_'' one_CD senior_JJ administration_NN official_NN said_VBD ._. A_DT draft_NN of_IN the_DT public_JJ warning_NN will_MD accuse_VB China_NNP of_IN seeking_VBG “_`` valuable_JJ intellectual_JJ property_NN and_CC public_JJ health_NN data_NNS through_IN illicit_JJ means_NNS related_JJ to_IN vaccines_NNS ,_, treatments_NNS and_CC testing_NN ,_, ”_'' according_VBG to_IN the_DT New_NNP York_NNP Times_NNP ._. “_`` China_NNP ’s_POS long_JJ history_NN of_IN bad_JJ behavior_NN in_IN cyberspace_NN is_VBZ well_RB documented_VBN ,_, so_RB it_PRP should_MD n’t_RB surprise_VB anyone_NN they_PRP are_VBP going_VBG after_IN the_DT critical_JJ organizations_NNS involved_VBN in_IN the_DT nation_NN ’s_POS response_NN to_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ,_, ”_'' Christopher_NNP Krebs_NNP ,_, the_DT director_NN of_IN the_DT Cybersecurity_NNP and_CC Infrastructure_NNP Security_NNP Agency_NNP ,_, told_VBD the_DT Times_NNP ._. China_NNP and_CC the_DT U.S._NNP have_VBP been_VBN embroiled_VBN in_IN a_DT furious_JJ war_NN of_IN words_NNS since_IN the_DT coronavirus_NN outbreak_NN began_VBD ,_, blaming_VBG one_CD another_DT for_IN mishandling_VBG the_DT pandemic_NN ._. CHINA_NNP ACCUSED_VBN OF_IN EFFORTS_NNS TO_TO 'INFILTRATE_VB '_'' US_NNP COLLEGES_NNS AS_IN GOP_NNP LAUNCHES_VBZ PROBE_NN Earlier_RBR this_DT week_NN ,_, China_NNP issued_VBD a_DT 30_CD -_HYPH page_NN rebuttal_NN of_IN what_WP it_PRP claims_VBZ are_VBP the_DT top_JJ 24_CD lies_NNS told_VBN by_IN U.S._NNP politicians_NNS over_IN Beijing_NNP ’s_POS handling_NN of_IN coronavirus_NN ,_, including_VBG where_WRB it_PRP originated_VBD and_CC allegations_NNS the_DT government_NN tried_VBD to_TO silence_VB whistleblowers_NNS and_CC cover_VB up_RP vital_JJ data_NNS ._. CLICK_VB HERE_RB FOR_IN THE_DT FOX_NNP NEWS_NN APP_NN And_CC earlier_RBR this_DT month_NN ,_, top_JJ Republicans_NNPS from_IN a_DT slew_NN of_IN House_NNP committees_NNS demanded_VBD information_NN about_IN what_WP they_PRP said_VBD is_VBZ the_DT Chinese_NNP Communist_NNP Party_NNP 's_POS ""_`` investment_NN in_IN American_JJ colleges_NNS and_CC universities_NNS to_TO further_VB its_PRP$ strategic_JJ and_CC propaganda_NN goals_NNS ""_'' --_, an_DT initiative_NN they_PRP claimed_VBD could_MD be_VB ""_`` foreign_JJ academic_JJ espionage_NN ._. ""_''","VB all the JJS NN on NN and RBR VBN RB to your NN . VB up RB . JJ NNS , JJ and JJ NN NNS VBP VBG VBN by JJ and JJ NNS in the NN of the NN NN , VBG to NNS . The NN of the NNS VBZ JJ that some NNP NNS VBP them as JJ to NN , VBG to the NNP NNP NNP , because they may VB VBN NN into a NN - 19 NN . The NNP and the NNP and NNP NNP NNP , the NN NN of the NNP of NNP NNP , VBP VBN to VB a “ JJ NN NN ” VBG NNP NN , the NNP VBZ . NNP , RB , VBZ VBN of VBG some of the JJ NNS , the NN VBZ . NNS VBN to NNP RB VBD NN at NNP NN NNP NNPS RB , VBG to NNP . “ It VBZ JJ , and RB JJ , to VB what VBZ JJ NN , but any JJ NN VBZ with it the NN of VBG JJ , JJ NNS , ” one JJ NN NN VBD . A NN of the JJ NN will VB NNP of VBG “ JJ JJ NN and JJ NN NNS through JJ NNS JJ to NNS , NNS and NN , ” VBG to the NNP NNP NNP . “ NNP ’s JJ NN of JJ NN in NN VBZ RB VBN , RB it should RB VB NN they VBP VBG after the JJ NNS VBN in the NN ’s NN to the NN - 19 NN , ” NNP NNP , the NN of the NNP and NNP NNP NNP , VBD the NNP . NNP and the NNP VBP VBN VBN in a JJ NN of NNS since the NN NN VBD , VBG one another for VBG the NN . NNP VBN OF NNS TO VB ' NNP NNS AS NNP VBZ NN RBR this NN , NNP VBD a 30 - NN NN of what it VBZ VBP the JJ 24 NNS VBN by NNP NNS over NNP ’s NN of NN , VBG where it VBD and NNS the NN VBD to VB NNS and VB up JJ NNS . VB RB FOR THE NNP NN NN And RBR this NN , JJ NNPS from a NN of NNP NNS VBD NN about what they VBD VBZ the NNP NNP NNP 's "" NN in JJ NNS and NNS to VB its JJ and NN NNS "" -- an NN they VBD could VB "" JJ JJ NN . """
239,611,mainstream,"Scientists_NNS at_IN Oxford_NNP University_NNP have_VBP begun_VBN clinical_JJ trials_NNS of_IN a_DT coronavirus_NN vaccine_NN that_WDT has_VBZ shown_VBN promise_NN in_IN rhesus_NN monkeys_NNS ,_, according_VBG to_IN news_NN reports_NNS ._. If_IN the_DT vaccine_NN can_MD effectively_RB protect_VB humans_NNS against_IN the_DT novel_JJ coronavirus_NN ,_, known_VBN as_IN SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ,_, the_DT first_JJ doses_NNS could_MD potentially_RB be_VB administered_VBN by_IN the_DT autumn_NN ,_, according_VBG to_IN a_DT on_IN the_DT official_JJ trial_NN 's_POS web_NN page_NN ._. The_DT vaccine_NN is_VBZ made_VBN up_RP of_IN a_DT weakened_VBN version_NN of_IN a_DT common_JJ cold_JJ virus_NN called_VBN an_DT adenovirus_NN that_WDT causes_VBZ infections_NNS in_IN chimpanzees_NNS ._. But_CC the_DT virus_NN has_VBZ been_VBN genetically_RB altered_VBN to_TO make_VB it_PRP ""_`` impossible_JJ ""_'' for_IN the_DT virus_NN to_TO grow_VB in_IN humans_NNS ,_, ._. Then_RB ,_, they_PRP combined_VBD the_DT weakened_VBN adenovirus_NN with_IN genes_NNS that_WDT code_VBP for_IN the_DT coronavirus_NN ""_`` spike_NN ""_'' protein_NN that_WDT SARS_NN -_HYPH CoV_NNP -_HYPH 2_CD uses_VBZ to_TO infect_VB human_JJ cells_NNS ._. In_IN theory_NN ,_, the_DT vaccine_NN will_MD train_VB the_DT body_NN to_TO recognize_VB and_CC develop_VB an_DT immune_JJ response_NN to_IN the_DT spike_NN protein_NN ,_, thereby_RB preventing_VBG SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD virus_NN from_IN entering_VBG human_JJ cells_NNS ,_, according_VBG to_IN the_DT statement_NN ._. Similar_JJ vaccines_NNS —_: made_VBN from_IN the_DT same_JJ backbone_NN ,_, the_DT weakened_VBN version_NN of_IN the_DT chimpanzee_NN adenovirus_NN —_: have_VBP been_VBN given_VBN to_IN more_JJR than_IN 320_CD people_NNS to_IN date_NN and_CC have_VBP been_VBN shown_VBN to_TO ""_`` be_VB safe_JJ and_CC well_RB tolerated_VBN ,_, ""_'' aside_RB from_IN temporary_JJ side_NN effects_NNS such_JJ as_IN fever_NN ,_, headache_NN and_CC a_DT sore_JJ arm_NN ,_, according_VBG to_IN the_DT statement_NN ._. The_DT trials_NNS began_VBD on_IN April_NNP 23_CD ,_, and_CC up_IN to_IN 1,102_CD healthy_JJ participants_NNS will_MD eventually_RB be_VB recruited_VBN in_IN Oxford_NNP ,_, Southampton_NNP ,_, London_NNP and_CC Bristol_NNP to_TO take_VB part_NN ._. Half_NN of_IN the_DT participants_NNS will_MD receive_VB the_DT novel_JJ vaccine_NN ;_, most_JJS of_IN those_DT people_NNS will_MD receive_VB one_CD dose_NN of_IN the_DT vaccine_NN ,_, but_CC 10_CD of_IN those_DT people_NNS will_MD receive_VB a_DT second_JJ dose_NN a_DT month_NN later_RBR ._. The_DT other_JJ half_NN of_IN the_DT participants_NNS will_MD receive_VB a_DT ""_`` control_NN ""_'' vaccine_NN —_: already_RB approved_VBN and_CC given_VBN routinely_RB to_IN teenagers_NNS since_IN 2015_CD —_: which_WDT protects_VBZ against_IN meningitis_NN and_CC sepsis_NN ._. The_DT reason_NN the_DT researchers_NNS decided_VBD to_TO use_VB this_DT control_NN vaccine_NN and_CC not_RB just_RB a_DT saltwater_NN solution_NN is_VBZ so_IN that_IN participants_NNS wo_MD n't_RB be_VB able_JJ to_TO guess_VB whether_IN they_PRP received_VBD the_DT actual_JJ vaccine_NN ._. The_DT researchers_NNS expect_VBP the_DT novel_JJ coronavirus_NN vaccine_NN to_TO cause_VB temporary_JJ side_NN effects_NNS such_JJ as_IN sore_JJ arm_NN ,_, headache_NN and_CC fever_NN ,_, side_NN effects_NNS that_WDT are_VBP also_RB expected_VBN from_IN the_DT control_NN vaccine_NN but_CC that_DT would_MD n't_RB be_VB expected_VBN from_IN a_DT saltwater_NN solution_NN ._. The_DT trial_NN will_MD last_VB up_IN to_IN six_CD months_NNS ,_, with_IN an_DT optional_JJ visit_NN one_CD year_NN after_IN vaccination_NN ._. ""_`` The_DT best_JJS -_HYPH case_NN scenario_NN is_VBZ that_IN by_IN the_DT autumn_NN of_IN 2020_CD ,_, we_PRP could_MD have_VB an_DT efficacy_NN result_NN from_IN the_DT phase_NN III_CD trial_NN to_TO show_VB that_IN the_DT vaccine_NN protects_VBZ against_IN the_DT virus_NN ,_, alongside_IN the_DT ability_NN to_TO manufacture_VB large_JJ amounts_NNS of_IN the_DT vaccine_NN ;_, but_CC these_DT best_JJS -_HYPH case_NN time_NN frames_NNS are_VBP highly_RB ambitious_JJ and_CC subject_JJ to_IN change_NN ,_, ""_'' the_DT researchers_NNS wrote_VBD in_IN the_DT blog_NN post_NN ._. Of_IN course_NN ,_, it_PRP 's_VBZ too_RB early_JJ to_TO tell_VB whether_IN or_CC not_RB the_DT vaccine_NN will_MD work_VB ,_, but_CC it_PRP has_VBZ shown_VBN promise_NN in_IN rhesus_NN monkeys_NNS ,_, according_VBG to_IN ._. Researchers_NNS gave_VBD the_DT vaccine_NN to_IN six_CD rhesus_NN macaque_NN monkeys_NNS at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP 's_POS Rocky_NNP Mountain_NNP Laboratory_NNP in_IN Montana_NNP ._. Researchers_NNS then_RB exposed_VBD them_PRP to_IN high_JJ amounts_NNS of_IN the_DT coronavirus_NN ,_, according_VBG to_IN the_DT Times_NNP ._. More_JJR than_IN 28_CD days_NNS later_RBR ,_, all_DT six_CD monkeys_NNS were_VBD healthy_JJ ._. Another_DT vaccine_NN ,_, this_DT one_NN made_VBN from_IN an_DT inactivated_VBN form_NN of_IN the_DT coronavirus_NN ,_, has_VBZ also_RB shown_VBN promise_NN in_IN monkeys_NNS in_IN China_NNP ,_, according_VBG to_IN a_DT ._. Researchers_NNS in_IN China_NNP are_VBP now_RB testing_VBG that_DT vaccine_NN on_IN humans_NNS in_IN clinical_JJ trials_NNS ._. More_JJR than_IN 70_CD other_JJ vaccines_NNS are_VBP under_IN development_NN worldwide_RB ,_, according_VBG to_IN the_DT World_NNP Health_NNP Organization_NNP ._. •_SYM None_NN 11_CD (_-LRB- sometimes_RB )_-RRB- deadly_JJ diseases_NNS that_WDT hopped_VBD across_IN species_NNS","NNS at NNP NNP VBP VBN JJ NNS of a NN NN that VBZ VBN NN in NN NNS , VBG to NN NNS . If the NN can RB VB NNS against the JJ NN , VBN as NNP - NNP - 2 , the JJ NNS could RB VB VBN by the NN , VBG to a on the JJ NN 's NN NN . The NN VBZ VBN up of a VBN NN of a JJ JJ NN VBN an NN that VBZ NNS in NNS . But the NN VBZ VBN RB VBN to VB it "" JJ "" for the NN to VB in NNS , . RB , they VBD the VBN NN with NNS that VBP for the NN "" NN "" NN that NN - NNP - 2 VBZ to VB JJ NNS . In NN , the NN will VB the NN to VB and VB an JJ NN to the NN NN , RB VBG NNP - NNP - 2 NN from VBG JJ NNS , VBG to the NN . JJ NNS — VBN from the JJ NN , the VBN NN of the NN NN — VBP VBN VBN to JJR than 320 NNS to NN and VBP VBN VBN to "" VB JJ and RB VBN , "" RB from JJ NN NNS JJ as NN , NN and a JJ NN , VBG to the NN . The NNS VBD on NNP 23 , and up to 1,102 JJ NNS will RB VB VBN in NNP , NNP , NNP and NNP to VB NN . NN of the NNS will VB the JJ NN ; JJS of those NNS will VB one NN of the NN , but 10 of those NNS will VB a JJ NN a NN RBR . The JJ NN of the NNS will VB a "" NN "" NN — RB VBN and VBN RB to NNS since 2015 — which VBZ against NN and NN . The NN the NNS VBD to VB this NN NN and RB RB a NN NN VBZ so that NNS wo RB VB JJ to VB whether they VBD the JJ NN . The NNS VBP the JJ NN NN to VB JJ NN NNS JJ as JJ NN , NN and NN , NN NNS that VBP RB VBN from the NN NN but that would RB VB VBN from a NN NN . The NN will VB up to six NNS , with an JJ NN one NN after NN . "" The JJS - NN NN VBZ that by the NN of 2020 , we could VB an NN NN from the NN III NN to VB that the NN VBZ against the NN , alongside the NN to VB JJ NNS of the NN ; but these JJS - NN NN NNS VBP RB JJ and JJ to NN , "" the NNS VBD in the NN NN . Of NN , it VBZ RB JJ to VB whether or RB the NN will VB , but it VBZ VBN NN in NN NNS , VBG to . NNS VBD the NN to six NN NN NNS at the NNP NNPS of NNP 's NNP NNP NNP in NNP . NNS RB VBD them to JJ NNS of the NN , VBG to the NNP . JJR than 28 NNS RBR , all six NNS VBD JJ . Another NN , this NN VBN from an VBN NN of the NN , VBZ RB VBN NN in NNS in NNP , VBG to a . NNS in NNP VBP RB VBG that NN on NNS in JJ NNS . JJR than 70 JJ NNS VBP under NN RB , VBG to the NNP NNP NNP . • NN 11 ( RB ) JJ NNS that VBD across NNS"
240,967,conspiracy,"China_NNP '_POS stock_NN investors_NNS and_CC forecasters_NNS have_VBP seen_VBN a_DT dismal_JJ year_NN plagued_VBN with_IN unwelcoming_JJ downward_JJ curves_NNS amid_IN the_DT continuing_VBG trade_NN war_NN with_IN the_DT United_NNP States_NNPS ._. The_DT benchmark_NN Shanghai_NNP Composite_NNP Index_NN fell_VBD below_IN 25_CD percent_NN compared_VBN to_IN where_WRB it_PRP started_VBD this_DT year_NN and_CC is_VBZ now_RB the_DT poorest_JJS -_HYPH performing_VBG major_JJ stock_NN market_NN in_IN the_DT world_NN ._. Then_RB there_EX is_VBZ the_DT trade_NN war_NN with_IN the_DT United_NNP States_NNPS which_WDT wiped_VBD out_RP a_DT massive_JJ $_$ 2.4_CD trillion_CD this_DT year_NN alone_RB ,_, while_IN a_DT deleveraging_NN drive_NN has_VBZ pinched_VBN margin_NN debt_NN to_IN just_RB a_DT third_NN of_IN its_PRP$ height_NN in_IN 2015_CD ._. As_IN foreign_JJ investors_NNS continue_VBP to_TO inject_VB money_NN into_IN onshore_JJ equities_NNS via_IN the_DT stock_NN connects_NNS and_CC state_NN funds_NNS in_IN an_DT attempt_NN to_TO rescue_VB shares_NNS ,_, the_DT still_RB did_VBD n't_RB halt_VB declines_NNS ._. Even_RB safer_JJR havens_NNS were_VBD losing_VBG ground_NN as_IN the_DT weak_JJ Chinese_JJ economy_NN hurt_VBD spending_NN and_CC weighed_VBD on_IN consumer_NN stocks_NNS ._. Meanwhile_RB ,_, a_DT vaccine_NN scandal_NN and_CC gene_NN -_HYPH editing_NN controversy_NN prompted_VBD a_DT massive_JJ sell_NN -_HYPH off_RP in_IN the_DT health_NN -_HYPH care_NN sector_NN ._. Here_RB are_VBP six_CD charts_NNS to_TO sum_VB up_RP the_DT year_NN according_VBG to_IN Bloomberg_NNP :_: Stock_NN declines_NNS have_VBP shaved_VBN $_$ 2.4_CD trillion_CD off_IN China_NNP ’s_POS market_NN value_NN this_DT year_NN as_IN of_IN Thursday_NNP ,_, the_DT biggest_JJS on_IN record_NN since_IN Bloomberg_NNP started_VBD compiling_VBG the_DT data_NNS in_IN 2002_CD ._. The_DT closest_JJS loss_NN was_VBD during_IN the_DT global_JJ financial_JJ crisis_NN ten_CD years_NNS ago_RB ,_, when_WRB the_DT Shanghai_NNP gauge_NN plunged_VBD 65_CD percent_NN ._. China_NNP also_RB ceded_VBD its_PRP$ place_NN as_IN the_DT world_NN ’s_POS second_RB -_HYPH biggest_JJS stock_NN market_NN to_IN Japan_NNP earlier_RBR this_DT year_NN ._. China_NNP 's_POS stock_NN market_NN saw_VBD the_DT most_RBS significant_JJ value_NN wipeout_NN since_IN at_IN least_JJS 2002_CD Investors_NNS have_VBP n’t_RB been_VBN this_DT disengaged_VBN with_IN stock_NN trading_NN in_IN years_NNS ._. Average_JJ daily_JJ turnover_NN on_IN both_CC the_DT Shanghai_NNP and_CC Shenzhen_NNP exchanges_NNS fell_VBD to_IN about_RB 368_CD billion_CD yuan_NNS (_-LRB- $_$ 53.7_CD billion_CD )_-RRB- this_DT year_NN ,_, the_DT lowest_JJS since_IN 2014_CD ,_, data_NN compiled_VBN by_IN Bloomberg_NNP show_NN ._. [_-LRB- RELATED_JJ ]_-RRB- Chinese_JJ Billionaire_NNP :_: America_NNP Will_MD ‘_`` Suffer_VB More_JJR ’_'' Than_IN China_NNP In_IN Trade_NN War_NN Just_RB 239.1_CD billion_CD yuan_NNS of_IN shares_NNS traded_VBN on_IN Friday_NNP ,_, about_RB 1/10_CD of_IN its_PRP$ peak_NN in_IN 2015_CD ._. None_NN of_IN the_DT sectors_NNS were_VBD safe_JJ enough_RB to_TO shield_VB investors_NNS from_IN losses_NNS ._. All_DT ten_CD industry_NN groups_NNS on_IN the_DT CSI_NNP 300_CD index_NN fell_VBD on_IN the_DT year_NN ,_, the_DT broadest_JJS decline_NN since_IN 2011_CD ,_, according_VBG to_IN data_NNS compiled_VBN by_IN Bloomberg_NNP ._. That_DT ’s_VBZ a_DT stark_JJ reversal_NN from_IN last_JJ year_NN when_WRB all_DT sector_NN gauges_NNS rose_VBD ._. All_DT ten_CD industry_NN groups_NNS on_IN China_NNP 's_POS CSI_NNP 300_CD Index_NN fell_VBD this_DT year_NN China_NNP ’s_POS crackdown_NN on_IN financial_JJ leverage_NN has_VBZ achieved_VBN some_DT results_NNS ,_, at_IN least_JJS in_IN the_DT stock_NN market_NN as_IN speculators_NNS disappeared_VBD ._. Outstanding_JJ margin_NN debt_NN stood_VBD at_IN 756_CD billion_CD yuan_NN as_IN of_IN Wednesday_NNP ,_, as_IN investors_NNS grew_VBD risk_NN -_HYPH averse_JJ ._. That_DT ’s_VBZ about_RB a_DT third_NN of_IN its_PRP$ 2015_CD peak_NN ,_, when_WRB investors_NNS borrowed_VBD record_JJ sums_NNS to_TO bet_VB on_IN further_JJR gains_NNS ,_, fueling_VBG the_DT great_JJ stock_NN market_NN bubble_NN ._. Burnt_JJ investors_NNS have_VBP hit_VBN the_DT exit_NN button_NN ._. A_DT total_NN of_IN 75_CD Chinese_JJ mutual_JJ funds_NNS with_IN an_DT equity_NN focus_NN liquidated_VBN this_DT year_NN ,_, Bloomberg_NNP compiled_VBD data_NNS show_VB --_, the_DT most_JJS since_IN 2007_CD when_WRB such_JJ data_NNS became_VBD available_JJ ._. That_DT compared_VBN with_IN the_DT 88_CD equity_NN mutual_JJ funds_NNS that_WDT were_VBD liquidated_VBN in_IN total_NN over_IN the_DT past_JJ 11_CD years_NNS ._. New_JJ mainland_NN listings_NNS usually_RB surge_VBP in_IN their_PRP$ early_JJ days_NNS of_IN trading_NN as_IN regulatory_JJ caps_NNS on_IN initial_JJ pricing_NN makes_VBZ it_PRP a_DT bargain_NN for_IN investors_NNS ._. Stocks_NNS that_WDT debuted_VBD on_IN domestic_JJ exchanges_NNS this_DT year_NN rose_VBD by_IN an_DT average_NN of_IN 193_CD percent_NN in_IN their_PRP$ first_JJ month_NN of_IN trading_NN ,_, Bloomberg_NNP data_NN show_VBP ._. While_IN that_DT may_MD not_RB seem_VB that_RB bad_JJ ,_, that_DT ’s_VBZ just_RB half_PDT the_DT return_NN seen_VBN in_IN 2016_CD ,_, and_CC it_PRP ’s_VBZ also_RB the_DT weakest_JJS performance_NN in_IN four_CD years_NNS ._. [_-LRB- RELATED_JJ ]_-RRB- China_NNP Halts_VBZ ALL_DT Oil_NN Imports_NNS From_IN US_NNP As_IN Trade_NNP War_NNP Turns_NNPS Nasty_JJ","NNP ' NN NNS and NNS VBP VBN a JJ NN VBN with JJ JJ NNS amid the VBG NN NN with the NNP NNPS . The NN NNP NNP NN VBD below 25 NN VBN to where it VBD this NN and VBZ RB the JJS - VBG JJ NN NN in the NN . RB there VBZ the NN NN with the NNP NNPS which VBD out a JJ $ 2.4 trillion this NN RB , while a NN NN VBZ VBN NN NN to RB a NN of its NN in 2015 . As JJ NNS VBP to VB NN into JJ NNS via the NN NNS and NN NNS in an NN to VB NNS , the RB VBD RB VB NNS . RB JJR NNS VBD VBG NN as the JJ JJ NN VBD NN and VBD on NN NNS . RB , a NN NN and NN - NN NN VBD a JJ NN - off in the NN - NN NN . RB VBP six NNS to VB up the NN VBG to NNP : NN NNS VBP VBN $ 2.4 trillion off NNP ’s NN NN this NN as of NNP , the JJS on NN since NNP VBD VBG the NNS in 2002 . The JJS NN VBD during the JJ JJ NN ten NNS RB , when the NNP NN VBD 65 NN . NNP RB VBD its NN as the NN ’s RB - JJS NN NN to NNP RBR this NN . NNP 's NN NN VBD the RBS JJ NN NN since at JJS 2002 NNS VBP RB VBN this VBN with NN NN in NNS . JJ JJ NN on both the NNP and NNP NNS VBD to RB 368 billion NNS ( $ 53.7 billion ) this NN , the JJS since 2014 , NN VBN by NNP NN . [ JJ ] JJ NNP : NNP Will ‘ VB JJR ’ Than NNP In NN NN RB 239.1 billion NNS of NNS VBN on NNP , RB 1/10 of its NN in 2015 . NN of the NNS VBD JJ RB to VB NNS from NNS . All ten NN NNS on the NNP 300 NN VBD on the NN , the JJS NN since 2011 , VBG to NNS VBN by NNP . That VBZ a JJ NN from JJ NN when all NN NNS VBD . All ten NN NNS on NNP 's NNP 300 NN VBD this NN NNP ’s NN on JJ NN VBZ VBN some NNS , at JJS in the NN NN as NNS VBD . JJ NN NN VBD at 756 billion NN as of NNP , as NNS VBD NN - JJ . That VBZ RB a NN of its 2015 NN , when NNS VBD JJ NNS to VB on JJR NNS , VBG the JJ NN NN NN . JJ NNS VBP VBN the NN NN . A NN of 75 JJ JJ NNS with an NN NN VBN this NN , NNP VBD NNS VB -- the JJS since 2007 when JJ NNS VBD JJ . That VBN with the 88 NN JJ NNS that VBD VBN in NN over the JJ 11 NNS . JJ NN NNS RB VBP in their JJ NNS of NN as JJ NNS on JJ NN VBZ it a NN for NNS . NNS that VBD on JJ NNS this NN VBD by an NN of 193 NN in their JJ NN of NN , NNP NN VBP . While that may RB VB RB JJ , that VBZ RB half the NN VBN in 2016 , and it VBZ RB the JJS NN in four NNS . [ JJ ] NNP VBZ ALL NN NNS From NNP As NNP NNP NNPS JJ"
241,1328,conspiracy,"It_PRP ’s_VBZ been_VBN only_RB 70_CD years_NNS since_IN World_NNP War_NNP II_CD ,_, and_CC the_DT mad_JJ scientists_NNS from_IN companies_NNS like_IN I.G._NNP Farben_NNP ,_, BASF_NNP ,_, Hoechst_NNP ,_, Dow_NNP and_CC Bayer_NNP ,_, who_WP created_VBD the_DT gas_NN chambers_NNS and_CC tested_VBD dangerous_JJ vaccines_NNS on_IN innocent_JJ Jews_NNPS ,_, did_VBD n’t_RB just_RB go_VB away_RB ._. In_IN fact_NN ,_, they_PRP went_VBD to_IN work_VB for_IN U.S._NNP corporations_NNS and_CC pharmaceutical_JJ companies_NNS that_WDT run_VBP the_DT vaccine_NN industry_NN today_NN ._. At_IN least_JJS a_DT dozen_CD of_IN these_DT cold_JJ blooded_JJ killers_NNS were_VBD hired_VBN fresh_JJ out_IN of_IN prison_NN ,_, just_RB 4_CD to_IN 7_CD years_NNS after_IN the_DT Nuremberg_NNP trials_NNS found_VBD them_PRP guilty_JJ of_IN mass_JJ murder_NN and_CC enslavement_NN ._. In_IN fact_NN ,_, at_IN the_DT close_NN of_IN WWII_NNP ,_, the_DT IG_NNP Farben_NNP building_NN in_IN Frankfort_NNP was_VBD protected_VBN from_IN allied_JJ bombings_NNS by_IN the_DT highest_JJS levels_NNS of_IN military_JJ command_NN ._. Why_WRB ?_. IG_NNP Farben_NNP was_VBD the_DT FDA_NNP /_, CDC_NNP type_NN of_IN “_`` pharmaceutical_JJ arm_NN ”_'' of_IN Hitler_NNP ’s_POS 4th_NNP Reich_NNP ,_, and_CC the_DT Rockefellers_NNPS had_VBD a_DT financial_JJ interest_NN in_IN maintaining_VBG and_CC controlling_VBG this_DT pharmaceutical_JJ empire_NN ,_, which_WDT would_MD soon_RB be_VB catapulted_VBN on_IN U.S._NNP soil_NN ._. Research_NN reveals_VBZ that_IN Hitler_NNP also_RB invested_VBD heavily_RB in_IN Merck_NNP and_CC other_JJ pharmaceutical_JJ companies_NNS ._. Nazi_NNP convicted_VBN mass_NN murderers_NNS became_VBD executives_NNS for_IN major_JJ U.S._NNP chemical_JJ and_CC pharmaceutical_JJ companies_NNS Fritz_NNP ter_NNP Meer_NNP ,_, found_VBN guilty_JJ of_IN slavery_NN and_CC mass_JJ murder_NN at_IN Auschwitz_NNP ,_, served_VBD only_RB seven_CD years_NNS in_IN prison_NN and_CC became_VBD Chairman_NN of_IN the_DT Board_NN at_IN Bayer_NNP in_IN 1956_CD ._. Still_RB trust_VB U.S._NNP vaccines_NNS ?_. This_DT is_VBZ the_DT same_JJ vaccine_NN industry_NN today_NN which_WDT protected_VBD and_CC employed_VBD Nazi_JJ war_NN criminals_NNS ._. The_DT very_JJ industry_NN that_WDT produced_VBD the_DT Nazi_NNP gas_NN chambers_NNS was_VBD purchased_VBN by_IN Bayer_NNP ._. So_RB ,_, exactly_RB whom_WP are_VBP you_PRP trusting_VBG with_IN your_PRP$ children_NNS ’s_POS health_NN and_CC welfare_NN ?_. Currently_RB ,_, the_DT U.S._NNP Government_NNP and_CC the_DT CDC_NNP rely_VBP solely_RB on_IN the_DT manufacturers_NNS of_IN vaccines_NNS to_TO report_VB problems_NNS ,_, injuries_NNS and_CC deaths_NNS ._. This_DT atrocity_NN is_VBZ like_IN letting_VBG murderers_NNS be_VB their_PRP$ own_JJ judges_NNS in_IN court_NN !_. Where_WRB are_VBP the_DT checks_NNS and_CC balances_NNS this_DT country_NN was_VBD founded_VBN upon_IN ?_. Vaccines_NNS have_VBP economic_JJ and_CC political_JJ agendas_NNS now_RB ,_, and_CC the_DT FDA_NNP does_VBZ absolutely_RB no_DT testing_NN of_IN their_PRP$ own_JJ before_IN making_VBG decisions_NNS to_TO release_VB vaccines_NNS to_IN the_DT masses_NNS ._. Want_VB more_JJR research_NN before_IN you_PRP or_CC your_PRP$ child_NN get_VB injected_VBN with_IN a_DT new_JJ concocted_VBN disease_NN for_IN which_WDT there_EX is_VBZ no_DT cure_NN ?_. Listen_VB to_IN stunning_JJ admissions_NNS by_IN vaccine_NN industry_NN experts_NNS ,_, including_VBG Dr._NNP Maurice_NNP Hilleman_NNP (_-LRB- formerly_RB w_NNP /_, Merck_NNP )_-RRB- ,_, who_WP admitted_VBD to_IN the_DT deadly_JJ nature_NN of_IN the_DT most_RBS trusted_VBN vaccines_NNS ._. Today_NN ’s_POS vaccines_NNS not_RB only_RB contain_VB live_JJ versions_NNS of_IN the_DT diseases_NNS you_PRP DO_VBP NOT_RB WANT_VB ,_, but_CC also_RB contain_VB GMOs_NNS ,_, hormones_NNS from_IN infected_VBN cows_NNS ,_, pigs_NNS ,_, chickens_NNS and_CC monkeys_NNS ,_, untested_JJ virus_NN combinations_NNS (_-LRB- like_IN H1N1_NN )_-RRB- ,_, aluminum_NN ,_, mercury_NN ,_, emulsifiers_NNS ,_, and_CC crossbred_VBN bacteria_NN from_IN animals_NNS ,_, mosquitoes_NNS ,_, and_CC diseased_VBN humans_NNS :_: Measles_NN Live_NN Virus_NN Vaccine_NN :_: (_-LRB- Attenuvax_NNP )_-RRB- Made_VBN by_IN Merck_NNP ._. Two_CD injections_NNS are_VBP given_VBN ;_, one_CD at_IN 1_CD year_NN and_CC another_DT at_IN 4_CD years_NNS old_JJ ._. Contains_VBZ gelatin_NN ,_, sorbitol_NN ,_, sodium_NN chloride_NN ,_, bovine_NN cow_NN serum_NN ,_, egg_NN protein_NN and_CC human_JJ albumin_NN ._. Measles_NNS and_CC Mumps_NNP Live_NNP Virus_NN Vaccine_NN :_: (_-LRB- M_NNP -_HYPH M_NNP -_HYPH Rvax_NNP )_-RRB- Made_VBN by_IN Merck_NNP ._. Injected_VBN into_IN one_CD year_NN old_JJ babies_NNS ._. Contains_VBZ gelatin_NN ,_, sorbitol_NN ,_, sodium_NN chloride_NN ,_, bovine_NN cow_NN serum_NN ,_, and_CC human_JJ albumin_NN ._. Diptheria_NNP ,_, Tetanus_NNP and_CC Polio_NNP Vaccine_NNP :_: Five_CD injections_NNS given_VBN between_IN 2_CD and_CC 6_CD years_NNS of_IN age_NN ,_, plus_CC boosters_NNS “_`` recommended_VBN ”_'' every_DT 10_CD years_NNS ._. Contains_VBZ formaldehyde_NN ,_, phenoxyethanol_NN and_CC aluminum_NN phosphate_NN ._. DTaP_NN ,_, IPV_NN ,_, HBV_NNP and_CC Hib*_NNP :_: (_-LRB- Diphtheria_NN ,_, tetanus_NN ,_, polio_NN ,_, hepatitis_NN B_NN and_CC Haemophilus_NN influenza_NN type_NN B_LS )_-RRB- Given_VBN to_IN infants_NNS 2_CD to_IN 12_CD months_NNS with_IN boosters_NNS less_JJR than_IN a_DT year_NN later_RBR ._. Contains_VBZ aluminum_NN hydroxide_NN ,_, formaldehyde_NN ,_, and_CC bovine_NN cow_NN serum_NN ._. Gardasil_NN HPV_NN :_: Human_JJ Papillomavirus_NN Vaccine_NN Made_VBN by_IN Merck_NNP ._. “_`` Recommended_VBN ”_'' 3_CD intramuscular_JJ injections_NNS ;_, given_VBN at_IN birth_NN ,_, 2_CD and_CC 6_CD months_NNS of_IN age_NN ._. Re-administered_VBN to_IN children_NNS as_RB young_JJ as_IN 9_CD years_NNS of_IN age_NN for_IN a_DT rare_JJ sexually_RB transmitted_VBN disease_NN ._. Contains_VBZ polysorbate_NN 80_CD ,_, sodium_NN chloride_NN ,_, aluminum_NN ,_, and_CC a_DT “_`` denatured_VBN ”_'' (_-LRB- fragmented_VBN and_CC weakened_VBN )_-RRB- form_NN of_IN the_DT virus_NN ._. •_SYM Bovine_NN cow_NN serum_NN :_: Extracted_VBN from_IN cow_NN skin_NN ._. When_WRB injected_VBN causes_VBZ connective_JJ tissue_NN disorders_NNS ,_, arthritis_NN and_CC lupus_NN ;_, also_RB shortness_NN of_IN breath_NN ,_, low_JJ blood_NN pressure_NN ,_, chest_NN pain_NN and_CC skin_NN reactions_NNS ._. •_SYM Sorbitol_NN :_: Synthetic_JJ sweetener_NN which_WDT metabolizes_VBZ very_RB slowly_RB and_CC aggravates_VBZ IBS_NN and_CC gastrointestinal_JJ issues_NNS ._. •_SYM Gelatin_NN :_: Derived_VBN from_IN the_DT collagen_NN inside_IN animals_NNS ’_POS skin_NN and_CC bones_NNS ._. Injecting_VBG gelatin_NN poses_VBZ the_DT risk_NN of_IN infection_NN from_IN synthetic_JJ growth_NN hormones_NNS and_CC BSE_NN infectivity_NN (_-LRB- mad_JJ cow_NN disease_NN )_-RRB- ._. •_SYM Egg_NN protein_NN :_: Vaccines_NNS are_VBP prepared_VBN in_IN eggs_NNS (_-LRB- certainly_RB not_RB organic_JJ )_-RRB- ._. May_MD contain_VB growth_NN hormones_NNS ,_, antibiotics_NNS ,_, and_CC salmonella_NN bacteria_NN ._. •_SYM Thimerosal_NNP :_: A_DT neurotoxic_JJ mercury_NN which_WDT causes_VBZ autism_NN :_: There_EX are_VBP 25_CD mcg_NN in_IN one_CD average_JJ flu_NN vaccine_NN ,_, and_CC the_DT EPA_NNP safety_NN limit_NN is_VBZ 5_CD micrograms_NNS ,_, so_RB children_NNS who_WP are_VBP vaccinated_VBN simultaneously_RB with_IN multiple_JJ *_NFP vaccines_NNS receive_VBP over_RB 10_CD times_NNS the_DT safety_NN limit_NN of_IN mercury_NN in_IN one_CD day_NN ._. •_SYM Human_JJ albumin_NN :_: The_DT protein_NN portion_NN of_IN blood_NN frompooled_VBN human_JJ venous_NN plasma_NN ;_, when_WRB injected_VBN causes_VBZ fever_NN ,_, chills_NNS ,_, hives_NNS ,_, rash_NN ,_, headache_NN ,_, nausea_NN ,_, breathing_NN difficulty_NN ,_, and_CC rapid_JJ heart_NN rate_NN ._. Injecting_VBG “_`` pooled_VBN blood_NN ”_'' can_MD result_VB in_IN a_DT loss_NN of_IN body_NN cell_NN mass_NN and_CC cause_VB immunodeficiency_NN virus_NN infection_NN ,_, or_CC contain_VB SV40_NN ,_, AIDS_NN ,_, cancer_NN or_CC Hepatitis_NN B_NN from_IN drug_NN addicts_NNS ._. •_SYM Formaldehyde_NN :_: Highly_RB carcinogenic_JJ fluid_NN used_VBN to_TO embalm_VB corpses_NNS ._. Ranked_VBN one_CD of_IN the_DT most_RBS hazardous_JJ compounds_NNS to_IN human_JJ health_NN ;_, can_MD cause_VB liver_NN damage_NN ,_, gastrointestinal_JJ issues_NNS ,_, reproductive_JJ deformation_NN ,_, respiratory_JJ distress_NN and_CC cancer_NN ._. Plus_CC ,_, formaldehyde_NN has_VBZ been_VBN known_VBN to_TO fail_VB todeactivate_VB the_DT virusthe_NN vaccine_NN is_VBZ intended_VBN to_TO cure_VB ,_, thus_RB enabling_VBG a_DT live_JJ virus_NN to_TO enter_VB your_PRP$ blood_NN and_CC infect_VB your_PRP$ system_NN ._. •_SYM Phenoxyethanol_NN :_: A_DT glycol_NN ether_NN /_, chemical_NN ;_, highly_RB toxic_JJ to_IN the_DT nervous_JJ system_NN ,_, kidneys_NNS ,_, and_CC liver_NN ._. The_DT FDA_NNP warns_VBZ “_`` can_MD cause_VB shut_VBN down_RP of_IN the_DT central_JJ nervous_JJ system_NN (_-LRB- CNS_NNP )_-RRB- ,_, vomiting_NN and_CC contact_NN dermatitis_NN ”_'' in_IN cosmetics_NNS ;_, imagine_VB when_WRB injected_VBN into_IN your_PRP$ blood_NN ._. •_SYM Aluminum_NN phosphate_NN :_: Greatly_RB increases_VBZ toxicity_NN of_IN mercury_NN ,_, so_RB caution_VB aboutminimum_JJ mercury_NN toleranceis_NN therefore_RB severely_RB underestimated_VBN ._. CDC_NNP scientists_NNS and_CC all_DT doctors_NNS are_VBP well_RB aware_JJ of_IN this_DT ._. •_SYM MSG_NN (_-LRB- monosodium_NN glutamate_NN )_-RRB- :_: When_WRB injected_VBN becomes_VBZ a_DT neurotoxin_NN ,_, causing_VBG CNS_NN disorders_NNS and_CC brain_NN damage_NN in_IN children_NNS ._. If_IN you_PRP especially_RB enjoy_VBP being_VBG lied_VBN to_IN ,_, visit_VB vaccinateyourbaby.org_ADD ,_, where_WRB they_PRP tell_VBP you_PRP formaldehyde_NN is_VBZ safe_JJ because_IN it_PRP is_VBZ “_`` present_JJ in_IN the_DT environment_NN and_CC is_VBZ a_DT byproduct_NN of_IN metabolism_NN ,_, so_RB it_PRP is_VBZ already_RB present_JJ in_IN the_DT human_JJ body_NN ._. ”_'' They_PRP also_RB inform_VBP you_PRP that_IN aluminum_NN is_VBZ good_JJ for_IN you_PRP ,_, because_IN “_`` [_-LRB- a_DT ]_-RRB- luminum_NN is_VBZ also_RB commonly_RB found_VBN in_IN food_NN ,_, water_NN ,_, infant_NN formula_NN and_CC even_RB breast_NN milk_NN ._. ”_'' Hey_UH ,_, if_IN it_PRP ’s_VBZ in_IN the_DT environment_NN ,_, it_PRP must_MD be_VB safe_JJ to_TO inject_VB into_IN your_PRP$ veins_NNS (_-LRB- so_IN why_WRB not_RB use_VB snake_NN venom_NN ,_, bleach_NN ,_, and_CC plutonium_NN ?_. )_-RRB- ._. Want_VB the_DT ultimate_JJ alternative_NN to_IN vaccines_NNS that_WDT prevents_VBZ disease_NN ?_. Buy_VB organic_JJ vitamins_NNS ,_, minerals_NNS ,_, antioxidants_NNS ,_, amino_NN acids_NNS ,_, and_CC enzymes_NNS !_.","It VBZ VBN RB 70 NNS since NNP NNP II , and the JJ NNS from NNS like NNP NNP , NNP , NNP , NNP and NNP , who VBD the NN NNS and VBD JJ NNS on JJ NNPS , VBD RB RB VB RB . In NN , they VBD to VB for NNP NNS and JJ NNS that VBP the NN NN NN . At JJS a dozen of these JJ JJ NNS VBD VBN JJ out of NN , RB 4 to 7 NNS after the NNP NNS VBD them JJ of JJ NN and NN . In NN , at the NN of NNP , the NNP NNP NN in NNP VBD VBN from JJ NNS by the JJS NNS of JJ NN . Why ? NNP NNP VBD the NNP / NNP NN of “ JJ NN ” of NNP ’s NNP NNP , and the NNPS VBD a JJ NN in VBG and VBG this JJ NN , which would RB VB VBN on NNP NN . NN VBZ that NNP RB VBD RB in NNP and JJ JJ NNS . NNP VBN NN NNS VBD NNS for JJ NNP JJ and JJ NNS NNP NNP NNP , VBN JJ of NN and JJ NN at NNP , VBD RB seven NNS in NN and VBD NN of the NN at NNP in 1956 . RB VB NNP NNS ? This VBZ the JJ NN NN NN which VBD and VBD JJ NN NNS . The JJ NN that VBD the NNP NN NNS VBD VBN by NNP . RB , RB whom VBP you VBG with your NNS ’s NN and NN ? RB , the NNP NNP and the NNP VBP RB on the NNS of NNS to VB NNS , NNS and NNS . This NN VBZ like VBG NNS VB their JJ NNS in NN ! Where VBP the NNS and NNS this NN VBD VBN upon ? NNS VBP JJ and JJ NNS RB , and the NNP VBZ RB no NN of their JJ before VBG NNS to VB NNS to the NNS . VB JJR NN before you or your NN VB VBN with a JJ VBN NN for which there VBZ no NN ? VB to JJ NNS by NN NN NNS , VBG NNP NNP NNP ( RB NNP / NNP ) , who VBD to the JJ NN of the RBS VBN NNS . NN ’s NNS RB RB VB JJ NNS of the NNS you VBP RB VB , but RB VB NNS , NNS from VBN NNS , NNS , NNS and NNS , JJ NN NNS ( like NN ) , NN , NN , NNS , and VBN NN from NNS , NNS , and VBN NNS : NN NN NN NN : ( NNP ) VBN by NNP . Two NNS VBP VBN ; one at 1 NN and another at 4 NNS JJ . VBZ NN , NN , NN NN , NN NN NN , NN NN and JJ NN . NNS and NNP NNP NN NN : ( NNP - NNP - NNP ) VBN by NNP . VBN into one NN JJ NNS . VBZ NN , NN , NN NN , NN NN NN , and JJ NN . NNP , NNP and NNP NNP : Five NNS VBN between 2 and 6 NNS of NN , plus NNS “ VBN ” every 10 NNS . VBZ NN , NN and NN NN . NN , NN , NNP and NNP : ( NN , NN , NN , NN NN and NN NN NN B ) VBN to NNS 2 to 12 NNS with NNS JJR than a NN RBR . VBZ NN NN , NN , and NN NN NN . NN NN : JJ NN NN VBN by NNP . “ VBN ” 3 JJ NNS ; VBN at NN , 2 and 6 NNS of NN . VBN to NNS RB JJ as 9 NNS of NN for a JJ RB VBN NN . VBZ NN 80 , NN NN , NN , and a “ VBN ” ( VBN and VBN ) NN of the NN . • NN NN NN : VBN from NN NN . When VBN VBZ JJ NN NNS , NN and NN ; RB NN of NN , JJ NN NN , NN NN and NN NNS . • NN : JJ NN which VBZ RB RB and VBZ NN and JJ NNS . • NN : VBN from the NN inside NNS ’ NN and NNS . VBG NN VBZ the NN of NN from JJ NN NNS and NN NN ( JJ NN NN ) . • NN NN : NNS VBP VBN in NNS ( RB RB JJ ) . May VB NN NNS , NNS , and NN NN . • NNP : A JJ NN which VBZ NN : There VBP 25 NN in one JJ NN NN , and the NNP NN NN VBZ 5 NNS , RB NNS who VBP VBN RB with JJ * NNS VBP RB 10 NNS the NN NN of NN in one NN . • JJ NN : The NN NN of NN VBN JJ NN NN ; when VBN VBZ NN , NNS , NNS , NN , NN , NN , NN NN , and JJ NN NN . VBG “ VBN NN ” can VB in a NN of NN NN NN and VB NN NN NN , or VB NN , NN , NN or NN NN from NN NNS . • NN : RB JJ NN VBN to VB NNS . VBN one of the RBS JJ NNS to JJ NN ; can VB NN NN , JJ NNS , JJ NN , JJ NN and NN . Plus , NN VBZ VBN VBN to VB VB the NN NN VBZ VBN to VB , RB VBG a JJ NN to VB your NN and VB your NN . • NN : A NN NN / NN ; RB JJ to the JJ NN , NNS , and NN . The NNP VBZ “ can VB VBN down of the JJ JJ NN ( NNP ) , NN and NN NN ” in NNS ; VB when VBN into your NN . • NN NN : RB VBZ NN of NN , RB VB JJ NN NN RB RB VBN . NNP NNS and all NNS VBP RB JJ of this . • NN ( NN NN ) : When VBN VBZ a NN , VBG NN NNS and NN NN in NNS . If you RB VBP VBG VBN to , VB vaccinateyourbaby.org , where they VBP you NN VBZ JJ because it VBZ “ JJ in the NN and VBZ a NN of NN , RB it VBZ RB JJ in the JJ NN . ” They RB VBP you that NN VBZ JJ for you , because “ [ a ] NN VBZ RB RB VBN in NN , NN , NN NN and RB NN NN . ” Hey , if it VBZ in the NN , it must VB JJ to VB into your NNS ( so why RB VB NN NN , NN , and NN ? ) . VB the JJ NN to NNS that VBZ NN ? VB JJ NNS , NNS , NNS , NN NNS , and NNS !"
242,927,mainstream,"A_DT first_JJ -_HYPH of_IN -_HYPH its_PRP$ -_HYPH kind_NN analysis_NN of_IN more_JJR than_IN 1300_CD Facebook_NNP pages_NNS with_IN nearly_RB 100_CD million_CD followers_NNS has_VBZ produced_VBN a_DT network_NN map_NN that_WDT ’s_VBZ alarming_VBG public_JJ health_NN professionals_NNS ._. Antivaccine_NN pages_NNS have_VBP fewer_JJR followers_NNS than_IN pro-vaccine_JJ pages_NNS but_CC are_VBP more_RBR numerous_JJ ,_, faster_JJR growing_VBG ,_, and_CC increasingly_RB more_RBR connected_VBN to_IN undecided_JJ pages_NNS ,_, the_DT study_NN finds_VBZ ._. If_IN the_DT current_JJ trends_NNS continue_VBP ,_, the_DT researchers_NNS predict_VBP ,_, antivaccine_NN views_NNS will_MD dominate_VB online_JJ discussion_NN in_IN 10_CD years_NNS —_: a_DT time_NN when_WRB a_DT future_JJ vaccine_NN against_IN COVID_NNP -_HYPH 19_CD may_MD be_VB critical_JJ to_IN public_JJ health_NN ._. “_`` The_DT reds_NNS are_VBP winning_VBG ,_, ”_'' says_VBZ anthropologist_NN Heidi_NNP Larson_NNP ,_, who_WP directs_VBZ the_DT Vaccine_NNP Confidence_NNP Project_NNP at_IN the_DT London_NNP School_NNP of_IN Hygiene_NNP &_CC Tropical_NNP Medicine_NNP ,_, referring_VBG to_IN the_DT color_NN of_IN antivaccine_NN Facebook_NNP pages_NNS on_IN the_DT new_JJ paper_NN ’s_POS map_NN ._. “_`` They_PRP are_VBP covering_VBG a_DT lot_NN more_JJR ground_NN with_IN fewer_JJR of_IN them_PRP ._. ”_'' The_DT online_JJ pages_NNS are_VBP “_`` a_DT battle_NN for_IN hearts_NNS and_CC minds_NNS ,_, and_CC there_EX was_VBD no_DT map_NN of_IN that_DT battlefield_NN at_IN the_DT system_NN level_NN ,_, ”_'' says_VBZ first_JJ author_NN Neil_NNP Johnson_NNP ,_, a_DT data_NN scientist_NN at_IN George_NNP Washington_NNP University_NNP who_WP previously_RB mapped_VBD the_DT online_JJ behavior_NN of_IN hate_NN groups_NNS and_CC the_DT Islamic_NNP State_NNP group_NN ._. “_`` We_PRP set_VBP out_RP to_TO take_VB a_DT look_NN at_IN that_DT ._. And_CC we_PRP were_VBD shocked_JJ ._. ”_'' For_IN their_PRP$ study_NN ,_, Johnson_NNP and_CC his_PRP$ colleagues_NNS first_RB identified_VBD Facebook_NNP pages_NNS as_IN pro-_NN or_CC antivaccine_NN based_VBN on_IN their_PRP$ content_NN ._. They_PRP further_RB identified_VBD engaged_VBN but_CC undecided_JJ pages_NNS by_IN their_PRP$ content_NN or_CC by_IN the_DT fact_NN that_IN the_DT administrators_NNS of_IN the_DT pages_NNS had_VBD “_`` liked_VBN ,_, ”_'' or_CC been_VBN “_`` liked_VBN ”_'' by_IN ,_, pro-_JJ or_CC antivaccine_FW pages_NNS ._. They_PRP found_VBD 124_CD pro-vaccine_JJ pages_NNS ,_, such_JJ as_IN the_DT Bill_NNP &_CC Melinda_NNP Gates_NNP Foundation_NNP ,_, with_IN a_DT combined_VBN total_NN of_IN 6.9_CD million_CD followers_NNS ._. They_PRP found_VBD 317_CD antivaccine_NN pages_NNS ,_, such_JJ as_IN RAGE_NNP Against_IN the_DT Vaccines_NNPS ,_, with_IN a_DT total_NN of_IN 4.2_CD million_CD followers_NNS ._. And_CC they_PRP identified_VBD 885_CD pages_NNS ,_, such_JJ as_IN Breastfeeding_NNP Moms_NNPS in_IN KY_NNP ,_, with_IN 74.1_CD million_CD followers_NNS ._. The_DT researchers_NNS next_RB counted_VBD each_DT page_NN ’s_POS links_NNS to_IN other_JJ vaccine_NN -_HYPH discussing_VBG pages_NNS ,_, and_CC those_DT pages_NNS ’_POS links_NNS to_IN still_RB others_NNS ,_, a_DT method_NN called_VBN snowball_NN sampling_NN ._. A_DT software_NN program_NN turned_VBD the_DT data_NNS into_IN a_DT map_NN in_IN which_WDT pages_NNS are_VBP represented_VBN as_IN circular_JJ nodes_NNS ,_, sized_VBN proportionally_RB to_IN their_PRP$ number_NN of_IN followers_NNS and_CC represented_VBN as_IN red_JJ (_-LRB- antivaccine_NN )_-RRB- ,_, blue_JJ (_-LRB- pro-vaccine_NN )_-RRB- ,_, or_CC green_JJ (_-LRB- undecided_JJ )_-RRB- ._. Highly_RB connected_VBN nodes_NNS occupy_VBP more_JJR central_JJ places_NNS on_IN the_DT map_NN ._. The_DT map_NN shows_VBZ many_JJ central_JJ red_JJ nodes_NNS intensely_RB interacting_VBG with_IN many_JJ greens_NNS ._. A_DT smaller_JJR number_NN of_IN blue_JJ nodes_NNS interact_VBP with_IN greens_NNS at_IN a_DT peripheral_JJ nexus_NN removed_VBN from_IN the_DT central_JJ “_`` battlefield_NN ,_, ”_'' as_IN the_DT researchers_NNS call_VBP it_PRP in_IN this_DT week_NN ’s_POS issue_NN of_IN Nature_NN ._. The_DT analysis_NN found_VBD that_IN antivaccination_NN pages_NNS are_VBP both_CC locally_RB and_CC globally_RB connected_VBN ,_, whereas_IN pro-vaccine_JJ pages_NNS are_VBP largely_RB global_JJ or_CC national_JJ ._. In_IN percentage_NN terms_NNS ,_, red_JJ pages_NNS grew_VBD their_PRP$ follower_NN numbers_NNS notably_RB more_RBR than_IN did_VBD blue_JJ pages_NNS during_IN the_DT study_NN period_NN of_IN February_NNP to_IN October_NNP 2019_CD ,_, which_WDT coincided_VBD with_IN a_DT global_JJ measles_NNS outbreak_NN ._. Red_JJ pages_NNS ’_POS connectedness_NN and_CC influence_NN also_RB grew_VBD more_JJR than_IN those_DT of_IN blue_JJ pages_NNS ._. (_-LRB- Total_JJ followers_NNS of_IN all_DT pages_NNS have_VBP since_RB grown_VBN by_IN millions_NNS ._. )_-RRB- “_`` The_DT blues_NNS are_VBP fighting_VBG in_IN the_DT wrong_JJ place_NN ,_, they_PRP are_VBP off_RB to_IN one_CD side_NN and_CC the_DT main_JJ activity_NN is_VBZ around_IN the_DT reds_NNS which_WDT are_VBP absolutely_RB entangled_VBN with_IN this_DT whole_JJ slew_NN of_IN green_JJ communities_NNS ,_, ”_'' Johnson_NNP says_VBZ ._. Blue_JJ and_CC red_JJ pages_NNS also_RB engage_VBP followers_NNS differently_RB ,_, says_VBZ Larson_NNP ,_, who_WP was_VBD not_RB part_NN of_IN the_DT research_NN ._. Pro-vaccine_NN groups_NNS impart_VBP information_NN on_IN one_CD theme_NN with_IN one_CD goal_NN :_: getting_VBG people_NNS vaccinated_VBN ,_, she_PRP notes_VBZ ._. By_IN contrast_NN ,_, the_DT study_NN found_VBD that_IN antivaccine_NN groups_NNS comprise_VBP multiple_JJ smaller_JJR groups_NNS discussing_VBG a_DT wide_JJ range_NN of_IN health_NN and_CC safety_NN topics_NNS ._. That_DT makes_VBZ them_PRP more_RBR responsive_JJ to_IN diverse_JJ concerns_NNS and_CC makes_VBZ undecided_JJ people_NNS feel_VB listened_VBN to_IN ,_, Larson_NNP says_VBZ ._. “_`` It_PRP ’s_VBZ like_IN we_PRP as_IN a_DT public_JJ health_NN community_NN still_RB have_VBP the_DT old_JJ IBM_NNP model_NN and_CC not_RB the_DT startup_NN Silicon_NNP Valley_NNP approach_NN ._. …_. The_DT reds_NNS have_VBP got_VBN that_DT down_RP ._. ”_'' Pro-vaccine_NN pages_NNS “_`` seem_VBP to_TO be_VB in_IN an_DT echo_NN chamber_NN and_CC their_PRP$ preaching_NN does_VBZ n’t_RB seem_VB to_TO go_VB any_RB further_RBR than_IN the_DT choir_NN ,_, ”_'' agrees_VBZ Bruce_NNP Gellin_NNP ,_, president_NN of_IN global_JJ immunization_NN at_IN the_DT Sabin_NNP Vaccine_NNP Institute_NNP ._. Sinan_NNP Aral_NNP ,_, an_DT econometrician_NN at_IN the_DT Massachusetts_NNP Institute_NNP of_IN Technology_NNP who_WP has_VBZ mapped_VBN the_DT online_JJ spread_NN of_IN misinformation_NN ,_, praises_VBZ the_DT analysis_NN ’s_POS large_JJ size_NN ._. But_CC he_PRP advises_VBZ a_DT “_`` skeptical_JJ eye_NN ._. ”_'' He_PRP says_VBZ it_PRP ’s_VBZ not_RB clear_JJ that_IN a_DT green_JJ page_NN ’s_POS linking_VBG to_IN a_DT red_JJ page_NN leads_VBZ to_IN persuasion_NN or_CC that_IN online_JJ interactions_NNS trigger_VBP actual_JJ changes_NNS in_IN vaccination_NN ._. He_PRP adds_VBZ that_IN the_DT predicted_VBN online_JJ dominance_NN of_IN red_JJ groups_NNS in_IN 10_CD years_NNS “_'' is_VBZ extrapolating_VBG a_DT lot_NN from_IN …_: limited_JJ data_NNS ._. ”_'' The_DT study_NN only_RB looks_VBZ at_IN how_WRB people_NNS ’s_POS views_NNS circulate_VBP ,_, not_RB the_DT content_NN of_IN pages_NNS ,_, “_'' as_IN if_IN people_NNS do_VBP n’t_RB have_VB reasons_NNS for_IN their_PRP$ views_NNS and_CC are_VBP only_RB being_VBG manipulated_VBN ,_, ”_'' says_VBZ another_DT critic_NN ,_, Bernice_NNP Hausman_NNP ,_, a_DT cultural_JJ theorist_NN at_IN Pennsylvania_NNP State_NNP University_NNP College_NNP of_IN Medicine_NNP ._. She_PRP calls_VBZ the_DT paper_NN ’s_POS battlefield_NN rhetoric_NN “_`` troublesome_JJ ,_, ”_'' arguing_VBG that_IN it_PRP betrays_VBZ the_DT very_JJ mindset_NN —_: casting_NN vaccine_NN resisters_NNS as_IN the_DT enemy_NN —_: that_WDT turns_VBZ the_DT vaccine_NN skeptical_JJ away_RB ._. But_CC Johnson_NNP stands_VBZ by_IN his_PRP$ terminology_NN ._. He_PRP concedes_VBZ that_IN the_DT map_NN is_VBZ a_DT first_JJ ,_, imperfect_JJ attempt_NN ,_, but_CC says_VBZ ,_, “_`` Because_IN we_PRP are_VBP looking_VBG at_IN the_DT system_NN level_NN ,_, the_DT main_JJ results_NNS of_IN our_PRP$ study_NN are_VBP robust_JJ ._. ”_''","A JJ - of - its - NN NN of JJR than 1300 NNP NNS with RB 100 million NNS VBZ VBN a NN NN that VBZ VBG JJ NN NNS . NN NNS VBP JJR NNS than JJ NNS but VBP RBR JJ , JJR VBG , and RB RBR VBN to JJ NNS , the NN VBZ . If the JJ NNS VBP , the NNS VBP , NN NNS will VB JJ NN in 10 NNS — a NN when a JJ NN against NNP - 19 may VB JJ to JJ NN . “ The NNS VBP VBG , ” VBZ NN NNP NNP , who VBZ the NNP NNP NNP at the NNP NNP of NNP & NNP NNP , VBG to the NN of NN NNP NNS on the JJ NN ’s NN . “ They VBP VBG a NN JJR NN with JJR of them . ” The JJ NNS VBP “ a NN for NNS and NNS , and there VBD no NN of that NN at the NN NN , ” VBZ JJ NN NNP NNP , a NN NN at NNP NNP NNP who RB VBD the JJ NN of NN NNS and the NNP NNP NN . “ We VBP out to VB a NN at that . And we VBD JJ . ” For their NN , NNP and his NNS RB VBD NNP NNS as NN or NN VBN on their NN . They RB VBD VBN but JJ NNS by their NN or by the NN that the NNS of the NNS VBD “ VBN , ” or VBN “ VBN ” by , JJ or FW NNS . They VBD 124 JJ NNS , JJ as the NNP & NNP NNP NNP , with a VBN NN of 6.9 million NNS . They VBD 317 NN NNS , JJ as NNP Against the NNPS , with a NN of 4.2 million NNS . And they VBD 885 NNS , JJ as NNP NNPS in NNP , with 74.1 million NNS . The NNS RB VBD each NN ’s NNS to JJ NN - VBG NNS , and those NNS ’ NNS to RB NNS , a NN VBN NN NN . A NN NN VBD the NNS into a NN in which NNS VBP VBN as JJ NNS , VBN RB to their NN of NNS and VBN as JJ ( NN ) , JJ ( NN ) , or JJ ( JJ ) . RB VBN NNS VBP JJR JJ NNS on the NN . The NN VBZ JJ JJ JJ NNS RB VBG with JJ NNS . A JJR NN of JJ NNS VBP with NNS at a JJ NN VBN from the JJ “ NN , ” as the NNS VBP it in this NN ’s NN of NN . The NN VBD that NN NNS VBP both RB and RB VBN , whereas JJ NNS VBP RB JJ or JJ . In NN NNS , JJ NNS VBD their NN NNS RB RBR than VBD JJ NNS during the NN NN of NNP to NNP 2019 , which VBD with a JJ NNS NN . JJ NNS ’ NN and NN RB VBD JJR than those of JJ NNS . ( JJ NNS of all NNS VBP RB VBN by NNS . ) “ The NNS VBP VBG in the JJ NN , they VBP RB to one NN and the JJ NN VBZ around the NNS which VBP RB VBN with this JJ NN of JJ NNS , ” NNP VBZ . JJ and JJ NNS RB VBP NNS RB , VBZ NNP , who VBD RB NN of the NN . NN NNS VBP NN on one NN with one NN : VBG NNS VBN , she VBZ . By NN , the NN VBD that NN NNS VBP JJ JJR NNS VBG a JJ NN of NN and NN NNS . That VBZ them RBR JJ to JJ NNS and VBZ JJ NNS VB VBN to , NNP VBZ . “ It VBZ like we as a JJ NN NN RB VBP the JJ NNP NN and RB the NN NNP NNP NN . … The NNS VBP VBN that down . ” NN NNS “ VBP to VB in an NN NN and their NN VBZ RB VB to VB RB RBR than the NN , ” VBZ NNP NNP , NN of JJ NN at the NNP NNP NNP . NNP NNP , an NN at the NNP NNP of NNP who VBZ VBN the JJ NN of NN , VBZ the NN ’s JJ NN . But he VBZ a “ JJ NN . ” He VBZ it VBZ RB JJ that a JJ NN ’s VBG to a JJ NN VBZ to NN or that JJ NNS VBP JJ NNS in NN . He VBZ that the VBN JJ NN of JJ NNS in 10 NNS “ VBZ VBG a NN from … JJ NNS . ” The NN RB VBZ at how NNS ’s NNS VBP , RB the NN of NNS , “ as if NNS VBP RB VB NNS for their NNS and VBP RB VBG VBN , ” VBZ another NN , NNP NNP , a JJ NN at NNP NNP NNP NNP of NNP . She VBZ the NN ’s NN NN “ JJ , ” VBG that it VBZ the JJ NN — NN NN NNS as the NN — that VBZ the NN JJ RB . But NNP VBZ by his NN . He VBZ that the NN VBZ a JJ , JJ NN , but VBZ , “ Because we VBP VBG at the NN NN , the JJ NNS of our NN VBP JJ . ”"
243,1157,mainstream,"An_DT Oxford_NNP University_NNP vaccine_NN considered_VBN likely_JJ to_TO come_VB online_RB this_DT year_NN may_MD not_RB be_VB available_JJ to_IN British_JJ people_NNS first_RB ,_, its_PRP$ lead_JJ scientist_NN has_VBZ suggested_VBN ._. Prof_NNP Sarah_NNP Gilbert_NNP ,_, whose_WP$ team_NN is_VBZ receiving_VBG UK_NNP Government_NN funding_NN ,_, said_VBD on_IN Sunday_NNP that_IN it_PRP is_VBZ focused_VBN on_IN providing_VBG protection_NN against_IN the_DT virus_NN ""_`` as_RB widely_RB as_IN possible_JJ across_IN the_DT world_NN ""_'' ._. Human_JJ trials_NNS for_IN the_DT vaccine_NN are_VBP due_JJ to_TO start_VB this_DT week_NN ,_, and_CC Prof_NNP Gilbert_NNP has_VBZ previously_RB said_VBN she_PRP is_VBZ 80_CD per_NN cent_NN confident_JJ it_PRP will_MD work_VB ,_, and_CC that_IN a_DT million_CD doses_NNS could_MD be_VB available_JJ by_IN September_NNP ._. However_RB ,_, asked_VBN twice_RB by_IN Andrew_NNP Marr_NNP whether_IN British_JJ people_NNS would_MD be_VB first_RB in_IN the_DT queue_NN for_IN it_PRP ,_, she_PRP said_VBD :_: ""_`` There_EX are_VBP discussions_NNS going_VBG on_RP about_IN mechanisms_NNS for_IN ensuring_VBG fair_JJ access_NN to_IN all_DT vaccines_NNS that_WDT work_VBP at_IN a_DT global_JJ level_NN ._. ""_'' Sir_NNP Patrick_NNP Vallance_NNP ,_, the_DT chief_JJ scientific_JJ adviser_NN ,_, on_IN Sunday_NNP moved_VBD to_TO temper_VB public_JJ expectations_NNS ,_, saying_VBG :_: ""_`` All_DT new_JJ vaccines_NNS that_WDT come_VBP into_IN development_NN are_VBP long_JJ shots_NNS ._. Only_RB some_DT end_VBP up_RP successful_JJ ._. Coronavirus_NN will_MD be_VB no_RB different_JJ and_CC presents_VBZ new_JJ challenges_NNS ._. This_DT will_MD take_VB time_NN ._. ""_''","An NNP NNP NN VBN JJ to VB RB this NN may RB VB JJ to JJ NNS RB , its JJ NN VBZ VBN . NNP NNP NNP , whose NN VBZ VBG NNP NN NN , VBD on NNP that it VBZ VBN on VBG NN against the NN "" RB RB as JJ across the NN "" . JJ NNS for the NN VBP JJ to VB this NN , and NNP NNP VBZ RB VBN she VBZ 80 NN NN JJ it will VB , and that a million NNS could VB JJ by NNP . RB , VBN RB by NNP NNP whether JJ NNS would VB RB in the NN for it , she VBD : "" There VBP NNS VBG on about NNS for VBG JJ NN to all NNS that VBP at a JJ NN . "" NNP NNP NNP , the JJ JJ NN , on NNP VBD to VB JJ NNS , VBG : "" All JJ NNS that VBP into NN VBP JJ NNS . RB some VBP up JJ . NN will VB RB JJ and VBZ JJ NNS . This will VB NN . """
244,119,mainstream,"WASHINGTON_NNP —_: Dr._NNP Anthony_NNP Fauci_NNP says_VBZ the_DT government_NN is_VBZ working_VBG on_IN several_JJ potential_JJ vaccines_NNS for_IN COVID_NN -_HYPH 19_CD ._. “_`` We_PRP have_VBP many_JJ candidates_NNS and_CC hope_VBP to_TO have_VB many_JJ winners_NNS ,_, ”_'' he_PRP told_VBD the_DT Senate_NNP Health_NNP ,_, Education_NNP ,_, Labor_NNP and_CC Pension_NNP committee_NNP ._. “_`` In_IN other_JJ words_NNS ,_, it_PRP is_VBZ many_JJ shots_NNS on_IN goal_NN ._. ”_'' Despite_IN the_DT rapid_JJ pace_NN of_IN work_NN on_IN vaccines_NNS ,_, Fauci_NNP was_VBD offering_VBG no_DT guarantees_NNS ._. He_PRP says_VBZ ,_, “_`` The_DT big_JJ unknown_JJ is_VBZ efficacy_NN ._. ”_'' Fauci_NNP heads_VBZ the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS and_CC is_VBZ the_DT government_NN ’s_POS leading_VBG expert_NN on_IN the_DT pandemic_NN ._. He_PRP says_VBZ he_PRP hopes_VBZ to_TO have_VB a_DT vaccine_NN in_IN advanced_JJ trials_NNS by_IN late_JJ fall_NN or_CC early_JJ winter_NN ._. WATCH_VB LIVE_NN :_: Fauci_NNP ,_, CDC_NNP director_NN testify_VB in_IN Senate_NNP hearing_NN on_IN how_WRB to_TO safely_RB return_VB to_IN work_NN and_CC school_NN","NNP — NNP NNP NNP VBZ the NN VBZ VBG on JJ JJ NNS for NN - 19 . “ We VBP JJ NNS and VBP to VB JJ NNS , ” he VBD the NNP NNP , NNP , NNP and NNP NNP . “ In JJ NNS , it VBZ JJ NNS on NN . ” Despite the JJ NN of NN on NNS , NNP VBD VBG no NNS . He VBZ , “ The JJ JJ VBZ NN . ” NNP VBZ the NNP NNP of NNP and NNP NNPS and VBZ the NN ’s VBG NN on the NN . He VBZ he VBZ to VB a NN in JJ NNS by JJ NN or JJ NN . VB NN : NNP , NNP NN VB in NNP NN on how to RB VB to NN and NN"
245,1300,mainstream,"A_DT large_JJ dog_NN roamed_VBD about_IN the_DT house_NN ;_: a_DT very_RB tall_JJ son_NN watched_VBD an_DT English_JJ soccer_NN match_NN ;_, and_CC Wakefield_NNP ,_, while_IN making_VBG coffee_NN and_CC emptying_VBG the_DT dishwasher_NN ,_, continued_VBD to_TO bat_VB away_RB charges_NNS ._. He_PRP claimed_VBD ,_, for_IN example_NN ,_, that_IN a_DT “_`` safer_JJR ”_'' measles_NN vaccine_NN for_IN which_WDT he_PRP filed_VBD a_DT patent_NN was_VBD not_RB ,_, in_IN fact_NN ,_, a_DT rival_NN to_IN M.M.R._NNP ,_, which_WDT would_MD have_VB been_VBN a_DT clear_JJ conflict_NN of_IN interest_NN ;_, it_PRP was_VBD instead_RB an_DT immune_JJ -_HYPH boosting_VBG vaccine_NN for_IN those_DT with_IN compromised_VBN immune_NN systems_NNS ,_, an_DT unfortunate_JJ semantic_JJ mix_NN -_HYPH up_NN ._. (_-LRB- “_`` He_PRP is_VBZ very_RB good_JJ at_IN what_WP I_PRP call_VBP whack_NN -_HYPH a_DT -_HYPH mole_NN arguments_NNS ,_, ”_'' says_VBZ Seth_NNP Mnookin_NNP ,_, author_NN of_IN “_`` The_DT Panic_NNP Virus_NNP ,_, ”_'' a_DT history_NN of_IN the_DT controversy_NN over_IN autism_NN and_CC vaccines_NNS ._. )_-RRB- Wakefield_NNP is_VBZ a_DT persuasive_JJ speaker_NN ,_, even_RB when_WRB the_DT listener_NN knows_VBZ better_RBR ._. As_IN we_PRP talked_VBD ,_, I_PRP could_MD n’t_RB help_VB thinking_VBG of_IN a_DT clip_NN of_IN Wakefield_NNP I_PRP saw_VBD on_IN YouTube_NNP ._. The_DT video_NN showed_VBD him_PRP at_IN a_DT conference_NN in_IN 1999_CD ,_, telling_VBG the_DT audience_NN about_IN the_DT time_NN he_PRP lined_VBD up_RP kids_NNS to_TO give_VB blood_NN samples_NNS at_IN the_DT birthday_NN party_NN of_IN one_CD of_IN his_PRP$ children_NNS :_: he_PRP needed_VBD a_DT control_NN group_NN of_IN children_NNS who_WP did_VBD not_RB have_VB autism_NN ,_, and_CC this_DT was_VBD convenient_JJ ._. “_`` Two_CD children_NNS fainted_VBD ,_, ”_'' he_PRP said_VBD ._. “_`` Another_DT threw_VBD up_RP over_IN his_PRP$ mother_NN ._. ”_'' For_IN their_PRP$ service_NN ,_, they_PRP were_VBD rewarded_VBN with_IN £_$ 5_CD ._. “_`` People_NNS said_VBD to_IN me_PRP ,_, ‘_`` Andrew_NNP ,_, you_PRP know_VBP you_PRP ca_MD n’t_RB do_VB this_DT to_IN people_NNS ;_, children_NNS wo_MD n’t_RB come_VB back_RB ,_, ’_'' ”_'' he_PRP recounted_VBD ._. “_`` I_PRP said_VBD ,_, ‘_`` You_PRP ’re_VBP wrong_JJ —_: listen_VB ,_, we_PRP live_VBP in_IN a_DT free_JJ -_HYPH market_NN economy_NN ;_, next_JJ year_NN ,_, they_PRP ’ll_MD want_VB £_$ 10_CD ._. ’_'' ”_'' Clearly_RB ,_, drawing_VBG blood_NN in_IN that_DT setting_NN was_VBD part_NN of_IN no_DT medical_JJ protocol_NN that_WDT an_DT ethics_NN committee_NN would_MD ever_RB approve_VB ._. The_DT General_NNP Medical_NNP Council_NNP ,_, in_IN its_PRP$ ruling_NN against_IN Wakefield_NNP ,_, said_VBD that_IN by_IN engaging_VBG in_IN this_DT behavior_NN ,_, he_PRP displayed_VBD conduct_NN that_IN “_`` fell_VBD seriously_RB short_JJ of_IN the_DT standards_NNS expected_VBN of_IN a_DT doctor_NN and_CC was_VBD a_DT breach_NN of_IN the_DT trust_NN that_WDT the_DT public_NN is_VBZ entitled_VBN to_TO have_VB in_IN members_NNS of_IN the_DT medical_JJ profession_NN ”_'' and_CC deemed_VBD the_DT episode_NN “_`` serious_JJ professional_JJ misconduct_NN ._. ”_'' Wakefield_NNP was_VBD either_CC naïve_JJ or_CC arrogant_JJ to_TO think_VB that_IN he_PRP could_MD joke_VB on_IN camera_NN about_IN the_DT lengths_NNS to_IN which_WDT he_PRP had_VBD gone_VBN in_IN the_DT pursuit_NN of_IN proving_VBG his_PRP$ theories_NNS right_RB ._. But_CC what_WP is_VBZ also_RB striking_VBG about_IN that_DT video_NN is_VBZ the_DT sound_NN of_IN the_DT audience_NN laughing_VBG ._. He_PRP had_VBD won_VBN over_IN a_DT room_NN full_JJ of_IN parents_NNS ,_, who_WP were_VBD caught_VBN up_RP in_IN the_DT charm_NN of_IN a_DT maverick_NN ._. It_PRP was_VBD hard_JJ to_TO imagine_VB Wakefield_NNP making_VBG such_PDT a_DT joke_NN now_RB ;_, he_PRP has_VBZ not_RB retreated_VBN from_IN his_PRP$ position_NN ,_, but_CC he_PRP has_VBZ shifted_VBN his_PRP$ sense_NN of_IN identity_NN from_IN that_DT of_IN a_DT renegade_NN to_IN that_DT of_IN a_DT martyr_NN ._. He_PRP often_RB says_VBZ that_IN he_PRP has_VBZ stuck_VBN by_IN a_DT theory_NN that_IN “_`` has_VBZ cost_VBN me_PRP my_PRP$ job_NN ,_, my_PRP$ livelihood_NN and_CC my_PRP$ country_NN ._. ”_'' The_DT more_JJR he_PRP has_VBZ sacrificed_VBN ,_, the_DT more_RBR he_PRP must_MD believe_VB in_IN his_PRP$ theory_NN —_: or_CC else_RB what_WP was_VBD it_PRP all_RB for_IN ?_. A_DT quote_NN from_IN Peter_NNP Medawar_NNP ,_, a_DT British_JJ scientist_NN who_WP wrote_VBD a_DT famous_JJ critique_NN of_IN a_DT book_NN of_IN specious_JJ ideas_NNS about_IN evolution_NN ,_, comes_VBZ to_IN mind_NN :_: “_`` Its_PRP$ author_NN can_MD be_VB excused_VBN of_IN dishonesty_NN only_RB on_IN the_DT grounds_NNS that_IN before_IN deceiving_VBG others_NNS he_PRP has_VBZ taken_VBN great_JJ pains_NNS to_TO deceive_VB himself_PRP ._. ”_'' Wakefield_NNP continues_VBZ to_TO work_VB with_IN a_DT sense_NN of_IN mission_NN and_CC an_DT entrepreneurial_JJ savvy_NN ._. Since_IN leaving_VBG Thoughtful_NNP House_NNP ,_, he_PRP has_VBZ been_VBN working_VBG on_IN a_DT book_NN about_IN parents_NNS who_WP have_VBP been_VBN falsely_RB accused_VBN of_IN Munchausen_NN syndrome_NN by_IN proxy_NN :_: the_DT world_NN of_IN false_JJ accusations_NNS ,_, of_IN unheard_JJ parents_NNS in_IN pain_NN —_: familiar_JJ territory_NN ,_, all_DT of_IN it_PRP ._. He_PRP is_VBZ also_RB trying_VBG to_TO raise_VB money_NN for_IN a_DT center_NN for_IN autistic_JJ adults_NNS ._. It_PRP is_VBZ a_DT shrewd_JJ business_NN move_NN with_IN explosive_JJ potential_NN for_IN growth_NN :_: 80_CD percent_NN of_IN the_DT autistic_JJ population_NN in_IN the_DT U.S._NNP is_VBZ currently_RB under_IN 18_CD ._. That_DT morning_NN in_IN Austin_NNP ,_, Wakefield_NNP was_VBD on_IN his_PRP$ way_NN to_IN yet_RB another_DT contentious_JJ interview_NN in_IN New_NNP York_NNP ,_, this_DT one_NN with_IN George_NNP Stephanopoulos_NNP ._. His_PRP$ son_NN ,_, who_WP drove_VBD Wakefield_NNP and_CC me_PRP to_IN the_DT airport_NN ,_, had_VBD no_DT plans_NNS to_TO follow_VB in_IN the_DT footsteps_NNS of_IN his_PRP$ parents_NNS and_CC his_PRP$ paternal_JJ grandparents_NNS ,_, all_DT of_IN whom_WP were_VBD doctors_NNS :_: he_PRP was_VBD majoring_VBG in_IN public_JJ relations_NNS and_CC marketing_NN instead_RB ._. Perhaps_RB his_PRP$ father_NN ’s_POS experience_NN had_VBD taught_VBN him_PRP something_NN about_IN the_DT perils_NNS of_IN science_NN and_CC about_IN the_DT power_NN of_IN messaging_NN ._. It_PRP seems_VBZ very_RB unlikely_JJ that_IN any_DT study_NN ,_, no_RB matter_RB how_WRB carefully_RB conducted_VBN ,_, will_MD assure_VB Wakefield_NNP of_IN the_DT safety_NN of_IN M.M.R._NNP at_IN this_DT point_NN :_: numbers_NNS can_MD lie_VB ,_, or_CC be_VB manipulated_VBN ,_, and_CC even_RB paranoids_NNS have_VBP enemies_NNS ._. Did_VBD n’t_RB they_PRP laugh_VB at_IN the_DT researcher_NN who_WP said_VBD bacteria_NNS caused_VBD ulcers_NNS ?_. Does_VBZ n’t_RB he_PRP owe_VB it_PRP to_IN the_DT children_NNS to_TO continue_VB on_IN ?_. Before_IN leaving_VBG for_IN the_DT airport_NN with_IN Wakefield_NNP and_CC his_PRP$ son_NN ,_, I_PRP took_VBD in_IN the_DT view_NN from_IN the_DT deck_NN ._. The_DT hills_NNS looked_VBD lofty_JJ ,_, peaceful_JJ ,_, a_DT little_JJ bit_NN blurred_VBN in_IN the_DT distance_NN —_: you_PRP could_MD believe_VB ,_, as_IN Wakefield_NNP had_VBD promised_VBN ,_, you_PRP were_VBD in_IN Tuscany_NNP ._. With_IN a_DT little_JJ effort_NN ,_, you_PRP can_MD believe_VB almost_RB anything_NN ._.","A JJ NN VBD about the NN ; a RB JJ NN VBD an JJ NN NN ; and NNP , while VBG NN and VBG the NN , VBD to VB RB NNS . He VBD , for NN , that a “ JJR ” NN NN for which he VBD a NN VBD RB , in NN , a NN to NNP , which would VB VBN a JJ NN of NN ; it VBD RB an JJ - VBG NN for those with VBN NN NNS , an JJ JJ NN - NN . ( “ He VBZ RB JJ at what I VBP NN - a - NN NNS , ” VBZ NNP NNP , NN of “ The NNP NNP , ” a NN of the NN over NN and NNS . ) NNP VBZ a JJ NN , RB when the NN VBZ RBR . As we VBD , I could RB VB VBG of a NN of NNP I VBD on NNP . The NN VBD him at a NN in 1999 , VBG the NN about the NN he VBD up NNS to VB NN NNS at the NN NN of one of his NNS : he VBD a NN NN of NNS who VBD RB VB NN , and this VBD JJ . “ Two NNS VBD , ” he VBD . “ Another VBD up over his NN . ” For their NN , they VBD VBN with £ 5 . “ NNS VBD to me , ‘ NNP , you VBP you ca RB VB this to NNS ; NNS wo RB VB RB , ’ ” he VBD . “ I VBD , ‘ You VBP JJ — VB , we VBP in a JJ - NN NN ; JJ NN , they ’ll VB £ 10 . ’ ” RB , VBG NN in that NN VBD NN of no JJ NN that an NN NN would RB VB . The NNP NNP NNP , in its NN against NNP , VBD that by VBG in this NN , he VBD NN that “ VBD RB JJ of the NNS VBN of a NN and VBD a NN of the NN that the NN VBZ VBN to VB in NNS of the JJ NN ” and VBD the NN “ JJ JJ NN . ” NNP VBD either JJ or JJ to VB that he could VB on NN about the NNS to which he VBD VBN in the NN of VBG his NNS RB . But what VBZ RB VBG about that NN VBZ the NN of the NN VBG . He VBD VBN over a NN JJ of NNS , who VBD VBN up in the NN of a NN . It VBD JJ to VB NNP VBG such a NN RB ; he VBZ RB VBN from his NN , but he VBZ VBN his NN of NN from that of a NN to that of a NN . He RB VBZ that he VBZ VBN by a NN that “ VBZ VBN me my NN , my NN and my NN . ” The JJR he VBZ VBN , the RBR he must VB in his NN — or RB what VBD it RB for ? A NN from NNP NNP , a JJ NN who VBD a JJ NN of a NN of JJ NNS about NN , VBZ to NN : “ Its NN can VB VBN of NN RB on the NNS that before VBG NNS he VBZ VBN JJ NNS to VB himself . ” NNP VBZ to VB with a NN of NN and an JJ NN . Since VBG NNP NNP , he VBZ VBN VBG on a NN about NNS who VBP VBN RB VBN of NN NN by NN : the NN of JJ NNS , of JJ NNS in NN — JJ NN , all of it . He VBZ RB VBG to VB NN for a NN for JJ NNS . It VBZ a JJ NN NN with JJ NN for NN : 80 NN of the JJ NN in the NNP VBZ RB under 18 . That NN in NNP , NNP VBD on his NN to RB another JJ NN in NNP NNP , this NN with NNP NNP . His NN , who VBD NNP and me to the NN , VBD no NNS to VB in the NNS of his NNS and his JJ NNS , all of whom VBD NNS : he VBD VBG in JJ NNS and NN RB . RB his NN ’s NN VBD VBN him NN about the NNS of NN and about the NN of NN . It VBZ RB JJ that any NN , RB RB how RB VBN , will VB NNP of the NN of NNP at this NN : NNS can VB , or VB VBN , and RB NNS VBP NNS . VBD RB they VB at the NN who VBD NNS VBD NNS ? VBZ RB he VB it to the NNS to VB on ? Before VBG for the NN with NNP and his NN , I VBD in the NN from the NN . The NNS VBD JJ , JJ , a JJ NN VBN in the NN — you could VB , as NNP VBD VBN , you VBD in NNP . With a JJ NN , you can VB RB NN ."
246,563,mainstream,"“_`` He_PRP told_VBD me_PRP he_PRP has_VBZ a_DT number_NN of_IN friends_NNS who_WP are_VBP affected_VBN ,_, ”_'' Mr._NNP Kennedy_NNP said_VBD of_IN the_DT conversation_NN with_IN the_DT president_NN -_HYPH elect_NN ,_, describing_VBG 2_CD -_HYPH year_NN -_HYPH old_JJ children_NNS who_WP had_VBD received_VBN “_`` a_DT battery_NN ”_'' of_IN vaccines_NNS and_CC then_RB exhibited_VBN a_DT high_JJ fever_NN followed_VBN by_IN changes_NNS in_IN behavior_NN ._. “_`` They_PRP all_DT have_VBP the_DT same_JJ story_NN ._. ”_'' Mr._NNP Kennedy_NNP said_VBD Mr._NNP Trump_NNP “_`` believes_VBZ in_IN those_DT anecdotal_JJ stories_NNS ”_'' about_IN the_DT dangers_NNS of_IN vaccines_NNS ._. He_PRP said_VBD the_DT president_NN -_HYPH elect_NN “_'' says_VBZ if_IN you_PRP have_VBP enough_JJ anecdotal_JJ stories_NNS saying_VBG the_DT exact_JJ same_JJ thing_NN ,_, that_IN you_PRP ca_MD n’t_RB dismiss_VB the_DT validity_NN ._. ”_'' He_PRP said_VBD a_DT commission_NN would_MD probably_RB last_VB a_DT year_NN and_CC be_VB made_VBN up_RP of_IN “_`` a_DT mix_NN of_IN science_NN people_NNS and_CC other_JJ people_NNS hopefully_RB from_IN the_DT media_NN and_CC other_JJ prominent_JJ Americans_NNPS who_WP hopefully_RB do_VBP n’t_RB have_VB a_DT position_NN going_VBG in_RP ._. ”_'' Mr._NNP Kennedy_NNP wrote_VBD a_DT book_NN in_IN 2014_CD ,_, “_`` Thimerosal_NNP :_: Let_VB the_DT Science_NNP Speak_VB ,_, ”_'' arguing_VBG that_IN a_DT mercury_NN -_HYPH based_VBN preservative_NN called_VBN thimerosal_NN ,_, found_VBN in_IN vaccines_NNS ,_, was_VBD responsible_JJ for_IN causing_VBG autism_NN in_IN children_NNS ._. On_IN his_PRP$ website_NN ,_, he_PRP accuses_VBZ the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP of_IN being_VBG a_DT “_`` cesspool_NN of_IN corruption_NN ,_, mismanagement_NN and_CC dysfunction_NN ”_'' that_WDT has_VBZ led_VBN the_DT agency_NN to_TO overlook_VB the_DT affects_NNS of_IN vaccines_NNS ._. “_`` With_IN the_DT research_NN ,_, regulatory_NN and_CC policy_NN -_HYPH making_VBG agencies_NNS captured_VBN ,_, the_DT courts_NNS closed_VBD to_IN the_DT public_NN ,_, the_DT lawyers_NNS disarmed_VBD ,_, the_DT politicians_NNS on_IN retainer_NN and_CC the_DT media_NN subverted_VBD ,_, there_EX is_VBZ no_DT one_NN left_VBN to_TO stand_VB between_IN a_DT greedy_JJ industry_NN and_CC vulnerable_JJ children_NNS ,_, except_IN parents_NNS ,_, ”_'' Mr._NNP Kennedy_NNP wrote_VBD ._. Such_JJ claims_NNS have_VBP been_VBN fueled_VBN over_IN the_DT past_JJ several_JJ years_NNS by_IN social_JJ media_NN ,_, sometimes_RB embraced_VBN by_IN actors_NNS or_CC fringe_JJ political_JJ candidates_NNS ,_, often_RB to_IN the_DT dismay_NN of_IN public_JJ health_NN officials_NNS ,_, who_WP say_VBP the_DT commentary_NN is_VBZ contrary_JJ to_IN the_DT facts_NNS ._. The_DT actress_NN Kirstie_NNP Alley_NNP has_VBZ written_VBN on_IN Twitter_NNP that_IN not_RB all_DT vaccines_NNS are_VBP harmless_JJ ._. Erin_NNP Brockovich_NNP ,_, an_DT environmental_JJ activist_NN ,_, wrote_VBD on_IN the_DT site_NN in_IN 2015_CD ,_, “_`` I_PRP ’ll_MD be_VB damned_VBN if_IN any_DT government_NN is_VBZ going_VBG to_TO tell_VB me_PRP what_WP to_TO put_VB in_IN my_PRP$ or_CC kids_NNS ’_POS bodies_NNS ._. ”_'' In_IN 2011_CD ,_, Michele_NNP Bachmann_NNP ,_, then_RB a_DT member_NN of_IN Congress_NNP from_IN Minnesota_NNP and_CC a_DT Republican_JJ presidential_JJ candidate_NN ,_, called_VBD the_DT vaccine_NN to_TO prevent_VB cervical_JJ cancer_NN “_`` dangerous_JJ ._. ”_''","“ He VBD me he VBZ a NN of NNS who VBP VBN , ” NNP NNP VBD of the NN with the NN - NN , VBG 2 - NN - JJ NNS who VBD VBN “ a NN ” of NNS and RB VBN a JJ NN VBN by NNS in NN . “ They all VBP the JJ NN . ” NNP NNP VBD NNP NNP “ VBZ in those JJ NNS ” about the NNS of NNS . He VBD the NN - NN “ VBZ if you VBP JJ JJ NNS VBG the JJ JJ NN , that you ca RB VB the NN . ” He VBD a NN would RB VB a NN and VB VBN up of “ a NN of NN NNS and JJ NNS RB from the NN and JJ JJ NNPS who RB VBP RB VB a NN VBG in . ” NNP NNP VBD a NN in 2014 , “ NNP : VB the NNP VB , ” VBG that a NN - VBN NN VBN NN , VBN in NNS , VBD JJ for VBG NN in NNS . On his NN , he VBZ the NNPS for NNP NNP and NNP of VBG a “ NN of NN , NN and NN ” that VBZ VBN the NN to VB the NNS of NNS . “ With the NN , NN and NN - VBG NNS VBN , the NNS VBD to the NN , the NNS VBD , the NNS on NN and the NN VBD , there VBZ no NN VBN to VB between a JJ NN and JJ NNS , except NNS , ” NNP NNP VBD . JJ NNS VBP VBN VBN over the JJ JJ NNS by JJ NN , RB VBN by NNS or JJ JJ NNS , RB to the NN of JJ NN NNS , who VBP the NN VBZ JJ to the NNS . The NN NNP NNP VBZ VBN on NNP that RB all NNS VBP JJ . NNP NNP , an JJ NN , VBD on the NN in 2015 , “ I ’ll VB VBN if any NN VBZ VBG to VB me what to VB in my or NNS ’ NNS . ” In 2011 , NNP NNP , RB a NN of NNP from NNP and a JJ JJ NN , VBD the NN to VB JJ NN “ JJ . ”"
247,999,mainstream,"America_NNP does_VBZ not_RB necessarily_RB elect_VB her_PRP$ politicians_NNS for_IN their_PRP$ scientific_JJ savvy_NN ._. So_RB when_WRB the_DT issues_NNS of_IN the_DT day_NN require_VBP a_DT grasp_NN on_IN science_NN ,_, politicians_NNS '_POS statements_NNS can_MD get_VB a_DT little_JJ weird_JJ ._. Here_RB are_VBP six_CD examples_NNS of_IN politicians_NNS who_WP have_VBP stumbled_VBN over_IN science_NN ._. Rep._NNP Todd_NNP Akin_NNP (_-LRB- R_NNP -_HYPH Mo_NNP )_-RRB- is_VBZ in_IN hot_JJ water_NN with_IN the_DT public_NN —_: and_CC his_PRP$ own_JJ political_JJ party_NN —_: for_IN claiming_VBG that_IN pregnancy_NN from_IN ""_`` legitimate_JJ rape_NN ""_'' is_VBZ rare_JJ because_IN ""_`` the_DT female_JJ body_NN has_VBZ ways_NNS to_TO try_VB to_TO shut_VB that_DT whole_JJ thing_NN down_RP ._. ""_'' Akin_NNP 's_POS views_NNS ,_, which_WDT he_PRP has_VBZ since_RB recanted_VBN ,_, are_VBP extremely_RB non-scientific_JJ ._. Pregnancy_NN requires_VBZ sperm_NN and_CC egg_NN ,_, and_CC it_PRP does_VBZ n't_RB matter_VB how_WRB the_DT two_CD meet_VBP ._. Rick_NNP Santorum_NNP 's_POS ""_`` Tell_VB that_DT to_IN a_DT plant_NN ._. ""_'' >_NFP Former_JJ Pennsylvania_NNP senator_NNP Rick_NNP Santorum_NNP is_VBZ an_DT avid_JJ denier_NN of_IN global_JJ warming_NN ,_, decrying_VBG warnings_NNS of_IN climate_NN change_NN as_IN a_DT hoax_NN ._. In_IN one_CD of_IN his_PRP$ more_RBR memorable_JJ comments_NNS ,_, Santorum_NNP scoffed_VBD at_IN fears_NNS of_IN carbon_NN emissions_NNS in_IN a_DT speech_NN at_IN the_DT Gulf_NNP Coast_NNP Energy_NNP Summit_NNP in_IN Biloxi_NNP ,_, Miss_NNP ._. ""_`` The_DT dangers_NNS of_IN carbon_NN dioxide_NN ?_. ""_'' Santorum_NNP said_VBD on_IN March_NNP 12_CD ,_, 2012_CD ._. ""_`` Tell_VB that_DT to_IN a_DT plant_NN ,_, how_WRB dangerous_JJ carbon_NN dioxide_NN is_VBZ ._. ""_'' Santorum_NNP is_VBZ not_RB alone_JJ in_IN his_PRP$ use_NN of_IN the_DT ""_`` carbon_NN is_VBZ not_RB dangerous_JJ ""_'' talking_NN point_NN ._. Rep._NNP Michele_NNP Bachmann_NNP (_-LRB- R_NNP -_HYPH Minn._NNP )_-RRB- has_VBZ downplayed_VBN human_JJ carbon_NN emissions_NNS arguing_VBG that_IN carbon_NN dioxide_NN is_VBZ ""_`` natural_JJ ,_, ""_'' and_CC saying_VBG ,_, ""_`` life_NN on_IN planet_NN Earth_NNP ca_MD n't_RB even_RB exist_VB without_IN carbon_NN dioxide_NN ._. ""_'' [_-LRB- Busted_VBN !_. 10_CD Climate_NNP Change_NNP Myths_NNPS ]_-RRB- Plants_NNS do_VBP require_VB carbon_NN dioxide_NN for_IN photosynthesis_NN ._. But_CC what_WP 's_VBZ the_DT saying_NN about_IN too_RB much_JJ of_IN a_DT good_JJ thing_NN ?_. In_IN fact_NN ,_, too_RB much_JJ CO2_NN can_MD actually_RB decrease_VB photosynthesis_NN in_IN some_DT plants_NNS ,_, according_VBG to_IN a_DT 1985_CD study_NN published_VBN in_IN the_DT journal_NN Photosynthesis_NNP Research_NNP ._. Overdosing_VBG on_IN CO2_NN can_MD also_RB prevent_VB some_DT grasses_NNS ,_, including_VBG wheat_NN ,_, from_IN taking_VBG up_RP nitrate_NN ,_, a_DT crucial_JJ nutrient_NN for_IN plant_NN growth_NN ,_, according_VBG to_IN research_NN published_VBN in_IN the_DT journal_NNP Science_NNP in_IN 2010_CD ._. More_RBR importantly_RB ,_, carbon_NN dioxide_NN is_VBZ a_DT greenhouse_NN gas_NN ,_, meaning_VBG it_PRP traps_VBZ heat_NN in_IN our_PRP$ atmosphere_NN ._. As_IN such_JJ the_DT gas_NN can_MD be_VB very_RB dangerous_JJ if_IN it_PRP means_VBZ an_DT increase_NN in_IN global_JJ average_JJ temperatures_NNS that_WDT melt_VBP ice_NN caps_NNS ,_, raise_VBP sea_NN levels_NNS and_CC cause_VBP more_JJR extreme_JJ weather_NN events_NNS ._. After_IN a_DT Republican_JJ debate_NN in_IN September_NNP 2011_CD ,_, then_RB -_HYPH presidential_JJ nominee_NN hopeful_JJ Rep._NNP Michele_NNP Bachmann_NNP went_VBD on_IN Fox_NNP News_NNP and_CC NBC_NNP with_IN an_DT anecdote_NN warning_NN against_IN Gardasil_NNP ,_, a_DT vaccine_NN that_WDT protects_VBZ against_IN a_DT virus_NN that_WDT can_MD cause_VB cervical_JJ cancer_NN ._. ""_`` There_EX ’s_VBZ a_DT woman_NN who_WP came_VBD up_RP crying_VBG to_IN me_PRP tonight_NN after_IN the_DT debate_NN ,_, ""_'' Bachmann_NNP told_VBD Fox_NNP 's_POS Greta_NNP Van_NNP Susteren_NNP ._. ""_`` She_PRP said_VBD her_PRP$ daughter_NN was_VBD given_VBN that_DT vaccine_NN ._. She_PRP told_VBD me_PRP her_PRP$ daughter_NN suffered_VBD mental_JJ retardation_NN as_IN a_DT result_NN of_IN that_DT vaccine_NN ._. There_EX are_VBP very_RB dangerous_JJ consequences_NNS ._. ""_'' Bachmann_NNP 's_POS comments_NNS reflect_VBP anti-vaccine_JJ notions_NNS found_VBN on_IN both_CC the_DT political_JJ right_NN and_CC left_JJ ,_, but_CC they_PRP do_VBP n't_RB appear_VB to_TO reflect_VB reality_NN ._. The_DT Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- and_CC the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- keep_VBP a_DT national_JJ database_NN of_IN adverse_JJ vaccine_NN reactions_NNS ._. For_IN Gardasil_NNP ,_, the_DT most_RBS common_JJ problems_NNS are_VBP fainting_VBG (_-LRB- from_IN the_DT jab_NN )_-RRB- ,_, pain_NN and_CC redness_NN at_IN the_DT site_NN of_IN the_DT injection_NN ,_, and_CC dizziness_NN ,_, nausea_NN and_CC headache_NN ._. There_EX have_VBP not_RB been_VBN reports_NNS of_IN mental_JJ retardation_NN caused_VBN by_IN the_DT vaccine_NN ._. Christine_NNP O'Donnell_NNP and_CC the_DT mice_NNS with_IN human_JJ brains_NNS Sometimes_RB ,_, political_JJ science_NN -_HYPH gaffes_NNS spring_NN from_IN misremembered_VBN news_NN bites_NNS ._. That_DT seems_VBZ to_TO be_VB the_DT case_NN for_IN Christine_NNP O'Donnell_NNP ,_, a_DT Tea_NNP Party_NNP favorite_NN who_WP ,_, during_IN an_DT appearance_NN on_IN The_DT O'Reilly_NNP Factor_NNP in_IN 2007_CD ,_, made_VBD a_DT strange_JJ case_NN against_IN cloning_NN and_CC stem_NN -_HYPH cell_NN research_NN ._. ""_`` American_JJ scientific_JJ companies_NNS are_VBP cross_NN -_HYPH breeding_NN humans_NNS and_CC animals_NNS and_CC coming_VBG up_RP with_IN mice_NNS with_IN fully_RB functioning_VBG human_JJ brains_NNS ,_, ""_'' O'Donnell_NNP said_VBD ._. ""_`` So_RB they_PRP 're_VBP already_RB into_IN this_DT experiment_NN ._. ""_'' Not_RB quite_RB ._. It_PRP seems_VBZ the_DT research_NN O'Donnell_NNP was_VBD referring_VBG to_IN was_VBD a_DT 2005_CD study_NN in_IN which_WDT fetal_JJ mice_NNS were_VBD injected_VBN with_IN human_JJ embryonic_JJ stem_NN cells_NNS ._. The_DT mice_NNS were_VBD born_VBN with_IN human_JJ brain_NN cells_NNS in_IN their_PRP$ skulls_NNS ,_, but_CC certainly_RB not_RB human_JJ brains_NNS —_: and_CC there_EX was_VBD no_DT ""_`` cross_NN -_HYPH breeding_NN ""_'' involved_VBN ._. The_DT mouse_NN brains_NNS were_VBD more_JJR than_IN 99_CD percent_NN mouse_NN cells_NNS ,_, and_CC the_DT interloping_VBG neurons_NNS did_VBD not_RB change_VB the_DT rodents_NNS '_POS behavior_NN ._. The_DT ultimate_JJ goal_NN of_IN the_DT study_NN was_VBD to_TO develop_VB stem_NN -_HYPH cell_NN treatments_NNS for_IN neurological_JJ diseases_NNS ,_, such_JJ as_IN Parkinson_NNP 's_POS and_CC Alzheimer's_NNP ._. Are_VBP breast_NN implants_NNS good_JJ or_CC bad_JJ for_IN you_PRP ?_. Do_VB n't_RB ask_VB Sen._NNP Tom_NNP Coburn_NNP (_-LRB- R_NNP -_HYPH Okla_NNP ._. )_-RRB- ._. During_IN a_DT 2005_CD Senate_NNP Judiciary_NNP Committee_NNP hearing_NN about_IN class_NN -_HYPH action_NN lawsuits_NNS ,_, Coburn_NNP brought_VBD up_RP lawsuits_NNS related_JJ to_IN silicone_NN breast_NN implants_NNS ._. ""_`` I_PRP thought_VBD I_PRP would_MD share_VB with_IN you_PRP what_WDT science_NN says_VBZ today_NN about_IN silicone_NN breast_NN implants_NNS ,_, ""_'' the_DT Washington_NNP Post_NNP quotes_VBZ Coburn_NNP saying_VBG ._. ""_`` If_IN you_PRP have_VBP them_PRP ,_, you_PRP 're_VBP healthier_JJR than_IN if_IN you_PRP do_VBP n't_RB ._. That_DT is_VBZ what_WP the_DT ultimate_JJ science_NN shows_VBZ ._. …_NFP In_IN fact_NN ,_, there_EX 's_VBZ no_DT science_NN that_WDT shows_VBZ that_IN silicone_NN breast_NN implants_NNS are_VBP detrimental_JJ and_CC ,_, in_IN fact_NN ,_, they_PRP make_VBP you_PRP healthier_JJR ._. ""_'' It_PRP 's_VBZ not_RB entirely_RB clear_JJ what_WDT health_NN benefits_NNS Coburn_NNP was_VBD referring_VBG to_IN ,_, though_IN SourceWatch_NNP ,_, a_DT website_NN run_VBN by_IN the_DT Center_NNP for_IN Media_NNP and_CC Democracy_NNP ,_, suggests_VBZ that_IN perhaps_RB he_PRP meant_VBD to_TO reference_VB a_DT 2005_CD study_NN published_VBN in_IN the_DT journal_NNP Breast_NNP Cancer_NNP Research_NNP that_WDT found_VBD that_IN women_NNS who_WP got_VBD breast_NN implants_NNS after_IN mastectomy_NN from_IN early_JJ -_HYPH stage_NN cancer_NN had_VBD less_JJR risk_NN for_IN later_JJR breast_NN cancer_NN mortality_NN than_IN women_NNS who_WP did_VBD not_RB get_VB them_PRP ._. The_DT women_NNS with_IN implants_NNS were_VBD younger_JJR and_CC less_RBR likely_JJ to_TO have_VB disease_NN that_WDT had_VBD spread_VBN than_IN the_DT women_NNS who_WP did_VBD not_RB get_VB the_DT implants_NNS ,_, however_RB ._. [_-LRB- Cleavage_NN Countdown_NN :_: 8_CD Facts_NNS About_IN Breasts_NNS ]_-RRB- According_VBG to_IN the_DT National_NNP Cancer_NNP Institute_NNP ,_, there_EX is_VBZ no_DT association_NN between_IN breast_NN implants_NNS and_CC later_JJR breast_NN cancer_NN ._. The_DT center_NN did_VBD not_RB ,_, however_RB ,_, report_VB any_DT health_NN benefits_NNS for_IN a_DT boob_NN job_NN ._. During_IN the_DT presidential_JJ campaign_NN of_IN 2008_CD ,_, then_RB -_HYPH candidate_NN Barack_NNP Obama_NNP struggled_VBD with_IN the_DT science_NN of_IN vaccines_NNS and_CC autism_NN ._. At_IN a_DT rally_NN in_IN Pennsylvania_NNP ,_, Obama_NNP told_VBD the_DT crowd_NN ,_, ""_`` We_PRP 've_VBP seen_VBN just_RB a_DT skyrocketing_VBG autism_NN rate_NN ._. Some_DT people_NNS are_VBP suspicious_JJ that_IN it's_PRP connected_VBN to_IN the_DT vaccines_NNS …_. The_DT science_NN right_RB now_RB is_VBZ inconclusive_JJ ,_, but_CC we_PRP have_VBP to_TO research_VB it_PRP ._. ""_'' While_IN Obama_NNP avoided_VBD touting_VBG a_DT link_NN between_IN vaccines_NNS and_CC autism_NN ,_, his_PRP$ statement_NN on_IN ""_`` inconclusive_JJ ""_'' research_NN does_VBZ n't_RB pass_VB muster_NN ._. There_EX is_VBZ no_DT evidence_NN that_IN vaccines_NNS cause_VBP autism_NN ,_, despite_IN multiple_JJ studies_NNS that_WDT attempted_VBD to_TO find_VB such_PDT a_DT link_NN ._. In_IN fact_NN ,_, the_DT study_NN that_WDT first_RB touted_VBD this_DT link_NN was_VBD retracted_VBN in_IN 2010_CD by_IN the_DT journal_NN The_DT Lancet_NNP ,_, after_IN an_DT independent_JJ council_NN concluded_VBD that_IN the_DT study_NN was_VBD fatally_RB flawed_JJ ._. For_IN example_NN ,_, the_DT 12_CD children_NNS in_IN the_DT study_NN were_VBD cherry_NN -_HYPH picked_VBN by_IN the_DT researchers_NNS rather_RB than_IN being_VBG an_DT arbitrary_JJ sample_NN of_IN patients_NNS as_IN the_DT paper_NN had_VBD claimed_VBN ._.","NNP VBZ RB RB VB her NNS for their JJ NN . RB when the NNS of the NN VBP a NN on NN , NNS ' NNS can VB a JJ JJ . RB VBP six NNS of NNS who VBP VBN over NN . NNP NNP NNP ( NNP - NNP ) VBZ in JJ NN with the NN — and his JJ JJ NN — for VBG that NN from "" JJ NN "" VBZ JJ because "" the JJ NN VBZ NNS to VB to VB that JJ NN down . "" NNP 's NNS , which he VBZ RB VBN , VBP RB JJ . NN VBZ NN and NN , and it VBZ RB VB how the two VBP . NNP NNP 's "" VB that to a NN . "" > JJ NNP NNP NNP NNP VBZ an JJ NN of JJ NN , VBG NNS of NN NN as a NN . In one of his RBR JJ NNS , NNP VBD at NNS of NN NNS in a NN at the NNP NNP NNP NNP in NNP , NNP . "" The NNS of NN NN ? "" NNP VBD on NNP 12 , 2012 . "" VB that to a NN , how JJ NN NN VBZ . "" NNP VBZ RB JJ in his NN of the "" NN VBZ RB JJ "" NN NN . NNP NNP NNP ( NNP - NNP ) VBZ VBN JJ NN NNS VBG that NN NN VBZ "" JJ , "" and VBG , "" NN on NN NNP ca RB RB VB without NN NN . "" [ VBN ! 10 NNP NNP NNPS ] NNS VBP VB NN NN for NN . But what VBZ the NN about RB JJ of a JJ NN ? In NN , RB JJ NN can RB VB NN in some NNS , VBG to a 1985 NN VBN in the NN NNP NNP . VBG on NN can RB VB some NNS , VBG NN , from VBG up NN , a JJ NN for NN NN , VBG to NN VBN in the NNP NNP in 2010 . RBR RB , NN NN VBZ a NN NN , VBG it VBZ NN in our NN . As JJ the NN can VB RB JJ if it VBZ an NN in JJ JJ NNS that VBP NN NNS , VBP NN NNS and VBP JJR JJ NN NNS . After a JJ NN in NNP 2011 , RB - JJ NN JJ NNP NNP NNP VBD on NNP NNP and NNP with an NN NN against NNP , a NN that VBZ against a NN that can VB JJ NN . "" There VBZ a NN who VBD up VBG to me NN after the NN , "" NNP VBD NNP 's NNP NNP NNP . "" She VBD her NN VBD VBN that NN . She VBD me her NN VBD JJ NN as a NN of that NN . There VBP RB JJ NNS . "" NNP 's NNS VBP JJ NNS VBN on both the JJ NN and JJ , but they VBP RB VB to VB NN . The NNP and NNP NNP ( NNP ) and the NNPS for NNP NNP and NNP ( NNP ) VBP a JJ NN of JJ NN NNS . For NNP , the RBS JJ NNS VBP VBG ( from the NN ) , NN and NN at the NN of the NN , and NN , NN and NN . There VBP RB VBN NNS of JJ NN VBN by the NN . NNP NNP and the NNS with JJ NNS RB , JJ NN - NNS NN from VBN NN NNS . That VBZ to VB the NN for NNP NNP , a NNP NNP NN who , during an NN on The NNP NNP in 2007 , VBD a JJ NN against NN and NN - NN NN . "" JJ JJ NNS VBP NN - NN NNS and NNS and VBG up with NNS with RB VBG JJ NNS , "" NNP VBD . "" RB they VBP RB into this NN . "" RB RB . It VBZ the NN NNP VBD VBG to VBD a 2005 NN in which JJ NNS VBD VBN with JJ JJ NN NNS . The NNS VBD VBN with JJ NN NNS in their NNS , but RB RB JJ NNS — and there VBD no "" NN - NN "" VBN . The NN NNS VBD JJR than 99 NN NN NNS , and the VBG NNS VBD RB VB the NNS ' NN . The JJ NN of the NN VBD to VB NN - NN NNS for JJ NNS , JJ as NNP 's and NNP . VBP NN NNS JJ or JJ for you ? VB RB VB NNP NNP NNP ( NNP - NNP . ) . During a 2005 NNP NNP NNP NN about NN - NN NNS , NNP VBD up NNS JJ to NN NN NNS . "" I VBD I would VB with you what NN VBZ NN about NN NN NNS , "" the NNP NNP VBZ NNP VBG . "" If you VBP them , you VBP JJR than if you VBP RB . That VBZ what the JJ NN VBZ . … In NN , there VBZ no NN that VBZ that NN NN NNS VBP JJ and , in NN , they VBP you JJR . "" It VBZ RB RB JJ what NN NNS NNP VBD VBG to , though NNP , a NN VBN by the NNP for NNP and NNP , VBZ that RB he VBD to VB a 2005 NN VBN in the NNP NNP NNP NNP that VBD that NNS who VBD NN NNS after NN from JJ - NN NN VBD JJR NN for JJR NN NN NN than NNS who VBD RB VB them . The NNS with NNS VBD JJR and RBR JJ to VB NN that VBD VBN than the NNS who VBD RB VB the NNS , RB . [ NN NN : 8 NNS About NNS ] VBG to the NNP NNP NNP , there VBZ no NN between NN NNS and JJR NN NN . The NN VBD RB , RB , VB any NN NNS for a NN NN . During the JJ NN of 2008 , RB - NN NNP NNP VBD with the NN of NNS and NN . At a NN in NNP , NNP VBD the NN , "" We VBP VBN RB a VBG NN NN . Some NNS VBP JJ that it's VBN to the NNS … The NN RB RB VBZ JJ , but we VBP to VB it . "" While NNP VBD VBG a NN between NNS and NN , his NN on "" JJ "" NN VBZ RB VB NN . There VBZ no NN that NNS VBP NN , despite JJ NNS that VBD to VB such a NN . In NN , the NN that RB VBD this NN VBD VBN in 2010 by the NN The NNP , after an JJ NN VBD that the NN VBD RB JJ . For NN , the 12 NNS in the NN VBD NN - VBN by the NNS RB than VBG an JJ NN of NNS as the NN VBD VBN ."
248,167,mainstream,"A_DT scientist_NN prepares_VBZ samples_NNS during_IN the_DT research_NN and_CC development_NN of_IN a_DT vaccine_NN against_IN the_DT coronavirus_NN disease_NN ...._. LONDON_NNP :_: Pharma_NN giant_NN AstraZeneca_NNP struck_VBD a_DT deal_NN Saturday_NNP with_IN Europe_NNP 's_POS Inclusive_NNP Vaccines_NNPS Alliance_NNP to_TO supply_VB up_IN to_IN 400_CD million_CD doses_NNS of_IN an_DT experimental_JJ COVID_NN -_HYPH 19_CD vaccine_NN ,_, as_IN efforts_NNS to_TO boost_VB manufacturing_NN capacity_NN continue_VBP at_IN pace_NN ._. The_DT alliance_NN ,_, which_WDT was_VBD forged_VBN by_IN Germany_NNP ,_, France_NNP ,_, Italy_NNP and_CC the_DT Netherlands_NNPS to_TO speed_VB up_RP production_NN of_IN a_DT vaccine_NN ,_, is_VBZ set_VBN to_TO take_VB delivery_NN of_IN the_DT vaccine_NN being_VBG tested_VBN by_IN the_DT University_NNP of_IN Oxford_NNP by_IN the_DT end_NN of_IN 2020_CD ._. The_DT agreement_NN with_IN AstraZeneca_NNP also_RB aims_VBZ to_TO make_VB the_DT vaccine_NN available_JJ to_IN other_JJ European_JJ countries_NNS that_WDT wish_VBP to_TO take_VB part_NN ._. The_DT cost_NN is_VBZ expected_VBN to_TO be_VB offset_VBN by_IN funding_NN from_IN the_DT governments_NNS ._. ""_`` This_DT agreement_NN will_MD ensure_VB that_IN hundreds_NNS of_IN millions_NNS of_IN Europeans_NNPS have_VBP access_NN to_IN Oxford_NNP University_NNP 's_POS vaccine_NN following_VBG approval_NN ,_, ""_'' AstraZeneca_NNP CEO_NN Pascal_NNP Soriot_NNP said_VBD ._. ""_`` With_IN our_PRP$ European_JJ supply_NN chain_NN due_JJ to_TO begin_VB production_NN soon_RB ,_, we_PRP hope_VBP to_TO make_VB the_DT vaccine_NN available_JJ widely_RB and_CC rapidly_RB ._. ""_`` The_DT agreement_NN is_VBZ the_DT latest_JJS in_IN a_DT series_NN to_TO make_VB the_DT vaccine_NN -_, even_RB though_IN it_PRP is_VBZ not_RB certain_JJ it_PRP will_MD work_VB ._. But_CC so_RB desperate_JJ is_VBZ the_DT need_NN that_WDT scaling_VBG up_RP of_IN manufacturing_NN continues_VBZ despite_IN the_DT risk_NN ._. The_DT Anglo_JJ -_HYPH Swedish_JJ company_NN recently_RB completed_VBD similar_JJ agreements_NNS with_IN Britain_NNP ,_, the_DT United_NNP States_NNPS the_DT Coalition_NNP for_IN Epidemic_NNP Preparedness_NNP Innovations_NNPS ,_, and_CC Gavi_NNP ,_, the_DT Vaccine_NNP Alliance_NNP for_IN 700_CD million_CD doses_NNS ._. A_DT license_NN also_RB has_VBZ been_VBN agreed_VBN with_IN the_DT Serum_NNP Institute_NNP of_IN India_NNP for_IN another_DT 1_CD billion_CD doses_NNS ._. The_DT vaccine_NN was_VBD developed_VBN by_IN Oxford_NNP University_NNP 's_POS Jenner_NNP Institute_NNP ,_, working_VBG with_IN the_DT Oxford_NNP Vaccine_NNP Group_NNP Testing_NNP of_IN the_DT experimental_JJ COVID_NNP -_HYPH 19_CD vaccine_NN began_VBD in_IN healthy_JJ volunteers_NNS in_IN Britain_NNP in_IN April_NNP with_IN over_RB 1,000_CD people_NNS aged_JJ 18_CD to_IN 55_CD ._. Another_DT round_NN with_IN 10,000_CD volunteers_NNS began_VBD last_JJ month_NN ._. Other_JJ companies_NNS ,_, including_VBG Moderna_NNP and_CC Sanofi_NNP ,_, are_VBP racing_VBG to_TO develop_VB and_CC produce_VB a_DT vaccine_NN against_IN the_DT new_JJ coronavirus_NN ,_, a_DT step_NN experts_NNS say_VBP will_MD be_VB crucial_JJ to_IN allowing_VBG countries_NNS to_TO ease_VB their_PRP$ lockdowns_NNS and_CC restrictions_NNS on_IN public_JJ life_NN ._.","A NN VBZ NNS during the NN and NN of a NN against the NN NN .... NNP : NN NN NNP VBD a NN NNP with NNP 's NNP NNPS NNP to VB up to 400 million NNS of an JJ NN - 19 NN , as NNS to VB NN NN VBP at NN . The NN , which VBD VBN by NNP , NNP , NNP and the NNPS to VB up NN of a NN , VBZ VBN to VB NN of the NN VBG VBN by the NNP of NNP by the NN of 2020 . The NN with NNP RB VBZ to VB the NN JJ to JJ JJ NNS that VBP to VB NN . The NN VBZ VBN to VB VBN by NN from the NNS . "" This NN will VB that NNS of NNS of NNPS VBP NN to NNP NNP 's NN VBG NN , "" NNP NN NNP NNP VBD . "" With our JJ NN NN JJ to VB NN RB , we VBP to VB the NN JJ RB and RB . "" The NN VBZ the JJS in a NN to VB the NN - RB though it VBZ RB JJ it will VB . But RB JJ VBZ the NN that VBG up of NN VBZ despite the NN . The JJ - JJ NN RB VBD JJ NNS with NNP , the NNP NNPS the NNP for NNP NNP NNPS , and NNP , the NNP NNP for 700 million NNS . A NN RB VBZ VBN VBN with the NNP NNP of NNP for another 1 billion NNS . The NN VBD VBN by NNP NNP 's NNP NNP , VBG with the NNP NNP NNP NNP of the JJ NNP - 19 NN VBD in JJ NNS in NNP in NNP with RB 1,000 NNS JJ 18 to 55 . Another NN with 10,000 NNS VBD JJ NN . JJ NNS , VBG NNP and NNP , VBP VBG to VB and VB a NN against the JJ NN , a NN NNS VBP will VB JJ to VBG NNS to VB their NNS and NNS on JJ NN ."
249,799,mainstream,"Pathogens_NNS are_VBP microbes_NNS that_WDT cause_VBP diseases_NNS ._. Vaccines_NNS allow_VBP a_DT dead_JJ or_CC altered_VBN form_NN of_IN the_DT disease_NN causing_VBG pathogen_NN to_TO be_VB introduced_VBN into_IN the_DT body_NN ,_, which_WDT contain_VBP a_DT specific_JJ antigen_NN ._. This_DT causes_VBZ the_DT immune_NN system_NN ,_, specifically_RB the_DT white_JJ blood_NN cells_NNS ,_, to_TO produce_VB complementary_JJ antibodies_NNS ,_, which_WDT target_VBP and_CC attach_VB to_IN the_DT antigen_NN ._. When_WRB a_DT white_JJ blood_NN cell_NN engulfs_VBZ and_CC digests_VBZ a_DT pathogen_NN it_PRP is_VBZ called_VBN phagocytosis_NN ._. During_IN the_DT primary_JJ infection_NN the_DT antibodies_NNS slowly_RB increase_VBP ,_, peak_VBP at_IN around_RB ten_CD days_NNS and_CC then_RB gradually_RB decrease_VB ._. A_DT second_JJ exposure_NN to_IN the_DT same_JJ pathogen_NN causes_VBZ the_DT white_JJ blood_NN cells_NNS to_TO respond_VB quickly_RB in_IN order_NN to_TO produce_VB lots_NNS of_IN the_DT relevant_JJ antibodies_NNS ,_, which_WDT prevents_VBZ infection_NN ._.","NNS VBP NNS that VBP NNS . NNS VBP a JJ or VBN NN of the NN VBG NN to VB VBN into the NN , which VBP a JJ NN . This VBZ the NN NN , RB the JJ NN NNS , to VB JJ NNS , which VBP and VB to the NN . When a JJ NN NN VBZ and VBZ a NN it VBZ VBN NN . During the JJ NN the NNS RB VBP , VBP at RB ten NNS and RB RB VB . A JJ NN to the JJ NN VBZ the JJ NN NNS to VB RB in NN to VB NNS of the JJ NNS , which VBZ NN ."
250,1035,mainstream,"People_NNS keep_VBP asking_VBG me_PRP when_WRB I_PRP think_VBP a_DT vaccine_NN against_IN ­coronavirus_NN will_MD be_VB available_JJ ._. It_PRP ’s_VBZ the_DT one_CD breakthrough_NN we_PRP ’re_VBP waiting_VBG for_IN to_TO get_VB life_NN back_RB to_IN normal_JJ ._. It_PRP ’s_VBZ the_DT magic_NN word_NN that_WDT puts_VBZ us_PRP in_IN control_NN of_IN the_DT spread_NN of_IN Covid_NNP -_HYPH 19_CD ,_, giving_VBG us_PRP immunity_NN and_CC ensuring_VBG the_DT R_NN value_NN would_MD always_RB be_VB under_IN 1_CD ._. Then_RB at_IN last_JJ we_PRP could_MD move_VB around_RB more_RBR freely_RB –_: visiting_VBG friends_NNS and_CC family_NN ,_, using_VBG public_JJ transport_NN ,_, returning_VBG to_IN work_NN ._. Ending_VBG lockdown_NN ._. Well_UH ,_, Elisabeth_NNP Mahase_NNP has_VBZ done_VBN a_DT status_NN report_NN in_IN the_DT BMJ_NNP on_IN where_WRB we_PRP stand_VBP on_IN the_DT development_NN of_IN a_DT vaccine_NN ._. And_CC the_DT news_NN is_VBZ encouraging_VBG ._. Robin_NNP Shattock_NNP ,_, who_WP is_VBZ leading_VBG a_DT trial_NN set_VBN to_TO begin_VB in_IN June_NNP at_IN Imperial_NNP College_NNP London_NNP ,_, said_VBD developing_VBG a_DT vaccine_NN should_MD be_VB relatively_RB easy_JJ because_IN ,_, unlike_IN influenza_NN and_CC HIV_NN ,_, the_DT Covid_NNP -_HYPH 19_CD virus_NN seems_VBZ to_TO be_VB relatively_RB stable_JJ ._. He_PRP says_VBZ scientifically_RB there_EX is_VBZ a_DT very_RB high_JJ chance_NN of_IN success_NN ._. Vaccine_NN development_NN is_VBZ a_DT lengthy_JJ process_NN that_WDT normally_RB takes_VBZ more_JJR than_IN 10_CD years_NNS and_CC costs_VBZ hundreds_NNS of_IN millions_NNS of_IN pounds_NNS ._. For_IN Covid_NNP -_HYPH 19_CD we_PRP ’re_VBP trying_VBG to_TO compress_VB the_DT whole_JJ process_NN into_IN months_NNS ._. Once_IN the_DT vaccine_NN is_VBZ found_VBN to_TO be_VB safe_JJ and_CC effective_JJ ,_, it_PRP must_MD then_RB pass_VB the_DT regulatory_JJ requirements_NNS and_CC gain_VB approval_NN for_IN general_JJ use_NN ._. Even_RB once_IN this_DT is_VBZ completed_VBN ,_, the_DT scaling_NN up_RP and_CC manufacturing_NN of_IN the_DT end_NN result_NN on_IN a_DT large_JJ scale_NN is_VBZ complex_JJ and_CC expensive_JJ ._. For_IN a_DT vaccine_NN to_TO be_VB rolled_VBN out_RP ­worldwide_RB ,_, requiring_VBG billions_NNS of_IN doses_NNS ,_, global_JJ manufacturing_NN capacity_NN has_VBZ to_TO start_VB from_IN scratch_NN ._. New_JJ production_NN sites_NNS need_VBP to_TO be_VB built_VBN before_IN clinical_JJ trials_NNS are_VBP completed_VBN to_TO ensure_VB it_PRP could_MD begin_VB being_VBG distributed_VBN as_RB soon_RB as_IN approval_NN is_VBZ given_VBN ._. The_DT sites_NNS should_MD be_VB located_VBN around_IN the_DT world_NN to_TO ensure_VB equitable_JJ distribution_NN ._. Ohid_NNP Yaqub_NNP ,_, senior_JJ lecturer_NN at_IN the_DT University_NNP of_IN Sussex_NNP ’s_POS Science_NNP Policy_NNP Research_NNP Unit_NNP ,_, warned_VBD that_IN “_`` there_EX is_VBZ a_DT long_JJ history_NN of_IN over_RB -_HYPH optimistic_JJ vaccine_NN predictions_NNS ”_'' ._. And_CC he_PRP said_VBD even_RB if_IN a_DT vaccine_NN became_VBD available_JJ ,_, it_PRP ’s_VBZ “_`` too_RB early_JJ even_RB to_TO speculate_VB whether_IN it_PRP will_MD have_VB high_JJ efficacy_NN or_CC low_JJ efficacy_NN ”_'' ._. Mr_NNP Yaqub_NNP added_VBD :_: “_`` I_PRP therefore_RB think_VBP public_JJ policy_NN attention_NN should_MD continue_VB to_TO focus_VB on_IN testing_NN and_CC on_IN healthcare_NN system_NN capacity_NN ,_, and_CC it_PRP should_MD focus_VB on_IN lockdown_NN and_CC managing_VBG the_DT social_JJ costs_NNS of_IN (_-LRB- partial_JJ )_-RRB- lockdown_NN for_IN as_RB long_RB as_IN possible_JJ ._. ”_'' I_PRP ’m_VBP not_RB sure_JJ I_PRP agree_VBP with_IN that_DT ._. We_PRP ’ve_VBP been_VBN caught_VBN on_IN the_DT hop_NN more_JJR than_IN once_RB with_IN this_DT virus_NN ._. At_IN all_DT costs_NNS we_PRP should_MD avoid_VB lack_NN of_IN preparedness_NN to_TO ­manufacture_VB a_DT vaccine_NN on_IN a_DT large_JJ scale_NN ._.","NNS VBP VBG me when I VBP a NN against NN will VB JJ . It VBZ the one NN we VBP VBG for to VB NN RB to JJ . It VBZ the NN NN that VBZ us in NN of the NN of NNP - 19 , VBG us NN and VBG the NN NN would RB VB under 1 . RB at JJ we could VB RB RBR RB – VBG NNS and NN , VBG JJ NN , VBG to NN . VBG NN . Well , NNP NNP VBZ VBN a NN NN in the NNP on where we VBP on the NN of a NN . And the NN VBZ VBG . NNP NNP , who VBZ VBG a NN VBN to VB in NNP at NNP NNP NNP , VBD VBG a NN should VB RB JJ because , unlike NN and NN , the NNP - 19 NN VBZ to VB RB JJ . He VBZ RB there VBZ a RB JJ NN of NN . NN NN VBZ a JJ NN that RB VBZ JJR than 10 NNS and VBZ NNS of NNS of NNS . For NNP - 19 we VBP VBG to VB the JJ NN into NNS . Once the NN VBZ VBN to VB JJ and JJ , it must RB VB the JJ NNS and VB NN for JJ NN . RB once this VBZ VBN , the NN up and NN of the NN NN on a JJ NN VBZ JJ and JJ . For a NN to VB VBN out RB , VBG NNS of NNS , JJ NN NN VBZ to VB from NN . JJ NN NNS VBP to VB VBN before JJ NNS VBP VBN to VB it could VB VBG VBN RB RB as NN VBZ VBN . The NNS should VB VBN around the NN to VB JJ NN . NNP NNP , JJ NN at the NNP of NNP ’s NNP NNP NNP NNP , VBD that “ there VBZ a JJ NN of RB - JJ NN NNS ” . And he VBD RB if a NN VBD JJ , it VBZ “ RB JJ RB to VB whether it will VB JJ NN or JJ NN ” . NNP NNP VBD : “ I RB VBP JJ NN NN should VB to VB on NN and on NN NN NN , and it should VB on NN and VBG the JJ NNS of ( JJ ) NN for RB RB as JJ . ” I VBP RB JJ I VBP with that . We VBP VBN VBN on the NN JJR than RB with this NN . At all NNS we should VB NN of NN to VB a NN on a JJ NN ."
251,205,mainstream,"In_IN the_DT American_JJ political_JJ system_NN ,_, lobbying_NN is_VBZ par_JJ for_IN the_DT course_NN ._. It_PRP has_VBZ come_VBN to_TO be_VB expected_VBN that_IN major_JJ industries_NNS ,_, and_CC the_DT leading_VBG corporations_NNS in_IN those_DT industries_NNS ,_, will_MD seek_VB to_TO influence_VB legislation_NN ,_, regulation_NN ,_, and_CC the_DT enforcement_NN of_IN government_NN decisions_NNS ,_, such_JJ that_IN they_PRP receive_VBP preferential_JJ treatment_NN ._. This_DT could_MD come_VB in_IN the_DT form_NN of_IN campaign_NN contributions_NNS ,_, or_CC actual_JJ lobbying_NN ,_, with_IN a_DT lobbyist_NN working_VBG on_IN behalf_NN of_IN the_DT corporation_NN that_WDT has_VBZ paid_VBN them_PRP to_TO influence_VB a_DT particular_JJ vote_NN or_CC governmental_JJ decision_NN ._. What_WP it_PRP is_VBZ they_PRP are_VBP lobbying_VBG for_IN ,_, though_RB ,_, is_VBZ a_DT more_RBR involved_VBN question_NN ._. Here_RB ,_, using_VBG data_NNS from_IN opensecrets.org_NNP ,_, we_PRP break_VBP down_RP lobbying_NN efforts_NNS ,_, industry_NN by_IN industry_NN ,_, combining_VBG all_DT political_JJ contributions_NNS and_CC lobbying_NN spending_NN from_IN Jan._NNP 1998_CD to_IN March_NNP 31_CD ,_, 2020_CD ._. Figures_NNS are_VBP calculations_NNS by_IN the_DT Center_NNP for_IN Responsive_NNP Politics_NNPS based_VBN on_IN data_NNS from_IN the_DT Senate_NNP Office_NNP of_IN Public_NNP Records_NNPS ._. Let_VB 's_PRP take_VB a_DT closer_JJR look_NN at_IN how_WRB much_JJ each_DT industry_NN spends_VBZ on_IN lobbying_NN ,_, the_DT top_JJ corporate_JJ spenders_NNS in_IN each_DT category_NN ,_, and_CC what_WP spurs_VBZ their_PRP$ lobbying_NN efforts_NNS ._. Spending_VBG $_$ 4.45_CD billion_CD over_IN the_DT past_JJ 22_CD years_NNS ,_, the_DT pharmaceutical_NN and_CC health_NN products_NNS industry_NN has_VBZ far_RB outpaced_VBN all_DT other_JJ industries_NNS in_IN lobbying_NN spending_NN ._. It_PRP 's_VBZ important_JJ to_TO note_VB that_IN this_DT industry_NN includes_VBZ not_RB only_RB drug_NN manufacturers_NNS ,_, but_CC also_RB the_DT sellers_NNS of_IN medical_JJ products_NNS and_CC nutritional_JJ and_CC dietary_NN supplements_NNS ._. From_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD ,_, spending_NN was_VBD topped_VBN by_IN the_DT Pharmaceutical_NNP Research_NNP and_CC Manufacturers_NNPS of_IN America_NNP and_CC Pfizer_NNP Inc_NNP ._. Overall_RB ,_, the_DT industry_NN is_VBZ primarily_RB concerned_JJ with_IN ""_`` resisting_VBG government_NN -_HYPH run_VBN health_NN care_NN ,_, ensuring_VBG a_DT quicker_JJR approval_NN process_NN for_IN drugs_NNS and_CC products_NNS entering_VBG the_DT market_NN ,_, and_CC strengthening_VBG intellectual_JJ property_NN protections_NNS ._. ”_'' In_IN recent_JJ years_NNS ,_, lobbying_NN has_VBZ focused_VBN more_RBR specifically_RB “_'' on_IN the_DT patent_NN system_NN ,_, research_NN funding_NN ,_, and_CC Medicare_NNP ._. ”_'' As_IN is_VBZ to_TO be_VB expected_VBN ,_, lobbying_NN efforts_NNS reached_VBD a_DT fever_NN pitch_NN in_IN 2009_CD ,_, around_IN the_DT drafting_NN of_IN the_DT Affordable_NNP Care_NNP Act_NNP (_-LRB- ACA_NNP )_-RRB- ,_, and_CC reported_VBD a_DT high_NN in_IN 2017_CD with_IN legislative_JJ enactments_NNS again_RB focusing_VBG on_IN changes_NNS to_IN health_NN care_NN ._. Including_VBG health_NN ,_, property_NN ,_, and_CC car_NN insurance_NN companies_NNS ,_, along_IN with_IN agents_NNS and_CC brokers_NNS ,_, the_DT insurance_NN industry_NN has_VBZ historically_RB been_VBN the_DT second_JJ most_RBS generous_JJ /_, aggressive_JJ industry_NN in_IN lobbying_VBG for_IN their_PRP$ interests_NNS ._. In_IN 2019_CD ,_, spending_NN was_VBD $_$ 155.3_CD million_CD ._. Following_VBG the_DT passage_NN of_IN the_DT ACA_NNP and_CC subsequent_JJ developments_NNS under_IN the_DT Trump_NNP administration_NN ,_, health_NN insurance_NN companies_NNS have_VBP been_VBN very_RB involved_VBN in_IN the_DT legislative_JJ process_NN ,_, looking_VBG to_TO influence_VB new_JJ regulations_NNS ._. In_IN 2019_CD ,_, the_DT leading_VBG insurance_NN industry_NN lobbyist_NN corporation_NN was_VBD Blue_NNP Cross_NNP /_, Blue_NNP Shield_NNP ._. The_DT electric_JJ utilities_NNS industry_NN monitors_VBZ legislative_JJ and_CC regulatory_JJ action_NN taken_VBN on_IN a_DT number_NN of_IN fronts_NNS ,_, including_VBG clean_JJ air_NN regulation_NN ,_, waste_NN storage_NN ,_, cybersecurity_NN ,_, and_CC infrastructure_NN ._. The_DT top_JJ lobbyist_NN in_IN electric_JJ utilities_NNS as_IN of_IN March_NNP 2020_CD is_VBZ Duke_NNP Energy_NNP ._. These_DT are_VBP your_PRP$ classic_JJ software_NN and_CC hardware_NN computer_NN tech_NN companies_NNS ,_, some_DT of_IN the_DT founders_NNS of_IN the_DT tech_NN movement_NN that_WDT exists_VBZ today_NN ._. As_IN this_DT industry_NN has_VBZ become_VBN increasingly_RB profitable_JJ ,_, its_PRP$ political_JJ contributions_NNS have_VBP increased_VBN ._. The_DT industry_NN is_VBZ relatively_RB non-partisan_JJ ,_, usually_RB given_VBN to_IN each_DT party_NN evenly_RB ,_, with_IN slight_JJ favoring_VBG to_IN the_DT party_NN in_IN the_DT White_NNP House_NNP ._. Given_VBN the_DT ubiquity_NN of_IN hardware_NN and_CC software_NN ,_, and_CC tech_NN more_RBR generally_RB ,_, it_PRP makes_VBZ sense_NN that_IN lobbying_NN from_IN the_DT electronics_NNS sector_NN is_VBZ varied_VBN ,_, with_IN lobbying_NN efforts_NNS on_IN homeland_NN security_NN ,_, taxes_NNS ,_, copyright_NN ,_, immigration_NN ,_, human_JJ rights_NNS ,_, cybersecurity_NN ,_, and_CC law_NN enforcement_NN data_NN storage_NN ._. As_IN of_IN March_NNP 2020_CD ,_, the_DT top_JJ lobbying_NN spenders_NNS were_VBD Qualcomm_NNP Inc_NNP and_CC Microsoft_NNP Corp_NNP ._. This_DT grouping_NN includes_VBZ small_JJ business_NN ,_, pro-business_JJ ,_, and_CC international_JJ trade_NN associations_NNS ,_, as_RB well_RB as_IN chambers_NNS of_IN commerce_NN ._. Business_NN associations_NNS lobby_VBP on_IN issues_NNS like_IN labor_NN regulations_NNS ,_, intellectual_JJ property_NN ,_, product_NN safety_NN ,_, and_CC taxes_NNS ,_, but_CC mostly_RB ,_, lobbying_NN efforts_NNS have_VBP focused_VBN on_IN civil_JJ justice_NN system_NN reform_NN ._. Business_NN associations_NNS want_VBP to_TO make_VB sure_JJ that_IN damages_NNS awarded_VBN to_IN plaintiffs_NNS involving_VBG torts_NNS or_CC wrongful_JJ acts_NNS that_WDT led_VBD to_IN legal_JJ liabilities_NNS are_VBP limited_VBN (_-LRB- asbestos_NN ,_, medical_JJ malpractice_NN ,_, etc._FW )_-RRB- ._. Other_JJ important_JJ legal_JJ issues_NNS include_VBP business_NN tax_NN reform_NN ,_, including_VBG corporate_JJ tax_NN policy_NN and_CC taxation_NN of_IN U.S._NNP subsidiaries_NNS of_IN foreign_JJ companies_NNS ._. The_DT top_JJ business_NN association_NN lobbyist_NN in_IN 2019_CD was_VBD the_DT U.S_NNP Chamber_NNP of_IN Commerce_NNP ._. As_IN you_PRP might_MD imagine_VB ,_, the_DT oil_NN and_CC gas_NN lobbying_NN sector_NN is_VBZ one_CD of_IN the_DT most_RBS active_JJ lobbying_NN groups_NNS ._. Lobbyist_NN efforts_NNS have_VBP historically_RB focused_VBN on_IN promoting_VBG legislators_NNS with_IN pro-energy_JJ views_NNS in_IN the_DT areas_NNS of_IN fossil_NN fuel_NN production_NN ,_, commodity_NN exploration_NN ,_, and_CC extraction_NN ._. As_IN of_IN March_NNP 2020_CD ,_, the_DT top_JJ lobbying_NN spenders_NNS in_IN the_DT industry_NN were_VBD Chevron_NNP Corp_NNP ,_, Koch_NNP Industries_NNP ,_, and_CC Exxon_NNP Mobil_NNP ._. With_IN spending_NN of_IN nearly_RB $_$ 1.9_CD billion_CD in_IN lobbying_NN efforts_NNS over_IN the_DT past_JJ 22_CD years_NNS ,_, miscellaneous_JJ manufacturing_NN and_CC distributing_VBG is_VBZ an_DT influential_JJ force_NN in_IN legislation_NN and_CC governmental_JJ regulation_NN ._. The_DT sector_NN has_VBZ members_NNS like_IN Honeywell_NNP International_NNP ,_, General_NNP Electric_NNP ,_, Cummins_NNP Inc._NNP ,_, 3_CD M_NNP ,_, and_CC Procter_NNP &_CC Gamble_NNP ,_, and_CC its_PRP$ lobbying_NN interests_NNS and_CC efforts_NNS reflect_VBP this_DT wide_JJ array_NN ._. Having_VBG spent_VBN $_$ 3.4_CD million_CD from_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD ,_, the_DT National_NNP Association_NNP of_IN Manufacturers_NNPS is_VBZ the_DT industry_NN ’s_POS top_JJ lobbyist_NN ._. This_DT category_NN includes_VBZ all_DT healthcare_NN institutions_NNS —_: hospitals_NNS ,_, nursing_NN homes_NNS ,_, hospice_NN providers_NNS ,_, and_CC drug_NN and_CC alcohol_NN inpatient_NN centers_NNS ._. Lobbying_NN in_IN this_DT industry_NN was_VBD especially_RB active_JJ in_IN 2009_CD and_CC again_RB in_IN 2017_CD with_IN legislative_JJ actions_NNS involving_VBG health_NN care_NN and_CC the_DT Affordable_NNP Care_NNP Act_NNP ._. At_IN present_NN ,_, lobbyist_NN efforts_NNS in_IN the_DT sector_NN are_VBP generally_RB focused_VBN on_IN cost_NN management_NN ,_, insurance_NN allocations_NNS ,_, spending_NN on_IN employee_NN training_NN ,_, prevention_NN of_IN physician_NN pay_NN reductions_NNS ,_, and_CC costs_NNS associated_VBN with_IN Medicaid_NN and_CC Medicare_NNP ._. The_DT leading_VBG spender_NN from_IN Jan._NNP 2020_CD through_IN March_NNP 2020_CD was_VBD the_DT American_NNP Hospital_NNP Association_NNP ,_, with_IN $_$ 7.2_CD million_CD ._. Political_JJ contributions_NNS and_CC lobbying_NN efforts_NNS from_IN the_DT education_NN industry_NN come_VBP mostly_RB from_IN individual_JJ educators_NNS or_CC administrators_NNS ,_, as_IN educational_JJ institutions_NNS are_VBP not_RB usually_RB able_JJ to_TO form_VB political_JJ action_NN committees_NNS (_-LRB- PACs_NNS )_-RRB- ._. Areas_NNS of_IN interest_NN for_IN educators_NNS and_CC education_NN lobbyists_NNS include_VBP the_DT federal_JJ budget_NN (_-LRB- allocations_NNS for_IN research_NN money_NN ,_, programs_NNS ,_, and_CC student_NN aid_NN )_-RRB- and_CC student_NN loans_NNS ,_, and_CC specifically_RB the_DT Student_NNP Loan_NNP Fairness_NNP Act_NNP ,_, which_WDT prevented_VBD student_NN loans_NNS from_IN doubling_VBG when_WRB the_DT congressional_JJ agreement_NN expired_VBD ._. Lobbyists_NNS in_IN the_DT education_NN sector_NN spent_VBD $_$ 82.2_CD million_CD in_IN 2019_CD with_IN the_DT Association_NNP of_IN American_NNP Medical_NNP Colleges_NNPS coming_VBG in_RP as_IN a_DT top_JJ spender_NN ._.","In the JJ JJ NN , NN VBZ JJ for the NN . It VBZ VBN to VB VBN that JJ NNS , and the VBG NNS in those NNS , will VB to VB NN , NN , and the NN of NN NNS , JJ that they VBP JJ NN . This could VB in the NN of NN NNS , or JJ NN , with a NN VBG on NN of the NN that VBZ VBN them to VB a JJ NN or JJ NN . What it VBZ they VBP VBG for , RB , VBZ a RBR VBN NN . RB , VBG NNS from NNP , we VBP down NN NNS , NN by NN , VBG all JJ NNS and NN NN from NNP 1998 to NNP 31 , 2020 . NNS VBP NNS by the NNP for NNP NNPS VBN on NNS from the NNP NNP of NNP NNPS . VB 's VB a JJR NN at how JJ each NN VBZ on NN , the JJ JJ NNS in each NN , and what VBZ their NN NNS . VBG $ 4.45 billion over the JJ 22 NNS , the NN and NN NNS NN VBZ RB VBN all JJ NNS in NN NN . It VBZ JJ to VB that this NN VBZ RB RB NN NNS , but RB the NNS of JJ NNS and JJ and NN NNS . From NNP 2020 through NNP 2020 , NN VBD VBN by the NNP NNP and NNPS of NNP and NNP NNP . RB , the NN VBZ RB JJ with "" VBG NN - VBN NN NN , VBG a JJR NN NN for NNS and NNS VBG the NN , and VBG JJ NN NNS . ” In JJ NNS , NN VBZ VBN RBR RB “ on the NN NN , NN NN , and NNP . ” As VBZ to VB VBN , NN NNS VBD a NN NN in 2009 , around the NN of the NNP NNP NNP ( NNP ) , and VBD a NN in 2017 with JJ NNS RB VBG on NNS to NN NN . VBG NN , NN , and NN NN NNS , along with NNS and NNS , the NN NN VBZ RB VBN the JJ RBS JJ / JJ NN in VBG for their NNS . In 2019 , NN VBD $ 155.3 million . VBG the NN of the NNP and JJ NNS under the NNP NN , NN NN NNS VBP VBN RB VBN in the JJ NN , VBG to VB JJ NNS . In 2019 , the VBG NN NN NN NN VBD NNP NNP / NNP NNP . The JJ NNS NN VBZ JJ and JJ NN VBN on a NN of NNS , VBG JJ NN NN , NN NN , NN , and NN . The JJ NN in JJ NNS as of NNP 2020 VBZ NNP NNP . These VBP your JJ NN and NN NN NN NNS , some of the NNS of the NN NN that VBZ NN . As this NN VBZ VBN RB JJ , its JJ NNS VBP VBN . The NN VBZ RB JJ , RB VBN to each NN RB , with JJ VBG to the NN in the NNP NNP . VBN the NN of NN and NN , and NN RBR RB , it VBZ NN that NN from the NNS NN VBZ VBN , with NN NNS on NN NN , NNS , NN , NN , JJ NNS , NN , and NN NN NN NN . As of NNP 2020 , the JJ NN NNS VBD NNP NNP and NNP NNP . This NN VBZ JJ NN , JJ , and JJ NN NNS , RB RB as NNS of NN . NN NNS VBP on NNS like NN NNS , JJ NN , NN NN , and NNS , but RB , NN NNS VBP VBN on JJ NN NN NN . NN NNS VBP to VB JJ that NNS VBN to NNS VBG NNS or JJ NNS that VBD to JJ NNS VBP VBN ( NN , JJ NN , FW ) . JJ JJ JJ NNS VBP NN NN NN , VBG JJ NN NN and NN of NNP NNS of JJ NNS . The JJ NN NN NN in 2019 VBD the NNP NNP of NNP . As you might VB , the NN and NN NN NN VBZ one of the RBS JJ NN NNS . NN NNS VBP RB VBN on VBG NNS with JJ NNS in the NNS of NN NN NN , NN NN , and NN . As of NNP 2020 , the JJ NN NNS in the NN VBD NNP NNP , NNP NNP , and NNP NNP . With NN of RB $ 1.9 billion in NN NNS over the JJ 22 NNS , JJ NN and VBG VBZ an JJ NN in NN and JJ NN . The NN VBZ NNS like NNP NNP , NNP NNP , NNP NNP , 3 NNP , and NNP & NNP , and its NN NNS and NNS VBP this JJ NN . VBG VBN $ 3.4 million from NNP 2020 through NNP 2020 , the NNP NNP of NNPS VBZ the NN ’s JJ NN . This NN VBZ all NN NNS — NNS , NN NNS , NN NNS , and NN and NN NN NNS . NN in this NN VBD RB JJ in 2009 and RB in 2017 with JJ NNS VBG NN NN and the NNP NNP NNP . At NN , NN NNS in the NN VBP RB VBN on NN NN , NN NNS , NN on NN NN , NN of NN NN NNS , and NNS VBN with NN and NNP . The VBG NN from NNP 2020 through NNP 2020 VBD the NNP NNP NNP , with $ 7.2 million . JJ NNS and NN NNS from the NN NN VBP RB from JJ NNS or NNS , as JJ NNS VBP RB RB JJ to VB JJ NN NNS ( NNS ) . NNS of NN for NNS and NN NNS VBP the JJ NN ( NNS for NN NN , NNS , and NN NN ) and NN NNS , and RB the NNP NNP NNP NNP , which VBD NN NNS from VBG when the JJ NN VBD . NNS in the NN NN VBD $ 82.2 million in 2019 with the NNP of NNP NNP NNPS VBG in as a JJ NN ."
252,1271,mainstream,"When_WRB the_DT parents_NNS of_IN Hannah_NNP Poling_NNP ,_, a_DT nine_CD -_HYPH year_NN -_HYPH old_JJ ,_, Athens_NNP ,_, Ga._NNP ,_, girl_NN who_WP was_VBD diagnosed_VBN with_IN autism_NN just_RB after_IN the_DT age_NN of_IN two_CD ,_, announced_VBD that_IN a_DT federal_JJ vaccine_NN injury_NN court_NN had_VBD awarded_VBN them_PRP a_DT settlement_NN ,_, the_DT case_NN reignited_VBD a_DT decade_NN -_HYPH old_JJ debate_NN about_IN whether_IN vaccines_NNS could_MD potentially_RB trigger_VB the_DT disorder_NN ._. But_CC what_WP was_VBD somewhat_RB lost_VBN in_IN much_JJ of_IN the_DT coverage_NN of_IN the_DT case_NN was_VBD a_DT little_RB -_HYPH known_VBN condition_NN that_WDT the_DT court_NN said_VBD was_VBD aggravated_VBN by_IN the_DT vaccine_NN ,_, and_CC which_WDT gave_VBD Hannah_NNP the_DT features_NNS of_IN autism_NN ._. That_DT little_JJ known_VBN condition_NN —_: ""_`` mitochondrial_JJ disorder_NN ""_'' —_: involves_VBZ the_DT parts_NNS of_IN cells_NNS frequently_RB referred_VBN to_IN as_IN their_PRP$ ""_`` power_NN plants_NNS ,_, ""_'' because_IN they_PRP turn_VBP sugar_NN into_IN energy_NN ._. Mitochondria_NN are_VBP found_VBN in_IN all_DT tissues_NNS and_CC organs_NNS in_IN the_DT body_NN ,_, and_CC when_WRB they_PRP do_VBP not_RB work_VB properly_RB they_PRP can_MD cause_VB or_CC worsen_VB diseases_NNS from_IN diabetes_NN to_IN brain_NN disorders_NNS ._. Jay_NNP Gargus_NNP ,_, a_DT specialist_NN in_IN human_JJ genetics_NN and_CC metabolism_NN at_IN the_DT University_NNP of_IN California_NNP ,_, Irvine_NNP ,_, says_VBZ mitochondrial_JJ disorders_NNS are_VBP a_DT bit_NN like_IN an_DT electrical_JJ brownout_NN :_: ""_`` As_IN the_DT electrical_JJ voltage_NN starts_VBZ falling_VBG ,_, different_JJ appliances_NNS will_MD start_VB to_TO fail_VB ,_, ""_'' he_PRP says_VBZ ._. ""_`` First_RB ,_, the_DT television_NN might_MD turn_VB off_RP ,_, then_RB the_DT lights_NNS might_MD go_VB off_RP ._. ""_'' In_IN July_NNP 2000_CD ,_, at_IN 19_CD months_NNS of_IN age_NN ,_, Poling_NNP received_VBD five_CD vaccines_NNS containing_VBG nine_CD immunizations_NNS —_: including_VBG inoculations_NNS against_IN rubella_NN (_-LRB- German_JJ measles_NNS )_-RRB- ,_, mumps_NNS and_CC chicken_NN pox_NN ._. The_DT girl_NN had_VBD been_VBN developing_VBG normally_RB ,_, according_VBG to_IN her_PRP$ parents_NNS —_: her_PRP$ father_NN ,_, Jon_NNP ,_, is_VBZ a_DT Johns_NNP Hopkins–trained_NNP ,_, practicing_VBG neurologist_NN ,_, her_PRP$ mother_NN is_VBZ an_DT attorney_NN and_CC registered_VBN nurse_NN —_: but_CC in_IN the_DT months_NNS after_IN the_DT shots_NNS ,_, she_PRP developed_VBD a_DT fever_NN and_CC litany_NN of_IN other_JJ symptoms_NNS :_: diarrhea_NN ,_, appetite_NN loss_NN and_CC intermittent_JJ screaming_NN ._. A_DT pediatric_JJ neurologist_NN examining_VBG her_PRP in_IN February_NNP 2001_CD later_RBR noted_VBD that_IN she_PRP had_VBD lost_VBN some_DT of_IN the_DT speech_NN she_PRP had_VBD previously_RB acquired_VBN ,_, was_VBD no_RB longer_RBR making_VBG eye_NN contact_NN ,_, and_CC was_VBD no_RB longer_RBR sleeping_VBG through_IN the_DT night_NN ._. In_IN its_PRP$ November_NNP 2007_CD decision_NN the_DT vaccine_NN court_NN said_VBD that_IN the_DT inoculations_NNS Poling_NNP received_VBD in_IN July_NNP 2000_CD worsened_VBD her_PRP$ underlying_JJ mitochondrial_JJ disorder_NN (_-LRB- which_WDT was_VBD discovered_VBN nearly_RB a_DT year_NN later_RBR )_-RRB- and_CC led_VBD to_IN brain_NN disease_NN that_WDT appeared_VBD as_IN symptoms_NNS of_IN autism_NN ._. Theoretically_RB ,_, that_DT makes_VBZ sense_NN :_: David_NNP Holtzman_NNP ,_, a_DT pediatric_JJ neurologist_NN at_IN Massachusetts_NNP General_NNP Hospital_NNP in_IN Boston_NNP ,_, notes_VBZ that_IN the_DT brain_NN is_VBZ particularly_RB dependent_JJ on_IN the_DT energy_NN supplied_VBN by_IN the_DT mitochondria_NN ._. ""_`` What_WP 's_VBZ surprising_JJ and_CC hard_JJ to_TO specifically_RB understand_VB is_VBZ why_WRB it's_PRP so_RB characteristically_RB affecting_VBG language_NN function_NN and_CC social_JJ function_NN ,_, ""_'' he_PRP adds_VBZ ._. (_-LRB- In_IN addition_NN to_IN symptoms_NNS of_IN autism_NN ,_, Poling_NNP also_RB reportedly_RB had_VBD muscle_NN weakness_NN ,_, difficulty_NN with_IN motor_NN coordination_NN ,_, and_CC a_DT host_NN of_IN gastrointestinal_JJ problems_NNS ._. )_-RRB- So_RB how_WRB common_JJ are_VBP mitochondrial_JJ disorders_NNS ?_. Could_MD they_PRP explain_VB why_WRB some_DT children_NNS who_WP receive_VBP vaccines_NNS develop_VBP autism_NN ,_, but_CC the_DT vast_JJ majority_NN do_VBP not_RB ?_. In_IN an_DT opinion_NN piece_NN in_IN The_DT Atlanta_NNP Journal_NNP -_HYPH Constitution_NNP ,_, Poling_NNP 's_POS father_NN cited_VBD a_DT 2005_CD study_NN by_IN a_DT Portuguese_JJ research_NN team_NN that_WDT estimates_VBZ as_RB many_JJ as_IN one_CD in_IN five_CD kids_NNS diagnosed_VBN with_IN autism_NN also_RB have_VBP a_DT mitochondrial_JJ disorders_NNS ._. He_PRP notes_VBZ that_IN such_PDT a_DT rate_NN ""_'' does_VBZ not_RB qualify_VB as_IN '_`` rare_JJ ._. '_'' In_IN fact_NN ,_, mitochondrial_JJ dysfunction_NN may_MD be_VB the_DT most_RBS common_JJ medical_JJ condition_NN associated_VBN with_IN autism_NN ._. ""_'' Hannah_NNP 's_POS disorder_NN is_VBZ likely_JJ due_IN to_IN a_DT rare_JJ mutation_NN in_IN her_PRP$ DNA_NN ._. Most_JJS of_IN the_DT DNA_NN responsible_JJ for_IN mitochondria_NN is_VBZ inherited_VBN from_IN mothers_NNS ,_, because_IN mitochondrial_JJ genes_NNS are_VBP carried_VBN in_IN the_DT egg_NN but_CC not_RB sperm_NN ._. Salvatore_NNP DiMauro_NNP ,_, a_DT mitochondria_NN expert_NN at_IN Columbia_NNP University_NNP ,_, notes_VBZ that_IN the_DT point_NN mutation_NN mentioned_VBN in_IN Poling_NNP 's_POS case_NN history_NN --_, published_VBN in_IN the_DT Journal_NNP of_IN Child_NNP Neurology_NNP -_, -_, would_MD imply_VB that_IN both_CC she_PRP and_CC her_PRP$ mother_NN carried_VBD the_DT genetic_JJ variation_NN in_IN all_PDT their_PRP$ tissues_NNS ._. So_RB ,_, he_PRP says_VBZ ,_, ""_`` you_PRP would_MD expect_VB to_TO see_VB the_DT same_JJ results_NNS ""_'' in_IN both_CC the_DT mother_NN and_CC the_DT daughter_NN ._. But_CC Poling_NNP 's_POS mother_NN ,_, Terry_NNP ,_, who_WP is_VBZ an_DT attorney_NN and_CC a_DT registered_VBN nurse_NN ,_, is_VBZ not_RB autistic_JJ ._. That_DT suggests_VBZ the_DT genetic_JJ defect_NN responsible_JJ for_IN Poling_NNP 's_POS condition_NN is_VBZ part_NN of_IN her_PRP$ nuclear_JJ DNA_NN ,_, which_WDT is_VBZ separate_JJ from_IN the_DT mitochondrial_JJ variety_NN ,_, says_VBZ DiMauro_NNP ._. This_DT means_VBZ that_IN ,_, scientifically_RB ,_, from_IN the_DT documents_NNS presented_VBN in_IN the_DT vaccine_NN court_NN ,_, the_DT Polings_NNPS did_VBD not_RB make_VB a_DT case_NN that_WDT deserved_VBD compensation_NN ._. (_-LRB- Attempts_NNS to_TO contact_VB Jon_NNP Poling_NNP about_IN DiMauro_NNP 's_POS concern_NN went_VBD unanswered_JJ ;_, however_RB ,_, he_PRP agreed_VBD that_IN his_PRP$ daughter_NN 's_POS causative_JJ genetic_JJ defect_NN was_VBD likely_RB not_RB in_IN her_PRP$ mitochondrial_JJ DNA_NN in_IN an_DT open_JJ letter_NN on_IN the_DT blog_NN NeuroLogica_NNP ._. )_-RRB- John_NNP Shoffner_NNP ,_, a_DT mitochondrial_JJ disease_NN expert_NN who_WP runs_VBZ a_DT laboratory_NN in_IN Atlanta_NNP ,_, agrees_VBZ ._. In_IN at_IN study_NN of_IN 40_CD patients_NNS with_IN autism_NN —_: including_VBG Poling_NNP ,_, he_PRP found_VBD that_IN two_CD thirds_NNS had_VBD muscle_NN weakness_NN ._. If_IN muscle_NN weakness_NN is_VBZ seen_VBN early_RB on_RP in_IN children_NNS ,_, it_PRP may_MD be_VB a_DT tip_NN -_HYPH off_RP to_IN an_DT underlying_JJ mitochondrial_JJ disorder_NN that_WDT could_MD cause_VB autism_NN ,_, because_IN muscles_NNS are_VBP heavily_RB dependent_JJ on_IN mitochondria_NN as_IN an_DT energy_NN source_NN ._. He_PRP also_RB believes_VBZ that_IN the_DT new_JJ work_NN —_: he_PRP presented_VBD preliminary_JJ results_NNS last_JJ week_NN at_IN the_DT American_NNP Academy_NNP of_IN Neurology_NNP Conference_NNP in_IN Chicago_NNP —_: will_MD help_VB explain_VB why_WRB some_DT children_NNS ,_, such_JJ as_IN Poling_NNP ,_, experience_VBP worsening_VBG symptoms_NNS as_IN a_DT result_NN of_IN a_DT fever_NN ._. He_PRP notes_VBZ that_IN the_DT route_NN from_IN the_DT vaccine_NN to_IN the_DT child_NN 's_POS autism_NN was_VBD by_IN no_DT means_NNS direct_JJ ._. Hannah_NNP 's_POS mitochondria_NN were_VBD already_RB underperforming_VBG ,_, so_RB when_WRB she_PRP developed_VBD a_DT fever_NN from_IN her_PRP$ vaccine_NN ,_, the_DT increased_VBN energy_NN requirements_NNS likely_RB pushed_VBD them_PRP past_IN their_PRP$ thresholds_NNS ._. A_DT fever_NN caused_VBN by_IN an_DT ear_NN infection_NN or_CC the_DT flu_NN would_MD likely_RB have_VB triggered_VBN the_DT autism_NN symptoms_NNS if_IN they_PRP occurred_VBD before_IN or_CC between_IN the_DT ages_NNS of_IN 24_CD and_CC 36_CD months_NNS ,_, he_PRP says_VBZ ,_, which_WDT is_VBZ when_WRB classic_JJ ,_, regressive_JJ autism_NN ,_, which_WDT affects_VBZ one_CD third_NN of_IN sufferers_NNS ,_, usually_RB appears_VBZ ._. Shoffner_NNP notes_VBZ that_IN parents_NNS and_CC advocates_NNS looking_VBG to_TO impugn_VB vaccines_NNS as_IN triggers_NNS for_IN autism_NN —_: or_CC mitochondrial_JJ disease_NN —_: need_VB direct_JJ ,_, not_RB just_RB circumstantial_JJ ,_, evidence_NN ._. ""_`` If_IN you_PRP were_VBD sitting_VBG in_IN a_DT waiting_NN room_NN full_JJ of_IN people_NNS and_CC one_CD person_NN suddenly_RB fell_VBD ill_JJ or_CC died_VBD or_CC something_NN ,_, ""_'' he_PRP says_VBZ ,_, ""_`` would_MD you_PRP arrest_VB the_DT person_NN sitting_VBG right_RB next_RB to_IN them_PRP ?_. ""_'' Jon_NNP Poling_NNP ,_, says_VBZ Shoffner_NNP ,_, has_VBZ been_VBN ""_`` muddying_VBG the_DT waters_NNS ""_'' with_IN some_DT of_IN his_PRP$ comments_NNS ._. ""_`` There_EX is_VBZ no_DT precedent_NN for_IN that_DT type_NN of_IN thinking_NN and_CC no_DT data_NNS for_IN that_DT type_NN of_IN thinking_NN ,_, ""_'' Shoffner_NNP says_VBZ ._.","When the NNS of NNP NNP , a nine - NN - JJ , NNP , NNP , NN who VBD VBN with NN RB after the NN of two , VBD that a JJ NN NN NN VBD VBN them a NN , the NN VBD a NN - JJ NN about whether NNS could RB VB the NN . But what VBD RB VBN in JJ of the NN of the NN VBD a RB - VBN NN that the NN VBD VBD VBN by the NN , and which VBD NNP the NNS of NN . That JJ VBN NN — "" JJ NN "" — VBZ the NNS of NNS RB VBN to as their "" NN NNS , "" because they VBP NN into NN . NN VBP VBN in all NNS and NNS in the NN , and when they VBP RB VB RB they can VB or VB NNS from NN to NN NNS . NNP NNP , a NN in JJ NN and NN at the NNP of NNP , NNP , VBZ JJ NNS VBP a NN like an JJ NN : "" As the JJ NN VBZ VBG , JJ NNS will VB to VB , "" he VBZ . "" RB , the NN might VB off , RB the NNS might VB off . "" In NNP 2000 , at 19 NNS of NN , NNP VBD five NNS VBG nine NNS — VBG NNS against NN ( JJ NNS ) , NNS and NN NN . The NN VBD VBN VBG RB , VBG to her NNS — her NN , NNP , VBZ a NNP NNP , VBG NN , her NN VBZ an NN and VBN NN — but in the NNS after the NNS , she VBD a NN and NN of JJ NNS : NN , NN NN and JJ NN . A JJ NN VBG her in NNP 2001 RBR VBD that she VBD VBN some of the NN she VBD RB VBN , VBD RB RBR VBG NN NN , and VBD RB RBR VBG through the NN . In its NNP 2007 NN the NN NN VBD that the NNS NNP VBD in NNP 2000 VBD her JJ JJ NN ( which VBD VBN RB a NN RBR ) and VBD to NN NN that VBD as NNS of NN . RB , that VBZ NN : NNP NNP , a JJ NN at NNP NNP NNP in NNP , VBZ that the NN VBZ RB JJ on the NN VBN by the NN . "" What VBZ JJ and JJ to RB VB VBZ why it's RB RB VBG NN NN and JJ NN , "" he VBZ . ( In NN to NNS of NN , NNP RB RB VBD NN NN , NN with NN NN , and a NN of JJ NNS . ) RB how JJ VBP JJ NNS ? Could they VB why some NNS who VBP NNS VBP NN , but the JJ NN VBP RB ? In an NN NN in The NNP NNP - NNP , NNP 's NN VBD a 2005 NN by a JJ NN NN that VBZ RB JJ as one in five NNS VBN with NN RB VBP a JJ NNS . He VBZ that such a NN "" VBZ RB VB as ' JJ . ' In NN , JJ NN may VB the RBS JJ JJ NN VBN with NN . "" NNP 's NN VBZ JJ due to a JJ NN in her NN . JJS of the NN JJ for NN VBZ VBN from NNS , because JJ NNS VBP VBN in the NN but RB NN . NNP NNP , a NN NN at NNP NNP , VBZ that the NN NN VBN in NNP 's NN NN -- VBN in the NNP of NNP NNP - - would VB that both she and her NN VBD the JJ NN in all their NNS . RB , he VBZ , "" you would VB to VB the JJ NNS "" in both the NN and the NN . But NNP 's NN , NNP , who VBZ an NN and a VBN NN , VBZ RB JJ . That VBZ the JJ NN JJ for NNP 's NN VBZ NN of her JJ NN , which VBZ JJ from the JJ NN , VBZ NNP . This VBZ that , RB , from the NNS VBN in the NN NN , the NNPS VBD RB VB a NN that VBD NN . ( NNS to VB NNP NNP about NNP 's NN VBD JJ ; RB , he VBD that his NN 's JJ JJ NN VBD RB RB in her JJ NN in an JJ NN on the NN NNP . ) NNP NNP , a JJ NN NN who VBZ a NN in NNP , VBZ . In at NN of 40 NNS with NN — VBG NNP , he VBD that two NNS VBD NN NN . If NN NN VBZ VBN RB on in NNS , it may VB a NN - off to an JJ JJ NN that could VB NN , because NNS VBP RB JJ on NN as an NN NN . He RB VBZ that the JJ NN — he VBD JJ NNS JJ NN at the NNP NNP of NNP NNP in NNP — will VB VB why some NNS , JJ as NNP , VBP VBG NNS as a NN of a NN . He VBZ that the NN from the NN to the NN 's NN VBD by no NNS JJ . NNP 's NN VBD RB VBG , RB when she VBD a NN from her NN , the VBN NN NNS RB VBD them past their NNS . A NN VBN by an NN NN or the NN would RB VB VBN the NN NNS if they VBD before or between the NNS of 24 and 36 NNS , he VBZ , which VBZ when JJ , JJ NN , which VBZ one NN of NNS , RB VBZ . NNP VBZ that NNS and NNS VBG to VB NNS as NNS for NN — or JJ NN — VB JJ , RB RB JJ , NN . "" If you VBD VBG in a NN NN JJ of NNS and one NN RB VBD JJ or VBD or NN , "" he VBZ , "" would you VB the NN VBG RB RB to them ? "" NNP NNP , VBZ NNP , VBZ VBN "" VBG the NNS "" with some of his NNS . "" There VBZ no NN for that NN of NN and no NNS for that NN of NN , "" NNP VBZ ."
253,349,conspiracy,"What_WP ’s_VBZ going_VBG on_RP in_IN the_DT fifth_RB largest_JJS economy_NN in_IN the_DT world_NN arguably_RB points_VBZ to_IN a_DT major_JJ collusion_NN scandal_NN in_IN which_WDT the_DT French_JJ government_NN is_VBZ helping_VBG Big_NNP Pharma_NNP to_TO profit_VB from_IN the_DT expansion_NN of_IN Covid_NNP -_HYPH 19_CD ._. Informed_VBN French_JJ citizens_NNS are_VBP absolutely_RB furious_JJ about_IN it_PRP ._. My_PRP$ initial_JJ question_NN to_IN a_DT serious_JJ ,_, unimpeachable_JJ Paris_NNP source_NN ,_, jurist_NN Valerie_NNP Bugault_NNP ,_, was_VBD about_IN the_DT liaisons_NNS dangereuses_NNS between_IN Macronism_NNP and_CC Big_NNP Pharma_NNP and_CC especially_RB about_IN the_DT mysterious_JJ “_`` disappearance_NN ”_'' –_: more_RBR likely_JJ outright_JJ theft_NN –_: of_IN all_PDT the_DT stocks_NNS of_IN chloroquine_NN in_IN possession_NN of_IN the_DT French_JJ government_NN ._. Respected_VBN Professor_NNP Christian_NNP Perronne_NNP talked_VBD about_IN the_DT theft_NN live_JJ in_IN one_CD of_IN France_NNP ’s_POS 24/7_CD info_NN channels_NNS :_: “_`` The_DT central_JJ pharmacy_NN for_IN the_DT hospitals_NNS announced_VBD today_NN that_IN they_PRP were_VBD facing_VBG a_DT total_JJ rupture_NN of_IN stocks_NNS ,_, that_IN they_PRP were_VBD pillaged_VBN ._. ”_'' With_IN input_NN from_IN another_DT ,_, anonymous_JJ source_NN ,_, it_PRP ’s_VBZ now_RB possible_JJ to_TO establish_VB a_DT timeline_NN that_WDT puts_VBZ in_RP much_RB -_HYPH needed_VBN perspective_NN the_DT recent_JJ actions_NNS of_IN the_DT French_JJ government_NN ._. Let_VB ’s_PRP start_VB with_IN Yves_NNP Levy_NNP ,_, who_WP was_VBD the_DT head_NN of_IN INSERM_NNP –_: the_DT French_NNP National_NNP Institute_NNP of_IN Health_NNP and_CC Medical_NNP Research_NNP –_: from_IN 2014_CD to_IN 2018_CD ,_, when_WRB he_PRP was_VBD appointed_VBN as_IN extraordinary_JJ state_NN councilor_NN for_IN the_DT Macron_NNP administration_NN ._. Only_RB 12_CD people_NNS in_IN France_NNP have_VBP reached_VBN this_DT status_NN ._. Levy_NNP is_VBZ married_VBN to_IN Agnes_NNP Buzy_NNP ,_, who_WP until_IN recently_RB was_VBD minister_NN of_IN health_NN under_IN Macron_NNP ._. Buzy_NNP was_VBD essentially_RB presented_VBN with_IN an_DT “_`` offer_NN you_PRP ca_MD n’t_RB refuse_VB ”_'' by_IN Macron_NNP ’s_POS party_NN to_TO leave_VB the_DT ministry_NN –_: in_IN the_DT middle_NN of_IN the_DT coronavirus_NN crisis_NN –_: and_CC run_VB for_IN Mayor_NNP of_IN Paris_NNP ,_, where_WRB she_PRP was_VBD mercilessly_RB trounced_VBN in_IN the_DT first_JJ round_NN on_IN March_NNP 16_CD ._. Levy_NNP has_VBZ a_DT vicious_JJ running_VBG feud_NN with_IN Professor_NNP Didier_NNP Raoult_NNP –_: prolific_JJ and_CC often_RB -_HYPH cited_VBN Marseille_NNP -_HYPH based_VBN specialist_NN in_IN communicable_JJ diseases_NNS ._. Levy_NNP withheld_VBD the_DT INSERM_NNP label_NN from_IN the_DT world_NN -_HYPH renowned_VBN IHU_NNP (_-LRB- Hospital_NNP -_HYPH University_NNP Institute_NNP )_-RRB- research_NN center_NN directed_VBN by_IN Raoult_NNP ._. In_IN practice_NN ,_, in_IN October_NNP 2019_CD ,_, Levy_NNP revoked_VBD the_DT status_NN of_IN “_`` foundation_NN ”_'' of_IN the_DT different_JJ IHUs_NNS so_IN he_PRP could_MD take_VB over_RP their_PRP$ research_NN ._. Raoult_NNP was_VBD part_NN of_IN a_DT clinical_JJ trial_NN in_IN which_WDT hydroxychloroquine_NN and_CC azithromycin_NN healed_VBD 90_CD %_NN of_IN Covid_NNP -_HYPH 19_CD cases_NNS if_IN they_PRP were_VBD tested_VBN very_RB early_RB ._. (_-LRB- Early_RB ,_, massive_JJ testing_NN is_VBZ at_IN the_DT heart_NN of_IN the_DT successful_JJ South_NNP Korean_JJ strategy_NN ._. )_-RRB- Raoult_NNP is_VBZ opposed_VBN to_IN the_DT total_JJ lockdown_NN of_IN sane_JJ individuals_NNS and_CC possible_JJ carriers_NNS –_: which_WDT he_PRP considers_VBZ “_`` medieval_JJ ,_, ”_'' in_IN an_DT anachronistic_JJ sense_NN ._. He_PRP ’s_VBZ in_IN favor_NN of_IN massive_JJ testing_NN (_-LRB- which_WDT ,_, besides_IN South_NNP Korea_NNP ,_, was_VBD successful_JJ in_IN Singapore_NNP ,_, Taiwan_NNP and_CC Vietnam_NNP )_-RRB- and_CC a_DT fast_JJ treatment_NN with_IN hydroxychloroquine_NN ._. Only_RB contaminated_VBN individuals_NNS should_MD be_VB confined_VBN ._. Chloroquine_NNP costs_VBZ one_CD euro_NN for_IN ten_CD pills_NNS ._. And_CC there_EX ’s_VBZ the_DT rub_NN :_: Big_NNP Pharma_NNP –_: which_WDT ,_, crucially_RB ,_, finances_VBZ INSERM_NNP ,_, and_CC includes_VBZ “_`` national_JJ champion_NN ”_'' Sanofi_NNP –_: would_MD rather_RB go_VB for_IN a_DT way_NN more_RBR profitable_JJ solution_NN ._. Sanofi_NNP for_IN the_DT moment_NN says_VBZ it_PRP is_VBZ “_`` actively_RB preparing_VBG ”_'' to_TO produce_VB chloroquine_NN ,_, but_CC that_DT may_MD take_VB “_`` weeks_NNS ,_, ”_'' and_CC there_EX ’s_VBZ no_DT mention_NN about_IN pricing_NN ._. On_IN January_NNP 13_CD ,_, Agnes_NNP Buzyn_NNP ,_, still_RB France_NNP ’s_POS Health_NNP Minister_NNP ,_, classifies_VBZ chloroquine_NN as_IN a_DT “_`` poisonous_JJ substance_NN ,_, ”_'' from_IN now_RB on_IN only_RB available_JJ by_IN prescription_NN ._. An_DT astonishing_JJ move_NN ,_, considering_VBG that_IN it_PRP has_VBZ been_VBN sold_VBN off_IN the_DT shelf_NN in_IN France_NNP for_IN half_PDT a_DT century_NN ._. On_IN March_NNP 16_CD ,_, the_DT Macron_NNP government_NN orders_VBZ a_DT partial_JJ lockdown_NN ._. There_EX ’s_VBZ not_RB a_DT peep_NN about_IN chloroquine_NN ._. Police_NNS initially_RB are_VBP not_RB required_VBN to_TO wear_VB masks_NNS ;_, most_JJS have_VBP been_VBN stolen_VBN anyway_RB ,_, and_CC there_EX are_VBP not_RB enough_JJ masks_NNS even_RB for_IN health_NN workers_NNS ._. In_IN 2011_CD France_NNP had_VBD nearly_RB 1.5_CD billion_CD masks_NNS :_: 800_CD million_CD surgical_JJ masks_NNS and_CC 600_CD million_CD masks_NNS for_IN health_NN professionals_NNS generally_RB ._. But_CC then_RB ,_, over_IN the_DT years_NNS ,_, the_DT strategic_JJ stocks_NNS were_VBD not_RB renewed_VBN ,_, to_TO please_VB the_DT EU_NNP and_CC to_TO apply_VB the_DT Maastricht_NNP criteria_NNS ,_, which_WDT limited_VBD membership_NN in_IN the_DT Growth_NN and_CC Stability_NN Pact_NN to_IN countries_NNS whose_WP$ budget_NN deficits_NNS did_VBD not_RB exceed_VB 3_CD %_NN of_IN GDP_NN ._. One_CD of_IN those_DT in_IN charge_NN at_IN the_DT time_NN was_VBD Jerome_NNP Salomon_NNP ,_, now_RB a_DT scientific_JJ counselor_NN to_IN the_DT Macron_NNP government_NN ._. On_IN March_NNP 17_CD ,_, Agnes_NNP Buzyn_NNP says_VBZ she_PRP has_VBZ learned_VBN the_DT spread_NN of_IN Covid_NNP -_HYPH 19_CD will_MD be_VB a_DT major_JJ tsunami_NN ,_, for_IN which_WDT the_DT French_JJ health_NN system_NN has_VBZ no_DT solution_NN ._. She_PRP also_RB says_VBZ it_PRP had_VBD been_VBN her_PRP$ understanding_NN that_IN the_DT Paris_NNP mayoral_JJ election_NN “_'' would_MD not_RB take_VB place_NN ”_'' and_CC that_IN it_PRP was_VBD ,_, ultimately_RB ,_, “_`` a_DT masquerade_NN ._. ”_'' What_WP she_PRP does_VBZ not_RB say_VB is_VBZ that_IN she_PRP did_VBD n’t_RB go_VB public_NN at_IN the_DT time_NN she_PRP was_VBD running_VBG because_IN the_DT whole_JJ political_JJ focus_NN by_IN the_DT Macron_NNP political_JJ machine_NN was_VBD on_IN winning_VBG the_DT “_`` masquerade_NN ._. ”_'' The_DT first_JJ round_NN of_IN the_DT election_NN meant_VBD nothing_NN ,_, as_IN Covid_NNP -_HYPH 19_CD was_VBD advancing_VBG ._. The_DT second_JJ round_NN was_VBD postponed_VBN indefinitely_RB ._. She_PRP had_VBD to_TO know_VB about_IN the_DT impending_JJ healthcare_NN disaster_NN ._. But_CC as_IN a_DT candidate_NN of_IN the_DT Macron_NNP machine_NN she_PRP did_VBD not_RB go_VB public_JJ in_IN timely_JJ fashion_NN ._. In_IN quick_JJ succession_NN :_: The_DT Macron_NNP government_NN refuses_VBZ to_TO apply_VB mass_JJ testing_NN ,_, as_IN practiced_VBN with_IN success_NN in_IN South_NNP Korea_NNP and_CC Germany_NNP ._. Le_NNP Monde_NNP and_CC the_DT French_JJ state_NN health_NN agency_NN characterize_VBP Raoult_NNP ’s_POS research_NN as_IN fake_JJ news_NN ,_, before_IN issuing_VBG a_DT retraction_NN ._. Professor_NNP Perrone_NNP reveals_VBZ on_IN the_DT 24/7_CD LCI_NNP news_NN channel_NN that_IN the_DT stock_NN of_IN chloroquine_NN at_IN the_DT French_JJ central_JJ pharmacy_NN has_VBZ been_VBN stolen_VBN ._. Thanks_NN to_IN a_DT tweet_NN by_IN Elon_NNP Musk_NNP ,_, President_NNP Trump_NNP says_VBZ chloroquine_NN should_MD be_VB available_JJ to_IN all_DT Americans_NNPS ._. Sufferers_NNS of_IN lupus_NN and_CC rheumatoid_NN arthritis_NN ,_, who_WP already_RB have_VBP supply_NN problems_NNS with_IN the_DT only_JJ drug_NN that_WDT offers_VBZ them_PRP relief_NN ,_, set_VBP social_JJ media_NN afire_RB with_IN their_PRP$ panic_NN ._. US_NNP doctors_NNS and_CC other_JJ medical_JJ professionals_NNS take_VBP to_IN hoarding_VBG the_DT medicine_NN for_IN the_DT use_NN of_IN themselves_PRP and_CC those_DT close_RB to_IN them_PRP ,_, faking_VBG prescriptions_NNS to_TO indicate_VB they_PRP are_VBP for_IN patients_NNS with_IN lupus_NN or_CC rheumatoid_JJ arthritis_NN ._. Morocco_NNP buys_VBZ the_DT stock_NN of_IN chloroquine_NN from_IN Sanofi_NNP in_IN Casablanca_NNP ._. Pakistan_NNP decides_VBZ to_TO increase_VB its_PRP$ production_NN of_IN chloroquine_NN to_TO be_VB sent_VBN to_IN China_NNP ._. Switzerland_NNP discards_VBZ the_DT total_JJ lockdown_NN of_IN its_PRP$ population_NN ;_, goes_VBZ for_IN mass_JJ testing_NN and_CC fast_JJ treatment_NN ;_, and_CC accuses_VBZ France_NNP of_IN practicing_VBG “_`` spectacle_NN politics_NNS ._. ”_'' Christian_NNP Estrosi_NNP ,_, the_DT mayor_NN of_IN Nice_NNP ,_, having_VBG had_VBN himself_PRP treated_VBN with_IN chloroquine_NN ,_, without_IN any_DT government_NN input_NN ,_, directly_RB calls_VBZ Sanofi_NNP so_IN they_PRP may_MD deliver_VB chloroquine_NN to_IN Nice_JJ hospitals_NNS ._. Because_IN of_IN Raoult_NNP ’s_POS research_NN ,_, a_DT large_JJ -_HYPH scale_NN chloroquine_NN test_NN finally_RB starts_VBZ in_IN France_NNP ,_, under_IN the_DT –_: predictable_JJ –_: direction_NN of_IN INSERM_NNP ,_, which_WDT wants_VBZ to_TO “_`` remake_VB the_DT experiments_NNS in_IN other_JJ independent_JJ medical_JJ centers_NNS ._. ”_'' This_DT will_MD take_VB at_IN least_JJS an_DT extra_JJ six_CD weeks_NNS –_: as_IN the_DT Elysee_NNP Palace_NNP ’s_POS scientific_JJ council_NN now_RB mulls_VBZ the_DT extension_NN of_IN France_NNP ’s_POS total_JJ lockdown_NN to_IN …_SYM six_CD weeks_NNS ._. If_IN joint_JJ use_NN of_IN hydroxychloroquine_NN and_CC azithromycin_NN proves_VBZ definitely_RB effective_JJ among_IN the_DT most_RBS gravely_RB ill_JJ ,_, quarantines_NNS may_MD be_VB reduced_VBN in_IN select_JJ clusters_NNS ._. The_DT only_JJ French_JJ company_NN that_WDT still_RB manufactures_VBZ chloroquine_NN is_VBZ under_IN judicial_JJ intervention_NN ._. That_DT puts_VBZ the_DT chloroquine_NN hoarding_NN and_CC theft_NN into_IN full_JJ perspective_NN ._. It_PRP will_MD take_VB time_NN for_IN these_DT stocks_NNS to_TO be_VB replenished_VBN ,_, thus_RB allowing_VBG Big_NNP Pharma_NNP the_DT leeway_NN to_TO have_VB what_WP it_PRP wants_VBZ :_: a_DT costly_JJ solution_NN ._. It_PRP appears_VBZ the_DT perpetrators_NNS of_IN the_DT chloroquine_NN theft_NN were_VBD very_RB well_RB informed_VBN ._. This_DT chain_NN of_IN events_NNS ,_, astonishing_JJ for_IN a_DT highly_RB developed_VBN G_NNP -_HYPH 7_CD nation_NN proud_JJ of_IN its_PRP$ health_NN service_NN ,_, is_VBZ part_NN of_IN a_DT long_JJ ,_, painful_JJ process_NN embedded_VBN in_IN neoliberal_JJ dogma_NN ._. EU_NNP -_HYPH driven_VBN austerity_NN mixed_VBN with_IN the_DT profit_NN motive_NN resulted_VBD in_IN a_DT very_RB lax_JJ attitude_NN towards_IN the_DT health_NN system_NN ._. As_IN Bugault_NNP told_VBD me_PRP ,_, “_`` test_NN kits_NNS –_: very_RB few_JJ in_IN number_NN –_: were_VBD always_RB available_JJ but_CC mostly_RB for_IN a_DT small_JJ group_NN connected_VBN to_IN the_DT French_JJ government_NN [_-LRB- former_JJ officials_NNS of_IN the_DT Ministry_NNP of_IN Finance_NNP ,_, CEOs_NNS of_IN large_JJ corporations_NNS ,_, oligarchs_NNS ,_, media_NN and_CC entertainment_NN moguls_NNS ]_-RRB- ._. Same_JJ for_IN chloroquine_NN ,_, which_WDT this_DT government_NN did_VBD everything_NN to_TO make_VB inaccessible_JJ for_IN the_DT population_NN ._. They_PRP did_VBD not_RB make_VB life_NN easy_JJ for_IN Professor_NNP Raoult_NNP –_: he_PRP received_VBD death_NN threats_NNS and_CC was_VBD intimidated_VBN by_IN ‘_`` journalists_NNS ._. ’_'' And_CC they_PRP did_VBD not_RB protect_VB vital_JJ stocks_NNS ._. Still_RB under_IN the_DT Hollande_NNP government_NN ,_, there_EX was_VBD a_DT conscious_JJ liquidation_NN of_IN the_DT stock_NN of_IN masks_NNS –_: which_WDT had_VBD existed_VBN in_IN large_JJ quantities_NNS in_IN all_DT hospitals_NNS ._. Not_RB to_TO mention_VB that_IN the_DT suppression_NN of_IN hospital_NN beds_NNS and_CC hospital_NN means_NNS accelerated_VBD under_IN Sarkozy_NNP ._. ”_'' This_DT ties_VBZ in_RP with_IN anguished_JJ reports_NNS by_IN French_JJ citizens_NNS of_IN nurses_NNS now_RB having_VBG to_TO use_VB trash_NN bags_NNS due_IN to_IN the_DT lack_NN of_IN proper_JJ medical_JJ gear_NN ._. At_IN the_DT same_JJ time_NN ,_, in_IN another_DT astonishing_JJ development_NN ,_, the_DT French_JJ state_NN refuses_VBZ to_TO requisition_VB private_JJ hospitals_NNS and_CC clinics_NNS –_: which_WDT are_VBP practically_RB empty_JJ at_IN this_DT stage_NN –_: even_RB as_IN the_DT president_NN of_IN their_PRP$ own_JJ association_NN ,_, Lamine_NNP Garbi_NNP ,_, has_VBZ pleaded_VBN for_IN such_PDT a_DT public_JJ service_NN initiative_NN :_: “_`` I_PRP solemnly_RB demand_VBP that_IN we_PRP are_VBP requisitioned_VBN to_TO help_VB public_JJ hospitals_NNS ._. Our_PRP$ facilities_NNS are_VBP prepared_VBN ._. The_DT wave_NN that_WDT surprised_VBD the_DT east_NN of_IN France_NNP must_MD teach_VB us_PRP a_DT lesson_NN ._. ”_'' Bugault_NNP reconfirms_VBZ the_DT health_NN situation_NN in_IN France_NNP “_'' is_VBZ very_RB serious_JJ and_CC will_MD become_VB even_RB worse_JJR due_IN to_IN these_DT political_JJ decisions_NNS –_: absence_NN of_IN masks_NNS ,_, political_JJ refusal_NN to_TO massively_RB test_VB people_NNS ,_, refusal_NN of_IN free_JJ access_NN to_IN chloroquine_NN –_: in_IN a_DT context_NN of_IN supreme_JJ distress_NN at_IN the_DT hospitals_NNS ._. This_DT will_MD last_VB and_CC destitution_NN will_MD be_VB the_DT norm_NN ._. ”_'' In_IN an_DT explosive_JJ development_NN on_IN Tuesday_NNP ,_, Raoult_NNP said_VBD he_PRP ’s_VBZ not_RB participating_VBG in_IN Macron_NNP ’s_POS scientific_JJ council_NN anymore_RB ,_, even_RB though_IN he_PRP ’s_VBZ not_RB quitting_VBG it_PRP altogether_RB ._. Raoult_NNP once_RB again_RB insists_VBZ on_IN massive_JJ testing_NN on_IN a_DT national_JJ scale_NN to_TO detect_VB suspected_VBN cases_NNS ,_, and_CC then_RB isolate_VB and_CC treat_VB patients_NNS who_WP tested_VBD positive_JJ ._. In_IN a_DT nutshell_NN :_: the_DT South_NNP Korean_JJ model_NN ._. That_DT ’s_VBZ exactly_RB what_WP is_VBZ expected_VBN from_IN the_DT IHU_NNP in_IN Marseille_NNP ,_, where_WRB hundreds_NNS of_IN residents_NNS continue_VBP to_TO queue_VB up_RP for_IN testing_NN ._. And_CC that_DT ties_VBZ in_RP with_IN the_DT conclusions_NNS by_IN a_DT top_JJ Chinese_JJ expert_NN on_IN Covid_NNP -_HYPH 19_CD ,_, Zhang_NNP Nanshan_NNP ,_, who_WP says_VBZ that_IN treatment_NN with_IN chloroquine_NN phospate_NN had_VBD a_DT “_`` positive_JJ impact_NN ,_, ”_'' with_IN patients_NNS testing_VBG negative_JJ after_IN around_RB four_CD days_NNS ._. The_DT key_JJ point_NN has_VBZ been_VBN stressed_VBN by_IN Raoult_NNP :_: Use_VB chloroquine_NN in_IN very_RB special_JJ circumstances_NNS ,_, for_IN people_NNS tested_VBN very_RB early_RB ,_, when_WRB the_DT disease_NN is_VBZ not_RB advanced_VBN yet_RB ,_, and_CC only_RB in_IN these_DT cases_NNS ._. He_PRP ’s_VBZ not_RB advocating_VBG chloroquine_NN for_IN everyone_NN ._. It_PRP ’s_VBZ exactly_RB what_WP the_DT Chinese_NNPS did_VBD ,_, along_IN with_IN their_PRP$ use_NN of_IN Interferon_NNP ._. For_IN years_NNS ,_, Raoult_NNP has_VBZ been_VBN pleading_VBG for_IN a_DT drastic_JJ revision_NN of_IN health_NN economic_JJ models_NNS ,_, so_RB the_DT treatments_NNS ,_, cure_NN and_CC therapies_NNS created_VBN mostly_RB during_IN the_DT 20th_JJ century_NN ,_, are_VBP considered_VBN a_DT patrimony_NN in_IN the_DT service_NN of_IN all_DT humanity_NN ._. “_`` That_DT ’s_VBZ not_RB the_DT case_NN ”_'' ,_, he_PRP says_VBZ ,_, “_'' because_IN we_PRP abandon_VBP medicine_NN that_WDT is_VBZ not_RB profitable_JJ ,_, even_RB if_IN it_PRP ’s_VBZ effective_JJ ._. That_DT ’s_VBZ why_WRB almost_RB no_DT antibiotics_NNS are_VBP manufactured_VBN in_IN the_DT West_NN ._. ”_'' On_IN Tuesday_NNP ,_, the_DT French_NNP Health_NNP Ministry_NNP officially_RB prohibited_VBD the_DT utilization_NN of_IN treatment_NN based_VBN on_IN chloroquine_NN recommended_VBN by_IN Raoult_NNP ._. In_IN fact_NN the_DT treatment_NN is_VBZ only_RB allowed_VBN for_IN terminal_JJ Covid_NNP -_HYPH 19_CD patients_NNS ,_, with_IN no_DT other_JJ possibility_NN of_IN healing_NN ._. This_DT cannot_MD but_CC expose_VB the_DT Macron_NNP government_NN to_IN more_JJR accusations_NNS of_IN at_IN least_JJS inefficiency_NN –_: added_VBN to_IN the_DT absence_NN of_IN masks_NNS ,_, tests_NNS ,_, contact_NN tracing_NN and_CC ventilators_NNS ._. On_IN Wednesday_NNP ,_, commenting_VBG on_IN the_DT new_JJ government_NN guidelines_NNS ,_, Raoult_NNP said_VBD ,_, “_`` When_WRB damage_NN to_IN the_DT lungs_NNS is_VBZ too_RB important_JJ ,_, and_CC patients_NNS arrive_VBP for_IN reanimation_NN ,_, they_PRP practically_RB do_VBP not_RB harbor_VB viruses_NNS in_IN their_PRP$ bodies_NNS any_RB more_JJR ._. It_PRP ’s_VBZ too_RB late_JJ to_TO treat_VB them_PRP with_IN chloroquine_NN ._. Are_VBP these_DT the_DT only_JJ cases_NNS –_: the_DT very_RB serious_JJ cases_NNS –_: that_WDT will_MD be_VB treated_VBN with_IN chloroquine_NN under_IN the_DT new_JJ directive_NN by_IN [_-LRB- French_NNP Health_NNP Minister_NNP ]_-RRB- Veran_NNP ?_. ”_'' If_IN so_RB ,_, he_PRP added_VBD ironically_RB ,_, “_`` then_RB they_PRP will_MD be_VB able_JJ to_TO say_VB with_IN scientific_JJ certainty_NN that_IN chloroquine_NN does_VBZ not_RB work_VB ._. ”_'' Raoult_NNP was_VBD unavailable_JJ for_IN comment_NN on_IN Western_JJ news_NN media_NN articles_NNS citing_VBG Chinese_JJ test_NN results_NNS that_WDT would_MD suggest_VB he_PRP is_VBZ wrong_JJ about_IN the_DT efficacy_NN of_IN chloroquine_NN in_IN dealing_VBG with_IN mild_JJ cases_NNS of_IN Covid_NNP -_HYPH 19_CD ._. Staffers_NNS pointed_VBD instead_RB to_IN his_PRP$ comments_NNS in_IN the_DT IHU_NN bulletin_NN ._. There_EX Raoult_NNP says_VBZ it_PRP ’s_VBZ “_`` insulting_JJ ”_'' to_TO ask_VB if_IN we_PRP can_MD trust_VB the_DT Chinese_NNP on_IN the_DT use_NN of_IN chloroquine_NN ._. “_`` If_IN this_DT was_VBD an_DT American_JJ disease_NN ,_, and_CC the_DT president_NN of_IN the_DT United_NNP States_NNPS said_VBD ,_, ‘_`` We_PRP need_VBP to_TO treat_VB patients_NNS with_IN that_DT ,_, ’_'' nobody_NN would_MD discuss_VB it_PRP ._. ”_'' In_IN China_NNP ,_, he_PRP adds_VBZ ,_, there_EX were_VBD “_`` enough_JJ elements_NNS so_IN the_DT Chinese_JJ government_NN and_CC all_DT Chinese_JJ experts_NNS who_WP know_VBP coronaviruses_NNS took_VBD an_DT official_JJ position_NN that_IN ‘_`` we_PRP must_MD treat_VB with_IN chloroquine_NN ._. ’_'' Between_IN the_DT moment_NN when_WRB we_PRP have_VBP the_DT first_JJ results_NNS and_CC an_DT accepted_VBN international_JJ publication_NN ,_, there_EX is_VBZ no_DT credible_JJ alternative_NN among_IN people_NNS who_WP are_VBP the_DT most_RBS knowledgeable_JJ in_IN the_DT world_NN ._. They_PRP took_VBD this_DT measure_NN in_IN the_DT interest_NN of_IN public_JJ health_NN ._. ”_'' Crucially_RB :_: if_IN he_PRP had_VBD coronavirus_NN ,_, Raoult_NNP says_VBZ he_PRP would_MD take_VB chloroquine_NN ._. Since_IN Raoult_NNP is_VBZ rated_VBN by_IN his_PRP$ peers_NNS as_IN the_DT number_NN one_CD world_NN expert_NN in_IN communicable_JJ diseases_NNS ,_, way_NN above_IN Dr._NNP Anthony_NNP Fauci_NNP in_IN the_DT US_NNP ,_, I_PRP would_MD say_VB the_DT new_JJ reports_NNS represent_VBP Big_NNP Pharma_NNP talking_VBG ._. Raoult_NNP has_VBZ been_VBN mercilessly_RB savaged_VBN and_CC demonized_VBN by_IN French_JJ corporate_JJ media_NN that_WDT are_VBP controlled_VBN by_IN a_DT few_JJ oligarchs_NNS closely_RB linked_VBN to_IN Macronism_NNP ._. Not_RB by_IN accident_NN the_DT demonization_NN has_VBZ reached_VBN gilets_NNS jaunes_NNS (_-LRB- yellow_JJ vest_NN )_-RRB- levels_NNS ,_, especially_RB because_IN of_IN the_DT extremely_RB popular_JJ hashtag_NN #_NN IlsSavaient_NNP (_-LRB- “_`` They_PRP knew_VBD ”_'' )_-RRB- ,_, with_IN which_WDT the_DT yellow_JJ vests_NNS stress_VBP that_IN French_JJ elites_NNS have_VBP “_`` managed_VBN ”_'' the_DT Covid_NNP -_HYPH 19_CD crisis_NN by_IN protecting_VBG themselves_PRP while_IN leaving_VBG the_DT population_NN defenseless_JJ against_IN the_DT virus_NN ._. That_DT ties_VBZ in_RP with_IN the_DT controversial_JJ analysis_NN by_IN crack_NN philosopher_NN Giorgio_NNP Agamben_NNP in_IN a_DT column_NN published_VBN a_DT month_NN ago_RB ,_, where_WRB he_PRP was_VBD already_RB arguing_VBG that_IN Covid_NNP -_HYPH 19_CD clearly_RB shows_VBZ that_IN the_DT state_NN of_IN exception_NN –_: similar_JJ to_IN a_DT state_NN of_IN emergency_NN but_CC with_IN differences_NNS important_JJ to_IN philosophers_NNS –_: has_VBZ become_VBN fully_RB normalized_VBN in_IN the_DT West_NNP ._. Agamben_NNP was_VBD speaking_VBG not_RB as_IN a_DT doctor_NN or_CC a_DT virologist_NN but_CC as_IN a_DT master_NN thinker_NN ,_, following_VBG in_IN the_DT steps_NNS of_IN Foucault_NNP ,_, Walter_NNP Benjamin_NNP and_CC Hannah_NNP Arendt_NNP ._. Noting_VBG how_WRB a_DT latent_JJ state_NN of_IN fear_NN has_VBZ metastasized_VBN into_IN a_DT state_NN of_IN collective_JJ panic_NN ,_, for_IN which_WDT Covid_NNP -_HYPH 19_CD “_'' offers_VBZ once_RB again_RB the_DT ideal_JJ pretext_NN ,_, ”_'' he_PRP described_VBD how_WRB ,_, “_`` in_IN a_DT perverse_JJ vicious_JJ circle_NN ,_, the_DT limitation_NN of_IN freedom_NN imposed_VBN by_IN governments_NNS is_VBZ accepted_VBN in_IN the_DT name_NN of_IN a_DT desire_NN for_IN security_NN that_WDT was_VBD induced_VBN by_IN the_DT same_JJ governments_NNS that_WDT now_RB intervene_VBP to_TO satisfy_VB it_PRP ._. ”_'' There_EX was_VBD no_DT state_NN of_IN collective_JJ panic_NN in_IN South_NNP Korea_NNP ,_, Singapore_NNP ,_, Taiwan_NNP and_CC Vietnam_NNP –_: to_TO mention_VB four_CD Asian_JJ examples_NNS outside_IN of_IN China_NNP ._. A_DT dogged_VBN combination_NN of_IN mass_JJ testing_NN and_CC contact_NN tracing_NN was_VBD applied_VBN with_IN immense_JJ professionalism_NN ._. It_PRP worked_VBD ._. In_IN the_DT Chinese_JJ case_NN ,_, with_IN the_DT help_NN of_IN chloroquine_NN ._. And_CC in_IN all_DT Asian_JJ cases_NNS ,_, without_IN a_DT murky_JJ profit_NN motive_NN to_IN the_DT benefit_NN of_IN Big_NNP Pharma_NNP ._. There_EX has_VBZ n’t_RB yet_RB appeared_VBN the_DT smoking_NN gun_NN that_WDT proves_VBZ the_DT Macron_NNP system_NN not_RB only_RB is_VBZ incompetent_JJ to_TO deal_VB with_IN Covid_NNP -_HYPH 19_CD but_CC also_RB is_VBZ dragging_VBG the_DT process_NN so_IN Big_NNP Pharma_NNP can_MD come_VB up_RP with_IN a_DT miracle_NN vaccine_NN ,_, fast_JJ ._. But_CC the_DT pattern_NN to_TO discourage_VB chloroquine_NN is_VBZ more_JJR than_IN laid_VBN out_RP above_IN –_: in_IN parallel_JJ to_IN the_DT demonization_NN of_IN Raoult_NNP ._.","What VBZ VBG on in the RB JJS NN in the NN RB VBZ to a JJ NN NN in which the JJ NN VBZ VBG NNP NNP to VB from the NN of NNP - 19 . VBN JJ NNS VBP RB JJ about it . My JJ NN to a JJ , JJ NNP NN , NN NNP NNP , VBD about the NNS NNS between NNP and NNP NNP and RB about the JJ “ NN ” – RBR JJ JJ NN – of all the NNS of NN in NN of the JJ NN . VBN NNP NNP NNP VBD about the NN JJ in one of NNP ’s 24/7 NN NNS : “ The JJ NN for the NNS VBD NN that they VBD VBG a JJ NN of NNS , that they VBD VBN . ” With NN from another , JJ NN , it VBZ RB JJ to VB a NN that VBZ in RB - VBN NN the JJ NNS of the JJ NN . VB ’s VB with NNP NNP , who VBD the NN of NNP – the NNP NNP NNP of NNP and NNP NNP – from 2014 to 2018 , when he VBD VBN as JJ NN NN for the NNP NN . RB 12 NNS in NNP VBP VBN this NN . NNP VBZ VBN to NNP NNP , who until RB VBD NN of NN under NNP . NNP VBD RB VBN with an “ NN you ca RB VB ” by NNP ’s NN to VB the NN – in the NN of the NN NN – and VB for NNP of NNP , where she VBD RB VBN in the JJ NN on NNP 16 . NNP VBZ a JJ VBG NN with NNP NNP NNP – JJ and RB - VBN NNP - VBN NN in JJ NNS . NNP VBD the NNP NN from the NN - VBN NNP ( NNP - NNP NNP ) NN NN VBN by NNP . In NN , in NNP 2019 , NNP VBD the NN of “ NN ” of the JJ NNS so he could VB over their NN . NNP VBD NN of a JJ NN in which NN and NN VBD 90 NN of NNP - 19 NNS if they VBD VBN RB RB . ( RB , JJ NN VBZ at the NN of the JJ NNP JJ NN . ) NNP VBZ VBN to the JJ NN of JJ NNS and JJ NNS – which he VBZ “ JJ , ” in an JJ NN . He VBZ in NN of JJ NN ( which , besides NNP NNP , VBD JJ in NNP , NNP and NNP ) and a JJ NN with NN . RB VBN NNS should VB VBN . NNP VBZ one NN for ten NNS . And there VBZ the NN : NNP NNP – which , RB , VBZ NNP , and VBZ “ JJ NN ” NNP – would RB VB for a NN RBR JJ NN . NNP for the NN VBZ it VBZ “ RB VBG ” to VB NN , but that may VB “ NNS , ” and there VBZ no NN about NN . On NNP 13 , NNP NNP , RB NNP ’s NNP NNP , VBZ NN as a “ JJ NN , ” from RB on RB JJ by NN . An JJ NN , VBG that it VBZ VBN VBN off the NN in NNP for half a NN . On NNP 16 , the NNP NN VBZ a JJ NN . There VBZ RB a NN about NN . NNS RB VBP RB VBN to VB NNS ; JJS VBP VBN VBN RB , and there VBP RB JJ NNS RB for NN NNS . In 2011 NNP VBD RB 1.5 billion NNS : 800 million JJ NNS and 600 million NNS for NN NNS RB . But RB , over the NNS , the JJ NNS VBD RB VBN , to VB the NNP and to VB the NNP NNS , which VBD NN in the NN and NN NN to NNS whose NN NNS VBD RB VB 3 NN of NN . One of those in NN at the NN VBD NNP NNP , RB a JJ NN to the NNP NN . On NNP 17 , NNP NNP VBZ she VBZ VBN the NN of NNP - 19 will VB a JJ NN , for which the JJ NN NN VBZ no NN . She RB VBZ it VBD VBN her NN that the NNP JJ NN “ would RB VB NN ” and that it VBD , RB , “ a NN . ” What she VBZ RB VB VBZ that she VBD RB VB NN at the NN she VBD VBG because the JJ JJ NN by the NNP JJ NN VBD on VBG the “ NN . ” The JJ NN of the NN VBD NN , as NNP - 19 VBD VBG . The JJ NN VBD VBN RB . She VBD to VB about the JJ NN NN . But as a NN of the NNP NN she VBD RB VB JJ in JJ NN . In JJ NN : The NNP NN VBZ to VB JJ NN , as VBN with NN in NNP NNP and NNP . NNP NNP and the JJ NN NN NN VBP NNP ’s NN as JJ NN , before VBG a NN . NNP NNP VBZ on the 24/7 NNP NN NN that the NN of NN at the JJ JJ NN VBZ VBN VBN . NN to a NN by NNP NNP , NNP NNP VBZ NN should VB JJ to all NNPS . NNS of NN and NN NN , who RB VBP NN NNS with the JJ NN that VBZ them NN , VBP JJ NN RB with their NN . NNP NNS and JJ JJ NNS VBP to VBG the NN for the NN of themselves and those RB to them , VBG NNS to VB they VBP for NNS with NN or JJ NN . NNP VBZ the NN of NN from NNP in NNP . NNP VBZ to VB its NN of NN to VB VBN to NNP . NNP VBZ the JJ NN of its NN ; VBZ for JJ NN and JJ NN ; and VBZ NNP of VBG “ NN NNS . ” NNP NNP , the NN of NNP , VBG VBN himself VBN with NN , without any NN NN , RB VBZ NNP so they may VB NN to JJ NNS . Because of NNP ’s NN , a JJ - NN NN NN RB VBZ in NNP , under the – JJ – NN of NNP , which VBZ to “ VB the NNS in JJ JJ JJ NNS . ” This will VB at JJS an JJ six NNS – as the NNP NNP ’s JJ NN RB VBZ the NN of NNP ’s JJ NN to … six NNS . If JJ NN of NN and NN VBZ RB JJ among the RBS RB JJ , NNS may VB VBN in JJ NNS . The JJ JJ NN that RB VBZ NN VBZ under JJ NN . That VBZ the NN NN and NN into JJ NN . It will VB NN for these NNS to VB VBN , RB VBG NNP NNP the NN to VB what it VBZ : a JJ NN . It VBZ the NNS of the NN NN VBD RB RB VBN . This NN of NNS , JJ for a RB VBN NNP - 7 NN JJ of its NN NN , VBZ NN of a JJ , JJ NN VBN in JJ NN . NNP - VBN NN VBN with the NN NN VBD in a RB JJ NN towards the NN NN . As NNP VBD me , “ NN NNS – RB JJ in NN – VBD RB JJ but RB for a JJ NN VBN to the JJ NN [ JJ NNS of the NNP of NNP , NNS of JJ NNS , NNS , NN and NN NNS ] . JJ for NN , which this NN VBD NN to VB JJ for the NN . They VBD RB VB NN JJ for NNP NNP – he VBD NN NNS and VBD VBN by ‘ NNS . ’ And they VBD RB VB JJ NNS . RB under the NNP NN , there VBD a JJ NN of the NN of NNS – which VBD VBN in JJ NNS in all NNS . RB to VB that the NN of NN NNS and NN NNS VBD under NNP . ” This VBZ in with JJ NNS by JJ NNS of NNS RB VBG to VB NN NNS due to the NN of JJ JJ NN . At the JJ NN , in another JJ NN , the JJ NN VBZ to VB JJ NNS and NNS – which VBP RB JJ at this NN – RB as the NN of their JJ NN , NNP NNP , VBZ VBN for such a JJ NN NN : “ I RB VBP that we VBP VBN to VB JJ NNS . Our NNS VBP VBN . The NN that VBD the NN of NNP must VB us a NN . ” NNP VBZ the NN NN in NNP “ VBZ RB JJ and will VB RB JJR due to these JJ NNS – NN of NNS , JJ NN to RB VB NNS , NN of JJ NN to NN – in a NN of JJ NN at the NNS . This will VB and NN will VB the NN . ” In an JJ NN on NNP , NNP VBD he VBZ RB VBG in NNP ’s JJ NN RB , RB though he VBZ RB VBG it RB . NNP RB RB VBZ on JJ NN on a JJ NN to VB VBN NNS , and RB VB and VB NNS who VBD JJ . In a NN : the NNP JJ NN . That VBZ RB what VBZ VBN from the NNP in NNP , where NNS of NNS VBP to VB up for NN . And that VBZ in with the NNS by a JJ JJ NN on NNP - 19 , NNP NNP , who VBZ that NN with NN NN VBD a “ JJ NN , ” with NNS VBG JJ after RB four NNS . The JJ NN VBZ VBN VBN by NNP : VB NN in RB JJ NNS , for NNS VBN RB RB , when the NN VBZ RB VBN RB , and RB in these NNS . He VBZ RB VBG NN for NN . It VBZ RB what the NNPS VBD , along with their NN of NNP . For NNS , NNP VBZ VBN VBG for a JJ NN of NN JJ NNS , RB the NNS , NN and NNS VBN RB during the JJ NN , VBP VBN a NN in the NN of all NN . “ That VBZ RB the NN ” , he VBZ , “ because we VBP NN that VBZ RB JJ , RB if it VBZ JJ . That VBZ why RB no NNS VBP VBN in the NN . ” On NNP , the NNP NNP NNP RB VBD the NN of NN VBN on NN VBN by NNP . In NN the NN VBZ RB VBN for JJ NNP - 19 NNS , with no JJ NN of NN . This cannot but VB the NNP NN to JJR NNS of at JJS NN – VBN to the NN of NNS , NNS , NN NN and NNS . On NNP , VBG on the JJ NN NNS , NNP VBD , “ When NN to the NNS VBZ RB JJ , and NNS VBP for NN , they RB VBP RB VB NNS in their NNS RB JJR . It VBZ RB JJ to VB them with NN . VBP these the JJ NNS – the RB JJ NNS – that will VB VBN with NN under the JJ NN by [ NNP NNP NNP ] NNP ? ” If RB , he VBD RB , “ RB they will VB JJ to VB with JJ NN that NN VBZ RB VB . ” NNP VBD JJ for NN on JJ NN NN NNS VBG JJ NN NNS that would VB he VBZ JJ about the NN of NN in VBG with JJ NNS of NNP - 19 . NNS VBD RB to his NNS in the NN NN . There NNP VBZ it VBZ “ JJ ” to VB if we can VB the NNP on the NN of NN . “ If this VBD an JJ NN , and the NN of the NNP NNPS VBD , ‘ We VBP to VB NNS with that , ’ NN would VB it . ” In NNP , he VBZ , there VBD “ JJ NNS so the JJ NN and all JJ NNS who VBP NNS VBD an JJ NN that ‘ we must VB with NN . ’ Between the NN when we VBP the JJ NNS and an VBN JJ NN , there VBZ no JJ NN among NNS who VBP the RBS JJ in the NN . They VBD this NN in the NN of JJ NN . ” RB : if he VBD NN , NNP VBZ he would VB NN . Since NNP VBZ VBN by his NNS as the NN one NN NN in JJ NNS , NN above NNP NNP NNP in the NNP , I would VB the JJ NNS VBP NNP NNP VBG . NNP VBZ VBN RB VBN and VBN by JJ JJ NN that VBP VBN by a JJ NNS RB VBN to NNP . RB by NN the NN VBZ VBN NNS NNS ( JJ NN ) NNS , RB because of the RB JJ NN NN NNP ( “ They VBD ” ) , with which the JJ NNS VBP that JJ NNS VBP “ VBN ” the NNP - 19 NN by VBG themselves while VBG the NN JJ against the NN . That VBZ in with the JJ NN by NN NN NNP NNP in a NN VBN a NN RB , where he VBD RB VBG that NNP - 19 RB VBZ that the NN of NN – JJ to a NN of NN but with NNS JJ to NNS – VBZ VBN RB VBN in the NNP . NNP VBD VBG RB as a NN or a NN but as a NN NN , VBG in the NNS of NNP , NNP NNP and NNP NNP . VBG how a JJ NN of NN VBZ VBN into a NN of JJ NN , for which NNP - 19 “ VBZ RB RB the JJ NN , ” he VBD how , “ in a JJ JJ NN , the NN of NN VBN by NNS VBZ VBN in the NN of a NN for NN that VBD VBN by the JJ NNS that RB VBP to VB it . ” There VBD no NN of JJ NN in NNP NNP , NNP , NNP and NNP – to VB four JJ NNS outside of NNP . A VBN NN of JJ NN and NN NN VBD VBN with JJ NN . It VBD . In the JJ NN , with the NN of NN . And in all JJ NNS , without a JJ NN NN to the NN of NNP NNP . There VBZ RB RB VBN the NN NN that VBZ the NNP NN RB RB VBZ JJ to VB with NNP - 19 but RB VBZ VBG the NN so NNP NNP can VB up with a NN NN , JJ . But the NN to VB NN VBZ JJR than VBN out above – in JJ to the NN of NNP ."
254,1023,mainstream,"Vacctivist_NNP is_VBZ a_DT blend_NN of_IN vaccine_NN and_CC activist_NN ,_, coined_VBN to_TO mock_VB the_DT anti-vaccination_NN (_-LRB- anti-vaxx_JJ )_-RRB- movement_NN ._. Anti-vaxxers_NNS broadly_RB believe_VBP vaccines_NNS cause_VBP humans_NNS more_JJR harm_NN than_IN good_JJ —_: such_JJ as_IN the_DT discredited_VBN claim_NN that_IN vaccines_NNS cause_VBP autism_NN ,_, a_DT position_NN notably_RB taken_VBN up_RP by_IN model_NN and_CC personality_NN Jenny_NNP McCarthy_NNP in_IN the_DT late_JJ 2000s_NNS ._. This_DT belief_NN has_VBZ compelled_VBN a_DT number_NN of_IN parents_NNS not_RB to_TO vaccinate_VB their_PRP$ children_NNS ,_, leading_VBG to_IN a_DT rash_NN of_IN diseases_NNS like_IN measles_NNS there_RB were_VBD virtually_RB eradicated_VBN ._. The_DT term_NN vacctivist_NN was_VBD apparently_RB coined_VBN in_IN 2008_CD by_IN Greg_NNP Allen_NNP on_IN his_PRP$ blog_NN for_IN new_JJ fathers_NNS ,_, Daddy_NNP Types_NNP ,_, in_IN his_PRP$ post_NN ,_, “_`` DT_NNP Friday_NNP Freakout_NNP :_: The_DT Vacctivists_NNPS Are_VBP n’t_RB Gonna_RB Like_IN This_DT Edition_NN ._. ”_'' This_DT roundup_NN exposes_VBZ the_DT lack_NN of_IN causation_NN between_IN autism_NN and_CC vaccines_NNS for_IN measles_NNS ,_, mumps_NNS ,_, and_CC rubella_NN (_-LRB- MMR_NNP )_-RRB- ._. Its_PRP$ use_NN of_IN vacctivist_NN is_VBZ jab_NN at_IN people_NNS who_WP do_VBP n’t_RB vaccinate_VB their_PRP$ children_NNS —_: and_CC are_VBP proud_JJ and_CC preachy_JJ about_IN it_PRP ._. Daddy_NNP Types_NNPS continued_VBD to_TO use_VB the_DT phrase_NN vacctivist_NN throughout_IN the_DT 2010s_NNS ._. However_RB ,_, some_DT anti-vaxxers_NNS embraced_VBD vacctivist_NN for_IN their_PRP$ cause_NN ,_, either_CC as_IN a_DT reclamation_NN of_IN the_DT insult_NN or_CC as_IN independent_JJ coinage_NN ._. For_IN instance_NN ,_, in_IN 2017_CD ,_, anti-vaxxer_JJ Guggie_NNP Daley_NNP wrote_VBD an_DT article_NN for_IN Natural_JJ Mother_NN ,_, “_`` Vacctivism_NN Technology_NN :_: How_WRB to_TO Empower_VB Instead_RB of_IN Cower_NN ,_, ”_'' about_IN how_WRB to_TO more_RBR effectively_RB promote_VB anti-vaxx_JJ messages_NNS ._. Backlash_NN against_IN the_DT anti-vaxx_JJ movement_NN ,_, though_RB ,_, led_VBD to_IN a_DT more_RBR prevailing_JJ sense_NN of_IN vacctivist_NN :_: someone_NN who_WP advocates_VBZ —_: based_VBN on_IN science_NN and_CC for_IN the_DT public_JJ good_NN —_: for_IN getting_VBG vaccines_NNS ._. This_DT vacctivist_NN is_VBZ pro-vaxx_JJ ,_, as_IN it_PRP were_VBD ._.","NNP VBZ a NN of NN and NN , VBN to VB the NN ( JJ ) NN . NNS RB VBP NNS VBP NNS JJR NN than JJ — JJ as the VBN NN that NNS VBP NN , a NN RB VBN up by NN and NN NNP NNP in the JJ NNS . This NN VBZ VBN a NN of NNS RB to VB their NNS , VBG to a NN of NNS like NNS RB VBD RB VBN . The NN NN VBD RB VBN in 2008 by NNP NNP on his NN for JJ NNS , NNP NNP , in his NN , “ NNP NNP NNP : The NNPS VBP RB RB Like This NN . ” This NN VBZ the NN of NN between NN and NNS for NNS , NNS , and NN ( NNP ) . Its NN of NN VBZ NN at NNS who VBP RB VB their NNS — and VBP JJ and JJ about it . NNP NNPS VBD to VB the NN NN throughout the NNS . RB , some NNS VBD NN for their NN , either as a NN of the NN or as JJ NN . For NN , in 2017 , JJ NNP NNP VBD an NN for JJ NN , “ NN NN : How to VB RB of NN , ” about how to RBR RB VB JJ NNS . NN against the JJ NN , RB , VBD to a RBR JJ NN of NN : NN who VBZ — VBN on NN and for the JJ NN — for VBG NNS . This NN VBZ JJ , as it VBD ."
255,1250,mainstream,"In_IN 1981_CD ,_, a_DT young_JJ man_NN visited_VBD Cedars_NNP -_HYPH Sinai_NNP hospital_NN ,_, in_IN Los_NNP Angeles_NNP ,_, with_IN shortness_NN of_IN breath_NN and_CC with_IN curious_JJ purplish_JJ lesions_NNS on_IN his_PRP$ skin_NN ._. After_IN reviewing_VBG biopsies_NNS and_CC scans_NNS ,_, a_DT twenty_CD -_HYPH eight_CD -_HYPH year_NN -_HYPH old_JJ medical_JJ resident_NN named_VBN David_NNP Ho_NNP found_VBD an_DT odd_JJ fungal_JJ infection_NN in_IN the_DT patient_NN ’s_POS lungs_NNS and_CC a_DT rare_JJ cancer_NN ,_, Kaposi_NNP ’s_POS sarcoma_NN ._. These_DT conditions_NNS were_VBD both_CC associated_VBN with_IN immune_NN deficiency_NN ,_, though_IN nothing_NN in_IN the_DT patient_NN ’s_POS history_NN explained_VBD why_WRB he_PRP would_MD be_VB in_IN such_PDT a_DT state_NN ._. He_PRP was_VBD given_VBN antibiotics_NNS and_CC discharged_VBN ;_, not_RB long_RB after_RB ,_, he_PRP died_VBD ._. Over_IN a_DT few_JJ months_NNS ,_, Ho_NNP and_CC his_PRP$ colleagues_NNS saw_VBD five_CD men_NNS with_IN similar_JJ symptoms_NNS ._. They_PRP wrote_VBD up_RP the_DT cases_NNS and_CC sent_VBD them_PRP to_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP —_: the_DT first_JJ report_NN of_IN what_WP became_VBD known_VBN as_IN AIDS_NN ._. Ho_NNP continued_VBD to_TO explore_VB the_DT disease_NN ._. “_`` Some_DT people_NNS were_VBD very_RB concerned_JJ that_IN I_PRP was_VBD so_RB intrigued_VBN by_IN those_DT few_JJ cases_NNS at_IN the_DT very_JJ beginning_NN of_IN my_PRP$ career_NN ,_, ”_'' he_PRP told_VBD me_PRP ._. “_`` ‘_`` Why_WRB would_MD you_PRP want_VB to_TO devote_VB your_PRP$ career_NN to_IN an_DT esoteric_JJ disease_NN ?_. ’_'' ”_'' Particularly_RB one_CD that_WDT seemed_VBD mainly_RB to_TO afflict_VB what_WP was_VBD considered_VBN a_DT fringe_NN population_NN —_: gay_JJ men_NNS ._. But_CC Ho_NNP ,_, who_WP had_VBD emigrated_VBN from_IN Taiwan_NNP when_WRB he_PRP was_VBD twelve_CD ,_, speaking_VBG no_DT English_NNP ,_, had_VBD an_DT underdog_JJ mentality_NN and_CC would_MD not_RB be_VB dissuaded_VBN ._. He_PRP made_VBD several_JJ discoveries_NNS throughout_IN the_DT nineteen_CD -_HYPH eighties_NNS about_IN H.I.V._NNP ,_, the_DT virus_NN that_WDT causes_VBZ AIDS_NN ,_, and_CC in_IN 1990_CD ,_, at_IN the_DT age_NN of_IN thirty_CD -_HYPH seven_CD ,_, he_PRP moved_VBD to_IN New_NNP York_NNP to_TO become_VB the_DT director_NN of_IN the_DT Aaron_NNP Diamond_NNP AIDS_NNP Research_NNP Center_NNP ._. A_DT year_NN later_RBR ,_, he_PRP received_VBD a_DT call_NN asking_VBG him_PRP to_TO fly_VB back_RB to_IN L.A._NNP to_TO test_VB a_DT very_RB important_JJ patient_NN ._. There_RB ,_, he_PRP confirmed_VBD that_IN Earvin_NNP (_-LRB- Magic_NNP )_-RRB- Johnson_NNP was_VBD H.I.V.-_RB positive_JJ ._. The_DT following_VBG week_NN ,_, Johnson_NNP disclosed_VBD his_PRP$ condition_NN and_CC announced_VBD that_IN he_PRP was_VBD retiring_VBG from_IN the_DT N.B.A_NNP ._. Ho_NNP has_VBZ cared_VBN for_IN him_PRP ever_RB since_RB ._. Johnson_NNP later_RBR said_VBD that_IN he_PRP ’d_VBD never_RB thought_VBN AIDS_NNP would_MD kill_VB him_PRP ,_, because_IN Ho_NNP had_VBD assured_VBN him_PRP that_IN better_JJR medicines_NNS were_VBD in_IN the_DT pipeline_NN ._. In_IN 1994_CD ,_, Ho_NNP found_VBD that_IN a_DT certain_JJ class_NN of_IN drugs_NNS could_MD dramatically_RB reduce_VB the_DT viral_JJ load_NN in_IN AIDS_NN patients_NNS ._. But_CC ,_, within_IN each_DT infected_VBN individual_NN ,_, the_DT virus_NN evolved_VBD quickly_RB ,_, evading_VBG treatments_NNS ._. One_CD drug_NN was_VBD not_RB enough_JJ ._. His_PRP$ team_NN devised_VBD the_DT idea_NN of_IN an_DT AIDS_NN “_`` cocktail_NN ”_'' —_: a_DT combination_NN of_IN three_CD or_CC four_CD drugs_NNS that_WDT ,_, acting_VBG in_IN concert_NN ,_, could_MD corner_VB the_DT virus_NN ._. In_IN 1996_CD ,_, Time_NNP named_VBN Ho_NNP its_PRP$ Man_NNP of_IN the_DT Year_NNP ._. In_IN November_NNP ,_, 2002_CD ,_, a_DT novel_JJ disease_NN broke_VBD out_RP in_IN China_NNP :_: severe_JJ acute_JJ respiratory_JJ syndrome_NN ,_, caused_VBN by_IN a_DT coronavirus_NN called_VBN SARS_NNP -_HYPH CoV_NNP ._. Ho_NNP was_VBD asked_VBN by_IN China_NNP ’s_POS top_JJ public_JJ -_HYPH health_NN officials_NNS to_TO advise_VB them_PRP ._. “_`` The_DT most_RBS dramatic_JJ memory_NN I_PRP have_VBP is_VBZ going_VBG to_IN Beijing_NNP ,_, arriving_VBG in_IN the_DT late_JJ afternoon_NN or_CC early_JJ evening_NN ,_, and_CC going_VBG to_IN the_DT hotel_NN along_IN the_DT biggest_JJS avenue_NN ,_, ”_'' he_PRP recalled_VBD ._. “_`` If_IN you_PRP remember_VBP the_DT Tiananmen_NNP incidents_NNS of_IN many_JJ years_NNS ago_RB ,_, with_IN the_DT protester_NN and_CC the_DT tank_NN ,_, that_DT ’s_VBZ the_DT boulevard_NN ._. It_PRP has_VBZ ten_CD or_CC twelve_CD lanes_NNS ._. There_EX was_VBD only_RB the_DT car_NN that_WDT ’s_VBZ driving_VBG me_PRP and_CC one_CD ambulance_NN for_IN as_RB far_RB as_IN one_PRP could_MD see_VB ._. ”_'' He_PRP went_VBD on_RP ,_, “_`` That_DT ’s_VBZ when_WRB I_PRP got_VBD interested_JJ in_IN coronaviruses_NNS ,_, serving_VBG as_IN a_DT consultant_NN and_CC seeing_VBG the_DT devastation_NN firsthand_JJ in_IN several_JJ cities_NNS throughout_IN China_NNP ._. ”_'' Back_RB in_IN New_NNP York_NNP ,_, Ho_NNP began_VBD investigating_VBG the_DT coronavirus_NN family_NN ._. Some_DT coronaviruses_NNS can_MD produce_VB lethal_JJ diseases_NNS ,_, like_IN SARS_NN ;_, others_NNS are_VBP among_IN the_DT causes_NNS of_IN the_DT common_JJ cold_NN ._. But_CC ,_, he_PRP said_VBD ,_, “_`` the_DT SARS_NNP epidemic_NN ended_VBD in_IN July_NNP of_IN 2003_CD ._. By_IN the_DT next_JJ year_NN ,_, there_EX was_VBD hardly_RB any_DT interest_NN ._. Funding_NN for_IN that_DT area_NN kind_NN of_IN dried_VBD up_RP ._. So_RB we_PRP simply_RB dropped_VBD it_PRP and_CC went_VBD on_RP with_IN our_PRP$ H.I.V._NN work_NN ._. ”_'' In_IN 2012_CD ,_, another_DT coronavirus_NN ,_, MERS_NNP -_HYPH CoV_NNP ,_, caused_VBD an_DT outbreak_NN in_IN the_DT Arabian_NNP Peninsula_NNP ;_, Middle_NNP East_NNP respiratory_JJ syndrome_NN ,_, as_IN it_PRP was_VBD called_VBN ,_, sickened_VBD more_JJR than_IN twenty_CD -_HYPH five_CD hundred_CD people_NNS and_CC killed_VBD more_JJR than_IN eight_CD hundred_CD ._. Ho_NNP followed_VBD it_PRP with_IN interest_NN ,_, but_CC this_DT outbreak_NN ,_, too_RB ,_, passed_VBD quickly_RB ._. Then_RB ,_, this_DT past_JJ December_NNP ,_, a_DT disease_NN with_IN similar_JJ symptoms_NNS flared_VBD up_RP in_IN China_NNP and_CC ,_, within_IN a_DT month_NN ,_, was_VBD linked_VBN to_IN another_DT coronavirus_NN ,_, SARS_NNP -_HYPH CoV_NNP -_HYPH 2_CD ._. Ho_NNP told_VBD me_PRP ,_, “_`` My_PRP$ Chinese_JJ heritage_NN caused_VBD me_PRP to_TO focus_VB more_JJR on_IN the_DT news_NN coming_VBG out_IN of_IN China_NNP in_IN late_JJ December_NNP and_CC early_JJ January_NNP ._. However_RB ,_, the_DT experience_NN with_IN SARS_NNP also_RB put_VBD a_DT pause_NN on_IN our_PRP$ natural_JJ reaction_NN to_TO jump_VB in_RP and_CC get_VB involved_VBN ._. ”_'' His_PRP$ attitude_NN shifted_VBD when_WRB the_DT story_NN did_VBD ._. “_`` It_PRP was_VBD the_DT growing_VBG magnitude_NN of_IN the_DT outbreak_NN that_WDT told_VBD us_PRP ,_, ‘_`` Oh_UH ,_, we_PRP ’d_MD better_RBR think_VB about_IN getting_VBG into_IN this_DT ,_, ’_'' ”_'' he_PRP said_VBD ._. Ho_NNP was_VBD just_RB setting_VBG up_RP his_PRP$ lab_NN at_IN its_PRP$ new_JJ home_NN ,_, at_IN Columbia_NNP University_NNP ._. He_PRP is_VBZ friendly_JJ with_IN Jack_NNP Ma_NNP ,_, the_DT founder_NN of_IN the_DT e-commerce_NN giant_NN Alibaba_NNP ,_, who_WP asked_VBD how_WRB he_PRP could_MD help_VB ._. In_IN February_NNP ,_, Columbia_NNP announced_VBD that_IN Ma_NNP ’s_POS foundation_NN had_VBD awarded_VBN a_DT $_$ 2.1_CD -_SYM million_CD grant_NN to_IN Ho_NNP and_CC several_JJ Columbia_NNP colleagues_NNS to_TO develop_VB antiviral_JJ drugs_NNS ._. This_DT project_NN was_VBD prompted_VBN by_IN the_DT COVID_NNP -_HYPH 19_CD crisis_NN ,_, but_CC the_DT mission_NN goes_VBZ beyond_IN it_PRP ;_, the_DT researchers_NNS are_VBP thinking_VBG not_RB only_RB about_IN the_DT current_JJ pandemic_NN but_CC about_IN future_JJ ones_NNS as_RB well_RB ._. What_WP will_MD the_DT next_JJ global_JJ pathogen_NN be_VB ?_. “_`` If_IN you_PRP ’d_VBD asked_VBN me_PRP that_IN three_CD or_CC four_CD months_NNS ago_RB ,_, I_PRP would_MD have_VB said_VBN influenza_NN ,_, ”_'' Ho_NNP told_VBD me_PRP ,_, with_IN a_DT chuckle_NN of_IN dismay_NN ._. For_IN scientists_NNS ,_, this_DT is_VBZ n’t_RB just_RB a_DT thought_NN experiment_NN ;_, it_PRP ’s_VBZ the_DT sort_NN of_IN question_NN that_WDT shapes_VBZ years_NNS of_IN research_NN ._. Two_CD years_NNS ago_RB ,_, a_DT team_NN at_IN Johns_NNP Hopkins_NNP issued_VBD a_DT report_NN titled_VBN “_`` The_DT Characteristics_NNPS of_IN Pandemic_NNP Pathogens_NNPS ,_, ”_'' which_WDT was_VBD based_VBN on_IN a_DT literature_NN review_NN ,_, interviews_NNS with_IN more_JJR than_IN a_DT hundred_CD and_CC twenty_CD experts_NNS ,_, and_CC a_DT meeting_NN devoted_VBN to_IN the_DT issue_NN ._. It_PRP grimly_RB considered_VBD the_DT possibilities_NNS ._. Could_MD bacteria_NN do_VB us_PRP in_IN ?_. Outbreaks_NNS of_IN plague_NN have_VBP wreaked_VBN havoc_NN throughout_IN history_NN ,_, but_CC the_DT development_NN of_IN effective_JJ antibiotics_NNS in_IN the_DT past_JJ century_NN “_'' took_VBD bacteria_NN off_IN the_DT table_NN as_IN a_DT global_JJ biological_JJ risk_NN for_IN the_DT most_JJS part_NN ,_, ”_'' Amesh_NNP Adalja_NNP ,_, a_DT physician_NN at_IN Johns_NNP Hopkins_NNP and_CC the_DT report_NN ’s_POS project_NN director_NN ,_, told_VBD me_PRP ._. Bacteria_NNS can_MD evolve_VB ,_, and_CC develop_VB drug_NN resistance_NN ,_, but_CC usually_RB not_RB quickly_RB ._. How_WRB about_IN fungi_NN ?_. They_PRP threaten_VBP some_DT species_NNS ,_, but_CC do_VBP n’t_RB adapt_VB well_RB to_IN warm_JJ -_HYPH blooded_VBN hosts_NNS (_-LRB- and_CC may_MD have_VB helped_VBN encourage_VB the_DT evolution_NN of_IN warm_JJ -_HYPH bloodedness_NN )_-RRB- ._. Prions_NNS ?_. These_DT are_VBP responsible_JJ for_IN mad_JJ -_HYPH cow_NN disease_NN and_CC its_PRP$ human_JJ variant_NN ,_, but_CC are_VBP mostly_RB avoidable_JJ by_IN preventing_VBG food_NN contamination_NN and_CC refraining_VBG from_IN cannibalism_NN ._. Protozoa_NN ?_. Malaria_NNP has_VBZ killed_VBN perhaps_RB half_NN of_IN all_DT humans_NNS who_WP have_VBP ever_RB lived_VBN ._. But_CC protozoa_NNS are_VBP typically_RB transmitted_VBN by_IN vectors_NNS such_JJ as_IN mosquitoes_NNS and_CC fleas_NNS ,_, which_WDT are_VBP limited_VBN by_IN climate_NN and_CC geography_NN ._. Viruses_NNS ,_, the_DT report_NN concluded_VBD ,_, are_VBP the_DT real_JJ menaces_NNS ._. Not_RB just_RB any_DT viruses_NNS ,_, though_RB ._. The_DT likeliest_JJS candidates_NNS are_VBP those_DT with_IN a_DT genome_NN of_IN RNA_NN ,_, which_WDT evolve_VBP faster_JJR than_IN those_DT with_IN DNA_NN ._. Viruses_NNS that_WDT spread_VBP before_IN symptoms_NNS appear_VBP also_RB have_VB a_DT considerable_JJ advantage_NN ._. (_-LRB- The_DT only_JJ infectious_JJ disease_NN we_PRP ’ve_VBP wiped_VBN out_RP ,_, smallpox_NN ,_, is_VBZ not_RB contagious_JJ during_IN the_DT incubation_NN period_NN ._. )_-RRB- And_CC the_DT most_RBS daunting_JJ are_VBP those_DT transmitted_VBN by_IN respiration_NN ,_, rather_RB than_IN by_IN feces_NNS or_CC bodily_NN fluids_NNS ,_, which_WDT can_MD be_VB controlled_VBN through_IN sanitation_NN ._. Viruses_NNS that_WDT can_MD move_VB between_IN animals_NNS and_CC humans_NNS are_VBP especially_RB hard_JJ to_TO manage_VB ._. All_DT in_IN all_DT ,_, this_DT character_NN sketch_NN gets_VBZ us_PRP pretty_RB close_RB to_IN identifying_VBG two_CD classes_NNS of_IN viral_JJ assailants_NNS :_: influenzas_NNS and_CC coronaviruses_NNS ._. None_NN of_IN our_PRP$ off_IN -_HYPH the_DT -_HYPH shelf_NN treatments_NNS equip_VBP us_PRP for_IN such_PDT a_DT pandemic_NN ._. If_IN bacteria_NNS invade_VBP ,_, there_EX ’s_VBZ a_DT long_JJ list_NN of_IN antibiotics_NNS you_PRP can_MD try_VB ._. Between_IN ciprofloxacin_NN and_CC amoxicillin_NN ,_, we_PRP can_MD treat_VB dozens_NNS of_IN different_JJ types_NNS of_IN bacterial_JJ infection_NN ._. For_IN the_DT roughly_RB two_CD hundred_CD identified_VBN viruses_NNS that_WDT afflict_VBP us_PRP ,_, there_EX are_VBP approved_VBN treatments_NNS for_IN only_RB ten_CD or_CC so_RB ._. And_CC the_DT antiviral_JJ drugs_NNS that_WDT exist_VBP tend_VBP to_TO have_VB narrow_JJ targets_NNS ._. Only_RB a_DT few_JJ have_VBP been_VBN approved_VBN for_IN use_NN against_IN more_JJR than_IN one_CD disease_NN ._. Many_JJ drugs_NNS that_WDT work_VBP on_IN one_CD virus_NN do_VBP n’t_RB work_VB on_IN others_NNS within_IN the_DT same_JJ family_NN ;_, antivirals_NNS suited_VBN for_IN some_DT herpesviruses_NNS (_-LRB- such_JJ as_IN the_DT one_NN that_WDT causes_VBZ chicken_NN pox_NN and_CC shingles_NNS )_-RRB- are_VBP n’t_RB suited_VBN for_IN others_NNS ._. Some_DT antivirals_NNS can’t_MD even_RB treat_VB different_JJ strains_NNS of_IN the_DT same_JJ virus_NN ._.","In 1981 , a JJ NN VBD NNP - NNP NN , in NNP NNP , with NN of NN and with JJ JJ NNS on his NN . After VBG NNS and NNS , a twenty - eight - NN - JJ JJ NN VBN NNP NNP VBD an JJ JJ NN in the NN ’s NNS and a JJ NN , NNP ’s NN . These NNS VBD both VBN with NN NN , though NN in the NN ’s NN VBD why he would VB in such a NN . He VBD VBN NNS and VBN ; RB RB RB , he VBD . Over a JJ NNS , NNP and his NNS VBD five NNS with JJ NNS . They VBD up the NNS and VBD them to the NNPS for NNP NNP — the JJ NN of what VBD VBN as NN . NNP VBD to VB the NN . “ Some NNS VBD RB JJ that I VBD RB VBN by those JJ NNS at the JJ NN of my NN , ” he VBD me . “ ‘ Why would you VB to VB your NN to an JJ NN ? ’ ” RB one that VBD RB to VB what VBD VBN a NN NN — JJ NNS . But NNP , who VBD VBN from NNP when he VBD twelve , VBG no NNP , VBD an JJ NN and would RB VB VBN . He VBD JJ NNS throughout the nineteen - NNS about NNP , the NN that VBZ NN , and in 1990 , at the NN of thirty - seven , he VBD to NNP NNP to VB the NN of the NNP NNP NNP NNP NNP . A NN RBR , he VBD a NN VBG him to VB RB to NNP to VB a RB JJ NN . RB , he VBD that NNP ( NNP ) NNP VBD RB JJ . The VBG NN , NNP VBD his NN and VBD that he VBD VBG from the NNP . NNP VBZ VBN for him RB RB . NNP RBR VBD that he VBD RB VBN NNP would VB him , because NNP VBD VBN him that JJR NNS VBD in the NN . In 1994 , NNP VBD that a JJ NN of NNS could RB VB the JJ NN in NN NNS . But , within each VBN NN , the NN VBD RB , VBG NNS . One NN VBD RB JJ . His NN VBD the NN of an NN “ NN ” — a NN of three or four NNS that , VBG in NN , could VB the NN . In 1996 , NNP VBN NNP its NNP of the NNP . In NNP , 2002 , a JJ NN VBD out in NNP : JJ JJ JJ NN , VBN by a NN VBN NNP - NNP . NNP VBD VBN by NNP ’s JJ JJ - NN NNS to VB them . “ The RBS JJ NN I VBP VBZ VBG to NNP , VBG in the JJ NN or JJ NN , and VBG to the NN along the JJS NN , ” he VBD . “ If you VBP the NNP NNS of JJ NNS RB , with the NN and the NN , that VBZ the NN . It VBZ ten or twelve NNS . There VBD RB the NN that VBZ VBG me and one NN for RB RB as one could VB . ” He VBD on , “ That VBZ when I VBD JJ in NNS , VBG as a NN and VBG the NN JJ in JJ NNS throughout NNP . ” RB in NNP NNP , NNP VBD VBG the NN NN . Some NNS can VB JJ NNS , like NN ; NNS VBP among the NNS of the JJ NN . But , he VBD , “ the NNP NN VBD in NNP of 2003 . By the JJ NN , there VBD RB any NN . NN for that NN NN of VBD up . RB we RB VBD it and VBD on with our NN NN . ” In 2012 , another NN , NNP - NNP , VBD an NN in the NNP NNP ; NNP NNP JJ NN , as it VBD VBN , VBD JJR than twenty - five hundred NNS and VBD JJR than eight hundred . NNP VBD it with NN , but this NN , RB , VBD RB . RB , this JJ NNP , a NN with JJ NNS VBD up in NNP and , within a NN , VBD VBN to another NN , NNP - NNP - 2 . NNP VBD me , “ My JJ NN VBD me to VB JJR on the NN VBG out of NNP in JJ NNP and JJ NNP . RB , the NN with NNP RB VBD a NN on our JJ NN to VB in and VB VBN . ” His NN VBD when the NN VBD . “ It VBD the VBG NN of the NN that VBD us , ‘ Oh , we ’d RBR VB about VBG into this , ’ ” he VBD . NNP VBD RB VBG up his NN at its JJ NN , at NNP NNP . He VBZ JJ with NNP NNP , the NN of the NN NN NNP , who VBD how he could VB . In NNP , NNP VBD that NNP ’s NN VBD VBN a $ 2.1 - million NN to NNP and JJ NNP NNS to VB JJ NNS . This NN VBD VBN by the NNP - 19 NN , but the NN VBZ beyond it ; the NNS VBP VBG RB RB about the JJ NN but about JJ NNS RB RB . What will the JJ JJ NN VB ? “ If you VBD VBN me that three or four NNS RB , I would VB VBN NN , ” NNP VBD me , with a NN of NN . For NNS , this VBZ RB RB a NN NN ; it VBZ the NN of NN that VBZ NNS of NN . Two NNS RB , a NN at NNP NNP VBD a NN VBN “ The NNPS of NNP NNPS , ” which VBD VBN on a NN NN , NNS with JJR than a hundred and twenty NNS , and a NN VBN to the NN . It RB VBD the NNS . Could NN VB us in ? NNS of NN VBP VBN NN throughout NN , but the NN of JJ NNS in the JJ NN “ VBD NN off the NN as a JJ JJ NN for the JJS NN , ” NNP NNP , a NN at NNP NNP and the NN ’s NN NN , VBD me . NNS can VB , and VB NN NN , but RB RB RB . How about NN ? They VBP some NNS , but VBP RB VB RB to JJ - VBN NNS ( and may VB VBN VB the NN of JJ - NN ) . NNS ? These VBP JJ for JJ - NN NN and its JJ NN , but VBP RB JJ by VBG NN NN and VBG from NN . NN ? NNP VBZ VBN RB NN of all NNS who VBP RB VBN . But NNS VBP RB VBN by NNS JJ as NNS and NNS , which VBP VBN by NN and NN . NNS , the NN VBD , VBP the JJ NNS . RB RB any NNS , RB . The JJS NNS VBP those with a NN of NN , which VBP JJR than those with NN . NNS that VBP before NNS VBP RB VB a JJ NN . ( The JJ JJ NN we VBP VBN out , NN , VBZ RB JJ during the NN NN . ) And the RBS JJ VBP those VBN by NN , RB than by NNS or NN NNS , which can VB VBN through NN . NNS that can VB between NNS and NNS VBP RB JJ to VB . All in all , this NN NN VBZ us RB RB to VBG two NNS of JJ NNS : NNS and NNS . NN of our off - the - NN NNS VBP us for such a NN . If NNS VBP , there VBZ a JJ NN of NNS you can VB . Between NN and NN , we can VB NNS of JJ NNS of JJ NN . For the RB two hundred VBN NNS that VBP us , there VBP VBN NNS for RB ten or RB . And the JJ NNS that VBP VBP to VB JJ NNS . RB a JJ VBP VBN VBN for NN against JJR than one NN . JJ NNS that VBP on one NN VBP RB VB on NNS within the JJ NN ; NNS VBN for some NNS ( JJ as the NN that VBZ NN NN and NNS ) VBP RB VBN for NNS . Some NNS can’t RB VB JJ NNS of the JJ NN ."
256,1348,mainstream,"Brain_NN scans_NNS ,_, analyzed_VBN using_VBG a_DT type_NN of_IN artificial_JJ intelligence_NN ,_, can_MD reveal_VB whether_IN 6_CD -_HYPH month_NN -_HYPH old_JJ babies_NNS are_VBP likely_JJ to_TO develop_VB autism_NN ,_, a_DT new_JJ study_NN shows_VBZ ._. The_DT study_NN examined_VBD 59_CD infants_NNS who_WP were_VBD at_IN high_JJ risk_NN of_IN developing_VBG autism_NN ;_, that_DT is_VBZ ,_, each_DT had_VBD an_DT older_JJR sibling_NN with_IN autism_NN ._. The_DT artificial_JJ intelligence_NN predicted_VBD with_IN 100_CD percent_NN accuracy_NN that_IN 48_CD infants_NNS would_MD not_RB develop_VB autism_NN ._. In_IN addition_NN ,_, of_IN the_DT 11_CD infants_NNS who_WP did_VBD develop_VB the_DT disorder_NN by_IN the_DT time_NN they_PRP were_VBD 2_CD years_NNS old_JJ ,_, the_DT system_NN correctly_RB predicted_VBD nine_CD of_IN the_DT cases_NNS ._. ""_`` It_PRP was_VBD extremely_RB accurate_JJ ,_, ""_'' Robert_NNP Emerson_NNP ,_, the_DT lead_JJ author_NN on_IN the_DT study_NN and_CC a_DT former_JJ cognitive_JJ neuroscience_NN postdoctoral_JJ fellow_NN at_IN the_DT University_NNP of_IN North_NNP Carolina_NNP (_-LRB- UNC_NNP )_-RRB- ,_, told_VBD Live_NNP Science_NNP ._. [_-LRB- 5_CD Things_NNS That_WDT May_MD Cause_VB Autism_NN ]_-RRB- Studies_NNS show_VBP that_IN 20_CD percent_NN of_IN babies_NNS who_WP have_VBP older_JJR siblings_NNS with_IN autism_NN will_MD develop_VB the_DT disorder_NN ;_: among_IN babies_NNS in_IN the_DT general_JJ population_NN ,_, 1.5_CD percent_NN develop_VBP autism_NN ,_, Emerson_NNP told_VBD Live_NNP Science_NNP ._. The_DT results_NNS of_IN the_DT new_JJ research_NN could_MD lead_VB to_IN new_JJ diagnostic_JJ tools_NNS that_WDT identify_VBP autism_NN before_IN symptoms_NNS occur_VBP ,_, giving_VBG clinicians_NNS the_DT opportunity_NN to_TO intervene_VB early_RB ,_, the_DT researchers_NNS said_VBD ._. ""_`` The_DT idea_NN is_VBZ that_IN we_PRP can_MD be_VB more_RBR effective_JJ if_IN we_PRP can_MD get_VB to_IN these_DT kids_NNS before_IN they_PRP develop_VBP autism_NN ,_, perhaps_RB ameliorating_VBG or_CC preventing_VBG it_PRP ,_, ""_'' Dr._NNP Joseph_NNP Piven_NNP ,_, a_DT professor_NN of_IN psychiatry_NN at_IN the_DT UNC_NNP School_NNP of_IN Medicine_NNP and_CC director_NN of_IN the_DT Carolina_NNP Institute_NNP for_IN Developmental_NNP Disabilities_NNPS ,_, told_VBD Live_NNP Science_NNP ._. The_DT researchers_NNS published_VBD their_PRP$ results_NNS today_NN (_-LRB- June_NNP 7_CD )_-RRB- in_IN the_DT journal_NNP Science_NNP Translational_NNP Medicine_NNP ._. Autism_NN spectrum_NN disorder_NN ,_, a_DT brain_NN -_HYPH based_VBN disorder_NN characterized_VBN by_IN a_DT wide_JJ range_NN of_IN social_JJ -_HYPH communication_NN challenges_NNS and_CC repetitive_JJ behaviors_NNS ,_, affects_VBZ about_RB one_CD out_IN of_IN every_DT 68_CD children_NNS in_IN the_DT United_NNP States_NNPS ._. Behavioral_JJ symptoms_NNS typically_RB begin_VBP to_TO appear_VB in_IN children_NNS at_IN around_IN age_NN 2_CD ._. Emerson_NNP and_CC his_PRP$ colleagues_NNS demonstrated_VBD that_IN they_PRP could_MD identify_VB biomarkers_NNS for_IN the_DT disorder_NN before_IN the_DT symptoms_NNS occur_VBP ._. As_IN part_NN of_IN their_PRP$ study_NN ,_, the_DT researchers_NNS used_VBD MRI_NN scanners_NNS to_TO image_VB the_DT brains_NNS of_IN the_DT infants_NNS while_IN they_PRP slept_VBD ._. During_IN the_DT scans_NNS ,_, the_DT researchers_NNS recorded_VBD the_DT neural_JJ activity_NN of_IN 230_CD different_JJ regions_NNS in_IN the_DT brain_NN ,_, looking_VBG particularly_RB at_IN whether_IN or_CC not_RB pairs_NNS of_IN these_DT region_NN —_: referred_VBN to_IN as_IN functional_JJ connections_NNS —_: were_VBD synchronized_VBN with_IN each_DT other_JJ ,_, and_CC if_IN so_RB ,_, to_IN what_WDT extent_NN ._. In_IN total_NN ,_, the_DT researchers_NNS measured_VBD 26,335_CD functional_JJ connections_NNS crucial_JJ for_IN cognition_NN ,_, memory_NN and_CC behavior_NN ._. When_WRB the_DT children_NNS reached_VBD age_NN 2_CD ,_, they_PRP came_VBD back_RB in_RP for_IN a_DT behavior_NN assessment_NN ._. The_DT researchers_NNS looked_VBD at_IN the_DT children_NNS 's_POS social_JJ interactions_NNS ,_, communication_NN ,_, motor_NN development_NN and_CC tendency_NN to_TO perform_VB repetitive_JJ actions_NNS ,_, and_CC determined_VBD whether_IN each_DT child_NN had_VBD autism_NN ._. [_-LRB- 11_CD Facts_NNS Every_DT Parent_NN Should_MD Know_VB About_IN Their_PRP$ Baby's_NNS Brain_NN ]_-RRB- With_IN all_DT of_IN the_DT data_NNS in_IN hand_NN ,_, the_DT researchers_NNS set_VBD out_RP to_TO first_RB train_VB their_PRP$ machine_NN learning_NN program_NN ,_, and_CC then_RB use_VB it_PRP to_TO run_VB predictions_NNS ._. They_PRP wanted_VBD to_TO see_VB how_WRB accurately_RB it_PRP could_MD predict_VB which_WDT infants_NNS had_VBD developed_VBN autism_NN ,_, using_VBG only_RB the_DT functional_JJ connections_NNS data_NNS from_IN when_WRB the_DT children_NNS were_VBD 6_CD months_NNS old_JJ ._. In_IN other_JJ words_NNS ,_, although_IN the_DT researchers_NNS knew_VBD which_WDT babies_NNS had_VBD developed_VBN into_IN toddlers_NNS with_IN autism_NN and_CC which_WDT had_VBD not_RB ,_, the_DT machine_NN learning_NN program_NN did_VBD not_RB ._. Machine_NN learning_NN is_VBZ a_DT kind_NN of_IN artificial_JJ intelligence_NN system_NN that_WDT gets_VBZ smarter_JJR based_VBN on_IN the_DT data_NNS it_PRP processes_VBZ ._. In_IN this_DT case_NN ,_, the_DT program_NN was_VBD learning_VBG to_TO spot_VB differences_NNS between_IN the_DT functional_JJ connections_NNS imaged_VBN in_IN the_DT MRI_NNP data_NNS collected_VBN at_IN 6_CD months_NNS old_JJ that_WDT correlate_VBP with_IN cognition_NN ,_, memory_NN and_CC behavior_NN and_CC the_DT details_NNS from_IN the_DT behavioral_JJ assessments_NNS collected_VBN at_IN 24_CD months_NNS ._. As_IN the_DT program_NN did_VBD this_DT ,_, it_PRP separated_VBD the_DT children_NNS into_IN two_CD groups_NNS —_: those_DT with_IN autism_NN and_CC those_DT without_IN the_DT condition_NN ._. Once_IN it_PRP was_VBD trained_VBN ,_, it_PRP could_MD make_VB predictions_NNS ._. [_-LRB- 7_CD Baby_NNP Myths_NNP Debunked_VBN ]_-RRB- But_CC during_IN the_DT training_NN process_NN ,_, the_DT researchers_NNS did_VBD n't_RB use_VB the_DT data_NNS from_IN all_DT 59_CD kids_NNS ._. Instead_RB ,_, they_PRP fed_VBD data_NNS in_RP from_IN 58_CD of_IN the_DT 59_CD infants_NNS to_TO train_VB the_DT model_NN ,_, and_CC then_RB to_TO get_VB the_DT prediction_NN ,_, they_PRP inputed_VBD the_DT data_NNS from_IN the_DT one_CD infant_NN they_PRP had_VBD left_VBN out_RP ._. They_PRP repeated_VBD this_DT for_IN all_DT 59_CD children_NNS ._. ""_`` Each_DT child_NN was_VBD predicted_VBN separately_RB based_VBN on_IN a_DT model_NN from_IN the_DT other_JJ children_NNS in_IN the_DT group_NN ,_, ""_'' Emerson_NNP said_VBD ._. In_IN the_DT end_NN ,_, the_DT machine_NN learning_NN program_NN was_VBD correct_JJ in_IN 82_CD percent_NN of_IN the_DT cases_NNS in_IN which_WDT the_DT children_NNS did_VBD develop_VB autism_NN ._. Piven_NNP said_VBD the_DT team_NN published_VBD a_DT study_NN earlier_RBR in_IN the_DT year_NN that_WDT also_RB showed_VBD an_DT impressive_JJ prediction_NN rate_NN ,_, but_CC that_DT study_NN required_VBD two_CD MRI_NN scans_NNS ,_, one_CD at_IN 6_CD months_NNS of_IN age_NN and_CC one_CD at_IN 1_CD year_NN ._. Moving_VBG the_DT needle_NN to_IN an_DT earlier_JJR age_NN is_VBZ a_DT big_JJ advance_NN ,_, Piven_NNP said_VBD ._. The_DT research_NN team_NN was_VBD amazed_VBN by_IN the_DT parents_NNS who_WP participated_VBD in_IN this_DT and_CC other_JJ studies_NNS over_IN the_DT years_NNS ,_, given_VBN all_DT that_WDT was_VBD required_VBN ,_, he_PRP said_VBD ._. ""_`` This_DT is_VBZ an_DT extraordinary_JJ group_NN of_IN people_NNS ,_, ""_'' Piven_NNP said_VBD ._. ""_`` Not_RB only_RB do_VBP they_PRP have_VB an_DT older_JJR child_NN with_IN autism_NN ,_, but_CC they_PRP bring_VBP their_PRP$ babies_NNS ,_, often_RB multiple_JJ times_NNS and_CC from_IN very_RB far_RB away_RB ,_, to_IN one_CD of_IN our_PRP$ four_CD clinical_JJ sites_NNS around_IN the_DT country_NN ._. ""_'' The_DT researchers_NNS said_VBD they_PRP hope_VBP their_PRP$ contributions_NNS will_MD lead_VB to_IN more_RBR effective_JJ interventions_NNS for_IN children_NNS on_IN the_DT brink_NN of_IN developing_VBG autism_NN ._.","NN NNS , VBN VBG a NN of JJ NN , can VB whether 6 - NN - JJ NNS VBP JJ to VB NN , a JJ NN VBZ . The NN VBD 59 NNS who VBD at JJ NN of VBG NN ; that VBZ , each VBD an JJR NN with NN . The JJ NN VBD with 100 NN NN that 48 NNS would RB VB NN . In NN , of the 11 NNS who VBD VB the NN by the NN they VBD 2 NNS JJ , the NN RB VBD nine of the NNS . "" It VBD RB JJ , "" NNP NNP , the JJ NN on the NN and a JJ JJ NN JJ NN at the NNP of NNP NNP ( NNP ) , VBD NNP NNP . [ 5 NNS That May VB NN ] NNS VBP that 20 NN of NNS who VBP JJR NNS with NN will VB the NN ; among NNS in the JJ NN , 1.5 NN VBP NN , NNP VBD NNP NNP . The NNS of the JJ NN could VB to JJ JJ NNS that VBP NN before NNS VBP , VBG NNS the NN to VB RB , the NNS VBD . "" The NN VBZ that we can VB RBR JJ if we can VB to these NNS before they VBP NN , RB VBG or VBG it , "" NNP NNP NNP , a NN of NN at the NNP NNP of NNP and NN of the NNP NNP for NNP NNPS , VBD NNP NNP . The NNS VBD their NNS NN ( NNP 7 ) in the NNP NNP NNP NNP . NN NN NN , a NN - VBN NN VBN by a JJ NN of JJ - NN NNS and JJ NNS , VBZ RB one out of every 68 NNS in the NNP NNPS . JJ NNS RB VBP to VB in NNS at around NN 2 . NNP and his NNS VBD that they could VB NNS for the NN before the NNS VBP . As NN of their NN , the NNS VBD NN NNS to VB the NNS of the NNS while they VBD . During the NNS , the NNS VBD the JJ NN of 230 JJ NNS in the NN , VBG RB at whether or RB NNS of these NN — VBN to as JJ NNS — VBD VBN with each JJ , and if RB , to what NN . In NN , the NNS VBD 26,335 JJ NNS JJ for NN , NN and NN . When the NNS VBD NN 2 , they VBD RB in for a NN NN . The NNS VBD at the NNS 's JJ NNS , NN , NN NN and NN to VB JJ NNS , and VBD whether each NN VBD NN . [ 11 NNS Every NN Should VB About Their NNS NN ] With all of the NNS in NN , the NNS VBD out to RB VB their NN NN NN , and RB VB it to VB NNS . They VBD to VB how RB it could VB which NNS VBD VBN NN , VBG RB the JJ NNS NNS from when the NNS VBD 6 NNS JJ . In JJ NNS , although the NNS VBD which NNS VBD VBN into NNS with NN and which VBD RB , the NN NN NN VBD RB . NN NN VBZ a NN of JJ NN NN that VBZ JJR VBN on the NNS it VBZ . In this NN , the NN VBD VBG to VB NNS between the JJ NNS VBN in the NNP NNS VBN at 6 NNS JJ that VBP with NN , NN and NN and the NNS from the JJ NNS VBN at 24 NNS . As the NN VBD this , it VBD the NNS into two NNS — those with NN and those without the NN . Once it VBD VBN , it could VB NNS . [ 7 NNP NNP VBN ] But during the NN NN , the NNS VBD RB VB the NNS from all 59 NNS . RB , they VBD NNS in from 58 of the 59 NNS to VB the NN , and RB to VB the NN , they VBD the NNS from the one NN they VBD VBN out . They VBD this for all 59 NNS . "" Each NN VBD VBN RB VBN on a NN from the JJ NNS in the NN , "" NNP VBD . In the NN , the NN NN NN VBD JJ in 82 NN of the NNS in which the NNS VBD VB NN . NNP VBD the NN VBD a NN RBR in the NN that RB VBD an JJ NN NN , but that NN VBD two NN NNS , one at 6 NNS of NN and one at 1 NN . VBG the NN to an JJR NN VBZ a JJ NN , NNP VBD . The NN NN VBD VBN by the NNS who VBD in this and JJ NNS over the NNS , VBN all that VBD VBN , he VBD . "" This VBZ an JJ NN of NNS , "" NNP VBD . "" RB RB VBP they VB an JJR NN with NN , but they VBP their NNS , RB JJ NNS and from RB RB RB , to one of our four JJ NNS around the NN . "" The NNS VBD they VBP their NNS will VB to RBR JJ NNS for NNS on the NN of VBG NN ."
257,536,mainstream,"Almost_RB £_$ 7bn_CD has_VBZ been_VBN raised_VBN to_TO immunise_VB 300_CD million_CD children_NNS at_IN a_DT virtual_JJ global_JJ vaccine_NN summit_NN hosted_VBN by_IN the_DT UK_NNP ._. Prime_NNP Minister_NNP Boris_NNP Johnson_NNP said_VBD up_IN to_IN eight_CD million_CD lives_NNS would_MD be_VB saved_VBN as_IN a_DT result_NN of_IN the_DT funds_NNS pledged_VBN at_IN the_DT Gavi_NNP vaccine_NN summit_NN on_IN Thursday_NNP ._. The_DT money_NN will_MD help_VB immunise_VB children_NNS against_IN diseases_NNS like_IN polio_NN ,_, diphtheria_NN and_CC measles_NNS over_IN five_CD years_NNS ._. Mr_NNP Johnson_NNP said_VBD the_DT triumph_NN of_IN humanity_NN over_IN disease_NN was_VBD the_DT ""_`` greatest_JJS shared_VBN endeavour_NN of_IN our_PRP$ lifetimes_NNS ""_'' ._. The_DT summit_NN raised_VBD funds_NNS for_IN Gavi_NNP ,_, a_DT global_JJ alliance_NN of_IN public_JJ and_CC private_JJ sector_NN organisations_NNS promoting_VBG vaccination_NN among_IN the_DT world_NN 's_POS poorest_JJS communities_NNS ._. Pledges_NNS by_IN more_JJR than_IN 50_CD countries_NNS and_CC individuals_NNS like_IN billionaire_NN philanthropist_NN Bill_NNP Gates_NNP saw_VBD the_DT total_NN surpass_VB an_DT initial_JJ target_NN of_IN $_$ 7.4bn_CD (_-LRB- almost_RB £_$ 6_CD bn_CD )_-RRB- ._. Mr_NNP Gates_NNP donated_VBD $_$ 1.6bn_CD (_-LRB- £_$ 1.3_CD bn_CD )_-RRB- from_IN his_PRP$ foundation_NN and_CC Mr_NNP Johnson_NNP pledged_VBD £_$ 1.65_CD bn_CD over_IN the_DT next_JJ five_CD years_NNS ,_, making_VBG the_DT UK_NNP the_DT organisation_NN 's_POS biggest_JJS donor_NN ._. The_DT summit_NN comes_VBZ as_IN the_DT world_NN continues_VBZ to_TO struggle_VB to_TO get_VB to_IN grips_NNS with_IN the_DT coronavirus_NN pandemic_NN ._. Mr_NNP Johnson_NNP also_RB used_VBD the_DT conference_NN to_TO urge_VB world_NN leaders_NNS to_TO renew_VB their_PRP$ ""_`` collective_JJ resolve_NN ""_'' to_TO find_VB a_DT Covid_NNP -_HYPH 19_CD vaccine_NN ._. ""_`` Just_RB as_IN we_PRP have_VBP great_JJ military_JJ alliances_NNS like_IN Nato_NNP ..._, where_WRB countries_NNS collaborate_VBP on_IN building_VBG their_PRP$ collective_JJ military_JJ defence_NN ,_, so_RB we_PRP now_RB need_VBP that_DT same_JJ spirit_NN of_IN collaboration_NN and_CC collective_JJ defence_NN against_IN the_DT common_JJ enemy_NN of_IN disease_NN ,_, ""_'' he_PRP said_VBD ._. ""_`` It_PRP will_MD require_VB a_DT new_JJ international_JJ effort_NN to_TO co-operate_VB on_IN the_DT surveillance_NN and_CC the_DT sharing_NN of_IN information_NN -_HYPH data_NNS is_VBZ king_NN -_, that_WDT can_MD underpin_VB a_DT global_JJ alert_NN system_NN ,_, so_RB we_PRP can_MD rapidly_RB identify_VB any_DT future_JJ outbreak_NN ._. And_CC it_PRP will_MD mean_VB a_DT radical_JJ scaling_NN -_HYPH up_RP of_IN our_PRP$ global_JJ capacity_NN to_TO respond_VB ._. ""_'' International_NNP Development_NNP Secretary_NNP Anne-Marie_NNP Trevelyan_NNP later_RBR said_VBD she_PRP believed_VBD the_DT UK_NNP was_VBD capable_JJ of_IN delivering_VBG a_DT coronavirus_NN vaccine_NN to_IN those_DT who_WP need_VBP it_PRP ""_`` at_IN speed_NN ""_'' when_WRB one_PRP becomes_VBZ available_JJ ._. US_NNP President_NNP Donald_NNP Trump_NNP made_VBD a_DT surprise_NN appearance_NN at_IN the_DT virtual_JJ global_JJ vaccine_NN summit_NN ._. Last_JJ week_NN ,_, Mr_NNP Trump_NNP severed_VBD ties_NNS with_IN the_DT UN's_NNP health_NN agency_NN ,_, the_DT World_NNP Health_NNP Organization_NNP ,_, stopping_VBG around_RB $_$ 400_CD m_CD (_-LRB- £_$ 317_CD m_CD )_-RRB- in_IN support_NN ,_, after_IN accusing_VBG it_PRP and_CC China_NNP of_IN mishandling_VBG the_DT outbreak_NN ._. There_EX was_VBD international_JJ criticism_NN of_IN the_DT decision_NN ,_, particularly_RB because_IN it_PRP was_VBD made_VBN in_IN the_DT middle_NN of_IN a_DT global_JJ pandemic_NN ._. But_CC at_IN the_DT summit_NN ,_, Mr_NNP Trump_NNP struck_VBD a_DT different_JJ tone_NN in_IN what_WP was_VBD a_DT very_RB brief_JJ and_CC seemingly_RB very_RB off_IN -_HYPH the_DT -_HYPH cuff_NN ,_, pre-recorded_JJ message_NN ._. ""_`` As_IN the_DT coronavirus_NN has_VBZ shown_VBN ,_, there_EX are_VBP no_DT borders_NNS ,_, it_PRP does_VBZ n't_RB discriminate_VB ,_, ""_'' he_PRP said_VBD ._. ""_`` It_PRP 's_VBZ mean_JJ ,_, it_PRP 's_VBZ nasty_JJ but_CC we_PRP 're_VBP going_VBG to_TO take_VB care_NN of_IN it_PRP together_RB ...._. We_PRP will_MD work_VB hard_RB ,_, we_PRP will_MD work_VB strong_JJ ..._, good_JJ luck_NN ,_, let_VB 's_PRP get_VB the_DT answer_NN ._. ""_''","RB £ 7bn VBZ VBN VBN to VB 300 million NNS at a JJ JJ NN NN VBN by the NNP . NNP NNP NNP NNP VBD up to eight million NNS would VB VBN as a NN of the NNS VBN at the NNP NN NN on NNP . The NN will VB VB NNS against NNS like NN , NN and NNS over five NNS . NNP NNP VBD the NN of NN over NN VBD the "" JJS VBN NN of our NNS "" . The NN VBD NNS for NNP , a JJ NN of JJ and JJ NN NNS VBG NN among the NN 's JJS NNS . NNS by JJR than 50 NNS and NNS like NN NN NNP NNP VBD the NN VB an JJ NN of $ 7.4bn ( RB £ 6 bn ) . NNP NNP VBD $ 1.6bn ( £ 1.3 bn ) from his NN and NNP NNP VBD £ 1.65 bn over the JJ five NNS , VBG the NNP the NN 's JJS NN . The NN VBZ as the NN VBZ to VB to VB to NNS with the NN NN . NNP NNP RB VBD the NN to VB NN NNS to VB their "" JJ NN "" to VB a NNP - 19 NN . "" RB as we VBP JJ JJ NNS like NNP ... where NNS VBP on VBG their JJ JJ NN , RB we RB VBP that JJ NN of NN and JJ NN against the JJ NN of NN , "" he VBD . "" It will VB a JJ JJ NN to VB on the NN and the NN of NN - NNS VBZ NN - that can VB a JJ NN NN , RB we can RB VB any JJ NN . And it will VB a JJ NN - up of our JJ NN to VB . "" NNP NNP NNP NNP NNP RBR VBD she VBD the NNP VBD JJ of VBG a NN NN to those who VBP it "" at NN "" when one VBZ JJ . NNP NNP NNP NNP VBD a NN NN at the JJ JJ NN NN . JJ NN , NNP NNP VBD NNS with the NNP NN NN , the NNP NNP NNP , VBG RB $ 400 m ( £ 317 m ) in NN , after VBG it and NNP of VBG the NN . There VBD JJ NN of the NN , RB because it VBD VBN in the NN of a JJ NN . But at the NN , NNP NNP VBD a JJ NN in what VBD a RB JJ and RB RB off - the - NN , JJ NN . "" As the NN VBZ VBN , there VBP no NNS , it VBZ RB VB , "" he VBD . "" It VBZ JJ , it VBZ JJ but we VBP VBG to VB NN of it RB .... We will VB RB , we will VB JJ ... JJ NN , VB 's VB the NN . """
258,1085,mainstream,"●_NFP World_NNP Economic_NNP Forum_NNP honours_VBZ 25_CD Young_JJ Scientists_NNS under_IN the_DT age_NN of_IN 40_CD in_IN recognition_NN of_IN their_PRP$ contribution_NN to_IN cutting_NN -_HYPH edge_NN research_NN Geneva_NNP ,_, Switzerland_NNP ,_, 26_CD May_NNP 2020_CD –_: The_DT World_NNP Economic_NNP Forum_NNP today_NN announces_VBZ its_PRP$ Class_NNP of_IN 2020_CD Young_NNP Scientists_NNPS ,_, representing_VBG 25_CD exceptional_JJ researchers_NNS at_IN the_DT forefront_NN of_IN scientific_JJ discovery_NN ._. Recognition_NN of_IN the_DT Young_NNP Scientists_NNPS comes_VBZ at_IN a_DT time_NN when_WRB the_DT need_NN for_IN evidence_NN -_HYPH based_VBN policy_NN has_VBZ never_RB been_VBN clearer_JJR ._. Although_IN the_DT challenge_NN of_IN COVID_NNP -_HYPH 19_CD has_VBZ unintentionally_RB diverted_VBN attention_NN away_RB from_IN other_JJ research_NN work_NN –_: despite_IN the_DT pressing_VBG global_JJ issues_NNS that_WDT these_DT efforts_NNS address_VBP –_: the_DT need_NN for_IN science_NN to_TO test_VB ,_, predict_VB and_CC explain_VB how_WRB different_JJ phenomena_NNS affect_VBP human_JJ and_CC ecological_JJ outcomes_NNS is_VBZ greater_JJR than_IN ever_RB ._. The_DT Young_NNP Scientists_NNPS were_VBD nominated_VBN by_IN leading_VBG research_NN institutes_NNS according_VBG to_IN criteria_NNS including_VBG research_NN excellence_NN ,_, leadership_NN potential_NN and_CC commitment_NN to_IN serving_VBG society_NN ._. These_DT brilliant_JJ academics_NNS ,_, 40_CD and_CC under_RB ,_, have_VBP been_VBN selected_VBN on_IN the_DT basis_NN of_IN their_PRP$ achievements_NNS in_IN expanding_VBG the_DT boundaries_NNS of_IN knowledge_NN and_CC practical_JJ applications_NNS of_IN science_NN in_IN issues_NNS as_RB diverse_JJ as_IN child_NN psychology_NN ,_, chemical_JJ oceanography_NN and_CC artificial_JJ intelligence_NN ._. Eight_CD of_IN this_DT year_NN ’s_POS Young_NNP Scientists_NNPS study_VBP in_IN Europe_NNP ,_, while_IN seven_CD work_NN in_IN Asia_NNP ,_, six_CD are_VBP based_VBN in_IN the_DT Americas_NNPS ,_, two_CD in_IN South_NNP Africa_NNP and_CC a_DT further_JJ two_CD in_IN the_DT Middle_NNP East_NNP ._. Fifteen_CD –_: more_JJR than_IN half_NN –_: of_IN the_DT 25_CD Young_JJ Scientists_NNS are_VBP women_NNS ._. “_`` We_PRP are_VBP looking_VBG forward_RB to_IN working_VBG with_IN the_DT Class_NNP of_IN 2020_CD Young_NNP Scientists_NNPS to_TO help_VB leaders_NNS from_IN the_DT public_JJ and_CC private_JJ sector_NN better_RBR engage_VB with_IN science_NN and_CC in_IN doing_VBG so_RB ,_, help_VB young_JJ researchers_NNS become_VB stronger_JJR ambassadors_NNS for_IN science_NN ,_, which_WDT the_DT world_NN needs_VBZ now_RB and_CC will_MD continue_VB to_TO need_VB post_NN -_HYPH COVID_NNP -_HYPH 19_CD ,_, ”_'' said_VBD Alice_NNP Hazelton_NNP ,_, Programme_NNP Lead_NNP ,_, Science_NNP and_CC Society_NNP ,_, World_NNP Economic_NNP Forum_NNP ._.","● NNP NNP NNP VBZ 25 JJ NNS under the NN of 40 in NN of their NN to NN - NN NN NNP , NNP , 26 NNP 2020 – The NNP NNP NNP NN VBZ its NNP of 2020 NNP NNPS , VBG 25 JJ NNS at the NN of JJ NN . NN of the NNP NNPS VBZ at a NN when the NN for NN - VBN NN VBZ RB VBN JJR . Although the NN of NNP - 19 VBZ RB VBN NN RB from JJ NN NN – despite the VBG JJ NNS that these NNS VBP – the NN for NN to VB , VB and VB how JJ NNS VBP JJ and JJ NNS VBZ JJR than RB . The NNP NNPS VBD VBN by VBG NN NNS VBG to NNS VBG NN NN , NN NN and NN to VBG NN . These JJ NNS , 40 and RB , VBP VBN VBN on the NN of their NNS in VBG the NNS of NN and JJ NNS of NN in NNS RB JJ as NN NN , JJ NN and JJ NN . Eight of this NN ’s NNP NNPS VBP in NNP , while seven NN in NNP , six VBP VBN in the NNPS , two in NNP NNP and a JJ two in the NNP NNP . Fifteen – JJR than NN – of the 25 JJ NNS VBP NNS . “ We VBP VBG RB to VBG with the NNP of 2020 NNP NNPS to VB NNS from the JJ and JJ NN RBR VB with NN and in VBG RB , VB JJ NNS VB JJR NNS for NN , which the NN VBZ RB and will VB to VB NN - NNP - 19 , ” VBD NNP NNP , NNP NNP , NNP and NNP , NNP NNP NNP ."
259,503,mainstream,"The_DT U.S._NNP government_NN alone_RB spends_VBZ $_$ 200_CD million_CD a_DT year_NN on_IN a_DT hunt_NN for_IN a_DT vaccine_NN against_IN AIDS_NN ._. At_IN the_DT forefront_NN of_IN that_DT search_NN stands_VBZ Dr._NNP David_NNP Baltimore_NNP ,_, chairman_NN of_IN the_DT National_NNP Institute_NNP of_IN Health's_NNP AIDS_NNP Vaccine_NNP Research_NNP Committee_NNP ._. Currently_RB president_NN of_IN the_DT California_NNP Institute_NNP of_IN Technology_NNP as_RB well_RB ,_, Baltimore_NNP won_VBD the_DT 1975_CD Nobel_NNP Prize_NNP in_IN Physiology_NNP or_CC Medicine_NNP ._. Betsey_NNP Arledge_NNP ,_, producer_NN of_IN the_DT NOVA_NNP film_NN ""_`` Surviving_NNP AIDS_NNP ,_, ""_'' interviewed_VBD a_DT cautiously_RB optimistic_JJ Baltimore_NNP on_IN the_DT current_JJ state_NN of_IN the_DT search_NN for_IN a_DT vaccine_NN ._. NOVA_NNP :_: Can_MD you_PRP give_VB me_PRP a_DT sense_NN of_IN the_DT magnitude_NN of_IN the_DT AIDS_NN epidemic_NN at_IN this_DT time_NN ?_. Baltimore_NNP :_: The_DT AIDS_NNP epidemic_NN in_IN this_DT country_NN is_VBZ a_DT serious_JJ issue_NN ,_, but_CC it's_VBZ not_RB a_DT major_JJ public_JJ health_NN disaster_NN the_DT way_NN it_PRP is_VBZ abroad_RB ._. In_IN the_DT world_NN today_NN there_EX are_VBP something_NN like_IN 34_CD million_CD infected_VBN people_NNS ,_, and_CC more_JJR people_NNS are_VBP being_VBG infected_VBN every_DT minute_NN ._. On_IN the_DT scale_NN of_IN any_DT public_JJ health_NN issue_NN in_IN the_DT world_NN ,_, this_DT is_VBZ one_CD of_IN the_DT major_JJ ones_NNS ._. There_EX are_VBP more_JJR people_NNS dying_VBG of_IN AIDS_NN than_IN of_IN almost_RB any_DT other_JJ infectious_JJ disease_NN ,_, with_IN tuberculosis_NN and_CC malaria_NN being_VBG in_IN the_DT same_JJ ballpark_NN ._. It_PRP 's_VBZ a_DT horrendous_JJ situation_NN ._. (_-LRB- See_VB AIDS_NN in_IN Perspective_NN ._. )_-RRB- NOVA_NNP :_: Do_VBP you_PRP think_VB we_PRP 're_VBP getting_VBG a_DT little_JJ complacent_JJ in_IN this_DT country_NN ?_. Baltimore_NNP :_: I_PRP 'm_VBP impressed_JJ that_IN AIDS_NNP remains_VBZ a_DT very_RB noted_VBN disease_NN in_IN the_DT United_NNP States_NNPS ._. It_PRP 's_VBZ noted_VBN in_IN the_DT newspapers_NNS all_PDT the_DT time_NN —_: what_WP 's_VBZ going_VBG on_RP in_IN the_DT world_NN and_CC in_IN the_DT country_NN ._. There_EX is_VBZ very_RB complete_JJ coverage_NN of_IN how_WRB good_JJ the_DT drugs_NNS are_VBP and_CC where_WRB the_DT vaccine_NN program_NN stands_VBZ ._. I_PRP do_VBP n't_RB think_VB we_PRP 've_VBP allowed_VBN it_PRP to_TO fall_VB off_IN the_DT radar_NN screen_NN ._. And_CC we_PRP do_VBP far_RB more_JJR AIDS_NN research_NN than_IN the_DT whole_JJ rest_NN of_IN the_DT world_NN ;_, in_IN the_DT vaccine_NN area_NN alone_RB ,_, we_PRP do_VBP probably_RB 90_CD percent_NN of_IN the_DT research_NN ._. NOVA_NNP :_: Can_MD you_PRP give_VB me_PRP a_DT sense_NN of_IN the_DT amount_NN of_IN effort_NN —_: not_RB just_RB money_NN ,_, but_CC intellectual_JJ effort_NN —_: that_WDT has_VBZ gone_VBN into_IN trying_VBG to_TO find_VB a_DT vaccine_NN over_IN the_DT past_JJ 10_CD or_CC 15_CD years_NNS ?_. Baltimore_NNP :_: When_WRB H.I.V._NNP was_VBD first_RB discovered_VBN ,_, the_DT first_JJ thing_NN that_WDT the_DT then_RB -Secretary_NNP of_IN what_WP became_VBD the_DT U.S._NNP Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS said_VBD was_VBD ,_, ""_`` We_PRP will_MD have_VB a_DT vaccine_NN in_IN short_JJ order_NN ._. ""_'' She_PRP was_VBD wrong_JJ about_IN that_DT ,_, but_CC it_PRP shows_VBZ that_IN from_IN the_DT very_JJ first_JJ moment_NN a_DT vaccine_NN was_VBD on_IN people_NNS 's_POS minds_NNS ._. Indeed_RB ,_, there_EX has_VBZ been_VBN a_DT significant_JJ effort_NN to_TO make_VB a_DT vaccine_NN from_IN the_DT very_JJ first_JJ day_NN ._. I_PRP think_VBP people_NNS thought_VBD it_PRP would_MD be_VB simple_JJ ,_, because_IN we_PRP 'd_VBD made_VBN vaccines_NNS for_IN so_RB many_JJ different_JJ viruses_NNS ._. The_DT polio_NN vaccine_NN is_VBZ effective_JJ because_IN ,_, for_IN the_DT most_JJS part_NN ,_, our_PRP$ bodies_NNS naturally_RB fight_VBP this_DT virus_NN ._. This_DT is_VBZ not_RB the_DT case_NN with_IN HIV_NN ._. The_DT thing_NN that_WDT worried_VBD me_PRP at_IN the_DT time_NN —_: and_CC it_PRP has_VBZ turned_VBN out_RP to_TO be_VB the_DT biggest_JJS worry_NN —_: was_VBD that_IN if_IN it_PRP were_VBD possible_JJ to_TO make_VB a_DT vaccine_NN ,_, why_WRB does_VBZ n't_RB the_DT body_NN ordinarily_RB fight_VB off_RP the_DT virus_NN ?_. Most_JJS viruses_NNS we_PRP fight_VBP off_RP very_RB well_RB ,_, including_VBG polio_NN and_CC even_RB smallpox_NN ._. A_DT certain_JJ fraction_NN of_IN people_NNS may_MD be_VB maimed_VBN or_CC killed_VBN by_IN those_DT viruses_NNS ,_, but_CC the_DT much_RB larger_JJR fraction_NN of_IN people_NNS get_VBP over_IN them_PRP ._. That_DT 's_VBZ not_RB true_JJ for_IN H.I.V_NNP ._. We_PRP knew_VBD that_DT from_IN very_RB early_RB on_RB ._. At_IN first_RB we_PRP thought_VBD it_PRP might_MD be_VB that_IN many_JJ people_NNS would_MD be_VB killed_VBN by_IN it_PRP ,_, and_CC then_RB we_PRP began_VBD to_TO realize_VB that_IN almost_RB everybody_NN who_WP had_VBD the_DT infection_NN was_VBD potentially_RB going_VBG to_TO be_VB killed_VBN by_IN it_PRP ._. That_DT 's_VBZ fundamentally_RB different_JJ than_IN other_JJ viruses_NNS ._. And_CC that_DT fundamental_JJ difference_NN was_VBD a_DT red_JJ flag_NN ._. The_DT initial_JJ impetus_NN that_WDT we'd_VBD be_VB able_JJ to_TO do_VB it_PRP ,_, it_PRP 's_VBZ around_IN the_DT corner_NN ,_, was_VBD just_RB all_RB wrong_JJ ._. NOVA_NNP :_: So_RB the_DT search_NN for_IN a_DT vaccine_NN has_VBZ been_VBN a_DT real_JJ struggle_NN ?_. Baltimore_NNP :_: It_PRP 's_VBZ been_VBN an_DT enormous_JJ struggle_NN ,_, because_IN the_DT obvious_JJ things_NNS did_VBD n't_RB work_VB ,_, and_CC people_NNS got_VBD very_RB frustrated_JJ by_IN that_DT ._. The_DT next_JJ question_NN became_VBD :_: Where_WRB do_VBP you_PRP turn_VB ?_. What_WP 's_VBZ not_RB obvious_JJ ?_. What_WP can_MD we_PRP do_VB ?_. That_DT involved_VBD bringing_VBG a_DT whole_JJ different_JJ level_NN of_IN people_NNS into_IN the_DT discussion_NN ._. Not_RB the_DT ordinary_JJ people_NNS who_WP make_VBP vaccines_NNS ,_, but_CC people_NNS whose_WP$ scientific_JJ focus_NN is_VBZ in_IN other_JJ areas_NNS of_IN immunology_NN ,_, of_IN infectious_JJ disease_NN —_: basic_JJ scientists_NNS ._. So_RB it_PRP 's_VBZ been_VBN a_DT ramping_NN up_RP process_NN to_TO get_VB more_JJR and_CC more_JJR people_NNS involved_VBN and_CC thinking_VBG about_IN it_PRP ._. Perhaps_RB the_DT most_RBS important_JJ role_NN of_IN the_DT committee_NN I_PRP 'm_VBP now_RB heading_VBG is_VBZ to_TO galvanize_VB the_DT scientific_JJ community_NN to_TO find_VB new_JJ routes_NNS in_IN thinking_VBG about_IN a_DT vaccine_NN ,_, so_IN that_IN maybe_RB we_PRP can_MD find_VB a_DT vaccine_NN through_IN some_DT very_RB non-traditional_JJ approach_NN ._. NOVA_NNP :_: An_DT international_JJ team_NN of_IN scientists_NNS announced_VBD recently_RB that_IN they_PRP had_VBD traced_VBN the_DT origin_NN of_IN the_DT AIDS_NNP virus_NN to_IN a_DT subspecies_NNS of_IN chimpanzee_NN in_IN Africa_NNP ._. If_IN this_DT report_NN is_VBZ verified_VBN ,_, how_WRB will_MD it_PRP help_VB in_IN the_DT search_NN for_IN a_DT vaccine_NN ?_. Baltimore_NNP :_: In_IN truth_NN ,_, it_PRP will_MD not_RB have_VB much_JJ effect_NN on_IN the_DT search_NN for_IN a_DT vaccine_NN ._. However_RB ,_, it_PRP tells_VBZ us_PRP a_DT lot_NN about_IN why_WRB HIV_NNP is_VBZ so_RB hard_JJ to_TO counter_VB ._. It_PRP is_VBZ not_RB a_DT virus_NN that_WDT is_VBZ native_JJ to_IN the_DT human_JJ species_NNS ,_, and_CC therefore_RB it_PRP is_VBZ continually_RB mutating_VBG in_IN an_DT effort_NN to_TO adapt_VB ._. Most_JJS human_JJ viruses_NNS are_VBP well_RB -_HYPH controlled_VBN by_IN the_DT human_JJ immune_JJ system_NN ,_, because_IN they_PRP have_VBP evolved_VBN with_IN it_PRP ,_, and_CC the_DT two_CD opposing_JJ forces_NNS are_VBP in_IN a_DT steady_JJ -_HYPH state_NN ._. We_PRP cannot_MD wait_VB until_IN we_PRP and_CC HIV_NNP evolve_VBP to_IN being_VBG comfortable_JJ with_IN each_DT other_JJ ._. We_PRP must_MD devise_VB a_DT vaccine_NN ,_, effectively_RB short_JJ -_HYPH circuiting_VBG the_DT usual_JJ process_NN of_IN adaptation_NN ._. NOVA_NNP :_: Who_WP are_VBP the_DT so_RB -_HYPH called_VBN long_JJ -_HYPH term_NN non-progressors_NNS ,_, and_CC how_WRB do_VBP they_PRP fit_VB into_IN the_DT search_NN ?_. Bob_NNP Massie_NNP is_VBZ a_DT long_JJ -_HYPH term_NN non-progressor_NN ._. His_PRP$ immune_NN system_NN 's_POS ability_NN to_TO fight_VB HIV_NNP is_VBZ inspiring_VBG a_DT new_JJ approach_NN to_IN fighting_VBG AIDS_NN ._. Baltimore_NNP :_: There_EX is_VBZ a_DT small_JJ group_NN of_IN H.I.V.-_JJ infected_VBN people_NNS —_: maybe_RB five_CD percent_NN —_: who_WP do_VBP n't_RB get_VB any_DT symptoms_NNS and_CC whose_WP$ virus_NN is_VBZ maintained_VBN at_IN a_DT very_RB low_JJ level_NN ._. If_IN we_PRP could_MD find_VB out_RP the_DT secret_NN behind_IN that_DT ,_, maybe_RB we_PRP could_MD replicate_VB it_PRP in_IN a_DT vaccine_NN ._. So_RB far_RB we_PRP have_VBP n't_RB found_VBN the_DT secret_NN ,_, but_CC there_EX are_VBP good_JJ correlations_NNS ._. These_DT people_NNS have_VBP a_DT good_JJ cytotoxic_JJ T_NN lymphocyte_NN response_NN ,_, they_PRP have_VBP a_DT good_JJ helper_NN T_NN cell_NN response_NN ._. [_-LRB- Cytotoxic_JJ T_NN lymphocytes_NN ,_, otherwise_RB known_VBN as_IN CTLs_NNS or_CC CD8_NN killer_NN T_NN -_HYPH cells_NNS ,_, are_VBP cells_NNS involved_VBN in_IN immune_NN defense_NN that_WDT can_MD kill_VB other_JJ cells_NNS infected_VBN by_IN viruses_NNS ._. So_RB -_HYPH called_VBN CD4_NN helper_NN T_NN cells_NNS are_VBP essential_JJ for_IN triggering_VBG antibody_NN production_NN ,_, activating_VBG CTLs_NNS ,_, and_CC initiating_VBG other_JJ immune_JJ responses_NNS ._. ]_-RRB- So_RB that_DT says_VBZ if_IN we_PRP can_MD make_VB those_DT a_DT focus_NN of_IN activity_NN ,_, maybe_RB we_PRP can_MD design_VB a_DT vaccine_NN around_IN those_DT principles_NNS ._. But_CC there_EX 's_VBZ no_DT certainty_NN that_IN those_DT are_VBP the_DT key_JJ issues_NNS ._. There_EX is_VBZ a_DT balance_NN of_IN three_CD things_NNS :_: whether_IN the_DT virus_NN that_WDT those_DT people_NNS have_VBP is_VBZ different_JJ than_IN the_DT virus_NN other_JJ people_NNS have_VBP ;_: whether_IN their_PRP$ immune_JJ system_NN is_VBZ somehow_RB responding_VBG to_IN it_PRP differently_RB than_IN other_JJ people_NNS 's_POS immune_JJ systems_NNS are_VBP ;_, and_CC whether_IN their_PRP$ genetics_NNS are_VBP different_JJ ._. Are_VBP they_PRP inherently_RB able_JJ to_TO fight_VB the_DT virus_NN ?_. Or_CC is_VBZ it_PRP something_NN that_WDT 's_VBZ learned_VBN and_CC that_IN therefore_RB we_PRP could_MD teach_VB other_JJ people_NNS to_TO do_VB ?_. Continue_VB Search_VB for_IN a_DT Vaccine_NN |_NFP See_VB HIV_NN in_IN Action_NN |_NFP AIDS_NN in_IN Perspective_NN The_DT Virus_NN Fighters_NNS |_NFP Fighting_NN Back_NN |_NFP Help_NN /_, Resources_NNS Teacher_NN 's_POS Guide_NN |_NFP Transcript_NN |_NFP Site_NN Map_NN |_NFP Surviving_VBG AIDS_NNP Home_NN","The NNP NN RB VBZ $ 200 million a NN on a NN for a NN against NN . At the NN of that NN VBZ NNP NNP NNP , NN of the NNP NNP of NNP NNP NNP NNP NNP . RB NN of the NNP NNP of NNP RB RB , NNP VBD the 1975 NNP NNP in NNP or NNP . NNP NNP , NN of the NNP NN "" NNP NNP , "" VBD a RB JJ NNP on the JJ NN of the NN for a NN . NNP : Can you VB me a NN of the NN of the NN NN at this NN ? NNP : The NNP NN in this NN VBZ a JJ NN , but VBZ RB a JJ JJ NN NN the NN it VBZ RB . In the NN NN there VBP NN like 34 million VBN NNS , and JJR NNS VBP VBG VBN every NN . On the NN of any JJ NN NN in the NN , this VBZ one of the JJ NNS . There VBP JJR NNS VBG of NN than of RB any JJ JJ NN , with NN and NN VBG in the JJ NN . It VBZ a JJ NN . ( VB NN in NN . ) NNP : VBP you VB we VBP VBG a JJ JJ in this NN ? NNP : I VBP JJ that NNP VBZ a RB VBN NN in the NNP NNPS . It VBZ VBN in the NNS all the NN — what VBZ VBG on in the NN and in the NN . There VBZ RB JJ NN of how JJ the NNS VBP and where the NN NN VBZ . I VBP RB VB we VBP VBN it to VB off the NN NN . And we VBP RB JJR NN NN than the JJ NN of the NN ; in the NN NN RB , we VBP RB 90 NN of the NN . NNP : Can you VB me a NN of the NN of NN — RB RB NN , but JJ NN — that VBZ VBN into VBG to VB a NN over the JJ 10 or 15 NNS ? NNP : When NNP VBD RB VBN , the JJ NN that the RB NNP of what VBD the NNP NNP of NNP and NNP NNPS VBD VBD , "" We will VB a NN in JJ NN . "" She VBD JJ about that , but it VBZ that from the JJ JJ NN a NN VBD on NNS 's NNS . RB , there VBZ VBN a JJ NN to VB a NN from the JJ JJ NN . I VBP NNS VBD it would VB JJ , because we VBD VBN NNS for RB JJ JJ NNS . The NN NN VBZ JJ because , for the JJS NN , our NNS RB VBP this NN . This VBZ RB the NN with NN . The NN that VBD me at the NN — and it VBZ VBN out to VB the JJS NN — VBD that if it VBD JJ to VB a NN , why VBZ RB the NN RB VB off the NN ? JJS NNS we VBP off RB RB , VBG NN and RB NN . A JJ NN of NNS may VB VBN or VBN by those NNS , but the RB JJR NN of NNS VBP over them . That VBZ RB JJ for NNP . We VBD that from RB RB RB . At RB we VBD it might VB that JJ NNS would VB VBN by it , and RB we VBD to VB that RB NN who VBD the NN VBD RB VBG to VB VBN by it . That VBZ RB JJ than JJ NNS . And that JJ NN VBD a JJ NN . The JJ NN that VBD VB JJ to VB it , it VBZ around the NN , VBD RB RB JJ . NNP : RB the NN for a NN VBZ VBN a JJ NN ? NNP : It VBZ VBN an JJ NN , because the JJ NNS VBD RB VB , and NNS VBD RB JJ by that . The JJ NN VBD : Where VBP you VB ? What VBZ RB JJ ? What can we VB ? That VBD VBG a JJ JJ NN of NNS into the NN . RB the JJ NNS who VBP NNS , but NNS whose JJ NN VBZ in JJ NNS of NN , of JJ NN — JJ NNS . RB it VBZ VBN a NN up NN to VB JJR and JJR NNS VBN and VBG about it . RB the RBS JJ NN of the NN I VBP RB VBG VBZ to VB the JJ NN to VB JJ NNS in VBG about a NN , so that RB we can VB a NN through some RB JJ NN . NNP : An JJ NN of NNS VBD RB that they VBD VBN the NN of the NNP NN to a NNS of NN in NNP . If this NN VBZ VBN , how will it VB in the NN for a NN ? NNP : In NN , it will RB VB JJ NN on the NN for a NN . RB , it VBZ us a NN about why NNP VBZ RB JJ to VB . It VBZ RB a NN that VBZ JJ to the JJ NNS , and RB it VBZ RB VBG in an NN to VB . JJS JJ NNS VBP RB - VBN by the JJ JJ NN , because they VBP VBN with it , and the two JJ NNS VBP in a JJ - NN . We cannot VB until we and NNP VBP to VBG JJ with each JJ . We must VB a NN , RB JJ - VBG the JJ NN of NN . NNP : Who VBP the RB - VBN JJ - NN NNS , and how VBP they VB into the NN ? NNP NNP VBZ a JJ - NN NN . His NN NN 's NN to VB NNP VBZ VBG a JJ NN to VBG NN . NNP : There VBZ a JJ NN of JJ VBN NNS — RB five NN — who VBP RB VB any NNS and whose NN VBZ VBN at a RB JJ NN . If we could VB out the NN behind that , RB we could VB it in a NN . RB RB we VBP RB VBN the NN , but there VBP JJ NNS . These NNS VBP a JJ JJ NN NN NN , they VBP a JJ NN NN NN NN . [ JJ NN NN , RB VBN as NNS or NN NN NN - NNS , VBP NNS VBN in NN NN that can VB JJ NNS VBN by NNS . RB - VBN NN NN NN NNS VBP JJ for VBG NN NN , VBG NNS , and VBG JJ JJ NNS . ] RB that VBZ if we can VB those a NN of NN , RB we can VB a NN around those NNS . But there VBZ no NN that those VBP the JJ NNS . There VBZ a NN of three NNS : whether the NN that those NNS VBP VBZ JJ than the NN JJ NNS VBP ; whether their JJ NN VBZ RB VBG to it RB than JJ NNS 's JJ NNS VBP ; and whether their NNS VBP JJ . VBP they RB JJ to VB the NN ? Or VBZ it NN that VBZ VBN and that RB we could VB JJ NNS to VB ? VB VB for a NN | VB NN in NN | NN in NN The NN NNS | NN NN | NN / NNS NN 's NN | NN | NN NN | VBG NNP NN"
260,323,conspiracy,"[_-LRB- Note_NN :_: This_DT is_VBZ Part_NN VI_CD in_IN a_DT series_NN of_IN articles_NNS adapted_VBN from_IN the_DT second_JJ Children_NNP ’s_POS Health_NNP Defense_NNP eBook_NNP :_: Conflicts_NNPS of_IN Interest_NNP Undermine_NNP Children_NNPS ’s_POS Health_NNP ._. The_DT first_JJ eBook_NNP ,_, The_DT Sickest_NNP Generation_NNP :_: The_DT Facts_NNPS Behind_IN the_DT Children_NNPS ’s_POS Health_NNP Crisis_NNP and_CC Why_WRB It_PRP Needs_VBZ to_TO End_VB ,_, described_VBD how_WRB children_NNS ’s_POS health_NN began_VBD to_TO worsen_VB dramatically_RB in_IN the_DT late_JJ 1980s_NNS following_VBG fateful_JJ changes_NNS in_IN the_DT childhood_NN vaccine_NN schedule_NN ._. ]_-RRB- A_DT concerted_VBN and_CC “_`` heavy_JJ -_HYPH handed_JJ ”_'' effort_NN is_VBZ under_IN way_NN to_TO censor_VB information_NN that_WDT contradicts_VBZ the_DT oversimplified_VBN sound_NN bites_NNS put_VBN forth_RB by_IN public_JJ health_NN agencies_NNS and_CC the_DT media_NN about_IN vaccines_NNS ._. However_RB ,_, while_IN brazen_JJ ,_, in_IN -_HYPH your_PRP$ -_HYPH face_NN censorship_NN —_: and_CC attacks_NNS on_IN health_NN freedom_NN —_: have_VBP ratcheted_VBN up_RP to_IN an_DT unprecedented_JJ degree_NN ,_, officialdom_NN ’s_POS wish_NN to_TO keep_VB vaccination_NN ’s_POS unflattering_JJ track_NN record_NN out_IN of_IN the_DT public_JJ eye_NN is_VBZ nothing_NN new_JJ ._. There_EX is_VBZ a_DT chasm_NN between_IN vaccine_NN rhetoric_NN and_CC reality_NN for_IN most_JJS if_IN not_RB all_DT vaccines_NNS ,_, but_CC four_CD vaccines_NNS —_: varicella_NN (_-LRB- chickenpox_NN )_-RRB- ,_, rotavirus_NN ,_, human_JJ papillomavirus_NN (_-LRB- HPV_NN )_-RRB- and_CC pertussis_NN -_HYPH containing_VBG vaccines_NNS —_: offer_VB especially_RB instructive_JJ before_IN -_HYPH and_CC -_HYPH after_IN case_NN studies_NNS ._. Analysis_NN of_IN the_DT U.S._NNP experience_NN with_IN these_DT vaccines_NNS raises_VBZ important_JJ questions_NNS ._. First_RB ,_, why_WRB did_VBD the_DT Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- race_VB to_TO approve_VB —_: and_CC why_WRB does_VBZ the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP (_-LRB- CDC_NNP )_-RRB- heavily_RB promote_VB —_: vaccines_NNS such_JJ as_IN varicella_NN and_CC rotavirus_NN when_WRB there_EX is_VBZ little_JJ public_JJ health_NN justification_NN for_IN them_PRP ?_. Second_RB ,_, why_WRB are_VBP federal_JJ agencies_NNS ignoring_VBG the_DT many_JJ serious_JJ risks_NNS that_WDT have_VBP surfaced_VBN in_IN the_DT vaccines_NNS ’_POS wake_VBP —_: problems_NNS unheard_JJ of_IN before_IN the_DT vaccines_NNS ’_POS introduction_NN ?_. The_DT rationale_NN for_IN the_DT varicella_NN and_CC rotavirus_NN vaccines_NNS was_VBD dubious_JJ from_IN the_DT start_NN ._. In_IN the_DT U.S._NNP and_CC other_JJ wealthy_JJ countries_NNS ,_, varicella_NN and_CC rotavirus_NN were_VBD nearly_RB universal_JJ and_CC mostly_RB benign_JJ childhood_NN infections_NNS ;_: in_IN those_DT settings_NNS ,_, the_DT pre-vaccine_JJ impact_NN of_IN the_DT two_CD conditions_NNS was_VBD largely_RB measured_VBN in_IN terms_NNS of_IN “_`` healthcare_NN costs_NNS ,_, missed_VBN daycare_NN ,_, and_CC loss_NN of_IN time_NN from_IN work_NN for_IN parents_NNS /_, guardians_NNS ”_'' rather_RB than_IN in_IN terms_NNS of_IN serious_JJ illness_NN or_CC mortality_NN ._. Childhood_NN chickenpox_NN infections_NNS served_VBD an_DT important_JJ purpose_NN for_IN all_DT ,_, conferring_VBG lifelong_JJ immunity_NN to_IN infected_VBN children_NNS while_IN boosting_VBG adult_JJ immunity_NN to_IN the_DT related_JJ shingles_NNS (_-LRB- herpes_NN zoster_NN )_-RRB- virus_NN ._. With_IN the_DT rollout_NN of_IN mass_JJ varicella_NN vaccination_NN ,_, shingles_NNS started_VBD cropping_VBG up_RP to_IN an_DT unprecedented_JJ extent_NN in_IN both_CC children_NNS and_CC adults_NNS ,_, eliminating_VBG boosting_NN for_IN adults_NNS and_CC shifting_VBG downward_RB the_DT average_JJ age_NN at_IN which_WDT shingles_NNS occurs_VBZ ._. Vaccine_NN waning_NN also_RB began_VBD increasing_VBG young_JJ adults_NNS ’_POS risk_NN for_IN varicella_NN outbreaks_NNS and_CC complications_NNS later_RBR in_IN life_NN ,_, presenting_VBG “_`` perverse_JJ public_JJ health_NN implications_NNS ._. ”_'' Meanwhile_RB ,_, the_DT CDC_NNP and_CC its_PRP$ local_JJ public_JJ health_NN partners_NNS worked_VBD hard_RB to_TO conceal_VB these_DT unwanted_JJ chickenpox_NN vaccine_NN outcomes_NNS from_IN the_DT public_NN ._. Rotavirus_NN vaccines_NNS have_VBP had_VBN a_DT similarly_RB checkered_VBN history_NN ._. Soon_RB after_IN their_PRP$ introduction_NN in_IN the_DT U.S._NNP ,_, reports_NNS emerged_VBD of_IN a_DT substantially_RB increased_VBN risk_NN in_IN infants_NNS of_IN an_DT otherwise_RB rare_JJ bowel_NN complication_NN called_VBN intussusception_NN ._. The_DT FDA_NNP knew_VBD about_IN the_DT problem_NN during_IN the_DT prelicensing_VBG regulatory_JJ review_NN process_NN but_CC ignored_VBD it_PRP ._. Although_IN the_DT agency_NN subsequently_RB withdrew_VBD its_PRP$ approval_NN for_IN one_CD of_IN the_DT problematic_JJ rotavirus_NN vaccines_NNS ,_, it_PRP was_VBD not_RB until_IN after_IN an_DT estimated_VBN 500,000_CD children_NNS received_VBD at_IN least_JJS one_CD million_CD doses_NNS ._. The_DT FDA_NNP never_RB explained_VBD the_DT “_`` precise_JJ mechanism_NN ”_'' by_IN which_WDT the_DT discontinued_VBN vaccine_NN caused_VBD intussusception_NN ._. Two_CD rotavirus_NN vaccines_NNS that_WDT display_VBP the_DT same_JJ intussusception_NN risks_NNS are_VBP still_RB on_IN the_DT U.S._NNP market_NN ._. Both_DT are_VBP contaminated_VBN with_IN foreign_JJ DNA_NN from_IN porcine_NN viruses_NNS capable_JJ of_IN causing_VBG severe_JJ immunodeficiency_NN in_IN pigs_NNS ._. Had_VBD the_DT presence_NN of_IN these_DT “_`` adventitious_JJ agents_NNS ”_'' been_VBN discovered_VBN prior_JJ to_IN vaccine_NN licensure_NN ,_, the_DT FDA_NNP probably_RB would_MD have_VB been_VBN forced_VBN to_TO shelve_VB the_DT vaccines_NNS ,_, yet_CC they_PRP remain_VBP on_IN the_DT vaccine_NN schedule_NN to_IN this_DT day_NN ._. •_NFP Nine_CD years_NNS later_RBR :_: HPV_NNP vaccine_NN injury_NN survivor_NN is_VBZ still_RB recovering_VBG The_DT HPV_NN vaccines_NNS Gardasil_NNP and_CC Gardasil_NNP -_HYPH 9_CD (_-LRB- manufactured_VBN by_IN Merck_NNP )_-RRB- represent_VBP perhaps_RB an_DT even_RB more_RBR compelling_JJ case_NN study_NN of_IN risk_NN -_HYPH laden_JJ vaccines_NNS that_WDT should_MD have_VB attracted_VBN strong_JJ up_RP -_HYPH front_JJ regulatory_JJ scrutiny_NN —_: but_CC did_VBD n’t_RB ._. The_DT speed_NN with_IN which_WDT the_DT FDA_NNP gave_VBD them_PRP the_DT go_NN -_HYPH ahead_RB —_: despite_IN obvious_JJ red_JJ flags_NNS regarding_VBG their_PRP$ safety_NN —_: illustrates_VBZ the_DT insincerity_NN of_IN the_DT agency_NN ’s_POS assertions_NNS that_IN its_PRP$ vaccine_NN approval_NN process_NN is_VBZ committed_VBN to_IN minimizing_VBG risks_NNS ._. The_DT FDA_NNP not_RB only_RB gave_VBD the_DT quadrivalent_NN Gardasil_NNP a_DT free_JJ pass_NN but_CC has_VBZ repeatedly_RB reapproved_VBN it_PRP and_CC the_DT nine_CD -_HYPH valent_NN Gardasil_NNP -_HYPH 9_CD for_IN wider_JJR use_NN ._. (_-LRB- Gardasil_NNP -_HYPH 9_CD is_VBZ a_DT newer_JJR formulation_NN that_WDT contains_VBZ more_JJR than_IN twice_RB the_DT amount_NN of_IN neurotoxic_JJ aluminum_NN adjuvant_NN as_IN Gardasil_NNP ._. )_-RRB- In_IN 2009_CD ,_, the_DT FDA_NNP also_RB okayed_VBD GlaxoSmithKline_NNP ’s_POS HPV_NN vaccine_NN ,_, Cervarix_NNP ,_, but_CC Merck_NNP ’s_POS FDA_NN -_HYPH facilitated_VBN stranglehold_NN on_IN the_DT market_NN prompted_VBD the_DT company_NN to_TO withdraw_VB Cervarix_NNP from_IN the_DT U.S._NNP in_IN 2016_CD ._. Merck_NNP is_VBZ now_RB aggressively_RB expanding_VBG its_PRP$ Gardasil_NNP “_`` franchise_NN ”_'' into_IN other_JJ countries_NNS ,_, generating_VBG unprecedented_JJ worldwide_JJ demand_NN ,_, while_IN continuing_VBG to_TO “_`` rev_VB up_RP ”_'' U.S._NNP sales_NNS ._. Since_IN 2006_CD ,_, the_DT FDA_NNP ’s_POS Gardasil_NN -_HYPH related_JJ decisions_NNS have_VBP included_VBN :_: •_SYM 2006_CD :_: Granting_VBG fast_RB -_HYPH tracked_VBN approval_NN for_IN the_DT original_JJ quadrivalent_NN Gardasil_NN vaccine_NN (_-LRB- girls_NNS and_CC women_NNS aged_JJ 9_CD to_IN 26_CD years_NNS )_-RRB- •_SYM 2009_CD :_: Approving_VBG Gardasil_NN ’s_POS use_NN in_IN boys_NNS and_CC men_NNS (_-LRB- ages_NNS 9_CD -_SYM 26_CD )_-RRB- An_DT eight_CD -_HYPH month_NN investigation_NN by_IN Slate_NNP identified_VBD numerous_JJ troubling_JJ aspects_NNS of_IN the_DT clinical_JJ trials_NNS that_WDT encouraged_VBD U.S._NNP and_CC European_JJ regulators_NNS to_TO approve_VB Gardasil_NNP ._. The_DT Slate_NNP reporter_NN also_RB criticized_VBD regulators_NNS for_IN allowing_VBG “_`` unreliable_JJ methods_NNS to_TO be_VB used_VBN to_TO test_VB the_DT vaccine_NN ’s_POS safety_NN ._. ”_'' These_DT included_VBD Merck_NNP ’s_POS use_NN of_IN “_`` a_DT convoluted_JJ method_NN ”_'' that_WDT made_VBD it_PRP difficult_JJ to_TO objectively_RB evaluate_VB and_CC report_VB side_NN effects_NNS ;_: its_PRP$ failure_NN to_TO document_VB “_`` symptom_NN severity_NN ,_, duration_NN ,_, outcome_NN ,_, or_CC overall_JJ seriousness_NN ”_'' ;_, restriction_NN of_IN adverse_JJ event_NN reporting_NN to_IN just_RB 14_CD days_NNS following_VBG each_DT injection_NN ;_, and_CC reliance_NN on_IN the_DT subjective_JJ opinion_NN of_IN clinical_JJ trial_NN investigators_NNS regarding_VBG “_`` whether_IN or_CC not_RB to_TO report_VB any_DT medical_JJ problem_NN as_IN an_DT adverse_JJ event_NN ._. ”_'' Not_RB infrequently_RB ,_, clinical_JJ trial_NN participants_NNS who_WP shared_VBD complaints_NNS of_IN debilitating_JJ symptoms_NNS with_IN trial_NN investigators_NNS were_VBD dismissed_VBN with_IN the_DT response_NN ,_, “_`` This_DT is_VBZ not_RB the_DT kind_NN of_IN side_NN effects_NNS we_PRP see_VBP with_IN this_DT vaccine_NN ._. ”_'' Two_CD years_NNS after_IN Gardasil_NNP ’s_POS initial_JJ approval_NN ,_, Judicial_NNP Watch_NNP pronounced_VBD it_PRP a_DT “_`` large_JJ -_HYPH scale_NN public_JJ health_NN experiment_NN ._. ”_'' Post_NN -_HYPH licensure_NN studies_NNS carried_VBN out_RP since_IN then_RB confirm_VB that_IN HPV_NN vaccines_NNS have_VBP grave_JJ risks_NNS ,_, including_VBG impaired_JJ fertility_NN ,_, demyelinating_VBG disease_NN ,_, chronic_JJ limb_NN pain_NN ,_, circulatory_JJ abnormalities_NNS and_CC autoimmune_JJ illness_NN ,_, to_TO name_VB just_RB some_DT of_IN the_DT disabilities_NNS reported_VBN in_IN the_DT aftermath_NN of_IN HPV_NN vaccines_NNS ’_POS introduction_NN ._. Overall_RB ,_, the_DT “_`` rate_NN of_IN reported_VBN serious_JJ adverse_JJ reactions_NNS (_-LRB- including_VBG deaths_NNS )_-RRB- from_IN HPV_NN vaccination_NN ”_'' is_VBZ many_JJ times_NNS higher_JJR than_IN the_DT cervical_JJ cancer_NN mortality_NN rate_NN ._. In_IN a_DT February_NNP 2019_CD letter_NN to_IN the_DT CDC_NNP ,_, Children_NNPS ’s_POS Health_NNP Defense_NNP Chairman_NNP Robert_NNP F._NNP Kennedy_NNP ,_, Jr._NNP noted_VBD ,_, “_`` During_IN Gardasil_NNP ’s_POS clinical_JJ trials_NNS ,_, an_DT extraordinary_JJ 49.5_CD %_NN of_IN the_DT subjects_NNS receiving_VBG Gardasil_NNP reported_VBD serious_JJ medical_JJ conditions_NNS within_IN seven_CD months_NNS of_IN the_DT start_NN of_IN the_DT clinical_JJ trials_NNS ._. Because_IN Merck_NNP did_VBD not_RB use_VB a_DT true_JJ placebo_NN in_IN its_PRP$ clinical_JJ trials_NNS ,_, its_PRP$ researchers_NNS were_VBD able_JJ to_TO dismiss_VB these_DT injuries_NNS as_IN sad_JJ coincidences_NNS ._. ”_'' A_DT current_JJ civil_JJ case_NN brought_VBN on_IN behalf_NN of_IN a_DT 24_CD -_HYPH year_NN -_HYPH old_JJ who_WP has_VBZ suffered_VBN from_IN systemic_JJ autoimmune_JJ dysregulation_NN since_IN receiving_VBG her_PRP$ third_JJ Gardasil_NNP vaccine_NN at_IN age_NN 16_CD alleges_VBZ that_IN Merck_NNP “_`` committed_VBD fraud_NN during_IN its_PRP$ clinical_JJ trials_NNS and_CC then_RB failed_VBD to_TO warn_VB [_-LRB- vaccine_NN recipients_NNS ]_-RRB- about_IN the_DT high_JJ risks_NNS and_CC meager_JJ benefits_NNS of_IN the_DT vaccine_NN ._. ”_'' The_DT trial_NN ’s_POS legal_JJ team_NN is_VBZ benefiting_VBG from_IN the_DT support_NN of_IN an_DT “_`` A_NN -_HYPH team_NN ”_'' of_IN plaintiffs_NNS ’_POS law_NN firms_NNS and_CC attorneys_NNS ,_, including_VBG Kennedy_NNP ,_, Jr_NNP ._. Recent_JJ data_NNS suggest_VBP that_IN HPV_NN vaccines_NNS may_MD be_VB increasing_VBG cervical_JJ cancer_NN risks_NNS ._. A_DT 2017_CD study_NN out_IN of_IN Australia_NNP —_: which_WDT has_VBZ heavily_RB promoted_VBN routine_JJ HPV_NN vaccination_NN since_IN 2007_CD —_: reported_VBD an_DT increased_VBN risk_NN of_IN difficult_JJ -_HYPH to_TO -_HYPH detect_VB malignant_JJ cervical_JJ lesions_NNS among_IN the_DT HPV_NN -_HYPH vaccinated_VBN ._. In_IN all_DT countries_NNS where_WRB HPV_NN vaccination_NN coverage_NN is_VBZ high_JJ ,_, including_VBG Australia_NNP ,_, official_JJ cancer_NN registries_NNS show_VBP “_`` an_DT increase_NN in_IN the_DT incidence_NN of_IN invasive_JJ cervical_JJ cancer_NN ”_'' in_IN the_DT vaccinated_VBN age_NN groups_NNS ._. In_IN England_NNP ,_, “_`` 2016_CD national_JJ statistics_NNS showed_VBD a_DT worrying_VBG and_CC substantial_JJ increase_NN in_IN the_DT rate_NN of_IN cervical_JJ cancer…at_NN ages_NNS 20_CD -_SYM 24_CD ”_'' —_: the_DT first_JJ HPV_NN -_HYPH vaccinated_VBN cohort_NN ._. The_DT proper_JJ decision_NN would_MD be_VB to_TO take_VB HPV_NN vaccines_NNS off_IN the_DT market_NN ,_, but_CC the_DT FDA_NNP and_CC CDC_NNP continue_VBP to_TO look_VB the_DT other_JJ way_NN ._. Both_DT agencies_NNS ’_POS unwavering_JJ support_NN for_IN Gardasil_NNP has_VBZ clearly_RB helped_VBN Merck_NNP ’s_POS commercial_JJ bottom_JJ line_NN ,_, so_RB much_RB so_IN that_IN the_DT CDC_NNP director_NN at_IN the_DT time_NN of_IN Gardasil_NNP ’s_POS approval_NN (_-LRB- Julie_NNP Gerberding_NNP )_-RRB- went_VBD on_RP to_TO be_VB appointed_VBN president_NN of_IN Merck_NNP ’s_POS profitable_JJ vaccine_NN division_NN (_-LRB- worth_JJ $_$ 5_CD billion_CD globally_RB )_-RRB- in_IN 2009_CD ._. The_DT agencies_NNS ’_POS willingness_NN to_TO aggressively_RB promote_VB HPV_NN vaccination_NN despite_IN its_PRP$ readily_RB apparent_JJ dangers_NNS illustrates_VBZ a_DT “_`` public_JJ health_NN flimflam_NN ”_'' of_IN the_DT first_JJ order_NN ._. Before_IN the_DT U.S._NNP introduction_NN of_IN HPV_NN vaccination_NN ,_, a_DT decades_NNS -_HYPH long_JJ pattern_NN of_IN declining_VBG cervical_JJ cancer_NN rates_NNS was_VBD already_RB well_RB underway_JJ ,_, thanks_NN to_IN routine_JJ cervical_JJ cancer_NN screening_NN ._. HPV_NN vaccines_NNS have_VBP never_RB even_RB been_VBN proven_VBN to_TO prevent_VB cervical_JJ cancer_NN ._. In_IN 2016_CD ,_, researchers_NNS admitted_VBD that_IN they_PRP would_MD be_VB unable_JJ to_TO ascertain_VB HPV_NN vaccines_NNS ’_POS long_JJ -_HYPH term_NN efficacy_NN for_IN “_`` at_IN least_JJS another_DT 15_CD -_SYM 20_CD years_NNS ._. ”_'' Alongside_IN their_PRP$ many_JJ misplaced_VBN claims_NNS about_IN various_JJ vaccines_NNS ’_POS rationale_NN and_CC safety_NN record_NN ,_, the_DT FDA_NNP and_CC CDC_NNP —_: as_IN echo_NN chambers_NNS for_IN the_DT vaccine_NN industry_NN —_: also_RB have_VBP misinformed_VBN the_DT public_NN about_IN vaccine_NN effectiveness_NN ._. Back_RB in_IN 1899_CD ,_, doctor_NN William_NNP Bailey_NNP (_-LRB- vaccination_NN enthusiast_NN and_CC member_NN of_IN the_DT State_NNP Board_NNP of_IN Health_NNP in_IN Louisville_NNP ,_, Kentucky_NNP )_-RRB- was_VBD more_RBR honest_JJ ,_, cautioning_VBG that_IN “_`` nothing_NN is_VBZ gained_VBN by_IN claiming_VBG too_RB much_JJ ”_'' about_IN vaccine_NN -_HYPH induced_VBN immunity_NN and_CC stating_VBG that_IN “_`` the_DT degree_NN of_IN immunity_NN may_MD vary_VB with_IN time_NN and_CC circumstance_NN ”_'' —_: presaging_VBG the_DT troublesome_JJ modern_JJ phenomena_NNS of_IN vaccine_NN failure_NN and_CC waning_VBG immunity_NN ._. In_IN the_DT present_JJ day_NN ,_, officials_NNS are_VBP only_RB too_RB willing_JJ to_TO “_`` claim_VB too_RB much_JJ ,_, ”_'' conveniently_RB ignoring_VBG historical_JJ evidence_NN that_IN reductions_NNS in_IN infectious_JJ disease_NN had_VBD little_JJ to_TO do_VB with_IN vaccines_NNS and_CC far_RB more_JJR to_TO do_VB with_IN improvements_NNS in_IN sanitation_NN and_CC nutrition_NN ._. Officials_NNS also_RB seem_VBP to_TO have_VB little_JJ interest_NN in_IN modern_JJ evidence_NN documenting_VBG many_JJ vaccines_NNS ’_POS inability_NN to_TO provide_VB the_DT promised_VBN protection_NN ,_, even_RB when_WRB vaccine_NN coverage_NN is_VBZ widespread_JJ ._. The_DT acellular_JJ version_NN of_IN pertussis_NN (_-LRB- whooping_NN cough_NN )_-RRB- —_: a_DT component_NN of_IN U.S._NNP vaccines_NNS such_JJ as_IN DTaP_NNP and_CC Tdap_NNP —_: is_VBZ one_CD of_IN the_DT vaccines_NNS noted_VBN for_IN its_PRP$ abysmal_JJ effectiveness_NN ._. The_DT vaccine_NN is_VBZ supposed_VBN to_TO protect_VB against_IN the_DT respiratory_JJ infection_NN caused_VBN by_IN Bordetella_NN pertussis_NN ._. Instead_RB ,_, according_VBG to_IN recent_JJ studies_NNS ,_, pertussis_NN is_VBZ making_VBG a_DT “_`` surprising_JJ ”_'' comeback_NN ;_, between_IN 1990_CD and_CC 2005_CD ,_, pertussis_NN epidemics_NNS increased_VBD in_IN the_DT U.S._NNP “_'' in_IN both_CC size_NN and_CC frequency_NN ,_, ”_'' and_CC over_RB half_NN of_IN all_DT cases_NNS occurred_VBD in_IN highly_RB vaccinated_VBN adolescents_NNS aged_JJ 10_CD to_IN 20_CD years_NNS old_JJ ._. In_IN fact_NN ,_, not_RB only_RB is_VBZ pertussis_NN at_IN its_PRP$ highest_JJS level_NN since_IN the_DT mid-1950s_NNS ,_, but_CC ,_, according_VBG to_IN CDC_NNP researchers_NNS ,_, it_PRP is_VBZ showing_VBG signs_NNS of_IN being_VBG vaccine_NN -_HYPH resistant_JJ ._. The_DT CDC_NNP researchers_NNS also_RB note_VBP “_`` substantial_JJ heterogeneity_NN among_IN vaccine_NN recipients_NNS in_IN terms_NNS of_IN the_DT durability_NN of_IN the_DT protection_NN they_PRP receive_VBP ._. ”_'' West_NNP Africa_NNP has_VBZ used_VBN the_DT DTP_NNP vaccine_NN since_IN the_DT 1980s_NNS —_: formulated_VBN with_IN a_DT whole_JJ -_HYPH cell_NN pertussis_NN component_NN instead_RB of_IN acellular_JJ pertussis_NN —_: and_CC it_PRP has_VBZ an_DT even_RB more_RBR horrifying_JJ safety_NN and_CC effectiveness_NN record_NN than_IN its_PRP$ acellular_JJ counterparts_NNS ._. Research_NN published_VBN in_IN 2017_CD by_IN a_DT prestigious_JJ team_NN of_IN international_JJ scientists_NNS and_CC led_VBN by_IN vaccinology_NN expert_NN Dr._NNP Peter_NNP Aaby_NNP found_VBD that_IN DTP_NN vaccination_NN had_VBD a_DT negative_JJ effect_NN on_IN child_NN survival_NN ,_, with_IN fivefold_CD higher_JJR mortality_NN in_IN young_JJ DTP_NN -_HYPH vaccinated_VBN infants_NNS (_-LRB- ages_NNS three_CD to_IN five_CD months_NNS )_-RRB- compared_VBN to_IN as_IN -_HYPH yet_RB -_HYPH unvaccinated_JJ infants_NNS ._. When_WRB the_DT researchers_NNS published_VBD results_NNS in_IN 2018_CD for_IN slightly_RB older_JJR DTP_NN -_HYPH vaccinated_VBN children_NNS (_-LRB- ages_NNS six_CD months_NNS to_IN three_CD years_NNS )_-RRB- ,_, they_PRP continued_VBD to_TO observe_VB more_JJR than_IN double_JJ the_DT risk_NN of_IN death_NN as_IN similarly_RB situated_VBN unvaccinated_JJ children_NNS ._. Explaining_VBG that_IN vaccines_NNS can_MD increase_VB susceptibility_NN to_IN other_JJ infections_NNS ,_, the_DT researchers_NNS concluded_VBD in_IN 2017_CD that_IN “_`` all_DT currently_RB available_JJ evidence_NN suggests_VBZ that_IN DTP_NN vaccine_NN may_MD kill_VB more_JJR children_NNS from_IN other_JJ causes_NNS than_IN it_PRP saves_VBZ from_IN diphtheria_NN ,_, tetanus_NN or_CC pertussis_NN ”_'' and_CC added_VBD in_IN 2018_CD that_IN “_`` all_DT studies_NNS of_IN the_DT introduction_NN of_IN DTP_NNP have_VBP found_VBN increased_VBN overall_JJ mortality_NN ._. ”_'' Efforts_NNS to_TO counter_VB the_DT official_JJ vaccine_NN narrative_NN with_IN evidence_NN about_IN negative_JJ consequences_NNS date_VBP back_RB to_IN the_DT days_NNS of_IN smallpox_NN ._. A_DT doctor_NN practicing_VBG in_IN the_DT 1870s_NNS observed_VBD that_IN smallpox_NN mortality_NN doubled_VBD (_-LRB- from_IN roughly_RB 7_CD %_NN to_IN 15_CD %_NN )_-RRB- after_IN adoption_NN of_IN smallpox_NN vaccination_NN ._. During_IN an_DT outbreak_NN in_IN 1871_CD and_CC 1872_CD ,_, this_DT doctor_NN stated_VBD ,_, faith_NN in_IN vaccination_NN received_VBD a_DT “_`` rude_JJ …_HYPH shock_NN ”_'' when_WRB “_`` [_-LRB- e]_RB very_JJ country_NN in_IN Europe_NNP was_VBD invaded_VBN with_IN a_DT severity_NN greater_JJR than_IN had_VBD ever_RB been_VBN witnessed_VBN during_IN the_DT three_CD preceding_VBG centuries_NNS ._. ”_'' The_DT doctor_NN also_RB noted_VBD that_IN “_`` many_JJ vaccinated_VBN persons_NNS in_IN almost_RB every_DT place_NN were_VBD attacked_VBN by_IN small_JJ -_HYPH pox_NN before_IN any_DT unvaccinated_JJ persons_NNS took_VBD the_DT disease_NN ._. ”_'' In_IN this_DT individual_NN ’s_POS estimation_NN ,_, these_DT facts_NNS were_VBD “_`` sufficient_JJ to_TO overthrow_VB the_DT entire_JJ theory_NN of_IN the_DT protective_JJ efficacy_NN of_IN vaccination_NN ._. ”_'' In_IN the_DT present_JJ era_NN ,_, federal_JJ agencies_NNS continue_VBP to_TO tout_VB difficult_JJ -_HYPH to_TO -_HYPH justify_VB but_CC money_NN -_HYPH spinning_VBG vaccines_NNS as_IN beneficial_JJ ,_, even_RB in_IN the_DT face_NN of_IN substantial_JJ evidence_NN to_IN the_DT contrary_NN ._. Now_RB ,_, more_JJR than_IN ever_RB ,_, it_PRP is_VBZ important_JJ to_TO illuminate_VB the_DT risks_NNS and_CC downsides_NNS that_WDT public_JJ health_NN agencies_NNS do_VBP not_RB want_VB us_PRP to_TO know_VB about_IN ._. Copyright_NN 2020_CD –_: permission_NN to_TO reprint_VB fully_RB granted_VBN ,_, WITH_IN links_NNS to_IN original_JJ story_NN","[ NN : This VBZ NN VI in a NN of NNS VBN from the JJ NNP ’s NNP NNP NNP : NNPS of NNP NNP NNPS ’s NNP . The JJ NNP , The NNP NNP : The NNPS Behind the NNPS ’s NNP NNP and Why It VBZ to VB , VBD how NNS ’s NN VBD to VB RB in the JJ NNS VBG JJ NNS in the NN NN NN . ] A VBN and “ JJ - JJ ” NN VBZ under NN to VB NN that VBZ the VBN NN NNS VBN RB by JJ NN NNS and the NN about NNS . RB , while JJ , in - your - NN NN — and NNS on NN NN — VBP VBN up to an JJ NN , NN ’s NN to VB NN ’s JJ NN NN out of the JJ NN VBZ NN JJ . There VBZ a NN between NN NN and NN for JJS if RB all NNS , but four NNS — NN ( NN ) , NN , JJ NN ( NN ) and NN - VBG NNS — VB RB JJ before - and - after NN NNS . NN of the NNP NN with these NNS VBZ JJ NNS . RB , why VBD the NNP and NNP NNP ( NNP ) VB to VB — and why VBZ the NNPS for NNP NNP and NNP ( NNP ) RB VB — NNS JJ as NN and NN when there VBZ JJ JJ NN NN for them ? RB , why VBP JJ NNS VBG the JJ JJ NNS that VBP VBN in the NNS ’ VBP — NNS JJ of before the NNS ’ NN ? The NN for the NN and NN NNS VBD JJ from the NN . In the NNP and JJ JJ NNS , NN and NN VBD RB JJ and RB JJ NN NNS ; in those NNS , the JJ NN of the two NNS VBD RB VBN in NNS of “ NN NNS , VBN NN , and NN of NN from NN for NNS / NNS ” RB than in NNS of JJ NN or NN . NN NN NNS VBD an JJ NN for all , VBG JJ NN to VBN NNS while VBG JJ NN to the JJ NNS ( NN NN ) NN . With the NN of JJ NN NN , NNS VBD VBG up to an JJ NN in both NNS and NNS , VBG NN for NNS and VBG RB the JJ NN at which NNS VBZ . NN NN RB VBD VBG JJ NNS ’ NN for NN NNS and NNS RBR in NN , VBG “ JJ JJ NN NNS . ” RB , the NNP and its JJ JJ NN NNS VBD RB to VB these JJ NN NN NNS from the NN . NN NNS VBP VBN a RB VBN NN . RB after their NN in the NNP , NNS VBD of a RB VBN NN in NNS of an RB JJ NN NN VBN NN . The NNP VBD about the NN during the VBG JJ NN NN but VBD it . Although the NN RB VBD its NN for one of the JJ NN NNS , it VBD RB until after an VBN 500,000 NNS VBD at JJS one million NNS . The NNP RB VBD the “ JJ NN ” by which the VBN NN VBD NN . Two NN NNS that VBP the JJ NN NNS VBP RB on the NNP NN . Both VBP VBN with JJ NN from NN NNS JJ of VBG JJ NN in NNS . VBD the NN of these “ JJ NNS ” VBN VBN JJ to NN NN , the NNP RB would VB VBN VBN to VB the NNS , yet they VBP on the NN NN to this NN . • Nine NNS RBR : NNP NN NN NN VBZ RB VBG The NN NNS NNP and NNP - 9 ( VBN by NNP ) VBP RB an RB RBR JJ NN NN of NN - JJ NNS that should VB VBN JJ up - JJ JJ NN — but VBD RB . The NN with which the NNP VBD them the NN - RB — despite JJ JJ NNS VBG their NN — VBZ the NN of the NN ’s NNS that its NN NN NN VBZ VBN to VBG NNS . The NNP RB RB VBD the NN NNP a JJ NN but VBZ RB VBN it and the nine - NN NNP - 9 for JJR NN . ( NNP - 9 VBZ a JJR NN that VBZ JJR than RB the NN of JJ NN NN as NNP . ) In 2009 , the NNP RB VBD NNP ’s NN NN , NNP , but NNP ’s NN - VBN NN on the NN VBD the NN to VB NNP from the NNP in 2016 . NNP VBZ RB RB VBG its NNP “ NN ” into JJ NNS , VBG JJ JJ NN , while VBG to “ VB up ” NNP NNS . Since 2006 , the NNP ’s NN - JJ NNS VBP VBN : • 2006 : VBG RB - VBN NN for the JJ NN NN NN ( NNS and NNS JJ 9 to 26 NNS ) • 2009 : VBG NN ’s NN in NNS and NNS ( NNS 9 - 26 ) An eight - NN NN by NNP VBD JJ JJ NNS of the JJ NNS that VBD NNP and JJ NNS to VB NNP . The NNP NN RB VBD NNS for VBG “ JJ NNS to VB VBN to VB the NN ’s NN . ” These VBD NNP ’s NN of “ a JJ NN ” that VBD it JJ to RB VB and VB NN NNS ; its NN to VB “ NN NN , NN , NN , or JJ NN ” ; NN of JJ NN NN to RB 14 NNS VBG each NN ; and NN on the JJ NN of JJ NN NNS VBG “ whether or RB to VB any JJ NN as an JJ NN . ” RB RB , JJ NN NNS who VBD NNS of JJ NNS with NN NNS VBD VBN with the NN , “ This VBZ RB the NN of NN NNS we VBP with this NN . ” Two NNS after NNP ’s JJ NN , NNP NNP VBD it a “ JJ - NN JJ NN NN . ” NN - NN NNS VBN out since RB VB that NN NNS VBP JJ NNS , VBG JJ NN , VBG NN , JJ NN NN , JJ NNS and JJ NN , to VB RB some of the NNS VBN in the NN of NN NNS ’ NN . RB , the “ NN of VBN JJ JJ NNS ( VBG NNS ) from NN NN ” VBZ JJ NNS JJR than the JJ NN NN NN . In a NNP 2019 NN to the NNP , NNPS ’s NNP NNP NNP NNP NNP NNP , NNP VBD , “ During NNP ’s JJ NNS , an JJ 49.5 NN of the NNS VBG NNP VBD JJ JJ NNS within seven NNS of the NN of the JJ NNS . Because NNP VBD RB VB a JJ NN in its JJ NNS , its NNS VBD JJ to VB these NNS as JJ NNS . ” A JJ JJ NN VBN on NN of a 24 - NN - JJ who VBZ VBN from JJ JJ NN since VBG her JJ NNP NN at NN 16 VBZ that NNP “ VBD NN during its JJ NNS and RB VBD to VB [ NN NNS ] about the JJ NNS and JJ NNS of the NN . ” The NN ’s JJ NN VBZ VBG from the NN of an “ NN - NN ” of NNS ’ NN NNS and NNS , VBG NNP , NNP . JJ NNS VBP that NN NNS may VB VBG JJ NN NNS . A 2017 NN out of NNP — which VBZ RB VBN JJ NN NN since 2007 — VBD an VBN NN of JJ - to - VB JJ JJ NNS among the NN - VBN . In all NNS where NN NN NN VBZ JJ , VBG NNP , JJ NN NNS VBP “ an NN in the NN of JJ JJ NN ” in the VBN NN NNS . In NNP , “ 2016 JJ NNS VBD a VBG and JJ NN in the NN of JJ NN NNS 20 - 24 ” — the JJ NN - VBN NN . The JJ NN would VB to VB NN NNS off the NN , but the NNP and NNP VBP to VB the JJ NN . Both NNS ’ JJ NN for NNP VBZ RB VBN NNP ’s JJ JJ NN , RB RB so that the NNP NN at the NN of NNP ’s NN ( NNP NNP ) VBD on to VB VBN NN of NNP ’s JJ NN NN ( JJ $ 5 billion RB ) in 2009 . The NNS ’ NN to RB VB NN NN despite its RB JJ NNS VBZ a “ JJ NN NN ” of the JJ NN . Before the NNP NN of NN NN , a NNS - JJ NN of VBG JJ NN NNS VBD RB RB JJ , NN to JJ JJ NN NN . NN NNS VBP RB RB VBN VBN to VB JJ NN . In 2016 , NNS VBD that they would VB JJ to VB NN NNS ’ JJ - NN NN for “ at JJS another 15 - 20 NNS . ” Alongside their JJ VBN NNS about JJ NNS ’ NN and NN NN , the NNP and NNP — as NN NNS for the NN NN — RB VBP VBN the NN about NN NN . RB in 1899 , NN NNP NNP ( NN NN and NN of the NNP NNP of NNP in NNP , NNP ) VBD RBR JJ , VBG that “ NN VBZ VBN by VBG RB JJ ” about NN - VBN NN and VBG that “ the NN of NN may VB with NN and NN ” — VBG the JJ JJ NNS of NN NN and VBG NN . In the JJ NN , NNS VBP RB RB JJ to “ VB RB JJ , ” RB VBG JJ NN that NNS in JJ NN VBD JJ to VB with NNS and RB JJR to VB with NNS in NN and NN . NNS RB VBP to VB JJ NN in JJ NN VBG JJ NNS ’ NN to VB the VBN NN , RB when NN NN VBZ JJ . The JJ NN of NN ( NN NN ) — a NN of NNP NNS JJ as NNP and NNP — VBZ one of the NNS VBN for its JJ NN . The NN VBZ VBN to VB against the JJ NN VBN by NN NN . RB , VBG to JJ NNS , NN VBZ VBG a “ JJ ” NN ; between 1990 and 2005 , NN NNS VBD in the NNP “ in both NN and NN , ” and RB NN of all NNS VBD in RB VBN NNS JJ 10 to 20 NNS JJ . In NN , RB RB VBZ NN at its JJS NN since the NNS , but , VBG to NNP NNS , it VBZ VBG NNS of VBG NN - JJ . The NNP NNS RB VBP “ JJ NN among NN NNS in NNS of the NN of the NN they VBP . ” NNP NNP VBZ VBN the NNP NN since the NNS — VBN with a JJ - NN NN NN RB of JJ NN — and it VBZ an RB RBR JJ NN and NN NN than its JJ NNS . NN VBN in 2017 by a JJ NN of JJ NNS and VBN by NN NN NNP NNP NNP VBD that NN NN VBD a JJ NN on NN NN , with fivefold JJR NN in JJ NN - VBN NNS ( NNS three to five NNS ) VBN to as - RB - JJ NNS . When the NNS VBD NNS in 2018 for RB JJR NN - VBN NNS ( NNS six NNS to three NNS ) , they VBD to VB JJR than JJ the NN of NN as RB VBN JJ NNS . VBG that NNS can VB NN to JJ NNS , the NNS VBD in 2017 that “ all RB JJ NN VBZ that NN NN may VB JJR NNS from JJ NNS than it VBZ from NN , NN or NN ” and VBD in 2018 that “ all NNS of the NN of NNP VBP VBN VBN JJ NN . ” NNS to VB the JJ NN NN with NN about JJ NNS VBP RB to the NNS of NN . A NN VBG in the NNS VBD that NN NN VBD ( from RB 7 NN to 15 NN ) after NN of NN NN . During an NN in 1871 and 1872 , this NN VBD , NN in NN VBD a “ JJ … NN ” when “ [ RB JJ NN in NNP VBD VBN with a NN JJR than VBD RB VBN VBN during the three VBG NNS . ” The NN RB VBD that “ JJ VBN NNS in RB every NN VBD VBN by JJ - NN before any JJ NNS VBD the NN . ” In this NN ’s NN , these NNS VBD “ JJ to VB the JJ NN of the JJ NN of NN . ” In the JJ NN , JJ NNS VBP to VB JJ - to - VB but NN - VBG NNS as JJ , RB in the NN of JJ NN to the NN . RB , JJR than RB , it VBZ JJ to VB the NNS and NNS that JJ NN NNS VBP RB VB us to VB about . NN 2020 – NN to VB RB VBN , WITH NNS to JJ NN"
261,354,mainstream,"The_DT agents_NNS of_IN infection_NN can_MD be_VB divided_VBN into_IN different_JJ groups_NNS on_IN the_DT basis_NN of_IN their_PRP$ size_NN ,_, biochemical_JJ characteristics_NNS ,_, or_CC manner_NN in_IN which_WDT they_PRP interact_VBP with_IN the_DT human_JJ host_NN ._. The_DT groups_NNS of_IN organisms_NNS that_WDT cause_VBP infectious_JJ diseases_NNS are_VBP categorized_VBN as_IN bacteria_NN ,_, viruses_NNS ,_, fungi_NN ,_, and_CC parasites_NNS ._. Bacteria_NNS can_MD survive_VB within_IN the_DT body_NN but_CC outside_IN individual_JJ cells_NNS ._. Some_DT bacteria_NNS ,_, classified_VBN as_IN aerobes_NNS ,_, require_VBP oxygen_NN for_IN growth_NN ,_, while_IN others_NNS ,_, such_JJ as_IN those_DT normally_RB found_VBN in_IN the_DT small_JJ intestine_NN of_IN healthy_JJ persons_NNS ,_, grow_VBP only_RB in_IN the_DT absence_NN of_IN oxygen_NN and_CC ,_, therefore_RB ,_, are_VBP called_VBN anaerobes_NNS ._. Most_JJS bacteria_NNS are_VBP surrounded_VBN by_IN a_DT capsule_NN that_WDT appears_VBZ to_TO play_VB an_DT important_JJ role_NN in_IN their_PRP$ ability_NN to_TO produce_VB disease_NN ._. Also_RB ,_, a_DT number_NN of_IN bacterial_JJ species_NNS give_VBP off_RP toxins_NNS that_WDT in_IN turn_NN may_MD damage_VB tissues_NNS ._. Bacteria_NNS are_VBP generally_RB large_JJ enough_RB to_TO be_VB seen_VBN under_IN a_DT light_NN microscope_NN ._. Streptococci_NN ,_, the_DT bacteria_NNS that_WDT cause_VBP scarlet_JJ fever_NN ,_, are_VBP about_RB 0.75_CD micrometre_NN (_-LRB- 0.00003_CD inch_NNS )_-RRB- in_IN diameter_NN ._. The_DT spirochetes_NNS ,_, which_WDT cause_VBP syphilis_NN ,_, leptospirosis_NN ,_, and_CC rat_NN -_HYPH bite_NN fever_NN ,_, are_VBP 5_CD to_IN 15_CD micrometres_NNS long_JJ ._. Bacterial_JJ infections_NNS can_MD be_VB treated_VBN with_IN antibiotics_NNS ._. Bacterial_JJ infections_NNS are_VBP commonly_RB caused_VBN by_IN pneumococci_NN ,_, staphylococci_NN ,_, and_CC streptococci_NN ,_, all_DT of_IN which_WDT are_VBP often_RB commensals_NNS (_-LRB- that_WDT is_VBZ ,_, organisms_NNS living_VBG harmlessly_RB on_IN their_PRP$ hosts_NNS )_-RRB- in_IN the_DT upper_JJ respiratory_JJ tract_NN but_CC that_DT can_MD become_VB virulent_JJ and_CC cause_VB serious_JJ conditions_NNS ,_, such_JJ as_IN pneumonia_NN ,_, septicemia_NN (_-LRB- blood_NN poisoning_NN )_-RRB- ,_, and_CC meningitis_NN ._. The_DT pneumococcus_NN is_VBZ the_DT most_RBS common_JJ cause_NN of_IN lobar_JJ pneumonia_NN ,_, the_DT disease_NN in_IN which_WDT one_CD or_CC more_JJR lobes_NNS ,_, or_CC segments_NNS ,_, of_IN the_DT lung_NN become_VBP solid_JJ and_CC airless_JJ as_IN a_DT result_NN of_IN inflammation_NN ._. Staphylococci_NN affect_VBP the_DT lungs_NNS either_CC in_IN the_DT course_NN of_IN staphylococcal_JJ septicemia_NN —_: when_WRB bacteria_NN in_IN the_DT circulating_VBG blood_NN cause_VBP scattered_VBN abscesses_NNS in_IN the_DT lungs_NNS —_: or_CC as_IN a_DT complication_NN of_IN a_DT viral_JJ infection_NN ,_, commonly_RB influenza_NN —_: when_WRB these_DT organisms_NNS invade_VBP the_DT damaged_VBN lung_NN cells_NNS and_CC cause_VBP a_DT life_NN -_HYPH threatening_VBG form_NN of_IN pneumonia_NN ._. Streptococcal_JJ pneumonia_NN is_VBZ the_DT least_JJS common_JJ of_IN the_DT three_CD and_CC occurs_VBZ usually_RB as_IN a_DT complication_NN of_IN influenza_NN or_CC other_JJ lung_NN disease_NN ._. Pneumococci_NN often_RB enter_VB the_DT bloodstream_NN from_IN inflamed_VBN lungs_NNS and_CC cause_VB septicemia_NN ,_, with_IN continued_VBN fever_NN but_CC no_DT other_JJ special_JJ symptoms_NNS ._. Staphylococci_NN produce_VBP a_DT type_NN of_IN septicemia_NN with_IN high_JJ spiking_NN fever_NN ;_: the_DT bacteria_NN can_MD reach_VB almost_RB any_DT organ_NN of_IN the_DT body_NN —_: including_VBG the_DT brain_NN ,_, the_DT bones_NNS ,_, and_CC especially_RB the_DT lungs_NNS —_: and_CC destructive_JJ abscesses_NNS form_VBP in_IN the_DT infected_VBN areas_NNS ._. Streptococci_NN also_RB cause_VBP septicemia_NN with_IN fever_NN ,_, but_CC the_DT organisms_NNS tend_VBP to_TO cause_VB inflammation_NN of_IN surface_NN lining_NN cells_NNS rather_RB than_IN abscesses_NNS —_: for_IN example_NN ,_, pleurisy_NN (_-LRB- inflammation_NN of_IN the_DT chest_NN lining_NN )_-RRB- rather_RB than_IN lung_NN abscess_NN ,_, and_CC peritonitis_NN (_-LRB- inflammation_NN of_IN the_DT membrane_NN lining_VBG the_DT abdomen_NN )_-RRB- rather_RB than_IN liver_NN abscess_NN ._. In_IN the_DT course_NN of_IN either_DT of_IN the_DT last_JJ two_CD forms_NNS of_IN septicemia_NN ,_, organisms_NNS may_MD enter_VB the_DT nervous_JJ system_NN and_CC cause_VB streptococcal_JJ or_CC staphylococcal_JJ meningitis_NN ,_, but_CC these_DT are_VBP rare_JJ conditions_NNS ._. Pneumococci_NN ,_, on_IN the_DT other_JJ hand_NN ,_, often_RB spread_VBD directly_RB into_IN the_DT central_JJ nervous_JJ system_NN ,_, causing_VBG one_CD of_IN the_DT common_JJ forms_NNS of_IN meningitis_NN ._. Staphylococci_NN and_CC streptococci_NN are_VBP common_JJ causes_NNS of_IN skin_NN diseases_NNS ._. Boils_NNS and_CC impetigo_NN (_-LRB- in_IN which_WDT the_DT skin_NN is_VBZ covered_VBN with_IN blisters_NNS ,_, pustules_NNS ,_, and_CC yellow_JJ crusts_NNS )_-RRB- may_MD be_VB caused_VBN by_IN either_RB ._. Staphylococci_NN also_RB can_MD cause_VB a_DT severe_JJ skin_NN infection_NN that_WDT strips_VBZ the_DT outer_JJ skin_NN layers_NNS off_IN the_DT body_NN and_CC leaves_VBZ the_DT underlayers_NNS exposed_VBN ,_, as_IN in_IN severe_JJ burns_NNS ,_, a_DT condition_NN known_VBN as_IN toxic_JJ epidermal_JJ necrolysis_NN ._. Streptococcal_JJ organisms_NNS can_MD cause_VB a_DT severe_JJ condition_NN known_VBN as_IN necrotizing_NN fasciitis_NN ,_, commonly_RB referred_VBN to_IN as_IN flesh_NN -_HYPH eating_NN disease_NN ,_, which_WDT has_VBZ a_DT fatality_NN rate_NN between_IN 25_CD and_CC 75_CD percent_NN ._. Streptococci_NN can_MD be_VB the_DT cause_NN of_IN the_DT red_JJ cellulitis_NN of_IN the_DT skin_NN known_VBN as_IN erysipelas_NNS ._. Some_DT staphylococci_NNS produce_VBP an_DT intestinal_JJ toxin_NN and_CC cause_VBP food_NN poisoning_NN ._. Certain_JJ streptococci_NN settling_NN in_IN the_DT throat_NN produce_VBP a_DT reddening_VBG toxin_NN that_WDT speeds_VBZ through_IN the_DT bloodstream_NN and_CC produces_VBZ the_DT symptoms_NNS of_IN scarlet_JJ fever_NN ._. Streptococci_NN and_CC staphylococci_NN also_RB can_MD cause_VB toxic_JJ shock_NN syndrome_NN ,_, a_DT potentially_RB fatal_JJ disease_NN ._. Streptococcal_JJ toxic_JJ shock_NN syndrome_NN (_-LRB- STSS_NNP )_-RRB- is_VBZ fatal_JJ in_IN some_DT 35_CD percent_NN of_IN cases_NNS ._. Meningococci_NNP are_VBP fairly_RB common_JJ inhabitants_NNS of_IN the_DT throat_NN ,_, in_IN most_JJS cases_NNS causing_VBG no_DT illness_NN at_IN all_DT ._. As_IN the_DT number_NN of_IN healthy_JJ carriers_NNS increases_VBZ in_IN any_DT population_NN ,_, however_RB ,_, there_EX is_VBZ a_DT tendency_NN for_IN the_DT meningococcus_NN to_TO become_VB more_RBR invasive_JJ ._. When_WRB an_DT opportunity_NN is_VBZ presented_VBN ,_, it_PRP can_MD gain_VB access_NN to_IN the_DT bloodstream_NN ,_, invade_VB the_DT central_JJ nervous_JJ system_NN ,_, and_CC cause_VB meningococcal_JJ meningitis_NN (_-LRB- formerly_RB called_VBN cerebrospinal_JJ meningitis_NN or_CC spotted_VBN fever_NN )_-RRB- ._. Meningococcal_JJ meningitis_NN ,_, at_IN one_CD time_NN a_DT dreaded_VBN and_CC still_RB a_DT very_RB serious_JJ disease_NN ,_, usually_RB responds_VBZ to_IN treatment_NN with_IN penicillin_NN if_IN diagnosed_VBN early_RB enough_RB ._. When_WRB meningococci_NNS invade_VBP the_DT bloodstream_NN ,_, some_DT gain_VBP access_NN to_IN the_DT skin_NN and_CC cause_VBP bloodstained_VBN spots_NNS ,_, or_CC purpura_NN ._. If_IN the_DT condition_NN is_VBZ diagnosed_VBN early_RB enough_RB ,_, antibiotics_NNS can_MD clear_VB the_DT bloodstream_NN of_IN the_DT bacterium_NN and_CC prevent_VB any_DT from_IN getting_VBG far_RB enough_RB to_TO cause_VB meningitis_NN ._. Sometimes_RB the_DT septicemia_NN takes_VBZ a_DT mild_JJ ,_, chronic_JJ ,_, relapsing_VBG form_NN with_IN no_DT tendency_NN toward_IN meningitis_NN ;_, this_DT is_VBZ curable_JJ once_IN it_PRP is_VBZ diagnosed_VBN ._. The_DT meningococcus_NN also_RB can_MD cause_VB one_CD of_IN the_DT most_RBS fulminating_VBG of_IN all_DT forms_NNS of_IN septicemia_NN ,_, meningococcemia_NN ,_, in_IN which_WDT the_DT body_NN is_VBZ rapidly_RB covered_VBN with_IN a_DT purple_JJ rash_NN ,_, purpura_NN fulminans_NNS ;_: in_IN this_DT form_NN the_DT blood_NN pressure_NN becomes_VBZ dangerously_RB low_JJ ,_, the_DT heart_NN and_CC blood_NN vessels_NNS are_VBP affected_VBN by_IN shock_NN ,_, and_CC the_DT infected_JJ person_NN dies_VBZ within_IN a_DT matter_NN of_IN hours_NNS ._. Few_JJ are_VBP saved_VBN ,_, despite_IN treatment_NN with_IN appropriate_JJ drugs_NNS ._. Haemophilus_NN influenzae_NN is_VBZ a_DT microorganism_NN named_VBN for_IN its_PRP$ occurrence_NN in_IN the_DT sputum_NN of_IN patients_NNS with_IN influenza_NN —_: an_DT occurrence_NN so_RB common_JJ that_IN it_PRP was_VBD at_IN one_CD time_NN thought_VBN to_TO be_VB the_DT cause_NN of_IN the_DT disease_NN ._. It_PRP is_VBZ now_RB known_VBN to_TO be_VB a_DT common_JJ inhabitant_NN of_IN the_DT nose_NN and_CC throat_NN that_WDT may_MD invade_VB the_DT bloodstream_NN ,_, producing_VBG meningitis_NN ,_, pneumonia_NN ,_, and_CC various_JJ other_JJ diseases_NNS ._. In_IN children_NNS it_PRP is_VBZ the_DT most_RBS common_JJ cause_NN of_IN acute_JJ epiglottitis_NN ,_, an_DT infection_NN in_IN which_WDT tissue_NN at_IN the_DT back_NN of_IN the_DT tongue_NN becomes_VBZ rapidly_RB swollen_JJ and_CC obstructs_VBZ the_DT airway_NN ,_, creating_VBG a_DT potentially_RB fatal_JJ condition_NN ._. H._NNP influenzae_NN also_RB is_VBZ the_DT most_RBS common_JJ cause_NN of_IN meningitis_NN and_CC pneumonia_NN in_IN children_NNS under_IN five_CD years_NNS of_IN age_NN ,_, and_CC it_PRP is_VBZ known_VBN to_TO cause_VB bronchitis_NN in_IN adults_NNS ._. The_DT diagnosis_NN is_VBZ established_VBN by_IN cultures_NNS of_IN blood_NN ,_, cerebrospinal_JJ fluid_NN ,_, or_CC other_JJ tissue_NN from_IN sites_NNS of_IN infection_NN ._. Antibiotic_NN therapy_NN is_VBZ generally_RB effective_JJ ,_, although_IN death_NN from_IN sepsis_NN or_CC meningitis_NN is_VBZ still_RB common_JJ ._. In_IN developed_JJ countries_NNS where_WRB H._NNP influenza_NN vaccine_NN is_VBZ used_VBN ,_, there_EX has_VBZ been_VBN a_DT great_JJ decrease_NN in_IN serious_JJ infections_NNS and_CC deaths_NNS ._. Chlamydia_NN are_VBP intracellular_JJ organisms_NNS found_VBN in_IN many_JJ vertebrates_NNS ,_, including_VBG birds_NNS and_CC humans_NNS and_CC other_JJ mammals_NNS ._. Clinical_JJ illnesses_NNS are_VBP caused_VBN by_IN the_DT species_NN C._NN trachomatis_NN ,_, which_WDT is_VBZ a_DT frequent_JJ cause_NN of_IN genital_JJ infections_NNS in_IN women_NNS ._. If_IN an_DT infant_NN passes_VBZ through_IN an_DT infected_VBN birth_NN canal_NN ,_, it_PRP can_MD produce_VB disease_NN of_IN the_DT eye_NN (_-LRB- conjunctivitis_NN )_-RRB- and_CC pneumonia_NN in_IN the_DT newborn_NN ._. Young_JJ children_NNS sometimes_RB develop_VBP ear_NN infections_NNS ,_, laryngitis_NN ,_, and_CC upper_JJ respiratory_JJ tract_NN disease_NN from_IN Chlamydia_NNP ._. Such_JJ infections_NNS can_MD be_VB treated_VBN with_IN erythromycin_NN ._. Another_DT chlamydial_JJ organism_NN ,_, Chlamydophila_FW psittaci_NN ,_, produces_VBZ psittacosis_NN ,_, a_DT disease_NN that_WDT results_VBZ from_IN exposure_NN to_IN the_DT discharges_NNS of_IN infected_VBN birds_NNS ._. The_DT illness_NN is_VBZ characterized_VBN by_IN high_JJ fever_NN with_IN chills_NNS ,_, a_DT slow_JJ heart_NN rate_NN ,_, pneumonia_NN ,_, headache_NN ,_, weakness_NN ,_, fatigue_NN ,_, muscle_NN pains_NNS ,_, anorexia_NN ,_, nausea_NN ,_, and_CC vomiting_NN ._. The_DT diagnosis_NN is_VBZ usually_RB suspected_VBN if_IN the_DT patient_NN has_VBZ a_DT history_NN of_IN exposure_NN to_IN birds_NNS ._. It_PRP is_VBZ confirmed_VBN by_IN blood_NN tests_NNS ._. Mortality_NN is_VBZ rare_JJ ,_, and_CC specific_JJ antibiotic_NN treatment_NN is_VBZ available_JJ ._.","The NNS of NN can VB VBN into JJ NNS on the NN of their NN , JJ NNS , or NN in which they VBP with the JJ NN . The NNS of NNS that VBP JJ NNS VBP VBN as NN , NNS , NN , and NNS . NNS can VB within the NN but outside JJ NNS . Some NNS , VBN as NNS , VBP NN for NN , while NNS , JJ as those RB VBN in the JJ NN of JJ NNS , VBP RB in the NN of NN and , RB , VBP VBN NNS . JJS NNS VBP VBN by a NN that VBZ to VB an JJ NN in their NN to VB NN . RB , a NN of JJ NNS VBP off NNS that in NN may VB NNS . NNS VBP RB JJ RB to VB VBN under a NN NN . NN , the NNS that VBP JJ NN , VBP RB 0.75 NN ( 0.00003 NNS ) in NN . The NNS , which VBP NN , NN , and NN - NN NN , VBP 5 to 15 NNS JJ . JJ NNS can VB VBN with NNS . JJ NNS VBP RB VBN by NN , NN , and NN , all of which VBP RB NNS ( that VBZ , NNS VBG RB on their NNS ) in the JJ JJ NN but that can VB JJ and VB JJ NNS , JJ as NN , NN ( NN NN ) , and NN . The NN VBZ the RBS JJ NN of JJ NN , the NN in which one or JJR NNS , or NNS , of the NN VBP JJ and JJ as a NN of NN . NN VBP the NNS either in the NN of JJ NN — when NN in the VBG NN VBP VBN NNS in the NNS — or as a NN of a JJ NN , RB NN — when these NNS VBP the VBN NN NNS and VBP a NN - VBG NN of NN . JJ NN VBZ the JJS JJ of the three and VBZ RB as a NN of NN or JJ NN NN . NN RB VB the NN from VBN NNS and VB NN , with VBN NN but no JJ JJ NNS . NN VBP a NN of NN with JJ NN NN ; the NN can VB RB any NN of the NN — VBG the NN , the NNS , and RB the NNS — and JJ NNS VBP in the VBN NNS . NN RB VBP NN with NN , but the NNS VBP to VB NN of NN NN NNS RB than NNS — for NN , NN ( NN of the NN NN ) RB than NN NN , and NN ( NN of the NN VBG the NN ) RB than NN NN . In the NN of either of the JJ two NNS of NN , NNS may VB the JJ NN and VB JJ or JJ NN , but these VBP JJ NNS . NN , on the JJ NN , RB VBD RB into the JJ JJ NN , VBG one of the JJ NNS of NN . NN and NN VBP JJ NNS of NN NNS . NNS and NN ( in which the NN VBZ VBN with NNS , NNS , and JJ NNS ) may VB VBN by RB . NN RB can VB a JJ NN NN that VBZ the JJ NN NNS off the NN and VBZ the NNS VBN , as in JJ NNS , a NN VBN as JJ JJ NN . JJ NNS can VB a JJ NN VBN as NN NN , RB VBN to as NN - NN NN , which VBZ a NN NN between 25 and 75 NN . NN can VB the NN of the JJ NN of the NN VBN as NNS . Some NNS VBP an JJ NN and VBP NN NN . JJ NN NN in the NN VBP a VBG NN that VBZ through the NN and VBZ the NNS of JJ NN . NN and NN RB can VB JJ NN NN , a RB JJ NN . JJ JJ NN NN ( NNP ) VBZ JJ in some 35 NN of NNS . NNP VBP RB JJ NNS of the NN , in JJS NNS VBG no NN at all . As the NN of JJ NNS VBZ in any NN , RB , there VBZ a NN for the NN to VB RBR JJ . When an NN VBZ VBN , it can VB NN to the NN , VB the JJ JJ NN , and VB JJ NN ( RB VBN JJ NN or VBN NN ) . JJ NN , at one NN a VBN and RB a RB JJ NN , RB VBZ to NN with NN if VBN RB RB . When NNS VBP the NN , some VBP NN to the NN and VBP VBN NNS , or NN . If the NN VBZ VBN RB RB , NNS can VB the NN of the NN and VB any from VBG RB RB to VB NN . RB the NN VBZ a JJ , JJ , VBG NN with no NN toward NN ; this VBZ JJ once it VBZ VBN . The NN RB can VB one of the RBS VBG of all NNS of NN , NN , in which the NN VBZ RB VBN with a JJ NN , NN NNS ; in this NN the NN NN VBZ RB JJ , the NN and NN NNS VBP VBN by NN , and the JJ NN VBZ within a NN of NNS . JJ VBP VBN , despite NN with JJ NNS . NN NN VBZ a NN VBN for its NN in the NN of NNS with NN — an NN RB JJ that it VBD at one NN VBN to VB the NN of the NN . It VBZ RB VBN to VB a JJ NN of the NN and NN that may VB the NN , VBG NN , NN , and JJ JJ NNS . In NNS it VBZ the RBS JJ NN of JJ NN , an NN in which NN at the NN of the NN VBZ RB JJ and VBZ the NN , VBG a RB JJ NN . NNP NN RB VBZ the RBS JJ NN of NN and NN in NNS under five NNS of NN , and it VBZ VBN to VB NN in NNS . The NN VBZ VBN by NNS of NN , JJ NN , or JJ NN from NNS of NN . NN NN VBZ RB JJ , although NN from NN or NN VBZ RB JJ . In JJ NNS where NNP NN NN VBZ VBN , there VBZ VBN a JJ NN in JJ NNS and NNS . NN VBP JJ NNS VBN in JJ NNS , VBG NNS and NNS and JJ NNS . JJ NNS VBP VBN by the NN NN NN , which VBZ a JJ NN of JJ NNS in NNS . If an NN VBZ through an VBN NN NN , it can VB NN of the NN ( NN ) and NN in the NN . JJ NNS RB VBP NN NNS , NN , and JJ JJ NN NN from NNP . JJ NNS can VB VBN with NN . Another JJ NN , FW NN , VBZ NN , a NN that VBZ from NN to the NNS of VBN NNS . The NN VBZ VBN by JJ NN with NNS , a JJ NN NN , NN , NN , NN , NN , NN NNS , NN , NN , and NN . The NN VBZ RB VBN if the NN VBZ a NN of NN to NNS . It VBZ VBN by NN NNS . NN VBZ JJ , and JJ NN NN VBZ JJ ."
262,50,conspiracy,"Western_JJ media_NNS and_CC Democratic_NNP Party_NNP politicians_NNS have_VBP made_VBN a_DT major_JJ campaign_NN accusing_VBG Russia_NNP of_IN “_`` meddling_VBG ”_'' in_IN the_DT U.S._NNP election_NN ,_, colluding_VBG with_IN and_CC helping_VBG Trump_NNP win_VB the_DT Presidency_NNP ._. The_DT charges_NNS began_VBD as_IN “_`` allegations_NNS ”_'' but_CC now_RB are_VBP routinely_RB asserted_VBN as_IN facts_NNS ._. The_DT Washington_NNP Post_NNP recently_RB ran_VBD a_DT long_JJ article_NN claiming_VBG all_PDT the_DT above_JJ plus_CC saying_VBG the_DT operation_NN was_VBD directed_VBN by_IN Russian_JJ President_NNP Putin_NNP himself_PRP and_CC implying_VBG not_RB enough_JJ has_VBZ been_VBN done_VBN to_TO “_`` punish_VB ”_'' Russia_NNP ._. The_DT July_NNP -_HYPH August_NNP 2017_CD edition_NN of_IN Mother_NNP Jones_NNP magazine_NN features_VBZ an_DT article_NN headlined_VBN “_`` The_DT Russian_JJ Connection_NN :_: Collusion_NN ?_. Maybe_RB ._. Active_JJ Enablers_NNS ?_. Definitely_RB ._. Trump_NNP Knew_VBD the_DT Truth_NNP ,_, but_CC he_PRP Remained_VBD on_IN the_DT Side_NNP of_IN the_DT Enemy_NNP ._. ”_'' Is_VBZ this_DT campaign_NN based_VBN on_IN facts_NNS or_CC political_JJ opportunism_NN ?_. Does_VBZ it_PRP help_VB or_CC hurt_VB the_DT progressive_JJ cause_NN of_IN peace_NN with_IN justice_NN ?_. Following_VBG are_VBP major_JJ problems_NNS with_IN the_DT “_`` anti-_JJ Russia_NNP ”_'' theme_NN ,_, starting_VBG with_IN the_DT lack_NN of_IN clear_JJ evidence_NN ._. Accusations_NNS that_IN Russia_NNP stole_VBD and_CC released_VBD the_DT Democratic_NNP National_NNP Committee_NNP (_-LRB- DNC_NNP )_-RRB- emails_NNS are_VBP based_VBN on_IN the_DT findings_NNS of_IN the_DT private_JJ company_NN Crowdstrike_NNP ._. The_DT DNC_NNP did_VBD not_RB allow_VB the_DT FBI_NNP to_TO scan_VB the_DT computers_NNS but_CC relied_VBD on_IN a_DT hired_VBN private_JJ company_NN which_WDT claims_VBZ to_TO have_VB found_VBN telltale_JJ Russian_JJ alphabet_NN characters_NNS (_-LRB- cyrrilic_JJ )_-RRB- in_IN the_DT computer_NN memory_NN ._. However_RB ,_, Crowdstrike_NNP is_VBZ known_VBN to_TO be_VB political_JJ biased_JJ ,_, connected_VBN to_IN the_DT Clintons_NNPS and_CC to_TO make_VB false_JJ accusations_NNS such_JJ as_IN this_DT one_NN documented_VBN by_IN Voice_NNP of_IN America_NNP ._. Recently_RB the_DT Wikileaks_NNP “_`` Vault7_NNP ”_'' findings_NNS reveal_VBP that_IN the_DT CIA_NNP has_VBZ developed_VBN software_NN which_WDT purposely_RB leaves_VBZ foreign_JJ language_NN characters_NNS in_IN memory_NN ,_, casting_VBG further_JJR doubt_NN on_IN the_DT Crowdstrike_NNP evidence_NN ._. The_DT accusations_NNS of_IN Trump_NNP -_HYPH Russia_NNP collusion_NN ,_, Putin_NNP direction_NN etc_FW are_VBP significantly_RB based_VBN on_IN the_DT so_RB -_HYPH called_VBN “_`` Steele_NNP Dossier_NNP ”_'' ._. This_DT is_VBZ the_DT 35_CD page_NN compilation_NN of_IN “_`` intelligence_NN reports_NNS ”_'' produced_VBN by_IN a_DT former_JJ MI6_NNP officer_NN ,_, Robert_NNP Steele_NNP ._. The_DT research_NN and_CC reports_NNS by_IN Steele_NNP were_VBD contracted_VBN by_IN anti-Trump_NNP Republicans_NNPS in_IN the_DT primary_JJ race_NN ,_, then_RB by_IN the_DT Clinton_NNP campaign_NN in_IN the_DT presidential_JJ race_NN ._. There_EX is_VBZ no_DT supporting_VBG evidence_NN or_CC verification_NN of_IN the_DT claims_NNS ;_, the_DT reports_NNS are_VBP essentially_RB that_IN a_DT Kremlin_NNP source_NN says_VBZ such_JJ -_HYPH and_CC -_HYPH such_JJ ._. It_PRP has_VBZ since_RB been_VBN revealed_VBN that_IN Steele_NNP was_VBD not_RB in_IN direct_JJ contact_NN but_CC collected_VBD the_DT information_NN via_IN Russians_NNPS in_IN the_DT UK_NNP who_WP in_IN turn_NN received_VBD it_PRP from_IN Kremlin_NNP insiders_NNS ._. The_DT reports_NNS were_VBD viewed_VBN skeptically_RB by_IN media_NN ,_, politicians_NNS and_CC the_DT intelligence_NN community_NN through_IN the_DT summer_NN and_CC fall_NN of_IN 2016_CD ._. But_CC then_RB ,_, just_RB prior_JJ to_IN the_DT election_NN ,_, the_DT dossier_NN was_VBD leaked_VBN to_IN the_DT public_NN with_IN sensational_JJ stories_NNS of_IN “_`` golden_JJ showers_NNS ”_'' by_IN prostitutes_NNS urinating_VBG at_IN Trump_NNP ’s_POS request_NN to_TO “_`` defile_VB ”_'' the_DT bed_NN where_WRB the_DT Obamas_NNPS previously_RB slept_VBD ._. Is_VBZ the_DT Steele_NNP dossier_NN accurate_JJ or_CC was_VBD it_PRP a_DT PR_NN dirty_JJ trick_NN designed_VBN to_TO damage_VB Trump_NNP ?_. The_DT latter_NN seems_VBZ at_IN least_JJS if_IN not_RB more_RBR likely_JJ ._. This_DT Newsweek_NNP article_NN ,_, “_`` Thirteen_CD things_NNS that_WDT do_VBP n’t_RB add_VB up_RP in_IN the_DT Russia_NNP -_HYPH Trump_NNP intelligence_NN dossier_NN ”_'' ,_, lists_VBZ some_DT of_IN the_DT reasons_NNS to_TO be_VB skeptical_JJ ._. 3_LS )_-RRB- The_DT “_`` assessment_NN ”_'' from_IN Intel_NNP Agencies_NNS gives_VBZ no_DT evidence_NN and_CC seems_VBZ politically_RB biased_JJ ._. On_IN 6_CD January_NNP 2017_CD the_DT office_NN of_IN the_DT Director_NNP of_IN National_NNP Intelligence_NNP (_-LRB- DNI_NNP )_-RRB- released_VBD a_DT 14_CD page_NN document_NN titled_VBN “_`` Background_NN to_IN ‘_`` Assessing_VBG Russian_JJ Activities_NNS and_CC Intentions_NNPS in_IN Recent_NNP US_NNP Elections_NNPS ”_'' ._. The_DT report_NN says_VBZ Russian_JJ President_NNP Putin_NNP ordered_VBD a_DT campaign_NN including_VBG cyber_NN activity_NN along_IN with_IN “_`` overt_JJ efforts_NNS ”_'' to_TO influence_VB the_DT election_NN through_IN official_JJ media_NN (_-LRB- RT_NNP )_-RRB- and_CC social_JJ media_NN ._. Half_NN of_IN the_DT report_NN (_-LRB- 7_CD pages_NNS )_-RRB- is_VBZ devoted_VBN to_IN describing_VBG the_DT effectiveness_NN and_CC growth_NN of_IN Russian_JJ sponsored_VBN media_NN known_VBN as_IN “_`` RT_NN ”_'' ._. The_DT report_NN gives_VBZ no_DT evidence_NN ,_, acknowledging_VBG that_DT is_VBZ “_'' does_VBZ not_RB and_CC cannot_MD include_VB the_DT full_JJ supporting_VBG information_NN ,_, including_VBG specific_JJ intelligence_NN and_CC sources_NNS and_CC methods_NNS ”_'' ._. Should_MD this_DT report_NN be_VB accepted_VBN uncritically_RB ?_. Not_RB if_IN you_PRP consider_VBP past_JJ performance_NN ._. The_DT CIA_NNP has_VBZ long_JJ history_NN of_IN deception_NN and_CC disinformation_NN ._. “_`` Intelligence_NN ”_'' is_VBZ sometimes_RB directed_VBN to_TO support_VB political_JJ goals_NNS ._. One_CD clear_JJ example_NN is_VBZ the_DT false_JJ claims_NNS about_IN Iraq_NNP that_WDT led_VBD to_IN the_DT U.S._NNP invasion_NN in_IN 2003_CD ._. In_IN addition_NN ,_, the_DT intelligence_NN leadership_NN is_VBZ known_VBN to_TO lie_VB under_IN oath_NN ._. For_IN example_NN ,_, DNI_NNP Director_NN James_NNP Clapper_NNP lied_VBD in_IN his_PRP$ testimony_NN before_IN Congress_NNP regarding_VBG the_DT extent_NN of_IN monitoring_NN and_CC recording_VBG private_JJ communications_NNS of_IN American_JJ citizens_NNS ._. The_DT truth_NN was_VBD later_RBR revealed_VBN by_IN Edward_NNP Snowden_NNP ._. In_IN short_JJ ,_, there_EX is_VBZ no_DT good_JJ reason_NN to_TO uncritically_RB accept_VB the_DT statements_NNS and_CC assertions_NNS of_IN the_DT U.S._NNP intelligence_NN community_NN ._. There_EX is_VBZ every_DT reason_NN to_TO be_VB skeptical_JJ and_CC require_VB credible_JJ and_CC verifiable_JJ evidence_NN ._. This_DT is_VBZ compounded_VBN by_IN the_DT conflict_NN between_IN Trump_NNP and_CC the_DT intelligence_NN agencies_NNS where_WRB they_PRP may_MD be_VB seeking_VBG retribution_NN against_IN him_PRP ._. Even_RB Democratic_NNP Senator_NNP Schumer_NNP warned_VBD Trump_NNP about_IN the_DT dangers_NNS of_IN bucking_VBG the_DT CIA_NNP and_CC other_JJ agencies_NNS :_: “_`` They_PRP have_VBP seven_CD ways_NNS to_IN Sunday_NNP to_TO get_VB back_RB at_IN you_PRP ._. ”_'' What_WDT better_JJR way_NN than_IN shining_VBG a_DT bright_JJ light_NN on_IN the_DT Steele_NNP dossier_NN and_CC giving_VBG credence_NN to_IN the_DT third_JJ hand_NN accusations_NNS ?_. It_PRP has_VBZ recently_RB been_VBN acknowledged_VBN by_IN the_DT NY_NNP Times_NNP that_IN the_DT assessment_NN was_VBD made_VBN by_IN four_CD not_RB seventeen_CD intelligence_NN agencies_NNS ._. DNI_NNP Director_NNP Clapper_NNP has_VBZ admitted_VBN the_DT assessment_NN was_VBD by_IN a_DT hand_NN picked_VBN group_NN of_IN analysts_NNS ._. Finally_RB ,_, it_PRP is_VBZ significant_JJ that_IN the_DT NSA_NNP would_MD only_RB grant_VB “_`` moderate_JJ confidence_NN ”_'' to_IN the_DT accusation_NN that_IN “_`` Putin_NNP and_CC the_DT Russian_JJ Government_NN aspired_VBD to_TO help_VB President_NNP -_HYPH elect_VB Trump_NNP ’s_POS election_NN chances_NNS ”_'' ._. By_IN their_PRP$ own_JJ definition_NN on_IN page_NN 13_CD ,_, moderate_JJ confidence_NN means_VBZ that_IN the_DT information_NN is_VBZ “_`` plausible_JJ but_CC not_RB of_IN sufficient_JJ quality_NN or_CC corroborated_VBN sufficiently_RB to_TO warrant_VB a_DT higher_JJR level_NN of_IN confidence_NN ._. ”_'' 4_LS )_-RRB- The_DT counter_NN -_HYPH evidence_NN seems_VBZ stronger_JJR and_CC more_RBR factual_JJ ._. Veteran_JJ intelligence_NN professionals_NNS ,_, including_VBG a_DT former_JJ technical_JJ director_NN of_IN the_DT NSA_NNP ,_, say_VBP the_DT DNC_NNP email_NN release_NN was_VBD caused_VBN by_IN a_DT leak_NN not_RB a_DT “_`` hack_NN ”_'' ._. The_DT distinction_NN is_VBZ important_JJ :_: a_DT hack_NN is_VBZ done_VBN over_IN the_DT internet_NN ;_, a_DT leak_NN is_VBZ done_VBN transferring_VBG files_NNS onto_IN a_DT memory_NN stick_NN with_IN little_JJ or_CC no_DT record_NN ._. VIPS_NNPS believes_VBZ the_DT emails_NNS were_VBD taken_VBN by_IN an_DT insider_NN who_WP transferred_VBD the_DT files_NNS onto_IN a_DT thumb_NN drive_NN ._. If_IN the_DT files_NNS had_VBD been_VBN transferred_VBN over_IN the_DT internet_NN ,_, the_DT National_NNP Security_NNP Agency_NNP (_-LRB- NSA_NNP )_-RRB- would_MD have_VB a_DT record_NN of_IN that_DT since_IN virtually_RB every_DT packet_NN is_VBZ stored_VBN ._. In_IN addition_NN ,_, the_DT publisher_NN of_IN the_DT DNC_NNP and_CC Podesta_NNP emails_NNS ,_, Wikileaks_NNP ,_, says_VBZ they_PRP did_VBD not_RB receive_VB the_DT emails_NNS from_IN Russia_NNP ._. Wikileaks_NNP founder_NN Julian_NNP Assange_NNP has_VBZ offered_VBN a_DT reward_NN for_IN the_DT discovery_NN of_IN the_DT murderer_NN of_IN Seth_NNP Rich_NNP ,_, the_DT young_JJ DNC_NNP Director_NNP of_IN Voter_NNP Expansion_NNP who_WP was_VBD mysteriously_RB murdered_VBN on_IN July_NNP 22_CD ._. When_WRB asked_VBN if_IN Seth_NNP Rich_NNP was_VBD the_DT source_NN of_IN the_DT DNC_NNP emails_NNS ,_, he_PRP does_VBZ not_RB reply_VB directly_RB but_CC it_PRP is_VBZ implied_VBN ._. In_IN addition_NN ,_, the_DT former_JJ UK_NNP Ambassador_NNP Craig_NNP Murray_NNP has_VBZ suggested_VBN that_IN he_PRP was_VBD involved_VBN in_IN a_DT later_JJR (_-LRB- Podesta_NNP )_-RRB- transfer_NN of_IN the_DT files_NNS from_IN Washington_NNP DC_NNP to_IN Wikileaks_NNP ._. Meanwhile_RB ,_, there_EX appears_VBZ to_TO be_VB an_DT effort_NN to_TO discredit_VB and_CC denigrate_VB research_NN or_CC investigation_NN into_IN the_DT Seth_NNP Rich_NNP theory_NN ._. If_IN DNC_NNP insiders_NNS such_JJ as_IN Seth_NNP Rich_NNP transferred_VBD the_DT emails_NNS to_IN Wikileaks_NNP ,_, the_DT anti-Russia_JJ campaign_NN collapses_VBZ ._. Since_IN Trump_NNP ’s_POS November_NNP victory_NN ,_, there_EX have_VBP been_VBN accusations_NNS of_IN “_`` Russian_JJ interference_NN ”_'' in_IN European_JJ elections_NNS ._. But_CC in_IN each_DT case_NN ,_, subsequent_JJ investigation_NN shows_VBZ the_DT opposite_NN ._. In_IN Germany_NNP ,_, France_NNP and_CC the_DT UK_NNP ,_, security_NN services_NNS found_VBD no_DT evidence_NN in_IN contrast_NN with_IN the_DT reports_NNS ._. The_DT French_JJ security_NN chief_NN dismissed_VBD the_DT claims_NNS of_IN the_DT Macron_NNP campaign_NN saying_VBG the_DT hack_NN “_'' was_VBD so_RB generic_JJ and_CC simple_JJ that_IN it_PRP could_MD have_VB been_VBN practically_RB anyone_NN ._. ”_'' 5_LS )_-RRB- The_DT purported_VBN “_`` crimes_NNS ”_'' have_VBP been_VBN wildly_RB inflated_VBN ._. The_DT leaking_NN of_IN DNC_NNP and_CC Podesta_NNP emails_NNS has_VBZ been_VBN inflated_VBN into_IN an_DT “_`` attack_NN on_IN US_NNP democracy_NN ”_'' and_CC “_`` act_NN of_IN war_NN ”_'' ._. Not_RB to_TO be_VB outdone_VBN in_IN the_DT hyperbole_NN department_NN ,_, the_DT Washington_NNP Post_NNP article_NN calls_VBZ this_DT “_`` the_DT crime_NN of_IN the_DT century_NN ”_'' ._. It_PRP ’s_VBZ quite_RB astounding_JJ ;_, even_RB if_IN Russia_NNP was_VBD guilty_JJ of_IN hacking_VBG the_DT DNC_NNP servers_NNS and_CC promoting_VBG anti-Clinton_JJ campaign_NN on_IN social_JJ media_NN ,_, which_WDT is_VBZ debatable_JJ ,_, the_DT notion_NN that_IN this_DT was_VBD an_DT “_`` act_NN of_IN war_NN ”_'' is_VBZ preposterous_JJ ._. These_DT events_NNS were_VBD secondary_JJ problems_NNS for_IN the_DT Clinton_NNP campaign_NN ._. The_DT FBI_NNP closing_NN and_CC then_RB re-opening_VBG the_DT criminal_JJ investigation_NN of_IN Clinton_NNP ’s_POS use_NN of_IN her_PRP$ private_JJ computers_NNS for_IN public_JJ work_NN was_VBD a_DT bigger_JJR factor_NN ._. There_EX are_VBP many_JJ real_JJ problems_NNS with_IN the_DT democratic_JJ process_NN in_IN the_DT USA_NNP and_CC talking_VBG about_IN them_PRP ,_, whether_IN on_IN RT_NNP or_CC elsewhere_RB ,_, is_VBZ good_JJ not_RB bad_JJ ._. Even_RB a_DT former_JJ U.S._NNP President_NNP ,_, Jimmy_NNP Carter_NNP ,_, questions_VBZ whether_IN the_DT U.S._NNP is_VBZ a_DT democracy_NN saying_VBG ,_, 6_LS )_-RRB- The_DT anti-Russia_JJ hysteria_NN has_VBZ reduced_VBN resistance_NN to_IN reactionary_JJ changes_NNS in_IN domestic_JJ policy_NN ._. There_EX is_VBZ an_DT immediate_JJ need_NN to_TO build_VB maximum_JJ opposition_NN to_IN Trump_NNP policies_NNS including_VBG the_DT loss_NN of_IN net_NN neutrality_NN ,_, increase_NN in_IN military_JJ spending_NN ,_, reductions_NNS in_IN environmental_JJ protection_NN ,_, education_NN and_CC health_NN care_NN budgets_NNS ,_, etc_FW ._. ._. The_DT anti-Russia_NNP and_CC “_`` hate_VBP Trump_NNP ”_'' campaigns_NNS have_VBP reduced_VBN the_DT credibility_NN of_IN liberals_NNS and_CC progressives_NNS with_IN conservatives_NNS and_CC make_VB it_PRP harder_JJR to_TO build_VB resistance_NN to_IN changes_NNS which_WDT hurt_VBP the_DT working_NN class_NN and_CC poor_JJ ._. 7_LS )_-RRB- The_DT DNC_NNP and_CC Podesta_NNP leaks_NNS were_VBD not_RB bad_JJ ;_, they_PRP were_VBD good_JJ ._. Far_RB from_IN being_VBG an_DT “_`` attack_NN on_IN democracy_NN ”_'' ,_, the_DT leaks_NNS of_IN DNC_NNP and_CC Podesta_NNP emails_NNS were_VBD positive_JJ ._. They_PRP exposed_VBD that_IN the_DT DNC_NNP itself_PRP was_VBD preventing_VBG the_DT will_NN of_IN Democratic_NNP Party_NNP members_NNS in_IN choosing_VBG their_PRP$ candidate_NN ._. The_DT releases_NNS exposed_VBD how_WRB the_DT Democratic_NNP National_NNP Committee_NNP (_-LRB- DNC_NNP )_-RRB- leadership_NN conspired_VBD and_CC acted_VBD to_TO boost_VB Clinton_NNP and_CC pr_NN event_NN a_DT successful_JJ challenge_NN by_IN Sanders_NNP ._. If_IN there_EX was_VBD an_DT “_`` attack_NN on_IN democracy_NN ”_'' it_PRP was_VBD by_IN the_DT DNC_NNP leadership_NN itself_PRP not_RB the_DT public_JJ release_NN of_IN authentic_JJ emails_NNS ._. 8_LS )_-RRB- Social_JJ media_NN criticizing_VBG Clinton_NNP was_VBD not_RB bad_JJ ;_, much_JJ of_IN the_DT criticism_NN was_VBD accurate_JJ ._. The_DT intelligence_NN agency_NN assessment_NN blames_VBZ Russia_NNP for_IN undermining_VBG “_`` public_JJ faith_NN in_IN the_DT US_NNP democratic_JJ process_NN ”_'' ,_, denigrating_VBG Secretary_NNP Clinton_NNP and_CC harming_VBG “_`` her_PRP$ electability_NN and_CC potential_JJ presidency_NN ”_'' ._. They_PRP suggest_VBP Russia_NNP was_VBD responsible_JJ for_IN anti-Clinton_JJ online_JJ messages_NNS ,_, tweets_NNS ,_, facebook_NN posts_NNS ,_, etc._FW ._. This_DT is_VBZ silly_JJ ._. It_PRP was_VBD predictable_JJ that_IN Hillary_NNP Clinton_NNP would_MD generate_VB a_DT lot_NN of_IN opposition_NN during_IN the_DT Presidential_JJ campaign_NN ._. She_PRP is_VBZ a_DT magnet_NN for_IN right_JJ and_CC left_JJ wing_NN criticism_NN ._. She_PRP is_VBZ strongly_RB disliked_VBN by_IN many_JJ progressives_NNS for_IN good_JJ and_CC real_JJ reasons_NNS ._. From_IN her_PRP$ aggressive_JJ and_CC warlike_JJ foreign_JJ policy_NN to_IN the_DT horrible_JJ role_NN of_IN the_DT Clinton_NNP Foundation_NNP in_IN Haiti_NNP ,_, there_EX are_VBP many_JJ deep_JJ and_CC profound_JJ things_NNS to_TO criticize_VB ._. Social_JJ media_NN was_VBD alive_JJ with_IN tweets_NNS ,_, pages_NNS ,_, posts_NNS and_CC campaigns_NNS against_IN Clinton_NNP ._. It_PRP is_VBZ self_NN -_HYPH deception_NN to_TO think_VB this_DT was_VBD initiated_VBN or_CC controlled_VBN in_IN any_DT substantial_JJ way_NN by_IN Moscow_NNP ._. The_DT criticism_NN and_CC opposition_NN to_IN Hillary_NNP Clinton_NNP was_VBD sincere_JJ and_CC home_NN grown_VBN ._. While_IN some_DT criticism_NN may_MD have_VB been_VBN undeserved_JJ ,_, much_JJ of_IN the_DT criticism_NN of_IN Clinton_NNP was_VBD accurate_JJ and_CC well_RB founded_VBN ._. 9_LS )_-RRB- The_DT anti-Russia_JJ hysteria_NN distracts_VBZ from_IN an_DT objective_JJ evaluation_NN of_IN why_WRB the_DT Democratic_NNP Party_NNP lost_VBD ._. Instead_RB of_IN doing_VBG an_DT honest_JJ and_CC objective_JJ assessment_NN of_IN the_DT election_NN failure_NN ,_, the_DT Democratic_NNP Party_NNP has_VBZ invested_VBN enormous_JJ time_NN and_CC resources_NNS in_IN promoting_VBG the_DT narrative_NN of_IN Russian_JJ “_`` meddling_NN ”_'' and_CC collusion_NN with_IN Trump_NNP ._. If_IN they_PRP want_VBP to_TO regain_VB popularity_NN ,_, they_PRP need_VBP to_TO review_VB their_PRP$ leadership_NN which_WDT has_VBZ changed_VBN very_RB little_RB in_IN over_RB 15_CD years_NNS ._. They_PRP need_VBP to_TO re-assess_VB unpopular_JJ policies_NNS and_CC their_PRP$ prioritization_NN of_IN Wall_NNP Street_NNP ._. If_IN the_DT DNC_NNP had_VBD run_VBN a_DT clean_JJ primary_JJ race_NN ,_, Sanders_NNP probably_RB would_MD have_VB prevailed_VBN over_IN Clinton_NNP in_IN the_DT primary_NN race_NN and_CC gone_VBN on_RP to_TO beat_VB Donald_NNP Trump_NNP for_IN president_NN ._. The_DT Democratic_NNP Party_NNP leadership_NN has_VBZ nobody_NN to_TO blame_VB but_CC themselves_PRP for_IN their_PRP$ defeat_NN ._. 10_LS )_-RRB- The_DT anti-Russia_JJ hysteria_NN reduces_VBZ resistance_NN to_IN neoconservative_JJ forces_NNS pushing_VBG for_IN more_JJR war_NN ._. Neoconservatives_NNPS and_CC the_DT military_JJ industrial_JJ complex_NN are_VBP campaigning_VBG for_IN another_DT war_NN in_IN the_DT Middle_NNP East_NNP ._. The_DT immediate_JJ flashpoint_NN is_VBZ Syria_NNP where_WRB the_DT Syrian_JJ government_NN and_CC allies_NNS are_VBP making_VBG slow_JJ but_CC steady_JJ progress_NN defeating_VBG tens_NNS of_IN thousands_NNS of_IN foreign_JJ funded_VBN extremists_NNS ._. In_IN response_NN ,_, the_DT US_NNP and_CC allies_NNS are_VBP escalating_VBG intervention_NN and_CC aggression_NN trying_VBG to_TO prolong_VB the_DT conflict_NN and_CC /_, or_CC grab_NN territory_NN to_TO block_VB a_DT Syrian_JJ victory_NN ._. The_DT situation_NN is_VBZ potentially_RB disastrous_JJ with_IN the_DT neocons_NNS threatening_VBG war_NN on_IN Iran_NNP and_CC even_RB Russia_NNP ._. The_DT Democratic_JJ and_CC liberal_JJ hysteria_NN around_IN Russia_NNP has_VBZ confused_VBN huge_JJ numbers_NNS of_IN people_NNS about_IN the_DT situation_NN who_WP now_RB think_VBP Russia_NNP is_VBZ the_DT ‘_`` enemy_NN ’_'' ._. The_DT anti-Russia_JJ hysteria_NN is_VBZ leading_VBG liberals_NNS to_TO ally_VB with_IN the_DT CIA_NNP and_CC war_NN hawks_NNS instead_RB of_IN confronting_VBG them_PRP as_IN the_DT danger_NN of_IN confrontation_NN keeps_VBZ rising_VBG ._. Democrats_NNPS and_CC liberals_NNS in_IN the_DT U.S._NNP are_VBP making_VBG a_DT huge_JJ mistake_NN uncritically_RB accepting_VBG and_CC promoting_VBG the_DT anti-Russia_JJ demonization_NN ._. The_DT accusations_NNS of_IN Russian_JJ “_`` meddling_NN ”_'' are_VBP either_CC exaggerated_VBN or_CC false_JJ ._. There_EX is_VBZ an_DT urgent_JJ need_NN to_TO resist_VB Trump_NNP ’s_POS assault_NN on_IN positive_JJ domestic_JJ policies_NNS and_CC oppose_VB the_DT slide_NN towards_IN a_DT new_JJ war_NN in_IN the_DT Middle_NNP East_NNP ._. If_IN this_DT is_VBZ not_RB stopped_VBN ,_, there_EX is_VBZ a_DT real_JJ risk_NN of_IN global_JJ and_CC possibly_RB nuclear_JJ war_NN ._.","JJ NNS and NNP NNP NNS VBP VBN a JJ NN VBG NNP of “ VBG ” in the NNP NN , VBG with and VBG NNP VB the NNP . The NNS VBD as “ NNS ” but RB VBP RB VBN as NNS . The NNP NNP RB VBD a JJ NN VBG all the JJ plus VBG the NN VBD VBN by JJ NNP NNP himself and VBG RB JJ VBZ VBN VBN to “ VB ” NNP . The NNP - NNP 2017 NN of NNP NNP NN VBZ an NN VBN “ The JJ NN : NN ? RB . JJ NNS ? RB . NNP VBD the NNP , but he VBD on the NNP of the NNP . ” VBZ this NN VBN on NNS or JJ NN ? VBZ it VB or VB the JJ NN of NN with NN ? VBG VBP JJ NNS with the “ JJ NNP ” NN , VBG with the NN of JJ NN . NNS that NNP VBD and VBD the NNP NNP NNP ( NNP ) NNS VBP VBN on the NNS of the JJ NN NNP . The NNP VBD RB VB the NNP to VB the NNS but VBD on a VBN JJ NN which VBZ to VB VBN JJ JJ NN NNS ( JJ ) in the NN NN . RB , NNP VBZ VBN to VB JJ JJ , VBN to the NNPS and to VB JJ NNS JJ as this NN VBN by NNP of NNP . RB the NNP “ NNP ” NNS VBP that the NNP VBZ VBN NN which RB VBZ JJ NN NNS in NN , VBG JJR NN on the NNP NN . The NNS of NNP - NNP NN , NNP NN FW VBP RB VBN on the RB - VBN “ NNP NNP ” . This VBZ the 35 NN NN of “ NN NNS ” VBN by a JJ NNP NN , NNP NNP . The NN and NNS by NNP VBD VBN by NNP NNPS in the JJ NN , RB by the NNP NN in the JJ NN . There VBZ no VBG NN or NN of the NNS ; the NNS VBP RB that a NNP NN VBZ JJ - and - JJ . It VBZ RB VBN VBN that NNP VBD RB in JJ NN but VBD the NN via NNPS in the NNP who in NN VBD it from NNP NNS . The NNS VBD VBN RB by NN , NNS and the NN NN through the NN and NN of 2016 . But RB , RB JJ to the NN , the NN VBD VBN to the NN with JJ NNS of “ JJ NNS ” by NNS VBG at NNP ’s NN to “ VB ” the NN where the NNPS RB VBD . VBZ the NNP NN JJ or VBD it a NN JJ NN VBN to VB NNP ? The NN VBZ at JJS if RB RBR JJ . This NNP NN , “ Thirteen NNS that VBP RB VB up in the NNP - NNP NN NN ” , VBZ some of the NNS to VB JJ . 3 ) The “ NN ” from NNP NNS VBZ no NN and VBZ RB JJ . On 6 NNP 2017 the NN of the NNP of NNP NNP ( NNP ) VBD a 14 NN NN VBN “ NN to ‘ VBG JJ NNS and NNPS in NNP NNP NNPS ” . The NN VBZ JJ NNP NNP VBD a NN VBG NN NN along with “ JJ NNS ” to VB the NN through JJ NN ( NNP ) and JJ NN . NN of the NN ( 7 NNS ) VBZ VBN to VBG the NN and NN of JJ VBN NN VBN as “ NN ” . The NN VBZ no NN , VBG that VBZ “ VBZ RB and cannot VB the JJ VBG NN , VBG JJ NN and NNS and NNS ” . Should this NN VB VBN RB ? RB if you VBP JJ NN . The NNP VBZ JJ NN of NN and NN . “ NN ” VBZ RB VBN to VB JJ NNS . One JJ NN VBZ the JJ NNS about NNP that VBD to the NNP NN in 2003 . In NN , the NN NN VBZ VBN to VB under NN . For NN , NNP NN NNP NNP VBD in his NN before NNP VBG the NN of NN and VBG JJ NNS of JJ NNS . The NN VBD RBR VBN by NNP NNP . In JJ , there VBZ no JJ NN to RB VB the NNS and NNS of the NNP NN NN . There VBZ every NN to VB JJ and VB JJ and JJ NN . This VBZ VBN by the NN between NNP and the NN NNS where they may VB VBG NN against him . RB NNP NNP NNP VBD NNP about the NNS of VBG the NNP and JJ NNS : “ They VBP seven NNS to NNP to VB RB at you . ” What JJR NN than VBG a JJ NN on the NNP NN and VBG NN to the JJ NN NNS ? It VBZ RB VBN VBN by the NNP NNP that the NN VBD VBN by four RB seventeen NN NNS . NNP NNP NNP VBZ VBN the NN VBD by a NN VBN NN of NNS . RB , it VBZ JJ that the NNP would RB VB “ JJ NN ” to the NN that “ NNP and the JJ NN VBD to VB NNP - VB NNP ’s NN NNS ” . By their JJ NN on NN 13 , JJ NN VBZ that the NN VBZ “ JJ but RB of JJ NN or VBN RB to VB a JJR NN of NN . ” 4 ) The NN - NN VBZ JJR and RBR JJ . JJ NN NNS , VBG a JJ JJ NN of the NNP , VBP the NNP NN NN VBD VBN by a NN RB a “ NN ” . The NN VBZ JJ : a NN VBZ VBN over the NN ; a NN VBZ VBN VBG NNS onto a NN NN with JJ or no NN . NNPS VBZ the NNS VBD VBN by an NN who VBD the NNS onto a NN NN . If the NNS VBD VBN VBN over the NN , the NNP NNP NNP ( NNP ) would VB a NN of that since RB every NN VBZ VBN . In NN , the NN of the NNP and NNP NNS , NNP , VBZ they VBD RB VB the NNS from NNP . NNP NN NNP NNP VBZ VBN a NN for the NN of the NN of NNP NNP , the JJ NNP NNP of NNP NNP who VBD RB VBN on NNP 22 . When VBN if NNP NNP VBD the NN of the NNP NNS , he VBZ RB VB RB but it VBZ VBN . In NN , the JJ NNP NNP NNP NNP VBZ VBN that he VBD VBN in a JJR ( NNP ) NN of the NNS from NNP NNP to NNP . RB , there VBZ to VB an NN to VB and VB NN or NN into the NNP NNP NN . If NNP NNS JJ as NNP NNP VBD the NNS to NNP , the JJ NN VBZ . Since NNP ’s NNP NN , there VBP VBN NNS of “ JJ NN ” in JJ NNS . But in each NN , JJ NN VBZ the NN . In NNP , NNP and the NNP , NN NNS VBD no NN in NN with the NNS . The JJ NN NN VBD the NNS of the NNP NN VBG the NN “ VBD RB JJ and JJ that it could VB VBN RB NN . ” 5 ) The VBN “ NNS ” VBP VBN RB VBN . The NN of NNP and NNP NNS VBZ VBN VBN into an “ NN on NNP NN ” and “ NN of NN ” . RB to VB VBN in the NN NN , the NNP NNP NN VBZ this “ the NN of the NN ” . It VBZ RB JJ ; RB if NNP VBD JJ of VBG the NNP NNS and VBG JJ NN on JJ NN , which VBZ JJ , the NN that this VBD an “ NN of NN ” VBZ JJ . These NNS VBD JJ NNS for the NNP NN . The NNP NN and RB VBG the JJ NN of NNP ’s NN of her JJ NNS for JJ NN VBD a JJR NN . There VBP JJ JJ NNS with the JJ NN in the NNP and VBG about them , whether on NNP or RB , VBZ JJ RB JJ . RB a JJ NNP NNP , NNP NNP , VBZ whether the NNP VBZ a NN VBG , 6 ) The JJ NN VBZ VBN NN to JJ NNS in JJ NN . There VBZ an JJ NN to VB JJ NN to NNP NNS VBG the NN of NN NN , NN in JJ NN , NNS in JJ NN , NN and NN NN NNS , FW . . The NNP and “ VBP NNP ” NNS VBP VBN the NN of NNS and NNS with NNS and VB it JJR to VB NN to NNS which VBP the NN NN and JJ . 7 ) The NNP and NNP NNS VBD RB JJ ; they VBD JJ . RB from VBG an “ NN on NN ” , the NNS of NNP and NNP NNS VBD JJ . They VBD that the NNP itself VBD VBG the NN of NNP NNP NNS in VBG their NN . The NNS VBD how the NNP NNP NNP ( NNP ) NN VBD and VBD to VB NNP and NN NN a JJ NN by NNP . If there VBD an “ NN on NN ” it VBD by the NNP NN itself RB the JJ NN of JJ NNS . 8 ) JJ NN VBG NNP VBD RB JJ ; JJ of the NN VBD JJ . The NN NN NN VBZ NNP for VBG “ JJ NN in the NNP JJ NN ” , VBG NNP NNP and VBG “ her NN and JJ NN ” . They VBP NNP VBD JJ for JJ JJ NNS , NNS , NN NNS , FW . This VBZ JJ . It VBD JJ that NNP NNP would VB a NN of NN during the JJ NN . She VBZ a NN for JJ and JJ NN NN . She VBZ RB VBN by JJ NNS for JJ and JJ NNS . From her JJ and JJ JJ NN to the JJ NN of the NNP NNP in NNP , there VBP JJ JJ and JJ NNS to VB . JJ NN VBD JJ with NNS , NNS , NNS and NNS against NNP . It VBZ NN - NN to VB this VBD VBN or VBN in any JJ NN by NNP . The NN and NN to NNP NNP VBD JJ and NN VBN . While some NN may VB VBN JJ , JJ of the NN of NNP VBD JJ and RB VBN . 9 ) The JJ NN VBZ from an JJ NN of why the NNP NNP VBD . RB of VBG an JJ and JJ NN of the NN NN , the NNP NNP VBZ VBN JJ NN and NNS in VBG the NN of JJ “ NN ” and NN with NNP . If they VBP to VB NN , they VBP to VB their NN which VBZ VBN RB RB in RB 15 NNS . They VBP to VB JJ NNS and their NN of NNP NNP . If the NNP VBD VBN a JJ JJ NN , NNP RB would VB VBN over NNP in the NN NN and VBN on to VB NNP NNP for NN . The NNP NNP NN VBZ NN to VB but themselves for their NN . 10 ) The JJ NN VBZ NN to JJ NNS VBG for JJR NN . NNPS and the JJ JJ NN VBP VBG for another NN in the NNP NNP . The JJ NN VBZ NNP where the JJ NN and NNS VBP VBG JJ but JJ NN VBG NNS of NNS of JJ VBN NNS . In NN , the NNP and NNS VBP VBG NN and NN VBG to VB the NN and / or NN NN to VB a JJ NN . The NN VBZ RB JJ with the NNS VBG NN on NNP and RB NNP . The JJ and JJ NN around NNP VBZ VBN JJ NNS of NNS about the NN who RB VBP NNP VBZ the ‘ NN ’ . The JJ NN VBZ VBG NNS to VB with the NNP and NN NNS RB of VBG them as the NN of NN VBZ VBG . NNPS and NNS in the NNP VBP VBG a JJ NN RB VBG and VBG the JJ NN . The NNS of JJ “ NN ” VBP either VBN or JJ . There VBZ an JJ NN to VB NNP ’s NN on JJ JJ NNS and VB the NN towards a JJ NN in the NNP NNP . If this VBZ RB VBN , there VBZ a JJ NN of JJ and RB JJ NN ."
263,692,conspiracy,"Dr._NNP Andrew_NNP Kaufman_NNP may_MD be_VB the_DT most_RBS censored_VBN doctor_NN in_IN the_DT U.S._NNP right_RB now_RB ._. His_PRP$ videos_NNS are_VBP removed_VBN and_CC censored_VBN from_IN YouTube_NNP very_RB quickly_RB ._. Dr._NNP Kaufman_NNP is_VBZ so_RB intelligent_JJ ,_, and_CC so_RB articulate_JJ ,_, that_IN the_DT “_`` mainstream_JJ ”_'' media_NN and_CC medical_JJ authorities_NNS obviously_RB fear_VBP him_PRP and_CC his_PRP$ message_NN ,_, and_CC they_PRP are_VBP doing_VBG everything_NN in_IN their_PRP$ power_NN to_TO suppress_VB him_PRP ._. This_DT video_NN (_-LRB- below_RB )_-RRB- he_PRP did_VBD with_IN Spiro_NNP Skouras_NNP ,_, for_IN example_NN ,_, was_VBD immediately_RB removed_VBN from_IN YouTube_NNP ,_, although_IN Spiro_NNP ’s_POS other_JJ videos_NNS remain_VBP for_IN the_DT most_JJS part_NN (_-LRB- for_IN now_RB )_-RRB- ._. Andrew_NNP Kaufman_NNP is_VBZ a_DT medical_JJ doctor_NN ._. Here_RB is_VBZ his_PRP$ full_JJ bio_NN from_IN his_PRP$ website_NN :_: He_PRP completed_VBD his_PRP$ psychiatric_JJ training_NN at_IN Duke_NNP University_NNP Medical_NNP Center_NNP after_IN graduating_VBG from_IN the_DT Medical_NNP University_NNP of_IN South_NNP Carolina_NNP ,_, and_CC has_VBZ a_DT B.S._NN from_IN M.I.T._NNP in_IN Molecular_NNP Biology_NNP ._. He_PRP has_VBZ conducted_VBN and_CC published_VBN original_JJ research_NN and_CC lectured_VBN ,_, supervised_VBN ,_, and_CC mentored_VBN medical_JJ students_NNS ,_, residents_NNS ,_, and_CC fellows_NNS in_IN all_DT psychiatric_JJ specialties_NNS ._. He_PRP has_VBZ been_VBN qualified_VBN as_IN an_DT expert_NN witness_NN in_IN local_JJ ,_, state_NN ,_, and_CC federal_JJ courts_NNS ._. He_PRP has_VBZ held_VBN leadership_NN positions_NNS in_IN academic_JJ medicine_NN and_CC professional_JJ organizations_NNS ._. He_PRP ran_VBD a_DT start_NN -_HYPH up_RP company_NN to_TO develop_VB a_DT medical_JJ device_NN he_PRP invented_VBD and_CC patented_VBD ._. Medical_NNP University_NNP of_IN South_NNP Carolina_NNP ,_, Doctor_NNP of_IN Medicine_NNP Massachusetts_NNP Institute_NNP of_IN Technology_NNP ,_, BS_NNP in_IN Biology_NNP American_NNP Board_NNP of_IN Psychiatry_NNP and_CC Neurology_NNP Board_NNP Certification_NNP in_IN Psychiatry_NNP and_CC Forensic_NNP Psychiatry_NNP (_-LRB- 2011_CD )_-RRB- SUNY_NNP Upstate_NNP Medical_NNP University_NNP ,_, Fellowship_NNP in_IN Forensic_NNP Psychiatry_NNP Duke_NNP University_NNP School_NNP of_IN Medicine_NNP ,_, Resident_NNP in_IN Psychiatry_NNP Knoll_NNP JL_NNP and_CC Kaufman_NNP AR_NNP ._. Suicide_NN in_IN Correctional_JJ Settings_NNS :_: Epidemiology_NN ,_, Risk_NN Assessment_NN ,_, and_CC Prevention_NN ._. Principles_NNS and_CC Practice_NNP of_IN Forensic_NNP Psychiatry_NNP edited_VBN by_IN Richard_NNP Rosner_NNP ,_, 3rd_JJ edition_NN ,_, 2017_CD ._. Way_NN BB_NNP ,_, Kaufman_NNP AR_NNP ,_, Knoll_NNP JL_NN ,_, Chlebowski_NNP ,_, S_NN :_: Suicidal_JJ Ideation_NN among_IN Inmate_NN -_HYPH Patients_NNS in_IN State_NN Prison_NN :_: Prevalence_NN ,_, Reluctance_NN to_TO Report_VB ,_, and_CC Treatment_NN Preferences_NNS ._. Behavioral_NNP Science_NNP and_CC the_DT Law_NNP ,_, 31_CD (_-LRB- 2_CD )_-RRB- :_: 230-8_CD ,_, 2013_CD ._. Kaufman_NNP AR_NNP ,_, Way_NNP BB_NNP ,_, Suardi_NNP E_NNP :_: Forty_CD Years_NNS after_IN Jackson_NNP v._NNP Indiana_NNP ._. States_NNPS ’_POS Compliance_NN with_IN “_`` Reasonable_JJ Period_NN of_IN Time_NN ”_'' Ruling_NN ._. Journal_NNP of_IN the_DT American_NNP Academy_NNP of_IN Psychiatry_NNP and_CC the_DT Law_NNP ,_, 40:261-5_CD ,_, 2012_CD ._. Kaufman_NNP AR_NNP ,_, Knoll_NNP JL_NNP ,_, Way_NNP BB_NNP ,_, Leonard_NNP C_NNP ,_, Widroff_NNP J_NNP :_: Survey_NN of_IN Forensic_NNP Mental_NNP Health_NNP Experts_NNS on_IN Pro_NNP Se_NNP Competence_NN After_IN Indiana_NNP v._NNP Edwards_NNP :_: Towards_IN an_DT Evidence_NNP -_HYPH Based_VBN Pro_NNP Se_NNP Competency_NNP Standard_NNP ._. Journal_NNP of_IN the_DT American_NNP Academy_NNP of_IN Psychiatry_NNP and_CC the_DT Law_NNP ,_, 39:565-70_CD ,_, 2011_CD ._. Knoll_NNP JL_NNP ,_, Leonard_NNP C_NNP ,_, Kaufman_NNP AR_NNP ,_, Way_NNP BB_NNP :_: A_DT Pilot_NNP Survey_NNP of_IN Trial_NNP Court_NNP Judges_NNS ’_POS Opinions_NNPS on_IN Pro_NNP Se_NNP Competence_NNP after_IN Indiana_NNP v._NNP Edwards_NNP ._. Journal_NNP of_IN the_DT American_NNP Academy_NNP of_IN Psychiatry_NNP and_CC the_DT Law_NNP ,_, 38:536-9_CD ,_, 2010_CD ._. Kaufman_NNP AR_NNP ,_, Way_NN B_NN :_: North_NNP Carolina_NNP Resident_NN Psychiatrists_NNS Knowledge_NN of_IN the_DT Commitment_NN Statutes_NNS :_: Do_VBP They_PRP Stray_VB from_IN the_DT Legal_JJ Standard_NNP in_IN the_DT Hypothetical_JJ Application_NN of_IN Involuntary_JJ Commitment_NN Criteria_NNS ?_. Psychiatric_NNP Quarterly_NNP ,_, 2010_CD ;_: 81_CD (_-LRB- 4_CD )_-RRB- :_: p.363_CD ._. Kaufman_NNP ,_, AR_NNP :_: More_JJR on_IN DSM_NNP -_, 5_CD :_: Will_MD “_`` Cross_NNP -_HYPH Cutting_VBG ”_'' Butcher_NNP Clinical_NNP Psychiatry_NNP ._. Correctional_JJ Mental_NNP Health_NNP Report_NN ,_, 2010_CD ;_: 12_CD (_-LRB- 2_CD )_-RRB- :_: p._NN 21_CD ._. Kaufman_NNP AR_NNP :_: Are_VBP Psychiatrists_NNS Lexa_NNP -_HYPH Professionals_NNS ?_. Correctional_JJ Mental_NNP Health_NNP Report_NN ,_, 2010_CD ;_: 11_CD (_-LRB- 5_CD )_-RRB- :_: p._NN 71_CD Kaufman_NNP AR_NNP :_: Should_MD We_PRP Use_VB Law_NN Enforcement_NN for_IN Emergency_NN Transportation_NN of_IN People_NNS With_IN Mental_JJ Illness_NN ?_. American_NNP Journal_NNP of_IN Psychiatry_NNP 2007_CD ;_: 164(3_CD )_-RRB- :_: Residents_NNS ’_POS Journal_NN p._NN 3_CD In_IN this_DT interview_NN with_IN Spiro_NNP Skouras_NNP ,_, you_PRP will_MD most_RBS likely_RB learn_VB things_NNS you_PRP have_VBP never_RB heard_VBN before_RB about_IN the_DT COVID_NN -_HYPH 19_CD pandemic_NN ._. Dr._NNP Kaufman_NNP will_MD explain_VB why_WRB this_DT is_VBZ all_RB planned_VBN ,_, and_CC is_VBZ not_RB really_RB about_IN a_DT dangerous_JJ virus_NN at_IN all_DT ,_, but_CC a_DT way_NN to_TO control_VB people_NNS ’s_POS lives_NNS ._. He_PRP will_MD explain_VB things_NNS about_IN the_DT new_JJ type_NN of_IN vaccine_NN they_PRP are_VBP rushing_VBG so_RB fast_RB to_TO develop_VB ,_, and_CC what_WP he_PRP believes_VBZ is_VBZ the_DT real_JJ objective_NN for_IN this_DT vaccine_NN ._. Dr._NNP Kaufman_NNP has_VBZ already_RB paid_VBN a_DT steep_JJ price_NN to_TO be_VB a_DT whistle_NN blower_NN ,_, and_CC he_PRP only_RB expects_VBZ it_PRP to_TO get_VB worse_JJR ._. This_DT is_VBZ the_DT only_JJ important_JJ thing_NN for_IN me_PRP to_TO do_VB now_RB ,_, is_VBZ to_TO get_VB this_DT information_NN out_RP ,_, so_IN that_IN we_PRP can_MD prevent_VB ourselves_PRP from_IN living_VBG in_IN a_DT horrible_JJ ,_, horrible_JJ future_NN ._. I_PRP have_VBP two_CD young_JJ children_NNS ,_, and_CC they_PRP are_VBP my_PRP$ main_JJ motivating_JJ factor_NN ,_, that_IN I_PRP do_VBP n’t_RB want_VB them_PRP to_TO live_VB in_IN a_DT world_NN where_WRB they_PRP have_VBP no_DT freedom_NN ._. And_CC that_DT ’s_VBZ where_WRB we_PRP ’re_VBP heading_VBG right_RB now_RB ._. And_CC so_RB whatever_WDT risks_NNS there_EX are_VBP ,_, they_PRP ’re_VBP risks_NNS that_WDT I_PRP simply_RB have_VBP to_TO take_VB ._. That_DT ’s_VBZ why_WRB I_PRP am_VBP doing_VBG what_WP I_PRP am_VBP doing_VBG ._. There_EX have_VBP been_VBN things_NNS that_WDT have_VBP occurred_VBN ._. I_PRP have_VBP had_VBN consequences_NNS ._. I_PRP was_VBD let_VBN go_VB from_IN my_PRP$ regular_JJ psychiatry_NN job_NN because_IN I_PRP refused_VBD to_TO wear_VB a_DT mask_NN ._. I_PRP have_VBP had_VBN several_JJ friends_NNS who_WP are_VBP doctors_NNS or_CC other_JJ health_NN care_NN professionals_NNS who_WP have_VBP been_VBN very_RB upset_JJ with_IN me_PRP ._. (_-LRB- They_PRP ’re_VBP )_-RRB- disappointed_VBN and_CC wo_MD n’t_RB talk_VB to_IN me_PRP anymore_RB ._. I_PRP knew_VBD that_IN those_DT risks_NNS were_VBD part_NN of_IN this_DT ._. But_CC that_DT ’s_VBZ not_RB what_WP ’s_VBZ important_JJ ._. I_PRP ’ll_MD tell_VB you_PRP that_IN I_PRP would_MD be_VB happy_JJ to_TO risk_VB being_VBG taken_VBN to_IN jail_NN as_RB well_RB ,_, because_IN I_PRP ’m_VBP not_RB going_VBG to_TO participate_VB in_IN any_DT of_IN these_DT measures_NNS ._. I_PRP respect_VBP other_JJ people_NNS ’s_POS rights_NNS to_TO make_VB their_PRP$ own_JJ choices_NNS ._. So_RB I_PRP do_VBP n’t_RB go_VB and_CC get_VB in_IN people_NNS ’s_POS faces_NNS ._. But_CC if_IN anyone_NN is_VBZ willing_JJ to_TO make_VB eye_NN contact_NN and_CC interact_VB with_IN me_PRP ,_, I_PRP do_VBP n’t_RB observe_VB any_DT social_JJ distancing_NN ,_, (_-LRB- and_CC so_RB )_-RRB- any_DT opportunity_NN to_TO hug_VB someone_NN ,_, especially_RB in_IN public_NN ,_, I_PRP always_RB take_VBP advantage_NN of_IN that_DT ,_, because_IN I_PRP want_VBP to_TO show_VB people_NNS that_IN actually_RB all_DT of_IN these_DT measures_NNS are_VBP really_RB voluntary_JJ ._. Even_RB Governor_NNP Cuomo_NNP has_VBZ made_VBN a_DT public_JJ statement_NN that_IN there_EX ’s_VBZ nothing_NN that_WDT they_PRP can_MD do_VB to_TO enforce_VB any_DT of_IN these_DT measures_NNS and_CC that_IN they_PRP are_VBP voluntary_JJ ._. And_CC I_PRP would_MD like_VB to_TO encourage_VB other_JJ people_NNS to_TO make_VB that_DT decision_NN ,_, because_IN if_IN we_PRP rely_VBP on_IN the_DT authority_NN to_TO give_VB us_PRP approval_NN of_IN how_WRB to_TO exercise_VB our_PRP$ freedom_NN ,_, they_PRP ’re_VBP going_VBG to_TO take_VB more_JJR freedoms_NNS away_RB ,_, as_IN they_PRP ’ve_VBP been_VBN doing_VBG ._. So_RB while_IN I_PRP respect_VBP people_NNS that_WDT to_TO go_VB and_CC protest_VB at_IN the_DT City_NNP Hall_NNP or_CC State_NNP Capital_NNP ,_, they_PRP are_VBP coming_VBG from_IN the_DT right_JJ point_NN of_IN view_NN ,_, they_PRP ’re_VBP just_RB asking_VBG the_DT authority_NN figures_NNS ,_, the_DT government_NN ,_, to_TO give_VB them_PRP permission_NN ,_, when_WRB they_PRP do_VBP n’t_RB need_VB permission_NN from_IN the_DT government_NN ._. They_PRP already_RB have_VBP permission_NN because_IN they_PRP have_VBP inalienable_JJ rights_NNS ._. It_PRP ’s_VBZ not_RB really_RB a_DT decision_NN for_IN me_PRP ._. It_PRP ’s_VBZ just_RB what_WP I_PRP feel_VBP that_IN I_PRP have_VBP to_TO do_VB to_TO preserve_VB the_DT way_NN of_IN life_NN that_WDT I_PRP want_VBP to_TO live_VB for_IN me_PRP and_CC my_PRP$ children_NNS ._. At_IN the_DT time_NN of_IN this_DT publication_NN ,_, this_DT interview_NN has_VBZ been_VBN viewed_VBN just_RB over_RB 15,000_CD times_NNS ._. It_PRP needs_VBZ to_TO be_VB MILLIONS_NNS !_. Please_UH watch_VB and_CC share_VB this_DT information_NN that_WDT they_PRP are_VBP trying_VBG so_RB hard_RB to_TO censor_VB ._.","NNP NNP NNP may VB the RBS VBN NN in the NNP RB RB . His NNS VBP VBN and VBN from NNP RB RB . NNP NNP VBZ RB JJ , and RB JJ , that the “ JJ ” NN and JJ NNS RB VBP him and his NN , and they VBP VBG NN in their NN to VB him . This NN ( RB ) he VBD with NNP NNP , for NN , VBD RB VBN from NNP , although NNP ’s JJ NNS VBP for the JJS NN ( for RB ) . NNP NNP VBZ a JJ NN . RB VBZ his JJ NN from his NN : He VBD his JJ NN at NNP NNP NNP NNP after VBG from the NNP NNP of NNP NNP , and VBZ a NN from NNP in NNP NNP . He VBZ VBN and VBN JJ NN and VBN , VBN , and VBN JJ NNS , NNS , and NNS in all JJ NNS . He VBZ VBN VBN as an NN NN in JJ , NN , and JJ NNS . He VBZ VBN NN NNS in JJ NN and JJ NNS . He VBD a NN - up NN to VB a JJ NN he VBD and VBD . NNP NNP of NNP NNP , NNP of NNP NNP NNP of NNP , NNP in NNP NNP NNP of NNP and NNP NNP NNP in NNP and NNP NNP ( 2011 ) NNP NNP NNP NNP , NNP in NNP NNP NNP NNP NNP of NNP , NNP in NNP NNP NNP and NNP NNP . NN in JJ NNS : NN , NN NN , and NN . NNS and NNP of NNP NNP VBN by NNP NNP , JJ NN , 2017 . NN NNP , NNP NNP , NNP NN , NNP , NN : JJ NN among NN - NNS in NN NN : NN , NN to VB , and NN NNS . NNP NNP and the NNP , 31 ( 2 ) : 230-8 , 2013 . NNP NNP , NNP NNP , NNP NNP : Forty NNS after NNP NNP NNP . NNPS ’ NN with “ JJ NN of NN ” NN . NNP of the NNP NNP of NNP and the NNP , 40:261-5 , 2012 . NNP NNP , NNP NNP , NNP NNP , NNP NNP , NNP NNP : NN of NNP NNP NNP NNS on NNP NNP NN After NNP NNP NNP : Towards an NNP - VBN NNP NNP NNP NNP . NNP of the NNP NNP of NNP and the NNP , 39:565-70 , 2011 . NNP NNP , NNP NNP , NNP NNP , NNP NNP : A NNP NNP of NNP NNP NNS ’ NNPS on NNP NNP NNP after NNP NNP NNP . NNP of the NNP NNP of NNP and the NNP , 38:536-9 , 2010 . NNP NNP , NN NN : NNP NNP NN NNS NN of the NN NNS : VBP They VB from the JJ NNP in the JJ NN of JJ NN NNS ? NNP NNP , 2010 ; 81 ( 4 ) : p.363 . NNP , NNP : JJR on NNP - 5 : Will “ NNP - VBG ” NNP NNP NNP . JJ NNP NNP NN , 2010 ; 12 ( 2 ) : NN 21 . NNP NNP : VBP NNS NNP - NNS ? JJ NNP NNP NN , 2010 ; 11 ( 5 ) : NN 71 NNP NNP : Should We VB NN NN for NN NN of NNS With JJ NN ? NNP NNP of NNP 2007 ; 164(3 ) : NNS ’ NN NN 3 In this NN with NNP NNP , you will RBS RB VB NNS you VBP RB VBN RB about the NN - 19 NN . NNP NNP will VB why this VBZ RB VBN , and VBZ RB RB about a JJ NN at all , but a NN to VB NNS ’s NNS . He will VB NNS about the JJ NN of NN they VBP VBG RB RB to VB , and what he VBZ VBZ the JJ NN for this NN . NNP NNP VBZ RB VBN a JJ NN to VB a NN NN , and he RB VBZ it to VB JJR . This VBZ the JJ JJ NN for me to VB RB , VBZ to VB this NN out , so that we can VB ourselves from VBG in a JJ , JJ NN . I VBP two JJ NNS , and they VBP my JJ JJ NN , that I VBP RB VB them to VB in a NN where they VBP no NN . And that VBZ where we VBP VBG RB RB . And RB whatever NNS there VBP , they VBP NNS that I RB VBP to VB . That VBZ why I VBP VBG what I VBP VBG . There VBP VBN NNS that VBP VBN . I VBP VBN NNS . I VBD VBN VB from my JJ NN NN because I VBD to VB a NN . I VBP VBN JJ NNS who VBP NNS or JJ NN NN NNS who VBP VBN RB JJ with me . ( They VBP ) VBN and wo RB VB to me RB . I VBD that those NNS VBD NN of this . But that VBZ RB what VBZ JJ . I ’ll VB you that I would VB JJ to VB VBG VBN to NN RB RB , because I VBP RB VBG to VB in any of these NNS . I VBP JJ NNS ’s NNS to VB their JJ NNS . RB I VBP RB VB and VB in NNS ’s NNS . But if NN VBZ JJ to VB NN NN and VB with me , I VBP RB VB any JJ NN , ( and RB ) any NN to VB NN , RB in NN , I RB VBP NN of that , because I VBP to VB NNS that RB all of these NNS VBP RB JJ . RB NNP NNP VBZ VBN a JJ NN that there VBZ NN that they can VB to VB any of these NNS and that they VBP JJ . And I would VB to VB JJ NNS to VB that NN , because if we VBP on the NN to VB us NN of how to VB our NN , they VBP VBG to VB JJR NNS RB , as they VBP VBN VBG . RB while I VBP NNS that to VB and VB at the NNP NNP or NNP NNP , they VBP VBG from the JJ NN of NN , they VBP RB VBG the NN NNS , the NN , to VB them NN , when they VBP RB VB NN from the NN . They RB VBP NN because they VBP JJ NNS . It VBZ RB RB a NN for me . It VBZ RB what I VBP that I VBP to VB to VB the NN of NN that I VBP to VB for me and my NNS . At the NN of this NN , this NN VBZ VBN VBN RB RB 15,000 NNS . It VBZ to VB NNS ! Please VB and VB this NN that they VBP VBG RB RB to VB ."
264,1051,mainstream,"European_NNP Commission_NNP President_NNP Ursula_NNP von_NNP der_NNP Leyen_NNP holds_VBZ a_DT press_NN conference_NN on_IN the_DT EU_NNP response_NN to_IN the_DT COVID_NNP -_HYPH 19_CD crisis_NN at_IN the_DT EU_NNP headquarters_NN in_IN Brussels_NNP on_IN April_NNP 15_CD ,_, 2020_CD ._. Celebrities_NNS ,_, world_NN leaders_NNS and_CC philanthropists_NNS pledged_VBD some_DT 7.4_CD billion_CD euros_NNS (_-LRB- $_$ 8.1_CD billion_CD )_-RRB- on_IN Monday_NNP for_IN research_NN into_IN coronavirus_NN vaccines_NNS ,_, treatments_NNS and_CC testing_NN during_IN an_DT EU_NNP -_HYPH led_VBN videoconference_NN that_WDT was_VBD snubbed_VBN by_IN the_DT United_NNP States_NNPS ._. European_NNP Commission_NNP chief_NN Ursula_NNP von_NNP der_NNP Leyen_NNP ,_, who_WP hosted_VBD the_DT conference_NN ,_, said_VBD a_DT vaccine_NN was_VBD the_DT best_JJS chance_NN of_IN beating_VBG the_DT COVID_NN -_HYPH 19_CD disease_NN ,_, which_WDT has_VBZ so_RB far_RB killed_VBN nearly_RB a_DT quarter_NN of_IN a_DT million_CD people_NNS around_IN the_DT world_NN --_, 140,000_CD of_IN them_PRP in_IN Europe_NNP ._. Major_JJ European_JJ powers_NNS ,_, along_IN with_IN Japan_NNP and_CC Canada_NNP ,_, made_VBD the_DT biggest_JJS pledges_NNS but_CC the_DT lack_NN of_IN US_NNP representation_NN raised_VBD the_DT prospect_NN of_IN an_DT uncoordinated_JJ competition_NN to_TO develop_VB and_CC produce_VB a_DT vaccine_NN ._. Some_DT wealthy_JJ American_JJ individuals_NNS did_VBD take_VB part_NN ,_, and_CC pop_NN star_NN Madonna_NNP 's_POS million_CD -_HYPH dollar_NN contribution_NN was_VBD feted_VBN by_IN EU_NNP officials_NNS ._. The_DT conference_NN narrowly_RB missed_VBD its_PRP$ target_NN of_IN 7.5_CD billion_CD euros_NNS --_, although_IN a_DT handful_NN of_IN contributors_NNS did_VBD not_RB put_VB a_DT sum_NN on_IN their_PRP$ pledges_NNS --_, but_CC UN_NNP chief_NN Antonio_NNP Guterres_NNP warned_VBD that_IN much_RB more_JJR would_MD be_VB needed_VBN ,_, putting_VBG the_DT final_JJ sum_NN required_VBN near_IN 38_CD billion_CD euros_NNS ._. ""_`` These_DT funds_NNS are_VBP a_DT kind_NN of_IN down_JJ payment_NN for_IN the_DT development_NN of_IN new_JJ tools_NNS at_IN the_DT speed_NN needed_VBN ,_, ""_'' Guterres_NNP told_VBD the_DT conference_NN ._. ""_`` But_CC to_TO reach_VB everyone_NN everywhere_RB we_PRP likely_RB need_VBP five_CD times_NNS that_DT amount_NN ._. ""_'' Nonetheless_RB ,_, World_NNP Health_NNP Organization_NNP chief_NN Tedros_NNP Adhanom_NNP Ghebreyesus_NNP hailed_VBD the_DT fundraising_NN as_IN a_DT powerful_JJ show_NN of_IN ""_`` global_JJ solidarity_NN ""_'' ._. The_DT donations_NNS came_VBD from_IN around_RB 40_CD countries_NNS ,_, the_DT UN_NNP ,_, research_NN institutes_NNS and_CC philanthropic_JJ bodies_NNS including_VBG the_DT Bill_NNP and_CC Melinda_NNP Gates_NNP Foundation_NNP ._. But_CC the_DT initiative_NN was_VBD undermined_VBN by_IN the_DT absence_NN of_IN the_DT United_NNP States_NNPS ,_, with_IN President_NNP Donald_NNP Trump_NNP at_IN loggerheads_NNS with_IN the_DT WHO_NNP over_IN its_PRP$ handling_NN of_IN the_DT pandemic_NN ._. Trump_NNP --_, fighting_VBG for_IN reelection_NN in_IN November_NNP --_, said_VBD on_IN Sunday_NNP the_DT United_NNP States_NNPS would_MD have_VB a_DT coronavirus_NN vaccine_NN ready_JJ by_IN the_DT end_NN of_IN the_DT year_NN ._. His_PRP$ prediction_NN was_VBD met_VBN with_IN scepticism_NN in_IN some_DT quarters_NNS ,_, with_IN Germany_NNP 's_POS Health_NNP Minister_NNP Jens_NNP Spahn_NNP warning_VBG it_PRP could_MD take_VB years_NNS for_IN anyone_NN to_TO develop_VB a_DT vaccine_NN ._. While_IN putting_VBG an_DT upbeat_JJ gloss_NN on_IN the_DT event_NN in_IN public_NN ,_, privately_RB EU_NNP officials_NNS were_VBD disappointed_VBN the_DT US_NNP did_VBD not_RB take_VB part_NN ._. ""_`` The_DT EU_NNP responded_VBD favourably_RB to_IN a_DT call_NN for_IN global_JJ action_NN ,_, the_DT US_NNP refused_VBD ._. They_PRP are_VBP the_DT ones_NNS who_WP are_VBP isolating_VBG themselves_PRP ,_, ""_'' one_CD official_NN said_VBD ._. ""_`` We_PRP 're_VBP only_RB at_IN the_DT start_NN of_IN the_DT process_NN ._. We_PRP hope_VBP the_DT American_JJ government_NN will_MD join_VB the_DT common_JJ effort_NN ._. ""_'' A_DT senior_JJ US_NNP official_NN said_VBD Washington_NNP welcomed_VBD the_DT telethon_NN effort_NN but_CC insisted_VBD many_JJ of_IN the_DT organisations_NNS making_VBG pledges_NNS had_VBD already_RB received_VBN substantial_JJ American_JJ support_NN ._. Pressed_VBN on_IN why_WRB the_DT United_NNP States_NNPS was_VBD staying_VBG away_RB ,_, the_DT official_NN called_VBD the_DT EU_NNP event_NN ""_`` one_CD of_IN many_JJ ""_'' and_CC said_VBD Washington_NNP was_VBD ""_`` at_IN the_DT forefront_NN of_IN those_DT international_JJ efforts_NNS ""_'' ._. But_CC other_JJ leaders_NNS are_VBP concerned_VBN that_IN Trump_NNP 's_POS ""_`` America_NNP First_JJ ""_'' approach_NN could_MD lead_VB to_IN a_DT counterproductive_JJ transatlantic_JJ race_NN to_TO find_VB a_DT vaccine_NN and_CC called_VBD instead_RB for_IN a_DT collaborative_JJ approach_NN ._. While_IN British_JJ Prime_NNP Minister_NNP Boris_NNP Johnson_NNP said_VBD the_DT world_NN ""_`` must_MD work_VB together_RB to_TO build_VB an_DT impregnable_JJ shield_NN around_IN all_PDT our_PRP$ people_NNS ""_'' ,_, his_PRP$ Japanese_JJ counterpart_NN Shinzo_NNP Abe_NNP urged_VBD the_DT international_JJ community_NN to_TO ""_`` unite_VB to_TO overcome_VB the_DT crisis_NN ""_'' ._. French_JJ President_NNP Emmanuel_NNP Macron_NNP said_VBD it_PRP was_VBD vital_JJ that_IN once_IN a_DT vaccine_NN has_VBZ been_VBN developed_VBN ,_, it_PRP is_VBZ treated_VBN as_IN ""_`` global_JJ public_JJ property_NN ""_'' with_IN access_NN available_JJ for_IN ""_`` the_DT whole_NN of_IN the_DT planet_NN ""_'' ._. In_IN March_NNP ,_, Germany_NNP was_VBD forced_VBN to_TO insist_VB that_IN the_DT rights_NNS to_IN coronavirus_NN vaccine_NN research_NN were_VBD not_RB for_IN sale_NN after_IN reports_NNS Trump_NNP wanted_VBD the_DT US_NNP to_TO buy_VB exclusive_JJ access_NN to_IN one_CD being_VBG developed_VBN by_IN a_DT German_JJ biotech_NN firm_NN ._. In_IN recent_JJ days_NNS the_DT Trump_NNP administration_NN has_VBZ stepped_VBN up_RP pressure_NN on_IN China_NNP ,_, where_WRB the_DT outbreak_NN began_VBD ,_, claiming_VBG it_PRP originated_VBD in_IN a_DT laboratory_NN in_IN the_DT city_NN of_IN Wuhan_NNP ._. Without_IN mentioning_VBG Washington_NNP ,_, China_NNP implicitly_RB hit_VBD back_RB at_IN the_DT donor_NN conference_NN ,_, where_WRB it_PRP was_VBD represented_VBN by_IN its_PRP$ ambassador_NN to_IN the_DT EU_NNP ._. ""_`` Multilateral_JJ cooperation_NN in_IN fighting_VBG the_DT virus_NN ,_, confidence_NN and_CC solidarity_NN are_VBP much_RB more_RBR valuable_JJ than_IN gold_NN ,_, ""_'' ambassador_NN Zhang_NNP Ming_NNP said_VBD ._. ""_`` Panic_NN and_CC blame_VB game_NN are_VBP not_RB useful_JJ at_IN all_DT ._. ""_'' Isabelle_NNP Marchais_NNP of_IN the_DT Delors_NNP Institute_NNP thinktank_NN said_VBD the_DT US_NNP was_VBD ready_JJ to_TO ""_`` put_VB all_PDT its_PRP$ forces_NNS into_IN the_DT battle_NN ""_'' to_TO win_VB a_DT ""_`` vaccine_NN war_NN ""_'' ._. In_IN an_DT analysis_NN published_VBN Monday_NNP ,_, she_PRP said_VBD more_JJR than_IN 100_CD vaccine_NN research_NN projects_NNS were_VBD going_VBG on_RP ,_, including_VBG eight_CD clinical_JJ trials_NNS in_IN the_DT US_NNP ,_, China_NNP and_CC Europe_NNP ._. ""_`` Given_VBN the_DT stakes_NNS in_IN the_DT current_JJ pandemic_NN ,_, some_DT companies_NNS --_, particularly_RB American_JJ and_CC Chinese_JJ ones_NNS --_, are_VBP ready_JJ to_TO start_VB production_NN before_IN the_DT end_NN of_IN clinical_JJ trials_NNS in_IN order_NN to_TO be_VB the_DT first_JJ ones_NNS to_TO get_VB the_DT vaccine_NN to_IN market_NN ,_, ""_'' she_PRP wrote_VBD ._. Of_IN the_DT 7.5_CD billion_CD euros_NNS ,_, four_CD billion_CD will_MD go_VB on_IN vaccine_NN development_NN ,_, two_CD billion_CD on_IN the_DT search_NN for_IN a_DT treatment_NN and_CC 1.5_CD billion_CD for_IN producing_VBG tests_NNS ,_, the_DT EU_NNP said_VBD ._.","NNP NNP NNP NNP NNP NNP NNP VBZ a NN NN on the NNP NN to the NNP - 19 NN at the NNP NN in NNP on NNP 15 , 2020 . NNS , NN NNS and NNS VBD some 7.4 billion NNS ( $ 8.1 billion ) on NNP for NN into NN NNS , NNS and NN during an NNP - VBN NN that VBD VBN by the NNP NNPS . NNP NNP NN NNP NNP NNP NNP , who VBD the NN , VBD a NN VBD the JJS NN of VBG the NN - 19 NN , which VBZ RB RB VBN RB a NN of a million NNS around the NN -- 140,000 of them in NNP . JJ JJ NNS , along with NNP and NNP , VBD the JJS NNS but the NN of NNP NN VBD the NN of an JJ NN to VB and VB a NN . Some JJ JJ NNS VBD VB NN , and NN NN NNP 's million - NN NN VBD VBN by NNP NNS . The NN RB VBD its NN of 7.5 billion NNS -- although a NN of NNS VBD RB VB a NN on their NNS -- but NNP NN NNP NNP VBD that RB JJR would VB VBN , VBG the JJ NN VBN near 38 billion NNS . "" These NNS VBP a NN of JJ NN for the NN of JJ NNS at the NN VBN , "" NNP VBD the NN . "" But to VB NN RB we RB VBP five NNS that NN . "" RB , NNP NNP NNP NN NNP NNP NNP VBD the NN as a JJ NN of "" JJ NN "" . The NNS VBD from RB 40 NNS , the NNP , NN NNS and JJ NNS VBG the NNP and NNP NNP NNP . But the NN VBD VBN by the NN of the NNP NNPS , with NNP NNP NNP at NNS with the NNP over its NN of the NN . NNP -- VBG for NN in NNP -- VBD on NNP the NNP NNPS would VB a NN NN JJ by the NN of the NN . His NN VBD VBN with NN in some NNS , with NNP 's NNP NNP NNP NNP VBG it could VB NNS for NN to VB a NN . While VBG an JJ NN on the NN in NN , RB NNP NNS VBD VBN the NNP VBD RB VB NN . "" The NNP VBD RB to a NN for JJ NN , the NNP VBD . They VBP the NNS who VBP VBG themselves , "" one NN VBD . "" We VBP RB at the NN of the NN . We VBP the JJ NN will VB the JJ NN . "" A JJ NNP NN VBD NNP VBD the NN NN but VBD JJ of the NNS VBG NNS VBD RB VBN JJ JJ NN . VBN on why the NNP NNPS VBD VBG RB , the NN VBD the NNP NN "" one of JJ "" and VBD NNP VBD "" at the NN of those JJ NNS "" . But JJ NNS VBP VBN that NNP 's "" NNP JJ "" NN could VB to a JJ JJ NN to VB a NN and VBD RB for a JJ NN . While JJ NNP NNP NNP NNP VBD the NN "" must VB RB to VB an JJ NN around all our NNS "" , his JJ NN NNP NNP VBD the JJ NN to "" VB to VB the NN "" . JJ NNP NNP NNP VBD it VBD JJ that once a NN VBZ VBN VBN , it VBZ VBN as "" JJ JJ NN "" with NN JJ for "" the NN of the NN "" . In NNP , NNP VBD VBN to VB that the NNS to NN NN NN VBD RB for NN after NNS NNP VBD the NNP to VB JJ NN to one VBG VBN by a JJ NN NN . In JJ NNS the NNP NN VBZ VBN up NN on NNP , where the NN VBD , VBG it VBD in a NN in the NN of NNP . Without VBG NNP , NNP RB VBD RB at the NN NN , where it VBD VBN by its NN to the NNP . "" JJ NN in VBG the NN , NN and NN VBP RB RBR JJ than NN , "" NN NNP NNP VBD . "" NN and VB NN VBP RB JJ at all . "" NNP NNP of the NNP NNP NN VBD the NNP VBD JJ to "" VB all its NNS into the NN "" to VB a "" NN NN "" . In an NN VBN NNP , she VBD JJR than 100 NN NN NNS VBD VBG on , VBG eight JJ NNS in the NNP , NNP and NNP . "" VBN the NNS in the JJ NN , some NNS -- RB JJ and JJ NNS -- VBP JJ to VB NN before the NN of JJ NNS in NN to VB the JJ NNS to VB the NN to NN , "" she VBD . Of the 7.5 billion NNS , four billion will VB on NN NN , two billion on the NN for a NN and 1.5 billion for VBG NNS , the NNP VBD ."
265,483,conspiracy,"Whether_IN this_DT seasons_NNS swine_NN flu_NN turns_VBZ out_RP to_TO be_VB deadly_JJ or_CC mild_JJ ,_, most_JJS experts_NNS agree_VBP that_IN its_NNS only_RB a_DT matter_NN of_IN time_NN before_IN were_NN hit_VBN by_IN a_DT truly_RB devastating_JJ flu_NN pandemicone_NN that_WDT might_MD kill_VB more_JJR people_NNS worldwide_RB than_IN have_VBP died_VBN of_IN the_DT plague_NN and_CC aids_NNS combined_VBN ._. In_IN the_DT U.S._NNP ,_, the_DT main_JJ lines_NNS of_IN defense_NN are_VBP pharmaceutical_JJ vaccines_NNS and_CC antiviral_JJ drugs_NNS to_TO limit_VB the_DT spread_NN of_IN flu_NN and_CC prevent_VB people_NNS from_IN dying_VBG from_IN it_PRP ._. Yet_CC now_RB some_DT flu_NN experts_NNS are_VBP challenging_VBG the_DT medical_JJ orthodoxy_NN and_CC arguing_VBG that_IN for_IN those_DT most_RBS in_IN need_NN of_IN protection_NN ,_, flu_NN shots_NNS and_CC antiviral_JJ drugs_NNS may_MD provide_VB little_JJ to_IN none_NN ._. So_RB where_WRB does_VBZ that_DT leave_VB us_PRP if_IN a_DT bad_JJ pandemic_NN strikes_VBZ ?_. Drive_VB too_RB fast_RB along_IN Red_NNP Lion_NNP Road_NNP ,_, beside_IN Philadelphias_NNP Northeast_NNP Airport_NNP ,_, and_CC you_PRP will_MD miss_VB the_DT low_JJ -_HYPH rise_NN cement_NN building_NN where_WRB the_DT biotech_NN company_NN MedImmune_NNP has_VBZ been_VBN quietly_RB pumping_VBG out_RP swine_NN flu_NN vaccine_NN at_IN about_RB a_DT million_CD doses_NNS a_DT week_NN ._. Through_IN the_DT summer_NN and_CC fall_NN ,_, workers_NNS wearing_VBG protective_JJ gear_NN that_WDT covered_VBD them_PRP from_IN head_NN to_TO toe_NN brewed_VBD up_RP batches_NNS of_IN live_JJ ,_, genetically_RB modified_VBN flu_NN virus_NN ._. Robots_NNS then_RB injected_VBD tiny_JJ doses_NNS of_IN virus_NN -_HYPH laden_JJ fluid_NN into_IN glass_NN vials_NNS ,_, which_WDT were_VBD mounted_VBN into_IN nasal_JJ spritzers_NNS ,_, labeled_VBN ,_, and_CC readied_VBD for_IN shipment_NN at_IN the_DT direction_NN of_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ,_, in_IN Atlanta_NNP ,_, which_WDT is_VBZ helping_VBG to_TO coordinate_VB the_DT nations_NNS pandemic_NN -_HYPH preparedness_NN plan_NN ._. In_IN the_DT most_RBS ambitious_JJ vaccination_NN program_NN the_DT nation_NN has_VBZ mounted_VBN since_IN the_DT anti-polio_JJ campaign_NN in_IN the_DT 1950s_NNS ,_, the_DT federal_JJ government_NN has_VBZ commissioned_VBN MedImmune_NNP and_CC four_CD other_JJ companies_NNS to_TO produce_VB enough_JJ vaccine_NN to_TO cover_VB the_DT entire_JJ U.S._NNP population_NN ._. Vaccination_NN is_VBZ central_JJ to_IN the_DT governments_NNS plan_NN for_IN preventing_VBG deaths_NNS from_IN swine_NN flu_NN ._. The_DT CDC_NNP has_VBZ recommended_VBN that_IN some_DT 159_CD million_CD adults_NNS and_CC children_NNS receive_VBP either_CC a_DT swine_NN flu_NN shot_NN or_CC a_DT dose_NN of_IN MedImmunes_NNPS nasal_JJ vaccine_NN this_DT year_NN ._. Shots_NNS are_VBP offered_VBN in_IN doctors_NNS _, offices_NNS ,_, hospitals_NNS ,_, airports_NNS ,_, pharmacies_NNS ,_, schools_NNS ,_, polling_NN places_NNS ,_, shopping_NN malls_NNS ,_, and_CC big_JJ -_HYPH box_NN stores_NNS like_IN Wal_NNP -_HYPH Mart_NNP ._. In_IN August_NNP ,_, New_NNP York_NNP state_NN required_VBD all_DT health_NN -_HYPH care_NN workers_NNS to_TO get_VB both_CC seasonal_JJ and_CC swine_NN flu_NN shots_NNS ._. To_TO further_RB protect_VB the_DT populace_NN ,_, the_DT federal_JJ government_NN has_VBZ spent_VBN upwards_JJ of_IN $_$ 3_CD billion_CD stockpiling_VBG millions_NNS of_IN doses_NNS of_IN antiviral_JJ drugs_NNS like_IN Tamiflu_NNP which_NN are_VBP being_VBG used_VBN both_CC to_TO prevent_VB swine_NN flu_NN and_CC to_TO treat_VB those_DT who_WP fall_VBP ill_JJ ._. But_CC what_WP if_IN everything_NN we_PRP think_VBP we_PRP know_VBP about_IN fighting_VBG influenza_NN is_VBZ wrong_JJ ?_. What_WP if_IN flu_NN vaccines_NNS do_VBP not_RB protect_VB people_NNS from_IN dying_VBG particularly_RB the_DT elderly_JJ ,_, who_WP account_VBP for_IN 90_CD percent_NN of_IN deaths_NNS from_IN seasonal_JJ flu_NN ?_. And_CC what_WP if_IN the_DT expensive_JJ antiviral_JJ drugs_NNS that_WDT the_DT government_NN has_VBZ stockpiled_VBN over_IN the_DT past_JJ few_JJ years_NNS also_RB have_VBP little_JJ ,_, if_IN any_DT ,_, power_NN to_TO reduce_VB the_DT number_NN of_IN people_NNS who_WP die_VBP or_CC are_VBP hospitalized_VBN ?_. The_DT U.S._NNP government_NN with_VBZ the_DT support_NN of_IN leaders_NNS in_IN the_DT public_JJ -_HYPH health_NN and_CC medical_JJ communities_NNS has_VBP put_VBN its_PRP$ faith_NN in_IN the_DT power_NN of_IN vaccines_NNS and_CC antiviral_JJ drugs_NNS to_TO limit_VB the_DT spread_NN and_CC lethality_NN of_IN swine_NN flu_NN ._. Other_JJ plans_NNS to_TO contain_VB the_DT pandemic_NN seem_VBP anemic_JJ by_IN comparison_NN ._. Yet_CC some_DT top_JJ flu_NN researchers_NNS are_VBP deeply_RB skeptical_JJ of_IN both_CC flu_NN vaccines_NNS and_CC antivirals_NNS ._. Like_IN the_DT engineers_NNS who_WP warned_VBD for_IN years_NNS about_IN the_DT levees_NNS of_IN New_NNP Orleans_NNP ,_, these_DT experts_NNS caution_VBP that_IN our_PRP$ defenses_NNS may_MD be_VB flawed_VBN ,_, and_CC quite_RB possibly_RB useless_JJ against_IN a_DT truly_RB lethal_JJ flu_NN ._. And_CC that_IN unless_IN we_PRP are_VBP willing_JJ to_TO ask_VB fundamental_JJ questions_NNS about_IN the_DT science_NN behind_IN flu_NN vaccines_NNS and_CC antiviral_JJ drugs_NNS ,_, we_PRP could_MD find_VB ourselves_PRP ,_, in_IN a_DT bad_JJ epidemic_NN ,_, as_RB helpless_JJ as_IN the_DT citizens_NNS of_IN New_NNP Orleans_NNP during_IN Hurricane_NNP Katrina_NNP ._. The_DT term_NN influenza_NN ,_, which_WDT dates_VBZ back_RB to_IN the_DT Middle_NNP Ages_NNPS ,_, is_VBZ taken_VBN from_IN the_DT Italian_JJ word_NN for_IN occult_JJ or_CC astral_JJ influence_NN ._. Then_RB as_IN now_RB ,_, flu_NN seemed_VBD to_TO appear_VB out_IN of_IN nowhere_RB each_DT winter_NN ,_, debilitating_VBG or_CC killing_VBG large_JJ numbers_NNS of_IN people_NNS ,_, only_RB to_TO vanish_VB in_IN the_DT spring_NN ._. Today_NN ,_, seasonal_JJ flu_NN is_VBZ estimated_VBN to_TO kill_VB about_RB 36,000_CD people_NNS in_IN the_DT United_NNP States_NNPS each_DT year_NN ,_, and_CC half_PDT a_DT million_CD worldwide_RB ._. Yet_CC the_DT flu_NN ,_, in_IN many_JJ important_JJ respects_NNS ,_, remains_VBZ mysterious_JJ ._. Determining_VBG how_WRB many_JJ deaths_NNS it_PRP really_RB causes_VBZ ,_, or_CC even_RB who_WP has_VBZ it_PRP ,_, is_VBZ no_DT simple_JJ matter_NN ._. We_PRP think_VBP we_PRP have_VBP the_DT flu_NN anytime_NN we_PRP fall_VBP ill_JJ with_IN an_DT ailment_NN that_WDT brings_VBZ on_RP headache_NN ,_, malaise_NN ,_, fever_NN ,_, coughing_NN ,_, sneezing_NN ,_, and_CC that_DT achy_JJ feeling_NN as_IN if_IN weve_RB been_VBN sleeping_VBG on_IN a_DT bed_NN of_IN rocks_NNS ,_, but_CC researchers_NNS have_VBP found_VBN that_IN at_IN most_JJS half_NN ,_, and_CC perhaps_RB as_RB few_JJ as_IN 7_CD or_CC 8_CD percent_NN ,_, of_IN such_JJ cases_NNS are_VBP actually_RB caused_VBN by_IN an_DT influenza_NN virus_NN in_IN any_DT given_VBN year_NN ._. More_JJR than_IN 200_CD known_VBN viruses_NNS and_CC other_JJ pathogens_NNS can_MD cause_VB the_DT suite_NN of_IN symptoms_NNS known_VBN as_IN influenza_NN -_HYPH like_IN illness_NN ;_, respiratory_JJ syncytial_NN virus_NN ,_, bocavirus_NN ,_, coronavirus_NN ,_, and_CC rhinovirus_NN are_VBP just_RB a_DT few_JJ of_IN the_DT bugs_NNS that_WDT can_MD make_VB a_DT person_NN feel_VB rotten_JJ ._. And_CC depending_VBG on_IN the_DT season_NN ,_, in_IN up_IN to_IN two_CD -_HYPH thirds_NN of_IN the_DT cases_NNS of_IN flu_NN -_HYPH like_JJ illness_NN ,_, no_DT cause_NN at_IN all_DT can_MD be_VB found_VBN ._. Nobody_NN knows_VBZ precisely_RB why_WRB we_PRP are_VBP much_RB more_RBR likely_JJ to_TO catch_VB the_DT flu_NN in_IN the_DT winter_NN months_NNS than_IN at_IN other_JJ times_NNS of_IN the_DT year_NN ._. Perhaps_RB its_NNS because_IN flu_NN viruses_NNS flourish_VBP in_IN cool_JJ temperatures_NNS and_CC are_VBP killed_VBN by_IN exposure_NN to_IN sunlight_NN ._. Or_CC maybe_RB its_NNS because_IN in_IN winter_NN ,_, people_NNS spend_VBP more_JJR time_NN indoors_RB ,_, where_WRB a_DT sneeze_NN or_CC a_DT cough_NN can_MD more_RBR easily_RB spread_VB a_DT virus_NN to_IN others_NNS ._. What_WP is_VBZ certain_JJ is_VBZ that_IN influenza_NN viruses_NNS mutate_VBP with_IN amazing_JJ speed_NN ,_, so_RB each_DT flu_NN season_NN sees_VBZ slightly_RB different_JJ genetic_JJ versions_NNS of_IN the_DT viruses_NNS that_WDT infected_VBD people_NNS the_DT year_NN before_RB ._. Every_DT year_NN ,_, the_DT World_NNP Health_NNP Organization_NNP and_CC the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP collect_VBP data_NNS from_IN 94_CD nations_NNS on_IN the_DT flu_NN viruses_NNS that_WDT circulated_VBD the_DT previous_JJ year_NN ,_, and_CC then_RB make_VBP an_DT educated_VBN guess_NN about_IN which_WDT viruses_NNS are_VBP likely_JJ to_TO circulate_VB in_IN the_DT coming_VBG fall_NN ._. Based_VBN on_IN that_DT information_NN ,_, the_DT U.S._NNP Food_NNP and_CC Drug_NNP Administration_NNP issues_VBZ orders_NNS to_IN manufacturers_NNS in_IN February_NNP for_IN a_DT vaccine_NN that_WDT includes_VBZ the_DT three_CD most_RBS likely_JJ strains_NNS ._. Every_DT once_RB in_IN a_DT while_NN ,_, however_RB ,_, a_DT very_RB different_JJ bug_NN pops_VBZ up_RP and_CC infects_VBZ far_RB more_JJR people_NNS than_IN the_DT normal_JJ seasonal_JJ flu_NN variants_NNS do_VBP ._. It_PRP is_VBZ these_DT novel_JJ viruses_NNS that_WDT are_VBP responsible_JJ for_IN pandemics_NNS ,_, defined_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP as_IN events_NNS that_WDT occur_VBP when_WRB a_JJ new_JJ influenza_NN virus_NN appears_VBZ against_IN which_WDT the_DT human_JJ population_NN has_VBZ no_DT immunity_NN _NN and_CC which_WDT can_MD sweep_VB around_IN the_DT world_NN in_IN a_DT very_RB short_JJ time_NN ._. The_DT worst_JJS flu_NN pandemic_NN in_IN recorded_VBN history_NN was_VBD the_DT _NNP Spanish_JJ flu_NN of_IN 1918_CD _NNP 19_CD ,_, at_IN the_DT end_NN of_IN World_NNP WarI_NNP ._. A_DT third_NN of_IN the_DT worlds_NNS population_NN was_VBD infected_VBN ,_, with_IN at_IN least_JJS 40_CD million_CD and_CC perhaps_RB as_RB many_JJ as_IN 100_CD million_CD people_NNS dying_VBG more_RB than_IN were_VBD killed_VBN in_IN World_NNP Wars_NNPS I_CD and_CC II_CD combined_VBD ._. (_-LRB- Some_DT scholars_NNS suggest_VBP that_IN one_CD reason_NN World_NNP WarI_NNP ended_VBD was_VBD that_IN so_RB many_JJ soldiers_NNS were_VBD sick_JJ or_CC dying_VBG from_IN flu_NN ._. )_-RRB- Since_IN then_RB ,_, two_CD other_JJ flu_NN pandemics_NNS have_VBP occurred_VBN ,_, in_IN 1957_CD and_CC 1968_CD ,_, neither_DT of_IN which_WDT was_VBD particularly_RB lethal_JJ ._. In_IN August_NNP ,_, the_DT Presidents_NNP Council_NNP of_IN Advisors_NNPS on_IN Science_NNP and_CC Technology_NNP projected_VBD that_IN this_DT fall_NN and_CC winter_NN ,_, the_DT swine_NN flu_NN ,_, H1N1_NN ,_, could_MD infect_VB anywhere_RB between_IN one_CD -_HYPH third_NN and_CC one_CD -_HYPH half_NN of_IN the_DT U.S._NNP population_NN and_CC could_MD kill_VB as_RB many_JJ as_IN 90,000_CD Americans_NNPS ,_, two_CD and_CC a_DT half_NN times_NNS the_DT number_NN killed_VBN in_IN a_DT typical_JJ flu_NN season_NN ._. But_CC precisely_RB how_WRB deadly_JJ ,_, or_CC even_RB how_WRB infectious_JJ ,_, this_DT years_NNS H1N1_NN pandemic_NN will_MD turn_VB out_RP to_TO be_VB wont_NN be_VB known_VBN until_IN its_NNS over_RB ._. Most_JJS reports_NNS coming_VBG from_IN the_DT Southern_NNP Hemisphere_NNP in_IN late_JJ August_NNP (_-LRB- the_DT end_NN of_IN winter_NN there_RB )_-RRB- suggested_VBD that_IN the_DT swine_NN flu_NN is_VBZ highly_RB infectious_JJ ,_, but_CC not_RB particularly_RB lethal_JJ ._. For_IN example_NN ,_, Australian_JJ officials_NNS estimated_VBD they_PRP would_MD finish_VB winter_NN with_IN under_IN 1,000_CD swine_NN flu_NN deaths_NNS fewer_RB than_IN the_DT usual_JJ 1,500_CD to_IN 3,000_CD from_IN seasonal_JJ flu_NN ._. Among_IN those_DT who_WP have_VBP died_VBN in_IN the_DT U.S._NNP ,_, about_RB 70_CD percent_NN were_VBD already_RB suffering_VBG from_IN congenital_JJ conditions_NNS like_IN cerebral_JJ palsy_NN or_CC underlying_JJ illnesses_NNS such_JJ as_IN cancer_NN ,_, asthma_NN ,_, or_CC AIDS_NN ,_, which_WDT make_VBP people_NNS more_RBR vulnerable_JJ ._. Public_JJ -_HYPH health_NN officials_NNS consider_VBP vaccine_NN their_PRP$ most_RBS formidable_JJ defense_NN against_IN the_DT pandemicindeed_JJ ,_, against_IN any_DT fluand_NN on_IN the_DT surface_NN ,_, their_PRP$ faith_NN seems_VBZ justified_VBN ._. Vaccines_NNS developed_VBN over_IN the_DT course_NN of_IN the_DT 20th_JJ century_NN slashed_VBD the_DT death_NN rates_NNS of_IN nearly_RB a_DT dozen_CD infectious_JJ diseases_NNS ,_, such_JJ as_IN smallpox_NN and_CC polio_NN ,_, and_CC vaccination_NN became_VBD one_CD of_IN medicines_NNS most_RBS potent_JJ weapons_NNS ._. Influenza_NN virus_NN was_VBD first_RB identified_VBN in_IN the_DT 1930s_NNS ,_, and_CC by_IN the_DT mid-1940s_NNS ,_, researchers_NNS had_VBD produced_VBN a_DT vaccine_NN that_WDT was_VBD given_VBN to_IN soldiers_NNS in_IN World_NNP WarII_NNP ._. The_DT U.S._NNP government_NN got_VBD serious_JJ about_IN promoting_VBG flu_NN vaccine_NN after_IN the_DT 1957_CD flu_NN pandemic_NN brought_VBD home_NN influenzas_NNS continuing_VBG potential_NN to_TO cause_VB widespread_JJ illness_NN and_CC death_NN ._. Today_NN ,_, flu_NN vaccine_NN is_VBZ a_DT staple_NN of_IN public_JJ -_HYPH health_NN policy_NN ;_, in_IN a_DT normal_JJ year_NN ,_, some_DT 100_CD million_CD Americans_NNPS get_VBP vaccinated_VBN ._. But_CC while_IN vaccines_NNS for_IN ,_, say_VB ,_, whooping_VBG cough_NN and_CC polio_NN clearly_RB and_CC dramatically_RB reduced_VBD death_NN rates_NNS from_IN those_DT diseases_NNS ,_, the_DT impact_NN of_IN flu_NN vaccine_NN has_VBZ been_VBN harder_JJR to_TO determine_VB ._. Flu_NN comes_VBZ and_CC goes_VBZ with_IN the_DT seasons_NNS ,_, and_CC often_RB it_PRP does_VBZ not_RB kill_VB people_NNS directly_RB ,_, but_CC rather_RB contributes_VBZ to_IN death_NN by_IN making_VBG the_DT body_NN more_RBR susceptible_JJ to_IN secondary_JJ infections_NNS like_IN pneumonia_NN or_CC bronchitis_NN ._. For_IN this_DT reason_NN ,_, researchers_NNS studying_VBG the_DT impact_NN of_IN flu_NN vaccination_NN typically_RB look_VBP at_IN deaths_NNS from_IN all_DT causes_NNS during_IN flu_NN season_NN ,_, and_CC compare_VBP the_DT vaccinated_VBN and_CC unvaccinated_JJ populations_NNS ._. Such_JJ comparisons_NNS have_VBP shown_VBN a_DT dramatic_JJ difference_NN in_IN mortality_NN between_IN these_DT two_CD groups_NNS :_: study_NN after_IN study_NN has_VBZ found_VBN that_IN people_NNS who_WP get_VBP a_DT flu_NN shot_NN in_IN the_DT fall_NN are_VBP about_RB half_NN as_RB likely_JJ to_TO die_VB that_DT winter_NN from_RB any_DT cause_NN as_IN people_NNS who_WP do_VBP not_RB ._. Get_VB your_PRP$ flu_NN shot_NN each_DT year_NN ,_, the_DT literature_NN suggests_VBZ ,_, and_CC you_PRP will_MD dramatically_RB reduce_VB your_PRP$ chance_NN of_IN dying_VBG during_IN flu_NN season_NN ._. Yet_CC in_IN the_DT view_NN of_IN several_JJ vaccine_NN skeptics_NNS ,_, this_DT claim_NN is_VBZ suspicious_JJ on_IN its_PRP$ face_NN ._. Influenza_NN causes_VBZ only_RB a_DT small_JJ minority_NN of_IN all_DT deaths_NNS in_IN the_DT U.S._NNP ,_, even_RB among_IN senior_JJ citizens_NNS ,_, and_CC even_RB after_IN adding_VBG in_IN the_DT deaths_NNS to_IN which_WDT flu_NN might_MD have_VB contributed_VBN indirectly_RB ._. When_WRB researchers_NNS from_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS included_VBD all_DT deaths_NNS from_IN illnesses_NNS that_WDT flu_NN aggravates_VBZ ,_, like_IN lung_NN disease_NN or_CC chronic_JJ heart_NN failure_NN ,_, they_PRP found_VBD that_IN flu_NN accounts_VBZ for_IN ,_, at_IN most_JJS ,_, 10_CD percent_NN of_IN winter_NN deaths_NNS among_IN the_DT elderly_JJ ._. So_RB how_WRB could_MD flu_NN vaccine_NN possibly_RB reduce_VB total_JJ deaths_NNS by_IN half_NN ?_. Tom_NNP Jefferson_NNP ,_, a_DT physician_NN based_VBN in_IN Rome_NNP and_CC the_DT head_NN of_IN the_DT Vaccines_NNP Field_NNP at_IN the_DT Cochrane_NNP Collaboration_NNP ,_, a_DT highly_RB respected_VBN international_JJ network_NN of_IN researchers_NNS who_WP appraise_VBP medical_JJ evidence_NN ,_, says_VBZ :_: _NFP For_IN a_DT vaccine_NN to_TO reduce_VB mortality_NN by_IN 50_CD percent_NN and_CC up_IN to_IN 90_CD percent_NN in_IN some_DT studies_NNS means_VBZ it_PRP has_VBZ to_TO prevent_VB deaths_NNS not_RB just_RB from_IN influenza_NN ,_, but_CC also_RB from_IN falls_NNS ,_, fires_NNS ,_, heart_NN disease_NN ,_, strokes_NNS ,_, and_CC car_NN accidents_NNS ._. That_DT s_VBZ not_RB a_DT vaccine_NN ,_, that_DT s_VBZ a_DT miracle_NN ._. _NFP The_DT estimate_NN of_IN 50_CD percent_NN mortality_NN reduction_NN is_VBZ based_VBN on_IN cohort_NNP studies_NNS ,_, _NN which_WDT compare_VBP death_NN rates_NNS in_IN large_JJ groups_NNS ,_, or_CC cohorts_NNS ,_, of_IN people_NNS who_WP choose_VBP to_TO be_VB vaccinated_VBN ,_, against_IN death_NN rates_NNS in_IN groups_NNS who_WP dont_VBP ._. But_CC people_NNS who_WP choose_VBP to_TO be_VB vaccinated_VBN may_MD differ_VB in_IN many_JJ important_JJ respects_NNS from_IN people_NNS who_WP go_VBP unvaccinated_JJ and_NN those_DT differences_NNS can_MD influence_VB the_DT chance_NN of_IN death_NN during_IN flu_NN season_NN ._. Education_NN ,_, lifestyle_NN ,_, income_NN ,_, and_CC many_JJ other_JJ confounding_NN _NN factors_NNS can_MD come_VB into_IN play_NN ,_, and_CC as_IN a_DT result_NN ,_, cohort_NN studies_NNS are_VBP notoriously_RB prone_JJ to_IN bias_NN ._. When_WRB researchers_NNS crunch_VBP the_DT numbers_NNS ,_, they_PRP typically_RB try_VBP to_TO factor_VB out_RP variables_NNS that_WDT could_MD bias_VB the_DT results_NNS ,_, but_CC ,_, as_IN Jefferson_NNP remarks_VBZ ,_, _RB you_PRP can_MD adjust_VB for_IN the_DT confounders_NNS you_PRP know_VBP about_IN ,_, not_RB for_IN the_DT ones_NNS you_PRP dont_VBP ,_, _NN and_CC researchers_NNS cant_MD always_RB anticipate_VB what_WDT factors_NNS are_VBP likely_JJ to_TO be_VB important_JJ to_IN whether_IN a_DT patient_NN dies_VBZ from_IN flu_NN ._. There_EX is_VBZ always_RB the_DT chance_NN that_IN they_PRP might_MD miss_VB some_DT critical_JJ confounder_NN that_WDT renders_VBZ their_PRP$ results_NNS entirely_RB wrong_JJ ._. When_WRB Lisa_NNP Jackson_NNP ,_, a_DT physician_NN and_CC senior_JJ investigator_NN with_IN the_DT Group_NNP Health_NNP Research_NNP Center_NNP ,_, in_IN Seattle_NNP ,_, began_VBD wondering_VBG aloud_RB to_IN colleagues_NNS if_IN maybe_RB something_NN was_VBD amiss_JJ with_IN the_DT estimate_NN of_IN 50_CD percent_NN mortality_NN reduction_NN for_IN people_NNS who_WP get_VBP flu_NN vaccine_NN ,_, the_DT response_NN she_PRP got_VBD sounded_VBN more_RBR like_IN doctrine_NN than_IN science_NN ._. _`` People_NNS told_VBD me_PRP ,_, _`` No_DT good_NN can_MD come_VB of_IN [_-LRB- asking_VBG ]_-RRB- this_DT ,_, _UH she_PRP says_VBZ ._. Potentially_RB a_DT lot_NN of_IN bad_JJ could_MD happen_VB for_IN me_PRP professionally_RB by_IN raising_VBG any_DT criticism_NN that_WDT might_MD dissuade_VB people_NNS from_IN getting_VBG vaccinated_VBN ,_, because_IN of_IN course_NN ,_, _`` We_PRP know_VBP that_IN vaccine_NN works_VBZ ._. _NFP This_DT was_VBD the_DT prevailing_JJ wisdom_NN ._. _NFP Nonetheless_RB ,_, in_IN 2004_CD ,_, Jackson_NNP and_CC three_CD colleagues_NNS set_VBD out_RP to_TO determine_VB whether_IN the_DT mortality_NN difference_NN between_IN the_DT vaccinated_VBN and_CC the_DT unvaccinated_JJ might_MD be_VB caused_VBN by_IN a_DT phenomenon_NN known_VBN as_IN the_DT healthy_JJ user_NN effect_NN ._. _NFP They_PRP hypothesized_VBD that_IN on_IN average_NN ,_, people_NNS who_WP get_VBP vaccinated_VBN are_VBP simply_RB healthier_JJR than_IN those_DT who_WP dont_VBP ,_, and_CC thus_RB less_RBR liable_JJ to_TO die_VB over_IN the_DT short_JJ term_NN ._. People_NNS who_WP dont_VBP get_VB vaccinated_VBN may_MD be_VB bedridden_JJ or_CC otherwise_RB too_RB sick_JJ to_TO go_VB get_VB a_DT shot_NN ._. They_PRP may_MD also_RB be_VB more_RBR likely_JJ to_TO succumb_VB to_IN flu_NN or_CC any_DT other_JJ illness_NN ,_, because_IN they_PRP are_VBP generally_RB older_JJR and_CC sicker_JJR ._. To_TO test_VB their_PRP$ thesis_NN ,_, Jackson_NNP and_CC her_PRP$ colleagues_NNS combed_VBD through_IN eight_CD years_NNS of_IN medical_JJ data_NNS on_IN more_JJR than_IN 72,000_CD people_NNS 65_CD and_CC older_JJR ._. They_PRP looked_VBD at_IN who_WP got_VBD flu_NN shots_NNS and_CC who_WP didnt_VBD ._. Then_RB they_PRP examined_VBD which_WDT groups_NNS members_NNS were_VBD more_RBR likely_JJ to_TO die_VB of_IN any_DT cause_NN when_WRB it_PRP was_VBD not_RB flu_NN season_NN ._. Jacksons_NNP findings_NNS showed_VBD that_IN outside_RB of_IN flu_NN season_NN ,_, the_DT baseline_NN risk_NN of_IN death_NN among_IN people_NNS who_WP did_VBD not_RB get_VB vaccinated_VBN was_VBD approximately_RB 60_CD percent_NN higher_JJR than_IN among_IN those_DT who_WP did_VBD ,_, lending_VBG support_NN to_IN the_DT hypothesis_NN that_IN on_IN average_NN ,_, healthy_JJ people_NNS chose_VBD to_TO get_VB the_DT vaccine_NN ,_, while_IN the_DT frail_NNP elderly_JJ _NN didnt_VBD or_CC couldnt_VBD ._. In_IN fact_NN ,_, the_DT healthy_JJ -_HYPH user_NN effect_NN explained_VBD the_DT entire_JJ benefit_NN that_WDT other_JJ researchers_NNS were_VBD attributing_VBG to_IN flu_NN vaccine_NN ,_, suggesting_VBG that_IN the_DT vaccine_NN itself_PRP might_MD not_RB reduce_VB mortality_NN at_IN all_DT ._. Jacksons_NNS papers_NNS are_VBP beautiful_JJ ,_, _NN says_VBZ Lone_NNP Simonsen_NNP ,_, who_WP is_VBZ a_DT professor_NN of_IN global_JJ health_NN at_IN George_NNP Washington_NNP University_NNP ,_, in_IN Washington_NNP ,_, D.C._NNP ,_, and_CC an_DT internationally_RB recognized_VBN expert_NN in_IN influenza_NN and_CC vaccine_NN epidemiology_NN ._. _`` They_PRP are_VBP classic_JJ studies_NNS in_IN epidemiology_NN ,_, they_PRP are_VBP so_RB carefully_RB done_VBN ._. _NFP The_DT results_NNS were_VBD also_RB so_RB unexpected_JJ that_IN many_JJ experts_NNS simply_RB refused_VBD to_TO believe_VB them_PRP ._. Jacksons_NNP papers_NNS were_VBD turned_VBN down_RP for_IN publication_NN in_IN the_DT top_NN -_HYPH ranked_VBN medical_JJ journals_NNS ._. One_CD flu_NN expert_NN who_WP reviewed_VBD her_PRP$ studies_NNS for_IN the_DT Journal_NNP of_IN the_DT American_NNP Medical_NNP Association_NNP wrote_VBD ,_, _`` To_TO accept_VB these_DT results_NNS would_MD be_VB to_TO say_VB that_IN the_DT earth_NN is_VBZ flat_JJ !_. When_WRB the_DT papers_NNS were_VBD finally_RB published_VBN in_IN 2006_CD ,_, in_IN the_DT less_RBR prominent_JJ International_NNP Journal_NNP of_IN Epidemiology_NNP ,_, they_PRP were_VBD largely_RB ignored_VBN by_IN doctors_NNS and_CC public_JJ -_HYPH health_NN officials_NNS ._. _`` The_DT answer_NN I_PRP got_VBD ,_, _NNP says_VBZ Jackson_NNP ,_, was_NNP not_RB the_DT right_JJ answer_NN ._. _NFP The_DT history_NN of_IN flu_NN vaccination_NN suggests_VBZ other_JJ reasons_NNS to_TO doubt_VB claims_NNS that_IN it_PRP dramatically_RB reduces_VBZ mortality_NN ._. In_IN 2004_CD ,_, for_IN example_NN ,_, vaccine_NN production_NN fell_VBD behind_RB ,_, causing_VBG a_DT 40_CD percent_NN drop_NN in_IN immunization_NN rates_NNS ._. Yet_CC mortality_NN did_VBD not_RB rise_VB ._. In_IN addition_NN ,_, vaccine_NN mismatches_NNS _NN occurred_VBD in_IN 1968_CD and_CC 1997_CD :_: in_IN both_DT years_NNS ,_, the_DT vaccine_NN that_WDT had_VBD been_VBN produced_VBN in_IN the_DT summer_NN protected_VBN against_IN one_CD set_NN of_IN viruses_NNS ,_, but_CC come_VB winter_NN ,_, a_DT different_JJ set_NN was_VBD circulating_VBG ._. In_IN effect_NN ,_, nobody_NN was_VBD vaccinated_VBN ._. Yet_CC death_NN rates_NNS from_IN all_DT causes_NNS ,_, including_VBG flu_NN and_CC the_DT various_JJ illnesses_NNS it_PRP can_MD exacerbate_VB ,_, did_VBD not_RB budge_VB ._. Sumit_NNP Majumdar_NNP ,_, a_DT physician_NN and_CC researcher_NN at_IN the_DT University_NNP of_IN Alberta_NNP ,_, in_IN Canada_NNP ,_, offers_VBZ another_DT historical_JJ observation_NN :_: rising_VBG rates_NNS of_IN vaccination_NN of_IN the_DT elderly_NN over_IN the_DT past_JJ two_CD decades_NNS have_VBP not_RB coincided_VBN with_IN a_DT lower_JJR overall_JJ mortality_NN rate_NN ._. In_IN 1989_CD ,_, only_RB 15_CD percent_NN of_IN people_NNS over_IN age_NN 65_CD in_IN the_DT U.S._NNP and_CC Canada_NNP were_VBD vaccinated_VBN against_IN flu_NN ._. Today_NN ,_, more_JJR than_IN 65_CD percent_NN are_VBP immunized_VBN ._. Yet_CC death_NN rates_NNS among_IN the_DT elderly_JJ during_IN flu_NN season_NN have_VBP increased_VBN rather_RB than_IN decreased_VBN ._. Vaccine_NN proponents_NNS call_VBP Majumdars_NNP last_JJ observation_NN an_DT ecological_JJ fallacy_NN ,_, _NN because_IN he_PRP fails_VBZ ,_, in_IN their_PRP$ view_NN ,_, to_TO consider_VB changes_NNS in_IN the_DT larger_JJR environment_NN that_WDT could_MD have_VB boosted_VBN death_NN rates_NNS over_IN the_DT yearseven_NN as_IN rising_VBG vaccination_NN rates_NNS were_VBD doing_VBG their_PRP$ part_NN to_TO keep_VB mortality_NN in_IN check_NN ._. The_DT proponents_NNS suggest_VBP ,_, for_IN instance_NN ,_, that_IN influenza_NN viruses_NNS may_MD have_VB become_VBN more_RBR contagious_JJ over_IN time_NN ,_, and_CC thus_RB are_VBP infecting_VBG greater_JJR numbers_NNS of_IN elderly_JJ people_NNS ,_, including_VBG some_DT who_WP have_VBP been_VBN vaccinated_VBN ._. Or_CC maybe_RB the_DT viruses_NNS are_VBP becoming_VBG more_RBR lethal_JJ ._. Or_CC maybe_RB the_DT elderly_JJ have_VBP less_JJR immunity_NN to_IN flu_NN than_IN they_PRP once_RB did_VBD because_IN ,_, say_VB ,_, their_PRP$ diets_NNS have_VBP changed_VBN ._. Or_CC maybe_RB vaccine_NN just_RB doesnt_RB prevent_VB deaths_NNS in_IN the_DT elderly_NN ._. Of_IN course_NN ,_, that_DT s_VBZ the_DT one_CD possibility_NN that_WDT vaccine_NN adherents_NNS wont_RB consider_VBP ._. Nancy_NNP Cox_NNP ,_, the_DT CDCs_NNP influenza_NN division_NN chief_NN ,_, says_VBZ flatly_RB ,_, _`` The_DT flu_NN vaccine_NN is_VBZ the_DT best_JJS way_NN to_TO protect_VB against_IN flu_NN ._. _NFP Anthony_NNP Fauci_NNP ,_, a_DT physician_NN and_CC the_DT director_NN of_IN the_DT National_NNP Institute_NNP of_IN Allergy_NNP and_CC Infectious_NNP Diseases_NNPS at_IN the_DT NIH_NNP ,_, where_WRB much_JJ of_IN the_DT basic_JJ science_NN of_IN flu_NN vaccine_NN has_VBZ been_VBN worked_VBN out_RP ,_, says_VBZ ,_, _`` I_PRP have_VBP no_DT doubt_NN that_IN it_PRP is_VBZ effective_JJ in_IN conferring_VBG some_DT degree_NN of_IN protection_NN ._. To_TO say_VB otherwise_RB is_VBZ a_DT minority_NN view_NN ._. _NFP Majumdar_NNP says_VBZ ,_, _`` We_PRP keep_VBP coming_VBG up_RP against_IN the_DT belief_NN that_IN weve_NN reduced_VBD mortality_NN by_IN 50_CD percent_NN ,_, _NN and_CC when_WRB researchers_NNS poke_VBP holes_NNS in_IN the_DT evidence_NN ,_, people_NNS pound_VBP the_DT pulpit_NN ._. _NFP The_DT most_RBS vocal_JJ and_NN undoubtedly_RB most_RBS vexing_JJ critic_NN of_IN the_DT gospel_NN of_IN flu_NN vaccine_NN is_VBZ the_DT Cochrane_NNP Collaborations_NNPS Jefferson_NNP ,_, whos_NNS also_RB an_DT epidemiologist_NN trained_VBN at_IN the_DT famed_VBN London_NNP School_NNP of_IN Tropical_NNP Hygiene_NNP ,_, and_CC who_WP ,_, in_IN Lisa_NNP Jacksons_NNP view_NN ,_, makes_VBZ other_JJ skeptics_NNS seem_VB _RB moderate_JJ by_IN comparison_NN ._. _NFP Among_IN his_PRP$ fellow_JJ flu_NN researchers_NNS ,_, Jeffersons_NNP outspokenness_NN has_VBZ made_VBN him_PRP something_NN of_IN a_DT pariah_NN ._. At_IN a_DT 2007_CD meeting_NN on_IN pandemic_NN preparedness_NN at_IN a_DT hotel_NN in_IN Bethesda_NNP ,_, Maryland_NNP ,_, Jefferson_NNP ,_, whod_VB been_VBN invited_VBN to_TO speak_VB at_IN the_DT conference_NN ,_, was_VBD not_RB greeted_VBN by_IN any_DT of_IN the_DT colleagues_NNS milling_VBG about_IN the_DT lobby_NN ._. He_PRP ate_VBD his_PRP$ meals_NNS in_IN the_DT hotel_NN restaurant_NN alone_RB ,_, surrounded_VBN by_IN scientists_NNS chatting_VBG amiably_RB at_IN other_JJ tables_NNS ._. He_PRP shrugs_VBZ off_RP such_JJ treatment_NN ._. As_IN a_DT medical_JJ officer_NN working_VBG for_IN the_DT United_NNP Nations_NNPS in_IN 1992_CD ,_, during_IN the_DT siege_NN of_IN Sarajevo_NNP ,_, he_PRP and_CC other_JJ peacekeepers_NNS were_VBD captured_VBN and_CC held_VBN for_IN more_JJR than_IN a_DT month_NN by_IN militiamen_NNS brandishing_VBG AK_NNP -_HYPH 47s_NNS and_CC reeking_NN of_IN alcohol_NN ._. Professional_JJ shunning_NN seems_VBZ trivial_JJ by_IN comparison_NN ,_, he_PRP says_VBZ ._. _NNP Tom_NNP Jefferson_NNP has_VBZ taken_VBN a_DT lot_NN of_IN heat_NN just_RB for_IN saying_VBG ,_, _NNP Heres_NNS the_DT evidence_NN :_: it_PRP s_VBZ not_RB very_RB good_JJ ,_, _NN says_VBZ Majumdar_NNP ._. _`` The_DT reaction_NN has_VBZ been_VBN so_RB dogmatic_JJ and_CC even_RB hysterical_JJ that_IN youd_PRP think_VBP he_PRP was_VBD advocating_VBG stealing_VBG babies_NNS ._. Yet_CC while_IN other_JJ flu_NN researchers_NNS may_MD not_RB like_VB what_WP Jefferson_NNP has_VBZ to_TO say_VB ,_, they_PRP cannot_MD ignore_VB the_DT fact_NN that_IN he_PRP knows_VBZ the_DT flu-_NN vaccine_NN literature_NN better_JJR than_IN anyone_NN else_JJ on_IN the_DT planet_NN ._. He_PRP leads_VBZ an_DT international_JJ team_NN of_IN researchers_NNS who_WP have_VBP combed_VBN through_IN hundreds_NNS of_IN flu-vaccine_NN studies_NNS ._. The_DT vast_JJ majority_NN of_IN the_DT studies_NNS were_VBD deeply_RB flawed_JJ ,_, says_VBZ Jefferson_NNP ._. _`` Rubbish_NN is_VBZ not_RB a_DT scientific_JJ term_NN ,_, but_CC I_PRP think_VBP its_VBZ the_DT term_NN that_WDT applies_VBZ ._. Only_RB four_CD studies_NNS were_VBD properly_RB designed_VBN to_TO pin_VB down_RP the_DT effectiveness_NN of_IN flu_NN vaccine_NN ,_, he_PRP says_VBZ ,_, and_CC two_CD of_IN those_DT showed_VBD that_IN it_PRP might_MD be_VB effective_JJ in_IN certain_JJ groups_NNS of_IN patients_NNS ,_, such_JJ as_IN school_NN -_HYPH age_NN children_NNS with_IN no_DT underlying_JJ health_NN issues_NNS like_IN asthma_NN ._. The_DT other_JJ two_CD showed_VBD equivocal_JJ results_NNS or_CC no_DT benefit_NN ._. Flu_NN researchers_NNS have_VBP been_VBN fooled_VBN into_IN thinking_VBG vaccine_NN is_VBZ more_RBR effective_JJ than_IN the_DT data_NNS suggest_VBP ,_, in_IN part_NN ,_, says_VBZ Jefferson_NNP ,_, by_IN the_DT imprecision_NN of_IN the_DT statistics_NNS ._. The_DT only_JJ way_NN to_TO know_VB if_IN someone_NN has_VBZ the_DT fluas_NNS opposed_VBN to_IN influenza_NN -_HYPH like_JJ illness_NN is_RB by_IN putting_VBG a_DT Q_NN -_HYPH tip_NN into_IN the_DT patients_NNS throat_NN or_CC nose_NN and_CC running_VBG a_DT test_NN ,_, which_WDT simply_RB is_VBZ nt_RB done_VBN that_RB often_RB ._. Likewise_RB ,_, nobody_NN really_RB has_VBZ a_DT handle_NN on_IN how_WRB many_JJ of_IN the_DT deaths_NNS that_WDT are_VBP blamed_VBN on_IN flu_NN were_VBD actually_RB caused_VBN by_IN a_DT flu_NN virus_NN ,_, because_IN few_JJ are_VBP confirmed_VBN by_IN a_DT laboratory_NN ._. _`` I_PRP used_VBD to_TO be_VB a_DT family_NN physician_NN ,_, _NNP says_VBZ Jefferson_NNP ._. _PRP Ive_VBP never_RB seen_VBN a_DT patient_NN come_VB to_IN my_PRP$ office_NN with_IN H1N1_NN written_VBN on_IN his_PRP$ forehead_NN ._. When_WRB an_DT old_JJ person_NN dies_VBZ of_IN respiratory_JJ failure_NN after_IN an_DT influenza_NN -_HYPH like_JJ illness_NN ,_, they_PRP nearly_RB always_RB get_VBP coded_VBN as_IN influenza_NN ._. _NFP Theres_VBZ one_CD other_JJ way_NN flu_NN researchers_NNS may_MD be_VB fooled_VBN into_IN thinking_VBG flu_NN vaccine_NN is_VBZ effective_JJ ,_, Jefferson_NNP says_VBZ ._. All_DT vaccines_NNS work_VBP by_IN delivering_VBG a_DT dose_NN of_IN killed_VBN or_CC weakened_VBN virus_NN or_CC bacteria_NN ,_, which_WDT provokes_VBZ the_DT immune_NN system_NN into_IN producing_VBG antibodies_NNS ._. When_WRB the_DT person_NN is_VBZ subsequently_RB exposed_VBN to_IN the_DT real_JJ thing_NN ,_, the_DT body_NN is_VBZ already_RB prepared_VBN to_TO repel_VB the_DT bug_NN completely_RB or_CC to_TO get_VB rid_JJ of_IN it_PRP after_IN a_DT mild_JJ illness_NN ._. Flu_NN researchers_NNS often_RB use_VBP antibody_NN response_NN as_IN a_DT way_NN of_IN gauging_VBG the_DT effectiveness_NN of_IN vaccine_NN ,_, on_IN the_DT assumption_NN that_IN levels_NNS of_IN antibodies_NNS in_IN the_DT blood_NN of_IN people_NNS who_WP have_VBP been_VBN vaccinated_VBN are_VBP a_DT good_JJ predictor_NN although_IN an_DT imperfect_JJ one_NN of_IN how_WRB well_RB they_PRP can_MD ward_VB off_RP the_DT infection_NN ._. There_EX s_VBZ some_DT merit_NN to_IN this_DT reasoning_NN ._. Unfortunately_RB ,_, the_DT very_JJ people_NNS who_WP most_RBS need_VBP protection_NN from_IN the_DT flu_NN also_RB have_VBP immune_NN systems_NNS that_WDT are_VBP least_RBS likely_JJ to_TO respond_VB to_IN vaccine_NN ._. Studies_NNS show_VBP that_IN young_JJ ,_, healthy_JJ people_NNS mount_VBP a_DT glorious_JJ immune_JJ response_NN to_IN seasonal_JJ flu_NN vaccine_NN ,_, and_CC their_PRP$ response_NN reduces_VBZ their_PRP$ chances_NNS of_IN getting_VBG the_DT flu_NN and_CC may_MD lessen_VB the_DT severity_NN of_IN symptoms_NNS if_IN they_PRP do_VBP get_VB it_PRP ._. But_CC they_PRP arent_VBP the_DT people_NNS who_WP die_VBP from_IN seasonal_JJ flu_NN ._. By_IN contrast_NN ,_, the_DT elderly_JJ ,_, particularly_RB those_DT over_IN age70_NN ,_, dont_NN have_VBP a_DT good_JJ immune_JJ response_NN to_IN vaccine_NN and_NN they_PRP re_VBP the_DT ones_NNS who_WP account_VBP for_IN most_JJS flu_NN deaths_NNS ._. (_-LRB- Infants_NNS with_IN severe_JJ disabilities_NNS ,_, such_JJ as_IN leukemia_NN and_CC congenital_JJ lung_NN disease_NN ,_, and_CC people_NNS who_WP are_VBP immune_JJ -_HYPH compromised_VBN from_CC AIDS_NN ,_, or_CC diabetes_NN ,_, or_CC cancer_NN treatment_NN make_VB up_RP the_DT rest_NN ._. As_IN of_IN August8_NNP ,_, only_RB 36_CD deaths_NNS from_IN swine_NN flu_NN had_VBD been_VBN confirmed_VBN among_IN children_NNS in_IN the_DT U.S._NNP ,_, and_CC the_DT overwhelming_JJ majority_NN of_IN those_DT children_NNS had_VBD multiple_JJ ,_, severe_JJ health_NN disorders_NNS ._. )_-RRB- In_IN Jeffersons_NNP view_NN ,_, this_DT raises_VBZ a_DT troubling_JJ conundrum_NN :_: Is_VBZ vaccine_NN necessary_JJ for_IN those_DT in_IN whom_WP it_PRP is_VBZ effective_JJ ,_, namely_RB the_DT young_JJ and_CC healthy_JJ ?_. Conversely_RB ,_, is_VBZ it_PRP effective_JJ in_IN those_DT for_IN whom_WP it_PRP seems_VBZ to_TO be_VB necessary_JJ ,_, namely_RB the_DT old_JJ ,_, the_DT very_RB young_JJ ,_, and_CC the_DT infirm_NN ?_. These_DT questions_NNS have_VBP led_VBN to_IN the_DT most_RBS controversial_JJ aspect_NN of_IN Jeffersons_NNPS work_NN :_: his_PRP$ call_NN for_IN placebo_NN -_HYPH controlled_VBN trials_NNS ,_, studies_NNS that_WDT would_MD randomly_RB give_VB half_PDT the_DT test_NN subjects_NNS vaccine_NN and_CC the_DT other_JJ half_PDT a_DT dummy_NN shot_NN ,_, or_CC placebo_NN ._. Only_RB such_JJ large_JJ ,_, well_RB -_HYPH constructed_VBN ,_, randomized_VBN trials_NNS can_MD show_VB with_IN any_DT precision_NN how_WRB effective_JJ vaccine_NN really_RB is_VBZ ,_, and_CC for_IN whom_WP ._. In_IN the_DT flu_NN -_HYPH vaccine_NN world_NN ,_, Jeffersons_NNPS call_VBP for_IN placebo_NN -_HYPH controlled_VBN studies_NNS is_VBZ considered_VBN so_RB radical_JJ that_IN even_RB some_DT of_IN his_PRP$ fellow_JJ skeptics_NNS oppose_VBP it_PRP ._. Majumdar_NNP ,_, the_DT Ottawa_NNP researcher_NN ,_, says_VBZ he_PRP believes_VBZ that_IN evidence_NN of_IN a_DT benefit_NN among_IN children_NNS is_VBZ established_VBN and_CC that_IN public_JJ -_HYPH health_NN officials_NNS should_MD try_VB to_TO protect_VB seniors_NNS by_IN immunizing_VBG children_NNS ,_, health_NN -_HYPH care_NN workers_NNS ,_, and_CC other_JJ people_NNS around_IN them_PRP ,_, and_CC thus_RB reduce_VB the_DT spread_NN of_IN the_DT flu_NN ._. Lone_NNP Simonsen_NNP explains_VBZ the_DT prevailing_JJ view_NN :_: _`` It_PRP is_VBZ considered_VBN unethical_JJ to_TO do_VB trials_NNS in_IN populations_NNS that_WDT are_VBP recommended_VBN to_TO have_VB vaccine_NN ,_, _UH a_DT stance_NN that_WDT is_VBZ shared_VBN by_IN everybody_NN from_IN the_DT CDCs_NNPS Nancy_NNP Cox_NNP to_IN Anthony_NNP Fauci_NNP at_IN the_DT NIH_NNP ._. They_PRP feel_VBP strongly_RB that_IN vaccine_NN has_VBZ been_VBN shown_VBN to_TO be_VB effective_JJ and_CC that_IN a_DT sham_NN vaccine_NN would_MD put_VB test_NN subjects_NNS at_IN unnecessary_JJ risk_NN of_IN getting_VBG a_DT serious_JJ case_NN of_IN the_DT flu_NN ._. In_IN a_DT phone_NN interview_NN ,_, Fauci_NNP at_IN first_RB voiced_VBD the_DT opinion_NN that_IN a_DT placebo_NN trial_NN in_IN the_DT elderly_NN might_MD be_VB acceptable_JJ ,_, but_CC he_PRP called_VBD back_RB later_RBR to_TO retract_VB his_PRP$ comment_NN ,_, saying_VBG that_IN such_PDT a_DT trial_NN would_MD be_VB unethical_JJ ._. Jefferson_NNP finds_VBZ this_DT view_NN almost_RB exactly_RB backward_RB :_: _`` What_WP do_VBP you_PRP do_VB when_WRB you_PRP have_VBP uncertainty_NN ?_. You_PRP test_VBP ,_, _'' he_PRP says_VBZ ._. _`` We_PRP have_VBP built_VBN huge_JJ ,_, population_NN -_HYPH based_VBN policies_NNS on_IN the_DT flimsiest_JJ of_IN scientific_JJ evidence_NN ._. The_DT most_RBS unethical_JJ thing_NN to_TO do_VB is_VBZ to_TO carry_VB on_IN business_NN as_IN usual_JJ ._. _NFP Just_RB after_IN 6_CD p.m._NN on_IN a_DT warm_JJ Friday_NNP evening_NN in_IN July_NNP ,_, Dr._NNP David_NNP Newman_NNP is_VBZ only_RB minutes_NNS into_IN a_DT 10_CD -_HYPH hour_NN shift_NN in_IN the_DT emergency_NN room_NN of_IN New_NNP York_NNP Citys_NNP St._NNP Lukes_NNP Hospital_NNP ,_, and_CC already_RB he_PRP has_VBZ assumed_VBN responsibility_NN for_IN 11_CD patients_NNS ._. The_DT young_JJ Italian_JJ tourist_NN sitting_VBG on_IN the_DT bed_NN in_IN front_NN of_IN the_DT doctor_NN has_VBZ meningitis_NN ,_, and_CC through_IN an_DT interpreter_NN ,_, Newman_NNP tells_VBZ him_PRP he_PRP almost_RB certainly_RB has_VBZ the_DT viral_JJ form_NN of_IN the_DT disease_NN ,_, which_WDT will_MD do_VB nothing_NN more_JJR than_IN make_VB him_PRP feel_VB ill_JJ for_IN a_DT few_JJ days_NNS ._. There_EX is_VBZ a_DT tiny_JJ chance_NN ,_, says_VBZ Newman_NNP ,_, that_IN the_DT illness_NN is_VBZ caused_VBN by_IN a_DT bacterium_NN ,_, which_WDT can_MD be_VB deadly_JJ ,_, but_CC he_PRP is_VBZ almost_RB positive_JJ thats_NNS not_RB what_WP the_DT tourist_NN has_VBZ ._. He_PRP says_VBZ to_IN his_PRP$ patient_NN ,_, _`` I_PRP cant_MD tell_VB you_PRP with_IN 100_CD percent_NN certainty_NN that_IN you_PRP dont_RB have_VB it_PRP ,_, but_CC if_IN you_PRP do_VBP ,_, youll_UH begin_VB to_TO feel_VB worse_JJR and_CC youll_PRP need_VBP to_TO come_VB back_RB ._. _NFP The_DT tourist_NN ,_, on_IN learning_VBG that_IN he_PRP might_MD be_VB infected_VBN with_IN a_DT potentially_RB lethal_JJ disease_NN ,_, looks_VBZ down_RP at_IN his_PRP$ feet_NNS and_CC confesses_VBZ that_IN he_PRP is_VBZ much_RB more_RBR worried_JJ about_IN another_DT illness_NN :_: swine_NN flu_NN ._. Newman_NNP smiles_VBZ patiently_RB ._. _`` It_PRP would_MD be_VB nice_JJ if_IN you_PRP had_VBD swine_NN flu_NN ,_, _'' he_PRP says_VBZ ._. _`` Compared_VBN to_IN bacterial_JJ meningitis_NN ,_, swine_NN flu_NN is_VBZ safe_JJ ._. _NFP Late_RB last_JJ spring_NN ,_, as_IN headlines_NNS and_CC airwaves_NNS warned_VBD of_IN a_DT possible_JJ pandemic_NN ,_, patients_NNS like_IN Newmans_NNPS began_VBD clogging_VBG emergency_NN rooms_NNS across_IN the_DT country_NN ,_, a_DT sneezing_NN ,_, coughing_VBG ,_, infectious_JJ tide_NN of_IN humanity_NN more_RBR worried_JJ than_IN truly_RB sick_JJ ,_, but_CC whose_WP$ mere_JJ presence_NN in_IN the_DT emergency_NN room_NN has_VBZ endangered_VBN the_DT lives_NNS of_IN others_NNS ._. _NFP Studies_NNS show_VBP that_IN when_WRB there_EX is_VBZ ER_NN crowding_NN ,_, mortality_NN goes_VBZ up_RP ,_, because_IN patients_NNS who_WP need_VBP immediate_JJ attention_NN dont_NN get_VB it_PRP ,_, _'' says_VBZ Newman_NNP ,_, the_DT director_NN of_IN clinical_JJ research_NN in_IN the_DT Department_NNP of_IN Emergency_NNP Medicine_NNP at_IN the_DT hospital_NN ,_, which_WDT is_VBZ affiliated_VBN with_IN Columbia_NNP University_NNP ._. In_IN an_DT average_JJ year_NN the_DT ER_NNP at_IN St._NNP Lukes_NNP ,_, a_DT sprawling_VBG 1,076_CD -_HYPH bed_NN hospital_NN on_IN 113th_NNP Street_NNP ,_, takes_VBZ in_RP 110,000_CD patients_NNS ,_, some_DT 300_CD a_DT day_NN ._. At_IN the_DT height_NN of_IN the_DT summer_NN swine_NN flu_NN outbreak_NN ,_, that_DT number_NN doubled_VBD ._. The_DT vast_JJ majority_NN of_IN panicky_JJ patients_NNS who_WP came_VBD in_IN the_DT door_NN at_IN St._NNP Lukes_NNP and_CC other_JJ emergency_NN departments_NNS didnt_RB actually_RB have_VB the_DT virus_NN ,_, and_CC of_IN those_DT who_WP did_VBD ,_, most_JJS were_VBD not_RB sick_JJ enough_RB to_TO need_VB hospitalization_NN ._. Even_RB so_RB ,_, says_VBZ Newman_NNP ,_, when_WRB patients_NNS with_IN even_RB mild_JJ flu_NN symptoms_NNS show_VBP up_RP in_IN the_DT hospital_NN ,_, they_PRP vastly_RB increase_VBP the_DT spread_NN of_IN the_DT virus_NN ,_, simply_RB because_IN they_PRP inevitably_RB sneeze_VBP and_CC cough_VBP in_IN rooms_NNS that_WDT are_VBP jammed_VBN with_IN other_JJ people_NNS ._. Many_JJ of_IN the_DT worried_JJ sick_JJ come_VBP to_IN St._NNP Lukes_NNP and_CC other_JJ hospitals_NNS in_IN search_NN of_IN antiviral_JJ drugs_NNS ._. The_DT CDC_NNP recommends_VBZ the_DT use_NN of_IN two_CD drugs_NNS against_IN H1N1_NN :_: oseltamivir_NN and_CC zanamivir_NN ,_, better_RBR known_VBN by_IN their_PRP$ brand_NN names_NNS ,_, Tamiflu_NNP and_CC Relenza_NNP ,_, which_WDT together_RB form_VBP the_DT second_JJ pillar_NN of_IN the_DT governments_NNS anti-pandemic_JJ -_HYPH flu_NN strategy_NN ._. Public_JJ -_HYPH health_NN officials_NNS at_IN the_DT state_NN and_CC local_JJ levels_NNS are_VBP also_RB recommending_VBG the_DT drugs_NNS ._. Guidelines_NNS issued_VBN by_IN the_DT New_NNP York_NNP City_NNP Department_NNP of_IN Health_NNP ,_, says_VBZ Newman_NNP ,_, encourage_VB us_PRP to_TO give_VB a_DT prescription_NN to_IN just_RB about_RB every_DT patient_NN with_IN the_DT sniffles_NNS ,_, _UH a_DT practice_NN that_WDT some_DT experts_NNS worry_VBP will_MD quickly_RB lead_VB to_IN resistant_JJ strains_NNS of_IN the_DT virus_NN ._. Indeed_RB ,_, that_DT s_VBZ already_RB happening_VBG ._. Daniel_NNP Janies_NNP ,_, an_DT associate_NN professor_NN of_IN biomedical_JJ informatics_NN at_IN Ohio_NNP State_NNP University_NNP ,_, tracks_VBZ the_DT genetic_JJ mutations_NNS that_WDT allow_VBP flu_NN virus_NN to_TO develop_VB resistance_NN to_IN drugs_NNS ._. Flu_NN can_MD become_VB resistant_JJ to_IN Tamiflu_NNP in_IN a_DT matter_NN of_IN days_NNS ,_, he_PRP says_VBZ ._. Handing_VBG out_RP the_DT drug_NN early_RB in_IN the_DT pandemic_NN ,_, when_WRB H1N1_NNP poses_VBZ only_RB a_DT minimal_JJ threat_NN to_IN the_DT vast_JJ majority_NN of_IN patients_NNS ,_, strikes_VBZ him_PRP as_IN shortsighted_NNP ._. Indeed_RB ,_, samples_NNS of_IN resistant_JJ H1N1_NN were_VBD cropping_VBG up_RP by_IN midsummer_NN ,_, increasing_VBG the_DT likelihood_NN that_WDT come_VB late_JJ fall_NN ,_, many_JJ people_NNS will_MD be_VB infected_VBN with_IN a_DT resistant_JJ strain_NN of_IN swine_NN flu_NN ._. Alarmed_VBN at_IN that_DT prospect_NN ,_, the_DT World_NNP Health_NNP Organization_NNP issued_VBD an_DT alert_NN on_IN August_NNP 21_CD ,_, recommending_VBG that_IN Tamiflu_NNP and_CC Relenza_NNP be_VB used_VBN only_RB in_IN severe_JJ cases_NNS and_CC in_IN patients_NNS who_WP are_VBP at_IN high_JJ risk_NN of_IN serious_JJ complications_NNS ._. By_IN mid-August_NNP ,_, two_CD U.S._NNP swine_NN flu_NN patients_NNS had_VBD developed_VBN Tamiflu_NN -_HYPH resistant_JJ strains_NNS ._. The_DT U.S._NNP first_RB began_VBD stockpiling_VBG Tamiflu_NNP and_CC Relenza_NNP back_RB in_IN 2005_CD ,_, in_IN the_DT wake_NN of_IN concern_NN that_IN an_DT outbreak_NN in_IN Southeast_NNP Asia_NNP of_IN bird_NN flu_NN ,_, a_DT far_RB more_RBR deadly_JJ form_NN of_IN the_DT disease_NN ,_, might_MD go_VB global_JJ ._. On_IN November_NNP 1_CD ,_, 2005_CD ,_, President_NNP George_NNP W.Bush_NNP pronounced_VBD pandemic_NN flu_NN a_DT danger_NNP to_IN our_PRP$ homeland_NN ,_, _NN and_CC he_PRP asked_VBD Congress_NNP to_TO approve_VB legislation_NN that_WDT included_VBD $_$ 1_CD billion_CD for_IN the_DT production_NN and_CC stockpiling_NN of_IN antivirals_NNS ._. This_DT was_VBD after_IN Congress_NNP had_VBD already_RB approved_VBN $_$ 1.8_CD billion_CD to_TO stockpile_VB Tamiflu_NNP for_IN the_DT military_NN ,_, a_DT decision_NN that_WDT was_VBD made_VBN during_IN the_DT tenure_NN of_IN Defense_NNP Secretary_NNP Donald_NNP Rumsfeld_NNP ._. (_-LRB- Before_IN joining_VBG the_DT Bush_NNP Cabinet_NNP ,_, Rumsfeld_NNP was_VBD chairman_NN for_IN four_CD years_NNS of_IN Gilead_NNP Sciences_NNPS ,_, the_DT company_NN that_WDT holds_VBZ the_DT patent_NN on_IN Tamiflu_NNP ,_, and_CC he_PRP held_VBD millions_NNS of_IN dollars_NNS worth_NN of_IN stock_NN in_IN the_DT company_NN ._. According_VBG to_IN Roll_NNP Call_NNP ,_, an_DT online_JJ newspaper_NN covering_VBG events_NNS on_IN Capitol_NNP Hill_NNP ,_, Rumsfeld_NNP says_VBZ he_PRP recused_VBD himself_PRP from_IN all_DT government_NN decisions_NNS involving_VBG Tamiflu_NNP ._. Gileads_NNP stock_NN price_NN rose_VBD more_JJR than_IN 50_CD percent_NN in_IN 2005_CD ,_, when_WRB the_DT governments_NNS plan_NN was_VBD announced_VBN ._. )_-RRB- As_IN with_IN vaccines_NNS ,_, the_DT scientific_JJ evidence_NN for_IN Tamiflu_NNP and_CC Relenza_NNP is_VBZ thin_JJ at_IN best_JJS ._. In_IN its_PRP$ general_JJ -_HYPH information_NN section_NN ,_, the_DT CDCs_NNP Web_NN site_NN tells_VBZ readers_NNS that_IN antiviral_JJ drugs_NNS can_MD make_VB you_PRP feel_VB better_RBR faster_JJR ._. True_JJ ,_, but_CC not_RB by_IN much_RB ._. On_IN average_NN ,_, Tamiflu_NNP (_-LRB- which_WDT accounts_VBZ for_IN 85_CD to_IN 90_CD percent_NN of_IN the_DT flu_NN antiviral_JJ -_HYPH drug_NN market_NN )_-RRB- cuts_VBZ the_DT duration_NN of_IN flu_NN symptoms_NNS by_IN 24hours_NNS in_IN otherwise_RB healthy_JJ people_NNS ._. In_IN exchange_NN for_IN a_DT slightly_RB shorter_JJR bout_NN of_IN illness_NN ,_, as_RB many_JJ as_IN one_CD in_IN five_CD people_NNS taking_VBG Tamiflu_NN will_MD experience_VB nausea_NN and_CC vomiting_NN ._. About_RB one_CD in_IN five_CD children_NNS will_MD have_VB neuropsychiatric_JJ side_NN effects_NNS ,_, possibly_RB including_VBG anxiety_NN and_CC suicidal_JJ behavior_NN ._. In_IN Japan_NNP ,_, where_WRB Tamiflu_NNP is_VBZ liberally_RB prescribed_VBN ,_, the_DT drug_NN may_MD have_VB been_VBN responsible_JJ for_IN 50_CD deaths_NNS from_IN cardiopulmonary_JJ arrest_NN ,_, from_IN 2001_CD to_IN 2007_CD ,_, according_VBG to_IN Rokuro_NNP Hama_NNP ,_, the_DT chair_NN of_IN the_DT Japan_NNP Institute_NNP of_IN Pharmacovigilance_NNP ._. Such_JJ side_NN effects_NNS might_MD be_VB worth_JJ risking_VBG if_IN the_DT antivirals_NNS prevented_VBD serious_JJ complications_NNS of_IN flu_NN ,_, such_JJ as_IN pneumonia_NN ,_, hospitalization_NN ,_, and_CC death_NN ._. Roche_NNP Laboratories_NNP ,_, the_DT company_NN licensed_VBN to_TO manufacture_VB and_CC market_VB Tamiflu_NNP ,_, says_VBZ its_PRP$ drug_NN does_VBZ just_RB that_DT ._. In_IN two_CD September2006_NNP press_NN releases_NNS ,_, the_DT company_NN announced_VBD ,_, _`` Tamiflu_NNP significantly_RB reduces_VBZ the_DT risk_NN of_IN death_NN from_IN influenza_NN :_: New_JJ data_NNS shows_VBZ treatment_NN was_VBD associated_VBN with_IN more_JJR than_IN a_DT two_CD third_JJ reduction_NN in_IN deaths_NNS ,_, _NN and_CC _`` Children_NNS with_IN influenza_NN [_-LRB- are_VBP ]_-RRB- 53_CD percent_NN less_RBR likely_JJ to_TO contract_VB pneumonia_NN when_WRB treated_VBN with_IN Tamiflu_NN ._. _NFP Once_RB again_RB cohort_NN studies_NNS (_-LRB- the_DT same_JJ kind_NN of_IN potentially_RB biased_VBN research_NN that_WDT led_VBD to_IN the_DT conclusion_NN that_IN flu_NN vaccine_NN cuts_VBZ mortality_NN by_IN 50_CD percent_NN )_-RRB- are_VBP behind_IN these_DT claims_NNS ._. Tamiflu_NNP costs_VBZ $_$ 10_CD a_DT pill_NN ._. It_PRP is_VBZ possible_JJ that_IN people_NNS who_WP take_VBP it_PRP are_VBP more_RBR likely_JJ to_TO be_VB insured_VBN and_CC affluent_JJ ,_, or_CC at_IN least_JJS middle_JJ -_HYPH class_NN ,_, than_IN those_DT who_WP do_VBP not_RB ,_, and_CC a_DT large_JJ body_NN of_IN evidence_NN shows_VBZ that_IN the_DT well_RB -_HYPH off_RP nearly_RB always_RB fare_VBP better_JJR than_IN the_DT poor_JJ when_WRB stricken_JJ with_IN an_DT infectious_JJ disease_NN ,_, including_VBG flu_NN ._. In_IN both_CC 2003_CD and_CC 2009_CD ,_, reviews_NNS of_IN randomized_VBN placebo_NN -_HYPH controlled_VBN studies_NNS found_VBD that_IN the_DT study_NN populations_NNS simply_RB werent_VBP large_JJ enough_RB to_TO answer_VB the_DT question_NN :_: Does_VBZ Tamiflu_NNP prevent_VB pneumonia_NN ?_. As_RB late_RB as_IN this_DT August_NNP ,_, the_DT companys_NNS own_JJ Web_NN site_NN contained_VBD the_DT following_VBG statement_NN ,_, which_WDT was_VBD written_VBN under_IN the_DT direction_NN of_IN the_DT FDA_NNP :_: _`` Tamiflu_NN has_VBZ not_RB been_VBN proven_VBN to_TO have_VB a_DT positive_JJ impact_NN on_IN the_DT potential_JJ consequences_NNS (_-LRB- such_JJ as_IN hospitalizations_NNS ,_, mortality_NN ,_, or_CC economic_JJ impact_NN )_-RRB- of_IN seasonal_JJ ,_, avian_NN ,_, or_CC pandemic_NN influenza_NN ._. _NFP An_DT FDA_NNP spokesperson_NN said_VBD recently_RB that_IN the_DT agency_NN is_VBZ unaware_JJ of_IN any_DT data_NNS submitted_VBN by_IN Roche_NNP that_WDT would_MD support_VB the_DT claims_NNS in_IN the_DT companys_NNS September_NNP 2006_CD news_NN release_NN about_IN the_DT drugs_NNS reducing_VBG flu_NN deaths_NNS ._. Why_WRB ,_, then_RB ,_, has_VBZ the_DT federal_JJ government_NN stockpiled_VBN millions_NNS of_IN doses_NNS of_IN antivirals_NNS ,_, at_IN a_DT cost_NN of_IN several_JJ billion_CD dollars_NNS ?_. And_CC why_WRB are_VBP physicians_NNS being_VBG encouraged_VBN to_TO hand_VB out_RP prescriptions_NNS to_IN large_JJ numbers_NNS of_IN people_NNS ,_, without_IN sound_NN evidence_NN that_IN the_DT drugs_NNS will_MD help_VB ?_. The_DT short_JJ answer_NN may_MD be_VB that_IN public_JJ -_HYPH health_NN officials_NNS feel_VBP they_PRP must_MD offer_VB something_NN ,_, and_CC these_DT drugs_NNS are_VBP the_DT only_JJ possible_JJ remedies_NNS at_IN hand_NN ._. _`` I_PRP have_VBP to_TO agree_VB with_IN the_DT critics_NNS the_DT antiviral_JJ question_NN is_VBZ not_RB cut_VBN -_HYPH and_CC -_HYPH dried_VBN ,_, _NN says_VBZ Fauci_NNP ._. _`` But_CC [_-LRB- these_DT drugs_NNS are_VBP ]_-RRB- the_DT best_JJS we_PRP have_VBP ._. The_DT CDCs_NNS Nancy_NNP Cox_NNP also_RB acknowledges_VBZ that_IN the_DT science_NN is_VBZ not_RB as_RB sound_JJ as_IN she_PRP might_MD like_VB ,_, but_CC the_DT government_NN still_RB recommends_VBZ their_PRP$ use_NN ._. And_CC as_IN with_IN vaccines_NNS ,_, she_PRP considers_VBZ additional_JJ randomized_VBN placebo_NN -_HYPH controlled_VBN trials_NNS of_IN the_DT antiviral_JJ drugs_NNS to_TO be_VB unethical_JJ _NN and_CC thus_RB out_IN of_IN the_DT question_NN ._. This_DT is_VBZ the_DT curious_JJ state_NN of_IN debate_NN about_IN the_DT governments_NNS two_CD main_JJ weapons_NNS in_IN the_DT fight_NN against_IN pandemic_NN flu_NN ._. At_IN first_RB ,_, government_NN officials_NNS declare_VBP that_IN both_CC vaccines_NNS and_CC drugs_NNS are_VBP effective_JJ ._. When_WRB faced_VBN with_IN contrary_JJ evidence_NN ,_, the_DT adherents_NNS acknowledge_VBP that_IN the_DT science_NN is_VBZ not_RB as_RB crisp_JJ as_IN they_PRP might_MD wish_VB ._. Then_RB ,_, in_IN response_NN to_IN calls_NNS for_IN placebo_NN -_HYPH controlled_VBN trials_NNS ,_, which_WDT would_MD provide_VB clear_JJ results_NNS one_CD way_NN or_CC the_DT other_JJ ,_, the_DT proponents_NNS say_VBP such_JJ studies_NNS would_MD deprive_VB patients_NNS of_IN vaccines_NNS and_CC drugs_NNS that_WDT have_VBP already_RB been_VBN deemed_VBN effective_JJ ._. _`` We_PRP cant_MD just_RB let_VB people_NNS die_VB ,_, _'' says_VBZ Cox_NNP ._. Students_NNS of_IN U.S._NNP medical_JJ history_NN will_MD find_VB this_DT circular_JJ logic_NN familiar_JJ :_: it_PRP is_VBZ a_DT long_JJ -_HYPH recurring_VBG theme_NN in_IN American_JJ medicine_NN ,_, and_CC one_CD that_WDT has_VBZ ,_, on_IN occasion_NN ,_, had_VBD deadly_JJ consequences_NNS ._. In_IN 1925_CD ,_, Sinclair_NNP Lewis_NNP caricatured_VBD a_DT medical_JJ culture_NN that_WDT allowed_VBD belief_NN and_NN profits_NNS to_TO distort_VB science_NN in_IN his_PRP$ Pulitzer_NNP Prizewinning_NNP book_NN ,_, Arrowsmith_NNP ._. Based_VBN on_IN the_DT lives_NNS of_IN the_DT real_JJ -_HYPH life_NN microbiologists_NNS Paul_NNP de_NNP Kruif_NNP and_CC Jacques_NNP Loeb_NNP ,_, Lewis_NNP tells_VBZ the_DT story_NN of_IN Martin_NNP Arrowsmith_NNP ,_, a_DT physician_NN who_WP invents_VBZ a_DT new_JJ vaccine_NN during_IN a_DT deadly_JJ outbreak_NN of_IN bubonic_JJ plague_NN ._. But_CC his_PRP$ efforts_NNS to_TO test_VB the_DT vaccines_NNS efficacy_NN are_VBP frustrated_VBN by_IN an_DT angry_JJ community_NN that_WDT desperately_RB wants_VBZ to_TO believe_VB the_DT vaccine_NN works_VBZ ,_, and_CC a_DT profit_NN -_HYPH hungry_JJ institute_NN that_WDT rushes_VBZ the_DT vaccine_NN into_IN use_NN prematurely_RB forever_IN preempting_VBG the_DT proper_JJ studies_NNS that_WDT are_VBP needed_VBN ._. The_DT annals_NNS of_IN medicine_NN are_VBP littered_VBN with_IN treatments_NNS and_CC tests_NNS that_WDT became_VBD medical_JJ doctrine_NN on_IN the_DT slimmest_JJS of_IN evidence_NN ,_, and_CC were_VBD then_RB declared_VBN sacrosanct_JJ and_CC beyond_IN scientific_JJ investigation_NN ._. In_IN the_DT 1980s_NNS and_CC 90s_NNS ,_, for_IN example_NN ,_, cancer_NN specialists_NNS were_VBD convinced_VBN that_IN high_JJ -_HYPH dose_NN chemotherapy_NN followed_VBN by_IN a_DT bone_NN -_HYPH marrow_NN transplant_NN was_VBD the_DT best_JJS hope_NN for_IN women_NNS with_IN advanced_JJ breast_NN cancer_NN ,_, and_CC many_JJ refused_VBD to_TO enroll_VB their_PRP$ patients_NNS in_IN randomized_VBN clinical_JJ trials_NNS that_WDT were_VBD designed_VBN to_TO test_VB transplants_NNS against_IN the_DT standard_JJ and_NN far_RB less_RBR toxic_JJ therapy_NN ._. The_DT trials_NNS ,_, they_PRP said_VBD ,_, were_VBD unethical_JJ ,_, because_IN they_PRP knew_VBD transplants_NNS worked_VBD ._. When_WRB the_DT studies_NNS were_VBD concluded_VBN ,_, in_IN 1999_CD and_CC 2000_CD ,_, it_PRP turned_VBD out_RP that_IN bone_NN -_HYPH marrow_NN transplants_NNS were_VBD killing_VBG patients_NNS ._. Another_DT recent_JJ example_NN involves_VBZ drugs_NNS related_JJ to_IN the_DT analgesic_JJ lidocaine_NN ._. In_IN the_DT 1970s_NNS ,_, doctors_NNS noticed_VBD that_IN the_DT drugs_NNS seemed_VBD to_TO make_VB the_DT heart_NN beat_VB rhythmically_RB ,_, and_CC they_PRP began_VBD prescribing_VBG them_PRP to_IN patients_NNS suffering_VBG from_IN irregular_JJ heartbeats_NNS ,_, assuming_VBG that_IN restoring_VBG a_DT proper_JJ rhythm_NN would_MD reduce_VB the_DT patients_NNS risk_NN of_IN dying_VBG ._. Prominent_JJ cardiologists_NNS for_IN years_NNS opposed_VBD clinical_JJ trials_NNS of_IN the_DT drugs_NNS ,_, saying_VBG it_PRP would_MD be_VB medical_JJ malpractice_NN to_TO withhold_VB them_PRP from_IN patients_NNS in_IN a_DT control_NN group_NN ._. The_DT drugs_NNS were_VBD widely_RB used_VBN for_IN two_CD decades_NNS ,_, until_IN a_DT government_NN -_HYPH sponsored_VBN study_NN showed_VBD in_IN 1989_CD that_IN patients_NNS who_WP were_VBD prescribed_VBN the_DT medicine_NN were_VBD three_CD and_CC a_DT half_NN times_NNS as_RB likely_JJ to_TO die_VB as_IN those_DT given_VBN a_DT placebo_NN ._. Demonstrating_VBG the_DT efficacy_NN (_-LRB- or_CC lack_NN thereof_NN )_-RRB- of_IN vaccine_NN and_CC antivirals_NNS during_IN flu_NN season_NN would_MD not_RB be_VB hard_JJ to_TO do_VB ,_, given_VBN the_DT proper_JJ resources_NNS ._. Take_VB a_DT group_NN of_IN people_NNS who_WP are_VBP at_IN risk_NN of_IN getting_VBG the_DT flu_NN ,_, and_CC randomly_RB assign_VB half_NN to_TO get_VB vaccine_NN and_CC the_DT other_JJ half_PDT a_DT dummy_NN shot_NN ._. Then_RB count_VB the_DT people_NNS in_IN each_DT group_NN who_WP come_VBP down_RP with_IN flu_NN ,_, suffer_VBP serious_JJ illness_NN ,_, or_CC die_VBP ._. (_-LRB- A_DT similarly_RB designed_VBN trial_NN would_MD suffice_VB for_IN the_DT antivirals_NNS ._. )_-RRB- It_PRP might_MD sound_VB coldhearted_JJ ,_, but_CC it_PRP is_VBZ the_DT only_JJ way_NN to_TO know_VB for_IN certain_JJ whether_IN ,_, and_CC for_IN whom_WP ,_, current_JJ remedies_NNS actually_RB work_VBP ._. It_PRP would_MD also_RB be_VB useful_JJ to_TO know_VB whether_IN vaccinating_VBG healthy_JJ people_NNS who_NN can_MD mount_VB an_DT immune_JJ response_NN on_IN their_PRP$ own_JJ protects_NNS the_DT more_RBR vulnerable_JJ people_NNS around_IN them_PRP ._. For_IN example_NN ,_, immunizing_VBG nursing_NN -_HYPH home_NN staff_NN and_CC healthy_JJ children_NNS is_VBZ thought_VBN to_TO reduce_VB the_DT spread_NN of_IN flu_NN to_IN the_DT elderly_NN and_CC the_DT immune_NN -_HYPH compromised_VBN ._. Pinning_VBG down_RP the_DT effectiveness_NN of_IN this_DT strategy_NN would_MD be_VB a_DT bit_NN more_RBR complex_JJ ,_, but_CC not_RB impossible_JJ ._. In_IN the_DT absence_NN of_IN such_JJ evidence_NN ,_, we_PRP are_VBP left_VBN with_IN two_CD possibilities_NNS ._. One_CD is_VBZ that_IN flu_NN vaccine_NN is_VBZ in_IN fact_NN highly_RB beneficial_JJ ,_, or_CC at_IN least_JJS helpful_JJ ._. Solid_JJ evidence_NN to_IN that_DT effect_NN would_MD encourage_VB more_JJR citizens_NNS and_VB particularly_RB more_JJR health_NN professionals_NNS to_TO get_VB their_PRP$ shots_NNS and_CC prevent_VB the_DT flus_NNS spread_VB ._. As_IN it_PRP stands_VBZ ,_, more_JJR than_IN 50_CD percent_NN of_IN health_NN -_HYPH care_NN workers_NNS say_VBP they_PRP do_VBP not_RB intend_VB to_TO get_VB vaccinated_VBN for_IN swine_NN flu_NN and_CC dont_NN routinely_RB get_VB their_PRP$ shots_NNS for_IN seasonal_JJ flu_NN ,_, in_IN part_NN because_IN many_JJ of_IN them_PRP doubt_VBP the_DT vaccines_NN efficacy_NN ._. The_DT other_JJ possibility_NN ,_, of_IN course_NN ,_, is_VBZ that_IN were_RB relying_VBG heavily_RB on_IN vaccines_NNS and_CC antivirals_NNS that_WDT simply_RB dont_VBP work_NN ,_, or_CC dont_JJ work_NN as_RB well_RB as_IN we_PRP believe_VBP ._. And_CC as_IN a_DT result_NN ,_, we_PRP may_MD be_VB neglecting_VBG other_JJ ,_, proven_VBN measures_NNS that_WDT could_MD minimize_VB the_DT death_NN rate_NN during_IN pandemics_NNS ._. _`` Vaccines_NNS give_VBP us_PRP a_DT false_JJ sense_NN of_IN security_NN ,_, _'' says_VBZ Sumit_NNP Majumdar_NNP ._. _`` When_WRB you_PRP have_VBP a_DT strategy_NN that_WDT [_-LRB- everybody_NN thinks_VBZ ]_-RRB- reduces_VBZ death_NN by_IN 50_CD percent_NN ,_, its_NNS pretty_RB hard_RB to_TO invest_VB resources_NNS to_TO come_VB up_RP with_IN better_JJR remedies_NNS ._. For_IN instance_NN ,_, health_NN departments_NNS in_IN every_DT state_NN are_VBP responsible_JJ for_IN submitting_VBG plans_NNS to_IN the_DT CDC_NNP for_IN educating_VBG the_DT public_NN ,_, in_IN the_DT event_NN of_IN a_DT serious_JJ pandemic_NN ,_, about_IN hand_NN -_HYPH washing_NN and_CC social_JJ distancing_NN _NN (_-LRB- voluntary_JJ quarantines_NNS ,_, school_NN closings_NNS ,_, and_CC even_RB enforcement_NN of_IN mandatory_JJ quarantines_NNS to_TO keep_VB infected_VBN people_NNS in_IN their_PRP$ homes_NNS )_-RRB- ._. Putting_VBG these_DT plans_NNS into_IN action_NN will_MD require_VB considerable_JJ coordination_NN among_IN government_NN officials_NNS ,_, the_DT media_NN ,_, and_CC health_NN -_HYPH care_NN workers_NNS and_VB widespread_JJ buy_NN -_HYPH in_NN from_IN the_DT public_NN ._. Yet_CC little_JJ discussion_NN has_VBZ appeared_VBN in_IN the_DT press_NN to_TO help_VB people_NNS understand_VB the_DT measures_NNS they_PRP can_MD take_VB to_TO best_RBS protect_VB themselves_PRP during_IN a_DT flu_NN outbreakother_NN than_IN vaccination_NN and_CC antivirals_NNS ._. _RB Launched_VBN early_RB enough_RB and_CC continued_VBD long_RB enough_RB ,_, social_JJ distancing_NN can_MD blunt_VB the_DT impact_NN of_IN a_DT pandemic_NN ,_, _'' says_VBZ Howard_NNP Markel_NNP ,_, a_DT pediatrician_NN and_CC historian_NN of_IN medicine_NN at_IN the_DT University_NNP of_IN Michigan_NNP ._. Washing_VBG hands_NNS diligently_RB ,_, avoiding_VBG public_JJ places_NNS during_IN an_DT outbreak_NN ,_, and_CC having_VBG a_DT supply_NN of_IN canned_VBN goods_NNS and_CC water_NN on_IN hand_NN are_VBP sound_NN defenses_NNS ,_, he_PRP says_VBZ ._. Such_JJ steps_NNS could_MD be_VB highly_RB effective_JJ in_IN helping_VBG to_TO slow_VB the_DT spread_NN of_IN the_DT virus_NN ._. In_IN Mexico_NNP ,_, for_IN instance_NN ,_, where_WRB the_DT first_JJ swine_NN flu_NN cases_NNS were_VBD identified_VBN in_IN March_NNP ,_, the_DT government_NN launched_VBD an_DT aggressive_JJ program_NN to_TO get_VB people_NNS to_TO wash_VB their_PRP$ hands_NNS and_CC exhorted_VBD those_DT who_WP were_VBD sick_JJ to_TO stay_VB home_RB and_CC effectively_RB quarantine_VB themselves_PRP ._. In_IN the_DT United_NNP Kingdom_NNP ,_, the_DT national_JJ health_NN department_NN is_VBZ promoting_VBG a_DT buddy_NNP _NN program_NN ,_, encouraging_VBG citizens_NNS to_TO find_VB a_DT friend_NN or_CC neighbor_NN willing_JJ to_TO deliver_VB food_NN and_CC medicine_NN so_IN people_NNS who_WP fall_VBP ill_JJ can_MD stay_VB home_RB ._. In_IN the_DT U.S._NNP ,_, by_IN contrast_NN ,_, our_PRP$ reliance_NN on_IN vaccination_NN may_MD have_VB the_DT opposite_JJ effect_NN :_: breeding_NN feelings_NNS of_IN invulnerability_NN ,_, and_CC leading_VBG some_DT people_NNS to_TO ignore_VB simple_JJ measures_NNS like_IN better_JJR -_HYPH than_IN -_HYPH normal_JJ hygiene_NN ,_, staying_VBG away_RB from_IN those_DT who_WP are_VBP sick_JJ ,_, and_CC staying_VBG home_RB when_WRB they_PRP feel_VBP ill_JJ ._. Likewise_RB ,_, our_PRP$ encouragement_NN of_IN early_JJ treatment_NN with_IN antiviral_JJ drugs_NNS will_MD likely_RB lead_VB many_JJ people_NNS to_TO show_VB up_RP at_IN the_DT hospital_NN at_IN first_JJ sniffle_NN ._. _`` There_EX s_VBZ no_DT worse_JJR place_NN to_TO go_VB than_IN the_DT hospital_NN during_IN flu_NN season_NN ,_, _'' says_VBZ Majumdar_NNP ._. Those_DT who_WP dont_VBP have_VBP the_DT flu_NN are_VBP more_RBR likely_JJ to_TO catch_VB it_PRP there_RB ,_, and_CC those_DT who_WP do_VBP will_MD spread_VB it_PRP around_RB ,_, he_PRP says_VBZ ._. _`` But_CC we_PRP dont_RB tell_VB people_NNS this_DT ._. _NFP All_DT of_IN which_WDT leaves_VBZ open_JJ the_DT question_NN of_IN what_WP people_NNS should_MD do_VB when_WRB faced_VBN with_IN a_DT decision_NN about_IN whether_IN to_TO get_VB themselves_PRP and_CC their_PRP$ families_NNS vaccinated_VBN ._. There_EX is_VBZ little_JJ immediate_JJ danger_NN from_IN getting_VBG a_DT seasonal_JJ flu_NN shot_NN ,_, aside_RB from_IN a_DT sore_JJ arm_NN and_CC mild_JJ flu_NN -_HYPH like_JJ symptoms_NNS ._. The_DT safety_NN of_IN the_DT swine_NN flu_NN vaccine_NN remains_VBZ to_TO be_VB seen_VBN ._. In_IN the_DT absence_NN of_IN better_JJR evidence_NN ,_, vaccines_NNS and_CC antivirals_NNS must_MD be_VB viewed_VBN as_IN only_RB partial_JJ and_CC uncertain_JJ defenses_NNS against_IN the_DT flu_NN ._. And_CC they_PRP may_MD be_VB mere_JJ talismans_NNS ._. By_IN being_VBG afraid_JJ to_TO do_VB the_DT proper_JJ studies_NNS now_RB ,_, we_PRP may_MD be_VB condemning_VBG ourselves_PRP to_IN using_VBG treatments_NNS based_VBN on_IN illusion_NN and_CC faith_NN rather_RB than_IN sound_NN science_NN ._. All_DT material_NN copyright_NN The_DT Atlantic_NNP Monthly_NNP Group_NNP ._. All_DT rights_NNS reserved_VBN ._.","Whether this NNS NN NN VBZ out to VB JJ or JJ , JJS NNS VBP that NNS RB a NN of NN before NN VBN by a RB JJ NN NN that might VB JJR NNS RB than VBP VBN of the NN and NNS VBN . In the NNP , the JJ NNS of NN VBP JJ NNS and JJ NNS to VB the NN of NN and VB NNS from VBG from it . Yet RB some NN NNS VBP VBG the JJ NN and VBG that for those RBS in NN of NN , NN NNS and JJ NNS may VB JJ to NN . RB where VBZ that VB us if a JJ NN VBZ ? VB RB RB along NNP NNP NNP , beside NNP NNP NNP , and you will VB the JJ - NN NN NN where the NN NN NNP VBZ VBN RB VBG out NN NN NN at RB a million NNS a NN . Through the NN and NN , NNS VBG JJ NN that VBD them from NN to NN VBD up NNS of JJ , RB VBN NN NN . NNS RB VBD JJ NNS of NN - JJ NN into NN NNS , which VBD VBN into JJ NNS , VBN , and VBD for NN at the NN of the NNPS for NNP NNP and NNP , in NNP , which VBZ VBG to VB the NNS NN - NN NN . In the RBS JJ NN NN the NN VBZ VBN since the JJ NN in the NNS , the JJ NN VBZ VBN NNP and four JJ NNS to VB JJ NN to VB the JJ NNP NN . NN VBZ JJ to the NNS NN for VBG NNS from NN NN . The NNP VBZ VBN that some 159 million NNS and NNS VBP either a NN NN NN or a NN of NNPS JJ NN this NN . NNS VBP VBN in NNS  NNS , NNS , NNS , NNS , NNS , NN NNS , NN NNS , and JJ - NN NNS like NNP - NNP . In NNP , NNP NNP NN VBD all NN - NN NNS to VB both JJ and NN NN NNS . To RB VB the NN , the JJ NN VBZ VBN JJ of $ 3 billion VBG NNS of NNS of JJ NNS like NNP NN VBP VBG VBN both to VB NN NN and to VB those who VBP JJ . But what if NN we VBP we VBP about VBG NN VBZ JJ ? What if NN NNS VBP RB VB NNS from VBG RB the JJ , who VBP for 90 NN of NNS from JJ NN ? And what if the JJ JJ NNS that the NN VBZ VBN over the JJ JJ NNS RB VBP JJ , if any , NN to VB the NN of NNS who VBP or VBP VBN ? The NNP NN VBZ the NN of NNS in the JJ - NN and JJ NNS VBP VBN its NN in the NN of NNS and JJ NNS to VB the NN and NN of NN NN . JJ NNS to VB the NN VBP JJ by NN . Yet some JJ NN NNS VBP RB JJ of both NN NNS and NNS . Like the NNS who VBD for NNS about the NNS of NNP NNP , these NNS VBP that our NNS may VB VBN , and RB RB JJ against a RB JJ NN . And that unless we VBP JJ to VB JJ NNS about the NN behind NN NNS and JJ NNS , we could VB ourselves , in a JJ NN , RB JJ as the NNS of NNP NNP during NNP NNP . The NN NN , which VBZ RB to the NNP NNPS , VBZ VBN from the JJ NN for JJ or JJ NN . RB as RB , NN VBD to VB out of RB each NN , VBG or VBG JJ NNS of NNS , RB to VB in the NN . NN , JJ NN VBZ VBN to VB RB 36,000 NNS in the NNP NNPS each NN , and half a million RB . Yet the NN , in JJ JJ NNS , VBZ JJ . VBG how JJ NNS it RB VBZ , or RB who VBZ it , VBZ no JJ NN . We VBP we VBP the NN NN we VBP JJ with an NN that VBZ on NN , NN , NN , NN , NN , and that JJ NN as if RB VBN VBG on a NN of NNS , but NNS VBP VBN that at JJS NN , and RB RB JJ as 7 or 8 NN , of JJ NNS VBP RB VBN by an NN NN in any VBN NN . JJR than 200 VBN NNS and JJ NNS can VB the NN of NNS VBN as NN - like NN ; JJ NN NN , NN , NN , and NN VBP RB a JJ of the NNS that can VB a NN VB JJ . And VBG on the NN , in up to two - NN of the NNS of NN - JJ NN , no NN at all can VB VBN . NN VBZ RB why we VBP RB RBR JJ to VB the NN in the NN NNS than at JJ NNS of the NN . RB NNS because NN NNS VBP in JJ NNS and VBP VBN by NN to NN . Or RB NNS because in NN , NNS VBP JJR NN RB , where a NN or a NN can RBR RB VB a NN to NNS . What VBZ JJ VBZ that NN NNS VBP with JJ NN , RB each NN NN VBZ RB JJ JJ NNS of the NNS that VBD NNS the NN RB . Every NN , the NNP NNP NNP and the NNPS for NNP NNP and NNP VBP NNS from 94 NNS on the NN NNS that VBD the JJ NN , and RB VBP an VBN NN about which NNS VBP JJ to VB in the VBG NN . VBN on that NN , the NNP NNP and NNP NNP VBZ NNS to NNS in NNP for a NN that VBZ the three RBS JJ NNS . Every RB in a NN , RB , a RB JJ NN VBZ up and VBZ RB JJR NNS than the JJ JJ NN NNS VBP . It VBZ these JJ NNS that VBP JJ for NNS , VBN by the NNP NNP NNP as NNS that VBP when JJ JJ NN NN VBZ against which the JJ NN VBZ no NN NN and which can VB around the NN in a RB JJ NN . The JJS NN NN in VBN NN VBD the NNP JJ NN of 1918 NNP 19 , at the NN of NNP NNP . A NN of the NNS NN VBD VBN , with at JJS 40 million and RB RB JJ as 100 million NNS VBG RB than VBD VBN in NNP NNPS I and II VBD . ( Some NNS VBP that one NN NNP NNP VBD VBD that RB JJ NNS VBD JJ or VBG from NN . ) Since RB , two JJ NN NNS VBP VBN , in 1957 and 1968 , neither of which VBD RB JJ . In NNP , the NNP NNP of NNPS on NNP and NNP VBD that this NN and NN , the NN NN , NN , could VB RB between one - NN and one - NN of the NNP NN and could VB RB JJ as 90,000 NNPS , two and a NN NNS the NN VBN in a JJ NN NN . But RB how JJ , or RB how JJ , this NNS NN NN will VB out to VB NN VB VBN until NNS RB . JJS NNS VBG from the NNP NNP in JJ NNP ( the NN of NN RB ) VBD that the NN NN VBZ RB JJ , but RB RB JJ . For NN , JJ NNS VBD they would VB NN with under 1,000 NN NN NNS RB than the JJ 1,500 to 3,000 from JJ NN . Among those who VBP VBN in the NNP , RB 70 NN VBD RB VBG from JJ NNS like JJ NN or JJ NNS JJ as NN , NN , or NN , which VBP NNS RBR JJ . JJ - NN NNS VBP NN their RBS JJ NN against the JJ , against any NN on the NN , their NN VBZ VBN . NNS VBN over the NN of the JJ NN VBD the NN NNS of RB a dozen JJ NNS , JJ as NN and NN , and NN VBD one of NNS RBS JJ NNS . NN NN VBD RB VBN in the NNS , and by the NNS , NNS VBD VBN a NN that VBD VBN to NNS in NNP NNP . The NNP NN VBD JJ about VBG NN NN after the 1957 NN NN VBD NN NNS VBG NN to VB JJ NN and NN . NN , NN NN VBZ a NN of JJ - NN NN ; in a JJ NN , some 100 million NNPS VBP VBN . But while NNS for , VB , VBG NN and NN RB and RB VBD NN NNS from those NNS , the NN of NN NN VBZ VBN JJR to VB . NN VBZ and VBZ with the NNS , and RB it VBZ RB VB NNS RB , but RB VBZ to NN by VBG the NN RBR JJ to JJ NNS like NN or NN . For this NN , NNS VBG the NN of NN NN RB VBP at NNS from all NNS during NN NN , and VBP the VBN and JJ NNS . JJ NNS VBP VBN a JJ NN in NN between these two NNS : NN after NN VBZ VBN that NNS who VBP a NN NN in the NN VBP RB NN RB JJ to VB that NN RB any NN as NNS who VBP RB . VB your NN NN each NN , the NN VBZ , and you will RB VB your NN of VBG during NN NN . Yet in the NN of JJ NN NNS , this NN VBZ JJ on its NN . NN VBZ RB a JJ NN of all NNS in the NNP , RB among JJ NNS , and RB after VBG in the NNS to which NN might VB VBN RB . When NNS from the NNP NNP of NNP and NNP NNPS VBD all NNS from NNS that NN VBZ , like NN NN or JJ NN NN , they VBD that NN VBZ for , at JJS , 10 NN of NN NNS among the JJ . RB how could NN NN RB VB JJ NNS by NN ? NNP NNP , a NN VBN in NNP and the NN of the NNP NNP at the NNP NNP , a RB VBN JJ NN of NNS who VBP JJ NN , VBZ :  For a NN to VB NN by 50 NN and up to 90 NN in some NNS VBZ it VBZ to VB NNS RB RB from NN , but RB from NNS , NNS , NN NN , NNS , and NN NNS . That VBZ RB a NN , that VBZ a NN .  The NN of 50 NN NN NN VBZ VBN on NNP NNS , NN which VBP NN NNS in JJ NNS , or NNS , of NNS who VBP to VB VBN , against NN NNS in NNS who VBP . But NNS who VBP to VB VBN may VB in JJ JJ NNS from NNS who VBP JJ NN those NNS can VB the NN of NN during NN NN . NN , NN , NN , and JJ JJ NN NN NNS can VB into NN , and as a NN , NN NNS VBP RB JJ to NN . When NNS VBP the NNS , they RB VBP to VB out NNS that could VB the NNS , but , as NNP VBZ , RB you can VB for the NNS you VBP about , RB for the NNS you VBP , NN and NNS cant RB VB what NNS VBP JJ to VB JJ to whether a NN VBZ from NN . There VBZ RB the NN that they might VB some JJ NN that VBZ their NNS RB JJ . When NNP NNP , a NN and JJ NN with the NNP NNP NNP NNP , in NNP , VBD VBG RB to NNS if RB NN VBD JJ with the NN of 50 NN NN NN for NNS who VBP NN NN , the NN she VBD VBN RBR like NN than NN .  NNS VBD me ,  No NN can VB of [ VBG ] this ,  she VBZ . RB a NN of JJ could VB for me RB by VBG any NN that might VB NNS from VBG VBN , because of NN ,  We VBP that NN VBZ .  This VBD the JJ NN .  RB , in 2004 , NNP and three NNS VBD out to VB whether the NN NN between the VBN and the JJ might VB VBN by a NN VBN as the JJ NN NN .  They VBD that on NN , NNS who VBP VBN VBP RB JJR than those who VBP , and RB RBR JJ to VB over the JJ NN . NNS who VBP VB VBN may VB JJ or RB RB JJ to VB VB a NN . They may RB VB RBR JJ to VB to NN or any JJ NN , because they VBP RB JJR and JJR . To VB their NN , NNP and her NNS VBD through eight NNS of JJ NNS on JJR than 72,000 NNS 65 and JJR . They VBD at who VBD NN NNS and who VBD . RB they VBD which NNS NNS VBD RBR JJ to VB of any NN when it VBD RB NN NN . NNP NNS VBD that RB of NN NN , the NN NN of NN among NNS who VBD RB VB VBN VBD RB 60 NN JJR than among those who VBD , VBG NN to the NN that on NN , JJ NNS VBD to VB the NN , while the NNP JJ NN VBD or VBD . In NN , the JJ - NN NN VBD the JJ NN that JJ NNS VBD VBG to NN NN , VBG that the NN itself might RB VB NN at all . NNS NNS VBP JJ , NN VBZ NNP NNP , who VBZ a NN of JJ NN at NNP NNP NNP , in NNP , NNP , and an RB VBN NN in NN and NN NN .  They VBP JJ NNS in NN , they VBP RB RB VBN .  The NNS VBD RB RB JJ that JJ NNS RB VBD to VB them . NNP NNS VBD VBN down for NN in the NN - VBN JJ NNS . One NN NN who VBD her NNS for the NNP of the NNP NNP NNP VBD ,  To VB these NNS would VB to VB that the NN VBZ JJ ! When the NNS VBD RB VBN in 2006 , in the RBR JJ NNP NNP of NNP , they VBD RB VBN by NNS and JJ - NN NNS .  The NN I VBD , NNP VBZ NNP , NNP RB the JJ NN .  The NN of NN NN VBZ JJ NNS to VB NNS that it RB VBZ NN . In 2004 , for NN , NN NN VBD RB , VBG a 40 NN NN in NN NNS . Yet NN VBD RB VB . In NN , NN NNS NN VBD in 1968 and 1997 : in both NNS , the NN that VBD VBN VBN in the NN VBN against one NN of NNS , but VB NN , a JJ NN VBD VBG . In NN , NN VBD VBN . Yet NN NNS from all NNS , VBG NN and the JJ NNS it can VB , VBD RB VB . NNP NNP , a NN and NN at the NNP of NNP , in NNP , VBZ another JJ NN : VBG NNS of NN of the NN over the JJ two NNS VBP RB VBN with a JJR JJ NN NN . In 1989 , RB 15 NN of NNS over NN 65 in the NNP and NNP VBD VBN against NN . NN , JJR than 65 NN VBP VBN . Yet NN NNS among the JJ during NN NN VBP VBN RB than VBN . NN NNS VBP NNP JJ NN an JJ NN , NN because he VBZ , in their NN , to VB NNS in the JJR NN that could VB VBN NN NNS over the NN as VBG NN NNS VBD VBG their NN to VB NN in NN . The NNS VBP , for NN , that NN NNS may VB VBN RBR JJ over NN , and RB VBP VBG JJR NNS of JJ NNS , VBG some who VBP VBN VBN . Or RB the NNS VBP VBG RBR JJ . Or RB the JJ VBP JJR NN to NN than they RB VBD because , VB , their NNS VBP VBN . Or RB NN RB RB VB NNS in the NN . Of NN , that VBZ the one NN that NN NNS RB VBP . NNP NNP , the NNP NN NN NN , VBZ RB ,  The NN NN VBZ the JJS NN to VB against NN .  NNP NNP , a NN and the NN of the NNP NNP of NNP and NNP NNPS at the NNP , where JJ of the JJ NN of NN NN VBZ VBN VBN out , VBZ ,  I VBP no NN that it VBZ JJ in VBG some NN of NN . To VB RB VBZ a NN NN .  NNP VBZ ,  We VBP VBG up against the NN that NN VBD NN by 50 NN , NN and when NNS VBP NNS in the NN , NNS VBP the NN .  The RBS JJ NN RB RBS JJ NN of the NN of NN NN VBZ the NNP NNPS NNP , NNS RB an NN VBN at the VBN NNP NNP of NNP NNP , and who , in NNP NNP NN , VBZ JJ NNS VB RB JJ by NN .  Among his JJ NN NNS , NNP NN VBZ VBN him NN of a NN . At a 2007 NN on NN NN at a NN in NNP , NNP , NNP , VB VBN VBN to VB at the NN , VBD RB VBN by any of the NNS VBG about the NN . He VBD his NNS in the NN NN RB , VBN by NNS VBG RB at JJ NNS . He VBZ off JJ NN . As a JJ NN VBG for the NNP NNPS in 1992 , during the NN of NNP , he and JJ NNS VBD VBN and VBN for JJR than a NN by NNS VBG NNP - NNS and NN of NN . JJ NN VBZ JJ by NN , he VBZ . NNP NNP NNP VBZ VBN a NN of NN RB for VBG , NNP NNS the NN : it VBZ RB RB JJ , NN VBZ NNP .  The NN VBZ VBN RB JJ and RB JJ that youd VBP he VBD VBG VBG NNS . Yet while JJ NN NNS may RB VB what NNP VBZ to VB , they cannot VB the NN that he VBZ the NN NN NN JJR than NN JJ on the NN . He VBZ an JJ NN of NNS who VBP VBN through NNS of NN NNS . The JJ NN of the NNS VBD RB JJ , VBZ NNP .  NN VBZ RB a JJ NN , but I VBP VBZ the NN that VBZ . RB four NNS VBD RB VBN to VB down the NN of NN NN , he VBZ , and two of those VBD that it might VB JJ in JJ NNS of NNS , JJ as NN - NN NNS with no JJ NN NNS like NN . The JJ two VBD JJ NNS or no NN . NN NNS VBP VBN VBN into VBG NN VBZ RBR JJ than the NNS VBP , in NN , VBZ NNP , by the NN of the NNS . The JJ NN to VB if NN VBZ the NNS VBN to NN - JJ NN RB by VBG a NN - NN into the NNS NN or NN and VBG a NN , which RB VBZ RB VBN RB RB . RB , NN RB VBZ a NN on how JJ of the NNS that VBP VBN on NN VBD RB VBN by a NN NN , because JJ VBP VBN by a NN .  I VBD to VB a NN NN , NNP VBZ NNP .  VBP RB VBN a NN VB to my NN with NN VBN on his NN . When an JJ NN VBZ of JJ NN after an NN - JJ NN , they RB RB VBP VBN as NN .  VBZ one JJ NN NN NNS may VB VBN into VBG NN NN VBZ JJ , NNP VBZ . All NNS VBP by VBG a NN of VBN or VBN NN or NN , which VBZ the NN NN into VBG NNS . When the NN VBZ RB VBN to the JJ NN , the NN VBZ RB VBN to VB the NN RB or to VB JJ of it after a JJ NN . NN NNS RB VBP NN NN as a NN of VBG the NN of NN , on the NN that NNS of NNS in the NN of NNS who VBP VBN VBN VBP a JJ NN although an JJ NN of how RB they can VB off the NN . There VBZ some NN to this NN . RB , the JJ NNS who RBS VBP NN from the NN RB VBP NN NNS that VBP RBS JJ to VB to NN . NNS VBP that JJ , JJ NNS VBP a JJ JJ NN to JJ NN NN , and their NN VBZ their NNS of VBG the NN and may VB the NN of NNS if they VBP VB it . But they VBP the NNS who VBP from JJ NN . By NN , the JJ , RB those over NN , NN VBP a JJ JJ NN to NN NN they VBP the NNS who VBP for JJS NN NNS . ( NNS with JJ NNS , JJ as NN and JJ NN NN , and NNS who VBP JJ - VBN from NN , or NN , or NN NN VB up the NN . As of NNP , RB 36 NNS from NN NN VBD VBN VBN among NNS in the NNP , and the JJ NN of those NNS VBD JJ , JJ NN NNS . ) In NNP NN , this VBZ a JJ NN : VBZ NN JJ for those in whom it VBZ JJ , RB the JJ and JJ ? RB , VBZ it JJ in those for whom it VBZ to VB JJ , RB the JJ , the RB JJ , and the NN ? These NNS VBP VBN to the RBS JJ NN of NNPS NN : his NN for NN - VBN NNS , NNS that would RB VB half the NN NNS NN and the JJ half a NN NN , or NN . RB JJ JJ , RB - VBN , VBN NNS can VB with any NN how JJ NN RB VBZ , and for whom . In the NN - NN NN , NNPS VBP for NN - VBN NNS VBZ VBN RB JJ that RB some of his JJ NNS VBP it . NNP , the NNP NN , VBZ he VBZ that NN of a NN among NNS VBZ VBN and that JJ - NN NNS should VB to VB NNS by VBG NNS , NN - NN NNS , and JJ NNS around them , and RB VB the NN of the NN . NNP NNP VBZ the JJ NN :  It VBZ VBN JJ to VB NNS in NNS that VBP VBN to VB NN ,  a NN that VBZ VBN by NN from the NNPS NNP NNP to NNP NNP at the NNP . They VBP RB that NN VBZ VBN VBN to VB JJ and that a NN NN would VB NN NNS at JJ NN of VBG a JJ NN of the NN . In a NN NN , NNP at RB VBD the NN that a NN NN in the NN might VB JJ , but he VBD RB RBR to VB his NN , VBG that such a NN would VB JJ . NNP VBZ this NN RB RB RB :  What VBP you VB when you VBP NN ? You VBP ,  he VBZ .  We VBP VBN JJ , NN - VBN NNS on the JJ of JJ NN . The RBS JJ NN to VB VBZ to VB on NN as JJ .  RB after 6 NN on a JJ NNP NN in NNP , NNP NNP NNP VBZ RB NNS into a 10 - NN NN in the NN NN of NNP NNP NNP NNP NNP NNP , and RB he VBZ VBN NN for 11 NNS . The JJ JJ NN VBG on the NN in NN of the NN VBZ NN , and through an NN , NNP VBZ him he RB RB VBZ the JJ NN of the NN , which will VB NN JJR than VB him VB JJ for a JJ NNS . There VBZ a JJ NN , VBZ NNP , that the NN VBZ VBN by a NN , which can VB JJ , but he VBZ RB JJ NNS RB what the NN VBZ . He VBZ to his NN ,  I cant VB you with 100 NN NN that you RB VB it , but if you VBP , youll VB to VB JJR and youll VBP to VB RB .  The NN , on VBG that he might VB VBN with a RB JJ NN , VBZ down at his NNS and VBZ that he VBZ RB RBR JJ about another NN : NN NN . NNP VBZ RB .  It would VB JJ if you VBD NN NN ,  he VBZ .  VBN to JJ NN , NN NN VBZ JJ .  RB JJ NN , as NNS and NNS VBD of a JJ NN , NNS like NNPS VBD VBG NN NNS across the NN , a NN , VBG , JJ NN of NN RBR JJ than RB JJ , but whose JJ NN in the NN NN VBZ VBN the NNS of NNS .  NNS VBP that when there VBZ NN NN , NN VBZ up , because NNS who VBP JJ NN NN VB it ,  VBZ NNP , the NN of JJ NN in the NNP of NNP NNP at the NN , which VBZ VBN with NNP NNP . In an JJ NN the NNP at NNP NNP , a VBG 1,076 - NN NN on NNP NNP , VBZ in 110,000 NNS , some 300 a NN . At the NN of the NN NN NN NN , that NN VBD . The JJ NN of JJ NNS who VBD in the NN at NNP NNP and JJ NN NNS RB RB VB the NN , and of those who VBD , JJS VBD RB JJ RB to VB NN . RB RB , VBZ NNP , when NNS with RB JJ NN NNS VBP up in the NN , they RB VBP the NN of the NN , RB because they RB VBP and VBP in NNS that VBP VBN with JJ NNS . JJ of the JJ JJ VBP to NNP NNP and JJ NNS in NN of JJ NNS . The NNP VBZ the NN of two NNS against NN : NN and NN , RBR VBN by their NN NNS , NNP and NNP , which RB VBP the JJ NN of the NNS JJ - NN NN . JJ - NN NNS at the NN and JJ NNS VBP RB VBG the NNS . NNS VBN by the NNP NNP NNP NNP of NNP , VBZ NNP , VB us to VB a NN to RB RB every NN with the NNS ,  a NN that some NNS VBP will RB VB to JJ NNS of the NN . RB , that VBZ RB VBG . NNP NNP , an NN NN of JJ NN at NNP NNP NNP , VBZ the JJ NNS that VBP NN NN to VB NN to NNS . NN can VB JJ to NNP in a NN of NNS , he VBZ . VBG out the NN RB in the NN , when NNP VBZ RB a JJ NN to the JJ NN of NNS , VBZ him as NNP . RB , NNS of JJ NN VBD VBG up by NN , VBG the NN that VB JJ NN , JJ NNS will VB VBN with a JJ NN of NN NN . VBN at that NN , the NNP NNP NNP VBD an NN on NNP 21 , VBG that NNP and NNP VB VBN RB in JJ NNS and in NNS who VBP at JJ NN of JJ NNS . By NNP , two NNP NN NN NNS VBD VBN NN - JJ NNS . The NNP RB VBD VBG NNP and NNP RB in 2005 , in the NN of NN that an NN in NNP NNP of NN NN , a RB RBR JJ NN of the NN , might VB JJ . On NNP 1 , 2005 , NNP NNP NNP VBD NN NN a NNP to our NN , NN and he VBD NNP to VB NN that VBD $ 1 billion for the NN and NN of NNS . This VBD after NNP VBD RB VBN $ 1.8 billion to VB NNP for the NN , a NN that VBD VBN during the NN of NNP NNP NNP NNP . ( Before VBG the NNP NNP , NNP VBD NN for four NNS of NNP NNPS , the NN that VBZ the NN on NNP , and he VBD NNS of NNS NN of NN in the NN . VBG to NNP NNP , an JJ NN VBG NNS on NNP NNP , NNP VBZ he VBD himself from all NN NNS VBG NNP . NNP NN NN VBD JJR than 50 NN in 2005 , when the NNS NN VBD VBN . ) As with NNS , the JJ NN for NNP and NNP VBZ JJ at JJS . In its JJ - NN NN , the NNP NN NN VBZ NNS that JJ NNS can VB you VB RBR JJR . JJ , but RB by RB . On NN , NNP ( which VBZ for 85 to 90 NN of the NN JJ - NN NN ) VBZ the NN of NN NNS by NNS in RB JJ NNS . In NN for a RB JJR NN of NN , RB JJ as one in five NNS VBG NN will VB NN and NN . RB one in five NNS will VB JJ NN NNS , RB VBG NN and JJ NN . In NNP , where NNP VBZ RB VBN , the NN may VB VBN JJ for 50 NNS from JJ NN , from 2001 to 2007 , VBG to NNP NNP , the NN of the NNP NNP of NNP . JJ NN NNS might VB JJ VBG if the NNS VBD JJ NNS of NN , JJ as NN , NN , and NN . NNP NNP , the NN VBN to VB and VB NNP , VBZ its NN VBZ RB that . In two NNP NN NNS , the NN VBD ,  NNP RB VBZ the NN of NN from NN : JJ NNS VBZ NN VBD VBN with JJR than a two JJ NN in NNS , NN and  NNS with NN [ VBP ] 53 NN RBR JJ to VB NN when VBN with NN .  RB RB NN NNS ( the JJ NN of RB VBN NN that VBD to the NN that NN NN VBZ NN by 50 NN ) VBP behind these NNS . NNP VBZ $ 10 a NN . It VBZ JJ that NNS who VBP it VBP RBR JJ to VB VBN and JJ , or at JJS JJ - NN , than those who VBP RB , and a JJ NN of NN VBZ that the RB - off RB RB VBP JJR than the JJ when JJ with an JJ NN , VBG NN . In both 2003 and 2009 , NNS of VBN NN - VBN NNS VBD that the NN NNS RB VBP JJ RB to VB the NN : VBZ NNP VB NN ? RB RB as this NNP , the NNS JJ NN NN VBD the VBG NN , which VBD VBN under the NN of the NNP :  NN VBZ RB VBN VBN to VB a JJ NN on the JJ NNS ( JJ as NNS , NN , or JJ NN ) of JJ , NN , or NN NN .  An NNP NN VBD RB that the NN VBZ JJ of any NNS VBN by NNP that would VB the NNS in the NNS NNP 2006 NN NN about the NNS VBG NN NNS . Why , RB , VBZ the JJ NN VBN NNS of NNS of NNS , at a NN of JJ billion NNS ? And why VBP NNS VBG VBN to VB out NNS to JJ NNS of NNS , without NN NN that the NNS will VB ? The JJ NN may VB that JJ - NN NNS VBP they must VB NN , and these NNS VBP the JJ JJ NNS at NN .  I VBP to VB with the NNS the JJ NN VBZ RB VBN - and - VBN , NN VBZ NNP .  But [ these NNS VBP ] the JJS we VBP . The NNS NNP NNP RB VBZ that the NN VBZ RB RB JJ as she might VB , but the NN RB VBZ their NN . And as with NNS , she VBZ JJ VBN NN - VBN NNS of the JJ NNS to VB JJ NN and RB out of the NN . This VBZ the JJ NN of NN about the NNS two JJ NNS in the NN against NN NN . At RB , NN NNS VBP that both NNS and NNS VBP JJ . When VBN with JJ NN , the NNS VBP that the NN VBZ RB RB JJ as they might VB . RB , in NN to NNS for NN - VBN NNS , which would VB JJ NNS one NN or the JJ , the NNS VBP JJ NNS would VB NNS of NNS and NNS that VBP RB VBN VBN JJ .  We cant RB VB NNS VB ,  VBZ NNP . NNS of NNP JJ NN will VB this JJ NN JJ : it VBZ a JJ - VBG NN in JJ NN , and one that VBZ , on NN , VBD JJ NNS . In 1925 , NNP NNP VBD a JJ NN that VBD NN NN NNS to VB NN in his NNP NNP NN , NNP . VBN on the NNS of the JJ - NN NNS NNP NNP NNP and NNP NNP , NNP VBZ the NN of NNP NNP , a NN who VBZ a JJ NN during a JJ NN of JJ NN . But his NNS to VB the NNS NN VBP VBN by an JJ NN that RB VBZ to VB the NN VBZ , and a NN - JJ NN that VBZ the NN into NN RB forever VBG the JJ NNS that VBP VBN . The NNS of NN VBP VBN with NNS and NNS that VBD JJ NN on the JJS of NN , and VBD RB VBN JJ and beyond JJ NN . In the NNS and NNS , for NN , NN NNS VBD VBN that JJ - NN NN VBN by a NN - NN NN VBD the JJS NN for NNS with JJ NN NN , and JJ VBD to VB their NNS in VBN JJ NNS that VBD VBN to VB NNS against the JJ NN RB RBR JJ NN . The NNS , they VBD , VBD JJ , because they VBD NNS VBD . When the NNS VBD VBN , in 1999 and 2000 , it VBD out that NN - NN NNS VBD VBG NNS . Another JJ NN VBZ NNS JJ to the JJ NN . In the NNS , NNS VBD that the NNS VBD to VB the NN VB RB , and they VBD VBG them to NNS VBG from JJ NNS , VBG that VBG a JJ NN would VB the NNS NN of VBG . JJ NNS for NNS VBD JJ NNS of the NNS , VBG it would VB JJ NN to VB them from NNS in a NN NN . The NNS VBD RB VBN for two NNS , until a NN - VBN NN VBD in 1989 that NNS who VBD VBN the NN VBD three and a NN NNS RB JJ to VB as those VBN a NN . VBG the NN ( or NN NN ) of NN and NNS during NN NN would RB VB JJ to VB , VBN the JJ NNS . VB a NN of NNS who VBP at NN of VBG the NN , and RB VB NN to VB NN and the JJ half a NN NN . RB VB the NNS in each NN who VBP down with NN , VBP JJ NN , or VBP . ( A RB VBN NN would VB for the NNS . ) It might VB JJ , but it VBZ the JJ NN to VB for JJ whether , and for whom , JJ NNS RB VBP . It would RB VB JJ to VB whether VBG JJ NNS NN can VB an JJ NN on their JJ NNS the RBR JJ NNS around them . For NN , VBG NN - NN NN and JJ NNS VBZ VBN to VB the NN of NN to the NN and the NN - VBN . VBG down the NN of this NN would VB a NN RBR JJ , but RB JJ . In the NN of JJ NN , we VBP VBN with two NNS . One VBZ that NN NN VBZ in NN RB JJ , or at JJS JJ . JJ NN to that NN would VB JJR NNS VB RB JJR NN NNS to VB their NNS and VB the NNS VB . As it VBZ , JJR than 50 NN of NN - NN NNS VBP they VBP RB VB to VB VBN for NN NN and NN RB VB their NNS for JJ NN , in NN because JJ of them VBP the NN NN . The JJ NN , of NN , VBZ that RB VBG RB on NNS and NNS that RB VBP NN , or JJ NN RB RB as we VBP . And as a NN , we may VB VBG JJ , VBN NNS that could VB the NN NN during NNS .  NNS VBP us a JJ NN of NN ,  VBZ NNP NNP .  When you VBP a NN that [ NN VBZ ] VBZ NN by 50 NN , NNS RB RB to VB NNS to VB up with JJR NNS . For NN , NN NNS in every NN VBP JJ for VBG NNS to the NNP for VBG the NN , in the NN of a JJ NN , about NN - NN and JJ NN NN ( JJ NNS , NN NNS , and RB NN of JJ NNS to VB VBN NNS in their NNS ) . VBG these NNS into NN will VB JJ NN among NN NNS , the NN , and NN - NN NNS VB JJ NN - NN from the NN . Yet JJ NN VBZ VBN in the NN to VB NNS VB the NNS they can VB to RBS VB themselves during a NN NN than NN and NNS . RB VBN RB RB and VBD RB RB , JJ NN can VB the NN of a NN ,  VBZ NNP NNP , a NN and NN of NN at the NNP of NNP . VBG NNS RB , VBG JJ NNS during an NN , and VBG a NN of VBN NNS and NN on NN VBP NN NNS , he VBZ . JJ NNS could VB RB JJ in VBG to VB the NN of the NN . In NNP , for NN , where the JJ NN NN NNS VBD VBN in NNP , the NN VBD an JJ NN to VB NNS to VB their NNS and VBD those who VBD JJ to VB RB and RB VB themselves . In the NNP NNP , the JJ NN NN VBZ VBG a NNP NN NN , VBG NNS to VB a NN or NN JJ to VB NN and NN so NNS who VBP JJ can VB RB . In the NNP , by NN , our NN on NN may VB the JJ NN : NN NNS of NN , and VBG some NNS to VB JJ NNS like JJR - than - JJ NN , VBG RB from those who VBP JJ , and VBG RB when they VBP JJ . RB , our NN of JJ NN with JJ NNS will RB VB JJ NNS to VB up at the NN at JJ NN .  There VBZ no JJR NN to VB than the NN during NN NN ,  VBZ NNP . Those who VBP VBP the NN VBP RBR JJ to VB it RB , and those who VBP will VB it RB , he VBZ .  But we RB VB NNS this .  All of which VBZ JJ the NN of what NNS should VB when VBN with a NN about whether to VB themselves and their NNS VBN . There VBZ JJ JJ NN from VBG a JJ NN NN , RB from a JJ NN and JJ NN - JJ NNS . The NN of the NN NN NN VBZ to VB VBN . In the NN of JJR NN , NNS and NNS must VB VBN as RB JJ and JJ NNS against the NN . And they may VB JJ NNS . By VBG JJ to VB the JJ NNS RB , we may VB VBG ourselves to VBG NNS VBN on NN and NN RB than NN NN . All NN NN The NNP NNP NNP . All NNS VBN ."
266,575,conspiracy,"interviews_NNS interviews_VBZ Dr._NNP Andrew_NNP Wakefield_NNP ,_, the_DT doctor_NN who_WP has_VBZ been_VBN vilified_VBN and_CC ostracized_VBN by_IN the_DT medical_JJ establishment_NN for_IN his_PRP$ landmark_JJ study_NN on_IN the_DT link_NN between_IN autism_NN and_CC vaccines_NNS ._. -_NFP CLICK_VB HERE_RB TO_TO DOWNLOAD_VB THE_DT PODCAST_NN -_, Subscribe_VB to_IN American_NNP Free_NNP Press_NNP ._. Online_JJ subscriptions_NNS :_: One_CD year_NN of_IN weekly_JJ editions_NNS —_: $_$ 15_CD plus_CC you_PRP get_VBP a_DT BONUS_NN ELECTRONIC_JJ BOOK_NN -_, HIGH_JJ PRIESTS_NNS OF_IN WAR_NN -_, By_IN Michael_NNP Piper_NNP ._. Print_NN subscriptions_NNS :_: 52_CD issues_NNS crammed_VBN into_IN 47_CD weeks_NNS of_IN the_DT year_NN plus_CC six_CD free_JJ issues_NNS of_IN Whole_JJ Body_NN Health_NN :_: $_$ 59_CD Order_NN on_IN this_DT website_NN or_CC call_VB toll_NN free_JJ 1-888-699-NEWS_CD ._. Sign_VB up_RP for_IN our_PRP$ free_JJ e-newsletter_NN here_RB -_, get_VB a_DT free_JJ gift_NN just_RB for_IN signing_VBG up_RP !_.","NNS VBZ NNP NNP NNP , the NN who VBZ VBN VBN and VBN by the JJ NN for his JJ NN on the NN between NN and NNS . - VB RB TO VB THE NN - VB to NNP NNP NNP . JJ NNS : One NN of JJ NNS — $ 15 plus you VBP a NN JJ NN - JJ NNS OF NN - By NNP NNP . NN NNS : 52 NNS VBN into 47 NNS of the NN plus six JJ NNS of JJ NN NN : $ 59 NN on this NN or VB NN JJ 1-888-699-NEWS . VB up for our JJ NN RB - VB a JJ NN RB for VBG up !"
267,1097,conspiracy,"‘_`` There_EX is_VBZ a_DT cure_NN ’_'' :_: California_NNP biotech_NN company_NN claims_VBZ it_PRP has_VBZ discovered_VBN an_DT antibody_NN that_WDT can_MD block_VB ‘_`` 100_CD %_NN ’_'' of_IN coronavirus_NN infections_NNS Scientists_NNS at_IN a_DT California_NNP biotech_NN company_NN have_VBP found_VBN an_DT antibody_NN that_WDT completely_RB blocks_VBZ coronavirus_NN in_IN a_DT discovery_NN they_PRP called_VBD a_DT ‘_`` cure_NN ,_, ’_'' Fox_NNP News_NNP reported_VBD ._. Sorrento_NNP Therapeutics_NNP ,_, based_VBN in_IN San_NNP Diego_NNP ,_, claims_VBZ its_PRP$ STI_NN -_HYPH 1499_CD antibody_NN stopped_VBD coronavirus_NN from_IN entering_VBG 100_CD percent_NN of_IN healthy_JJ human_JJ cells_NNS in_IN petri_JJ dish_NN experiments_NNS ._. It_PRP ’s_VBZ one_CD of_IN several_JJ antibodies_NNS planned_VBN to_TO be_VB combined_VBN for_IN a_DT drug_NN ‘_`` cocktail_NN ’_'' Sorrento_NNP is_VBZ developing_VBG in_IN collaboration_NN with_IN Mt_NNP Sinai_NNP School_NNP of_IN Medicine_NNP in_IN New_NNP York_NNP ._. In_IN a_DT press_NN release_NN ,_, Sorrento_NNP said_VBD it_PRP could_MD produce_VB up_IN to_IN 200,000_CD doses_NNS of_IN the_DT antibody_NN a_DT month_NN –_: a_DT production_NN timeline_NN that_WDT would_MD likely_RB make_VB the_DT drug_NN available_JJ months_NNS sooner_RBR than_IN a_DT COVID_NN -_HYPH 19_CD vaccine_NN is_VBZ expected_VBN ._. The_DT company_NN has_VBZ filed_VBN for_IN emergency_NN approval_NN from_IN the_DT US_NNP Food_NNP and_CC Drug_NNP Administration_NNP (_-LRB- FDA_NNP )_-RRB- ,_, but_CC has_VBZ not_RB yet_RB received_VBN the_DT green_JJ light_NN ._. Stocks_NNS for_IN Sorrento_NNP soared_VBD by_IN nearly_RB 220_CD percent_NN on_IN the_DT heels_NNS of_IN the_DT announcement_NN ._. This_DT article_NN was_VBD posted_VBN :_: Saturday_NNP ,_, May_NNP 16_CD ,_, 2020_CD at_IN 5:59_CD am_NN","‘ There VBZ a NN ’ : NNP NN NN VBZ it VBZ VBN an NN that can VB ‘ 100 NN ’ of NN NNS NNS at a NNP NN NN VBP VBN an NN that RB VBZ NN in a NN they VBD a ‘ NN , ’ NNP NNP VBD . NNP NNP , VBN in NNP NNP , VBZ its NN - 1499 NN VBD NN from VBG 100 NN of JJ JJ NNS in JJ NN NNS . It VBZ one of JJ NNS VBN to VB VBN for a NN ‘ NN ’ NNP VBZ VBG in NN with NNP NNP NNP of NNP in NNP NNP . In a NN NN , NNP VBD it could VB up to 200,000 NNS of the NN a NN – a NN NN that would RB VB the NN JJ NNS RBR than a NN - 19 NN VBZ VBN . The NN VBZ VBN for NN NN from the NNP NNP and NNP NNP ( NNP ) , but VBZ RB RB VBN the JJ NN . NNS for NNP VBD by RB 220 NN on the NNS of the NN . This NN VBD VBN : NNP , NNP 16 , 2020 at 5:59 NN"
268,624,conspiracy,"Autism_NN is_VBZ on_IN the_DT rise_NN and_CC the_DT statistics_NNS are_VBP skyrocketing_VBG ._. Back_RB in_IN 1990_CD ,_, less_JJR than_IN 30_CD years_NNS ago_RB ,_, studies_NNS reveal_VBP there_EX were_VBD roughly_RB three_CD autism_NN cases_NNS per_IN 10,000_CD children_NNS in_IN the_DT United_NNP States_NNPS ._. Fast_RB forward_VB to_IN this_DT past_JJ Spring_NN ,_, 2018_CD ,_, when_WRB the_DT CDC_NNP released_VBD new_JJ data_NNS revealing_VBG that_IN one_CD in_IN every_DT 59_CD American_JJ kids_NNS have_VBP some_DT form_NN of_IN Autism_NNP Spectrum_NNP Disorder_NN (_-LRB- ASD_NNP )_-RRB- ,_, with_IN a_DT much_RB higher_JJR incident_NN in_IN boys_NNS than_IN girls_NNS ._. What_WP changed_VBD so_RB drastically_RB in_IN less_JJR than_IN three_CD decades_NNS that_IN autism_NN cases_NNS went_VBD from_IN three_CD per_IN 10,000_CD to_IN 170_CD per_IN 10,000_CD ?_. Currently_RB more_JJR than_IN 20_CD million_CD people_NNS worldwide_RB are_VBP diagnosed_VBN with_IN some_DT form_NN of_IN autism_NN ._. Let_VB ’s_PRP take_VB a_DT super_RB close_JJ look_NN at_IN possible_JJ factors_NNS and_CC eliminate_VB the_DT “_`` smoke_NN and_CC mirrors_NNS ”_'' created_VBN to_TO distract_VB us_PRP from_IN unmasking_VBG the_DT truth_NN about_IN autism_NN spectrum_NN disorder_NN ,_, a_DT conundrum_NN wrapped_VBN inside_IN a_DT paradox_NN and_CC lost_VBN in_IN a_DT labyrinth_NN that_WDT medical_JJ doctors_NNS are_VBP n’t_RB allowed_VBN to_TO question_VB or_CC solve_VB ,_, only_RB medicate_VB with_IN chemicals_NNS that_WDT add_VBP to_IN the_DT issues_NNS ._. First_JJ things_NNS first_RB ,_, no_DT child_NN has_VBZ ever_RB been_VBN reported_VBN born_VBN with_IN autism_NN spectrum_NN disorder_NN ,_, so_RB the_DT “_`` inherited_VBN ”_'' genetics_NN theory_NN should_MD be_VB tossed_VBN out_RP the_DT window_NN immediately_RB ._. Medical_JJ doctors_NNS love_VBP to_TO blame_VB parental_JJ genes_NNS so_IN you_PRP wo_MD n’t_RB look_VB for_IN a_DT cure_NN ,_, and_CC so_RB you_PRP will_MD accept_VB the_DT condition_NN as_IN something_NN permanent_JJ ,_, requiring_VBG chemical_JJ medications_NNS for_IN life_NN ._. Autism_NN signs_NNS and_CC symptoms_NNS emerge_VBP between_IN 12_CD and_CC 18_CD months_NNS of_IN age_NN ,_, and_CC issues_NNS with_IN brain_NN development_NN often_RB increase_VBP during_IN the_DT second_JJ year_NN of_IN life_NN ,_, when_WRB symptoms_NNS and_CC functional_JJ difficulties_NNS begin_VBP to_TO include_VB speech_NN delay_NN ,_, problems_NNS paying_VBG attention_NN ,_, inappropriate_JJ social_JJ interaction_NN ,_, repetitive_JJ movements_NNS ,_, tics_NNS ,_, anxiety_NN ,_, and_CC compulsive_JJ behaviors_NNS ._. Most_JJS neurological_JJ afflictions_NNS arise_VBP from_IN an_DT overload_NN of_IN toxins_NNS in_IN the_DT body_NN Our_PRP$ cleansing_NN organs_NNS have_VBP a_DT very_RB tough_JJ job_NN :_: filter_VB out_RP all_PDT the_DT toxins_NNS we_PRP consume_VBP ,_, including_VBG those_DT we_PRP eat_VBP ,_, drink_VBP ,_, breathe_VBP in_RP ,_, put_VBP on_IN our_PRP$ skin_NN ,_, hair_NN and_CC nails_NNS ,_, and_CC those_DT that_WDT are_VBP injected_VBN into_IN our_PRP$ muscle_NN tissue_NN ._. But_CC how_WRB can_MD our_PRP$ kidneys_NNS ,_, liver_NN ,_, and_CC pancreas_NN do_VB their_PRP$ filtration_NN jobs_NNS if_IN they_PRP are_VBP completely_RB overwhelmed_VBN ,_, confused_JJ ,_, and_CC constantly_RB barraged_VBN with_IN parasites_NNS ,_, pathogens_NNS ,_, heavy_JJ metal_NN toxins_NNS ,_, and_CC genetically_RB mutated_VBN organisms_NNS from_IN other_JJ animals_NNS ?_. Let_VB ’s_PRP face_VB it_PRP ,_, the_DT past_JJ thirty_CD years_NNS have_VBP changed_VBN drastically_RB for_IN Americans_NNPS ,_, including_VBG the_DT invasion_NN of_IN GMOs_NNS in_IN food_NN and_CC medicine_NN ,_, pharmaceutical_JJ drugs_NNS including_VBG opiates_NNS ,_, and_CC a_DT CDC_NNP -_HYPH recommended_VBN schedule_NN of_IN 55_CD vaccines_NNS before_IN age_NN seven_CD ._. Wow_UH ._. According_VBG to_IN TruthWiki_NNP ,_, Autism_NNP Spectrum_NNP Disorder_NNP is_VBZ a_DT broad_JJ umbrella_NN term_NN for_IN Autism_NN ,_, Asperger_NNP (_-LRB- or_CC Asperger_NNP ’s_POS )_-RRB- syndrome_NN ,_, and_CC any_DT other_JJ pervasive_JJ developmental_JJ ,_, cognitive_JJ ,_, behavioral_JJ ,_, social_JJ communication_NN or_CC language_NN disorder_NN ._. Autism_NN occurs_VBZ when_WRB nerve_NN cells_NNS and_CC synapses_NNS in_IN the_DT brain_NN are_VBP altered_VBN ,_, blocked_VBN ,_, disrupted_VBN and_CC disturbed_VBN ._. So_RB the_DT question_NN resides_VBZ :_: How_WRB do_VBP the_DT brain_NN and_CC central_JJ nervous_JJ system_NN become_VB so_RB violently_RB disturbed_VBN after_IN birth_NN ?_. Could_MD it_PRP be_VB all_DT of_IN that_DT vaccine_NN violence_NN ?_. The_DT ASD_NN spike_NN perfectly_RB coincides_VBZ with_IN the_DT vaccine_NN schedule_NN increase_NN and_CC the_DT rise_NN of_IN genetically_RB modified_VBN organisms_NNS in_IN food_NN ,_, which_WDT both_DT catapulted_VBD in_IN the_DT early_JJ 1990s_NNS ._. Go_VB figure_NN ._. Though_IN the_DT CDC_NNP lies_VBZ and_CC swears_VBZ that_IN mercury_NN has_VBZ been_VBN removed_VBN from_IN all_DT childhood_NN vaccines_NNS ,_, the_DT flu_NN shot_NN is_VBZ over_RB -_HYPH loaded_VBN with_IN mercury_NN and_CC the_DT CDC_NNP recommends_VBZ the_DT influenza_NN vaccine_NN to_IN ALL_DT pregnant_JJ women_NNS and_CC all_DT infants_NNS at_IN 6_CD months_NNS of_IN age_NN ._. Wait_VB ,_, what_WP ?_. Mercury_NNP is_VBZ the_DT second_RB most_RBS poisonous_JJ element_NN known_VBN to_IN mankind_NN ,_, second_RB only_RB to_IN uranium_NN ._. It_PRP is_VBZ a_DT scientific_JJ FACT_NN that_IN human_JJ brain_NN neurons_NNS permanently_RB disintegrate_VBP in_IN the_DT presence_NN of_IN mercury_NN within_IN one_CD hour_NN of_IN exposure_NN ._. Here_RB comes_VBZ the_DT rub_NN ._. Thimerosal_NNP is_VBZ a_DT mercury_NN -_HYPH containing_VBG preservative_NN (_-LRB- about_RB 50_CD percent_NN mercury_NN )_-RRB- and_CC the_DT World_NNP Health_NNP Organization_NNP warned_VBD about_IN its_PRP$ use_NN in_IN vaccines_NNS way_RB back_RB in_IN 1990_CD ._. Plus_CC ,_, mercury_NN ,_, an_DT unstable_JJ metal_NN ,_, is_VBZ a_DT cumulative_JJ poison_NN ,_, meaning_VBG the_DT body_NN has_VBZ difficulty_NN removing_VBG it_PRP and_CC it_PRP accumulates_VBZ significantly_RB over_IN time_NN ._. Does_VBZ any_DT pediatrician_NN in_IN America_NNP ever_RB recommend_VB testing_VBG infants_NNS for_IN heavy_JJ metal_NN poisoning_NN ?_. Nope_UH ._. Does_VBZ any_DT pediatrician_NN or_CC nurse_NN in_IN America_NNP read_VB the_DT vaccine_NN insert_NN and_CC ingredients_NNS word_NN for_IN word_NN to_IN their_PRP$ patients_NNS and_CC parents_NNS of_IN newborns_NNS ?_. Nope_UH ._. Horrific_JJ fact_NN :_: Some_DT infants_NNS receive_VBP more_JJR mercury_NN in_IN one_CD day_NN than_IN the_DT World_NNP Health_NNP Organization_NNP (_-LRB- WHO_NNP )_-RRB- recommends_VBZ as_IN a_DT maximum_NN for_IN adults_NNS for_IN three_CD months_NNS worth_NN of_IN exposure_NN ._. Still_RB ,_, the_DT maximum_JJ amount_NN of_IN mercury_NN for_IN any_DT human_NN to_TO ingest_VB should_MD actually_RB be_VB zero_CD ._. There_EX is_VBZ no_DT safe_JJ amount_NN of_IN mercury_NN for_IN the_DT human_JJ body_NN ,_, and_CC to_TO suggest_VB that_IN there_EX is_VBZ would_MD be_VB like_IN setting_VBG a_DT maximum_JJ amount_NN of_IN uranium_NN intake_NN ,_, or_CC plutonium_NN ,_, or_CC cesium_NN 137_CD (_-LRB- radio_NN cesium_NN )_-RRB- ,_, for_IN that_DT matter_NN ._. We_PRP do_VBP n’t_RB even_RB have_VB time_NN to_TO talk_VB about_IN amalgam_NN (_-LRB- mercury_NN -_HYPH loaded_VBN )_-RRB- dental_JJ fillings_NNS right_RB now_RB ._. Vaccine_NN Spectrum_NN Disorder_NN is_VBZ reversible_JJ –_: Involves_VBZ detoxification_NN of_IN heavy_JJ metal_NN toxins_NNS ,_, pesticides_NNS ,_, and_CC GMOs_NNS Is_VBZ your_PRP$ child_NN ,_, brother_NN ,_, aunt_NN ,_, uncle_NN ,_, sister_NN ,_, mother_NN or_CC father_NN suffering_VBG from_IN VSD_NN right_RB now_RB ?_. Maybe_RB their_PRP$ central_JJ nervous_JJ system_NN ,_, brain_NN ,_, gut_NN ,_, and_CC cleansing_NN organs_NNS are_VBP polluted_VBN with_IN mercury_NN ,_, embalming_NN fluid_NN (_-LRB- formaldehyde_NN )_-RRB- ,_, aluminum_NN ,_, lead_NN ,_, pesticides_NNS ,_, herbicides_NNS ,_, fluoride_NN ,_, and_CC GMOs_NNS ._. How_WRB many_JJ kids_NNS with_IN autism_NN now_RB will_MD suffer_VB from_IN dementia_NN later_RBR in_IN life_NN ?_. There_EX ’s_VBZ a_DT statistic_NN we_PRP need_VBP to_TO know_VB ._. It_PRP ’s_VBZ time_NN to_TO question_VB why_WRB Vaccine_NNP Spectrum_NNP Disorder_NNP barely_RB existed_VBD before_IN the_DT 1990s_NNS ._. Before_IN the_DT 1990s_NNS ,_, American_JJ staple_NN foods_NNS like_IN corn_NN and_CC soy_NN were_VBD n’t_RB infested_VBN with_IN pesticide_NN genes_NNS and_CC coated_VBN with_IN glyphosate_NN (_-LRB- Roundup_NN )_-RRB- ._. Humans_NNS were_VBD n’t_RB using_VBG microwave_NN ovens_NNS to_TO nuke_VB their_PRP$ food_NN ,_, and_CC cancer_NN -_HYPH causing_VBG artificial_JJ sweeteners_NNS were_VBD n’t_RB in_IN everything_NN labeled_VBN “_`` diet_NN ”_'' and_CC “_`` zero_CD ._. ”_'' Today_NN ’s_POS newborns_NNS ,_, infants_NNS ,_, toddlers_NNS and_CC children_NNS are_VBP inundated_VBN with_IN toxic_JJ food_NN colorings_NNS ,_, deadly_JJ flu_NN shots_NNS and_CC unnecessary_JJ booster_NN vaccines_NNS ._. Look_VB into_IN natural_JJ foods_NNS that_WDT pull_VBP heavy_JJ metal_NN toxins_NNS out_IN of_IN the_DT body_NN ,_, like_IN chia_NN seeds_NNS ,_, cilantro_NN ,_, and_CC chlorella_NN ._. Chlorella_NNP is_VBZ an_DT amazing_JJ microalgae_NN superfood_NN and_CC detoxifier_NN commonly_RB used_VBN for_IN colon_NN cleansing_NN because_IN it_PRP binds_VBZ to_IN heavy_JJ metals_NNS and_CC other_JJ toxic_JJ substances_NNS and_CC removes_VBZ them_PRP from_IN the_DT body_NN safely_RB and_CC naturally_RB ._. Plus_CC ,_, probiotics_NNS also_RB remove_VBP heavy_JJ metal_NN toxins_NNS naturally_RB —_: read_VB more_RBR recent_JJ research_NN to_TO find_VB out_RP ._. TRUE_JJ stories_NNS of_IN recovery_NN from_IN Autism_NN ,_, plus_CC significant_JJ injury_NN settlements_NNS from_IN vaccine_NN damages_NNS Feeling_VBG helpless_JJ after_IN leaving_VBG some_DT allopathic_JJ doctor_NN ’s_POS office_NN ?_. You_PRP ’re_VBP not_RB alone_JJ ._. It_PRP ’s_VBZ time_NN to_TO visit_VB a_DT complementary_JJ and_CC alternative_JJ medicine_NN physician_NN ._. These_DT are_VBP doctors_NNS who_WP investigate_VBP the_DT causes_NNS of_IN disease_NN and_CC disorder_NN ,_, then_RB eradicate_VBP them_PRP ,_, instead_RB of_IN simply_RB medicating_VBG the_DT symptoms_NNS with_IN chemicals_NNS ._. Could_MD autism_NN be_VB a_DT form_NN of_IN chronic_JJ mercury_NN poisoning_NN ?_. The_DT vaccine_NN industry_NN has_VBZ spent_VBN $_$ 3.5_CD billion_CD in_IN private_JJ ,_, secretive_JJ injury_NN settlements_NNS to_TO convince_VB the_DT rest_NN of_IN the_DT country_NN it_PRP ’s_VBZ not_RB ._. Maybe_RB it_PRP ’s_VBZ time_NN to_TO take_VB your_PRP$ loved_VBN one_NN who_WP ’s_VBZ suffering_VBG from_IN VSD_NN to_IN a_DT Naturopathic_JJ doctor_NN who_WP can_MD test_VB their_PRP$ blood_NN and_CC recommend_VB the_DT right_JJ nutrition_NN ,_, detoxification_NN and_CC supplementation_NN regimen_NN right_RB away_RB and_CC from_IN now_RB on_RB ._. Think_VB you_PRP ca_MD n’t_RB afford_VB to_TO go_VB organic_JJ ?_. Maybe_RB you_PRP should_MD sue_VB the_DT vaccine_NN industry_NN ._. Recent_JJ cases_NNS of_IN vaccine_NN injury_NN settlement_NN are_VBP published_VBN and_CC you_PRP may_MD need_VB an_DT attorney_NN to_TO help_VB you_PRP fight_VB the_DT secretive_JJ vaccine_NN court_NN ._. Here_RB are_VBP some_DT attorneys_NNS in_IN New_NNP York_NNP that_WDT have_VBP won_VBN millions_NNS of_IN dollars_NNS for_IN parents_NNS whose_WP$ kids_NNS are_VBP suffering_VBG from_IN VSD_NN ._.","NN VBZ on the NN and the NNS VBP VBG . RB in 1990 , JJR than 30 NNS RB , NNS VBP there VBD RB three NN NNS per 10,000 NNS in the NNP NNPS . RB VB to this JJ NN , 2018 , when the NNP VBD JJ NNS VBG that one in every 59 JJ NNS VBP some NN of NNP NNP NN ( NNP ) , with a RB JJR NN in NNS than NNS . What VBD RB RB in JJR than three NNS that NN NNS VBD from three per 10,000 to 170 per 10,000 ? RB JJR than 20 million NNS RB VBP VBN with some NN of NN . VB ’s VB a RB JJ NN at JJ NNS and VB the “ NN and NNS ” VBN to VB us from VBG the NN about NN NN NN , a NN VBN inside a NN and VBN in a NN that JJ NNS VBP RB VBN to VB or VB , RB VB with NNS that VBP to the NNS . JJ NNS RB , no NN VBZ RB VBN VBN VBN with NN NN NN , RB the “ VBN ” NN NN should VB VBN out the NN RB . JJ NNS VBP to VB JJ NNS so you wo RB VB for a NN , and RB you will VB the NN as NN JJ , VBG JJ NNS for NN . NN NNS and NNS VBP between 12 and 18 NNS of NN , and NNS with NN NN RB VBP during the JJ NN of NN , when NNS and JJ NNS VBP to VB NN NN , NNS VBG NN , JJ JJ NN , JJ NNS , NNS , NN , and JJ NNS . JJS JJ NNS VBP from an NN of NNS in the NN Our NN NNS VBP a RB JJ NN : VB out all the NNS we VBP , VBG those we VBP , VBP , VBP in , VBP on our NN , NN and NNS , and those that VBP VBN into our NN NN . But how can our NNS , NN , and NN VB their NN NNS if they VBP RB VBN , JJ , and RB VBN with NNS , NNS , JJ NN NNS , and RB VBN NNS from JJ NNS ? VB ’s VB it , the JJ thirty NNS VBP VBN RB for NNPS , VBG the NN of NNS in NN and NN , JJ NNS VBG NNS , and a NNP - VBN NN of 55 NNS before NN seven . Wow . VBG to NNP , NNP NNP NNP VBZ a JJ NN NN for NN , NNP ( or NNP ’s ) NN , and any JJ JJ JJ , JJ , JJ , JJ NN or NN NN . NN VBZ when NN NNS and NNS in the NN VBP VBN , VBN , VBN and VBN . RB the NN VBZ : How VBP the NN and JJ JJ NN VB RB RB VBN after NN ? Could it VB all of that NN NN ? The NN NN RB VBZ with the NN NN NN and the NN of RB VBN NNS in NN , which both VBD in the JJ NNS . VB NN . Though the NNP VBZ and VBZ that NN VBZ VBN VBN from all NN NNS , the NN NN VBZ RB - VBN with NN and the NNP VBZ the NN NN to ALL JJ NNS and all NNS at 6 NNS of NN . VB , what ? NNP VBZ the RB RBS JJ NN VBN to NN , RB RB to NN . It VBZ a JJ NN that JJ NN NNS RB VBP in the NN of NN within one NN of NN . RB VBZ the NN . NNP VBZ a NN - VBG NN ( RB 50 NN NN ) and the NNP NNP NNP VBD about its NN in NNS RB RB in 1990 . Plus , NN , an JJ NN , VBZ a JJ NN , VBG the NN VBZ NN VBG it and it VBZ RB over NN . VBZ any NN in NNP RB VB VBG NNS for JJ NN NN ? Nope . VBZ any NN or NN in NNP VB the NN NN and NNS NN for NN to their NNS and NNS of NNS ? Nope . JJ NN : Some NNS VBP JJR NN in one NN than the NNP NNP NNP ( NNP ) VBZ as a NN for NNS for three NNS NN of NN . RB , the JJ NN of NN for any NN to VB should RB VB zero . There VBZ no JJ NN of NN for the JJ NN , and to VB that there VBZ would VB like VBG a JJ NN of NN NN , or NN , or NN 137 ( NN NN ) , for that NN . We VBP RB RB VB NN to VB about NN ( NN - VBN ) JJ NNS RB RB . NN NN NN VBZ JJ – VBZ NN of JJ NN NNS , NNS , and NNS VBZ your NN , NN , NN , NN , NN , NN or NN VBG from NN RB RB ? RB their JJ JJ NN , NN , NN , and NN NNS VBP VBN with NN , NN NN ( NN ) , NN , NN , NNS , NNS , NN , and NNS . How JJ NNS with NN RB will VB from NN RBR in NN ? There VBZ a NN we VBP to VB . It VBZ NN to VB why NNP NNP NNP RB VBD before the NNS . Before the NNS , JJ NN NNS like NN and NN VBD RB VBN with NN NNS and VBN with NN ( NN ) . NNS VBD RB VBG NN NNS to VB their NN , and NN - VBG JJ NNS VBD RB in NN VBN “ NN ” and “ zero . ” NN ’s NNS , NNS , NNS and NNS VBP VBN with JJ NN NNS , JJ NN NNS and JJ NN NNS . VB into JJ NNS that VBP JJ NN NNS out of the NN , like NN NNS , NN , and NN . NNP VBZ an JJ NN NN and NN RB VBN for NN NN because it VBZ to JJ NNS and JJ JJ NNS and VBZ them from the NN RB and RB . Plus , NNS RB VBP JJ NN NNS RB — VB RBR JJ NN to VB out . JJ NNS of NN from NN , plus JJ NN NNS from NN NNS VBG JJ after VBG some JJ NN ’s NN ? You VBP RB JJ . It VBZ NN to VB a JJ and JJ NN NN . These VBP NNS who VBP the NNS of NN and NN , RB VBP them , RB of RB VBG the NNS with NNS . Could NN VB a NN of JJ NN NN ? The NN NN VBZ VBN $ 3.5 billion in JJ , JJ NN NNS to VB the NN of the NN it VBZ RB . RB it VBZ NN to VB your VBN NN who VBZ VBG from NN to a JJ NN who can VB their NN and VB the JJ NN , NN and NN NN RB RB and from RB RB . VB you ca RB VB to VB JJ ? RB you should VB the NN NN . JJ NNS of NN NN NN VBP VBN and you may VB an NN to VB you VB the JJ NN NN . RB VBP some NNS in NNP NNP that VBP VBN NNS of NNS for NNS whose NNS VBP VBG from NN ."
269,14,mainstream,"WASHINGTON_NNP (_-LRB- AP_NN )_-RRB- —_: America_NNP faces_VBZ the_DT “_`` darkest_JJS winter_NN in_IN modern_JJ history_NN ”_'' unless_IN leaders_NNS act_VBP decisively_RB to_TO prevent_VB a_DT rebound_NN of_IN the_DT coronavirus_NN ,_, says_VBZ a_DT government_NN whistleblower_NN who_WP alleges_VBZ he_PRP was_VBD ousted_VBN from_IN his_PRP$ job_NN after_IN warning_VBG the_DT Trump_NNP administration_NN to_TO prepare_VB for_IN the_DT pandemic_NN ._. Immunologist_NN Dr._NNP Rick_NNP Bright_NNP ,_, wearing_VBG a_DT protective_JJ mask_NN ,_, testified_VBD Thursday_NNP before_IN the_DT House_NNP Energy_NNP and_CC Commerce_NNP Committee_NNP ._. Aspects_NNS of_IN his_PRP$ complaint_NN about_IN early_JJ administration_NN handling_NN of_IN the_DT crisis_NN were_VBD expected_VBN to_TO be_VB backed_VBN up_RP by_IN testimony_NN from_IN an_DT executive_NN of_IN a_DT company_NN that_WDT manufactures_VBZ respirator_NN masks_NNS ._. A_DT federal_JJ watchdog_NN agency_NN has_VBZ found_VBN “_`` reasonable_JJ grounds_NNS ”_'' that_IN Bright_NNP was_VBD removed_VBN from_IN his_PRP$ post_NN as_IN head_NN of_IN the_DT Biomedical_NNP Advanced_NNP Research_NNP and_CC Development_NNP Authority_NNP after_IN sounding_VBG the_DT alarm_NN at_IN the_DT Department_NNP of_IN Health_NNP and_CC Human_NNP Services_NNPS ._. Bright_NNP alleged_VBD he_PRP became_VBD a_DT target_NN of_IN criticism_NN when_WRB he_PRP urged_VBD early_JJ efforts_NNS to_TO invest_VB in_IN vaccine_NN development_NN and_CC stock_VB up_RP on_IN supplies_NNS ._. “_`` Our_PRP$ window_NN of_IN opportunity_NN is_VBZ closing_VBG ,_, ”_'' Bright_NNP said_VBD in_IN his_PRP$ prepared_VBN testimony_NN ._. “_`` If_IN we_PRP fail_VBP to_TO develop_VB a_DT national_JJ coordinated_VBN response_NN ,_, based_VBN in_IN science_NN ,_, I_PRP fear_VBP the_DT pandemic_NN will_MD get_VB far_RB worse_JJR and_CC be_VB prolonged_VBN ,_, causing_VBG unprecedented_JJ illness_NN and_CC fatalities_NNS ._. ”_'' Bright_NNP ’s_POS testimony_NN follows_VBZ this_DT week_NN ’s_POS warning_NN by_IN Dr._NNP Anthony_NNP Fauci_NNP ,_, the_DT government_NN ’s_POS top_JJ infectious_JJ disease_NN expert_NN ,_, that_IN a_DT rushed_VBN lifting_NN of_IN store_NN -_HYPH closing_NN and_CC stay_VB -_HYPH at_IN -_HYPH home_NN restrictions_NNS could_MD “_`` turn_VB back_RP the_DT clock_NN ,_, ”_'' seeding_VBG more_JJR suffering_NN and_CC death_NN and_CC complicating_VBG efforts_NNS to_TO get_VB the_DT economy_NN rolling_VBG again_RB ._. President_NNP Donald_NNP Trump_NNP on_IN Thursday_NNP dismissed_VBD Bright_NNP in_IN a_DT tweet_NN as_IN “_`` a_DT disgruntled_JJ employee_NN ,_, not_RB liked_VBN or_CC respected_VBN by_IN people_NNS I_PRP spoke_VBD to_IN and_CC who_WP ,_, with_IN his_PRP$ attitude_NN ,_, should_MD no_RB longer_RBR be_VB working_VBG for_IN our_PRP$ government_NN !_. ”_'' It_PRP ’s_VBZ a_DT sentiment_NN some_DT of_IN the_DT president_NN ’s_POS political_JJ allies_NNS have_VBP expressed_VBN about_IN Fauci_NNP as_RB well_RB ._. More_JJR than_IN 84,000_CD people_NNS have_VBP died_VBN in_IN the_DT U.S._NNP ,_, representing_VBG more_JJR than_IN one_CD -_HYPH fourth_NN of_IN global_JJ deaths_NNS and_CC the_DT world_NN ’s_POS highest_JJS toll_NN ,_, according_VBG to_IN figures_NNS compiled_VBN by_IN Johns_NNP Hopkins_NNP University_NNP ._. On_IN the_DT planet_NN more_JJR than_IN 4.3_CD million_CD have_VBP been_VBN infected_VBN and_CC about_RB 298,000_CD have_VBP died_VBN ._. Eager_JJ to_TO restart_VB the_DT U.S._NNP economy_NN ,_, Trump_NNP has_VBZ been_VBN urging_VBG states_NNS to_TO lift_VB restrictions_NNS ,_, and_CC many_JJ governors_NNS are_VBP doing_VBG so_RB gradually_RB ,_, though_IN consumers_NNS remain_VBP leery_JJ of_IN going_VBG back_RB to_IN restaurants_NNS ,_, social_JJ events_NNS and_CC sporting_NN competitions_NNS ._. In_IN his_PRP$ prepared_VBN testimony_NN ,_, Bright_NNP said_VBD ,_, “_`` The_DT undeniable_JJ fact_NN is_VBZ there_EX will_MD be_VB a_DT resurgence_NN of_IN (_-LRB- COVID_NN -_SYM 19_CD )_-RRB- this_DT fall_NN ,_, greatly_RB compounding_VBG the_DT challenges_NNS of_IN seasonal_JJ influenza_NN and_CC putting_VBG an_DT unprecedented_JJ strain_NN on_IN our_PRP$ health_NN care_NN system_NN ._. ”_'' “_`` Without_IN clear_JJ planning_NN and_CC implementation_NN of_IN the_DT steps_NNS that_WDT I_PRP and_CC other_JJ experts_NNS have_VBP outlined_VBN ,_, 2020_CD will_MD be_VB darkest_JJS winter_NN in_IN modern_JJ history_NN ,_, ”_'' Bright_NNP said_VBD ._. The_DT vaccine_NN expert_NN told_VBD Rep._NNP Anna_NNP Eshoo_NNP ,_, D_NNP -_HYPH Ct._NNP ,_, a_DT member_NN of_IN the_DT House_NNP Committee_NNP on_IN Energy_NNP and_CC Commerce_NNP ,_, that_IN government_NN officials_NNS “_`` could_MD have_VB done_VBN better_RBR ”_'' to_TO take_VB early_JJ action_NN to_TO address_VB the_DT coronavirus_NN ._. Bright_NNP added_VBD that_IN his_PRP$ efforts_NNS to_TO push_VB more_JJR swift_JJ response_NN were_VBD “_`` not_RB responded_VBN to_IN with_IN action_NN ”_'' and_CC he_PRP was_VBD removed_VBN from_IN key_JJ meetings_NNS on_IN COVID_NNP -_HYPH 19_CD as_IN a_DT result_NN of_IN his_PRP$ urgency_NN ._. As_IN part_NN of_IN his_PRP$ whistleblower_NN complaint_NN ,_, Bright_NNP is_VBZ seeking_VBG to_TO be_VB reinstated_VBN in_IN his_PRP$ old_JJ job_NN ._. HHS_NNP ,_, his_PRP$ employer_NN ,_, says_VBZ it_PRP strongly_RB disagrees_VBZ with_IN his_PRP$ allegations_NNS and_CC that_IN it_PRP reassigned_VBD him_PRP to_IN a_DT high_JJ -_HYPH profile_NN position_NN helping_VBG to_TO lead_VB the_DT development_NN of_IN new_JJ coronavirus_NN tests_NNS at_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ._. BARDA_NNP ,_, the_DT agency_NN Bright_NNP worked_VBD at_IN for_IN 10_CD years_NNS ,_, was_VBD created_VBN to_TO help_VB the_DT government_NN respond_VB to_IN bioterrorism_NN ,_, infectious_JJ diseases_NNS and_CC radiological_JJ attacks_NNS ._. It_PRP focuses_VBZ on_IN developing_VBG and_CC procuring_VBG counter_NN -_HYPH measures_NNS such_JJ as_IN vaccines_NNS and_CC treatments_NNS ._. Prior_JJ to_IN his_PRP$ reassignment_NN Bright_NNP had_VBD received_VBN an_DT “_`` outstanding_JJ ”_'' performance_NN review_NN ._. He_PRP says_VBZ friction_NN with_IN HHS_NNP leaders_NNS escalated_VBD after_IN he_PRP opposed_VBD widespread_JJ use_NN of_IN hydroxychloroquine_NN ,_, a_DT malaria_NN drug_NN that_WDT Trump_NNP touted_VBD without_IN proof_NN as_IN a_DT “_`` game_NN -_HYPH changer_NN ”_'' for_IN treating_VBG COVID_NN -_HYPH 19_CD patients_NNS ._. Subsequent_JJ studies_NNS have_VBP indicated_VBN the_DT drug_NN may_MD do_VB more_JJR harm_NN than_IN good_JJ ._. Bright_NNP was_VBD summarily_RB removed_VBN in_IN late_JJ April_NNP ._. One_CD aspect_NN of_IN Bright_NNP ’s_POS complaint_NN is_VBZ expected_VBN to_TO get_VB backing_NN at_IN Thursday_NNP ’s_POS hearing_NN from_IN an_DT executive_NN of_IN a_DT Texas_NNP company_NN that_WDT manufactures_VBZ N95_NN respirator_NN masks_NNS ._. Michael_NNP Bowen_NNP ,_, executive_JJ vice_NN president_NN of_IN Prestige_NNP Ameritech_NNP ,_, emailed_VBD with_IN Bright_NNP repeatedly_RB starting_VBG in_IN late_JJ January_NNP ._. Bowen_NNP offered_VBD to_TO crank_VB up_RP production_NN lines_NNS that_WDT were_VBD sitting_VBG idle_RB ,_, while_IN warning_VBG that_IN the_DT world_NN supply_NN of_IN masks_NNS was_VBD being_VBG snapped_VBN up_RP by_IN other_JJ countries_NNS ._. Bright_NNP said_VBD in_IN his_PRP$ complaint_NN that_IN it_PRP took_VBD five_CD weeks_NNS to_TO move_VB the_DT federal_JJ bureaucracy_NN ._. In_IN written_VBN testimony_NN to_IN the_DT committee_NN ,_, Bowen_NNP said_VBD Bright_JJ and_CC other_JJ BARDA_NNP directors_NNS he_PRP ’d_VBD worked_VBN with_IN previously_RB all_DT wanted_VBD to_TO address_VB a_DT chronic_JJ problem_NN of_IN not_RB enough_JJ masks_NNS in_IN the_DT government_NN stockpile_NN ,_, “_'' but_CC in_IN my_PRP$ opinion_NN did_VBD n’t_RB have_VB enough_JJ authority_NN ._. ”_'' After_IN the_DT terrorist_NN attacks_NNS of_IN Sept._NNP 11_CD ,_, 2001_CD ,_, America_NNP was_VBD told_VBN that_IN restrictive_JJ “_`` governmental_JJ ‘_`` silos_NNS ’_'' had_VBD been_VBN torn_VBN down_RP …_, so_IN that_IN different_JJ federal_JJ agencies_NNS could_MD work_VB together_RB for_IN national_JJ security_NN ,_, ”_'' Bowen_NNP added_VBD ._. “_`` But_CC I_PRP did_VBD n’t_RB see_VB evidence_NN of_IN that_DT ._. ”_''","NNP ( NN ) — NNP VBZ the “ JJS NN in JJ NN ” unless NNS VBP RB to VB a NN of the NN , VBZ a NN NN who VBZ he VBD VBN from his NN after VBG the NNP NN to VB for the NN . NN NNP NNP NNP , VBG a JJ NN , VBD NNP before the NNP NNP and NNP NNP . NNS of his NN about JJ NN NN of the NN VBD VBN to VB VBN up by NN from an NN of a NN that VBZ NN NNS . A JJ NN NN VBZ VBN “ JJ NNS ” that NNP VBD VBN from his NN as NN of the NNP NNP NNP and NNP NNP after VBG the NN at the NNP of NNP and NNP NNPS . NNP VBD he VBD a NN of NN when he VBD JJ NNS to VB in NN NN and VB up on NNS . “ Our NN of NN VBZ VBG , ” NNP VBD in his VBN NN . “ If we VBP to VB a JJ VBN NN , VBN in NN , I VBP the NN will VB RB JJR and VB VBN , VBG JJ NN and NNS . ” NNP ’s NN VBZ this NN ’s NN by NNP NNP NNP , the NN ’s JJ JJ NN NN , that a VBN NN of NN - NN and VB - at - NN NNS could “ VB back the NN , ” VBG JJR NN and NN and VBG NNS to VB the NN VBG RB . NNP NNP NNP on NNP VBD NNP in a NN as “ a JJ NN , RB VBN or VBN by NNS I VBD to and who , with his NN , should RB RBR VB VBG for our NN ! ” It VBZ a NN some of the NN ’s JJ NNS VBP VBN about NNP RB RB . JJR than 84,000 NNS VBP VBN in the NNP , VBG JJR than one - NN of JJ NNS and the NN ’s JJS NN , VBG to NNS VBN by NNP NNP NNP . On the NN JJR than 4.3 million VBP VBN VBN and RB 298,000 VBP VBN . JJ to VB the NNP NN , NNP VBZ VBN VBG NNS to VB NNS , and JJ NNS VBP VBG RB RB , though NNS VBP JJ of VBG RB to NNS , JJ NNS and NN NNS . In his VBN NN , NNP VBD , “ The JJ NN VBZ there will VB a NN of ( NN - 19 ) this NN , RB VBG the NNS of JJ NN and VBG an JJ NN on our NN NN NN . ” “ Without JJ NN and NN of the NNS that I and JJ NNS VBP VBN , 2020 will VB JJS NN in JJ NN , ” NNP VBD . The NN NN VBD NNP NNP NNP , NNP - NNP , a NN of the NNP NNP on NNP and NNP , that NN NNS “ could VB VBN RBR ” to VB JJ NN to VB the NN . NNP VBD that his NNS to VB JJR JJ NN VBD “ RB VBN to with NN ” and he VBD VBN from JJ NNS on NNP - 19 as a NN of his NN . As NN of his NN NN , NNP VBZ VBG to VB VBN in his JJ NN . NNP , his NN , VBZ it RB VBZ with his NNS and that it VBD him to a JJ - NN NN VBG to VB the NN of JJ NN NNS at the NNP NNPS of NNP . NNP , the NN NNP VBD at for 10 NNS , VBD VBN to VB the NN VB to NN , JJ NNS and JJ NNS . It VBZ on VBG and VBG NN - NNS JJ as NNS and NNS . JJ to his NN NNP VBD VBN an “ JJ ” NN NN . He VBZ NN with NNP NNS VBD after he VBD JJ NN of NN , a NN NN that NNP VBD without NN as a “ NN - NN ” for VBG NN - 19 NNS . JJ NNS VBP VBN the NN may VB JJR NN than JJ . NNP VBD RB VBN in JJ NNP . One NN of NNP ’s NN VBZ VBN to VB NN at NNP ’s NN from an NN of a NNP NN that VBZ NN NN NNS . NNP NNP , JJ NN NN of NNP NNP , VBD with NNP RB VBG in JJ NNP . NNP VBD to VB up NN NNS that VBD VBG RB , while VBG that the NN NN of NNS VBD VBG VBN up by JJ NNS . NNP VBD in his NN that it VBD five NNS to VB the JJ NN . In VBN NN to the NN , NNP VBD JJ and JJ NNP NNS he VBD VBN with RB all VBD to VB a JJ NN of RB JJ NNS in the NN NN , “ but in my NN VBD RB VB JJ NN . ” After the NN NNS of NNP 11 , 2001 , NNP VBD VBN that JJ “ JJ ‘ NNS ’ VBD VBN VBN down … so that JJ JJ NNS could VB RB for JJ NN , ” NNP VBD . “ But I VBD RB VB NN of that . ”"
